Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A3GALT2 "A3GALT2P, IGB3S, IGBS3S" ENSG00000184389 "Alpha 1,3-galactosyltransferase 2" U3KPV4 1 33306766-33321098 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 2.1" "Group enriched" "Detected in some" 4 "HeLa: 5.2;SiHa: 3.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.86e-2)" "unprognostic (2.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (2.61e-3)" "unprognostic (4.96e-2)" "unprognostic (6.83e-2)" "unprognostic (5.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" "unprognostic (4.90e-8)" "unprognostic (1.17e-1)" "unprognostic (1.12e-2)" "unprognostic (7.87e-2)" 0.7 0.1 0.1 1.2 0.2 1.3 0.4 1.3 0.9 0.4 0.2 0.0 0.5 0.0 0.2 0.2 1.4 0.1 0.2 0.1 0.4 0.1 0.5 0.1 0.0 0.4 0.1 0.0 0.4 0.1 0.6 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.8 0.3 2.1 0.4 0.0 0.2 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 5.2 0.0 0.2 0.0 0.0 0.7 0.2 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria NA NA Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.4 0.0 0.0 21.9 17.9 11.2 2.9 3.2 0.6 1.1 2.3 1.2 7.2 5.2 5.2 3.8 0.7 7.1 3.5 0.1 0.0 1.4 0.1 11.8 0.2 6.6 0.0 0.5 10.5 1.0 3.1 0.5 1.0 2.6 0.0 0.0 0.0 2.8 10.1 0.0 0.0 0.9 0.5 1.8 0.0 1.7 0.7 14.8 12.7 0.1 0.0 9.1 0.2 0.0 1.4 5.8 0.8 15.7 0.0 1.4 13.4 3.8 1.5 6.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 0.0 0.3 1.4 28.5 8.1 0.0 14.6 2.5 2.7 9.1 17.4 0.0 36.7 11.6 18.0 0.4 40.9 0.0 23.3 1.0 26.1 24.9 31.4 1.1 0.2 4.8 0.0 0.0 22.1 1.8 1.5 42.8 5.4 6.8 52.3 0.0 0.5 3.7 0.0 28.3 45.6 0.4 38.8 39.6 0.4 0.4 7.8 7.9 1.0 0.0 69.8 AADACL2 MGC72001 ENSG00000197953 "Arylacetamide deacetylase like 2" Q6P093 3 151733916-151761339 "Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "placenta: 8.6;skin 1: 26.1;tongue: 22.2" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "hTCEpi: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.20e-2)" "unprognostic (3.10e-3)" "unprognostic (2.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (3.00e-1)" "unprognostic (2.91e-4)" 1.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.8 0.0 0.7 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.4 0.0 0.2 26.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 22.2 1.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.0 AADACL3 ENSG00000188984 "Arylacetamide deacetylase like 3" Q5VUY0 1 12716115-12728759 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "placenta: 13.4;skin 1: 4.7" "Cell type enhanced" "Detected in single" 35 "Extravillous trophoblasts: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.01e-1)" "unprognostic (2.54e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AAED1 C9orf21 ENSG00000158122 "AhpC/TSA antioxidant enzyme domain containing 1" Q7RTV5 9 96639577-96655303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021294 Approved NA NA "HPA021294: AB_1845818" "unprognostic (4.17e-2)" "unprognostic (1.21e-1)" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (1.85e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (4.83e-2)" "unprognostic (4.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.13e-2)" "unprognostic (1.66e-1)" "unprognostic (8.38e-3)" "unprognostic (3.70e-2)" 27.7 7.4 4.9 7.4 6.3 12.5 20.5 2.6 4.8 11.5 10.5 6.2 3.0 4.6 11.2 11.2 11.6 11.3 11.2 41.9 5.1 4.8 13.7 11.1 13.1 15.8 7.3 3.3 13.9 10.5 4.5 6.0 8.0 5.6 9.9 5.6 9.4 6.0 5.1 26.6 7.0 7.4 14.0 10.0 15.3 8.2 10.7 5.2 2.9 19.1 11.1 7.5 16.3 10.0 6.7 5.4 25.7 7.1 3.6 6.9 1.9 7.1 3.7 1.8 6.4 15.4 26.5 7.3 7.8 12.0 6.8 6.5 8.2 8.1 0.2 6.5 12.8 13.1 6.8 6.3 3.8 4.0 7.0 3.9 4.1 3.3 6.8 11.8 3.2 11.7 12.6 6.7 4.7 6.0 6.7 5.8 2.9 7.9 3.1 6.9 5.0 0.1 5.7 2.5 2.9 7.0 0.1 5.4 0.1 9.4 1.7 2.9 3.7 5.7 5.0 4.2 5.7 1.9 5.9 10.6 11.4 4.7 11.0 5.2 8.2 3.6 2.7 4.9 3.0 10.4 25.7 6.5 13.9 6.8 7.1 6.9 6.7 6.4 6.7 5.4 5.3 3.4 5.7 1.3 3.6 6.3 3.5 6.4 1.9 4.9 6.3 2.6 4.3 5.1 4.8 7.3 3.3 5.6 5.2 20.8 13.7 17.6 56.0 41.3 1.1 17.3 17.8 24.1 11.4 12.2 2.0 13.0 11.6 8.3 31.2 27.2 3.9 0.0 9.9 59.5 20.5 30.3 49.5 8.9 50.9 7.9 47.1 29.4 29.5 40.4 31.9 50.1 59.1 13.6 2.9 5.2 10.9 4.8 14.9 18.3 1.3 12.9 96.7 20.5 8.1 26.2 5.3 15.8 5.8 22.1 AARD "C8orf85, LOC441376" ENSG00000205002 "Alanine and arginine rich domain containing protein" Q4LEZ3 8 116938199-116944487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 18.4;testis: 43.6" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 22.2;granulocytes: 13.9;Spermatocytes: 27.6" "Cancer enriched" "Detected in many" 8 "breast cancer: 27.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 19.8;JURKAT: 6.8;SK-BR-3: 11.2;U-2 OS: 5.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 4 "midbrain: 7.3" HPA068290 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA068290: " "unprognostic (5.81e-2)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" "unprognostic (7.28e-8)" "unprognostic (3.42e-2)" "unprognostic (4.32e-3)" "unprognostic (4.34e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (8.29e-2)" "unprognostic (8.57e-3)" "unprognostic (4.20e-1)" "unprognostic (2.23e-6)" "unprognostic (1.67e-1)" "unprognostic (9.78e-3)" "unprognostic (3.77e-2)" "unprognostic (5.27e-4)" 0.4 0.8 0.7 1.8 1.2 0.3 4.9 0.0 0.9 0.3 4.5 0.0 0.0 0.2 1.1 0.8 8.1 0.2 0.4 0.1 0.5 0.6 1.3 0.1 2.9 1.0 0.4 0.5 0.1 0.1 0.1 0.0 0.6 0.5 8.4 0.7 4.0 2.1 0.2 0.2 1.1 0.8 18.4 0.1 0.3 7.2 43.6 0.1 0.0 0.2 0.2 0.5 10.2 5.6 1.1 1.0 3.3 0.9 1.5 2.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.5 0.0 0.2 0.1 2.3 0.0 0.2 0.4 0.0 0.1 0.1 0.2 0.0 6.8 0.0 2.3 0.1 0.4 0.8 0.1 1.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 1.9 0.3 0.0 11.2 0.0 0.2 0.5 0.0 0.0 0.1 5.5 0.2 0.0 1.6 4.1 0.0 2.9 0.1 0.3 3.3 0.9 0.6 0.6 0.4 0.3 0.6 0.5 0.4 0.2 1.1 0.5 0.6 3.1 1.5 0.6 1.0 2.0 0.1 0.7 1.2 0.0 0.4 0.5 0.6 0.4 0.5 0.5 0.1 11.9 22.2 0.0 0.2 0.7 0.5 0.8 0.0 1.4 9.1 7.0 0.0 0.1 1.7 0.0 7.5 0.0 0.0 0.0 0.0 0.6 0.4 0.8 13.9 0.0 0.0 1.6 0.0 0.0 0.0 7.9 3.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 10.5 0.0 0.0 0.5 27.6 6.0 0.5 0.2 0.0 0.0 0.3 ABCA10 EST698739 ENSG00000154263 "ATP binding cassette subfamily A member 10" Q8WWZ4 17 69147214-69244846 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.6" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 189.3;Late spermatids: 66.1;Leydig cells: 47.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 11 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "ASC diff: 1.7;HSkMC: 3.8;HUVEC TERT2: 3.7;RT4: 3.5;U-2197: 5.5" HPA014535 Uncertain NA NA "HPA014535: AB_1844426" "unprognostic (1.45e-4)" "unprognostic (3.17e-1)" "unprognostic (7.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.52e-2)" "unprognostic (1.17e-2)" "unprognostic (3.78e-2)" "unprognostic (1.40e-1)" "unprognostic (4.51e-3)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (4.91e-1)" "unprognostic (2.70e-4)" "unprognostic (5.23e-3)" "unprognostic (6.98e-2)" "unprognostic (4.37e-2)" "unprognostic (9.86e-3)" 4.6 0.5 0.0 0.0 0.2 0.0 10.4 5.0 0.4 1.6 1.7 0.6 2.7 2.4 1.1 6.3 3.1 2.7 0.1 0.2 0.5 2.7 2.5 0.1 0.1 11.6 1.3 0.1 1.3 0.0 0.8 3.8 2.6 0.2 3.5 4.1 1.4 1.7 0.2 0.3 1.0 1.6 3.1 0.3 1.3 1.9 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 3.8 0.5 0.8 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.9 7.1 2.4 0.0 4.0 0.0 0.0 23.6 0.0 0.0 0.4 189.3 1.7 2.5 0.0 0.2 0.0 3.8 0.3 0.0 1.0 0.1 0.0 4.7 0.6 0.0 66.1 47.2 0.9 1.7 2.8 2.9 3.1 0.6 0.0 11.0 0.3 7.6 0.0 1.4 7.7 2.8 0.4 0.0 0.0 0.5 0.5 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022032: AB_1844427, HPA062904: AB_2732692" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favorable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.5 7.9 5.7 0.5 4.5 4.9 4.7 7.0 0.6 1.6 0.0 2.4 3.9 3.7 6.4 1.0 3.7 5.3 0.1 3.0 0.0 4.8 3.0 10.5 0.0 2.7 5.6 4.6 2.0 5.4 1.0 10.2 1.6 0.0 1.7 0.4 3.7 2.6 0.0 1.6 1.6 3.0 0.3 0.1 0.4 0.9 7.2 8.9 1.4 16.1 7.4 4.6 1.5 7.6 2.7 7.4 5.3 1.5 4.9 0.9 9.2 0.2 0.3 2.2 0.0 4.8 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 17.9 16.9 10.2 30.0 58.2 127.4 22.1 28.1 49.5 14.8 36.6 110.0 11.6 5.0 9.2 14.9 17.1 72.6 0.0 8.6 4.9 18.8 32.6 13.9 89.4 6.2 100.1 108.2 18.4 4.8 9.5 59.0 8.9 96.2 47.7 65.8 49.9 12.8 38.6 43.2 10.2 117.6 90.5 24.0 103.0 47.0 46.9 19.8 13.8 26.6 34.4 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872160-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;retina: 10.0;skin 1: 21.6" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 136.7" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.3;neutrophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9" "Region enriched" "Detected in single" 5 "thalamus: 2.3" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 1.1 0.2 2.4 0.4 10.0 2.4 2.8 0.3 5.2 0.2 1.5 5.4 0.3 0.2 0.8 0.4 0.7 2.0 0.4 0.5 1.4 1.2 0.6 0.2 0.8 0.4 2.2 2.7 0.3 1.1 1.3 0.3 0.4 2.2 0.3 2.4 10.0 0.2 0.2 0.2 21.6 0.3 0.2 0.7 0.2 0.2 1.2 3.9 0.0 0.4 0.0 0.3 0.2 0.2 0.0 0.1 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.5 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.9 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 2.4 10.0 0.3 5.2 1.4 1.2 2.2 2.7 2.2 3.9 0.0 0.0 0.0 0.0 0.3 3.3 1.4 0.0 14.7 0.0 1.8 2.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 1.1 0.0 0.0 0.0 0.9 136.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.2 1.3 0.2 0.0 1.6 0.1 ABHD13 "bA153I24.2, BEM46L1, C13orf6, FLJ14906" ENSG00000139826 "Abhydrolase domain containing 13" Q7L211 13 108218379-108234255 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032143, HPA032144" Approved Approved Cytosol NA NA Cytosol "HPA032143: AB_2674178, HPA032144: AB_10602304" "unprognostic (2.69e-1)" "unprognostic (2.81e-1)" "unprognostic (1.36e-2)" "unprognostic (2.91e-2)" "unprognostic (8.36e-2)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.63e-1)" "unprognostic (8.75e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (6.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (1.14e-1)" "unprognostic (5.62e-2)" 13.6 12.5 13.8 14.3 14.2 26.7 14.9 17.0 15.5 13.6 17.0 6.8 14.5 13.8 16.3 21.0 15.2 13.5 13.8 12.9 11.7 10.4 12.5 20.1 15.4 14.8 10.1 10.4 13.2 12.4 9.6 14.1 16.5 11.1 13.0 15.0 10.5 14.7 18.1 12.9 12.7 16.7 13.7 10.1 20.0 13.9 8.9 8.2 26.4 15.4 11.3 14.5 13.3 18.6 8.5 8.9 19.2 10.4 11.8 11.8 10.1 9.0 3.8 10.2 5.6 8.0 9.5 4.9 9.0 9.1 7.9 9.5 5.8 8.7 7.7 9.5 7.0 7.8 8.3 7.5 10.4 12.7 10.3 6.6 9.4 5.4 5.7 8.0 19.4 11.6 9.7 10.0 6.2 8.1 7.5 9.3 10.7 5.0 4.4 8.1 3.8 9.4 8.2 4.8 13.5 4.5 8.1 7.3 4.5 11.2 8.2 7.7 9.6 4.8 8.0 9.7 9.4 7.4 18.1 9.7 5.7 5.9 6.6 6.0 8.5 6.7 8.4 13.4 12.2 10.2 8.7 10.4 19.2 8.0 9.5 11.8 8.5 10.9 9.5 8.9 8.1 10.5 8.7 11.3 11.8 8.4 6.7 10.2 10.1 13.8 14.2 17.0 15.5 11.7 10.4 10.1 10.4 11.1 8.2 20.8 11.0 23.1 17.8 39.4 12.5 6.1 22.9 8.1 9.1 10.4 0.0 18.2 8.3 16.4 13.8 17.2 11.8 0.0 18.5 12.2 20.3 17.8 13.9 24.5 17.6 17.5 29.3 19.0 17.3 14.3 14.4 18.7 25.3 17.2 11.7 11.8 16.0 11.5 16.3 10.0 11.6 19.4 18.8 12.8 10.9 44.7 17.8 24.5 10.0 19.0 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles NA NA 260000 Vesicles "HPA038153: AB_2675868, HPA056913: AB_2683275" "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favorable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 11.8 28.0 23.3 6.0 25.8 9.0 9.2 39.6 45.0 18.3 7.3 12.2 8.5 8.0 6.9 23.2 5.4 19.6 9.3 16.4 22.3 27.8 26.2 13.0 9.7 8.9 16.6 23.4 14.8 20.6 15.6 21.3 7.0 18.7 11.6 5.6 26.1 17.7 12.5 23.8 3.9 6.6 8.8 14.5 7.7 11.0 6.2 7.0 6.6 24.1 8.4 8.8 9.2 7.4 15.4 13.9 4.5 6.0 12.0 30.9 15.3 2.8 5.4 3.5 10.6 35.3 17.8 1.9 3.8 6.3 4.6 6.2 6.2 11.5 3.2 2.6 9.4 5.2 2.4 3.8 4.2 1.5 10.3 4.3 9.4 16.2 20.5 9.9 12.8 12.6 16.7 2.9 3.9 2.0 10.3 5.9 6.2 3.8 10.9 7.1 3.2 5.9 13.1 2.0 13.5 13.0 4.2 1.8 30.3 8.8 4.4 7.3 11.3 9.5 2.0 5.6 0.8 3.0 14.1 3.4 4.2 4.5 10.0 4.3 15.9 14.8 2.6 7.8 20.6 6.0 2.1 6.0 4.5 30.2 3.5 30.9 15.4 26.7 26.8 10.4 12.4 24.6 26.2 0.6 12.0 2.2 13.9 25.7 15.3 23.3 25.8 39.6 45.0 22.3 27.8 16.6 23.4 18.7 7.0 6.0 17.1 20.4 20.4 8.7 89.3 21.0 15.3 24.1 19.4 31.4 23.6 9.0 28.2 13.8 3.6 14.2 8.5 0.0 10.8 11.5 41.8 21.4 15.0 11.6 25.9 55.6 38.7 17.2 11.8 18.4 81.4 13.0 11.8 4.6 11.8 36.2 13.3 2.9 31.1 69.3 86.1 19.4 11.3 16.9 59.2 4.8 4.1 34.6 14.0 13.2 ABHD18 "C4orf29, FLJ21106" ENSG00000164074 "Abhydrolase domain containing 18" Q0P651 4 127965306-128039927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050168, HPA051676" Approved Approved "Nuclear membrane" "Intracellular and membrane" NA NA "Nuclear membrane" "HPA050168: AB_2681040, HPA051676: AB_2681571" "unprognostic (1.91e-1)" "unprognostic (8.66e-2)" "prognostic favorable (5.35e-4)" "unprognostic (1.74e-2)" "unprognostic (4.99e-2)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (5.60e-2)" "unprognostic (3.34e-1)" "unprognostic (1.14e-2)" "unprognostic (1.76e-3)" "unprognostic (2.17e-3)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" "unprognostic (7.32e-2)" "prognostic favorable (9.13e-4)" 7.6 8.2 7.4 13.2 10.5 9.9 8.4 14.1 7.9 7.1 13.6 8.6 8.3 13.7 9.2 9.8 7.2 7.8 9.6 25.1 7.0 7.5 9.1 15.7 9.2 12.0 7.2 5.2 10.8 24.5 8.0 16.3 7.0 8.4 6.8 10.2 7.5 8.9 11.1 18.7 10.6 19.0 9.8 9.7 10.0 8.2 4.0 8.1 18.2 9.2 10.9 10.5 8.4 7.5 10.2 8.8 14.2 7.1 5.2 8.8 3.5 3.5 2.9 3.7 4.5 2.9 4.1 5.5 3.6 2.9 3.2 4.2 6.8 6.3 9.7 5.9 1.4 2.9 3.5 7.7 4.2 3.5 8.0 2.5 7.1 4.7 5.4 4.1 12.0 9.0 3.4 2.9 3.4 2.2 3.8 5.6 7.4 11.7 7.1 2.9 6.4 15.7 5.7 3.8 7.6 2.9 8.8 1.3 6.2 4.7 3.7 8.5 3.1 3.4 6.1 3.7 5.5 5.2 5.0 4.8 2.0 2.7 5.2 3.4 12.7 12.6 11.5 3.5 13.0 3.3 11.1 7.1 9.5 6.3 5.9 4.6 6.8 8.0 7.3 5.7 10.2 8.7 8.8 14.2 5.2 4.2 8.8 8.2 3.5 7.4 10.5 14.1 7.9 7.0 7.5 7.2 5.2 8.4 8.1 6.0 12.5 5.3 8.0 0.0 13.0 0.0 5.1 6.7 10.3 7.0 19.6 4.5 0.0 4.0 2.8 3.0 8.5 0.0 6.4 3.9 2.1 10.7 1.1 20.2 6.7 17.5 5.8 9.2 17.0 0.9 5.8 10.9 0.0 3.6 11.7 6.5 6.5 3.5 5.3 6.2 17.4 12.9 0.0 5.5 3.6 0.0 7.7 5.0 10.1 7.8 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 114.8;Horizontal cells: 68.3;Late spermatids: 221.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 28.4;U-266/70: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: AB_2683638" "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 5.4 14.7 24.7 6.0 23.6 6.4 3.7 20.3 34.0 4.6 5.4 4.1 6.1 4.6 5.9 3.7 3.9 6.2 5.4 6.8 22.0 17.5 6.1 12.4 7.3 6.5 12.3 17.1 9.3 11.0 11.4 9.1 8.9 9.0 7.9 1.6 8.5 12.6 11.6 11.4 6.8 3.6 4.6 4.6 7.7 6.5 19.6 6.9 4.8 6.6 3.2 3.8 4.8 4.6 1.3 6.0 5.6 4.8 3.2 3.6 1.7 11.4 3.3 1.7 6.7 2.2 0.7 18.1 2.3 3.2 2.5 3.3 2.9 7.9 0.8 3.2 1.8 4.0 1.6 1.6 4.0 0.5 13.5 11.1 3.7 5.0 4.9 7.3 0.2 5.3 2.1 2.5 4.3 0.5 4.0 1.9 6.6 3.3 6.6 1.0 0.6 4.5 0.6 3.2 1.9 28.4 6.8 5.3 3.3 2.2 1.1 2.1 11.3 5.2 1.7 7.2 1.5 7.2 6.6 1.1 2.4 5.2 12.0 4.1 21.7 16.3 4.1 8.0 4.5 2.1 0.1 4.8 5.6 2.5 3.7 1.7 0.7 3.6 2.1 6.0 1.3 2.9 2.6 3.0 3.2 4.0 2.9 2.5 1.7 24.7 23.6 20.3 34.0 22.0 17.5 12.3 17.1 9.0 6.9 0.0 2.2 3.0 4.6 3.4 51.4 1.8 7.6 0.0 3.4 7.0 17.7 15.8 6.6 12.4 114.8 3.6 0.5 0.0 7.5 7.4 7.3 5.2 4.6 12.5 19.9 68.3 6.9 1.8 7.6 221.4 11.5 6.0 1.7 26.2 3.1 27.9 7.4 2.9 24.1 7.8 30.3 6.5 3.5 18.4 1.4 3.6 20.7 3.8 1.4 2.8 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Cell line enhanced" "Detected in some" "Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053618: AB_2682208, HPA054824: AB_2682616" "unprognostic (1.69e-1)" "prognostic favorable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favorable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 18.8 0.3 0.1 0.8 0.0 2.0 0.0 0.4 5.8 10.2 0.0 0.2 0.0 0.4 2.3 6.7 0.2 0.0 0.1 6.7 20.2 0.0 0.0 0.0 0.0 12.6 0.7 0.0 2.5 0.1 0.4 0.1 0.1 0.0 10.8 0.1 0.2 0.2 0.3 0.0 0.0 1.0 0.0 5.9 2.9 20.9 0.1 0.2 2.1 21.0 0.0 0.2 15.4 1.0 4.1 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 29.8 21.1 7.8 15.2 15.1 60.3 21.8 25.5 10.7 17.0 1.8 2.0 1.9 0.0 15.6 33.8 21.5 39.3 0.0 5.5 2.5 13.4 17.6 18.5 0.8 27.7 11.1 14.5 18.4 24.0 112.5 12.7 28.3 18.6 18.0 35.9 29.4 29.8 25.9 8.9 5.8 18.0 38.8 21.7 1.9 7.5 14.8 1.8 13.8 49.9 22.6 ABRA STARS ENSG00000174429 "Actin binding Rho activating protein" Q8N0Z2 8 106759483-106770245 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Actin-binding, Activator" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "heart muscle: 21.6;skeletal muscle: 77.6;tongue: 35.0" "Group enriched" "Detected in some" 23 "Cardiomyocytes: 188.3;Early spermatids: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (9.08e-3)" "unprognostic (1.61e-2)" "unprognostic (3.26e-1)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "unprognostic (2.64e-2)" "unprognostic (1.35e-2)" "unprognostic (6.84e-2)" "unprognostic (2.69e-1)" "unprognostic (2.09e-1)" "unprognostic (2.69e-1)" "unprognostic (1.15e-2)" "unprognostic (4.34e-1)" "unprognostic (6.21e-3)" 1.2 0.2 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.3 0.1 0.0 0.8 0.1 0.6 1.7 2.1 0.2 0.1 21.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.6 0.7 0.1 0.0 2.6 1.6 77.6 0.1 0.1 0.5 0.1 0.1 0.1 0.9 0.0 0.0 2.6 35.0 1.2 0.6 2.2 0.7 0.5 2.6 0.6 0.6 0.5 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.5 0.1 0.4 0.0 0.0 0.7 0.5 0.4 0.1 0.2 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.6 0.2 0.5 0.3 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.5 0.8 0.2 0.0 1.2 0.2 0.6 0.1 0.1 0.1 0.2 0.6 1.3 0.1 0.4 0.0 0.2 0.4 0.1 0.2 0.7 0.5 0.5 2.6 0.6 0.5 0.5 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 4.4 0.9 0.7 0.1 0.0 0.0 0.0 0.0 ABTB2 "ABTB2A, BTBD22, DKFZP586C1619" ENSG00000166016 "Ankyrin repeat and BTB domain containing 2" Q8N961 11 34150988-34358008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 31.6" "Cell type enhanced" "Detected in many" 7 "monocytes: 16.2;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "eosinophil: 8.1;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 8.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020065, HPA030699" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA020065: AB_1844459, HPA030699: AB_2673576" "unprognostic (3.00e-1)" "prognostic unfavorable (5.70e-5)" "unprognostic (2.61e-1)" "unprognostic (9.09e-2)" "unprognostic (3.17e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-3)" "unprognostic (2.86e-1)" "prognostic favorable (3.51e-5)" "unprognostic (1.50e-1)" "unprognostic (1.42e-1)" "unprognostic (3.81e-2)" "unprognostic (6.58e-2)" 3.1 13.7 4.8 2.7 6.7 3.2 2.2 5.0 5.8 8.0 8.5 10.6 18.2 11.7 7.4 6.3 4.4 4.1 3.2 13.0 4.7 3.9 8.4 8.0 2.9 2.7 9.0 1.5 2.8 2.2 0.3 2.8 8.1 15.8 4.5 3.6 7.5 8.7 31.6 19.4 5.6 20.2 3.6 20.2 1.2 3.0 3.1 7.7 6.4 2.1 3.5 2.8 3.4 5.0 0.0 2.8 8.1 0.4 0.0 0.1 0.1 4.0 12.0 4.9 1.3 1.3 0.1 4.9 2.4 1.9 2.1 4.1 2.9 3.0 0.1 4.1 3.0 12.7 7.8 2.7 2.7 1.7 0.1 6.6 0.0 7.1 12.7 0.7 6.4 0.9 0.7 1.5 4.2 1.8 7.8 0.0 0.5 1.3 0.3 1.3 10.1 0.2 7.8 6.1 6.0 6.6 1.2 2.9 4.5 7.6 9.7 6.2 5.1 6.0 18.7 4.7 3.4 4.0 2.8 0.6 2.4 0.4 7.4 4.3 0.7 0.3 0.1 5.5 1.8 7.3 0.0 0.1 8.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.1 0.1 4.8 6.7 5.0 5.6 4.7 3.9 9.0 1.5 15.8 7.7 0.0 2.9 0.8 2.3 4.1 2.8 7.4 5.1 0.0 0.0 12.2 0.0 1.9 5.0 4.5 0.8 0.6 10.3 0.0 3.9 0.9 5.5 5.8 1.1 5.7 0.7 0.0 6.9 0.0 1.0 0.0 1.1 0.8 1.7 16.2 1.6 6.2 7.3 0.8 5.6 1.1 0.3 0.0 3.3 0.5 0.6 4.3 23.7 0.0 1.3 6.0 AC008560.1 ENSG00000253251 "Uncharacterized protein FLJ26957 " Q6ZNX1 5 65624765-65630891 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 2.3;Cytotrophoblasts: 3.3;Extravillous trophoblasts: 3.7;Hofbauer cells: 3.1;Syncytiotrophoblasts: 4.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 5.8 7.1 7.3 6.5 13.1 31.5 10.0 8.7 13.3 5.4 6.6 7.1 5.5 7.0 5.9 7.4 6.3 5.3 6.1 4.9 8.2 7.9 11.6 9.7 6.2 9.9 9.9 8.0 5.9 8.7 3.8 13.1 6.5 11.3 10.7 7.6 5.7 6.4 6.6 6.6 7.0 7.6 7.8 9.1 8.9 6.0 7.5 8.6 10.4 6.9 6.4 8.3 5.3 5.0 5.0 4.4 13.4 4.1 6.3 8.8 2.9 2.7 3.7 5.7 11.9 3.3 3.8 6.8 4.3 3.8 6.0 7.7 6.4 8.7 5.0 4.9 5.0 7.1 3.6 5.5 5.2 9.2 6.7 6.9 4.6 9.6 8.5 2.6 5.0 7.9 2.3 7.3 6.4 6.8 1.8 4.1 8.5 6.5 11.9 5.0 7.1 7.1 7.3 4.5 1.6 2.2 4.9 5.4 7.9 5.0 6.0 7.7 5.8 3.8 3.5 10.8 3.9 4.2 4.5 3.1 5.7 7.5 4.4 6.8 7.5 13.8 11.2 4.2 6.2 5.2 13.4 4.1 7.5 5.4 3.7 5.7 5.0 6.5 5.6 3.7 4.9 8.8 8.1 4.3 6.3 4.1 4.4 7.9 2.9 7.3 13.1 8.7 13.3 8.2 7.9 9.9 8.0 11.3 8.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 AC083902.2 ENSG00000248713 "Homo sapiens uncharacterized LOC285556 (LOC285556), mRNA." 4 99636529-99654648 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 40.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.5;SK-BR-3: 3.6;SK-MEL-30: 2.0;WM-115: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" NA NA "unprognostic (3.91e-2)" "unprognostic (3.76e-1)" "unprognostic (4.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.76e-2)" "unprognostic (4.00e-3)" "unprognostic (2.31e-3)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (2.20e-1)" "unprognostic (2.42e-3)" "unprognostic (1.89e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.2 0.0 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 40.9 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.1 0.7 6.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091057.5 ENSG00000284906 "Rho GTPase-activating protein 11B " Q3KRB8 15 30624548-30685606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles NA Yes Vesicles "HPA064479: AB_2685272" 0.2 0.1 0.8 10.3 1.8 7.1 0.5 0.7 0.9 0.1 5.1 0.6 0.0 1.1 0.8 0.2 1.8 0.2 0.3 0.2 1.0 0.0 0.1 0.9 2.8 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.6 0.0 1.2 0.3 0.1 0.1 0.4 0.9 1.5 0.8 1.9 1.4 1.0 5.8 2.1 14.4 0.0 1.4 5.7 0.5 0.0 1.0 1.0 1.6 0.3 0.0 0.8 0.0 4.4 2.9 5.0 2.5 0.1 0.6 2.8 4.6 1.9 3.2 3.7 3.0 3.7 2.8 1.8 1.9 3.6 4.0 2.6 1.6 2.8 6.1 3.1 7.4 10.0 1.3 0.0 4.7 5.3 0.2 0.2 2.1 1.6 1.1 2.2 6.6 4.4 8.7 2.2 2.1 3.6 4.0 1.5 2.2 1.5 5.1 5.1 1.3 0.9 2.8 2.4 2.2 5.4 2.0 1.0 1.4 2.5 2.4 2.5 5.0 4.2 2.4 3.9 3.0 3.2 6.1 1.7 5.4 4.0 1.6 0.3 0.2 0.4 0.0 0.0 0.6 0.8 0.6 0.1 1.0 0.1 0.1 0.1 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACCSL ENSG00000205126 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like" Q4AC99 11 44047981-44059977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.6;testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 4.1;U-266/70: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065042 Approved Cytosol NA NA Cytosol "HPA065042: " "unprognostic (2.37e-2)" "unprognostic (2.91e-1)" "unprognostic (9.76e-5)" "unprognostic (7.42e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACER1 ASAH3 ENSG00000167769 "Alkaline ceramidase 1" Q8TDN7 19 6306142-6333629 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "esophagus: 14.3;skin 1: 38.2;tongue: 17.3" "Cell type enhanced" "Detected in some" 23 "Melanocytes: 1.7;Spermatocytes: 1.8;Suprabasal keratinocytes: 5.1" "Group enriched" "Detected in some" 7 "head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 2.2;T-47d: 8.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-2)" "unprognostic (2.87e-4)" "unprognostic (5.04e-2)" "unprognostic (6.18e-2)" "unprognostic (8.16e-4)" "unprognostic (7.27e-4)" "unprognostic (2.17e-2)" "unprognostic (1.61e-1)" "unprognostic (1.99e-1)" "unprognostic (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.30e-5)" "unprognostic (2.11e-1)" "unprognostic (4.44e-2)" "unprognostic (4.22e-1)" "unprognostic (2.24e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 2.2 0.1 0.1 3.8 0.1 0.1 0.1 0.0 0.4 0.1 14.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.1 1.4 0.1 0.2 38.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 17.3 3.5 0.1 2.2 0.6 0.4 0.4 0.2 1.0 3.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 8.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 3.6 0.1 3.5 1.6 0.0 0.6 2.3 2.3 0.4 1.0 0.2 0.4 2.0 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.5 5.1 0.0 0.0 0.0 0.1 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 27.4" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 9.1 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.2 3.2 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.3 0.0 0.4 1.4 1.4 0.1 3.3 0.7 0.4 3.1 0.1 0.4 0.1 0.2 16.5 0.0 21.3 2.0 0.4 0.1 0.4 0.1 0.7 0.2 1.0 0.3 0.2 0.4 0.2 0.1 14.4 3.7 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.0 27.4 0.0 0.2 0.2 0.6 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.9 2.2 0.3 0.0 0.0 0.0 0.7 ACP7 "FLJ16165, PAPL, PAPL1" ENSG00000183760 "Acid phosphatase 7, tartrate resistant (putative)" Q6ZNF0 19 39083913-39111493 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 21.5;U-87 MG: 28.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA042613 Uncertain "Secreted - unknown location" NA NA "HPA042613: AB_10963214" "unprognostic (6.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-3)" "unprognostic (1.92e-3)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (4.94e-3)" "unprognostic (2.66e-1)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" "unprognostic (1.51e-5)" "unprognostic (4.36e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-2)" "unprognostic (2.42e-1)" 0.3 0.3 1.6 0.3 5.5 0.3 1.0 15.2 5.4 0.9 0.3 4.2 0.3 0.4 0.4 1.4 1.1 0.3 0.9 0.3 2.5 1.2 0.3 0.3 0.4 0.3 6.5 0.7 0.3 0.3 0.3 0.0 0.3 5.2 1.2 0.3 0.0 0.6 0.3 0.3 14.1 0.3 0.3 4.1 0.3 0.6 0.4 5.3 0.0 0.3 5.5 6.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.4 0.5 0.3 3.2 0.0 0.0 0.0 21.5 0.2 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.9 0.7 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.5 15.2 5.4 2.5 1.2 6.5 0.7 5.2 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACR ENSG00000100312 Acrosin P10323 22 50738196-50745334 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "testis: 106.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 388.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.0;Hep G2: 1.8;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA048687 Enhanced "Secreted in male reproductive system" NA NA "HPA048687: AB_2680494" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" "unprognostic (6.27e-3)" "unprognostic (3.58e-2)" "unprognostic (8.04e-2)" "unprognostic (3.30e-3)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (1.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (1.25e-1)" 0.9 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.7 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 1.2 0.0 106.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 1.5 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 388.8 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 8.6 0.0 86.9 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 28.8 1.7 0.0 0.0 0.0 1.5 0.1 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Group enriched" "Detected in many" 6 "Early spermatids: 884.1;Late spermatids: 605.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Cell line enhanced" "Detected in some" "HEL: 5.5;HMC-1: 7.3;U-266/70: 16.3;U-266/84: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.9 2.7 1.0 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.1 0.0 0.5 0.0 0.2 0.6 0.0 5.5 0.6 0.0 2.1 0.1 7.3 0.1 3.7 1.0 0.1 0.7 0.6 1.9 3.6 0.0 0.1 0.4 0.2 1.9 1.7 4.5 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.2 0.0 0.7 1.2 1.4 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.3 10.7 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 0.0 2.2 0.0 0.2 0.1 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 884.1 0.5 1.2 0.0 0.4 0.2 0.4 0.0 5.8 0.0 9.0 0.0 0.0 2.5 11.7 605.9 7.5 3.9 0.0 0.0 0.9 1.0 0.2 0.9 4.2 0.8 1.5 6.5 0.1 127.7 7.2 0.0 0.1 0.0 0.9 0.1 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.4;brain: 40.5;skin 1: 19.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 26.8;Spermatogonia: 7.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 8.1;SK-MEL-30: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles NA NA Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 1.1 11.4 16.9 1.5 26.9 4.5 3.8 6.6 27.0 1.1 1.2 10.5 0.0 1.6 1.2 2.3 1.3 5.9 1.3 1.1 16.4 8.5 1.0 1.0 1.7 1.6 21.1 13.9 1.2 1.0 0.9 0.3 1.1 32.9 2.0 1.1 0.0 1.5 1.4 1.2 19.9 1.5 1.2 40.5 1.3 1.2 5.4 19.0 0.0 1.2 0.0 1.1 1.5 0.2 0.4 3.9 1.2 0.2 0.6 0.2 1.5 0.8 0.1 1.6 2.4 0.0 0.0 0.6 0.5 0.0 0.5 0.1 0.5 0.6 0.8 0.2 0.1 0.6 0.9 0.1 0.3 0.2 0.4 1.4 0.7 1.4 0.7 0.0 0.7 1.6 0.6 0.0 0.4 0.2 0.5 0.2 1.0 0.5 1.1 0.1 0.4 0.6 1.4 8.1 0.7 0.3 0.3 1.0 0.5 0.0 1.0 0.6 0.9 0.4 1.0 3.8 1.0 0.5 0.5 1.0 0.6 0.6 0.5 0.3 0.9 0.3 0.9 0.3 0.6 1.6 0.4 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.4 0.2 0.1 1.2 0.6 0.2 3.9 0.0 1.5 16.9 26.9 6.6 17.9 16.4 8.5 21.1 13.9 32.9 19.0 0.0 1.3 0.0 0.3 1.0 2.1 2.0 0.0 26.8 4.5 0.0 3.9 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.9 0.9 7.7 0.5 0.3 0.0 0.0 0.3 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 216.0;Erythroid cells: 116.8;Rod photoreceptor cells: 126.2" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 14.9;U-937: 8.7" HPA040470 Enhanced NA NA "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.6 4.8 16.5 1.5 15.7 21.3 0.7 22.8 34.0 0.5 0.7 5.3 30.1 5.4 0.5 1.0 0.9 0.7 0.9 2.0 12.4 9.7 2.3 2.6 0.8 2.5 9.6 12.1 0.5 1.9 13.0 2.7 1.1 12.1 0.8 0.8 3.3 0.8 35.8 3.6 0.6 3.3 0.5 4.2 1.2 1.2 23.0 4.7 0.0 0.9 0.0 1.5 0.7 0.3 0.1 0.0 0.6 0.1 1.2 4.2 1.1 0.0 0.0 0.3 0.1 0.6 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.1 1.6 0.2 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.2 2.1 0.0 0.1 0.0 0.1 0.0 0.0 2.1 1.0 0.2 0.0 0.0 0.0 1.5 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 14.9 0.7 0.2 0.2 1.2 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 8.7 0.5 0.6 0.1 0.1 1.5 0.0 3.5 0.1 2.1 4.2 0.0 0.1 3.9 1.8 0.2 1.2 0.0 0.0 0.1 1.1 16.5 15.7 22.8 18.8 12.4 9.7 9.6 12.1 12.1 4.7 23.8 33.5 0.5 1.0 1.6 55.8 0.0 2.5 14.7 29.6 1.8 216.0 0.3 6.6 0.4 22.7 0.4 0.7 116.8 0.2 0.2 1.1 1.0 9.3 5.7 0.1 20.6 2.4 2.5 1.2 3.6 0.3 7.9 0.0 0.0 0.6 20.4 0.2 0.9 1.8 0.3 126.2 0.0 0.8 16.1 1.3 1.1 0.2 10.7 0.2 0.9 ACSM4 ENSG00000215009 "Acyl-CoA synthetase medium chain family member 4" P0C7M7 12 7304284-7328724 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.0;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 3.8;Karpas-707: 2.6;NB-4: 4.0;SH-SY5Y: 4.7;U-87 MG: 6.7" "Region enhanced" "Detected in single" "olfactory region: 0.6" "Not detected" "Not detected" HPA049895 Uncertain NA NA "HPA049895: AB_2680940" "unprognostic (9.50e-5)" "unprognostic (5.45e-2)" "unprognostic (4.84e-2)" "unprognostic (6.06e-4)" "unprognostic (1.77e-2)" "unprognostic (1.76e-2)" "unprognostic (2.24e-3)" "unprognostic (3.31e-3)" "unprognostic (3.85e-2)" "unprognostic (8.78e-2)" "unprognostic (3.27e-1)" "unprognostic (3.60e-1)" "unprognostic (2.45e-9)" "unprognostic (1.82e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.73e-1)" 0.2 0.5 0.1 0.7 0.1 0.0 0.1 0.1 0.6 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.3 0.0 0.1 2.0 0.1 3.6 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.5 0.4 0.3 0.0 0.0 0.7 4.7 0.7 1.1 0.0 0.0 0.0 1.5 1.0 0.5 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 ACSM6 "bA310E22.3, C10orf129" ENSG00000173124 "Acyl-CoA synthetase medium chain family member 6" Q6P461 10 95194200-95228928 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.3;pancreas: 7.3;stomach 1: 6.2" "Group enriched" "Detected in some" 16 "Cone photoreceptor cells: 2.0;Early spermatids: 1.9;Rod photoreceptor cells: 4.6" "Cancer enriched" "Detected in single" 7 "urothelial cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 30 "RT4: 9.2" HPA044593 Uncertain NA NA "HPA044593: AB_10960261" "unprognostic (2.91e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (5.73e-2)" "unprognostic (2.48e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (3.75e-3)" "unprognostic (2.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.71e-4)" 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.8 0.4 0.0 6.2 0.3 0.0 16.3 0.8 0.0 0.0 2.5 1.9 0.1 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTL10 C20orf134 ENSG00000182584 "Actin like 10" Q5JWF8 20 33666498-33668525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.3" "Group enriched" "Detected in many" 53 "Early spermatids: 282.6;Late spermatids: 423.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 6.2;RPMI-8226: 8.0;SiHa: 5.8" "Not detected" "Not detected" NA NA "unprognostic (5.69e-3)" "unprognostic (3.62e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-1)" "unprognostic (5.91e-3)" "unprognostic (4.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.31e-2)" "unprognostic (2.35e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-3)" "unprognostic (5.90e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (8.61e-2)" 0.3 0.3 0.3 0.4 0.4 0.1 0.4 0.2 0.9 0.6 0.9 0.4 1.2 0.9 0.5 1.9 1.0 0.6 1.7 0.4 0.6 0.2 0.8 0.2 0.3 1.1 0.1 0.2 0.9 6.4 0.4 0.5 0.3 0.2 1.3 0.4 0.3 1.6 0.7 0.2 0.8 0.7 0.1 0.1 0.8 1.9 46.3 0.4 0.9 1.0 0.2 0.9 0.7 1.3 3.6 1.3 2.4 1.8 6.0 6.5 0.7 0.1 0.0 0.1 0.1 1.2 0.7 0.3 1.1 0.5 0.3 0.6 2.5 3.4 3.4 1.8 0.8 0.0 6.2 0.0 1.2 0.0 3.0 0.0 1.3 0.6 0.0 0.5 0.0 1.8 0.5 0.7 0.3 0.3 0.5 0.7 0.0 0.1 3.1 0.0 2.7 0.1 1.4 0.3 3.4 3.4 0.0 0.2 8.0 0.9 1.2 2.3 1.4 5.8 4.6 1.0 0.0 2.1 0.5 2.1 0.3 0.1 0.3 0.0 2.0 2.4 0.4 1.3 0.6 0.1 0.0 1.1 2.4 1.3 1.0 1.3 1.0 2.5 3.4 1.3 3.6 1.7 1.9 0.0 6.0 1.8 1.0 6.5 0.7 0.3 0.4 0.2 0.9 0.6 0.2 0.1 0.2 0.2 0.4 0.0 0.3 0.0 3.4 0.5 0.4 0.3 0.0 0.0 0.0 1.8 0.0 0.3 1.7 4.1 282.6 0.4 2.6 0.0 6.7 0.4 0.7 1.9 0.0 0.5 0.8 0.0 1.2 0.6 0.6 423.5 4.9 1.8 1.7 1.8 4.9 0.8 3.9 3.5 2.8 1.3 0.0 0.0 0.4 2.8 1.2 1.1 0.1 1.5 2.6 2.5 ACTL7B Tact1 ENSG00000148156 "Actin like 7B" Q9Y614 9 108854589-108856967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 437 "testis: 43.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 1482.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021803, HPA024664" Enhanced NA NA "HPA021803: AB_1844551, HPA024664: AB_1844552" "unprognostic (7.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.09e-1)" "unprognostic (3.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1482.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 301.1 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 7.9 3.2 0.0 0.0 0.0 0.0 0.0 ACTR3B "ARP11, ARP3beta" ENSG00000133627 "ARP3 actin related protein 3 homolog B" Q9P1U1 7 152759749-152855378 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 45.5;Peritubular cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047016, HPA051683" Uncertain NA NA "HPA047016: AB_2679903, HPA051683: AB_2681573" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-1)" "unprognostic (7.34e-3)" "unprognostic (5.89e-2)" "unprognostic (5.72e-2)" "unprognostic (9.28e-3)" "unprognostic (6.11e-3)" "unprognostic (5.62e-2)" "prognostic favorable (1.66e-4)" "prognostic favorable (4.53e-4)" "unprognostic (4.14e-2)" "unprognostic (3.04e-1)" "unprognostic (7.48e-2)" 3.3 8.2 16.4 3.8 38.1 3.9 7.5 12.7 37.3 4.6 4.0 6.2 7.8 4.4 5.2 8.8 3.3 8.6 3.2 5.1 21.9 11.2 7.1 7.0 3.5 4.5 8.1 14.1 6.8 8.7 11.7 10.9 3.9 7.9 4.4 4.5 5.3 13.6 5.4 6.6 4.4 3.6 3.7 5.1 3.3 5.0 14.8 5.8 2.6 5.7 1.8 4.8 4.2 2.7 2.7 1.9 0.4 0.8 2.5 4.7 2.7 11.9 5.8 10.9 13.6 3.3 4.2 9.1 6.3 4.0 2.6 2.6 7.0 7.1 10.2 4.9 4.1 4.9 4.4 10.0 3.0 3.2 3.7 5.3 4.1 4.0 6.5 3.5 5.6 1.7 2.1 3.7 1.5 3.9 1.8 3.3 4.2 21.3 0.2 5.6 12.5 8.2 11.0 23.6 11.8 6.5 6.7 4.2 8.0 4.3 6.7 21.6 18.2 8.0 6.3 5.3 4.2 6.5 4.5 1.9 2.6 0.6 3.4 5.4 9.1 9.9 7.0 5.3 8.1 5.5 0.0 0.8 0.0 2.1 0.5 2.7 1.7 2.2 4.3 1.9 2.7 4.7 2.7 0.4 2.5 0.3 1.0 3.0 2.7 16.4 38.1 12.7 23.9 21.9 11.2 8.1 14.1 7.9 5.8 6.0 0.6 7.6 4.5 2.4 18.0 3.6 2.5 6.7 3.4 3.5 21.6 7.4 26.6 4.8 25.5 3.5 1.3 0.0 4.9 6.3 3.4 5.7 4.6 7.4 2.7 14.3 10.4 2.5 1.8 29.5 39.7 2.7 45.5 1.8 3.6 31.9 4.4 3.5 50.9 5.1 19.9 6.5 4.7 24.4 23.4 1.4 10.4 1.8 3.7 3.4 ACTR3C ARP11 ENSG00000106526 "ARP3 actin related protein 3 homolog C" Q9C0K3 7 150243916-150323725 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 27.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.6;RT4: 18.2;SiHa: 12.2" NA NA "unprognostic (3.41e-1)" "unprognostic (4.79e-2)" "unprognostic (9.62e-2)" "unprognostic (8.25e-2)" "unprognostic (6.07e-6)" "unprognostic (2.83e-1)" "unprognostic (6.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.10e-2)" "unprognostic (2.91e-1)" "unprognostic (9.69e-3)" "unprognostic (1.65e-2)" "unprognostic (3.27e-2)" "unprognostic (4.73e-3)" "unprognostic (1.72e-1)" "unprognostic (9.14e-2)" "unprognostic (5.53e-3)" 1.5 9.0 3.1 8.7 5.0 1.2 4.4 5.7 3.2 3.9 7.5 0.8 8.3 3.5 2.9 6.4 5.9 3.9 8.1 2.4 3.1 3.1 21.7 22.5 8.4 5.6 2.1 1.1 1.8 17.5 39.0 19.6 13.2 3.0 4.5 4.9 5.1 5.0 9.8 1.4 2.4 7.5 1.9 1.6 2.6 4.0 3.2 1.2 2.1 4.2 2.6 8.0 4.3 7.4 6.5 4.5 3.3 1.7 4.1 7.5 2.0 4.5 0.4 0.1 0.2 0.0 0.0 0.9 0.1 0.1 0.8 1.0 3.5 21.6 1.7 5.8 0.8 0.6 9.4 0.0 0.0 0.5 4.7 1.3 1.3 5.6 3.1 2.4 0.0 0.8 0.8 2.9 0.0 0.0 0.5 0.2 2.2 8.7 4.9 0.0 6.4 4.9 0.2 2.5 3.0 0.0 0.0 3.4 6.7 3.6 18.2 4.8 3.8 12.2 2.7 1.8 0.7 5.9 1.1 0.1 0.0 0.0 0.2 0.0 1.8 2.2 0.0 0.1 0.0 0.0 0.3 1.7 3.3 7.5 1.5 3.5 5.7 6.4 4.7 2.6 6.5 6.9 5.5 2.0 4.1 0.6 4.5 4.6 2.0 3.1 5.0 5.7 3.2 3.1 3.1 2.1 1.1 3.0 1.2 3.0 7.4 0.9 5.3 17.9 5.5 1.2 0.0 13.4 5.7 17.4 27.5 5.3 11.6 9.0 3.6 0.8 6.9 0.0 18.4 0.9 1.0 5.1 11.5 13.0 1.1 1.6 3.4 1.3 0.6 0.9 0.9 2.0 1.7 7.2 3.9 13.8 11.8 0.0 0.7 12.0 4.5 0.0 0.7 6.6 1.9 13.0 5.9 2.1 4.9 4.7 ACTRT1 "AIP1, ARIP1, Arp-T1, KIAA0705" ENSG00000123165 "Actin related protein T1" Q8TDG2 X 128050962-128052398 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 83 "testis: 8.2" "Group enriched" "Detected in some" 64 "Early spermatids: 21.8;Late spermatids: 68.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003119 Supported NA NA "HPA003119: AB_1078219" "unprognostic (3.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 ACTRT2 "Arp-T2, ARPM2, FLJ25424" ENSG00000169717 "Actin related protein T2" Q8TDY3 1 3021483-3022903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 60.2" "Group enriched" "Detected in some" 120 "Early spermatids: 1117.5;Late spermatids: 2561.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;NTERA-2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006480, HPA025079" Enhanced NA NA "HPA006480: AB_1845047, HPA025079: AB_1845048" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1117.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2561.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 6.5 0.0 15.3 6.6 0.0 0.0 0.0 0.0 0.0 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 57.4" "Cell type enriched" "Detected in many" 9 "Early spermatids: 728.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 1.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;HSkMC: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.0 0.7 0.9 0.4 1.1 0.5 1.5 2.4 1.3 1.0 0.5 0.5 1.3 0.7 0.7 1.4 0.6 1.4 0.5 0.7 0.7 0.9 1.8 1.7 0.7 0.6 1.0 0.4 1.1 0.3 0.8 1.0 0.7 1.1 1.0 0.4 0.6 0.5 1.3 0.7 0.3 0.5 1.0 0.6 0.1 0.8 57.4 0.7 0.2 1.0 0.1 0.5 1.5 3.1 1.2 0.5 0.0 0.0 0.0 3.4 0.4 3.6 2.2 0.2 1.1 16.0 5.2 0.0 4.4 2.6 2.7 2.3 0.0 4.6 0.0 6.1 4.9 1.8 2.3 1.2 2.1 2.8 2.7 1.6 8.4 1.9 0.4 2.6 0.9 0.7 10.3 0.5 3.3 0.6 1.8 4.9 1.0 0.0 0.0 4.8 1.8 0.3 0.1 3.9 3.1 4.6 0.7 0.0 0.1 2.9 0.9 2.9 2.0 5.2 1.3 0.1 0.5 2.2 3.6 2.2 0.0 0.0 2.2 0.0 0.5 0.2 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.7 0.0 3.4 1.2 0.0 1.1 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.9 1.1 2.4 1.3 0.7 0.9 1.0 0.4 1.1 0.7 0.0 1.0 0.0 0.7 0.3 1.0 0.6 0.0 2.7 2.3 0.0 2.0 1.4 1.7 2.0 728.6 0.7 0.0 0.0 1.8 1.1 1.4 0.4 1.1 1.7 1.4 3.2 0.0 1.8 0.6 82.5 8.9 0.6 1.7 0.0 0.1 1.4 1.3 0.0 5.3 2.5 1.1 12.9 1.9 5.5 4.0 0.0 0.7 0.0 0.4 0.3 ADAD1 Tenr ENSG00000164113 "Adenosine deaminase domain containing 1" Q96M93 4 122378966-122429802 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 331 "testis: 65.5" "Group enriched" "Detected in some" 11 "Early spermatids: 815.1;Late spermatids: 770.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 815.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 770.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 69.4 16.8 0.0 0.0 0.0 0.0 0.0 ADAD2 "FLJ00337, TENRL" ENSG00000140955 "Adenosine deaminase domain containing 2" Q8NCV1 16 84191138-84197168 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 68.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 57.9;Spermatocytes: 124.2;Spermatogonia: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enhanced" "Detected in single" "dendritic cells: 1.6" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA079443 Enhanced NA NA "HPA079443: " "unprognostic (5.73e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-2)" "unprognostic (2.18e-2)" "unprognostic (6.72e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (3.01e-2)" "unprognostic (6.68e-2)" "unprognostic (1.69e-1)" "unprognostic (7.40e-2)" "unprognostic (3.18e-1)" "unprognostic (3.52e-1)" "unprognostic (2.47e-2)" 0.2 0.0 0.9 0.1 1.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 1.9 0.0 68.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 7.9 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.1 0.1 0.6 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.9 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 57.9 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.1 0.0 14.6 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 124.2 23.3 1.6 0.0 0.0 0.0 3.0 ADAL ENSG00000168803 "Adenosine deaminase like" Q6DHV7 15 43330657-43354555 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 77.1;Spermatogonia: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039879, HPA048175, HPA058795" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA039879: , HPA048175: AB_2680298, HPA058795: " "unprognostic (1.65e-2)" "unprognostic (1.53e-3)" "unprognostic (9.80e-2)" "unprognostic (3.15e-3)" "unprognostic (2.46e-3)" "unprognostic (1.86e-1)" "unprognostic (2.00e-1)" "unprognostic (5.83e-2)" "unprognostic (5.90e-2)" "unprognostic (2.68e-1)" "unprognostic (6.85e-3)" "unprognostic (1.69e-1)" "prognostic favorable (7.64e-9)" "unprognostic (2.37e-3)" "unprognostic (8.77e-2)" "unprognostic (5.31e-2)" "unprognostic (2.44e-2)" 6.9 7.9 10.0 4.6 12.4 4.7 7.1 9.0 11.3 4.0 6.2 9.9 4.2 6.9 6.8 11.0 5.1 4.3 4.7 23.8 9.3 10.3 14.1 10.6 4.2 5.2 10.5 9.0 4.6 5.2 15.6 10.6 3.4 10.7 7.7 5.9 11.8 4.9 8.0 20.9 3.5 8.6 8.8 14.0 4.7 4.7 12.5 9.2 4.4 13.0 9.7 5.6 6.1 3.6 5.0 7.3 8.8 4.6 5.0 8.7 3.0 4.7 2.5 9.8 10.5 4.1 5.5 4.5 5.5 5.8 8.9 13.9 9.8 2.4 5.8 9.5 6.2 11.9 5.2 0.0 4.0 8.0 5.6 6.5 13.5 16.2 8.0 5.8 0.0 10.3 7.1 7.9 6.5 6.8 5.8 1.9 13.4 14.3 11.3 9.7 3.3 8.3 6.7 3.9 5.2 3.6 10.9 14.3 8.5 8.3 2.9 12.5 8.4 9.4 8.3 8.4 5.5 8.8 9.4 2.4 15.8 7.4 12.0 11.6 11.9 19.7 2.3 8.9 14.5 12.9 8.8 3.3 7.7 5.9 4.6 4.7 5.0 5.5 5.0 4.5 5.0 5.8 7.0 2.3 5.0 3.9 7.3 8.7 3.0 10.0 12.4 9.0 11.3 9.3 10.3 10.5 9.0 10.7 9.2 8.9 9.3 12.5 7.9 6.3 39.1 42.8 10.2 12.0 5.7 17.4 76.6 6.4 49.7 7.8 9.3 6.9 8.7 0.0 7.3 5.5 7.6 7.8 7.0 27.2 7.5 39.7 7.5 10.4 5.4 9.6 8.9 11.2 8.5 3.6 7.3 33.0 5.4 0.0 8.1 24.8 77.1 6.5 8.0 33.7 66.1 3.9 2.2 9.2 9.9 2.4 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44759031-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 42.3;heart muscle: 11.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 6.1;Cardiomyocytes: 10.8;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.7" "Cell line enriched" "Detected in some" 4 "HEK 293: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced NA NA "HPA074550: AB_2732259" "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 1.2 0.5 8.5 0.6 7.5 1.0 0.6 42.3 23.1 0.9 0.8 0.7 0.0 0.8 4.0 1.1 1.1 1.2 1.5 11.2 11.4 4.2 0.7 0.6 0.7 0.7 2.7 9.8 0.9 0.6 0.7 0.6 0.7 5.5 1.6 0.6 0.2 0.5 2.2 0.8 2.5 0.7 2.6 1.5 0.7 0.7 2.3 1.1 0.0 0.6 0.0 0.6 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.6 4.9 0.2 0.0 0.3 0.1 0.0 1.4 0.4 0.7 0.2 0.1 0.3 0.0 2.2 0.0 3.6 0.0 0.4 1.4 21.0 0.2 0.4 0.3 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.4 0.4 0.1 4.2 0.1 2.4 0.9 1.6 1.3 2.9 0.1 0.4 0.0 0.1 3.8 1.9 0.0 0.1 1.1 0.4 1.4 0.7 0.0 0.6 1.7 1.8 0.4 0.7 0.2 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 8.5 7.5 42.3 21.0 11.4 4.2 2.7 9.8 5.5 1.1 0.0 0.0 0.0 0.2 0.0 6.1 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 1.4 0.0 2.7 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 ADAM18 "ADAM27, tMDCIII" ENSG00000168619 "ADAM metallopeptidase domain 18" Q9Y3Q7 8 39584489-39730064 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 42.7" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 41.4;Late spermatids: 19.4;Spermatocytes: 111.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.4;SuSa: 1.1" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (2.10e-4)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 111.2 2.2 0.0 2.1 0.0 0.0 0.0 ADAM2 "CT15, FTNB, PH-30b, PH30" ENSG00000104755 "ADAM metallopeptidase domain 2" Q99965 8 39743735-39838289 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 416 "testis: 50.6" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 72.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.1" "Not detected" "Not detected" "CAB022390, HPA024621, HPA026581" Enhanced NA NA "CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577" "unprognostic (4.74e-2)" "unprognostic (1.67e-3)" "unprognostic (3.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 72.7 0.2 0.0 0.2 0.0 0.0 0.0 ADAM20 ENSG00000134007 "ADAM metallopeptidase domain 20" O43506 14 70522358-70535015 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 18.7" "Cell type enriched" "Detected in some" 9 "Early spermatids: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" HPA059377 Enhanced NA NA "HPA059377: AB_2683997" "unprognostic (4.13e-3)" "unprognostic (3.45e-2)" "unprognostic (1.14e-1)" "unprognostic (8.34e-2)" "unprognostic (2.06e-1)" "unprognostic (1.57e-2)" "unprognostic (5.61e-2)" "unprognostic (2.89e-2)" "unprognostic (1.58e-3)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.46e-3)" "unprognostic (2.64e-1)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (9.52e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.7 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.6 0.0 1.0 0.0 0.3 0.3 0.4 0.2 0.0 0.0 0.3 0.2 0.1 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.5 0.4 0.2 0.0 0.0 0.3 0.6 0.6 0.2 0.5 0.3 0.0 0.2 0.0 0.1 1.1 0.6 0.4 0.7 0.3 0.4 0.9 0.4 0.2 0.0 0.3 0.5 0.6 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.7 0.4 0.0 0.1 0.2 0.0 0.5 0.3 0.4 0.1 0.1 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 4.2 0.4 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 36.8 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 2.3 0.1 0.1 0.1 0.0 0.0 0.3 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70452157-70459899 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 19.7" "Group enriched" "Detected in some" 46 "Early spermatids: 54.9;Late spermatids: 93.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-138 MG: 4.5;U-251 MG: 4.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059016 Uncertain NA NA "HPA059016: AB_2683882" "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 19.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 1.6 0.3 0.9 0.2 0.4 0.8 1.6 1.6 0.5 0.9 0.6 0.2 0.4 0.2 1.0 0.0 0.6 0.7 0.9 0.1 0.5 1.6 1.0 0.6 0.8 0.6 0.1 0.4 0.3 0.0 0.3 1.0 0.1 0.4 0.9 2.5 0.3 1.0 0.2 0.8 2.1 0.0 2.0 0.2 0.1 0.3 0.2 1.3 1.2 0.0 0.3 0.0 0.7 0.7 0.0 0.7 1.7 0.5 0.5 1.7 0.5 4.5 0.2 0.3 4.3 0.3 2.3 0.0 2.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.2 0.0 0.8 0.8 1.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.3 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 54.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 1.6 0.9 0.0 0.1 0.0 0.0 0.0 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell type enhanced" "Detected in many" 15 "B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 24.8;OE19: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.8 0.2 0.8 0.0 0.8 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 7.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 3.0 5.9 115.5 2.2 0.8 0.0 0.9 25.5 17.4 62.6 3.5 0.0 0.3 0.0 7.1 0.9 0.7 0.5 0.0 3.1 8.1 1.1 2.0 2.3 0.0 9.0 0.0 0.0 0.0 12.3 1.8 0.6 32.1 5.0 5.4 0.1 0.0 32.8 0.0 0.4 3.6 0.0 6.5 0.3 0.2 0.1 0.5 0.5 6.9 0.9 6.3 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672803-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;gallbladder: 12.3;placenta: 13.5" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Paneth cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 11 "monocytes: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.8;CAPAN-2: 10.4;K-562: 11.6;RH-30: 6.3;U-138 MG: 10.5" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.4" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 1.7 0.5 4.6 5.4 10.7 1.1 0.6 1.0 4.7 1.3 3.3 13.4 1.0 4.1 1.4 1.0 1.8 1.1 12.3 2.8 7.2 3.0 0.7 0.5 2.7 2.0 8.1 5.7 0.7 0.5 0.2 0.4 13.5 4.0 1.1 3.6 2.6 1.6 0.4 0.4 2.5 5.7 3.9 4.6 0.8 2.6 0.9 5.9 0.5 0.4 2.3 2.3 6.7 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 4.8 0.0 1.2 3.7 0.3 2.0 0.0 10.4 0.0 0.8 1.9 0.5 0.8 0.0 0.0 0.1 4.0 0.0 0.4 0.0 0.3 0.0 0.0 2.7 0.4 0.1 0.9 0.2 1.2 0.0 0.0 11.6 0.0 1.5 0.0 0.0 1.0 0.4 0.1 0.0 0.0 6.3 0.2 0.0 0.0 4.0 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.0 10.5 0.1 0.9 0.5 1.0 0.0 0.0 0.5 1.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.6 10.7 1.0 4.7 7.2 3.0 8.1 5.7 4.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 1.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 ADAMTS15 ENSG00000166106 "ADAM metallopeptidase with thrombospondin type 1 motif 15" Q8TE58 11 130448974-130476641 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.4" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA042867 Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "HPA042867: AB_10794535" "unprognostic (7.64e-2)" "unprognostic (1.49e-3)" "unprognostic (7.15e-2)" "unprognostic (1.34e-3)" "unprognostic (1.07e-3)" "unprognostic (7.07e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (6.18e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (5.95e-3)" "unprognostic (6.68e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.63e-5)" 47.4 1.1 0.2 1.7 0.3 0.1 14.5 0.1 0.8 3.4 3.8 0.8 3.0 0.6 3.7 9.8 3.8 9.3 9.1 12.6 0.4 0.3 9.1 0.4 6.6 5.6 0.8 0.2 7.0 1.6 0.9 1.0 16.4 1.3 3.7 2.1 10.9 1.0 1.3 1.6 4.1 3.1 6.9 1.4 1.9 4.9 2.4 0.6 0.7 9.8 2.5 0.8 8.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.4 36.6 22.1 0.0 1.3 2.6 0.5 0.1 0.2 0.6 0.0 18.4 0.1 1.3 3.4 0.3 0.3 0.1 0.0 0.8 0.0 1.6 0.0 0.3 0.0 0.0 7.2 0.0 0.3 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.0 2.7 1.9 0.0 0.0 0.3 4.3 3.5 1.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.4 0.3 0.8 0.2 1.3 0.6 0.0 0.0 0.0 0.1 0.5 0.0 9.6 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.5 8.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.3 0.0 0.5 0.0 0.7 0.0 0.7 0.8 0.0 0.0 3.3 0.1 0.3 0.3 0.7 0.0 2.1 0.0 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 7.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" Yes No "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.5 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.1 3.3 0.0 4.7 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.8 0.0 0.0 0.3 0.1 0.0 0.0 6.1 0.2 0.7 0.0 0.3 0.8 0.4 1.1 0.1 0.1 0.3 1.7 0.1 2.5 0.5 3.2 0.1 0.1 0.0 1.1 0.1 0.1 0.1 0.2 5.6 0.1 0.2 0.1 3.2 4.8 8.9 2.1 0.5 0.2 0.1 4.6 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971589-100342005 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 111.4;Horizontal cells: 20.6;Late spermatids: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HEK 293: 7.4;JURKAT: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "HPA062487: AB_2684780" "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 1.2 2.0 3.6 2.7 3.1 1.5 1.9 0.7 4.5 1.9 2.1 2.9 6.4 2.5 4.9 1.9 5.1 2.9 1.9 2.2 3.4 1.6 2.2 15.7 10.5 2.0 1.6 1.0 3.0 12.2 0.3 3.5 1.6 1.7 1.9 2.1 2.7 8.3 4.7 13.5 5.0 2.8 6.6 2.1 2.5 3.6 4.0 2.0 20.1 1.9 2.7 2.1 2.7 2.1 0.1 0.0 1.4 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.1 1.3 0.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 25.8 0.0 0.1 0.1 0.6 2.2 0.4 0.2 1.2 1.1 0.0 0.6 2.8 0.0 0.3 2.3 0.4 0.3 2.8 3.7 0.6 0.0 0.4 0.4 0.0 0.9 0.7 0.0 0.4 0.0 0.0 0.0 0.5 3.4 1.4 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.0 0.1 0.5 0.5 0.4 0.2 0.1 0.0 0.0 0.1 3.6 3.1 0.7 4.5 3.4 1.6 1.6 1.0 1.7 2.0 0.0 0.0 0.0 0.6 0.9 0.9 3.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 111.4 0.7 0.1 0.0 0.7 0.0 0.8 1.7 0.0 3.9 6.1 20.6 0.0 0.0 0.6 51.8 2.0 0.0 0.0 0.0 0.3 2.3 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 1.4 0.5 0.1 1.3 0.3 0.8 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" Q8TE59 5 129460265-129738683 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 12.0;SH-SY5Y: 27.6" "Region enriched" "Detected in single" 5 "olfactory region: 4.8" "Low region specificity" "Detected in all" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.2 1.2 0.7 0.6 3.6 0.1 0.2 0.0 4.9 16.6 0.5 1.2 0.0 0.4 14.6 0.3 1.5 2.6 0.8 0.5 1.0 0.8 0.7 0.1 0.2 0.2 0.5 4.3 2.8 0.2 0.2 0.1 5.3 1.8 0.4 0.6 0.9 1.1 0.2 0.8 0.2 0.3 9.0 1.0 0.2 0.2 0.4 0.8 0.0 0.1 1.8 0.1 0.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 12.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.0 4.9 1.0 0.8 0.5 4.3 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 15.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 0.0 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110851-179345430 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Ito cells: 28.8;Kupffer cells: 58.6;Sertoli cells: 25.8;Smooth muscle cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 14.0;ASC TERT1: 14.0;BJ: 12.3;fHDF/TERT166: 14.5;HHSteC: 45.5;HSkMC: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 24.2 4.3 0.9 5.8 0.7 0.7 29.1 0.9 2.3 16.3 10.1 0.4 3.9 2.7 12.0 9.5 6.0 7.2 9.5 10.1 0.7 1.2 4.2 7.4 13.1 25.9 1.0 1.3 6.3 2.7 1.0 8.7 15.1 2.4 6.0 2.6 3.8 2.5 3.8 3.8 4.6 4.6 13.8 0.7 16.5 4.2 4.3 0.5 0.8 3.2 5.9 1.2 8.8 14.7 1.4 1.3 2.1 0.3 0.8 0.6 0.1 0.0 0.0 0.0 0.3 14.0 14.0 0.0 12.3 2.1 4.7 5.0 0.0 0.0 0.0 0.1 14.5 0.3 0.0 0.7 0.0 2.0 0.0 0.7 0.0 0.0 0.9 45.5 0.0 0.0 36.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.5 0.0 0.0 0.1 0.8 0.0 4.0 0.0 7.9 1.2 10.3 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.5 0.3 0.4 0.6 0.2 0.3 0.6 0.5 0.4 1.3 1.4 0.5 0.5 2.1 0.8 0.1 0.8 0.5 0.1 0.9 0.7 0.9 2.3 0.7 1.2 1.0 1.3 2.4 0.5 0.0 0.6 0.0 0.3 1.9 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.1 13.5 0.2 1.1 0.5 3.9 0.0 0.0 28.8 58.6 2.1 4.6 2.9 0.0 0.0 0.0 0.0 0.8 0.0 12.0 0.0 0.0 25.8 16.1 0.5 2.6 2.4 0.0 0.0 0.0 0.1 ADAMTS20 GON-1 ENSG00000173157 "ADAM metallopeptidase with thrombospondin type 1 motif 20" P59510 12 43353866-43551921 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 2.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;SuSa: 4.4;U-266/70: 7.4;U-266/84: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027608, HPA027609" Uncertain "Secreted to extracellular matrix" NA NA "HPA027608: AB_10600098, HPA027609: AB_10599024" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (1.91e-2)" "unprognostic (2.04e-1)" "unprognostic (9.61e-2)" "unprognostic (3.29e-1)" "unprognostic (6.67e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-4)" "unprognostic (7.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.81e-3)" "unprognostic (2.57e-1)" 0.2 0.0 0.7 0.1 1.4 0.1 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.2 0.0 3.6 5.1 0.0 0.0 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 2.3 1.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.6 0.2 0.0 0.0 2.9 5.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 4.4 1.4 0.0 0.0 0.0 0.7 0.0 0.0 7.4 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.2 0.3 0.7 0.6 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 ADAMTS3 "ADAMTS-4, KIAA0366" ENSG00000156140 "ADAM metallopeptidase with thrombospondin type 1 motif 3" O15072 4 72280969-72569386 "Cancer-related genes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 13.7;Leydig cells: 18.4;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.6;AN3-CA: 7.3;HEL: 12.9;K-562: 11.0;SH-SY5Y: 6.6;U-2 OS: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021368, HPA021369" Uncertain Approved "Intermediate filaments" "Secreted to extracellular matrix" NA NA "Intermediate filaments" "HPA021368: AB_2670681, HPA021369: AB_2670682" "unprognostic (1.93e-1)" "unprognostic (3.47e-3)" "unprognostic (1.41e-1)" "unprognostic (1.05e-3)" "unprognostic (6.11e-2)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (1.60e-3)" "unprognostic (5.92e-4)" "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (8.63e-3)" "unprognostic (1.65e-3)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" "unprognostic (1.50e-4)" 5.3 2.6 3.3 4.4 5.6 2.1 7.8 0.3 4.6 4.4 2.3 1.1 1.9 0.5 9.6 14.4 1.0 7.5 1.9 2.8 1.3 0.9 4.7 2.7 3.1 2.0 0.7 2.2 7.5 1.0 12.4 1.1 8.2 2.2 2.6 1.1 3.9 1.4 3.4 0.8 1.5 0.9 4.6 1.8 1.9 1.6 5.6 1.3 0.6 4.4 0.8 1.0 2.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 7.3 0.1 0.3 0.1 0.6 2.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.6 0.0 1.8 0.0 1.6 12.9 1.0 0.0 0.2 0.0 0.0 1.7 0.1 0.6 0.1 3.1 0.0 0.0 11.0 0.0 0.0 0.0 1.1 0.0 2.0 0.0 3.8 0.0 2.5 0.0 4.3 0.0 0.5 6.6 0.0 0.5 0.2 1.4 0.1 0.1 0.1 5.4 8.1 0.0 0.6 0.0 0.0 0.0 1.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.6 0.3 4.6 1.3 0.9 0.7 2.2 2.2 1.3 0.0 4.3 0.0 1.0 0.5 0.8 0.8 0.0 0.0 2.3 1.8 13.7 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.2 1.6 0.7 1.1 0.0 0.0 0.0 0.0 2.5 0.0 1.3 18.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.2 0.2 11.9 0.0 0.7 1.0 0.4 0.0 0.0 0.0 0.0 0.0 ADAMTS6 ADAM-TS6 ENSG00000049192 "ADAM metallopeptidase with thrombospondin type 1 motif 6" Q9UKP5 5 65148736-65481920 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 32.4" "Cell type enhanced" "Detected in many" 7 "B-cells: 16.4;Cytotrophoblasts: 28.3;Muller glia cells: 28.3;Peritubular cells: 17.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 4.8;naive B-cell: 3.6" "Group enriched" "Detected in many" 13 "B-cells: 4.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ: 10.0;HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;hTERT-HME1: 12.2;TIME: 11.5;U-2197: 13.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043441 Enhanced "Secreted to extracellular matrix" NA Yes "HPA043441: AB_2678484" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.70e-3)" "unprognostic (4.33e-2)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (8.24e-2)" "unprognostic (1.65e-2)" "unprognostic (4.77e-2)" "unprognostic (8.04e-2)" "unprognostic (1.56e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-6)" "unprognostic (3.23e-5)" "unprognostic (2.09e-1)" "unprognostic (3.02e-4)" "unprognostic (4.18e-3)" 2.2 0.7 0.9 2.0 0.8 0.3 1.8 0.2 1.8 2.9 1.4 0.8 1.6 0.6 5.1 3.0 1.0 2.7 6.3 2.3 0.8 0.9 1.5 0.5 2.3 1.7 0.8 1.4 1.8 0.5 0.4 2.0 32.4 2.9 2.3 0.9 1.4 0.6 0.9 0.4 0.8 2.4 5.4 3.2 3.4 1.8 1.9 0.7 3.3 0.9 1.2 1.9 3.6 1.7 4.8 0.2 0.0 0.0 0.0 1.4 0.1 2.1 0.0 0.5 0.5 0.0 1.7 0.0 10.0 5.9 6.2 7.4 0.0 0.2 0.0 0.0 3.8 4.4 0.4 0.1 1.9 11.0 1.5 0.0 0.1 3.7 0.2 0.3 0.0 0.5 0.7 0.0 10.2 12.2 3.0 5.5 1.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 2.1 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 1.4 0.0 0.0 11.5 2.4 3.7 13.1 8.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 1.3 0.0 1.0 4.8 0.3 0.5 0.0 3.6 1.3 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.8 0.2 1.4 0.8 0.9 0.8 1.4 2.9 0.7 0.0 0.0 16.4 0.0 0.2 7.8 2.2 0.0 0.0 0.0 3.5 0.0 28.3 0.0 0.7 12.3 9.9 0.0 0.0 0.0 3.5 4.0 0.1 1.1 0.0 2.2 0.0 0.0 5.5 0.0 6.4 11.2 2.9 0.0 0.0 0.6 28.3 1.7 0.0 17.0 0.8 0.7 6.5 4.1 4.9 1.3 0.0 11.9 0.0 0.2 0.0 ADAMTS8 "ADAM-TS8, FLJ41712, METH2" ENSG00000134917 "ADAM metallopeptidase with thrombospondin type 1 motif 8" Q9UP79 11 130404925-130428993 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 13.0;lung: 21.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Bipolar cells: 1.1;Cardiomyocytes: 2.5;Ciliated cells: 4.0;Club cells: 2.3;Fibroblasts: 2.6;granulocytes: 1.1;Melanocytes: 1.7;Peritubular cells: 1.4;Smooth muscle cells: 3.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.0;HeLa: 1.8;HMC-1: 5.8;NTERA-2: 2.9;U-2 OS: 13.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2" HPA066349 Approved "Secreted to extracellular matrix" NA NA 2200000 "HPA066349: AB_2685662" "unprognostic (4.76e-6)" "unprognostic (3.92e-2)" "unprognostic (6.13e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.41e-1)" "unprognostic (7.81e-2)" "unprognostic (3.09e-2)" "unprognostic (9.83e-2)" "unprognostic (1.09e-4)" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (4.66e-3)" "unprognostic (4.03e-3)" "unprognostic (5.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-1)" 2.1 0.1 1.5 10.2 2.5 0.0 0.5 0.6 4.4 1.3 5.3 0.5 0.2 1.1 2.6 1.5 3.1 1.7 13.0 3.9 1.6 0.6 2.1 0.2 21.0 0.2 0.7 0.2 1.0 0.7 0.0 0.8 2.7 0.9 2.9 0.5 0.7 0.3 5.7 0.4 0.1 1.6 7.4 0.8 0.9 5.6 0.2 0.4 0.2 0.4 0.2 0.4 3.8 3.4 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 2.5 0.6 3.2 1.6 0.6 0.7 0.2 0.9 0.4 0.0 1.1 0.0 0.2 0.3 1.1 2.5 0.0 4.0 2.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 3.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800083-77935012 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Uncertain Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA051012: AB_2681310, HPA055014: AB_2682672" "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.70e-4)" "prognostic favorable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 7.2 11.0 11.0 7.0 15.2 7.4 6.9 6.8 20.5 5.6 10.3 19.0 7.7 11.2 7.7 10.3 7.7 7.1 9.1 11.1 12.4 10.4 8.8 10.5 6.2 6.0 13.5 9.4 6.6 9.8 11.3 11.3 7.8 15.0 8.2 10.3 13.8 10.6 8.9 13.7 8.5 8.5 10.5 10.6 9.7 7.5 5.5 11.5 10.8 9.1 7.8 7.5 6.9 5.0 4.0 8.9 1.4 7.2 3.4 5.3 3.1 3.3 5.4 3.3 10.8 8.1 4.6 4.3 3.4 5.7 3.1 3.8 3.0 8.0 7.3 5.5 6.0 5.7 6.4 17.8 5.4 2.0 4.2 5.6 1.9 3.4 4.9 8.3 2.8 4.1 5.8 10.1 1.2 3.9 3.2 4.4 6.4 7.0 4.5 4.0 16.8 3.4 5.6 6.4 12.3 6.4 5.6 0.5 5.8 4.4 8.5 7.2 4.0 6.6 9.3 4.0 5.1 13.3 6.2 3.9 2.9 2.3 5.9 3.1 4.6 5.0 4.2 4.4 4.9 3.8 1.4 4.7 1.3 5.3 7.2 3.5 1.7 2.2 3.1 8.9 4.0 2.5 4.6 0.4 3.4 2.8 7.0 3.7 3.1 11.0 15.2 6.8 20.5 12.4 10.4 13.5 9.4 15.0 11.5 0.0 3.0 0.8 1.8 0.8 5.0 4.8 0.0 1.4 1.2 0.0 19.6 6.8 3.3 3.6 1.2 1.2 2.1 0.0 4.3 3.6 2.0 1.3 1.1 5.8 8.2 7.9 1.7 1.8 5.1 0.4 1.4 5.4 0.0 1.0 3.6 3.2 3.0 0.0 1.8 3.3 8.8 0.0 1.9 1.7 9.7 1.3 4.5 1.8 4.9 0.9 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140673153-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 12.3 10.6 15.3 11.3 16.6 8.8 13.4 15.4 27.0 12.3 15.1 26.3 13.2 8.8 10.3 11.4 18.0 20.0 10.3 10.2 16.6 18.2 12.3 12.5 12.8 15.6 19.5 13.1 14.5 22.8 21.4 12.7 19.9 18.2 14.4 13.2 10.7 16.8 14.0 12.5 25.8 13.0 10.9 24.0 13.6 13.0 7.6 13.3 20.6 25.1 9.9 16.2 13.4 18.9 8.2 12.0 3.2 5.0 5.1 7.3 2.2 16.0 11.6 2.7 12.7 10.0 11.4 16.5 8.3 10.2 8.7 5.8 10.5 11.4 21.6 12.6 5.8 20.4 13.3 13.9 9.5 2.6 15.9 14.2 4.5 4.5 5.1 13.9 3.0 11.3 9.5 29.1 5.0 6.9 9.0 7.5 15.4 7.9 10.6 3.1 20.0 22.5 7.5 4.0 12.8 12.6 17.8 0.1 10.4 4.7 16.1 10.8 7.6 11.4 16.7 11.4 5.5 14.8 6.1 7.9 10.9 3.8 18.1 16.0 7.4 11.2 15.8 16.1 12.1 12.9 0.0 3.7 3.2 5.4 5.0 4.9 8.2 4.8 5.3 5.7 4.2 7.3 4.7 0.1 5.1 3.0 12.0 6.0 2.2 15.3 16.6 15.4 27.0 16.6 18.2 19.5 13.1 18.2 13.3 8.9 5.1 8.2 18.5 11.0 11.4 5.8 5.1 2.7 1.2 8.7 0.0 25.4 5.0 5.3 16.9 9.0 8.5 0.0 6.4 18.4 7.1 15.5 11.5 8.6 27.9 11.1 16.1 6.7 7.9 12.5 3.1 11.8 3.3 7.2 13.8 11.6 5.9 14.4 12.7 4.8 4.8 0.0 6.9 5.9 3.1 12.2 28.3 7.7 11.3 16.1 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041218, HPA048241" Uncertain Approved Cytosol NA NA Cytosol "HPA041218: AB_2677365, HPA048241: AB_2680326" "unprognostic (1.98e-1)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 6.3 4.3 7.0 17.4 9.7 14.9 3.9 1.2 5.2 3.7 5.0 9.8 0.8 2.8 3.7 4.8 13.2 5.3 6.9 7.3 5.3 4.2 3.3 3.6 16.4 16.5 8.8 4.4 17.1 3.7 1.0 3.4 9.7 8.6 3.5 5.9 6.2 6.5 1.6 1.8 7.9 10.4 5.0 12.3 26.9 4.9 2.1 9.2 21.8 3.7 3.1 26.0 6.6 6.1 3.6 12.5 6.5 16.7 8.4 7.0 5.0 4.0 5.5 0.2 0.8 0.6 7.1 0.5 2.8 1.3 2.2 2.0 5.2 8.4 1.6 7.6 11.4 0.1 14.7 5.8 2.4 2.7 15.4 2.0 23.3 4.2 1.5 6.5 4.4 65.3 3.8 2.4 1.6 2.6 1.2 0.6 5.3 8.5 3.2 3.1 2.3 1.7 10.4 1.0 1.9 7.9 1.6 2.1 32.4 1.5 0.4 1.0 2.7 1.5 0.6 1.3 1.4 0.1 13.0 5.2 0.3 7.6 0.8 0.8 0.3 0.1 3.5 2.4 9.5 1.0 6.5 7.8 2.9 7.0 11.7 5.1 3.2 2.8 5.0 12.5 3.6 2.6 3.7 4.4 8.4 16.7 6.5 3.9 5.0 7.0 9.7 1.2 5.2 5.3 4.2 8.8 4.4 8.6 9.2 17.9 34.7 6.9 0.3 3.3 1.0 0.6 0.0 0.0 12.5 0.0 5.9 9.3 0.0 1.6 1.3 1.0 1.7 0.0 0.2 0.9 11.4 0.3 48.6 0.2 30.2 0.0 0.0 1.8 61.4 0.5 0.6 41.8 5.0 3.6 0.5 0.9 3.1 7.0 1.1 0.0 0.4 6.5 1.4 0.0 0.7 3.4 3.3 18.5 2.1 1.0 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.9" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 3.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 121.8 14.8 0.0 3.9 0.0 0.0 0.0 236.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 2.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.2 3.0 0.0 0.0 0.0 0.0 0.0 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.8;brain: 26.6" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 1.1;Cholangiocytes: 2.5;Ito cells: 6.2" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "RH-30: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042773 Approved NA NA "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.8 7.8 9.9 0.7 9.3 0.7 0.7 3.5 26.6 0.7 0.7 3.2 0.0 0.7 0.7 0.7 0.7 4.3 0.7 0.7 11.6 14.6 1.0 1.1 0.9 0.7 7.5 6.6 0.7 0.8 0.7 1.9 0.7 5.3 0.7 0.7 0.3 4.1 0.7 0.7 0.7 0.7 0.7 4.6 1.0 0.8 1.0 1.4 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.3 3.5 19.0 11.6 14.6 7.5 6.6 5.3 1.4 0.0 0.0 0.0 0.0 0.0 0.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 ADGRD2 "GPR144, PGR24" ENSG00000180264 "Adhesion G protein-coupled receptor D2" Q7Z7M1 9 124451425-124478589 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8" "Group enriched" "Detected in some" 18 "Early spermatids: 27.1;Late spermatids: 64.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 1.5" "Group enriched" "Detected in some" 4 "hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7" NA NA "unprognostic (7.39e-4)" "unprognostic (1.34e-2)" "unprognostic (4.21e-2)" "unprognostic (8.01e-3)" "unprognostic (6.29e-2)" "unprognostic (3.23e-6)" "unprognostic (1.15e-1)" "unprognostic (3.15e-1)" "unprognostic (5.82e-2)" "unprognostic (4.22e-2)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "unprognostic (3.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.41e-1)" 0.0 0.6 0.1 0.0 0.1 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.3 0.0 0.0 5.8 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.9 ADGRE1 "EMR1, TM7LN3" ENSG00000174837 "Adhesion G protein-coupled receptor E1" Q14246 19 6887566-6940459 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 64.1;lymphoid tissue: 50.0" "Cell type enriched" "Detected in some" 9 "Kupffer cells: 25.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 64.1" "Group enriched" "Detected in many" 17 "granulocytes: 64.1;monocytes: 20.2" "Cell line enhanced" "Detected in some" "A549: 5.8;BJ hTERT+: 7.9;GAMG: 8.3;HDLM-2: 19.2;HMC-1: 13.7;Karpas-707: 16.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA052809 Uncertain NA NA 9100 "HPA052809: AB_2681959" "unprognostic (2.06e-2)" "unprognostic (3.45e-1)" "unprognostic (1.32e-1)" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (6.93e-5)" "unprognostic (6.77e-2)" "unprognostic (1.18e-1)" "unprognostic (5.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-7)" "unprognostic (6.69e-2)" "unprognostic (3.33e-4)" "unprognostic (1.11e-2)" "unprognostic (1.35e-1)" 1.8 0.5 0.7 7.2 2.4 5.9 0.5 0.3 1.7 0.5 0.6 0.3 0.0 2.8 0.4 0.9 0.4 0.6 0.7 1.3 1.5 0.7 0.7 4.1 4.6 6.6 1.7 0.0 0.3 0.4 0.0 1.0 1.8 0.9 0.5 0.5 0.5 0.5 0.0 0.4 0.3 2.8 1.7 1.9 50.0 0.7 1.2 1.0 6.9 0.5 0.0 1.7 2.8 0.4 0.0 2.4 64.1 20.2 0.1 2.0 1.9 2.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 19.2 0.0 0.1 0.0 0.0 0.0 0.4 13.7 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 16.8 0.0 0.1 0.5 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.3 0.1 0.9 3.0 0.1 3.9 3.7 0.0 27.2 4.3 64.1 0.0 12.0 0.0 0.0 1.5 0.2 2.4 0.0 2.0 0.1 1.6 0.1 20.2 0.1 0.4 1.9 0.7 2.4 0.3 1.7 1.5 0.7 1.7 0.0 0.9 1.0 3.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.8 25.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.0 0.0 0.0 ADGRE3 EMR3 ENSG00000131355 "Adhesion G protein-coupled receptor E3" Q9BY15 19 14619117-14690027 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 70.7;lung: 26.3" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7" "Lineage enriched" "Detected in many" 9 "granulocytes: 70.7" "Cell line enriched" "Detected in single" 38 "HMC-1: 32.5" "Not detected" "Not detected" HPA015638 Uncertain "Secreted to blood" NA NA "HPA015638: AB_1848039" "unprognostic (2.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (5.69e-2)" "unprognostic (5.63e-2)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (8.07e-2)" "unprognostic (9.61e-2)" "unprognostic (9.11e-4)" "unprognostic (4.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.13e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 1.7 0.2 0.3 8.5 0.8 4.0 0.3 0.2 0.7 0.2 0.4 0.3 0.1 2.1 0.2 0.7 0.4 0.6 1.2 0.6 0.3 0.3 0.4 1.1 26.3 5.9 0.4 0.1 0.5 0.3 0.0 0.3 1.7 0.7 0.6 0.5 0.7 6.2 0.1 0.9 0.2 3.2 0.7 0.6 8.1 0.4 0.8 0.3 0.8 0.5 0.9 3.4 2.6 0.4 0.0 0.7 70.7 8.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 3.2 69.6 0.0 7.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 70.7 0.0 8.0 0.0 0.0 0.9 0.3 0.8 0.2 0.7 0.3 0.3 0.4 0.1 0.7 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRF2 "GPR111, hGPCR35, PGR20" ENSG00000164393 "Adhesion G protein-coupled receptor F2" Q8IZF7 6 47656436-47697797 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7" "Cell type enhanced" "Detected in single" 21 "Ciliated cells: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;U-87 MG: 3.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA035507 Uncertain NA NA "HPA035507: AB_10601809" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.74e-2)" "unprognostic (5.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (2.51e-4)" "unprognostic (3.05e-2)" "unprognostic (3.86e-2)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (7.99e-2)" 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.4 1.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 6.0 4.2 0.0 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.6 0.3 0.2 0.0 0.0 0.4 0.0 4.7 6.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.7 5.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRF3 "GPR113, hGPCR37, PGR23" ENSG00000173567 "Adhesion G protein-coupled receptor F3" Q8IZF5 2 26308173-26346817 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 7.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.2;Late spermatids: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 3.9;U-937: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044500 Uncertain NA NA "HPA044500: AB_10794290" "unprognostic (9.58e-3)" "unprognostic (2.13e-2)" "unprognostic (4.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (6.68e-4)" "unprognostic (8.98e-3)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" "unprognostic (9.66e-4)" "unprognostic (2.29e-1)" "unprognostic (8.09e-2)" "unprognostic (3.53e-2)" "unprognostic (2.58e-1)" "unprognostic (4.08e-2)" "unprognostic (8.70e-5)" 0.4 0.5 0.4 1.1 0.9 1.4 0.5 2.1 1.2 1.0 1.2 0.1 0.1 2.0 0.8 0.1 0.8 0.5 0.5 1.3 3.3 0.3 3.4 0.7 2.6 1.8 0.3 0.1 0.8 3.2 0.0 0.8 0.7 1.5 0.6 0.4 0.1 2.7 2.6 0.4 0.8 0.7 0.1 1.5 1.4 0.8 2.8 0.7 2.0 0.9 0.1 0.5 0.7 7.6 1.3 0.0 2.0 0.8 0.5 1.5 0.0 0.5 0.2 0.4 1.5 0.1 0.3 2.1 0.2 0.2 0.0 0.3 0.7 0.0 2.4 1.7 0.2 0.0 0.9 0.0 0.0 0.0 0.5 0.5 1.0 1.7 0.2 0.0 0.9 1.0 0.3 0.0 0.1 0.0 0.0 0.6 1.4 0.1 1.0 0.1 0.1 3.9 1.1 2.8 0.0 0.0 2.3 2.2 1.0 0.2 3.1 1.9 0.9 0.0 1.0 0.0 0.1 0.1 0.2 0.4 0.1 0.5 0.9 0.3 1.8 1.4 2.7 0.1 3.5 0.4 0.0 0.0 2.0 1.1 0.8 0.8 1.3 0.5 0.6 0.0 0.3 0.7 1.5 0.1 0.5 0.3 0.0 1.5 0.0 0.4 0.9 2.1 1.2 3.3 0.3 0.3 0.1 1.5 0.7 0.0 0.0 0.0 0.1 0.0 0.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.2 0.0 0.1 1.1 0.4 0.0 0.1 0.0 0.0 0.0 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 ADGRG4 "GPR112, PGR17, RP1-299I16" ENSG00000156920 "Adhesion G protein-coupled receptor G4" Q8IZF6 X 136300963-136416888 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "intestine: 23.6" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "TIME: 3.3" HPA035324 Uncertain NA NA "HPA035324: AB_10671512" "unprognostic (3.40e-3)" "unprognostic (7.68e-5)" "unprognostic (7.61e-2)" 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.9 0.0 0.0 7.1 0.7 1.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 23.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 39.7 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 28.1;OE19: 9.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 9.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.4 0.0 ADM2 "AM2, FLJ21135" ENSG00000128165 "Adrenomedullin 2" Q7Z4H4 22 50481556-50486440 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 30.2;salivary gland: 32.2" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 8.8;Pancreatic endocrine cells: 8.9;Proximal tubular cells: 19.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 22.1;hTCEpi: 13.8;Karpas-707: 22.0;SK-MEL-30: 14.5;U-266/70: 16.1" "Not detected" "Not detected" "Secreted to blood" NA NA 61300 "unprognostic (1.30e-2)" "unprognostic (4.96e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-1)" "unprognostic (3.15e-1)" "unprognostic (4.62e-3)" "unprognostic (7.26e-3)" "unprognostic (1.50e-1)" "unprognostic (3.44e-1)" "unprognostic (7.20e-2)" "unprognostic (9.41e-2)" "unprognostic (7.30e-3)" "unprognostic (1.17e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.06e-2)" 0.5 0.5 0.4 2.9 0.4 0.1 0.7 0.4 0.4 0.8 1.2 0.0 1.3 3.7 0.5 2.9 2.2 0.6 5.6 0.4 0.4 0.4 11.4 6.6 0.8 4.1 0.4 0.0 0.4 30.2 0.0 0.6 0.7 0.2 2.6 0.4 0.1 32.2 2.2 0.4 0.5 5.2 0.0 0.5 2.0 4.3 0.6 0.0 1.6 11.7 1.7 4.0 0.5 0.6 0.9 0.5 2.0 0.5 0.4 1.4 0.2 1.0 0.2 0.3 1.1 0.7 1.3 4.1 5.2 0.5 0.7 1.7 2.1 0.9 0.0 0.8 4.4 0.9 0.8 1.1 0.7 0.2 9.9 0.0 0.0 0.2 1.5 22.1 2.1 1.4 4.4 13.8 2.4 5.0 0.0 0.0 5.8 1.3 22.0 0.1 3.2 0.2 0.4 0.7 6.0 3.3 0.0 0.0 8.2 1.0 0.1 0.5 2.4 0.0 3.2 14.5 0.7 4.4 6.9 0.0 0.0 4.9 0.0 0.0 16.1 2.2 2.8 0.4 0.0 1.2 0.7 0.5 0.4 0.6 0.2 0.3 0.6 0.5 0.6 0.0 0.9 1.4 1.1 2.0 0.4 0.5 0.5 0.3 0.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.2 0.0 0.0 4.0 2.4 0.6 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.0 3.3 2.7 0.0 0.0 3.2 0.0 8.8 0.6 0.4 2.7 0.0 1.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.7 1.0 5.2 0.0 8.9 0.3 0.0 19.2 0.0 0.0 0.0 0.2 0.7 0.4 0.8 0.7 1.2 0.7 ADM5 "AM5, C19orf76" ENSG00000224420 "Adrenomedullin 5 (putative)" C9JUS6 19 49688664-49690575 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 5.5;Early spermatids: 5.7;Melanocytes: 5.0;Suprabasal keratinocytes: 5.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 15.9" "Secreted - unknown location" NA NA "unprognostic (2.34e-2)" "unprognostic (2.56e-1)" "unprognostic (3.08e-3)" "unprognostic (5.62e-2)" "unprognostic (2.18e-2)" "unprognostic (2.64e-2)" "unprognostic (1.28e-1)" "unprognostic (2.39e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (1.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.21e-11)" "unprognostic (2.39e-2)" "unprognostic (9.25e-2)" "unprognostic (9.92e-3)" "prognostic favorable (6.74e-4)" 5.5 0.9 1.0 1.8 1.2 3.2 4.2 2.6 1.5 1.8 1.1 2.2 3.1 1.0 2.0 3.9 1.8 0.7 0.7 1.0 1.5 0.7 3.5 2.7 1.0 1.4 1.0 0.4 1.7 2.2 2.6 0.6 1.6 1.1 2.4 6.5 1.6 2.3 0.9 5.0 1.1 1.6 1.5 2.0 1.3 2.1 0.6 0.2 0.0 0.3 0.0 1.1 0.0 3.0 5.1 3.0 2.1 0.1 0.0 3.6 0.3 0.2 1.0 0.5 5.9 2.8 4.6 1.1 0.2 0.2 0.9 5.4 1.7 0.4 5.3 10.3 5.1 1.2 3.7 0.1 1.5 3.5 0.5 3.9 0.7 0.4 0.8 1.0 4.9 3.7 3.4 0.2 4.8 2.3 15.9 4.1 0.5 1.5 6.5 2.3 4.7 0.5 5.3 1.9 0.8 0.7 1.5 1.3 0.8 3.3 2.2 0.8 1.7 6.2 0.9 1.2 11.7 9.1 5.2 1.1 8.9 1.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 1.1 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.9 5.5 3.9 0.0 2.5 1.4 1.2 0.0 0.0 0.4 0.0 0.4 5.7 3.3 0.5 0.0 1.0 0.4 1.4 0.7 0.0 0.0 0.2 0.0 1.2 4.3 1.8 2.3 0.6 1.1 5.0 0.0 1.2 0.9 0.4 0.0 0.7 0.0 2.0 0.0 0.3 0.9 0.3 5.5 0.1 0.0 1.6 0.9 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.4;Suprabasal keratinocytes: 56.2;Urothelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8;myeloid DC: 8.4" "Group enriched" "Detected in many" 86 "dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5" "Cell line enhanced" "Detected in many" "GAMG: 50.2;HMC-1: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA NA Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 1.5 1.5 7.6 4.5 9.1 1.6 1.8 7.3 8.7 2.9 15.3 2.4 0.0 0.8 1.7 1.5 11.1 2.2 3.8 1.2 6.6 3.0 0.6 0.7 4.1 1.0 1.9 5.4 0.6 2.8 0.4 1.9 9.0 5.2 1.7 12.8 10.5 1.9 0.7 0.7 10.4 1.6 2.8 3.9 0.7 2.6 0.7 2.6 0.1 0.6 4.4 4.5 6.8 5.6 0.0 8.4 12.8 4.5 0.0 0.0 1.5 10.0 5.5 0.1 0.2 1.8 3.5 0.2 1.9 8.7 5.7 7.1 2.6 10.5 1.3 2.4 1.7 50.2 15.8 2.4 14.5 7.6 2.8 5.5 9.7 1.8 3.8 7.1 0.0 50.7 2.0 6.2 8.1 18.9 9.8 2.8 1.5 0.4 0.0 5.6 2.6 0.6 1.9 0.6 21.6 7.8 0.0 0.1 0.0 5.8 2.7 0.2 0.3 4.3 1.0 2.6 4.3 0.0 1.5 2.4 2.0 5.4 5.6 9.0 0.8 0.0 0.0 8.1 0.0 2.8 12.8 4.0 2.6 0.0 4.5 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.4 0.0 2.3 0.1 0.0 1.5 7.6 9.1 7.3 8.7 6.6 3.0 1.9 5.4 5.2 2.6 3.0 3.4 0.0 12.7 65.4 0.0 1.2 2.5 8.1 7.9 0.0 0.0 10.1 0.0 6.2 0.3 0.6 4.9 0.0 0.8 2.8 6.1 11.9 0.0 0.0 4.6 0.0 2.4 0.0 2.7 0.0 0.0 5.1 6.8 0.0 1.4 7.4 0.8 4.8 0.0 0.0 0.5 0.0 1.9 0.5 1.2 56.2 5.1 0.0 3.7 26.7 ADPRHL1 ARH2 ENSG00000153531 "ADP-ribosylhydrolase like 1" Q8NDY3 13 113399610-113453524 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 89.6;skeletal muscle: 68.1" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.7;T-47d: 26.4" "Region enhanced" "Detected in single" "cerebellum: 2.6" "Not detected" "Not detected" "HPA066478, HPA072123" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA066478: AB_2685673, HPA072123: " "unprognostic (3.03e-1)" "unprognostic (1.38e-2)" "unprognostic (2.31e-1)" "unprognostic (8.88e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.35e-1)" "unprognostic (2.56e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-2)" "unprognostic (1.53e-2)" "unprognostic (4.99e-3)" "unprognostic (1.02e-1)" 1.8 1.0 0.6 0.2 1.1 0.0 0.8 0.5 3.0 0.4 1.4 0.3 0.0 0.9 0.4 4.0 2.2 1.9 0.7 89.6 0.5 0.8 0.2 0.4 0.5 0.1 0.7 1.1 0.5 1.5 0.0 1.8 1.4 0.3 0.9 0.5 0.0 1.9 0.1 68.1 0.9 3.0 0.2 0.5 0.3 1.0 1.3 0.0 0.1 0.7 21.8 0.6 0.3 0.5 1.9 2.8 1.7 1.6 1.1 2.5 1.0 4.0 9.6 1.0 3.0 3.1 5.0 2.7 1.5 0.7 0.5 0.4 2.7 9.9 1.4 5.7 1.7 2.8 2.2 3.8 0.2 0.4 1.4 1.6 4.1 2.3 0.7 1.0 0.3 1.7 1.7 2.3 3.2 0.4 0.4 0.1 3.6 1.2 0.4 4.0 8.7 0.6 2.4 2.2 10.4 5.1 6.3 2.5 3.6 1.0 0.4 14.7 3.4 1.0 4.8 1.2 1.2 26.4 0.5 0.3 0.1 1.8 4.4 0.5 1.4 1.1 4.7 2.9 0.8 2.1 0.4 1.2 0.1 0.1 1.6 1.8 1.9 0.8 2.5 2.8 0.8 1.4 1.5 1.7 1.1 1.3 0.5 1.3 1.0 0.6 1.1 0.5 3.0 0.5 0.8 0.7 1.1 0.3 0.0 0.0 5.8 0.0 1.9 1.1 1.3 122.4 0.0 8.1 4.5 0.0 0.0 3.2 0.0 2.8 1.1 1.6 3.8 0.0 2.9 2.2 1.5 2.3 0.0 1.0 0.5 1.6 4.1 1.3 0.3 1.3 0.0 0.5 1.7 0.0 5.1 2.1 1.4 5.8 1.4 0.3 1.7 0.0 0.5 1.8 2.6 2.3 2.1 0.0 3.2 2.8 ADRA2C "ADRA2L2, ADRA2RL2, ADRARL2" ENSG00000184160 "Adrenoceptor alpha 2C" P18825 4 3766348-3768526 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.1" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 12.2;Muller glia cells: 5.2;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 11.1;MCF7: 18.4;NTERA-2: 6.5;OE19: 7.3;SCLC-21H: 7.1;SH-SY5Y: 8.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 41.4" HPA057688 Uncertain NA NA "HPA057688: AB_2683503" "unprognostic (1.44e-2)" "unprognostic (2.21e-3)" "unprognostic (1.23e-1)" "unprognostic (2.02e-2)" "unprognostic (4.70e-2)" "unprognostic (1.11e-1)" "unprognostic (7.12e-2)" "unprognostic (6.69e-2)" "unprognostic (1.88e-1)" "unprognostic (3.71e-1)" "unprognostic (3.24e-2)" "unprognostic (9.08e-3)" "unprognostic (1.01e-2)" "unprognostic (6.00e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (6.48e-2)" 6.5 2.4 2.1 1.0 9.8 0.4 9.2 0.5 2.6 35.1 1.5 0.6 12.8 1.0 20.3 18.0 2.1 6.4 5.5 3.0 1.2 1.0 9.2 1.3 2.0 1.2 0.7 1.6 7.6 4.1 0.5 4.2 27.6 1.1 7.3 0.6 3.6 0.8 24.6 2.6 2.1 0.9 3.0 0.7 7.5 0.7 6.2 2.0 0.2 0.8 1.9 0.5 2.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.1 0.5 0.0 0.2 0.4 0.0 0.0 0.0 2.0 1.2 0.0 2.1 0.3 0.7 0.0 0.2 0.0 0.0 0.0 5.7 0.0 0.0 11.1 0.6 0.0 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.7 18.4 0.0 0.0 6.5 7.3 0.0 0.0 6.0 0.0 0.0 0.3 7.1 8.5 2.5 0.0 0.1 1.7 6.1 0.1 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 9.8 0.5 1.4 1.2 1.0 0.7 1.6 1.1 2.0 0.0 0.0 0.0 0.1 0.0 1.4 0.9 2.5 0.0 0.0 12.2 0.0 0.8 3.3 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.2 0.2 0.0 3.5 1.8 0.0 0.0 4.1 0.0 0.7 0.0 1.4 0.0 0.0 0.1 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA048113: AB_2680268" "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.7 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.5 0.3 1.6 0.8 0.0 0.7 0.3 1.1 0.7 0.0 4.8 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.9 3.6 10.5 7.5 35.9 0.2 8.6 0.0 1.2 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.1 13.5 0.7 0.1 0.0 0.1 0.6 0.0 0.3 1.3 0.0 0.3 19.4 12.9 0.9 0.3 1.0 0.5 15.2 0.0 2.7 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 0.0 1.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.1 44.7 0.7 109.7 0.1 113.2 23.3 2.2 0.1 1.0 0.5 5.7 0.0 8.9 0.0 5.2 0.0 0.3 127.1 1.7 1.3 1.7 47.7 36.6 0.0 5.0 73.7 0.7 0.0 0.0 0.0 1.0 1.5 0.8 5.0 0.1 5.7 46.8 0.4 AFMID "DKFZp686F03259, KF" ENSG00000183077 Arylformamidase Q63HM1 17 78187317-78207701 "Enzymes, Predicted intracellular proteins" "Tryptophan catabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.7" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 68.8;Hepatocytes: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.5" "Group enriched" "Detected in all" 5 "B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5" "Cell line enhanced" "Detected in all" "Hep G2: 62.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023861, HPA026536" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023861: AB_1844636, HPA026536: AB_1844637" "unprognostic (3.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.53e-1)" "unprognostic (2.65e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.78e-1)" "unprognostic (1.83e-1)" "unprognostic (1.49e-3)" "unprognostic (1.53e-2)" "unprognostic (5.78e-2)" "unprognostic (9.59e-3)" "unprognostic (9.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (7.79e-2)" 5.9 3.5 12.1 5.4 17.1 4.6 33.0 27.1 18.3 6.1 7.5 44.8 11.7 8.5 7.5 7.0 7.7 11.3 11.4 9.4 17.3 12.0 39.4 78.7 10.6 5.2 29.7 13.3 15.9 27.7 6.9 4.1 12.4 18.1 10.7 9.2 5.8 24.7 11.8 7.9 15.5 7.1 6.6 27.0 6.2 10.2 6.2 23.9 3.9 6.5 5.6 6.2 6.7 7.4 5.1 6.7 1.7 14.5 1.6 1.1 1.5 7.0 10.0 8.8 8.0 10.0 11.7 4.8 10.1 5.8 7.2 8.6 10.6 5.9 22.1 6.7 7.7 4.2 6.1 14.9 8.9 10.1 14.0 11.9 17.8 11.8 62.3 8.7 14.7 9.2 15.6 9.4 8.3 10.9 11.8 13.4 6.7 18.0 7.8 5.5 7.0 11.2 22.4 7.2 17.2 17.3 12.8 9.0 26.5 9.7 6.5 19.7 14.6 8.7 26.3 8.2 9.2 7.9 14.3 6.6 11.0 7.2 6.9 7.1 11.9 7.8 22.7 9.1 7.2 2.8 1.1 6.1 0.7 0.7 14.5 1.1 5.1 1.0 1.1 6.7 2.0 0.6 0.6 1.7 1.6 9.3 4.4 0.9 1.5 12.1 17.1 27.1 18.3 17.3 12.0 29.7 13.3 18.1 23.9 14.9 13.6 10.0 19.1 23.5 1.4 11.5 68.8 17.4 12.5 61.1 3.9 10.9 14.9 10.4 0.3 14.7 12.9 0.0 7.4 9.5 15.0 15.8 2.3 100.2 9.5 1.6 12.6 21.5 21.9 1.5 20.8 18.3 28.7 10.8 20.6 1.7 8.6 24.9 20.5 39.6 1.5 0.0 7.5 1.2 11.8 35.9 9.6 4.4 25.0 12.2 AGAP4 "AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2" ENSG00000188234 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 4" Q96P64 10 45825594-45853875 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 124.6;Late spermatids: 42.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-1)" "unprognostic (7.50e-2)" "unprognostic (2.50e-2)" "unprognostic (4.10e-4)" "unprognostic (4.13e-3)" "unprognostic (5.72e-2)" "unprognostic (3.68e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.76e-5)" "unprognostic (7.49e-2)" "unprognostic (3.19e-1)" "unprognostic (8.58e-2)" "unprognostic (5.28e-4)" 2.6 5.6 3.4 4.8 5.2 4.3 5.9 13.6 5.2 3.2 4.1 8.4 4.5 6.2 2.6 4.3 3.9 3.3 3.9 4.1 4.0 3.9 3.8 5.8 3.2 5.6 4.2 1.7 7.5 2.5 5.4 4.3 4.1 5.1 4.6 12.7 4.8 2.8 3.2 8.0 4.4 5.6 4.8 3.7 3.2 3.3 1.5 1.3 4.8 1.4 2.3 2.2 0.3 4.9 3.0 13.9 8.3 5.1 6.9 7.2 6.0 4.2 4.9 7.9 7.5 12.3 4.9 5.5 3.7 2.1 11.7 8.5 6.9 6.9 5.1 8.7 0.5 11.8 13.2 7.5 6.3 6.2 5.2 9.8 7.3 9.1 6.8 4.8 13.4 8.7 6.6 3.4 5.5 9.7 21.2 8.9 4.1 1.4 9.5 4.1 7.2 6.3 6.4 10.3 11.2 3.2 8.7 7.3 10.3 9.7 4.8 4.8 3.4 7.3 6.5 8.8 9.9 8.9 9.0 5.8 11.6 1.8 4.8 1.1 2.5 1.6 1.4 1.2 0.6 0.8 2.2 1.3 1.5 0.8 1.1 3.8 2.3 0.6 1.0 0.8 0.3 17.9 8.0 0.8 1.5 0.3 3.8 4.7 7.6 10.7 9.1 1.8 9.8 4.0 0.0 1.6 124.6 3.1 4.9 0.0 1.6 1.1 1.7 2.5 12.7 2.1 2.0 0.0 1.2 4.9 2.8 42.5 2.0 2.1 0.0 1.8 4.4 2.2 1.0 0.0 4.9 0.8 5.1 6.5 1.0 5.0 4.1 0.1 1.6 3.2 5.2 1.4 AGAP5 "CTGLF2, Em:AC073389.1" ENSG00000172650 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 5" A6NIR3 10 73674285-73698159 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 66.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (1.84e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (4.45e-3)" "unprognostic (1.40e-1)" "unprognostic (4.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (4.04e-3)" "unprognostic (4.33e-3)" "unprognostic (5.83e-5)" "unprognostic (3.33e-2)" "unprognostic (2.87e-1)" "unprognostic (7.29e-2)" "unprognostic (1.17e-2)" 2.8 4.3 1.7 3.4 2.5 2.7 4.6 4.7 1.7 3.3 2.4 3.4 3.3 4.4 2.6 3.1 2.3 4.1 2.0 1.9 3.3 5.4 2.9 4.0 1.8 5.3 9.2 3.0 5.0 2.4 4.3 3.1 6.4 2.5 8.5 6.9 3.7 2.0 2.3 4.4 3.5 7.5 4.1 2.6 2.4 3.0 1.4 1.8 2.9 0.8 0.0 2.0 0.2 3.0 3.9 5.0 5.6 4.1 3.1 7.5 3.9 2.8 2.7 2.2 5.0 4.3 3.7 3.1 3.0 1.1 7.7 3.8 3.1 1.8 4.4 4.3 2.9 7.6 5.6 3.4 7.4 4.9 3.4 3.5 3.0 8.2 7.0 2.2 5.5 3.8 7.6 2.3 2.9 2.8 9.6 1.4 3.3 10.6 3.8 2.2 2.8 2.7 3.0 2.3 2.0 2.2 8.1 4.5 3.8 4.5 6.1 3.6 3.5 4.6 3.4 4.8 9.0 4.5 2.2 3.4 8.6 1.4 2.9 0.7 0.4 2.0 0.8 0.5 0.8 0.8 0.3 0.5 1.4 0.4 0.5 0.3 0.0 0.3 1.8 0.1 0.2 0.0 7.0 0.0 0.3 1.6 2.0 0.0 0.0 8.1 5.7 3.5 5.9 1.2 0.0 1.2 66.3 1.9 1.6 0.0 1.8 0.7 0.9 1.1 3.5 3.9 1.3 3.2 0.0 4.9 1.3 13.7 1.1 1.3 1.7 1.8 2.0 1.9 2.3 0.0 3.5 0.3 2.6 0.0 0.4 2.5 1.9 1.1 0.6 1.0 1.9 0.4 AGAP6 "bA324H6.1, CTGLF3" ENSG00000204149 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 6" Q5VW22 10 49982190-50010499 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 78.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.07e-3)" "unprognostic (2.96e-1)" "unprognostic (1.71e-1)" "unprognostic (7.60e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-2)" "unprognostic (5.51e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.66e-4)" "unprognostic (9.93e-3)" "prognostic unfavorable (9.70e-10)" "unprognostic (8.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.85e-2)" "prognostic favorable (1.83e-7)" 5.1 4.5 2.9 5.5 4.6 6.1 6.0 11.2 4.0 4.3 5.1 10.0 5.2 5.2 3.4 4.5 3.9 3.5 3.3 3.4 5.2 8.8 5.3 7.5 2.9 5.7 7.4 2.9 10.2 3.8 7.0 5.0 7.8 4.6 14.1 12.4 6.2 4.5 2.7 8.9 4.8 7.2 7.5 4.8 3.3 4.4 2.0 2.0 4.0 1.6 3.4 2.4 0.6 5.6 5.3 8.9 10.1 8.3 6.8 7.0 7.1 4.1 5.4 5.4 10.8 6.5 6.9 4.3 4.2 2.2 10.3 5.9 5.3 5.0 5.1 11.3 8.1 14.1 9.8 3.5 12.0 15.4 7.1 9.7 5.8 12.5 7.3 4.5 10.3 11.9 10.6 4.1 8.2 10.9 31.0 5.0 3.6 11.3 9.8 5.2 4.1 6.1 6.8 7.3 9.0 2.8 10.8 5.0 6.3 8.2 9.7 7.7 7.3 9.4 4.9 9.6 11.9 7.7 8.8 5.7 17.1 3.4 4.0 1.6 2.0 2.4 0.7 1.5 0.8 0.9 0.9 0.8 2.0 1.4 1.9 2.2 3.4 0.1 2.0 1.3 0.6 17.9 7.5 0.8 1.2 3.0 5.8 7.2 2.5 9.4 12.5 0.0 3.9 2.0 0.0 1.9 78.3 3.8 3.6 0.0 2.2 1.2 3.3 2.7 7.0 3.4 1.9 3.2 7.0 4.9 6.0 19.7 5.2 2.1 0.0 1.8 5.5 2.6 2.1 3.5 4.2 0.4 7.3 0.0 1.9 9.1 7.8 4.5 1.1 3.5 5.5 1.7 AGBL3 "CCP3, MGC32955" ENSG00000146856 "ATP/GTP binding protein like 3" Q8NEM8 7 134986508-135147963 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 40.4;Spermatocytes: 19.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020397, HPA024150" Uncertain Approved Cytosol NA No Cytosol "HPA020397: AB_2242453, HPA024150: AB_1844639" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (4.72e-2)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-3)" "unprognostic (3.32e-3)" "unprognostic (4.18e-2)" "unprognostic (7.15e-4)" "unprognostic (5.00e-3)" "unprognostic (6.10e-4)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.18e-2)" "unprognostic (2.14e-1)" "unprognostic (8.13e-2)" "unprognostic (1.11e-3)" 3.2 2.7 4.2 4.1 8.4 3.8 4.6 8.7 4.5 4.3 2.4 4.4 4.5 1.6 5.5 15.4 2.2 3.6 3.1 2.4 5.0 3.4 5.3 2.6 3.6 4.0 2.7 4.5 6.8 4.5 0.6 9.2 1.9 3.3 3.8 3.0 3.1 4.9 4.3 4.2 4.7 3.7 3.3 2.9 6.5 4.4 18.7 3.7 2.7 5.4 0.8 2.8 3.3 2.5 2.2 1.7 0.5 0.2 2.2 5.0 1.7 2.6 1.4 3.6 0.8 1.0 1.4 2.2 0.7 0.0 0.5 0.8 4.7 3.0 4.3 1.3 0.0 1.4 2.8 1.3 0.5 0.0 3.4 8.8 3.6 5.3 4.6 0.0 1.6 0.0 0.2 0.0 2.1 0.0 0.0 1.6 4.7 2.6 2.5 0.6 2.5 0.9 1.5 3.1 0.4 0.3 2.5 0.2 1.2 2.6 0.5 2.1 2.4 0.5 0.0 0.3 0.1 1.9 3.5 0.0 0.4 0.9 0.5 1.6 5.3 1.6 1.9 1.8 4.3 4.4 0.0 0.2 0.4 2.4 0.0 1.8 2.1 1.2 2.5 0.5 2.2 2.0 5.0 0.5 2.2 0.1 1.7 1.7 1.7 4.2 8.4 8.7 4.5 5.0 3.4 2.7 4.5 3.3 3.7 3.0 1.1 1.3 1.0 1.1 4.9 1.6 5.1 5.3 2.3 8.7 2.0 0.2 6.6 3.1 40.4 3.8 0.3 0.0 2.5 0.3 1.4 1.5 1.1 1.6 0.4 3.2 2.9 5.5 1.6 8.5 3.1 0.3 5.0 11.8 0.3 2.7 1.6 0.0 2.1 5.1 2.9 0.0 2.3 19.5 3.6 0.3 0.1 1.0 0.0 0.8 AGBL4 "CCP6, FLJ14442" ENSG00000186094 "ATP/GTP binding protein like 4" Q5VU57 1 48532855-50023913 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20.4;pituitary gland: 31.5" "Cell type enhanced" "Detected in some" 23 "Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 22.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.7;SCLC-21H: 5.3;SH-SY5Y: 2.0;SuSa: 1.8;U-937: 2.2" "Low region specificity" "Detected in many" HPA037994 Approved NA NA "HPA037994: AB_10673036" "unprognostic (3.06e-2)" "unprognostic (2.76e-1)" "unprognostic (2.58e-2)" "unprognostic (3.31e-4)" "unprognostic (3.42e-4)" "unprognostic (1.72e-1)" "unprognostic (3.86e-3)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (5.85e-3)" "unprognostic (3.91e-2)" "unprognostic (1.51e-4)" "unprognostic (5.95e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.85e-1)" 1.4 4.5 7.8 0.8 13.6 1.1 1.5 1.3 20.4 1.0 0.8 3.0 0.1 0.7 1.0 4.5 0.9 7.8 1.0 3.7 7.1 7.2 10.2 4.6 1.6 0.8 3.2 11.6 1.3 2.7 3.6 31.5 2.7 6.7 1.0 0.7 4.6 0.8 1.5 0.9 1.5 0.8 0.7 1.5 1.3 1.1 10.7 1.9 0.0 3.4 0.0 0.8 0.7 0.7 0.8 0.5 2.2 0.3 0.6 1.8 0.2 0.0 0.5 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.4 3.7 0.0 0.4 0.1 0.1 0.1 0.1 0.3 5.3 2.0 0.0 0.2 0.0 1.8 0.0 0.3 0.0 0.0 1.4 0.2 0.0 0.2 0.0 0.1 0.1 2.2 0.5 2.2 0.3 0.4 0.3 0.3 1.8 0.5 0.2 0.1 0.2 0.8 0.4 0.2 1.0 0.6 0.2 0.5 0.3 0.2 7.8 13.6 1.3 20.4 7.1 7.2 3.2 11.6 6.7 1.9 0.0 0.0 0.0 0.6 0.2 2.3 1.0 0.0 9.4 1.2 3.5 80.5 0.1 1.7 0.1 9.7 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 4.8 5.8 0.6 0.0 6.5 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 3.8 22.3 0.0 0.0 13.6 3.6 0.0 0.1 0.0 0.0 0.1 AKNAD1 "C1orf62, MGC26989" ENSG00000162641 "AKNA domain containing 1" Q5T1N1 1 108815898-108858228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 12.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 58.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HBEC3-KT: 1.3;hTCEpi: 4.0;hTERT-HME1: 2.2;LHCN-M2: 1.2" "HPA030270, HPA030271, HPA030272" Uncertain Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA Cytosol "Microtubules, Cytokinetic bridge" "HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342" "unprognostic (4.93e-2)" "unprognostic (1.72e-1)" "unprognostic (5.52e-2)" "unprognostic (2.00e-3)" "unprognostic (7.22e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-5)" "unprognostic (8.15e-2)" "unprognostic (5.95e-2)" "unprognostic (2.83e-2)" "unprognostic (1.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.00e-8)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "unprognostic (5.75e-2)" "unprognostic (8.22e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.9 0.6 0.0 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 3.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 58.5 1.0 0.0 0.0 0.2 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.6 2.3 0.0 1.7 0.0 0.3 0.6 0.3 0.0 1.1 0.0 0.0 0.0 0.7 0.5 0.7 0.1 0.6 0.0 0.4 0.0 ALDH3B2 ALDH8 ENSG00000132746 "Aldehyde dehydrogenase 3 family member B2" P48448 11 67662162-67681200 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MCF7: 31.6;SK-BR-3: 32.7" "Not detected" "Not detected" HPA045132 Approved NA NA "HPA045132: AB_10795993" "unprognostic (2.25e-1)" "unprognostic (2.41e-1)" "unprognostic (1.65e-1)" "unprognostic (8.65e-2)" "unprognostic (2.13e-1)" "unprognostic (6.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-2)" "unprognostic (2.59e-2)" "unprognostic (1.61e-1)" "unprognostic (1.15e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 28.1 0.1 0.1 6.7 0.1 0.1 5.0 0.0 1.5 2.4 48.2 1.5 0.1 0.1 0.1 0.0 0.6 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.6 0.3 11.2 0.1 1.8 0.0 0.1 17.1 4.6 0.1 38.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.1 25.7 34.2 4.6 11.6 1.0 0.1 0.6 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 1.8 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 2.6 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 32.7 0.0 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.9 0.0 1.5 1.4 0.0 0.3 0.0 0.0 0.0 5.2 0.0 8.5 1.7 0.3 0.0 0.0 0.0 0.0 0.2 8.0 0.4 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.2 0.0 0.0 6.2 ALG10 "ALG10A, DIE2, FLJ14751" ENSG00000139133 "ALG10, alpha-1,2-glucosyltransferase" Q5BKT4 12 34022281-34029694 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (3.16e-3)" "unprognostic (2.80e-2)" "unprognostic (9.23e-2)" "unprognostic (3.49e-2)" "unprognostic (5.88e-4)" "unprognostic (2.13e-1)" "unprognostic (1.73e-2)" "unprognostic (8.01e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "unprognostic (9.29e-2)" "unprognostic (8.99e-2)" "unprognostic (1.53e-1)" "unprognostic (2.43e-1)" "unprognostic (6.45e-2)" 6.2 7.0 2.7 5.4 5.9 6.9 6.9 4.0 5.5 5.3 4.6 3.8 3.6 3.4 10.3 5.5 6.0 6.2 3.7 4.6 2.6 2.9 4.6 5.7 5.4 6.7 4.1 1.7 7.1 7.8 7.5 6.1 7.2 3.5 5.8 4.1 8.7 9.0 4.4 4.6 5.1 5.0 4.0 3.5 6.1 5.1 8.0 3.6 17.2 6.2 3.0 9.8 5.8 4.8 2.7 1.8 4.5 2.7 2.1 3.8 1.6 4.5 5.4 3.5 5.8 4.2 3.3 12.4 4.4 4.1 4.8 8.6 7.9 11.0 6.9 6.5 2.2 7.1 6.9 6.6 5.6 6.5 11.0 6.3 6.4 5.7 3.1 1.7 9.2 6.7 3.6 3.3 10.1 7.7 2.3 3.2 6.2 9.6 11.7 3.9 6.2 5.9 5.1 13.1 2.7 6.8 5.3 12.7 7.0 2.6 6.8 3.1 2.5 7.7 3.3 5.5 10.5 7.9 2.5 6.8 6.6 9.8 8.8 5.5 6.4 11.5 13.3 4.6 3.7 5.2 0.0 2.7 4.5 1.9 1.2 3.0 2.5 2.6 1.1 1.8 2.7 3.1 3.8 0.4 2.1 1.2 1.8 3.0 1.6 2.7 5.9 4.0 5.5 2.6 2.9 4.1 1.7 3.5 3.6 6.0 0.3 3.0 2.5 1.3 3.5 0.8 2.5 4.0 3.4 5.2 3.9 6.4 1.7 1.9 0.6 2.1 1.0 0.0 3.3 4.7 2.1 0.6 1.1 2.4 2.9 1.6 1.2 0.6 2.7 0.0 1.4 2.1 0.0 4.6 1.9 3.7 2.6 0.0 1.1 1.1 4.1 0.0 1.0 7.5 3.0 2.4 2.6 4.3 1.7 1.4 ALG1L ALG1L1 ENSG00000189366 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 11.4;urinary bladder: 12.5" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 30.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 11.0;CAPAN-2: 10.0;HaCaT: 10.7;MCF7: 20.7;OE19: 13.1;T-47d: 13.9" HPA036108 Uncertain NA NA "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favorable (6.24e-4)" 0.0 0.5 2.3 0.8 1.6 0.0 1.1 0.3 1.8 0.8 0.9 0.0 0.9 11.4 1.3 2.0 0.4 0.1 1.6 2.0 1.0 1.0 0.7 0.0 2.2 1.7 0.7 0.0 1.2 1.2 1.2 0.6 1.6 0.6 5.9 5.5 0.1 0.2 1.0 0.0 1.1 0.5 1.0 2.3 12.5 0.9 3.1 2.4 4.8 0.2 5.3 5.0 2.1 0.7 0.6 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.1 0.3 11.0 10.0 3.0 4.9 0.0 0.2 10.7 0.3 0.0 0.6 0.4 2.5 0.5 1.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.8 1.0 0.0 20.7 0.6 0.2 4.5 13.1 2.6 0.1 0.0 5.0 0.0 0.6 1.7 0.7 0.4 0.1 0.5 2.4 13.9 0.2 0.2 0.1 1.7 0.1 0.0 7.8 1.1 4.0 0.1 0.0 0.7 4.8 0.1 0.2 3.9 0.2 2.1 3.1 2.1 4.2 0.0 1.9 2.3 1.6 0.8 5.3 0.0 2.4 5.0 2.1 0.0 0.3 0.8 1.6 3.0 0.2 0.0 0.0 30.8 3.4 1.8 0.0 2.8 1.7 0.3 1.5 0.0 0.0 0.0 0.3 1.8 1.5 0.6 1.1 0.0 0.2 0.0 1.7 0.0 0.0 1.5 1.7 0.0 1.7 0.0 0.0 0.6 0.4 0.8 2.8 0.7 0.0 0.0 1.2 1.7 1.6 4.4 1.1 0.0 0.2 6.4 ALPK1 "FLJ22670, KIAA1527, Lak" ENSG00000073331 "Alpha kinase 1" Q96QP1 4 112285509-112442620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027435, HPA027443" Approved Approved Centrosome NA NA Centrosome "HPA027435: AB_10599614, HPA027443: AB_10599421" "unprognostic (6.24e-2)" "unprognostic (1.92e-1)" "unprognostic (9.30e-2)" "unprognostic (1.69e-2)" "unprognostic (7.40e-2)" "unprognostic (5.45e-2)" "unprognostic (2.55e-2)" "unprognostic (7.47e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (7.14e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.82e-7)" "unprognostic (1.60e-1)" "unprognostic (4.17e-2)" "unprognostic (2.81e-1)" "prognostic favorable (1.17e-4)" 15.1 10.6 5.3 8.3 7.7 17.3 9.3 1.3 5.9 10.8 9.5 5.8 3.0 4.5 9.8 9.2 8.8 9.2 7.5 6.1 6.1 2.3 10.8 13.4 13.2 11.4 9.7 1.0 17.4 9.7 11.0 14.0 11.5 6.6 14.0 7.8 9.6 10.4 6.8 5.0 11.8 12.1 11.3 16.6 16.2 7.4 4.2 8.5 13.7 12.4 4.7 13.7 13.6 11.6 0.9 3.2 16.3 4.3 0.4 0.8 1.2 1.6 5.0 1.6 0.3 6.6 10.6 2.0 1.9 3.5 2.6 3.3 0.5 7.7 5.1 3.3 3.3 5.3 1.1 1.7 3.0 3.9 6.5 1.7 3.6 2.0 0.4 10.6 2.2 2.2 13.1 8.6 3.8 7.9 5.9 1.0 2.7 0.9 8.9 5.0 3.1 1.3 2.0 0.4 3.7 1.3 0.6 1.1 1.6 3.9 1.9 0.5 0.8 1.8 6.6 2.9 0.3 3.0 4.1 1.9 2.4 2.1 3.7 1.3 2.3 0.7 4.4 5.7 4.6 2.1 1.3 3.2 1.4 0.2 4.3 0.6 0.8 0.6 0.1 3.2 0.9 0.8 0.6 16.3 0.4 1.9 0.5 0.0 1.2 5.3 7.7 1.3 5.9 6.1 2.3 9.7 1.0 6.6 8.5 11.9 20.3 0.9 9.4 2.6 0.2 3.1 0.0 20.1 13.6 5.2 0.0 4.0 0.0 5.6 7.5 5.5 7.0 0.0 5.8 2.6 4.1 7.1 5.8 5.8 8.7 0.0 1.2 5.5 14.8 1.6 3.4 14.0 6.8 10.0 8.5 11.3 6.3 8.6 7.1 4.0 0.2 6.5 5.1 0.7 0.5 4.0 6.1 2.2 5.7 10.3 ALPK2 HAK ENSG00000198796 "Alpha kinase 2" Q86TB3 18 58481247-58628957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 79.2;Cone photoreceptor cells: 45.2;monocytes: 31.5" "Cancer enriched" "Detected in some" 6 "renal cancer: 7.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 26.6;BJ hTERT+: 16.2;fHDF/TERT166: 24.0;U-138 MG: 13.5" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "HPA027377, HPA027976, HPA028084, HPA029801" Uncertain Approved Cytosol NA NA Cytosol "HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006" "unprognostic (7.35e-2)" "unprognostic (4.91e-2)" "unprognostic (1.64e-1)" "unprognostic (4.60e-3)" "unprognostic (2.64e-1)" "unprognostic (8.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (5.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-2)" 0.8 0.0 0.1 2.8 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.8 0.0 0.4 35.3 0.1 0.0 5.2 2.8 0.1 3.3 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.2 0.4 0.1 35.3 0.3 0.6 0.1 0.1 0.2 1.2 0.6 0.1 5.5 0.3 12.4 7.9 0.5 0.1 0.0 0.5 0.0 1.8 0.0 0.3 0.0 0.0 7.0 0.5 0.0 0.2 1.8 0.1 26.6 16.2 11.2 9.7 1.7 0.0 0.0 2.8 24.0 1.5 0.0 0.0 0.0 11.5 5.8 0.0 0.0 2.2 0.9 1.5 0.0 0.0 1.6 0.0 3.4 0.1 0.3 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 13.5 6.0 1.8 4.5 10.9 9.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 79.2 0.0 0.0 0.0 0.0 45.2 0.0 1.7 0.4 14.2 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.0 2.4 0.5 1.6 0.0 0.6 0.0 15.3 0.3 0.9 0.0 31.5 0.0 2.9 0.3 0.2 0.0 9.8 0.5 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 ALPPL2 ENSG00000163286 "Alkaline phosphatase, placental like 2" P10696 2 232406843-232410714 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.2;lung: 9.4" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7" "CAB020698, HPA038764, HPA038765, HPA051699" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.2 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 21.4 0.0 0.0 0.0 0.0 15.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 AMELY AMGL ENSG00000099721 "Amelogenin, Y-linked" Q99218 Y 6865918-6874027 "Predicted secreted proteins" Biomineralization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AMIGO3 ENSG00000176020 "Adhesion molecule with Ig like domain 3" Q86WK7 3 49716834-49719695 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 23 "Intestinal endocrine cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 12.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 12.6" "Cell line enhanced" "Detected in some" "CACO-2: 4.6;HeLa: 5.6;HMC-1: 3.7;SH-SY5Y: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.33e-2)" "unprognostic (5.15e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-1)" "unprognostic (2.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.92e-3)" "unprognostic (3.75e-3)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (7.56e-2)" "unprognostic (7.85e-3)" "unprognostic (3.10e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-1)" "unprognostic (3.58e-3)" 2.4 1.3 1.6 1.5 1.7 4.8 1.0 2.8 4.3 1.0 0.9 1.7 5.8 2.0 1.4 4.5 1.8 1.9 1.2 1.6 0.7 2.1 1.0 3.5 1.6 3.6 0.7 0.5 2.0 2.9 0.7 6.6 0.9 1.9 1.9 0.7 1.9 4.1 5.4 11.7 5.3 1.7 0.7 0.9 2.0 1.7 8.7 0.9 8.7 1.7 5.7 3.8 0.8 1.1 0.4 12.6 0.1 0.1 1.1 1.1 0.4 0.2 0.0 0.2 0.0 0.0 0.4 1.2 0.0 0.0 0.1 0.1 4.6 0.5 0.0 0.4 0.0 0.1 2.6 0.0 0.0 0.0 2.5 1.4 0.0 5.6 2.3 0.0 0.8 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.8 0.0 2.6 2.9 1.6 0.0 0.0 0.0 0.1 0.4 0.2 0.0 2.5 1.4 3.7 0.5 0.2 0.0 0.0 0.3 0.7 0.6 0.4 1.3 0.9 0.2 3.1 2.2 0.4 0.0 1.4 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.2 1.1 0.1 0.1 0.4 0.7 0.1 1.1 0.0 12.6 0.4 0.4 1.6 1.7 2.8 4.3 0.7 2.1 0.7 0.5 1.9 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AMN1 ENSG00000151743 "Antagonist of mitotic exit network 1 homolog" Q8IY45 12 31671137-31729174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.5" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 268.2;Late spermatids: 111.1;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046157, HPA062290" Approved Approved Centrosome NA NA Centrosome "HPA046157: AB_10965846, HPA062290: AB_2684739" "unprognostic (2.11e-2)" "unprognostic (2.52e-1)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "unprognostic (2.80e-1)" "unprognostic (5.93e-2)" "unprognostic (8.60e-3)" "unprognostic (4.08e-2)" "unprognostic (6.48e-2)" "unprognostic (3.01e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-2)" "unprognostic (2.48e-1)" "unprognostic (4.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" 5.3 9.9 24.8 6.1 20.9 3.1 9.0 13.8 28.3 9.6 4.3 11.1 2.9 3.8 10.8 7.9 6.0 17.0 6.9 10.1 22.4 20.9 11.3 5.8 6.5 10.3 19.6 15.2 16.0 8.2 8.5 16.1 5.4 14.8 8.9 4.3 8.9 5.9 7.8 12.8 5.4 4.1 7.3 19.4 8.4 8.4 46.5 16.2 11.7 7.9 4.2 9.0 7.7 5.5 12.3 6.6 27.4 2.7 4.7 9.8 3.4 3.5 7.7 6.3 0.7 6.1 7.9 3.7 3.7 5.8 2.6 5.1 4.0 14.1 1.8 8.5 3.3 20.1 2.0 2.9 4.4 5.4 3.0 3.7 6.2 2.8 5.7 11.0 3.3 3.2 5.2 7.3 4.5 6.4 20.1 14.9 9.6 5.4 5.8 10.0 2.2 1.8 2.6 8.7 7.7 3.7 2.7 10.1 2.9 6.0 8.0 10.1 8.4 4.9 1.3 7.7 14.3 11.9 3.7 8.4 4.5 3.7 3.7 6.8 6.4 6.1 6.3 5.6 3.1 8.4 4.3 2.7 3.3 4.3 1.9 4.3 12.3 4.5 4.6 2.1 11.5 9.8 5.9 27.4 4.7 1.6 6.6 6.7 3.4 24.8 20.9 13.8 28.3 22.4 20.9 19.6 15.2 14.8 16.2 6.0 2.4 19.9 18.4 8.2 10.7 3.1 5.1 13.4 5.7 15.7 25.5 5.7 23.2 7.9 268.2 9.8 2.0 0.0 6.2 4.6 7.4 13.9 7.0 3.2 7.6 28.6 13.8 7.4 6.9 111.1 9.5 4.8 15.1 2.8 1.7 10.1 9.1 0.0 12.7 7.9 40.5 0.0 12.3 84.7 16.4 11.0 6.1 7.5 2.0 23.5 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015826 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" NA NA Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavorable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.20e-4)" 11.4 11.7 18.0 10.8 32.6 9.5 17.8 21.6 22.7 14.5 9.3 16.9 8.6 8.6 14.8 14.2 10.2 12.2 10.4 9.2 17.4 13.8 13.3 13.0 11.0 15.8 17.0 13.9 19.1 10.5 15.5 14.8 10.8 13.8 14.5 11.0 12.3 9.8 11.2 11.0 15.1 10.7 12.2 14.9 15.5 10.5 9.0 15.9 19.5 14.0 7.9 14.9 10.8 9.7 7.8 7.2 7.6 5.9 14.1 11.3 6.7 8.7 7.0 11.4 9.7 8.7 12.9 10.2 7.2 12.0 11.5 11.5 4.7 6.5 8.5 6.6 7.1 6.4 6.9 13.1 6.9 11.7 15.9 7.9 8.5 5.6 4.6 9.6 8.4 10.2 7.9 8.9 9.0 9.3 9.8 9.7 7.7 9.8 8.8 13.2 2.9 9.6 5.7 26.9 4.8 5.1 4.9 20.5 8.9 9.0 5.9 5.6 16.3 8.6 11.7 13.3 12.7 9.0 6.2 7.2 9.5 5.1 11.7 10.9 6.5 6.2 5.7 10.7 6.3 8.7 7.4 5.9 7.6 7.4 5.5 9.1 7.8 9.2 7.6 7.2 5.3 9.8 8.1 4.0 14.1 4.4 4.4 11.3 6.7 18.0 32.6 21.6 22.7 17.4 13.8 17.0 13.9 13.8 15.9 44.7 9.8 14.6 7.5 6.2 21.3 12.6 17.8 28.1 15.9 12.2 9.8 12.8 10.0 8.7 1.2 11.3 6.7 0.0 9.2 12.6 10.6 8.8 16.2 11.5 10.5 27.0 6.4 11.6 19.2 1.5 14.4 11.3 3.3 10.8 9.2 13.4 8.4 7.0 13.1 13.5 17.6 19.4 9.0 7.4 16.2 6.0 9.2 18.1 8.8 6.2 ANGPTL1 "ANG3, ANGPT3, AngY, ARP1" ENSG00000116194 "Angiopoietin like 1" O95841 1 178849705-178871052 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Leydig cells: 394.4;Peritubular cells: 199.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.3;naive B-cell: 2.9" "Lineage enhanced" "Detected in single" "B-cells: 2.9" "Group enriched" "Detected in some" 18 "ASC diff: 48.7;ASC TERT1: 19.6;HHSteC: 21.1;HSkMC: 48.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009976 Approved "Secreted to blood" NA NA 100000 "HPA009976: AB_1844822" "unprognostic (2.59e-2)" "unprognostic (1.31e-1)" "unprognostic (5.80e-3)" "unprognostic (2.63e-2)" "unprognostic (3.60e-1)" "unprognostic (1.71e-2)" "prognostic favorable (8.73e-4)" "unprognostic (3.81e-2)" "unprognostic (5.78e-3)" "unprognostic (1.47e-1)" "unprognostic (1.39e-1)" "unprognostic (5.31e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.61e-3)" 17.7 16.3 1.2 8.5 1.1 0.0 14.4 0.7 1.4 26.3 36.2 0.9 9.6 2.6 34.6 46.5 33.6 29.7 16.6 12.9 1.0 0.6 15.9 7.1 12.4 15.8 0.6 2.5 35.7 6.4 0.0 2.2 42.0 1.6 16.7 8.7 0.9 14.2 4.2 20.0 4.5 28.2 22.7 1.8 7.0 13.1 24.7 0.4 0.9 19.3 57.5 2.8 25.5 13.7 2.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 48.7 19.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 21.1 0.0 0.0 48.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.7 1.4 1.0 0.6 0.6 2.5 1.6 0.4 0.0 0.0 0.5 0.0 3.3 2.2 3.1 30.6 1.4 0.0 1.8 5.9 0.5 1.7 0.7 0.8 2.9 0.0 0.0 0.4 0.6 51.8 0.1 0.0 0.9 1.3 0.0 0.0 11.6 0.0 1.9 394.4 0.0 3.3 0.0 0.0 36.6 0.0 0.0 199.4 0.0 12.4 38.8 35.0 0.7 0.7 3.1 1.1 0.0 0.0 0.1 ANHX ENSG00000227059 "Anomalous homeobox" E9PGG2 12 133218312-133236095 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 9.9" "Cell type enriched" "Detected in some" 12 "Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 55 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.28e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 22.4 0.0 0.0 0.0 0.0 0.0 ANKAR FLJ25415 ENSG00000151687 "Ankyrin and armadillo repeat containing" Q7Z5J8 2 189674290-189761193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.3;testis: 9.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 63.4;Late spermatids: 36.4;Rod photoreceptor cells: 48.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "TIME: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036168 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036168: AB_10673345" "unprognostic (2.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.06e-2)" "unprognostic (5.41e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (5.03e-3)" "unprognostic (2.89e-1)" "unprognostic (2.65e-2)" "unprognostic (6.34e-4)" "unprognostic (2.43e-1)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" 0.2 0.4 0.2 0.0 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.0 0.3 0.7 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 0.2 1.2 0.3 0.1 0.5 0.3 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.2 0.6 9.0 0.6 0.1 0.2 0.2 2.3 0.3 0.5 0.4 0.0 0.6 0.1 0.6 0.5 0.4 0.5 0.4 1.1 0.0 0.0 0.7 0.2 0.5 0.9 1.1 0.3 0.3 1.0 0.1 0.8 0.7 0.0 0.3 1.0 0.6 0.6 0.5 1.3 0.0 1.8 0.2 1.3 0.2 0.3 1.4 0.2 0.0 0.0 0.1 0.9 0.3 0.4 0.0 0.5 0.0 0.8 0.7 0.3 0.4 0.0 0.6 2.3 0.0 0.0 0.5 0.3 0.8 0.1 2.4 1.8 2.7 0.8 1.1 0.0 0.0 1.1 0.4 0.1 0.5 0.1 0.2 0.0 0.0 0.5 0.6 0.4 0.1 0.6 0.3 0.1 0.1 2.3 0.2 0.5 0.0 0.0 0.3 0.3 0.0 0.1 3.0 5.1 0.5 5.6 1.1 12.0 4.1 2.5 1.4 3.4 10.4 13.7 1.2 1.7 3.0 63.4 6.8 3.4 0.0 3.7 0.9 4.6 3.6 0.0 2.1 2.1 3.2 0.0 3.7 1.3 36.4 20.1 4.0 6.8 1.0 4.5 8.9 3.5 5.5 13.1 2.1 48.1 6.5 3.3 11.1 4.7 1.1 0.1 4.4 3.8 3.5 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958700 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 29.1" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.9 12.4 7.9 3.7 9.5 3.2 2.3 7.9 9.4 4.3 2.2 0.6 3.5 1.9 4.7 7.6 5.1 5.9 3.9 3.6 8.3 3.9 2.0 1.3 4.4 6.3 4.2 9.8 5.8 7.6 3.5 4.4 5.4 3.5 3.3 0.5 2.4 3.3 4.2 1.5 4.9 2.4 6.5 3.0 14.2 2.6 8.6 1.1 0.0 3.8 0.9 1.6 5.1 4.0 1.0 1.5 1.4 1.9 6.8 4.0 0.8 1.0 2.9 1.4 1.3 2.2 1.7 5.7 1.3 3.5 1.4 2.0 1.6 1.4 1.3 1.5 2.9 1.2 1.4 2.9 0.2 1.1 0.7 0.8 1.4 3.0 1.1 1.6 1.1 2.3 1.3 0.4 0.9 0.5 0.8 1.0 1.3 0.2 19.2 0.4 2.7 0.5 2.1 1.7 0.5 1.3 0.8 0.8 9.1 0.1 14.4 2.9 3.5 0.7 1.0 1.3 1.3 1.1 1.1 1.4 2.6 2.7 2.3 1.3 5.3 18.6 1.0 2.9 2.6 0.8 1.0 0.9 0.1 2.1 1.9 0.8 1.0 1.1 3.2 1.5 0.7 0.8 0.8 1.4 6.8 1.8 0.0 4.0 0.8 7.9 9.5 7.9 9.4 8.3 3.9 4.2 9.8 3.5 1.1 0.0 2.2 0.0 4.9 4.9 9.4 1.2 0.0 0.0 1.2 0.0 11.8 2.7 0.0 0.7 0.8 8.0 0.0 0.0 1.9 4.6 7.0 2.2 5.7 0.0 4.9 3.2 1.2 1.3 5.4 0.9 57.2 7.9 10.1 0.0 0.0 36.1 4.2 0.0 73.9 0.0 6.6 12.9 13.9 1.4 1.1 3.1 1.8 4.1 0.0 4.1 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.0;testis: 22.7" "Group enriched" "Detected in many" 13 "Early spermatids: 319.3;Late spermatids: 291.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favorable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.11e-1)" 5.6 2.9 1.4 2.3 2.4 0.5 3.7 5.7 2.0 2.7 3.1 0.8 11.3 2.9 1.9 4.2 4.7 4.9 4.0 3.2 2.3 2.5 5.7 6.7 2.3 1.3 1.5 1.1 3.6 25.0 5.3 13.6 1.7 4.1 3.4 3.0 3.0 4.2 13.0 1.7 2.9 3.6 1.0 1.2 1.8 5.1 22.7 1.0 3.2 8.6 2.5 3.9 2.1 2.6 2.5 1.6 0.7 0.1 1.5 5.4 1.3 10.0 10.3 1.4 2.5 2.1 1.2 5.9 1.9 0.1 1.8 0.9 5.9 9.1 0.0 3.1 0.4 10.8 8.7 1.8 12.0 2.2 0.0 1.6 1.3 2.0 5.5 1.4 1.1 0.2 3.7 8.6 1.5 1.7 4.2 1.5 3.9 3.8 8.9 0.4 3.1 1.6 0.0 4.3 12.0 2.4 0.0 0.0 6.8 4.4 6.5 7.7 3.9 4.6 10.2 0.0 3.6 8.9 0.9 1.1 1.3 1.4 0.1 1.9 9.2 17.8 1.5 2.6 0.3 1.7 0.0 0.0 0.0 2.8 0.1 5.4 2.5 3.3 2.6 0.2 2.3 4.1 3.0 0.7 1.5 0.0 1.6 3.8 1.3 1.4 2.4 5.7 2.0 2.3 2.5 1.5 1.1 4.1 1.0 3.0 4.1 0.0 2.1 0.2 1.2 1.5 0.0 24.1 2.3 7.0 0.0 1.9 1.7 4.0 319.3 0.7 2.2 0.0 5.4 1.5 0.2 1.6 1.1 7.8 1.1 3.2 5.1 0.0 0.3 291.0 3.1 1.4 0.0 0.0 4.6 1.0 5.4 4.5 3.9 2.1 4.8 0.0 0.1 5.0 2.4 0.3 1.3 1.3 3.4 1.3 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.9 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.4 16.8 0.0 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 1.5 0.0 1.7 0.0 0.3 0.1 5.8 0.0 0.0 0.0 0.4 5.6 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 0.0 0.6 0.0 0.1 0.5 0.0 0.6 0.0 34.8 0.0 0.0 0.0 0.3 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 6.5 0.3 5.9 2.1 0.4 2.4 0.0 0.0 0.9 ANKK1 X-kinase ENSG00000170209 "Ankyrin repeat and kinase domain containing 1" Q8NFD2 11 113387791-113400418 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.7;tongue: 6.3" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 1.4;Horizontal cells: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 1.4;naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.0;hTCEpi: 6.7;RT4: 3.2;U-266/70: 1.3" "Not detected" "Not detected" HPA012813 Uncertain NA NA "HPA012813: AB_1844832" "unprognostic (5.63e-3)" "unprognostic (6.67e-3)" "unprognostic (5.09e-3)" "unprognostic (6.27e-3)" "unprognostic (5.56e-4)" "unprognostic (7.02e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.50e-1)" "unprognostic (3.15e-1)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (5.39e-6)" "unprognostic (3.17e-2)" "unprognostic (3.83e-2)" "unprognostic (2.79e-1)" "unprognostic (4.65e-2)" 0.6 0.5 0.6 0.6 2.0 0.4 1.2 0.6 1.4 1.5 0.6 0.6 0.6 0.4 0.7 0.9 0.6 3.3 0.6 0.6 0.6 1.2 0.6 0.6 0.6 1.1 0.6 0.6 1.0 0.6 0.4 4.7 0.6 0.6 1.9 0.1 0.6 1.8 1.0 0.7 9.7 0.6 0.6 2.3 0.9 0.2 1.0 0.6 0.6 1.2 6.3 1.5 0.6 1.2 1.3 0.2 1.4 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.1 0.3 3.2 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.6 0.0 0.0 0.2 0.0 1.4 0.1 0.2 0.4 0.1 0.1 0.0 0.1 0.0 0.0 1.3 0.2 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.6 2.0 0.6 1.4 0.6 1.2 0.6 0.6 0.6 0.6 0.0 0.3 0.0 0.6 0.6 0.9 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 147.5;Late spermatids: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.3 11.7 2.5 4.7 2.3 3.3 10.6 2.5 3.9 2.1 2.9 3.7 11.0 5.3 0.5 2.8 3.2 5.8 4.9 6.0 2.5 9.8 4.0 10.5 5.7 9.8 1.9 5.8 10.1 5.3 14.7 2.0 14.1 6.5 2.2 8.5 9.7 6.8 3.6 5.1 5.3 9.6 2.1 9.2 7.0 15.2 7.7 8.4 3.3 11.5 6.0 4.4 2.1 5.6 7.8 3.2 4.8 9.0 2.7 8.0 2.7 3.1 4.4 15.8 3.9 5.1 4.5 8.9 6.1 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 0.0 7.2 2.7 1.6 0.8 3.4 1.8 2.5 30.8 10.3 3.5 3.9 2.8 1.7 2.2 147.5 2.8 4.3 0.0 3.7 1.6 1.5 2.0 5.7 5.5 2.5 3.2 4.1 3.1 7.0 162.8 3.7 4.0 0.0 4.6 4.6 1.9 2.5 0.0 2.8 2.6 3.5 0.0 1.3 14.7 8.8 1.9 2.4 4.4 4.9 1.4 ANKRD13C "dJ677H15.3, DKFZP566D1346" ENSG00000118454 "Ankyrin repeat domain 13C" Q8N6S4 1 70260588-70354734 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.05e-3)" "unprognostic (3.11e-1)" "unprognostic (1.28e-2)" "unprognostic (1.91e-2)" "unprognostic (6.38e-3)" "unprognostic (6.59e-2)" "unprognostic (3.48e-2)" "unprognostic (2.41e-1)" "unprognostic (2.28e-2)" "unprognostic (3.17e-2)" "unprognostic (1.47e-3)" "unprognostic (1.57e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-1)" "unprognostic (7.42e-2)" 16.4 16.2 16.9 13.5 18.6 8.5 14.9 33.0 23.0 16.2 15.3 18.9 10.6 13.0 16.6 11.5 13.7 12.3 13.0 11.4 17.0 15.7 16.7 13.1 13.4 15.2 15.3 16.8 17.9 14.8 21.5 14.8 12.9 17.2 15.6 15.9 15.9 13.0 12.6 18.2 17.4 14.3 15.3 17.6 15.1 14.2 8.1 13.9 22.5 15.5 9.6 14.3 14.0 13.4 10.5 11.2 13.1 9.6 8.3 14.2 9.3 12.7 6.1 10.6 10.6 13.6 18.3 4.1 12.0 14.4 10.7 10.8 8.2 7.3 11.2 11.7 14.8 10.7 8.7 10.6 7.4 13.1 15.8 11.8 11.9 14.4 7.6 14.0 12.9 6.5 15.2 8.6 12.9 11.6 9.9 10.5 6.0 9.9 16.0 10.8 5.8 7.6 6.3 11.0 6.1 12.0 8.0 13.0 7.6 16.1 8.4 8.0 8.1 15.8 19.6 16.7 10.6 10.1 8.7 12.9 16.8 10.6 25.4 14.6 15.6 19.8 9.2 14.5 10.4 13.9 13.1 7.6 8.8 10.1 9.6 13.8 10.5 12.7 12.3 11.2 8.5 12.0 11.2 0.8 8.3 8.1 5.9 14.2 9.3 16.9 18.6 33.0 23.0 17.0 15.7 15.3 16.8 17.2 13.9 26.8 10.8 7.0 10.6 14.3 16.0 12.6 5.1 20.1 18.2 10.4 29.5 7.5 11.6 9.3 1.1 10.5 8.4 0.0 9.2 8.9 15.5 15.6 3.5 6.6 8.9 6.4 12.0 12.9 16.2 1.3 10.9 8.7 16.9 8.2 12.0 10.8 10.1 10.5 10.6 8.6 22.1 0.0 22.8 7.5 5.5 10.7 11.0 15.7 8.0 14.0 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 16.6" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.5 3.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.9 0.0 0.0 0.9 3.4 3.2 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.6 0.4 0.0 2.3 0.0 3.1 1.7 0.0 7.0 1.6 0.3 0.3 4.3 0.1 0.8 3.6 5.8 2.0 0.0 6.3 6.3 2.1 1.9 1.5 3.0 2.3 0.5 0.1 7.4 2.5 7.9 4.3 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 0.0 1.0 0.0 1.8 0.6 3.9 6.5 0.0 17.4 5.7 1.8 2.0 0.0 1.7 4.4 4.9 0.0 0.7 0.0 2.0 0.1 0.0 2.0 0.0 0.5 0.1 0.0 4.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 3.6 13.3 3.7 2.9 0.4 0.1 33.7 0.0 0.1 25.6 2.0 1.5 0.0 0.0 2.3 0.7 ANKRD20A1 "ANKRD20A, DKFZp434A171" ENSG00000260691 "Ankyrin repeat domain 20 family member A1" Q5TYW2 9 67859147-67902094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 6.5" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.6;Ciliated cells: 4.0;Spermatocytes: 6.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "Karpas-707: 7.1;U-266/70: 11.7;U-266/84: 3.9" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.92e-1)" "unprognostic (4.31e-3)" "unprognostic (3.97e-1)" "unprognostic (2.30e-2)" "unprognostic (5.94e-2)" "unprognostic (2.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-2)" "unprognostic (7.17e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.9 0.2 0.1 0.0 0.4 0.1 0.3 0.8 0.0 6.5 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.3 0.0 0.2 0.4 1.4 0.6 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.4 0.9 1.0 0.4 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.4 7.1 0.0 0.0 1.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 0.6 1.0 11.7 3.9 0.0 0.5 0.0 1.9 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 1.1 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 6.3 1.9 0.0 0.0 0.0 0.9 0.0 ANKRD20A8P ANKRD20B ENSG00000229089 "Ankyrin repeat domain 20 family member A8, pseudogene" Q5CZ79 2 94811046-94857282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 3.2;thyroid gland: 5.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Cardiomyocytes: 3.0;Club cells: 9.1;granulocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "RT4: 2.8;U-2 OS: 9.8" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (3.08e-1)" "unprognostic (3.86e-1)" "unprognostic (3.79e-2)" "unprognostic (1.30e-4)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 0.0 0.0 0.0 3.0 0.0 1.4 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88822132-88851818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.2;stomach 1: 27.6;tongue: 29.0" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 15.4" "Group enriched" "Detected in many" 13 "granulocytes: 15.4;monocytes: 6.8" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.4 0.5 2.3 8.4 3.6 5.3 2.3 0.3 3.2 6.7 6.7 0.5 0.0 2.0 0.3 0.2 21.9 0.3 4.3 1.1 4.0 0.6 6.0 1.6 1.3 6.1 3.6 0.2 0.3 40.2 0.1 1.6 0.2 2.7 2.0 7.2 0.1 3.7 0.0 0.3 18.5 2.1 1.3 7.4 8.8 27.6 0.3 1.4 7.9 0.3 29.0 14.6 4.4 8.6 0.1 0.4 15.4 6.8 0.5 0.8 1.2 8.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.1 0.0 0.0 6.7 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.7 6.4 0.1 20.7 0.1 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 1.3 0.0 0.0 12.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.1 0.1 4.8 2.5 0.1 6.8 0.0 0.0 0.4 0.1 0.4 0.1 0.8 0.2 15.4 0.5 1.2 0.4 0.0 1.2 2.3 3.6 0.3 3.2 4.0 0.6 3.6 0.2 2.7 1.4 0.0 3.0 0.0 16.2 33.1 0.0 0.1 10.2 0.0 1.2 7.0 0.0 0.0 0.0 2.6 0.0 0.0 6.4 0.0 5.2 0.0 0.7 10.4 0.0 0.0 2.4 0.0 1.7 0.0 7.2 0.0 0.3 12.3 1.7 1.0 11.8 0.0 4.5 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 89.8 0.0 0.7 11.2 29.8 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;U-266/70: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.4 2.1 6.0 0.8 8.5 1.1 1.2 1.4 22.1 1.0 1.1 0.8 0.1 1.9 1.0 2.1 0.5 1.4 1.3 0.6 5.1 4.4 1.8 5.5 1.1 1.0 4.1 9.4 1.4 3.3 2.4 3.8 1.9 2.3 4.3 0.9 1.0 1.7 1.7 2.5 1.1 1.5 0.7 2.3 1.5 1.6 7.3 1.8 0.1 1.9 0.1 0.6 0.6 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 3.2 0.3 3.4 0.2 0.1 0.0 0.0 0.1 0.1 0.1 2.0 0.4 0.2 0.2 0.1 0.5 0.0 2.4 0.3 0.1 0.1 0.1 1.8 0.1 0.3 1.8 0.1 0.3 0.8 0.5 0.1 2.0 0.1 5.6 0.0 0.7 0.0 0.1 2.5 0.7 0.7 0.4 0.0 0.4 0.0 0.2 0.9 0.2 0.1 0.1 0.3 0.6 0.7 0.4 0.0 0.1 1.2 0.9 0.0 18.9 1.6 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 8.5 1.4 22.1 5.1 4.4 4.1 9.4 2.3 1.8 0.0 3.4 0.0 0.2 0.0 0.8 0.8 2.5 0.0 2.3 0.0 3.9 0.2 0.0 0.1 0.5 0.0 0.3 0.0 0.0 17.7 0.0 0.2 0.0 1.0 0.3 0.0 3.5 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.7 1.1 0.0 0.9 0.0 0.2 0.0 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 202.5;Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;T-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.7;BJ hTERT+: 12.1;hTCEpi: 12.0;PC-3: 11.5;U-2197: 15.0;U-87 MG: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favorable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favorable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favorable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 11.8 6.1 8.9 6.6 6.6 0.2 9.9 1.9 15.1 8.4 3.0 3.7 3.0 1.2 13.1 6.4 6.5 9.6 4.4 4.9 9.8 5.3 2.5 1.6 25.2 14.6 8.7 6.2 12.4 0.8 18.4 6.0 0.3 17.9 7.0 1.8 4.3 5.1 7.5 3.2 3.2 4.5 9.8 3.2 2.0 11.7 2.9 3.1 1.6 2.3 5.5 11.1 4.8 9.1 0.0 1.6 0.0 0.0 0.0 1.1 0.0 1.6 4.8 0.0 0.0 1.2 12.7 0.1 4.8 12.1 1.9 2.4 2.2 0.4 0.0 0.7 2.2 9.5 2.4 0.0 6.3 0.4 0.1 4.4 0.0 3.1 0.1 0.2 0.0 0.3 3.3 12.0 1.9 3.2 1.8 1.2 0.0 0.0 0.2 3.2 0.5 0.0 0.0 0.8 4.0 11.5 0.0 0.3 1.1 3.0 1.7 0.7 5.9 1.2 0.2 0.1 0.2 1.4 0.0 2.8 0.3 1.7 15.0 4.2 0.0 0.0 0.0 15.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 8.9 6.6 1.9 15.1 9.8 5.3 8.7 6.2 17.9 3.1 202.5 27.6 0.0 7.4 4.5 4.2 7.1 5.1 2.7 10.3 1.8 62.8 0.0 5.0 1.8 30.7 19.4 0.4 0.0 1.0 0.0 2.0 4.4 3.5 0.9 2.3 39.7 1.7 9.2 0.6 20.2 6.6 2.4 6.8 0.0 0.5 0.9 6.8 0.2 19.1 8.6 3.7 12.9 38.7 2.7 2.0 2.5 0.0 0.0 0.9 2.7 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125788-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "breast: 31.7;testis: 17.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 12.3;Late spermatids: 4.8;Spermatocytes: 23.6" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "A549: 3.9;U-266/70: 15.6" HPA071849 Uncertain Nucleoli NA NA Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 23.6 1.7 0.0 0.2 0.0 0.0 0.0 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14852738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 42.2" "Group enriched" "Detected in some" 8 "Early spermatids: 10.7;Late spermatids: 11.2;Spermatocytes: 17.0" "Cancer enhanced" "Detected in single" "breast cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 31.8" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA060455: AB_2684282, HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.3 0.2 1.2 0.1 2.5 0.1 2.3 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.9 0.1 0.1 0.1 0.1 0.4 1.2 0.1 0.6 0.1 0.0 0.1 1.0 0.1 0.2 2.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 42.2 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.8 2.6 0.1 31.8 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 1.8 0.9 0.9 0.4 1.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 10.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 11.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.4 0.3 0.5 0.0 0.6 0.1 ANKRD30BL "ANKRD30BP3, NCRNA00164" ENSG00000163046 "Ankyrin repeat domain 30B like" A7E2S9 2 132147591-132257969 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 6.4" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 1.2;U-266/70: 1.1" NA NA "unprognostic (1.67e-1)" "unprognostic (1.42e-1)" "unprognostic (5.57e-2)" "unprognostic (2.15e-1)" "unprognostic (2.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.3 0.5 0.1 0.0 0.0 0.0 0.0 ANKRD33 "C12orf7, DKFZp686O1689, PANKY" ENSG00000167612 "Ankyrin repeat domain 33" Q7Z3H0 12 51887960-51891664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "placenta: 21.9;retina: 19.5" "Group enriched" "Detected in some" 23 "Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 154.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA058753 Enhanced NA NA "HPA058753: AB_2683808" "unprognostic (4.42e-2)" "unprognostic (2.13e-5)" "unprognostic (8.25e-4)" "unprognostic (2.37e-1)" "unprognostic (3.25e-5)" "unprognostic (2.42e-1)" "unprognostic (4.07e-1)" "unprognostic (6.21e-2)" "unprognostic (5.51e-10)" "unprognostic (4.41e-3)" "unprognostic (5.56e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 21.9 0.0 0.0 0.0 19.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 154.5 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959442-145964582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 18.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.1;Cardiomyocytes: 2.9;Muller glia cells: 1.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.5;T-cells: 3.5" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol NA NA Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.8 1.3 6.4 2.0 10.5 0.3 0.6 7.8 18.1 0.9 0.7 1.2 0.0 1.6 1.5 1.2 0.9 0.7 1.1 1.7 4.2 0.5 0.2 0.7 1.4 0.4 6.7 1.6 0.5 2.0 1.2 0.5 5.7 1.7 0.4 1.3 0.8 2.2 2.3 0.8 1.6 1.6 0.0 1.4 1.1 0.5 1.0 0.0 0.6 0.0 1.5 0.9 0.0 1.5 0.4 0.6 0.3 0.3 3.5 1.0 1.4 0.8 0.7 2.5 3.6 2.8 0.3 2.7 5.2 0.6 1.7 0.2 0.8 2.8 0.3 3.5 1.4 0.6 1.1 0.8 0.4 5.9 1.7 0.2 2.1 0.0 0.5 0.3 2.3 2.5 0.3 2.3 2.6 3.7 0.9 2.3 1.3 6.4 4.0 2.5 1.1 0.8 0.3 0.2 3.1 0.3 0.7 12.6 1.1 0.1 3.5 2.5 0.5 0.1 1.6 0.3 3.6 0.4 0.8 6.3 4.3 5.3 1.4 4.5 8.6 0.4 6.2 2.2 0.5 0.0 0.1 0.6 3.5 0.3 2.6 1.5 1.7 1.9 0.4 1.4 2.3 3.4 0.3 0.3 0.0 0.1 1.7 1.0 0.0 0.0 0.0 0.4 0.2 8.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.5 0.3 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.4 0.3 1.4 0.0 0.7 0.4 0.4 0.1 0.1 0.0 0.0 0.1 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 46.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.7 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 11.0 0.3 1.6 4.0 0.5 1.3 0.4 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.3 3.1 0.1 3.8 0.5 0.3 0.1 0.1 0.5 0.0 0.0 0.0 2.4 0.0 0.0 4.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 0.0 0.0 0.0 14.7 4.0 1.5 1.2 2.5 4.0 1.2 1.8 0.0 0.1 0.0 0.0 3.6 1.0 0.0 0.0 0.4 0.1 20.2 8.0 19.5 8.6 8.7 0.0 0.0 1.8 1.6 4.7 33.6 1.1 5.0 0.0 0.0 39.3 0.1 0.0 47.7 0.0 1.4 0.0 5.2 0.0 0.9 10.8 0.2 7.5 0.0 12.9 ANKRD36 UNQ2430 ENSG00000135976 "Ankyrin repeat domain 36" A6QL64 2 97113496-97264521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 71.9;Spermatocytes: 72.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 13.9" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (4.24e-3)" "unprognostic (7.59e-2)" "unprognostic (6.15e-3)" "unprognostic (9.86e-2)" "unprognostic (9.83e-3)" "unprognostic (5.25e-3)" "unprognostic (5.65e-2)" "unprognostic (1.49e-2)" "unprognostic (4.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (9.14e-7)" "unprognostic (1.67e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.75e-1)" 5.1 3.3 8.8 6.0 14.5 22.0 6.8 20.5 10.2 5.6 4.6 4.8 2.2 3.0 8.5 7.7 2.4 6.0 3.8 3.9 7.6 3.3 3.2 1.8 5.0 5.0 4.0 11.3 8.9 5.1 5.3 9.2 2.3 6.8 4.8 5.2 4.7 4.3 3.1 2.2 5.9 4.3 4.7 3.7 5.9 5.1 13.3 8.2 5.6 5.4 2.1 3.7 4.0 4.9 9.9 11.7 9.3 3.3 4.9 9.2 1.7 6.2 1.5 5.1 3.2 1.1 2.6 2.4 2.4 1.7 1.9 1.9 1.6 3.2 8.0 1.6 2.3 1.5 3.1 1.9 2.1 1.6 3.8 2.8 6.0 6.8 2.9 0.5 4.4 2.6 1.7 1.4 1.4 2.4 3.0 3.4 11.2 4.1 13.9 0.8 1.1 5.5 5.8 1.2 0.5 2.9 5.3 2.1 2.2 1.4 3.0 3.6 2.6 2.5 1.5 0.8 2.9 1.6 2.5 5.2 5.4 5.3 6.2 2.8 8.2 3.5 6.5 3.1 6.4 1.8 9.3 2.6 3.5 9.2 1.2 9.1 9.9 8.4 7.3 1.2 9.9 8.6 9.2 3.9 4.9 3.3 11.7 7.0 1.7 8.8 14.5 20.5 10.2 7.6 3.3 4.0 11.3 6.8 8.2 41.7 27.2 12.9 8.0 14.0 47.0 19.1 0.0 44.2 27.3 7.0 70.7 0.9 0.0 5.7 53.0 19.6 2.0 0.0 15.9 4.8 14.4 5.5 25.5 0.8 4.5 20.6 13.2 9.8 4.6 5.3 24.2 17.3 37.1 4.6 6.8 13.0 9.3 3.4 17.0 1.4 71.9 0.0 23.1 72.1 11.9 8.2 0.3 25.4 8.5 12.9 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 135.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: AB_2683614" "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 7.7 8.9 11.0 3.9 15.2 3.3 10.9 9.9 20.9 17.2 7.5 6.0 5.4 4.8 4.9 4.1 35.8 8.0 4.8 13.6 12.0 9.6 6.4 14.2 12.4 3.0 12.3 5.8 14.8 13.5 1.7 11.7 10.7 16.8 24.1 7.0 8.4 35.4 21.9 22.1 7.3 4.9 5.0 16.1 4.6 5.2 8.7 14.2 1.5 14.2 18.6 12.2 14.3 22.8 7.7 4.2 10.2 3.9 3.2 8.1 3.0 6.2 0.9 0.7 3.6 4.9 3.1 3.4 2.9 2.2 2.1 4.7 1.5 1.8 3.0 1.2 5.3 4.4 2.4 3.4 3.7 2.7 8.5 0.9 2.0 3.2 4.5 2.1 1.9 4.7 0.6 4.0 2.0 2.8 15.7 2.7 2.0 3.1 5.1 5.9 1.6 1.6 7.5 1.0 0.6 5.0 0.5 1.0 8.2 2.6 0.5 5.0 8.9 2.0 2.0 8.6 2.7 1.8 1.2 3.5 4.6 3.7 2.6 3.3 9.6 2.8 1.3 13.1 1.4 5.3 0.4 3.8 10.2 5.5 3.5 4.7 7.6 4.3 8.1 2.6 7.7 3.3 4.7 2.0 3.2 3.9 4.2 5.1 3.0 11.0 15.2 9.9 20.9 12.0 9.6 12.3 5.8 16.8 14.2 20.8 23.7 16.6 23.8 52.8 24.8 1.2 0.0 101.7 22.7 8.7 27.5 15.7 21.6 17.9 3.7 11.7 61.7 23.3 20.0 36.6 28.6 40.4 63.2 20.4 13.8 9.5 115.1 10.4 6.7 2.0 8.6 24.5 135.0 28.9 93.8 89.4 40.5 35.1 11.0 15.7 103.2 6.5 35.0 13.3 15.1 42.0 70.6 11.7 31.3 16.2 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 73.6;Early spermatids: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.9 3.3 6.8 10.7 11.2 3.0 8.1 6.3 4.8 3.0 4.2 4.8 1.7 10.5 7.2 9.7 8.5 3.5 5.5 4.0 2.2 2.8 2.8 9.4 2.7 7.4 7.8 6.6 6.6 6.6 12.1 6.5 9.4 4.9 2.8 8.1 1.6 6.9 5.8 1.1 8.6 2.8 6.1 4.4 1.9 5.0 2.0 16.0 4.7 2.7 3.5 10.5 6.6 2.1 4.6 9.9 4.4 7.1 7.5 5.2 27.2 3.7 2.1 4.7 3.3 5.9 4.9 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 8.9 13.6 3.2 17.5 10.0 3.0 6.7 7.6 73.6 7.9 7.0 37.3 2.7 8.3 6.6 123.0 7.1 3.6 0.0 5.8 2.7 8.7 10.0 12.8 3.8 4.4 1.6 2.9 9.2 8.2 53.0 8.1 9.0 6.8 6.4 3.2 6.7 5.4 3.6 9.9 11.4 21.3 12.9 8.7 38.6 18.1 13.4 4.6 7.0 3.1 11.2 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433170-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.8" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.2;BEWO: 31.2;HAP1: 9.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles NA NA Vesicles "CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310" "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.9 2.2 11.7 3.0 7.8 1.6 3.9 47.8 17.8 5.7 2.9 2.8 1.1 1.0 6.1 4.4 4.9 11.7 5.7 8.9 7.8 9.1 5.4 4.5 5.7 2.5 4.2 12.0 15.6 4.3 9.3 4.2 4.3 7.3 3.6 1.1 6.6 7.7 2.3 4.0 1.9 1.8 5.4 5.0 2.0 2.6 6.1 3.7 2.0 5.6 3.3 2.5 4.4 4.0 0.3 0.1 3.0 2.9 0.6 1.0 0.3 0.0 1.3 10.2 4.3 0.1 0.4 31.2 0.1 0.1 0.0 0.6 0.3 0.8 0.0 1.0 0.0 4.7 0.0 9.3 5.2 0.4 0.0 6.9 3.7 0.0 0.3 0.1 0.0 1.4 0.6 1.4 0.0 0.0 0.0 1.0 0.9 0.3 2.3 0.0 1.1 0.1 0.3 2.9 0.4 1.0 3.6 0.0 0.0 1.5 5.2 6.7 2.4 0.8 6.9 3.4 6.5 2.0 2.2 0.0 1.7 0.6 0.1 0.8 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.4 3.0 1.0 2.9 0.0 0.0 0.7 0.0 0.1 0.3 0.3 0.4 0.7 0.6 0.0 0.0 0.2 0.3 11.7 7.8 47.8 11.6 7.8 9.1 4.2 12.0 7.3 3.7 14.9 14.2 0.0 4.6 0.8 0.6 3.9 10.2 10.7 7.9 1.8 11.8 2.5 10.0 4.8 2.5 4.1 0.0 0.0 10.0 6.5 4.7 1.8 10.4 2.5 2.3 0.0 1.7 4.9 2.7 4.3 8.9 1.1 3.3 3.6 0.0 5.7 4.2 0.0 26.2 3.4 1.6 6.5 3.3 5.4 4.9 1.0 1.6 1.3 0.0 4.3 ANKRD62 DKFZp779B1634 ENSG00000181626 "Ankyrin repeat domain 62" A6NC57 18 12093853-12129749 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 47.1" "Group enriched" "Detected in some" 12 "Spermatocytes: 42.4;Spermatogonia: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-2 OS: 2.6" HPA059835 Enhanced NA NA "HPA059835: AB_2684136" "unprognostic (2.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-3)" "unprognostic (9.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (6.61e-2)" "unprognostic (7.95e-2)" "unprognostic (3.27e-1)" "unprognostic (2.55e-4)" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (4.52e-3)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.2 0.3 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.3 0.3 0.0 1.4 0.7 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.4 0.0 1.0 0.0 0.0 42.4 12.4 1.0 0.0 0.0 0.0 0.3 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;fallopian tube: 33.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "myeloid DC: 4.8;plasmacytoid DC: 10.4" "Lineage enriched" "Detected in single" 20 "dendritic cells: 10.4" "Group enriched" "Detected in some" 7 "Hep G2: 20.3;RT4: 20.0;SCLC-21H: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065720 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA065720: AB_2685545" "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 4.6 1.1 12.4 2.8 20.8 0.4 4.2 8.0 13.3 6.7 4.8 21.0 3.7 2.2 4.0 5.6 6.7 33.6 2.7 2.2 12.0 8.6 1.9 0.9 9.9 7.1 37.8 8.2 6.9 13.3 1.1 0.6 6.3 13.7 8.9 1.8 2.1 14.0 21.2 2.8 4.8 2.1 3.8 16.7 1.4 4.3 3.1 28.0 4.2 1.8 1.0 6.3 13.2 3.3 0.5 10.4 0.3 0.3 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.5 0.0 2.6 0.2 2.5 0.0 0.3 0.2 0.0 0.0 20.3 0.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 2.7 0.0 0.0 20.0 27.7 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 4.8 0.5 0.1 0.4 0.0 0.0 0.0 10.4 0.0 0.2 12.4 20.8 8.0 13.3 12.0 8.6 37.8 8.2 13.7 28.0 20.8 25.3 0.0 11.4 1.9 8.4 0.6 12.7 56.2 20.5 1.8 0.0 21.2 8.3 12.9 0.0 5.0 0.0 0.0 27.8 0.4 3.8 7.3 8.1 0.6 2.0 7.9 1.7 1.8 0.6 0.0 19.2 2.9 3.3 1.8 0.0 16.0 12.0 0.0 27.3 0.3 2.2 0.0 2.6 0.4 0.3 2.8 14.1 0.0 0.0 7.9 ANKRD66 ENSG00000230062 "Ankyrin repeat domain 66" B4E2M5 6 46746917-46759506 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 210.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Region enhanced" "Detected in many" "pons and medulla: 15.0" "Cell type enriched" "Detected in single" 6 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (2.52e-1)" "unprognostic (2.44e-2)" "unprognostic (2.03e-2)" "unprognostic (9.36e-2)" "unprognostic (4.30e-3)" "unprognostic (2.19e-1)" 0.1 0.2 2.0 0.2 4.3 0.1 0.2 0.0 0.6 1.7 0.1 5.9 0.0 0.1 0.9 12.1 0.1 36.0 0.1 0.1 3.0 3.0 0.1 0.1 7.1 0.2 0.0 0.0 11.1 0.1 0.1 0.5 0.2 15.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.9 1.9 0.0 0.2 0.1 0.2 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.3 0.0 0.6 3.0 3.0 0.0 0.0 15.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 210.1 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "testis: 184.1" "Group enriched" "Detected in some" 4 "Early spermatids: 2368.8;Spermatocytes: 2786.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.9 0.0 1.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.1 0.4 1.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.2 1.6 0.0 3.1 0.0 0.1 0.3 0.1 1.4 1.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.4 0.7 0.0 0.4 0.0 5.8 0.0 2.2 1.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 2.4 0.0 0.0 1.9 0.0 0.0 1.2 0.4 0.0 1.1 0.3 0.0 12.7 0.6 0.5 1.8 0.0 4.0 0.0 0.0 1.0 0.4 0.0 0.3 3.1 0.2 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.8 0.1 1.0 0.4 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.1 5.0 0.1 2368.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 635.0 36.5 0.0 1.7 0.0 0.0 1.2 0.1 0.0 27.6 1.4 0.0 25.8 0.1 2786.2 17.7 0.1 0.0 0.0 0.0 0.0 ANKRD9 ENSG00000156381 "Ankyrin repeat domain 9" Q96BM1 14 102501760-102509799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.4" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 136.2;Enterocytes: 127.7;Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055985 Uncertain NA NA "HPA055985: AB_2682996" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (3.05e-2)" "unprognostic (1.26e-2)" "unprognostic (7.76e-2)" "unprognostic (7.31e-3)" "unprognostic (6.78e-2)" "unprognostic (3.97e-2)" "unprognostic (3.35e-1)" "unprognostic (2.99e-1)" "unprognostic (3.68e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.17e-7)" "unprognostic (3.89e-1)" "unprognostic (4.74e-1)" "unprognostic (1.32e-2)" "unprognostic (1.15e-1)" 5.5 5.1 7.1 2.6 4.5 10.0 4.6 5.6 11.8 2.5 12.6 3.6 2.3 31.6 2.0 4.9 5.8 1.5 6.7 27.0 6.0 4.2 6.3 3.8 3.8 0.9 5.5 4.3 2.8 5.2 8.0 1.8 8.3 9.0 5.4 6.8 4.6 7.1 3.9 67.4 6.2 20.5 3.0 6.1 2.6 10.2 10.1 4.6 0.4 2.6 13.3 2.7 4.7 4.1 0.5 0.4 1.2 2.3 0.9 1.1 0.4 9.0 4.3 7.9 7.4 8.2 3.4 12.4 10.9 4.1 4.9 4.9 1.1 6.1 0.0 12.3 3.0 5.5 14.9 3.8 2.2 2.5 6.4 15.6 2.4 7.3 2.0 4.2 0.8 8.0 1.7 13.4 2.7 2.7 3.2 2.1 1.2 4.6 0.8 2.3 7.9 1.2 2.5 3.7 14.1 19.7 12.2 7.4 0.5 5.0 9.4 6.4 6.8 7.7 5.1 13.3 4.8 7.7 3.4 4.8 5.1 6.5 24.5 8.4 7.1 3.8 0.2 6.0 1.7 4.9 0.7 0.4 0.2 0.3 0.5 0.6 0.2 0.3 0.2 0.4 0.5 0.5 0.3 1.2 0.9 2.3 0.4 1.1 0.4 7.1 4.5 5.6 11.8 6.0 4.2 5.5 4.3 9.0 4.6 17.9 5.0 2.0 30.5 11.6 7.4 37.9 17.8 1.4 6.8 14.0 2.0 8.0 77.9 3.1 136.2 5.8 127.7 116.8 4.2 22.7 7.3 36.9 32.2 11.1 23.3 15.9 16.0 6.2 5.7 14.0 5.2 3.6 10.1 0.0 37.8 10.8 4.7 48.6 9.2 11.9 7.2 12.9 5.7 2.3 7.6 17.7 15.3 3.2 43.8 52.4 ANKUB1 C3orf16 ENSG00000206199 "Ankyrin repeat and ubiquitin domain containing 1" A6NFN9 3 149761100-149968385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 12.2;lung: 11.9;ovary: 10.4" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 100.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.2" "Cell type enriched" "Detected in single" 8 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.8" "Cell line enhanced" "Detected in some" "OE19: 4.6" "Low region specificity" "Detected in all" HPA053749 Uncertain NA NA "HPA053749: AB_2682248" "unprognostic (1.71e-2)" "unprognostic (1.89e-4)" "unprognostic (1.01e-1)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-1)" "unprognostic (1.61e-2)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (2.18e-9)" "unprognostic (3.06e-1)" "unprognostic (2.96e-1)" "unprognostic (3.17e-1)" "unprognostic (7.07e-4)" 0.0 0.0 0.8 0.2 1.2 0.6 0.0 0.0 0.3 2.1 0.0 1.8 0.0 0.2 0.9 0.1 0.0 12.2 0.1 0.0 1.5 1.7 0.0 0.0 11.9 0.1 0.0 0.0 10.4 0.1 0.0 1.1 0.1 5.2 0.1 0.0 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.3 0.2 0.3 2.2 0.8 0.0 0.0 0.6 0.1 0.1 0.0 0.4 0.3 4.8 0.4 0.2 0.3 0.0 0.4 0.6 0.6 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.9 0.9 0.8 0.2 0.0 0.2 1.4 0.4 0.4 0.2 0.5 0.3 0.8 1.9 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.4 0.8 0.0 0.3 0.5 0.8 0.4 4.6 0.5 0.9 0.6 0.5 0.0 0.8 0.5 0.1 0.4 0.4 0.0 0.3 0.7 0.2 0.0 0.6 0.5 0.2 0.3 0.5 0.4 0.8 0.4 0.7 0.2 0.5 0.4 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.4 0.1 0.3 4.8 0.2 0.1 0.3 0.1 0.0 0.8 1.2 0.0 0.3 1.5 1.7 0.0 0.0 5.2 0.8 0.0 1.7 0.0 0.6 0.5 0.0 0.3 0.0 100.4 20.5 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 3.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 ANO4 "FLJ34221, FLJ34272, FLJ35277, TMEM16D" ENSG00000151572 "Anoctamin 4" Q32M45 12 100717526-101128641 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 3.9;Early spermatids: 4.4;Intestinal endocrine cells: 4.1;Late spermatids: 1.9;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 14.3;LHCN-M2: 6.9;SK-MEL-30: 11.1;TIME: 22.8;WM-115: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053412 Uncertain NA NA "HPA053412: AB_2682140" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "unprognostic (4.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (2.02e-1)" "unprognostic (3.76e-2)" "unprognostic (1.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-1)" "unprognostic (6.54e-2)" "prognostic favorable (5.48e-5)" "unprognostic (1.16e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.41e-1)" 0.9 20.3 10.3 0.6 16.7 0.6 0.7 2.8 13.0 13.3 0.8 17.2 1.4 1.1 7.9 1.2 0.7 1.0 0.8 0.8 9.5 5.8 0.8 0.6 0.7 0.6 10.9 8.6 13.8 1.6 0.8 2.2 0.7 12.1 8.7 0.9 0.0 3.6 14.0 0.6 0.7 0.9 1.5 4.4 0.6 0.6 2.1 19.2 0.0 0.8 0.0 1.3 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.8 1.1 0.0 5.0 4.5 4.2 2.0 0.0 0.0 0.0 0.0 14.3 0.0 0.2 5.2 4.3 3.9 0.0 0.0 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.9 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.1 5.8 0.0 0.0 22.8 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 16.7 2.8 13.0 9.5 5.8 10.9 8.6 12.1 19.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 75.4;tongue: 34.2" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Cholangiocytes: 17.8;Ciliated cells: 20.1;Club cells: 36.4;Extravillous trophoblasts: 14.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;myeloid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;monocytes: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 72.8;HBEC3-KT: 110.8;hTCEpi: 29.4;SiHa: 26.2" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.7 1.2 35.9 1.2 0.0 0.9 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.9 0.0 0.0 1.1 0.7 0.0 75.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 34.2 13.3 6.9 0.6 0.0 5.0 0.8 3.2 0.5 0.0 0.5 14.5 3.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.3 2.6 0.0 0.1 0.0 0.1 72.8 0.0 110.8 0.0 6.2 0.0 0.0 7.1 0.0 2.6 0.0 0.1 0.0 29.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 16.9 0.0 0.0 26.2 2.3 0.0 1.4 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 26.8 1.4 0.0 3.1 0.0 0.0 3.0 17.8 20.1 36.4 0.0 0.0 7.2 0.0 0.7 0.1 0.0 2.0 0.0 0.2 14.1 0.8 1.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.1 5.6 0.3 0.0 0.0 0.0 12.9 0.0 0.2 1.0 1.0 5.3 0.0 0.1 3.0 AP3M2 "AP47B, CLA20" ENSG00000070718 "Adaptor related protein complex 3 mu 2 subunit" P53677 8 42152946-42171673 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014876, HPA045591, HPA048380" Approved NA NA "CAB014876: , HPA045591: AB_2679377, HPA048380: AB_2680379" "unprognostic (5.53e-2)" "unprognostic (2.26e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (2.02e-2)" "unprognostic (8.20e-2)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-1)" "unprognostic (4.80e-2)" "unprognostic (3.61e-2)" "unprognostic (2.69e-1)" "unprognostic (4.32e-1)" "unprognostic (8.04e-2)" "prognostic favorable (2.38e-4)" 6.6 10.1 17.1 6.4 25.8 8.0 7.6 20.0 30.0 7.7 5.9 10.6 7.8 6.2 11.4 11.7 6.2 14.6 9.1 11.6 15.7 22.2 11.0 3.6 9.3 9.5 16.9 28.1 8.7 5.5 21.1 11.5 17.4 29.2 9.3 7.8 10.1 4.9 10.6 6.8 10.6 5.7 8.8 16.2 8.4 5.3 19.4 8.2 3.8 11.8 4.1 8.7 8.2 6.1 3.9 5.9 2.5 2.4 6.4 14.5 4.4 11.9 12.5 11.1 12.9 10.1 10.0 2.4 14.1 14.0 13.6 16.0 6.9 14.7 7.2 9.1 8.0 15.3 14.2 17.3 8.9 17.5 9.9 16.3 13.6 10.0 4.7 9.3 5.8 8.2 9.1 15.3 14.8 8.4 18.7 9.1 21.1 16.3 6.8 12.2 5.7 17.2 6.9 12.3 14.7 8.8 16.7 21.1 7.7 10.3 14.3 15.8 11.4 8.6 4.3 15.1 12.1 12.8 3.8 5.7 8.3 11.9 12.1 6.4 5.9 11.2 6.4 11.6 0.8 22.7 2.5 1.6 1.3 6.8 2.4 8.9 3.9 14.5 7.4 3.7 2.9 13.7 5.5 2.0 6.4 2.3 5.9 4.9 4.4 17.1 25.8 20.0 30.0 15.7 22.2 16.9 28.1 29.2 8.2 11.9 3.5 9.5 17.6 15.5 33.8 14.3 2.5 20.1 12.5 14.0 37.3 5.7 5.0 9.6 45.4 16.5 1.2 0.0 6.5 3.8 12.4 6.3 3.5 3.0 5.6 33.4 2.9 11.6 1.0 54.7 4.9 6.4 35.4 16.2 2.2 17.6 11.9 1.5 8.5 5.3 35.0 19.4 17.6 24.6 45.0 17.2 2.4 15.2 3.7 17.5 AP3S2 sigma3b ENSG00000157823 "Adaptor related protein complex 3 sigma 2 subunit" P59780 15 89830599-89894638 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA Vesicles "HPA049270: AB_2680696" "unprognostic (1.46e-1)" "unprognostic (1.60e-2)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (2.68e-1)" "unprognostic (3.78e-2)" "unprognostic (5.27e-2)" "unprognostic (3.03e-1)" "unprognostic (7.59e-2)" "unprognostic (1.22e-1)" "unprognostic (4.31e-2)" "prognostic favorable (5.55e-16)" "unprognostic (7.97e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (8.67e-3)" 18.0 20.9 18.4 7.9 20.2 6.7 14.3 16.8 24.7 13.5 13.2 20.4 13.4 7.9 9.9 12.6 15.3 13.2 12.8 22.2 16.6 19.4 27.3 29.3 11.6 8.6 19.8 14.6 15.2 20.0 36.4 17.3 15.3 19.2 11.5 14.4 21.6 10.8 16.6 43.3 9.5 12.8 13.2 20.1 11.5 10.8 10.9 12.8 12.2 19.4 9.2 12.8 11.7 8.9 6.0 10.1 13.9 16.4 7.2 7.4 7.8 5.1 24.7 13.3 13.9 26.9 18.6 11.2 22.9 29.5 29.6 24.1 10.5 13.6 4.6 20.7 15.1 19.7 12.1 22.5 12.8 23.4 19.6 11.3 14.2 11.1 13.6 11.2 6.1 8.8 12.4 16.0 8.2 16.6 16.3 15.2 12.0 11.1 13.0 19.0 11.2 10.2 3.2 14.7 26.5 4.7 6.0 13.4 9.5 16.7 14.5 10.1 8.9 27.0 16.7 15.7 29.4 10.5 5.3 6.3 16.0 7.7 24.5 7.5 11.2 34.8 11.2 14.1 7.3 9.4 3.9 14.6 6.9 5.0 13.0 7.3 3.9 7.0 7.1 10.1 6.0 5.6 3.9 13.9 7.2 16.4 6.8 7.4 7.8 18.4 20.2 16.8 24.7 16.6 19.4 19.8 14.6 19.2 12.8 11.9 19.1 6.9 3.7 3.0 18.3 15.3 12.7 10.7 14.8 5.2 33.4 8.1 8.3 11.3 2.1 4.4 19.6 0.0 14.0 3.6 4.7 5.4 8.1 13.9 5.7 17.5 13.8 8.0 10.3 2.5 6.6 8.3 8.5 15.4 11.7 13.7 11.8 14.4 7.1 10.9 28.2 0.0 5.0 11.5 6.8 2.5 5.4 5.2 14.2 3.2 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515131 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 39.2;smooth muscle: 10.9" "Cell type enhanced" "Detected in single" 29 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 43.4;hTEC/SVTERT24-B: 15.4;HUVEC TERT2: 15.6;TIME: 30.5;U-87 MG: 19.2" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria No No Mitochondria "HPA067015: AB_2685764" "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.5 0.6 0.2 0.6 0.2 0.0 5.2 0.6 0.1 3.3 1.2 0.1 0.0 0.1 2.4 0.2 0.8 0.0 2.1 5.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 3.6 0.7 3.2 39.2 1.7 0.6 0.9 0.8 10.9 0.3 0.0 0.6 0.1 0.0 0.0 0.1 1.0 0.6 6.1 5.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 9.2 0.0 0.9 0.7 0.0 2.8 0.0 0.0 43.4 0.2 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.3 0.0 15.4 0.2 3.1 15.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 6.5 0.4 0.0 8.5 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APLN "apelin, XNPEP2" ENSG00000171388 Apelin Q9ULZ1 X 129645259-129654937 "Predicted secreted proteins" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;placenta: 52.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 2.2;Cardiomyocytes: 5.5;Glandular cells: 1.5;Melanocytes: 1.7" "Group enriched" "Detected in all" 6 "glioma: 44.2;renal cancer: 21.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 106.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.50e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (9.32e-4)" "prognostic unfavorable (6.09e-4)" "unprognostic (4.71e-2)" "unprognostic (2.25e-1)" "unprognostic (3.30e-1)" "unprognostic (9.12e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (2.26e-1)" "unprognostic (8.42e-2)" 3.8 9.7 10.0 2.8 8.0 0.7 2.3 2.0 10.9 0.9 1.2 21.8 0.0 1.5 1.4 1.0 1.3 0.9 1.1 8.3 9.7 10.3 5.2 1.0 13.6 0.8 13.9 7.6 12.5 0.9 0.9 4.3 52.0 14.5 1.5 1.0 0.0 1.3 1.2 2.9 1.2 1.0 2.5 19.3 1.1 1.1 1.6 10.7 0.0 1.6 0.2 0.9 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 0.1 0.4 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.3 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 1.7 0.0 1.5 0.0 0.0 106.9 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.3 0.0 5.7 0.0 0.1 0.1 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.1 18.1 0.4 0.0 7.8 0.4 0.1 0.0 0.0 7.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 8.0 2.0 8.1 9.7 10.3 13.9 7.6 14.5 10.7 0.0 2.2 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.8 1.2 1.5 1.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.0 0.0 APOBEC4 "C1orf169, FLJ25691, MGC26594, RP1-127C7.4" ENSG00000173627 "Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4" Q8WW27 1 183646404-183653316 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 15.9;testis: 23.6" "Group enriched" "Detected in some" 5 "Ciliated cells: 93.7;Early spermatids: 101.4;Late spermatids: 71.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.27e-1)" "prognostic favorable (2.65e-4)" "unprognostic (2.61e-1)" "unprognostic (3.84e-2)" "unprognostic (1.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.10e-2)" "unprognostic (4.00e-2)" 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.1 0.2 5.4 0.0 15.9 0.0 0.0 0.1 0.1 0.0 0.0 4.1 0.0 0.0 0.0 5.6 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 23.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 93.7 19.4 0.0 0.0 0.0 0.0 0.0 101.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 APOL4 APOLIV ENSG00000100336 "Apolipoprotein L4" Q9BPW4 22 36189124-36204840 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4" "HPA049797, HPA055435" Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA049797: AB_2680887, HPA055435: AB_2682816" "unprognostic (2.73e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.51e-1)" "unprognostic (5.31e-1)" "unprognostic (3.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "prognostic favorable (3.45e-4)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.00e-5)" "unprognostic (4.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.18e-2)" "prognostic favorable (2.40e-6)" 2.3 0.8 1.1 2.7 1.3 0.0 2.3 0.9 1.0 2.4 1.2 0.7 0.7 2.2 2.0 0.7 2.4 3.1 3.2 2.8 0.8 1.0 10.3 1.1 7.3 1.7 1.0 0.7 4.2 0.9 0.0 1.9 3.0 1.2 9.0 1.5 1.8 2.9 1.6 1.0 1.6 5.4 2.1 2.3 1.1 2.3 0.7 1.2 7.1 1.1 0.7 2.3 7.4 1.4 0.4 3.8 0.6 4.3 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.9 8.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 46.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.3 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 21.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 4.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 3.8 0.3 0.0 0.0 0.2 0.8 0.2 0.0 0.0 1.2 1.1 1.3 0.9 1.0 0.8 1.0 1.0 0.7 1.2 1.2 0.0 7.9 0.0 0.9 1.1 0.2 1.1 2.5 4.0 3.4 0.0 0.0 0.4 3.3 0.1 0.0 3.8 0.0 0.0 0.6 0.6 6.3 1.2 2.3 0.0 2.4 1.6 14.3 1.3 4.5 0.0 2.6 5.3 0.0 1.8 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.4 0.0 0.0 1.0 5.1 0.0 0.1 1.4 APOL5 APOLV ENSG00000128313 "Apolipoprotein L5" Q9BWW9 22 35717872-35729483 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 1.8;skeletal muscle: 5.4;testis: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "U-698: 6.2" NA NA "unprognostic (2.23e-1)" "unprognostic (7.61e-4)" "unprognostic (9.34e-2)" "unprognostic (1.39e-2)" "unprognostic (3.23e-1)" "unprognostic (4.18e-2)" "unprognostic (4.37e-5)" "unprognostic (3.23e-2)" "unprognostic (2.78e-2)" "unprognostic (2.94e-2)" "unprognostic (1.59e-1)" 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648395-35668409 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 40.6 9.2 4.8 18.8 5.5 10.1 32.3 1.9 4.2 7.4 17.9 4.1 5.0 14.0 8.8 9.5 9.8 5.9 12.5 9.3 4.0 4.3 15.4 36.9 15.8 17.0 4.6 2.2 17.0 4.7 3.7 5.1 8.9 5.9 11.7 8.9 6.4 10.1 5.6 7.4 3.6 36.6 6.4 7.6 19.5 10.1 2.5 4.5 12.7 24.8 7.7 13.4 8.5 14.1 1.2 2.8 9.2 9.0 5.9 9.1 4.2 7.2 2.3 0.2 0.9 18.1 9.1 10.2 3.1 8.2 10.2 12.9 1.1 8.2 10.0 1.5 8.0 7.5 9.4 0.0 5.0 2.7 18.9 0.1 4.2 1.5 2.3 14.3 5.8 7.4 11.6 3.4 3.5 2.0 2.3 2.1 4.6 0.4 18.3 1.9 0.7 8.1 1.8 0.3 0.5 3.1 3.4 4.0 4.8 4.5 16.6 0.2 0.1 4.9 4.2 5.6 0.7 0.7 6.8 2.2 2.5 1.5 1.7 1.6 9.7 7.7 1.0 4.8 9.3 3.6 6.4 5.6 2.9 9.1 8.9 7.7 1.2 6.1 7.2 2.8 1.0 6.0 6.7 9.2 5.9 9.0 0.3 6.3 4.2 4.8 5.5 1.9 4.2 4.0 4.3 4.6 2.2 5.9 4.5 65.5 29.3 17.5 9.9 7.1 0.1 6.6 38.2 40.2 40.9 12.2 0.0 6.7 8.3 30.0 10.4 23.9 70.1 0.0 36.3 26.7 19.5 29.2 36.8 105.8 31.4 0.0 45.4 41.7 43.9 4.6 24.2 30.8 8.5 23.4 48.8 3.1 38.3 42.1 17.7 23.8 0.0 0.0 13.4 0.2 0.2 4.5 2.1 51.7 25.8 43.1 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.2 0.8 0.8 1.5 0.2 4.2 7.0 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.5 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.4 10.9 3.2 2.4 0.4 1.8 2.2 0.9 0.7 0.7 0.1 1.0 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.6 0.4 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.5 2.8 4.9 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 6.0 4.0 21.4 2.2 16.1 4.2 7.0 7.6 8.1 9.1 0.0 3.9 1.5 0.0 0.9 1.6 140.0 1.1 70.0 0.4 1.1 8.4 3.7 7.0 1.6 5.1 3.2 3.5 65.7 14.5 1.1 4.0 5.7 27.0 3.6 4.7 64.4 0.8 0.0 0.4 0.3 3.3 109.9 101.3 3.2 0.7 13.6 0.8 20.8 6.3 2.8 APOPT1 "APOP-1, C14orf153, MGC2562" ENSG00000256053 "Apoptogenic 1, mitochondrial" Q96IL0 14 103562962-103607523 "Predicted intracellular proteins" Apoptosis "Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 626.8;Late spermatids: 837.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (4.06e-1)" "unprognostic (1.93e-1)" "unprognostic (6.74e-3)" "prognostic unfavorable (6.34e-5)" "unprognostic (1.83e-1)" "unprognostic (7.59e-2)" "prognostic favorable (4.78e-4)" "unprognostic (2.24e-1)" "unprognostic (2.26e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-2)" "unprognostic (2.98e-2)" "unprognostic (3.14e-1)" "unprognostic (3.99e-1)" 14.2 10.2 26.0 7.9 21.8 7.0 32.0 10.1 22.8 12.9 12.2 8.1 11.9 11.7 12.5 12.9 13.3 9.5 10.4 26.5 22.2 18.4 14.1 14.2 10.0 16.7 21.4 13.9 10.8 32.5 6.4 9.0 10.2 12.0 11.1 12.5 7.1 16.7 11.6 53.8 12.5 10.1 16.4 19.2 8.0 10.0 30.5 9.6 6.2 17.2 19.8 10.6 13.0 15.4 24.5 24.7 30.8 27.5 26.1 25.2 22.4 12.6 10.3 9.7 16.5 20.9 22.0 14.4 15.4 15.3 16.6 20.9 8.4 21.2 11.8 18.9 16.8 17.2 16.8 7.8 15.6 22.3 17.9 5.8 6.6 7.9 11.0 26.0 10.0 9.2 17.1 25.8 11.3 26.5 20.6 20.7 11.9 9.0 16.2 19.5 14.7 10.5 12.4 9.9 33.3 26.2 7.4 9.7 9.7 24.3 11.8 14.3 7.8 10.1 12.0 24.8 13.6 19.4 11.1 14.8 13.8 9.4 24.2 18.0 10.0 16.8 16.0 21.3 10.6 14.2 28.3 27.5 30.8 20.1 23.0 17.7 24.5 19.7 21.6 24.7 22.5 16.5 19.9 13.6 26.1 19.4 18.9 25.2 22.4 26.0 21.8 10.1 22.8 22.2 18.4 21.4 13.9 12.0 9.6 41.7 12.5 36.8 34.5 47.3 20.6 54.9 22.9 16.0 31.8 38.4 19.6 64.7 102.8 69.7 626.8 40.5 52.9 0.0 37.9 45.9 40.9 31.7 29.9 46.0 75.3 14.3 45.5 27.0 41.2 837.9 37.7 44.1 40.5 47.7 51.0 22.6 68.7 40.3 38.2 97.7 29.0 25.8 33.0 66.9 39.6 52.9 58.0 35.5 57.0 41.3 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.0 3.3 1.4 2.2 3.2 0.8 1.4 1.7 0.8 1.6 0.7 7.8 1.6 1.6 0.8 0.7 12.3 1.0 0.5 0.1 0.8 4.8 1.3 1.3 1.1 13.0 1.0 2.7 1.5 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.8 1.0 1.8 1.6 1.0 1.8 1.4 7.5 3.0 1.4 3.5 0.6 0.9 1.2 1.4 1.0 2.1 0.4 0.8 1.1 1.6 0.4 0.9 1.3 4.1 2.5 1.1 1.1 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 0.0 0.0 0.0 0.7 0.1 7.5 0.4 7.6 0.0 0.0 1.8 0.0 6.6 0.0 1.2 30.5 0.3 15.8 0.0 3.4 10.1 0.9 1.2 4.6 21.5 1.0 0.0 4.1 0.0 0.3 51.4 14.4 0.0 1.7 0.0 3.1 29.1 3.7 3.1 10.6 15.3 5.0 0.0 0.7 35.9 5.8 0.1 13.3 0.0 5.6 0.1 AQP12A AQP12 ENSG00000184945 "Aquaporin 12A" Q8IXF9 2 240691845-240698483 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 182 "pancreas: 65.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.8" HPA042216 Supported NA NA "HPA042216: AB_2677905" "unprognostic (9.82e-2)" "unprognostic (1.63e-2)" "unprognostic (9.48e-2)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP12B INSSA3 ENSG00000185176 "Aquaporin 12B" A6NM10 2 240676418-240682906 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 386 "pancreas: 82.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.5" HPA042216 Supported NA NA "HPA042216: AB_2677905" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 4.5;Collecting duct cells: 5.2" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in many" HPA015278 Enhanced NA NA "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.3 2.0 0.1 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 1.1 1.2 0.0 0.9 0.0 0.0 0.2 0.3 0.0 0.0 0.2 1.4 0.0 0.1 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.1 1.1 0.0 0.2 0.4 0.6 0.0 0.9 0.0 0.6 0.4 5.1 1.0 1.0 0.1 0.5 0.9 0.0 0.5 2.1 0.7 0.0 0.7 0.3 0.0 0.1 0.0 0.6 0.9 0.0 0.5 0.2 0.2 0.0 0.2 0.2 0.4 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.7 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 AQP8 ENSG00000103375 "Aquaporin 8" O94778 16 25215731-25228940 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "intestine: 40.9;pancreas: 163.4" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 43.3;Exocrine glandular cells: 9.2;granulocytes: 9.2;Intestinal endocrine cells: 12.6;Paneth cells: 16.9" "Group enriched" "Detected in some" 42 "colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "Hep G2: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046259 Enhanced NA NA "HPA046259: AB_10960494" "unprognostic (8.75e-2)" "unprognostic (2.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.93e-2)" "unprognostic (8.67e-2)" "unprognostic (3.34e-3)" "unprognostic (8.47e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-1)" "unprognostic (2.05e-2)" "unprognostic (8.23e-2)" "unprognostic (1.06e-2)" "unprognostic (2.67e-2)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (3.71e-2)" 0.2 0.0 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 40.9 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 163.4 0.0 0.2 0.2 0.2 0.2 19.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 5.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 43.3 0.0 9.2 0.1 0.0 0.1 9.2 0.0 0.1 1.6 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.2 0.1 2.5 16.9 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.0 5.4 0.0 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 127.8;liver: 147.0" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 258.5" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 20 "neutrophil: 127.8" "Lineage enriched" "Detected in many" 20 "granulocytes: 127.8" "Cell line enriched" "Detected in single" 27 "U-87 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA074762, CAB075684" Enhanced NA NA "CAB075684: , HPA074762: AB_2732267" "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavorable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 7.8 0.3 0.6 12.9 0.7 9.8 0.6 0.7 1.4 0.2 0.3 0.1 1.0 0.0 0.2 7.8 0.7 3.0 0.8 2.0 0.4 0.2 0.8 147.0 8.6 12.0 2.4 0.4 1.2 0.3 2.8 0.4 1.4 0.6 0.4 0.0 0.5 0.4 0.8 0.4 6.9 0.3 1.0 0.5 15.8 0.7 2.5 0.4 0.4 0.5 0.1 0.4 1.3 0.6 0.0 0.2 127.8 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.9 0.1 0.0 0.0 6.2 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 127.8 0.0 2.3 0.0 0.0 1.7 0.6 0.7 0.7 1.4 0.4 0.2 2.4 0.4 0.6 0.4 0.0 19.3 4.3 0.1 0.3 0.0 1.2 5.1 2.7 5.7 0.0 0.0 0.3 0.0 0.1 1.9 0.1 0.0 0.0 0.2 0.5 0.4 0.0 7.0 258.5 43.2 0.0 0.0 8.0 34.5 0.8 0.3 57.7 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.7 1.3 0.0 0.1 ARGFX ENSG00000186103 "Arginine-fifty homeobox" A6NJG6 3 121570704-121586634 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;testis: 2.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 119 "testis cancer: 6.4" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "K-562: 1.7;Karpas-707: 1.5;U-698: 1.9" HPA043049 Uncertain NA NA "HPA043049: AB_2678288" "unprognostic (6.00e-2)" 0.3 0.1 0.2 0.5 0.2 0.9 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.3 0.3 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 1.1 0.8 0.4 0.0 0.1 0.5 0.1 2.2 0.1 0.0 0.2 0.1 0.4 0.2 3.6 0.8 0.7 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.2 1.0 0.5 0.7 0.0 0.4 0.0 1.1 0.0 0.3 0.4 0.0 0.2 0.0 0.2 1.7 1.5 0.4 0.0 0.0 0.1 0.4 0.8 1.0 0.3 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.6 0.0 1.4 0.4 0.5 0.0 0.2 0.5 0.0 0.5 1.2 0.5 1.9 0.0 0.2 0.2 0.8 0.3 0.4 0.2 0.4 0.2 0.4 0.1 0.1 0.2 0.4 0.2 0.3 3.6 0.7 0.8 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP11B ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30638805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.6;intestine: 2.7;stomach 1: 1.9" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 93.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.9" HPA064479 Uncertain Uncertain Vesicles NA NA Vesicles "HPA064479: AB_2685272" 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.1 1.1 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.9 0.4 0.0 0.9 0.3 1.0 0.8 0.0 0.0 0.0 1.3 0.0 2.9 0.4 0.0 1.8 0.6 0.6 1.6 0.2 1.0 1.3 0.5 4.6 3.1 0.0 1.4 1.0 1.8 5.3 4.2 0.1 2.5 4.1 0.4 0.0 17.9 1.4 0.4 0.9 0.2 0.4 0.1 0.5 1.1 0.9 1.5 0.0 1.3 7.8 3.9 0.2 2.4 0.6 0.9 1.4 0.3 0.9 1.8 1.2 1.3 4.6 2.7 1.0 1.1 1.3 0.6 0.7 1.5 3.3 1.3 4.8 2.7 0.1 3.0 3.0 2.1 1.4 1.1 3.7 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.3 0.9 0.8 1.0 0.3 0.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 11.2 1.0 1.8 3.4 0.7 0.0 1.4 0.0 1.8 5.9 0.0 0.0 0.4 20.2 0.5 1.7 93.5 0.5 0.0 0.9 0.9 1.1 0.8 0.0 3.2 0.0 4.3 5.7 12.8 2.0 2.9 0.0 3.6 4.0 13.2 0.4 3.4 1.1 0.3 2.4 0.0 1.0 13.6 10.0 1.3 0.0 5.3 2.9 0.9 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.1;RH-30: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.6 4.6 0.1 2.6 3.5 3.2 0.6 0.9 1.1 2.1 4.4 23.1 0.7 6.5 1.7 4.1 7.8 2.3 1.7 1.1 0.0 2.0 11.2 9.1 1.5 4.6 0.1 0.0 3.3 2.2 4.3 0.7 2.6 1.7 2.8 0.4 0.0 3.5 0.6 1.2 0.0 5.6 6.4 5.7 3.4 16.0 0.4 5.4 15.0 2.5 1.6 7.7 0.3 6.1 10.0 0.8 1.4 3.0 3.0 3.7 3.6 1.7 3.3 0.0 4.5 3.5 2.7 13.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 44.7 4.0 5.1 4.8 2.2 2.6 4.2 10.2 16.0 21.6 3.5 23.6 0.6 1.7 4.1 72.6 2.9 10.0 23.3 3.3 1.8 4.5 10.0 0.0 5.9 1.3 1.6 1.7 9.2 0.3 27.0 1.1 2.2 10.1 0.0 2.8 31.8 6.5 5.7 2.5 15.8 60.0 38.8 12.3 1.9 1.6 3.0 5.4 0.0 2.4 17.3 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 5 "Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Group enriched" "Detected in some" 4 "BEWO: 9.0;HeLa: 4.0;SiHa: 11.2" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in all" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 9.0 0.8 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.3 4.0 0.3 0.7 0.4 0.3 0.8 1.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.5 0.3 11.2 0.4 0.0 1.1 0.0 0.3 0.6 0.2 1.5 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 0.0 1.0 0.0 0.1 0.0 2.5 0.4 0.0 5.3 1.2 0.0 0.0 0.8 0.0 0.1 25.0 0.3 0.0 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.2 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.2 3.1 0.0 0.7 30.7 34.3 0.1 0.5 0.0 0.0 0.2 ARHGEF37 FLJ41603 ENSG00000183111 "Rho guanine nucleotide exchange factor 37" A1IGU5 5 149551947-149634968 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 66.1;seminal vesicle: 73.8" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.0;neutrophil: 4.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "EFO-21: 10.1;HaCaT: 18.5;hTCEpi: 24.5" "Region enhanced" "Detected in some" "cerebellum: 9.5" "Low region specificity" "Detected in all" "HPA043885, HPA053487" Uncertain Approved Cytosol NA NA Cytosol "HPA043885: AB_2678715, HPA053487: AB_2682167" "unprognostic (3.51e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-1)" "unprognostic (3.92e-1)" "unprognostic (1.17e-1)" "unprognostic (6.87e-2)" "unprognostic (1.54e-3)" "unprognostic (1.54e-1)" "unprognostic (2.64e-1)" "unprognostic (6.93e-2)" "unprognostic (2.13e-3)" "unprognostic (1.16e-2)" "prognostic favorable (6.85e-4)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.50e-2)" "unprognostic (2.10e-1)" 2.5 2.7 10.8 1.9 13.2 3.0 16.8 6.7 7.1 4.0 10.2 17.5 66.1 4.5 4.4 9.5 7.6 7.4 4.6 6.4 12.8 9.5 4.6 1.4 4.3 1.0 19.1 5.8 2.2 7.0 29.6 5.3 3.6 12.3 16.0 5.2 12.0 23.2 73.8 11.9 29.3 4.8 7.0 31.7 1.0 11.7 4.8 15.1 0.7 2.1 4.8 3.4 6.4 5.4 0.7 1.1 9.0 1.2 0.2 0.8 0.0 3.0 1.2 0.8 3.6 0.2 0.4 2.1 0.4 0.6 0.6 0.6 0.0 4.0 0.4 10.1 0.4 1.1 18.5 0.3 1.8 1.2 0.8 0.9 0.3 1.9 0.2 0.7 0.0 0.5 0.5 24.5 1.9 2.4 2.0 3.0 1.3 0.4 0.7 0.0 0.4 0.5 0.6 0.2 7.5 2.2 0.3 0.4 0.0 4.1 1.5 1.5 3.6 2.2 0.2 0.3 0.4 5.5 0.1 2.4 0.2 0.7 0.0 0.5 0.5 1.0 0.3 0.7 0.1 2.6 9.0 0.9 0.5 0.4 1.2 0.5 0.2 0.3 0.3 0.3 0.7 0.8 0.6 4.9 0.2 0.5 1.1 0.2 0.0 10.8 13.2 6.7 7.1 12.8 9.5 19.1 5.8 12.3 15.1 0.0 5.0 3.7 8.4 6.1 4.1 14.8 15.3 6.7 6.8 8.7 3.9 4.9 0.0 3.2 4.2 6.0 12.6 0.0 4.5 1.2 2.1 9.6 6.9 2.6 2.8 4.8 10.9 6.7 2.8 1.0 1.7 3.7 3.3 4.6 6.1 40.8 4.1 8.0 9.9 1.3 7.3 6.5 4.1 13.2 5.5 8.4 3.8 4.4 7.5 4.5 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 35.5" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.2 0.2 0.2 3.2 0.2 0.0 10.8 0.2 0.2 3.5 7.6 0.0 1.6 2.3 1.4 15.7 0.4 1.1 11.7 0.2 0.2 0.2 13.8 0.4 16.1 0.0 0.2 0.0 1.3 12.9 0.0 35.5 0.4 0.0 14.6 5.6 0.2 13.9 0.5 0.2 1.0 9.6 0.0 0.2 0.2 4.1 0.6 0.0 0.0 8.0 0.7 2.0 0.5 0.4 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 16.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 6.0 33.6 0.0 0.9 0.0 0.0 1.4 2.5 45.5 18.2 12.2 0.0 0.1 8.3 4.2 1.2 0.0 4.1 0.0 5.0 0.1 0.0 13.9 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 7.7 0.0 3.3 5.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.4 ARIH2OS C3orf71 ENSG00000221883 "Ariadne RBR E3 ubiquitin protein ligase 2 opposite strand" Q8N7S6 3 48917788-48919385 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.40e-5)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (6.67e-3)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (3.01e-3)" "unprognostic (9.00e-4)" "unprognostic (1.01e-1)" "unprognostic (2.88e-1)" "unprognostic (4.72e-5)" "unprognostic (4.02e-2)" "unprognostic (4.06e-4)" "unprognostic (1.90e-1)" "unprognostic (2.73e-1)" "unprognostic (3.31e-1)" "unprognostic (2.46e-1)" 2.1 2.7 3.0 2.1 5.6 5.5 2.2 2.1 2.4 2.1 2.1 2.1 2.1 1.9 2.2 2.9 2.1 3.2 2.1 2.5 3.2 3.0 2.2 2.1 2.1 3.1 3.6 2.1 5.5 2.7 1.3 3.6 2.1 2.1 2.6 1.5 2.1 4.3 2.2 2.1 2.7 2.5 2.1 3.8 2.5 2.0 5.4 2.1 2.1 3.2 2.1 2.1 2.1 2.1 5.0 7.6 9.1 3.2 4.7 7.9 2.2 1.2 0.0 0.9 2.0 5.0 1.6 3.7 1.3 1.5 2.3 1.1 0.4 2.7 1.6 1.0 0.8 1.5 0.6 0.8 0.7 0.9 2.0 1.3 2.2 1.8 1.9 3.4 0.7 1.2 4.7 2.4 2.0 1.6 1.2 1.3 7.2 1.1 7.1 0.6 0.9 3.4 1.5 1.3 1.1 1.1 0.9 0.8 4.9 1.8 1.0 1.2 3.3 3.0 1.6 3.7 1.5 2.3 1.8 0.8 1.0 1.8 1.0 0.8 4.4 5.7 4.0 1.0 1.8 2.6 4.5 3.2 7.4 3.9 2.9 3.4 4.9 3.9 4.8 3.7 5.0 7.9 5.7 9.1 4.7 2.1 7.6 4.8 2.2 3.0 5.6 2.1 2.1 3.2 3.0 3.6 2.1 2.1 2.1 3.0 3.2 3.0 2.1 1.6 16.9 1.6 2.5 2.7 5.7 1.8 43.2 4.2 1.7 2.2 0.7 3.0 8.5 0.0 1.8 1.6 3.3 1.6 5.8 1.7 4.4 4.8 5.8 6.2 5.1 0.4 2.0 6.3 5.0 6.4 4.2 11.2 2.4 2.5 1.1 2.2 40.7 0.0 3.8 6.9 2.5 2.5 2.7 11.5 5.0 0.9 ARL10 ARL10A ENSG00000175414 "ADP ribosylation factor like GTPase 10" Q8N8L6 5 176365468-176401865 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 31.9;Horizontal cells: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047044 Approved NA NA "HPA047044: AB_2679915" "unprognostic (2.50e-2)" "unprognostic (4.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (6.00e-3)" "unprognostic (2.78e-1)" "unprognostic (9.29e-2)" "unprognostic (5.92e-3)" "unprognostic (7.96e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-2)" "unprognostic (4.33e-2)" 5.0 3.4 11.1 4.4 11.7 7.0 5.5 11.0 15.6 7.6 7.6 10.1 3.3 2.6 8.0 5.9 8.5 4.6 7.0 6.4 8.7 7.7 3.6 1.9 3.5 5.5 9.2 10.9 11.8 3.9 5.7 9.0 5.9 6.7 5.9 2.9 4.3 3.3 6.2 9.8 25.7 4.8 8.2 10.8 5.1 3.8 3.3 7.9 4.3 4.0 3.1 4.5 6.1 7.6 2.5 0.9 1.4 0.4 1.2 2.0 0.3 0.4 0.1 12.1 5.6 6.5 8.0 0.6 3.1 1.5 4.9 5.2 0.3 0.4 1.1 0.6 6.2 0.2 7.9 0.1 0.9 7.3 0.1 4.9 1.1 9.7 1.2 3.9 0.2 1.5 4.7 0.5 6.3 0.0 2.6 8.0 2.2 0.4 1.2 6.5 7.4 1.4 0.3 2.2 0.9 1.3 3.5 3.0 0.0 3.0 4.2 11.1 11.6 2.8 1.7 2.4 5.5 0.4 0.9 6.0 4.6 3.8 3.4 0.6 0.5 0.8 0.4 3.7 0.2 1.5 0.7 0.3 0.4 1.4 0.3 1.3 2.5 1.1 2.0 0.3 2.3 0.8 1.5 1.4 1.2 0.4 0.9 1.3 0.3 11.1 11.7 11.0 15.6 8.7 7.7 9.2 10.9 6.7 7.9 3.0 31.9 1.3 3.6 3.5 12.4 9.8 2.5 9.4 11.4 7.0 5.9 0.4 0.0 1.7 0.8 4.2 0.0 0.0 0.2 0.6 6.0 2.4 16.2 0.6 1.1 19.1 0.0 3.7 1.9 0.0 6.1 1.9 3.3 1.0 0.3 4.3 1.0 0.0 6.7 1.4 5.2 0.0 4.2 1.1 0.7 6.6 0.3 1.7 0.1 2.3 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.6" "Group enriched" "Detected in some" 23 "Early spermatids: 58.2;Late spermatids: 44.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.7" "HPA037377, HPA037378" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA037377: AB_2675442, HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.6 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 1.2 0.4 0.1 0.1 0.2 0.3 16.6 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.8 0.2 0.0 0.4 0.1 0.5 0.0 1.1 1.9 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.0 0.0 6.7 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 1.2 1.1 0.7 0.0 1.7 0.1 0.0 0.0 0.0 0.4 0.4 0.3 0.9 0.3 0.0 0.1 0.7 0.0 0.2 0.0 0.4 1.6 0.0 0.1 0.7 0.0 0.4 0.0 0.1 1.2 0.3 0.1 0.0 0.3 2.0 0.6 0.3 0.0 0.0 0.3 0.2 0.2 1.3 0.3 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.0 ARL17A "ARF1P2, ARL17P1" ENSG00000185829 "ADP ribosylation factor like GTPase 17A" Q8IVW1 17 46516702-46579682 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 51.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046814 Uncertain NA NA "HPA046814: AB_2679821" "unprognostic (8.57e-4)" "unprognostic (7.48e-2)" "unprognostic (1.98e-1)" "unprognostic (2.72e-1)" "unprognostic (1.16e-1)" "unprognostic (6.57e-5)" "unprognostic (2.07e-1)" "unprognostic (2.61e-2)" "unprognostic (1.70e-1)" "unprognostic (4.01e-1)" "unprognostic (2.58e-2)" "unprognostic (4.12e-2)" "unprognostic (2.48e-4)" "unprognostic (1.04e-1)" "unprognostic (2.57e-1)" "unprognostic (1.43e-1)" "unprognostic (4.61e-2)" 3.5 3.3 2.8 6.4 3.2 6.1 5.3 7.6 6.0 4.3 4.5 1.7 6.6 6.1 5.8 5.0 1.4 3.7 3.3 2.9 3.4 2.2 4.3 7.6 2.4 7.3 4.7 2.9 7.1 2.4 6.2 6.3 5.6 3.3 9.2 7.4 4.6 5.2 3.5 4.9 4.5 2.9 6.1 6.0 4.3 6.1 6.8 6.9 5.4 4.6 6.6 6.6 1.4 2.4 3.1 8.0 4.6 1.5 2.4 2.2 3.7 0.7 1.2 2.2 12.4 3.3 15.5 2.4 1.2 10.7 3.4 2.7 2.2 2.8 8.2 14.8 2.3 18.9 9.6 2.8 3.8 3.3 1.9 8.2 1.8 2.0 2.5 5.2 4.9 3.9 5.6 5.3 1.0 5.9 4.6 3.9 1.1 1.5 11.3 12.5 5.4 1.6 6.1 3.3 2.5 2.6 0.9 1.0 3.2 6.9 7.6 8.6 14.2 10.0 2.8 2.4 10.5 12.8 3.5 2.8 8.6 5.1 5.4 4.6 2.6 6.1 3.7 3.9 5.7 5.3 6.2 4.6 6.8 4.6 6.6 2.3 6.6 4.1 6.9 3.2 1.4 20.8 10.2 18.6 7.6 5.4 19.0 6.4 2.5 10.7 6.8 15.7 51.1 5.0 8.3 7.2 6.5 5.8 5.1 0.0 2.1 4.4 5.8 5.6 5.8 2.6 5.7 14.3 6.4 9.8 7.3 4.1 12.0 6.0 3.3 19.0 6.5 7.6 3.3 5.8 8.5 4.8 30.1 12.9 6.2 12.4 6.4 7.3 3.0 17.0 8.1 6.8 ARL17B ARL17 ENSG00000228696 "ADP ribosylation factor like GTPase 17B" Q8IVW1 17 46274784-46361797 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 19.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 21.6;HEK 293: 16.1;U-266/84: 14.1" HPA046814 Uncertain NA NA "HPA046814: AB_2679821" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (8.11e-2)" "unprognostic (1.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.56e-2)" "unprognostic (5.29e-2)" "unprognostic (1.99e-1)" "unprognostic (7.25e-2)" "unprognostic (6.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (7.57e-2)" "unprognostic (1.57e-1)" "unprognostic (8.36e-2)" "unprognostic (2.78e-2)" "unprognostic (8.83e-2)" 3.1 4.9 2.6 3.3 2.4 4.6 5.1 6.2 4.9 3.9 4.3 0.2 5.0 2.4 4.2 3.5 0.4 4.9 3.0 3.0 4.1 3.2 2.3 3.2 2.6 7.3 3.6 2.3 3.4 1.3 3.5 3.6 2.7 3.9 5.4 2.3 2.3 5.8 3.1 2.4 2.6 2.6 4.4 3.5 3.6 3.3 10.0 16.2 4.1 10.9 6.0 10.9 4.4 2.1 0.4 3.9 1.7 1.7 0.7 0.6 1.5 1.0 3.0 2.5 13.0 1.9 6.2 1.1 3.0 21.6 0.5 3.8 1.8 3.5 5.1 16.1 1.2 5.4 4.9 1.3 1.1 1.4 0.4 2.5 1.0 0.8 1.4 4.8 3.8 0.8 2.5 6.1 0.6 1.6 1.8 1.3 1.0 0.6 3.7 9.7 3.3 6.6 1.6 1.5 0.9 1.6 1.2 0.1 2.6 1.2 4.9 2.0 5.3 10.0 1.3 1.1 4.2 14.1 0.8 1.0 4.5 1.0 4.1 10.9 2.4 6.3 6.5 5.5 8.8 8.8 9.4 9.2 10.0 10.9 9.6 1.9 6.0 7.4 16.2 6.9 4.4 6.0 2.1 6.0 1.9 4.4 7.2 3.6 0.0 4.0 5.7 3.5 9.8 2.3 3.3 1.8 3.2 3.8 1.1 0.0 2.5 1.2 3.1 2.1 3.5 0.0 1.4 7.9 3.4 3.1 1.2 3.0 4.6 3.2 3.3 4.6 1.2 4.6 1.5 0.0 5.6 0.8 12.1 19.4 4.7 10.2 3.7 3.4 0.7 5.0 1.7 8.8 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56525481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;testis: 12.6" "Group enriched" "Detected in some" 11 "Early spermatids: 81.2;Late spermatids: 192.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA072942: AB_2686561" "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 1.3 1.1 4.4 0.8 4.9 3.4 2.0 1.5 7.1 1.3 1.3 0.6 2.4 1.0 2.0 1.1 1.1 1.2 2.4 0.8 3.9 3.2 0.5 0.5 0.6 1.0 1.3 2.9 3.0 0.4 0.4 1.6 0.3 8.7 2.2 1.0 1.9 0.9 3.8 0.4 4.1 1.0 3.7 2.5 0.8 1.0 12.6 0.6 0.1 1.1 1.2 0.7 1.5 2.5 2.1 2.2 1.6 0.4 1.4 1.4 0.1 0.0 0.5 0.6 0.5 1.2 2.9 0.1 0.9 0.5 2.1 2.1 0.5 0.7 0.7 0.0 1.5 0.1 0.2 0.4 0.2 1.2 0.1 0.1 0.3 0.0 0.1 2.8 0.3 0.7 4.4 0.7 1.9 0.4 0.4 2.1 0.2 0.2 0.9 2.0 0.0 0.3 0.1 2.2 0.1 1.3 8.7 0.0 0.1 0.1 0.3 9.2 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.4 0.3 0.4 0.0 0.1 0.4 0.4 0.4 0.1 0.0 0.3 0.8 0.4 0.4 0.7 0.4 0.4 1.0 1.2 1.0 0.3 2.1 1.4 0.6 1.6 1.4 0.4 2.2 1.0 0.1 4.4 4.9 1.5 7.1 3.9 3.2 1.3 2.9 8.7 0.6 0.0 1.4 0.0 0.8 5.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 81.2 0.2 0.0 0.0 0.2 0.1 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.3 192.4 1.4 0.0 5.0 0.0 0.3 1.0 0.6 0.0 1.1 0.3 0.0 0.0 0.2 12.2 0.9 1.4 0.0 0.0 0.4 0.3 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Group enriched" "Detected in some" 65 "Early spermatids: 374.1;Late spermatids: 785.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.2 3.8 7.3 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 1.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.8 0.0 0.0 9.7 2.3 0.1 1.3 3.7 0.7 2.8 0.1 4.5 1.1 0.4 6.6 0.8 0.5 0.0 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.2 0.0 0.0 0.5 1.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.2 0.3 4.0 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 0.0 0.0 0.0 1.7 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 374.1 0.6 0.0 0.0 0.0 0.0 0.4 0.5 0.0 2.4 0.0 0.0 0.0 0.0 1.6 785.6 7.8 0.0 0.0 0.0 0.1 0.8 0.0 0.0 3.9 0.1 0.1 0.0 0.5 8.9 5.4 0.1 0.0 0.0 0.0 0.3 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974472 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 88.3;Early spermatids: 89.1;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA025809: AB_1845032, HPA053696: AB_2682233" "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 6.0 5.2 13.3 5.6 19.6 7.8 7.3 9.6 14.7 7.4 4.2 7.9 2.1 2.0 8.2 11.9 3.7 21.5 5.4 9.4 12.2 7.0 4.6 2.8 8.8 4.0 4.0 11.8 6.1 3.3 9.9 20.0 7.0 16.7 4.4 4.9 5.7 3.8 5.2 3.7 5.3 3.5 4.4 6.3 5.8 4.9 31.8 7.1 2.4 11.0 2.8 4.3 4.0 5.0 2.7 4.6 9.5 4.7 4.8 7.0 1.6 3.4 2.1 10.3 6.5 5.1 6.4 2.3 2.1 2.9 5.4 7.2 3.1 3.1 5.4 2.7 3.4 8.3 3.0 5.6 4.2 9.4 1.5 4.8 5.1 4.7 3.2 2.8 7.8 2.3 7.3 5.9 6.2 1.8 7.2 5.0 16.6 2.1 8.4 5.5 2.6 6.7 7.1 3.2 3.3 2.6 7.7 8.5 4.4 4.9 4.1 14.4 5.3 7.3 1.9 5.1 6.0 3.7 4.0 2.5 4.6 2.4 3.8 2.8 3.9 5.2 4.6 7.8 5.5 5.7 4.3 3.5 0.9 3.4 4.7 3.2 1.4 2.7 3.7 2.8 2.7 1.6 3.9 9.5 4.8 3.7 4.6 7.0 1.6 13.3 19.6 9.6 14.7 12.2 7.0 4.0 11.8 16.7 7.1 8.9 3.0 0.0 1.1 0.9 1.5 4.3 2.5 88.3 18.2 0.0 0.0 1.3 0.0 0.8 89.1 1.2 0.0 0.0 0.8 1.7 1.3 0.8 0.0 0.2 3.2 1.6 1.7 0.6 3.7 112.4 6.4 1.3 5.0 0.0 0.3 1.8 0.7 0.0 9.6 1.2 5.2 0.0 2.3 27.6 5.5 1.3 0.5 2.9 0.5 0.7 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 40.2;fallopian tube: 38.6;testis: 25.7" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 236.9;Early spermatids: 288.3;Late spermatids: 68.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.0" "Region enhanced" "Detected in many" "pons and medulla: 40.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "CAPAN-2: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037823, HPA037824" Enhanced NA NA "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.3 0.4 3.5 0.3 10.1 0.3 0.4 0.0 1.0 1.9 0.3 11.3 0.0 0.3 1.7 9.0 0.5 38.6 0.3 0.4 4.7 4.1 0.7 0.3 4.1 0.3 1.9 2.2 4.5 0.6 0.3 4.1 0.3 40.2 0.3 0.3 0.0 0.3 0.5 0.3 0.3 0.3 0.4 1.0 0.3 0.3 25.7 6.3 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.9 2.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.3 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 3.5 10.1 0.0 1.0 4.7 4.1 1.9 2.2 40.2 6.3 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 236.9 31.8 0.0 5.9 0.0 0.0 0.4 288.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.0 0.8 0.0 0.0 27.1 1.9 0.0 0.0 0.0 0.0 0.0 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell type enhanced" "Detected in many" 7 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 14.9 0.1 13.3 12.1 0.1 16.3 20.5 0.4 0.4 0.0 6.3 0.0 0.0 21.4 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.5 0.0 14.1 0.1 0.0 19.1 5.2 12.8 0.1 20.2 17.3 0.0 0.0 0.1 48.1 0.0 0.0 0.2 34.7 0.9 0.1 4.0 26.6 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 27.9 7.6 0.0 3.8 18.4 19.6 11.5 0.1 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 14.9 5.4 4.4 13.8 3.8 11.2 22.2 7.6 2.7 15.9 31.4 7.9 1.0 3.3 8.0 0.1 13.0 0.0 0.0 1.8 0.4 20.2 13.8 2.3 0.4 3.6 1.6 8.7 16.0 2.1 0.4 22.5 4.0 5.0 11.8 2.2 7.0 3.1 0.0 23.0 4.2 9.7 58.2 26.4 1.4 1.1 2.6 4.2 2.5 1.2 6.2 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.9 12.4 7.0 25.4 15.1 2.4 14.1 13.7 12.6 24.7 4.8 6.5 7.1 14.4 13.2 13.2 7.0 12.0 5.7 9.9 6.1 7.3 6.7 11.0 6.3 11.7 6.5 8.4 9.4 5.8 7.7 4.0 17.6 12.8 3.7 5.5 9.2 18.9 16.4 9.5 0.0 8.9 8.7 1.6 9.8 16.6 2.6 9.1 0.9 6.8 6.4 8.2 0.0 10.5 9.9 5.8 3.1 9.9 15.4 6.9 21.4 3.2 11.4 6.1 0.0 4.6 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 8.9 7.8 28.4 14.8 11.8 4.8 8.1 12.7 1.4 6.8 29.6 15.7 31.9 19.9 36.6 0.4 25.1 3.1 0.0 24.2 14.6 30.1 15.7 13.9 13.4 60.4 9.5 15.7 23.4 19.6 1.3 17.3 28.6 35.4 30.7 15.5 28.2 25.6 14.0 18.7 17.2 4.1 25.8 15.6 2.6 2.2 14.1 28.8 33.1 13.8 15.9 ARMS2 "ARMD8, LOC387715" ENSG00000254636 "Age-related maculopathy susceptibility 2" P0C7Q2 10 122454653-122457352 "Disease related genes, Predicted intracellular proteins" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 21.2;testis: 6.6" "Group enriched" "Detected in some" 4 "Early spermatids: 16.7;Late spermatids: 45.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HeLa: 1.3;HSkMC: 1.5;SiHa: 1.1;SuSa: 2.1;TIME: 1.3;WM-115: 2.0" HPA067225 Enhanced NA NA "HPA067225: AB_2685806" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (2.61e-2)" "unprognostic (2.84e-2)" "unprognostic (3.49e-2)" "unprognostic (1.98e-2)" "unprognostic (3.47e-3)" "unprognostic (3.60e-2)" "unprognostic (5.29e-5)" "unprognostic (2.53e-2)" "unprognostic (9.46e-3)" "unprognostic (2.68e-2)" "unprognostic (5.25e-2)" 0.5 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.7 0.2 0.2 0.2 0.4 1.7 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 2.3 0.2 0.0 1.0 21.2 0.2 0.2 0.0 0.2 2.7 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.1 0.0 0.0 2.1 0.0 0.0 1.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.5 0.0 7.2 0.0 0.0 0.0 ARPC1A "Arc40, SOP2Hs, SOP2L" ENSG00000241685 "Actin related protein 2/3 complex subunit 1A" Q92747 7 99325910-99366262 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA004334 Approved Approved "Cell Junctions,Cytosol" NA NA 2400000 "Cell Junctions" Cytosol "HPA004334: AB_1078215" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (6.22e-3)" "unprognostic (1.93e-2)" "unprognostic (8.38e-3)" "unprognostic (1.95e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (2.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.89e-2)" "unprognostic (7.88e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (7.07e-2)" "unprognostic (1.83e-1)" 36.6 39.8 40.2 25.2 41.0 18.7 49.1 32.3 55.9 40.0 43.6 32.3 37.9 50.1 30.4 45.9 58.3 43.3 32.1 65.3 45.9 43.5 30.6 41.2 29.6 32.2 38.6 39.7 47.2 41.9 30.9 31.4 31.8 40.6 28.2 44.2 33.9 31.7 36.7 20.9 46.1 55.0 31.9 27.9 26.8 53.1 28.6 25.1 23.7 44.4 41.8 31.6 31.5 33.9 11.1 16.1 33.2 29.1 10.9 12.6 9.9 45.5 24.8 28.2 12.9 26.3 44.9 24.0 32.8 38.5 33.4 33.4 27.8 52.6 16.0 48.5 39.7 49.5 19.4 37.0 47.5 40.5 7.9 31.1 8.5 18.5 22.4 29.0 10.0 11.2 41.7 26.6 43.1 46.0 39.7 54.7 13.2 21.3 18.5 51.3 66.6 16.8 13.4 26.5 51.0 56.2 9.9 19.5 19.5 24.8 27.7 29.2 24.9 32.1 46.1 43.6 49.9 23.0 14.8 42.4 42.9 38.4 75.5 52.2 7.2 13.3 22.7 37.0 22.6 56.2 33.2 18.9 31.9 9.8 28.6 7.6 11.0 9.3 12.6 16.1 11.1 12.1 9.1 23.8 10.9 29.1 11.7 12.1 9.9 40.2 41.0 32.3 55.9 45.9 43.5 38.6 39.7 40.6 25.1 47.6 40.3 44.7 107.8 36.9 36.8 41.2 86.6 64.3 34.2 55.8 17.7 167.1 114.4 166.9 15.6 83.7 206.9 116.8 242.7 281.6 45.8 130.5 12.7 70.0 73.9 31.8 71.2 92.1 68.9 20.6 61.9 41.2 75.9 60.5 155.3 53.9 324.8 150.8 63.3 116.3 29.0 181.1 159.3 117.8 120.8 41.9 108.5 26.7 144.4 216.4 ARSH ENSG00000205667 "Arylsulfatase family member H" Q5FYA8 X 3006613-3033571 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 3.1;epididymis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;hTERT-RPE1: 1.2;OE19: 1.7;RT4: 1.2;SK-BR-3: 1.2" NA NA "unprognostic (3.43e-1)" "unprognostic (1.95e-1)" "unprognostic (2.01e-2)" "unprognostic (8.90e-2)" "unprognostic (6.79e-2)" "unprognostic (2.56e-2)" "unprognostic (1.83e-1)" "unprognostic (8.56e-4)" "unprognostic (3.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.63e-1)" "unprognostic (2.65e-2)" "unprognostic (6.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 3.7 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARSJ FLJ23548 ENSG00000180801 "Arylsulfatase family member J" Q5FYB0 4 113900284-113979727 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Basal glandular cells: 42.2;Glandular cells: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ: 20.4;HUVEC TERT2: 18.4;LHCN-M2: 18.6;TIME: 23.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 15.4" "HPA036481, HPA036482" Uncertain Enhanced "Actin filaments" "Secreted in other tissues" NA NA "Actin filaments" "HPA036481: AB_2675146, HPA036482: AB_10672356" "unprognostic (1.98e-1)" "unprognostic (1.55e-2)" "unprognostic (4.23e-1)" "unprognostic (5.31e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (6.08e-4)" "unprognostic (2.54e-2)" "unprognostic (2.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-1)" "unprognostic (5.31e-2)" "unprognostic (2.20e-1)" "prognostic favorable (2.97e-6)" "unprognostic (2.26e-1)" "unprognostic (8.37e-2)" "unprognostic (1.30e-1)" "unprognostic (2.07e-2)" 3.5 2.2 2.6 2.0 2.7 0.0 2.6 10.3 3.4 7.9 4.7 0.9 4.1 1.0 4.8 2.2 9.1 4.6 6.0 5.2 1.5 1.2 9.4 3.4 6.9 3.5 1.8 3.6 4.7 2.6 13.3 1.8 6.7 4.2 7.2 5.4 1.8 9.1 3.9 0.8 1.7 1.7 10.5 2.9 0.5 5.8 0.9 2.0 0.6 1.9 3.6 1.7 7.5 18.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 2.5 0.2 0.0 4.5 9.3 0.0 20.4 15.5 12.8 5.0 0.5 1.4 0.0 2.6 9.6 4.5 2.2 0.1 5.0 16.1 0.0 0.9 0.0 2.0 0.0 13.9 0.0 0.0 5.7 5.1 8.6 17.8 9.0 18.4 0.0 0.0 0.0 18.6 0.1 0.0 0.0 0.6 0.0 3.7 0.0 2.2 0.0 16.8 0.0 0.0 0.7 1.3 0.2 0.9 3.4 0.1 0.0 23.4 14.8 4.0 2.2 9.6 0.0 0.0 0.0 7.2 0.0 4.5 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 10.3 3.4 1.5 1.2 1.8 3.6 4.2 2.0 32.8 9.8 0.0 42.2 2.6 0.1 0.9 10.2 4.0 12.5 24.4 0.0 0.3 0.0 7.3 0.0 4.0 0.9 0.0 0.7 0.1 13.6 38.6 0.0 1.3 0.4 1.6 22.5 3.7 0.0 0.0 2.3 0.7 3.3 0.0 16.4 5.2 3.6 2.9 1.4 2.9 0.1 0.0 15.1 0.0 0.2 1.0 0.3 0.5 4.3 22.3 ART1 "ART2, CD296" ENSG00000129744 "ADP-ribosyltransferase 1" P52961 11 3645128-3664416 "CD markers, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 20 "skeletal muscle: 50.9;tongue: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051148 Uncertain NA NA "HPA051148: AB_2681363" "unprognostic (3.73e-1)" "unprognostic (4.58e-2)" "unprognostic (3.12e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" 1.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.2 0.1 50.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 13.7 0.5 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ART4 "CD297, DO, DOK1" ENSG00000111339 "ADP-ribosyltransferase 4 (Dombrock blood group)" Q93070 12 14825569-14843533 "Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3" "Cancer enhanced" "Detected in some" "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4" "Region enhanced" "Detected in single" "olfactory region: 2.2" "Low region specificity" "Detected in single" HPA075664 Approved "Rods & Rings" "Secreted to blood" NA NA 11000000 "Rods & Rings" "HPA075664: " "unprognostic (2.50e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.90e-2)" "unprognostic (2.62e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-3)" "unprognostic (1.05e-1)" "unprognostic (1.71e-1)" 2.7 2.0 0.2 1.7 0.2 2.4 2.1 0.2 0.2 1.4 1.3 0.1 1.9 0.0 1.1 3.7 3.1 1.9 6.1 10.1 0.2 0.2 6.6 33.7 2.1 17.0 0.2 0.0 1.3 1.9 0.0 0.4 17.8 0.3 0.8 0.2 0.0 0.7 0.4 1.9 0.5 0.8 1.5 0.2 17.8 0.5 1.4 0.0 0.1 4.6 1.3 1.3 1.3 1.2 0.6 0.6 1.4 0.4 0.6 1.3 0.3 0.0 0.0 0.2 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.4 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.6 0.5 1.3 1.4 0.6 0.2 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.6 0.0 0.8 0.2 1.8 1.4 12.7 0.0 0.0 1.8 11.8 0.1 0.0 0.7 0.4 2.8 0.0 93.5 1.8 1.4 1.9 0.1 0.0 21.3 0.1 0.0 0.0 55.3 7.5 0.0 1.7 0.6 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 12.6 6.5 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 ART5 ENSG00000167311 "ADP-ribosyltransferase 5" Q96L15 11 3638503-3642316 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 12.1;testis: 33.3" "Group enriched" "Detected in some" 4 "Early spermatids: 12.7;Late spermatids: 14.5;Spermatocytes: 15.9" "Cancer enhanced" "Detected in some" "testis cancer: 4.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enriched" "Detected in some" 5 "SuSa: 17.9" "Region enriched" "Detected in single" 5 "olfactory region: 0.5" "Not detected" "Not detected" "HPA041637, HPA044099" Uncertain "Secreted in other tissues" NA NA "HPA041637: AB_2677589, HPA044099: AB_2678808" "unprognostic (6.32e-2)" "unprognostic (3.26e-5)" "unprognostic (4.09e-3)" "unprognostic (2.06e-4)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-2)" "unprognostic (5.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.85e-4)" "unprognostic (3.10e-3)" "unprognostic (3.46e-2)" "unprognostic (1.96e-1)" "unprognostic (3.18e-1)" 0.8 0.1 0.3 0.3 0.5 0.0 0.8 0.3 0.6 3.3 0.3 0.3 1.0 0.0 3.3 0.9 0.4 1.5 1.2 2.9 0.3 0.2 0.7 0.6 0.9 0.3 0.3 0.3 9.3 0.3 1.7 0.6 1.7 0.5 1.1 0.0 5.3 1.2 0.8 12.1 0.3 0.4 1.0 0.3 0.5 0.3 33.3 0.5 0.3 3.5 5.2 0.5 0.5 1.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.0 2.2 0.0 0.0 3.7 0.2 1.8 0.9 2.1 0.1 0.0 0.0 0.9 0.2 0.0 0.0 1.8 0.0 0.5 0.0 2.6 0.0 0.4 0.2 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.0 0.2 0.4 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.8 0.1 17.9 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.6 0.3 0.2 0.3 0.3 0.5 0.5 0.0 2.6 0.0 1.8 0.2 0.4 1.6 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.4 12.7 0.3 0.0 0.0 0.2 0.4 0.7 0.6 0.0 1.7 0.1 0.0 0.0 0.0 0.3 14.5 3.1 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.1 0.3 0.7 0.0 0.2 15.9 1.7 0.3 2.4 0.0 0.0 0.1 ASAH2B "ASAH2C, ASAH2L, bA449O16.3, bA98I6.3" ENSG00000204147 "N-acylsphingosine amidohydrolase 2B" P0C7U1 10 50739318-50816495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "intestine: 27.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 19.2" HPA061171 Supported Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (6.86e-3)" "unprognostic (1.91e-2)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "unprognostic (1.18e-2)" "unprognostic (5.42e-3)" "unprognostic (5.03e-3)" "unprognostic (2.21e-2)" "unprognostic (1.11e-1)" "unprognostic (3.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-3)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" 2.8 8.3 6.5 3.3 10.7 2.3 4.6 4.4 14.5 4.0 4.5 1.5 3.8 27.5 5.1 6.2 4.4 4.8 4.3 7.8 7.2 9.0 7.3 12.2 3.7 2.9 5.7 8.3 5.6 7.6 8.8 12.8 2.1 7.4 6.3 5.3 7.0 6.6 4.4 5.7 3.0 16.0 4.4 3.9 3.0 6.4 5.2 2.0 2.7 5.6 6.8 4.8 3.8 3.4 1.4 3.2 0.5 0.1 0.7 6.0 1.5 1.9 2.0 3.1 5.2 1.1 2.6 2.5 9.7 5.3 5.9 4.9 6.8 4.9 0.1 3.7 2.1 2.0 2.0 3.6 4.1 4.8 3.7 4.0 1.3 5.8 4.5 3.9 1.7 1.9 3.3 4.8 5.6 8.7 1.9 1.2 0.0 6.2 2.5 4.8 4.3 2.8 0.2 4.0 5.5 19.2 0.1 7.3 2.4 3.5 7.2 6.0 12.1 3.3 4.1 3.4 3.5 6.9 1.2 6.4 2.5 11.6 5.3 11.4 3.0 0.4 0.0 12.8 0.0 4.3 0.5 0.1 0.0 2.2 0.0 6.0 0.7 3.5 2.5 0.0 1.4 4.9 4.5 0.4 0.7 0.1 3.2 3.9 1.5 6.5 10.7 4.4 14.5 7.2 9.0 5.7 8.3 7.4 2.0 3.0 0.6 0.5 0.8 1.4 5.5 4.9 2.5 1.4 1.2 5.2 7.9 1.3 5.0 4.1 0.1 1.5 2.0 0.0 4.1 1.2 1.8 1.1 0.0 6.8 0.3 0.0 6.4 1.8 0.0 0.8 1.7 0.0 1.7 0.0 5.1 4.0 3.3 3.4 1.1 4.1 4.4 0.0 2.1 3.7 1.8 0.4 0.5 2.2 4.1 0.8 ASB14 DKFZp313L0121 ENSG00000239388 "Ankyrin repeat and SOCS box containing 14" A6NK59 3 57268347-57292682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "skeletal muscle: 26.3;tongue: 33.6" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Cardiomyocytes: 6.7;Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-3)" "unprognostic (1.85e-1)" "unprognostic (3.64e-1)" "unprognostic (7.14e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.37e-3)" "unprognostic (1.81e-4)" "unprognostic (1.11e-1)" "unprognostic (1.37e-1)" "unprognostic (1.24e-2)" "unprognostic (1.45e-2)" "unprognostic (6.69e-2)" "unprognostic (6.87e-2)" "unprognostic (9.68e-2)" "unprognostic (5.93e-2)" "unprognostic (5.71e-3)" 0.7 0.4 0.3 0.6 0.3 1.9 0.7 0.6 0.6 0.4 0.3 0.3 0.3 0.3 0.3 0.6 0.5 0.5 0.3 5.0 0.3 0.3 0.3 0.3 0.6 0.7 0.3 0.3 0.7 2.3 0.0 0.3 0.3 0.3 0.3 0.0 0.6 0.8 0.3 26.3 1.0 0.6 0.3 0.3 0.6 0.5 0.3 0.3 0.3 0.8 33.6 1.3 0.3 0.7 2.4 1.6 0.0 0.5 0.5 0.6 0.1 0.8 0.4 0.6 1.3 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.7 2.3 3.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.7 0.8 1.4 2.8 0.3 0.0 2.7 1.5 0.0 0.0 0.0 0.0 2.1 0.0 1.5 0.4 2.1 0.0 0.4 2.4 3.0 0.6 0.5 1.1 0.5 0.8 0.6 0.0 2.1 0.8 2.7 0.6 1.1 0.3 1.3 1.0 0.5 1.0 0.5 0.8 2.4 2.0 1.5 1.8 1.3 2.3 1.8 0.8 0.0 0.5 0.0 0.2 0.1 0.2 0.7 0.3 0.0 0.4 2.4 0.6 0.6 0.0 0.5 0.2 1.6 0.0 0.1 0.3 0.3 0.6 0.4 0.3 0.3 0.3 0.3 0.3 0.3 3.0 0.3 0.0 0.0 0.0 0.0 6.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASB17 ENSG00000154007 "Ankyrin repeat and SOCS box containing 17" Q8WXJ9 1 75918873-75932431 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 33.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 933.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 933.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 226.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.7 0.0 0.0 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 ASB18 ENSG00000182177 "Ankyrin repeat and SOCS box containing 18" Q6ZVZ8 2 236194872-236264409 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "heart muscle: 9.8;skeletal muscle: 14.3" "Cell type enriched" "Detected in single" 21 "Cardiomyocytes: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.4;K-562: 2.8;MCF7: 3.1;PC-3: 1.4;RH-30: 2.5;SiHa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (7.33e-3)" "unprognostic (3.07e-1)" "unprognostic (1.78e-6)" "unprognostic (4.75e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.0 1.9 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.4 0.0 2.5 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.0 1.4 0.6 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ASB4 ASB-4 ENSG00000005981 "Ankyrin repeat and SOCS box containing 4" Q9Y574 7 95478444-95540232 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Ciliated cells: 2.7;Early spermatids: 1.9;Late spermatids: 1.6" "Cancer enhanced" "Detected in some" "stomach cancer: 1.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 7.0;Hep G2: 11.4;SCLC-21H: 7.2" "Group enriched" "Detected in some" 4 "basal ganglia: 10.0;hypothalamus: 37.1" "Region enriched" "Detected in single" 7 "midbrain: 3.7" HPA055240 Uncertain NA NA "HPA055240: AB_2682753" "unprognostic (1.41e-1)" "unprognostic (3.67e-1)" "unprognostic (1.88e-2)" "unprognostic (2.66e-1)" "unprognostic (3.71e-1)" "unprognostic (2.85e-3)" "unprognostic (1.17e-1)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "unprognostic (2.92e-2)" "unprognostic (4.24e-1)" "unprognostic (9.13e-7)" "unprognostic (1.71e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-1)" "unprognostic (7.23e-2)" 0.3 28.6 0.7 0.1 1.1 0.3 0.2 0.1 1.3 0.1 0.1 1.3 0.1 0.2 0.1 0.3 0.1 0.2 0.4 2.6 0.7 0.6 0.1 1.0 0.4 0.1 1.7 0.5 0.1 0.4 0.0 40.1 1.3 0.2 0.2 0.0 0.1 0.3 0.1 20.7 0.2 0.2 0.1 1.6 0.1 0.4 0.2 0.1 0.2 0.2 2.5 0.4 0.1 0.1 1.0 0.6 1.3 0.3 0.9 0.7 0.0 0.3 7.0 0.3 2.5 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.8 1.3 0.2 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.5 11.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.3 0.1 0.6 0.0 0.2 0.2 0.3 0.2 0.2 1.6 0.2 0.2 0.0 0.2 0.2 7.2 0.0 0.1 0.4 0.7 0.3 0.1 0.3 0.3 0.4 0.4 0.1 0.2 0.8 0.2 0.4 0.2 0.4 0.2 0.3 0.3 0.5 0.6 0.1 0.7 1.0 0.6 0.5 0.2 1.0 0.7 0.7 1.3 0.9 0.3 0.6 0.3 0.0 0.7 1.1 0.1 1.3 0.7 0.6 1.7 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 2.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 229.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 3.6 7.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 229.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 ASB8 "FLJ21255, MGC5540" ENSG00000177981 "Ankyrin repeat and SOCS box containing 8" Q9H765 12 48147788-48181213 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.4" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003299 Approved NA NA "HPA003299: AB_1845072" "unprognostic (1.35e-2)" "unprognostic (1.32e-1)" "unprognostic (2.91e-2)" "unprognostic (8.82e-3)" "unprognostic (1.07e-1)" "unprognostic (1.06e-2)" "unprognostic (2.40e-3)" "unprognostic (3.51e-2)" "unprognostic (3.66e-2)" "unprognostic (1.29e-3)" "unprognostic (3.82e-3)" "unprognostic (1.14e-1)" "prognostic favorable (6.57e-6)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.04e-2)" "unprognostic (6.26e-2)" 12.6 12.8 11.1 8.2 13.8 22.7 9.1 18.2 17.2 9.8 9.7 12.2 7.4 9.0 11.5 9.9 10.7 8.3 8.6 19.0 10.2 10.4 13.3 13.4 7.5 9.2 10.9 10.2 9.8 10.3 14.5 14.7 7.7 16.8 9.3 11.5 15.4 10.2 10.0 106.4 9.3 11.3 10.6 9.6 10.1 9.0 8.5 8.8 15.7 10.2 22.3 11.1 10.5 7.2 11.1 9.3 42.7 12.3 13.1 14.2 8.2 9.3 7.6 9.5 13.8 13.9 12.4 6.7 17.9 11.6 11.6 11.1 12.4 11.8 15.7 13.6 14.9 6.7 8.4 14.8 10.2 13.2 19.0 12.2 19.0 10.8 6.4 10.6 18.3 17.7 12.1 9.8 15.2 10.0 21.1 11.7 18.3 14.5 19.8 10.4 8.7 16.6 13.0 3.4 12.0 14.2 11.0 14.4 16.4 9.1 9.9 14.2 9.4 10.6 12.5 10.4 9.0 23.0 12.4 9.0 10.2 7.4 10.2 7.6 17.5 20.5 13.8 12.8 40.7 5.6 25.6 8.7 42.7 12.3 9.7 11.5 11.1 13.3 12.3 8.5 8.9 13.6 14.2 20.7 13.1 12.3 9.3 12.6 8.2 11.1 13.8 18.2 17.2 10.2 10.4 10.9 10.2 16.8 8.8 20.8 23.5 28.9 6.9 6.3 59.5 59.8 22.9 18.7 15.9 15.7 58.9 17.8 34.9 18.5 16.6 20.4 24.8 0.0 19.1 10.9 14.7 9.7 19.7 27.7 21.0 38.1 17.9 17.2 20.0 58.2 22.5 17.2 20.3 19.8 23.8 46.1 15.6 24.3 26.2 29.5 113.0 51.8 15.3 29.3 17.3 9.7 14.3 34.6 21.8 7.4 ASCL3 "bHLHa42, HASH3, Sgn1" ENSG00000176009 "Achaete-scute family bHLH transcription factor 3" Q9NQ33 11 8937579-8938211 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "salivary gland: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;CACO-2: 1.1;HeLa: 1.0;U-2 OS: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA027032 Uncertain NA NA "HPA027032: AB_10602434" "unprognostic (8.91e-2)" "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 2.6 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.9 2.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASNSD1 "FLJ20752, NBLA00058, NS3TP1" ENSG00000138381 "Asparagine synthetase domain containing 1" "L0R819, Q9NWL6" 2 189661385-189670831 "Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036132, HPA036133, HPA075042" Uncertain Approved Cytosol NA NA Cytosol "HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731" "unprognostic (1.32e-1)" "unprognostic (1.70e-1)" "unprognostic (4.88e-2)" "unprognostic (2.15e-3)" "prognostic favorable (4.54e-4)" "unprognostic (8.42e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (5.68e-2)" "unprognostic (1.35e-2)" "unprognostic (1.41e-3)" "unprognostic (2.09e-1)" "unprognostic (6.32e-3)" "unprognostic (8.98e-3)" "unprognostic (8.11e-2)" "unprognostic (2.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" 23.1 22.4 25.5 15.9 24.7 25.5 29.1 41.0 29.4 22.7 19.5 14.1 18.1 18.0 23.6 17.3 18.2 20.6 18.2 23.9 22.9 26.0 25.0 31.9 16.9 22.3 24.2 22.6 33.2 22.4 20.8 36.8 26.8 29.1 19.6 16.5 13.2 18.2 18.6 52.4 14.0 15.4 23.9 27.8 22.0 18.1 14.0 21.8 20.1 25.0 19.8 20.8 22.4 23.6 15.9 11.0 41.9 11.2 21.5 24.5 15.2 13.4 10.5 22.2 18.6 24.2 23.6 19.5 29.3 27.6 31.7 31.6 26.2 9.6 26.8 17.8 25.1 15.0 11.2 23.9 20.3 37.3 28.2 26.7 24.9 20.1 26.3 26.9 24.5 14.0 24.1 15.1 27.8 24.5 20.2 28.4 18.5 23.1 20.2 29.4 17.7 29.0 26.2 33.2 20.8 41.3 16.5 20.0 25.5 17.8 19.1 25.4 16.1 21.2 15.7 24.9 29.3 22.6 22.7 22.1 25.7 20.0 21.7 28.8 29.7 40.0 47.0 21.8 14.6 22.8 24.6 11.2 41.9 17.7 9.4 21.5 15.8 19.5 19.0 11.0 15.9 23.3 20.8 20.4 21.5 10.3 10.1 24.5 15.2 25.5 24.7 41.0 29.4 22.9 26.0 24.2 22.6 29.1 21.8 50.6 27.5 45.5 20.4 26.7 19.3 37.6 20.4 36.1 39.8 15.7 11.8 58.7 69.6 30.2 4.1 29.1 17.7 0.0 39.1 34.4 35.2 20.0 18.5 48.0 29.2 14.3 34.5 29.4 26.6 4.6 37.7 28.0 16.9 27.1 23.3 29.4 31.7 8.6 31.8 45.3 23.4 45.3 32.3 27.7 32.4 24.8 100.2 41.5 24.7 17.5 ASPG C14orf76 ENSG00000166183 Asparaginase Q86U10 14 104085679-104115581 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 29.7;liver: 88.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 19.5;Hepatocytes: 83.1;Proximal tubular cells: 39.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.5;HMC-1: 3.2;RPTEC TERT1: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA069761 Enhanced NA NA "HPA069761: AB_2686191" "unprognostic (1.45e-2)" "unprognostic (7.43e-3)" "unprognostic (2.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-2)" "unprognostic (1.74e-2)" "unprognostic (1.72e-2)" "unprognostic (3.47e-2)" "unprognostic (1.98e-1)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "unprognostic (1.10e-1)" "unprognostic (8.75e-2)" "unprognostic (7.98e-2)" "unprognostic (3.85e-1)" "unprognostic (1.52e-2)" "unprognostic (2.32e-2)" 0.7 0.5 0.4 0.4 0.5 0.0 2.1 0.4 0.5 1.5 2.3 0.5 0.4 0.5 1.6 1.0 10.2 2.0 0.8 29.7 0.4 0.0 9.8 88.7 1.3 0.9 0.4 0.4 4.9 0.4 0.7 0.4 0.8 0.7 0.4 0.8 1.2 0.8 0.4 0.4 5.2 0.8 1.1 0.4 0.4 1.6 0.9 0.4 0.4 1.3 0.6 1.7 0.5 2.8 0.2 0.0 1.0 0.1 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 1.8 0.8 2.6 0.0 0.0 0.2 0.0 0.0 0.0 3.0 0.0 0.0 2.5 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.1 0.7 1.0 0.0 0.7 0.6 1.9 1.9 1.5 1.2 0.0 0.1 0.8 0.2 1.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.7 0.4 6.0 1.7 0.0 0.1 1.5 1.0 19.5 2.5 2.7 0.0 0.0 0.0 0.1 3.3 0.0 0.4 0.3 8.4 0.0 0.2 0.1 0.6 0.2 0.0 83.1 0.2 4.8 1.7 3.7 0.6 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.3 5.9 1.1 39.3 0.2 0.0 0.0 0.4 0.7 8.0 0.5 0.0 3.0 2.5 ASPHD2 FLJ39838 ENSG00000128203 "Aspartate beta-hydroxylase domain containing 2" Q6ICH7 22 26429273-26445015 "Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.1;Early spermatids: 25.3;Late spermatids: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000820 Uncertain NA NA "HPA000820: AB_1078231" "unprognostic (1.12e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-2)" "unprognostic (8.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (6.55e-2)" "unprognostic (9.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.11e-2)" 0.9 1.1 7.6 3.8 23.9 2.1 1.1 17.6 13.1 1.8 3.3 1.2 0.3 2.0 2.1 10.5 2.0 0.7 2.7 0.5 5.8 5.0 3.6 0.6 1.5 6.4 3.3 4.4 1.0 1.1 0.4 5.6 2.0 3.9 1.4 3.5 1.1 1.3 1.3 0.6 8.5 2.2 1.4 1.7 4.1 13.0 2.7 4.2 2.4 3.4 0.6 5.3 3.5 1.0 1.7 4.0 0.9 7.7 0.0 1.5 0.7 1.3 0.7 3.5 5.7 0.5 0.3 1.9 1.8 3.9 3.8 5.5 0.0 0.3 1.1 0.4 1.7 3.8 1.6 3.9 6.2 2.1 8.1 5.3 0.3 0.0 0.2 3.6 2.0 0.9 0.7 3.0 2.0 2.6 4.2 4.0 3.1 1.4 19.1 1.1 0.4 1.5 0.8 3.5 7.1 0.8 10.2 2.0 3.0 5.3 0.5 9.7 4.2 1.8 0.2 1.9 2.1 0.2 3.0 3.6 2.4 12.0 0.6 3.7 5.5 1.4 2.4 3.6 7.3 1.5 0.0 2.1 0.9 0.7 5.4 1.5 1.6 1.2 1.2 3.5 1.7 0.8 0.7 0.6 0.0 7.7 4.0 0.7 0.7 7.6 23.9 17.6 11.4 5.8 5.0 3.3 4.4 3.9 4.2 0.0 1.4 5.6 1.4 1.5 11.1 0.4 2.5 0.0 0.0 0.0 9.8 0.2 0.0 0.8 25.3 0.3 0.1 0.0 0.6 9.0 0.7 4.3 0.0 0.0 1.4 6.4 0.0 1.3 2.6 15.7 0.9 1.1 1.7 0.0 3.5 1.5 4.2 0.0 0.7 0.6 10.0 0.0 0.9 1.0 1.4 1.0 0.9 0.5 1.9 3.7 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 19.9;brain: 52.5" "Cell type enhanced" "Detected in some" 20 "Horizontal cells: 22.3;Late spermatids: 9.9;Rod photoreceptor cells: 8.8" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.0;NTERA-2: 4.6;SCLC-21H: 2.8;U-2 OS: 3.7;U-266/84: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA074112: AB_2686662" "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 1.4 19.9 21.5 1.6 23.8 1.1 1.7 15.0 52.5 1.3 1.5 7.4 1.9 1.5 2.3 5.4 1.2 3.2 1.9 1.7 17.4 13.7 1.3 1.4 1.4 1.2 8.5 18.8 8.9 1.7 1.2 8.2 1.6 9.8 2.4 1.6 2.2 2.0 3.3 1.3 1.1 1.5 2.2 5.8 3.6 1.2 1.9 7.2 0.0 1.2 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 23.8 15.0 27.2 17.4 13.7 8.5 18.8 9.8 7.2 0.0 0.0 0.0 0.0 0.1 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 22.3 0.0 1.8 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 8.8 0.0 0.1 4.2 0.2 0.0 0.1 0.0 0.0 0.0 ASXL3 KIAA1713 ENSG00000141431 "Additional sex combs like 3, transcriptional regulator" Q9C0F0 18 33578233-33751192 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Group enriched" "Detected in many" 6 "Early spermatids: 40.9;Late spermatids: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.1;RPMI-8226: 12.2;SCLC-21H: 4.7;SH-SY5Y: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039539, HPA040034" Uncertain NA NA "HPA039539: , HPA040034: " "unprognostic (2.05e-2)" "unprognostic (6.88e-2)" "unprognostic (2.91e-1)" "unprognostic (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (3.19e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (9.16e-2)" "unprognostic (5.35e-3)" "unprognostic (5.92e-2)" "unprognostic (2.47e-12)" "unprognostic (4.69e-2)" "unprognostic (2.32e-1)" "unprognostic (4.98e-3)" "unprognostic (1.67e-2)" 1.0 0.7 6.6 0.7 5.4 0.4 0.8 0.4 10.3 3.4 1.7 1.7 1.7 1.5 1.4 1.8 0.6 2.6 2.0 2.1 4.0 3.3 2.8 1.3 0.9 0.6 5.4 8.8 9.2 1.7 3.7 2.5 1.0 4.3 2.3 1.1 0.9 1.0 2.8 0.4 0.5 1.8 7.4 5.5 0.8 2.3 6.1 5.4 0.0 3.2 0.0 0.5 1.7 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 12.2 0.0 0.0 4.7 2.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.6 5.4 0.4 10.3 4.0 3.3 5.4 8.8 4.3 5.4 0.0 0.0 0.0 1.0 0.1 0.6 4.0 2.5 0.0 5.7 1.8 0.0 0.4 1.7 1.6 40.9 0.0 1.1 0.0 0.0 0.1 1.3 0.3 1.1 1.8 0.2 1.6 2.9 0.6 0.0 26.2 2.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 1.8 0.9 0.5 0.0 1.0 0.9 1.7 0.0 0.3 0.0 0.2 0.3 ATAD3C FLJ34599 ENSG00000215915 "ATPase family, AAA domain containing 3C" Q5T2N8 1 1449689-1470158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 17.5;Collecting duct cells: 19.2;Distal tubular cells: 38.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 16.5" HPA065305 Approved Mitochondria NA NA Mitochondria "HPA065305: AB_2685459" "unprognostic (9.23e-2)" "unprognostic (3.48e-2)" "unprognostic (3.20e-2)" "unprognostic (4.35e-3)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (3.79e-2)" "prognostic favorable (5.15e-4)" "unprognostic (1.23e-1)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (2.65e-1)" "unprognostic (3.80e-2)" "unprognostic (1.83e-1)" "unprognostic (5.74e-2)" "unprognostic (2.22e-1)" "unprognostic (2.12e-3)" 0.7 0.0 2.1 1.7 2.3 0.7 2.7 0.3 1.5 1.3 1.8 0.9 1.4 2.6 0.7 2.5 1.3 0.4 2.8 1.5 3.1 4.9 2.2 0.7 2.6 1.1 5.0 0.1 1.5 0.3 4.0 0.6 5.4 4.5 0.2 1.2 0.5 1.3 4.3 0.5 0.5 0.7 4.1 0.9 2.2 0.9 2.1 0.6 2.9 0.6 1.6 4.3 0.7 0.3 0.0 0.3 0.5 0.5 0.1 0.4 0.1 0.1 0.2 0.1 1.6 3.3 0.3 0.4 0.1 0.1 0.4 1.3 0.5 0.1 0.1 1.3 0.3 0.9 2.0 0.2 0.3 0.3 0.0 0.2 0.2 1.0 0.1 0.0 0.4 0.3 3.9 0.1 0.9 0.5 1.0 0.6 0.1 0.2 0.4 0.1 16.5 1.1 0.4 2.8 1.0 0.0 0.6 0.2 3.0 3.6 0.3 0.3 0.2 0.3 0.5 0.2 1.9 2.7 0.6 0.2 0.4 0.1 2.9 0.6 1.1 1.1 0.4 4.3 2.1 1.5 1.3 0.1 1.3 1.9 1.4 2.5 1.6 0.3 0.6 2.0 0.7 6.0 17.5 0.8 3.2 3.1 4.3 3.3 0.0 1.4 3.4 19.2 15.7 0.7 38.1 4.6 0.3 3.6 0.6 0.0 8.0 0.2 1.0 3.5 3.5 5.9 1.6 6.4 4.1 3.1 2.1 1.1 1.1 1.3 3.3 0.0 1.6 2.8 4.5 0.0 4.6 10.8 8.0 0.0 1.0 0.5 0.9 5.0 0.7 2.9 1.2 2.2 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 67.1" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9" "Lineage enriched" "Detected in many" 7 "T-cells: 11.0" "Group enriched" "Detected in some" 5 "BEWO: 17.0;CAPAN-2: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 0.0 0.2 8.8 0.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.5 1.2 15.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 6.1 67.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.8 10.5 0.0 0.1 1.6 0.8 0.2 0.1 0.4 11.0 1.9 0.7 0.0 0.9 0.2 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 5.5 0.4 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 2.0 0.5 0.7 0.0 1.5 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.2 1.3 0.0 1.2 1.1 6.0 1.6 0.0 1.6 11.0 4.1 0.0 0.4 0.1 0.8 5.9 1.9 0.0 0.0 3.2 0.2 0.0 1.7 1.1 0.0 16.0 0.0 0.0 0.0 6.6 0.0 0.3 27.7 1.0 0.0 0.0 0.2 2.3 0.0 0.3 14.9 0.0 1.7 0.0 0.0 3.7 0.0 21.7 0.6 0.2 0.0 0.0 0.0 0.5 2.4 0.0 0.7 0.0 0.4 0.0 0.2 16.9 10.4 0.3 96.6 2.2 0.0 1.1 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell type enriched" "Detected in some" 36 "Mucus-secreting cells: 198.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HL-60: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 ATOH8 "bHLHa21, FLJ14708, HATH6" ENSG00000168874 "Atonal bHLH transcription factor 8" Q96SQ7 2 85751344-85788066 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 41.8" "Cell type enhanced" "Detected in many" 7 "Club cells: 22.7;Hepatocytes: 31.6;Late spermatids: 19.8;Muller glia cells: 25.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.9;MAIT T-cell: 1.7" "Group enriched" "Detected in many" 12 "monocytes: 2.9;T-cells: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RH-30: 19.2;RT4: 12.3;TIME: 18.1;U-2197: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028406 Supported Nucleoplasm NA NA Nucleoplasm "HPA028406: AB_2672587" "unprognostic (7.70e-2)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (2.84e-3)" "unprognostic (2.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.78e-1)" "unprognostic (6.28e-3)" "unprognostic (1.56e-1)" "prognostic favorable (8.98e-6)" "unprognostic (3.32e-2)" "prognostic favorable (3.80e-5)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-2)" 36.4 2.4 3.7 2.4 4.3 0.8 19.9 2.9 4.9 10.5 4.0 4.3 4.5 2.7 11.5 2.2 5.0 7.6 5.7 12.9 5.0 2.0 3.6 30.8 21.1 4.5 6.3 2.1 9.7 4.3 1.0 2.3 3.2 5.4 9.0 1.3 6.4 3.5 12.1 25.2 8.4 3.2 5.8 4.1 8.1 4.4 2.0 4.6 0.3 41.8 4.2 1.1 10.4 24.5 0.0 0.2 0.0 2.9 0.0 1.7 0.4 0.0 3.6 5.1 11.4 5.0 0.3 0.1 9.5 1.0 2.9 1.3 0.0 0.0 0.0 3.6 7.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.5 0.5 3.3 0.0 0.0 3.7 0.0 0.0 0.0 6.0 1.9 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.1 2.5 0.1 0.0 19.2 0.1 0.0 12.3 8.5 1.8 1.8 0.0 0.6 0.0 0.0 0.0 18.1 4.5 0.2 12.5 0.0 0.0 0.0 0.0 1.5 0.0 8.9 0.0 2.9 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 3.7 4.3 2.9 4.9 5.0 2.0 6.3 2.1 5.4 4.6 8.9 16.5 0.0 6.2 2.3 0.2 11.5 7.6 2.7 22.7 1.8 0.0 0.1 0.0 7.5 11.2 11.7 0.0 0.0 2.0 0.5 9.0 5.6 1.1 31.6 2.4 0.0 4.1 5.5 2.4 19.8 3.1 3.3 1.7 0.0 1.9 25.7 0.9 0.0 0.4 0.3 0.3 0.0 9.4 1.1 0.7 1.3 0.2 0.0 0.8 1.1 ATP10A "ATP10C, ATPVA, ATPVC, KIAA0566" ENSG00000206190 "ATPase phospholipid transporting 10A (putative)" O60312 15 25677273-25865172 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 29.8;Early spermatids: 17.6;granulocytes: 15.0;Late spermatids: 14.7;Melanocytes: 16.9;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 12 "dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0" "Cell line enhanced" "Detected in some" "BJ: 13.0;fHDF/TERT166: 19.1;HMC-1: 12.7;RPTEC TERT1: 10.2;SK-MEL-30: 17.3" "Low region specificity" "Detected in all" "HPA041496, HPA042509" Uncertain NA NA "HPA041496: AB_2677513, HPA042509: AB_2678032" "unprognostic (3.70e-1)" "unprognostic (2.83e-2)" "unprognostic (2.30e-4)" "unprognostic (1.18e-1)" "unprognostic (9.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.67e-1)" "unprognostic (4.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.60e-5)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" "unprognostic (4.89e-2)" "unprognostic (9.42e-2)" 7.4 14.1 5.3 5.4 9.8 4.7 5.7 3.4 11.0 5.3 3.3 6.2 1.4 1.5 1.9 2.1 3.7 3.1 7.1 2.9 8.0 5.8 6.0 1.0 12.2 14.8 9.3 9.0 1.6 1.9 1.9 2.5 3.6 11.3 3.6 2.3 4.0 14.4 1.5 0.7 3.3 3.6 5.3 6.4 3.5 4.0 6.0 6.2 1.5 3.0 1.6 3.3 4.2 3.3 0.0 3.0 0.0 0.3 4.7 4.0 1.7 0.0 3.4 0.7 0.0 2.7 2.6 0.0 13.0 6.3 4.0 7.1 0.0 0.0 0.0 0.7 19.1 0.0 0.0 6.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.6 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 2.5 0.0 0.5 0.0 0.9 0.0 0.8 2.4 2.4 0.8 10.2 0.0 0.0 0.0 0.0 0.0 17.3 0.0 5.2 0.5 0.0 5.3 0.2 7.6 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.3 0.0 1.9 0.2 1.9 0.0 2.2 2.1 0.4 0.0 4.0 3.7 0.0 4.7 0.1 3.0 0.7 1.7 5.3 9.8 3.4 11.0 8.0 5.8 9.3 9.0 11.3 6.2 29.8 7.5 0.0 0.0 0.9 0.0 1.4 2.5 6.7 7.9 0.0 0.0 0.0 0.0 0.2 17.6 0.8 0.0 0.0 0.0 0.1 2.8 0.9 15.0 0.0 2.2 0.0 0.0 0.6 2.1 14.7 3.7 4.4 16.9 0.0 0.0 0.0 0.6 0.0 16.6 0.0 0.0 0.0 8.1 0.4 0.7 0.4 0.0 4.4 0.0 0.0 ATP10B "ATPVB, FLJ21477, KIAA0715" ENSG00000118322 "ATPase phospholipid transporting 10B (putative)" O94823 5 160563120-160852214 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;intestine: 35.4" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 80.4;Mucus-secreting cells: 52.8;Paneth cells: 67.1;Undifferentiated cells: 77.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "WM-115: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034574 Uncertain NA NA "HPA034574: AB_10669992" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (4.47e-4)" "unprognostic (3.99e-2)" "unprognostic (6.10e-3)" "unprognostic (4.69e-2)" "unprognostic (4.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.20e-2)" "unprognostic (3.42e-2)" "unprognostic (5.12e-2)" "unprognostic (2.38e-3)" "unprognostic (5.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-1)" "unprognostic (2.14e-1)" 0.5 0.4 4.3 4.1 9.4 0.4 0.7 5.1 10.0 1.7 33.8 27.8 1.5 18.9 0.4 11.4 8.2 0.7 12.8 0.5 5.5 2.8 0.5 0.4 0.5 0.4 13.8 6.8 0.4 4.2 0.4 0.4 0.4 13.1 0.5 35.4 0.0 2.8 1.0 0.4 8.4 21.1 1.6 20.2 0.4 4.1 0.7 14.0 0.0 0.5 0.0 2.5 1.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 9.4 5.1 10.0 5.5 2.8 13.8 6.8 13.1 14.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 25.5 0.0 0.0 1.8 0.0 0.0 0.0 11.1 0.1 0.0 80.4 0.0 17.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 1.7 2.8 52.8 0.0 25.1 67.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 77.9 1.0 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 57.5;Syncytiotrophoblasts: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" "Cell line enhanced" "Detected in many" "HAP1: 24.4" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.4 1.0 2.3 1.6 6.7 7.3 0.4 10.4 12.6 5.0 9.0 5.4 9.0 4.6 3.9 16.8 8.5 2.7 24.4 8.7 7.7 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.5 16.5 8.4 2.3 0.0 2.5 13.6 0.5 2.4 0.7 0.8 0.0 1.3 2.8 5.3 0.0 9.1 1.8 1.5 2.9 4.8 1.2 3.1 5.4 2.2 1.2 12.7 12.4 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 3.9 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 8.9 6.9 15.0 7.9 17.1 10.9 3.6 0.0 2.7 2.3 15.7 29.5 27.1 1.7 4.3 1.6 14.0 1.6 0.0 4.1 7.4 11.8 5.8 2.3 4.9 11.7 12.7 9.2 17.8 16.1 0.6 57.5 9.1 6.8 7.2 4.3 28.8 2.7 2.5 23.7 9.1 8.9 25.8 9.8 0.4 2.7 23.6 147.8 11.5 3.7 6.5 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193402077-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051932 Approved Nucleoplasm NA NA Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.6 0.7 11.2 0.6 11.1 0.6 17.8 2.6 10.1 1.8 2.2 8.4 9.0 0.9 0.6 46.4 11.8 2.7 4.3 0.6 11.1 5.1 0.8 0.7 22.0 0.8 7.5 7.7 0.8 3.9 52.5 3.5 0.6 9.0 0.6 3.2 0.5 4.5 16.7 0.6 11.2 0.6 0.7 6.1 0.7 7.6 0.8 7.5 0.0 51.2 7.8 9.5 0.6 3.7 0.4 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.1 1.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.9 1.0 1.5 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 11.2 11.1 2.6 10.1 11.1 5.1 7.5 7.7 9.0 7.5 59.6 19.6 0.0 0.0 0.1 1.9 0.4 12.7 13.4 22.7 0.0 0.0 0.8 0.0 2.1 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 1.1 0.0 0.2 1.6 0.0 1.8 0.8 0.8 0.0 0.6 1.7 0.0 1.5 0.6 1.2 1.7 0.4 0.2 0.9 0.0 0.0 0.7 1.2 1.4 0.6 0.8 1.7 0.0 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274790-193378843 "Predicted membrane proteins" Translocase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 17.5;salivary gland: 28.9" "Cell type enhanced" "Detected in some" 25 "Club cells: 2.3;Early spermatids: 1.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Region enriched" "Detected in many" 10 "pons and medulla: 15.2" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "PC-3: 1.7;SK-BR-3: 5.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031774" Uncertain NA NA "HPA031771: AB_2674038, HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.1 0.0 1.4 0.1 1.5 0.1 17.5 0.3 0.9 0.1 0.1 2.8 0.1 0.0 0.3 0.9 0.9 0.0 0.1 0.1 1.0 0.7 0.1 0.1 0.4 0.1 0.9 0.1 0.2 0.1 0.1 0.2 0.1 15.2 0.3 0.0 0.4 28.9 0.1 1.3 5.1 0.1 0.1 0.3 0.1 1.4 0.3 0.1 0.4 1.4 1.3 0.7 0.1 0.1 0.4 0.4 4.1 0.3 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.7 1.0 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.2 0.7 0.0 1.7 0.3 1.0 0.0 0.0 0.4 0.7 0.0 0.0 5.8 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.3 1.0 0.0 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 4.1 0.3 0.0 0.4 0.1 0.1 1.4 1.5 0.3 0.9 1.0 0.7 0.9 0.1 15.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP4A ATP6A ENSG00000105675 "ATPase H+/K+ transporting alpha subunit" P20648 19 35550043-35563658 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 120.1" "Group enriched" "Detected in some" 4 "Early spermatids: 7.3;Late spermatids: 15.2" "Cancer enriched" "Detected in single" 21 "stomach cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-138 MG: 1.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA039154, HPA076684" Enhanced NA NA 790000 "HPA039154: AB_10672772, HPA076684: " "unprognostic (3.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.77e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (9.68e-2)" "unprognostic (1.47e-3)" "unprognostic (3.90e-3)" "unprognostic (3.92e-2)" "unprognostic (4.86e-2)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" 0.1 0.2 0.1 0.1 0.6 0.0 0.1 0.1 0.6 0.1 0.1 3.4 0.1 0.0 0.1 0.1 4.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 120.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 1.5 0.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.6 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.6 0.0 0.0 0.0 0.0 0.0 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1493.8;Hofbauer cells: 948.2;Proximal tubular cells: 1347.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved NA NA "HPA051469: AB_2681496" "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 39.1 60.1 52.8 34.8 48.0 49.7 64.3 47.4 72.1 46.4 57.0 49.5 38.2 50.3 57.0 63.3 52.3 71.2 48.2 107.6 45.9 43.7 60.3 60.1 46.8 105.6 49.3 57.9 67.3 99.2 47.9 50.8 34.0 42.2 46.4 73.3 49.7 69.1 43.1 165.8 50.3 45.4 53.3 51.3 51.6 57.4 38.1 32.9 82.1 46.2 92.9 67.0 47.4 41.7 112.1 133.4 30.2 96.4 71.7 99.0 126.2 27.5 59.0 62.3 56.3 43.0 105.1 29.3 24.3 54.7 72.6 49.8 20.1 65.2 33.4 59.7 47.5 23.6 26.6 79.6 56.3 64.6 55.9 95.3 91.2 47.6 41.4 93.6 69.3 45.5 116.7 83.9 70.3 117.2 117.6 93.2 41.0 64.6 98.9 73.6 72.2 70.7 169.1 53.1 58.4 65.9 71.5 59.1 83.0 88.5 34.7 32.5 59.6 32.8 38.2 81.8 56.9 123.9 126.6 44.5 35.6 49.1 27.3 37.6 51.8 43.3 24.3 53.0 73.2 54.4 30.2 96.4 27.1 68.9 89.6 75.8 112.1 89.2 73.6 133.4 99.5 99.0 81.4 22.0 71.7 79.5 103.0 92.7 126.2 52.8 48.0 47.4 72.1 45.9 43.7 49.3 57.9 42.2 32.9 169.7 211.4 0.0 0.0 0.0 0.0 0.0 0.0 396.2 325.3 500.7 0.0 597.2 1493.8 365.1 0.0 0.0 0.0 0.0 588.0 662.7 0.0 0.0 206.9 0.0 948.2 0.0 0.0 0.0 0.0 0.0 0.0 161.9 0.0 664.6 0.0 0.0 433.3 0.0 0.0 1347.7 0.0 0.0 0.0 0.0 0.0 0.0 424.6 0.0 0.0 0.0 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175184607 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 189.6" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 786.5;Distal tubular cells: 2259.7;Extravillous trophoblasts: 831.6;Hofbauer cells: 886.9;Proximal tubular cells: 1680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favorable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 26.1 26.7 26.6 26.3 28.7 19.8 34.3 26.9 50.9 15.7 51.1 11.4 23.6 61.7 17.4 22.2 38.9 15.5 28.7 189.6 25.8 27.4 63.9 60.8 21.2 34.8 31.1 31.5 13.6 28.4 36.7 19.0 16.8 27.6 17.1 53.3 16.6 34.2 25.0 115.7 20.0 47.3 24.6 18.5 17.6 31.9 12.3 15.8 21.8 19.1 95.9 27.7 19.3 20.2 38.5 78.8 22.6 59.9 34.5 37.2 66.1 33.7 30.2 45.6 50.3 39.1 34.8 51.3 31.3 33.0 44.3 38.7 90.2 28.3 84.3 37.0 34.9 49.0 44.7 57.3 54.1 46.9 35.4 52.8 67.7 44.1 114.0 30.1 87.5 41.0 37.4 41.8 50.0 31.9 34.2 44.4 40.8 73.0 40.5 48.4 46.3 67.5 73.9 59.9 81.6 94.6 53.0 42.1 82.7 86.3 76.8 40.9 26.0 25.2 68.6 68.2 68.1 41.3 71.5 29.6 7.4 35.4 0.2 43.0 32.0 40.4 72.9 42.5 52.8 33.0 17.6 53.4 22.6 33.3 59.9 33.6 38.5 35.3 36.1 78.8 30.4 33.5 35.9 6.2 34.5 53.7 58.3 37.2 66.1 26.6 28.7 26.9 50.9 25.8 27.4 31.1 31.5 27.6 15.8 163.8 131.1 0.0 0.0 0.0 0.0 0.0 0.0 238.3 230.9 294.8 0.0 786.5 2259.7 429.4 0.0 0.0 0.0 0.0 326.9 831.6 0.0 0.0 81.4 0.0 886.9 0.0 0.0 0.0 0.0 0.0 0.0 111.5 0.0 358.9 0.0 0.0 350.5 0.0 0.0 1680.5 0.0 0.0 0.0 0.0 0.0 0.0 577.8 0.0 0.0 0.0 ATP6AP1L ENSG00000205464 "ATPase H+ transporting accessory protein 1 like" Q52LC2 5 82279462-82386977 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "MOLT-4: 15.7" HPA053771 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA053771: AB_2682257" "unprognostic (1.64e-1)" "unprognostic (8.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (5.09e-1)" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-3)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" 1.6 1.0 2.6 0.2 2.4 0.6 0.7 2.5 2.1 1.8 1.2 0.1 1.5 0.1 1.4 2.4 1.7 2.0 2.7 1.8 0.8 1.4 1.5 0.7 2.5 4.4 2.4 0.1 2.0 0.7 1.4 0.6 2.6 2.5 3.3 5.1 0.2 0.6 2.7 0.8 1.8 3.8 1.5 0.4 0.9 0.5 0.1 1.3 0.0 0.1 1.5 1.2 0.0 0.1 0.0 0.1 1.0 0.6 0.3 0.0 0.1 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.9 1.3 0.0 0.3 2.9 0.0 1.3 0.6 0.5 0.2 0.3 2.3 0.2 0.0 2.1 1.1 0.0 2.6 0.2 0.5 0.2 0.7 1.2 0.0 0.2 15.7 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.7 1.2 0.0 1.5 0.0 1.3 0.0 0.0 0.0 1.6 0.5 2.3 1.9 12.1 2.4 0.0 14.7 1.2 5.2 27.5 6.1 1.7 2.6 20.6 1.8 1.3 0.0 2.9 2.7 3.8 1.2 2.3 1.6 1.2 1.6 1.2 4.9 1.5 16.6 4.4 1.3 0.0 1.0 1.8 10.6 2.6 0.0 2.8 1.1 14.2 0.0 1.4 14.0 5.5 1.3 2.9 1.9 1.1 1.3 ATP6V0B "ATP6F, HATPL, VMA16" ENSG00000117410 "ATPase H+ transporting V0 subunit b" Q99437 1 43974487-43978295 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 173.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044281 Approved Cytosol NA NA Cytosol "HPA044281: " "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (5.69e-2)" "unprognostic (5.31e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (7.23e-2)" "prognostic favorable (3.24e-4)" "unprognostic (6.13e-2)" "prognostic favorable (3.62e-6)" "unprognostic (5.55e-2)" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.87e-4)" 20.4 35.7 35.4 21.8 35.3 84.2 28.5 29.1 56.4 23.3 28.3 32.2 26.7 19.2 13.9 35.6 21.9 20.0 22.0 24.8 41.2 44.7 47.6 56.3 25.8 28.5 43.6 31.5 12.9 87.0 32.5 36.3 35.0 33.9 27.0 32.0 32.4 34.8 22.2 27.9 20.1 20.2 19.1 34.8 33.2 25.2 15.3 24.8 16.3 38.7 19.5 24.7 23.2 16.5 23.7 58.0 173.6 78.0 8.8 14.2 87.6 23.7 23.2 19.3 24.2 29.7 15.7 23.6 21.4 31.8 41.6 36.0 24.9 26.0 22.1 19.8 22.6 49.4 19.7 45.0 32.2 19.6 20.7 46.9 27.6 40.1 35.8 47.1 42.9 53.7 19.3 42.5 45.8 40.6 26.7 20.0 31.0 27.5 48.5 34.0 25.1 17.7 71.5 31.8 34.5 49.6 25.1 18.5 60.2 43.3 29.3 45.5 22.5 14.4 57.1 53.6 22.8 23.4 77.2 10.1 21.5 18.3 38.7 51.4 39.3 57.7 24.5 29.2 61.2 33.5 31.9 78.0 64.2 13.2 48.1 13.0 23.7 14.2 12.7 48.1 19.1 10.8 10.9 173.6 8.8 44.0 58.0 13.7 87.6 35.4 35.3 29.1 56.4 41.2 44.7 43.6 31.5 33.9 24.8 74.5 137.9 144.5 130.3 298.3 238.3 92.4 122.3 100.4 66.0 268.7 96.2 165.0 170.8 307.8 2.7 147.4 174.0 23.3 286.0 191.3 151.0 308.8 203.1 213.0 743.7 122.3 214.8 101.3 356.6 8.6 73.1 420.3 266.6 357.1 190.7 203.9 311.9 371.7 61.5 175.0 164.2 77.6 135.2 133.6 224.9 313.3 415.2 116.5 165.6 262.4 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154228 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 56.8" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 177.4" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles NA NA Vesicles "HPA055327: AB_2682784, HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 6.6 0.3 0.2 1.3 0.3 0.8 0.3 0.2 0.2 0.2 1.5 0.0 11.9 0.7 0.2 1.0 0.2 0.2 0.1 0.2 0.3 0.3 56.8 0.3 12.2 1.2 0.5 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.8 2.0 5.7 1.1 1.2 0.2 0.9 1.0 0.0 0.3 0.4 0.3 0.2 0.0 1.0 0.4 0.3 0.6 0.3 0.2 2.2 1.7 4.6 1.0 2.0 1.5 0.3 0.5 1.2 0.6 0.7 0.0 0.5 2.3 0.0 0.0 1.0 0.3 0.3 0.4 0.3 0.2 0.0 1.6 2.5 0.7 1.6 0.4 0.4 0.1 0.8 1.7 0.1 0.0 0.7 1.4 0.6 0.1 0.9 0.7 1.9 0.4 0.3 0.4 0.7 0.5 0.9 0.0 0.7 0.2 0.3 0.2 0.2 0.2 0.3 0.0 1.1 3.4 0.3 0.1 0.8 5.6 9.2 1.8 0.1 0.3 0.6 0.8 0.7 0.5 0.4 0.2 0.6 8.6 0.6 0.7 2.6 1.0 0.8 1.1 0.5 0.8 1.2 1.0 0.9 0.5 2.2 1.5 1.3 4.6 2.0 1.0 1.7 0.9 0.3 0.2 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 29.5 0.0 177.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.5 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP6V0E1 "ATP6H, ATP6V0E, M9.2" ENSG00000113732 "ATPase H+ transporting V0 subunit e1" O15342 5 172983757-173035445 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.24e-1)" "unprognostic (3.08e-1)" "unprognostic (3.61e-1)" "unprognostic (1.51e-1)" "unprognostic (5.34e-2)" "unprognostic (1.54e-3)" "unprognostic (2.25e-3)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (6.63e-2)" "unprognostic (1.47e-1)" "unprognostic (8.33e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-1)" "unprognostic (2.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.02e-1)" 53.2 54.8 22.3 34.4 26.6 18.1 77.1 9.1 21.5 45.3 50.7 30.6 53.2 28.8 41.8 152.2 53.0 35.6 43.5 70.0 20.0 24.9 90.5 78.6 54.4 68.2 33.3 15.5 49.0 53.1 18.3 65.2 83.1 40.5 48.6 36.3 52.6 59.4 54.6 47.6 34.2 54.1 46.3 34.1 61.3 43.8 34.6 21.9 34.8 91.8 42.2 45.6 56.6 43.5 86.8 90.7 183.9 94.9 50.1 69.0 145.1 31.5 34.5 11.3 34.3 105.0 42.3 26.7 62.1 57.9 31.1 48.3 38.7 49.4 13.7 88.9 72.8 83.5 22.8 22.5 44.2 34.8 94.6 22.3 12.9 35.0 36.5 51.3 24.3 45.4 55.7 54.5 35.7 19.8 38.1 37.3 15.3 8.4 40.5 67.8 62.5 15.1 35.2 13.1 25.1 29.8 16.3 16.2 24.6 61.5 40.4 16.5 11.1 27.3 33.7 48.6 33.0 37.3 34.1 56.0 74.5 16.6 52.9 51.8 35.0 71.7 15.0 40.3 40.8 24.3 157.8 94.9 141.6 59.4 69.5 54.4 86.8 68.3 61.8 61.0 72.9 66.5 69.0 183.9 50.1 65.6 90.7 67.8 145.1 22.3 26.6 9.1 21.5 20.0 24.9 33.3 15.5 40.5 21.9 122.1 195.0 243.7 272.1 260.3 17.2 175.6 267.5 147.2 136.5 492.0 5.9 429.9 275.2 586.3 22.7 294.4 265.3 70.0 319.5 476.4 327.8 370.1 248.2 359.4 643.5 35.0 204.6 243.0 435.2 23.0 316.9 443.2 349.2 1058.6 186.8 258.2 473.5 340.1 315.7 579.4 18.7 239.3 199.8 88.1 109.0 248.7 704.7 265.8 182.5 358.6 ATP6V0E2 "ATP6V0E2L, C7orf32" ENSG00000171130 "ATPase H+ transporting V0 subunit e2" Q8NHE4 7 149872968-149880698 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 92.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 112.2;Horizontal cells: 108.1;Muller glia cells: 136.8;Proximal tubular cells: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 51.0" NA NA "unprognostic (8.72e-2)" "unprognostic (4.73e-2)" "unprognostic (3.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.23e-1)" "unprognostic (2.42e-2)" "unprognostic (5.84e-3)" "unprognostic (3.57e-2)" "prognostic favorable (5.80e-4)" "unprognostic (1.21e-1)" "prognostic favorable (8.26e-7)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.48e-3)" 11.8 17.3 60.1 6.5 56.5 3.6 8.6 70.5 92.7 6.4 6.7 26.4 14.2 5.0 4.3 6.2 6.0 13.4 5.9 27.9 73.7 55.3 26.9 27.9 6.8 12.1 61.1 39.7 4.9 11.7 14.0 25.3 3.1 57.1 26.2 5.3 18.7 37.0 24.8 8.7 4.7 4.6 6.3 29.4 8.3 7.3 3.2 12.2 8.4 26.6 2.0 8.1 4.9 1.7 7.0 6.4 1.5 6.9 12.0 30.6 11.2 7.5 21.2 8.8 28.6 3.6 0.6 5.5 3.9 5.4 10.8 11.1 7.4 9.5 15.4 16.6 5.2 11.2 6.7 18.7 6.6 4.6 19.8 20.8 4.8 6.5 42.5 5.3 3.5 10.6 1.2 6.9 11.9 0.7 8.4 8.9 19.5 5.1 7.6 0.7 12.9 2.5 8.0 7.6 9.7 14.9 16.8 0.3 7.2 8.4 8.1 51.0 28.9 5.1 17.8 11.9 2.2 10.0 2.3 1.6 3.1 3.3 32.7 14.5 10.6 13.5 7.4 19.9 6.1 10.1 1.5 3.1 0.7 16.7 5.8 15.4 7.0 21.0 19.5 6.4 6.3 27.5 24.7 0.4 12.0 6.9 3.0 30.6 11.2 60.1 56.5 70.5 66.4 73.7 55.3 61.1 39.7 57.1 12.2 14.9 13.7 15.9 4.7 3.8 112.2 25.4 22.9 6.7 10.3 26.2 23.6 17.3 46.4 40.1 0.1 3.2 0.9 0.0 11.2 2.1 6.7 22.5 10.4 50.4 21.2 108.1 21.4 9.2 6.6 1.3 4.9 9.6 42.2 5.4 16.3 136.8 6.3 0.0 10.6 94.9 61.7 6.5 10.3 0.5 12.4 3.9 4.2 28.7 2.6 3.3 ATP6V1G3 "ATP6G3, Vma10" ENSG00000151418 "ATPase H+ transporting V1 subunit G3" Q96LB4 1 198523222-198540945 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "ductus deferens: 16.9;kidney: 33.4" "Cell type enriched" "Detected in some" 43 "Distal tubular cells: 376.4" "Cancer enriched" "Detected in single" 140 "renal cancer: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028701 Enhanced NA NA "HPA028701: AB_10611681" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 1.8 1.3 0.4 0.0 0.0 0.0 0.6 6.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.5 0.1 1.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 376.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP8B3 ATPIK ENSG00000130270 "ATPase phospholipid transporting 8B3" O60423 19 1782075-1812276 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 55.8" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 8.9;Spermatocytes: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.6;Karpas-707: 18.7;U-266/70: 15.6" "Not detected" "Not detected" NA NA "unprognostic (6.50e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.05e-5)" "unprognostic (6.66e-2)" "unprognostic (7.91e-2)" "unprognostic (1.86e-2)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (2.55e-3)" "unprognostic (1.28e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (4.80e-9)" "unprognostic (8.05e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-2)" "unprognostic (1.19e-1)" 0.6 3.1 0.2 3.1 0.2 7.1 0.6 0.2 0.7 1.5 0.7 0.2 0.2 0.4 1.8 4.3 0.6 0.6 1.0 2.2 0.3 0.2 0.4 1.0 1.9 1.1 0.2 0.5 1.9 0.3 0.3 0.6 0.5 0.4 0.5 0.4 1.1 0.5 1.6 0.2 0.8 0.7 1.0 0.7 4.8 0.4 55.8 0.0 5.5 0.7 1.2 1.5 0.8 1.0 0.1 1.2 1.7 6.9 2.2 2.8 1.2 0.6 5.1 0.6 0.8 0.7 0.5 0.0 2.0 3.1 2.0 1.9 0.0 2.1 2.2 2.3 1.6 0.2 0.1 0.4 0.0 0.9 2.1 0.1 0.7 2.5 1.0 0.2 1.3 10.6 0.2 0.2 0.0 2.2 3.0 0.5 6.5 1.6 18.7 3.3 0.0 1.4 3.9 0.1 0.3 2.4 2.2 0.4 0.3 2.7 0.1 0.0 0.7 0.5 0.0 0.3 0.6 0.6 6.5 4.9 0.1 4.1 0.8 2.1 15.6 7.6 0.6 4.0 6.5 2.6 0.0 2.2 1.7 1.9 6.9 0.8 0.0 1.4 1.1 1.2 0.1 0.6 1.9 0.6 2.2 1.8 0.5 2.8 1.2 0.2 0.2 0.2 0.7 0.3 0.2 0.2 0.5 0.4 0.0 0.0 1.1 0.0 0.6 0.7 1.9 1.4 2.5 0.0 0.0 0.0 2.0 0.1 0.0 0.8 6.2 1.0 0.0 0.0 0.2 0.9 1.4 0.3 1.1 0.8 1.3 0.0 0.0 5.5 3.3 8.9 0.3 0.5 1.7 0.0 0.0 0.8 0.2 0.0 0.4 0.0 0.6 0.0 0.9 26.5 3.2 1.3 0.3 2.5 0.0 0.1 ATP9B ATPIIB ENSG00000166377 "ATPase phospholipid transporting 9B (putative)" O43861 18 79069285-79378287 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 119.1;Alveolar cells type 2: 156.1;Ciliated cells: 168.6;Club cells: 95.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029364 Approved NA NA "HPA029364: AB_10602595" "unprognostic (2.84e-3)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (7.32e-2)" "unprognostic (7.66e-4)" "unprognostic (2.45e-2)" "unprognostic (7.43e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (2.93e-1)" "unprognostic (1.92e-3)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.05e-2)" "unprognostic (1.09e-2)" 14.5 11.0 11.7 16.8 11.6 30.1 11.7 16.8 15.2 14.3 10.7 17.5 15.2 7.1 21.8 17.6 11.3 11.9 14.5 10.7 11.4 8.2 13.1 16.7 13.9 13.2 10.8 9.7 18.2 14.3 25.8 15.5 10.9 11.3 12.8 11.4 12.3 14.2 17.3 18.8 13.3 9.1 14.8 17.1 9.7 11.5 22.1 12.4 19.3 14.6 9.6 16.4 14.6 13.3 9.8 8.4 14.2 16.3 8.6 12.2 6.9 15.2 8.0 11.2 12.4 5.8 9.8 8.7 8.2 5.6 4.9 4.2 8.6 10.9 8.5 13.7 5.9 4.7 6.9 9.2 4.6 8.0 13.1 3.9 10.0 9.2 6.1 7.7 18.2 10.7 7.8 5.8 8.0 4.9 7.3 6.8 10.5 9.6 21.5 6.9 13.3 11.9 7.1 15.9 9.7 10.0 11.4 9.3 11.4 7.0 13.2 8.3 8.7 9.2 9.7 5.6 20.2 11.4 10.8 12.0 10.4 16.9 4.7 5.4 10.8 17.6 19.1 6.0 12.1 10.7 14.2 12.0 9.1 8.4 10.1 9.8 9.0 9.6 8.1 8.4 9.8 12.2 9.5 13.0 8.6 16.3 8.0 7.4 6.9 11.7 11.6 16.8 15.2 11.4 8.2 10.8 9.7 11.3 12.4 119.1 156.1 11.9 6.2 5.0 34.8 10.3 15.3 168.6 95.5 8.7 39.3 5.6 1.7 5.4 19.8 9.8 5.4 0.0 4.9 3.3 7.8 5.5 40.6 6.4 12.9 39.7 11.5 9.2 11.3 34.5 14.7 12.2 6.8 5.4 7.8 17.8 6.6 9.0 10.6 3.1 39.0 6.5 7.3 26.1 16.4 6.4 6.4 16.0 8.1 7.0 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria NA NA 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.5 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 4.2 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 8.6 0.0 8.6 0.0 6.9 9.4 0.2 8.0 0.0 6.7 0.0 0.1 5.9 13.7 8.9 3.1 0.0 3.4 9.9 0.0 0.0 0.2 3.8 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 0.0 0.0 0.0 0.1 0.6 40.4 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.0 0.0 2.2 9.5 0.0 32.5 3.2 28.8 1.4 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.7 0.3 4.4 0.0 0.4 41.3 5.3 0.1 0.2 0.0 0.0 0.0 AVPR1B AVPR3 ENSG00000198049 "Arginine vasopressin receptor 1B" P47901 1 206109692-206117699 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "pituitary gland: 52.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;NTERA-2: 1.0;PC-3: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075404 Enhanced NA NA "HPA075404: AB_2732291" "unprognostic (4.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.82e-1)" "unprognostic (2.82e-1)" "unprognostic (2.87e-1)" "unprognostic (1.08e-2)" "unprognostic (3.33e-1)" "unprognostic (2.96e-2)" "unprognostic (6.23e-2)" "unprognostic (7.65e-2)" "unprognostic (1.86e-1)" "unprognostic (6.66e-3)" 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.5 0.1 1.3 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 52.8 0.1 0.1 0.2 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 1.0 0.0 3.6 0.0 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AXDND1 "C1orf125, FLJ32940" ENSG00000162779 "Axonemal dynein light chain domain containing 1" Q5T1B0 1 179365720-179554735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 18.0" "Group enriched" "Detected in some" 7 "Early spermatids: 179.9;Late spermatids: 188.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.8;HBF TERT88: 1.9;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071114 Enhanced NA NA "HPA071114: AB_2686345" "unprognostic (1.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.81e-2)" "unprognostic (1.05e-1)" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (3.78e-4)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-3)" "unprognostic (2.09e-2)" "unprognostic (1.31e-1)" "unprognostic (5.17e-3)" "unprognostic (1.92e-1)" "unprognostic (5.48e-2)" "unprognostic (5.04e-2)" "unprognostic (2.25e-1)" 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 1.7 1.2 0.3 18.0 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.2 0.0 2.1 0.4 0.0 0.6 0.0 0.4 0.0 0.0 0.9 0.0 0.0 2.8 0.9 0.3 0.9 0.2 0.0 0.9 0.3 0.1 0.0 0.5 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 1.0 0.0 0.9 0.0 0.3 0.0 1.1 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.1 1.2 0.6 0.0 0.0 0.3 1.7 0.0 0.0 0.2 0.8 0.7 0.0 0.2 0.7 0.5 0.0 0.1 1.0 1.4 0.0 0.8 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.1 0.1 0.0 0.6 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.8 0.0 4.0 1.2 0.0 2.0 0.1 0.0 0.0 179.9 0.0 5.5 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 188.8 1.4 0.2 0.0 0.0 0.6 0.4 0.3 1.4 1.8 0.0 0.4 0.0 0.0 27.1 3.2 0.0 0.1 0.0 3.3 0.1 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8" "Group enriched" "Detected in many" 5 "Enterocytes: 85.3;Intestinal endocrine cells: 27.7;Mucus-secreting cells: 45.4;Paneth cells: 85.2;Undifferentiated cells: 35.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "basal ganglia: 15.8" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.6;RPTEC TERT1: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054092, HPA054684" Approved "Intracellular and membrane" NA NA "HPA054092: AB_2682375, HPA054684: AB_2682573" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favorable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.1 0.3 0.5 3.1 15.8 0.1 1.8 0.3 1.5 3.0 16.2 0.6 0.0 19.4 1.4 1.6 2.3 1.0 12.9 0.2 1.3 1.5 0.6 0.3 0.2 0.1 0.7 0.1 0.7 6.2 0.1 7.9 0.7 2.2 1.0 27.1 2.2 5.5 0.1 0.2 1.1 23.4 0.7 2.0 0.2 3.8 0.6 3.6 1.8 1.1 0.8 14.8 1.1 5.9 0.2 0.2 1.0 0.2 0.3 0.2 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.1 0.5 0.0 2.1 0.1 22.0 1.4 3.7 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.0 0.2 0.0 0.0 0.5 15.8 0.3 1.5 1.3 1.5 0.7 0.1 2.2 3.6 0.0 0.0 0.0 0.2 0.0 6.7 1.7 10.2 1.4 7.9 5.2 0.0 0.0 0.0 6.5 0.3 0.0 85.3 0.0 4.1 0.0 0.0 0.4 4.6 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.6 0.0 0.0 0.0 45.4 1.4 6.0 85.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 35.9 6.7 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.8 0.2 0.8 0.1 0.1 1.0 15.0 1.7 4.6 0.2 0.1 3.9 0.2 0.0 0.1 0.2 0.4 11.8 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.8 0.2 0.3 0.3 0.3 0.1 0.6 0.1 0.5 4.9 5.8 2.6 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 5.7 0.5 10.5 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.2 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 38.7 24.6 2.2 1.2 2.1 0.2 0.8 84.1 75.0 33.0 1.8 2.0 0.4 0.0 13.5 0.3 0.7 75.7 0.0 73.7 52.0 2.2 11.2 9.2 0.0 9.0 0.0 99.1 3.7 7.0 0.9 1.4 13.6 3.3 4.6 119.1 0.5 58.2 46.0 7.8 0.1 1.6 0.0 1.4 0.7 1.3 2.4 1.7 6.9 275.6 13.2 B3GNT9 MGC4655 ENSG00000237172 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9" Q6UX72 16 67148105-67151214 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 10.6;Peritubular cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.5;T-cells: 1.9" "Cell line enhanced" "Detected in many" "SiHa: 24.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052743, HPA062734" Approved Approved "Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoli fibrillar center" "HPA052743: AB_2681934, HPA062734: AB_2684854" "unprognostic (2.56e-2)" "unprognostic (2.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.07e-1)" "unprognostic (6.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.28e-2)" "unprognostic (3.01e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (4.96e-3)" "unprognostic (7.56e-3)" 5.6 7.3 5.0 5.2 7.1 0.6 7.2 0.9 8.8 12.6 5.7 12.4 12.6 3.5 11.7 11.3 6.6 11.4 11.4 11.4 6.0 3.9 7.0 5.0 7.3 4.6 12.2 5.3 20.6 3.1 34.7 17.9 7.9 5.5 12.0 3.6 16.6 8.9 15.9 2.1 4.7 4.4 8.0 5.3 5.0 6.1 9.7 7.1 0.8 25.2 4.6 3.9 8.6 7.9 0.1 1.5 0.2 0.1 0.0 1.9 0.1 2.2 4.1 0.3 0.4 13.5 14.0 0.5 10.6 17.1 6.9 8.9 1.8 0.4 0.3 0.7 16.3 2.9 5.2 0.1 0.5 3.8 3.5 1.5 0.3 4.6 1.6 10.9 0.2 0.2 11.6 4.0 6.7 0.2 17.2 0.9 0.2 0.4 1.3 10.7 1.2 1.2 0.6 2.5 1.7 3.7 3.4 6.2 2.0 1.0 2.8 2.4 5.3 24.0 0.1 0.3 2.1 0.6 1.8 2.1 12.4 0.5 12.3 4.7 1.6 1.1 0.4 15.4 0.6 6.0 0.0 0.1 0.2 0.9 0.0 1.1 0.1 1.9 1.6 0.2 0.0 0.4 0.2 0.0 0.0 0.0 1.5 0.6 0.1 5.0 7.1 0.9 8.8 6.0 3.9 12.2 5.3 5.5 7.1 6.0 5.3 0.0 3.2 2.9 1.1 2.8 7.6 4.0 2.3 3.5 0.0 0.2 0.0 1.2 4.4 1.1 0.1 0.0 1.5 0.3 8.0 2.5 0.0 0.0 1.4 0.0 2.4 5.5 0.8 3.6 10.6 0.7 1.7 0.0 0.7 0.3 0.9 0.0 12.7 0.5 0.0 6.5 4.2 0.5 2.1 3.6 0.7 0.0 0.6 0.9 B3GNTL1 B3GNT8 ENSG00000175711 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1" Q67FW5 17 82942155-83051810 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Late spermatids: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.9;HL-60: 18.6;THP-1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023585, HPA024547" Supported Approved "Nucleoli,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli, Nucleoli fibrillar center" Vesicles "HPA023585: AB_2061075, HPA024547: AB_1845240" "unprognostic (1.51e-2)" "unprognostic (9.84e-2)" "unprognostic (4.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (8.11e-2)" "unprognostic (2.61e-7)" "unprognostic (9.95e-2)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (8.74e-2)" "unprognostic (2.80e-2)" "unprognostic (4.17e-9)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (3.39e-3)" 3.7 4.3 6.5 7.2 13.9 17.7 4.0 6.4 10.7 4.7 3.6 4.2 1.7 4.7 6.3 6.1 3.7 8.3 3.9 6.2 6.9 4.7 2.9 3.4 4.4 5.6 3.8 7.1 6.6 7.6 1.7 6.1 3.9 7.1 4.6 2.8 3.7 5.6 4.5 5.0 4.4 3.3 5.1 4.4 6.6 4.9 4.0 3.7 6.9 4.4 4.8 3.3 4.3 3.8 3.7 8.8 16.9 5.7 2.4 11.2 3.3 8.2 5.5 0.1 2.7 1.5 4.9 3.4 3.0 2.7 3.5 2.7 3.3 17.9 4.0 5.9 3.7 8.5 1.6 1.4 0.0 3.0 6.2 3.6 8.5 8.2 11.0 5.6 18.6 0.3 1.8 1.5 2.1 3.5 1.7 4.2 6.4 3.7 3.9 2.8 1.8 5.2 7.1 1.3 5.6 4.0 6.8 0.7 0.3 2.0 1.8 1.7 0.6 2.5 1.9 2.5 2.6 0.0 17.9 6.9 6.8 4.6 1.0 5.3 0.8 1.9 3.0 7.5 2.4 0.9 2.6 5.7 0.9 2.7 5.0 4.1 2.8 4.3 3.0 8.8 3.7 3.8 4.6 16.9 2.4 2.5 3.5 11.2 3.3 6.5 13.9 6.4 10.7 6.9 4.7 3.8 7.1 7.1 3.7 3.0 5.0 1.3 1.7 0.9 3.9 1.7 2.5 17.4 6.8 5.2 3.9 5.1 1.7 1.6 11.7 1.5 0.3 0.0 0.8 2.1 3.0 1.5 6.9 1.0 7.2 3.2 1.2 1.8 8.1 15.2 2.8 6.7 1.7 3.6 1.2 1.1 1.9 2.9 4.6 2.2 3.4 0.0 1.2 0.7 4.3 1.5 1.6 6.4 2.7 2.0 B4GALT5 beta4GalT-V ENSG00000158470 "Beta-1,4-galactosyltransferase 5" O43286 20 49632945-49713878 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 10.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (7.98e-2)" "unprognostic (5.27e-2)" "unprognostic (2.62e-1)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (3.30e-2)" "unprognostic (5.41e-1)" "unprognostic (2.07e-1)" "unprognostic (2.69e-2)" 20.0 37.2 16.2 13.8 15.8 53.3 15.7 22.6 19.0 15.5 16.4 8.5 10.6 16.5 17.2 7.5 27.4 14.6 21.1 32.7 12.4 12.6 16.8 17.3 20.1 7.7 10.4 9.9 19.5 11.7 7.0 14.1 17.8 17.3 12.4 16.1 15.3 15.7 15.7 46.9 6.4 15.5 24.7 13.5 22.6 16.9 16.6 9.3 3.9 9.5 8.0 13.7 19.2 16.0 0.4 1.1 10.2 1.6 1.7 2.4 0.6 15.8 18.3 24.4 10.3 25.5 17.4 21.4 7.8 14.7 36.0 17.3 23.5 19.8 4.8 33.7 13.0 34.1 25.4 15.3 11.7 21.2 14.9 4.2 12.9 10.0 14.0 8.0 16.7 25.3 26.0 11.0 15.6 7.5 33.3 21.8 8.7 20.8 3.0 10.4 7.9 1.0 15.4 12.7 15.7 11.9 8.7 21.1 7.0 17.3 11.3 29.2 14.8 28.0 35.9 15.7 18.8 8.1 23.1 16.7 21.7 17.5 11.5 16.4 3.7 3.2 11.8 11.3 16.1 13.7 1.3 1.6 3.7 2.2 1.6 2.4 0.3 1.0 2.1 1.1 0.4 0.2 1.5 10.2 1.7 1.6 0.9 1.3 0.6 16.2 15.8 22.6 19.0 12.4 12.6 10.4 9.9 17.3 9.3 14.9 45.0 3.2 24.2 16.8 6.2 15.3 30.6 24.1 35.2 34.9 9.8 19.4 1.7 27.9 4.5 43.9 21.4 23.3 17.1 21.5 24.3 41.5 84.0 20.2 21.9 11.1 33.0 47.3 27.6 5.3 18.4 28.0 20.3 9.0 23.7 5.2 29.8 28.6 30.8 31.6 4.8 25.8 26.8 7.5 17.7 15.3 4.7 15.2 16.4 107.6 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell type enhanced" "Detected in many" 16 "Ito cells: 27.0;Muller glia cells: 94.5" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 24.9;BJ hTERT+: 8.7;SCLC-21H: 13.6;SH-SY5Y: 10.0;U-87 MG: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: AB_2685971" "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.9 0.2 0.2 7.4 0.0 1.3 8.7 0.0 0.1 0.2 0.0 0.1 0.2 4.7 0.1 0.4 0.4 0.0 0.0 0.0 1.5 0.2 0.3 0.0 0.6 0.0 0.5 1.5 1.4 0.3 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.5 0.1 0.1 0.5 0.0 0.0 13.6 10.0 0.3 0.0 0.0 2.3 0.1 0.1 1.4 7.9 0.5 0.2 0.5 0.0 0.1 0.1 37.1 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 0.0 2.6 0.0 0.7 4.8 2.5 0.6 12.7 17.4 1.2 0.0 0.0 0.0 6.6 17.6 3.0 18.8 0.0 0.0 21.5 0.0 2.6 0.4 0.0 0.5 1.0 0.0 17.0 27.0 2.2 5.6 1.4 0.7 13.5 8.2 0.0 94.5 6.5 0.0 0.0 0.0 2.9 0.0 3.0 0.0 0.1 3.4 0.0 1.7 0.0 0.8 BARHL1 ENSG00000125492 "BarH like homeobox 1" Q9BZE3 9 132582185-132590266 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "brain: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "cerebellum: 23.8;pons and medulla: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 105 "SCLC-21H: 19.8" "Group enriched" "Detected in some" 5 "cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1" "Region enhanced" "Detected in many" "cerebellum: 16.3" HPA004809 Enhanced NA NA "HPA004809: AB_1078266" "unprognostic (2.29e-1)" "unprognostic (6.42e-2)" "unprognostic (8.07e-2)" "unprognostic (9.31e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.2 0.0 0.2 0.9 0.0 0.0 0.0 40.1 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.5 2.2 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BBC3 "JFY1, PUMA" ENSG00000105327 "BCL2 binding component 3" "Q96PG8, Q9BXH1" 19 47220822-47232766 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 104.3;Glandular cells: 98.1;Suprabasal keratinocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;neutrophil: 6.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.4" "Cell line enhanced" "Detected in many" "HHSteC: 19.0;NB-4: 21.8" "CAB007752, HPA070403" Approved Approved Cytosol NA NA Cytosol "CAB007752: AB_562336, HPA070403: " "unprognostic (4.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.31e-4)" "unprognostic (2.95e-2)" "unprognostic (4.74e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (1.93e-1)" "unprognostic (8.38e-3)" "unprognostic (7.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-2)" "unprognostic (4.66e-3)" "unprognostic (5.06e-2)" "unprognostic (3.57e-1)" "prognostic favorable (2.62e-5)" 6.8 5.4 4.0 4.7 2.9 9.4 6.5 14.0 7.2 6.3 8.9 1.4 2.3 5.9 5.4 3.7 8.2 5.0 8.0 5.8 4.9 3.9 4.6 5.9 19.0 11.8 3.6 4.3 5.2 11.8 1.6 2.5 5.6 3.4 9.8 4.9 4.5 9.2 4.2 28.6 9.4 6.6 5.7 2.8 7.4 7.9 3.2 3.0 13.3 6.2 1.7 3.2 8.2 3.0 0.2 0.4 6.4 1.0 1.0 1.1 0.3 2.4 5.3 5.9 1.2 1.4 2.7 14.4 3.8 5.2 0.9 2.3 1.5 4.0 9.3 1.7 0.9 1.6 0.8 0.8 3.4 0.1 6.0 10.3 2.6 1.8 10.2 19.0 0.4 8.8 6.5 5.5 2.0 1.8 2.4 6.6 2.8 6.7 5.9 0.6 5.4 1.0 21.8 3.7 4.1 0.7 2.6 0.8 10.7 0.2 0.8 1.0 8.9 1.7 3.6 11.4 4.9 1.2 7.3 4.4 1.1 7.3 0.1 1.2 9.6 2.1 5.8 1.7 1.4 4.0 6.1 0.9 0.5 0.9 1.0 0.8 0.2 0.2 0.6 0.4 0.0 1.1 0.7 6.4 1.0 0.8 0.1 0.5 0.3 4.0 2.9 14.0 5.7 4.9 3.9 3.6 4.3 3.4 3.0 8.9 9.0 16.4 66.9 104.3 5.5 2.4 10.2 0.0 4.5 7.0 0.0 3.5 0.0 40.9 10.7 7.0 29.7 0.0 34.2 4.0 6.6 98.1 12.7 3.2 6.7 0.0 20.5 1.8 9.7 2.4 5.8 17.3 60.8 13.6 20.7 2.7 47.6 21.8 3.9 2.1 4.0 6.5 26.4 0.5 1.3 125.3 17.2 27.7 19.1 48.3 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 326.6;Early spermatids: 164.7;Late spermatids: 84.6;Spermatocytes: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.8 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 6.8 1.5 8.9 2.5 0.9 3.1 3.8 7.4 1.2 0.4 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 1.3 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 11.9 7.2 0.0 4.2 0.0 7.2 0.0 5.1 326.6 55.7 3.5 27.5 1.6 13.3 7.3 164.7 2.2 0.4 23.3 3.1 2.2 3.0 3.9 1.1 2.5 2.0 6.4 2.4 4.9 0.6 84.6 10.0 1.7 0.0 1.0 3.2 5.7 2.4 0.0 5.6 14.4 27.4 0.0 0.0 82.2 13.0 0.0 0.8 3.2 0.8 2.8 BCL6B "BAZF, ZBTB28, ZNF62" ENSG00000161940 "B cell CLL/lymphoma 6B" Q8N143 17 7023020-7030290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Endothelial cells: 32.1;Ito cells: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 7.8;HMC-1: 24.0;HUVEC TERT2: 42.7;TIME: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059147, HPA075112" Uncertain Approved Vesicles NA NA Vesicles "HPA059147: AB_2683928, HPA075112: AB_2732279" "unprognostic (5.61e-2)" "unprognostic (9.43e-3)" "unprognostic (2.33e-2)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (8.56e-5)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-1)" "unprognostic (6.10e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (7.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "unprognostic (4.26e-2)" 23.9 4.0 2.5 4.4 3.4 0.0 11.5 2.0 4.1 5.2 3.9 2.3 1.2 2.5 9.7 3.9 4.0 4.2 10.8 12.7 2.4 2.4 6.0 6.1 26.2 5.2 3.4 0.8 7.4 3.0 2.4 4.7 15.9 4.9 6.8 1.8 4.5 4.6 2.9 8.6 3.5 4.0 6.3 2.9 17.9 3.4 2.3 2.4 0.5 10.0 8.2 2.5 6.6 28.6 1.1 0.6 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.2 0.0 24.0 0.0 0.0 0.0 0.0 0.0 42.7 0.1 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 16.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 3.4 2.0 4.1 2.4 2.4 3.4 0.8 4.9 2.4 3.0 6.2 0.0 0.0 1.9 0.0 2.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.0 0.0 23.9 3.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.3 1.5 1.1 0.1 0.0 0.0 0.1 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 1.0 1.0 9.7 0.3 0.1 4.9 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.6 0.3 0.6 0.2 0.1 0.1 0.3 0.0 0.7 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 1.4 0.0 0.2 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.1 0.6 0.1 0.2 0.5 8.6 0.6 0.1 0.2 0.2 0.2 1.4 0.7 0.2 0.1 0.3 0.4 2.7 0.1 0.4 0.5 0.1 0.1 5.6 0.2 1.4 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 8.4 0.3 0.0 0.0 0.0 8.9 0.6 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 8.0 0.3 0.0 3.3 0.0 0.0 0.0 1.0 0.0 2.1 0.0 0.9 0.0 0.5 2.9 0.3 0.1 2.4 0.0 0.0 0.3 BEND2 "CXorf20, MGC33653" ENSG00000177324 "BEN domain containing 2" Q8NDZ0 X 18162931-18220883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 23.2" "Cell type enhanced" "Detected in some" 16 "Leydig cells: 17.3;Peritubular cells: 12.4;Sertoli cells: 6.5;Spermatocytes: 24.7;Spermatogonia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.1;neutrophil: 1.8" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.1" "Cell line enhanced" "Detected in single" "HeLa: 1.6" "HPA009420, HPA013142" Enhanced NA NA "HPA009420: AB_2064489, HPA013142: AB_2668784" "unprognostic (2.23e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 4.1 0.4 0.4 0.4 5.1 0.4 0.2 0.4 0.8 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.5 0.2 0.1 0.2 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.1 0.4 1.6 0.2 0.1 0.5 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.5 0.5 0.8 0.3 0.5 0.1 0.5 0.4 0.3 0.3 0.3 0.3 0.7 0.0 0.4 0.4 0.0 0.2 0.3 0.4 0.4 0.2 0.1 0.8 0.4 0.2 0.4 0.1 0.9 0.2 0.8 0.2 0.7 0.4 4.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 0.2 0.1 0.4 0.3 0.4 1.8 0.4 0.1 0.3 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.4 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 6.5 0.2 24.7 6.1 0.4 0.0 0.0 0.0 0.3 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Group enriched" "Detected in some" 7 "Muller glia cells: 10.2;Spermatogonia: 35.8" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 23.9 0.0 0.0 0.0 5.8 14.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 4.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 0.0 0.0 0.9 0.1 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.2 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 35.8 0.0 0.0 0.0 0.0 0.0 BEST2 "FLJ20132, VMD2L1" ENSG00000039987 "Bestrophin 2" Q8NFU1 19 12751702-12758458 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 25.2;retina: 28.7;skin 1: 11.7" "Cell type enriched" "Detected in some" 62 "Mucus-secreting cells: 105.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.5" HPA046229 Approved NA NA "HPA046229: AB_10966140" "unprognostic (3.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.54e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-2)" "unprognostic (4.02e-3)" "unprognostic (2.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (2.43e-1)" "unprognostic (3.46e-3)" "unprognostic (9.18e-6)" "unprognostic (3.45e-2)" "unprognostic (6.95e-2)" "unprognostic (2.90e-1)" "unprognostic (1.64e-5)" 0.2 0.1 0.2 4.1 0.2 1.8 0.3 0.2 1.3 0.4 25.2 0.2 0.2 0.0 0.2 0.7 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.2 2.2 0.2 0.2 0.4 0.2 0.4 0.2 0.2 0.2 0.2 12.8 28.7 0.6 0.2 0.2 11.7 11.5 0.5 0.2 0.2 0.1 0.3 0.2 0.2 0.4 1.5 5.2 0.2 1.0 3.1 2.7 2.2 0.8 1.7 2.1 1.2 0.9 0.7 2.3 3.5 0.0 0.4 1.6 1.0 0.0 0.5 0.7 2.6 3.6 2.9 0.9 1.2 0.7 1.8 0.0 0.5 0.6 3.3 1.6 2.4 3.3 0.9 0.4 1.2 5.2 0.5 0.3 0.4 0.3 1.4 0.3 0.6 0.6 1.5 0.5 3.0 0.8 1.9 3.0 0.2 2.6 0.4 1.3 0.5 1.0 1.2 1.9 1.9 1.5 0.7 0.6 2.7 1.8 0.9 2.6 0.9 1.0 1.6 2.1 0.9 1.3 1.1 1.3 2.7 1.9 1.7 0.5 0.4 1.4 0.8 1.1 2.2 1.0 0.8 0.2 3.1 2.1 2.1 2.2 1.7 0.5 2.7 0.7 1.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 1.6 0.1 BEST3 "MGC13168, MGC40411, VMD2L3" ENSG00000127325 "Bestrophin 3" Q8N1M1 12 69643360-69699476 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 125.0" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 7.9;Late spermatids: 13.0;Muller glia cells: 7.5" "Cancer enriched" "Detected in single" 9 "glioma: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "REH: 18.7;RPMI-8226: 20.1;U-698: 33.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054582 Approved NA NA "HPA054582: AB_2682530" "unprognostic (1.53e-1)" "unprognostic (7.00e-2)" "unprognostic (9.83e-2)" "unprognostic (1.67e-2)" "unprognostic (5.15e-3)" "unprognostic (2.26e-3)" "unprognostic (7.30e-7)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (5.36e-2)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (4.82e-2)" "unprognostic (4.47e-2)" "unprognostic (3.03e-1)" 1.6 0.5 1.7 0.1 1.9 2.4 0.6 6.3 9.3 0.2 0.2 0.9 0.0 0.2 0.2 2.4 1.7 0.1 0.2 0.4 1.8 0.7 0.4 0.3 0.1 0.2 1.8 0.6 0.2 1.0 0.1 0.7 0.3 1.2 1.7 0.2 0.1 1.9 0.1 125.0 0.9 0.1 0.1 1.9 0.1 0.1 2.5 1.0 0.5 0.2 21.9 0.7 0.1 0.0 1.2 0.9 1.7 0.5 0.6 1.0 0.7 0.1 0.2 0.7 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.4 0.1 0.2 1.3 0.3 0.0 1.1 0.1 0.0 0.0 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.8 0.1 0.0 0.0 0.7 0.3 0.3 18.7 0.6 20.1 1.0 0.1 0.4 0.0 0.1 0.1 0.0 1.3 0.2 0.0 0.1 0.2 0.5 0.1 0.7 0.1 0.2 33.5 1.4 0.0 0.1 0.3 0.5 0.3 0.5 0.4 0.8 1.2 1.0 0.7 0.3 0.8 1.0 1.0 1.7 0.6 0.4 0.9 0.4 0.7 1.7 1.9 6.3 1.5 1.8 0.7 1.8 0.6 1.2 1.0 0.0 0.0 0.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.0 0.0 0.0 1.7 0.0 0.0 7.5 0.4 0.0 0.0 2.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 BEST4 VMD2L2 ENSG00000142959 "Bestrophin 4" Q8NFU0 1 44783585-44787705 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 34.3" "Cell type enriched" "Detected in some" 35 "Paneth cells: 745.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 7.4;U-698: 5.3" "Low region specificity" "Detected in all" HPA058564 Uncertain NA NA "HPA058564: AB_2683759" "unprognostic (5.76e-2)" "unprognostic (1.22e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-2)" "unprognostic (6.51e-3)" "unprognostic (1.09e-1)" "unprognostic (8.39e-2)" "unprognostic (1.45e-3)" "unprognostic (1.04e-1)" "unprognostic (8.97e-2)" "unprognostic (5.72e-2)" "unprognostic (1.29e-1)" "unprognostic (2.69e-5)" "unprognostic (1.43e-1)" "unprognostic (3.72e-1)" "unprognostic (1.28e-1)" "unprognostic (4.13e-3)" 0.5 1.1 0.6 1.4 2.5 0.4 0.5 2.1 0.7 1.2 32.7 0.5 0.5 8.8 0.7 2.6 0.5 7.2 0.5 0.5 1.0 3.2 0.5 0.5 1.1 0.5 0.5 0.5 0.5 0.5 0.4 1.8 0.5 0.5 0.5 15.9 0.5 0.5 0.5 0.5 1.8 34.3 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 3.0 0.9 0.7 0.1 0.9 2.8 0.4 0.2 0.6 1.1 1.2 0.4 0.4 3.5 0.8 0.4 0.3 0.1 0.4 1.5 0.3 1.5 0.4 0.8 1.6 0.3 0.2 0.4 0.8 0.7 0.2 1.9 7.4 0.4 0.0 0.9 0.7 0.9 0.4 0.7 1.8 1.0 1.3 0.2 0.6 0.2 0.2 0.0 0.5 2.4 0.2 0.2 0.4 0.3 0.7 0.5 0.1 2.5 0.9 0.3 0.2 0.3 0.8 1.2 0.1 1.7 0.5 0.5 0.5 0.5 1.2 0.3 5.3 1.2 0.3 0.2 0.1 0.1 0.5 1.1 0.1 2.7 3.0 1.9 2.8 0.0 2.0 1.0 1.8 0.7 0.9 0.0 0.9 2.2 0.4 0.6 2.5 2.1 0.7 1.0 3.2 0.5 0.5 0.5 0.5 0.0 0.0 0.8 0.7 0.2 0.7 0.4 0.0 21.4 3.4 5.2 0.0 0.3 1.7 0.5 0.0 0.3 15.8 0.0 0.7 0.1 0.2 0.4 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.9 0.3 0.0 0.0 3.4 1.0 0.4 745.7 0.4 0.6 0.1 0.0 0.3 0.5 0.7 0.5 0.2 1.3 5.0 0.4 BHLHE22 "Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20" ENSG00000180828 "Basic helix-loop-helix family member e22" Q8NFJ8 8 64580367-64583628 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.7" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "THP-1: 41.9" "Group enriched" "Detected in many" 5 "amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8" "Group enriched" "Detected in all" 8 "amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6" "HPA064128, HPA064872, HPA067500" Enhanced NA NA "HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855" "unprognostic (9.17e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-2)" "unprognostic (2.28e-5)" "unprognostic (7.22e-3)" "unprognostic (6.47e-4)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.52e-1)" "unprognostic (3.71e-2)" "unprognostic (2.86e-7)" "unprognostic (3.20e-2)" "unprognostic (2.29e-1)" "unprognostic (6.72e-3)" "unprognostic (1.86e-1)" 2.9 1.3 30.7 2.9 1.4 0.3 1.7 21.1 15.8 1.7 1.7 1.2 0.3 1.1 0.5 0.4 2.2 0.6 1.1 0.8 27.2 2.1 0.5 1.3 1.4 2.4 1.7 6.5 0.4 1.3 0.5 1.2 0.2 3.4 0.5 1.4 2.5 1.2 5.4 0.5 0.8 1.7 1.1 2.6 2.9 1.1 0.7 0.2 0.0 0.6 0.0 1.3 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 1.4 21.1 10.6 27.2 2.1 1.7 6.5 3.4 0.2 0.0 0.0 0.0 0.0 1.0 28.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.4 0.0 2.5 0.0 6.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 BHLHE23 "bA305P22.3, Beta4, BHLHB4, bHLHe23" ENSG00000125533 "Basic helix-loop-helix family member e23" Q8NDY6 20 63005927-63007035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8" "Cell type enriched" "Detected in single" 34 "Cardiomyocytes: 3.4" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "MOLT-4: 16.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.0" HPA030575 Uncertain NA NA "HPA030575: AB_10601459" "unprognostic (1.74e-1)" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 4.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 16.8 0.7 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 5.1 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.8 0.0 1.1 9.5 0.0 27.4 0.0 0.3 0.0 0.0 7.8 0.3 1.1 0.0 14.8 6.4 0.1 11.7 13.6 2.7 0.7 0.5 2.4 3.5 4.6 17.3 1.2 2.0 5.4 1.4 3.0 12.4 4.5 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.5 19.9 0.8 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BIVM FLJ20159 ENSG00000134897 "Basic, immunoglobulin-like variable motif containing" Q86UB2 13 102799049-102841535 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.6;NK-cells: 6.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050126 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA050126: AB_2681027" "unprognostic (8.86e-2)" "unprognostic (1.02e-1)" "unprognostic (3.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.19e-2)" "unprognostic (1.83e-3)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (6.89e-3)" "unprognostic (6.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.79e-2)" "unprognostic (2.73e-1)" "unprognostic (7.29e-2)" "unprognostic (3.33e-2)" 6.8 7.6 10.8 3.3 15.6 3.4 9.6 32.3 16.9 9.2 6.9 6.9 10.5 6.8 10.1 14.3 5.6 7.7 6.9 18.7 10.9 8.4 17.7 17.6 6.4 4.5 9.3 10.8 10.1 10.3 6.4 10.7 7.4 10.4 8.7 8.2 6.3 6.7 9.8 16.9 8.3 6.7 8.8 7.1 7.0 8.9 2.2 9.8 4.3 8.4 7.4 3.6 6.7 6.3 0.6 1.2 3.6 0.4 6.3 4.9 0.9 7.5 2.4 9.0 10.4 11.6 17.9 2.1 9.1 9.2 5.7 6.4 2.7 3.4 0.0 4.1 8.7 4.3 5.2 7.3 7.2 8.1 6.9 9.1 6.4 6.8 4.6 10.4 7.2 11.2 14.4 9.2 3.1 10.2 13.8 8.6 10.4 6.9 0.0 11.7 1.6 8.2 9.4 2.1 10.6 6.4 0.0 4.3 3.2 26.3 3.2 14.0 12.1 3.7 4.3 5.9 3.7 6.9 9.9 6.2 7.3 1.9 5.4 5.5 6.0 2.7 0.0 9.3 0.0 12.7 3.6 0.4 0.8 2.4 0.2 4.9 0.5 1.4 3.1 1.2 0.6 0.9 2.1 0.4 6.3 0.1 0.5 1.2 0.9 10.8 15.6 32.3 16.9 10.9 8.4 9.3 10.8 10.4 9.8 8.9 10.9 3.0 3.0 3.3 15.7 24.6 12.7 8.1 13.6 17.4 13.7 6.3 24.9 4.5 0.2 11.7 5.2 0.0 4.8 5.9 11.4 4.1 5.8 26.7 5.7 22.3 20.9 19.6 5.2 0.2 12.7 4.2 3.3 1.0 16.5 7.7 4.7 10.5 10.6 25.2 11.5 19.4 9.5 0.5 8.7 4.3 2.1 10.1 15.1 2.6 BMP5 ENSG00000112175 "Bone morphogenetic protein 5" P22003 6 55753645-55875564 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.7;prostate: 29.4;retina: 21.2" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 22.6;U-2 OS: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (2.84e-4)" "unprognostic (9.07e-4)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.21e-2)" "unprognostic (1.58e-1)" "unprognostic (2.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (6.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-1)" "unprognostic (4.76e-2)" 2.1 0.6 0.2 3.3 0.2 0.1 1.5 0.7 0.7 0.2 4.3 0.0 0.0 5.0 0.1 0.2 1.9 0.2 1.5 3.4 0.3 0.2 1.6 1.9 14.3 0.2 2.0 1.4 0.2 1.2 0.1 5.0 42.7 5.2 29.4 4.7 21.2 1.7 0.0 7.0 0.2 10.2 5.5 3.6 0.1 1.9 0.2 0.0 0.0 1.5 5.0 0.1 11.8 1.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.7 0.3 0.2 2.0 1.4 5.2 0.0 0.0 4.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.4 12.4 0.0 0.0 0.0 2.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 BMP8A ENSG00000183682 "Bone morphogenetic protein 8a" Q7Z5Y6 1 39491646-39525935 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "thyroid gland: 45.6" "Group enriched" "Detected in some" 74 "Early spermatids: 42.2;Late spermatids: 125.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 16.2;U-266/70: 7.9;U-266/84: 7.1" "Secreted to blood" NA NA "unprognostic (9.62e-3)" "unprognostic (2.11e-2)" "unprognostic (7.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.91e-3)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (2.95e-9)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" 0.7 1.0 1.7 1.2 2.0 0.9 0.5 0.8 3.6 3.3 1.0 8.5 0.0 1.4 3.7 1.2 0.7 2.0 2.6 1.2 1.9 1.3 0.6 0.5 0.7 5.6 4.6 1.1 8.9 3.8 0.5 0.9 1.0 4.8 1.0 0.6 0.4 1.3 1.8 1.4 1.6 2.2 1.9 8.3 1.4 1.0 4.0 2.3 1.7 45.6 0.0 0.6 0.9 0.9 0.7 0.0 0.0 0.6 0.0 0.1 0.4 0.4 0.8 0.4 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.4 1.9 0.0 1.7 0.3 3.9 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.2 2.9 0.0 1.7 0.0 2.1 1.1 0.2 0.1 0.5 0.3 2.4 0.1 0.1 1.5 0.4 0.1 0.2 1.2 0.3 0.7 2.9 0.1 0.0 0.7 16.2 0.0 7.9 7.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 2.0 0.8 3.6 1.9 1.3 4.6 1.1 4.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 BMP8B "BMP8, OP-2" ENSG00000116985 "Bone morphogenetic protein 8b" P34820 1 39757182-39788861 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 21.9;thyroid gland: 26.8" "Group enriched" "Detected in some" 15 "Early spermatids: 74.8;Late spermatids: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 47.4;U-266/70: 14.3;U-266/84: 20.5;WM-115: 22.9" "Secreted to blood" NA NA "unprognostic (1.53e-3)" "unprognostic (7.29e-2)" "unprognostic (2.18e-1)" "unprognostic (6.64e-3)" "unprognostic (8.79e-2)" "unprognostic (3.44e-2)" "unprognostic (7.27e-2)" "unprognostic (7.56e-2)" "unprognostic (1.88e-1)" "unprognostic (7.41e-2)" "unprognostic (2.68e-1)" "unprognostic (4.72e-4)" "unprognostic (1.79e-2)" "unprognostic (3.15e-1)" "unprognostic (9.67e-2)" "unprognostic (8.68e-3)" "unprognostic (4.82e-1)" 2.8 8.1 5.5 2.4 6.7 1.4 1.6 2.5 4.1 3.8 13.2 6.9 8.2 7.5 2.6 14.2 3.5 2.3 2.1 1.6 5.0 3.3 1.6 1.0 3.1 3.6 6.1 5.5 1.4 9.9 6.6 5.8 2.3 2.8 5.1 4.0 3.6 3.6 4.7 1.2 3.2 21.9 2.1 3.6 2.4 3.0 3.1 6.2 0.4 26.8 3.4 3.1 2.1 3.3 1.7 0.2 0.8 0.7 2.6 1.9 0.3 1.0 1.9 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 2.2 0.0 0.7 0.0 0.3 0.2 1.7 0.0 0.0 0.4 2.3 1.9 1.6 0.1 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 7.6 0.1 1.5 0.0 1.0 0.3 1.1 0.7 1.1 6.5 2.5 1.6 1.1 5.4 1.4 1.7 0.1 5.3 0.4 1.3 47.4 0.0 0.0 0.1 1.7 0.1 14.3 20.5 0.8 0.0 1.5 22.9 0.8 0.7 0.1 0.5 0.3 0.6 1.7 0.2 1.9 0.1 0.7 0.3 0.4 0.6 2.6 0.3 0.2 0.1 0.3 5.5 6.7 2.5 4.1 5.0 3.3 6.1 5.5 2.8 6.2 0.0 2.6 0.0 0.5 0.3 0.2 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 74.8 0.0 3.5 0.0 3.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 1.2 0.0 0.0 77.6 1.1 0.3 5.0 0.0 2.0 0.1 3.1 2.9 0.7 0.0 0.4 0.0 2.2 0.5 0.3 0.0 0.0 0.0 0.7 0.7 BPIFA3 "bA49G10.4, C20orf71, SPLUNC3" ENSG00000131059 "BPI fold containing family A member 3" Q9BQP9 20 33217310-33227758 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 86.6" "Group enriched" "Detected in some" 99 "Early spermatids: 659.6;Late spermatids: 2410.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062708 Enhanced "Secreted in male reproductive system" NA NA "HPA062708: AB_2684843" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 659.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2410.5 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 6.5 0.0 15.6 7.9 0.0 0.0 0.0 0.0 0.0 BPIFB3 "C20orf185, dJ726C3.4, LPLUNC3, RYA3" ENSG00000186190 "BPI fold containing family B member 3" P59826 20 33055424-33073628 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0" "Cell type enhanced" "Detected in single" 30 "Early spermatids: 1.6" "Cancer enriched" "Detected in single" 7 "ovarian cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "HEL: 8.3;HMC-1: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA045741 Uncertain "Intracellular and membrane" NA NA "HPA045741: AB_2679439" "unprognostic (4.33e-2)" "unprognostic (1.06e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFB4 "C20orf186, dJ726C3.5, LPLUNC4" ENSG00000186191 "BPI fold containing family B member 4" P59827 20 33079644-33111751 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 4.0;pituitary gland: 12.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HSkMC: 5.4;U-2 OS: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (1.32e-1)" "unprognostic (1.16e-1)" "unprognostic (1.61e-1)" "unprognostic (2.75e-2)" "unprognostic (1.31e-3)" "unprognostic (4.70e-2)" "unprognostic (3.42e-2)" "unprognostic (2.03e-1)" "unprognostic (3.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (8.97e-2)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 12.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 BPIFC "BPIL2, dJ149A16.7" ENSG00000184459 "BPI fold containing family C" Q8NFQ6 22 32413847-32464484 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "skin 1: 39.5;tongue: 16.4" "Group enriched" "Detected in some" 32 "Early spermatids: 16.4;Late spermatids: 6.5;Suprabasal keratinocytes: 4.1" "Group enriched" "Detected in some" 11 "head and neck cancer: 1.6;melanoma: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 56 "basophil: 5.5" "Lineage enriched" "Detected in single" 56 "granulocytes: 5.5" "Group enriched" "Detected in some" 5 "HDLM-2: 3.4;hTCEpi: 1.7;SCLC-21H: 4.7;U-87 MG: 2.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.74e-1)" "unprognostic (3.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (2.58e-1)" "unprognostic (3.48e-2)" "unprognostic (2.74e-1)" "unprognostic (2.58e-1)" "unprognostic (2.76e-3)" "unprognostic (1.41e-2)" "unprognostic (2.80e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 2.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 39.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 16.4 0.8 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.1 0.0 0.0 0.0 0.0 BRINP2 "DBCCR1L2, FAM5B" ENSG00000198797 "BMP/retinoic acid inducible neural specific 2" Q9C0B6 1 177171497-177282422 "Predicted secreted proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 11.5;brain: 27.9" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 14.3" "Cancer enriched" "Detected in some" 5 "glioma: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050681 Uncertain "Secreted in other tissues" NA NA "HPA050681: " "unprognostic (7.78e-2)" "unprognostic (4.49e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.43e-2)" "unprognostic (1.77e-1)" "unprognostic (5.77e-2)" "unprognostic (1.23e-2)" "unprognostic (1.95e-2)" "unprognostic (2.20e-4)" "unprognostic (8.95e-2)" "unprognostic (1.78e-2)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (2.60e-2)" "unprognostic (4.82e-3)" 0.4 11.5 12.2 0.3 8.2 0.3 1.9 0.4 27.9 0.3 0.4 0.6 0.0 0.3 0.5 0.9 0.3 0.6 0.4 0.4 7.0 6.0 0.3 0.4 0.3 0.3 4.5 3.6 0.3 0.3 0.3 2.0 1.0 0.8 0.4 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.4 1.5 0.5 0.3 1.8 0.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 2.6 3.0 0.0 0.0 0.0 0.0 9.7 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 8.2 0.4 15.9 7.0 6.0 4.5 3.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 BSPH1 "BSP1, ELSPBP2" ENSG00000188334 "Binder of sperm protein homolog 1" Q075Z2 19 47968046-47992170 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "epididymis: 97.1" "Cell type enhanced" "Detected in single" 34 "Bipolar cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 1.2;HMC-1: 1.4;NB-4: 4.6" "Not detected" "Not detected" HPA048335 Enhanced "Secreted in male reproductive system" NA NA "HPA048335: AB_2732546" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 18.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.8 11.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 2.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.4 0.1 0.0 0.0 27.0 0.3 0.0 0.4 31.4 0.0 0.4 0.0 14.1 1.8 3.9 6.2 0.0 0.0 13.6 0.0 0.8 13.7 1.9 0.0 0.0 0.0 0.0 0.0 4.4 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 6.0 5.8 2.4 1.7 0.9 0.6 1.6 15.3 2.7 4.5 26.2 5.9 8.1 33.2 59.2 0.1 0.1 12.9 0.0 58.0 0.7 0.4 15.4 3.5 0.8 1.2 0.0 19.7 0.0 0.0 0.2 0.0 0.1 10.1 1.8 19.3 0.3 56.5 14.0 0.0 15.3 9.1 0.0 0.0 0.5 2.3 12.4 5.6 0.5 24.3 13.9 BSX BSX1 ENSG00000188909 "Brain specific homeobox" Q3C1V8 11 122977570-122981720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.9;pituitary gland: 1.7;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "HDLM-2: 1.5;SCLC-21H: 2.7;SH-SY5Y: 2.0" "Region enriched" "Detected in single" 5 "hypothalamus: 5.3" "Region enriched" "Detected in single" 8 "hypothalamus: 4.5" HPA015654 Uncertain NA NA "HPA015654: AB_1845470" 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 1.7 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.8 0.0 4.9 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318413-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 61.8" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 4.6;Peritubular cells: 3.9;Suprabasal keratinocytes: 6.8;Urothelial cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 19.3;Hep G2: 10.2;MOLT-4: 12.9;PC-3: 9.1;RT4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055898: AB_2682964, HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.9 1.1 3.7 2.4 6.6 3.3 2.7 4.6 10.2 6.8 1.0 2.2 3.2 1.1 1.3 1.5 24.1 0.8 1.2 1.0 2.9 9.4 3.7 1.4 1.0 4.0 8.3 3.0 0.6 1.2 61.8 3.2 2.0 19.0 3.1 1.0 1.7 6.2 1.6 0.9 8.4 1.6 1.0 4.9 1.5 1.0 1.1 1.2 24.8 14.4 9.5 9.0 2.3 7.9 0.3 1.3 2.8 0.8 0.3 7.2 1.2 0.1 19.3 3.9 0.0 1.5 0.4 0.0 0.4 0.0 0.2 0.0 0.2 3.1 0.0 4.8 0.1 1.8 7.0 3.9 7.3 0.2 0.0 1.2 0.0 0.1 10.2 0.0 0.1 0.0 1.6 3.1 0.0 2.3 3.0 0.5 8.0 0.0 0.0 0.1 0.6 12.9 1.5 4.0 0.4 9.1 0.0 6.2 0.0 0.0 8.7 5.0 1.9 0.0 0.2 0.0 0.4 0.4 0.5 0.8 0.0 0.2 0.0 1.5 0.0 0.0 0.0 5.1 2.0 0.0 1.3 0.8 1.1 2.1 0.3 7.2 0.1 2.4 1.4 1.3 0.3 3.0 2.7 2.8 0.3 0.6 0.2 1.1 1.2 3.7 6.6 4.6 10.2 2.9 9.4 8.3 3.0 19.0 1.2 0.0 0.0 0.0 3.1 4.6 1.0 1.7 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.8 0.0 0.5 0.3 1.6 3.4 0.0 0.8 0.0 0.6 2.0 0.0 0.0 0.0 0.3 0.2 0.0 3.9 0.6 0.3 0.0 1.1 0.0 0.0 6.8 0.3 0.0 0.0 3.8 BTBD18 ENSG00000233436 "BTB domain containing 18" B2RXH4 11 57743514-57751781 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.5;testis: 7.0" "Group enriched" "Detected in some" 8 "Bipolar cells: 1.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 1.4;Spermatocytes: 1.5;Spermatogonia: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;Hep G2: 2.5;PC-3: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049325 Uncertain NA NA "HPA049325: AB_2680713" "unprognostic (6.68e-2)" "unprognostic (3.13e-2)" "unprognostic (3.43e-1)" "unprognostic (4.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.47e-2)" "unprognostic (8.69e-3)" "unprognostic (4.84e-3)" "unprognostic (1.77e-1)" "unprognostic (2.96e-1)" "unprognostic (7.17e-3)" "unprognostic (5.95e-3)" "unprognostic (1.42e-2)" "unprognostic (2.34e-2)" "unprognostic (3.15e-1)" "unprognostic (3.34e-1)" "unprognostic (2.88e-1)" 0.0 0.0 0.1 0.1 0.3 1.2 0.0 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 1.4 0.1 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 2.5 0.8 0.3 1.0 0.3 2.1 0.2 0.3 0.4 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.5 2.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.7 0.4 0.0 0.1 1.6 0.5 0.4 0.1 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.1 0.4 0.5 0.6 0.1 0.1 0.5 0.0 0.6 0.6 0.5 0.6 0.4 0.2 0.0 0.6 0.0 0.2 1.0 0.1 0.9 1.1 0.7 0.2 2.5 2.1 0.9 0.3 0.3 0.6 0.8 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.5 3.4 0.0 0.0 0.0 0.0 0.0 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 6.7 8.7 3.5 3.6 1.9 2.7 4.9 0.6 2.8 13.5 2.0 2.4 6.2 1.6 13.9 21.4 2.1 6.4 4.2 3.8 1.3 1.4 4.2 2.2 4.1 1.8 1.4 4.0 8.4 1.5 3.2 11.9 7.9 6.3 5.6 1.8 7.6 1.7 8.3 1.8 1.2 2.2 5.6 1.9 2.3 2.2 3.5 0.6 0.1 6.0 2.0 1.4 2.1 4.3 0.0 0.2 2.3 0.1 0.0 0.2 0.0 0.1 1.1 1.0 1.1 2.3 2.6 0.7 2.1 1.3 1.0 2.0 0.0 0.8 0.1 1.0 3.7 0.5 0.3 0.0 1.1 0.4 0.9 0.2 2.0 0.3 1.1 2.3 0.0 1.6 3.9 0.1 3.7 0.7 7.0 6.4 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.3 0.1 1.2 1.3 0.0 0.0 14.9 3.8 3.0 1.8 1.6 0.5 0.1 0.0 2.3 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 3.5 1.9 0.6 2.8 1.3 1.4 1.4 4.0 6.3 0.6 3.0 3.4 0.0 1.6 1.8 0.0 1.0 2.5 1.4 4.5 1.8 0.0 0.2 0.0 0.9 0.4 3.5 2.1 0.0 0.5 0.2 3.8 0.9 2.3 2.8 2.7 0.0 0.0 3.7 6.0 0.0 2.8 4.6 3.3 0.0 1.3 1.5 0.8 0.8 1.1 2.7 0.0 0.0 4.6 0.7 0.2 1.9 1.0 0.0 0.7 1.3 BTBD8 ENSG00000189195 "BTB domain containing 8" Q5XKL5 1 92080305-92184725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 42.3" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.2" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 3.4 4.6 11.7 1.2 27.3 0.7 3.3 20.3 42.3 2.3 2.4 4.0 0.6 1.7 3.4 4.7 2.0 3.3 2.3 2.8 7.8 2.1 2.4 1.9 2.5 1.4 4.5 23.3 5.0 2.7 5.1 6.0 2.5 16.4 3.3 2.5 1.2 2.8 2.7 2.3 1.8 2.1 2.0 6.6 1.8 2.4 8.3 9.9 0.2 3.7 0.0 1.1 4.7 2.7 0.5 0.8 0.6 0.7 0.9 2.3 0.4 2.7 2.2 1.6 0.0 5.0 10.2 5.5 1.8 2.5 1.5 1.8 0.5 3.2 1.2 6.5 1.6 6.0 0.8 1.2 3.2 2.3 2.8 1.8 2.1 0.6 0.9 1.1 1.1 1.2 6.0 2.7 0.9 1.8 6.8 1.5 2.9 2.5 0.8 2.8 1.7 0.8 2.1 1.7 3.8 1.7 1.8 1.6 0.2 3.2 2.0 0.9 1.5 2.9 1.4 1.4 3.0 2.3 1.6 1.0 1.9 1.2 1.1 0.7 2.1 0.9 0.0 1.5 0.2 0.4 0.0 0.6 0.0 2.3 0.1 0.5 0.5 1.0 0.9 0.0 0.5 1.8 1.4 0.6 0.9 0.7 0.8 0.9 0.4 11.7 27.3 20.3 42.3 7.8 2.1 4.5 23.3 16.4 9.9 0.0 2.6 0.0 1.0 0.3 8.7 0.7 5.1 5.3 5.7 5.2 5.9 1.9 1.7 3.1 4.5 0.6 1.7 0.0 2.5 0.9 1.1 1.8 0.0 0.8 0.6 3.2 0.0 1.3 2.4 0.5 5.5 1.3 1.7 1.8 2.3 6.5 3.2 2.9 3.5 1.1 16.7 0.0 0.5 3.7 8.2 0.5 1.1 0.5 2.3 0.9 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.8" "Group enriched" "Detected in some" 6 "Early spermatids: 46.0;Late spermatids: 57.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Karpas-707: 8.6;U-266/70: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA057157: AB_2683354" "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.2 0.4 6.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.7 1.6 0.1 0.0 0.0 1.0 0.0 8.6 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.4 0.0 0.4 6.0 2.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.7 3.4 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 8.2 1.2 0.0 0.0 0.0 0.0 0.0 BTNL2 "BTL-II, BTN7, HSBLMHC1" ENSG00000204290 "Butyrophilin like 2" Q9UIR0 6 32393963-32407128 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;Karpas-707: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-2)" "unprognostic (8.13e-4)" "unprognostic (3.74e-2)" "unprognostic (1.33e-1)" "unprognostic (1.21e-1)" "unprognostic (3.04e-1)" "unprognostic (9.36e-2)" "unprognostic (2.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.67e-1)" "unprognostic (8.03e-2)" 0.0 1.0 0.7 0.0 1.3 0.0 0.1 0.2 0.5 0.2 0.0 1.3 0.3 0.2 0.0 0.3 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 1.0 0.0 0.1 0.0 3.0 0.1 0.9 0.0 0.3 0.7 0.5 0.4 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTNL3 "BTN9.1, BTNLR" ENSG00000168903 "Butyrophilin like 3" Q6UXE8 5 180988845-181006727 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 82.5" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 102.3;Mucus-secreting cells: 20.3;Paneth cells: 51.8;Undifferentiated cells: 16.9" "Group enriched" "Detected in some" 7 "colorectal cancer: 5.5;pancreatic cancer: 1.2;stomach cancer: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 178 "neutrophil: 17.8" "Lineage enriched" "Detected in single" 178 "granulocytes: 17.8" "Cell line enhanced" "Detected in some" "BEWO: 1.0;CACO-2: 2.5;HMC-1: 1.0;RPMI-8226: 2.5;U-266/84: 2.4" NA NA "unprognostic (4.07e-2)" "unprognostic (3.64e-2)" "unprognostic (9.21e-2)" "unprognostic (4.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.57e-2)" "unprognostic (2.19e-2)" "unprognostic (5.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" 0.1 0.0 0.1 2.1 0.1 0.0 0.1 0.1 0.1 0.1 32.5 0.1 0.1 44.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 9.4 0.1 0.1 0.1 0.1 0.0 82.5 0.1 0.1 0.5 0.4 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 102.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 2.4 1.8 0.3 1.1 0.0 0.0 0.0 0.0 20.3 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 138.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Group enriched" "Detected in some" 4 "OE19: 7.5;U-698: 28.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.1 0.2 1.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 2.9 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.7 0.3 0.0 0.1 0.1 0.1 0.1 7.5 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.1 4.4 0.1 0.0 0.2 0.1 28.3 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 0.0 6.7 3.0 0.6 2.1 0.4 27.4 0.0 4.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 29.2 0.0 0.0 0.2 0.1 0.2 0.3 1.1 0.4 0.1 0.0 4.1 138.7 12.7 1.1 2.0 1.0 3.3 0.0 4.0 0.2 0.1 0.0 0.4 0.0 0.3 12.9 2.1 4.3 11.1 1.9 0.1 0.5 1.1 0.6 C10orf105 FLJ00245 ENSG00000214688 "Chromosome 10 open reading frame 105" Q8TEF2 10 71711702-71737824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 20.1;lymphoid tissue: 8.6" "Group enriched" "Detected in some" 13 "Early spermatids: 8.0;Late spermatids: 3.6;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.3;myeloid DC: 1.6;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 4.8" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.60e-3)" "unprognostic (6.76e-3)" "unprognostic (5.45e-1)" "unprognostic (4.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.37e-6)" "unprognostic (5.25e-2)" "unprognostic (2.10e-3)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.35e-1)" "unprognostic (7.37e-2)" "unprognostic (4.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" 1.2 0.7 6.8 2.8 8.8 1.8 0.5 0.7 5.6 0.7 0.8 20.1 0.0 1.0 0.8 0.3 0.9 0.8 1.2 0.6 8.9 10.6 0.4 0.7 1.1 3.7 11.7 5.2 1.0 0.3 0.4 0.1 0.8 13.7 0.6 0.7 0.0 0.6 0.4 0.8 1.9 1.3 0.6 4.2 8.6 0.5 3.0 8.7 0.5 0.4 0.0 2.0 1.2 0.2 0.0 1.6 0.7 4.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 4.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 4.8 0.0 0.0 0.3 6.8 8.8 0.7 4.9 8.9 10.6 11.7 5.2 13.7 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 C10orf113 bA165O3.1 ENSG00000204683 "Chromosome 10 open reading frame 113" Q5VZT2 10 21125763-21146559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "salivary gland: 1.2;testis: 4.8" "Group enriched" "Detected in some" 4 "Early spermatids: 3.0;Late spermatids: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;hTCEpi: 1.2;RT4: 2.0" HPA037013 Uncertain NA NA "HPA037013: AB_10672106" "unprognostic (2.55e-2)" "unprognostic (6.57e-2)" "unprognostic (4.18e-1)" "unprognostic (5.00e-1)" "unprognostic (3.11e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.8 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 C10orf120 bA318C4.1 ENSG00000183559 "Chromosome 10 open reading frame 120" Q5SQS8 10 122697709-122699822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 25.6" "Cell type enriched" "Detected in some" 9 "Early spermatids: 609.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 609.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 C10orf142 ENSG00000277288 "Chromosome 10 open reading frame 142" B7Z368 10 44292569-44294649 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 3.8;pancreas: 2.6" "Group enriched" "Detected in some" 9 "Early spermatids: 4.0;Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;RPMI-8226: 4.3;U-2 OS: 1.6;U-2197: 10.7;U-87 MG: 3.9" NA NA "unprognostic (3.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.75e-1)" "unprognostic (7.31e-2)" "unprognostic (4.17e-3)" "unprognostic (6.17e-2)" "unprognostic (2.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.80e-1)" "unprognostic (1.14e-1)" "unprognostic (2.51e-3)" 1.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 1.1 0.0 0.3 0.0 1.0 3.8 0.0 0.8 0.1 1.8 0.0 2.6 0.0 0.0 0.0 0.0 1.1 0.1 1.3 0.7 0.1 0.0 2.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.7 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 1.6 10.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 35.7;Ciliated cells: 49.5;Late spermatids: 23.1;Spermatocytes: 63.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 5.3;SiHa: 8.5" HPA038131 Approved Approved Vesicles,Microtubules,Mitochondria NA No "Vesicles, Microtubules, Mitochondria" "HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.7 0.1 2.4 0.2 0.2 1.6 0.2 5.3 0.2 0.7 1.7 0.5 0.4 0.1 0.7 0.4 1.0 0.1 0.0 0.6 1.7 0.7 1.0 0.2 0.0 0.2 0.2 0.8 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.1 0.2 0.4 1.7 0.4 0.9 0.4 8.5 0.4 0.1 0.3 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.1 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 35.7 3.7 0.0 0.0 2.5 0.1 1.1 0.0 49.5 3.4 0.0 0.0 0.0 1.7 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 12.2 0.8 6.5 0.0 63.7 2.1 1.1 0.0 0.0 0.0 0.0 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 12.7;testis: 44.7" "Group enriched" "Detected in some" 97 "Early spermatids: 967.9;Late spermatids: 1530.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 127 "basophil: 12.7" "Lineage enriched" "Detected in single" 127 "granulocytes: 12.7" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 4.9;NTERA-2: 2.7;SuSa: 5.6;T-47d: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043022 Approved Mitochondria Yes NA Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.4 1.1 0.4 0.9 1.2 0.2 1.0 0.8 3.3 0.4 0.7 0.0 1.0 0.3 0.3 1.5 1.2 0.3 0.3 0.5 0.4 1.3 0.5 0.3 0.2 0.2 0.4 0.9 3.2 0.9 0.2 1.2 0.3 4.1 1.1 0.4 0.6 1.8 1.1 0.2 0.4 0.6 0.7 2.0 0.3 0.4 44.7 0.0 0.0 3.3 0.0 0.2 0.4 1.9 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.8 3.3 0.4 1.3 0.4 0.9 4.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 967.9 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1530.3 8.3 0.0 1.7 0.0 0.8 0.0 0.1 0.0 4.9 0.0 0.0 12.9 0.0 10.2 7.8 0.0 0.0 0.0 0.6 0.3 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Group enriched" "Detected in some" 27 "Early spermatids: 96.0;Late spermatids: 93.2" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.1 0.0 2.0 0.0 15.1 0.3 0.0 10.6 0.0 15.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 96.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 93.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 3.5 0.0 0.0 0.0 C11orf16 ENSG00000176029 "Chromosome 11 open reading frame 16" Q9NQ32 11 8920076-8933006 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 19.1;lymphoid tissue: 10.8" "Cell type enriched" "Detected in some" 17 "Ciliated cells: 135.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enhanced" "Detected in some" "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.0;T-reg: 1.6" "Group enriched" "Detected in many" 9 "monocytes: 1.0;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 1.5;CACO-2: 1.6;EFO-21: 1.6" "Low region specificity" "Detected in some" NA NA "unprognostic (5.32e-3)" "unprognostic (1.03e-2)" "unprognostic (4.09e-3)" "prognostic favorable (3.32e-4)" "unprognostic (1.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.94e-5)" "unprognostic (6.40e-4)" "unprognostic (1.58e-2)" "unprognostic (9.99e-2)" "unprognostic (4.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.71e-1)" "unprognostic (1.13e-3)" 0.0 0.2 0.5 0.0 0.8 0.0 0.2 0.0 0.3 2.3 0.0 0.7 0.0 0.1 0.6 3.1 0.0 19.1 0.0 0.0 0.8 1.3 0.4 0.0 5.2 0.0 0.0 0.0 2.8 0.0 0.0 1.6 0.0 2.9 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 2.7 0.0 10.8 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.1 1.6 0.0 0.9 1.3 1.3 0.5 0.0 0.0 1.5 0.4 0.0 0.0 0.0 1.6 0.2 0.1 1.6 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.7 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 1.2 0.1 0.0 0.0 0.6 0.9 0.6 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.7 0.0 1.1 0.0 0.0 0.3 0.4 0.0 0.7 1.0 0.5 0.3 0.2 0.0 0.3 0.0 0.2 0.6 1.1 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.5 0.8 0.0 0.3 0.8 1.3 0.0 0.0 2.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 135.1 7.9 5.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295645-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1" HPA037607 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.5 0.4 0.7 8.7 0.5 30.4 0.7 0.2 0.7 1.5 0.8 1.7 0.8 0.2 1.6 1.3 0.7 1.0 5.4 15.6 0.4 0.4 1.0 1.3 5.2 8.5 2.2 0.9 0.7 0.6 0.0 0.8 0.8 1.0 0.8 0.8 1.4 9.3 0.1 0.4 0.8 3.3 0.6 1.4 16.0 2.0 0.9 1.0 6.4 1.1 2.7 11.5 1.0 0.9 2.6 7.3 29.5 23.2 9.5 10.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 30.8 0.0 0.1 0.3 11.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.1 0.0 29.5 6.3 18.7 10.6 13.1 7.3 2.0 3.6 8.4 7.3 2.6 5.4 7.5 5.5 9.5 23.2 0.7 2.6 6.4 0.7 0.5 0.2 0.7 0.4 0.4 2.2 0.9 1.0 1.0 0.0 6.2 1.9 0.0 0.3 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 15.1 0.0 3.4 0.0 0.0 1.3 14.3 0.0 0.0 12.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.5 0.0 0.0 C11orf40 NOV1 ENSG00000171987 "Chromosome 11 open reading frame 40" Q8WZ69 11 4571423-4577820 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "epididymis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPMI-8226: 1.4;SK-MEL-30: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205566-6211132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 27.9" "Group enriched" "Detected in some" 136 "Early spermatids: 149.9;Late spermatids: 529.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.2;HeLa: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane, Vesicles" "HPA063404: AB_2685006" "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 1.0 1.2 0.1 0.2 0.1 0.1 1.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.3 27.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.5 2.5 0.4 1.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.8 0.6 0.1 0.0 0.3 1.9 0.0 0.0 0.0 0.6 4.2 0.0 4.8 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.9 0.4 0.0 0.8 0.9 0.4 1.5 0.3 1.3 0.8 1.2 0.2 0.0 0.4 1.2 0.3 0.2 1.1 0.5 0.6 0.4 0.9 0.4 1.0 0.4 2.0 0.3 0.5 1.1 0.4 0.7 1.8 0.4 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 529.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 C11orf45 "FLJ43646, MGC35558" ENSG00000174370 "Chromosome 11 open reading frame 45" Q8TAV5 11 128899565-128906035 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Hofbauer cells: 8.1;Kupffer cells: 4.1;Late spermatids: 5.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.4;U-937: 9.6" HPA039716 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039716: AB_10672892" "unprognostic (8.32e-2)" "unprognostic (3.93e-2)" "unprognostic (5.99e-3)" "unprognostic (1.35e-3)" "unprognostic (1.01e-1)" "unprognostic (9.93e-2)" "unprognostic (4.50e-5)" "unprognostic (1.97e-2)" "unprognostic (4.78e-2)" "unprognostic (3.10e-1)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "unprognostic (2.55e-9)" "unprognostic (2.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.87e-2)" "unprognostic (7.22e-2)" 0.7 4.9 1.1 0.3 5.3 0.4 0.7 0.0 1.0 0.9 0.4 1.2 0.3 0.4 3.3 0.9 2.1 5.0 0.7 0.9 1.6 0.2 2.8 0.3 1.1 0.7 4.1 4.7 3.7 2.1 1.2 0.6 1.7 3.6 0.0 8.0 0.6 0.1 1.5 1.6 2.0 1.0 1.8 0.6 1.7 1.8 0.4 3.5 0.0 1.8 0.0 1.1 0.6 2.4 4.8 0.0 0.0 0.1 0.4 1.8 0.8 5.1 1.9 4.8 6.9 6.2 0.0 3.5 0.4 4.4 2.5 2.5 12.4 0.9 0.0 1.2 0.3 3.0 0.0 0.2 0.0 0.0 0.3 1.7 1.4 0.8 4.1 1.1 3.8 0.0 0.3 2.1 1.3 2.7 2.5 2.0 1.0 3.5 1.2 5.0 0.5 4.4 1.2 0.0 0.2 2.0 5.7 0.4 1.4 0.8 4.1 0.6 0.0 7.1 0.0 0.8 0.1 0.0 0.0 0.9 9.6 0.2 0.0 1.8 0.0 0.3 0.8 0.7 0.4 0.5 0.5 3.5 0.4 1.1 0.7 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.3 0.0 1.0 2.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.6 1.4 0.0 0.0 0.0 0.7 2.1 0.2 0.1 1.1 0.0 8.1 0.0 0.0 0.0 4.1 5.7 0.0 2.6 0.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.6 1.0 0.0 0.0 0.7 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245805-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 7.6" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 51.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 1.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 2.6 1.2 1.6 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.8 0.0 0.6 1.2 0.4 2.4 4.1 0.0 3.2 0.0 3.0 0.0 0.0 0.0 4.5 7.6 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 11.2 0.0 2.1 0.0 51.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 6.6 0.3 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 3.5 C11orf70 MGC13040 ENSG00000137691 "Chromosome 11 open reading frame 70" Q9BRQ4 11 102047443-102084560 "Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.5;testis: 54.7" "Group enriched" "Detected in many" 9 "Ciliated cells: 186.0;Early spermatids: 270.4;Spermatocytes: 221.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038585 Enhanced Approved Centrosome NA NA Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.5 3.7 2.9 1.1 4.2 0.1 3.1 0.7 1.4 5.9 1.6 5.4 11.6 0.8 5.3 11.9 2.3 25.5 4.9 1.7 3.9 4.5 3.0 0.3 7.2 1.2 1.7 1.3 7.5 0.8 3.7 13.7 4.0 16.0 5.6 0.8 4.2 1.1 7.0 0.5 1.6 0.8 5.5 1.9 0.2 1.6 54.7 2.2 0.0 3.3 1.1 0.8 3.8 2.5 0.6 0.3 2.3 0.6 0.3 0.4 0.2 0.0 6.7 6.8 0.0 6.1 14.8 0.2 2.6 6.8 3.7 5.2 0.5 8.7 0.0 1.6 5.2 1.8 1.7 1.6 0.8 2.7 0.0 1.0 0.0 1.1 0.0 4.3 0.0 0.0 6.3 8.5 9.5 6.4 7.2 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 10.0 1.9 7.5 0.0 8.6 0.1 0.0 0.0 7.6 0.0 1.0 0.9 2.9 8.9 2.1 0.1 0.0 0.0 3.0 0.0 0.4 1.6 0.6 0.4 0.3 0.2 0.2 0.5 0.3 0.3 0.1 0.6 0.4 0.3 2.3 0.3 0.2 0.3 0.2 0.2 2.9 4.2 0.7 1.4 3.9 4.5 1.7 1.3 16.0 2.2 0.0 3.4 0.0 5.8 10.2 0.3 0.0 2.5 186.0 13.6 0.0 2.0 6.6 0.0 0.0 270.4 0.1 0.0 0.0 0.0 0.2 8.0 1.2 1.1 0.0 0.4 0.0 9.1 1.3 0.0 24.5 10.6 1.1 5.0 0.0 0.4 7.8 0.0 0.0 5.3 0.0 0.8 12.9 2.8 221.4 17.7 4.0 1.6 0.0 0.0 1.8 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 83.2" "Group enriched" "Detected in many" 15 "Early spermatids: 502.7;Late spermatids: 1567.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 3.9 7.3 5.7 3.4 12.1 2.2 5.7 4.1 8.1 4.2 4.9 10.2 5.6 5.5 3.7 18.0 3.2 5.4 3.9 5.4 6.9 6.1 10.6 15.0 3.9 4.3 10.3 4.7 5.0 6.9 8.7 6.9 2.5 6.7 5.6 4.6 5.7 7.2 5.0 9.9 5.6 5.1 2.1 5.7 5.4 5.2 83.2 12.2 6.4 9.5 4.7 3.2 3.1 3.1 10.5 13.6 14.5 17.7 13.2 11.9 11.3 1.2 3.3 3.5 11.1 5.3 3.1 2.5 0.5 1.4 1.4 1.3 2.7 19.9 5.3 7.1 0.8 6.9 5.1 2.3 2.3 1.7 6.1 1.4 4.0 2.4 5.3 5.0 2.3 4.5 5.0 2.6 1.8 5.6 1.6 1.7 8.9 4.1 5.0 2.6 4.5 4.2 3.5 1.8 4.4 2.1 3.1 2.8 13.6 3.1 2.4 9.6 3.8 12.5 1.4 1.9 3.8 9.4 1.3 1.7 0.3 5.2 3.9 0.9 4.9 7.9 4.1 0.7 5.5 1.4 11.7 17.7 11.1 10.3 11.1 6.3 7.0 7.0 7.1 10.6 10.5 11.4 11.9 14.5 13.2 12.2 13.6 7.7 11.3 5.7 12.1 4.1 8.1 6.9 6.1 10.3 4.7 6.7 12.2 3.0 11.2 1.5 13.8 2.4 9.8 18.7 0.0 24.1 5.7 5.2 3.9 14.3 69.6 12.0 502.7 7.0 13.5 0.0 16.8 2.2 3.7 14.4 5.8 0.0 10.1 12.7 17.4 0.0 0.0 1567.4 12.0 9.1 5.0 10.0 19.0 23.4 11.0 17.5 8.5 59.7 12.5 6.5 4.1 23.4 8.8 2.3 12.2 1.7 15.1 9.5 C11orf80 "FLJ22531, TOPOVIBL" ENSG00000173715 "Chromosome 11 open reading frame 80" Q8N6T0 11 66744451-66843328 "Predicted intracellular proteins" Meiosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 50.6;Late spermatids: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038932, HPA038933" Approved Approved Centrosome NA NA Centrosome "HPA038932: AB_2676275, HPA038933: AB_10671867" "unprognostic (2.81e-1)" "unprognostic (4.39e-2)" "unprognostic (1.71e-2)" "unprognostic (6.69e-2)" "unprognostic (3.30e-1)" "unprognostic (2.09e-1)" "unprognostic (5.54e-3)" "unprognostic (4.16e-1)" "unprognostic (4.26e-2)" "unprognostic (6.59e-2)" "unprognostic (4.04e-2)" "unprognostic (2.53e-2)" "unprognostic (6.31e-2)" "unprognostic (1.23e-1)" "unprognostic (4.98e-1)" "unprognostic (3.72e-2)" "unprognostic (1.26e-1)" 2.8 7.6 15.0 12.9 15.0 4.8 10.3 26.2 11.9 7.1 10.1 1.7 4.7 7.7 5.9 13.3 16.4 5.4 4.6 4.2 8.3 7.2 13.4 2.2 4.4 5.8 5.0 11.9 3.3 4.7 10.9 12.4 3.9 8.0 10.0 9.0 5.5 10.7 9.5 1.3 35.6 17.3 4.2 2.7 6.8 5.1 15.2 2.5 15.1 3.6 7.6 15.3 4.8 8.8 10.6 9.7 3.1 1.0 1.7 4.2 0.7 8.7 4.7 9.6 6.5 0.5 3.1 1.8 3.7 4.4 4.4 5.5 16.1 10.7 14.3 2.1 3.0 2.9 16.0 4.4 5.6 4.4 3.6 2.6 2.3 5.7 4.0 1.0 1.6 2.7 0.8 19.5 3.4 6.5 6.7 13.9 5.4 4.1 5.5 2.6 9.6 5.7 5.2 15.2 25.1 6.5 3.3 4.5 11.0 19.0 3.0 7.1 7.2 6.0 16.8 13.0 8.8 11.6 1.1 6.1 3.1 5.7 3.3 5.3 3.9 8.5 10.3 3.5 2.8 3.9 1.9 0.9 3.1 2.1 0.5 3.7 10.6 3.8 3.0 0.5 8.9 4.2 3.5 2.3 1.7 1.0 9.7 4.0 0.7 15.0 15.0 26.2 11.9 8.3 7.2 5.0 11.9 8.0 2.5 17.9 5.1 14.7 2.8 10.3 3.0 0.4 0.0 4.0 5.7 33.2 17.7 1.5 8.3 15.1 50.6 1.6 14.7 23.3 10.4 1.9 3.5 3.2 4.6 0.9 2.8 0.0 13.2 1.8 1.2 92.7 2.3 1.8 3.3 7.2 9.1 1.5 12.6 10.8 0.4 3.5 7.1 6.5 2.2 11.6 24.7 17.6 1.3 6.1 8.1 2.7 C11orf88 FLJ46266 ENSG00000183644 "Chromosome 11 open reading frame 88" Q6PI97 11 111514785-111537031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.8;fallopian tube: 53.7" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 1019.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Region enriched" "Detected in many" 4 "pons and medulla: 48.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 4.6;Karpas-707: 4.9;SuSa: 3.7;U-266/70: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.25e-1)" "unprognostic (3.07e-5)" "unprognostic (3.85e-4)" "unprognostic (4.16e-2)" "unprognostic (4.44e-5)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "unprognostic (5.49e-3)" "unprognostic (2.86e-1)" "unprognostic (9.96e-3)" "unprognostic (2.70e-1)" "unprognostic (4.40e-2)" "unprognostic (6.80e-3)" "unprognostic (7.57e-2)" "unprognostic (6.22e-2)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" 0.2 0.2 5.7 0.3 10.9 0.3 0.2 0.2 1.0 5.8 0.2 5.7 0.0 0.4 2.2 13.1 0.2 53.7 0.4 0.2 7.3 7.6 0.2 0.2 13.9 0.3 0.6 0.2 8.3 0.2 0.2 0.5 0.4 48.8 0.3 0.2 0.0 0.3 0.3 0.2 0.3 0.3 0.2 1.1 0.3 0.3 13.5 1.5 0.1 0.7 0.0 0.2 0.2 0.0 0.7 0.6 2.6 0.5 0.6 0.4 0.0 0.3 1.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.1 0.0 4.6 2.1 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.2 0.4 0.4 0.0 0.5 0.0 0.4 0.0 0.7 0.1 4.9 0.0 0.5 0.3 0.2 0.2 0.0 0.5 0.0 0.8 0.0 0.1 0.2 0.2 0.5 0.3 0.1 0.0 3.7 0.9 0.0 0.0 0.7 0.6 0.7 0.9 2.8 0.4 0.2 0.4 0.3 0.9 1.7 0.5 1.2 0.3 0.2 0.4 0.5 0.2 0.1 0.4 0.7 0.3 0.3 2.6 0.6 0.5 0.6 0.4 0.0 5.7 10.9 0.2 1.0 7.3 7.6 0.6 0.2 48.8 1.5 3.0 6.9 0.0 0.2 0.0 0.0 4.4 0.0 1019.8 70.5 0.0 0.0 0.1 0.0 0.0 106.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 31.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.1 7.1 0.0 0.0 0.0 0.0 0.5 C11orf91 ENSG00000205177 "Chromosome 11 open reading frame 91" Q3C1V1 11 33698261-33700801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 10.1;Late spermatids: 2.3;Sertoli cells: 6.5;Spermatocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.2;hTERT-HME1: 9.8;HUVEC TERT2: 7.8;TIME: 11.9;U-2197: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047064, HPA050487" Uncertain Supported Vesicles NA NA Vesicles "HPA047064: AB_2679920, HPA050487: AB_2681142" "unprognostic (9.22e-3)" "unprognostic (1.51e-2)" "unprognostic (1.76e-1)" "unprognostic (6.60e-2)" "unprognostic (1.62e-2)" "unprognostic (3.63e-2)" "unprognostic (2.31e-1)" "unprognostic (5.68e-3)" "unprognostic (7.41e-2)" "unprognostic (2.97e-2)" "unprognostic (1.99e-2)" "unprognostic (3.01e-1)" "unprognostic (8.33e-2)" "unprognostic (4.06e-2)" "unprognostic (3.95e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" 7.2 0.2 1.2 2.1 3.0 0.9 2.1 0.3 1.3 0.3 0.3 0.3 0.3 0.0 0.4 0.9 4.3 0.3 7.2 0.7 0.4 0.6 0.9 0.9 1.4 0.3 0.7 0.3 0.6 1.9 0.0 0.3 1.0 1.3 0.3 0.0 0.3 0.9 0.3 0.4 1.3 0.3 0.8 0.8 0.3 2.7 16.6 0.3 0.6 0.3 0.3 0.3 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 1.7 0.0 0.8 0.4 0.2 0.6 0.0 0.1 1.8 0.2 0.6 0.5 15.2 1.2 0.4 0.0 0.0 2.9 0.8 0.3 0.0 0.0 0.0 0.1 1.2 9.8 0.5 7.8 0.2 0.0 2.4 3.7 0.0 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.0 1.1 2.0 0.0 0.3 0.0 1.5 0.1 0.5 0.0 0.0 11.9 1.1 0.3 9.8 0.3 0.7 0.5 0.0 2.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.0 0.3 1.3 0.4 0.6 0.7 0.3 1.3 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.2 5.4 0.2 0.0 0.1 0.0 0.0 1.1 C12orf4 ENSG00000047621 "Chromosome 12 open reading frame 4" Q9NQ89 12 4487728-4538508 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037871 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA037871: AB_10670531" "unprognostic (5.88e-2)" "unprognostic (2.81e-1)" "unprognostic (5.64e-2)" "unprognostic (2.51e-2)" "unprognostic (3.07e-2)" "unprognostic (6.69e-2)" "unprognostic (2.96e-3)" "unprognostic (8.59e-2)" "unprognostic (6.85e-2)" "unprognostic (2.75e-2)" "unprognostic (2.26e-2)" "unprognostic (5.93e-2)" "unprognostic (1.26e-2)" "unprognostic (7.83e-2)" "unprognostic (2.74e-1)" "unprognostic (5.02e-2)" "unprognostic (3.92e-1)" 12.4 9.6 15.6 13.6 20.8 12.9 12.1 22.1 28.3 11.8 12.0 9.9 7.2 6.9 11.1 9.1 12.4 10.3 10.7 11.6 17.7 11.4 10.5 9.4 10.7 14.7 11.7 19.0 12.4 10.0 11.2 22.7 15.4 22.0 12.7 13.6 6.8 9.5 11.5 17.9 9.4 10.4 15.3 14.5 14.4 10.2 14.1 13.6 13.4 13.0 9.5 15.8 12.8 10.2 5.0 7.0 2.7 13.8 4.2 6.7 4.4 8.4 6.5 8.1 9.5 8.1 12.1 17.1 16.3 6.8 15.0 18.4 11.4 7.0 7.2 3.4 10.5 12.4 6.3 11.3 9.4 20.5 21.3 7.7 12.4 6.3 5.6 11.8 10.6 11.7 10.7 5.5 18.0 20.3 9.5 8.5 8.9 7.3 12.5 14.0 4.0 8.4 4.5 11.8 7.3 6.2 9.2 12.7 4.5 9.3 8.8 3.2 6.3 11.1 8.1 6.8 23.0 3.4 9.2 8.8 13.1 12.1 14.3 17.0 2.9 3.8 17.6 9.7 8.8 12.1 0.0 7.8 2.7 4.6 12.8 5.0 5.0 4.5 4.6 6.7 5.0 5.0 4.5 2.5 4.2 13.8 7.0 6.7 4.4 15.6 20.8 22.1 28.3 17.7 11.4 11.7 19.0 22.0 13.6 14.9 8.1 11.0 3.0 2.6 12.9 12.5 5.1 9.4 10.3 3.5 27.5 5.9 3.3 6.1 40.6 6.5 3.8 0.0 7.2 6.5 7.5 2.3 1.1 3.8 23.7 7.9 5.8 8.0 13.6 12.3 7.5 6.6 1.7 5.4 4.6 6.3 6.8 2.6 6.3 4.1 11.4 6.5 6.9 18.2 14.3 2.9 5.1 7.4 5.0 1.8 C12orf42 FLJ25323 ENSG00000179088 "Chromosome 12 open reading frame 42" Q96LP6 12 103237591-103496010 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 45.4" "Group enriched" "Detected in some" 18 "Early spermatids: 327.9;Late spermatids: 270.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 7.4;naive B-cell: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 1.7;NTERA-2: 1.1;SCLC-21H: 1.6;U-266/70: 4.0" NA NA "unprognostic (9.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.96e-2)" "unprognostic (1.05e-2)" "unprognostic (2.66e-1)" "unprognostic (9.83e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (8.96e-4)" "unprognostic (4.89e-2)" "unprognostic (2.20e-3)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-2)" "unprognostic (3.30e-1)" 0.0 0.0 0.4 0.6 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 45.4 0.0 0.4 0.0 0.0 1.0 0.1 0.0 8.3 1.5 0.0 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.6 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 7.4 1.9 2.3 0.2 8.3 2.1 2.3 0.0 0.0 0.0 1.5 2.9 1.3 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 327.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 270.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.9 2.0 0.0 0.0 0.0 0.0 0.0 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482503-48496512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 34.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 2100.5" "Group enriched" "Detected in some" 9 "cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6" HPA073090 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 34.8 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 9.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.6 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.6 0.0 22.3 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 444.4 0.1 0.0 0.0 0.0 0.1 0.4 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2100.5 10.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 12.4 0.2 0.0 6.5 1.4 12.9 6.4 1.9 0.0 0.0 0.0 8.4 C12orf56 ENSG00000185306 "Chromosome 12 open reading frame 56" Q8IXR9 12 64264762-64391192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.9;testis: 15.0" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 49.8;Late spermatids: 26.6;Muller glia cells: 11.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "hTEC/SVTERT24-B: 10.1;SCLC-21H: 8.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA056986 Enhanced NA NA "HPA056986: AB_2683300" "unprognostic (5.85e-3)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.36e-1)" "unprognostic (9.24e-2)" "unprognostic (9.35e-4)" "unprognostic (1.79e-4)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (9.51e-2)" "unprognostic (6.22e-3)" "unprognostic (4.00e-2)" "unprognostic (2.38e-4)" "unprognostic (8.86e-2)" "unprognostic (3.91e-2)" "unprognostic (3.40e-2)" "unprognostic (1.69e-2)" 0.3 0.1 0.1 0.0 0.5 0.2 0.1 1.3 0.2 1.8 0.4 0.9 1.0 0.0 0.1 0.0 1.8 0.2 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.4 0.2 0.1 2.7 0.5 0.0 0.0 1.6 0.1 0.0 0.1 0.2 0.1 15.0 0.0 8.9 0.0 0.6 0.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.2 0.1 0.5 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.1 8.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.3 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 4.9 5.0 0.0 49.8 0.0 0.0 0.0 0.0 3.6 0.4 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 26.6 0.0 0.4 0.0 0.0 1.0 11.8 0.2 0.0 0.4 7.1 0.7 0.0 0.0 4.2 1.3 0.3 1.5 0.0 0.6 1.4 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803572-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Cell type enriched" "Detected in many" 7 "Early spermatids: 342.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 1.7 8.9 2.6 2.3 9.9 1.7 1.8 1.9 4.7 1.5 1.3 4.8 1.6 0.7 1.1 2.9 1.3 2.9 1.8 5.4 3.7 2.0 4.8 8.7 2.0 3.2 6.3 4.7 1.5 2.1 1.7 3.8 1.6 7.2 2.1 1.2 5.1 1.9 1.4 2.5 1.3 1.4 0.8 9.2 5.5 1.9 22.5 4.9 1.7 3.3 1.0 2.0 1.5 1.7 3.9 1.1 3.6 1.4 3.3 4.5 1.2 2.5 2.8 2.8 8.1 3.1 2.2 2.5 1.9 1.0 2.0 2.4 1.2 2.8 2.2 2.3 0.6 3.0 2.9 3.1 6.2 2.7 5.0 3.1 1.7 0.8 1.9 2.5 2.6 0.9 1.1 3.8 2.0 4.2 2.7 3.8 3.6 2.8 0.5 2.7 0.8 1.0 1.5 9.6 3.8 1.6 3.1 4.8 3.3 3.6 0.8 2.0 2.5 4.1 1.0 3.6 8.6 3.2 1.2 2.9 1.8 2.0 1.4 2.1 1.4 0.9 7.3 2.2 2.4 2.5 0.3 1.3 3.6 2.3 1.4 3.7 3.9 1.9 3.3 1.1 2.6 4.5 3.8 0.3 3.3 0.8 1.0 3.6 1.2 2.6 9.9 1.9 4.7 3.7 2.0 6.3 4.7 7.2 4.9 0.0 0.0 7.5 0.4 0.2 3.3 3.3 0.0 5.3 2.3 5.2 19.6 1.4 6.6 1.3 342.1 2.3 0.0 0.0 1.0 1.7 1.2 0.4 0.0 0.8 1.0 1.6 0.0 0.0 1.2 51.4 2.8 1.1 0.0 3.6 0.1 2.5 0.6 0.0 2.5 2.9 16.1 19.4 1.0 10.5 7.9 0.9 0.2 2.5 0.3 0.3 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C12orf74 ENSG00000214215 "Chromosome 12 open reading frame 74" Q32Q52 12 92702843-92708549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "memory B-cell: 3.7;naive B-cell: 3.1" "Lineage enriched" "Detected in single" 21 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8" HPA062856 Approved "Nucleoplasm,Nuclear bodies,Aggresome" NA NA Nucleoplasm "Nuclear bodies, Aggresome" "HPA062856: " "unprognostic (2.75e-2)" "unprognostic (4.33e-2)" "unprognostic (2.28e-3)" "unprognostic (4.55e-3)" "unprognostic (7.95e-4)" "unprognostic (2.23e-1)" "unprognostic (2.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (5.84e-2)" "unprognostic (5.83e-4)" "unprognostic (3.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 12.3 0.1 0.0 0.2 0.1 0.1 2.1 0.7 0.0 3.6 0.3 0.7 6.9 1.7 4.5 0.3 0.2 0.1 0.1 1.3 0.5 6.6 1.9 0.1 0.0 1.0 1.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.9 0.9 0.1 0.2 1.8 0.0 0.1 2.6 2.1 0.5 0.0 0.1 0.2 0.0 10.5 2.5 1.4 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 2.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: AB_2677797" "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favorable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.3 9.4 11.4 10.3 8.2 16.9 12.6 5.6 3.2 5.4 4.1 7.7 6.2 7.8 6.7 2.5 4.2 12.6 4.7 4.6 4.1 11.6 10.0 7.8 14.3 15.5 7.8 12.7 15.3 13.5 15.4 4.7 8.7 19.7 8.5 12.7 11.6 20.5 5.6 6.8 6.4 20.9 8.9 4.0 8.6 12.2 7.0 12.6 9.8 6.2 22.9 12.4 7.0 5.2 12.5 12.0 11.4 6.6 10.8 8.3 6.0 6.3 3.3 9.4 10.8 6.4 9.1 7.3 4.7 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 29.8 14.2 10.7 13.8 7.0 23.3 6.3 20.4 36.1 10.3 15.7 2.0 24.1 29.9 10.0 16.2 13.1 6.3 0.0 13.2 8.0 13.6 10.2 4.7 17.3 22.8 30.2 5.8 16.5 19.2 9.0 24.2 16.1 18.6 15.4 11.0 32.3 9.6 7.0 31.8 32.3 20.5 6.5 14.4 26.2 10.1 7.4 10.1 20.8 10.7 5.8 C14orf177 FLJ25773 ENSG00000176605 "Chromosome 14 open reading frame 177" Q52M58 14 98711613-98717761 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "blood: 1.6;testis: 5.4" "Group enriched" "Detected in some" 50 "Early spermatids: 7.2;Late spermatids: 5.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Not detected" "Not detected" HPA018091 Uncertain NA NA "HPA018091: AB_1848845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C14orf178 FLJ25976 ENSG00000197734 "Chromosome 14 open reading frame 178" Q8N769 14 77760830-77769742 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 8.5;testis: 13.7" "Cell type enhanced" "Detected in single" 23 "Early spermatids: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 4.7;TIME: 5.0" HPA062581 Uncertain NA NA "HPA062581: AB_2684799" "unprognostic (2.50e-2)" "unprognostic (1.65e-3)" "unprognostic (1.84e-2)" "unprognostic (2.06e-1)" "unprognostic (7.93e-2)" "unprognostic (1.71e-1)" "unprognostic (8.96e-2)" "unprognostic (7.33e-4)" "unprognostic (2.10e-1)" "unprognostic (1.48e-1)" "unprognostic (9.45e-3)" "unprognostic (1.06e-1)" "unprognostic (1.23e-2)" "unprognostic (9.20e-2)" 0.8 0.7 4.6 1.4 2.6 3.9 1.0 1.7 3.2 0.8 0.9 1.7 0.0 0.8 1.4 4.5 1.5 0.8 1.5 1.0 1.5 1.4 0.8 0.8 0.7 2.0 1.5 0.4 1.6 0.5 1.5 1.9 2.5 2.5 1.0 0.8 1.5 1.1 0.6 1.7 4.9 0.9 0.3 1.4 1.1 0.6 13.7 0.8 0.4 2.1 0.6 1.3 1.1 0.7 6.5 8.5 1.5 3.1 5.1 4.2 1.5 0.2 1.1 2.7 1.9 2.2 0.0 1.2 0.4 0.3 0.6 0.5 4.7 2.4 0.9 0.6 1.1 1.3 1.0 0.3 0.0 1.1 0.6 1.6 0.5 1.0 2.2 0.7 0.8 1.8 0.5 0.0 0.0 1.6 1.6 0.0 2.1 0.4 1.3 0.5 1.7 1.7 1.7 2.0 0.6 0.0 1.2 0.3 0.7 0.0 2.2 1.9 0.4 1.6 2.2 0.1 0.6 1.3 0.3 5.0 1.1 1.1 1.3 0.2 1.4 0.9 1.7 0.7 2.3 0.4 0.2 1.1 0.4 4.2 3.1 2.9 3.5 1.4 1.9 0.5 6.5 3.0 2.3 1.5 5.1 2.4 8.5 0.4 1.5 4.6 2.6 1.7 3.2 1.5 1.4 1.5 0.4 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 0.0 0.0 C14orf28 DRIP-1 ENSG00000179476 "Chromosome 14 open reading frame 28" Q4W4Y0 14 44897295-44907257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 147.4;Late spermatids: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059635 Approved Cytosol NA NA Cytosol "HPA059635: AB_2684091" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.23e-1)" "unprognostic (3.06e-6)" "unprognostic (1.18e-1)" "unprognostic (6.64e-3)" "unprognostic (2.37e-2)" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (5.35e-2)" "unprognostic (3.13e-3)" "unprognostic (7.33e-2)" "unprognostic (3.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.30e-1)" "unprognostic (4.68e-2)" "unprognostic (2.01e-1)" 8.8 5.3 5.0 4.1 5.6 1.6 11.8 4.0 6.2 13.3 10.3 7.2 10.7 7.3 14.4 8.4 6.5 9.2 8.9 8.5 4.8 4.1 5.1 14.4 5.1 4.4 10.6 4.3 12.4 12.4 4.4 5.0 5.7 5.6 12.8 5.8 5.9 11.4 8.7 7.4 5.9 9.0 20.4 5.4 5.9 8.5 16.1 5.4 1.7 6.6 3.2 5.0 19.0 9.2 6.8 3.4 6.9 3.5 3.9 9.7 2.1 2.4 1.7 3.3 5.6 6.6 3.5 7.4 4.9 5.4 2.4 3.8 0.1 3.1 3.2 2.9 3.3 5.4 1.3 0.8 2.3 4.2 11.7 0.6 1.5 0.8 3.3 1.9 1.4 3.7 2.8 4.0 0.7 3.9 4.6 1.3 3.9 0.8 4.5 1.8 4.7 1.3 2.7 0.6 4.6 1.9 2.3 4.0 1.3 3.3 3.1 0.7 1.0 2.0 4.0 2.1 2.7 7.1 1.4 2.0 9.1 4.4 1.5 1.0 6.3 5.1 2.1 2.6 0.7 2.8 1.8 1.7 6.9 4.3 2.6 4.9 6.8 4.4 5.6 2.0 5.1 9.7 5.5 3.8 3.9 3.5 3.4 4.8 2.1 5.0 5.6 4.0 6.2 4.8 4.1 10.6 4.3 5.6 5.4 3.0 2.4 6.2 7.6 2.7 3.2 10.3 0.0 0.0 2.3 5.2 0.0 4.6 8.3 7.7 147.4 5.6 5.4 0.0 7.5 3.8 8.0 8.6 1.1 9.6 4.1 3.2 2.9 6.2 4.3 91.1 9.8 2.8 5.0 4.6 7.5 3.1 6.1 3.5 15.2 12.8 2.9 19.4 10.8 19.2 9.4 3.9 5.5 8.7 4.9 5.8 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 70.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.6 0.0 0.1 0.0 21.7 0.0 0.0 1.6 0.0 17.6 0.2 2.3 0.0 1.1 0.0 4.8 0.0 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.6 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.7 0.0 1.0 0.0 0.0 70.5 6.1 0.0 0.0 0.0 0.0 0.1 C15orf48 "MIR147BHG, NMES1" ENSG00000166920 "Chromosome 15 open reading frame 48" Q9C002 15 45430529-45448761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 95.5;lymphoid tissue: 56.1;testis: 47.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 2464.8;Exocrine glandular cells: 1795.4;Pancreatic endocrine cells: 2949.0;Paneth cells: 2168.3;Undifferentiated cells: 1451.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.2;intermediate monocyte: 3.7;myeloid DC: 3.0;neutrophil: 2.1" "Group enriched" "Detected in many" 10 "dendritic cells: 3.0;granulocytes: 2.1;monocytes: 3.7" "Cell line enhanced" "Detected in some" "A-431: 21.6;CAPAN-2: 40.7;GAMG: 41.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012943 Enhanced NA NA "HPA012943: AB_2668774" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (7.83e-2)" "unprognostic (1.17e-1)" "unprognostic (9.74e-3)" "unprognostic (1.48e-3)" "unprognostic (1.28e-3)" "unprognostic (1.59e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-3)" "unprognostic (5.95e-2)" "unprognostic (8.86e-2)" "unprognostic (2.37e-1)" "unprognostic (6.51e-2)" "unprognostic (1.39e-1)" "unprognostic (3.66e-1)" 0.6 0.1 0.4 56.1 0.4 7.2 2.9 0.4 0.4 9.0 87.2 0.5 26.0 6.0 0.9 0.9 33.5 0.6 6.0 2.8 0.4 0.1 1.4 1.6 11.2 0.4 0.4 0.4 0.6 3.3 0.0 0.4 10.6 0.5 2.5 95.5 0.8 6.1 21.5 0.5 14.9 54.6 3.1 0.8 0.6 10.8 47.2 0.4 1.6 0.9 33.1 19.6 1.4 10.9 0.0 3.0 2.1 3.7 0.0 0.2 1.6 21.6 5.3 0.0 0.1 0.3 0.0 0.9 1.1 7.8 1.4 4.0 0.8 40.7 0.0 1.0 0.1 41.1 0.5 0.6 0.3 3.4 2.4 0.5 0.0 0.1 0.1 3.7 0.0 9.4 0.4 0.3 7.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.0 0.5 0.0 9.7 0.1 0.0 0.1 0.1 0.8 1.7 0.0 0.2 1.3 2.5 0.1 4.6 0.4 0.5 0.2 0.1 0.5 0.3 0.2 0.7 0.3 0.1 0.7 0.2 0.1 0.0 3.2 0.3 0.2 3.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 2.1 0.0 0.4 0.5 0.0 1.6 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.5 0.4 14.9 19.6 4.5 8.9 59.0 0.6 0.8 79.0 9.4 5.7 5.2 0.0 201.6 3.3 743.8 142.7 6.0 2464.8 0.0 1795.4 122.1 24.0 129.7 33.4 0.2 417.3 108.1 620.4 1.8 8.8 208.7 6.6 354.6 55.6 852.2 1284.5 0.4 2949.0 2168.3 7.1 14.2 1.1 0.0 22.1 577.6 53.2 53.4 138.4 4.3 1451.5 477.3 C15orf53 FLJ35695 ENSG00000175779 "Chromosome 15 open reading frame 53" Q8NAA6 15 38628005-39180499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 8.0;gallbladder: 6.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.1;Distal tubular cells: 1.7;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 1.0;T-cells: 2.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 1.2" "Cell type enriched" "Detected in single" 10 "T-reg: 8.0" "Lineage enriched" "Detected in single" 81 "T-cells: 8.0" "Group enriched" "Detected in some" 9 "HEL: 4.7;HMC-1: 3.6" HPA041914 Uncertain NA NA "HPA041914: AB_10794640" "unprognostic (9.94e-3)" "unprognostic (3.48e-2)" "unprognostic (2.30e-1)" "unprognostic (5.38e-5)" "unprognostic (1.02e-1)" "unprognostic (8.93e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (3.58e-1)" "unprognostic (4.30e-5)" "unprognostic (2.59e-1)" "unprognostic (4.17e-2)" "unprognostic (2.54e-1)" "unprognostic (2.49e-3)" 0.2 0.1 0.1 2.8 0.1 0.2 0.2 0.4 0.1 0.3 1.9 0.0 0.0 0.3 0.3 1.8 0.7 0.3 6.3 0.2 0.1 0.1 0.3 0.2 2.3 0.5 0.3 0.0 1.3 0.1 0.0 0.1 0.0 1.2 0.2 0.3 0.0 1.3 0.1 0.2 0.6 1.0 0.8 0.7 1.7 0.5 0.2 0.0 0.1 0.2 2.4 3.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.2 4.6 1.2 5.1 5.4 7.8 3.3 1.9 3.4 3.5 2.8 3.5 3.0 3.6 4.1 2.1 4.1 5.0 4.6 1.3 2.9 2.1 10.9 3.8 3.5 4.6 3.5 4.7 3.2 8.1 3.5 1.1 4.3 2.5 1.6 11.1 4.3 8.0 1.1 2.4 3.8 7.7 1.9 3.4 5.8 5.2 2.6 13.1 2.5 3.0 6.8 5.1 3.3 3.2 5.8 2.3 2.8 7.2 1.6 4.7 7.2 5.9 4.8 7.6 11.0 8.7 2.0 9.2 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 20.8 9.1 25.1 28.7 59.6 71.3 69.8 20.4 6.7 7.9 15.7 35.3 35.6 68.0 21.1 136.1 26.6 30.6 0.0 25.8 25.7 33.5 30.2 33.5 33.8 26.4 12.7 26.0 17.2 20.2 22.0 38.0 16.0 35.4 7.2 47.0 62.2 24.4 38.6 24.1 54.0 68.8 32.3 28.3 136.2 21.8 53.2 17.2 31.9 43.0 15.6 C15orf62 LOC643338 ENSG00000188277 "Chromosome 15 open reading frame 62" A8K5M9 15 40770080-40772449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8" "Group enriched" "Detected in some" 5 "Basal glandular cells: 2.8;Glandular cells: 4.5;Horizontal cells: 3.2;Urothelial cells: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.0;SK-BR-3: 6.4" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Low region specificity" "Detected in all" HPA044636 Approved NA NA "HPA044636: AB_10794052" "unprognostic (9.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.52e-1)" "unprognostic (2.83e-2)" "unprognostic (5.56e-2)" "unprognostic (2.24e-2)" "unprognostic (5.37e-3)" "unprognostic (7.68e-3)" "unprognostic (1.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "unprognostic (3.40e-1)" 1.5 0.9 0.8 1.5 1.1 1.5 1.1 4.0 1.7 1.7 1.0 0.8 0.8 2.0 1.1 0.8 22.8 0.9 1.4 0.8 0.8 0.6 0.9 1.9 1.6 2.1 1.1 0.8 1.3 0.9 0.0 1.3 0.8 0.9 1.1 0.0 0.8 5.4 1.8 1.9 11.9 1.8 0.8 0.8 1.5 1.2 0.9 0.8 1.8 1.0 18.8 21.9 0.9 3.8 0.4 0.7 0.0 0.1 0.4 1.0 0.1 0.6 0.5 1.8 2.3 0.7 0.2 0.4 0.8 0.2 0.1 0.2 2.0 2.5 1.1 2.0 0.0 1.6 4.5 0.8 0.0 0.0 1.6 1.9 1.1 4.1 0.6 0.0 0.9 1.4 0.2 1.0 0.0 0.1 2.0 0.6 0.8 0.9 1.4 0.0 0.5 1.4 1.8 0.7 3.0 0.8 1.6 0.3 0.6 20.0 1.7 4.0 1.0 0.6 6.4 0.2 0.7 2.2 1.5 0.9 2.2 1.0 2.0 0.7 1.6 1.0 1.0 0.7 3.3 0.8 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.9 0.6 0.0 0.4 1.0 1.0 0.0 0.4 0.0 0.7 0.8 0.1 0.8 1.1 4.0 0.9 0.8 0.6 1.1 0.8 0.9 0.8 0.0 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.5 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.3 8.8 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408548-55418764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 50.9;Early spermatids: 140.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6" "Cell line enhanced" "Detected in many" "hTCEpi: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 3.4 3.1 6.5 0.9 7.4 0.8 5.4 2.4 6.7 7.7 5.2 3.7 5.4 2.9 3.7 11.2 3.4 13.7 5.3 7.0 6.0 7.6 11.2 1.9 3.8 2.2 5.2 6.8 4.6 11.0 6.2 17.2 1.2 12.0 5.8 6.2 2.8 27.6 5.3 8.7 2.4 2.5 3.7 3.4 1.9 7.8 11.3 4.6 1.7 7.1 0.6 1.8 3.6 1.5 2.3 0.6 6.5 1.6 0.0 0.7 0.4 0.8 1.7 2.9 1.8 4.5 6.7 0.5 1.6 2.2 1.4 2.8 0.0 1.5 1.3 4.4 5.2 3.5 1.3 0.0 2.7 0.5 2.4 2.0 1.2 10.1 0.4 8.8 2.9 1.6 2.8 14.9 4.2 1.2 7.8 2.7 0.0 2.3 4.3 6.2 2.2 0.1 9.3 0.9 5.3 3.3 0.5 0.0 11.2 7.6 0.0 7.9 4.8 2.0 3.4 12.8 1.6 6.9 2.8 1.9 2.4 0.9 2.5 0.9 1.9 5.0 1.2 6.2 7.2 1.2 6.5 1.1 3.9 0.5 1.6 0.0 1.9 0.1 0.7 0.6 2.3 0.1 0.0 2.1 0.0 0.8 0.2 0.0 0.4 6.5 7.4 2.4 6.7 6.0 7.6 5.2 6.8 12.0 4.6 3.0 0.6 0.8 3.6 1.1 0.8 7.3 2.5 50.9 4.5 5.2 0.0 1.0 14.9 7.1 140.3 3.6 2.1 0.0 9.6 1.1 3.1 4.5 4.6 1.0 2.5 3.2 3.5 3.1 1.9 6.8 4.0 0.2 3.3 1.0 16.7 3.6 7.0 11.5 5.3 16.8 7.5 6.5 2.8 5.8 2.8 1.5 0.0 0.0 4.6 1.7 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 80.6;Late spermatids: 78.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 2.0 2.5 5.2 1.8 6.8 2.2 3.1 3.3 8.6 2.8 1.4 3.5 1.3 1.3 2.8 4.4 1.7 8.6 2.0 1.4 5.8 5.8 2.4 3.0 2.2 1.1 5.9 6.0 1.7 2.6 2.9 14.4 3.2 8.6 3.0 1.4 3.5 2.0 2.4 2.5 1.0 1.0 1.9 4.2 1.1 1.1 25.2 2.5 1.5 8.9 0.5 1.3 1.9 1.3 0.2 0.4 1.1 0.4 0.0 2.0 0.0 2.8 0.5 1.1 0.5 5.2 1.0 2.6 0.6 3.6 2.0 1.2 0.6 4.0 0.7 1.8 0.7 2.5 1.0 1.1 2.0 3.6 0.6 0.7 0.8 2.3 2.7 3.1 1.0 2.2 2.1 1.6 4.7 2.9 2.2 1.7 1.4 1.7 1.4 1.6 2.0 0.3 5.5 1.3 1.0 0.6 2.2 0.3 0.4 3.5 1.7 1.5 1.4 4.0 1.3 0.7 1.7 1.2 1.4 1.4 0.9 0.4 0.8 0.7 1.5 2.1 1.6 1.8 1.4 1.0 0.0 0.4 1.1 0.2 0.0 2.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 5.2 6.8 3.3 8.6 5.8 5.8 5.9 6.0 8.6 2.5 0.0 2.9 0.0 8.1 1.6 2.1 2.0 0.0 20.1 3.4 0.0 3.9 6.3 5.0 0.8 80.6 1.6 0.0 0.0 0.4 13.6 2.3 6.0 0.0 2.9 2.8 0.0 1.2 1.3 1.2 78.6 7.5 1.0 5.0 0.0 1.2 2.9 0.4 0.0 7.1 3.1 7.0 0.0 2.0 32.0 4.9 2.4 5.3 0.0 0.9 5.5 C16orf71 "DKFZp686H2240, FLJ43261" ENSG00000166246 "Chromosome 16 open reading frame 71" Q8IYS4 16 4734272-4749396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 14.1;testis: 48.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 18.7;Early spermatids: 20.4;Late spermatids: 45.3;Spermatocytes: 48.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 7.6;U-2197: 8.3" HPA049468 Enhanced Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA049468: AB_2680779" "unprognostic (1.24e-2)" "unprognostic (8.87e-2)" "unprognostic (2.39e-1)" "prognostic favorable (7.49e-4)" "unprognostic (7.06e-2)" "unprognostic (2.17e-2)" "unprognostic (5.36e-3)" "unprognostic (2.21e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-2)" "unprognostic (6.79e-3)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-5)" "unprognostic (1.65e-1)" 0.3 0.5 0.7 0.3 1.9 0.0 0.3 1.0 1.0 0.9 0.3 2.4 0.6 0.2 0.6 2.5 0.4 14.1 0.8 0.3 1.1 1.0 1.0 1.1 1.7 0.1 0.7 0.5 1.2 0.4 0.8 1.7 0.1 3.6 0.5 0.1 0.4 1.3 1.1 0.4 0.2 0.3 0.4 0.5 0.2 0.3 48.9 0.7 0.2 1.1 0.0 0.4 0.3 0.5 1.4 4.1 0.0 1.1 0.0 0.7 0.4 0.6 3.3 0.7 1.9 4.4 1.9 1.4 1.8 1.6 1.5 1.9 1.5 1.4 0.1 1.8 2.7 4.4 1.5 1.7 1.7 0.3 0.7 1.1 0.4 2.4 0.1 1.4 1.4 0.6 0.5 0.4 5.8 1.6 1.1 0.8 1.3 1.1 0.9 1.5 7.6 0.4 1.2 1.0 2.1 1.6 0.5 0.8 2.2 4.0 0.7 4.9 1.8 1.8 1.5 0.6 1.3 6.7 0.4 0.6 1.2 1.4 8.3 0.9 3.3 2.6 0.8 0.7 0.4 1.3 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.7 0.1 0.9 1.4 0.4 0.5 0.0 0.0 1.1 4.1 0.0 0.4 0.7 1.9 1.0 1.0 1.1 1.0 0.7 0.5 3.6 0.7 0.0 0.6 0.0 0.2 0.0 0.8 0.8 0.0 18.7 5.7 0.0 3.9 0.2 0.0 0.5 20.4 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 45.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 1.3 1.7 0.0 0.0 48.1 6.6 0.0 0.1 0.0 0.0 0.0 C16orf78 MGC33367 ENSG00000166152 "Chromosome 16 open reading frame 78" Q8WTQ4 16 49373823-49399431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 96 "testis: 30.6" "Group enriched" "Detected in some" 116 "Early spermatids: 327.3;Late spermatids: 1170.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 327.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1170.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.5 0.0 5.9 1.9 0.0 0.0 0.0 0.0 0.0 C16orf86 FLJ41802 ENSG00000159761 "Chromosome 16 open reading frame 86" Q6ZW13 16 67666816-67668758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.9" "Group enriched" "Detected in many" 7 "Early spermatids: 83.1;Spermatocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 7.0;T-47d: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA073475 Enhanced NA NA "HPA073475: AB_2686607" "unprognostic (1.01e-2)" "unprognostic (1.38e-2)" "unprognostic (6.33e-2)" "unprognostic (5.20e-2)" "unprognostic (2.16e-1)" "unprognostic (9.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.87e-2)" "unprognostic (4.05e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.47e-4)" "unprognostic (1.59e-1)" "prognostic favorable (2.12e-7)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "unprognostic (5.92e-2)" "unprognostic (3.05e-1)" 4.6 3.4 2.0 2.9 5.9 1.6 2.6 8.6 4.0 2.5 2.9 2.6 5.8 0.9 3.0 4.2 2.8 2.8 4.7 4.1 1.9 2.3 3.7 3.6 2.4 3.6 2.6 2.1 2.3 1.9 4.6 2.2 2.4 3.9 3.5 1.3 2.6 2.9 3.1 6.7 1.3 1.9 2.6 3.0 3.1 1.6 26.9 3.0 4.5 2.6 1.3 2.2 2.9 1.8 5.9 10.2 4.1 3.3 1.2 2.6 2.5 0.3 1.0 1.4 0.5 2.0 1.8 1.3 1.8 3.6 0.8 1.2 0.1 0.0 0.1 0.9 1.9 0.0 0.2 0.2 0.4 0.3 0.0 0.2 0.2 0.2 0.0 3.7 0.1 1.9 7.0 0.2 1.5 0.2 1.2 1.6 3.0 0.3 4.3 1.8 0.0 0.2 0.9 0.6 0.6 0.0 2.6 0.0 3.0 4.3 0.2 1.0 0.5 0.0 0.0 0.2 0.3 4.4 0.6 0.1 0.2 0.1 0.9 0.1 0.5 1.2 1.2 1.5 0.2 0.3 1.7 3.3 4.1 1.1 1.0 1.8 2.9 2.6 1.5 5.3 5.9 0.9 1.7 1.1 1.2 1.1 10.2 1.8 2.5 2.0 5.9 8.6 4.0 1.9 2.3 2.6 2.1 3.9 3.0 0.0 3.0 8.1 3.0 1.3 7.1 1.4 2.5 0.0 2.3 5.2 5.9 1.1 6.6 2.1 83.1 4.6 0.0 0.0 0.6 0.4 4.3 0.8 11.5 2.9 5.3 4.8 2.9 8.6 4.8 10.7 5.2 3.4 3.3 6.4 0.6 10.4 0.9 0.0 7.1 10.9 7.4 0.0 2.3 77.5 2.7 1.4 0.7 4.4 0.3 0.8 C16orf90 LOC646174 ENSG00000215131 "Chromosome 16 open reading frame 90" A8MZG2 16 3493484-3495480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 111 "testis: 27.8" "Group enriched" "Detected in some" 9 "Early spermatids: 189.7;Late spermatids: 419.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;NTERA-2: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (1.96e-2)" "unprognostic (1.03e-3)" "unprognostic (3.17e-1)" "unprognostic (2.18e-1)" "unprognostic (1.08e-1)" "unprognostic (9.33e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (6.29e-3)" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.7 0.0 1.4 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 0.5 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 189.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 419.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 33.8 2.2 0.0 0.0 0.0 0.0 0.0 C16orf91 "CCSMST1, gs103, URLC5" ENSG00000174109 "Chromosome 16 open reading frame 91" Q4G0I0 16 1419744-1420800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.97e-2)" "unprognostic (4.62e-2)" "unprognostic (4.11e-3)" "unprognostic (6.35e-2)" "unprognostic (2.11e-1)" "unprognostic (2.10e-1)" "unprognostic (5.47e-3)" "unprognostic (5.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.26e-1)" "unprognostic (4.33e-1)" "unprognostic (7.12e-2)" "prognostic favorable (1.11e-4)" "unprognostic (9.81e-3)" "unprognostic (5.67e-2)" "unprognostic (4.19e-2)" "unprognostic (9.97e-2)" 8.5 16.4 11.4 13.5 17.0 7.9 12.3 12.8 21.3 8.3 11.4 5.2 4.4 11.5 8.9 8.5 11.3 11.0 10.9 13.7 11.4 8.1 9.4 13.8 6.4 8.9 9.2 14.8 7.8 12.1 3.0 6.6 10.1 11.5 7.9 9.3 6.8 9.6 12.9 22.8 13.4 10.4 8.4 6.8 9.4 9.0 8.5 9.3 9.1 8.0 15.4 10.5 7.4 11.0 23.9 21.2 15.3 13.6 22.2 21.3 10.6 7.8 17.3 4.6 4.1 9.8 7.7 7.3 7.4 7.6 11.7 10.6 16.8 13.0 8.5 10.2 7.9 9.7 7.9 11.6 10.9 7.5 8.4 16.7 4.8 16.4 11.7 14.2 11.6 7.4 7.7 20.1 13.0 13.2 6.0 10.2 14.4 13.2 9.8 7.1 21.8 8.5 11.2 9.1 13.9 12.7 14.4 5.8 19.7 10.2 4.6 6.2 9.8 9.1 9.1 8.3 4.3 10.9 25.3 7.2 5.9 4.2 4.9 6.3 9.9 9.8 17.1 5.5 8.0 7.0 15.3 13.6 7.1 19.3 13.1 21.1 23.9 18.1 14.4 15.2 18.7 21.3 16.7 6.8 22.2 8.4 21.2 13.3 10.6 11.4 17.0 12.8 21.3 11.4 8.1 9.2 14.8 11.5 9.3 6.0 4.1 14.3 20.0 39.4 12.0 12.8 25.5 29.4 11.4 7.0 11.8 29.0 38.1 17.8 2.9 17.4 15.1 0.0 18.0 21.5 17.4 18.6 15.0 20.2 19.2 12.7 15.0 12.3 11.3 0.5 12.0 12.9 15.1 27.1 20.4 24.3 17.8 14.0 10.6 20.1 21.8 12.9 15.6 17.3 20.3 53.3 30.9 19.1 26.0 25.4 C16orf92 FLJ25404 ENSG00000167194 "Chromosome 16 open reading frame 92" Q96LL3 16 30023334-30027736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.0" "Group enriched" "Detected in some" 27 "Early spermatids: 79.3;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;MCF7: 2.4;NTERA-2: 2.4;RPMI-8226: 3.9;SCLC-21H: 13.1;SH-SY5Y: 3.0" NA NA "unprognostic (2.48e-1)" "unprognostic (4.97e-2)" 0.1 1.8 0.4 0.1 0.2 0.4 0.1 1.2 3.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.3 0.0 2.4 0.5 0.1 2.4 0.0 0.0 0.6 0.1 3.9 0.0 0.0 13.1 3.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.6 0.8 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.4 0.4 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 C16orf95 ENSG00000260456 "Chromosome 16 open reading frame 95" Q9H693 16 87083562-87317420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 47.2" "Group enriched" "Detected in many" 9 "Early spermatids: 56.7;Erythroid cells: 23.3;Late spermatids: 77.4;Sertoli cells: 25.8;Spermatocytes: 52.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA040850, HPA067924" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA040850: AB_10794882, HPA067924: AB_2685924" "unprognostic (3.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-2)" "unprognostic (4.30e-2)" "unprognostic (3.92e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.45e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-1)" "unprognostic (6.71e-2)" "unprognostic (1.79e-1)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.61e-2)" "unprognostic (1.23e-1)" 1.5 1.7 1.7 1.0 2.6 2.2 0.8 1.5 2.0 0.5 1.0 1.5 1.2 1.2 0.7 1.2 0.5 0.8 1.2 1.0 1.7 1.4 1.1 2.6 0.7 0.9 1.9 0.9 0.7 2.1 1.0 0.9 0.5 1.8 0.6 0.6 0.9 1.1 1.2 3.0 0.5 1.2 1.2 1.3 0.7 1.1 47.2 1.1 1.2 0.7 0.6 0.9 0.7 0.4 3.4 6.0 1.1 6.0 1.5 5.7 3.2 3.2 9.1 3.2 3.8 3.7 2.2 5.4 3.0 1.2 3.0 2.3 4.4 5.2 8.1 8.6 0.6 3.3 2.7 2.9 2.0 1.4 3.9 5.3 7.6 3.2 5.9 3.2 0.8 1.5 3.8 0.7 3.4 1.1 1.5 2.8 6.0 6.7 4.1 3.6 8.4 2.8 6.9 2.9 2.0 5.5 6.4 1.4 4.6 1.7 1.3 4.0 3.3 7.4 0.4 2.5 1.2 4.5 3.6 3.3 5.5 2.4 3.2 2.8 12.6 10.2 15.4 7.4 7.6 3.7 0.0 4.9 1.1 4.9 4.8 3.6 3.4 4.3 4.5 4.5 2.9 3.5 5.7 0.8 1.5 6.0 6.0 5.1 3.2 1.7 2.6 1.5 2.0 1.7 1.4 1.9 0.9 1.8 1.1 0.0 1.0 2.2 0.4 1.4 2.3 2.0 2.5 1.4 0.0 0.0 2.0 1.9 1.7 2.8 56.7 0.6 4.9 23.3 3.0 2.7 1.1 0.4 0.0 4.2 2.5 1.6 0.0 2.5 1.5 77.4 3.1 1.6 0.0 3.6 2.5 2.4 3.6 2.9 4.9 2.4 2.0 25.8 0.5 52.2 4.3 0.5 0.9 1.5 5.3 0.3 C17orf107 ENSG00000205710 "Chromosome 17 open reading frame 107" Q6ZR85 17 4899418-4902932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.7;salivary gland: 26.0" "Group enriched" "Detected in many" 11 "Early spermatids: 54.2;Late spermatids: 207.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.5;HMC-1: 7.3;hTCEpi: 6.7" "Not detected" "Not detected" HPA069713 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069713: AB_2686181" "prognostic favorable (5.06e-5)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "unprognostic (1.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-3)" "unprognostic (9.61e-2)" "unprognostic (5.03e-2)" "unprognostic (4.15e-1)" "unprognostic (2.05e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.29e-2)" "unprognostic (2.65e-1)" "unprognostic (2.71e-1)" "unprognostic (3.12e-1)" 2.4 3.7 5.0 2.3 5.1 4.2 3.0 7.7 8.7 3.9 1.4 0.2 5.9 2.1 1.9 5.9 1.3 1.8 3.3 15.3 3.8 4.3 2.2 8.8 2.9 1.0 1.6 4.2 6.4 7.7 6.2 25.7 1.5 1.7 4.5 0.9 2.1 26.0 6.4 0.6 3.3 1.6 1.2 2.2 2.1 4.6 4.7 0.6 0.1 1.9 0.6 2.7 3.3 1.9 0.0 0.0 6.7 0.2 0.0 0.9 0.1 0.7 0.8 1.0 0.3 2.2 1.7 1.5 3.9 0.5 0.2 0.6 0.7 0.7 0.4 0.6 5.5 0.0 1.4 0.1 0.5 0.3 0.1 0.8 2.1 0.6 0.8 3.1 0.0 7.3 1.8 6.7 0.1 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.7 0.1 0.6 0.3 1.9 0.8 0.3 0.2 2.9 0.3 0.3 0.1 0.5 0.6 2.3 0.3 0.5 0.7 1.1 0.5 0.3 0.7 0.6 0.5 0.6 0.6 0.1 0.5 0.1 0.3 0.0 0.2 0.8 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.8 6.7 0.0 0.1 0.0 0.0 0.1 5.0 5.1 7.7 8.7 3.8 4.3 1.6 4.2 1.7 0.6 0.0 2.2 0.9 2.5 1.5 0.5 12.3 0.0 0.0 1.2 0.0 0.0 0.3 1.7 0.3 54.2 0.7 0.0 0.0 1.1 1.6 2.2 2.2 11.5 3.4 0.9 4.8 0.0 0.6 1.5 207.3 1.4 4.3 1.7 0.0 1.6 0.0 0.8 0.0 1.1 1.6 0.6 0.0 3.1 1.0 1.1 1.1 4.3 0.7 0.2 0.9 C17orf47 FLJ40121 ENSG00000181013 "Chromosome 17 open reading frame 47" Q8NEP4 17 58541587-58544368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 26.7" "Group enriched" "Detected in some" 57 "Early spermatids: 7.5;Late spermatids: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;hTERT-RPE1: 1.1;Karpas-707: 1.5;MCF7: 2.6;SCLC-21H: 1.5;T-47d: 1.6" HPA028424 Uncertain NA NA "HPA028424: AB_10601690" "unprognostic (4.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (2.65e-1)" "unprognostic (4.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.62e-3)" "unprognostic (4.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.62e-8)" "unprognostic (9.29e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-3)" "unprognostic (3.37e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.3 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.3 26.7 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.4 0.0 1.5 0.0 2.6 0.0 0.1 0.1 0.3 0.3 0.2 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.2 0.0 0.4 1.6 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760897-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 63.6" "Group enriched" "Detected in some" 88 "Early spermatids: 590.0;Late spermatids: 956.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "HaCaT: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA043184, HPA063464" Supported Nucleoplasm Yes NA Nucleoplasm "HPA043184: AB_2678358, HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.5 0.0 0.6 0.2 3.7 0.6 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.6 0.0 0.3 0.0 0.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 1.9 2.3 2.0 1.2 0.0 1.9 3.5 3.7 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 590.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 956.8 7.8 0.0 0.0 0.0 0.6 1.0 0.0 0.0 5.3 0.5 0.0 6.5 0.0 8.4 6.1 0.0 0.0 0.0 0.6 0.1 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Early spermatids: 18.9;Horizontal cells: 23.8;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: AB_2681728" "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.2 2.3 8.0 7.4 7.0 2.2 7.2 3.6 5.2 6.0 12.2 0.4 3.5 4.1 3.9 6.4 0.3 9.9 3.8 8.7 11.1 15.4 0.7 5.7 5.1 13.8 0.9 3.9 6.6 3.4 10.6 11.6 1.9 3.7 9.5 1.9 0.8 4.4 0.0 7.7 0.4 4.4 3.3 5.2 7.5 4.9 0.5 1.9 0.5 5.2 0.9 6.7 0.2 5.3 8.7 0.1 0.3 6.7 6.2 6.3 14.7 8.6 2.3 2.8 13.7 7.4 1.3 7.2 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 0.0 0.6 1.5 4.4 4.4 20.9 3.3 0.0 4.0 2.3 1.8 15.7 0.4 5.0 1.8 18.9 2.8 0.0 0.0 3.1 1.5 6.1 2.9 0.0 2.6 1.1 23.8 1.2 1.3 0.3 11.5 5.8 1.3 5.0 0.0 1.3 5.2 1.6 0.0 7.8 2.1 28.0 0.0 7.9 13.0 6.5 1.9 0.2 0.9 0.9 1.2 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell type enhanced" "Detected in some" 30 "Early spermatids: 846.4;Late spermatids: 397.1;Spermatocytes: 173.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.4;MCF7: 11.0;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.0 0.0 0.6 0.7 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.6 0.0 11.0 0.3 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.7 0.3 0.0 0.1 0.1 0.0 1.7 1.3 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 846.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 397.1 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 173.7 15.3 0.1 0.0 0.0 0.0 0.0 C17orf78 FLJ39647 ENSG00000278505 "Chromosome 17 open reading frame 78" Q8N4C9 17 37375986-37392708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 401 "intestine: 83.8" "Cell type enhanced" "Detected in some" 14 "Late spermatids: 1.5;Spermatocytes: 1.4" "Group enriched" "Detected in some" 8 "colorectal cancer: 0.8;stomach cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;NB-4: 1.6;RPMI-8226: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.73e-3)" "unprognostic (1.91e-1)" "unprognostic (8.98e-2)" "unprognostic (4.90e-3)" "unprognostic (5.31e-2)" "unprognostic (7.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.02e-1)" "unprognostic (7.62e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (5.53e-6)" "unprognostic (1.94e-2)" "unprognostic (7.23e-3)" "unprognostic (4.85e-2)" "unprognostic (3.19e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.2 0.0 1.6 0.2 0.0 0.3 0.2 0.1 1.5 0.1 0.0 0.9 0.7 0.2 0.0 0.2 0.0 0.3 0.0 0.3 0.1 0.1 0.8 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 128.4;Late spermatids: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.9 10.5 14.6 8.9 10.7 9.2 14.2 13.1 11.4 18.6 17.7 9.9 8.2 18.9 9.3 6.7 12.7 10.0 20.2 7.5 21.8 6.8 13.7 17.4 11.0 11.6 9.4 18.3 10.3 7.2 9.4 12.3 10.2 9.3 15.9 12.8 18.7 11.3 12.3 5.7 21.1 8.7 11.5 11.0 11.3 12.8 40.2 9.6 9.7 7.5 17.9 16.1 6.9 12.8 15.2 24.1 14.0 11.5 8.7 19.5 18.0 6.3 12.4 12.9 15.3 18.3 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 6.0 10.8 3.4 1.6 4.4 8.2 17.9 7.6 25.4 11.4 5.2 19.6 7.3 8.3 4.8 128.4 7.1 5.1 0.0 3.4 4.8 4.1 1.7 7.0 3.9 4.1 7.9 5.2 4.3 5.3 75.5 4.9 5.4 1.7 5.4 3.0 9.8 4.2 4.0 7.1 5.3 14.7 0.0 4.7 23.5 12.3 3.9 14.1 4.1 4.4 1.3 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410327-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.2" "Group enriched" "Detected in many" 11 "Early spermatids: 432.9;Late spermatids: 984.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 8.9;U-2197: 11.8" HPA023583 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 4.9 6.0 2.4 10.6 1.9 2.7 5.2 8.7 3.9 3.6 4.2 4.4 2.2 3.5 4.5 2.4 13.6 6.6 3.8 5.2 6.1 7.6 1.9 3.8 2.8 4.0 7.6 3.8 3.8 3.4 8.2 1.4 6.2 3.3 2.9 4.2 3.5 5.8 4.3 2.5 4.7 1.9 2.8 2.1 2.4 53.2 2.9 5.0 6.9 1.8 1.9 3.1 1.8 0.4 0.9 2.7 0.4 0.8 1.4 0.2 2.6 3.8 1.8 2.2 1.0 0.8 0.9 2.0 1.3 1.5 0.9 0.1 4.0 0.7 1.5 4.3 1.2 8.9 4.8 1.0 1.4 0.3 0.6 1.9 3.3 0.3 3.4 0.4 0.8 1.0 2.5 3.3 0.4 2.2 1.5 4.4 0.3 0.1 1.0 2.2 6.4 3.4 2.8 7.9 1.2 0.7 0.4 2.4 6.2 2.2 0.6 2.1 2.4 3.4 0.5 3.2 2.0 2.9 1.4 1.8 0.9 11.8 0.8 0.2 0.2 0.0 2.3 0.9 1.1 0.4 0.4 2.7 0.3 0.2 0.0 0.2 0.2 0.8 0.5 0.4 1.4 1.3 0.2 0.8 0.4 0.9 0.0 0.2 6.0 10.6 5.2 8.7 5.2 6.1 4.0 7.6 6.2 2.9 3.0 5.1 0.0 3.8 3.0 4.3 5.3 10.2 62.9 11.4 19.2 19.6 0.9 53.0 10.2 432.9 1.8 10.5 23.3 3.1 0.2 3.7 3.9 2.3 4.7 1.7 1.6 15.4 1.8 0.0 984.3 7.8 2.5 3.3 4.6 9.3 10.0 4.7 5.8 6.0 19.3 22.2 6.5 2.1 58.4 13.3 0.9 0.7 0.0 8.5 0.9 C18orf63 DKFZP781G0119 ENSG00000206043 "Chromosome 18 open reading frame 63" Q68DL7 18 74315813-74359187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 17.4" "Cell type enriched" "Detected in some" 14 "Spermatocytes: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.1" "Not detected" "Not detected" HPA042233 Approved Mitochondria NA NA Mitochondria "HPA042233: AB_10960843" "unprognostic (1.40e-1)" "unprognostic (1.43e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 47.2 3.4 0.0 0.0 0.0 0.0 0.0 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 22.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 83.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 4.6;HEK 293: 6.6;RT4: 4.4" "HPA014527, HPA079195" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014527: AB_1845612, HPA079195: " "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favorable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.1 1.7 1.4 1.1 1.8 0.4 3.6 1.1 1.1 1.1 1.3 1.1 1.1 0.8 1.4 5.6 1.1 1.8 1.4 4.2 1.9 1.8 1.1 1.1 1.1 1.1 2.1 1.1 1.3 1.1 1.0 3.6 1.1 3.1 2.7 0.8 1.1 1.2 1.6 4.2 1.2 1.1 1.1 2.3 1.1 0.8 22.6 1.1 1.1 1.3 1.1 1.1 1.1 1.1 2.8 1.6 0.7 0.9 0.8 1.2 0.4 0.2 0.0 1.9 4.6 1.1 1.5 1.4 2.2 0.5 0.6 1.4 0.0 0.4 0.5 1.0 0.6 0.5 0.1 0.1 0.0 1.5 0.0 6.6 0.4 0.0 1.5 1.7 0.0 1.1 1.8 2.7 0.1 0.4 1.6 0.3 1.0 0.2 0.0 3.3 0.0 0.9 0.0 0.1 0.0 0.4 1.3 0.0 1.2 1.1 4.4 2.0 0.5 0.9 0.0 0.6 1.5 1.6 1.5 0.9 0.3 0.5 0.6 0.5 0.9 3.9 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.1 0.2 0.0 2.8 1.0 0.6 1.6 1.3 0.6 1.2 0.5 0.8 0.9 1.0 0.0 0.4 1.4 1.8 1.1 1.1 1.9 1.8 2.1 1.1 3.1 1.1 3.0 2.1 0.0 0.4 0.3 0.5 3.2 0.0 2.7 2.3 0.0 0.0 0.3 0.0 1.7 83.6 1.0 0.4 0.0 0.2 0.5 0.8 0.5 0.0 1.3 0.4 0.0 0.0 3.7 1.0 16.0 2.0 0.0 1.7 1.0 1.8 1.8 0.7 0.0 0.7 0.2 2.8 6.5 1.2 3.5 2.2 0.5 0.2 0.0 1.1 0.3 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell type enhanced" "Detected in many" 18 "Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Cell line enriched" "Detected in some" 4 "U-937: 32.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.5 0.8 0.1 0.2 0.0 0.3 0.6 0.1 0.2 3.8 0.3 0.0 0.1 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.5 0.4 4.1 0.4 0.7 0.2 0.1 0.1 0.4 0.2 8.1 0.1 1.4 0.1 5.9 0.3 0.2 0.3 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.8 0.0 0.6 0.1 0.1 5.6 0.0 0.0 0.0 0.7 0.0 4.9 2.3 1.1 0.0 32.8 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 0.0 2.6 12.3 0.3 0.7 0.0 0.6 0.0 2.7 1.2 1.8 2.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 1.1 0.6 1.1 0.4 2.3 0.9 21.2 0.0 0.0 0.0 101.9 5.3 0.9 32.6 1.7 24.4 0.5 2.3 0.2 3.5 0.7 0.4 1.0 6.5 0.1 27.0 15.8 0.6 0.6 0.8 0.3 0.6 C19orf85 ENSG00000283567 "Chromosome 19 open reading frame 85" 19 55463002-55464707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lung: 1.7;seminal vesicle: 1.3;testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 15.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Group enriched" "Detected in some" 119 "Early spermatids: 1095.9;Late spermatids: 535.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "K-562: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1095.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 535.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 0.0 0.0 0.0 C1orf115 FLJ14146 ENSG00000162817 "Chromosome 1 open reading frame 115" Q9H7X2 1 220689845-220699157 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 32.9;intestine: 32.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 168.2;Hepatocytes: 103.9;Syncytiotrophoblasts: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6" "Lineage enhanced" "Detected in single" "B-cells: 3.6" "Cell line enhanced" "Detected in many" "Hep G2: 23.6;HUVEC TERT2: 19.4;TIME: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (5.16e-2)" "prognostic favorable (6.52e-4)" "unprognostic (1.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.03e-1)" "unprognostic (5.69e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.12e-5)" "unprognostic (3.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.74e-2)" "unprognostic (4.24e-1)" "unprognostic (4.54e-2)" "unprognostic (9.21e-3)" "unprognostic (1.07e-1)" 12.4 1.6 16.2 3.2 27.0 0.0 8.9 3.1 32.9 3.9 8.1 2.1 2.4 30.6 3.1 5.8 2.9 3.8 4.6 4.7 9.6 2.9 14.4 27.6 6.2 1.7 2.5 17.8 4.9 3.9 8.5 6.2 19.0 5.7 8.6 6.2 3.3 20.2 2.8 3.3 2.6 32.1 3.2 1.1 12.7 5.5 2.8 3.7 1.0 5.5 1.1 2.2 2.1 2.3 3.6 0.2 0.0 0.6 0.0 0.9 0.3 0.6 2.8 0.1 4.0 0.0 0.0 11.5 0.8 3.1 1.6 7.3 2.8 2.9 0.0 1.2 0.2 3.4 0.1 6.6 1.3 1.5 0.0 6.6 0.1 0.6 23.6 3.8 0.0 0.1 0.5 2.2 0.1 0.8 0.0 19.4 0.0 1.7 0.0 0.1 2.5 0.0 0.1 4.8 7.8 2.0 0.0 0.0 0.2 3.5 3.7 2.1 2.9 0.0 4.8 11.6 7.3 7.9 0.1 36.2 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.8 0.0 0.3 1.9 0.9 0.2 0.2 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 16.2 27.0 3.1 32.9 9.6 2.9 2.5 17.8 5.7 3.7 3.0 7.0 9.9 3.4 3.1 11.4 12.2 10.2 1.4 5.7 29.6 5.9 57.1 33.2 10.0 1.1 33.7 168.2 0.0 14.6 51.0 2.4 13.3 0.0 103.9 5.6 0.0 8.1 11.1 4.7 1.9 2.8 1.1 8.5 7.2 22.1 5.6 13.2 46.0 18.0 52.2 3.9 0.0 3.1 0.3 3.9 1.5 153.8 0.5 13.3 2.1 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 14.9;fallopian tube: 12.8;testis: 18.7" "Group enriched" "Detected in some" 4 "Ciliated cells: 84.3;Early spermatids: 83.3;Late spermatids: 78.9;Muller glia cells: 34.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 14.9" "Group enriched" "Detected in some" 5 "basophil: 2.5;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Cell line enriched" "Detected in single" 37 "HEL: 18.1" "Low region specificity" "Detected in all" HPA035316 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.1 1.3 0.3 0.1 1.9 0.0 0.0 0.1 1.1 0.0 12.8 0.2 0.0 2.6 1.8 0.1 0.1 2.0 0.1 0.3 0.7 1.8 0.0 0.0 1.0 0.0 14.9 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 18.7 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 2.5 0.1 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 18.1 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.5 1.1 2.6 0.1 1.3 2.6 1.8 0.3 0.7 14.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 84.3 15.9 0.0 0.0 0.0 0.0 0.0 83.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 78.9 1.7 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.7 0.0 1.3 0.0 0.0 6.0 0.7 0.0 0.1 0.0 0.0 0.0 C1orf146 ENSG00000203910 "Chromosome 1 open reading frame 146" Q5VVC0 1 92217940-92245813 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 12.7" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (2.89e-2)" "unprognostic (4.26e-3)" "unprognostic (1.81e-1)" "unprognostic (5.37e-3)" "unprognostic (8.77e-2)" "unprognostic (1.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" "unprognostic (1.90e-1)" "unprognostic (7.13e-2)" "unprognostic (4.17e-2)" "unprognostic (2.78e-7)" "unprognostic (3.36e-2)" "unprognostic (6.76e-2)" "unprognostic (3.17e-1)" "unprognostic (5.19e-3)" 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 1.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 12.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.5 0.5 2.6 0.1 0.7 0.5 0.0 0.4 0.0 0.9 2.3 0.0 0.5 1.1 0.3 0.0 0.6 0.7 0.0 1.2 2.1 0.3 0.0 0.1 0.8 0.3 0.0 0.0 0.5 1.0 0.9 0.7 0.0 0.0 0.7 1.9 0.5 0.3 0.9 0.0 0.6 0.3 1.7 0.0 0.8 0.0 1.3 1.1 1.7 0.7 0.1 0.0 0.6 0.2 0.3 0.0 1.6 0.7 0.1 0.4 1.2 0.0 1.4 0.2 1.2 1.0 1.2 0.9 1.0 0.9 1.9 0.4 0.9 0.5 1.0 0.5 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.2 0.4 0.1 0.5 0.3 0.2 2.6 0.7 0.1 0.5 0.0 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 7.5 0.0 0.0 0.0 0.0 0.0 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746215-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 23.5;testis: 74.6" "Group enriched" "Detected in some" 13 "Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Region enhanced" "Detected in many" "pons and medulla: 9.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.7 0.0 2.4 0.3 0.0 0.0 0.2 0.9 0.0 6.2 0.0 0.0 0.4 4.2 0.1 23.5 0.1 0.0 1.0 1.4 0.0 0.0 2.8 0.1 0.2 0.1 4.8 0.1 0.0 0.4 0.1 9.3 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.2 0.1 0.1 74.6 0.9 0.0 0.5 0.0 0.1 0.0 0.0 0.9 0.6 2.3 0.6 1.1 0.8 0.1 0.5 1.3 1.1 0.7 0.6 0.0 1.0 0.1 0.3 0.2 0.2 1.3 0.7 1.1 0.3 0.3 0.4 0.4 0.1 0.1 0.2 0.2 0.7 1.1 1.9 0.5 0.0 0.9 1.0 0.1 0.7 0.3 0.1 0.4 0.1 0.5 0.9 1.4 0.3 0.5 0.2 0.7 1.5 0.3 0.5 0.6 0.3 0.9 0.1 0.5 1.9 0.8 0.5 0.6 0.3 1.4 0.7 0.2 0.5 0.5 0.8 0.4 0.8 0.6 0.5 1.2 1.0 1.1 0.5 1.6 0.6 0.5 0.7 0.5 0.6 0.5 0.5 0.5 0.1 0.9 0.8 0.7 2.3 1.1 0.6 0.6 0.4 0.1 0.7 2.4 0.0 0.2 1.0 1.4 0.2 0.1 9.3 0.9 3.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 105.7 7.9 0.0 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 65.2 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 7.9 1.3 0.0 0.0 0.0 0.0 0.1 C1orf159 FLJ20584 ENSG00000131591 "Chromosome 1 open reading frame 159" Q96HA4 1 1081818-1116361 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 48.9;Late spermatids: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA010019, HPA075399" Approved Approved "Nucleoli rim,Mitotic chromosome,Intermediate filaments" Yes No "Nucleoli rim, Mitotic chromosome, Intermediate filaments" "HPA010019: AB_1078885, HPA075399: " "unprognostic (2.79e-1)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (9.58e-6)" "unprognostic (1.34e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" "unprognostic (9.29e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (1.77e-6)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.62e-4)" 3.7 6.6 8.3 4.9 9.0 5.6 3.1 7.6 10.0 5.5 6.0 11.3 5.4 6.1 6.0 6.9 6.6 4.0 5.9 3.8 8.8 5.8 5.0 5.0 5.6 4.2 6.6 4.9 5.8 5.3 2.2 4.4 5.6 5.0 6.6 1.8 5.8 10.2 6.5 3.6 23.7 5.5 7.5 5.2 7.0 9.0 17.5 5.6 5.2 4.0 5.2 6.4 5.4 4.4 5.0 4.3 9.9 4.9 4.7 5.7 3.9 11.9 9.7 4.5 7.8 1.4 1.4 10.2 6.8 1.6 6.2 4.1 5.2 12.6 3.4 8.4 2.1 5.0 9.9 1.9 6.3 1.8 6.4 14.1 2.3 16.6 5.4 2.9 4.0 5.6 3.1 3.0 3.2 1.2 1.9 3.0 5.5 13.8 2.7 2.2 9.2 7.4 10.2 4.1 4.5 15.6 9.2 5.3 6.2 3.6 4.3 9.4 12.5 5.3 9.5 5.4 1.4 6.6 5.2 5.0 6.7 7.1 9.8 7.0 4.5 6.1 6.0 5.8 10.9 5.4 9.9 4.9 2.6 5.3 4.4 5.4 5.0 4.9 5.7 3.2 4.7 5.3 5.0 1.1 4.7 3.1 4.3 1.7 3.9 8.3 9.0 7.6 10.0 8.8 5.8 6.6 4.9 5.0 5.6 0.0 10.6 1.5 3.4 6.6 6.2 1.8 5.1 9.4 5.7 8.7 3.9 4.7 1.7 7.6 48.9 3.6 5.1 23.3 5.9 11.7 5.0 4.2 5.7 4.7 3.6 12.7 4.1 1.8 1.8 101.9 2.6 2.7 3.3 8.2 7.0 3.0 6.1 2.9 1.4 1.1 7.4 0.0 4.1 11.2 6.6 6.0 4.1 3.8 6.9 4.4 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.1;lymphoid tissue: 86.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7" HPA026988 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 39.8 9.3 9.2 25.1 17.9 37.5 20.1 4.6 9.3 5.2 6.3 4.9 0.8 2.7 5.4 7.4 4.9 10.2 11.7 14.8 13.4 4.7 17.3 14.8 40.1 86.6 17.5 1.9 5.8 4.5 1.3 9.7 5.6 15.3 5.0 6.9 5.0 5.9 2.5 7.2 3.6 8.3 13.5 31.0 78.1 5.8 6.1 13.9 10.6 6.2 1.1 20.0 7.2 6.7 24.7 83.3 98.7 119.1 40.1 27.8 74.8 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 45.4 0.1 0.1 0.1 0.0 0.2 22.1 3.7 0.0 0.9 0.3 0.3 0.3 0.6 0.2 0.2 0.1 0.1 0.1 0.1 12.3 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.1 17.5 0.0 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.1 36.7 0.5 68.4 82.5 98.7 14.2 119.1 4.1 17.5 17.7 8.2 83.3 24.7 27.8 16.8 11.4 40.1 86.3 24.9 5.0 74.8 9.2 17.9 4.6 9.3 13.4 4.7 17.5 1.9 15.3 13.9 20.8 66.7 71.8 0.5 7.0 3.7 3.1 12.7 1.4 7.9 7.0 2.0 1.1 0.0 0.2 33.3 3.7 0.6 0.0 0.2 1.2 5.8 0.7 175.8 6.4 198.4 0.0 1.7 17.8 675.1 60.1 2.6 367.2 11.8 1.0 0.0 0.3 0.2 0.0 0.7 0.6 3.9 32.3 4.2 1.8 1.7 5.6 1.4 95.6 0.6 0.3 C1orf167 "DKFZp434E1410, RP11-56N19.2" ENSG00000215910 "Chromosome 1 open reading frame 167" Q5SNV9 1 11761787-11789585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "testis: 34.0" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Early spermatids: 12.6;Late spermatids: 13.2;Spermatocytes: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 52 "U-698: 26.4" HPA039114 Enhanced NA NA "HPA039114: AB_10673606" "unprognostic (2.93e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-3)" "unprognostic (3.96e-1)" "unprognostic (2.38e-4)" "unprognostic (2.71e-1)" "unprognostic (5.55e-3)" "unprognostic (3.92e-2)" "unprognostic (5.10e-2)" "unprognostic (4.90e-3)" "unprognostic (3.96e-2)" "unprognostic (8.38e-5)" "unprognostic (5.46e-4)" "unprognostic (1.52e-1)" "unprognostic (2.71e-1)" "unprognostic (2.38e-2)" 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.1 34.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.9 1.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.8 1.6 0.0 1.1 1.0 0.6 0.4 0.0 0.0 1.2 3.5 0.0 0.5 1.7 0.9 12.6 1.0 0.7 0.0 7.3 0.2 4.1 1.8 0.0 0.0 0.4 4.8 0.0 4.9 0.8 13.2 5.8 0.3 0.0 0.0 0.0 0.3 3.6 2.9 3.5 3.7 0.3 0.0 4.1 14.1 3.4 1.5 0.2 0.0 0.0 3.1 C1orf185 FLJ27485 ENSG00000204006 "Chromosome 1 open reading frame 185" Q5T7R7 1 51102234-51148086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 23.8" "Cell type enriched" "Detected in some" 14 "Early spermatids: 474.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 1.1;THP-1: 1.2" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 474.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Group enriched" "Detected in some" 10 "Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 6.3 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 0.0 2.6 0.0 0.2 0.0 0.6 2.0 0.0 776.3 56.9 0.0 0.0 0.0 0.0 0.0 1757.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2679.4 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 17.7 0.0 0.0 6.5 0.0 176.3 13.0 0.1 0.0 0.0 0.0 0.0 C1orf228 "MGC33556, NCRNA00082, p40" ENSG00000198520 "Chromosome 1 open reading frame 228" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.0;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.9 2.2 6.3 0.7 11.2 4.3 1.5 3.2 6.8 1.7 1.0 5.6 3.9 0.7 3.1 6.8 1.3 14.0 1.5 0.6 6.5 2.4 1.4 7.0 2.0 1.5 1.4 7.5 4.5 1.4 3.0 5.4 0.8 7.7 1.8 0.9 3.3 1.6 1.4 0.5 1.7 0.8 0.9 2.4 0.8 1.4 17.9 5.4 0.2 1.3 0.0 1.0 0.8 0.8 1.4 6.2 10.4 2.7 0.5 2.3 1.8 0.2 0.3 2.0 0.1 0.7 2.6 0.5 0.0 0.3 0.5 0.3 0.5 4.3 0.3 0.3 0.9 1.0 0.5 0.0 0.0 0.0 1.1 0.2 1.0 2.6 0.6 0.2 8.6 5.1 2.0 0.3 0.8 0.0 1.5 0.2 0.3 0.1 0.8 0.2 0.1 7.1 10.1 0.1 0.6 0.1 3.7 0.2 2.4 0.9 0.0 1.4 0.9 0.0 1.4 1.1 1.4 0.4 4.5 0.0 0.3 0.3 0.4 0.0 0.3 0.3 0.2 0.3 13.7 0.4 10.4 2.7 7.5 0.3 0.8 0.1 0.7 1.5 1.0 1.3 1.4 2.2 2.3 1.2 0.5 0.1 6.2 0.1 1.8 6.3 11.2 3.2 6.8 6.5 2.4 1.4 7.5 7.7 5.4 6.0 5.0 14.5 0.4 0.7 1.1 0.0 0.0 46.8 9.1 0.0 11.8 0.3 0.0 0.0 45.0 0.0 0.3 0.0 0.0 0.1 0.7 0.4 81.7 3.2 10.7 1.6 9.8 0.0 15.0 39.8 0.3 6.1 0.0 0.0 0.6 6.1 0.0 0.0 0.7 0.0 4.3 6.5 0.3 2.3 14.3 0.6 0.1 1.0 0.6 0.1 C1orf43 "DKFZp586G1722, NICE-3" ENSG00000143612 "Chromosome 1 open reading frame 43" Q9BWL3 1 154206706-154220637 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010725 Approved NA NA "HPA010725: AB_1078341" "unprognostic (3.90e-2)" "unprognostic (1.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.87e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.72e-1)" "unprognostic (2.78e-1)" "unprognostic (2.64e-2)" "unprognostic (3.51e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" 36.4 36.5 45.5 20.4 47.7 20.7 43.4 36.0 43.5 29.0 33.7 36.2 28.0 34.9 23.1 36.7 30.9 30.9 31.8 53.5 39.9 35.2 55.5 80.2 30.5 27.6 48.4 29.4 23.4 68.9 28.8 24.2 25.1 31.1 29.8 37.2 25.2 31.0 29.0 124.2 27.0 36.6 27.4 46.1 27.0 30.1 19.5 33.8 22.0 38.4 49.0 28.4 32.7 29.0 29.2 59.0 39.0 56.1 21.2 41.6 56.4 29.2 31.3 26.3 31.0 39.4 39.7 16.3 29.5 51.2 34.4 32.1 21.4 41.7 38.8 45.0 26.5 29.9 30.0 36.1 26.7 24.8 30.5 39.9 29.8 34.8 27.7 61.4 37.4 35.6 32.2 63.6 36.5 76.3 47.0 39.7 43.4 31.3 36.9 44.6 46.8 28.1 34.3 50.7 66.9 48.0 25.8 24.2 70.0 42.9 31.0 42.9 56.5 26.6 71.0 99.6 31.7 70.1 83.1 27.0 26.9 22.6 32.2 37.1 68.1 66.2 37.0 45.0 37.7 71.5 39.0 56.1 35.7 25.4 50.4 30.5 29.2 29.6 27.7 59.0 25.6 31.3 26.1 32.2 21.2 45.3 43.6 41.6 56.4 45.5 47.7 36.0 43.5 39.9 35.2 48.4 29.4 31.1 33.8 107.2 81.5 107.4 106.1 83.7 119.7 121.4 99.3 81.7 92.1 68.0 27.5 74.2 213.9 137.1 214.9 101.4 115.5 23.3 177.2 103.3 70.6 146.8 60.1 134.8 162.0 55.6 117.1 78.0 135.6 130.5 60.1 121.7 118.1 155.1 116.8 73.7 139.3 133.6 70.4 192.0 62.3 71.1 86.3 64.5 69.8 88.0 105.5 73.4 115.3 130.8 C1orf54 FLJ23221 ENSG00000118292 "Chromosome 1 open reading frame 54" Q8WWF1 1 150268200-150280916 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "myeloid DC: 36.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 36.2" "Cell line enhanced" "Detected in many" "AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2" "Low region specificity" "Detected in all" "HPA026518, HPA043874" Approved Approved "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "HPA026518: AB_1845647, HPA043874: AB_2732511" "unprognostic (4.64e-3)" "unprognostic (6.81e-3)" "unprognostic (4.01e-3)" "unprognostic (5.69e-3)" "unprognostic (2.22e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-2)" "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.16e-2)" "unprognostic (8.06e-2)" "unprognostic (1.33e-2)" "unprognostic (4.48e-2)" 16.0 8.8 16.4 19.0 19.3 4.5 13.8 5.8 10.5 11.9 14.0 4.5 19.1 5.8 19.8 21.1 11.0 17.1 21.6 13.8 13.7 13.7 12.7 12.0 11.8 21.5 21.8 8.3 8.3 6.8 2.0 6.7 24.4 14.0 15.3 11.1 10.9 9.8 30.4 13.4 4.5 8.1 24.1 20.4 27.3 8.3 5.7 14.8 4.9 8.3 17.1 11.2 22.0 14.3 0.3 36.2 0.4 7.7 0.2 1.5 2.2 0.5 0.1 20.9 31.6 22.4 37.5 0.6 3.4 5.0 0.9 3.0 0.2 0.6 0.2 1.1 3.0 0.4 0.9 0.0 0.1 1.1 0.3 3.7 0.6 0.5 0.3 4.6 1.1 0.8 30.3 1.5 6.3 0.5 3.7 29.2 0.5 0.4 4.1 3.2 1.2 0.2 7.2 1.7 0.0 1.1 5.2 0.5 0.4 0.3 1.6 0.4 0.4 0.4 0.2 2.3 4.2 0.4 15.8 0.2 7.5 0.6 0.2 0.3 1.7 1.4 0.3 16.6 0.9 0.2 0.0 7.7 0.3 0.2 6.8 0.9 0.3 1.5 0.6 36.2 0.3 1.5 0.8 0.4 0.2 1.9 0.7 0.6 2.2 16.4 19.3 5.8 10.5 13.7 13.7 21.8 8.3 14.0 14.8 3.0 5.0 2.4 2.0 5.7 0.8 6.2 2.5 0.0 2.3 21.0 0.0 1.0 64.6 0.5 7.4 64.6 2.1 0.0 2.0 0.7 22.1 1.8 1.1 0.8 45.5 0.0 1.2 49.1 98.9 15.7 88.1 71.5 11.8 20.8 1.1 11.1 1.5 0.8 97.9 2.6 1.3 32.3 69.0 16.6 1.3 4.4 3.0 2.5 1.2 5.5 C1orf56 "FLJ20519, MENT" ENSG00000143443 "Chromosome 1 open reading frame 56" Q9BUN1 1 151047740-151051986 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 54.8;testis: 67.7" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 336.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037429, HPA037430" Enhanced "Secreted to blood" NA NA 90000000 "HPA037429: AB_10671755, HPA037430: AB_2675473" "unprognostic (7.60e-2)" "unprognostic (8.26e-2)" "unprognostic (1.09e-2)" "unprognostic (3.83e-1)" "unprognostic (4.31e-2)" "unprognostic (2.83e-2)" "unprognostic (1.11e-2)" "unprognostic (3.81e-3)" "unprognostic (1.59e-2)" "unprognostic (2.70e-3)" "unprognostic (3.28e-3)" "unprognostic (5.29e-2)" "unprognostic (3.61e-2)" "unprognostic (3.61e-2)" "unprognostic (6.16e-2)" "unprognostic (2.26e-1)" "unprognostic (4.79e-2)" 3.3 6.4 2.9 2.0 3.6 0.9 3.1 3.8 3.5 3.7 2.7 5.2 5.1 2.9 3.4 5.6 3.1 4.3 4.6 5.6 3.1 2.1 4.0 6.4 2.6 2.8 3.3 2.0 4.8 7.0 3.9 6.3 3.0 3.4 4.7 1.2 4.3 6.5 6.4 4.0 3.3 2.0 3.8 2.3 2.7 3.1 67.7 3.8 0.7 7.1 1.2 1.7 3.3 3.0 16.3 7.8 54.8 15.4 15.5 28.4 1.0 4.0 8.1 2.8 1.3 4.8 4.7 2.6 2.3 3.4 1.5 1.2 3.5 5.8 0.9 3.7 2.5 3.2 5.5 1.6 0.3 0.8 5.2 1.8 1.0 6.4 4.3 3.3 1.1 0.8 3.4 1.8 2.3 0.8 2.9 2.2 1.8 2.1 2.1 1.3 15.8 1.5 2.8 4.7 3.2 4.6 1.3 2.8 2.9 1.2 2.3 3.8 7.4 7.4 3.8 5.3 5.6 7.5 3.0 2.3 2.0 3.6 5.3 2.0 5.0 3.9 12.7 3.8 0.6 2.5 54.8 7.3 13.7 27.8 15.4 20.8 14.2 24.2 24.2 5.5 16.3 20.6 28.4 20.2 15.5 12.7 7.8 13.7 1.0 2.9 3.6 3.8 3.5 3.1 2.1 3.3 2.0 3.4 3.8 6.0 8.5 68.1 31.4 57.5 18.6 7.0 48.4 6.7 10.3 40.1 19.6 38.8 33.2 18.8 336.7 30.8 8.0 46.7 12.8 26.9 47.4 29.5 39.1 34.7 28.3 17.5 14.3 63.3 73.4 44.3 26.4 65.6 84.4 83.0 12.5 13.8 26.2 17.5 24.1 24.8 24.2 25.8 37.6 148.7 13.6 72.8 74.8 126.9 12.0 45.1 C1orf61 CROC4 ENSG00000125462 "Chromosome 1 open reading frame 61" Q13536 1 156404250-156430701 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 29 "brain: 184.8" "Group enriched" "Detected in some" 7 "Late spermatids: 222.1;Muller glia cells: 843.1" "Cancer enriched" "Detected in some" 116 "glioma: 77.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 6.3;MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 34 "T-cells: 6.3" "Cell line enriched" "Detected in some" 6 "BEWO: 17.3" NA NA "unprognostic (6.20e-2)" "unprognostic (2.46e-3)" "unprognostic (3.32e-1)" "unprognostic (1.28e-1)" "unprognostic (7.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.35e-2)" "unprognostic (9.00e-2)" "unprognostic (1.75e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-2)" "unprognostic (3.64e-2)" "unprognostic (8.16e-7)" "unprognostic (5.87e-3)" "unprognostic (9.89e-2)" "unprognostic (1.44e-2)" "unprognostic (5.88e-2)" 2.0 1.9 71.9 1.9 69.5 2.1 2.0 20.2 184.8 1.9 2.0 19.3 0.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 48.9 45.2 1.9 2.0 1.9 2.1 65.3 23.6 1.9 1.9 2.0 0.0 1.9 27.4 1.9 2.0 1.4 2.0 1.9 1.9 1.9 2.0 2.0 22.7 2.1 1.9 3.1 14.8 0.0 1.9 0.0 2.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.5 0.0 0.8 0.0 0.3 0.0 0.0 17.3 0.0 0.0 0.0 0.1 0.3 0.3 1.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.8 1.4 0.8 0.0 0.5 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.9 0.3 0.4 0.0 0.0 0.0 6.3 0.0 5.2 0.0 1.5 3.3 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.6 0.5 71.9 69.5 20.2 43.5 48.9 45.2 65.3 23.6 27.4 14.8 0.0 1.1 0.0 0.2 0.6 8.1 2.4 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 76.9 0.3 0.0 0.0 0.5 2.2 0.3 0.2 0.0 0.0 0.8 0.0 1.2 0.6 0.0 222.1 0.9 0.0 0.0 0.0 0.0 843.1 0.0 0.0 1.1 0.0 21.1 0.0 0.3 37.7 5.3 0.0 4.0 1.3 0.0 0.1 C1orf74 "FLJ25078, URLC4" ENSG00000162757 "Chromosome 1 open reading frame 74" Q96LT6 1 209779208-209784559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028496 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028496: AB_10602698" "unprognostic (3.25e-1)" "prognostic unfavorable (8.52e-6)" "unprognostic (8.41e-3)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-2)" "unprognostic (9.98e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.95e-1)" "unprognostic (2.81e-1)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (1.07e-1)" "unprognostic (5.40e-2)" 2.5 3.9 5.7 5.5 8.5 2.3 5.8 10.4 8.9 2.7 3.8 5.8 4.0 3.3 2.3 5.2 10.4 2.8 2.3 4.1 3.7 2.9 4.9 4.1 2.2 9.8 5.1 4.6 2.5 4.5 4.5 6.5 3.4 4.8 4.6 5.2 3.9 5.1 2.7 2.3 15.0 4.1 2.4 4.9 4.9 3.9 3.9 5.0 4.9 3.2 0.0 5.7 3.9 4.7 6.3 5.5 5.9 1.9 2.8 2.9 1.9 5.6 3.0 1.9 1.1 2.6 3.0 4.4 3.2 4.2 4.0 4.1 6.0 4.4 6.0 1.9 2.1 2.4 11.5 1.2 9.4 4.7 5.9 3.9 4.0 2.2 0.5 3.6 5.5 1.8 1.8 8.3 4.9 8.1 3.3 2.3 8.2 7.8 4.4 3.4 2.9 4.6 5.7 8.0 4.0 5.1 4.9 9.1 8.4 3.4 4.9 7.7 8.2 4.4 3.4 4.9 4.6 5.3 2.9 2.2 3.4 3.9 3.5 5.2 4.0 4.1 6.6 3.0 4.6 4.7 5.9 1.6 1.4 2.9 1.9 2.1 3.8 1.4 2.3 3.2 6.3 2.4 2.8 1.1 2.8 1.0 5.5 1.2 1.9 5.7 8.5 10.4 8.9 3.7 2.9 5.1 4.6 4.8 5.0 3.0 2.1 1.4 6.1 1.9 1.4 2.0 0.0 1.4 1.2 0.0 0.0 3.1 6.6 1.7 0.0 0.6 2.0 0.0 1.8 5.7 0.6 4.8 1.1 2.0 2.3 1.6 3.5 1.3 0.3 0.2 2.3 0.8 0.0 1.8 4.4 2.3 2.7 2.6 0.0 4.8 1.2 0.0 0.4 3.7 3.6 4.3 3.3 0.0 2.9 11.4 C1orf87 "CREF, MGC34837" ENSG00000162598 "Chromosome 1 open reading frame 87" Q8N0U7 1 59987269-60073770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;fallopian tube: 33.4" "Group enriched" "Detected in some" 6 "Ciliated cells: 156.6;Early spermatids: 60.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in many" 4 "basal ganglia: 19.1;pons and medulla: 17.7" "Cell type enriched" "Detected in single" 19 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;HSkMC: 3.3;SCLC-21H: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA031366, HPA031368" Enhanced NA NA "HPA031366: AB_2673847, HPA031368: AB_10600795" "unprognostic (1.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.83e-2)" "unprognostic (1.92e-2)" "unprognostic (6.69e-2)" "unprognostic (7.11e-2)" "unprognostic (8.95e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" 0.3 0.3 3.2 0.3 19.1 0.3 0.3 0.0 0.9 1.7 0.3 3.4 0.0 0.3 0.9 4.8 0.3 33.4 0.3 0.3 3.8 4.5 0.5 0.3 6.8 0.3 1.3 0.7 5.1 0.4 0.7 0.8 0.3 17.7 0.4 0.3 2.5 3.4 0.6 0.3 0.3 0.3 0.3 0.9 0.3 0.3 1.2 3.6 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.2 19.1 0.0 0.9 3.8 4.5 1.3 0.7 17.7 3.6 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 156.6 19.4 1.8 0.0 0.0 0.0 0.0 60.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.0 0.0 C1QL2 "C1QTNF10, CTRP10" ENSG00000144119 "Complement C1q like 2" Q7Z5L3 2 119156243-119158889 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 15.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 2.7;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "GAMG: 1.9;NTERA-2: 2.2;SCLC-21H: 7.3" "Region enhanced" "Detected in many" "hippocampal formation: 25.0" "Low region specificity" "Detected in many" HPA057934 Uncertain "Secreted in brain" NA NA "HPA057934: AB_2683558" "unprognostic (6.95e-2)" "unprognostic (9.74e-2)" "unprognostic (4.48e-3)" "unprognostic (1.08e-1)" "unprognostic (9.91e-4)" "unprognostic (2.60e-5)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 0.7 0.7 15.3 0.7 6.8 0.7 1.1 0.9 15.1 0.7 0.7 3.1 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.8 15.4 9.0 0.7 0.8 0.7 1.3 4.5 5.4 0.7 0.7 0.7 0.3 0.7 1.3 0.7 0.7 2.4 1.0 0.7 0.7 0.9 0.7 0.7 1.5 0.8 0.7 1.1 3.1 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 6.8 0.9 15.1 15.4 9.0 4.5 5.4 1.3 3.1 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 7.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C1QL3 "C1ql, C1QTNF13, CTRP13, K100" ENSG00000165985 "Complement C1q like 3" Q5VWW1 10 16513743-16522005 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.8" "Cell type enhanced" "Detected in some" 28 "Cardiomyocytes: 1.2;Rod photoreceptor cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 24.9;SCLC-21H: 15.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6" "Secreted in brain" NA NA "unprognostic (7.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (8.19e-3)" "unprognostic (6.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.76e-2)" "unprognostic (2.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "prognostic favorable (6.29e-5)" "unprognostic (3.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.59e-2)" "unprognostic (6.12e-2)" 1.2 1.5 24.8 1.0 14.6 0.5 0.5 7.4 33.8 0.5 0.6 0.1 0.0 2.6 0.7 0.4 0.7 0.5 0.6 1.4 22.8 4.3 1.9 0.8 0.9 1.3 1.4 23.4 0.4 0.9 0.4 0.3 0.6 2.3 1.0 0.4 0.2 1.0 0.5 1.7 1.6 1.2 0.4 0.9 1.0 0.9 0.5 0.0 0.0 1.6 0.0 0.5 1.2 0.4 1.0 0.9 0.8 2.0 0.7 2.8 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 0.8 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 24.9 0.3 1.4 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.2 0.1 0.1 0.9 0.9 0.1 0.9 0.2 1.4 0.1 0.5 15.4 1.3 1.3 0.2 0.8 0.3 0.1 0.2 0.0 0.0 0.1 0.7 0.0 0.6 0.8 0.7 0.1 1.4 0.6 0.0 1.1 0.8 2.1 2.0 1.3 1.0 1.6 1.8 0.5 0.8 1.7 2.8 0.2 0.7 1.4 0.9 1.7 0.6 24.8 14.6 7.4 29.5 22.8 4.3 1.4 23.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QL4 "C1QTNF11, CTRP11" ENSG00000186897 "Complement C1q like 4" Q86Z23 12 49332411-49337188 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;testis: 7.4" "Group enriched" "Detected in some" 11 "Early spermatids: 21.0;Horizontal cells: 23.8;Late spermatids: 67.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 27.9;HAP1: 4.3;PC-3: 4.7;U-2 OS: 7.4" "Region enhanced" "Detected in some" "midbrain: 7.4" "Group enriched" "Detected in some" 5 "midbrain: 5.1;pons and medulla: 9.7" "Secreted in brain" NA NA "unprognostic (1.97e-2)" "unprognostic (2.77e-2)" "unprognostic (4.87e-2)" "unprognostic (7.37e-2)" "unprognostic (4.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.49e-3)" "unprognostic (8.64e-3)" "unprognostic (2.89e-1)" "unprognostic (5.11e-3)" "unprognostic (7.62e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (9.73e-2)" "unprognostic (2.85e-2)" "unprognostic (9.40e-2)" "unprognostic (3.72e-2)" 0.4 0.3 2.0 0.1 1.0 0.1 0.4 0.4 2.3 0.7 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.6 2.4 0.8 0.2 0.1 0.1 1.4 0.0 0.6 0.1 0.1 0.4 0.1 9.2 0.2 0.1 0.8 0.1 0.1 0.4 1.7 0.1 0.2 2.1 0.4 0.1 7.4 0.9 0.0 3.6 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.3 27.9 0.0 0.0 0.1 0.0 0.1 0.4 1.5 0.7 0.1 0.3 1.6 0.0 1.6 0.0 4.3 0.0 0.5 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.1 4.7 0.1 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.2 1.3 0.0 0.6 0.1 0.0 0.4 7.4 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.4 2.1 0.6 2.4 1.4 0.0 9.2 0.9 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 67.3 0.9 0.0 3.3 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.8 0.0 0.5 1.6 1.4 0.1 0.0 0.0 0.0 0.0 C1QTNF7 CTRP7 ENSG00000163145 "C1q and TNF related 7" Q9BXJ2 4 15339818-15446166 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 39.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.7" "Group enriched" "Detected in some" 5 "ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB007055, HPA051797, HPA055392" Uncertain Approved Vesicles "Secreted to blood" NA NA 238000000 Vesicles "CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596" "unprognostic (6.61e-2)" "unprognostic (4.50e-2)" "unprognostic (6.16e-2)" "unprognostic (6.50e-4)" "unprognostic (1.24e-1)" "unprognostic (4.98e-3)" "unprognostic (2.31e-2)" "unprognostic (7.69e-3)" "unprognostic (7.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.97e-4)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (7.56e-3)" "unprognostic (7.28e-3)" 16.0 0.9 0.6 24.7 0.8 0.0 7.4 0.3 0.7 39.6 12.0 0.5 3.3 0.6 24.6 10.1 17.3 6.2 20.3 5.4 0.6 0.6 4.0 1.0 7.9 0.5 0.8 0.5 15.9 1.3 0.0 1.4 5.4 0.8 22.0 3.2 5.4 2.7 2.4 2.2 3.5 4.1 22.1 0.7 10.2 10.4 4.4 0.1 0.3 4.2 13.0 2.0 16.3 15.8 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.4 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.3 0.7 0.6 0.6 0.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 3.2 15.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 10.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 21.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 29.7 1.0 0.9 6.5 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 C20orf141 dJ860F19.4 ENSG00000258713 "Chromosome 20 open reading frame 141" Q9NUB4 20 2814987-2815833 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 42 "testis: 63.6" "Group enriched" "Detected in some" 145 "Early spermatids: 1209.3;Late spermatids: 3211.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 20.7;U-2197: 5.5" "Not detected" "Not detected" NA NA "unprognostic (4.52e-1)" "unprognostic (1.40e-2)" "unprognostic (1.35e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1209.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3211.9 11.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 13.1 0.0 0.2 6.5 0.0 15.2 6.9 0.0 0.7 0.0 0.0 0.0 C20orf144 "bclt, dJ63M2.6" ENSG00000149609 "Chromosome 20 open reading frame 144" Q9BQM9 20 33662284-33665619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 165 "testis: 53.4" "Group enriched" "Detected in many" 120 "Early spermatids: 1862.6;Late spermatids: 1796.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.4;PC-3: 1.5" HPA019029 Enhanced NA NA "HPA019029: AB_2670016" "unprognostic (2.16e-2)" "unprognostic (2.04e-2)" "unprognostic (2.32e-2)" "unprognostic (4.37e-2)" "unprognostic (2.09e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" "unprognostic (3.21e-2)" "unprognostic (2.13e-1)" "unprognostic (3.64e-2)" "unprognostic (4.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-1)" "unprognostic (3.36e-2)" "unprognostic (5.66e-2)" "unprognostic (2.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 2.9 0.0 0.6 2.6 0.7 0.2 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 1862.6 0.0 0.0 0.0 0.0 0.2 1.0 0.9 1.1 0.0 0.2 0.0 0.0 0.0 0.8 1796.7 15.3 1.8 11.8 0.0 0.0 0.2 0.1 0.0 10.3 0.0 2.0 6.5 0.9 13.0 10.2 1.4 0.2 1.0 0.0 0.4 C20orf173 dJ477O4.4 ENSG00000125975 "Chromosome 20 open reading frame 173" Q96LM9 20 35523186-35529652 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 89 "testis: 28.3" "Group enriched" "Detected in some" 80 "Early spermatids: 471.4;Late spermatids: 118.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" NA NA "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 471.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 C20orf196 FLJ25067 ENSG00000171984 "Chromosome 20 open reading frame 196" Q8IYI0 20 5750393-5863912 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 31.0;U-698: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favorable (4.05e-5)" 5.4 13.9 7.1 15.5 7.3 17.8 8.1 10.6 8.7 6.8 7.9 9.2 12.6 11.9 7.7 8.7 7.4 6.7 8.0 12.3 7.0 7.0 6.9 4.1 9.3 17.6 8.9 6.7 7.7 11.1 2.8 10.6 5.1 6.9 8.7 7.4 10.9 19.1 12.9 15.1 5.6 13.7 6.7 7.1 14.2 6.2 4.2 7.8 20.4 9.6 9.4 16.8 6.4 6.6 21.7 10.9 15.6 10.8 16.2 22.7 10.2 4.8 6.1 3.1 1.4 1.9 1.6 1.3 1.4 2.4 2.0 2.8 2.8 5.5 19.1 3.7 1.4 1.5 2.3 2.0 3.6 2.2 5.7 2.3 6.9 0.9 10.3 4.2 8.3 3.3 2.4 5.2 2.9 2.0 1.8 3.9 5.5 9.7 7.7 3.5 2.1 11.7 31.0 3.6 6.4 3.3 9.6 4.1 8.6 2.9 2.4 4.9 4.6 2.9 2.8 5.6 1.6 2.2 8.8 2.3 2.2 3.1 1.9 3.0 5.3 8.8 25.3 1.0 8.7 3.7 11.2 8.7 15.6 17.0 10.4 13.2 19.7 19.5 16.7 9.2 21.7 18.8 13.4 3.9 16.2 10.8 10.9 22.7 10.2 7.1 7.3 10.6 8.7 7.0 7.0 8.9 6.7 6.9 7.8 3.0 5.5 7.5 7.2 3.3 6.3 0.0 7.6 1.4 0.0 0.0 2.0 6.1 0.0 0.0 0.1 4.2 5.8 0.0 0.0 6.0 3.2 8.1 1.1 0.8 15.0 3.2 12.1 3.7 10.3 0.5 1.7 7.3 5.0 0.0 11.4 7.7 0.0 6.8 2.1 0.0 5.0 0.0 2.5 4.8 12.2 3.8 4.9 18.7 7.3 10.1 C20orf202 ENSG00000215595 "Chromosome 20 open reading frame 202" A1L168 20 1203454-1208274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 8.2" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 1.8;Early spermatids: 2.9;Late spermatids: 1.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Lineage enriched" "Detected in single" 11 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "Daudi: 4.1;U-266/70: 3.1;U-266/84: 1.4" "Low region specificity" "Detected in all" HPA042786 Uncertain NA NA "HPA042786: AB_10795760" "unprognostic (8.20e-2)" "unprognostic (1.66e-1)" "unprognostic (7.27e-2)" "unprognostic (2.73e-2)" "unprognostic (3.49e-3)" "unprognostic (1.92e-3)" "unprognostic (1.15e-2)" "unprognostic (7.41e-3)" "unprognostic (1.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (7.55e-2)" "unprognostic (5.82e-3)" "unprognostic (7.98e-2)" "unprognostic (5.70e-3)" "unprognostic (1.26e-1)" "unprognostic (7.24e-3)" 1.3 0.1 1.3 0.2 1.0 0.0 0.7 2.6 0.8 0.3 0.7 0.6 0.2 0.0 0.6 1.0 1.5 1.1 1.2 1.1 0.9 0.2 3.2 0.3 1.4 0.0 0.7 1.0 0.4 8.2 0.1 0.5 0.8 1.4 1.0 1.1 2.5 0.3 1.7 0.4 0.6 1.4 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.2 0.0 0.4 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.1 4.1 0.1 0.0 0.3 0.2 0.1 0.2 0.1 1.0 0.3 0.4 0.0 1.0 0.2 0.4 0.0 0.2 0.1 0.0 0.4 0.2 0.0 0.0 1.2 1.2 0.0 0.3 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.3 3.1 1.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf203 FLJ33706 ENSG00000198547 "Chromosome 20 open reading frame 203" Q8NBC4 20 32631652-32673941 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;ovary: 2.1" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 14.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 4.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 4.2" "Cell line enhanced" "Detected in some" "HEL: 7.7;HMC-1: 5.4;NB-4: 2.3;U-266/70: 1.6" NA NA "unprognostic (6.24e-2)" "unprognostic (3.39e-3)" "unprognostic (8.39e-3)" "unprognostic (2.06e-1)" "unprognostic (1.19e-2)" "unprognostic (6.70e-3)" "unprognostic (7.53e-2)" "unprognostic (2.52e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (1.00e-2)" "unprognostic (1.39e-3)" "unprognostic (1.25e-10)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (7.46e-5)" 0.1 0.0 0.0 0.3 0.3 1.1 0.2 0.0 0.0 1.0 1.1 0.4 1.1 0.0 0.5 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.7 0.0 0.0 0.0 0.4 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.1 0.3 2.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.4 0.0 1.1 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.0 2.7 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 C20orf24 "PNAS-11, RIP5" ENSG00000101084 "Chromosome 20 open reading frame 24" Q9BUV8 20 36605734-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol NA NA Cytosol "HPA057387: AB_2683425" "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 17.0 19.7 15.1 18.5 16.3 25.1 29.1 11.9 21.1 15.8 31.1 10.9 15.2 21.9 11.8 18.1 55.5 10.8 25.1 24.2 14.3 14.0 35.6 71.1 21.4 24.4 15.0 11.7 9.5 27.6 15.4 8.5 19.3 12.6 13.3 26.5 9.8 21.5 17.9 70.0 13.6 26.1 14.6 12.7 26.2 20.0 19.0 11.3 20.4 21.6 42.3 28.3 14.3 20.4 10.0 15.8 41.3 24.2 6.1 11.9 7.7 36.1 27.2 9.0 12.0 21.6 12.4 24.2 22.7 12.4 21.7 19.7 74.4 45.6 15.7 56.2 19.4 40.6 26.9 19.3 35.4 20.7 11.8 20.1 37.4 38.6 81.4 25.3 39.3 18.4 15.5 37.5 31.3 17.8 11.1 19.8 16.5 25.5 37.0 20.4 24.5 23.0 50.8 16.5 35.5 58.1 18.4 23.2 39.4 18.7 27.0 16.7 12.6 32.7 84.8 28.4 14.9 17.9 32.4 22.4 32.4 22.3 33.5 34.3 23.7 38.2 26.5 35.0 45.9 17.2 7.2 24.2 29.9 6.2 12.4 6.2 10.0 7.4 9.6 15.8 8.1 9.0 6.7 41.3 6.1 14.7 10.8 11.9 7.7 15.1 16.3 11.9 21.1 14.3 14.0 15.0 11.7 12.6 11.3 32.8 18.6 61.3 37.0 155.3 30.6 0.0 104.4 17.4 23.9 0.0 23.6 72.8 0.0 0.0 42.7 44.2 136.6 23.3 0.0 105.9 54.2 76.8 47.1 249.1 216.1 12.7 52.7 58.9 146.9 62.8 40.6 64.6 67.4 0.0 79.2 49.6 0.0 118.5 40.3 0.0 29.0 58.2 32.8 171.5 84.7 183.9 113.4 69.2 118.3 184.6 C20orf85 "bA196N14.1, LLC1" ENSG00000124237 "Chromosome 20 open reading frame 85" Q9H1P6 20 58150904-58161150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 113.6;testis: 62.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 1056.0;Early spermatids: 339.0;Late spermatids: 299.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 57.9" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 3.5" "Region enriched" "Detected in single" 5 "basal ganglia: 1.5" "Low region specificity" "Detected in many" "HPA058271, HPA065540" Enhanced NA NA "HPA058271: AB_2683661, HPA065540: AB_2685510" "unprognostic (4.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "unprognostic (6.46e-2)" "unprognostic (3.62e-1)" "unprognostic (2.79e-2)" 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.1 7.4 0.0 0.5 0.2 0.0 1.4 26.9 0.0 113.6 0.0 0.0 0.1 0.8 0.0 0.0 29.4 0.3 0.0 0.0 29.0 0.0 0.0 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 62.8 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.1 0.8 0.0 0.0 1.5 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1056.0 97.8 0.0 0.0 0.0 0.0 0.0 339.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 299.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 78.9 1.9 0.0 0.0 0.0 0.0 0.0 C20orf96 dJ1103G7.2 ENSG00000196476 "Chromosome 20 open reading frame 96" Q9NUD7 20 270863-290778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 105.7;Early spermatids: 80.0;Spermatocytes: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048649 Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA048649: AB_2680476" "unprognostic (1.59e-2)" "unprognostic (4.15e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (6.12e-5)" "unprognostic (4.62e-2)" "unprognostic (5.12e-1)" "unprognostic (3.24e-1)" "prognostic favorable (4.12e-5)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "prognostic favorable (1.05e-4)" 5.6 8.6 10.4 5.5 18.4 7.1 8.2 11.2 13.6 10.5 7.8 13.5 7.7 9.7 16.9 21.8 4.4 33.9 9.1 6.5 11.7 9.9 13.2 4.7 10.3 5.2 12.5 9.1 17.7 7.3 8.3 25.1 4.0 22.0 11.2 8.8 11.8 10.2 8.6 3.4 3.8 8.1 10.8 13.8 8.0 8.2 23.4 13.4 5.9 15.1 2.0 5.2 7.4 6.7 3.5 6.4 0.0 2.8 2.5 2.9 1.6 4.2 13.4 14.1 12.4 3.7 3.6 6.3 3.0 4.0 4.5 6.2 2.6 8.3 10.7 2.0 3.7 8.0 3.7 5.2 2.3 5.3 2.6 8.1 7.1 0.1 14.5 10.4 5.8 3.1 5.1 2.1 7.8 0.9 11.6 9.1 13.8 14.4 5.4 3.9 2.1 6.8 22.6 4.6 4.2 5.9 20.9 2.5 8.7 7.1 6.6 1.5 12.7 3.6 5.3 9.0 6.8 9.1 13.0 6.1 4.6 8.0 4.0 2.5 12.3 12.4 7.3 2.5 18.2 4.2 0.0 2.8 0.0 1.6 2.2 1.0 3.5 1.0 1.3 6.4 3.4 2.2 2.9 0.0 2.5 1.6 3.0 1.4 1.6 10.4 18.4 11.2 13.6 11.7 9.9 12.5 9.1 22.0 13.4 3.0 2.2 1.5 4.6 3.3 3.0 0.7 12.7 105.7 11.4 17.4 5.9 4.0 33.2 9.4 80.0 7.5 4.2 0.0 6.0 2.6 8.0 7.9 14.9 3.0 7.9 6.4 8.1 10.4 4.4 25.9 10.0 4.6 3.3 3.6 7.1 7.2 7.9 0.0 17.0 15.1 9.4 6.5 6.7 50.9 45.4 1.4 2.3 2.2 8.8 2.1 C21orf140 ENSG00000222018 "Chromosome 21 open reading frame 140" B9A014 21 34400317-34401072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "Early spermatids: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 4.3" HPA045123 Uncertain NA NA "HPA045123: AB_10961912" 0.9 2.2 1.0 1.0 1.9 0.4 1.1 2.8 6.1 1.3 1.6 0.9 2.2 0.2 3.9 1.1 1.9 1.4 1.3 0.9 0.9 0.4 2.0 2.4 1.0 2.4 2.4 0.2 1.5 0.8 1.4 0.2 1.3 0.2 3.2 1.5 0.7 0.2 0.8 0.8 5.0 7.4 2.2 0.2 2.6 1.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 0.1 1.6 0.8 0.0 0.0 0.6 1.6 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.9 0.2 2.3 2.4 0.0 1.3 1.4 0.0 0.0 0.0 0.0 4.3 0.0 1.1 0.0 1.3 0.0 0.2 0.6 0.4 0.9 0.4 0.0 0.1 0.2 1.3 0.0 0.0 0.1 1.4 1.2 0.2 0.3 0.6 2.9 2.2 0.0 1.2 0.7 0.6 0.9 1.2 0.7 0.1 1.0 2.8 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 29.3" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.3 1.8 2.2 4.3 5.0 11.1 5.2 3.6 3.1 3.2 3.5 4.6 3.3 4.7 2.2 9.7 3.1 27.2 3.2 2.6 2.9 2.9 1.3 1.3 9.1 5.9 2.9 1.8 8.0 3.2 1.4 25.1 2.1 5.8 2.3 2.7 1.9 2.5 1.7 1.6 5.3 4.3 1.5 1.8 2.8 3.7 5.7 2.2 22.7 1.8 2.1 4.6 1.7 2.1 2.1 1.8 8.2 0.5 0.7 1.8 0.9 12.1 5.6 14.8 9.2 1.5 2.0 8.2 7.5 2.8 5.3 5.2 2.5 9.0 8.8 1.9 2.1 6.2 9.8 3.9 3.2 1.6 9.2 8.6 14.1 14.6 1.4 0.3 4.0 8.1 0.9 0.7 3.7 0.9 1.9 3.3 22.0 8.0 23.5 4.3 5.0 19.8 5.4 6.3 3.4 2.8 29.3 6.7 7.8 1.6 2.3 12.2 7.6 5.6 4.0 1.8 3.3 9.9 8.0 2.2 3.2 9.3 3.2 4.5 9.5 4.2 4.2 5.7 17.5 8.4 8.2 0.5 1.1 0.9 0.3 0.5 0.2 1.1 1.2 0.1 2.1 1.8 1.4 0.7 0.7 0.2 1.8 1.3 0.9 2.2 5.0 3.6 3.1 2.9 2.9 2.9 1.8 5.8 2.2 3.0 1.6 3.0 1.2 0.8 17.1 3.6 0.0 203.4 22.7 1.8 25.5 3.5 0.0 1.9 13.4 1.1 2.3 140.2 0.9 5.4 3.6 1.8 2.3 1.6 3.4 4.8 66.7 3.7 1.8 25.4 4.9 2.7 0.0 1.0 3.5 4.3 1.1 3.5 2.5 0.6 28.6 0.0 2.1 52.4 42.1 1.3 1.1 2.6 5.9 0.7 C21orf62 "B37, C21orf120, PRED81" ENSG00000205929 "Chromosome 21 open reading frame 62" Q9NYP8 21 32793564-32813743 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 40.8;Distal tubular cells: 19.9" "Cancer enriched" "Detected in some" 6 "glioma: 11.0" "Region enriched" "Detected in many" 4 "pons and medulla: 13.4" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "AF22: 7.2;RPTEC TERT1: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016899 Enhanced "Secreted - unknown location" NA NA "HPA016899: AB_1845704" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (1.23e-1)" "unprognostic (4.37e-3)" "unprognostic (9.56e-2)" "unprognostic (3.05e-3)" "unprognostic (2.95e-2)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" 2.2 0.4 1.6 1.1 2.1 0.3 0.3 0.3 2.4 0.1 0.3 3.9 0.0 0.1 0.2 8.4 0.3 1.2 0.4 0.4 3.0 2.4 18.2 0.3 0.2 0.2 1.5 1.0 16.2 5.6 0.1 38.6 0.1 13.4 4.1 0.1 0.0 0.3 0.3 0.3 0.3 0.6 0.3 1.8 0.2 0.3 0.4 3.1 0.0 0.2 0.0 1.1 0.2 0.3 0.0 0.4 1.1 0.0 0.0 1.7 0.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.4 1.7 0.1 1.6 2.1 0.3 2.4 3.0 2.4 1.5 1.0 13.4 3.1 0.0 0.0 0.5 0.8 0.8 5.1 0.1 40.8 0.0 0.0 5.2 5.9 1.1 19.9 0.0 1.2 0.6 0.0 0.0 0.0 0.4 1.1 0.3 0.0 0.0 0.2 0.0 2.9 2.5 0.6 0.0 3.7 0.0 3.3 0.0 0.0 5.6 0.0 0.0 1.8 2.1 6.2 0.0 0.4 0.9 1.1 0.9 0.2 1.7 0.0 0.3 C22orf15 "FLJ36561, N27C7-3" ENSG00000169314 "Chromosome 22 open reading frame 15" Q8WYQ4 22 23763021-23765861 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 22.3" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 200.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.7" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 3.0;BJ: 2.2;BJ hTERT+: 4.8;HSkMC: 2.0;hTERT-RPE1: 6.5;MOLT-4: 3.0" "Secreted in female reproductive system" NA NA "unprognostic (2.37e-2)" "unprognostic (3.28e-3)" "unprognostic (1.28e-1)" "prognostic favorable (8.53e-5)" "unprognostic (1.86e-2)" "unprognostic (2.07e-2)" "unprognostic (4.38e-2)" "unprognostic (6.14e-2)" "unprognostic (3.60e-2)" "unprognostic (7.70e-2)" "unprognostic (4.58e-2)" "unprognostic (2.60e-1)" "unprognostic (9.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.28e-2)" "unprognostic (3.08e-3)" 0.0 0.1 1.0 0.0 1.7 0.4 0.1 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 22.3 0.2 0.0 1.4 1.9 0.0 0.0 2.7 0.2 0.0 0.5 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 1.8 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.2 4.8 0.0 0.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 6.5 0.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.6 1.0 0.8 0.4 0.5 1.8 0.5 0.0 0.0 0.0 2.9 0.0 0.2 0.0 2.6 0.0 0.0 0.1 0.5 0.0 0.0 200.8 15.9 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.3 0.0 0.0 0.0 0.0 1.3 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 12.7 3.8 0.3 0.0 0.0 0.0 0.0 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.4;testis: 12.7" "Group enriched" "Detected in some" 15 "Early spermatids: 55.4;Late spermatids: 34.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.4" "Not detected" "Not detected" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.0 0.4 0.9 0.0 3.4 0.0 0.4 0.4 0.9 0.5 0.3 0.2 0.4 1.6 0.5 0.5 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.8 1.1 0.0 0.2 0.4 0.0 0.2 0.3 0.5 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.6 12.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.4 0.6 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.9 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.0 0.0 0.0 C22orf42 ENSG00000205856 "Chromosome 22 open reading frame 42" Q6IC83 22 32149006-32159322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 12.9;testis: 28.6" "Group enriched" "Detected in some" 7 "Early spermatids: 73.0;Late spermatids: 23.6" "Group enriched" "Detected in some" 5 "pancreatic cancer: 0.8;prostate cancer: 1.0" "Group enriched" "Detected in some" 14 "hypothalamus: 12.9;pons and medulla: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.5" HPA019531 Enhanced NA NA "HPA019531: AB_1853016" "unprognostic (5.67e-2)" "unprognostic (6.13e-3)" "unprognostic (8.21e-3)" "unprognostic (7.06e-2)" "unprognostic (4.54e-2)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.4 0.0 3.8 0.0 5.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.5 1.0 28.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.1 12.9 0.6 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" NA NA Nucleoplasm Nucleoli "HPA052741: AB_2681933" "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.8 4.5 11.1 6.8 8.2 8.7 10.1 7.5 8.1 6.4 8.6 4.5 5.8 5.5 5.5 6.2 6.3 4.1 5.7 5.8 7.7 19.7 5.4 6.1 9.4 3.8 4.8 4.5 12.0 6.9 7.8 10.7 7.6 4.9 1.6 8.6 9.9 8.2 5.6 14.6 3.5 5.5 4.5 13.4 3.5 5.1 9.2 6.1 5.4 6.1 2.7 4.2 8.7 7.9 11.3 8.5 9.0 5.5 4.3 8.4 14.4 4.4 3.9 17.5 17.8 5.1 5.0 5.5 11.4 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 11.9 16.5 7.1 3.9 1.9 9.4 18.9 5.1 8.1 11.4 7.0 13.7 8.3 1.7 4.2 65.6 7.1 8.4 0.0 4.2 5.8 4.9 2.0 7.0 4.0 4.2 3.2 2.9 9.2 7.3 8.2 4.9 8.3 1.7 9.0 7.2 9.7 3.7 3.7 6.0 1.3 6.2 0.0 3.5 12.0 11.5 2.3 7.1 15.8 4.0 1.4 C2CD4A "FAM148A, NLF1" ENSG00000198535 "C2 calcium dependent domain containing 4A" Q8NCU7 15 62066977-62070917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "endometrium 1: 6.8;liver: 25.9;pancreas: 20.4;pituitary gland: 21.9" "Cell type enhanced" "Detected in some" 19 "Exocrine glandular cells: 5.5;Intestinal endocrine cells: 20.0;Pancreatic endocrine cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 19 "OE19: 24.1;RPTEC TERT1: 21.7" NA NA "unprognostic (3.85e-2)" "unprognostic (6.68e-2)" "unprognostic (5.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.32e-1)" "unprognostic (5.38e-3)" "unprognostic (5.49e-3)" "unprognostic (3.85e-1)" "unprognostic (1.67e-1)" "unprognostic (9.21e-2)" "unprognostic (3.89e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.72e-2)" "unprognostic (2.07e-2)" "unprognostic (6.26e-2)" "unprognostic (3.35e-1)" 0.3 1.0 0.5 1.3 0.4 0.3 0.5 0.2 0.7 1.0 1.2 0.1 0.1 2.2 6.8 0.3 0.2 0.1 0.9 0.2 0.4 0.9 2.5 25.9 2.0 0.3 0.3 0.1 0.4 20.4 0.0 21.9 0.8 1.3 1.1 1.4 0.2 1.2 0.1 0.8 1.1 1.1 0.1 0.4 0.2 2.2 0.2 0.1 1.2 0.9 0.1 1.2 1.3 0.1 0.8 0.9 2.5 0.5 0.9 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 24.1 0.1 0.1 0.0 0.1 21.7 0.5 0.9 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.5 0.4 0.4 0.2 0.4 0.5 0.4 0.2 0.1 0.8 0.5 0.3 2.5 0.9 0.2 0.9 1.0 0.1 0.5 0.4 0.2 0.4 0.4 0.9 0.3 0.1 1.3 0.1 0.0 0.0 0.0 1.7 0.5 0.1 0.8 0.0 1.4 3.4 0.0 0.0 0.0 1.7 1.5 0.0 2.6 0.2 0.0 5.5 0.0 0.2 2.6 0.0 0.0 0.1 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.7 0.2 5.6 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 C2CD4B "FAM148B, NLF2" ENSG00000205502 "C2 calcium dependent domain containing 4B" A6NLJ0 15 62163535-62165283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "pancreas: 192.0" "Group enriched" "Detected in many" 6 "Endothelial cells: 53.8;Intestinal endocrine cells: 205.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;HUVEC TERT2: 6.2;NTERA-2: 2.5;SCLC-21H: 1.8;TIME: 1.3" HPA046880 Uncertain NA NA "HPA046880: AB_10959458" "unprognostic (6.60e-2)" "prognostic favorable (4.22e-4)" "unprognostic (2.24e-2)" "unprognostic (1.25e-1)" "unprognostic (4.15e-1)" "unprognostic (4.06e-3)" "unprognostic (2.29e-1)" "unprognostic (5.02e-2)" "unprognostic (3.36e-2)" "unprognostic (2.33e-1)" "unprognostic (5.30e-2)" "unprognostic (1.83e-1)" "unprognostic (6.16e-3)" "unprognostic (7.89e-2)" "unprognostic (5.24e-1)" "unprognostic (8.64e-3)" "unprognostic (1.48e-1)" 12.1 1.0 0.2 4.3 0.5 3.0 7.9 0.1 0.7 1.7 2.0 0.3 0.4 2.2 3.7 3.2 3.2 1.2 5.0 2.0 0.3 0.3 0.7 1.7 9.2 0.7 0.5 0.0 1.6 192.0 0.7 2.5 1.4 0.6 2.2 0.6 0.5 0.9 1.0 2.8 1.6 1.8 1.5 0.9 0.4 7.8 1.0 0.2 4.6 0.9 4.1 0.6 3.9 4.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.3 0.3 0.3 0.5 0.0 0.6 0.2 3.0 8.5 0.0 2.3 6.1 0.8 1.2 7.6 0.0 1.2 1.8 0.0 0.0 0.0 1.1 0.0 53.8 1.7 0.0 20.3 0.0 4.1 2.3 2.3 0.4 0.3 0.0 205.6 6.2 1.3 0.0 0.0 0.2 3.3 2.8 9.3 0.0 15.9 0.6 0.0 0.0 0.5 0.0 2.3 0.0 0.4 6.0 0.0 0.0 1.1 2.0 C2CD4D FAM148D ENSG00000225556 "C2 calcium dependent domain containing 4D" B7Z1M9 1 151837819-151840557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 4.1;skin 1: 4.9" "Cell type enhanced" "Detected in some" 10 "Distal tubular cells: 8.3;Intestinal endocrine cells: 5.2;Syncytiotrophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0;T-reg: 2.2" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 9 "HDLM-2: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.17e-3)" "unprognostic (5.08e-1)" "unprognostic (3.00e-1)" "unprognostic (3.60e-2)" "unprognostic (1.62e-2)" "unprognostic (9.03e-4)" "unprognostic (2.69e-1)" "unprognostic (9.66e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.84e-3)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (2.41e-3)" "unprognostic (1.51e-1)" "unprognostic (2.62e-1)" "unprognostic (3.28e-2)" 0.4 0.8 0.9 0.7 0.6 0.0 0.4 1.9 2.3 0.1 1.0 0.5 0.0 0.0 0.6 0.5 0.7 0.4 1.6 0.8 0.9 0.2 0.8 0.8 1.4 0.0 2.6 0.0 1.2 0.0 1.0 0.1 4.1 0.6 0.4 4.9 0.6 0.0 3.3 0.5 1.9 0.5 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.1 2.1 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 20.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.7 0.0 0.0 2.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.1 1.5 1.1 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 1.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.8 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 8.3 0.2 0.0 0.1 0.3 0.0 0.4 0.1 0.0 1.5 0.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.6 0.0 3.3 0.0 2.1 0.9 0.5 2.6 0.4 0.6 0.3 0.0 0.0 0.2 0.2 0.9 8.9 1.3 2.3 0.7 C2orf15 MGC29762 ENSG00000273045 "Chromosome 2 open reading frame 15" Q8WU43 2 99141485-99151487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 22.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 12.0;Distal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.2;NK-cells: 6.5;T-cells: 7.4" "Cell line enhanced" "Detected in many" "RT4: 11.0;SCLC-21H: 11.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.61e-2)" "unprognostic (7.88e-2)" "unprognostic (4.22e-2)" "unprognostic (4.85e-2)" "unprognostic (2.06e-1)" "unprognostic (6.99e-2)" "unprognostic (5.37e-2)" "unprognostic (9.05e-3)" "unprognostic (1.62e-2)" "prognostic favorable (4.95e-4)" "unprognostic (2.54e-3)" "unprognostic (1.04e-1)" "prognostic favorable (1.23e-4)" "unprognostic (2.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.08e-1)" "unprognostic (2.97e-2)" 1.0 1.7 4.2 1.2 7.7 1.6 5.4 9.3 4.9 3.9 4.9 0.9 5.4 5.9 1.8 9.3 2.5 6.1 3.9 0.7 7.4 4.5 12.1 1.2 2.1 6.3 3.4 2.9 2.0 6.0 8.0 22.2 1.6 3.7 2.2 3.5 2.1 5.8 4.6 0.7 2.7 4.5 0.3 3.5 2.6 5.5 3.4 2.3 2.4 9.5 0.8 2.1 3.7 1.4 3.2 0.5 1.3 0.4 6.5 7.4 2.2 8.6 1.4 0.3 1.1 0.1 0.0 6.5 0.0 0.7 0.4 0.3 9.2 6.2 3.7 2.8 0.0 0.7 5.4 1.3 1.2 0.0 0.7 3.9 0.3 1.4 5.6 0.1 1.2 1.6 0.1 2.0 0.0 0.7 0.3 0.0 4.9 0.3 0.7 0.3 7.6 1.1 1.6 2.0 4.7 2.0 0.6 0.1 4.2 8.9 11.0 11.0 1.4 0.7 8.8 0.3 1.6 7.1 0.4 0.0 0.4 0.4 0.3 0.3 2.5 4.1 1.2 0.2 1.1 0.1 0.2 0.4 0.3 3.2 0.2 7.4 3.2 4.9 4.0 0.3 3.2 6.8 3.3 1.3 6.5 0.2 0.5 2.6 2.2 4.2 7.7 9.3 4.9 7.4 4.5 3.4 2.9 3.7 2.3 3.0 1.9 1.3 1.9 0.2 5.3 0.3 2.5 12.0 2.3 7.0 5.9 5.0 13.3 4.7 1.6 0.2 0.0 0.0 2.6 0.6 0.2 1.7 0.0 0.0 0.6 6.4 1.2 0.0 0.0 0.0 0.6 0.7 0.0 0.0 2.7 4.3 2.9 3.2 0.4 6.3 8.4 0.0 0.2 3.0 2.4 0.3 1.7 0.5 2.7 1.1 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 22.3" "Cell type enriched" "Detected in some" 10 "Early spermatids: 68.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.3;SiHa: 4.5" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA052136: AB_2681742, HPA056962: AB_2683290" "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 1.0 0.5 0.1 0.4 0.5 0.2 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.6 22.3 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.0 0.3 0.3 1.0 0.0 0.6 0.1 1.6 1.6 2.3 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 2.1 0.8 2.0 0.0 1.5 0.5 0.0 0.0 0.0 1.4 0.4 3.0 1.2 1.6 0.0 1.7 1.3 0.0 0.0 0.2 0.0 1.1 0.2 0.9 1.2 2.2 0.1 0.4 0.0 0.8 0.4 0.8 0.0 1.2 1.3 0.6 0.0 1.5 6.3 1.1 4.5 1.2 0.6 0.4 1.0 1.1 2.7 1.5 2.1 1.0 1.0 0.4 0.0 1.9 0.5 0.3 2.1 0.0 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 68.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 1.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 C2orf40 "augurin, ECRG4" ENSG00000119147 "Chromosome 2 open reading frame 40" Q9H1Z8 2 106063246-106078159 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ciliated cells: 481.8;Early spermatids: 894.2" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 72.8" "Region enriched" "Detected in all" 7 "pons and medulla: 44.8" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.0;naive CD8 T-cell: 8.2" "Lineage enriched" "Detected in single" 77 "T-cells: 10.0" "Cell line enhanced" "Detected in some" "BEWO: 2.2;HSkMC: 1.0;NB-4: 1.3" "Group enriched" "Detected in many" 5 "basal ganglia: 44.8;cerebellum: 37.1;hippocampal formation: 85.7;pons and medulla: 114.2;thalamus: 69.1" "Low region specificity" "Detected in many" HPA008546 Uncertain "Secreted to blood" NA NA "HPA008546: AB_2066524" "prognostic favorable (4.58e-4)" "unprognostic (3.91e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-2)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.61e-3)" "unprognostic (6.56e-3)" "unprognostic (1.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (1.36e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (9.11e-3)" "unprognostic (1.30e-4)" 27.5 14.0 1.6 7.6 3.2 0.4 12.7 4.1 4.1 21.8 11.0 18.7 19.9 2.9 19.5 25.8 16.5 15.9 10.3 6.5 3.2 5.1 14.7 1.4 8.4 1.0 6.2 3.7 7.9 3.4 1.0 27.6 4.2 44.8 37.1 3.0 33.9 10.2 50.7 4.1 3.2 6.4 66.8 9.6 12.0 50.6 11.0 1.9 0.1 44.2 8.2 2.5 46.6 26.8 0.1 0.0 0.0 0.0 0.1 10.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 2.4 1.6 0.0 0.0 10.0 8.2 0.0 0.1 0.0 0.0 0.7 1.7 1.6 3.2 4.1 4.1 3.2 5.1 6.2 3.7 44.8 1.9 0.0 1.4 0.0 1.8 7.1 0.1 6.3 0.0 481.8 40.9 19.2 0.0 1.4 0.0 0.6 894.2 5.8 0.0 0.0 0.0 0.7 22.3 1.6 1.1 0.0 2.3 3.2 10.2 11.1 0.3 110.5 19.0 2.7 1.7 0.0 0.0 0.2 0.0 0.0 59.4 0.0 0.2 38.8 97.8 9.7 3.6 0.9 2.6 0.5 0.0 1.8 C2orf54 FLJ22671 ENSG00000172478 "Chromosome 2 open reading frame 54" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 50.6;Intestinal endocrine cells: 48.2;Paneth cells: 56.1;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.4" "Group enriched" "Detected in some" 6 "CACO-2: 21.6;HaCaT: 16.2;SK-BR-3: 57.4" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.3 0.0 0.3 1.5 0.3 0.0 0.9 0.3 0.3 8.9 3.9 0.3 0.3 6.3 0.7 0.4 63.8 0.3 0.3 0.3 0.3 0.0 2.8 2.8 5.5 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.7 0.3 0.5 1.1 0.3 7.6 0.3 0.3 18.6 3.6 0.3 0.3 0.3 1.0 0.3 0.3 1.0 0.3 35.5 28.6 0.8 19.1 0.8 0.1 0.7 0.2 3.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.6 1.4 0.1 0.1 0.0 0.0 16.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 5.3 0.1 3.2 1.0 0.0 0.0 57.4 0.0 0.0 0.4 0.2 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.8 0.1 0.2 0.1 3.4 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 50.6 1.7 0.0 0.8 2.5 0.0 0.3 0.0 1.4 10.3 1.8 0.0 1.1 5.0 1.4 0.0 0.0 2.1 0.0 3.2 0.1 0.4 1.3 0.0 3.4 0.0 0.0 48.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 10.5 56.1 0.0 12.6 0.0 0.0 0.2 0.0 0.0 22.7 0.2 0.0 1.2 6.3 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85606654-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: AB_2681360" "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.7 9.8 7.0 17.4 12.3 11.5 16.5 16.6 9.9 16.5 15.2 17.2 17.7 13.1 17.1 15.0 13.6 14.3 16.2 13.7 7.7 6.6 13.5 16.8 17.5 15.6 16.1 7.2 22.2 25.4 13.3 14.6 21.8 11.4 16.5 14.1 10.8 20.6 20.6 23.3 18.6 18.5 14.8 10.9 17.5 13.4 15.1 12.3 37.1 17.2 20.4 17.6 15.2 17.0 15.4 16.5 36.1 22.7 19.2 20.1 9.5 8.6 8.1 13.3 10.0 13.7 6.8 9.0 4.0 5.3 6.7 8.9 7.3 10.6 11.8 6.1 7.3 6.2 9.6 7.3 8.0 7.2 6.2 15.3 20.2 11.9 7.6 11.3 10.8 10.7 10.4 9.3 5.0 13.3 9.7 10.9 13.2 10.2 13.3 6.4 9.9 12.3 10.6 6.4 10.6 7.0 13.8 25.4 11.6 8.6 9.2 17.1 12.3 6.2 8.3 8.0 8.2 9.4 5.5 6.4 4.8 13.3 5.4 3.8 17.2 12.0 11.0 7.1 11.0 5.8 18.0 22.7 36.1 15.4 15.0 14.5 10.9 14.7 14.5 16.5 15.4 20.1 18.7 36.1 19.2 16.9 10.6 11.9 9.5 7.0 12.3 16.6 9.9 7.7 6.6 16.1 7.2 11.4 12.3 59.6 76.5 21.4 16.8 5.3 17.5 9.3 38.2 25.4 34.2 33.2 33.4 38.5 14.9 14.0 3.3 9.0 23.5 0.0 17.1 14.2 11.3 12.3 32.5 19.2 20.3 23.8 18.5 19.0 31.3 7.0 22.5 24.2 13.5 14.4 15.8 10.8 17.3 10.5 12.7 19.2 23.7 19.4 7.6 37.2 20.6 8.5 20.8 28.0 16.8 17.6 C2orf73 FLJ40298 ENSG00000177994 "Chromosome 2 open reading frame 73" Q8N5S3 2 54330034-54383742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;pituitary gland: 11.9;testis: 39.2" "Group enriched" "Detected in some" 10 "Early spermatids: 988.4;Late spermatids: 409.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enhanced" "Detected in single" "B-cells: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;BJ hTERT+: 1.3;CAPAN-2: 1.3;HSkMC: 1.5;hTERT-RPE1: 4.3;RPTEC TERT1: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055221, HPA059596" Uncertain NA NA "HPA055221: AB_2682744, HPA059596: AB_2684077" "unprognostic (1.56e-2)" "unprognostic (7.00e-3)" "unprognostic (1.51e-2)" "unprognostic (1.39e-2)" "unprognostic (5.46e-2)" "unprognostic (2.74e-2)" "unprognostic (6.69e-3)" "unprognostic (2.36e-2)" "unprognostic (1.62e-3)" "unprognostic (7.69e-2)" "unprognostic (3.00e-2)" "unprognostic (5.01e-3)" "unprognostic (1.17e-2)" "unprognostic (8.99e-2)" "unprognostic (3.80e-2)" 0.4 0.9 2.0 0.3 6.4 0.3 0.4 0.9 1.6 0.7 0.4 4.1 1.6 0.3 0.6 3.5 0.4 7.3 0.3 0.4 2.7 1.2 0.8 0.4 1.6 0.3 0.9 4.4 0.9 0.9 1.0 11.9 0.3 11.8 0.6 0.3 0.3 0.4 0.6 0.4 0.4 0.4 0.3 1.5 0.4 0.4 39.2 1.7 0.0 1.7 0.0 0.3 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.4 0.6 0.0 2.1 0.0 0.0 1.3 0.0 0.7 0.0 1.3 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.5 0.3 0.8 0.0 4.3 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.4 0.9 1.6 2.7 1.2 0.9 4.4 11.8 1.7 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 68.3 14.8 3.5 0.0 0.0 5.0 0.1 988.4 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 409.8 7.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.9 2.5 2.0 0.0 0.0 57.5 7.3 0.1 0.0 0.0 0.0 0.1 C2orf78 "COG5373, FLJ43987, hCG1989538" ENSG00000187833 "Chromosome 2 open reading frame 78" A6NCI8 2 73784189-73817147 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 141 "testis: 14.0" "Cell type enriched" "Detected in some" 13 "Early spermatids: 42.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 4.1;U-266/70: 1.7;U-266/84: 1.2" "Not detected" "Not detected" NA NA "unprognostic (5.25e-2)" "unprognostic (6.56e-3)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.7 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190073 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Cell line enhanced" "Detected in some" "NTERA-2: 5.9" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.9 1.0 20.8 1.3 20.8 2.4 0.9 0.4 35.3 0.7 1.1 1.1 0.0 1.0 1.0 0.9 2.2 1.0 1.4 0.9 16.3 14.2 0.9 1.1 1.0 1.1 8.0 13.1 1.0 0.7 0.8 0.4 0.9 9.6 1.1 1.1 0.5 1.4 1.4 1.2 2.0 1.3 0.9 2.1 1.0 1.2 1.7 2.4 0.0 1.1 0.0 0.8 0.9 0.0 1.5 1.7 8.4 1.2 1.0 0.7 0.2 0.4 0.5 2.7 0.9 0.0 0.0 0.2 0.6 0.6 0.0 0.0 1.0 1.2 1.5 1.0 0.3 0.6 0.4 0.0 0.0 0.0 0.4 0.3 1.0 1.3 0.4 0.0 1.2 1.8 0.4 0.5 0.3 0.3 0.3 0.0 0.5 0.6 1.5 0.0 0.8 0.0 1.6 5.9 0.4 1.8 0.4 0.3 0.4 0.0 1.2 0.8 1.3 0.3 0.9 0.2 0.4 0.5 0.0 0.8 0.5 0.3 0.4 0.5 0.8 0.3 1.1 0.0 0.6 0.9 4.3 1.2 0.9 0.7 0.7 0.5 0.9 0.7 0.7 0.3 1.5 0.6 0.7 8.4 1.0 0.5 1.7 0.3 0.2 20.8 20.8 0.4 23.1 16.3 14.2 8.0 13.1 9.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C2orf83 DKFZp547H025 ENSG00000042304 "Chromosome 2 open reading frame 83" Q53S99 2 227610090-227648606 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "placenta: 16.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 1.6;Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2197: 12.6" HPA030319 Approved NA NA "HPA030319: AB_10602112" "unprognostic (1.12e-2)" "unprognostic (1.03e-1)" 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Cell type enhanced" "Detected in single" 22 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AN3-CA: 5.2;HDLM-2: 17.9" HPA042517 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.2 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.1 17.9 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.4 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 3.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62318973-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 111.9;Spermatocytes: 148.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 106.9" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 3.8 14.7 28.2 5.6 23.6 1.0 35.0 16.4 31.2 5.0 3.9 7.7 2.5 3.3 5.5 6.8 11.0 4.1 6.8 4.6 20.9 22.0 9.6 2.9 6.4 5.0 19.9 20.5 8.2 6.3 2.3 19.0 4.8 25.9 17.8 4.1 4.1 5.0 5.6 1.0 12.0 2.7 6.8 15.2 3.0 6.1 20.9 8.1 1.2 9.2 3.8 8.2 13.5 3.4 3.7 6.7 5.2 21.0 0.7 6.1 2.1 0.0 5.8 7.0 0.0 5.1 7.4 5.4 9.5 5.7 12.0 11.9 0.0 8.5 0.0 0.0 6.4 24.7 1.5 0.0 6.0 9.2 0.0 4.0 5.1 0.0 0.0 3.4 0.0 11.2 3.3 8.1 13.5 11.1 0.2 5.8 0.0 0.6 0.1 11.8 106.9 0.0 0.0 8.8 8.4 12.0 0.0 0.0 2.9 9.8 16.3 12.3 10.4 6.3 22.6 8.7 6.1 9.2 5.8 0.1 5.9 0.0 27.4 9.4 5.8 0.0 0.0 5.7 0.0 20.5 5.2 4.3 0.4 0.2 14.3 0.1 3.7 3.6 2.8 4.6 1.1 1.0 0.7 0.3 0.7 21.0 6.7 6.1 2.1 28.2 23.6 16.4 31.2 20.9 22.0 19.9 20.5 25.9 8.1 20.8 10.2 2.7 19.7 32.6 31.2 4.5 7.6 4.0 19.4 21.0 3.9 16.3 51.4 31.3 111.9 11.7 2.6 0.0 47.7 18.9 20.3 22.1 1.1 3.0 27.0 35.0 84.0 4.9 7.8 44.2 13.0 19.5 43.9 83.8 2.6 27.9 29.7 0.0 9.9 34.8 23.1 0.0 15.5 148.6 37.5 25.1 8.2 4.4 3.8 17.0 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 26.3;Early spermatids: 47.6;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7" "Cell line enhanced" "Detected in many" "HDLM-2: 29.8" "Group enriched" "Detected in many" 4 "cerebellum: 31.6;olfactory region: 33.8" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol No No Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 5.1 6.7 10.0 3.4 12.3 1.2 6.2 34.5 20.1 6.0 6.1 8.0 2.2 2.2 8.0 5.1 5.0 8.4 6.0 25.3 8.1 9.7 6.0 3.0 4.1 3.9 11.4 9.3 14.0 6.1 19.2 7.4 2.6 10.3 8.5 3.2 11.9 7.3 11.0 32.4 2.8 2.9 10.4 6.9 4.1 5.2 9.8 6.1 1.8 6.9 7.2 4.0 6.8 4.9 2.9 0.9 0.8 0.5 2.1 7.7 3.0 1.1 1.7 1.9 0.4 6.6 5.9 0.6 6.9 10.8 6.3 4.6 0.1 1.7 1.4 1.7 9.4 6.0 0.1 0.0 2.7 3.3 29.8 0.2 2.8 3.9 0.5 3.3 0.0 3.8 5.8 0.4 6.1 0.3 5.1 1.2 4.5 0.6 1.3 3.7 0.2 0.2 0.9 2.4 1.2 7.7 0.6 0.2 1.6 0.3 0.2 2.2 10.3 1.8 0.4 0.1 2.3 2.1 0.8 0.3 6.4 5.0 11.5 0.8 1.8 1.5 0.2 9.1 3.1 0.1 0.0 0.5 0.8 6.3 0.2 7.7 2.9 5.5 6.0 0.5 1.8 6.4 7.7 0.0 2.1 0.1 0.9 2.5 3.0 10.0 12.3 34.5 20.1 8.1 9.7 11.4 9.3 10.3 6.1 0.0 0.6 0.0 1.5 1.0 9.2 26.3 0.0 1.4 2.3 1.8 7.9 0.4 3.3 1.8 47.6 1.6 0.0 0.0 1.6 0.5 4.1 0.6 0.0 1.7 1.4 1.6 1.7 2.5 0.3 47.3 4.4 0.4 0.0 15.4 0.3 8.9 0.7 0.0 3.9 1.8 15.9 12.9 3.0 2.8 1.7 0.4 0.1 2.2 0.1 0.1 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 27 "Early spermatids: 16.4;Late spermatids: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HEL: 12.2;U-698: 9.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 12.2 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.5 0.8 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 C3orf22 MGC34728 ENSG00000180697 "Chromosome 3 open reading frame 22" Q8N5N4 3 126526999-126558965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "testis: 28.3" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1235.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "MCF7: 1.5;SCLC-21H: 1.0" "Not detected" "Not detected" HPA059199 Enhanced NA NA "HPA059199: AB_2683946" "unprognostic (2.10e-1)" "unprognostic (5.14e-5)" "unprognostic (2.55e-1)" "unprognostic (9.21e-2)" "unprognostic (2.01e-1)" "unprognostic (2.75e-1)" "unprognostic (1.08e-3)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1235.7 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 8.6 3.8 0.0 0.0 0.0 0.0 0.0 C3orf30 "FLJ32859, TSCPA" ENSG00000163424 "Chromosome 3 open reading frame 30" Q96M34 3 119146150-119160042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 156 "testis: 46.4" "Group enriched" "Detected in some" 128 "Early spermatids: 547.1;Late spermatids: 266.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.9;HEL: 1.3" HPA062468 Enhanced NA NA "HPA062468: AB_2684772" "unprognostic (4.06e-3)" "unprognostic (3.67e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 547.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 266.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 6.6;HeLa: 1.7;TIME: 5.2" HPA046432 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: AB_2679664" "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819362-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Group enriched" "Detected in some" 12 "Early spermatids: 19.9;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.7" "Not detected" "Not detected" HPA053582 Uncertain Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "HPA053582: AB_2682199" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.4 0.1 0.5 0.4 1.0 0.9 0.4 1.8 4.0 0.4 0.4 0.4 0.4 1.3 0.5 0.4 1.7 0.4 0.4 0.8 0.5 0.5 0.4 0.6 0.6 0.4 0.4 0.4 1.2 1.3 0.0 0.4 0.4 0.4 0.4 0.0 0.4 0.5 0.4 2.6 2.0 0.4 0.4 0.4 0.4 0.3 3.6 0.4 0.4 0.7 0.4 0.4 0.5 0.4 1.1 0.5 1.7 0.9 2.2 1.1 0.1 0.7 2.0 1.0 1.3 0.0 0.3 1.2 1.7 0.0 0.1 0.0 1.2 1.0 2.6 0.4 0.0 0.7 1.1 0.0 0.1 0.3 1.5 1.8 2.2 4.7 0.5 0.0 0.8 0.8 0.2 0.1 0.0 0.1 0.5 0.0 0.9 1.3 1.2 0.0 4.4 1.2 1.2 1.3 1.2 0.4 1.7 1.1 2.5 0.1 1.1 1.2 0.8 0.3 2.6 0.3 0.3 0.7 1.0 1.5 0.8 1.0 1.7 2.0 0.8 2.4 0.5 2.7 3.7 1.0 1.7 0.6 0.2 1.1 0.4 0.4 0.6 0.6 0.8 0.4 1.1 1.1 1.0 1.2 2.2 0.9 0.5 0.8 0.1 0.5 1.0 1.8 1.3 0.5 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.3 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 C3orf56 FLJ40141 ENSG00000214324 "Chromosome 3 open reading frame 56" Q8N813 3 127193131-127198185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 3.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;U-937: 1.0" NA NA "unprognostic (1.12e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 C3orf67 "FLJ42117, FLJ42930" ENSG00000163689 "Chromosome 3 open reading frame 67" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 10.4;testis: 28.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 80.6;Late spermatids: 61.4;Spermatocytes: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2;T-reg: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 2.2;T-cells: 2.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.5 1.8 1.2 1.0 4.3 0.3 0.6 0.5 2.0 1.5 0.7 0.5 0.0 0.1 0.6 1.6 10.4 3.4 0.7 0.4 0.9 0.9 0.7 1.9 0.6 1.8 0.5 0.9 0.7 0.8 1.3 8.4 1.3 1.3 1.0 0.9 1.6 2.6 0.4 0.2 0.4 0.3 0.5 0.6 0.4 0.5 28.4 0.5 0.4 0.4 2.0 3.6 0.3 2.9 2.2 0.0 0.0 0.1 0.1 2.2 0.3 10.5 1.7 3.0 0.0 1.8 5.8 0.0 5.0 1.7 2.2 1.8 0.9 3.5 11.0 1.7 1.2 0.0 1.1 4.7 2.4 4.0 1.7 0.3 0.0 1.8 0.0 1.0 0.0 0.0 1.1 2.4 4.7 3.8 2.8 4.6 7.3 8.4 0.1 3.0 1.4 0.5 0.0 3.7 3.4 7.5 10.6 0.0 4.5 2.4 0.1 7.7 3.6 1.4 1.0 3.2 5.1 3.4 0.0 0.1 0.2 3.4 5.5 2.3 4.5 9.4 2.1 2.6 0.0 7.0 0.0 0.1 0.0 0.2 0.0 0.0 1.7 0.7 0.0 0.0 2.2 0.1 0.7 0.0 0.1 0.0 0.0 2.2 0.3 1.2 4.3 0.5 2.0 0.9 0.9 0.5 0.9 1.3 0.5 0.0 0.0 0.0 1.5 0.8 0.1 0.8 0.0 13.4 2.3 1.8 0.0 0.7 1.7 3.2 80.6 0.9 0.0 0.0 0.3 1.6 1.6 0.9 0.0 1.7 0.8 0.0 2.4 0.6 0.3 61.4 2.0 0.2 1.7 0.0 0.5 0.6 4.1 0.0 1.1 0.8 0.3 0.0 1.2 27.9 15.8 0.1 0.5 0.0 1.2 1.4 C3orf70 ENSG00000187068 "Chromosome 3 open reading frame 70" A6NLC5 3 185078050-185153014 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 26.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 17.4;Melanocytes: 37.1;Peritubular cells: 46.7" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "RH-30: 4.7;SCLC-21H: 19.5;SK-BR-3: 8.4;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041861 Uncertain Approved Cytosol NA NA Cytosol "HPA041861: AB_10804119" "unprognostic (1.45e-1)" "unprognostic (2.17e-3)" "unprognostic (3.92e-3)" "unprognostic (2.77e-1)" "unprognostic (2.31e-1)" "unprognostic (6.62e-4)" "unprognostic (5.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-1)" "unprognostic (5.98e-3)" "unprognostic (9.91e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.06e-1)" "unprognostic (8.48e-2)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" 4.6 2.3 14.4 4.7 13.8 0.9 2.0 7.9 18.2 7.2 12.1 11.1 7.9 5.3 12.1 6.1 10.1 6.8 6.1 3.3 11.1 10.2 1.6 1.3 2.4 1.3 11.4 7.1 5.9 1.1 4.0 1.4 2.9 10.5 10.2 8.2 5.2 5.5 16.4 1.5 2.9 6.5 26.6 11.1 4.2 4.4 7.5 7.0 0.0 2.4 1.0 1.7 13.2 3.3 1.2 1.2 3.4 1.6 1.7 1.1 0.5 0.0 0.1 2.3 0.0 0.0 0.1 0.1 3.0 0.1 0.5 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.1 1.0 0.0 0.2 0.0 0.8 2.5 0.1 0.7 0.0 0.4 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 1.0 2.2 0.2 0.1 4.7 0.1 0.0 0.5 19.5 0.2 0.9 8.4 0.5 0.1 0.6 2.2 0.8 0.0 2.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 10.5 3.4 1.2 1.7 0.8 1.0 1.0 1.0 0.8 0.8 0.6 1.2 1.0 1.1 3.3 1.7 1.6 1.2 0.7 0.5 14.4 13.8 7.9 9.6 11.1 10.2 11.4 7.1 10.5 7.0 0.0 0.0 1.5 0.2 3.7 17.4 1.2 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 1.0 2.3 4.0 0.0 0.2 0.6 2.3 0.3 0.0 0.0 3.1 3.2 1.2 4.9 0.6 1.2 3.1 0.0 37.1 1.0 8.1 1.3 0.2 0.0 46.7 0.0 6.2 6.5 15.8 7.9 12.5 1.6 0.7 0.0 5.3 0.3 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225496-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.0;intestine: 8.6" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 4.5;Horizontal cells: 6.4;Intestinal endocrine cells: 4.1;Spermatocytes: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 57.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047439 Uncertain NA NA "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 1.3 0.4 5.2 1.6 9.3 1.4 0.7 5.4 25.0 0.5 8.6 0.1 0.0 1.8 1.2 0.5 5.7 0.3 1.4 0.6 4.3 2.0 0.6 0.8 2.0 0.3 1.7 9.3 0.3 0.4 1.4 0.7 0.3 1.2 1.8 3.3 0.0 0.6 0.8 0.2 0.2 1.3 1.8 0.5 2.7 2.5 1.3 0.0 0.0 0.5 0.0 0.4 2.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.7 4.8 1.3 0.0 0.0 0.9 57.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.1 11.7 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.4 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 9.3 5.4 25.0 4.3 2.0 1.7 9.3 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 6.4 4.1 1.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 2.1 0.5 0.0 0.0 0.0 0.0 0.0 C3orf84 ENSG00000236980 "Chromosome 3 open reading frame 84" H3BNL1 3 49177632-49191858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 10.8" "Group enriched" "Detected in some" 89 "Early spermatids: 89.8;Late spermatids: 61.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NB-4: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in some" "A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 1.9 0.0 4.0 0.7 0.1 0.1 0.0 0.0 1.1 0.0 1.4 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 1.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 0.0 1.0 0.0 0.1 0.0 0.6 0.0 0.0 163.3 23.9 0.0 0.0 0.0 0.0 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 40.9 2.3 0.0 0.0 0.0 0.0 0.0 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;fallopian tube: 20.3;testis: 20.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 125.8;Early spermatids: 125.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;hTERT-RPE1: 8.3;U-87 MG: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.9 0.5 4.4 0.7 13.3 0.8 3.7 1.7 4.0 1.8 0.7 3.6 0.8 0.6 2.2 12.3 0.7 20.3 1.8 1.2 3.8 3.8 2.4 1.0 3.3 0.5 2.4 2.9 3.0 1.3 1.0 7.1 0.7 20.8 1.2 0.7 2.1 1.0 1.4 0.6 1.9 0.7 1.0 4.7 0.8 0.5 20.6 5.5 0.0 7.3 0.0 0.6 1.0 0.6 0.1 0.7 4.1 0.6 0.9 0.6 0.2 3.9 0.0 0.4 2.1 0.8 4.1 1.2 0.1 0.3 0.3 0.5 0.6 2.4 0.1 0.8 0.1 0.4 0.3 0.5 0.6 0.9 0.8 0.7 0.0 0.1 0.6 1.0 0.0 0.3 0.9 0.9 1.0 0.4 8.3 0.0 0.9 0.5 0.2 3.0 0.5 0.0 0.0 0.5 0.0 1.5 0.1 0.0 0.3 1.1 0.1 2.2 1.0 0.7 0.1 2.4 0.8 0.2 0.6 1.2 0.6 0.3 0.0 0.1 1.7 0.0 0.0 10.0 0.0 0.2 0.0 0.6 0.6 0.2 0.1 0.4 0.0 0.6 0.6 0.2 0.1 0.1 0.2 4.1 0.9 0.2 0.7 0.0 0.2 4.4 13.3 1.7 4.0 3.8 3.8 2.4 2.9 20.8 5.5 3.0 1.0 0.0 0.5 0.6 0.6 0.5 0.0 125.8 17.0 3.5 9.8 0.1 1.7 1.2 125.8 0.6 0.0 0.0 0.5 1.2 0.8 1.2 0.0 0.0 0.2 1.6 0.0 1.3 0.3 7.5 0.6 0.4 1.7 0.0 0.0 1.6 1.4 0.0 0.7 3.2 14.2 0.0 1.0 3.5 4.3 0.5 0.2 0.0 0.0 0.3 C4orf50 FLJ46481 ENSG00000181215 "Chromosome 4 open reading frame 50" Q6ZRC1 4 5897373-6018507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "brain: 6.0" "Cell type enhanced" "Detected in some" 15 "Horizontal cells: 1.6;Late spermatids: 1.1;Muller glia cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 5.0" NA NA "unprognostic (7.02e-3)" "unprognostic (6.55e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (6.64e-3)" "unprognostic (1.11e-1)" "unprognostic (4.35e-2)" "unprognostic (9.94e-5)" "unprognostic (4.31e-2)" "unprognostic (4.86e-3)" "unprognostic (2.61e-1)" "unprognostic (2.88e-6)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.68e-2)" 0.0 0.5 1.0 0.2 6.0 0.2 0.0 0.0 4.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.7 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C5orf34 FLJ32363 ENSG00000172244 "Chromosome 5 open reading frame 34" Q96MH7 5 43486701-43515145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Sertoli cells: 19.4;Spermatocytes: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045386 Approved NA NA "HPA045386: AB_10965552" "unprognostic (2.67e-2)" "unprognostic (1.25e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (2.65e-6)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.66e-4)" "unprognostic (7.79e-3)" "unprognostic (6.51e-3)" "unprognostic (4.00e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-1)" "unprognostic (9.97e-6)" "unprognostic (9.87e-2)" "unprognostic (1.45e-1)" "unprognostic (1.39e-3)" "unprognostic (5.99e-2)" 3.1 1.7 2.9 6.1 6.6 3.0 4.5 2.7 6.1 4.5 2.9 0.9 1.9 2.0 3.0 1.5 3.5 3.0 2.0 2.0 4.8 2.5 2.5 1.4 2.4 7.3 1.9 3.2 2.7 1.3 1.6 1.5 3.2 4.9 7.1 3.9 2.0 3.6 3.9 1.6 3.9 2.6 9.2 3.0 3.2 2.4 12.8 1.0 15.0 3.6 2.0 7.9 8.5 3.6 1.9 5.9 0.8 0.5 2.0 3.5 0.9 4.2 5.0 7.3 8.7 1.1 2.5 8.3 6.4 5.9 10.6 8.4 3.1 4.4 11.2 6.8 2.0 14.4 4.2 8.8 3.0 11.8 5.2 10.5 2.3 18.2 2.6 0.5 6.1 1.3 2.0 1.0 10.7 5.8 1.6 5.0 6.2 7.1 3.0 8.3 3.2 3.3 8.5 5.2 1.8 5.7 6.2 14.7 7.0 2.8 2.0 5.1 6.4 10.9 5.4 4.4 4.6 9.0 6.5 3.1 8.4 10.3 8.7 6.7 3.3 4.5 6.9 4.8 7.8 8.9 0.0 0.2 0.1 1.2 0.5 2.1 1.9 1.3 1.3 0.7 1.1 1.9 3.5 0.8 2.0 0.3 5.9 0.5 0.9 2.9 6.6 2.7 6.1 4.8 2.5 1.9 3.2 4.9 1.0 3.0 0.3 0.0 1.6 1.4 0.1 0.8 0.0 0.0 0.0 1.8 0.0 2.5 1.7 0.6 1.1 0.8 0.0 0.0 1.4 3.8 1.2 0.8 4.7 0.0 1.4 0.0 0.0 0.6 1.5 0.2 1.1 1.3 1.7 4.6 0.1 0.0 0.4 0.0 0.7 0.3 0.4 19.4 2.2 13.4 5.6 1.8 0.3 1.5 0.5 2.0 C5orf38 "CEI, IRX2NB" ENSG00000186493 "Chromosome 5 open reading frame 38" Q86SI9 5 2752131-2755397 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.9" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 32.4;Distal tubular cells: 87.9;Melanocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 38.2;HaCaT: 13.1;hTCEpi: 20.9;MCF7: 11.1;SiHa: 16.0;SK-BR-3: 15.0" HPA073667 Approved "Golgi apparatus,Vesicles" "Secreted - unknown location" NA NA "Golgi apparatus, Vesicles" "HPA073667: AB_2686624" "unprognostic (5.00e-3)" "unprognostic (4.10e-2)" "unprognostic (1.71e-2)" "unprognostic (3.72e-5)" "unprognostic (4.08e-2)" "unprognostic (2.24e-2)" "unprognostic (2.67e-2)" "unprognostic (8.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-2)" "unprognostic (7.60e-2)" "unprognostic (3.84e-7)" "unprognostic (2.60e-2)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (5.60e-2)" 8.3 0.5 4.5 0.6 7.6 0.5 16.3 10.4 3.0 0.6 1.1 1.5 9.8 0.7 0.7 6.8 4.1 0.6 0.6 2.4 6.0 7.0 6.6 0.5 19.4 1.1 10.5 2.0 0.5 3.8 5.0 2.6 4.3 14.8 5.9 0.7 3.4 34.9 3.9 0.9 10.6 0.5 0.5 12.2 0.7 11.2 1.5 4.7 0.0 5.0 1.6 2.4 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 6.9 0.0 3.0 2.1 38.2 4.9 3.9 3.3 2.9 1.9 0.0 0.0 0.0 0.9 0.0 13.1 0.7 3.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 20.9 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.8 11.1 0.0 0.1 1.0 4.3 0.0 0.0 1.4 0.0 4.3 0.0 1.0 0.0 16.0 15.0 0.0 2.3 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.6 10.4 0.3 6.0 7.0 10.5 2.0 14.8 4.7 11.9 8.3 0.0 13.3 21.9 0.0 0.6 0.0 1.4 6.8 12.2 0.0 32.4 87.9 0.0 0.7 0.6 0.0 0.0 0.2 12.9 3.0 11.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.5 37.1 0.0 1.3 0.0 0.5 0.0 0.4 0.7 0.6 0.0 17.8 0.4 0.9 18.7 12.2 0.0 1.2 2.4 C5orf47 LOC133491 ENSG00000185056 "Chromosome 5 open reading frame 47" Q569G3 5 173973779-174006140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "testis: 70.1" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 567.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-266/84: 4.5" "Low region specificity" "Detected in many" NA NA "unprognostic (7.54e-2)" "unprognostic (4.81e-3)" "unprognostic (3.81e-1)" "unprognostic (1.64e-2)" "unprognostic (1.31e-2)" "unprognostic (3.94e-1)" "unprognostic (8.72e-3)" "unprognostic (2.00e-2)" "unprognostic (2.82e-1)" "unprognostic (4.09e-2)" "unprognostic (3.03e-3)" "unprognostic (2.59e-1)" "unprognostic (2.63e-1)" "unprognostic (2.99e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.2 6.4 0.0 0.0 1.0 0.0 1.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 567.4 86.7 0.0 0.0 0.0 0.0 0.0 C5orf49 LOC134121 ENSG00000215217 "Chromosome 5 open reading frame 49" A4QMS7 5 7830378-7851490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 35.9;fallopian tube: 65.6;testis: 28.9" "Group enriched" "Detected in many" 13 "Ciliated cells: 337.3;Early spermatids: 639.5;Late spermatids: 261.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;CAPAN-2: 2.0;RPTEC TERT1: 2.3;SCLC-21H: 1.5;T-47d: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043759 Enhanced NA NA "HPA043759: AB_2678655" "unprognostic (1.55e-1)" "unprognostic (5.82e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (2.13e-3)" "unprognostic (4.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (7.93e-2)" "unprognostic (7.54e-3)" "unprognostic (1.85e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (2.28e-2)" "unprognostic (2.20e-2)" 1.0 1.3 9.7 1.0 16.9 0.8 1.6 0.5 7.4 3.0 0.9 12.2 1.2 1.0 2.1 9.9 0.9 65.6 1.3 0.9 10.4 12.4 3.5 1.3 10.1 0.9 5.7 6.3 6.9 2.4 2.7 5.9 0.9 35.9 2.3 0.9 0.7 0.9 2.0 0.9 1.1 0.9 1.1 2.7 0.9 1.4 28.9 4.0 0.0 1.6 0.0 0.9 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 1.2 0.0 0.0 0.0 0.2 0.0 2.3 0.1 1.5 0.8 0.9 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 16.9 0.5 7.4 10.4 12.4 5.7 6.3 35.9 4.0 0.0 4.8 0.0 1.7 0.0 0.3 0.3 0.0 337.3 31.8 8.7 0.0 0.1 3.3 3.5 639.5 0.1 0.0 0.0 0.8 2.6 1.3 7.2 1.1 0.8 0.1 1.6 5.2 0.0 0.0 261.9 8.1 0.9 3.3 0.0 0.1 2.4 1.5 0.0 3.5 29.2 3.5 6.5 0.0 11.1 4.7 0.5 0.2 0.0 0.0 0.7 C5orf52 ENSG00000187658 "Chromosome 5 open reading frame 52" A6NGY3 5 157671553-157680143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.2" "Group enriched" "Detected in some" 40 "Early spermatids: 361.8;Late spermatids: 1330.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.7" NA NA "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.64e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.9 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 361.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1330.4 7.2 0.0 0.0 0.0 0.0 0.0 0.1 4.0 6.0 0.0 0.0 6.5 0.0 21.2 4.1 0.0 0.0 0.0 1.2 0.0 C5orf63 "FLJ44606, YDR286C" ENSG00000164241 "Chromosome 5 open reading frame 63" A6NC05 5 127042558-127073492 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 46.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 32.7" HPA043240 Approved Approved Approved Mitochondria NA NA Mitochondria "HPA043240: AB_10962511" "unprognostic (2.71e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-1)" "unprognostic (2.63e-1)" "unprognostic (1.62e-1)" "unprognostic (1.93e-1)" "unprognostic (2.94e-4)" "unprognostic (1.34e-1)" "unprognostic (9.67e-2)" "unprognostic (3.40e-2)" "unprognostic (1.43e-4)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" 4.4 4.4 3.3 10.1 4.6 2.8 5.9 6.8 21.4 2.9 10.9 5.5 3.3 5.6 7.5 4.8 7.6 4.2 3.8 7.3 4.4 4.9 8.0 7.0 4.6 6.8 4.6 4.8 4.4 7.5 9.2 27.7 2.7 6.8 5.5 11.0 11.3 13.7 3.9 6.6 3.3 9.2 3.2 6.2 5.6 6.8 13.8 3.0 8.5 9.0 5.1 9.1 4.9 5.1 11.9 9.8 3.9 1.5 12.3 10.1 2.9 0.5 2.5 0.7 1.4 1.9 3.0 0.4 2.7 0.3 3.3 2.0 6.1 7.7 0.0 11.2 2.1 4.9 1.0 4.7 2.9 4.8 1.0 3.8 6.2 9.4 7.3 4.7 3.6 0.3 3.1 7.5 4.3 2.2 2.4 2.8 2.7 0.4 1.2 3.3 5.0 0.1 3.3 0.4 5.2 1.9 2.7 1.6 4.3 3.7 3.8 6.2 5.1 3.5 1.6 0.2 1.4 6.4 5.4 2.2 7.1 6.5 8.1 1.7 3.8 9.7 0.2 32.7 0.4 3.6 3.4 0.3 3.9 6.7 1.5 5.3 11.9 6.1 7.1 3.0 10.8 9.2 6.8 1.4 12.3 0.4 9.8 10.1 2.9 3.3 4.6 6.8 3.2 4.4 4.9 4.6 4.8 6.8 3.0 6.0 13.2 11.9 9.8 0.9 10.3 29.0 5.1 16.0 3.4 15.7 13.7 9.2 16.6 13.8 20.7 3.3 8.4 0.0 8.6 7.4 2.7 7.2 9.3 8.1 4.5 0.0 10.4 3.7 0.8 12.1 2.3 1.9 8.5 1.8 10.6 10.9 10.6 15.3 2.1 5.1 9.8 6.5 1.7 46.5 13.4 1.0 2.3 4.4 13.2 11.9 C6orf10 TSBP ENSG00000204296 "Chromosome 6 open reading frame 10" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 28.6" "Cell type enriched" "Detected in some" 12 "Early spermatids: 313.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 1.1;U-2197: 1.3" HPA047479 Approved Cytosol NA NA Cytosol "HPA047479: " "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309607 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6" "Group enriched" "Detected in some" 7 "Ciliated cells: 329.2;Early spermatids: 104.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 7.4;SCLC-21H: 4.3" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria NA NA Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.3 0.3 4.4 0.3 11.4 0.3 0.3 0.1 0.8 1.5 0.3 7.5 0.1 0.3 1.0 7.2 0.3 23.9 0.3 0.3 4.3 2.7 0.3 0.3 4.7 0.3 0.3 1.0 3.4 0.3 0.3 10.4 0.3 14.5 0.3 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.3 0.8 0.3 0.3 9.6 3.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.4 0.1 0.8 4.3 2.7 0.3 1.0 14.5 3.9 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.0 329.2 22.7 0.0 0.0 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 C6orf136 Em:AB023049.8 ENSG00000204564 "Chromosome 6 open reading frame 136" Q5SQH8 6 30647039-30653210 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046804 Uncertain NA NA "HPA046804: AB_2679815" "unprognostic (1.94e-2)" "unprognostic (1.71e-3)" "unprognostic (1.26e-1)" "unprognostic (8.01e-3)" "unprognostic (1.65e-2)" "unprognostic (2.76e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (4.72e-3)" "unprognostic (3.43e-1)" "prognostic favorable (9.16e-8)" "unprognostic (2.33e-2)" "unprognostic (4.54e-2)" "unprognostic (6.03e-2)" "prognostic favorable (7.51e-4)" 7.4 13.4 13.5 7.1 19.0 7.5 6.9 22.6 30.0 8.1 22.5 11.9 8.4 24.2 6.2 16.4 9.6 8.4 6.8 16.9 13.5 15.1 14.4 11.7 9.2 8.1 15.8 18.1 5.2 13.3 20.4 12.3 7.0 24.9 7.3 21.3 8.4 8.9 12.1 21.3 14.3 21.5 7.7 11.7 8.2 9.1 7.6 9.5 3.6 10.7 13.0 6.8 10.0 5.8 3.5 2.5 2.2 1.2 1.1 3.9 1.2 3.7 6.2 3.3 2.9 5.1 6.3 5.8 1.4 1.7 3.8 5.3 4.0 2.7 3.2 2.3 1.1 3.2 5.1 0.5 0.2 4.1 2.8 4.7 1.7 4.3 2.4 1.4 5.3 5.5 2.8 5.7 2.8 3.5 3.8 1.5 5.3 4.3 2.4 0.8 6.3 2.3 5.8 3.7 5.9 3.4 4.5 3.1 6.5 8.3 5.5 8.0 1.5 1.9 6.5 4.3 1.3 3.2 1.2 0.7 1.1 5.6 2.2 4.8 6.4 7.4 2.2 2.0 4.7 2.5 0.1 1.2 0.2 2.0 1.0 2.6 3.5 2.4 1.4 1.2 2.3 3.9 2.3 2.2 1.1 1.1 2.5 1.7 1.2 13.5 19.0 22.6 30.0 13.5 15.1 15.8 18.1 24.9 9.5 0.0 4.1 10.4 10.9 8.2 16.6 22.2 12.7 4.0 4.5 34.9 3.9 14.7 49.7 15.7 11.6 9.3 69.1 0.0 15.5 9.0 7.8 8.5 12.7 9.4 13.5 11.1 22.0 6.7 3.5 13.1 7.2 8.6 10.1 11.8 43.6 13.0 14.3 49.1 6.0 20.3 18.9 6.5 5.7 23.6 47.3 9.4 14.1 10.1 40.5 15.5 C6orf141 MGC46457 ENSG00000197261 "Chromosome 6 open reading frame 141" Q5SZD1 6 49550646-49561907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;gallbladder: 18.9" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "basal ganglia: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5" HPA036199 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA036199: AB_2675002" "prognostic favorable (3.92e-6)" "unprognostic (1.58e-1)" "unprognostic (9.87e-2)" "prognostic favorable (1.15e-4)" "unprognostic (4.95e-2)" "unprognostic (2.15e-2)" "unprognostic (1.39e-3)" "unprognostic (8.13e-2)" "unprognostic (7.02e-2)" "unprognostic (2.85e-2)" "unprognostic (6.37e-3)" "unprognostic (1.41e-1)" "unprognostic (1.89e-8)" "unprognostic (2.33e-2)" "unprognostic (5.81e-1)" "unprognostic (3.77e-1)" "unprognostic (4.43e-1)" 4.7 0.2 1.0 3.0 30.6 0.0 4.9 3.1 1.8 3.7 2.1 0.3 4.4 10.5 4.4 3.6 2.9 1.9 18.9 0.4 0.3 0.4 0.3 1.1 0.6 0.6 0.5 0.1 0.5 3.3 0.0 2.0 0.2 2.8 1.1 1.4 0.0 2.2 0.9 1.2 4.6 1.4 1.4 0.3 0.1 9.1 3.1 2.9 0.0 1.1 0.4 0.8 1.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.1 0.0 0.0 0.0 0.0 1.6 0.8 0.9 0.0 0.0 0.2 3.3 0.0 0.5 1.5 8.0 8.8 1.0 2.3 0.0 0.0 5.6 0.0 7.0 0.0 0.3 0.0 0.0 0.3 6.9 0.0 5.0 2.7 1.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.3 1.2 12.0 0.0 0.0 0.0 1.6 5.2 0.2 0.0 2.2 0.0 0.0 0.4 7.5 0.0 2.7 0.4 0.0 0.0 5.7 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 30.6 3.1 1.3 0.3 0.4 0.5 0.1 2.8 2.9 0.0 1.9 0.0 22.6 36.7 0.0 2.0 7.6 5.3 12.5 0.0 0.0 2.9 0.0 32.6 0.2 8.8 2.0 0.0 8.1 15.4 0.9 2.7 0.0 0.0 0.8 0.0 102.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 7.8 7.0 0.4 0.0 0.0 0.0 0.9 0.5 0.5 31.5 1.7 0.0 1.7 13.2 C6orf15 STG ENSG00000204542 "Chromosome 6 open reading frame 15" Q6UXA7 6 31111223-31112559 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "RH-30: 8.3;U-2 OS: 3.7" "Not detected" "Not detected" HPA001436 Uncertain "Secreted - unknown location" NA NA "HPA001436: AB_2243752" "unprognostic (2.73e-2)" "unprognostic (5.39e-2)" "unprognostic (1.46e-2)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.35e-1)" "unprognostic (3.42e-2)" "unprognostic (1.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.3 10.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 7.3 0.0 11.5 3.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf201 dJ1013A10.5 ENSG00000185689 "Chromosome 6 open reading frame 201" Q7Z4U5 6 4079206-4130951 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 46 "testis: 27.6" "Group enriched" "Detected in some" 22 "Early spermatids: 387.3;Late spermatids: 525.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-2)" "unprognostic (3.87e-1)" "unprognostic (3.91e-2)" "unprognostic (4.85e-3)" "unprognostic (1.22e-3)" "unprognostic (2.69e-3)" "unprognostic (3.47e-1)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (9.86e-2)" "unprognostic (4.72e-3)" "unprognostic (3.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (3.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 6.7 3.4 0.0 0.0 0.0 0.0 0.0 387.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 525.7 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.4 0.0 0.0 20.4 3.2 0.0 0.2 0.0 0.0 0.0 C6orf223 MGC45491 ENSG00000181577 "Chromosome 6 open reading frame 223" Q8N319 6 44000580-44005958 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 23.6;lung: 9.4" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.9;JURKAT: 18.7;RPTEC TERT1: 22.6;THP-1: 9.4" "HPA035765, HPA046117" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA035765: AB_2797225, HPA046117: AB_10964082" "unprognostic (2.94e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-2)" "unprognostic (4.31e-2)" "unprognostic (2.74e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.06e-3)" "unprognostic (2.34e-4)" "unprognostic (1.39e-3)" "unprognostic (2.70e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (2.95e-1)" "unprognostic (5.15e-2)" "unprognostic (2.62e-1)" "unprognostic (1.31e-1)" 0.1 0.4 1.1 1.3 0.9 0.5 23.6 0.2 3.0 0.7 1.4 0.0 0.0 1.8 0.8 4.7 0.1 0.2 6.9 2.9 1.1 0.8 4.9 1.4 9.4 2.8 0.1 1.2 0.1 2.4 0.1 0.8 0.2 0.9 0.2 0.7 3.4 3.1 0.1 0.3 0.5 3.1 0.2 0.0 0.7 0.2 0.3 0.0 1.0 2.1 1.1 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.3 0.0 18.7 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.2 0.3 0.0 0.1 1.9 3.4 1.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.2 3.0 1.1 0.8 0.1 1.2 0.9 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.6 0.5 1.4 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.4 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 17.7" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 33.5;Early spermatids: 33.2;Late spermatids: 22.3;Spermatocytes: 32.4;Spermatogonia: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.7;NB-4: 7.7" "Low region specificity" "Detected in all" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.6 2.4 5.6 1.4 4.8 0.9 3.0 2.7 4.3 1.2 1.5 4.4 5.5 7.7 1.4 9.0 0.9 8.0 1.2 0.7 4.9 5.3 3.8 1.4 1.7 1.1 4.5 3.2 1.9 7.7 1.5 2.9 1.5 4.4 3.1 1.0 0.7 1.8 1.7 1.2 2.5 2.1 0.9 4.0 1.0 1.6 17.7 2.6 1.6 2.1 1.0 1.6 1.0 2.0 0.7 1.0 4.7 1.0 1.4 6.2 0.6 1.1 2.7 2.5 2.2 0.9 0.0 4.4 0.2 0.1 0.3 0.6 3.0 2.4 0.1 4.0 0.0 2.9 0.2 2.4 0.0 1.0 1.4 4.2 0.6 0.5 0.4 0.0 0.8 0.4 0.5 3.9 1.1 1.5 0.3 0.0 2.5 4.7 0.3 1.1 8.7 1.8 7.7 2.3 1.6 3.0 1.5 0.2 1.0 1.2 0.6 5.0 3.1 0.9 0.6 4.9 2.6 0.2 1.5 0.4 2.0 0.7 1.5 1.8 3.6 7.5 1.5 3.5 1.1 1.9 0.0 0.5 4.7 1.2 1.0 0.4 0.5 1.5 1.3 1.0 0.7 0.7 0.6 0.6 1.4 0.7 0.8 6.2 0.6 5.6 4.8 2.7 4.3 4.9 5.3 4.5 3.2 4.4 2.6 0.0 2.4 0.0 1.7 1.3 1.8 0.5 2.5 33.5 1.2 3.5 2.0 2.4 5.0 3.1 33.2 1.0 1.1 0.0 5.3 2.1 1.5 1.5 0.0 1.6 1.0 1.6 2.9 2.5 0.3 22.3 2.0 0.7 3.3 2.8 0.5 3.8 2.8 2.9 0.0 8.1 0.6 0.0 2.1 32.4 23.4 1.3 1.1 0.0 1.8 0.7 C6orf62 "DKFZP564G182, FLJ12619, XTP12" ENSG00000112308 "Chromosome 6 open reading frame 62" Q9GZU0 6 24704861-24720836 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 306.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030564, HPA030566" Supported Approved Cytosol NA NA Cytosol "HPA030564: AB_10600000, HPA030566: AB_10599425" "unprognostic (2.07e-2)" "unprognostic (2.92e-1)" "unprognostic (7.10e-2)" "unprognostic (6.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.18e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.04e-4)" "unprognostic (4.16e-3)" "unprognostic (3.94e-2)" "unprognostic (3.08e-2)" "unprognostic (9.01e-2)" "unprognostic (4.03e-1)" "unprognostic (1.93e-2)" "prognostic favorable (3.62e-6)" 38.9 38.3 46.0 42.8 49.9 37.8 52.0 34.3 50.1 30.7 35.4 31.4 49.9 30.8 31.0 42.6 33.1 32.0 41.9 27.8 38.2 40.5 35.1 49.0 54.6 67.6 50.0 36.7 37.8 52.9 35.6 33.6 37.9 33.9 33.6 31.3 33.8 47.4 52.6 31.1 33.7 38.6 28.8 36.4 58.3 38.9 46.0 38.1 75.2 41.5 28.1 56.5 35.6 34.2 48.4 48.7 64.0 62.3 52.7 65.3 103.5 23.0 14.3 17.6 29.8 22.2 28.7 19.3 27.4 35.8 41.3 44.2 17.9 20.8 26.6 43.2 32.1 40.8 19.3 20.1 26.8 45.8 44.8 9.7 27.9 23.3 24.0 37.9 33.9 33.4 22.3 54.1 27.9 37.2 27.6 31.9 16.6 24.5 19.9 38.7 19.1 26.0 51.0 19.4 14.1 14.5 20.9 19.1 26.7 24.6 34.9 29.8 16.8 32.8 37.4 49.7 20.6 32.8 27.2 28.3 37.4 18.1 14.1 37.2 46.8 73.7 33.1 13.4 46.9 36.1 47.7 62.1 64.0 55.7 62.0 58.6 48.4 57.4 60.6 47.7 41.8 57.6 65.3 44.2 52.7 62.3 48.7 53.4 103.5 46.0 49.9 34.3 50.1 38.2 40.5 50.0 36.7 33.9 38.1 77.4 66.5 104.0 40.4 51.1 48.9 29.1 107.0 54.9 46.6 89.0 47.1 43.9 31.5 55.4 110.4 61.6 88.0 93.5 64.0 46.9 51.8 87.1 54.3 110.1 83.6 39.7 92.1 86.5 306.8 40.0 50.0 84.3 47.2 83.8 78.0 40.4 70.7 77.0 44.6 54.9 60.4 51.8 42.8 83.7 91.8 48.9 62.9 96.5 75.2 51.5 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.4 6.6 15.4 10.7 6.0 8.7 6.7 5.9 9.7 6.0 8.7 4.7 13.3 8.8 5.0 18.5 12.4 8.7 6.2 4.4 5.1 12.6 4.9 5.9 9.2 12.6 11.8 15.9 6.9 9.3 5.8 6.1 5.2 10.6 14.4 12.9 10.1 5.7 18.8 10.2 24.4 13.0 5.6 12.5 20.9 5.2 11.2 6.3 9.8 8.6 16.0 6.5 21.7 9.0 7.1 9.9 17.8 7.6 8.1 26.6 8.8 14.6 12.3 12.1 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 8.9 7.5 6.1 8.2 13.5 6.1 5.3 10.2 4.0 5.7 1.8 5.9 10.4 0.0 7.5 5.8 9.3 8.4 0.0 8.8 9.1 9.3 8.5 1.1 6.4 11.6 4.8 12.1 14.7 10.3 3.2 7.5 9.8 6.8 4.6 12.3 6.7 9.2 10.5 8.1 6.3 6.1 6.5 13.2 11.2 13.8 11.2 8.1 14.6 10.2 6.0 C7orf33 ENSG00000170279 "Chromosome 7 open reading frame 33" Q8WU49 7 148590565-148615860 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "retina: 3.9;testis: 2.0" "Cell type enhanced" "Detected in some" 19 "Cone photoreceptor cells: 2.0;Early spermatids: 1.1;Extravillous trophoblasts: 4.0;Late spermatids: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "SCLC-21H: 7.2" NA NA "unprognostic (4.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 C7orf57 ENSG00000164746 "Chromosome 7 open reading frame 57" Q8NEG2 7 48035511-48061304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;fallopian tube: 20.9;testis: 11.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 143.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 20.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Cell line enhanced" "Detected in some" "GAMG: 6.2;hTERT-HME1: 9.8;U-266/70: 5.8;U-698: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021286 Enhanced NA NA "HPA021286: AB_1845760" "unprognostic (1.74e-2)" "unprognostic (4.82e-2)" "unprognostic (3.13e-2)" "unprognostic (1.28e-2)" "unprognostic (2.77e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.37e-1)" "unprognostic (4.98e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-5)" "unprognostic (5.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.42e-3)" "unprognostic (1.20e-1)" 0.2 0.2 2.3 0.2 5.0 0.5 0.3 0.1 1.0 0.8 0.2 3.5 0.0 0.3 0.9 7.1 1.4 20.9 0.2 0.3 3.7 4.0 0.3 0.2 4.3 0.3 0.1 0.4 1.6 0.1 0.7 0.4 0.2 20.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.7 0.2 0.2 11.4 2.1 0.0 0.5 1.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.6 2.3 0.1 0.7 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.5 0.3 0.4 0.0 2.4 0.0 0.2 0.1 6.2 0.3 0.0 1.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.8 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.1 0.0 0.3 0.8 0.0 0.0 0.1 0.6 0.9 0.4 0.6 5.8 0.8 3.3 1.4 0.0 0.9 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.6 0.6 0.1 0.0 0.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 2.3 5.0 0.1 1.0 3.7 4.0 0.1 0.4 20.0 2.1 0.0 4.8 0.0 0.0 0.0 0.0 0.8 0.0 143.2 22.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 9.4 0.4 0.0 0.0 0.0 0.0 0.0 C7orf61 IMAGE:4839025 ENSG00000185955 "Chromosome 7 open reading frame 61" Q8IZ16 7 100456615-100464271 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 80.4" "Group enriched" "Detected in many" 48 "Early spermatids: 438.3;Late spermatids: 271.6" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 22.2;NB-4: 8.1;TIME: 13.0" HPA060395 Enhanced Approved Vesicles NA NA Vesicles "HPA060395: AB_2684274" "unprognostic (1.88e-1)" "unprognostic (5.02e-1)" "unprognostic (1.26e-2)" "unprognostic (7.70e-5)" "unprognostic (1.65e-1)" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.26e-1)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (2.53e-1)" "unprognostic (6.39e-13)" "unprognostic (9.54e-2)" "unprognostic (2.93e-1)" "unprognostic (1.33e-2)" "unprognostic (1.24e-2)" 0.5 0.3 2.8 0.6 3.1 1.2 0.5 1.4 3.4 0.5 0.5 0.5 0.5 0.1 0.8 0.8 0.5 0.7 0.6 0.5 3.0 2.3 0.5 0.5 0.5 0.8 3.2 0.5 1.0 0.5 0.4 0.9 0.6 0.6 0.5 0.2 0.5 0.5 0.7 0.5 0.7 0.5 0.5 3.1 1.0 0.1 80.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.6 1.3 1.2 0.8 2.9 0.2 0.8 0.2 0.7 0.8 0.9 2.0 0.3 0.3 1.3 0.2 0.7 0.9 0.4 0.6 1.5 0.8 1.2 0.6 0.3 0.0 0.5 0.8 1.5 1.2 1.7 0.0 1.1 0.4 0.3 0.3 0.4 0.8 1.2 2.1 22.2 2.1 0.6 1.1 1.3 2.1 0.4 8.1 0.5 0.3 1.0 2.1 0.0 0.4 0.3 0.3 0.0 0.0 0.5 0.7 1.3 0.4 0.4 2.2 13.0 1.2 2.0 2.5 0.4 0.3 0.2 0.8 0.2 1.9 0.1 0.0 1.2 0.0 0.8 0.7 0.3 0.0 1.1 0.6 0.6 0.1 0.1 1.6 1.3 0.8 0.4 0.0 2.9 0.2 2.8 3.1 1.4 1.5 3.0 2.3 3.2 0.5 0.6 0.5 0.0 0.0 0.0 0.4 7.3 1.5 0.9 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 438.3 1.5 0.3 0.0 0.0 0.3 1.3 0.6 0.0 0.0 0.8 3.2 0.0 0.0 0.3 271.6 7.2 1.7 5.0 1.0 0.2 6.3 0.3 0.0 3.5 0.0 0.0 6.5 0.8 3.6 2.5 5.4 0.1 0.0 0.4 0.4 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.3 0.2 1.4 4.5 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.2 0.3 0.3 0.8 0.2 0.1 5.8 0.7 1.0 0.4 0.3 0.1 0.5 0.1 0.6 0.8 1.6 0.3 0.1 0.7 0.3 1.0 5.1 0.6 0.1 0.5 2.6 0.0 0.1 0.2 5.4 0.1 0.6 0.4 1.1 0.2 0.3 0.3 0.0 0.6 2.6 0.2 0.1 1.0 0.6 3.4 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 14.9 16.0 0.0 0.6 1.4 1.2 1.2 0.0 28.1 6.8 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.9 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.2 0.6 0.3 0.0 0.0 0.4 C8orf44 FLJ11267 ENSG00000213865 "Chromosome 8 open reading frame 44" Q96CB5 8 66667615-66685564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043660, HPA054753" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043660: AB_10794889, HPA054753: AB_2682592" "unprognostic (6.19e-2)" "unprognostic (7.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-3)" "unprognostic (8.20e-3)" "unprognostic (4.42e-2)" "unprognostic (2.73e-2)" "prognostic favorable (4.21e-4)" "unprognostic (7.35e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (4.01e-2)" "unprognostic (9.35e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.68e-6)" 5.8 4.5 15.8 6.1 18.1 8.6 9.6 16.6 14.9 6.6 5.3 10.4 7.2 4.3 8.4 27.7 4.2 7.7 5.6 5.8 10.6 7.7 5.9 4.0 4.7 10.1 11.4 9.0 10.2 4.6 6.8 14.6 5.8 8.6 6.8 8.3 8.9 7.7 7.0 11.6 12.4 5.3 5.9 9.2 7.5 6.4 15.3 11.5 9.4 10.8 3.0 8.0 6.8 6.0 5.8 4.4 5.7 3.1 0.6 3.8 1.5 8.7 3.4 5.8 4.1 3.5 6.9 3.2 2.4 2.3 3.3 3.9 3.5 9.9 9.8 1.6 4.1 4.7 6.0 5.5 2.1 4.6 7.3 5.3 8.3 10.5 7.2 2.8 3.7 5.9 5.8 4.9 4.4 4.8 6.5 4.1 10.9 9.4 6.5 3.3 3.2 4.1 5.1 5.0 6.5 4.3 4.0 1.9 2.0 4.8 1.8 4.7 3.8 2.6 1.7 3.1 4.3 5.8 2.4 5.9 3.5 4.7 3.4 1.5 7.7 2.6 4.0 5.7 4.0 1.8 5.7 3.1 4.0 1.9 2.5 1.4 5.8 2.4 2.2 2.6 4.8 3.8 2.8 3.6 0.6 1.3 4.4 3.4 1.5 15.8 18.1 16.6 14.9 10.6 7.7 11.4 9.0 8.6 11.5 3.0 3.4 3.7 5.3 0.6 8.6 26.0 0.0 5.3 4.5 7.0 7.9 2.7 10.0 2.0 0.9 3.8 2.6 0.0 3.4 1.6 4.4 4.8 3.5 2.4 2.6 1.6 6.3 3.7 4.4 1.3 8.6 4.9 1.7 1.8 3.6 7.0 2.4 4.3 8.5 3.3 6.0 12.9 3.9 16.4 5.7 1.4 1.4 2.9 3.3 3.4 C8orf46 MGC33510 ENSG00000169085 "Chromosome 8 open reading frame 46" Q8TAG6 8 66460003-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 51.7" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 1.4;Hepatocytes: 2.4;Leydig cells: 2.6;Peritubular cells: 1.8" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 6.5;LHCN-M2: 4.0;SK-MEL-30: 4.4;T-47d: 5.6;WM-115: 5.6" "Group enriched" "Detected in many" 8 "amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA075134: AB_2686736" "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 1.2 1.4 14.9 1.2 16.6 1.2 1.2 1.8 51.7 1.6 1.2 16.3 0.0 1.0 1.6 1.3 1.5 1.2 1.7 2.2 39.1 8.3 1.3 1.2 1.4 1.4 13.8 19.4 1.1 1.8 1.1 0.2 1.1 10.9 2.2 1.3 0.0 1.7 5.3 3.1 1.4 1.4 2.0 17.9 1.2 1.1 1.4 10.0 0.0 1.3 0.0 1.1 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.7 0.1 3.1 0.2 0.4 2.0 0.0 0.1 0.0 0.3 0.3 0.5 0.1 0.0 3.0 0.0 0.3 3.0 6.5 0.1 0.0 0.0 2.2 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 4.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 1.3 0.1 0.5 0.0 0.0 0.0 4.4 0.4 5.6 0.0 0.0 0.4 0.7 0.2 2.7 0.1 1.1 0.0 1.1 0.1 5.6 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.9 16.6 1.8 26.7 39.1 8.3 13.8 19.4 10.9 10.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.4 0.1 0.0 0.0 0.6 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 C8orf58 FLJ34715 ENSG00000241852 "Chromosome 8 open reading frame 58" Q8NAV2 8 22599601-22604150 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 26.7;Sertoli cells: 25.8;Syncytiotrophoblasts: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA024667, HPA028286" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA024667: AB_1845783, HPA028286: AB_1845784" "unprognostic (8.88e-3)" "unprognostic (4.58e-2)" "unprognostic (1.99e-1)" "unprognostic (1.69e-2)" "unprognostic (6.72e-2)" "unprognostic (9.68e-2)" "unprognostic (2.60e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (8.70e-2)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.67e-1)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" 12.3 5.4 6.0 6.3 6.2 4.4 14.5 12.9 7.1 10.3 5.9 6.5 5.8 4.0 10.9 7.6 8.6 7.3 8.9 6.7 6.3 3.6 9.4 5.7 9.2 7.4 4.2 5.9 10.5 5.5 5.8 4.4 28.5 5.3 12.3 3.9 10.2 7.1 7.1 8.2 13.0 6.2 7.3 3.3 19.7 4.9 11.6 4.2 4.0 7.9 6.5 5.7 6.3 7.6 1.8 0.5 3.7 1.6 0.1 2.3 0.6 4.6 7.0 19.5 11.2 5.4 6.2 5.3 10.5 8.9 13.2 9.5 1.3 4.0 0.9 5.1 11.5 9.1 4.6 3.5 9.9 8.5 1.4 1.6 2.7 6.8 0.7 9.5 0.9 4.3 8.9 8.5 7.9 5.0 12.0 7.6 3.7 1.7 1.4 10.4 3.3 2.0 5.0 11.9 3.8 4.7 3.4 4.9 1.0 8.0 4.3 2.0 6.3 5.2 3.7 11.8 21.2 3.5 2.2 10.5 14.4 11.7 9.9 9.6 1.7 1.0 0.9 7.4 2.0 11.7 0.0 0.9 3.7 0.7 1.6 0.4 1.7 0.4 1.0 0.5 1.8 2.3 1.8 0.0 0.1 0.0 0.5 0.0 0.6 6.0 6.2 12.9 7.1 6.3 3.6 4.2 5.9 5.3 4.2 3.0 1.3 5.0 2.9 9.2 2.5 1.6 0.0 2.7 4.5 0.0 0.0 22.8 0.0 10.1 0.9 10.5 3.0 0.0 6.0 26.7 6.2 2.7 1.1 0.6 8.1 1.6 4.1 16.5 4.4 2.2 8.1 3.6 3.3 11.8 1.9 6.3 9.7 3.1 6.0 1.6 4.1 25.8 6.6 0.7 2.4 8.4 46.7 2.5 1.9 2.4 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219957-123241398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 59.8" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavorable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 11.9 15.4 13.5 11.4 21.8 13.8 14.5 18.5 15.2 12.0 13.5 11.5 27.0 11.8 9.2 16.1 16.4 9.5 11.2 11.1 11.5 11.8 10.1 19.3 10.2 15.9 11.8 10.6 9.8 12.3 8.5 24.0 15.5 10.9 11.5 15.8 12.5 13.9 23.7 16.9 10.0 12.5 10.8 9.4 15.9 10.4 7.4 14.4 18.8 13.9 9.9 18.3 10.3 10.7 12.7 17.2 24.4 18.9 13.4 18.6 11.0 8.5 7.9 7.4 5.2 7.2 6.7 5.0 8.1 7.9 9.5 9.6 7.2 6.3 5.9 8.9 7.7 7.1 6.6 8.4 4.4 10.8 9.3 12.0 6.9 3.6 10.1 13.1 3.6 5.7 4.9 8.6 8.5 7.1 5.7 8.4 9.3 9.8 4.6 7.8 25.0 10.5 8.2 6.0 20.9 13.8 5.6 3.8 6.7 8.1 7.1 9.7 9.1 8.1 59.8 8.5 7.9 7.3 8.8 4.6 5.4 10.4 5.8 6.6 6.1 6.7 6.3 5.8 8.2 5.8 15.9 16.7 24.4 13.3 18.9 13.9 11.2 14.5 16.8 17.2 12.7 13.9 13.7 9.8 13.4 15.3 14.9 18.6 11.0 13.5 21.8 18.5 15.2 11.5 11.8 11.8 10.6 10.9 14.4 11.9 1.3 15.7 15.3 11.9 7.9 4.8 5.1 14.7 5.7 1.8 9.8 23.3 5.0 14.4 2.3 5.8 16.8 0.0 10.4 25.8 12.4 15.5 21.9 9.8 20.4 128.7 23.7 8.0 17.1 3.0 11.8 16.5 13.5 19.0 12.8 10.2 13.7 14.4 7.1 7.9 7.1 19.4 4.5 13.1 19.3 10.0 33.6 13.8 14.0 34.2 C8orf86 FLJ43582 ENSG00000196166 "Chromosome 8 open reading frame 86" Q6ZUL3 8 38510834-38528662 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;intestine: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.2" HPA025066 Uncertain NA NA "HPA025066: AB_1848937" "unprognostic (9.54e-2)" "unprognostic (9.14e-3)" "unprognostic (2.38e-2)" "unprognostic (2.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" 0.5 0.2 0.6 0.1 0.4 0.6 0.2 1.5 0.9 0.2 0.2 3.9 0.2 0.2 0.3 0.4 0.6 0.1 0.7 0.7 0.5 0.8 0.0 0.0 0.5 0.2 0.3 0.0 1.1 0.0 0.2 0.1 0.3 0.0 1.0 0.6 1.8 0.0 0.3 0.2 0.7 0.5 0.0 0.0 0.3 0.1 1.3 0.7 2.3 0.6 1.4 0.7 0.2 0.1 0.0 0.2 0.6 0.7 2.2 0.3 1.8 0.4 0.1 0.2 0.5 0.3 0.5 0.3 0.0 0.5 1.0 0.1 0.0 0.2 0.9 0.3 0.0 1.0 0.0 0.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.6 0.7 0.0 1.4 0.1 1.6 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.5 0.3 0.6 0.4 0.3 0.5 1.2 0.0 0.7 0.6 0.5 1.2 0.1 0.6 1.0 0.6 0.4 0.3 0.1 2.0 0.6 0.4 0.5 0.3 0.5 0.9 0.5 0.5 0.3 1.3 0.7 0.7 2.3 1.4 0.4 0.7 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 C8orf89 ENSG00000274443 "Chromosome 8 open reading frame 89" P0DMQ9 8 73241329-73259502 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 8.8;testis: 10.5" "Group enriched" "Detected in some" 5 "Early spermatids: 6.8;Spermatocytes: 16.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 8.8" "Lineage enriched" "Detected in many" 8 "B-cells: 8.8" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;BJ hTERT+: 1.1;HEK 293: 1.3;HHSteC: 1.2;hTCEpi: 1.8;hTERT-RPE1: 1.0;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.52e-3)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" "unprognostic (2.38e-1)" "unprognostic (6.34e-2)" "unprognostic (3.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (3.19e-1)" "unprognostic (1.17e-1)" "unprognostic (4.01e-2)" "unprognostic (4.62e-4)" "unprognostic (5.50e-2)" "unprognostic (2.16e-1)" "unprognostic (9.26e-2)" "unprognostic (6.32e-2)" 0.3 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.7 0.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.1 0.0 10.5 0.0 1.0 0.0 8.8 0.9 0.0 0.2 1.1 0.3 0.3 0.2 0.0 0.4 0.0 3.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.2 0.2 0.0 0.9 8.8 0.3 0.2 0.0 1.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.1 0.6 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 2.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.8 0.2 0.0 0.2 0.0 0.0 0.1 C9orf131 MGC41945 ENSG00000174038 "Chromosome 9 open reading frame 131" Q5VYM1 9 35041095-35045991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 46.6" "Group enriched" "Detected in some" 32 "Early spermatids: 99.2;Late spermatids: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 4.0;RT4: 14.0" "Not detected" "Not detected" HPA022029 Approved Mitochondria NA NA Mitochondria "HPA022029: AB_10960628" "unprognostic (1.10e-2)" "unprognostic (8.99e-2)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-3)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.66e-1)" "unprognostic (9.45e-2)" "unprognostic (4.63e-2)" "unprognostic (1.75e-2)" "unprognostic (2.37e-2)" "unprognostic (9.34e-2)" "unprognostic (1.82e-1)" "unprognostic (9.90e-4)" "unprognostic (4.19e-3)" 0.2 0.1 0.2 0.2 0.3 1.3 0.3 0.6 0.3 1.0 0.2 0.2 0.2 0.0 2.2 0.8 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.3 0.7 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.8 0.5 0.2 0.2 0.2 0.2 0.2 46.6 0.2 0.2 0.3 0.2 0.2 0.3 0.2 1.0 0.1 2.7 0.5 0.9 1.4 0.0 3.4 0.1 0.3 0.8 0.7 0.0 1.0 1.0 0.0 0.0 0.0 0.9 1.8 0.7 0.3 0.0 1.2 2.2 0.0 0.0 0.4 0.3 0.5 1.2 4.0 0.9 0.0 0.4 1.2 0.0 0.5 0.0 0.0 0.0 0.5 1.4 3.4 2.4 0.0 0.5 0.7 1.8 0.6 1.0 0.0 0.0 0.3 0.0 0.3 14.0 0.3 0.0 1.2 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.9 1.3 0.3 0.5 1.5 2.7 0.5 0.0 0.5 0.0 0.0 0.5 0.4 1.4 0.0 1.0 0.5 0.8 1.3 0.9 0.0 0.1 0.1 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 99.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 26.1 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.3 0.0 0.5 0.0 0.0 0.0 C9orf152 bA470J20.2 ENSG00000188959 "Chromosome 9 open reading frame 152" Q5JTZ5 9 110190048-110208189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 16 "Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 8 "OE19: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA050769 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050769: AB_2681230" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "prognostic favorable (7.22e-5)" "unprognostic (2.28e-1)" "unprognostic (1.79e-3)" "unprognostic (6.86e-2)" "unprognostic (1.34e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (5.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (4.57e-1)" "unprognostic (2.49e-1)" "unprognostic (1.06e-2)" 0.4 0.0 0.4 1.7 0.4 0.0 6.1 0.4 0.4 5.3 16.1 0.5 10.5 9.1 1.0 0.4 2.4 1.5 7.1 0.4 0.4 0.0 0.4 0.5 3.6 0.4 0.4 0.4 0.4 3.9 0.0 0.8 0.4 0.4 11.6 20.9 0.4 34.3 17.0 0.4 3.8 7.0 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 1.6 5.2 1.3 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 57.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 8.9 12.3 0.0 2.5 0.2 0.0 0.2 22.9 5.3 10.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 7.7 0.0 9.9 0.0 0.2 16.2 0.0 0.9 0.1 0.0 24.9 0.0 0.0 0.0 0.0 0.2 10.1 0.0 113.3 0.0 5.3 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 69.7 4.7 C9orf47 "bA791O21.3, C9orf108, FLJ37523" ENSG00000186354 "Chromosome 9 open reading frame 47" Q6ZRZ4 9 88990863-88996140 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 12.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "classical monocyte: 2.2" "Lineage enriched" "Detected in single" 6 "monocytes: 2.2" "Cell line enhanced" "Detected in some" "AF22: 6.6;ASC diff: 3.2;HeLa: 5.6;JURKAT: 3.5" CAB009902 Approved "Secreted - unknown location" NA NA "CAB009902: AB_2184764" "unprognostic (6.51e-3)" "unprognostic (2.50e-1)" "unprognostic (2.94e-4)" "unprognostic (2.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (2.47e-2)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "unprognostic (2.98e-1)" "unprognostic (7.39e-2)" "unprognostic (1.98e-1)" "unprognostic (4.19e-6)" "unprognostic (5.61e-2)" "unprognostic (3.72e-2)" "unprognostic (6.91e-2)" "unprognostic (1.77e-2)" 1.7 5.3 0.6 1.0 0.7 0.8 2.3 0.0 0.7 1.8 1.0 0.3 1.1 0.6 2.1 2.1 0.9 1.8 0.8 0.5 3.9 0.8 1.0 1.7 0.4 0.4 1.7 0.0 3.3 1.2 1.9 0.2 0.3 0.8 0.0 0.0 0.8 1.4 0.5 1.7 1.0 0.0 0.7 0.5 0.9 1.9 0.0 0.2 0.3 2.2 0.0 0.0 0.4 0.0 0.4 6.6 0.2 3.2 1.9 0.1 1.1 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.4 0.5 0.0 0.1 0.0 5.6 0.0 0.0 0.4 0.0 0.2 0.1 0.7 0.0 0.2 0.7 3.5 0.3 0.0 0.0 0.5 1.6 1.4 0.4 0.0 0.3 0.7 0.0 0.0 0.0 0.6 0.2 0.5 0.3 0.1 0.0 0.7 0.1 1.8 1.8 0.6 1.4 1.1 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 2.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.0 2.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 1.2 1.0 0.0 0.0 0.2 3.2 0.0 0.6 0.0 0.0 0.3 0.0 1.7 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 12.9 1.4 0.0 0.2 0.3 0.2 0.0 0.0 0.6 C9orf50 FLJ35803 ENSG00000179058 "Chromosome 9 open reading frame 50" Q5SZB4 9 129612225-129620776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 9.4" "Group enriched" "Detected in some" 16 "Early spermatids: 60.3;Late spermatids: 168.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.9;MCF7: 4.4" HPA026743 Enhanced NA NA "HPA026743: AB_1845829" "unprognostic (2.23e-1)" "unprognostic (3.80e-2)" "unprognostic (3.27e-1)" "unprognostic (2.05e-1)" "unprognostic (3.79e-3)" "unprognostic (5.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" "unprognostic (9.28e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (4.20e-2)" "unprognostic (4.01e-2)" "unprognostic (6.08e-2)" "unprognostic (1.24e-1)" "unprognostic (4.44e-3)" "unprognostic (5.28e-2)" 0.0 0.4 1.5 0.1 1.2 0.2 0.0 0.9 2.5 0.2 0.2 0.0 0.2 0.0 0.0 1.5 1.5 0.0 1.0 1.4 0.4 0.0 0.1 0.1 1.1 0.0 0.0 0.1 0.5 0.2 0.1 0.0 0.8 1.5 0.0 0.0 0.0 0.4 0.8 0.3 0.1 9.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.7 0.3 1.9 0.2 0.8 0.0 0.5 1.7 1.2 0.5 0.0 0.6 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 1.1 0.0 0.0 1.4 0.3 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.6 4.4 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.6 0.2 0.1 1.6 0.4 0.2 0.0 0.1 0.4 0.0 0.0 1.2 0.3 0.2 0.1 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.2 60.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 168.5 0.9 0.0 0.0 0.0 0.0 7.0 0.2 0.0 1.8 0.5 0.2 0.0 0.5 1.2 2.2 0.0 0.0 0.0 0.0 0.1 C9orf57 ENSG00000204669 "Chromosome 9 open reading frame 57" Q5W0N0 9 72051376-72072721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 114 "testis: 31.4" "Cell type enriched" "Detected in some" 16 "Spermatocytes: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 3.2" NA NA "unprognostic (3.26e-2)" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 C9orf66 FLJ31158 ENSG00000183784 "Chromosome 9 open reading frame 66" Q5T8R8 9 212824-215741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 20.9;kidney: 17.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 60.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 20.9" "Group enriched" "Detected in many" 4 "granulocytes: 20.9;monocytes: 6.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;MCF7: 3.7;RT4: 3.6;THP-1: 7.8" HPA035652 Uncertain NA NA "HPA035652: AB_10601151" "unprognostic (1.24e-1)" "unprognostic (7.20e-2)" "unprognostic (7.64e-2)" "unprognostic (1.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (9.48e-2)" "unprognostic (6.65e-3)" "unprognostic (9.92e-2)" "unprognostic (5.66e-2)" "prognostic favorable (1.32e-5)" "unprognostic (2.04e-2)" "unprognostic (1.63e-1)" "unprognostic (2.73e-2)" "unprognostic (3.10e-3)" 0.5 3.1 0.3 0.3 0.9 1.7 0.7 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.5 0.1 0.3 0.3 0.3 0.1 17.8 0.5 0.3 0.3 0.3 0.3 0.5 1.3 1.9 0.3 0.3 0.3 0.7 0.0 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 1.4 0.2 0.7 0.8 0.3 1.3 0.3 0.3 0.4 0.3 2.0 3.0 20.9 6.0 1.6 0.6 0.6 0.1 0.4 0.3 0.4 0.1 0.1 3.6 0.1 0.0 0.2 0.1 0.7 2.1 0.4 1.0 0.3 0.4 0.6 0.1 0.0 0.0 0.3 1.1 0.3 0.5 0.3 0.1 0.9 1.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 1.9 0.8 0.0 3.7 0.2 2.4 0.4 0.1 0.8 0.4 0.3 2.1 0.1 3.6 0.6 0.4 0.0 0.2 0.5 0.3 1.6 7.8 1.1 0.3 0.8 0.5 0.2 0.9 0.4 0.1 0.2 1.3 0.7 7.0 4.9 8.0 0.3 3.3 0.1 1.8 0.6 0.4 3.0 2.0 0.1 0.2 20.9 1.6 6.0 0.7 0.1 0.6 0.3 0.9 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.8 0.0 0.3 2.0 1.5 1.0 0.6 1.1 2.5 1.4 0.0 10.4 13.7 8.5 10.0 1.1 0.0 0.3 0.0 0.0 4.7 1.7 0.7 1.5 0.0 0.4 4.9 0.0 3.4 0.0 3.1 0.0 0.9 3.8 0.0 6.4 2.6 0.8 1.1 0.0 0.4 60.2 3.2 6.5 1.0 2.2 5.5 0.1 3.9 2.1 0.2 1.4 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Group enriched" "Detected in some" 5 "Early spermatids: 46.5;Spermatocytes: 81.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Cell line enriched" "Detected in some" 5 "U-2 OS: 22.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA032108 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.8 1.1 0.4 0.0 0.0 0.3 0.0 0.0 22.4 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 0.1 0.0 0.6 1.2 0.0 1.4 1.2 0.0 2.0 0.0 13.3 0.0 46.5 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.6 0.0 11.5 2.8 0.0 0.0 0.0 0.0 0.2 0.9 0.0 3.5 0.0 0.3 6.5 0.0 81.0 5.5 0.0 0.0 0.0 0.0 0.7 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 59.5;cervix, uterine: 23.4" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 230.7;Early spermatids: 106.6;Late spermatids: 56.3" "Cancer enhanced" "Detected in some" "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.2;RT4: 3.8;SCLC-21H: 11.7;SuSa: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA054825: AB_2682617, HPA057837: AB_2683542" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.5 3.8 14.4 0.5 6.3 0.5 0.5 59.5 36.7 23.4 0.8 1.7 0.0 0.8 0.7 0.5 0.6 0.7 0.6 0.5 8.0 12.4 7.8 0.5 0.5 0.5 7.0 5.0 2.5 0.8 0.5 1.8 14.2 18.3 0.5 0.7 2.9 1.5 0.5 0.5 0.5 1.1 0.6 4.2 0.5 0.6 6.0 1.3 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 2.2 3.8 11.7 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 6.3 59.5 17.9 8.0 12.4 7.0 5.0 18.3 1.3 0.0 0.0 0.0 0.0 0.0 230.7 0.3 0.0 0.0 0.0 3.5 3.9 0.0 13.3 0.0 106.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 56.3 1.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 9.7 0.0 0.0 0.9 1.0 0.0 0.1 0.0 0.0 0.0 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.9 0.5 0.1 0.0 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 163.3 13.6 3.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CABS1 "C4orf35, CLPH, FLJ32897, NYD-SP26" ENSG00000145309 "Calcium binding protein, spermatid associated 1" Q96KC9 4 70334966-70337116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "testis: 75.3" "Group enriched" "Detected in some" 102 "Early spermatids: 1181.5;Late spermatids: 2745.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "NTERA-2: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044016, HPA055352" Enhanced NA NA "HPA044016: AB_10964494, HPA055352: AB_2682790" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1181.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2745.2 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 19.3 5.9 0.0 0.0 0.0 0.0 0.0 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24255553-24362801 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 32.2" "Cell type enriched" "Detected in some" 46 "Horizontal cells: 166.8" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077238 Enhanced NA NA "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.4 1.8 12.8 0.4 13.1 0.5 0.3 0.2 32.2 0.3 0.4 0.1 0.0 0.3 0.3 0.4 0.3 0.4 0.3 0.3 12.7 2.2 0.3 0.4 0.3 0.4 1.8 2.3 0.4 0.3 0.3 0.0 0.4 0.3 0.4 0.4 0.1 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.2 0.9 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.8 13.1 0.2 20.0 12.7 2.2 1.8 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CACNG5 ENSG00000075429 "Calcium voltage-gated channel auxiliary subunit gamma 5" Q9UF02 17 66835117-66885486 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 6.5;lymphoid tissue: 3.3;retina: 8.8" "Cell type enriched" "Detected in single" 17 "Horizontal cells: 4.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.6;SuSa: 1.3;THP-1: 1.6" "Region enhanced" "Detected in all" "olfactory region: 152.3" "Low region specificity" "Detected in all" HPA050115 Uncertain NA NA "HPA050115: AB_2681022" "unprognostic (1.85e-3)" "unprognostic (3.84e-2)" "unprognostic (1.44e-1)" "unprognostic (2.46e-6)" "unprognostic (4.52e-2)" "unprognostic (1.29e-1)" 0.3 0.3 2.7 0.7 2.6 0.3 0.3 1.7 6.5 0.4 0.7 6.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.4 2.1 2.0 1.0 0.3 0.3 3.3 1.1 2.3 0.3 0.7 0.3 0.8 0.3 0.7 0.5 0.5 8.8 0.3 0.3 0.3 0.4 0.7 0.3 1.7 1.3 0.3 0.7 3.8 0.0 0.3 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 3.6 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.6 1.7 6.5 2.1 2.0 1.1 2.3 0.7 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53992288-54012669 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skeletal muscle: 45.4" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 5.3;Horizontal cells: 1.6;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 96 "basophil: 11.4;eosinophil: 7.8" "Lineage enriched" "Detected in single" 114 "granulocytes: 11.4" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 22.3;HHSteC: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 45.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 12.7 0.3 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 1.1 0.0 22.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.8 0.0 0.1 0.1 0.0 0.0 0.0 2.1 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.2 1.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.9 0.0 2.6 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.0 11.4 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909335-53943941 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 54.4" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 127.1" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 1.2 1.8 22.2 1.3 15.6 1.2 1.2 22.7 54.4 1.2 1.3 8.3 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 21.4 13.7 1.2 1.2 1.3 1.2 16.5 10.3 1.2 1.3 1.2 1.8 1.2 9.9 1.2 1.2 0.3 1.2 1.3 1.2 1.2 1.4 1.3 13.5 1.2 1.3 1.5 4.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 26.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 20.9 0.2 0.0 0.0 0.0 26.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 1.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 15.6 22.7 25.9 21.4 13.7 16.5 10.3 9.9 4.5 0.0 0.0 0.0 0.0 0.0 7.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53963040-53990215 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 7.9;brain: 22.8" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 47.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4" "Cell type enriched" "Detected in some" 7 "basophil: 7.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.9" "Group enriched" "Detected in some" 5 "AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041351 Enhanced NA NA "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.4 0.4 9.4 0.4 9.1 0.6 0.4 0.7 22.8 0.3 0.3 2.1 0.0 0.4 0.5 0.4 0.3 0.4 0.4 0.3 20.3 5.4 0.3 0.3 0.4 0.4 2.3 2.0 0.4 0.3 0.5 0.0 0.3 1.5 0.4 0.4 0.0 0.4 0.3 0.9 0.7 0.4 0.4 0.9 0.4 0.6 1.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 7.9 0.2 0.3 0.3 0.1 0.0 2.1 6.4 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.9 2.4 0.5 0.0 1.0 0.0 21.3 0.3 0.0 0.0 0.2 7.6 2.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.2 0.0 13.0 0.1 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 7.9 0.2 1.1 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.3 0.1 0.1 9.4 9.1 0.7 13.6 20.3 5.4 2.3 2.0 1.5 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.8 0.0 4.0 1.2 1.8 0.0 0.0 0.0 1.4 0.4 1.9 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 47.7 0.0 3.1 1.5 1.1 0.0 0.0 0.0 0.0 0.4 1.0 0.1 0.0 0.4 0.0 1.5 0.0 0.8 5.0 6.4 1.0 0.1 0.0 0.5 1.0 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958981-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 214.8;Cone photoreceptor cells: 488.9;Rod photoreceptor cells: 463.1" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 5.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.0" "Cell line enhanced" "Detected in some" "AF22: 6.4;AN3-CA: 18.4;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced NA NA 350000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 5.8 6.3 33.5 2.1 22.7 1.7 3.6 44.8 52.7 2.3 3.0 7.0 0.0 2.0 2.0 2.2 2.7 4.6 2.6 4.2 28.6 11.7 1.9 2.5 2.2 1.8 16.3 31.0 2.3 2.4 3.0 5.5 1.9 24.2 3.4 2.7 8.8 2.3 6.2 4.9 2.0 2.6 2.1 14.0 2.0 3.2 2.2 20.5 0.0 2.1 0.0 1.8 2.0 1.1 1.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 22.7 44.8 49.5 28.6 11.7 16.3 31.0 24.2 20.5 0.0 0.6 0.0 0.3 0.9 214.8 4.4 0.0 0.0 1.2 0.0 488.9 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.1 1.0 0.7 0.0 0.0 0.3 89.0 1.7 4.9 0.0 1.7 1.7 0.0 3.3 0.0 0.0 62.5 0.2 0.0 0.4 0.0 463.1 0.0 0.8 0.4 1.1 0.9 0.0 0.0 0.0 0.3 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390438 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 50.6;brain: 118.9" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 89.2;granulocytes: 237.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol NA NA 6400 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 50.6 11.6 10.1 5.1 7.5 0.9 18.2 31.2 9.9 1.7 8.9 1.7 0.0 1.7 1.4 3.0 3.0 2.4 2.0 2.2 5.9 74.2 0.9 0.9 2.1 0.9 17.7 7.5 5.6 1.4 0.9 3.0 0.9 118.9 1.1 6.0 4.9 2.1 1.3 1.0 1.0 2.7 2.7 7.5 0.9 1.2 14.6 1.5 0.0 0.8 0.2 1.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.7 6.6 0.0 0.2 0.0 1.3 0.2 0.1 0.2 0.0 0.0 8.2 0.0 0.1 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.2 0.0 0.0 52.2 0.0 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 14.9 0.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 7.5 31.2 9.9 5.9 74.2 17.7 7.5 118.9 1.5 8.9 11.1 0.0 0.0 0.2 3.5 0.3 0.0 2.7 0.0 0.0 5.9 0.0 0.0 1.7 2.1 0.1 0.0 0.0 89.2 0.1 0.4 0.1 237.6 0.0 0.1 28.6 0.0 0.0 0.0 2.3 5.8 0.0 5.0 0.0 0.0 2.5 10.4 0.0 0.0 0.0 6.7 0.0 0.3 0.3 3.6 0.0 0.1 0.0 0.0 0.1 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.3 3.8 0.9 1.2 14.3 23.8 4.6 18.8 19.1 5.8 8.2 1.6 2.6 1.6 2.1 21.5 0.3 2.5 1.9 0.0 1.1 0.2 10.8 3.8 1.1 0.3 6.5 0.6 0.3 8.1 0.0 1.7 0.0 10.8 6.8 4.1 0.8 10.0 3.7 12.3 1.4 1.7 2.4 1.1 3.4 4.5 1.5 3.6 0.5 0.4 2.7 1.2 0.7 3.1 1.0 0.4 0.6 1.2 12.1 1.8 2.3 6.4 1.3 1.5 3.5 1.9 15.9 11.8 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 3.0 1.1 3.4 2.8 4.7 0.0 2.8 2.5 0.0 0.0 3.5 0.0 2.0 0.0 3.1 0.8 20.4 0.0 0.0 0.2 63.7 23.4 0.8 8.1 0.0 47.4 0.0 1.2 28.3 27.5 0.8 42.3 14.7 8.5 1.8 0.0 0.3 0.2 0.0 15.2 0.3 0.0 19.4 29.8 0.7 0.2 3.3 16.0 17.3 0.0 1.0 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.8;testis: 2.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;myeloid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "U-266/84: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.1 0.8 0.3 0.9 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.4 2.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 2.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 1.8 0.0 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.3 3.3 0.4 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 17.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 CALHM4 "C6orf78, FAM26D, FLJ32239" ENSG00000164451 "Calcium homeostasis modulator family member 4" Q5JW98 6 116529013-116558868 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "placenta: 29.7;skin 1: 9.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 45.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 2.8;SuSa: 6.2" "Intracellular and membrane" NA NA "unprognostic (7.95e-2)" "unprognostic (3.44e-4)" "unprognostic (1.99e-1)" "unprognostic (1.44e-2)" 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 29.7 1.4 0.0 0.0 0.2 0.0 0.0 0.5 9.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.1 0.0 2.8 0.0 0.3 0.2 0.2 0.3 0.0 0.3 0.6 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 6.2 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 CALHM5 "C6orf188, dJ493F7.3, FAM26E, MGC45451" ENSG00000178033 "Calcium homeostasis modulator family member 5" Q8N5C1 6 116511646-116524792 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 19 "Alveolar cells type 2: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 6.3;fHDF/TERT166: 6.6;HUVEC TERT2: 6.7;LHCN-M2: 7.1;TIME: 10.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034969, HPA034970" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA034969: AB_10670299, HPA034970: AB_2674390" "unprognostic (2.71e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-2)" "unprognostic (1.01e-1)" "unprognostic (1.36e-1)" "unprognostic (3.92e-1)" "unprognostic (1.93e-2)" "unprognostic (5.37e-2)" "unprognostic (4.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.06e-1)" "unprognostic (9.16e-2)" "unprognostic (1.24e-7)" "unprognostic (1.16e-2)" "unprognostic (2.98e-2)" "unprognostic (7.69e-2)" "unprognostic (6.65e-3)" 11.5 1.7 1.0 2.5 1.6 0.2 8.1 0.6 1.7 5.9 4.3 1.9 0.4 1.4 7.9 6.2 7.6 2.9 3.6 10.1 1.2 1.1 6.0 1.4 4.0 5.8 1.5 2.1 4.6 0.8 1.6 1.4 18.5 1.8 5.3 2.6 14.4 2.1 2.6 4.0 3.2 2.9 11.0 1.3 4.0 2.1 5.2 0.6 0.0 4.4 6.8 1.5 8.2 4.0 0.1 0.0 0.1 0.6 0.3 0.0 0.6 0.0 0.0 5.5 0.0 3.4 5.4 0.0 4.3 6.3 1.7 4.7 0.2 0.0 0.0 0.4 6.6 4.7 0.0 0.0 0.0 1.8 0.0 0.2 0.9 0.0 0.0 0.8 0.0 0.0 3.3 0.0 4.1 0.0 1.3 6.7 0.0 0.0 1.3 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 10.6 3.0 1.0 0.3 0.2 0.0 0.0 0.0 2.6 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.6 1.0 1.6 0.6 1.7 1.2 1.1 1.5 2.1 1.8 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CALHM6 "C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5" ENSG00000188820 "Calcium homeostasis modulator family member 6" Q5R3K3 6 116461370-116463779 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.3;lymphoid tissue: 58.7" "Cell type enriched" "Detected in some" 7 "Hofbauer cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 83.9;non-classical monocyte: 95.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 10.0;Karpas-707: 16.7;RPMI-8226: 56.6;U-937: 21.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.14e-2)" "unprognostic (2.31e-2)" "unprognostic (6.46e-3)" "unprognostic (7.15e-3)" "unprognostic (9.53e-3)" "unprognostic (4.10e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (8.19e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.31e-10)" "unprognostic (1.69e-1)" "unprognostic (2.12e-2)" "unprognostic (3.85e-3)" "unprognostic (9.25e-3)" 3.0 2.7 2.8 19.6 5.2 12.9 3.1 1.1 2.1 1.5 3.4 1.5 1.7 3.9 1.1 1.3 2.0 1.5 3.9 4.3 3.1 3.2 2.9 8.1 4.2 30.6 2.6 1.8 2.8 1.0 0.4 2.5 4.6 3.4 3.1 2.2 2.7 4.2 0.7 1.0 0.9 8.1 3.7 5.1 58.7 2.2 3.3 1.7 7.3 2.1 1.9 7.5 3.5 1.4 39.6 23.3 13.8 95.3 3.1 3.8 17.8 2.3 0.0 0.2 0.1 0.2 0.7 4.3 0.0 0.4 0.7 0.5 0.0 0.3 0.0 1.3 0.5 0.0 0.0 0.1 0.0 1.6 0.2 0.1 10.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 16.7 2.0 0.0 0.9 1.7 1.3 0.0 0.0 0.8 0.0 56.6 0.8 0.1 1.0 0.0 5.4 0.0 4.0 0.6 0.1 2.6 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 21.5 1.4 1.8 24.7 5.5 2.1 83.9 2.1 27.0 2.9 1.9 23.3 39.6 3.8 1.9 13.8 3.1 95.3 10.2 0.3 17.8 2.8 5.2 1.1 2.1 3.1 3.2 2.6 1.8 3.4 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 9.1 4.9 0.0 0.0 0.0 0.0 118.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 174.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.8 5.7 3.5 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.1 2.5 2.0 1.1 2.3 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.3 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.1 2.9 5.2 3.9 2.9 0.6 7.2 5.7 7.7 4.9 12.0 2.3 8.5 5.6 5.1 0.9 4.3 2.9 3.4 2.5 2.3 6.8 1.8 1.7 3.4 2.5 3.8 3.5 6.6 6.3 10.6 6.3 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 0.0 1.0 0.9 0.6 1.3 8.8 0.3 15.3 174.0 26.1 3.5 0.0 0.4 0.0 2.0 4.8 1.9 38.6 0.0 3.9 0.4 1.0 1.2 0.0 7.2 3.1 7.9 7.5 6.7 11.9 0.0 3.4 3.4 0.0 0.0 15.0 1.7 1.8 38.6 6.3 5.8 2.2 0.0 0.3 0.0 0.5 1.8 0.1 1.8 18.3 1.1 CALML6 CAGLP ENSG00000169885 "Calmodulin like 6" Q8TD86 1 1914827-1917296 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "skeletal muscle: 51.4;tongue: 73.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.9" "Not detected" "Not detected" NA NA "unprognostic (3.85e-2)" "unprognostic (3.04e-2)" "unprognostic (1.59e-4)" "unprognostic (1.66e-1)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-3)" "unprognostic (9.72e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-2)" "unprognostic (9.76e-2)" "unprognostic (5.21e-10)" "unprognostic (5.06e-3)" "unprognostic (1.93e-1)" "unprognostic (1.23e-2)" "unprognostic (6.48e-2)" 0.2 0.0 0.1 0.1 0.6 0.1 0.2 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 0.0 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.3 0.1 0.1 0.7 0.1 0.1 1.8 0.2 51.4 0.8 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 73.7 0.7 0.1 0.5 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 4.9 1.5 0.9 2.9 1.0 0.0 0.4 0.5 0.0 2.9 1.0 0.1 1.2 0.3 1.5 0.3 0.5 0.0 0.7 0.3 0.0 1.1 0.0 0.4 0.1 0.6 2.1 3.0 0.4 0.3 0.4 0.2 0.2 0.0 1.7 0.1 1.0 0.0 0.1 0.9 0.7 0.8 1.5 0.1 2.5 0.5 0.2 0.2 0.5 0.0 0.3 0.1 2.6 0.8 0.3 0.0 0.1 0.0 2.7 0.1 1.5 0.3 2.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.6 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261463 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5" "Cell type enriched" "Detected in some" 11 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA050835: AB_2681253, HPA075200: " "unprognostic (7.28e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 1.3 14.2 22.2 1.3 9.6 1.1 1.3 29.7 38.3 1.3 1.3 3.2 0.0 1.4 1.2 1.2 1.2 1.3 1.3 1.2 12.3 32.7 1.3 1.7 1.2 1.2 18.0 8.2 1.1 37.0 2.0 12.5 1.3 25.1 1.4 1.3 1.1 1.2 1.4 1.1 1.2 1.4 1.4 9.3 1.2 1.7 1.3 4.5 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 11.3 0.2 1.4 0.6 0.4 0.4 1.0 0.3 4.2 2.7 2.8 0.4 0.5 0.4 2.8 0.2 5.5 1.5 0.7 0.5 1.5 9.3 0.4 0.3 0.2 0.4 0.1 0.2 1.4 0.3 0.7 0.4 1.9 0.6 0.0 0.3 0.0 3.3 0.4 6.0 0.1 0.1 8.1 0.2 3.7 19.0 5.5 1.6 0.6 2.2 20.0 4.3 1.8 0.5 0.1 0.1 6.1 0.1 0.0 20.8 9.1 1.9 3.3 2.2 3.3 2.7 4.8 1.2 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.2 9.6 29.7 38.3 12.3 32.7 18.0 8.2 25.1 4.5 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 58.8 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 4.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.1 0.7 0.1 25.2 0.0 0.1 0.8 0.0 4.8 0.0 0.0 8.6 5.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 0.0 0.0 0.0 0.0 0.2 2.3 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.2 1.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.7 0.1 0.2 0.0 0.1 0.0 CAPN11 ENSG00000137225 "Calpain 11" Q9UMQ6 6 44158811-44184402 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 63.7" "Group enriched" "Detected in some" 13 "Early spermatids: 16.7;Late spermatids: 7.9;Spermatocytes: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 4.4;TIME: 11.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB018070, HPA030955" Enhanced NA NA "CAB018070: AB_2069481, HPA030955: AB_2673672" "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (1.64e-2)" "unprognostic (2.75e-1)" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (3.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (8.96e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (3.62e-6)" "unprognostic (2.38e-2)" "unprognostic (3.51e-1)" "unprognostic (2.27e-2)" "unprognostic (8.89e-2)" 1.1 0.3 0.1 0.2 0.1 0.2 1.9 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.6 0.3 0.2 0.1 0.1 0.0 63.7 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.4 1.2 1.3 0.1 0.1 0.8 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.4 0.4 0.0 0.0 0.0 0.3 4.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.2 11.1 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.4 0.1 0.2 1.3 0.1 0.0 1.2 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.7 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.0 7.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 24.2 0.9 0.0 0.0 0.0 0.0 0.0 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Group enriched" "Detected in many" 7 "basophil: 24.5;NK-cell: 12.7" "Group enriched" "Detected in many" 7 "granulocytes: 24.5;NK-cells: 12.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 17.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "hippocampal formation: 3.6" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA053322: AB_2682111" "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.6 0.4 0.2 4.7 0.2 0.2 0.7 0.2 0.3 4.2 4.1 0.1 5.6 1.2 1.1 1.0 1.2 3.6 21.0 0.7 1.0 0.4 7.1 21.8 2.0 1.8 0.2 0.1 0.4 5.0 0.2 0.7 0.5 2.4 2.2 0.7 0.4 34.3 3.0 0.3 4.5 1.9 0.5 0.4 4.9 1.6 0.6 0.1 0.4 0.4 1.6 5.2 1.5 1.0 1.7 0.0 24.5 0.0 12.7 2.6 0.7 0.2 1.8 0.1 0.0 0.3 0.1 2.2 0.1 0.0 0.0 0.1 3.2 0.1 0.7 0.1 0.0 0.3 1.3 0.0 0.8 0.0 0.1 0.0 0.3 0.7 0.9 0.0 0.0 17.6 0.8 2.5 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.1 0.4 0.1 0.4 0.1 1.4 0.0 0.0 0.1 0.0 0.4 0.9 0.7 0.0 0.1 0.0 0.7 24.5 0.0 1.8 2.6 0.0 2.5 1.5 0.7 1.3 0.0 1.7 0.0 0.6 0.4 12.7 0.0 0.0 0.5 0.7 0.2 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.4 0.1 11.9 27.1 15.9 8.0 8.4 1.2 0.6 50.9 5.3 5.7 5.2 0.0 1.5 0.0 9.1 0.4 1.8 4.2 0.0 6.3 8.2 1.1 2.3 4.7 12.7 0.9 0.0 3.5 1.3 1.0 0.2 0.6 2.0 3.3 0.0 18.8 1.7 4.0 3.5 0.4 16.5 0.6 0.0 1.7 0.3 2.4 8.3 2.4 25.4 16.4 4.3 CAPN14 ENSG00000214711 "Calpain 14" A8MX76 2 31173056-31233858 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "esophagus: 92.6;lymphoid tissue: 25.0" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 8.0" "Group enriched" "Detected in some" 7 "cervical cancer: 2.9;head and neck cancer: 2.3;lung cancer: 0.8;stomach cancer: 1.4;urothelial cancer: 0.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enriched" "Detected in some" 6 "U-266/70: 7.9" "Not detected" "Not detected" NA NA "unprognostic (5.81e-3)" "unprognostic (1.20e-1)" "unprognostic (4.57e-2)" "unprognostic (1.88e-2)" "unprognostic (3.85e-2)" "unprognostic (3.30e-1)" "unprognostic (3.61e-2)" "unprognostic (4.67e-2)" "unprognostic (1.71e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" "unprognostic (1.60e-1)" "unprognostic (3.71e-4)" "unprognostic (8.42e-2)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (4.47e-4)" 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.5 0.3 1.1 0.1 0.0 0.0 0.0 0.4 0.0 92.6 0.1 0.0 0.2 0.2 0.3 0.1 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 3.2 25.0 0.2 0.4 1.3 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.4 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.4 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.3 0.5 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 8.0 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "OE19: 51.0;RT4: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" No NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: AB_2686646" "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 51.0 1.6 0.0 0.0 0.0 0.6 30.2 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 26.8 123.4 0.0 6.0 0.1 0.0 2.2 15.3 24.1 94.4 24.4 0.0 0.1 0.0 0.4 1.4 0.0 30.0 0.0 19.7 0.0 0.0 3.3 10.4 0.0 0.5 0.0 2.9 0.0 0.0 3.5 1.7 0.4 0.0 0.0 49.6 0.0 21.9 16.9 3.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 13.2 15.4 CAPNS2 "MGC12536, MGC14804" ENSG00000256812 "Calpain small subunit 2" Q96L46 16 55566672-55567687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 56.0;skin 1: 44.1;tongue: 45.6" "Group enriched" "Detected in some" 12 "Basal keratinocytes: 78.1;Suprabasal keratinocytes: 130.6" "Group enriched" "Detected in many" 15 "cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 6.9;intermediate monocyte: 2.1" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 2.1" "Cell line enriched" "Detected in some" 10 "hTCEpi: 71.5" "Not detected" "Not detected" "HPA059749, HPA076768" Enhanced Approved Cytosol NA NA Cytosol "HPA059749: AB_2732639, HPA076768: AB_2732322" "unprognostic (3.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.77e-3)" "unprognostic (4.14e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (7.21e-2)" "unprognostic (3.38e-2)" "unprognostic (3.62e-1)" "unprognostic (2.42e-2)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" 0.1 0.0 0.1 0.1 0.4 0.2 3.4 0.1 0.1 5.8 0.1 0.1 0.1 0.0 0.4 0.1 56.0 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.2 6.7 0.1 0.6 44.1 0.1 1.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 45.6 14.6 12.3 10.8 0.0 0.5 6.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 71.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 6.9 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.0 78.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 1.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 130.6 1.9 0.0 0.0 8.1 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.3 3.7 1.0 0.3 1.9 1.4 0.1 0.7 0.2 2.0 2.2 0.0 1.7 0.3 3.3 0.5 0.8 0.8 0.0 1.6 1.4 1.2 0.6 1.5 0.6 0.0 0.0 0.2 0.0 0.6 1.0 1.7 0.3 12.1 0.2 1.3 0.3 0.6 2.6 0.0 1.8 1.4 0.5 0.0 0.5 0.0 0.0 0.2 2.6 0.0 2.1 1.0 0.2 0.1 1.2 0.2 1.2 0.5 0.8 1.9 0.8 0.4 0.3 0.2 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 8.9 3.2 0.0 2.5 1.5 0.7 7.1 2.5 96.4 17.0 5.2 3.9 1.0 5.0 0.8 21.6 1.7 0.0 0.0 1.5 0.5 1.7 1.5 0.0 1.5 0.5 1.6 0.0 2.5 1.8 11.5 5.8 0.9 0.0 0.0 1.7 5.8 0.4 0.0 6.7 2.5 20.8 0.0 1.4 9.1 0.9 0.5 0.2 0.0 0.6 0.5 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904295-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.9;epididymis: 18.3;fallopian tube: 59.4" "Group enriched" "Detected in some" 5 "Ciliated cells: 455.0;Early spermatids: 136.1;Late spermatids: 117.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 14.1;ovarian cancer: 3.4" "Region enriched" "Detected in many" 7 "pons and medulla: 34.9" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.9;REH: 7.8;U-698: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules No No "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.1 0.2 3.6 0.1 4.4 0.2 0.2 0.0 0.5 2.4 0.1 4.3 0.4 0.1 1.3 18.3 0.2 59.4 0.2 0.2 5.2 5.3 0.7 0.1 11.8 0.1 0.3 0.0 6.7 0.4 0.1 17.0 0.2 34.9 0.2 0.1 0.0 0.4 0.4 0.2 0.2 0.1 0.2 0.8 0.1 0.2 5.4 0.5 0.5 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.5 6.4 0.0 0.0 2.2 0.0 0.9 0.1 0.0 0.1 0.0 4.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.0 1.3 2.2 0.0 0.5 0.0 0.0 19.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 4.4 0.0 0.3 5.2 5.3 0.3 0.0 34.9 0.5 3.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 455.0 51.2 1.8 0.0 0.0 1.7 0.0 136.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 117.8 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052000-24069728 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.6;pituitary gland: 7.8;skin 1: 9.4" "Cell type enriched" "Detected in single" 8 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 8.4;HMC-1: 5.9;Karpas-707: 5.3;SCLC-21H: 8.7;SH-SY5Y: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain NA NA "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.6 1.6 6.5 1.4 5.2 1.0 0.8 30.6 7.9 0.6 0.9 3.3 0.0 2.3 0.6 0.5 1.0 0.6 1.6 0.4 7.4 5.2 1.0 0.8 0.9 1.4 2.8 2.4 0.6 1.3 0.5 7.8 0.5 7.2 0.8 1.0 1.7 1.6 0.7 0.5 9.4 1.6 0.7 2.9 1.0 1.2 3.1 2.8 0.0 1.0 0.0 2.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.1 0.3 0.0 0.0 1.4 0.0 0.1 0.1 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.3 1.3 0.0 0.5 0.1 0.1 0.6 0.0 0.0 0.0 0.1 8.7 4.2 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 5.2 30.6 7.7 7.4 5.2 2.8 2.4 7.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CASC1 "FLJ10921, LAS1, PPP1R54" ENSG00000118307 "Cancer susceptibility 1" Q6TDU7 12 25108420-25195162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.1;pituitary gland: 21.5;testis: 25.3" "Group enriched" "Detected in many" 4 "Ciliated cells: 190.1;Early spermatids: 245.8;Late spermatids: 64.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Group enriched" "Detected in many" 5 "B-cells: 2.6;granulocytes: 4.2" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039662 Enhanced NA NA "HPA039662: AB_10795468" "unprognostic (6.42e-3)" "unprognostic (1.26e-2)" "unprognostic (1.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.62e-1)" "unprognostic (1.85e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (2.22e-1)" "unprognostic (3.91e-2)" "unprognostic (6.21e-4)" "unprognostic (2.54e-2)" "prognostic favorable (3.13e-4)" "unprognostic (2.01e-1)" "unprognostic (8.74e-3)" "unprognostic (7.16e-2)" "unprognostic (1.19e-1)" 0.6 1.0 3.1 0.5 7.6 0.8 2.0 0.7 4.6 2.7 0.6 3.7 1.9 0.2 2.2 12.4 0.9 17.1 1.0 0.9 3.5 4.0 3.6 0.3 4.8 0.7 1.5 4.1 5.4 1.3 5.5 21.5 0.4 12.2 1.4 0.3 1.1 1.0 3.4 0.4 1.4 0.4 0.7 2.4 0.5 1.0 25.3 2.5 0.0 5.2 0.0 0.4 0.6 0.6 2.6 0.7 4.2 0.4 0.2 0.6 0.3 0.5 1.1 1.2 0.9 0.0 0.7 0.7 0.0 0.9 0.8 0.8 0.1 3.3 3.4 1.1 0.0 0.4 0.6 0.1 0.6 0.7 1.0 0.2 0.0 0.1 0.0 0.0 0.4 1.3 0.0 0.5 0.6 0.0 1.9 0.0 3.2 1.7 1.1 0.0 0.0 0.5 1.3 0.4 0.4 0.0 1.1 0.5 0.0 3.2 0.3 2.1 0.8 0.5 0.0 0.6 1.5 3.2 0.2 0.0 0.2 2.6 1.6 0.3 1.4 0.6 2.7 0.9 0.6 0.6 0.4 0.3 0.8 0.3 0.3 0.3 1.6 0.1 0.6 0.1 2.6 0.4 0.5 4.2 0.2 0.4 0.7 0.0 0.3 3.1 7.6 0.7 4.6 3.5 4.0 1.5 4.1 12.2 2.5 0.0 2.7 0.0 1.1 0.2 2.0 2.0 0.0 190.1 18.2 5.2 5.9 0.2 6.6 0.4 245.8 0.4 0.0 0.0 0.2 0.1 0.5 0.6 1.1 0.0 0.1 1.6 0.0 0.0 0.0 64.6 2.0 0.3 0.0 0.0 0.0 3.0 0.2 0.0 3.5 3.7 11.9 0.0 0.0 38.6 7.4 0.1 0.1 0.0 0.0 0.3 CASC10 "bA418C1.3, C10orf114" ENSG00000204682 "Cancer susceptibility 10" Q5T4H9 10 21492658-21497262 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;liver: 13.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 5.9;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 10.3;AF22: 10.4;AN3-CA: 14.4;BEWO: 13.9;SK-BR-3: 9.1" HPA064131 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064131: AB_2685196" "unprognostic (2.69e-2)" "unprognostic (1.46e-2)" "unprognostic (5.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (3.22e-2)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.00e-1)" "unprognostic (8.55e-2)" "unprognostic (1.85e-1)" "unprognostic (4.04e-3)" "unprognostic (1.09e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (5.86e-4)" 1.8 2.6 8.9 0.9 6.2 0.9 0.9 2.0 8.0 2.5 0.8 6.1 0.1 1.0 1.3 1.1 1.2 2.4 1.7 3.8 11.8 3.8 6.3 13.6 1.5 1.3 3.3 4.2 2.6 1.3 3.7 3.3 7.2 2.7 1.9 0.7 2.0 1.0 1.8 5.0 3.3 0.9 1.5 2.2 0.8 0.9 2.6 5.3 0.1 5.6 0.0 0.8 2.3 1.6 0.6 0.4 2.2 0.3 1.0 0.4 0.2 1.7 10.3 10.4 14.4 1.9 1.0 13.9 0.9 0.4 0.1 0.2 1.6 3.6 0.5 1.5 0.8 1.8 2.2 1.8 0.6 0.1 0.3 1.9 0.1 1.5 2.3 0.5 0.0 0.1 1.3 1.8 0.1 0.2 1.5 0.9 0.6 0.6 0.1 0.1 1.6 0.7 0.6 1.4 0.0 0.9 0.8 0.1 0.0 2.1 1.5 1.4 5.1 4.8 9.1 0.6 3.5 1.7 7.9 2.5 0.9 8.1 0.2 1.1 0.1 0.2 0.1 4.5 0.0 4.5 1.5 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.1 0.0 0.6 0.2 0.4 2.2 1.0 0.3 0.4 0.2 0.2 8.9 6.2 2.0 8.0 11.8 3.8 3.3 4.2 2.7 5.3 0.0 0.6 0.0 0.4 1.0 2.3 2.2 0.0 2.7 0.0 1.8 0.0 2.0 5.0 0.0 0.2 3.7 0.0 0.0 0.0 2.3 1.9 0.1 0.0 5.9 0.7 4.8 0.0 3.7 0.3 0.0 4.4 0.0 1.7 0.0 0.0 2.9 0.2 0.0 1.8 10.5 0.6 0.0 0.3 0.2 0.2 0.6 3.2 0.0 0.0 0.1 CATSPER3 CACRC ENSG00000152705 "Cation channel sperm associated 3" Q86XQ3 5 134967906-135011707 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 31.9" "Group enriched" "Detected in some" 39 "Early spermatids: 152.2;Late spermatids: 43.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 7.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (2.59e-2)" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (1.57e-2)" "unprognostic (4.87e-2)" "unprognostic (2.63e-1)" "unprognostic (3.71e-2)" "unprognostic (8.00e-2)" "unprognostic (2.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (5.58e-3)" "unprognostic (9.39e-2)" "unprognostic (1.51e-1)" "unprognostic (4.96e-3)" 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.5 0.4 0.5 0.4 0.8 0.4 0.4 0.4 0.4 0.6 1.0 0.4 0.4 0.4 0.4 0.6 0.8 0.2 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 2.7 0.3 0.4 0.4 0.4 0.4 0.3 31.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.3 1.4 0.4 0.6 3.2 1.8 0.4 0.4 3.6 1.4 1.6 1.1 0.4 0.8 0.6 0.3 7.2 0.6 2.0 3.1 1.4 1.8 0.3 0.7 1.1 2.3 1.2 0.7 1.9 2.7 0.3 2.0 1.2 0.7 0.9 0.8 0.4 1.8 0.6 2.8 0.7 0.0 0.9 1.5 2.6 0.5 1.6 1.5 2.3 0.4 2.7 1.9 1.9 0.6 0.8 3.1 0.5 1.1 1.1 1.3 1.0 1.1 1.2 1.4 2.2 1.0 0.1 1.3 0.3 1.6 1.2 1.0 0.4 0.7 2.3 0.5 0.0 0.6 0.0 0.4 0.1 0.0 0.8 0.7 0.7 1.4 3.3 1.8 0.7 0.4 3.2 0.1 0.7 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 152.2 0.1 0.0 0.0 1.0 0.2 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.3 43.8 1.4 0.0 0.0 1.0 0.0 0.4 0.3 0.0 0.7 1.0 2.5 0.0 0.3 2.1 1.1 0.3 0.1 0.0 0.1 0.0 CATSPER4 ENSG00000188782 "Cation channel sperm associated 4" Q7RTX7 1 26190561-26202968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;hTCEpi: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045257 Enhanced NA NA "HPA045257: AB_10968995" "unprognostic (7.20e-2)" "unprognostic (2.06e-2)" "unprognostic (4.56e-2)" "unprognostic (2.69e-2)" "unprognostic (3.49e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-2)" "unprognostic (2.16e-1)" "unprognostic (3.06e-1)" "unprognostic (6.78e-2)" "unprognostic (6.98e-2)" "unprognostic (6.67e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.1;Exocrine glandular cells: 9.3;Pancreatic endocrine cells: 11.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;OE19: 4.0;U-937: 3.7" "Not detected" "Not detected" HPA035134 Uncertain Uncertain Vesicles NA NA Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.6 0.1 0.0 0.6 0.0 0.0 1.4 0.0 0.2 0.4 0.9 0.3 0.4 0.4 0.6 0.7 1.2 0.6 0.0 0.0 0.3 0.2 0.9 1.1 0.0 0.2 15.1 1.0 0.3 0.0 0.9 0.7 3.7 0.0 1.7 4.2 1.2 0.1 0.0 0.8 2.0 2.0 0.9 0.6 0.5 0.3 0.4 0.2 1.1 0.2 0.7 1.6 0.4 0.6 0.0 0.7 1.6 0.0 0.0 1.8 0.2 0.3 0.0 0.0 2.3 3.8 1.1 0.9 0.0 0.1 0.6 0.0 0.5 0.7 1.4 2.0 0.4 1.2 2.2 0.0 1.6 0.8 0.6 0.7 0.4 0.5 1.5 0.0 1.0 0.5 0.2 0.4 2.2 0.6 0.7 0.2 4.0 0.5 0.3 0.0 0.0 0.4 0.9 1.6 0.1 0.0 0.8 1.5 1.7 0.4 2.1 0.9 0.2 0.2 0.0 0.3 0.9 0.8 0.3 0.2 3.7 1.0 1.1 0.2 0.6 1.1 0.0 1.5 0.4 1.6 1.0 0.0 0.2 1.1 1.4 0.4 0.7 0.2 0.2 0.0 0.4 3.0 1.0 0.0 0.2 0.1 0.0 0.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.6 11.1 0.0 0.3 0.0 9.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 1.0 2.1 0.0 11.1 0.9 0.0 0.5 0.0 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.4 0.3 CATSPERE "C1orf101, MGC33370" ENSG00000179397 "Catsper channel auxiliary subunit epsilon" Q5SY80 1 244454377-244641177 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 26.9" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 16.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.7;hTERT-RPE1: 2.6" "Low region specificity" "Detected in many" NA NA "unprognostic (3.22e-1)" "unprognostic (4.50e-2)" "unprognostic (2.02e-1)" "unprognostic (7.31e-2)" "unprognostic (3.32e-1)" "unprognostic (2.50e-3)" "unprognostic (3.76e-3)" "unprognostic (5.39e-4)" "unprognostic (1.96e-2)" "unprognostic (3.41e-2)" "unprognostic (4.37e-4)" "unprognostic (4.43e-2)" "unprognostic (9.09e-2)" "unprognostic (1.76e-1)" "unprognostic (5.79e-2)" "unprognostic (6.74e-3)" "unprognostic (5.85e-2)" 0.9 1.1 1.3 0.5 3.2 1.1 1.2 1.7 2.7 1.2 0.5 4.6 0.4 0.5 1.6 4.1 0.6 2.1 0.9 0.5 3.1 1.3 1.4 1.5 1.0 1.8 1.2 1.3 1.4 2.4 2.6 2.2 0.9 3.2 1.0 0.5 1.3 0.9 1.1 1.0 0.7 0.7 1.5 2.8 0.9 0.7 26.9 0.7 0.5 1.6 0.0 0.6 1.0 0.8 0.8 0.9 0.8 0.1 0.1 0.8 0.1 0.3 0.0 0.6 0.0 1.3 2.7 0.2 1.5 1.5 0.2 0.2 0.0 0.7 0.5 1.8 1.7 0.0 0.7 0.4 0.2 0.5 0.0 1.5 0.0 0.4 0.1 0.9 0.0 1.4 2.2 0.7 0.2 0.0 2.6 0.7 0.7 0.2 0.5 0.2 0.0 0.2 0.3 0.3 0.0 0.2 1.4 0.0 0.0 0.8 0.0 1.6 1.0 0.7 0.0 0.3 0.4 0.1 0.8 1.8 0.1 0.0 0.0 1.0 0.9 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.7 0.0 0.2 0.8 0.1 0.3 0.0 0.6 0.8 0.1 0.0 0.1 0.1 0.9 0.2 0.1 1.3 3.2 1.7 2.7 3.1 1.3 1.2 1.3 3.2 0.7 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 16.0 2.3 1.8 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300391-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "testis: 139.5" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6" HPA052822 Approved Nucleoplasm NA NA Nucleoplasm "HPA052822: AB_2797245" "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.1 0.0 0.5 0.0 0.4 0.0 0.8 0.1 0.9 0.2 0.1 0.1 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 139.5 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.5 0.4 0.6 0.6 0.0 0.3 0.0 0.0 4.1 0.3 0.0 0.5 1.0 5.7 0.0 0.3 0.0 0.0 15.6 3.2 0.1 0.2 0.2 0.2 3.4 3.2 0.5 0.1 0.0 0.0 1.5 0.1 1.0 0.1 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.2 0.0 1.6 0.7 0.2 0.7 0.0 0.7 1.1 4.5 9.3 1.7 0.0 2.0 4.5 1.5 0.1 0.9 1.7 0.5 0.2 0.3 7.6 0.4 0.3 0.2 0.1 2.1 0.0 0.4 0.1 0.5 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 29.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 33.8" "Cell type enriched" "Detected in some" 7 "Intestinal endocrine cells: 36.4" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA 1300000 "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.6 0.7 5.4 0.8 10.4 0.4 0.6 0.8 33.8 1.0 2.9 0.9 0.0 2.5 0.5 0.4 0.5 0.5 0.4 0.4 4.5 9.5 1.5 0.9 0.4 0.5 7.0 16.4 0.6 0.4 0.4 0.3 0.4 17.8 1.8 2.6 1.9 0.4 8.2 0.4 0.9 3.8 1.5 2.6 0.4 0.6 0.6 0.0 0.0 0.4 0.0 1.3 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.8 33.8 4.5 9.5 7.0 16.4 17.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.0 0.0 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 54.7" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 6.3 14.1 5.5 5.3 6.7 3.8 7.2 5.5 4.5 4.9 5.5 4.6 4.5 8.3 10.4 5.0 3.5 7.0 4.9 6.9 16.3 10.1 5.7 4.1 5.9 5.5 10.5 7.5 7.6 8.3 7.2 5.7 8.6 4.5 7.5 7.1 4.1 4.2 4.8 5.6 6.1 6.3 10.0 7.3 6.9 5.1 8.2 28.0 7.0 28.2 4.5 7.6 15.6 12.7 4.8 7.0 3.7 9.2 8.4 15.6 6.7 4.4 9.4 7.2 7.0 4.9 11.7 8.8 2.4 5.7 2.2 3.4 6.4 10.2 20.0 11.9 0.1 11.4 21.5 10.0 33.8 5.3 7.4 3.1 2.2 18.5 6.1 10.0 6.0 3.9 25.9 7.7 15.3 7.3 54.7 7.0 11.2 10.5 14.1 10.7 22.3 12.2 36.3 12.7 7.7 13.8 5.1 5.1 18.1 10.9 32.4 10.4 5.0 7.1 6.4 5.8 3.1 4.2 13.4 12.4 18.1 5.8 1.2 25.3 7.0 4.2 28.2 6.8 8.2 7.6 6.7 28.0 5.6 6.7 7.3 3.8 4.5 21.3 7.4 6.6 15.6 50.6 47.9 33.7 27.4 42.4 48.0 46.0 25.5 38.8 59.1 33.2 102.1 83.3 29.9 60.1 37.4 22.4 21.9 0.0 103.4 31.0 20.3 19.4 30.2 16.0 28.7 36.5 30.0 18.4 26.3 13.0 16.7 36.5 30.4 85.6 35.3 24.9 55.6 28.1 12.4 58.7 53.6 32.3 38.2 33.7 19.8 44.3 104.4 16.0 55.5 21.8 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 97.9;monocytes: 81.2;Suprabasal keratinocytes: 104.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 2.0 5.7 3.2 2.6 6.0 0.3 4.3 7.0 4.1 5.6 3.6 0.9 4.1 4.9 5.9 2.1 2.5 9.1 3.1 4.5 8.9 6.6 1.8 1.3 3.2 3.0 3.6 7.7 5.3 3.4 4.1 3.6 4.3 5.0 15.0 1.7 2.2 5.0 1.6 2.3 3.3 1.2 6.2 2.5 4.2 2.5 7.8 26.5 13.8 27.4 7.5 10.4 17.5 8.0 4.8 5.4 6.1 14.1 6.5 10.1 6.3 4.0 5.0 6.5 8.2 5.0 10.6 19.3 6.6 22.7 6.8 5.6 7.0 6.7 3.6 15.0 8.8 8.7 15.3 4.7 3.7 4.2 6.1 4.3 7.2 4.3 9.5 8.9 5.7 5.0 11.6 7.2 8.6 11.7 12.5 6.4 15.4 10.7 5.6 14.1 27.8 13.1 13.0 14.8 4.3 16.3 2.4 2.7 18.9 7.7 10.8 10.6 4.2 5.9 2.5 6.0 4.5 18.7 5.6 6.9 23.0 9.9 4.2 27.4 13.8 5.2 27.1 5.6 7.3 7.9 6.1 26.5 7.8 6.8 6.2 7.5 7.5 21.2 6.5 10.4 17.5 8.9 15.6 26.1 9.5 97.9 11.0 42.0 15.3 37.5 18.2 14.0 15.7 14.3 33.2 23.7 12.9 14.6 8.4 0.0 12.5 11.1 14.6 8.9 15.1 10.6 8.4 12.7 2.4 6.7 8.8 11.8 10.0 23.9 25.3 81.2 8.2 9.5 12.7 12.9 16.3 23.0 12.3 0.0 15.5 16.8 11.1 104.9 21.6 10.9 14.4 9.7 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 34.4" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 3.8 6.0 4.4 6.6 4.9 4.0 6.5 5.7 5.1 2.7 4.7 4.2 2.9 2.1 5.4 3.0 1.8 2.9 4.8 4.4 7.7 11.1 2.9 5.7 4.5 3.6 10.7 4.2 5.0 5.5 4.1 3.2 3.7 3.6 5.2 4.9 7.6 2.8 3.9 5.0 6.3 3.2 5.1 4.3 4.5 3.5 20.3 24.4 34.4 33.9 5.7 14.0 19.9 21.3 15.9 7.8 12.1 5.8 1.9 10.3 10.7 4.2 4.5 5.3 4.4 21.0 24.7 10.4 7.7 21.0 26.2 14.3 21.0 12.4 38.0 9.2 9.5 36.2 21.0 7.4 17.9 11.9 4.8 6.5 8.2 10.8 9.0 10.5 28.3 17.3 20.2 6.6 13.7 20.9 23.9 11.4 25.5 26.7 9.5 24.3 26.9 5.1 9.2 12.1 7.8 17.6 10.6 13.1 15.1 7.6 20.8 5.0 7.0 17.9 11.5 20.5 11.9 47.4 30.3 21.0 26.5 12.6 9.1 33.9 24.8 11.6 27.2 10.0 20.3 10.8 11.9 24.4 18.4 11.7 10.9 34.4 5.7 19.0 18.3 14.0 19.9 23.8 25.9 16.0 14.0 12.9 27.1 24.2 7.6 40.2 34.2 10.4 27.5 11.9 1.7 5.1 3.3 7.5 11.7 0.0 10.0 6.7 4.7 7.5 11.6 7.3 4.6 11.1 4.1 7.4 13.0 1.7 4.6 8.7 5.0 22.6 6.5 4.3 6.9 14.0 2.8 5.0 34.5 6.5 5.3 10.1 5.0 18.7 12.9 10.2 8.1 9.5 CBWD5 ENSG00000147996 "COBW domain containing 5" Q5RIA9 9 65668805-65734041 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (8.18e-2)" "unprognostic (4.23e-3)" "unprognostic (5.25e-3)" "unprognostic (1.02e-3)" "unprognostic (5.32e-3)" "unprognostic (9.24e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-2)" "unprognostic (1.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-3)" "unprognostic (1.17e-1)" "unprognostic (5.68e-2)" "unprognostic (3.87e-1)" 4.1 6.0 5.2 3.7 6.8 2.5 9.2 8.2 3.7 2.8 3.3 5.4 1.7 4.8 3.3 1.7 2.2 2.4 6.2 6.0 7.6 17.9 1.9 2.6 4.8 2.1 6.6 2.9 4.0 2.9 4.3 5.5 2.2 3.8 2.1 2.8 4.4 2.5 2.6 5.7 2.2 2.1 5.1 4.4 5.4 1.5 5.5 11.7 7.7 14.0 2.5 5.5 9.3 15.0 16.2 5.8 7.4 8.9 4.1 7.0 10.7 7.2 8.5 8.7 2.1 13.9 20.5 6.9 6.2 12.2 11.1 26.3 8.5 16.1 3.3 6.3 5.7 26.2 36.4 6.7 12.9 3.7 7.2 9.9 7.8 6.3 10.7 15.3 7.9 8.1 15.3 8.6 18.2 6.4 13.7 7.1 26.0 17.5 11.2 8.0 20.5 13.5 9.9 7.7 7.8 8.7 6.8 3.1 10.7 31.8 8.6 4.3 3.8 14.2 11.7 12.2 5.0 13.4 4.9 16.1 14.9 14.5 1.6 11.6 7.7 3.4 14.0 3.7 5.5 5.5 4.7 11.7 2.9 5.1 4.1 7.1 2.5 8.5 4.9 4.1 9.3 38.7 47.5 48.4 29.8 57.9 38.4 30.2 33.1 36.1 52.4 19.2 64.8 36.3 18.3 30.3 7.7 18.2 41.3 23.3 34.0 18.7 12.4 16.5 9.3 42.4 14.1 33.4 16.1 15.4 24.3 4.1 19.5 26.9 28.7 55.1 26.5 9.8 28.6 45.6 16.3 31.8 56.7 6.5 25.0 26.5 16.8 74.8 42.2 19.8 27.6 26.5 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96032684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA044091, HPA072122" Enhanced Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA044091: AB_2732514, HPA072122: AB_2686489" "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.5 1.7 1.0 1.7 1.0 1.7 0.6 0.3 3.1 0.8 0.8 0.6 2.3 0.2 0.8 1.3 2.0 0.8 0.6 0.6 0.6 0.3 0.9 1.1 0.9 0.8 0.2 0.0 0.4 0.7 0.9 0.0 0.5 0.1 1.6 2.6 0.9 1.2 0.7 1.4 0.6 10.6 4.0 0.0 1.0 1.1 4.1 1.0 1.8 1.0 0.8 2.9 0.5 1.2 4.0 3.9 7.2 0.2 0.4 4.1 3.9 0.4 0.6 0.1 4.2 0.8 5.1 3.1 0.0 4.0 2.8 0.3 0.2 0.0 4.9 8.8 9.2 3.4 3.2 0.0 9.8 0.6 0.7 0.0 0.4 0.1 1.7 0.3 1.3 7.9 3.0 0.9 2.5 4.5 3.3 8.5 3.0 6.6 11.6 3.5 4.3 0.7 1.3 7.1 3.8 4.3 1.1 2.7 5.1 7.0 4.4 3.4 4.5 4.5 3.1 5.6 2.6 11.0 0.1 3.4 10.0 2.9 0.0 1.0 0.2 1.9 0.3 2.9 3.4 1.4 1.1 0.9 4.1 1.3 0.4 1.8 0.8 0.8 1.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC105 FLJ40365 ENSG00000160994 "Coiled-coil domain containing 105" Q8IYK2 19 15010744-15023269 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "testis: 38.7" "Cell type enriched" "Detected in some" 8 "Early spermatids: 149.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058585 Approved NA NA "HPA058585: AB_2683763" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.2 19.4 3.5 13.4 12.2 8.6 8.1 3.3 2.4 5.2 6.0 17.6 22.3 2.6 4.4 6.5 6.4 15.3 7.1 2.4 10.9 8.1 7.1 3.7 9.5 11.4 7.7 9.2 7.2 16.1 6.0 8.8 3.2 10.0 10.8 5.1 4.2 5.6 4.4 5.7 22.2 6.1 1.4 4.1 28.6 4.3 3.9 6.5 6.9 9.7 6.6 4.7 5.1 4.7 7.5 13.9 7.7 10.0 12.2 4.5 6.6 10.3 25.6 6.0 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 62.5 23.5 48.4 32.4 62.4 31.1 0.6 61.1 25.4 15.9 78.5 7.9 12.3 14.9 64.0 5.7 40.2 115.3 0.0 122.5 55.2 43.7 39.9 34.5 68.4 86.5 30.2 84.6 43.0 48.7 20.1 55.0 66.1 108.0 39.7 73.5 46.8 82.6 80.7 96.2 54.7 32.0 116.4 97.8 27.9 59.2 58.5 11.6 95.8 40.0 23.7 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 11.4;hTERT-HME1: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 4.3 6.7 5.0 8.5 9.5 1.8 7.5 2.4 5.6 5.5 5.5 7.2 8.8 3.3 8.0 10.7 4.5 8.6 5.9 8.3 6.1 5.0 10.4 5.7 5.5 4.6 9.8 5.8 12.2 6.9 8.4 15.6 8.2 6.0 9.8 6.9 3.6 5.7 4.8 3.3 7.8 7.3 9.8 6.4 7.7 5.8 9.7 11.0 5.2 10.9 4.5 4.7 6.2 11.8 3.6 3.0 6.4 2.6 3.6 1.9 1.0 2.2 1.8 0.8 0.0 0.7 4.5 2.3 5.9 6.5 3.0 3.4 3.2 8.0 3.6 3.3 3.5 5.2 3.5 0.8 0.9 4.3 5.8 2.8 1.5 1.0 1.8 8.6 0.9 0.4 11.4 7.2 4.5 11.8 2.6 1.5 1.5 0.0 1.1 4.2 2.7 0.5 0.6 1.0 0.5 1.9 0.8 0.0 1.9 4.7 1.3 2.1 3.1 3.9 0.1 3.5 4.8 0.7 0.6 6.9 0.2 0.8 5.3 0.0 0.0 0.0 1.6 3.0 0.1 3.1 6.4 1.6 2.4 1.3 1.4 1.6 2.4 1.9 1.4 1.2 3.6 1.3 1.4 3.9 3.6 2.6 3.0 1.7 1.0 5.0 9.5 2.4 5.6 6.1 5.0 9.8 5.8 6.0 11.0 8.9 9.4 2.7 7.8 2.7 1.5 11.2 7.6 25.4 11.4 7.0 0.0 14.2 16.6 10.3 2.0 5.8 4.4 0.0 9.0 8.0 6.1 7.9 1.1 3.9 1.8 9.5 17.3 7.4 2.2 0.4 16.4 2.5 1.7 1.0 9.1 12.3 7.2 0.0 7.4 8.7 0.6 0.0 5.1 20.5 23.7 3.3 6.6 1.3 8.1 5.9 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597379-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.4" "Group enriched" "Detected in many" 18 "Early spermatids: 588.1;Late spermatids: 350.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 75.4" "Lineage enriched" "Detected in all" 18 "granulocytes: 75.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 31000000 "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.7 8.1 8.7 4.4 9.2 6.9 19.5 11.6 13.2 7.4 6.5 5.6 5.8 8.7 8.0 5.3 6.6 6.7 6.2 5.7 13.8 8.9 7.6 11.7 6.5 9.3 10.5 3.9 7.4 9.8 12.2 12.6 4.6 11.1 6.0 6.5 5.8 7.5 6.5 10.0 6.6 9.4 6.7 12.9 6.1 6.8 41.3 8.1 5.4 9.9 5.0 8.6 7.0 7.7 3.8 3.0 75.4 3.6 2.9 4.1 2.9 4.8 3.4 7.5 9.5 12.6 7.1 17.3 6.1 6.0 5.3 7.7 3.6 1.6 10.4 9.7 5.1 10.1 2.8 3.2 2.9 6.9 2.2 4.3 1.8 1.4 4.6 5.1 4.7 9.3 7.5 8.5 1.7 1.6 4.4 7.0 4.4 4.1 3.0 6.3 2.2 3.2 5.7 3.5 6.4 4.3 2.2 11.9 3.1 5.5 2.2 4.6 8.6 6.3 6.1 4.5 12.2 5.1 4.4 8.4 3.1 5.6 7.1 4.8 8.4 8.3 7.4 3.5 6.9 16.9 75.4 3.6 16.4 3.0 3.3 3.7 3.8 3.3 3.5 3.0 3.2 4.1 3.2 6.9 2.9 3.1 0.6 3.6 2.9 8.7 9.2 11.6 13.2 13.8 8.9 10.5 3.9 11.1 8.1 6.0 7.2 7.1 7.0 16.9 12.6 8.3 7.6 9.4 3.4 12.2 7.9 9.0 6.6 10.1 588.1 10.5 5.8 0.0 8.0 5.6 10.4 7.1 6.9 12.7 6.2 7.9 14.5 10.4 5.1 350.6 10.6 7.9 13.5 6.4 8.6 7.2 8.1 6.2 13.4 7.2 12.6 12.9 12.2 26.8 23.8 20.7 16.9 7.5 5.6 5.9 CCDC129 FLJ38344 ENSG00000180347 "Coiled-coil domain containing 129" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.2;salivary gland: 10.9" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024103 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.6 2.0 0.1 3.3 7.9 0.3 3.7 0.9 1.2 0.0 2.1 1.1 0.2 0.1 0.1 0.1 0.0 0.4 1.4 0.1 0.0 0.4 0.0 5.0 0.0 0.0 0.2 0.0 0.4 0.9 17.2 0.1 0.2 0.0 10.9 0.0 0.0 4.5 0.9 1.1 0.2 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.8 1.1 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.1 2.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 2.7 0.0 0.0 0.0 5.6 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.2 0.1 0.1 0.8 1.0 0.4 1.1 0.1 0.0 0.8 0.0 0.1 0.1 2.0 7.9 0.3 0.4 1.4 5.0 0.0 17.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 CCDC140 FLJ32447 ENSG00000163081 "Coiled-coil domain containing 140" Q96MF4 2 222298147-222305217 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;NB-4: 3.8;RH-30: 2.1;SK-MEL-30: 4.0;WM-115: 2.4" "HPA042500, HPA048166" Uncertain NA NA "HPA042500: AB_2678028, HPA048166: AB_2680295" "unprognostic (2.50e-2)" "unprognostic (3.54e-1)" "unprognostic (5.25e-2)" 0.3 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.1 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.2 0.0 0.5 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 2.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CCDC142 FLJ14397 ENSG00000135637 "Coiled-coil domain containing 142" Q17RM4 2 74471986-74483408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 29.9;Ciliated cells: 56.2;Club cells: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056946 Approved NA NA "HPA056946: AB_2683282" "unprognostic (2.00e-1)" "unprognostic (3.25e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.73e-1)" "unprognostic (1.69e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.05e-2)" "unprognostic (5.15e-2)" "unprognostic (2.44e-2)" "unprognostic (5.65e-3)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.71e-7)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "unprognostic (5.31e-3)" 5.5 6.5 5.7 6.3 5.3 3.8 4.5 11.7 6.1 9.6 5.1 9.8 9.2 12.5 10.6 4.0 5.8 5.5 3.7 4.0 5.6 3.6 5.2 10.0 4.2 7.9 7.6 3.5 8.3 5.1 12.1 6.9 3.6 5.3 6.7 5.0 6.3 9.3 7.4 3.4 6.8 9.1 7.8 3.3 7.8 5.4 6.5 6.4 18.1 5.8 2.6 7.1 5.8 4.6 9.4 5.1 8.0 5.0 6.9 8.1 1.7 3.2 2.4 4.4 3.9 2.6 2.8 10.1 4.8 2.4 3.5 2.6 7.5 4.6 3.8 3.4 1.9 4.3 6.2 2.6 3.4 1.8 5.5 10.8 6.9 7.7 4.7 1.1 4.0 5.3 1.9 2.2 5.4 1.9 4.5 2.5 3.9 3.2 2.3 3.3 2.4 4.9 3.8 4.7 5.1 6.8 6.8 8.1 3.5 1.8 3.9 7.0 4.4 3.5 8.0 3.5 3.2 5.2 2.7 2.2 7.7 5.0 5.2 6.2 8.3 3.8 3.3 3.1 2.1 4.2 8.0 5.0 7.4 8.1 2.8 6.7 5.2 5.0 5.6 2.5 9.4 7.8 6.0 4.4 6.9 5.0 5.1 2.3 1.7 5.7 5.3 11.7 6.1 5.6 3.6 7.6 3.5 5.3 6.4 8.9 29.9 8.2 2.2 2.9 14.4 1.7 5.1 56.2 28.4 0.0 17.7 2.5 1.7 2.2 0.7 4.3 5.9 0.0 1.7 1.8 2.9 1.4 17.4 1.7 1.8 4.8 5.8 6.7 4.4 0.0 6.9 2.7 0.0 1.0 3.4 16.2 1.1 3.6 5.6 0.8 23.3 0.0 4.1 8.1 3.6 2.6 1.6 6.9 4.5 1.7 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 52.2;Cone photoreceptor cells: 51.1;Early spermatids: 46.7;Rod photoreceptor cells: 51.7;Spermatocytes: 128.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.1;TIME: 9.4" "HPA022996, HPA047220, HPA047851, HPA066260" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.6 3.9 0.9 2.4 3.5 11.1 0.4 0.2 0.0 0.2 0.2 4.9 0.1 0.5 3.4 6.8 0.3 6.0 5.0 0.3 0.3 3.5 0.3 0.5 0.5 0.4 0.2 0.7 3.2 2.0 0.1 2.3 0.2 1.1 0.1 0.2 0.5 0.3 2.2 0.2 0.1 1.2 0.8 1.0 0.4 1.5 0.2 0.1 0.1 4.7 1.3 1.4 0.7 0.2 1.4 2.0 4.0 0.2 9.4 0.8 0.5 5.3 1.5 6.7 6.9 0.2 0.4 7.0 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 0.0 9.3 3.0 6.4 3.5 52.2 2.5 2.5 5.3 2.3 0.0 51.1 4.2 0.0 1.6 46.7 6.5 1.3 0.0 0.0 5.8 8.2 6.7 25.4 1.7 3.5 31.8 1.2 3.7 5.1 2.9 6.6 4.9 5.0 0.0 2.0 8.3 2.2 3.4 8.5 0.5 51.7 6.5 5.7 128.1 36.1 3.1 1.6 6.9 1.6 5.1 CCDC149 DKFZp761B107 ENSG00000181982 "Coiled-coil domain containing 149" Q6ZUS6 4 24806117-24980204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Lineage enriched" "Detected in single" 6 "monocytes: 4.5" "Cell line enhanced" "Detected in many" "U-87 MG: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044158, HPA047913" Uncertain Approved Nucleoli NA NA Nucleoli "HPA044158: AB_2678840, HPA047913: AB_2680207" "unprognostic (1.68e-1)" "unprognostic (2.43e-1)" "unprognostic (1.09e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.06e-1)" "unprognostic (4.11e-4)" "unprognostic (9.71e-5)" "unprognostic (2.68e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-2)" "unprognostic (8.59e-3)" "unprognostic (2.25e-1)" "unprognostic (2.80e-3)" "unprognostic (8.87e-2)" "unprognostic (2.25e-1)" "unprognostic (5.03e-2)" "unprognostic (4.80e-2)" 11.7 8.3 20.1 8.2 14.7 2.8 16.7 14.8 20.6 13.2 10.8 6.9 11.1 5.3 12.9 9.2 7.9 13.9 9.9 10.9 15.9 11.5 7.5 10.3 10.0 4.4 11.5 12.7 15.9 31.7 12.8 11.2 11.6 11.3 14.3 8.6 7.5 29.8 10.1 8.6 6.9 6.4 14.5 9.9 5.8 13.8 5.4 9.4 0.9 11.9 4.6 4.3 9.6 18.3 0.0 0.8 0.8 4.5 0.2 0.0 1.2 4.1 1.6 3.3 0.5 5.2 9.6 1.0 6.0 9.1 4.8 5.6 0.0 4.6 0.0 2.9 11.4 5.4 0.7 1.0 0.7 3.1 0.0 0.0 0.0 0.3 0.3 4.4 0.0 0.0 6.6 4.3 2.7 0.0 13.5 3.8 0.0 0.0 0.8 2.9 4.4 0.0 0.1 3.8 0.4 4.6 0.0 0.0 0.2 8.6 3.0 4.6 0.0 2.5 3.8 12.3 3.7 6.4 9.2 9.3 7.0 0.8 5.2 5.1 0.1 0.0 0.0 21.5 0.9 4.8 0.0 4.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.2 1.5 0.7 0.0 1.2 20.1 14.7 14.8 20.0 15.9 11.5 11.5 12.7 11.3 9.4 0.0 7.4 0.0 6.2 5.6 11.5 5.3 5.1 4.0 3.4 7.0 9.8 4.5 0.0 5.6 0.9 13.5 1.1 0.0 8.8 1.5 5.8 10.2 0.0 6.0 9.7 4.8 1.7 6.2 11.1 1.3 10.0 3.0 8.5 0.0 10.9 9.4 7.5 3.5 11.0 2.2 11.5 6.5 11.3 1.4 1.9 2.8 8.9 0.5 4.3 5.6 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2;testis: 19.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 34.8;Erythroid cells: 23.3;Spermatocytes: 93.6;Spermatogonia: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 1.9 1.3 2.2 2.5 3.9 3.2 5.2 1.2 2.4 1.6 2.2 2.2 0.3 1.3 2.2 2.9 2.4 2.1 1.5 0.9 1.9 1.2 1.2 2.4 2.6 2.0 1.6 0.8 1.7 2.3 1.7 3.8 1.6 1.6 3.0 1.6 1.5 7.7 2.2 0.8 3.7 1.8 1.2 3.3 2.5 1.5 19.4 2.3 16.2 1.3 2.6 2.9 2.6 2.2 1.5 1.1 6.7 1.7 2.3 3.9 1.3 4.7 0.9 6.4 0.0 0.5 1.8 0.0 5.2 6.4 4.9 6.1 0.1 4.0 5.6 4.6 1.8 9.8 3.8 2.7 3.5 8.9 4.7 1.1 6.9 0.8 1.5 0.2 2.0 4.0 0.4 2.5 10.2 5.1 0.9 3.7 7.2 4.6 5.8 10.3 1.0 4.2 2.3 1.5 4.1 5.9 5.3 11.7 1.8 0.7 2.0 3.6 3.2 3.0 0.3 1.3 3.2 7.3 1.8 2.6 10.1 2.3 4.4 6.4 1.4 1.5 4.9 1.4 11.3 6.7 6.7 1.3 1.7 2.4 1.7 2.5 0.8 2.2 3.9 0.4 1.5 3.1 3.4 0.8 2.3 1.7 1.1 3.7 1.3 2.2 3.9 1.2 2.4 1.9 1.2 1.6 0.8 1.6 2.3 3.0 1.4 0.9 1.3 4.4 4.7 0.6 0.0 4.0 3.4 0.0 0.0 0.4 0.0 2.0 34.8 3.0 0.0 23.3 2.9 0.2 1.7 1.4 9.2 1.0 2.8 3.2 1.2 0.6 3.3 21.2 4.0 2.6 3.3 0.0 1.2 3.4 1.3 0.0 2.1 0.7 2.5 6.5 2.0 93.6 24.9 3.3 0.1 2.2 0.6 0.3 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756801-42802360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.8;pituitary gland: 24.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 56.6;Muller glia cells: 33.6;Spermatocytes: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 10.6;JURKAT: 10.6;U-2 OS: 19.2;U-266/84: 12.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 4.0 6.0 7.5 2.5 10.2 1.6 3.0 1.0 8.4 2.1 2.3 4.1 0.5 5.0 2.7 1.9 2.0 1.6 6.1 4.6 7.1 3.2 3.6 52.8 3.2 8.6 4.9 5.5 8.2 2.1 0.0 24.3 2.8 20.9 2.1 0.3 1.9 2.1 0.3 1.5 3.1 12.4 0.6 8.8 6.9 1.9 5.7 8.5 8.5 1.7 0.5 3.0 2.9 3.1 3.6 10.0 0.3 0.7 6.2 6.1 1.3 0.3 0.1 0.8 0.1 2.7 3.5 0.0 4.6 0.1 0.0 0.3 0.0 0.2 0.0 0.3 2.0 3.4 3.6 0.0 0.0 0.4 0.0 0.3 0.2 10.6 4.4 2.7 0.1 0.0 4.4 0.0 1.9 0.0 7.0 1.4 10.6 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.3 5.3 0.0 0.1 0.0 4.2 0.4 0.1 0.1 0.2 19.2 4.4 0.1 0.1 12.8 0.1 5.6 0.1 0.1 0.1 0.1 0.1 4.0 0.7 4.9 2.2 3.0 5.0 0.7 3.6 4.0 6.1 0.3 6.2 0.3 10.0 1.9 1.3 7.5 10.2 1.0 8.4 7.1 3.2 4.9 5.5 20.9 8.5 56.6 31.3 4.9 0.2 3.3 13.9 8.1 0.0 6.7 13.6 1.8 0.0 1.3 0.0 0.6 5.7 3.5 2.3 0.0 1.0 1.0 10.4 0.3 9.2 4.0 2.3 31.8 1.2 4.9 10.5 5.3 6.1 2.9 3.3 1.0 2.5 33.6 2.0 2.9 7.1 0.5 2.2 0.0 6.6 65.5 22.6 3.4 1.5 10.9 1.2 0.3 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" A6NI56 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.8" "Cell type enhanced" "Detected in many" 19 "Cone photoreceptor cells: 7.9;Early spermatids: 36.6;Spermatocytes: 12.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.5;SCLC-21H: 26.6;U-266/70: 4.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 5.4" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 1.5 0.6 1.5 1.1 1.6 0.5 4.5 1.4 1.0 0.7 2.6 1.3 0.4 0.0 1.5 0.7 0.2 0.7 0.9 1.2 0.4 0.4 2.5 0.5 1.3 1.1 0.0 3.9 0.6 2.9 0.0 1.2 0.8 1.2 2.9 1.2 0.2 0.7 3.4 3.7 10.8 2.8 0.6 0.2 0.6 0.7 0.0 0.8 0.1 0.0 1.1 0.0 7.5 0.3 0.2 0.5 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.3 0.1 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.5 0.0 3.8 0.2 0.0 0.1 2.2 0.1 0.1 0.0 0.1 26.6 0.4 0.1 0.1 1.1 0.1 0.8 1.9 0.0 0.4 0.1 0.3 0.0 4.8 1.2 0.0 0.0 3.8 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.3 0.5 2.5 1.4 0.0 3.5 7.9 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.1 0.0 0.7 6.4 0.0 0.0 0.8 4.4 1.4 0.5 1.7 0.0 0.0 3.2 0.0 0.0 0.4 0.2 3.9 0.0 1.0 12.0 1.3 0.4 0.0 0.0 0.0 0.1 CCDC157 ENSG00000187860 "Coiled-coil domain containing 157" Q569K6 22 30356635-30378658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 11.5;testis: 43.7" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 38.8;Early spermatids: 94.7;Late spermatids: 106.4;Spermatocytes: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042943 Uncertain NA NA "HPA042943: AB_10794767" "unprognostic (3.69e-3)" "unprognostic (1.72e-4)" "unprognostic (4.35e-2)" "unprognostic (1.24e-2)" "unprognostic (3.61e-1)" "unprognostic (7.74e-3)" "unprognostic (8.72e-4)" "unprognostic (1.35e-2)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.89e-4)" "unprognostic (2.33e-2)" "unprognostic (2.60e-2)" "unprognostic (4.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.42e-1)" "unprognostic (3.45e-2)" 0.9 1.8 4.3 1.5 5.9 2.5 2.0 3.3 4.0 1.6 1.4 2.5 2.2 1.5 1.6 3.0 1.4 11.5 2.0 1.1 4.4 5.8 3.3 1.0 3.5 2.0 2.3 1.9 2.1 3.0 1.7 4.5 0.9 5.9 1.6 0.9 2.1 2.4 1.7 0.9 1.8 1.1 0.9 1.2 1.8 1.4 43.7 1.8 1.3 4.4 1.2 1.2 1.1 0.8 1.6 2.3 6.7 1.6 1.9 2.3 1.2 2.8 3.3 3.0 5.7 1.8 1.1 3.7 1.5 1.9 2.9 2.9 4.2 2.2 2.5 1.9 1.5 4.3 2.8 1.6 2.0 1.6 1.7 7.0 1.4 3.1 2.4 2.0 2.7 2.4 1.1 1.4 5.3 0.9 2.0 1.8 3.8 2.2 2.3 2.4 2.8 3.4 2.8 3.8 1.9 1.8 2.9 1.7 2.2 7.0 3.0 10.3 6.7 4.6 1.7 1.8 2.3 5.5 1.2 3.1 2.8 3.6 1.8 1.2 1.9 0.9 2.1 4.5 1.6 2.3 2.0 1.6 2.0 2.1 1.1 2.3 0.9 1.8 2.1 0.9 1.6 1.1 1.8 6.7 1.9 1.4 2.3 1.4 1.2 4.3 5.9 3.3 4.0 4.4 5.8 2.3 1.9 5.9 1.8 3.0 3.5 0.5 2.2 1.1 5.9 0.8 2.5 38.8 9.1 8.7 11.8 2.0 0.0 4.5 94.7 2.3 1.8 0.0 2.1 2.0 2.6 1.0 2.3 0.8 1.6 6.4 1.2 4.3 1.5 106.4 3.4 2.5 0.0 1.0 1.1 3.9 2.7 2.9 2.5 5.6 27.3 0.0 2.7 37.4 16.4 1.5 2.9 2.5 1.7 1.3 CCDC158 FLJ25770 ENSG00000163749 "Coiled-coil domain containing 158" Q5M9N0 4 76312997-76421868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 26.3" "Group enriched" "Detected in some" 52 "Early spermatids: 54.8;Late spermatids: 56.3;Spermatocytes: 86.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.2;SiHa: 1.5;WM-115: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (3.31e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-2)" "unprognostic (3.30e-2)" "unprognostic (3.29e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-3)" "unprognostic (6.99e-2)" "unprognostic (1.57e-1)" "unprognostic (9.70e-2)" "unprognostic (1.08e-3)" "unprognostic (2.18e-1)" "unprognostic (9.77e-3)" "unprognostic (6.22e-2)" "unprognostic (3.65e-2)" "unprognostic (9.29e-2)" "unprognostic (2.68e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.2 0.2 1.2 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 26.3 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 1.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 56.3 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 86.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 270.6;Late spermatids: 182.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.8" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 7.9 24.6 21.0 13.4 35.1 22.2 10.9 15.5 28.6 14.8 12.9 30.6 28.3 17.8 13.9 21.1 11.8 14.2 19.0 13.6 22.8 11.9 13.4 18.9 12.8 14.7 38.5 22.9 19.2 15.1 34.3 20.8 7.3 28.0 24.7 9.5 17.7 14.5 17.4 6.3 14.6 14.3 12.5 24.2 24.1 16.1 28.2 43.5 7.5 17.8 8.5 11.2 13.7 12.6 9.9 16.5 21.2 28.0 15.7 15.2 11.8 2.2 2.0 1.7 5.2 6.8 9.9 1.7 3.7 3.9 4.4 5.9 0.6 2.4 1.9 9.6 7.0 1.3 1.9 1.0 5.9 2.7 9.2 1.4 4.5 1.6 2.4 12.0 1.7 6.8 11.8 15.6 3.2 4.3 4.6 12.3 3.4 4.0 21.8 2.2 2.8 2.7 3.6 0.9 3.1 7.4 3.0 0.0 12.2 4.0 3.2 0.7 2.8 3.7 4.3 6.8 3.2 6.3 7.5 8.1 3.5 1.0 6.0 3.4 20.0 4.8 3.8 4.7 9.2 5.0 21.2 28.0 19.1 12.1 23.6 11.7 8.1 8.2 11.0 16.5 9.9 7.5 5.9 13.2 15.7 16.4 4.3 15.2 11.8 21.0 35.1 15.5 28.6 22.8 11.9 38.5 22.9 28.0 43.5 14.9 9.9 9.0 13.1 6.6 11.2 9.8 12.7 21.4 14.8 17.4 39.3 4.9 21.6 7.6 270.6 9.1 14.8 0.0 8.4 4.4 8.4 23.8 33.5 9.6 20.4 6.4 10.4 12.9 26.0 182.1 10.6 15.7 11.8 13.6 10.6 14.8 7.5 23.0 12.7 31.6 28.9 0.0 8.2 4.8 3.8 7.0 5.0 21.5 8.1 17.5 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC169 "C13orf38, LOC728591, RP11-251J8.1" ENSG00000242715 "Coiled-coil domain containing 169" A6NNP5 13 36222008-36297840 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "testis: 46.7" "Group enriched" "Detected in many" 14 "Early spermatids: 732.1;Late spermatids: 1719.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 17.5;U-937: 10.3" "Low region specificity" "Detected in single" NA NA "unprognostic (9.12e-3)" "unprognostic (1.05e-1)" "unprognostic (7.09e-2)" "unprognostic (2.38e-1)" "unprognostic (3.51e-2)" "unprognostic (7.26e-4)" "unprognostic (6.91e-2)" "unprognostic (3.31e-2)" "unprognostic (5.78e-3)" "unprognostic (2.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (8.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.14e-2)" 0.5 0.7 0.7 0.5 2.2 2.2 0.7 0.4 1.8 0.6 0.9 0.5 5.6 0.3 1.3 2.4 0.5 0.5 0.4 0.5 0.7 0.7 0.9 0.4 0.4 0.3 0.7 1.6 0.4 0.5 2.5 0.4 3.9 1.5 1.1 0.4 0.8 0.4 10.2 0.7 0.5 0.5 3.5 1.3 0.4 0.6 46.7 0.2 0.0 0.5 0.0 0.1 2.0 0.5 1.4 0.6 2.2 0.7 0.9 0.9 0.1 0.2 0.5 0.9 0.4 1.6 2.9 6.0 1.0 1.3 0.7 0.7 0.3 0.3 0.7 0.6 0.3 3.0 0.5 5.8 0.2 1.6 0.8 0.6 5.1 1.3 0.3 4.1 17.5 0.5 2.0 1.3 0.7 1.1 1.3 3.6 0.4 4.3 1.8 3.0 0.2 0.5 6.3 0.5 0.1 0.4 0.5 1.5 0.4 0.7 2.5 0.8 2.6 0.4 0.7 0.3 5.3 0.5 7.0 1.2 1.0 2.6 0.8 2.0 0.8 0.7 0.2 0.9 10.3 0.9 1.2 0.7 0.3 0.8 0.5 0.9 0.7 0.6 0.6 0.6 1.4 0.7 0.7 2.2 0.9 0.6 0.6 0.2 0.1 0.7 2.2 0.4 1.8 0.7 0.7 0.7 1.6 1.5 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.0 1.2 1.8 3.9 2.5 0.0 0.0 732.1 0.0 0.0 0.0 0.0 3.5 0.6 0.7 0.0 0.0 0.4 3.2 1.2 0.0 0.0 1719.4 12.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 6.7 3.7 0.0 12.9 0.1 86.1 14.8 0.1 4.7 0.0 0.0 0.6 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553086-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.5;HEL: 14.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 2.5 2.5 5.8 5.5 7.5 4.0 3.6 8.2 7.8 4.1 2.4 1.1 6.9 1.9 11.6 5.8 2.4 4.6 3.4 2.6 4.9 4.1 2.8 1.3 2.5 2.4 3.4 7.6 6.3 3.4 4.2 7.8 7.3 6.6 3.4 2.5 2.0 1.9 7.4 2.4 4.9 2.2 7.1 6.1 1.5 3.1 20.4 3.3 20.2 4.3 1.4 2.2 2.5 2.8 1.6 0.7 5.1 0.6 0.4 1.8 0.2 1.7 0.9 2.2 2.1 1.2 2.6 1.4 1.4 1.1 1.4 1.5 0.6 0.8 9.5 0.7 0.8 2.5 0.4 0.9 1.3 1.5 2.0 0.9 14.8 1.5 1.3 1.8 2.1 1.9 1.5 2.6 1.1 2.1 1.0 0.6 5.4 0.4 2.6 1.6 0.7 4.1 1.9 1.7 0.8 2.1 4.9 1.6 0.3 1.0 1.4 3.1 1.5 2.8 1.0 3.6 1.9 1.1 1.5 1.1 2.9 1.6 0.8 0.9 1.4 1.7 6.2 1.2 1.2 2.0 5.1 0.6 0.0 0.8 0.6 1.8 0.7 0.7 0.7 0.7 1.6 0.5 0.9 0.5 0.4 0.4 0.7 0.6 0.2 5.8 7.5 8.2 7.8 4.9 4.1 3.4 7.6 6.6 3.3 0.0 6.9 0.0 5.3 2.5 24.3 7.0 0.0 17.4 9.1 3.5 15.7 4.8 5.0 2.0 152.4 2.6 2.7 0.0 3.1 3.6 1.9 0.5 1.1 0.8 1.6 9.5 1.2 2.5 0.3 134.7 5.5 1.1 0.0 1.8 2.6 11.2 2.0 0.0 5.6 1.4 44.6 12.9 2.1 149.3 27.2 2.9 4.7 0.7 3.6 2.6 CCDC173 "C2orf77, LOC129881" ENSG00000154479 "Coiled-coil domain containing 173" Q0VFZ6 2 169645425-169694433 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 19.5;testis: 53.4" "Group enriched" "Detected in many" 8 "Ciliated cells: 338.6;Early spermatids: 622.4;Spermatocytes: 260.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 15.3;HMC-1: 3.7;SCLC-21H: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042995, HPA048454" Uncertain NA NA "HPA042995: AB_2678260, HPA048454: AB_2680400" "unprognostic (1.66e-2)" "unprognostic (2.68e-2)" "unprognostic (2.27e-1)" "unprognostic (3.16e-2)" "unprognostic (9.20e-2)" "unprognostic (4.18e-2)" "unprognostic (3.56e-3)" "unprognostic (3.05e-1)" "unprognostic (3.14e-2)" "unprognostic (1.69e-1)" "unprognostic (5.26e-6)" "unprognostic (8.73e-2)" "unprognostic (1.20e-1)" "unprognostic (2.20e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-2)" "unprognostic (1.41e-1)" 0.6 0.6 2.8 0.9 5.1 2.5 1.4 0.7 3.5 1.3 0.6 5.6 1.8 0.8 1.8 7.8 0.6 11.0 1.0 0.5 4.8 3.2 2.1 0.8 4.0 0.5 1.3 2.6 4.1 1.4 1.3 19.5 0.5 14.3 0.7 0.7 0.7 0.5 1.0 0.4 0.5 0.7 0.8 1.4 0.5 0.7 53.4 4.0 0.0 3.1 0.0 0.4 0.5 0.5 0.3 0.4 2.2 0.9 0.2 1.0 0.1 0.7 1.2 1.2 0.3 0.0 0.1 1.3 0.6 0.0 0.7 0.1 0.4 0.2 0.2 0.2 0.0 1.1 0.9 1.1 1.4 1.0 0.1 0.7 15.3 1.1 0.4 0.0 1.5 3.7 0.0 0.2 2.0 0.0 0.9 0.0 0.8 3.4 0.1 0.0 1.8 0.3 0.4 0.3 0.4 0.8 0.0 0.0 0.0 0.5 0.7 3.9 1.0 0.1 0.0 0.1 0.4 0.9 0.1 0.1 0.4 0.2 1.1 0.5 0.6 0.4 0.4 0.9 0.0 0.4 2.2 0.2 0.0 0.3 0.9 1.0 0.3 0.2 0.5 0.3 0.2 0.3 0.3 0.8 0.2 0.0 0.4 0.0 0.1 2.8 5.1 0.7 2.9 4.8 3.2 1.3 2.6 14.3 4.0 8.9 8.8 0.0 2.3 0.1 2.1 0.0 0.0 338.6 53.4 1.8 7.9 0.1 5.0 0.2 622.4 0.3 0.0 0.0 0.4 1.4 0.5 0.7 2.3 0.6 0.0 0.0 0.0 1.3 0.0 43.6 6.9 0.6 1.7 0.0 0.0 6.3 0.2 0.0 6.3 1.6 13.2 12.9 0.1 260.2 9.4 0.0 0.1 0.5 0.0 0.6 CCDC177 "C14orf162, PLPL" ENSG00000267909 "Coiled-coil domain containing 177" Q9NQR7 14 69569816-69574837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 17.5" "Group enriched" "Detected in some" 9 "Bipolar cells: 15.0;Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 9.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.9;HDLM-2: 1.0;NTERA-2: 2.9;SCLC-21H: 5.6;SH-SY5Y: 1.1;SK-BR-3: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.21e-1)" "unprognostic (2.33e-2)" "unprognostic (6.94e-3)" "unprognostic (1.34e-2)" "unprognostic (2.64e-3)" "unprognostic (1.77e-3)" "unprognostic (6.34e-4)" "unprognostic (2.58e-2)" "unprognostic (1.19e-1)" "unprognostic (1.99e-2)" "unprognostic (3.16e-1)" "unprognostic (7.84e-5)" "unprognostic (2.15e-4)" "unprognostic (3.81e-1)" "unprognostic (1.45e-1)" 0.4 1.1 3.2 0.4 3.7 0.3 1.0 17.5 8.5 0.3 0.3 0.2 0.0 0.3 0.4 3.1 0.4 0.4 0.3 0.3 2.2 1.6 0.3 0.6 0.3 0.3 0.5 4.4 0.4 0.3 0.3 0.3 0.3 2.3 0.3 0.3 1.8 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 1.5 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 1.1 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.7 17.5 8.5 2.2 1.6 0.5 4.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 15.0 1.1 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 CCDC178 "C18orf34, FLJ44050" ENSG00000166960 "Coiled-coil domain containing 178" Q5BJE1 18 32937402-33441101 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.3;breast: 18.4;testis: 16.4" "Group enriched" "Detected in some" 6 "Early spermatids: 58.8;Late spermatids: 53.2;Spermatocytes: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HUVEC TERT2: 9.4;U-87 MG: 8.3" "Not detected" "Not detected" NA NA "unprognostic (1.15e-2)" "unprognostic (2.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (9.88e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (2.58e-3)" "unprognostic (2.92e-1)" "unprognostic (5.95e-4)" "unprognostic (4.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.94e-4)" "unprognostic (2.86e-1)" "unprognostic (1.42e-3)" "unprognostic (9.03e-3)" 23.3 0.2 0.1 0.6 0.3 0.0 18.4 0.1 0.6 7.1 3.2 0.1 3.5 0.5 2.7 3.0 2.9 1.3 2.7 1.0 0.3 0.2 3.0 0.1 2.0 1.0 0.2 0.1 4.8 0.1 0.0 0.6 0.5 0.2 8.6 0.4 0.1 0.9 2.3 3.2 0.7 0.6 1.7 0.2 9.8 0.7 16.4 0.1 0.3 1.5 0.5 0.5 3.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 8.3 0.0 58.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.1 30.7 8.1 0.3 0.0 0.0 0.0 0.0 CCDC180 "BDAG1, C9orf174, DKFZp434I2420, KIAA1529" ENSG00000197816 "Coiled-coil domain containing 180" Q9P1Z9 9 97307304-97378524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 54.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 104.4;Early spermatids: 106.3;Late spermatids: 128.7;Spermatocytes: 49.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;memory B-cell: 1.5" "Group enriched" "Detected in many" 14 "B-cells: 1.5;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HDLM-2: 6.6;U-266/70: 9.6;U-266/84: 6.8" "Low region specificity" "Detected in some" NA NA "unprognostic (9.92e-2)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-3)" "unprognostic (2.94e-2)" "unprognostic (3.52e-2)" "unprognostic (2.94e-1)" "unprognostic (1.52e-1)" "unprognostic (5.53e-5)" "unprognostic (2.33e-2)" "unprognostic (7.34e-3)" "unprognostic (1.64e-1)" "unprognostic (2.54e-1)" "unprognostic (1.41e-2)" "unprognostic (7.50e-3)" 0.5 0.8 1.2 0.3 4.1 0.3 1.1 8.4 2.2 1.2 0.9 4.8 0.7 0.0 1.8 5.7 0.5 8.4 0.6 0.7 1.5 1.5 1.0 0.5 3.1 0.7 1.4 0.3 2.7 0.9 1.4 5.4 0.9 8.1 1.1 0.6 0.5 0.7 0.9 0.8 0.3 0.7 1.2 1.6 0.9 0.6 54.4 1.2 0.9 4.2 0.3 0.5 0.7 1.0 1.5 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.9 1.5 0.9 1.1 3.4 0.0 0.6 1.1 1.1 0.9 1.5 0.9 0.0 1.8 0.0 0.9 0.0 1.1 0.0 0.3 6.6 0.6 2.3 1.8 0.8 0.3 2.8 3.7 1.9 1.3 0.0 0.5 4.0 0.0 2.9 1.5 1.3 0.0 0.2 0.6 3.0 1.1 0.0 0.2 0.0 0.3 0.4 0.8 1.1 1.5 1.3 0.3 0.0 1.0 0.5 1.0 0.8 0.0 1.1 0.5 2.9 1.6 9.6 6.8 0.0 0.2 0.0 2.8 0.0 0.0 0.0 1.1 0.0 0.6 1.5 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 4.1 8.4 2.2 1.5 1.5 1.4 0.3 8.1 1.2 0.0 10.9 0.0 0.5 0.3 12.2 0.6 2.5 104.4 19.4 0.0 19.6 0.1 1.7 0.3 106.3 1.4 0.4 0.0 1.2 0.0 0.8 0.4 9.2 0.0 0.4 12.7 1.2 3.7 0.6 128.7 1.7 1.9 1.7 4.6 0.8 4.4 0.3 0.0 2.8 11.2 27.5 0.0 0.5 49.3 5.1 0.1 0.3 1.5 1.1 0.3 CCDC181 "C1orf114, FLJ25846" ENSG00000117477 "Coiled-coil domain containing 181" Q5TID7 1 169394870-169460669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 22.3;testis: 29.2" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 168.6;Early spermatids: 201.9;Rod photoreceptor cells: 81.8;Spermatocytes: 143.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "AF22: 7.2;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.5;SH-SY5Y: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027189, HPA027275, HPA027281, HPA027312" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349" "unprognostic (2.45e-1)" "unprognostic (2.20e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-3)" "unprognostic (3.00e-1)" "unprognostic (5.97e-2)" "unprognostic (6.87e-2)" "unprognostic (2.15e-3)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (4.89e-4)" "unprognostic (4.03e-2)" "unprognostic (3.06e-2)" "unprognostic (1.18e-2)" "unprognostic (8.41e-2)" 0.8 3.3 6.3 1.0 8.3 0.9 0.9 5.9 8.4 2.6 0.7 1.6 0.4 0.7 4.6 2.7 0.9 14.5 4.6 2.3 6.6 9.9 7.5 0.6 2.4 0.6 5.2 5.0 8.0 3.0 17.3 22.3 0.5 8.7 2.9 0.7 5.3 0.8 2.9 0.7 1.1 0.9 2.7 4.9 0.5 1.2 29.2 4.1 0.0 1.1 0.0 0.5 1.4 0.8 0.1 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.3 7.2 0.1 0.2 0.2 0.2 0.1 0.0 1.8 3.8 0.1 0.1 0.1 0.1 0.0 7.4 0.1 0.3 0.0 0.3 0.2 1.6 1.7 0.1 0.0 0.0 1.9 0.1 0.7 0.0 0.4 0.0 0.2 0.1 5.7 0.1 0.1 1.3 0.1 4.3 0.0 13.8 0.1 0.0 0.0 5.9 0.1 1.1 0.0 8.5 10.0 0.0 0.3 0.5 4.0 0.0 0.0 0.5 1.4 4.5 0.2 6.1 2.1 1.8 0.0 2.8 0.1 5.5 3.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 6.3 8.3 5.9 8.4 6.6 9.9 5.2 5.0 8.7 4.1 3.0 6.6 0.0 0.1 0.0 68.6 5.8 0.0 168.6 38.7 8.7 62.8 0.0 13.3 0.9 201.9 0.4 0.0 0.0 1.4 0.0 0.0 0.3 1.1 0.0 0.1 23.8 18.5 0.6 0.0 50.5 2.8 0.0 0.0 0.0 0.0 18.7 0.7 0.0 9.9 14.1 81.8 6.5 1.7 143.9 41.9 0.0 0.1 0.0 0.0 0.6 CCDC182 ENSG00000166329 "Coiled-coil domain containing 182" A6NF36 17 57744481-57745312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.5" "Group enriched" "Detected in some" 92 "Early spermatids: 201.1;Late spermatids: 143.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "REH: 3.1;THP-1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA023446 Uncertain NA NA "HPA023446: AB_1859510" "unprognostic (1.22e-1)" "unprognostic (3.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 CCDC183 "bA216L13.7, KIAA1984, MGC15438" ENSG00000213213 "Coiled-coil domain containing 183" Q5T5S1 9 136796350-136807741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 26.4" "Group enriched" "Detected in many" 8 "Early spermatids: 186.3;Late spermatids: 116.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 4.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.5" "Cell line enhanced" "Detected in some" "Hep G2: 2.1;HL-60: 1.4;HSkMC: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043812 Uncertain NA NA "HPA043812: AB_10961860" "unprognostic (2.91e-1)" "unprognostic (8.34e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.27e-2)" "unprognostic (2.37e-1)" "unprognostic (6.89e-5)" "unprognostic (3.45e-2)" "unprognostic (2.26e-2)" "unprognostic (6.49e-2)" "unprognostic (8.16e-3)" "unprognostic (4.32e-2)" "unprognostic (6.98e-2)" "unprognostic (1.86e-2)" "unprognostic (1.30e-1)" "unprognostic (6.20e-2)" "unprognostic (5.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.6 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.2 3.4 0.4 0.0 4.0 2.3 1.8 0.0 2.0 1.7 0.9 186.3 0.2 2.6 0.0 0.6 0.8 1.5 3.7 0.0 0.5 0.4 4.8 7.5 1.3 1.5 116.1 2.6 0.7 3.3 1.0 5.9 2.9 1.2 20.1 3.5 0.7 4.4 6.5 0.9 3.2 0.8 0.1 5.8 1.3 4.9 0.8 CCDC187 MGC50722 ENSG00000260220 "Coiled-coil domain containing 187" A0A096LP49 9 136249971-136306901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 10.2;testis: 35.9" "Group enriched" "Detected in some" 5 "Early spermatids: 100.2;Late spermatids: 351.2" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Cell type enriched" "Detected in single" 5 "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 7 "RPMI-8226: 14.8;SCLC-21H: 4.6" NA NA "unprognostic (1.11e-1)" "unprognostic (9.60e-3)" "unprognostic (1.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (4.31e-2)" "unprognostic (6.18e-2)" "unprognostic (1.72e-1)" "unprognostic (2.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (5.54e-2)" "unprognostic (8.93e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 35.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 14.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 41.5 6.8 1.8 0.0 0.0 0.0 0.0 100.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 351.2 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.0 CCDC189 "C16orf93, MGC104706" ENSG00000196118 "Coiled-coil domain containing 189" A1A4V9 16 30757423-30762710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 91.0;Early spermatids: 152.5;Late spermatids: 229.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041806, HPA046289, HPA075094" Approved Approved Cytosol NA NA Cytosol "HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: " "unprognostic (5.84e-2)" "unprognostic (3.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.45e-4)" "unprognostic (3.60e-2)" "unprognostic (5.41e-3)" "unprognostic (7.76e-5)" "unprognostic (1.66e-2)" "unprognostic (1.82e-2)" "unprognostic (5.11e-3)" "unprognostic (2.15e-4)" "unprognostic (1.22e-3)" "unprognostic (1.06e-7)" "unprognostic (1.75e-3)" "unprognostic (2.14e-1)" "unprognostic (6.63e-2)" "unprognostic (3.41e-2)" 1.0 4.2 4.7 3.1 5.3 11.0 4.8 0.9 6.4 3.2 2.8 2.9 5.5 2.0 2.2 15.0 1.2 15.6 4.2 0.8 5.5 6.8 4.5 0.9 5.5 1.9 7.5 3.3 3.1 3.0 4.4 10.3 1.2 7.6 3.0 3.1 2.3 3.4 5.1 0.4 1.8 1.4 1.3 1.3 1.9 2.0 23.7 2.2 2.3 6.3 1.6 3.4 1.7 0.8 1.2 13.0 6.2 3.1 1.8 1.1 0.8 7.2 5.0 1.5 5.9 1.6 1.9 0.4 2.8 1.0 3.0 2.3 0.4 5.4 0.3 4.8 2.1 1.6 9.1 0.8 4.5 1.2 0.8 11.8 1.9 10.3 3.1 0.3 3.0 2.1 0.4 0.4 5.5 4.5 4.5 2.2 2.0 2.7 1.3 2.1 3.7 3.1 6.0 2.3 2.2 2.7 3.1 1.9 5.6 6.7 0.1 5.1 1.8 3.0 8.3 1.9 1.5 8.2 3.8 1.9 1.5 1.3 2.6 2.8 3.9 2.2 2.7 8.8 7.7 0.7 1.2 1.3 6.2 0.2 1.4 1.1 1.2 0.0 0.2 1.8 0.1 0.0 0.4 0.6 1.8 3.1 13.0 0.1 0.8 4.7 5.3 0.9 6.4 5.5 6.8 7.5 3.3 7.6 2.2 0.0 1.9 0.0 3.2 0.0 0.4 0.0 0.0 91.0 6.8 7.0 3.9 2.0 5.0 3.3 152.5 1.0 0.0 46.7 2.6 0.9 1.0 5.3 1.1 0.8 4.0 0.0 2.4 0.0 1.5 229.1 6.9 2.3 0.0 4.6 2.2 3.3 1.5 0.9 4.6 6.2 11.7 0.0 0.0 45.1 9.6 0.0 2.1 1.0 1.7 3.0 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;lung: 7.2;tongue: 7.5" "Cell type enriched" "Detected in some" 27 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.2 0.1 1.1 0.2 1.7 0.0 0.2 0.2 0.9 0.3 0.2 0.2 0.2 0.0 0.2 0.8 8.3 1.1 1.3 1.0 1.2 0.7 0.2 0.2 7.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.2 0.3 0.2 0.1 0.7 0.2 0.6 0.2 7.5 2.4 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.1 2.6 5.1 5.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.4 0.0 9.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.2 0.6 1.2 0.7 0.4 0.2 0.2 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 48.2 0.0 1.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 CCDC191 KIAA1407 ENSG00000163617 "Coiled-coil domain containing 191" Q8NCU4 3 113964137-114056613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 191.4;Spermatocytes: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047833 Approved Approved Mitochondria NA NA Mitochondria "HPA047833: AB_10961639" "unprognostic (2.59e-2)" "unprognostic (3.93e-2)" "unprognostic (1.86e-1)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (1.42e-2)" "unprognostic (6.57e-2)" "unprognostic (5.91e-2)" "unprognostic (1.08e-1)" "unprognostic (2.90e-1)" "unprognostic (6.33e-2)" "unprognostic (3.64e-2)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.62e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.45e-4)" 3.8 4.5 6.3 4.5 13.3 4.2 7.6 3.0 9.7 7.6 4.0 11.7 11.5 2.9 8.2 12.4 3.4 18.5 5.7 2.4 8.2 7.8 7.7 2.4 7.2 6.1 6.2 9.8 7.7 6.6 16.7 31.1 3.4 12.5 6.5 5.2 7.1 5.0 7.9 1.6 11.4 5.1 7.0 8.9 7.5 4.8 12.7 7.9 3.6 11.3 2.4 6.1 5.2 4.5 10.0 4.4 5.3 0.9 0.8 2.2 1.0 4.9 2.8 4.4 3.6 1.2 6.6 1.4 1.2 2.2 1.7 2.7 0.6 5.8 1.3 2.0 2.3 1.3 6.2 1.3 2.4 4.0 0.9 1.1 0.9 0.9 0.5 1.8 1.6 0.7 2.8 6.3 2.2 3.3 3.0 3.3 3.8 0.4 3.1 1.0 2.4 3.0 0.6 0.8 3.4 2.1 2.0 0.9 2.9 6.1 2.5 2.5 4.3 2.0 0.5 2.1 2.3 10.6 0.6 3.4 2.7 0.8 1.4 0.8 4.5 3.6 5.0 3.8 0.8 1.4 0.1 0.9 1.8 1.1 0.9 1.2 10.0 2.2 1.8 1.0 9.4 1.1 1.8 5.3 0.8 0.6 4.4 1.6 1.0 6.3 13.3 3.0 9.7 8.2 7.8 6.2 9.8 12.5 7.9 11.9 11.8 7.3 3.8 0.0 8.7 0.0 0.0 191.4 29.6 12.2 35.3 1.4 11.6 3.7 21.9 1.4 1.1 0.0 3.1 0.4 1.5 2.6 1.1 0.8 2.7 19.1 4.7 5.5 1.8 10.9 3.7 0.7 0.0 1.0 3.0 20.1 2.4 0.0 4.9 3.6 39.1 0.0 0.0 76.7 12.3 0.0 0.2 0.0 3.2 1.7 CCDC27 FLJ32825 ENSG00000162592 "Coiled-coil domain containing 27" Q2M243 1 3746460-3771645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 53.3" "Group enriched" "Detected in some" 46 "Early spermatids: 60.7;Late spermatids: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "THP-1: 6.2" HPA044395 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044395: AB_10962987" "unprognostic (1.36e-1)" "unprognostic (6.67e-3)" "unprognostic (3.23e-4)" "unprognostic (3.13e-2)" "unprognostic (3.42e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (7.18e-2)" "unprognostic (1.20e-1)" "unprognostic (2.17e-2)" "unprognostic (2.54e-3)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "unprognostic (2.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.5 0.0 7.5 1.3 13.6 2.5 0.4 22.3 5.7 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.6 0.3 0.0 10.7 0.6 0.5 0.0 0.1 0.7 0.1 0.0 3.7 1.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 3.3 0.0 0.0 0.0 0.0 14.8 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 0.0 0.0 0.0 6.2 44.5 1.0 4.4 0.0 0.0 1.2 0.0 0.0 0.2 1.7 0.0 0.2 8.3 0.0 0.0 0.0 0.1 9.1 1.9 0.0 0.2 0.3 0.0 0.0 8.0 0.0 1.1 20.8 1.6 13.5 0.0 0.0 0.5 0.1 0.0 57.0 0.3 1.9 32.3 95.9 0.0 3.8 32.5 0.2 0.0 0.0 1.0 CCDC30 "FLJ20972, LOC728621, PFD6L" ENSG00000186409 "Coiled-coil domain containing 30" Q5VVM6 1 42463330-42654664 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.1" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 140.5;Club cells: 35.2;Early spermatids: 48.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 18 "HMC-1: 16.5" "HPA036344, HPA036345" Approved NA NA "HPA036344: AB_10795572, HPA036345: AB_10796213" "unprognostic (3.21e-2)" "unprognostic (8.48e-2)" "unprognostic (3.33e-1)" "unprognostic (4.46e-2)" "unprognostic (2.35e-1)" "unprognostic (5.72e-3)" "unprognostic (6.77e-3)" "unprognostic (7.68e-3)" "unprognostic (4.61e-3)" "unprognostic (1.41e-2)" "unprognostic (3.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.70e-3)" "unprognostic (6.95e-3)" 1.4 1.7 5.5 1.2 11.1 1.1 2.5 4.1 7.9 3.2 1.4 1.9 9.2 1.1 2.1 14.3 1.1 8.0 1.9 1.2 4.9 3.7 5.5 1.2 6.5 1.1 2.2 6.0 3.2 2.1 6.8 27.1 1.4 13.7 2.3 1.1 1.7 1.5 9.5 1.1 1.3 1.3 1.3 2.0 1.8 1.2 12.4 2.2 0.0 5.3 0.0 1.2 1.4 1.4 0.6 0.5 2.9 0.3 0.4 0.8 0.2 0.2 0.1 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 16.5 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.9 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.2 0.2 0.3 2.9 0.3 0.9 0.4 0.1 0.4 0.4 0.3 0.1 0.4 0.6 0.8 0.4 1.6 0.4 0.2 0.5 0.6 0.2 5.5 11.1 4.1 7.9 4.9 3.7 2.2 6.0 13.7 2.2 6.0 14.6 0.0 2.4 1.1 4.7 2.4 5.1 140.5 35.2 7.0 7.9 1.1 1.7 4.4 48.5 2.9 2.2 0.0 2.1 0.9 2.0 2.0 9.2 0.8 1.1 6.4 2.9 2.5 3.2 30.7 5.5 2.7 1.7 3.6 1.6 5.7 1.4 1.1 6.7 6.3 8.7 6.5 3.6 20.9 4.3 0.9 1.5 1.8 1.2 2.2 CCDC38 FLJ40089 ENSG00000165972 "Coiled-coil domain containing 38" Q502W7 12 95867048-95942974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.0" "Cell type enhanced" "Detected in some" 33 "Early spermatids: 66.8;Late spermatids: 12.6;Spermatocytes: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (7.54e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-1)" "unprognostic (5.22e-2)" "unprognostic (1.61e-3)" "unprognostic (3.29e-1)" "unprognostic (5.11e-2)" "unprognostic (8.37e-2)" "unprognostic (1.17e-3)" "unprognostic (2.25e-2)" "unprognostic (2.32e-1)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (4.96e-5)" "unprognostic (1.08e-2)" 0.1 0.7 0.1 0.1 0.2 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 3.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.1 0.7 0.0 37.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.7 3.0 0.5 0.7 0.7 0.1 0.5 1.5 0.9 0.8 0.5 0.2 0.7 0.3 0.1 0.4 0.7 0.7 0.5 0.7 0.3 0.2 2.0 1.0 0.8 0.2 0.8 1.4 1.3 1.2 1.2 0.6 0.2 1.1 0.3 0.4 0.6 1.0 0.2 0.5 0.1 2.8 0.2 1.4 0.2 0.4 0.8 1.2 0.6 0.2 1.3 0.6 0.3 0.7 0.4 0.7 1.5 3.4 1.5 0.9 1.8 0.9 0.6 1.0 0.3 0.9 0.9 1.8 0.2 1.8 2.1 1.2 1.1 0.5 0.9 1.4 0.5 0.9 0.6 0.3 0.4 0.5 0.4 0.3 0.2 1.2 0.6 0.7 3.0 0.7 0.2 0.7 0.6 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.6 0.3 12.6 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 17.9 1.5 0.0 0.1 0.0 0.0 0.0 CCDC39 ENSG00000284862 "Coiled-coil domain containing 39" Q9UFE4 3 180602858-180679500 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 200.8;Cone photoreceptor cells: 60.9;Early spermatids: 78.4;Late spermatids: 44.6;Rod photoreceptor cells: 44.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA035363, HPA035364" Enhanced NA NA "HPA035363: AB_2674588, HPA035364: AB_10601095" 0.0 1.7 1.1 3.6 7.5 1.8 0.0 0.3 2.9 0.6 0.1 3.3 0.0 3.1 2.0 10.4 1.2 5.8 3.4 1.4 1.7 0.1 0.0 5.7 10.3 0.0 1.3 4.6 0.3 0.0 6.4 0.0 23.3 0.7 0.0 1.4 1.6 0.0 0.2 10.7 2.7 0.0 0.2 4.2 1.6 12.4 1.1 0.0 3.5 0.0 0.0 1.9 0.0 1.2 0.6 0.0 0.2 0.7 1.5 0.3 3.9 2.6 8.3 2.2 0.0 0.0 2.7 1.9 0.0 0.0 0.0 3.1 3.7 10.5 3.5 0.0 1.8 3.5 0.1 0.0 0.0 5.8 5.0 5.0 6.8 6.7 0.0 8.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 10.2 3.4 0.7 0.3 1.0 4.0 0.1 5.1 1.8 5.2 5.5 2.7 13.2 0.0 5.6 3.9 4.4 2.3 2.3 1.5 4.0 5.7 5.2 6.3 6.9 3.0 2.2 6.5 6.6 4.5 10.9 4.4 7.6 1.4 0.0 0.2 0.0 0.8 0.1 1.5 1.2 0.4 0.0 0.2 0.3 1.1 0.3 0.0 0.7 0.2 0.6 1.1 0.3 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 200.8 13.6 0.0 60.9 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.2 0.0 1.7 0.2 0.0 0.0 0.0 1.6 0.0 16.0 1.9 44.6 12.4 0.0 1.7 0.0 0.0 2.4 0.0 0.0 9.2 0.0 44.0 6.5 0.0 32.4 6.1 0.5 0.0 0.0 0.0 0.0 CCDC40 "CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640" ENSG00000141519 "Coiled-coil domain containing 40" Q4G0X9 17 80036632-80100613 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.3;testis: 29.5" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 105.7;Rod photoreceptor cells: 28.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.0;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022974 Enhanced Approved Microtubules NA NA Microtubules "HPA022974: AB_1848791" "unprognostic (5.89e-3)" "unprognostic (2.30e-1)" "unprognostic (8.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.04e-5)" "unprognostic (7.38e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.86e-1)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" "unprognostic (4.26e-2)" 3.4 3.6 3.0 3.0 10.4 1.0 3.6 2.5 5.1 3.2 2.4 10.2 2.3 1.3 4.5 10.1 1.5 24.3 3.8 3.8 6.2 4.8 5.5 2.3 5.5 1.5 3.3 3.1 4.5 3.2 3.6 10.2 1.4 19.4 4.4 1.3 4.8 2.5 4.1 2.6 2.2 2.6 2.8 3.5 2.3 3.2 29.5 5.0 0.0 6.0 1.2 1.2 2.0 1.4 0.9 0.5 2.5 0.4 0.7 1.1 0.1 2.4 7.9 7.2 8.0 0.9 1.1 1.9 2.3 1.7 2.0 2.1 0.8 3.4 0.3 1.1 1.6 3.4 0.8 1.8 1.7 0.5 0.1 1.5 0.1 3.9 3.8 1.7 0.2 2.6 1.9 2.5 2.5 0.2 3.5 1.1 1.4 0.9 0.0 1.6 2.7 0.1 0.5 3.3 3.4 2.7 2.0 4.0 0.0 4.1 1.6 14.0 10.2 3.5 1.7 1.6 4.1 3.2 0.2 1.3 4.5 2.7 2.9 0.5 2.3 0.7 0.3 1.0 0.2 2.2 1.7 0.4 0.4 0.5 0.2 1.1 0.5 0.3 0.2 0.0 0.9 0.5 0.4 2.5 0.7 0.2 0.5 0.1 0.1 3.0 10.4 2.5 5.1 6.2 4.8 3.3 3.1 19.4 5.0 11.9 6.9 0.5 1.9 0.6 3.9 3.1 0.0 105.7 14.8 7.0 13.7 0.3 1.7 2.3 9.4 1.1 0.0 0.0 1.3 0.8 1.0 1.9 0.0 1.0 1.2 11.1 2.9 1.8 1.9 5.4 1.1 1.4 0.0 0.0 1.2 6.0 0.9 0.0 3.2 1.6 28.4 0.0 1.0 18.4 5.2 0.3 0.2 0.0 0.4 0.9 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Group enriched" "Detected in some" 54 "Early spermatids: 233.1;Late spermatids: 164.1" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "MCF7: 9.9" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 164.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.7 3.4 0.0 0.1 0.0 0.0 0.0 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CCDC73 NY-SAR-79 ENSG00000186714 "Coiled-coil domain containing 73" Q6ZRK6 11 32602246-32794658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 13.7" "Group enriched" "Detected in some" 8 "Spermatocytes: 70.1;Spermatogonia: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 2.8;MOLT-4: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038668, HPA038669" Uncertain NA NA "HPA038668: AB_10673292, HPA038669: AB_2676142" "unprognostic (9.41e-3)" "unprognostic (2.46e-2)" "unprognostic (2.36e-1)" "unprognostic (8.65e-2)" "unprognostic (5.79e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.73e-4)" "unprognostic (1.74e-1)" "unprognostic (2.02e-2)" "unprognostic (2.10e-2)" "unprognostic (3.27e-2)" "unprognostic (1.62e-5)" "unprognostic (3.87e-1)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "unprognostic (1.20e-3)" 0.2 0.6 0.2 0.2 0.2 0.7 0.2 0.8 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.4 1.0 0.2 0.4 0.2 0.2 1.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.1 0.0 13.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.5 1.3 0.0 0.0 0.2 0.2 0.0 0.5 0.5 0.0 0.0 0.4 2.8 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.0 0.3 0.9 0.1 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.4 0.0 0.3 5.9 1.2 0.4 0.2 0.5 0.2 0.4 0.2 0.0 0.7 0.3 0.4 0.2 0.3 0.0 0.3 0.2 0.2 0.0 0.4 0.3 0.4 1.3 1.6 0.4 0.4 0.2 0.8 0.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.2 0.2 0.2 0.8 0.4 0.2 0.5 0.2 0.2 0.2 0.2 3.0 1.1 0.0 0.3 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.0 2.5 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.9 0.2 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.8 0.6 6.5 0.0 70.1 32.4 0.0 0.1 0.0 0.0 0.4 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.1;testis: 41.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 107.1;Early spermatids: 339.1;Late spermatids: 203.8;Spermatocytes: 157.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 3.3" "Lineage enhanced" "Detected in single" "dendritic cells: 3.3" "Cell line enhanced" "Detected in many" "NTERA-2: 19.3;SCLC-21H: 15.9" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favorable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 1.3 12.8 5.8 2.7 6.5 0.2 6.8 1.1 4.4 5.6 1.9 3.2 4.7 0.9 7.1 7.1 1.9 26.1 5.1 2.2 5.1 6.8 3.0 0.5 3.0 0.9 2.2 4.1 7.1 1.5 13.3 14.1 0.9 13.6 5.2 1.3 2.4 1.8 5.1 0.9 3.5 0.8 5.9 3.0 1.0 1.0 41.2 1.9 2.2 2.6 0.9 1.2 4.5 2.7 0.0 3.3 0.0 0.1 0.0 0.8 0.2 0.0 3.9 4.0 0.2 5.8 14.1 0.3 3.4 5.6 3.1 2.3 0.1 6.0 1.5 2.1 5.2 5.3 3.0 1.7 1.0 1.3 3.9 7.5 0.0 3.8 0.1 0.7 0.1 0.3 4.6 0.4 3.1 0.0 6.2 1.2 8.5 2.2 4.4 2.8 2.4 8.5 2.3 19.3 1.5 2.6 4.1 0.0 1.8 7.9 0.0 15.9 11.5 0.4 0.6 0.6 1.6 5.5 0.8 1.3 0.9 3.0 12.2 2.5 0.9 0.7 0.5 13.1 0.4 5.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 3.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 5.8 6.5 1.1 4.4 5.1 6.8 2.2 4.1 13.6 1.9 0.0 0.3 0.0 8.2 4.5 0.4 0.4 2.5 107.1 11.4 7.0 0.0 0.3 6.6 6.5 339.1 0.5 0.0 0.0 0.6 0.3 12.3 7.9 0.0 0.0 0.3 0.0 7.5 1.8 0.0 203.8 34.2 1.8 1.7 0.0 0.3 7.7 2.1 0.0 64.3 2.4 0.9 0.0 3.1 157.3 16.4 5.3 0.2 0.0 1.5 4.8 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.4;testis: 22.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 66.9;Early spermatids: 268.8;Late spermatids: 93.0;Spermatocytes: 141.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6;SH-SY5Y: 15.1" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 0.0 1.4 2.8 0.1 2.4 0.0 0.4 0.0 2.2 8.3 0.1 0.0 3.5 0.6 0.1 12.4 1.1 0.1 3.0 4.0 1.0 0.0 1.0 0.1 0.9 2.1 0.2 7.5 7.7 0.0 2.7 0.0 0.2 2.5 0.0 0.1 0.0 1.0 1.4 0.0 0.0 22.7 3.7 0.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.9 2.9 0.1 2.7 5.8 0.6 2.2 1.2 0.3 0.5 0.8 0.7 0.1 3.6 2.0 3.4 1.0 0.2 0.3 0.4 2.0 5.5 0.0 6.9 0.1 0.3 0.1 0.2 1.2 0.0 0.9 0.0 3.6 0.2 1.4 0.1 1.7 0.8 2.0 0.0 0.0 5.9 0.5 6.0 4.5 0.0 3.2 1.7 0.0 10.6 15.1 1.6 0.1 0.3 0.7 6.0 0.7 0.4 1.1 5.0 6.1 0.5 0.1 0.2 0.0 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.0 0.3 0.0 2.0 0.5 0.4 0.4 2.5 66.9 3.4 5.2 0.0 0.1 3.3 1.1 268.8 0.1 0.0 0.0 0.2 0.7 2.4 3.9 0.0 0.0 0.3 3.2 10.9 0.0 0.0 93.0 9.5 0.2 0.0 0.0 0.0 3.5 0.0 0.0 11.7 0.3 0.0 0.0 2.1 141.1 14.6 1.0 0.1 0.0 0.0 0.3 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 57.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;RPMI-8226: 10.3;SCLC-21H: 12.4;U-266/70: 10.2" NA NA "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.3 1.1 3.6 1.1 11.3 1.2 0.5 2.0 1.2 2.5 0.4 6.4 1.3 0.3 1.1 21.3 0.3 47.9 0.6 0.4 4.3 4.7 0.4 0.4 13.3 1.1 1.9 0.1 5.7 0.3 0.7 2.3 0.6 20.1 0.6 0.5 0.3 0.7 1.0 0.4 0.4 0.6 0.4 2.6 0.9 0.9 1.1 1.7 0.2 0.5 0.1 1.6 1.0 0.1 0.4 1.2 1.3 0.0 1.2 3.2 0.1 0.5 1.0 1.2 2.9 1.3 1.2 1.4 1.1 2.5 0.6 0.4 0.4 4.8 1.0 1.1 0.6 0.8 0.8 2.7 1.5 0.1 8.8 0.0 2.4 1.4 0.0 1.5 0.8 1.6 3.8 0.9 0.4 4.4 3.1 0.4 2.9 0.3 3.3 0.9 6.1 0.0 2.1 1.8 2.2 0.3 2.1 0.9 10.3 4.2 1.8 12.4 1.2 1.1 7.3 0.6 0.6 4.7 1.6 1.0 1.0 0.4 0.0 0.1 10.2 0.2 2.7 1.0 1.2 2.8 0.0 0.0 1.3 0.2 0.0 3.2 0.4 0.1 1.9 0.0 0.1 0.0 0.0 0.0 1.2 0.0 1.2 0.1 0.1 3.6 11.3 2.0 1.2 4.3 4.7 1.9 0.1 20.1 1.7 0.0 0.0 0.5 0.1 0.0 3.2 0.4 0.0 57.6 5.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 0.0 0.0 0.8 3.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.1 0.0 1.3 0.0 0.0 CCDC81 "FLJ16339, FLJ23514" ENSG00000149201 "Coiled-coil domain containing 81" Q6ZN84 11 86374736-86423109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.2;fallopian tube: 28.9" "Cell type enhanced" "Detected in some" 20 "Ciliated cells: 56.2;Early spermatids: 14.1;Extravillous trophoblasts: 30.4;Sertoli cells: 12.9" "Cancer enhanced" "Detected in single" "testis cancer: 1.5" "Region enriched" "Detected in many" 8 "pons and medulla: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.5;BJ hTERT+: 4.1;HBF TERT88: 4.3;SuSa: 4.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.02e-1)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (7.00e-3)" "unprognostic (8.54e-3)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.14e-4)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" 0.5 0.3 0.9 0.3 1.6 0.3 0.3 0.4 0.7 1.6 0.3 7.4 0.8 0.0 2.0 4.5 0.3 28.9 0.5 0.3 1.5 1.8 0.2 0.1 1.5 1.1 0.5 0.6 4.3 0.1 0.3 5.5 3.1 15.2 0.6 0.3 0.8 0.1 0.9 0.7 0.2 0.2 1.1 0.7 0.3 0.2 5.6 1.7 0.0 0.5 0.4 0.4 0.6 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.3 2.4 0.0 0.8 0.3 0.9 7.5 4.1 1.2 0.9 0.8 0.7 0.4 3.0 1.1 0.3 0.5 1.2 0.2 4.3 0.5 0.4 0.8 0.2 0.7 0.4 0.4 0.5 0.2 1.4 2.2 0.6 1.2 1.4 0.6 0.4 0.1 1.0 1.2 1.0 2.2 0.2 1.0 0.0 0.4 0.2 0.7 0.6 0.0 0.4 0.4 0.3 0.6 0.0 4.7 0.4 0.9 0.4 1.9 1.0 1.7 0.2 0.1 0.6 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.6 0.4 0.7 1.5 1.8 0.5 0.6 15.2 1.7 3.0 0.3 0.0 0.2 0.2 0.8 0.9 0.0 56.2 9.1 0.0 0.0 0.9 0.0 0.1 14.1 0.2 0.0 0.0 0.0 30.4 0.3 0.3 0.0 0.0 2.1 0.0 0.0 3.1 0.0 2.1 1.4 0.3 0.0 1.0 0.0 0.3 0.0 0.0 0.7 0.0 0.7 12.9 0.4 0.4 0.2 0.5 2.3 0.0 0.0 0.1 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Group enriched" "Detected in some" 11 "Early spermatids: 142.1;Late spermatids: 149.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "MCF7: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 7.9 0.1 0.4 0.0 1.3 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC85A KIAA1912 ENSG00000055813 "Coiled-coil domain containing 85A" Q96PX6 2 56184123-56386173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.8" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 23.8;Fibroblasts: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 2.3" "Lineage enriched" "Detected in single" 23 "B-cells: 2.3" "Cell line enhanced" "Detected in some" "Daudi: 22.8;fHDF/TERT166: 37.2;U-266/70: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043106, HPA057020" Uncertain "Intracellular and membrane" NA NA "HPA043106: AB_10794770, HPA057020: AB_2683311" "unprognostic (2.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.87e-2)" "unprognostic (3.66e-2)" "unprognostic (7.87e-2)" "unprognostic (7.62e-2)" "unprognostic (3.07e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-1)" "unprognostic (6.55e-5)" "unprognostic (3.28e-2)" "unprognostic (1.00e-1)" "unprognostic (2.88e-2)" "unprognostic (1.83e-2)" 16.0 1.4 10.5 1.3 7.5 0.4 7.8 3.4 18.8 4.2 1.6 4.9 3.0 0.9 9.3 1.6 1.4 3.5 2.1 6.5 7.9 8.5 1.9 0.7 8.1 1.1 6.6 10.2 1.2 1.4 3.0 1.0 14.4 8.8 3.4 1.4 1.0 1.9 4.5 7.2 2.7 1.3 7.3 10.6 1.4 1.3 1.0 5.2 0.0 13.5 2.2 1.3 1.8 3.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.3 0.4 0.0 5.7 0.5 5.0 0.5 0.0 0.0 22.8 0.8 37.2 0.0 1.0 0.0 0.0 2.9 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 1.7 0.1 0.0 0.6 2.8 4.9 0.0 0.0 3.1 0.6 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 1.1 2.7 0.0 7.5 4.0 1.1 0.0 0.4 16.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 7.5 3.4 18.8 7.9 8.5 6.6 10.2 8.8 5.2 23.8 1.1 0.0 0.5 3.0 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 5.1 0.0 0.0 0.3 0.0 7.1 0.3 0.0 0.0 1.7 0.0 1.2 5.5 0.0 5.9 0.3 0.3 5.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 1.4 0.0 2.2 0.0 0.4 1.1 0.1 0.0 0.0 0.1 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85684866-85686277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.6" "Cell type enriched" "Detected in some" 11 "Early spermatids: 332.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;GAMG: 5.2;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040628 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.7 0.9 0.9 0.1 1.8 0.0 1.3 6.4 1.3 1.5 0.6 2.0 0.9 0.1 2.8 0.9 0.3 10.5 1.1 1.0 1.2 1.2 1.4 0.3 1.2 0.6 0.9 1.2 5.9 0.2 2.7 5.2 0.7 3.7 1.7 0.7 0.9 0.4 1.9 0.7 0.5 0.5 2.6 1.2 0.4 1.1 40.6 0.9 0.1 0.4 0.2 0.0 0.7 0.7 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.1 3.8 5.0 0.2 1.4 0.0 0.0 0.1 0.2 0.0 0.1 5.4 4.2 5.2 1.9 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 2.6 0.0 0.0 2.8 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 4.3 0.0 0.3 2.8 7.3 1.8 0.0 0.9 0.0 0.1 0.6 0.0 0.0 3.7 0.0 8.3 3.4 0.0 3.7 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 6.4 1.3 1.2 1.2 0.9 1.2 3.7 0.9 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 29.4 1.2 0.0 0.0 0.0 0.0 0.0 332.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.3 6.4 0.0 0.6 1.2 13.3 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.2 1.2 0.5 0.0 0.1 3.4 0.9 0.3 0.0 0.0 0.0 0.1 CCDC96 FLJ90575 ENSG00000173013 "Coiled-coil domain containing 96" Q2M329 4 7040849-7042939 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 52.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 53.5;Early spermatids: 56.9;Late spermatids: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047546 Enhanced NA NA "HPA047546: AB_2680082" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "unprognostic (7.95e-2)" "prognostic favorable (4.05e-4)" "unprognostic (1.22e-2)" "unprognostic (3.51e-3)" "unprognostic (1.77e-1)" "unprognostic (9.24e-3)" "unprognostic (1.01e-2)" "unprognostic (3.92e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.43e-1)" "prognostic favorable (3.80e-5)" "unprognostic (4.37e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 0.8 1.4 1.7 0.5 3.9 1.1 1.2 1.1 2.6 0.8 0.6 2.4 0.6 0.9 0.9 3.3 0.8 10.5 1.0 0.5 2.4 2.7 1.2 0.5 1.7 0.7 1.5 2.4 3.0 1.3 1.1 3.0 0.5 4.0 0.9 0.6 0.8 0.9 1.2 0.6 1.6 0.6 0.7 1.2 0.8 1.0 52.9 1.5 0.0 1.5 0.5 0.6 0.6 1.0 0.6 1.6 0.5 3.8 0.4 1.6 0.6 1.6 4.6 2.4 2.0 3.2 2.2 0.5 4.6 2.8 5.2 3.1 1.6 4.1 1.0 1.3 2.6 6.9 2.1 0.9 2.1 1.6 0.1 0.7 1.0 2.1 1.1 1.6 1.3 2.6 2.0 2.2 3.1 0.4 0.6 2.1 3.2 0.7 0.4 3.3 3.9 2.7 1.6 1.0 1.5 2.8 1.1 1.6 0.3 9.1 1.6 6.7 1.5 3.7 1.7 0.8 2.4 1.7 2.4 2.3 4.3 1.2 2.7 3.5 0.0 0.1 0.9 3.4 0.1 1.4 0.0 1.6 0.0 0.3 3.8 0.7 0.6 0.4 0.0 1.6 0.0 0.3 1.6 0.5 0.4 2.9 0.0 0.0 0.6 1.7 3.9 1.1 2.6 2.4 2.7 1.5 2.4 4.0 1.5 0.0 3.7 0.0 0.7 0.6 2.5 0.8 0.0 53.5 10.3 3.5 11.8 0.6 1.7 2.0 56.9 1.4 0.5 0.0 1.0 0.5 0.7 1.1 0.0 0.8 1.1 0.0 5.2 2.5 1.8 64.6 2.8 2.6 1.7 1.8 1.1 6.7 1.4 2.9 3.9 4.3 18.2 0.0 0.4 13.7 4.0 0.9 0.5 0.0 0.8 0.7 CCER2 ENSG00000262484 "Coiled-coil glutamate rich protein 2" I3L3R5 19 38908980-38912158 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5;skin 1: 9.9" "Cell type enriched" "Detected in some" 9 "Melanocytes: 585.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.0;THP-1: 4.0" "Low region specificity" "Detected in many" HPA069716 Uncertain "Secreted - unknown location" NA NA "HPA069716: AB_2686183" "unprognostic (6.58e-2)" "unprognostic (2.24e-2)" "unprognostic (5.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (2.76e-3)" "unprognostic (3.88e-2)" "unprognostic (2.16e-1)" "unprognostic (5.97e-2)" "unprognostic (1.45e-1)" "unprognostic (4.08e-3)" "unprognostic (3.82e-2)" "unprognostic (1.01e-9)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.32e-4)" 0.9 1.0 2.7 1.1 5.1 2.4 1.6 4.7 4.6 1.2 0.9 2.7 0.4 1.3 1.5 1.6 3.9 1.0 0.6 0.6 3.1 2.4 0.9 2.1 0.9 1.5 2.5 0.4 1.0 0.6 1.4 2.6 0.7 9.5 1.1 0.9 1.4 1.1 1.2 4.4 9.9 1.4 0.8 3.5 1.2 1.1 4.0 1.4 0.4 0.8 0.4 0.8 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.3 4.0 1.0 0.4 0.7 0.2 0.8 0.0 0.0 0.1 0.2 0.3 1.5 2.8 0.3 0.2 0.2 0.4 0.6 0.1 0.0 1.1 1.3 0.2 0.8 0.0 0.0 1.6 1.6 0.4 0.7 0.3 0.0 0.1 0.0 2.8 0.7 2.7 0.0 2.7 0.6 1.2 0.9 0.2 0.5 2.0 0.4 0.7 0.3 1.9 1.2 0.8 0.5 0.5 0.0 0.3 3.0 4.0 0.0 0.2 2.0 0.1 0.1 1.8 1.3 0.7 0.3 2.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 2.7 5.1 4.7 4.6 3.1 2.4 2.5 0.4 9.5 1.4 3.0 0.0 0.0 0.0 68.3 3.0 0.1 2.5 0.0 0.0 1.8 3.9 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.5 0.2 0.0 1.2 0.0 0.0 3.7 0.3 0.5 585.4 0.0 0.2 1.8 0.1 0.0 0.0 0.1 3.8 0.0 0.1 0.9 1.6 2.6 0.2 0.0 0.6 0.0 CCIN "BTBD20, KBTBD14" ENSG00000185972 Calicin Q13939 9 36169394-36171334 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 72.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 864.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "myeloid DC: 1.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 3.6;BJ: 5.5;fHDF/TERT166: 6.6;hTEC/SVTERT24-B: 8.2;TIME: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.10e-2)" "unprognostic (9.26e-3)" "unprognostic (6.27e-2)" "unprognostic (8.26e-6)" "unprognostic (1.78e-2)" "unprognostic (5.38e-2)" "unprognostic (1.57e-2)" "unprognostic (7.74e-3)" "unprognostic (5.43e-3)" "unprognostic (4.49e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-1)" "unprognostic (5.98e-5)" "unprognostic (3.27e-3)" "unprognostic (7.86e-2)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 0.2 0.2 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.7 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.0 72.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.4 3.6 5.5 0.5 0.1 0.2 0.0 0.0 0.0 1.5 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 2.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 11.0 0.1 1.8 0.3 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 864.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.6 184.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.1 4.2 2.6 0.0 0.1 0.0 0.0 0.0 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffolding protein" Q9NUG4 20 32010450-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 22.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 10.6;HUVEC TERT2: 12.5;NTERA-2: 6.8;RH-30: 4.7;SCLC-21H: 11.6;TIME: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 7.2 1.8 2.1 1.8 2.0 0.2 15.0 2.1 2.2 4.4 1.4 1.7 2.1 1.2 7.1 2.3 1.9 2.6 2.4 5.4 2.0 1.7 3.1 1.0 15.1 1.3 2.3 1.5 1.8 1.0 1.4 1.4 6.7 2.5 1.9 1.2 4.9 1.4 2.0 3.5 1.5 1.6 3.2 1.4 53.0 1.4 1.6 1.6 0.2 3.0 5.2 1.0 2.0 4.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.5 1.3 0.0 0.0 0.0 3.5 0.0 0.0 6.8 0.2 0.0 0.8 4.7 0.2 0.0 0.0 11.6 1.3 0.3 0.0 0.0 1.7 3.7 0.0 6.3 0.1 2.0 0.0 0.0 0.2 0.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 2.0 2.1 2.2 2.0 1.7 2.3 1.5 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.5 3.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 20.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.3 0.0 0.0 0.0 0.0 CCNG2 ENSG00000138764 "Cyclin G2" Q16589 4 77157151-77433388 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034684 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034684: AB_10669894" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (1.46e-2)" "unprognostic (2.29e-1)" "unprognostic (5.73e-2)" "unprognostic (8.15e-2)" "unprognostic (8.40e-3)" "unprognostic (1.72e-2)" "unprognostic (1.20e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.57e-4)" "unprognostic (2.04e-1)" "prognostic favorable (2.47e-5)" "unprognostic (7.98e-2)" "unprognostic (2.20e-1)" "unprognostic (2.28e-1)" "unprognostic (1.05e-3)" 18.4 8.1 11.3 13.5 15.1 25.9 26.7 53.0 17.2 15.1 12.3 8.9 9.6 8.6 16.4 10.7 45.2 8.0 10.4 6.3 9.6 5.4 23.0 3.4 12.8 21.4 7.3 10.6 12.5 7.2 8.8 7.7 20.0 7.3 26.1 11.0 12.2 18.4 10.5 7.5 12.8 9.8 13.5 7.4 14.2 7.7 8.0 7.8 25.3 17.3 7.2 22.6 20.3 18.6 4.8 2.2 16.0 2.3 1.6 4.6 0.6 10.3 1.3 23.4 12.4 15.5 19.9 15.8 8.7 25.2 6.8 12.8 1.5 15.1 20.9 14.1 8.1 6.5 7.5 6.1 28.9 13.2 14.5 4.1 1.7 6.0 3.0 8.1 3.1 21.9 16.8 14.4 3.2 7.1 22.9 10.2 12.4 1.0 12.8 12.5 4.0 14.2 6.6 2.3 5.0 1.4 8.2 22.8 1.3 43.0 28.8 6.2 19.9 10.3 16.4 6.1 14.6 12.2 4.7 9.5 9.3 9.5 6.7 1.4 9.5 7.2 14.8 6.5 4.9 4.6 11.4 1.5 16.0 0.8 2.0 1.9 2.7 1.2 0.8 1.5 4.8 0.9 0.5 6.5 1.6 2.3 2.2 4.6 0.6 11.3 15.1 53.0 17.2 9.6 5.4 7.3 10.6 7.3 7.8 11.9 10.5 50.6 33.0 33.0 67.4 4.0 5.1 4.0 4.5 52.4 21.6 23.6 72.9 23.7 0.6 35.4 27.6 0.0 17.2 86.4 68.4 86.4 38.1 1.6 26.8 23.8 16.0 31.9 38.3 0.9 25.6 27.7 54.0 67.7 29.5 17.3 37.9 17.5 25.8 40.8 46.6 64.7 34.8 5.2 10.0 23.3 13.2 22.4 13.5 38.8 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.4 0.0 0.6 24.0 0.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.4 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 3.7 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.4 1.7 0.0 1.7 0.0 1.4 0.1 0.0 0.9 1.1 0.0 0.1 1.6 1.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 3.3 4.2 1.2 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 3.5 0.6 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 25.5;AN3-CA: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: AB_2683623" "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 7.1 10.5 5.0 8.9 9.2 18.1 7.7 11.4 8.2 6.9 8.6 6.4 9.3 8.1 10.8 8.3 6.7 8.7 8.0 5.3 4.9 5.5 11.4 6.4 8.2 8.2 5.0 3.7 8.7 9.3 11.3 11.0 7.4 6.6 7.1 7.1 9.2 7.6 7.3 7.3 5.3 11.7 7.7 5.0 13.4 7.4 9.9 5.7 16.3 7.2 5.8 8.3 6.8 5.0 1.9 6.9 1.1 4.0 1.2 3.1 2.1 5.1 4.2 25.5 25.4 2.6 2.0 3.7 3.2 3.9 5.0 4.4 10.6 2.3 7.1 3.8 3.1 4.0 3.1 16.9 3.5 6.4 3.4 6.8 6.9 3.1 15.0 6.1 6.9 3.3 3.9 4.8 4.6 11.0 4.5 11.4 6.6 10.0 0.1 3.0 5.0 11.7 7.9 14.1 0.4 3.5 14.1 1.1 0.5 5.6 4.9 3.9 13.6 3.7 1.0 7.0 8.8 5.9 7.6 5.7 3.1 6.8 3.5 7.6 1.4 0.5 6.6 3.6 12.2 2.0 0.3 4.0 1.1 2.3 3.3 3.1 1.8 2.0 1.2 6.9 1.9 2.9 2.6 0.5 1.2 3.2 1.4 1.5 2.1 5.0 9.2 11.4 8.2 4.9 5.5 5.0 3.7 6.6 5.7 6.0 1.9 3.7 2.5 1.6 4.9 2.8 2.5 5.3 2.3 5.2 13.7 1.3 3.3 2.4 2.8 3.3 1.3 0.0 2.4 1.8 2.3 3.0 0.0 1.3 3.2 1.6 4.1 7.4 8.4 5.4 1.7 3.6 1.7 1.0 3.9 3.4 3.5 0.0 1.8 2.1 3.3 0.0 3.1 6.3 4.3 1.3 0.9 1.7 3.1 2.7 CCNJL FLJ14166 ENSG00000135083 "Cyclin J like" Q8IV13 5 160249106-160345396 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 48.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 25.5;Mucus-secreting cells: 27.9;Paneth cells: 20.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 19 "cerebellum: 48.9" "Group enriched" "Detected in some" 19 "neutrophil: 13.5;NK-cell: 4.1" "Group enriched" "Detected in many" 35 "granulocytes: 13.5;NK-cells: 4.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.8;WM-115: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049970 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049970: AB_2680974" "unprognostic (1.09e-2)" "unprognostic (2.36e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.79e-1)" "unprognostic (4.31e-2)" "unprognostic (1.60e-4)" "unprognostic (1.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.75e-2)" "unprognostic (6.27e-3)" "unprognostic (6.63e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.10e-4)" "prognostic favorable (8.02e-4)" 1.0 3.0 0.9 3.4 1.2 1.3 2.1 48.9 1.5 2.1 9.0 0.9 1.5 1.8 1.1 1.5 0.8 1.0 1.0 4.4 2.5 0.8 2.7 1.2 9.0 2.5 1.5 1.1 5.3 0.2 0.0 17.0 1.7 2.1 2.0 7.9 3.9 7.6 2.0 0.6 0.4 2.7 1.0 0.9 5.8 4.4 10.7 1.2 4.8 8.4 1.7 2.6 4.0 5.4 0.1 0.2 13.5 0.0 4.1 0.0 0.2 3.0 11.3 9.2 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.4 4.9 8.8 0.0 8.7 0.1 7.7 3.8 1.2 26.8 0.7 0.0 0.2 4.8 4.0 3.5 0.1 0.0 1.0 0.0 2.3 1.5 6.7 5.7 6.8 3.1 0.0 0.0 2.9 1.6 0.0 7.9 8.5 0.0 6.3 1.8 3.0 1.0 7.1 14.3 3.1 8.3 1.5 2.3 10.2 3.6 5.1 0.5 8.2 1.6 10.3 0.0 5.6 0.0 0.0 0.0 0.0 0.0 20.3 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 13.5 4.1 0.0 0.2 0.0 0.2 0.9 1.2 48.9 1.5 2.5 0.8 1.5 1.1 2.1 1.2 20.8 25.5 0.0 1.2 0.2 0.6 4.8 0.0 1.4 7.9 3.5 0.0 0.0 5.0 2.6 0.7 0.9 3.6 0.0 0.2 0.0 1.3 0.8 1.1 0.0 0.1 0.0 2.4 1.8 0.0 3.0 2.0 0.1 5.0 1.0 27.9 7.3 1.1 20.1 2.5 0.0 0.0 0.0 1.0 0.5 5.7 0.4 0.0 0.0 2.3 1.6 CCR7 "BLR2, CD197, CDw197, CMKBR7, EBI1" ENSG00000126353 "C-C motif chemokine receptor 7" P32248 17 40553769-40565472 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "blood: 252.3;lymphoid tissue: 110.6" "Cell type enriched" "Detected in many" 6 "monocytes: 2758.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 252.3" "Lineage enriched" "Detected in many" 4 "T-cells: 252.3" "Cell line enriched" "Detected in some" 79 "HDLM-2: 175.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB003796, HPA031383, HPA074467" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693" "prognostic favorable (3.84e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.26e-3)" "unprognostic (1.32e-3)" "unprognostic (2.35e-3)" "prognostic favorable (7.61e-7)" "unprognostic (2.71e-4)" "unprognostic (2.58e-2)" "unprognostic (4.48e-2)" "unprognostic (4.68e-4)" "unprognostic (1.10e-2)" "unprognostic (3.11e-1)" "unprognostic (1.08e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.02e-1)" "unprognostic (7.95e-2)" 2.8 0.4 0.2 26.0 0.2 5.2 1.7 0.2 0.3 2.2 1.2 0.3 0.8 0.3 1.2 0.5 1.4 2.3 2.0 1.9 0.2 0.2 1.5 1.7 3.4 110.6 0.3 0.2 1.5 0.3 0.0 1.0 1.0 0.4 1.3 2.1 0.7 8.4 0.2 0.2 1.1 16.2 0.2 0.4 20.3 1.8 1.2 0.3 57.1 2.0 1.2 53.8 4.2 1.3 58.8 2.9 2.3 0.3 44.1 252.3 109.3 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 175.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.1 1.1 0.2 0.0 0.0 1.1 0.3 0.2 3.1 0.1 3.6 37.2 53.3 15.3 0.2 58.8 252.3 133.9 2.3 44.1 0.2 2.9 30.3 109.3 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.3 0.0 5.9 116.5 1.4 4.4 0.0 0.3 0.0 0.0 2.3 1.8 0.0 111.5 0.0 0.4 0.1 0.1 0.0 0.0 6.9 6.3 3.3 0.0 2.3 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 12.9 15.1 2758.4 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 3.9 0.2 0.5 3.9 432.7 16.2 0.0 3.3 CCSER1 "FAM190A, KIAA1680" ENSG00000184305 "Coiled-coil serine rich protein 1" Q9C0I3 4 90127535-91601913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 166.9;Early spermatids: 257.4;Late spermatids: 243.9;Rod photoreceptor cells: 81.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;myeloid DC: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;OE19: 6.3;RT4: 3.2;SCLC-21H: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041880, HPA054709" Uncertain NA NA "HPA041880: AB_10796461, HPA054709: AB_2682581" "unprognostic (4.03e-4)" "unprognostic (4.21e-3)" "unprognostic (6.45e-2)" "unprognostic (2.44e-2)" "unprognostic (3.32e-1)" "unprognostic (3.45e-2)" "unprognostic (5.61e-2)" "unprognostic (8.13e-2)" "unprognostic (1.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.87e-1)" "unprognostic (2.04e-1)" "unprognostic (2.42e-6)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (1.64e-4)" "unprognostic (6.94e-2)" 2.9 6.4 2.4 1.9 5.2 3.4 4.5 17.0 7.6 2.2 3.4 0.0 6.3 2.0 2.1 2.1 2.1 4.1 1.9 4.7 7.4 1.9 5.6 1.7 2.1 2.3 1.8 7.6 1.9 3.3 1.7 10.4 1.4 2.1 3.0 1.8 2.9 5.0 7.1 1.7 3.0 6.4 1.7 2.5 2.7 2.6 11.4 0.5 0.0 4.6 0.0 2.6 4.9 5.9 1.0 1.0 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.1 0.0 0.2 0.2 0.2 0.0 0.0 4.0 0.2 1.0 0.8 0.1 0.0 1.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.4 0.0 0.2 0.1 0.2 0.4 6.3 0.7 0.1 0.0 0.3 0.3 3.2 3.4 1.3 0.0 1.0 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.9 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 2.4 5.2 17.0 7.6 7.4 1.9 1.8 7.6 2.1 0.5 6.0 2.7 5.0 12.5 3.9 22.4 10.7 2.5 0.0 3.4 3.5 166.9 2.8 8.3 1.1 257.4 1.4 10.3 0.0 2.9 3.8 0.5 6.8 4.7 0.0 0.9 4.8 3.4 3.7 0.6 243.9 2.8 2.2 1.7 1.0 4.9 2.3 4.7 3.5 1.1 1.7 81.5 6.5 0.3 3.2 2.8 1.9 1.5 0.0 3.4 13.2 CCT8L2 CESK1 ENSG00000198445 "Chaperonin containing TCP1 subunit 8 like 2" Q96SF2 22 16590751-16592810 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 187 "testis: 18.6" "Group enriched" "Detected in some" 46 "Early spermatids: 137.7;Late spermatids: 71.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 CD200R1L "CD200R2, CD200RLa" ENSG00000206531 "CD200 receptor 1 like" Q6Q8B3 3 112815709-112846856 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 85 "blood: 31.3;testis: 7.8" "Group enriched" "Detected in some" 28 "Early spermatids: 13.7;Late spermatids: 33.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 304 "basophil: 31.3" "Lineage enriched" "Detected in single" 313 "granulocytes: 31.3" "Cell line enhanced" "Detected in some" "A-431: 4.0;CACO-2: 3.6;CAPAN-2: 1.3;RPMI-8226: 1.9" NA NA "unprognostic (3.80e-1)" "unprognostic (1.88e-1)" "unprognostic (2.37e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-2)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 31.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 33.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Group enriched" "Detected in some" 12 "granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.4 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 15.0 0.0 29.5 0.0 0.0 0.0 28.1 0.0 0.0 33.8 1.7 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CDADC1 NYD-SP15 ENSG00000102543 "Cytidine and dCMP deaminase domain containing 1" Q9BWV3 13 49247925-49293485 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 173.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047615, HPA058314" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047615: AB_2680104, HPA058314: AB_2683677" "unprognostic (2.81e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-1)" "unprognostic (2.86e-1)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-3)" "prognostic favorable (6.03e-4)" "unprognostic (7.68e-2)" "unprognostic (6.06e-2)" "unprognostic (2.35e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-5)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (5.40e-2)" "unprognostic (8.27e-3)" 9.3 13.8 11.6 6.5 10.4 11.0 8.6 14.1 12.9 8.4 8.6 7.1 8.4 6.3 9.7 12.5 6.7 7.6 6.7 8.5 9.5 9.7 18.6 15.4 7.0 5.7 9.8 11.2 9.5 5.6 8.8 12.5 4.3 10.7 8.2 6.7 7.6 6.8 9.5 7.9 4.7 6.0 8.4 14.2 8.7 8.0 23.5 8.8 5.5 18.5 7.2 5.2 6.5 7.4 1.0 1.3 10.3 2.7 1.8 3.3 1.4 2.6 3.2 2.8 3.4 14.0 7.7 1.4 6.2 3.9 3.1 3.3 3.2 2.1 3.5 1.3 2.7 3.1 4.4 5.7 2.8 4.0 7.6 4.6 4.0 3.1 3.3 6.1 7.5 2.2 5.3 6.9 3.0 3.8 5.6 4.6 7.0 2.5 2.6 3.9 0.9 7.1 6.2 1.0 4.3 2.8 4.8 3.0 3.5 4.6 0.8 1.6 1.4 4.2 2.7 3.5 1.9 1.9 6.6 3.4 1.7 3.1 4.4 2.8 0.8 2.8 2.2 1.4 8.7 4.6 10.3 1.9 1.5 2.4 1.5 2.6 0.7 1.8 3.3 1.3 1.0 1.6 2.3 2.0 1.8 2.7 1.3 2.5 1.4 11.6 10.4 14.1 12.9 9.5 9.7 9.8 11.2 10.7 8.8 6.0 11.3 3.9 7.2 7.1 12.0 13.6 5.1 24.1 7.9 17.4 11.8 4.0 8.3 4.8 173.6 8.9 5.3 23.3 9.3 7.7 10.8 5.9 24.3 11.5 5.4 3.2 6.4 8.6 9.4 52.5 14.7 8.5 6.8 2.8 7.6 23.8 6.1 5.8 13.4 16.7 12.1 0.0 16.9 32.9 4.1 4.6 2.1 14.4 6.0 5.0 CDC42EP5 "Borg3, CEP5" ENSG00000167617 "CDC42 effector protein 5" Q6NZY7 19 54465026-54473264 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.7" "Group enriched" "Detected in many" 4 "Enterocytes: 254.3;Glandular cells: 236.7;Mucus-secreting cells: 305.7;Paneth cells: 150.3;Undifferentiated cells: 129.3;Urothelial cells: 346.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;ASC TERT1: 1.9;BEWO: 1.4;CACO-2: 2.6;HBEC3-KT: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA043449 Approved NA NA "HPA043449: AB_10961041" "unprognostic (7.67e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-1)" "unprognostic (3.36e-1)" "unprognostic (7.30e-3)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (6.49e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.73e-2)" "unprognostic (5.41e-2)" "unprognostic (6.37e-3)" "prognostic favorable (1.36e-4)" 11.0 1.8 0.0 9.6 0.1 1.8 8.1 0.0 1.8 12.9 32.7 0.4 2.7 1.8 6.1 4.5 7.3 4.1 7.2 7.2 0.0 0.0 4.2 1.8 9.4 10.4 0.7 0.0 5.9 3.8 1.8 1.1 5.8 0.4 17.0 1.8 4.4 9.8 2.9 4.7 2.7 29.4 6.3 0.9 4.8 6.1 7.9 0.0 4.4 2.8 5.3 6.5 17.7 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.9 1.4 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 56.5 9.2 0.8 0.6 0.0 0.0 0.0 17.4 0.0 0.1 0.0 3.0 5.1 12.7 254.3 0.0 10.0 10.1 32.7 236.7 9.2 0.4 0.8 0.0 37.5 27.6 1.0 5.4 9.5 0.0 16.9 1.0 305.7 15.2 11.1 150.3 8.5 0.3 2.2 6.5 5.7 0.2 0.1 6.6 0.6 0.7 129.3 346.2 CDCP2 ENSG00000157211 "CUB domain containing protein 2" Q5VXM1 1 54132968-54153770 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.4" HPA031143 Uncertain "Secreted - unknown location" NA NA "HPA031143: AB_10611819" "unprognostic (1.08e-1)" "unprognostic (5.16e-2)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-2)" "unprognostic (4.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.86e-2)" "unprognostic (2.57e-1)" "unprognostic (1.33e-1)" "unprognostic (1.67e-2)" "unprognostic (7.67e-6)" "unprognostic (2.37e-1)" "unprognostic (1.48e-1)" "unprognostic (5.12e-1)" "unprognostic (2.21e-2)" 0.5 0.3 0.1 0.1 0.5 0.3 0.9 0.1 0.6 1.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.2 0.0 2.2 0.2 0.1 0.6 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.7 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH11 "CAD11, OB" ENSG00000140937 "Cadherin 11" P55287 16 64943753-65126112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 71.0" "Group enriched" "Detected in many" 5 "Fibroblasts: 97.0;Ito cells: 32.5;Leydig cells: 48.6;Muller glia cells: 51.3;Peritubular cells: 72.9;Sertoli cells: 25.8;Smooth muscle cells: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 48.0;BJ hTERT+: 27.9;fHDF/TERT166: 65.6;HSkMC: 45.2;PC-3: 56.5;U-2197: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013072 Enhanced NA NA 70000 "CAB013072: AB_2533068" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (6.93e-2)" "unprognostic (6.00e-2)" "unprognostic (1.02e-1)" "unprognostic (6.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.09e-1)" "unprognostic (2.30e-2)" "unprognostic (3.74e-2)" "unprognostic (6.75e-2)" "prognostic unfavorable (2.48e-9)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (1.26e-1)" "unprognostic (5.07e-3)" 8.1 3.6 5.5 9.2 12.1 0.3 6.1 5.5 8.8 24.1 4.3 7.5 2.4 2.7 25.9 5.9 3.0 6.8 22.4 4.6 7.3 5.1 4.8 1.0 20.8 5.9 7.8 8.5 71.0 1.7 1.2 6.0 44.2 8.3 8.0 4.9 22.2 7.3 9.7 2.5 5.7 3.4 20.5 10.6 35.1 5.1 4.0 5.4 0.1 4.8 1.9 4.9 18.4 11.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 7.4 16.3 0.0 48.0 27.9 12.4 7.1 0.9 0.0 0.0 0.0 65.6 0.0 0.0 0.0 0.3 8.9 0.0 0.4 0.0 0.2 0.0 6.2 0.0 2.9 45.2 0.0 15.1 3.0 0.0 3.5 0.0 0.0 0.0 6.6 0.0 0.0 0.0 3.8 7.2 56.5 0.1 7.5 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 25.6 3.5 38.6 13.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 12.1 5.5 8.8 7.3 5.1 7.8 8.5 8.3 5.4 3.0 0.0 0.0 1.1 3.4 11.0 2.8 2.5 0.0 4.5 0.0 0.0 1.8 0.0 0.0 2.4 9.0 0.0 0.0 0.0 1.4 97.0 0.8 0.0 0.0 4.2 0.0 0.0 32.5 0.0 3.1 48.6 1.1 5.0 0.0 0.0 51.3 0.6 0.0 72.9 1.0 1.1 25.8 24.7 0.6 1.1 2.8 4.7 0.0 0.0 0.4 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Group enriched" "Detected in some" 12 "Bipolar cells: 17.4;Horizontal cells: 19.1;Rod photoreceptor cells: 55.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.3;SCLC-21H: 7.6;U-2 OS: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles NA NA Vesicles "HPA029325: AB_2672998" "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.3 0.2 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 0.0 0.0 0.0 0.0 0.1 17.4 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 55.7 0.0 0.0 2.2 1.2 0.0 0.1 0.0 0.0 0.0 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918984 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 139.7" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 586.2" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 96 "RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB013526, HPA036260" Enhanced NA NA "CAB013526: , HPA036260: AB_2675027" "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favorable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.3 0.0 3.5 0.1 3.4 0.2 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 586.2 0.0 0.0 63.0 0.1 2.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 105.4 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.4 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 51 "Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.0 4.0 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 21.9 1.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 94.0 0.1 0.2 0.0 0.7 0.1 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.3 0.1 36.3 0.0 0.1 0.1 0.1 0.2 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 404.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 149.4 0.0 0.0 316.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 191.5 0.0 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19472951-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 105.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 68.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 105.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.8;GAMG: 10.1;hTERT-RPE1: 5.3;U-2 OS: 9.1;U-2197: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" NA NA "HPA014416: AB_2668996" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.7 9.3 6.9 0.7 7.1 0.7 0.6 105.4 23.2 1.0 0.6 0.0 0.0 0.7 0.6 0.6 0.7 0.7 0.7 0.6 4.6 8.1 0.9 0.6 0.7 0.8 1.8 8.3 0.7 1.2 2.1 11.3 0.6 7.1 0.8 0.7 2.2 0.6 0.8 0.9 0.8 0.7 0.6 2.2 0.7 0.6 3.7 1.3 0.0 0.6 0.0 0.6 0.6 0.3 0.7 0.3 1.2 0.5 0.6 0.4 0.5 1.5 0.0 0.3 0.0 0.9 3.8 3.4 0.2 2.1 0.1 0.6 0.0 0.0 0.0 5.8 0.0 10.1 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 2.3 5.3 0.0 0.1 0.2 0.7 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.0 1.8 9.1 8.0 0.0 2.2 0.0 0.0 2.6 0.0 0.0 1.1 0.5 0.3 0.4 0.1 0.2 0.3 0.2 0.2 0.2 0.7 0.4 0.4 1.2 0.6 0.4 0.3 0.2 0.5 6.9 7.1 105.4 14.1 4.6 8.1 1.8 8.3 7.1 1.3 0.0 0.0 0.0 0.8 0.0 3.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 68.6 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.3 0.0 0.0 2.1 2.4 0.0 0.2 0.0 0.0 0.0 CDH19 CDH7 ENSG00000071991 "Cadherin 19" Q9H159 18 66501083-66604138 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.1" "Group enriched" "Detected in some" 4 "Ito cells: 20.9;Melanocytes: 42.2" "Cancer enriched" "Detected in some" 21 "melanoma: 16.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Group enriched" "Detected in some" 12 "SK-MEL-30: 20.1;WM-115: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056332 Uncertain NA NA 160000 "HPA056332: AB_2683102" "unprognostic (1.63e-2)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (3.14e-2)" "unprognostic (1.93e-1)" "unprognostic (3.79e-1)" "unprognostic (1.02e-1)" "unprognostic (4.39e-2)" "unprognostic (9.33e-2)" "unprognostic (2.25e-2)" "unprognostic (4.58e-3)" "unprognostic (8.16e-3)" "unprognostic (8.21e-2)" "unprognostic (1.56e-5)" 4.5 7.5 4.1 5.4 17.4 0.5 2.3 0.9 10.2 6.4 17.9 5.7 4.6 3.8 1.6 3.2 11.7 2.4 4.7 37.1 5.2 2.3 1.1 7.0 2.1 0.5 22.0 5.5 2.0 2.2 0.6 1.1 5.2 13.1 4.7 5.2 6.9 4.5 7.6 6.0 2.6 5.9 7.2 12.5 4.0 5.8 1.9 20.0 0.0 1.7 2.7 0.4 5.7 12.6 0.2 0.0 1.3 0.1 0.2 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.0 2.3 0.1 0.0 0.1 0.0 35.9 0.0 0.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 4.1 17.4 0.9 10.2 5.2 2.3 22.0 5.5 13.1 20.0 0.0 0.0 0.0 0.1 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.9 1.2 0.0 4.9 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.7 0.3 0.0 0.0 0.0 0.4 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333582-61555773 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 8.8;brain: 32.8" "Group enriched" "Detected in some" 8 "Bipolar cells: 15.9;Muller glia cells: 13.4" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 4.5" "Lineage enriched" "Detected in single" 39 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "AF22: 3.2;ASC diff: 10.1;HHSteC: 4.7;SH-SY5Y: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain NA NA "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 8.8 1.2 13.4 1.1 13.7 1.0 1.2 6.9 32.8 1.5 1.1 16.8 0.0 1.0 1.1 2.3 2.5 1.3 1.1 1.1 16.0 7.3 1.2 1.0 1.0 1.1 20.4 9.8 1.0 1.3 1.0 1.1 1.1 12.6 1.5 1.0 0.5 1.0 1.1 3.4 2.0 1.0 1.1 12.8 1.2 1.1 1.4 18.9 0.0 1.2 0.5 1.0 1.1 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.4 0.0 0.0 3.2 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 13.4 13.7 6.9 14.0 16.0 7.3 20.4 9.8 12.6 18.9 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.0 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173733-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 9.4;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 6.8;Late spermatids: 5.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012164, HPA012715" Uncertain Supported NA NA "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.7 4.2 10.2 0.5 5.7 0.5 0.8 55.8 15.5 0.7 0.6 1.0 0.0 0.6 0.7 0.7 1.2 4.0 0.5 1.0 3.5 3.7 0.7 0.5 0.6 0.5 1.2 8.7 0.9 4.2 0.5 1.1 0.5 3.0 1.5 0.7 1.8 1.0 1.8 1.2 10.4 0.9 0.5 1.9 0.5 0.9 1.4 1.3 0.0 0.7 0.0 0.5 0.5 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.2 5.7 55.8 14.8 3.5 3.7 1.2 8.7 3.0 1.3 0.0 0.0 0.0 1.1 0.7 9.4 2.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 45.5;Club cells: 18.2;Glandular cells: 12.1;Syncytiotrophoblasts: 12.5" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "RT4: 34.7" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.4 0.4 0.0 0.1 0.0 0.0 0.6 0.0 34.7 0.7 0.1 0.3 0.2 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 6.0 6.7 0.0 0.9 0.1 0.7 0.6 0.0 45.5 18.2 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.0 0.0 0.0 0.2 12.1 1.1 0.0 0.5 0.0 0.0 0.0 1.5 1.1 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 12.5 0.0 0.0 6.7 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Group enriched" "Detected in some" 6 "Horizontal cells: 15.9;Muller glia cells: 21.8" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "AF22: 8.1;hTERT-HME1: 10.7;U-2 OS: 14.5;U-251 MG: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA015613: AB_2732414" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 8.1 0.0 0.1 0.6 0.1 2.2 0.0 4.1 0.4 0.2 0.0 0.0 0.2 2.7 2.6 2.9 0.0 4.4 1.7 0.2 0.0 0.0 0.1 0.1 5.6 0.0 0.1 0.8 1.1 0.8 10.7 2.2 0.8 0.3 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.8 1.9 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 14.5 0.1 25.3 4.7 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 3.0 0.0 0.0 0.5 0.2 1.2 1.2 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 21.8 0.2 0.0 0.4 0.0 1.8 0.0 0.5 0.1 1.7 0.3 0.0 0.0 0.0 0.1 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890341 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 44.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 17.3;HEK 293: 3.2;Karpas-707: 6.3;RH-30: 8.3;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061419 Supported NA NA "HPA061419: AB_2684511" "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.4 0.6 2.6 0.3 4.3 0.6 0.4 15.3 7.5 0.3 0.3 0.0 0.0 0.4 0.3 0.6 0.3 0.3 0.4 0.4 0.5 2.5 0.3 0.6 0.4 0.3 1.5 2.1 1.6 0.3 0.3 1.2 0.3 16.7 3.6 0.5 1.3 0.4 1.9 1.0 0.5 0.3 0.2 1.3 0.4 0.3 1.8 0.1 0.7 0.5 0.0 0.4 0.3 0.2 0.8 0.5 1.9 0.4 0.6 0.4 0.1 0.0 0.2 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 8.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.8 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 3.9 0.0 0.0 1.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.8 0.4 0.4 1.9 0.6 0.3 0.5 0.2 0.1 2.6 4.3 15.3 5.2 0.5 2.5 1.5 2.1 16.7 0.1 0.0 0.0 0.0 0.5 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 4.1 6.5 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.1;Ciliated cells: 4.0;Early spermatids: 3.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "AF22: 7.0;fHDF/TERT166: 6.1;HaCaT: 13.9;LHCN-M2: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.1 0.0 13.9 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 16.8 0.0 0.0 0.0 1.3 0.0 1.3 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 0.0 0.3 0.0 0.7 0.1 10.1 1.1 0.0 4.0 1.2 0.0 0.0 0.9 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 0.4 1.2 2.6 0.1 0.2 0.0 0.0 0.6 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell type enhanced" "Detected in single" 37 "Proximal tubular cells: 3.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Cell line enhanced" "Detected in some" "K-562: 9.4;NTERA-2: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.5 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.7 0.0 0.9 1.3 0.3 0.3 0.2 0.3 0.1 0.6 0.0 0.1 0.3 0.5 0.7 2.5 0.0 0.0 1.6 0.6 0.7 0.0 0.0 0.0 0.2 0.8 9.4 2.3 0.0 1.5 0.8 0.5 13.9 0.2 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.5 2.7 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.8 1.0 4.4 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799835 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 37.8;fallopian tube: 42.7" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 132.5" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Region enhanced" "Detected in some" "pons and medulla: 5.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.7;HeLa: 4.5" "Region enhanced" "Detected in many" "basal ganglia: 17.7" "Low region specificity" "Detected in single" HPA076277 Enhanced "Intracellular and membrane" NA NA "HPA076277: AB_2732306" "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.2 0.1 0.4 0.1 1.6 0.3 0.1 0.0 0.0 4.9 0.2 1.9 0.0 0.1 1.3 37.8 0.1 42.7 0.1 0.1 0.7 0.9 0.1 0.1 11.4 0.1 0.0 0.0 8.0 0.0 0.0 0.8 0.6 5.7 0.1 0.1 0.0 0.1 0.2 0.1 0.9 0.1 0.3 0.2 0.0 0.1 3.9 0.0 0.0 0.0 0.5 0.2 0.2 0.1 1.1 1.5 3.0 4.1 1.3 0.4 5.8 0.5 1.8 0.5 0.3 0.5 4.7 0.3 0.4 0.1 1.0 1.0 0.0 2.7 0.0 0.2 1.1 0.6 0.5 0.1 0.0 0.3 0.3 0.3 0.8 4.5 1.0 0.0 0.3 0.5 0.7 1.5 0.8 0.3 1.2 0.0 0.3 0.2 0.7 0.0 0.0 0.0 0.8 0.3 0.6 0.2 0.8 0.2 0.0 0.0 0.3 0.1 0.1 1.6 1.1 0.0 0.1 0.2 0.1 0.0 0.6 0.2 0.7 0.1 0.7 2.4 0.1 2.2 1.3 0.0 3.0 4.1 0.4 0.4 1.6 0.3 0.4 0.3 0.3 1.5 1.1 0.3 0.4 2.5 1.3 0.2 0.5 0.2 5.8 0.4 1.6 0.0 0.0 0.7 0.9 0.0 0.0 5.7 0.0 0.0 4.3 0.0 0.1 0.1 0.0 0.4 0.0 132.5 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 0.5 0.0 0.0 0.0 0.0 0.1 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.4 6.8 0.2 2.0 0.2 0.7 0.2 0.5 1.5 0.2 0.7 5.1 15.6 0.1 0.4 1.3 1.6 28.6 0.4 0.3 0.4 2.4 0.3 0.1 9.7 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.1 0.4 0.0 1.2 0.8 0.1 0.4 0.2 0.2 7.1 0.8 0.0 0.4 0.0 1.9 3.7 0.1 0.2 2.3 2.0 0.1 0.8 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 0.3 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.1;testis: 19.0" "Group enriched" "Detected in some" 16 "Early spermatids: 60.5;Late spermatids: 42.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 6.9" HPA055952 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055952: AB_2682983" "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.3 0.0 1.5 0.0 0.5 0.1 0.3 0.1 0.2 0.2 0.9 0.1 0.0 0.4 0.2 0.4 0.2 0.1 0.1 0.1 0.5 0.2 3.8 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.1 5.1 1.0 0.0 0.3 1.1 0.4 19.0 0.5 0.0 0.2 0.2 0.2 0.3 0.5 0.1 0.0 2.0 0.0 1.3 2.3 1.6 3.7 0.0 0.0 0.9 1.4 0.0 0.0 0.1 4.4 0.6 3.7 0.9 0.0 0.5 1.7 0.0 0.0 0.0 3.7 6.9 2.1 3.8 3.1 0.0 1.7 2.7 0.0 0.0 0.0 0.0 1.4 0.0 1.8 1.7 0.8 0.0 0.9 1.8 2.7 1.5 2.6 2.3 1.4 0.7 1.5 0.0 1.9 1.8 3.3 0.4 1.0 0.6 5.2 0.8 0.9 2.0 6.0 0.8 1.4 1.6 1.2 1.4 1.7 0.9 2.8 4.3 0.0 0.1 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 CDRT15L2 ENSG00000214819 "CMT1A duplicated region transcript 15 like 2" A8MXV6 17 20579724-20580911 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 15.3" "Cell type enriched" "Detected in some" 7 "Early spermatids: 54.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;AN3-CA: 1.7;Hep G2: 1.3;HMC-1: 1.4;U-138 MG: 2.3" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.1 1.7 0.0 0.0 1.0 0.3 0.0 0.2 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 0.7 0.0 2.3 0.0 0.0 0.3 0.9 0.2 0.5 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.5 0.7 0.0 0.0 0.0 0.0 0.0 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: AB_2732714" "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favorable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favorable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.4 0.2 0.6 0.1 0.0 0.0 12.0 0.0 0.1 0.3 0.2 4.8 20.5 0.0 0.9 0.0 2.4 12.1 3.7 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.6 0.0 3.7 0.4 0.0 0.7 0.0 0.0 0.0 8.1 0.1 0.0 1.7 19.7 0.8 0.0 0.0 2.4 5.7 8.7 4.8 0.1 1.3 27.8 0.0 2.3 8.5 0.2 0.0 0.0 0.6 1.2 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 14.9 36.5 0.5 24.3 25.8 16.5 1.6 17.8 105.7 27.3 38.4 9.8 49.0 3.3 23.6 5.9 2.1 44.6 0.0 20.1 9.6 1.5 29.0 0.0 0.0 10.4 20.6 21.5 1.8 2.2 3.1 0.6 5.6 0.0 1.0 45.1 28.4 30.8 31.6 0.4 14.7 28.1 0.0 1.3 2.3 3.8 47.3 47.9 0.0 47.2 32.3 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "Carcinoembryonic antigen related cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7" "Group enriched" "Detected in some" 4 "B-cells: 4.4;Early spermatids: 5.3;granulocytes: 4.6;Hofbauer cells: 7.6;Ito cells: 14.1;Kupffer cells: 6.9;Late spermatids: 7.8;Macrophages: 4.6;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 9.8;Karpas-707: 7.8;U-266/70: 8.6;U-937: 6.5" HPA043411 Uncertain NA NA "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favorable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.8 1.2 1.6 18.5 1.7 21.1 1.3 1.0 1.4 3.5 3.8 2.4 0.0 1.2 3.9 1.4 1.5 1.4 1.1 2.1 2.0 7.2 1.4 1.8 7.2 19.2 8.4 0.5 1.1 0.7 0.3 1.0 2.4 1.9 1.2 1.2 2.0 4.3 6.2 0.5 0.6 5.0 0.9 3.3 22.7 1.4 1.5 1.6 11.1 1.2 0.7 22.4 2.9 0.8 6.9 7.0 13.0 4.6 10.3 19.1 10.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.8 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 8.6 1.5 1.6 0.0 6.5 0.0 0.0 2.6 10.8 19.1 4.6 12.8 6.7 16.5 13.1 2.8 6.9 14.2 13.8 13.0 10.3 2.8 7.0 14.6 10.1 1.6 1.7 1.0 1.4 2.0 7.2 8.4 0.5 1.9 1.6 0.0 0.0 4.4 0.2 0.0 0.0 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 7.6 0.0 0.0 14.1 6.9 7.8 0.0 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 10.0 0.0 0.0 CELA2B "ELA2B, RP11-265F14.2" ENSG00000215704 "Chymotrypsin like elastase family member 2B" P08218 1 15465909-15491400 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 188 "pancreas: 697.9" "Cell type enriched" "Detected in some" 42 "Exocrine glandular cells: 1081.3" "Cancer enriched" "Detected in single" 574 "pancreatic cancer: 69.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.7" "Cell line enriched" "Detected in some" 5 "U-138 MG: 9.3" "Secreted to digestive system" NA NA "unprognostic (4.36e-3)" "unprognostic (5.45e-2)" "unprognostic (6.66e-2)" "unprognostic (5.31e-3)" "unprognostic (4.47e-3)" "unprognostic (1.37e-3)" "unprognostic (4.66e-2)" "unprognostic (6.32e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-1)" "unprognostic (2.94e-1)" "unprognostic (3.85e-2)" "unprognostic (1.22e-6)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-1)" "unprognostic (7.80e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 697.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.5 0.0 0.1 1.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.7 1.0 1.8 0.7 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.2 1.1 0.0 0.0 0.0 0.0 0.4 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.5 0.4 0.0 0.0 9.3 0.0 0.0 0.0 0.9 0.1 0.3 0.4 0.0 0.0 3.7 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1081.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CENPBD1 MGC16385 ENSG00000177946 "CENPB DNA-binding domain containing 1" B2RD01 16 89969773-89972832 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEK 293: 7.8;K-562: 4.7" "HPA052759, HPA060522" Uncertain Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA052759: AB_2681938, HPA060522: AB_2684304" "unprognostic (2.63e-2)" "unprognostic (2.22e-3)" "unprognostic (4.43e-2)" "unprognostic (3.48e-3)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.37e-2)" "unprognostic (1.86e-3)" "unprognostic (1.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-2)" "unprognostic (6.44e-2)" "prognostic favorable (5.27e-11)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-2)" 7.2 5.9 6.6 2.6 7.3 4.5 6.3 6.1 9.5 3.3 4.0 4.9 10.5 5.9 3.6 5.0 4.0 3.6 4.6 4.2 6.6 6.1 7.6 5.6 6.7 7.1 7.9 7.0 7.6 8.9 3.9 7.1 4.4 6.2 4.9 6.0 3.8 6.0 4.8 4.2 5.1 2.9 3.8 5.6 6.6 4.7 8.2 6.3 2.5 3.5 1.8 2.5 4.8 2.7 3.7 3.6 1.4 1.6 1.4 2.7 1.3 1.2 0.0 0.2 0.4 0.5 0.9 2.1 0.8 0.3 0.0 0.0 0.6 0.0 1.3 1.2 0.9 0.3 2.0 0.0 0.0 0.3 0.0 7.8 0.0 0.3 0.5 0.4 0.4 1.3 0.0 1.4 0.0 0.0 0.2 0.0 0.6 4.7 0.9 0.0 1.1 1.4 0.6 0.7 0.4 0.5 3.2 1.6 0.0 0.0 0.0 2.7 2.0 2.9 0.3 0.1 0.3 0.7 0.0 0.0 0.2 1.9 0.3 1.2 0.8 1.3 1.0 0.5 1.2 0.5 0.6 1.6 1.4 2.4 0.7 2.1 1.2 1.9 0.8 3.6 3.7 2.7 2.3 0.5 1.4 1.4 3.1 1.1 1.3 6.6 7.3 6.1 9.5 6.6 6.1 7.9 7.0 6.2 6.3 8.9 10.7 3.7 3.1 4.1 9.6 0.4 5.1 6.7 9.1 5.2 17.7 3.7 6.6 5.6 1.5 1.6 3.4 0.0 5.1 3.6 3.5 3.4 6.9 5.8 7.4 4.8 1.2 1.3 6.3 1.3 4.4 6.9 5.0 9.0 3.2 12.6 5.2 2.9 4.9 5.0 22.5 0.0 2.8 21.8 18.8 2.8 4.2 3.2 2.6 2.1 CEP295NL "DDC8, KIAA1731NL" ENSG00000178404 "CEP295 N-terminal like" Q96MC4 17 78870910-78903217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.7" "Group enriched" "Detected in some" 129 "Early spermatids: 285.7;Late spermatids: 373.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.5" "HPA023609, HPA024619, HPA025717" Uncertain Approved Vesicles NA NA Vesicles "HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900" "unprognostic (1.68e-3)" "unprognostic (4.56e-2)" "unprognostic (2.62e-1)" "unprognostic (5.04e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (9.03e-2)" "unprognostic (8.16e-2)" "unprognostic (9.80e-2)" "unprognostic (2.08e-1)" "unprognostic (3.89e-3)" "unprognostic (3.65e-3)" "unprognostic (1.03e-1)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.75e-3)" 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 37.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 3.5 0.4 0.1 0.1 0.0 0.7 0.1 0.0 0.9 0.2 0.6 4.0 1.7 0.1 0.6 1.1 0.2 0.6 0.0 1.1 0.6 2.5 0.1 0.0 0.2 0.6 0.0 0.0 0.0 1.3 0.3 0.4 0.2 0.1 0.4 0.0 1.2 0.0 0.2 0.4 0.1 0.0 3.2 0.1 0.0 0.3 0.0 0.3 0.0 0.6 0.8 0.5 0.1 0.2 0.0 0.1 0.9 0.5 0.4 0.7 0.9 0.1 1.1 3.2 1.4 5.5 1.7 0.7 1.2 1.6 0.0 0.0 0.1 1.7 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 3.5 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 285.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.3 373.8 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavorable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavorable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favorable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.2 10.4 23.0 6.5 12.8 10.8 19.5 20.5 17.7 19.7 18.7 24.5 14.7 14.0 17.2 29.0 10.3 8.7 10.0 7.9 19.6 22.1 10.2 11.7 8.8 14.8 25.6 11.9 16.0 18.5 12.0 16.2 15.1 25.9 17.9 12.3 8.8 13.0 24.7 16.2 10.3 32.4 14.7 5.2 10.1 13.5 15.0 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 15.8 11.2 13.7 17.1 17.0 11.4 12.7 8.9 12.7 12.1 11.3 13.4 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 17.9 17.3 12.1 17.3 15.3 41.7 5.6 15.3 9.4 14.8 14.0 19.6 27.6 6.6 19.6 0.6 14.9 9.1 0.0 12.2 48.5 20.0 10.2 15.0 3.8 17.4 30.2 15.0 15.4 17.0 1.1 15.5 16.5 11.8 30.7 7.0 21.7 14.2 7.0 16.3 6.8 36.1 32.3 17.6 8.1 7.5 12.5 28.1 20.0 6.0 11.3 CES4A "CES8, FLJ37464" ENSG00000172824 "Carboxylesterase 4A" Q5XG92 16 66988589-67009758 "Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 32.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 19.8" "Not detected" "Not detected" HPA035701 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA035701: AB_10696357" "unprognostic (6.34e-2)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-1)" "unprognostic (6.20e-2)" "unprognostic (2.12e-2)" "unprognostic (2.04e-2)" "unprognostic (5.78e-3)" "unprognostic (3.93e-2)" "unprognostic (2.02e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-3)" 3.2 3.6 12.9 2.4 11.8 2.2 3.6 8.7 13.8 2.6 1.7 8.5 3.5 2.3 1.6 13.0 2.2 32.3 2.0 3.2 9.1 2.6 3.9 11.7 3.1 1.4 5.8 13.7 2.1 3.0 3.3 10.0 2.2 7.2 2.1 1.7 2.1 4.2 3.5 5.8 13.9 2.3 1.4 2.4 1.5 2.3 2.0 9.9 0.0 5.0 1.0 2.0 2.4 1.6 0.9 1.6 0.0 5.0 0.0 1.6 1.3 0.3 1.2 0.1 0.0 1.0 0.9 0.0 0.1 0.4 0.1 0.0 0.0 1.5 0.0 0.1 1.5 0.0 0.7 0.0 0.2 0.0 19.8 0.0 0.0 0.9 0.0 0.1 0.0 4.7 1.6 3.3 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.5 0.2 0.0 1.2 0.0 0.2 0.9 0.9 4.3 2.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 4.6 1.3 0.0 1.8 0.0 0.0 0.0 2.1 0.0 0.7 3.3 0.9 0.9 1.6 1.1 1.6 0.0 1.2 0.2 0.0 0.0 5.0 1.5 0.4 1.3 12.9 11.8 8.7 13.8 9.1 2.6 5.8 13.7 7.2 9.9 0.0 10.7 2.7 3.8 4.7 21.1 2.7 7.6 49.5 6.8 5.2 13.7 3.5 1.7 0.9 1.4 0.4 4.0 0.0 1.4 0.4 4.1 3.9 9.2 19.7 4.5 0.0 8.6 1.3 3.8 0.8 12.7 2.9 0.0 6.4 1.7 12.1 0.9 5.8 12.0 1.0 16.1 0.0 1.0 27.7 4.8 4.5 3.8 2.9 2.6 4.8 CES5A "CAUXIN, CES4C1, CES5, CES7, FLJ31547" ENSG00000159398 "Carboxylesterase 5A" Q6NT32 16 55846154-55956031 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 43.4" "Group enriched" "Detected in some" 4 "Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5" "Cancer enhanced" "Detected in single" "liver cancer: 0.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "U-266/70: 13.3" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.07e-1)" "unprognostic (2.55e-1)" "unprognostic (6.34e-2)" "unprognostic (4.82e-2)" "unprognostic (3.78e-1)" "unprognostic (2.33e-1)" "unprognostic (3.12e-2)" "unprognostic (1.72e-7)" "unprognostic (1.55e-2)" "unprognostic (2.27e-1)" 0.1 0.1 0.7 0.1 0.6 0.0 0.1 0.1 0.8 0.1 0.1 0.1 3.6 0.0 0.1 43.4 0.1 0.0 1.4 0.1 0.8 0.5 0.1 6.6 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.3 0.1 1.2 0.1 0.1 1.8 0.1 0.0 1.7 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.8 0.5 1.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP100 "CCDC37, FLJ40083, MIA1" ENSG00000163885 "Cilia and flagella associated protein 100" Q494V2 3 126394939-126436556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 38.7;fallopian tube: 29.2;testis: 21.9" "Group enriched" "Detected in some" 4 "Early spermatids: 282.0;Late spermatids: 505.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Group enriched" "Detected in many" 6 "basal ganglia: 14.7;pons and medulla: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2" "Low region specificity" "Detected in all" HPA046354 Enhanced NA NA "HPA046354: AB_2679634" "unprognostic (1.79e-2)" "unprognostic (3.75e-3)" "unprognostic (7.17e-5)" "unprognostic (1.61e-3)" "unprognostic (6.75e-2)" "unprognostic (9.99e-3)" "unprognostic (1.47e-1)" "unprognostic (7.83e-2)" "unprognostic (1.61e-1)" "unprognostic (3.70e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.70e-5)" "unprognostic (3.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.96e-2)" "unprognostic (3.58e-4)" 0.3 0.3 1.6 0.3 14.7 0.3 0.3 0.0 0.8 3.2 0.3 10.9 0.0 0.3 1.5 12.0 0.3 29.2 0.3 0.3 4.5 3.0 0.4 0.3 8.2 0.4 0.1 1.1 3.4 0.3 0.3 1.9 0.3 38.7 0.3 0.3 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 21.9 4.5 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 14.7 0.0 0.8 4.5 3.0 0.1 1.1 38.7 4.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 88.3 21.6 0.0 0.0 0.0 0.0 0.0 282.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 505.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 6.5 0.0 4.1 1.2 0.0 0.0 0.0 0.0 0.0 CFAP126 "C1orf192, Flattop, Fltp" ENSG00000188931 "Cilia and flagella associated protein 126" Q5VTH2 1 161364731-161367874 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 53.4;fallopian tube: 85.7" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 370.7" "Not detected" "Not detected" "Region enriched" "Detected in all" 7 "pons and medulla: 53.4" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;RPTEC TERT1: 2.5;SCLC-21H: 2.5;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045904 Enhanced NA NA "HPA045904: AB_10960411" 0.7 0.7 5.8 0.7 7.5 0.7 1.1 1.2 2.7 3.0 0.7 23.3 0.0 0.7 2.7 14.8 0.7 85.7 0.8 0.7 7.0 8.0 1.8 0.8 8.1 0.7 4.1 3.9 11.2 0.8 0.7 3.3 0.7 53.4 0.8 0.7 0.0 0.7 1.2 2.8 0.7 0.7 0.7 3.3 0.7 0.7 15.3 4.3 0.0 2.7 0.1 0.8 0.7 0.0 0.0 0.1 0.6 0.5 0.0 1.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.8 7.5 1.2 2.7 7.0 8.0 4.1 3.9 53.4 4.3 6.0 2.6 0.0 0.5 0.0 0.4 0.0 0.0 370.7 35.2 0.0 0.0 0.0 0.0 0.3 53.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 1.1 1.0 0.1 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.1 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 348.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favorable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.3 0.9 1.2 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 2.3 4.6 0.0 0.0 0.0 3.4 1.1 0.9 7.6 2.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.5 0.0 2.8 3.1 0.7 0.0 6.6 1.3 0.5 0.9 1.7 4.9 2.0 0.9 1.5 0.0 0.4 6.4 1.1 1.9 3.6 0.7 0.2 3.2 0.3 1.7 1.9 1.5 5.0 0.8 1.0 2.6 1.2 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 8.9 10.9 0.0 0.2 0.0 0.6 0.0 0.0 348.0 51.2 0.0 0.0 0.0 1.7 0.3 44.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.2 0.2 0.0 0.0 0.0 0.3 61.4 0.3 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.7 0.3 0.2 0.0 0.0 11.4 1.1 0.0 0.0 0.0 0.2 0.1 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 42.8;Club cells: 6.8;Early spermatids: 13.4;Spermatocytes: 11.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 18.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HEL: 42.4;K-562: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076975 Supported NA NA "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.8 0.4 2.3 0.4 5.2 0.9 0.6 0.4 1.1 1.5 0.4 6.8 0.2 0.2 1.1 5.4 0.4 22.4 0.5 1.1 3.3 3.3 0.5 0.5 4.0 0.3 0.6 1.1 4.2 2.7 0.2 9.9 2.1 18.0 0.4 0.3 14.9 0.5 0.5 0.5 0.9 0.4 0.6 0.8 0.9 0.5 18.2 1.5 0.0 1.0 0.0 0.6 0.5 0.2 0.0 0.3 2.3 0.4 0.0 0.7 7.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 42.4 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.1 0.5 0.0 0.9 0.0 14.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.1 2.3 0.0 0.1 0.1 0.0 7.3 2.3 5.2 0.4 1.1 3.3 3.3 0.6 1.1 18.0 1.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 42.8 6.8 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 2.5 0.0 0.0 0.0 0.0 0.1 CFAP43 "bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96" ENSG00000197748 "Cilia and flagella associated protein 43" Q8NDM7 10 104129888-104232362 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 424.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.2;U-266/70: 6.5;U-266/84: 5.3" "Low region specificity" "Detected in many" NA NA "unprognostic (1.20e-2)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "unprognostic (6.46e-3)" "unprognostic (2.03e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.78e-1)" "unprognostic (1.56e-1)" "unprognostic (2.80e-1)" "unprognostic (6.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.41e-1)" "unprognostic (3.35e-2)" "unprognostic (9.11e-4)" "unprognostic (6.67e-2)" 0.5 0.9 5.3 0.6 15.3 0.5 2.4 0.9 4.4 4.6 0.6 7.1 3.2 0.7 2.7 21.6 0.5 37.7 1.1 0.5 6.0 7.5 2.5 0.8 9.1 0.6 1.1 1.9 5.2 1.3 4.3 10.9 0.7 25.5 1.3 0.6 1.8 1.2 1.5 0.5 1.1 0.8 0.6 1.7 0.6 0.9 40.3 2.9 0.0 4.1 0.1 0.6 0.7 0.3 0.0 0.0 0.5 0.4 0.0 1.1 0.0 3.2 1.2 1.1 2.1 0.0 0.7 0.2 0.0 0.9 0.7 0.5 0.2 8.2 0.0 0.1 0.0 3.0 1.1 0.2 1.2 1.5 0.4 1.4 0.0 0.5 0.5 0.2 0.0 0.3 0.8 1.1 0.9 0.6 1.8 0.3 0.6 2.3 0.2 0.0 2.0 0.2 0.4 0.3 0.8 0.5 0.2 0.0 0.0 2.9 0.0 1.8 1.8 0.8 0.1 1.6 1.1 1.1 0.0 0.1 0.3 0.7 1.0 0.4 6.5 5.3 0.7 0.5 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 1.1 0.0 5.3 15.3 0.9 4.4 6.0 7.5 1.1 1.9 25.5 2.9 3.0 5.9 0.0 0.7 0.0 1.1 0.8 0.0 424.3 70.5 1.8 9.8 0.1 0.0 0.7 71.7 0.3 0.0 0.0 0.0 0.1 0.0 0.9 5.8 0.0 0.1 0.0 3.5 0.6 0.0 43.4 1.4 0.0 0.0 1.0 0.0 1.2 0.2 0.0 2.1 1.0 8.9 0.0 0.0 53.3 3.8 0.0 0.0 0.0 0.0 0.3 CFAP46 "bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40" ENSG00000171811 "Cilia and flagella associated protein 46" Q8IYW2 10 132808392-132942823 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.8;testis: 35.5" "Group enriched" "Detected in many" 5 "Ciliated cells: 108.4;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 75.3;Spermatocytes: 65.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.7" "Lineage enhanced" "Detected in single" "monocytes: 2.7" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;CAPAN-2: 2.5;HAP1: 3.4;RPTEC TERT1: 3.1;SH-SY5Y: 3.6" "Low region specificity" "Detected in all" "HPA037786, HPA038034, HPA038867, HPA038868" Uncertain NA NA "HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247" "unprognostic (2.83e-2)" "unprognostic (4.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.83e-1)" "unprognostic (4.11e-1)" "unprognostic (5.40e-2)" "unprognostic (6.41e-3)" "unprognostic (1.39e-1)" "unprognostic (1.64e-4)" "unprognostic (1.21e-2)" "unprognostic (8.08e-2)" "unprognostic (4.56e-3)" "unprognostic (2.08e-2)" 0.4 0.7 3.4 0.4 6.7 0.4 0.6 0.7 4.6 1.1 0.4 6.8 2.7 0.6 0.6 9.9 0.7 8.7 0.6 0.8 5.3 3.9 2.4 0.6 2.1 0.4 2.7 3.8 2.3 0.9 1.5 4.2 0.4 9.0 0.5 0.4 1.5 0.6 1.0 32.8 0.5 0.6 0.4 0.9 0.5 3.1 35.5 2.0 0.0 3.5 0.0 0.4 0.4 0.2 0.0 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.1 0.6 2.0 0.0 0.0 0.0 0.9 0.0 0.6 0.1 0.0 2.5 0.0 0.2 0.1 0.3 0.8 3.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.1 0.4 0.0 0.0 0.0 0.0 3.1 0.0 0.1 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.7 0.0 0.0 0.0 3.4 6.7 0.7 4.6 5.3 3.9 2.7 3.8 9.0 2.0 0.0 7.4 0.0 0.2 0.0 4.4 3.4 0.0 108.4 17.0 7.0 90.3 0.0 5.0 3.9 11.5 0.4 0.0 0.0 0.2 0.0 0.2 0.5 3.5 0.0 0.5 1.6 0.0 4.3 0.8 9.4 1.1 0.0 0.0 0.0 0.0 3.8 1.5 0.0 2.1 4.8 75.3 0.0 0.3 65.8 6.8 0.0 0.0 0.0 0.0 0.2 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 37.5;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 4.2;U-266/70: 7.8" "HPA044633, HPA054859" Uncertain NA NA "HPA044633: AB_10960684, HPA054859: AB_2682627" "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.3 0.3 2.0 0.2 5.9 0.2 0.3 0.3 1.2 0.9 0.3 6.2 1.2 0.2 0.7 7.0 0.3 12.8 0.2 0.3 3.7 1.3 0.4 0.5 3.7 0.2 1.2 1.5 5.3 0.3 2.3 24.5 0.3 12.4 0.3 0.2 2.0 0.3 0.3 0.3 0.3 0.3 0.2 1.1 0.3 0.3 2.1 2.7 0.0 1.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 4.2 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 0.3 1.2 3.7 1.3 1.2 1.5 12.4 2.7 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 37.5 4.5 1.8 7.9 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 0.0 0.0 2.5 5.1 0.0 0.0 0.0 0.0 0.0 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;testis: 15.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 54.7;Ciliated cells: 195.4;Club cells: 78.5" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 16.5;pons and medulla: 30.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.8;TIME: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 1.0 0.9 3.4 1.9 16.5 4.5 1.4 1.0 3.4 2.0 1.4 9.5 1.8 2.3 3.3 8.6 1.2 8.9 1.5 0.9 5.3 3.6 1.4 1.5 8.1 1.9 1.3 3.1 3.8 0.7 1.3 11.7 0.9 30.7 1.7 1.5 0.3 1.8 1.9 1.8 2.9 1.5 1.9 1.7 1.9 1.6 15.1 5.2 0.0 2.4 0.5 1.6 1.0 1.1 2.7 1.6 3.7 1.4 1.5 1.7 0.1 1.6 0.8 1.4 1.8 0.8 1.2 1.2 1.4 0.3 0.4 0.6 0.8 2.4 1.4 2.1 0.5 1.3 1.3 0.7 0.4 0.5 2.3 1.0 1.4 3.1 0.8 0.2 2.7 1.7 0.4 0.5 2.0 0.8 2.9 10.8 1.3 0.7 5.0 1.4 0.7 1.2 2.4 2.4 0.6 1.5 1.5 1.5 1.7 3.1 1.9 2.4 1.7 1.3 0.8 1.5 1.6 2.3 0.7 12.9 2.5 3.0 2.2 2.4 5.6 2.4 1.1 1.7 1.2 1.7 3.7 1.4 1.4 1.7 0.9 1.4 1.4 1.3 1.3 0.4 2.7 1.6 1.5 3.7 1.5 1.1 1.6 1.0 0.1 3.4 16.5 1.0 3.4 5.3 3.6 1.3 3.1 30.7 5.2 65.5 54.7 0.9 0.2 0.0 3.0 0.8 0.0 195.4 78.5 0.0 21.6 0.2 0.0 0.0 22.0 1.6 0.0 0.0 0.0 0.2 0.3 0.2 34.9 0.0 0.2 0.0 1.2 0.0 0.6 12.3 0.3 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.0 0.0 7.8 0.0 0.0 11.1 6.9 0.0 0.0 0.0 0.0 0.3 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172149-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.6;testis: 29.2" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 6.9;HDLM-2: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol NA NA Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.4 0.4 1.6 0.3 6.7 0.2 0.6 0.1 1.8 1.6 0.3 4.2 0.0 0.3 1.0 9.1 0.4 25.6 0.5 0.4 3.6 2.7 1.5 2.7 4.7 0.2 0.3 1.4 7.1 0.9 0.4 5.9 0.5 12.7 0.7 0.3 0.3 0.5 0.5 0.4 0.9 0.3 0.3 0.4 0.2 0.4 29.2 0.4 0.0 1.9 0.0 0.3 0.5 0.2 3.2 2.4 0.7 4.8 1.2 1.5 1.4 2.9 1.0 0.8 0.6 0.2 0.2 0.9 1.1 1.8 1.4 1.4 0.9 1.2 0.3 1.3 2.4 0.8 6.9 0.4 0.9 2.6 4.5 0.2 0.4 0.6 0.6 0.5 0.0 0.3 0.2 1.2 1.1 0.4 1.9 2.0 0.4 0.2 0.1 0.2 0.1 0.3 0.3 1.4 0.2 0.1 0.4 1.0 0.2 3.0 0.5 1.2 0.5 1.4 0.2 1.1 0.8 1.7 0.5 3.9 0.2 1.5 0.7 0.8 0.4 0.6 0.3 0.3 0.8 0.9 0.5 1.1 0.7 1.4 2.0 1.4 2.2 1.4 1.2 2.4 3.2 1.3 1.3 0.0 1.2 4.8 1.9 1.5 1.4 1.6 6.7 0.1 1.8 3.6 2.7 0.3 1.4 12.7 0.4 6.0 0.3 0.0 0.1 0.0 0.4 0.4 0.0 156.6 10.3 0.0 5.9 0.8 0.0 0.3 22.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 1.6 0.0 0.6 0.0 21.6 0.9 0.0 0.0 3.6 0.0 0.5 0.2 0.0 0.7 1.4 0.8 0.0 0.0 18.7 3.3 0.0 0.0 0.0 0.0 0.1 CFAP61 "C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156" ENSG00000089101 "Cilia and flagella associated protein 61" Q8NHU2 20 20052514-20360702 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5" "Group enriched" "Detected in some" 4 "Early spermatids: 72.8;Late spermatids: 61.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.3;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.3;HMC-1: 4.2;SCLC-21H: 9.7;SK-MEL-30: 3.8;U-87 MG: 7.3" "Low region specificity" "Detected in all" HPA009079 Approved NA NA "HPA009079: AB_1078344" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (6.73e-2)" "unprognostic (1.38e-3)" "unprognostic (6.20e-3)" "unprognostic (3.67e-3)" "unprognostic (8.58e-4)" "unprognostic (8.24e-2)" "unprognostic (8.29e-2)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.56e-1)" "unprognostic (2.76e-4)" "unprognostic (2.77e-1)" "unprognostic (9.27e-2)" "unprognostic (3.10e-3)" "unprognostic (3.06e-1)" 0.2 1.2 1.0 0.2 9.5 0.1 0.5 0.6 2.6 0.9 0.2 5.3 0.8 0.1 1.1 4.5 0.2 15.1 0.3 14.8 4.0 1.9 1.1 0.2 3.5 0.2 0.9 2.0 3.3 0.5 1.0 15.0 0.2 11.4 0.5 0.2 0.1 0.3 0.4 23.9 0.5 0.3 0.3 0.7 0.2 0.3 25.5 1.1 0.0 1.1 0.0 0.2 0.2 0.2 0.0 1.5 0.0 0.0 0.6 2.3 0.0 0.4 1.3 0.2 0.5 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.0 0.7 4.3 0.1 0.0 1.8 0.1 0.2 0.0 0.1 1.2 1.5 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.7 0.0 0.0 0.2 0.0 0.6 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.4 0.3 0.0 0.3 2.1 0.7 0.0 9.7 0.2 0.3 0.4 3.8 0.0 0.7 0.0 0.7 0.0 0.4 0.6 0.4 1.4 0.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.5 0.0 0.0 1.0 9.5 0.6 2.6 4.0 1.9 0.9 2.0 11.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 9.8 0.0 16.0 4.5 1.8 3.9 0.0 0.0 0.0 72.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 61.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 8.2 5.1 0.0 0.0 0.0 0.0 0.0 CFAP69 "C7orf63, FAP69, FLJ21062" ENSG00000105792 "Cilia and flagella associated protein 69" A5D8W1 7 90245174-90311063 "Predicted intracellular proteins" "Differentiation, Olfaction, Sensory transduction, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 95.0;Spermatocytes: 24.9" "Cancer enhanced" "Detected in many" "prostate cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062883 Uncertain NA NA "HPA062883: AB_2684893" "unprognostic (7.69e-4)" "unprognostic (9.93e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-2)" "unprognostic (3.13e-3)" "unprognostic (3.12e-2)" "unprognostic (4.11e-1)" "unprognostic (2.83e-1)" "unprognostic (4.51e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-2)" "unprognostic (9.83e-2)" "unprognostic (1.30e-1)" "unprognostic (6.46e-3)" "unprognostic (2.44e-3)" 6.7 2.5 3.4 4.1 9.4 0.5 10.5 2.8 6.3 7.4 5.2 3.5 6.7 3.0 11.1 18.6 3.3 16.3 7.2 4.3 4.0 4.9 7.6 5.1 6.4 1.0 1.7 6.3 7.5 4.0 11.0 17.5 1.4 10.3 23.1 3.5 7.4 4.6 8.1 2.8 4.5 3.2 7.3 3.3 3.4 3.9 11.1 2.8 0.0 9.2 4.1 1.5 5.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.3 0.3 4.3 4.9 5.0 0.9 0.2 3.4 1.4 2.1 7.9 3.2 0.4 0.2 3.9 5.5 1.3 1.5 1.8 2.4 0.0 1.5 0.0 1.0 2.3 2.8 0.5 0.1 5.7 2.3 5.7 2.1 7.7 1.4 0.4 1.8 0.0 2.4 2.1 0.0 3.3 2.1 0.1 1.1 0.0 0.5 0.0 7.9 1.0 0.8 1.8 3.5 0.4 0.8 0.9 1.3 0.1 0.2 4.4 0.9 4.2 1.4 0.9 0.2 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 9.4 2.8 6.3 4.0 4.9 1.7 6.3 10.3 2.8 3.0 7.5 0.0 1.2 0.0 4.1 2.4 2.5 95.0 12.5 5.2 17.7 0.2 1.7 1.6 13.3 0.0 0.0 0.0 1.4 0.1 0.3 5.1 0.0 1.7 0.1 7.9 0.0 0.6 0.3 3.6 1.1 0.0 0.0 0.0 0.9 5.6 0.4 0.0 2.1 3.3 17.9 0.0 0.5 24.9 1.6 0.0 0.1 0.0 0.9 1.2 CFAP70 "FLJ25765, TTC18" ENSG00000156042 "Cilia and flagella associated protein 70" Q5T0N1 10 73253759-73358859 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.2;testis: 22.3" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 329.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037582, HPA070304" Enhanced NA NA "HPA037582: AB_2675560, HPA070304: AB_2732153" "unprognostic (2.29e-3)" "unprognostic (4.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.43e-2)" "unprognostic (2.41e-1)" "unprognostic (9.94e-2)" "unprognostic (2.81e-1)" "unprognostic (4.60e-2)" "unprognostic (2.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-3)" "unprognostic (5.95e-3)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" 1.6 3.8 3.8 1.1 7.1 0.6 3.9 3.3 4.3 2.6 0.8 8.2 8.7 1.6 2.1 13.8 0.9 17.3 1.8 1.4 4.2 5.3 4.0 2.2 3.3 1.0 3.7 3.8 4.0 2.4 10.1 27.2 0.8 14.7 4.2 0.9 4.0 2.9 8.5 1.2 3.5 0.8 1.3 4.4 1.4 1.7 22.3 6.5 0.5 6.1 0.5 1.1 0.8 1.0 2.7 1.2 1.1 0.5 1.5 4.1 1.0 1.8 2.1 2.5 2.1 4.2 3.6 0.7 0.9 0.3 0.6 0.6 1.7 7.7 0.9 1.3 0.3 1.6 1.2 1.3 1.7 0.9 1.7 3.7 1.5 1.9 1.8 0.4 0.8 0.9 2.2 4.1 1.3 1.1 3.1 0.0 5.2 0.7 5.0 0.7 3.0 2.0 1.6 0.8 1.7 9.0 1.3 2.0 3.9 3.8 0.6 3.4 0.3 0.8 1.6 1.3 1.5 3.1 1.3 1.4 0.6 2.1 0.9 2.2 5.1 2.8 2.2 2.9 1.7 0.6 0.2 0.1 1.1 1.0 0.5 2.2 1.8 2.0 1.6 0.6 2.7 4.1 3.6 0.3 1.5 0.4 1.2 1.8 1.0 3.8 7.1 3.3 4.3 4.2 5.3 3.7 3.8 14.7 6.5 8.9 6.7 0.5 3.6 0.0 14.8 1.9 2.5 329.2 67.1 5.2 27.5 1.0 3.3 1.1 45.6 1.1 0.0 0.0 0.5 0.1 0.4 6.0 2.3 1.1 0.4 6.4 4.7 1.8 0.3 32.5 4.4 0.4 0.0 0.0 0.6 23.4 0.3 0.0 2.8 1.8 30.3 6.5 0.2 52.5 12.2 0.0 0.2 0.0 0.8 2.5 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Group enriched" "Detected in some" 8 "Ciliated cells: 42.8;Club cells: 11.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in some" "Daudi: 6.4;REH: 3.3;T-47d: 3.9;U-698: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: AB_2680434" "unprognostic (2.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.1 6.4 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.2 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.4 0.0 0.0 1.1 0.3 1.1 0.4 1.2 0.2 3.3 0.0 0.5 0.9 0.7 0.6 0.1 0.0 0.9 0.0 0.3 3.9 0.0 0.2 0.1 1.1 0.3 0.2 0.6 0.2 13.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 42.8 11.4 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CFAP74 "C1orf222, FLJ45476, KIAA1751" ENSG00000142609 "Cilia and flagella associated protein 74" Q9C0B2 1 1921951-2003837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;fallopian tube: 12.1;testis: 26.4" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 33.5;Late spermatids: 12.8;Spermatocytes: 21.5;Spermatogonia: 12.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028521, HPA029274, HPA030240" Enhanced NA NA "HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455" "unprognostic (5.41e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (9.12e-3)" "unprognostic (3.95e-2)" "unprognostic (2.21e-1)" "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.47e-1)" "unprognostic (1.26e-6)" "unprognostic (1.28e-1)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" 0.4 2.3 1.3 0.5 4.8 1.6 0.3 11.8 3.8 1.7 0.4 3.9 0.4 0.4 1.0 6.6 1.6 12.1 1.2 0.3 1.9 1.8 0.2 1.7 3.1 1.0 0.8 1.5 2.5 0.1 0.3 2.4 0.5 5.4 0.2 0.4 0.0 0.5 0.7 1.2 5.5 0.3 0.2 0.4 0.4 0.3 26.4 1.0 0.0 1.9 0.0 0.2 0.9 0.1 1.4 1.2 1.5 1.4 1.9 1.1 0.1 1.6 0.0 2.5 1.5 0.0 3.6 2.1 0.3 0.0 0.0 1.2 3.5 0.3 2.1 3.1 0.6 1.6 0.6 0.0 0.6 0.5 1.9 2.9 4.3 5.2 2.3 0.6 3.3 1.4 2.3 2.2 0.0 0.0 1.0 0.0 1.4 6.0 1.6 1.2 0.6 1.6 1.1 1.9 0.2 2.6 1.7 0.7 1.0 0.0 3.4 3.2 1.2 0.6 0.3 0.1 0.7 0.7 0.9 3.6 2.0 2.0 0.9 2.3 2.2 0.8 2.2 0.2 3.3 1.0 0.3 1.4 1.1 0.8 0.6 0.3 1.0 0.6 0.5 0.5 1.4 0.8 1.1 1.5 1.9 0.9 1.2 0.6 0.1 1.3 4.8 11.8 3.8 1.9 1.8 0.8 1.5 5.4 1.0 0.0 2.6 0.0 0.9 0.0 1.4 1.6 0.0 33.5 7.9 0.0 7.9 0.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.8 0.1 0.0 0.0 4.9 1.3 12.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 21.5 12.4 0.0 0.7 0.0 0.0 0.4 CFAP97D1 C17orf105 ENSG00000231256 "CFAP97 domain containing 1" B2RV13 17 43780435-43787612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053028 Approved NA NA "HPA053028: AB_2682020" "unprognostic (7.80e-2)" "unprognostic (5.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.64e-2)" "unprognostic (1.87e-1)" "unprognostic (1.36e-1)" "unprognostic (1.98e-1)" "unprognostic (2.77e-1)" "unprognostic (4.80e-2)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.73e-1)" "unprognostic (6.24e-2)" "unprognostic (2.28e-3)" "unprognostic (1.41e-1)" 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.1 45.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.9 3.0 1.0 1.3 0.7 0.3 1.0 0.1 0.2 1.0 0.2 0.2 0.5 0.4 0.0 0.0 0.2 0.4 0.6 0.8 0.2 0.1 0.9 0.6 0.3 0.4 0.3 0.4 0.7 1.8 1.2 0.6 0.1 0.4 0.9 0.5 0.0 0.8 0.6 0.9 0.5 0.9 0.5 1.0 0.1 0.1 1.2 2.0 0.6 0.2 0.5 0.9 0.7 0.2 0.3 0.6 1.1 1.0 0.6 0.6 0.7 1.3 1.5 1.8 0.6 1.0 1.7 0.9 0.4 0.4 0.5 0.2 0.7 1.6 0.7 2.1 1.0 0.9 0.7 0.6 0.5 0.8 0.5 0.3 0.4 1.5 0.7 0.7 3.0 1.3 0.7 0.9 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CGB1 ENSG00000267631 "Chorionic gonadotropin beta subunit 1" A6NKQ9 19 49035610-49036895 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "pancreas: 8.4" "Cell type enriched" "Detected in single" 125 "Syncytiotrophoblasts: 58.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 20.5" "HPA038925, HPA038934" Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.9 0.0 0.1 0.1 0.0 0.0 0.5 0.3 4.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.0 CGB7 CG-beta-a ENSG00000196337 "Chorionic gonadotropin beta subunit 7" P0DN87 19 49054275-49058860 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 8.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (9.53e-2)" "unprognostic (1.99e-1)" "unprognostic (1.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.60e-5)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (8.37e-2)" "unprognostic (2.88e-2)" "unprognostic (4.80e-2)" "unprognostic (8.83e-4)" "unprognostic (1.54e-1)" "unprognostic (3.89e-8)" "unprognostic (1.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.05e-1)" "unprognostic (9.28e-2)" 0.3 0.2 0.3 0.3 0.3 0.0 0.8 0.3 1.5 1.7 0.3 0.3 3.7 0.3 1.2 0.5 4.0 1.0 2.0 2.0 0.4 0.2 1.0 0.3 0.8 0.3 0.3 0.3 0.9 2.5 0.0 2.7 3.7 1.3 4.6 0.0 0.8 1.3 3.9 6.4 8.1 0.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.9 2.2 0.3 2.4 2.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.8 0.2 1.5 0.0 0.2 7.1 0.6 0.0 1.4 1.2 1.2 2.6 0.0 0.1 1.3 2.1 5.7 0.2 4.8 0.5 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 6.9 0.4 0.7 1.6 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.1 0.1 1.4 0.1 0.1 1.7 1.0 0.2 0.2 2.3 2.3 0.0 10.4 0.3 0.4 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.3 1.5 0.4 0.2 0.3 0.3 1.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 49.1 0.0 0.0 0.0 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119115 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 9.8;Peritubular cells: 8.1;Spermatogonia: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 18.7;SK-BR-3: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 22000 "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 5.0 3.0 15.7 1.4 28.8 2.2 7.1 14.8 31.6 2.1 3.2 2.8 0.2 4.6 5.6 2.0 3.4 5.9 4.6 2.8 16.1 13.8 3.4 10.3 0.9 0.8 8.5 15.9 11.0 3.8 0.4 1.4 0.7 10.3 5.1 4.6 0.8 13.7 1.4 3.1 2.1 6.3 6.4 2.6 1.0 13.4 4.0 3.6 0.0 0.7 1.6 2.8 4.0 0.5 1.0 0.9 0.9 1.0 0.9 1.1 0.6 3.5 3.0 0.1 3.8 9.0 3.4 0.2 4.3 0.0 0.4 0.1 0.8 2.9 0.0 1.2 8.5 1.1 0.2 0.6 0.9 0.2 0.0 1.8 0.1 5.2 7.6 8.4 2.3 0.3 2.3 8.7 1.2 1.0 5.7 0.3 0.5 0.1 0.1 0.5 11.1 1.7 3.1 1.0 18.7 8.3 0.1 0.0 0.2 0.0 0.1 8.7 13.0 8.4 38.0 4.3 0.1 12.2 6.4 0.0 0.0 3.4 0.0 0.3 1.1 0.3 0.3 0.0 0.1 4.9 0.9 1.0 0.0 0.7 0.8 0.5 1.0 1.0 0.7 0.5 0.7 0.6 1.1 0.6 0.9 0.4 0.9 0.7 0.6 15.7 28.8 14.8 20.5 16.1 13.8 8.5 15.9 10.3 3.6 0.0 0.0 0.0 0.1 0.6 9.8 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 1.4 0.1 1.3 2.2 0.0 3.9 0.3 0.0 0.0 3.1 0.8 1.3 4.0 0.0 0.0 0.0 4.2 0.5 1.2 0.0 8.1 3.6 2.0 0.0 0.9 2.1 13.6 0.4 0.1 0.0 0.0 0.1 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" NA NA "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: AB_2681714" "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.2 2.1 2.7 6.1 8.3 0.0 4.6 6.1 3.8 4.6 2.8 5.2 1.9 6.4 4.1 7.5 1.2 3.0 2.2 8.4 4.7 3.7 2.8 3.4 0.0 3.9 0.0 5.5 5.7 2.7 7.1 3.8 4.8 5.3 1.9 0.7 18.5 7.3 0.6 1.6 0.0 6.6 0.0 4.1 1.6 5.4 1.2 4.7 2.0 1.2 1.7 5.2 2.5 5.5 3.8 2.0 1.1 6.2 4.4 4.2 8.6 2.8 5.2 13.0 0.0 6.4 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 3.0 7.8 2.7 4.2 2.4 10.0 9.8 7.6 2.7 4.5 3.5 5.9 0.0 0.0 3.2 3.3 6.8 1.4 0.0 2.9 0.0 5.0 5.6 4.7 1.7 1.2 12.7 0.0 5.5 1.0 1.6 2.8 1.5 5.0 1.0 6.3 5.0 2.1 5.8 8.5 8.4 6.8 0.0 3.6 2.1 1.9 4.0 0.0 5.7 2.9 3.8 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHPF2 "ChSy-3, CSGlcA-T, KIAA1402" ENSG00000033100 "Chondroitin polymerizing factor 2" Q9P2E5 7 151232489-151238827 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020992 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA020992: AB_1847267" "unprognostic (8.31e-2)" "unprognostic (2.14e-3)" "unprognostic (1.02e-3)" "unprognostic (1.14e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (4.07e-1)" "unprognostic (1.71e-1)" "unprognostic (4.54e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.04e-1)" "unprognostic (2.68e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-2)" "unprognostic (8.59e-3)" 13.5 29.3 13.4 19.0 12.9 22.6 19.1 13.1 20.2 15.3 14.4 11.4 20.7 14.9 19.5 16.9 13.3 14.9 17.6 18.8 13.7 12.5 14.9 20.7 17.4 23.4 11.4 17.4 14.4 23.7 16.7 41.5 18.6 11.8 18.5 10.8 12.2 25.4 19.8 7.9 14.2 17.1 17.3 9.4 28.1 20.1 12.9 11.1 16.2 17.5 7.4 13.7 18.9 12.8 2.7 9.5 9.9 5.6 2.6 5.7 3.7 9.0 7.4 5.0 14.5 17.4 17.3 7.5 19.1 29.8 10.4 12.7 4.9 15.4 2.7 33.8 30.3 14.2 11.4 2.2 13.6 4.5 10.4 6.8 2.9 8.1 6.8 16.3 5.8 24.2 26.4 7.7 9.8 3.5 21.6 16.3 4.6 2.7 8.0 16.5 14.9 5.4 22.9 6.6 3.8 8.6 5.1 2.9 9.1 10.1 7.2 5.4 9.6 10.2 10.1 4.8 3.9 3.9 9.6 22.2 11.6 1.9 15.3 16.1 14.8 2.1 4.0 42.1 7.8 15.6 1.2 5.6 7.9 5.7 5.1 5.4 2.7 3.1 5.1 6.3 2.7 2.2 2.3 9.9 2.6 5.0 9.5 3.4 3.7 13.4 12.9 13.1 20.2 13.7 12.5 11.4 17.4 11.8 11.1 8.9 10.2 11.5 4.8 4.0 9.5 1.6 12.7 4.0 4.5 10.4 3.9 9.1 1.7 10.3 0.5 4.7 10.2 23.3 14.5 12.1 9.7 9.5 5.8 8.3 11.2 23.8 8.1 13.5 11.6 0.7 15.8 8.5 6.8 7.2 10.1 4.3 14.8 15.9 14.2 3.3 6.9 19.4 6.2 3.4 1.7 3.9 8.6 12.1 8.1 8.9 CHRFAM7A "CHRNA7-DR1, D-10" ENSG00000166664 "CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion" Q494W8 15 30357766-30393849 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.2;parathyroid gland: 6.3" "Cell type enhanced" "Detected in some" 15 "Horizontal cells: 11.1;Spermatocytes: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HEL: 6.0;RH-30: 4.8;SH-SY5Y: 6.2;U-937: 6.4" NA NA "unprognostic (3.61e-2)" "unprognostic (1.52e-1)" "unprognostic (5.59e-2)" "unprognostic (2.66e-3)" "unprognostic (2.40e-1)" "unprognostic (2.02e-1)" "unprognostic (3.55e-1)" "unprognostic (7.20e-2)" "unprognostic (3.53e-1)" "unprognostic (7.45e-2)" "unprognostic (2.41e-1)" "unprognostic (4.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.71e-4)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" 0.9 3.5 1.3 1.1 1.3 6.2 0.4 0.0 2.5 0.6 0.4 0.7 0.3 0.2 0.1 0.8 0.4 2.4 0.9 1.6 0.2 0.0 1.2 0.5 2.8 0.6 0.9 6.3 1.0 0.0 1.0 0.6 0.2 0.5 0.1 0.4 1.8 0.6 1.6 0.8 0.9 5.5 3.2 0.2 0.8 0.5 0.2 2.8 5.2 2.1 1.0 0.3 0.4 0.0 0.6 1.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 2.3 0.0 6.3 0.0 0.0 0.0 3.7 6.0 0.2 0.6 0.1 1.2 2.1 0.4 0.0 0.2 0.0 3.1 0.6 1.4 0.6 0.0 1.8 0.0 0.0 0.6 0.7 0.2 0.0 0.0 4.8 0.0 1.5 1.9 0.4 6.2 0.0 0.0 0.0 0.8 0.1 1.3 2.6 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 2.1 5.2 0.3 0.7 0.1 0.2 0.0 0.0 2.8 0.1 0.0 0.3 0.0 1.0 0.1 0.6 0.1 0.4 0.0 0.0 0.0 0.7 0.0 1.1 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.3 0.0 1.0 0.0 0.0 0.4 1.1 0.0 0.7 11.1 1.2 0.6 0.3 0.0 0.0 0.0 0.0 1.8 2.5 0.8 0.6 0.0 1.4 0.0 0.0 0.0 0.1 3.0 1.9 0.0 0.0 0.0 1.0 1.5 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968720-34067457 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 22.8" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 3.0;Early spermatids: 5.2;Extravillous trophoblasts: 13.6;Late spermatids: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "BEWO: 5.5;HMC-1: 19.3" "Region enhanced" "Detected in many" "hypothalamus: 15.4" "Low region specificity" "Detected in many" HPA013172 Uncertain NA NA "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.3 0.5 1.2 0.9 15.7 1.3 2.1 0.8 6.9 0.3 0.4 5.1 0.0 1.1 0.5 0.8 0.5 0.3 0.6 0.3 6.8 4.4 0.6 0.9 0.4 1.0 5.8 4.5 0.5 1.0 0.1 0.5 4.8 17.8 0.6 0.3 0.0 0.5 0.1 0.7 1.8 1.8 0.2 22.8 0.7 0.6 5.2 0.0 0.0 2.3 0.0 0.3 0.4 0.3 0.3 0.9 4.8 0.3 0.2 0.3 0.0 0.1 0.2 0.8 0.3 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.7 0.3 0.2 0.0 0.5 19.3 0.4 0.0 0.2 0.1 0.2 0.0 0.5 0.6 1.2 0.1 0.2 0.2 2.2 0.2 0.2 0.3 0.1 0.3 0.2 0.0 0.4 0.4 0.3 0.3 0.7 0.2 0.2 0.2 1.2 0.2 0.2 0.2 0.2 0.1 0.9 0.3 0.4 0.1 0.2 0.3 1.5 0.3 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.2 4.8 0.2 0.1 0.9 0.2 0.0 1.2 15.7 0.8 6.9 6.8 4.4 5.8 4.5 17.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 5.2 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 CHRNB3 ENSG00000147432 "Cholinergic receptor nicotinic beta 3 subunit" Q05901 8 42697376-42737407 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.6;pancreas: 6.8;testis: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.6" "Group enriched" "Detected in many" 5 "cerebellum: 19.6;midbrain: 8.2" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.5;T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 6 "NTERA-2: 3.3;U-266/84: 7.3" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 32 "cerebellum: 21.0;midbrain: 30.4" HPA045555 Enhanced NA NA "HPA045555: AB_10960891" "unprognostic (8.63e-2)" "unprognostic (4.12e-1)" "unprognostic (7.29e-2)" "unprognostic (1.62e-1)" 0.1 0.1 0.3 0.1 0.8 0.1 0.1 19.6 2.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.4 0.1 0.1 0.1 0.8 8.2 2.3 0.1 6.8 0.1 0.9 0.1 1.1 0.1 0.1 3.4 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.8 19.6 2.7 0.4 0.4 8.2 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403560-2448483 "Enzymes, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Ito cells: 159.0;T-cells: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 430000 "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 24.2 12.0 9.4 12.1 10.5 14.5 11.2 17.8 16.5 11.9 10.1 13.2 9.0 13.5 14.4 10.6 5.9 11.7 10.9 12.0 8.8 7.7 9.3 6.8 13.6 10.3 10.4 9.2 9.6 17.5 4.9 14.4 9.6 12.7 11.8 4.2 12.3 14.1 11.6 11.9 11.5 10.1 8.1 9.5 25.0 12.4 10.2 8.6 9.0 11.2 4.4 11.8 10.6 10.3 5.7 21.0 16.4 3.5 37.4 30.2 6.7 3.9 4.0 2.5 4.5 3.7 2.7 12.7 7.2 3.4 3.1 4.3 4.5 1.5 3.5 13.6 3.2 6.8 3.2 1.6 1.9 0.9 4.6 8.5 2.4 3.5 5.0 1.7 8.0 26.2 3.7 1.2 2.8 0.3 3.2 3.2 5.9 6.2 12.7 1.4 3.6 8.4 27.1 8.5 1.2 7.3 3.1 3.3 18.3 1.5 2.1 3.0 12.5 3.5 2.6 1.8 2.5 3.3 10.2 5.4 4.6 12.0 9.0 6.3 38.6 14.9 1.6 3.7 4.1 7.9 15.5 3.5 16.4 30.2 2.8 18.9 5.2 10.7 24.5 6.6 5.7 4.5 13.5 1.0 37.4 1.2 21.0 10.2 6.7 9.4 10.5 17.8 16.5 8.8 7.7 10.4 9.2 12.7 8.6 14.9 44.5 41.3 35.2 16.1 44.3 6.7 10.2 17.4 30.7 17.4 62.8 84.2 1.7 17.6 4.4 44.9 6.7 23.3 13.5 8.5 48.9 15.3 36.9 5.9 22.1 44.5 12.2 159.0 21.8 2.7 88.6 20.1 20.3 17.2 9.4 16.0 13.1 7.0 63.6 10.3 46.4 19.4 19.6 27.6 19.4 13.4 111.7 128.5 13.1 9.1 CHST5 "FLJ22167, I-GLCNAC-6-ST" ENSG00000135702 "Carbohydrate sulfotransferase 5" Q9GZS9 16 75528535-75535247 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 32.9" "Group enriched" "Detected in some" 18 "Ciliated cells: 2.7;Enterocytes: 5.7;Intestinal endocrine cells: 2.4;Mucus-secreting cells: 3.0;Paneth cells: 5.9;Undifferentiated cells: 2.2" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.4;stomach cancer: 1.5" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 4.6" "HPA043804, HPA068029" Enhanced "Intracellular and membrane" NA NA "HPA043804: AB_10960563, HPA068029: " "unprognostic (6.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.99e-3)" "unprognostic (1.03e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-2)" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (2.09e-2)" "unprognostic (9.03e-3)" "unprognostic (4.27e-2)" "unprognostic (2.05e-3)" "unprognostic (3.56e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 0.4 0.0 0.7 0.4 1.7 0.0 0.4 2.4 1.1 0.4 17.5 0.4 0.4 32.9 0.4 0.4 0.4 1.1 0.4 0.4 0.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.4 0.4 0.4 21.6 0.4 0.4 0.4 2.1 0.0 28.5 0.4 0.4 0.4 1.7 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.1 3.0 1.3 1.1 1.1 0.4 0.4 1.0 1.4 1.6 0.4 1.0 0.8 0.0 0.3 0.6 0.5 0.6 1.9 1.2 0.6 0.3 0.2 1.1 0.1 0.7 0.0 0.4 1.4 0.2 0.5 1.9 0.3 0.7 0.8 1.1 0.1 0.0 0.4 0.5 0.2 1.1 0.4 1.3 0.0 2.7 0.7 3.8 0.9 0.1 4.6 0.5 0.4 2.6 1.6 0.5 2.2 3.7 1.9 1.4 0.2 0.2 1.0 0.3 0.3 1.6 1.1 2.7 0.3 0.8 1.9 0.2 1.0 0.4 0.9 3.0 1.0 1.0 0.9 1.0 0.8 1.0 0.8 0.7 0.5 1.3 1.1 1.1 2.6 1.1 1.3 1.1 0.7 0.4 0.7 1.7 2.4 1.1 0.8 0.8 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 5.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 CHST9 "GALNAC-4-ST2, GALNAC4ST-2" ENSG00000154080 "Carbohydrate sulfotransferase 9" Q7L1S5 18 26906481-27185317 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.4" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 422.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Hep G2: 9.5;RPTEC TERT1: 30.0;SCLC-21H: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA011393 Uncertain "Intracellular and membrane" NA NA "HPA011393: AB_1846733" "unprognostic (9.24e-3)" "unprognostic (1.13e-2)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (4.53e-3)" "unprognostic (9.98e-3)" "unprognostic (9.21e-3)" "unprognostic (7.92e-2)" "unprognostic (1.61e-1)" "unprognostic (2.04e-2)" "unprognostic (3.54e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (3.93e-3)" 0.3 0.4 1.7 0.3 2.4 0.2 3.7 1.0 2.6 4.0 2.1 4.5 0.7 0.4 0.3 0.9 2.2 13.6 4.5 3.4 3.7 2.7 2.4 12.1 8.6 0.1 2.6 0.8 1.2 11.9 0.1 4.3 0.1 4.9 4.8 0.4 5.3 23.4 2.7 0.4 0.4 0.7 0.3 5.3 7.1 1.0 8.5 4.2 0.0 0.3 3.9 7.0 2.6 10.5 0.5 0.1 0.8 0.1 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 30.0 0.0 6.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.5 0.2 0.3 0.5 0.3 0.0 0.1 0.1 0.0 1.7 2.4 1.0 2.6 3.7 2.7 2.6 0.8 4.9 4.2 0.0 2.4 0.0 29.8 0.6 1.3 7.7 38.2 422.9 93.3 5.2 0.0 0.2 10.0 8.9 6.1 0.0 0.0 0.0 0.5 0.1 1.1 6.5 4.7 8.9 0.3 0.0 3.4 0.0 0.0 2.4 0.6 0.0 6.8 0.0 0.0 72.3 2.1 0.0 0.4 0.1 1.8 0.0 0.5 0.7 0.7 0.0 0.2 0.0 0.0 37.1 CHSY3 "CHSY-2, CSS3" ENSG00000198108 "Chondroitin sulfate synthase 3" Q70JA7 5 129904472-130186634 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 8.9;Ito cells: 4.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;ASC TERT1: 11.3;HSkMC: 7.4;TIME: 6.8;U-138 MG: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044612 Uncertain "Intracellular and membrane" NA NA "HPA044612: AB_10795883" "unprognostic (3.43e-2)" "unprognostic (6.28e-3)" "unprognostic (1.76e-2)" "unprognostic (5.83e-2)" "unprognostic (5.88e-2)" "unprognostic (8.17e-2)" "unprognostic (3.37e-2)" "unprognostic (1.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (9.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.08e-6)" "unprognostic (5.22e-3)" "unprognostic (9.93e-2)" "unprognostic (4.61e-3)" "unprognostic (1.74e-2)" 11.7 1.6 7.0 2.7 8.9 0.3 5.7 0.4 10.4 12.5 1.7 2.1 0.0 1.5 4.2 1.6 1.8 2.6 7.2 3.0 4.8 2.2 1.0 4.8 4.6 1.4 2.1 8.9 1.1 1.1 2.1 0.9 5.6 1.0 1.4 1.6 6.3 1.3 1.8 2.2 2.8 1.3 5.2 1.5 1.9 1.5 1.9 2.1 0.0 2.9 1.3 1.3 3.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.0 12.7 11.3 1.0 2.8 0.1 0.4 0.4 0.0 0.1 0.0 0.2 4.2 0.0 0.0 0.0 0.1 0.0 0.0 1.5 1.7 5.6 0.4 1.2 0.0 0.0 7.4 0.0 0.1 1.1 0.6 3.0 0.0 0.0 1.8 4.9 0.0 0.0 0.0 0.6 0.0 1.2 0.4 5.4 0.0 0.2 0.0 4.4 0.0 0.0 0.0 0.2 1.1 0.2 0.4 6.8 13.6 2.8 0.1 1.8 0.0 0.0 0.0 0.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 8.9 0.4 10.4 4.8 2.2 2.1 8.9 1.0 2.1 8.9 0.6 0.0 0.0 0.5 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.1 2.3 0.0 0.0 2.0 1.4 0.0 0.0 4.9 1.8 0.0 1.1 0.0 3.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 6.5 2.5 1.4 0.6 0.3 0.3 0.0 0.0 0.0 CILP2 MGC45771 ENSG00000160161 "Cartilage intermediate layer protein 2" Q8IUL8 19 19538248-19546659 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 9.4;testis: 10.1" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 20.5;Late spermatids: 15.9;Sertoli cells: 6.5;Spermatogonia: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC diff: 8.9;HEK 293: 5.2;NB-4: 3.9;THP-1: 5.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA041847 Uncertain "Secreted to extracellular matrix" NA NA 11000000 "HPA041847: AB_10795599" "unprognostic (6.51e-2)" "unprognostic (2.54e-2)" "unprognostic (5.42e-4)" "prognostic unfavorable (3.22e-6)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (4.31e-2)" "unprognostic (4.13e-3)" "unprognostic (4.48e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.09e-2)" "unprognostic (1.41e-2)" "unprognostic (0.00e+0)" "unprognostic (1.59e-2)" "unprognostic (3.19e-2)" "unprognostic (3.12e-3)" "unprognostic (1.36e-2)" 2.8 0.1 0.9 1.1 1.0 3.1 3.6 0.3 1.1 3.1 0.7 0.0 0.8 0.1 0.7 1.1 0.8 0.9 5.6 1.0 0.8 1.4 0.2 0.7 0.9 2.5 0.3 0.0 9.4 0.2 1.4 0.9 2.4 0.4 1.2 0.2 3.0 2.8 0.9 4.0 0.7 0.3 0.5 0.1 0.7 0.2 10.1 0.0 0.0 7.8 0.4 1.8 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.3 0.2 8.9 0.3 1.2 1.1 0.0 0.5 0.1 2.4 0.9 0.1 2.3 0.4 0.1 1.0 0.2 0.0 0.1 0.6 5.2 0.0 0.2 0.3 0.3 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 3.9 3.3 2.7 1.6 0.6 0.0 0.0 0.1 0.0 0.1 2.2 0.5 2.8 0.3 0.5 0.5 5.0 0.0 0.1 1.1 0.4 0.2 0.7 2.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 1.1 0.8 1.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.5 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.3 3.7 4.5 0.5 0.0 0.0 0.0 0.4 CKLF "C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1" ENSG00000217555 "Chemokine like factor" Q9UBR5 16 66552563-66566251 "Predicted membrane proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 142.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA062779 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA062779: AB_2684867" "unprognostic (1.64e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (4.97e-2)" "unprognostic (3.06e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.79e-2)" "unprognostic (8.05e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.06e-9)" "unprognostic (2.36e-1)" "unprognostic (2.65e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.07e-1)" 18.8 21.1 16.1 27.7 16.9 29.9 18.8 19.0 14.9 14.8 20.6 11.0 9.1 15.7 14.8 15.2 12.5 16.4 22.8 11.0 14.9 13.4 15.0 14.6 28.9 41.2 23.1 11.0 14.5 12.0 11.4 13.5 14.6 15.0 14.6 22.0 10.9 13.0 9.7 6.8 9.0 26.5 16.9 20.8 44.4 12.2 42.5 18.6 40.2 12.3 11.7 24.6 17.6 13.0 9.4 32.2 142.0 39.6 17.7 25.6 34.2 35.7 31.9 6.7 19.3 18.1 14.8 4.9 17.9 13.6 19.6 29.3 29.7 43.9 14.1 22.7 15.3 20.5 19.3 13.3 10.7 27.6 17.4 6.7 10.3 28.4 36.3 10.9 32.0 27.8 10.1 8.7 24.4 8.7 23.5 23.3 43.6 16.4 40.7 24.4 11.9 30.9 31.8 2.2 21.1 51.8 53.1 35.4 39.2 65.4 19.9 9.4 11.4 54.8 3.6 16.6 4.7 10.6 21.7 14.2 28.4 25.7 9.8 21.0 19.3 39.7 71.8 23.9 28.2 22.9 64.6 39.6 74.8 20.6 19.8 25.6 9.4 19.2 20.0 32.2 8.8 10.2 14.1 142.0 17.7 18.6 16.3 22.9 34.2 16.1 16.9 19.0 14.9 14.9 13.4 23.1 11.0 15.0 18.6 17.9 66.2 46.2 20.8 24.3 8.2 0.8 101.9 65.6 35.2 54.1 0.0 40.5 14.9 120.7 24.7 44.8 58.0 23.3 113.2 92.3 41.3 13.1 334.0 34.2 227.1 1.6 31.7 66.9 154.7 20.5 45.8 289.2 38.8 30.7 61.5 19.0 153.7 40.3 28.3 75.1 6.4 32.3 33.5 349.8 69.4 20.1 14.5 215.8 65.0 23.3 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Ciliated cells: 34.8;Collecting duct cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 2.1 5.3 5.4 2.6 12.5 2.0 6.6 3.5 13.5 7.6 3.4 5.2 11.8 2.3 6.8 15.1 5.1 18.9 6.5 2.4 6.2 6.5 8.9 6.1 7.4 1.8 3.3 5.9 6.8 11.3 13.2 15.3 2.4 5.3 7.6 3.5 7.6 6.3 8.3 1.3 9.2 2.2 4.4 2.1 2.4 5.9 23.9 1.8 1.8 17.6 1.0 2.3 4.2 3.3 1.8 2.3 2.4 1.1 1.0 1.4 0.5 4.0 7.3 2.2 6.9 2.2 3.3 3.4 3.3 3.1 4.0 1.8 0.7 7.2 0.4 7.0 3.3 2.1 8.8 0.8 4.9 2.5 3.3 2.6 0.3 6.3 0.3 7.9 1.7 1.8 2.1 11.4 4.3 8.5 6.8 2.3 3.5 2.4 1.1 2.3 13.8 0.7 5.2 2.9 4.0 7.0 2.6 1.2 2.3 8.6 2.4 14.4 7.5 4.7 2.1 3.8 1.5 15.0 2.5 2.4 5.0 2.3 10.1 2.5 1.4 0.9 0.3 6.4 0.5 3.5 1.8 1.1 0.4 1.4 1.1 0.3 1.2 1.4 0.3 0.5 1.8 0.6 1.3 2.4 1.0 1.0 2.3 0.6 0.5 5.4 12.5 3.5 13.5 6.2 6.5 3.3 5.9 5.3 1.8 14.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 34.8 4.5 15.7 0.0 1.2 3.3 6.2 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "gallbladder: 37.4;lung: 91.9;stomach 1: 126.9" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 1488.8" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.7;stomach cancer: 186.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "OE19: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 0.1 0.1 0.3 0.1 37.4 2.0 0.1 0.0 0.1 0.1 91.9 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 126.9 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.9 0.3 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.6 18.9 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.5 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 1488.8 318.5 0.0 0.0 0.0 0.8 18.9 0.0 1.4 20.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 9.9 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 257.5 0.0 0.0 0.0 1.4 0.0 0.0 6.6 3.8 0.0 0.0 0.0 0.0 0.0 CLDN20 ENSG00000171217 "Claudin 20" P56880 6 155264013-155276548 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 1.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.5;WM-115: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (3.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-1)" "unprognostic (2.84e-1)" "unprognostic (4.04e-2)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (6.26e-2)" "unprognostic (6.40e-2)" "unprognostic (7.33e-3)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (3.29e-2)" "unprognostic (2.05e-1)" 0.2 1.0 0.1 0.5 0.2 3.1 0.4 0.8 1.3 0.1 0.3 0.5 1.6 0.0 0.7 0.1 1.2 0.4 0.8 0.2 1.2 0.5 0.4 1.3 0.8 0.6 0.7 0.0 0.4 0.1 0.3 0.0 1.2 0.0 0.7 3.6 1.0 2.4 2.1 1.2 0.6 1.3 1.6 0.0 0.4 0.9 0.9 0.1 0.8 0.3 0.0 0.6 0.0 0.4 1.5 0.6 1.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.9 0.6 2.9 0.4 0.0 0.3 1.6 0.0 0.0 0.0 0.3 1.0 1.0 2.1 3.5 0.3 1.7 0.6 1.4 0.0 0.0 0.0 0.2 0.0 0.4 1.3 1.5 0.0 2.5 0.1 1.6 0.1 0.3 0.2 0.9 0.4 0.2 0.0 3.3 0.3 1.1 0.5 0.3 0.5 0.2 0.9 0.2 1.8 1.3 0.7 0.9 1.9 0.7 0.4 2.1 0.8 1.1 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.9 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN22 CLDN21 ENSG00000177300 "Claudin 22" Q8N7P3 4 183318194-183320774 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "fallopian tube: 4.2;salivary gland: 7.2" "Group enriched" "Detected in some" 18 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0;Club cells: 3.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 1.0;MCF7: 1.0;RT4: 1.3;SCLC-21H: 1.5;THP-1: 1.1" NA NA 0.0 0.4 0.2 0.0 0.4 0.2 0.0 0.3 0.5 0.1 0.1 0.0 1.0 0.0 0.9 4.2 0.0 0.0 0.5 0.2 1.1 1.3 0.1 0.0 0.1 0.0 0.2 0.1 0.4 0.0 0.4 0.0 7.2 0.1 0.5 0.4 0.0 0.1 0.2 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701938-8704106 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Enterocytes: 128.5;Paneth cells: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4;plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA070578 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA070578: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favorable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 9.1 1.0 0.3 7.1 1.4 0.3 6.1 0.4 0.6 2.6 14.8 0.5 3.8 5.5 1.0 6.3 2.8 1.4 10.6 1.4 0.9 0.2 6.5 13.3 8.7 3.1 1.1 0.3 2.6 3.2 1.5 0.7 15.7 1.7 3.3 8.8 2.8 6.0 2.5 0.9 10.0 20.0 0.5 0.3 2.4 18.0 1.5 0.5 0.4 8.8 4.3 3.0 6.0 5.3 0.5 3.9 0.8 2.4 0.0 0.0 0.6 0.2 3.2 0.0 0.2 1.0 0.1 9.8 2.4 1.9 2.6 4.0 1.9 5.2 7.8 0.0 0.1 1.0 3.1 0.0 0.1 0.2 1.5 0.0 0.0 1.0 0.1 4.6 0.0 0.1 1.3 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.3 4.0 0.1 0.2 2.5 0.4 1.6 0.0 0.0 0.0 1.2 8.3 0.4 1.2 3.2 8.5 0.1 1.0 1.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.8 0.0 2.4 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.6 0.3 1.4 0.4 0.6 0.9 0.2 1.1 0.3 1.7 0.5 8.9 1.9 1.3 6.7 0.1 0.0 0.5 20.4 6.7 1.2 1.8 0.0 15.9 6.6 19.6 0.0 1.0 128.5 0.0 9.5 15.2 3.5 2.8 4.6 6.8 15.3 0.0 7.5 8.0 1.9 0.0 0.3 2.9 3.3 1.0 23.5 0.2 20.1 76.4 0.4 3.8 1.1 6.5 2.1 0.0 0.0 0.5 7.9 0.0 18.9 10.5 CLDN5 "AWAL, BEC1, CPETRL1, TMVCF" ENSG00000184113 "Claudin 5" O00501 22 19523024-19527545 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 101.1" "Group enriched" "Detected in many" 22 "Endothelial cells: 667.5;Ito cells: 611.4" "Cancer enhanced" "Detected in all" "glioma: 32.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 7.4;naive CD4 T-cell: 3.4;neutrophil: 4.1" "Group enriched" "Detected in many" 20 "granulocytes: 7.4;T-cells: 3.4" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 41.0;SCLC-21H: 25.8" "Low region specificity" "Detected in all" CAB002607 Approved NA NA 730000 "CAB002607: " "unprognostic (1.26e-1)" "unprognostic (2.05e-3)" "unprognostic (1.77e-2)" "unprognostic (2.07e-1)" "unprognostic (3.05e-3)" "unprognostic (6.00e-2)" "unprognostic (4.98e-2)" "unprognostic (3.24e-3)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (2.29e-3)" "unprognostic (1.15e-1)" "unprognostic (7.31e-2)" "unprognostic (2.01e-2)" "unprognostic (2.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.96e-2)" 101.1 4.9 13.9 6.8 17.9 1.9 45.5 7.1 20.0 10.6 19.4 10.2 3.0 9.9 10.2 5.1 7.8 9.5 11.7 14.1 16.9 15.0 7.6 6.0 43.6 9.2 19.8 4.5 8.6 5.5 2.4 1.5 13.1 20.0 8.2 5.0 5.4 4.1 5.1 26.2 10.2 10.3 7.6 18.9 13.5 8.8 6.5 11.9 0.3 20.1 7.3 3.7 7.6 34.7 0.1 0.2 7.4 0.2 0.0 3.4 20.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 41.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 3.4 0.1 4.1 0.0 0.0 0.1 0.0 20.9 13.9 17.9 7.1 15.8 16.9 15.0 19.8 4.5 20.0 11.9 3.0 10.6 2.2 1.1 28.7 0.6 15.4 2.5 0.0 1.2 7.0 0.0 0.2 0.0 0.0 3.6 667.5 0.0 0.0 0.7 0.2 7.1 3.4 1.1 1.0 0.7 0.0 2.4 611.4 25.1 2.3 4.9 2.8 13.5 0.0 0.0 2.5 0.0 0.0 0.7 0.0 4.4 0.0 16.5 0.7 0.9 26.7 0.0 5.7 0.0 6.3 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 31.4" "Cell type enriched" "Detected in many" 15 "Early spermatids: 230.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" HPA056971 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA056971: AB_2683294" "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 7.7 7.8 6.8 3.2 11.1 13.3 3.3 10.9 16.5 2.6 3.6 1.4 8.4 7.7 3.0 2.5 2.9 2.8 4.5 2.5 9.9 4.7 2.8 3.5 4.0 3.2 19.6 5.2 6.7 9.1 1.5 2.9 1.8 7.4 3.8 2.4 1.7 7.5 6.0 11.9 1.5 7.1 3.8 10.2 7.3 3.3 31.4 10.6 0.0 2.9 2.2 1.2 3.2 3.0 1.7 3.0 5.8 2.0 5.3 4.5 0.7 2.1 6.0 2.2 3.0 3.3 2.9 1.2 1.0 0.5 1.0 1.3 0.7 7.1 5.6 1.2 0.6 0.7 2.7 0.7 0.3 0.2 3.9 9.7 4.9 9.4 11.7 1.3 1.4 1.4 2.2 1.0 0.2 0.6 1.5 0.7 2.8 3.1 4.1 0.9 1.3 1.2 8.1 0.9 6.1 7.6 1.1 5.1 2.2 1.6 1.6 1.3 1.5 2.6 0.5 2.1 1.1 1.5 0.4 1.4 2.2 4.4 2.3 0.9 3.8 4.0 2.0 5.4 5.6 1.3 5.8 0.9 4.1 3.5 2.0 2.0 1.7 0.8 4.5 1.4 1.1 0.6 1.5 0.5 5.3 0.7 3.0 1.2 0.7 6.8 11.1 10.9 16.5 9.9 4.7 19.6 5.2 7.4 10.6 0.0 5.9 7.8 5.0 1.4 5.5 3.6 12.7 9.4 1.2 15.7 0.0 1.9 3.3 0.7 230.3 1.7 6.6 0.0 0.6 1.1 2.3 4.4 15.1 13.4 2.3 3.2 9.9 7.4 2.4 9.1 5.8 4.6 1.7 1.8 14.5 2.3 0.8 5.8 6.0 3.0 1.9 0.0 2.7 2.3 1.3 2.4 0.7 4.5 10.5 4.6 CLEC18B MRCL2 ENSG00000140839 "C-type lectin domain family 18 member B" Q6UXF7 16 74408270-74421953 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 28.1" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 18.2" "Group enriched" "Detected in some" 12 "glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (5.69e-2)" "unprognostic (1.46e-1)" "unprognostic (5.30e-3)" "unprognostic (9.37e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (7.15e-2)" "unprognostic (7.51e-2)" "unprognostic (4.49e-3)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (9.91e-2)" "unprognostic (3.58e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-2)" "unprognostic (5.87e-2)" "unprognostic (5.43e-2)" "unprognostic (4.27e-2)" 0.1 1.1 1.1 0.3 1.4 0.1 0.1 2.5 1.2 0.1 0.1 0.4 0.1 0.6 1.2 0.1 0.3 0.0 1.0 1.0 28.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.1 2.0 0.1 0.1 6.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 1.6 2.9 1.8 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.2 1.1 0.5 0.5 1.0 0.9 0.0 0.1 0.3 0.2 0.4 0.3 0.1 0.7 0.0 0.3 1.7 0.4 0.1 0.1 0.7 0.0 4.1 7.3 0.0 0.3 0.0 0.0 0.0 1.2 0.3 0.8 0.4 0.0 1.6 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.2 0.9 2.7 1.6 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.4 0.0 0.0 18.2 1.1 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 CLEC18C "MGC34761, MRCL3" ENSG00000157335 "C-type lectin domain family 18 member C" Q8NCF0 16 70173322-70187361 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "kidney: 16.5;testis: 4.6" "Cell type enriched" "Detected in single" 48 "Proximal tubular cells: 18.8" "Cancer enriched" "Detected in single" 9 "renal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;RT4: 1.3;TIME: 3.0" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (3.90e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-4)" "unprognostic (5.55e-2)" "unprognostic (5.72e-3)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (6.98e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 16.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.3 1.3 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CLEC19A ENSG00000261210 "C-type lectin domain containing 19A" Q6UXS0 16 19285739-19322145 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "brain: 7.2;retina: 24.4" "Group enriched" "Detected in some" 16 "Ciliated cells: 2.7;Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;EFO-21: 1.2;MCF7: 1.6;NTERA-2: 1.0;OE19: 2.5;RPMI-8226: 1.8;U-2 OS: 1.5" "Secreted - unknown location" NA NA "unprognostic (3.19e-1)" "unprognostic (3.72e-1)" "unprognostic (1.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" 0.1 0.0 2.6 0.0 0.2 0.0 0.0 0.8 7.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 4.5 1.3 0.0 0.1 0.5 0.3 0.3 0.2 0.0 0.1 0.0 0.3 0.1 1.2 0.8 0.1 24.4 0.4 0.0 0.3 1.2 0.1 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 1.0 2.5 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.6 0.2 0.8 5.0 4.5 1.3 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CLEC1A "CLEC1, MGC34328" ENSG00000150048 "C-type lectin domain family 1 member A" Q8NC01 12 10069554-10111627 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.8" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 45.1;Endothelial cells: 22.2;Extravillous trophoblasts: 51.1;Ito cells: 14.7;Syncytiotrophoblasts: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 1.3;myeloid DC: 5.2;neutrophil: 2.8" "Group enriched" "Detected in many" 14 "dendritic cells: 5.2;granulocytes: 2.8;monocytes: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 18.8;HUVEC TERT2: 15.9;SuSa: 5.1;U-266/70: 4.3;U-266/84: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (5.96e-2)" "unprognostic (2.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (7.15e-2)" "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.94e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" 27.4 2.1 1.6 4.9 3.0 0.5 14.0 1.2 1.9 9.7 3.1 1.2 2.4 1.4 16.1 6.0 4.3 4.2 4.9 4.8 2.0 1.8 3.6 2.5 19.9 4.5 3.1 0.6 4.9 4.1 1.0 2.6 40.8 3.4 5.2 2.0 2.3 2.0 2.3 4.8 2.9 3.0 7.6 3.5 5.8 2.6 3.3 1.7 20.4 5.6 3.6 3.0 6.4 12.3 0.2 5.2 2.8 2.2 0.2 0.1 0.5 0.0 0.0 0.3 0.2 0.2 0.1 18.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.0 1.6 0.0 0.0 0.0 0.4 2.6 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.2 0.0 5.1 0.0 0.0 1.2 0.0 0.2 0.2 0.0 4.3 9.5 0.0 0.2 0.0 0.0 0.2 2.2 0.1 0.0 1.3 0.1 0.1 0.0 0.0 5.2 0.2 0.1 0.0 2.8 0.2 0.5 0.2 0.0 0.5 1.6 3.0 1.2 1.9 2.0 1.8 3.1 0.6 3.4 1.7 0.0 0.3 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.3 22.2 0.0 0.0 0.0 51.1 1.7 0.2 0.0 0.0 4.4 0.0 0.0 14.7 6.5 0.0 6.9 1.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 2.4 1.4 43.6 0.0 0.0 0.4 CLEC4F "CLECSF13, FLJ39110, KCLR" ENSG00000152672 "C-type lectin domain family 4 member F" Q8N1N0 2 70808643-70820600 "Predicted membrane proteins" Endocytosis Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 5.8" "Lineage enriched" "Detected in single" 11 "monocytes: 7.9" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;BEWO: 2.1;HAP1: 1.7;SH-SY5Y: 1.4;T-47d: 3.1" "Not detected" "Not detected" HPA056101 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA056101: " "unprognostic (8.14e-3)" "unprognostic (3.73e-2)" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (4.91e-2)" "unprognostic (5.41e-2)" "unprognostic (3.66e-2)" "unprognostic (2.07e-2)" "unprognostic (9.29e-2)" "unprognostic (3.45e-1)" "unprognostic (2.68e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-2)" "unprognostic (9.59e-2)" "unprognostic (2.44e-1)" 3.1 0.0 0.5 3.2 0.5 0.0 2.1 0.7 0.7 1.8 4.2 0.5 6.8 2.5 2.9 1.4 1.5 1.5 7.0 1.5 0.5 0.1 1.2 2.4 9.0 1.8 1.2 0.5 1.3 0.5 0.0 1.4 0.5 0.5 2.9 1.3 0.8 3.3 2.7 1.4 2.3 7.6 2.0 0.5 6.8 0.7 2.0 0.5 0.9 0.6 0.5 2.0 1.5 2.5 0.0 0.7 0.0 7.9 0.0 0.0 0.6 0.0 0.1 0.1 6.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 0.5 0.5 0.7 0.5 0.5 0.1 1.2 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.3 0.7 0.0 1.7 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 4 "B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" "Group enriched" "Detected in some" 5 "HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2" HPA063928 Supported "Plasma membrane,Centriolar satellite" NA NA "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 56.8 0.0 31.2 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 0.0 0.0 69.2 0.1 1.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.0 4.7 0.2 21.8 0.0 0.0 0.6 84.7 1.1 0.3 31.4 11.8 69.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.2 0.0 0.0 1.6 0.2 12.5 0.0 0.1 CLIC6 "CLIC1L, CLIC5" ENSG00000159212 "Chloride intracellular channel 6" Q96NY7 21 34669389-34718227 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.3;retina: 85.1;stomach 1: 45.1" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 30.6;Ciliated cells: 72.3;Club cells: 52.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 63.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.4;NTERA-2: 5.9;T-47d: 12.0;THP-1: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065285 Enhanced NA NA "HPA065285: AB_2685454" "prognostic favorable (6.11e-5)" "unprognostic (2.17e-2)" "unprognostic (1.65e-2)" "unprognostic (4.27e-2)" "unprognostic (2.93e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-2)" "prognostic favorable (3.15e-5)" "unprognostic (4.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.43e-3)" 7.7 0.0 0.8 3.0 1.7 0.0 5.7 0.6 2.3 8.7 1.8 12.4 0.6 0.9 1.0 5.2 1.2 6.1 4.5 6.3 5.4 1.0 0.9 0.6 6.4 0.4 0.4 0.5 2.3 1.2 0.0 1.3 0.6 63.3 4.0 1.3 85.1 10.9 3.8 1.9 2.3 1.1 1.9 0.6 0.7 45.1 1.1 0.6 2.4 8.2 0.9 1.8 7.5 2.0 0.3 0.1 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.4 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 1.7 12.0 5.3 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.1 0.8 1.7 0.6 2.3 5.4 1.0 0.4 0.5 63.3 0.6 6.0 20.2 0.0 4.6 0.6 0.0 5.3 30.6 72.3 52.4 8.7 0.0 0.0 1.7 6.3 0.0 0.0 0.2 0.0 0.8 0.0 3.8 9.0 1.1 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.3 0.0 6.8 1.0 1.0 0.0 15.9 0.0 2.8 0.0 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 3.3 13.7 CLPSL1 "C6orf127, dJ510O8.6" ENSG00000204140 "Colipase like 1" A2RUU4 6 35781017-35793675 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "epididymis: 123.5;pancreas: 103.6" "Group enriched" "Detected in some" 40 "Exocrine glandular cells: 32.7;Pancreatic endocrine cells: 14.1" "Group enriched" "Detected in some" 6 "breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "T-47d: 13.9" HPA073155 Enhanced "Secreted in male reproductive system" NA NA "HPA073155: AB_2686576" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (4.75e-1)" "unprognostic (2.54e-1)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.60e-2)" "unprognostic (7.06e-3)" 0.1 0.1 1.6 0.0 0.2 0.0 0.8 0.1 0.9 0.1 0.1 0.0 9.6 0.0 0.1 123.5 0.1 0.1 0.0 0.1 1.8 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 103.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 13.9 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.1 0.9 1.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 CLRN2 ENSG00000249581 "Clarin 2" A0PK11 4 17515165-17527104 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 1.2;salivary gland: 1.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042407 Uncertain NA NA "HPA042407: AB_10806237" 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN3 "MGC32871, TMEM12, USH3AL1" ENSG00000180745 "Clarin 3" Q8NCR9 10 127877841-127892947 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 69.3;kidney: 14.7;liver: 25.6" "Group enriched" "Detected in some" 5 "Enterocytes: 118.1;Hepatocytes: 34.8;Intestinal endocrine cells: 39.9;Mucus-secreting cells: 70.4;Paneth cells: 98.2;Proximal tubular cells: 59.1;Undifferentiated cells: 39.3" "Group enriched" "Detected in many" 10 "colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "OE19: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014482 Approved NA NA "HPA014482: AB_2082885" "unprognostic (7.34e-3)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (1.46e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (6.22e-2)" "unprognostic (4.67e-1)" "unprognostic (8.86e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.74e-1)" "unprognostic (2.89e-3)" "unprognostic (3.00e-2)" 0.4 0.2 0.3 3.1 0.2 0.0 0.2 0.2 0.3 0.2 27.5 0.3 0.2 23.7 0.2 1.3 0.2 0.1 9.5 0.2 0.3 0.2 14.7 25.6 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 23.5 0.2 0.2 0.2 0.2 0.1 69.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 1.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.1 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 118.1 0.0 0.5 0.0 0.0 0.0 0.0 34.8 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 0.2 98.2 0.0 59.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 0.0 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 335.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 24.6" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.6 3.9 7.5 5.1 0.0 0.0 4.5 2.9 0.2 0.0 0.0 3.1 1.5 3.1 0.7 0.0 2.7 1.1 0.0 0.4 0.0 2.5 7.0 5.2 2.1 24.6 0.0 1.7 1.0 0.2 0.0 0.0 0.0 1.3 0.3 7.7 7.3 9.1 0.0 0.8 3.1 5.6 0.5 3.2 1.8 6.3 3.5 11.0 0.8 0.8 6.6 4.6 2.9 1.8 2.2 6.3 2.4 0.8 0.6 3.0 4.4 2.1 1.4 5.2 9.1 6.5 2.4 3.4 2.6 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 0.0 1.6 0.0 3.4 0.0 23.9 0.1 0.0 4.0 2.3 0.0 19.6 0.4 1.7 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.1 8.5 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 46.9 0.0 0.0 1.1 0.3 335.8 6.5 0.0 8.4 4.5 0.1 0.3 0.0 0.0 1.4 CLVS2 "bA160A10.4, C6orf212, C6orf213, RLBP1L2" ENSG00000146352 "Clavesin 2" Q5SYC1 6 122995971-123072927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 71.4" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 14.7;SCLC-21H: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043764 Uncertain NA NA "HPA043764: AB_10960281" "unprognostic (1.35e-1)" "unprognostic (3.28e-2)" "unprognostic (4.68e-2)" "unprognostic (3.60e-1)" "unprognostic (2.38e-1)" "unprognostic (7.04e-2)" "unprognostic (1.43e-2)" "unprognostic (5.72e-3)" "unprognostic (9.60e-2)" "unprognostic (8.71e-2)" 0.7 2.8 5.0 0.9 9.6 0.7 0.8 39.9 22.6 2.1 1.1 0.6 0.0 0.9 3.1 0.7 0.8 0.7 0.8 0.7 5.8 3.9 0.7 0.8 0.7 0.8 3.0 10.2 0.7 0.7 0.7 6.3 0.7 8.5 7.9 1.1 0.1 0.8 1.1 0.7 0.8 0.9 2.8 1.3 0.7 0.8 1.0 1.8 0.0 0.7 0.0 0.7 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 9.6 39.9 22.6 5.8 3.9 3.0 10.2 8.5 1.8 0.0 0.0 0.0 13.8 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 71.4 0.0 0.0 0.4 0.0 4.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 1.8 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Group enriched" "Detected in some" 13 "Early spermatids: 60.6;Late spermatids: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "REH: 16.8" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.7 4.5 4.7 1.4 2.9 2.0 3.0 1.6 1.4 3.4 1.9 0.3 2.4 7.4 1.3 0.7 3.0 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 6.9 2.3 4.0 3.5 2.8 1.9 1.6 7.4 3.8 1.0 0.6 2.5 16.8 14.4 4.6 4.0 2.0 3.2 4.3 7.8 0.6 2.0 0.2 2.0 2.8 5.7 8.0 12.7 4.8 2.4 2.8 6.7 7.3 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 113.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 6.5 0.0 4.8 0.4 0.3 0.1 0.0 0.0 0.0 CNBD1 FLJ35802 ENSG00000176571 "Cyclic nucleotide binding domain containing 1" Q8NA66 8 86866442-87615219 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 16.9" "Group enriched" "Detected in some" 49 "Early spermatids: 118.7;Late spermatids: 73.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Karpas-707: 9.3;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025037, HPA027469, HPA027786" Uncertain "Secreted in male reproductive system" NA NA "HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 118.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 CNBD2 "C20orf152, CNMPD1, dJ954P9.1" ENSG00000149646 "Cyclic nucleotide binding domain containing 2" Q96M20 20 35954564-36030700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 141.3;Late spermatids: 79.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA043182 Uncertain NA NA "HPA043182: AB_10794389" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.58e-1)" "unprognostic (3.27e-2)" "unprognostic (2.81e-2)" "unprognostic (6.59e-3)" "unprognostic (2.77e-2)" "unprognostic (6.71e-2)" "unprognostic (2.22e-1)" "unprognostic (1.44e-1)" "unprognostic (4.82e-4)" "unprognostic (1.63e-1)" "unprognostic (1.29e-1)" "unprognostic (2.05e-1)" "unprognostic (2.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" 1.7 1.7 1.8 2.4 3.2 4.9 2.5 3.3 4.6 1.7 3.3 0.5 1.8 2.4 1.7 9.6 1.7 1.6 3.3 2.2 2.0 1.8 5.2 3.2 1.7 2.2 1.8 1.1 1.7 2.5 2.4 1.8 0.7 2.6 1.7 1.6 2.6 3.8 1.9 10.0 1.9 2.7 1.3 1.7 2.0 1.7 31.1 2.5 2.0 2.7 6.5 1.9 1.6 1.6 0.8 0.2 2.5 2.2 3.3 2.6 0.2 1.9 2.8 4.5 4.1 3.3 1.7 2.8 0.4 1.6 3.1 2.8 7.1 4.0 3.2 1.4 2.3 2.4 1.6 2.9 5.1 3.2 1.2 4.6 4.8 8.4 14.2 2.7 2.7 0.7 3.1 4.7 2.3 2.6 1.5 4.7 5.3 1.4 16.3 1.9 4.7 3.1 7.5 0.7 2.8 4.6 1.8 2.8 11.3 4.3 1.9 8.3 3.7 1.7 4.7 2.2 1.1 2.7 4.4 1.9 2.1 2.2 0.8 0.5 13.9 8.0 8.0 2.1 4.6 0.9 2.5 0.5 0.3 2.6 2.2 0.3 0.5 0.5 1.2 0.2 0.8 0.4 0.6 2.1 3.3 0.7 0.2 2.1 0.2 1.8 3.2 3.3 4.6 2.0 1.8 1.8 1.1 2.6 2.5 0.0 6.2 11.5 9.1 0.2 10.5 0.4 17.8 4.0 5.7 10.4 21.6 6.1 24.9 3.7 141.3 0.6 14.2 0.0 4.7 5.7 0.9 6.2 1.1 10.4 6.9 22.3 12.2 8.6 12.0 79.9 6.1 4.1 0.0 2.8 12.5 18.2 3.0 8.0 2.8 14.6 36.8 19.4 1.0 21.1 15.2 0.1 4.1 12.9 9.5 6.5 CNGA2 "CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA" ENSG00000183862 "Cyclic nucleotide gated channel alpha 2" Q16280 X 151738451-151745304 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Calmodulin-binding, Ion channel, Ligand-gated ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Region enriched" "Detected in single" 4 "olfactory region: 0.6" "Not detected" "Not detected" HPA015065 Uncertain NA NA "HPA015065: AB_1847034" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNIH3 "CNIH-3, FLJ38993" ENSG00000143786 "Cornichon family AMPA receptor auxiliary protein 3" Q8TBE1 1 224434660-224740549 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 16.1;pancreas: 21.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 26.6;Early spermatids: 14.0;Late spermatids: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;hTERT-RPE1: 14.1;NTERA-2: 9.2;U-266/70: 13.3;U-87 MG: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (5.18e-2)" "unprognostic (2.88e-1)" "unprognostic (7.18e-2)" "unprognostic (4.96e-2)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (4.63e-2)" "unprognostic (3.15e-1)" "unprognostic (2.30e-1)" "unprognostic (5.23e-5)" "unprognostic (1.03e-1)" "unprognostic (3.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.63e-1)" 2.0 0.8 7.0 0.5 5.1 0.2 1.3 1.0 16.1 1.7 0.6 0.6 0.0 0.8 1.5 0.9 0.6 1.9 1.2 0.6 9.8 5.0 1.5 0.6 0.9 0.9 5.4 8.0 3.6 21.7 0.3 0.7 0.4 3.5 0.9 0.7 0.2 0.6 1.1 0.7 0.4 0.6 1.0 1.4 0.6 0.6 3.9 0.1 0.2 1.0 0.0 0.9 0.7 0.9 0.9 0.3 0.0 0.0 1.8 0.9 0.1 0.2 0.2 0.3 0.3 0.3 0.5 0.1 1.8 9.8 0.2 0.5 0.0 2.2 0.0 0.9 4.2 0.7 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.7 0.3 0.0 24.9 0.3 14.1 0.0 0.1 0.0 0.0 1.4 0.0 0.0 3.0 9.2 0.1 1.1 0.0 0.5 0.0 1.5 0.9 0.3 0.2 0.0 0.0 6.1 1.0 0.0 0.2 0.0 0.0 2.3 0.0 0.2 13.3 0.5 0.0 29.6 0.1 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.1 7.0 5.1 1.0 11.1 9.8 5.0 5.4 8.0 3.5 0.1 0.0 1.3 0.5 2.4 2.5 3.3 1.2 2.5 13.4 0.0 1.8 0.0 1.5 26.6 0.6 14.0 2.7 0.4 0.0 2.6 0.4 3.2 2.0 2.3 1.7 5.2 0.0 1.2 1.8 0.0 26.2 2.6 1.9 0.0 1.0 2.3 9.2 0.7 0.0 1.1 9.0 0.5 0.0 0.9 2.3 9.6 1.9 4.2 1.8 1.7 1.3 CNPPD1 "C2orf24, CGI-57" ENSG00000115649 "Cyclin Pas1/PHO80 domain containing 1" Q9BV87 2 219171897-219178106 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049303 Uncertain NA NA "HPA049303: AB_2680703" "unprognostic (9.24e-2)" "unprognostic (4.12e-2)" "unprognostic (1.09e-1)" "unprognostic (9.43e-2)" "unprognostic (3.68e-2)" "unprognostic (5.74e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (1.77e-1)" "unprognostic (4.15e-3)" "unprognostic (5.54e-3)" "unprognostic (8.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.62e-10)" "unprognostic (1.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-2)" "unprognostic (2.54e-2)" 25.9 41.2 17.2 21.2 21.5 34.6 25.7 21.5 22.5 17.9 30.8 36.1 16.8 30.3 21.2 22.7 40.2 17.0 26.4 24.1 15.4 13.3 61.3 27.3 24.9 27.3 26.1 20.4 22.7 29.1 30.7 11.5 26.2 20.4 22.1 23.1 28.0 24.6 26.7 39.2 29.5 32.6 25.5 24.6 32.9 23.0 22.6 23.4 21.5 32.1 20.6 32.2 28.7 21.4 37.3 38.7 31.1 45.6 21.1 28.3 26.5 15.9 12.0 12.1 22.3 25.0 12.6 17.4 20.7 12.2 17.2 13.8 25.8 19.9 9.1 12.2 20.1 13.8 22.4 16.0 16.7 10.1 23.3 9.3 37.1 12.5 25.6 30.7 21.7 25.9 13.4 21.5 17.0 15.3 15.5 14.4 24.8 29.5 34.4 9.9 29.0 23.7 16.6 7.7 18.5 15.4 35.5 9.0 30.9 26.6 22.5 15.8 18.9 11.9 29.9 21.8 13.8 23.8 25.1 13.5 14.1 13.3 27.6 19.6 27.3 10.6 19.5 19.1 26.1 9.1 28.3 25.1 24.5 22.7 37.3 19.7 34.0 22.2 22.7 38.7 37.3 15.6 17.3 31.1 21.1 45.6 21.4 28.3 26.5 17.2 21.5 21.5 22.5 15.4 13.3 26.1 20.4 20.4 23.4 17.9 15.3 25.9 13.1 11.9 11.4 20.5 35.7 10.7 15.9 40.1 3.9 26.8 48.0 30.2 1.5 21.1 77.8 46.7 28.8 17.9 17.8 21.2 12.7 19.5 33.2 11.1 27.7 25.8 41.2 1.5 20.8 28.2 20.3 113.6 43.1 26.0 33.1 40.3 19.8 48.8 11.0 19.4 21.3 22.6 33.4 13.9 46.0 33.3 35.7 13.6 CNPY4 "MGC40499, PRAT4B" ENSG00000166997 "Canopy FGF signaling regulator 4" Q8N129 7 100119613-100125511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Leydig cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014166, HPA025240" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA014166: AB_1853895, HPA025240: AB_2082630" "unprognostic (9.64e-2)" "unprognostic (1.59e-2)" "unprognostic (4.09e-3)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (6.16e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (6.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (1.35e-2)" 12.9 18.3 10.9 13.4 9.9 5.5 11.6 16.5 13.1 22.8 13.0 14.8 8.8 6.1 23.5 15.8 6.3 16.2 20.3 13.6 9.9 9.1 11.0 6.7 9.2 15.5 9.5 9.9 26.1 7.2 17.6 17.8 20.8 10.4 14.0 10.3 18.0 6.5 17.0 4.7 8.3 9.5 21.7 11.4 14.0 8.4 9.1 13.7 16.4 11.1 9.6 9.5 13.0 16.2 2.8 5.2 8.8 9.3 8.3 15.2 4.7 3.3 5.8 14.6 26.1 34.4 16.6 7.3 12.6 13.6 6.6 12.4 3.1 3.0 7.3 14.6 22.5 4.8 3.4 5.7 6.1 6.9 6.8 5.8 3.0 9.6 4.4 9.8 5.1 5.7 15.1 1.7 6.0 2.7 14.5 22.8 3.6 2.5 4.9 9.4 9.6 10.7 6.7 7.5 2.1 8.4 3.1 11.0 3.9 6.7 0.8 3.6 7.4 12.0 9.7 6.4 9.9 4.9 2.8 18.4 21.2 12.8 8.8 5.6 4.2 6.7 6.6 12.4 7.9 8.6 8.8 3.7 5.7 11.8 8.0 15.2 2.8 12.1 14.7 5.2 2.4 9.9 14.9 1.7 8.3 9.3 3.3 9.6 4.7 10.9 9.9 16.5 13.1 9.9 9.1 9.5 9.9 10.4 13.7 6.0 1.6 0.0 2.0 3.2 6.6 3.2 5.1 4.0 4.5 12.2 2.0 29.6 1.7 5.4 0.4 11.7 2.3 23.3 2.2 8.4 26.6 0.6 9.2 0.9 11.9 7.9 2.4 19.6 1.6 0.9 32.5 3.6 15.1 5.4 1.8 25.5 2.7 2.9 29.7 2.3 13.7 12.9 12.3 1.0 3.8 3.3 15.3 6.5 1.9 0.7 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Group enriched" "Detected in many" 12 "Ciliated cells: 80.3;Early spermatids: 53.3;Late spermatids: 75.8;Spermatocytes: 135.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.3;ASC diff: 4.3;SiHa: 3.3;T-47d: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.3 0.7 0.5 1.3 4.3 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.4 0.6 1.3 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 3.3 0.3 0.8 0.1 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 3.0 2.9 0.0 0.4 0.3 1.6 0.8 0.0 80.3 3.4 0.0 0.0 0.2 5.0 0.2 53.3 0.3 0.5 0.0 0.3 0.3 0.6 7.4 5.8 0.9 0.3 6.4 0.0 0.0 1.0 75.8 2.3 0.7 0.0 0.0 4.6 1.2 0.3 0.0 1.1 0.3 0.4 6.5 0.9 135.1 2.7 0.5 0.2 0.5 2.1 0.9 CNTD2 "CCNP, FLJ13265" ENSG00000105219 "Cyclin N-terminal domain containing 2" Q9H8S5 19 40222208-40226697 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 8.0;brain: 12.0;liver: 7.9" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 8.7;Early spermatids: 3.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 12.0" "Cell type enriched" "Detected in single" 81 "basophil: 8.0" "Lineage enriched" "Detected in single" 81 "granulocytes: 8.0" "Cell line enhanced" "Detected in some" "Hep G2: 1.8;Karpas-707: 1.4;SCLC-21H: 6.7;T-47d: 1.5" "Low region specificity" "Detected in single" HPA045615 Uncertain NA NA "HPA045615: AB_2679390" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (4.41e-2)" "unprognostic (1.07e-2)" "unprognostic (9.79e-4)" "unprognostic (5.27e-2)" "unprognostic (3.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (2.23e-1)" "unprognostic (9.43e-3)" "unprognostic (1.97e-2)" "unprognostic (3.10e-1)" "unprognostic (7.65e-2)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" 3.9 1.0 0.7 0.1 1.2 0.3 1.4 12.0 1.8 1.0 0.2 0.4 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.5 1.1 0.8 5.6 7.9 0.3 0.2 0.5 0.0 0.4 0.1 0.1 3.5 2.8 1.3 1.5 0.5 0.4 0.4 0.3 0.7 0.6 0.6 0.4 0.8 0.6 0.7 1.0 0.0 0.0 1.4 0.7 0.1 0.2 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.9 0.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 1.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.2 1.1 0.4 0.1 0.0 0.2 0.1 0.0 6.7 0.4 0.6 0.0 0.7 0.3 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 12.0 1.8 1.1 0.8 0.5 0.0 1.3 0.0 0.0 0.0 0.5 0.1 2.1 1.9 1.4 0.0 1.4 0.0 8.7 0.0 0.5 0.0 0.1 3.9 0.4 0.9 0.0 0.5 0.0 0.2 0.3 1.1 0.8 0.2 1.6 0.0 0.6 0.3 1.0 0.9 0.0 1.7 0.0 0.1 2.4 0.3 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 2.5 3.2 0.0 0.5 0.1 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein like 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;esophagus: 9.5" "Cell type enhanced" "Detected in many" 11 "Ito cells: 22.1;Muller glia cells: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 22 "neutrophil: 10.6" "Lineage enriched" "Detected in single" 107 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 12.7;AF22: 15.4;TIME: 9.7;WM-115: 25.7" HPA047731 Uncertain "Intracellular and membrane" NA NA "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.9 0.1 1.2 0.3 4.8 1.0 2.6 0.4 2.5 0.8 2.4 0.6 0.2 0.2 9.5 1.6 1.1 4.1 1.2 1.3 1.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.3 1.7 1.6 1.4 2.8 1.7 0.0 8.3 1.0 2.5 1.1 2.4 0.1 1.9 1.3 0.3 0.5 1.9 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.7 12.7 15.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.9 3.2 1.3 2.9 0.0 0.0 1.1 0.0 3.4 0.3 0.1 0.2 0.0 0.4 2.8 0.0 1.1 6.5 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 3.9 0.0 0.4 3.5 0.3 0.5 1.4 0.5 4.5 0.0 2.5 1.7 0.0 2.1 9.7 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 3.4 5.6 0.8 2.5 7.6 2.7 0.0 1.8 2.0 0.7 0.0 0.3 1.3 5.8 0.0 0.0 0.2 0.6 0.9 0.8 0.0 1.8 0.1 0.0 3.4 22.1 1.3 0.8 0.3 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.5 0.4 0.0 0.5 0.9 5.8 6.8 0.6 0.0 0.0 2.5 CNTNAP3B ENSG00000154529 "Contactin associated protein like 3B" Q96NU0 9 41890314-42129510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 28.1;Ito cells: 77.3;Muller glia cells: 26.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "neutrophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" "Cell line enhanced" "Detected in some" "A549: 18.4;AF22: 26.3;WM-115: 17.7" HPA047731 Uncertain NA NA "HPA047731: AB_2680137" "unprognostic (2.68e-2)" "unprognostic (9.63e-3)" "unprognostic (2.20e-2)" "unprognostic (2.87e-1)" "unprognostic (1.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.20e-3)" "unprognostic (5.70e-2)" "unprognostic (2.27e-1)" "unprognostic (7.20e-2)" "unprognostic (3.74e-3)" "unprognostic (1.64e-1)" "unprognostic (7.74e-2)" "unprognostic (5.78e-3)" "unprognostic (7.93e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-4)" 4.1 0.6 1.1 0.3 2.2 0.0 4.7 0.5 2.2 1.5 1.1 0.4 1.3 0.0 7.3 1.9 1.3 2.5 1.3 1.4 4.9 1.0 2.1 0.0 0.9 0.4 0.3 0.0 1.2 2.4 1.0 1.7 1.9 1.1 0.7 6.5 0.6 1.9 0.9 1.6 0.5 1.1 0.8 0.1 2.0 1.4 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 18.4 26.3 0.0 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.4 2.3 1.5 1.4 0.0 0.0 0.9 0.0 3.3 1.6 0.6 0.9 0.0 2.0 2.2 0.2 0.3 6.6 4.3 0.0 0.4 0.1 0.0 0.1 0.0 0.0 2.5 0.6 5.6 0.0 0.5 7.1 0.8 0.5 1.9 0.2 0.7 0.0 3.5 0.8 0.0 2.5 4.5 0.1 1.7 0.1 0.5 0.0 0.0 0.0 0.0 0.8 17.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 6.7 3.8 2.9 6.1 2.5 14.7 0.0 3.5 0.0 2.1 0.0 1.6 1.8 28.1 0.0 0.0 2.8 1.0 1.3 1.5 1.1 7.5 0.1 0.0 1.7 77.3 3.8 0.9 0.9 1.0 5.0 0.0 0.6 26.6 2.0 0.0 0.7 6.0 0.5 0.0 1.0 0.7 2.2 4.5 0.6 0.5 0.0 6.2 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 5.6;Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 0.0 0.0 0.0 0.0 0.0 5.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 COL21A1 ENSG00000124749 "Collagen type XXI alpha 1 chain" Q96P44 6 56056590-56394094 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3" HPA031212 Supported Cytosol "Secreted to extracellular matrix" NA NA 180000 Cytosol "HPA031212: AB_10599941" "unprognostic (1.69e-1)" "unprognostic (4.53e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-1)" "unprognostic (1.21e-1)" "unprognostic (9.32e-3)" "unprognostic (6.84e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-3)" "unprognostic (2.17e-1)" "unprognostic (5.29e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-3)" "unprognostic (3.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-3)" 3.9 1.6 6.6 2.1 2.3 0.3 3.0 5.1 3.6 25.8 11.3 5.2 7.9 0.8 20.0 7.0 3.3 7.6 3.9 4.5 8.5 2.5 1.4 1.5 7.4 0.7 3.6 4.6 3.9 2.1 0.8 3.6 26.4 6.9 5.4 2.2 5.9 4.4 10.9 2.3 6.3 2.6 24.2 5.3 0.7 5.7 3.8 5.8 0.0 2.1 4.1 0.8 10.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.1 0.0 1.0 18.9 6.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.6 0.1 0.0 19.2 0.7 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 2.3 5.1 3.6 8.5 2.5 3.6 4.6 6.9 5.8 0.0 1.0 0.0 2.3 5.3 0.0 36.4 0.0 58.9 12.5 0.0 0.0 17.6 0.0 0.0 3.5 3.4 0.0 0.0 0.0 52.2 33.7 0.1 0.0 0.0 5.4 0.0 0.0 4.3 0.8 1.1 14.1 1.0 5.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 6.6 0.2 0.6 3.6 19.5 0.0 0.0 1.5 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914006 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 46.5" "Group enriched" "Detected in some" 4 "Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 12.0 0.2 1.3 1.1 0.0 0.1 6.8 1.1 1.3 0.7 1.4 10.8 0.3 2.4 1.9 0.2 0.5 0.4 0.2 0.3 0.8 2.8 0.1 0.1 0.5 0.3 0.0 0.3 0.2 1.7 46.5 0.0 1.9 4.7 0.1 1.6 0.8 5.1 0.5 0.1 0.4 2.2 1.8 0.3 3.7 0.8 0.1 1.4 0.3 0.7 1.7 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.2 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.8 0.3 0.3 0.8 0.3 0.0 1.9 0.1 0.0 0.0 0.0 2.8 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 30.8 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 25.2 0.3 0.0 0.0 1.0 0.0 26.2 2.1 0.0 0.0 0.0 1.1 0.0 0.3 1.1 0.8 0.0 0.0 0.0 0.0 1.3 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535853 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 16.0;Cone photoreceptor cells: 17.7" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9" "Region enriched" "Detected in single" 8 "olfactory region: 4.5" "Not detected" "Not detected" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA043844: AB_2732508, HPA060468: AB_2684288" "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 2.7 3.7 1.0 7.0 1.1 0.3 3.1 2.4 1.6 10.2 11.8 0.6 11.5 1.3 2.9 16.2 14.7 5.5 5.7 7.0 1.3 2.2 2.8 1.9 1.3 1.0 9.8 0.2 2.9 5.8 0.1 12.2 0.5 6.1 5.8 4.7 12.8 19.3 6.2 5.6 2.1 6.6 16.0 7.9 0.3 5.7 3.2 0.2 0.2 1.4 10.2 0.9 8.4 14.2 0.6 0.3 1.6 0.2 2.1 1.0 0.0 2.0 0.0 0.0 0.0 0.2 1.1 0.3 0.1 0.6 0.0 0.0 1.6 0.6 0.3 0.1 0.1 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.3 2.0 0.2 0.3 0.0 0.9 1.2 0.5 0.0 0.1 0.0 3.3 0.1 0.2 0.0 0.1 1.0 0.0 0.5 0.1 0.9 1.0 0.0 0.7 1.8 0.0 14.2 3.8 0.0 0.2 0.8 6.9 0.5 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.6 0.4 1.0 1.6 2.1 0.1 0.3 0.0 0.0 1.0 1.1 2.4 1.3 1.3 2.2 9.8 0.2 6.1 0.2 0.0 2.6 0.0 0.1 0.2 4.6 0.8 0.0 16.0 5.7 3.5 17.7 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.1 4.8 0.0 3.1 0.0 0.8 0.9 0.0 0.0 0.0 0.3 2.4 0.5 2.8 0.7 0.3 4.5 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.3 0.1 COLCA2 "C11orf93, CASC13" ENSG00000214290 "Colorectal cancer associated 2" A8K830 11 111298555-111308735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 21.4;Early spermatids: 64.4;Late spermatids: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 2.6" "Lineage enriched" "Detected in single" 27 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "Hep G2: 8.2;OE19: 29.4;RT4: 7.6;T-47d: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.73e-3)" "unprognostic (5.15e-2)" "unprognostic (6.97e-3)" "unprognostic (1.30e-3)" "unprognostic (1.15e-1)" "unprognostic (9.04e-2)" "unprognostic (1.13e-3)" "unprognostic (3.28e-2)" "unprognostic (6.03e-3)" "unprognostic (3.54e-2)" "unprognostic (3.34e-2)" "unprognostic (1.90e-1)" "prognostic favorable (8.97e-6)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.05e-2)" "unprognostic (2.46e-1)" 2.9 2.4 10.3 3.2 9.1 0.2 4.1 1.9 8.2 4.8 7.9 9.7 10.8 9.3 7.6 24.9 6.9 17.8 8.7 0.8 11.7 4.9 7.3 2.0 3.8 3.6 4.5 5.8 11.4 8.4 10.1 2.5 2.4 7.7 8.5 10.3 6.1 15.7 14.7 1.7 1.4 6.9 13.9 3.0 0.7 17.6 11.2 7.3 0.4 8.8 3.9 4.0 12.3 6.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.2 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.2 0.1 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.4 29.4 0.0 0.5 0.0 0.0 0.0 7.6 1.4 0.3 0.3 3.1 0.0 0.8 4.1 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 9.1 1.9 8.2 11.7 4.9 4.5 5.8 7.7 7.3 0.0 0.3 0.9 9.9 0.3 0.0 0.2 20.4 21.4 3.4 7.0 0.0 0.0 10.0 4.9 64.4 0.1 3.0 0.0 14.7 0.0 2.5 1.4 1.1 0.8 0.0 0.0 1.7 0.0 0.0 47.2 7.8 0.9 1.7 0.0 11.4 0.0 7.4 2.9 5.3 2.8 0.0 0.0 1.7 1.0 0.2 0.1 0.0 0.0 5.2 4.8 COPZ2 MGC23008 ENSG00000005243 "Coatomer protein complex subunit zeta 2" Q9P299 17 48026167-48038030 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.3;Fibroblasts: 56.4;Leydig cells: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 39.7;ASC TERT1: 45.1;BJ: 29.5;BJ hTERT+: 30.7;fHDF/TERT166: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055999 Uncertain NA NA "HPA055999: AB_2683003" "unprognostic (2.66e-1)" "unprognostic (9.32e-2)" "unprognostic (2.18e-2)" "unprognostic (1.46e-1)" "unprognostic (6.28e-2)" "unprognostic (1.12e-1)" "unprognostic (2.77e-2)" "unprognostic (1.59e-1)" "unprognostic (9.34e-2)" "unprognostic (2.49e-1)" "unprognostic (7.02e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (3.45e-9)" "unprognostic (7.42e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (2.89e-6)" "prognostic unfavorable (4.66e-4)" 27.1 10.9 5.1 6.0 4.2 0.0 25.6 2.0 4.2 17.4 10.8 4.8 13.7 2.3 11.0 21.2 13.9 7.3 17.7 29.3 6.5 3.4 7.6 15.9 7.1 10.2 7.4 4.1 6.4 11.7 6.8 8.8 9.9 9.3 13.9 6.4 13.9 9.5 16.9 38.3 14.7 4.5 31.4 12.6 4.6 6.6 6.1 4.8 0.7 14.0 17.0 5.3 19.3 9.3 0.3 0.7 0.0 2.1 0.5 2.4 0.3 8.7 1.7 0.9 0.0 39.7 45.1 0.0 29.5 30.7 8.2 9.1 0.0 0.9 0.0 6.7 62.1 0.0 9.1 0.0 0.1 8.2 0.4 0.0 3.0 4.7 0.0 16.4 0.0 0.2 26.7 3.5 6.1 0.8 9.5 1.2 0.0 0.0 0.1 20.1 3.9 0.1 0.0 0.0 0.5 0.5 0.0 0.0 1.3 0.5 0.0 0.0 1.3 5.7 0.0 6.2 0.2 1.4 0.9 7.9 22.0 3.5 17.2 0.1 21.8 2.4 0.2 23.7 0.0 3.0 0.0 2.1 0.0 1.7 1.7 0.0 0.0 0.7 2.4 0.7 0.3 0.3 1.8 0.0 0.5 0.7 0.0 0.0 0.3 5.1 4.2 2.0 4.2 6.5 3.4 7.4 4.1 9.3 4.8 8.9 2.1 0.0 11.6 44.3 0.3 31.3 0.0 0.0 0.0 7.0 0.0 0.8 10.0 0.9 5.9 16.9 0.0 0.0 4.5 0.7 56.4 5.7 1.1 34.1 5.9 0.0 0.0 20.3 3.3 14.4 46.6 2.4 27.0 0.0 1.5 20.7 4.0 0.0 39.3 15.9 1.2 6.5 34.4 15.2 1.1 22.7 1.9 5.7 0.4 6.5 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266858-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: AB_2686061" "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavorable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favorable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favorable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 2.9 12.4 5.0 2.3 6.8 2.2 3.1 7.6 7.3 3.7 2.9 4.8 5.9 1.9 3.6 7.7 4.3 5.2 3.2 43.5 4.5 5.4 7.2 12.8 3.5 3.4 5.6 3.9 4.5 5.5 6.0 9.9 1.7 4.8 4.1 2.7 14.0 6.5 5.6 103.7 2.2 2.9 3.7 3.6 3.8 2.6 2.4 3.0 4.9 5.4 46.1 6.2 2.7 3.3 11.7 6.8 8.0 1.1 5.0 8.6 3.6 2.5 10.3 10.0 6.5 5.7 5.8 4.2 3.6 8.6 12.7 12.7 8.0 3.8 14.7 8.2 9.0 3.6 2.4 11.5 2.0 7.6 2.3 12.8 6.8 9.4 8.3 7.8 5.4 4.2 6.0 3.4 9.4 3.7 8.0 6.6 10.4 4.5 6.1 11.8 3.3 7.7 19.3 8.5 1.8 6.0 16.6 10.9 9.7 7.0 1.5 14.5 15.6 12.3 2.6 3.8 7.7 4.0 6.0 4.7 2.4 7.1 6.7 3.6 12.8 13.7 7.2 7.1 5.1 1.8 8.0 1.0 0.9 7.7 1.1 7.9 11.7 7.1 8.2 1.7 6.7 8.6 8.4 0.4 5.0 0.8 6.8 4.6 3.6 5.0 6.8 7.6 7.3 4.5 5.4 5.6 3.9 4.8 3.0 3.0 7.4 6.1 12.1 11.8 17.4 115.4 7.6 12.0 4.5 10.4 15.7 5.0 44.7 2.4 0.1 9.6 2.1 0.0 4.0 5.9 8.0 4.7 4.6 14.0 4.4 30.2 15.5 2.5 1.6 1.4 7.8 2.5 11.8 1.8 2.8 21.7 2.5 3.4 15.9 11.0 30.0 38.8 18.9 1.7 17.7 9.3 2.5 13.4 4.5 4.3 COQ10B FLJ13448 ENSG00000115520 "Coenzyme Q10B" Q9H8M1 2 197453423-197475308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046057 Approved Approved Cytosol NA NA Cytosol "HPA046057: AB_2679518" "unprognostic (9.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.82e-3)" "unprognostic (8.28e-3)" "unprognostic (5.76e-3)" "unprognostic (4.55e-1)" "unprognostic (2.93e-1)" "unprognostic (7.18e-2)" "unprognostic (6.00e-2)" "unprognostic (4.13e-2)" "unprognostic (3.99e-1)" "unprognostic (2.87e-3)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (3.13e-3)" 24.5 34.0 19.3 14.5 18.2 34.0 21.8 13.3 23.2 15.1 16.8 16.6 13.0 13.9 19.2 14.6 16.7 14.9 23.2 28.7 18.7 18.8 30.1 34.3 17.3 15.3 18.3 14.1 15.2 25.0 20.4 23.0 33.1 20.6 16.1 18.2 17.6 17.4 16.3 16.0 13.3 22.3 25.5 17.3 17.7 17.8 9.1 12.6 11.5 18.7 16.2 16.4 21.1 14.1 14.8 11.7 40.6 17.8 13.9 24.1 16.0 6.9 6.7 4.9 8.6 23.5 16.8 11.4 18.2 26.3 19.6 21.9 13.4 8.4 6.5 15.6 14.6 24.5 6.4 7.0 9.7 22.4 12.8 6.0 9.3 9.6 15.7 19.7 7.5 21.7 18.7 15.1 18.6 13.3 10.7 10.6 9.5 7.8 17.5 18.7 9.1 8.1 11.7 7.5 8.2 13.7 6.2 7.2 8.5 21.1 18.9 3.1 6.1 8.3 11.0 22.6 18.1 7.8 10.6 11.1 19.4 6.7 21.6 13.0 16.7 23.6 7.3 24.2 7.3 14.9 27.3 13.6 24.4 20.7 15.6 23.3 14.8 20.0 20.5 11.7 11.5 21.1 21.4 40.6 13.9 17.8 7.4 24.1 16.0 19.3 18.2 13.3 23.2 18.7 18.8 18.3 14.1 20.6 12.6 17.9 14.5 31.9 92.5 93.8 29.4 27.1 22.9 29.4 15.9 38.4 39.3 28.2 109.5 35.0 38.1 42.3 36.8 46.7 40.9 38.0 47.3 53.4 59.9 32.1 27.7 60.4 25.8 20.9 18.3 14.4 19.0 38.3 67.4 32.5 31.3 50.9 41.3 28.1 28.7 58.7 32.0 45.3 69.0 19.3 34.7 93.2 145.4 45.8 12.3 83.8 CORT MGC32686 ENSG00000241563 Cortistatin O00230 1 10449719-10451902 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 28.8" "Group enriched" "Detected in some" 4 "Early spermatids: 4.5;Late spermatids: 3.6;Spermatocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.25e-2)" "unprognostic (1.79e-2)" "unprognostic (1.65e-1)" "unprognostic (3.70e-3)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.94e-3)" "unprognostic (7.08e-7)" "unprognostic (2.01e-1)" "unprognostic (9.01e-4)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.14e-4)" 1.0 0.7 3.3 0.9 28.8 0.9 0.6 3.2 26.6 0.7 1.0 0.1 0.0 1.3 0.8 1.0 0.5 0.7 1.0 0.6 2.3 2.5 1.2 0.8 0.7 0.7 1.0 6.2 1.0 0.9 1.0 3.2 1.7 0.0 1.1 0.8 0.0 0.7 0.8 0.8 1.1 1.2 0.7 0.7 0.8 0.9 2.1 20.3 0.0 1.1 0.0 0.5 0.8 0.5 0.2 0.4 0.0 0.1 1.2 0.3 0.3 1.2 3.7 1.8 2.3 0.2 0.2 0.8 1.1 0.2 0.4 0.4 3.2 0.5 1.2 0.9 0.0 0.3 1.0 1.1 0.0 0.0 2.1 3.2 1.7 2.8 3.0 0.4 2.4 1.1 0.0 0.3 0.5 0.0 0.2 0.0 1.6 1.1 1.0 0.3 2.5 0.5 2.3 0.3 0.2 4.5 0.9 1.6 0.5 0.2 0.9 1.6 0.8 0.9 1.1 0.7 0.9 0.7 0.0 1.7 0.3 1.8 2.2 0.6 0.9 2.8 1.1 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.3 3.3 28.8 3.2 21.5 2.3 2.5 1.0 6.2 0.0 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.4 0.3 0.0 0.0 0.0 0.1 COX6A2 ENSG00000156885 "Cytochrome c oxidase subunit 6A2" Q02221 16 31427731-31428428 "Predicted intracellular proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8" "Cell type enriched" "Detected in some" 64 "Cardiomyocytes: 3924.5" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 125 "NK-cell: 12.5" "Lineage enriched" "Detected in single" 125 "NK-cells: 12.5" "Cell line enriched" "Detected in some" 4 "U-266/84: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.66e-1)" "unprognostic (1.73e-3)" "unprognostic (2.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.68e-2)" "unprognostic (3.88e-1)" "unprognostic (5.61e-2)" "unprognostic (7.20e-2)" "unprognostic (8.71e-2)" "unprognostic (6.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-1)" 3.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 9.3 5.6 0.1 0.1 398.6 0.1 0.3 0.2 0.9 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.8 0.1 0.0 2.3 0.1 0.9 8.4 0.1 421.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 5.5 230.8 11.4 0.1 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3924.5 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 61.4 2.1 3.2 0.0 0.6 2.1 0.8 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.7 20.3 3.9 19.4 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Group enriched" "Detected in some" 11 "Early spermatids: 811.2;Late spermatids: 1407.4;Spermatocytes: 393.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "U-937: 18.0" "Not detected" "Not detected" HPA003127 Approved NA NA "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 811.2 0.0 0.0 0.0 0.0 10.6 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1407.4 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 19.4 0.0 393.6 80.8 0.1 2.9 0.0 0.0 0.1 CPA5 ENSG00000158525 "Carboxypeptidase A5" Q8WXQ8 7 130344816-130368730 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "blood: 25.2;testis: 30.4" "Group enriched" "Detected in some" 20 "Early spermatids: 46.3;Late spermatids: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2" "Lineage enriched" "Detected in single" 114 "T-cells: 25.2" "Cell line enhanced" "Detected in some" "RH-30: 11.2;RT4: 5.1;U-266/84: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020322 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA020322: AB_10960562" "unprognostic (2.44e-1)" "unprognostic (3.76e-1)" "unprognostic (1.50e-1)" "unprognostic (5.94e-2)" "unprognostic (4.96e-2)" "unprognostic (7.10e-3)" "unprognostic (1.64e-2)" "unprognostic (1.41e-2)" "unprognostic (3.26e-1)" "unprognostic (5.02e-2)" "unprognostic (5.83e-4)" "unprognostic (1.43e-1)" "unprognostic (8.88e-13)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (8.81e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.4 0.0 1.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 1.6 0.0 30.4 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.0 0.0 0.2 0.0 0.0 25.2 3.1 0.8 0.0 0.1 0.6 0.0 0.0 0.0 0.4 3.3 0.2 0.4 2.4 0.0 0.0 0.0 0.0 1.1 0.1 0.4 0.7 0.0 0.0 1.9 0.7 0.7 1.2 0.5 0.0 0.0 0.0 1.1 0.0 1.2 1.4 0.0 0.9 0.0 1.6 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 11.2 0.4 1.5 5.1 1.4 0.2 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 8.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 8.0 4.1 0.0 0.0 2.1 20.3 0.0 0.0 0.0 0.0 25.2 3.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 2.8 0.0 0.0 46.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 106.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 1.9 0.0 3.9 0.0 0.0 0.0 CPEB2 ENSG00000137449 "Cytoplasmic polyadenylation element binding protein 2" Q7Z5Q1 4 15002674-15070153 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 76.2;Suprabasal keratinocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072513 Approved Cytosol Yes No Cytosol "HPA072513: AB_2686529" "unprognostic (6.59e-2)" "unprognostic (4.21e-3)" "unprognostic (4.75e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-2)" "unprognostic (2.36e-2)" "unprognostic (5.67e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-1)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (8.62e-2)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" 10.0 7.5 18.5 6.0 21.5 23.0 13.6 11.5 21.0 8.8 11.5 28.7 13.2 9.6 8.2 9.4 13.6 7.1 10.7 7.8 17.4 16.2 13.5 18.9 9.5 6.4 27.2 17.4 7.9 5.4 23.8 6.4 7.4 16.4 10.2 10.7 20.7 8.9 21.9 7.1 23.0 9.5 10.8 21.7 6.6 10.8 37.4 27.6 3.6 6.1 7.8 7.2 8.3 12.6 0.4 0.7 2.4 0.4 1.3 1.6 0.3 1.3 8.3 0.8 0.3 6.2 11.4 1.4 4.6 3.1 2.9 2.1 0.2 1.6 0.8 0.9 4.2 5.4 1.5 1.8 1.0 1.8 2.3 0.6 0.2 6.4 1.4 2.9 0.3 1.1 5.6 5.5 7.0 6.8 3.6 2.6 0.1 0.1 6.0 11.8 0.6 0.1 1.8 0.8 2.4 1.2 0.1 0.6 0.3 25.2 1.1 0.7 4.6 1.5 1.0 4.7 3.9 0.6 5.3 5.1 10.4 0.9 6.5 2.5 3.9 0.5 0.4 8.5 4.7 3.8 0.0 0.4 1.7 0.5 0.4 1.6 0.1 0.8 0.5 0.7 0.4 0.9 0.3 2.4 1.3 0.2 0.3 0.2 0.3 18.5 21.5 11.5 21.0 17.4 16.2 27.2 17.4 16.4 27.6 29.8 13.9 5.8 9.4 76.2 7.6 18.3 15.3 1.4 6.8 29.6 25.5 1.1 1.7 3.5 47.6 11.4 23.2 0.0 4.2 1.2 11.0 8.7 10.4 21.2 9.1 14.3 9.8 12.9 15.4 15.5 5.8 12.2 50.6 2.8 10.9 6.1 5.9 11.9 7.8 10.3 19.0 0.0 13.4 14.7 3.1 113.2 1.1 6.4 6.6 14.4 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988677-121297444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 35.2;Ito cells: 30.7;Peritubular cells: 76.7;Smooth muscle cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3" "Group enriched" "Detected in many" 9 "dendritic cells: 17.2;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.7;Hep G2: 16.5;K-562: 55.7;LHCN-M2: 19.7;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA012058 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favorable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 21.6 8.3 3.2 8.0 3.7 0.1 7.8 1.1 2.7 19.4 16.3 4.1 15.0 3.7 21.8 15.7 10.5 12.2 14.4 10.3 2.9 1.7 3.9 19.4 9.0 1.5 5.1 1.9 36.8 2.0 0.4 4.5 10.6 3.1 20.7 6.7 18.5 2.8 17.1 24.4 2.9 10.6 48.9 8.7 9.9 8.6 7.1 3.8 0.2 4.9 15.9 1.4 34.3 14.6 1.0 17.2 1.4 7.8 0.0 0.1 2.1 1.9 0.0 0.1 0.0 4.7 13.8 0.1 8.1 28.7 2.8 7.7 0.2 0.1 0.3 0.1 4.3 3.2 0.1 0.1 0.0 7.4 0.1 0.3 2.2 0.1 16.5 8.2 0.0 0.0 5.6 0.0 6.6 0.1 2.2 1.4 0.0 55.7 4.2 19.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.3 5.5 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.2 0.8 16.8 0.4 14.0 7.7 1.8 0.0 0.2 1.9 0.0 0.8 1.4 7.6 0.0 0.0 7.8 0.1 1.0 0.0 0.0 17.2 0.3 0.0 0.0 0.3 0.0 4.8 10.3 0.0 2.1 3.2 3.7 1.1 2.7 2.9 1.7 5.1 1.9 3.1 3.8 17.9 0.3 1.3 0.5 2.7 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.5 35.2 0.8 0.0 20.2 3.9 3.2 0.0 30.7 11.5 0.0 19.5 25.2 3.3 1.0 0.0 21.5 0.0 0.0 76.7 0.0 0.2 0.0 39.2 0.3 0.4 1.8 0.3 0.0 0.0 1.3 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884020 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.3;epididymis: 80.1" "Cell type enhanced" "Detected in some" 29 "Horizontal cells: 90.6;Intestinal endocrine cells: 35.2;Late spermatids: 18.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Group enriched" "Detected in some" 22 "A549: 106.1;Hep G2: 64.0;SCLC-21H: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 1.7 23.3 72.6 2.0 32.7 1.4 1.3 79.0 95.3 1.3 2.6 2.6 0.3 2.7 1.3 80.1 1.4 1.4 1.4 1.3 68.3 16.3 1.4 1.3 2.1 1.3 37.2 26.3 1.3 7.9 1.3 11.3 1.3 17.9 1.4 2.2 0.2 1.3 1.4 1.3 1.4 2.5 1.6 4.0 1.3 5.1 3.1 3.7 0.0 1.4 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 106.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 45.2 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 72.6 32.7 79.0 66.6 68.3 16.3 37.2 26.3 17.9 3.7 0.0 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.6 35.2 0.0 0.0 18.1 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 3.8 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 CPLX3 CPX-III ENSG00000213578 "Complexin 3" Q8WVH0 15 74826547-74831802 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 506.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.6;Karpas-707: 4.9;SCLC-21H: 2.2;SK-BR-3: 2.8;U-266/84: 3.2;U-698: 2.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB079003 Supported NA NA "CAB079003: " 0.4 2.5 6.4 0.5 7.4 0.4 0.4 20.8 19.6 0.5 0.5 3.3 0.0 0.4 0.4 0.5 0.5 0.4 0.4 13.4 6.4 0.8 0.4 0.4 0.4 0.5 0.6 7.9 0.4 0.4 0.4 1.7 0.4 8.2 56.4 0.4 32.8 9.8 0.4 0.4 0.5 0.6 0.4 1.0 31.8 4.6 2.2 1.2 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.1 0.0 5.6 0.1 0.0 0.0 0.2 0.1 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.1 0.0 0.9 0.1 0.0 0.3 0.2 0.0 0.4 0.0 0.1 2.2 0.1 0.0 2.8 1.2 0.3 1.7 0.0 0.0 0.1 0.1 0.5 0.0 1.4 3.2 2.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 7.4 20.8 19.6 6.4 0.8 0.6 7.9 8.2 1.2 0.0 0.0 0.0 0.2 0.0 506.7 0.0 0.0 0.0 0.0 0.0 72.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 14.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 54.1 0.0 0.0 8.1 1.7 0.0 0.0 0.0 0.0 0.1 CPLX4 CPX-IV ENSG00000166569 "Complexin 4" Q7Z7G2 18 59275156-59318649 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 61.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 55.6;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 128.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 6.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047627 Enhanced NA NA "HPA047627: " "unprognostic (1.85e-1)" "unprognostic (4.46e-1)" "unprognostic (4.20e-2)" "unprognostic (4.05e-2)" "unprognostic (9.90e-3)" 0.1 0.3 0.2 0.0 0.1 2.8 0.1 6.3 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.1 0.0 61.9 0.3 0.0 0.3 1.9 0.1 0.0 0.2 0.3 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.6 0.7 1.7 0.3 0.8 0.7 0.1 0.2 0.8 0.5 0.8 0.7 0.2 0.9 0.9 0.0 0.1 0.0 0.3 0.6 0.5 0.1 0.2 0.2 1.1 0.2 0.0 1.2 0.3 0.0 0.2 1.6 0.9 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.7 0.7 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.2 0.0 0.9 0.0 0.6 0.1 0.3 0.6 0.6 0.2 0.9 0.0 0.8 0.4 0.4 0.1 0.2 0.7 0.4 0.3 0.1 0.3 0.0 0.3 0.1 0.4 0.3 0.0 0.6 0.2 0.7 1.7 0.8 0.1 0.7 0.2 0.1 0.2 0.1 6.3 0.1 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 55.6 0.3 0.0 0.0 0.0 0.0 106.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPSF4L ENSG00000187959 "Cleavage and polyadenylation specific factor 4 like" A6NMK7 17 73248449-73262352 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.9;neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "Hep G2: 7.9;OE19: 2.4" "Low region specificity" "Detected in all" HPA044047 Uncertain NA NA "HPA044047: AB_10961638" "unprognostic (7.30e-2)" "unprognostic (1.54e-2)" "unprognostic (2.47e-1)" "unprognostic (3.02e-1)" "unprognostic (1.99e-1)" "unprognostic (7.73e-2)" "unprognostic (2.32e-2)" "unprognostic (5.59e-2)" "unprognostic (6.57e-3)" "unprognostic (9.76e-2)" "unprognostic (1.83e-1)" "unprognostic (3.66e-2)" "unprognostic (9.03e-8)" "unprognostic (6.71e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-2)" "unprognostic (7.44e-3)" 0.6 0.6 0.3 0.0 0.5 0.0 1.9 0.3 0.3 0.5 0.4 0.6 0.7 1.2 0.4 1.2 0.2 0.5 0.3 0.2 0.1 0.5 0.4 0.0 0.5 0.9 1.9 0.0 0.5 0.0 0.4 0.6 2.3 0.3 0.1 0.6 0.3 0.0 0.2 0.2 0.6 2.1 0.7 0.0 0.1 0.1 0.0 0.0 1.9 0.8 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.0 0.0 0.1 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.7 0.8 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPXCR1 CT77 ENSG00000147183 "CPX chromosome region, candidate 1" Q8N123 X 88747225-88754785 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 12.1" "Cell type enriched" "Detected in some" 10 "Early spermatids: 56.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;Karpas-707: 3.5;U-266/70: 1.9" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 CPXM1 "CPX-1, CPX1, CPXM" ENSG00000088882 "Carboxypeptidase X, M14 family member 1" Q96SM3 20 2794069-2800637 "Enzymes, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.3" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 29.4;Leydig cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 22 "memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 26 "B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9" "Cell line enhanced" "Detected in some" "AF22: 45.9;HSkMC: 25.0;NB-4: 40.3;REH: 41.1;SH-SY5Y: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.48e-2)" "unprognostic (3.61e-1)" "unprognostic (6.70e-2)" "unprognostic (1.47e-2)" "unprognostic (3.41e-1)" "unprognostic (5.24e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (9.32e-2)" "unprognostic (7.02e-2)" "unprognostic (3.23e-2)" "prognostic unfavorable (4.62e-10)" "unprognostic (1.30e-1)" "unprognostic (1.49e-1)" "unprognostic (5.55e-3)" "unprognostic (1.27e-2)" 24.0 2.4 0.5 4.6 1.1 5.6 14.9 0.9 3.7 32.2 7.4 1.3 7.6 0.2 43.6 41.4 1.4 13.6 31.1 14.4 0.5 0.2 4.3 0.6 2.7 1.9 2.1 0.6 20.7 1.7 0.6 2.7 60.3 2.4 8.5 0.2 16.2 2.7 5.3 2.2 5.8 1.4 14.5 1.4 0.5 1.0 10.1 0.3 15.2 8.8 0.7 1.5 23.0 15.2 2.3 1.4 0.0 0.0 3.9 0.0 0.7 0.0 0.0 45.9 0.0 0.0 1.4 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.1 0.2 2.3 6.0 0.0 0.0 0.6 0.0 0.9 25.0 0.0 2.1 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.1 40.3 9.7 0.0 0.0 41.1 0.0 1.1 0.0 0.0 0.0 30.9 0.0 0.0 0.0 7.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.0 1.1 0.0 0.7 0.5 1.1 0.9 1.1 0.5 0.2 2.1 0.6 2.4 0.3 0.0 0.3 0.5 2.6 2.4 0.0 0.5 0.0 5.3 1.2 3.5 0.0 2.4 0.0 1.9 2.1 0.5 0.0 0.0 0.0 2.1 29.4 0.8 2.3 0.0 6.0 0.0 0.0 1.3 0.0 1.8 16.1 0.3 1.7 1.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.9 0.0 1.7 1.8 2.7 0.0 0.0 0.9 CPXM2 "CPX2, UNQ676" ENSG00000121898 "Carboxypeptidase X, M14 family member 2" Q8N436 10 123706207-123940267 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 16.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048375 Uncertain "Secreted - unknown location" NA NA "HPA048375: AB_2680377" "unprognostic (1.50e-1)" "unprognostic (3.66e-1)" "unprognostic (2.58e-2)" "unprognostic (4.02e-3)" "unprognostic (2.69e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.57e-2)" "unprognostic (4.42e-2)" "unprognostic (2.14e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (1.16e-3)" 17.0 4.1 0.8 5.0 2.1 0.1 12.3 1.3 1.6 6.4 40.9 6.7 5.7 3.8 12.2 37.8 20.0 9.1 9.4 14.3 1.7 4.0 6.6 1.5 4.6 3.7 6.1 0.7 12.8 3.2 1.9 7.1 11.6 16.9 14.7 4.5 26.5 5.6 8.3 5.0 4.5 9.1 45.5 21.6 13.8 14.4 7.7 3.4 2.6 9.5 11.9 4.0 32.5 20.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.4 0.6 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 2.1 1.3 1.6 1.7 4.0 6.1 0.7 16.9 3.4 0.0 1.1 0.0 0.0 1.9 0.0 1.4 0.0 0.0 0.0 1.8 0.0 6.6 1.7 0.1 85.6 13.5 0.0 0.0 0.2 0.2 2.3 0.0 0.0 0.0 0.3 1.6 0.0 13.5 0.0 150.5 10.0 0.0 3.3 0.0 0.5 0.0 0.2 0.0 74.3 0.0 0.0 0.0 2.8 1.1 1.9 1.8 4.2 0.0 1.1 0.0 CRIP3 "bA480N24.2, TLP, TLP-A" ENSG00000146215 "Cysteine rich protein 3" Q6Q6R5 6 43299710-43308797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;heart muscle: 24.8;liver: 29.0" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Distal tubular cells: 8.3;Late spermatids: 6.8;Spermatocytes: 5.9" "Cancer enhanced" "Detected in some" "liver cancer: 3.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 14 "myeloid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HEK 293: 4.9;HeLa: 5.1;Hep G2: 9.2;NTERA-2: 8.4;RPMI-8226: 6.8;THP-1: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036198 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036198: AB_10670791" "unprognostic (8.35e-3)" "unprognostic (4.14e-3)" "unprognostic (6.37e-2)" "unprognostic (5.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (2.30e-2)" "unprognostic (4.34e-2)" "unprognostic (1.46e-2)" "unprognostic (8.49e-4)" "unprognostic (1.86e-2)" "unprognostic (7.30e-3)" "unprognostic (5.02e-2)" "unprognostic (4.89e-2)" "unprognostic (4.46e-2)" "unprognostic (2.80e-4)" 0.4 0.5 4.2 5.6 5.8 2.5 2.1 9.4 3.0 0.8 0.8 0.6 3.1 2.2 0.8 2.7 0.9 1.0 4.6 24.8 3.5 3.5 10.4 29.0 0.6 5.3 2.3 2.2 1.0 2.4 0.8 1.1 0.7 2.1 4.1 0.5 1.0 0.7 9.5 0.5 1.8 4.5 1.0 1.7 4.4 0.3 13.5 0.4 0.6 1.1 0.4 6.1 1.8 0.5 1.7 25.5 0.5 1.5 0.2 0.0 0.9 0.0 1.2 0.3 0.1 0.4 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.4 0.0 0.2 0.9 4.1 0.1 0.0 0.0 4.9 0.0 5.1 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 6.8 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.9 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.5 0.5 0.0 1.0 0.0 1.4 0.0 0.0 25.5 1.7 0.0 0.0 0.4 0.2 1.3 0.2 0.0 0.9 4.2 5.8 9.4 3.0 3.5 3.5 2.3 2.2 2.1 0.4 0.0 0.0 2.2 0.2 0.6 0.4 1.8 5.1 0.0 0.0 0.0 0.0 0.0 8.3 0.8 3.1 0.0 0.3 0.0 0.2 0.0 0.2 0.1 0.0 2.9 0.2 0.0 0.0 0.0 0.8 6.8 1.1 0.0 0.0 1.0 0.0 0.3 0.4 0.0 0.0 2.4 0.7 0.0 0.0 5.9 0.9 0.0 0.0 0.0 0.1 0.1 CRISPLD1 "Cocoacrisp, DKFZp762F133, LCRISP1" ENSG00000121005 "Cysteine rich secretory protein LCCL domain containing 1" Q9H336 8 74984515-75034558 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 22.7;Cytotrophoblasts: 18.0;Glandular cells: 13.7;Ito cells: 28.3" "Cancer enhanced" "Detected in many" "glioma: 30.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 32 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 32 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "AF22: 51.9;SH-SY5Y: 28.1;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024725 Uncertain "Secreted - unknown location" NA NA "HPA024725: AB_1847238" "unprognostic (2.16e-1)" "unprognostic (5.88e-2)" "unprognostic (4.01e-2)" "unprognostic (3.78e-2)" "unprognostic (3.85e-2)" "unprognostic (1.65e-1)" "unprognostic (2.09e-4)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (5.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (7.39e-3)" "unprognostic (2.38e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" 3.2 1.0 5.3 1.7 24.7 1.0 22.4 0.7 8.2 5.4 3.8 15.9 0.0 0.5 7.1 4.0 4.0 5.9 7.8 8.4 10.2 6.4 1.6 1.6 2.2 1.8 7.8 4.7 4.7 1.8 12.1 1.9 5.7 34.4 20.0 1.2 3.1 15.1 2.2 0.7 3.2 1.7 5.4 29.6 1.4 1.7 3.2 9.3 6.0 12.9 1.6 1.1 2.4 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 51.9 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.7 0.3 0.0 0.0 7.4 0.0 0.8 0.0 4.3 0.0 0.0 0.0 1.9 0.0 1.9 0.0 1.1 0.0 0.4 2.8 0.1 0.0 0.4 6.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 5.3 0.0 1.9 0.0 7.1 0.0 0.0 0.0 0.3 28.1 0.0 0.0 2.9 11.2 3.9 2.4 0.0 1.4 7.8 0.0 0.2 0.9 0.3 0.0 1.8 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.3 24.7 0.7 8.2 10.2 6.4 7.8 4.7 34.4 9.3 3.0 0.0 0.0 7.5 0.7 1.0 0.4 0.0 22.7 9.1 1.8 0.0 18.0 0.0 0.0 10.9 0.7 0.0 0.0 0.0 1.0 4.8 13.7 3.5 0.0 1.6 0.0 0.0 28.3 2.4 1.1 3.7 0.0 6.8 0.0 0.0 9.7 0.0 0.0 1.4 0.0 0.7 0.0 1.0 1.4 4.1 0.9 10.1 0.0 0.0 0.4 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 19 "Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Cell line enhanced" "Detected in many" "ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 15.3 5.7 23.8 11.6 10.3 9.3 6.6 1.5 0.9 0.0 1.0 10.1 2.7 0.3 0.0 0.0 9.4 0.0 0.0 0.1 0.2 0.0 56.8 0.0 0.1 23.8 0.0 2.7 0.0 3.1 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 1.5 0.6 0.0 0.1 0.1 0.1 1.8 2.3 0.1 2.7 1.2 0.2 3.4 4.7 0.3 1.3 0.1 0.6 9.7 0.3 0.1 0.0 1.9 0.0 0.2 1.4 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 3.0 2.9 0.8 7.9 41.0 0.6 7.6 0.0 1.4 2.3 0.0 0.0 6.0 0.0 1.1 10.8 12.0 0.4 0.0 0.4 24.6 126.1 19.2 6.9 0.0 4.4 1.6 2.9 60.2 40.4 10.7 251.5 12.2 45.5 0.0 4.2 5.0 0.8 0.0 250.0 0.0 0.5 90.5 678.7 0.9 0.9 37.4 7.6 4.8 1.3 5.2 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 25.1 16.9 0.1 5.1 0.0 0.1 6.3 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 3.0 0.0 1.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.9 1.7 1.8 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163576 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-138 MG: 1.3" "Not detected" "Not detected" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.1 0.0 1.0 0.1 1.8 0.0 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.1 0.1 0.9 1.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.1 1.5 0.9 1.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGN ENSG00000127377 "Crystallin gamma N" Q8WXF5 7 151428835-151440813 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "seminal vesicle: 4.3;thyroid gland: 16.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 25 "thyroid cancer: 15.7" "Group enriched" "Detected in some" 31 "memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 35 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 1.7;CAPAN-2: 2.7;MOLT-4: 2.0;SCLC-21H: 3.6" "Region enriched" "Detected in single" 4 "basal ganglia: 9.3" "Not detected" "Not detected" HPA050788 Uncertain NA NA "HPA050788: AB_2681239" "unprognostic (1.69e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-3)" "unprognostic (5.50e-2)" "unprognostic (2.94e-5)" "unprognostic (2.49e-3)" "unprognostic (1.55e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (3.67e-2)" "unprognostic (1.39e-1)" "unprognostic (8.48e-2)" "unprognostic (8.93e-10)" "unprognostic (2.55e-4)" "unprognostic (2.71e-1)" "unprognostic (2.36e-2)" "unprognostic (3.36e-1)" 0.3 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.4 1.1 0.3 0.0 0.9 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 2.6 0.8 0.3 0.3 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 16.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.0 0.8 1.0 2.7 0.3 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.3 0.4 0.0 2.0 0.5 1.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.4 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CSAG1 "CSAGE, CT24.1" ENSG00000198930 "Chondrosarcoma associated gene 1" Q6PB30 X 152727484-152733735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.2;lymphoid tissue: 3.3;testis: 6.3" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 38.2;HMC-1: 21.2;K-562: 13.5;OE19: 44.1;PC-3: 19.1;U-266/70: 33.6" NA NA "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" "unprognostic (8.96e-3)" "unprognostic (4.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.83e-3)" "unprognostic (5.96e-2)" "unprognostic (4.21e-1)" "unprognostic (6.68e-3)" "unprognostic (3.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-6)" "unprognostic (5.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-3)" "unprognostic (8.70e-3)" 0.2 0.2 3.3 1.1 4.2 0.2 0.2 1.6 4.1 0.2 0.3 1.5 0.0 0.2 0.8 0.2 0.2 0.4 0.2 0.2 3.2 1.8 0.3 0.4 0.3 3.3 3.0 0.9 0.2 0.2 0.2 0.0 0.3 2.0 0.4 0.3 0.0 0.5 0.5 0.2 0.5 0.6 0.7 1.3 0.5 0.4 6.3 2.7 0.1 0.9 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.0 21.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.1 0.0 0.0 0.0 0.0 0.0 44.1 19.1 0.0 0.0 0.1 0.0 0.0 2.1 11.9 0.0 7.1 5.6 0.0 0.3 0.0 0.1 1.3 0.3 6.9 2.2 33.6 0.5 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.2 1.6 4.1 3.2 1.8 3.0 0.9 2.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 10.7 0.0 0.1 0.0 0.0 0.6 CSAG3 CSAG3A ENSG00000268916 "CSAG family member 3" Q9Y5P2 X 152753921-152760222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 3.4;skin 1: 2.4;testis: 5.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 18.9;HMC-1: 11.1;OE19: 26.9;SH-SY5Y: 14.4;SK-BR-3: 13.3;U-266/70: 34.4;U-266/84: 17.4" NA NA "unprognostic (1.56e-1)" "unprognostic (9.48e-2)" "unprognostic (1.41e-1)" "unprognostic (7.12e-3)" "unprognostic (4.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.02e-2)" "unprognostic (7.06e-2)" "unprognostic (7.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-2)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.3 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 8.9 0.0 0.0 0.0 0.0 0.0 26.9 0.1 0.0 0.0 1.1 0.0 0.0 2.9 14.4 0.0 13.3 0.5 0.0 0.0 0.5 0.0 0.0 10.5 0.0 0.0 34.4 17.4 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSHL1 "CS-5, CSHP1, CSL, hCS-L, MGC149868" ENSG00000204414 "Chorionic somatomammotropin hormone like 1" Q14406 17 63909597-63918838 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 864 "pituitary gland: 334.1;placenta: 293.7" "Cell type enriched" "Detected in some" 16 "Syncytiotrophoblasts: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7" "CAB025646, HPA043715" Enhanced "Secreted to blood" NA NA "CAB025646: , HPA043715: AB_2678632" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 334.1 293.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.1 0.0 0.0 0.0 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113437099 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 26.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 4.8;Bipolar cells: 6.4;Early spermatids: 10.2;Spermatocytes: 15.3;Spermatogonia: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.4;hTCEpi: 2.4;hTERT-HME1: 1.7;LHCN-M2: 3.4;RH-30: 2.1;SCLC-21H: 1.5;U-2 OS: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029007 Uncertain NA NA "HPA029007: AB_10601802" "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 1.0 1.0 26.6 1.0 21.9 1.0 1.0 6.0 18.3 1.6 1.1 2.2 0.0 1.1 1.1 1.1 1.0 2.3 1.0 1.0 14.2 6.7 1.1 1.0 1.1 1.0 3.0 15.8 1.0 1.0 1.0 5.7 1.0 10.9 2.1 1.2 0.0 1.0 2.1 1.0 1.0 1.2 1.1 3.6 2.4 1.3 5.0 7.0 0.0 1.0 0.0 1.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.4 0.0 1.7 0.6 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 21.9 6.0 18.3 14.2 6.7 3.0 15.8 10.9 7.0 0.0 4.8 0.0 0.1 0.2 6.4 1.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 10.2 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 15.3 5.6 0.5 0.0 0.0 0.0 0.2 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 10.5;testis: 9.0" "Group enriched" "Detected in some" 8 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 40 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.5" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.2 10.5 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 10.5 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 1.5 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.4 1.1 2.4 0.2 0.0 0.0 1.0 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.7;pituitary gland: 21.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 49.8;Cone photoreceptor cells: 66.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Approved Uncertain "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 2.1 5.5 9.3 1.4 24.9 0.7 6.7 8.8 31.7 5.7 2.0 3.2 0.4 2.1 6.3 2.3 2.0 2.5 2.5 3.4 9.3 10.2 3.7 1.8 1.4 1.1 5.3 13.2 7.8 8.0 6.0 21.1 1.1 7.8 3.9 2.5 4.0 4.9 5.1 0.9 2.1 1.7 5.7 2.9 2.1 2.0 1.9 4.8 0.0 5.3 0.0 1.0 1.9 2.5 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.9 0.6 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 3.1 0.0 0.1 0.8 0.7 0.0 9.5 7.7 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.8 0.3 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 24.9 8.8 31.7 9.3 10.2 5.3 13.2 7.8 4.8 3.0 3.2 0.0 2.6 4.6 49.8 6.7 10.2 0.0 1.2 10.4 66.8 0.3 3.3 1.8 2.5 2.9 0.5 0.0 2.1 0.1 4.7 0.3 0.0 2.9 2.0 11.1 7.5 1.3 0.3 1.3 6.9 0.0 6.8 0.0 2.6 18.3 1.0 1.9 7.8 5.0 17.9 6.5 14.6 0.7 0.7 4.0 0.2 0.0 2.9 1.4 CST9 "CLM, CTES7A" ENSG00000173335 "Cystatin 9" Q5W186 20 23602410-23605876 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "breast: 6.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 37 "breast cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029190 Uncertain "Secreted - unknown location" NA NA "HPA029190: AB_10602804" "unprognostic (2.06e-2)" "unprognostic (2.21e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSTL1 "CTES1, dJ322G13.4" ENSG00000125823 "Cystatin like 1" Q9H114 20 23439685-23444930 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 7.5" "Group enriched" "Detected in some" 434 "Early spermatids: 55.2;Late spermatids: 53.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 4.3;OE19: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (1.54e-1)" "unprognostic (3.25e-3)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (3.63e-1)" "unprognostic (2.97e-1)" "unprognostic (6.87e-2)" "unprognostic (2.35e-1)" "unprognostic (5.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Group enriched" "Detected in some" 18 "Alveolar cells type 2: 2.2;Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.5 0.0 0.0 0.9 66.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 47.3" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A1 CT47.1 ENSG00000236371 "Cancer/testis antigen family 47, member A1" Q5JQC4 X 120982476-120985788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-266/70: 7.3" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A10 CT47.10 ENSG00000224089 "Cancer/testis antigen family 47, member A10" Q5JQC4 X 120938701-120942023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A11 CT47.11 ENSG00000226929 "Cancer/testis antigen family 47, member A11" Q5JQC4 X 120933840-120937158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "EFO-21: 1.6;U-87 MG: 1.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CT47A12 CT47.12 ENSG00000226685 "Cancer/testis antigen family 47, member A12" Q5JQC4 X 120930250-120932301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;U-2197: 1.1;U-266/70: 3.0" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 3.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 CT47A2 CT47.2 ENSG00000242362 "Cancer/testis antigen family 47, member A2" Q5JQC4 X 120977606-120980928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A3 CT47.3 ENSG00000236126 "Cancer/testis antigen family 47, member A3" Q5JQC4 X 120972746-120976068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A4 CT47.4 ENSG00000230594 "Cancer/testis antigen family 47, member A4" Q5JQC4 X 120967886-120971208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A5 CT47.5 ENSG00000237957 "Cancer/testis antigen family 47, member A5" Q5JQC4 X 120963026-120966348 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A6 CT47.6 ENSG00000226023 "Cancer/testis antigen family 47, member A6" Q5JQC4 X 120958165-120961487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "U-266/70: 4.2;U-266/84: 1.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 CT47A7 CT47.7 ENSG00000228517 "Cancer/testis antigen family 47, member A7" Q5JQC4 X 120953288-120956600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A8 CT47.8 ENSG00000230347 "Cancer/testis antigen family 47, member A8" Q5JQC4 X 120948422-120951744 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A9 CT47.9 ENSG00000226600 "Cancer/testis antigen family 47, member A9" Q5JQC4 X 120943561-120946883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT62 ENSG00000225362 "Cancer/testis antigen 62" P0C5K7 15 71110244-71115494 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 50 "testis: 31.2" "Group enriched" "Detected in some" 57 "Early spermatids: 181.5;Late spermatids: 60.0" "Group enriched" "Detected in some" 8 "breast cancer: 2.3;prostate cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;HaCaT: 3.4;T-47d: 7.6;U-2197: 6.0" HPA045306 Uncertain NA NA "HPA045306: AB_10960632" "unprognostic (1.55e-1)" "unprognostic (3.53e-3)" "unprognostic (9.17e-2)" "unprognostic (3.55e-1)" "unprognostic (5.49e-2)" "unprognostic (2.16e-2)" "unprognostic (9.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.95e-5)" "unprognostic (2.89e-2)" "unprognostic (2.03e-1)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 31.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.2 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 1.5 0.0 0.2 7.6 0.0 0.9 0.0 0.0 6.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 181.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.1 0.0 0.0 0.0 CTAGE1 "CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2" ENSG00000212710 "Cutaneous T cell lymphoma-associated antigen 1" "Q96RT6, Q9HC47" 18 22413601-22417915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 12.9" "Cell type enriched" "Detected in some" 11 "Early spermatids: 62.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 2.3;U-2 OS: 1.8" "HPA000387, HPA000922, CAB016204" Uncertain NA NA "CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.41e-1)" "unprognostic (5.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.52e-1)" "unprognostic (1.70e-2)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 4.9 0.5 0.3 0.1 0.0 0.0 0.3 CTAGE15 CTAGE15P ENSG00000271079 "CTAGE family member 15" A4D2H0 7 143571801-143574387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 8.1" "Cell type enhanced" "Detected in single" 34 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (2.82e-1)" "unprognostic (8.64e-2)" "unprognostic (3.23e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-1)" "unprognostic (2.23e-1)" "unprognostic (4.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-2)" "unprognostic (3.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.33e-1)" "unprognostic (2.91e-2)" "unprognostic (2.39e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE4 "cTAGE-4, FLJ43692" ENSG00000225932 "CTAGE family member 4" Q8IX94 7 144183466-144186053 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.3;T-reg: 2.0" "Lineage enriched" "Detected in single" 5 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "A-431: 13.8;hTCEpi: 12.2;RPTEC TERT1: 10.9;T-47d: 7.7;WM-115: 7.4" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.76e-1)" "unprognostic (3.24e-3)" "unprognostic (2.89e-1)" "unprognostic (5.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.65e-3)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (4.69e-2)" "unprognostic (1.91e-2)" "unprognostic (9.50e-3)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (8.36e-2)" "unprognostic (2.68e-1)" 1.3 0.9 0.2 0.0 0.7 0.0 3.8 0.1 0.2 0.7 1.2 3.7 1.4 2.5 1.3 1.1 1.9 1.4 0.2 0.4 1.3 1.6 2.0 0.0 0.7 1.9 4.1 0.0 2.1 0.8 1.3 3.5 2.0 0.3 0.3 9.1 1.0 0.0 0.4 1.3 2.4 4.9 7.5 0.0 0.8 1.3 0.4 0.0 0.0 0.0 0.0 2.0 0.0 13.8 0.1 0.0 0.0 0.0 0.0 5.8 0.4 0.2 0.0 0.2 1.3 4.4 0.0 0.0 0.5 0.3 0.4 0.0 2.5 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.3 12.2 0.4 3.8 0.6 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.5 3.9 0.0 0.0 0.0 0.0 10.9 3.6 0.0 0.0 5.0 5.1 0.4 2.3 7.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.0 3.5 0.0 0.1 0.6 0.0 0.4 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 CTAGE6 "CTAGE6P, MGC41943" ENSG00000271321 "CTAGE family member 6" Q86UF2 7 143755089-143757696 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 15.0" "Cell type enhanced" "Detected in single" 27 "Early spermatids: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HeLa: 1.6;U-266/70: 1.0" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.51e-2)" "unprognostic (8.90e-12)" "unprognostic (1.73e-2)" "unprognostic (2.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.8 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 CTAGE9 ENSG00000236761 "CTAGE family member 9" A4FU28 6 131708684-131711017 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 11.6" "Cell type enhanced" "Detected in some" 17 "Club cells: 2.3;Early spermatids: 1.9;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A-431: 1.3" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (3.92e-2)" "unprognostic (6.84e-2)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (9.89e-3)" "unprognostic (2.36e-1)" "unprognostic (5.55e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-2)" "unprognostic (5.74e-4)" "unprognostic (3.15e-2)" "unprognostic (9.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.2 0.2 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.4 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75219000-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2272 "pancreas: 1908.8" "Cell type enriched" "Detected in some" 12 "Exocrine glandular cells: 26371.2" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 5.0;U-2 OS: 2.5;U-251 MG: 1.6" "Secreted to digestive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 1908.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.0 0.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.2 1.6 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 26371.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.1 0.0 0.0 2264.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTRB2 ENSG00000168928 "Chymotrypsinogen B2" Q6GPI1 16 75204096-75207185 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5240 "pancreas: 3761.5" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 45669.7" "Cancer enriched" "Detected in single" 1696 "pancreatic cancer: 540.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.1;HDLM-2: 1.9;U-2 OS: 9.3;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4" "Secreted to digestive system" NA NA "unprognostic (9.41e-4)" "unprognostic (2.20e-1)" "unprognostic (1.28e-2)" "unprognostic (2.10e-1)" "unprognostic (2.92e-2)" "unprognostic (2.77e-1)" "unprognostic (5.95e-2)" "unprognostic (9.56e-2)" "unprognostic (3.54e-3)" "unprognostic (7.06e-2)" "unprognostic (2.17e-1)" "unprognostic (7.57e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 3761.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 9.3 0.0 1.9 0.1 2.6 2.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 1.0 0.0 0.0 0.0 45669.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 0.3 0.0 0.0 376.1 0.0 0.0 8606.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTRL ENSG00000141086 "Chymotrypsin like" P40313 16 67927640-67932414 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 281 "pancreas: 639.8" "Group enriched" "Detected in some" 39 "Exocrine glandular cells: 185.6;Pancreatic endocrine cells: 95.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034504, HPA034505" Enhanced "Secreted to digestive system" NA NA "HPA034504: AB_2674196, HPA034505: AB_10602212" "unprognostic (3.03e-5)" "unprognostic (3.53e-3)" "unprognostic (3.46e-2)" "unprognostic (1.37e-1)" "unprognostic (9.66e-2)" "unprognostic (2.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (6.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.88e-1)" "unprognostic (3.20e-4)" "unprognostic (6.69e-2)" "unprognostic (2.79e-1)" "unprognostic (2.63e-1)" "unprognostic (1.29e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 639.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1.1 1.1 0.7 0.0 2.2 0.5 0.5 3.7 1.1 0.3 0.2 0.1 1.8 0.3 0.7 1.2 1.3 2.3 1.4 0.7 0.4 0.7 1.2 1.0 5.7 0.7 3.1 1.4 6.4 0.8 1.1 1.4 0.3 0.9 2.5 1.2 0.2 3.9 1.0 0.5 0.0 1.9 1.6 1.0 0.6 1.1 0.7 2.8 6.3 1.3 2.3 2.9 0.5 4.6 0.0 0.9 2.7 1.4 1.3 0.7 0.6 0.9 1.2 4.4 1.7 0.1 2.1 0.5 1.6 6.6 2.8 3.6 0.2 0.8 0.8 0.6 0.7 0.3 1.5 0.7 0.2 0.3 1.1 0.5 0.9 0.6 0.5 2.2 1.1 0.0 0.7 1.1 0.0 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 185.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.6 0.4 0.0 95.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 CTSO CTSO1 ENSG00000256043 "Cathepsin O" P43234 4 155924118-155953917 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.5;HSkMC: 14.8;Karpas-707: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002041 Approved "Intracellular and membrane" NA NA 24000 "HPA002041: AB_1078408" "unprognostic (3.96e-3)" "unprognostic (1.62e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (9.10e-3)" "unprognostic (2.55e-1)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (6.62e-2)" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.55e-2)" "unprognostic (4.87e-3)" "unprognostic (4.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" 13.7 16.4 11.9 12.6 12.0 1.8 14.9 3.7 12.4 16.0 18.5 11.6 10.2 13.3 19.3 27.3 10.8 15.6 16.9 19.7 9.7 8.6 21.2 41.6 26.4 19.4 10.2 6.7 16.3 10.7 13.6 9.4 18.7 9.7 16.1 9.8 24.0 13.8 16.8 5.9 6.2 27.5 14.4 11.4 19.3 10.8 9.0 7.7 5.5 17.1 10.2 10.3 12.4 12.5 7.0 8.9 5.3 14.8 12.0 10.9 8.9 0.3 0.2 1.5 1.6 5.7 12.5 0.0 3.6 7.2 1.3 1.8 0.0 4.6 0.0 0.7 2.4 0.4 0.0 0.0 0.3 0.9 5.3 0.1 0.4 0.0 0.0 5.9 0.7 0.1 14.8 1.3 0.8 0.6 8.4 1.2 0.2 0.0 27.8 4.1 0.3 0.3 0.1 0.3 0.2 0.2 1.7 0.3 1.7 5.4 2.3 0.2 1.7 0.9 3.0 1.1 0.8 1.5 1.0 2.1 4.4 0.2 0.4 1.2 3.2 0.0 0.0 7.9 0.0 5.9 5.3 12.0 0.8 7.9 14.8 10.9 5.8 6.1 7.3 8.9 7.0 6.7 6.8 0.5 12.0 10.7 8.3 6.8 8.9 11.9 12.0 3.7 12.4 9.7 8.6 10.2 6.7 9.7 7.7 35.7 17.3 20.1 9.8 9.3 6.6 4.8 35.7 12.0 14.8 24.4 2.0 16.9 11.6 16.2 0.4 26.9 14.2 0.0 17.8 5.0 32.5 16.5 8.1 50.0 15.1 4.8 6.4 36.8 29.9 0.4 28.1 17.9 28.7 13.6 10.0 15.8 12.5 7.0 23.7 8.4 1.3 19.4 16.4 0.2 1.1 8.0 8.8 13.1 5.6 7.8 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Group enriched" "Detected in some" 23 "Exocrine glandular cells: 224.1;Pancreatic endocrine cells: 71.0" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.2;LHCN-M2: 8.0" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.7 1.7 0.0 0.5 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.7 0.9 0.7 1.1 0.0 1.7 0.0 1.5 2.6 2.3 2.2 3.6 4.7 0.8 0.3 0.0 3.8 1.2 0.3 1.5 7.2 0.2 1.8 1.5 1.3 1.5 8.0 0.4 2.0 2.7 1.7 0.9 1.3 0.0 4.0 0.6 1.4 1.3 1.9 0.7 0.9 0.4 1.1 2.0 1.3 1.9 3.6 0.0 2.4 0.9 0.0 1.9 1.4 3.2 1.3 5.9 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 224.1 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 4.5 0.3 0.0 0.0 6.4 0.0 0.0 71.0 0.0 0.4 0.0 0.5 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.0 0.0 CWH43 "CWH43-C, FLJ21511" ENSG00000109182 "Cell wall biogenesis 43 C-terminal homolog" Q9H720 4 48986247-49062081 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 26.1;seminal vesicle: 22.9" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 22.7;Collecting duct cells: 7.0;Glandular cells: 8.2;Paneth cells: 11.5;Suprabasal keratinocytes: 8.0;Undifferentiated cells: 8.9" "Cancer enhanced" "Detected in many" "prostate cancer: 20.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;NB-4: 1.4;SH-SY5Y: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA042814, HPA048140" Uncertain NA NA "HPA042814: AB_2678182, HPA048140: AB_2680280" "unprognostic (9.38e-3)" "unprognostic (6.23e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.32e-4)" "unprognostic (2.14e-1)" "unprognostic (5.00e-2)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.29e-11)" "unprognostic (5.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.82e-2)" "unprognostic (2.51e-2)" 0.1 0.0 0.1 9.3 0.1 0.0 1.0 0.1 0.2 5.1 9.7 0.2 11.1 0.0 2.0 2.2 19.8 8.6 0.4 0.1 0.1 0.1 7.6 1.1 0.8 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 26.1 9.1 0.4 2.7 22.9 0.1 16.9 0.1 1.9 0.1 0.1 5.2 0.7 0.1 0.3 10.6 12.6 3.6 3.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 1.6 0.0 0.3 0.0 22.7 2.3 7.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 11.5 0.0 3.4 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 8.9 0.3 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733526-4739922 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 715.4;Late spermatids: 3190.9;monocytes: 938.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7" "Group enriched" "Detected in many" 7 "dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7" "Cell line enhanced" "Detected in many" "A-431: 35.0;CACO-2: 24.1;CAPAN-2: 19.0;HaCaT: 39.2;T-47d: 18.9" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1100000 4000000 "Golgi apparatus" Vesicles "HPA053253: AB_2682091, HPA066315: AB_2685657" "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 32.5 9.5 8.2 18.7 9.7 16.3 9.7 2.0 6.6 8.0 17.2 15.8 3.4 19.1 4.8 10.5 13.1 9.5 23.0 5.2 9.9 6.9 12.5 34.8 41.9 28.8 13.3 5.1 10.6 11.0 34.6 8.6 9.7 10.0 9.8 8.3 12.7 26.6 5.9 3.3 11.3 29.5 5.2 16.5 34.1 18.7 51.9 10.0 4.5 8.1 8.5 10.1 9.7 7.4 3.4 10.7 25.9 37.7 0.0 0.3 6.9 35.0 4.8 0.0 11.3 0.1 0.9 4.5 0.4 3.4 3.4 4.6 24.1 19.0 0.0 4.2 0.2 2.1 39.2 5.6 4.0 1.2 3.6 6.4 0.0 0.5 10.6 2.4 0.0 5.2 0.2 6.7 1.8 0.2 1.3 0.9 0.1 0.0 0.2 0.3 7.4 0.1 0.6 0.0 10.1 3.0 0.4 0.0 5.2 7.2 5.8 0.0 0.4 7.1 2.9 1.8 0.4 18.9 0.4 0.1 0.5 2.5 0.8 2.0 1.2 1.6 0.0 0.1 0.1 0.9 0.0 18.3 4.0 0.1 29.3 0.1 2.9 0.3 0.2 10.7 3.4 0.1 0.3 25.9 0.0 37.7 4.6 0.0 6.9 8.2 9.7 2.0 6.6 9.9 6.9 13.3 5.1 10.0 10.0 68.5 50.1 21.2 107.8 62.3 2.0 0.7 40.8 14.7 37.5 38.4 2.0 2.4 3.3 146.2 715.4 13.4 32.3 0.0 129.6 1.8 13.6 179.9 71.7 5.9 190.7 3.2 29.6 160.8 160.8 3190.9 22.7 246.0 25.3 938.6 23.4 6.8 134.1 45.6 28.3 6.8 0.8 19.4 18.9 20.7 11.8 66.9 2.4 10.0 19.3 257.2 CXCR6 "BONZO, CD186, STRL33, TYMSTR" ENSG00000172215 "C-X-C motif chemokine receptor 6" O00574 3 45940933-45948353 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 66.4;T-cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 4 "MAIT T-cell: 81.3" "Lineage enriched" "Detected in many" 6 "T-cells: 81.3" "Cell line enhanced" "Detected in some" "BEWO: 4.1;CAPAN-2: 15.7;JURKAT: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-3)" "prognostic favorable (4.92e-4)" "unprognostic (1.77e-3)" "prognostic favorable (6.74e-6)" "unprognostic (6.67e-2)" "prognostic favorable (2.16e-4)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.93e-2)" "unprognostic (3.65e-4)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (3.46e-2)" "unprognostic (1.57e-2)" 2.5 1.1 0.5 7.6 0.5 0.5 2.1 0.4 0.5 2.3 9.9 1.1 1.5 3.0 2.7 3.2 3.0 2.4 5.2 1.7 0.6 0.6 2.5 2.5 9.2 10.4 0.6 0.2 3.7 1.6 0.0 0.9 18.9 1.0 2.6 2.6 3.0 3.3 0.2 7.7 1.1 10.8 1.0 1.3 22.3 6.0 2.3 0.2 5.2 4.1 5.3 14.6 5.2 2.6 0.0 0.1 0.1 0.0 13.4 81.3 3.8 0.3 0.1 0.0 0.3 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.1 15.7 0.3 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.2 0.5 0.0 0.2 0.8 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.3 0.9 0.0 2.1 0.2 0.8 0.4 1.5 0.7 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 17.3 0.0 81.3 0.0 4.9 20.3 0.0 0.0 0.2 3.1 0.1 13.4 0.0 0.1 14.5 3.8 0.5 0.5 0.4 0.5 0.6 0.6 0.6 0.2 1.0 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.7 0.0 0.0 0.0 0.0 2.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.5 0.1 1.1 0.8 0.7 0.0 0.0 1.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.0 1.0 8.6 54.5 0.0 0.0 CXorf21 FLJ11577 ENSG00000120280 "Chromosome X open reading frame 21" Q9HAI6 X 30558824-30577844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7" "Cell type enhanced" "Detected in some" 13 "B-cells: 25.2;granulocytes: 15.0;Hofbauer cells: 20.5;Kupffer cells: 21.1;Macrophages: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "THP-1: 59.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001185 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 6.5 2.1 4.6 9.8 4.0 16.0 2.0 0.8 4.4 1.4 3.0 2.3 0.2 4.3 1.2 2.4 1.4 1.5 3.6 1.5 5.0 2.1 1.9 2.8 6.1 12.9 6.3 0.0 1.0 2.0 0.7 1.5 2.7 5.1 1.5 3.1 1.1 3.3 0.5 0.8 1.1 5.3 1.8 9.9 16.7 3.1 0.8 5.2 9.1 1.4 1.2 9.3 4.8 1.4 11.1 21.9 14.9 18.9 3.2 1.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 7.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.1 0.0 0.0 0.0 0.0 0.0 5.6 0.5 2.7 0.0 8.5 0.0 3.4 10.3 11.4 0.8 9.6 0.1 11.1 1.0 0.5 12.0 10.8 1.0 0.7 14.9 3.2 18.9 21.9 1.6 3.5 4.6 4.0 0.8 4.4 5.0 2.1 6.3 0.0 5.1 5.2 0.0 2.2 25.2 0.2 0.5 0.0 0.2 0.0 2.7 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 15.0 0.0 20.5 0.0 0.0 0.6 21.1 0.0 0.0 39.3 8.5 5.4 0.0 2.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.2 1.3 0.0 0.1 CXorf36 "DIA1R, FLJ14103" ENSG00000147113 "Chromosome X open reading frame 36" Q9H7Y0 X 45148374-45200901 "Disease related genes, Predicted secreted proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "Endothelial cells: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.4" "Cell line enriched" "Detected in single" 59 "HUVEC TERT2: 43.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA002806 Uncertain "Secreted - unknown location" NA NA 370000 "HPA002806: AB_1078595" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (8.51e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "unprognostic (4.07e-3)" "unprognostic (7.30e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (3.39e-1)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (1.75e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (8.47e-2)" "unprognostic (3.11e-2)" 42.1 3.2 3.8 6.2 4.4 0.8 47.7 1.4 3.2 17.9 7.3 2.9 6.7 2.4 28.5 10.2 8.0 9.9 7.5 23.6 4.7 3.7 4.5 2.1 9.3 12.1 6.8 1.2 7.9 4.2 4.3 3.7 39.6 4.2 12.0 3.5 4.3 4.4 7.7 14.4 4.9 4.7 17.7 6.4 5.0 4.2 5.6 2.0 0.3 12.3 12.0 3.7 10.6 26.5 0.5 0.2 2.4 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.3 0.4 0.4 0.4 0.0 0.5 0.4 0.3 2.4 0.1 0.0 0.2 0.1 0.1 3.8 4.4 1.4 3.2 4.7 3.7 6.8 1.2 4.2 2.0 3.0 2.2 0.0 0.4 3.9 0.0 4.5 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.2 94.9 0.0 0.0 0.2 0.1 1.0 0.1 1.1 0.0 0.2 0.0 0.0 13.5 1.2 1.5 0.9 1.3 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.1 0.0 0.1 4.1 0.2 0.0 0.0 0.5 CXorf40B ENSG00000197021 "Chromosome X open reading frame 40B" Q96DE9 X 149929527-149938811 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA060897 Approved NA NA "HPA060897: AB_2684381" "unprognostic (5.44e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-1)" "unprognostic (8.49e-2)" "unprognostic (2.33e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-3)" "unprognostic (1.36e-1)" "unprognostic (5.35e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-2)" "unprognostic (7.57e-2)" "unprognostic (6.38e-2)" "unprognostic (5.94e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.14e-3)" 16.1 48.4 15.1 16.7 21.5 40.1 21.4 15.2 27.7 16.8 17.0 17.4 23.0 14.9 18.4 27.8 16.4 14.9 20.7 19.9 15.2 13.6 19.2 23.4 16.0 18.3 19.5 20.7 25.4 28.4 16.0 25.5 33.1 17.3 18.4 15.4 16.7 24.6 25.6 13.8 28.2 15.7 15.0 14.4 22.2 17.1 15.7 18.1 15.8 18.6 13.9 20.0 15.9 15.0 17.2 22.3 20.9 15.7 32.2 23.3 16.9 13.3 19.3 11.1 9.6 10.4 15.2 12.0 13.7 14.3 16.8 20.9 14.9 11.1 17.9 37.3 14.2 14.3 7.3 15.6 14.7 12.2 11.2 16.4 8.1 23.2 14.6 19.8 15.9 15.2 15.9 20.4 20.3 19.9 11.7 16.6 11.2 9.6 22.8 15.0 36.0 12.4 16.8 8.2 16.9 23.2 11.8 11.3 21.7 10.2 18.6 8.6 7.6 6.0 14.7 15.4 10.4 9.8 11.0 12.7 13.4 8.2 22.7 27.5 17.3 8.9 43.2 14.8 21.2 12.1 17.0 15.7 20.9 23.3 12.2 20.9 17.2 17.3 22.1 17.1 15.6 17.4 20.9 6.6 32.2 10.3 22.3 20.8 16.9 15.1 21.5 15.2 27.7 15.2 13.6 19.5 20.7 17.3 18.1 6.0 6.1 15.2 11.6 12.4 3.2 4.2 2.5 8.1 5.7 7.0 0.0 40.0 11.6 8.1 1.7 7.0 7.0 0.0 6.6 16.5 11.8 8.6 13.9 5.1 11.3 0.0 12.6 11.1 5.6 1.9 6.4 9.4 23.6 38.7 7.5 7.0 7.2 5.8 12.7 14.0 2.1 12.9 15.0 10.0 10.4 14.3 76.4 15.2 6.0 18.5 CXorf49 ENSG00000215115 "Chromosome X open reading frame 49" A8MYA2 X 71714371-71718151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 5.8" "Cell type enriched" "Detected in single" 12 "Alveolar cells type 1: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "A-431: 14.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 CXorf49B ENSG00000215113 "Chromosome X open reading frame 49B" A8MYA2 X 71763424-71767204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "A-431: 14.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 CXorf58 FLJ25444 ENSG00000165182 "Chromosome X open reading frame 58" Q96LI9 X 23907801-23939507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 18.3;Spermatocytes: 20.0;Spermatogonia: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "monocytes: 1.0;T-cells: 1.8" "Cell line enhanced" "Detected in some" "GAMG: 4.4;PC-3: 2.0;U-266/70: 1.9" "HPA031542, HPA031543, HPA031544" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929" "unprognostic (9.74e-2)" "unprognostic (9.17e-3)" "unprognostic (2.52e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-2)" "unprognostic (1.24e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-2)" "unprognostic (1.43e-1)" "unprognostic (4.14e-3)" "unprognostic (8.19e-2)" "unprognostic (3.82e-2)" "unprognostic (1.10e-1)" "unprognostic (3.21e-2)" "unprognostic (7.39e-2)" "unprognostic (5.06e-3)" 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.2 0.2 0.3 0.6 0.2 0.1 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 8.4 0.6 0.0 0.2 0.0 0.1 0.2 0.1 1.0 0.0 1.8 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.1 0.0 0.8 1.0 0.2 0.0 4.4 0.5 0.1 0.7 0.0 0.4 0.5 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.7 0.6 0.5 0.0 0.0 1.6 0.3 0.2 0.1 0.1 0.1 0.8 0.0 0.1 2.0 0.4 0.0 0.1 1.0 0.0 0.9 0.1 0.5 0.1 0.4 0.1 1.1 0.1 0.4 0.0 0.0 0.2 0.3 1.9 0.9 0.2 0.2 0.1 0.3 0.0 0.0 0.1 0.3 1.0 1.4 0.1 1.3 1.0 0.0 0.1 1.0 0.7 0.0 0.0 0.2 0.2 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 4.0 0.0 0.0 0.0 0.1 1.7 0.0 18.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.0 0.0 2.3 0.0 0.0 20.0 5.2 0.0 0.1 0.0 0.0 0.0 CXorf66 "RP11-35F15.2, SGPX" ENSG00000203933 "Chromosome X open reading frame 66" Q5JRM2 X 139955725-139965520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 17.8" "Cell type enriched" "Detected in some" 12 "Early spermatids: 95.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.87e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 CYB561D1 "FLJ39035, FLJ44753" ENSG00000174151 "Cytochrome b561 family member D1" Q8N8Q1 1 109494052-109502932 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027028 Uncertain NA NA "HPA027028: AB_1847365" "unprognostic (2.15e-2)" "unprognostic (3.49e-1)" "unprognostic (1.04e-2)" "unprognostic (1.98e-1)" "unprognostic (2.27e-1)" "prognostic favorable (4.68e-4)" "unprognostic (4.53e-4)" "unprognostic (1.32e-1)" "unprognostic (3.45e-1)" "unprognostic (5.29e-2)" "prognostic favorable (5.16e-6)" "unprognostic (4.30e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.20e-3)" "unprognostic (2.75e-1)" "unprognostic (4.95e-3)" "unprognostic (5.82e-2)" 6.1 10.5 8.7 10.7 12.0 9.1 7.0 21.7 13.4 4.2 8.4 7.9 13.4 7.1 6.9 14.8 9.3 7.0 6.7 4.6 9.6 5.6 8.2 4.2 7.4 12.8 9.7 10.2 9.4 19.4 11.1 11.2 7.0 8.8 6.8 7.7 4.6 10.8 8.4 7.8 22.5 12.2 6.8 7.8 12.1 9.0 3.9 11.1 10.6 10.3 6.6 12.8 7.0 12.2 4.5 3.0 10.8 4.5 8.7 8.3 3.5 8.3 5.0 3.6 4.2 12.6 9.3 9.3 7.3 5.7 8.4 6.0 4.9 3.8 7.6 7.9 9.4 5.5 9.7 4.8 6.0 5.5 6.2 4.4 5.1 6.8 3.8 5.9 10.3 16.0 9.9 15.0 8.3 4.4 5.3 6.0 7.5 3.2 3.5 5.4 10.6 3.7 5.5 1.7 6.4 7.7 6.1 14.8 3.0 7.7 14.3 5.4 4.7 8.3 8.2 7.7 5.3 5.6 5.6 7.8 8.4 9.9 11.3 5.9 4.0 2.9 3.8 8.5 8.6 9.2 3.8 3.8 5.6 6.3 4.2 5.5 3.5 6.6 5.6 2.7 4.5 8.3 5.8 10.8 8.7 4.5 3.0 4.7 3.5 8.7 12.0 21.7 13.4 9.6 5.6 9.7 10.2 8.8 11.1 0.0 6.6 4.9 1.5 2.1 7.6 3.4 5.1 2.7 3.4 3.5 2.0 2.2 0.0 2.8 0.0 2.1 7.4 0.0 6.9 1.0 2.1 1.5 1.1 1.8 1.1 3.2 4.1 1.3 3.8 0.0 2.3 2.3 1.7 1.0 2.7 2.4 4.5 0.0 3.9 2.3 5.5 0.0 2.8 1.1 1.5 2.6 0.9 6.9 3.4 2.3 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 56.2;Early spermatids: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 14.0 13.0 13.2 5.5 22.5 7.2 13.1 14.1 16.8 10.5 7.9 14.0 12.8 6.5 10.9 17.0 7.9 28.2 9.4 13.9 14.4 12.0 19.2 13.0 8.8 4.7 9.4 13.5 14.6 13.1 9.7 18.1 7.0 16.5 11.0 7.8 11.7 10.5 13.2 9.9 10.1 6.0 9.4 6.5 5.9 8.4 14.5 11.7 6.9 22.8 8.6 5.6 7.4 7.5 3.4 3.1 2.7 2.3 1.6 5.9 1.8 16.1 12.0 5.8 15.4 10.4 9.3 3.5 8.3 8.3 9.0 8.6 7.6 3.1 7.0 5.9 6.7 5.3 14.5 12.8 10.9 13.5 4.6 14.7 4.6 15.7 10.8 4.7 8.1 3.3 7.8 13.8 15.6 14.1 5.5 9.5 17.1 3.3 4.8 4.9 7.0 12.6 3.3 7.3 10.5 12.5 8.7 2.7 7.0 14.1 3.1 7.9 5.3 13.2 7.4 7.6 6.2 8.7 3.3 6.6 7.0 6.1 12.2 10.5 2.5 6.1 3.9 14.5 4.5 4.4 0.5 2.3 0.1 2.7 1.9 3.3 3.4 2.4 1.4 3.1 1.5 5.9 3.1 2.7 1.6 1.1 1.4 2.2 1.8 13.2 22.5 14.1 16.8 14.4 12.0 9.4 13.5 16.5 11.7 11.9 24.5 1.9 4.1 4.5 4.2 0.2 10.2 56.2 15.9 5.2 19.6 3.6 11.6 3.6 65.5 6.8 5.1 0.0 2.7 2.1 5.3 8.0 10.4 7.6 3.4 1.6 5.8 6.2 1.0 34.0 4.4 4.0 5.0 0.0 7.5 6.8 5.2 3.5 3.5 9.6 18.0 6.5 3.8 2.8 2.5 5.4 2.2 1.3 7.6 1.6 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011032, HPA042299" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted - unknown location" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA011032: , HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favorable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favorable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favorable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 13.1 17.3 18.7 5.1 26.4 3.6 15.0 20.6 27.5 15.0 8.1 21.8 14.6 13.3 13.9 27.1 9.8 17.4 14.5 10.3 17.8 21.6 22.9 25.3 8.6 7.4 19.7 26.1 19.5 17.0 28.5 18.5 9.9 19.1 12.0 6.8 17.3 17.5 16.8 12.2 11.7 10.3 7.8 21.7 7.9 12.3 54.1 17.1 4.8 20.6 7.1 6.8 12.0 8.6 9.4 13.0 14.7 12.7 5.9 12.5 9.0 7.9 10.7 6.2 6.5 40.1 11.8 2.6 7.7 16.7 5.7 5.8 3.1 5.3 2.6 7.0 8.9 4.8 11.3 2.6 3.6 2.3 8.5 12.9 2.4 6.7 5.3 7.3 1.0 4.9 15.4 8.6 3.1 6.2 11.9 10.2 5.8 2.5 15.8 4.3 9.8 3.7 1.6 2.2 6.8 5.8 4.5 5.5 6.3 13.1 4.2 5.0 4.2 8.7 5.1 11.4 7.2 13.5 1.6 13.7 8.3 2.1 7.6 4.0 3.0 2.3 2.0 10.2 2.2 3.2 0.6 12.7 14.7 7.2 10.4 8.1 9.4 11.4 8.8 12.0 9.4 10.8 9.7 11.7 5.9 9.4 13.0 12.5 9.0 18.7 26.4 20.6 27.5 17.8 21.6 19.7 26.1 19.1 17.1 11.9 9.3 19.5 18.9 47.7 26.3 8.5 56.0 45.5 11.4 29.6 55.0 44.7 44.7 26.6 19.7 31.6 18.6 0.0 23.9 24.3 20.3 8.4 10.5 31.1 17.8 38.1 13.3 29.4 21.3 23.3 26.7 17.5 13.5 14.4 13.8 34.2 24.3 17.3 26.9 34.9 30.0 0.0 21.2 83.1 23.6 37.5 32.3 15.2 15.8 7.8 CYB5RL LOC606495 ENSG00000215883 "Cytochrome b5 reductase like" Q6IPT4 1 54169651-54200036 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 9.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042671, HPA060463" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042671: AB_2678107, HPA060463: AB_2684286" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-2)" "unprognostic (1.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-3)" "unprognostic (1.90e-4)" "unprognostic (6.45e-3)" "unprognostic (9.75e-2)" "unprognostic (2.04e-1)" "unprognostic (5.93e-2)" "unprognostic (2.58e-1)" "unprognostic (2.35e-1)" "unprognostic (1.80e-2)" "unprognostic (5.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.86e-1)" 1.7 4.9 1.9 0.8 1.9 1.6 2.4 1.3 1.7 2.5 2.2 2.6 2.5 2.3 2.1 2.9 2.0 3.5 2.1 1.7 2.7 2.6 1.5 2.1 2.3 5.0 4.1 1.8 4.2 1.1 2.1 2.7 3.2 1.4 3.7 3.9 1.5 2.4 1.8 2.5 2.8 1.2 3.1 2.2 2.8 1.8 1.4 1.8 2.6 3.5 3.1 1.5 1.2 3.9 5.3 7.3 7.5 5.9 5.7 2.5 3.1 4.5 6.1 6.6 4.9 4.3 6.6 3.7 2.1 13.9 3.6 11.3 3.3 6.9 7.4 4.6 7.5 8.5 5.0 4.4 6.3 3.8 3.0 4.4 7.2 3.3 4.3 5.3 6.0 8.0 3.1 4.4 4.8 6.3 3.5 7.2 4.5 4.2 10.2 8.9 6.0 2.7 4.5 10.7 5.3 2.1 7.2 6.3 6.1 5.0 4.9 2.4 4.7 3.8 6.9 5.5 4.7 7.5 9.7 5.2 13.6 7.1 2.2 1.8 1.6 1.0 3.5 0.8 1.1 1.5 0.6 1.6 1.4 1.2 1.2 2.6 3.1 0.8 1.8 0.5 1.2 0.0 7.4 0.9 1.0 0.1 3.7 4.2 0.0 9.4 4.5 3.5 3.9 1.5 6.6 2.4 0.0 3.6 0.9 0.0 3.6 1.7 1.5 1.1 2.3 2.1 4.6 0.0 2.4 3.1 1.0 0.6 1.4 1.4 0.0 1.0 0.7 2.0 1.3 0.0 1.8 2.2 3.1 0.0 1.4 0.9 5.3 0.6 0.2 0.5 2.4 0.8 CYLC1 ENSG00000183035 "Cylicin 1" P35663 X 83861126-83886699 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 24.4" "Group enriched" "Detected in some" 197 "Early spermatids: 395.0;Late spermatids: 1009.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070355 Enhanced NA NA "HPA070355: AB_2686261" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 395.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1009.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 CYLC2 ENSG00000155833 "Cylicin 2" Q14093 9 102995311-103018488 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 61 "testis: 34.0" "Group enriched" "Detected in some" 177 "Early spermatids: 1820.7;Late spermatids: 2014.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.1" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 1.1 0.4 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.4 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.9 0.5 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1820.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2014.1 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 10.8 4.2 0.0 0.0 0.0 0.0 0.0 CYP26C1 ENSG00000187553 "Cytochrome P450 family 26 subfamily C member 1" Q6V0L0 10 93060808-93069536 "Disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.3;lymphoid tissue: 2.0;testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SiHa: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.39e-2)" "unprognostic (3.41e-2)" "unprognostic (3.88e-1)" "unprognostic (5.05e-2)" "unprognostic (3.25e-2)" "unprognostic (3.43e-2)" "unprognostic (4.97e-2)" "unprognostic (1.70e-1)" "unprognostic (8.85e-2)" "unprognostic (5.29e-2)" "unprognostic (2.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-2)" "unprognostic (1.74e-4)" "unprognostic (8.59e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" 0.1 1.3 0.2 0.1 0.1 0.0 0.1 0.1 0.8 0.3 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 2.0 0.1 1.8 0.1 1.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 CYP2A7 CYP2A ENSG00000198077 "Cytochrome P450 family 2 subfamily A member 7" P20853 19 40875439-40882752 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "liver: 53.7" "Cell type enhanced" "Detected in some" 29 "Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7" "Group enriched" "Detected in some" 238 "breast cancer: 9.2;liver cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 2.0" "CAB033510, HPA046713, HPA047262" Enhanced "Intracellular and membrane" NA NA "CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (2.65e-3)" "unprognostic (8.89e-2)" "unprognostic (1.39e-2)" "unprognostic (3.95e-1)" "unprognostic (9.21e-2)" "unprognostic (8.71e-2)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 29.0 0.0 0.0 0.0 12.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 CYP39A1 ENSG00000146233 "Cytochrome P450 family 39 subfamily A member 1" Q9NYL5 6 46549580-46652830 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.2" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 58.9" "Cancer enhanced" "Detected in many" "prostate cancer: 11.9" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 6.9;hTCEpi: 15.5;OE19: 6.7;SiHa: 9.3;U-698: 10.9" "Region enhanced" "Detected in many" "olfactory region: 24.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-1)" "unprognostic (1.62e-2)" "unprognostic (8.46e-3)" "unprognostic (5.89e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (4.99e-2)" "unprognostic (7.33e-2)" "unprognostic (6.11e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.54e-1)" "unprognostic (5.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" 2.6 2.0 1.7 2.9 1.9 0.0 2.9 19.3 1.9 3.6 1.9 1.5 6.4 0.4 1.9 12.0 4.9 2.3 3.4 4.8 1.6 1.1 3.3 52.2 2.6 0.2 2.3 0.9 6.5 8.7 8.6 8.3 0.2 2.3 8.2 1.9 8.0 21.0 1.8 0.5 8.5 1.4 1.7 2.2 0.6 2.7 3.3 0.9 0.0 9.4 2.3 2.1 2.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 2.0 0.3 0.0 0.0 0.0 1.2 0.4 0.1 0.0 0.6 6.9 5.0 0.0 1.0 1.9 0.9 1.6 0.0 0.0 3.0 0.0 1.8 2.0 4.7 0.0 0.0 0.5 15.5 0.0 1.8 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.7 1.7 0.5 1.3 0.1 3.3 4.4 0.8 0.0 9.3 0.0 0.2 0.5 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 19.3 1.9 1.6 1.1 2.3 0.9 2.3 0.9 14.9 1.0 0.0 7.1 3.5 0.2 4.6 10.2 8.1 4.5 3.5 2.0 0.0 5.0 1.6 11.8 2.3 0.5 0.0 0.3 0.9 1.7 12.3 0.0 58.9 0.2 0.0 0.0 0.0 1.9 15.3 5.8 0.2 3.3 0.0 3.1 8.0 0.9 2.9 8.9 4.1 1.5 0.0 2.1 0.7 0.1 13.4 0.0 0.0 2.3 6.0 CYP4F22 FLJ39501 ENSG00000171954 "Cytochrome P450 family 4 subfamily F member 22" Q6NT55 19 15508493-15552317 "Disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" Ichthyosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 44.6;skin 1: 29.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.9;granulocytes: 6.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 2.6" "Group enriched" "Detected in many" 7 "breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2" "Group enriched" "Detected in many" 9 "monocytes: 13.2;T-cells: 4.6" "Cell line enhanced" "Detected in some" "HEL: 1.3;JURKAT: 2.8;MCF7: 5.1;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA058960 Uncertain NA NA "HPA058960: AB_2683862" "unprognostic (2.32e-3)" "unprognostic (1.17e-2)" "unprognostic (6.81e-2)" "unprognostic (2.47e-2)" "unprognostic (1.03e-1)" "unprognostic (7.02e-2)" "unprognostic (1.30e-1)" "unprognostic (2.43e-1)" "unprognostic (3.33e-1)" "unprognostic (1.89e-2)" "unprognostic (9.33e-2)" "unprognostic (3.00e-2)" "unprognostic (2.21e-5)" "unprognostic (8.10e-2)" "unprognostic (3.16e-1)" "unprognostic (7.25e-3)" "unprognostic (2.03e-2)" 0.5 0.0 0.0 0.1 0.0 0.1 3.6 0.0 0.0 5.4 0.1 0.0 10.3 0.2 0.6 0.2 12.1 0.1 0.6 0.0 0.0 0.0 0.0 19.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.2 0.0 0.0 1.6 44.6 1.2 29.0 0.1 1.0 0.0 0.3 0.5 0.7 0.0 0.4 0.0 14.7 6.7 5.5 10.3 0.0 0.2 0.0 13.2 1.0 4.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.8 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.8 6.1 4.6 0.0 0.6 1.5 0.2 0.0 0.0 0.4 0.0 1.0 13.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.9 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.0 0.9 0.0 0.2 CYP4X1 MGC40051 ENSG00000186377 "Cytochrome P450 family 4 subfamily X member 1" Q8N118 1 47023568-47050751 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 38.1" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5" "Low region specificity" "Detected in all" HPA017661 Approved NA NA "HPA017661: AB_2669633" "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (1.78e-2)" "unprognostic (9.88e-2)" "unprognostic (1.56e-3)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (2.76e-2)" "unprognostic (3.03e-2)" "unprognostic (1.79e-3)" "unprognostic (3.65e-2)" "unprognostic (8.56e-2)" "unprognostic (5.03e-2)" 7.9 3.6 9.0 1.1 14.9 0.5 16.0 7.1 16.9 38.1 2.0 1.6 2.5 2.1 3.6 3.2 12.0 9.7 2.0 6.7 4.8 10.6 6.3 10.0 8.9 2.0 3.3 13.5 1.7 2.0 2.0 4.1 1.5 7.8 8.0 2.3 17.6 23.7 3.4 4.5 5.0 1.8 2.4 2.0 1.0 14.3 4.2 0.9 0.0 4.0 6.9 8.8 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.9 1.0 0.0 0.0 0.5 0.0 0.6 0.2 3.8 0.0 0.0 0.3 0.0 0.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 14.9 7.1 16.9 4.8 10.6 3.3 13.5 7.8 0.9 20.8 10.5 0.0 23.5 2.3 0.9 1.0 0.0 156.6 27.3 0.0 0.0 0.0 0.0 0.3 6.0 2.3 0.0 0.0 0.6 0.0 1.9 10.7 0.0 2.5 2.9 0.0 0.0 0.6 0.3 5.6 9.8 0.6 5.0 0.0 0.0 0.0 0.2 0.0 19.4 1.3 0.7 0.0 14.5 0.0 1.5 1.3 0.1 0.0 0.6 26.2 CYP4Z1 CYP4A20 ENSG00000186160 "Cytochrome P450 family 4 subfamily Z member 1" Q86W10 1 47067488-47118319 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "breast: 23.1" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9" "Cancer enriched" "Detected in some" 50 "breast cancer: 42.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 39 "HDLM-2: 13.7;SK-BR-3: 5.9" NA NA "unprognostic (4.11e-2)" "unprognostic (2.57e-2)" "unprognostic (2.46e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (4.33e-4)" "unprognostic (1.10e-1)" "unprognostic (3.53e-3)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (6.82e-3)" "unprognostic (5.09e-3)" "unprognostic (3.88e-2)" "unprognostic (6.46e-2)" "unprognostic (3.49e-3)" 2.5 0.2 0.4 0.4 0.9 0.0 23.1 0.4 2.0 1.0 0.4 0.4 0.4 0.0 0.4 0.8 0.8 0.7 0.4 0.4 0.4 1.8 0.4 1.5 2.1 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.7 1.3 0.0 0.4 1.5 0.8 0.5 2.2 0.4 0.4 0.4 0.4 0.2 1.0 0.4 0.6 0.4 0.4 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 2.0 0.4 1.8 0.4 0.4 0.7 0.4 8.9 0.6 0.0 0.4 0.1 0.0 0.2 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.7;Ito cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Cell line enhanced" "Detected in some" "AF22: 9.0;NTERA-2: 25.2;PC-3: 6.9;RH-30: 10.7;SCLC-21H: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034921: AB_2089315, HPA067685: AB_2685887" "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 3.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.2 0.0 6.9 0.0 10.7 0.0 1.0 0.0 21.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 0.0 1.1 0.9 1.1 10.4 0.0 5.6 0.0 1.4 2.3 14.0 0.0 0.1 3.3 0.0 0.6 113.7 0.0 0.0 0.0 0.2 6.1 0.4 0.0 0.0 0.3 0.0 0.0 60.8 2.7 0.9 2.0 1.2 6.8 1.0 0.0 0.5 0.1 0.0 0.0 2.6 0.0 0.0 3.3 0.2 1.1 4.6 0.2 0.0 0.0 0.7 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148458-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;epididymis: 9.3;fallopian tube: 8.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 3.2;Muller glia cells: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HAP1: 11.5" "Low region specificity" "Detected in some" "HPA000258, HPA001367" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.9 0.9 7.9 0.6 29.5 0.6 0.6 0.2 17.8 1.0 0.8 0.3 0.0 1.2 1.2 9.3 0.7 8.0 0.6 0.6 13.5 10.8 2.4 0.6 0.9 0.6 3.4 10.4 1.4 1.1 0.7 1.3 0.6 11.8 1.5 0.7 1.6 0.7 0.8 0.6 0.7 1.3 0.8 0.7 0.6 1.4 0.7 1.7 0.0 0.7 0.0 0.6 1.4 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 29.5 0.2 16.8 13.5 10.8 3.4 10.4 11.8 1.7 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DACT2 "bA503C24.7, C6orf116, DAPPER2" ENSG00000164488 "Dishevelled binding antagonist of beta catenin 2" Q5SW24 6 168292830-168319754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 14.2;placenta: 54.8" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 180.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Region enriched" "Detected in many" 8 "basal ganglia: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5" "Low region specificity" "Detected in many" HPA030251 Enhanced Supported NA NA "HPA030251: AB_10611108" "unprognostic (5.22e-6)" "unprognostic (3.13e-2)" "unprognostic (1.04e-2)" "prognostic favorable (1.07e-5)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (4.04e-1)" "unprognostic (1.31e-1)" "unprognostic (7.05e-3)" "unprognostic (2.48e-1)" "prognostic favorable (5.76e-5)" "unprognostic (1.51e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-4)" "unprognostic (4.23e-2)" 1.0 1.3 0.5 0.4 14.2 0.0 0.4 1.5 1.4 2.3 1.1 1.2 1.0 0.9 3.7 2.2 0.7 2.2 2.9 2.7 0.9 0.5 2.2 2.4 2.0 0.4 1.1 0.9 0.9 1.6 0.0 0.4 54.8 1.7 6.1 0.4 1.6 5.3 0.5 0.4 5.6 0.8 0.8 0.7 0.4 0.5 1.0 0.7 0.9 0.4 0.4 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 15.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 14.2 1.5 1.4 0.9 0.5 1.1 0.9 1.7 0.7 0.0 1.3 0.0 1.8 2.7 9.8 0.5 2.5 0.0 2.3 1.8 0.0 38.3 0.0 1.5 0.0 0.1 0.0 0.0 0.2 4.7 1.1 0.8 0.0 0.0 4.6 0.0 5.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.1 22.6 0.4 0.0 0.0 4.9 0.7 0.0 0.0 0.0 0.0 1.3 180.9 0.0 1.8 0.0 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974762 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;heart muscle: 13.7" "Cell type enriched" "Detected in single" 29 "Cardiomyocytes: 13.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.2 2.0 0.9 0.9 2.5 3.0 0.4 1.4 1.4 0.2 3.6 2.1 0.0 0.4 0.4 0.4 0.3 0.1 0.7 13.7 0.4 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.4 0.4 0.4 0.2 0.0 3.8 0.2 0.5 3.6 2.6 0.0 0.2 0.7 2.5 0.4 1.6 0.1 0.7 0.8 0.3 0.0 0.5 0.0 0.0 0.3 0.2 1.6 1.4 5.3 0.6 1.4 1.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.7 0.3 0.0 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.1 0.8 0.4 1.3 0.0 0.5 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.2 0.1 1.1 21.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.1 2.7 0.6 1.3 0.7 0.4 0.6 0.9 0.4 0.4 0.2 1.6 0.7 1.2 5.3 1.4 0.3 1.4 0.2 0.3 0.9 2.5 1.4 0.8 0.4 0.3 0.5 0.0 3.8 0.3 0.0 0.0 0.0 0.2 0.1 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 DBX2 FLJ16139 ENSG00000185610 "Developing brain homeobox 2" Q6ZNG2 12 45014672-45051099 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 32 "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 1.2;HeLa: 1.7;SCLC-21H: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066053 Uncertain NA NA "HPA066053: AB_2685605" "unprognostic (1.13e-4)" "unprognostic (9.99e-2)" "unprognostic (7.82e-3)" "unprognostic (5.24e-2)" "unprognostic (5.62e-2)" "unprognostic (1.51e-1)" "unprognostic (9.22e-2)" "unprognostic (4.76e-2)" "unprognostic (1.64e-1)" "unprognostic (5.19e-1)" 2.0 0.5 4.4 0.5 3.6 0.5 1.8 1.2 10.7 0.9 0.5 5.1 0.2 0.4 0.5 0.4 0.6 0.6 0.7 0.9 4.4 4.6 1.1 0.4 0.5 0.5 5.9 3.1 0.4 0.4 0.5 0.0 0.4 10.3 0.7 0.5 0.0 0.8 0.7 0.7 2.1 0.4 0.5 10.3 0.4 0.5 2.9 1.8 0.0 0.7 1.3 0.6 0.6 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 3.6 1.2 4.6 4.4 4.6 5.9 3.1 10.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 15.7;epididymis: 53.6;testis: 15.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HAP1: 5.9;NTERA-2: 4.9;U-2 OS: 8.1" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 1.1 1.2 1.1 0.1 1.9 0.1 2.3 0.5 2.1 1.9 0.9 0.0 15.7 0.1 2.4 53.6 0.5 3.0 0.2 0.4 1.0 3.9 0.4 0.1 0.2 0.2 1.0 1.7 1.9 0.2 2.4 1.3 0.1 1.3 2.0 0.2 0.2 0.6 5.6 0.4 0.5 0.5 2.0 0.8 0.2 0.7 15.8 0.1 0.0 0.4 0.0 0.3 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.5 2.1 1.0 3.9 1.0 1.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAF4L1 WDR21B ENSG00000182308 "DDB1 and CUL4 associated factor 4 like 1" Q3SXM0 4 41981696-41986467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 37.5" "Group enriched" "Detected in some" 5 "Spermatocytes: 81.2;Spermatogonia: 91.3" "Cancer enriched" "Detected in single" 49 "testis cancer: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "REH: 3.6" CAB073535 Enhanced NA NA "CAB073535: " "unprognostic (6.24e-2)" "unprognostic (7.52e-3)" "unprognostic (8.11e-3)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (9.63e-3)" "unprognostic (4.64e-4)" "unprognostic (1.62e-1)" "unprognostic (1.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.83e-2)" "unprognostic (4.03e-1)" "unprognostic (3.76e-3)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-4)" 0.1 0.1 0.1 0.2 0.2 0.1 1.1 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.1 0.5 0.0 37.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 1.4 0.3 0.0 0.4 0.0 0.1 0.2 0.3 2.4 0.1 0.1 1.5 0.4 0.1 0.3 0.2 0.3 0.8 0.6 0.3 0.1 0.3 0.8 2.0 0.2 0.6 0.2 0.8 2.1 2.0 0.4 0.2 2.3 1.3 0.1 2.2 0.6 0.3 0.0 0.0 0.7 1.0 0.0 0.2 0.1 0.8 2.9 0.3 0.4 0.6 3.6 0.4 0.6 0.2 0.4 0.7 0.7 0.2 0.1 0.3 0.4 0.2 0.2 0.4 0.3 2.1 0.6 2.1 0.9 2.8 0.3 0.3 2.0 1.0 0.9 0.3 0.1 0.3 0.2 0.0 0.3 0.4 0.2 0.1 0.6 0.0 0.4 1.4 0.0 0.3 0.3 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.3 1.3 0.9 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 17.6 0.7 0.0 0.0 0.5 0.2 0.4 1.2 0.0 0.8 0.3 0.0 0.0 0.0 2.6 5.4 1.1 0.1 3.3 1.0 0.0 0.0 0.6 0.0 0.4 0.0 1.3 0.0 0.0 81.2 91.3 0.6 0.5 0.0 0.4 0.1 DCAF8L1 WDR42B ENSG00000226372 "DDB1 and CUL4 associated factor 8 like 1" A6NGE4 X 27977993-27981449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 8.4" "Group enriched" "Detected in some" 14 "Spermatocytes: 2.8;Spermatogonia: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "Karpas-707: 20.8" HPA043787 Enhanced NA NA "HPA043787: AB_10961430" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 5.3 0.0 0.0 0.0 0.0 0.0 DCAF8L2 WDR42C ENSG00000189186 "DDB1 and CUL4 associated factor 8 like 2" P0C7V8 X 27590382-27748821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 35.0" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 14.9" NA NA "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 DCDC1 ENSG00000170959 "Doublecortin domain containing 1" P59894 11 30830369-31369810 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.2;pituitary gland: 26.7" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 56.2;Cone photoreceptor cells: 19.6;Early spermatids: 31.2;Rod photoreceptor cells: 20.7;Spermatocytes: 15.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basal ganglia: 5.6;pons and medulla: 19.2" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.8;U-266/70: 5.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.6 0.6 1.0 0.1 5.6 0.2 1.0 0.4 1.0 1.3 0.5 2.7 3.3 0.1 1.3 13.3 0.4 9.9 4.3 0.5 1.9 1.6 3.4 6.4 4.8 0.2 0.6 0.2 4.2 2.4 3.9 26.7 0.2 19.2 0.6 0.2 2.8 0.7 2.0 0.4 0.5 0.4 0.2 0.6 0.4 0.5 11.5 1.1 0.0 2.8 0.0 0.2 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.9 0.0 0.2 1.1 0.8 0.6 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.0 1.0 0.4 0.1 0.1 1.0 0.4 0.6 0.0 0.1 1.5 0.0 0.2 0.3 0.7 0.0 0.3 0.3 0.3 0.0 1.0 0.3 0.1 0.2 0.1 0.2 0.0 1.4 0.4 0.0 0.0 0.3 0.0 2.8 0.0 0.8 0.1 1.4 0.0 0.1 0.2 0.2 0.0 0.1 0.5 0.8 1.1 0.2 5.5 0.3 0.2 1.2 0.0 0.3 1.4 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 5.6 0.4 1.0 1.9 1.6 0.6 0.2 19.2 1.1 0.0 1.0 0.0 0.1 0.2 1.9 0.8 0.0 56.2 6.8 0.0 19.6 0.0 0.0 0.6 31.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.4 0.1 0.0 0.0 0.0 0.6 13.2 1.4 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.4 1.0 20.7 0.0 0.0 15.2 3.7 0.0 0.0 0.0 0.0 0.0 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 8.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 24.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.4;SCLC-21H: 3.3;SH-SY5Y: 2.7;U-2 OS: 1.9;U-2197: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040685 Approved NA NA "HPA040685: AB_2732487" "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 1.1 0.4 2.6 1.4 10.0 0.3 0.1 0.1 2.3 0.5 0.2 0.3 0.0 0.5 0.3 0.1 0.1 0.2 0.6 0.9 1.4 0.9 0.0 0.1 0.3 0.2 0.6 0.0 0.0 0.2 0.4 1.8 1.1 0.4 0.3 0.3 1.3 1.7 0.2 2.7 0.4 0.4 0.9 0.7 0.1 0.0 8.0 3.2 0.0 0.9 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 2.7 0.1 0.3 0.0 0.2 0.0 0.4 0.3 0.0 1.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 10.0 0.1 2.3 1.4 0.9 0.6 0.0 0.4 3.2 0.0 0.0 0.0 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 DCST2 FLJ32934 ENSG00000163354 "DC-STAMP domain containing 2" Q5T1A1 1 155018520-155033781 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.6;testis: 20.8" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 15.7;Early spermatids: 43.0;Late spermatids: 21.0;Rod photoreceptor cells: 17.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;Karpas-707: 3.7;U-266/70: 4.9" "Low region specificity" "Detected in some" NA NA "unprognostic (8.08e-2)" "unprognostic (5.67e-2)" "unprognostic (6.04e-4)" "unprognostic (1.63e-2)" "unprognostic (3.34e-2)" "unprognostic (1.88e-3)" "unprognostic (8.25e-2)" "unprognostic (2.65e-2)" "unprognostic (2.94e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (8.92e-2)" "unprognostic (2.78e-10)" "unprognostic (6.95e-3)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-3)" 0.8 0.2 0.5 0.5 0.5 0.1 2.2 0.7 0.5 1.8 0.6 0.5 0.5 2.5 0.7 0.5 1.2 1.5 0.5 0.5 0.5 0.1 0.5 0.8 0.5 0.5 0.5 0.5 0.8 0.5 0.0 0.5 0.5 0.5 1.9 0.7 5.3 3.0 1.2 0.5 8.6 1.5 0.5 0.5 0.5 0.6 20.8 0.5 0.5 0.7 0.5 0.5 0.5 2.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.4 1.2 1.6 0.9 0.8 0.9 0.1 0.5 0.3 0.0 0.0 1.2 0.2 1.0 0.2 0.3 3.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.2 0.1 0.9 2.2 0.1 0.4 0.5 0.0 0.1 0.1 3.7 0.0 1.1 0.0 0.1 0.2 1.3 0.2 0.3 0.1 1.3 0.4 0.1 0.6 0.3 1.1 0.6 0.8 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.0 4.9 1.9 0.0 0.0 0.4 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.5 0.5 0.1 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.8 0.8 1.1 0.4 0.0 0.0 0.0 0.0 15.7 0.3 0.0 0.0 43.0 0.1 1.1 0.0 0.2 9.8 0.2 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.7 0.5 17.6 0.0 0.8 2.6 1.6 1.1 0.7 0.0 0.6 0.4 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.6;testis: 16.3" "Cell type enhanced" "Detected in some" 12 "Kupffer cells: 5.3;Spermatocytes: 12.0;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 1.3 1.0 0.8 6.1 0.8 7.0 1.7 0.8 1.2 1.9 2.3 1.2 0.2 1.3 1.5 2.6 5.5 1.0 0.4 2.6 0.9 0.7 1.0 2.3 3.1 5.0 0.8 0.6 1.3 0.9 0.0 0.5 2.5 1.0 0.9 2.0 0.2 2.1 0.2 10.1 2.3 1.9 1.5 0.9 5.5 1.1 16.3 0.9 17.6 0.8 9.5 5.9 1.8 1.8 2.0 4.5 5.8 10.7 1.9 0.7 3.2 6.0 9.6 9.9 7.2 1.0 1.5 7.3 11.5 4.9 12.8 14.9 9.4 7.6 7.4 17.3 2.6 10.1 11.6 16.7 7.2 17.7 13.4 9.0 10.5 4.9 4.2 0.1 12.9 9.3 0.3 0.7 16.1 7.4 1.1 6.0 9.2 10.6 12.8 11.3 8.8 12.1 10.5 11.8 16.7 11.0 9.0 19.2 9.5 2.7 10.1 7.4 10.0 7.1 7.2 2.7 10.1 7.8 5.4 2.8 12.8 17.4 33.7 14.0 7.3 19.1 25.7 4.0 9.3 12.1 0.6 10.7 3.9 0.5 8.3 0.3 1.1 0.3 0.7 4.5 2.0 0.7 0.4 5.8 1.9 7.8 1.4 0.5 3.2 0.8 0.8 0.8 1.2 0.9 0.7 0.8 0.6 1.0 0.9 0.0 0.0 4.6 0.8 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 1.4 0.0 0.5 2.7 0.0 0.0 0.0 0.5 4.3 0.0 0.3 0.0 0.5 2.2 0.0 0.0 1.3 5.3 1.6 0.3 1.6 0.0 0.0 0.2 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.3 12.0 15.1 0.0 0.2 0.0 0.6 0.9 DDO ENSG00000203797 "D-aspartate oxidase" Q99489 6 110391771-110415562 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.9;myeloid DC: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037525, HPA037526" Enhanced Enhanced Cytosol NA NA Cytosol "HPA037525: AB_2675523, HPA037526: AB_10672352" "unprognostic (1.37e-1)" "unprognostic (1.54e-1)" "unprognostic (6.51e-2)" "unprognostic (1.30e-2)" "unprognostic (2.00e-1)" "unprognostic (3.28e-2)" "unprognostic (3.71e-2)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.91e-1)" "unprognostic (6.97e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.69e-5)" "unprognostic (3.51e-4)" "unprognostic (3.36e-3)" "unprognostic (1.27e-3)" "unprognostic (9.06e-2)" 3.7 11.0 5.2 1.1 12.1 1.6 3.3 1.9 5.5 2.7 3.6 10.8 4.9 8.6 2.7 5.4 1.2 6.1 3.9 21.0 6.9 3.4 12.3 12.8 3.9 1.3 8.0 6.1 1.2 5.5 18.6 1.9 2.1 8.0 2.9 3.9 2.3 4.9 3.2 11.3 0.8 7.9 5.6 7.7 2.6 1.9 0.4 8.2 0.0 3.3 5.7 0.5 3.6 1.6 0.0 7.3 0.1 4.9 1.7 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.1 5.0 1.2 0.8 0.0 0.0 0.0 0.7 0.7 10.9 0.0 0.0 0.0 2.2 4.5 0.0 4.6 0.0 3.9 1.6 0.0 0.0 0.1 0.0 2.5 0.1 2.2 0.0 0.0 0.0 1.8 4.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.8 14.2 0.0 4.5 0.1 0.1 0.0 0.4 0.6 0.0 0.7 1.0 0.8 1.0 0.1 0.0 2.3 0.1 0.3 0.0 1.9 15.8 0.0 0.1 4.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 1.7 1.6 0.0 0.0 1.5 5.2 12.1 1.9 5.5 6.9 3.4 8.0 6.1 8.0 8.2 0.0 0.0 0.0 0.8 0.0 0.0 14.1 0.0 1.4 0.0 0.0 2.0 0.1 3.3 2.8 0.0 0.3 2.7 0.0 1.9 0.1 0.3 0.3 0.0 4.4 1.8 0.0 4.1 2.5 4.0 0.0 0.3 1.1 0.0 1.0 5.9 9.1 1.2 6.0 0.0 9.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.3 DDTL ENSG00000099974 "D-dopachrome tautomerase like" A6NHG4 22 23966901-23972532 "Predicted intracellular proteins" Lyase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 36.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 6.0;Cardiomyocytes: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA074115 Approved NA NA "HPA074115: " "unprognostic (6.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (6.34e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "prognostic favorable (5.98e-4)" "unprognostic (2.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-2)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (3.70e-2)" "unprognostic (3.58e-3)" 3.1 4.7 2.3 5.9 6.8 6.6 6.3 3.3 4.3 2.7 7.8 2.6 4.3 8.3 3.5 4.6 4.7 2.8 5.9 10.7 2.7 2.2 7.0 36.5 3.4 6.5 2.6 4.6 5.0 22.6 0.6 3.3 3.7 4.5 6.1 4.3 2.9 9.0 6.1 10.1 7.0 11.0 3.9 3.0 5.4 6.1 4.4 1.7 3.2 4.6 7.2 3.5 4.6 3.5 2.0 1.6 6.4 2.0 2.5 2.9 0.9 3.0 2.1 2.4 2.6 1.5 0.5 3.1 1.6 0.0 0.0 0.0 4.6 3.0 5.2 1.1 0.2 2.1 7.8 2.5 0.6 0.1 1.9 10.1 2.9 7.7 4.4 1.9 7.3 3.2 0.9 1.1 0.5 0.0 3.3 0.5 1.7 2.9 3.8 0.0 2.2 1.3 4.3 0.9 2.3 1.8 4.3 2.5 1.6 1.4 4.3 2.6 1.3 2.3 4.5 7.6 3.0 3.7 1.4 1.1 4.6 3.6 1.4 1.2 2.9 0.8 2.2 1.1 3.6 2.7 6.4 1.4 2.2 2.0 2.0 2.1 1.9 1.4 2.9 1.2 2.0 1.1 1.7 0.6 2.5 0.4 1.6 1.4 0.9 2.3 6.8 3.3 4.3 2.7 2.2 2.6 4.6 4.5 1.7 6.0 1.9 0.0 1.1 0.9 0.8 10.4 0.0 0.0 2.3 0.0 3.9 1.1 5.0 0.8 0.8 1.1 2.9 0.0 0.4 1.1 0.6 0.8 1.1 4.7 0.8 0.0 1.2 1.8 1.9 0.4 0.6 1.2 0.0 1.0 1.1 0.5 1.2 2.6 1.1 3.6 0.7 0.0 0.4 0.2 0.6 0.6 2.1 0.0 2.7 0.7 DDX43 "CT13, DKFZp434H2114, HAGE" ENSG00000080007 "DEAD-box helicase 43" Q9NXZ2 6 73394748-73417569 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 35.2" "Group enriched" "Detected in many" 6 "Spermatocytes: 50.6;Spermatogonia: 31.3" "Cancer enriched" "Detected in many" 15 "testis cancer: 13.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.0;CAPAN-2: 15.1;HHSteC: 4.2;MCF7: 2.8;U-2 OS: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA031381 Enhanced NA NA "HPA031381: AB_10601885" "unprognostic (4.03e-3)" "unprognostic (8.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (3.59e-4)" "unprognostic (1.64e-2)" "unprognostic (3.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (3.08e-1)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (2.68e-1)" "unprognostic (1.58e-1)" "unprognostic (8.78e-2)" 1.3 0.7 0.6 1.0 0.7 0.7 1.9 0.4 0.8 0.8 2.6 1.2 2.1 1.4 1.0 0.4 1.1 0.7 6.1 1.2 0.7 0.6 0.8 1.0 1.6 0.9 1.0 0.0 2.9 1.9 0.1 0.7 5.7 3.3 1.8 0.7 1.5 4.3 2.2 0.4 1.4 1.7 3.0 1.9 1.2 2.4 35.2 0.7 0.4 1.8 1.3 1.9 1.7 0.7 2.3 0.8 2.9 0.9 1.6 3.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.0 0.0 0.1 15.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 2.9 3.3 0.9 2.6 2.3 2.5 2.8 0.8 2.3 1.3 0.4 0.6 1.6 0.8 0.2 1.4 0.7 0.6 0.7 0.4 0.8 0.7 0.6 1.0 0.0 3.3 0.7 3.0 4.8 0.5 1.1 2.4 0.3 0.4 0.0 1.4 3.4 0.0 0.0 6.5 0.0 0.4 2.2 2.2 0.0 0.0 0.8 2.9 1.1 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.3 2.0 1.8 3.3 1.0 0.0 0.4 1.3 0.0 1.1 1.4 0.9 0.0 0.4 50.6 31.3 1.3 5.0 2.5 0.0 0.7 DDX60L FLJ31033 ENSG00000181381 "DExD/H-box 60 like" Q5H9U9 4 168356735-168537786 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.5" "Group enriched" "Detected in all" 4 "granulocytes: 22.5;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 23.3" "HPA043211, HPA055501" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043211: AB_10794390, HPA055501: AB_2682838" "unprognostic (8.86e-2)" "unprognostic (2.77e-1)" "unprognostic (1.16e-1)" "unprognostic (2.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.20e-2)" "unprognostic (1.05e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.13e-1)" "unprognostic (8.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.69e-1)" 12.7 5.0 2.8 13.1 3.1 33.0 9.9 1.4 3.2 7.2 8.4 3.2 2.7 6.0 9.2 7.9 3.8 6.9 6.7 6.0 2.4 2.4 4.5 6.0 25.8 17.7 3.8 1.4 7.3 5.1 4.4 5.2 32.6 3.4 5.0 6.5 6.8 7.0 5.7 3.3 4.3 14.0 5.3 4.2 11.9 9.5 2.7 3.1 25.3 5.8 3.5 8.1 4.9 6.8 1.6 2.4 22.5 7.8 1.7 3.7 1.6 6.1 3.6 1.4 0.6 3.7 10.8 7.0 6.2 13.1 23.3 16.2 0.0 14.5 0.1 0.3 6.3 12.7 2.4 0.6 3.7 6.8 3.5 0.5 13.6 4.0 0.3 4.5 5.5 3.4 3.0 1.1 8.4 0.7 4.9 16.4 3.1 0.2 0.1 14.9 0.1 4.9 3.5 0.3 0.6 3.1 2.7 3.2 0.0 2.2 3.6 0.2 1.9 11.0 1.3 6.2 0.2 1.0 7.8 17.5 1.2 8.2 2.9 2.1 5.9 0.9 0.0 4.1 16.5 1.8 1.6 4.0 3.5 2.7 6.3 3.7 0.9 2.7 2.7 2.4 1.6 2.2 2.3 22.5 1.7 7.8 0.0 3.6 1.6 2.8 3.1 1.4 3.2 2.4 2.4 3.8 1.4 3.4 3.1 8.9 7.9 0.0 2.1 0.9 1.3 8.1 5.1 12.0 3.4 3.5 21.6 4.5 0.0 6.8 10.7 13.1 11.6 0.0 8.7 29.4 7.0 2.6 8.1 5.4 22.5 0.0 0.0 9.2 23.2 3.6 3.1 29.7 0.0 26.2 13.2 3.2 17.0 14.0 3.9 3.3 16.8 6.5 3.3 0.5 1.3 2.0 5.9 8.7 3.8 1.4 DEC1 CTS9 ENSG00000173077 "Deleted in esophageal cancer 1" Q9P2X7 9 115141818-115402644 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 1.4;testis: 2.3" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 4.3;Intestinal endocrine cells: 1.7;Late spermatids: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;HeLa: 4.7;SuSa: 1.5;WM-115: 1.8" NA NA "unprognostic (9.06e-2)" "unprognostic (1.40e-1)" "unprognostic (3.28e-2)" "unprognostic (2.18e-2)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" "unprognostic (2.86e-1)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (4.77e-1)" "unprognostic (1.12e-1)" "unprognostic (1.66e-2)" "unprognostic (1.78e-5)" "unprognostic (1.75e-1)" "unprognostic (2.88e-2)" "unprognostic (3.74e-1)" "unprognostic (3.18e-3)" 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 1.4 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.3 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 DEFB105A "DEFB-5, DEFB105" ENSG00000186562 "Defensin beta 105A" Q8NG35 8 7821966-7823889 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 438 "epididymis: 227.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;GAMG: 1.3;NB-4: 12.8;SH-SY5Y: 2.6" "Secreted in male reproductive system" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 227.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105B ENSG00000186599 "Defensin beta 105B" Q8NG35 8 7487669-7489593 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 396 "epididymis: 150.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "NB-4: 2.2" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 150.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107A "DEFB-7, DEFB107" ENSG00000186572 "Defensin beta 107A" Q8IZN7 8 7811720-7815716 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 100 "epididymis: 77.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.8" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.3 77.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107B HsT21816 ENSG00000198129 "Defensin beta 107B" Q8IZN7 8 7495846-7509311 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 95 "epididymis: 78.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.8" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.3 78.7 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB108B ENSG00000184276 "Defensin beta 108B" Q8NET1 11 71833200-71837710 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "HaCaT: 2.8" HPA042588 Uncertain "Secreted - unknown location" NA NA "HPA042588: AB_10959523" 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB118 "C20orf63, DEFB-18, dJ1018D12.3, ESC42" ENSG00000131068 "Defensin beta 118" Q96PH6 20 31368618-31373923 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 147 "epididymis: 167.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.9;NB-4: 4.5;RPMI-8226: 1.6" HPA042634 Enhanced "Secreted in male reproductive system" NA NA "HPA042634: AB_10797505" "unprognostic (3.24e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 167.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB119 "DEFB-19, DEFB-20, DEFB120" ENSG00000180483 "Defensin beta 119" Q8N690 20 31377164-31390603 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 61 "epididymis: 218.6;testis: 126.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 32.4;Cone photoreceptor cells: 37.3;Early spermatids: 56.5;Late spermatids: 59.1;Rod photoreceptor cells: 148.5" "Cancer enriched" "Detected in single" 67 "testis cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.1;RPMI-8226: 3.2;SCLC-21H: 1.2;SH-SY5Y: 2.4" HPA043059 Supported "Secreted in male reproductive system" NA NA "HPA043059: AB_10797025" "unprognostic (2.03e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 218.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 126.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 1.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 56.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 59.1 11.5 0.0 0.0 0.0 0.0 16.4 0.0 0.0 6.0 0.0 148.5 12.9 0.0 7.7 7.7 0.0 0.0 0.0 0.0 0.0 DEFB123 DEFB-23 ENSG00000180424 "Defensin beta 123" Q8N688 20 31440519-31450257 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 403 "epididymis: 39.9;testis: 75.3" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 12.5;Late spermatids: 37.8;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 17 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;U-2197: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (9.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 3.6 3.9 0.0 0.0 0.0 0.0 0.0 DEFB125 DEFB-25 ENSG00000178591 "Defensin beta 125" Q8N687 20 87250-97094 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 13.6 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 DEFB129 "bA530N10.3, C20orf87, DEFB-29" ENSG00000125903 "Defensin beta 129" Q9H1M3 20 227258-229886 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "epididymis: 223.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;NB-4: 7.1;RPMI-8226: 1.6;SH-SY5Y: 3.5" "Not detected" "Not detected" HPA014581 Enhanced "Secreted in male reproductive system" NA NA "HPA014581: AB_2732410" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 14.0 0.0 0.2 223.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB130A "DEFB-30, DEFB130, DEFB30" ENSG00000232948 "Defensin beta 130A" P0DP74 8 12310962-12318316 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "epididymis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB130B ENSG00000233050 "Defensin beta 130B" P0DP73 8 12064389-12071747 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "epididymis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131A "DEFB-31, DEFB131" ENSG00000186146 "Defensin beta 131A" P59861 4 9444534-9450514 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "ductus deferens: 31.3;epididymis: 65.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 18 "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "TIME: 6.8" "Secreted in other tissues" NA NA "unprognostic (2.11e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 9.0 0.0 31.3 5.5 0.1 65.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 10.9 0.1 0.1 10.3 0.0 0.1 0.1 0.2 0.3 0.0 0.0 8.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DENND2A "FAM31D, KIAA1277" ENSG00000146966 "DENN domain containing 2A" Q9ULE3 7 140518420-140673993 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 50.5;Horizontal cells: 84.2;Mucus-secreting cells: 40.3;Paneth cells: 54.3;Undifferentiated cells: 40.9" "Cancer enriched" "Detected in all" 6 "glioma: 28.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.1;BJ hTERT+: 23.8;PC-3: 13.4;RPTEC TERT1: 31.3;U-2197: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.02e-2)" "unprognostic (1.14e-1)" "prognostic favorable (9.35e-4)" "unprognostic (1.78e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.95e-2)" "unprognostic (1.43e-1)" "unprognostic (3.10e-2)" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-3)" "unprognostic (2.09e-2)" "prognostic unfavorable (3.05e-6)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (3.54e-2)" "unprognostic (2.38e-3)" 12.7 4.8 15.6 2.9 18.7 1.1 6.5 7.7 14.8 23.1 6.7 15.7 1.9 4.4 21.2 6.2 10.3 19.5 11.3 9.8 15.3 13.2 6.9 3.4 12.9 2.4 18.5 9.0 22.3 2.7 5.3 19.0 15.5 17.2 8.6 6.3 12.8 2.8 6.4 7.1 2.4 5.6 16.7 12.5 9.9 4.6 2.6 15.4 0.0 2.9 4.3 2.0 10.2 24.1 1.2 0.9 4.4 0.7 1.4 0.8 0.2 0.1 0.4 25.1 0.2 2.4 0.5 5.6 1.1 23.8 3.7 6.5 0.0 0.0 0.0 0.2 0.2 4.5 0.1 4.5 0.3 8.1 0.0 0.4 0.0 0.1 0.0 0.7 0.1 0.0 1.2 0.3 6.4 0.8 9.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 5.9 0.0 13.4 0.9 1.7 0.1 31.3 0.0 2.1 6.7 0.0 0.0 0.0 7.0 0.0 0.2 0.0 5.0 1.1 14.7 2.9 0.1 0.0 0.0 0.4 0.0 1.9 2.7 0.7 0.6 0.6 0.3 0.5 0.6 0.6 0.5 0.1 1.2 0.8 0.7 4.4 1.4 0.3 0.9 0.4 0.2 15.6 18.7 7.7 12.0 15.3 13.2 18.5 9.0 17.2 15.4 0.0 4.0 0.0 1.4 1.1 7.5 3.3 0.0 1.4 2.3 0.0 7.9 0.6 6.6 0.0 0.8 2.7 50.5 0.0 0.0 3.5 7.6 2.2 11.5 0.4 1.9 84.2 9.2 9.2 0.3 0.4 17.3 1.0 1.7 0.0 40.3 16.6 0.1 54.3 9.9 0.0 10.6 12.9 2.3 0.0 0.7 0.4 0.3 0.7 40.9 1.0 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327060 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 8.3;RPMI-8226: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.41e-4)" "prognostic favorable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.7 5.5 11.6 4.3 17.0 2.0 3.2 21.1 22.8 5.7 2.8 7.5 5.5 2.5 5.2 5.3 3.4 24.7 6.2 2.3 8.4 10.2 5.7 1.3 7.3 5.2 4.9 14.4 4.3 6.4 6.8 15.1 2.3 10.4 4.7 2.3 4.1 5.9 7.4 1.1 5.0 3.0 3.6 3.2 4.4 4.2 9.0 4.5 0.0 6.0 1.0 3.5 4.4 2.7 0.7 1.8 0.5 3.9 1.0 0.7 0.9 0.6 2.3 5.0 5.4 1.2 4.8 0.0 1.0 2.4 0.6 0.4 0.1 3.5 8.3 2.1 2.3 0.3 4.2 0.1 0.1 0.2 2.0 1.2 1.4 4.0 0.2 1.1 0.2 3.7 4.1 5.3 0.1 0.7 4.9 1.0 0.1 1.8 1.5 1.2 3.6 0.0 0.8 0.3 2.5 0.2 1.2 0.0 12.0 6.2 2.0 2.1 4.0 2.7 3.4 0.4 0.2 5.5 1.2 1.1 0.9 0.8 0.8 0.1 1.3 0.3 1.2 2.2 0.9 1.0 0.5 2.6 0.1 0.4 3.2 0.6 0.6 0.6 0.7 1.8 0.7 0.6 0.7 0.5 1.0 3.9 1.4 0.6 0.9 11.6 17.0 21.1 22.8 8.4 10.2 4.9 14.4 10.4 4.5 3.0 2.6 18.2 2.8 1.0 4.9 1.1 7.6 30.8 7.9 5.2 21.6 0.2 3.3 4.8 20.6 3.4 4.9 23.3 1.6 0.6 4.0 3.3 5.7 0.8 12.8 1.6 9.8 3.7 21.8 47.0 2.3 13.7 5.0 26.2 3.4 6.4 2.6 2.3 2.5 14.1 15.4 0.0 1.2 23.6 17.9 0.5 0.8 7.2 3.3 2.3 DEPDC4 "DEP.4, FLJ33505" ENSG00000166153 "DEP domain containing 4" Q8N2C3 12 100203669-100267079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.5" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 9.9;Late spermatids: 14.1" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 7 "naive B-cell: 2.8;naive CD4 T-cell: 2.1;naive CD8 T-cell: 1.8" "Group enriched" "Detected in many" 8 "B-cells: 2.8;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039323 Uncertain Approved Microtubules NA NA Microtubules "HPA039323: AB_10674283" "unprognostic (8.89e-2)" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (4.33e-2)" "unprognostic (3.62e-1)" "unprognostic (7.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (9.09e-4)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-2)" 0.2 0.6 1.3 0.2 1.0 0.7 1.4 0.2 1.3 0.4 1.0 2.1 0.5 0.7 1.1 0.6 0.6 0.6 1.0 1.2 3.3 2.2 0.3 0.3 1.1 1.3 1.8 1.0 1.2 1.1 1.3 1.4 0.9 1.9 0.3 0.6 0.6 0.2 1.6 0.1 0.9 7.5 0.8 0.2 1.0 0.5 2.8 0.0 0.0 0.3 0.0 2.1 0.0 2.1 3.1 5.7 1.6 0.3 0.7 3.6 2.9 2.1 6.3 3.7 4.8 1.2 2.2 1.9 1.6 1.8 3.3 4.9 2.5 6.9 2.5 5.4 7.9 1.5 5.4 0.7 2.6 3.2 0.6 1.5 2.2 0.5 1.3 1.6 4.1 4.7 1.0 2.8 2.2 1.6 4.7 2.7 2.7 3.2 3.3 5.8 5.3 2.9 1.3 1.6 3.5 1.7 2.3 1.8 3.5 4.7 2.8 0.3 4.3 1.7 1.7 2.3 2.6 2.6 5.0 1.3 2.0 3.5 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 2.8 2.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 1.0 0.8 1.8 0.8 0.0 2.7 3.4 5.2 3.9 2.9 5.0 0.4 9.9 0.6 0.5 0.0 1.1 1.7 0.9 0.6 0.0 0.4 0.9 0.0 0.0 0.0 0.3 14.1 1.1 0.0 1.7 0.0 0.6 1.0 0.4 0.0 0.0 3.4 3.9 0.0 0.5 4.7 6.6 0.3 1.0 0.0 1.6 0.9 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.5 13.9 7.5 13.2 30.6 16.9 6.9 14.7 15.4 9.7 9.2 6.5 10.0 11.3 22.2 16.6 10.5 12.4 8.8 15.8 8.3 26.6 19.8 5.6 9.1 27.5 17.6 9.6 10.7 17.1 18.3 9.4 11.0 15.7 13.9 16.2 12.8 11.4 10.7 16.8 11.9 10.5 10.5 11.8 14.5 11.1 9.9 17.3 11.9 7.1 15.5 13.6 14.0 15.5 11.7 6.6 12.3 16.8 15.2 9.8 10.5 23.0 9.6 15.1 11.6 3.3 8.6 20.7 11.0 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 6.0 8.9 13.4 27.4 29.7 18.1 0.0 48.4 8.1 2.3 26.2 11.8 20.0 64.6 22.3 6.3 18.5 9.7 0.0 31.5 17.9 28.6 35.2 1.1 87.3 33.0 22.3 14.3 38.1 12.3 11.5 69.6 8.7 15.1 16.2 13.5 38.1 25.7 13.9 80.6 56.2 12.9 19.4 35.5 2.4 2.7 28.4 9.7 18.1 16.8 37.0 DGAT2L6 "DC3, FLJ25989" ENSG00000184210 "Diacylglycerol O-acyltransferase 2 like 6" Q6ZPD8 X 70177483-70205545 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "breast: 6.9;skin 1: 10.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NB-4: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.90e-2)" "unprognostic (3.08e-1)" "unprognostic (1.43e-3)" "unprognostic (3.47e-3)" "unprognostic (8.60e-2)" "unprognostic (5.82e-2)" "unprognostic (1.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DGKB "DAGK2, DGK, DGK-BETA, KIAA0718" ENSG00000136267 "Diacylglycerol kinase beta" Q9Y6T7 7 14145049-14974777 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.7" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 16.8;Club cells: 3.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 11 "glioma: 1.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.8;fHDF/TERT166: 5.7;hTEC/SVTERT24-B: 2.2;SCLC-21H: 2.9;SH-SY5Y: 2.1;U-266/70: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020321 Supported NA NA "HPA020321: " "unprognostic (9.89e-2)" "unprognostic (9.72e-5)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.32e-2)" "unprognostic (3.37e-1)" "unprognostic (7.34e-2)" "unprognostic (5.91e-2)" "unprognostic (6.19e-2)" "unprognostic (8.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (5.98e-2)" "unprognostic (2.37e-3)" "unprognostic (6.13e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-4)" 1.1 5.2 11.5 1.1 37.7 0.8 0.8 1.3 34.0 4.9 1.6 1.4 0.0 0.9 6.1 0.9 1.6 2.7 1.3 1.4 10.5 4.3 2.6 1.1 0.8 0.8 2.2 11.3 0.8 0.9 0.8 1.8 0.7 4.8 1.1 1.7 0.0 0.9 0.9 1.2 0.9 1.2 3.1 3.5 0.8 0.8 0.9 7.9 0.0 0.9 0.0 0.8 1.5 0.6 0.7 0.6 1.3 0.3 0.6 0.5 0.1 0.1 0.0 2.8 0.1 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.2 0.0 0.1 0.0 5.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.9 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.0 0.0 0.0 7.6 0.0 0.0 0.1 0.1 0.1 0.7 0.3 0.3 0.5 0.2 0.4 0.3 0.5 0.2 0.1 0.7 0.5 0.4 1.3 0.6 0.2 0.6 0.2 0.1 11.5 37.7 1.3 19.1 10.5 4.3 2.2 11.3 4.8 7.9 0.0 0.0 0.0 0.2 0.1 16.8 1.2 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.2 6.5 1.4 0.2 0.2 0.4 0.0 0.0 0.0 0.3 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362237 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.4" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 3.1 6.9 13.4 3.1 7.1 14.5 1.9 53.4 23.1 2.7 3.5 6.2 1.1 3.0 1.9 14.6 8.5 7.7 2.2 15.0 15.3 7.4 3.1 2.1 4.3 2.1 7.4 11.3 2.0 1.6 4.7 7.5 13.5 25.2 3.1 2.1 7.8 1.9 4.0 2.4 1.4 2.7 5.3 5.6 2.0 3.3 1.2 7.1 0.0 2.5 0.0 2.1 4.8 2.4 0.6 2.9 5.3 4.2 0.0 0.0 1.3 2.7 4.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.4 0.0 2.9 0.2 0.0 0.0 0.0 20.2 0.0 2.7 0.0 2.9 0.0 6.4 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.1 0.1 2.2 0.4 0.0 1.2 1.4 0.0 2.3 0.0 0.0 0.5 0.0 0.8 0.0 1.7 0.0 0.1 4.2 0.0 0.0 0.7 2.1 2.4 0.0 7.7 0.0 12.8 6.0 2.3 0.0 4.2 2.4 0.0 2.4 0.0 0.6 0.0 0.0 2.9 0.3 0.0 0.0 5.3 0.0 2.8 0.5 0.0 1.3 13.4 7.1 53.4 14.7 15.3 7.4 7.4 11.3 25.2 7.1 0.0 1.7 1.5 0.1 0.3 0.0 16.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.2 2.4 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.0 1.9 1.6 0.0 27.6 2.7 2.0 1.7 2.3 0.0 1.0 0.0 7.5 0.7 0.0 0.4 0.8 0.0 12.9 16.7 0.0 0.0 0.4 0.1 0.0 0.0 0.4 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804157 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.6" "Low region specificity" "Detected in all" "CAB034238, HPA057028, HPA058315" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 15.6 6.4 6.9 4.1 7.1 3.9 11.1 5.2 10.9 9.5 7.6 13.8 7.1 5.5 8.4 16.0 7.7 7.5 7.4 8.3 6.0 6.0 14.2 15.8 8.7 4.8 5.8 6.2 10.4 37.6 11.1 10.0 7.3 8.0 7.7 4.7 14.0 11.5 13.0 10.4 10.1 12.2 8.3 7.2 8.3 7.3 3.9 6.5 4.4 10.2 6.9 9.2 6.4 5.7 6.0 4.5 36.3 7.3 1.6 11.6 5.7 0.9 3.1 5.6 7.6 2.5 5.4 5.2 1.7 3.9 2.2 1.2 3.5 15.6 3.9 1.2 3.2 3.5 1.9 0.1 0.8 0.3 3.6 2.7 1.2 1.0 3.2 6.7 0.7 1.1 3.4 6.0 0.7 3.2 7.1 5.2 3.6 1.6 4.4 2.5 4.5 1.5 3.2 6.7 7.0 0.5 0.5 0.7 6.4 8.8 2.6 3.4 7.1 2.6 5.7 6.8 8.3 5.9 3.9 9.1 1.3 1.9 0.3 1.8 2.1 1.5 1.9 4.0 2.1 4.9 2.9 7.3 0.2 6.4 6.2 11.6 6.0 9.9 8.0 4.0 5.6 8.8 6.2 36.3 1.6 7.0 4.5 8.6 5.7 6.9 7.1 5.2 10.9 6.0 6.0 5.8 6.2 8.0 6.5 11.9 15.0 11.1 11.1 10.1 10.7 13.2 17.8 16.0 7.9 15.7 7.9 20.5 44.7 8.8 21.4 11.2 6.8 0.0 14.6 15.3 9.1 9.3 11.5 27.6 14.7 3.2 9.9 8.6 10.7 43.5 10.3 9.4 13.5 9.0 12.3 24.0 14.0 13.1 9.2 51.9 18.3 0.0 12.3 1.6 6.3 13.0 19.9 13.3 11.5 9.2 DHRS13 "MGC23280, SDR7C5" ENSG00000167536 "Dehydrogenase/reductase 13" Q6UX07 17 28897781-28903071 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022991 Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA022991: AB_1853865" "unprognostic (8.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (2.38e-1)" "unprognostic (4.74e-2)" "unprognostic (5.65e-2)" "unprognostic (1.20e-2)" "unprognostic (7.57e-2)" "unprognostic (1.73e-2)" "unprognostic (3.72e-2)" "unprognostic (2.63e-1)" "unprognostic (7.22e-3)" "unprognostic (2.55e-1)" 2.3 6.0 5.9 5.1 7.9 31.7 5.9 24.9 5.7 6.4 4.5 6.4 9.0 4.1 2.6 6.5 6.7 4.0 3.0 2.7 5.3 10.9 6.9 27.0 4.1 8.6 6.7 5.4 3.6 9.5 8.5 5.3 9.5 9.9 14.9 3.5 5.0 11.8 10.9 1.1 6.8 3.0 3.2 5.6 8.0 5.5 2.8 3.6 4.4 5.5 1.2 8.1 9.2 5.1 4.0 3.1 29.7 3.5 4.6 6.3 3.1 5.6 3.6 8.5 10.8 1.3 1.9 8.3 3.1 4.0 5.7 8.8 11.2 3.4 15.6 5.3 0.6 6.6 5.1 12.0 3.4 2.4 15.7 11.6 8.8 6.7 6.1 3.2 4.4 1.0 1.4 3.1 3.6 3.8 4.0 1.7 11.0 19.7 5.4 1.1 10.2 9.7 7.4 5.2 14.9 0.5 15.5 8.1 12.0 10.5 9.6 12.3 10.3 4.9 34.0 6.6 4.7 22.6 7.2 0.5 1.8 5.6 4.4 4.2 12.6 11.8 9.7 5.4 5.6 4.5 0.4 2.3 1.6 4.8 3.5 5.9 3.6 6.1 6.0 3.1 4.0 6.3 4.6 29.7 4.6 3.3 1.7 5.7 3.1 5.9 7.9 24.9 5.7 5.3 10.9 6.7 5.4 9.9 3.6 3.0 3.4 3.0 11.5 1.3 5.4 0.4 2.5 0.0 3.4 7.0 2.0 21.6 8.3 7.8 10.7 2.9 2.4 46.7 2.4 18.2 1.9 9.4 1.1 3.8 5.2 4.8 2.9 6.7 0.8 3.8 1.1 2.7 5.0 24.4 2.7 6.9 3.2 2.9 0.4 2.9 5.0 6.5 1.4 1.5 12.6 1.5 11.3 5.3 5.7 4.3 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Hepatocytes: 186.0;Proximal tubular cells: 502.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 6.3 11.2 6.9 12.8 7.9 3.0 11.4 14.6 9.6 7.2 9.9 3.4 2.6 12.1 5.6 10.4 25.5 5.4 4.3 8.9 5.0 4.1 42.0 33.0 16.7 7.2 4.6 2.4 7.1 28.4 6.0 5.2 3.1 7.6 8.3 9.5 5.4 14.2 10.9 18.7 9.8 14.9 6.4 5.6 8.1 7.1 28.2 4.5 13.8 5.9 32.8 14.5 5.3 7.1 10.4 22.3 3.2 27.2 7.9 11.5 14.7 8.5 12.9 2.2 11.0 21.4 22.4 0.2 7.7 15.3 11.3 8.4 3.7 10.1 5.6 5.3 15.5 7.3 9.3 9.9 12.9 9.4 18.2 6.0 1.3 11.2 23.0 15.8 7.1 22.2 23.1 16.4 7.3 10.8 7.8 13.2 17.3 4.3 19.9 12.1 26.9 17.7 7.4 4.4 20.1 14.3 28.0 9.1 17.4 16.2 11.3 12.0 7.2 10.6 9.8 6.4 4.9 11.8 10.7 9.3 6.0 6.2 7.0 3.9 11.6 9.2 1.6 5.2 10.3 8.5 2.3 27.2 3.2 10.1 22.5 10.4 10.4 10.8 11.5 22.3 8.2 11.1 10.1 1.3 7.9 13.2 18.3 10.3 14.7 6.9 7.9 14.6 9.6 5.0 4.1 4.6 2.4 7.6 4.5 14.9 23.5 21.4 38.6 24.6 9.7 15.1 17.8 32.1 23.9 24.4 2.0 16.3 107.8 33.6 16.0 33.7 49.1 23.3 48.9 6.2 41.2 29.1 17.3 186.0 120.7 11.1 35.8 45.4 59.2 31.0 40.6 42.6 49.0 45.9 56.0 58.7 33.6 63.1 35.0 502.2 6.9 32.3 38.1 8.9 1.4 35.1 10.9 27.3 69.8 32.0 DHRS7C SDR32C2 ENSG00000184544 "Dehydrogenase/reductase 7C" A6NNS2 17 9771434-9791297 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 62.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "BJ hTERT+: 4.5;HeLa: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (6.83e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 2.7 0.0 87.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "kidney: 36.1;liver: 50.8;thyroid gland: 67.7" "Cell type enhanced" "Detected in some" 22 "Cholangiocytes: 17.8;Hepatocytes: 52.9;Proximal tubular cells: 83.0" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 26 "Hep G2: 17.0;SK-BR-3: 41.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 36.1 50.8 0.4 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 67.7 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 41.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 13.7 17.8 0.0 0.0 0.0 0.0 0.2 10.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 52.9 0.4 0.0 0.0 0.6 2.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 DIRC1 ENSG00000174325 "Disrupted in renal carcinoma 1" Q969H9 2 188734155-188790104 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 5.9;gallbladder: 2.1" "Group enriched" "Detected in some" 7 "Early spermatids: 1.8;Late spermatids: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 24.7;HSkMC: 9.0" HPA068508 Approved Nucleoplasm NA NA Nucleoplasm "HPA068508: AB_2732783" "unprognostic (3.11e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (2.77e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (7.39e-4)" "unprognostic (6.95e-2)" 1.4 0.0 0.0 0.4 0.0 0.0 5.9 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 24.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 15.6;Enterocytes: 12.9;Horizontal cells: 17.5;Mucus-secreting cells: 14.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 5.2;HaCaT: 8.1;SCLC-21H: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 5.2 8.1 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.3 0.5 0.9 0.6 1.0 1.3 0.3 0.2 0.4 0.4 2.0 1.1 0.2 0.4 0.5 0.3 2.1 16.7 2.4 0.3 0.2 0.2 0.5 0.4 0.2 0.5 1.2 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 3.0 5.1 0.0 2.0 0.0 15.6 1.4 2.5 4.0 7.9 3.5 9.8 0.2 0.0 0.3 0.9 1.0 12.9 0.0 0.3 0.2 0.8 1.1 8.1 0.0 0.8 17.5 9.2 0.6 0.0 1.5 1.1 0.9 0.0 0.0 14.1 1.7 0.2 2.9 0.0 0.0 7.2 0.0 0.4 4.2 6.6 0.0 0.2 0.0 4.8 1.0 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.9 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 0.0 2.0 0.0 0.2 3.2 11.0 2.4 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 21.7" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 6.8;Fibroblasts: 6.3;Hofbauer cells: 12.7;Ito cells: 4.9;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 13 "T-cells: 3.0" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 6.6 1.2 3.0 1.5 2.5 0.0 4.8 1.8 3.6 21.7 3.6 0.2 0.0 0.1 1.4 2.4 2.0 0.9 1.6 3.1 2.9 2.2 0.4 0.3 7.9 0.9 2.0 1.5 6.3 0.3 0.9 3.4 3.4 2.5 2.9 0.7 6.8 2.7 2.4 2.4 6.1 0.5 0.9 2.3 1.7 0.4 0.5 0.2 0.1 1.3 4.4 3.7 1.1 2.6 0.0 0.2 0.0 0.1 0.0 3.0 0.0 0.0 0.0 3.7 0.0 0.7 0.4 0.0 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.1 0.1 3.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.5 1.8 3.6 2.9 2.2 2.0 1.5 2.5 0.2 0.0 0.0 0.0 0.0 6.8 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 6.3 0.0 0.0 0.0 12.7 0.0 0.0 4.9 0.3 0.0 3.7 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 6.5 0.0 0.0 0.0 0.0 DLEC1 "CFAP81, DLC1" ENSG00000008226 "Deleted in lung and esophageal cancer 1" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 23.2;testis: 28.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 68.3;Club cells: 21.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 0.8 0.3 1.3 0.7 8.3 1.1 0.5 0.0 0.6 3.3 0.6 6.1 3.5 0.7 1.1 21.1 0.3 23.2 1.3 0.3 1.7 2.5 0.3 0.3 10.0 1.7 0.5 0.2 6.3 0.2 0.6 14.2 0.3 9.8 0.8 0.6 0.8 0.6 1.8 0.2 0.7 0.7 0.3 0.6 0.7 0.6 28.9 1.7 0.0 0.8 0.0 0.6 0.4 0.1 0.2 0.1 0.9 0.4 0.1 1.1 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.3 0.0 0.4 0.2 0.1 3.4 0.5 0.0 0.0 0.0 0.2 0.1 2.8 0.5 0.2 0.3 1.7 0.5 0.2 0.1 0.3 0.0 0.0 0.5 0.3 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.8 0.2 0.4 0.2 1.1 0.0 0.1 0.1 0.2 0.0 0.9 0.1 0.1 0.1 0.2 0.1 1.3 8.3 0.0 0.6 1.7 2.5 0.5 0.2 9.8 1.7 3.0 4.8 0.0 0.6 0.5 1.1 0.6 0.0 68.3 21.6 0.0 0.0 0.1 0.0 0.1 2.7 0.3 0.7 0.0 0.2 0.1 0.6 0.5 2.3 0.2 0.4 0.0 1.2 0.0 0.0 4.3 0.9 0.9 0.0 1.0 0.4 0.1 0.1 0.8 0.0 0.0 0.5 0.0 0.2 8.4 1.0 0.3 0.1 0.5 0.0 0.4 DLEU7 FLJ44882 ENSG00000186047 "Deleted in lymphocytic leukemia, 7" Q6UYE1 13 50711008-50843939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 13.2" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 13.2;Hofbauer cells: 6.2;Kupffer cells: 30.1;Macrophages: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "NTERA-2: 15.4;U-698: 6.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053750 Uncertain NA NA "HPA053750: AB_2682249" "unprognostic (3.97e-2)" "unprognostic (2.53e-1)" "unprognostic (7.03e-2)" "unprognostic (9.31e-2)" "unprognostic (3.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-1)" "unprognostic (1.24e-1)" "unprognostic (8.75e-3)" "unprognostic (1.23e-1)" "unprognostic (1.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.59e-1)" "unprognostic (4.52e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" 0.7 1.0 4.8 0.8 7.8 0.5 0.5 5.8 13.2 0.6 0.7 0.5 0.0 0.6 0.8 3.0 0.5 0.5 0.4 0.5 4.6 5.7 1.4 0.5 0.5 0.4 3.7 4.2 0.6 0.7 0.4 0.1 0.5 4.1 0.7 0.8 0.0 0.4 0.5 0.5 1.0 0.8 0.5 1.2 0.8 0.5 0.9 0.8 1.3 1.9 0.0 0.5 0.4 0.1 1.3 0.0 1.2 1.5 0.0 1.4 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 15.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 1.2 0.0 0.0 0.0 1.4 0.7 4.8 7.8 5.8 9.9 4.6 5.7 3.7 4.2 4.1 0.8 0.0 0.3 0.0 0.0 0.0 13.2 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 30.1 0.0 0.0 7.8 0.0 1.8 0.0 0.2 0.0 0.0 1.4 0.5 1.8 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DLX6 ENSG00000006377 "Distal-less homeobox 6" P56179 7 97005548-97011039 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.2;placenta: 11.3;testis: 10.4" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 24.7;Extravillous trophoblasts: 48.9;Sertoli cells: 12.9;Syncytiotrophoblasts: 14.5" "Cancer enriched" "Detected in many" 8 "endometrial cancer: 12.5" "Region enhanced" "Detected in many" "basal ganglia: 23.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.3;BEWO: 24.3;HAP1: 10.9;SH-SY5Y: 8.0;SuSa: 14.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory region: 44.2" "HPA030608, HPA061460" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA030608: AB_10600867, HPA061460: AB_2684529" "unprognostic (7.50e-2)" "unprognostic (1.91e-1)" "unprognostic (5.19e-2)" "unprognostic (8.06e-2)" "unprognostic (8.16e-2)" "unprognostic (3.05e-1)" "unprognostic (4.32e-2)" "unprognostic (2.51e-1)" "unprognostic (2.86e-1)" "unprognostic (6.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.12e-7)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (5.58e-2)" "unprognostic (8.12e-2)" 0.9 0.4 1.8 0.3 23.2 0.9 0.4 0.3 6.1 5.7 0.6 0.5 0.0 0.4 7.0 2.4 0.3 1.5 0.3 0.5 3.9 2.6 0.4 0.3 0.3 1.0 0.5 2.8 0.9 0.3 0.4 0.4 11.3 0.0 0.7 0.3 0.0 1.7 2.5 0.5 1.6 0.3 0.9 0.3 0.5 0.4 10.4 4.2 0.1 0.7 0.0 0.8 0.9 0.6 0.4 0.6 1.5 0.7 0.5 0.7 0.3 0.0 0.0 0.0 7.3 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 0.0 1.3 10.9 0.0 0.0 0.0 2.8 0.0 4.1 4.9 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 1.1 0.0 0.0 0.0 0.0 1.5 5.3 8.0 0.7 0.0 0.2 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.8 0.6 1.1 0.5 0.6 0.2 0.3 0.5 0.4 0.4 0.3 0.3 0.4 0.7 0.6 1.5 0.5 0.7 0.6 0.5 0.3 1.8 23.2 0.3 6.1 3.9 2.6 0.5 2.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 9.5 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 1.7 7.1 0.0 14.5 0.0 0.0 0.1 DMRT2 ENSG00000173253 "Doublesex and mab-3 related transcription factor 2" Q9Y5R5 9 1049858-1057552 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 97.8" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;RH-30: 5.3;RPMI-8226: 19.8;SCLC-21H: 3.1;SK-MEL-30: 5.4;THP-1: 3.8;WM-115: 3.8" "Region enhanced" "Detected in some" "cerebral cortex: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA029297 Uncertain NA NA "HPA029297: AB_10600905" "unprognostic (5.67e-2)" "unprognostic (2.20e-3)" "unprognostic (3.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (7.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.43e-3)" "unprognostic (8.93e-2)" "unprognostic (8.62e-2)" "unprognostic (4.93e-2)" "unprognostic (1.27e-3)" 3.8 0.5 1.9 0.5 6.5 0.4 4.5 0.5 4.5 0.5 1.6 11.0 2.6 0.4 0.5 1.3 0.6 0.6 0.4 0.5 3.2 1.3 27.3 0.4 2.4 0.6 7.0 2.5 0.4 0.4 52.9 0.7 0.6 3.6 0.6 1.1 0.0 1.4 1.5 9.0 0.6 0.4 0.5 3.0 0.4 0.4 0.9 6.2 18.4 0.4 6.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 19.8 0.0 0.9 3.1 0.0 0.0 0.0 5.4 0.3 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.5 0.5 4.5 3.2 1.3 7.0 2.5 3.6 6.2 0.0 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 97.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.7 0.3 0.0 2.3 0.0 0.0 1.7 0.0 0.0 4.2 1.5 0.1 0.1 0.0 1.5 0.1 DMRTA1 ENSG00000176399 "DMRT like family A1" Q5VZB9 9 22446841-22455740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 12.2;salivary gland: 16.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 13.3;Hepatocytes: 25.3;Proximal tubular cells: 21.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.0;hTERT-RPE1: 11.0;LHCN-M2: 4.2;RPTEC TERT1: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 2.5" "HPA044764, HPA062253" Uncertain Approved Vesicles NA NA Vesicles "HPA044764: AB_10959788, HPA062253: AB_2684726" "unprognostic (1.47e-1)" "unprognostic (2.48e-2)" "unprognostic (2.86e-1)" "unprognostic (7.74e-4)" "unprognostic (3.81e-2)" "unprognostic (2.67e-3)" "unprognostic (4.36e-2)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (9.64e-2)" "unprognostic (3.65e-3)" "unprognostic (2.92e-1)" "prognostic favorable (1.14e-6)" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (8.53e-3)" 2.1 0.2 0.7 1.4 0.7 0.0 5.6 0.8 0.7 2.4 1.0 0.7 1.1 0.7 1.2 1.8 5.5 0.3 1.2 0.6 0.6 0.5 5.5 12.2 1.1 1.4 0.8 0.4 0.6 2.7 6.1 2.9 0.0 0.9 2.4 0.4 1.9 16.3 0.5 0.9 0.5 0.8 0.7 0.7 0.4 2.8 0.6 0.0 1.1 5.0 0.6 2.0 0.9 1.7 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.5 0.1 0.0 0.4 0.1 0.2 0.0 9.0 0.3 0.3 0.1 0.1 0.0 2.0 0.0 0.2 0.3 1.8 2.4 0.3 0.0 0.6 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.7 11.0 0.6 0.0 0.0 3.3 4.2 0.9 0.0 0.0 1.8 0.4 3.0 0.0 0.2 1.2 4.3 0.0 0.1 0.0 1.1 0.7 2.0 2.2 0.0 0.0 3.1 0.0 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.8 0.7 0.6 0.5 0.8 0.4 0.9 0.0 0.0 2.4 0.0 4.7 0.0 0.5 1.1 2.5 4.0 4.5 5.2 0.0 0.0 13.3 5.4 0.0 0.0 2.6 0.0 6.0 0.0 1.3 5.6 0.0 25.3 0.3 0.0 2.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 4.8 5.6 0.0 0.0 21.4 0.0 0.0 0.4 0.0 0.6 0.4 0.1 0.0 1.9 6.2 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 3.7;Intestinal endocrine cells: 1.2" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: AB_2684911" "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 1.9 0.0 1.3 4.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 3.3 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 DMRTB1 ENSG00000143006 "DMRT like family B with proline rich C-terminal 1" Q96MA1 1 53459399-53467488 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 104 "testis: 78.1" "Group enriched" "Detected in some" 17 "Early spermatids: 42.1;Late spermatids: 90.9;Spermatocytes: 144.5;Spermatogonia: 150.6" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.3" "Low region specificity" "Detected in single" "HPA036490, HPA058553" Enhanced NA NA "HPA036490: AB_10671844, HPA058553: AB_2683753" "unprognostic (2.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.5 0.0 144.5 150.6 0.0 0.0 0.0 0.0 0.0 DMRTC1 ENSG00000269502 "DMRT like family C1" Q5HYR2 X 72872025-72943814 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Group enriched" "Detected in many" 17 "B-cells: 2.2;T-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;Daudi: 3.6;JURKAT: 2.6;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.0" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (1.83e-1)" 0.0 1.3 0.0 0.0 0.0 4.0 0.6 0.1 0.0 1.1 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.6 0.7 0.0 1.1 2.0 0.8 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.0 2.2 0.7 1.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTC1B ENSG00000184911 "DMRT like family C1B" Q5HYR2 X 72777009-72848802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.1;ovary: 12.1;pituitary gland: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 12 "B-cells: 2.1;T-cells: 2.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;SK-BR-3: 1.0;SuSa: 2.2;U-266/70: 1.5" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (2.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-1)" "unprognostic (6.52e-2)" 0.3 4.6 11.0 1.7 15.1 0.1 0.7 4.5 14.3 1.7 0.6 2.2 1.4 0.5 2.2 9.6 0.3 3.3 0.6 0.2 8.6 14.2 1.6 0.2 1.1 1.4 4.9 9.1 12.1 5.2 1.5 12.1 0.2 2.2 3.8 0.8 2.4 1.0 1.9 0.2 0.5 0.5 0.6 2.2 1.3 1.2 7.1 2.9 0.7 3.9 0.2 2.1 0.3 0.2 2.1 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.8 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.4 0.0 2.1 2.1 2.8 0.0 0.2 0.0 0.0 0.0 0.2 11.0 15.1 4.5 11.4 8.6 14.2 4.9 9.1 2.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTC2 ENSG00000142025 "DMRT like family C2" Q8IXT2 19 41844743-41852333 "Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 53.5" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 176.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.3;monocytes: 1.1" "Cell line enhanced" "Detected in some" "HMC-1: 1.6" "Not detected" "Not detected" HPA045016 Uncertain NA NA "HPA045016: AB_10960404" "unprognostic (6.80e-3)" "unprognostic (4.38e-2)" "unprognostic (5.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.3 1.1 0.2 0.2 0.0 0.2 0.0 0.5 1.0 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.7 1.1 0.1 0.1 0.2 0.2 0.6 0.0 0.0 0.0 1.2 0.6 0.0 0.8 0.2 0.0 0.6 1.6 0.3 0.0 0.2 0.0 1.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.5 1.1 0.7 1.3 0.9 0.1 0.3 0.3 0.4 0.2 0.2 0.9 0.1 1.0 1.2 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.2 1.3 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 176.3 24.5 0.0 0.0 0.0 0.0 0.0 DNAH10OS FLJ45278 ENSG00000250091 "Dynein axonemal heavy chain 10 opposite strand" P0CZ25 12 123926424-123934984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.3;Cone photoreceptor cells: 3.9;Horizontal cells: 1.6;Rod photoreceptor cells: 1.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 9.0" HPA039786 Enhanced NA NA "HPA039786: AB_10795115" "unprognostic (1.62e-2)" "unprognostic (1.97e-2)" "unprognostic (8.74e-3)" "unprognostic (1.04e-2)" "unprognostic (7.76e-2)" "unprognostic (2.73e-1)" "unprognostic (8.78e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-1)" "unprognostic (3.52e-2)" "unprognostic (3.12e-3)" "unprognostic (3.45e-1)" "unprognostic (8.63e-3)" "unprognostic (3.20e-2)" "unprognostic (4.49e-2)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 0.9 0.3 3.6 0.4 5.2 0.8 1.2 7.6 6.3 0.4 0.7 0.3 0.8 0.8 0.5 0.5 0.6 1.0 3.7 1.5 3.7 0.5 1.5 0.4 1.4 1.6 2.7 2.1 1.1 0.6 1.1 0.4 0.9 1.8 1.7 0.6 0.4 1.3 1.0 0.8 1.4 0.9 1.8 0.4 0.4 0.3 0.6 0.3 3.3 0.7 0.3 1.0 0.3 0.5 3.8 3.1 4.2 2.0 1.9 1.1 0.6 3.3 0.5 0.5 0.3 0.3 0.4 1.3 1.6 0.5 0.3 0.9 0.2 0.2 1.8 0.5 0.7 0.3 0.2 0.7 0.3 2.8 0.3 1.1 0.8 0.2 9.0 0.7 3.1 0.2 0.7 0.7 2.5 0.3 0.6 0.3 0.1 0.4 0.2 0.2 0.1 3.2 1.2 0.7 3.1 0.3 0.3 0.7 3.1 0.7 0.3 1.2 4.4 0.2 1.0 0.4 2.0 0.8 0.2 2.7 0.4 1.6 1.1 0.7 0.3 1.0 0.4 0.8 0.6 0.3 0.8 0.1 0.6 0.4 0.5 3.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 439.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enriched" "Detected in many" 8 "pons and medulla: 23.0" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1" "HPA037493, HPA058203, HPA061365" Enhanced NA NA "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493" "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.2 0.3 0.6 0.1 3.0 0.1 0.4 0.2 0.5 1.3 0.2 5.3 0.0 0.1 1.4 11.6 0.2 16.7 0.5 0.1 2.9 0.8 0.2 0.3 17.5 0.2 0.4 0.0 7.6 3.1 0.1 8.9 0.1 23.0 0.2 0.2 0.0 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.2 0.2 17.6 1.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.5 0.0 0.0 1.2 0.9 0.1 0.3 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.2 0.3 0.0 3.1 0.3 0.1 0.0 0.4 1.9 0.4 0.0 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.1 0.4 0.4 0.2 0.6 0.2 0.1 2.1 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.9 0.1 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.0 0.5 0.0 0.1 0.6 3.0 0.2 0.3 2.9 0.8 0.4 0.0 23.0 1.0 3.0 1.4 0.0 0.2 0.0 0.2 0.8 0.0 439.0 70.5 0.0 0.0 0.1 0.0 0.1 38.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.0 0.1 0.0 1.7 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.4 0.4 0.0 0.0 0.0 24.4 2.6 0.0 0.0 0.0 0.0 0.0 DNAH14 "C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277" ENSG00000185842 "Dynein axonemal heavy chain 14" Q0VDD8 1 224896262-225399292 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 32.4;testis: 29.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 102.3;Spermatocytes: 58.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 3.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 25.5" "HPA027718, HPA028545, HPA031379" Uncertain Supported Centrosome NA NA Centrosome "HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851" "unprognostic (1.16e-1)" "unprognostic (1.77e-2)" "unprognostic (2.95e-1)" "unprognostic (1.86e-2)" "unprognostic (5.92e-2)" "unprognostic (1.09e-3)" "unprognostic (9.94e-4)" "unprognostic (4.23e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.51e-1)" "unprognostic (2.33e-9)" "unprognostic (6.76e-2)" "unprognostic (7.39e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" 1.6 5.2 6.3 2.7 2.5 2.5 5.2 0.9 3.4 3.1 2.9 0.2 3.8 1.7 3.3 6.5 2.0 2.6 5.3 3.7 7.0 5.5 4.2 6.8 5.4 0.6 2.9 4.6 5.5 11.2 3.4 32.4 2.6 7.2 4.3 3.7 3.6 3.4 7.8 0.6 1.0 1.1 4.6 8.5 1.0 3.8 29.9 0.8 3.2 7.1 0.9 0.4 2.5 1.9 0.6 0.2 0.4 0.2 3.5 0.9 0.0 10.4 5.4 4.9 5.4 2.0 4.1 11.8 2.2 2.0 4.0 3.5 8.4 11.5 0.0 5.4 2.2 0.0 0.1 7.6 2.1 6.8 0.0 12.6 5.0 3.6 1.8 2.4 10.3 1.7 3.9 4.6 5.5 3.9 4.3 1.3 7.3 25.5 0.0 6.8 2.8 1.8 10.8 13.9 11.8 6.6 0.0 18.8 9.5 3.7 4.8 8.3 9.4 8.4 6.3 16.9 8.6 11.6 9.0 0.2 0.0 8.0 0.2 0.1 11.6 7.2 0.1 0.0 0.0 7.5 0.0 0.1 0.3 0.1 0.2 0.0 0.6 0.3 0.7 0.2 0.3 0.4 0.5 0.4 3.5 0.1 0.0 0.9 0.0 6.3 2.5 0.9 3.4 7.0 5.5 2.9 4.6 7.2 0.8 11.9 11.5 0.0 10.9 1.8 29.3 4.4 10.2 5.3 4.5 19.2 31.4 8.6 6.6 11.0 102.3 2.9 1.1 0.0 8.7 10.5 3.0 8.7 13.9 7.6 3.0 27.0 7.9 2.5 0.0 31.3 2.6 1.6 3.3 1.0 4.3 11.2 8.0 0.0 3.2 6.4 3.4 6.5 0.9 58.5 19.2 0.6 9.6 0.0 4.1 6.8 DNAH2 "DNHD3, FLJ46675, KIAA1503" ENSG00000183914 "Dynein axonemal heavy chain 2" Q9P225 17 7717354-7833744 "Predicted intracellular proteins, Predicted membrane proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0" "Group enriched" "Detected in some" 7 "Ciliated cells: 33.5;Rod photoreceptor cells: 127.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.8;OE19: 3.5;SCLC-21H: 4.6;SiHa: 4.5" "Low region specificity" "Detected in many" HPA067103 Enhanced Approved Microtubules NA NA Microtubules "HPA067103: AB_2685778" "unprognostic (2.03e-2)" "unprognostic (1.79e-2)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-1)" "unprognostic (7.50e-3)" "unprognostic (1.29e-2)" "unprognostic (8.28e-2)" "unprognostic (2.51e-3)" "unprognostic (1.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (8.74e-3)" "unprognostic (4.60e-2)" 0.2 0.1 1.5 0.2 4.8 0.5 0.5 1.8 0.9 1.3 0.2 7.9 1.1 0.2 0.7 5.7 0.2 14.3 0.4 0.2 2.1 1.9 0.2 0.3 5.5 0.2 0.2 0.6 3.0 0.5 20.0 1.2 1.8 7.0 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 21.0 0.7 0.2 0.3 0.2 0.2 0.2 0.2 1.2 0.6 3.2 0.7 0.6 0.7 0.1 4.8 0.2 0.3 0.3 0.1 0.0 0.8 0.2 0.1 0.0 0.1 7.5 4.8 0.2 2.3 0.1 0.1 0.4 0.0 1.1 0.1 0.1 0.2 0.1 0.5 0.2 1.2 0.3 0.2 0.4 0.0 0.8 0.1 0.7 0.0 0.3 0.2 0.4 0.0 0.9 0.1 0.4 0.4 3.5 1.6 0.2 0.5 0.1 0.0 1.4 4.6 0.3 4.5 0.1 2.3 0.4 0.4 0.3 0.2 0.4 0.9 0.1 0.0 0.4 0.1 0.2 0.1 0.1 0.8 0.7 0.7 0.4 0.7 0.3 0.5 0.5 0.4 0.6 0.2 1.2 0.5 0.7 3.2 0.6 0.3 0.6 0.3 0.1 1.5 4.8 1.8 0.9 2.1 1.9 0.2 0.6 7.0 0.7 0.0 1.4 0.0 0.8 0.2 2.1 1.7 0.0 33.5 4.5 0.0 2.0 0.0 0.0 0.1 5.0 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 1.6 6.4 0.6 0.3 1.7 0.3 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 127.6 0.0 0.4 11.6 2.3 0.1 0.0 0.0 0.0 0.7 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 6.2" "Group enriched" "Detected in some" 5 "Ciliated cells: 87.0;Early spermatids: 28.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.2;hTEC/SVTERT24-B: 1.4;U-698: 1.2" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 10.4 0.0 0.0 0.5 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.0 1.2 0.1 0.4 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.6 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.0 1.6 0.0 87.0 9.1 0.0 0.0 0.2 0.0 0.0 28.8 0.3 0.9 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.3 0.5 0.0 0.0 1.9 0.1 DNAH6 "Dnahc6, DNHL1, FLJ37357, HL-2" ENSG00000115423 "Dynein axonemal heavy chain 6" Q9C0G6 2 84516455-84819589 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4" "Group enriched" "Detected in many" 6 "Ciliated cells: 149.9;Early spermatids: 61.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "GAMG: 3.1;OE19: 5.9;SK-MEL-30: 1.8" "Low region specificity" "Detected in many" "HPA036391, HPA061401" Enhanced NA NA "HPA036391: AB_10672220, HPA061401: " "unprognostic (4.87e-2)" "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.72e-2)" "unprognostic (1.67e-1)" "unprognostic (6.43e-2)" "unprognostic (6.06e-2)" "unprognostic (3.46e-1)" "unprognostic (8.11e-8)" "unprognostic (2.04e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.80e-2)" "unprognostic (5.97e-2)" 1.4 1.2 7.7 0.8 17.7 0.7 1.7 0.6 10.0 1.8 1.0 3.2 0.7 0.7 2.0 11.0 0.6 15.3 0.8 0.6 7.9 3.5 1.9 3.6 4.8 1.0 0.9 7.2 5.1 1.2 6.2 17.4 0.7 23.7 1.1 1.1 0.5 0.6 1.3 0.5 0.7 0.8 0.8 1.6 0.8 2.0 7.2 3.0 0.0 3.9 0.0 0.8 0.7 0.6 0.0 0.2 0.1 0.0 0.0 3.8 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.5 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.3 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.8 0.1 0.0 0.3 0.0 0.3 0.3 0.2 0.1 1.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.2 0.0 0.4 7.7 17.7 0.6 10.0 7.9 3.5 0.9 7.2 23.7 3.0 6.0 2.6 0.0 1.6 0.1 0.3 1.2 2.5 149.9 17.0 0.0 2.0 1.0 0.0 0.3 61.0 0.7 0.0 0.0 0.8 0.1 0.4 1.3 0.0 3.9 0.1 0.0 0.0 0.0 0.3 10.6 0.6 0.6 1.7 0.0 0.7 1.5 0.2 0.0 0.7 0.8 3.5 0.0 0.0 8.6 4.9 0.0 0.2 0.5 1.6 0.4 DNAJB7 HSC3 ENSG00000172404 "DnaJ heat shock protein family (Hsp40) member B7" Q7Z6W7 22 40859549-40862126 "Predicted intracellular proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 24.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 549.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000534 Approved NA NA "HPA000534: AB_1078693" "unprognostic (3.89e-2)" "unprognostic (1.12e-2)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (2.66e-2)" "unprognostic (1.16e-2)" "unprognostic (5.56e-3)" "unprognostic (1.62e-1)" "unprognostic (7.42e-2)" "unprognostic (1.22e-3)" "unprognostic (2.81e-2)" "unprognostic (4.46e-4)" "unprognostic (3.32e-3)" "unprognostic (3.06e-2)" "unprognostic (7.05e-2)" "unprognostic (2.45e-2)" 0.1 0.1 0.1 0.2 0.2 0.9 0.1 1.1 0.3 0.2 0.1 0.1 0.1 0.9 0.2 1.3 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.6 0.3 0.9 0.1 0.1 0.2 0.3 24.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.9 0.5 2.4 0.6 0.5 1.6 0.1 0.4 0.1 1.0 1.5 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.3 0.3 1.6 0.2 0.1 0.8 0.6 0.0 0.0 0.0 0.1 0.8 0.6 2.3 0.6 0.0 1.5 0.5 0.0 0.0 0.2 0.0 0.4 0.0 0.6 1.1 1.8 0.1 0.6 1.9 1.9 1.3 0.5 0.3 1.1 1.1 0.7 0.0 0.6 1.7 0.4 0.5 0.7 0.3 1.0 0.3 1.0 0.0 1.1 1.6 1.4 0.5 1.7 0.9 1.0 0.1 0.5 1.3 1.9 0.5 0.3 0.7 0.4 0.7 0.3 0.6 0.6 0.3 0.9 1.6 0.9 2.4 0.5 0.6 0.5 0.2 0.1 0.1 0.2 1.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 549.9 0.0 0.9 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.1 1.6 0.0 0.0 0.0 68.8 2.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.5 0.0 9.9 0.0 0.0 2.7 1.4 0.0 0.2 0.0 0.8 0.0 DNAJC14 "DNAJ, DRIP78, FLJ32792, HDJ3, LIP6" ENSG00000135392 "DnaJ heat shock protein family (Hsp40) member C14" Q6Y2X3 12 55820960-55830824 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017653 Approved NA NA "HPA017653: AB_1847799" "unprognostic (2.54e-2)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.90e-1)" "unprognostic (6.04e-2)" "unprognostic (3.14e-2)" "unprognostic (6.91e-3)" "unprognostic (6.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.63e-1)" "unprognostic (4.34e-2)" "unprognostic (3.89e-3)" "unprognostic (4.73e-2)" "unprognostic (7.98e-2)" "unprognostic (9.17e-2)" "unprognostic (8.92e-2)" 18.0 20.6 17.0 15.8 17.8 16.5 17.6 19.5 24.7 19.4 16.8 20.0 15.7 15.2 23.5 18.7 18.4 21.0 18.3 19.1 17.6 14.5 21.7 26.2 17.8 19.0 17.7 13.8 17.9 29.7 31.4 22.0 26.6 15.1 17.7 16.9 18.6 18.2 20.2 14.9 17.7 20.9 18.4 17.7 23.3 17.1 32.5 19.3 37.8 24.9 14.3 20.8 18.7 14.4 16.0 16.5 22.6 14.1 14.8 19.7 12.8 14.3 17.9 20.2 19.0 19.5 18.6 21.6 16.8 22.3 21.0 15.2 14.8 26.2 17.9 32.1 17.7 14.8 18.1 15.7 19.3 18.4 32.2 12.3 26.9 19.9 14.1 18.5 14.9 23.6 15.5 15.7 21.0 18.8 33.4 22.3 25.5 20.6 23.2 23.5 21.8 27.7 14.8 14.6 15.5 15.1 21.8 17.6 16.3 17.9 15.5 26.5 24.4 14.5 19.9 12.6 19.2 39.6 22.5 21.7 20.1 19.8 18.9 13.7 26.7 25.2 18.2 20.8 14.6 25.9 22.6 12.3 18.7 19.7 10.9 15.2 16.0 13.8 16.4 11.3 12.3 12.8 15.0 13.3 14.8 14.1 16.5 11.6 12.8 17.0 17.8 19.5 24.7 17.6 14.5 17.7 13.8 15.1 19.3 6.0 7.7 2.2 3.2 3.5 7.1 0.8 5.1 2.7 7.9 10.4 9.8 8.4 3.3 8.4 3.6 6.6 6.4 0.0 6.8 11.2 6.0 4.2 1.1 6.4 8.7 1.6 6.9 4.3 8.6 3.6 8.9 7.6 6.8 7.2 6.0 7.0 7.0 8.5 8.5 6.5 4.3 6.5 3.8 5.6 8.8 3.6 10.9 5.7 6.6 2.7 DNAJC16 KIAA0962 ENSG00000116138 "DnaJ heat shock protein family (Hsp40) member C16" Q9Y2G8 1 15526813-15592379 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043643 Approved Approved Vesicles NA NA Vesicles "HPA043643: AB_10796794" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "prognostic favorable (6.77e-4)" "unprognostic (4.52e-2)" "unprognostic (5.51e-2)" "unprognostic (2.05e-2)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (4.28e-2)" "unprognostic (2.35e-2)" "unprognostic (3.74e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" "unprognostic (5.38e-2)" "unprognostic (4.70e-2)" 9.6 11.5 9.8 9.5 18.7 3.9 12.3 13.2 24.3 10.2 10.9 18.4 14.2 12.0 12.9 14.7 11.5 13.0 11.2 9.1 11.0 10.8 22.1 20.0 8.9 10.5 11.1 10.8 13.1 13.4 20.1 20.3 13.9 17.2 10.8 11.2 12.0 12.1 10.8 19.2 10.2 11.2 11.9 10.7 11.3 9.9 11.1 11.0 11.4 13.9 8.9 12.5 10.3 9.4 6.9 4.1 3.8 4.1 3.2 8.0 3.6 7.5 7.2 6.0 10.9 16.4 13.3 5.6 9.0 9.2 9.1 9.8 6.2 11.1 6.5 6.1 9.0 11.9 9.4 7.3 8.0 12.9 7.7 3.4 6.7 8.3 10.7 16.3 10.3 7.8 9.6 9.5 14.7 8.2 11.4 10.1 5.5 14.1 6.0 10.4 3.0 5.2 5.3 5.7 6.8 5.1 6.2 7.7 7.3 11.2 5.2 6.7 6.3 9.3 8.9 7.6 9.0 5.6 4.2 13.7 16.1 5.8 14.8 4.9 8.2 11.5 5.9 10.0 6.0 7.6 3.8 4.1 3.0 5.6 4.0 8.0 6.8 5.8 5.0 4.1 6.9 7.4 6.3 2.3 3.2 2.9 3.7 5.3 3.6 9.8 18.7 13.2 24.3 11.0 10.8 11.1 10.8 17.2 11.0 0.0 8.3 11.2 4.1 4.5 13.4 12.0 20.4 21.4 11.4 24.4 21.6 10.5 1.7 8.1 7.1 8.7 8.6 0.0 6.0 6.3 8.6 10.7 8.1 15.3 9.4 17.5 11.1 16.5 19.9 5.4 11.5 5.8 6.8 5.4 11.3 12.4 8.2 7.0 10.6 13.8 15.0 6.5 4.6 22.7 14.5 5.1 18.4 4.3 11.5 5.2 DNAJC18 MGC29463 ENSG00000170464 "DnaJ heat shock protein family (Hsp40) member C18" Q9H819 5 139408588-139444491 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.4" "Group enriched" "Detected in many" 20 "Early spermatids: 425.4;Late spermatids: 1065.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036538, HPA060154" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA036538: AB_10670802, HPA060154: AB_2684212" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (2.73e-3)" "unprognostic (8.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "prognostic favorable (5.89e-4)" "unprognostic (8.09e-2)" "unprognostic (1.69e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (6.96e-2)" "unprognostic (1.97e-2)" 4.1 4.0 8.2 2.9 15.7 1.9 4.3 10.7 19.5 4.7 3.3 12.4 0.7 1.8 7.6 4.9 3.9 4.9 4.2 6.3 8.7 8.7 4.5 1.2 4.5 3.3 8.8 11.7 10.7 2.3 6.5 7.1 4.1 16.2 4.9 3.0 3.4 2.1 5.9 8.4 2.2 2.4 6.8 9.0 2.9 2.4 51.4 7.5 1.2 5.1 1.7 2.6 3.4 3.3 3.5 2.0 2.1 2.0 6.0 6.7 1.4 1.6 1.8 11.3 10.4 6.3 6.7 1.2 3.4 7.5 6.0 11.0 4.0 1.3 7.5 9.3 5.3 13.3 2.9 6.3 10.2 6.3 17.0 8.4 5.1 3.8 1.9 5.0 0.6 2.5 9.0 1.3 10.0 6.1 10.2 8.2 2.9 2.2 7.3 8.9 0.9 2.2 2.4 7.8 0.6 2.5 6.2 12.3 1.2 3.6 1.8 10.5 11.0 3.5 1.4 7.7 15.2 1.6 3.8 10.5 8.0 0.0 2.4 7.2 8.7 11.4 4.0 4.3 3.8 3.4 1.9 2.0 2.1 2.2 1.3 3.2 3.5 3.2 4.1 1.5 3.5 3.2 2.0 0.6 6.0 0.7 2.0 6.7 1.4 8.2 15.7 10.7 19.5 8.7 8.7 8.8 11.7 16.2 7.5 3.0 4.6 2.2 8.0 1.3 29.0 8.8 0.0 2.7 7.9 1.8 9.8 3.8 1.7 4.8 425.4 11.3 0.5 0.0 0.9 3.3 5.4 2.7 9.2 0.0 2.4 15.9 12.1 12.9 3.1 1065.4 13.0 2.6 5.0 4.6 2.5 14.5 2.5 1.4 17.7 2.9 18.4 19.4 8.5 37.2 4.9 1.0 3.9 3.2 1.2 2.6 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346917-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 10.0;intestine: 10.0;liver: 18.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 40.8;Enterocytes: 38.0;Exocrine glandular cells: 37.8;Hepatocytes: 39.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 15.7;EFO-21: 16.9;MCF7: 13.8;OE19: 28.8;T-47d: 12.5" "Region enhanced" "Detected in single" "midbrain: 1.4" "Not detected" "Not detected" HPA039953 Approved Vesicles NA NA Vesicles "HPA039953: AB_2676770" "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favorable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavorable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 1.1 0.3 0.5 0.4 1.0 0.0 0.4 0.4 2.2 1.5 5.4 0.8 0.4 10.0 2.2 1.3 0.4 0.8 10.0 0.4 0.7 0.5 5.2 18.9 0.4 0.4 1.0 1.2 0.4 5.2 2.7 0.4 0.9 4.6 0.4 5.2 0.8 1.2 0.4 0.4 0.2 8.3 0.4 0.8 0.4 4.4 0.6 0.4 0.4 6.6 0.4 0.4 0.4 0.7 0.7 0.8 2.7 0.5 0.5 0.5 0.4 1.4 9.4 0.0 10.0 0.0 0.0 3.3 0.3 3.0 1.0 2.2 15.7 9.9 0.0 16.9 0.3 0.9 0.1 1.4 0.0 1.7 0.1 2.3 0.3 0.2 7.8 2.4 0.0 1.7 0.1 0.0 1.5 0.3 4.0 1.4 0.0 0.1 0.3 0.7 13.8 0.0 0.0 0.0 28.8 4.8 0.0 4.8 0.0 0.2 0.0 1.6 0.8 0.3 0.5 3.1 0.2 12.5 0.2 0.2 1.0 3.1 0.1 1.3 0.0 0.0 0.0 2.3 0.0 2.0 2.3 0.5 0.5 0.5 0.3 0.3 0.4 0.4 0.3 0.1 0.7 0.3 0.3 2.7 0.5 0.4 0.8 0.2 0.4 0.5 1.0 0.4 2.2 0.7 0.5 1.0 1.2 4.6 0.4 0.0 0.6 0.0 1.8 0.6 0.1 0.3 40.8 8.1 1.2 1.8 0.0 0.1 0.0 13.9 3.9 0.3 38.0 0.0 37.8 0.2 1.3 0.5 1.1 39.4 0.1 3.2 20.2 1.3 0.3 1.3 0.0 0.0 3.3 1.0 24.6 0.6 20.2 23.0 0.7 18.0 0.3 0.0 0.3 0.0 0.4 0.3 0.3 0.0 23.4 0.1 DNAJC5G "CSP-gamma, FLJ40417" ENSG00000163793 "DnaJ heat shock protein family (Hsp40) member C5 gamma" Q8N7S2 2 27275421-27281499 "Predicted membrane proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "epididymis: 35.8;testis: 58.0" "Group enriched" "Detected in some" 6 "Early spermatids: 52.3;Late spermatids: 63.1;Spermatocytes: 116.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 2.8;HAP1: 3.6;JURKAT: 3.7;SH-SY5Y: 1.9" "Not detected" "Not detected" HPA041445 Approved NA NA "HPA041445: AB_2677485" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (2.26e-1)" "unprognostic (3.99e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.06e-1)" "unprognostic (1.75e-4)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (7.67e-2)" "unprognostic (1.97e-2)" 0.1 0.7 0.5 0.1 0.1 0.0 0.1 0.1 2.1 0.4 0.1 0.1 0.1 0.0 0.3 35.8 0.1 0.2 0.1 1.3 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 58.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.9 2.4 0.9 0.4 0.7 0.8 2.8 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 1.0 0.3 0.0 1.4 0.1 0.9 1.6 0.0 0.0 0.0 0.6 0.5 0.5 3.7 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 1.5 1.5 0.4 0.0 0.4 0.2 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.6 0.9 0.6 0.3 0.5 0.2 0.2 0.3 0.3 0.1 0.5 0.7 0.3 2.4 0.4 0.6 0.9 0.2 0.8 0.5 0.1 0.1 2.1 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 116.2 14.0 0.0 0.0 0.0 0.0 0.0 DNASE2B DLAD ENSG00000137976 "Deoxyribonuclease 2 beta" Q8WZ79 1 84398532-84415018 "Enzymes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "salivary gland: 98.7" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 1.4;Early spermatids: 1.6;Glandular cells: 2.3;Hofbauer cells: 5.7;Late spermatids: 2.4;Paneth cells: 1.7" "Cancer enhanced" "Detected in some" "prostate cancer: 9.3" "Region enhanced" "Detected in single" "basal ganglia: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.6;U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.24e-1)" "unprognostic (3.57e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-1)" "unprognostic (2.86e-1)" "unprognostic (1.62e-2)" "unprognostic (9.87e-2)" "unprognostic (7.90e-2)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (3.82e-5)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" 16.2 0.1 0.2 0.1 2.2 0.1 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.6 0.1 0.2 13.0 1.2 0.3 0.0 0.3 0.4 0.0 0.4 0.1 0.2 2.9 0.3 0.0 98.7 0.1 1.8 0.0 0.1 0.1 1.7 0.5 0.6 0.3 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 5.7 0.0 1.2 0.0 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 46.7;Spermatocytes: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.3 4.0 3.5 5.1 4.3 2.0 2.0 2.3 1.5 3.5 3.9 3.7 0.9 1.6 3.2 7.4 2.1 1.7 2.7 2.3 3.9 3.1 6.0 2.7 2.2 4.3 1.9 3.5 2.9 4.2 6.2 2.2 1.0 5.2 3.7 4.4 1.6 0.9 1.4 4.8 4.3 1.2 3.4 2.2 1.8 2.8 2.4 2.5 2.3 4.4 1.3 4.2 3.1 3.4 2.2 4.6 1.9 2.3 2.5 5.1 2.9 10.7 8.4 5.7 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 0.0 4.3 3.0 1.1 0.8 9.3 3.6 0.0 4.0 5.7 0.0 3.9 0.3 0.0 0.2 8.7 2.2 2.0 46.7 0.3 0.2 1.1 1.8 1.1 4.9 0.7 9.5 0.0 3.1 1.5 9.6 0.9 1.2 0.0 1.0 1.7 5.6 0.3 1.5 1.1 0.3 9.1 0.0 1.2 17.5 1.7 3.3 0.6 0.5 1.7 1.6 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081100-129090438 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" NA NA Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 6.4 12.8 10.0 6.8 10.6 7.7 6.8 11.7 19.3 8.3 17.1 17.7 8.6 28.6 6.0 7.4 18.8 6.6 9.2 4.1 10.1 10.7 9.4 21.8 6.7 6.6 13.2 10.6 7.7 10.5 10.4 6.9 11.6 12.5 10.0 14.2 6.1 10.3 5.8 5.2 10.3 27.7 6.3 15.2 8.5 11.8 12.2 11.0 9.4 6.3 8.5 9.1 7.8 8.0 8.8 12.5 9.8 8.3 7.9 21.7 7.2 4.1 16.0 15.7 14.4 5.3 4.5 18.2 10.3 6.0 19.6 11.0 20.6 13.9 8.1 9.1 6.4 15.0 30.3 16.1 8.6 8.3 9.4 9.9 10.6 10.8 15.7 9.4 11.0 13.2 4.9 12.1 12.8 10.2 4.5 8.7 15.1 17.5 8.1 5.5 21.0 12.5 11.4 13.5 30.9 13.0 14.8 12.7 14.5 7.1 6.7 18.0 11.8 13.0 11.8 4.3 9.6 21.7 7.3 7.1 16.9 8.1 15.9 13.9 10.1 19.4 12.3 7.5 2.2 11.1 4.4 6.8 9.8 8.9 8.1 21.7 8.8 10.9 10.8 8.5 6.0 11.1 10.5 1.4 7.9 8.3 12.5 10.1 7.2 10.0 10.6 11.7 19.3 10.1 10.7 13.2 10.6 12.5 11.0 6.0 4.6 3.7 2.9 2.1 3.2 1.6 5.1 0.0 2.3 1.8 5.9 16.9 1.7 5.9 0.5 2.4 26.6 0.0 8.4 11.4 3.3 2.7 5.7 17.0 6.5 3.2 3.5 6.2 3.8 0.4 2.0 2.3 5.0 4.6 9.0 9.1 5.4 13.3 3.9 3.8 3.4 0.0 3.1 4.5 8.7 3.4 13.7 3.8 12.2 3.4 DOPEY1 "dJ202D23.2, KIAA1117" ENSG00000083097 "Dopey family member 1" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favorable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 9.7 8.7 15.7 11.3 19.5 5.5 13.3 25.2 21.2 11.9 9.5 10.1 10.1 9.5 13.9 9.5 9.5 12.0 8.9 10.6 15.2 7.0 8.9 7.5 9.1 8.3 10.9 12.9 17.7 12.1 20.3 21.7 7.3 17.3 12.4 11.0 9.0 13.8 14.9 12.7 16.6 11.7 9.5 13.1 9.5 9.5 14.9 12.8 10.7 16.9 8.5 8.9 12.2 10.7 2.3 2.8 1.4 1.4 1.2 4.1 1.3 3.7 2.7 9.1 8.2 8.2 8.7 4.3 6.4 5.3 4.4 6.4 5.8 0.9 7.3 4.6 6.9 5.5 5.0 9.1 6.9 5.5 6.3 10.3 6.1 3.7 2.1 4.5 8.9 6.4 6.9 9.7 6.1 15.9 5.8 6.4 11.4 12.6 5.4 4.7 3.5 2.6 4.0 1.9 2.7 5.5 7.3 6.9 2.6 5.8 10.5 16.4 3.0 4.8 3.0 1.2 6.8 4.8 5.1 10.7 5.5 2.0 5.6 4.9 6.8 4.8 4.2 3.0 4.1 4.3 0.1 1.3 1.4 1.9 1.4 1.6 2.3 1.6 4.1 2.8 1.9 3.0 1.4 0.2 1.2 1.2 1.2 1.5 1.3 15.7 19.5 25.2 21.2 15.2 7.0 10.9 12.9 17.3 12.8 17.9 7.8 3.2 6.1 10.2 24.8 8.1 2.5 14.7 15.9 3.5 37.3 3.7 1.7 5.4 4.0 6.2 10.2 0.0 7.6 0.9 3.7 2.9 15.1 4.3 3.5 11.1 9.8 8.6 6.9 2.7 9.8 6.4 1.7 1.0 8.3 6.3 4.5 11.8 8.9 4.1 42.6 6.5 4.2 23.8 16.0 8.5 2.9 6.9 8.1 5.9 DPCR1 "bCX105N19.6, C6orf37, PBLT" ENSG00000168631 "Diffuse panbronchiolitis critical region 1" Q3MIW9 6 30934523-30954221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "gallbladder: 53.4;stomach 1: 70.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 42.0;Cholangiocytes: 48.4" "Group enriched" "Detected in some" 9 "pancreatic cancer: 56.8;stomach cancer: 55.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;OE19: 4.7;RPTEC TERT1: 1.3" HPA014036 Enhanced NA NA "HPA014036: AB_1847841" "unprognostic (2.81e-1)" "unprognostic (4.49e-2)" "unprognostic (9.13e-4)" "unprognostic (6.74e-2)" "unprognostic (4.29e-2)" "unprognostic (8.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.79e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (4.76e-2)" "unprognostic (9.80e-2)" "unprognostic (3.20e-2)" "unprognostic (3.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.0 0.0 4.8 0.0 53.4 0.0 0.0 0.0 0.0 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 42.0 0.0 0.2 0.0 0.0 0.0 48.4 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 DPEP3 ENSG00000141096 "Dipeptidase 3" Q9H4B8 16 67975663-67980829 "Enzymes, Predicted intracellular proteins" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 56.7" "Group enriched" "Detected in some" 7 "Spermatocytes: 154.2;Spermatogonia: 290.0" "Group enriched" "Detected in many" 10 "melanoma: 3.7;ovarian cancer: 16.9;testis cancer: 5.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 9.2;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 9.2;NK-cells: 2.3" "Cell line enriched" "Detected in single" 11 "U-266/70: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031870, HPA058607" Enhanced "Intracellular and membrane" NA NA 16000000 "HPA031870: AB_2674079, HPA058607: AB_2683775" "unprognostic (9.93e-2)" "unprognostic (2.81e-3)" "unprognostic (1.86e-1)" "unprognostic (9.52e-2)" "unprognostic (3.61e-2)" "unprognostic (1.37e-2)" "unprognostic (1.55e-1)" "unprognostic (6.52e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.49e-3)" "unprognostic (9.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-3)" "unprognostic (1.13e-1)" "unprognostic (3.98e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.1 0.4 0.4 1.0 0.6 0.1 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.4 1.4 0.2 56.7 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.8 0.1 9.2 0.5 2.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.5 0.3 0.4 0.0 0.0 0.1 0.8 0.8 0.3 9.2 2.3 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.3 0.3 0.1 0.1 0.0 0.9 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 30.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 25.8 0.0 154.2 290.0 0.0 0.2 0.0 0.0 0.0 DPPA5 Esg1 ENSG00000203909 "Developmental pluripotency associated 5" A6NC42 6 73353062-73354295 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lung: 2.0;testis: 6.8" "Cell type enhanced" "Detected in single" 35 "Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 2209 "testis cancer: 347.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "SuSa: 12.7" "Not detected" "Not detected" "HPA055016, HPA064505" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055016: , HPA064505: AB_2685275" "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 DPY19L1 KIAA0877 ENSG00000173852 "Dpy-19 like C-mannosyltransferase 1" Q2PZI1 7 34928876-35038271 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 183.8;Late spermatids: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059139 Uncertain Approved Vesicles NA NA Vesicles "HPA059139: AB_2683921" "unprognostic (4.66e-2)" "unprognostic (1.11e-3)" "unprognostic (8.53e-3)" "unprognostic (2.47e-3)" "unprognostic (2.50e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (3.57e-2)" "unprognostic (1.14e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.21e-1)" "unprognostic (1.88e-2)" "unprognostic (3.99e-1)" "unprognostic (2.69e-2)" "unprognostic (1.37e-1)" "unprognostic (4.12e-2)" 9.7 12.2 11.0 10.2 13.0 9.0 13.7 16.9 27.0 15.6 9.3 13.5 4.5 4.8 17.7 4.3 7.1 10.3 13.8 18.1 11.8 13.4 7.2 25.2 13.0 9.9 16.3 12.0 8.6 6.7 5.0 11.2 19.0 23.6 8.6 11.3 10.3 6.4 8.4 4.0 4.5 6.8 17.5 38.1 14.1 9.0 31.7 5.8 2.3 10.4 3.6 8.4 11.5 11.3 1.6 1.6 2.8 2.3 1.6 4.1 1.0 5.3 21.0 12.0 15.2 23.7 18.9 2.5 11.9 10.8 7.4 10.6 5.0 14.0 7.7 17.5 12.3 30.8 9.5 9.1 6.5 16.8 4.0 7.3 11.3 13.3 8.2 8.6 10.5 10.5 9.7 5.4 10.1 6.7 21.3 30.6 3.8 8.4 31.6 26.0 3.0 0.1 10.5 7.7 12.5 9.5 7.8 15.8 11.0 28.2 18.5 5.5 14.5 10.6 1.5 6.1 19.7 10.7 12.7 35.3 14.9 18.0 10.2 16.0 14.3 30.8 8.7 18.4 9.8 41.3 2.8 1.7 0.1 3.9 2.3 4.1 1.3 1.7 3.1 1.5 1.6 0.6 1.8 0.3 1.6 0.8 1.6 1.0 1.0 11.0 13.0 16.9 27.0 11.8 13.4 16.3 12.0 23.6 5.8 26.8 16.0 1.9 5.0 6.4 7.2 12.0 5.1 10.7 14.8 7.0 17.7 10.8 0.0 6.4 183.8 10.5 4.5 0.0 14.0 3.5 8.7 7.7 26.5 13.9 7.4 11.1 14.3 21.5 8.2 52.5 8.6 4.0 5.0 0.0 5.0 7.2 16.9 5.8 9.6 1.5 13.3 0.0 6.6 8.3 3.4 4.3 17.7 5.3 6.3 9.5 DPY19L3 ENSG00000178904 "Dpy-19 like C-mannosyltransferase 3" Q6ZPD9 19 32405543-32485895 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008325 Approved Approved Microtubules NA NA Microtubules "HPA008325: AB_1847853" "unprognostic (9.58e-3)" "unprognostic (3.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.55e-4)" "unprognostic (2.00e-2)" "unprognostic (3.76e-2)" "unprognostic (1.28e-3)" "unprognostic (3.27e-1)" "prognostic favorable (1.70e-4)" "unprognostic (3.26e-1)" "unprognostic (1.02e-2)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" 8.4 10.9 20.7 8.1 23.0 11.5 10.1 11.2 18.5 12.8 6.2 15.2 9.9 4.2 10.7 9.3 6.1 8.9 9.7 6.4 17.9 14.1 8.6 7.4 7.6 7.1 15.3 11.0 19.3 11.3 15.0 13.3 11.7 14.5 16.1 6.7 9.8 10.2 8.7 3.6 4.9 5.9 7.6 15.7 10.8 9.8 12.3 10.2 6.8 15.3 4.5 6.9 8.3 7.5 2.9 2.2 9.0 2.7 1.3 2.2 0.8 3.0 5.8 22.0 9.7 22.6 11.7 11.0 9.4 6.7 3.9 7.0 6.8 3.4 11.9 6.0 6.7 2.8 1.6 8.9 4.1 7.4 6.0 5.8 15.9 5.9 6.2 14.9 8.2 9.2 12.1 2.3 4.8 4.6 7.5 9.2 5.7 11.4 3.8 10.1 5.1 2.1 4.1 9.2 5.8 2.3 5.8 8.8 3.5 7.4 7.5 4.9 13.2 4.6 4.5 5.0 12.8 3.4 9.7 10.1 8.0 5.7 4.8 9.9 5.9 12.0 8.0 11.2 10.0 12.8 6.0 2.5 7.4 1.8 1.9 1.0 2.0 1.7 1.7 2.2 2.9 1.4 1.6 9.0 1.3 2.7 1.6 2.2 0.8 20.7 23.0 11.2 15.0 17.9 14.1 15.3 11.0 14.5 10.2 6.0 10.0 3.2 3.5 1.8 11.0 3.1 0.0 6.7 5.7 14.0 9.8 5.5 1.7 1.9 1.7 6.5 3.9 0.0 3.5 4.5 7.7 14.9 1.1 4.9 4.7 74.7 3.5 26.4 14.8 2.2 10.0 2.1 1.7 0.0 8.7 25.9 3.2 4.3 11.0 3.3 12.0 0.0 3.1 10.4 21.2 2.6 12.5 2.1 3.6 3.1 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.6 0.1 5.9 0.0 0.0 0.3 0.4 0.1 16.6 0.0 0.2 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.3 14.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 0.0 2.3 0.0 1.1 0.6 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 5.3 1.2 0.0 2.0 1.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.5 0.1 11.8 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.9 0.0 10.6 0.2 DRC1 "C2orf39, CCDC164, CILD21, FLJ32660, MGC16372" ENSG00000157856 "Dynein regulatory complex subunit 1" Q96MC2 2 26401916-26456711 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.5;fallopian tube: 36.8;testis: 29.6" "Group enriched" "Detected in some" 7 "Ciliated cells: 339.9;Early spermatids: 110.1;Late spermatids: 214.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.3" "Region enriched" "Detected in many" 4 "pons and medulla: 20.5" "Cell type enriched" "Detected in single" 64 "neutrophil: 11.2" "Lineage enriched" "Detected in single" 64 "granulocytes: 11.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.7;SCLC-21H: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-3)" "unprognostic (2.68e-2)" "unprognostic (5.36e-2)" "unprognostic (5.27e-3)" "unprognostic (3.41e-3)" "unprognostic (8.56e-3)" "unprognostic (7.02e-4)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (7.26e-2)" "unprognostic (1.97e-3)" "unprognostic (2.99e-1)" "unprognostic (3.06e-3)" "unprognostic (8.19e-2)" "unprognostic (9.91e-3)" "unprognostic (2.16e-1)" "unprognostic (1.30e-2)" 0.3 0.4 2.4 0.3 3.6 1.0 0.3 0.1 2.1 2.0 0.3 7.7 0.0 0.3 1.3 11.3 0.3 36.8 0.3 0.3 3.6 4.8 0.4 0.3 6.0 0.3 1.3 1.8 5.2 0.3 0.3 4.8 0.3 20.5 0.4 0.3 0.0 0.3 0.7 0.3 0.3 0.3 0.3 1.0 0.3 0.4 29.6 2.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.2 0.6 0.6 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.8 4.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 2.4 3.6 0.1 2.1 3.6 4.8 1.3 1.8 20.5 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 339.9 21.6 1.8 0.0 0.0 0.0 0.0 110.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 214.9 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 33.5 1.1 0.0 0.0 0.0 0.0 0.0 DRC3 "CFAP134, DKFZP586M1120, LRRC48" ENSG00000171962 "Dynein regulatory complex subunit 3" Q9H069 17 17972813-18016889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.9" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 239.6;Cone photoreceptor cells: 117.8;Rod photoreceptor cells: 86.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 7.2;U-87 MG: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036040, HPA036041" Approved NA NA "HPA036040: AB_10602349, HPA036041: AB_2674915" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-3)" "unprognostic (9.48e-2)" "prognostic favorable (4.05e-5)" "unprognostic (1.06e-1)" "unprognostic (7.64e-5)" "unprognostic (6.11e-2)" "unprognostic (5.47e-3)" "unprognostic (8.59e-2)" "unprognostic (3.67e-1)" "unprognostic (1.33e-4)" "unprognostic (1.62e-1)" "unprognostic (1.15e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.56e-2)" 0.7 1.1 3.3 0.4 5.9 0.3 2.2 1.2 3.1 5.0 0.7 8.2 7.2 0.9 5.3 15.9 0.7 46.9 2.3 1.1 5.1 5.1 3.7 1.1 6.5 0.7 0.8 2.3 8.2 3.3 6.8 18.5 0.6 13.4 2.2 0.7 6.1 1.6 2.1 1.3 1.2 0.5 1.9 1.2 0.9 0.8 15.4 2.6 0.0 7.0 0.3 0.5 0.6 1.0 0.4 0.4 3.1 0.7 0.0 1.0 0.2 1.0 3.9 0.6 2.3 0.5 1.5 0.3 1.0 0.5 1.9 2.0 0.6 4.2 0.0 3.4 0.6 1.2 3.4 1.3 0.5 1.1 0.2 2.8 0.1 0.3 0.0 1.4 0.6 0.2 1.3 1.1 3.0 0.4 2.4 0.6 0.5 0.0 0.3 2.3 1.2 0.2 0.1 0.7 0.3 0.8 0.2 1.2 0.0 7.2 1.5 1.2 3.5 1.4 0.1 3.7 2.7 3.9 0.0 1.1 1.1 0.9 0.2 0.5 0.5 0.2 0.1 5.8 0.0 3.3 0.0 0.7 2.0 0.3 0.2 0.2 0.4 0.1 1.0 0.4 0.3 0.3 0.6 3.1 0.0 0.2 0.2 0.0 0.2 3.3 5.9 1.2 3.1 5.1 5.1 0.8 2.3 13.4 2.6 3.0 1.9 0.0 3.5 0.0 8.7 0.0 0.0 239.6 25.0 10.4 117.8 0.4 5.0 2.5 24.3 0.6 0.0 0.0 0.7 2.1 0.0 2.0 0.0 0.0 0.4 19.1 0.0 5.5 1.6 6.6 4.6 0.3 0.0 0.0 0.1 9.7 0.9 0.0 4.2 8.7 86.1 0.0 0.0 42.6 12.5 0.0 0.7 4.3 0.3 1.1 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.3;Intestinal endocrine cells: 1.7;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 11.3;TIME: 19.0;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 2.4 0.1 0.1 0.2 0.1 0.5 0.1 0.4 1.0 0.0 0.4 0.3 0.3 0.1 0.7 0.0 0.3 0.0 0.8 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.5 1.5 0.0 0.8 0.0 0.1 1.4 0.5 0.0 1.0 1.6 0.0 1.3 0.5 0.1 0.1 0.1 0.3 11.3 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.1 19.0 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 0.0 0.0 0.0 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060942 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060942: AB_2684392" "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.4 0.0 4.7 7.0 0.3 19.9 11.5 5.1 2.2 0.0 0.0 0.0 0.0 10.1 1.3 0.1 0.4 0.9 4.9 0.0 0.0 0.0 2.2 0.0 4.0 0.0 0.0 7.0 1.3 3.1 7.4 1.9 1.0 0.0 0.0 0.2 24.9 0.0 0.0 0.0 0.3 0.0 2.1 0.2 5.3 0.0 2.3 0.0 0.9 1.1 1.8 0.0 0.0 1.1 0.0 0.0 1.7 25.9 0.8 1.8 2.2 0.1 0.0 0.0 5.4 0.0 2.2 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 6.0 14.4 2.0 8.0 10.3 9.4 14.3 43.3 0.0 2.3 10.4 3.9 2.4 0.0 7.9 1.1 11.3 0.5 0.0 2.0 69.4 40.8 6.6 4.6 12.9 2.2 3.2 6.3 16.0 2.1 1.4 22.7 2.9 6.8 0.0 0.1 14.3 5.4 0.0 34.6 18.8 4.2 12.9 12.3 13.1 11.7 11.5 7.4 2.5 0.6 5.4 DTHD1 FLJ16686 ENSG00000197057 "Death domain containing 1" Q6ZMT9 4 36281622-36345756 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;fallopian tube: 20.6;lung: 18.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 286.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (9.79e-6)" "unprognostic (4.04e-2)" "unprognostic (1.15e-2)" "unprognostic (5.54e-3)" "unprognostic (2.85e-1)" "unprognostic (5.45e-5)" "unprognostic (5.12e-3)" "unprognostic (9.11e-2)" "unprognostic (1.82e-2)" "unprognostic (7.59e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.05e-5)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.65e-2)" "unprognostic (7.12e-3)" 0.7 0.5 1.9 5.8 14.8 0.9 0.4 0.3 0.3 2.1 1.1 2.8 1.4 0.7 1.1 11.9 0.7 20.6 3.5 0.4 3.1 2.9 0.4 0.7 18.5 5.4 0.4 0.0 8.1 0.3 0.2 0.8 0.2 16.6 0.5 0.7 0.1 0.6 0.3 0.2 0.2 1.3 0.4 0.7 8.0 0.8 2.2 4.5 0.0 0.6 1.2 4.0 3.1 0.5 0.0 0.0 0.1 0.0 1.1 6.8 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.1 6.8 0.0 1.2 0.0 0.6 2.1 0.0 0.0 0.0 2.6 0.0 1.1 0.0 0.0 0.0 0.7 1.9 14.8 0.3 0.2 3.1 2.9 0.4 0.0 16.6 4.5 3.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 286.4 40.9 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.6 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 20.1 0.0 0.0 DUS4L "DUS4, PP35" ENSG00000105865 "Dihydrouridine synthase 4 like" O95620 7 107563484-107578464 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044301 Approved Approved Cytosol NA NA Cytosol "HPA044301: AB_10967460" "unprognostic (7.95e-2)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (5.66e-2)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-3)" "unprognostic (2.29e-2)" "unprognostic (9.21e-3)" "unprognostic (7.74e-3)" "unprognostic (6.72e-3)" 4.5 6.2 9.4 7.0 10.4 2.9 7.8 5.0 8.2 5.5 5.7 7.5 6.2 4.8 5.7 10.4 5.5 6.0 4.7 10.1 8.0 7.7 9.9 9.0 3.9 5.0 10.3 6.2 7.8 5.4 8.0 5.1 4.8 7.6 7.8 5.7 5.7 5.1 4.8 7.1 7.1 5.2 5.3 11.0 4.3 5.4 7.7 6.6 6.6 8.5 5.9 5.7 6.2 4.5 1.5 1.3 0.5 1.3 1.2 2.4 0.7 6.5 3.0 3.0 1.8 1.2 2.0 3.9 1.9 2.6 2.8 2.7 3.4 5.4 7.0 3.6 1.5 7.4 2.0 3.1 4.0 4.3 2.1 2.6 2.5 1.6 3.7 3.0 4.8 0.4 2.0 5.4 2.7 9.2 3.2 4.1 6.6 8.7 2.6 4.3 4.8 6.6 8.4 4.3 5.2 5.4 3.6 2.7 7.9 5.4 3.4 2.7 6.8 3.1 6.4 5.4 3.9 3.1 3.8 2.9 4.0 3.2 3.0 4.4 4.9 6.0 7.9 4.3 6.8 4.8 0.0 1.2 0.1 1.4 1.3 1.6 1.5 2.3 1.2 1.3 0.7 1.9 2.4 0.5 1.2 0.7 1.1 1.7 0.7 9.4 10.4 5.0 8.2 8.0 7.7 10.3 6.2 7.6 6.6 6.0 4.6 5.6 7.5 4.5 8.8 8.0 2.5 22.7 6.8 10.4 3.9 7.9 6.6 8.7 20.0 2.7 3.8 0.0 13.9 7.4 4.2 5.5 13.8 8.9 6.1 3.2 9.2 4.9 4.6 17.7 4.0 4.9 3.3 5.4 4.5 13.0 11.5 5.3 3.5 13.2 9.1 12.9 4.2 11.2 10.9 3.4 3.1 3.8 5.5 6.4 DUSP27 ENSG00000198842 "Dual specificity phosphatase 27, atypical" Q5VZP5 1 167094045-167129165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 131.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 12.8;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 18.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012912 Approved Nucleoplasm NA NA Nucleoplasm "HPA012912: AB_2668767" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.44e-3)" "unprognostic (1.22e-1)" "unprognostic (2.10e-3)" "unprognostic (4.65e-2)" "unprognostic (1.53e-1)" "unprognostic (8.19e-2)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.72e-1)" "unprognostic (7.65e-2)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 2.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 46.8 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.0 0.0 0.9 0.0 64.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.5 18.2 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 131.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 374.6;Late spermatids: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.5 14.3 1.7 1.0 1.5 1.7 2.7 4.5 3.7 2.2 2.9 1.0 3.2 5.8 0.8 4.1 1.5 3.2 1.6 1.9 4.4 2.0 2.9 2.9 3.9 0.0 2.7 2.2 2.9 1.8 3.0 2.2 6.6 1.1 2.5 3.2 1.8 4.4 0.1 2.4 0.7 1.9 0.1 0.1 2.0 1.8 5.3 0.8 7.4 5.6 3.3 1.4 3.7 0.5 0.0 4.5 0.9 0.8 4.9 2.8 3.7 1.9 3.4 2.4 2.6 4.6 2.2 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 6.0 11.1 11.2 13.5 7.6 12.9 6.5 7.6 8.1 6.8 3.5 15.7 12.3 16.6 7.5 374.6 6.3 6.1 0.0 10.8 7.9 10.8 9.4 5.8 9.7 5.9 4.8 15.5 6.7 4.9 209.7 16.4 6.7 11.8 4.6 7.0 16.2 6.4 8.6 11.7 11.7 14.7 12.9 10.8 58.1 11.8 4.8 16.8 13.1 6.8 7.3 DYDC2 "bA36D19.6, MGC16186" ENSG00000133665 "DPY30 domain containing 2" Q96IM9 10 80344745-80368073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 56.4" "Cell type enriched" "Detected in some" 9 "Ciliated cells: 337.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Group enriched" "Detected in many" 5 "amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 4.4;NTERA-2: 7.0;SCLC-21H: 6.0;SH-SY5Y: 4.0;U-2197: 4.4" "Low region specificity" "Detected in all" "HPA038006, HPA038007" Enhanced NA NA "HPA038006: AB_10672734, HPA038007: AB_2675783" "unprognostic (1.60e-3)" "unprognostic (7.35e-2)" "unprognostic (1.89e-2)" "unprognostic (9.26e-3)" "unprognostic (8.85e-2)" "unprognostic (3.26e-1)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (2.34e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-4)" "unprognostic (9.86e-2)" "unprognostic (5.40e-2)" 0.2 0.2 6.3 0.2 9.1 0.6 0.4 0.1 1.7 1.6 0.3 3.0 0.1 0.3 1.3 10.0 0.5 56.4 0.4 0.2 7.7 6.8 0.3 0.3 3.6 0.2 0.2 0.4 4.3 0.6 0.2 0.1 0.4 16.3 0.3 0.2 0.1 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 0.4 5.2 0.7 0.1 0.3 0.1 0.2 0.2 0.1 0.6 0.6 2.4 0.3 1.2 0.4 0.0 0.2 0.1 4.4 0.1 0.5 0.0 0.1 0.0 0.6 0.4 0.1 0.4 0.7 0.1 0.9 0.1 1.0 0.2 0.3 0.1 0.1 0.2 0.6 0.3 0.2 1.5 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.0 0.0 1.4 0.2 0.3 0.3 0.3 0.7 0.0 7.0 0.0 0.0 1.8 0.5 1.6 0.0 0.1 6.0 4.0 0.2 0.0 0.7 1.7 0.0 2.7 0.1 0.1 0.3 4.4 0.0 0.1 0.1 0.3 0.4 0.0 0.0 2.4 0.3 0.1 0.3 0.1 0.4 0.3 0.3 0.2 0.0 0.6 0.3 0.4 0.5 1.2 0.2 0.6 0.0 0.0 6.3 9.1 0.1 1.6 7.7 6.8 0.2 0.4 16.3 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 337.3 30.7 0.0 0.0 0.0 1.7 0.4 35.5 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 24.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.9 2.2 0.0 0.0 0.0 0.0 0.1 DYTN ENSG00000232125 Dystrotelin A2CJ06 2 206651621-206718396 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.5;bone marrow: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HEL: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.23e-3)" "unprognostic (8.52e-2)" 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EBF4 "COE4, KIAA1442, O/E-4, RP5-860F19.3" ENSG00000088881 "Early B cell factor 4" Q9BQW3 20 2692878-2760108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 15.9;Cholangiocytes: 17.8;Glandular cells: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.8;SH-SY5Y: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.59e-4)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (7.79e-3)" "unprognostic (3.82e-1)" "prognostic favorable (2.47e-5)" "unprognostic (2.68e-2)" "unprognostic (5.58e-3)" "unprognostic (1.87e-3)" "unprognostic (2.91e-1)" "unprognostic (1.17e-2)" "unprognostic (2.87e-3)" 3.8 5.9 8.4 3.7 9.3 0.9 8.8 2.8 13.6 14.9 11.6 10.7 9.5 4.1 19.2 5.4 6.0 8.3 4.8 2.9 9.0 7.3 4.3 1.6 5.0 2.4 9.3 5.3 17.5 5.6 21.8 5.8 5.5 8.4 14.5 2.2 8.8 6.3 14.1 1.9 2.7 5.0 11.9 6.7 3.5 6.2 2.8 10.5 0.6 13.9 0.1 2.0 8.4 13.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.5 5.0 1.5 0.2 0.2 0.5 1.2 2.3 1.3 0.5 0.2 0.2 0.0 2.1 0.5 3.8 0.3 0.3 0.1 0.6 5.1 4.7 0.0 0.2 0.1 3.1 0.0 0.1 0.4 0.2 0.2 0.0 0.1 0.4 1.8 0.0 0.0 0.1 0.6 0.0 5.8 0.7 0.0 0.3 4.2 0.5 0.3 0.0 4.6 2.9 17.2 1.2 0.0 0.7 2.3 2.0 0.2 0.1 0.3 0.5 0.1 2.5 0.6 0.1 0.4 0.0 0.4 2.5 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 8.4 9.3 2.8 8.6 9.0 7.3 9.3 5.3 8.4 10.5 0.0 0.6 0.0 15.9 3.1 7.0 1.7 17.8 5.3 6.8 1.8 0.0 0.2 0.0 1.8 0.3 2.2 0.0 0.0 0.3 0.0 4.1 12.8 0.0 3.9 0.2 4.8 0.0 6.2 0.3 0.0 3.1 0.3 1.7 0.0 0.1 5.2 0.5 0.0 6.7 0.0 1.9 6.5 3.3 0.2 1.3 0.9 0.2 0.0 0.2 6.4 EBLN1 ENSG00000223601 "Endogenous Bornavirus like nucleoprotein 1" P0CF75 10 22208814-22210021 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 7.4" "Group enriched" "Detected in some" 26 "Early spermatids: 14.7;Late spermatids: 4.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "myeloid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "GAMG: 4.8;U-2 OS: 1.6" NA NA "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.2 1.2 0.0 2.1 0.0 15.3 2.6 0.5 0.3 2.4 1.5 1.0 2.6 2.5 1.8 3.1 1.1 2.1 0.1 0.0 0.8 1.8 3.1 1.7 0.1 5.1 2.6 1.2 1.2 1.9 1.6 2.4 3.1 0.5 1.3 2.2 2.1 1.4 1.0 2.1 1.8 0.9 2.4 1.5 2.4 2.9 2.6 2.2 6.3 1.5 1.1 3.8 0.2 1.3 0.9 5.3 4.7 1.4 3.0 4.0 2.1 0.4 1.3 1.0 2.6 4.3 3.3 0.8 2.8 1.3 1.8 2.0 2.2 2.7 1.3 1.2 2.2 5.0 2.3 0.8 4.2 4.9 2.9 1.6 2.7 2.6 2.6 1.8 2.9 1.6 5.1 1.5 2.8 2.0 5.9 3.3 1.1 1.4 5.3 1.3 2.0 1.4 5.5 1.2 2.6 1.3 2.3 0.7 3.9 3.5 1.6 3.4 1.5 2.9 4.0 3.2 5.1 2.4 2.6 1.5 4.6 2.6 0.3 1.5 6.3 3.6 0.5 3.0 1.5 3.2 3.1 0.5 2.6 2.7 3.8 3.3 1.1 0.6 2.2 3.7 0.2 0.0 2.1 5.0 11.6 5.0 4.7 0.8 15.3 2.7 2.3 3.5 7.9 7.1 0.0 3.1 1.5 4.5 4.5 23.3 1.4 5.4 6.2 7.7 1.1 4.4 2.5 3.2 4.1 7.4 3.3 0.2 7.8 3.9 1.7 1.8 3.3 2.8 3.5 3.5 3.5 0.1 5.0 6.5 3.1 3.7 4.8 5.5 12.2 7.5 3.3 11.2 ECM2 ENSG00000106823 "Extracellular matrix protein 2" O94769 9 92493554-92536655 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 43.8;Hepatocytes: 36.8;Leydig cells: 113.1;Peritubular cells: 65.4;Smooth muscle cells: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 11.4;ASC TERT1: 20.8;HSkMC: 21.9;hTCEpi: 24.9;hTERT-HME1: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035347 Approved "Secreted to extracellular matrix" NA NA 5500000 "HPA035347: AB_10669856" "unprognostic (2.48e-1)" "unprognostic (2.11e-1)" "unprognostic (2.27e-2)" "unprognostic (2.20e-2)" "unprognostic (5.35e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.50e-5)" "unprognostic (6.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.12e-3)" "unprognostic (2.39e-2)" "unprognostic (3.80e-2)" "unprognostic (6.63e-3)" 43.3 5.0 5.4 7.2 4.3 0.0 18.6 9.5 1.9 20.9 6.5 5.4 11.6 2.9 14.7 27.5 8.4 11.6 11.2 13.8 9.3 3.6 10.1 28.2 8.8 2.3 11.0 4.2 34.6 1.9 4.9 4.7 1.4 17.8 16.4 2.4 5.8 3.4 8.1 6.0 5.8 5.4 10.1 15.8 0.5 2.8 15.4 7.4 1.1 8.3 15.5 2.4 13.7 8.8 0.3 0.6 0.0 0.5 0.1 0.5 0.0 0.4 0.0 0.2 0.0 11.4 20.8 0.7 0.4 0.6 0.0 0.3 0.3 0.0 0.0 0.0 1.1 0.2 0.3 0.5 0.4 0.0 2.4 0.0 0.0 0.0 0.0 1.9 0.1 0.0 21.9 24.9 0.5 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 5.4 4.3 9.5 1.9 9.3 3.6 11.0 4.2 17.8 7.4 0.0 2.9 0.0 0.1 10.2 2.5 4.5 0.0 5.3 3.4 0.0 2.0 0.0 0.0 0.0 3.8 2.9 0.7 0.0 0.0 9.4 43.8 0.1 0.0 36.8 0.4 0.0 0.0 3.7 1.9 5.5 113.1 1.1 5.0 0.0 0.0 0.0 0.0 0.0 65.4 6.7 2.8 25.8 33.0 0.7 0.6 8.0 0.7 0.0 0.0 0.1 ECT2L "ARHGEF32, C6orf91, FBXO49, LFDH" ENSG00000203734 "Epithelial cell transforming 2 like" Q008S8 6 138795926-138904070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 133.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 8.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 2.8;SCLC-21H: 2.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA035488 Uncertain NA NA "HPA035488: AB_10672865" "unprognostic (2.88e-2)" "unprognostic (7.88e-2)" "unprognostic (2.52e-2)" "unprognostic (5.53e-3)" "unprognostic (3.48e-2)" "unprognostic (8.45e-3)" "unprognostic (9.42e-2)" "unprognostic (2.44e-2)" "unprognostic (1.18e-1)" "unprognostic (7.03e-2)" "unprognostic (5.90e-4)" "unprognostic (2.32e-1)" "unprognostic (5.21e-2)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (7.07e-3)" "unprognostic (2.65e-3)" 0.5 0.3 0.7 0.2 1.1 0.5 0.4 0.8 0.7 1.1 0.3 4.2 0.0 0.2 0.6 7.7 1.0 18.5 1.7 2.7 1.1 1.1 0.1 0.2 12.2 0.2 0.3 0.0 9.4 0.1 0.3 1.8 0.2 8.1 0.3 0.1 0.8 0.6 0.2 0.5 0.7 0.6 1.6 0.3 0.3 0.3 1.2 0.8 0.0 0.4 0.0 0.1 0.8 0.3 0.6 0.3 1.7 0.6 0.7 0.8 0.0 0.2 0.1 0.2 0.8 0.0 0.5 1.2 0.0 0.0 0.1 0.1 0.8 0.8 0.8 0.3 0.0 0.3 0.3 0.0 0.0 0.9 0.2 0.5 2.8 0.2 0.0 0.1 0.9 0.4 1.3 1.0 0.0 0.0 0.6 0.0 0.2 0.2 0.9 0.0 0.3 0.6 1.0 0.6 0.2 0.6 0.5 0.3 0.2 0.0 0.7 2.9 0.7 0.2 0.8 0.4 0.5 0.3 1.2 0.0 0.6 0.3 0.8 0.3 0.4 0.2 0.3 0.4 0.8 0.2 1.7 0.3 0.6 0.3 0.3 0.4 0.3 0.2 0.7 0.1 0.6 0.7 0.8 0.6 0.7 0.6 0.3 0.2 0.0 0.7 1.1 0.8 0.7 1.1 1.1 0.3 0.0 8.1 0.8 0.0 0.6 0.0 0.5 0.5 2.2 1.2 0.0 133.8 21.6 0.0 2.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.3 EDDM3A "FAM12A, HE3-ALPHA" ENSG00000181562 "Epididymal protein 3A" Q14507 14 20745892-20748380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "ductus deferens: 61.8;epididymis: 129.9" "Cell type enriched" "Detected in some" 22 "Collecting duct cells: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 13 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 2.9;NB-4: 3.4;SH-SY5Y: 1.5" HPA049952 Approved "Secreted in male reproductive system" NA NA "HPA049952: AB_2680970" "unprognostic (1.42e-1)" "unprognostic (9.88e-2)" "unprognostic (8.56e-3)" "unprognostic (2.10e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 61.8 0.0 0.1 129.9 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.2 14.7 0.1 0.1 0.1 0.0 0.1 0.4 0.4 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Group enriched" "Detected in many" 21 "Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 9.1 0.0 1.2 0.0 4.0 9.3 0.0 0.1 0.9 0.0 0.3 0.0 4.5 0.0 0.0 0.2 0.0 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.3 0.3 3.8 1.6 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.1 7.2 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 0.0 5.1 0.0 6.6 6.1 0.0 0.4 0.0 342.6 18.2 0.0 0.0 0.3 0.0 0.1 456.6 0.1 0.0 0.0 1.3 0.1 1.9 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 332.2 4.4 1.2 1.7 0.0 0.0 0.0 2.0 0.0 5.3 0.0 0.0 0.0 0.8 5.7 4.4 1.6 0.2 0.0 0.0 1.8 EFCAB10 ENSG00000185055 "EF-hand calcium binding domain 10" A6NFE3 7 105565120-105600875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.0;testis: 34.9" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 275.7;Early spermatids: 163.2;Late spermatids: 68.5;Spermatocytes: 62.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA019751 Uncertain NA NA "HPA019751: AB_1848011" "unprognostic (1.20e-1)" "unprognostic (2.24e-3)" "unprognostic (8.96e-2)" "unprognostic (4.76e-3)" "unprognostic (4.11e-2)" "unprognostic (3.58e-2)" "unprognostic (3.58e-2)" "unprognostic (6.07e-3)" "unprognostic (1.47e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-3)" "unprognostic (6.87e-2)" "unprognostic (3.07e-9)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" "unprognostic (5.67e-2)" 0.4 0.8 2.0 0.9 9.6 2.2 0.3 0.7 3.7 1.5 0.7 4.2 0.0 0.7 1.3 6.2 0.9 29.0 0.5 0.5 2.9 3.5 0.7 0.7 6.4 1.0 0.7 3.5 6.9 1.6 0.2 2.0 0.4 11.8 0.7 0.5 0.0 1.0 0.2 1.3 1.4 0.8 0.2 1.1 0.9 0.8 34.9 2.3 0.0 0.7 0.0 0.3 0.8 0.4 2.9 1.7 3.7 1.2 1.4 3.0 0.6 2.1 6.0 3.2 2.1 0.6 0.3 1.4 2.9 0.0 0.0 0.1 1.1 1.4 2.9 2.6 0.1 0.6 0.8 0.1 0.0 0.0 1.1 5.4 1.5 4.1 3.3 0.4 1.9 1.9 0.2 0.0 0.2 0.0 2.0 0.0 1.4 4.4 2.4 0.1 4.5 2.1 4.1 5.3 1.4 2.2 1.4 3.3 6.3 0.3 1.3 3.1 4.2 1.7 6.2 1.0 4.4 1.2 2.2 1.6 3.1 2.1 6.4 1.9 3.4 4.0 2.7 1.8 3.0 1.5 3.7 1.2 1.0 1.9 0.9 1.7 1.6 1.9 1.6 0.7 2.9 3.0 2.2 1.4 1.4 0.9 1.7 1.2 0.6 2.0 9.6 0.7 3.7 2.9 3.5 0.7 3.5 11.8 2.3 0.0 4.1 0.0 0.1 0.0 0.7 0.3 0.0 275.7 12.5 0.0 0.0 0.0 0.0 0.0 163.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 68.5 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.3 0.1 0.0 0.0 62.1 1.9 0.0 0.1 0.0 0.0 0.0 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.9" "Group enriched" "Detected in many" 7 "Early spermatids: 451.2;Late spermatids: 287.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA051209: AB_2681389" "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 4.7 5.8 10.2 6.2 8.1 5.3 9.3 5.7 7.6 5.6 5.2 10.4 6.7 5.1 4.9 6.9 6.2 11.0 4.9 3.7 7.8 6.6 7.6 5.8 3.2 3.3 8.6 5.7 5.2 4.8 8.3 8.2 8.4 7.7 5.4 5.6 6.1 5.6 5.4 2.4 3.7 3.6 6.3 8.4 6.7 4.4 36.9 6.2 2.5 7.9 3.3 6.3 5.2 4.1 2.6 2.1 12.8 5.3 3.3 1.6 0.8 4.8 7.5 6.5 8.2 4.0 4.4 18.5 7.2 6.5 9.8 6.9 8.8 17.4 7.6 13.7 4.8 7.0 10.7 5.6 14.3 14.2 8.6 3.6 5.5 6.4 14.3 0.9 7.0 13.3 3.0 3.5 6.4 7.3 5.6 8.1 8.2 5.7 7.6 11.6 25.3 5.2 9.4 2.8 19.9 13.6 6.0 10.4 5.5 9.0 13.6 2.8 4.6 9.1 16.9 8.4 14.2 13.7 5.0 6.9 5.3 7.4 5.6 7.0 4.5 13.0 13.2 7.7 3.3 9.7 12.8 1.3 3.4 0.6 3.0 0.3 2.6 1.0 1.0 2.1 2.6 1.6 1.4 4.0 3.3 5.3 1.8 1.3 0.8 10.2 8.1 5.7 7.6 7.8 6.6 8.6 5.7 7.7 6.2 0.0 0.6 12.8 5.3 4.5 8.4 3.5 17.8 49.5 6.8 17.4 2.0 13.9 8.3 10.8 451.2 6.0 2.7 0.0 14.8 23.8 8.0 3.2 4.7 5.8 10.3 3.2 0.0 4.3 3.7 287.7 5.2 6.4 3.3 12.6 3.3 4.2 5.4 6.2 7.1 13.3 10.8 0.0 3.1 26.2 12.8 2.9 6.4 2.9 9.5 4.6 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Group enriched" "Detected in many" 4 "Early spermatids: 161.3;Late spermatids: 143.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 4.0 1.7 0.2 2.1 7.3 3.1 2.2 0.5 0.7 1.2 1.7 5.6 0.3 6.6 0.8 0.0 1.1 0.0 0.4 4.0 0.2 0.6 5.2 3.3 0.5 2.1 4.0 0.6 1.3 1.9 2.7 0.0 5.0 4.5 4.1 1.5 9.9 2.4 0.1 1.7 2.3 0.9 2.8 3.2 4.7 1.3 1.8 9.2 3.2 1.2 0.6 1.2 0.1 2.6 1.3 6.6 4.7 1.6 0.3 1.3 0.4 1.1 10.2 7.0 0.9 6.3 7.8 4.3 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 8.9 2.1 2.0 1.7 0.7 2.3 3.8 0.0 5.3 1.2 0.0 0.0 0.2 0.0 0.7 161.3 6.3 0.5 0.0 0.7 0.2 1.3 1.0 5.8 0.8 1.7 3.2 2.9 3.7 2.1 143.2 1.7 1.3 0.0 1.8 0.2 1.1 1.2 0.0 3.5 0.8 2.6 0.0 2.3 34.1 7.9 0.5 0.0 0.0 0.6 1.0 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 161.9;Early spermatids: 83.3;Late spermatids: 104.3;Spermatocytes: 117.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 34.8;THP-1: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (4.88e-2)" 11.0 12.5 16.7 5.6 18.6 10.8 14.7 20.1 15.5 11.6 7.3 23.6 13.9 3.0 18.7 19.5 9.6 32.1 13.1 13.7 18.0 14.3 12.5 6.5 11.2 7.8 22.3 12.3 10.6 12.1 14.6 20.6 14.7 16.3 9.2 11.3 11.8 7.4 16.0 15.5 6.1 6.5 13.2 20.9 6.4 10.5 24.4 21.9 5.4 23.7 13.5 9.1 11.5 16.0 3.6 10.8 4.9 1.8 2.9 0.8 1.2 3.1 4.0 9.1 2.3 3.3 7.8 11.1 4.0 4.3 5.2 4.8 10.2 8.6 11.0 8.7 5.0 5.5 2.5 3.6 2.3 3.2 1.1 2.2 5.3 15.9 4.5 7.0 5.4 34.8 6.7 4.9 7.0 6.6 6.2 7.9 0.3 20.3 9.0 4.4 3.3 1.1 14.9 11.6 4.5 3.0 20.8 1.4 2.9 13.2 5.4 7.2 9.7 7.0 2.7 5.8 10.7 2.6 30.7 1.2 6.4 2.4 3.5 14.5 3.1 5.1 7.3 5.1 15.6 5.1 1.2 1.7 2.8 0.5 1.8 0.8 3.6 0.7 0.4 5.5 3.3 0.6 0.6 4.9 2.9 1.3 10.8 0.8 1.2 16.7 18.6 20.1 15.5 18.0 14.3 22.3 12.3 16.3 21.9 3.0 12.6 4.7 9.1 4.5 12.5 54.7 0.0 161.9 21.6 22.7 13.7 12.8 43.1 5.7 83.3 11.4 2.6 0.0 9.5 40.1 10.4 6.8 0.0 6.8 9.8 4.8 18.1 8.0 14.2 104.3 8.3 9.8 6.8 6.4 6.3 12.5 5.9 5.8 6.0 14.4 20.0 6.5 11.8 117.5 31.9 2.6 28.6 6.2 6.0 8.8 EFCAB3 FLJ25818 ENSG00000172421 "EF-hand calcium binding domain 3" Q8N7B9 17 62343941-62416479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 11.3" "Cell type enriched" "Detected in some" 8 "Early spermatids: 41.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.1;T-47d: 2.2" "Not detected" "Not detected" HPA046862 Uncertain NA NA "HPA046862: AB_2679844" "unprognostic (2.99e-6)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.2 1.9 0.3 0.5 1.3 0.4 0.0 0.1 0.3 0.0 0.4 0.8 0.1 0.0 0.1 0.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.8 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.1 0.6 0.2 0.9 0.6 1.5 1.4 0.1 0.0 1.5 0.0 1.1 0.5 0.6 0.7 2.1 0.0 1.9 0.3 0.5 2.2 0.0 0.5 0.2 0.4 0.5 0.1 0.0 0.5 0.2 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 41.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.6 0.0 4.9 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 EFCC1 "C3orf73, CCDC48, FLJ12057" ENSG00000114654 "EF-hand and coiled-coil domain containing 1" Q9HA90 3 129001629-129040742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 34.1" "Cell type enhanced" "Detected in some" 9 "Endothelial cells: 4.6;Intestinal endocrine cells: 9.1;Leydig cells: 4.4;Peritubular cells: 7.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 3.3;HL-60: 8.7;U-266/84: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042798, HPA050888" Uncertain NA NA "HPA042798: AB_2678173, HPA050888: AB_2681263" "unprognostic (1.74e-1)" "unprognostic (5.16e-3)" "unprognostic (1.65e-1)" "unprognostic (1.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.54e-2)" "unprognostic (1.66e-3)" "unprognostic (7.23e-3)" "unprognostic (1.57e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.70e-4)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.82e-1)" "unprognostic (2.20e-1)" 3.7 0.5 0.9 4.7 0.5 0.3 1.9 1.7 1.0 2.3 4.6 0.5 2.2 4.8 5.1 2.3 1.6 0.8 34.1 1.9 1.5 0.8 1.8 0.7 12.9 0.4 0.4 0.2 6.1 0.5 0.3 1.5 1.0 2.3 2.7 1.2 1.4 1.8 1.6 2.3 1.1 3.8 5.0 0.4 6.2 4.5 0.6 0.0 0.3 2.6 3.6 0.7 2.0 2.5 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.5 1.7 1.0 1.5 0.8 0.4 0.2 2.3 0.0 0.0 1.4 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 4.6 0.0 0.0 0.5 0.0 1.6 0.1 0.0 0.0 0.1 0.0 9.1 3.1 0.3 3.9 4.4 0.0 1.7 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.0 6.5 1.7 0.2 0.5 0.4 0.1 0.0 0.0 0.1 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.3;testis: 19.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 129.8;Early spermatids: 43.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 33 "RPTEC TERT1: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078067 Approved Nucleoli NA NA Nucleoli "HPA078067: AB_2732370" "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 1.1 1.5 3.9 0.7 6.0 0.7 1.8 0.7 4.3 2.0 0.7 6.5 0.0 0.6 2.0 7.8 1.0 23.3 1.3 0.8 6.3 4.7 1.8 0.7 3.9 0.7 4.4 2.2 5.5 0.5 0.5 1.6 1.0 9.5 1.0 1.0 2.3 0.6 1.3 0.7 1.1 0.6 1.6 3.1 1.2 0.6 19.2 6.0 0.0 1.2 0.0 0.8 0.7 0.6 1.3 0.6 1.1 0.8 0.4 2.2 0.4 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 21.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 2.2 0.1 0.1 0.8 0.3 0.4 0.0 1.3 0.5 0.3 1.1 0.4 0.3 0.6 0.0 0.4 3.9 6.0 0.7 3.8 6.3 4.7 4.4 2.2 9.5 6.0 0.0 0.6 0.0 0.4 0.1 0.5 0.3 7.6 129.8 20.5 3.5 2.0 0.8 5.0 0.3 43.0 0.2 0.5 0.0 0.2 0.4 1.1 0.3 3.5 0.4 0.4 1.6 1.2 0.6 1.3 16.0 2.3 0.7 0.0 0.0 0.0 3.6 0.4 0.0 2.1 4.5 0.7 0.0 0.3 18.4 3.3 0.1 0.7 0.0 0.3 0.1 EGFL6 MAEG ENSG00000198759 "EGF like domain multiple 6" Q8IUX8 X 13569605-13633575 "Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 137.5" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 17.4;Cytotrophoblasts: 12.5;Fibroblasts: 9.4;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 9.6;NTERA-2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001838 Enhanced "Secreted to extracellular matrix" NA NA "HPA001838: AB_2666457" "unprognostic (1.66e-1)" "unprognostic (1.32e-2)" "unprognostic (9.15e-3)" "unprognostic (3.76e-3)" "unprognostic (1.77e-2)" "prognostic favorable (9.73e-4)" "unprognostic (4.13e-3)" "unprognostic (1.37e-1)" "unprognostic (5.19e-3)" "prognostic favorable (4.95e-4)" "unprognostic (2.39e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-9)" "unprognostic (7.10e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.82e-3)" 16.1 0.1 0.3 0.2 0.2 0.1 2.3 0.0 0.2 0.4 4.1 0.0 0.1 0.2 0.5 0.4 3.3 0.6 1.5 0.6 0.1 0.7 0.2 0.1 18.6 0.2 0.1 0.1 0.2 0.3 0.1 1.7 137.5 0.9 0.6 0.2 27.1 0.2 0.1 0.1 0.4 0.2 2.0 0.6 0.2 0.4 0.2 0.0 0.0 0.2 0.2 0.4 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.1 0.7 0.1 0.1 0.9 0.0 0.0 1.3 0.0 1.3 0.9 4.9 0.3 0.0 17.4 6.8 0.0 0.0 12.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 8.1 9.4 0.1 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 7.3 0.0 0.2 0.4 22.1 0.0 0.0 3.8 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 102.0;Intestinal endocrine cells: 272.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6;HMC-1: 7.5;MCF7: 24.5;SK-MEL-30: 16.4" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.5 4.6 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.2 0.2 0.0 0.6 0.1 0.1 0.2 0.1 0.0 24.5 0.0 0.2 0.1 1.7 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.4 0.2 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 6.0 18.6 7.5 26.7 20.5 1.6 35.5 0.0 2.7 3.4 0.0 0.0 1.2 0.0 2.5 19.0 17.5 0.9 0.0 3.9 1.1 23.9 18.9 102.0 0.4 3.7 0.0 272.8 20.9 12.3 6.2 2.8 11.0 20.3 0.0 12.8 3.0 2.6 2.9 0.4 0.0 1.1 0.0 23.7 0.0 0.2 43.7 8.1 0.0 4.3 3.1 EGR4 "NGFI-C, PAT133" ENSG00000135625 "Early growth response 4" Q05215 2 73290929-73293705 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Cell type enriched" "Detected in some" 10 "Intestinal endocrine cells: 95.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028983 Enhanced NA NA "HPA028983: AB_10603665" "unprognostic (7.75e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-4)" "unprognostic (2.43e-3)" "unprognostic (2.68e-2)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (5.20e-2)" "unprognostic (4.00e-1)" "unprognostic (2.29e-4)" "unprognostic (2.41e-1)" "unprognostic (1.75e-2)" "unprognostic (3.20e-2)" "unprognostic (1.77e-1)" "unprognostic (1.21e-2)" "unprognostic (4.07e-3)" 1.1 0.8 4.9 1.0 15.9 0.9 0.6 17.2 20.0 0.6 0.6 1.2 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 8.8 1.9 0.6 0.6 0.6 0.6 0.3 4.4 0.6 0.5 0.6 2.3 0.6 0.0 0.7 0.6 0.0 0.5 0.5 0.6 0.6 0.6 0.6 0.3 0.6 0.7 4.9 2.6 0.0 0.5 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 15.9 17.2 20.0 8.8 1.9 0.3 4.4 0.0 2.6 0.0 0.0 0.5 1.6 2.4 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.2 2.0 9.2 0.0 0.2 0.0 95.4 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.4 0.0 3.0 1.9 0.7 0.0 0.1 0.1 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34661057 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 340.0;Ciliated cells: 235.5;Club cells: 254.8;Urothelial cells: 370.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "myeloid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 34.8;HaCaT: 23.9;HBEC3-KT: 26.3;OE19: 29.4;RT4: 53.2;T-47d: 53.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.8 1.0 0.8 9.3 0.9 0.0 32.1 0.7 0.7 19.3 16.0 0.5 152.4 6.9 4.5 21.4 69.0 23.0 22.1 0.7 0.9 0.9 11.6 1.6 9.9 0.1 1.5 0.3 4.7 10.5 0.2 0.9 0.5 1.4 20.7 22.3 0.2 118.0 161.8 0.7 12.8 10.1 1.7 3.3 0.7 10.1 1.4 0.5 0.4 1.2 50.3 59.7 13.7 30.3 0.0 4.9 0.0 0.4 0.0 0.0 0.2 11.4 6.7 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 34.8 0.0 4.4 0.0 0.0 23.9 0.0 26.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 29.4 0.2 0.0 0.0 0.2 4.7 53.2 0.0 0.0 0.1 3.6 0.0 0.0 53.9 0.1 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.7 0.7 0.9 0.9 1.5 0.3 1.4 0.5 44.7 66.1 0.0 340.0 97.3 0.0 0.4 43.3 235.5 254.8 52.4 0.0 0.0 13.3 55.4 8.4 0.2 36.0 0.0 76.2 0.0 1.9 138.5 1.1 0.6 0.1 0.0 22.3 0.0 0.0 0.0 0.0 5.3 11.8 9.0 45.3 3.9 68.8 28.8 0.0 0.1 0.0 0.0 2.3 0.1 0.0 148.7 1.1 0.0 33.6 370.0 EIF4E3 MGC39820 ENSG00000163412 "Eukaryotic translation initiation factor 4E family member 3" Q8N5X7 3 71675416-71754773 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.8" "Group enriched" "Detected in many" 8 "granulocytes: 14.8;monocytes: 4.2;T-cells: 5.4" "Cell line enhanced" "Detected in many" "Karpas-707: 20.0;U-937: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058649, HPA076465" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA058649: AB_2683785, HPA076465: " "unprognostic (3.16e-3)" "unprognostic (7.60e-3)" "unprognostic (4.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.31e-2)" "prognostic favorable (6.63e-4)" "unprognostic (3.10e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.16e-2)" "unprognostic (4.58e-2)" "prognostic favorable (6.99e-5)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.64e-2)" "unprognostic (1.83e-2)" 18.8 9.4 17.2 11.8 22.6 17.7 25.6 13.9 19.4 9.6 16.3 11.5 3.7 10.4 11.0 8.5 16.0 12.2 11.9 30.3 18.6 14.6 10.5 8.8 13.7 11.7 15.2 12.4 17.9 19.4 26.7 14.6 4.7 12.8 14.8 13.0 10.8 12.9 14.5 40.4 7.2 17.6 25.6 19.4 15.3 9.9 5.9 6.7 7.8 19.7 14.5 7.8 17.6 21.8 0.2 0.9 14.8 4.2 1.0 5.4 1.6 0.3 1.3 1.3 4.3 1.3 3.4 1.7 1.1 1.2 1.1 0.6 0.7 0.6 0.0 2.9 1.1 7.4 1.6 4.7 6.5 0.9 14.9 1.4 0.0 0.1 0.1 4.6 2.3 2.6 3.0 4.2 0.3 3.6 0.6 3.6 2.7 0.5 20.0 0.2 5.0 2.0 0.5 10.5 0.5 2.3 1.1 5.2 0.6 14.3 7.2 2.7 7.2 7.8 1.7 0.2 4.3 7.5 0.1 0.9 0.6 3.4 9.2 1.0 14.1 13.1 0.0 0.5 27.1 2.6 1.2 4.2 5.9 2.2 1.8 3.4 0.2 3.1 3.6 0.9 0.1 2.3 2.7 14.8 1.0 2.3 0.0 5.4 1.6 17.2 22.6 13.9 19.4 18.6 14.6 15.2 12.4 12.8 6.7 26.8 12.6 0.0 8.5 9.0 10.3 35.1 7.6 2.7 10.3 10.4 0.0 3.3 3.3 4.9 0.9 9.3 27.6 0.0 4.9 2.3 8.4 10.8 6.9 4.9 4.0 1.6 8.7 14.7 15.7 1.1 11.8 5.8 3.3 1.0 11.1 13.5 8.0 14.4 8.9 11.4 0.5 0.0 17.5 0.2 0.4 11.8 1.3 13.8 6.4 7.6 EIF5AL1 "bA342M3.3, EIF5AP1" ENSG00000253626 "Eukaryotic translation initiation factor 5A-like 1" Q6IS14 10 79512601-79516440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 19.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-251 MG: 5.7" NA NA "unprognostic (2.16e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.55e-1)" "unprognostic (4.14e-3)" "unprognostic (1.50e-1)" "unprognostic (3.48e-2)" "unprognostic (4.25e-2)" "unprognostic (2.50e-3)" "unprognostic (2.04e-2)" "unprognostic (3.57e-1)" "unprognostic (1.01e-1)" "unprognostic (8.79e-3)" "unprognostic (1.56e-1)" "unprognostic (8.63e-2)" "unprognostic (1.87e-1)" "unprognostic (6.68e-2)" "unprognostic (1.81e-1)" 0.8 1.0 0.6 0.8 1.0 0.7 0.7 0.6 1.0 1.2 1.1 0.5 1.6 0.7 0.6 0.7 2.5 0.5 0.8 2.5 0.5 0.5 1.0 8.4 1.0 1.0 0.5 0.0 0.7 3.7 1.4 0.9 0.5 0.8 1.5 0.8 0.0 1.7 0.5 2.6 1.4 2.7 0.4 0.3 1.6 0.8 19.5 0.4 3.3 1.1 2.8 1.1 1.6 0.7 3.9 6.5 2.3 4.9 4.0 3.7 1.3 1.2 2.1 0.9 4.7 0.1 0.6 0.9 0.7 0.5 0.8 0.5 1.6 0.9 2.3 0.8 0.2 0.5 1.4 0.5 0.1 0.5 0.7 1.8 0.6 2.8 0.9 0.5 0.7 1.8 0.1 0.1 0.3 0.4 0.1 0.6 0.2 0.5 0.9 0.3 1.6 2.5 2.3 3.4 0.3 0.3 0.8 2.1 1.5 1.4 2.2 0.6 1.4 1.4 1.3 1.5 0.3 2.2 1.9 0.7 1.3 2.8 3.1 5.7 1.2 1.3 2.1 2.1 0.6 1.8 2.3 2.1 1.5 3.3 4.9 3.7 3.6 3.1 3.7 3.8 3.9 2.4 3.5 2.0 4.0 2.9 6.5 2.5 1.3 0.6 1.0 0.6 1.0 0.5 0.5 0.5 0.0 0.8 0.4 14.9 35.4 7.2 2.5 30.0 0.6 38.6 2.5 9.4 25.0 0.0 0.0 18.6 10.0 58.5 11.5 13.8 60.4 0.0 41.0 29.8 19.2 2.9 47.3 4.9 15.9 1.6 57.6 2.5 8.1 4.4 4.6 16.8 18.6 64.1 60.4 1.3 56.7 66.6 2.8 3.6 0.5 0.0 27.6 84.1 3.8 30.2 23.1 7.5 80.1 2.7 ELAVL3 "DKFZp547J036, HUC, HUCL, MGC20653, PLE21" ENSG00000196361 "ELAV like RNA binding protein 3" Q14576 19 11451326-11481046 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 53.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 7.3;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Rod photoreceptor cells: 7.7" "Cancer enriched" "Detected in some" 10 "glioma: 11.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9;naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Group enriched" "Detected in some" 8 "SCLC-21H: 40.6;SH-SY5Y: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013066 Enhanced NA NA "CAB013066: AB_221448" "unprognostic (1.47e-2)" "unprognostic (2.29e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-3)" "unprognostic (8.76e-2)" "unprognostic (2.95e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (1.86e-2)" "unprognostic (2.15e-3)" "unprognostic (2.26e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (9.60e-3)" 1.0 2.4 14.0 1.5 13.2 1.0 1.0 45.2 53.8 1.0 1.3 12.2 0.0 1.2 1.1 1.6 1.2 1.0 1.0 1.1 17.3 13.0 1.1 1.1 1.1 1.0 14.3 18.3 1.0 1.0 1.0 1.3 1.0 9.5 1.6 1.2 0.1 1.0 1.2 4.0 1.0 1.2 1.2 21.9 1.1 1.2 1.5 5.1 0.0 1.0 0.0 1.0 1.0 0.0 1.9 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 14.0 13.2 45.2 35.2 17.3 13.0 14.3 18.3 9.5 5.1 0.0 0.0 0.0 0.6 0.6 2.8 7.3 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 7.7 0.0 1.9 1.8 2.5 0.1 0.0 0.0 0.0 0.3 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.9;RH-30: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 3.5 0.4 2.2 0.3 0.4 0.0 1.8 0.1 0.0 0.1 1.2 0.1 0.0 0.4 0.1 0.0 0.0 0.1 11.9 1.5 0.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 1.8 0.0 27.1 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.3 0.0 0.7 0.1 0.0 0.0 3.6 0.0 2.1 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 0.0 3.8 0.0 0.4 0.0 30.4 3.6 0.0 8.1 2.3 0.0 15.7 0.1 0.0 0.0 8.5 0.7 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.8 0.1 35.0 0.0 0.6 0.3 14.0 0.3 1.4 0.0 0.0 0.0 6.5 0.0 0.0 0.4 3.6 17.8 0.0 0.5 0.9 0.4 2.8 0.0 0.0 0.0 0.3 ELOA3B "HsT828, TCEB3CL" ENSG00000278674 "Elongin A3 family member B" Q3SY89 18 47022287-47023927 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205851-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;granulocytes: 11.5;Ito cells: 14.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 23.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 2.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 2.3" "Group enriched" "Detected in some" 4 "HEL: 13.2;NB-4: 45.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 19.3 17.8 3.6 12.7 11.7 2.4 3.5 17.9 2.9 5.4 14.2 2.2 4.8 10.5 2.5 0.9 10.4 4.8 1.3 12.6 6.1 7.7 2.1 7.0 13.3 5.6 14.7 4.8 12.7 4.5 1.2 4.7 3.8 5.2 3.4 2.9 4.7 4.2 0.7 3.6 7.4 2.3 2.6 31.0 7.0 2.1 6.9 4.6 8.4 0.5 2.2 5.0 1.4 0.1 0.0 0.0 0.0 2.3 0.3 0.1 0.0 0.1 2.3 4.9 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.6 0.3 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 5.2 4.1 13.2 0.0 0.5 0.3 1.8 1.0 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.1 0.0 0.0 3.6 0.1 45.9 0.5 0.0 0.2 0.0 0.1 5.0 0.0 0.0 6.3 3.0 0.2 0.0 0.0 0.4 1.9 2.4 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 17.8 12.7 3.5 17.9 12.6 6.1 5.6 14.7 3.8 6.9 0.0 4.5 0.0 0.8 2.5 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.1 2.2 0.0 23.3 1.2 0.1 3.1 2.4 11.5 0.2 0.3 0.0 0.0 14.7 0.8 0.2 2.8 0.0 0.0 1.0 0.0 1.2 0.7 0.0 1.8 1.4 0.5 0.0 2.8 0.0 1.5 1.8 0.2 0.5 0.0 0.4 EML5 "EMAP-2, HuEMAP-2" ENSG00000165521 "Echinoderm microtubule associated protein like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;ovary: 26.8" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 29.6;Cone photoreceptor cells: 56.9;Horizontal cells: 19.1;Rod photoreceptor cells: 32.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 10.6;SH-SY5Y: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054019, HPA055379" Uncertain NA NA "HPA054019: AB_2682345, HPA055379: AB_2682799" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.8 9.1 5.1 1.5 9.0 0.8 1.4 23.0 5.0 0.8 1.6 1.9 0.1 1.2 1.7 0.7 1.6 1.7 1.1 0.9 5.8 2.6 1.9 1.1 1.2 1.5 1.6 4.7 26.8 2.2 6.0 13.7 0.7 3.8 7.6 0.7 4.5 1.6 0.7 0.6 1.3 1.4 1.8 1.6 1.5 1.6 4.9 2.1 0.9 3.9 0.8 1.1 1.2 0.9 0.9 0.3 0.0 0.2 0.0 2.4 0.4 2.0 1.4 2.0 1.9 0.0 0.0 4.0 2.0 0.3 0.2 0.1 0.6 1.7 1.0 0.8 0.0 1.1 4.7 3.7 0.1 0.1 3.2 2.9 1.4 1.3 1.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 1.9 0.0 5.0 1.5 10.6 0.0 2.6 3.6 1.2 1.6 1.8 2.2 2.4 2.1 1.0 0.1 4.1 5.4 22.8 2.6 4.6 1.5 1.5 2.0 1.5 0.8 2.2 0.4 0.3 2.7 4.9 1.3 4.4 0.9 1.3 0.9 0.0 0.0 0.0 0.2 0.2 2.4 0.9 0.5 0.2 0.3 0.5 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.4 5.1 9.0 23.0 5.0 5.8 2.6 1.6 4.7 3.8 2.1 0.0 4.3 0.8 0.6 0.5 29.6 1.0 0.0 8.1 2.3 0.0 56.9 0.1 0.0 0.7 2.6 0.1 0.0 0.0 0.3 0.1 0.4 5.4 1.1 0.0 0.0 19.1 10.3 0.0 0.0 2.3 0.6 0.0 3.3 0.0 0.1 3.3 0.2 0.0 1.1 0.3 32.2 0.0 0.9 7.4 8.3 0.4 0.1 0.5 0.0 0.6 EML6 FLJ42562 ENSG00000214595 "Echinoderm microtubule associated protein like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2;lymphoid tissue: 11.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 25.5;Cone photoreceptor cells: 53.0;Horizontal cells: 36.5;Rod photoreceptor cells: 32.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "Daudi: 7.3;SCLC-21H: 20.5;U-698: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA062808: AB_2684872, HPA068759: AB_2686027" "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.1 3.3 1.8 4.0 2.8 0.0 0.2 7.2 4.2 0.0 0.6 0.6 0.0 1.3 0.3 0.4 0.1 0.0 1.9 2.1 1.3 0.2 0.1 7.9 1.5 0.0 0.5 3.0 3.4 1.4 0.4 0.8 0.1 0.4 0.6 0.8 1.8 0.3 0.5 2.7 0.4 1.5 3.1 11.9 0.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.1 0.7 0.2 1.5 0.1 0.2 0.2 0.2 0.6 0.2 7.3 0.1 0.4 0.3 0.2 1.0 0.3 0.3 0.7 0.3 0.4 0.6 2.8 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.1 4.0 0.0 1.2 0.0 0.7 1.4 0.2 0.3 0.1 1.2 0.6 0.5 0.6 0.0 0.7 20.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.6 0.4 0.4 5.0 1.3 23.3 1.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.2 1.6 3.3 25.5 1.4 0.0 5.3 5.7 3.5 53.0 0.4 0.0 0.1 12.7 1.7 0.4 0.0 0.4 0.4 0.7 1.5 0.0 0.8 1.0 36.5 2.4 1.8 1.3 9.6 0.6 1.0 0.0 0.0 1.7 19.3 0.1 0.0 0.7 0.5 32.8 0.0 2.1 3.9 1.9 3.9 0.1 0.0 0.2 2.3 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell type enhanced" "Detected in single" 16 "Spermatocytes: 1.2" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA045646: AB_2679404, HPA069809: AB_2686205" "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavorable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.5 27.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.9 0.0 5.9 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 3.5 0.0 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 8.1 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521040-34523041 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 79.6" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 53.5" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "myeloid DC: 19.4" "Lineage enriched" "Detected in many" 7 "dendritic cells: 19.4" "Cell line enhanced" "Detected in many" "AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted to blood" NA NA 4240000 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.5 1.9 58.0 1.9 59.3 1.7 3.7 15.5 79.6 2.9 3.9 13.9 0.0 3.0 1.4 1.4 1.5 3.6 1.8 1.8 36.3 37.5 1.5 12.0 2.0 1.4 52.0 27.1 1.5 2.6 1.2 1.0 1.3 13.7 5.2 3.2 0.1 1.8 1.7 1.6 3.8 3.6 1.3 17.1 1.6 5.3 6.4 13.4 0.0 1.4 0.0 1.4 1.5 0.0 0.0 19.4 0.0 2.5 2.7 0.0 0.4 0.1 1.0 5.3 13.4 0.1 0.0 0.3 0.0 0.0 2.1 2.2 0.5 0.2 2.2 3.7 0.0 4.3 0.2 6.1 0.4 0.4 0.3 5.9 0.0 0.1 1.2 0.2 0.0 3.0 0.0 0.1 0.0 0.2 0.0 0.0 4.3 0.0 1.9 0.5 0.3 0.0 0.0 18.5 1.0 3.7 0.1 0.0 0.3 0.5 0.0 9.4 8.9 0.7 4.1 0.4 0.7 0.3 1.7 0.0 0.4 2.1 0.1 0.1 1.1 1.3 0.1 0.5 0.0 3.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 2.7 0.7 1.0 0.0 0.4 58.0 59.3 15.5 37.0 36.3 37.5 52.0 27.1 13.7 13.4 0.0 0.3 0.0 2.5 2.5 4.3 0.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.2 1.0 10.2 0.0 2.6 2.6 4.8 1.7 1.3 0.3 2.7 0.3 3.2 1.7 1.0 0.0 53.5 0.0 0.0 0.4 0.3 2.8 0.0 0.1 0.5 5.9 2.8 0.0 0.0 0.0 0.5 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.1 0.2 2.7 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.9 0.1 1.1 0.1 0.0 0.7 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 1.2 0.6 0.9 0.0 2.2 0.1 0.0 1.8 5.2 0.0 0.5 0.0 0.8 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 0.0 0.0 0.0 0.2 0.1 4.4 0.2 0.0 36.1 0.0 0.0 21.6 0.2 0.0 0.3 11.9 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 4.8 1.7 0.0 0.0 8.8 1.1 0.1 0.0 1.0 0.0 1.3 0.2 0.0 0.7 0.6 9.0 0.0 0.2 7.6 2.7 0.0 0.1 0.0 0.1 0.0 ENTHD1 FLJ25421 ENSG00000176177 "ENTH domain containing 1" Q8IYW4 22 39743044-39893864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 15.8" "Group enriched" "Detected in some" 5 "Early spermatids: 12.8;granulocytes: 9.2;Late spermatids: 12.4;Spermatocytes: 26.1" "Cancer enriched" "Detected in single" 30 "melanoma: 7.0" "Region enriched" "Detected in single" 20 "basal ganglia: 2.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 7.0" "Not detected" "Not detected" HPA019800 Uncertain NA NA "HPA019800: AB_1848842" "unprognostic (5.28e-3)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (9.84e-3)" "unprognostic (2.97e-4)" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (2.17e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-4)" "unprognostic (3.60e-2)" "unprognostic (7.75e-10)" "unprognostic (3.68e-2)" "unprognostic (8.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 15.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.2 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 26.1 3.0 0.0 0.0 0.0 0.0 0.0 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659506-99706240 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 14.1;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 24000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 3.1 5.6 2.2 5.1 2.1 6.4 2.7 2.4 3.3 4.4 15.7 1.3 11.3 18.6 3.9 5.7 9.1 3.1 9.1 3.2 2.0 1.7 6.0 14.5 4.2 7.1 1.4 1.9 3.2 23.9 3.6 8.6 8.5 1.5 5.6 4.9 3.4 9.0 13.2 1.6 4.4 46.1 5.6 1.4 5.4 5.1 3.5 0.5 2.5 3.5 6.0 6.3 11.4 5.0 0.9 7.7 3.7 2.2 2.7 2.2 1.3 5.2 6.0 8.0 14.8 4.0 4.0 9.7 9.9 20.6 12.9 10.8 11.0 5.9 4.5 5.8 13.3 3.9 13.9 6.7 4.0 10.6 1.9 5.3 3.4 4.7 10.1 6.0 12.0 7.8 3.7 6.9 16.2 15.4 15.0 13.0 4.8 6.4 4.4 5.1 4.7 2.4 2.5 4.7 6.5 2.6 0.0 6.2 2.4 14.1 17.0 3.3 6.4 6.9 2.6 8.6 5.7 7.2 6.1 8.2 11.2 7.2 7.2 8.3 4.5 7.5 4.1 10.9 3.7 3.0 0.3 2.2 3.7 2.2 2.2 2.0 0.9 0.8 1.8 5.0 0.3 1.4 0.9 2.0 2.7 1.2 7.7 0.6 1.3 2.2 2.1 2.4 3.3 2.0 1.7 1.4 1.9 1.5 0.5 0.0 0.0 0.0 14.1 7.2 0.4 0.6 0.0 4.0 2.3 5.2 2.0 4.5 0.0 1.9 1.4 1.0 6.5 0.0 4.3 4.4 1.5 1.8 0.0 3.4 1.7 0.0 5.2 0.6 1.2 2.2 0.9 1.3 0.0 6.4 2.7 0.7 3.4 2.9 0.7 1.3 1.8 0.0 1.4 1.4 0.7 6.5 4.2 0.0 1.4 22.1 EPB41L4B EHM2 ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171975-109320964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.1;pancreas: 59.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 6.5 4.2 7.3 1.2 14.6 0.0 4.8 4.9 11.4 1.1 18.4 1.5 7.1 15.1 0.7 5.9 0.7 3.2 1.8 3.5 2.9 3.5 1.9 28.1 1.7 0.2 1.6 6.8 4.7 59.8 3.3 0.9 1.1 2.7 2.2 18.7 2.4 8.0 3.5 2.2 5.6 16.1 0.3 2.2 0.2 9.4 2.7 1.3 0.4 14.6 1.3 1.2 1.2 1.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 4.2 5.3 0.3 0.4 0.4 0.0 16.0 0.5 0.2 1.8 0.9 9.0 4.2 0.0 1.1 0.5 4.5 6.9 10.6 5.6 2.0 4.4 2.5 0.0 1.7 12.8 1.1 0.2 0.0 0.1 25.1 0.7 8.6 0.5 0.1 3.9 0.1 0.0 2.6 10.7 0.1 0.1 6.9 30.4 7.8 0.0 0.0 0.2 6.4 6.4 6.6 0.7 1.7 11.1 0.0 3.3 2.6 0.0 0.2 3.8 3.9 1.2 1.5 0.0 0.0 0.0 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.6 4.9 11.4 2.9 3.5 1.6 6.8 2.7 1.3 6.0 3.2 0.8 4.6 10.2 8.3 14.9 22.9 16.0 5.7 7.0 0.0 3.3 0.0 3.2 8.7 0.7 67.5 0.0 18.0 1.6 2.2 9.9 0.0 107.1 0.5 36.5 49.7 4.3 1.6 1.5 12.4 0.2 1.7 0.0 52.8 1.8 12.8 37.4 2.5 0.6 1.0 0.0 0.4 1.4 14.8 21.0 1.6 0.0 34.5 5.7 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 67 "Early spermatids: 305.1;Late spermatids: 156.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 8.2;U-266/70: 24.9" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 8.2 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.9 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.3 2.8 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.6 0.2 0.0 0.1 3.4 2.3 0.0 0.1 0.0 0.0 0.0 EPHX4 "ABHD7, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029982-92063536 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 13.3;brain: 20.7" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 13.3" "Lineage enriched" "Detected in single" 24 "T-cells: 13.3" "Cell line enhanced" "Detected in some" "A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035067 Uncertain Approved Vesicles NA NA Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavorable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 1.0 1.3 5.8 1.3 14.1 0.3 3.2 1.7 20.7 2.4 1.0 0.3 0.1 1.6 1.7 1.3 2.1 1.3 1.2 1.2 3.3 2.4 0.9 0.4 1.5 0.7 3.1 9.8 0.6 0.3 0.5 1.3 1.9 4.4 2.2 1.4 1.5 0.4 4.1 0.4 0.6 0.9 2.5 1.1 0.4 0.5 2.6 2.1 0.0 3.9 0.0 0.7 1.9 0.4 0.1 0.0 0.0 0.0 0.5 13.3 1.4 10.0 0.3 2.0 0.0 0.0 0.0 0.5 0.2 3.7 0.3 0.2 0.0 8.8 0.0 17.9 0.0 2.7 0.1 0.3 0.8 0.3 0.0 5.4 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.4 0.0 0.0 6.5 3.1 0.0 0.0 0.0 0.3 0.6 1.4 0.3 1.9 0.0 3.5 0.3 0.2 0.0 24.8 2.0 1.2 1.5 6.1 0.0 1.8 0.1 0.0 1.4 0.1 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 2.3 0.1 1.7 3.3 0.0 0.0 0.4 3.4 0.0 0.5 0.0 0.0 0.0 1.4 5.8 14.1 1.7 20.7 3.3 2.4 3.1 9.8 4.4 2.1 0.0 0.0 0.0 0.1 0.1 0.8 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.3 1.3 2.9 0.0 0.0 0.7 0.6 0.5 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 8.1 3.0 0.0 0.0 0.0 1.8 0.0 0.8 3.8 0.7 0.4 0.0 0.0 0.0 0.3 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532543-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 17.4;Cytotrophoblasts: 52.4;Mucus-secreting cells: 17.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 6.8;pons and medulla: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 12.0;HBEC3-KT: 16.6;MCF7: 26.7;OE19: 25.1;RT4: 20.9;SK-BR-3: 10.8;T-47d: 24.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055546: AB_2682844, HPA063224: AB_2684964" "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.4 7.7 0.5 1.9 0.7 0.4 1.9 1.1 6.8 5.3 7.8 1.5 24.0 5.1 0.7 3.8 26.2 6.0 12.6 6.6 0.5 0.7 10.9 0.4 0.7 0.0 2.0 1.4 10.3 18.3 9.6 0.9 8.4 17.8 9.3 3.4 0.3 16.7 18.7 0.4 19.7 5.1 0.5 0.6 0.3 23.8 2.2 0.0 3.4 1.2 15.9 21.9 8.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.1 5.2 0.0 0.1 0.0 0.0 12.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 9.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.1 0.0 0.0 25.1 0.2 0.0 0.0 0.0 0.1 20.9 0.2 0.0 0.0 10.8 0.0 0.1 24.1 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.1 6.8 0.5 0.7 2.0 1.4 17.8 0.0 0.0 0.0 0.0 3.4 2.1 0.3 4.8 7.6 0.0 0.0 17.4 0.0 52.4 5.0 5.6 0.4 0.1 9.3 0.0 10.0 5.6 0.3 4.4 0.0 0.0 5.1 0.0 3.5 0.0 0.0 1.8 2.6 0.0 0.0 1.0 17.7 0.5 5.2 10.5 0.0 0.0 0.3 0.0 0.3 0.0 0.4 4.8 8.9 0.0 16.6 5.8 EPSTI1 "BRESI1, MGC29634" ENSG00000133106 "Epithelial stromal interaction 1" Q96J88 13 42886388-42992271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 146.8;monocytes: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 36.9;BJ hTERT+ SV40 Large T+ RasG12V: 38.7;HDLM-2: 27.2;RPMI-8226: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017362 Approved NA NA "HPA017362: AB_1848226" "unprognostic (2.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.80e-1)" "unprognostic (3.59e-2)" "unprognostic (2.35e-1)" "unprognostic (9.55e-2)" "unprognostic (2.31e-1)" "unprognostic (2.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.05e-3)" "unprognostic (8.13e-2)" 22.4 11.9 3.9 42.2 5.5 18.2 7.1 1.4 3.7 6.5 14.1 5.1 5.9 20.3 7.0 9.7 6.8 5.4 11.2 7.5 3.8 3.9 14.8 7.9 14.6 18.7 5.4 3.9 5.4 2.9 5.1 4.7 18.1 6.4 6.5 6.8 6.6 10.5 16.8 3.0 2.7 22.2 5.8 7.4 28.3 9.2 5.8 4.0 28.5 7.6 4.3 18.0 10.1 5.4 12.7 14.4 19.3 26.8 10.2 26.4 9.7 1.0 0.0 0.0 0.0 0.0 2.0 1.1 0.9 9.8 36.9 38.7 8.6 2.1 1.3 0.3 1.2 3.9 4.3 0.0 1.4 4.7 27.2 0.0 4.3 0.0 0.0 9.0 0.0 0.7 6.8 2.0 2.9 0.2 0.5 0.5 2.1 0.0 6.8 0.9 0.0 6.8 1.0 0.2 0.7 0.0 0.0 0.0 13.0 6.1 0.2 0.7 0.0 0.1 0.0 0.7 0.1 0.2 0.7 1.4 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.7 0.0 0.4 19.3 16.2 13.0 5.5 26.8 5.7 12.7 11.1 6.0 14.4 10.9 5.3 4.0 7.8 10.2 16.6 1.7 26.4 9.7 3.9 5.5 1.4 3.7 3.8 3.9 5.4 3.9 6.4 4.0 17.9 10.4 22.5 1.3 3.8 0.0 2.4 12.7 4.0 9.1 5.2 0.0 8.1 1.7 29.5 48.9 12.4 65.2 0.0 34.8 146.8 15.4 3.9 10.4 5.9 77.7 0.0 23.6 15.4 21.0 17.6 13.8 49.5 10.1 201.0 13.5 0.2 43.1 16.5 4.6 28.0 0.0 0.0 4.2 2.1 1.9 3.3 12.1 22.4 16.6 3.1 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963679-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "placenta: 67.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTERT-RPE1: 8.2;U-266/70: 2.0" "Region enhanced" "Detected in single" "midbrain: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" NA NA "HPA038212: AB_10672739, HPA045455: AB_2679330" "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 67.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EQTN "AFAF, C9orf11, equatorin, SPACA8" ENSG00000120160 Equatorin Q9NQ60 9 27284659-27297139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 39.9" "Cell type enriched" "Detected in some" 26 "Early spermatids: 558.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1" "HPA015089, HPA015504" Enhanced "Intracellular and membrane" NA NA "HPA015089: AB_1845795, HPA015504: AB_2067598" "unprognostic (7.83e-2)" "unprognostic (1.55e-1)" "unprognostic (5.64e-2)" "unprognostic (8.12e-3)" "unprognostic (1.34e-3)" "unprognostic (4.41e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.32e-1)" "unprognostic (1.89e-1)" "unprognostic (5.67e-2)" "unprognostic (1.14e-1)" "unprognostic (4.59e-2)" "unprognostic (8.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.1 39.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 1.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 1.1 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 558.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.1 1.9 0.3 0.1 0.0 0.2 0.1 ERAS "HRAS2, HRASP" ENSG00000187682 "ES cell expressed Ras" Q7Z444 X 48826513-48830138 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5" "Cell type enhanced" "Detected in some" 18 "Spermatocytes: 1.9;Spermatogonia: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;NB-4: 2.3;THP-1: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.47e-2)" "unprognostic (1.28e-2)" "unprognostic (4.50e-2)" "unprognostic (3.93e-2)" "unprognostic (3.61e-1)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (1.87e-2)" "unprognostic (2.72e-4)" "unprognostic (9.40e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (1.98e-1)" "unprognostic (1.08e-1)" "unprognostic (2.25e-2)" 0.1 0.2 1.7 0.0 1.7 0.7 0.0 4.2 2.7 0.2 0.2 0.0 1.0 0.3 0.1 0.4 0.1 0.0 1.1 5.5 0.5 1.1 0.4 0.0 1.2 0.7 0.0 0.9 1.4 0.2 0.2 0.0 0.7 1.1 0.6 1.0 0.4 0.6 1.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.3 0.2 0.0 0.5 0.5 0.0 0.0 0.3 0.0 2.8 0.6 0.0 0.1 0.0 0.0 0.2 0.5 1.7 0.4 0.0 0.5 0.0 0.8 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.5 0.1 0.5 0.0 0.0 0.0 2.3 0.8 0.0 1.0 0.4 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.3 0.6 0.2 0.0 2.1 0.0 0.0 0.8 0.5 0.0 0.6 0.6 0.4 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 ERFE "C1QTNF15, CTRP15, FAM132B, FLJ37034" ENSG00000178752 Erythroferrone Q4G0M1 2 238158982-238168900 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 7.5;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 3.3;granulocytes: 4.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.2" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 14.1;hTEC/SVTERT24-B: 13.7;REH: 14.0;RH-30: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 277000 "unprognostic (1.66e-1)" "unprognostic (9.14e-2)" "unprognostic (3.64e-4)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.84e-1)" "unprognostic (9.61e-4)" "unprognostic (4.68e-3)" "unprognostic (3.16e-3)" "unprognostic (9.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.31e-4)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (4.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.33e-2)" 1.6 0.0 2.4 2.5 1.0 3.5 0.1 9.2 2.5 2.1 0.5 0.4 0.1 0.6 0.9 3.0 0.8 0.1 0.3 3.2 1.9 0.1 3.3 0.3 0.5 0.1 0.1 0.7 0.4 0.3 0.2 0.1 3.5 0.5 0.4 0.3 0.4 1.5 1.6 12.4 0.0 1.1 0.5 0.1 0.5 0.7 13.8 0.1 0.4 25.6 4.8 0.4 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 2.1 0.6 0.9 1.9 0.1 3.4 0.2 1.4 2.0 3.5 5.8 0.1 5.2 0.0 4.0 0.3 6.9 0.2 9.3 0.4 3.1 0.0 14.1 0.0 0.2 0.1 1.2 0.0 1.0 7.3 1.0 13.7 9.8 0.4 0.1 4.5 3.0 0.0 9.0 2.8 0.0 5.8 1.5 0.6 0.9 14.0 17.9 0.6 7.3 0.0 0.3 5.4 2.1 0.4 7.9 1.8 0.3 10.5 0.8 5.5 5.1 2.1 7.2 0.0 0.0 0.6 9.3 2.9 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 1.0 9.2 2.5 1.9 0.1 0.1 0.7 0.5 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 1.8 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ERI2 "EXOD1, KIAA1504, MGC16943, ZGRF5" ENSG00000196678 "ERI1 exoribonuclease family member 2" A8K979 16 20780193-20900349 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7;Spermatocytes: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 11.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035384, HPA035385" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA035384: AB_10602316, HPA035385: AB_2674600" "unprognostic (1.25e-1)" "unprognostic (1.47e-1)" "unprognostic (2.01e-3)" "unprognostic (4.36e-2)" "unprognostic (8.64e-2)" "unprognostic (2.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.99e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-2)" "unprognostic (1.08e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.05e-2)" "unprognostic (9.28e-3)" 18.5 14.3 9.2 7.5 10.4 8.5 15.0 7.8 11.9 8.3 11.2 12.0 9.3 12.2 8.2 12.1 12.4 9.1 8.9 8.4 9.0 7.9 12.7 19.4 8.2 5.3 11.7 7.4 9.9 14.4 19.2 14.9 10.1 11.1 12.0 15.7 8.1 10.3 11.0 7.0 10.7 12.1 11.8 12.2 6.4 12.7 21.3 9.7 10.8 9.7 12.1 6.6 9.6 15.1 0.6 2.4 11.8 2.9 0.7 0.9 0.6 10.8 5.2 14.3 6.2 4.4 5.6 8.6 8.5 5.1 7.8 9.9 6.5 11.3 3.0 9.9 4.7 5.4 8.2 14.2 8.9 14.6 9.6 7.5 7.4 6.1 11.2 4.0 14.1 6.2 5.1 11.1 10.5 8.8 4.2 4.7 0.0 23.3 9.0 13.1 9.6 2.0 12.6 8.8 11.3 2.9 16.2 11.7 6.7 7.2 8.5 7.3 8.9 5.5 10.6 6.5 7.9 22.2 15.7 3.5 8.4 4.7 8.0 11.4 5.5 8.3 1.8 7.9 11.5 11.5 11.8 2.3 2.0 0.6 1.7 0.4 0.6 0.5 0.6 2.4 0.1 0.4 0.3 0.1 0.7 2.9 0.8 0.9 0.6 9.2 10.4 7.8 11.9 9.0 7.9 11.7 7.4 11.1 9.7 14.9 4.1 0.0 5.0 4.4 4.5 6.4 5.1 14.7 9.1 8.7 0.0 6.2 8.3 3.5 14.0 2.9 5.1 46.7 4.5 7.5 3.3 4.6 0.0 9.6 7.2 3.2 0.0 2.5 6.1 11.4 5.8 4.1 1.7 6.4 9.6 4.7 4.5 7.8 4.9 5.7 3.1 0.0 3.3 36.3 22.0 3.1 3.1 2.2 7.6 4.3 ERICH3 "C1orf173, DKFZp547I048, RP11-653A5.1" ENSG00000178965 "Glutamate rich 3" Q5RHP9 1 74568111-74673738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 21.1;testis: 26.4" "Group enriched" "Detected in some" 6 "Ciliated cells: 431.0;Early spermatids: 257.5;Late spermatids: 256.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;SCLC-21H: 3.3" "HPA028655, HPA072916" Approved NA NA "HPA028655: AB_10961002, HPA072916: " "unprognostic (4.49e-4)" "unprognostic (1.02e-2)" "prognostic favorable (1.56e-5)" "unprognostic (1.71e-2)" "unprognostic (5.94e-2)" "unprognostic (6.83e-2)" "unprognostic (6.53e-2)" "unprognostic (4.76e-2)" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-4)" "unprognostic (9.21e-3)" "unprognostic (2.25e-1)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" 0.4 3.5 12.7 0.5 10.7 0.4 1.4 7.0 14.5 7.6 0.5 0.5 0.0 0.5 1.7 3.0 0.4 21.1 0.5 0.5 12.0 4.2 0.5 0.6 3.7 0.7 1.0 10.3 1.2 0.4 0.4 6.3 0.5 2.4 0.5 0.6 0.0 0.7 0.5 0.4 0.5 0.5 0.5 0.7 0.6 0.6 26.4 1.6 0.0 0.5 0.0 0.7 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.5 0.0 3.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 10.7 7.0 12.0 12.0 4.2 1.0 10.3 2.4 1.6 3.0 1.9 0.0 0.0 0.0 4.0 0.5 0.0 431.0 52.4 0.0 0.0 0.0 0.0 0.0 257.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 3.4 0.0 0.0 256.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.3 6.5 0.0 35.8 1.4 0.0 0.1 0.0 0.0 0.3 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 84.1;Ciliated cells: 72.3;Ductal cells: 42.6" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Cell line enhanced" "Detected in some" "A549: 6.5;HAP1: 6.0;HEK 293: 8.8;JURKAT: 11.6;RPTEC TERT1: 5.8;RT4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.1 0.0 3.8 3.4 1.3 1.8 1.4 0.1 2.0 0.0 5.0 0.9 2.8 0.3 6.0 0.1 2.2 0.0 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 11.6 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.1 2.6 0.0 0.0 0.1 5.8 15.3 3.5 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 3.0 0.0 0.0 1.1 0.0 0.0 5.9 84.1 72.3 5.7 7.0 0.0 0.3 0.0 42.6 0.3 0.0 0.7 0.0 16.3 1.5 0.0 3.1 0.0 3.9 0.1 0.0 17.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 2.3 5.8 17.1 0.0 0.0 19.3 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 3.3 1.3 ERICH6 "C3orf44, ERICH6A, FAM194A, MGC39662" ENSG00000163645 "Glutamate rich 6" Q7L0X2 3 150659885-150703971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 35.4" "Group enriched" "Detected in some" 6 "Early spermatids: 72.0;Late spermatids: 42.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 3.7;SH-SY5Y: 3.9;U-266/70: 4.1;U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA048373 Enhanced NA NA "HPA048373: AB_2680375" "unprognostic (7.38e-2)" "unprognostic (3.89e-3)" "unprognostic (7.02e-3)" "unprognostic (2.52e-2)" "unprognostic (7.38e-3)" "unprognostic (1.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (1.96e-1)" "unprognostic (8.44e-2)" "unprognostic (1.71e-2)" "unprognostic (1.80e-2)" "unprognostic (7.27e-2)" "unprognostic (2.21e-1)" "unprognostic (1.49e-2)" "unprognostic (3.16e-2)" 0.4 0.4 0.4 0.2 1.8 0.3 0.3 0.4 1.5 0.3 0.3 0.4 0.1 0.6 0.5 1.9 0.3 0.4 0.8 0.4 0.7 0.4 0.8 0.3 0.3 0.6 0.3 0.6 0.5 0.5 0.0 3.9 0.4 0.5 0.5 0.1 0.3 0.3 0.5 0.2 0.3 0.4 0.4 0.3 0.4 0.4 35.4 0.6 0.0 1.3 0.0 0.2 0.4 0.3 2.6 3.5 0.1 0.1 5.9 8.0 2.0 0.2 3.7 0.2 1.5 0.0 0.0 0.0 0.3 0.0 0.3 0.6 1.7 1.5 0.0 2.2 0.0 1.4 0.2 0.0 0.0 0.2 1.6 1.2 1.0 0.6 0.1 0.0 0.0 0.1 0.2 0.0 1.0 0.0 0.0 0.0 1.2 0.0 2.5 0.0 0.6 0.9 0.0 0.9 0.0 0.0 1.0 0.9 0.0 0.1 0.8 1.8 3.9 0.0 0.3 0.0 0.0 0.9 1.3 0.1 0.6 1.4 1.5 0.2 4.1 6.3 0.8 0.7 0.1 0.0 0.0 0.1 0.1 4.1 0.0 8.0 2.6 2.6 3.1 0.1 2.3 3.5 3.6 0.1 5.9 0.1 3.5 2.5 2.0 0.4 1.8 0.4 1.5 0.7 0.4 0.3 0.6 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 9.1 1.0 0.0 0.0 0.0 0.0 0.0 ERICH6B "FAM194B, FLJ32682" ENSG00000165837 "Glutamate rich 6B" Q5W0A0 13 45534522-45615739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 6.7" "Group enriched" "Detected in some" 13 "Early spermatids: 27.8;Late spermatids: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043559 Uncertain NA NA "HPA043559: AB_2678552" "unprognostic (6.77e-3)" "unprognostic (3.52e-3)" "unprognostic (3.80e-2)" "unprognostic (2.06e-2)" "unprognostic (2.05e-1)" "unprognostic (7.08e-2)" "unprognostic (1.25e-1)" "unprognostic (7.98e-3)" "unprognostic (7.27e-3)" "unprognostic (9.81e-2)" "unprognostic (3.05e-3)" "unprognostic (3.37e-3)" "unprognostic (5.70e-8)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (9.74e-2)" "unprognostic (7.89e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.9 0.0 0.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 0.0 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HAP1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favorable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 2.0 0.0 0.3 21.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 0.4 0.2 0.8 2.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.3 0.7 1.3 0.0 0.2 0.1 0.2 0.6 3.5 2.0 0.6 1.8 1.0 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990809-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;monocytes: 2.5" "Cell line enhanced" "Detected in many" "AN3-CA: 19.5" "HPA017209, HPA046508" Enhanced Approved Vesicles NA NA Vesicles "HPA017209: AB_2732419, HPA046508: AB_2732525" "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 27.2 41.3 9.9 9.0 11.7 8.6 18.3 13.8 11.6 9.4 7.1 8.7 5.6 3.9 11.2 31.9 18.9 9.0 17.9 8.4 10.1 7.2 7.3 4.0 10.7 5.6 11.2 9.2 10.6 7.6 9.6 19.3 21.2 11.7 8.1 6.5 9.3 14.9 13.1 5.1 14.2 5.8 8.5 13.2 7.0 6.9 9.4 12.7 12.6 10.2 6.2 10.2 10.5 13.8 0.9 1.2 10.1 2.5 1.4 1.5 1.1 2.1 0.7 12.7 19.5 8.0 3.3 8.6 4.0 4.5 1.4 3.3 0.7 14.2 3.5 3.7 1.5 2.7 2.5 1.7 0.9 2.2 2.6 0.9 1.9 0.6 6.8 0.6 5.2 2.5 3.9 1.1 1.3 0.3 7.5 8.1 4.1 8.4 7.0 5.3 5.3 3.3 3.2 3.6 6.8 0.8 7.7 0.5 2.5 2.2 4.4 2.4 12.3 4.3 1.2 0.4 14.1 3.2 11.5 6.6 4.9 0.6 3.6 2.0 2.2 5.1 1.1 3.9 15.1 2.9 0.1 1.5 3.4 0.9 2.5 0.8 0.7 0.2 0.7 1.2 0.9 0.6 0.6 10.1 1.4 0.8 0.7 1.5 1.1 9.9 11.7 13.8 11.6 10.1 7.2 11.2 9.2 11.7 12.7 3.0 9.6 34.1 15.5 3.8 26.4 1.8 15.3 10.7 11.4 15.7 27.5 14.5 8.3 12.4 5.5 11.3 6.7 23.3 15.3 9.4 6.9 10.3 8.1 2.1 8.2 17.5 13.3 15.4 15.4 4.1 10.6 15.5 10.1 13.6 7.2 14.0 14.3 7.0 9.2 2.2 18.2 6.5 7.1 9.8 9.5 5.0 33.6 25.8 6.0 22.2 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 19.7" "Cell type enriched" "Detected in some" 31 "Syncytiotrophoblasts: 218.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 11.7;SuSa: 9.8" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 19.1;SuSa: 12.9;T-47d: 5.4" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 ESPNL FLJ42568 ENSG00000144488 "Espin like" Q6ZVH7 2 238100157-238133287 "Predicted intracellular proteins" Hearing Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.9;pituitary gland: 8.2" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.7;Muller glia cells: 1.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 5 "cerebellum: 9.9" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 3.6;Daudi: 5.1;fHDF/TERT166: 4.7;HHSteC: 5.4;THP-1: 3.7;U-87 MG: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA055103 Uncertain NA NA "HPA055103: AB_2682694" "unprognostic (8.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.34e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-2)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (3.20e-1)" "unprognostic (1.79e-1)" "unprognostic (2.18e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (3.94e-6)" "unprognostic (3.49e-2)" "unprognostic (8.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.67e-2)" 0.6 0.5 0.3 6.0 0.3 0.0 0.6 9.9 0.6 1.2 1.1 0.6 0.3 1.4 1.5 0.3 0.8 2.8 0.3 1.3 0.3 0.0 1.1 3.5 0.7 2.6 0.3 0.3 4.0 1.3 0.0 8.2 0.3 2.0 1.5 0.2 0.6 2.0 3.5 0.3 0.1 4.9 1.6 0.3 3.8 0.8 0.4 0.8 0.3 2.0 0.3 2.8 0.4 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 1.4 0.6 2.0 1.0 1.7 1.8 0.0 0.0 5.1 2.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.9 1.8 5.4 0.0 1.1 1.9 0.0 0.2 0.0 0.0 0.0 1.6 1.7 0.0 2.0 0.0 0.0 2.3 0.4 0.0 0.0 1.6 0.2 0.7 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 4.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 9.9 0.6 0.3 0.0 0.3 0.3 2.0 0.8 0.0 0.0 0.8 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ETV2 ER71 ENSG00000105672 "ETS variant 2" O00321 19 35641745-35644871 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.2;testis: 40.3" "Group enriched" "Detected in many" 13 "Early spermatids: 128.4;Late spermatids: 360.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 19.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 19.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.14e-1)" "unprognostic (3.24e-2)" "unprognostic (1.73e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (2.83e-1)" "unprognostic (2.69e-3)" "unprognostic (8.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-4)" "unprognostic (2.48e-1)" "unprognostic (1.41e-1)" "unprognostic (2.74e-1)" 1.8 2.2 0.9 1.5 1.2 0.9 1.4 1.5 0.9 2.3 3.0 0.5 3.9 4.4 2.0 2.1 3.5 1.1 2.2 0.8 0.8 0.9 3.0 3.5 1.2 1.0 0.8 1.0 2.2 6.6 0.8 1.5 0.7 1.0 3.1 0.8 1.8 5.0 8.1 0.6 3.5 4.3 1.2 1.3 1.4 1.6 40.3 0.9 2.3 2.2 1.7 2.4 1.6 2.4 2.0 19.2 0.8 2.8 0.7 3.3 1.5 2.3 3.2 2.1 2.6 2.5 4.9 0.5 0.9 1.4 2.5 3.9 1.1 1.3 0.3 3.5 1.7 0.5 0.8 0.2 1.8 0.3 3.7 4.0 4.4 1.8 2.2 4.3 1.2 5.8 4.3 3.5 1.2 1.9 1.4 0.8 1.3 1.3 1.8 1.3 2.9 2.0 1.2 0.3 3.8 1.0 2.8 5.3 3.4 3.6 2.2 2.7 1.9 3.3 0.6 5.0 0.5 2.1 5.0 0.7 7.3 3.7 3.9 2.8 2.0 3.8 0.7 3.5 1.4 7.0 0.0 1.8 0.8 2.6 2.6 3.0 2.0 3.3 3.3 2.1 1.1 1.8 2.4 0.6 0.7 2.8 19.2 2.5 1.5 0.9 1.2 1.5 0.9 0.8 0.9 0.8 1.0 1.0 0.9 0.0 0.6 3.0 2.6 5.0 3.7 1.2 5.1 1.4 0.0 5.2 0.0 1.6 6.6 1.9 128.4 2.9 12.9 0.0 4.6 2.5 3.8 3.3 1.1 19.0 2.0 0.0 7.5 3.1 0.0 360.8 8.3 2.7 1.7 0.0 6.0 2.4 2.2 3.5 2.5 14.0 2.7 0.0 1.8 4.3 2.6 11.3 1.6 2.2 7.8 3.7 ETV3L FLJ16478 ENSG00000253831 "ETS variant 3 like" Q6ZN32 1 157092044-157099808 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.8;breast: 4.4;lymphoid tissue: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.8;pons and medulla: 7.8" "Group enriched" "Detected in some" 13 "classical monocyte: 1.5;intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Cell line enriched" "Detected in some" 17 "HDLM-2: 27.7" "Not detected" "Not detected" NA NA "unprognostic (7.39e-4)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (1.79e-5)" "unprognostic (2.25e-1)" "unprognostic (5.91e-2)" "unprognostic (1.57e-2)" "unprognostic (3.09e-4)" "unprognostic (1.88e-1)" "unprognostic (5.37e-2)" "unprognostic (3.37e-1)" 0.1 0.0 0.9 2.0 3.8 0.1 4.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.3 0.3 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.0 1.8 0.1 7.8 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.1 0.0 5.0 0.1 0.1 0.1 0.0 5.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.8 0.0 0.7 0.5 0.3 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 EVA1C "B18, B19, C21orf63, C21orf64, FAM176C, PRED34" ENSG00000166979 "Eva-1 homolog C" P58658 21 32412006-32515397 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 77.7;Late spermatids: 136.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 1.8;NK-cells: 3.8;T-cells: 5.2" "Cell line enhanced" "Detected in many" "A549: 13.4;CAPAN-2: 13.5;HBEC3-KT: 9.6;hTCEpi: 10.7;HUVEC TERT2: 10.4;SK-MEL-30: 11.7;TIME: 9.4;U-87 MG: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015720, HPA029944, CAB034174" Enhanced NA NA "CAB034174: AB_1564317, HPA015720: AB_1845705, HPA029944: AB_10601092" "unprognostic (7.55e-3)" "unprognostic (8.91e-3)" "unprognostic (5.51e-2)" "unprognostic (2.55e-1)" "unprognostic (3.16e-2)" "prognostic favorable (5.06e-4)" "unprognostic (1.40e-3)" "unprognostic (4.24e-3)" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.84e-2)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.73e-1)" "unprognostic (5.95e-3)" "unprognostic (4.25e-3)" 17.1 3.9 5.0 4.5 11.9 1.7 28.1 5.0 7.9 11.9 9.3 12.2 19.5 2.6 18.8 12.8 13.1 23.9 14.3 12.6 4.8 4.2 5.1 2.6 14.3 8.0 9.4 4.1 12.0 5.9 7.5 6.7 8.3 9.8 16.4 3.5 7.4 11.8 25.8 5.8 14.2 5.3 17.2 7.2 5.3 8.2 10.5 8.5 0.5 9.1 10.5 10.7 14.2 14.9 0.0 0.1 1.8 0.5 3.8 5.2 1.8 0.0 13.4 0.1 0.5 2.9 2.0 0.3 2.9 0.5 0.9 0.2 0.0 13.5 0.1 0.3 0.1 1.4 0.0 0.5 9.6 0.2 1.5 0.0 0.0 6.3 0.4 3.6 0.0 0.0 0.9 10.7 1.9 7.5 2.1 10.4 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.6 3.0 0.0 0.3 0.0 0.3 0.2 4.0 0.6 8.4 0.7 11.7 0.1 0.5 0.0 9.4 1.2 0.4 1.6 0.6 0.2 0.0 0.1 11.6 0.1 3.0 1.8 0.0 0.0 4.6 0.2 5.2 0.0 4.9 4.5 0.1 0.0 1.0 2.5 0.0 3.8 0.5 0.0 0.6 1.8 5.0 11.9 5.0 7.9 4.8 4.2 9.4 4.1 9.8 8.5 17.9 19.4 0.0 77.7 37.9 6.0 6.1 45.9 28.1 30.7 8.7 0.0 0.3 0.0 70.1 70.4 46.2 4.5 0.0 9.2 0.2 9.5 39.2 5.8 1.0 0.5 6.4 1.7 22.1 1.5 136.2 13.6 4.7 21.9 4.6 4.5 25.1 6.1 3.5 13.8 1.7 1.7 19.4 29.7 2.2 1.6 25.7 0.6 13.1 6.6 38.9 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Group enriched" "Detected in many" 4 "granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA045033: AB_2679191, HPA057051: AB_2683321" "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.7 10.6 0.0 1.3 2.2 1.7 6.1 0.0 0.5 9.0 0.0 1.7 9.9 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 20.2 10.4 11.4 13.1 0.0 2.4 7.0 2.6 0.6 8.3 0.3 33.4 13.2 0.1 7.4 11.4 0.0 0.0 0.0 7.8 1.3 51.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 4.3 7.3 0.2 0.3 4.8 15.0 0.0 10.1 5.9 7.6 6.0 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 0.0 6.4 31.5 0.3 3.5 0.2 0.3 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.5 2.6 0.2 75.5 0.8 100.8 0.0 0.0 7.4 231.8 0.0 0.3 127.6 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.7 0.0 1.6 0.1 0.2 2.8 1.1 130.3 0.0 0.3 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377662-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.2;lymphoid tissue: 10.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.9;Basal glandular cells: 1.7;Club cells: 2.3;Collecting duct cells: 1.8;Spermatogonia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.9;HaCaT: 1.9;HeLa: 3.3;hTCEpi: 11.5;RT4: 4.0;SiHa: 2.1;T-47d: 3.5" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 3.3 0.5 0.0 0.7 0.4 0.8 0.9 22.2 0.4 0.8 0.0 0.0 0.0 0.9 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.7 0.2 0.0 2.1 3.1 0.1 7.8 0.4 1.4 0.0 0.1 1.7 2.5 0.0 0.1 2.2 9.5 10.4 3.5 7.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 2.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.5 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.0 EVX1 ENSG00000106038 "Even-skipped homeobox 1" P49640 7 27242700-27250493 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9" "Group enriched" "Detected in some" 29 "Early spermatids: 49.8;Late spermatids: 47.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 26 "pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "OE19: 21.4;RT4: 13.3" "Group enriched" "Detected in some" 15 "midbrain: 1.0;pons and medulla: 1.0" "Not detected" "Not detected" HPA055132 Approved Nucleoplasm NA NA Nucleoplasm "HPA055132: AB_2682707" "unprognostic (2.73e-2)" "unprognostic (3.59e-1)" "unprognostic (4.31e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-3)" "unprognostic (2.08e-2)" "unprognostic (8.48e-3)" "unprognostic (5.94e-2)" "unprognostic (1.26e-8)" "unprognostic (2.94e-1)" "unprognostic (1.39e-1)" "unprognostic (9.12e-2)" "unprognostic (1.83e-2)" 0.1 6.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.2 0.6 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 3.0 6.4 0.7 0.1 0.1 6.7 0.1 0.0 0.1 1.9 0.1 0.1 0.0 1.7 0.1 0.1 0.1 0.1 0.1 8.9 5.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.2 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 EVX2 ENSG00000174279 "Even-skipped homeobox 2" Q03828 2 176077472-176083913 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9" "Group enriched" "Detected in some" 5 "Early spermatids: 8.2;Intestinal endocrine cells: 2.4;Late spermatids: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8" "Group enriched" "Detected in some" 15 "midbrain: 1.6;pons and medulla: 1.2" "Not detected" "Not detected" HPA041576 Uncertain NA NA "HPA041576: AB_10796347" "unprognostic (2.27e-1)" "unprognostic (1.68e-3)" "unprognostic (1.83e-1)" "unprognostic (3.41e-1)" "unprognostic (5.75e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-3)" "unprognostic (2.32e-1)" "unprognostic (4.93e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.8 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.3 EXD3 "FLJ20433, LOC54932, mut-7" ENSG00000187609 "Exonuclease 3'-5' domain containing 3" Q8N9H8 9 137306896-137423262 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "granulocytes: 63.2;Late spermatids: 57.2;Paneth cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 21.6" "Low region specificity" "Detected in all" HPA047395 Approved Approved "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "HPA047395: AB_10962864" "unprognostic (2.91e-1)" "unprognostic (5.67e-2)" "unprognostic (1.75e-3)" "prognostic favorable (4.30e-4)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (1.37e-1)" "unprognostic (2.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "unprognostic (7.99e-3)" "unprognostic (2.05e-1)" "unprognostic (8.67e-2)" "unprognostic (5.05e-2)" 9.7 10.9 8.0 10.1 11.1 8.4 10.4 11.9 12.4 11.2 15.5 16.5 14.9 22.8 10.2 17.5 11.1 11.5 14.1 10.5 8.7 7.9 11.8 7.3 12.3 8.0 9.5 11.2 11.1 13.3 8.3 13.8 8.3 11.0 14.0 8.9 13.9 17.5 11.4 15.9 17.4 20.6 15.8 7.4 16.3 14.3 5.1 9.1 1.7 11.4 6.8 7.8 10.0 10.8 4.0 5.3 10.8 6.0 5.3 8.5 3.6 5.7 4.9 2.4 6.8 2.0 3.0 5.7 2.9 3.3 2.5 3.9 3.3 12.4 2.5 7.9 2.1 6.3 10.7 0.7 3.1 0.8 5.8 5.9 2.0 8.7 5.1 6.2 1.4 21.6 3.4 4.3 2.2 1.9 7.3 8.6 0.0 4.7 4.6 2.1 15.4 0.1 4.9 2.8 12.6 3.4 4.4 2.0 17.2 5.1 3.3 3.3 6.0 2.8 6.0 2.7 2.9 9.7 6.4 10.7 3.5 3.4 5.5 4.3 6.1 2.7 2.1 6.7 4.5 6.6 10.8 5.0 10.6 3.5 6.0 4.0 3.9 6.0 3.3 5.3 4.0 4.8 3.7 1.2 5.3 5.8 3.4 8.5 3.6 8.0 11.1 11.9 12.4 8.7 7.9 9.5 11.2 11.0 9.1 0.0 4.6 0.5 9.4 5.3 13.3 4.5 5.1 5.3 6.8 7.0 13.7 8.3 8.3 6.2 13.5 11.3 39.9 0.0 9.8 2.8 5.3 8.7 63.2 5.5 7.6 20.6 7.0 16.5 4.9 57.2 5.5 5.1 3.3 2.8 22.2 8.6 6.3 178.5 7.4 10.3 10.3 12.9 7.1 2.8 9.4 7.9 3.3 6.9 28.5 7.4 EXOC1L ENSG00000250821 "Exocyst complex component 1 like" 4 55819819-55837487 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.7;blood: 5.2;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 52 "NK-cell: 5.2" "Lineage enriched" "Detected in single" 52 "NK-cells: 5.2" "Group enriched" "Detected in some" 6 "HEK 293: 5.8;HSkMC: 2.3" "Region enriched" "Detected in single" 4 "pons and medulla: 3.0" "Not detected" "Not detected" NA NA 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 5.8 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184366-67190204 "Predicted intracellular proteins" Exocytosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 11.7;Ito cells: 32.5;Leydig cells: 14.4;Peritubular cells: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.1;SuSa: 3.8;TIME: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 2.4 0.3 1.8 0.9 0.0 2.4 0.4 1.2 1.4 0.6 0.3 0.3 0.8 3.6 0.8 1.2 0.9 1.5 4.5 1.3 0.2 3.3 1.4 8.7 1.8 0.3 0.8 2.0 1.0 0.4 1.1 6.0 1.0 1.6 0.3 2.4 1.1 0.5 1.8 0.7 1.0 0.8 1.0 26.6 0.7 1.0 0.3 0.3 4.1 1.0 0.5 1.0 0.5 0.0 0.7 1.8 2.0 0.0 0.0 0.3 0.2 0.1 1.2 0.4 0.0 0.1 3.1 0.4 0.0 0.0 0.0 1.4 0.3 0.1 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 5.8 0.6 0.5 0.0 0.1 0.2 0.3 0.1 0.5 0.1 0.6 1.3 1.2 0.2 0.0 0.2 11.1 1.3 1.5 0.3 0.1 3.8 1.0 0.1 4.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.8 0.0 0.3 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.3 0.3 0.9 0.4 1.2 1.3 0.2 0.3 0.8 1.0 0.3 0.0 0.0 0.0 1.6 0.8 1.7 0.8 0.0 0.0 0.0 3.5 0.0 0.4 6.6 0.7 1.6 11.7 4.2 0.0 3.3 2.5 0.2 0.3 0.0 0.8 0.8 3.2 1.2 32.5 1.5 3.1 14.4 0.3 0.0 1.0 3.3 0.2 0.5 1.7 17.3 0.1 0.8 0.0 0.1 0.4 0.9 1.8 0.7 0.0 2.3 1.3 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" Q2M3D2 19 45212621-45245431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "Ito cells: 57.1" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "Group enriched" "Detected in some" 7 "HEL: 18.2;K-562: 16.8" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: AB_2684431" 3.2 4.3 0.0 2.0 0.0 0.9 3.0 0.0 0.3 3.6 2.1 0.1 2.4 2.3 14.5 1.2 2.3 0.6 6.9 1.9 0.0 12.7 9.4 3.4 6.3 0.0 0.0 3.4 2.8 2.4 3.5 0.4 0.0 3.7 0.2 13.7 3.3 3.6 1.0 2.4 3.9 1.6 0.0 12.6 2.4 2.1 0.0 0.0 4.6 1.5 3.2 1.6 3.3 0.5 0.3 2.5 0.4 0.2 0.4 0.2 0.1 0.3 2.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 1.2 0.0 0.1 0.0 0.1 0.0 18.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.8 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.5 1.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.7 0.1 0.3 0.4 0.8 1.6 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.1 1.6 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 2.5 0.2 0.3 0.3 0.1 0.2 0.0 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 57.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.2 3.4 0.6 0.0 0.0 0.0 0.1 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 58.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA010726, HPA037749" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 68000 Centrosome Vesicles "HPA010726: , HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.6 2.1 15.3 0.6 9.5 0.5 2.0 1.1 21.1 1.3 0.6 1.4 0.0 0.7 2.5 0.7 1.5 1.7 1.2 6.0 12.7 3.7 0.7 0.5 0.7 0.8 3.7 7.9 2.3 1.0 0.5 0.5 1.0 2.9 1.2 0.6 2.7 0.8 0.9 20.5 1.6 0.7 2.9 2.7 2.2 0.6 1.0 0.8 0.0 0.9 3.2 0.6 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 15.3 9.5 1.1 21.1 12.7 3.7 3.7 7.9 2.9 0.8 0.0 0.0 0.0 0.0 0.1 6.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.4 1.4 0.0 6.8 0.0 0.0 0.6 0.0 0.0 2.5 0.0 1.4 0.0 0.3 0.2 0.2 0.0 0.8 0.0 0.0 0.0 FAAH2 "AMDD, FAAH-2, FLJ31204, RP11-479E16.1" ENSG00000165591 "Fatty acid amide hydrolase 2" Q6GMR7 X 57286706-57489196 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.6;pituitary gland: 42.8" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 24.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 18.0" "Cell type enhanced" "Detected in many" "T-reg: 13.6" "Lineage enriched" "Detected in many" 8 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3" NA NA "unprognostic (1.37e-1)" "unprognostic (1.78e-2)" "unprognostic (7.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.02e-1)" "unprognostic (4.51e-2)" "unprognostic (7.93e-3)" "unprognostic (4.47e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.99e-4)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.47e-13)" "unprognostic (9.16e-3)" "unprognostic (2.27e-1)" "prognostic favorable (2.66e-4)" "prognostic favorable (6.83e-5)" 1.0 1.4 1.0 6.8 1.5 0.0 6.7 18.0 1.0 3.5 3.9 0.2 3.8 2.6 1.4 4.7 5.5 5.8 2.4 0.6 1.2 2.3 9.7 20.1 3.5 5.7 1.1 0.5 1.9 43.6 12.7 42.8 1.4 1.8 9.3 3.6 3.8 9.1 5.3 0.3 10.0 6.4 0.6 1.1 2.3 4.1 0.6 0.3 8.5 15.3 2.7 11.0 3.0 3.6 1.8 1.0 0.3 0.0 0.7 13.6 1.5 2.5 0.2 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.0 0.0 1.8 10.7 0.1 3.1 0.0 0.0 0.4 0.8 1.9 0.0 9.6 5.2 0.3 2.5 0.7 0.0 1.1 0.0 0.0 3.2 0.0 0.0 0.1 0.0 1.0 1.2 4.8 0.0 1.0 0.5 0.0 1.8 2.2 0.0 0.0 1.8 19.4 6.3 3.4 1.8 0.1 0.1 3.0 0.0 4.6 3.0 0.0 0.0 0.0 0.2 0.0 0.1 16.3 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 4.7 1.8 7.7 3.2 0.0 0.6 7.5 0.9 0.3 0.7 0.0 1.0 13.6 1.5 1.0 1.5 18.0 1.0 1.2 2.3 1.1 0.5 1.8 0.3 3.0 5.6 0.0 11.2 2.4 3.1 0.3 2.5 24.1 6.8 5.2 17.7 4.4 8.3 8.3 0.0 0.0 3.9 0.0 12.2 2.1 0.5 10.4 0.0 9.0 0.6 1.6 12.7 0.6 0.0 0.0 0.6 0.0 3.3 1.0 5.6 1.2 11.6 3.4 0.4 4.5 12.2 0.0 0.1 0.0 0.0 5.8 4.7 2.5 4.7 9.0 FABP12 ENSG00000197416 "Fatty acid binding protein 12" A6NFH5 8 81524981-81531378 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 6.7;testis: 13.2" "Group enriched" "Detected in some" 5 "Early spermatids: 65.5;Late spermatids: 133.2" "Cancer enhanced" "Detected in single" "cervical cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;RT4: 1.1" "Not detected" "Not detected" HPA044041 Enhanced NA NA "HPA044041: AB_10962213" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 65.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.2 0.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 20.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 FADS3 "CYB5RP, LLCDL3" ENSG00000221968 "Fatty acid desaturase 3" Q9Y5Q0 11 61873519-61892051 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 63.1" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 109.7;Rod photoreceptor cells: 109.4;Smooth muscle cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.9;naive B-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 63.4;HHSteC: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045224 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA045224: AB_10967570" "unprognostic (4.69e-3)" "unprognostic (1.31e-2)" "unprognostic (5.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.91e-2)" "prognostic unfavorable (9.54e-5)" "unprognostic (1.76e-3)" "unprognostic (3.46e-1)" "unprognostic (6.45e-2)" "unprognostic (1.49e-1)" "unprognostic (1.28e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.50e-9)" "unprognostic (1.14e-1)" "unprognostic (3.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.37e-1)" 63.1 25.9 15.7 17.5 17.9 4.1 23.5 8.7 16.5 9.3 8.3 13.8 5.9 4.3 9.8 25.4 7.4 9.0 9.9 22.7 14.4 11.6 16.6 8.5 16.3 15.4 16.9 10.0 12.7 12.1 12.4 5.0 48.2 15.1 7.1 4.4 16.8 5.5 11.3 15.7 4.2 9.0 14.9 13.3 9.7 8.3 6.0 15.6 1.1 6.1 7.3 15.7 10.4 9.9 10.6 0.7 5.7 1.2 0.6 2.4 0.7 7.7 2.4 0.7 4.9 63.4 12.8 15.8 15.8 38.6 16.9 16.4 3.4 2.8 5.8 10.3 31.4 13.2 4.3 2.9 42.9 9.0 1.6 1.6 4.8 10.3 6.9 54.9 0.4 0.9 14.0 18.7 20.3 38.8 10.3 19.5 3.1 4.6 11.0 28.7 9.0 1.7 2.4 2.3 0.8 6.4 9.7 31.3 16.1 18.9 2.7 1.2 1.6 18.0 2.4 16.0 6.8 3.5 1.0 13.2 16.5 11.5 4.8 6.9 3.4 1.6 7.0 13.8 2.3 11.9 0.0 0.7 5.7 1.8 1.2 1.6 8.9 1.6 2.4 0.7 10.6 0.1 0.6 0.3 0.6 0.8 0.0 0.4 0.7 15.7 17.9 8.7 15.4 14.4 11.6 16.9 10.0 15.1 15.6 29.8 6.9 31.8 7.1 6.1 10.3 18.6 7.6 2.7 1.2 5.2 7.9 34.9 1.7 39.5 16.2 27.8 7.0 23.3 17.7 109.7 19.7 8.5 6.9 8.5 17.2 1.6 6.4 18.4 3.7 8.3 26.4 14.0 33.7 12.6 3.6 57.1 21.1 3.5 16.6 9.1 109.4 19.4 106.1 2.1 3.8 4.8 56.9 4.3 4.8 3.3 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.3 1.5 1.4 0.4 0.7 1.9 1.4 0.0 0.8 0.7 2.2 0.1 2.6 1.2 0.6 0.8 3.6 3.4 14.0 0.3 1.3 0.0 44.0 0.1 0.3 0.2 0.0 0.0 0.0 2.2 0.0 5.5 0.1 1.1 0.0 1.2 1.9 12.3 9.4 0.4 0.5 1.6 0.0 10.5 4.6 5.1 0.7 0.5 0.0 1.3 0.5 12.2 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.8 20.8 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 89.3 8.2 0.9 4.4 7.4 0.7 0.0 2.5 0.0 3.4 0.0 0.0 0.7 0.0 0.0 1.1 6.3 22.2 0.0 0.0 1.5 5.9 7.8 49.6 0.2 83.6 0.0 59.1 4.3 69.4 2.0 4.0 37.7 11.8 0.0 39.6 2.5 0.0 37.1 3.2 0.0 0.9 0.0 3.8 20.5 57.7 5.9 1.1 30.5 41.5 2.7 FAM110D "FLJ14050, GRRP1" ENSG00000197245 "Family with sequence similarity 110 member D" Q8TAY7 1 26159020-26163962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Endothelial cells: 29.6;Ito cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "TIME: 4.0;U-2 OS: 5.0;U-937: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA013664 Approved NA NA "HPA013664: AB_1234332" "unprognostic (7.53e-2)" "unprognostic (4.45e-3)" "unprognostic (4.80e-4)" "unprognostic (1.84e-2)" "unprognostic (1.07e-3)" "unprognostic (3.16e-3)" "unprognostic (7.67e-5)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (4.51e-2)" "unprognostic (7.29e-3)" "unprognostic (6.63e-2)" "unprognostic (9.87e-2)" "unprognostic (6.94e-2)" "unprognostic (2.91e-1)" "unprognostic (1.51e-1)" "unprognostic (2.96e-1)" 17.2 2.2 2.8 2.5 5.4 2.4 14.2 1.2 3.3 10.4 3.8 1.1 3.7 3.3 12.5 5.0 8.6 10.9 6.5 11.6 3.5 2.3 6.3 1.3 8.8 2.9 4.5 0.0 4.8 6.6 3.6 3.7 2.2 5.6 6.9 2.2 4.6 7.9 3.5 9.4 5.3 4.2 8.7 3.4 1.6 4.9 3.3 2.4 0.1 6.9 10.4 2.5 4.2 14.5 1.2 0.9 4.4 0.9 1.6 0.8 0.2 0.4 0.5 1.5 1.0 0.0 0.0 0.7 0.2 0.1 0.3 0.5 0.3 1.0 1.9 2.0 0.0 0.2 0.3 0.6 0.6 0.1 0.6 0.4 0.4 0.9 1.1 0.3 0.5 0.1 0.6 0.4 0.2 0.3 0.2 2.1 0.7 0.3 0.8 0.3 0.5 0.8 0.4 1.7 0.3 0.2 0.3 0.1 0.4 0.1 0.4 1.6 1.5 0.3 0.1 0.3 1.4 0.6 0.7 4.0 0.2 5.0 0.4 0.1 0.1 0.6 0.4 0.0 3.0 0.3 3.8 0.9 0.9 0.8 0.5 0.5 0.7 0.6 0.5 0.3 1.2 0.7 0.7 4.4 1.6 0.7 0.9 0.3 0.2 2.8 5.4 1.2 3.3 3.5 2.3 4.5 0.0 5.6 2.4 0.0 4.3 0.0 0.7 0.9 1.1 1.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 29.6 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.6 0.0 19.6 1.5 0.0 0.6 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.1 0.7 0.6 0.2 0.0 0.0 0.2 FAM120AOS C9orf10OS ENSG00000188938 "Family with sequence similarity 120A opposite strand" Q5T036 9 93446494-93453592 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021475 Approved NA NA "HPA021475: AB_2670718" "unprognostic (1.20e-1)" "unprognostic (2.33e-1)" "unprognostic (1.56e-1)" "unprognostic (1.48e-2)" "unprognostic (1.10e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.10e-1)" "unprognostic (3.42e-1)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.93e-1)" "prognostic favorable (6.04e-4)" "unprognostic (2.33e-1)" "unprognostic (7.91e-2)" "unprognostic (8.45e-3)" "unprognostic (1.42e-1)" 18.2 18.4 20.5 18.4 19.7 9.5 22.4 12.5 23.1 17.0 22.5 20.0 19.4 13.1 17.3 34.8 17.4 15.6 17.9 21.8 16.9 17.8 20.4 16.9 16.1 13.9 18.0 15.5 19.3 23.8 29.3 32.1 48.4 18.4 23.7 23.6 28.1 17.5 20.1 18.2 18.0 20.6 19.2 17.8 14.9 21.7 9.1 13.2 21.9 27.6 11.1 18.5 19.4 22.8 15.0 11.1 12.6 14.2 10.6 11.7 6.1 16.5 15.3 11.0 12.0 16.1 7.0 17.7 10.6 11.1 11.7 9.0 11.5 13.3 14.5 13.4 11.6 16.5 21.2 11.3 10.9 10.8 23.2 9.0 14.7 14.4 12.8 16.2 12.1 9.5 8.9 15.4 11.0 18.7 12.6 12.6 12.0 15.2 20.6 10.9 38.9 15.5 5.7 15.1 22.7 17.0 13.1 15.1 14.3 15.8 14.9 23.6 11.3 15.5 16.8 15.2 13.5 18.0 9.2 8.2 7.3 11.6 25.1 14.5 15.0 19.5 6.2 11.9 7.5 14.8 10.8 12.3 7.8 6.5 11.9 8.5 15.0 9.8 8.6 10.1 11.0 11.7 9.0 12.6 10.6 14.2 11.1 9.2 6.1 20.5 19.7 12.5 23.1 16.9 17.8 18.0 15.5 18.4 13.2 32.8 35.5 24.1 39.8 11.2 26.1 35.0 12.7 34.8 61.4 17.4 13.7 86.9 33.2 30.0 0.4 26.0 41.6 0.0 42.3 121.2 27.7 44.1 22.0 19.4 35.8 6.4 27.2 17.8 24.1 2.5 22.2 20.4 11.8 43.3 31.5 21.5 29.2 30.9 31.5 27.6 26.0 25.8 31.6 12.4 16.4 22.6 208.2 24.0 28.3 49.2 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 41.5;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 14.9" HPA059961 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 4.2 3.8 4.1 4.7 6.0 8.7 4.1 2.9 5.0 4.6 3.8 7.9 3.8 1.8 11.5 4.2 3.5 4.7 3.4 3.9 4.0 4.2 3.6 3.2 5.6 7.1 6.3 4.6 22.0 2.1 2.9 5.5 2.9 5.3 4.4 3.2 11.5 6.6 3.2 2.9 3.3 4.0 7.9 6.2 6.4 4.7 12.0 5.2 9.1 3.8 2.1 6.5 5.9 3.5 4.8 7.0 7.3 5.8 4.5 3.8 2.1 1.1 1.4 4.4 4.5 1.2 1.7 2.6 3.7 3.3 3.4 4.7 3.2 4.5 1.5 5.7 1.6 7.4 1.7 3.7 1.3 2.5 3.7 1.4 2.6 14.9 1.4 1.3 3.9 2.3 1.8 0.7 3.3 2.1 2.3 2.8 11.6 10.9 8.7 2.4 6.8 4.0 3.2 2.4 1.2 3.3 6.9 3.0 3.2 1.1 1.0 1.8 3.0 2.3 0.7 3.8 3.3 1.1 1.1 0.9 2.0 1.3 3.1 2.4 3.3 2.9 6.5 2.9 4.4 2.2 2.7 2.8 7.3 2.6 3.1 2.7 4.8 3.0 3.8 1.9 4.1 3.7 3.3 5.3 4.5 5.8 7.0 2.7 2.1 4.1 6.0 2.9 5.0 4.0 4.2 6.3 4.6 5.3 5.2 6.0 5.0 0.0 2.1 1.1 4.2 1.9 0.0 13.4 3.4 1.8 13.7 1.3 1.7 1.0 41.5 5.7 2.3 23.3 1.6 2.2 2.0 1.3 12.7 0.5 1.9 3.2 1.2 4.9 1.9 4.5 3.7 2.7 3.3 3.6 1.7 4.6 2.0 1.1 2.1 1.1 13.0 0.0 2.3 10.7 1.9 1.0 1.6 8.7 1.7 2.2 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5" HPA042800 Uncertain Approved "Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 8.1 14.9 18.8 4.6 26.4 2.5 5.0 21.9 54.7 5.4 6.4 8.0 4.8 6.3 7.5 4.9 7.5 7.7 8.4 11.9 28.1 13.0 4.1 3.0 6.0 3.4 9.1 25.9 8.8 11.3 9.2 16.4 5.0 7.8 6.7 3.5 3.3 7.1 11.7 9.3 10.5 5.8 8.7 5.9 5.3 5.5 7.0 7.0 0.8 3.5 3.9 2.7 5.5 4.1 2.1 5.5 11.1 6.5 1.6 2.2 2.5 8.2 3.4 5.5 9.7 7.5 6.2 5.2 3.7 8.4 5.9 4.6 2.6 2.9 1.2 15.5 3.6 12.6 7.8 0.0 6.7 3.8 8.8 9.3 0.0 5.2 5.6 7.6 0.1 6.5 4.6 1.1 5.0 11.6 5.5 11.8 5.7 1.8 1.3 2.2 6.4 3.2 0.2 9.4 5.1 6.9 5.8 2.2 7.9 5.9 0.2 16.9 17.6 2.3 6.5 8.6 3.7 19.1 2.1 11.9 7.2 5.6 5.8 11.6 14.0 8.4 0.8 23.2 1.2 5.1 2.0 4.8 6.0 1.5 6.5 1.6 2.0 1.2 1.6 5.5 2.1 1.2 1.5 11.1 1.6 3.4 2.3 2.2 2.5 18.8 26.4 21.9 54.7 28.1 13.0 9.1 25.9 7.8 7.0 6.0 5.3 6.7 16.9 9.8 21.2 5.1 10.2 16.0 1.2 14.0 13.7 8.2 1.7 5.6 3.9 8.8 13.1 23.3 2.9 2.7 5.4 12.7 6.9 1.5 6.8 22.3 9.2 15.4 5.4 0.7 17.3 8.3 1.7 9.0 6.4 14.1 7.4 8.6 19.4 3.0 16.3 6.5 10.3 11.6 6.8 12.8 27.8 4.4 8.1 13.1 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 27.7;Cone photoreceptor cells: 27.5;Early spermatids: 96.5;Late spermatids: 22.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "RH-30: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 14.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 0.0 0.0 0.0 0.0 0.0 27.7 1.1 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 96.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 22.0 1.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 FAM149A "DKFZP564J102, MST119, MSTP119" ENSG00000109794 "Family with sequence similarity 149 member A" A5PLN7 4 186104419-186172667 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.7" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 34.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 11.3;JURKAT: 8.1;MOLT-4: 8.0;RT4: 9.3;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "HPA044019, HPA055004" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA044019: AB_2732513, HPA055004: AB_2682667" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (4.64e-2)" "prognostic favorable (2.67e-6)" "unprognostic (7.08e-2)" "unprognostic (9.12e-2)" "unprognostic (1.41e-3)" "unprognostic (1.06e-1)" "unprognostic (2.52e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.81e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" 8.7 4.3 17.6 3.7 22.7 0.3 8.6 5.1 12.4 6.1 7.3 8.2 4.7 4.6 6.0 9.8 9.1 11.1 12.8 7.3 15.4 10.0 27.3 37.7 4.3 1.1 8.9 5.8 6.2 19.6 8.8 3.7 1.9 7.4 7.5 6.2 12.2 12.2 13.3 7.0 1.7 3.9 13.8 12.4 1.9 8.4 3.6 5.7 1.0 2.7 3.2 1.5 8.4 4.9 1.0 0.7 0.2 0.0 0.0 4.0 0.0 0.0 3.2 2.9 0.1 11.3 4.6 0.1 0.0 0.0 0.3 0.3 0.0 1.9 0.0 1.6 1.5 2.9 0.0 5.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.7 0.1 0.2 2.1 0.3 0.2 0.0 1.1 0.0 8.1 0.0 2.5 1.3 1.6 8.0 0.3 5.1 0.0 0.0 0.3 0.0 2.0 1.7 9.3 14.2 3.9 0.1 0.0 4.4 0.9 1.0 0.0 0.8 0.2 1.7 0.0 1.6 0.0 0.0 0.0 0.8 0.0 1.3 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.1 1.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.7 4.0 0.0 17.6 22.7 5.1 12.4 15.4 10.0 8.9 5.8 7.4 5.7 0.0 1.0 0.0 2.3 0.5 11.0 6.9 17.8 10.7 6.8 5.2 43.2 0.6 5.0 8.6 10.0 0.3 0.8 0.0 4.8 0.7 2.0 2.4 0.0 11.4 0.2 1.6 9.1 1.3 1.5 3.2 3.1 1.6 3.3 0.0 2.7 20.8 4.0 3.5 3.9 7.7 34.6 6.5 2.2 1.0 2.8 0.3 0.7 0.0 3.0 1.8 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168166-73244504 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039189: AB_10805355, HPA039859: AB_2676712" "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 9.3 8.9 21.3 7.3 17.0 5.4 10.1 7.7 15.1 12.2 13.4 14.9 10.3 5.4 9.1 10.6 10.5 11.4 12.8 15.7 19.2 14.2 17.5 15.2 7.9 6.3 20.8 9.8 12.6 9.3 12.9 10.8 10.3 13.6 10.5 8.0 8.1 9.0 9.1 9.4 5.8 9.5 9.3 22.8 5.9 7.2 16.6 13.2 6.2 9.8 13.4 7.3 8.3 7.3 2.7 2.7 5.0 1.8 4.6 3.4 1.3 6.9 5.3 11.9 10.9 26.1 16.3 7.7 8.0 15.7 5.4 9.6 3.3 12.2 5.2 3.1 13.9 6.2 6.7 6.9 10.0 6.5 6.3 3.5 6.6 4.1 5.6 13.6 9.1 4.4 13.9 7.4 7.0 27.3 24.0 13.6 8.3 5.9 9.7 9.8 6.3 6.0 8.6 5.1 15.0 13.9 4.0 7.5 5.3 14.6 7.0 2.6 11.3 6.2 16.7 9.6 11.1 9.6 5.8 7.2 5.3 5.4 5.3 10.0 10.7 4.8 4.6 9.1 9.1 4.2 5.0 0.7 2.5 2.2 1.8 2.8 2.7 2.2 2.1 1.5 2.2 3.4 3.1 1.5 4.6 1.0 2.7 2.5 1.3 21.3 17.0 7.7 15.1 19.2 14.2 20.8 9.8 13.6 13.2 3.0 1.9 3.7 3.0 1.8 6.6 10.2 5.1 10.7 5.7 1.8 5.9 5.8 1.7 3.8 17.7 5.8 4.7 0.0 3.1 4.8 4.3 4.0 2.3 3.4 4.8 3.2 7.5 5.5 4.5 19.6 7.8 2.5 1.7 1.8 5.8 4.2 4.0 0.0 4.2 6.8 12.1 12.9 5.2 10.9 3.8 3.1 6.9 2.1 5.2 3.7 FAM151A "C1orf179, MGC27169" ENSG00000162391 "Family with sequence similarity 151 member A" Q8WW52 1 54609182-54623556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 45.8;kidney: 59.3" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 116.1" "Group enriched" "Detected in many" 5 "liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enriched" "Detected in single" 45 "CACO-2: 41.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA016840 Approved NA NA "HPA016840: AB_2669461" "unprognostic (1.89e-1)" "unprognostic (6.90e-3)" "unprognostic (3.73e-2)" "unprognostic (1.97e-6)" "unprognostic (1.71e-2)" "unprognostic (4.84e-3)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.05e-2)" "unprognostic (4.91e-3)" "unprognostic (9.99e-2)" "prognostic favorable (4.09e-5)" "unprognostic (5.85e-2)" "unprognostic (8.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-3)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.6 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 59.3 5.6 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 45.8 0.1 0.1 0.5 0.0 0.3 0.1 0.3 0.1 0.1 0.9 0.1 0.1 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 41.7 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.0 11.6 0.0 4.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.8 0.0 116.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 FAM153A NY-REN-7 ENSG00000170074 "Family with sequence similarity 153 member A" Q9UHL3 5 177707981-177783398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.6;lymphoid tissue: 8.9;testis: 15.2" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 55.5;Late spermatids: 14.2;Peritubular cells: 20.8;Sertoli cells: 38.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 5.1;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 13 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "A549: 2.6;Daudi: 1.1;K-562: 1.3" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain NA NA "HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836" "unprognostic (5.92e-5)" "unprognostic (1.41e-1)" "unprognostic (5.94e-2)" "unprognostic (4.20e-3)" "unprognostic (1.58e-2)" "unprognostic (5.55e-3)" "unprognostic (1.70e-2)" "unprognostic (3.41e-2)" "unprognostic (1.44e-1)" "unprognostic (1.77e-2)" "unprognostic (4.75e-2)" "unprognostic (4.33e-2)" "unprognostic (1.30e-1)" "unprognostic (5.33e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" 0.5 0.3 1.3 0.5 3.5 1.1 0.2 10.6 4.3 1.3 0.2 0.6 0.4 0.4 0.4 1.2 0.5 0.3 2.0 1.5 0.3 0.3 0.5 1.2 0.0 5.3 0.5 0.3 5.2 0.2 3.9 0.3 0.3 0.5 0.5 1.5 0.5 0.2 0.0 8.9 0.3 15.2 1.3 1.4 0.2 0.6 0.3 0.1 0.0 0.0 0.0 5.1 0.2 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.3 5.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.9 0.0 2.6 0.6 1.0 1.6 0.0 1.4 2.3 0.0 3.9 0.0 0.0 0.5 55.5 0.7 0.0 0.0 0.0 0.3 0.2 0.9 2.3 0.0 0.1 0.0 0.0 0.6 0.0 14.2 13.0 0.3 0.0 0.0 0.0 0.5 1.0 0.0 20.8 0.0 0.6 38.8 0.6 0.7 0.4 0.5 0.0 0.0 0.0 0.3 FAM153B ENSG00000182230 "Family with sequence similarity 153 member B" P0C7A2 5 176060689-176116015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.2;ovary: 15.3;testis: 14.7" "Group enriched" "Detected in many" 4 "Early spermatids: 211.9;Leydig cells: 93.7;Sertoli cells: 304.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-2 OS: 4.9" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain NA NA "HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836" "unprognostic (1.08e-2)" "unprognostic (4.15e-2)" "unprognostic (1.92e-1)" "unprognostic (2.66e-2)" "unprognostic (2.45e-1)" "unprognostic (1.09e-3)" "unprognostic (1.66e-2)" "unprognostic (3.62e-3)" "unprognostic (3.59e-1)" "unprognostic (4.47e-2)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (5.66e-2)" "unprognostic (2.62e-2)" "unprognostic (3.06e-1)" 2.1 2.1 8.1 1.7 5.6 1.4 0.4 16.2 11.1 1.5 0.4 0.4 0.4 0.3 0.7 2.8 0.4 4.5 2.6 1.5 7.9 2.6 0.6 0.4 1.3 3.5 0.4 2.6 15.3 1.2 0.3 7.1 0.4 1.4 2.7 0.6 0.6 0.6 0.9 0.5 0.7 0.6 0.4 1.0 8.5 0.5 14.7 1.8 0.4 1.2 0.4 1.9 0.4 0.4 0.5 2.6 0.7 0.3 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.1 0.3 0.0 0.5 0.5 0.4 0.4 0.0 0.4 3.1 3.0 0.5 0.3 0.1 2.6 0.0 0.3 8.1 5.6 16.2 11.1 7.9 2.6 0.4 2.6 1.4 1.8 0.0 0.3 0.0 2.6 1.8 3.5 1.1 2.5 1.4 0.0 0.0 2.0 0.0 0.0 0.6 211.9 0.7 0.0 0.0 0.2 0.1 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 21.2 93.7 1.0 1.7 0.0 0.0 2.3 0.3 0.0 48.4 0.0 0.7 304.0 0.9 3.9 1.6 2.4 0.0 0.0 0.0 1.1 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome NA NA "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: AB_2683813" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 2.5 0.1 5.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 4.4 0.0 0.0 0.2 0.0 11.7 1.9 7.2 16.3 0.0 0.0 0.0 0.2 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.4 0.0 3.5 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 3.0 18.2 0.0 0.4 0.1 15.9 0.7 0.0 0.0 3.4 3.5 0.0 0.0 0.0 1.4 42.2 2.9 0.0 0.0 0.0 0.1 1.8 0.8 0.0 0.0 0.2 35.0 0.0 1.8 0.0 14.6 1.7 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.1 0.0 1.5 6.5 0.2 1.1 0.9 0.0 0.0 0.0 0.0 0.1 FAM155B "CXorf63, TED, TMEM28" ENSG00000130054 "Family with sequence similarity 155 member B" O75949 X 69505241-69532508 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 18.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.9;HAP1: 15.4;Hep G2: 5.6;NTERA-2: 21.3;OE19: 6.0;SCLC-21H: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036093 Uncertain NA NA "HPA036093: AB_10673613" "prognostic unfavorable (4.61e-5)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (5.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.49e-2)" "unprognostic (3.09e-4)" "unprognostic (7.07e-2)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (1.83e-4)" "prognostic favorable (6.63e-4)" "unprognostic (1.46e-2)" "unprognostic (3.50e-2)" "unprognostic (2.21e-1)" "unprognostic (8.21e-2)" 0.0 0.5 1.4 0.0 1.1 0.0 0.1 3.5 1.4 0.1 0.0 0.0 0.2 0.3 0.0 0.7 0.1 25.0 1.1 2.1 0.5 0.0 0.0 0.0 1.3 0.0 1.8 0.9 1.1 0.0 0.9 0.0 1.1 6.7 0.0 0.0 0.0 0.0 0.4 0.6 0.5 0.8 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 4.3 0.0 0.0 0.0 15.4 0.6 0.0 0.0 4.2 0.0 0.0 5.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.8 0.0 0.0 21.3 6.0 0.0 0.0 0.0 0.0 0.2 0.0 10.2 0.7 0.1 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 18.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.4 0.8 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 FAM160A1 FLJ43373 ENSG00000164142 "Family with sequence similarity 160 member A1" Q05DH4 4 151409216-151663632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 13 "dendritic cells: 5.8" "Cell line enhanced" "Detected in many" "A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046348 Enhanced Approved Cytosol NA NA Cytosol "HPA046348: AB_10966145" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.21e-3)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.33e-2)" "unprognostic (4.55e-2)" "unprognostic (1.52e-1)" "unprognostic (7.21e-3)" "unprognostic (1.30e-3)" "unprognostic (2.39e-1)" "unprognostic (1.51e-12)" "unprognostic (2.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (1.28e-1)" 1.4 1.2 3.0 3.4 0.8 1.5 3.8 7.5 0.9 6.3 5.2 0.6 10.4 1.7 6.1 5.9 13.1 2.8 4.9 6.5 0.7 0.7 7.0 1.6 5.4 0.1 0.6 0.0 3.7 23.7 11.1 9.4 1.8 4.8 4.5 3.3 10.0 11.1 12.5 33.6 12.6 9.0 1.8 0.7 0.7 2.3 3.5 0.0 0.9 11.4 22.0 10.0 6.2 5.0 0.0 5.8 0.4 0.0 0.1 0.1 0.0 8.3 0.7 0.0 0.2 0.0 0.0 3.1 0.4 2.0 0.8 0.2 3.6 3.1 0.0 0.9 0.1 2.8 7.6 2.2 6.3 1.3 0.0 3.6 0.0 10.1 0.8 0.0 0.0 0.1 0.1 6.3 0.0 9.5 1.9 0.1 0.7 0.0 0.0 0.5 1.2 0.0 0.0 2.9 2.6 0.8 0.0 2.1 0.3 4.4 5.7 1.4 0.4 9.0 7.9 0.0 2.5 3.4 0.0 0.0 0.6 3.7 0.2 1.4 0.0 0.0 0.0 2.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 3.0 0.8 7.5 0.9 0.7 0.7 0.6 0.0 4.8 0.0 3.0 1.3 0.0 6.2 10.5 0.0 1.6 0.0 0.0 6.8 0.0 0.0 0.3 0.0 1.3 1.8 0.3 3.4 0.0 1.5 0.5 0.3 5.9 1.1 0.5 0.2 7.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.0 3.7 1.2 0.0 0.0 0.3 4.5 0.0 0.3 2.1 4.1 12.7 1.4 0.0 1.4 6.8 FAM160B2 "FLJ21801, RAI16" ENSG00000158863 "Family with sequence similarity 160 member B2" Q86V87 8 22089159-22104898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025040 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025040: AB_1856049" "unprognostic (3.45e-1)" "unprognostic (2.08e-3)" "unprognostic (1.60e-1)" "unprognostic (8.85e-3)" "unprognostic (2.28e-2)" "prognostic favorable (4.56e-4)" "unprognostic (2.35e-2)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (8.38e-3)" "unprognostic (7.67e-3)" "unprognostic (3.38e-2)" "unprognostic (6.30e-2)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" "unprognostic (2.75e-3)" 15.8 11.8 9.6 13.1 10.0 6.6 14.3 14.3 14.8 12.9 13.2 12.9 20.8 12.0 13.2 16.9 13.7 14.1 14.5 26.0 8.5 6.9 12.3 9.8 11.0 11.2 12.5 10.5 11.4 22.1 15.3 14.1 22.4 10.9 14.4 6.0 13.4 18.8 25.1 15.1 24.4 13.4 25.3 10.4 12.3 16.1 6.4 10.3 6.5 16.0 11.6 13.2 19.9 11.2 2.7 0.9 0.5 1.4 1.7 3.2 2.1 3.7 9.3 4.5 6.9 9.1 8.4 6.9 5.8 12.6 8.6 6.0 3.8 4.6 3.9 6.4 18.2 7.8 5.3 3.3 10.4 1.8 3.4 3.5 5.8 2.5 2.6 12.3 1.5 5.3 14.1 7.1 6.3 4.2 8.9 8.8 8.9 3.9 3.3 8.1 7.8 4.2 2.2 1.8 7.9 3.3 4.4 3.3 2.2 7.3 9.2 1.6 4.8 3.5 7.5 4.8 4.7 4.5 3.4 8.4 8.7 6.7 7.8 4.0 2.6 0.8 0.7 9.2 2.8 9.4 0.0 1.2 0.5 3.2 0.7 1.9 2.7 2.1 2.6 0.8 2.3 1.9 2.7 0.3 1.7 1.4 0.9 0.3 2.1 9.6 10.0 14.3 14.8 8.5 6.9 12.5 10.5 10.9 10.3 11.9 15.0 9.0 8.7 5.3 22.4 21.8 20.4 2.7 4.5 12.2 25.5 7.0 0.0 8.0 3.6 12.2 13.8 0.0 12.8 11.4 8.0 10.8 6.9 12.2 6.4 22.3 12.7 17.8 11.8 1.9 10.0 5.4 1.7 4.6 9.7 12.7 13.7 12.5 5.3 3.8 24.2 0.0 7.3 1.7 5.9 6.6 12.5 8.6 8.6 8.1 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765723 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.6" "Group enriched" "Detected in some" 4 "Sertoli cells: 64.7;Smooth muscle cells: 58.7" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.0;BJ hTERT+: 19.0;BJ hTERT+ SV40 Large T+ RasG12V: 18.3;HHSteC: 5.3;HSkMC: 6.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 6.9" "HPA036112, HPA060342" Enhanced NA NA "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 11.4 12.5 2.2 1.0 4.0 0.5 11.2 0.5 8.6 13.0 3.8 1.1 4.8 1.1 7.8 7.0 6.5 6.7 4.9 7.7 2.0 1.8 4.3 1.0 14.6 2.4 2.7 5.8 7.7 1.5 2.5 6.1 51.6 1.9 9.7 2.2 6.0 6.5 11.8 7.3 2.5 1.9 3.7 1.3 0.5 3.0 2.9 0.5 0.0 8.7 5.2 1.4 5.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 7.0 19.0 3.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.0 0.5 8.6 2.0 1.8 2.7 5.8 1.9 0.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.9 4.5 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 2.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 64.7 58.7 3.5 6.0 0.6 0.5 0.0 0.0 0.0 FAM163A "C1orf76, MGC16664, NDSP" ENSG00000143340 "Family with sequence similarity 163 member A" Q96GL9 1 179743163-179816198 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2" "Group enriched" "Detected in some" 12 "Early spermatids: 27.4;Late spermatids: 35.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 9 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 51.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.74e-3)" "unprognostic (3.42e-2)" "unprognostic (1.32e-2)" "unprognostic (3.24e-1)" "unprognostic (2.62e-1)" "unprognostic (1.66e-1)" "unprognostic (5.67e-6)" "unprognostic (5.56e-2)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (3.81e-3)" "unprognostic (9.14e-2)" "unprognostic (7.75e-5)" "unprognostic (1.67e-2)" "unprognostic (2.83e-1)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" 0.2 10.9 0.7 2.1 1.5 0.0 0.0 0.4 2.1 0.0 1.3 0.7 0.0 1.9 0.1 1.7 0.0 0.6 5.5 0.3 0.4 0.8 0.1 0.4 0.0 1.0 1.2 1.0 0.4 0.6 0.0 24.2 0.4 19.2 0.4 0.9 0.2 0.0 0.1 0.1 0.1 1.3 0.6 0.2 0.4 1.7 9.0 0.0 25.5 1.5 0.0 1.2 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 51.2 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.7 1.5 0.4 2.1 0.4 0.8 1.2 1.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 15.1" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 40.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.8 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM166A ENSG00000188163 "Family with sequence similarity 166 member A" Q6J272 9 137243584-137247770 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "testis: 54.2" "Group enriched" "Detected in some" 96 "Early spermatids: 561.7;Late spermatids: 950.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "T-47d: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA023307 Enhanced NA NA "HPA023307: AB_1848930" "unprognostic (2.22e-1)" "unprognostic (8.39e-2)" "unprognostic (1.01e-3)" "unprognostic (1.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (9.83e-2)" "unprognostic (2.18e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (2.67e-4)" "unprognostic (7.81e-2)" "unprognostic (1.77e-3)" "unprognostic (1.83e-1)" "unprognostic (2.02e-2)" "unprognostic (2.09e-1)" "unprognostic (4.18e-3)" 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 54.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 1.4 0.5 1.2 0.8 0.0 0.7 0.0 0.5 0.0 0.0 0.5 2.0 0.6 0.1 0.0 0.3 1.0 0.0 0.0 0.0 1.1 0.7 0.5 1.2 1.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.2 0.9 0.0 0.3 0.3 1.9 0.3 0.3 0.1 0.6 0.1 0.8 0.8 0.8 0.3 1.0 0.8 0.4 3.2 0.9 0.7 0.8 1.0 0.3 0.1 0.8 1.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.4 0.3 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 561.7 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.8 0.1 0.0 0.0 0.6 0.3 950.4 5.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 6.0 0.0 0.5 0.0 0.0 7.9 3.0 0.3 0.2 0.0 0.0 0.1 FAM166B ENSG00000215187 "Family with sequence similarity 166 member B" A8MTA8 9 35561831-35563899 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9" "Group enriched" "Detected in some" 4 "Ciliated cells: 26.8;Club cells: 6.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 11.7;ovarian cancer: 4.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.5;Hep G2: 5.6" "Low region specificity" "Detected in many" HPA045540 Enhanced NA NA "HPA045540: AB_10962627" "unprognostic (4.18e-5)" "unprognostic (7.56e-3)" "unprognostic (1.65e-1)" "prognostic favorable (2.61e-5)" "unprognostic (5.66e-3)" "unprognostic (3.48e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (2.21e-1)" "prognostic favorable (6.20e-6)" "unprognostic (3.69e-3)" "unprognostic (9.09e-2)" "unprognostic (4.37e-3)" "unprognostic (5.82e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (3.52e-5)" 2.8 77.3 0.9 0.7 1.2 0.0 0.7 0.1 0.5 1.3 0.6 3.1 0.3 0.0 0.5 9.4 0.8 26.1 0.9 0.1 1.3 1.5 0.4 0.1 2.7 0.1 0.1 0.2 2.5 0.1 0.0 0.2 0.1 3.8 0.1 0.0 0.7 0.6 0.6 102.9 0.2 0.3 0.3 0.4 0.2 0.0 0.5 0.6 0.1 0.3 1.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 2.5 0.7 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.3 1.3 0.0 1.3 0.2 1.4 0.5 0.9 0.0 0.3 0.0 0.0 5.6 0.0 0.4 0.4 0.0 0.5 0.0 0.5 0.2 0.4 1.9 0.0 0.6 0.0 0.1 0.0 0.4 0.5 0.5 0.6 0.0 0.2 0.0 2.0 0.3 0.8 0.0 0.0 0.0 0.0 1.8 0.6 0.0 1.1 0.7 0.4 0.8 0.0 1.3 0.8 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.2 0.1 0.5 1.3 1.5 0.1 0.2 3.8 0.6 0.0 0.3 0.0 1.1 4.1 0.0 0.2 0.0 26.8 6.8 0.0 2.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 1.3 0.1 0.0 0.2 0.2 0.0 1.8 0.0 0.0 0.0 0.3 FAM167B "C1orf90, MGC10820" ENSG00000183615 "Family with sequence similarity 167 member B" Q9BTA0 1 32247233-32248856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "vagina: 91.1" "Cell type enriched" "Detected in some" 10 "Ito cells: 188.4" "Cancer enhanced" "Detected in all" "melanoma: 46.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in many" 4 "T-cells: 4.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 7.0;EFO-21: 8.9;SK-MEL-30: 21.5;U-2197: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029398, HPA062074" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA029398: AB_10602807, HPA062074: AB_2684677" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.03e-2)" "unprognostic (1.74e-2)" "unprognostic (3.36e-3)" "unprognostic (7.44e-3)" "unprognostic (3.64e-1)" "unprognostic (3.00e-3)" "unprognostic (1.02e-2)" "unprognostic (1.30e-2)" "unprognostic (8.89e-2)" "unprognostic (4.80e-2)" "unprognostic (2.69e-2)" "unprognostic (1.60e-1)" "unprognostic (8.04e-2)" "unprognostic (5.08e-2)" 17.2 10.5 1.4 5.0 1.7 0.1 20.1 1.7 1.9 6.1 3.1 1.1 7.4 3.6 7.8 2.2 4.5 3.4 5.5 11.3 1.8 1.7 20.3 18.4 22.4 6.2 3.2 0.6 3.8 6.6 5.2 8.5 5.8 3.3 9.2 2.7 5.2 2.6 8.2 3.3 1.1 4.1 7.5 2.6 1.4 4.0 1.8 2.7 1.2 11.8 1.5 1.9 7.2 91.1 1.0 0.0 0.8 0.0 0.3 4.5 0.7 0.6 1.3 0.4 0.0 0.9 0.8 0.0 3.1 7.0 1.4 1.9 0.0 0.6 0.1 8.9 5.2 1.6 1.0 0.2 0.0 0.4 0.1 0.0 0.0 2.8 0.4 0.3 0.0 0.1 0.8 0.5 1.0 0.3 1.8 2.6 0.4 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.1 3.0 0.6 0.0 0.8 0.9 0.3 1.3 0.3 2.0 0.1 21.5 0.5 0.3 0.0 2.3 0.6 0.7 22.0 0.0 0.1 0.2 0.5 0.2 0.1 0.3 0.0 0.0 0.8 2.6 0.0 0.7 0.5 0.8 0.8 0.0 1.0 0.5 1.6 0.0 0.3 0.0 0.0 4.5 0.7 1.4 1.7 1.7 1.9 1.8 1.7 3.2 0.6 3.3 2.7 0.0 1.4 3.9 0.4 0.2 0.2 0.4 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.4 0.0 19.1 0.0 0.0 0.7 0.3 0.9 0.6 0.0 1.0 0.5 0.0 0.0 188.4 11.9 0.0 2.6 0.4 1.7 0.0 1.0 0.0 0.2 0.2 1.1 0.0 0.6 0.0 1.2 0.0 0.2 0.9 0.2 3.3 0.4 0.3 FAM169B ENSG00000283597 "Family with sequence similarity 169 member B" Q8N8A8 15 98437162-98547728 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "stomach 1: 1.0" "Cell type enhanced" "Detected in single" 19 "Early spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM170A ZNFD ENSG00000164334 "Family with sequence similarity 170 member A" A1A519 5 119629559-119635822 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 37.0" "Group enriched" "Detected in some" 17 "Early spermatids: 12.9;Late spermatids: 7.4;Sertoli cells: 6.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037900, HPA037902" Enhanced NA NA "HPA037900: AB_2675728, HPA037902: AB_2675730" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (9.70e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-4)" "unprognostic (2.12e-1)" "unprognostic (2.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.6 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 11.4 0.3 0.0 0.0 0.0 0.0 0.0 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell type enriched" "Detected in many" 6 "Bipolar cells: 137.0" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 25.4;U-138 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.8 4.2 13.1 12.5 9.5 0.1 2.6 4.6 3.2 4.6 7.7 12.6 0.0 0.9 7.3 5.5 0.3 5.7 2.5 4.6 0.0 3.3 2.8 1.3 0.0 1.0 0.8 1.0 12.1 1.0 2.5 2.0 4.2 7.0 2.2 0.0 25.4 6.1 1.6 1.6 0.0 5.6 0.0 2.8 0.0 8.1 0.6 5.0 9.0 13.2 7.2 1.3 0.8 3.5 2.6 1.0 0.6 4.1 17.6 2.3 0.3 1.6 6.8 6.5 0.0 5.4 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 0.0 0.0 0.0 2.1 7.9 137.0 0.8 10.2 0.0 2.3 0.0 13.7 7.9 0.0 0.7 1.4 10.5 0.0 0.0 0.3 0.8 6.6 1.2 0.0 0.0 1.7 22.3 4.6 8.0 0.3 2.5 7.2 1.1 3.3 1.0 0.0 16.5 0.5 0.0 13.1 0.1 15.5 0.0 4.1 0.1 1.4 4.5 6.9 0.0 0.0 0.5 FAM172A "C5orf21, DKFZP564D172" ENSG00000113391 "Family with sequence similarity 172 member A" Q8WUF8 5 93618069-94111699 "Predicted intracellular proteins, Predicted secreted proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012299, HPA045505" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA012299: AB_1845724, HPA045505: AB_2679354" "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (3.10e-2)" "unprognostic (7.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (1.51e-1)" "unprognostic (1.57e-2)" "unprognostic (2.52e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.38e-1)" "unprognostic (6.56e-2)" "unprognostic (1.72e-2)" "unprognostic (1.03e-2)" 18.4 15.4 24.2 17.8 21.8 9.8 19.3 28.8 20.8 19.9 14.4 15.5 13.9 11.2 19.1 16.1 17.7 18.8 14.3 14.0 21.0 19.9 18.5 8.0 14.9 22.4 18.9 13.0 23.0 18.2 20.7 28.4 15.1 15.6 19.4 12.3 12.6 14.3 22.6 6.2 11.8 12.9 26.2 20.8 13.6 13.7 8.3 16.6 16.1 22.8 9.5 16.1 19.0 15.7 9.8 7.1 13.1 7.3 12.3 11.9 6.4 4.6 5.4 13.3 14.9 16.0 19.4 6.9 9.9 7.7 4.3 4.3 3.7 6.5 6.7 7.5 11.6 7.7 4.1 4.0 14.0 10.1 4.5 4.8 8.9 11.3 2.5 6.8 6.8 10.3 16.9 8.0 3.9 7.6 15.6 9.8 6.3 1.8 2.0 17.7 5.1 5.7 5.2 2.0 8.6 4.4 6.4 14.0 6.3 6.8 9.0 11.9 21.2 8.0 3.4 7.3 8.7 8.2 8.3 9.7 10.3 9.3 6.7 11.7 8.6 12.5 7.6 16.2 7.6 18.8 13.1 5.4 7.0 11.9 7.3 11.9 9.4 8.9 8.7 7.1 9.8 10.1 10.2 13.0 12.3 5.1 6.8 9.2 6.4 24.2 21.8 28.8 20.8 21.0 19.9 18.9 13.0 15.6 16.6 50.6 23.7 24.4 21.0 10.9 48.1 20.2 28.1 62.9 25.0 10.4 29.5 11.1 51.4 16.4 38.4 23.3 15.8 0.0 18.6 10.7 16.0 19.5 24.3 12.4 10.1 39.7 16.3 17.8 18.0 23.9 35.6 17.5 20.3 22.6 11.5 34.6 17.2 13.9 34.3 27.9 51.6 12.9 17.9 19.0 23.5 8.8 9.2 23.5 16.4 20.4 FAM173A "C16orf24, MGC2494" ENSG00000103254 "Family with sequence similarity 173 member A" Q9BQD7 16 720581-722601 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046262 Approved Approved Cytosol NA NA Cytosol "HPA046262: AB_10963070" "unprognostic (3.94e-2)" "unprognostic (8.78e-2)" "unprognostic (1.55e-1)" "unprognostic (2.61e-1)" "unprognostic (6.54e-2)" "prognostic favorable (8.88e-4)" "unprognostic (2.11e-1)" "unprognostic (4.49e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (4.02e-2)" "unprognostic (5.70e-2)" "prognostic favorable (4.24e-5)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (9.28e-2)" "unprognostic (3.60e-3)" 16.0 10.4 15.6 10.3 9.1 7.3 9.6 8.9 21.5 4.8 15.5 8.2 9.3 19.1 6.5 8.3 6.1 5.2 10.6 11.1 13.6 11.5 18.6 15.8 7.5 7.5 11.3 12.2 4.3 10.2 8.5 13.4 5.8 9.2 8.4 3.5 6.5 15.1 8.6 37.3 6.2 14.5 5.6 9.5 15.0 19.3 21.8 7.9 8.6 7.8 11.1 7.1 5.9 8.9 9.0 6.0 5.3 6.8 6.3 18.0 4.2 6.4 4.3 0.8 2.3 0.1 0.3 10.3 5.6 1.4 1.3 1.6 4.3 5.4 8.3 10.1 0.6 2.4 10.1 0.8 2.8 0.4 18.3 11.4 3.5 4.5 4.5 2.0 5.8 4.8 0.7 2.1 0.6 1.7 2.9 0.5 5.8 7.3 3.8 1.2 10.5 0.9 14.0 3.3 3.6 14.1 3.5 2.1 15.5 3.6 2.3 3.7 9.7 2.9 4.8 9.3 0.5 5.3 5.2 4.7 1.2 10.0 3.6 3.9 33.6 15.0 8.9 2.5 4.3 3.2 0.0 6.8 5.3 7.3 3.9 16.5 9.0 5.8 12.9 4.4 9.0 5.9 18.0 0.8 6.3 4.8 6.0 12.5 4.2 15.6 9.1 8.9 21.5 13.6 11.5 11.3 12.2 9.2 7.9 6.0 5.4 49.9 28.1 9.0 86.9 11.2 50.9 1.4 0.0 61.1 33.4 40.1 99.5 47.3 182.0 14.5 140.4 0.0 56.0 31.2 20.0 36.4 28.7 74.6 77.3 50.9 50.1 27.6 51.9 314.4 23.6 43.6 45.5 55.1 53.9 57.8 49.3 73.7 17.7 139.1 71.7 25.8 27.8 65.4 88.0 8.3 21.4 60.6 62.2 31.4 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535305-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "neutrophil: 28.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 28.0" "Cell line enhanced" "Detected in many" "U-266/84: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 15.6 24.6 18.8 8.3 21.0 3.0 15.3 14.2 26.8 11.1 12.0 16.5 14.0 11.8 11.3 15.2 18.0 35.9 9.5 17.3 22.0 25.0 18.3 15.2 17.6 5.5 19.3 18.2 9.1 26.8 23.6 21.9 15.6 24.1 19.5 9.1 16.6 16.5 13.7 38.8 20.4 10.7 9.6 19.4 10.1 15.5 37.3 12.2 4.4 14.3 17.0 9.6 9.9 11.7 1.5 2.2 28.0 2.7 2.5 2.7 1.6 5.0 5.3 2.2 6.9 5.3 4.3 7.7 11.6 6.5 4.8 6.5 1.1 6.6 0.9 23.6 5.0 8.3 4.3 1.8 7.5 3.4 6.1 5.5 0.6 9.2 3.1 7.2 2.6 6.4 5.6 18.0 3.6 2.8 10.8 7.1 2.7 1.8 6.9 7.8 10.1 0.7 5.4 1.1 0.6 14.5 1.7 8.3 8.7 8.3 6.1 4.4 11.7 8.1 7.3 6.4 2.6 7.1 5.7 8.1 6.0 3.8 9.6 9.1 22.0 28.7 1.1 7.5 3.5 5.2 3.6 2.5 3.4 1.8 2.7 2.7 1.4 1.8 2.2 2.2 1.5 1.6 2.1 28.0 2.5 2.7 2.2 2.2 1.6 18.8 21.0 14.2 26.8 22.0 25.0 19.3 18.2 24.1 12.2 29.8 25.6 12.6 27.4 78.3 24.0 14.9 20.4 211.5 31.8 27.9 3.9 33.9 36.5 26.0 16.2 23.7 14.7 0.0 26.4 32.0 28.2 31.9 12.7 27.2 20.9 28.6 33.5 31.9 14.3 4.0 16.7 17.1 47.2 19.0 31.7 63.9 27.0 20.1 23.0 32.2 36.9 12.9 22.6 86.9 16.8 100.6 42.1 13.1 19.9 34.6 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617443-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 98.3;Mucus-secreting cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;MCF7: 25.6;OE19: 21.5;RPMI-8226: 30.0;RT4: 63.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 6.1 3.5 5.9 3.3 6.3 0.7 17.9 3.9 8.6 10.9 6.2 2.9 21.5 3.6 5.1 4.9 5.2 14.6 6.4 4.2 7.4 8.3 3.3 4.0 16.3 5.5 6.5 6.2 10.2 57.6 2.5 15.9 4.6 6.7 19.4 9.2 7.7 47.7 10.8 16.3 4.9 5.0 4.6 4.9 3.2 17.3 9.7 3.6 4.2 28.9 3.9 4.8 24.4 15.3 0.4 4.5 3.7 0.9 0.7 10.9 0.7 0.0 3.6 2.3 0.7 0.0 0.0 0.3 1.3 6.3 0.0 0.0 21.3 2.4 0.3 6.1 0.1 1.7 0.1 4.0 0.1 0.0 0.1 1.8 0.2 0.4 0.2 0.4 0.3 0.9 0.3 0.1 0.0 0.0 0.1 3.0 2.0 0.3 15.8 3.5 25.6 0.7 0.0 11.5 21.5 0.0 2.4 6.6 30.0 1.5 63.4 1.4 1.1 1.8 12.2 3.9 7.0 9.8 2.2 0.0 0.0 0.5 0.1 2.9 0.5 4.7 0.7 0.0 0.2 1.5 1.1 0.8 0.9 0.2 0.9 0.4 0.4 2.5 0.0 0.6 0.3 2.8 3.3 3.7 0.7 0.0 4.5 10.9 0.7 5.9 6.3 3.9 8.6 7.4 8.3 6.5 6.2 6.7 3.6 98.3 20.3 0.0 14.7 2.1 5.3 4.1 10.2 14.7 18.2 7.0 7.9 1.1 6.6 4.4 19.8 5.8 2.3 0.0 12.4 15.9 4.1 29.2 18.4 5.8 4.2 11.1 40.5 30.7 4.3 39.0 5.5 1.8 11.8 0.0 61.2 3.5 17.4 0.0 1.8 1.1 2.7 0.0 5.3 1.0 3.4 2.6 0.6 2.1 4.7 23.7 FAM177B "FLJ43505, RP11-452F19.2" ENSG00000197520 "Family with sequence similarity 177 member B" A6PVY3 1 222737207-222750805 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 26.5;stomach 1: 34.2" "Group enriched" "Detected in some" 8 "B-cells: 12.3;Cardiomyocytes: 15.7;Cholangiocytes: 15.3;Early spermatids: 7.0;Late spermatids: 7.7;Mucus-secreting cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 21 "memory B-cell: 17.9;naive B-cell: 26.5" "Lineage enriched" "Detected in many" 25 "B-cells: 26.5" "Cell line enhanced" "Detected in some" "Daudi: 1.6;fHDF/TERT166: 1.2;HUVEC TERT2: 2.4;RPMI-8226: 2.4" "Low region specificity" "Detected in some" HPA063059 Uncertain NA NA "HPA063059: AB_2684933" "unprognostic (8.19e-2)" "unprognostic (1.72e-1)" "unprognostic (4.88e-3)" "unprognostic (3.09e-2)" "unprognostic (7.70e-3)" "unprognostic (1.57e-3)" "unprognostic (2.65e-2)" "unprognostic (1.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.56e-6)" "unprognostic (5.13e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-2)" "unprognostic (4.29e-2)" 0.6 1.1 1.1 6.4 5.5 0.0 0.5 0.4 2.3 0.4 4.6 0.2 2.0 3.3 0.5 0.1 0.8 0.4 12.6 0.4 1.8 0.7 0.6 0.5 1.6 10.3 1.8 0.0 0.4 0.6 0.2 1.3 2.0 2.0 0.8 6.5 0.6 8.3 0.3 0.4 0.4 14.2 0.6 4.9 5.6 34.2 1.2 1.5 0.3 0.5 1.4 14.6 1.0 0.6 26.5 1.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 1.6 0.2 1.2 0.0 0.7 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 1.0 1.1 0.0 0.0 2.4 0.5 1.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 26.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.6 1.1 5.5 0.4 2.3 1.8 0.7 1.8 0.0 2.0 1.5 0.0 0.0 12.3 0.6 0.3 0.0 15.7 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.0 1.3 0.0 0.3 0.0 0.5 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.3 7.7 0.0 0.0 0.0 0.0 27.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.4 0.4 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 6.9;Late spermatids: 5.1;Spermatogonia: 19.4" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD4 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in some" "K-562: 17.5;OE19: 4.8;RH-30: 4.8;RPMI-8226: 19.1;WM-115: 19.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 0.8 0.0 2.4 0.6 3.8 18.2 0.6 1.0 1.5 0.6 1.0 0.6 0.6 0.1 0.7 6.8 0.6 1.5 0.6 0.6 3.4 1.9 0.6 0.6 0.6 0.6 5.3 0.6 0.6 0.6 0.0 0.6 1.1 0.6 0.6 0.2 1.0 0.6 1.0 0.6 1.2 0.6 0.6 8.5 13.3 0.0 29.5 0.6 0.6 0.6 0.6 0.6 1.0 0.6 0.0 0.8 0.0 0.0 0.1 2.6 0.6 4.2 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.4 1.7 0.0 0.0 0.1 4.8 0.0 0.0 4.8 19.1 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 19.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 1.7 0.0 0.1 0.0 0.8 0.0 0.6 2.4 3.8 1.0 1.5 3.4 1.9 5.3 0.6 0.6 0.6 0.0 0.0 0.8 0.6 0.7 0.1 0.3 0.0 0.0 0.0 0.0 2.0 2.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.9 1.4 0.2 0.0 0.0 1.1 1.6 0.0 0.6 0.0 5.1 0.9 0.3 3.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 1.7 19.4 1.5 2.1 0.0 0.0 0.1 FAM180A "HWKM1940, UNQ1940" ENSG00000189320 "Family with sequence similarity 180 member A" Q6UWF9 7 135728348-135748846 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.0" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "U-2197: 74.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021224 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA021224: AB_1851352" "unprognostic (3.85e-2)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.27e-1)" "unprognostic (5.05e-2)" "unprognostic (1.97e-3)" "unprognostic (5.62e-2)" "unprognostic (7.55e-2)" "unprognostic (8.88e-4)" "unprognostic (3.14e-3)" "unprognostic (1.82e-1)" "unprognostic (4.35e-4)" "unprognostic (6.62e-4)" 9.3 2.6 0.1 1.7 0.5 0.0 5.6 0.1 1.0 7.8 5.7 0.3 0.5 0.7 9.4 2.0 5.1 3.0 21.2 14.7 0.1 0.1 8.7 23.0 4.6 0.0 0.1 0.0 8.1 1.1 0.0 0.3 1.4 0.5 6.1 1.8 1.9 2.2 0.1 3.5 5.5 3.2 8.1 0.4 0.9 1.6 3.9 0.1 0.0 4.6 4.8 0.9 6.6 8.3 0.6 0.2 2.0 0.3 0.4 0.5 0.1 0.0 0.0 0.0 0.0 8.1 8.4 0.0 4.2 16.1 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 10.3 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 16.7 0.0 74.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.1 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.6 0.4 0.5 0.8 0.4 0.3 0.2 0.2 0.1 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 6.6 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 2.6 0.0 6.8 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 2.8 0.0 0.0 4.3 0.6 0.0 0.0 0.0 FAM181A C14orf152 ENSG00000140067 "Family with sequence similarity 181 member A" Q8N9Y4 14 93918894-93929608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;testis: 19.2" "Group enriched" "Detected in some" 6 "Early spermatids: 37.0;Spermatocytes: 48.6" "Group enriched" "Detected in some" 6 "endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AF22: 10.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 31.1" HPA001603 Enhanced NA NA "HPA001603: AB_1078326" "unprognostic (8.19e-2)" "unprognostic (6.78e-2)" "unprognostic (1.28e-2)" "unprognostic (1.31e-1)" "unprognostic (2.05e-2)" "unprognostic (1.84e-2)" "unprognostic (6.27e-2)" "unprognostic (4.44e-2)" "unprognostic (5.37e-2)" 0.6 0.6 9.3 0.6 8.3 0.6 0.6 2.1 6.0 0.8 0.6 7.6 0.0 0.6 0.8 0.6 0.7 5.2 0.7 0.7 6.4 6.6 0.6 0.6 1.4 0.6 5.3 6.0 0.6 0.6 0.6 1.5 0.6 6.8 0.6 0.6 0.0 0.7 0.7 3.7 0.6 0.6 0.6 6.4 0.6 0.7 19.2 3.8 0.0 2.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 8.3 2.1 5.7 6.4 6.6 5.3 6.0 6.8 3.8 3.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 6.7 4.5 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.2 0.0 0.0 48.6 0.6 0.0 0.0 0.0 0.0 0.0 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 5.2;Distal tubular cells: 3.3;Muller glia cells: 18.0;Smooth muscle cells: 3.1" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 6.7;SH-SY5Y: 3.6;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.1 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.1 0.1 1.2 0.0 0.2 0.1 0.0 0.0 0.2 6.7 1.0 3.6 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.1 3.5 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 0.0 0.0 0.0 0.2 0.2 0.2 2.7 0.0 0.0 0.0 5.2 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 18.0 0.0 0.0 0.4 0.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 FAM182B ENSG00000175170 "Family with sequence similarity 182 member B" Q5T319 20 25763466-25868225 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6;testis: 9.9" "Group enriched" "Detected in some" 37 "Early spermatids: 201.1;Late spermatids: 281.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SCLC-21H: 17.4" HPA050100 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050100: AB_2681014" "unprognostic (8.05e-2)" "unprognostic (1.48e-2)" "unprognostic (1.29e-2)" "unprognostic (3.63e-1)" "unprognostic (2.68e-1)" "unprognostic (1.50e-2)" "unprognostic (1.88e-4)" "unprognostic (1.61e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-2)" "unprognostic (3.30e-1)" "unprognostic (2.47e-9)" "unprognostic (2.36e-1)" "unprognostic (4.40e-2)" "unprognostic (6.54e-2)" "unprognostic (3.18e-1)" 0.4 0.9 2.9 0.2 3.8 0.0 0.8 7.6 5.9 0.6 0.2 0.1 1.2 0.3 0.6 6.4 0.2 0.3 3.0 3.7 0.4 0.0 1.2 0.2 2.0 1.7 0.8 0.5 2.7 4.4 1.7 0.1 0.8 0.5 1.2 5.2 0.7 0.4 1.2 0.8 0.6 9.9 1.4 0.0 0.0 0.4 0.2 0.2 2.1 0.1 0.7 1.2 0.4 2.2 1.0 1.2 1.2 0.6 0.1 0.5 0.3 0.0 0.1 0.4 0.0 3.0 0.2 1.3 1.5 1.0 4.1 0.0 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.3 0.2 1.1 0.9 0.1 0.0 1.1 0.0 0.1 1.4 1.0 2.8 0.0 0.1 1.4 0.7 0.1 1.7 1.6 0.1 0.1 0.6 0.4 0.0 17.4 1.1 0.7 0.2 1.2 1.2 0.5 0.6 0.3 0.2 3.7 0.8 0.5 1.8 0.3 0.8 0.2 0.5 1.5 0.0 0.1 1.7 0.6 0.0 0.6 0.1 1.0 0.3 0.2 0.2 0.9 1.2 2.1 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 3.0 0.6 0.4 0.0 0.0 0.0 1.8 5.9 0.5 1.7 0.0 201.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 281.2 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 6.5 1.4 5.1 1.3 2.5 0.0 0.0 0.0 0.0 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.2 15.9 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.2 1.1 0.0 0.2 6.0 0.0 4.9 0.0 0.2 1.2 9.4 0.5 1.4 7.0 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.3 0.0 13.4 13.0 0.5 0.2 0.3 0.3 0.0 5.3 0.6 1.2 0.0 0.0 0.0 0.1 0.1 10.4 7.7 0.5 0.5 1.5 3.0 2.1 1.8 0.2 0.8 0.4 0.1 4.0 4.0 4.3 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 44.7 90.2 0.0 6.1 2.2 36.7 3.9 5.1 60.2 31.8 3.5 27.5 45.2 14.9 0.8 12.9 1.9 0.1 0.0 1.0 13.5 5.0 0.9 5.8 3.4 4.9 12.7 5.8 3.1 0.3 5.4 3.4 0.8 0.0 0.0 0.0 12.5 0.5 0.0 6.7 1.3 27.8 6.5 2.3 64.6 15.4 3.0 222.8 4.1 0.4 1.0 FAM184B KIAA1276 ENSG00000047662 "Family with sequence similarity 184 member B" Q9ULE4 4 17629306-17781512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.1;skeletal muscle: 11.1" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.0;Erythroid cells: 23.3;Horizontal cells: 30.2;Muller glia cells: 22.9;Rod photoreceptor cells: 27.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.9;T-47d: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044119, HPA048458" Enhanced NA NA "HPA044119: AB_2678817, HPA048458: AB_2680401" "unprognostic (1.20e-2)" "unprognostic (4.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (9.64e-2)" "unprognostic (1.71e-2)" "unprognostic (5.13e-4)" "unprognostic (2.04e-2)" "unprognostic (7.46e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (1.54e-4)" 1.5 0.6 3.2 0.5 5.0 0.8 0.6 2.0 5.1 0.3 1.1 2.5 0.0 0.3 0.4 0.8 0.4 0.3 0.4 0.3 3.6 2.7 1.2 0.3 0.4 0.5 3.3 1.2 0.5 0.3 0.8 0.4 0.3 3.7 0.5 0.8 0.1 0.9 0.3 11.1 1.1 0.4 0.3 2.0 0.5 0.5 0.6 2.9 0.0 0.4 0.4 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.4 0.8 0.0 0.1 0.2 0.7 0.0 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.5 0.1 0.2 1.0 0.1 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 6.9 0.2 0.0 0.0 1.0 0.2 1.8 0.2 0.3 0.0 0.0 0.1 0.3 0.2 0.2 0.1 0.1 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.3 0.9 0.2 0.0 0.1 0.0 0.0 0.0 3.2 5.0 2.0 3.1 3.6 2.7 3.3 1.2 3.7 2.9 0.0 1.3 5.2 5.5 3.9 30.0 0.6 5.1 0.0 1.2 0.0 13.7 3.9 0.0 0.0 0.7 1.4 0.3 23.3 0.9 2.9 3.1 3.5 13.8 1.7 1.1 30.2 4.1 0.6 2.7 0.9 10.6 3.1 3.3 0.0 0.1 22.9 0.8 0.0 7.1 0.5 27.9 0.0 1.9 6.9 8.7 8.4 4.5 2.5 0.2 4.7 FAM185A MGC35361 ENSG00000222011 "Family with sequence similarity 185 member A" Q8N0U4 7 102748971-102809225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020470, HPA029883" Uncertain Approved Cytosol NA NA Cytosol "HPA020470: AB_1853890, HPA029883: AB_10601903" "unprognostic (8.28e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (6.06e-2)" "unprognostic (1.63e-2)" "unprognostic (1.59e-3)" "unprognostic (3.97e-2)" "unprognostic (4.45e-2)" "unprognostic (7.11e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.36e-5)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (2.13e-3)" "unprognostic (5.25e-2)" 3.7 4.6 6.6 3.0 4.9 3.6 3.8 9.3 6.3 5.6 4.3 4.4 4.1 2.3 3.8 3.1 4.4 3.1 3.4 4.2 4.2 2.3 4.0 9.4 4.8 2.3 5.1 6.0 4.7 3.7 8.7 4.8 2.8 4.0 5.2 4.3 6.1 5.1 8.4 9.5 4.6 3.1 3.7 4.5 3.0 5.9 2.2 5.1 3.0 3.8 2.4 2.7 4.4 4.0 3.3 2.6 7.5 3.0 1.2 2.2 0.9 1.4 3.5 1.6 4.1 0.6 1.7 4.2 0.9 1.7 1.6 0.5 3.4 2.9 0.0 2.2 1.2 4.3 3.6 2.3 2.4 1.6 1.8 2.0 0.2 0.4 4.2 1.0 2.9 0.4 0.0 2.7 1.0 1.2 3.3 2.0 1.1 2.1 1.5 1.7 2.7 1.4 0.3 1.8 2.7 0.0 0.3 0.1 10.2 0.8 2.5 1.4 3.0 3.4 5.4 0.4 0.9 3.3 0.0 3.6 0.4 1.7 2.5 0.5 4.9 1.6 0.6 0.7 0.9 0.0 0.0 3.0 3.3 2.1 2.2 0.9 3.3 1.4 2.2 2.6 1.9 1.3 1.5 7.5 1.2 1.0 2.4 1.6 0.9 6.6 4.9 9.3 6.3 4.2 2.3 5.1 6.0 4.0 5.1 3.0 1.0 2.4 5.9 3.8 7.7 4.4 10.2 2.7 6.8 0.0 9.8 11.6 16.6 3.7 3.1 4.5 2.3 0.0 2.0 4.9 3.3 3.1 0.0 5.9 4.0 4.8 1.2 4.3 1.3 1.9 6.6 1.9 6.8 1.8 2.2 3.5 2.2 0.0 4.9 9.1 21.2 12.9 2.8 5.2 3.6 4.0 6.8 4.9 3.5 5.1 FAM186A LOC121006 ENSG00000185958 "Family with sequence similarity 186 member A" A6NE01 12 50326230-50396622 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 19.3" "Cell type enriched" "Detected in some" 16 "Early spermatids: 388.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA047128 Uncertain NA NA "HPA047128: AB_10967726" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.69e-2)" "unprognostic (3.48e-3)" "unprognostic (1.43e-2)" "unprognostic (1.30e-2)" "unprognostic (6.96e-2)" "unprognostic (4.65e-5)" "unprognostic (1.93e-1)" "unprognostic (2.42e-5)" "unprognostic (1.65e-1)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (3.22e-3)" 0.2 0.2 0.4 0.3 0.8 0.9 0.2 0.9 0.8 0.2 0.2 0.2 0.2 0.1 0.2 1.2 0.2 0.1 0.2 0.3 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 2.0 0.8 0.3 0.2 0.2 0.3 0.0 19.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.9 3.1 1.5 1.8 1.4 0.3 0.6 0.3 0.2 2.1 0.0 0.0 1.0 0.3 0.0 0.1 0.0 0.2 1.0 0.8 0.7 0.6 0.7 0.3 0.1 0.2 0.0 1.2 0.8 0.4 1.0 1.0 0.4 0.6 0.9 1.0 0.3 0.0 0.2 0.5 0.0 0.7 0.9 1.6 1.0 1.7 0.2 0.8 0.9 0.3 0.2 0.7 0.5 0.2 0.1 1.3 0.4 0.2 0.4 0.4 0.2 0.2 1.1 0.3 0.0 0.6 0.9 0.5 0.5 1.2 0.5 0.8 0.9 0.1 0.2 2.4 1.5 1.2 1.4 0.7 0.8 0.5 0.8 0.5 0.2 0.8 0.9 1.2 3.1 1.8 0.6 0.9 0.4 0.3 0.4 0.8 0.9 0.8 0.4 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 388.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.6 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 FAM186B "C12orf25, DKFZP434J0113" ENSG00000135436 "Family with sequence similarity 186 member B" Q8IYM0 12 49582885-49605639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 58.0" "Group enriched" "Detected in some" 9 "Early spermatids: 62.4;Late spermatids: 75.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Group enriched" "Detected in many" 7 "B-cells: 2.3;T-cells: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039736, HPA040028" Uncertain NA NA "HPA039736: AB_10795295, HPA040028: AB_10795684" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.94e-1)" "unprognostic (3.00e-1)" "unprognostic (5.55e-2)" "unprognostic (1.53e-1)" "unprognostic (3.37e-3)" "unprognostic (1.44e-1)" "unprognostic (4.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-5)" "unprognostic (1.56e-1)" "unprognostic (6.18e-2)" "unprognostic (2.10e-5)" "unprognostic (7.23e-2)" 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.5 1.0 0.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 58.0 0.2 0.2 0.6 0.2 0.2 0.2 0.2 2.3 0.2 0.0 0.2 0.2 1.4 0.0 0.8 3.7 0.4 1.3 0.4 0.2 2.0 0.0 0.5 0.2 0.4 4.8 1.5 2.8 0.9 0.3 0.9 1.4 0.7 0.7 0.4 0.9 1.1 1.6 2.1 0.7 0.4 3.1 0.8 0.2 1.1 0.7 2.1 0.4 0.3 1.2 2.5 2.2 0.7 2.6 0.3 0.3 0.6 1.3 1.4 1.0 0.3 1.3 1.4 1.3 3.3 0.8 1.6 0.7 2.4 0.9 1.6 1.4 1.5 0.3 1.6 1.3 0.8 1.5 1.1 4.9 0.6 1.3 0.7 0.0 0.2 0.0 0.1 0.1 1.4 0.1 0.4 0.1 0.2 2.3 1.0 0.4 0.0 0.2 0.1 0.2 1.3 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 62.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 75.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.1 7.5 1.1 0.0 0.0 0.0 0.0 0.0 FAM187B "FLJ25660, TMEM162" ENSG00000177558 "Family with sequence similarity 187 member B" Q17R55 19 35224800-35228729 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 56.0" "Group enriched" "Detected in some" 117 "Early spermatids: 555.2;Late spermatids: 1683.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079535 Enhanced NA NA "HPA079535: " "unprognostic (3.34e-1)" "unprognostic (4.96e-1)" "unprognostic (2.40e-1)" "unprognostic (2.84e-1)" "unprognostic (2.72e-1)" "unprognostic (2.12e-1)" "unprognostic (1.25e-3)" "unprognostic (2.71e-1)" "unprognostic (2.49e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 555.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1683.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 7.6 4.2 0.0 0.0 0.0 0.0 0.0 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;parathyroid gland: 6.5" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7" "Low region specificity" "Detected in many" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.8 1.5 12.8 0.6 7.9 0.4 0.6 4.2 9.5 0.4 4.0 1.5 0.0 1.0 1.1 0.8 0.6 1.5 0.5 0.7 15.3 4.7 1.7 0.5 1.5 0.5 3.5 3.4 0.4 3.3 6.5 0.0 0.7 4.0 0.8 3.0 0.0 1.1 0.5 0.4 0.8 3.2 1.0 0.7 1.3 0.6 2.3 0.3 0.0 1.9 0.0 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.2 15.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.8 7.9 4.2 9.5 15.3 4.7 3.5 3.4 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 0.1 0.2 3.5 1.4 0.8 0.3 0.0 0.2 0.5 1.2 0.0 0.0 0.0 2.9 0.5 FAM196A "C10orf141, FLJ45557, INSYN2" ENSG00000188916 "Family with sequence similarity 196 member A" Q6ZSG2 10 127135426-127196158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 11 "Bipolar cells: 10.9;Leydig cells: 14.4;Peritubular cells: 12.4" "Group enriched" "Detected in some" 13 "breast cancer: 3.4;glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 30 "dendritic cells: 3.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 5.4;U-87 MG: 10.6" "Low region specificity" "Detected in many" "HPA035898, HPA035899" Uncertain NA NA "HPA035898: AB_10964352, HPA035899: AB_10961723" "unprognostic (4.00e-2)" "unprognostic (9.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.66e-3)" "unprognostic (2.18e-1)" "unprognostic (4.70e-2)" "unprognostic (7.30e-2)" "unprognostic (3.62e-1)" "unprognostic (2.18e-2)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (5.47e-2)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" 0.6 0.4 3.7 1.0 11.7 0.4 3.0 2.3 8.3 0.3 1.7 0.9 0.0 0.8 0.4 1.7 0.6 0.4 1.0 1.0 2.8 5.0 1.2 0.3 0.5 0.5 4.4 3.0 3.4 0.9 0.3 0.8 0.4 4.7 3.6 0.7 0.3 3.4 0.7 0.4 0.8 1.4 0.8 1.9 1.5 0.9 3.0 2.9 2.2 0.5 0.0 0.7 1.6 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 1.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.5 0.0 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.7 11.7 2.3 3.6 2.8 5.0 4.4 3.0 4.7 2.9 0.0 0.0 0.0 0.0 0.0 10.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 14.4 0.0 0.0 1.0 0.0 0.4 0.0 0.0 12.4 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 FAM196B C5orf57 ENSG00000204767 "Family with sequence similarity 196 member B" A6NMK8 5 169864264-169980740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;breast: 14.4;salivary gland: 10.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.1;HUVEC TERT2: 12.9;U-138 MG: 33.5;U-251 MG: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047227 Uncertain NA NA "HPA047227: AB_2679992" "unprognostic (5.30e-2)" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (1.26e-3)" "unprognostic (2.31e-2)" "unprognostic (1.98e-2)" "unprognostic (3.31e-5)" "unprognostic (5.16e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.37e-1)" "unprognostic (6.38e-2)" "unprognostic (3.73e-3)" 1.4 1.5 3.8 1.3 8.8 1.1 14.4 2.3 10.4 0.6 0.6 13.5 0.0 0.5 0.8 0.5 0.6 0.6 1.1 0.8 4.9 3.6 1.4 0.7 0.7 0.6 6.7 3.5 4.6 0.6 0.5 3.3 0.6 5.2 2.1 0.6 6.7 10.6 0.6 0.5 1.0 0.5 1.1 7.9 3.0 0.5 0.7 5.9 0.0 2.3 0.0 0.5 0.8 0.4 0.3 0.1 0.9 0.4 0.0 0.4 0.0 0.1 0.2 0.7 0.0 5.3 1.9 0.0 3.6 1.8 3.0 2.4 0.0 0.0 0.0 8.0 20.1 5.8 0.0 0.1 6.2 5.9 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 0.7 0.0 4.2 3.7 5.8 12.9 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 33.5 0.3 0.9 11.3 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 3.8 8.8 2.3 8.3 4.9 3.6 6.7 3.5 5.2 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.5 40.6 3.1 0.8 0.6 0.1 1.0 3.5 1.3 0.0 0.1 1.3 1.4 0.0 19.0 5.0 0.5 0.0 0.0 0.2 0.0 9.7 14.4 0.1 0.0 46.6 1.2 6.6 0.7 2.2 52.0 0.0 3.3 0.0 9.6 0.2 0.0 0.0 0.1 11.3 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.0 0.0 7.5 2.1 9.6 1.4 0.0 2.5 4.4 4.8 2.6 1.6 0.0 0.0 11.8 0.6 0.0 20.0 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 8.9 3.8 1.7 1.7 8.1 0.0 30.3 0.0 2.7 2.3 3.5 0.0 3.6 0.0 0.5 2.4 51.3 2.6 0.0 5.0 0.9 14.8 2.4 1.1 0.8 56.1 6.4 1.7 49.7 140.4 4.3 32.5 27.2 8.5 0.0 6.5 0.0 3.2 1.9 39.6 0.0 0.0 6.5 10.3 4.4 0.5 6.5 4.9 2.2 2.9 1.0 FAM19A2 "TAFA-2, TAFA2" ENSG00000198673 "Family with sequence similarity 19 member A2, C-C motif chemokine like" Q8N3H0 12 61708259-62279150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;brain: 25.8" "Group enriched" "Detected in many" 7 "Early spermatids: 155.9;Late spermatids: 77.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 17.7;neutrophil: 9.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.7" "Cell line enhanced" "Detected in some" "hTCEpi: 9.8;SCLC-21H: 3.7;WM-115: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.89e-3)" "unprognostic (9.33e-2)" "unprognostic (1.02e-1)" "unprognostic (1.37e-2)" "unprognostic (2.78e-1)" "unprognostic (4.83e-1)" "unprognostic (6.62e-2)" "unprognostic (4.16e-3)" "unprognostic (4.08e-1)" "unprognostic (1.80e-1)" "unprognostic (3.22e-5)" "unprognostic (1.05e-1)" "unprognostic (2.22e-2)" "unprognostic (3.31e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" 1.7 1.7 16.7 1.3 10.1 3.8 1.5 1.3 25.8 3.1 1.7 1.1 0.0 1.8 1.9 1.0 0.9 1.3 1.2 0.7 13.1 7.0 0.9 0.8 0.9 1.4 5.8 12.7 4.3 1.8 0.9 5.7 4.9 9.9 2.4 1.5 0.2 1.2 11.1 0.6 1.3 1.3 1.0 2.1 1.8 1.2 5.3 0.0 0.0 1.0 0.0 0.7 1.5 2.5 0.4 0.4 17.7 1.9 0.4 2.8 0.4 0.2 0.0 1.9 0.4 1.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.8 0.1 0.0 0.3 0.3 0.3 0.7 0.4 1.3 3.0 0.0 0.3 1.4 2.2 0.1 9.8 0.0 0.0 0.3 0.0 2.7 1.9 1.1 0.0 0.0 2.5 0.5 0.8 0.3 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.3 0.8 0.0 0.6 0.7 0.4 0.4 0.1 0.4 1.1 0.2 0.5 0.8 0.9 0.5 0.0 0.6 8.1 17.7 1.9 3.8 0.3 0.6 0.1 0.4 0.8 0.4 0.2 0.2 0.7 0.2 9.2 0.4 0.2 0.4 2.8 0.4 16.7 10.1 1.3 25.8 13.1 7.0 5.8 12.7 9.9 0.0 0.0 0.0 3.7 1.0 1.6 1.7 2.5 0.0 4.0 0.0 0.0 2.0 1.3 5.0 0.5 155.9 1.6 1.5 0.0 1.0 1.1 3.2 0.6 1.1 2.4 1.6 0.0 2.4 0.6 10.4 77.3 3.7 1.2 1.7 0.0 1.5 2.5 0.9 1.9 0.4 1.3 1.7 6.5 0.8 17.3 5.6 0.5 2.2 2.5 1.7 1.4 FAM19A3 "TAFA-3, TAFA3" ENSG00000184599 "Family with sequence similarity 19 member A3, C-C motif chemokine like" Q7Z5A8 1 112720419-112727235 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 19.6;brain: 5.2;testis: 8.8" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 44.6;Cone photoreceptor cells: 64.8;Muller glia cells: 15.8;Rod photoreceptor cells: 17.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;BJ hTERT+: 9.5;HEL: 3.7;U-87 MG: 3.8" HPA055927 Approved "Secreted in other tissues" NA NA "HPA055927: AB_2682972" "unprognostic (9.96e-2)" "unprognostic (4.30e-1)" "unprognostic (3.36e-2)" "unprognostic (5.63e-4)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.66e-1)" "unprognostic (3.40e-2)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (1.32e-1)" "unprognostic (9.82e-2)" "unprognostic (2.51e-1)" "unprognostic (5.14e-6)" "unprognostic (2.10e-4)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" 0.1 19.6 0.4 0.1 0.0 0.0 0.3 5.2 0.4 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.4 3.9 0.6 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.2 0.0 0.0 0.6 0.8 0.2 9.5 0.7 0.6 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.1 0.5 0.4 1.6 0.3 3.7 0.0 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.5 0.0 0.2 0.0 0.4 0.4 0.4 0.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.1 0.0 1.1 0.0 1.4 1.3 0.2 0.5 0.1 0.0 0.0 3.8 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.6 0.4 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.6 0.9 0.0 0.1 0.0 0.0 0.0 FAM19A5 TAFA-5 ENSG00000219438 "Family with sequence similarity 19 member A5, C-C motif chemokine like" Q7Z5A7 22 48489460-48850912 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.2" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 15.0;Muller glia cells: 37.6;Peritubular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 13.8;HEK 293: 9.3;Hep G2: 21.3;NTERA-2: 12.0;SCLC-21H: 6.1;U-2 OS: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025629 Approved "Secreted in brain" NA NA "CAB025629: " "unprognostic (2.86e-1)" "unprognostic (2.98e-1)" "unprognostic (3.42e-2)" "unprognostic (2.19e-1)" "unprognostic (3.57e-1)" "unprognostic (1.80e-1)" "unprognostic (2.82e-3)" "unprognostic (2.41e-2)" "unprognostic (6.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (9.31e-3)" "unprognostic (2.64e-2)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.94e-2)" 1.9 2.5 22.7 1.7 18.7 0.7 2.7 19.1 40.2 12.2 1.8 8.5 0.1 2.0 8.1 6.9 1.1 3.4 3.4 1.4 23.6 22.8 1.9 3.0 2.2 1.2 18.1 12.9 8.3 2.4 0.8 1.9 0.8 8.7 4.0 1.0 0.7 7.3 5.7 1.5 1.9 2.6 1.8 9.9 1.1 3.7 2.5 7.3 1.3 1.1 0.0 1.0 2.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.8 0.1 0.0 0.9 0.0 0.0 0.0 9.3 0.0 0.1 21.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 12.0 0.4 0.0 0.5 0.0 5.1 0.0 0.0 6.1 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.7 19.1 21.9 23.6 22.8 18.1 12.9 8.7 7.3 3.0 2.9 0.0 0.0 1.6 15.0 1.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.6 0.0 0.0 0.3 0.0 5.6 1.0 0.0 0.0 0.2 3.2 0.0 0.6 0.0 0.0 6.4 0.2 5.0 0.0 0.0 37.6 0.7 0.0 8.9 1.8 1.5 0.0 0.9 0.5 3.4 1.4 0.0 0.0 0.0 0.0 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297930-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: AB_2684663" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 31.2 17.5 30.0 18.5 31.6 40.3 28.1 18.9 37.8 24.9 26.8 20.0 19.6 17.9 27.4 29.5 26.1 19.2 19.2 29.5 25.4 21.7 25.0 24.8 21.4 22.4 23.4 25.9 26.2 21.4 19.1 31.3 19.1 30.4 21.1 21.6 19.4 21.9 20.7 36.3 17.1 18.5 34.0 31.2 24.1 20.8 39.9 20.9 19.8 26.0 21.9 23.0 32.8 18.4 27.4 32.4 36.6 35.1 17.5 27.2 28.7 21.6 9.8 16.1 22.4 16.1 17.6 9.2 17.1 32.3 24.9 22.6 11.5 20.3 15.4 10.7 18.4 11.2 18.7 13.4 17.9 22.7 24.1 16.7 12.7 10.0 10.1 24.1 33.1 18.2 12.1 22.0 18.2 38.4 20.9 21.1 19.9 13.3 18.2 20.5 12.0 20.3 30.8 11.4 9.5 8.7 17.4 31.2 11.2 22.5 11.0 10.4 16.4 11.7 11.0 25.2 8.3 17.5 24.0 14.7 13.1 12.2 11.5 26.0 13.1 11.6 22.1 25.5 35.9 13.2 29.8 31.7 36.6 21.7 34.4 22.7 27.4 24.6 19.8 32.4 20.2 21.3 24.7 17.6 17.5 35.1 23.5 27.2 28.7 30.0 31.6 18.9 37.8 25.4 21.7 23.4 25.9 30.4 20.9 56.6 51.4 57.2 54.8 49.3 36.8 71.2 50.9 53.5 47.8 41.8 68.7 32.9 114.4 58.3 206.7 61.6 25.0 46.7 98.7 40.6 62.0 51.0 65.9 40.6 54.1 31.8 40.3 59.5 64.6 82.8 70.8 79.5 57.3 48.7 48.6 54.4 77.4 58.3 65.7 92.5 54.8 25.8 71.2 217.2 170.6 44.3 25.6 57.4 45.3 52.2 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 99.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;THP-1: 2.3" HPA071267 Enhanced Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA071267: AB_2686376" "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM209A "C20orf106, dJ1153D9.3" ENSG00000124103 "Family with sequence similarity 209 member A" Q5JX71 20 56517187-56526142 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 40.3" "Cell type enriched" "Detected in some" 15 "Early spermatids: 1951.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;neutrophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;Karpas-707: 3.0;U-266/84: 3.9" NA NA "unprognostic (1.03e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (8.58e-3)" "unprognostic (1.06e-2)" "unprognostic (2.12e-1)" "unprognostic (2.10e-1)" "unprognostic (9.83e-2)" "unprognostic (5.56e-3)" "unprognostic (7.68e-2)" "unprognostic (1.86e-9)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-2)" 0.2 0.0 0.0 0.3 0.0 8.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.1 40.3 0.0 0.5 0.0 0.1 0.6 0.3 2.3 0.2 0.0 1.9 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.3 0.3 0.2 1.9 0.3 0.5 0.2 0.2 0.5 0.2 0.2 0.3 0.3 0.6 0.4 0.0 0.2 1.5 5.5 0.3 1.6 0.0 0.2 0.2 0.0 1.7 0.0 3.0 0.0 1.3 0.2 1.9 0.2 0.1 0.2 1.0 0.9 1.2 0.0 0.7 0.5 0.0 0.0 2.1 0.5 0.0 0.4 0.9 0.0 0.5 0.3 0.8 0.3 1.4 3.9 2.0 0.0 0.2 0.1 0.0 0.2 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.2 0.3 0.0 0.0 0.0 2.9 0.0 0.1 0.1 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1951.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.1 0.0 0.1 0.0 1.2 1.8 0.3 132.6 8.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 7.5 4.1 0.0 0.2 0.0 0.1 0.1 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 40.8" "Cell type enriched" "Detected in some" 10 "Early spermatids: 1427.6" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 5.0" HPA042144 Enhanced NA NA "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.2 0.0 0.0 0.2 0.1 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.9 0.1 40.8 0.0 0.3 0.0 0.0 1.0 0.8 3.4 1.1 0.0 2.1 0.4 0.0 2.7 0.7 0.0 0.0 0.3 0.4 1.1 1.9 2.4 0.9 1.7 0.1 0.3 1.8 1.2 0.6 1.4 1.2 0.7 2.1 0.4 1.1 1.2 0.0 1.1 0.0 2.2 4.2 1.3 2.0 0.2 1.5 0.0 0.0 1.9 0.2 1.9 0.0 2.6 0.8 2.0 0.5 0.2 1.5 0.7 0.8 0.2 1.5 0.9 1.7 0.4 0.9 3.4 0.6 0.8 1.5 0.6 0.0 0.3 0.7 1.7 0.1 5.0 4.5 0.9 0.4 1.0 0.3 0.0 1.1 3.4 2.1 0.4 0.3 0.0 0.1 1.3 0.8 1.0 0.7 0.0 1.8 0.0 0.7 0.0 0.0 0.4 0.0 3.4 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1427.6 0.0 0.0 0.0 1.4 0.4 0.0 0.3 1.1 0.0 0.5 0.0 1.2 0.0 0.3 148.4 10.6 0.7 0.0 1.0 0.0 0.0 0.6 0.0 7.8 0.5 0.0 0.0 0.5 6.9 6.8 0.0 0.0 0.0 0.0 0.6 FAM216A "C12orf24, HSU79274" ENSG00000204856 "Family with sequence similarity 216 member A" Q8WUB2 12 110468364-110490385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.9" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 244.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038286 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA038286: AB_2675931" "unprognostic (7.91e-2)" "unprognostic (3.73e-2)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (3.04e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (8.49e-2)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (4.18e-10)" "unprognostic (7.60e-2)" "unprognostic (4.35e-2)" "unprognostic (6.66e-2)" "unprognostic (1.05e-1)" 3.3 6.6 8.6 6.1 11.7 3.7 3.9 15.8 19.7 4.6 2.5 3.8 0.7 1.8 4.9 1.5 2.6 3.9 4.2 7.0 11.6 13.0 3.0 3.2 2.1 6.3 8.3 11.9 6.5 2.3 4.4 4.0 3.7 12.5 4.1 2.5 1.2 2.2 5.1 6.0 1.9 2.3 5.6 6.6 4.3 2.2 43.9 6.2 5.0 3.0 1.4 4.4 3.8 2.5 9.9 5.5 3.2 4.9 2.5 12.3 5.4 8.0 7.0 5.1 6.6 3.8 7.0 1.3 14.3 3.9 16.5 7.6 6.9 2.3 29.2 3.8 6.6 4.3 5.9 9.5 8.6 18.8 9.3 23.0 15.0 4.4 5.0 5.6 17.8 11.8 6.4 2.2 8.4 18.5 9.9 5.5 12.6 16.0 7.6 10.9 2.7 14.3 22.9 17.6 3.2 13.0 7.2 7.7 20.5 5.8 0.1 25.3 8.3 7.0 4.4 3.5 1.6 11.6 10.4 4.8 5.5 2.4 4.8 13.8 14.1 10.2 22.8 9.0 16.6 10.1 1.4 4.9 1.9 3.1 3.3 4.4 9.2 4.8 5.0 5.5 9.9 12.3 7.3 3.2 2.5 3.1 2.9 3.3 5.4 8.6 11.7 15.8 19.7 11.6 13.0 8.3 11.9 12.5 6.2 0.0 1.0 8.5 4.7 1.4 10.2 15.3 0.0 5.3 4.5 3.5 2.0 0.6 0.0 3.2 29.5 5.8 0.0 0.0 0.8 1.9 5.1 1.6 10.3 3.9 6.7 12.7 1.2 4.9 4.5 44.3 8.9 2.1 3.3 1.8 0.0 4.6 2.5 0.0 5.3 2.9 4.1 12.9 5.1 244.4 20.0 1.8 0.5 3.2 0.2 1.3 FAM216B "C13orf30, FLJ40919" ENSG00000179813 "Family with sequence similarity 216 member B" Q8N7L0 13 42781550-42791549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 348.0" "Group enriched" "Detected in some" 10 "endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 9.5;pons and medulla: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-87 MG: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040118 Uncertain NA NA "HPA040118: AB_10674429" "unprognostic (1.03e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.35e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (2.54e-2)" "unprognostic (5.44e-3)" "unprognostic (1.32e-1)" "unprognostic (2.27e-1)" "unprognostic (8.14e-3)" "unprognostic (1.37e-1)" "unprognostic (1.30e-2)" 0.3 0.2 1.7 0.9 9.5 0.2 0.2 0.1 0.6 3.0 0.3 8.0 0.0 0.3 1.3 18.2 0.2 51.3 0.4 10.0 3.1 3.2 0.2 0.2 28.5 2.2 0.1 0.0 18.3 0.3 0.2 2.0 0.2 21.0 0.2 0.5 0.0 0.7 0.2 0.2 0.2 1.5 0.2 0.5 0.3 0.3 1.0 1.7 0.0 0.2 0.0 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.5 0.1 0.6 3.1 3.2 0.1 0.0 21.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 7.7 0.0 348.0 42.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAM217A "C6orf146, MGC43581" ENSG00000145975 "Family with sequence similarity 217 member A" Q8IXS0 6 4049434-4087344 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 16.9" "Group enriched" "Detected in some" 23 "Early spermatids: 174.7;Late spermatids: 307.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HeLa: 1.2" "Low region specificity" "Detected in many" HPA035455 Uncertain NA NA "HPA035455: AB_10669905" "unprognostic (5.93e-2)" "unprognostic (3.70e-2)" "unprognostic (1.24e-1)" "unprognostic (8.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.53e-2)" "unprognostic (2.99e-2)" "unprognostic (1.08e-2)" "unprognostic (2.09e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (4.54e-1)" "unprognostic (6.55e-2)" "unprognostic (2.86e-1)" "unprognostic (1.85e-1)" "unprognostic (1.53e-2)" "unprognostic (5.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.3 0.1 0.3 0.4 0.5 1.3 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 10.6 2.7 0.0 0.0 0.0 0.0 0.0 FAM217B "C20orf177, dJ551D2.5" ENSG00000196227 "Family with sequence similarity 217 member B" Q9NTX9 20 59933764-59948680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041021, HPA056698" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041021: AB_10959734, HPA056698: AB_2683212" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (9.43e-2)" "unprognostic (5.05e-2)" "unprognostic (9.04e-8)" "unprognostic (2.78e-3)" "unprognostic (4.51e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-1)" "unprognostic (9.89e-2)" "unprognostic (1.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" 5.5 5.2 17.7 7.2 18.2 14.7 6.2 18.7 29.6 6.4 5.4 10.7 5.0 6.2 8.6 7.3 5.9 7.2 5.1 11.7 15.5 14.3 6.8 2.8 6.5 10.3 14.4 19.1 13.7 4.0 5.9 14.3 7.7 14.1 9.6 4.6 4.7 5.8 11.8 16.5 4.3 7.1 5.8 10.7 7.4 5.6 10.8 11.6 8.5 8.5 4.9 10.4 7.0 6.8 7.2 8.0 13.8 7.0 9.3 13.5 6.9 5.3 3.7 8.6 5.9 4.1 6.2 6.9 7.7 6.6 8.5 6.2 19.1 11.8 11.9 13.0 3.2 6.8 13.3 9.3 6.4 8.4 6.5 5.8 11.1 9.2 10.9 2.7 17.6 15.1 3.6 7.9 6.2 2.0 3.5 2.5 14.4 7.9 5.1 5.5 9.8 30.7 9.7 8.4 5.0 7.6 7.5 8.5 11.6 3.3 8.4 8.8 10.5 10.3 13.4 11.3 8.4 12.9 12.6 3.5 7.1 8.3 7.3 4.0 8.6 14.6 14.1 9.9 11.6 4.6 9.6 7.0 9.5 11.0 4.6 13.5 6.6 10.6 10.0 8.0 7.2 11.0 11.6 13.8 9.3 4.3 6.4 9.1 6.9 17.7 18.2 18.7 29.6 15.5 14.3 14.4 19.1 14.1 11.6 14.9 14.2 20.3 4.0 4.7 30.9 27.4 10.2 16.0 10.3 10.4 21.6 18.9 14.9 4.7 19.0 13.4 14.2 0.0 7.0 8.9 11.7 8.1 27.8 4.9 15.8 57.2 8.1 13.5 31.8 16.0 16.1 16.4 11.8 10.0 6.2 23.6 7.1 5.8 9.6 11.8 29.6 32.3 16.5 51.9 14.7 4.6 5.7 22.4 9.2 4.3 FAM220A "ACPIN1, C7orf70, MGC12966, SIPAR" ENSG00000178397 "Family with sequence similarity 220 member A" Q7Z4H9 7 6329409-6348981 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.7;testis: 40.9" "Group enriched" "Detected in many" 14 "Early spermatids: 230.4;Late spermatids: 278.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055050 Approved Vesicles NA NA Vesicles "HPA055050: AB_2682684" "unprognostic (3.49e-2)" "unprognostic (3.53e-1)" "unprognostic (2.69e-2)" "unprognostic (9.79e-2)" "unprognostic (3.26e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (2.78e-1)" "unprognostic (1.43e-2)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (8.84e-3)" "unprognostic (1.14e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (3.71e-2)" 5.8 6.9 10.5 5.1 9.3 2.3 7.7 14.0 16.6 7.5 6.1 6.8 3.8 4.3 8.1 6.1 8.9 6.2 5.9 12.6 10.3 9.7 6.5 5.1 4.9 6.8 8.3 11.6 8.7 10.5 15.3 7.2 6.0 7.9 6.6 4.4 5.6 7.2 6.9 56.7 7.7 4.6 7.3 7.9 5.8 5.3 40.9 5.4 9.7 9.1 11.8 7.7 7.5 6.3 11.1 9.6 9.5 5.5 16.2 10.2 3.8 15.9 10.1 7.4 17.3 17.2 14.6 8.2 8.2 10.2 9.9 11.7 6.7 8.9 13.3 9.5 9.7 19.9 11.8 11.2 6.9 13.0 9.2 7.2 4.4 8.1 7.5 18.7 8.0 6.7 8.1 23.4 7.4 18.0 9.6 9.2 10.1 8.6 12.8 8.5 12.5 4.9 14.7 17.3 8.4 13.2 12.8 11.1 11.1 9.1 5.8 7.6 13.1 11.5 14.2 17.1 15.6 13.6 21.0 6.9 7.9 18.1 15.3 10.4 13.8 21.3 14.5 9.2 14.5 24.1 6.7 5.5 9.5 5.5 4.5 5.7 11.1 6.6 8.5 9.6 10.6 10.2 8.4 2.4 16.2 4.7 7.7 8.3 3.8 10.5 9.3 14.0 16.6 10.3 9.7 8.3 11.6 7.9 5.4 3.0 1.4 4.4 4.7 6.9 2.7 8.5 0.0 1.4 9.1 1.8 5.9 5.4 1.7 4.8 230.4 3.3 2.5 0.0 4.1 6.2 5.2 3.7 1.1 3.4 5.7 0.0 5.8 5.5 5.9 278.7 7.8 5.7 3.3 6.4 4.0 3.7 5.0 2.3 12.4 2.2 1.8 0.0 4.2 17.9 10.4 8.8 6.9 3.3 3.2 5.9 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.9 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 12.0 0.2 0.1 1.0 0.3 0.7 0.5 0.8 0.0 0.2 7.7 1.8 1.5 0.4 2.7 0.1 1.1 1.6 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.5 0.2 0.1 4.8 0.3 1.5 1.3 1.4 2.4 1.0 3.5 0.5 1.5 0.6 8.5 51.4 1.1 1.6 3.4 0.2 1.9 1.3 0.1 0.2 1.4 0.6 1.0 1.3 1.7 1.0 0.1 0.8 1.7 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 0.0 0.0 0.5 0.6 1.9 21.6 6.1 2.5 0.0 0.0 1.8 31.4 0.1 6.6 1.4 23.4 0.8 0.6 0.0 0.7 0.1 1.7 1.4 0.0 1.3 0.3 73.1 7.5 0.0 0.0 11.0 1.1 0.3 6.8 0.0 4.1 10.0 0.8 0.0 0.4 0.6 48.4 0.0 1.4 0.7 2.6 1.6 0.7 0.0 0.8 0.2 FAM227B "C15orf33, FLJ32800" ENSG00000166262 "Family with sequence similarity 227 member B" Q96M60 15 49326962-49620931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 25.4;Early spermatids: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049774, HPA061695" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049774: AB_2680873, HPA061695: AB_2684588" "unprognostic (1.19e-2)" "unprognostic (2.57e-1)" "unprognostic (1.89e-2)" "unprognostic (4.74e-3)" "unprognostic (1.17e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-4)" "unprognostic (3.32e-2)" "unprognostic (9.21e-2)" "unprognostic (6.57e-3)" "unprognostic (6.32e-3)" "unprognostic (6.41e-2)" "unprognostic (7.48e-5)" "unprognostic (2.70e-1)" "unprognostic (9.01e-2)" "unprognostic (7.47e-2)" "unprognostic (1.76e-1)" 1.9 7.6 8.0 6.4 8.4 1.8 9.1 2.4 6.7 10.5 6.5 11.6 10.6 3.8 9.0 10.5 4.8 11.0 5.3 11.5 7.8 7.2 10.9 9.7 4.9 7.6 9.8 7.1 13.9 8.6 9.0 28.4 1.8 6.6 8.1 3.9 6.7 7.2 8.7 10.8 5.2 4.0 11.3 9.5 3.7 4.5 19.0 8.1 12.1 10.1 5.2 5.6 8.6 4.0 5.5 4.7 7.8 0.9 3.3 8.2 2.6 0.9 0.9 5.9 3.2 1.8 3.5 0.7 2.4 3.4 3.7 6.0 0.8 2.8 1.7 5.7 3.9 4.3 0.9 2.1 3.5 4.4 3.9 1.7 3.7 1.5 1.8 5.0 1.6 1.6 3.7 4.7 2.2 2.3 7.2 3.4 8.6 5.8 2.7 8.1 3.8 3.4 1.4 2.6 1.3 1.5 3.0 5.0 8.8 5.5 1.1 4.5 6.1 2.2 2.9 6.7 4.9 3.5 1.3 2.4 2.5 2.1 3.4 1.4 14.0 11.4 5.3 2.9 4.4 2.7 7.8 0.3 2.4 4.9 0.7 6.4 4.0 4.9 6.4 0.5 5.5 8.2 7.8 0.6 3.3 0.9 4.7 4.2 2.6 8.0 8.4 2.4 6.7 7.8 7.2 9.8 7.1 6.6 8.1 8.9 4.5 2.0 4.7 2.5 4.5 9.1 2.5 25.4 13.6 3.5 0.0 1.6 21.6 3.2 25.3 1.6 1.2 0.0 2.9 1.1 3.2 4.0 3.5 4.3 0.5 4.8 8.1 0.6 0.3 19.0 3.7 1.1 3.3 0.0 2.2 10.5 2.7 0.9 2.8 9.1 5.9 0.0 1.9 18.5 12.9 3.8 0.3 4.3 2.3 2.0 FAM228A "C2orf84, FLJ30851" ENSG00000186453 "Family with sequence similarity 228 member A" Q86W67 2 24175069-24200849 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "testis: 54.1" "Group enriched" "Detected in some" 10 "Early spermatids: 71.6;Spermatocytes: 138.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 5.5;hTERT-RPE1: 2.6;TIME: 8.5" NA NA "unprognostic (2.57e-1)" "unprognostic (7.14e-2)" "unprognostic (2.92e-2)" "unprognostic (1.98e-3)" "unprognostic (7.13e-4)" "unprognostic (2.19e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (9.57e-2)" "unprognostic (2.14e-1)" "unprognostic (4.44e-5)" "unprognostic (1.73e-2)" "unprognostic (1.04e-4)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-2)" 1.4 0.9 1.1 0.6 0.9 0.0 1.0 0.6 1.4 0.7 1.4 0.5 3.0 0.2 0.7 0.9 0.9 0.3 1.1 1.2 0.8 0.9 0.3 0.3 1.5 0.7 0.8 0.2 0.6 0.2 0.0 0.2 1.1 0.6 1.0 0.3 0.8 0.6 3.2 0.3 0.3 0.4 3.6 0.7 0.3 0.4 54.1 0.2 0.6 0.7 0.2 0.5 1.1 0.2 0.0 3.1 0.7 1.1 0.0 1.6 0.5 0.2 0.0 0.8 0.0 0.4 0.2 0.0 0.6 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 5.5 0.1 0.2 0.4 0.0 0.0 0.0 2.6 0.9 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.5 1.1 0.0 0.0 0.4 0.7 0.0 0.2 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 1.2 0.0 0.0 0.6 0.0 0.6 1.1 1.6 0.0 0.3 0.6 0.0 0.0 0.6 0.8 0.7 0.0 0.3 3.1 0.0 0.5 1.1 0.9 0.6 1.1 0.8 0.9 0.8 0.2 0.6 0.2 3.0 0.3 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 71.6 0.1 0.0 0.0 0.4 0.2 1.4 0.1 0.0 0.0 0.4 1.6 0.0 0.6 0.0 10.5 2.6 0.2 0.0 0.0 0.0 0.5 0.9 0.0 4.2 0.0 0.0 6.5 1.6 138.4 6.8 0.1 0.1 0.0 0.0 0.1 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145397-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 49.5" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 52.1;Ciliated cells: 77.6;Club cells: 67.1;Collecting duct cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 26.5;HUVEC TERT2: 18.3" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 43.2 4.8 3.3 11.9 3.0 7.0 49.5 3.6 3.1 6.9 9.5 4.6 10.7 3.1 8.9 6.0 7.6 5.2 6.2 18.5 4.3 3.0 6.4 6.9 10.2 7.2 5.6 1.8 5.2 3.8 7.1 6.3 12.6 3.4 9.7 3.2 2.8 22.3 17.2 11.6 7.2 4.7 9.0 4.3 9.7 8.3 7.7 3.6 6.3 8.5 7.3 6.0 9.3 24.7 2.7 2.8 5.7 1.7 1.7 1.7 0.7 4.0 1.6 1.6 1.3 8.6 4.9 2.5 3.4 0.8 0.6 1.1 1.2 5.1 26.5 3.2 1.8 2.3 1.9 2.6 3.6 1.2 12.4 4.3 2.9 3.9 2.1 5.1 6.5 1.7 5.3 5.8 1.0 6.2 1.3 18.3 3.8 5.3 12.8 2.1 4.1 2.4 4.7 2.1 6.6 3.8 5.4 2.7 5.4 2.7 3.9 3.0 2.5 3.2 5.9 1.6 2.5 4.2 2.8 11.5 2.1 6.3 1.4 1.2 5.4 7.0 12.2 4.9 3.2 2.7 5.7 1.7 1.6 1.5 1.3 1.3 1.5 1.6 1.1 0.9 2.7 1.5 1.7 4.2 1.7 1.6 2.8 1.7 0.7 3.3 3.0 3.6 2.4 4.3 3.0 5.6 1.8 3.4 3.6 56.6 52.1 0.0 0.0 0.0 0.0 0.0 0.0 77.6 67.1 31.4 0.0 1.4 6.6 11.8 0.0 0.0 0.0 0.0 14.9 2.2 0.0 0.0 30.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 8.2 0.0 0.0 21.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 FAM35A "bA163M19.1, FAM35A1, MGC5560" ENSG00000122376 "Family with sequence similarity 35 member A" Q86V20 10 87094161-87191468 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favorable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 17.3 16.9 5.4 14.4 7.2 5.4 15.4 6.4 4.9 12.6 20.2 4.7 9.1 15.0 10.8 10.6 12.6 9.3 7.4 11.5 6.0 6.1 31.2 35.3 12.5 16.4 9.0 3.5 12.7 10.2 3.6 19.4 7.4 6.8 14.0 11.6 7.4 11.4 14.0 9.3 9.1 33.1 14.8 6.9 15.6 8.7 7.1 7.9 12.0 30.7 12.6 9.4 12.3 13.6 9.0 10.7 4.9 11.1 11.2 13.7 8.5 16.1 13.1 7.5 17.2 8.5 8.2 11.0 10.9 15.4 14.7 16.2 15.0 12.5 11.9 6.1 14.8 8.6 10.8 18.5 8.3 15.2 16.9 12.2 16.4 12.5 14.1 13.1 25.6 14.4 7.5 15.4 13.4 23.2 13.0 9.8 13.0 20.8 21.5 13.6 9.3 20.7 18.3 8.6 11.8 9.2 12.9 14.9 13.1 13.5 13.6 3.7 15.5 8.4 10.0 14.5 7.3 22.0 14.5 9.5 8.4 7.7 12.5 21.7 12.1 26.4 28.8 14.2 32.0 4.5 4.9 7.0 2.3 6.8 11.1 13.7 9.0 10.3 10.0 10.7 7.2 10.5 10.5 0.1 11.2 8.4 3.7 9.7 8.5 5.4 7.2 6.4 4.9 6.0 6.1 9.0 3.5 6.8 7.9 17.9 16.3 7.2 11.3 9.3 7.7 0.0 15.3 14.7 21.6 0.0 13.7 5.6 0.0 0.0 16.8 8.6 14.8 0.0 0.0 13.2 13.9 20.1 9.2 58.0 13.0 6.4 6.9 16.0 18.4 17.8 19.0 20.0 16.9 0.0 16.0 14.3 0.0 12.9 18.7 0.0 21.1 12.9 5.3 15.7 6.8 9.8 1.8 13.1 15.7 14.6 FAM43A FLJ90022 ENSG00000185112 "Family with sequence similarity 43 member A" Q8N2R8 3 194686544-194689037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 61.8;Extravillous trophoblasts: 69.8;Ito cells: 78.5;Syncytiotrophoblasts: 135.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 47.9;NB-4: 28.5;PC-3: 22.6;TIME: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048345 Uncertain Approved Vesicles NA NA Vesicles "HPA048345: AB_2680367" "unprognostic (1.61e-1)" "unprognostic (1.11e-1)" "unprognostic (9.18e-2)" "unprognostic (1.90e-2)" "unprognostic (5.71e-3)" "unprognostic (5.13e-3)" "unprognostic (9.80e-2)" "unprognostic (8.28e-2)" "unprognostic (4.96e-2)" "unprognostic (1.38e-1)" "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.14e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.91e-3)" "prognostic unfavorable (9.96e-4)" 10.7 1.8 1.6 3.5 1.6 2.4 10.4 2.7 4.2 5.2 4.2 2.1 1.6 0.8 4.8 2.7 5.3 6.0 4.2 7.0 2.7 1.6 4.6 23.5 5.6 8.0 2.5 3.6 3.5 7.0 0.5 2.7 9.3 4.1 7.9 1.7 3.3 6.7 2.1 5.5 8.6 3.8 2.9 1.6 20.6 2.7 6.1 2.3 2.6 2.6 5.8 5.2 5.7 8.9 5.0 8.7 3.6 1.3 2.8 1.4 0.4 0.1 0.7 0.6 0.4 9.7 4.7 3.9 1.2 3.3 0.0 0.0 0.2 0.1 0.5 13.7 4.5 3.1 1.4 0.8 0.3 0.0 0.3 2.5 1.7 3.8 0.5 0.8 0.4 5.0 1.2 2.0 0.2 0.0 0.2 47.9 0.0 1.0 0.9 0.1 0.7 0.0 28.5 2.2 4.8 22.6 2.1 0.1 0.2 0.0 0.0 13.3 1.1 0.9 0.9 2.8 1.0 0.5 5.9 24.0 0.5 0.7 0.6 0.3 0.0 0.5 1.2 0.2 13.0 9.0 3.6 1.3 1.5 1.0 1.1 1.4 2.3 0.6 0.9 1.3 5.0 0.1 0.3 1.6 2.8 0.7 8.7 0.4 0.4 1.6 1.6 2.7 4.2 2.7 1.6 2.5 3.6 4.1 2.3 0.0 4.5 27.4 20.1 3.5 14.8 31.3 0.0 0.0 0.0 1.8 7.9 18.7 6.6 4.5 0.1 61.8 15.4 0.0 1.5 69.8 14.0 21.7 15.0 0.5 5.1 0.0 6.3 78.5 9.7 0.8 15.3 3.1 11.8 0.0 2.5 2.1 4.4 17.5 9.2 0.5 1.7 25.8 17.6 0.5 5.9 3.4 135.8 15.2 7.3 11.2 FAM43B FLJ44952 ENSG00000183114 "Family with sequence similarity 43 member B" Q6ZT52 1 20552439-20555010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 21.9;brain: 14.9;epididymis: 8.7" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 1.2;Distal tubular cells: 3.3" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;BJ hTERT+: 3.3;fHDF/TERT166: 6.7;Hep G2: 4.9;SCLC-21H: 6.0;SiHa: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050813 Approved Approved Cytosol NA NA Cytosol "HPA050813: AB_2681244" "unprognostic (1.51e-1)" "unprognostic (5.85e-2)" "unprognostic (2.80e-3)" "unprognostic (1.48e-1)" "unprognostic (5.97e-3)" "unprognostic (1.74e-1)" "unprognostic (8.33e-2)" "unprognostic (5.87e-4)" "unprognostic (1.86e-2)" "unprognostic (7.46e-2)" "unprognostic (8.85e-3)" "unprognostic (2.73e-1)" "unprognostic (1.78e-4)" "unprognostic (1.06e-2)" "unprognostic (6.05e-3)" "unprognostic (6.48e-2)" "unprognostic (2.12e-2)" 3.2 21.9 5.6 1.5 14.9 0.9 1.5 8.8 14.4 1.6 1.3 2.4 0.0 1.1 1.4 8.7 1.3 1.6 1.5 3.3 5.3 12.1 2.6 1.4 1.2 1.0 10.1 6.0 1.0 1.2 0.9 0.7 2.5 11.2 1.4 1.1 0.5 1.2 1.3 2.8 1.0 1.2 2.9 4.0 1.4 0.9 1.3 2.8 0.0 1.3 1.7 0.9 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.6 0.2 0.1 0.0 0.5 3.3 0.6 0.0 0.1 0.0 0.0 0.2 6.7 1.2 0.0 0.7 0.0 0.1 0.0 1.0 0.2 0.3 4.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.0 0.7 11.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 14.9 8.8 14.4 5.3 12.1 10.1 6.0 11.2 2.8 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.3 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 FAM45A ENSG00000119979 "Family with sequence similarity 45 member A" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 12.2 13.2 16.2 8.5 20.0 17.0 9.5 10.2 17.6 11.6 12.5 10.2 6.5 7.6 9.4 10.7 16.0 9.0 8.5 10.8 13.5 10.4 16.6 18.9 8.6 6.8 10.6 17.6 17.3 8.8 11.6 5.4 10.8 18.4 8.9 11.0 7.7 10.7 8.3 14.0 12.0 9.7 9.8 13.5 8.4 9.7 7.1 11.5 10.1 14.8 10.8 9.9 13.1 14.7 2.3 9.9 30.2 19.2 3.8 10.0 6.0 8.3 9.8 12.5 14.5 21.4 21.4 5.5 11.9 29.8 10.7 10.3 9.5 11.2 5.9 4.5 14.6 11.2 12.7 10.6 10.5 9.3 10.0 6.0 1.3 3.4 8.3 24.4 3.5 2.8 22.3 9.0 7.8 11.0 22.2 14.4 5.1 2.8 6.7 13.4 6.7 4.4 6.0 7.5 6.3 4.0 4.8 15.7 4.3 10.3 8.9 2.1 8.3 8.5 9.0 17.4 12.2 8.6 12.3 14.6 7.6 3.9 7.9 6.0 7.3 2.7 6.5 12.3 15.3 3.4 23.0 15.1 30.2 4.2 18.3 3.4 2.3 6.3 5.5 9.9 1.9 3.1 4.1 20.1 3.8 19.2 2.5 10.0 6.0 16.2 20.0 10.2 17.6 13.5 10.4 10.6 17.6 18.4 11.5 8.9 21.6 15.2 23.3 15.8 17.0 32.3 28.1 20.1 17.0 24.4 0.0 45.9 94.5 28.0 2.0 15.3 46.3 0.0 43.7 21.6 29.9 20.6 19.7 52.9 46.9 7.9 24.2 51.0 96.9 4.7 23.9 34.6 28.7 36.1 27.9 29.4 40.7 45.6 25.8 78.7 16.9 19.4 11.8 18.5 23.2 22.2 37.9 28.7 34.5 24.3 FAM47A MGC27003 ENSG00000185448 "Family with sequence similarity 47 member A" Q5JRC9 X 34129756-34132314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 12.7" "Cell type enriched" "Detected in some" 5 "Early spermatids: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "REH: 1.5;U-266/84: 1.1" HPA000610 Uncertain NA NA "HPA000610: AB_1078805" "unprognostic (1.68e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 FAM47B FLJ35782 ENSG00000189132 "Family with sequence similarity 47 member B" Q8NA70 X 34942796-34944915 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 18.8" "Group enriched" "Detected in some" 52 "Early spermatids: 42.9;Late spermatids: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.6" "HPA046829, HPA050996" Uncertain NA NA "HPA046829: AB_2679828, HPA050996: AB_2681301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 FAM47C ENSG00000198173 "Family with sequence similarity 47 member C" Q5HY64 X 37008397-37011666 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 7.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283780 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 75.0;Early spermatids: 25.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 3.1;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 3.1;dendritic cells: 2.3" "Cell line enriched" "Detected in many" 5 "OE19: 24.0" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 5.5 6.8 12.5 0.8 8.5 1.2 8.9 2.4 14.8 3.7 3.2 9.2 4.4 4.3 2.4 15.5 1.6 23.5 5.1 3.2 10.1 13.7 9.1 11.2 4.8 0.9 10.7 15.5 1.2 9.7 9.9 10.3 10.0 12.1 5.2 3.8 2.7 5.4 4.0 9.5 2.0 4.2 3.0 13.3 1.8 6.0 9.2 6.2 0.0 13.2 1.5 0.9 2.6 1.1 3.1 2.3 0.1 0.4 0.1 0.5 0.1 0.4 2.0 1.8 0.5 1.4 0.2 0.4 0.2 1.3 0.3 0.4 2.3 1.7 0.1 0.5 0.7 4.1 0.6 0.8 0.4 0.7 1.8 0.1 0.1 1.1 3.3 0.8 0.4 0.3 0.8 0.5 0.5 0.5 0.7 0.2 0.2 0.2 1.1 0.6 2.8 0.1 0.2 0.4 24.0 0.9 0.3 0.5 0.3 2.5 1.6 3.1 2.2 0.8 1.0 0.3 0.5 1.0 0.2 0.5 0.4 0.4 1.1 0.3 4.4 1.0 0.1 1.3 0.2 0.6 0.0 0.4 0.1 0.2 0.0 0.5 0.2 0.2 0.1 0.2 3.1 0.4 0.1 0.1 0.1 0.4 2.3 0.0 0.1 12.5 8.5 2.4 14.8 10.1 13.7 10.7 15.5 12.1 6.2 8.9 1.6 0.5 2.2 0.6 11.4 6.2 5.1 75.0 7.9 0.0 11.8 2.2 8.3 5.8 25.0 1.5 5.4 0.0 6.9 0.9 1.5 4.2 0.0 3.0 0.7 1.6 7.5 2.5 0.0 3.1 0.6 0.0 1.7 0.0 4.9 4.3 5.1 2.9 0.4 7.8 6.9 0.0 1.2 10.9 3.9 0.3 2.9 0.0 2.7 1.6 FAM49A "DKFZP566A1524, FLJ11080" ENSG00000197872 "Family with sequence similarity 49 member A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.8;brain: 39.5" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.0;Kupffer cells: 96.6;monocytes: 191.2;Syncytiotrophoblasts: 125.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.3;HUVEC TERT2: 18.6;RH-30: 41.7;SK-BR-3: 12.2;TIME: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB017847: , HPA060398: AB_2684275" "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (4.46e-4)" 10.8 9.1 22.7 15.6 28.0 15.3 7.0 6.6 39.5 13.7 5.3 7.0 1.2 2.9 8.2 2.1 4.3 6.2 8.7 3.3 17.2 14.1 1.9 6.1 9.6 13.4 10.2 25.2 10.0 2.4 1.1 4.8 15.3 9.9 6.9 5.3 2.9 3.2 7.3 6.0 2.9 4.6 8.6 6.0 20.1 3.4 1.8 6.3 1.9 31.8 1.1 13.6 7.7 7.4 8.9 15.5 45.8 34.4 13.4 5.3 8.5 0.2 0.0 2.6 0.1 2.8 0.8 7.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.8 1.6 0.6 1.0 0.0 2.8 0.1 1.6 0.0 0.0 1.4 0.0 23.3 1.3 1.0 0.2 0.0 2.1 18.6 0.0 0.1 2.0 1.6 0.1 0.0 5.4 1.1 0.1 0.0 0.9 41.7 0.1 2.2 10.3 0.4 1.5 0.0 12.2 0.0 3.4 0.4 0.7 14.5 0.2 2.4 0.0 0.0 1.2 0.0 1.4 6.1 1.2 0.8 0.0 23.6 31.4 5.3 29.8 0.6 8.9 0.2 2.7 15.5 6.1 0.2 2.1 45.8 13.4 34.4 7.7 0.1 8.5 22.7 28.0 6.6 33.3 17.2 14.1 10.2 25.2 9.9 6.3 3.0 17.3 26.5 17.4 10.0 3.2 1.4 0.0 1.4 9.1 0.0 2.0 40.6 0.0 2.9 0.8 6.0 0.0 23.3 0.8 90.0 12.5 8.1 11.5 1.0 31.7 0.0 0.0 29.4 96.6 0.0 2.0 70.2 28.7 191.2 0.0 22.8 0.2 0.0 1.8 0.0 2.4 12.9 14.1 0.0 2.1 7.3 125.4 11.7 0.0 24.3 FAM57B DKFZP434I2117 ENSG00000149926 "Family with sequence similarity 57 member B" Q71RH2 16 30024427-30052978 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;retina: 20.8;testis: 51.7" "Group enriched" "Detected in some" 6 "Bipolar cells: 45.7;Cone photoreceptor cells: 170.8;Early spermatids: 100.4;Late spermatids: 48.9;Rod photoreceptor cells: 171.7;Spermatocytes: 57.2" "Cancer enriched" "Detected in some" 5 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 8.2;SCLC-21H: 44.0;SH-SY5Y: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.31e-2)" "unprognostic (9.72e-4)" "unprognostic (7.78e-3)" "unprognostic (1.13e-1)" "unprognostic (8.06e-2)" "unprognostic (2.45e-1)" "unprognostic (1.54e-2)" "unprognostic (9.72e-2)" "unprognostic (2.60e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (4.51e-2)" "unprognostic (2.40e-11)" "unprognostic (1.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.09e-3)" 1.2 3.8 12.0 1.4 14.2 2.6 1.5 36.4 35.7 1.1 1.3 1.7 0.0 1.5 1.2 1.1 1.5 1.3 1.2 1.2 11.8 7.9 1.2 1.2 1.2 1.6 7.6 9.5 1.2 1.3 1.2 10.4 1.2 29.4 1.3 1.3 20.8 1.4 1.2 13.9 1.5 1.3 1.2 3.9 1.2 1.4 51.7 2.8 0.0 1.2 1.8 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.3 1.6 0.7 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 1.1 0.5 0.0 0.0 0.2 0.3 0.1 0.0 0.4 1.3 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 4.7 0.0 4.7 0.1 0.3 1.3 0.3 8.2 0.1 0.4 3.4 0.6 0.5 0.0 0.0 44.0 16.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.2 0.2 0.2 4.3 0.1 0.1 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.0 14.2 36.4 35.7 11.8 7.9 7.6 9.5 29.4 2.8 0.0 0.0 0.0 0.2 0.1 45.7 0.6 0.0 0.0 0.0 0.0 170.8 0.0 0.0 0.0 100.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 15.9 0.0 0.0 0.3 48.9 2.6 0.0 0.0 0.0 0.0 15.2 0.2 0.0 1.1 0.0 171.7 0.0 0.3 57.2 1.7 0.0 0.0 0.0 0.0 0.1 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favorable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.3 4.8 2.0 4.8 7.5 14.1 2.4 13.6 28.1 7.7 15.7 2.7 0.9 14.8 2.5 25.0 15.4 5.6 0.3 10.2 12.8 5.9 4.8 0.5 3.8 6.9 2.7 1.3 0.9 8.4 8.2 17.0 3.9 13.1 0.1 9.1 5.2 15.7 9.7 1.6 4.9 1.2 3.5 7.3 1.9 4.4 14.5 4.5 1.1 4.5 4.9 3.8 3.8 3.8 5.0 4.6 1.8 0.4 0.5 9.1 7.0 17.7 4.8 23.8 22.7 17.3 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 0.0 2.4 9.3 3.5 10.1 1.3 3.6 7.6 10.7 1.2 5.2 2.0 25.6 3.3 1.6 1.5 3.0 1.3 0.0 2.1 4.9 9.9 3.7 0.0 13.2 3.7 7.9 0.0 4.9 3.7 2.3 0.9 2.2 6.8 16.2 3.2 0.7 2.8 0.0 7.1 4.4 1.3 0.0 9.2 0.7 1.6 8.2 21.2 5.7 2.5 1.8 FAM69C C18orf51 ENSG00000187773 "Family with sequence similarity 69 member C" Q0P6D2 18 74434099-74457944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;heart muscle: 10.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 197.8" "Group enriched" "Detected in some" 18 "glioma: 11.1;melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-MEL-30: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048928 Enhanced NA NA "HPA048928: AB_2680560" "unprognostic (6.35e-2)" "unprognostic (1.13e-2)" "unprognostic (8.09e-2)" "unprognostic (3.32e-2)" "unprognostic (4.08e-2)" "unprognostic (3.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (8.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.10e-2)" "unprognostic (1.91e-4)" "unprognostic (2.16e-1)" "unprognostic (6.73e-2)" "unprognostic (3.23e-2)" "unprognostic (4.40e-3)" 1.1 0.9 13.8 0.7 20.5 0.6 1.1 3.5 29.1 3.4 1.0 9.5 0.0 0.7 0.9 0.8 0.8 1.0 1.3 10.8 11.0 9.0 0.8 1.1 0.6 0.7 15.5 5.2 0.7 0.9 0.8 0.1 0.9 9.9 1.1 0.9 3.7 0.9 1.7 2.3 7.0 0.9 0.9 5.3 0.8 3.0 7.3 18.8 0.0 0.8 0.0 0.7 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 20.5 3.5 10.3 11.0 9.0 15.5 5.2 9.9 18.8 0.0 0.0 0.0 0.0 1.1 1.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.4 38.1 0.0 2.5 0.8 2.0 0.0 0.0 30.4 0.0 0.0 197.8 0.8 0.0 0.0 0.0 3.7 12.9 1.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 FAM71A FLJ32796 ENSG00000162771 "Family with sequence similarity 71 member A" Q8IYT1 1 212624474-212626778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 149 "testis: 57.1" "Group enriched" "Detected in many" 135 "Early spermatids: 1249.7;Late spermatids: 344.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;SK-BR-3: 1.6;U-266/70: 1.0" "Not detected" "Not detected" "HPA028462, HPA060344" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA028462: AB_10601904, HPA060344: " 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.8 0.5 0.0 0.0 2.5 0.0 3.4 0.0 0.0 2.0 0.0 0.4 1249.7 0.1 0.5 0.0 1.1 1.5 0.4 2.9 1.1 0.0 1.2 0.0 1.2 3.1 0.0 344.8 4.9 1.0 0.0 0.0 2.6 0.3 1.0 0.9 2.5 0.0 0.0 0.0 0.9 3.6 1.8 0.1 2.4 0.0 1.7 0.6 FAM71D C14orf54 ENSG00000172717 "Family with sequence similarity 71 member D" Q8N9W8 14 67189393-67228550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 42.6" "Group enriched" "Detected in many" 16 "Early spermatids: 196.4;Late spermatids: 192.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 2.5;U-2 OS: 4.1;U-937: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.58e-2)" "unprognostic (8.05e-4)" "unprognostic (2.34e-2)" "unprognostic (2.86e-1)" "unprognostic (5.80e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (6.62e-2)" "unprognostic (5.01e-1)" "unprognostic (6.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.96e-5)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (8.85e-2)" "unprognostic (5.01e-5)" 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 1.8 2.0 0.7 0.9 0.9 0.1 0.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.2 0.6 0.0 0.0 0.6 0.4 2.5 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.6 0.7 0.0 0.7 0.0 0.0 1.6 1.0 0.0 0.7 0.3 0.0 0.8 0.0 0.4 0.5 0.0 0.0 1.0 4.1 0.3 0.5 0.9 1.1 0.2 0.6 3.1 0.0 0.1 0.7 0.0 0.9 0.3 0.0 0.4 0.2 0.2 0.2 0.4 0.7 0.6 2.0 0.9 0.3 1.8 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.2 2.9 0.0 1.8 0.0 12.0 5.7 0.0 0.0 3.7 0.0 7.6 196.4 0.8 5.4 0.0 6.5 2.8 1.7 0.1 10.4 0.9 2.6 0.0 9.9 1.3 1.2 192.4 3.4 2.5 0.0 8.2 9.0 0.4 7.7 7.0 0.7 0.2 0.7 0.0 1.4 2.3 1.5 1.9 3.7 1.7 8.5 0.1 FAM71E1 ENSG00000142530 "Family with sequence similarity 71 member E1" Q6IPT2 19 50466785-50476753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.0" "Group enriched" "Detected in many" 54 "Early spermatids: 1823.2;Late spermatids: 2935.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 17.3" "Low region specificity" "Detected in many" HPA048111 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA048111: " "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (8.19e-2)" "unprognostic (7.61e-2)" "unprognostic (1.99e-1)" "unprognostic (5.45e-3)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.35e-7)" "unprognostic (7.26e-2)" "unprognostic (1.45e-1)" "unprognostic (1.32e-1)" "unprognostic (2.37e-2)" 0.5 1.3 4.3 0.9 5.4 0.5 1.3 3.6 4.3 2.0 1.3 0.0 7.1 2.2 0.9 3.6 1.2 2.7 2.1 1.6 3.1 5.0 2.3 3.6 3.5 0.5 5.5 2.8 2.6 5.6 1.4 10.9 1.1 1.5 1.9 0.8 0.6 7.4 4.7 4.6 1.3 1.8 0.5 2.1 0.7 1.9 36.0 0.5 1.5 3.6 4.6 0.7 0.8 0.3 2.4 2.3 1.6 0.9 3.6 3.5 0.8 2.4 1.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.3 0.4 0.0 0.1 0.6 3.7 0.0 0.9 0.0 0.2 17.3 0.0 0.9 0.0 2.9 0.1 2.2 0.8 1.9 0.2 0.4 0.2 0.0 1.2 0.6 1.2 0.0 3.3 0.6 0.0 0.0 4.3 2.6 1.8 0.3 1.0 1.1 3.2 4.0 1.0 1.2 4.2 0.5 1.1 3.2 1.2 0.0 0.0 1.1 0.2 0.3 0.9 1.8 0.1 0.0 0.0 0.2 0.8 0.9 1.6 2.3 0.1 3.5 1.4 2.2 1.3 0.2 2.4 2.3 3.0 0.7 3.6 0.5 2.3 0.2 0.8 4.3 5.4 3.6 4.3 3.1 5.0 5.5 2.8 1.5 0.5 0.0 0.3 0.0 2.8 0.6 4.7 1.7 0.0 2.7 0.0 3.5 0.0 5.6 10.0 3.2 1823.2 0.6 1.3 0.0 4.8 3.2 0.9 3.6 0.0 1.5 1.6 4.8 2.9 1.8 0.0 2935.1 15.8 0.6 0.0 2.8 4.6 7.4 2.6 2.3 14.2 11.9 5.8 19.4 0.4 44.4 24.9 2.0 11.7 0.0 3.3 3.5 FAM71E2 "C19orf16, DKFZp434G1729" ENSG00000180043 "Family with sequence similarity 71 member E2" Q8N5Q1 19 55354908-55363260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 103 "testis: 41.0" "Group enriched" "Detected in some" 16 "Early spermatids: 3.6;Late spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 4.4" NA NA "unprognostic (5.97e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 146 "testis: 64.8" "Group enriched" "Detected in some" 103 "Early spermatids: 1001.4;Late spermatids: 1429.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "NTERA-2: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020636 Uncertain Cytosol No NA Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 1.5 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1001.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1429.0 11.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.3 0.0 1.8 0.0 0.0 11.7 5.5 0.1 1.0 0.0 0.0 0.0 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 28.1" "Group enriched" "Detected in many" 7 "Early spermatids: 138.1;Late spermatids: 512.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020513: AB_1853077, HPA024248: AB_2671497" "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 1.1 0.7 0.7 1.2 1.3 0.7 1.8 1.1 0.7 0.7 0.7 0.7 0.4 0.7 1.6 0.7 0.5 0.8 0.9 0.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.2 2.5 0.7 0.7 0.9 0.5 0.7 1.6 0.7 1.6 1.3 0.7 1.0 0.7 1.2 1.0 28.1 0.7 0.7 0.9 0.7 0.7 0.7 0.7 1.4 1.3 4.2 0.8 1.2 0.9 0.2 0.8 1.3 1.5 2.9 2.6 2.0 0.7 1.7 0.4 0.4 1.0 0.3 1.4 0.9 0.8 2.8 1.0 2.0 0.2 0.7 0.7 0.9 1.3 0.5 2.7 0.2 0.7 0.7 1.9 1.7 0.7 3.0 0.5 2.0 0.4 0.9 0.4 1.4 1.2 1.3 0.4 1.4 0.9 0.3 1.9 1.1 0.3 0.4 1.0 3.5 1.2 0.8 0.7 0.8 2.2 1.9 1.1 0.4 4.3 1.9 0.7 3.9 1.6 2.9 2.5 0.9 1.0 1.2 1.3 3.9 0.8 0.6 0.5 0.4 0.5 0.8 0.6 0.5 0.3 1.4 0.6 0.6 4.2 1.2 0.5 1.3 0.9 0.2 0.7 1.2 1.8 1.1 0.7 0.7 0.7 0.7 0.7 0.7 3.0 2.1 0.0 1.4 0.0 12.1 1.1 0.0 0.0 0.0 3.5 49.1 0.4 0.0 1.3 138.1 0.7 0.3 0.0 0.6 0.7 0.8 1.6 2.3 0.6 0.8 0.0 1.2 1.8 2.2 512.3 3.7 0.2 0.0 1.0 1.3 2.9 1.0 1.5 2.8 0.0 17.9 0.0 0.9 10.2 2.7 0.1 2.1 0.0 1.4 0.8 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 4.7;Spermatocytes: 14.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 12.0 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.4 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 20.0 10.3 0.6 0.4 5.9 12.0 1.9 4.5 22.2 15.0 16.4 5.4 5.0 10.0 16.5 13.9 6.5 9.1 15.0 15.9 12.2 2.9 1.4 8.0 4.6 4.8 3.8 3.7 7.9 5.0 15.6 1.5 6.2 10.5 12.0 11.3 14.6 18.2 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 0.0 0.0 3.7 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.7 1.0 1.7 0.0 0.2 1.9 0.5 0.0 0.0 0.0 0.9 0.0 0.0 3.1 0.6 1.2 0.6 0.7 0.0 3.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 14.9 3.4 0.9 0.1 1.0 0.4 0.0 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145096000-145112696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Cell type enhanced" "Detected in some" 22 "Extravillous trophoblasts: 4.6;Spermatocytes: 17.9;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 1.1 0.7 0.8 7.2 0.8 5.5 0.7 4.0 0.9 0.6 1.1 0.6 0.4 1.4 0.8 0.4 4.4 0.2 0.5 0.4 1.0 0.7 0.5 0.4 1.3 7.6 1.0 0.4 0.4 0.4 0.3 0.4 1.5 0.8 0.4 1.6 0.4 0.6 0.4 0.4 2.9 2.0 0.5 1.1 3.3 0.8 6.7 0.4 17.7 0.4 2.7 7.4 1.1 2.5 0.1 0.7 0.1 1.7 0.0 1.0 0.5 8.4 5.1 6.0 2.4 0.2 0.5 6.6 4.8 1.4 6.1 3.8 3.4 7.6 13.8 4.9 0.7 5.5 8.9 7.3 1.4 7.2 11.0 7.3 6.9 2.5 5.0 0.1 12.2 7.7 0.3 0.5 4.8 9.3 1.0 2.7 16.7 13.6 19.2 4.0 6.3 8.3 11.9 11.5 10.5 7.1 7.3 7.6 16.2 2.1 1.1 5.9 5.0 3.7 3.3 2.2 7.9 9.3 7.9 1.2 4.5 5.0 3.8 8.6 14.6 22.8 21.4 0.0 9.8 5.1 0.0 1.2 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.8 0.8 4.0 0.9 1.0 0.7 1.0 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.5 0.0 0.0 0.0 4.6 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.0 1.2 1.7 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 17.9 4.1 0.9 0.2 0.5 0.1 0.0 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725979-27763122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 122.7;Late spermatids: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: AB_2686867" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favorable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 22.1 8.6 10.6 12.2 17.2 14.3 14.1 17.9 18.3 14.7 12.8 17.4 8.4 10.2 15.9 16.6 13.9 13.8 15.3 13.8 11.3 11.4 13.7 13.8 13.1 11.3 9.5 16.1 14.6 14.4 11.7 19.5 12.8 14.3 12.9 16.2 15.7 12.4 16.8 39.7 15.4 12.1 17.8 11.9 12.1 13.8 28.5 10.9 13.6 18.7 17.8 13.8 14.0 14.1 13.6 14.6 13.7 12.2 12.0 16.0 6.4 8.8 7.1 8.1 8.4 10.3 9.0 14.7 8.3 8.7 12.3 12.1 8.1 11.9 16.1 5.4 9.2 11.6 11.7 10.2 9.1 9.6 8.3 7.7 5.0 10.0 9.5 8.3 7.9 7.8 9.1 9.9 13.4 13.6 6.2 6.1 8.7 9.4 15.2 8.8 8.5 18.7 7.3 12.8 8.5 7.1 11.4 9.7 9.1 9.7 12.7 11.8 5.3 9.5 10.3 9.9 10.4 7.4 3.1 6.5 14.6 6.3 16.8 5.7 13.9 15.1 13.2 9.0 10.4 6.2 10.0 12.2 13.7 14.7 12.1 15.6 12.2 15.3 14.0 10.4 13.6 14.5 16.0 8.3 12.0 12.1 14.6 11.3 6.4 10.6 17.2 17.9 18.3 11.3 11.4 9.5 16.1 14.3 10.9 26.8 17.1 25.3 8.5 16.9 27.1 13.2 7.6 26.8 9.1 22.7 25.5 23.1 18.3 9.7 122.7 11.3 8.6 23.3 8.5 9.5 13.4 4.4 10.5 15.3 10.5 27.0 4.1 20.9 15.6 84.8 15.5 14.5 37.1 7.2 9.5 20.5 8.4 8.5 35.0 12.4 35.8 19.4 17.9 20.0 49.8 23.6 38.0 17.8 8.5 3.9 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276547 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.7;skeletal muscle: 32.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 4.9 1.5 2.9 9.3 4.6 12.4 2.5 1.1 4.3 1.0 1.6 3.4 0.8 1.8 1.2 1.1 1.1 1.1 2.0 19.2 3.8 2.0 2.1 2.5 8.0 18.4 4.3 1.0 1.8 0.8 0.8 1.0 5.8 3.2 1.3 1.1 5.4 2.7 0.7 32.3 0.8 6.1 1.2 3.6 15.9 2.3 20.1 2.4 23.7 1.5 1.8 15.0 3.1 0.8 14.4 5.2 14.5 10.9 2.5 10.5 6.9 0.3 0.1 1.1 2.6 0.8 0.2 18.5 0.2 0.1 0.2 0.1 0.1 0.1 7.7 0.1 0.1 0.3 0.0 7.4 0.1 0.0 1.9 0.6 17.4 0.2 0.1 0.3 17.2 0.8 0.2 0.4 0.0 0.0 0.2 10.3 5.0 6.1 2.2 0.2 2.6 0.7 27.2 1.2 0.1 0.3 1.8 1.1 10.7 0.1 0.0 0.7 0.9 1.0 0.3 1.0 0.4 0.6 24.3 0.3 1.1 1.2 0.6 0.0 1.6 0.8 4.4 0.1 16.3 0.2 0.4 8.6 14.5 8.6 10.9 6.8 12.5 8.3 9.3 5.2 14.4 10.5 8.7 8.8 2.5 8.1 2.4 8.2 6.9 2.9 4.6 1.1 4.3 3.8 2.0 4.3 1.0 3.2 2.4 0.0 1.0 24.3 0.0 0.8 57.8 12.8 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 73.4 3.1 0.0 0.0 0.0 28.2 1.3 0.0 1.1 0.0 22.1 0.0 0.0 3.7 14.3 101.2 4.6 10.1 1.7 5.4 0.0 0.8 0.2 0.0 3.2 0.0 1.7 0.0 0.5 1.2 0.4 0.6 1.1 14.4 0.0 0.1 FAM78B ENSG00000188859 "Family with sequence similarity 78 member B" Q5VT40 1 166057426-166166969 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 82.5;Horizontal cells: 77.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HDLM-2: 12.4;SK-MEL-30: 11.2;U-2 OS: 3.0;WM-115: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052789, HPA073246" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA052789: AB_2681949, HPA073246: AB_2686588" "unprognostic (7.38e-3)" "unprognostic (1.14e-3)" "unprognostic (7.96e-2)" "unprognostic (3.16e-2)" "unprognostic (3.77e-2)" "unprognostic (3.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-3)" "unprognostic (3.25e-2)" "unprognostic (1.69e-3)" "unprognostic (3.87e-2)" "unprognostic (1.87e-11)" "unprognostic (7.41e-2)" "unprognostic (2.09e-1)" "unprognostic (5.41e-2)" "unprognostic (2.69e-2)" 3.3 1.5 5.1 2.7 6.4 1.4 3.1 8.6 10.5 3.6 2.8 1.0 0.3 3.5 3.6 1.1 1.6 1.1 2.3 3.2 2.4 1.1 2.7 2.8 1.6 1.8 1.1 3.1 2.1 5.2 1.1 3.5 1.4 2.1 1.8 1.1 5.7 2.2 1.3 3.1 2.0 1.6 1.1 1.2 2.2 3.6 3.7 1.5 0.0 1.7 1.7 1.3 2.7 2.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.3 0.1 0.6 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.8 0.5 0.0 0.2 11.2 0.0 0.3 0.4 0.2 0.7 3.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 6.4 8.6 10.5 2.4 1.1 1.1 3.1 2.1 1.5 0.0 1.7 0.0 0.4 0.5 11.9 9.8 2.5 0.0 0.0 0.0 82.5 0.0 1.7 0.6 1.4 0.7 0.0 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.0 77.9 0.0 0.6 0.3 1.8 1.1 0.0 1.7 1.0 0.4 2.0 0.3 0.0 0.7 1.2 13.4 0.0 0.3 0.5 2.1 0.1 0.0 0.0 0.9 0.1 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 29.6;Horizontal cells: 9.5;Melanocytes: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Cell line enriched" "Detected in many" 4 "Daudi: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.8 8.5 0.6 0.1 0.2 0.1 3.5 0.3 0.0 0.6 1.7 1.0 1.0 37.3 0.2 0.1 8.2 4.5 4.8 1.4 1.1 0.4 2.5 0.0 5.7 0.3 0.0 3.1 0.8 0.0 0.9 0.2 0.4 0.4 0.0 1.5 0.1 0.0 0.5 2.0 0.0 0.1 0.5 1.5 3.1 0.8 8.6 0.9 1.9 2.1 1.8 0.5 3.4 0.1 5.5 0.4 1.5 1.9 0.2 1.4 4.4 1.7 6.3 0.0 0.0 0.4 1.4 1.2 3.9 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 0.0 2.2 1.9 0.9 0.5 0.0 6.2 0.0 6.7 1.2 29.6 0.0 0.1 5.0 0.4 0.4 0.6 0.7 0.0 0.2 1.1 0.4 2.1 1.1 0.0 1.1 9.5 1.2 0.0 0.3 0.4 0.3 0.7 8.5 0.0 0.9 1.0 0.3 1.9 0.0 0.1 0.1 0.0 0.9 0.1 1.3 0.4 0.0 0.0 3.7 0.9 FAM84A "FLJ35392, NSE1" ENSG00000162981 "Family with sequence similarity 84 member A" Q96KN4 2 14632686-14650814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.0" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 143.9;Mucus-secreting cells: 133.7;Syncytiotrophoblasts: 173.8;Undifferentiated cells: 210.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.1;hTCEpi: 12.0;RT4: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047703 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047703: AB_2680123" "unprognostic (1.05e-2)" "unprognostic (9.22e-2)" "unprognostic (2.24e-3)" "unprognostic (1.13e-1)" "unprognostic (4.28e-2)" "unprognostic (7.38e-2)" "unprognostic (2.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-1)" "unprognostic (4.44e-2)" "unprognostic (1.20e-1)" "unprognostic (9.27e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-1)" "unprognostic (1.58e-1)" "unprognostic (5.57e-3)" "unprognostic (1.36e-1)" 0.9 1.8 22.0 9.1 14.8 0.6 2.7 3.1 31.8 9.9 34.0 1.7 0.9 22.4 3.0 29.0 22.6 2.8 5.6 2.1 7.7 7.7 3.3 1.8 5.6 0.8 3.6 11.2 7.9 3.3 2.0 3.0 5.9 2.4 11.1 31.9 1.6 15.9 2.5 1.3 14.4 21.3 3.0 2.5 0.8 3.0 20.0 3.9 0.6 2.2 10.4 3.8 9.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 1.6 0.4 0.3 0.0 0.2 0.0 0.0 0.2 0.0 6.1 0.6 2.7 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 12.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.8 4.9 0.0 0.1 0.5 0.0 2.6 0.0 0.0 0.1 4.6 31.9 2.8 1.3 0.0 1.2 0.0 0.2 0.0 0.0 1.9 5.5 0.4 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 14.8 3.1 31.8 7.7 7.7 3.6 11.2 2.4 3.9 0.0 1.4 2.4 19.6 10.0 1.7 1.5 2.5 8.1 5.7 29.6 0.0 143.9 10.0 2.2 8.0 14.9 93.2 0.0 6.4 16.6 4.4 47.3 10.3 0.9 10.6 0.0 47.6 30.7 3.8 9.6 4.6 1.1 6.8 1.0 133.7 13.7 5.4 57.5 2.8 0.8 1.1 0.0 11.3 0.5 0.9 23.1 173.8 1.7 210.4 69.9 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 5.8" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.9 2.0 3.2 1.0 6.9 1.2 0.7 4.8 7.5 0.8 0.5 2.2 4.0 1.3 1.2 2.8 1.3 1.1 3.3 4.1 1.3 0.1 1.2 0.7 2.8 5.0 0.9 2.0 5.4 0.3 2.6 0.0 2.4 1.0 2.0 3.0 0.7 0.1 2.3 1.4 0.3 0.6 2.6 0.0 0.8 1.1 0.2 0.6 0.9 0.1 0.0 0.8 0.2 0.5 2.9 0.0 5.8 0.0 0.7 2.5 4.7 0.3 1.1 0.7 1.6 1.3 1.0 0.2 0.2 1.1 4.9 1.0 0.8 0.8 0.5 0.8 0.2 0.7 0.8 3.1 2.0 2.2 0.3 0.5 0.5 1.4 1.3 0.2 2.4 1.6 1.6 0.2 2.7 0.0 1.3 1.9 0.6 0.5 1.5 1.0 0.7 0.3 1.3 4.7 1.0 0.9 0.5 0.6 0.4 2.2 0.0 0.0 1.0 0.9 4.0 1.6 0.6 1.4 0.6 0.8 0.1 0.8 0.8 0.1 0.7 0.1 0.0 0.7 0.2 0.8 0.5 0.3 0.0 0.6 0.7 0.9 0.0 0.0 0.6 0.4 0.2 3.0 2.6 0.8 2.5 1.0 2.6 0.4 5.1 10.7 4.5 1.8 2.0 1.3 5.0 3.9 4.4 1.1 0.5 0.0 1.6 1.2 2.9 2.2 1.1 0.8 1.9 1.6 4.1 1.8 1.9 4.0 1.7 1.1 3.3 0.0 1.2 2.3 2.9 0.0 2.5 6.8 1.2 0.0 2.1 0.9 0.7 1.1 0.9 0.0 2.0 1.3 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 10.9 11.9 1.4 6.9 1.5 5.2 6.1 6.4 5.4 6.3 6.7 2.0 8.0 10.0 7.2 3.7 2.2 5.3 2.7 4.6 1.0 16.1 5.6 3.2 2.0 4.6 6.8 2.8 6.0 5.0 9.6 3.2 5.8 3.5 3.7 16.4 9.0 11.0 3.7 12.1 4.0 2.1 1.0 18.2 12.8 8.3 2.9 5.9 7.7 5.8 2.4 7.1 6.4 11.4 3.8 0.7 8.6 8.7 4.8 2.8 7.8 8.8 7.6 11.9 6.0 4.2 7.4 6.5 4.5 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 8.9 9.9 17.1 21.7 19.2 13.2 4.3 10.2 6.7 5.7 22.7 11.8 10.3 18.3 17.4 5.0 9.3 43.8 0.0 28.7 9.4 10.0 14.8 15.0 11.9 9.9 11.1 24.6 10.4 10.5 2.1 17.3 14.7 21.9 12.6 32.7 11.1 19.7 34.5 17.3 15.9 11.6 12.9 11.4 27.3 41.1 26.1 5.1 20.3 33.5 22.0 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 53.0" "Group enriched" "Detected in some" 88 "Early spermatids: 499.8;Late spermatids: 668.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Cell line enhanced" "Detected in some" "CACO-2: 4.8;Daudi: 1.5;HEL: 2.5;MCF7: 2.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA076166 Approved Vesicles NA NA Vesicles "HPA076166: " "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 8.4 1.6 0.4 0.4 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 0.6 1.5 0.7 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.3 0.0 0.1 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.2 0.1 0.0 1.2 0.6 0.3 0.9 0.6 0.4 0.5 0.3 0.3 0.4 0.2 0.4 0.2 0.1 0.8 0.3 0.3 8.4 0.4 1.6 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.8 0.0 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 668.2 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 5.1 2.4 0.0 0.0 0.0 0.0 0.0 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92352096-92896470 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;seminal vesicle: 6.0" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.2;Collecting duct cells: 14.0;Peritubular cells: 7.1;Spermatogonia: 5.1" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.1;fHDF/TERT166: 2.4;NTERA-2: 2.7;SuSa: 2.6;U-2 OS: 2.3;U-251 MG: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026878 Uncertain NA NA "HPA026878: AB_1848430" "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.5 0.1 2.6 0.1 10.5 0.1 0.3 1.4 7.3 0.4 0.2 0.1 0.4 1.0 0.1 0.4 0.2 0.2 1.8 2.2 0.4 0.1 1.4 0.0 2.2 0.8 0.0 0.0 1.8 0.2 3.2 0.2 0.1 6.0 0.2 0.1 0.1 0.2 0.2 0.2 1.2 0.8 0.0 0.4 1.3 0.3 0.2 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.0 1.6 2.4 0.0 1.3 0.0 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.1 11.2 1.2 0.0 0.0 0.0 14.0 0.0 0.1 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 7.1 0.0 0.9 0.0 3.3 0.4 5.1 0.0 0.0 0.0 0.0 0.0 FAXC "C6orf168, dJ273F20, MGC2817" ENSG00000146267 "Failed axon connections homolog" Q5TGI0 6 99271169-99350062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 17.5;Bipolar cells: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 16.2;HAP1: 14.5;SCLC-21H: 21.3;SH-SY5Y: 14.8;SK-MEL-30: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039106 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039106: AB_10697546" "unprognostic (8.03e-2)" "unprognostic (4.91e-2)" "unprognostic (5.04e-3)" "unprognostic (6.44e-2)" "unprognostic (3.80e-1)" "unprognostic (5.00e-3)" "unprognostic (7.56e-2)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (2.47e-3)" "unprognostic (6.70e-4)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.86e-2)" "unprognostic (3.49e-3)" 0.7 3.3 9.4 2.1 12.2 0.4 4.6 11.0 19.7 1.8 13.3 1.8 5.1 2.3 4.5 15.3 8.6 2.4 3.5 1.3 7.7 10.3 2.5 0.3 2.3 0.4 9.1 9.9 3.4 2.2 9.3 10.4 1.4 7.5 10.1 4.3 1.4 5.8 15.1 0.9 0.4 2.1 19.1 4.8 0.8 5.2 2.8 1.6 0.0 2.0 0.2 0.5 13.6 1.7 1.2 0.6 1.4 0.6 0.8 0.4 0.0 2.3 1.9 6.4 8.8 0.0 0.0 2.3 3.0 1.9 5.0 4.4 1.1 0.7 0.0 0.3 0.6 16.2 0.1 14.5 2.8 4.4 0.0 7.2 0.0 1.2 0.4 0.4 0.0 0.0 0.3 4.6 0.1 2.3 3.7 0.0 1.2 0.3 0.0 1.6 4.1 0.0 0.0 7.5 0.0 2.9 0.0 0.6 0.0 2.7 0.1 21.3 14.8 2.7 2.0 13.0 2.7 6.1 0.0 0.6 1.6 2.9 0.0 9.2 0.0 0.0 0.0 0.1 0.0 11.9 0.8 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.2 1.2 0.3 0.4 1.4 0.8 0.3 0.6 0.2 0.0 9.4 12.2 11.0 17.4 7.7 10.3 9.1 9.9 7.5 1.6 23.8 17.5 0.0 3.4 0.3 12.6 0.8 0.0 2.7 10.3 1.8 9.8 0.8 8.3 1.7 2.1 0.6 0.0 0.0 0.6 0.1 0.4 4.1 3.5 0.0 0.2 3.2 0.0 1.3 0.8 3.6 0.0 0.4 1.7 0.0 0.2 3.1 1.3 0.0 1.8 0.8 11.6 0.0 0.7 0.9 9.0 0.3 0.2 0.0 0.2 1.0 FAXDC2 "C5orf4, FLJ13758" ENSG00000170271 "Fatty acid hydroxylase domain containing 2" Q96IV6 5 154818491-154859252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.9;parathyroid gland: 112.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 38.7;Leydig cells: 43.7;Muller glia cells: 45.6;Peritubular cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 21.4;ASC TERT1: 16.1;HSkMC: 14.3;hTERT-RPE1: 15.3;SK-MEL-30: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.38e-3)" "unprognostic (2.88e-2)" "unprognostic (6.26e-2)" "unprognostic (5.11e-2)" "unprognostic (3.12e-2)" "unprognostic (2.70e-2)" "prognostic favorable (3.87e-5)" "unprognostic (8.29e-2)" "unprognostic (2.52e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (3.42e-2)" "prognostic favorable (9.71e-10)" "unprognostic (1.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.07e-3)" "unprognostic (3.94e-1)" 15.9 15.7 14.5 2.9 25.1 12.2 12.9 7.7 31.6 11.9 19.9 77.9 6.7 4.1 14.9 23.7 7.7 16.8 12.7 13.7 19.8 12.3 11.2 55.3 15.3 3.4 29.0 15.3 25.8 6.7 112.1 6.6 5.7 35.9 12.6 8.1 25.6 16.7 14.1 5.0 10.1 7.2 16.9 38.7 5.6 9.0 8.8 33.6 0.0 29.7 5.6 3.1 11.4 8.3 1.9 1.4 6.7 1.2 4.3 0.9 8.8 0.9 0.8 3.0 6.1 21.4 16.1 2.4 2.1 6.2 0.9 3.9 0.8 7.8 1.1 1.3 3.7 0.2 0.8 0.0 1.0 0.8 0.6 0.9 11.8 1.9 4.6 3.2 1.6 1.1 14.3 4.1 2.1 0.5 15.3 4.7 0.8 7.0 0.4 5.3 0.3 1.0 2.4 1.4 2.9 0.2 1.0 2.0 0.4 1.5 0.9 0.3 5.2 0.9 0.5 13.4 6.8 0.4 0.4 1.7 2.2 1.3 0.9 0.6 0.9 0.6 0.7 2.9 0.9 1.3 4.4 1.2 2.2 0.7 0.9 0.6 0.7 0.8 0.7 1.4 1.9 0.7 0.9 6.7 4.3 0.7 1.1 0.4 8.8 14.5 25.1 7.7 31.6 19.8 12.3 29.0 15.3 35.9 33.6 38.7 10.2 0.0 10.9 2.6 1.2 16.9 12.7 20.1 11.4 8.7 0.0 2.8 8.3 2.2 9.9 16.7 1.7 0.0 0.6 0.4 9.7 3.7 5.8 35.5 1.8 3.2 2.9 20.9 8.8 7.3 43.7 5.8 5.0 1.0 17.3 45.6 7.6 5.8 47.7 2.2 1.6 0.0 9.0 1.9 0.9 3.1 1.1 1.3 1.1 3.5 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188216 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4" "Lineage enriched" "Detected in single" 36 "T-cells: 18.5" "Cell line enhanced" "Detected in some" "AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" NA NA 27000 "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 7.5 5.8 2.9 9.0 3.4 1.1 10.4 10.3 16.4 12.4 2.3 1.6 4.1 1.7 6.5 8.2 2.9 10.5 7.1 3.3 4.0 3.8 2.5 6.6 3.7 11.8 6.9 4.2 2.8 3.4 16.7 27.4 13.6 10.5 4.7 2.0 14.7 3.9 9.0 1.9 7.1 3.8 3.2 2.2 7.3 4.1 2.0 1.1 8.7 14.9 5.5 9.5 3.6 10.4 0.0 0.5 0.0 0.0 0.0 18.5 3.5 0.0 0.1 17.5 0.0 1.9 1.4 0.0 3.8 12.5 4.2 6.6 0.0 0.1 0.0 0.1 5.7 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.8 0.9 0.0 0.0 1.3 0.1 7.0 0.0 9.2 1.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 4.4 0.2 0.0 11.3 9.0 0.0 0.0 0.5 0.1 0.5 0.1 3.6 0.6 0.5 18.1 0.5 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 18.5 0.2 0.0 0.0 16.2 0.5 0.0 0.0 0.0 0.5 17.4 3.5 2.9 3.4 10.3 16.4 4.0 3.8 6.9 4.2 10.5 1.1 3.0 0.3 0.0 0.7 3.9 3.7 0.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 1.9 2.1 0.0 0.0 0.2 5.9 4.7 0.4 1.1 1.0 0.4 3.2 0.0 0.6 0.0 1.7 0.3 0.0 16.9 0.0 0.0 2.2 0.4 0.0 4.9 0.5 7.2 6.5 4.7 0.1 0.2 3.3 1.3 4.4 0.0 0.3 FBN3 ENSG00000142449 "Fibrillin 3" Q75N90 19 8065402-8149846 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 5.2;salivary gland: 7.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.4;Cardiomyocytes: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 8.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 3.7;NTERA-2: 12.6;REH: 18.2;SuSa: 4.9" "Low region specificity" "Detected in many" HPA049482 Uncertain "Secreted to extracellular matrix" NA NA "HPA049482: AB_2680786" "unprognostic (9.66e-3)" "unprognostic (5.15e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (4.14e-2)" "unprognostic (5.14e-3)" "unprognostic (6.26e-2)" "unprognostic (4.10e-3)" "unprognostic (3.17e-2)" "unprognostic (8.94e-2)" "unprognostic (4.61e-2)" "unprognostic (1.53e-1)" "unprognostic (2.76e-2)" "unprognostic (1.34e-2)" "unprognostic (2.57e-1)" "unprognostic (1.17e-2)" "unprognostic (3.17e-1)" 0.2 0.0 1.0 0.2 1.2 0.0 0.5 0.2 2.4 0.2 0.2 2.8 0.2 0.0 0.7 0.2 0.5 1.8 0.2 0.2 1.0 1.1 3.6 0.5 5.2 0.2 2.4 0.2 0.8 0.2 0.0 1.9 0.2 2.1 1.7 0.3 0.2 7.5 0.2 0.9 0.6 0.3 0.3 2.0 0.2 0.1 1.1 1.7 0.8 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 12.6 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.2 2.4 1.0 1.1 2.4 0.2 2.1 1.7 6.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 FBXL13 "DRC6, Fbl13, MGC21636" ENSG00000161040 "F-box and leucine rich repeat protein 13" Q8NEE6 7 102813230-103074843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 23.2;testis: 24.8" "Group enriched" "Detected in many" 6 "Early spermatids: 149.2;Late spermatids: 321.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 46 "eosinophil: 6.2;neutrophil: 23.2" "Lineage enriched" "Detected in single" 73 "granulocytes: 23.2" "Cell line enhanced" "Detected in some" "HEL: 6.7;HUVEC TERT2: 12.7;U-266/84: 15.5;U-87 MG: 8.9;U-937: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA057232 Uncertain NA NA "HPA057232: AB_2683375" "unprognostic (1.46e-2)" "unprognostic (1.91e-1)" "unprognostic (6.73e-4)" "unprognostic (1.97e-2)" "unprognostic (1.69e-3)" "unprognostic (4.41e-2)" "unprognostic (2.31e-2)" "unprognostic (6.64e-2)" "unprognostic (7.81e-2)" "unprognostic (1.49e-1)" "unprognostic (7.72e-2)" "unprognostic (2.62e-1)" "unprognostic (1.33e-3)" "unprognostic (4.54e-2)" "unprognostic (1.25e-1)" "unprognostic (1.93e-2)" "unprognostic (1.47e-1)" 0.7 1.7 1.9 0.6 2.6 0.6 0.6 0.5 2.1 1.0 0.5 3.4 2.8 0.4 2.2 5.2 0.5 6.7 0.6 0.6 1.6 1.1 1.3 0.4 1.3 0.5 1.5 0.8 4.6 0.9 0.5 6.0 0.4 7.3 0.8 0.6 4.0 0.5 0.7 0.4 0.7 0.5 0.7 1.8 0.7 6.2 24.8 1.5 0.0 1.5 0.0 0.3 0.6 0.6 0.3 0.0 23.2 0.0 0.0 0.1 0.0 0.5 0.1 0.2 1.1 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.5 0.4 0.9 0.4 0.3 0.8 0.3 0.0 0.0 0.4 0.5 0.2 6.7 1.1 0.2 2.3 6.1 0.3 0.0 0.1 3.6 0.1 1.1 12.7 0.7 2.0 0.3 0.9 0.4 0.5 5.6 0.9 0.1 0.4 0.2 0.0 0.5 1.6 0.3 0.5 0.5 0.2 0.0 0.1 0.3 0.0 0.2 0.3 1.9 3.6 1.5 0.1 0.8 15.5 1.6 8.9 11.0 5.4 0.0 0.0 6.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 23.2 0.0 0.0 0.0 0.0 0.0 1.9 2.6 0.5 2.1 1.6 1.1 1.5 0.8 7.3 1.5 0.0 0.6 0.0 0.8 1.5 0.8 0.6 0.0 38.8 2.3 0.0 11.8 0.1 3.3 1.1 149.2 1.0 0.0 0.0 1.0 0.1 0.7 0.6 0.0 0.0 0.1 0.0 1.7 0.6 0.0 321.2 0.6 0.8 0.0 0.0 0.0 1.8 1.1 0.0 3.2 1.1 8.5 12.9 21.7 12.2 6.3 0.6 0.1 0.0 0.0 0.7 FBXL16 "C16orf22, Fbl16, MGC33974" ENSG00000127585 "F-box and leucine rich repeat protein 16" Q8N461 16 692498-705829 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 102.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 36.2;Collecting duct cells: 10.4;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 9 "T-cells: 3.3" "Cell line enhanced" "Detected in many" "AN3-CA: 13.0;GAMG: 8.7;MCF7: 10.5;SCLC-21H: 21.7;SH-SY5Y: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039504, HPA056354" Enhanced NA NA "HPA039504: AB_10794197, HPA056354: AB_2683105" "unprognostic (5.51e-2)" "unprognostic (3.39e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.58e-2)" "unprognostic (4.79e-3)" "unprognostic (1.83e-1)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.34e-5)" "unprognostic (1.62e-3)" "prognostic favorable (1.87e-4)" "unprognostic (1.90e-2)" "unprognostic (4.71e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-2)" 1.7 5.7 53.5 2.0 75.8 1.6 1.8 17.7 102.2 1.6 1.8 2.5 0.1 2.2 1.6 1.6 1.7 1.8 1.6 1.6 44.9 10.2 2.1 1.6 1.7 1.8 10.2 25.8 1.6 3.6 2.6 3.8 1.6 5.1 1.9 1.6 0.0 5.5 2.4 1.6 2.2 1.9 1.5 2.5 2.0 2.8 5.0 11.9 0.0 2.0 0.0 1.7 1.6 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.3 0.4 0.6 0.2 13.0 0.1 0.1 0.4 0.4 0.1 2.4 0.1 1.2 0.1 0.2 3.5 0.0 8.7 2.4 1.0 1.4 0.1 6.4 0.3 0.0 3.0 0.5 0.0 1.3 0.3 0.0 2.0 0.0 1.2 1.1 0.0 0.5 0.7 3.2 0.0 10.5 0.3 0.0 0.6 0.1 4.1 0.0 0.0 7.3 0.1 0.0 21.7 16.2 2.2 0.4 0.2 0.0 1.1 0.0 0.0 0.1 4.5 0.0 1.7 0.6 3.7 1.6 1.8 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.5 0.2 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 1.2 0.3 53.5 75.8 17.7 56.5 44.9 10.2 10.2 25.8 5.1 11.9 0.0 3.0 0.0 0.8 0.9 36.2 1.1 0.0 0.0 6.8 10.4 2.0 0.4 1.7 0.2 0.9 0.0 0.4 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.1 30.2 9.2 0.6 0.0 0.4 0.6 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 0.2 4.2 0.0 0.0 5.5 4.3 1.4 2.1 0.9 0.4 0.2 FBXL17 "DKFZP434C1715, Fbl17, Fbx13, FBXO13" ENSG00000145743 "F-box and leucine rich repeat protein 17" Q9UF56 5 107859035-108382098 "Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036410, HPA036411" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA036410: AB_2675109, HPA036411: AB_10669603" "unprognostic (8.15e-2)" "unprognostic (3.77e-2)" "unprognostic (2.18e-2)" "unprognostic (1.21e-1)" "unprognostic (4.58e-2)" "unprognostic (2.72e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-1)" "unprognostic (6.67e-2)" "unprognostic (3.08e-2)" "unprognostic (5.98e-2)" "unprognostic (6.30e-2)" "prognostic favorable (4.60e-8)" "unprognostic (1.86e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.35e-2)" 13.7 13.8 22.2 7.8 27.4 5.4 13.3 18.0 27.4 11.5 9.8 7.9 12.0 10.3 10.1 9.3 12.0 9.3 10.4 25.1 18.5 19.0 16.8 13.6 9.8 12.0 16.8 17.1 9.7 9.8 27.5 12.5 6.1 11.7 12.0 10.5 12.4 9.6 14.4 46.1 9.6 10.5 11.6 12.3 10.4 9.6 8.2 8.9 16.8 23.8 9.7 10.0 10.8 9.0 2.0 1.9 3.3 1.3 1.0 2.3 0.5 6.5 6.5 7.5 13.7 12.6 13.3 5.0 8.0 18.1 6.6 9.0 1.3 13.9 7.3 12.7 12.9 10.2 2.9 6.0 9.2 10.3 7.3 5.4 6.9 7.6 3.2 6.6 4.6 8.0 9.5 13.8 6.1 4.5 12.9 7.8 3.0 1.0 9.5 14.4 4.9 4.0 5.9 1.0 5.0 6.1 5.7 10.1 9.4 9.2 9.1 6.5 11.1 10.4 9.3 9.8 5.5 7.3 11.1 8.4 15.0 4.7 4.6 10.3 7.5 10.4 5.5 13.3 7.1 9.7 0.4 0.9 3.3 2.1 1.3 2.2 1.1 1.9 2.3 1.1 2.0 2.0 1.6 1.7 1.0 0.7 1.9 1.3 0.5 22.2 27.4 18.0 27.4 18.5 19.0 16.8 17.1 11.7 8.9 17.9 16.4 11.5 6.7 14.9 34.9 31.5 10.2 2.7 6.8 27.9 53.0 3.9 14.9 5.4 3.7 11.2 14.7 0.0 11.2 5.4 7.7 10.1 16.1 18.4 7.4 28.6 28.7 21.5 18.4 2.9 13.0 9.7 15.1 1.0 24.2 19.3 10.7 17.3 15.6 11.2 49.7 0.0 7.8 8.6 4.3 21.5 3.8 12.1 14.3 7.0 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA008867 Approved Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavorable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 6.1 5.8 3.1 7.7 3.6 6.0 8.2 8.1 5.6 6.9 13.4 3.7 9.9 14.3 4.4 7.5 8.3 4.4 12.0 2.7 2.9 3.1 5.7 15.5 11.6 9.9 3.8 2.6 2.7 13.8 5.1 4.6 6.1 3.2 4.9 6.3 3.6 9.6 9.4 4.6 7.5 19.1 3.1 2.9 8.3 6.2 5.6 3.5 6.0 3.9 6.8 6.5 5.1 4.7 0.7 2.4 1.9 4.3 0.8 1.2 0.2 8.1 2.5 1.8 11.9 2.5 0.6 3.7 4.2 4.6 4.1 2.8 2.7 3.5 3.9 5.2 1.9 2.0 5.4 2.2 5.4 0.9 7.1 3.2 7.9 1.5 6.8 3.8 1.9 7.9 1.1 4.9 2.3 6.1 1.0 3.4 6.0 3.7 6.0 1.5 14.1 5.2 1.9 2.6 8.6 8.0 6.3 2.2 12.5 5.3 2.6 3.0 2.9 4.7 7.2 7.0 1.1 11.9 3.3 2.9 2.0 7.8 9.8 4.9 2.4 1.8 2.7 3.1 4.7 2.6 0.0 0.6 1.9 1.2 1.3 1.1 0.7 0.9 0.8 0.5 0.5 0.1 0.4 0.2 0.8 4.3 2.4 0.1 0.2 3.1 3.6 8.1 5.6 2.9 3.1 3.8 2.6 3.2 3.5 6.0 1.3 10.8 5.1 5.0 9.1 1.2 5.1 1.4 5.7 0.0 13.7 7.4 5.0 3.8 1.7 3.8 31.6 0.0 5.3 8.6 4.5 5.9 1.1 5.9 6.2 1.6 2.4 6.7 4.1 1.0 4.9 7.3 5.0 1.0 13.3 7.3 6.4 9.5 1.8 6.3 8.1 0.0 4.2 2.3 8.0 5.8 3.2 5.9 13.5 5.1 FBXL7 "FBL6, FBL7, KIAA0840" ENSG00000183580 "F-box and leucine rich repeat protein 7" Q9UJT9 5 15500196-15939795 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 17.3;Horizontal cells: 28.6;Ito cells: 17.2;Leydig cells: 27.9;Peritubular cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA055464 Uncertain NA NA "HPA055464: AB_2682822" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" "unprognostic (3.34e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (4.54e-2)" "unprognostic (1.46e-1)" "unprognostic (1.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.41e-2)" "unprognostic (4.29e-3)" "unprognostic (3.42e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.94e-3)" 13.8 23.3 11.5 6.2 13.6 0.8 10.6 4.0 11.9 16.5 12.1 24.2 9.4 3.0 28.1 12.9 11.9 11.8 10.2 18.4 13.2 4.7 4.5 3.1 7.3 3.3 14.1 9.3 26.8 2.0 1.8 4.1 8.1 11.1 11.9 6.8 12.3 4.4 24.0 3.1 3.9 5.0 28.9 10.1 5.5 8.8 5.7 16.8 0.0 6.6 5.7 3.1 12.2 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 10.1 14.7 8.4 6.5 0.0 8.7 10.5 6.3 6.6 0.0 0.0 0.0 0.0 13.3 6.5 0.0 5.1 3.2 6.3 0.0 0.7 0.0 0.0 0.0 3.3 0.0 0.0 7.6 0.0 5.0 0.4 7.7 14.4 0.0 0.0 3.8 4.6 0.0 0.0 0.0 3.4 0.0 1.6 0.0 7.2 0.0 0.0 0.0 2.9 10.0 0.0 3.0 9.1 9.6 0.0 0.0 14.1 13.1 2.7 7.3 3.8 0.0 0.0 0.0 7.3 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 13.6 4.0 11.9 13.2 4.7 14.1 9.3 11.1 16.8 3.0 3.4 0.0 2.1 2.2 3.9 10.1 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.4 17.3 0.0 0.0 0.0 0.1 9.7 2.8 1.1 0.0 0.6 28.6 0.0 17.2 0.0 0.0 27.9 0.5 5.0 0.0 0.0 2.6 0.0 0.0 38.9 0.4 2.1 6.5 9.0 1.1 1.6 1.5 0.0 0.0 0.0 1.6 FBXO15 "FBX15, MGC39671" ENSG00000141665 "F-box protein 15" Q8NCQ5 18 74073353-74147865 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 56.2;Early spermatids: 27.6;Spermatocytes: 46.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 5 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "GAMG: 3.9;JURKAT: 5.5;SCLC-21H: 5.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "basal ganglia: 13.1" NA NA "unprognostic (1.69e-2)" "unprognostic (1.97e-1)" "unprognostic (6.34e-6)" "unprognostic (1.65e-2)" "unprognostic (4.20e-1)" "unprognostic (6.77e-2)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (3.38e-2)" "unprognostic (1.00e-2)" "unprognostic (9.62e-2)" "unprognostic (4.46e-5)" "unprognostic (4.64e-2)" "unprognostic (3.35e-2)" "unprognostic (1.62e-4)" "unprognostic (2.87e-1)" 0.6 1.8 3.1 0.4 7.6 0.6 1.3 1.6 4.1 1.9 0.5 6.3 4.0 0.7 0.8 5.5 0.9 9.4 1.0 0.5 3.3 2.9 3.4 1.7 1.9 0.9 2.2 3.2 1.2 1.1 2.4 7.1 0.6 3.8 1.0 0.4 3.0 1.5 2.4 0.9 1.0 0.6 0.4 2.6 1.2 0.9 19.2 3.4 0.8 2.0 0.0 0.6 0.8 0.5 0.9 0.3 0.0 0.3 0.0 4.2 1.1 0.0 0.3 0.4 0.5 0.2 0.5 0.3 0.3 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.1 3.9 1.6 0.1 0.0 0.8 1.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.7 0.7 0.0 5.5 0.1 0.4 0.3 0.4 0.3 0.2 1.2 0.7 2.1 0.7 0.0 0.0 0.7 0.1 5.6 1.7 0.3 0.0 2.1 1.0 0.1 1.0 0.0 0.7 0.1 0.0 0.1 0.3 2.5 2.2 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 1.6 0.6 0.0 0.9 4.2 2.6 0.0 0.0 0.3 0.3 0.1 1.1 3.1 7.6 1.6 3.9 3.3 2.9 2.2 3.2 3.8 3.4 6.0 0.6 0.0 0.8 0.2 5.6 0.4 0.0 56.2 5.7 1.8 0.0 0.4 3.3 0.4 27.6 0.5 0.0 0.0 0.2 0.6 0.2 0.2 0.0 0.2 3.2 4.8 0.0 0.6 0.3 14.2 1.1 0.1 0.0 0.0 0.0 7.2 0.1 0.0 1.4 4.4 10.4 0.0 0.4 46.1 7.2 0.0 0.3 0.0 0.0 0.5 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Cell line enhanced" "Detected in many" "AF22: 15.7;Karpas-707: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.3 2.6 15.7 6.1 0.4 0.0 0.4 0.1 0.6 2.4 4.6 2.4 3.6 4.7 5.7 0.1 6.5 4.1 1.7 2.5 2.4 1.9 2.9 2.2 0.2 1.3 0.3 2.7 1.6 0.2 8.4 0.6 2.6 1.1 0.0 4.0 0.8 18.1 1.0 4.1 0.3 3.7 3.4 1.6 3.6 0.1 3.7 7.2 3.3 2.1 10.2 4.3 0.4 2.5 6.8 2.9 10.9 4.6 0.5 1.3 4.8 2.8 2.2 4.0 3.5 3.9 5.3 0.6 2.8 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 3.0 2.6 0.0 2.3 0.1 7.9 2.0 5.1 26.8 6.8 3.5 33.4 0.5 6.6 4.5 8.6 0.0 0.0 0.0 3.9 0.2 0.9 2.7 0.0 2.4 2.0 4.8 9.8 0.6 1.0 8.4 1.1 0.0 0.0 0.0 1.9 7.8 2.9 0.0 0.7 4.0 42.0 0.0 1.2 7.4 3.4 0.0 0.0 0.0 0.8 1.0 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141988-117190531 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 78.4" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 208.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 8.1 29.4 17.8 8.8 21.6 5.2 11.4 27.0 28.0 12.6 10.5 18.8 25.5 10.6 16.1 70.1 10.2 78.4 14.2 18.9 17.9 18.4 33.3 17.0 11.2 8.2 13.5 21.4 38.8 19.0 17.3 18.8 12.3 17.5 17.4 9.8 14.0 10.7 19.8 16.3 11.8 9.5 12.8 17.0 11.6 11.8 27.8 14.2 9.9 19.1 6.9 9.3 12.7 10.2 12.8 8.5 3.7 10.5 9.2 13.0 7.1 9.5 22.8 14.4 7.9 11.9 12.4 16.5 12.8 14.0 12.1 9.9 14.7 6.8 12.6 12.7 13.1 9.0 13.1 16.9 12.8 14.6 7.1 15.1 0.6 12.6 11.8 10.8 4.1 4.5 12.2 12.4 9.6 15.5 19.8 16.8 11.2 5.0 4.2 10.3 15.6 11.6 2.9 21.5 14.7 14.9 13.8 20.9 13.2 12.1 22.9 28.6 17.3 32.1 8.5 6.9 12.1 19.9 1.6 12.9 8.1 10.4 9.4 8.3 7.4 7.6 16.5 11.7 6.4 11.2 1.1 5.8 3.7 10.7 10.5 11.2 9.8 11.3 11.1 8.5 12.8 13.0 11.7 0.5 9.2 10.1 5.8 11.4 7.1 17.8 21.6 27.0 28.0 17.9 18.4 13.5 21.4 17.5 14.2 29.8 27.8 27.2 40.8 33.1 41.6 47.8 30.6 36.1 45.5 48.8 39.3 49.4 38.1 52.1 35.4 34.8 15.1 0.0 44.6 30.7 30.8 42.7 3.5 35.9 13.3 69.9 37.5 41.1 21.5 46.7 92.3 14.7 21.9 16.2 24.9 57.0 28.8 17.5 208.9 69.6 32.7 103.5 45.3 20.0 40.5 39.5 54.8 27.7 25.9 40.4 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013109 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 54.9;Cone photoreceptor cells: 33.4;Early spermatids: 33.5;Spermatocytes: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053865: AB_2682282" "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favorable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 4.0 7.8 8.9 1.9 12.6 1.9 7.3 4.1 12.2 6.7 2.8 11.9 4.7 3.2 5.4 8.9 3.8 21.7 3.9 2.9 8.3 9.1 10.3 3.7 4.9 2.1 8.1 6.9 6.8 3.7 11.7 11.7 3.6 10.1 6.4 3.0 9.3 5.0 5.8 2.0 6.1 3.2 3.9 8.9 2.1 3.7 14.0 5.2 2.7 14.8 2.8 2.7 2.9 3.3 2.8 3.6 0.8 1.7 2.7 4.5 1.2 1.3 2.6 3.1 1.2 1.5 9.4 6.1 1.6 4.3 2.3 4.0 0.8 4.1 0.1 0.9 2.8 2.8 1.0 1.4 0.8 4.0 0.3 0.9 0.5 0.9 1.6 6.0 1.0 0.4 9.9 7.0 4.4 3.4 3.0 2.4 4.5 1.8 0.8 2.7 5.2 2.2 2.4 8.1 2.8 2.9 2.6 0.9 0.6 4.1 1.0 2.9 3.7 2.6 2.1 1.1 3.6 4.5 1.8 1.8 3.8 1.4 6.1 0.6 2.8 2.3 0.9 4.7 0.5 2.8 0.1 1.7 0.1 2.5 1.3 2.1 2.8 1.9 1.7 3.6 2.0 4.5 2.5 0.8 2.7 0.9 1.7 3.5 1.2 8.9 12.6 4.1 12.2 8.3 9.1 8.1 6.9 10.1 5.2 8.9 1.4 0.0 2.9 3.4 7.0 3.1 0.0 54.9 10.3 10.4 33.4 1.6 13.3 4.9 33.5 2.4 1.8 0.0 5.8 1.5 3.1 2.8 0.0 2.4 0.9 9.5 0.0 1.8 1.0 5.4 3.1 1.2 3.3 4.6 1.4 6.6 4.5 0.0 3.9 7.5 27.5 6.5 2.7 34.9 10.3 4.0 1.8 0.5 1.5 1.1 FBXO39 "CT144, Fbx39, MGC35179" ENSG00000177294 "F-box protein 39" Q8N4B4 17 6776223-6797101 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "testis: 39.2" "Group enriched" "Detected in some" 148 "Early spermatids: 350.7;Late spermatids: 407.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Karpas-707: 4.7;REH: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (6.73e-2)" "unprognostic (1.69e-2)" "unprognostic (1.78e-2)" "unprognostic (2.15e-2)" "unprognostic (7.19e-2)" "unprognostic (7.93e-2)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-3)" "unprognostic (2.36e-1)" "unprognostic (3.73e-9)" "unprognostic (5.11e-2)" "unprognostic (2.67e-1)" "unprognostic (5.93e-2)" "unprognostic (3.79e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 39.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.4 1.1 0.0 0.0 1.3 0.8 3.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.5 1.3 0.0 0.0 0.0 0.0 1.4 0.0 0.7 0.3 0.0 0.2 0.0 0.0 1.3 1.0 0.0 4.7 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 350.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 407.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 2.1 1.3 0.0 0.0 0.0 0.0 0.0 FBXO40 "Fbx40, KIAA1195" ENSG00000163833 "F-box protein 40" Q9UH90 3 121593119-121630295 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0" "Cell type enriched" "Detected in single" 2762 "Cardiomyocytes: 346.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.5;U-266/70: 3.0;U-266/84: 1.9" "Region enhanced" "Detected in some" "pons and medulla: 1.8" "Low region specificity" "Detected in single" NA NA "unprognostic (1.67e-2)" "unprognostic (1.23e-4)" "unprognostic (9.17e-2)" "unprognostic (6.65e-2)" "unprognostic (2.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.22e-1)" "unprognostic (7.01e-2)" "unprognostic (2.91e-1)" "unprognostic (2.50e-1)" "unprognostic (3.48e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-1)" "unprognostic (4.30e-2)" 1.0 0.1 0.2 0.0 0.1 0.3 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 0.6 1.1 0.1 0.1 48.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 1.3 2.3 0.0 58.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.9 38.0 3.9 0.1 0.1 0.5 0.6 2.8 0.8 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.6 0.1 0.3 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.3 0.5 0.4 0.0 0.0 0.0 3.0 1.9 0.8 0.2 0.1 0.0 0.2 0.8 0.8 0.9 0.6 0.3 0.2 0.8 0.2 0.2 0.5 0.4 0.6 2.8 0.2 0.4 0.6 0.9 0.1 0.2 0.1 0.1 1.0 0.1 0.1 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.6 1.8 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.1 2.1 27.0 0.1 0.1 2.7 3.0 3.8 2.4 1.2 11.2 0.3 8.2 4.1 1.7 0.9 12.4 6.3 1.5 0.9 0.0 0.9 3.3 0.2 7.4 1.6 4.4 1.2 0.9 4.3 11.6 2.7 1.3 1.6 15.2 7.0 13.1 0.8 1.3 9.4 3.5 4.6 2.0 2.9 0.2 2.6 5.2 0.2 4.2 3.7 3.8 0.7 5.3 2.2 12.8 1.1 13.7 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 0.0 1.1 1.7 0.3 0.2 10.8 1.7 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.2 0.1 0.6 0.7 2.3 0.0 1.7 6.4 11.5 1.3 2.6 0.9 0.3 0.9 1.7 1.8 0.0 0.6 1.0 0.0 0.7 0.0 2.2 0.0 0.5 0.5 1.7 0.3 0.0 1.3 0.4 0.1 FBXO47 ENSG00000204952 "F-box protein 47" Q5MNV8 17 38936432-38967402 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "testis: 12.2;vagina: 3.5" "Cell type enhanced" "Detected in some" 32 "Sertoli cells: 6.5;Spermatocytes: 26.2;Spermatogonia: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;Daudi: 1.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA057438 Uncertain NA NA "HPA057438: AB_2683441" "unprognostic (1.53e-1)" "unprognostic (2.98e-1)" "unprognostic (2.82e-1)" "unprognostic (3.92e-1)" "unprognostic (6.04e-2)" "unprognostic (2.59e-2)" "unprognostic (2.29e-2)" "unprognostic (6.85e-2)" "unprognostic (4.15e-1)" 0.1 0.1 0.1 0.0 0.5 0.0 1.9 0.7 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.1 0.1 0.0 0.4 0.1 1.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 1.2 0.1 0.1 12.2 0.7 0.0 0.1 0.0 0.0 0.1 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.4 0.0 0.1 0.1 0.0 1.2 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.7 0.4 0.1 0.1 1.0 0.3 1.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 26.2 6.8 0.0 0.0 0.0 0.0 0.1 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174284264 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favorable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 16.8 18.5 13.5 9.2 14.1 7.3 16.4 19.4 14.0 15.6 17.3 14.0 10.7 13.4 13.1 19.5 16.4 15.1 13.1 19.1 13.3 12.0 20.2 43.5 11.8 9.5 14.6 10.1 15.7 22.6 16.5 26.9 27.1 14.3 16.8 15.3 14.7 13.3 13.1 7.4 16.0 18.9 18.8 14.7 13.9 14.7 10.0 14.0 18.2 19.9 6.5 12.4 20.6 18.2 12.6 8.6 19.2 8.9 9.8 15.5 7.8 4.8 3.2 6.6 2.2 14.9 16.3 5.2 9.9 9.1 6.6 6.7 2.5 8.6 3.7 9.4 6.4 5.6 3.1 4.4 5.7 7.0 11.1 10.0 3.2 5.5 4.0 11.4 4.4 3.6 9.3 14.2 6.0 8.0 11.8 6.5 4.1 6.8 19.1 8.6 4.8 4.5 4.6 1.8 7.8 3.4 2.7 4.3 5.8 10.2 2.0 6.2 40.1 4.4 7.8 11.0 6.7 4.4 4.8 7.4 3.8 3.7 11.0 5.5 9.9 4.7 3.1 13.0 3.2 5.3 19.2 6.2 12.7 12.3 7.8 15.5 12.6 14.2 12.1 8.5 10.7 13.5 11.8 6.2 9.8 8.9 8.6 15.0 7.8 13.5 14.1 19.4 14.0 13.3 12.0 14.6 10.1 14.3 14.0 3.0 11.4 16.0 15.8 18.3 11.9 9.0 12.7 18.7 13.6 21.0 5.9 29.9 43.1 14.8 14.7 16.8 18.2 23.3 9.7 44.8 19.0 18.2 2.3 50.0 18.5 17.5 11.6 19.0 16.9 4.1 16.1 8.5 10.1 19.8 20.1 20.7 11.1 19.3 24.8 32.6 16.1 12.9 14.7 33.3 17.4 27.5 74.9 17.5 13.4 20.6 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744024-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 15.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Early spermatids: 30.2;Late spermatids: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;ASC diff: 2.1;CAPAN-2: 3.1;HaCaT: 4.3;HeLa: 3.4" HPA047457 Approved Nucleoplasm NA NA Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.7 0.1 0.1 0.7 0.0 0.1 1.9 0.6 0.6 0.1 0.1 0.1 0.4 0.1 2.1 0.2 0.8 0.4 0.1 0.6 0.3 0.2 1.1 0.3 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.6 0.1 0.0 0.4 0.3 0.2 0.8 0.1 0.4 0.1 0.1 0.1 0.3 15.9 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.8 0.0 0.1 2.1 1.3 0.1 0.0 0.2 0.0 0.3 0.1 3.1 0.1 0.1 0.4 0.2 4.3 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.9 0.6 0.6 0.3 0.1 0.8 1.6 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.4 0.1 0.0 0.0 0.0 0.1 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "pancreas: 12.4" "Group enriched" "Detected in some" 10 "Early spermatids: 8.6;Late spermatids: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5" "HPA037491, HPA037492" Uncertain NA NA "HPA037491: AB_2675504, HPA037492: AB_2675505" "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 12.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 1.0 0.0 0.2 0.0 0.2 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1, rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favorable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 23.9 26.0 19.5 18.4 23.0 18.3 27.1 15.7 21.6 25.6 21.6 24.6 25.9 14.4 29.5 18.5 30.4 30.6 17.8 21.9 17.7 18.2 24.6 25.1 21.1 24.2 25.2 17.5 32.7 18.3 23.1 34.5 24.4 23.8 22.8 23.2 20.8 22.7 25.4 26.3 20.3 19.3 23.8 34.9 21.4 19.8 19.4 21.6 28.3 37.8 23.3 30.5 26.6 24.0 19.0 25.2 15.8 14.5 12.1 18.1 6.8 36.1 26.7 19.3 21.8 30.8 27.3 25.5 31.8 24.5 31.8 28.5 29.6 29.9 32.4 20.8 27.7 15.4 26.7 32.2 30.0 56.4 30.0 14.0 22.4 16.8 19.3 22.3 27.3 20.7 21.3 26.6 33.7 35.5 25.3 29.6 28.2 26.8 19.6 28.5 25.8 31.7 9.8 25.9 21.1 31.1 24.2 38.0 15.4 16.2 29.7 13.6 19.8 40.8 21.7 18.1 22.4 27.7 19.1 26.9 25.5 27.3 24.0 36.3 17.3 45.3 50.4 24.2 26.1 28.2 10.0 14.5 15.8 16.6 12.3 18.1 19.0 16.0 14.2 11.2 18.7 17.4 17.8 12.1 12.1 14.2 25.2 15.4 6.8 19.5 23.0 15.7 21.6 17.7 18.2 25.2 17.5 23.8 21.6 6.0 19.4 22.2 6.5 2.7 6.9 18.9 43.3 62.9 18.2 12.2 5.9 10.3 13.3 15.2 17.6 13.6 14.2 46.7 16.3 12.5 7.3 6.1 25.4 87.3 11.2 11.1 9.8 34.4 35.1 8.8 14.4 12.0 0.0 8.2 14.0 14.5 15.2 8.6 15.9 10.7 6.3 12.9 5.2 10.6 11.9 4.3 7.3 13.8 14.2 5.5 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121096310 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8;epididymis: 36.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4" "Cancer enhanced" "Detected in single" "glioma: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 19.2;neutrophil: 21.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NB-4: 10.7;THP-1: 40.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 4.2 2.3 6.6 13.2 6.2 3.9 1.3 0.8 3.2 0.8 0.5 3.0 0.2 0.5 0.9 36.9 0.5 0.8 1.5 7.4 5.0 4.2 1.0 1.1 4.8 7.9 8.9 0.2 1.1 1.9 0.4 1.5 8.1 6.4 0.6 0.6 0.4 1.3 0.5 0.2 0.0 0.4 4.2 11.3 6.8 0.5 0.5 6.2 0.4 1.8 0.2 0.4 1.5 0.2 0.0 5.2 21.8 19.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 19.2 0.2 0.0 11.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 21.8 0.0 6.2 0.1 0.0 5.3 6.6 6.2 0.8 3.0 5.0 4.2 8.9 0.2 6.4 6.2 0.0 1.3 0.8 0.0 0.0 0.8 2.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 68.7 3.2 0.0 0.0 38.3 8.2 1.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.4 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 FER1L5 DKFZp434I0121 ENSG00000249715 "Fer-1 like family member 5" A0AVI2 2 96642737-96704887 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.9" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 15.5;Late spermatids: 4.2;Spermatocytes: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;AF22: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.4;HSkMC: 1.5;NTERA-2: 1.1;U-87 MG: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-3)" "unprognostic (5.81e-3)" "unprognostic (2.06e-1)" "unprognostic (1.12e-4)" "unprognostic (4.49e-4)" "unprognostic (1.39e-2)" "unprognostic (6.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-2)" "unprognostic (2.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.16e-3)" 0.2 0.2 2.8 0.2 3.7 0.2 1.2 2.0 3.2 0.4 0.2 1.5 1.9 0.2 0.4 1.5 0.3 0.8 0.5 0.3 1.6 0.6 0.2 0.5 0.2 0.0 3.8 0.7 1.3 0.3 3.2 0.5 0.4 1.0 0.2 2.0 0.4 3.0 0.2 0.2 0.2 0.3 0.2 0.3 0.3 17.9 0.6 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 1.4 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 1.1 0.0 0.0 1.1 0.0 2.7 1.2 0.0 0.0 0.0 1.7 0.4 15.5 0.0 0.0 0.0 0.6 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 3.3 1.0 0.0 0.2 0.0 0.0 0.3 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 29.3" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 12.4;Late spermatids: 25.1;Pancreatic endocrine cells: 6.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;ASC TERT1: 5.0;BJ hTERT+: 3.3;PC-3: 4.4;U-87 MG: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA054117 Enhanced NA NA "HPA054117: AB_2682387" "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.1 1.7 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 3.8 0.0 0.0 0.0 29.3 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.2 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 1.3 4.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.9 0.0 0.0 0.0 3.9 0.0 6.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 FEZF2 "FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312" ENSG00000153266 "FEZ family zinc finger 2" Q8TBJ5 3 62369681-62374324 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 22.0" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 1.7;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Rod photoreceptor cells: 2.7" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in many" 7 "amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 5.2;NTERA-2: 3.5;U-266/84: 2.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2" NA NA "unprognostic (2.37e-1)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" 0.7 0.5 12.2 0.4 6.4 0.4 0.5 0.0 18.0 0.4 1.4 1.8 0.0 0.4 0.5 0.4 0.4 0.5 0.5 0.5 22.0 1.8 0.7 0.5 0.5 0.4 1.1 10.0 0.5 0.4 0.4 0.7 0.5 0.0 0.6 0.4 1.1 0.5 0.5 0.8 0.6 0.5 0.4 0.0 0.8 0.9 0.5 0.3 3.3 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 6.4 0.0 11.3 22.0 1.8 1.1 10.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF11 "FHF3, FLJ16061, MGC102953, MGC45269" ENSG00000161958 "Fibroblast growth factor 11" Q92914 17 7438273-7444937 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 17.5;Muller glia cells: 12.7;Suprabasal keratinocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 9.4;HaCaT: 17.3;LHCN-M2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066605, HPA075188" Enhanced Approved Centrosome NA NA Centrosome "HPA066605: AB_2685693, HPA075188: AB_2732283" "unprognostic (7.35e-2)" "unprognostic (1.14e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-4)" "unprognostic (9.15e-2)" "unprognostic (3.28e-2)" "unprognostic (7.31e-2)" "unprognostic (3.11e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.69e-2)" "unprognostic (2.89e-3)" "unprognostic (2.00e-6)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.90e-3)" "unprognostic (4.97e-3)" 3.3 23.5 10.5 3.0 13.8 2.1 2.9 4.5 11.6 6.4 1.6 4.6 0.1 1.8 3.1 1.9 13.0 1.7 3.2 11.6 11.7 4.6 3.4 1.1 1.3 6.2 8.1 5.2 1.6 1.3 1.5 1.0 2.0 10.6 1.4 1.4 6.8 3.7 1.7 8.8 19.7 1.3 2.9 4.1 2.4 1.6 2.8 9.9 2.5 7.2 7.1 9.0 2.9 8.7 0.0 0.0 1.6 0.6 0.0 0.3 0.0 9.4 0.6 5.3 0.0 3.1 0.1 2.7 0.2 3.3 0.3 0.6 0.2 1.0 2.8 0.7 0.1 0.1 17.3 2.0 5.4 1.2 5.9 4.2 5.2 0.5 1.3 0.5 0.2 5.8 0.6 1.5 0.4 0.2 0.5 0.2 2.2 2.0 0.2 11.4 2.1 1.7 2.3 1.9 0.4 0.2 4.5 4.8 1.2 0.7 0.8 1.1 5.4 0.6 0.6 0.4 3.1 0.3 0.4 0.2 0.3 5.7 0.0 0.2 0.4 1.3 0.9 1.3 3.2 0.6 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 10.5 13.8 4.5 11.6 11.7 4.6 8.1 5.2 10.6 9.9 0.0 0.0 0.0 0.3 4.8 2.8 0.4 2.5 0.0 0.0 1.8 5.9 0.3 3.3 0.5 1.3 0.8 0.4 0.0 0.2 0.4 0.4 0.5 0.0 0.0 0.3 17.5 0.0 0.6 0.3 3.4 1.7 0.3 1.7 0.0 0.3 12.7 1.0 0.0 2.1 0.1 2.5 0.0 0.9 1.2 1.3 8.4 0.6 0.0 0.6 0.9 FHAD1 KIAA1937 ENSG00000142621 "Forkhead associated phosphopeptide binding domain 1" B1AJZ9 1 15247272-15400283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5" "Group enriched" "Detected in many" 6 "Ciliated cells: 366.7;Early spermatids: 202.9;Late spermatids: 182.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "pons and medulla: 13.8" "Cell type enhanced" "Detected in many" "gdT-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HMC-1: 39.8;K-562: 8.5;U-87 MG: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054284 Enhanced NA NA "HPA054284: AB_2682436" "unprognostic (3.18e-2)" "unprognostic (1.12e-3)" "unprognostic (2.36e-3)" "unprognostic (2.15e-2)" "unprognostic (5.55e-2)" "unprognostic (8.32e-2)" "unprognostic (2.46e-1)" "unprognostic (2.06e-2)" "unprognostic (1.04e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.40e-1)" "unprognostic (1.17e-3)" "unprognostic (2.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.83e-1)" "unprognostic (1.04e-3)" 0.4 0.4 1.4 0.8 2.0 0.0 1.1 0.2 0.9 2.6 0.4 6.7 0.8 1.0 1.0 16.0 0.2 17.9 0.6 0.2 3.0 2.6 0.6 0.3 7.6 0.2 0.5 0.2 8.2 0.9 1.8 1.1 0.5 13.8 1.0 0.3 0.5 0.6 1.3 0.1 0.3 1.1 0.3 0.6 0.2 2.5 28.5 2.8 0.0 1.4 0.1 0.3 0.9 0.3 0.8 0.4 0.0 1.6 1.2 3.6 0.8 0.9 0.2 0.8 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.6 0.3 0.1 0.1 0.2 0.1 0.0 0.1 13.8 0.1 0.0 0.0 0.0 0.2 1.2 39.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 3.5 0.1 4.1 0.0 0.0 4.5 0.0 21.4 0.0 0.1 0.0 1.6 0.0 3.6 0.6 0.1 0.8 0.4 1.2 0.4 0.0 0.0 1.5 0.0 1.2 1.2 0.0 0.0 0.8 1.4 2.0 0.2 0.9 3.0 2.6 0.5 0.2 13.8 2.8 0.0 2.1 0.0 0.6 0.1 0.2 1.2 0.0 366.7 45.5 0.0 0.0 0.0 0.0 1.5 202.9 0.7 0.7 0.0 1.2 0.0 0.7 0.4 0.0 0.0 2.3 3.2 1.7 0.0 1.0 182.6 2.0 1.5 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.4 0.0 12.9 1.4 7.9 11.4 0.0 0.1 0.0 0.3 1.1 FITM1 FIT1 ENSG00000139914 "Fat storage inducing transmembrane protein 1" A5D6W6 14 24131275-24132849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 228.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 17 "RH-30: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA019842 Uncertain NA NA "HPA019842: AB_1853025" "unprognostic (1.81e-2)" "unprognostic (4.29e-7)" "unprognostic (2.77e-1)" "unprognostic (2.02e-3)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "prognostic favorable (1.00e-3)" "unprognostic (1.20e-4)" "unprognostic (4.57e-1)" "unprognostic (2.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.68e-2)" "unprognostic (2.47e-1)" "unprognostic (2.86e-2)" "unprognostic (5.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.12e-3)" 0.8 1.7 0.0 0.2 0.0 0.6 0.3 0.4 0.2 0.2 0.3 0.0 0.0 0.5 0.2 2.2 1.2 0.2 0.2 56.1 0.0 0.0 0.2 13.1 0.2 0.3 0.0 0.0 0.2 11.9 0.2 0.2 0.2 0.0 0.7 0.2 0.1 2.9 0.3 94.7 0.5 0.4 0.2 0.0 2.5 0.3 0.3 0.0 0.0 0.5 79.9 3.6 0.3 0.0 0.8 0.3 0.0 1.1 0.4 1.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.6 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.2 27.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.5 1.1 0.3 0.2 1.1 1.5 0.3 0.8 0.6 0.6 0.0 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 228.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1.9 0.3 2.0 0.0 2.6 0.1 0.5 0.4 0.0 26.1 0.2 0.0 1.2 0.6 1.5 2.7 0.0 0.1 0.0 1.0 1.0 0.8 1.1 0.0 0.7 0.1 0.3 0.0 0.4 1.2 0.2 0.5 0.6 0.8 0.8 0.1 FITM2 "C20orf142, dJ881L22.2, FIT2" ENSG00000197296 "Fat storage inducing transmembrane protein 2" Q8N6M3 20 44302838-44311169 "Predicted membrane proteins" "Deafness, Disease mutation, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 56.7" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.92e-2)" "unprognostic (7.61e-2)" "unprognostic (2.27e-2)" "unprognostic (2.10e-3)" "unprognostic (1.02e-1)" "unprognostic (3.57e-3)" "unprognostic (1.63e-2)" "unprognostic (3.90e-2)" "unprognostic (8.43e-2)" "unprognostic (5.19e-2)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "prognostic favorable (8.98e-12)" "unprognostic (2.07e-1)" "unprognostic (2.54e-1)" "unprognostic (3.38e-3)" "unprognostic (2.49e-3)" 8.8 9.9 5.0 2.6 5.7 1.2 9.5 7.1 8.2 4.0 4.5 4.3 3.8 3.8 3.7 7.7 3.1 3.5 3.3 56.7 4.9 5.1 7.7 8.0 3.6 2.0 4.7 5.5 4.3 7.8 13.0 4.5 1.9 6.6 5.8 5.3 4.7 5.3 4.2 6.9 4.5 3.7 4.6 4.7 2.5 3.8 3.6 5.1 0.2 5.5 4.4 2.4 3.9 3.8 2.0 2.7 1.7 3.0 3.8 6.2 2.5 4.5 7.0 3.0 4.3 21.2 8.7 3.0 7.4 5.4 5.9 3.2 8.6 3.3 3.1 4.3 8.3 9.3 10.2 3.7 5.0 6.4 0.9 1.7 1.0 4.4 14.4 4.4 2.0 2.6 6.6 11.3 4.1 3.1 3.2 4.2 2.0 1.7 9.3 5.9 14.1 0.7 2.1 0.7 6.8 9.1 1.2 5.5 3.1 3.3 4.3 1.8 2.1 15.7 8.9 6.5 1.4 10.8 1.5 5.1 18.8 8.4 10.8 4.3 3.4 8.8 0.8 8.3 3.1 9.3 1.4 3.0 1.7 3.4 2.7 3.5 1.8 3.6 2.8 2.7 2.0 6.2 4.8 1.4 3.8 2.1 1.7 3.2 2.5 5.0 5.7 7.1 8.2 4.9 5.1 4.7 5.5 6.6 5.1 6.0 8.9 7.3 3.1 6.2 5.8 134.0 15.3 4.0 3.4 5.2 5.9 1.9 1.7 4.5 3.6 3.6 4.3 0.0 7.4 2.7 4.7 2.9 0.0 12.1 3.0 6.4 8.7 9.8 4.0 0.4 7.2 1.7 6.8 1.8 5.6 5.3 5.4 5.3 7.1 5.1 5.7 0.0 4.7 7.5 5.2 7.0 1.3 3.8 8.0 2.0 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four jointed box 1" Q86VR8 11 35618419-35620868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 15.5;Cytotrophoblasts: 18.7;Extravillous trophoblasts: 14.0;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059220: AB_2683950" "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavorable (6.56e-4)" 6.0 3.5 7.8 3.5 10.3 0.7 3.6 6.6 25.4 8.8 1.4 7.9 0.0 1.1 10.1 3.4 3.1 6.1 4.5 2.4 8.0 4.9 3.8 4.9 2.2 2.3 5.7 5.7 12.2 17.0 1.7 1.8 6.6 7.7 4.1 1.1 2.7 2.6 4.7 1.1 10.3 1.1 3.4 5.1 7.8 1.7 1.2 3.3 1.7 2.2 3.0 3.4 3.7 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 9.8 4.9 5.2 1.6 1.8 5.8 1.6 11.1 7.5 10.6 7.7 6.2 3.1 0.0 2.5 4.3 22.0 10.5 1.8 18.3 9.1 0.1 14.5 0.9 1.9 0.2 4.4 1.1 0.0 2.1 14.0 5.5 16.9 1.7 4.8 0.5 5.2 0.0 10.2 2.3 0.3 0.0 7.2 0.0 14.7 0.6 11.7 2.2 8.1 12.2 5.0 2.8 1.2 0.9 3.1 4.0 21.1 0.2 9.4 8.5 15.7 1.6 26.1 0.0 0.0 0.0 15.2 0.4 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.3 6.6 12.3 8.0 4.9 5.7 5.7 7.7 3.3 0.0 0.0 0.0 9.3 15.5 0.4 1.0 0.0 4.0 3.4 0.0 11.8 18.7 1.7 7.9 0.0 5.6 0.0 0.0 0.2 14.0 4.5 1.5 0.0 0.0 3.1 0.0 0.0 16.0 0.6 0.0 0.6 1.5 0.0 0.0 0.0 10.3 1.1 0.0 0.7 6.7 0.3 0.0 5.3 0.4 1.1 8.3 10.0 0.0 0.0 2.6 FMR1NB "CT37, FLJ25736, NY-SAR-35" ENSG00000176988 "FMR1 neighbor" Q8N0W7 X 147981329-148026667 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 38.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 302.9;Spermatogonia: 264.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-266/70: 35.2;U-266/84: 27.5" "HPA011284, CAB026403" Enhanced NA NA "CAB026403: , HPA011284: AB_1078898" "unprognostic (2.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (4.38e-2)" "unprognostic (4.11e-3)" "unprognostic (2.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 38.8 0.0 302.9 264.0 0.0 0.2 0.0 0.0 0.0 FNDC1 "bA243O10.1, dJ322A24.1, FNDC2, KIAA1866" ENSG00000164694 "Fibronectin type III domain containing 1" Q4ZHG4 6 159169397-159272109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enriched" "Detected in some" 5 "Fibroblasts: 15.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Region enriched" "Detected in single" 6 "hippocampal formation: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA030962, HPA030963" Approved Approved "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "HPA030962: AB_10696212, HPA030963: AB_2673676" "unprognostic (4.59e-2)" "unprognostic (9.17e-3)" "unprognostic (7.62e-2)" "prognostic favorable (6.10e-5)" "unprognostic (4.57e-1)" "unprognostic (2.11e-1)" "unprognostic (5.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "unprognostic (4.18e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.93e-6)" "unprognostic (6.49e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.76e-3)" 5.2 0.6 0.5 7.6 0.7 0.0 2.5 0.3 0.7 9.7 12.9 3.2 0.0 2.1 4.8 2.2 2.2 0.9 13.1 3.5 4.8 0.5 1.0 1.5 1.2 2.1 0.7 0.0 4.8 1.2 0.0 0.4 0.7 0.5 0.7 1.6 1.0 2.5 0.6 6.2 1.2 7.0 10.2 1.5 0.7 0.7 2.1 0.1 1.0 36.6 11.8 3.6 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 2.4 6.6 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 7.4 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.7 4.8 0.5 0.7 0.0 0.5 0.1 0.0 1.1 0.0 0.0 2.9 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 15.5 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.4 0.3 1.3 0.1 0.0 0.0 0.0 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712657-108742740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.0;testis: 5.2" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 1.1;Early spermatids: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8" "Not detected" "Not detected" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" NA NA "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: AB_2682441" "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.1 0.1 0.6 0.1 0.8 0.6 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.5 0.6 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.9 0.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.3 0.1 0.0 1.1 0.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.5 0.3 0.3 0.1 0.4 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 1.1 1.7 0.7 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FNDC8 DKFZp434H2215 ENSG00000073598 "Fibronectin type III domain containing 8" Q8TC99 17 35121579-35130732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 85.2" "Group enriched" "Detected in some" 61 "Early spermatids: 549.6;Late spermatids: 1824.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 15 "B-cells: 1.3;T-cells: 2.0" "Cell line enhanced" "Detected in some" "HEK 293: 4.1;JURKAT: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA026521 Supported NA NA "HPA026521: AB_2106163" "unprognostic (1.45e-1)" "unprognostic (6.58e-2)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.25e-2)" "unprognostic (2.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-1)" "unprognostic (8.43e-2)" "unprognostic (3.48e-3)" "unprognostic (9.02e-2)" "unprognostic (6.41e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.2 0.7 2.1 0.7 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 2.4 0.4 0.0 0.2 0.2 0.2 0.0 0.0 0.6 4.1 0.1 0.7 0.2 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.7 1.2 0.1 0.4 1.7 1.1 0.5 0.3 0.4 2.5 1.2 2.4 0.0 0.6 0.5 0.6 0.9 0.6 0.4 0.1 0.4 0.7 0.0 0.0 0.2 0.7 0.9 1.6 2.1 2.3 0.2 0.7 0.5 0.0 0.1 0.0 0.2 0.1 1.3 0.6 0.6 0.0 0.0 1.3 2.0 0.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 549.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1824.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 19.4 0.0 6.8 4.1 0.0 0.0 0.0 0.0 0.0 FNDC9 "C5orf40, MGC27121" ENSG00000172568 "Fibronectin type III domain containing 9" Q8TBE3 5 157341600-157345721 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0" "Cell type enriched" "Detected in single" 5 "Bipolar cells: 3.4" "Cancer enriched" "Detected in single" 16 "glioma: 0.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6" "Group enriched" "Detected in many" 5 "basal ganglia: 21.9;hypothalamus: 28.4" "Low region specificity" "Detected in all" HPA011115 Uncertain NA NA "HPA011115: AB_1079374" "unprognostic (2.35e-3)" "unprognostic (3.80e-2)" "unprognostic (2.93e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-3)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.68e-1)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (6.35e-6)" "unprognostic (3.63e-2)" "unprognostic (6.39e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" 0.6 9.4 3.9 1.5 21.1 2.0 0.6 9.1 24.0 0.5 1.1 0.0 0.0 0.6 0.6 0.9 0.5 0.6 0.6 0.7 1.9 22.0 0.7 0.6 0.5 0.9 1.3 3.8 0.5 0.5 0.5 10.0 0.6 5.8 0.6 1.2 0.0 0.5 0.6 0.6 0.6 0.8 0.8 1.3 0.6 0.6 0.5 0.4 0.0 0.6 0.0 0.5 0.6 0.0 0.5 0.3 0.8 0.8 0.0 1.9 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.4 1.0 0.0 0.2 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.4 0.1 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.6 1.0 0.3 0.3 1.6 0.0 1.0 0.4 0.0 0.1 0.0 0.0 0.8 1.9 0.2 0.1 0.0 0.6 1.3 0.0 0.5 0.8 1.5 0.2 0.0 0.8 0.3 0.0 0.1 3.9 21.1 9.1 13.3 1.9 22.0 1.3 3.8 5.8 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;testis: 3.1" "Cell type enriched" "Detected in single" 7 "monocytes: 4.6" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "THP-1: 8.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.6 0.6 1.2 0.5 1.4 0.1 0.1 5.7 1.5 0.4 0.2 0.4 0.7 0.1 0.1 0.3 0.1 0.2 1.3 1.5 1.6 0.2 0.6 0.7 0.8 0.3 0.5 0.2 0.7 0.6 0.7 0.3 0.3 0.5 1.4 0.3 0.6 0.4 0.4 1.0 0.6 3.1 0.2 0.2 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.4 0.8 0.4 3.7 0.2 0.4 0.0 0.3 1.0 0.2 3.7 0.6 0.0 0.1 0.0 0.9 0.2 0.3 3.6 3.0 0.0 0.5 0.3 0.2 2.6 1.9 0.5 0.0 0.0 0.1 0.6 0.0 0.2 1.2 1.6 0.1 1.4 0.3 2.1 0.1 0.5 1.8 0.3 0.8 0.5 0.9 1.9 1.8 1.4 1.0 0.6 0.0 0.3 0.9 8.9 0.5 1.1 1.1 0.7 1.3 0.1 0.4 0.8 0.8 2.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.4 0.6 0.3 1.0 1.2 0.0 0.2 1.5 1.3 0.7 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.4 1.0 0.7 0.2 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.0 0.4 0.1 0.2 0.5 0.1 0.5 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.5 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.2 1.0 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.8 1.0 0.4 0.0 0.1 0.2 0.7 0.0 0.1 0.5 0.0 0.4 1.0 0.5 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXI2 FLJ46831 ENSG00000186766 "Forkhead box I2" Q6ZQN5 10 127737235-127741186 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 6.5;pituitary gland: 10.3" "Group enriched" "Detected in some" 6 "Distal tubular cells: 3.3;Urothelial cells: 1.6" "Cancer enriched" "Detected in some" 6 "renal cancer: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NTERA-2: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.12e-3)" "unprognostic (4.71e-4)" "unprognostic (6.78e-3)" "prognostic favorable (4.23e-7)" "unprognostic (6.31e-3)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "unprognostic (1.65e-2)" 0.7 0.0 0.1 3.0 0.1 0.0 0.7 0.1 0.3 5.4 0.4 0.1 3.1 0.1 1.8 2.7 4.7 0.7 0.2 0.5 0.1 0.1 6.5 0.1 0.4 0.9 0.1 0.1 1.2 0.2 0.1 10.3 0.1 0.4 1.2 0.0 0.1 2.3 1.7 0.3 1.4 0.4 0.5 0.1 2.3 0.5 0.3 0.1 0.4 0.1 0.9 0.8 1.6 2.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 FOXI3 ENSG00000214336 "Forkhead box I3" A8MTJ6 2 88446787-88452656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 11.6;retina: 15.7" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 3.2;Muller glia cells: 5.6;Syncytiotrophoblasts: 2.3" "Cancer enhanced" "Detected in some" "testis cancer: 10.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BEWO: 24.7;SuSa: 33.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.72e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-1)" "unprognostic (6.72e-4)" "unprognostic (8.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 11.6 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.9 0.5 0.9 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 33.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.2 0.4 0.2 0.3 0.4 0.4 0.3 0.2 0.7 0.4 0.6 1.5 0.9 0.5 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 FOXL1 "FKH6, FKHL11, FREAC7" ENSG00000176678 "Forkhead box L1" Q12952 16 86576368-86582160 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 15.8" "Group enriched" "Detected in some" 12 "Pancreatic endocrine cells: 6.1;Peritubular cells: 7.4;Sertoli cells: 6.5;Smooth muscle cells: 6.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 8.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.5;CAPAN-2: 16.0;hTEC/SVTERT24-B: 11.3;PC-3: 20.7;REH: 12.2;U-87 MG: 45.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.21e-1)" "unprognostic (3.31e-3)" "unprognostic (2.98e-1)" "unprognostic (1.12e-2)" "unprognostic (3.79e-1)" "unprognostic (4.62e-2)" "unprognostic (1.43e-3)" "unprognostic (1.79e-2)" "unprognostic (1.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.33e-3)" "unprognostic (1.35e-1)" "unprognostic (2.36e-8)" "unprognostic (1.50e-1)" "unprognostic (9.77e-2)" "unprognostic (3.16e-2)" "unprognostic (5.17e-3)" 2.8 1.0 1.4 3.4 1.4 0.1 1.6 0.4 2.0 2.8 7.2 0.6 0.0 6.4 1.5 1.9 1.1 1.9 15.8 4.5 0.6 0.4 2.8 0.5 2.7 3.5 0.9 0.7 3.8 0.2 0.1 1.3 0.3 1.6 3.5 5.1 6.7 1.2 1.0 4.9 0.9 5.9 1.1 2.1 0.2 5.8 5.8 0.6 0.1 1.2 1.5 0.3 6.2 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.7 5.7 0.0 3.8 12.5 3.4 1.2 0.0 16.0 0.0 0.8 1.1 1.7 0.4 0.0 1.2 3.8 0.0 0.0 0.0 3.3 0.0 1.7 0.0 0.0 1.4 0.4 11.3 2.6 1.3 1.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 20.7 12.2 0.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 2.6 5.8 0.0 8.7 2.2 0.0 0.0 1.1 45.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 1.4 0.4 2.0 0.6 0.4 0.9 0.7 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 7.4 0.0 0.0 6.5 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 FOXL2NB "C3orf72, FLJ43329" ENSG00000206262 "FOXL2 neighbor" Q6ZUU3 3 138947234-138953451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 51.6;parathyroid gland: 25.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;fHDF/TERT166: 10.7;HEL: 10.6;hTCEpi: 5.0;SiHa: 8.3" "HPA061017, HPA071790" Enhanced "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA061017: AB_2684415, HPA071790: AB_2686447" "unprognostic (3.32e-1)" "unprognostic (1.13e-1)" "unprognostic (3.86e-2)" "unprognostic (4.07e-2)" "unprognostic (4.40e-5)" "unprognostic (3.30e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-10)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (2.77e-1)" "unprognostic (1.22e-2)" 0.1 1.0 0.6 0.1 1.4 0.2 0.1 0.2 0.9 15.3 0.1 0.5 0.1 0.0 12.6 0.9 0.2 7.3 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.5 0.4 51.6 0.4 25.0 9.4 3.2 1.0 0.1 0.0 1.3 0.1 0.5 0.1 0.3 0.1 2.5 0.3 0.1 0.0 0.4 0.3 0.1 0.4 0.3 0.1 0.4 2.3 0.6 0.5 2.8 0.4 0.7 0.4 0.0 2.1 1.4 0.7 5.5 0.3 0.1 2.3 0.1 0.0 0.2 0.0 0.3 0.4 0.2 1.1 10.7 0.1 0.5 0.2 0.1 0.2 0.1 0.3 10.6 3.3 0.1 0.0 0.1 0.4 0.2 5.0 0.2 0.1 0.6 0.0 0.3 4.0 0.3 2.6 0.3 0.1 0.3 0.3 0.2 0.2 0.1 0.0 0.0 0.5 1.5 0.2 0.2 8.3 0.2 0.0 1.0 0.2 3.1 0.2 0.4 0.3 0.3 0.1 0.4 0.2 0.1 0.3 0.3 0.1 1.3 0.4 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.2 0.6 0.4 0.3 2.8 0.7 0.2 0.5 0.4 0.0 0.6 1.4 0.2 0.9 0.3 0.2 0.5 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXQ1 HFH1 ENSG00000164379 "Forkhead box Q1" Q9C009 6 1312440-1314748 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 65.5;vagina: 39.9" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 53.7;Collecting duct cells: 38.4;Suprabasal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;HaCaT: 16.4;Hep G2: 34.5;OE19: 46.8;RT4: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059700 Supported Nucleoplasm Yes NA Nucleoplasm "HPA059700: AB_2684107" "unprognostic (2.04e-3)" "unprognostic (3.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.18e-2)" "unprognostic (1.50e-3)" "unprognostic (2.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.68e-4)" "unprognostic (1.49e-2)" "unprognostic (3.16e-3)" "unprognostic (2.82e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 0.6 0.5 2.3 0.6 4.0 0.5 1.4 1.6 5.9 7.1 1.9 3.2 0.0 6.9 1.1 0.7 7.2 3.2 31.8 0.5 2.2 1.9 7.1 3.6 5.8 0.5 2.7 1.5 0.5 10.1 0.5 1.8 1.2 3.8 18.2 0.8 7.5 35.8 1.3 0.6 16.8 0.8 6.6 1.9 0.5 65.5 0.6 0.8 0.8 3.1 7.8 11.7 26.3 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 14.0 8.5 0.0 0.2 0.0 0.0 16.4 0.0 0.7 0.0 0.0 0.4 0.0 3.0 34.5 0.0 0.0 0.9 0.0 6.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.2 0.0 0.0 0.0 0.1 14.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.0 1.6 5.9 2.2 1.9 2.7 1.5 3.8 0.8 14.9 8.8 0.0 2.1 53.7 0.0 0.8 0.0 2.7 13.6 38.4 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 6.9 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 39.6 0.0 0.0 0.0 3.1 FOXS1 "FKHL18, FREAC10" ENSG00000179772 "Forkhead box S1" O43638 20 31844301-31845619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 28 "Peritubular cells: 53.4;Sertoli cells: 129.4;Smooth muscle cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;hTERT-RPE1: 13.3;RH-30: 11.1;U-2 OS: 14.8;U-251 MG: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042475 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042475: AB_10964265" "unprognostic (2.28e-1)" "unprognostic (8.05e-2)" "unprognostic (1.72e-2)" "unprognostic (5.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.86e-1)" "unprognostic (3.10e-2)" "unprognostic (4.23e-1)" "unprognostic (2.65e-1)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (1.10e-8)" "unprognostic (1.09e-3)" "unprognostic (2.04e-2)" "unprognostic (5.02e-2)" "unprognostic (9.00e-2)" 5.9 3.1 2.7 3.0 4.7 0.3 11.7 2.7 4.9 9.7 2.6 4.8 1.8 0.9 15.5 6.2 2.8 3.6 11.7 14.0 3.2 2.6 5.5 0.9 6.5 4.6 4.1 4.8 4.0 1.1 0.8 3.2 14.4 5.2 5.0 1.6 7.0 2.0 7.0 4.5 1.8 1.8 3.7 2.6 5.5 1.6 9.7 0.6 3.0 4.9 7.0 3.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 14.8 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.7 2.7 4.9 3.2 2.6 4.1 4.8 5.2 0.6 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.4 0.0 3.4 0.1 0.0 0.0 0.4 0.0 0.0 1.3 0.0 4.0 4.6 0.0 1.7 0.0 0.0 0.0 3.3 0.0 53.4 0.0 0.0 129.4 31.6 0.5 0.5 0.3 0.2 0.0 0.0 0.0 FPR2 "ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R" ENSG00000171049 "Formyl peptide receptor 2" P25090 19 51752026-51770526 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 128.2;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 13 "Hofbauer cells: 10.2;Kupffer cells: 24.7;Late spermatids: 14.9;Macrophages: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "neutrophil: 128.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 128.2" "Cell line enriched" "Detected in some" 18 "U-937: 26.0" HPA029154 Approved NA NA "HPA029154: AB_10602133" "unprognostic (3.11e-1)" "unprognostic (5.20e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (3.90e-4)" "unprognostic (3.41e-5)" "unprognostic (1.08e-2)" "unprognostic (4.69e-2)" "unprognostic (5.10e-2)" "unprognostic (1.90e-1)" 7.9 1.1 0.6 30.7 2.1 8.7 0.8 0.4 1.9 0.6 0.8 0.8 0.0 0.4 0.6 0.2 1.0 2.6 3.3 5.0 1.9 0.6 1.3 2.4 17.3 32.2 2.8 0.0 1.6 1.1 0.0 1.1 4.4 2.3 0.6 0.1 1.1 1.0 0.0 1.1 0.4 1.1 3.3 3.0 29.1 1.2 2.5 1.6 0.8 1.0 0.9 0.3 4.4 2.2 0.0 1.7 128.2 12.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.7 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.8 26.0 0.0 0.4 12.7 0.6 0.0 11.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 128.2 0.0 7.5 0.3 0.0 3.9 0.6 2.1 0.4 1.9 1.9 0.6 2.8 0.0 2.3 1.6 0.0 5.3 0.8 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.4 10.2 0.0 0.0 0.6 24.7 14.9 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 FPR3 "FMLPY, FPRH1, FPRL2, RMLP-R-I" ENSG00000187474 "Formyl peptide receptor 3" P25089 19 51795163-51826189 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.9" "Group enriched" "Detected in some" 10 "Hofbauer cells: 59.4;Kupffer cells: 71.5;Macrophages: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "classical monocyte: 3.2;intermediate monocyte: 9.6;myeloid DC: 3.4" "Group enriched" "Detected in many" 43 "dendritic cells: 3.4;monocytes: 9.6" "Group enriched" "Detected in some" 4 "HEL: 14.7;hTERT-RPE1: 4.2" NA NA "unprognostic (3.77e-2)" "unprognostic (1.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-1)" "unprognostic (1.84e-1)" "unprognostic (8.41e-2)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (7.14e-2)" "unprognostic (3.17e-1)" "unprognostic (9.37e-2)" "unprognostic (1.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (1.96e-1)" "unprognostic (4.28e-2)" 35.9 10.0 1.5 12.9 2.1 0.0 6.2 0.6 1.8 3.2 6.6 1.8 0.5 5.9 3.1 7.0 3.4 3.0 10.7 6.3 1.7 1.2 6.8 13.0 25.9 15.1 2.8 0.9 5.4 3.2 0.7 2.2 5.2 2.4 5.0 10.3 4.9 5.1 1.3 4.6 2.3 10.9 4.6 5.2 10.8 3.4 3.3 1.1 8.0 2.7 6.4 10.1 9.3 2.6 0.0 3.4 0.1 9.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 14.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 9.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 1.5 2.1 0.6 1.8 1.7 1.2 2.8 0.9 2.4 1.1 0.0 1.7 2.4 0.0 4.9 0.0 0.3 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.2 0.0 0.5 59.4 0.0 0.0 1.8 71.5 0.0 0.3 66.8 6.8 4.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 4.0 0.7 0.0 0.0 0.0 FRAT2 ENSG00000181274 "FRAT2, WNT signaling pathway regulator" O75474 10 97332497-97334709 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 46.0" "Cancer enhanced" "Detected in all" "testis cancer: 70.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 29.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049763: AB_2680868" "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favorable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.0 3.8 5.7 8.7 7.5 23.8 9.7 8.6 9.4 5.7 18.8 4.8 10.2 21.9 6.0 5.9 13.2 6.4 7.2 7.7 6.1 4.9 5.8 15.6 12.0 22.4 5.6 2.0 3.0 16.5 4.8 3.2 9.6 7.7 8.8 14.0 5.4 22.4 4.9 8.7 17.8 20.3 3.7 5.9 28.0 11.5 14.9 7.3 9.0 8.1 8.3 11.1 7.9 13.2 1.2 1.9 29.3 3.7 0.6 1.1 1.1 5.3 2.1 3.5 15.7 2.5 2.1 13.0 1.2 4.4 1.9 1.9 3.3 6.2 6.5 4.3 1.2 1.1 10.1 9.1 4.7 1.5 9.7 14.0 8.7 4.5 7.2 1.5 13.9 10.5 1.6 10.1 1.8 5.8 4.0 4.6 5.8 7.5 2.1 0.9 8.7 6.0 17.6 21.7 17.7 8.8 6.2 1.4 9.2 4.5 4.8 6.3 5.2 1.5 9.6 6.0 14.9 14.5 22.0 2.1 1.1 1.4 0.8 3.1 5.8 5.9 3.2 1.3 24.1 0.4 3.3 3.7 7.1 0.6 2.3 0.3 0.5 0.7 0.9 1.9 1.2 1.1 0.7 29.3 0.6 3.5 0.4 0.3 1.1 5.7 7.5 8.6 9.4 6.1 4.9 5.6 2.0 7.7 7.3 0.0 4.6 7.7 21.9 28.2 16.8 5.6 7.6 4.0 2.3 14.0 3.9 4.1 10.0 2.1 31.9 4.7 16.0 0.0 4.5 15.6 4.8 26.8 1.1 8.2 7.7 11.1 13.3 3.1 18.0 31.4 2.0 6.4 10.1 1.0 28.5 4.3 4.1 17.3 2.5 2.2 16.9 0.0 7.6 1.2 3.9 46.0 6.5 5.7 27.3 25.6 FRG2 FRG2A ENSG00000205097 "FSHD region gene 2" Q64ET8 4 190024351-190027257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.0;brain: 2.8;skin 1: 3.8" "Cell type enriched" "Detected in single" 8 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 2.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "GAMG: 1.1;HMC-1: 2.1;Karpas-707: 1.1" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.2 0.1 2.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.6 0.0 0.2 0.0 1.1 0.3 0.1 0.0 0.0 1.1 0.4 0.8 0.4 0.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 0.3 0.3 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.7 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRG2B ENSG00000225899 "FSHD region gene 2 family member B" Q96QU4 10 133623895-133626795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;kidney: 1.9;pancreas: 1.2" "Cell type enriched" "Detected in single" 33 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enriched" "Detected in single" 22 "HDLM-2: 13.4" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 13.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMD1 "bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260" ENSG00000153303 "FERM domain containing 1" Q8N878 6 168053166-168101511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 10.8;lymphoid tissue: 29.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 26.3;Paneth cells: 59.6;Proximal tubular cells: 14.4" "Cancer enriched" "Detected in single" 6 "colorectal cancer: 1.9" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 4.7;RPMI-8226: 7.5" "Low region specificity" "Detected in many" HPA030347 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA030347: AB_10600207" "unprognostic (2.43e-2)" "unprognostic (2.74e-1)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.25e-1)" "unprognostic (2.58e-4)" "unprognostic (8.63e-2)" "unprognostic (2.62e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (8.23e-2)" "unprognostic (1.71e-2)" "unprognostic (1.01e-1)" "unprognostic (9.11e-3)" 6.4 0.1 0.0 6.0 0.2 0.0 10.8 0.2 0.1 0.2 9.8 0.0 0.0 2.3 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 5.6 0.2 0.1 0.0 1.5 0.2 0.2 0.2 0.0 0.1 0.3 0.6 0.1 6.8 1.1 1.7 0.0 2.6 0.2 4.5 0.1 1.0 2.9 7.5 8.1 0.0 29.4 0.1 1.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.7 0.0 26.3 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.5 0.0 0.0 10.1 0.6 0.0 0.0 0.0 14.0 0.0 0.0 59.6 1.4 14.4 0.0 0.0 0.0 13.7 4.3 0.0 0.1 0.0 13.7 0.1 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.1 1.8 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.5 0.4 2.3 0.9 0.4 0.1 0.1 0.0 0.0 0.1 0.1 11.2 2.4 1.3 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.2 23.5 3.5 0.0 1.5 37.7 3.1 4.9 13.9 6.7 0.7 0.1 0.4 0.3 0.8 0.4 2.1 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.6 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 20.8 0.6 0.0 1.0 0.9 102.0 66.5 10.2 0.0 2.3 1.8 74.6 0.3 14.9 2.5 112.3 13.1 26.2 0.0 1.7 0.9 2.1 1.0 0.0 0.2 0.8 95.3 1.2 3.1 4.6 100.0 2.0 1.5 0.0 0.0 19.4 2.0 2.0 7.0 4.6 8.7 4.7 71.1 28.9 1.6 1.4 1.1 0.1 0.0 1.6 1.3 FRMPD3 "KIAA1817, RP5-1070B1.1" ENSG00000147234 "FERM and PDZ domain containing 3" Q5JV73 X 107522450-107605251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.6;ovary: 10.3;thyroid gland: 6.0" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 1.1;Cone photoreceptor cells: 3.9;Melanocytes: 1.7" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 1.7" "Cell line enhanced" "Detected in some" "Daudi: 10.9;SCLC-21H: 3.3;U-698: 3.0;WM-115: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003164 Uncertain NA NA "HPA003164: AB_1078260" "unprognostic (1.27e-1)" "unprognostic (3.36e-1)" "unprognostic (5.44e-2)" "unprognostic (2.48e-4)" "unprognostic (1.69e-2)" "unprognostic (6.19e-2)" "unprognostic (2.43e-2)" "unprognostic (4.35e-2)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-9)" "unprognostic (4.59e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-3)" "unprognostic (1.26e-1)" 0.0 0.5 2.5 0.7 1.8 0.1 0.5 8.6 6.7 0.2 0.1 0.0 0.9 0.0 0.1 0.4 0.4 0.0 3.1 5.0 0.0 0.0 0.2 1.3 2.6 10.3 0.1 0.0 0.4 0.0 0.6 0.2 0.4 2.6 0.0 0.0 0.0 1.1 2.2 0.2 0.0 0.5 6.0 0.9 0.1 0.0 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 2.1 0.7 0.0 0.0 0.0 0.8 0.0 0.4 0.2 0.0 0.5 10.9 0.0 0.1 1.3 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.4 3.3 0.2 0.6 0.2 0.0 0.5 0.4 0.0 0.0 1.0 1.2 0.1 0.1 0.0 0.0 3.0 0.1 0.0 4.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.2 1.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 FRRS1 "SDFR2, SDR2" ENSG00000156869 "Ferric chelate reductase 1" Q6ZNA5 1 99708632-99766631 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 27.1" "Cell type enhanced" "Detected in some" 5 "Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.5" "Cell line enhanced" "Detected in many" "HEL: 27.8;K-562: 18.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017883 Approved NA NA "HPA017883: AB_2294223" "unprognostic (3.97e-2)" "unprognostic (8.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (8.54e-3)" "unprognostic (7.00e-2)" "unprognostic (2.64e-1)" "unprognostic (8.25e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (2.65e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (3.54e-2)" 10.3 6.2 0.6 2.7 1.2 1.5 5.1 0.5 1.2 6.4 6.1 1.2 14.5 2.6 10.7 6.5 11.2 2.0 3.4 2.9 0.6 0.6 1.9 27.1 3.8 1.7 2.1 0.0 5.3 2.0 1.5 2.3 9.8 0.9 4.4 4.0 1.6 8.4 13.4 2.0 7.2 8.0 3.3 3.1 1.5 4.2 2.9 1.3 1.4 5.6 5.4 6.0 5.1 7.0 0.3 0.5 5.5 0.8 0.0 0.1 0.1 5.5 1.0 2.4 2.1 7.7 4.1 12.3 1.4 2.7 1.7 6.5 6.7 7.3 3.2 5.8 1.6 2.3 12.8 3.8 5.9 2.2 6.5 2.5 27.8 2.7 7.3 1.1 3.1 7.5 6.1 7.6 3.4 1.3 0.4 0.3 2.1 18.6 0.2 1.4 1.7 1.0 1.2 1.7 12.5 5.1 0.0 9.1 1.3 1.1 13.9 0.5 0.1 2.3 10.5 5.4 1.9 3.8 4.0 0.6 3.0 4.1 2.6 1.5 2.3 0.0 5.5 6.7 1.3 1.4 0.5 0.4 5.5 0.0 0.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.6 1.2 0.5 1.2 0.6 0.6 2.1 0.0 0.9 1.3 0.0 0.0 0.0 1.7 1.6 0.0 0.7 0.0 2.7 0.0 1.8 0.0 2.1 0.0 0.2 0.1 0.1 1.3 0.0 0.0 1.6 1.3 1.0 0.0 2.5 1.0 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 1.0 0.0 0.8 0.3 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.3 2.4 3.1 0.0 0.2 2.2 FSCB "C14orf155, DKFZP434F1017" ENSG00000189139 "Fibrous sheath CABYR binding protein" Q5H9T9 14 44504342-44507279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 27.0" "Group enriched" "Detected in some" 55 "Early spermatids: 273.7;Late spermatids: 442.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003546 Supported NA NA "HPA003546: AB_1845561" "unprognostic (8.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 273.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 442.7 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 6.5 0.0 4.4 1.9 0.0 0.0 0.0 0.0 0.0 FSCN3 ENSG00000106328 "Fascin actin-bundling protein 3" Q9NQT6 7 127591409-127602144 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 62.1" "Cell type enriched" "Detected in some" 6 "Late spermatids: 1905.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTCEpi: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA075174 Enhanced NA NA "HPA075174: " "unprognostic (7.77e-2)" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (9.59e-2)" "unprognostic (1.39e-1)" "unprognostic (3.87e-1)" "unprognostic (5.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.91e-3)" "unprognostic (2.00e-1)" "unprognostic (1.68e-4)" "unprognostic (1.34e-1)" "unprognostic (1.14e-5)" "unprognostic (1.27e-1)" "unprognostic (9.21e-3)" "unprognostic (2.01e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.3 0.0 0.0 0.3 0.0 0.0 1.1 0.3 0.8 0.0 0.0 1.4 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 2.5 0.6 0.0 0.0 0.0 0.5 0.3 0.6 0.0 0.7 0.7 0.7 1.4 0.0 0.0 0.5 0.7 0.2 0.0 0.5 0.2 0.3 0.0 1.5 0.0 0.3 0.0 0.6 0.0 0.1 0.1 0.5 0.0 0.8 0.3 0.7 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 317.1 0.3 0.0 0.0 0.2 0.2 0.2 0.3 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1905.7 8.6 0.9 1.7 0.0 0.1 0.2 0.2 0.6 7.8 0.0 0.4 0.0 0.3 9.8 5.8 1.1 0.2 0.0 0.1 0.1 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.8;pituitary gland: 11.8;testis: 13.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Early spermatids: 47.1;Late spermatids: 39.8;Spermatocytes: 27.4" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 7.3" "Low region specificity" "Detected in many" HPA041002 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.8 0.7 2.9 0.7 9.3 1.1 1.9 1.0 5.7 0.8 11.7 1.5 0.8 0.5 1.4 2.5 0.6 2.3 0.7 0.8 3.1 3.0 1.6 0.7 0.9 0.5 1.2 4.1 0.7 0.6 1.7 11.8 0.8 4.5 0.8 17.8 0.6 0.5 0.7 0.9 1.7 0.6 0.9 1.1 0.6 1.1 13.9 1.4 0.5 1.0 0.0 0.5 1.0 0.9 1.0 1.0 1.8 1.3 1.5 3.4 1.4 0.6 2.3 6.2 0.9 1.1 2.1 0.1 7.3 1.5 1.2 2.2 1.7 0.6 0.5 0.6 2.1 3.1 1.5 1.0 1.2 1.9 2.5 0.6 4.5 1.7 0.1 0.6 0.9 5.0 1.4 5.2 2.8 1.2 1.6 1.3 2.5 0.2 0.6 1.9 0.3 0.6 0.4 0.7 0.3 1.2 0.6 1.2 0.1 2.4 2.7 1.6 4.7 1.5 0.2 0.3 0.5 2.1 0.5 1.0 3.0 1.7 1.6 0.8 1.3 2.7 0.3 6.2 1.7 1.4 1.8 1.3 1.5 3.4 0.8 2.7 0.8 1.8 2.1 1.0 1.0 1.1 0.9 1.1 1.5 1.0 0.0 0.4 1.4 2.9 9.3 1.0 5.7 3.1 3.0 1.2 4.1 4.5 1.4 0.0 0.3 0.5 0.3 0.6 1.0 0.6 2.5 17.4 3.4 1.8 11.8 0.7 1.7 0.6 47.1 0.1 4.9 0.0 0.4 0.1 0.9 0.7 15.1 0.0 0.1 0.0 0.0 0.6 0.0 39.8 1.1 0.1 0.0 0.0 2.2 1.5 0.1 0.0 0.7 2.4 4.9 0.0 0.2 27.4 7.8 0.0 4.7 1.0 1.5 0.3 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738895-185833290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 27.6" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 128.1;Alveolar cells type 2: 68.3;Ciliated cells: 83.0;Early spermatids: 179.5;Spermatocytes: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;OE19: 2.0;RT4: 4.7;SuSa: 2.1;U-266/70: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.4 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.3 0.3 2.7 0.1 0.1 0.0 0.6 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.4 0.6 0.5 0.5 0.3 1.4 0.3 0.2 0.1 0.1 0.3 0.6 0.6 0.1 0.5 3.6 27.6 0.1 0.1 0.4 0.1 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 2.0 0.7 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 128.1 68.3 0.8 0.2 0.5 14.6 3.2 0.0 83.0 56.9 0.0 9.8 0.2 0.0 0.5 179.5 0.6 2.6 0.0 0.2 0.1 0.6 0.3 37.2 0.0 0.3 17.5 7.5 1.8 0.0 20.4 2.0 1.4 1.7 0.0 13.3 5.8 3.2 0.0 3.5 0.0 8.0 0.0 0.5 69.0 2.7 0.3 0.2 0.0 0.6 0.1 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" NA NA Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.4 7.6 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.8 0.9 0.3 6.2 0.0 0.8 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.4 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.2 0.0 0.3 3.4 4.0 0.0 7.2 0.8 0.3 8.2 7.8 0.8 0.3 0.7 7.7 0.0 8.4 33.1 0.7 1.7 1.4 0.1 7.8 2.8 0.3 0.2 0.3 1.4 0.4 0.2 11.9 11.8 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 0.0 1.9 0.0 1.7 1.4 10.3 7.3 0.0 6.7 7.9 0.0 13.7 0.3 0.0 0.2 31.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 8.6 0.0 0.0 13.9 0.3 0.0 10.1 0.0 0.0 3.3 0.8 0.0 0.7 2.3 2.4 6.5 0.0 0.4 0.6 1.4 0.0 0.0 0.0 2.6 FSTL5 "DKFZp566D234, KIAA1263" ENSG00000168843 "Follistatin like 5" Q8N475 4 161383897-162164035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 106.9" "Group enriched" "Detected in some" 10 "Bipolar cells: 248.5;Cone photoreceptor cells: 435.9;Rod photoreceptor cells: 131.6" "Cancer enriched" "Detected in single" 6 "melanoma: 1.7" "Region enriched" "Detected in all" 6 "cerebellum: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (4.90e-2)" "unprognostic (4.46e-1)" "unprognostic (1.52e-2)" "unprognostic (2.03e-1)" "unprognostic (3.66e-2)" "unprognostic (2.99e-2)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.61e-1)" "unprognostic (1.08e-10)" "unprognostic (8.45e-4)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (6.60e-3)" 0.5 12.1 3.5 0.6 6.9 0.5 0.5 106.9 19.9 0.5 0.6 0.6 0.0 0.5 0.5 1.7 0.5 0.6 0.5 0.5 3.2 5.9 0.6 0.5 0.5 0.5 3.0 3.0 0.5 1.0 0.5 1.1 0.7 18.2 0.5 0.8 7.1 0.5 0.6 0.5 0.8 0.6 0.6 3.1 0.5 0.5 1.5 2.9 0.0 0.6 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 5.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.9 106.9 6.9 3.2 5.9 3.0 3.0 18.2 2.9 0.0 0.0 0.0 0.0 0.2 248.5 0.1 0.0 0.0 0.0 0.0 435.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.0 0.0 0.0 0.0 1.7 0.6 0.0 1.7 0.0 0.0 18.6 0.1 0.0 0.4 0.0 131.6 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 FTCDNL1 FONG ENSG00000226124 "Formiminotransferase cyclodeaminase N-terminal like" E5RQL4 2 199760544-199851173 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065748 Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA065748: " "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-2)" "unprognostic (9.80e-2)" "unprognostic (3.09e-1)" "unprognostic (7.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (5.37e-2)" "unprognostic (9.86e-2)" "prognostic favorable (3.31e-4)" "unprognostic (3.92e-2)" "unprognostic (4.63e-2)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.21e-2)" 4.5 9.4 5.5 1.8 19.0 4.0 4.2 1.6 12.0 1.7 2.3 9.7 2.6 2.1 1.2 3.9 2.9 3.9 2.0 5.3 5.8 4.8 8.0 17.9 2.8 3.5 7.6 7.5 2.4 4.3 1.9 2.0 1.5 7.9 2.8 2.5 2.7 4.8 1.7 13.1 2.4 1.8 3.4 9.1 8.0 2.1 2.8 4.0 0.1 11.0 2.4 1.8 1.6 1.9 3.8 10.6 2.0 6.2 1.2 2.4 1.9 0.7 2.4 0.1 0.1 2.5 1.5 1.8 0.9 0.9 1.2 0.5 0.0 4.3 2.4 0.3 1.0 7.2 0.0 1.1 6.4 1.5 2.9 0.8 1.8 1.0 2.0 0.9 6.4 8.1 1.1 0.2 0.5 0.1 0.9 0.0 6.1 3.4 0.1 0.9 7.4 2.4 2.6 2.0 0.6 5.1 0.4 0.2 0.1 0.5 0.0 2.9 0.0 4.2 3.9 4.0 1.8 6.0 8.5 0.7 3.5 0.0 2.2 1.5 6.5 3.5 1.4 6.5 3.3 1.7 0.0 5.3 2.0 0.6 6.2 2.3 3.8 2.2 0.8 6.9 2.1 1.5 2.4 0.0 1.2 5.6 10.6 0.0 1.9 5.5 19.0 1.6 12.0 5.8 4.8 7.6 7.5 7.9 4.0 0.0 0.0 0.5 2.3 2.4 3.3 4.5 5.1 0.0 2.3 3.5 3.9 1.1 1.7 0.2 1.6 1.1 0.0 0.0 0.6 1.2 1.4 1.8 0.0 5.8 7.0 1.6 0.0 2.5 6.2 0.8 0.3 4.3 6.8 1.0 0.6 0.9 0.5 0.0 0.4 8.7 5.4 0.0 3.6 0.5 0.7 1.9 0.2 0.0 0.9 0.7 FTHL17 CT38 ENSG00000132446 "Ferritin heavy chain like 17" Q9BXU8 X 31071241-31072053 "Predicted intracellular proteins" "Iron storage" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.7" "Cell type enriched" "Detected in single" 23 "Spermatocytes: 14.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "hTERT-HME1: 1.4;T-47d: 1.2" NA NA "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.5 0.0 0.0 0.0 0.0 0.0 FUK FLJ39408 ENSG00000157353 Fucokinase Q8N0W3 16 70454421-70480274 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041971 Approved Approved Vesicles NA NA Vesicles "HPA041971: AB_10795648" "unprognostic (4.55e-1)" "unprognostic (3.21e-1)" "unprognostic (1.73e-2)" "unprognostic (3.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.79e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (4.82e-3)" "unprognostic (4.85e-2)" "prognostic favorable (8.91e-4)" "unprognostic (2.49e-2)" "unprognostic (9.68e-2)" "unprognostic (8.89e-2)" "prognostic favorable (8.38e-4)" 6.7 11.3 11.5 9.8 13.2 8.5 7.3 13.9 13.5 7.5 12.1 15.5 15.1 18.5 8.3 11.5 8.2 10.8 9.4 7.2 9.4 7.4 13.1 11.9 8.1 9.1 12.5 12.4 10.5 12.2 17.1 16.4 11.0 9.8 9.1 7.7 12.9 10.8 9.4 9.0 13.0 13.1 6.3 9.3 9.7 12.2 6.1 12.5 7.2 12.0 4.2 11.1 7.6 6.8 4.3 3.2 3.9 4.4 2.9 6.7 2.5 3.1 4.4 2.6 5.7 1.5 1.8 9.9 1.8 2.9 2.4 3.1 3.9 10.3 2.2 8.8 1.7 0.7 4.5 1.8 4.5 1.5 4.2 6.3 2.9 8.0 4.5 3.8 3.7 2.2 3.0 5.3 1.8 4.5 3.6 4.5 4.3 5.4 2.7 1.8 9.8 4.4 8.5 1.6 5.1 2.5 6.5 0.6 9.7 6.1 5.5 4.2 5.1 10.2 3.5 5.2 2.1 15.0 7.2 4.7 1.9 2.5 4.1 2.1 9.6 4.5 4.5 3.4 3.5 4.2 0.6 4.4 1.8 4.8 2.5 4.1 1.9 4.8 4.8 2.7 4.3 6.7 3.1 3.9 2.9 2.8 3.2 3.2 2.5 11.5 13.2 13.9 13.5 9.4 7.4 12.5 12.4 9.8 12.5 3.0 8.1 1.5 1.7 1.0 5.0 4.5 2.5 0.0 3.4 15.7 3.9 4.7 1.7 4.5 0.8 3.6 15.4 0.0 6.3 2.2 2.5 2.6 0.0 5.8 4.2 9.5 4.1 7.4 3.8 1.1 2.8 2.1 1.7 3.6 10.7 4.5 4.5 11.5 6.0 5.5 7.3 0.0 1.7 4.2 2.0 2.4 4.3 2.9 13.6 1.3 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 187.5;Late spermatids: 217.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: AB_2682327, HPA058655: AB_2683789" "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.2 4.4 7.1 8.4 11.1 11.3 3.7 4.5 7.3 4.4 5.9 6.7 3.9 2.5 5.5 5.6 3.7 6.1 10.2 4.1 4.4 5.7 3.9 8.4 3.7 7.3 5.1 1.8 3.0 7.9 7.4 1.1 5.4 9.4 8.7 4.6 7.6 3.4 4.1 1.3 6.5 2.8 10.0 6.3 2.9 4.9 5.5 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 7.8 3.8 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 3.0 1.3 0.0 2.6 2.4 3.1 2.2 5.1 1.4 3.4 3.5 9.8 9.6 1.7 4.1 187.5 3.0 2.6 0.0 3.5 5.8 4.1 1.1 5.7 3.9 3.0 3.2 3.5 4.3 1.8 217.3 6.4 1.9 1.7 2.8 2.9 31.7 3.1 0.0 4.6 2.8 10.8 0.0 2.8 1.6 2.4 1.5 5.0 0.5 2.9 1.3 FUT3 "CD174, LE" ENSG00000171124 "Fucosyltransferase 3 (Lewis blood group)" P21217 19 5842888-5851474 "Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 106.6;Mucus-secreting cells: 61.1;Paneth cells: 66.6;Undifferentiated cells: 39.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 29.9;hTCEpi: 4.7;OE19: 13.4;RH-30: 10.1;SK-BR-3: 4.8" HPA046966 Supported NA NA "HPA046966: AB_2679879" "prognostic unfavorable (6.86e-4)" "unprognostic (2.59e-1)" "unprognostic (1.06e-1)" "unprognostic (9.12e-2)" "unprognostic (8.58e-3)" "unprognostic (1.63e-3)" "unprognostic (3.88e-2)" "unprognostic (2.03e-2)" "unprognostic (4.02e-2)" "unprognostic (3.98e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "prognostic favorable (8.22e-7)" "unprognostic (5.66e-3)" "unprognostic (9.56e-2)" "unprognostic (4.30e-2)" "unprognostic (1.07e-1)" 0.2 0.1 0.2 14.5 0.2 0.0 0.4 0.2 0.2 10.9 40.4 0.2 32.5 18.8 0.4 0.5 53.6 0.7 21.5 0.1 0.2 0.2 3.8 0.9 5.1 0.1 0.2 0.1 0.5 4.7 0.0 0.3 0.6 0.1 1.0 18.1 0.2 27.5 31.6 0.1 1.0 49.3 1.0 0.2 0.1 8.1 1.3 0.1 0.3 0.1 14.9 38.4 2.9 16.1 0.2 1.6 0.8 0.6 0.0 0.5 0.0 29.9 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.4 0.0 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 13.4 0.0 0.0 10.1 1.0 0.0 0.5 0.0 0.1 0.0 4.8 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.8 0.0 0.0 1.6 0.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 4.5 0.0 1.8 0.0 1.4 0.3 12.7 2.7 2.3 0.0 0.0 0.0 0.0 33.7 4.3 0.0 106.6 0.0 12.8 0.1 0.0 0.5 9.2 0.2 0.0 0.0 13.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 61.1 1.4 29.6 66.6 0.0 12.0 32.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 39.4 16.0 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.2 2.9 5.3 1.5 0.7 1.3 1.5 7.1 2.3 0.0 3.6 2.5 0.7 0.8 1.7 0.1 1.3 10.7 1.7 5.3 1.2 0.1 1.6 20.8 4.7 2.5 0.0 1.7 0.0 0.3 2.1 4.8 5.3 0.0 1.6 0.8 4.3 13.5 2.0 6.5 2.0 3.9 0.0 0.0 1.4 1.1 1.4 0.5 0.9 2.1 0.8 3.1 1.2 26.3 1.9 1.1 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.7 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 0.0 0.0 0.0 2.3 1.4 0.6 0.8 20.4 2.7 2.3 1.8 3.9 12.9 0.0 12.8 0.2 1.3 12.1 0.0 15.5 2.0 4.6 1.6 0.0 0.8 7.7 0.0 9.8 2.5 10.6 0.2 4.0 3.3 3.3 10.0 20.8 0.5 18.4 3.5 1.1 1.9 8.8 0.0 1.4 0.9 3.2 0.5 1.8 2.5 14.4 1.2 FUT5 FUC-TV ENSG00000130383 "Fucosyltransferase 5" Q11128 19 5865826-5870540 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.8;SH-SY5Y: 3.0;U-266/70: 1.7" HPA046966 Uncertain NA NA "HPA046966: AB_2679879" "unprognostic (7.72e-2)" "unprognostic (3.59e-1)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" 0.2 0.1 1.0 0.1 0.5 3.6 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.3 1.1 0.4 0.3 0.2 1.1 0.1 0.2 0.9 0.2 0.5 0.1 0.3 0.1 0.1 0.1 0.4 0.1 1.2 0.5 0.1 0.1 0.8 0.2 0.1 1.6 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 2.9;Exocrine glandular cells: 1.6" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.1 4.1 0.0 0.0 0.0 0.0 0.0 9.5 9.7 0.2 0.0 5.5 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 0.0 0.0 0.0 0.6 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 FZD9 "CD349, FZD3" ENSG00000188763 "Frizzled class receptor 9" O00144 7 73433783-73436120 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.4" "Group enriched" "Detected in some" 5 "Early spermatids: 7.3;Late spermatids: 10.0;Muller glia cells: 4.8;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.4;MCF7: 3.6;NTERA-2: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (9.60e-2)" "unprognostic (4.03e-2)" "unprognostic (3.16e-2)" "unprognostic (9.15e-3)" "unprognostic (1.10e-1)" "unprognostic (6.91e-2)" "unprognostic (2.29e-2)" "unprognostic (2.26e-1)" "unprognostic (2.04e-1)" "unprognostic (7.17e-3)" "unprognostic (1.20e-1)" "unprognostic (7.24e-2)" "unprognostic (5.90e-5)" "unprognostic (8.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.22e-1)" "unprognostic (5.21e-2)" 4.4 1.2 6.8 0.7 4.7 2.4 1.1 3.3 7.0 1.1 1.3 4.5 0.0 1.9 0.9 0.9 1.3 0.9 0.7 0.8 7.1 6.3 0.9 0.8 0.9 0.9 7.0 4.5 0.9 3.8 1.6 4.3 1.9 5.0 3.0 0.8 1.4 4.4 1.4 14.4 1.7 2.9 0.9 3.6 1.0 1.0 5.4 6.7 0.3 0.9 1.7 0.8 0.7 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 2.7 2.8 3.1 0.0 0.1 0.0 1.9 0.0 0.4 0.1 0.7 0.0 0.0 0.9 0.1 1.2 0.2 1.4 0.0 0.0 0.0 8.4 0.0 0.6 0.9 1.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.0 2.8 0.0 0.2 3.6 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 2.4 1.7 1.8 0.4 1.7 0.9 0.1 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 6.8 4.7 3.3 7.0 7.1 6.3 7.0 4.5 5.0 6.7 0.0 0.0 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.3 0.6 0.0 0.0 0.3 0.2 0.3 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 1.0 0.0 4.8 0.2 0.0 0.4 0.0 0.7 6.5 0.5 0.4 0.3 1.0 0.0 0.0 0.0 0.3 GAB4 ENSG00000215568 "GRB2 associated binding protein family member 4" Q2WGN9 22 16961936-17008222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 19.6" "Group enriched" "Detected in some" 4 "Early spermatids: 6.2;Late spermatids: 17.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.2" HPA044621 Uncertain NA NA "HPA044621: AB_10967265" 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.4 0.6 0.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.7 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.2 0.0 0.4 0.0 0.3 0.9 1.8 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.6 0.4 0.4 0.1 0.5 9.6 0.5 0.1 0.8 1.2 0.2 4.5 0.4 5.1 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 38.4 3.9 0.0 3.3 0.0 6.4 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 6.9 0.6 0.0 1.7 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 GABRA4 ENSG00000109158 "Gamma-aminobutyric acid type A receptor alpha4 subunit" P48169 4 46918900-46994407 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 11.0;Muller glia cells: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "REH: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.78e-2)" "unprognostic (6.57e-3)" "unprognostic (2.46e-1)" "unprognostic (2.23e-1)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "unprognostic (6.91e-2)" 0.0 0.1 2.7 0.1 8.9 0.0 0.0 0.3 16.1 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.1 4.0 1.9 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.5;TIME: 1.1;U-266/70: 2.5" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in some" 44 "cerebellum: 189.6" CAB022462 Approved NA NA "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRE ENSG00000102287 "Gamma-aminobutyric acid type A receptor epsilon subunit" P78334 X 151953124-151974680 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 36.4;vagina: 27.7" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 51.4;Urothelial cells: 32.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "hypothalamus: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.4;EFO-21: 14.9;HeLa: 6.7;SiHa: 7.0" "Low region specificity" "Detected in many" HPA045918 Uncertain NA NA "HPA045918: AB_10961281" "unprognostic (1.33e-2)" "unprognostic (6.75e-2)" "unprognostic (3.50e-3)" "unprognostic (1.39e-3)" "unprognostic (2.43e-1)" "unprognostic (7.52e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (3.58e-2)" "unprognostic (1.55e-1)" "unprognostic (6.44e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (4.05e-11)" "unprognostic (1.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (5.28e-2)" 14.8 1.0 1.5 2.2 2.8 0.3 16.5 1.0 1.6 8.9 5.8 0.0 2.2 1.4 6.0 4.1 5.0 1.5 4.2 16.3 1.0 21.8 1.1 0.9 2.3 0.7 1.1 0.6 1.6 2.5 0.4 4.1 36.4 4.5 5.9 0.8 3.8 2.0 6.3 0.9 5.6 10.1 2.5 1.1 0.9 1.0 0.9 0.4 0.0 2.5 5.9 3.5 2.9 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.4 0.0 0.0 0.6 0.0 1.1 0.5 2.3 0.8 0.0 14.9 3.1 0.0 2.4 0.0 0.8 0.7 0.0 0.5 1.7 6.7 0.9 0.2 0.0 0.2 1.0 0.7 1.2 0.3 1.4 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 1.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 1.0 1.3 1.0 21.8 1.1 0.6 4.5 0.4 14.9 5.7 0.0 20.6 15.2 0.0 6.4 12.7 2.7 14.8 1.8 0.0 17.3 0.0 3.6 1.7 7.9 9.3 0.0 0.3 2.0 9.7 14.0 0.0 0.8 2.7 0.0 1.7 4.3 0.6 1.8 1.4 0.2 1.7 0.0 1.8 0.5 3.7 8.6 2.1 0.0 0.3 0.0 4.7 1.1 1.7 9.5 51.4 0.5 2.3 32.0 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor gamma1 subunit" Q8N1C3 4 46035769-46124081 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 35.7" "Group enriched" "Detected in some" 5 "Early spermatids: 5.9;Muller glia cells: 15.1;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035622, HPA058102" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA035622: AB_10603669, HPA058102: " "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 1.5 1.5 20.3 1.2 25.9 1.2 1.3 26.4 35.7 1.3 1.3 12.2 0.0 1.4 1.4 1.3 1.3 1.7 1.3 1.2 26.0 14.6 1.4 1.4 1.2 1.3 10.2 14.0 3.9 1.2 1.3 1.6 1.2 17.9 1.2 1.3 0.0 1.2 1.3 1.2 1.2 1.4 1.4 17.8 1.4 1.3 1.8 17.8 0.0 1.5 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.3 1.8 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 25.9 26.4 18.5 26.0 14.6 10.2 14.0 17.9 17.8 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 1.8 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GABRG3 ENSG00000182256 "Gamma-aminobutyric acid type A receptor gamma3 subunit" Q99928 15 26971282-27541991 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;prostate: 13.5;testis: 16.6" "Group enriched" "Detected in some" 36 "Early spermatids: 81.6;Late spermatids: 207.6;Muller glia cells: 241.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 5.0;PC-3: 6.5;SK-MEL-30: 4.2;U-2 OS: 3.0;U-266/70: 3.8;U-87 MG: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054010 Approved NA NA "HPA054010: AB_2682342" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (3.50e-2)" "unprognostic (2.61e-1)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (4.41e-1)" "unprognostic (1.43e-5)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" 0.5 1.3 2.2 0.8 10.4 0.5 1.2 3.1 15.3 2.2 0.5 0.8 0.0 0.4 0.7 4.4 0.5 1.3 0.5 0.4 3.0 5.8 1.0 0.6 0.5 1.5 1.0 7.8 0.5 0.4 0.4 6.4 0.5 2.7 13.5 0.5 4.0 1.5 3.4 0.5 0.9 0.4 0.6 0.8 2.3 0.4 16.6 0.5 0.3 3.3 0.0 1.9 0.4 0.7 0.8 0.3 0.9 0.4 0.3 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 6.5 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.8 0.0 0.0 17.1 0.1 0.0 0.4 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.8 0.3 0.1 0.9 0.3 0.1 0.3 0.1 0.0 2.2 10.4 3.1 15.3 3.0 5.8 1.0 7.8 2.7 0.5 0.0 0.0 0.0 0.1 0.0 3.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 81.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 207.6 0.9 0.0 0.0 0.0 0.0 241.7 0.0 0.0 0.7 0.2 2.6 0.0 0.0 1.4 4.9 0.0 0.0 0.0 0.0 0.1 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor pi subunit" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;lymphoid tissue: 57.7" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 48.4;Pancreatic endocrine cells: 33.1;Urothelial cells: 141.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 10.1" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;monocytes: 6.1" "Cell line enhanced" "Detected in many" "A-431: 39.5;EFO-21: 46.1;HeLa: 27.7;PC-3: 63.2;SuSa: 85.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 1.5 0.5 0.5 1.3 0.5 1.1 31.6 0.5 1.1 18.5 1.7 0.6 2.6 2.6 30.4 9.9 37.0 2.2 8.6 1.0 0.5 0.4 6.9 3.8 2.5 0.5 0.5 0.5 1.1 4.3 0.0 2.4 5.5 0.6 6.8 0.4 0.8 25.5 3.2 2.0 10.0 3.9 0.5 0.5 0.8 5.0 1.0 0.5 2.5 0.6 3.1 57.7 1.2 20.0 0.9 1.1 10.1 6.1 0.2 1.3 3.1 39.5 1.8 1.9 1.3 0.1 0.8 4.6 0.7 0.2 0.1 0.1 7.1 4.5 0.6 46.1 0.2 0.4 14.3 1.2 0.0 0.1 0.6 1.4 2.6 27.7 1.0 0.1 0.9 2.2 0.3 0.5 0.5 0.3 1.5 0.2 2.5 10.6 5.0 0.0 1.2 1.7 0.8 16.2 0.7 63.2 2.5 1.2 1.5 2.6 2.2 1.6 0.7 14.6 0.7 0.4 85.1 0.8 0.4 1.6 3.7 13.5 3.0 2.9 1.9 1.2 1.1 0.5 2.6 0.5 10.1 2.3 6.8 0.5 1.7 1.3 0.3 0.5 0.4 0.7 0.9 0.7 0.6 5.4 0.2 6.1 1.1 0.7 3.1 0.5 0.5 0.5 0.6 0.5 0.4 0.5 0.5 0.6 0.5 3.0 1.1 0.0 14.6 0.0 0.0 0.4 48.4 12.0 15.9 1.8 0.0 3.6 0.0 0.8 0.0 0.0 0.0 0.0 12.6 0.1 0.8 15.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.4 141.9 GABRQ THETA ENSG00000268089 "Gamma-aminobutyric acid type A receptor theta subunit" Q9UN88 X 152638183-152657534 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 28.9;cervix, uterine: 16.2" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.5;Spermatogonia: 1.1;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 9.0;SiHa: 8.7;SuSa: 4.1;U-87 MG: 28.8" "Region enriched" "Detected in many" 5 "hypothalamus: 61.6" "Region enhanced" "Detected in many" "midbrain: 24.9" NA NA "unprognostic (3.68e-3)" "unprognostic (7.78e-2)" "unprognostic (9.16e-2)" "unprognostic (1.17e-4)" "unprognostic (3.38e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-4)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-1)" "unprognostic (3.76e-2)" "unprognostic (3.10e-5)" "unprognostic (3.43e-3)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.70e-2)" 0.2 4.4 10.5 0.2 5.7 0.1 0.1 0.0 7.5 16.2 0.2 1.5 1.0 0.2 2.6 0.5 1.1 0.3 0.1 0.2 23.4 0.2 0.1 0.1 0.2 0.0 13.6 0.1 0.1 0.1 0.0 0.3 28.9 0.9 0.2 0.0 0.1 1.7 0.1 0.7 0.5 1.6 7.2 0.2 0.1 4.7 1.0 0.0 0.3 1.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 1.2 8.7 1.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 1.6 0.7 0.0 0.0 0.3 GABRR1 ENSG00000146276 "Gamma-aminobutyric acid type A receptor rho1 subunit" P24046 6 89177501-89231278 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 12.3;testis: 4.6" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 53.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "amygdala: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" "unprognostic (3.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.90e-2)" "unprognostic (5.78e-2)" "unprognostic (4.90e-2)" "unprognostic (8.32e-3)" "unprognostic (2.52e-3)" "unprognostic (1.74e-1)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (1.62e-5)" "unprognostic (1.18e-1)" "unprognostic (9.90e-2)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" 0.4 0.0 2.2 0.1 0.1 0.0 0.2 0.3 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 1.0 0.3 0.2 0.1 12.3 0.2 0.1 0.7 0.6 0.7 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.2 0.6 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 6.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.6 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 53.4 0.3 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 3.8 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.1 GABRR2 ENSG00000111886 "Gamma-aminobutyric acid type A receptor rho2 subunit" P28476 6 89257208-89315299 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "retina: 18.8" "Cell type enriched" "Detected in some" 13 "Bipolar cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Lineage enhanced" "Detected in single" "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "U-266/70: 4.4;U-266/84: 1.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-2)" "unprognostic (1.47e-4)" "unprognostic (1.56e-1)" "unprognostic (1.88e-4)" "unprognostic (4.19e-1)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (9.13e-2)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-1)" "unprognostic (1.41e-1)" "unprognostic (1.54e-6)" "unprognostic (3.69e-2)" "unprognostic (7.81e-2)" "unprognostic (5.79e-2)" "unprognostic (7.15e-3)" 0.2 0.6 0.2 0.5 0.4 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.0 0.7 0.5 0.2 0.1 0.4 0.2 0.3 0.2 0.3 0.4 0.1 0.9 0.3 0.1 0.1 0.8 0.0 0.2 0.1 0.1 0.3 0.0 18.8 0.6 0.2 1.5 0.5 0.1 0.1 0.2 0.4 0.1 0.6 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 4.4 1.6 0.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.4 0.3 0.3 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, O76087, P0CL82" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 16.2;testis: 58.6" "Cell type enriched" "Detected in single" 5 "Spermatogonia: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 136.7;K-562: 133.6" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 58.6 0.0 0.0 0.0 0.0 7.0 8.5 3.1 9.1 9.6 14.7 16.2 1.1 0.0 0.0 136.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.5 6.9 0.9 0.0 0.1 0.0 7.9 0.0 0.0 0.0 17.0 0.9 9.1 3.1 3.9 7.5 2.5 7.0 10.3 7.2 0.0 6.2 8.5 7.5 0.9 9.6 6.3 8.5 14.7 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 33 "blood: 7.4;stomach 1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 7.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "AN3-CA: 149.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 1.3 2.5 0.4 7.4 6.2 0.0 0.0 0.0 149.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 2.5 1.3 0.8 2.2 1.3 1.5 3.6 0.5 0.0 2.6 0.6 3.2 0.0 0.4 1.8 1.4 7.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT13 "GalNAc-T13, KIAA1918" ENSG00000144278 "Polypeptide N-acetylgalactosaminyltransferase 13" Q8IUC8 2 153871913-154453849 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 23.8;Bipolar cells: 15.1;Cone photoreceptor cells: 49.1;Horizontal cells: 68.3" "Cancer enriched" "Detected in some" 5 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SH-SY5Y: 28.2;U-251 MG: 7.4;WM-115: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060775 Approved NA NA "HPA060775: AB_2684358" "unprognostic (1.97e-1)" "unprognostic (3.43e-3)" "unprognostic (2.47e-2)" "unprognostic (1.00e-3)" "unprognostic (4.21e-3)" "unprognostic (7.73e-3)" "unprognostic (6.50e-2)" "unprognostic (8.17e-2)" "unprognostic (3.57e-1)" "unprognostic (9.15e-2)" "unprognostic (3.83e-2)" "unprognostic (3.09e-2)" "unprognostic (5.17e-2)" "unprognostic (2.05e-5)" "unprognostic (8.61e-3)" "unprognostic (1.52e-1)" "unprognostic (2.05e-1)" 3.0 7.7 8.5 0.7 6.2 0.6 1.4 39.0 29.1 3.1 0.9 7.9 0.6 0.7 3.1 2.3 0.7 1.0 1.1 0.6 7.8 8.9 0.6 0.4 3.4 0.4 8.3 3.1 1.1 1.0 0.5 3.1 1.0 10.5 3.6 1.0 1.1 10.9 2.6 1.7 0.8 0.8 2.0 10.4 0.5 1.1 1.3 4.3 0.0 0.4 0.0 0.5 1.5 0.2 0.2 0.6 2.2 0.9 0.2 0.8 0.0 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.4 0.0 0.0 0.0 1.8 0.0 3.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.1 4.7 0.1 4.4 0.0 0.2 0.6 0.0 0.0 4.8 28.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.1 7.4 0.3 0.0 0.0 4.6 0.0 21.1 0.0 0.9 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.1 0.2 0.0 0.6 0.4 0.0 8.5 6.2 39.0 7.4 7.8 8.9 8.3 3.1 10.5 4.3 23.8 1.4 0.0 0.0 0.1 15.1 0.8 0.0 0.0 2.3 0.0 49.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 68.3 3.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.4 0.1 0.0 0.0 0.0 0.0 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 44.9 44.3 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 33.7 0.0 0.4 0.5 0.3 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 7.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 0.0 1.7 0.0 0.5 0.5 0.8 1.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.5 15.2 0.0 0.0 0.0 0.0 2.9 1.2 1.1 0.2 0.1 0.0 0.0 39.9 0.6 10.6 1.7 0.2 0.0 0.0 0.0 48.3 0.2 0.0 0.7 0.0 3.1 0.0 1.2 10.2 0.5 0.6 0.0 0.0 0.0 0.1 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell type enhanced" "Detected in single" 28 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.5 0.0 0.0 30.5 0.0 10.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270876-11622005 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 41.7;Cytotrophoblasts: 37.3;Endothelial cells: 34.9;Muller glia cells: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "A-431: 18.9;HaCaT: 24.2;HBEC3-KT: 16.9;PC-3: 17.0;RPMI-8226: 17.7;SK-BR-3: 22.1;U-87 MG: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012955, HPA070681" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 200000 "Golgi apparatus" "Vesicles, Cytosol" "HPA012955: AB_1849460, HPA070681: " "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.6 6.0 15.5 4.9 13.5 0.8 9.1 21.3 16.2 7.0 13.3 5.8 8.3 3.9 15.0 6.4 7.8 7.6 12.6 21.9 13.1 7.0 19.7 6.6 31.2 5.8 10.0 12.1 3.8 9.5 9.1 4.3 26.6 12.8 8.2 4.3 7.1 10.4 11.5 6.1 7.6 4.9 15.0 6.5 4.0 4.1 13.3 8.4 0.7 39.2 5.6 4.2 10.3 9.1 0.0 0.0 0.0 0.0 0.0 1.7 0.3 18.9 6.9 0.9 4.2 0.0 0.0 0.1 2.1 5.2 0.2 0.0 0.7 2.5 0.0 1.5 0.0 2.6 24.2 4.6 16.9 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 7.0 0.0 6.4 0.0 0.0 8.6 0.0 0.0 0.9 4.6 0.2 0.0 0.7 0.0 17.0 0.0 0.0 17.7 13.1 2.3 0.3 1.9 3.5 22.1 0.1 0.6 4.6 0.0 0.0 0.3 3.8 0.1 0.1 0.0 0.0 0.0 16.0 0.0 4.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.5 13.5 21.3 16.2 13.1 7.0 10.0 12.1 12.8 8.4 41.7 5.8 0.0 5.8 4.9 0.8 7.3 22.9 12.0 14.8 19.2 2.0 37.3 13.3 18.3 2.1 34.9 0.0 0.0 3.4 2.2 2.8 9.8 1.1 2.6 2.3 0.0 0.0 22.1 1.5 0.7 1.4 0.5 1.7 0.0 0.0 44.1 5.8 0.0 2.8 28.1 1.8 12.9 5.2 0.5 1.0 4.6 12.9 0.0 0.8 1.0 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 35.4" "Cell type enriched" "Detected in many" 4 "granulocytes: 164.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 3.1 1.8 4.0 4.1 9.5 4.4 10.6 1.0 5.1 19.5 13.4 15.4 0.5 11.8 0.9 14.4 2.8 3.7 6.8 0.8 7.1 3.6 2.5 0.8 4.1 4.0 14.4 3.6 1.4 6.3 0.4 1.6 9.9 5.8 1.3 3.9 0.9 23.8 6.3 0.6 5.5 16.9 0.8 8.3 5.5 35.4 0.8 9.7 6.6 1.8 2.3 6.6 2.2 2.2 2.9 3.7 23.8 6.5 10.8 3.4 2.8 11.5 1.2 0.2 0.0 0.0 0.1 18.5 19.3 33.6 8.3 5.6 33.2 6.1 0.1 1.8 10.9 0.0 11.1 0.6 8.4 5.2 2.6 1.2 7.3 0.2 0.2 0.3 3.9 26.1 0.7 7.8 7.4 7.1 0.0 20.3 4.2 1.6 0.3 0.0 22.6 12.4 2.9 1.6 28.5 20.9 0.0 0.0 3.3 6.5 0.8 0.1 7.4 0.1 33.8 0.0 3.9 18.8 1.7 23.9 0.0 4.2 0.0 0.0 0.6 0.1 1.0 2.3 8.7 0.1 4.5 4.4 23.8 3.4 3.7 1.4 0.8 1.7 2.6 3.7 2.9 2.7 2.3 0.8 10.8 6.5 3.1 1.1 2.8 4.0 9.5 1.0 5.1 7.1 3.6 14.4 3.6 5.8 9.7 3.0 3.7 15.2 2.7 2.6 0.4 0.8 2.5 10.7 14.8 1.8 0.0 11.3 3.3 2.7 1.6 1.4 20.4 0.0 9.8 40.7 1.7 5.0 164.7 0.0 13.2 0.0 0.0 2.5 12.0 1.0 0.0 11.8 1.7 1.0 14.2 0.0 15.6 26.2 0.4 1.8 0.0 0.0 0.9 0.2 1.2 8.2 4.0 8.7 9.2 5.4 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 6 "Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5" "Not detected" "Not detected" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Yes No "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 26.1 0.0 0.0 0.2 0.1 9.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 11.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 6.0 0.3 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.3 0.0 0.0 88.4 1.4 0.0 0.0 0.0 32.6 0.1 0.3 0.0 2.5 1.0 0.3 6.5 0.0 11.6 3.6 0.0 0.0 0.0 1.8 0.0 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019934 "Disease related genes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.0" "Group enriched" "Detected in some" 89 "Early spermatids: 360.6;Late spermatids: 297.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced NA NA "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 297.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.7 1.5 0.0 0.0 0.0 0.0 0.0 GALNTL6 "GalNAc-T6L, GALNT17" ENSG00000174473 "Polypeptide N-acetylgalactosaminyltransferase like 6" Q49A17 4 171812254-173041559 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 7.3;testis: 6.4" "Group enriched" "Detected in some" 5 "Club cells: 3.4;Early spermatids: 11.9;Exocrine glandular cells: 3.7;Late spermatids: 13.6;Melanocytes: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.5;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 8 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.2;Karpas-707: 2.2;SCLC-21H: 2.3;SK-MEL-30: 1.8;U-266/70: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031019 Uncertain "Intracellular and membrane" NA NA "HPA031019: AB_10601653" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-2)" "unprognostic (5.73e-2)" "unprognostic (7.50e-2)" "unprognostic (8.32e-2)" "unprognostic (3.25e-1)" "unprognostic (9.55e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (2.80e-1)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-2)" "unprognostic (4.84e-3)" "unprognostic (1.73e-2)" 0.2 0.7 3.9 1.2 8.3 1.1 0.7 1.0 9.5 3.3 1.0 0.6 0.0 0.7 0.3 0.3 0.2 0.3 0.5 0.5 3.6 4.1 0.3 0.5 0.5 1.3 7.6 2.4 0.1 0.5 0.1 0.0 0.1 1.8 2.2 0.7 1.3 0.3 0.2 0.5 0.6 1.2 0.3 0.5 7.3 2.9 6.4 1.2 0.0 0.5 1.1 0.4 0.5 0.6 4.5 0.5 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.7 1.1 0.0 1.2 0.0 0.3 0.6 0.0 0.0 0.0 3.2 0.0 0.3 0.7 2.2 0.2 1.0 0.3 0.5 1.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.9 0.0 0.5 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 2.6 0.0 0.0 0.3 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.3 1.0 5.9 3.6 4.1 7.6 2.4 1.8 1.2 0.0 1.0 0.0 0.0 0.2 0.6 1.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 13.6 0.3 0.0 5.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.9 0.3 0.0 0.0 0.1 0.1 GALP ENSG00000197487 "Galanin like peptide" Q9UBC7 19 56176020-56185775 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Hormone, Neuropeptide" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 4.4;liver: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enhanced" "Detected in many" "pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;EFO-21: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hippocampal formation: 29.0" HPA053938 Uncertain "Secreted in brain" NA NA "HPA053938: AB_2682315" "unprognostic (8.51e-3)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (7.02e-2)" 0.0 0.2 1.2 0.0 1.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.1 1.1 0.7 0.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016949, HPA051522" Approved Approved Cytosol NA NA Cytosol "HPA016949: AB_1849465, HPA051522: " "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favorable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 13.3 14.0 12.5 17.3 20.7 17.6 14.4 16.6 14.2 15.8 14.3 25.6 15.4 11.7 17.9 26.0 20.7 12.9 13.0 12.4 13.4 10.4 13.5 18.0 30.5 13.8 25.0 13.7 18.8 13.1 17.4 20.5 10.8 19.8 13.1 17.8 18.3 20.4 13.7 23.9 13.9 15.4 15.9 25.1 15.5 13.1 24.5 22.6 17.4 16.8 12.3 18.3 16.2 16.3 17.6 12.2 9.3 10.1 4.0 7.4 4.7 6.2 3.2 7.9 8.6 9.6 13.6 5.0 13.7 14.8 15.1 12.7 4.7 4.4 3.4 7.5 13.8 10.5 13.0 9.5 14.6 10.5 8.5 4.4 8.5 8.6 9.2 8.1 8.2 7.4 9.2 8.7 6.1 10.5 8.5 10.2 8.7 8.8 9.6 11.9 1.3 5.5 9.1 4.9 2.7 4.2 10.6 9.3 11.8 11.4 5.8 6.0 8.5 7.7 6.7 4.8 4.5 2.5 19.4 9.2 15.9 4.2 13.1 8.2 10.4 13.7 6.9 7.5 15.1 8.7 9.3 9.3 7.4 3.7 10.1 5.0 16.2 5.7 6.9 12.2 17.6 7.4 4.4 5.0 4.0 8.1 9.6 5.5 4.7 12.5 20.7 16.6 14.2 13.4 10.4 25.0 13.7 19.8 22.6 17.9 36.3 8.3 15.1 9.3 5.1 6.9 2.5 12.0 10.3 1.8 9.8 4.4 5.0 4.3 9.0 4.0 8.4 0.0 3.3 4.2 4.5 6.5 10.4 9.0 6.0 3.2 4.1 7.4 11.6 3.0 6.6 10.3 13.5 11.8 5.5 10.4 5.0 16.5 6.0 6.3 6.5 12.9 5.2 14.2 14.4 4.5 2.4 5.0 7.5 21.3 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 7.8;RPMI-8226: 5.6;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: AB_2732270" "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.5 0.3 1.7 1.8 0.6 0.0 1.6 0.1 0.6 0.9 3.2 0.0 0.3 0.0 1.3 0.0 2.7 1.8 0.8 0.7 0.3 0.1 2.5 0.0 0.0 2.3 1.2 2.8 1.3 1.0 0.1 0.9 0.0 0.6 0.7 7.8 2.6 0.1 1.9 5.6 3.0 3.9 2.0 6.1 1.3 4.4 0.5 1.0 1.5 0.0 0.0 0.3 1.8 0.0 0.6 3.9 3.7 1.9 0.8 0.9 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 0.0 0.0 0.0 1.8 2.4 11.8 6.2 5.1 0.0 3.4 3.5 0.0 0.5 1.7 0.3 1.4 1.0 0.5 0.0 0.6 0.1 3.7 3.3 0.0 1.8 0.7 1.6 1.2 1.3 1.8 0.4 6.9 0.6 1.7 0.0 0.9 5.7 0.6 0.9 3.2 1.1 0.9 0.0 1.7 1.4 3.9 1.8 0.2 0.0 0.8 0.8 GAS1 ENSG00000180447 "Growth arrest specific 1" P54826 9 86944363-86947189 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 61.8" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 57.5;Muller glia cells: 106.0;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 19.7;ASC diff: 13.5;BJ hTERT+: 26.7;HSkMC: 19.1;RH-30: 40.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB024164, HPA036085, HPA066902" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.97e-2)" "unprognostic (6.15e-2)" "unprognostic (2.84e-2)" "unprognostic (6.46e-2)" "unprognostic (6.91e-2)" "unprognostic (3.32e-1)" "unprognostic (1.28e-3)" "unprognostic (2.25e-3)" "unprognostic (4.30e-2)" "prognostic unfavorable (1.96e-5)" "prognostic unfavorable (8.26e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.13e-5)" "unprognostic (3.59e-2)" 26.5 2.9 0.9 8.3 1.1 0.0 14.0 1.3 1.3 26.4 9.1 2.1 15.0 0.9 61.8 37.1 10.0 20.9 11.8 9.9 1.0 0.5 4.5 0.8 4.1 5.7 1.8 0.8 31.5 4.3 0.8 3.2 50.1 2.0 18.1 1.0 8.7 4.8 8.9 8.1 10.1 3.4 24.5 0.9 1.2 6.3 18.9 0.5 3.6 6.0 3.8 1.6 11.3 15.6 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.0 0.0 3.3 19.7 13.5 5.1 0.3 3.7 26.7 1.3 1.1 0.0 0.0 0.0 0.2 6.9 0.1 0.2 0.0 0.1 0.5 2.2 7.6 0.0 11.1 0.0 6.9 0.0 0.3 19.1 2.9 0.4 2.4 0.0 0.0 0.4 0.0 0.0 5.6 0.0 0.0 0.1 4.1 0.1 0.0 3.9 40.7 0.0 0.2 0.0 0.4 1.7 5.5 0.0 5.8 2.3 0.0 0.1 0.0 5.8 1.6 0.4 1.3 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.9 1.1 1.3 1.2 1.0 0.5 1.8 0.8 2.0 0.5 0.0 1.1 0.0 8.0 23.0 6.5 5.8 0.0 0.0 1.2 14.0 9.8 17.4 8.3 0.6 0.0 6.1 0.0 0.0 0.3 3.8 57.5 1.9 0.0 0.0 5.2 4.8 0.0 23.4 0.6 0.0 30.0 1.0 16.9 0.0 0.0 106.0 0.3 0.0 11.7 2.2 2.8 38.8 10.3 0.1 0.7 10.9 3.8 0.0 0.0 0.3 GBGT1 "A3GALNT, FS, MGC44848, UDP-GalNAc" ENSG00000148288 "Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)" Q8N5D6 9 133152948-133163945 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "granulocytes: 11.5;Hofbauer cells: 19.5;Kupffer cells: 23.4;Macrophages: 13.6;monocytes: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 30.7;HMC-1: 28.7;HUVEC TERT2: 11.9;NB-4: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051298 Approved "Intracellular and membrane" NA NA "HPA051298: AB_2681428" "unprognostic (4.63e-3)" "unprognostic (8.03e-2)" "prognostic unfavorable (6.22e-4)" "unprognostic (2.70e-1)" "unprognostic (8.87e-2)" "unprognostic (4.38e-1)" "unprognostic (2.97e-2)" "unprognostic (7.43e-2)" "unprognostic (9.04e-2)" "unprognostic (2.27e-3)" "unprognostic (2.35e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (2.92e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-2)" "unprognostic (6.35e-2)" 10.2 12.9 6.7 13.7 5.7 10.3 15.5 8.1 7.8 5.8 5.6 6.3 4.7 4.1 8.5 5.7 6.7 7.8 9.0 7.2 7.0 4.6 7.7 2.0 11.2 20.4 6.7 4.3 15.8 4.4 5.6 5.6 19.7 8.8 8.4 3.9 16.7 6.3 8.2 2.9 4.2 7.3 8.2 7.2 11.2 21.7 4.3 5.7 1.7 8.1 3.2 11.5 8.3 9.0 3.4 3.2 5.2 11.2 0.9 0.5 2.5 0.0 0.8 0.8 0.0 0.5 0.6 0.2 2.3 1.8 1.3 0.0 0.0 0.4 0.6 7.8 2.3 0.9 8.6 5.1 0.5 0.0 0.0 0.2 30.7 0.5 0.0 6.3 1.1 28.7 2.7 0.8 0.3 0.0 5.4 11.9 0.4 8.9 0.1 0.4 0.1 0.1 13.8 2.5 0.2 0.2 2.2 0.2 0.8 0.8 0.1 0.2 0.9 0.0 1.2 0.0 1.0 0.0 6.8 7.4 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.1 4.9 0.4 4.7 11.2 5.2 0.2 7.7 0.5 1.7 0.4 0.0 3.2 3.4 0.1 0.1 2.0 0.9 6.4 2.3 0.2 2.5 6.7 5.7 8.1 7.8 7.0 4.6 6.7 4.3 8.8 5.7 0.0 1.7 0.9 2.6 0.7 0.1 2.0 0.0 0.0 1.2 1.8 0.0 2.0 0.0 3.6 0.0 1.1 0.0 0.0 0.5 0.8 3.7 1.2 11.5 0.0 19.5 0.0 0.0 0.6 23.4 0.0 6.9 13.6 0.0 11.8 0.0 2.4 1.2 10.4 1.8 1.4 0.3 0.0 3.5 0.0 0.1 1.0 3.0 1.0 1.2 1.0 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181148-89198932 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 56.2;Endothelial cells: 79.8;Ito cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.0;HDLM-2: 8.0;HEL: 10.7;REH: 9.0;RT4: 15.1;U-266/70: 13.6" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 25.4 4.4 3.9 18.4 5.9 3.6 9.4 2.1 5.0 7.8 5.8 4.4 2.9 8.0 10.5 7.4 7.9 6.3 5.7 9.2 4.6 4.4 8.5 9.8 34.7 20.5 5.8 4.4 12.8 2.4 9.3 4.8 9.1 6.9 12.7 4.8 17.4 4.8 4.8 12.0 3.2 11.0 5.1 7.4 23.4 7.4 2.6 2.7 8.1 23.3 5.7 15.2 9.3 7.7 3.3 2.0 5.1 12.6 12.2 7.6 4.4 0.7 0.0 0.1 0.3 0.1 0.1 0.6 1.5 6.4 6.8 6.2 0.1 10.0 0.5 0.9 1.9 0.6 0.8 0.0 0.3 0.3 8.0 0.1 10.7 0.3 0.3 0.9 0.2 0.3 0.3 0.0 0.1 0.0 1.0 1.6 0.2 0.3 2.0 0.0 0.1 5.3 0.3 0.4 0.0 0.1 9.0 0.2 0.3 0.1 15.1 0.2 0.5 0.2 0.5 0.3 0.7 0.5 1.1 0.4 0.2 1.4 0.2 0.1 13.6 0.2 0.3 0.3 0.1 1.9 0.4 3.8 0.4 6.6 12.6 5.8 2.3 7.3 7.3 2.0 3.3 5.5 5.1 5.1 12.2 11.5 0.7 7.6 4.4 3.9 5.9 2.1 5.0 4.6 4.4 5.8 4.4 6.9 2.7 29.8 44.9 10.0 7.8 4.0 2.1 2.8 10.2 56.2 37.5 5.2 7.9 0.7 0.0 1.9 1.5 79.8 2.5 23.3 2.9 1.1 5.6 14.8 20.8 6.4 8.7 0.0 0.0 89.0 20.0 0.5 3.4 22.5 5.0 29.7 2.8 16.2 21.4 1.9 1.8 0.7 10.6 0.0 5.7 2.6 4.5 2.6 1.3 21.3 0.5 12.5 GBP6 DKFZp686G0786 ENSG00000183347 "Guanylate binding protein family member 6" Q6ZN66 1 89364058-89386461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3" "Group enriched" "Detected in some" 8 "Ciliated cells: 16.0;Club cells: 4.5" "Group enriched" "Detected in many" 7 "cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;T-cells: 2.7" "Group enriched" "Detected in some" 9 "A-431: 8.0;HaCaT: 17.7" HPA027744 Enhanced NA NA "HPA027744: AB_10602809" "unprognostic (7.60e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (7.05e-3)" "unprognostic (5.85e-2)" "unprognostic (5.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "unprognostic (7.99e-4)" "unprognostic (1.63e-1)" "unprognostic (2.04e-6)" "unprognostic (1.43e-1)" "unprognostic (1.03e-1)" "unprognostic (3.41e-1)" "unprognostic (3.91e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.1 0.0 106.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 15.6 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 61.3 60.5 0.1 6.8 0.6 0.6 3.4 0.6 0.3 2.7 0.4 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 17.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.9 0.6 0.4 0.7 0.2 1.2 0.6 0.9 1.2 0.4 0.4 0.7 0.7 3.4 0.3 0.4 0.6 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 16.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 GBP7 "FLJ38822, GBP4L" ENSG00000213512 "Guanylate binding protein 7" Q8N8V2 1 89131751-89176040 "Predicted intracellular proteins" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "liver: 48.1" "Cell type enhanced" "Detected in some" 20 "Endothelial cells: 6.0;Hepatocytes: 14.3;Ito cells: 3.7" "Cancer enriched" "Detected in single" 58 "liver cancer: 10.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA051245 Uncertain NA NA "HPA051245: AB_2681404" "unprognostic (4.22e-5)" "unprognostic (7.32e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.63e-1)" "unprognostic (3.66e-3)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (2.80e-1)" "unprognostic (8.79e-2)" "unprognostic (1.57e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.57e-1)" "unprognostic (6.35e-2)" 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.3 1.3 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.0 0.2 0.9 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.2 1.3 1.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 14.3 1.0 0.0 0.0 3.7 0.6 0.0 0.6 0.8 0.0 0.0 0.0 2.8 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.0 0.0 0.4 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 1.8" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 32.5;BEWO: 5.6;PC-3: 9.6;TIME: 5.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Yes NA Nucleoplasm "HPA067809: AB_2685900" "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 32.5 1.2 0.0 0.0 5.6 0.4 0.0 0.9 0.0 0.7 0.0 0.0 0.6 0.0 1.0 0.0 0.2 0.1 0.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 2.1 0.0 0.4 0.8 0.0 0.2 0.8 0.0 9.6 0.0 3.5 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.3 1.0 0.0 0.0 5.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing homolog 1" Q9NP62 6 53126964-53148829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "placenta: 102.4" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.5" "Group enriched" "Detected in many" 8 "B-cells: 1.8;granulocytes: 4.5" "Cell line enriched" "Detected in some" 5 "BEWO: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011343, HPA073469" Enhanced Approved Vesicles NA NA Vesicles "HPA011343: AB_2668489, HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.3 0.3 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 1.5 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.2 102.4 0.1 0.2 0.0 0.1 0.1 0.1 3.1 0.0 0.4 0.1 0.1 2.2 0.0 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.8 0.2 4.5 0.3 0.4 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 30.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 6.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.6 0.3 2.2 0.2 0.1 0.2 0.7 0.1 0.1 0.2 1.8 0.2 0.2 4.5 0.4 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.3 1.9 0.0 0.0 0.0 0.2 166.4 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 222.5 0.0 0.0 0.0 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 99.5;Ductal cells: 59.9;Enterocytes: 119.9;Pancreatic endocrine cells: 45.2;Paneth cells: 59.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 29.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 54.4;EFO-21: 9.4;Hep G2: 10.9;OE19: 27.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.3 0.5 0.3 8.8 0.4 0.0 0.3 0.3 0.3 5.3 37.6 0.3 0.3 25.4 1.3 0.4 8.7 0.7 29.6 0.3 0.3 0.2 9.9 0.4 0.7 0.3 0.3 0.3 1.1 1.7 0.0 0.4 1.0 0.5 1.0 33.4 0.3 27.4 0.3 0.3 0.2 103.3 0.9 0.3 0.3 6.5 1.7 0.3 0.5 0.7 5.2 15.5 0.7 14.0 1.2 1.4 3.4 0.8 1.1 0.7 0.1 0.0 54.4 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 2.3 2.2 0.2 9.4 0.0 3.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 10.9 0.0 0.1 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 27.6 0.1 0.1 0.0 0.2 3.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.1 0.1 0.2 3.4 0.1 0.0 2.6 0.8 0.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.2 0.4 0.6 3.4 1.1 0.4 1.4 0.5 0.1 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.5 0.3 0.0 2.1 0.0 6.7 0.0 0.0 0.5 12.7 0.0 0.0 99.5 0.0 0.0 0.0 59.9 7.6 0.0 119.9 0.0 13.4 0.0 0.0 4.7 0.0 0.0 0.1 0.0 7.5 0.0 0.3 13.3 0.0 0.0 0.0 1.8 18.6 0.0 45.2 59.6 0.0 3.3 0.0 6.5 0.0 0.9 0.1 0.0 0.0 0.0 30.8 43.7 GCNT4 C2GNT3 ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4, core 2" Q9P109 5 75025346-75030899 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.6;intestine: 13.1;stomach 1: 10.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Group enriched" "Detected in many" 54 "granulocytes: 13.6;T-cells: 11.6" "Cell line enriched" "Detected in some" 5 "RT4: 26.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.6 0.6 0.3 1.0 0.7 0.0 0.9 0.0 2.3 1.1 1.1 13.1 1.4 0.6 1.3 1.1 2.5 0.3 0.3 0.1 1.8 0.4 1.0 1.7 0.1 0.9 3.0 8.4 0.1 3.0 1.0 0.2 0.5 2.4 1.0 1.5 10.8 0.7 0.0 0.6 10.4 1.0 0.5 1.1 6.4 2.0 0.0 0.0 13.6 0.1 0.2 11.6 1.6 0.2 0.1 1.0 1.6 1.8 0.6 0.1 2.0 5.2 1.0 0.9 2.5 0.1 0.0 0.2 1.5 0.6 0.7 1.0 1.8 0.2 0.0 0.0 0.8 0.2 0.2 0.8 0.0 0.0 0.3 2.9 0.1 0.4 0.0 0.0 1.5 0.0 0.3 0.1 0.0 1.4 0.0 0.4 5.7 0.0 0.0 0.0 2.6 0.2 26.6 0.0 0.0 0.2 0.0 0.0 5.4 0.0 0.0 0.0 0.5 0.1 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 13.6 0.0 0.0 0.9 0.0 3.5 0.0 8.1 2.6 0.0 0.0 8.1 5.9 0.1 0.2 0.1 0.0 11.6 1.6 3.0 5.3 0.0 5.5 0.6 0.0 0.4 35.7 0.0 4.5 12.2 0.0 27.4 8.3 6.1 0.1 1.0 6.7 0.0 3.7 0.7 1.1 1.5 7.0 0.8 2.1 0.0 0.0 4.9 0.8 0.0 3.7 0.0 0.0 1.0 0.5 0.0 4.9 1.7 2.5 0.6 0.0 6.5 0.9 0.0 0.2 0.1 20.4 0.0 0.6 4.1 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 3.9;bone marrow: 9.6" "Cell type enhanced" "Detected in single" 33 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052617, HPA059403" Uncertain Approved "Nuclear bodies,Vesicles,Cytosol" NA NA "Nuclear bodies, Vesicles" Cytosol "HPA052617: AB_2681886, HPA059403: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.2 0.2 0.0 0.7 0.0 9.6 0.3 0.6 0.3 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.3 0.4 0.4 0.0 0.5 0.5 0.0 0.6 0.1 0.3 0.0 0.4 0.0 0.3 1.0 0.4 0.0 0.1 0.5 0.3 1.6 0.3 0.0 0.6 0.3 1.0 0.9 3.9 0.7 0.3 1.1 0.1 0.6 1.0 0.8 0.5 0.0 0.0 1.1 1.0 0.0 0.0 0.0 2.1 0.5 0.1 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.1 1.2 1.7 0.5 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.0 1.5 0.0 1.3 0.7 1.4 0.5 0.1 0.7 0.1 0.4 0.5 0.0 1.9 1.0 0.5 1.2 1.0 0.2 0.5 0.8 0.2 0.0 2.2 0.4 0.5 0.6 1.6 0.1 0.5 0.3 0.6 0.5 1.1 0.7 0.9 0.8 0.5 0.8 0.7 0.7 0.5 0.4 1.0 1.1 0.4 3.9 0.3 0.7 0.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 48.3;brain: 17.6" "Cell type enriched" "Detected in some" 27 "granulocytes: 214.1" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enriched" "Detected in some" 10 "cerebellum: 17.6" "Cell type enriched" "Detected in single" 439 "basophil: 48.3" "Lineage enriched" "Detected in single" 439 "granulocytes: 48.3" "Group enriched" "Detected in some" 73 "HEL: 28.5;HMC-1: 113.3" "Low region specificity" "Detected in single" "HPA027507, HPA027510" Uncertain Approved Cytosol NA NA Cytosol "HPA027507: AB_10600756, HPA027510: AB_2672309" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 3.7 0.3 0.4 1.1 0.4 2.4 1.6 17.6 0.4 3.8 2.1 0.2 0.0 2.2 2.4 2.2 1.9 0.6 2.7 1.3 0.4 0.5 0.5 0.4 5.6 1.1 0.5 0.0 0.3 0.5 0.1 0.4 0.3 1.7 9.5 2.4 0.4 1.0 0.9 0.5 1.2 2.5 6.6 0.9 0.5 1.4 5.3 0.0 1.4 0.4 2.4 1.5 3.4 9.4 0.1 0.0 48.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 113.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 48.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 17.6 0.4 0.4 0.5 0.5 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 6.7 0.1 0.0 0.0 0.0 0.0 0.3 1.3 214.1 0.0 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 6.9 1.6 0.5 0.0 0.0 0.0 0.0 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.1;hTERT-HME1: 1.0;SK-MEL-30: 1.2" HPA058578 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 GDAP1L1 ENSG00000124194 "Ganglioside induced differentiation associated protein 1 like 1" Q96MZ0 20 44247099-44280917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.8;Early spermatids: 7.1;Horizontal cells: 14.3;Late spermatids: 21.0" "Cancer enriched" "Detected in single" 14 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 9.8;SCLC-21H: 24.2;SH-SY5Y: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054182, HPA063265" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA054182: , HPA063265: AB_2684972" "unprognostic (6.58e-3)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (2.23e-4)" "unprognostic (3.69e-1)" "unprognostic (5.15e-1)" "unprognostic (6.45e-2)" "unprognostic (7.69e-2)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (4.74e-3)" "unprognostic (2.41e-1)" "unprognostic (3.81e-5)" "unprognostic (8.57e-2)" "unprognostic (1.87e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-1)" 1.1 3.9 18.9 1.3 14.9 1.2 1.1 17.8 47.4 1.2 1.2 1.4 0.0 1.0 1.5 1.1 1.1 1.2 1.1 1.3 13.1 14.3 1.1 1.0 1.0 1.0 9.1 12.2 3.0 1.8 2.4 7.1 1.0 10.6 1.1 1.1 0.9 1.0 1.1 1.1 1.5 1.3 1.2 2.6 1.0 1.9 2.8 1.6 0.0 1.1 0.0 1.0 1.1 0.0 0.1 0.0 0.7 0.1 0.5 0.8 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 11.8 0.0 0.1 1.0 0.2 0.0 3.1 0.1 0.9 0.5 0.2 0.0 0.0 0.1 0.6 0.8 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.7 0.5 0.1 0.0 0.0 0.0 18.9 14.9 17.8 25.7 13.1 14.3 9.1 12.2 10.6 1.6 0.0 0.0 0.0 0.0 0.0 8.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 21.0 0.6 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.0 4.1 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300386-47313547 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.8;tongue: 14.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2" "Region enriched" "Detected in many" 8 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 6.8 4.4 1.4 0.3 2.8 0.0 10.8 7.6 5.2 1.9 0.4 1.7 0.0 0.0 2.3 2.4 5.4 0.5 2.9 2.1 3.0 0.0 0.0 15.8 0.9 0.0 5.0 0.1 11.6 0.2 0.0 0.0 0.9 2.8 0.3 6.8 3.0 0.3 2.5 0.3 0.1 0.6 0.8 0.1 0.1 10.5 0.8 0.0 3.7 14.8 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.3 17.8 0.6 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 4.7 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.2 0.9 0.0 1.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 34.3 0.0 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 GDF5OS ENSG00000204183 "Growth differentiation factor 5 opposite strand" Q5U4N7 20 35433029-35435450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2197: 2.8;U-87 MG: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA062720 Uncertain NA NA "HPA062720: AB_2684848" "unprognostic (2.87e-2)" "unprognostic (9.00e-3)" "unprognostic (7.43e-2)" "unprognostic (1.46e-1)" "unprognostic (4.13e-4)" "unprognostic (1.13e-1)" 1.4 0.2 0.0 0.0 0.1 1.6 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.4 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.7 0.6 0.1 0.1 0.0 0.0 0.4 0.1 0.2 0.0 1.8 0.0 0.1 0.9 0.1 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 0.0 1.0 0.6 2.3 0.5 0.5 1.3 0.0 0.2 0.7 0.1 0.6 0.0 1.0 0.8 1.0 0.3 0.1 0.0 0.3 0.8 0.1 0.3 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.3 0.2 1.0 0.2 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.1 1.4 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.3 0.0 0.9 0.4 0.0 0.2 0.5 0.0 0.5 0.6 0.0 0.0 1.1 0.4 2.8 0.3 0.4 0.0 0.5 1.8 0.4 0.1 1.0 0.5 0.9 0.2 0.2 0.3 0.3 0.5 0.2 0.1 1.0 0.2 0.3 2.3 0.5 0.3 0.6 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 GDF7 BMP12 ENSG00000143869 "Growth differentiation factor 7" Q7Z4P5 2 20666664-20679245 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 13.3;seminal vesicle: 22.0" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 1: 6.0;Cardiomyocytes: 6.2;Club cells: 5.7;Collecting duct cells: 5.2;Hepatocytes: 6.2;Horizontal cells: 4.8;Proximal tubular cells: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 8 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "HAP1: 2.6;Hep G2: 6.3;RT4: 12.2;SH-SY5Y: 5.0" "Region enhanced" "Detected in single" "amygdala: 0.3" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.35e-1)" "unprognostic (9.93e-3)" "unprognostic (5.10e-1)" "unprognostic (2.44e-3)" "unprognostic (1.35e-1)" "unprognostic (2.06e-3)" "unprognostic (8.63e-3)" "unprognostic (6.31e-3)" "unprognostic (8.00e-3)" "unprognostic (3.85e-1)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.28e-3)" "unprognostic (8.02e-3)" "unprognostic (2.05e-1)" "unprognostic (3.44e-2)" "unprognostic (1.89e-3)" 0.3 0.3 0.4 1.5 0.5 0.0 0.2 0.5 1.3 13.3 0.4 0.2 4.7 0.0 6.8 3.1 0.9 0.6 1.8 2.4 0.2 0.2 3.3 7.2 0.5 3.1 2.9 0.9 0.4 0.8 0.0 0.6 2.3 0.4 3.6 0.0 2.4 1.1 22.0 0.6 1.5 1.5 1.0 0.2 3.2 0.7 0.7 1.2 0.2 0.2 0.0 1.5 1.6 6.0 2.6 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.2 1.9 12.2 0.0 5.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.5 0.5 1.3 0.2 0.2 2.9 0.9 0.4 1.2 6.0 0.0 0.5 0.5 0.0 0.2 6.2 0.0 1.4 5.7 5.2 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 6.2 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.2 GDPD2 "FLJ20207, GDE3, OBDPF" ENSG00000130055 "Glycerophosphodiester phosphodiesterase domain containing 2" Q9HCC8 X 70423031-70433390 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 50.5;Enterocytes: 47.9;Muller glia cells: 24.7" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "AF22: 9.4;NTERA-2: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.53e-3)" "unprognostic (5.79e-2)" "unprognostic (5.37e-2)" "unprognostic (5.00e-7)" "unprognostic (3.15e-3)" "unprognostic (3.65e-2)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (1.19e-1)" "unprognostic (8.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.41e-2)" "unprognostic (5.52e-2)" "unprognostic (2.22e-1)" "unprognostic (8.91e-2)" 0.4 0.4 6.8 0.6 5.7 0.4 1.0 1.1 4.0 0.3 13.0 8.2 8.3 8.0 0.4 22.5 0.4 0.5 0.5 0.8 7.6 4.0 0.6 0.3 0.4 0.4 4.3 5.6 0.4 0.4 0.3 2.6 0.4 8.4 0.3 3.0 0.2 1.1 0.6 0.6 33.2 19.5 0.4 1.5 37.5 1.6 0.3 4.9 0.0 0.4 0.6 0.3 1.0 0.3 0.4 0.1 1.4 0.2 0.1 0.2 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 20.2 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.4 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.0 6.8 5.7 1.1 4.0 7.6 4.0 4.3 5.6 8.4 4.9 0.0 0.0 0.0 0.0 50.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.7 0.1 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 2.7 0.0 1.5 0.1 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GDPD4 GDE6 ENSG00000178795 "Glycerophosphodiester phosphodiesterase domain containing 4" Q6W3E5 11 77216558-77301687 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.6" "Group enriched" "Detected in some" 14 "Early spermatids: 8.8;Late spermatids: 13.7;Spermatocytes: 12.7;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 10 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;HEL: 3.5;U-937: 1.1" "Region enriched" "Detected in single" 24 "olfactory region: 2.8" NA NA "unprognostic (6.73e-6)" "unprognostic (3.30e-1)" "unprognostic (2.01e-2)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (3.55e-4)" "unprognostic (4.13e-2)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "unprognostic (2.63e-2)" "unprognostic (3.10e-2)" "unprognostic (4.75e-2)" "unprognostic (1.05e-4)" "unprognostic (1.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (1.64e-2)" 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 4.5 0.0 0.2 0.0 0.0 0.0 GFOD2 "FLJ23802, MGC11335" ENSG00000141098 "Glucose-fructose oxidoreductase domain containing 2" Q3B7J2 16 67674531-67719421 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040939, HPA041112" Uncertain Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA040939: AB_10796564, HPA041112: AB_10794541" "unprognostic (9.80e-2)" "unprognostic (2.20e-1)" "unprognostic (2.06e-2)" "unprognostic (3.16e-3)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (2.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.17e-1)" "prognostic favorable (8.66e-4)" "unprognostic (1.90e-1)" "unprognostic (1.76e-1)" "unprognostic (7.87e-2)" "unprognostic (9.64e-2)" 9.0 9.4 9.6 7.7 13.8 13.4 8.6 42.9 18.9 10.7 10.6 5.0 9.4 10.7 8.1 5.9 21.8 12.2 8.4 6.8 10.1 12.4 9.8 24.4 7.9 6.9 8.2 11.1 5.6 9.0 14.1 11.7 19.4 10.8 7.4 8.7 6.4 8.7 7.2 6.5 14.1 8.1 8.6 5.7 12.8 7.5 8.3 5.1 6.1 9.7 13.2 12.8 9.0 16.4 9.1 6.5 10.6 5.5 6.4 10.2 4.1 9.3 15.2 9.3 19.2 9.5 7.1 11.0 7.8 10.1 14.6 15.0 12.9 8.6 15.8 7.3 9.0 7.8 11.8 9.6 9.0 12.4 9.4 11.8 4.0 8.1 18.3 7.2 6.5 7.8 5.9 10.4 19.3 5.8 7.2 21.0 16.2 8.2 3.1 8.1 19.9 10.6 7.8 12.6 5.6 8.3 17.0 5.5 12.2 8.9 13.3 19.1 11.2 19.3 6.5 5.9 5.7 9.9 4.3 16.1 11.4 11.4 10.1 7.7 8.0 11.3 17.2 7.0 9.5 8.1 0.7 5.5 5.7 5.6 3.5 9.0 8.0 9.5 9.6 5.6 9.1 8.4 6.6 10.6 6.4 3.4 6.5 10.2 4.1 9.6 13.8 42.9 18.9 10.1 12.4 8.2 11.1 10.8 5.1 0.0 5.9 5.4 11.8 20.4 12.7 3.7 20.4 20.1 10.3 10.4 13.7 8.1 5.0 17.9 77.4 35.6 18.8 0.0 10.2 17.9 10.3 10.3 4.6 39.5 5.8 20.6 41.5 26.4 6.3 21.4 8.1 4.7 8.5 3.6 15.0 11.3 13.3 18.2 10.6 10.1 9.9 6.5 12.3 14.2 17.9 23.8 18.5 10.2 15.6 15.5 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273467 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 12.1;Fibroblasts: 17.1;Hepatocytes: 38.6;Muller glia cells: 12.1" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 17.1;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;EFO-21: 18.2;fHDF/TERT166: 33.0;HBF TERT88: 25.0;MCF7: 21.8;U-251 MG: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 89000 "Golgi apparatus" Nucleoplasm "HPA043829: AB_2678689" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 24.0 4.3 6.3 9.5 13.8 0.3 26.8 0.8 8.4 12.5 14.9 1.8 5.9 2.2 6.7 23.4 11.1 12.7 11.5 6.4 4.8 6.7 7.0 21.9 3.2 7.4 9.5 2.7 10.0 7.3 2.2 3.9 0.3 2.9 12.1 4.8 3.4 5.4 6.6 7.5 6.8 7.2 9.8 3.4 5.8 7.8 5.3 1.9 2.6 2.6 10.7 8.1 10.5 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.8 0.0 0.0 0.0 0.0 2.9 0.1 17.1 29.9 0.0 0.0 0.0 18.2 33.0 0.0 0.0 0.0 0.0 25.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 4.3 0.0 1.5 0.0 3.6 0.0 0.0 2.2 21.8 2.7 0.0 1.9 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 13.8 0.8 4.6 4.8 6.7 9.5 2.7 2.9 1.9 0.0 0.0 0.9 0.0 5.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 12.1 0.0 17.1 0.1 5.8 38.6 0.0 0.0 5.8 0.0 1.0 8.3 7.5 0.0 5.0 0.0 0.0 12.1 0.2 0.0 0.0 1.1 0.3 0.0 8.6 0.1 0.4 4.0 0.0 0.0 0.0 0.1 GGT6 FLJ90165 ENSG00000167741 "Gamma-glutamyltransferase 6" Q6P531 17 4556927-4560818 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.4;salivary gland: 52.7" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Group enriched" "Detected in some" 8 "RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023362, HPA027213" Approved NA NA 33000 "HPA023362: AB_1848955, HPA027213: AB_10601326" "unprognostic (2.23e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-3)" "unprognostic (4.51e-2)" "unprognostic (9.71e-2)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "prognostic favorable (4.35e-4)" "unprognostic (2.10e-1)" "unprognostic (2.33e-1)" "unprognostic (3.07e-2)" "unprognostic (5.06e-2)" "prognostic favorable (9.42e-7)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (9.17e-2)" "unprognostic (8.07e-3)" 0.3 0.4 0.3 12.7 0.3 0.0 3.2 0.3 0.4 4.1 24.9 0.4 1.0 17.0 0.9 15.9 25.2 3.0 7.7 0.3 0.3 0.1 18.8 0.6 4.2 0.3 0.3 0.3 1.5 28.6 0.0 1.0 0.4 0.4 5.7 12.7 0.4 52.7 3.7 0.3 25.2 40.4 2.8 0.3 0.3 8.7 0.8 0.3 1.0 0.7 19.6 18.8 16.5 8.2 0.6 0.7 3.5 0.5 0.6 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 30.5 0.1 0.1 0.0 10.4 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.5 0.2 0.4 0.3 0.2 0.3 0.5 0.3 0.1 0.6 0.5 0.4 1.9 0.6 0.5 0.7 0.4 0.0 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.4 0.3 32.8 5.8 2.2 16.1 3.7 0.0 0.2 17.8 33.5 29.6 22.7 2.0 0.0 18.3 16.4 0.0 0.0 136.8 0.0 33.4 0.0 0.3 3.4 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 0.6 1.3 0.0 3.6 63.3 0.2 14.4 98.2 0.0 32.1 0.2 0.0 1.0 0.0 0.1 18.2 0.0 0.5 77.9 19.7 GGTLC1 "dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4" ENSG00000149435 "Gamma-glutamyltransferase light chain 1" Q9BX51 20 23985050-23988779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "lung: 24.2;testis: 11.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 128.1;Early spermatids: 37.6;Late spermatids: 92.1" "Cancer enriched" "Detected in some" 8 "lung cancer: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.3;SK-BR-3: 1.7;T-47d: 1.2;U-2197: 4.5" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-2)" "unprognostic (5.32e-1)" "unprognostic (4.19e-1)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.1 0.0 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.1 4.5 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 128.1 14.9 0.0 0.0 0.0 0.0 0.0 5.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 GGTLC2 GGTL4 ENSG00000100121 "Gamma-glutamyltransferase light chain 2" Q14390 22 22644475-22647903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.1" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 20.8;Early spermatids: 22.5;Late spermatids: 5.2;Spermatocytes: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.6;RPMI-8226: 4.6;THP-1: 2.8;U-2 OS: 2.4" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (2.58e-2)" "unprognostic (2.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.96e-1)" "unprognostic (4.31e-1)" "unprognostic (1.57e-2)" "unprognostic (1.06e-3)" "unprognostic (1.48e-2)" "unprognostic (1.55e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.3 0.9 1.4 1.3 0.8 0.7 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 4.6 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.3 2.8 0.0 0.0 2.4 0.0 0.0 0.7 0.5 0.1 0.0 0.2 0.0 0.5 1.3 0.0 0.0 0.5 0.2 0.3 0.7 0.4 0.9 0.0 0.0 0.3 1.4 0.8 0.7 0.0 0.7 0.6 20.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 10.9 0.1 0.0 0.0 0.0 0.0 0.0 GIMAP6 "FLJ22690, IAN6" ENSG00000133561 "GTPase, IMAP family member 6" Q6P9H5 7 150625375-150632648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Endothelial cells: 57.3;Erythroid cells: 23.3;Hofbauer cells: 24.5;Ito cells: 77.3;Kupffer cells: 57.9;T-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "monocytes: 17.2;NK-cells: 46.4;T-cells: 31.1" "Cell line enhanced" "Detected in some" "HMC-1: 7.7;HUVEC TERT2: 51.3;MOLT-4: 16.9;TIME: 14.6" HPA026715 Uncertain NA NA "HPA026715: AB_1849675" "unprognostic (8.58e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.22e-1)" "prognostic favorable (2.91e-4)" "prognostic favorable (1.56e-4)" "unprognostic (2.88e-2)" "unprognostic (8.75e-2)" "unprognostic (8.87e-2)" "unprognostic (4.68e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (2.75e-1)" "unprognostic (2.48e-2)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" 32.5 6.7 4.8 15.5 5.5 0.8 21.2 2.0 4.5 12.1 8.6 5.2 3.3 6.4 11.9 7.6 6.3 10.4 9.4 17.6 5.2 4.7 10.7 7.1 19.6 41.9 6.8 3.8 5.6 4.7 3.3 3.4 15.9 5.6 10.0 6.0 8.1 6.1 5.6 10.7 5.3 14.0 12.8 7.0 42.0 6.8 4.7 5.5 19.9 12.2 8.1 16.1 9.3 10.6 0.1 5.1 2.6 17.2 46.4 31.1 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.5 0.0 0.0 0.0 0.1 7.7 0.0 0.0 0.0 0.0 0.0 51.3 0.2 0.0 1.9 0.0 0.0 16.9 2.1 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 14.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.2 0.0 2.6 13.1 0.4 27.5 17.2 31.1 0.1 25.9 29.2 5.1 0.0 27.3 25.7 1.8 46.4 12.6 0.1 23.3 32.0 4.8 5.5 2.0 4.5 5.2 4.7 6.8 3.8 5.6 5.5 0.0 0.6 2.4 0.0 3.4 0.0 5.6 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 57.3 0.0 23.3 0.2 0.2 1.4 0.0 2.3 1.1 24.5 0.0 0.0 77.3 57.9 1.5 1.1 8.6 1.7 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.2 0.0 2.8 0.3 48.4 0.0 0.1 GIMAP8 "DKFZp667I133, hIAN6, IAN9" ENSG00000171115 "GTPase, IMAP family member 8" Q8ND71 7 150450630-150479392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 42.5;Ito cells: 81.6;Kupffer cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA014474, HPA017765" Supported NA NA "HPA014474: AB_1849685, HPA017765: AB_1849683" "unprognostic (7.86e-2)" "unprognostic (7.87e-3)" "unprognostic (1.04e-1)" "unprognostic (4.42e-3)" "unprognostic (2.11e-1)" "unprognostic (8.09e-3)" "unprognostic (1.07e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (6.26e-3)" "unprognostic (2.15e-1)" "unprognostic (1.04e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (3.85e-1)" "unprognostic (1.31e-1)" 17.9 4.5 2.6 13.4 4.8 0.2 23.4 1.3 3.8 8.3 5.4 3.1 3.0 4.3 11.3 9.8 5.3 7.1 8.9 16.6 3.8 2.8 6.7 7.5 31.9 34.6 4.0 1.5 4.3 4.3 3.6 2.9 10.3 3.1 7.9 4.8 5.3 4.9 3.6 8.4 4.3 8.4 8.6 4.7 32.8 4.4 3.9 3.1 3.5 10.9 6.2 8.7 7.3 10.2 0.2 5.6 2.1 25.9 6.4 8.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 5.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 18.7 0.0 7.0 25.9 8.0 0.2 6.9 6.3 5.6 0.0 7.9 6.3 2.1 6.4 22.6 0.3 3.2 10.1 2.6 4.8 1.3 3.8 3.8 2.8 4.0 1.5 3.1 3.1 3.0 7.7 0.0 0.4 2.7 0.0 4.0 7.6 2.7 0.0 1.8 0.0 0.0 0.0 0.0 0.1 42.5 0.0 0.0 0.0 0.0 0.9 0.1 3.5 0.6 5.7 0.0 0.0 81.6 70.3 0.0 0.3 8.9 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 1.5 0.1 12.8 0.0 0.4 GIMD1 ENSG00000250298 "GIMAP family P-loop NTPase domain containing 1" P0DJR0 4 106357485-106368825 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "intestine: 24.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;HBF TERT88: 1.0;HEL: 1.0;NB-4: 1.2;U-138 MG: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 23.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 1.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 8700 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: AB_2677611" "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 32.1 26.3 21.3 17.8 34.7 20.0 51.5 26.1 27.6 28.8 25.7 22.4 29.0 14.2 29.3 36.9 21.5 24.1 24.3 48.2 20.3 18.3 51.3 29.6 28.4 32.9 43.6 21.4 31.7 28.3 27.1 17.5 34.0 23.0 23.6 19.8 21.7 20.7 40.1 29.2 20.9 17.3 36.7 31.3 18.6 22.8 31.0 30.2 11.5 41.5 21.6 13.1 28.6 22.6 16.8 12.6 23.7 16.0 8.0 8.1 7.7 7.9 5.7 9.3 12.5 50.2 30.1 15.2 27.2 31.9 20.7 26.0 7.4 10.7 5.9 15.0 25.7 19.1 16.4 6.0 13.6 27.1 9.8 13.4 5.6 5.5 8.8 19.2 11.0 5.4 33.4 11.8 17.5 12.1 22.7 22.2 8.1 7.2 9.8 19.4 10.2 6.9 8.3 3.2 11.7 6.1 7.4 16.7 4.4 29.4 7.0 5.9 5.7 27.1 16.1 5.6 10.7 10.1 11.2 15.5 11.2 11.8 28.5 17.9 9.7 11.2 7.3 20.8 9.9 10.3 11.9 13.7 17.1 6.8 13.2 7.9 16.8 8.1 7.4 10.0 11.7 7.9 6.4 23.7 8.0 16.0 12.6 7.5 7.7 21.3 34.7 26.1 27.6 20.3 18.3 43.6 21.4 23.0 30.2 74.5 47.2 33.3 50.3 41.6 20.9 44.8 30.6 33.5 43.3 62.8 27.5 69.7 33.2 80.6 144.2 73.7 38.6 0.0 70.5 63.5 82.2 48.5 27.8 35.6 40.9 15.9 25.7 88.4 45.9 261.3 120.0 45.3 40.5 82.0 22.0 80.5 55.4 29.4 106.1 117.9 21.9 97.0 65.6 141.4 88.4 41.0 102.6 28.7 25.1 50.0 GJA10 CX62 ENSG00000135355 "Gap junction protein alpha 10" Q969M2 6 89894469-89921760 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 2.3" "Cell type enriched" "Detected in single" 148 "Horizontal cells: 17.5" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 2.8;NTERA-2: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021145 Uncertain NA NA "HPA021145: AB_2670600" "unprognostic (1.09e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA9 "CX58, CX59, GJA10" ENSG00000131233 "Gap junction protein alpha 9" P57773 1 38874451-38881587 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.3" "Low region specificity" "Detected in all" HPA067850 Uncertain NA NA "HPA067850: AB_2685910" "unprognostic (2.00e-1)" "unprognostic (8.78e-2)" "unprognostic (4.55e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-2)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-2)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (4.11e-3)" "unprognostic (2.32e-2)" 1.1 0.1 0.7 0.4 0.9 0.2 0.4 0.9 1.0 0.4 0.7 0.7 0.4 0.9 0.4 0.4 1.4 0.6 0.8 2.3 1.2 0.6 0.4 0.4 0.4 0.4 1.2 0.4 0.4 0.4 0.0 0.9 0.4 0.7 0.5 1.3 1.8 0.8 0.4 0.6 1.9 0.5 0.4 1.8 0.4 1.2 15.8 0.4 0.4 1.1 0.4 0.4 1.2 0.7 1.5 1.0 1.8 1.2 0.4 1.5 0.4 0.5 0.8 0.7 0.5 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.2 1.7 0.4 0.1 0.0 4.3 0.2 0.0 0.3 0.2 0.7 0.7 0.3 0.6 1.1 0.0 0.8 0.6 0.0 0.4 0.3 0.0 0.2 0.0 0.9 0.3 1.2 0.1 0.2 0.4 0.1 0.3 0.3 0.4 0.6 0.2 0.1 0.0 1.3 0.7 0.7 0.0 0.5 1.4 1.1 0.3 0.4 1.8 1.6 0.4 0.4 0.1 0.3 0.6 0.4 1.6 0.5 0.7 0.0 1.1 0.0 0.6 1.2 0.4 0.9 0.5 0.3 1.0 1.5 1.1 0.6 1.8 0.4 0.3 0.3 1.5 0.4 0.7 0.9 0.9 1.0 1.2 0.6 1.2 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJB5 CX31.1 ENSG00000189280 "Gap junction protein beta 5" O95377 1 34755047-34758512 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0" "Group enriched" "Detected in some" 16 "Basal glandular cells: 21.6;Basal keratinocytes: 43.0;Suprabasal keratinocytes: 73.0;Urothelial cells: 70.5" "Group enriched" "Detected in many" 5 "cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.9;HaCaT: 31.8;HBEC3-KT: 14.2;hTCEpi: 52.7;hTERT-HME1: 8.4;RT4: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038146 Uncertain NA NA "HPA038146: AB_10697242" "unprognostic (2.62e-1)" "unprognostic (1.63e-1)" "unprognostic (3.48e-1)" "unprognostic (5.71e-2)" "unprognostic (8.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.89e-2)" "unprognostic (2.76e-2)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.30e-2)" "unprognostic (1.09e-3)" "unprognostic (2.36e-1)" "unprognostic (2.41e-3)" "unprognostic (5.59e-2)" "unprognostic (5.67e-3)" 0.0 0.1 0.7 0.0 0.5 0.1 2.6 0.6 2.3 7.5 0.1 0.0 0.5 0.0 0.1 2.1 39.0 0.4 3.3 0.1 0.8 0.1 0.1 0.1 0.3 0.0 0.2 0.5 0.1 0.6 0.0 0.4 7.0 0.2 3.0 0.1 0.0 5.6 2.1 0.2 37.7 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.6 0.6 28.0 26.1 3.4 11.7 0.0 0.0 0.0 0.8 0.0 0.1 0.8 9.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 31.8 0.0 14.2 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 52.7 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 17.7 0.0 0.0 1.2 0.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.7 0.5 0.6 2.3 0.8 0.1 0.2 0.5 0.2 0.0 0.0 0.6 0.0 21.6 43.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 73.0 0.3 0.0 0.0 70.5 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GJC3 "CX30.2, GJE1" ENSG00000176402 "Gap junction protein gamma 3" Q8NFK1 7 99923269-99929620 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 9.1;pancreas: 12.1;salivary gland: 9.0" "Cell type enhanced" "Detected in many" 11 "Exocrine glandular cells: 20.9;Glandular cells: 18.1;Pancreatic endocrine cells: 8.3;Proximal tubular cells: 8.2;Urothelial cells: 9.7" "Group enriched" "Detected in many" 5 "breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;T-reg: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "OE19: 3.3;SK-MEL-30: 5.7;U-2197: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015024 Uncertain NA NA "HPA015024: AB_1847132" "unprognostic (9.31e-2)" "unprognostic (6.43e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-2)" "unprognostic (2.54e-1)" "unprognostic (2.88e-2)" "unprognostic (7.68e-2)" "unprognostic (9.14e-2)" "unprognostic (6.71e-2)" "unprognostic (4.78e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (1.14e-1)" "unprognostic (4.17e-1)" "unprognostic (3.49e-1)" "unprognostic (5.81e-3)" 1.0 0.5 0.1 0.0 0.3 0.0 9.1 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 1.1 2.8 0.1 0.1 0.6 0.3 12.1 0.0 0.1 1.2 4.3 0.0 9.0 0.0 0.0 2.0 0.0 0.1 0.7 0.0 0.8 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.6 0.8 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 1.2 2.6 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.2 0.3 0.9 0.2 2.3 0.0 0.4 0.3 0.4 0.0 0.1 0.6 0.2 1.1 1.8 1.4 1.7 0.3 1.3 0.5 1.2 3.0 3.3 0.2 0.0 1.2 0.8 0.0 1.1 0.5 0.6 0.3 1.0 5.7 1.5 1.8 0.2 0.8 0.2 1.0 4.8 0.3 0.4 1.4 0.1 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 2.1 0.4 3.0 3.0 0.0 4.8 0.2 0.0 0.0 2.5 0.0 1.2 1.8 0.0 0.0 1.7 0.3 0.2 0.6 0.0 0.0 20.9 0.0 0.0 18.1 4.6 3.9 0.1 0.0 1.2 0.0 0.0 0.5 0.3 0.0 0.0 1.0 0.0 3.7 8.3 0.0 0.0 8.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 9.7 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605410-35608935 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.4;brain: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 5.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "RH-30: 5.9" "Not detected" "Not detected" HPA038266 Uncertain NA NA "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.2 0.2 0.7 0.2 1.0 2.5 0.2 0.2 3.5 0.5 0.2 0.2 0.2 1.0 0.7 0.2 0.3 0.2 1.3 0.3 0.6 1.3 0.2 0.3 0.2 0.4 0.8 0.2 0.2 0.4 0.3 0.5 0.4 0.2 0.3 0.3 0.2 0.8 0.2 1.5 2.6 0.8 0.2 0.3 0.4 0.8 0.9 0.2 0.2 0.9 0.2 0.2 0.4 0.2 0.7 0.9 5.4 0.6 0.6 0.8 0.2 0.9 0.9 0.5 1.5 0.2 0.0 1.4 0.2 0.0 0.0 0.3 0.7 1.4 1.0 0.6 0.1 0.6 1.5 0.1 0.3 0.3 1.1 0.8 0.9 0.4 0.6 0.0 0.2 0.9 0.3 0.3 0.4 0.1 1.2 0.2 0.9 1.8 2.0 0.2 1.3 1.4 1.0 0.9 0.6 2.4 0.8 5.9 0.4 0.1 1.6 1.2 0.8 0.8 0.6 1.3 0.7 1.0 1.4 1.4 1.1 2.0 0.8 0.6 1.0 0.6 0.3 0.9 0.8 1.0 1.8 0.6 0.7 0.5 0.2 0.4 0.6 0.5 0.4 0.4 0.7 0.8 0.7 5.4 0.6 0.2 0.9 0.2 0.2 0.7 1.0 0.2 3.3 0.6 1.3 0.8 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 GK2 "GKP2, GKTA" ENSG00000196475 "Glycerol kinase 2" Q14410 4 79406352-79408293 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 61.0" "Group enriched" "Detected in some" 6 "Early spermatids: 439.5;Late spermatids: 112.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "SCLC-21H: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060687 Uncertain NA NA "HPA060687: AB_2684343" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 439.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 44.6 2.7 0.0 0.0 0.0 0.0 0.0 GK3P "GKP3, GKTB" ENSG00000229894 "Glycerol kinase 3 pseudogene" Q14409 4 165277812-165279679 "Enzymes, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.0" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.9" "Cell line enhanced" "Detected in single" "TIME: 1.1" HPA060687 Uncertain NA NA "HPA060687: AB_2684343" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.17e-2)" "unprognostic (2.11e-2)" "unprognostic (3.94e-1)" "unprognostic (1.61e-1)" "unprognostic (2.04e-1)" "unprognostic (6.19e-2)" "unprognostic (6.99e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (4.56e-1)" "unprognostic (3.34e-4)" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 2.9 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5 (putative)" Q6ZS86 3 142157527-142225607 "Enzymes, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: AB_2683573" "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 6.1 12.2 5.6 5.7 7.2 10.8 10.9 9.0 9.4 11.5 10.9 8.4 11.5 14.4 10.9 14.8 7.9 7.2 8.3 5.4 5.5 4.1 5.7 3.1 6.2 3.5 9.3 6.0 11.5 4.8 5.4 20.3 3.7 12.6 13.5 11.8 6.7 14.8 14.7 5.0 8.8 14.0 9.4 11.6 3.5 8.1 6.2 5.3 4.6 7.4 4.2 6.1 8.5 6.7 1.3 1.1 3.6 5.3 3.8 3.8 0.5 11.0 2.8 4.0 2.7 8.3 15.9 6.9 3.7 2.6 4.1 2.6 4.2 6.1 8.0 3.3 3.5 4.5 4.7 4.6 3.5 5.4 2.8 4.4 5.2 6.6 3.1 4.5 5.9 6.9 6.5 3.1 2.7 3.6 2.6 2.3 9.2 4.5 4.9 7.3 7.1 5.2 4.9 2.6 7.4 3.2 4.9 4.3 2.9 4.2 6.9 3.9 2.9 10.2 10.8 3.3 2.5 15.0 3.9 2.5 3.2 2.7 7.1 4.0 5.1 4.9 8.1 5.8 3.7 5.4 3.6 1.1 0.7 3.8 0.9 1.9 0.5 1.3 1.4 0.8 1.3 1.0 1.7 3.2 3.8 5.3 1.1 0.6 0.5 5.6 7.2 9.0 9.4 5.5 4.1 9.3 6.0 12.6 5.3 35.7 27.8 0.0 11.1 3.5 30.1 9.3 15.3 21.4 27.3 26.2 27.5 11.1 6.6 12.3 2.0 5.9 31.1 0.0 17.9 6.4 7.8 21.5 8.1 11.1 5.0 14.3 26.9 2.5 10.0 3.6 31.4 8.2 3.3 1.0 51.9 13.2 13.9 39.1 43.9 5.1 35.7 25.8 4.9 4.2 4.7 3.4 5.7 17.5 38.6 11.6 GKN1 "AMP18, BRICD1, CA11" ENSG00000169605 "Gastrokine 1" Q9NS71 2 68974573-68980974 "Plasma proteins, Predicted secreted proteins" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "stomach 1: 918.9" "Cell type enriched" "Detected in some" 61 "Pancreatic endocrine cells: 201.5" "Cancer enriched" "Detected in some" 116 "stomach cancer: 255.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA047684 Enhanced "Secreted to digestive system" NA NA 26000000 "HPA047684: AB_2680120" "unprognostic (5.40e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.54e-1)" "prognostic favorable (4.53e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.4 0.0 2.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 918.9 0.0 0.0 1.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.0 13.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 8.8 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GLB1L MGC10771 ENSG00000163521 "Galactosidase beta 1 like" Q6UWU2 2 219236606-219245478 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.0" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043058 Enhanced "Secreted - unknown location" NA NA "HPA043058: AB_10806375" "unprognostic (4.30e-2)" "unprognostic (6.93e-2)" "unprognostic (2.68e-2)" "unprognostic (2.08e-3)" "unprognostic (4.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.67e-3)" "unprognostic (3.32e-2)" "unprognostic (4.77e-1)" "unprognostic (2.39e-1)" "unprognostic (8.48e-3)" "unprognostic (3.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.28e-1)" "unprognostic (9.23e-3)" "unprognostic (1.33e-1)" "unprognostic (8.50e-2)" 6.9 5.4 2.7 2.0 3.7 2.3 5.6 1.6 3.3 4.0 5.8 4.6 4.5 1.6 5.3 7.9 2.5 14.3 8.6 3.4 3.1 3.5 18.5 3.5 4.1 2.5 2.1 2.1 6.1 3.1 11.7 6.7 7.4 5.6 4.5 2.0 13.2 5.8 3.0 1.4 2.5 4.4 3.4 2.3 3.9 2.1 57.0 1.4 3.1 5.0 1.4 2.4 4.0 2.0 1.7 2.8 3.2 8.9 1.4 1.8 2.2 2.4 4.3 6.7 5.4 7.4 9.1 3.4 4.1 8.7 5.2 4.9 1.6 6.9 0.8 3.7 3.6 3.9 1.3 1.9 4.0 4.1 2.2 3.3 2.5 6.2 3.9 18.3 0.9 4.0 10.8 2.5 4.9 3.0 12.3 4.6 3.8 1.5 4.8 4.8 3.5 2.1 2.5 1.1 0.9 1.2 2.2 3.7 3.4 10.5 1.4 4.3 3.9 3.4 4.8 4.0 4.7 7.5 2.2 3.6 4.4 5.3 2.5 2.2 4.6 1.3 1.3 8.1 1.1 11.0 2.0 7.0 0.5 1.1 8.9 0.6 0.6 0.9 1.1 2.8 1.7 1.8 1.3 3.2 1.4 6.7 1.2 0.3 2.2 2.7 3.7 1.6 3.3 3.1 3.5 2.1 2.1 5.6 1.4 3.0 3.2 0.8 2.5 1.5 4.8 1.7 2.5 24.1 7.9 3.5 11.8 2.9 3.3 3.1 21.1 2.5 2.1 0.0 1.6 1.5 4.4 2.7 0.0 1.0 11.7 3.2 4.7 9.8 6.1 17.2 10.0 4.5 8.5 1.0 2.8 3.5 1.7 2.3 6.0 15.3 9.5 6.5 1.2 80.3 5.4 1.5 1.1 2.1 1.7 1.6 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 36.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 158.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 11.2" "Cell type enhanced" "Detected in many" "gdT-cell: 5.8;NK-cell: 5.8" "Group enriched" "Detected in many" 23 "NK-cells: 5.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 0.8 1.2 1.6 4.4 4.2 0.1 4.5 0.3 2.5 6.0 13.5 4.5 8.7 3.6 20.5 6.6 3.0 17.1 15.7 0.8 2.2 2.7 13.8 0.3 4.1 1.3 0.9 1.4 9.5 6.5 22.7 8.6 5.4 11.2 23.5 7.8 36.2 5.2 17.4 0.8 5.9 2.7 5.6 0.7 0.2 5.7 7.0 0.3 1.4 15.0 5.2 2.6 5.1 2.9 0.2 0.0 0.0 0.0 5.8 5.8 0.8 6.0 0.6 3.3 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 5.1 19.6 0.0 6.5 0.0 2.7 20.7 9.9 0.1 0.0 0.0 9.4 0.0 2.6 0.2 0.9 0.0 11.4 0.1 0.3 0.0 0.0 0.0 0.0 3.0 9.9 0.0 0.0 5.8 1.6 1.1 1.8 47.6 7.2 0.0 0.0 0.5 5.6 4.3 14.0 5.2 4.4 5.6 0.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 5.8 0.0 2.3 0.0 1.3 2.3 0.0 0.2 1.6 2.6 0.0 5.8 0.0 0.0 0.0 0.8 1.6 4.2 0.3 2.5 2.2 2.7 0.9 1.4 11.2 0.3 0.0 2.6 0.0 4.2 1.9 6.1 1.0 2.5 8.1 3.4 0.0 39.3 0.2 0.0 2.0 1.7 0.6 9.7 0.0 2.1 0.9 1.5 7.6 0.0 0.0 0.2 4.8 8.6 0.0 0.0 4.9 1.1 0.0 5.0 0.0 5.8 8.1 1.7 8.2 0.7 8.1 158.9 0.0 1.9 2.3 4.2 0.6 0.1 1.3 10.7 2.6 GLB1L3 FLJ90231 ENSG00000166105 "Galactosidase beta 1 like 3" Q8NCI6 11 134274245-134319564 "Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 18.5;seminal vesicle: 10.8" "Group enriched" "Detected in some" 4 "Early spermatids: 2.2;Extravillous trophoblasts: 3.0;Spermatocytes: 3.9;Spermatogonia: 7.5" "Cancer enhanced" "Detected in some" "prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "gdT-cell: 2.3;memory CD4 T-cell: 5.7;memory CD8 T-cell: 3.5;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6;T-reg: 2.4" "Lineage enriched" "Detected in single" 57 "T-cells: 5.7" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;JURKAT: 14.3;NTERA-2: 4.2;PC-3: 5.6;SCLC-21H: 8.9" "Not detected" "Not detected" HPA039916 Uncertain NA NA "HPA039916: AB_2676746" "unprognostic (1.64e-3)" "unprognostic (7.80e-3)" "unprognostic (5.12e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (8.69e-3)" "prognostic favorable (1.97e-4)" "unprognostic (6.58e-3)" "unprognostic (3.81e-1)" "unprognostic (6.95e-3)" "unprognostic (9.73e-2)" "unprognostic (1.52e-5)" "unprognostic (1.39e-1)" "unprognostic (6.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.07e-1)" 0.5 2.7 4.0 1.2 19.1 0.6 1.2 10.3 14.4 0.8 1.2 0.0 0.0 0.5 3.8 0.4 0.5 0.4 0.5 0.4 2.7 2.6 1.3 0.4 0.5 2.1 1.4 6.1 0.4 0.6 0.4 1.1 0.5 5.8 18.5 0.5 1.0 3.4 10.8 0.5 5.4 0.5 0.5 0.6 0.6 0.6 2.4 1.4 0.0 3.4 0.0 0.8 0.9 1.2 0.0 0.0 0.0 0.0 0.0 5.7 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.3 0.0 2.4 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 2.5 0.0 4.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 8.9 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 5.7 3.5 0.0 0.0 4.8 3.6 0.0 0.0 0.0 0.0 2.4 1.0 4.0 19.1 10.3 14.4 2.7 2.6 1.4 6.1 5.8 1.4 0.0 0.0 0.0 0.0 0.5 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.6 0.0 0.0 3.9 7.5 0.1 1.0 0.0 0.0 0.0 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Group enriched" "Detected in many" 13 "Early spermatids: 154.8;Spermatocytes: 290.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 5.8;SK-BR-3: 8.5;U-2 OS: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.6 0.3 0.6 4.4 2.6 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 1.1 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.8 3.3 0.6 0.1 0.9 1.4 0.6 2.3 3.8 0.2 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 1.2 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.5 2.5 0.4 2.5 0.2 1.2 1.0 11.3 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 0.0 1.9 0.0 3.9 0.8 4.6 3.6 0.0 14.7 1.2 0.0 0.0 1.3 8.3 0.4 154.8 1.0 0.0 0.0 0.0 0.2 1.1 0.8 1.1 0.0 0.5 1.6 0.0 0.0 0.0 14.7 6.9 0.1 0.0 0.0 0.0 5.6 0.2 0.0 5.3 1.0 2.0 6.5 1.0 290.6 16.8 0.4 0.3 0.0 0.0 2.3 GLIS1 FLJ36155 ENSG00000174332 "GLIS family zinc finger 1" Q8NBF1 1 53506237-53738106 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 8.9;seminal vesicle: 14.7" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 6.0;Early spermatids: 2.7;Late spermatids: 2.5;Melanocytes: 3.3;Proximal tubular cells: 5.0;Spermatogonia: 2.8" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;BJ hTERT+: 5.9;GAMG: 7.8;hTERT-RPE1: 6.3;PC-3: 9.5;U-138 MG: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001409 Uncertain NA NA "HPA001409: AB_1078974" "unprognostic (1.30e-1)" "unprognostic (1.46e-1)" "unprognostic (2.07e-1)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (1.54e-2)" "unprognostic (8.91e-3)" "unprognostic (1.92e-1)" "unprognostic (2.27e-3)" "unprognostic (2.30e-1)" "unprognostic (3.03e-2)" "unprognostic (1.15e-2)" "unprognostic (1.93e-1)" "unprognostic (4.06e-2)" "unprognostic (1.55e-1)" "unprognostic (6.37e-4)" "unprognostic (1.98e-4)" 1.1 0.1 0.5 0.6 1.2 0.0 0.9 3.9 1.6 4.2 0.5 0.5 0.5 0.6 1.4 1.0 0.6 0.8 1.0 1.0 2.3 0.7 3.3 0.5 0.5 0.5 0.5 0.5 1.0 0.5 0.0 0.5 1.2 0.8 8.9 0.1 5.5 0.5 14.7 0.5 1.7 0.6 0.5 0.5 0.5 0.9 4.1 0.5 0.5 0.5 0.5 1.0 2.7 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 3.8 5.0 0.0 2.6 5.9 2.3 1.7 0.0 0.0 0.0 0.1 2.7 7.8 0.0 0.0 0.0 0.7 0.0 1.7 0.0 1.7 0.1 1.3 0.0 0.0 3.5 0.2 2.8 2.6 6.3 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 1.2 0.1 1.7 0.0 0.0 4.2 0.5 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 3.9 1.6 2.3 0.7 0.5 0.5 0.8 0.5 0.0 0.0 0.0 0.0 6.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.1 5.0 0.0 0.0 1.4 1.9 2.8 1.5 0.1 0.0 0.0 0.0 GLIS3 "MGC33662, ZNF515" ENSG00000107249 "GLIS family zinc finger 3" Q8NEA6 9 3824127-4348392 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Congenital hypothyroidism, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 57.8" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 66.3;Ductal cells: 42.5;Intestinal endocrine cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HSkMC: 23.4;RPTEC TERT1: 14.5;U-251 MG: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056426 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056426: AB_2683128" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.63e-3)" "unprognostic (4.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.81e-2)" "unprognostic (7.14e-2)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.63e-1)" "unprognostic (1.91e-3)" "unprognostic (6.88e-3)" "unprognostic (8.54e-2)" "unprognostic (1.04e-1)" "unprognostic (6.35e-2)" 5.6 2.8 5.6 4.4 7.4 1.0 2.9 3.5 9.5 13.4 2.9 10.7 33.5 1.6 6.1 6.5 1.5 15.0 14.7 4.7 8.9 4.5 11.4 5.1 5.7 2.6 7.7 3.8 10.4 17.3 6.4 8.8 2.8 16.3 5.3 4.0 4.6 5.2 57.8 2.1 1.4 2.2 5.1 26.7 3.8 3.2 4.6 10.2 0.0 29.3 1.4 1.7 5.6 8.8 0.0 0.0 1.8 0.9 0.3 0.7 0.0 0.6 6.7 2.0 0.0 2.7 7.4 0.2 5.1 15.4 2.3 3.4 1.1 2.4 0.0 4.0 3.7 7.7 0.0 1.3 0.0 4.8 1.5 1.0 0.0 0.3 0.0 8.1 0.7 0.0 23.4 0.0 7.1 0.7 4.2 0.4 0.0 0.0 0.1 1.9 0.2 0.0 0.9 0.1 0.0 0.9 0.0 4.6 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 5.1 2.6 0.6 2.7 12.1 0.0 0.0 0.0 7.1 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 1.1 0.3 0.9 0.0 0.1 0.0 5.6 7.4 3.5 9.5 8.9 4.5 7.7 3.8 16.3 10.2 8.9 20.0 0.9 6.4 1.6 0.2 1.1 45.9 29.4 30.7 66.3 0.0 2.0 0.0 42.5 3.6 5.8 2.0 0.0 20.0 2.7 6.6 10.3 1.1 6.6 2.1 0.0 42.0 6.2 1.0 1.8 12.7 2.7 3.3 3.6 1.1 22.1 34.5 2.9 10.6 17.0 0.2 0.0 10.3 0.7 4.3 1.1 3.5 1.0 3.5 3.9 GLP2R ENSG00000065325 "Glucagon like peptide 2 receptor" O95838 17 9822206-9892102 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 32.7" "Cell type enriched" "Detected in some" 6 "Rod photoreceptor cells: 24.5" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.1" "Group enriched" "Detected in some" 4 "basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HeLa: 42.8" "Group enriched" "Detected in some" 6 "cerebral cortex: 2.1;hippocampal formation: 2.6" "Low region specificity" "Detected in some" "CAB022690, HPA049244" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022690: , HPA049244: AB_2680690" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (2.66e-3)" "unprognostic (2.21e-2)" "unprognostic (3.81e-3)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (5.15e-2)" "unprognostic (7.63e-2)" "unprognostic (7.14e-2)" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (3.40e-8)" "unprognostic (9.53e-5)" "unprognostic (5.51e-2)" "unprognostic (3.92e-1)" "unprognostic (6.48e-3)" 7.9 0.7 0.6 2.0 2.9 0.0 2.6 0.3 4.3 6.6 14.5 0.0 1.7 12.4 1.9 0.4 5.3 1.4 32.7 0.9 0.6 0.5 0.4 3.2 1.4 0.7 0.6 1.6 0.8 2.1 0.0 0.3 1.5 0.5 8.4 7.5 0.8 0.4 0.2 0.3 0.3 15.4 15.6 0.6 0.3 4.9 1.1 0.2 0.0 0.5 0.1 0.4 13.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.3 4.1 0.6 0.5 0.6 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLRA4 ENSG00000188828 "Glycine receptor alpha 4" Q5JXX5 X 103707224-103728655 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7" "Cell type enriched" "Detected in single" 21 "Enterocytes: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 7.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044759 Uncertain NA NA "HPA044759: AB_10795885" "unprognostic (4.96e-2)" "unprognostic (2.09e-2)" "unprognostic (3.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (4.94e-7)" "unprognostic (4.49e-1)" "unprognostic (1.94e-1)" "unprognostic (1.87e-1)" 0.0 0.0 0.9 0.1 1.5 0.0 0.3 2.8 3.5 1.9 1.4 0.9 0.0 2.2 5.1 0.1 0.2 0.6 0.1 0.1 1.5 1.8 0.0 0.0 0.0 0.0 0.5 1.0 1.2 0.0 2.4 0.2 0.0 1.2 0.5 1.8 0.0 0.0 0.4 0.1 0.3 2.3 6.7 1.5 0.0 0.1 1.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 7.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 1.5 2.8 3.5 1.5 1.8 0.5 1.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.1;bone marrow: 25.4;liver: 24.7" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 23.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 23.1" "Group enriched" "Detected in some" 6 "MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 3.0 0.6 7.0 7.0 12.4 25.4 0.6 7.1 15.5 1.8 0.6 1.2 0.2 0.5 4.1 1.4 0.9 2.1 2.1 1.2 6.3 10.5 1.2 24.7 2.2 4.5 5.8 6.4 0.6 1.2 0.4 1.0 1.0 7.6 1.3 0.7 2.6 0.4 1.9 8.2 1.3 0.6 3.6 1.6 9.2 0.6 14.7 1.3 0.1 2.0 0.0 0.8 1.7 0.6 0.0 1.4 23.1 3.8 0.0 0.3 0.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.3 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.1 0.0 1.1 1.4 0.0 0.8 7.0 12.4 7.1 15.5 6.3 10.5 5.8 6.4 7.6 1.3 0.0 0.0 0.5 0.0 0.8 0.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.5 0.0 0.0 1.8 11.4 34.0 0.3 1.7 1.7 0.0 0.0 9.8 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.6 0.2 0.3 0.1 0.0 0.0 0.0 GLT6D1 GLTDC1 ENSG00000204007 "Glycosyltransferase 6 domain containing 1" Q7Z4J2 9 135623656-135639540 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 28 "testis: 10.3" "Group enriched" "Detected in some" 22 "Early spermatids: 13.2;Late spermatids: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023424 Uncertain "Intracellular and membrane" NA NA "HPA023424: AB_1849729" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988984-104064183 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 28.7;Fibroblasts: 28.3;Ito cells: 20.9;Leydig cells: 51.8;Peritubular cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;hTERT-RPE1: 20.6;RPTEC TERT1: 17.6" "Group enriched" "Detected in many" 5 "amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.58e-6)" "prognostic unfavorable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 10.2 5.2 2.2 9.9 3.3 0.2 12.0 0.7 2.4 32.8 10.3 1.4 8.8 2.5 24.5 23.1 13.5 13.3 19.1 18.8 2.2 1.8 3.4 2.8 6.9 2.2 2.1 2.1 25.5 2.5 5.9 12.5 6.9 3.5 19.6 5.3 21.8 6.7 8.3 4.0 2.7 6.7 17.3 2.2 1.0 5.5 7.8 0.8 1.0 26.0 10.9 5.7 11.2 13.1 0.8 0.9 0.2 0.6 0.0 2.1 0.0 0.1 0.2 0.2 8.7 11.4 27.9 0.2 12.5 34.4 3.2 4.2 0.1 0.0 0.3 0.7 14.3 0.1 0.0 0.1 4.6 2.8 0.6 3.9 0.2 4.6 0.0 5.1 0.3 0.2 25.8 0.2 3.9 5.5 20.6 1.7 0.2 0.1 0.5 14.1 0.1 0.2 0.1 1.0 0.0 2.6 0.3 13.4 0.1 17.6 0.1 0.5 0.7 13.1 0.3 0.1 1.0 2.3 0.2 0.2 5.3 2.5 0.5 0.7 1.5 0.3 0.1 0.4 0.2 0.4 0.0 0.0 0.0 2.1 0.6 0.7 0.8 0.3 1.3 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.9 0.0 0.0 2.2 3.3 0.7 2.4 2.2 1.8 2.1 2.1 3.5 0.8 0.0 5.8 0.0 3.5 2.5 0.8 2.4 0.0 0.0 0.0 0.0 2.0 3.5 0.0 0.0 28.7 5.9 0.0 0.0 0.0 0.8 28.3 0.5 0.0 0.2 0.5 0.0 1.7 20.9 0.6 9.6 51.8 0.0 3.3 1.0 0.4 0.3 0.5 0.0 48.8 0.0 0.3 6.5 17.0 1.1 0.9 2.0 1.1 0.5 0.0 0.0 GLYATL3 "bA28H17.2, C6orf140" ENSG00000203972 "Glycine-N-acyltransferase like 3" Q5SZD4 6 49499958-49527047 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 2.0;liver: 5.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 73 "T-47d: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044044 Uncertain NA NA "HPA044044: AB_10960855" "unprognostic (3.57e-1)" "unprognostic (6.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GML LY6DL ENSG00000104499 "Glycosylphosphatidylinositol anchored molecule like" Q99445 8 142834247-142916506 "Predicted intracellular proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "adrenal gland: 68.3" "Cell type enhanced" "Detected in some" 28 "granulocytes: 4.6;Sertoli cells: 6.5;Spermatocytes: 24.7;Spermatogonia: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Group enriched" "Detected in some" 19 "HMC-1: 1.2;JURKAT: 2.1;SK-MEL-30: 1.6;U-937: 2.5" "Intracellular and membrane" NA NA 0.0 68.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 2.2 0.0 0.8 1.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 24.7 7.2 0.0 0.0 0.0 0.0 0.0 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 1781.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.7 32.8 55.4 25.8 94.2 43.0 49.8 56.4 51.6 64.5 46.3 95.8 50.6 32.0 87.9 73.2 46.2 42.3 50.8 75.1 43.7 21.1 30.6 35.6 49.9 62.7 43.5 20.7 22.4 51.3 38.2 31.3 42.2 51.2 48.9 39.5 31.2 43.7 42.5 133.6 105.4 50.6 17.6 6.4 34.7 64.9 48.5 56.5 51.7 38.7 68.7 157.4 78.4 77.9 62.9 50.7 59.5 56.7 53.7 85.7 77.0 30.8 53.1 76.8 49.5 67.6 37.6 10.1 43.7 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 205.4 224.1 189.5 151.9 115.9 363.0 884.0 242.0 250.3 255.9 247.7 53.0 672.6 376.4 220.5 577.5 343.9 323.7 303.7 196.1 292.5 221.9 260.9 133.0 165.2 333.8 1781.3 444.7 335.7 327.9 1338.6 245.7 276.8 210.9 147.9 250.3 861.2 313.5 239.3 185.3 130.9 175.1 207.0 226.4 48.2 25.4 103.0 1013.3 142.4 268.2 212.5 GNAT2 ACHM4 ENSG00000134183 "G protein subunit alpha transducin 2" P19087 1 109603267-109619929 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 27.6" "Cell type enriched" "Detected in some" 14 "Cone photoreceptor cells: 56.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "HAP1: 5.5;U-698: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.1 0.4 0.1 0.1 0.3 0.0 0.4 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.6 0.2 0.2 0.2 0.1 2.5 0.5 0.3 0.1 0.1 0.1 0.4 0.4 0.8 1.2 0.3 0.2 0.5 27.6 0.4 0.3 0.1 0.1 0.6 0.2 0.1 0.4 0.1 6.4 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 0.3 3.0 0.4 0.0 0.3 0.0 0.9 0.2 0.3 0.9 0.4 0.3 0.1 0.5 0.3 0.6 0.1 2.2 0.8 2.4 2.1 0.1 0.8 0.2 5.5 0.1 0.9 0.0 0.1 0.1 0.5 0.9 0.0 2.2 0.3 1.1 0.8 1.3 1.0 0.0 1.4 0.5 1.4 1.5 0.8 1.8 0.7 0.2 1.0 1.1 0.5 0.7 0.0 1.1 0.7 0.6 1.8 0.0 1.9 0.5 2.9 0.0 0.4 0.0 0.0 0.4 0.6 1.0 0.5 2.7 1.6 3.9 0.7 0.4 0.5 0.0 0.0 3.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.2 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 56.9 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.1 0.0 0.0 0.0 GNAT3 "GDCA, gustducin" ENSG00000214415 "G protein subunit alpha transducin 3" A8MTJ3 7 80458671-80512020 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 14.5" "Cell type enriched" "Detected in single" 22 "Early spermatids: 2.2" "Group enriched" "Detected in some" 6 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 8.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "olfactory region: 1.8" NA NA "unprognostic (2.01e-1)" 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNGT2 GNG9 ENSG00000167083 "G protein subunit gamma transducin 2" O14610 17 49202791-49210574 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "blood: 29.1;lymphoid tissue: 21.1;retina: 46.7" "Cell type enhanced" "Detected in many" 18 "Cone photoreceptor cells: 68.7;Kupffer cells: 22.4;Macrophages: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 29.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 36.4;HDLM-2: 31.2;HUVEC TERT2: 9.4;RH-30: 11.6;TIME: 9.1;U-698: 11.2" "Low region specificity" "Detected in some" HPA043381 Enhanced NA NA "HPA043381: AB_2678455" "unprognostic (9.11e-2)" "unprognostic (4.09e-3)" "unprognostic (1.99e-2)" "unprognostic (4.62e-5)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (1.75e-1)" "unprognostic (7.37e-2)" "unprognostic (1.30e-2)" "unprognostic (2.11e-2)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (1.23e-1)" 2.7 2.1 2.7 9.4 3.7 1.3 1.8 0.7 2.2 2.1 2.3 2.0 0.4 2.6 1.6 1.2 1.8 1.7 3.3 2.4 2.5 1.9 3.0 2.6 6.2 12.2 3.2 0.4 1.7 1.2 0.1 1.4 1.9 2.2 2.2 3.3 46.7 1.6 1.1 0.6 0.6 4.9 2.9 4.5 21.1 1.7 0.8 2.5 6.0 2.5 1.4 16.6 3.6 5.1 2.0 9.7 0.9 29.1 10.6 14.4 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.5 0.0 0.0 36.4 0.3 0.1 0.0 0.0 0.0 0.0 2.1 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.4 4.5 0.0 0.2 0.8 0.0 2.7 2.2 0.3 0.0 0.0 7.0 11.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 9.1 0.0 5.8 0.0 0.0 0.1 1.6 11.2 0.1 0.1 0.0 0.0 4.3 0.4 14.4 21.5 12.6 1.9 2.4 10.2 9.7 2.0 1.5 5.9 0.9 10.6 29.1 0.8 1.8 5.4 2.7 3.7 0.7 2.2 2.5 1.9 3.2 0.4 2.2 2.5 0.0 1.4 5.6 0.0 0.3 2.3 0.6 0.0 0.0 1.2 0.0 68.7 0.0 3.3 0.0 0.6 4.7 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 11.1 0.0 0.0 2.5 22.4 6.5 0.6 17.7 0.0 7.2 0.0 3.3 0.0 0.0 0.0 0.0 12.3 6.5 0.0 0.0 0.0 0.1 0.2 14.0 0.0 0.0 GNRH2 ENSG00000125787 "Gonadotropin releasing hormone 2" O43555 20 3043622-3045747 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 10.2" "Cell type enriched" "Detected in single" 7 "Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 7.5" HPA004338 Uncertain "Secreted to blood" NA NA "HPA004338: AB_1079012" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (1.20e-2)" "unprognostic (2.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (7.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.47e-4)" "unprognostic (2.69e-1)" "unprognostic (2.98e-2)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" 0.8 0.9 0.6 1.2 0.9 0.4 0.5 5.1 1.7 1.6 0.5 0.5 0.5 0.3 1.3 10.2 0.5 2.4 2.0 1.1 0.7 1.2 1.7 3.3 0.5 0.6 1.5 0.5 5.6 0.5 0.5 1.8 0.5 1.2 4.2 0.1 1.0 1.6 2.0 0.5 0.1 0.5 0.5 0.5 0.5 2.2 3.9 0.5 0.5 2.8 0.5 0.5 0.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 3.2 4.0 2.0 0.5 0.6 0.8 0.0 0.5 0.8 1.9 0.8 1.5 0.1 0.2 1.2 3.3 1.3 1.1 0.9 1.2 3.6 1.3 1.1 2.5 0.0 0.2 2.2 2.5 2.6 2.5 0.0 0.4 0.8 2.6 1.5 0.5 1.3 1.1 0.8 2.5 1.4 0.0 0.0 0.9 0.4 0.8 0.5 2.8 4.5 2.1 0.2 2.7 1.5 1.5 2.9 1.4 0.0 1.9 0.9 1.6 1.8 1.1 7.5 1.0 1.7 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 5.1 1.7 0.7 1.2 1.5 0.5 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA7B "bA451M19.3, bA459F3.4, C10orf132, C10orf133" ENSG00000155265 "Golgin A7 family member B" Q2TAP0 10 97850239-97871580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 39.6;epididymis: 35.9;skin 1: 21.4" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 11.1;Cholangiocytes: 15.3;Intestinal endocrine cells: 11.5;Rod photoreceptor cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 24 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "A-431: 4.7;GAMG: 13.6;HDLM-2: 5.1;SK-MEL-30: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain NA NA "HPA046878: AB_2679854" "unprognostic (7.90e-2)" "unprognostic (1.70e-3)" "unprognostic (7.10e-3)" "unprognostic (1.06e-2)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-4)" "unprognostic (1.95e-1)" "unprognostic (4.45e-1)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (4.13e-2)" "unprognostic (1.15e-7)" "unprognostic (2.12e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-3)" "unprognostic (5.90e-3)" 2.5 4.5 16.4 2.1 12.0 1.3 2.5 39.6 24.1 1.3 1.5 4.4 1.3 3.2 1.3 35.9 2.3 1.1 1.5 3.4 19.8 12.8 1.0 1.1 1.7 2.8 11.1 20.4 1.0 6.6 1.0 6.7 1.3 10.7 1.3 1.8 0.6 1.4 1.7 4.9 21.4 3.8 1.2 5.4 1.5 2.3 1.7 6.2 0.0 1.4 0.5 2.5 1.2 1.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.1 0.0 13.6 1.8 0.0 0.3 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.9 0.3 0.0 1.7 0.1 0.1 0.3 0.7 1.4 0.0 0.9 20.3 0.0 2.0 0.1 0.1 0.1 0.0 0.0 0.2 1.6 0.7 0.0 3.7 2.1 2.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 2.3 1.9 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 1.2 0.3 16.4 12.0 39.6 24.1 19.8 12.8 11.1 20.4 10.7 6.2 0.0 0.3 0.0 0.1 11.1 2.7 2.2 15.3 0.0 0.0 1.8 2.0 0.0 0.0 6.4 4.5 0.6 0.4 0.0 3.7 0.0 0.2 0.2 0.0 0.0 5.4 3.2 11.5 0.6 0.0 8.8 0.3 0.0 6.8 1.0 1.1 2.8 7.5 0.0 0.4 0.0 17.0 0.0 0.2 1.9 1.6 4.4 0.0 0.0 0.2 0.2 GOLGA8A "GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 196.5;Alveolar cells type 2: 83.2;Bipolar cells: 84.1;Ciliated cells: 85.6;Club cells: 217.2;Cone photoreceptor cells: 94.2;Horizontal cells: 79.4;Rod photoreceptor cells: 127.5" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.1;HeLa: 30.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 2.6 4.7 3.6 5.1 4.4 3.1 5.8 20.1 3.5 6.3 3.5 5.8 5.3 18.0 4.1 3.7 3.6 2.9 3.9 3.7 2.6 0.4 2.3 6.5 3.3 7.4 3.3 8.0 2.4 0.7 4.6 0.8 6.7 5.3 2.6 18.4 4.0 1.2 3.8 8.3 3.3 8.3 5.7 0.6 2.6 5.3 0.7 0.0 0.8 0.0 2.7 0.2 0.0 1.0 6.0 1.7 6.0 0.0 0.0 1.3 9.3 0.0 1.6 0.7 10.5 0.0 0.0 1.7 1.1 3.5 9.8 4.3 3.1 2.5 9.1 3.6 22.1 30.5 6.6 0.7 8.4 6.0 0.0 9.0 1.0 0.2 1.0 0.1 3.3 20.0 18.7 4.2 1.9 2.3 15.4 3.2 2.9 3.3 9.0 5.3 7.5 3.5 6.2 8.1 3.8 6.2 4.2 1.0 0.0 1.6 5.1 4.9 7.5 1.7 0.0 1.6 18.0 5.9 2.5 2.3 18.0 1.6 0.0 0.0 0.8 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 196.5 83.2 10.2 10.7 23.2 84.1 26.4 2.5 85.6 217.2 1.8 94.2 2.3 0.0 3.8 22.3 15.7 6.7 0.0 2.2 2.8 11.6 7.7 12.8 0.9 2.1 79.4 15.4 14.1 6.5 5.4 29.1 11.1 21.9 1.8 9.1 17.7 4.1 6.0 19.8 0.3 127.5 0.0 17.9 29.0 20.5 18.9 2.7 13.8 11.7 7.5 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 25.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 178.6;Club cells: 128.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "basophil: 2.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "HeLa: 14.6;Hep G2: 13.0;NB-4: 20.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 2.6 3.4 0.0 2.8 0.6 6.8 4.3 2.5 2.7 2.5 2.0 0.0 4.1 6.1 0.8 3.8 2.8 1.6 0.0 0.7 3.0 2.3 4.5 8.0 0.0 9.0 25.2 0.1 4.9 0.9 5.4 0.1 4.6 5.2 1.8 3.3 5.4 0.5 0.0 5.2 4.0 5.3 16.4 3.1 3.0 1.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 2.0 2.3 0.2 4.3 2.4 4.7 6.1 1.9 0.6 2.1 3.5 2.2 2.9 0.0 4.1 2.0 0.2 1.7 0.8 1.9 1.8 3.0 7.1 0.3 14.6 13.0 3.5 1.8 2.3 6.7 2.7 1.3 3.9 2.4 2.1 3.3 0.7 0.2 1.9 1.0 0.9 20.1 2.7 4.1 3.9 0.1 0.0 0.3 1.8 4.1 3.2 4.9 1.0 0.3 2.2 3.4 1.9 3.9 0.0 3.1 7.4 0.9 3.3 1.4 1.3 3.0 1.0 0.9 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.6 44.8 21.6 8.2 19.5 41.4 30.9 17.8 53.5 128.5 29.6 68.7 5.9 1.7 7.8 32.7 8.9 3.2 0.0 11.0 3.6 7.6 6.5 9.2 25.1 1.4 42.9 6.9 12.9 8.1 3.9 36.5 6.7 20.3 9.0 8.5 9.4 15.0 3.5 35.3 2.2 68.6 12.9 8.1 34.9 26.8 12.9 2.4 37.1 6.9 6.0 GOLT1A "CGI-141, FLJ42654, GOT1, MGC62027, YMR292W" ENSG00000174567 "Golgi transport 1A" Q6ZVE7 1 204198160-204214092 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 35.9;liver: 74.9" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 38.2;Hepatocytes: 109.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 80.7" "Group enriched" "Detected in many" 5 "basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 12 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 10.8;Hep G2: 13.3;MCF7: 22.5;OE19: 8.5;RT4: 14.7;SK-BR-3: 14.8" "Not detected" "Not detected" NA NA "unprognostic (3.43e-1)" "unprognostic (1.13e-1)" "unprognostic (2.22e-3)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (6.20e-3)" "unprognostic (2.14e-1)" "unprognostic (8.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.26e-2)" "unprognostic (7.33e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.35e-5)" "unprognostic (1.37e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-3)" "prognostic favorable (1.51e-4)" 0.3 0.0 1.2 0.8 8.8 0.0 1.7 3.8 0.8 3.5 13.7 0.4 1.7 15.5 0.3 3.6 0.3 1.0 3.4 0.3 1.0 3.8 5.9 74.9 3.1 0.3 0.8 0.4 0.4 12.5 7.1 8.7 1.0 0.9 2.9 1.6 0.5 1.0 3.7 0.6 0.0 35.9 1.6 0.6 0.3 1.9 0.5 0.3 0.4 0.6 0.3 0.4 10.9 2.5 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.2 4.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 9.3 10.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.1 8.5 0.1 0.0 0.0 0.2 4.6 14.7 0.7 1.0 0.4 14.8 0.0 0.4 4.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 1.4 1.4 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.6 1.2 8.8 3.8 0.8 1.0 3.8 0.8 0.4 0.9 0.3 0.0 17.9 0.0 11.9 0.0 2.5 0.3 38.2 0.0 5.7 15.7 0.0 11.4 11.6 24.4 0.6 0.0 13.1 0.0 16.1 0.2 0.4 10.6 1.1 109.9 1.1 1.6 9.9 3.1 2.8 0.0 0.0 0.0 1.7 0.0 3.2 0.0 18.5 1.7 0.0 10.4 0.1 0.0 0.1 2.3 0.9 0.1 22.1 0.0 7.4 12.9 GOT1L1 MGC33309 ENSG00000169154 "Glutamic-oxaloacetic transaminase 1 like 1" Q8NHS2 8 37934281-37940129 "Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 16.4" "Cell type enriched" "Detected in some" 7 "Early spermatids: 100.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028778 Uncertain NA NA "HPA028778: AB_10602138" "unprognostic (6.93e-3)" "unprognostic (5.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309572-20327808 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 354 "pancreas: 1812.8" "Cell type enhanced" "Detected in some" 30 "Cholangiocytes: 117.2;Exocrine glandular cells: 424.3;Glandular cells: 76.3" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015739, HPA016668" Enhanced "Intracellular and membrane" NA NA 27000 "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 5.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.4 1812.8 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.4 1.4 2.3 0.9 0.6 0.8 0.3 0.5 0.3 0.6 1.0 0.0 0.2 1.3 0.3 0.0 0.5 0.2 1.3 0.7 1.3 1.4 0.4 0.6 0.7 0.1 0.4 0.7 0.3 0.2 0.4 1.3 0.2 0.0 0.4 0.9 0.0 0.3 0.2 0.0 0.5 0.0 0.5 0.8 0.8 0.5 0.0 0.5 0.6 0.1 0.1 1.2 0.8 0.8 1.8 0.1 0.2 0.7 0.5 0.6 1.4 0.2 0.7 0.5 0.5 0.0 1.1 2.2 0.8 1.0 0.7 0.8 0.3 0.3 0.6 0.3 2.0 0.9 0.7 0.8 0.3 0.5 0.6 0.7 0.7 0.1 1.4 0.7 0.7 2.3 0.6 0.2 1.4 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 117.2 0.0 0.0 0.0 0.0 0.0 8.3 0.8 6.1 0.0 0.6 0.0 424.3 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 7.2 2.0 0.2 32.3 13.9 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 1.4 GPAT2 CT123 ENSG00000186281 "Glycerol-3-phosphate acyltransferase 2, mitochondrial" Q6NUI2 2 96021946-96039451 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0" "Low region specificity" "Detected in single" HPA036841 Uncertain Approved Mitochondria NA NA Mitochondria "HPA036841: AB_10601479" "unprognostic (1.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.69e-2)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.38e-3)" "unprognostic (4.99e-2)" "unprognostic (3.28e-2)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (5.96e-2)" "unprognostic (4.67e-2)" "unprognostic (7.43e-6)" "unprognostic (2.11e-1)" "unprognostic (7.68e-2)" "unprognostic (3.49e-1)" "unprognostic (3.65e-1)" 4.3 1.1 1.5 1.9 3.1 1.5 3.6 0.2 1.6 0.8 1.0 0.0 1.1 5.1 0.9 1.0 2.2 3.9 1.1 0.7 0.5 0.5 1.3 3.2 1.2 0.9 1.1 0.0 0.2 2.0 0.6 1.5 1.8 4.9 1.4 0.5 1.3 2.4 2.3 4.4 3.0 7.3 1.2 2.6 2.6 0.8 4.3 1.1 0.5 2.5 0.2 3.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.0 17.5 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 2.6 1.9 2.8 4.3 1.3 2.0 1.1 4.1 0.8 3.0 0.0 0.2 2.5 0.0 1.3 1.5 0.0 0.6 2.4 0.6 0.9 0.7 1.6 2.5 0.0 0.0 1.8 0.0 0.1 1.7 1.7 1.5 2.9 0.4 0.0 1.6 0.2 2.2 0.5 1.1 0.0 2.2 7.9 0.0 6.7 1.0 4.3 0.6 1.0 1.7 1.0 0.7 0.9 0.8 0.6 0.0 0.0 0.2 97.0 18.3 27.9 16.8 0.1 0.1 0.7 1.3 1.6 GPBAR1 "BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5" ENSG00000179921 "G protein-coupled bile acid receptor 1" Q8TDU6 2 218259496-218263859 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.6;gallbladder: 73.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 14.0;Intestinal endocrine cells: 44.2;Kupffer cells: 42.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 85.6;non-classical monocyte: 78.5" "Lineage enriched" "Detected in many" 5 "monocytes: 85.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HHSteC: 5.1;SCLC-21H: 2.6;U-937: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA062890 Enhanced NA NA "HPA062890: AB_2684896" "unprognostic (8.47e-2)" "unprognostic (3.72e-3)" "unprognostic (1.88e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (2.54e-1)" "unprognostic (2.63e-1)" "unprognostic (8.76e-3)" "unprognostic (4.32e-2)" "unprognostic (4.64e-2)" "unprognostic (1.55e-1)" "unprognostic (7.40e-7)" "unprognostic (4.18e-2)" "unprognostic (4.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.29e-1)" 19.9 1.1 0.3 2.6 0.4 1.8 11.4 0.2 0.4 0.7 2.7 0.5 0.8 1.0 1.1 1.4 1.3 0.9 73.8 3.8 0.2 0.0 3.2 1.7 2.2 3.8 0.4 0.2 1.4 1.5 0.0 0.7 8.9 0.4 2.0 0.5 0.9 0.5 0.9 0.8 0.8 3.2 10.3 0.2 6.5 5.5 1.5 0.2 1.0 1.5 1.8 0.6 3.2 0.7 0.0 17.4 0.8 85.6 0.0 0.1 15.8 0.2 0.1 0.4 0.0 3.1 0.1 0.9 0.0 0.4 0.0 0.1 0.8 0.4 0.2 0.3 0.3 0.2 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.5 0.4 5.1 0.4 1.4 0.0 2.5 0.0 0.0 0.2 0.2 0.4 0.3 0.5 0.6 0.3 0.2 0.7 0.2 0.0 0.0 0.2 0.0 0.2 1.6 1.1 2.6 2.3 0.3 0.7 0.4 0.2 0.0 0.8 0.0 0.1 0.3 0.3 0.2 0.3 0.7 0.1 0.3 5.1 0.3 0.0 36.4 0.0 0.1 85.6 0.1 0.0 0.0 0.1 17.4 0.0 0.0 0.0 0.8 0.0 78.5 0.7 0.1 15.8 0.3 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.4 0.2 0.0 4.3 0.9 0.1 0.2 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.4 10.0 0.0 2.6 0.5 0.0 0.0 0.4 2.8 1.9 0.1 1.1 0.0 14.0 0.0 44.2 3.1 42.9 1.6 3.1 6.8 0.0 1.0 0.3 0.0 0.4 0.8 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.4 1.4 0.0 0.1 0.2 GPC2 "cerebroglycan, DKFZp547M109, FLJ38962" ENSG00000213420 "Glypican 2" Q8N158 7 100169606-100177372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 30.9;Intestinal endocrine cells: 10.3;Spermatocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.2;AN3-CA: 9.7;BEWO: 8.6;SH-SY5Y: 26.7" "Low region specificity" "Detected in all" CAB025423 Uncertain "Intracellular and membrane" NA NA "CAB025423: " "unprognostic (4.33e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-4)" "unprognostic (3.42e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-3)" "unprognostic (6.67e-2)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-4)" "unprognostic (7.25e-4)" "unprognostic (1.67e-4)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.94e-4)" 0.5 0.5 3.2 3.5 1.9 1.9 0.6 2.2 4.3 0.8 0.9 2.1 0.0 0.5 2.6 0.3 0.2 0.4 0.4 0.3 2.9 1.6 0.2 0.1 0.5 2.2 2.0 0.9 0.8 0.3 0.5 0.7 0.3 1.5 0.5 0.8 0.5 1.7 0.4 0.8 9.4 0.7 0.8 3.3 1.4 0.3 16.7 2.0 34.3 0.3 0.7 2.0 0.6 1.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.1 24.2 9.7 0.0 0.0 8.6 0.8 0.0 0.1 0.2 0.0 0.3 2.0 0.5 0.2 1.4 0.8 0.8 0.3 0.0 0.0 0.7 0.2 0.3 0.0 0.4 0.5 3.7 0.8 0.4 0.5 0.0 0.4 1.1 5.4 0.9 0.0 0.6 0.3 5.5 0.7 4.2 0.4 1.4 6.3 1.7 0.0 0.1 0.4 6.4 26.7 0.5 0.6 0.8 3.5 0.4 0.4 0.9 0.2 3.9 0.5 0.1 0.8 0.3 2.8 0.2 1.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.3 3.2 1.9 2.2 1.7 2.9 1.6 2.0 0.9 1.5 2.0 0.0 0.0 0.0 0.9 1.5 0.1 1.4 0.0 0.0 0.0 1.8 3.9 0.3 0.0 1.1 30.9 0.6 0.0 0.0 0.8 0.6 0.6 0.7 0.0 0.0 0.3 0.0 10.3 0.0 0.3 4.1 0.9 0.6 0.0 0.0 0.8 1.7 1.2 0.0 1.1 0.0 1.8 0.0 0.9 12.5 5.5 3.3 0.3 0.0 1.2 0.6 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 54.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "CACO-2: 31.4;HeLa: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA040152: AB_2676863, HPA044081: AB_2678801" "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 0.0 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.1 54.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 17.6 29.7 15.4 13.8 17.9 14.2 20.1 15.2 23.1 22.2 24.3 24.3 27.0 20.4 20.6 20.8 25.1 26.1 23.5 14.0 14.6 12.3 35.4 33.9 19.6 17.1 20.5 12.9 22.6 41.5 30.9 15.1 27.1 17.2 24.0 17.7 31.3 35.4 27.4 10.6 19.1 29.2 16.9 15.7 20.9 20.6 26.3 19.4 17.2 38.8 14.7 23.1 21.4 19.8 14.8 25.8 54.3 36.3 23.1 26.7 35.5 11.7 12.8 7.9 15.5 31.1 16.9 9.0 9.2 27.9 12.8 13.6 7.9 13.5 5.6 17.1 18.7 15.3 10.1 8.9 19.1 6.6 22.5 10.3 9.1 13.5 10.4 30.6 5.8 12.4 18.3 36.7 12.3 24.9 17.0 14.9 13.7 9.1 37.5 12.9 8.1 10.2 8.4 5.7 21.3 11.4 8.3 9.0 21.2 26.6 11.6 0.0 8.6 9.3 15.2 14.0 7.1 14.5 14.1 12.3 7.3 4.7 23.2 9.7 24.3 13.1 3.9 25.2 18.7 7.8 20.4 35.8 35.7 26.7 32.7 24.3 14.8 21.4 22.5 25.8 14.1 15.5 17.7 54.3 23.1 36.3 9.2 23.4 35.5 15.4 17.9 15.2 23.1 14.6 12.3 20.5 12.9 17.2 19.4 8.9 12.6 24.2 35.3 23.6 27.7 7.3 35.7 17.4 7.9 34.9 21.6 51.9 31.5 69.1 25.9 30.8 74.1 0.0 96.9 31.1 27.5 30.8 25.4 22.9 52.7 20.6 20.8 38.6 25.1 69.5 21.9 38.9 28.7 56.9 51.5 33.6 68.5 77.2 17.3 45.7 33.2 38.8 26.8 22.1 14.0 27.9 49.0 40.7 43.6 33.9 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR137B TM7SF1 ENSG00000077585 "G protein-coupled receptor 137B" O60478 1 236142505-236221865 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 130.8;Muller glia cells: 234.3;Rod photoreceptor cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;SK-MEL-30: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026422 Approved NA NA "HPA026422: AB_1849338" "unprognostic (1.59e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (6.49e-2)" "unprognostic (2.42e-1)" "unprognostic (1.96e-1)" "unprognostic (5.54e-2)" "unprognostic (1.41e-1)" "unprognostic (5.06e-2)" "unprognostic (2.73e-2)" "unprognostic (5.53e-2)" "unprognostic (4.77e-2)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (7.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 12.6 6.0 26.3 11.6 32.0 4.5 11.3 12.1 23.2 16.3 7.8 18.4 5.6 7.6 14.9 31.8 7.5 5.1 15.8 19.7 24.1 16.3 51.2 16.7 12.7 18.8 23.4 16.7 10.2 3.3 2.0 3.1 22.4 18.9 8.7 8.8 31.1 5.5 12.2 1.7 13.2 6.8 12.7 26.5 16.2 8.4 3.1 20.0 3.8 11.9 1.7 12.7 19.0 10.4 0.5 1.2 11.7 6.8 0.1 2.7 0.4 1.7 2.4 2.0 1.8 27.3 15.5 0.6 3.9 8.7 2.4 3.3 0.5 2.1 0.2 6.3 4.1 5.4 1.4 2.6 2.4 2.3 1.7 5.1 1.0 0.3 0.4 3.8 1.3 9.7 10.0 8.2 1.8 0.9 7.6 3.8 2.4 0.1 0.0 4.0 2.0 1.1 0.5 1.0 0.7 0.9 1.9 3.2 0.7 3.5 6.3 1.5 3.0 1.4 5.4 67.0 1.6 7.0 2.3 3.3 3.6 2.5 8.5 3.8 0.3 2.1 0.2 2.2 0.9 5.5 11.7 0.9 9.2 0.9 4.0 0.5 0.5 0.7 2.7 1.2 0.3 0.4 0.9 0.2 0.1 6.8 0.3 1.8 0.4 26.3 32.0 12.1 17.6 24.1 16.3 23.4 16.7 18.9 20.0 0.0 1.7 13.7 19.2 22.9 31.8 21.6 5.1 0.0 0.0 12.2 33.4 32.4 14.9 10.9 0.0 5.1 0.8 0.0 9.1 8.0 22.8 18.1 20.7 3.9 78.6 49.3 8.2 13.5 52.0 0.0 8.3 34.3 65.8 130.8 3.6 234.3 10.4 2.9 5.6 77.4 135.9 0.0 10.3 0.1 0.2 17.3 34.1 17.5 2.3 23.0 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.6;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.2 7.5 2.4 0.7 3.3 3.4 2.3 3.6 8.6 1.5 1.6 0.8 2.5 2.8 7.6 1.9 2.7 0.5 5.3 1.2 1.9 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 0.8 1.8 1.8 1.2 3.6 5.1 4.0 0.3 1.1 2.0 1.5 4.8 1.8 5.1 0.3 1.1 5.7 8.3 10.5 1.7 0.5 0.2 3.6 5.1 0.0 0.3 8.2 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 0.0 2.2 0.0 0.7 0.6 19.6 2.2 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 1.3 3.0 0.0 0.0 0.2 0.2 1.5 2.4 0.0 0.4 0.4 6.4 1.2 3.7 1.0 1.5 0.6 0.6 1.7 0.0 0.5 5.1 0.0 0.0 0.7 0.1 19.2 0.0 2.1 4.1 2.8 0.6 0.1 0.0 0.0 0.3 GPR139 PGR3 ENSG00000180269 "G protein-coupled receptor 139" Q6DWJ6 16 20031485-20073917 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046596 Uncertain NA NA "HPA046596: AB_2679713" "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR141 PGR13 ENSG00000187037 "G protein-coupled receptor 141" Q7Z602 7 37683796-37833788 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;brain: 18.1" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 4.8;granulocytes: 22.0;Kupffer cells: 8.5;Macrophages: 4.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 11.4;eosinophil: 8.1;gdT-cell: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.8;HMC-1: 30.8;NTERA-2: 16.6;THP-1: 4.9;U-937: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.91e-2)" "unprognostic (3.44e-1)" "unprognostic (3.26e-4)" "unprognostic (4.70e-3)" "unprognostic (8.67e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.51e-2)" "unprognostic (7.93e-3)" "unprognostic (1.44e-1)" "unprognostic (1.51e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-3)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" 1.7 0.9 2.5 4.4 3.3 27.6 0.9 1.0 3.2 1.9 1.4 0.6 0.0 1.0 1.9 2.0 1.8 1.5 3.7 1.7 3.2 1.4 1.2 1.3 4.3 10.0 5.3 0.7 0.6 1.5 0.3 1.0 2.8 5.8 2.0 2.0 2.7 1.7 0.5 0.6 1.2 1.8 1.8 18.1 10.0 1.2 1.5 5.1 2.9 1.1 1.0 2.1 4.8 2.3 0.0 5.8 10.7 11.4 0.6 4.8 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 7.8 0.6 0.0 0.0 0.1 30.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 13.0 0.0 0.0 11.4 8.1 4.8 0.9 0.0 0.0 1.2 4.5 5.8 0.0 0.5 3.3 10.7 0.6 0.1 0.2 0.0 3.4 2.5 3.3 1.0 3.2 3.2 1.4 5.3 0.7 5.8 5.1 3.0 4.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.8 0.0 0.0 0.0 8.5 0.6 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.0 0.0 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR146 PGR8 ENSG00000164849 "G protein-coupled receptor 146" Q96CH1 7 1044576-1059261 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 26 "Endothelial cells: 40.7;Extravillous trophoblasts: 225.4;Syncytiotrophoblasts: 68.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 36.2" "Group enriched" "Detected in many" 4 "granulocytes: 36.2;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BEWO: 22.8;NB-4: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.39e-2)" "unprognostic (7.83e-2)" "unprognostic (6.27e-4)" "unprognostic (5.51e-3)" "unprognostic (1.78e-1)" "unprognostic (2.33e-1)" "unprognostic (2.30e-1)" "unprognostic (2.69e-1)" "unprognostic (2.99e-2)" "unprognostic (3.48e-3)" "unprognostic (2.51e-2)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (3.27e-3)" "unprognostic (1.41e-1)" "unprognostic (4.19e-2)" "unprognostic (1.03e-2)" 37.2 4.2 7.4 3.0 7.2 10.3 35.1 10.8 10.3 6.9 8.5 6.2 4.0 4.2 8.2 4.3 6.0 9.2 9.8 10.2 6.9 5.6 5.0 17.8 16.8 5.7 8.7 3.4 8.5 8.1 2.6 2.1 13.7 11.1 7.3 2.0 6.4 12.0 8.2 9.9 7.0 4.7 5.1 7.9 4.2 9.6 4.9 10.5 0.4 6.0 5.0 2.2 8.5 8.5 0.0 5.6 36.2 0.1 0.4 11.4 2.1 1.2 1.2 0.4 1.1 1.2 0.3 22.8 0.1 0.8 0.2 1.1 0.9 1.0 0.4 0.9 0.1 3.3 0.7 0.0 0.2 0.1 0.8 1.2 1.6 0.7 1.8 1.5 0.1 0.2 0.5 0.0 0.7 0.0 2.3 1.6 0.5 1.1 1.2 0.2 0.9 0.0 6.4 1.6 1.1 0.7 5.2 0.0 1.6 0.3 0.2 1.2 1.7 1.7 0.2 1.8 0.9 1.1 2.0 0.5 0.9 1.3 1.6 0.8 2.0 2.0 0.1 6.0 2.0 2.0 0.0 0.0 36.2 0.3 0.0 0.5 0.0 3.9 0.3 0.7 0.0 11.4 2.2 0.0 0.4 0.1 5.6 6.1 2.1 7.4 7.2 10.8 10.3 6.9 5.6 8.7 3.4 11.1 10.5 0.0 3.2 0.5 0.8 1.5 2.4 0.3 0.0 0.0 3.4 1.8 0.0 6.0 1.7 0.8 0.0 40.7 0.0 0.0 0.5 225.4 1.8 0.6 2.3 16.8 9.2 3.2 4.1 7.4 0.3 0.4 2.8 0.7 3.3 0.0 0.0 22.9 1.0 0.0 3.2 2.5 4.7 0.0 0.6 0.5 1.1 1.9 68.9 0.0 1.0 0.3 GPR148 PGR6 ENSG00000173302 "G protein-coupled receptor 148" Q8TDV2 2 130729070-130730336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 2.5;SCLC-21H: 2.5" "Low region specificity" "Detected in all" HPA060527 Uncertain NA NA "HPA060527: AB_2684307" "unprognostic (7.16e-4)" "unprognostic (3.38e-1)" 0.0 0.2 0.1 0.0 0.4 0.0 0.0 2.6 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154337672-154429715 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7" "Cell type enhanced" "Detected in single" 37 "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 23.5;pons and medulla: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in all" HPA018020 Uncertain NA NA "HPA018020: AB_1849334" 0.2 0.3 0.2 0.2 23.5 0.2 0.2 0.0 0.8 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.8 0.0 0.2 0.2 0.2 6.5 0.2 6.5 0.3 0.3 0.4 0.2 8.7 0.2 0.3 0.3 0.2 0.6 0.2 0.5 1.1 2.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.5 0.0 0.8 0.2 1.9 0.8 0.0 6.5 2.1 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPR15 ENSG00000154165 "G protein-coupled receptor 15" P49685 3 98531899-98533150 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9" "Group enriched" "Detected in many" 30 "B-cells: 4.4;T-cells: 12.9" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 11.1;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA013775 Approved NA NA "HPA013775: AB_1849264" "unprognostic (8.03e-2)" "unprognostic (1.04e-2)" "unprognostic (3.72e-3)" "unprognostic (5.66e-2)" "unprognostic (9.48e-3)" "unprognostic (5.60e-5)" "unprognostic (5.17e-1)" "unprognostic (6.77e-3)" "unprognostic (3.96e-1)" "unprognostic (3.03e-2)" "unprognostic (2.82e-1)" "unprognostic (2.83e-1)" "unprognostic (4.04e-3)" "unprognostic (4.23e-3)" "unprognostic (1.89e-1)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" 0.9 0.1 0.1 13.4 0.1 0.0 2.5 0.1 0.2 1.1 15.3 0.1 0.1 1.8 0.1 0.1 2.6 0.2 2.1 0.2 0.1 0.1 0.3 0.4 1.9 24.9 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.3 1.4 27.1 0.3 4.6 0.7 0.1 0.4 11.8 1.5 0.2 4.3 1.1 0.2 0.1 3.6 0.7 2.0 26.3 9.4 2.4 4.4 0.2 0.2 0.0 0.0 12.9 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.9 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.4 4.4 12.9 6.1 0.0 0.7 0.6 1.0 0.2 0.0 0.0 0.2 12.9 2.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR151 "GALR4, PGR7" ENSG00000173250 "G protein-coupled receptor 151" Q8TDV0 5 146513103-146516190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 1.5;brain: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "thalamus: 36.8" "Region enriched" "Detected in many" 7 "thalamus: 4.6" HPA065728 Supported NA NA "HPA065728: " "unprognostic (2.09e-1)" "unprognostic (2.30e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-2)" 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR152 PGR5 ENSG00000175514 "G protein-coupled receptor 152" Q8TDT2 11 67451301-67452729 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.7;lymphoid tissue: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RPMI-8226: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035078 Uncertain NA NA "HPA035078: AB_10670286" "unprognostic (3.81e-2)" "unprognostic (1.69e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.76e-3)" 0.1 0.0 0.0 0.6 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 1.7 0.0 0.1 1.6 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.5 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR153 PGR1 ENSG00000158292 "G protein-coupled receptor 153" Q6NV75 1 6247346-6260975 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 31.4;Horizontal cells: 60.4;Mucus-secreting cells: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "granulocytes: 1.3;monocytes: 1.0;T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 14.2;PC-3: 36.4;RH-30: 17.2;SCLC-21H: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007159 Approved NA NA "HPA007159: AB_1849268" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (5.74e-3)" "unprognostic (3.33e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (8.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.31e-1)" "unprognostic (1.51e-2)" "unprognostic (1.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" 11.0 2.9 11.9 3.8 5.2 0.5 16.1 1.3 10.6 16.1 19.9 3.7 4.6 5.4 8.3 15.9 7.0 7.1 5.8 7.7 5.8 5.1 2.7 6.3 12.6 2.3 2.0 2.7 14.8 2.1 5.9 10.2 9.2 4.2 6.8 7.1 7.2 2.6 4.9 1.4 8.7 18.3 6.6 1.2 8.8 3.0 2.9 2.5 1.8 1.6 5.5 3.5 6.1 9.6 0.0 0.3 1.3 1.0 0.3 1.7 0.1 3.1 0.5 7.7 9.2 14.2 5.6 0.6 2.1 1.9 0.8 0.9 1.3 1.2 0.0 3.2 2.2 1.8 4.0 0.4 9.0 0.3 2.0 1.9 0.0 1.2 0.2 2.8 0.3 1.2 3.4 2.4 0.6 0.4 1.4 0.6 2.8 0.4 0.0 2.6 3.4 1.0 2.4 0.6 1.8 36.4 3.8 17.2 0.2 0.3 1.7 17.5 6.3 1.4 5.3 4.3 2.2 2.0 1.6 1.8 1.9 1.8 0.2 0.9 0.1 0.1 0.7 0.9 4.1 0.7 1.3 0.0 0.9 1.4 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.3 0.0 0.1 11.9 5.2 1.3 10.6 5.8 5.1 2.0 2.7 4.2 2.5 0.0 0.0 0.0 1.1 3.1 0.6 3.9 5.1 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.9 1.4 4.5 0.0 0.0 0.2 15.5 0.6 1.1 31.4 0.9 60.4 3.4 1.3 1.0 1.5 4.4 2.8 5.0 3.6 39.4 2.0 0.4 4.8 7.1 1.4 1.8 0.0 3.9 0.0 1.5 6.5 0.3 0.5 1.8 13.5 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 117.8;Melanocytes: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 16.3;WM-115: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.5 5.7 3.2 0.6 4.3 1.5 0.7 2.4 0.3 0.4 2.4 1.4 3.0 1.5 0.4 1.4 1.3 2.4 0.9 1.7 2.6 1.4 0.2 1.1 0.9 1.4 4.6 3.6 2.1 0.7 4.6 1.1 3.4 0.4 6.2 4.8 0.7 1.7 1.2 0.6 2.6 1.7 2.1 6.2 1.2 2.4 1.6 6.7 5.7 1.3 1.0 2.2 3.1 0.4 0.4 3.1 3.1 1.2 4.5 0.6 16.3 2.3 0.4 3.6 0.8 10.8 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 11.9 2.2 11.7 2.9 37.9 30.8 21.8 2.5 0.0 10.3 10.4 117.8 1.2 1.7 2.0 0.3 9.0 0.3 0.0 5.0 1.0 7.7 3.4 1.1 16.1 5.9 47.7 12.2 20.9 36.6 0.9 13.8 21.7 145.1 1.8 0.2 15.6 5.6 0.0 30.1 34.6 22.9 0.0 10.8 3.3 2.6 25.0 0.7 17.9 1.1 1.5 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285094 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Group enriched" "Detected in some" 8 "Early spermatids: 6.5;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.1;PC-3: 3.0;SiHa: 8.1;U-2 OS: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.9 0.5 0.8 1.6 2.2 0.0 1.0 0.1 1.0 1.4 0.7 0.0 0.0 0.0 1.2 0.0 1.9 3.4 1.3 0.2 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.0 1.4 0.0 0.0 1.4 1.2 0.7 1.9 0.2 0.4 2.4 1.5 0.1 0.3 0.2 1.6 1.5 0.1 0.3 7.7 1.2 0.0 0.1 0.0 0.4 2.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.8 0.1 0.9 1.3 0.1 0.6 0.0 0.9 3.1 0.7 0.1 0.1 0.1 0.5 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 2.0 0.2 0.5 0.0 0.2 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.0 1.6 8.1 0.0 1.0 0.4 1.1 0.1 0.2 0.2 4.5 0.0 0.3 1.0 0.4 0.1 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.1 1.0 0.4 0.3 0.3 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell type enriched" "Detected in many" 5 "monocytes: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.7 2.7 0.8 2.2 0.7 0.7 4.4 1.5 1.0 1.2 1.7 2.1 1.8 0.6 1.9 1.5 1.6 10.1 2.4 1.0 1.8 13.1 4.0 0.0 7.8 3.2 2.7 0.0 1.1 0.7 2.1 2.1 1.3 1.2 1.0 2.0 0.7 17.3 0.5 3.4 1.9 1.0 0.9 2.3 3.4 0.3 0.7 2.3 0.8 3.2 1.2 3.3 5.8 34.0 2.8 1.7 4.8 0.6 7.1 4.3 1.1 11.1 0.7 16.7 2.7 0.0 3.2 6.7 1.8 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 6.0 9.9 0.5 6.4 12.0 0.2 12.1 5.1 2.7 6.8 5.2 2.0 25.6 0.0 3.0 0.0 2.9 5.6 0.0 3.3 9.1 3.8 4.4 0.0 12.9 3.8 1.6 0.0 0.0 1.2 0.0 1.7 4.5 6.8 184.0 4.3 1.4 9.2 4.8 4.9 1.4 1.5 0.0 3.9 0.5 2.5 21.2 40.3 2.1 4.3 13.7 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037929-170085403 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.0" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA006970 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 7.0 1.4 3.1 21.7 2.5 23.6 8.2 0.9 1.8 2.6 31.2 1.5 7.9 18.0 1.9 21.5 2.6 1.8 16.2 3.0 1.9 1.7 27.4 2.1 23.2 25.6 2.7 0.4 1.6 14.7 71.0 3.5 2.9 1.8 10.7 18.1 11.8 14.2 4.7 2.0 1.8 43.2 0.9 4.7 17.9 18.0 2.9 2.4 6.6 3.8 1.0 10.7 9.1 6.9 11.2 2.9 10.1 1.1 0.3 3.0 1.2 15.9 0.3 0.0 0.1 0.1 0.1 4.0 0.1 0.1 0.1 0.5 2.9 2.0 7.4 3.4 0.1 1.0 0.1 2.2 0.1 0.2 11.3 4.4 4.8 0.2 6.0 0.0 9.4 6.5 0.0 0.2 0.5 0.6 0.7 0.3 3.5 1.5 19.2 0.1 10.2 0.7 2.0 2.6 9.8 0.6 1.3 0.3 31.0 8.4 22.1 1.6 0.4 0.2 24.8 1.1 2.2 14.5 48.9 0.5 0.0 0.1 1.8 1.2 54.0 31.0 12.9 0.2 10.2 0.7 1.5 1.1 8.1 0.5 0.4 0.9 6.8 0.9 0.4 2.2 11.2 3.0 1.1 10.1 0.3 0.1 2.9 0.3 1.2 3.1 2.5 0.9 1.8 1.9 1.7 2.7 0.4 1.8 2.4 8.9 39.0 27.8 3.1 0.3 7.9 1.0 25.5 18.7 18.2 59.3 37.3 2.6 46.4 10.6 24.4 4.5 103.3 0.0 63.8 15.0 0.4 47.4 1.1 0.5 7.0 14.3 186.9 16.0 9.2 32.2 0.6 10.0 27.0 97.4 129.6 7.7 48.2 137.8 0.4 121.7 156.5 0.0 0.3 6.4 11.9 0.6 22.8 2.5 149.6 25.7 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.5 9.9 3.7 6.6 0.0 5.9 6.5 5.1 5.4 24.0 1.0 0.0 3.3 8.9 9.6 18.4 3.7 5.8 3.0 2.3 4.8 2.2 3.0 0.1 1.6 0.6 1.5 2.3 3.8 4.4 7.1 11.9 10.2 1.9 2.0 0.1 7.7 0.5 0.7 0.1 6.3 10.3 6.0 1.8 6.7 0.0 2.7 1.7 3.1 13.7 6.5 0.2 17.8 6.1 3.4 0.7 13.7 10.5 5.5 14.1 6.7 0.0 0.0 0.0 2.8 0.0 2.7 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 3.0 0.6 0.0 5.0 1.9 1.7 2.0 0.0 1.4 1.2 0.0 0.0 0.4 0.0 3.6 0.4 6.3 0.0 0.0 7.2 0.2 6.3 4.6 0.0 0.0 0.7 149.4 0.0 4.3 1.8 0.6 6.9 1.3 1.7 1.8 1.7 2.7 2.9 0.0 15.9 0.0 1.5 19.4 12.2 0.0 0.7 1.3 0.3 0.0 2.3 2.3 GPR162 "A-2, GRCA" ENSG00000250510 "G protein-coupled receptor 162" Q16538 12 6821545-6829972 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 75.9;Ciliated cells: 49.5;Horizontal cells: 38.1;Muller glia cells: 46.3" "Cancer enriched" "Detected in many" 6 "glioma: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7" "Group enriched" "Detected in many" 6 "granulocytes: 14.7;monocytes: 6.3" "Cell line enhanced" "Detected in many" "AF22: 13.0;AN3-CA: 15.4;hTERT-RPE1: 13.4;NTERA-2: 14.5;SH-SY5Y: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055135 Enhanced Approved "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA055135: AB_2682710" "unprognostic (4.76e-2)" "unprognostic (8.00e-2)" "unprognostic (8.24e-3)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (2.38e-1)" "unprognostic (4.78e-2)" "unprognostic (2.25e-2)" "unprognostic (5.83e-3)" "unprognostic (1.18e-1)" "prognostic favorable (4.29e-5)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.37e-6)" "unprognostic (3.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.64e-2)" 2.7 6.7 19.6 4.2 13.2 1.5 2.4 41.3 47.6 2.1 3.4 4.7 0.8 3.1 3.8 2.8 1.9 16.9 5.7 4.2 25.9 18.4 1.4 3.7 6.0 1.7 9.9 17.7 2.0 1.7 5.3 8.4 4.3 10.2 2.1 3.0 3.6 1.3 2.1 1.6 1.7 4.2 5.7 5.3 2.8 2.0 1.2 3.6 0.1 1.1 0.0 1.1 2.4 0.5 0.0 1.8 14.7 6.3 0.0 0.0 1.7 0.0 2.9 13.0 15.4 1.4 1.0 0.0 1.0 3.4 2.9 1.7 0.2 0.0 0.0 0.1 1.8 0.1 0.0 2.0 0.0 1.4 0.0 0.9 1.5 0.1 0.0 2.2 0.3 0.0 2.4 0.0 4.4 0.2 13.4 7.9 1.1 0.7 0.1 1.0 0.0 0.4 1.1 14.5 0.0 0.1 0.0 1.6 2.6 1.0 0.0 1.1 9.9 0.0 0.0 0.4 9.3 0.1 3.8 5.2 2.0 12.3 1.0 1.7 0.0 0.9 0.0 2.2 2.7 0.2 0.0 6.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.7 0.0 1.3 1.6 0.0 1.7 19.6 13.2 41.3 32.4 25.9 18.4 9.9 17.7 10.2 3.6 0.0 0.0 0.0 0.1 0.7 75.9 1.1 0.0 49.5 1.2 1.8 3.9 0.1 1.7 0.0 0.0 2.4 0.0 0.0 0.0 0.1 2.1 0.5 0.0 0.4 2.2 38.1 0.0 5.5 3.4 0.4 6.9 3.2 0.0 0.0 0.0 46.3 0.1 0.0 13.8 0.3 7.8 0.0 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 43.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 4.0" "Lineage enriched" "Detected in single" 11 "B-cells: 4.0" "Cell line enhanced" "Detected in some" "HeLa: 4.6;REH: 7.7;TIME: 7.6;U-2 OS: 3.2;U-2197: 3.6;U-251 MG: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles NA NA Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 7.0 2.2 23.7 6.8 21.3 0.8 5.4 4.1 25.6 2.4 16.4 43.8 0.0 3.3 11.2 3.3 5.0 4.0 4.3 12.5 20.6 1.2 2.3 1.6 9.3 2.4 9.1 9.9 1.4 4.6 0.5 0.4 2.7 18.8 3.9 0.8 0.1 1.7 0.5 13.1 6.7 3.8 0.5 6.3 12.6 5.0 1.8 22.6 0.0 2.8 0.0 0.5 6.1 3.9 4.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.6 0.9 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.6 0.3 0.1 0.0 0.2 7.7 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.3 0.3 0.0 7.6 0.0 3.2 3.6 4.5 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.7 21.3 4.1 25.6 20.6 1.2 9.1 9.9 18.8 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203201 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0" "Cell type enhanced" "Detected in many" 26 "Horizontal cells: 20.6;monocytes: 22.6;T-cells: 87.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 45.2" "Lineage enriched" "Detected in many" 18 "T-cells: 45.2" "Cell line enriched" "Detected in single" 26 "U-266/70: 25.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 4.1 0.9 0.4 15.1 0.4 0.4 1.6 0.3 0.3 4.0 6.8 0.3 0.6 3.5 1.4 1.6 2.7 3.9 4.6 1.3 0.4 0.4 4.3 2.7 10.7 33.0 0.7 0.5 1.9 1.0 0.0 0.7 0.8 1.5 2.2 3.8 1.7 2.4 1.2 1.0 1.1 19.5 1.1 2.7 20.7 4.0 1.0 0.5 19.9 2.2 1.8 8.5 7.0 2.4 0.1 0.8 1.0 0.1 2.5 45.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 11.6 0.0 45.2 0.0 16.2 21.5 0.8 0.1 9.9 8.4 0.3 2.5 0.1 0.7 8.0 3.4 0.4 0.4 0.3 0.3 0.4 0.4 0.7 0.5 1.5 0.5 0.0 2.1 2.4 0.3 1.0 3.6 0.3 0.0 0.0 2.3 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.3 1.1 0.1 20.6 0.0 3.1 3.1 0.0 0.0 6.9 0.0 22.6 0.0 5.6 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.9 0.1 0.5 0.6 87.7 0.0 0.3 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.1 0.5 4.6 2.7 0.0 1.3 2.9 2.1 2.5 0.8 0.1 0.2 2.0 2.8 6.4 0.6 10.2 0.0 1.9 0.6 1.0 0.5 8.3 0.3 6.7 0.5 0.1 6.6 0.0 3.3 4.6 7.5 3.5 0.0 0.0 5.7 3.2 4.2 0.0 0.0 6.3 0.4 3.6 0.1 2.4 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 5.5 1.1 0.1 6.4 3.5 5.1 2.3 1.1 0.2 0.3 0.7 2.5 0.0 1.9 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 0.0 0.0 0.0 0.4 0.2 6.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.2 6.4 3.4 1.8 0.3 0.0 2.8 0.0 1.7 0.0 0.1 2.7 0.1 0.0 4.2 0.0 2.8 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Group enriched" "Detected in some" 20 "Alveolar cells type 2: 3.7;Club cells: 1.2;Collecting duct cells: 1.8;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "JURKAT: 24.1;MOLT-4: 39.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041025 Enhanced Uncertain Vesicles NA NA Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.7 0.0 0.0 39.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 GPR176 Gm1012 ENSG00000166073 "G protein-coupled receptor 176" Q14439 15 39799032-39920892 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 9.4;Early spermatids: 17.9;Late spermatids: 11.5;Muller glia cells: 13.2;Pancreatic endocrine cells: 8.3;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 69.8;fHDF/TERT166: 47.0;U-138 MG: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039943, HPA039979" Approved NA NA "HPA039943: AB_10697711, HPA039979: AB_2676782" "unprognostic (4.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (1.04e-2)" "unprognostic (2.75e-2)" "unprognostic (1.38e-3)" "unprognostic (9.32e-2)" "unprognostic (3.23e-2)" "unprognostic (2.74e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (9.38e-7)" "prognostic unfavorable (6.84e-5)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (3.26e-2)" 9.8 9.6 9.7 5.9 18.4 0.5 8.9 22.6 16.0 8.0 2.9 2.5 1.3 2.8 5.6 3.1 2.9 3.8 10.5 5.4 8.4 12.7 4.7 2.8 5.4 8.0 7.2 7.4 2.5 2.3 3.3 4.1 3.6 11.3 10.9 3.5 3.2 2.5 5.7 3.1 3.0 2.5 6.9 3.0 5.6 2.5 9.9 2.0 1.2 5.1 3.1 8.0 9.5 4.5 0.0 0.5 2.8 0.0 0.0 0.0 0.0 12.6 0.6 0.8 0.1 9.2 16.7 0.0 27.0 69.8 16.6 25.7 1.0 2.1 0.1 2.4 47.0 9.6 0.4 2.0 2.1 24.9 0.4 3.1 2.0 2.1 0.0 10.3 0.0 0.1 12.6 0.2 14.9 12.4 16.6 6.2 0.7 0.3 0.2 22.8 0.6 0.0 0.0 0.8 0.1 2.6 0.8 8.4 0.1 0.4 0.1 3.4 13.2 7.0 0.0 1.1 0.2 2.5 0.1 7.8 30.6 8.9 1.8 9.9 0.3 1.0 0.0 6.3 0.0 11.9 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.7 18.4 22.6 14.3 8.4 12.7 7.2 7.4 11.3 2.0 0.0 0.0 0.0 0.2 1.5 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.9 1.1 0.0 0.0 3.2 0.0 2.5 2.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 11.5 1.1 0.8 1.7 0.0 0.0 13.2 8.3 0.0 1.1 1.2 1.1 12.9 4.7 2.1 3.1 0.9 0.0 0.0 0.0 0.0 GPR180 ITR ENSG00000152749 "G protein-coupled receptor 180" Q86V85 13 94601903-94634645 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047250 Approved Approved Vesicles NA NA Vesicles "HPA047250: AB_2679998" "unprognostic (3.91e-3)" "unprognostic (3.28e-1)" "unprognostic (4.16e-3)" "unprognostic (2.95e-1)" "unprognostic (1.17e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (6.71e-2)" "unprognostic (1.47e-1)" "unprognostic (2.86e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (2.49e-2)" "unprognostic (1.10e-1)" "unprognostic (8.47e-2)" "unprognostic (2.80e-2)" 14.6 6.8 7.6 6.6 11.4 2.7 15.9 14.7 13.1 8.3 6.1 7.6 5.2 5.7 7.1 5.8 5.3 7.3 5.3 7.6 7.9 8.8 7.5 18.7 6.8 6.3 8.8 7.8 7.3 10.6 7.5 18.8 9.9 10.8 7.6 7.4 12.3 7.5 7.2 5.6 5.7 5.1 8.1 12.1 6.0 7.7 3.5 8.8 8.6 10.2 3.9 7.3 6.4 6.9 1.5 2.5 0.3 1.5 1.5 4.3 1.3 13.2 3.4 4.8 5.1 10.3 11.2 2.0 9.1 7.2 8.9 11.9 4.1 9.2 4.4 4.0 7.8 6.2 8.5 6.8 6.4 12.3 11.5 4.3 8.6 4.6 0.0 8.1 12.3 7.0 6.4 5.5 5.4 7.4 8.0 9.0 6.4 2.4 2.2 8.8 2.0 6.1 2.7 3.2 9.5 3.8 7.1 6.5 1.8 10.0 4.0 7.1 5.1 4.2 9.4 11.1 6.4 6.6 5.1 8.1 5.5 4.4 6.5 7.5 3.6 3.7 2.1 9.1 10.1 7.4 0.3 1.5 0.3 2.4 1.0 4.3 1.5 2.9 1.7 2.5 1.5 3.5 2.9 0.0 1.5 1.1 1.8 3.4 1.3 7.6 11.4 14.7 13.1 7.9 8.8 8.8 7.8 10.8 8.8 3.0 2.6 9.3 5.8 5.4 12.8 4.1 5.1 10.7 2.3 12.2 29.5 8.1 5.0 7.7 0.6 6.7 3.1 0.0 8.9 23.3 9.7 9.6 4.7 27.1 9.6 17.5 9.9 8.6 4.4 0.0 8.9 4.6 6.8 3.6 8.7 14.0 10.3 3.5 5.3 6.3 22.2 6.5 8.2 1.2 10.8 4.1 3.4 5.7 5.2 4.2 GPR182 "ADMR, AM-R, G10D, hrhAMR" ENSG00000166856 "G protein-coupled receptor 182" O15218 12 56994446-56998441 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "liver: 9.5;lymphoid tissue: 29.1;testis: 12.9" "Group enriched" "Detected in some" 32 "Early spermatids: 67.2;Ito cells: 90.2;Late spermatids: 117.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;RH-30: 6.2;SuSa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027037 Enhanced NA NA "HPA027037: AB_1844622" "unprognostic (6.13e-2)" "unprognostic (6.23e-2)" "unprognostic (3.56e-2)" "unprognostic (5.88e-2)" "unprognostic (2.60e-2)" "unprognostic (3.30e-1)" "unprognostic (2.10e-4)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (4.94e-1)" "unprognostic (1.67e-2)" "unprognostic (8.13e-2)" "unprognostic (5.62e-3)" "unprognostic (9.31e-2)" "unprognostic (2.88e-2)" "unprognostic (1.42e-1)" "unprognostic (4.34e-3)" 0.4 3.2 0.0 0.8 0.0 0.0 0.6 0.1 0.3 0.7 0.4 0.0 0.6 0.0 1.2 0.7 1.3 0.7 0.1 0.3 0.0 0.0 1.3 9.5 1.9 7.5 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.1 0.3 0.3 0.7 0.0 29.1 0.2 12.9 0.0 0.2 1.4 0.3 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.5 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.8 0.8 0.0 1.4 1.1 0.7 0.0 0.1 0.0 0.3 6.2 0.0 0.0 0.6 0.1 0.5 0.0 0.2 0.0 1.8 0.4 0.0 0.0 0.1 0.5 0.3 0.0 0.5 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 90.2 2.8 117.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 GPR19 ENSG00000183150 "G protein-coupled receptor 19" Q15760 12 12660891-12696207 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.2;brain: 13.3;pituitary gland: 9.8;testis: 9.8" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 1.5;Early spermatids: 3.2;Muller glia cells: 1.5;Spermatocytes: 4.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 9.2" "Group enriched" "Detected in many" 16 "granulocytes: 4.2;T-cells: 9.2" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7;NTERA-2: 23.6;SuSa: 17.8;WM-115: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013955 Uncertain NA NA "HPA013955: AB_1849287" "unprognostic (1.92e-1)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (8.62e-5)" "unprognostic (1.60e-1)" "unprognostic (3.21e-1)" "unprognostic (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "unprognostic (6.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.70e-2)" "unprognostic (2.67e-12)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-1)" 1.0 2.4 7.5 4.8 13.3 2.3 1.2 11.5 13.0 0.8 1.5 2.8 0.0 1.1 0.7 0.7 1.5 1.0 1.1 0.7 8.5 8.4 0.7 0.8 0.8 4.3 5.6 6.3 0.5 1.1 1.0 9.8 1.1 3.7 0.5 1.9 0.4 0.6 0.6 0.4 2.2 1.1 1.1 6.7 1.7 1.3 9.8 3.6 0.3 0.7 0.0 5.8 1.3 0.2 0.3 0.0 4.2 0.0 0.4 9.2 0.5 0.9 0.3 9.8 0.2 0.0 0.0 4.2 0.9 1.0 1.7 1.5 3.8 5.9 3.9 1.5 0.7 1.3 0.7 1.6 0.2 2.9 22.7 0.2 0.9 0.4 0.6 0.0 1.0 0.4 0.0 0.0 1.9 1.1 0.7 0.3 0.4 0.1 8.2 0.3 1.4 0.3 0.5 23.6 1.0 1.8 2.5 1.5 0.1 0.1 0.8 3.2 3.0 0.4 0.8 7.5 17.8 0.5 0.9 0.0 0.5 4.4 0.8 2.2 4.5 3.9 7.6 1.8 2.7 12.0 0.0 0.0 0.0 1.8 0.0 1.4 0.3 3.8 2.1 0.0 0.1 0.7 1.4 4.2 0.4 0.0 0.0 9.2 0.5 7.5 13.3 11.5 10.6 8.5 8.4 5.6 6.3 3.7 3.6 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.2 0.0 0.1 0.8 0.0 0.0 GPR21 ENSG00000188394 "G protein-coupled receptor 21" Q99679 9 123034527-123035696 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HBEC3-KT: 8.4" "Low region specificity" "Detected in many" HPA041651 Uncertain NA NA "HPA041651: AB_10794673" "unprognostic (9.22e-3)" "unprognostic (1.46e-1)" 3.6 0.0 1.1 1.7 2.2 0.2 1.1 0.1 4.6 2.1 0.4 0.0 2.7 1.0 1.9 0.9 0.8 0.5 0.7 0.4 0.3 0.0 0.5 1.9 0.3 1.4 0.0 0.2 0.0 1.5 0.1 0.6 0.1 0.7 0.4 0.6 0.3 1.7 0.4 0.9 0.5 0.0 1.0 0.9 1.3 2.0 0.9 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475659 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 31.5;heart muscle: 18.7" "Group enriched" "Detected in some" 8 "Bipolar cells: 15.6;Cardiomyocytes: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 33 "SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.6 2.7 10.9 0.6 4.4 0.7 0.6 15.5 31.5 6.3 0.6 0.0 0.0 0.6 4.1 0.6 0.6 0.6 0.6 18.7 19.4 2.0 1.0 0.6 0.6 0.6 1.8 13.0 0.6 0.6 0.6 0.3 0.6 6.0 0.6 0.6 0.0 0.6 0.8 0.6 0.6 0.6 1.0 0.7 0.6 0.6 0.6 1.1 0.0 0.6 0.0 0.6 0.6 1.7 1.0 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.3 0.9 0.4 0.5 0.0 1.0 0.4 1.0 0.3 0.2 0.2 0.2 0.4 0.0 10.9 4.4 15.5 31.5 19.4 2.0 1.8 13.0 6.0 1.1 0.0 0.0 0.0 0.0 0.2 15.6 57.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.0;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 13.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 12.5 0.7 0.0 2.2 0.0 0.9 0.0 0.0 2.7 0.0 0.0 0.0 10.8 0.9 0.2 21.5 0.0 0.0 0.0 0.0 0.0 10.4 5.8 2.3 8.2 2.8 0.0 0.0 2.9 7.5 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 0.0 1.4 0.0 4.0 1.6 11.0 2.8 5.1 2.7 2.3 12.2 3.9 1.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 1.1 0.9 4.5 0.0 0.0 1.0 0.0 1.2 0.0 5.1 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.4 0.0 1.1 0.0 0.3 0.0 0.4 0.2 0.9 1.5 0.2 0.0 0.0 1.8 GPR31 "12-HETER, HETER1" ENSG00000120436 "G protein-coupled receptor 31" O00270 6 167156271-167158329 "G-protein coupled receptors, Predicted membrane proteins" "Lipid metabolism" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "myeloid DC: 2.7" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014014, HPA027108" Uncertain NA NA "HPA014014: AB_1849292, HPA027108: AB_10601474" "unprognostic (9.92e-2)" "unprognostic (1.52e-1)" "unprognostic (1.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-3)" "unprognostic (2.20e-3)" "unprognostic (5.95e-3)" "unprognostic (4.03e-2)" "unprognostic (3.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (8.10e-4)" "unprognostic (2.45e-1)" "unprognostic (6.01e-2)" 0.0 0.0 0.1 0.9 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.5 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 4.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.2 2.1 0.3 1.1 0.1 1.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR32 RVDR1 ENSG00000142511 "G protein-coupled receptor 32" O75388 19 50770464-50771732 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 52 "parathyroid gland: 63.4" "Group enriched" "Detected in some" 10 "Extravillous trophoblasts: 4.2;Syncytiotrophoblasts: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "BEWO: 29.5" "Low region specificity" "Detected in some" NA NA "unprognostic (4.77e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 63.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 GPR33 ENSG00000214943 "G protein-coupled receptor 33 (gene/pseudogene)" Q49SQ1 14 31482875-31488142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.7" "Lineage enhanced" "Detected in many" "dendritic cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (8.10e-3)" "unprognostic (6.53e-4)" "unprognostic (9.13e-2)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" 0.1 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 2.0 0.0 1.1 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 1.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.9 0.1 0.5 0.0 1.5 0.1 0.0 0.6 1.3 0.0 0.0 5.7 1.8 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell type enhanced" "Detected in some" 23 "granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.4 0.1 1.1 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.3 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 0.0 3.2 2.7 0.2 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.3 1.7 0.1 35.9 0.0 198.9 0.0 1.2 3.1 113.1 0.6 0.9 46.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 19.4 0.0 0.0 0.1 0.9 2.1 1.7 0.0 0.0 GPR35 ENSG00000178623 "G protein-coupled receptor 35" Q9HC97 2 240605431-240631259 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 109.6" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 80.6;granulocytes: 38.0;Mucus-secreting cells: 25.1;Paneth cells: 24.6;Undifferentiated cells: 21.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1" "Group enriched" "Detected in many" 14 "dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7" "Cell line enhanced" "Detected in some" "CACO-2: 10.8;CAPAN-2: 27.2;HDLM-2: 9.0;Hep G2: 17.3;HMC-1: 17.1;OE19: 20.1;U-937: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.53e-1)" "unprognostic (5.99e-2)" "unprognostic (3.94e-3)" "unprognostic (2.71e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.98e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (7.03e-3)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-3)" 0.8 0.2 1.5 7.0 1.8 2.4 1.4 2.4 2.2 1.6 50.4 1.0 0.5 27.2 1.7 1.8 1.1 3.4 24.1 0.8 1.5 1.5 2.2 0.7 3.1 6.6 1.6 0.8 2.5 0.5 0.3 3.2 0.7 1.8 1.8 11.2 0.6 0.8 0.7 3.9 1.2 109.6 1.3 1.4 8.9 10.8 2.0 1.6 1.9 1.2 0.9 2.4 1.0 1.0 0.0 14.5 16.8 22.7 0.3 1.3 5.5 0.0 0.2 0.1 0.5 0.5 0.0 0.2 0.0 0.1 0.0 0.1 10.8 27.2 0.1 0.1 0.1 0.4 0.2 0.0 0.0 0.0 9.0 0.3 4.5 0.2 17.3 0.2 0.2 17.1 0.1 0.0 0.3 0.1 0.2 0.0 0.7 0.2 1.5 0.0 0.3 0.2 8.4 0.4 20.1 0.1 1.0 0.0 0.2 0.1 0.1 1.0 0.4 0.0 0.1 0.2 0.3 0.1 3.0 0.4 0.1 0.1 0.7 0.0 1.9 0.8 0.1 0.0 9.5 0.2 0.0 16.4 16.8 0.7 22.7 1.3 0.0 0.4 0.4 14.5 0.0 0.2 0.5 0.2 0.3 6.1 0.3 0.1 5.5 1.5 1.8 2.4 2.2 1.5 1.5 1.6 0.8 1.8 1.6 0.0 7.9 0.0 0.0 1.8 1.3 0.8 2.5 0.0 0.0 1.8 0.0 0.1 0.0 1.2 0.0 0.2 80.6 0.0 2.9 0.0 0.4 0.1 38.0 0.0 11.0 1.6 6.4 0.0 5.1 0.0 0.3 8.8 0.0 2.8 25.1 0.2 8.3 24.6 1.1 2.1 2.4 0.0 0.5 1.1 0.7 1.0 0.2 2.5 21.8 0.1 GPR4 ENSG00000177464 "G protein-coupled receptor 4" P46093 19 45589764-45602208 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 32.0" "Group enriched" "Detected in some" 7 "Endothelial cells: 19.4;Ito cells: 25.2;Sertoli cells: 6.5;Smooth muscle cells: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HUVEC TERT2: 15.0;TIME: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014278 Uncertain NA NA "HPA014278: AB_1849300" "unprognostic (2.49e-2)" "unprognostic (6.62e-3)" "unprognostic (1.33e-2)" "unprognostic (2.93e-2)" "unprognostic (2.70e-1)" "unprognostic (1.31e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (1.29e-1)" "unprognostic (6.23e-2)" "unprognostic (1.70e-1)" "unprognostic (4.66e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (6.46e-3)" "unprognostic (1.93e-1)" "unprognostic (9.18e-2)" "unprognostic (2.49e-3)" 22.6 5.4 6.7 8.4 14.8 1.9 19.7 6.1 12.0 3.3 3.3 3.0 0.3 3.0 5.4 2.7 2.9 4.0 8.6 23.1 8.1 4.5 7.5 4.9 18.6 4.1 8.4 1.3 3.8 6.6 4.5 4.4 10.3 18.6 4.1 2.5 4.5 2.1 3.2 7.7 2.2 3.1 6.8 13.0 4.5 4.4 1.8 8.9 0.0 12.7 2.4 2.2 5.4 32.0 1.1 0.7 1.4 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.2 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.5 0.3 0.4 0.5 0.4 0.4 0.1 1.1 0.4 0.8 1.4 0.7 0.2 0.7 0.3 0.0 6.7 14.8 6.1 12.0 8.1 4.5 8.4 1.3 18.6 8.9 0.0 0.3 0.0 0.2 2.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 19.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 25.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.5 10.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 GPR45 "PSP24, PSP24A" ENSG00000135973 "G protein-coupled receptor 45" Q9Y5Y3 2 105241743-105243049 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 5.7" "Group enriched" "Detected in some" 42 "Early spermatids: 3.5;Late spermatids: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 3.1;U-2 OS: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055940 Uncertain NA NA "HPA055940: AB_2682977" "unprognostic (3.80e-3)" "unprognostic (5.92e-2)" "unprognostic (2.19e-3)" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.13e-1)" "unprognostic (3.96e-1)" "unprognostic (1.61e-3)" "unprognostic (1.11e-2)" "unprognostic (3.13e-4)" "unprognostic (2.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" 0.1 0.1 1.4 0.1 2.3 0.0 0.1 0.0 5.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 1.4 3.1 0.1 0.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.2 0.4 0.4 0.0 0.4 0.2 0.2 1.2 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 9.9 0.0 0.1 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174448111-174449198 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "basal ganglia: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;Daudi: 1.5;Karpas-707: 2.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.3 0.3 0.8 0.2 28.0 2.2 0.1 0.2 7.4 0.1 0.2 0.1 0.0 0.1 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.6 0.2 0.6 0.0 0.2 0.3 0.4 5.0 0.0 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.0 0.2 3.2 0.2 0.7 0.2 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPR82 ENSG00000171657 "G protein-coupled receptor 82" Q96P67 X 41724155-41730135 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 12.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 19.6;Kupffer cells: 18.0;Macrophages: 18.7;T-cells: 20.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 23.2;NK-cell: 6.6" "Group enriched" "Detected in many" 9 "granulocytes: 23.2;NK-cells: 6.6" "Cell line enriched" "Detected in single" 16 "HMC-1: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035914 Approved NA NA "HPA035914: AB_10670671" "unprognostic (5.62e-3)" "unprognostic (1.81e-2)" "unprognostic (4.65e-2)" "unprognostic (3.88e-3)" "unprognostic (1.15e-2)" "unprognostic (3.28e-2)" "unprognostic (4.62e-4)" "unprognostic (1.41e-3)" "unprognostic (2.12e-2)" "unprognostic (5.00e-2)" "unprognostic (1.39e-1)" "unprognostic (3.01e-1)" "unprognostic (7.45e-2)" "unprognostic (2.37e-2)" "unprognostic (2.26e-1)" "unprognostic (8.00e-3)" "unprognostic (1.18e-1)" 1.2 2.2 1.6 3.9 5.9 0.2 1.1 0.6 1.5 0.9 2.7 0.3 0.0 3.0 0.8 1.1 1.1 1.1 1.1 0.7 2.5 1.1 4.7 5.0 10.0 9.0 2.5 0.1 0.7 1.5 0.1 1.1 0.3 3.2 1.1 2.1 0.8 0.8 0.7 0.4 0.7 5.2 0.6 7.3 3.6 1.6 0.4 2.3 1.6 0.8 0.6 12.0 2.4 0.9 0.1 0.2 23.2 1.6 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 23.2 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 6.6 1.4 0.0 0.0 0.1 1.6 5.9 0.6 1.5 2.5 1.1 2.5 0.1 3.2 2.3 0.0 11.1 5.2 4.1 4.1 14.7 0.3 0.0 1.4 9.1 1.8 19.6 0.7 0.0 1.8 0.2 2.2 3.9 0.0 1.0 0.2 5.1 2.7 0.0 0.8 1.3 12.7 1.2 4.3 18.0 0.0 3.7 18.7 3.3 1.8 1.3 0.9 1.7 4.2 2.8 0.0 16.7 0.0 3.8 1.0 1.1 2.4 0.6 20.2 3.2 3.1 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377311-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 20.0;thyroid gland: 9.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.7" "Region enhanced" "Detected in many" "basal ganglia: 61.1" "Low region specificity" "Detected in all" NA NA "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.6 2.6 3.3 0.8 6.1 2.0 0.6 20.0 11.7 0.8 0.7 0.9 0.0 0.7 0.8 1.2 0.5 0.8 0.8 1.2 19.8 6.7 1.2 1.2 0.7 1.1 1.0 3.7 0.7 0.7 0.5 0.6 0.5 1.7 0.5 0.6 0.3 0.6 0.6 1.3 1.4 0.8 0.6 1.8 1.1 0.8 1.1 1.0 0.0 9.3 0.0 0.7 0.5 0.3 0.7 0.5 2.6 0.6 1.6 0.6 0.2 0.3 0.5 0.9 1.2 0.0 0.2 0.9 0.7 0.1 0.1 0.2 5.7 1.1 1.1 0.5 0.1 0.4 1.3 0.4 0.2 0.1 0.8 0.5 1.2 1.2 0.7 0.0 1.6 3.0 0.2 0.5 0.4 0.2 0.6 0.0 1.0 1.2 1.3 0.1 0.8 0.4 2.5 1.1 0.6 0.7 1.1 0.2 0.8 0.1 0.9 0.7 0.7 0.5 0.8 0.2 1.3 0.9 0.1 0.4 0.8 1.3 0.8 0.9 1.2 1.5 0.5 0.5 1.0 1.2 2.6 0.6 0.5 0.5 0.3 0.4 0.4 0.5 0.6 0.2 0.7 0.4 0.4 1.4 1.6 0.6 0.5 0.3 0.2 3.3 6.1 20.0 11.7 19.8 6.7 1.0 3.7 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 GPR84 EX33 ENSG00000139572 "G protein-coupled receptor 84" Q9NQS5 12 54362445-54364487 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 20.5;Macrophages: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "basophil: 6.0;classical monocyte: 8.7;myeloid DC: 12.9;neutrophil: 5.3" "Group enriched" "Detected in many" 53 "dendritic cells: 12.9;granulocytes: 6.0;monocytes: 8.7" "Group enriched" "Detected in some" 5 "HL-60: 9.4;NB-4: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027603 Enhanced NA NA "HPA027603: AB_10612115" "unprognostic (5.40e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (3.92e-2)" "unprognostic (2.36e-2)" "unprognostic (4.54e-2)" "unprognostic (6.16e-3)" "unprognostic (7.43e-2)" "unprognostic (9.29e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.92e-1)" "unprognostic (1.36e-9)" "unprognostic (1.27e-1)" "unprognostic (4.42e-2)" "unprognostic (1.40e-1)" "unprognostic (9.44e-2)" 7.2 2.3 2.7 11.2 6.8 27.2 0.7 0.4 3.3 1.0 0.9 5.0 0.0 0.8 0.6 0.9 1.1 1.7 1.8 3.2 1.6 2.1 2.4 0.8 5.3 2.7 4.4 0.0 2.7 1.0 0.7 2.3 6.7 5.0 1.2 1.3 0.7 1.2 0.7 1.1 1.4 0.8 2.8 6.7 8.0 1.2 2.1 7.5 0.9 2.1 0.0 2.8 3.0 2.1 0.0 12.9 6.0 8.7 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.4 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.7 0.0 6.0 8.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.8 2.7 6.8 0.4 3.3 1.6 2.1 4.4 0.0 5.0 7.5 0.0 0.3 0.0 0.1 0.8 2.9 0.1 0.0 0.0 1.2 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 20.5 0.0 0.0 0.0 2.7 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.4 0.7 0.0 0.0 0.0 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538137-100542018 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 62.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Group enriched" "Detected in many" 7 "basal ganglia: 62.7;thalamus: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HSkMC: 4.9;SCLC-21H: 6.1" "Region enriched" "Detected in many" 11 "basal ganglia: 643.5" "Region enriched" "Detected in some" 34 "basal ganglia: 223.4" HPA007488 Approved NA NA "HPA007488: AB_2667844" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.7 0.6 1.2 0.5 62.7 0.2 10.9 0.0 6.8 0.1 0.3 0.8 0.0 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.9 0.8 0.3 13.1 0.2 0.3 0.7 1.1 3.8 0.1 4.6 0.5 0.2 7.0 0.6 0.5 0.3 0.7 0.1 0.3 0.1 0.5 0.3 0.5 13.7 0.4 0.2 32.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 62.7 0.0 6.8 0.9 0.8 0.7 1.1 7.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GPRC5D ENSG00000111291 "G protein-coupled receptor class C group 5 member D" Q9NZD1 12 12940775-12952147 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.4;skin 1: 33.9" "Group enriched" "Detected in some" 12 "B-cells: 3.9;Early spermatids: 5.3;Late spermatids: 4.5;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.1" "Cell type enriched" "Detected in some" 4 "memory B-cell: 18.4" "Lineage enriched" "Detected in many" 17 "B-cells: 18.4" "Group enriched" "Detected in some" 10 "Karpas-707: 37.5;RPMI-8226: 36.3;U-266/84: 10.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071909 Approved NA NA "HPA071909: AB_2686470" "unprognostic (4.27e-2)" "unprognostic (8.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.09e-4)" "unprognostic (3.00e-5)" "unprognostic (4.06e-2)" "unprognostic (3.06e-2)" "unprognostic (5.53e-2)" "unprognostic (7.01e-2)" "unprognostic (2.27e-2)" "unprognostic (8.33e-3)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-2)" "unprognostic (6.63e-2)" 1.0 0.5 0.4 3.1 0.4 0.3 4.2 0.4 0.4 0.8 3.8 0.4 0.4 2.4 1.0 0.4 3.7 0.3 1.5 0.7 0.4 0.2 0.8 0.7 4.4 5.9 0.4 0.4 0.4 2.9 0.0 1.0 0.9 2.1 0.9 3.4 0.7 8.6 0.4 0.4 33.9 3.8 0.4 0.4 5.1 3.3 3.7 0.4 0.4 1.3 5.2 4.1 1.3 0.7 18.4 0.1 1.0 0.0 0.0 0.2 1.9 0.5 0.6 0.0 0.6 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 37.5 0.1 1.3 0.0 0.0 0.3 1.6 0.0 0.0 0.0 36.3 0.0 1.5 1.2 0.2 0.8 0.6 0.0 1.6 0.0 0.0 1.0 0.0 1.7 0.0 0.0 1.9 10.3 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 18.4 0.1 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 2.1 0.4 0.0 0.0 3.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 75.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 12.1 0.1 0.0 12.6 0.2 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 5.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 0.0 19.9 3.7 0.7 1.0 9.4 14.6 5.1 1.4 9.1 3.5 0.0 0.1 1.7 1.1 0.1 3.6 9.6 0.0 8.2 0.0 2.3 0.2 7.0 0.0 18.9 25.4 75.7 2.5 26.9 0.0 0.3 31.5 1.7 5.4 25.1 0.8 1.7 5.8 1.1 1.8 10.3 77.6 8.2 0.1 0.1 0.9 0.2 34.6 21.8 0.3 GPX6 GPXP3 ENSG00000198704 "Glutathione peroxidase 6" P59796 6 28503296-28528215 "Enzymes, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 9.3" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 2.5;Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;HEL: 1.6" "Region enriched" "Detected in single" 16 "basal ganglia: 21.3" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 GREB1 KIAA0575 ENSG00000196208 "Growth regulation by estrogen in breast cancer 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 74.9" "Cell type enhanced" "Detected in many" 18 "Leydig cells: 18.7;Peritubular cells: 51.9" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.1;Hep G2: 14.3;MCF7: 22.4;SH-SY5Y: 15.3;T-47d: 51.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.2 2.0 3.0 0.6 5.0 0.5 11.1 1.3 5.4 13.7 0.5 2.8 3.0 0.7 21.3 15.6 0.6 11.2 1.8 2.3 3.9 3.0 1.3 1.5 0.6 0.6 3.9 3.5 74.9 2.9 0.6 5.0 9.4 3.8 19.2 0.5 2.8 0.7 2.4 2.1 1.2 0.6 7.3 3.2 0.4 0.8 10.9 3.2 0.0 0.5 0.5 0.5 0.8 5.7 0.8 1.0 2.8 0.6 1.0 1.3 0.4 0.0 0.4 15.1 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 2.6 0.1 1.1 0.0 0.0 1.8 1.3 0.0 0.1 14.3 0.1 0.1 0.8 0.2 0.8 0.2 0.1 0.1 0.0 1.4 0.1 0.3 0.1 22.4 0.4 0.7 4.9 0.0 0.0 10.4 0.0 0.6 0.0 0.0 4.4 15.3 0.3 0.4 11.1 2.1 51.8 0.2 0.0 1.5 0.7 0.1 0.0 2.2 1.5 8.8 2.6 4.3 0.4 2.6 0.6 0.8 0.7 0.3 0.3 0.5 0.5 0.4 0.4 0.8 0.5 1.3 2.8 1.0 0.5 1.0 0.5 0.4 3.0 5.0 1.3 5.4 3.9 3.0 3.9 3.5 3.8 3.2 0.0 0.3 0.0 1.7 0.7 3.1 7.3 7.6 5.3 1.2 0.0 2.0 0.1 0.0 0.4 0.5 1.4 0.0 0.0 0.2 2.1 5.1 9.8 3.5 6.0 2.5 3.2 0.0 0.6 0.0 1.3 18.7 0.3 5.0 0.0 0.0 0.2 0.5 0.0 51.9 1.9 0.3 0.0 0.8 0.9 1.5 0.3 0.2 0.0 0.0 2.6 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 55.4" "Cell type enriched" "Detected in some" 22 "Horizontal cells: 444.9" "Group enriched" "Detected in some" 18 "glioma: 5.9;renal cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;NTERA-2: 5.2;RPMI-8226: 3.0;SCLC-21H: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 1.1 7.4 11.4 1.5 13.1 0.9 4.5 55.4 52.9 2.6 1.8 8.1 0.0 0.9 1.5 2.9 1.0 2.2 1.2 0.9 9.3 16.0 1.4 0.9 1.0 1.6 12.1 17.4 1.3 1.6 0.9 2.2 1.3 24.8 1.2 2.0 2.8 4.1 1.5 1.0 1.5 4.5 1.0 11.5 0.9 6.6 1.1 6.9 0.0 1.0 0.0 1.3 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 3.0 0.0 0.0 5.8 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.1 55.4 23.3 9.3 16.0 12.1 17.4 24.8 6.9 0.0 0.0 0.0 0.0 0.1 18.9 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 444.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.5 7.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GRID1 "GluD1, KIAA1220" ENSG00000182771 "Glutamate ionotropic receptor delta type subunit 1" Q9ULK0 10 85599555-86366493 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 9.5;Melanocytes: 5.0;Peritubular cells: 4.2;Sertoli cells: 12.9" "Group enriched" "Detected in many" 5 "glioma: 3.6;thyroid cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Daudi: 6.4;HEL: 6.2;SH-SY5Y: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.60e-2)" "unprognostic (2.75e-2)" "unprognostic (5.92e-2)" "unprognostic (4.31e-2)" "unprognostic (4.24e-1)" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.49e-3)" "unprognostic (8.30e-2)" "unprognostic (8.26e-2)" "unprognostic (4.58e-9)" "unprognostic (3.15e-3)" "unprognostic (5.91e-2)" "unprognostic (2.21e-1)" "unprognostic (8.65e-3)" 2.5 4.2 8.8 1.0 13.0 0.8 1.6 3.1 15.7 4.5 1.4 20.9 0.0 1.7 2.6 3.4 1.3 4.8 1.6 1.3 8.8 6.9 1.0 1.3 2.1 1.7 19.6 8.7 1.4 1.2 1.1 0.9 3.1 9.9 2.1 1.3 1.0 1.1 4.4 1.4 2.1 1.7 2.4 6.4 0.9 1.2 2.8 14.2 0.0 7.0 0.0 1.5 1.2 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.8 6.4 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.3 1.4 6.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 13.0 3.1 14.3 8.8 6.9 19.6 8.7 9.9 14.2 3.0 0.3 0.0 0.1 0.5 9.5 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 2.0 0.0 5.0 0.0 0.0 0.7 0.0 0.0 4.2 0.0 0.5 12.9 1.9 0.1 0.9 0.0 0.1 0.0 0.0 0.0 GRIFIN ENSG00000275572 "Galectin-related inter-fiber protein" A4D1Z8 7 2474844-2476894 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.6;skin 1: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.18e-2)" "unprognostic (2.98e-2)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.68e-2)" "unprognostic (4.31e-1)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" 1.6 0.7 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIK3 "GluK3, GLUR7" ENSG00000163873 "Glutamate ionotropic receptor kainate type subunit 3" Q13003 1 36795527-37034129 "Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;pituitary gland: 13.1" "Group enriched" "Detected in some" 5 "Late spermatids: 5.1;Muller glia cells: 14.3" "Cancer enhanced" "Detected in some" "glioma: 13.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.20e-2)" "unprognostic (1.90e-1)" "unprognostic (7.66e-2)" "unprognostic (9.26e-3)" "unprognostic (2.87e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-1)" "unprognostic (2.60e-3)" "unprognostic (9.06e-2)" "unprognostic (1.04e-1)" "unprognostic (3.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.28e-2)" "unprognostic (3.53e-3)" "unprognostic (2.06e-1)" "unprognostic (9.37e-2)" "unprognostic (2.08e-2)" 1.7 4.6 5.4 1.8 9.4 0.6 5.4 5.7 24.7 2.1 8.4 3.3 1.5 2.1 0.8 4.5 3.1 1.2 2.2 1.9 3.8 9.6 0.8 0.7 0.9 0.9 9.1 10.4 1.3 1.6 1.5 13.1 0.6 13.1 1.9 3.3 9.0 2.2 5.8 0.7 1.1 2.9 1.8 3.6 1.0 2.1 2.0 2.7 0.0 1.0 0.2 1.4 1.1 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.3 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 9.4 5.7 14.2 3.8 9.6 9.1 10.4 13.1 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.3 0.0 1.7 0.0 0.0 14.3 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIK4 "GluK4, GRIK, KA1" ENSG00000149403 "Glutamate ionotropic receptor kainate type subunit 4" Q16099 11 120511700-120988904 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.3;ovary: 8.5" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 33.4" "Cancer enriched" "Detected in some" 5 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.4;HEL: 19.7;T-47d: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074453 Enhanced NA NA "HPA074453: AB_2732255" "unprognostic (9.63e-2)" "unprognostic (4.96e-2)" "unprognostic (1.58e-1)" "unprognostic (2.49e-1)" "unprognostic (2.37e-1)" "unprognostic (6.64e-4)" "unprognostic (1.48e-2)" "unprognostic (7.26e-2)" "unprognostic (3.16e-1)" "unprognostic (2.38e-1)" "unprognostic (4.53e-2)" "unprognostic (2.50e-1)" "unprognostic (4.84e-11)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (4.47e-3)" "unprognostic (2.58e-2)" 1.0 5.4 11.3 1.0 9.0 0.8 1.3 3.9 19.3 1.2 1.1 9.4 0.0 1.2 1.1 0.9 1.2 1.7 1.1 1.6 13.9 7.2 1.0 0.8 3.1 1.0 8.7 11.0 8.5 0.8 0.8 2.6 1.5 12.3 1.5 1.1 0.0 1.1 1.0 1.0 1.3 1.2 1.0 6.3 1.4 0.9 2.0 8.2 0.0 6.3 0.0 1.0 1.2 0.4 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 6.4 0.6 19.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 5.1 0.0 0.2 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 11.3 9.0 3.9 14.0 13.9 7.2 8.7 11.0 12.3 8.2 0.0 1.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.3 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.1 0.0 0.0 0.4 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074001: AB_2732248" "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 14.5 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.0 8.9 0.1 0.0 24.4 0.0 0.1 4.0 0.0 7.0 15.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 0.0 0.0 0.0 0.1 0.3 21.4 2.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.6 0.0 0.0 17.5 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.4 0.0 20.6 0.0 0.9 3.8 1.5 0.4 0.0 0.0 0.0 0.0 GRIN3B GluN3B ENSG00000116032 "Glutamate ionotropic receptor NMDA type subunit 3B" O60391 19 1000419-1009732 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.7" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 2.7;Early spermatids: 2.6;Spermatogonia: 9.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 8.4" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Low region specificity" "Detected in some" NA NA "unprognostic (7.86e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-2)" "unprognostic (3.43e-3)" "unprognostic (1.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (9.20e-2)" "unprognostic (1.49e-1)" "unprognostic (3.78e-3)" "unprognostic (9.35e-3)" "unprognostic (3.62e-2)" "unprognostic (3.34e-5)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" 0.3 0.5 0.1 0.4 0.4 0.2 0.1 0.6 0.1 2.0 0.0 0.7 0.3 0.0 0.1 8.7 0.0 0.0 0.3 0.4 1.0 0.0 2.2 1.1 0.0 0.2 0.6 0.0 0.7 0.2 0.2 0.0 0.5 0.0 0.4 1.6 0.4 0.0 0.2 3.0 0.4 0.7 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 1.0 0.7 0.3 0.3 1.5 2.6 1.3 0.2 0.0 0.0 0.1 0.2 1.2 1.7 0.0 0.7 0.8 0.0 0.2 0.0 0.5 2.6 0.5 0.6 0.3 0.1 0.2 1.9 0.1 0.1 0.0 0.0 0.1 0.1 0.5 0.5 1.2 0.0 0.8 0.4 0.3 0.4 0.1 0.1 2.7 0.3 1.0 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.2 0.4 1.0 1.1 0.3 0.7 0.8 0.1 8.4 2.0 0.2 0.1 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 1.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 9.0 0.0 0.0 0.0 0.0 0.0 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990058-143993415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 331.5;monocytes: 538.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 76.4 48.8 46.6 52.3 61.0 89.0 70.2 73.8 85.8 37.1 28.4 34.5 37.1 35.6 33.1 42.1 30.5 41.4 37.5 35.2 54.2 45.1 61.7 143.7 49.7 67.4 47.4 51.5 46.1 32.0 66.8 29.3 42.4 46.5 42.6 17.7 49.3 44.4 99.4 32.8 37.4 33.5 38.0 43.3 82.0 23.2 52.2 24.3 24.3 54.7 19.2 26.8 43.2 31.3 4.5 12.4 10.2 19.3 1.6 2.6 6.4 12.8 25.2 12.9 21.9 68.8 34.7 19.1 18.4 43.6 31.4 29.1 15.3 10.8 9.2 20.3 41.5 21.9 11.6 23.0 27.2 12.9 13.1 15.8 9.6 14.6 18.1 72.9 2.0 15.5 44.7 75.4 22.7 33.2 33.0 15.2 4.0 8.9 13.0 27.0 77.6 5.3 5.2 9.0 12.4 38.2 7.3 6.5 17.8 16.1 36.5 8.8 14.3 26.8 30.2 35.8 18.3 58.1 12.7 15.2 19.9 21.9 26.5 13.4 21.1 12.1 6.9 25.2 12.7 11.3 0.9 16.6 4.6 1.4 19.3 2.0 4.5 1.4 1.6 7.1 4.3 2.6 2.3 10.2 1.6 18.0 12.4 1.2 6.4 46.6 61.0 73.8 85.8 54.2 45.1 47.4 51.5 46.5 24.3 17.9 65.6 14.3 28.0 33.1 86.7 19.7 40.8 17.4 18.2 50.6 74.6 108.2 19.9 63.5 214.4 42.1 42.7 46.7 60.2 47.1 58.4 38.3 15.1 167.7 158.2 31.8 40.5 54.0 188.9 331.5 57.0 128.7 35.4 538.4 24.1 77.3 64.0 46.0 63.6 61.9 71.2 45.3 40.6 89.2 11.3 32.2 220.9 15.9 22.4 21.6 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018645-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "brain: 101.6" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 1.8;Early spermatids: 3.4;Intestinal endocrine cells: 2.9;Late spermatids: 1.5;Spermatogonia: 4.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Region enriched" "Detected in many" 21 "cerebellum: 101.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 6.5;SCLC-21H: 26.0" "Region enhanced" "Detected in all" "cerebellum: 83.5" "Region enriched" "Detected in all" 4 "cerebellum: 252.6" CAB022096 Enhanced NA NA "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.2 0.1 0.4 0.3 4.9 0.2 0.2 101.6 7.2 0.6 0.1 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.5 0.9 0.2 0.3 0.3 0.2 0.3 0.4 0.2 3.5 0.1 0.0 0.3 4.3 0.3 0.2 0.1 0.1 0.2 0.3 0.6 0.8 0.7 1.1 0.1 0.2 1.6 0.5 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.9 101.6 1.0 0.5 0.9 0.3 0.4 4.3 0.5 0.0 0.0 0.0 0.3 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 4.0 0.0 0.1 0.0 0.0 0.1 GRPR "BB2, BB2R" ENSG00000126010 "Gastrin releasing peptide receptor" P30550 X 16123556-16153021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 24.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 6.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "PC-3: 18.0;T-47d: 22.5;U-138 MG: 30.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069604 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA069604: AB_2686158" "unprognostic (3.32e-2)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (2.87e-1)" "unprognostic (9.17e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (1.01e-1)" "unprognostic (3.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (5.59e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-1)" "unprognostic (2.86e-2)" 0.5 0.4 3.4 4.7 2.3 0.2 3.5 0.3 3.5 3.7 1.4 0.0 2.5 0.2 1.0 2.8 7.5 0.3 0.2 0.5 3.5 0.4 0.3 0.3 0.4 0.2 0.3 1.9 0.3 24.5 0.4 0.3 0.2 1.1 0.7 0.6 2.0 0.4 0.4 0.4 0.3 0.5 1.2 0.4 0.3 2.1 0.4 0.0 0.0 0.4 0.0 0.2 0.4 0.4 0.6 0.2 0.4 1.9 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.5 0.0 2.3 1.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 22.5 0.0 0.1 30.8 0.3 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 3.4 2.3 0.3 3.5 3.5 0.4 0.3 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSC2 GSCL ENSG00000063515 "Goosecoid homeobox 2" O15499 22 19148576-19150283 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "THP-1: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043011 Uncertain NA NA "HPA043011: AB_10959883" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSX2 Gsh2 ENSG00000180613 "GS homeobox 2" Q9BZM3 4 54099523-54102505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Dystonia, Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.8;retina: 16.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 2.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.9;hTERT-RPE1: 1.6;RPTEC TERT1: 1.8" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Low region specificity" "Detected in single" NA NA "unprognostic (4.48e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (1.89e-1)" 0.0 0.0 3.3 0.4 4.8 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.7 0.1 0.0 0.0 0.4 1.0 0.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 16.7 0.0 0.0 0.0 1.7 0.3 0.0 0.7 0.2 0.1 2.2 0.5 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.8 0.0 0.9 0.7 0.7 1.0 0.8 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTDC1 "FLJ11753, Hmat-Xa" ENSG00000121964 "Glycosyltransferase like domain containing 1" Q4AE62 2 143938068-144332568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036694 Approved Cytosol NA NA Cytosol "HPA036694: AB_10671709" "unprognostic (1.44e-1)" "unprognostic (1.22e-1)" "unprognostic (9.00e-3)" "unprognostic (3.36e-2)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-7)" "unprognostic (8.01e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-3)" "unprognostic (6.96e-2)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.44e-1)" "unprognostic (8.23e-2)" "unprognostic (6.31e-3)" "unprognostic (1.89e-1)" 14.5 12.9 22.1 7.1 17.3 12.3 8.9 7.3 26.7 12.9 6.9 15.3 1.6 4.0 6.8 9.8 7.5 6.0 10.1 15.2 21.4 14.1 9.4 6.4 8.0 9.8 18.2 14.9 12.6 7.0 10.9 10.7 9.3 14.1 6.4 6.7 7.0 5.9 6.0 8.8 5.3 4.8 7.1 24.0 12.6 4.8 11.7 11.6 6.1 10.6 3.1 11.2 8.9 6.3 4.3 2.0 10.8 2.5 8.0 12.3 3.4 4.7 2.0 14.2 2.6 14.6 13.5 4.3 3.3 8.3 7.3 10.1 2.2 4.4 10.2 2.3 5.9 4.7 1.3 2.8 4.9 15.7 13.0 3.3 15.7 1.7 2.2 6.0 6.3 8.6 9.3 12.2 7.9 11.6 5.0 10.4 4.2 2.8 11.9 16.7 2.2 1.6 7.0 4.0 3.6 3.2 4.7 7.3 2.7 8.1 9.7 7.1 5.7 6.4 5.5 6.5 9.3 3.6 7.2 6.4 8.1 6.0 3.6 4.1 7.6 0.0 5.7 4.8 4.2 10.9 2.1 2.5 7.3 5.7 2.2 12.3 4.3 3.8 9.5 2.0 3.4 0.8 6.3 10.8 8.0 2.4 0.7 4.7 3.4 22.1 17.3 7.3 26.7 21.4 14.1 18.2 14.9 14.1 11.6 8.9 30.5 7.5 3.9 6.4 19.2 15.9 0.0 18.7 17.0 5.2 3.9 3.4 5.0 3.7 8.5 11.3 3.5 0.0 9.0 3.8 16.5 3.7 16.3 3.0 9.0 17.5 4.1 23.9 16.9 3.6 11.8 12.1 5.0 10.8 2.6 11.0 7.4 3.5 13.1 5.7 3.5 12.9 17.3 3.7 19.6 4.1 3.5 16.0 3.5 7.8 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990918-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria No No Mitochondria "HPA034831: AB_10671506, HPA058631: AB_2683783" "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favorable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 7.5 9.3 7.4 7.3 7.8 9.5 7.3 8.5 10.1 7.1 11.9 9.2 8.3 8.0 8.3 5.2 12.2 6.4 7.4 20.0 7.6 7.6 12.2 8.2 6.2 13.2 7.6 8.3 10.4 12.1 13.0 12.1 9.3 9.5 8.2 9.3 6.6 9.6 5.2 25.3 6.5 11.8 7.4 11.7 9.3 9.1 22.7 8.9 25.4 13.4 14.3 10.2 9.6 8.0 6.7 12.2 6.7 7.0 11.9 15.8 7.8 19.6 9.0 11.9 13.4 7.3 12.6 9.5 13.6 11.8 14.0 17.5 15.8 8.5 12.9 8.0 7.5 11.3 13.5 15.8 13.1 16.1 5.7 11.1 35.3 9.0 8.2 6.9 22.5 8.7 10.0 9.4 7.7 5.5 14.5 12.8 15.2 12.4 15.3 13.4 7.7 14.3 11.0 24.5 9.9 17.1 12.2 11.0 8.2 9.8 12.4 13.8 14.0 11.0 8.7 18.1 10.7 9.8 15.3 7.7 10.2 15.1 3.7 12.7 10.0 13.1 18.0 10.2 18.7 11.2 6.7 7.0 4.5 10.4 4.6 9.1 6.7 11.9 10.0 12.2 5.9 15.8 10.3 1.0 11.9 3.9 5.8 8.2 7.8 7.4 7.8 8.5 10.1 7.6 7.6 7.6 8.3 9.5 8.9 14.9 9.6 16.3 11.9 11.9 9.3 24.2 7.6 13.4 7.9 5.2 5.9 23.6 19.9 14.6 58.0 10.3 10.5 23.3 15.9 20.5 12.6 10.8 19.6 7.2 20.3 9.5 9.8 10.4 14.5 21.7 10.9 14.2 10.1 12.6 9.7 8.9 13.4 10.2 5.3 23.1 12.2 0.0 17.5 35.6 28.1 10.7 12.7 16.7 11.9 16.1 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43726998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 104.1" "Group enriched" "Detected in some" 119 "Early spermatids: 2558.4;Late spermatids: 2369.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 7.5" "Lineage enriched" "Detected in many" 5 "T-cells: 7.5" "Cell line enhanced" "Detected in some" "Daudi: 1.3;EFO-21: 1.3;REH: 4.0;U-698: 4.4" "Low region specificity" "Detected in some" HPA054694 Enhanced Uncertain Nucleoli NA NA Nucleoli "HPA054694: AB_2682576" "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 104.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.9 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.4 0.6 0.8 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2558.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2369.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 20.6 8.0 0.0 0.0 0.0 0.0 0.0 GUCY2F "CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2" ENSG00000101890 "Guanylate cyclase 2F, retinal" P51841 X 109372906-109482072 "Enzymes, Plasma proteins, Predicted membrane proteins" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 23.1" "Cell type enriched" "Detected in some" 33 "Rod photoreceptor cells: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "THP-1: 4.5;U-266/70: 1.6;U-937: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 0.4" NA NA "unprognostic (1.91e-1)" "unprognostic (4.45e-2)" "unprognostic (2.96e-1)" "unprognostic (2.23e-1)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.1 0.0 7.2 6.6 13.0 1.1 1.1 2.7 2.6 6.4 0.3 0.8 0.0 2.0 3.0 14.6 0.1 0.7 1.4 2.5 0.0 0.8 0.0 4.8 7.7 8.4 3.0 0.0 12.5 0.7 6.3 1.0 3.9 0.0 14.1 3.5 0.1 1.5 1.6 22.3 0.1 4.3 0.1 1.4 0.1 6.1 0.0 0.8 1.1 0.7 3.3 6.2 0.3 0.8 1.4 2.4 0.9 0.0 2.8 9.0 8.7 4.1 0.6 0.1 0.1 7.3 1.4 4.9 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 3.0 1.6 0.0 1.5 1.6 0.6 9.8 2.5 1.4 1.2 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.9 0.0 1.0 0.2 14.2 1.3 0.0 0.0 0.3 0.0 3.4 1.3 0.0 17.8 7.5 0.3 0.0 0.0 2.3 2.5 1.2 0.0 6.7 0.4 0.4 0.0 1.0 2.9 3.2 0.4 0.7 0.0 1.5 0.4 GYPE "GPE, MNS" ENSG00000197465 "Glycophorin E (MNS blood group)" P15421 4 143870867-143905563 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 14.5;lymphoid tissue: 6.9" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Group enriched" "Detected in many" 12 "B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3" "Group enriched" "Detected in some" 11 "HEL: 50.9;K-562: 16.4" NA NA "unprognostic (2.17e-1)" "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.00e-2)" "unprognostic (4.71e-2)" "unprognostic (1.09e-4)" "unprognostic (2.05e-2)" "unprognostic (1.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-2)" "unprognostic (2.81e-3)" "unprognostic (1.10e-4)" "unprognostic (7.81e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (3.49e-2)" 2.7 0.2 1.2 1.5 0.5 14.5 1.2 0.5 1.2 0.9 0.5 0.5 0.5 0.0 0.5 0.8 0.5 0.1 0.7 2.6 1.1 0.3 0.7 0.5 3.7 1.0 0.5 0.5 1.5 0.5 0.0 0.5 5.7 1.1 0.5 0.4 0.5 0.5 0.6 0.5 0.5 1.7 0.5 0.7 6.9 0.4 0.8 0.5 1.5 1.4 0.5 3.1 0.9 0.5 3.5 0.1 0.0 0.0 2.1 1.3 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.0 1.2 2.7 0.6 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 50.9 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.5 0.0 0.0 0.0 1.1 0.8 0.6 0.0 2.1 0.0 0.1 0.0 0.0 1.2 0.5 0.5 1.2 1.1 0.3 0.5 0.5 1.1 0.5 14.9 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 70.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.0 H1FNT "H1T2, HANP1" ENSG00000187166 "H1 histone family member N, testis specific" Q75WM6 12 48328980-48330279 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 57 "testis: 71.7" "Group enriched" "Detected in some" 102 "Early spermatids: 1547.2;Late spermatids: 3533.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Group enriched" "Detected in some" 7 "U-266/70: 5.0;U-266/84: 1.2" "Not detected" "Not detected" HPA046204 Approved NA NA "HPA046204: AB_2679586" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "unprognostic (1.95e-1)" "unprognostic (1.50e-3)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-5)" "unprognostic (1.91e-1)" "unprognostic (7.68e-4)" "unprognostic (3.41e-1)" "unprognostic (2.87e-2)" "unprognostic (5.79e-3)" "unprognostic (9.84e-2)" 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1547.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3533.3 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 12.9 0.0 25.0 12.1 0.0 0.0 0.0 0.0 0.0 H1FOO ENSG00000178804 "H1 histone family member O oocyte specific" Q8IZA3 3 129543214-129551467 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 80 "testis: 10.8" "Cell type enriched" "Detected in some" 11 "Early spermatids: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.1;SCLC-21H: 1.5" "Low region specificity" "Detected in many" HPA037992 Enhanced NA NA "HPA037992: AB_10671517" "unprognostic (5.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 HAGHL MGC2605 ENSG00000103253 "Hydroxyacylglutathione hydrolase like" Q6PII5 16 726936-735525 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 50.9;Ciliated cells: 34.8;Distal tubular cells: 29.9;Hofbauer cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 30.0;U-266/70: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074402 Approved NA NA "HPA074402: AB_2732254" "unprognostic (6.74e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.49e-1)" "unprognostic (4.56e-2)" "unprognostic (5.62e-3)" "unprognostic (9.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-2)" "unprognostic (6.37e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.92e-2)" "unprognostic (5.36e-1)" "unprognostic (3.41e-2)" "unprognostic (2.41e-1)" 2.7 8.7 10.0 6.2 19.7 4.5 1.2 13.0 15.5 1.7 2.1 9.4 2.5 2.9 3.7 2.7 1.1 7.9 2.6 5.3 10.6 10.9 4.9 1.4 4.0 8.3 15.9 6.7 1.4 2.4 5.8 8.1 2.3 10.7 2.6 0.9 4.5 9.6 4.0 1.3 2.7 4.5 1.1 13.9 8.4 5.8 3.5 9.1 2.9 0.9 1.6 3.8 1.8 1.0 13.1 3.7 1.3 1.5 8.5 7.2 3.1 2.1 2.3 0.6 3.1 0.5 1.1 2.4 2.0 1.3 0.4 0.5 1.0 3.0 4.9 3.0 0.1 0.8 2.9 0.5 0.8 0.0 14.3 2.0 1.6 5.4 1.8 3.7 6.1 4.6 2.1 0.8 0.0 1.0 1.3 0.3 4.9 2.8 4.4 0.6 14.6 0.1 8.6 3.3 3.6 5.1 3.2 1.4 30.0 1.2 0.7 11.3 6.7 1.0 8.8 9.3 0.1 5.5 10.7 1.9 2.4 3.6 0.8 1.2 32.2 4.1 6.8 3.8 6.2 4.3 0.0 1.5 1.3 6.2 0.5 7.2 13.1 4.1 6.8 1.9 3.5 1.2 4.6 0.0 8.5 0.2 3.7 4.7 3.1 10.0 19.7 13.0 14.1 10.6 10.9 15.9 6.7 10.7 9.1 3.0 1.1 11.5 1.9 1.0 50.9 10.1 0.0 34.8 3.4 3.5 0.0 0.4 29.9 2.8 4.3 0.6 0.0 0.0 0.0 1.0 2.4 4.9 8.1 0.6 34.5 11.1 3.5 0.6 5.4 9.1 6.4 7.2 18.6 6.4 1.1 10.3 2.2 0.3 5.6 6.9 7.8 0.0 2.0 7.5 6.5 0.3 0.3 10.2 1.4 0.6 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478264 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.6;testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 36.0;SuSa: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040925 Uncertain Uncertain "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA040925: AB_10796563" "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 6.0 0.1 9.7 0.1 0.0 0.1 0.1 0.1 0.1 35.1 0.0 0.0 4.4 0.1 0.0 0.1 0.1 5.3 25.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 3.6 0.0 5.4 2.6 0.1 0.1 0.0 0.1 0.1 20.8 14.2 0.1 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 36.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavorable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.1 0.0 0.0 28.3 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.4 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 HAPLN2 BRAL1 ENSG00000132702 "Hyaluronan and proteoglycan link protein 2" Q9GZV7 1 156619294-156625725 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 39 "brain: 108.1" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 32.3" "Cancer enriched" "Detected in some" 10 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045765 Enhanced "Secreted in brain" NA NA "HPA045765: AB_10964781" "unprognostic (3.19e-3)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-1)" "unprognostic (2.44e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-3)" "unprognostic (1.31e-1)" "unprognostic (8.25e-2)" "unprognostic (5.54e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-2)" "unprognostic (1.08e-1)" "unprognostic (2.25e-1)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.5 1.5 11.0 1.3 21.1 1.3 1.3 4.4 45.3 1.3 1.3 43.6 0.0 2.7 1.6 1.3 1.3 1.4 1.3 1.3 21.2 13.9 1.4 1.3 1.4 1.3 49.3 9.3 1.3 1.3 1.6 0.0 1.3 43.1 1.9 1.3 0.0 1.4 1.5 1.9 1.6 1.7 1.3 108.1 1.3 1.3 1.7 31.5 0.0 1.3 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 4.6 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 21.1 4.4 15.1 21.2 13.9 49.3 9.3 43.1 31.5 0.0 0.0 0.0 0.0 0.1 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 32.3 7.6 0.7 1.9 0.0 0.0 0.0 0.0 0.1 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 899.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;U-2 OS: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.4 0.9 9.8 2.8 3.0 3.1 2.7 0.6 1.0 1.3 2.8 4.1 0.0 7.8 3.4 1.6 1.0 9.3 1.2 0.0 21.0 8.2 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 2.0 0.1 0.1 4.6 0.4 0.0 6.0 0.4 0.1 0.0 0.0 7.3 0.0 0.1 0.0 0.4 7.3 1.8 0.1 0.1 2.7 0.5 0.5 3.7 1.2 0.0 0.4 0.8 7.1 21.0 5.3 0.4 0.9 0.0 0.0 2.5 0.0 6.1 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 0.0 4.3 0.9 6.0 28.4 2.6 7.7 0.0 1.4 5.7 1.8 9.8 5.6 0.0 5.7 0.0 18.6 0.0 0.0 1.8 899.6 9.3 3.9 1.1 0.0 17.6 0.0 0.0 3.1 0.0 0.0 0.9 2.9 16.9 16.2 0.2 2.4 8.7 0.0 0.7 0.1 108.4 12.9 38.9 0.5 1.7 21.1 17.0 3.2 0.2 6.8 HAPLN4 "BRAL2, KIAA1926" ENSG00000187664 "Hyaluronan and proteoglycan link protein 4" Q86UW8 19 19255641-19262796 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.5;intestine: 24.3" "Cell type enriched" "Detected in single" 6 "Hepatocytes: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055856 Enhanced "Secreted in brain" NA NA "HPA055856: AB_2682946" "unprognostic (3.36e-4)" 0.5 1.9 3.0 0.4 7.5 0.4 0.7 8.9 38.5 2.4 0.6 1.6 0.0 19.6 1.6 0.5 0.4 0.7 0.6 0.5 8.9 9.4 0.5 7.5 0.6 0.4 7.8 2.7 1.4 1.3 0.4 0.2 0.7 26.4 1.1 0.6 0.4 0.5 0.8 0.4 0.4 24.3 0.6 3.8 0.4 0.8 0.5 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 5.7 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 7.5 8.9 38.5 8.9 9.4 7.8 2.7 26.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Cell line enriched" "Detected in some" 4 "U-87 MG: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067602: AB_2685871" "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 0.0 2.6 0.0 0.1 23.7 4.2 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.1 2.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.3 8.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.6 0.0 24.7 0.0 0.1 15.6 0.1 0.0 0.0 0.1 HAS2 ENSG00000170961 "Hyaluronan synthase 2" Q92819 8 121612116-121641390 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.8" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052060 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052060: AB_2681712" "unprognostic (7.01e-2)" "unprognostic (1.34e-2)" "unprognostic (4.07e-2)" "unprognostic (4.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.91e-2)" "unprognostic (5.33e-2)" "unprognostic (2.57e-3)" "unprognostic (3.44e-2)" "unprognostic (1.34e-1)" "unprognostic (8.19e-3)" "unprognostic (1.24e-1)" "unprognostic (1.66e-7)" "unprognostic (1.47e-3)" "unprognostic (3.67e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-3)" 22.8 0.9 1.6 9.1 2.4 0.0 5.5 0.8 1.7 4.0 8.5 2.0 0.0 2.6 1.5 2.5 4.8 3.9 7.7 8.3 1.7 1.7 1.2 2.7 6.5 4.5 1.8 0.6 1.2 1.8 0.3 0.7 2.1 5.7 4.3 5.6 2.7 1.9 0.1 2.7 3.8 9.5 3.7 4.2 0.3 2.3 3.2 2.6 0.4 1.7 5.5 2.1 5.7 1.4 0.0 0.2 0.7 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 1.0 2.6 0.0 4.9 3.7 6.5 11.2 0.0 0.0 0.0 0.0 4.4 0.0 0.8 0.0 0.0 34.7 0.0 0.1 0.0 0.1 0.0 4.4 0.0 0.0 6.8 0.0 33.4 3.0 0.1 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.7 0.0 0.0 0.4 0.0 0.1 2.1 0.0 1.1 2.0 0.0 0.0 0.0 87.1 0.3 8.1 25.8 0.0 0.0 0.0 1.8 0.0 1.7 0.5 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.3 0.2 0.2 0.1 0.0 1.6 2.4 0.8 1.7 1.7 1.7 1.8 0.6 5.7 2.6 0.0 0.0 0.0 44.7 14.4 0.0 1.2 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.7 12.7 2.2 0.0 0.0 0.0 0.0 34.9 5.5 13.8 0.0 0.2 0.0 1.2 0.0 0.0 1.6 1.7 1.6 28.7 0.0 1.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.0 10.5 0.1 0.0 3.3 95.7 HAS3 ENSG00000103044 "Hyaluronan synthase 3" O00219 16 69105564-69118719 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;urinary bladder: 22.9" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2" "Group enriched" "Detected in many" 8 "cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 14.4;PC-3: 76.9;RT4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031554, CAB033850" Supported Approved Microtubules NA NA Microtubules "CAB033850: AB_2116418, HPA031554: AB_10670703" "unprognostic (3.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (7.59e-3)" "unprognostic (2.86e-3)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (2.46e-1)" "unprognostic (3.27e-3)" "unprognostic (3.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-2)" "unprognostic (3.40e-3)" 0.4 0.2 0.4 0.4 1.0 0.3 5.5 1.1 1.3 3.3 3.7 0.4 0.4 1.9 0.8 1.1 22.6 0.7 3.5 2.4 0.6 0.6 1.2 0.7 18.0 0.4 0.4 0.4 0.9 2.2 0.1 1.0 3.3 1.1 3.5 2.3 0.6 7.6 2.1 0.6 5.7 2.1 1.4 0.4 0.4 9.0 2.0 0.4 0.5 4.0 11.7 11.1 22.9 13.6 1.5 1.2 2.2 1.4 0.4 2.0 1.1 0.9 4.8 0.3 0.2 0.1 0.1 1.8 0.3 0.1 0.2 0.1 1.0 2.5 0.2 0.6 0.1 1.1 14.4 0.8 8.6 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 2.4 0.3 0.8 1.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.1 4.3 5.0 76.9 0.5 0.0 0.0 7.9 30.4 5.4 0.2 0.5 0.0 0.1 0.9 0.2 0.2 0.1 0.2 0.2 8.4 0.5 0.3 0.2 0.0 0.3 0.0 0.1 0.8 1.4 2.2 1.4 0.7 1.3 0.7 1.1 0.5 1.2 1.5 2.0 0.7 0.5 0.4 1.1 1.0 1.5 1.1 0.4 1.0 1.1 1.3 0.6 0.6 0.4 0.4 1.1 0.4 0.0 25.0 0.0 35.3 144.1 1.4 1.4 0.0 0.0 4.5 0.0 2.0 0.9 0.0 3.2 10.2 2.0 2.0 0.0 3.1 0.7 0.8 9.4 0.0 0.0 0.3 0.0 0.0 1.3 0.0 17.0 1.1 0.6 3.3 0.0 0.3 0.1 2.3 0.0 0.4 0.6 0.9 0.0 2.5 0.6 0.4 138.5 0.2 0.5 1.5 89.2 HBM "HBAP2, HBK" ENSG00000206177 "Hemoglobin subunit mu" Q6B0K9 16 153892-166768 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 109.8;placenta: 50.2" "Cell type enriched" "Detected in some" 740 "Erythroid cells: 12474.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.3" "Low region specificity" "Detected in some" NA NA 400000 "unprognostic (1.30e-1)" "unprognostic (7.59e-2)" 0.9 0.2 0.4 0.2 0.5 109.8 0.3 0.1 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.6 0.2 0.2 4.4 0.3 0.4 1.7 2.6 16.5 0.2 0.7 0.0 1.6 0.2 0.2 1.1 50.2 1.2 0.5 0.2 1.2 0.2 0.2 0.4 0.2 0.2 0.2 0.4 17.5 0.2 0.2 0.0 1.0 2.0 0.1 0.3 2.1 4.9 0.1 0.5 0.5 0.0 0.9 0.4 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.0 10.5 0.4 0.5 0.1 0.2 0.3 0.4 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12474.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.3 0.1 0.0 0.0 0.0 0.0 HDGFL1 "dJ309H15.1, Hdgfrp1, HRP-1, PWWP1" ENSG00000112273 "HDGF like 1" Q5TGJ6 6 22569493-22571666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 296 "testis: 97.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 75.8;Late spermatids: 90.5;Spermatocytes: 112.6" "Cancer enriched" "Detected in some" 41 "testis cancer: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 5.0" "HPA045679, HPA063707" Enhanced NA NA "HPA045679: AB_2679415, HPA063707: AB_2685099" "unprognostic (1.55e-1)" "unprognostic (6.18e-2)" "unprognostic (4.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 112.6 23.3 0.0 0.0 0.0 0.0 0.0 HEATR4 MGC48595 ENSG00000187105 "HEAT repeat containing 4" Q86WZ0 14 73478484-73558947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 14.0" "Cell type enriched" "Detected in some" 6 "Early spermatids: 54.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 5.8;SCLC-21H: 5.8" "Not detected" "Not detected" "HPA003642, HPA079348" Enhanced NA NA "HPA003642: AB_1079376, HPA079348: " "unprognostic (5.25e-2)" "unprognostic (2.45e-3)" "unprognostic (2.85e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-2)" "unprognostic (2.60e-2)" "unprognostic (3.50e-1)" "unprognostic (8.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (5.50e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" 0.3 0.3 0.7 0.7 1.1 0.8 0.4 3.4 1.1 0.7 0.3 2.0 1.0 0.1 0.5 0.7 0.7 0.7 0.9 0.8 0.3 0.9 0.4 1.6 0.5 1.0 0.8 0.5 0.5 0.1 0.5 0.0 0.8 0.0 2.0 4.4 0.7 0.0 0.8 0.9 0.7 14.0 1.0 0.0 0.2 0.7 3.0 1.0 1.7 0.7 1.4 2.3 0.4 1.6 1.8 0.9 1.3 0.1 0.0 0.7 0.8 0.0 0.1 0.3 0.5 0.4 1.8 0.1 0.0 0.3 3.6 0.0 0.0 0.2 0.5 0.4 1.3 0.3 0.1 0.3 1.2 2.4 0.0 0.0 0.2 0.0 1.3 0.0 1.9 0.6 0.7 0.0 5.8 0.5 2.1 0.8 0.4 1.8 1.0 0.9 0.8 0.0 2.5 5.8 0.7 2.0 2.6 2.9 1.3 3.0 0.2 1.1 0.2 2.2 1.8 0.2 1.5 0.5 0.4 1.2 0.5 0.2 1.0 0.7 0.3 1.8 0.5 1.0 2.1 2.2 1.2 0.3 3.0 2.3 2.3 1.7 1.4 0.1 1.0 1.1 0.4 0.0 1.0 0.0 0.3 0.2 0.8 0.8 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 54.9 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 8.7 0.6 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.5 0.6 0.1 0.0 0.0 0.1 HECTD2 FLJ37306 ENSG00000165338 "HECT domain E3 ubiquitin protein ligase 2" Q5U5R9 10 91409280-91514829 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 25.5;Horizontal cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 6.7" "Lineage enriched" "Detected in many" 7 "NK-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037767 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA037767: AB_10671378" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.26e-2)" "unprognostic (3.34e-1)" "unprognostic (6.65e-3)" "unprognostic (1.10e-2)" "unprognostic (9.37e-4)" "unprognostic (1.42e-1)" "unprognostic (1.59e-1)" "unprognostic (2.31e-1)" "unprognostic (2.54e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.67e-5)" "unprognostic (6.98e-3)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.84e-2)" 8.7 8.8 16.5 6.9 17.9 2.4 10.8 20.3 19.5 14.3 10.1 5.1 9.1 4.6 17.2 16.6 8.3 12.1 11.4 8.1 11.9 8.7 7.3 4.7 8.7 4.7 5.8 11.3 16.8 7.4 14.4 18.6 10.2 6.5 24.8 7.6 7.5 7.7 24.3 7.7 6.8 6.0 18.4 6.8 5.3 7.5 9.7 6.4 2.9 9.8 5.1 3.6 13.7 10.5 0.6 0.4 0.1 0.8 6.7 1.0 0.5 4.1 2.1 21.4 8.8 4.7 5.2 3.8 3.4 4.5 6.9 6.3 0.2 3.9 0.0 2.9 3.4 4.0 0.3 5.8 2.4 8.5 4.4 7.2 2.4 15.0 1.3 2.4 0.4 1.6 5.3 2.2 5.0 4.3 9.7 5.1 5.1 3.1 10.7 10.6 1.9 2.5 1.3 8.9 0.4 2.1 6.4 14.1 2.4 4.8 1.2 5.0 5.4 6.6 1.5 6.7 6.9 9.7 1.4 5.4 6.9 4.8 0.5 6.3 0.7 1.4 5.9 6.1 0.0 4.0 0.0 0.1 0.0 1.0 0.8 0.6 0.2 0.5 0.7 0.4 0.6 0.5 0.6 0.1 6.7 0.2 0.0 0.1 0.5 16.5 17.9 20.3 19.5 11.9 8.7 5.8 11.3 6.5 6.4 0.0 3.2 0.0 7.0 5.5 21.3 6.5 5.1 5.3 5.7 5.2 25.5 0.3 18.3 2.4 1.5 8.3 0.7 0.0 3.0 0.3 11.3 4.2 3.5 0.8 5.3 27.0 8.6 9.2 7.0 1.5 11.2 3.8 6.8 3.6 3.0 12.0 2.5 0.6 13.4 1.3 8.2 12.9 7.6 6.7 8.1 3.9 0.3 1.5 1.3 3.0 HELT "bHLHb44, HCM1228, HESL, MEGANE, Mgn" ENSG00000187821 "Helt bHLH transcription factor" A6NFD8 4 185018841-185020804 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 2.9;lung: 2.2;skin 1: 2.0" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 5.2;HEK 293: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036188, HPA036189" Uncertain NA NA "HPA036188: AB_10672237, HPA036189: AB_2674997" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021361-94113751 "Predicted membrane proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 68.0" "Cell type enriched" "Detected in some" 5 "Basal keratinocytes: 9.3" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.4;HaCaT: 4.2;HBEC3-KT: 7.5" "Region enriched" "Detected in single" 21 "olfactory region: 1.4" "Not detected" "Not detected" HPA031517 Uncertain NA NA 51000000 "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavorable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 68.0 16.2 0.0 4.8 1.1 0.3 0.1 0.0 0.9 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.1 4.2 0.0 7.5 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.3 1.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443111 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 8.0 7.5 7.8 7.2 10.2 7.3 6.3 2.1 14.6 13.6 6.3 5.9 3.4 5.4 13.2 9.6 23.9 10.4 11.2 9.8 7.7 8.4 10.4 5.0 8.3 4.6 7.3 15.8 9.8 6.3 5.2 8.4 7.1 8.5 9.1 6.5 7.2 28.4 5.7 2.9 4.3 7.1 8.5 5.6 8.0 7.3 3.9 5.3 9.0 5.9 7.6 7.8 7.2 13.8 3.6 2.7 4.5 6.4 5.6 13.4 4.2 2.6 1.7 0.1 0.3 0.1 1.6 0.5 0.3 8.8 47.0 35.0 0.1 3.3 0.0 0.6 0.8 7.6 1.0 4.3 2.2 3.1 5.3 0.9 2.4 1.5 0.2 1.5 4.3 1.7 2.1 0.5 3.6 0.1 2.8 1.3 2.0 0.0 0.6 1.0 1.5 2.0 1.3 0.6 2.3 0.9 1.3 0.0 0.1 3.2 3.2 0.1 1.1 3.2 1.1 5.2 2.4 1.9 0.8 0.4 0.6 0.9 0.1 0.8 0.1 0.0 0.0 2.1 1.0 2.1 4.4 3.1 4.5 6.7 3.1 13.4 3.6 9.4 6.5 2.7 2.7 7.5 5.1 1.9 5.6 6.4 0.3 11.8 4.2 7.8 10.2 2.1 14.6 7.7 8.4 7.3 15.8 8.5 5.3 11.9 8.8 2.4 4.4 2.5 11.4 10.6 5.1 16.0 10.3 5.2 15.7 4.9 0.0 6.6 0.9 8.4 5.2 0.0 15.0 1.3 3.7 8.2 5.7 2.1 4.3 1.6 1.7 4.3 3.7 1.3 4.0 2.2 5.0 4.6 2.9 4.3 9.1 3.1 5.3 3.6 1.0 6.5 2.0 0.5 1.1 1.0 2.1 7.7 1.7 6.2 HES2 bHLHb40 ENSG00000069812 "Hes family bHLH transcription factor 2" Q9Y543 1 6412418-6424670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;placenta: 60.9" "Cell type enhanced" "Detected in many" 11 "Mucus-secreting cells: 46.1;Paneth cells: 29.4;Syncytiotrophoblasts: 83.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.9;neutrophil: 3.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "BEWO: 10.9;HaCaT: 20.3;HBEC3-KT: 17.5;hTCEpi: 10.1;PC-3: 7.3;TIME: 29.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039462 Uncertain NA NA "HPA039462: AB_10673533" "unprognostic (1.96e-1)" "unprognostic (7.00e-2)" "unprognostic (1.66e-1)" "unprognostic (6.82e-3)" "unprognostic (1.13e-2)" "unprognostic (1.89e-1)" "unprognostic (2.56e-4)" "unprognostic (4.74e-2)" "unprognostic (7.41e-2)" "unprognostic (3.20e-2)" "unprognostic (5.63e-3)" "unprognostic (1.38e-1)" "unprognostic (7.67e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-2)" 0.8 0.0 0.2 0.7 0.2 0.2 0.7 0.2 0.3 6.7 6.0 0.2 0.2 0.1 0.4 0.4 22.6 2.5 0.2 0.2 0.2 0.0 1.0 0.4 3.8 0.2 0.2 0.2 0.5 0.2 0.2 0.4 60.9 0.3 1.2 4.6 0.5 2.9 0.6 0.2 14.5 0.9 0.2 0.2 0.2 0.0 1.8 0.2 0.7 0.2 8.6 6.0 0.3 11.9 0.6 0.6 4.9 0.4 0.5 0.6 0.2 0.9 0.3 0.0 0.1 0.2 0.0 10.9 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.9 0.1 0.1 20.3 0.5 17.5 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 10.1 0.0 0.4 0.0 5.3 0.0 0.1 0.2 0.0 1.5 0.0 0.8 0.0 1.1 7.3 0.0 0.0 0.1 0.1 0.3 0.1 0.0 1.0 5.7 0.2 1.1 0.8 0.3 29.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.4 0.6 0.5 0.3 0.3 0.4 0.5 0.4 0.1 0.6 0.4 0.6 3.9 0.5 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 8.9 4.6 0.8 5.2 5.8 1.5 8.1 0.0 16.0 7.9 1.8 3.9 1.5 0.0 0.3 11.3 1.8 8.9 0.0 0.0 3.6 1.9 8.3 1.1 0.0 0.9 0.0 2.9 1.8 0.3 25.8 0.3 1.3 1.7 0.0 46.1 1.2 0.3 29.4 0.7 3.3 5.4 0.0 1.0 5.6 5.7 17.1 83.1 0.0 11.0 21.1 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 291.1;Glandular cells: 254.1;Paneth cells: 238.4;Smooth muscle cells: 271.9;Urothelial cells: 423.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Cell line enriched" "Detected in some" 8 "HEK 293: 66.9" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA062465: AB_2684771" "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favorable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.6 0.5 0.5 0.0 0.0 0.0 5.9 2.8 0.3 1.7 1.8 0.7 1.5 0.0 6.7 0.2 0.8 8.2 0.7 0.1 0.0 0.0 66.9 0.0 0.7 0.9 0.6 0.0 0.5 0.0 0.7 0.1 0.1 0.2 0.2 0.8 1.3 0.1 0.0 2.4 3.7 0.2 0.0 1.0 6.5 0.0 0.6 1.4 0.6 0.0 0.4 1.5 1.9 4.7 8.4 0.2 3.5 0.0 0.3 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 0.0 0.0 0.0 291.1 46.2 3.5 11.8 22.9 0.0 2.3 55.8 0.0 0.9 26.6 14.8 0.8 15.3 10.3 0.0 2.5 35.2 22.6 254.1 55.1 0.0 4.4 0.0 10.3 16.0 3.5 0.8 6.9 13.3 109.6 1.0 10.5 119.5 9.0 238.4 14.5 0.6 10.7 161.7 271.9 2.3 28.1 72.3 2.9 0.7 11.0 423.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 105.2" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 0.0 0.0 0.0 0.2 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 105.2 0.0 3.5 0.0 0.0 4.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 1.1 0.1 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 105.3;Mucus-secreting cells: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 8.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "NB-4: 51.5;SCLC-21H: 34.1;SK-MEL-30: 49.2;THP-1: 22.8;U-937: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073997 Approved "Nuclear bodies,Cytosol" NA No "Nuclear bodies" Cytosol "HPA073997: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.79e-4)" "prognostic favorable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 2.1 5.2 15.4 3.4 10.6 10.5 3.0 7.3 47.4 3.7 12.2 17.1 0.8 18.1 6.3 1.5 1.6 14.3 5.7 1.7 17.5 9.1 1.9 2.5 2.2 3.3 11.4 12.3 1.3 13.9 5.3 23.6 1.7 14.3 2.0 9.6 1.5 3.8 1.7 8.2 1.7 12.9 3.3 18.8 4.6 5.2 9.4 11.7 0.4 5.5 1.7 2.8 1.3 1.0 0.3 1.4 8.0 0.3 0.1 1.0 0.2 1.2 1.5 6.5 7.4 0.4 0.2 4.2 0.4 0.5 0.6 1.0 1.2 0.8 0.0 1.0 0.1 2.7 0.8 6.6 0.5 0.2 2.8 7.9 1.5 1.0 13.4 1.1 10.7 9.0 0.6 4.0 0.9 1.3 0.3 0.4 6.9 13.5 0.1 0.4 3.2 1.6 51.5 10.4 1.2 1.1 7.3 16.5 3.1 0.8 0.6 34.1 14.9 2.0 2.9 49.2 0.8 2.6 22.8 0.6 0.6 1.3 3.6 3.8 3.0 0.5 2.2 2.3 26.2 1.1 0.1 0.3 8.0 1.0 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.3 1.4 0.7 0.2 15.4 10.6 7.3 39.3 17.5 9.1 11.4 12.3 14.3 11.7 0.0 1.4 8.0 4.1 3.0 8.1 2.8 0.0 9.4 3.4 3.5 21.6 1.0 6.6 9.9 10.9 3.7 18.1 46.7 27.8 3.1 3.8 5.1 0.0 3.8 4.8 3.2 105.3 3.7 1.6 5.6 1.4 5.5 33.7 11.8 104.6 6.1 11.9 16.9 1.4 3.7 4.7 0.0 14.6 24.6 32.4 1.8 0.2 6.2 33.2 1.8 HEXDC FLJ23825 ENSG00000169660 "Hexosaminidase D" Q8WVB3 17 82418318-82442645 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 30.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022834, HPA023379, HPA027844" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center, Mitochondria" "HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711" "unprognostic (8.69e-3)" "prognostic favorable (7.70e-4)" "unprognostic (7.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.51e-2)" "prognostic favorable (2.71e-4)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.71e-1)" "unprognostic (1.14e-2)" "prognostic favorable (5.57e-4)" "unprognostic (9.04e-3)" "unprognostic (1.83e-1)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.52e-5)" 12.7 8.5 7.1 16.6 9.3 14.3 8.7 13.2 7.3 10.1 7.6 8.8 12.8 8.0 10.0 11.1 7.9 10.3 9.4 5.7 7.2 4.6 9.9 11.6 12.4 11.6 12.8 5.5 13.6 72.9 10.2 14.6 5.7 7.4 14.1 4.2 7.0 13.3 9.2 20.4 11.3 12.3 6.0 6.1 15.6 8.8 4.7 11.4 8.6 11.7 8.6 10.7 8.3 8.8 5.9 30.3 3.3 11.5 11.9 9.8 4.4 3.0 7.7 3.4 5.3 10.4 9.0 10.5 3.9 4.8 4.1 4.7 2.7 10.4 8.1 4.3 1.6 2.8 4.3 2.0 2.3 1.9 5.6 13.1 3.6 6.8 4.5 9.3 2.4 9.3 6.4 2.3 1.1 4.2 5.6 5.3 6.2 4.6 2.8 1.1 7.0 8.4 9.0 3.1 5.6 4.7 10.0 2.9 15.8 3.1 4.6 4.8 10.2 8.1 5.3 7.3 1.6 8.5 9.2 5.3 2.7 5.1 2.0 2.7 12.7 2.4 6.0 2.1 6.9 2.7 3.3 1.7 2.7 9.8 11.5 6.5 4.6 2.2 3.4 2.0 5.9 3.5 5.1 3.0 11.9 4.9 30.3 1.4 4.4 7.1 9.3 13.2 7.3 7.2 4.6 12.8 5.5 7.4 11.4 3.0 8.5 8.3 9.5 4.1 19.2 4.4 12.7 9.4 12.5 17.4 17.7 4.7 8.3 5.4 1.2 8.0 16.8 0.0 8.2 5.3 6.2 10.5 10.3 12.9 13.7 39.7 13.3 16.0 9.5 2.1 33.1 11.5 5.0 16.2 14.4 18.7 5.8 10.1 23.3 6.1 29.0 19.4 6.2 6.0 10.2 2.0 3.3 12.9 12.0 7.5 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702827 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 96.4;Cardiomyocytes: 54.3;Muller glia cells: 48.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;HSkMC: 1.3;Karpas-707: 1.2;NTERA-2: 1.4;RPMI-8226: 4.2;THP-1: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018174 Enhanced NA NA "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 1.5 1.6 12.9 1.3 29.0 1.3 1.9 2.3 15.2 1.5 1.4 36.5 0.0 1.3 1.7 1.5 2.7 2.0 1.5 184.7 14.5 8.9 1.4 1.3 1.5 1.4 51.6 10.5 1.4 1.8 1.4 0.9 1.4 25.9 1.9 1.4 5.4 4.7 1.4 93.6 1.6 1.4 1.4 57.1 1.4 1.3 1.7 39.9 0.0 9.3 7.2 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.0 4.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.3 0.5 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 29.0 2.3 15.2 14.5 8.9 51.6 10.5 25.9 39.9 0.0 0.0 0.0 0.0 0.3 96.4 54.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 48.8 0.3 0.0 0.0 0.0 9.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 HHLA1 PLA2L ENSG00000132297 "HERV-H LTR-associating 1" C9JL84 8 132061486-132111159 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "placenta: 1.3" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 13.7;Ciliated cells: 2.7;Club cells: 4.5;granulocytes: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "NTERA-2: 4.8;SuSa: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.6 0.0 2.7 4.5 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST1H1T "H1FT, H1t" ENSG00000187475 "Histone cluster 1 H1 family member t" P22492 6 26107419-26108136 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "testis: 257.2" "Group enriched" "Detected in some" 22 "Spermatocytes: 1.9;Spermatogonia: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 44 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SiHa: 4.0;U-2 OS: 1.0;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065718, HPA068266" Enhanced NA NA "HPA065718: AB_2685543, HPA068266: AB_2685967" "unprognostic (1.06e-2)" "unprognostic (1.80e-2)" "unprognostic (9.52e-2)" "unprognostic (9.94e-2)" "unprognostic (5.12e-1)" "unprognostic (1.57e-1)" "unprognostic (7.48e-3)" "unprognostic (6.51e-2)" "unprognostic (6.86e-3)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (6.28e-3)" 0.0 0.0 0.2 0.8 0.3 0.4 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.3 0.1 0.1 0.6 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.2 0.2 0.0 257.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 1.8 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.7 0.2 0.3 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 4.7 0.0 0.1 0.0 0.0 0.0 HIVEP3 "FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C" ENSG00000127124 "Human immunodeficiency virus type I enhancer binding protein 3" Q5T1R4 1 41506365-42035925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;lymphoid tissue: 16.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.9;hTEC/SVTERT24-B: 9.3;Karpas-707: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005728 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA005728: AB_10612117" "unprognostic (2.87e-3)" "unprognostic (2.38e-2)" "unprognostic (4.65e-2)" "unprognostic (2.56e-1)" "unprognostic (1.55e-2)" "unprognostic (6.50e-2)" "unprognostic (2.70e-3)" "unprognostic (3.73e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (2.07e-8)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" 4.2 1.5 7.5 5.4 5.7 3.8 3.6 20.3 11.7 1.2 1.4 5.1 0.0 1.2 1.1 1.1 3.2 1.3 2.0 2.1 6.1 3.0 1.4 1.2 4.6 4.1 4.8 4.7 1.6 2.4 2.3 8.3 1.8 6.5 2.2 1.5 0.5 3.7 1.1 1.6 11.7 1.3 2.2 5.0 2.9 1.9 1.4 5.1 16.6 2.9 1.8 5.4 1.9 1.6 1.0 1.5 0.1 3.7 0.2 2.1 1.1 1.8 0.6 0.2 1.7 2.3 1.0 0.0 0.9 0.2 2.3 4.0 0.1 0.3 3.8 0.6 0.9 1.4 2.6 0.4 0.4 3.1 17.9 0.5 0.2 0.8 0.0 0.4 0.3 0.3 5.6 0.4 9.3 1.1 0.6 0.5 1.3 0.0 10.8 1.7 1.1 2.8 0.8 0.6 0.6 2.2 1.9 2.8 2.0 1.5 0.3 2.0 0.6 2.5 0.7 0.5 1.1 0.8 3.2 3.3 2.0 2.2 0.6 4.4 3.2 1.3 2.6 8.1 0.2 7.3 0.1 1.7 0.0 2.1 3.7 0.5 0.6 0.9 1.0 1.5 1.0 0.2 0.8 0.1 0.2 3.1 0.3 0.3 1.1 7.5 5.7 20.3 11.7 6.1 3.0 4.8 4.7 6.5 5.1 6.0 8.0 2.2 24.6 21.1 15.2 5.1 0.0 1.4 12.5 1.8 2.0 0.3 1.7 3.1 7.6 4.3 2.1 23.3 2.4 2.8 11.6 16.0 1.1 2.8 6.1 23.8 3.5 13.5 5.1 18.7 8.1 10.5 5.0 0.0 1.1 15.6 2.3 0.0 3.9 2.2 3.5 6.5 9.0 8.6 8.3 7.5 0.7 17.0 0.8 7.3 HKR1 ZNF875 ENSG00000181666 "HKR1, GLI-Kruppel zinc finger family member" P10072 19 37312837-37369365 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA036126, HPA044855" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA036126: AB_10670708, HPA044855: AB_2679113" "unprognostic (1.04e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-1)" "unprognostic (3.58e-1)" "unprognostic (2.78e-1)" "unprognostic (4.81e-2)" "unprognostic (2.29e-1)" "unprognostic (1.02e-3)" "unprognostic (4.92e-3)" "unprognostic (9.82e-2)" "prognostic favorable (4.41e-4)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.34e-1)" "unprognostic (5.04e-2)" "unprognostic (2.00e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" 13.0 25.8 14.6 13.2 22.4 12.6 24.9 29.8 27.2 20.5 14.5 22.9 21.5 7.7 24.8 24.1 12.4 22.9 17.9 26.9 14.6 15.6 19.3 12.3 12.9 14.3 14.9 17.4 22.6 14.2 31.0 35.5 17.2 21.2 27.5 13.8 49.4 18.7 19.3 18.1 27.1 13.4 17.0 13.3 20.2 14.2 22.6 15.5 16.4 30.9 13.7 20.1 15.0 15.6 12.4 7.9 10.0 5.1 9.9 14.8 5.7 4.1 10.4 13.5 17.9 9.9 8.6 9.4 7.0 10.7 13.1 14.2 5.2 4.9 14.6 17.1 7.4 5.9 3.5 8.8 9.4 13.6 7.6 15.0 5.1 12.6 5.6 13.0 4.7 12.5 12.7 11.6 8.8 19.4 13.4 7.9 10.5 0.9 0.9 9.4 8.4 10.5 9.3 27.1 7.2 6.0 7.1 5.9 5.6 11.4 16.8 16.8 22.8 7.0 9.0 8.8 20.6 12.8 9.0 7.1 10.4 7.5 7.8 10.9 18.8 19.7 15.1 1.1 5.8 11.6 10.0 4.2 6.6 8.0 5.1 14.8 10.7 10.6 11.4 6.3 12.4 14.4 12.0 4.0 9.9 3.6 7.9 12.2 5.7 14.6 22.4 29.8 27.2 14.6 15.6 14.9 17.4 21.2 15.5 6.0 2.9 7.8 6.4 4.6 45.3 16.5 2.5 18.7 11.4 10.4 102.1 9.3 16.6 7.7 9.5 11.1 2.9 0.0 6.8 4.6 6.1 9.7 11.5 5.9 6.1 39.7 9.2 9.2 3.7 5.9 11.2 5.5 8.5 9.0 5.0 22.8 5.1 3.5 12.0 10.9 129.7 6.5 7.6 15.5 16.3 5.4 8.2 8.5 5.4 7.3 HLF MGC33822 ENSG00000108924 "HLF, PAR bZIP transcription factor" Q16534 17 55265012-55325065 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 78.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 2.4;T-reg: 2.1" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 6 "Hep G2: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 9.5 15.2 13.3 2.0 26.2 1.0 10.8 15.2 38.0 10.5 10.6 6.4 2.4 1.7 10.3 8.5 18.1 9.3 6.1 15.9 12.6 6.9 9.2 78.8 9.5 2.1 6.6 24.5 34.6 2.7 2.8 8.0 1.5 12.3 9.9 3.1 23.7 15.9 9.5 5.3 11.6 3.0 14.3 5.5 5.7 4.7 3.4 6.3 0.0 23.4 7.1 5.6 9.2 5.2 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.0 60.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 5.0 0.0 4.2 0.2 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 1.9 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 13.3 26.2 15.2 38.0 12.6 6.9 6.6 24.5 12.3 6.3 3.0 36.8 0.0 4.7 19.8 122.6 31.9 15.3 1.4 11.4 7.0 9.8 0.1 10.0 1.5 0.9 8.6 0.0 0.0 0.8 0.0 6.0 1.2 0.0 152.5 0.1 87.4 2.9 4.9 4.1 2.7 26.2 1.0 10.1 0.0 0.1 54.5 0.3 0.0 36.7 18.9 13.0 12.9 6.2 0.3 2.7 24.1 1.0 2.2 0.0 0.5 HMCN2 "DKFZp434P0216, FLJ23816" ENSG00000148357 "Hemicentin 2" Q8NDA2 9 130265882-130434123 "Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 15.6;Enterocytes: 21.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.2;RH-30: 19.2;SCLC-21H: 2.8;SH-SY5Y: 4.5;U-138 MG: 3.2;U-87 MG: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053903, HPA070647" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 7700000 Vesicles "HPA053903: AB_2682301, HPA070647: AB_2686290" "unprognostic (1.61e-1)" "unprognostic (8.05e-3)" "unprognostic (1.69e-1)" "unprognostic (5.53e-4)" "unprognostic (1.05e-1)" "unprognostic (1.12e-2)" "unprognostic (1.10e-1)" "unprognostic (8.78e-3)" "unprognostic (3.23e-1)" "unprognostic (3.97e-4)" "unprognostic (3.36e-2)" "unprognostic (3.93e-1)" "unprognostic (1.04e-3)" "unprognostic (1.53e-2)" "unprognostic (3.62e-2)" "unprognostic (8.96e-3)" "unprognostic (8.63e-2)" 7.4 1.7 0.2 10.2 0.2 0.1 3.8 0.1 0.4 18.3 25.0 0.0 1.0 5.9 21.9 25.1 4.9 5.1 5.0 8.7 0.4 0.4 1.4 0.4 2.7 2.3 0.0 0.0 8.9 0.8 0.2 0.1 0.3 0.8 5.1 2.3 0.1 1.7 3.4 24.3 2.8 11.2 20.8 0.5 0.3 2.3 6.3 0.0 1.8 2.6 10.9 1.5 12.1 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.2 0.5 0.0 19.2 0.1 0.0 0.1 2.8 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.4 0.4 0.0 0.0 0.8 0.0 3.0 6.9 0.5 0.2 0.8 0.5 3.6 0.0 6.7 6.8 0.0 0.0 0.0 1.7 0.0 15.6 1.3 21.5 0.0 0.0 0.1 2.4 0.7 7.0 1.1 0.3 1.6 0.0 0.6 0.3 8.0 0.0 0.9 1.7 0.0 1.9 0.0 0.1 7.0 0.0 1.1 0.6 0.0 3.8 0.2 0.7 0.5 0.2 0.0 2.9 3.3 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 151.8" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli NA NA Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 12.0 14.2 8.2 14.5 14.4 15.3 16.1 14.5 17.4 11.3 10.3 15.0 15.4 8.3 13.9 20.0 9.3 13.5 12.1 9.4 8.6 8.3 11.6 11.7 14.7 10.3 10.1 11.0 15.0 13.8 151.8 15.3 11.8 12.9 17.6 10.8 16.8 12.4 18.4 12.5 13.1 9.9 12.8 8.9 14.4 12.0 17.7 7.3 15.3 14.7 10.1 12.0 11.2 10.1 5.8 6.2 5.1 5.9 2.2 8.1 3.7 11.5 13.5 9.6 15.0 13.8 11.7 16.7 11.1 20.6 16.8 21.2 18.9 14.1 11.0 13.1 15.2 35.9 8.5 18.1 19.1 14.6 10.2 13.0 9.6 14.2 9.2 19.2 18.4 21.9 15.2 14.4 24.5 19.4 21.4 11.9 8.9 12.6 11.6 17.6 9.1 11.4 9.6 7.2 7.7 20.3 10.0 13.3 10.6 10.0 14.4 12.4 12.4 9.7 23.9 24.7 8.7 11.1 12.0 10.2 25.1 10.7 12.1 20.5 13.6 12.9 15.7 29.3 14.1 12.9 5.1 4.7 4.0 7.0 5.9 5.5 5.8 5.7 4.9 6.2 5.0 4.4 4.6 0.5 2.2 3.9 4.6 8.1 3.7 8.2 14.4 14.5 17.4 8.6 8.3 10.1 11.0 12.9 7.3 8.9 13.8 19.3 22.2 10.1 30.5 6.7 17.8 30.8 21.6 8.7 33.4 13.0 18.3 19.2 5.0 17.9 6.9 0.0 19.0 10.2 11.0 28.3 17.4 11.3 23.8 68.3 14.9 16.0 9.4 1.6 12.4 12.5 3.3 27.1 10.4 22.7 26.2 8.6 11.7 8.5 42.8 12.9 8.5 22.9 20.4 10.7 12.9 12.5 14.0 24.4 HMSD "ACC-6, ACC6, C18orf53" ENSG00000221887 "Histocompatibility minor serpin domain containing" "A8MTL9, P0C7T4" 18 63949301-63981774 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 26.1" "Cell type enriched" "Detected in some" 5 "monocytes: 49.5" "Cancer enhanced" "Detected in single" "cervical cancer: 1.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 5.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.7;GAMG: 8.7;HDLM-2: 18.0;Karpas-707: 7.1" "Secreted to blood" NA NA "unprognostic (5.83e-3)" "unprognostic (1.40e-1)" "unprognostic (1.40e-2)" "unprognostic (5.42e-3)" "unprognostic (6.20e-2)" "unprognostic (1.16e-2)" "unprognostic (4.91e-2)" "unprognostic (3.80e-1)" "unprognostic (1.41e-2)" "unprognostic (5.19e-3)" "unprognostic (8.67e-2)" "unprognostic (1.44e-1)" "unprognostic (7.14e-6)" "unprognostic (1.22e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-3)" "unprognostic (3.55e-1)" 1.7 1.9 3.9 3.4 8.4 0.5 1.5 0.6 4.8 0.4 0.8 11.3 0.0 0.7 0.3 0.2 1.3 0.8 0.4 1.0 5.8 4.2 0.3 1.9 3.0 5.9 15.1 1.0 1.2 0.9 0.2 0.3 0.3 12.1 0.3 2.1 0.0 0.6 0.5 0.5 2.9 1.0 0.4 26.1 2.1 1.5 2.1 11.2 1.4 0.8 0.2 4.9 0.5 1.3 0.2 5.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 3.3 7.7 0.0 0.6 2.1 0.3 4.0 0.0 0.8 0.0 0.0 0.9 8.7 3.3 1.3 0.2 2.6 18.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 2.8 0.1 1.0 0.0 0.0 0.0 7.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.0 3.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 3.9 8.4 0.6 3.7 5.8 4.2 15.1 1.0 12.1 11.2 3.0 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 49.5 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 9.4 0.1 0.1 0.0 0.5 0.0 HMX1 "H6, NKX5-3" ENSG00000215612 "H6 family homeobox 1" Q9NP08 4 8846076-8871817 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cataract, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;retina: 17.4" "Group enriched" "Detected in some" 16 "Horizontal cells: 252.6;Muller glia cells: 197.6" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 12.1;EFO-21: 7.1;HEK 293: 13.1;SH-SY5Y: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.11e-2)" "unprognostic (1.63e-2)" "unprognostic (2.97e-1)" "unprognostic (6.35e-2)" "unprognostic (7.94e-2)" "unprognostic (9.36e-2)" "unprognostic (1.97e-1)" 0.5 1.0 3.9 0.4 3.6 0.3 0.3 0.8 5.0 0.3 0.3 1.1 0.0 0.8 0.3 0.3 0.3 0.3 0.3 0.3 3.1 3.5 0.3 0.3 0.3 0.3 3.6 0.1 0.3 0.3 0.3 0.4 0.3 2.7 0.3 0.4 17.4 0.5 0.3 0.5 0.6 0.3 0.3 1.8 0.3 0.4 3.5 1.6 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.6 0.8 2.8 3.1 3.5 3.6 0.1 2.7 1.6 0.0 0.0 0.0 0.0 0.0 14.5 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 252.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.6 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148122-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 5.1;kidney: 5.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Group enriched" "Detected in some" 41 "hypothalamus: 5.1;pons and medulla: 3.0" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in some" 13 "REH: 29.0" "Region enhanced" "Detected in single" "hypothalamus: 0.6" "Group enriched" "Detected in some" 4 "basal ganglia: 1.1;hypothalamus: 4.0" "CAB013268, CAB022752" Approved NA NA "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 HNRNPA1L2 LOC144983 ENSG00000139675 "Heterogeneous nuclear ribonucleoprotein A1-like 2" Q32P51 13 52640786-52643796 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 86.8;Suprabasal keratinocytes: 76.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "prognostic favorable (2.58e-4)" "unprognostic (1.37e-1)" "unprognostic (8.39e-2)" "unprognostic (2.05e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (2.30e-1)" "unprognostic (1.66e-2)" "unprognostic (3.68e-2)" "unprognostic (5.48e-2)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.88e-2)" "unprognostic (2.89e-1)" "unprognostic (7.38e-2)" "unprognostic (9.49e-3)" "unprognostic (1.92e-2)" 1.8 1.7 2.3 2.2 3.4 7.8 2.9 3.9 2.9 2.8 1.9 0.9 3.1 3.6 1.2 2.7 0.9 1.7 2.2 2.6 1.9 1.1 2.0 3.6 2.6 5.0 1.7 1.4 2.7 1.4 2.5 2.2 1.7 2.5 1.7 2.4 1.6 1.8 2.5 3.2 1.2 2.0 2.7 3.3 2.5 1.8 4.8 6.1 4.4 1.2 5.3 4.9 4.3 3.8 2.9 7.1 9.1 3.4 3.9 3.7 5.4 4.4 3.0 2.5 4.2 4.9 7.6 1.6 3.0 2.4 6.7 5.5 6.0 5.3 7.5 4.5 7.6 8.0 6.0 5.6 12.8 2.0 4.9 5.2 3.5 7.8 6.7 6.8 7.2 4.1 3.7 3.5 4.8 9.3 14.2 5.9 1.6 3.7 7.8 5.0 4.3 4.8 6.7 3.6 6.4 2.5 3.5 4.7 5.0 3.5 8.0 4.7 4.2 4.3 4.0 5.2 4.5 4.2 8.6 2.0 6.4 3.9 1.4 1.2 4.4 4.4 1.0 4.9 4.6 4.0 4.5 2.0 4.8 4.9 3.7 0.1 5.3 0.9 6.1 3.2 4.3 3.0 2.2 22.5 4.7 86.8 2.8 11.8 15.3 2.7 6.8 0.0 2.0 45.0 0.0 4.3 12.9 12.3 5.2 0.0 5.9 62.3 30.3 2.1 10.3 2.4 19.1 1.6 27.7 15.4 16.7 3.0 37.4 6.3 32.1 6.4 20.8 2.8 5.1 21.0 22.3 1.4 2.5 6.5 9.9 12.1 20.3 76.9 40.7 30.5 39.7 2.0 HNRNPCL3 ENSG00000277058 "Heterogeneous nuclear ribonucleoprotein C-like 3" B7ZW38 1 13060869-13062229 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.30e-2)" "unprognostic (3.33e-2)" "unprognostic (2.90e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 709.1" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 6.8 0.0 11.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 54.2 0.1 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 22.1 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 32.3 0.1 709.1 118.4 8.2 1.8 0.0 0.0 0.0 HOXA11 "HOX1, HOX1I" ENSG00000005073 "Homeobox A11" P31270 7 27181510-27185223 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3" "Cell type enhanced" "Detected in some" 10 "Distal tubular cells: 5.0;Fibroblasts: 4.3;Intestinal endocrine cells: 5.1;Smooth muscle cells: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 14.7;BJ hTERT+: 17.8;HEK 293: 25.0;THP-1: 17.9;U-937: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006770, HPA035623" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006770: AB_2667672, HPA035623: AB_10601576" "unprognostic (5.95e-2)" "unprognostic (9.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.70e-2)" "unprognostic (6.29e-2)" "unprognostic (9.78e-2)" "unprognostic (2.82e-3)" "unprognostic (4.36e-2)" "unprognostic (1.61e-2)" "unprognostic (3.05e-2)" "unprognostic (2.08e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (2.17e-2)" "unprognostic (6.90e-2)" "unprognostic (2.03e-2)" "unprognostic (2.56e-1)" 1.5 0.4 0.0 1.7 0.0 0.0 2.0 0.0 0.0 35.7 9.3 0.0 5.7 0.0 60.9 8.8 0.0 0.7 0.0 0.2 0.0 0.0 3.6 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 9.0 0.0 16.5 2.4 0.0 0.1 6.3 4.9 0.7 0.2 27.3 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 20.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.1 0.0 6.8 8.4 5.9 0.0 14.7 17.8 10.5 7.5 0.1 0.8 0.0 3.4 12.5 0.0 1.6 8.7 0.0 7.7 0.8 25.0 3.1 6.1 0.3 0.5 6.2 0.9 3.7 0.3 0.0 0.0 0.0 7.6 0.6 0.2 0.0 1.1 0.1 0.0 4.8 0.0 2.1 7.4 0.4 0.0 0.1 5.0 4.3 3.2 0.0 3.6 0.0 1.0 2.1 0.6 17.9 0.0 0.1 7.2 1.6 0.7 0.0 0.0 0.0 0.1 23.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.3 2.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.7 HOXA4 "HOX1, HOX1D" ENSG00000197576 "Homeobox A4" Q00056 7 27128507-27130799 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Distal tubular cells: 13.3;Ito cells: 12.3;Proximal tubular cells: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 18 "pons and medulla: 26.7" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 19.1;HEK 293: 14.5;REH: 13.4;WM-115: 19.0" "Region enriched" "Detected in single" 47 "pons and medulla: 11.9" "Region enriched" "Detected in single" 60 "pons and medulla: 24.6" HPA060088 Approved Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA060088: AB_2684200" "unprognostic (3.37e-2)" "unprognostic (6.27e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.32e-1)" "unprognostic (4.22e-1)" "unprognostic (1.31e-1)" "unprognostic (7.39e-2)" "unprognostic (4.23e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (3.38e-1)" "unprognostic (3.59e-4)" "unprognostic (3.93e-2)" 8.9 6.2 0.4 2.2 0.3 0.2 11.6 0.3 1.2 2.7 7.5 0.4 8.2 3.5 3.9 10.3 27.5 18.1 5.7 4.8 0.3 0.0 9.6 2.0 10.5 3.0 1.4 0.3 8.8 1.1 17.6 0.3 0.5 26.7 4.1 1.7 0.3 0.7 5.6 29.8 3.5 5.2 4.9 25.8 5.5 9.3 1.6 0.4 0.3 2.3 3.4 1.2 5.5 10.9 0.9 1.4 0.1 0.5 0.1 0.3 0.2 6.0 2.0 0.0 19.1 0.0 0.0 1.2 0.5 0.6 2.0 2.0 3.8 1.2 1.6 0.1 1.8 1.8 2.6 0.7 0.3 1.6 0.0 14.5 0.0 0.6 8.7 2.2 2.0 3.6 2.1 1.6 6.8 0.5 0.0 6.7 0.5 0.0 0.0 6.5 1.6 0.0 7.1 0.0 2.1 4.7 13.4 2.9 0.1 9.6 1.4 0.9 0.0 1.9 0.0 7.0 0.7 0.4 1.0 8.8 0.0 3.1 5.0 0.1 0.0 0.0 0.7 4.1 3.3 19.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.1 0.5 1.4 0.0 0.2 0.4 0.3 0.3 1.2 0.3 0.0 1.4 0.3 26.7 0.4 0.0 0.0 0.0 2.9 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.4 1.9 0.7 0.0 0.0 0.5 0.3 0.6 0.0 0.0 0.2 0.0 2.9 12.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 10.1 0.0 0.0 2.1 0.2 2.7 1.1 0.1 0.0 2.0 2.4 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 10.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 5.9;NK-cell: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 5.9;NK-cells: 2.0" "Group enriched" "Detected in some" 9 "AN3-CA: 29.3;HEK 293: 39.9" "Region enriched" "Detected in single" 34 "pons and medulla: 3.5" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.2 2.9 0.0 1.2 0.0 0.0 2.3 0.0 0.0 1.6 5.4 0.0 6.7 4.6 0.1 10.4 0.0 0.0 0.0 0.0 5.9 0.0 2.3 0.8 0.0 0.0 0.0 0.5 0.0 0.0 2.5 1.5 0.0 2.2 1.0 3.2 4.2 1.4 1.0 0.0 1.2 0.0 0.0 0.0 4.3 1.3 0.1 0.5 5.9 0.1 2.0 0.2 0.0 0.5 0.9 0.0 29.3 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.7 3.4 0.7 1.1 0.2 0.1 1.3 0.7 0.0 0.0 0.8 39.9 0.4 0.5 0.4 0.0 0.6 1.0 2.4 0.0 0.0 0.3 0.0 1.3 0.9 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 1.0 3.8 0.0 0.0 2.8 1.8 3.1 0.0 1.3 0.1 0.6 0.0 0.3 0.3 0.0 0.0 0.4 1.6 1.0 0.0 0.0 0.6 0.0 2.8 2.9 5.9 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 4.8 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 4.4 1.0 HOXB3 "HOX2, HOX2G" ENSG00000120093 "Homeobox B3" P14651 17 48548870-48604912 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4" "Group enriched" "Detected in many" 5 "Collecting duct cells: 94.2;Early spermatids: 27.9;Ito cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.7;EFO-21: 18.1;HEK 293: 21.9;RPTEC TERT1: 17.0;U-251 MG: 19.5" "Region enriched" "Detected in single" 40 "pons and medulla: 9.3" "Region enriched" "Detected in single" 29 "pons and medulla: 12.9" "CAB009860, HPA064990" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009860: AB_2119262, HPA064990: AB_2685398" "unprognostic (5.88e-2)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (7.04e-2)" "unprognostic (8.39e-3)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (3.09e-2)" "unprognostic (4.32e-3)" "unprognostic (8.14e-2)" "unprognostic (8.27e-2)" "unprognostic (3.17e-1)" "unprognostic (7.60e-2)" "unprognostic (7.85e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.45e-6)" 8.3 4.5 1.0 7.3 1.1 0.2 8.0 1.0 1.0 11.3 16.4 1.0 56.7 2.3 10.1 44.9 5.5 17.7 3.6 1.7 1.0 0.0 16.3 1.6 4.8 1.6 1.0 1.0 2.8 1.7 6.7 1.0 3.8 2.6 4.1 4.9 1.0 1.0 68.4 4.0 2.9 11.3 3.5 4.8 6.5 7.8 3.7 1.0 1.0 1.8 1.0 1.1 6.4 5.2 0.1 2.8 1.7 0.9 1.4 1.1 0.4 3.3 7.0 4.7 2.2 3.9 5.5 1.2 0.1 0.0 0.1 0.1 3.2 20.7 1.7 18.1 14.8 2.3 0.1 1.0 0.3 0.0 5.3 21.9 5.1 3.1 0.0 6.4 0.0 13.6 6.4 0.0 6.1 0.4 2.8 6.4 6.7 6.9 0.1 3.8 0.1 0.3 0.1 0.1 6.7 0.7 0.0 3.4 0.7 17.0 3.1 0.0 0.0 0.7 0.0 3.3 3.8 6.6 1.4 7.2 2.2 7.1 1.2 19.5 1.8 2.1 0.1 4.6 0.0 3.8 1.7 0.1 0.0 0.9 0.1 0.4 0.0 0.5 1.1 0.3 0.1 0.8 1.0 0.0 1.4 0.9 2.8 1.1 0.4 1.0 1.1 1.0 1.0 1.0 0.0 1.0 1.0 2.6 1.0 0.0 3.4 0.0 2.3 2.3 0.0 0.8 0.0 0.0 1.2 94.2 0.0 2.5 6.6 0.2 27.9 7.7 7.4 0.0 0.0 0.7 5.1 3.6 8.1 0.2 0.6 0.0 2.4 27.6 2.1 7.9 0.3 1.0 5.0 0.0 6.3 0.0 0.4 3.5 0.4 0.6 0.0 0.0 3.3 4.5 9.2 1.3 0.3 1.3 9.7 4.7 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48614939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6" "Group enriched" "Detected in some" 7 "Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enriched" "Detected in single" 82 "pons and medulla: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0" "Region enriched" "Detected in single" 48 "pons and medulla: 6.8" "Low region specificity" "Detected in many" HPA075905 Supported Nucleoplasm NA NA Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.5 4.3 0.0 1.6 0.0 0.0 2.5 0.0 0.0 7.7 2.1 0.0 45.4 0.0 2.1 39.2 0.0 0.9 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.2 8.2 1.9 0.8 0.0 0.1 34.6 0.2 0.4 4.0 1.1 49.3 0.0 4.3 2.8 0.0 0.1 0.1 0.0 0.0 5.0 6.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 3.3 0.0 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 20.9 3.3 0.4 0.0 0.0 0.0 0.0 9.4 21.6 0.5 0.0 0.0 0.2 0.0 3.1 0.6 0.0 0.0 0.0 0.4 1.4 0.1 6.2 0.0 11.0 0.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 0.0 23.0 0.6 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 5.2 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 83.7 0.0 0.0 61.3 0.0 0.1 0.5 1.3 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.2 0.0 42.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.3 0.5 9.6 0.0 0.0 0.0 4.1 0.0 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 31.2" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 17 "pons and medulla: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8" "Region enriched" "Detected in single" 23 "pons and medulla: 1.5" "Not detected" "Not detected" HPA054981 Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 10.9 11.2 0.4 1.2 0.4 0.0 16.3 0.4 0.4 0.7 1.9 0.6 0.4 0.0 3.9 14.8 3.1 13.5 0.4 2.0 0.4 0.0 11.3 0.4 0.9 3.0 0.4 0.4 31.2 0.4 0.0 0.4 4.0 7.0 0.8 0.0 0.4 0.4 0.4 11.0 7.6 8.8 6.1 8.1 1.0 0.3 3.3 0.4 0.4 0.6 0.8 0.4 0.7 2.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.5 1.8 0.0 38.1 13.9 13.3 0.4 1.9 1.9 3.1 2.9 1.6 2.9 1.1 2.5 19.0 0.9 4.3 1.5 0.2 2.8 31.8 11.0 2.0 4.9 0.0 1.5 0.2 4.8 12.6 2.0 6.2 2.2 0.0 0.1 0.1 1.3 0.0 11.0 0.6 0.0 1.2 0.0 0.3 1.6 0.0 1.4 0.0 9.6 0.1 0.0 4.7 2.9 2.8 7.8 3.4 6.7 0.5 0.0 4.0 8.6 4.3 2.7 0.3 0.3 0.0 1.4 0.3 8.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 7.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.3 14.9 0.0 1.1 0.2 0.0 0.0 0.0 2.5 27.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 20.8 0.4 11.8 0.0 0.0 0.2 0.0 0.0 14.2 7.8 1.9 6.5 5.0 39.3 1.1 3.4 0.2 0.0 0.0 0.0 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188579-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.4 0.6 1.5 1.1 3.5 0.3 2.0 0.6 3.9 0.5 5.2 18.8 11.8 0.7 0.8 14.1 0.9 8.8 1.4 0.3 4.1 2.2 6.8 0.2 5.7 0.9 9.8 1.3 1.2 0.5 0.2 0.2 0.3 15.5 1.7 3.7 0.3 1.0 20.4 0.3 1.2 4.4 0.9 18.9 1.5 0.7 2.2 6.3 0.0 0.4 0.0 0.5 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 5.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 18.8 14.4 5.0 0.9 0.0 0.0 0.9 0.8 0.0 0.0 3.3 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.5 0.6 3.2 4.1 2.2 9.8 1.3 15.5 6.3 3.0 21.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 4.5 7.0 0.0 0.0 21.6 0.0 0.0 2.9 18.8 0.0 0.0 0.0 0.1 0.5 2.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 16.6 0.0 0.1 11.5 0.4 2.9 0.0 0.0 0.1 2.6 6.4 2.3 0.0 0.0 20.6 1.8 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151222-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.0;seminal vesicle: 26.2" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Region enriched" "Detected in some" 7 "pons and medulla: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1" "Region enriched" "Detected in single" 28 "pons and medulla: 8.2" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA054383: AB_2682470, HPA070349: AB_2686258" "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 3.4 4.9 0.5 0.5 0.5 0.0 4.0 0.5 0.7 2.8 3.4 0.5 13.8 0.2 15.6 21.0 0.5 7.9 0.5 0.5 0.5 0.0 10.2 0.5 0.5 0.6 1.1 0.5 9.7 0.5 0.0 0.5 0.5 7.6 1.5 0.8 0.5 0.5 26.2 1.3 1.0 3.5 5.3 3.7 4.4 0.4 1.5 0.5 0.5 0.8 0.5 0.5 2.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 1.8 0.0 0.1 0.4 0.0 0.6 0.5 0.0 0.0 9.3 1.6 0.4 0.1 1.5 0.0 0.2 0.0 22.1 0.2 0.0 0.0 0.3 0.0 0.0 5.0 1.5 0.0 0.2 0.1 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 16.4 2.6 1.3 2.2 0.3 0.0 6.1 0.4 0.0 0.0 2.8 0.2 0.1 1.4 1.2 0.0 0.0 0.0 1.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.0 1.1 0.5 7.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 3.7 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 4.4 0.0 1.7 0.0 0.6 0.0 0.1 0.0 2.8 5.3 0.0 6.5 0.5 0.2 0.2 0.5 0.0 0.0 1.2 0.0 HOXD8 "HOX4, HOX4E" ENSG00000175879 "Homeobox D8" P13378 2 176129694-176132695 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 37.6;epididymis: 42.6" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 57.6;Distal tubular cells: 180.8;Early spermatids: 75.5;Peritubular cells: 50.5;Spermatocytes: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 21.6;RPTEC TERT1: 35.3;TIME: 15.4" "Region enriched" "Detected in single" 15 "pons and medulla: 0.6" "Not detected" "Not detected" NA NA "unprognostic (1.22e-1)" "unprognostic (6.31e-2)" "unprognostic (2.19e-3)" "unprognostic (2.68e-2)" "unprognostic (3.35e-1)" "unprognostic (3.49e-1)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.78e-4)" "unprognostic (2.79e-1)" "unprognostic (1.40e-2)" "unprognostic (3.93e-1)" "unprognostic (3.05e-1)" "unprognostic (3.63e-2)" "unprognostic (4.80e-2)" "unprognostic (5.21e-2)" "unprognostic (8.31e-2)" "unprognostic (2.80e-2)" 11.1 9.1 0.3 2.4 0.3 0.0 9.8 0.2 0.4 10.3 5.9 0.4 37.6 0.3 12.6 42.6 2.0 7.7 2.5 2.6 0.3 0.0 32.8 0.2 0.7 1.9 0.2 0.2 16.9 1.7 0.2 0.2 1.4 1.2 5.6 1.8 0.3 0.8 27.5 6.9 2.4 4.2 5.3 11.5 9.1 0.8 21.0 0.2 0.3 2.9 2.3 0.9 5.3 10.8 0.2 0.0 0.0 0.0 0.0 0.2 0.0 6.4 1.0 0.0 0.0 4.3 6.8 0.1 0.8 3.4 1.0 0.1 0.0 0.0 0.0 8.3 4.9 0.8 0.0 2.2 0.2 2.6 0.0 3.2 1.0 0.3 0.0 1.4 0.6 0.4 11.9 21.6 0.1 3.3 0.0 10.7 2.0 0.1 0.0 1.7 0.0 0.0 0.1 0.1 0.0 1.2 0.0 2.3 0.0 35.3 4.4 6.9 13.0 2.0 0.0 12.8 0.6 0.0 0.0 15.4 0.6 4.4 7.3 4.3 0.0 0.0 0.0 10.3 0.0 12.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.3 0.0 0.2 0.2 1.2 0.2 0.0 0.6 0.0 2.2 2.4 0.0 2.0 0.0 1.4 0.0 57.6 0.0 0.0 180.8 0.0 75.5 29.8 0.9 0.0 0.0 0.0 9.7 1.5 0.0 0.0 0.1 0.0 4.6 0.6 0.0 19.6 47.5 0.0 10.1 0.0 1.3 0.0 0.0 0.0 50.5 16.1 0.0 32.3 3.3 62.8 9.6 2.5 0.1 0.0 4.1 0.5 HPR ENSG00000261701 "Haptoglobin-related protein" P00739 16 72063224-72077246 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 151.4" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 430.8" "Cancer enriched" "Detected in some" 53 "liver cancer: 185.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "Hep G2: 33.6" HPA047750 Supported Approved Vesicles "Secreted to blood" NA NA 49000000000 77000000000 Vesicles "HPA047750: AB_2680146" "unprognostic (2.43e-1)" "unprognostic (4.69e-2)" "unprognostic (5.97e-3)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.66e-1)" "unprognostic (8.21e-2)" "unprognostic (2.30e-1)" "unprognostic (3.44e-6)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" 0.2 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 15.2 0.7 0.8 0.1 151.4 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 2.9 1.1 1.0 0.4 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.6 1.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 1.3 1.0 0.1 0.5 0.4 0.4 0.3 1.1 2.0 1.1 0.3 0.4 0.3 2.9 2.3 0.3 0.0 9.8 0.0 0.0 0.1 0.0 14.9 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 23.3 0.2 0.0 0.2 0.0 0.0 430.8 0.0 0.0 0.0 9.8 7.3 2.1 9.2 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.9 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HRH2 ENSG00000113749 "Histamine receptor H2" P25021 5 175658030-175710756 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 45.7;bone marrow: 30.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 21.0;Kupffer cells: 24.0;Macrophages: 14.4;Smooth muscle cells: 45.1" "Cancer enhanced" "Detected in many" "renal cancer: 4.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 45.7" "Group enriched" "Detected in many" 5 "granulocytes: 45.7;monocytes: 13.1" "Group enriched" "Detected in some" 4 "RPMI-8226: 36.2;SK-MEL-30: 10.8;THP-1: 10.0;U-937: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013770 Approved NA NA "HPA013770: AB_1851086" "unprognostic (8.56e-3)" "unprognostic (1.62e-1)" "unprognostic (6.66e-2)" "unprognostic (5.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (9.93e-2)" "unprognostic (5.76e-2)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (3.71e-3)" "unprognostic (2.01e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-3)" "unprognostic (1.77e-2)" 7.9 1.5 5.9 11.1 11.6 30.1 2.8 1.0 12.1 3.9 2.8 0.9 0.5 5.9 2.3 1.3 1.6 2.7 2.6 18.6 3.4 1.7 2.4 1.2 5.4 12.3 2.3 4.9 1.6 1.6 0.3 1.3 9.5 2.4 3.0 1.3 0.6 1.7 4.8 1.2 2.1 7.2 3.5 4.4 9.9 10.3 1.2 5.6 9.9 1.8 0.2 3.0 2.8 2.0 0.0 6.4 45.7 13.1 0.6 2.3 3.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.8 1.7 0.0 0.0 3.9 0.0 36.2 0.0 0.2 0.2 0.0 0.0 0.0 10.8 1.0 0.0 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 2.4 28.9 12.9 13.6 0.0 12.0 0.1 0.0 1.1 0.2 6.4 0.0 2.3 1.4 45.7 0.6 13.1 5.0 0.8 3.7 5.9 11.6 1.0 12.1 3.4 1.7 2.3 4.9 2.4 5.6 0.0 4.5 0.5 0.1 0.7 4.5 21.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 2.2 0.1 5.2 0.1 2.3 0.0 10.1 1.6 0.0 0.0 24.0 0.7 0.0 14.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 45.1 0.2 1.1 0.3 0.0 2.5 0.0 0.0 HS3ST4 3OST4 ENSG00000182601 "Heparan sulfate-glucosamine 3-sulfotransferase 4" Q9Y661 16 25692026-26137688 "Enzymes, Predicted membrane proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.9" "Cell type enriched" "Detected in single" 8 "Bipolar cells: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 5.5;SCLC-21H: 2.3;SuSa: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.09e-2)" "unprognostic (1.87e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.43e-3)" "unprognostic (1.27e-1)" "unprognostic (3.84e-1)" "unprognostic (8.81e-3)" "unprognostic (6.71e-2)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (3.67e-2)" 0.7 0.8 6.9 0.6 9.3 0.6 5.1 6.8 23.9 1.1 0.6 2.6 0.0 0.6 0.7 1.3 0.9 0.7 0.6 0.6 11.5 10.0 0.7 0.6 0.6 0.6 5.9 10.8 0.7 0.6 0.6 0.1 0.6 14.3 2.0 0.6 0.3 0.8 0.6 0.6 0.7 0.6 0.6 2.2 3.7 1.1 1.3 1.5 0.0 0.6 0.0 0.8 1.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 9.3 6.8 13.4 11.5 10.0 5.9 10.8 14.3 1.5 0.0 0.0 0.0 0.4 0.0 5.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 19.6 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 HSD11B1L "SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 17.2" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" NA NA Vesicles "HPA049078: AB_2680622" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 8.8 34.4 2.1 19.2 4.7 5.0 10.3 29.7 3.9 2.9 5.4 3.7 2.6 3.6 8.5 2.2 7.6 4.8 3.8 25.4 16.1 6.7 3.5 4.4 2.3 11.7 20.4 6.1 6.2 5.8 8.5 2.5 10.7 4.0 1.9 3.2 9.1 6.9 15.0 6.9 2.9 2.7 6.0 2.6 3.3 4.3 7.5 0.0 6.6 1.3 1.8 2.5 2.2 2.5 4.8 2.5 5.8 1.4 4.5 1.7 2.9 2.8 10.4 1.9 4.9 5.3 2.1 2.2 4.5 1.0 4.5 1.3 2.9 0.7 4.9 1.9 0.8 1.5 1.2 1.6 1.0 2.4 3.1 1.9 2.5 1.8 3.4 0.7 7.1 5.2 3.5 1.6 1.5 9.6 1.6 4.4 1.9 2.8 4.2 0.4 1.8 2.0 2.8 12.5 3.3 3.3 0.4 2.5 8.7 0.7 2.8 17.2 0.5 1.5 11.0 3.8 2.4 0.6 2.8 2.6 4.6 4.4 1.8 6.9 2.3 0.8 7.2 1.1 2.0 1.7 2.5 0.2 1.2 5.8 1.6 1.2 3.2 3.6 2.3 2.5 4.5 3.9 2.5 1.4 2.9 4.8 0.9 1.7 34.4 19.2 10.3 29.7 25.4 16.1 11.7 20.4 10.7 7.5 0.0 1.6 0.8 7.6 7.2 11.2 2.0 5.1 13.4 4.5 22.7 13.7 4.0 13.3 8.9 6.8 3.8 3.8 0.0 4.1 3.9 8.9 8.0 10.3 3.2 4.2 7.9 24.6 8.0 2.8 9.6 6.6 3.6 5.0 2.8 4.3 17.0 4.8 2.8 12.0 23.7 11.7 0.0 9.9 10.3 10.6 8.9 2.4 3.3 3.5 7.5 HSF5 FLJ40311 ENSG00000176160 "Heat shock transcription factor 5" Q4G112 17 58420167-58488384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 65.6" "Group enriched" "Detected in some" 5 "Early spermatids: 28.4;Spermatocytes: 63.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.7;T-cells: 3.2" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA063613 Enhanced NA NA "HPA063613: AB_2685060" "unprognostic (2.13e-1)" "unprognostic (1.21e-4)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (7.48e-3)" "unprognostic (7.40e-2)" "unprognostic (8.85e-3)" "unprognostic (2.13e-3)" "unprognostic (2.58e-2)" "unprognostic (6.65e-4)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (8.75e-2)" "unprognostic (3.64e-2)" 0.1 0.0 0.0 2.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 65.6 0.0 3.3 0.0 0.1 2.4 0.0 0.0 3.7 0.1 0.0 0.0 0.5 3.2 0.8 0.0 0.0 0.1 0.4 0.0 0.6 0.2 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 3.1 1.7 1.5 0.1 3.7 3.2 2.2 0.0 0.5 0.0 0.1 2.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.4 0.0 0.0 63.6 3.1 0.0 0.0 0.0 0.0 0.0 HTR1F "5-HT1F, HTR1EL" ENSG00000179097 "5-hydroxytryptamine receptor 1F" P30939 3 87990696-87993835 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 5.7" "Group enriched" "Detected in some" 10 "Muller glia cells: 19.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Group enriched" "Detected in some" 6 "A549: 1.2;K-562: 4.5;LHCN-M2: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005555 Uncertain NA NA "HPA005555: AB_1856708" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.03e-2)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (4.78e-1)" "unprognostic (1.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (2.67e-6)" "unprognostic (1.25e-4)" "unprognostic (1.55e-2)" "unprognostic (3.33e-2)" "unprognostic (3.31e-2)" 2.8 0.5 0.7 0.0 0.6 1.5 1.6 0.0 1.8 1.4 0.0 0.0 1.2 0.3 0.1 0.4 0.1 0.3 0.6 0.4 0.6 0.0 0.9 0.1 0.8 0.4 0.7 0.3 1.4 5.7 0.4 0.0 0.1 1.0 0.6 0.4 0.0 1.3 0.3 1.7 0.0 0.3 1.5 0.5 0.6 0.7 0.1 0.2 3.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 19.5 0.1 0.0 0.0 0.0 1.0 19.4 11.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 HTR5A 5-HT5A ENSG00000157219 "5-hydroxytryptamine receptor 5A" P47898 7 155070324-155085749 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.4" "Group enriched" "Detected in some" 14 "Early spermatids: 6.5;Late spermatids: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB017467 Approved NA NA "CAB017467: AB_2122566" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.4 0.4 2.6 0.4 3.9 0.4 0.4 15.4 15.0 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 2.6 5.9 0.4 0.4 0.4 0.4 2.3 2.5 0.4 0.4 0.4 0.1 0.4 2.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.8 0.4 0.4 1.4 0.3 3.3 0.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 3.9 15.4 9.8 2.6 5.9 2.3 2.5 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HTRA4 FLJ90724 ENSG00000169495 "HtrA serine peptidase 4" P83105 8 38974164-38988662 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 55.2" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 319.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 23 "BEWO: 72.8" "Region enhanced" "Detected in some" "hippocampal formation: 2.3" "Low region specificity" "Detected in some" HPA045402 Enhanced "Secreted in female reproductive system" NA NA "HPA045402: AB_2679316" "unprognostic (1.20e-1)" "unprognostic (5.83e-4)" "unprognostic (8.02e-2)" "unprognostic (2.13e-2)" "unprognostic (8.20e-2)" "unprognostic (2.42e-2)" "unprognostic (1.80e-1)" "unprognostic (7.40e-3)" "unprognostic (1.40e-1)" "unprognostic (5.14e-4)" "unprognostic (1.01e-1)" "unprognostic (8.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.58e-1)" "unprognostic (5.19e-3)" "unprognostic (2.39e-3)" "unprognostic (1.19e-3)" 2.6 1.1 0.2 0.3 0.2 3.4 0.9 0.2 0.4 1.2 0.5 0.2 1.9 0.0 2.3 0.5 0.5 0.1 0.2 0.2 0.2 0.0 0.2 0.2 4.3 1.0 0.2 0.2 0.4 0.3 0.4 0.5 55.2 0.4 0.5 0.3 1.8 0.8 0.5 0.6 0.4 0.6 0.3 1.8 2.5 0.1 0.4 0.2 0.2 0.6 0.2 0.8 0.5 0.9 3.1 2.2 2.5 1.0 1.0 1.7 0.0 0.1 0.1 0.1 0.2 0.3 0.2 72.8 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 3.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 1.5 0.8 2.3 1.4 0.7 1.7 1.5 1.3 1.2 0.6 3.1 1.3 1.4 2.5 1.0 1.0 2.2 1.4 0.0 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.1 0.1 0.5 0.4 0.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 319.8 0.2 1.2 0.0 0.0 10.7 1.6 0.0 2.5 0.3 0.0 0.0 1.5 1.7 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 33.8 0.0 0.2 0.7 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 15.5;SiHa: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 12.6 11.3 6.0 6.4 9.0 3.3 31.3 2.1 15.3 29.6 8.2 3.5 14.9 5.0 17.4 10.8 13.0 11.0 14.3 14.9 6.4 5.0 14.8 15.0 9.4 8.1 5.5 3.9 35.0 5.4 3.2 8.0 9.8 7.9 15.2 3.7 6.1 8.1 30.1 8.4 8.0 5.3 10.5 11.8 5.7 11.1 6.2 4.1 1.2 9.4 4.9 3.8 20.7 25.5 0.0 0.3 2.1 1.1 0.4 0.8 0.2 5.2 15.5 4.4 8.4 3.3 5.2 13.4 7.9 0.7 1.2 1.2 0.8 8.7 0.1 3.2 1.8 3.6 11.5 0.2 0.9 0.2 0.7 1.1 0.0 3.3 1.4 2.5 0.1 0.1 5.7 1.2 0.9 0.1 7.0 0.5 0.1 0.4 2.8 0.2 13.5 0.1 0.6 0.4 1.3 8.2 0.7 0.3 2.2 4.7 0.7 2.0 2.6 21.8 7.1 8.9 1.9 2.2 1.4 3.2 7.6 4.5 5.1 11.2 1.5 1.0 0.1 9.6 1.5 3.3 0.0 1.1 0.0 0.3 0.6 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 2.1 0.4 0.2 0.1 0.0 0.2 6.0 9.0 2.1 9.0 6.4 5.0 5.5 3.9 7.9 4.1 14.9 1.7 2.9 5.9 6.1 6.0 1.4 20.4 2.7 4.5 45.4 0.0 3.5 8.3 10.6 0.7 11.1 16.9 0.0 22.8 5.4 12.9 12.2 0.0 9.7 25.2 3.2 10.3 29.4 15.4 1.1 10.0 9.2 13.5 3.6 14.6 14.0 18.0 9.3 6.7 14.3 2.7 25.8 20.8 0.0 1.7 4.0 6.8 1.0 8.4 6.7 IFFO1 "HOM-TES-103, IFFO" ENSG00000010295 "Intermediate filament family orphan 1" Q0D2I5 12 6538375-6556083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069344 Approved NA NA "HPA069344: AB_2686126" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (4.38e-2)" "unprognostic (3.33e-3)" "unprognostic (2.69e-2)" "unprognostic (1.43e-3)" "unprognostic (4.37e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (5.25e-2)" "prognostic favorable (6.53e-5)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.47e-7)" "unprognostic (5.71e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (5.58e-2)" 11.7 12.6 13.2 12.2 11.2 14.6 9.1 22.8 20.0 10.6 10.4 10.3 2.6 6.9 13.9 8.0 6.2 9.8 10.0 13.1 11.5 8.8 6.1 7.5 11.9 14.4 9.2 13.3 11.8 5.1 2.1 9.9 11.2 12.7 7.9 6.2 13.5 5.0 12.1 19.9 4.6 7.5 12.3 12.9 17.8 5.4 10.3 10.6 6.5 5.3 6.8 10.6 9.7 9.4 1.7 4.8 3.9 9.2 3.9 2.8 3.0 0.0 0.0 4.6 0.0 7.1 11.7 0.1 6.8 6.2 5.5 4.9 1.0 0.0 1.4 0.0 6.5 1.7 0.0 3.5 0.9 1.8 10.3 11.4 5.2 0.1 7.4 4.9 5.6 8.8 7.1 0.0 4.1 0.0 6.6 5.4 5.7 0.0 1.6 13.6 0.0 4.8 4.2 10.7 0.0 0.0 7.9 8.0 2.4 1.8 0.0 0.0 4.2 0.0 0.0 3.3 4.9 0.0 5.9 8.1 5.4 0.0 4.5 3.9 2.3 0.8 4.1 4.0 2.2 14.0 0.2 6.6 3.9 2.7 5.0 2.6 1.3 2.4 2.8 4.8 1.7 1.0 1.5 2.3 3.9 9.2 2.5 1.7 3.0 13.2 11.2 22.8 20.0 11.5 8.8 9.2 13.3 12.7 10.6 0.0 3.7 3.2 0.4 2.3 13.3 9.3 0.0 0.0 1.2 0.0 3.9 3.5 1.7 0.5 8.9 9.0 0.5 0.0 1.2 2.5 9.5 0.2 1.1 5.1 18.8 20.6 0.0 12.3 23.8 7.8 17.5 15.2 18.6 3.6 1.2 10.6 0.4 0.6 12.7 2.1 12.2 32.3 8.6 5.9 4.5 1.8 1.0 13.3 0.4 0.1 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: AB_2685296" "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.4 13.8 3.7 10.3 2.4 1.9 6.0 6.4 4.2 3.5 2.4 18.9 9.9 0.1 8.2 4.8 4.0 21.2 2.8 13.5 2.8 50.5 2.5 0.1 2.6 7.4 1.7 1.4 16.2 1.2 13.8 4.7 6.0 5.8 7.4 0.4 0.6 1.7 2.3 1.7 1.4 1.3 1.6 8.7 3.3 4.7 2.3 3.6 2.0 5.4 11.9 0.6 4.8 6.8 4.7 4.0 1.8 0.7 20.2 4.7 6.6 2.7 18.3 3.6 3.9 0.2 3.2 2.1 5.5 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 3.0 4.8 0.9 68.5 107.4 5.7 5.5 15.3 12.0 4.5 1.8 0.0 4.1 1.7 12.7 1.2 7.1 1.0 0.0 15.2 5.8 3.6 12.6 3.5 3.9 2.0 23.8 2.4 6.2 0.8 2.2 1.1 4.0 13.5 2.8 0.6 5.1 13.4 2.9 2.8 8.1 1.6 0.0 8.5 0.7 0.5 87.7 3.3 2.9 1.0 39.7 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 57.7" "Low region specificity" "Detected in all" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 11.4 39.9 38.6 18.3 23.8 17.0 18.8 15.2 24.7 19.9 16.0 23.5 8.7 11.6 15.8 9.6 24.5 21.9 20.8 38.9 29.7 32.4 13.2 3.7 16.5 21.5 37.1 22.8 25.9 13.2 11.7 20.6 5.4 27.4 10.6 9.7 20.4 7.2 12.5 4.0 16.0 13.5 15.5 35.7 17.0 15.7 9.1 22.9 13.8 8.5 16.0 22.5 12.0 17.2 31.5 29.6 19.8 38.7 6.0 30.5 31.9 8.4 5.9 1.7 12.1 8.7 22.4 1.1 15.9 16.4 12.0 14.1 1.6 3.9 3.7 17.4 17.1 10.6 10.5 1.3 21.1 4.9 25.3 0.9 5.8 5.9 0.5 14.8 6.8 16.0 20.3 7.8 7.1 4.4 20.5 7.9 14.6 0.5 57.7 12.4 15.9 3.9 4.1 2.1 5.6 6.8 0.1 5.6 4.9 18.2 3.3 3.1 4.7 0.4 0.1 10.2 3.3 19.6 11.4 7.7 8.0 4.9 10.7 4.4 23.6 19.5 1.3 25.6 15.2 5.2 19.8 38.7 7.1 25.6 25.9 16.4 31.5 24.4 28.1 29.6 27.4 17.6 23.0 5.7 6.0 18.8 24.6 30.5 31.9 38.6 23.8 15.2 22.8 29.7 32.4 37.1 22.8 27.4 22.9 35.7 60.1 82.7 48.1 82.4 19.9 126.7 48.4 18.7 11.4 169.3 19.6 1.8 150.9 127.6 5.8 62.7 86.6 0.0 26.4 2.5 85.0 7.4 88.9 2.6 167.2 22.3 95.7 122.2 166.9 22.7 169.5 141.7 224.4 80.2 146.1 108.3 55.0 123.8 108.5 51.2 76.6 122.9 100.0 4.5 24.8 58.5 2.4 89.6 75.5 44.4 IFI44 "MTAP44, p44, TLDC5" ENSG00000137965 "Interferon induced protein 44" Q8TCB0 1 78649796-78664078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 36.8;Ito cells: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 46.1;BJ hTERT+ SV40 Large T+ RasG12V: 57.0;GAMG: 46.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA027148, HPA043858" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027148: AB_1851411, HPA043858: AB_2678702" "unprognostic (1.20e-1)" "unprognostic (6.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.13e-3)" "unprognostic (1.63e-1)" "unprognostic (8.81e-2)" "unprognostic (5.52e-2)" "unprognostic (8.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.71e-1)" "unprognostic (2.07e-3)" "unprognostic (8.89e-2)" "unprognostic (4.90e-2)" 35.2 12.6 10.2 16.2 11.7 47.8 13.0 4.3 8.2 10.0 8.1 6.6 10.5 10.5 13.6 29.9 15.2 8.3 24.9 10.7 10.8 9.8 26.9 11.2 18.6 16.5 11.9 10.5 10.9 5.2 3.0 19.6 11.4 10.5 11.0 5.3 11.3 35.4 13.2 7.5 5.5 8.8 10.2 15.1 32.3 11.2 4.8 11.0 22.3 13.8 11.3 8.1 13.6 8.0 2.2 5.9 3.7 13.0 6.1 12.4 5.5 1.9 0.0 0.3 0.0 1.4 9.6 0.0 1.2 16.8 46.1 57.0 0.0 5.6 2.6 13.1 1.2 46.6 1.0 0.0 0.7 7.5 5.6 0.0 6.7 4.9 0.0 1.9 0.0 0.0 6.0 0.0 19.9 0.2 3.6 8.6 1.7 0.0 9.0 10.9 0.0 5.5 0.4 0.0 0.0 3.7 4.3 13.9 0.3 1.3 1.2 0.1 0.3 0.4 0.1 19.7 0.0 0.0 0.2 10.5 8.5 3.6 0.9 8.4 0.7 0.9 0.0 13.1 7.6 2.3 0.3 13.0 0.1 6.2 12.3 12.4 2.2 9.1 5.9 5.9 1.6 3.9 5.0 3.7 6.1 6.3 1.7 4.3 5.5 10.2 11.7 4.3 8.2 10.8 9.8 11.9 10.5 10.5 11.0 26.8 23.9 0.5 8.9 3.2 0.0 4.5 5.1 21.4 15.9 8.7 0.0 0.2 0.0 9.9 0.4 36.8 0.8 0.0 10.8 0.2 9.8 3.6 17.4 2.4 27.7 0.0 6.4 48.5 34.5 0.5 12.4 26.5 5.0 4.6 1.5 0.8 8.5 0.0 16.3 2.1 0.2 19.4 9.5 0.0 0.4 4.0 0.0 12.5 1.5 11.7 IFI44L "C1orf29, GS3686" ENSG00000137959 "Interferon induced protein 44 like" Q53G44 1 78619922-78646145 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 70.0;Peritubular cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 25.6;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;GAMG: 9.2;HSkMC: 14.9;SK-MEL-30: 11.7" "Low region specificity" "Detected in all" "HPA053247, HPA060372" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053247: AB_2682088, HPA060372: AB_2684267" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.99e-3)" "prognostic unfavorable (2.95e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.35e-1)" "unprognostic (4.52e-3)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (3.26e-2)" "unprognostic (3.33e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (7.58e-2)" "unprognostic (1.10e-3)" "unprognostic (2.24e-1)" "unprognostic (9.03e-2)" 33.6 5.3 9.4 6.2 10.6 36.2 7.6 3.3 10.4 3.8 4.0 12.3 2.7 3.5 10.6 19.7 3.8 4.9 15.0 7.4 9.2 11.0 15.7 4.9 9.5 5.1 10.6 9.4 6.6 2.2 1.9 5.6 8.6 21.6 5.4 3.1 14.4 26.3 5.2 3.5 2.7 3.8 7.0 17.2 23.1 3.7 5.0 12.2 21.6 10.0 4.9 5.2 10.4 3.2 3.6 2.2 2.3 5.6 4.4 2.2 1.5 0.0 0.0 1.0 0.0 0.5 6.9 0.0 0.2 5.3 25.6 27.8 0.0 0.3 5.7 3.1 0.1 9.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.6 0.1 0.1 14.9 0.1 1.9 0.3 4.8 0.2 0.0 0.0 0.8 0.5 0.0 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 1.3 0.1 0.0 0.0 6.9 0.0 11.7 0.0 0.0 0.1 0.2 0.2 0.4 0.5 0.7 1.2 0.2 0.0 4.2 0.0 0.0 0.1 5.0 0.3 0.5 5.6 1.6 3.6 2.2 1.7 1.6 1.6 0.8 0.8 2.3 4.4 2.1 2.2 0.5 1.5 9.4 10.6 3.3 10.4 9.2 11.0 10.6 9.4 21.6 12.2 0.0 9.0 7.2 2.5 3.5 0.0 1.7 2.5 17.4 9.1 7.0 0.0 0.1 0.0 4.0 0.6 70.0 0.0 0.0 7.5 0.1 6.1 1.5 2.3 0.0 22.8 0.0 0.0 22.1 13.0 1.8 21.9 14.1 3.3 2.8 0.0 1.2 1.6 0.0 45.3 0.6 0.2 6.5 4.2 0.3 0.0 1.8 0.2 6.2 0.0 3.1 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria NA NA Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.4 7.3 4.0 9.0 4.7 21.7 134.5 157.3 0.7 5.7 0.5 54.1 2.1 35.6 0.5 0.5 1.0 4.4 11.1 1.8 3.4 1.1 0.4 1.9 1.1 4.5 4.3 0.1 8.1 0.1 2.1 1.2 3.1 0.2 9.5 1.5 0.4 4.1 14.5 0.4 2.7 4.5 2.8 1.2 1.3 1.1 0.0 3.2 2.9 5.8 1.3 95.5 0.7 0.6 4.4 2.1 1.2 1.9 0.9 0.8 11.3 6.4 0.3 2.4 10.1 3.5 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 131.0 105.4 20.9 17.6 20.8 10.1 13.4 73.9 88.3 37.5 61.1 9.8 3308.6 16.6 186.8 2.9 139.0 7.0 0.0 304.1 1015.8 142.9 71.5 60.2 43.3 628.8 3.2 56.0 68.2 47.6 8.5 102.4 129.6 67.4 56.9 22.2 79.9 144.2 8.7 192.3 28.3 5.5 109.9 38.2 1.7 0.9 19.6 3573.6 51.2 8.0 13.6 IFITM10 ENSG00000244242 "Interferon induced transmembrane protein 10" A6NMD0 11 1732410-1750591 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 17.2;granulocytes: 27.7;Hofbauer cells: 21.3;Ito cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;hTERT-RPE1: 6.6;MCF7: 5.5;SH-SY5Y: 13.1;U-87 MG: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.22e-6)" "unprognostic (6.49e-3)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (3.66e-1)" "unprognostic (4.09e-1)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-1)" "unprognostic (2.44e-2)" "unprognostic (3.76e-2)" 1.9 13.3 0.7 1.0 2.2 4.3 0.9 1.4 2.0 0.7 0.8 4.3 2.2 1.2 0.7 1.0 0.8 0.7 3.0 0.6 1.0 0.7 1.8 6.6 2.1 0.7 7.4 0.2 0.8 0.6 0.5 0.4 1.0 4.1 2.7 0.6 31.4 6.7 4.8 1.2 2.0 1.0 1.0 8.2 2.2 0.6 1.6 2.7 0.0 0.5 10.8 1.6 2.6 3.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 6.6 0.1 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.1 0.0 0.0 2.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.8 0.0 7.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 1.4 2.0 1.0 0.7 7.4 0.2 4.1 2.7 3.0 1.1 2.2 10.8 1.9 17.2 1.7 2.5 4.0 5.7 0.0 0.0 1.2 1.7 2.1 0.1 0.5 3.3 0.0 2.1 0.5 2.1 0.8 27.7 0.6 21.3 1.6 0.0 54.6 6.5 0.0 0.9 3.0 0.0 3.6 0.7 2.0 2.1 3.5 1.4 0.0 1.3 0.0 1.7 0.5 1.1 0.6 2.2 2.5 1.5 10.5 IFNA16 IFN-alphaO ENSG00000147885 "Interferon alpha 16" P05015 9 21216373-21217311 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNE IFNE1 ENSG00000184995 "Interferon epsilon" Q86WN2 9 21480839-21482313 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 3.9;urinary bladder: 4.1" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 3.6;Glandular cells: 1.1;Urothelial cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "BJ: 4.1;HeLa: 10.6;hTERT-RPE1: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (1.52e-3)" "unprognostic (8.36e-2)" "unprognostic (5.44e-2)" "unprognostic (1.56e-5)" "unprognostic (2.70e-1)" "unprognostic (2.25e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-1)" "unprognostic (2.68e-2)" "unprognostic (1.14e-2)" "unprognostic (1.43e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" "unprognostic (6.58e-3)" "unprognostic (3.34e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.6 2.6 0.2 1.3 0.0 1.4 0.3 3.9 3.3 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.1 0.8 0.0 0.0 2.4 0.0 0.0 0.1 1.5 0.0 0.6 0.7 4.1 1.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 2.5 0.0 0.0 1.2 1.2 0.2 4.1 0.2 0.2 0.3 0.1 2.7 0.0 0.8 0.8 0.4 1.4 0.0 2.6 0.4 0.0 0.0 0.0 10.6 0.0 0.7 0.0 0.0 1.1 0.5 1.6 2.3 13.1 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 IFNL2 "IL-28A, IL28A" ENSG00000183709 "Interferon lambda 2" Q8IZJ0 19 39268514-39270092 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 4.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "HDLM-2: 16.7" CAB025489 Uncertain "Secreted to blood" NA NA "CAB025489: " "unprognostic (1.37e-1)" "unprognostic (2.84e-1)" "unprognostic (1.05e-1)" "unprognostic (2.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFT88 "D13S1056E, hTg737, MGC26259, Tg737, TTC10" ENSG00000032742 "Intraflagellar transport 88" Q13099 13 20567069-20691437 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.1" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 141.8;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 130.4;Spermatocytes: 215.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-2)" "unprognostic (6.57e-2)" "unprognostic (3.22e-2)" "unprognostic (7.71e-3)" "unprognostic (2.94e-1)" "unprognostic (3.21e-1)" "unprognostic (2.60e-1)" "unprognostic (7.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (5.17e-4)" "unprognostic (4.11e-1)" "prognostic favorable (1.33e-4)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (2.57e-1)" "unprognostic (4.53e-2)" 4.9 8.1 7.7 4.9 10.2 5.0 6.7 6.6 9.9 10.5 6.3 12.3 7.6 7.2 11.4 12.7 4.0 15.8 7.3 5.4 8.2 9.0 19.0 12.9 7.2 4.3 9.8 7.1 11.9 6.9 9.7 36.5 4.5 12.5 7.3 7.1 11.5 4.7 9.1 5.7 4.4 7.0 8.9 10.1 5.5 5.4 53.1 13.7 10.3 15.8 3.6 5.0 6.2 7.2 10.1 4.4 11.0 6.2 9.0 8.9 3.3 6.3 8.7 12.5 15.1 6.8 13.7 8.7 5.1 7.7 7.6 5.5 5.1 11.4 5.5 5.3 7.9 8.7 12.0 8.8 7.3 11.5 5.5 3.8 7.1 4.4 9.5 10.3 7.3 5.5 7.4 7.7 17.5 9.5 15.3 11.1 10.9 9.2 2.3 13.4 5.9 8.8 6.3 4.4 14.8 3.0 10.4 9.0 1.1 15.0 3.5 5.7 12.2 10.0 4.6 10.6 9.6 13.0 9.3 6.8 5.4 5.3 8.8 6.3 3.0 6.3 4.5 6.8 3.4 8.5 1.8 5.2 4.1 5.7 5.9 5.1 8.3 5.8 5.7 4.4 10.1 6.2 8.9 11.0 9.0 6.2 3.6 5.1 3.3 7.7 10.2 6.6 9.9 8.2 9.0 9.8 7.1 12.5 13.7 29.8 9.6 3.7 9.6 3.0 24.2 15.4 15.3 141.8 30.7 33.2 111.9 10.4 23.2 12.2 71.8 10.8 14.0 0.0 5.2 5.8 9.4 6.0 11.5 19.1 6.4 20.6 9.2 10.4 6.0 70.7 24.7 8.8 3.3 4.6 13.0 30.3 6.7 14.2 19.1 41.1 130.4 25.8 7.3 215.8 55.3 2.9 4.9 7.0 12.3 4.3 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 0.0 0.0 0.0 0.2 0.0 4.0 0.5 0.0 0.0 0.0 1.8 31.4 90.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 38.7 0.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 12.6 0.0 34.6 0.0 0.0 0.0 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 67.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 18.6 0.0 0.1 0.0 19.5 0.1 0.0 0.0 69.8 67.7 1.1 0.0 0.0 43.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Group enriched" "Detected in some" 64 "CACO-2: 28.9;OE19: 58.1" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.9 1.9 0.4 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.4 8.0 7.0 4.1 2.2 0.0 1.3 0.0 IGFL4 ENSG00000204869 "IGF like family member 4" Q6B9Z1 19 46039748-46077118 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5;skin 1: 13.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 6.6;HaCaT: 5.9;OE19: 10.3" HPA047655 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA047655: AB_2680113" "unprognostic (1.22e-2)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" "unprognostic (7.96e-2)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.39e-1)" "unprognostic (8.25e-2)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (1.09e-2)" "unprognostic (3.59e-4)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" 0.1 0.8 4.4 0.3 4.4 0.2 0.3 3.9 8.5 0.2 0.3 0.0 0.0 0.9 1.0 2.9 1.9 0.4 1.1 1.9 2.8 2.8 0.3 0.4 0.7 0.9 1.2 6.0 2.0 0.2 3.3 4.5 0.2 2.1 0.9 0.5 4.6 1.1 0.0 0.5 13.9 0.7 0.1 1.6 0.5 0.7 0.8 0.5 0.0 1.5 0.6 0.2 1.2 0.2 0.3 1.6 1.3 0.7 0.2 0.5 0.1 0.1 6.6 0.2 0.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 1.4 0.3 0.9 0.1 0.1 0.9 5.9 0.0 0.0 0.0 0.7 1.1 0.0 0.8 1.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.7 0.0 0.7 0.1 0.5 0.3 10.3 0.3 0.1 2.9 1.4 0.0 0.3 0.4 0.4 0.0 0.1 1.7 0.8 0.4 1.2 0.6 0.8 1.4 0.4 0.4 0.8 0.4 0.2 0.1 0.9 1.8 1.3 0.7 0.7 0.5 0.3 0.3 0.3 0.2 0.1 0.1 0.3 0.1 0.4 0.9 0.2 0.1 1.6 0.4 0.1 4.4 4.4 3.9 8.5 2.8 2.8 1.2 6.0 2.1 0.5 0.0 0.0 0.0 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.4 1.3 1.0 0.0 0.0 0.0 0.0 IGLL5 ENSG00000254709 "Immunoglobulin lambda like polypeptide 5" B9A064 22 22887780-22896107 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 87.9;lymphoid tissue: 102.9" "Cell type enriched" "Detected in some" 923 "Melanocytes: 89092.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 230 "memory B-cell: 87.9;naive B-cell: 72.8" "Lineage enriched" "Detected in single" 252 "B-cells: 87.9" "Group enriched" "Detected in some" 7 "Daudi: 103.5;U-266/70: 74.1;U-698: 70.4" "Secreted to blood" NA NA 120000000000 "prognostic favorable (6.10e-4)" "unprognostic (7.64e-3)" "unprognostic (4.33e-2)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.76e-2)" "unprognostic (2.18e-1)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.94e-8)" "unprognostic (1.85e-1)" "unprognostic (4.63e-1)" "unprognostic (8.52e-2)" "unprognostic (6.50e-2)" 3.5 1.8 1.3 82.6 1.5 6.5 12.3 1.3 1.5 3.3 37.7 1.4 1.3 39.0 1.5 1.7 7.5 4.3 5.8 1.3 1.3 0.3 4.6 3.6 10.8 22.8 1.5 1.3 2.1 1.3 0.0 1.3 1.5 1.7 2.1 23.3 3.3 42.9 2.8 1.5 0.6 25.2 1.3 1.3 102.9 27.7 3.1 1.3 5.8 5.8 2.9 69.8 38.2 2.6 87.9 0.3 0.1 0.0 0.0 0.0 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 103.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 74.1 12.0 70.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.9 0.0 0.0 0.1 72.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 10.7 1.3 1.5 1.3 1.5 1.3 0.3 1.5 1.3 1.7 1.3 3.0 54.3 41.7 0.0 96.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 23.3 0.0 0.0 1.0 0.0 10.5 0.0 0.0 0.0 1.2 1.3 0.3 2.7 0.0 1.6 89092.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.8 0.0 0.9 0.0 0.0 IGLON5 LOC402665 ENSG00000142549 "IgLON family member 5" A6NGN9 19 51311848-51330354 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 33.6;testis: 11.5" "Group enriched" "Detected in some" 15 "Bipolar cells: 30.6;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "testis cancer: 12.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 25.2;NTERA-2: 11.4;SH-SY5Y: 16.4;SuSa: 7.4;U-2 OS: 4.8" "Low region specificity" "Detected in all" HPA041994 Approved "Secreted in brain" NA NA "HPA041994: AB_10794641" "unprognostic (2.09e-1)" "unprognostic (5.76e-2)" "unprognostic (1.80e-2)" "unprognostic (8.87e-3)" "unprognostic (2.33e-1)" "unprognostic (2.66e-1)" "unprognostic (3.47e-4)" "unprognostic (6.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.89e-3)" "unprognostic (1.59e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.62e-7)" "unprognostic (1.77e-2)" "unprognostic (9.28e-2)" "unprognostic (1.36e-2)" "unprognostic (1.86e-3)" 2.0 4.6 9.6 1.1 6.0 1.9 0.7 33.6 16.5 0.6 0.8 0.8 0.0 0.9 0.8 2.2 2.8 0.7 1.0 1.2 9.5 13.7 0.6 2.3 0.6 0.6 11.1 8.4 1.5 1.1 0.5 0.5 1.3 29.3 1.1 0.7 3.0 1.1 2.4 0.6 1.5 1.1 0.8 10.9 0.7 0.7 11.5 2.6 0.0 0.6 0.0 0.6 1.1 0.4 0.0 0.9 1.4 0.3 0.2 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 2.4 0.0 0.1 0.1 16.4 0.0 0.0 0.0 7.4 0.1 1.5 0.0 0.0 4.8 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.9 0.0 0.0 9.6 6.0 33.6 10.7 9.5 13.7 11.1 8.4 29.3 2.6 0.0 0.0 0.0 0.0 0.0 30.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 74.7 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 0.0 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IGSF21 "MGC15730, RP11-121A23.1" ENSG00000117154 "Immunoglobin superfamily member 21" Q96ID5 1 18107746-18378483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.5;lymphoid tissue: 16.5" "Cell type enriched" "Detected in some" 17 "Bipolar cells: 179.6" "Group enriched" "Detected in many" 5 "breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 7900 "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.50e-3)" "unprognostic (7.06e-2)" "unprognostic (3.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.66e-2)" "unprognostic (7.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.34e-2)" "unprognostic (2.33e-1)" "unprognostic (7.85e-4)" "unprognostic (3.76e-5)" "unprognostic (2.10e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" 3.1 9.0 14.1 1.7 12.3 1.6 6.0 48.5 32.7 3.0 1.8 7.2 0.0 0.9 1.9 1.8 2.6 1.8 2.4 1.8 21.1 10.4 1.7 1.7 2.5 1.3 10.9 13.9 2.0 4.1 1.8 1.1 3.3 10.1 4.5 1.5 5.5 1.9 3.0 1.4 1.5 1.2 2.7 6.5 16.5 1.6 1.8 4.5 0.0 1.4 0.0 2.1 4.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 12.3 48.5 27.4 21.1 10.4 10.9 13.9 10.1 4.5 0.0 0.0 0.9 0.0 0.2 179.6 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.6 2.9 0.0 10.5 8.3 0.6 1.6 0.0 0.0 0.0 3.7 0.2 0.6 0.0 0.0 10.8 6.5 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.1 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704305-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "salivary gland: 22.7" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 22.7;Distal tubular cells: 18.3" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 3.9" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RH-30: 2.9" "CAB026459, HPA037851" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026459: , HPA037851: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.3 0.1 0.7 0.2 3.9 0.0 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.6 0.3 0.2 0.2 0.1 0.7 0.3 0.4 1.5 0.2 0.2 0.2 0.3 0.3 0.2 1.2 0.5 0.0 0.5 0.2 0.2 0.2 0.0 0.2 22.7 0.2 0.5 4.6 0.4 0.2 0.2 0.2 0.0 2.2 0.2 0.2 0.2 1.3 0.3 0.5 0.2 0.2 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.7 3.9 0.2 1.1 0.4 1.5 0.3 0.2 0.2 0.2 0.0 0.3 1.5 3.6 2.2 1.3 1.5 0.0 2.7 1.2 22.7 0.0 0.0 18.3 2.6 1.0 0.0 0.7 0.0 3.8 0.0 0.6 3.7 2.3 0.0 1.3 1.6 3.5 0.6 0.3 3.2 1.4 0.8 0.0 1.0 4.9 0.5 7.4 3.5 0.7 1.4 0.9 0.0 0.5 0.0 0.4 1.5 0.0 1.7 2.9 7.5 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Group enriched" "Detected in some" 8 "Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA051811: AB_2681621, HPA054591: AB_2682535" "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.7 0.0 0.6 14.0 0.5 0.0 1.0 0.4 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.3 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.4 2.3 0.0 0.0 0.3 0.0 2.6 0.5 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 7.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.5;WM-115: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.4 9.3 7.2 1.8 1.6 3.5 19.3 0.0 0.2 0.7 0.2 5.3 3.1 0.0 2.9 0.0 4.0 15.2 3.2 7.5 0.3 62.5 2.3 2.9 3.6 0.1 0.0 0.2 5.7 0.4 5.9 0.0 1.3 1.3 0.0 1.0 0.9 0.0 0.1 19.1 0.2 0.1 4.5 3.3 0.2 2.2 8.8 0.0 5.5 6.8 4.2 12.8 2.2 21.5 13.7 14.4 7.2 0.3 0.0 1.2 4.3 0.0 5.6 0.0 0.3 0.0 0.5 0.1 60.3 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 14.9 25.2 0.0 7.0 17.4 1.9 14.4 12.7 8.1 5.7 14.0 0.0 10.1 3.3 13.2 1.8 2.1 14.7 0.0 1.7 24.6 6.6 7.2 1.1 0.0 1.9 6.4 2.9 1.8 1.6 2.1 1.1 0.9 8.5 5.4 5.5 12.8 11.2 8.6 0.0 11.3 0.5 0.0 2.1 0.5 4.3 24.2 11.1 0.0 7.1 9.6 IGSF5 JAM4 ENSG00000183067 "Immunoglobulin superfamily member 5" Q9NSI5 21 39745407-39802096 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 5.8" "Cell type enriched" "Detected in some" 9 "Syncytiotrophoblasts: 95.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Cell type enriched" "Detected in single" 5 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "T-47d: 10.8" "Low region specificity" "Detected in all" HPA057282 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA057282: AB_2683395" "unprognostic (1.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.06e-2)" "unprognostic (9.73e-5)" "unprognostic (1.56e-2)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (2.09e-1)" "unprognostic (8.35e-2)" "unprognostic (9.61e-2)" "unprognostic (4.01e-1)" "unprognostic (4.18e-1)" "unprognostic (3.75e-2)" "unprognostic (6.89e-2)" "unprognostic (1.07e-2)" 0.0 2.0 0.9 0.0 3.4 0.1 1.3 0.1 0.7 1.1 0.3 0.2 0.9 3.4 0.0 0.9 0.3 5.8 1.2 2.3 0.3 0.3 0.1 0.2 1.3 1.5 2.5 0.3 1.5 4.3 2.4 0.9 0.9 0.4 0.0 0.6 0.1 0.4 0.7 0.3 0.6 1.5 0.8 0.2 0.5 0.2 0.4 0.3 2.2 0.4 0.0 0.4 0.0 1.3 0.7 4.5 1.1 4.4 3.6 1.2 0.8 1.2 1.3 2.0 0.7 1.3 1.4 1.2 1.7 1.7 1.2 1.5 3.0 2.5 2.3 2.1 1.4 3.3 0.5 2.8 1.9 0.6 3.2 5.5 2.9 3.2 2.2 0.6 0.7 2.6 0.9 1.7 1.6 0.3 0.6 2.5 1.1 0.8 0.7 2.0 0.8 1.9 1.9 2.0 0.5 1.2 3.0 1.8 2.1 10.8 1.1 0.4 2.0 2.3 1.0 1.8 1.0 0.8 0.9 1.1 1.4 2.0 0.1 0.4 0.4 0.4 0.0 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.2 2.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 8.7 0.0 0.0 0.0 1.8 0.0 0.9 5.0 0.3 11.1 0.0 0.0 0.0 0.2 0.9 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.4 2.7 0.1 0.0 0.2 0.5 0.1 0.0 95.4 0.0 0.0 0.9 IGSF6 DORA ENSG00000140749 "Immunoglobulin superfamily member 6" O95976 16 21639537-21652660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 96.8;lymphoid tissue: 49.7" "Group enriched" "Detected in many" 7 "Hofbauer cells: 183.3;Kupffer cells: 173.4;Macrophages: 302.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 96.8" "Lineage enhanced" "Detected in many" "granulocytes: 96.8" "Cell line enhanced" "Detected in some" "THP-1: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041023, HPA041072" Uncertain NA NA "HPA041023: AB_10794434, HPA041072: AB_10794262" "unprognostic (7.94e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.18e-2)" "prognostic favorable (1.54e-5)" "unprognostic (3.27e-1)" "unprognostic (4.03e-2)" "unprognostic (2.31e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-2)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (8.12e-2)" "unprognostic (1.81e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-1)" "unprognostic (2.02e-1)" 17.8 3.9 5.0 16.7 7.7 2.0 2.0 0.9 5.1 2.3 5.8 3.8 0.0 4.1 1.1 2.7 1.2 2.1 1.3 3.6 4.7 2.7 1.7 8.5 16.2 30.2 6.5 0.2 3.5 1.4 0.8 1.1 6.5 5.9 2.1 1.6 0.8 3.6 2.1 0.7 0.9 3.5 1.3 10.6 49.7 2.4 0.6 6.2 3.4 1.2 0.9 2.1 1.5 1.0 0.2 18.7 96.8 28.5 0.2 0.1 12.7 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.6 1.7 0.1 0.1 1.0 0.4 0.1 0.1 0.1 1.0 0.0 0.4 0.0 0.7 0.0 1.6 1.2 0.1 0.0 0.1 0.0 0.2 0.2 0.3 0.5 0.4 0.1 0.5 0.7 0.9 0.6 0.0 0.0 1.7 0.0 0.6 0.3 0.8 0.5 0.3 0.3 0.1 0.2 0.2 0.3 2.0 0.4 1.7 0.1 0.1 0.9 0.8 0.4 1.3 0.6 0.8 0.3 0.0 23.7 3.4 0.0 28.5 0.0 0.2 0.0 0.0 18.7 0.0 0.0 0.1 96.8 0.2 18.6 4.0 0.0 12.7 5.0 7.7 0.9 5.1 4.7 2.7 6.5 0.2 5.9 6.2 3.0 13.5 13.7 0.7 2.9 1.2 1.1 5.1 8.1 9.1 1.8 9.8 0.5 0.0 0.0 0.3 1.5 0.0 0.0 0.0 1.0 2.6 0.4 9.3 0.9 183.3 0.0 0.0 2.5 173.4 0.0 0.9 302.4 8.5 29.7 0.0 0.9 0.0 0.0 0.0 0.3 1.8 0.0 1.2 0.1 0.0 1.8 1.1 2.5 0.0 0.3 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol NA NA Cytosol "HPA010744: AB_2668357, HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 0.4 3.1 2.6 0.0 0.1 2.8 2.4 0.0 0.0 0.0 0.2 0.7 3.8 0.0 0.0 0.0 0.5 0.2 0.0 3.3 0.0 0.0 0.0 1.8 0.3 0.3 1.9 8.2 0.1 0.0 0.0 0.0 0.3 0.0 17.7 9.0 0.1 0.2 0.0 2.9 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 0.0 0.0 0.0 0.1 3.1 2.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.4 0.0 0.7 0.0 1.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 IL17B "IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7" ENSG00000127743 "Interleukin 17B" Q9UHF5 5 149371324-149404202 "Cancer-related genes, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Peritubular cells: 12.4;Sertoli cells: 25.8;Smooth muscle cells: 8.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "midbrain: 8.9" "Cell type enriched" "Detected in single" 14 "basophil: 4.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "HEL: 4.5;Hep G2: 2.1;K-562: 1.7;Karpas-707: 3.7;NB-4: 2.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042441 Uncertain "Secreted to blood" NA NA 75000 "HPA042441: AB_10797014" "unprognostic (2.83e-4)" "unprognostic (2.71e-2)" "unprognostic (4.90e-3)" "unprognostic (9.22e-2)" "unprognostic (7.43e-2)" "unprognostic (5.03e-2)" "unprognostic (9.62e-3)" "unprognostic (3.00e-1)" "unprognostic (1.80e-1)" "unprognostic (6.54e-2)" "unprognostic (9.30e-3)" "unprognostic (3.22e-1)" "unprognostic (6.98e-8)" "unprognostic (2.66e-1)" "unprognostic (1.53e-1)" "unprognostic (6.47e-2)" "unprognostic (1.10e-1)" 2.1 3.3 0.1 2.2 0.1 0.6 7.5 0.1 0.8 4.7 4.2 0.1 2.8 0.7 6.8 3.6 4.1 1.6 1.1 5.1 0.1 0.0 0.8 0.1 0.9 0.1 8.9 1.2 0.7 0.1 0.0 0.1 0.4 1.4 3.6 0.4 2.4 7.1 5.6 1.5 1.3 1.7 5.3 5.4 1.1 1.3 5.9 0.4 0.4 0.6 1.6 0.3 1.8 1.3 0.0 0.2 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.8 0.6 0.0 0.0 0.0 0.0 0.5 0.0 4.5 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 3.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.5 0.0 0.5 0.2 0.1 0.0 0.0 1.0 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.1 0.0 8.9 1.2 1.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 25.8 8.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 IL17D "FLJ30846, IL-17D, IL-22, IL-27, IL27" ENSG00000172458 "Interleukin 17D" Q8TAD2 13 20702127-20723098 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 36.1;skeletal muscle: 65.7" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 15.7;Late spermatids: 24.2;Leydig cells: 10.6;Melanocytes: 8.5;Muller glia cells: 18.6" "Group enriched" "Detected in many" 9 "glioma: 10.8;melanoma: 3.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.0;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 1.0" "Cell line enhanced" "Detected in many" "TIME: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 25000 "unprognostic (1.76e-2)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.26e-2)" "unprognostic (3.86e-2)" "unprognostic (5.96e-2)" "unprognostic (1.37e-2)" "unprognostic (4.00e-2)" "unprognostic (3.28e-2)" "unprognostic (1.35e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (5.97e-2)" 2.5 3.2 22.4 1.3 24.6 0.6 2.1 9.5 36.1 3.6 1.9 16.1 0.2 5.6 2.9 1.1 5.5 1.4 3.2 3.9 16.5 13.9 0.8 0.5 3.5 1.0 16.7 9.4 5.3 3.7 0.7 0.6 1.4 11.0 3.1 0.7 2.2 1.8 1.4 65.7 2.0 3.5 1.2 14.6 0.7 1.4 1.9 10.9 0.0 2.5 1.1 0.6 2.6 1.6 0.3 0.0 0.1 0.1 1.9 1.0 0.1 10.7 1.5 2.4 5.2 5.7 3.2 12.5 3.0 0.8 0.3 0.6 5.0 5.9 7.3 0.6 0.3 3.7 5.7 1.0 0.1 0.1 2.6 8.3 0.5 0.5 6.0 0.7 7.9 1.6 4.4 0.1 0.4 0.0 4.7 3.4 10.3 2.9 0.0 2.0 10.4 8.7 6.5 7.3 12.7 1.8 11.6 5.9 0.8 0.1 9.4 14.2 4.6 1.7 2.6 11.8 4.4 6.5 6.8 18.2 1.2 2.1 0.9 3.7 1.3 1.1 1.9 2.8 3.8 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 1.0 0.0 0.2 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.1 22.4 24.6 9.5 15.2 16.5 13.9 16.7 9.4 11.0 10.9 0.0 0.0 0.0 0.2 2.2 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 15.7 0.4 0.2 0.0 0.2 6.2 2.0 0.1 0.0 0.0 0.3 0.0 0.0 1.8 0.0 24.2 10.6 0.0 8.5 0.0 0.0 18.6 0.3 0.0 1.1 0.0 4.3 0.0 1.4 0.5 0.7 1.8 0.9 0.0 0.2 0.1 IL17REL FLJ41993 ENSG00000188263 "Interleukin 17 receptor E like" Q6ZVW7 22 49994513-50012659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.7;stomach 1: 4.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.9;hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.2;SK-BR-3: 3.9" HPA045546 Supported NA NA "HPA045546: AB_10963836" "unprognostic (3.33e-1)" "unprognostic (1.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-1)" "unprognostic (6.33e-2)" "unprognostic (4.65e-4)" "unprognostic (2.72e-2)" "unprognostic (1.01e-3)" "unprognostic (4.45e-2)" "unprognostic (1.52e-1)" "unprognostic (3.94e-1)" "unprognostic (3.02e-2)" "unprognostic (4.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (6.31e-3)" "unprognostic (8.31e-2)" 0.1 0.1 0.3 11.7 0.3 0.0 0.1 0.2 1.9 0.3 0.4 0.0 0.0 1.7 0.2 0.9 0.2 0.3 0.0 0.1 0.2 1.4 0.1 0.1 0.8 3.9 0.4 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.5 0.0 2.0 0.0 0.1 0.3 3.3 0.0 0.1 1.9 4.6 0.6 0.0 8.1 0.2 0.6 8.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.9 0.2 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL1RAPL2 "IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1" ENSG00000189108 "Interleukin 1 receptor accessory protein like 2" Q9NP60 X 104566315-105767829 "Predicted membrane proteins" "Hydrolase, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.0;parathyroid gland: 8.9" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 1.2;Early spermatids: 1.5;Leydig cells: 5.5;Syncytiotrophoblasts: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.8;hTERT-HME1: 11.0;NTERA-2: 2.0;RT4: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.62e-1)" "unprognostic (1.50e-1)" "unprognostic (1.66e-2)" "unprognostic (3.09e-1)" "unprognostic (1.48e-4)" "unprognostic (9.32e-3)" "unprognostic (1.67e-1)" "unprognostic (6.80e-5)" "unprognostic (1.78e-2)" "unprognostic (2.79e-3)" "unprognostic (5.91e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.84e-2)" 0.2 4.2 1.5 0.0 5.0 0.0 1.2 1.1 8.0 0.4 0.6 0.0 0.8 0.4 0.1 0.2 0.2 0.4 1.9 0.5 0.4 0.8 0.4 2.8 0.1 0.0 1.1 2.2 0.9 0.2 8.9 0.1 1.1 2.2 0.4 0.1 0.0 0.8 1.1 0.1 0.3 0.2 0.4 0.3 0.1 0.4 1.9 0.5 0.0 0.2 0.0 0.1 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.7 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 1.1 8.0 0.4 0.8 1.1 2.2 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.4 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031748-14053216 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 25.2;lymphoid tissue: 32.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 31.8;Kupffer cells: 33.3;T-cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles NA NA 4100000 Vesicles "HPA073441: " "prognostic favorable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 8.4 2.1 2.8 26.0 2.7 3.5 20.6 3.0 3.5 3.5 3.9 1.1 2.7 3.6 3.6 2.0 3.4 4.2 4.1 5.8 3.8 3.6 4.8 2.1 11.8 25.3 2.6 2.3 2.3 3.5 8.1 1.1 2.0 2.5 5.0 3.4 1.2 7.4 2.1 2.8 2.6 9.0 3.0 2.5 18.0 4.1 2.4 1.6 32.3 4.9 2.2 28.3 6.0 6.8 14.6 18.2 5.3 19.7 19.1 25.2 16.9 8.3 3.6 3.7 4.9 0.3 1.9 1.5 3.9 8.2 7.2 10.4 1.7 6.8 0.1 4.2 3.5 3.3 1.6 5.7 2.3 5.6 16.0 3.9 20.3 0.8 3.0 0.6 9.7 0.3 1.9 0.9 3.4 0.7 5.8 2.8 5.1 14.0 15.2 0.3 11.7 7.2 21.1 4.8 5.0 2.5 6.4 2.1 7.7 4.4 2.0 3.2 1.7 5.0 0.3 5.7 2.0 6.4 6.0 4.5 0.7 9.0 7.3 4.2 15.8 7.6 7.4 0.7 19.8 4.7 5.3 19.7 0.5 22.9 16.3 20.2 14.6 22.7 18.9 18.2 12.8 25.2 19.4 1.5 19.1 7.5 6.8 19.9 16.9 2.8 2.7 3.0 3.5 3.8 3.6 2.6 2.3 2.5 1.6 0.0 10.6 31.8 10.6 1.6 0.0 1.2 5.1 0.0 7.9 3.5 0.0 0.5 0.0 9.0 0.3 16.3 0.0 0.0 2.3 1.6 3.0 6.3 17.3 0.8 20.7 1.6 2.4 20.9 33.3 0.0 3.1 26.0 5.0 4.6 0.9 0.2 4.1 0.0 3.2 0.7 0.0 0.0 1.7 0.1 13.4 1.1 0.1 61.2 1.1 3.1 IL31 IL-31 ENSG00000204671 "Interleukin 31" Q6EBC2 12 122172030-122174199 "Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "HDLM-2: 1.3;Karpas-707: 2.5" CAB025657 Uncertain "Secreted to blood" NA NA 37800 "CAB025657: " "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IL36B "FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882" ENSG00000136696 "Interleukin 36 beta" Q9NZH7 2 113022091-113052867 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "GAMG: 34.4;U-87 MG: 35.3" HPA035664 Uncertain "Secreted to blood" NA NA 15300 "HPA035664: AB_10669672" "unprognostic (8.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.56e-2)" "unprognostic (1.06e-1)" "unprognostic (3.77e-2)" "unprognostic (2.40e-3)" "unprognostic (2.05e-1)" "unprognostic (7.10e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL9 "HP40, IL-9, P40" ENSG00000145839 "Interleukin 9" P15248 5 135892246-135895827 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;skin 1: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 267 "HDLM-2: 31.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 11000 0.1 0.2 0.3 0.0 2.2 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 2.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.2 0.3 1.1 0.7 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL9R CD129 ENSG00000124334 "Interleukin 9 receptor" Q01113 X 155997581-156010817 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;urinary bladder: 10.9" "Cell type enriched" "Detected in some" 4 "granulocytes: 4.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.4" "Group enriched" "Detected in some" 6 "basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Group enriched" "Detected in many" 25 "B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4" "Cell line enriched" "Detected in some" 11 "HMC-1: 76.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA063240, HPA064557" Approved "Intracellular and membrane" NA NA "HPA063240: AB_2732700, HPA064557: AB_2732716" "unprognostic (1.07e-2)" "unprognostic (3.27e-3)" "unprognostic (9.52e-3)" "unprognostic (4.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.26e-4)" "unprognostic (8.94e-2)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.82e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (3.98e-8)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (4.07e-1)" "prognostic favorable (1.90e-7)" 0.3 0.1 0.3 1.1 1.7 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.7 3.0 0.3 0.5 0.4 0.9 0.3 0.3 0.2 0.3 0.5 1.3 3.2 0.3 0.3 0.3 0.3 0.0 0.3 0.3 4.7 0.4 1.2 0.3 0.4 0.3 0.3 0.4 2.4 0.3 0.3 3.5 0.8 0.3 1.5 0.3 0.4 0.3 2.9 10.9 0.3 4.1 0.0 6.3 0.0 0.1 2.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.0 0.0 0.1 76.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.2 0.0 0.3 2.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 1.8 0.8 1.3 0.0 4.1 0.0 0.0 1.8 0.1 0.0 0.0 2.4 0.3 0.3 1.7 0.4 0.3 0.3 0.2 0.3 0.3 4.7 1.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 116.0" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.2 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.2 0.0 5.1 0.0 3.3 0.1 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 12.5 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.1 1.6 1.2 0.0 0.0 13.8 0.6 0.0 0.0 1.0 0.0 116.0 0.1 0.0 0.0 4.6 6.5 0.0 0.1 3.3 1.3 0.0 0.2 0.0 0.2 0.0 IMMP1L "FLJ25059, IMMP1" ENSG00000148950 "Inner mitochondrial membrane peptidase subunit 1" Q96LU5 11 31432401-31509645 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038372, HPA058308" Approved Enhanced Mitochondria NA NA Mitochondria "HPA038372: AB_10669643, HPA058308: AB_2732620" "unprognostic (2.39e-1)" "unprognostic (1.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.17e-2)" "unprognostic (9.67e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (7.59e-2)" "unprognostic (4.66e-3)" "unprognostic (5.15e-3)" "prognostic favorable (6.72e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-2)" "unprognostic (4.66e-1)" "unprognostic (4.52e-2)" "unprognostic (1.37e-2)" "unprognostic (1.04e-3)" 9.1 16.6 25.4 11.6 27.8 8.8 15.4 28.4 18.5 10.0 11.3 11.7 12.8 12.1 9.6 25.6 8.4 7.7 5.1 20.4 21.7 17.4 16.2 11.9 10.7 11.2 16.1 12.1 14.0 23.8 7.2 18.2 8.7 11.4 11.2 8.3 17.4 13.6 12.0 39.8 10.1 10.3 9.3 13.2 7.6 10.8 13.8 12.6 17.6 10.0 13.3 10.8 6.8 7.5 16.4 20.0 14.8 1.7 16.9 21.7 7.8 10.2 15.0 39.6 11.7 5.3 3.6 7.4 13.6 3.0 5.7 4.4 11.4 7.9 10.7 9.5 5.8 16.5 11.9 13.6 10.3 8.6 14.4 28.8 12.6 22.4 14.5 5.7 16.5 12.2 3.0 9.2 3.3 7.4 15.9 6.1 21.7 20.2 12.9 5.4 12.7 20.7 23.7 8.0 42.7 13.2 16.3 34.2 10.4 19.4 12.7 10.9 12.5 15.8 7.9 13.5 26.8 18.0 16.9 2.9 13.4 13.3 10.4 21.7 11.8 24.4 18.6 17.6 11.3 13.1 9.0 1.7 14.8 15.6 1.6 14.5 16.4 14.0 15.5 4.0 15.0 17.7 21.7 0.3 16.9 1.6 20.0 16.6 7.8 25.4 27.8 28.4 18.5 21.7 17.4 16.1 12.1 11.4 12.6 32.8 10.5 28.2 25.1 16.3 29.6 46.2 20.4 24.1 9.1 57.6 31.4 31.7 101.2 15.6 27.8 14.6 14.3 23.3 21.0 26.9 15.5 23.7 20.9 35.9 18.2 41.3 54.3 17.8 9.5 7.0 12.4 11.6 8.5 10.8 27.6 51.1 14.4 21.0 19.4 81.2 35.9 32.3 15.3 62.7 19.8 23.8 19.8 28.7 31.9 22.3 IMMP2L "IMMP2L-IT1, IMP2" ENSG00000184903 "Inner mitochondrial membrane peptidase subunit 2" Q96T52 7 110663051-111562517 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026711 Approved Approved Mitochondria NA NA Mitochondria "HPA026711: AB_1851760" "unprognostic (2.55e-2)" "unprognostic (1.40e-2)" "unprognostic (4.29e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (5.64e-3)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (5.68e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.89e-3)" "unprognostic (1.32e-1)" "unprognostic (6.65e-2)" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" 12.4 12.4 7.9 7.3 10.8 2.9 11.8 5.4 9.1 12.4 11.1 5.7 10.6 5.2 23.8 10.4 8.0 11.5 5.8 8.6 7.1 6.0 23.8 17.7 7.4 4.4 5.7 6.1 14.4 10.0 13.4 15.7 8.0 6.3 13.8 5.8 31.6 11.6 15.8 18.6 7.5 10.9 14.4 5.6 5.3 9.8 9.0 5.6 8.2 16.7 8.3 9.5 11.0 9.2 18.1 11.7 5.8 8.4 24.3 15.1 5.1 7.9 4.7 2.8 11.8 7.6 7.8 5.0 5.5 5.5 3.7 3.9 2.3 9.2 13.0 15.0 4.7 6.8 4.5 3.0 10.9 6.1 8.1 3.1 4.4 18.9 6.4 11.7 8.2 0.5 13.5 14.6 1.5 10.2 16.7 4.8 12.2 14.2 10.1 2.7 5.5 10.8 9.2 2.8 15.1 7.4 2.3 23.7 6.8 13.3 3.4 3.4 10.5 2.4 11.2 30.2 8.5 4.5 4.8 3.0 5.6 5.9 5.6 6.5 5.8 1.5 7.9 6.2 3.9 29.5 5.8 5.1 1.6 6.4 6.4 11.4 16.3 10.8 7.2 9.4 18.1 15.1 10.5 0.2 24.3 8.4 11.7 6.4 5.1 7.9 10.8 5.4 9.1 7.1 6.0 5.7 6.1 6.3 5.6 17.9 10.4 9.1 30.1 29.2 10.8 17.3 10.2 12.0 18.2 45.4 7.9 18.7 135.9 25.4 7.3 16.5 7.1 0.0 7.2 20.5 12.8 27.2 3.5 21.5 10.0 7.9 18.6 7.4 5.9 4.0 45.8 4.9 20.3 14.4 6.8 10.4 12.7 5.9 32.9 52.2 15.8 12.9 24.0 17.5 9.1 23.2 13.6 4.3 10.0 16.1 INAFM2 "LINC00984, OGU1" ENSG00000259330 "InaF motif containing 2" P0DMQ5 15 40323664-40326715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 24.1" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 16.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.5;granulocytes: 5.8;monocytes: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.59e-2)" "unprognostic (9.05e-2)" "unprognostic (8.01e-3)" "unprognostic (2.43e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (1.88e-7)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" 4.6 3.2 3.7 3.6 3.1 4.0 2.2 2.3 6.4 2.7 12.1 3.5 10.4 2.2 3.8 2.7 4.6 6.0 24.1 12.2 4.6 2.1 2.2 4.5 1.5 2.5 3.5 5.5 4.5 5.6 2.4 7.4 4.2 5.6 5.7 3.8 4.7 10.7 3.8 0.5 6.3 7.4 3.8 4.7 2.9 3.8 2.6 0.6 15.7 0.8 1.9 6.1 5.5 0.6 2.5 5.8 2.4 0.2 0.5 1.5 8.8 0.8 8.3 5.2 7.2 3.5 19.2 11.2 5.6 8.9 7.4 3.3 1.8 0.7 9.9 6.1 5.3 20.3 12.9 13.2 12.6 2.6 4.3 24.0 3.3 1.8 9.3 12.7 17.1 9.2 4.9 3.3 9.4 13.2 9.2 6.3 12.9 19.5 12.5 1.2 3.7 10.2 6.1 6.9 6.9 1.9 10.0 21.3 6.5 10.3 17.9 7.1 4.0 4.8 3.8 14.9 4.6 15.9 11.9 12.4 9.2 6.2 8.0 5.1 1.2 2.3 9.2 20.9 11.8 1.4 2.4 5.8 0.3 2.3 0.2 0.6 0.3 0.1 1.3 0.1 0.0 0.3 1.8 0.2 2.3 2.5 0.5 1.5 0.0 3.0 0.9 0.9 0.0 5.9 12.3 7.6 2.7 1.2 3.5 3.9 2.5 0.0 1.8 11.0 3.5 0.5 0.0 2.1 0.4 1.3 2.4 1.1 2.4 16.3 7.9 2.4 13.5 12.0 2.1 1.1 7.6 0.0 1.0 1.9 5.8 2.1 0.0 4.6 0.7 4.5 0.0 1.6 9.2 3.6 0.0 1.1 0.0 1.3 2.6 INHBC ENSG00000175189 "Inhibin beta C subunit" P55103 12 57434760-57450828 "Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 256 "liver: 121.3" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 5.0" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 9.7;Karpas-707: 10.0;RH-30: 5.0;U-266/70: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 11000000 "unprognostic (5.26e-2)" "unprognostic (4.58e-1)" "unprognostic (3.43e-3)" "unprognostic (4.08e-3)" "unprognostic (3.76e-1)" "unprognostic (1.98e-2)" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-4)" "unprognostic (2.90e-2)" "unprognostic (1.52e-1)" "unprognostic (3.55e-3)" "unprognostic (5.05e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.0 0.0 0.2 0.2 0.1 0.1 1.5 0.1 0.5 0.0 9.7 0.0 0.4 0.1 0.4 0.0 0.0 0.7 0.0 0.0 2.7 0.1 10.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 5.0 0.7 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 0.5 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 INPP4B ENSG00000109452 "Inositol polyphosphate-4-phosphatase type II B" O15327 4 142023160-142847432 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 19.2" "Group enriched" "Detected in many" 6 "NK-cells: 9.1;T-cells: 19.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.6;SK-MEL-30: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037681, HPA037682" Approved Approved Centrosome NA NA Centrosome "HPA037681: AB_10670389, HPA037682: AB_10671377" "unprognostic (9.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.25e-2)" "unprognostic (1.77e-1)" "unprognostic (8.24e-2)" "unprognostic (3.03e-3)" "unprognostic (5.76e-3)" "unprognostic (1.95e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.58e-2)" "unprognostic (1.26e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (1.39e-2)" 15.4 4.7 8.4 8.5 12.5 2.2 21.2 5.1 10.3 28.1 7.1 1.8 5.6 5.0 19.7 18.4 9.1 9.2 8.7 18.4 5.9 6.1 6.1 2.0 9.9 10.8 5.5 8.9 15.4 4.0 2.3 3.8 6.2 4.6 8.3 5.8 1.7 4.9 6.8 10.8 4.7 7.3 10.2 3.1 7.0 7.0 19.6 2.4 8.2 6.5 4.9 7.4 15.8 14.6 0.0 0.0 2.2 0.1 9.1 19.2 3.7 9.3 3.9 2.6 1.2 2.0 1.2 0.5 11.3 13.3 2.9 5.5 1.0 52.6 0.2 3.2 10.1 4.5 14.3 0.0 13.2 6.9 0.0 0.4 2.2 1.5 0.0 0.6 0.4 1.8 2.1 1.8 2.0 7.0 8.8 1.6 0.0 0.0 0.5 6.3 16.7 0.3 0.0 0.1 5.7 2.8 0.1 8.7 0.4 4.0 17.4 0.2 0.2 1.3 4.0 23.4 1.6 12.0 1.6 1.0 6.7 8.2 9.9 0.1 0.1 0.0 0.0 1.5 10.3 17.4 2.2 0.1 0.0 3.3 0.0 6.5 0.0 19.2 8.5 0.0 0.0 13.2 5.7 0.2 9.1 0.0 0.0 9.8 3.7 8.4 12.5 5.1 10.3 5.9 6.1 5.5 8.9 4.6 2.4 0.0 1.1 0.0 9.8 6.0 7.3 36.2 7.6 17.4 9.1 8.7 0.0 1.4 5.0 12.2 163.6 10.8 8.4 0.0 26.9 3.9 4.1 13.4 5.8 0.0 6.2 6.4 8.5 3.7 4.4 196.7 12.7 1.9 69.2 0.0 3.4 0.8 47.4 0.0 6.0 0.8 0.6 84.1 43.7 3.1 2.0 2.3 1.6 16.6 3.4 41.0 INS-IGF2 ENSG00000129965 "INS-IGF2 readthrough" F8WCM5 11 2132538-2161209 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 148 "pancreas: 467.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.2;SH-SY5Y: 5.8" CAB019430 Enhanced "Secreted to digestive system" NA NA "CAB019430: AB_10691857" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.3 0.0 0.4 467.6 0.0 0.1 3.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INSL6 RIF1 ENSG00000120210 "Insulin like 6" Q9Y581 9 5131979-5185668 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 22.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 106.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;HL-60: 1.6" "Low region specificity" "Detected in single" HPA021364 Enhanced "Secreted to blood" NA NA "HPA021364: AB_1851807" "unprognostic (3.85e-4)" "unprognostic (7.41e-4)" "unprognostic (1.28e-1)" "unprognostic (1.94e-1)" "unprognostic (2.22e-1)" "unprognostic (6.92e-2)" "unprognostic (2.31e-2)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (2.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 22.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 20.6 9.0 0.0 0.2 0.0 0.0 0.0 IPP KLHL27 ENSG00000197429 "Intracisternal A particle-promoted polypeptide" Q9Y573 1 45694324-45750650 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075545 Approved NA NA "HPA075545: " "unprognostic (8.45e-3)" "unprognostic (1.35e-1)" "prognostic favorable (9.11e-4)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (5.84e-3)" "prognostic unfavorable (2.27e-4)" "unprognostic (2.99e-1)" "unprognostic (1.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.77e-1)" "unprognostic (7.03e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.68e-2)" "unprognostic (6.44e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-1)" 6.6 8.7 7.2 5.1 10.1 3.5 7.9 5.8 11.3 6.8 7.1 13.8 7.6 6.1 15.0 7.2 8.2 8.7 7.6 8.6 7.7 7.4 9.4 8.7 5.3 7.8 7.8 8.3 10.2 8.5 16.5 12.7 5.5 10.7 10.1 7.4 10.5 10.7 8.8 17.7 7.2 8.4 11.4 9.2 4.5 7.2 14.8 6.7 16.0 12.7 5.8 9.3 8.9 6.6 4.7 1.0 5.1 1.2 5.0 7.5 3.5 8.3 8.0 7.2 10.6 9.2 16.9 5.8 9.0 6.4 6.2 6.4 4.9 6.1 4.6 9.5 10.9 7.2 6.2 7.8 6.6 9.0 10.5 5.0 6.5 7.2 6.0 9.3 1.8 5.8 14.3 7.6 13.5 7.4 7.5 6.0 8.7 7.9 9.3 10.9 5.5 6.2 0.5 4.5 6.1 4.6 2.6 13.3 3.7 5.1 9.1 10.6 6.8 17.0 9.2 8.4 8.6 9.0 1.7 7.2 6.8 8.6 4.7 6.9 7.7 8.8 8.4 11.0 2.8 10.7 4.5 0.9 5.1 7.5 0.6 5.6 4.7 4.6 6.0 1.0 4.4 5.8 6.7 4.2 5.0 1.2 1.0 6.8 3.5 7.2 10.1 5.8 11.3 7.7 7.4 7.8 8.3 10.7 6.7 11.9 10.6 3.4 5.8 2.3 11.9 14.8 5.1 10.7 7.9 5.2 11.8 6.8 3.3 5.2 12.7 3.6 7.0 0.0 6.5 5.8 4.1 4.3 12.7 5.1 1.3 17.5 5.2 3.7 1.5 4.9 6.6 0.9 1.7 4.6 6.2 19.3 4.8 3.5 6.0 7.1 15.8 0.0 3.3 33.9 13.6 4.1 6.4 7.2 5.6 3.7 IQCA1 "DRC11, FLJ22527, IQCA" ENSG00000132321 "IQ motif containing with AAA domain 1" Q86XH1 2 236324147-236507542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.8;thyroid gland: 30.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 163.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 4.4" "Group enriched" "Detected in many" 4 "NK-cells: 1.2;T-cells: 4.4" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA057320 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA057320: " "unprognostic (1.73e-2)" "unprognostic (6.38e-2)" "unprognostic (3.75e-3)" "unprognostic (1.62e-2)" "unprognostic (6.27e-3)" "unprognostic (1.73e-2)" "unprognostic (3.23e-5)" "unprognostic (1.55e-1)" "unprognostic (7.23e-3)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.54e-4)" "unprognostic (1.19e-3)" "unprognostic (1.67e-3)" "unprognostic (1.91e-3)" "unprognostic (5.30e-2)" 1.8 2.7 13.4 1.4 19.2 0.8 3.5 3.8 11.6 2.2 1.0 6.7 0.4 0.9 3.4 9.1 1.6 17.8 3.5 1.1 12.9 10.0 6.6 0.8 5.1 1.3 8.8 9.3 4.7 2.4 0.9 27.8 1.1 13.0 3.1 1.0 2.7 2.6 2.8 0.8 0.9 1.2 1.5 3.2 5.5 1.1 7.4 8.0 1.4 30.0 0.0 1.6 3.0 1.0 0.7 0.0 0.0 0.0 1.2 4.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.1 0.0 0.0 4.0 0.0 1.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 8.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.1 0.0 15.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.8 0.0 0.7 1.1 4.4 0.0 1.2 0.0 0.0 0.3 0.1 13.4 19.2 3.8 10.0 12.9 10.0 8.8 9.3 13.0 8.0 14.9 15.9 0.0 6.7 0.5 20.3 0.8 12.7 163.3 30.7 3.5 15.7 0.4 0.0 10.2 19.7 3.8 0.0 0.0 1.4 3.6 0.9 1.1 1.1 0.0 0.3 0.0 0.0 1.3 0.0 11.0 2.0 0.5 0.0 0.0 0.0 0.2 1.7 0.0 5.6 7.9 1.8 0.0 0.3 23.3 27.1 0.3 0.2 0.0 0.0 2.6 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.4;testis: 33.8" "Group enriched" "Detected in many" 7 "Ciliated cells: 124.5;Early spermatids: 118.9;Late spermatids: 69.7;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.4;GAMG: 8.9;RPTEC TERT1: 11.1;U-698: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA046810: AB_2679818, HPA048782: AB_2680519" "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favorable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 1.2 1.2 2.8 1.3 6.4 0.6 1.8 2.0 3.8 2.6 1.1 6.8 1.7 0.6 2.3 6.3 1.8 22.4 1.4 1.6 3.8 3.2 3.4 0.6 3.0 1.3 4.8 1.5 2.5 1.4 5.4 8.7 1.2 11.4 1.1 1.2 1.6 1.2 1.7 0.7 0.9 0.7 1.4 2.5 0.6 1.0 33.8 6.4 0.0 4.0 1.1 3.3 1.6 1.0 0.6 3.7 3.6 2.8 0.0 0.1 0.5 2.7 3.2 1.1 0.8 1.2 1.3 0.7 0.4 22.4 1.1 1.5 0.5 8.7 3.0 2.4 0.6 8.9 0.5 0.5 0.9 1.8 0.2 0.9 1.0 1.1 0.5 0.7 0.3 0.7 0.5 0.7 3.5 1.1 6.1 0.7 1.2 0.2 0.2 0.2 3.2 0.2 5.8 0.2 1.4 0.8 0.2 0.5 0.8 11.1 3.4 2.5 1.0 0.7 1.1 3.5 0.9 4.0 1.7 0.3 0.5 1.7 1.1 0.6 0.9 0.7 12.0 1.6 0.1 1.9 3.6 2.8 0.0 0.1 0.2 0.0 0.6 0.0 0.0 2.1 0.2 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.5 2.8 6.4 2.0 3.8 3.8 3.2 4.8 1.5 11.4 6.4 3.0 1.7 0.0 2.7 2.2 0.4 3.4 5.1 124.5 11.4 5.2 13.7 1.2 11.6 2.3 118.9 0.1 1.3 0.0 0.7 0.2 2.4 1.7 0.0 0.4 1.9 0.0 6.3 1.8 0.0 69.7 2.0 1.3 3.3 2.8 0.6 6.5 0.7 0.3 4.9 11.8 4.8 0.0 1.4 74.6 4.7 1.5 1.6 0.8 0.0 3.5 IQCF1 MGC39725 ENSG00000173389 "IQ motif containing F1" Q8N6M8 3 51894876-51903335 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 228 "testis: 47.4" "Group enriched" "Detected in some" 151 "Early spermatids: 1159.2;Late spermatids: 2587.3" "Cancer enriched" "Detected in single" 30 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 1.4;PC-3: 3.1;U-2 OS: 1.0" "Low region specificity" "Detected in many" NA NA "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1159.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2587.3 9.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 11.2 5.1 0.0 0.0 0.0 0.0 0.0 IQCF3 ENSG00000229972 "IQ motif containing F3" P0C7M6 3 51817604-51830856 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "testis: 71.2" "Group enriched" "Detected in some" 141 "Early spermatids: 1497.4;Late spermatids: 4174.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;U-2 OS: 2.2;U-698: 1.0;U-937: 4.6" NA NA "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.2 0.1 0.2 0.7 0.0 1.0 0.0 4.6 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1497.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4174.7 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 12.9 0.0 18.9 8.5 0.0 0.0 0.0 0.0 0.0 IQCF5 ENSG00000214681 "IQ motif containing F5" A8MTL0 3 51873721-51875584 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 92 "testis: 41.2" "Group enriched" "Detected in some" 68 "Early spermatids: 751.7;Late spermatids: 1880.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.1;U-2 OS: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 751.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1880.8 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 19.4 0.0 11.9 5.3 0.0 0.0 0.0 0.0 0.0 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254800-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.5;testis: 20.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 30.8;Early spermatids: 45.3;Late spermatids: 30.4;Spermatocytes: 43.6;Spermatogonia: 18.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040845 Uncertain Approved Cytosol NA NA Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.9 1.8 1.3 0.4 2.9 0.2 2.5 0.9 2.8 1.4 0.8 2.9 4.1 0.3 1.3 6.4 0.9 10.0 2.1 1.3 1.6 2.1 3.3 1.5 2.4 0.5 1.2 1.8 2.7 1.4 6.5 14.5 0.5 2.6 1.2 1.1 3.5 1.0 1.4 0.9 1.0 0.8 0.6 1.4 0.8 1.6 20.9 1.4 0.6 6.1 0.7 0.4 1.3 1.0 1.0 1.2 0.1 0.3 0.2 2.1 0.3 2.8 3.0 1.3 2.2 2.0 4.6 1.0 1.5 1.2 2.4 1.6 0.3 3.1 1.8 1.4 2.5 2.6 4.8 4.4 1.8 4.0 0.3 2.1 0.6 3.0 0.4 3.5 0.9 0.6 3.1 1.8 5.0 4.8 2.1 0.9 5.2 4.2 2.0 1.7 3.0 0.7 0.8 1.6 1.8 1.9 0.6 2.1 2.1 2.7 1.2 4.6 1.2 2.0 2.8 7.9 2.9 7.2 0.5 2.0 2.6 1.3 4.1 1.8 4.1 5.4 0.5 5.3 2.2 2.7 0.0 0.3 0.1 1.2 0.0 2.1 0.4 1.0 1.1 1.1 1.0 0.9 0.8 0.0 0.2 0.1 1.2 0.8 0.3 1.3 2.9 0.9 2.8 1.6 2.1 1.2 1.8 2.6 1.4 3.0 0.6 0.0 0.9 1.1 1.4 0.8 0.0 30.8 3.4 1.8 7.9 0.2 0.0 0.8 45.3 0.7 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 30.4 0.9 0.0 0.0 1.8 0.5 1.4 0.7 0.0 0.7 1.7 6.0 0.0 0.5 43.6 18.5 0.4 0.2 0.0 0.0 0.9 IQCJ ENSG00000214216 "IQ motif containing J" Q1A5X6 3 158962928-159266307 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 19.5" "Group enriched" "Detected in some" 105 "Early spermatids: 26.3;Late spermatids: 33.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "Daudi: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052835 Uncertain NA NA "HPA052835: AB_2681970" "unprognostic (1.99e-2)" 0.5 0.5 19.5 0.5 10.0 0.5 1.6 0.4 14.5 0.5 0.5 0.1 0.0 0.5 0.5 0.5 0.8 0.5 0.7 1.0 9.4 0.6 0.6 0.5 0.5 0.9 0.9 7.4 0.6 0.5 0.5 3.6 0.5 6.8 0.5 0.5 0.0 0.5 0.9 0.5 0.5 0.5 0.5 0.5 0.5 0.5 4.8 1.5 0.0 0.5 0.0 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 10.0 0.4 14.5 9.4 0.6 0.9 7.4 6.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 107.1;Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 96.8;Spermatocytes: 80.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 5.5 4.8 9.3 2.8 11.4 1.1 7.8 3.7 7.1 10.1 3.7 13.9 19.4 5.1 6.3 19.9 2.5 25.2 7.5 4.8 10.4 11.2 11.2 3.0 5.3 2.3 8.3 8.9 8.9 5.7 20.7 14.6 4.4 12.1 5.4 4.2 9.3 8.2 22.4 4.0 3.3 2.7 5.3 8.5 2.6 5.1 27.2 7.9 1.1 21.0 3.2 1.9 5.7 3.5 1.5 1.0 0.0 3.8 0.1 3.0 1.0 2.6 7.2 9.2 6.1 2.8 9.1 0.6 0.0 4.6 4.3 3.4 0.4 5.0 0.3 5.1 2.5 2.7 3.0 2.0 3.5 3.0 1.1 1.9 0.1 1.9 3.5 9.0 1.7 0.1 5.1 3.0 5.5 1.3 4.8 4.6 4.5 2.7 0.8 2.7 8.8 1.6 1.0 2.8 2.8 6.7 5.5 0.7 0.5 10.8 1.9 8.5 3.6 3.7 1.3 5.6 1.8 3.7 0.9 3.1 0.9 1.0 4.9 0.9 0.2 0.5 0.0 5.6 0.2 1.8 0.0 0.7 0.0 1.4 3.8 2.5 1.5 1.6 2.3 0.4 0.6 3.0 1.5 0.0 0.1 3.5 1.0 1.2 1.0 9.3 11.4 3.7 7.1 10.4 11.2 8.3 8.9 12.1 7.9 14.9 3.2 0.8 9.3 5.5 41.5 0.8 20.4 107.1 17.0 43.6 108.0 4.2 39.7 39.8 32.8 16.9 2.7 0.0 25.9 2.1 10.0 6.5 0.0 1.5 4.9 3.2 5.2 9.2 2.7 25.2 16.7 2.6 16.9 1.0 4.3 25.1 23.3 0.0 17.0 27.5 96.8 6.5 9.2 80.7 34.9 4.4 3.4 1.0 5.8 4.3 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 32.6;Horizontal cells: 108.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.7;U-266/70: 13.0;U-266/84: 3.1;U-937: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 13.0 3.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 3.0 0.0 0.0 0.0 0.2 32.6 1.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.1 0.1 2.3 0.0 1.2 108.1 0.0 1.8 1.0 3.3 0.6 0.0 0.0 0.0 0.0 6.1 0.2 0.0 0.0 4.5 15.7 0.0 0.0 2.2 8.8 0.1 0.0 0.5 0.0 0.0 IRGC "CINEMA, Iigp5, IRGC1" ENSG00000124449 "Immunity related GTPase cinema" Q6NXR0 19 43716010-43720021 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 49.4" "Group enriched" "Detected in some" 133 "Early spermatids: 1421.4;Late spermatids: 1839.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in single" "Karpas-707: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046769, HPA060064" Enhanced NA NA "HPA046769: AB_2679797, HPA060064: AB_2684195" "unprognostic (3.38e-2)" "unprognostic (3.83e-2)" "unprognostic (8.52e-2)" "unprognostic (1.26e-1)" "unprognostic (2.55e-1)" "unprognostic (2.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1421.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1839.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 6.5 0.0 12.2 5.3 0.0 0.0 0.0 0.0 0.0 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3596054-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.1;breast: 36.0;salivary gland: 20.9" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 6.0;Collecting duct cells: 5.2;Distal tubular cells: 13.3;Smooth muscle cells: 4.5" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 7.2;REH: 29.0;U-251 MG: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 5.3 0.4 2.6 0.4 2.1 1.4 36.0 6.6 1.5 0.4 0.4 2.0 6.0 0.4 0.4 1.7 0.8 0.4 0.4 1.0 3.1 3.2 13.9 0.4 8.0 0.6 4.2 1.0 0.4 0.7 0.4 0.7 0.4 16.1 0.5 0.4 2.8 20.9 1.5 0.4 6.8 0.4 0.4 5.1 0.4 0.4 0.5 1.6 3.0 0.5 0.5 0.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 0.0 0.0 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 6.6 0.2 3.1 3.2 4.2 1.0 16.1 1.6 6.0 3.0 0.0 0.0 3.2 0.5 2.0 0.0 2.7 1.2 5.2 0.0 0.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.5 0.0 0.2 2.6 0.2 0.0 0.0 0.0 IRX3 IRX-1 ENSG00000177508 "Iroquois homeobox 3" P78415 16 54283304-54286763 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 87.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 59.7;Basal glandular cells: 41.5;Ciliated cells: 72.3;Club cells: 48.9;Suprabasal keratinocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.1;NB-4: 48.3;RPTEC TERT1: 58.2;T-47d: 30.1;THP-1: 48.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA062522 Approved Vesicles NA NA Vesicles "HPA062522: AB_2797268" "unprognostic (4.21e-3)" "unprognostic (4.50e-2)" "unprognostic (2.34e-2)" "unprognostic (1.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.35e-2)" "unprognostic (1.52e-1)" "unprognostic (9.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (3.15e-2)" "unprognostic (5.40e-2)" "unprognostic (2.39e-1)" "unprognostic (8.20e-2)" "unprognostic (1.25e-1)" 4.4 2.5 1.8 0.1 2.1 0.0 38.3 3.8 0.7 15.3 0.5 1.5 46.8 0.1 4.0 18.1 14.1 5.3 0.2 46.9 3.2 3.6 9.8 1.0 46.8 1.9 4.6 0.3 1.6 2.1 15.4 3.4 1.0 7.8 10.0 0.0 5.9 20.5 87.8 9.1 33.8 0.2 0.6 8.2 0.2 7.7 1.4 3.2 0.4 8.9 9.1 6.5 2.6 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.2 0.2 3.8 3.7 2.1 0.8 0.4 1.6 3.5 3.4 0.8 1.0 1.6 0.0 0.5 2.4 1.3 7.1 3.0 0.8 4.6 3.4 2.4 0.0 5.1 3.5 0.1 3.9 1.0 0.6 14.8 6.5 3.0 2.4 0.0 4.6 0.0 0.0 29.1 1.8 7.2 48.3 0.2 0.0 0.0 5.5 4.7 0.0 58.2 1.5 2.6 0.4 4.9 12.6 0.5 0.4 30.1 48.1 0.8 14.4 1.6 2.6 1.2 0.0 0.0 0.0 9.4 12.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.8 2.1 3.8 0.3 3.2 3.6 4.6 0.3 7.8 3.2 17.9 59.7 0.0 41.5 22.1 0.3 10.6 0.0 72.3 48.9 5.2 0.0 0.0 1.7 4.6 0.0 5.1 0.0 0.0 0.2 0.1 14.7 23.1 0.0 2.9 0.3 0.0 0.0 6.2 1.2 0.0 0.0 2.3 10.1 0.0 0.0 10.6 0.2 0.0 0.0 2.2 0.9 0.0 4.2 0.5 0.4 36.1 0.0 0.0 0.0 31.4 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55323760-55330760 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favorable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 11.1 0.0 0.2 0.2 1.4 0.0 18.9 0.2 0.5 3.3 0.2 0.2 0.2 0.0 0.6 0.2 0.5 0.0 0.2 11.1 0.2 0.4 1.5 0.2 2.3 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.0 2.0 2.5 0.2 2.7 9.3 0.2 0.2 0.2 1.6 0.0 0.6 0.2 3.5 0.7 0.2 2.3 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 10.6 0.0 0.2 0.1 0.1 1.8 6.8 0.1 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.6 1.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.8 0.0 0.0 3.3 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173671-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3" "Region enriched" "Detected in all" 5 "olfactory region: 145.0" "Low region specificity" "Detected in many" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 110000000 "Plasma membrane" "Golgi apparatus" "HPA040326: AB_2676928, HPA050811: AB_2681243" "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 24.6 6.8 3.3 10.4 4.6 0.1 21.4 2.0 12.1 72.8 19.7 2.9 13.2 4.1 67.3 36.3 23.0 22.1 29.6 17.7 1.7 1.7 8.0 2.5 10.2 5.8 3.3 7.2 80.2 3.4 1.2 13.8 31.5 3.9 32.2 4.0 36.4 10.0 17.9 12.5 13.6 8.8 27.5 9.0 9.8 10.3 16.3 0.6 1.3 18.9 17.0 9.9 27.9 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 33.9 18.2 0.1 5.2 0.0 0.0 0.0 0.0 2.1 0.0 0.3 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 4.0 0.0 0.1 0.5 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.6 2.0 12.1 1.7 1.7 3.3 7.2 3.9 0.6 0.0 2.2 0.0 0.1 10.4 0.0 3.1 0.0 2.7 1.2 0.0 0.0 1.1 0.0 0.2 1.7 8.7 0.0 0.0 0.2 1.6 63.6 0.1 0.0 0.0 3.5 0.0 0.0 7.4 0.0 3.2 199.0 0.8 11.8 0.0 0.0 0.1 1.3 0.0 150.3 0.0 0.3 25.8 21.7 0.9 0.5 7.8 0.8 0.0 0.0 0.2 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;testis: 11.6" "Group enriched" "Detected in some" 7 "Early spermatids: 48.2;Late spermatids: 45.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "SCLC-21H: 27.5;SH-SY5Y: 41.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012930, HPA067333" Uncertain NA NA 66000 "HPA012930: AB_2668772, HPA067333: AB_2685824" "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.6 2.1 7.5 1.0 16.8 0.4 1.5 2.0 25.9 2.4 1.2 0.1 0.0 1.1 3.9 0.6 1.2 2.0 1.6 6.3 3.5 4.8 0.5 0.5 1.2 2.6 0.7 7.2 0.6 1.3 1.3 0.6 0.6 1.7 0.7 0.9 3.0 0.9 1.1 3.0 1.0 2.0 1.8 0.3 1.5 1.0 11.6 3.4 0.0 0.7 2.1 0.6 0.9 0.4 1.1 0.9 2.5 0.7 0.5 0.4 0.2 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 41.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 1.5 0.7 0.2 0.4 0.3 0.2 0.5 0.3 0.2 0.2 1.1 0.4 0.4 2.5 0.5 0.4 0.9 0.2 0.2 7.5 16.8 2.0 20.3 3.5 4.8 0.7 7.2 1.7 3.4 0.0 1.1 0.0 0.0 0.1 0.3 6.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 48.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.9 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.0 ISM1 "bA149I18.1, C20orf82" ENSG00000101230 "Isthmin 1" B1AKI9 20 13221771-13300651 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 33.8" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 4.0;Fibroblasts: 8.1;Proximal tubular cells: 3.1;Suprabasal keratinocytes: 2.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Group enriched" "Detected in some" 5 "ASC diff: 36.3;Hep G2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.13e-2)" "unprognostic (3.55e-1)" "unprognostic (4.43e-3)" "unprognostic (5.27e-3)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.06e-1)" "unprognostic (4.48e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.32e-6)" "unprognostic (2.58e-2)" "unprognostic (2.10e-1)" "unprognostic (6.83e-2)" "unprognostic (1.81e-2)" 7.8 2.4 0.8 0.5 1.1 0.0 17.0 0.7 1.5 2.4 2.1 0.8 2.0 0.3 1.8 2.3 4.5 2.3 4.4 2.2 1.0 1.7 2.4 4.5 3.2 1.0 0.7 0.9 1.1 5.7 0.1 1.0 12.7 1.3 1.9 0.2 0.8 8.9 0.7 2.3 9.2 1.1 1.7 0.6 4.8 1.9 1.2 0.8 1.4 33.8 5.5 1.1 3.8 6.1 0.0 0.0 0.0 0.0 0.0 4.0 1.5 0.0 0.3 0.2 0.5 36.3 5.1 0.2 0.3 3.0 0.0 0.0 2.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.3 0.3 0.0 0.2 1.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 1.0 0.1 0.7 0.0 0.0 0.0 2.1 0.3 0.1 0.2 0.0 3.4 0.6 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.8 1.1 0.7 1.5 1.0 1.7 0.7 0.9 1.3 0.8 0.0 0.3 0.0 0.5 4.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 2.3 0.0 0.0 0.0 0.2 8.1 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.8 0.0 0.2 2.5 0.6 0.5 0.0 0.1 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 91.4" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 240.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.1 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 148.4 0.0 0.0 0.0 ITGA10 ENSG00000143127 "Integrin subunit alpha 10" O75578 1 145891208-145910189 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 36.3;Endothelial cells: 21.6;Horizontal cells: 19.1;Ito cells: 30.7;Late spermatids: 33.3" "Cancer enhanced" "Detected in many" "melanoma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.8;HSkMC: 18.0;hTERT-HME1: 15.8;LHCN-M2: 27.3;TIME: 46.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.18e-4)" "unprognostic (4.53e-1)" "unprognostic (4.44e-3)" "unprognostic (2.32e-2)" "unprognostic (3.60e-2)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-1)" "unprognostic (4.37e-1)" "unprognostic (5.72e-3)" "unprognostic (6.48e-2)" "unprognostic (5.79e-2)" "unprognostic (2.58e-6)" "unprognostic (2.77e-3)" "unprognostic (1.54e-1)" "unprognostic (2.05e-5)" "unprognostic (2.57e-2)" 3.7 2.9 2.7 1.8 6.0 0.7 9.7 5.1 7.1 12.6 4.4 3.3 0.0 3.2 6.7 5.0 2.5 3.0 3.4 7.2 2.2 1.5 2.5 1.3 13.1 2.1 9.7 4.1 4.9 1.4 2.8 4.8 4.3 10.2 3.7 1.8 12.2 4.2 2.4 16.0 3.3 4.0 4.5 15.5 1.7 3.4 3.4 3.7 0.0 4.4 4.2 2.1 6.8 2.5 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.5 0.1 0.1 0.5 19.8 0.0 0.2 5.3 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.2 0.2 0.0 0.1 0.0 0.2 3.6 0.0 0.2 18.0 1.0 0.7 15.8 7.4 8.8 0.5 0.0 0.0 27.3 0.1 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 46.2 8.5 0.1 0.1 0.1 0.1 0.2 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.1 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.0 5.1 7.1 2.2 1.5 9.7 4.1 10.2 3.7 0.0 3.0 0.0 5.9 2.1 10.6 2.4 0.0 0.0 4.5 7.0 7.9 0.8 0.0 0.0 36.3 21.6 0.1 0.0 0.2 0.7 1.0 2.8 0.0 0.8 0.5 19.1 0.0 30.7 0.0 33.3 0.9 0.8 0.0 0.0 0.1 0.7 0.0 0.0 0.7 0.0 7.3 0.0 3.8 6.0 2.0 2.4 0.7 0.5 0.3 1.1 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.2 0.4 16.6 2.1 1.4 5.9 0.0 0.0 0.1 0.1 0.6 0.1 2.6 0.0 21.4 0.7 0.6 11.4 0.7 1.6 0.2 0.0 0.2 0.0 8.0 0.0 0.7 0.0 0.0 0.7 4.7 0.2 0.9 10.2 0.8 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 0.1 1.8 0.0 1.4 0.0 33.2 0.9 0.2 0.7 3.2 0.0 8.3 0.3 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.9 0.0 0.0 1.0 0.0 47.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 11.9 3.7 0.8 99.3 29.5 5.2 3.1 43.3 78.9 30.7 36.6 0.0 12.5 6.6 22.1 2.3 1.9 4.6 0.0 15.3 0.9 3.2 109.9 1.1 0.0 3.1 1.6 32.6 1.3 1.5 3.5 40.9 12.4 3.3 55.1 6.8 26.0 24.5 6.2 42.1 44.6 1.2 0.0 1.4 0.5 0.7 10.8 4.1 0.5 7.3 146.8 ITGBL1 "OSCP, TIED" ENSG00000198542 "Integrin subunit beta like 1" O95965 13 101452593-101720856 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Fibroblasts: 24.6;Ito cells: 14.7;Peritubular cells: 7.8;Spermatocytes: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 45.2;ASC TERT1: 30.3;fHDF/TERT166: 71.2;LHCN-M2: 65.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (1.70e-1)" "unprognostic (2.12e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.12e-4)" "unprognostic (1.45e-1)" "unprognostic (3.18e-1)" "unprognostic (2.54e-1)" "unprognostic (1.86e-1)" "unprognostic (8.84e-2)" "unprognostic (2.16e-2)" "unprognostic (9.50e-2)" "unprognostic (1.13e-5)" "unprognostic (1.44e-2)" "unprognostic (2.55e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.70e-4)" 16.7 6.3 1.2 1.1 1.7 0.0 24.0 8.3 1.6 17.6 1.4 2.7 2.0 0.3 3.4 1.7 19.5 3.5 25.5 13.6 2.7 2.2 2.0 4.9 17.9 0.7 4.0 4.0 3.6 5.2 3.4 18.8 21.6 5.9 8.4 1.7 15.8 18.1 3.0 6.5 9.9 0.4 19.5 7.7 2.4 5.8 3.8 1.6 0.4 6.2 14.3 2.7 11.9 17.4 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 45.2 30.3 0.0 13.6 14.1 6.2 4.0 0.0 0.5 0.0 0.0 71.2 2.9 14.7 0.0 5.0 9.8 0.0 0.0 4.3 0.1 0.0 4.7 0.0 0.0 12.8 0.3 3.5 10.0 11.8 16.0 0.0 0.3 0.1 65.3 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.1 7.1 5.7 0.0 1.7 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.2 1.7 8.3 1.6 2.7 2.2 4.0 4.0 5.9 1.6 3.0 0.3 0.0 0.0 3.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 3.0 0.1 0.0 0.0 0.2 0.4 24.6 0.0 0.0 0.4 0.5 4.8 0.0 14.7 0.0 1.1 0.0 0.3 5.0 0.0 0.0 0.3 0.7 0.0 7.8 0.0 0.4 0.0 6.6 8.6 7.2 2.0 0.7 0.0 0.0 0.1 ITLN2 HL-2 ENSG00000158764 "Intelectin 2" Q8WWU7 1 160945025-160954799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 88.4" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 71.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4" "HPA006683, HPA067326" Enhanced "Secreted to digestive system" NA NA "HPA006683: AB_2129681, HPA067326: AB_2732764" "unprognostic (1.42e-1)" "unprognostic (9.62e-3)" "unprognostic (4.61e-2)" "unprognostic (7.45e-2)" "unprognostic (2.25e-1)" "unprognostic (6.84e-4)" "unprognostic (2.47e-2)" "unprognostic (5.74e-2)" "unprognostic (1.31e-2)" "unprognostic (1.36e-1)" "unprognostic (5.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.49e-1)" "unprognostic (2.31e-1)" "unprognostic (4.91e-2)" 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 27.4 0.1 0.1 53.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 2.5 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 88.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 2.6 0.0 4.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.0 0.0 0.0 4.9 5.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 71.5 7.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 8.0 0.0 0.0 1.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 33.0" "Group enriched" "Detected in some" 30 "Early spermatids: 576.2;Late spermatids: 208.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;RH-30: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain NA NA "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 576.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.1 0.0 0.1 0.0 3.5 0.6 0.0 208.4 4.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 3.2 0.0 0.1 12.9 0.4 4.1 4.5 0.4 0.0 0.0 0.0 1.6 IZUMO4 C19orf36 ENSG00000099840 "IZUMO family member 4" Q1ZYL8 19 2096429-2099593 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 108.2" "Group enriched" "Detected in many" 5 "Early spermatids: 1393.1;Late spermatids: 1780.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 11.1;RPMI-8226: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048496 Enhanced "Secreted in male reproductive system" NA NA "HPA048496: AB_2680419" "unprognostic (2.75e-3)" "unprognostic (1.10e-2)" "unprognostic (3.65e-2)" "prognostic favorable (7.08e-4)" "unprognostic (1.40e-1)" "unprognostic (2.18e-5)" "unprognostic (2.67e-2)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (2.48e-1)" "prognostic favorable (1.69e-4)" "unprognostic (2.12e-1)" "unprognostic (6.58e-5)" "unprognostic (6.38e-2)" "unprognostic (2.17e-1)" "unprognostic (5.68e-1)" "unprognostic (7.51e-3)" 1.6 1.1 4.4 0.9 5.6 0.6 0.9 1.3 4.4 1.0 0.8 2.9 1.2 0.6 0.9 1.6 1.0 1.4 1.3 1.6 4.4 2.1 1.1 2.0 0.9 1.1 10.5 3.3 3.0 8.3 0.8 2.7 0.6 4.2 1.9 0.8 0.6 1.4 1.6 0.9 1.4 0.7 0.7 3.6 0.8 1.0 108.2 6.6 0.4 1.3 0.8 1.4 0.9 0.6 5.3 2.8 3.4 3.1 1.0 5.1 2.6 0.8 0.7 0.4 3.4 1.5 1.6 0.5 0.5 0.8 0.6 0.1 0.3 0.7 0.6 0.8 0.8 0.0 0.7 0.1 3.8 0.2 1.6 0.3 0.0 1.3 1.0 4.3 0.0 0.6 0.6 1.4 1.0 1.1 1.2 0.0 2.0 0.0 11.1 1.4 0.2 1.0 0.3 0.3 1.4 0.9 0.8 0.0 13.4 1.7 0.4 0.6 0.9 0.5 1.2 0.5 0.2 0.6 1.3 0.5 0.5 0.2 0.1 0.3 1.2 1.4 1.0 1.8 1.2 0.3 0.0 1.6 1.4 1.6 2.2 3.5 5.3 5.1 3.7 2.2 1.8 4.1 1.7 3.4 1.0 3.1 2.8 4.7 2.6 4.4 5.6 1.3 4.4 4.4 2.1 10.5 3.3 4.2 6.6 0.0 0.0 0.9 3.8 2.2 3.7 1.2 2.5 0.0 0.0 8.7 7.9 0.4 5.0 2.0 1393.1 0.6 1.6 0.0 5.1 3.3 0.9 6.1 0.0 8.9 0.8 0.0 7.5 0.6 2.1 1780.5 26.4 1.6 11.8 16.2 1.9 6.0 2.5 0.0 18.7 7.2 8.7 6.5 1.3 339.6 12.2 1.5 1.4 5.1 2.6 3.7 JAKMIP3 "bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2" ENSG00000188385 "Janus kinase and microtubule interacting protein 3" Q5VZ66 10 132104671-132184809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.9;Cardiomyocytes: 5.3;Cone photoreceptor cells: 2.0;Early spermatids: 2.0;Horizontal cells: 3.2;Leydig cells: 2.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.6;GAMG: 2.5;RPMI-8226: 2.5;U-266/84: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022872 Uncertain NA NA "HPA022872: AB_2249331" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (4.55e-3)" "unprognostic (8.90e-2)" "unprognostic (2.72e-1)" "unprognostic (9.39e-2)" "unprognostic (2.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.22e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-5)" "unprognostic (1.55e-2)" "unprognostic (5.71e-6)" "unprognostic (1.43e-1)" "unprognostic (2.11e-1)" "unprognostic (7.19e-4)" "unprognostic (1.59e-2)" 0.2 1.8 2.7 0.0 2.8 0.1 0.6 5.2 8.8 0.3 0.1 0.0 1.2 0.6 0.5 0.9 0.6 1.0 4.2 4.1 0.0 0.0 0.2 0.0 5.2 3.5 0.6 0.0 2.8 0.0 3.3 0.2 0.4 1.6 1.5 0.2 0.1 1.0 7.0 0.1 0.5 1.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.2 2.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 1.7 0.2 1.8 0.3 2.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 1.3 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.9 0.3 0.1 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 10.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 5.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.6 2.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 JHY "C11orf63, FLJ23554, Jhy" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882528-122959798 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 51.0" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 11.9;Ciliated cells: 34.8;Club cells: 13.6;Proximal tubular cells: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favorable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favorable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (7.79e-2)" 3.6 0.9 1.9 1.6 2.1 0.2 2.3 1.6 2.2 2.1 2.4 1.2 1.0 0.7 1.5 2.5 1.0 5.1 1.5 1.6 1.5 2.6 5.3 1.0 2.8 1.0 1.7 1.4 2.1 1.5 6.3 4.2 2.3 1.7 2.3 0.8 1.9 1.0 1.5 2.4 1.0 1.2 1.0 2.2 1.3 1.0 51.0 1.3 1.4 3.4 1.5 1.2 1.7 1.2 2.4 4.9 0.3 0.6 4.3 4.1 1.1 2.6 3.7 2.2 0.1 0.6 0.4 0.7 5.7 6.6 2.4 1.0 0.2 9.9 0.0 1.4 8.8 13.4 2.3 2.6 1.3 1.1 8.8 2.7 0.1 1.8 0.1 0.9 1.5 4.6 2.8 7.3 0.4 0.6 6.2 3.6 3.9 0.0 0.0 1.8 1.6 0.0 0.6 0.3 7.7 3.4 0.9 0.0 1.2 6.9 3.0 5.7 4.0 6.8 3.7 2.4 2.9 4.5 0.6 1.2 7.8 1.0 0.2 4.5 0.1 0.0 0.0 2.0 2.0 5.2 0.3 0.6 0.1 2.9 0.1 4.1 2.4 3.0 3.9 4.9 1.4 2.1 2.1 0.3 4.3 0.0 1.1 0.6 1.1 1.9 2.1 1.6 2.2 1.5 2.6 1.7 1.4 1.7 1.3 11.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 34.8 13.6 5.2 0.0 0.0 3.3 4.9 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 2.9 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.9 23.6 20.3 16.6 15.2 20.1 15.5 31.3 26.8 18.5 22.1 7.4 36.6 9.9 28.1 28.9 21.3 14.5 14.9 19.3 25.0 29.7 8.5 10.0 15.2 14.7 20.2 16.6 19.7 21.9 21.9 17.3 11.9 29.7 18.8 13.8 9.0 19.9 34.7 18.0 9.1 12.8 11.1 16.9 20.8 10.7 24.7 9.1 31.9 19.8 8.7 15.2 28.4 22.8 16.6 15.5 23.0 12.8 24.7 19.5 25.6 17.8 20.5 9.3 16.5 11.5 27.6 11.3 24.5 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 20.8 28.2 18.6 27.3 26.7 28.5 9.4 48.4 64.3 19.4 43.6 17.7 52.1 6.6 41.7 127.9 21.5 16.0 70.0 47.9 55.4 37.6 25.8 34.6 34.4 51.7 27.0 30.0 31.9 57.1 50.5 32.8 38.3 45.5 31.5 24.3 40.3 41.2 21.0 29.7 46.2 24.2 12.9 28.6 93.1 41.2 25.5 24.9 26.6 23.5 13.7 JMJD8 C16orf20 ENSG00000161999 "Jumonji domain containing 8" Q96S16 16 681671-684528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.32e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-2)" "unprognostic (1.63e-2)" "unprognostic (4.96e-3)" "unprognostic (5.53e-2)" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "unprognostic (7.04e-2)" 21.3 29.8 11.3 12.4 14.0 11.8 18.4 10.2 21.8 28.7 22.8 16.1 26.3 13.9 27.1 28.9 28.2 24.8 28.6 30.3 11.4 9.4 36.8 48.0 17.3 20.0 9.2 9.5 34.3 33.8 32.0 20.7 24.3 11.4 27.9 9.1 22.5 33.1 30.0 13.9 18.1 19.0 29.9 8.2 21.6 22.3 27.8 10.7 18.5 32.8 14.0 17.0 23.5 18.2 5.1 9.0 0.3 7.3 3.6 7.9 3.1 8.3 22.2 5.8 26.4 25.1 10.1 3.7 10.4 21.0 11.4 13.4 12.5 21.2 2.9 11.6 15.8 0.0 15.8 7.2 14.2 4.4 11.6 9.1 6.3 11.9 1.4 11.6 14.3 11.7 12.0 9.6 7.5 9.1 8.2 17.6 5.4 7.6 17.5 6.8 19.0 7.6 9.8 14.9 14.4 9.0 8.5 1.4 31.7 22.6 5.2 10.5 11.0 16.1 18.4 3.4 3.4 19.0 14.2 9.0 0.3 9.4 5.2 5.2 10.0 5.2 3.5 3.1 6.3 9.3 0.3 7.3 0.1 6.2 5.6 7.9 4.3 6.7 6.2 9.0 5.1 6.0 5.9 0.3 3.6 4.7 5.4 7.1 3.1 11.3 14.0 10.2 21.8 11.4 9.4 9.2 9.5 11.4 10.7 8.9 17.6 11.9 18.7 12.2 15.2 10.3 22.9 6.7 13.6 22.7 13.7 30.1 24.9 35.3 16.9 15.8 15.8 0.0 36.7 33.3 22.7 18.5 2.3 23.2 18.2 15.9 20.7 14.1 13.6 37.9 21.6 11.5 16.9 19.0 16.4 25.2 29.2 8.6 27.6 25.8 19.7 0.0 25.8 24.5 13.0 16.9 25.4 10.2 17.8 12.9 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.5 0.0 0.0 5.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 0.0 0.0 0.0 0.0 0.0 25.0 2.8 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 44.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.9 3.4 0.0 0.1 0.0 0.0 0.0 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in many" 19 "Bipolar cells: 144.6;Horizontal cells: 387.7" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 10.1 25.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 0.0 1.1 0.0 0.1 0.0 144.6 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 387.7 1.7 2.5 1.3 0.0 10.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 13.8 0.0 7.7 12.9 0.3 0.4 2.7 0.0 0.0 0.0 0.0 0.8 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 36.1;Early spermatids: 121.0;Late spermatids: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: AB_2732646" "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 11.5 7.8 10.4 10.2 12.3 1.4 10.3 11.1 9.8 12.5 10.1 6.2 7.9 8.2 13.0 9.1 9.7 12.3 8.7 8.4 9.2 6.8 9.1 5.9 8.0 9.7 10.0 7.8 16.4 7.0 13.4 15.6 12.0 10.0 13.5 10.7 6.0 9.7 11.7 9.9 8.9 12.4 12.8 17.9 10.4 9.9 17.9 13.1 11.6 14.0 6.3 10.3 12.4 14.8 5.3 9.0 6.0 5.7 3.9 7.6 3.4 6.8 4.3 9.0 6.6 18.2 20.2 6.5 11.6 8.0 8.4 11.0 7.3 16.6 9.4 17.0 10.7 10.7 10.7 4.4 7.9 9.8 10.1 4.1 8.7 11.1 5.5 14.6 4.9 5.6 9.6 12.6 12.1 15.2 15.6 7.5 10.9 4.6 4.1 13.5 1.4 6.3 14.1 1.3 12.3 5.9 6.5 8.7 7.6 10.3 7.2 3.6 6.5 6.7 4.7 5.1 8.8 5.7 6.7 9.2 16.2 7.2 14.1 4.6 3.5 7.7 5.5 7.5 7.9 6.9 6.0 5.7 5.5 3.8 4.5 5.3 5.3 6.0 4.7 5.7 4.1 7.6 6.8 2.1 3.9 5.2 9.0 2.8 3.4 10.4 12.3 11.1 9.8 9.2 6.8 10.0 7.8 10.0 13.1 8.9 4.3 5.0 9.5 4.1 7.1 5.5 12.7 36.1 15.9 0.0 3.9 5.3 1.7 9.6 121.0 5.5 5.7 0.0 4.5 4.6 7.1 6.7 3.5 2.1 4.3 7.9 5.8 7.4 4.1 37.3 7.8 5.2 1.7 4.6 8.8 4.5 6.4 5.5 8.9 5.4 11.5 0.0 9.0 9.5 4.3 5.3 3.3 3.8 7.3 6.4 KAAG1 "RU2, RU2AS" ENSG00000146049 "Kidney associated antigen 1" Q9UBP8 6 24356903-24358284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.1;pancreas: 4.3" "Cell type enhanced" "Detected in single" 15 "Spermatocytes: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 8.7;EFO-21: 7.0;Hep G2: 8.5" HPA036021 Approved NA NA "HPA036021: AB_10601918" "unprognostic (7.57e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.65e-1)" "unprognostic (3.32e-2)" "unprognostic (3.58e-2)" "unprognostic (3.05e-1)" "unprognostic (3.05e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (2.23e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.4 0.0 0.0 0.0 9.1 1.3 0.0 0.0 0.0 0.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 23.5 0.1 0.0 0.1 0.0 3.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 9.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.7 0.4 0.0 21.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 0.0 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.2 0.0 0.0 0.0 7.3 14.9 0.8 0.0 0.0 0.5 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.3 0.0 3.5 0.2 0.3 0.0 1.7 0.0 0.1 0.0 4.6 0.0 0.6 0.0 KBTBD12 "FLJ46299, KLHDC6" ENSG00000187715 "Kelch repeat and BTB domain containing 12" Q3ZCT8 3 127915232-127987671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 8.5;Early spermatids: 25.7;Exocrine glandular cells: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 3.1;neutrophil: 1.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 1.8;RT4: 2.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 14.9" NA NA "unprognostic (3.60e-2)" "unprognostic (2.19e-2)" "unprognostic (3.37e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (3.01e-1)" "unprognostic (3.35e-2)" "unprognostic (4.69e-3)" "unprognostic (3.62e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-2)" "unprognostic (1.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (5.70e-2)" "unprognostic (9.49e-2)" 0.6 0.5 2.1 1.2 2.7 0.6 0.5 2.6 2.6 0.4 1.5 0.8 1.0 1.1 0.7 1.3 1.4 1.2 1.1 13.1 2.2 0.7 1.1 0.4 0.5 0.5 0.7 2.2 0.5 3.7 0.4 0.5 0.5 1.6 0.8 1.5 1.4 1.7 0.8 44.5 0.7 1.0 1.0 0.5 0.4 1.9 0.9 1.2 0.0 0.4 16.6 0.7 1.0 0.4 0.3 0.4 3.1 0.3 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.4 0.3 0.1 0.6 0.2 0.1 0.2 0.0 0.1 0.1 1.8 2.4 0.5 0.2 0.2 0.1 0.0 0.2 0.3 0.1 0.6 0.3 0.2 0.5 0.1 0.4 0.4 0.0 0.2 0.1 0.3 3.1 0.3 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.2 1.5 0.2 0.1 0.4 0.0 0.0 2.1 2.7 2.6 2.6 2.2 0.7 0.7 2.2 1.6 1.2 3.0 3.0 0.0 0.0 0.1 1.7 8.5 0.0 1.4 2.3 1.8 5.9 0.0 1.7 0.2 25.7 0.0 1.1 0.0 8.0 0.0 0.2 0.0 0.0 0.0 0.1 1.6 2.4 0.0 0.0 1.3 0.0 0.7 0.0 0.0 5.3 1.0 3.6 5.8 0.0 0.0 0.6 0.0 0.3 5.4 7.2 0.3 0.0 0.0 2.3 0.0 KBTBD3 BKLHD3 ENSG00000182359 "Kelch repeat and BTB domain containing 3" Q8NAB2 11 106051098-106077765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 79.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047385 Uncertain NA NA "HPA047385: AB_2680023" "unprognostic (9.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (2.17e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-2)" "unprognostic (4.09e-2)" "unprognostic (8.73e-3)" "unprognostic (6.35e-3)" "unprognostic (1.01e-1)" "unprognostic (3.63e-2)" "unprognostic (2.43e-1)" "prognostic favorable (3.42e-7)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.54e-3)" "unprognostic (1.55e-2)" 4.6 6.7 9.3 3.7 11.4 2.4 7.8 29.8 13.6 7.2 4.7 11.9 4.1 5.0 6.2 11.2 5.0 6.4 2.8 7.6 10.6 7.1 10.9 6.9 5.9 4.0 15.7 9.4 9.2 7.3 8.3 17.1 2.6 18.1 6.4 4.5 4.6 9.8 7.7 7.1 5.1 4.4 5.0 12.9 4.7 5.0 8.1 14.5 2.7 9.8 2.9 4.7 5.1 4.8 10.4 6.1 18.5 4.6 10.8 11.9 6.3 3.0 2.5 4.6 5.3 6.5 6.4 1.3 2.8 4.0 2.5 2.1 2.0 6.2 2.1 7.8 1.1 3.5 2.3 2.5 2.6 2.1 4.2 1.1 5.0 1.2 2.2 2.8 1.7 3.9 2.6 6.8 2.3 2.2 5.5 3.8 3.4 2.0 4.1 2.6 0.7 4.4 4.4 2.1 4.8 3.4 2.2 3.1 7.7 9.0 0.8 3.9 4.4 3.6 4.2 3.0 3.7 5.8 2.6 3.2 1.4 2.2 1.4 1.2 1.8 1.0 3.9 2.6 4.2 2.2 18.5 4.6 13.8 10.4 2.6 9.2 10.4 11.8 10.6 6.1 9.1 11.3 9.6 2.9 10.8 2.5 3.4 11.9 6.3 9.3 11.4 29.8 13.6 10.6 7.1 15.7 9.4 18.1 14.5 8.9 10.9 5.4 15.0 5.6 17.2 22.6 22.9 9.4 5.7 12.2 19.6 9.4 31.5 10.9 79.4 14.6 10.9 0.0 25.8 7.4 8.5 7.3 16.1 18.8 8.6 15.9 5.8 12.3 6.3 16.6 10.9 9.6 18.6 15.4 14.4 21.3 11.3 14.0 15.9 28.3 18.1 12.9 5.1 4.7 4.2 8.5 2.2 15.2 12.8 7.4 KCNA6 "HBK2, Kv1.6, PPP1R96" ENSG00000151079 "Potassium voltage-gated channel subfamily A member 6" P17658 12 4809176-4813412 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.4;JURKAT: 4.5;TIME: 1.0;U-698: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.7 0.8 3.8 2.7 4.7 0.8 2.0 0.7 9.6 1.0 0.7 6.8 0.0 2.2 0.8 0.6 0.8 0.8 0.6 0.7 5.8 0.7 0.8 0.9 0.9 2.1 3.9 7.2 0.9 0.8 0.6 2.0 0.7 4.3 0.8 0.6 0.0 0.8 0.6 1.2 0.7 0.8 0.7 1.7 1.5 0.8 2.0 8.4 0.0 0.8 0.0 0.6 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 2.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 4.7 0.7 9.6 5.8 0.7 3.9 7.2 4.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA7 "HAK6, Kv1.7" ENSG00000104848 "Potassium voltage-gated channel subfamily A member 7" Q96RP8 19 49067418-49072941 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 40.6" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 25.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 4.0;U-251 MG: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (1.68e-1)" "unprognostic (4.31e-2)" "unprognostic (3.17e-2)" "unprognostic (6.97e-2)" "unprognostic (2.94e-2)" "unprognostic (1.26e-1)" "unprognostic (2.21e-8)" "unprognostic (1.70e-1)" "unprognostic (2.62e-1)" "unprognostic (5.80e-2)" "unprognostic (5.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 0.3 0.0 0.0 1.1 0.9 3.3 0.8 0.9 0.8 0.2 0.7 0.3 0.4 2.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.5 0.9 0.4 0.2 0.2 0.7 1.3 0.1 0.2 0.0 0.4 0.6 0.2 1.5 0.4 0.2 0.6 4.0 0.1 0.3 0.1 0.1 0.4 0.0 0.4 0.5 1.1 0.1 0.5 0.3 0.7 0.5 0.3 0.3 0.4 0.2 0.5 0.2 0.5 0.4 0.4 1.5 0.3 0.1 0.6 0.5 1.1 0.7 1.4 0.5 0.9 4.0 0.7 0.3 0.3 0.6 0.4 0.5 3.3 0.8 0.7 0.8 0.4 0.5 0.5 0.7 0.7 0.2 1.1 0.7 0.8 2.6 0.9 0.7 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 25.9 0.0 1.2 0.3 0.4 3.1 0.0 1.4 5.7 0.0 5.9 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.1 0.4 0.5 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.7 0.3 0.9 0.0 0.0 0.3 KCNAB3 "AKR6A9, KCNA3B" ENSG00000170049 "Potassium voltage-gated channel subfamily A regulatory beta subunit 3" O43448 17 7921859-7929803 "Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 36.1;endometrium 1: 17.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 123.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "cerebellum: 36.1;cerebral cortex: 31.6" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 14.9;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077993 Approved Mitochondria NA NA Mitochondria "HPA077993: AB_2686872" "unprognostic (3.02e-2)" "unprognostic (5.59e-2)" "unprognostic (6.95e-2)" "unprognostic (2.62e-2)" "unprognostic (6.13e-2)" "unprognostic (5.84e-4)" "unprognostic (2.19e-1)" "unprognostic (5.72e-2)" "unprognostic (8.50e-2)" "unprognostic (8.55e-2)" "unprognostic (3.27e-4)" "unprognostic (7.47e-3)" "unprognostic (3.03e-6)" "unprognostic (2.12e-1)" "unprognostic (5.00e-2)" "unprognostic (4.97e-2)" "unprognostic (9.54e-3)" 1.4 0.7 4.2 2.7 5.2 5.5 1.2 36.1 31.6 1.8 1.4 0.8 0.0 1.3 17.2 2.2 0.8 3.5 2.1 0.7 4.7 2.9 1.7 1.1 1.5 3.8 2.4 6.3 2.1 1.0 0.8 4.9 1.6 5.9 2.3 2.0 3.8 1.3 1.4 1.0 3.3 1.9 11.4 5.2 2.6 2.2 1.7 1.9 0.8 1.6 0.0 3.3 1.0 1.0 0.1 1.7 0.5 0.2 0.0 0.7 0.1 1.3 1.1 5.5 1.4 0.6 1.4 2.0 4.9 3.1 4.2 4.8 0.7 0.3 2.2 0.3 0.8 0.2 0.4 1.5 0.7 6.0 1.8 2.3 0.7 0.9 0.0 5.1 0.2 3.0 2.2 1.6 4.6 0.2 0.2 0.3 6.1 0.5 0.3 0.7 1.0 0.8 2.6 0.8 0.0 0.7 14.9 1.5 0.6 0.5 1.7 0.3 8.1 0.4 0.0 0.9 0.2 1.4 0.1 0.3 0.7 2.8 1.1 0.4 1.1 1.2 1.2 2.1 3.0 1.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.1 0.2 0.2 0.5 0.0 0.0 1.7 0.0 0.1 4.2 5.2 36.1 31.6 4.7 2.9 2.4 6.3 5.9 1.9 3.0 2.4 0.0 0.6 0.5 22.9 0.8 0.0 0.0 1.2 0.0 3.9 0.2 0.0 0.5 0.3 0.1 0.4 0.0 0.5 0.2 1.1 0.6 1.1 0.2 0.7 123.9 0.0 0.6 0.0 0.0 1.7 0.8 0.0 1.8 0.3 12.0 0.5 0.0 0.7 0.0 6.3 0.0 0.3 3.1 1.5 0.4 0.1 0.0 0.2 0.1 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KCNH4 "elk1, Kv12.3" ENSG00000089558 "Potassium voltage-gated channel subfamily H member 4" Q9UQ05 17 42156891-42181278 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;K-562: 6.0;RPMI-8226: 11.4;RT4: 4.3;U-266/70: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.07e-3)" "unprognostic (1.02e-2)" "unprognostic (4.02e-2)" "unprognostic (1.70e-1)" "unprognostic (9.30e-2)" "unprognostic (2.08e-3)" "unprognostic (4.59e-3)" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (9.92e-2)" "unprognostic (4.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.36e-6)" "unprognostic (9.52e-2)" "unprognostic (2.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.72e-3)" 1.2 1.0 0.7 2.4 11.2 0.7 0.3 0.0 7.9 0.7 0.3 0.1 0.0 0.7 0.2 0.1 0.1 0.4 0.5 0.7 0.4 0.9 0.2 0.2 0.3 1.0 0.3 1.0 0.2 0.3 0.0 0.4 0.3 0.0 0.5 0.3 0.0 0.8 0.5 0.2 0.4 0.5 0.3 0.1 0.8 0.6 0.9 2.6 0.0 0.2 0.0 1.1 3.1 0.1 0.4 0.6 0.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 6.3 0.5 0.9 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 1.1 0.0 0.0 1.9 0.0 0.0 1.1 0.0 0.0 0.0 11.4 0.0 4.3 2.6 1.4 0.4 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.1 0.8 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.7 11.2 0.0 7.9 0.4 0.9 0.3 1.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838730 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;pituitary gland: 5.4" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 22.7;Horizontal cells: 20.6;Ito cells: 12.9;Late spermatids: 55.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;neutrophil: 3.0" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.0" "Group enriched" "Detected in some" 13 "SCLC-21H: 10.7;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018039 Uncertain NA NA "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.4 1.0 4.4 0.9 6.8 0.8 0.4 6.0 11.0 0.4 0.4 0.0 0.7 0.7 0.4 0.6 0.4 0.5 0.4 1.0 2.6 1.8 0.6 2.7 0.5 0.5 0.7 4.6 0.4 1.0 0.3 5.4 0.6 3.1 0.4 0.3 0.4 0.4 1.5 0.3 0.4 0.5 0.4 0.7 1.1 2.5 1.6 0.3 0.0 0.4 0.0 0.3 0.4 0.4 0.1 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.7 0.7 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 4.4 6.8 6.0 11.0 2.6 1.8 0.7 4.6 3.1 0.3 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.6 0.0 12.9 1.6 55.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 0.0 0.0 0.0 1.6 0.5 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.7 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 0.0 0.0 3.3 0.0 1.7 3.7 0.6 0.0 0.0 0.0 0.9 0.0 0.2 0.7 1.9 0.0 0.1 0.0 0.2 0.2 KCNJ9 "GIRK3, Kir3.3" ENSG00000162728 "Potassium voltage-gated channel subfamily J member 9" Q92806 1 160081570-160090563 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "brain: 52.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.8;Horizontal cells: 7.9" "Cancer enriched" "Detected in single" 35 "glioma: 2.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070478 Enhanced NA NA "HPA070478: AB_2686270" "unprognostic (2.35e-1)" "unprognostic (6.53e-2)" "unprognostic (2.17e-2)" "unprognostic (4.73e-1)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (1.66e-1)" "unprognostic (3.33e-2)" "unprognostic (2.64e-1)" "unprognostic (3.29e-1)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-2)" "unprognostic (2.66e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (5.24e-2)" 1.4 1.9 15.6 1.4 15.3 1.4 1.4 32.1 52.0 1.4 1.4 11.9 0.0 1.4 1.4 1.4 1.4 1.4 1.4 1.4 18.4 11.1 1.5 1.4 1.4 1.4 18.3 20.6 1.4 1.4 1.4 0.7 1.4 7.4 1.4 1.4 0.0 1.4 1.4 1.4 1.4 1.5 1.4 11.4 1.4 1.5 1.7 11.6 0.0 1.4 0.0 1.4 1.4 0.0 0.8 0.0 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.2 2.3 2.7 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 2.9 0.2 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.1 0.4 0.2 1.1 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 15.6 15.3 32.1 27.2 18.4 11.1 18.3 20.6 7.4 11.6 0.0 0.0 0.0 0.0 0.0 12.8 0.6 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47516581-47570939 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 8.7;Cone photoreceptor cells: 13.7;Early spermatids: 6.7;Extravillous trophoblasts: 30.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "REH: 22.1;SCLC-21H: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 1.1 1.7 9.8 5.1 4.6 1.0 0.9 22.7 16.1 0.8 1.1 2.4 0.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 5.6 3.4 1.0 0.8 1.0 1.6 7.2 4.0 1.2 0.8 0.9 5.5 1.7 8.1 1.0 0.9 0.6 0.9 0.8 1.2 1.0 0.9 0.9 10.1 1.1 1.2 1.5 2.1 0.0 1.0 0.0 1.5 1.0 0.3 0.7 0.1 0.2 0.0 0.4 1.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.3 0.0 0.5 22.1 0.0 1.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.7 1.0 1.8 0.1 0.2 1.1 1.0 0.2 0.4 0.0 0.0 1.1 0.2 9.8 4.6 22.7 16.1 5.6 3.4 7.2 4.0 8.1 2.1 0.0 0.0 1.9 0.0 0.1 8.7 0.8 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 30.7 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.3 4.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.4 0.0 0.5 0.7 1.4 0.0 0.7 2.2 0.0 0.0 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Cell line enhanced" "Detected in some" "GAMG: 2.4;RT4: 4.2;SuSa: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" NA NA "Nuclear speckles, Cell Junctions" "HPA003514: AB_2666978" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.9 0.0 0.0 0.8 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.4 4.2 1.8 0.5 0.0 1.8 1.2 7.1 0.0 1.6 0.0 0.0 2.1 0.0 0.6 0.6 1.8 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.5 0.6 0.0 5.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.1 0.0 0.0 0.1 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Group enriched" "Detected in some" 4 "Exocrine glandular cells: 7.3;granulocytes: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 42.5" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592855-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 35.0;tongue: 20.7" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 90.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6" "Group enriched" "Detected in many" 12 "B-cells: 2.9;granulocytes: 4.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077577 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 0.6 0.6 0.8 0.3 0.7 3.9 2.6 1.6 2.1 1.4 0.5 0.8 0.3 0.4 0.4 0.3 10.8 0.6 0.3 0.5 0.8 0.4 0.3 0.3 0.3 0.3 0.6 1.1 0.6 0.3 0.1 0.3 0.5 0.4 0.3 0.1 0.3 0.8 0.4 1.8 35.0 0.5 0.3 0.7 0.5 0.3 0.3 0.5 0.7 0.3 20.7 5.7 0.3 3.4 2.9 0.0 4.8 0.2 0.2 0.3 0.1 0.5 2.3 0.1 0.7 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.3 1.7 0.8 0.7 0.2 0.4 3.8 0.0 0.0 0.0 0.8 2.6 0.8 1.2 1.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 0.0 1.6 1.4 2.2 0.7 1.7 0.9 0.7 1.0 1.0 2.2 1.6 0.0 0.4 1.0 0.2 12.4 2.8 0.5 0.7 1.2 0.1 0.7 2.2 0.0 0.6 1.9 1.9 0.1 2.0 1.3 0.5 1.4 1.1 1.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.9 0.1 0.0 3.6 0.2 0.2 0.0 0.0 0.1 0.8 0.7 1.6 2.1 0.8 0.4 0.6 1.1 0.4 0.5 0.0 0.3 0.0 0.4 16.9 2.3 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 1.2 0.0 1.5 1.3 0.6 0.0 3.3 0.0 0.3 0.2 0.1 2.8 0.0 0.0 0.8 6.5 1.9 0.1 0.5 90.7 0.0 0.0 0.5 1.0 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell type enhanced" "Detected in some" 6 "Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Cell line enriched" "Detected in some" 12 "REH: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" Yes No "Actin filaments, Cytosol" "HPA065938: AB_2685582" "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 2.1 0.0 0.1 0.1 0.9 1.9 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 0.0 0.0 0.0 2.5 2.3 2.2 0.8 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.0 2.3 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.9 0.9 5.0 3.6 0.0 1.3 0.2 0.0 1.8 0.0 0.9 0.0 1.9 0.4 4.3 3.3 0.1 0.7 0.0 1.4 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 31.0 0.3 0.0 0.1 0.0 0.4 0.0 1.2 0.0 7.7 8.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.9 3.9 10.0 0.3 0.0 2.9 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 11.9 2.4 0.0 0.5 1.1 0.2 2.2 0.0 32.1 3.4 0.0 2.0 0.0 3.3 0.2 2.6 16.9 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.0 0.4 0.0 4.1 5.5 0.0 6.2 0.3 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.5 0.1 1.5 0.0 0.0 0.0 0.1 KCTD18 "6530404F10Rik, FLJ31322, FLJ37818" ENSG00000155729 "Potassium channel tetramerization domain containing 18" Q6PI47 2 200488952-200519784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045498, HPA058028" Approved Approved Mitochondria NA NA Mitochondria "HPA045498: AB_10959387, HPA058028: AB_2683583" "unprognostic (2.90e-1)" "unprognostic (1.81e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-1)" "unprognostic (4.01e-1)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.40e-2)" "unprognostic (1.18e-2)" "unprognostic (5.21e-1)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" 14.3 14.6 13.7 13.1 15.4 11.5 14.3 9.2 14.8 12.3 13.8 17.4 15.5 11.6 13.5 19.4 16.1 12.5 16.5 14.8 13.6 11.2 13.8 13.3 11.4 14.9 16.3 11.4 15.0 16.5 17.1 13.2 10.0 14.9 15.9 11.7 13.7 14.1 14.0 14.7 12.3 11.3 24.0 17.6 13.0 12.9 9.3 14.6 18.0 19.4 19.9 14.6 17.4 11.7 7.2 7.2 11.4 7.9 7.1 9.6 5.6 7.3 6.8 3.4 12.6 16.4 20.4 8.7 9.0 11.5 5.8 7.7 5.4 8.4 5.2 6.9 9.1 9.5 7.1 3.3 10.9 7.5 12.4 3.6 7.4 4.9 3.8 11.1 6.0 8.8 13.6 20.7 6.7 12.9 13.6 5.0 7.8 5.0 7.1 10.3 7.5 12.9 5.9 1.9 6.3 6.2 9.0 7.7 6.0 7.6 7.3 3.9 5.4 7.1 6.2 10.7 7.7 8.2 9.7 8.3 11.9 2.7 6.0 4.3 13.6 9.8 5.9 13.7 6.4 8.4 11.4 5.5 10.4 5.9 7.9 9.0 7.2 7.7 8.5 5.9 7.1 9.6 9.6 4.4 7.1 5.2 7.2 8.5 5.6 13.7 15.4 9.2 14.8 13.6 11.2 16.3 11.4 14.9 14.6 6.0 6.5 7.5 5.0 3.9 7.0 5.3 10.2 8.1 6.8 3.5 0.0 6.5 1.7 5.8 17.3 5.1 5.9 0.0 7.5 5.9 5.4 4.4 2.3 7.8 6.5 9.5 1.2 9.2 8.3 4.5 10.9 7.6 6.8 16.2 7.9 10.0 5.1 7.0 11.7 9.4 9.3 19.4 4.7 17.6 14.5 3.4 4.2 6.7 8.0 3.1 KCTD19 FLJ40162 ENSG00000168676 "Potassium channel tetramerization domain containing 19" Q17RG1 16 67289428-67326763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 57.3" "Group enriched" "Detected in some" 8 "Early spermatids: 30.1;Spermatocytes: 63.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 6.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;granulocytes: 6.6" "Cell line enhanced" "Detected in some" "JURKAT: 10.5;U-266/70: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049310, HPA053321" Uncertain NA NA "HPA049310: AB_2680706, HPA053321: AB_2682110" "unprognostic (2.44e-1)" "unprognostic (2.14e-2)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.60e-2)" "unprognostic (9.01e-2)" "unprognostic (9.32e-2)" "unprognostic (1.75e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-4)" "unprognostic (4.44e-1)" "unprognostic (2.76e-3)" "unprognostic (1.19e-2)" "unprognostic (2.91e-2)" "unprognostic (9.71e-2)" "unprognostic (8.44e-2)" 0.2 0.1 0.2 0.7 0.8 3.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.4 0.3 0.6 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.0 0.3 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.4 1.4 0.1 0.1 0.1 0.3 0.3 57.3 0.3 1.4 0.2 0.1 0.1 0.4 0.1 1.1 5.3 6.6 0.9 1.0 0.6 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.6 0.7 1.0 0.5 0.9 0.5 0.8 0.5 0.0 0.0 0.2 1.1 0.0 3.4 0.6 2.4 0.9 0.0 0.0 0.5 0.3 0.4 0.7 0.9 1.0 0.5 0.0 0.2 10.5 0.9 0.3 0.0 0.0 0.9 0.9 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.6 1.3 0.1 0.6 0.1 1.0 0.2 0.5 1.0 0.0 0.7 3.2 0.1 9.5 1.6 0.6 1.1 0.1 0.9 1.6 0.9 0.8 0.6 0.5 0.4 0.6 0.4 0.5 0.3 1.1 0.5 0.5 6.6 1.0 0.5 5.3 0.4 0.6 0.2 0.8 0.1 0.2 0.1 0.4 0.1 0.4 0.3 0.3 0.0 2.9 0.0 1.4 0.3 0.9 0.9 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 30.1 0.3 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.9 0.8 3.3 1.0 0.0 0.2 0.0 0.0 0.7 0.0 2.2 0.0 0.2 63.5 1.7 0.3 0.1 0.0 0.0 1.1 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 7.6;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 16.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;NTERA-2: 2.9;PC-3: 1.8;SCLC-21H: 10.9;U-2 OS: 3.3" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles NA NA Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 0.0 0.0 0.0 0.6 0.0 2.7 0.2 7.6 0.0 0.0 3.5 3.9 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 1.0 16.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 KDELR3 ENSG00000100196 "KDEL endoplasmic reticulum protein retention receptor 3" O43731 22 38468062-38483447 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 48.5;salivary gland: 57.2" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 62.1;Fibroblasts: 54.4;Mucus-secreting cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.3;BJ: 36.7;BJ hTERT+: 37.8;fHDF/TERT166: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043477, HPA076405" Uncertain Supported "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA043477: AB_10962952, HPA076405: AB_2686797" "unprognostic (1.76e-1)" "unprognostic (3.77e-2)" "unprognostic (1.81e-1)" "unprognostic (1.20e-2)" "unprognostic (2.90e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.26e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-1)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.05e-10)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (8.24e-2)" "unprognostic (2.07e-2)" 10.5 4.0 1.3 3.4 1.4 0.2 11.6 0.9 1.3 15.7 7.7 1.8 5.3 6.6 6.2 14.8 5.5 5.7 20.9 14.2 1.5 1.1 10.9 44.5 8.6 5.8 1.0 1.2 7.2 48.5 9.3 12.4 11.6 1.8 9.2 10.3 5.5 57.2 7.1 2.1 3.6 15.1 6.6 2.2 3.0 15.5 4.1 0.9 1.1 6.7 6.5 16.9 6.8 6.5 1.2 4.3 0.9 0.1 0.3 2.4 0.3 7.0 2.2 1.8 7.8 30.9 58.3 1.3 36.7 37.8 9.0 22.5 4.0 9.3 0.0 7.8 59.5 3.2 1.0 1.8 2.2 10.9 0.0 4.1 0.5 1.9 11.1 13.6 0.0 4.9 21.4 1.7 11.3 1.2 12.8 10.8 0.0 1.7 0.0 14.8 11.5 0.0 0.2 0.4 30.6 6.4 0.0 0.5 2.3 10.9 0.9 0.1 0.9 9.4 0.5 4.6 0.8 2.7 0.4 8.2 9.7 6.1 33.3 3.6 0.3 0.1 0.0 15.6 0.0 13.4 0.0 0.1 0.0 0.8 0.1 2.4 1.2 0.8 0.2 0.2 0.4 0.8 0.8 0.9 0.3 0.1 4.3 0.7 0.3 1.3 1.4 0.9 1.3 1.5 1.1 1.0 1.2 1.8 0.9 0.0 3.7 1.5 4.6 6.8 1.0 2.4 7.6 8.1 7.9 14.0 2.0 4.0 6.6 16.9 0.1 8.7 9.7 0.0 28.0 62.1 54.4 28.3 1.1 5.0 4.1 0.0 4.7 22.1 1.9 0.2 30.2 1.7 15.1 1.8 58.9 5.7 29.2 3.5 15.2 0.5 1.0 0.0 7.6 0.2 1.9 6.1 6.9 0.0 9.9 4.8 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 19.4;Spermatocytes: 29.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 2.9 2.9 10.3 2.0 12.9 0.9 2.2 8.8 14.6 4.7 1.3 2.6 1.2 0.6 3.9 3.3 2.7 6.2 2.6 3.4 8.5 8.4 1.3 0.4 1.8 3.1 8.6 5.7 7.4 4.4 5.0 9.6 1.5 4.7 4.4 1.4 2.9 1.3 3.6 2.7 1.0 1.1 2.4 6.2 0.9 2.9 8.2 4.1 5.4 5.9 1.7 3.4 2.2 2.1 2.7 2.6 3.8 0.2 2.5 5.2 2.0 2.9 4.2 0.8 2.3 4.0 4.6 2.0 5.7 5.5 8.8 13.1 4.0 2.3 6.2 2.2 2.5 4.5 2.8 5.9 1.2 6.7 5.9 4.2 4.1 3.4 0.0 5.2 2.0 0.1 5.9 2.5 8.7 2.4 3.7 1.9 6.5 3.0 7.5 3.5 6.9 0.4 1.9 3.9 0.5 8.4 0.9 0.0 5.0 1.4 0.1 10.5 2.2 3.2 0.1 0.2 2.9 0.1 6.2 0.1 1.9 4.0 1.1 6.0 12.7 7.6 4.5 0.1 1.7 0.7 3.8 0.2 0.0 4.4 0.0 2.6 2.7 2.8 4.9 0.7 1.9 2.2 3.4 0.0 2.5 0.0 2.6 5.2 2.0 10.3 12.9 8.8 12.4 8.5 8.4 8.6 5.7 4.7 4.1 0.0 1.0 3.0 3.2 0.7 7.8 1.8 0.0 0.0 2.3 3.5 2.0 1.5 1.7 0.8 9.3 0.3 0.0 0.0 3.3 0.3 3.1 1.7 0.0 0.0 0.4 12.7 0.0 0.0 0.0 12.1 2.0 0.0 3.3 1.0 0.5 11.5 2.3 0.0 3.2 0.0 6.8 19.4 1.9 29.8 12.9 0.5 0.1 4.3 0.9 0.4 KIAA0825 "C5orf36, DKFZp686F0372, MGC34713" ENSG00000185261 KIAA0825 Q8IV33 5 94152966-94618597 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 22.4" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 47.1;Horizontal cells: 14.3;Rod photoreceptor cells: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "neutrophil: 13.4" "Lineage enriched" "Detected in single" 18 "granulocytes: 13.4" "Cell line enhanced" "Detected in many" "HeLa: 13.9" "HPA038030, HPA038031" Uncertain NA NA "HPA038030: AB_10672735, HPA038031: AB_2675794" "unprognostic (1.26e-1)" "unprognostic (7.73e-2)" "unprognostic (1.93e-4)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (7.63e-3)" "unprognostic (4.44e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-1)" "unprognostic (4.95e-3)" "unprognostic (2.14e-1)" "unprognostic (1.07e-1)" "unprognostic (9.02e-5)" "unprognostic (3.00e-2)" "unprognostic (8.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.09e-2)" 2.7 3.5 5.1 1.9 10.4 2.9 3.6 14.1 10.7 4.5 2.1 1.2 4.1 1.4 4.4 5.4 3.4 8.0 3.8 2.7 4.9 4.8 5.4 2.9 3.1 2.1 2.6 4.2 5.2 2.8 5.5 22.4 2.8 5.3 3.4 2.4 4.9 2.2 3.0 1.9 1.9 2.3 3.0 2.6 4.0 1.9 8.5 1.9 4.1 5.9 1.3 1.6 3.7 2.6 0.7 0.6 13.4 0.6 0.6 0.7 0.2 0.7 0.3 1.0 2.5 3.4 4.4 0.3 2.3 2.1 1.6 2.3 0.0 1.8 0.4 2.6 0.9 1.6 1.3 0.4 1.7 2.1 0.0 0.5 0.4 13.9 0.3 2.4 0.4 0.2 2.4 1.7 2.0 0.5 2.1 1.6 1.4 0.3 0.1 3.0 1.6 1.1 1.1 1.4 0.4 0.3 1.2 0.2 0.1 3.1 0.8 1.6 2.0 2.5 0.2 0.4 1.7 1.2 1.8 1.5 1.3 0.3 2.0 1.0 0.6 0.5 0.0 3.1 0.8 1.2 0.0 0.6 0.0 0.4 0.3 0.2 0.7 0.4 0.7 0.5 0.5 0.2 0.4 13.4 0.6 0.4 0.6 0.2 0.2 5.1 10.4 14.1 10.7 4.9 4.8 2.6 4.2 5.3 1.9 6.0 5.5 0.0 1.2 1.1 9.6 2.0 0.0 13.4 2.3 1.8 47.1 0.9 0.0 1.0 7.3 1.4 1.1 0.0 0.6 0.5 1.6 0.8 1.1 1.5 0.9 14.3 0.0 1.3 1.5 4.7 1.1 1.2 0.0 0.0 0.1 4.3 0.8 0.0 1.4 2.4 21.2 0.0 1.3 6.9 3.2 1.0 0.2 1.0 0.4 0.7 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 69.3;Late spermatids: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: AB_2670571, HPA061066: AB_2684423" "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.3 4.5 9.3 9.1 0.2 0.2 2.1 2.0 2.3 4.4 5.4 1.9 3.8 0.0 2.0 0.4 7.7 4.2 12.0 3.9 3.9 0.6 7.6 0.1 7.0 1.7 1.6 1.2 0.2 1.0 7.1 3.9 5.0 5.4 0.1 4.0 2.9 0.1 0.5 2.4 3.6 2.6 0.4 1.9 1.1 1.4 0.4 0.0 10.1 0.8 28.4 9.9 3.6 8.6 2.6 6.6 8.6 1.3 0.0 0.6 2.2 1.3 2.9 4.2 9.4 0.0 1.8 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 6.0 2.4 0.0 4.2 8.7 17.4 2.6 5.1 16.0 3.4 3.5 25.5 1.9 5.0 4.7 69.3 1.1 0.4 0.0 2.5 1.3 0.9 3.6 1.1 5.0 0.4 11.1 8.1 0.0 0.0 54.0 2.6 0.2 3.3 0.0 1.0 5.0 3.7 1.4 0.4 9.4 15.7 6.5 1.0 21.6 12.4 7.5 0.6 0.0 1.0 1.4 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175602-67184040 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 69.1;Cone photoreceptor cells: 41.2;Early spermatids: 91.4;Horizontal cells: 101.7;Late spermatids: 145.2;Rod photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.3;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA065996: AB_2685593" "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favorable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 9.5 20.7 18.1 8.1 19.8 5.2 5.9 46.3 25.0 8.8 6.8 11.5 11.5 10.7 15.4 13.4 6.6 15.0 10.0 7.7 15.1 10.6 9.8 4.6 8.7 3.6 13.0 27.7 21.8 7.6 18.0 24.1 9.5 18.5 10.5 8.8 13.2 8.4 10.3 5.9 9.8 9.5 11.7 16.2 11.0 13.7 13.5 12.4 4.4 13.2 4.3 3.2 7.2 6.8 0.0 2.8 0.0 0.8 0.2 1.1 0.3 2.3 4.1 14.7 9.2 2.7 6.5 9.8 6.4 1.6 2.8 2.6 4.0 2.4 4.4 4.2 2.4 2.5 9.2 4.1 3.5 1.7 4.3 5.7 6.5 10.5 3.8 2.2 2.8 13.3 3.6 1.5 3.5 1.3 10.2 4.6 9.5 6.6 4.3 3.6 3.7 6.7 4.9 3.3 2.2 6.7 18.6 7.2 8.3 4.8 5.6 17.5 14.7 7.2 3.7 1.8 7.0 8.1 4.7 5.4 10.0 7.1 4.6 2.6 5.7 4.6 4.6 12.6 4.3 5.2 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.9 1.1 2.3 0.0 0.1 0.2 0.0 0.2 0.4 2.8 0.0 0.3 18.1 19.8 46.3 24.1 15.1 10.6 13.0 27.7 18.5 12.4 3.0 9.3 1.7 3.6 2.6 69.1 2.8 5.1 2.7 11.4 7.0 41.2 3.3 3.3 4.8 91.4 3.8 4.2 0.0 2.2 5.4 3.7 5.3 4.6 3.6 3.5 101.7 12.6 9.8 0.6 145.2 6.4 1.7 5.0 1.0 4.4 18.9 3.6 4.5 10.3 1.1 68.7 19.4 3.9 4.7 10.2 2.0 2.5 0.9 5.4 3.7 KIAA1024 ENSG00000169330 KIAA1024 Q9UPX6 15 79432516-79472290 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.8;brain: 10.8" "Group enriched" "Detected in some" 12 "Horizontal cells: 15.9;Muller glia cells: 22.6" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 10.8;pons and medulla: 8.5" "Group enriched" "Detected in some" 12 "eosinophil: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "granulocytes: 2.5;monocytes: 1.9" "Cell line enhanced" "Detected in many" "U-138 MG: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 16.8 0.8 0.2 0.6 0.7 0.5 10.8 2.0 0.6 0.2 0.4 0.1 0.0 0.4 0.5 0.5 0.1 0.6 0.1 0.5 1.4 0.2 0.1 0.1 0.6 1.2 1.5 0.2 3.5 0.0 0.7 0.5 8.5 1.2 0.3 0.7 4.2 0.2 0.6 0.2 0.2 0.2 1.7 0.3 0.2 1.1 1.0 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.1 2.5 1.9 0.0 0.1 0.0 0.4 0.3 0.6 0.8 1.8 1.7 0.7 0.9 1.5 0.7 0.8 0.0 0.4 1.1 0.2 1.3 1.0 0.3 1.5 0.1 0.5 1.3 1.7 3.0 0.7 0.0 1.0 4.1 1.5 0.7 0.3 1.2 0.2 1.5 0.8 1.4 0.2 0.0 0.3 0.0 0.6 1.5 0.7 0.7 0.7 0.6 0.2 0.6 0.2 0.0 3.1 1.6 0.3 2.7 1.6 1.3 0.4 2.0 0.5 14.5 0.5 0.0 3.0 1.8 2.1 0.5 1.4 2.3 1.7 0.0 0.0 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.8 0.6 10.8 2.0 0.5 1.4 1.2 1.5 8.5 1.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.3 1.5 0.0 0.0 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.1 15.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 22.6 0.3 0.6 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.1 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 2.6;Late spermatids: 7.0;Leydig cells: 3.4;Peritubular cells: 5.6" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Group enriched" "Detected in some" 5 "basophil: 2.0;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.0" "Group enriched" "Detected in some" 8 "Daudi: 2.2;MCF7: 4.2;SK-BR-3: 2.3;U-2 OS: 2.6" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 24.6 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.7 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 0.2 0.2 2.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 2.3 0.2 0.3 0.1 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 1.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.2 0.0 0.0 0.0 KIAA1257 ENSG00000114656 KIAA1257 Q9ULG3 3 128909866-129002690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;testis: 38.5" "Group enriched" "Detected in many" 5 "Early spermatids: 154.5;Late spermatids: 157.4;Spermatocytes: 41.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 14 "neutrophil: 23.3" "Lineage enriched" "Detected in single" 47 "granulocytes: 23.3" "Cell line enhanced" "Detected in many" "AF22: 8.5;BEWO: 13.2;HL-60: 14.3;THP-1: 8.8" "HPA042811, HPA048445" Uncertain NA NA "HPA042811: AB_2678180, HPA048445: AB_2680397" "unprognostic (4.17e-2)" "unprognostic (5.16e-2)" "unprognostic (2.46e-1)" "unprognostic (2.67e-1)" "unprognostic (9.41e-3)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (4.22e-2)" "unprognostic (6.48e-3)" "unprognostic (7.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.88e-2)" "unprognostic (1.42e-2)" "unprognostic (3.38e-1)" "unprognostic (4.69e-2)" "unprognostic (2.52e-1)" "unprognostic (5.50e-2)" 0.6 0.5 1.7 0.9 7.7 1.9 0.8 0.8 3.2 0.5 0.5 2.4 0.2 0.8 0.5 1.7 1.0 4.1 1.6 0.5 2.5 1.6 0.6 0.4 1.8 0.9 0.6 1.7 1.3 0.6 1.1 3.6 3.7 2.1 0.9 0.7 0.1 0.7 0.7 0.4 5.3 0.6 0.3 0.5 1.0 0.9 38.5 0.9 0.8 0.7 0.0 0.1 0.7 0.5 0.3 0.2 23.3 0.4 0.1 0.4 0.1 1.2 1.8 8.5 1.8 0.0 0.1 13.2 0.1 0.3 0.0 0.0 2.4 1.2 2.1 0.4 0.0 1.1 1.3 2.8 0.1 0.0 0.8 1.5 4.3 1.1 1.1 0.1 14.3 0.8 0.0 1.4 0.0 0.0 0.3 0.0 4.1 1.0 2.4 0.0 1.6 1.8 3.1 1.7 2.4 1.9 1.3 0.8 1.3 0.0 1.9 1.6 0.7 0.5 0.4 0.8 1.9 2.3 8.8 0.3 0.8 1.4 0.7 0.6 2.8 2.7 3.7 0.7 5.4 0.8 0.4 0.4 1.7 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.4 23.3 0.1 0.2 0.2 0.1 0.1 1.7 7.7 0.8 3.2 2.5 1.6 0.6 1.7 2.1 0.9 3.0 1.4 0.0 0.7 0.6 0.4 0.8 0.0 21.4 1.2 0.0 3.9 0.1 0.0 0.3 154.5 1.1 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.0 0.2 1.6 8.2 2.5 0.6 157.4 2.8 0.9 0.0 0.0 1.3 1.5 0.3 0.0 0.4 0.0 1.1 0.0 0.8 41.4 10.4 0.3 0.0 0.0 0.4 0.7 KIAA1324 "EIG121, maba1" ENSG00000116299 KIAA1324 Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8;salivary gland: 169.4" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "neutrophil: 33.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.8" "Cell line enhanced" "Detected in some" "MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favorable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favorable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favorable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.7 0.9 3.7 3.6 7.9 0.0 16.4 0.7 5.6 23.9 11.8 0.4 0.0 14.6 5.5 5.7 1.3 7.8 19.1 0.6 3.3 2.3 0.6 0.6 2.2 0.7 1.0 2.7 1.2 79.8 6.1 46.6 0.0 1.1 15.8 10.0 0.0 169.4 0.0 0.6 2.5 16.5 0.2 0.9 0.9 27.3 9.4 1.1 0.0 3.9 5.2 11.5 0.9 0.6 0.2 0.0 33.8 0.0 0.2 4.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.3 14.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 9.3 0.2 0.0 11.3 0.0 0.0 38.6 0.0 0.2 0.0 1.4 0.0 0.1 0.8 2.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.9 0.2 3.9 1.7 0.0 0.0 1.8 0.7 33.8 0.2 0.0 0.0 4.6 1.0 3.7 7.9 0.7 5.6 3.3 2.3 1.0 2.7 1.1 1.1 14.9 43.1 0.0 6.2 0.5 5.1 1.5 0.0 34.8 62.6 0.0 3.9 0.5 0.0 0.9 32.7 0.5 13.1 0.0 33.1 0.6 1.6 98.1 22.1 0.0 0.9 1.6 156.4 1.3 1.6 12.3 4.0 2.3 3.3 0.0 151.0 1.4 16.5 24.6 2.1 0.0 2.6 0.0 1.4 13.7 1.7 1.4 0.5 4.4 73.4 8.3 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell type enriched" "Detected in some" 4 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.3 7.8 2.1 1.2 0.0 0.3 10.2 0.1 11.7 10.2 0.7 0.4 3.8 3.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 5.8 7.6 9.5 0.2 0.0 9.7 8.3 0.0 0.1 0.0 0.7 0.0 4.9 0.0 0.8 0.0 0.0 5.1 1.1 1.2 0.1 0.0 3.2 0.1 0.0 0.0 23.0 30.4 6.4 0.7 10.6 0.0 0.0 0.0 8.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 0.0 0.0 0.0 0.3 1.8 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.6 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 3.2 0.0 1.8 0.0 0.4 0.0 0.2 16.9 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.5 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180913154-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.8;retina: 23.8" "Group enriched" "Detected in many" 17 "Bipolar cells: 91.9;Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 171.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 58.8" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "RH-30: 12.3;SH-SY5Y: 31.1" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.6 1.5 2.4 1.4 2.6 0.1 2.2 58.8 11.3 4.5 4.6 1.8 0.8 3.0 5.2 1.6 4.6 3.5 3.1 7.5 2.7 1.4 3.0 0.4 3.2 1.1 1.5 3.8 6.3 2.1 0.0 1.3 3.6 3.3 3.5 0.5 23.8 4.6 2.8 2.1 3.0 2.5 4.1 1.4 2.6 2.2 1.2 2.5 0.4 7.6 0.9 0.4 4.3 5.1 0.5 0.5 4.4 0.5 0.5 0.6 0.3 1.1 0.5 0.9 2.1 3.0 7.5 3.3 2.2 2.6 1.1 0.6 1.0 1.2 0.5 2.1 2.7 0.5 2.2 0.2 0.0 0.3 0.6 0.9 1.6 0.4 1.4 4.1 1.0 1.2 3.5 0.1 0.1 0.0 1.8 1.5 1.7 1.3 0.8 1.0 0.9 1.3 0.4 2.3 0.3 0.3 0.7 12.3 1.6 1.8 1.0 8.5 31.1 0.7 0.8 4.9 1.0 0.9 1.4 3.5 2.4 1.8 2.8 0.9 1.6 2.0 1.0 0.3 0.8 1.6 4.4 0.5 1.2 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.4 0.6 0.4 0.7 0.5 0.1 0.5 0.2 0.3 2.4 2.6 58.8 11.3 2.7 1.4 1.5 3.8 3.3 2.5 0.0 2.6 0.0 0.8 0.3 91.9 2.8 0.0 0.0 2.3 1.8 123.7 0.2 1.7 0.2 3.4 1.7 0.0 0.0 0.2 0.4 2.8 0.3 1.1 0.0 1.4 3.2 0.0 2.5 0.0 1.3 7.2 0.0 3.3 1.8 0.0 7.6 1.0 0.0 5.3 1.3 171.7 6.5 1.4 0.7 0.2 0.3 0.2 0.0 0.0 0.0 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in some" 16 "Leydig cells: 3.4;Peritubular cells: 7.1;Proximal tubular cells: 2.9" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 40.9;ASC diff: 6.2;ASC TERT1: 9.4;WM-115: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA051064: AB_2681331" "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.2 40.9 0.0 6.2 9.4 0.0 4.0 2.3 0.0 0.0 0.2 1.2 0.0 0.2 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 1.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.3 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.0 1.3 3.4 0.0 1.7 0.0 0.0 0.0 0.3 0.0 7.1 2.9 0.0 0.0 0.9 0.4 0.2 0.3 0.0 0.0 0.0 0.0 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 69.6;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051240: AB_2681401" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 5.1 3.6 9.8 3.9 8.9 2.3 4.3 13.3 12.4 10.0 7.1 7.0 1.0 5.5 4.4 6.8 3.8 7.5 3.6 5.2 9.6 11.6 2.6 2.3 8.0 3.2 8.8 12.1 2.4 3.6 3.9 8.2 3.5 20.6 9.6 8.3 3.6 3.6 3.1 3.7 8.5 5.9 5.4 10.1 3.3 5.6 7.5 6.2 3.3 4.0 2.7 3.5 4.3 3.7 1.5 1.2 4.8 2.5 1.4 3.7 0.6 4.6 9.0 11.8 5.1 6.8 7.7 3.7 8.9 2.2 4.6 4.3 2.7 3.0 1.9 2.4 6.8 9.5 5.9 7.5 3.0 6.5 8.1 1.8 1.7 6.2 7.5 3.7 2.1 1.7 3.6 4.9 8.3 2.9 5.3 6.4 2.7 1.7 1.5 12.8 0.4 1.8 1.4 3.7 5.4 1.8 6.0 9.7 0.4 5.8 9.5 7.0 4.4 10.7 2.4 3.2 9.2 1.8 2.5 8.4 7.5 2.8 6.0 6.0 0.8 2.4 2.8 5.4 1.5 5.1 0.8 1.4 4.8 1.3 1.5 1.2 1.5 1.2 0.6 1.2 0.6 0.2 1.0 3.0 1.4 2.5 0.8 3.7 0.6 9.8 8.9 13.3 12.4 9.6 11.6 8.8 12.1 20.6 6.2 6.0 4.3 0.0 2.9 2.3 12.4 6.5 2.5 69.6 15.9 3.5 53.0 0.9 0.0 3.1 2.4 3.8 5.1 0.0 5.4 2.2 6.6 4.4 1.1 1.0 5.0 7.9 7.5 5.5 4.0 1.7 3.4 4.2 3.3 9.0 4.3 4.8 7.6 7.0 1.8 0.5 45.8 0.0 3.6 10.4 19.2 2.9 0.3 2.2 4.5 2.6 KIAA2012 ENSG00000182329 KIAA2012 Q0VF49 2 202073289-202205203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;fallopian tube: 19.2" "Group enriched" "Detected in some" 11 "Ciliated cells: 78.9;Early spermatids: 38.5;Late spermatids: 23.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;BJ hTERT+: 1.2;CAPAN-2: 1.8;SCLC-21H: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077834 Enhanced NA NA "HPA077834: " "unprognostic (1.91e-2)" "unprognostic (3.17e-1)" "unprognostic (2.56e-1)" "unprognostic (5.35e-2)" "unprognostic (2.85e-2)" "unprognostic (3.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "unprognostic (7.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.81e-2)" "unprognostic (6.94e-5)" "unprognostic (1.60e-1)" "unprognostic (9.44e-2)" "unprognostic (3.37e-1)" "unprognostic (9.95e-3)" 0.3 0.5 6.2 0.4 10.0 0.3 0.4 0.6 8.4 1.2 0.4 5.1 0.0 0.5 0.5 2.5 0.4 19.2 0.4 0.4 6.7 3.5 0.4 2.5 2.0 0.4 0.2 4.4 3.8 0.4 0.3 2.8 0.4 6.5 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 2.6 1.0 0.0 0.4 0.0 0.3 0.4 0.1 0.6 0.5 0.9 0.6 0.5 0.8 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.1 0.7 1.2 0.1 0.0 0.4 1.8 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.1 0.9 0.3 0.6 0.2 0.2 0.5 0.5 0.2 0.6 0.8 0.4 0.3 0.5 0.5 0.5 0.0 0.0 6.2 10.0 0.6 8.4 6.7 3.5 0.2 4.4 6.5 1.0 3.0 0.0 0.0 0.3 0.0 2.6 0.8 0.0 78.9 3.4 0.0 2.0 0.1 0.0 0.0 38.5 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 4.3 0.1 3.2 0.0 1.3 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.1 1.5 0.0 0.0 0.0 0.0 0.0 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favorable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.9 2.9 6.0 3.9 4.6 7.4 2.9 4.1 5.7 3.7 3.5 1.9 3.3 7.5 1.5 4.9 4.6 3.0 3.5 3.1 5.6 17.2 2.9 22.4 6.5 2.9 3.6 7.9 10.4 4.5 4.2 3.2 5.4 7.0 5.8 4.7 2.4 13.4 4.7 1.7 4.2 13.6 3.4 3.3 2.5 4.7 3.9 3.8 4.0 3.8 8.3 4.9 3.8 3.3 3.1 4.3 3.4 10.1 6.8 7.1 4.3 3.6 4.4 10.4 8.2 7.5 3.6 3.7 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 41.7 31.3 33.5 27.5 39.6 86.1 47.2 25.5 16.0 17.0 36.6 74.6 12.9 6.6 15.8 25.2 35.7 26.7 23.3 11.7 8.8 23.6 29.1 18.6 14.5 14.8 42.9 37.0 29.4 26.4 11.5 65.3 26.1 21.9 29.7 28.8 49.5 15.0 30.8 71.8 8.6 74.2 45.3 32.0 129.1 110.7 45.8 25.1 37.4 25.6 35.9 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.8 1.5 0.9 0.4 1.0 0.0 1.2 2.0 0.7 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.4 1.0 0.0 0.1 0.6 0.0 1.8 0.1 0.0 0.0 2.5 0.1 1.8 0.0 0.1 0.0 0.6 0.0 0.7 1.5 0.5 0.0 0.3 1.6 0.0 0.0 0.0 0.6 5.1 0.5 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 2.7 0.0 1.8 3.9 0.1 0.0 0.0 35.8 12.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 4.0 0.0 0.0 16.5 1.5 60.3 1.1 3.3 1.7 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 19.4 1.4 1.5 4.2 1.1 1.4 0.0 0.0 0.1 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;fallopian tube: 25.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 34.8;Intestinal endocrine cells: 22.8;Ito cells: 19.6;Mucus-secreting cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.5" "Lineage enriched" "Detected in single" 55 "T-cells: 5.5" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: AB_2686593" "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.6 0.9 9.3 1.6 29.5 1.1 1.1 25.8 14.1 2.1 3.1 17.4 0.0 6.6 1.1 1.1 1.1 25.2 1.6 1.1 11.9 6.6 0.9 1.6 3.1 1.0 25.0 4.2 1.1 3.0 0.9 0.3 0.8 6.5 0.9 2.1 0.8 2.5 1.3 1.0 0.8 5.2 1.6 6.2 11.6 2.2 1.2 29.9 0.0 2.3 0.0 1.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.9 1.6 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 9.3 29.5 25.8 14.1 11.9 6.6 25.0 4.2 6.5 29.9 0.0 0.0 0.0 0.3 0.0 0.9 1.1 0.0 34.8 7.9 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 2.5 0.2 0.2 0.0 0.0 0.1 0.0 22.8 19.6 1.2 0.0 0.0 0.0 3.3 0.0 10.6 7.5 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.2 1.4 0.1 0.0 0.0 1.3 0.1 KIF25 KNSL3 ENSG00000125337 "Kinesin family member 25" Q9UIL4 6 167996241-168045089 "Predicted intracellular proteins" "Motor protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 6.2;brain: 9.9" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 3.5;granulocytes: 4.6;Horizontal cells: 3.2;Spermatogonia: 2.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 2.2;HDLM-2: 5.3;HMC-1: 2.8;SiHa: 2.2;U-266/84: 3.2;U-937: 3.1;WM-115: 2.3" "Not detected" "Not detected" HPA046153 Uncertain NA NA "HPA046153: AB_10960550" "unprognostic (1.11e-1)" "unprognostic (9.32e-3)" "unprognostic (1.39e-1)" "unprognostic (6.65e-2)" "unprognostic (1.60e-1)" "unprognostic (4.46e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-3)" "unprognostic (2.45e-1)" "unprognostic (7.08e-5)" "unprognostic (1.55e-2)" "unprognostic (5.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.77e-3)" 6.2 0.0 2.0 0.2 3.1 0.1 1.3 9.9 2.7 0.2 0.3 0.2 0.1 0.9 0.0 0.6 1.5 1.9 2.7 2.3 0.0 0.3 0.3 0.9 3.5 2.0 0.0 0.0 0.0 1.9 0.8 1.1 1.0 0.1 3.1 2.0 0.2 0.2 3.1 0.8 0.3 1.6 0.0 0.3 1.6 0.0 0.7 0.3 1.7 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 2.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.7 5.3 0.9 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.2 0.5 0.4 0.1 0.5 1.6 0.1 0.0 0.8 0.2 0.5 2.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.1 0.1 0.1 3.2 0.1 0.1 3.1 2.3 1.7 0.3 0.9 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 1.4 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 1.7 0.6 0.0 0.0 0.0 3.5 0.0 0.9 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.1 4.6 0.0 0.1 3.2 0.0 0.6 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709431 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 7.0;Cone photoreceptor cells: 3.9;Exocrine glandular cells: 4.4;Pancreatic endocrine cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 58 "dendritic cells: 6.3" "Cell line enhanced" "Detected in some" "HSkMC: 10.6;REH: 18.9;SH-SY5Y: 10.3;U-937: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.7 3.9 7.1 3.0 6.3 0.7 2.1 10.2 9.7 5.2 1.7 8.7 6.0 1.2 3.7 2.9 1.3 2.1 4.2 1.3 5.6 7.2 3.2 1.1 2.7 1.7 7.8 4.6 1.2 1.8 1.4 1.4 7.6 9.6 3.7 0.8 1.1 1.2 7.7 0.9 2.7 1.1 2.3 4.9 1.1 2.9 2.9 3.7 1.3 3.4 1.2 1.4 4.0 0.8 0.0 6.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 2.6 0.5 0.8 1.9 2.1 1.5 0.1 0.1 3.2 0.0 0.0 3.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.3 10.6 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 18.9 0.1 0.0 1.9 0.0 2.6 10.3 0.0 0.0 0.0 1.8 0.0 1.0 0.3 2.0 0.1 0.0 0.8 0.0 0.0 0.1 0.3 9.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 0.0 7.1 6.3 10.2 9.7 5.6 7.2 7.8 4.6 9.6 3.7 0.0 0.3 0.0 0.1 0.8 0.8 2.2 0.0 2.7 0.0 7.0 3.9 1.8 0.0 1.8 1.7 0.0 0.0 0.0 4.4 2.0 0.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.6 0.4 3.3 1.0 0.0 0.3 5.5 0.0 0.0 0.0 0.1 0.0 0.4 0.5 1.0 1.1 2.1 0.0 0.0 0.0 KIF27 DKFZp434D0917 ENSG00000165115 "Kinesin family member 27" Q86VH2 9 83836698-83921465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.7" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 75.0;Early spermatids: 137.7;Late spermatids: 100.4;Spermatocytes: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 15.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 15.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (9.75e-2)" "unprognostic (3.86e-2)" "unprognostic (1.46e-1)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (2.83e-3)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" "unprognostic (3.86e-3)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (2.55e-1)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (1.85e-1)" "unprognostic (2.01e-1)" 4.1 3.7 5.4 2.9 9.3 3.1 5.0 4.0 7.5 6.6 3.8 6.0 9.1 3.2 7.1 11.9 3.7 10.8 4.3 3.9 6.1 4.7 4.5 3.9 5.1 3.5 4.9 3.6 7.2 5.3 7.6 14.5 5.3 21.3 4.8 3.2 5.2 5.3 5.5 3.8 5.6 3.8 4.9 5.4 4.3 4.4 31.7 6.2 8.4 15.1 3.9 3.0 3.5 4.6 1.4 1.2 15.7 0.7 1.1 1.0 0.3 6.3 6.6 5.0 7.7 3.6 3.6 9.7 3.2 3.6 2.0 1.6 1.7 3.4 0.7 2.8 1.5 6.0 5.7 2.2 2.3 2.5 6.4 1.7 1.9 2.2 2.7 5.6 4.7 1.8 2.2 5.4 2.8 7.5 7.6 3.0 7.3 2.0 2.5 0.8 4.7 6.1 4.5 2.8 4.5 3.4 6.1 4.8 1.5 3.6 2.1 5.5 4.5 4.4 1.1 3.8 7.0 2.3 3.7 1.6 3.6 4.0 3.6 3.0 4.2 3.0 0.9 2.1 1.9 3.5 1.3 0.7 2.2 0.6 0.7 0.6 1.4 0.7 0.6 0.7 1.1 1.0 0.6 15.7 1.1 0.2 1.2 0.1 0.3 5.4 9.3 4.0 7.5 6.1 4.7 4.9 3.6 21.3 6.2 6.0 9.8 0.0 4.4 3.1 5.5 8.3 2.5 75.0 23.9 3.5 15.7 2.2 1.7 3.3 137.7 4.9 1.9 0.0 3.3 1.5 2.9 3.5 3.5 2.0 1.2 11.1 1.7 3.7 1.3 100.4 9.2 3.0 3.3 1.0 2.8 11.5 2.1 2.6 6.3 2.1 13.3 6.5 3.9 55.7 20.9 2.0 2.2 2.2 2.3 1.8 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.9 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.1 0.5 0.7 1.2 1.0 0.0 0.7 0.5 0.6 1.3 0.2 0.3 0.0 0.5 0.5 0.2 0.8 1.3 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 36.2;skin 1: 48.2" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 4.2 5.1 18.7 4.2 28.4 4.5 3.4 36.2 35.0 3.1 6.3 2.3 6.6 8.8 2.7 5.2 7.0 2.9 4.4 2.2 13.5 7.2 4.7 2.8 3.8 4.8 4.4 16.8 2.1 7.9 9.8 7.9 2.5 8.3 7.2 4.8 2.2 7.5 6.5 2.3 48.2 7.9 2.1 2.6 8.1 8.7 5.2 6.6 1.6 4.1 1.3 3.5 5.0 4.9 0.8 0.1 0.1 0.1 0.0 0.8 0.1 8.0 6.9 3.3 7.4 4.9 2.9 7.9 4.9 3.5 2.6 2.6 2.7 10.0 8.4 2.8 2.7 4.4 16.5 3.3 4.4 1.1 8.5 2.9 5.1 17.0 3.5 6.3 1.4 15.0 3.8 15.7 2.6 3.4 12.5 1.7 8.3 5.5 8.8 2.0 13.8 6.1 4.3 0.5 8.9 10.3 15.3 0.2 5.0 11.0 12.7 10.6 9.7 3.5 10.7 3.9 2.8 28.4 2.8 4.7 5.2 15.7 5.5 4.9 4.3 2.1 2.3 10.1 7.1 2.8 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.3 0.6 0.1 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 18.7 28.4 36.2 35.0 13.5 7.2 4.4 16.8 8.3 6.6 8.9 9.9 2.2 2.6 5.4 8.9 0.8 7.6 2.7 6.8 14.0 5.9 1.6 1.7 3.2 5.2 0.6 17.3 0.0 1.2 1.5 2.6 3.1 8.1 5.4 2.4 14.3 22.4 2.5 6.2 6.9 7.2 4.8 3.3 1.0 9.9 7.2 2.7 14.0 2.8 4.3 3.3 0.0 1.9 5.1 5.5 9.9 2.5 5.7 9.9 2.6 KLF7 UKLF ENSG00000118263 "Kruppel like factor 7" O75840 2 207074137-207167267 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003423, HPA030490" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003423: , HPA030490: AB_10601922" "unprognostic (5.93e-2)" "unprognostic (2.49e-3)" "unprognostic (2.98e-1)" "unprognostic (3.99e-3)" "unprognostic (2.56e-1)" "unprognostic (2.85e-3)" "unprognostic (5.44e-2)" "unprognostic (1.24e-2)" "unprognostic (6.75e-2)" "unprognostic (8.78e-2)" "unprognostic (3.67e-2)" "unprognostic (1.47e-1)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (3.47e-2)" 22.2 10.1 10.3 15.1 12.0 40.7 17.3 30.2 12.0 12.2 12.1 14.6 9.3 5.7 19.7 13.4 11.6 10.2 13.8 12.1 10.3 8.0 9.9 8.4 17.1 15.7 12.9 9.1 17.1 6.1 3.0 6.4 7.0 17.4 10.2 6.7 7.0 8.9 9.3 6.2 7.9 11.9 24.2 25.7 11.3 10.7 7.9 14.7 14.4 10.8 8.5 8.3 18.4 18.2 4.5 3.0 24.0 11.7 12.9 9.0 3.5 4.5 3.2 8.7 0.6 3.0 8.0 1.8 5.3 4.2 8.2 3.6 0.0 3.7 0.0 3.4 10.7 14.3 11.3 7.4 24.2 4.4 3.1 0.4 0.1 8.9 1.8 5.3 2.3 3.6 10.6 8.2 5.7 19.0 11.9 9.5 2.4 0.0 4.3 6.3 0.1 2.8 0.8 5.1 0.5 1.6 1.2 2.3 3.2 2.0 3.5 13.5 16.5 4.5 6.4 4.3 7.3 1.0 3.6 18.8 16.4 7.9 6.9 6.2 3.3 2.2 0.0 14.5 2.0 3.2 11.5 5.4 6.8 0.9 6.8 0.4 3.0 5.1 1.0 3.0 4.5 9.0 6.1 24.0 12.9 11.7 1.4 4.1 3.5 10.3 12.0 30.2 12.0 10.3 8.0 12.9 9.1 17.4 14.7 38.7 7.0 15.0 23.7 19.5 5.6 12.5 20.4 8.1 15.9 8.7 11.8 0.4 1.7 20.8 4.5 58.3 0.9 0.0 44.8 0.2 12.4 9.7 11.5 13.5 13.1 11.1 5.8 86.0 44.8 3.3 12.7 20.0 3.3 17.2 0.7 8.2 55.3 0.3 9.6 4.5 8.5 45.3 20.2 0.5 7.5 13.4 0.9 4.9 0.6 7.4 KLHDC1 MST025 ENSG00000197776 "Kelch domain containing 1" Q8N7A1 14 49693105-49753152 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 8.9;ASC TERT1: 8.5;HSkMC: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020461 Approved Supported Cytosol No No Cytosol "HPA020461: AB_1852556" "unprognostic (2.97e-2)" "unprognostic (6.30e-2)" "unprognostic (8.49e-3)" "unprognostic (1.26e-2)" "unprognostic (5.46e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (1.95e-2)" "unprognostic (1.01e-1)" "unprognostic (2.53e-1)" "prognostic favorable (1.94e-4)" "unprognostic (3.42e-1)" "unprognostic (5.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" 8.6 9.7 8.5 8.0 14.5 3.3 11.0 13.4 15.2 10.9 8.7 15.4 8.6 4.5 13.3 13.3 5.3 8.9 7.2 9.9 9.2 10.0 7.2 5.9 6.6 7.5 12.0 12.2 18.2 6.7 11.0 13.2 6.0 10.7 10.2 5.6 12.4 7.1 14.2 14.1 11.3 6.5 11.0 12.9 7.9 6.5 11.7 11.7 2.9 12.5 4.4 6.0 7.1 8.5 3.0 3.7 2.5 2.2 1.6 4.8 1.7 1.0 0.5 1.0 0.7 8.9 8.5 0.0 2.4 3.2 0.7 0.6 0.0 2.8 0.5 0.6 0.9 0.8 0.7 0.3 0.0 0.7 2.3 0.8 0.4 0.2 0.0 4.6 0.2 1.0 7.1 0.4 0.3 0.3 4.5 1.8 1.6 0.4 0.0 3.5 0.3 0.7 1.1 0.0 0.3 0.4 0.6 0.7 0.0 1.7 0.2 0.3 2.4 0.4 0.0 0.9 1.1 1.0 1.8 2.6 2.0 2.2 0.7 0.2 0.8 0.1 0.6 2.0 0.3 1.1 1.4 1.0 2.5 2.1 2.2 4.2 3.0 2.8 2.4 1.1 2.1 4.8 4.0 0.1 1.6 1.1 3.7 0.9 1.7 8.5 14.5 13.4 15.2 9.2 10.0 12.0 12.2 10.7 11.7 20.8 6.2 0.8 3.8 3.2 9.9 7.0 5.1 2.7 9.1 0.0 3.9 0.9 8.3 0.7 1.7 5.8 2.2 0.0 0.7 0.6 3.9 1.9 1.1 2.0 2.2 12.7 1.7 5.5 1.3 2.1 16.7 2.6 5.0 1.0 2.2 16.0 0.4 2.9 9.6 1.1 13.1 0.0 6.6 17.9 5.6 2.9 0.2 2.9 1.3 1.3 KLHDC3 "dJ20C7.3, hPeas, PEAS" ENSG00000124702 "Kelch domain containing 3" Q9BQ90 6 43014103-43021298 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.7" "Group enriched" "Detected in all" 9 "Early spermatids: 436.9;Late spermatids: 1305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030131, HPA030132, HPA030133, HPA030134" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350" "unprognostic (3.85e-2)" "prognostic favorable (9.15e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (9.97e-3)" "unprognostic (2.80e-1)" "unprognostic (2.09e-3)" "unprognostic (1.05e-2)" "unprognostic (5.09e-2)" "unprognostic (1.58e-3)" "prognostic favorable (9.08e-4)" "unprognostic (6.34e-2)" "unprognostic (2.88e-2)" "unprognostic (8.73e-2)" "unprognostic (9.78e-2)" "unprognostic (2.88e-1)" "unprognostic (1.52e-1)" 16.1 19.0 37.2 11.6 41.6 14.7 17.6 38.0 68.2 15.2 16.7 14.6 15.4 14.4 12.8 21.2 16.1 19.9 13.6 34.0 34.2 25.7 14.8 20.2 14.4 14.4 26.7 41.6 20.3 15.2 15.6 17.6 20.9 29.6 16.3 15.0 13.5 21.3 18.5 122.7 15.1 14.7 15.9 14.6 14.1 15.4 47.0 15.3 17.4 19.3 17.6 15.6 13.7 11.2 19.5 39.4 41.6 36.3 21.6 31.5 29.8 26.4 8.2 27.3 45.6 18.8 14.2 19.6 12.0 15.5 23.5 25.8 23.5 13.9 26.3 13.7 17.5 8.8 14.1 29.0 15.5 16.1 14.0 39.5 32.7 23.6 24.4 18.5 19.2 23.4 22.8 15.6 18.1 10.6 18.3 22.7 30.1 39.7 18.8 8.8 32.9 31.4 33.1 35.5 66.8 8.8 30.6 20.0 31.5 14.4 15.4 50.6 39.5 12.7 14.6 20.4 18.5 25.4 55.7 13.4 10.7 20.0 11.8 11.8 20.6 25.8 38.2 4.7 27.6 9.0 14.9 36.3 41.6 28.5 33.8 24.0 19.2 23.8 25.8 39.4 19.5 31.5 24.5 17.7 21.6 25.8 21.8 25.1 29.8 37.2 41.6 38.0 68.2 34.2 25.7 26.7 41.6 29.6 15.3 11.9 17.1 31.9 30.7 16.7 29.1 32.5 30.6 5.3 6.8 17.4 13.7 84.7 72.9 52.9 436.9 20.2 33.8 23.3 48.1 97.9 40.2 39.5 13.8 24.5 56.1 30.2 50.3 24.5 35.6 1305.6 41.4 26.0 32.1 61.3 43.7 33.2 40.4 43.6 55.5 45.1 21.9 51.8 26.8 102.4 30.2 18.1 89.5 30.2 50.7 28.0 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50548033-50551022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.4;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 5 "monocytes: 30.7" "Cancer enhanced" "Detected in many" "cervical cancer: 42.3;urothelial cancer: 40.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favorable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.4 0.4 0.3 3.9 1.2 1.2 0.7 0.3 1.5 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.2 0.3 0.3 0.3 0.1 8.4 1.1 1.1 4.0 0.3 0.3 0.8 0.3 12.5 2.2 0.3 0.9 0.7 0.0 0.8 3.0 0.3 0.3 0.3 2.0 0.3 0.3 5.4 0.5 0.3 0.3 6.5 2.9 0.3 1.7 3.0 0.3 3.8 2.0 2.4 4.0 1.4 5.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.1 47.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.4 2.2 0.2 4.5 4.0 3.3 3.8 4.7 5.7 2.0 3.1 5.2 4.3 0.4 1.4 2.8 0.7 4.1 2.5 0.3 1.2 0.3 1.5 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.1 3.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 5.7 0.0 1.6 0.0 0.0 0.0 4.7 0.0 0.0 1.7 0.0 30.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.4 0.0 0.1 KLHDC8A FLJ10748 ENSG00000162873 "Kelch domain containing 8A" Q8IYD2 1 205336065-205357090 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "ovary: 93.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 46.6;Erythroid cells: 46.7;Muller glia cells: 17.4;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "glioma: 45.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.7;HAP1: 11.5;NTERA-2: 2.8;SCLC-21H: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (4.18e-2)" "unprognostic (4.80e-2)" "unprognostic (3.43e-2)" "unprognostic (3.21e-1)" "unprognostic (2.63e-2)" "unprognostic (2.97e-1)" "unprognostic (4.92e-1)" "unprognostic (8.37e-3)" "unprognostic (7.39e-3)" "unprognostic (4.03e-2)" "unprognostic (1.84e-7)" "unprognostic (4.53e-3)" "unprognostic (5.83e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.20e-2)" 0.3 8.0 2.2 0.4 6.0 2.3 0.5 7.8 2.4 0.7 0.5 2.3 0.1 0.6 1.2 1.7 1.4 5.7 0.5 0.4 3.6 5.0 0.3 0.3 0.4 0.3 2.2 1.8 93.4 1.1 0.3 6.5 0.3 8.0 0.4 0.5 3.0 2.2 0.3 0.3 0.5 0.5 1.2 1.3 0.4 1.4 1.8 0.8 0.0 1.5 1.7 1.4 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 11.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 11.7 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 6.0 7.8 2.4 3.6 5.0 2.2 1.8 8.0 0.8 0.0 0.0 0.0 0.0 0.0 46.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.8 0.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 17.4 0.5 0.0 19.8 0.0 4.6 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171611-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.4" "Group enriched" "Detected in many" 9 "granulocytes: 19.4;monocytes: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 15.0 44.0 5.6 4.7 5.8 3.2 12.6 4.5 8.8 12.8 19.3 6.2 10.5 4.6 15.9 12.2 22.6 11.6 13.6 30.5 3.7 8.5 5.6 8.8 6.6 6.3 4.9 5.4 29.6 6.2 5.2 4.2 7.9 5.2 15.2 2.5 21.8 8.4 9.5 15.8 9.8 5.4 18.0 2.4 6.7 6.7 10.0 3.0 2.0 17.1 10.7 6.6 20.0 8.8 0.1 0.6 19.4 5.7 0.0 1.4 1.6 1.5 3.4 14.3 7.2 8.8 5.2 4.4 5.2 3.0 5.2 4.2 2.2 4.6 0.0 3.0 8.7 1.5 0.0 3.5 3.2 1.3 2.8 0.9 9.2 9.3 5.8 16.8 0.0 5.4 8.7 15.3 6.8 0.5 11.8 13.4 3.3 14.3 0.1 3.9 0.4 0.9 10.2 4.7 0.8 8.2 1.4 1.4 0.4 3.9 0.8 0.6 16.2 4.2 0.1 10.4 3.1 4.3 4.5 5.8 4.0 11.3 7.1 1.6 1.3 0.4 0.2 2.9 0.0 1.9 0.0 3.8 19.4 0.8 5.7 0.3 0.0 0.4 0.6 0.3 0.1 1.4 0.8 6.7 0.0 5.0 0.6 0.1 1.6 5.6 5.8 4.5 8.8 3.7 8.5 4.9 5.4 5.2 3.0 8.9 10.4 0.5 10.9 6.8 1.2 36.6 7.6 0.0 5.7 7.0 2.0 6.9 14.9 13.0 6.0 17.8 0.7 0.0 5.2 7.0 14.6 6.8 1.1 5.8 37.1 0.0 6.4 33.7 5.4 5.8 14.1 6.3 11.8 0.0 2.0 19.8 8.8 1.4 13.4 11.3 2.6 97.0 26.4 3.7 4.1 8.5 41.6 2.1 1.5 6.2 KLHL1 "FLJ30047, KIAA1490, MRP2" ENSG00000150361 "Kelch like family member 1" Q9NR64 13 69700594-70108493 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 17.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HeLa: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021196 Uncertain NA NA "HPA021196: AB_1852567" "unprognostic (5.81e-2)" "unprognostic (7.40e-3)" "unprognostic (2.43e-1)" "unprognostic (1.41e-1)" 0.3 1.4 2.0 0.5 5.0 0.3 0.3 3.5 6.9 0.3 0.5 0.0 0.0 0.4 0.3 0.3 0.4 0.3 0.3 0.3 1.8 7.6 0.8 0.3 0.3 0.3 17.6 2.3 0.3 0.7 0.5 1.9 0.3 16.2 2.1 0.4 1.0 0.3 0.4 0.3 0.3 0.6 0.4 5.3 0.3 0.7 1.5 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.0 3.5 4.2 1.8 7.6 17.6 2.3 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960587-965715 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 4.7 7.0 9.9 8.7 8.9 8.2 8.8 14.0 10.0 6.2 5.1 4.9 4.1 8.4 6.5 4.8 9.9 4.6 5.8 4.2 8.4 4.2 7.2 6.1 5.6 8.1 6.7 3.4 1.5 9.5 5.4 12.4 5.7 6.3 6.8 2.3 6.0 11.6 5.6 5.2 19.1 6.1 6.6 4.2 9.8 7.7 9.8 8.2 5.6 5.4 4.0 7.6 6.5 6.7 0.4 1.0 0.0 1.2 0.0 1.7 0.4 4.6 5.2 6.5 15.5 2.3 2.4 7.1 9.1 2.5 5.1 5.0 6.8 7.0 1.7 6.4 3.9 4.9 9.9 6.0 3.7 0.8 9.3 14.4 3.0 18.9 9.6 1.5 3.4 9.5 2.0 1.8 5.0 1.4 6.4 3.1 9.7 9.9 3.0 2.2 5.4 5.6 12.0 7.1 1.8 7.7 9.1 2.6 3.2 2.7 1.8 15.8 14.9 2.6 8.2 8.3 2.1 4.5 6.1 5.4 9.8 13.2 8.5 7.5 6.0 2.1 3.9 5.6 7.8 4.5 0.0 1.2 0.0 1.7 0.1 0.4 0.4 0.3 0.4 0.0 0.4 0.7 0.4 0.0 0.0 0.6 1.0 0.0 0.4 9.9 8.9 14.0 10.0 8.4 4.2 6.7 3.4 6.3 8.2 0.0 1.9 2.0 0.9 2.3 4.5 2.5 0.0 0.0 0.0 3.5 2.0 1.1 0.0 0.9 1.1 0.7 0.9 0.0 0.7 1.6 1.1 0.8 0.0 0.6 1.1 6.4 2.9 4.3 1.8 1.5 0.3 1.9 3.3 0.0 1.6 1.0 1.6 0.0 1.4 1.0 6.4 0.0 1.0 3.7 5.5 2.6 0.7 0.9 1.0 1.0 KLHL28 "BTBD5, FLJ20081" ENSG00000179454 "Kelch like family member 28" Q9NXS3 14 44924319-45042322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000988 Approved Cytosol NA NA Cytosol "HPA000988: AB_1845480" "unprognostic (8.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (7.84e-3)" "unprognostic (9.20e-2)" "unprognostic (4.36e-3)" "unprognostic (4.92e-2)" "unprognostic (2.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.68e-2)" "unprognostic (7.55e-2)" "unprognostic (4.34e-1)" "unprognostic (1.75e-2)" "unprognostic (6.53e-2)" 10.9 9.0 8.8 11.6 12.7 39.2 10.4 22.9 15.5 12.1 9.9 11.1 10.5 9.1 12.6 9.4 12.8 11.2 9.9 8.9 10.3 10.4 8.6 11.2 10.1 13.5 11.2 9.4 14.4 10.6 9.8 18.1 9.9 16.7 10.2 10.8 12.2 12.6 9.0 13.8 11.5 11.0 10.5 12.8 11.5 8.8 14.2 10.9 27.9 13.6 8.6 12.7 11.3 10.8 10.2 6.0 17.7 7.0 13.0 23.1 4.5 4.5 6.9 9.2 6.0 8.4 7.6 7.0 6.1 6.8 9.1 7.7 3.0 7.2 6.8 6.7 10.6 2.4 8.0 8.2 6.5 10.0 12.6 4.4 5.9 7.1 3.5 7.5 9.4 12.9 5.8 9.1 5.8 9.3 5.2 7.2 10.7 5.2 17.0 5.2 6.6 7.4 4.8 5.7 5.2 6.6 6.5 10.3 3.7 5.2 8.3 10.6 6.5 7.9 5.3 8.4 6.2 10.0 4.0 9.1 8.1 9.5 5.7 3.4 10.1 11.0 9.4 2.8 4.2 4.9 17.7 5.0 11.9 12.4 6.9 23.1 10.2 12.4 13.0 4.4 9.6 14.9 12.6 11.6 13.0 7.0 6.0 9.3 4.5 8.8 12.7 22.9 15.5 10.3 10.4 11.2 9.4 16.7 10.9 14.9 6.5 22.3 14.8 21.8 23.0 10.7 7.6 18.7 11.4 17.4 33.4 6.0 6.6 8.4 28.5 11.7 10.5 23.3 4.9 6.4 12.6 10.9 18.5 10.5 8.1 14.3 13.4 14.7 16.2 34.2 20.1 15.3 21.9 12.6 11.1 27.6 9.0 11.6 16.6 6.3 20.9 12.9 16.0 9.9 4.2 26.3 11.8 25.5 10.0 13.6 KLHL29 "KBTBD9, KIAA1921" ENSG00000119771 "Kelch like family member 29" Q96CT2 2 23385217-23708611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.5;RH-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049057, HPA057379" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA049057: AB_2680615, HPA057379: AB_2683422" "unprognostic (8.08e-3)" "unprognostic (2.91e-1)" "unprognostic (7.43e-3)" "unprognostic (2.65e-2)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (3.54e-3)" "unprognostic (1.16e-1)" "unprognostic (4.71e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.19e-4)" "unprognostic (2.53e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.12e-2)" "unprognostic (9.06e-2)" "unprognostic (7.44e-2)" "unprognostic (5.25e-4)" 9.5 20.8 8.9 6.4 14.5 0.8 7.4 9.0 11.7 6.7 9.4 2.6 5.2 2.6 10.9 3.5 5.4 4.8 10.7 3.3 6.7 7.5 4.7 5.4 6.2 5.7 3.6 9.0 4.0 4.7 5.8 17.7 7.6 6.3 10.8 3.4 11.7 4.2 11.7 12.0 6.9 4.2 7.2 2.7 10.6 5.5 2.5 3.7 0.5 1.9 1.8 4.0 7.5 6.4 0.1 0.4 0.0 0.0 0.9 0.7 0.0 1.0 0.9 6.0 3.0 5.7 3.8 10.3 6.1 4.7 2.5 1.8 0.0 0.3 3.9 2.1 2.3 13.5 0.2 1.4 5.2 1.7 0.0 6.3 0.0 5.1 0.0 2.0 0.0 7.9 2.7 7.1 3.3 9.3 0.8 4.2 0.1 0.0 0.0 1.3 0.5 1.3 0.0 3.0 0.0 1.8 0.3 15.4 0.0 4.6 1.8 9.0 1.8 0.8 0.6 3.5 2.5 0.0 0.0 4.2 2.5 11.7 5.3 2.1 0.1 0.0 0.0 9.5 0.4 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.7 0.0 0.9 0.0 0.4 0.0 0.0 8.9 14.5 9.0 11.7 6.7 7.5 3.6 9.0 6.3 3.7 6.0 4.0 0.0 9.1 4.1 2.3 2.0 5.1 1.4 1.2 1.8 25.5 0.7 0.0 1.0 1.7 1.4 0.0 0.0 0.2 0.9 1.7 1.7 0.0 0.4 0.2 1.6 4.1 0.6 0.0 0.0 4.6 0.0 1.7 0.0 0.6 1.3 0.4 0.0 3.9 1.3 23.5 6.5 5.1 0.0 1.1 5.1 0.7 0.0 0.2 1.3 KLHL30 FLJ43374 ENSG00000168427 "Kelch like family member 30" Q0D2K2 2 238138722-238152947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 62.8" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 11.5;Smooth muscle cells: 5.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.1;CAPAN-2: 3.2;EFO-21: 3.1;REH: 2.6;RH-30: 8.8;THP-1: 4.3" "Region enriched" "Detected in single" 35 "olfactory region: 11.6" "Low region specificity" "Detected in all" HPA062095 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA062095: AB_2684680" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (2.07e-4)" "unprognostic (6.02e-5)" "unprognostic (1.29e-1)" "unprognostic (1.22e-2)" "unprognostic (1.31e-1)" "unprognostic (4.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "unprognostic (8.17e-4)" "unprognostic (2.75e-2)" "unprognostic (2.30e-1)" "unprognostic (2.06e-1)" 4.4 0.1 0.1 0.3 0.1 0.1 2.4 0.1 0.1 1.2 0.5 0.1 0.1 0.2 1.2 2.3 1.3 0.4 0.4 6.1 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.7 0.3 1.4 0.1 0.8 1.7 0.6 62.8 0.2 0.3 1.5 0.1 0.1 0.3 0.4 0.0 0.0 0.9 8.7 0.2 1.6 1.4 0.7 1.4 1.1 2.5 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.0 6.1 0.0 0.1 0.1 0.0 0.2 3.2 0.0 3.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.0 0.3 2.2 0.2 0.0 0.0 2.6 8.8 1.4 0.7 0.0 0.1 0.2 0.1 0.8 0.3 0.5 0.0 4.3 0.0 0.1 0.5 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.1 0.5 2.5 0.3 0.2 0.5 0.2 0.7 0.1 0.1 1.4 0.6 0.2 0.3 1.1 0.5 0.3 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL31 "bA345L23.2, BKLHD6, KBTBD1" ENSG00000124743 "Kelch like family member 31" Q9H511 6 53647901-53665708 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9" "Cell type enriched" "Detected in single" 284 "Cardiomyocytes: 217.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 2.8;SCLC-21H: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (7.67e-4)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (3.98e-2)" "unprognostic (5.50e-2)" "unprognostic (4.24e-1)" "unprognostic (1.09e-4)" "unprognostic (8.73e-2)" "unprognostic (2.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" 13.1 0.5 0.1 0.3 0.3 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 1.2 1.3 0.6 0.1 77.7 0.2 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.0 1.6 0.0 57.7 0.6 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 40.9 2.2 0.3 0.2 0.7 0.0 0.0 0.1 0.9 0.6 0.0 1.0 0.7 0.2 0.2 0.0 0.0 0.5 0.0 0.2 0.2 0.1 1.2 2.5 0.0 0.2 0.0 0.7 1.9 0.8 0.4 0.1 0.1 1.3 0.4 1.7 1.6 0.1 0.6 0.0 2.1 2.6 0.0 0.5 0.5 0.0 1.4 0.0 0.2 0.0 0.8 0.9 0.0 0.3 1.3 0.8 0.1 2.8 0.1 0.8 0.9 3.7 0.4 0.2 0.6 0.0 0.3 1.2 0.0 0.0 0.1 0.5 0.0 0.2 0.5 0.1 0.0 0.3 2.1 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.0 0.2 0.0 0.3 0.2 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.6 0.3 217.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.4 KLHL32 "BKLHD5, KIAA1900" ENSG00000186231 "Kelch like family member 32" Q96NJ5 6 96924620-97140754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 47.1;fallopian tube: 12.8" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 24.1;Horizontal cells: 17.5;Intestinal endocrine cells: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.2;T-cells: 5.5" "Cell line enhanced" "Detected in some" "Daudi: 6.0;HDLM-2: 8.2;JURKAT: 3.1;RPMI-8226: 3.7;SCLC-21H: 3.5;U-266/70: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039150 Enhanced NA NA "HPA039150: AB_2676367" "unprognostic (1.75e-1)" "unprognostic (7.99e-2)" "unprognostic (6.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (5.00e-1)" "unprognostic (3.12e-3)" "unprognostic (5.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.51e-5)" "unprognostic (5.82e-2)" "unprognostic (6.04e-2)" "unprognostic (7.01e-2)" "unprognostic (1.86e-2)" "unprognostic (7.48e-2)" "unprognostic (4.49e-4)" 1.0 2.6 14.2 1.5 47.1 1.1 1.5 8.8 36.9 1.5 2.0 19.4 0.0 2.3 1.3 1.8 1.0 12.8 1.5 2.1 16.2 11.1 4.3 2.0 2.2 1.6 31.0 14.7 2.7 3.2 2.6 3.0 1.0 22.0 1.2 2.5 0.1 1.8 1.3 2.9 1.1 2.9 1.2 30.6 1.4 1.7 3.7 32.2 0.0 2.3 0.0 1.6 1.1 0.5 2.2 0.1 0.1 0.0 0.7 5.5 1.5 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.5 6.0 0.2 0.0 0.0 0.2 0.6 0.2 0.0 8.2 1.3 0.4 0.1 0.2 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.9 3.0 0.0 0.0 1.5 0.4 0.4 0.3 0.3 0.2 0.0 3.7 0.0 0.0 3.5 1.2 0.0 0.0 0.8 0.2 0.2 0.2 0.4 0.0 0.1 0.0 0.0 4.4 0.7 2.4 0.2 0.3 0.4 0.0 0.0 0.0 0.9 0.0 2.1 2.2 3.6 1.3 0.1 1.5 4.2 5.5 0.1 0.7 0.0 0.0 2.5 1.5 14.2 47.1 8.8 36.9 16.2 11.1 31.0 14.7 22.0 32.2 3.0 0.0 0.0 0.2 0.0 0.1 2.2 0.0 24.1 0.0 5.2 0.0 0.0 3.3 0.1 4.6 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 17.5 10.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.4 0.0 KLHL34 "FLJ34960, RP11-450P7.3" ENSG00000185915 "Kelch like family member 34" Q8N239 X 21654690-21658330 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 31.1" "Cell type enhanced" "Detected in some" 27 "Cone photoreceptor cells: 13.7;Horizontal cells: 15.9;Rod photoreceptor cells: 62.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA060287 Uncertain NA NA "HPA060287: AB_2684243" "unprognostic (2.00e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (3.02e-1)" "unprognostic (3.14e-2)" "unprognostic (8.68e-2)" "unprognostic (9.17e-2)" "unprognostic (3.24e-1)" "unprognostic (3.40e-2)" "unprognostic (3.74e-1)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (8.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (3.29e-1)" 0.3 0.1 0.7 0.1 0.9 0.0 0.0 1.7 0.8 0.0 0.3 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.0 1.8 0.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 3.1 0.6 0.0 31.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 2.8 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.5 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.1 0.0 1.1 0.1 0.8 0.2 0.0 0.2 1.0 0.5 0.0 0.1 0.0 0.9 0.1 0.1 0.8 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.3 3.0 0.9 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.9 1.7 0.8 0.5 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 6.5 7.8 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 2.0 0.0 0.0 62.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 KLHL5 ENSG00000109790 "Kelch like family member 5" Q96PQ7 4 39045039-39126857 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013958 Approved NA NA "HPA013958: AB_1852590" "unprognostic (6.02e-2)" "unprognostic (3.94e-1)" "unprognostic (3.92e-1)" "unprognostic (7.54e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-2)" "unprognostic (3.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-1)" "unprognostic (6.04e-2)" "unprognostic (2.87e-2)" "unprognostic (1.42e-2)" "unprognostic (1.05e-2)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" "unprognostic (3.24e-3)" 24.6 15.0 31.9 21.2 27.6 5.1 33.1 10.4 20.9 11.9 29.5 20.7 15.6 8.1 12.7 9.2 21.3 6.7 15.1 10.1 31.5 25.2 16.4 35.2 14.0 19.6 33.4 11.9 12.5 7.3 7.3 6.4 33.1 18.1 24.4 10.9 6.5 8.1 44.5 6.1 4.6 9.8 32.3 34.2 14.3 10.9 6.9 20.7 6.9 14.0 4.6 23.9 25.7 14.3 7.4 4.1 5.6 5.2 1.8 2.6 1.3 12.5 17.8 9.5 6.9 5.4 14.0 13.8 10.1 74.2 8.5 8.3 14.6 9.2 19.4 12.3 10.3 45.2 0.7 11.6 25.6 10.9 1.9 2.3 8.2 16.8 10.4 46.8 2.4 2.8 17.7 14.4 12.9 32.4 31.5 16.9 3.1 6.2 3.9 20.0 5.3 2.5 4.3 2.9 3.2 17.4 4.6 12.5 0.4 7.3 5.2 0.6 6.9 5.7 1.8 4.9 12.0 4.4 5.1 21.4 22.8 15.6 5.9 12.0 4.5 4.0 17.9 18.5 6.4 5.2 5.6 3.9 0.8 1.4 5.2 2.1 7.4 2.6 1.5 4.1 5.9 2.1 1.0 4.3 1.8 2.3 1.5 0.5 1.3 31.9 27.6 10.4 15.8 31.5 25.2 33.4 11.9 18.1 20.7 14.9 1.4 25.3 7.3 3.3 6.5 3.9 15.3 24.1 29.6 10.4 3.9 0.5 14.9 33.8 2.4 26.3 0.0 0.0 18.5 50.9 10.0 14.8 2.3 27.6 12.6 66.7 1.2 20.3 18.6 5.4 7.5 19.4 16.9 22.6 0.0 9.2 18.6 0.0 13.1 17.9 3.2 0.0 16.5 8.4 4.4 3.0 4.8 7.5 0.0 6.7 KLK13 KLK-L4 ENSG00000167759 "Kallikrein related peptidase 13" Q9UKR3 19 51056206-51065114 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 100.5" "Cell type enriched" "Detected in some" 7 "Late spermatids: 184.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 42.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "HaCaT: 20.8" "Not detected" "Not detected" HPA062136 Enhanced "Secreted in other tissues" NA NA "HPA062136: AB_2684694" "unprognostic (1.99e-3)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (3.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.69e-1)" "unprognostic (6.76e-2)" "unprognostic (2.18e-2)" "unprognostic (8.30e-2)" "unprognostic (7.07e-6)" "unprognostic (7.33e-2)" "unprognostic (2.53e-1)" "unprognostic (6.38e-2)" "unprognostic (7.06e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 15.7 0.4 0.2 0.1 0.2 0.3 0.1 100.5 0.2 0.9 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.4 1.7 0.0 0.5 0.1 0.2 0.1 0.0 0.3 12.4 0.1 1.2 2.1 0.4 0.1 0.1 0.1 0.2 6.1 0.1 0.1 0.1 17.9 12.8 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 20.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.4 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 184.3 0.3 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.7 1.1 0.0 0.0 0.0 2.0 KLK9 KLK-L3 ENSG00000213022 "Kallikrein related peptidase 9" Q9UKQ9 19 51003111-51009634 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "tongue: 37.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "HaCaT: 1.2;HBEC3-KT: 4.2" CAB025049 Enhanced "Secreted to digestive system" NA NA "CAB025049: " "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 37.6 3.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in some" 19 "Club cells: 1.2;Intestinal endocrine cells: 1.7;T-cells: 1.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;GAMG: 5.1;HEL: 2.2;HeLa: 11.6;HSkMC: 2.2;SuSa: 2.8;U-698: 3.2" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.6 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 KLRC4 NKG2-F ENSG00000183542 "Killer cell lectin like receptor C4" O43908 12 10407382-10409757 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.3;lymphoid tissue: 11.8" "Cell type enriched" "Detected in some" 4 "T-cells: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "gdT-cell: 9.3;memory CD8 T-cell: 6.5;naive CD8 T-cell: 7.5;NK-cell: 5.4" "Group enriched" "Detected in many" 67 "NK-cells: 5.4;T-cells: 9.3" "Cell line enhanced" "Detected in some" "HeLa: 9.7;HSkMC: 1.9;SuSa: 3.9;U-698: 3.5" NA NA "unprognostic (3.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.60e-1)" "unprognostic (7.00e-2)" "unprognostic (1.55e-4)" "unprognostic (1.89e-2)" "unprognostic (1.52e-1)" "unprognostic (3.32e-1)" "unprognostic (2.92e-1)" "unprognostic (4.36e-1)" "unprognostic (3.44e-7)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (5.51e-3)" 1.6 0.8 2.3 2.5 1.6 1.6 1.7 1.3 3.9 5.0 2.6 0.6 0.6 1.4 0.9 0.6 0.8 1.0 2.8 0.6 2.6 1.5 3.7 1.9 3.5 5.6 1.9 0.6 0.6 0.6 0.0 0.6 1.3 1.5 1.1 1.6 2.1 1.2 3.8 0.6 0.3 4.2 0.6 2.0 11.8 2.6 0.6 0.6 1.2 1.5 0.6 6.9 2.1 1.1 0.0 0.0 0.1 0.0 5.4 9.3 1.5 0.0 0.2 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.5 9.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.3 0.0 0.0 6.5 0.0 0.0 0.0 7.5 0.1 5.4 0.0 0.0 0.0 1.5 2.3 1.6 1.3 1.4 2.6 1.5 1.9 0.6 1.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 KNCN "FLJ32011, KINO, L5" ENSG00000162456 Kinocilin A6PVL3 1 46545644-46551527 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.9;pituitary gland: 1.0;testis: 2.5" "Group enriched" "Detected in some" 41 "Early spermatids: 10.4;Late spermatids: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.99e-3)" "unprognostic (2.28e-2)" "unprognostic (2.80e-2)" 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160447-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 7.0;Ciliated cells: 22.7;Club cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 10 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;EFO-21: 2.9;MCF7: 2.6;NTERA-2: 3.6;RPMI-8226: 5.0;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.1 11.4 14.7 1.2 13.2 1.0 1.2 23.9 26.2 2.1 1.1 5.4 0.0 1.1 3.9 2.7 1.0 14.6 1.5 1.2 11.3 12.1 1.5 5.5 4.2 1.1 8.3 13.2 10.9 2.1 1.0 13.2 1.9 8.5 2.0 1.1 0.7 2.5 3.2 1.2 1.2 1.2 1.9 3.2 1.7 1.4 2.8 3.5 0.0 2.4 0.0 1.1 1.1 0.3 0.3 0.0 0.0 3.1 0.0 0.0 0.1 0.6 0.9 0.5 4.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.5 0.6 0.0 2.9 0.3 1.4 0.6 0.1 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 3.6 0.1 0.0 0.0 0.1 5.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 4.9 0.4 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 14.7 13.2 23.9 25.2 11.3 12.1 8.3 13.2 8.5 3.5 0.0 7.0 0.0 0.0 0.0 0.8 2.0 2.5 22.7 6.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 4.3 0.2 1.6 2.9 0.0 1.0 0.8 3.4 0.4 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "placenta: 78.4;testis: 68.5" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 1048.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 9.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 9.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 1.1 1.8 1.6 0.3 2.1 0.3 1.4 2.1 2.3 1.9 1.6 1.8 1.2 0.8 2.6 5.4 2.1 1.9 1.2 2.3 1.4 1.2 1.4 0.3 0.7 0.7 1.4 1.2 3.2 2.3 0.3 1.9 78.4 1.6 1.6 1.0 2.3 2.1 2.7 0.5 2.5 1.0 2.3 1.8 0.7 1.1 68.5 0.6 0.2 2.5 1.1 0.8 1.2 1.1 0.8 1.7 1.2 1.2 9.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 10.6 0.0 0.0 0.0 22.9 0.0 11.2 0.8 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.5 0.0 16.1 10.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 8.2 0.0 31.8 0.0 3.4 1.1 0.0 1.7 0.0 0.6 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.9 0.0 9.0 1.2 1.7 0.5 0.2 1.6 2.1 2.1 2.3 1.4 1.2 1.4 1.2 1.6 0.6 0.0 1.6 0.0 2.5 0.0 6.5 4.8 5.1 1.4 3.4 5.2 2.0 9.4 16.6 4.1 134.8 0.4 0.7 0.0 10.5 8.6 1.6 1.5 0.0 0.5 2.0 1.6 0.0 1.3 0.0 72.9 18.7 0.0 0.0 0.0 0.8 12.4 6.2 1.9 12.7 1.7 7.4 12.9 3.3 1048.9 159.2 0.0 7.6 0.0 1.7 0.8 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46446857-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065295 Approved Nucleoplasm NA NA Nucleoplasm "HPA065295: AB_2685456" "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.87e-6)" "prognostic favorable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.17e-4)" 17.8 11.3 16.9 10.5 22.3 6.8 17.0 24.9 21.0 14.4 14.2 19.9 11.7 7.9 25.6 27.9 8.5 16.0 14.1 10.6 13.6 16.6 12.0 16.4 13.5 15.5 16.1 16.8 22.4 14.0 17.3 24.5 20.3 22.2 16.8 11.1 13.2 9.8 14.6 8.7 13.4 10.5 18.1 17.2 19.7 10.3 6.4 19.0 12.6 17.0 9.3 14.5 14.3 12.9 17.4 12.5 13.7 8.8 13.8 17.8 8.2 14.8 8.5 13.7 10.4 13.5 14.2 8.3 14.5 13.3 13.5 12.4 7.5 13.7 8.5 9.7 12.4 22.1 10.6 16.9 8.1 16.0 8.3 7.2 7.0 17.6 7.1 14.6 10.3 11.5 15.8 9.0 18.5 15.4 12.0 12.6 13.1 7.5 9.4 12.1 8.6 10.6 5.2 12.3 5.8 15.6 7.5 12.7 10.5 8.7 6.2 5.0 9.7 12.5 6.1 13.9 24.3 10.1 10.4 11.3 15.2 15.1 19.7 11.8 10.3 11.6 12.2 13.0 0.5 13.6 12.2 6.7 13.7 12.7 8.2 13.3 13.2 13.7 12.2 6.6 17.4 17.8 12.7 5.1 13.8 8.8 12.5 11.6 8.2 16.9 22.3 24.9 21.0 13.6 16.6 16.1 16.8 22.2 19.0 6.0 6.7 12.3 3.7 1.9 5.7 6.3 10.2 5.3 4.5 5.2 3.9 11.8 8.3 7.0 0.2 12.3 2.0 0.0 4.0 6.6 7.5 4.3 7.0 4.0 8.1 9.5 1.2 16.5 6.5 0.9 7.2 4.6 6.8 3.6 3.6 10.1 3.1 4.3 10.6 4.5 7.8 12.9 5.1 1.9 5.1 2.4 11.3 8.7 4.3 1.4 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88055729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: AB_2681907" "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 22.5 15.0 23.1 30.6 27.3 5.7 25.9 23.5 20.4 23.3 29.9 15.8 19.9 20.7 17.8 29.1 26.4 18.4 16.5 21.4 27.0 15.7 21.5 28.1 23.4 22.3 30.3 15.2 20.3 19.4 24.8 23.8 17.3 23.8 24.0 29.7 12.1 20.8 37.9 23.0 16.7 28.9 24.7 28.2 22.0 17.5 10.0 29.9 20.2 26.9 14.5 20.5 22.1 20.2 18.3 12.7 37.2 11.6 14.8 16.5 8.0 11.5 7.1 11.2 8.2 27.1 32.1 8.3 18.3 20.5 9.8 9.7 0.6 15.6 16.4 6.6 11.6 15.0 6.0 2.5 3.8 11.1 17.2 3.5 3.1 1.9 1.1 19.8 4.7 2.2 16.0 19.1 6.5 14.1 25.7 11.0 13.3 4.4 8.2 21.1 9.8 5.4 6.6 8.5 16.8 4.8 11.1 2.0 1.7 14.8 6.3 8.7 8.8 7.0 9.7 21.3 8.7 6.8 19.6 15.3 11.7 0.8 19.1 5.7 18.7 13.0 13.1 12.5 12.7 27.4 24.7 11.0 37.2 10.1 11.6 11.7 18.3 12.4 12.3 12.7 16.9 14.2 11.2 17.9 14.8 10.0 11.2 16.5 8.0 23.1 27.3 23.5 20.4 27.0 15.7 30.3 15.2 23.8 29.9 32.8 32.4 29.1 30.1 29.3 9.3 36.0 35.7 69.6 47.8 33.2 2.0 40.4 51.4 41.9 2.6 25.4 58.0 0.0 62.9 15.7 37.7 49.3 41.6 47.4 42.5 9.5 40.0 35.6 34.9 3.1 44.3 35.7 27.0 47.7 57.8 33.8 42.5 69.1 40.7 60.7 5.4 19.4 29.2 38.7 19.0 37.3 35.0 34.6 65.3 23.8 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2963944-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;skin 1: 12.5" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 12.6;Cone photoreceptor cells: 5.9;Mucus-secreting cells: 9.5;Rod photoreceptor cells: 10.0;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 6 "B-cells: 3.2;monocytes: 1.4" "Cell line enhanced" "Detected in many" "HMC-1: 20.3;MCF7: 10.2;RPMI-8226: 19.1;T-47d: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavorable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.2 0.1 1.6 2.0 0.7 1.7 0.2 0.2 3.0 1.8 0.4 0.2 4.5 0.3 0.3 0.8 3.8 0.6 0.3 0.2 1.9 0.3 0.2 0.2 0.2 0.8 0.7 0.2 0.2 0.4 0.0 0.2 0.2 0.3 1.6 0.0 1.9 1.6 0.2 0.6 12.5 0.6 0.2 1.7 0.9 0.5 2.1 0.2 13.1 0.2 1.8 6.8 0.2 0.6 3.2 0.3 0.0 1.4 0.0 0.0 0.0 1.2 0.8 0.3 7.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 2.9 1.1 5.3 1.5 0.0 0.8 6.0 0.9 0.5 0.0 0.8 0.8 0.3 1.7 1.7 0.0 0.4 20.3 0.2 0.0 0.0 0.1 0.6 0.0 0.6 2.1 2.1 0.0 10.2 1.2 2.4 2.0 2.1 1.5 3.2 8.3 19.1 0.0 0.2 2.1 1.2 1.4 3.3 3.3 0.2 10.3 1.9 0.1 0.6 8.9 0.7 0.5 3.8 0.8 3.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.7 0.2 2.3 1.9 0.3 0.7 0.2 0.3 0.2 0.0 0.0 0.0 0.6 12.6 0.4 0.8 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.4 1.6 0.0 2.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.3 0.0 9.5 0.2 0.2 0.2 0.0 0.0 10.0 0.0 0.0 0.5 5.9 4.8 0.1 0.0 0.2 0.3 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 22.0;Cholangiocytes: 12.7;Horizontal cells: 27.0;Muller glia cells: 33.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 16.3" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195" "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 3.8 5.0 9.6 0.7 18.3 0.6 1.3 15.6 21.7 2.3 1.8 0.2 0.9 1.2 1.9 11.8 1.2 1.2 8.3 1.0 10.0 10.0 1.3 9.4 1.4 1.1 8.6 13.4 0.9 1.7 1.6 5.2 0.6 14.3 3.2 2.3 0.8 0.7 4.6 0.6 0.8 2.3 3.1 3.3 3.4 1.0 1.4 3.3 0.0 1.2 0.3 1.1 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 18.3 15.6 21.7 10.0 10.0 8.6 13.4 14.3 3.3 0.0 0.3 0.0 0.5 0.1 22.0 0.4 12.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.3 1.4 0.0 0.0 0.2 0.1 0.0 0.1 2.3 2.9 0.0 27.0 0.0 0.6 0.0 0.0 6.1 0.0 0.0 0.0 0.0 33.2 0.1 0.0 0.7 1.2 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRT32 "Ha-2, KRTHA2" ENSG00000108759 "Keratin 32" Q14532 17 41459811-41467429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "esophagus: 12.8;skin 1: 18.0" "Cell type enhanced" "Detected in single" 25 "Peritubular cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.8;HaCaT: 1.3;hTERT-RPE1: 4.4;MCF7: 1.4;PC-3: 2.1;U-2197: 1.1;U-87 MG: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 230000000 "unprognostic (1.39e-2)" "unprognostic (3.29e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "unprognostic (2.32e-2)" "unprognostic (2.67e-3)" "unprognostic (2.72e-9)" "unprognostic (1.31e-2)" "unprognostic (1.77e-1)" 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 KRT33A "Ha-3I, Krt1-3, KRTHA3A" ENSG00000006059 "Keratin 33A" O76009 17 41346092-41350812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 30.4" "Group enriched" "Detected in some" 6 "Early spermatids: 2.1;Late spermatids: 1.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 5.5" HPA055194 Supported NA NA 160000000 "HPA055194: AB_2682733" "unprognostic (1.93e-1)" "unprognostic (1.30e-2)" "unprognostic (4.58e-2)" "unprognostic (4.34e-1)" "unprognostic (2.16e-1)" 0.5 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 5.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 30.4 0.1 0.1 0.1 0.1 0.0 3.3 0.1 2.8 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT84 "Hb-4, KRTHB4" ENSG00000161849 "Keratin 84" Q9NSB2 12 52377812-52385652 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 86.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "gdT-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 1.2;HaCaT: 1.7;U-251 MG: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA039714 Supported NA NA 79000000 "HPA039714: AB_2676641" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.0 86.0 3.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-3 KAP1.3 ENSG00000221880 "Keratin associated protein 1-3" Q8IUG1 17 41033884-41034855 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 88 "skin 1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 2.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 40.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-4 KAP1.4 ENSG00000204887 "Keratin associated protein 1-4" P0C5Y4 17 41029697-41030104 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skin 1: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HDLM-2: 1.7;HeLa: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-1 "KAP10.1, KAP18.1, KRTAP18-1" ENSG00000215455 "Keratin associated protein 10-1" P60331 21 44538981-44540195 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 13.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-10 "KAP10.10, KAP18.10, KRTAP18-10" ENSG00000221859 "Keratin associated protein 10-10" P60014 21 44637356-44638455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "skin 1: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.7" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-12 "KAP10.12, KRTAP18-12, KRTAP18.12" ENSG00000189169 "Keratin associated protein 10-12" P60413 21 44697172-44698044 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "skin 1: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SCLC-21H: 1.0" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-2 "KAP10.2, KAP18.2, KRTAP18-2" ENSG00000205445 "Keratin associated protein 10-2" P60368 21 44550357-44551505 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skin 1: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enhanced" "Detected in single" "granulocytes: 1.5" "Cell line enriched" "Detected in single" 6 "U-266/84: 3.6" NA NA "unprognostic (1.26e-1)" 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-3 "KAP10.3, KAP18.3, KRTAP18-3" ENSG00000212935 "Keratin associated protein 10-3" P60369 21 44557790-44558760 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "skin 1: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "SCLC-21H: 2.0" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP13-1 KAP13.1 ENSG00000198390 "Keratin associated protein 13-1" Q8IUC0 21 30396074-30396822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skin 1: 13.0;tongue: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 2000000 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-1 KAP2.1A ENSG00000212725 "Keratin associated protein 2-1" Q9BYU5 17 41046541-41047316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "skin 1: 34.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;SCLC-21H: 2.5" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRTAP2-2 KAP2.2 ENSG00000214518 "Keratin associated protein 2-2" Q9BYT5 17 41054498-41055230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 305 "skin 1: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP24-1 KAP24.1 ENSG00000188694 "Keratin associated protein 24-1" Q3LI83 21 30281309-30282958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "skin 1: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017604 Enhanced NA NA "HPA017604: AB_2669625" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP27-1 ENSG00000206107 "Keratin associated protein 27-1" Q3LI81 21 30337013-30337694 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021522, HPA048826" Approved NA NA "HPA021522: AB_1852643, HPA048826: AB_2680534" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-1 "KAP4.1, KAP4.10, KRTAP4-10" ENSG00000198443 "Keratin associated protein 4-1" Q9BYQ7 17 41184102-41185342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 14.8" "Cell type enriched" "Detected in single" 6 "Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.2;A549: 3.5;CAPAN-2: 2.6;HDLM-2: 9.8;SCLC-21H: 2.4;SK-BR-3: 2.0" "Not detected" "Not detected" NA NA "unprognostic (1.21e-1)" "unprognostic (3.57e-1)" "unprognostic (1.64e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.49e-2)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 1.3 0.1 0.1 0.2 0.1 14.8 1.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 1.4 0.0 0.0 2.4 0.0 0.0 2.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRTAP4-3 KAP4.3 ENSG00000196156 "Keratin associated protein 4-3" Q9BYR4 17 41167231-41168194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enriched" "Detected in single" 52 "HDLM-2: 5.2" NA NA 390000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-6 "KAP4.15, KAP4.6, KRTAP4-15" ENSG00000198090 "Keratin associated protein 4-6" Q9BYQ5 17 41139433-41140487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "skin 1: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 13 "B-cells: 1.5" "Group enriched" "Detected in some" 13 "CACO-2: 1.2;HaCaT: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-8 KAP4.8 ENSG00000204880 "Keratin associated protein 4-8" Q9BYQ9 17 41096981-41098141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.1;BJ hTERT+ SV40 Large T+: 1.2;HBF TERT88: 4.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-9 KAP4.9 ENSG00000212722 "Keratin associated protein 4-9" Q9BYQ8 17 41105332-41106488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "skin 1: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.9;BJ hTERT+ SV40 Large T+: 1.4;U-138 MG: 1.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-10 KRTAP5.10 ENSG00000204572 "Keratin associated protein 5-10" Q6L8G5 11 71565563-71566738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 5.6;skin 1: 8.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 1.4;Club cells: 1.2;Early spermatids: 1.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "RT4: 8.9" NA NA "unprognostic (4.05e-2)" "unprognostic (5.64e-3)" "unprognostic (1.39e-2)" "unprognostic (6.47e-2)" "unprognostic (7.81e-2)" "unprognostic (4.70e-2)" "unprognostic (5.55e-2)" "unprognostic (1.68e-1)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-4)" "unprognostic (9.43e-2)" "unprognostic (1.37e-1)" "unprognostic (6.21e-2)" "unprognostic (2.27e-4)" 0.3 0.0 0.2 0.0 0.7 0.1 0.6 0.4 0.1 0.1 0.1 0.0 0.0 5.6 0.1 0.9 0.2 0.0 0.2 0.1 0.4 0.4 0.1 0.0 0.1 0.1 1.8 0.0 0.2 0.0 0.4 0.3 0.1 1.1 0.7 8.3 0.3 0.0 0.2 0.2 0.1 0.8 0.2 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.5 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 KRTAP5-5 "KRTAP5-11, KRTAP5.5" ENSG00000185940 "Keratin associated protein 5-5" Q701N2 11 1629775-1630707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skin 1: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.45e-2)" "unprognostic (1.00e-2)" "unprognostic (7.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.7 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP7-1 KAP7.1 ENSG00000274749 "Keratin associated protein 7-1 (gene/pseudogene)" Q8IUC3 21 30829039-30829759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.3;skin 1: 1.6;tongue: 3.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 16 "urothelial cancer: 1.2" "Cell type enriched" "Detected in single" 13 "T-reg: 2.3" "Lineage enriched" "Detected in single" 13 "T-cells: 2.3" "Group enriched" "Detected in some" 5 "SiHa: 3.4;SK-MEL-30: 2.0;WM-115: 2.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-9 "KAP9.5, KAP9.9, KRTAP9-5" ENSG00000198083 "Keratin associated protein 9-9" Q9BYP9 17 41255384-41256364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 208 "skin 1: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Cell line enhanced" "Detected in some" "A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 28.1 0.2 0.7 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.1 9.0 32.2 0.2 0.2 0.0 0.0 10.3 0.2 7.3 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.7 0.3 0.1 0.0 7.5 0.3 1.9 6.1 14.3 0.1 0.1 0.2 0.7 0.0 0.0 15.1 0.5 0.4 9.4 0.6 0.5 0.2 0.2 0.0 0.3 0.7 0.3 0.2 1.6 1.1 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 20.8 18.0 3.7 106.9 20.7 2.6 0.2 86.6 56.2 43.3 40.1 7.9 15.0 5.0 85.6 4.7 0.8 81.3 0.0 157.5 26.3 1.5 101.7 4.6 12.1 1.8 1.6 59.7 1.3 0.6 3.6 0.3 1.8 6.8 4.6 108.5 1.5 121.7 98.2 0.0 4.9 5.9 0.0 1.0 2.7 33.8 13.6 6.6 1.0 162.2 123.8 LACTBL1 ENSG00000215906 "Lactamase beta like 1" A8MY62 1 22953043-22965338 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 2.2" "Cell type enriched" "Detected in single" 7 "Bipolar cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "Hep G2: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA066810 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA066810: " 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAMB4 ENSG00000091128 "Laminin subunit beta 4" A4D0S4 7 108023548-108130356 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6" "Cell type enhanced" "Detected in some" 22 "Basal keratinocytes: 31.0;Early spermatids: 8.6;Late spermatids: 7.6;Suprabasal keratinocytes: 12.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 6.1;HMC-1: 3.6" "Low region specificity" "Detected in many" "HPA020242, HPA024247" Approved "Secreted to extracellular matrix" NA NA "HPA020242: AB_2670388, HPA024247: AB_2671496" "unprognostic (7.41e-2)" "unprognostic (1.79e-1)" "unprognostic (4.85e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (6.29e-4)" "unprognostic (8.90e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.27e-2)" "unprognostic (1.23e-4)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 13.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 31.1 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 21.6 2.0 0.1 0.1 0.6 0.5 1.6 0.3 1.0 0.4 0.2 0.0 0.9 0.3 0.1 0.6 0.5 6.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.8 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.1 0.0 3.6 1.0 0.2 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.3 0.4 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 1.6 0.3 0.1 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.6 0.3 0.2 1.6 1.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 5.0 0.0 8.6 0.1 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.2 0.3 12.0 1.1 0.0 0.0 0.0 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.1;lung: 6.8" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 7.8;Suprabasal keratinocytes: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 17.2;HMC-1: 5.6;K-562: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria NA NA Mitochondria "HPA005470: AB_2134886, HPA076575: AB_2732315" "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 1.2 0.8 0.7 0.3 2.3 0.9 0.4 2.5 2.4 1.2 3.8 0.7 0.2 0.6 0.5 0.3 4.6 0.2 0.9 0.7 1.1 2.8 0.4 0.2 6.8 0.4 1.3 1.3 1.3 0.2 0.1 1.7 0.2 2.2 0.6 2.8 2.5 1.1 0.9 1.0 2.6 1.1 1.9 1.8 0.2 2.2 1.8 0.9 0.2 1.2 1.7 1.2 1.8 2.9 0.3 0.2 7.1 0.2 1.1 1.8 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.1 2.5 0.3 0.0 0.0 0.3 17.2 1.8 0.0 0.0 0.0 5.6 0.0 0.5 0.0 0.1 0.0 0.3 0.0 3.9 0.0 1.2 0.0 0.2 0.3 0.4 0.2 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 1.2 0.0 0.0 1.6 0.7 0.0 0.0 2.9 0.0 0.4 7.1 0.2 0.9 1.0 0.2 0.8 0.2 0.4 1.8 0.1 0.3 0.1 1.0 1.1 1.1 0.2 0.2 0.6 0.7 0.7 2.3 2.5 2.4 1.1 2.8 1.3 1.3 2.2 0.9 3.0 2.6 0.0 1.1 7.8 0.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.2 0.1 0.4 0.5 1.1 0.0 0.1 3.2 1.7 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.5 1.3 0.9 1.4 0.0 1.4 0.0 1.7 0.2 1.7 3.9 0.1 1.0 0.6 2.2 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.8;Endothelial cells: 33.1;Peritubular cells: 51.9;Sertoli cells: 32.3;Urothelial cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "myeloid DC: 10.3;T-reg: 11.8" "Group enriched" "Detected in many" 111 "dendritic cells: 10.3;T-cells: 11.8" "Cell line enhanced" "Detected in many" "BJ: 39.7;BJ hTERT+: 43.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.6;fHDF/TERT166: 25.7;HSkMC: 25.5;hTERT-RPE1: 25.7;U-138 MG: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol NA NA Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 7.7 2.3 9.3 5.9 12.8 1.3 8.0 1.7 12.5 11.3 21.2 28.9 3.0 4.0 15.1 10.5 5.3 12.8 17.0 5.6 12.6 7.5 4.1 1.4 9.6 12.4 20.6 5.9 39.5 2.3 1.6 5.4 13.1 12.3 13.2 3.8 10.9 4.4 17.9 4.8 2.1 8.2 21.7 10.1 7.5 12.1 4.6 13.1 4.6 26.9 4.8 5.0 11.3 10.1 0.0 10.3 0.0 0.0 0.0 11.8 0.4 0.1 1.0 0.2 0.0 7.1 13.7 1.9 39.7 43.3 20.1 27.6 0.0 0.0 0.0 0.3 25.7 5.0 0.8 2.5 0.2 20.8 0.0 0.1 0.2 0.0 0.0 12.1 0.0 0.0 25.5 0.0 8.3 0.0 25.7 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 1.3 4.8 0.1 0.0 0.1 9.9 0.0 0.1 0.1 29.8 22.0 0.2 19.3 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.8 0.4 9.3 12.8 1.7 12.5 12.6 7.5 20.6 5.9 12.3 13.1 17.9 3.2 0.0 43.8 1.9 0.2 1.4 5.1 18.7 13.6 0.0 0.0 1.1 0.0 5.9 2.2 33.1 0.0 0.0 0.2 1.2 6.5 13.4 1.1 0.0 0.7 0.0 0.0 4.3 1.2 1.3 21.0 1.3 0.0 0.0 0.0 0.2 0.7 0.0 51.9 0.0 0.1 32.3 10.8 0.0 0.7 1.9 0.5 2.2 0.0 40.4 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 21 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.4 0.0 0.0 0.0 13.6 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCN12 MGC48935 ENSG00000184925 "Lipocalin 12" Q6JVE5 9 136949551-136955497 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 131.5" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 47.1;Distal tubular cells: 16.6;Intestinal endocrine cells: 15.7;Muller glia cells: 26.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 44.8" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 21 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 21 "dendritic cells: 2.0" "Cell line enhanced" "Detected in some" "A549: 2.8;BEWO: 1.4;Daudi: 1.0;EFO-21: 1.7;HEL: 1.5;SH-SY5Y: 1.1" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (7.27e-3)" "unprognostic (5.72e-3)" "unprognostic (2.45e-2)" "unprognostic (7.14e-2)" "unprognostic (4.53e-4)" "unprognostic (9.33e-3)" "unprognostic (1.97e-3)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (7.33e-3)" "unprognostic (2.18e-1)" "unprognostic (5.73e-2)" "unprognostic (5.21e-3)" "unprognostic (3.06e-1)" "unprognostic (5.00e-2)" "unprognostic (7.91e-4)" 0.3 0.4 0.9 0.3 1.8 0.3 0.3 0.2 0.9 0.9 0.3 0.4 24.4 0.4 0.5 131.5 0.3 2.4 0.3 0.3 0.8 0.8 2.3 1.2 0.3 0.3 1.0 0.7 0.6 0.7 0.3 1.9 0.3 1.2 0.3 0.3 1.6 0.3 10.9 0.3 0.3 0.4 0.3 0.9 0.6 0.4 1.1 0.9 0.0 8.6 0.0 0.3 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.9 1.8 0.2 0.9 0.8 0.8 1.0 0.7 1.2 0.9 0.0 2.1 0.5 0.3 0.0 0.2 6.9 0.0 1.4 2.3 47.1 2.0 0.1 16.6 1.0 0.6 0.0 2.9 0.0 1.1 0.0 0.2 0.9 0.0 10.2 0.2 0.0 15.7 0.0 0.3 0.8 13.8 0.0 0.0 0.0 2.6 26.1 0.7 0.0 10.3 5.9 0.9 0.0 0.0 1.4 0.2 0.0 0.2 0.0 4.7 0.2 LCN8 LCN5 ENSG00000204001 "Lipocalin 8" Q6JVE9 9 136754386-136758543 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 72.1" "Cell type enriched" "Detected in single" 8 "B-cells: 2.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Region enriched" "Detected in single" 7 "cerebellum: 5.3" "Group enriched" "Detected in some" 57 "memory B-cell: 5.3;naive B-cell: 9.3" "Lineage enriched" "Detected in single" 72 "B-cells: 9.3" "Cell line enriched" "Detected in some" 6 "REH: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (6.71e-2)" "unprognostic (2.11e-2)" "unprognostic (2.92e-1)" "unprognostic (2.89e-1)" "unprognostic (2.00e-1)" 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.3 0.7 0.1 0.0 0.0 2.5 0.0 0.2 72.1 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.5 0.0 0.0 0.9 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 7.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 5.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCN9 ENSG00000148386 "Lipocalin 9" Q8WX39 9 135663322-135666422 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 19.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060941 Enhanced "Secreted in male reproductive system" NA NA "HPA060941: AB_2732654" "unprognostic (7.64e-4)" 0.3 0.0 0.5 0.0 0.5 0.0 0.0 0.2 2.1 0.2 0.0 0.1 17.2 0.0 0.0 5.0 0.0 0.5 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 7.7 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.4 0.5 0.3 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCNL1 FLJ45224 ENSG00000214402 "Lipocalin like 1" Q6ZST4 9 136981904-136986410 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.1;seminal vesicle: 3.7;testis: 2.5" "Group enriched" "Detected in some" 30 "Leydig cells: 49.5;Muller glia cells: 41.0;Peritubular cells: 119.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 2.0;fHDF/TERT166: 1.4;HSkMC: 1.0;TIME: 1.3" NA NA "unprognostic (1.39e-1)" "unprognostic (4.60e-3)" "unprognostic (1.08e-3)" "unprognostic (5.14e-2)" "unprognostic (3.39e-1)" "unprognostic (2.03e-5)" "unprognostic (6.46e-2)" "unprognostic (6.67e-2)" "unprognostic (7.79e-2)" "unprognostic (9.51e-2)" "unprognostic (2.16e-1)" "unprognostic (9.82e-2)" "unprognostic (1.34e-9)" "unprognostic (4.31e-2)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" 0.1 0.0 2.2 0.0 1.8 0.0 0.1 0.4 1.9 1.0 0.1 0.0 0.3 1.6 0.0 0.4 0.2 0.5 2.0 1.3 0.3 0.0 0.2 0.7 3.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 3.7 1.0 0.0 0.2 0.1 2.6 0.3 0.1 2.5 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 49.5 0.0 0.0 0.0 0.0 41.0 0.0 0.0 119.9 0.0 1.4 0.0 0.4 0.3 0.7 0.0 0.1 0.0 0.0 0.0 LDHAL6A "LDH6A, MGC23940" ENSG00000166800 "Lactate dehydrogenase A like 6A" Q6ZMR3 11 18455824-18479600 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.9" "Group enriched" "Detected in some" 6 "Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HL-60: 15.6" NA NA "unprognostic (1.41e-1)" "unprognostic (4.84e-2)" "unprognostic (8.95e-2)" "unprognostic (5.35e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (7.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.23e-1)" "unprognostic (1.60e-1)" "unprognostic (2.35e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" 0.2 0.7 0.6 0.4 0.6 1.4 0.2 2.4 1.9 0.1 0.2 0.4 0.0 0.9 0.2 0.4 0.4 0.2 0.3 1.1 0.4 0.5 0.4 0.2 0.2 0.6 0.3 0.7 0.7 0.4 0.0 0.4 0.2 2.2 0.2 0.1 1.9 0.3 0.3 0.2 1.5 0.8 0.0 0.3 0.4 0.4 18.9 0.0 0.1 0.8 0.0 0.1 0.2 0.2 1.3 0.7 3.5 0.5 1.6 1.9 0.2 0.2 0.4 1.0 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.5 0.5 0.9 0.3 0.0 0.2 0.6 0.1 0.3 0.4 0.7 1.0 0.6 0.9 0.5 0.0 15.6 0.7 0.1 0.3 0.0 0.2 0.2 0.0 1.0 0.4 1.2 0.1 0.3 0.4 1.1 0.4 0.2 0.7 0.8 0.4 1.5 0.1 1.1 0.6 0.5 0.5 0.3 0.2 0.5 0.4 2.2 0.8 0.6 0.2 1.0 0.3 2.7 0.6 0.2 0.3 0.6 0.3 2.1 0.4 0.4 1.9 0.3 0.3 0.9 0.5 0.5 0.7 1.3 1.1 1.0 3.5 1.6 0.5 0.5 1.3 0.2 0.6 0.6 2.4 1.9 0.4 0.5 0.3 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.6 0.0 0.0 4.6 3.6 0.0 0.2 0.0 0.0 0.0 LDLRAD2 ENSG00000187942 "Low density lipoprotein receptor class A domain containing 2" Q5SZI1 1 21812265-21825221 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 2: 1.1;Ciliated cells: 1.4;Collecting duct cells: 1.8;Early spermatids: 1.0;Ito cells: 1.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 1.9;plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;NTERA-2: 2.5;REH: 3.4;THP-1: 2.9;TIME: 6.3" HPA030478 Approved "Secreted - unknown location" NA NA "HPA030478: AB_10601541" "unprognostic (4.16e-2)" "unprognostic (1.22e-1)" "unprognostic (4.13e-2)" "unprognostic (4.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.22e-3)" "unprognostic (1.35e-2)" "unprognostic (4.85e-2)" "unprognostic (7.52e-2)" "unprognostic (3.80e-2)" "unprognostic (5.34e-2)" "unprognostic (5.38e-2)" "unprognostic (1.04e-3)" "unprognostic (7.39e-3)" "unprognostic (3.14e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" 5.4 1.9 0.2 2.2 0.2 2.7 2.2 0.0 0.1 1.7 3.2 4.7 3.1 0.0 1.3 2.2 1.6 3.6 0.5 1.1 1.5 0.1 1.0 1.8 0.0 0.5 1.1 0.0 0.9 0.2 3.1 0.3 5.7 0.1 2.7 1.3 1.7 0.2 0.0 2.3 3.2 0.8 1.6 0.9 2.2 1.8 0.6 2.5 1.9 0.0 0.7 0.0 0.0 0.5 0.7 0.4 0.6 0.2 0.0 1.3 0.9 0.0 0.0 0.0 0.4 1.5 0.0 2.4 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.4 1.2 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.9 0.4 0.1 0.3 0.0 0.0 0.2 0.0 1.4 2.5 0.3 0.4 3.4 0.5 0.0 0.0 0.4 0.0 0.3 0.5 0.1 0.1 0.7 0.2 2.9 6.3 0.6 0.6 0.8 0.0 0.0 0.1 0.4 0.1 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.5 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.2 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.4 0.2 0.0 0.0 0.0 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.0;Peritubular cells: 23.3;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 28.5;RH-30: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavorable (2.14e-5)" 12.0 5.0 9.5 6.0 13.7 2.0 23.4 32.5 17.9 9.3 2.8 20.7 1.7 2.9 8.2 4.7 8.8 5.0 6.5 3.6 10.8 7.2 3.0 2.6 3.3 4.4 18.0 4.0 15.0 5.1 1.5 9.2 3.4 18.1 14.8 3.2 5.3 23.9 6.0 5.5 17.0 3.3 7.2 24.4 2.9 3.4 4.8 13.5 0.1 3.0 2.6 4.8 5.3 6.5 0.0 4.1 1.9 7.7 0.0 0.0 2.0 4.8 4.6 14.4 8.7 11.5 12.6 11.0 2.8 2.5 6.4 5.7 3.4 3.0 0.0 2.1 3.0 9.6 2.5 4.4 6.3 9.0 0.4 9.3 15.7 3.0 1.0 15.2 3.4 1.9 15.1 28.5 2.9 25.2 2.6 10.7 0.0 4.0 0.6 11.7 2.7 0.0 0.8 5.9 0.5 8.1 0.0 26.9 1.5 1.1 0.7 4.9 11.1 4.9 5.4 15.8 5.8 7.5 4.6 10.7 7.7 6.9 0.6 9.3 0.3 0.0 0.0 3.8 4.2 13.7 1.9 6.1 0.6 0.0 6.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 7.7 0.3 0.0 2.0 9.5 13.7 32.5 9.1 10.8 7.2 18.0 4.0 18.1 13.5 0.0 5.6 0.5 6.7 13.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 2.1 0.0 3.6 12.5 5.5 0.0 0.0 0.9 11.4 4.4 19.0 0.0 0.6 3.8 0.0 0.0 9.8 13.5 11.9 8.9 5.1 6.8 1.0 0.0 0.5 1.2 0.0 23.3 1.6 0.0 12.9 8.2 0.5 3.0 22.7 1.1 0.0 0.4 2.2 LEFTY1 "LEFTB, LEFTYB" ENSG00000243709 "Left-right determination factor 1" O75610 1 225886282-225911382 "Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5" "Cell type enriched" "Detected in many" 4 "Undifferentiated cells: 330.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.8" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 35 "basophil: 12.1" "Lineage enriched" "Detected in single" 35 "granulocytes: 12.1" "Cell line enriched" "Detected in some" 6 "NTERA-2: 34.0" "HPA047883, HPA056210" Approved "Secreted in other tissues" NA NA "HPA047883: AB_2680200, HPA056210: AB_2683067" "unprognostic (2.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.26e-2)" "unprognostic (1.18e-2)" "unprognostic (1.83e-2)" "unprognostic (3.50e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" "unprognostic (2.19e-1)" "unprognostic (1.28e-1)" "unprognostic (7.76e-2)" "unprognostic (6.13e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (2.78e-2)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (2.61e-2)" 0.2 0.0 0.6 4.5 1.1 0.0 0.2 1.2 0.9 0.6 26.6 0.2 1.5 0.0 0.7 19.0 0.4 0.1 0.2 0.2 0.6 0.7 3.6 0.2 0.3 0.2 0.2 0.2 2.0 46.5 0.0 0.3 0.3 0.2 0.6 15.1 0.3 0.5 1.6 0.2 0.0 0.8 0.4 0.2 0.2 0.4 2.1 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.0 0.0 12.1 0.0 0.3 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 3.6 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.7 0.6 1.1 1.2 0.9 0.6 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 14.5 1.5 0.0 6.7 0.0 27.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 2.1 1.4 0.0 0.0 0.0 45.3 0.8 0.5 73.7 1.8 4.8 1.3 0.0 0.3 1.6 1.5 0.0 0.0 0.0 330.1 1.3 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" Q6ZMV7 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 29.8" "Group enriched" "Detected in many" 10 "Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.6;U-266/70: 6.2" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 1.4 1.7 1.4 2.5 4.6 0.6 2.7 1.4 2.2 1.5 1.0 1.6 3.5 1.7 1.3 8.2 0.9 6.3 1.7 1.4 1.5 2.0 2.8 1.3 3.0 1.6 1.1 1.4 2.9 2.7 4.8 4.5 0.5 2.2 1.7 1.1 2.5 1.6 4.9 0.7 0.9 1.6 0.8 1.9 1.8 1.5 29.8 0.7 4.4 4.0 0.7 1.4 1.2 1.8 3.2 1.9 2.5 0.3 2.5 2.0 0.4 6.6 2.7 0.1 1.6 1.2 0.6 0.4 0.4 1.0 1.4 1.1 0.3 3.8 0.1 2.0 1.1 2.6 2.5 0.0 0.5 2.7 1.2 0.6 2.5 0.5 0.0 0.0 2.1 0.6 3.1 1.6 0.5 1.9 0.8 0.6 0.1 1.5 1.6 2.4 2.4 0.0 1.9 2.2 1.9 1.5 0.0 1.8 1.5 2.1 0.6 4.2 1.7 2.2 1.5 0.1 0.5 4.6 3.6 0.0 0.4 0.7 0.5 1.0 6.2 1.0 0.0 1.2 1.5 2.3 2.5 0.3 0.3 0.7 0.1 1.4 3.1 1.6 0.6 1.2 3.2 1.8 0.9 0.3 2.5 0.2 1.9 2.0 0.4 1.4 4.6 1.4 2.2 1.5 2.0 1.1 1.4 2.2 0.7 0.0 1.4 0.0 1.1 1.1 1.3 0.8 2.5 34.8 3.4 3.5 2.0 0.2 3.3 0.6 63.2 0.4 1.3 0.0 1.4 0.1 0.5 0.7 1.1 1.6 0.2 3.2 0.0 0.0 1.8 32.2 1.4 1.1 1.7 1.8 0.6 1.4 0.7 0.0 1.8 3.3 4.5 0.0 0.3 49.4 3.2 0.6 0.1 1.3 0.8 0.8 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Group enriched" "Detected in some" 129 "Early spermatids: 869.0;Late spermatids: 3077.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.9 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 0.0 1.6 0.0 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 869.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3077.5 11.8 0.0 0.0 0.0 0.0 0.9 4.0 0.0 13.1 1.5 0.7 6.5 0.0 15.3 7.2 0.0 0.3 0.0 0.0 2.2 LENEP LEP503 ENSG00000163352 "Lens epithelial protein" Q9Y5L5 1 154993586-154994315 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0" "Cell type enhanced" "Detected in single" 35 "Muller glia cells: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 1.7;hippocampal formation: 3.0;pons and medulla: 2.5" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 1.8;BEWO: 1.1;Daudi: 1.1;HaCaT: 1.6;HAP1: 1.6;Karpas-707: 1.2;MCF7: 1.1;PC-3: 1.4" "Not detected" "Not detected" NA NA "unprognostic (1.03e-1)" "unprognostic (3.60e-2)" "unprognostic (4.71e-2)" "unprognostic (1.16e-1)" "unprognostic (2.04e-2)" "unprognostic (9.50e-3)" "unprognostic (2.72e-2)" "unprognostic (4.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.79e-1)" "unprognostic (9.51e-2)" "unprognostic (8.04e-2)" "unprognostic (1.32e-5)" "unprognostic (5.26e-2)" "unprognostic (4.50e-3)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" 0.1 0.4 1.7 0.1 0.2 0.0 0.2 0.4 0.2 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 3.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.3 0.0 0.3 0.2 2.5 0.6 0.3 0.1 1.9 0.1 0.5 1.4 1.3 0.1 1.8 0.1 0.3 0.3 0.1 0.1 1.6 0.1 0.1 0.1 0.2 0.2 0.8 0.0 0.1 0.0 1.0 0.0 0.9 1.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.4 1.2 0.0 1.1 0.0 0.0 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.2 0.4 0.2 3.0 0.2 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786167 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 1.0;HDLM-2: 2.3" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LEXM "C1orf177, FLJ40201, LEM" ENSG00000162398 "Lymphocyte expansion molecule" Q3ZCV2 1 54806063-54842252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.0;esophagus: 14.2;testis: 5.2" "Group enriched" "Detected in some" 22 "Early spermatids: 34.6;Late spermatids: 32.5" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.1;CAPAN-2: 2.5;HaCaT: 1.6;Karpas-707: 1.9;U-266/84: 2.0;U-87 MG: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035889, HPA035890" Uncertain NA NA "HPA035889: AB_2674844, HPA035890: AB_10669535" "unprognostic (1.61e-1)" "unprognostic (2.18e-2)" "unprognostic (5.01e-2)" "unprognostic (3.69e-2)" "unprognostic (1.50e-2)" "unprognostic (8.32e-2)" "unprognostic (7.28e-2)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (5.13e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.64e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.5 0.5 2.3 0.0 0.0 14.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.2 5.2 0.0 0.6 0.0 3.8 0.0 0.2 1.6 0.0 3.0 7.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.1 0.2 0.0 0.2 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.2 0.0 0.2 0.8 1.1 0.2 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 0.0 1.0 2.0 0.0 1.2 0.3 0.1 0.0 0.0 1.6 7.0 0.0 0.4 0.0 1.5 3.4 0.0 0.0 0.3 4.6 0.0 3.0 0.0 0.2 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.1 LGALS16 ENSG00000249861 "Galectin 16" A8MUM7 19 39655894-39660647 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 14.2" "Cell type enriched" "Detected in some" 76 "Syncytiotrophoblasts: 852.8" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "BEWO: 5.5;SuSa: 16.1" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.6 0.5 0.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 852.8 0.0 0.0 0.0 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Cell line enhanced" "Detected in some" "AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.0 0.9 10.4 0.4 0.0 14.7 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 0.0 0.0 0.0 0.1 0.1 0.4 2.6 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 1.6 0.0 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146825-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 20.3;Melanocytes: 38.8" "Cancer enhanced" "Detected in many" "melanoma: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" NA NA Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 1.2 4.8 13.1 1.1 26.4 1.1 1.2 7.7 52.2 2.6 1.2 35.5 0.0 1.4 1.5 1.3 6.1 2.0 1.1 1.5 20.7 15.7 1.1 1.0 17.7 1.0 24.2 10.4 1.1 1.5 0.9 0.7 1.0 24.9 2.3 1.1 4.6 1.2 4.2 1.0 16.3 1.4 1.7 29.8 1.1 1.3 1.4 14.8 0.0 14.9 0.0 1.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 2.1 1.1 0.8 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.3 0.0 4.6 0.6 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 26.4 7.7 32.1 20.7 15.7 24.2 10.4 24.9 14.8 0.0 20.3 0.0 0.0 2.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 38.8 0.0 0.0 1.0 0.1 0.0 6.7 0.0 2.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LHFPL1 ENSG00000182508 "LHFPL tetraspan subfamily member 1" Q86WI0 X 112630648-112680054 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SK-MEL-30: 5.4;SuSa: 8.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 6.1" HPA003029 Uncertain NA NA "HPA003029: AB_1079248" "unprognostic (2.23e-2)" "unprognostic (2.78e-3)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "unprognostic (2.65e-1)" "unprognostic (1.54e-1)" "unprognostic (5.31e-3)" "unprognostic (1.29e-1)" "unprognostic (4.41e-3)" "unprognostic (5.19e-5)" "unprognostic (1.33e-1)" "unprognostic (7.63e-3)" "unprognostic (4.83e-2)" "unprognostic (1.21e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-1)" 0.2 0.6 3.1 0.4 13.7 0.1 2.0 0.1 3.8 1.5 0.3 0.6 0.9 0.3 0.6 0.9 0.5 1.3 0.2 2.2 2.8 2.5 0.6 0.2 0.2 0.4 4.5 1.5 1.1 0.1 0.3 15.9 0.5 3.8 1.2 0.4 0.0 8.2 3.3 0.5 0.3 0.5 0.3 0.5 0.4 0.2 0.4 1.6 0.3 6.1 0.1 0.5 0.5 0.2 0.7 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 1.2 0.2 0.7 0.1 0.3 0.1 0.2 0.0 0.0 5.4 8.6 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.7 1.0 2.6 0.0 0.6 0.2 0.8 0.0 0.8 0.0 0.0 0.1 0.4 3.1 13.7 0.1 2.7 2.8 2.5 4.5 1.5 3.8 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0;plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 7 "dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7" "Cell line enhanced" "Detected in many" "GAMG: 41.5;hTERT-HME1: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042402, HPA076743" Uncertain Approved "Nuclear bodies,Vesicles,Plasma membrane" NA NA 110000 "Plasma membrane" "Nuclear bodies, Vesicles" "HPA042402: AB_10794276, HPA076743: " "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 17.1 18.2 10.3 16.1 11.7 11.5 34.7 3.5 9.1 15.8 15.4 12.0 14.1 17.6 14.6 15.0 7.6 10.7 17.6 14.1 11.7 7.6 3.8 4.7 17.2 10.3 15.2 7.2 18.7 18.0 9.2 7.3 11.3 12.9 13.3 13.5 18.2 21.4 20.5 4.6 6.7 27.1 16.6 18.0 4.7 10.8 10.9 13.1 5.7 10.3 4.9 10.4 15.4 18.2 0.9 7.9 8.0 4.7 0.0 0.1 1.5 3.2 12.3 3.7 4.9 22.8 6.6 11.6 3.8 9.7 6.6 11.6 4.3 9.9 8.3 1.7 7.4 41.5 5.8 3.5 4.1 11.0 0.0 3.2 8.2 2.5 7.3 16.9 0.0 0.0 7.5 16.5 20.3 31.7 10.5 15.6 0.3 0.0 6.2 15.0 1.7 0.0 0.4 4.1 2.7 3.6 1.6 5.3 2.3 2.5 14.7 0.7 5.1 6.2 2.3 21.1 8.2 1.3 1.0 10.2 7.7 4.2 21.2 11.3 0.2 0.0 11.9 20.6 0.0 13.8 8.0 4.7 4.8 0.0 1.8 0.1 0.9 0.0 0.0 1.1 0.9 0.0 0.0 1.0 0.0 0.6 7.9 0.1 1.5 10.3 11.7 3.5 9.1 11.7 7.6 15.2 7.2 12.9 13.1 3.0 4.3 4.2 6.0 7.7 6.1 3.4 2.5 2.7 7.9 7.0 0.0 3.2 0.0 6.9 1.1 22.2 23.7 23.3 11.2 2.0 20.9 10.4 0.0 0.5 56.6 3.2 2.4 33.7 28.3 0.5 17.8 20.5 10.1 1.0 10.7 5.0 15.0 8.6 31.5 0.3 2.1 6.5 8.2 0.5 0.9 4.3 6.1 0.0 8.6 11.1 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 7.0" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;K-562: 2.2;SCLC-21H: 4.1;SH-SY5Y: 5.5;SK-BR-3: 4.6;SK-MEL-30: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles No NA Vesicles "HPA069691: AB_2686171" "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.2 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.1 5.5 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.0 1.4 0.0 0.0 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.1 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.0 10.5 0.0 0.5 0.0 3.8 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 0.0 0.0 0.0 2.6 0.0 39.8 0.6 0.0 0.0 0.0 0.0 17.7 0.5 0.0 0.3 0.4 0.0 0.5 0.0 0.2 0.8 0.3 1.5 1.1 0.0 0.2 14.3 1.2 4.9 0.3 0.4 0.0 0.0 0.0 0.0 0.6 1.3 0.3 1.4 0.0 0.1 16.4 0.0 0.1 1.7 1.0 0.0 1.1 0.0 1.0 2.5 LHFPL6 "LHFP, MGC22429" ENSG00000183722 "LHFPL tetraspan subfamily member 6" Q9Y693 13 39342892-39603528 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 9.4;plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 9.4" "Cell line enhanced" "Detected in many" "ASC diff: 66.1;HSkMC: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058975 Approved Approved Nucleoli NA NA Nucleoli "HPA058975: AB_2683866" "unprognostic (6.98e-2)" "unprognostic (2.71e-1)" "unprognostic (2.00e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (4.10e-2)" "unprognostic (5.84e-2)" "unprognostic (1.08e-1)" "unprognostic (2.76e-1)" "unprognostic (5.45e-2)" "unprognostic (8.68e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (4.41e-3)" "unprognostic (5.25e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (2.30e-4)" 57.2 26.8 12.5 14.8 17.7 0.9 45.7 40.8 19.0 20.3 16.4 12.3 8.5 5.3 28.6 23.7 17.9 27.0 34.9 49.4 12.7 12.9 12.8 6.9 27.0 27.4 19.3 12.6 25.7 8.3 7.1 14.3 62.0 16.8 21.4 8.4 19.8 11.4 18.8 13.6 13.1 9.6 33.1 18.5 18.5 10.2 16.2 11.9 1.3 22.7 22.1 8.3 20.1 25.8 0.2 9.4 0.1 0.6 0.0 0.0 0.4 2.7 1.0 30.0 1.3 66.1 30.0 13.1 15.3 22.1 7.8 5.9 0.1 2.9 4.2 0.3 21.3 10.2 4.3 3.7 8.9 6.5 4.1 4.4 11.5 0.9 0.0 6.9 0.2 0.3 48.3 1.2 7.0 11.7 7.0 7.2 0.2 0.0 0.0 15.0 2.4 0.0 3.5 2.2 0.0 4.0 1.8 13.0 0.0 5.2 3.7 0.1 0.9 1.4 1.8 4.1 17.9 1.7 0.0 13.5 19.9 2.9 6.1 8.3 0.2 0.0 12.0 8.3 0.0 14.3 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.1 3.2 0.0 0.4 12.5 17.7 40.8 19.0 12.7 12.9 19.3 12.6 16.8 11.9 3.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 18.2 0.0 0.0 3.1 1.7 0.6 0.0 0.0 0.0 0.0 0.6 146.6 0.0 0.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462034-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;stomach 1: 2.1;testis: 2.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.8 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 6.7 1.2 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 LILRA1 "CD85i, LIR-6, LIR6" ENSG00000104974 "Leukocyte immunoglobulin like receptor A1" O75019 19 54593582-54602090 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 22.2;lymphoid tissue: 21.0" "Cell type enriched" "Detected in some" 4 "Kupffer cells: 35.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 17.9;non-classical monocyte: 22.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "REH: 1.3;THP-1: 2.4" NA NA "unprognostic (4.52e-2)" "unprognostic (1.12e-1)" "unprognostic (6.30e-2)" "unprognostic (1.59e-1)" "unprognostic (2.34e-1)" "unprognostic (9.46e-3)" "unprognostic (1.17e-1)" "unprognostic (4.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.90e-2)" "unprognostic (8.72e-2)" "unprognostic (1.13e-1)" "unprognostic (8.28e-3)" "unprognostic (8.82e-2)" "unprognostic (3.79e-4)" "unprognostic (2.53e-1)" "unprognostic (9.83e-2)" 0.7 0.9 1.0 3.7 1.7 1.0 0.6 0.2 1.3 0.5 0.3 1.1 0.0 0.4 0.2 1.7 0.6 0.5 1.0 0.6 0.9 0.8 0.5 2.1 2.4 18.8 1.5 0.5 0.4 0.4 0.6 0.3 0.8 1.6 0.4 0.7 0.8 1.0 0.3 0.5 0.3 1.0 0.5 2.2 21.0 0.5 0.3 1.1 0.1 0.4 0.4 0.9 0.9 0.2 0.0 5.4 6.1 22.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 7.4 6.1 0.0 17.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 5.3 0.0 22.2 0.7 0.0 4.2 1.0 1.7 0.2 1.3 0.9 0.8 1.5 0.5 1.6 1.1 0.0 3.4 0.5 0.0 0.0 0.0 0.0 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 35.6 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LILRA6 "CD85b, ILT8, LILRB6" ENSG00000244482 "Leukocyte immunoglobulin like receptor A6" Q6PI73 19 54236592-54242791 "Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.4;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 6.2;Hofbauer cells: 12.4;Kupffer cells: 34.4;Macrophages: 12.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.5;neutrophil: 9.4" "Group enriched" "Detected in many" 23 "granulocytes: 9.4;monocytes: 4.5" "Cell line enhanced" "Detected in single" "PC-3: 1.5" NA NA 18000000 "unprognostic (1.00e-1)" "unprognostic (8.38e-2)" "unprognostic (5.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.95e-2)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (2.51e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-1)" "unprognostic (9.11e-2)" "unprognostic (1.51e-1)" "unprognostic (7.47e-5)" "unprognostic (7.76e-2)" "unprognostic (4.01e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-2)" 4.9 1.1 0.2 4.0 0.2 4.4 0.8 0.2 0.6 0.2 0.5 0.2 0.2 0.3 0.2 2.2 1.9 1.3 1.4 0.8 0.2 0.0 0.4 5.5 6.0 0.2 0.2 0.2 1.1 0.2 0.0 0.2 1.9 0.7 1.1 0.0 0.2 0.8 0.2 0.8 0.1 1.1 4.0 0.2 16.0 0.5 0.8 0.2 0.2 0.6 0.2 0.2 1.3 0.2 0.0 0.3 9.4 4.5 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.4 0.0 1.0 0.0 0.0 1.2 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.2 0.7 0.2 0.0 6.2 0.0 0.0 0.2 0.0 0.4 5.1 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.5 0.2 12.4 0.0 0.0 1.3 34.4 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 LIMS3 ENSG00000256977 "LIM zinc finger domain containing 3" P0CW19 2 109898428-109924868 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 11.9;endometrium 1: 9.7" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 1.7;Club cells: 1.2;Distal tubular cells: 1.7;Exocrine glandular cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 11.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 9.8;HMC-1: 29.8" HPA058455 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.23e-2)" 1.2 2.8 0.5 2.2 0.5 0.0 1.0 0.8 0.5 1.0 0.7 0.3 4.2 0.2 9.7 2.8 1.2 7.1 0.9 2.6 0.5 0.5 2.6 0.6 0.8 2.8 0.6 0.3 2.2 0.7 0.3 2.4 5.6 0.3 1.0 0.8 0.6 2.2 0.6 3.0 0.8 0.5 1.2 0.6 0.6 0.7 3.7 0.3 0.3 1.0 0.3 0.3 2.6 0.7 0.7 2.5 11.9 5.5 1.1 6.2 8.0 0.0 0.1 1.3 1.5 0.5 0.4 0.0 1.5 0.0 0.2 0.7 1.5 0.0 0.0 4.7 0.3 3.1 0.8 0.0 1.8 1.3 2.4 0.0 9.8 0.5 0.9 1.4 1.7 29.8 2.2 1.1 1.1 1.3 0.0 2.4 0.0 2.0 1.6 3.3 0.1 0.0 0.2 1.6 0.9 0.6 1.8 3.1 1.0 0.8 1.5 0.4 3.6 4.0 0.0 0.8 0.0 0.0 0.5 7.3 6.4 5.9 3.3 0.3 0.0 0.0 1.9 0.8 0.0 1.9 4.7 3.3 11.9 0.9 5.5 1.5 0.7 5.0 1.7 2.5 0.2 0.9 0.3 0.7 1.1 5.2 0.2 6.2 8.0 0.5 0.5 0.8 0.5 0.5 0.5 0.6 0.3 0.3 0.3 0.0 0.3 0.0 0.1 0.1 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 10.5;smooth muscle: 11.4" "Group enriched" "Detected in some" 6 "Bipolar cells: 7.3;Early spermatids: 12.0;Late spermatids: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;hTERT-HME1: 2.3;SH-SY5Y: 13.7;U-87 MG: 2.4;WM-115: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016633, CAB025361" Approved NA NA "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.3 1.8 0.0 1.7 0.0 0.0 1.0 3.4 0.3 0.0 0.0 10.5 1.0 0.0 0.4 1.0 0.0 1.4 4.1 0.6 0.0 0.0 0.0 0.6 0.0 0.0 2.7 0.6 1.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.3 0.0 0.4 1.8 3.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.4 1.7 0.0 0.5 0.3 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.4 0.0 6.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 1.7 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.2 0.6 0.0 0.0 1.2 0.9 0.0 0.2 0.0 0.0 0.0 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151806154 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;skeletal muscle: 17.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 1.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;JURKAT: 1.5;Karpas-707: 1.1;SH-SY5Y: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060781 Uncertain NA NA "HPA060781: AB_2684361" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.3 0.0 0.1 0.3 0.7 0.1 0.1 0.0 0.0 0.3 0.4 1.2 0.0 0.8 0.0 0.4 0.1 17.7 0.3 0.0 0.0 0.3 0.0 0.3 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 32.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.7;NB-4: 1.0;SK-MEL-30: 2.4;U-2197: 1.0" HPA048594 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA048594: AB_2680456" "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.3 0.0 0.3 0.0 0.2 1.0 0.3 0.1 0.0 0.4 0.2 1.6 0.0 1.1 0.1 0.1 0.4 0.5 0.2 0.7 0.0 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.3 11.5 0.9 0.4 0.5 0.1 0.7 0.0 1.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.1 0.7 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 LIPK "bA186O14.2, LIPL2" ENSG00000204021 "Lipase family member K" Q5VXJ0 10 88724544-88752786 "Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 27.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.65e-2)" "unprognostic (8.64e-2)" "unprognostic (3.57e-2)" "unprognostic (3.19e-7)" "unprognostic (1.25e-1)" "unprognostic (1.60e-2)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 LIPM "bA304I5.1, LIPL3" ENSG00000173239 "Lipase family member M" Q5VYY2 10 88802730-88820546 "Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "skin 1: 30.1" "Cell type enriched" "Detected in single" 9 "Suprabasal keratinocytes: 1.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 1.0" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 6.9;HL-60: 3.9;NB-4: 3.3;OE19: 6.1;RT4: 2.9;T-47d: 3.3;U-937: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.72e-2)" "unprognostic (8.49e-4)" "unprognostic (1.42e-2)" "unprognostic (2.23e-4)" "unprognostic (6.70e-3)" "unprognostic (3.01e-3)" "unprognostic (5.75e-2)" "unprognostic (6.63e-2)" "unprognostic (5.61e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.59e-2)" "unprognostic (5.93e-2)" "unprognostic (7.05e-3)" "unprognostic (4.17e-2)" "unprognostic (9.02e-2)" "unprognostic (9.70e-6)" 0.0 0.0 0.0 0.8 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 1.0 0.0 0.1 0.1 2.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 6.1 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.3 3.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 LIPN "bA186O14.3, LIPL4" ENSG00000204020 "Lipase family member N" Q5VXI9 10 88761406-88778242 "Disease related genes, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase Ichthyosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 12.5;skin 1: 25.5" "Cell type enhanced" "Detected in single" 23 "Kupffer cells: 1.2" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Group enriched" "Detected in many" 5 "classical monocyte: 4.8;eosinophil: 12.5;intermediate monocyte: 10.7;neutrophil: 7.7;non-classical monocyte: 11.3" "Group enriched" "Detected in many" 6 "granulocytes: 12.5;monocytes: 11.3" "Group enriched" "Detected in some" 7 "Daudi: 3.3;HL-60: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.03e-2)" "unprognostic (9.75e-2)" "unprognostic (2.54e-2)" "unprognostic (4.40e-2)" "unprognostic (5.77e-3)" "unprognostic (1.65e-1)" 1.5 0.1 0.0 2.8 0.0 3.7 1.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 25.5 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.4 1.1 0.0 1.8 12.5 11.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 9.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 1.1 4.8 12.5 0.0 10.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 7.7 0.0 11.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell type enriched" "Detected in some" 16 "Muller glia cells: 199.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Group enriched" "Detected in some" 11 "RPTEC TERT1: 24.5;SuSa: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: AB_2683715" "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.8 0.0 0.0 0.0 1.4 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIX1L MGC46719 ENSG00000271601 "Limb and CNS expressed 1 like" Q8IVB5 1 145933423-145958001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 53.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063598 Approved Cytosol NA NA Cytosol "HPA063598: AB_2685055" "unprognostic (5.21e-2)" "unprognostic (4.09e-1)" "unprognostic (6.84e-3)" "unprognostic (2.85e-2)" "unprognostic (3.71e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (9.81e-2)" "unprognostic (3.46e-1)" "unprognostic (3.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.10e-3)" "unprognostic (4.95e-1)" "unprognostic (1.25e-2)" "prognostic unfavorable (5.27e-4)" 13.8 8.9 4.6 6.5 4.4 2.1 6.0 4.1 5.9 14.4 8.0 7.1 3.2 2.7 15.9 7.6 5.8 6.3 10.6 10.0 4.3 4.2 5.4 6.4 9.2 5.7 4.0 19.6 1.7 4.4 9.4 7.5 4.0 11.6 4.2 11.4 3.3 10.7 10.5 2.4 4.0 12.7 4.2 9.4 2.6 7.4 5.8 11.1 4.6 4.5 9.5 11.8 8.4 4.3 4.2 5.1 4.4 4.8 11.1 3.1 3.2 4.6 14.2 15.7 29.7 25.2 0.2 7.3 13.3 11.4 8.4 0.3 3.0 8.6 8.1 14.7 4.3 0.1 6.5 6.1 10.8 7.9 2.1 4.8 5.2 4.6 9.8 11.3 11.4 15.4 2.8 9.3 13.5 18.4 22.0 11.6 7.0 13.9 18.0 0.1 14.9 9.5 4.1 0.0 6.0 10.1 7.1 14.2 11.7 0.0 5.1 14.5 15.0 0.0 10.8 6.1 0.5 9.0 16.9 19.4 5.3 12.6 12.2 11.2 7.9 8.9 13.7 9.5 9.3 4.8 2.9 4.6 8.0 2.7 9.7 4.0 9.2 8.0 2.7 4.3 8.6 11.1 5.1 4.8 4.4 4.2 6.7 3.1 0.0 7.2 19.0 10.3 10.1 15.1 14.6 12.7 1.4 3.4 10.4 7.9 1.3 3.3 8.4 5.7 31.4 0.0 23.3 8.5 3.8 21.4 7.3 4.7 17.3 18.5 12.7 12.1 35.6 19.6 3.2 33.1 14.0 27.0 21.6 2.2 22.7 8.5 0.0 53.0 5.7 12.0 25.8 37.6 13.6 3.4 6.8 0.7 21.9 1.8 3.8 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.5;testis: 18.0" "Group enriched" "Detected in some" 36 "Early spermatids: 401.3;Late spermatids: 525.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 12.5" "Lineage enriched" "Detected in many" 11 "monocytes: 12.5" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 9.6" "Low region specificity" "Detected in many" HPA056463 Approved Nucleoplasm NA NA Nucleoplasm "HPA056463: AB_2683139" "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.5 0.0 3.4 0.3 2.9 0.6 0.1 1.5 2.9 0.0 0.2 0.6 0.1 0.0 0.0 1.8 0.0 0.0 1.7 3.1 0.1 0.0 0.3 0.2 1.2 0.0 0.7 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.3 18.0 0.1 0.0 0.0 0.0 0.1 1.0 0.8 12.5 0.0 0.8 0.8 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 1.8 0.7 0.3 0.0 1.5 9.3 0.0 0.2 0.0 0.0 9.6 2.3 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.8 0.1 7.9 0.6 0.1 0.7 0.2 1.0 0.0 0.8 0.2 0.0 0.0 12.5 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.5 0.0 0.0 1.3 2.4 525.6 3.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.8 0.0 0.7 12.9 0.5 3.7 5.5 0.0 0.1 0.0 0.0 0.0 LLCFC1 "C7orf34, CTM-1" ENSG00000165131 "LLLL and CFNLAS motif containing 1" Q96L11 7 142939343-142940868 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "testis: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Group enriched" "Detected in some" 5 "K-562: 3.2;RT4: 3.4;SiHa: 1.5" "Intracellular and membrane" NA NA "unprognostic (5.05e-2)" "unprognostic (9.94e-2)" "unprognostic (5.49e-3)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.85e-3)" "unprognostic (3.54e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.5 0.0 31.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.2 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 3.4 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMAN1L "ERGIC-53L, ERGL" ENSG00000140506 "Lectin, mannose binding 1 like" Q9HAT1 15 74812716-74825758 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3" "Group enriched" "Detected in some" 4 "Glandular cells: 9.7;Spermatocytes: 6.5" "Cancer enriched" "Detected in single" 45 "prostate cancer: 2.2" "Region enriched" "Detected in some" 22 "cerebellum: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.8;HEK 293: 2.4;SCLC-21H: 2.5;SK-BR-3: 2.5;U-698: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.51e-1)" "unprognostic (2.44e-1)" "unprognostic (4.26e-2)" "unprognostic (3.09e-1)" 0.1 1.1 0.2 4.8 0.2 0.0 0.1 45.5 0.9 0.3 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.0 0.5 18.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 2.0 37.0 0.0 0.1 17.3 0.1 0.1 0.0 0.2 0.1 0.3 13.5 2.5 0.7 0.1 0.1 0.1 0.3 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.9 0.3 0.0 1.1 0.0 0.5 2.5 0.1 0.0 2.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.6 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 45.5 0.9 0.1 0.0 0.1 0.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 3.9 4.9 5.2 2.5 11.0 2.3 4.5 6.1 9.1 6.2 3.5 5.8 14.3 2.2 4.8 20.3 3.5 9.3 5.1 5.9 5.7 7.4 6.6 3.7 8.1 3.5 5.6 8.9 6.5 6.1 8.8 15.0 3.9 11.6 4.6 4.1 5.4 4.2 11.7 3.7 6.5 2.3 4.0 5.5 3.0 3.9 27.0 4.4 1.2 7.6 3.0 2.6 3.5 3.7 1.9 1.9 0.8 2.4 1.8 2.4 1.2 6.5 2.5 2.9 3.5 5.8 8.2 2.5 3.4 3.1 6.1 5.1 2.4 2.4 2.1 15.8 2.4 13.3 2.5 2.7 2.7 9.0 0.3 2.0 1.2 2.1 1.8 3.6 3.6 1.8 3.9 6.1 7.6 5.0 3.6 2.6 5.3 6.3 4.0 5.9 4.8 2.2 3.2 3.3 4.7 5.9 2.5 0.7 2.2 6.3 1.7 4.8 1.4 4.7 4.2 3.4 3.5 11.0 2.8 5.7 7.6 1.1 9.1 5.7 7.1 13.7 0.6 10.8 6.4 6.8 0.2 0.6 0.5 1.2 2.4 1.7 1.9 0.8 1.6 1.9 1.1 2.2 2.4 0.8 1.8 0.9 0.5 0.0 1.2 5.2 11.0 6.1 9.1 5.7 7.4 5.6 8.9 11.6 4.4 14.9 11.3 1.9 1.5 1.8 7.7 9.2 2.5 32.1 13.6 8.7 15.7 2.5 0.0 2.5 29.2 2.5 1.0 0.0 2.3 2.1 3.3 1.9 2.3 2.4 4.2 7.9 4.6 4.3 2.8 18.6 4.4 2.0 3.3 0.0 3.1 7.7 1.8 0.0 5.3 3.7 16.3 0.0 3.2 29.2 24.7 1.5 2.4 1.3 2.3 1.3 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Group enriched" "Detected in some" 15 "Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038640: AB_2676127" "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.6 2.4 3.1 5.5 1.2 0.2 0.0 0.3 0.2 0.1 0.0 3.5 0.1 0.2 0.1 0.3 0.9 0.1 1.0 0.8 2.0 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 0.1 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.7 0.1 0.5 0.4 0.2 0.2 0.2 6.7 0.1 6.9 0.2 0.4 3.9 0.8 0.3 1.5 0.3 0.2 0.9 24.0 0.2 0.8 1.3 1.7 0.3 1.6 2.6 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 0.0 0.0 0.5 1.1 0.0 0.0 0.4 0.0 26.8 2.3 0.0 0.0 0.2 1.7 0.0 38.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.7 LMO7DN C13orf45 ENSG00000178734 "LMO7 downstream neighbor" F2Z398 13 75871038-75883811 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 3.4" "Cell type enhanced" "Detected in single" 26 "Leydig cells: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.5;fHDF/TERT166: 2.5;LHCN-M2: 5.2;U-2197: 1.4" HPA052013 Uncertain NA NA "HPA052013: AB_2681693" "unprognostic (2.85e-2)" "unprognostic (2.83e-2)" "unprognostic (2.37e-2)" "unprognostic (1.51e-2)" "unprognostic (3.08e-4)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (1.04e-1)" "unprognostic (2.43e-3)" "unprognostic (1.91e-2)" "unprognostic (2.95e-1)" "unprognostic (8.72e-3)" "unprognostic (6.19e-2)" 0.6 0.1 0.1 0.0 0.8 0.2 1.8 0.0 0.8 0.0 0.1 1.2 0.3 0.6 2.7 0.8 3.4 0.2 0.3 0.5 0.3 0.0 1.6 0.4 0.3 0.6 0.0 0.1 3.0 0.2 0.1 0.1 0.7 0.0 0.4 0.3 1.3 0.6 0.3 0.0 0.6 1.4 0.7 0.0 0.4 0.4 0.2 0.1 0.0 0.0 1.0 0.3 0.1 0.3 0.3 0.3 0.4 0.6 0.5 0.3 1.5 0.3 0.0 0.6 1.3 0.2 0.1 0.0 2.5 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.2 0.0 0.3 0.1 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401193-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.9" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 107.8;Horizontal cells: 243.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 3.1 2.8 6.5 1.7 11.4 0.6 2.7 7.9 9.7 3.4 2.3 1.5 3.4 1.2 4.6 8.4 1.9 4.0 2.7 9.5 5.3 7.2 4.8 7.4 3.8 1.4 5.7 5.6 6.3 4.5 3.0 17.0 3.7 7.4 2.8 2.2 9.0 2.4 3.3 4.3 1.0 1.5 4.5 4.2 1.8 1.9 31.9 3.5 1.6 5.3 0.8 1.7 3.1 1.8 0.9 0.2 0.0 0.4 0.2 2.7 0.8 2.9 1.6 8.5 1.2 5.5 2.4 0.7 2.3 5.6 1.9 2.2 0.6 0.7 2.6 1.0 1.6 3.0 1.9 2.2 2.0 2.2 2.6 2.3 6.2 0.8 2.8 1.7 3.6 0.7 2.6 0.7 1.0 4.8 2.5 0.4 1.3 2.4 9.7 1.7 2.1 5.0 3.6 5.8 1.7 12.8 3.8 4.7 5.1 1.7 0.3 8.8 4.4 1.7 2.5 3.5 2.5 0.6 0.4 0.6 0.9 9.0 0.8 2.0 11.4 12.2 7.5 2.6 3.1 1.6 0.0 0.4 0.0 1.1 0.2 2.5 0.9 1.1 0.6 0.2 0.9 1.0 1.1 0.0 0.2 0.0 0.0 2.7 0.8 6.5 11.4 7.9 9.7 5.3 7.2 5.7 5.6 7.4 3.5 0.0 0.3 4.2 1.2 0.9 32.6 9.6 0.0 5.3 2.3 1.8 47.1 1.2 6.6 0.4 107.8 0.7 0.4 23.3 0.8 1.6 3.1 0.9 0.0 1.6 0.6 243.1 2.4 0.0 0.3 17.2 3.1 0.0 20.3 1.0 1.0 9.4 0.6 0.0 1.1 3.1 35.6 0.0 2.2 31.5 2.7 0.5 0.3 0.0 0.6 0.1 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100273291-100322733 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;epididymis: 32.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 74.2;Cardiomyocytes: 34.4;Horizontal cells: 104.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 6.5;GAMG: 8.1;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057366 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057366: AB_2683420" "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 1.6 23.0 8.4 0.6 32.9 0.2 2.2 21.1 15.4 5.1 1.7 1.3 2.3 0.5 19.0 32.6 2.0 17.8 1.7 4.3 5.6 9.9 1.3 0.7 1.5 0.5 3.9 7.0 10.5 4.4 9.6 7.8 0.6 6.4 3.2 0.7 1.6 1.5 3.2 4.6 0.4 0.5 19.8 4.5 0.5 1.5 1.8 4.3 0.4 3.5 0.8 0.4 1.4 1.3 0.7 0.5 1.7 0.4 0.7 0.5 0.1 0.0 6.5 2.0 2.4 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.2 0.0 1.1 0.0 8.1 0.0 6.4 0.0 0.0 0.5 6.9 0.0 0.4 0.0 0.2 0.1 5.7 0.0 0.0 0.3 0.0 0.4 0.0 1.8 3.7 0.1 0.0 4.2 0.0 0.3 0.4 1.2 5.9 0.0 0.0 0.0 1.6 0.2 14.0 3.8 0.0 0.0 1.0 2.3 3.5 0.1 0.1 0.1 0.8 0.0 0.4 0.0 0.0 0.0 2.8 0.0 0.3 1.1 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.7 0.4 0.5 1.7 0.7 0.3 0.5 0.2 0.1 8.4 32.9 21.1 9.7 5.6 9.9 3.9 7.0 6.4 4.3 0.0 13.2 0.0 1.2 0.7 74.2 34.4 5.1 5.3 5.7 5.2 29.5 1.7 5.0 2.4 0.4 1.0 0.0 0.0 1.8 0.2 1.5 5.8 5.7 0.5 0.4 104.9 10.9 0.0 0.0 1.5 3.1 0.3 1.7 0.0 0.1 10.0 2.1 0.0 11.0 0.3 18.2 6.5 3.3 0.5 0.2 0.1 2.4 0.0 0.4 0.5 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.5;epididymis: 9.7;testis: 22.0" "Group enriched" "Detected in some" 84 "Early spermatids: 168.6;Late spermatids: 330.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 5 "basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "THP-1: 3.5;WM-115: 1.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 1.0" HPA077128 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 1.7 0.0 0.4 0.0 2.4 2.7 0.4 0.1 1.9 0.0 0.1 0.2 15.5 0.0 0.0 9.7 0.1 1.7 0.1 0.5 0.2 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.4 4.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.0 0.7 0.1 22.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.4 2.4 0.1 1.9 0.2 0.1 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 168.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 330.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6636447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 28.4;brain: 20.3;esophagus: 21.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;Enterocytes: 15.1;granulocytes: 16.1;Hofbauer cells: 29.9;Paneth cells: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 28.4;T-cells: 23.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HEL: 13.9;HMC-1: 20.2;K-562: 10.3;U-698: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013170 Approved NA NA "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favorable (6.56e-5)" "unprognostic (7.43e-2)" 2.1 3.2 11.2 5.6 12.4 1.1 1.6 1.3 8.9 5.8 10.2 20.3 0.5 11.2 0.7 3.2 21.1 2.0 1.9 3.6 10.9 4.0 1.3 1.5 2.1 9.2 9.3 4.0 0.9 0.8 0.9 1.4 7.2 9.2 1.7 9.7 1.7 6.3 1.6 0.3 6.8 9.3 1.3 11.7 10.6 8.3 1.7 13.6 2.2 2.0 1.1 13.5 3.4 9.0 28.4 5.5 2.5 1.8 1.3 23.9 6.5 4.1 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 7.6 3.2 1.0 0.0 0.1 5.3 0.0 2.2 0.0 0.0 0.0 13.9 0.4 0.3 0.0 0.0 20.2 0.0 2.6 0.1 1.1 0.0 0.0 3.0 10.3 0.0 0.0 0.3 0.4 4.3 0.0 6.7 0.7 3.6 0.0 0.0 0.0 2.4 0.1 0.1 2.1 0.0 0.0 0.8 0.0 1.6 0.1 0.0 3.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 2.5 0.1 0.0 23.9 1.0 18.0 28.4 4.0 14.1 5.5 27.8 4.0 8.9 0.2 1.3 1.8 0.3 5.4 6.5 11.2 12.4 1.3 8.9 10.9 4.0 9.3 4.0 9.2 13.6 0.0 0.0 17.5 0.5 1.3 0.0 1.6 0.0 0.0 2.3 1.8 0.0 0.2 0.0 0.4 2.2 0.0 15.1 0.0 0.8 0.2 0.6 0.6 16.1 0.0 29.9 0.0 1.2 0.6 10.7 13.0 0.0 3.7 0.0 6.4 10.6 0.0 5.5 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.1 0.5 6.9 9.1 1.7 LRCH2 KIAA1495 ENSG00000130224 "Leucine rich repeats and calponin homology domain containing 2" Q5VUJ6 X 115110616-115234072 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 10.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003233 Approved Approved "Nucleoli,Plasma membrane" NA NA Nucleoli "Plasma membrane" "HPA003233: AB_2265929" "unprognostic (9.74e-2)" "unprognostic (9.48e-2)" "unprognostic (1.14e-2)" "unprognostic (4.22e-5)" "unprognostic (2.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (1.01e-2)" "unprognostic (1.84e-1)" "unprognostic (4.29e-5)" "unprognostic (1.09e-3)" "unprognostic (1.34e-1)" "unprognostic (7.75e-2)" "unprognostic (1.16e-2)" 5.1 8.7 11.6 3.4 10.2 0.7 3.3 11.2 10.6 11.2 11.6 5.5 4.0 1.6 9.9 4.5 3.6 4.6 5.3 4.7 7.9 8.9 2.6 1.0 5.7 1.8 5.7 4.6 13.8 1.6 1.3 20.9 13.7 7.6 16.4 4.2 2.5 1.3 14.5 1.2 1.1 3.2 13.7 6.4 3.7 3.6 4.3 7.9 0.0 4.8 0.4 1.1 11.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.9 5.5 4.6 0.0 3.5 7.6 3.4 7.9 0.0 0.0 0.1 0.0 4.6 2.7 0.3 17.8 0.0 5.2 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.1 2.7 0.0 1.4 0.2 9.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 5.2 0.0 3.8 0.0 4.3 0.5 0.0 6.8 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.1 0.0 4.9 11.8 2.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 10.2 11.2 8.4 7.9 8.9 5.7 4.6 7.6 7.9 3.0 10.5 0.0 0.0 0.6 6.7 5.5 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 5.7 4.5 0.0 0.0 0.0 0.1 5.4 1.2 0.0 0.0 0.5 1.6 0.0 1.8 0.0 1.5 8.1 0.0 1.7 0.0 0.0 6.6 0.0 0.0 6.0 0.0 2.4 25.8 7.1 3.6 3.0 0.1 0.2 0.0 0.0 0.0 LRCOL1 ENSG00000204583 "Leucine rich colipase like 1" A6NCL2 12 132603150-132610543 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "epididymis: 54.8" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 39.8" "Cancer enhanced" "Detected in some" "liver cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0" "Secreted in male reproductive system" NA NA "unprognostic (5.09e-3)" "unprognostic (7.83e-3)" "unprognostic (3.26e-1)" "unprognostic (6.94e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-2)" "prognostic favorable (7.04e-4)" "unprognostic (4.54e-2)" "unprognostic (6.08e-2)" "unprognostic (5.29e-2)" "unprognostic (4.66e-3)" "unprognostic (1.52e-1)" "unprognostic (6.50e-6)" "unprognostic (1.46e-3)" "unprognostic (9.63e-2)" "unprognostic (3.31e-1)" "unprognostic (4.00e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 54.8 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.5 1.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 3.1 1.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 LRFN3 "FIGLER1, MGC2656, SALM4" ENSG00000126243 "Leucine rich repeat and fibronectin type III domain containing 3" Q9BTN0 19 35935358-35945767 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Ito cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in single" 5 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048923 Approved NA NA "HPA048923: AB_2680558" "unprognostic (1.88e-1)" "unprognostic (7.22e-3)" "unprognostic (1.82e-1)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (7.37e-2)" "unprognostic (8.14e-2)" "unprognostic (2.34e-3)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (3.49e-3)" "unprognostic (1.74e-1)" "prognostic favorable (8.46e-7)" "unprognostic (6.84e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-2)" "unprognostic (1.03e-1)" 7.2 4.8 6.5 3.6 10.6 0.2 3.8 13.8 17.1 5.9 4.6 3.2 2.9 7.5 7.4 2.6 4.3 5.1 5.4 3.8 6.3 5.1 4.5 6.9 8.9 2.1 3.8 9.4 9.3 7.1 8.1 9.3 3.2 5.0 5.7 3.2 4.4 7.7 7.6 6.5 5.3 7.2 5.8 2.2 5.0 6.3 7.7 2.9 3.2 3.9 2.2 2.1 4.9 5.0 0.5 0.1 0.0 0.0 0.0 2.9 0.5 10.3 11.8 5.4 8.4 11.3 6.0 2.5 4.4 5.6 4.2 4.3 2.1 4.9 5.9 9.1 5.2 5.3 3.9 2.3 4.9 2.5 11.8 4.6 0.7 2.6 2.3 4.4 0.3 9.2 6.7 6.8 2.6 2.7 5.3 5.1 7.5 1.7 8.8 3.8 7.5 4.7 0.3 4.2 7.1 5.2 6.2 3.2 0.2 3.1 3.9 7.0 9.3 6.0 4.6 3.5 2.9 3.6 2.9 6.4 9.8 8.7 8.8 6.7 3.4 3.5 0.2 8.8 3.2 6.7 0.0 0.0 0.0 2.7 0.0 2.9 0.3 2.2 2.6 0.0 0.5 1.4 0.5 0.0 0.0 0.0 0.1 1.1 0.5 6.5 10.6 13.8 17.1 6.3 5.1 3.8 9.4 5.0 2.9 0.0 0.0 0.8 2.8 1.0 7.7 8.7 0.0 0.0 0.0 3.5 2.0 0.3 0.0 3.2 0.4 2.1 5.4 0.0 3.7 1.7 2.3 3.1 0.0 3.4 1.6 7.9 2.9 10.4 0.3 0.4 4.0 0.4 0.0 0.0 2.2 2.8 3.5 4.8 7.1 2.2 4.6 6.5 2.1 0.2 1.1 1.0 0.1 0.0 2.9 1.4 LRGUK "CFAP246, FLJ32786" ENSG00000155530 "Leucine rich repeats and guanylate kinase domain containing" Q96M69 7 134127299-134264591 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.5;pituitary gland: 11.5;testis: 22.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 26.8;Early spermatids: 14.4;Spermatocytes: 8.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 5.1;SH-SY5Y: 4.9;SK-MEL-30: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029505, HPA029506" Uncertain NA NA "HPA029505: AB_10599606, HPA029506: AB_10601752" "unprognostic (4.08e-3)" "unprognostic (1.87e-1)" "unprognostic (6.94e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-2)" "unprognostic (2.64e-2)" "unprognostic (7.85e-4)" "unprognostic (6.92e-2)" "unprognostic (2.43e-1)" "unprognostic (4.28e-2)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (1.27e-3)" "unprognostic (2.22e-3)" "unprognostic (3.83e-2)" "unprognostic (3.01e-3)" "unprognostic (2.10e-2)" 0.7 0.6 2.3 0.6 6.4 1.3 1.2 0.5 1.4 1.2 0.5 4.1 0.3 0.5 1.5 4.0 0.4 9.1 0.7 0.4 2.4 1.2 1.2 0.9 3.4 0.4 0.3 0.6 2.4 1.9 0.4 11.5 0.4 12.5 1.6 0.7 2.2 1.3 0.5 0.2 1.2 0.5 0.5 1.6 1.3 0.6 22.4 0.9 0.0 2.2 0.0 0.6 0.5 0.4 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.4 0.7 1.1 0.1 0.3 0.3 0.0 0.1 0.5 0.4 0.0 1.0 0.2 0.3 0.1 1.0 0.3 0.4 0.1 0.8 0.5 0.5 0.1 0.3 0.2 0.1 0.2 0.6 0.3 0.7 0.9 0.0 0.1 0.2 0.7 0.2 0.8 0.8 0.2 0.3 0.6 5.1 0.2 1.2 0.7 0.1 0.0 0.8 0.4 1.6 4.9 1.5 0.0 5.1 0.7 0.2 1.1 0.0 0.3 0.6 0.3 0.6 1.2 1.7 1.5 1.4 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 6.4 0.5 1.4 2.4 1.2 0.3 0.6 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 26.8 2.3 0.0 0.0 0.0 0.0 0.2 14.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 1.4 0.0 0.0 0.4 0.0 1.8 0.0 0.0 8.3 0.7 0.4 0.2 0.0 0.0 0.1 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073209-113132260 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 510000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 8.3 7.7 10.1 11.4 10.6 4.7 10.7 15.6 10.0 11.6 9.2 16.1 6.0 10.8 15.1 14.9 7.8 9.2 8.2 7.3 9.3 9.1 9.2 6.3 8.0 9.7 13.0 6.7 15.0 8.5 13.4 11.6 10.1 9.2 9.3 8.6 14.6 9.0 11.2 13.1 16.6 9.5 8.9 11.6 10.1 8.1 9.4 13.4 10.4 12.6 5.0 10.7 8.6 10.7 4.4 2.6 4.9 2.5 4.8 3.9 1.7 4.3 2.4 6.7 5.0 6.4 6.6 3.8 2.8 4.2 3.4 5.8 3.5 2.8 4.5 5.0 3.5 1.9 5.0 4.6 3.0 5.7 3.1 2.7 4.8 4.5 1.7 6.5 5.7 2.3 6.5 5.5 5.4 7.1 5.3 4.4 6.3 5.7 4.3 4.2 3.2 5.7 6.1 6.2 1.8 4.0 5.3 8.4 2.2 3.3 2.9 4.8 3.8 5.0 3.3 6.4 5.7 2.5 6.4 6.6 6.4 3.4 8.7 4.5 4.7 2.2 4.6 6.8 3.6 5.9 4.9 2.5 1.5 3.1 2.0 3.5 3.1 3.4 3.2 1.9 4.4 3.9 3.6 1.7 4.8 2.1 2.6 2.6 1.7 10.1 10.6 15.6 10.0 9.3 9.1 13.0 6.7 9.2 13.4 0.0 13.3 5.9 2.5 7.4 19.1 8.1 12.7 12.0 6.8 14.0 35.3 5.8 0.0 3.2 0.9 6.3 9.9 0.0 2.3 3.7 5.7 4.7 5.7 4.3 4.1 17.5 5.2 6.2 8.5 0.0 17.0 5.9 6.8 1.8 7.1 27.0 2.7 7.0 15.2 4.1 21.3 0.0 4.2 8.6 14.9 5.8 4.5 7.0 8.3 3.4 LRIG3 "FLJ90440, KIAA3016" ENSG00000139263 "Leucine rich repeats and immunoglobulin like domains 3" Q6UXM1 12 58872149-58920522 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010773 Approved Approved Cytosol NA NA Cytosol "HPA010773: AB_1853275" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-2)" "unprognostic (3.88e-2)" "unprognostic (2.53e-1)" "unprognostic (3.46e-2)" "unprognostic (1.83e-2)" "unprognostic (1.34e-3)" "unprognostic (1.21e-1)" "unprognostic (1.92e-1)" "unprognostic (3.04e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-3)" "unprognostic (2.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.46e-2)" 15.8 1.7 3.6 11.8 4.1 0.0 16.4 1.0 3.7 18.7 14.8 7.8 12.1 8.4 14.2 13.8 17.1 9.9 17.8 4.7 4.6 1.8 6.5 6.1 9.6 5.0 3.6 2.6 14.7 15.3 4.8 10.3 6.8 5.8 15.5 16.0 13.5 24.9 11.6 5.0 25.9 10.0 21.6 3.0 7.2 13.5 6.4 6.6 5.4 37.6 15.0 12.8 15.7 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 1.9 7.4 0.5 13.6 15.9 1.7 4.9 14.3 4.8 5.1 5.8 2.7 1.9 10.0 5.4 5.8 9.6 2.7 12.6 3.5 14.6 9.6 0.5 3.3 2.8 2.6 0.8 0.2 15.7 27.4 5.1 11.0 9.4 13.1 2.2 0.1 2.4 3.2 0.9 2.3 0.0 7.9 2.4 2.9 0.0 6.3 4.8 3.7 10.6 7.5 0.0 4.3 2.7 4.5 11.0 5.0 0.1 5.6 6.5 4.5 3.9 6.4 1.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 4.1 1.0 3.7 4.6 1.8 3.6 2.6 5.8 6.6 14.9 17.4 0.0 7.5 19.9 2.6 4.1 33.1 13.4 23.9 1.8 0.0 0.7 0.0 9.0 0.3 11.4 10.7 0.0 15.8 0.4 8.2 2.6 0.0 6.8 1.9 3.2 11.1 4.3 0.3 0.0 25.0 0.2 3.3 0.0 11.8 2.8 7.5 14.0 27.3 4.2 0.1 6.5 11.3 0.4 1.5 19.6 0.2 0.0 25.9 2.7 LRIT1 "DKFZP434K091, FIGLER9, LRRC21, PAL" ENSG00000148602 "Leucine rich repeat, Ig-like and transmembrane domains 1" Q9P2V4 10 84231593-84241461 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 67 "retina: 20.7;testis: 10.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 13.8;Early spermatids: 21.9;Late spermatids: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220495-84225589 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 25.4;skin 1: 8.5" "Group enriched" "Detected in some" 6 "Bipolar cells: 5.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced NA NA "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.1 0.2 0.2 0.1 3.4 0.0 0.1 0.1 2.2 0.1 1.6 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 25.4 0.1 0.1 0.1 8.5 0.7 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.5 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818798-149864026 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 640000 "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 12.0 16.5 17.8 4.4 26.9 1.6 11.2 17.9 25.6 14.0 11.5 15.1 9.4 10.5 10.6 14.8 20.2 20.2 10.5 8.0 19.7 19.3 18.2 9.0 12.1 2.2 15.0 16.9 15.3 17.2 46.2 15.2 14.7 20.6 23.3 11.4 10.8 14.2 12.3 8.1 20.2 8.7 10.9 13.3 3.6 14.4 7.2 15.6 0.8 20.8 13.8 6.4 17.3 14.2 3.5 1.0 0.0 1.7 0.0 0.7 0.1 9.5 8.4 6.4 5.6 14.3 26.2 1.2 10.0 19.6 7.0 8.5 2.5 20.0 0.1 13.7 15.7 30.9 25.6 7.2 18.2 5.0 15.4 7.2 4.5 30.9 11.0 8.8 4.6 0.1 16.3 35.5 9.0 17.8 19.9 10.8 4.4 9.3 4.3 8.3 16.5 0.1 0.1 3.8 19.0 8.4 5.0 9.6 2.2 12.6 19.6 8.5 5.7 31.6 17.7 6.0 3.3 14.5 9.6 8.4 8.8 2.0 18.3 7.6 0.0 3.0 2.2 15.9 4.7 5.1 0.0 0.1 0.0 0.2 0.4 0.0 3.5 0.7 0.6 1.0 0.6 0.2 0.3 0.0 0.0 1.7 0.0 0.0 0.1 17.8 26.9 17.9 25.6 19.7 19.3 15.0 16.9 20.6 15.6 6.0 3.2 0.8 10.9 10.1 10.5 7.6 20.4 24.1 5.7 19.2 2.0 1.4 5.0 5.6 26.8 6.8 3.9 0.0 19.4 2.2 12.9 21.0 0.0 8.3 2.9 7.9 28.3 11.1 1.8 24.2 15.3 1.1 13.5 0.0 3.7 6.3 16.2 2.9 13.8 5.4 5.4 0.0 5.6 6.1 5.9 12.5 4.7 0.0 11.3 20.6 LRP3 "hLRp105, LRP-3" ENSG00000130881 "LDL receptor related protein 3" O75074 19 33177603-33208867 "Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.0" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.5;Hepatocytes: 25.9;Leydig cells: 24.2;Peritubular cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.8;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 4 "monocytes: 2.8" "Cell line enhanced" "Detected in many" "THP-1: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041658 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA041658: " "unprognostic (3.10e-1)" "unprognostic (2.55e-2)" "unprognostic (3.25e-2)" "unprognostic (1.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (1.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.07e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.12e-7)" "unprognostic (1.34e-1)" "unprognostic (2.71e-3)" "unprognostic (4.36e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.32e-1)" 23.5 16.6 28.3 5.1 33.1 15.3 15.6 14.2 41.2 12.1 7.8 6.6 4.4 7.1 11.2 8.8 7.4 12.4 8.2 10.9 27.6 13.0 4.2 15.5 5.3 3.2 15.4 19.4 50.0 16.8 9.8 10.3 3.8 11.0 15.5 3.4 10.0 14.4 12.7 21.9 5.0 6.6 10.6 6.3 4.8 7.0 5.6 7.7 0.0 9.5 4.7 3.1 9.0 9.1 0.0 0.0 0.6 2.8 0.5 0.1 0.7 0.0 20.7 5.7 20.6 14.4 5.4 4.3 5.3 5.2 4.9 1.9 5.9 0.2 0.0 13.9 6.5 6.9 0.0 5.5 0.5 0.4 0.0 11.2 0.0 4.6 20.7 5.5 7.4 0.7 8.2 4.9 1.3 0.7 0.8 4.0 0.0 0.0 0.0 6.2 19.1 0.0 8.4 11.7 4.1 1.0 0.0 2.6 0.0 0.0 8.3 12.6 19.0 8.6 0.0 1.5 0.6 8.7 26.2 0.0 10.2 9.1 15.1 3.0 0.0 0.0 0.1 0.0 12.5 3.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 2.6 0.0 0.0 0.7 28.3 33.1 14.2 41.2 27.6 13.0 15.4 19.4 11.0 7.7 0.0 2.2 0.9 2.1 3.0 28.5 0.4 10.2 0.0 3.4 5.2 3.9 0.1 0.0 5.8 2.2 1.8 0.9 0.0 6.5 0.6 7.0 8.2 0.0 25.9 8.2 22.3 1.7 6.2 10.0 5.2 24.2 2.3 3.3 1.8 6.6 23.0 8.9 0.0 30.8 0.5 3.6 6.5 5.2 0.2 0.4 2.3 0.0 0.0 4.9 1.4 LRP5L DKFZp434O0213 ENSG00000100068 "LDL receptor related protein 5 like" A4QPB2 22 25351418-25405377 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 6.3;NK-cell: 10.7" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;NK-cells: 10.7" "Low cell line specificity" "Detected in many" HPA028717 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028717: AB_10601767" "unprognostic (5.90e-2)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.34e-3)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (1.13e-1)" "unprognostic (5.98e-3)" "unprognostic (5.11e-1)" "unprognostic (9.64e-2)" "unprognostic (9.78e-2)" "unprognostic (4.38e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "prognostic favorable (6.93e-6)" 6.0 4.7 4.8 8.0 3.8 17.6 18.5 1.5 6.2 10.0 7.0 4.1 11.4 4.1 8.2 8.1 3.9 6.3 8.0 5.3 3.9 2.0 9.1 17.4 5.9 8.5 8.1 1.7 7.7 8.0 6.3 3.8 2.1 4.1 8.9 4.7 6.5 11.0 12.2 2.7 6.1 5.7 7.7 3.4 8.4 4.8 5.0 3.6 3.7 15.5 4.3 6.7 6.3 7.5 1.1 0.2 6.3 0.5 10.7 1.0 0.3 2.0 3.1 1.2 6.2 2.3 1.0 2.2 1.8 2.8 2.4 2.6 2.9 1.0 0.8 2.4 2.0 1.9 4.0 2.2 3.1 1.5 2.9 7.0 4.0 5.1 7.3 2.8 7.7 8.2 4.1 3.0 2.7 11.5 3.9 1.0 3.6 2.5 2.5 1.6 6.9 1.4 7.2 2.8 6.5 4.5 6.9 2.7 3.0 2.8 4.8 4.0 4.7 1.4 2.2 2.2 1.3 2.6 2.8 1.8 2.7 11.7 1.8 3.0 6.4 1.3 1.7 1.6 4.7 1.4 6.3 0.5 2.1 1.0 0.4 0.9 0.2 0.3 0.3 0.1 1.1 0.1 0.3 0.2 10.7 0.2 0.2 0.0 0.3 4.8 3.8 1.5 6.2 3.9 2.0 8.1 1.7 4.1 3.6 0.0 2.7 0.9 3.4 6.0 1.7 1.4 2.5 2.7 6.8 1.8 0.0 0.4 0.0 2.5 0.5 2.9 2.6 0.0 1.0 0.4 1.1 3.7 0.0 4.4 2.2 9.5 3.5 2.5 4.3 0.0 3.7 4.0 1.7 1.8 5.2 1.5 2.6 5.8 1.8 0.3 1.5 12.9 5.2 0.9 3.4 3.4 0.2 4.4 4.3 2.8 LRRC10 "HRLRRP, LRRC10A" ENSG00000198812 "Leucine rich repeat containing 10" Q5BKY1 12 69608564-69611162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "heart muscle: 42.5" "Cell type enriched" "Detected in single" 323 "Cardiomyocytes: 32.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.76e-4)" "unprognostic (4.59e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 1.0 0.5 0.4 0.8 0.1 0.1 0.5 0.6 0.6 0.0 0.0 0.5 0.2 0.0 1.0 0.4 0.3 0.3 1.0 0.3 0.1 0.2 0.7 0.0 0.1 0.0 2.5 0.7 0.5 0.7 0.6 0.1 0.0 0.8 0.2 0.7 0.6 0.0 0.9 0.4 0.5 0.6 0.1 0.1 0.0 0.8 0.4 0.2 0.0 0.4 0.9 0.1 0.1 0.8 1.3 0.8 0.9 0.0 0.1 0.0 0.7 0.3 0.1 0.4 0.2 0.8 0.5 0.4 0.6 0.4 0.8 1.0 1.3 0.1 0.4 0.5 0.4 0.6 0.2 0.5 0.7 0.5 0.6 0.1 1.3 0.8 0.7 1.0 0.4 0.3 1.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 48.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.5 1.6 1.2 0.0 0.0 0.0 0.0 26.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102912991-102944949 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.0" "Group enriched" "Detected in some" 4 "Leydig cells: 94.3;Peritubular cells: 29.7;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "eosinophil: 12.0" "Lineage enriched" "Detected in single" 75 "granulocytes: 12.0" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 172.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" NA NA Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.30e-4)" 5.1 1.3 1.1 0.5 1.2 0.0 6.2 1.4 2.0 15.0 1.4 1.5 5.6 0.5 8.3 17.1 5.2 8.9 13.5 6.4 1.2 1.3 1.5 1.4 1.6 1.6 1.1 2.1 39.0 2.6 1.2 1.7 1.8 2.5 7.8 1.4 2.7 2.8 2.5 5.3 2.0 2.6 5.1 1.2 1.2 3.5 5.1 0.2 2.2 2.6 6.7 1.3 6.7 4.2 0.1 0.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.8 4.3 0.0 0.2 2.5 0.0 0.4 0.0 0.0 0.0 0.4 0.2 1.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 4.0 0.1 3.0 0.0 20.0 19.6 0.0 0.0 0.0 172.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.2 2.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.4 2.0 1.2 1.3 1.1 2.1 2.5 0.2 0.0 0.6 0.0 0.1 0.8 3.7 0.8 0.0 0.0 0.0 1.8 2.0 0.2 0.0 1.5 2.4 3.6 0.0 0.0 0.3 0.1 11.8 0.2 1.1 0.6 0.3 0.0 0.0 9.2 0.0 0.7 94.3 0.0 5.0 1.0 0.0 0.2 0.2 0.0 29.7 0.0 1.9 64.7 14.3 0.6 0.3 0.5 0.0 0.0 0.1 0.1 LRRC18 "MGC34773, UNQ933, UNQ9338, VKGE9338" ENSG00000165383 "Leucine rich repeat containing 18" Q8N456 10 48909483-48914232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.1;testis: 15.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 174.5" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HDLM-2: 1.4;HL-60: 2.1;JURKAT: 3.1;NB-4: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039256 Enhanced NA NA "HPA039256: AB_10671873" "unprognostic (1.31e-2)" "unprognostic (3.66e-2)" "unprognostic (9.83e-4)" "unprognostic (3.10e-1)" "unprognostic (4.82e-2)" "unprognostic (1.98e-1)" "unprognostic (2.00e-1)" "unprognostic (8.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.16e-2)" "unprognostic (8.57e-3)" "unprognostic (4.08e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.3 0.2 0.7 0.2 0.2 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 9.1 0.1 0.2 0.8 0.9 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.8 0.3 0.0 0.1 0.0 0.0 15.5 0.0 0.0 0.3 0.0 1.4 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.4 0.1 1.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.4 0.2 0.0 0.0 2.1 0.6 0.4 0.4 0.0 0.2 0.3 0.7 3.1 0.2 0.0 0.0 0.0 0.1 3.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.2 0.1 0.4 0.0 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.2 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.3 0.0 0.0 0.0 0.0 0.0 174.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 LRRC19 FLJ21302 ENSG00000184434 "Leucine rich repeat containing 19" Q9H756 9 26993136-27005693 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 61.3;kidney: 50.0" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 22.7;Enterocytes: 78.3;Paneth cells: 39.5;Proximal tubular cells: 50.0;Undifferentiated cells: 24.0" "Group enriched" "Detected in some" 5 "colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 2.4;RPTEC TERT1: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 96000 "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (6.30e-2)" "unprognostic (5.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (4.16e-2)" "unprognostic (9.21e-5)" "unprognostic (1.87e-2)" "unprognostic (4.48e-2)" "prognostic favorable (7.08e-8)" "unprognostic (2.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" 0.2 0.2 0.2 5.9 0.2 0.0 0.2 0.2 0.2 0.2 23.4 0.1 0.1 11.9 0.2 1.3 0.2 0.2 2.9 0.1 0.2 0.2 50.0 0.8 0.2 0.1 0.2 0.1 0.2 0.6 0.0 0.2 0.1 0.1 0.2 17.0 0.1 0.2 0.1 0.1 0.2 61.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.2 2.0 0.9 1.1 0.7 0.4 0.8 0.0 2.4 0.6 0.3 0.4 0.0 0.4 0.9 0.7 0.0 0.0 0.0 0.6 0.3 0.3 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.6 1.0 0.5 0.0 0.6 0.8 0.1 0.5 0.0 0.3 1.0 0.0 0.2 0.3 1.0 0.0 0.3 0.5 1.5 1.7 0.3 1.1 0.5 0.5 0.6 4.2 0.4 0.6 0.3 1.7 0.3 0.1 0.6 0.3 0.5 1.2 0.8 0.4 1.6 0.5 0.3 0.3 0.1 0.2 0.6 0.2 1.0 0.7 0.6 0.5 0.6 0.4 0.6 0.8 0.4 0.5 2.0 0.8 0.7 1.1 0.4 0.6 0.9 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.4 20.4 0.0 0.0 22.7 0.0 0.0 8.3 0.1 0.0 0.0 78.3 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.1 0.1 39.5 0.4 50.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515423-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0" "Cell type enriched" "Detected in many" 17 "Cardiomyocytes: 175.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 1.8 0.5 1.9 0.4 1.4 0.4 1.0 1.4 3.0 2.6 1.1 0.2 0.0 0.4 3.9 1.4 1.1 1.1 1.4 53.9 1.3 0.4 2.2 2.5 0.6 0.3 0.5 2.3 2.8 0.7 0.1 2.2 0.5 1.0 1.2 0.8 0.4 1.4 0.2 70.3 1.2 0.6 2.3 0.4 1.3 1.0 0.4 0.0 1.4 10.1 20.0 1.2 1.7 1.8 1.2 0.8 2.6 0.7 1.1 2.5 0.3 0.2 0.1 0.2 0.3 1.0 2.3 0.1 0.8 1.5 0.6 0.8 0.0 0.2 0.3 0.2 10.8 0.1 0.2 3.8 0.0 1.4 0.5 0.1 6.2 0.4 0.2 0.3 0.2 0.1 0.2 0.1 4.3 0.0 3.6 0.2 0.8 0.1 0.4 6.2 0.1 0.8 0.1 1.5 0.5 0.2 0.1 0.1 0.3 0.1 0.3 0.5 1.2 0.8 0.2 1.6 1.3 0.2 0.8 4.9 0.3 0.6 2.5 1.6 0.4 0.3 2.9 0.2 0.1 1.4 2.2 0.7 0.6 0.6 0.4 0.4 0.7 1.6 0.3 0.2 1.2 0.8 0.6 2.6 1.1 0.5 0.8 2.5 0.3 1.9 1.4 1.4 3.0 1.3 0.4 0.5 2.3 1.0 0.0 8.9 0.6 0.0 0.8 1.6 0.0 175.7 2.5 1.4 0.0 1.8 0.0 0.1 8.3 0.2 2.0 1.5 0.0 0.0 0.8 0.0 4.3 0.4 10.3 8.9 1.5 0.0 2.9 5.5 0.0 1.7 0.6 1.1 10.1 0.0 1.5 0.3 1.5 0.0 0.0 0.5 0.1 0.0 3.9 0.6 0.2 2.0 0.1 0.7 1.7 0.4 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "fallopian tube: 94.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 279.7;Rod photoreceptor cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 3.6 4.2 11.4 2.4 12.8 3.4 4.8 10.5 10.9 5.8 3.1 10.8 6.9 2.2 6.0 13.1 2.9 94.2 4.2 4.7 12.2 12.9 6.9 3.7 9.4 2.9 7.3 9.6 5.9 2.5 9.3 9.0 3.4 9.9 4.8 3.3 9.4 4.0 5.0 5.5 3.5 2.1 4.8 7.0 3.5 4.5 21.1 8.4 2.2 7.1 2.4 3.7 3.1 3.1 7.8 5.9 9.0 4.4 5.3 4.7 2.2 5.2 10.1 1.7 3.8 7.6 5.9 6.0 2.1 7.2 3.5 6.7 2.1 10.7 4.6 2.3 5.5 10.1 1.3 3.1 4.4 7.5 3.6 1.5 3.2 4.0 4.1 6.2 1.7 3.1 4.1 8.2 6.7 6.1 9.1 4.7 11.3 1.9 2.6 4.0 5.8 4.0 1.2 1.1 7.7 3.0 3.7 8.4 5.3 7.1 1.5 2.8 6.6 3.3 4.5 6.3 11.2 2.3 4.1 2.0 3.5 9.2 3.9 2.3 2.5 1.7 3.8 8.5 2.3 5.0 1.3 4.4 9.0 3.7 4.2 4.7 7.8 3.6 3.1 4.0 4.8 4.1 4.0 0.7 5.3 3.8 5.9 0.2 2.2 11.4 12.8 10.5 10.9 12.2 12.9 7.3 9.6 9.9 8.4 0.0 28.5 7.0 9.6 5.8 17.2 7.5 22.9 279.7 46.6 12.2 47.1 7.2 31.5 10.7 32.5 6.2 4.2 23.3 15.1 9.4 10.8 6.9 5.7 6.4 11.8 12.7 17.2 9.2 8.6 32.8 7.8 8.7 8.5 8.2 7.9 28.7 13.0 3.5 11.7 28.1 113.4 12.9 10.0 62.1 12.6 5.1 3.8 9.6 6.5 6.3 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 100.1;Cone photoreceptor cells: 68.7;Late spermatids: 50.7;Rod photoreceptor cells: 63.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 4.2;SCLC-21H: 4.5;SH-SY5Y: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles NA NA Vesicles "HPA028171: AB_2672504, HPA052250: AB_2681774" "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.4 0.8 0.6 1.6 0.8 0.5 1.8 0.5 0.6 0.7 0.6 0.2 1.6 0.8 3.5 0.2 0.3 0.1 0.0 0.0 0.1 1.2 2.3 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.4 0.3 0.9 0.9 0.1 0.1 4.2 1.2 1.7 0.2 0.2 0.8 1.8 0.1 0.6 0.1 0.5 4.5 12.4 0.4 0.1 0.4 0.0 3.8 1.3 0.0 0.1 1.2 0.5 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 0.0 2.9 0.0 0.5 0.8 100.1 0.0 2.5 0.0 1.2 1.8 68.7 0.4 3.3 0.2 19.3 0.0 1.8 0.0 0.2 0.4 0.8 1.5 0.0 2.4 0.4 28.6 10.3 0.0 1.5 50.7 2.6 0.8 5.0 0.0 1.7 12.1 0.4 1.9 2.8 3.0 63.8 0.0 1.4 4.8 2.9 0.4 0.3 0.0 1.6 0.5 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132379918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 52.9" "Group enriched" "Detected in many" 8 "Early spermatids: 394.8;Late spermatids: 739.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.5;hTERT-RPE1: 18.9" "Low region specificity" "Detected in all" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: AB_2732766" "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 2.1 2.8 8.1 1.5 8.4 1.0 4.1 2.2 8.9 3.6 2.1 6.1 7.5 2.0 3.8 5.6 1.6 10.5 3.5 2.2 6.6 5.4 4.4 2.4 3.1 1.9 4.3 7.3 5.4 3.1 7.5 5.8 2.1 6.5 4.1 2.1 4.8 3.1 4.0 1.2 2.1 2.6 3.4 3.5 3.3 3.0 52.9 4.5 0.7 5.1 1.0 1.2 2.5 1.8 4.7 7.8 4.4 6.8 3.1 2.8 2.7 2.5 4.7 10.3 14.5 9.1 9.3 1.0 2.5 8.1 4.2 3.8 0.8 5.2 1.4 1.5 5.8 3.2 1.8 2.3 1.2 2.6 2.9 2.0 0.3 3.3 2.4 6.5 1.1 1.7 4.0 8.0 4.2 5.7 18.9 3.0 3.6 0.8 1.0 3.2 4.3 2.2 3.2 2.9 1.8 1.6 1.9 1.7 0.8 7.5 0.6 1.8 5.2 1.2 0.8 3.3 2.2 2.3 2.6 3.9 1.7 2.1 3.8 1.5 0.7 0.3 0.8 7.7 2.2 1.0 4.4 6.8 1.1 1.7 5.7 1.3 3.4 1.1 1.0 7.3 4.7 2.8 1.6 0.5 3.1 3.6 7.8 0.7 2.7 8.1 8.4 2.2 8.9 6.6 5.4 4.3 7.3 6.5 4.5 8.9 10.9 1.3 2.4 2.5 7.8 4.4 7.6 48.2 7.9 3.5 9.8 3.1 16.6 5.9 394.8 4.5 1.7 0.0 4.6 1.0 5.2 2.9 8.1 2.1 6.6 7.9 5.2 14.7 8.0 739.5 4.4 7.1 6.8 7.2 1.9 8.9 3.3 0.0 11.0 11.9 17.7 6.5 2.3 75.2 20.4 2.8 1.1 4.9 3.3 1.4 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 131.5;Late spermatids: 330.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 9.1 9.5 7.5 5.3 12.7 7.4 7.3 12.7 15.4 7.7 10.4 8.1 6.1 15.8 6.9 7.6 9.9 5.0 8.8 10.8 7.5 6.5 17.7 42.3 6.2 6.3 6.9 8.4 5.8 18.1 9.1 10.8 5.9 9.8 6.3 9.5 9.3 8.6 6.9 18.0 12.1 18.2 7.8 6.7 6.3 9.1 24.1 5.2 17.7 7.4 8.2 8.6 7.9 7.3 4.8 6.0 21.8 6.9 3.4 7.0 4.2 2.9 7.1 7.1 9.1 10.2 14.4 3.0 3.1 8.7 5.3 6.3 5.5 6.3 5.9 5.7 7.3 6.6 6.5 5.1 9.8 7.8 3.6 7.5 4.0 3.3 5.5 9.0 3.9 6.5 8.5 13.6 5.0 10.0 12.0 16.7 9.5 3.5 5.9 11.0 5.6 10.6 6.5 2.9 22.4 2.5 6.5 6.0 5.3 11.3 9.3 3.2 4.1 7.3 4.0 11.4 11.2 6.2 7.4 6.0 5.2 3.6 4.0 6.0 12.1 16.7 3.6 6.7 3.8 9.7 15.6 6.9 21.8 5.5 5.5 4.3 4.8 5.2 5.7 6.0 4.1 4.8 4.1 3.6 3.4 5.3 5.0 7.0 4.2 7.5 12.7 12.7 15.4 7.5 6.5 6.9 8.4 9.8 5.2 14.9 2.6 9.7 11.4 12.2 20.0 13.3 10.2 10.7 6.8 10.4 21.6 15.0 23.2 11.2 131.5 10.5 25.7 23.3 25.7 18.2 9.3 9.5 2.3 32.1 16.9 20.6 8.7 11.1 19.8 330.3 11.8 8.6 13.5 17.2 15.4 14.3 13.6 20.1 8.1 54.9 19.0 0.0 12.0 42.3 35.8 13.8 10.9 15.0 13.6 11.9 LRRC31 FLJ23259 ENSG00000114248 "Leucine rich repeat containing 31" Q6UY01 3 169839179-169869930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.3;salivary gland: 7.0;stomach 1: 7.6" "Cell type enhanced" "Detected in some" 22 "Intestinal endocrine cells: 9.9;Mucus-secreting cells: 20.2;Paneth cells: 6.6;Undifferentiated cells: 4.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-2)" "unprognostic (5.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.90e-2)" "unprognostic (4.40e-2)" "unprognostic (7.90e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-4)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (2.27e-1)" "unprognostic (5.96e-3)" 0.3 0.0 0.3 1.2 0.3 0.0 0.3 0.3 0.3 0.9 14.2 0.3 0.3 6.4 0.3 0.3 0.3 0.0 1.0 0.3 0.3 0.0 0.3 3.9 0.6 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.5 17.3 0.3 7.0 0.3 0.3 0.0 10.5 0.3 0.3 0.3 7.6 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 6.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.1 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793428-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 13.7;testis: 23.8" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 7 "B-cells: 2.2;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Cell Junctions, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 2.8 1.1 4.8 1.2 9.6 2.7 2.3 1.1 4.0 2.3 0.9 4.2 1.4 1.0 1.9 3.9 1.0 13.7 1.1 2.0 4.1 3.8 2.1 0.9 3.4 1.9 3.5 5.6 2.2 0.5 1.0 7.9 0.9 11.8 2.0 0.7 2.6 1.3 2.4 0.9 1.0 1.1 2.0 3.6 1.8 1.1 23.8 4.8 1.7 2.7 0.5 1.2 1.0 0.9 2.2 4.6 0.1 0.3 0.0 0.5 0.4 2.7 0.4 0.8 0.0 1.1 4.1 0.0 1.2 2.4 2.8 2.7 0.1 0.0 1.6 0.0 0.7 3.8 0.0 2.5 0.0 1.0 0.4 7.4 9.3 0.1 0.0 0.7 9.8 2.4 1.4 0.4 1.1 0.0 0.1 1.7 8.1 0.2 0.0 1.0 0.0 0.9 1.9 9.9 0.0 3.1 4.9 0.0 0.5 2.3 0.2 4.9 3.8 0.8 0.1 0.0 0.3 0.0 4.7 0.4 0.6 0.0 0.3 0.0 0.0 0.0 2.3 4.5 0.1 2.6 0.0 0.2 0.0 0.0 0.3 0.2 2.2 0.0 0.0 1.4 1.5 0.0 0.0 0.1 0.0 0.0 4.6 0.5 0.4 4.8 9.6 1.1 4.0 4.1 3.8 3.5 5.6 11.8 4.8 3.0 1.6 0.0 0.9 0.3 5.3 2.8 0.0 144.6 15.9 5.2 35.3 0.2 1.7 0.5 74.2 1.5 0.0 0.0 0.2 0.2 3.2 0.7 1.1 0.0 2.2 11.1 4.1 11.1 0.3 23.5 9.8 1.7 0.0 6.4 0.5 6.0 0.2 0.0 9.9 3.2 18.6 0.0 1.7 29.6 8.6 0.3 0.5 0.7 0.1 0.3 LRRC36 FLJ11004 ENSG00000159708 "Leucine rich repeat containing 36" Q1X8D7 16 67326798-67385203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 11.7;placenta: 9.3;testis: 31.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 68.2;Early spermatids: 152.0;Late spermatids: 96.7;Spermatocytes: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 11.7" "Lineage enriched" "Detected in many" 10 "dendritic cells: 11.7" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.5;hTEC/SVTERT24-B: 4.7;JURKAT: 4.3;TIME: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058479 Enhanced NA NA "HPA058479: AB_2683728" "unprognostic (4.59e-2)" "unprognostic (6.84e-2)" "unprognostic (2.17e-2)" "unprognostic (2.26e-5)" "unprognostic (5.27e-2)" "unprognostic (4.32e-2)" "unprognostic (5.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.65e-1)" "unprognostic (3.32e-3)" "unprognostic (4.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.26e-1)" "unprognostic (3.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.88e-2)" 0.2 0.1 0.3 0.0 1.5 0.0 0.2 0.5 0.4 0.3 0.1 0.0 0.0 0.0 0.4 2.3 0.1 2.6 0.3 0.1 1.2 0.4 0.3 0.1 4.3 0.2 0.2 0.0 0.3 2.0 0.0 1.2 9.3 2.5 0.1 0.4 0.5 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.4 31.9 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 11.7 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.7 0.0 0.0 0.1 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.3 1.5 0.5 0.4 1.2 0.4 0.2 0.0 2.5 0.2 3.0 68.2 0.0 0.4 0.2 0.4 0.8 0.0 18.7 1.2 0.0 0.0 0.0 0.0 0.4 152.0 0.5 0.4 0.0 0.0 0.1 0.6 0.1 8.1 0.0 0.2 0.0 2.4 0.0 0.0 96.7 2.0 0.8 6.8 0.0 0.7 1.9 0.1 0.0 1.4 1.1 0.1 0.0 0.0 48.3 10.6 0.3 0.2 0.0 1.3 0.1 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 9.4;testis: 15.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 8.0" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 0.9 0.4 1.4 2.0 1.8 1.4 1.7 2.6 1.7 0.7 0.9 0.5 1.1 0.4 1.1 1.0 0.5 1.1 1.5 1.2 0.9 0.6 0.9 1.5 0.6 1.2 0.9 0.5 2.1 0.7 1.3 1.0 1.0 0.9 9.4 1.8 1.3 0.6 0.8 1.2 0.8 15.2 1.2 0.9 1.1 1.1 1.4 1.7 2.1 1.4 2.1 1.5 0.2 0.2 0.2 1.6 0.2 0.3 0.0 0.5 0.1 0.4 0.1 0.2 3.6 0.3 8.0 0.3 0.3 2.5 0.3 0.0 0.0 0.0 0.5 1.2 0.4 4.0 2.7 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.5 0.3 0.2 0.6 0.9 0.0 0.3 0.7 1.2 0.0 0.0 2.7 2.9 1.8 0.0 1.9 0.5 1.1 0.2 0.6 0.1 0.0 0.5 3.6 1.2 1.4 2.4 0.4 0.2 3.6 2.5 0.5 1.3 2.4 2.3 2.1 1.1 1.0 1.0 1.0 0.9 0.8 0.8 1.5 1.1 1.4 1.3 1.1 1.9 2.1 1.4 1.7 1.0 0.2 3.0 0.3 0.0 0.3 0.1 0.6 3.6 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.2 18.2 0.0 1.3 0.0 0.4 0.0 0.2 0.1 1.1 0.0 0.3 0.0 1.2 0.0 2.7 1.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.7 0.2 0.1 0.1 0.5 1.0 0.0 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Early spermatids: 32.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.3;U-138 MG: 2.5" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.5 0.7 0.4 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 4.0 0.1 0.3 0.8 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 0.0 2.0 0.1 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.0 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 0.0 1.4 4.3 0.8 2.5 1.9 0.0 0.8 1.4 1.1 0.5 0.2 1.0 1.6 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 20.8 10.5 0.8 3.8 1.3 7.1 2.0 2.5 14.7 7.9 0.0 11.8 1.0 0.0 1.9 32.7 1.9 1.0 0.0 0.8 0.8 1.9 1.9 10.5 0.4 1.2 12.7 1.7 1.3 1.5 7.5 3.1 3.2 0.0 0.0 1.7 2.8 0.9 1.4 1.8 0.3 8.4 12.9 2.0 6.8 2.5 1.9 0.6 4.4 1.0 2.7 LRRC37A3 "FLJ34306, KIAA0563" ENSG00000176809 "Leucine rich repeat containing 37 member A3" O60309 17 64854312-64919480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.2;Horizontal cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA042121, HPA043056, HPA045090" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211" "unprognostic (2.28e-1)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.84e-2)" "unprognostic (2.27e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-2)" "unprognostic (5.31e-6)" "unprognostic (1.83e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (2.26e-1)" "unprognostic (4.89e-2)" "unprognostic (5.18e-2)" "unprognostic (7.43e-3)" 4.4 6.6 14.8 5.5 14.0 6.2 8.8 27.9 16.0 4.3 3.6 7.4 5.4 3.2 6.9 16.0 3.9 7.8 6.8 3.8 15.1 15.0 15.7 3.4 4.8 4.3 12.8 7.2 8.4 5.2 5.7 18.8 4.6 12.1 6.7 4.0 8.3 4.3 6.2 6.4 7.1 4.0 4.2 6.6 4.6 4.2 25.8 12.6 7.3 14.3 0.3 3.1 4.6 10.0 2.3 2.3 5.3 1.0 3.1 1.2 0.3 2.3 4.5 4.4 9.8 4.9 3.1 3.1 3.2 2.6 2.4 2.5 2.0 3.4 2.3 1.5 1.6 3.9 1.9 1.2 0.9 1.0 3.0 4.4 7.1 2.7 1.4 2.0 2.7 1.8 2.1 1.7 1.6 0.7 9.9 1.6 3.0 1.4 1.3 1.6 6.1 1.3 4.6 3.4 0.5 1.3 1.5 2.3 1.0 5.0 2.1 2.9 11.0 1.2 5.6 1.3 13.1 2.5 4.9 5.3 4.0 1.3 1.6 1.7 1.9 1.8 1.8 2.8 11.3 6.8 5.3 0.4 0.7 0.7 0.7 0.8 0.6 1.0 0.4 0.6 2.3 1.2 1.1 2.0 3.1 1.0 2.3 0.9 0.3 14.8 14.0 27.9 16.0 15.1 15.0 12.8 7.2 12.1 12.6 0.0 2.1 1.4 1.8 1.5 10.2 2.1 0.0 9.4 2.3 1.8 3.9 1.1 1.7 1.8 23.2 2.6 1.2 0.0 1.2 0.1 1.6 1.7 2.3 0.8 1.4 23.8 1.2 3.7 1.9 5.6 2.0 0.8 1.7 1.8 0.8 4.3 0.7 1.4 2.8 5.1 3.6 6.5 1.2 6.0 1.7 0.9 0.8 1.3 0.6 1.4 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 71.2;Spermatocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.1 3.9 12.5 7.1 3.2 4.0 3.9 1.9 7.1 5.5 7.1 5.4 2.1 5.6 4.0 4.3 6.9 2.8 7.4 1.5 4.4 1.6 6.3 2.6 5.8 2.0 4.7 10.1 4.8 4.2 4.7 5.0 12.8 5.3 4.6 9.6 6.1 5.4 2.1 1.9 17.6 15.6 3.8 1.9 2.7 12.4 2.9 4.5 3.1 5.2 2.4 4.0 4.8 3.1 6.5 4.3 8.2 16.3 3.9 3.9 2.7 8.6 4.6 5.4 7.7 5.6 2.8 10.2 2.8 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 6.0 7.8 2.7 6.4 3.7 7.8 4.4 10.2 8.1 10.3 1.8 0.0 1.8 8.3 8.5 71.2 5.0 2.9 23.3 9.0 1.9 5.0 8.3 3.5 2.9 8.3 3.2 1.7 7.4 7.9 11.8 6.4 8.3 8.5 7.2 5.5 9.2 8.3 0.0 6.7 6.9 8.7 0.0 9.6 37.1 10.6 4.4 1.8 10.1 5.4 6.5 LRRC3C ENSG00000204913 "Leucine rich repeat containing 3C" A6NJW4 17 39941474-39944747 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 1.9;testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HDLM-2: 2.2;Karpas-707: 3.9;U-266/70: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071271 Uncertain NA NA "HPA071271: AB_2686378" "unprognostic (1.59e-1)" "unprognostic (6.57e-2)" "unprognostic (6.17e-2)" "unprognostic (2.81e-1)" "unprognostic (3.16e-4)" "unprognostic (9.20e-2)" "unprognostic (4.27e-1)" "unprognostic (6.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.14e-1)" "unprognostic (1.90e-2)" 0.2 0.0 0.3 0.3 0.2 0.1 0.2 0.0 0.2 0.6 0.1 0.0 0.4 0.3 0.0 0.8 0.0 0.6 0.2 0.0 0.2 0.5 0.2 0.0 0.1 0.3 0.1 1.9 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.4 0.1 0.1 0.2 0.0 0.2 3.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.4 0.1 0.0 0.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.6" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 40.2;Early spermatids: 18.7;Late spermatids: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 2.9;HSkMC: 3.3;HUVEC TERT2: 6.5;SCLC-21H: 5.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039425: AB_2676501" "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.9 0.9 3.0 0.3 5.0 0.8 0.7 1.2 4.6 1.5 0.7 4.1 1.3 1.0 1.4 6.6 0.4 26.6 1.6 1.5 4.5 3.0 3.1 0.5 2.5 0.4 3.1 1.5 3.3 1.2 3.5 3.4 0.5 6.4 1.3 0.5 2.9 1.8 2.2 0.4 0.8 0.5 0.6 1.0 0.8 0.7 10.8 1.8 0.0 2.5 0.0 0.4 0.7 0.3 0.0 0.9 0.0 0.6 2.9 1.9 0.8 0.0 0.0 0.3 0.0 0.3 0.7 0.4 0.0 1.8 0.5 0.5 0.6 0.1 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 2.9 0.1 0.7 3.3 0.0 1.0 0.0 0.0 6.5 0.6 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.3 5.3 1.2 0.0 0.2 0.3 0.0 0.8 1.6 0.5 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.9 0.0 2.9 0.6 0.9 0.0 0.8 3.0 5.0 1.2 4.6 4.5 3.0 3.1 1.5 6.4 1.8 6.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 40.2 3.4 1.8 3.9 0.0 1.7 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.6 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 8.3 0.0 0.0 0.0 8.4 1.1 0.0 0.1 0.0 0.0 0.0 LRRC46 MGC16309 ENSG00000141294 "Leucine rich repeat containing 46" Q96FV0 17 47831627-47837713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 51.2;testis: 94.4" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 239.6;Early spermatids: 97.9;Late spermatids: 46.8;Spermatocytes: 76.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.4" "Region enriched" "Detected in many" 4 "pons and medulla: 14.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6.4;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021882, HPA074893" Enhanced Approved Cytosol NA NA Cytosol "HPA021882: AB_1853320, HPA074893: AB_2732271" "unprognostic (1.06e-1)" "unprognostic (6.01e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.40e-1)" "unprognostic (2.81e-2)" "unprognostic (4.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.21e-3)" "unprognostic (3.63e-2)" "unprognostic (2.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-1)" 0.3 0.4 1.8 0.3 3.3 0.6 0.5 0.4 0.5 2.3 0.3 5.2 1.6 0.4 1.5 13.8 0.4 51.2 0.5 0.5 2.0 2.4 0.7 0.4 11.8 0.5 0.3 0.1 8.8 0.5 0.3 4.2 0.4 14.0 0.5 0.3 1.8 0.4 1.3 0.3 0.3 0.3 0.3 0.6 0.5 0.3 94.4 1.1 1.2 1.4 0.0 0.4 0.3 0.1 0.6 2.5 4.4 1.6 2.4 1.0 0.5 1.5 6.4 0.8 3.2 0.5 1.4 1.8 0.2 1.7 1.7 3.3 3.0 1.4 0.7 4.1 0.8 1.7 1.4 0.8 1.1 2.6 2.8 2.8 1.3 1.8 1.0 0.3 0.1 1.5 0.0 1.0 3.5 1.3 0.5 0.3 1.1 1.2 0.8 2.3 2.4 2.1 0.3 0.2 0.5 1.3 2.0 0.2 1.3 2.8 1.1 2.7 2.0 0.7 0.0 0.9 0.3 7.6 0.2 0.5 3.5 1.3 0.6 0.4 1.4 1.3 1.3 2.4 0.5 0.3 4.4 1.3 2.0 0.2 1.6 0.0 0.6 0.1 1.0 2.5 0.4 0.7 0.0 1.6 2.4 1.5 1.3 0.2 0.5 1.8 3.3 0.4 0.5 2.0 2.4 0.3 0.1 14.0 1.1 0.0 2.9 0.0 0.3 0.0 0.6 0.3 0.0 239.6 27.3 5.2 2.0 0.1 0.0 0.3 97.9 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 46.8 2.6 0.7 0.0 1.0 0.1 0.9 0.5 0.0 1.8 1.0 5.4 0.0 0.1 76.7 4.0 0.0 0.1 0.0 0.0 0.1 LRRC49 FLJ20156 ENSG00000137821 "Leucine rich repeat containing 49" Q8IUZ0 15 70853239-71053657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 50.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 138.5;Ciliated cells: 62.9;Cone photoreceptor cells: 58.9;Early spermatids: 63.6;Late spermatids: 73.7;Spermatocytes: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015596 Uncertain NA NA "HPA015596: AB_2669230" "unprognostic (9.74e-2)" "unprognostic (7.94e-2)" "unprognostic (3.25e-3)" "unprognostic (1.15e-2)" "unprognostic (6.10e-2)" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (1.72e-1)" "unprognostic (3.36e-2)" "unprognostic (9.43e-2)" "unprognostic (7.66e-4)" "unprognostic (3.02e-1)" "unprognostic (5.29e-2)" "unprognostic (7.60e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.09e-2)" 2.1 5.0 9.1 2.0 17.8 1.1 3.6 27.4 17.9 6.0 3.1 5.6 2.9 1.8 9.2 28.8 2.7 10.7 4.7 50.3 10.3 11.1 4.8 1.3 3.7 1.4 11.6 10.8 12.8 2.3 14.3 27.3 2.1 23.0 6.5 2.9 6.1 2.1 6.1 1.6 2.3 2.1 6.7 5.9 1.6 2.8 13.2 7.2 0.1 5.3 1.1 1.5 5.7 3.5 1.0 0.6 0.6 2.4 0.9 1.7 0.6 2.0 3.7 7.6 11.8 2.8 4.6 0.0 2.6 6.1 2.2 4.4 1.1 1.6 0.0 2.9 2.5 6.2 3.1 9.0 4.7 2.3 0.0 3.4 0.6 3.2 0.1 23.4 0.0 1.0 2.7 1.1 7.3 12.6 10.1 5.5 0.0 0.1 0.0 3.1 0.7 0.0 0.6 4.3 0.3 2.2 0.0 4.8 0.0 5.4 3.3 13.5 13.0 4.2 1.4 3.2 3.4 3.5 1.0 3.8 2.2 8.2 5.2 5.5 1.3 3.7 0.0 5.9 0.1 2.3 0.6 0.2 0.1 1.5 2.4 1.7 1.0 1.1 0.1 0.6 0.4 0.1 0.7 0.4 0.9 0.8 0.2 0.0 0.6 9.1 17.8 27.4 17.9 10.3 11.1 11.6 10.8 23.0 7.2 3.0 3.0 0.0 18.3 2.1 53.2 138.5 2.5 62.9 17.0 7.0 58.9 0.0 5.0 5.1 63.6 8.6 1.1 0.0 0.8 0.1 4.9 9.4 0.0 0.0 0.1 28.6 17.7 3.7 0.0 73.7 5.2 0.3 0.0 0.0 1.9 9.1 1.3 1.5 9.2 2.2 36.1 0.0 4.3 70.7 6.4 1.4 0.2 0.0 1.2 7.4 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568045 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.9" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 18.8;Horizontal cells: 9.5;Peritubular cells: 4.2;Spermatogonia: 5.3" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.0;HMC-1: 22.2;REH: 6.1;SH-SY5Y: 19.4;U-2 OS: 18.2;WM-115: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain NA NA 2300000 "HPA058986: AB_2683871" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 3.0 8.8 28.7 2.3 24.6 1.2 1.3 21.7 52.9 13.4 2.3 4.0 0.0 2.3 9.4 1.4 3.3 3.6 2.8 2.5 23.4 22.9 1.7 1.7 3.6 2.7 17.8 20.6 2.8 1.7 1.3 8.8 6.9 12.8 2.2 1.4 2.2 2.3 2.8 1.7 1.7 3.2 3.1 15.0 1.9 2.4 2.3 8.5 0.0 1.8 0.0 1.9 3.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.5 0.1 0.1 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.6 0.1 0.0 5.7 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 19.4 0.0 0.0 3.8 0.1 0.0 0.2 0.0 0.0 18.2 0.0 0.0 0.4 0.0 0.0 0.1 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 28.7 24.6 21.7 31.9 23.4 22.9 17.8 20.6 12.8 8.5 0.0 0.0 0.0 0.0 0.0 18.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 1.3 0.0 1.6 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.2 0.0 1.0 0.0 2.1 3.9 5.3 0.0 0.1 0.0 0.0 0.0 LRRC56 "DKFZp761L1518, FLJ00101" ENSG00000161328 "Leucine rich repeat containing 56" Q8IYG6 11 537527-554916 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 15.5;testis: 20.8" "Group enriched" "Detected in many" 5 "Early spermatids: 54.0;Late spermatids: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;Daudi: 3.0;Karpas-707: 5.9;SK-BR-3: 3.7;T-47d: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038728 Approved NA NA "HPA038728: AB_10671864" "unprognostic (2.77e-2)" "unprognostic (9.54e-3)" "unprognostic (1.28e-2)" "prognostic favorable (7.39e-4)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (2.29e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.32e-4)" "unprognostic (1.17e-1)" "unprognostic (7.89e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-3)" 0.6 0.7 2.4 2.9 9.6 1.1 0.6 3.2 1.7 1.6 1.7 1.2 8.1 0.9 1.2 9.1 2.1 4.6 5.0 0.5 2.1 1.6 1.7 0.8 7.8 3.0 0.5 1.3 3.4 4.5 0.4 15.5 0.6 2.8 1.9 0.8 1.7 2.2 2.0 1.1 4.8 2.8 0.5 0.4 1.0 3.6 20.8 0.7 0.3 1.8 0.1 5.3 1.0 0.8 0.5 0.1 0.2 0.3 0.3 1.2 0.7 0.0 0.0 0.1 4.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.5 0.0 3.0 0.0 0.0 0.1 1.0 0.1 0.4 0.0 0.0 0.0 0.0 1.5 0.1 1.7 1.0 2.6 1.0 1.9 0.0 0.3 0.0 0.0 1.1 0.0 5.9 0.0 0.0 0.3 1.5 0.0 1.5 1.7 0.0 0.0 1.2 0.5 0.0 0.8 0.5 0.0 3.7 0.0 0.2 4.6 0.1 0.1 0.7 0.1 0.2 0.2 0.8 0.2 0.1 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.3 0.1 0.5 0.1 0.6 0.1 0.1 0.1 0.6 0.0 0.3 0.1 0.0 1.2 0.7 2.4 9.6 3.2 1.7 2.1 1.6 0.5 1.3 2.8 0.7 0.0 4.3 1.7 1.5 1.4 1.5 0.4 2.5 5.3 2.3 3.5 15.7 0.1 0.0 0.8 54.0 0.0 1.3 0.0 0.4 0.1 0.3 1.7 0.0 0.0 0.2 6.4 12.0 0.6 0.8 96.6 1.1 0.0 1.7 0.0 2.2 2.5 0.5 0.9 1.1 0.7 6.6 0.0 0.0 4.4 2.1 0.6 0.5 1.5 0.5 0.6 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150322639-150338150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 41.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 31.1;Hep G2: 20.7;NTERA-2: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favorable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 2.8 14.7 6.7 9.0 9.3 2.3 4.1 7.5 7.3 6.7 6.0 3.5 4.5 5.8 7.0 4.0 6.4 20.8 8.0 3.3 5.4 13.1 10.8 18.3 4.8 9.1 5.0 3.4 18.5 12.7 12.2 10.9 7.3 5.1 6.4 2.9 10.6 6.2 6.7 3.0 5.4 7.9 3.8 3.0 10.1 6.6 6.6 3.9 41.0 16.4 3.0 11.8 4.2 9.0 9.5 15.1 11.6 2.4 6.5 10.5 4.2 7.8 0.2 0.2 0.0 0.0 0.0 3.7 0.0 0.0 1.0 3.2 14.8 7.8 2.4 3.3 0.1 0.0 7.1 0.0 0.0 0.5 31.1 10.1 2.8 9.5 20.7 5.7 0.0 1.5 0.6 3.2 0.0 0.0 0.2 0.0 16.2 9.8 4.6 0.0 14.2 14.3 1.2 27.3 5.3 0.0 0.0 0.0 6.4 2.3 5.1 14.1 13.8 13.2 2.9 5.4 2.3 2.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 1.6 0.0 0.0 0.0 0.0 2.3 2.4 6.7 9.5 1.0 7.6 8.0 6.8 7.3 2.6 9.5 6.7 7.7 11.6 6.5 1.0 15.1 10.5 4.2 6.7 9.3 7.5 7.3 5.4 13.1 5.0 3.4 5.1 3.9 6.0 1.0 6.5 4.0 1.0 7.7 2.1 10.2 20.1 4.5 15.7 0.0 22.6 16.6 22.1 4.7 2.1 9.6 0.0 24.7 21.2 2.4 4.0 1.1 18.3 5.5 12.7 18.6 1.3 1.3 12.9 9.5 1.8 3.3 24.4 7.6 13.0 27.0 13.9 5.3 27.2 4.7 0.0 0.8 20.4 22.8 2.4 22.5 8.7 9.5 2.6 LRRC66 ENSG00000188993 "Leucine rich repeat containing 66" Q68CR7 4 51993702-52017620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 50.2" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 11.9;Mucus-secreting cells: 4.0;Paneth cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.0;CAPAN-2: 5.1;OE19: 6.5" "Low region specificity" "Detected in all" "HPA014549, HPA027839" Uncertain NA NA "HPA014549: AB_1853062, HPA027839: AB_10602705" "unprognostic (1.10e-1)" "unprognostic (4.87e-2)" "unprognostic (8.62e-2)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-1)" "unprognostic (2.57e-2)" "unprognostic (4.83e-3)" "unprognostic (2.93e-1)" "unprognostic (4.09e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (6.31e-3)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-1)" "unprognostic (4.06e-1)" 0.5 0.1 0.8 2.6 1.0 0.0 0.5 1.4 0.9 0.5 11.3 0.5 0.5 19.6 0.5 0.5 0.5 0.5 1.6 0.6 0.8 0.8 0.9 0.5 0.5 0.5 0.8 0.5 0.5 0.5 0.5 3.1 0.5 0.5 0.5 5.2 0.5 0.5 0.5 6.7 0.0 50.2 0.5 0.6 0.5 4.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.2 0.4 0.6 1.7 4.0 0.1 0.6 1.0 0.3 0.7 0.2 5.1 0.0 0.1 0.9 0.1 0.0 0.3 0.2 0.3 1.6 0.6 0.0 0.2 0.0 0.2 0.1 0.1 1.6 0.8 0.8 0.2 1.3 0.4 0.3 0.0 0.0 2.0 0.0 0.1 0.0 0.0 6.5 0.9 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.4 1.1 0.0 0.7 0.5 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.4 0.9 0.8 0.8 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 11.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.0 4.0 0.0 0.3 2.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 38.9;Late spermatids: 11.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;SuSa: 6.1;U-266/70: 17.7;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.8 0.9 0.2 1.5 0.2 0.0 1.0 0.0 0.1 0.7 0.5 0.1 0.5 1.9 0.7 0.4 0.5 1.1 0.1 0.1 0.9 0.7 0.7 1.9 0.3 0.4 0.7 0.3 0.6 0.5 1.0 1.5 1.1 0.3 0.6 3.5 0.6 1.4 0.3 1.2 0.6 6.6 1.3 1.1 1.0 0.8 1.9 2.0 1.5 1.1 0.4 2.3 0.1 0.6 0.7 0.2 0.5 0.7 1.5 1.2 0.4 0.1 0.3 0.3 1.1 0.9 1.0 0.5 0.2 0.1 0.6 0.7 1.2 0.3 0.3 6.8 1.5 1.8 0.5 0.2 0.5 1.1 0.4 1.1 0.4 0.8 0.4 0.1 1.2 1.1 0.6 0.4 0.2 0.3 0.5 0.7 1.1 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 6.1 1.6 1.2 0.2 0.3 0.7 0.2 0.9 17.7 9.8 4.0 0.1 2.2 0.9 1.3 0.6 1.5 1.5 1.1 1.5 1.2 1.6 0.6 0.1 1.9 2.3 1.2 0.1 0.4 0.6 2.0 2.1 0.1 0.0 0.6 0.8 2.4 4.1 1.8 2.4 0.0 6.7 1.2 3.5 3.9 1.9 3.3 1.3 38.9 2.1 0.5 0.0 1.0 1.5 2.2 3.1 0.0 0.8 0.8 0.0 2.4 3.7 2.1 11.9 2.6 1.7 6.8 4.6 1.4 1.1 1.5 0.9 1.1 0.2 3.2 0.0 2.1 2.3 2.5 4.5 0.8 0.0 1.4 2.0 LRRC70 "LOC100130733, SLRN" ENSG00000186105 "Leucine rich repeat containing 70" Q7Z2Q7 5 62578735-62581448 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 25 "Endothelial cells: 1.1;granulocytes: 3.5;Ito cells: 1.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.0" "Group enriched" "Detected in many" 20 "granulocytes: 1.5;NK-cells: 3.0;T-cells: 1.3" "Group enriched" "Detected in some" 18 "HUVEC TERT2: 18.4;TIME: 9.9" "Low region specificity" "Detected in all" HPA013409 Uncertain NA NA "HPA013409: AB_10601911" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (4.04e-1)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.17e-4)" "unprognostic (3.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.60e-1)" "unprognostic (2.19e-1)" "unprognostic (4.15e-1)" "unprognostic (7.40e-4)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 18.4 1.6 1.3 3.2 2.1 5.9 18.0 0.9 2.2 9.5 4.2 0.0 3.4 1.5 5.3 2.4 5.4 4.2 6.7 4.6 2.0 1.6 10.0 5.9 3.9 5.9 1.7 0.2 5.7 2.2 2.6 4.8 9.6 2.7 6.8 2.7 2.8 2.4 1.1 2.8 4.9 3.5 6.5 3.4 25.2 2.3 4.9 1.8 3.5 10.4 4.1 1.5 6.1 17.6 0.0 0.0 1.5 0.0 3.0 1.3 0.2 0.2 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 18.4 0.3 0.2 0.8 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 9.9 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.3 0.2 1.5 3.0 0.0 0.0 0.0 0.2 1.3 2.1 0.9 2.2 2.0 1.6 1.7 0.2 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 LRRC71 "C1orf92, FLJ32884" ENSG00000160838 "Leucine rich repeat containing 71" Q8N4P6 1 156920650-156933094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;fallopian tube: 16.9;testis: 26.4" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 96.4;Early spermatids: 207.3;Late spermatids: 442.9" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.4;PC-3: 3.8;TIME: 3.4;U-2 OS: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (8.91e-2)" "unprognostic (4.21e-2)" "unprognostic (6.13e-2)" "unprognostic (1.95e-3)" "unprognostic (5.43e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (8.02e-2)" "unprognostic (5.07e-3)" "unprognostic (5.18e-1)" "unprognostic (1.68e-7)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" 0.3 0.8 1.1 0.1 4.0 0.1 0.1 0.0 0.3 1.1 0.1 5.6 0.0 0.1 0.5 5.6 0.1 16.9 0.1 0.1 1.7 1.8 0.1 0.1 3.0 0.1 0.2 0.4 3.6 0.1 0.1 0.0 0.3 9.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 26.4 1.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 4.0 0.0 0.3 1.7 1.8 0.2 0.4 9.5 1.2 0.0 2.6 0.0 0.0 0.0 0.2 0.4 0.0 96.4 18.2 0.0 0.0 0.0 0.0 0.0 207.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 442.9 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 10.9 2.3 0.0 0.0 0.0 0.0 0.0 LRRC72 ENSG00000205858 "Leucine rich repeat containing 72" A6NJI9 7 16526880-16581568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 117.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020554 Uncertain NA NA "HPA020554: AB_1859508" "unprognostic (1.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5;testis: 31.6" "Cell type enriched" "Detected in many" 7 "Early spermatids: 299.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol NA NA Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 1.2 6.1 10.4 0.9 19.4 0.8 1.1 2.3 23.5 1.4 1.3 2.3 0.9 2.1 1.4 1.5 1.0 11.3 1.8 1.8 8.9 5.2 3.0 1.2 1.6 0.9 3.1 12.1 2.0 2.8 7.5 4.1 1.2 6.2 1.9 1.1 0.6 1.4 2.1 1.0 1.1 1.2 1.5 1.1 1.2 1.8 31.6 1.8 0.0 1.6 0.0 0.9 1.4 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.8 5.7 0.9 2.9 0.2 0.2 1.6 0.5 0.3 0.0 0.3 0.2 0.1 1.0 0.8 2.2 0.7 0.7 0.0 0.1 0.9 0.0 0.4 0.2 0.9 0.0 0.1 0.5 1.1 1.8 0.3 2.8 0.1 0.3 0.3 0.5 1.0 5.7 0.0 0.0 0.1 8.0 0.7 0.0 0.0 0.1 1.5 0.0 2.1 2.5 0.5 0.4 0.2 0.0 5.8 0.0 0.2 0.4 0.6 2.1 0.2 0.5 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 19.4 2.3 23.5 8.9 5.2 3.1 12.1 6.2 1.8 0.0 0.0 0.0 2.4 0.3 4.9 0.8 0.0 8.1 2.3 3.5 0.0 0.1 6.6 0.6 299.6 0.1 1.3 0.0 0.7 0.1 0.6 2.3 0.0 0.4 0.1 27.0 5.2 0.0 0.0 27.3 4.0 0.0 1.7 0.0 2.0 8.3 0.2 0.0 3.9 5.1 6.6 6.5 1.1 41.7 9.7 0.0 0.2 0.0 0.6 0.6 LRRC74A "C14orf166B, LRRC74" ENSG00000100565 "Leucine rich repeat containing 74A" Q0VAA2 14 76826372-76870302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 19.8" "Group enriched" "Detected in some" 88 "Early spermatids: 50.3;Late spermatids: 81.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "NTERA-2: 1.1;RH-30: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA035094 Uncertain NA NA "HPA035094: AB_10600793" "unprognostic (7.71e-3)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-1)" "unprognostic (5.29e-3)" "unprognostic (3.22e-1)" "unprognostic (1.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.11e-2)" "unprognostic (5.21e-4)" "unprognostic (1.72e-1)" "unprognostic (9.96e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 81.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 LRRC74B ENSG00000187905 "Leucine rich repeat containing 74B" Q6ZQY2 22 21045960-21064168 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.1;epididymis: 5.6;fallopian tube: 11.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 132.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 1.7;U-87 MG: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049947 Uncertain NA NA "HPA049947: AB_2680966" "unprognostic (3.43e-2)" "unprognostic (1.76e-1)" "unprognostic (3.28e-4)" "unprognostic (1.06e-1)" "unprognostic (6.44e-3)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (7.57e-9)" "unprognostic (4.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-2)" "unprognostic (4.92e-2)" 0.2 0.2 2.1 0.2 2.3 0.2 0.2 0.4 1.6 1.5 0.2 3.7 0.0 0.4 0.3 5.6 0.2 11.4 0.2 0.2 1.5 1.2 0.2 0.2 1.9 0.2 0.1 0.7 1.9 0.2 0.2 0.9 0.2 17.1 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.2 0.2 3.6 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 0.4 1.6 1.5 1.2 0.1 0.7 17.1 0.3 0.0 2.6 0.0 0.6 0.0 1.0 0.4 0.0 132.5 22.7 0.0 3.9 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 1.6 0.0 0.6 0.0 0.4 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.2 0.0 0.0 0.0 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LRRC75B "C22orf36, FAM211B, MGC131773" ENSG00000178026 "Leucine rich repeat containing 75B" Q2VPJ9 22 24585620-24593208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 22.2;Muller glia cells: 39.6;Proximal tubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.7;NK-cell: 2.0" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;NK-cells: 2.0" "Cell line enhanced" "Detected in many" "Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002540 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002540: AB_1079263" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.47e-1)" "unprognostic (2.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.21e-2)" "unprognostic (4.52e-2)" "unprognostic (2.48e-2)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (2.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-2)" "unprognostic (9.69e-2)" 4.2 1.9 7.5 1.4 6.0 3.0 2.6 3.8 6.6 3.5 3.8 2.6 11.5 1.4 2.4 5.8 3.4 3.3 9.8 4.3 5.5 9.1 6.0 3.4 1.7 1.7 7.8 4.0 7.3 7.2 1.4 1.5 2.3 4.1 6.9 2.0 4.9 7.5 15.0 10.7 4.3 8.2 6.7 7.0 2.7 2.6 8.3 0.5 0.0 8.6 3.0 2.1 5.5 2.7 0.0 0.3 2.7 0.4 2.0 0.2 0.0 0.1 4.2 0.0 2.3 0.6 1.7 0.4 0.6 0.7 1.5 1.6 3.1 0.0 0.0 1.0 1.2 1.2 4.7 0.4 2.3 0.0 1.3 2.8 0.3 0.6 8.3 4.2 0.0 0.0 0.0 1.8 1.5 0.2 0.9 1.1 0.0 0.4 0.0 0.1 7.4 0.0 1.5 2.1 5.0 1.7 0.0 0.2 0.0 1.9 0.4 2.2 6.6 2.2 0.7 0.6 0.5 0.0 0.7 2.4 2.5 1.6 0.9 0.8 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 7.5 6.0 3.8 5.6 5.5 9.1 7.8 4.0 4.1 0.5 11.9 5.1 0.0 2.0 0.0 2.2 3.1 17.8 0.0 0.0 7.0 0.0 1.7 10.0 8.0 1.1 0.8 14.2 0.0 7.9 0.3 1.8 7.4 0.0 22.2 1.0 1.6 1.2 1.3 1.6 5.8 11.8 0.5 0.0 0.0 5.5 39.6 4.2 3.4 9.2 38.2 0.9 0.0 4.1 0.5 0.7 0.0 0.9 0.0 4.5 1.0 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.4;pituitary gland: 13.9;testis: 14.3" "Group enriched" "Detected in some" 9 "Early spermatids: 98.5;Late spermatids: 64.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 7.3;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.6 0.4 0.6 0.1 7.3 0.2 0.1 0.2 1.1 0.3 0.1 3.2 0.0 0.1 0.2 1.4 0.1 3.4 0.1 0.1 1.4 1.2 0.2 0.2 0.1 0.1 0.5 1.3 1.0 0.2 4.8 13.9 0.1 16.4 1.3 0.1 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.9 0.1 0.2 14.3 2.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.2 1.1 1.4 1.2 0.5 1.3 16.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 64.1 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 8.8 0.9 0.0 0.1 0.0 0.0 0.0 LRRD1 IMAGE:4798971 ENSG00000240720 "Leucine rich repeats and death domain containing 1" A4D1F6 7 92112159-92179531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.1" "Group enriched" "Detected in some" 82 "Early spermatids: 257.1;Late spermatids: 670.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055670, HPA079440" Enhanced Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA055670: , HPA079440: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (3.72e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.27e-2)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" "unprognostic (1.77e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.13e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 19.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.7 3.8 0.6 0.7 0.8 0.1 0.9 0.2 0.9 0.9 0.4 1.7 0.6 0.8 0.0 0.5 0.4 0.3 1.3 0.9 0.2 0.0 0.5 0.7 0.1 0.0 0.7 0.9 0.9 0.6 1.0 0.3 0.4 3.3 1.1 0.2 0.4 0.7 0.3 0.9 0.5 1.3 1.2 2.4 0.9 2.0 0.8 2.5 0.4 0.1 0.7 0.5 0.9 0.5 0.1 0.7 0.7 0.6 0.1 0.3 0.1 0.7 0.5 0.4 1.3 1.0 1.2 1.0 0.7 1.2 0.3 1.3 0.4 0.9 0.4 3.8 0.6 0.4 0.5 0.3 0.4 0.5 0.5 0.4 0.1 1.0 0.4 0.5 1.9 0.7 0.4 0.7 0.8 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.3 0.2 0.7 0.2 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 257.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.1 0.0 0.1 1.6 0.0 0.0 0.0 670.8 4.4 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.8 0.0 0.4 0.0 0.1 5.6 2.7 0.3 0.0 0.0 0.0 0.3 LRRIQ1 "FLJ12303, KIAA1801" ENSG00000133640 "Leucine rich repeats and IQ motif containing 1" Q96JM4 12 85036314-85263224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 24.9;testis: 20.1" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 433.6;Cone photoreceptor cells: 174.7;Early spermatids: 267.1;Late spermatids: 186.4;Rod photoreceptor cells: 250.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 6.5;SH-SY5Y: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046162 Uncertain NA NA "HPA046162: AB_10963055" "unprognostic (3.55e-2)" "unprognostic (7.81e-2)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (1.01e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" "unprognostic (4.05e-3)" "unprognostic (1.52e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-2)" "unprognostic (6.98e-2)" "unprognostic (1.25e-3)" "unprognostic (3.35e-2)" "unprognostic (6.10e-3)" "unprognostic (1.64e-1)" 0.4 1.2 2.4 0.5 8.2 0.3 1.5 0.4 3.1 2.0 0.5 2.2 2.0 0.2 1.9 8.2 0.3 13.4 0.9 0.5 4.7 3.7 5.3 0.3 4.6 0.3 1.0 3.4 4.7 0.7 3.1 24.9 0.3 21.5 1.8 0.3 1.0 0.6 1.0 0.2 0.3 0.3 1.0 1.0 0.4 0.6 20.1 3.4 0.0 2.8 0.2 0.3 0.3 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.8 0.0 1.0 2.0 0.4 0.6 0.6 1.7 0.4 0.0 0.1 0.0 0.2 0.4 2.3 0.1 1.4 1.7 0.4 0.0 2.5 0.6 0.2 0.0 0.0 0.0 0.0 1.0 2.7 1.3 1.9 2.0 0.3 3.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.4 0.0 0.6 0.0 6.5 0.0 2.4 4.3 0.2 0.2 0.2 0.7 1.9 0.0 0.0 3.6 1.0 1.4 0.2 0.0 1.1 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 8.2 0.4 3.1 4.7 3.7 1.0 3.4 21.5 3.4 3.0 4.5 0.0 1.3 0.3 9.6 0.8 2.5 433.6 76.2 15.7 174.7 0.0 8.3 7.9 267.1 0.7 0.0 0.0 1.1 0.0 0.7 5.8 1.1 0.0 0.1 0.0 11.1 0.0 0.0 186.4 4.0 0.5 3.3 0.0 0.0 15.1 2.3 0.0 3.9 4.4 250.0 12.9 0.3 126.2 42.6 0.0 0.1 0.0 0.0 0.3 LRRN2 "FIGLER7, GAC1, LRANK1, LRRN5" ENSG00000170382 "Leucine rich repeat neuronal 2" O75325 1 204617170-204685733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 49.3" "Group enriched" "Detected in many" 6 "breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029124 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029124: AB_10601545" "unprognostic (2.16e-2)" "unprognostic (1.93e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.59e-7)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" "unprognostic (1.21e-1)" "unprognostic (4.63e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (1.68e-2)" "unprognostic (1.43e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-1)" "unprognostic (1.59e-3)" 4.9 6.6 11.8 3.7 16.5 2.4 3.3 9.7 20.3 1.9 7.9 5.3 1.0 1.9 3.9 0.8 2.4 10.2 6.1 6.0 11.7 12.8 7.3 0.7 2.5 2.9 6.3 13.8 3.3 1.4 19.1 9.7 1.3 8.1 1.6 7.5 12.2 2.8 3.7 2.2 0.7 3.3 9.9 3.1 6.3 1.4 3.8 6.1 3.2 2.8 0.0 1.3 2.1 1.5 0.4 0.1 1.7 0.3 0.7 0.8 0.2 0.0 3.3 2.7 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 7.1 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 1.1 0.0 14.3 0.0 0.1 0.2 0.0 22.2 0.0 0.1 1.9 0.3 4.4 0.1 0.0 8.2 7.9 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.7 0.7 0.0 0.1 0.8 0.2 11.8 16.5 9.7 15.7 11.7 12.8 6.3 13.8 8.1 6.1 0.0 0.0 0.0 0.5 0.3 4.6 1.0 0.0 0.0 0.0 1.8 2.0 0.1 0.0 2.7 0.0 0.7 1.7 0.0 0.8 0.1 1.1 0.3 0.0 0.0 5.3 49.3 10.9 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.9 3.3 0.3 0.0 2.7 0.9 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.7 0.3 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.7 1.8 6.8 2.9 0.0 8.3 18.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.4 0.0 0.0 0.0 8.5 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 0.0 7.0 0.0 0.0 0.0 33.5 12.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.3 9.6 0.0 1.1 0.0 0.7 3.2 1.7 1.3 0.0 3.4 52.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 15.2 0.0 3.9 0.0 1.2 0.9 0.5 0.1 0.3 3.2 0.0 0.1 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686402-62689899 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 17.2;Leydig cells: 25.0;Melanocytes: 32.1;Peritubular cells: 16.3" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;ASC TERT1: 19.1;HHSteC: 14.9;HSkMC: 8.0;LHCN-M2: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 15.7 4.8 0.2 5.0 0.6 0.6 11.6 0.6 0.9 27.2 12.1 0.1 3.5 2.1 27.0 14.0 19.1 11.4 6.7 9.3 0.3 0.2 0.8 0.2 3.1 1.8 0.3 0.6 24.9 2.1 0.4 1.2 4.4 2.2 10.8 2.5 17.8 3.2 6.7 17.0 6.8 4.3 15.1 1.9 0.3 5.7 8.5 0.0 0.0 3.5 10.4 2.4 18.2 11.2 0.9 0.6 3.3 0.8 0.8 0.6 0.1 0.0 0.1 0.2 0.2 5.7 19.1 0.2 2.0 2.9 0.2 1.0 0.2 0.1 0.1 0.2 3.2 0.0 0.3 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.1 14.9 0.2 0.1 8.0 0.2 0.4 0.0 0.1 0.0 0.3 0.2 0.1 9.7 0.1 0.2 0.4 0.4 0.1 0.1 0.1 1.3 0.3 0.0 0.1 0.6 0.2 0.3 0.2 0.6 0.1 0.1 0.2 0.2 1.8 0.1 2.0 0.1 0.2 0.2 0.2 1.1 0.2 0.0 0.9 0.8 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.9 0.5 0.6 3.3 0.8 0.4 0.6 0.2 0.1 0.2 0.6 0.6 0.9 0.3 0.2 0.3 0.6 2.2 0.0 0.0 2.6 0.0 1.9 6.0 1.9 1.1 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.1 17.2 0.8 1.1 0.0 0.3 1.6 1.2 1.3 1.2 0.0 25.0 1.5 32.1 0.0 0.1 0.3 0.0 0.0 16.3 0.1 0.7 0.0 1.7 0.4 0.2 6.0 0.1 0.0 0.0 1.0 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.8;salivary gland: 19.8" "Group enriched" "Detected in some" 4 "Distal tubular cells: 1.7;Sertoli cells: 6.5" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.7;U-266/70: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062660 Approved NA NA "HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.7 2.2 8.1 1.0 17.8 0.5 0.6 0.5 17.6 1.5 2.2 2.7 0.1 1.7 1.7 1.2 1.1 2.8 0.9 1.3 10.7 6.3 0.9 0.7 0.7 0.5 2.5 7.8 0.9 0.5 0.5 1.3 0.5 1.8 0.9 1.1 1.7 19.8 2.8 0.5 0.7 1.9 1.1 2.1 0.5 0.9 0.7 2.4 0.0 2.9 0.0 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 17.8 0.5 17.6 10.7 6.3 2.5 7.8 1.8 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.4 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRTM2 KIAA0416 ENSG00000146006 "Leucine rich repeat transmembrane neuronal 2" O43300 5 138868923-138875368 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 33.1" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 6.0;Bipolar cells: 9.8;Cone photoreceptor cells: 3.9;Horizontal cells: 6.4;Ito cells: 3.7" "Cancer enriched" "Detected in single" 11 "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "HDLM-2: 18.3;SCLC-21H: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.77e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (2.85e-1)" "unprognostic (3.58e-1)" "unprognostic (8.72e-2)" "unprognostic (4.31e-2)" "unprognostic (4.48e-1)" "unprognostic (4.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.13e-2)" "unprognostic (3.13e-2)" "unprognostic (2.86e-2)" "unprognostic (8.11e-2)" "unprognostic (1.08e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" 2.3 4.1 11.0 1.1 15.7 1.1 1.5 15.6 33.1 1.3 1.4 5.1 0.0 1.3 1.1 1.0 1.0 1.1 1.4 1.1 9.7 9.1 1.2 1.3 1.1 1.2 5.4 17.7 1.2 1.4 0.9 0.7 4.5 8.4 1.0 1.4 1.0 1.0 0.9 1.1 1.2 1.5 1.4 5.8 1.9 1.0 0.9 9.9 0.0 1.1 0.0 1.0 1.2 0.3 0.5 0.0 1.0 0.8 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 18.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.8 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 11.0 15.7 15.6 20.8 9.7 9.1 5.4 17.7 8.4 9.9 6.0 1.0 0.8 0.2 0.0 9.8 0.6 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.1 6.4 0.0 3.7 0.3 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.5;Late spermatids: 100.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;Daudi: 2.3;HAP1: 10.8;NTERA-2: 2.3;RPMI-8226: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 100.5 8.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.3 0.0 0.3 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 LRRTM4 FLJ12568 ENSG00000176204 "Leucine rich repeat transmembrane neuronal 4" Q86VH4 2 76747719-77593319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 12.7;Cone photoreceptor cells: 3.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "Karpas-707: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (3.13e-1)" "unprognostic (4.72e-4)" "unprognostic (7.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-1)" "unprognostic (5.84e-2)" "unprognostic (4.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (5.77e-3)" "unprognostic (3.54e-2)" "unprognostic (7.99e-2)" 1.2 1.5 13.7 1.2 15.7 4.5 0.8 1.8 25.4 1.0 1.5 1.6 0.8 2.1 1.3 3.7 2.4 1.2 2.3 1.3 8.9 8.0 0.9 3.4 1.9 1.9 4.1 16.4 2.4 1.2 0.2 7.9 2.3 5.5 1.7 1.2 1.0 1.9 3.1 2.8 2.1 1.2 0.8 3.1 1.5 1.8 1.2 5.1 0.0 2.2 0.0 0.8 1.6 1.6 0.0 0.4 3.3 0.6 0.9 1.2 0.2 0.8 1.3 0.5 0.5 0.1 0.0 0.8 0.1 0.0 0.0 0.0 1.1 0.3 0.5 1.3 0.5 0.4 0.4 0.0 0.0 0.1 0.3 1.1 0.2 1.9 1.7 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 54.3 0.1 1.1 0.2 0.5 5.5 0.1 0.5 0.7 0.0 1.2 0.0 2.3 2.0 0.6 0.3 0.4 0.5 0.9 0.8 0.4 0.0 1.6 2.0 0.2 0.2 0.3 1.2 0.1 1.2 0.1 1.5 0.0 0.6 0.9 0.3 0.4 0.1 0.0 1.0 0.9 0.0 0.0 1.2 0.7 3.3 0.9 0.3 0.4 0.4 0.2 13.7 15.7 1.8 25.4 8.9 8.0 4.1 16.4 5.5 5.1 0.0 0.3 0.0 0.0 0.0 12.7 0.3 0.0 1.4 0.0 0.0 3.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.4 0.0 2.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTM1 HT017 ENSG00000144771 "Leucine rich repeats and transmembrane domains 1" Q9HBL6 3 54918237-54967088 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3" "Cell type enriched" "Detected in many" 14 "Bipolar cells: 403.4" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (9.56e-2)" "unprognostic (2.16e-1)" "unprognostic (1.87e-3)" 0.3 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.3 3.6 0.1 0.4 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.1 0.4 2.9 1.2 0.0 18.8 2.1 0.4 22.5 0.1 0.3 0.0 1.0 12.2 0.1 0.3 0.0 0.0 0.1 15.3 0.5 0.1 0.1 0.7 1.0 2.3 1.9 0.7 0.9 0.5 0.5 0.3 1.7 0.2 0.2 0.0 1.8 0.0 0.5 0.9 1.6 0.3 1.3 0.0 0.8 0.8 0.0 1.0 0.4 1.5 0.6 1.0 0.2 4.3 1.1 0.9 0.2 0.5 1.1 1.8 0.4 0.7 0.2 0.1 0.1 0.3 0.1 1.6 0.3 0.2 0.4 2.3 1.5 0.0 0.5 0.1 0.3 1.3 0.2 0.7 0.5 0.7 0.5 2.3 0.3 0.7 1.2 0.3 0.0 0.7 0.9 0.7 0.1 0.0 1.0 0.1 0.4 0.6 0.9 2.3 0.5 0.6 0.7 0.6 0.9 0.7 0.6 0.3 1.0 0.3 0.8 0.6 1.5 0.7 1.9 0.6 0.7 0.5 0.3 0.3 0.1 0.2 0.3 0.2 0.3 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.3 403.4 0.4 0.0 0.0 0.0 1.8 15.7 7.8 0.0 0.0 2.0 0.2 0.0 0.0 0.3 1.1 0.8 0.4 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 16.2 1.4 0.0 4.2 0.0 28.5 0.0 1.0 3.0 2.2 0.4 18.5 0.0 0.0 0.4 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Cell type enhanced" "Detected in some" 29 "Bipolar cells: 3.7;Cone photoreceptor cells: 2.0;Horizontal cells: 11.1;Rod photoreceptor cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 9.2;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055094, HPA062745" Uncertain Approved Cytosol NA NA Cytosol "HPA055094: AB_2682693, HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 LUZP6 "MPD6, MTPNUT" ENSG00000267697 "Leucine zipper protein 6" Q538Z0 7 135927274-135927450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "naive CD4 T-cell: 2.4;naive CD8 T-cell: 2.7;plasmacytoid DC: 2.9;T-reg: 4.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;T-cells: 4.4" "Group enriched" "Detected in some" 5 "MOLT-4: 9.8;OE19: 6.1;SK-MEL-30: 19.4" HPA077907 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA077907: AB_2686869" 1.2 1.2 2.3 1.2 3.5 1.2 1.2 1.2 1.8 3.6 1.2 1.2 1.2 1.2 4.9 2.9 1.2 1.2 2.1 0.8 1.2 1.3 1.2 1.2 1.9 1.2 1.2 1.2 2.0 1.2 1.2 1.2 1.2 1.2 7.2 1.2 1.2 1.2 0.5 3.4 1.2 1.2 1.2 1.2 1.2 1.2 0.5 2.9 0.1 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 9.8 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 2.4 2.7 0.0 0.6 0.0 2.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6E "RIG-E, SCA-2, TSA-1" ENSG00000160932 "Lymphocyte antigen 6 family member E" Q16553 8 143017982-143023832 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 1253.6;Extravillous trophoblasts: 3995.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 91.0;MCF7: 95.8" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.05e-1)" "unprognostic (8.80e-2)" "unprognostic (3.88e-2)" "unprognostic (3.70e-3)" "unprognostic (9.08e-3)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" "unprognostic (6.64e-2)" "unprognostic (4.94e-1)" "unprognostic (7.34e-2)" "unprognostic (1.74e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (6.74e-8)" "unprognostic (2.68e-1)" "unprognostic (2.28e-3)" "unprognostic (1.84e-3)" "unprognostic (2.12e-2)" 29.6 35.1 24.8 16.7 33.0 40.4 30.2 22.6 53.4 42.1 10.4 10.1 9.0 11.3 26.6 38.6 30.3 30.8 42.9 19.3 34.8 15.8 39.9 127.1 50.6 27.8 13.0 20.9 41.2 13.1 5.2 13.8 72.6 13.0 20.7 6.7 23.3 57.8 25.4 7.7 17.8 10.2 23.3 8.6 45.9 19.5 16.4 4.7 23.2 19.2 22.6 27.3 18.5 22.6 34.8 19.2 4.9 79.3 50.7 47.6 44.1 12.6 21.5 0.2 10.6 16.8 31.0 28.2 26.9 50.1 64.5 91.0 0.4 22.9 8.9 18.3 22.1 9.0 26.4 6.5 14.5 7.7 6.0 9.0 27.8 10.4 9.0 16.5 2.2 6.9 31.9 5.5 11.4 4.8 6.7 5.3 8.6 7.5 24.3 4.3 95.8 7.0 9.7 6.6 40.8 14.8 6.2 0.0 22.4 14.2 9.4 16.2 5.7 31.3 19.8 28.4 9.9 25.9 4.5 3.5 4.0 22.6 10.5 0.1 0.2 1.1 0.2 8.7 7.8 12.0 2.6 23.2 2.0 47.6 70.4 29.1 33.4 38.0 38.4 19.2 34.8 25.9 34.6 4.9 50.7 79.3 3.5 30.3 44.1 24.8 33.0 22.6 53.4 34.8 15.8 13.0 20.9 13.0 4.7 20.8 12.0 124.3 378.0 155.9 9.6 2.0 188.5 24.1 45.5 43.6 0.0 1253.6 19.9 233.6 2.8 206.7 1.1 0.0 19.5 3995.5 396.8 163.3 53.0 298.0 333.3 44.5 28.2 108.6 68.1 5.4 268.4 147.6 150.1 29.7 10.8 11.8 122.7 0.0 208.9 188.8 2.4 142.3 89.3 1.4 29.4 102.6 446.8 262.9 12.0 497.8 LYG1 SALW1939 ENSG00000144214 "Lysozyme g1" Q8N1E2 2 99284238-99304742 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "kidney: 22.5" "Group enriched" "Detected in some" 6 "Distal tubular cells: 18.3;Proximal tubular cells: 70.3" "Cancer enriched" "Detected in many" 15 "renal cancer: 31.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted - unknown location" NA NA "unprognostic (1.53e-2)" "unprognostic (3.13e-2)" "unprognostic (1.53e-2)" "unprognostic (3.73e-1)" "unprognostic (9.74e-2)" "unprognostic (3.76e-4)" "unprognostic (6.94e-4)" "unprognostic (2.58e-2)" "unprognostic (4.72e-2)" "unprognostic (9.74e-3)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.58e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-3)" 1.0 0.4 1.0 1.1 1.0 0.7 2.1 2.3 1.0 1.1 1.0 1.0 1.0 1.2 1.4 1.9 1.0 0.7 1.0 1.0 1.0 0.4 22.5 3.1 1.0 1.5 1.0 1.0 1.1 1.0 0.0 1.0 1.0 1.0 1.6 1.1 1.0 1.0 1.0 2.0 1.5 1.2 1.0 1.0 2.6 0.6 2.9 1.0 1.0 1.2 1.0 1.2 1.0 1.0 1.0 0.4 1.2 0.9 0.0 2.4 0.5 0.5 3.9 3.0 4.9 6.9 4.1 3.4 1.5 1.7 1.6 2.7 0.8 3.5 0.8 2.7 0.7 0.4 1.7 4.0 0.6 1.9 2.7 2.4 2.2 2.9 1.3 1.4 0.8 5.4 3.2 4.3 2.6 1.0 3.6 0.8 5.2 1.2 2.6 1.8 0.8 2.0 6.7 0.7 2.0 3.8 4.9 1.7 1.3 6.9 1.5 1.7 1.0 0.6 1.2 1.1 3.8 0.5 0.7 2.2 2.0 2.5 3.6 1.7 3.0 1.8 0.6 0.6 4.0 1.0 0.0 0.9 1.2 1.5 0.1 1.4 0.2 0.2 0.6 0.4 1.0 1.2 0.7 0.0 0.0 0.0 0.0 2.4 0.5 1.0 1.0 2.3 1.0 1.0 0.4 1.0 1.0 1.0 1.0 0.0 0.0 0.0 0.2 0.0 1.0 0.3 0.0 0.0 2.3 1.8 2.0 0.2 18.3 0.5 7.8 0.3 0.3 0.0 0.2 0.1 0.4 0.5 4.6 0.0 0.3 0.0 0.0 1.3 0.3 3.6 0.3 0.4 0.0 1.0 0.3 0.3 0.6 0.0 0.4 70.3 0.5 0.0 0.4 1.8 0.2 0.0 0.5 0.5 0.2 0.1 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Group enriched" "Detected in many" 5 "Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.8 5.4 0.0 0.0 0.0 0.0 1.1 0.6 2.4 0.5 0.4 0.6 0.0 10.1 2.0 1.6 5.2 0.0 0.0 1.2 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 1.0 14.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.3 0.1 2.1 0.0 0.0 0.0 7.1 0.1 0.7 1.3 0.6 0.0 15.2 13.7 0.0 0.1 0.7 0.3 7.6 3.2 31.7 0.0 0.0 0.0 6.2 0.0 63.9 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 0.0 0.0 0.0 0.0 0.1 0.8 0.2 5.1 0.0 0.0 5.2 0.0 0.0 1.7 49.4 4.4 0.0 0.0 0.0 65.7 0.0 0.1 0.1 0.0 0.0 0.1 14.3 1.7 0.6 0.3 6.3 3.7 0.0 0.0 108.2 0.0 1.5 67.6 0.0 0.0 2.2 0.8 0.0 5.3 1.1 1.8 0.0 0.0 0.0 0.0 0.0 LYPD2 "LYPDC2, RGTR430, UNQ430" ENSG00000197353 "LY6/PLAUR domain containing 2" Q6UXB3 8 142750150-142752534 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9" "Cell type enriched" "Detected in single" 13 "Ito cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "non-classical monocyte: 76.5" "Lineage enriched" "Detected in many" 20 "monocytes: 76.5" "Cell line enhanced" "Detected in some" "EFO-21: 15.1;HaCaT: 4.1;OE19: 2.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028599 Uncertain "Intracellular and membrane" NA NA "HPA028599: AB_10603777" "prognostic favorable (2.00e-4)" "unprognostic (3.10e-2)" "prognostic favorable (2.63e-4)" "unprognostic (3.85e-3)" "unprognostic (3.75e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-2)" "unprognostic (3.11e-3)" "unprognostic (1.53e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.12e-1)" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.3 0.0 77.5 0.2 0.1 1.2 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 7.7 0.0 0.5 6.5 0.0 0.0 0.0 0.1 11.6 0.0 0.0 5.7 0.0 37.9 69.2 0.0 10.1 0.2 3.7 0.0 76.5 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 76.5 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 LYPD4 MGC42718 ENSG00000273111 "LY6/PLAUR domain containing 4" Q6UWN0 19 41837074-41844697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "testis: 120.3" "Group enriched" "Detected in some" 55 "Early spermatids: 232.6;Late spermatids: 649.6;Spermatocytes: 177.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "BEWO: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (4.07e-2)" "unprognostic (2.92e-1)" "unprognostic (3.21e-1)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.8 1.2 1.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.7 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.8 0.3 0.5 0.6 0.4 0.9 0.6 0.5 0.5 0.5 0.5 0.6 0.8 1.5 1.7 1.2 0.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 649.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.0 177.4 5.0 0.0 0.0 0.0 0.0 0.0 LYPD6B "CT116, LYPD7" ENSG00000150556 "LY6/PLAUR domain containing 6B" Q8NI32 2 149038107-149215262 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 38.9" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 202.8;Late spermatids: 80.2;Suprabasal keratinocytes: 60.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.0;LHCN-M2: 41.7;NB-4: 13.6;RT4: 22.0;SK-BR-3: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049239 Uncertain "Intracellular and membrane" NA NA "HPA049239: AB_2680688" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (3.12e-3)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (2.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.64e-2)" "unprognostic (7.95e-3)" "unprognostic (2.59e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (1.32e-3)" 0.2 0.2 1.4 0.1 1.5 0.0 8.9 0.7 2.4 1.4 2.3 0.6 21.8 1.1 1.1 0.5 2.1 12.2 27.3 0.1 5.0 2.4 4.0 0.4 2.7 2.4 0.7 0.6 1.7 13.2 9.8 0.6 0.6 0.9 5.0 1.5 2.5 11.9 26.6 0.1 38.9 2.9 1.8 0.6 1.3 20.3 16.9 0.7 0.2 0.2 0.6 2.3 9.1 3.7 2.8 0.0 14.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.6 2.7 1.0 0.3 0.0 0.0 0.0 26.0 0.0 5.6 0.6 0.6 8.6 0.0 3.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 9.4 0.0 13.6 0.8 5.8 0.1 0.0 0.1 1.7 1.3 22.0 1.5 0.0 0.1 13.2 0.0 2.7 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 14.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.5 0.7 2.4 5.0 2.4 0.7 0.6 0.9 0.7 0.0 1.3 2.0 20.2 26.6 0.0 1.1 50.9 22.7 6.8 43.6 0.0 0.0 6.6 10.6 202.8 0.8 3.6 0.0 16.3 0.5 0.8 26.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 80.2 2.0 1.1 5.0 1.0 3.1 0.0 23.2 6.5 0.0 0.0 0.0 0.0 0.9 1.5 1.5 60.3 0.2 0.0 2.5 35.1 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 144.2;Late spermatids: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA059840: AB_2684137" "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favorable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favorable (9.50e-4)" 25.4 18.9 19.1 15.0 17.4 12.8 25.5 12.6 17.8 17.5 16.6 9.6 14.0 9.5 17.1 21.1 16.2 24.9 17.0 34.2 15.4 18.2 30.6 101.6 11.2 19.2 18.8 13.8 25.3 26.1 20.5 13.9 9.0 24.9 21.1 14.0 13.1 14.1 19.1 28.7 10.6 12.6 27.6 17.9 11.5 15.7 22.9 9.0 16.2 19.4 14.9 12.9 25.3 19.7 12.7 7.2 47.4 10.2 8.4 14.2 10.1 12.1 13.0 12.1 9.6 32.9 26.2 4.0 10.1 16.9 5.8 8.8 14.6 15.2 8.5 39.5 12.1 8.5 8.5 5.3 10.6 9.5 15.9 8.3 3.9 3.6 37.6 24.5 12.7 7.7 19.0 9.4 16.3 46.8 16.5 24.1 12.7 8.5 15.1 25.2 16.1 12.5 8.6 12.6 18.1 6.9 17.2 6.7 10.2 21.0 7.1 11.9 11.4 6.3 10.5 16.8 7.0 10.8 7.4 6.4 8.4 6.1 13.2 6.9 14.9 20.9 13.3 21.9 13.7 7.3 47.4 7.2 23.3 8.6 9.1 11.8 12.7 13.2 10.6 5.9 11.2 10.7 10.8 26.8 8.4 10.2 7.2 14.2 10.1 19.1 17.4 12.6 17.8 15.4 18.2 18.8 13.8 24.9 9.0 17.9 13.9 29.7 49.4 18.7 29.4 53.1 25.5 24.1 10.3 22.7 13.7 23.9 64.6 36.2 144.2 28.7 7.0 0.0 38.2 7.9 24.2 36.6 15.1 41.4 13.8 14.3 28.8 11.1 11.6 327.6 26.7 12.7 16.9 55.9 15.3 26.4 29.5 14.0 35.7 98.2 27.2 12.9 22.0 66.8 24.3 18.2 12.5 26.1 25.2 44.5 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA029152: AB_10602033, HPA059824: AB_2684135" "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 8.8 4.7 5.8 11.6 8.7 4.7 11.1 8.6 14.1 9.5 6.4 7.8 3.6 8.1 9.3 11.4 11.4 5.5 8.3 9.2 7.1 5.6 4.7 6.6 7.0 3.9 4.7 5.7 7.8 6.5 14.9 5.4 5.0 6.7 6.3 5.9 8.3 15.9 7.7 12.3 25.2 6.5 6.9 7.9 4.5 5.6 6.8 6.3 5.4 4.1 11.1 6.3 4.6 8.4 3.1 4.8 8.0 4.0 1.0 6.2 3.4 3.7 3.5 7.2 4.2 8.1 7.4 4.3 4.3 3.0 3.7 5.4 8.8 3.3 4.1 2.5 3.9 6.4 11.0 5.6 6.9 4.3 0.8 10.1 2.7 7.2 6.0 4.6 1.9 5.1 4.2 10.2 3.4 4.0 2.3 4.9 12.0 6.5 5.3 2.4 4.4 5.1 5.4 4.8 10.4 4.1 3.6 5.1 2.0 6.6 9.8 4.2 3.7 7.8 2.4 4.1 9.7 1.7 3.7 6.3 3.0 8.3 4.1 1.8 7.0 9.3 3.3 3.9 4.8 3.2 0.0 2.0 8.0 3.8 3.3 2.9 1.8 5.2 4.5 1.1 3.1 6.2 2.8 0.7 1.0 4.0 4.8 5.0 3.4 5.8 8.7 8.6 14.1 7.1 5.6 4.7 5.7 6.7 6.3 6.0 3.5 0.8 7.0 7.7 8.9 9.7 7.6 2.7 3.4 3.5 9.8 2.0 1.7 3.4 5.6 4.6 4.0 23.3 8.4 2.1 4.5 1.5 0.0 3.6 3.6 9.5 2.9 5.5 2.2 4.3 4.9 4.7 1.7 11.8 4.0 10.8 5.7 2.9 6.3 3.8 10.0 12.9 6.1 10.8 5.5 8.0 1.1 2.5 2.2 3.9 LYZL1 "LYC2, MGC33408" ENSG00000120563 "Lysozyme like 1" Q6UWQ5 10 29289061-29318328 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 371 "testis: 39.5" "Group enriched" "Detected in some" 48 "Early spermatids: 474.4;Late spermatids: 148.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;SuSa: 2.9" "Secreted in male reproductive system" NA NA "unprognostic (1.88e-1)" "unprognostic (8.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 474.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 4.2 1.9 0.0 0.0 0.0 0.0 0.0 LYZL2 ENSG00000151033 "Lysozyme like 2" Q7Z4W2 10 30611779-30629762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "testis: 34.2" "Group enriched" "Detected in some" 53 "Early spermatids: 605.6;Late spermatids: 151.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 8.2" "Secreted in male reproductive system" NA NA "unprognostic (2.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 605.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.6 1.6 0.0 0.0 0.0 0.0 0.0 LYZL4 "LYC4, MGC26768" ENSG00000157093 "Lysozyme like 4" Q96KX0 3 42397078-42410600 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 29.0" "Group enriched" "Detected in some" 72 "Early spermatids: 297.8;Late spermatids: 112.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "OE19: 9.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA038806 Approved "Secreted in male reproductive system" NA NA "HPA038806: AB_10674841" "unprognostic (4.03e-1)" "unprognostic (5.68e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 297.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.4 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.3 0.0 0.0 1.9 2.1 0.0 0.0 0.0 0.0 0.0 LZTS3 "KIAA0552, ProSAPiP1" ENSG00000088899 "Leucine zipper tumor suppressor family member 3" O60299 20 3162617-3173592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.9;salivary gland: 36.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 9.3;Cardiomyocytes: 12.0;Club cells: 11.4;Collecting duct cells: 10.4;Distal tubular cells: 10.0;Proximal tubular cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031008, HPA031009" Approved Approved Vesicles NA NA Vesicles "HPA031008: AB_10601610, HPA031009: AB_10670162" "unprognostic (4.09e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (1.15e-1)" "unprognostic (6.19e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.98e-4)" "unprognostic (3.31e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (9.69e-3)" "prognostic favorable (5.92e-8)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (8.47e-2)" "unprognostic (1.38e-1)" 2.4 5.3 17.6 1.4 31.1 1.7 3.5 51.9 45.7 11.5 2.4 4.2 2.1 8.6 4.6 3.7 1.7 6.4 6.8 5.4 16.4 10.7 11.9 2.7 5.6 1.2 7.1 17.4 9.0 17.0 11.8 4.1 2.2 10.5 5.0 2.2 7.4 36.2 7.9 5.1 1.4 6.5 2.7 4.5 1.7 7.7 1.9 6.0 0.0 7.1 0.4 1.0 2.6 1.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 2.8 2.7 3.8 4.2 5.3 1.5 2.6 2.8 6.1 4.8 7.1 15.3 8.0 4.8 1.6 5.5 6.3 1.4 2.1 3.0 3.7 0.1 2.7 0.2 0.5 12.5 12.0 0.2 1.3 1.9 6.6 6.7 2.6 1.8 0.7 4.5 2.7 1.5 2.3 1.2 0.3 0.6 8.5 6.5 2.6 1.3 1.3 5.1 6.0 1.0 15.0 4.6 2.3 3.3 2.3 5.8 7.7 0.1 4.3 5.2 9.8 2.0 0.8 3.0 0.4 1.4 2.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.8 0.5 0.0 17.6 31.1 51.9 45.7 16.4 10.7 7.1 17.4 10.5 6.0 17.9 9.3 2.2 0.0 1.3 0.0 12.0 0.0 4.0 11.4 10.4 0.0 1.1 10.0 4.9 0.0 0.7 0.0 0.0 4.3 0.3 0.7 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 8.1 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.0 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "GAMG: 42.1" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: AB_2686310" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.9 0.0 0.2 0.0 7.0 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 12.1 8.9 0.0 9.4 0.0 0.0 0.0 MAGEB3 CT3.5 ENSG00000198798 "MAGE family member B3" O15480 X 30230436-30237492 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "epididymis: 20.5;testis: 7.8" "Cell type enhanced" "Detected in some" 23 "Late spermatids: 1.1;Spermatocytes: 4.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SuSa: 4.3;U-266/70: 6.4" "Not detected" "Not detected" HPA072203 Approved NA NA "HPA072203: AB_2686492" "unprognostic (3.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 6.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.1 0.0 0.0 0.0 0.0 0.0 MAGEB5 "CT3.3, MAGE-B5" ENSG00000188408 "MAGE family member B5" Q9BZ81 X 26216169-26218270 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 3.3" "Group enriched" "Detected in some" 7 "Early spermatids: 3.2;Late spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052627 Uncertain NA NA "HPA052627: AB_2681890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 MAGEE2 HCA3 ENSG00000186675 "MAGE family member E2" Q8TD90 X 75782988-75785236 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.8" "Cell type enhanced" "Detected in single" 39 "Bipolar cells: 1.5" "Cancer enriched" "Detected in single" 9 "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030625 Uncertain NA NA "HPA030625: AB_10601863" "unprognostic (5.92e-2)" "unprognostic (9.33e-2)" "unprognostic (2.24e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (3.01e-3)" "unprognostic (5.79e-3)" "unprognostic (3.47e-2)" "unprognostic (6.43e-2)" 0.5 3.6 2.6 0.5 6.4 0.3 0.7 8.1 8.8 0.9 1.0 0.3 0.0 0.8 1.2 1.2 0.8 0.6 1.0 0.8 2.5 6.7 1.0 0.4 0.9 0.3 2.0 3.8 1.6 0.3 0.3 1.9 0.3 4.1 1.1 1.4 0.4 0.8 1.1 0.3 0.9 1.1 1.3 2.0 0.4 0.4 0.5 0.9 0.0 0.5 0.0 0.4 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 6.4 8.1 7.2 2.5 6.7 2.0 3.8 4.1 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAJIN C11orf85 ENSG00000168070 "Membrane anchored junction protein" Q3KP22 11 64937517-64972085 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 43.7" "Group enriched" "Detected in some" 15 "Distal tubular cells: 3.3;Proximal tubular cells: 4.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebellum: 4.9" "Cell type enhanced" "Detected in some" "memory B-cell: 4.1;naive B-cell: 1.7" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Group enriched" "Detected in some" 9 "CAPAN-2: 12.5;SiHa: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.37e-1)" "unprognostic (6.43e-3)" "unprognostic (3.69e-2)" "unprognostic (7.05e-2)" "unprognostic (9.64e-3)" "unprognostic (2.92e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" "unprognostic (9.11e-2)" "unprognostic (4.11e-2)" "unprognostic (1.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.48e-2)" "unprognostic (2.43e-1)" "unprognostic (2.79e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-2)" 0.2 0.2 0.2 1.2 0.7 0.0 0.2 4.9 0.4 0.3 0.2 0.1 0.7 0.0 0.2 2.2 0.2 1.1 2.9 0.4 0.1 0.1 1.4 1.0 0.2 1.5 0.2 0.0 0.1 1.7 0.0 1.5 0.0 0.7 0.3 0.1 0.5 0.3 0.6 0.1 1.2 0.6 0.0 0.2 1.6 0.2 43.7 0.0 0.0 0.8 0.1 1.2 0.3 0.5 4.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.3 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 4.9 0.4 0.1 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" NA NA "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 23.0 7.8 0.7 4.5 2.0 1.0 1.9 0.0 0.5 0.0 0.3 0.8 0.6 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.4 0.0 24.0 0.0 0.0 1.4 0.2 0.6 0.4 8.2 1.9 0.0 0.0 0.2 29.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.6 2.8 10.1 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 28.7 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.4 5.5 0.4 3.1 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.0 37.9 2.9 0.0 0.0 0.2 5.7 21.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 9.1 89.5 0.7 10.1 0.0 0.0 15.4 0.3 0.0 77.1 0.3 0.2 38.8 25.0 0.3 0.4 4.3 0.2 0.0 0.0 0.0 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 18.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.6 2.6 1.5 2.9 0.6 0.1 18.9 2.7 0.3 0.3 0.6 2.0 1.6 1.4 0.6 0.7 0.8 2.2 0.3 1.3 0.0 2.1 0.9 0.8 5.3 2.3 1.2 0.2 4.9 0.8 1.7 1.4 0.6 1.4 0.6 2.5 2.7 1.2 0.2 4.2 1.0 3.7 1.4 1.1 0.7 1.6 0.4 2.5 0.9 1.4 1.7 2.1 0.6 1.3 1.1 1.0 4.4 0.9 0.8 7.6 4.8 1.5 0.4 3.1 1.6 0.4 1.7 2.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 0.0 4.3 0.0 0.8 0.7 5.4 6.2 12.7 2.7 0.0 1.8 0.0 2.2 1.7 0.8 1.7 1.4 19.8 0.0 4.4 2.8 2.6 1.3 0.0 16.6 2.4 15.9 0.0 2.5 2.4 1.9 1.7 2.2 0.0 1.0 19.5 2.6 0.9 12.5 1.4 2.1 7.4 0.0 1.4 1.2 2.2 0.4 1.9 1.3 10.3 0.7 MAMSTR "FLJ36070, MASTR" ENSG00000176909 "MEF2 activating motif and SAP domain containing transcriptional regulator" Q6ZN01 19 48712742-48719721 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.9" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 6.8;Peritubular cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 7.6;RH-30: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049765 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049765: AB_2680870" "unprognostic (6.00e-2)" "unprognostic (3.20e-2)" "unprognostic (5.98e-2)" "unprognostic (6.07e-2)" "unprognostic (1.65e-1)" "unprognostic (6.50e-3)" "unprognostic (4.34e-4)" "unprognostic (2.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (4.65e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (2.79e-1)" "unprognostic (4.84e-2)" "unprognostic (1.39e-2)" 2.4 14.7 1.8 1.0 1.9 0.5 0.9 8.0 4.3 7.9 1.0 2.2 1.1 0.7 13.5 3.5 2.7 4.8 1.0 2.7 1.6 1.0 0.7 0.4 0.9 0.7 1.0 4.3 9.5 1.0 2.7 2.7 1.4 0.7 4.7 0.8 3.3 1.5 1.7 53.9 1.7 0.9 3.6 0.8 2.9 0.7 7.7 1.1 0.0 0.9 9.2 1.1 1.4 2.4 4.1 2.9 1.1 0.9 0.7 4.0 0.6 0.6 1.4 1.5 3.8 3.0 5.2 1.5 5.1 4.1 2.5 4.0 1.5 1.0 0.7 0.3 4.8 1.5 1.1 0.2 0.9 1.0 0.5 1.7 0.3 0.5 7.6 1.6 0.1 1.1 3.1 1.0 3.5 0.5 3.5 0.9 1.5 0.3 1.0 1.6 0.7 1.2 0.6 0.1 1.2 1.1 1.4 18.3 0.4 0.3 0.3 1.7 3.1 0.8 0.4 0.3 0.4 0.6 0.0 0.3 5.2 0.9 4.2 0.7 1.1 0.7 0.5 1.9 0.6 1.0 0.0 0.5 1.1 3.9 0.9 2.5 3.1 4.0 3.8 1.0 4.1 4.0 3.5 0.4 0.7 0.9 2.9 1.7 0.6 1.8 1.9 8.0 4.3 1.6 1.0 1.0 4.3 0.7 1.1 0.0 0.0 0.0 1.5 0.8 1.7 2.8 0.0 0.0 2.3 1.8 2.0 0.8 5.0 1.4 0.4 1.6 0.4 0.0 0.9 2.4 2.5 0.5 0.0 0.0 1.0 0.0 0.0 2.5 0.0 1.4 5.2 1.6 6.8 1.8 0.3 4.8 0.5 0.0 5.6 0.6 2.5 0.0 2.2 0.5 1.7 0.6 0.8 0.9 0.6 1.0 MAN2A2 "HsT19662, MANA2X" ENSG00000196547 "Mannosidase alpha class 2A member 2" P49641 15 90902218-90922584 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.4;neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077930 Approved "Cytoplasmic bodies" NA NA 30000000 "Cytoplasmic bodies" "HPA077930: AB_2732363" "unprognostic (5.17e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (3.41e-1)" "unprognostic (2.27e-1)" "unprognostic (5.06e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (7.55e-3)" "unprognostic (1.13e-1)" "unprognostic (8.36e-2)" "unprognostic (2.33e-2)" 17.8 12.1 15.9 11.5 24.3 58.1 17.3 33.7 31.2 7.2 9.9 52.4 6.3 12.0 8.9 9.8 7.6 8.0 9.4 22.7 17.8 14.0 8.1 16.7 13.3 12.4 31.6 19.7 9.7 24.0 13.0 15.2 12.4 31.0 9.2 9.0 17.2 20.6 12.6 41.8 14.8 13.0 7.6 33.1 19.1 12.4 12.7 28.3 3.8 13.8 2.7 9.1 7.5 10.7 1.5 2.1 10.0 3.2 0.1 1.4 1.5 5.8 6.1 4.3 10.2 13.0 3.5 8.4 4.3 3.9 4.5 3.5 4.9 4.4 0.8 10.6 5.0 4.1 6.7 4.5 2.5 2.8 14.5 10.6 40.0 9.2 3.3 4.3 5.8 21.7 2.5 4.7 5.4 4.4 9.0 5.9 10.7 15.0 5.3 2.0 7.9 3.8 11.6 1.4 9.7 1.9 5.2 4.1 6.1 5.6 14.1 10.4 6.0 5.9 11.1 8.4 4.5 5.2 19.1 5.0 3.7 4.0 4.5 5.6 8.1 24.9 2.1 4.3 8.5 6.2 8.4 1.6 0.6 1.4 1.1 0.9 1.0 0.6 0.8 0.3 1.5 0.4 0.4 10.0 0.1 3.2 2.1 1.3 1.5 15.9 24.3 33.7 31.2 17.8 14.0 31.6 19.7 31.0 28.3 11.9 23.5 5.6 2.9 5.4 24.8 12.6 7.6 5.3 10.3 8.7 25.5 7.3 0.0 3.9 5.9 7.9 8.1 23.3 5.6 1.8 6.4 5.8 15.1 19.2 5.4 23.8 4.1 7.4 12.2 5.2 6.4 13.5 28.7 10.0 7.2 18.0 4.1 5.7 4.6 3.0 69.2 12.9 8.5 8.8 6.1 4.1 6.3 8.7 7.9 3.0 MANBA ENSG00000109323 "Mannosidase beta" O00462 4 102630770-102760994 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053478 Approved Supported Vesicles "Intracellular and membrane" NA NA 12000000 Vesicles "HPA053478: AB_2682165" "unprognostic (2.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.80e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (1.32e-1)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (7.78e-2)" "unprognostic (1.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (7.12e-2)" "unprognostic (4.81e-2)" "unprognostic (2.13e-1)" 12.7 23.5 8.5 12.2 11.9 8.6 17.1 13.4 8.4 12.1 9.9 12.9 11.7 8.1 11.6 13.6 9.3 11.0 15.5 12.1 8.7 8.6 11.8 10.3 17.7 20.2 15.1 6.2 16.7 18.1 25.1 18.4 25.0 10.8 12.0 10.8 12.4 27.4 11.4 5.4 7.8 14.0 14.2 15.3 21.3 14.4 4.6 13.5 9.4 19.2 3.6 12.8 17.9 12.6 3.9 9.5 25.2 11.6 3.6 3.1 3.9 7.0 3.9 1.9 1.9 37.5 17.4 4.9 4.9 9.7 2.1 4.2 5.1 8.2 7.6 6.6 6.8 6.8 3.3 5.0 10.8 1.7 5.3 2.1 4.3 4.5 7.8 11.4 8.0 19.6 14.8 18.5 9.1 7.6 27.8 3.9 3.3 7.2 7.8 7.7 3.2 1.9 7.7 2.7 8.7 3.2 3.9 4.5 2.1 6.1 8.3 1.2 0.9 5.8 10.1 7.6 20.0 14.4 5.5 3.0 5.8 2.8 13.0 2.6 4.2 8.7 0.7 10.5 3.6 4.2 6.2 11.5 25.2 1.8 10.6 1.4 3.8 3.1 2.0 9.5 3.9 3.0 2.0 10.1 3.6 11.6 2.3 1.6 3.9 8.5 11.9 13.4 8.4 8.7 8.6 15.1 6.2 10.8 13.5 29.8 35.2 25.3 8.3 5.3 5.4 10.4 12.7 4.0 12.5 8.7 5.9 32.0 1.7 5.7 1.9 7.2 4.6 0.0 2.4 6.3 10.6 7.4 33.5 15.8 38.4 6.4 1.7 9.2 46.4 1.1 8.3 42.8 0.0 29.7 10.9 4.3 5.7 21.0 18.7 7.6 7.1 0.0 8.3 0.2 1.1 4.0 18.9 10.9 10.5 8.3 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793802-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.6;Horizontal cells: 25.4;Intestinal endocrine cells: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 6 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 24000 "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.6 9.5 12.3 2.6 15.2 0.4 6.4 11.2 21.7 4.1 7.6 6.6 2.4 4.5 2.6 8.8 4.8 3.8 2.4 1.5 12.0 20.3 3.8 11.4 3.9 1.5 10.4 9.6 1.8 12.8 6.2 16.2 1.3 15.4 5.6 8.2 4.1 4.4 3.8 4.6 5.2 4.4 3.1 6.2 1.9 6.3 3.5 3.8 0.8 7.3 1.8 2.4 2.7 2.1 0.6 0.3 0.1 0.4 0.0 3.6 0.6 8.1 10.4 1.9 20.1 2.6 0.9 18.2 1.5 9.0 7.8 3.4 17.2 19.3 13.5 6.7 1.0 9.3 1.8 3.8 2.0 2.8 16.0 8.2 10.0 9.4 13.7 0.2 14.2 8.3 0.3 10.8 0.4 0.3 11.0 0.2 2.4 5.8 10.8 1.2 16.0 3.9 0.0 6.3 19.4 11.0 6.2 13.8 15.8 4.6 21.6 50.0 15.1 21.9 0.7 8.1 0.4 9.6 1.5 1.2 11.1 6.8 10.7 13.9 15.6 14.7 4.5 1.8 4.7 8.2 0.0 0.0 0.0 1.5 0.1 3.6 0.6 0.7 0.8 0.0 0.6 0.0 1.2 0.1 0.0 0.4 0.3 0.6 0.6 12.3 15.2 11.2 21.7 12.0 20.3 10.4 9.6 15.4 3.8 3.0 2.4 0.8 0.9 0.5 15.6 0.7 2.5 0.0 0.0 3.5 3.9 0.1 0.0 1.5 0.2 0.4 1.1 0.0 5.0 1.3 0.3 1.2 0.0 2.9 0.8 25.4 29.2 0.0 0.3 0.0 0.3 0.2 3.3 0.0 4.5 4.1 3.2 0.0 0.0 0.2 8.4 0.0 0.4 0.0 1.4 0.0 0.1 0.0 3.0 1.1 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350541 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 24 "neutrophil: 37.5" "Lineage enriched" "Detected in many" 36 "granulocytes: 37.5" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 27.2;OE19: 28.5;RPTEC TERT1: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" NA NA 28000000 "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 13.1 8.8 9.7 5.1 13.7 4.2 14.7 10.1 18.4 13.5 17.8 7.5 12.9 13.4 15.1 14.1 27.3 11.2 19.3 7.9 9.2 7.6 9.5 7.6 8.4 6.6 6.9 9.0 11.3 26.4 18.5 19.5 11.0 9.0 15.0 18.5 12.8 42.6 15.2 3.6 13.3 13.3 14.4 5.8 8.4 21.3 9.1 6.2 0.0 9.5 16.7 18.2 12.6 12.9 0.2 0.2 37.5 0.5 0.2 1.0 0.1 0.1 3.0 0.9 0.0 3.1 3.0 3.3 2.1 2.5 1.1 1.4 2.5 9.7 0.0 2.3 2.0 1.1 0.4 3.8 1.7 0.8 0.0 3.4 4.3 3.8 2.0 0.5 0.6 1.2 1.9 2.9 0.7 0.5 7.6 27.2 0.1 2.7 0.0 0.3 5.7 0.0 0.3 3.4 28.5 1.6 0.1 0.0 0.0 14.1 9.9 1.3 5.4 1.1 9.1 3.1 1.6 8.2 2.7 10.6 1.5 1.3 0.4 2.8 0.2 0.1 1.4 1.1 0.0 1.1 1.5 0.5 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 1.0 0.1 37.5 0.2 0.1 0.0 0.0 0.1 9.7 13.7 10.1 18.4 9.2 7.6 6.9 9.0 9.0 6.2 8.9 20.5 6.9 7.0 3.5 6.8 2.1 28.1 18.7 6.8 22.7 7.9 28.7 1.7 15.0 0.8 20.4 18.1 0.0 33.2 5.4 6.9 10.2 2.3 7.5 6.5 9.5 20.8 30.1 5.9 1.8 12.7 1.4 0.0 1.0 32.2 11.7 15.8 28.1 15.6 1.6 12.6 0.0 4.7 1.7 1.5 4.1 14.2 4.4 25.5 7.2 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 31.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.2" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.7 0.0 0.7 3.0 0.4 1.5 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.2 3.7 0.7 2.2 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.2 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.7 0.5 0.3 1.6 4.7 0.7 0.9 1.4 2.9 1.7 0.1 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.4 1.2 1.1 11.2 0.4 1.5 0.2 0.9 4.1 1.1 3.6 2.6 3.8 3.0 4.7 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 0.0 1.7 1.4 17.3 21.5 1.1 31.3 0.0 1.4 3.4 0.0 0.0 2.2 6.6 0.2 9.2 8.2 3.5 0.0 0.0 1.9 8.9 10.1 6.9 1.5 3.9 12.7 1.7 3.1 8.1 13.4 4.4 10.2 10.1 0.0 1.0 0.5 0.3 3.5 3.5 1.3 1.2 0.0 14.4 20.0 8.4 18.7 9.5 6.9 0.8 18.6 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964491-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;fallopian tube: 23.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 18.3" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.1;U-266/70: 2.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 20.2" HPA011388 Uncertain Cytosol NA NA Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.1 0.2 1.7 0.2 6.2 0.1 0.1 0.0 0.5 1.1 0.2 7.3 0.0 0.2 1.0 6.7 0.2 23.9 0.1 0.1 2.9 3.8 0.2 0.2 5.6 0.2 0.5 1.5 7.3 0.1 0.1 1.0 0.1 18.3 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 7.6 3.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 6.2 0.0 0.5 2.9 3.8 0.5 1.5 18.3 3.1 0.0 0.6 0.0 0.0 0.0 0.2 0.4 0.0 151.3 17.0 0.0 9.8 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 MARCH11 "MARCH-XI, RNF226" ENSG00000183654 "Membrane associated ring-CH-type finger 11" A6NNE9 5 16067139-16180762 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 42.1" "Group enriched" "Detected in some" 7 "Early spermatids: 83.9;Spermatocytes: 30.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 44.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (9.91e-3)" "unprognostic (1.08e-1)" "unprognostic (2.98e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" 0.4 1.1 1.8 0.3 3.4 0.3 0.4 3.7 3.7 0.3 0.4 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.3 2.2 2.0 3.2 0.5 0.5 0.4 0.3 1.5 2.0 0.5 1.0 0.3 6.8 0.4 2.1 0.6 0.4 0.6 1.4 0.3 0.3 0.3 0.4 0.3 0.5 0.3 0.4 42.1 0.0 0.0 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 44.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.4 3.7 3.7 2.0 3.2 1.5 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 5.9 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 2.4 6.5 0.0 30.3 1.4 0.0 0.0 0.0 0.0 0.0 MARCH4 "KIAA1399, MARCH-IV, RNF174" ENSG00000144583 "Membrane associated ring-CH-type finger 4" Q9P2E8 2 216257865-216372027 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.6;pituitary gland: 13.1" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014348 Approved NA NA "HPA014348: AB_1853578" "unprognostic (4.84e-2)" "unprognostic (1.02e-4)" "unprognostic (1.63e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (6.49e-2)" "unprognostic (5.55e-3)" "unprognostic (1.07e-1)" "unprognostic (6.81e-5)" "unprognostic (4.82e-2)" "unprognostic (2.06e-1)" "unprognostic (1.23e-1)" "unprognostic (1.09e-3)" 0.7 2.9 7.0 0.7 11.9 0.7 0.6 1.0 16.6 0.6 1.1 0.3 0.0 1.5 0.7 0.7 0.6 2.5 0.6 0.6 5.8 5.6 0.6 0.6 0.8 0.6 2.0 4.8 0.6 1.5 0.6 13.1 3.1 3.4 0.7 1.2 0.1 0.6 0.6 0.6 0.7 1.4 0.6 1.6 0.6 5.1 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 5.6 1.2 0.0 0.0 0.1 0.8 0.0 33.8 11.6 7.3 2.6 0.0 0.5 0.0 5.2 21.5 12.2 0.0 0.0 13.3 7.2 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.6 10.0 4.7 9.5 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 1.1 0.0 0.0 15.9 11.3 11.8 0.0 9.0 0.0 0.0 0.0 2.6 0.0 8.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.0 11.9 1.0 16.6 5.8 5.6 2.0 4.8 3.4 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MARCOL ENSG00000248109 "MARCO like" 5 148221650-148243580 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ductus deferens: 3.8;epididymis: 5.7;seminal vesicle: 3.1;skeletal muscle: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HeLa: 127.7" NA NA 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 0.0 3.8 0.0 0.7 5.7 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.1 2.9 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.9;pancreas: 34.5" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 154.2;Paneth cells: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 11.7;BEWO: 17.6;CACO-2: 13.0;CAPAN-2: 12.6;HaCaT: 11.9;MCF7: 22.2;RT4: 10.4;SK-BR-3: 10.5;T-47d: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" No NA Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favorable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.4 0.3 0.4 12.5 0.3 0.0 5.0 0.7 1.2 2.0 35.7 0.3 5.2 17.3 1.3 8.6 4.1 2.1 15.4 0.5 0.5 0.4 14.2 4.3 3.3 0.5 0.3 0.1 1.0 34.5 5.4 1.2 5.3 2.4 6.5 10.5 2.4 10.4 4.3 0.3 3.0 52.9 0.7 0.4 0.4 2.1 1.2 0.1 1.3 8.3 2.3 4.6 3.0 3.4 1.5 1.4 4.1 0.8 1.5 0.8 0.2 11.7 0.4 0.2 0.5 0.0 0.1 17.6 0.0 0.0 0.0 0.0 13.0 12.6 0.1 1.3 0.0 0.0 11.9 1.1 5.7 0.0 0.0 6.8 0.0 0.1 3.4 0.0 0.1 0.1 0.5 7.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 22.2 0.1 0.2 2.0 7.4 0.1 0.0 0.0 4.7 0.2 10.4 2.1 0.1 0.2 10.5 0.0 1.5 14.9 0.2 0.0 0.0 0.2 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 4.1 0.8 0.8 0.7 0.5 0.4 0.8 0.8 0.6 0.3 1.5 0.7 0.7 4.0 1.5 0.5 1.4 0.7 0.2 0.4 0.3 0.7 0.5 0.5 0.4 0.3 0.1 2.4 0.1 8.9 5.9 0.0 25.0 7.0 5.9 0.4 38.2 20.1 12.5 8.7 0.0 31.8 1.7 23.0 4.2 0.0 154.2 0.0 29.6 0.7 1.0 32.3 0.0 5.0 2.5 0.0 59.0 0.6 1.2 2.2 0.3 1.0 0.0 1.0 62.0 0.8 24.0 84.2 0.7 20.2 19.7 0.0 1.0 7.7 4.3 3.1 4.0 1.3 44.3 38.8 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L2 ENSG00000230522 "Methyl-CpG binding domain protein 3 like 2" Q8NHZ7 19 7049321-7051735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.9" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003813 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.7" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 133.5;Muller glia cells: 95.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles NA NA Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.32e-4)" 2.3 2.9 12.8 2.9 18.0 24.2 10.1 10.1 20.2 6.0 8.2 16.6 1.2 3.1 5.3 3.5 14.2 3.7 4.3 5.1 14.7 12.4 8.0 1.3 10.9 2.9 23.3 10.3 6.8 2.1 34.7 5.5 3.8 16.2 16.1 9.3 6.4 5.6 4.1 1.2 12.3 4.3 4.6 18.5 2.5 6.9 2.7 17.8 1.9 5.3 16.1 10.3 4.4 7.5 0.0 0.8 6.7 0.7 0.0 0.2 0.3 8.4 2.6 7.9 3.4 3.6 8.0 4.6 4.1 1.5 5.3 3.5 0.7 13.5 2.4 4.9 9.7 4.2 6.5 7.0 8.2 8.0 7.5 12.1 10.1 3.7 0.0 4.4 0.0 3.2 5.8 4.9 5.0 3.5 11.7 2.8 3.5 8.6 1.9 4.6 2.2 3.0 0.2 3.1 3.8 10.0 4.5 12.5 0.1 7.8 1.2 4.7 14.5 4.2 25.5 4.0 4.1 4.8 2.9 1.5 9.4 5.0 7.2 11.6 0.7 0.2 2.7 14.7 1.4 3.1 6.3 0.7 2.8 0.0 0.2 0.0 0.0 0.2 0.1 0.8 0.0 0.2 0.1 6.7 0.0 0.2 0.1 0.0 0.3 12.8 18.0 10.1 15.8 14.7 12.4 23.3 10.3 16.2 17.8 17.9 10.1 4.5 2.9 3.0 18.3 10.6 5.1 16.0 19.4 38.4 7.9 2.5 5.0 4.5 7.3 8.8 10.3 46.7 1.4 1.3 9.8 21.0 8.1 0.0 1.7 133.5 36.0 4.3 2.1 7.8 4.9 4.3 13.5 44.1 49.8 95.3 52.2 20.4 7.1 8.4 7.2 6.5 12.0 10.7 23.7 4.4 1.6 2.1 11.9 29.8 MCCD1 ENSG00000204511 "Mitochondrial coiled-coil domain 1" P59942 6 31528717-31530232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 188 "kidney: 63.6" "Group enriched" "Detected in some" 34 "Distal tubular cells: 339.8;Proximal tubular cells: 251.4" "Cancer enhanced" "Detected in some" "liver cancer: 2.4;renal cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (2.71e-1)" "unprognostic (3.22e-2)" "prognostic favorable (1.73e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 339.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 251.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Group enriched" "Detected in many" 11 "Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Cell line enhanced" "Detected in many" "HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.8 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 1.9 0.0 0.3 0.2 0.1 9.4 1.4 4.0 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.7 0.0 0.7 2.5 1.2 8.2 0.5 1.2 1.2 0.9 1.3 0.0 1.6 5.4 0.0 1.5 0.4 0.2 2.6 0.9 1.0 0.0 2.1 0.6 0.5 0.9 0.6 0.0 0.9 0.1 0.1 3.3 3.5 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 0.0 2.1 0.0 0.4 0.3 64.6 1.2 0.0 4.0 0.0 5.2 208.1 0.2 0.0 0.1 86.7 0.7 0.3 0.0 0.2 0.1 0.7 0.2 1.1 0.0 0.4 7.9 0.0 3.1 0.6 11.7 0.9 1.0 1.7 2.8 0.0 3.0 0.2 0.0 0.4 0.0 135.4 0.0 0.4 0.7 3.4 0.4 1.1 2.1 0.0 0.6 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Cell line enhanced" "Detected in many" "Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 20.0 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 20.5 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.9 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 8.5 20.7 3.0 0.1 28.3 7.4 0.2 0.5 6.8 1.6 0.1 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.6 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 3.0 9.6 0.0 0.1 16.1 2.0 2.5 0.0 4.0 6.8 3.5 0.0 0.3 0.0 0.0 20.6 29.9 0.0 0.0 0.2 0.1 3.0 0.6 61.2 0.5 10.7 3.2 0.0 1.8 33.5 12.2 0.6 35.3 11.8 0.0 0.0 3.6 0.8 0.0 0.0 0.0 3.7 0.0 2.2 1.4 1.4 11.7 0.2 2.2 0.0 0.4 MDFIC2 ENSG00000242120 "MyoD family inhibitor domain containing 2" A0A1B0GVS7 3 70196894-70312726 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.5;salivary gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HeLa: 2.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MDH1B "FLJ25341, RP11-95H11" ENSG00000138400 "Malate dehydrogenase 1B" Q5I0G3 2 206737763-206765547 "Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.7;testis: 27.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 121.8;Early spermatids: 123.3;Spermatocytes: 50.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 7.2;SCLC-21H: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073761 Approved NA NA "HPA073761: AB_2732241" "unprognostic (1.03e-2)" "unprognostic (9.44e-2)" "unprognostic (1.58e-1)" "unprognostic (9.84e-2)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (2.01e-1)" "unprognostic (3.66e-2)" "unprognostic (3.23e-3)" "unprognostic (3.08e-1)" "unprognostic (6.10e-3)" "unprognostic (1.15e-1)" "unprognostic (3.09e-2)" "unprognostic (7.84e-3)" "unprognostic (3.01e-1)" 0.9 2.3 3.1 0.7 9.0 0.6 1.9 1.5 5.7 2.0 1.1 5.0 3.6 0.5 2.5 6.6 1.1 26.7 1.5 1.9 3.4 4.2 4.2 0.6 3.6 0.8 2.4 3.5 4.5 1.1 6.3 15.1 0.5 9.5 1.3 1.1 2.8 1.7 2.2 0.9 1.0 0.6 1.5 1.6 0.6 1.1 27.6 1.8 0.1 5.2 0.0 0.7 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.7 2.4 1.8 4.9 0.4 2.3 0.7 0.0 0.9 1.0 0.7 0.2 1.6 1.1 1.1 0.2 2.2 1.1 0.1 1.4 1.0 0.1 0.1 0.5 0.4 1.5 1.1 0.8 2.5 1.4 0.5 0.1 0.3 1.1 1.4 2.3 0.1 1.4 0.7 2.9 1.5 0.6 3.2 0.3 2.9 3.1 1.8 0.1 7.2 0.3 6.9 1.5 2.2 1.1 0.6 1.1 2.2 0.0 0.1 1.2 1.2 0.3 0.6 0.7 2.9 0.4 2.6 0.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 3.1 9.0 1.5 5.7 3.4 4.2 2.4 3.5 9.5 1.8 6.0 1.0 0.0 1.2 0.7 3.0 1.2 2.5 121.8 6.8 0.0 0.0 0.1 11.6 0.7 123.3 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.1 3.2 1.2 0.0 0.0 17.1 1.7 0.2 1.7 0.0 0.0 7.7 0.1 0.0 2.8 5.1 9.9 0.0 1.0 50.4 4.0 0.3 0.0 0.0 0.0 0.4 ME3 ENSG00000151376 "Malic enzyme 3" Q16798 11 86441108-86672636 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 48.7;Distal tubular cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 5.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 24.5;hTERT-RPE1: 29.4;HUVEC TERT2: 16.3;TIME: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038473 Approved NA NA "HPA038473: AB_10672747" "unprognostic (1.83e-3)" "unprognostic (8.00e-2)" "unprognostic (1.99e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "unprognostic (5.74e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.73e-1)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" 17.2 15.9 16.0 6.3 27.7 5.8 13.1 15.7 26.1 19.3 14.3 4.8 7.3 7.8 15.8 7.6 5.0 9.0 12.9 21.9 12.2 13.1 12.6 3.9 8.1 4.3 12.5 18.1 22.1 16.7 28.5 15.4 5.4 20.2 13.0 15.0 11.5 13.6 10.3 21.2 3.0 7.1 15.6 5.5 7.3 20.8 8.8 8.4 2.8 8.2 6.3 2.9 10.3 10.2 0.0 5.0 0.0 0.9 2.2 3.1 1.0 0.0 8.2 2.3 0.0 3.7 7.8 0.0 2.8 4.3 5.8 7.4 6.2 24.5 0.0 2.5 2.6 14.7 0.1 0.0 0.0 2.6 4.3 0.0 4.2 6.8 0.0 5.5 0.5 0.0 5.4 1.2 4.7 0.0 29.4 16.3 0.0 0.0 0.0 3.8 0.8 1.1 0.0 0.5 0.7 3.4 3.6 0.0 0.3 5.2 9.5 2.8 0.0 1.7 0.0 0.0 1.0 0.4 0.6 18.1 0.7 0.5 12.2 0.4 0.0 1.5 0.0 0.6 7.6 0.7 0.0 0.9 0.0 1.9 0.1 0.0 0.0 1.9 3.1 5.0 0.0 2.3 2.7 0.0 2.2 0.3 0.6 0.0 1.0 16.0 27.7 15.7 26.1 12.2 13.1 12.5 18.1 20.2 8.4 3.0 3.5 0.8 4.4 2.1 15.2 48.7 5.1 17.4 4.5 3.5 0.0 0.1 36.5 6.9 0.5 8.3 11.0 0.0 6.9 0.3 3.9 5.3 0.0 0.5 6.9 19.1 8.6 11.1 1.8 1.3 5.8 2.5 1.7 1.8 11.2 1.7 8.3 9.3 6.0 5.5 2.3 12.9 3.7 0.3 0.2 1.4 0.0 1.3 9.3 6.0 MEDAG "AWMS3, C13orf33, FLJ14834, MEDA-4" ENSG00000102802 "Mesenteric estrogen dependent adipogenesis" Q5VYS4 13 30906191-30925572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 63.0" "Cell type enhanced" "Detected in some" 16 "Fibroblasts: 43.8;Leydig cells: 17.5;Smooth muscle cells: 18.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.6" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC diff: 77.9;ASC TERT1: 21.9;U-2197: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.44e-2)" "unprognostic (3.42e-2)" "unprognostic (6.06e-3)" "unprognostic (8.80e-2)" "unprognostic (1.07e-1)" "unprognostic (3.71e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (8.69e-3)" "unprognostic (2.48e-1)" "unprognostic (5.41e-3)" "unprognostic (7.52e-2)" 63.0 1.9 0.1 7.4 0.3 0.2 43.8 0.1 0.4 9.0 10.0 0.3 7.5 1.2 10.2 24.8 13.3 14.5 7.2 18.6 0.4 0.4 2.0 0.4 5.3 7.3 0.4 0.5 17.9 6.8 0.5 2.2 6.4 2.6 3.6 3.2 4.6 6.0 1.7 27.1 8.0 3.5 10.8 2.4 0.4 5.2 9.5 0.1 0.0 15.3 12.7 3.6 21.5 10.5 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 77.9 21.9 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 9.2 0.0 11.1 0.0 0.0 10.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 11.1 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.4 0.4 0.4 0.5 2.6 0.1 0.0 0.3 0.0 0.0 10.2 0.0 4.2 0.0 1.4 2.3 0.0 0.0 0.1 0.0 1.2 1.0 6.7 0.0 0.0 0.0 0.4 43.8 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 1.3 17.5 0.6 10.1 0.0 0.0 0.0 0.3 0.0 9.2 0.1 0.0 0.0 18.8 0.0 0.0 9.2 0.2 0.0 0.0 0.5 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.7;fallopian tube: 16.3" "Group enriched" "Detected in many" 6 "Early spermatids: 136.6;Horizontal cells: 119.2;Late spermatids: 159.9" "Cancer enhanced" "Detected in some" "glioma: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HEK 293: 3.6;RPTEC TERT1: 12.7;SCLC-21H: 9.9" "Region enriched" "Detected in many" 4 "cerebellum: 39.2" "Region enriched" "Detected in all" 7 "cerebellum: 62.2" NA NA "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.6 0.8 8.7 0.9 5.4 1.3 0.6 34.7 17.1 0.6 0.7 5.3 0.0 0.6 0.8 2.3 0.7 16.3 0.7 0.6 11.6 5.7 4.6 0.6 1.6 0.9 6.5 2.5 0.7 1.0 0.5 1.5 0.6 9.2 0.7 0.6 3.4 0.6 0.8 0.6 3.2 0.7 0.6 9.2 0.9 1.0 2.6 5.5 0.0 0.7 0.0 0.7 0.6 0.2 0.3 0.1 0.5 0.2 0.0 1.5 0.0 0.0 0.1 0.5 4.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.8 0.0 0.3 0.1 0.3 0.0 0.1 0.2 3.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.5 0.0 0.1 12.7 0.3 9.9 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.5 0.5 0.0 0.0 0.1 0.1 0.0 8.7 5.4 34.7 4.7 11.6 5.7 6.5 2.5 9.2 5.5 0.0 3.0 0.0 0.5 1.9 4.9 0.6 0.0 1.4 0.0 3.5 7.9 0.2 0.0 0.0 136.6 0.7 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 119.2 0.0 1.3 0.3 159.9 2.3 0.9 0.0 0.0 0.0 3.5 0.1 0.0 1.4 0.8 25.0 0.0 0.5 2.1 2.0 3.3 0.5 0.0 0.0 0.4 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol NA NA 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: AB_2681060" "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favorable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.7 10.7 9.4 2.9 13.1 8.1 3.0 2.8 2.4 0.7 1.0 0.6 1.6 10.1 4.2 2.6 3.4 11.8 13.5 4.8 2.0 8.2 3.9 1.4 20.1 4.4 5.6 4.0 8.7 3.8 14.8 4.6 3.7 26.3 6.6 5.5 3.2 4.8 7.8 7.8 7.9 1.4 0.4 6.0 2.9 6.0 10.5 4.3 19.3 8.9 9.3 7.9 3.3 2.7 7.9 1.6 8.1 4.1 7.7 2.8 1.6 10.4 4.2 8.8 10.3 3.3 4.0 4.8 16.1 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 80.4 47.6 4.9 4.8 24.4 27.8 23.0 15.3 6.7 21.6 22.7 200.3 0.3 0.0 3.9 0.6 7.3 6.5 23.3 4.7 1.1 6.1 8.8 6.9 41.0 5.9 12.7 6.3 10.4 54.2 0.9 10.6 18.5 25.3 2.8 3.3 28.2 11.0 6.8 11.0 5.0 70.5 12.9 9.9 8.4 6.1 38.3 1.0 9.6 6.0 5.7 MEI1 "MGC40042, SPATA38" ENSG00000167077 "Meiotic double-stranded break formation protein 1" Q5TIA1 22 41699499-41799456 "Predicted intracellular proteins, Predicted secreted proteins" Meiosis "Disease mutation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 26.8;lymphoid tissue: 20.3;testis: 34.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 50.5;Late spermatids: 37.4;monocytes: 22.6;T-cells: 22.5" "Cancer enhanced" "Detected in many" "cervical cancer: 5.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 7.9;HMC-1: 6.4;Karpas-707: 21.4;U-266/70: 22.7" "Group enriched" "Detected in many" 17 "amygdala: 1.6;basal ganglia: 1.7;cerebral cortex: 2.6;hippocampal formation: 1.7;olfactory region: 1.9" "Region enriched" "Detected in single" 4 "olfactory region: 4.2" HPA049240 Approved "Secreted in male reproductive system" NA NA "HPA049240: AB_2680689" "unprognostic (1.95e-3)" "prognostic favorable (1.59e-6)" "unprognostic (6.13e-3)" "unprognostic (1.86e-2)" "unprognostic (9.70e-2)" "unprognostic (2.97e-3)" "unprognostic (9.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (5.96e-2)" "unprognostic (9.65e-2)" "unprognostic (2.62e-1)" "unprognostic (2.45e-10)" "unprognostic (2.82e-1)" "unprognostic (3.02e-1)" "unprognostic (1.85e-1)" "unprognostic (7.39e-2)" 2.1 0.9 1.4 7.7 1.4 12.4 3.1 1.7 3.3 1.6 6.3 0.5 0.9 2.6 0.8 3.6 1.6 1.2 1.9 1.5 1.2 1.8 2.2 1.3 3.5 20.3 1.1 0.4 0.9 1.0 0.0 1.0 1.6 1.6 1.2 3.3 3.3 6.0 1.0 0.7 1.1 6.5 0.6 1.1 15.5 4.5 34.7 0.3 3.8 1.9 1.8 17.1 4.0 1.3 11.0 3.2 7.3 3.7 7.8 26.8 8.8 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.7 0.0 0.2 0.4 0.1 0.4 0.4 0.1 0.2 0.1 0.0 0.0 0.0 5.0 0.0 1.4 7.9 0.9 1.3 1.0 6.4 0.1 0.1 0.0 0.0 0.3 0.3 0.6 0.2 21.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.7 0.4 0.0 0.0 0.0 22.7 3.6 0.9 0.3 2.1 0.1 6.2 3.7 7.3 15.8 2.7 15.2 11.0 15.8 13.3 3.2 7.3 11.7 12.8 0.7 7.8 1.1 1.2 26.8 8.8 1.4 1.4 1.7 3.3 1.2 1.8 1.1 0.4 1.6 0.3 0.0 5.6 14.9 0.2 0.8 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 50.5 1.0 0.0 0.0 0.0 0.1 1.4 0.2 13.9 0.8 7.4 0.0 0.0 1.8 1.9 37.4 0.6 6.3 16.9 22.6 0.3 0.0 3.2 0.0 1.1 0.3 0.6 0.0 2.5 19.7 19.0 0.9 0.0 22.5 0.0 0.2 MEIKIN ENSG00000239642 "Meiotic kinetochore factor" A0A087WXM9 5 131806993-131945698 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 16.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 16.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.7;non-classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SuSa: 2.3;U-2 OS: 5.9" "Low region specificity" "Detected in all" NA NA "unprognostic (3.21e-1)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-1)" "unprognostic (4.64e-6)" "unprognostic (2.38e-1)" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.5 0.0 3.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 2.7 0.4 0.5 0.1 0.1 1.5 0.5 1.0 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 4.1 0.0 0.0 0.0 0.0 0.0 MEIOB "C16orf73, MGC35212" ENSG00000162039 "Meiosis specific with OB domains" Q8N635 16 1833987-1884294 "Disease related genes, Predicted intracellular proteins" Meiosis "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 41.2" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 383.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 12.5;K-562: 40.4;THP-1: 34.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (7.18e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-2)" "unprognostic (9.73e-2)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (2.00e-2)" "unprognostic (2.68e-2)" "unprognostic (7.30e-3)" "unprognostic (1.34e-1)" "unprognostic (3.80e-1)" "unprognostic (2.18e-3)" 0.1 0.1 0.8 0.0 0.9 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.6 0.3 0.9 0.3 0.0 0.0 0.1 0.8 0.3 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.3 0.0 0.1 41.2 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 4.2 0.4 0.0 0.2 0.4 34.5 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.7 0.6 0.3 0.1 0.8 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 37.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 4.6 0.0 0.1 3.2 0.0 0.0 0.0 10.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.3 0.2 6.5 0.0 383.1 43.7 0.4 0.0 0.0 0.0 0.4 MEIOC "C17orf104, FLJ35848" ENSG00000180336 "Meiosis specific with coiled-coil domain" A2RUB1 17 44656404-44690308 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 59.6" "Group enriched" "Detected in some" 5 "Early spermatids: 263.1;Late spermatids: 392.6;Spermatocytes: 236.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 13.4;HMC-1: 20.5;NTERA-2: 7.1;SiHa: 7.5;SuSa: 10.2;THP-1: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA027266 Enhanced Uncertain "Cell Junctions" NA NA "Cell Junctions" "HPA027266: AB_1848900" "unprognostic (5.82e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.96e-2)" "unprognostic (9.12e-2)" "unprognostic (2.31e-1)" "unprognostic (2.13e-1)" "unprognostic (3.63e-2)" "unprognostic (8.89e-2)" "unprognostic (7.58e-2)" "unprognostic (6.83e-4)" "unprognostic (1.85e-1)" "unprognostic (6.24e-3)" "unprognostic (1.72e-1)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (8.89e-3)" 0.2 0.2 0.4 0.2 0.8 0.6 0.2 2.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.2 0.3 0.7 0.6 1.4 0.3 0.2 0.3 0.4 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.5 0.7 0.2 0.2 0.3 0.2 0.1 59.6 0.2 0.2 0.3 0.2 0.3 0.2 0.2 1.8 1.9 2.2 0.8 0.8 1.0 0.1 0.2 6.2 0.9 1.0 0.2 0.0 0.5 0.8 0.0 0.5 1.7 0.4 0.2 0.7 1.5 0.3 0.2 0.2 13.4 0.0 0.2 0.6 5.4 0.5 0.8 0.3 0.0 0.5 20.5 0.0 0.0 0.8 0.0 1.4 0.0 1.3 0.4 0.6 0.1 1.2 0.4 1.2 7.1 0.2 0.6 0.3 0.7 0.4 0.0 0.2 1.5 2.0 7.5 0.2 0.1 10.2 0.9 10.2 0.2 0.4 0.2 1.5 0.7 0.5 0.8 0.3 0.5 0.7 1.2 1.9 0.8 0.7 0.9 0.5 0.5 0.9 0.8 0.5 0.2 1.8 1.0 0.9 2.2 0.8 0.6 1.9 0.5 0.1 0.4 0.8 2.5 0.9 0.7 0.6 0.4 0.2 0.3 0.2 0.0 0.6 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 0.2 3.3 0.2 263.1 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 1.0 392.6 4.4 0.5 0.0 0.0 0.0 1.0 0.3 0.0 3.5 1.1 2.2 19.4 0.0 236.7 55.3 0.0 0.2 0.0 0.0 0.5 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419523 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 35.3;endometrium 1: 28.8" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 22.3;Horizontal cells: 42.9;Late spermatids: 47.6;Muller glia cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;HMC-1: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavorable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 5.6 3.9 35.3 4.7 10.6 0.0 5.0 11.0 25.3 8.4 4.7 2.4 3.8 3.5 28.8 2.2 6.0 14.2 6.0 3.7 23.2 11.6 1.5 1.1 3.1 1.2 2.6 14.6 7.4 1.7 1.1 4.9 7.4 3.8 7.0 2.1 4.1 3.6 6.4 1.4 1.6 3.8 22.5 1.7 2.4 2.6 3.3 2.0 0.5 3.4 1.6 1.4 6.1 4.7 0.0 0.2 0.5 0.7 0.0 0.1 0.4 0.3 12.1 28.4 0.1 15.4 13.3 0.4 12.7 19.4 9.9 17.5 1.1 1.9 0.0 1.4 20.8 8.2 1.4 2.9 3.5 3.4 18.9 4.3 0.0 4.4 0.1 10.0 0.2 24.6 9.8 0.7 3.9 2.1 3.5 0.0 0.0 0.2 2.8 1.1 11.5 0.0 0.1 8.3 0.3 0.7 0.0 2.1 0.3 0.6 0.9 1.1 23.0 10.9 0.9 5.2 11.8 0.6 3.5 0.0 7.6 19.3 5.5 1.7 0.0 0.0 0.0 21.2 1.1 15.2 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.4 35.3 10.6 11.0 25.3 23.2 11.6 2.6 14.6 3.8 2.0 0.0 2.7 0.0 1.0 0.7 4.8 0.8 0.0 2.7 3.4 3.5 5.9 0.1 0.0 0.0 22.3 0.5 0.0 0.0 0.0 0.2 9.9 3.2 0.0 0.0 0.5 42.9 0.0 1.8 0.0 47.6 10.6 1.1 6.8 0.0 0.0 18.0 0.1 0.0 3.9 0.0 2.7 12.9 6.9 2.6 4.7 0.9 0.7 0.0 0.0 0.7 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 14.1;prostate: 10.9" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 6.3;prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 14.1 1.6 6.8 1.4 4.3 1.1 3.8 7.3 8.8 2.5 1.9 1.1 0.1 1.3 1.0 1.0 0.9 1.0 2.9 3.9 4.9 5.0 1.3 1.2 1.1 1.1 3.3 4.3 1.0 1.2 1.1 1.1 0.8 2.4 10.9 1.0 1.3 3.0 1.2 7.0 0.9 1.1 0.9 1.4 0.9 1.0 1.4 1.9 0.0 1.0 2.2 0.9 0.9 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 5.7 2.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.3 0.0 2.3 0.0 0.7 0.0 0.4 0.0 0.0 5.0 5.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.1 0.8 1.4 0.0 0.0 9.5 0.2 0.0 1.3 0.1 0.0 4.4 0.1 1.1 1.9 1.2 0.0 0.1 0.7 0.0 0.0 0.3 3.4 1.1 2.3 0.8 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.8 4.3 7.3 8.8 4.9 5.0 3.3 4.3 2.4 1.9 0.0 0.6 0.8 2.6 0.2 10.5 5.2 12.7 0.0 0.0 1.8 9.8 1.8 10.0 16.5 3.7 0.7 17.0 0.0 37.0 0.1 1.0 36.0 4.6 11.5 2.0 7.9 5.8 3.1 2.2 1.0 1.1 2.1 6.8 2.8 4.6 12.7 7.1 10.5 0.0 11.1 15.3 0.0 1.0 42.6 14.3 0.3 0.2 4.4 11.0 5.0 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.8;placenta: 193.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 18.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "AN3-CA: 525.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 44.9 26.0 7.8 4.7 12.9 3.4 63.8 2.6 22.7 2.4 7.5 3.4 1.1 7.9 7.3 4.6 2.6 5.2 6.6 3.7 7.9 8.0 6.7 13.7 18.8 4.1 3.3 9.0 7.8 13.0 2.5 15.4 193.5 15.5 4.1 6.1 8.4 7.0 2.5 2.2 2.1 7.2 5.3 3.2 22.4 3.0 10.1 3.3 2.0 4.3 2.5 1.9 4.5 3.7 3.1 6.7 8.6 2.0 2.7 18.8 5.3 3.2 1.7 8.5 525.5 0.1 0.0 0.0 3.5 1.6 3.7 1.7 10.1 4.9 1.6 1.2 0.1 3.2 0.4 0.1 0.0 1.4 0.0 0.0 2.8 2.7 1.6 14.5 0.1 0.0 0.2 0.1 2.7 0.0 18.9 1.4 0.0 3.1 0.0 7.1 4.5 0.3 3.5 5.3 4.8 0.8 0.0 94.6 1.0 4.0 3.0 30.0 0.0 3.1 10.2 0.0 9.0 0.3 2.4 1.4 1.2 0.0 11.7 0.2 0.1 0.3 0.0 4.5 0.0 0.4 8.6 1.9 6.2 0.7 2.0 1.7 3.1 2.0 1.4 6.7 2.8 7.6 18.8 1.1 2.7 1.2 0.3 0.1 5.3 7.8 12.9 2.6 22.7 7.9 8.0 3.3 9.0 15.5 3.3 6.0 3.8 2.4 36.0 3.9 9.1 0.6 17.8 4.0 5.7 15.7 3.9 680.5 10.0 19.8 53.5 3.4 10.9 0.0 35.4 99.2 31.1 18.0 0.0 15.8 79.5 1.6 28.4 35.6 7.7 27.3 78.6 1.9 1.7 1.0 19.5 40.4 28.9 28.1 12.7 9.2 19.9 19.4 5.2 33.9 38.5 0.5 836.0 0.0 33.2 16.5 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell type enriched" "Detected in many" 8 "Muller glia cells: 554.6" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 53.4;PC-3: 41.3" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in all" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.5 4.4 22.5 7.9 4.4 7.2 5.3 2.7 2.1 1.4 3.3 6.6 0.4 12.5 3.7 8.2 9.9 0.6 5.2 0.3 1.4 9.9 0.9 4.1 17.0 4.8 1.9 2.9 10.7 5.7 0.6 1.3 6.7 0.7 6.3 1.5 0.5 1.6 53.4 0.7 6.5 1.6 2.9 41.3 7.3 5.1 7.3 5.5 0.7 7.0 8.9 2.1 5.9 27.4 0.5 8.9 3.8 2.4 6.1 11.7 7.1 4.6 3.4 0.9 0.4 9.6 1.4 14.4 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 0.0 2.1 4.2 14.7 3.4 38.6 14.0 50.9 2.7 0.0 15.7 13.7 0.6 43.1 6.3 6.5 12.6 15.0 0.0 4.2 1.8 8.7 28.3 0.0 27.2 5.2 66.7 26.2 19.0 5.1 14.5 10.3 4.8 10.1 0.0 8.1 554.6 5.4 14.7 8.9 43.5 29.1 25.8 15.3 3.9 11.3 2.6 0.3 6.4 8.6 14.2 METRNL ENSG00000176845 "Meteorin like, glial cell differentiation regulator" Q641Q3 17 83079691-83095119 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 40.7;U-2197: 54.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023792 Uncertain "Secreted to blood" NA NA 445000 "HPA023792: AB_2144182" "unprognostic (7.99e-2)" "unprognostic (2.32e-1)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (6.41e-3)" "unprognostic (7.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (1.01e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-3)" "unprognostic (4.43e-1)" "unprognostic (2.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.61e-2)" 21.8 4.0 3.7 13.3 4.0 16.9 19.9 3.4 4.8 20.4 18.8 4.2 8.8 25.9 7.5 12.7 37.0 8.5 13.3 29.4 3.7 2.9 15.6 4.4 19.4 9.7 3.1 2.8 11.4 17.7 16.0 8.2 27.9 8.0 10.1 4.6 15.6 15.3 8.5 10.3 52.3 21.8 13.3 4.1 13.9 13.5 8.8 3.3 2.5 25.3 23.3 18.0 20.5 26.3 1.2 4.8 10.8 7.8 3.2 2.1 1.4 3.9 0.1 2.0 2.4 2.1 7.9 9.0 4.2 1.9 3.0 3.4 0.4 2.8 0.2 1.6 3.1 2.1 9.8 0.6 0.2 1.9 2.7 1.5 8.6 10.9 1.0 5.2 2.6 16.7 3.8 0.8 12.1 0.8 1.9 1.5 0.0 5.4 0.0 2.5 6.1 0.2 8.1 0.4 5.7 5.3 2.6 3.8 1.2 0.4 1.5 0.1 1.2 5.8 10.3 4.5 2.0 9.1 2.9 3.6 40.7 4.6 54.7 1.2 0.0 0.0 0.1 9.5 1.1 2.5 6.5 3.6 10.8 2.1 6.2 0.1 1.2 0.4 1.4 4.8 0.2 0.0 0.6 6.1 3.2 7.8 1.8 1.8 1.4 3.7 4.0 3.4 4.8 3.7 2.9 3.1 2.8 8.0 3.3 23.8 42.7 4.8 15.0 20.4 3.3 30.3 12.7 1.4 9.1 47.1 5.9 9.8 3.3 11.0 7.6 13.9 56.8 23.3 12.2 4.6 31.9 16.1 31.3 0.5 44.3 1.6 5.8 15.4 48.0 0.0 7.2 49.5 15.1 4.6 28.5 87.9 15.3 27.7 3.2 6.4 22.5 0.0 14.9 1.1 3.8 43.0 16.0 17.3 22.7 48.9 METTL24 "C6orf186, dJ71D21.2" ENSG00000053328 "Methyltransferase like 24" Q5JXM2 6 110245928-110358272 "Predicted secreted proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Early spermatids: 4.3;Horizontal cells: 1.6;Late spermatids: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 34 "T-cells: 7.3" "Cell line enhanced" "Detected in some" "AF22: 2.7;fHDF/TERT166: 2.6;HHSteC: 3.1;SCLC-21H: 4.6;SH-SY5Y: 2.8;SuSa: 4.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037441, HPA037442" Uncertain "Secreted - unknown location" NA NA "HPA037441: AB_10670933, HPA037442: AB_10696931" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (9.31e-3)" "unprognostic (5.02e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (6.12e-2)" "unprognostic (2.06e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.45e-2)" "unprognostic (5.96e-2)" "unprognostic (1.54e-4)" "unprognostic (4.08e-2)" "unprognostic (1.23e-2)" "unprognostic (1.63e-2)" "unprognostic (4.78e-3)" 2.1 1.9 2.4 3.7 2.8 0.0 1.8 2.8 2.1 11.9 10.8 2.9 4.8 1.5 16.2 5.0 5.6 7.0 9.6 3.2 2.1 1.9 5.2 1.1 2.4 0.6 2.1 2.7 9.2 2.3 5.8 4.6 0.3 2.2 8.6 5.0 10.2 1.1 8.6 0.4 1.1 4.0 16.1 2.8 0.6 6.0 2.8 1.5 0.6 2.1 3.0 1.5 13.3 5.1 0.0 0.1 0.0 0.0 0.2 7.3 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 2.8 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 7.3 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 2.4 2.8 2.8 2.1 2.1 1.9 2.1 2.7 2.2 1.5 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358497-82479236 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Uncertain Uncertain "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 8.3 9.2 8.7 8.5 8.1 5.0 11.1 23.6 8.3 8.2 7.7 8.1 9.0 7.5 8.2 9.1 10.0 8.0 5.8 8.7 9.1 3.1 8.8 6.3 6.5 8.1 7.6 5.7 10.8 6.5 7.8 25.9 6.8 7.6 8.0 9.2 5.8 10.5 6.0 10.7 9.7 8.2 7.5 5.8 8.6 6.7 11.0 13.0 9.9 10.2 8.7 7.4 8.8 8.5 7.9 13.2 14.4 7.6 9.8 7.6 3.8 1.4 3.3 4.5 0.9 5.1 6.0 4.6 7.0 4.0 3.7 2.7 4.3 3.9 8.6 1.5 5.1 0.9 1.5 8.9 1.1 2.4 8.2 7.5 4.1 1.8 4.1 3.1 7.2 5.0 4.4 4.2 1.2 0.0 7.3 7.6 3.1 3.1 3.9 3.8 4.9 3.1 6.3 6.8 3.9 1.0 1.7 2.7 4.4 11.5 5.2 3.4 2.6 2.5 4.2 4.4 3.9 3.7 6.8 2.8 1.7 1.6 2.8 3.9 4.9 3.0 3.2 2.8 4.4 3.9 14.4 7.6 4.4 4.9 6.4 7.3 6.4 5.3 4.0 6.0 7.9 7.6 5.4 13.6 9.8 5.7 13.2 4.5 3.8 8.7 8.1 23.6 8.3 9.1 3.1 7.6 5.7 7.6 13.0 8.9 8.1 3.7 6.4 4.0 6.1 10.1 7.6 16.0 3.4 3.5 5.9 10.0 6.6 4.2 2.8 6.2 4.5 0.0 2.7 4.4 6.1 4.2 3.5 3.9 5.0 3.2 7.0 6.7 3.1 1.1 4.4 5.4 5.0 15.4 4.2 3.5 4.1 5.5 9.9 6.8 9.7 0.0 5.1 11.8 6.4 5.4 6.5 4.9 5.5 3.1 METTL4 "FLJ23017, HsT661" ENSG00000101574 "Methyltransferase like 4" Q8N3J2 18 2537525-2571509 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040061, HPA046734" Approved Approved Mitochondria NA NA Mitochondria "HPA040061: AB_10697713, HPA046734: AB_2732532" "unprognostic (1.85e-2)" "unprognostic (1.27e-1)" "unprognostic (7.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (5.06e-3)" "unprognostic (1.12e-5)" "unprognostic (1.74e-1)" "unprognostic (5.12e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.72e-2)" "unprognostic (3.26e-1)" "unprognostic (4.00e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-3)" 13.2 8.9 10.1 13.5 15.7 6.1 15.8 18.4 15.6 13.5 10.6 8.6 15.7 9.7 14.0 12.3 11.9 11.1 10.9 9.9 10.1 11.8 10.5 9.2 11.2 19.9 15.9 8.5 13.9 8.6 16.3 23.6 10.4 14.2 12.9 12.7 10.1 17.7 15.6 6.4 11.0 14.6 12.6 17.3 19.9 10.0 12.4 15.8 15.3 16.2 7.2 19.5 13.8 16.8 7.5 3.5 14.4 2.5 5.6 9.4 4.8 7.8 3.4 10.8 6.4 4.9 7.6 12.4 12.3 11.2 12.9 12.8 6.9 5.9 16.5 7.8 5.8 10.5 7.0 17.4 6.6 16.6 11.9 6.0 6.3 6.8 5.9 7.5 14.6 8.4 4.9 14.8 13.2 8.5 7.4 13.3 10.2 8.8 20.7 11.0 3.8 10.9 4.8 6.2 6.9 5.6 7.5 8.6 11.3 7.6 4.9 19.4 8.9 9.8 6.8 12.9 9.5 7.6 10.1 8.6 14.8 18.5 14.3 17.6 10.3 26.4 9.6 9.9 10.3 17.1 14.4 2.5 6.5 6.6 2.3 8.0 6.8 7.6 8.6 1.9 7.5 9.4 8.6 10.1 5.6 2.0 3.5 8.4 4.8 10.1 15.7 18.4 15.6 10.1 11.8 15.9 8.5 14.2 15.8 11.9 8.0 10.0 10.0 4.2 10.1 3.1 5.1 13.4 12.5 3.5 13.7 6.4 0.0 4.9 2.5 9.0 7.8 0.0 6.3 7.9 5.7 9.4 6.9 3.8 5.1 7.9 2.4 12.9 7.6 2.6 11.8 5.7 3.3 1.8 5.1 8.0 6.6 4.2 10.3 4.0 5.8 12.9 6.6 27.0 20.9 4.3 8.7 10.9 4.9 15.4 METTL6 MGC24132 ENSG00000206562 "Methyltransferase like 6" Q8TCB7 3 15381275-15440566 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.3;Late spermatids: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035166 Uncertain Approved Vesicles No No Vesicles "HPA035166: AB_10602709" "unprognostic (2.73e-1)" "unprognostic (3.53e-1)" "unprognostic (2.60e-1)" "unprognostic (1.29e-2)" "unprognostic (6.60e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.66e-6)" "unprognostic (3.98e-1)" "unprognostic (1.82e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" 8.6 9.6 19.4 8.6 19.3 5.0 11.7 18.4 18.9 11.7 7.1 16.8 6.2 7.1 10.7 10.6 10.0 11.5 7.7 9.3 13.1 14.3 8.4 7.9 7.8 10.3 13.3 9.6 14.8 10.7 12.5 17.9 11.0 13.7 10.6 8.7 12.0 7.5 11.3 7.8 8.8 6.4 12.4 14.2 8.7 7.8 20.2 11.3 11.8 11.8 3.8 12.0 9.0 8.3 14.1 16.5 15.7 14.0 14.2 14.5 9.4 8.0 13.4 14.6 12.6 13.1 15.4 39.1 14.8 16.2 19.8 19.8 8.5 10.9 13.7 9.6 14.4 15.1 6.8 15.1 12.9 20.3 9.6 16.9 13.3 13.2 12.0 26.4 12.6 11.5 13.5 16.6 23.3 10.7 14.7 16.9 13.9 13.7 14.0 19.3 18.1 13.2 9.9 16.2 8.9 17.0 10.2 18.8 13.5 11.3 11.6 6.5 11.7 12.6 12.5 12.0 11.1 18.1 11.0 10.9 14.2 9.1 13.8 13.3 15.0 25.3 16.7 14.9 12.3 13.3 9.0 11.1 15.7 13.8 14.0 13.4 10.6 13.1 13.5 12.3 14.1 13.4 14.5 6.7 14.2 13.0 16.5 11.9 9.4 19.4 19.3 18.4 18.9 13.1 14.3 13.3 9.6 13.7 11.3 3.0 5.6 0.8 6.7 3.5 16.3 5.2 2.5 10.7 4.5 8.7 5.9 7.9 5.0 9.2 171.3 6.8 1.7 0.0 11.8 16.3 5.4 4.1 4.7 1.9 8.0 19.1 1.7 4.9 5.4 95.3 8.3 6.6 5.0 7.2 2.2 11.0 7.0 3.5 8.5 5.0 14.0 6.5 5.3 30.2 13.8 2.5 9.7 8.5 3.9 5.3 METTL8 "FLJ13984, TIP" ENSG00000123600 "Methyltransferase like 8" Q9H825 2 171317405-171434802 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035421 Uncertain Approved Cytosol NA NA Cytosol "HPA035421: AB_10670116" "unprognostic (3.13e-1)" "unprognostic (2.72e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.76e-1)" "unprognostic (3.76e-1)" "unprognostic (1.43e-4)" "unprognostic (2.94e-3)" "unprognostic (7.29e-2)" "unprognostic (6.52e-3)" "unprognostic (4.83e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.45e-1)" "unprognostic (2.04e-1)" "unprognostic (2.10e-3)" "unprognostic (2.59e-3)" 10.8 8.0 7.4 8.4 9.6 6.8 8.8 6.2 8.5 9.4 12.6 10.4 9.2 4.6 8.4 6.3 21.0 5.9 7.2 6.7 8.7 6.4 8.6 8.6 5.5 6.0 13.2 4.5 6.4 8.1 6.1 5.0 7.8 10.9 10.9 14.1 5.2 6.2 11.6 6.9 15.1 8.2 20.5 12.5 7.8 6.3 11.2 10.1 4.0 4.7 13.5 8.9 13.7 10.3 6.6 10.1 1.2 4.4 7.0 7.5 3.6 8.4 6.4 3.1 9.5 10.4 12.4 17.2 10.5 8.0 9.9 12.4 14.0 11.8 17.5 8.4 5.0 8.5 8.6 11.2 17.1 12.5 9.2 5.8 9.7 5.7 19.7 8.4 14.8 7.5 12.2 18.9 15.7 24.7 2.5 19.5 9.3 17.9 4.0 13.5 9.2 10.4 3.6 13.1 7.4 5.8 5.5 12.2 19.0 7.4 8.3 11.5 4.5 11.1 8.5 7.7 5.4 6.1 5.6 9.6 8.7 6.8 6.1 5.8 2.1 9.3 10.6 6.9 10.5 9.0 0.8 3.0 0.9 5.4 4.4 7.5 4.3 6.3 5.0 4.0 6.6 2.9 3.3 1.2 7.0 2.1 10.1 6.3 3.6 7.4 9.6 6.2 8.5 8.7 6.4 13.2 4.5 10.9 10.1 6.0 6.7 33.5 8.2 22.7 7.5 7.5 17.8 8.1 17.0 3.5 2.0 14.4 10.0 7.3 11.1 8.1 7.4 23.3 5.3 17.3 10.8 7.0 5.8 8.6 10.6 11.1 6.4 5.5 9.4 2.9 13.0 11.6 10.1 7.2 4.2 7.7 7.5 2.9 15.2 14.4 9.6 6.5 10.5 6.1 18.1 23.3 10.8 12.5 12.5 8.1 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.6 10.4 26.4 22.8 27.3 49.5 9.5 21.9 31.4 17.3 21.0 7.5 24.9 24.0 18.7 38.3 16.7 8.6 17.5 19.6 23.7 18.2 14.3 10.4 10.5 27.9 19.6 8.1 21.6 29.1 20.9 17.9 23.4 32.6 33.1 26.9 15.3 19.8 34.2 15.1 21.1 13.6 23.7 17.0 10.8 30.8 20.5 21.8 28.5 13.4 15.3 27.6 18.6 12.9 46.7 20.7 13.1 4.2 18.7 28.8 12.6 17.6 13.4 16.8 27.0 19.3 28.3 20.2 20.3 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 17.9 25.0 67.7 73.4 63.7 38.7 50.8 28.1 17.4 25.0 82.0 43.2 62.9 238.8 101.7 6.4 91.1 45.1 0.0 107.0 99.3 82.6 115.4 48.3 10.4 80.8 42.9 81.5 80.4 211.5 4.5 58.7 86.5 99.5 101.8 76.5 49.9 98.9 45.6 61.2 326.8 37.5 64.7 68.4 13.2 20.0 67.2 116.4 146.0 75.0 107.4 MFAP2 "MAGP, MAGP-1" ENSG00000117122 "Microfibril associated protein 2" P55001 1 16974502-16980835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.7" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 148.9;Fibroblasts: 84.5;Leydig cells: 49.8;Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 7 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 48.7;ASC TERT1: 50.2;HUVEC TERT2: 51.4;SH-SY5Y: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007354 Enhanced "Secreted to extracellular matrix" NA NA "HPA007354: AB_1079365" "unprognostic (5.10e-2)" "unprognostic (3.81e-2)" "unprognostic (2.62e-1)" "unprognostic (2.92e-2)" "unprognostic (4.86e-1)" "unprognostic (1.53e-3)" "unprognostic (3.72e-3)" "unprognostic (2.21e-1)" "unprognostic (1.85e-2)" "unprognostic (1.98e-1)" "unprognostic (9.45e-3)" "unprognostic (9.12e-2)" "prognostic unfavorable (2.52e-8)" "unprognostic (2.18e-3)" "unprognostic (1.34e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" 13.1 1.6 0.2 6.0 0.4 0.0 20.8 0.4 0.8 24.8 5.0 0.5 6.7 1.6 28.7 14.0 5.7 6.6 29.7 29.6 0.6 0.3 3.4 0.8 12.5 1.2 0.3 1.0 23.6 33.9 0.0 4.7 51.7 1.8 16.9 1.7 15.4 6.9 5.0 4.6 10.9 4.3 18.3 2.9 1.3 3.5 10.4 0.3 0.7 3.8 7.4 3.3 10.3 13.2 0.3 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.0 19.0 0.0 48.7 50.2 1.2 4.8 20.0 7.5 14.7 4.3 0.2 0.0 16.6 16.7 0.0 0.0 1.3 1.5 3.0 0.0 14.8 0.0 7.0 0.4 4.6 0.0 0.0 20.5 3.7 21.1 8.4 23.3 51.4 0.0 0.0 3.1 3.7 2.3 0.0 0.0 22.1 0.1 0.1 0.2 0.0 0.6 0.2 0.0 1.0 43.1 1.6 7.2 1.8 15.6 2.4 2.5 14.2 13.1 27.4 10.6 0.5 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.8 0.6 0.3 0.3 1.0 1.8 0.3 0.0 1.7 0.0 5.7 6.0 0.0 0.4 2.5 1.4 7.9 3.5 0.0 3.9 0.0 0.9 13.1 0.6 0.0 0.0 0.7 148.9 84.5 1.0 0.0 0.0 6.7 0.0 9.7 1.8 0.0 4.5 49.8 0.9 16.9 0.0 0.3 26.5 3.2 0.0 60.1 0.0 0.8 0.0 4.1 1.1 8.1 5.5 24.3 0.0 0.0 0.8 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038906-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: AB_2680672" "unprognostic (6.02e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 21.3 7.6 5.8 8.0 12.2 7.9 11.3 12.6 11.4 11.1 8.3 6.3 7.8 7.2 14.1 7.3 11.6 7.5 8.9 9.2 7.2 6.8 9.5 9.4 10.9 6.8 6.4 7.1 9.4 6.3 27.2 9.6 15.0 8.8 7.8 8.4 9.5 8.8 6.4 13.2 6.4 9.5 11.7 8.9 7.9 7.4 8.3 7.0 9.1 11.3 6.3 9.2 12.2 10.1 3.0 10.6 14.6 10.3 7.7 9.6 5.4 9.7 12.7 21.6 22.7 19.5 18.3 21.2 17.6 18.9 18.4 23.8 19.1 22.2 14.0 20.5 16.6 18.3 22.0 20.3 22.0 29.5 6.3 13.3 9.2 19.5 6.9 18.6 16.4 10.8 19.7 21.9 22.0 18.7 15.2 25.7 12.7 10.4 15.2 16.0 6.4 9.1 3.7 11.2 10.4 7.5 8.7 25.6 12.8 11.9 13.8 22.3 24.9 19.3 21.8 17.4 20.0 22.9 8.1 23.3 24.0 16.8 13.2 17.9 15.3 19.6 13.2 12.2 11.3 18.8 8.1 10.3 14.6 6.5 9.8 9.6 3.0 5.6 4.9 10.6 3.0 7.4 5.4 8.4 7.7 7.0 3.8 4.9 5.4 5.8 12.2 12.6 11.4 7.2 6.8 6.4 7.1 8.8 7.0 0.0 0.3 0.0 0.9 5.4 3.3 2.0 0.0 0.0 0.0 5.2 5.9 3.5 1.7 0.9 4.5 4.8 2.0 0.0 1.0 2.4 2.7 1.1 4.6 1.6 1.6 3.2 0.0 0.0 1.2 3.3 1.7 2.5 8.5 1.0 0.6 7.8 0.9 0.0 0.0 1.1 4.3 0.0 3.0 2.1 2.1 4.8 5.0 1.3 0.6 1.4 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA 14000 "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.9 6.4 1.6 5.0 8.7 8.2 10.3 23.4 10.5 8.3 8.2 2.6 14.8 4.2 17.2 14.9 5.0 7.8 4.0 5.1 7.8 16.6 10.9 11.2 4.9 1.1 9.4 41.3 28.1 12.2 6.7 7.5 2.1 3.3 6.5 2.8 8.7 8.6 14.7 3.4 2.5 12.2 1.6 6.3 16.4 5.6 2.4 36.6 3.0 3.9 4.8 7.2 17.2 13.3 4.1 2.0 10.5 16.2 21.3 11.9 4.6 17.6 11.5 27.4 19.2 2.3 15.0 30.0 8.3 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 17.9 31.3 39.5 33.3 19.1 11.9 17.1 12.7 40.2 29.6 21.0 5.9 23.7 16.6 28.2 3.5 25.1 25.5 23.3 24.8 27.2 23.6 39.9 47.4 30.1 192.2 17.5 21.9 39.3 259.8 5.3 11.2 135.3 30.4 15.4 26.6 23.4 26.7 20.1 10.6 25.9 10.0 12.9 15.5 8.8 7.0 22.7 46.8 15.4 24.0 47.5 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 231.7;Early spermatids: 185.4;Late spermatids: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain Approved "Nuclear speckles" Yes No "Nuclear speckles" "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.90e-4)" 17.2 20.7 13.9 14.3 21.3 15.6 18.7 20.4 25.0 18.0 20.9 19.6 16.9 17.4 18.8 18.8 24.1 13.4 14.3 23.5 13.3 14.8 13.3 19.2 17.4 22.0 20.1 16.1 14.4 17.4 24.6 27.9 27.4 18.1 14.8 22.8 32.8 21.3 17.3 26.8 20.8 17.7 16.8 17.9 19.0 21.7 28.6 19.7 15.6 18.0 16.8 18.6 16.8 21.6 8.0 14.9 16.7 16.1 6.3 18.3 8.2 13.8 7.9 9.3 8.8 20.0 12.2 10.9 12.3 11.5 11.9 10.6 15.8 25.4 11.2 10.5 12.5 13.1 13.6 6.5 6.4 12.4 5.1 13.1 11.3 14.9 10.9 9.6 6.0 11.2 14.4 10.5 15.2 6.9 17.3 22.6 15.1 13.5 16.8 15.1 10.6 13.5 9.8 3.9 15.8 4.6 10.7 12.1 23.3 9.2 10.3 9.0 15.2 11.8 16.8 10.5 14.3 29.5 9.2 15.9 21.7 10.7 13.6 10.2 18.7 7.4 17.0 16.8 5.3 14.3 11.2 14.1 11.3 15.2 16.1 6.4 7.5 13.6 15.3 14.9 8.0 8.5 10.6 16.7 6.3 12.5 10.7 18.3 8.2 13.9 21.3 20.4 25.0 13.3 14.8 20.1 16.1 18.1 19.7 11.9 12.3 7.5 17.8 14.9 36.0 15.1 10.2 4.0 14.8 14.0 231.7 33.6 5.0 13.3 185.4 14.8 23.9 0.0 15.9 60.6 17.0 13.3 26.5 15.6 29.3 38.1 16.1 17.2 21.9 141.7 17.0 18.6 18.6 21.6 14.2 18.8 16.6 10.5 13.1 8.7 96.6 6.5 12.8 33.4 10.4 15.1 34.6 17.5 14.3 12.5 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Horizontal cells: 20.6;Syncytiotrophoblasts: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 3.8 3.3 8.8 5.9 15.7 9.0 2.6 18.0 18.7 2.4 7.0 8.5 0.4 10.2 4.3 1.8 3.0 2.4 4.7 5.2 9.0 6.5 3.3 5.7 14.1 5.6 7.9 8.7 2.3 5.1 2.8 4.4 7.2 8.2 3.1 6.4 3.9 3.0 2.3 3.9 17.4 7.5 4.9 5.2 6.9 7.1 5.8 8.6 2.3 5.7 1.8 6.7 3.1 2.5 5.0 7.5 5.5 7.2 2.2 5.8 3.4 9.3 4.3 3.3 7.9 0.3 0.3 5.1 1.9 4.9 3.7 8.7 8.5 12.9 8.4 9.8 0.7 3.6 11.7 6.2 5.0 1.4 10.6 5.5 10.3 6.1 4.4 8.5 5.2 10.1 4.3 2.1 2.1 3.8 3.1 4.3 11.4 2.3 4.6 0.3 1.9 8.7 3.4 5.6 8.2 4.2 10.6 0.5 1.4 1.7 2.5 8.2 7.8 1.8 1.0 4.2 1.2 4.8 3.5 1.3 1.7 2.1 2.1 2.6 1.6 4.1 10.9 9.6 8.6 2.4 0.7 7.2 5.5 5.2 5.3 5.2 5.0 5.0 4.1 7.5 2.8 5.2 5.8 4.4 2.2 3.0 0.8 1.4 3.4 8.8 15.7 18.0 18.7 9.0 6.5 7.9 8.7 8.2 8.6 17.9 9.6 0.0 1.2 0.0 6.8 0.0 2.5 1.4 1.2 1.8 3.9 1.5 0.0 2.4 1.1 2.3 2.9 0.0 3.2 2.5 0.7 1.4 1.1 4.9 15.8 20.6 2.4 4.9 3.5 0.4 0.9 7.8 0.0 4.6 3.9 3.0 2.8 5.7 2.1 1.2 13.5 0.0 0.0 3.4 2.9 0.0 23.8 1.5 6.0 0.9 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.7 13.1 10.2 28.8 20.7 20.9 25.3 22.0 22.5 22.1 8.4 31.1 31.3 15.1 21.7 26.1 57.4 15.6 16.1 22.0 22.3 8.4 10.7 16.1 12.6 20.5 33.8 20.0 18.9 24.4 23.8 18.3 12.6 19.2 17.2 20.3 18.6 29.9 19.7 24.7 19.4 19.2 38.0 13.5 12.4 30.1 10.1 24.0 20.0 12.6 16.6 21.5 25.5 26.7 16.4 11.6 20.0 20.6 23.6 16.7 36.2 23.3 20.6 25.5 8.6 21.0 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 6.0 21.9 13.7 20.2 0.0 11.2 0.0 17.8 13.4 12.5 41.8 3.9 12.4 6.6 15.2 2.6 11.3 7.1 0.0 16.4 22.4 13.2 30.5 3.5 10.4 25.8 4.8 7.0 27.0 63.5 2.1 15.5 18.5 0.0 10.8 26.6 18.1 22.0 15.8 15.2 5.7 9.1 12.9 0.0 10.4 17.5 0.0 16.0 13.8 14.9 41.4 MFSD14C "HIATL2, MGC12945" ENSG00000196312 "Major facilitator superfamily domain containing 14C" Q5VZR4 9 96887373-97013708 "Predicted membrane proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 25.4;Club cells: 38.7;Collecting duct cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 21.3" NA NA "unprognostic (3.81e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.74e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.34e-2)" "unprognostic (4.26e-2)" "unprognostic (1.38e-2)" "unprognostic (8.78e-2)" "unprognostic (3.94e-1)" "unprognostic (3.29e-1)" "unprognostic (5.42e-2)" "unprognostic (3.12e-1)" 6.6 6.0 9.1 8.2 14.1 10.9 10.7 8.1 11.2 9.4 5.0 6.3 4.9 4.8 7.6 10.5 9.3 5.5 7.7 7.3 7.8 5.0 5.2 7.4 8.3 7.3 9.5 6.6 13.0 8.8 4.6 6.0 5.3 6.0 9.9 4.0 7.1 7.9 8.4 8.3 13.2 4.8 10.8 5.9 6.5 8.0 11.3 6.7 4.5 8.1 2.8 6.4 7.3 11.7 2.5 2.9 9.3 2.4 0.7 1.6 0.4 5.3 1.2 2.3 1.3 1.5 8.3 3.3 2.8 0.9 3.4 3.2 3.5 1.9 1.4 0.8 3.7 9.1 4.9 21.3 2.4 4.2 10.8 10.5 9.0 2.5 2.8 0.1 2.0 4.6 3.0 2.9 2.2 1.0 3.2 2.8 4.2 3.2 2.2 7.0 1.0 6.8 1.8 2.2 1.9 6.5 2.2 2.1 0.6 6.6 3.2 11.0 1.1 0.6 1.2 1.8 2.3 1.3 1.9 2.3 5.0 1.6 1.3 1.8 1.2 0.5 4.9 8.4 0.8 2.1 9.3 2.4 2.0 1.5 2.2 0.5 2.5 0.7 0.5 0.8 2.1 1.6 1.4 4.9 0.7 1.4 2.9 0.5 0.4 9.1 14.1 8.1 10.6 7.8 5.0 9.5 6.6 6.0 6.7 20.8 20.5 0.0 4.9 0.0 4.9 0.0 5.1 25.4 38.7 26.2 5.9 1.1 8.3 11.9 5.2 2.0 0.0 0.0 10.8 1.0 0.0 3.6 11.6 0.4 1.5 4.8 0.0 0.0 2.8 1.3 1.4 5.3 0.0 12.6 0.4 2.8 9.6 0.0 1.8 4.5 7.6 0.0 0.0 3.9 5.8 0.0 0.5 0.0 0.4 6.8 MFSD3 ENSG00000167700 "Major facilitator superfamily domain containing 3" Q96ES6 8 144509074-144511213 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056013 Uncertain Approved Vesicles NA NA Vesicles "HPA056013: AB_2683009" "unprognostic (7.92e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (2.00e-1)" "unprognostic (5.18e-2)" "unprognostic (6.50e-2)" "unprognostic (3.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.06e-1)" "unprognostic (5.49e-2)" "unprognostic (5.29e-2)" "prognostic favorable (5.44e-7)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" 7.7 12.3 12.5 7.4 12.5 3.0 7.2 12.0 17.3 5.6 12.7 5.6 19.6 19.8 4.3 12.5 8.0 6.3 10.3 10.2 8.8 9.2 17.7 21.2 8.0 6.4 10.0 15.3 3.5 19.2 14.3 9.7 4.8 10.4 10.5 5.5 5.0 24.0 9.4 23.5 11.3 13.1 3.0 4.6 6.4 12.7 4.1 9.1 4.2 12.8 8.7 5.5 5.8 4.9 4.7 17.2 3.4 6.6 3.2 4.0 3.2 7.8 10.9 2.7 2.3 3.0 2.3 9.0 2.5 2.7 1.4 2.1 3.6 5.6 11.5 8.9 2.4 2.9 7.7 1.3 6.0 0.2 5.4 22.2 3.6 9.7 8.9 5.8 1.7 5.1 3.4 11.4 0.9 4.0 6.3 3.7 8.1 6.8 3.1 3.4 26.3 4.3 9.2 7.3 11.3 18.7 4.9 1.5 20.1 6.7 4.7 20.1 10.1 6.5 16.1 5.4 1.8 16.8 2.5 3.9 1.9 5.1 2.1 3.5 3.1 1.2 3.9 4.1 5.6 3.3 1.6 6.6 3.4 3.7 5.6 3.5 4.7 3.6 3.8 9.9 2.4 3.5 3.5 0.4 3.2 3.1 17.2 4.0 3.2 12.5 12.5 12.0 17.3 8.8 9.2 10.0 15.3 10.4 9.1 3.0 3.0 13.7 9.1 5.4 8.0 8.5 25.5 0.0 3.4 26.2 9.8 13.2 31.5 15.6 0.4 3.7 33.3 23.3 18.4 11.6 4.1 11.3 0.0 16.3 13.7 15.9 19.0 2.5 2.8 0.2 4.0 6.8 8.5 4.6 15.9 14.3 14.0 17.8 4.6 53.6 9.1 0.0 2.3 3.2 12.6 6.1 7.8 2.9 24.5 6.7 MFSD4A "DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064" ENSG00000174514 "Major facilitator superfamily domain containing 4A" Q8N468 1 205568885-205602918 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;kidney: 37.6;stomach 1: 60.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.0;Ciliated cells: 5.3;Club cells: 11.4;Collecting duct cells: 8.7;Distal tubular cells: 11.6;Exocrine glandular cells: 5.6;Proximal tubular cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;HAP1: 2.7;HMC-1: 4.6;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0" NA NA "unprognostic (7.15e-4)" "prognostic favorable (7.54e-4)" "unprognostic (5.60e-2)" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic favorable (4.59e-4)" "unprognostic (2.73e-2)" "unprognostic (1.65e-2)" "unprognostic (3.20e-2)" "unprognostic (6.97e-3)" "prognostic favorable (2.27e-13)" "unprognostic (1.58e-1)" "unprognostic (4.44e-2)" "unprognostic (5.75e-3)" "unprognostic (8.78e-2)" 1.7 0.6 17.3 0.8 10.6 0.3 2.1 18.8 24.9 4.9 7.3 1.3 0.0 1.2 0.8 5.2 1.0 1.6 11.1 0.8 11.9 4.3 37.6 0.5 3.8 0.5 3.6 13.3 0.6 1.0 0.4 3.2 3.5 8.4 1.1 9.5 2.4 8.6 0.6 0.6 3.3 1.1 0.7 2.8 0.6 60.0 0.5 0.2 0.0 0.7 0.8 2.8 0.9 0.8 1.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.8 0.0 0.1 2.1 2.7 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.6 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.2 0.5 5.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 17.3 10.6 18.8 24.9 11.9 4.3 3.6 13.3 8.4 0.2 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 11.4 8.7 0.0 0.5 11.6 1.2 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MFSD4B "KIAA1919, MGC33953" ENSG00000173214 "Major facilitator superfamily domain containing 4B" Q5TF39 6 111259348-111271167 "Predicted membrane proteins" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 40.3;Ciliated cells: 18.7;Club cells: 25.0;Cytotrophoblasts: 18.5;granulocytes: 18.6;Syncytiotrophoblasts: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 15.7" "Low region specificity" "Detected in all" HPA031784 Approved NA NA "HPA031784: AB_10603775" "unprognostic (2.98e-2)" "unprognostic (1.64e-2)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (7.50e-5)" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (6.84e-2)" "unprognostic (2.94e-2)" "unprognostic (3.41e-1)" "unprognostic (6.04e-3)" "unprognostic (9.27e-2)" "unprognostic (3.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.98e-4)" 4.7 5.8 5.3 7.2 8.7 4.6 6.4 5.5 6.6 6.4 8.3 4.1 7.8 9.1 6.8 10.1 5.4 5.9 3.9 5.5 3.4 3.5 13.3 8.4 5.4 5.0 3.2 2.6 5.7 6.2 6.0 12.3 26.1 3.3 5.2 5.3 6.9 7.8 8.0 6.1 8.3 14.6 4.0 3.6 5.9 5.3 9.1 3.0 8.1 6.5 2.7 7.6 5.0 5.3 6.0 4.0 3.6 3.3 2.4 3.7 1.8 1.5 2.6 3.0 6.9 2.3 1.4 5.3 2.0 2.4 2.7 3.5 5.5 2.9 3.9 3.1 1.7 2.6 3.8 5.1 1.9 3.6 3.0 2.2 5.4 4.3 4.4 3.3 4.9 8.7 1.3 4.0 3.3 2.1 3.9 2.1 5.8 6.0 4.9 2.9 2.5 3.4 3.1 2.1 2.4 1.0 3.7 2.1 1.8 4.5 3.2 2.5 2.4 2.3 2.6 1.4 2.9 2.0 4.4 3.1 3.3 2.1 15.7 3.2 3.5 2.7 3.9 4.0 3.1 3.3 3.0 3.3 3.6 3.7 3.1 3.6 6.0 2.1 2.9 2.5 3.9 3.1 3.5 3.5 2.4 2.3 4.0 1.5 1.8 5.3 8.7 5.5 6.6 3.4 3.5 3.2 2.6 3.3 3.0 8.9 40.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 25.0 5.2 0.0 18.5 1.7 4.8 0.0 0.0 0.0 0.0 3.1 10.5 0.0 0.0 18.6 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 4.6 0.0 0.0 3.9 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 MFSD6L FLJ35773 ENSG00000185156 "Major facilitator superfamily domain containing 6 like" Q8IWD5 17 8797162-8799349 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 8.5;testis: 20.1" "Group enriched" "Detected in some" 6 "Early spermatids: 104.1;Late spermatids: 27.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 6 "HMC-1: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA023164 Uncertain NA NA "HPA023164: AB_2142777" "prognostic favorable (1.84e-4)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (3.64e-2)" "unprognostic (1.07e-4)" "unprognostic (3.31e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (7.26e-2)" "unprognostic (3.98e-3)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (7.68e-3)" "unprognostic (1.25e-1)" 0.5 0.0 0.5 3.2 0.5 0.0 0.5 0.5 0.5 1.4 2.1 0.5 0.5 1.8 0.5 0.9 0.5 1.6 0.5 0.5 0.5 0.0 1.1 0.5 2.2 0.5 0.5 0.5 0.5 8.5 4.8 4.3 0.5 0.5 0.5 2.6 0.5 5.5 1.8 0.5 0.2 1.0 0.5 0.5 0.5 3.4 20.1 0.5 0.5 3.1 0.5 0.5 0.7 0.5 0.0 0.3 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.1 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 2.3 0.0 6.0 104.1 0.0 0.0 0.0 6.7 0.1 0.0 0.6 0.0 0.0 0.6 0.0 1.2 0.0 0.8 27.4 0.9 0.0 0.0 0.0 5.8 0.0 3.0 0.0 1.1 0.0 0.0 0.0 0.1 10.7 0.2 0.0 1.3 0.0 3.7 0.6 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102715840-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA055293: AB_2682775, HPA061859: AB_2684627" "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 4.3 4.1 3.0 3.5 3.1 6.2 6.2 12.9 5.2 4.6 8.4 2.4 11.0 11.6 2.8 3.8 7.2 2.7 4.1 3.8 2.3 2.8 7.2 16.2 3.0 4.5 2.3 1.5 3.3 16.8 6.3 10.7 3.4 4.8 3.4 7.9 5.1 9.0 6.8 2.2 4.4 16.0 4.0 2.7 4.8 6.7 2.7 1.7 10.0 5.0 3.9 6.3 5.5 3.5 3.0 4.4 6.4 3.2 4.1 4.3 3.0 3.9 3.3 3.6 6.3 4.2 1.8 8.7 2.6 2.4 3.9 3.9 10.0 6.0 3.2 4.2 1.8 6.4 6.2 4.9 2.6 2.7 13.0 5.0 5.8 3.6 13.1 3.6 4.5 7.7 2.1 6.5 2.7 1.4 3.4 2.6 9.2 3.5 2.0 1.8 3.8 4.3 7.0 3.4 7.8 3.7 3.5 5.6 3.3 6.7 13.5 6.9 5.1 2.6 7.8 7.7 3.9 3.3 6.5 1.9 3.1 5.7 4.2 3.4 4.7 3.7 2.4 2.8 9.7 3.6 3.7 1.2 6.4 4.3 3.2 3.3 3.0 3.4 3.1 2.6 2.7 3.7 3.8 5.0 4.1 1.9 4.4 2.2 3.0 3.0 3.1 12.9 5.2 2.3 2.8 2.3 1.5 4.8 1.7 0.0 1.0 4.4 2.9 3.0 1.5 2.2 2.5 2.7 4.5 7.0 3.9 7.3 0.0 5.3 13.0 1.2 8.4 0.0 7.4 7.2 2.1 3.9 3.5 7.8 4.1 0.0 2.9 0.6 1.2 3.0 0.9 2.1 0.0 4.6 7.9 1.7 8.5 8.6 1.1 2.9 2.6 6.5 1.2 0.9 4.9 3.9 9.6 5.2 6.3 8.0 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Group enriched" "Detected in some" 10 "Early spermatids: 21.0;Late spermatids: 12.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Group enriched" "Detected in some" 8 "OE19: 5.5;RH-30: 4.0" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 4.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MGAT3 GNT-III ENSG00000128268 "Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase" Q09327 22 39457344-39492194 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0;intestine: 27.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 41.7;Bipolar cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 9 "B-cells: 1.7;granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 28.1;HMC-1: 24.3;OE19: 24.3;U-266/70: 31.6;U-266/84: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017598 Approved "Intracellular and membrane" NA NA 78000 "HPA017598: AB_1853853" "unprognostic (1.41e-3)" "unprognostic (5.98e-3)" "unprognostic (4.79e-2)" "unprognostic (2.96e-1)" "unprognostic (2.76e-1)" "unprognostic (5.71e-3)" "unprognostic (8.92e-2)" "unprognostic (2.17e-1)" "unprognostic (4.35e-3)" "unprognostic (6.77e-2)" "unprognostic (8.12e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.04e-8)" "unprognostic (6.73e-2)" "unprognostic (1.46e-1)" "unprognostic (5.89e-2)" "unprognostic (4.92e-2)" 5.3 1.2 17.1 3.9 18.7 9.2 3.6 29.0 24.6 7.1 11.9 8.9 0.0 21.1 3.4 1.2 1.4 4.0 7.9 3.0 18.1 14.9 3.3 0.4 14.9 7.2 13.1 13.4 1.0 3.1 0.9 1.4 10.5 10.7 1.0 4.9 1.7 2.1 1.4 1.6 2.5 27.1 3.2 10.4 3.3 7.8 4.9 9.0 0.2 1.1 0.0 8.9 3.0 2.7 1.7 0.1 3.5 0.2 0.0 0.2 0.1 0.1 0.1 4.6 0.4 0.0 0.0 28.1 0.2 0.3 0.2 0.0 6.2 1.5 9.7 3.4 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.2 7.8 0.0 0.0 0.1 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.4 1.2 0.0 0.1 0.2 0.6 1.3 24.3 0.0 0.4 0.0 1.6 0.2 0.2 2.6 1.9 0.0 0.0 0.0 8.4 0.3 0.4 0.0 0.0 3.7 0.0 0.0 31.6 12.8 13.7 0.0 0.0 0.7 3.5 0.1 3.3 0.1 0.2 0.1 1.7 0.0 0.0 0.1 1.2 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.1 17.1 18.7 29.0 24.6 18.1 14.9 13.1 13.4 10.7 9.0 41.7 4.0 3.7 0.1 0.3 30.0 1.2 2.5 2.7 1.2 0.0 5.9 4.6 0.0 0.0 11.0 2.3 5.2 0.0 0.2 10.1 0.6 0.0 2.3 0.0 1.3 12.7 7.5 0.0 0.0 16.2 4.0 0.7 0.0 0.0 3.2 1.5 1.3 3.4 3.5 1.3 2.3 6.5 1.4 0.7 1.0 0.5 3.1 0.9 3.4 1.3 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0" "Group enriched" "Detected in some" 6 "Early spermatids: 99.1;Late spermatids: 74.0" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016418 Approved Approved "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Vesicles, Plasma membrane" "Centriolar satellite" "HPA016418: AB_2732416" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 1.0 3.0 5.5 1.0 12.3 1.1 0.9 4.9 12.8 1.3 1.2 2.5 0.4 0.9 1.0 10.9 1.1 1.1 1.2 3.6 9.4 3.9 1.0 0.9 1.0 0.9 3.0 9.3 0.9 0.9 0.9 25.9 0.8 10.6 1.1 1.2 0.0 0.9 2.4 0.8 1.0 1.0 1.0 4.3 0.9 1.0 7.8 5.1 0.0 18.0 0.0 0.8 0.9 0.6 0.5 0.3 0.8 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 11.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.8 0.2 0.1 0.3 0.2 0.0 5.5 12.3 4.9 12.8 9.4 3.9 3.0 9.3 10.6 5.1 6.0 0.6 0.0 0.1 0.1 9.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.0 15.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 3.9 0.0 1.6 0.0 0.0 1.7 0.6 0.1 0.0 0.0 0.0 0.3 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "testis: 33.8" "Cell type enhanced" "Detected in some" 33 "Early spermatids: 12.4;Late spermatids: 20.4;Spermatocytes: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced NA NA "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 70.7 1.0 0.0 0.0 0.0 0.0 0.0 MGAT5 GNT-V ENSG00000152127 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase" Q09328 2 134119983-134454621 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010919 Approved NA NA 96000 "HPA010919: AB_10601864" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.21e-2)" "unprognostic (3.65e-1)" "unprognostic (3.76e-1)" "unprognostic (4.45e-3)" "unprognostic (3.41e-3)" "unprognostic (5.68e-2)" "unprognostic (8.63e-3)" "unprognostic (1.59e-1)" "unprognostic (2.64e-1)" "unprognostic (5.97e-2)" "unprognostic (1.81e-2)" "unprognostic (9.27e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-1)" 8.4 9.8 13.0 21.7 15.7 12.0 8.0 21.3 17.6 9.0 13.2 17.2 4.6 14.2 8.5 6.3 8.2 17.5 15.1 33.9 13.9 17.5 14.3 4.9 9.3 20.1 23.6 11.6 11.3 11.1 18.8 7.9 22.0 28.0 7.9 13.8 8.3 11.9 9.1 3.2 6.6 19.2 10.1 28.7 23.1 15.0 6.6 13.2 16.5 10.3 5.1 28.9 11.0 9.2 7.5 1.8 2.3 0.8 2.4 3.1 1.1 10.2 4.1 10.5 7.5 9.4 18.0 7.3 13.7 20.9 5.5 4.7 1.7 5.1 16.5 10.5 10.9 6.3 3.6 8.2 6.4 10.7 16.1 4.8 9.2 5.3 21.4 6.1 8.9 32.9 4.9 6.7 11.6 7.2 7.5 41.3 8.3 4.7 11.3 10.0 6.6 4.8 4.2 4.8 10.7 10.2 6.0 12.4 10.3 4.3 12.6 17.4 21.4 4.4 3.8 26.1 7.4 2.9 6.2 18.6 17.5 9.3 12.7 7.1 3.2 1.5 6.2 14.7 12.8 27.8 1.2 0.7 1.8 1.6 0.7 2.7 5.6 3.1 2.1 0.6 7.5 1.3 1.6 2.3 2.4 0.8 1.8 1.9 1.1 13.0 15.7 21.3 17.2 13.9 17.5 23.6 11.6 28.0 13.2 3.0 3.7 22.6 5.1 7.1 27.7 52.8 5.1 13.4 3.4 1.8 2.0 3.0 0.0 8.0 14.2 11.6 18.6 0.0 7.8 24.2 4.1 7.5 0.0 2.9 12.9 15.9 6.9 11.1 12.7 10.6 4.0 7.3 13.5 1.8 17.2 8.8 10.4 14.2 8.9 2.1 4.7 0.0 11.8 0.3 7.0 6.4 4.5 10.2 9.4 13.2 MICU3 "DKFZp313A0139, EFHA2" ENSG00000155970 "Mitochondrial calcium uptake family member 3" Q86XE3 8 17027238-17122644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 76.0;Horizontal cells: 69.9;Rod photoreceptor cells: 78.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.0;HBF TERT88: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024048, HPA024771, HPA024779" Uncertain NA NA "HPA024048: AB_1848021, HPA024771: AB_1848022, HPA024779: AB_1848023" "unprognostic (2.99e-2)" "unprognostic (7.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.80e-2)" "unprognostic (1.19e-1)" "unprognostic (7.49e-2)" "unprognostic (2.25e-2)" "unprognostic (9.01e-5)" "unprognostic (9.82e-2)" "unprognostic (2.80e-1)" "unprognostic (1.11e-3)" "unprognostic (8.45e-2)" "unprognostic (2.32e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (4.65e-2)" 9.1 11.7 13.7 3.3 18.7 1.4 7.0 34.1 32.3 8.6 4.1 7.7 1.9 2.0 10.4 7.0 5.1 5.4 6.0 6.6 15.4 12.0 7.3 14.8 5.5 4.1 10.5 15.1 12.9 4.6 13.9 13.3 22.1 19.8 9.5 3.5 5.8 5.2 7.5 5.4 2.4 2.7 9.1 10.2 6.9 3.5 7.9 6.3 1.8 7.9 1.3 3.2 6.1 7.5 1.4 0.0 0.1 0.0 0.8 0.9 0.0 0.0 1.1 5.7 2.2 4.4 6.6 1.5 8.4 12.0 6.5 5.3 0.0 0.2 0.1 1.7 4.4 4.6 0.0 2.5 1.7 12.3 0.0 1.5 0.0 0.0 2.1 7.6 0.0 0.3 4.9 0.0 5.5 5.5 6.0 2.5 4.3 0.3 1.6 6.0 0.0 0.7 1.0 4.0 0.0 1.4 0.0 2.6 0.0 4.5 0.0 9.4 4.4 0.0 0.0 3.3 2.6 0.0 0.0 3.1 2.8 1.1 0.4 1.5 1.6 1.2 2.9 5.3 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.4 0.0 0.0 1.4 0.9 0.7 0.0 0.8 0.0 0.0 0.0 0.0 13.7 18.7 34.1 24.3 15.4 12.0 10.5 15.1 19.8 6.3 6.0 5.9 3.9 6.9 0.8 76.0 14.4 5.1 2.7 3.4 5.2 39.3 1.6 6.6 4.2 4.0 4.5 0.0 0.0 2.6 1.1 11.2 5.0 8.1 13.2 0.5 69.9 0.0 4.3 2.1 5.8 25.3 1.0 1.7 2.8 0.0 25.8 3.2 0.0 22.6 3.3 78.8 38.8 26.4 23.6 12.0 1.4 6.1 1.0 0.0 2.0 MISP3 ENSG00000141854 "MISP family member 3" Q96FF7 19 14072536-14075062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 8.9;Collecting duct cells: 14.0;Distal tubular cells: 29.9;Exocrine glandular cells: 9.9;Proximal tubular cells: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.7;gdT-cell: 1.8;neutrophil: 4.8" "Group enriched" "Detected in many" 6 "granulocytes: 4.8;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Karpas-707: 9.7;OE19: 19.9;RPMI-8226: 11.0;U-266/70: 6.7;U-266/84: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042225 Uncertain NA NA "HPA042225: AB_10795396" "unprognostic (1.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.01e-2)" "unprognostic (3.66e-2)" "unprognostic (1.76e-3)" "unprognostic (9.77e-2)" "unprognostic (1.31e-2)" "unprognostic (8.81e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.52e-4)" "prognostic favorable (3.11e-5)" "unprognostic (2.97e-1)" "unprognostic (1.01e-1)" "unprognostic (9.78e-2)" 3.0 2.8 14.7 2.0 11.6 2.6 2.7 16.0 16.0 2.8 11.9 6.8 8.7 16.0 1.9 3.0 2.8 7.8 5.2 6.0 14.3 13.2 12.9 3.6 4.2 1.2 11.8 9.8 1.1 16.2 5.5 2.4 8.6 7.8 4.8 6.5 2.1 17.0 8.6 3.7 6.7 15.4 1.6 10.8 2.0 13.5 1.6 7.2 0.0 3.6 1.4 2.9 2.0 2.2 0.0 0.4 4.8 0.5 0.0 1.8 4.2 3.0 1.6 0.6 1.2 1.1 0.8 0.3 0.2 0.2 0.0 0.2 0.1 0.6 0.2 2.1 0.2 0.1 1.1 1.4 0.0 0.1 3.7 2.7 0.5 0.8 1.5 0.1 0.3 0.6 0.3 0.0 0.1 0.2 1.4 0.3 1.9 0.4 9.7 0.0 5.3 0.5 1.3 0.0 19.9 1.4 0.8 0.3 11.0 2.0 0.0 2.9 0.8 0.0 1.0 1.1 0.1 1.8 0.1 0.2 0.0 0.9 1.0 0.0 6.7 7.4 0.8 1.5 2.4 0.2 0.0 0.5 1.7 1.8 0.2 0.2 0.0 0.5 0.6 0.3 0.0 0.0 0.3 4.8 0.0 0.2 0.4 0.3 4.2 14.7 11.6 16.0 16.0 14.3 13.2 11.8 9.8 7.8 7.2 8.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.4 14.0 0.0 0.2 29.9 1.9 0.0 0.0 0.0 0.0 9.9 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 3.4;Ciliated cells: 6.7;Club cells: 2.3;Peritubular cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "BJ: 19.3;BJ hTERT+: 11.1;BJ hTERT+ SV40 Large T+: 12.7;BJ hTERT+ SV40 Large T+ RasG12V: 8.7;fHDF/TERT166: 55.2;SiHa: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.3 11.1 12.7 8.7 0.0 0.0 0.0 0.0 55.2 0.5 0.0 0.1 0.0 3.4 0.0 1.2 0.0 3.5 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 1.2 0.0 2.4 0.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 8.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 0.0 3.4 0.0 0.0 0.0 0.1 1.4 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 MLNR GPR38 ENSG00000102539 "Motilin receptor" O43193 13 49220338-49222377 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;stomach 1: 2.8;thyroid gland: 5.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;NTERA-2: 3.0;THP-1: 9.2" "Low region specificity" "Detected in many" NA NA "unprognostic (9.75e-2)" "unprognostic (2.13e-2)" "unprognostic (2.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.03e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-2)" "unprognostic (7.79e-2)" "unprognostic (1.88e-2)" "unprognostic (3.74e-1)" "unprognostic (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.38e-1)" 0.1 0.1 0.2 0.0 0.2 3.9 0.0 0.0 0.1 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.1 2.8 0.4 5.6 0.0 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.8 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392613-55421992 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.1;brain: 40.5;breast: 46.0" "Cell type enhanced" "Detected in many" 6 "monocytes: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;HSkMC: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles NA NA Vesicles "HPA026978: AB_2672068" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.52e-5)" "prognostic unfavorable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.12e-2)" 61.1 6.6 33.4 7.1 40.5 5.3 46.0 2.0 23.7 2.6 5.6 4.1 1.7 5.0 3.2 4.9 3.6 1.8 4.7 5.0 26.9 7.5 3.2 6.0 4.7 9.0 11.2 5.1 1.5 1.6 0.9 2.1 13.4 4.6 3.2 6.5 3.2 2.2 4.1 2.5 2.5 4.7 5.4 6.5 8.7 2.4 7.8 5.0 1.4 3.3 1.2 5.6 5.7 4.1 4.1 3.6 9.6 1.6 2.2 4.2 15.9 5.1 13.2 19.5 3.8 32.8 25.9 9.6 3.2 1.5 2.0 3.0 2.0 15.3 7.4 9.4 1.1 5.8 0.3 5.4 4.1 4.3 9.7 1.9 2.7 0.7 23.9 8.8 2.6 0.8 59.3 1.3 2.9 3.3 4.6 2.6 7.2 0.9 5.9 4.3 0.7 7.3 1.9 5.3 0.9 3.4 2.9 12.6 2.7 5.7 1.4 1.8 18.6 1.1 2.0 2.9 12.7 4.3 4.7 2.4 5.4 6.5 4.3 3.6 2.6 1.3 10.4 7.8 2.2 4.3 9.6 1.3 1.5 1.4 1.6 4.2 3.6 1.6 2.9 3.6 4.1 2.7 2.9 3.8 2.2 1.5 1.1 1.7 15.9 33.4 40.5 2.0 16.9 26.9 7.5 11.2 5.1 4.6 5.0 3.0 1.1 10.5 17.0 4.7 24.9 4.3 7.6 0.0 1.2 7.0 3.9 8.1 13.3 22.9 2.1 11.3 2.6 46.7 1.2 13.7 8.0 18.3 0.0 17.0 32.6 15.9 7.5 10.4 35.9 2.5 1.7 28.4 6.8 74.9 5.8 11.5 12.0 0.0 3.2 7.1 9.3 19.4 5.2 15.6 16.0 15.3 16.7 12.5 7.9 4.0 MMEL1 "MMEL2, NEPII, NL1, NL2, SEP" ENSG00000142606 "Membrane metalloendopeptidase like 1" Q495T6 1 2590639-2632990 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.2" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 8.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007876, HPA008205, CAB020786" Uncertain "Intracellular and membrane" NA NA "CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011" "unprognostic (5.80e-2)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (4.27e-2)" "unprognostic (1.33e-1)" "unprognostic (2.71e-2)" "unprognostic (1.45e-1)" "unprognostic (7.96e-2)" "unprognostic (1.36e-2)" "unprognostic (2.37e-1)" "unprognostic (4.54e-3)" "unprognostic (2.44e-2)" "unprognostic (4.79e-2)" "unprognostic (3.18e-1)" "unprognostic (2.82e-1)" "unprognostic (2.18e-3)" "unprognostic (7.01e-4)" 1.5 0.5 0.8 1.8 8.5 0.6 1.8 0.4 0.6 4.3 4.2 0.4 1.9 3.2 0.8 10.3 3.0 3.0 9.6 1.3 1.0 2.6 1.4 0.4 1.4 1.4 1.7 0.4 1.1 7.3 0.3 0.4 0.7 0.5 4.2 1.4 0.4 2.0 2.0 0.4 0.3 2.6 0.9 0.7 1.4 7.9 30.2 0.9 0.8 1.1 0.8 0.8 3.7 1.6 0.6 1.1 6.6 5.1 2.3 6.1 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.5 0.0 17.8 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.5 6.6 0.5 3.9 0.3 0.6 1.7 0.7 1.1 0.0 4.5 2.2 1.0 2.3 5.1 0.2 6.1 2.2 0.8 8.5 0.4 0.6 1.0 2.6 1.7 0.4 0.5 0.9 0.0 0.0 0.0 4.6 0.0 0.0 0.8 28.1 10.7 2.3 17.4 0.0 0.0 0.0 7.1 82.5 0.6 15.7 0.0 3.1 0.0 0.3 12.4 0.0 0.0 1.3 0.0 1.2 0.6 1.5 27.3 1.7 0.5 0.0 0.0 14.9 0.5 2.7 37.7 1.1 0.0 0.0 0.0 0.4 0.5 0.9 0.0 0.0 0.0 9.7 10.9 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125766453-125775821 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets, Heterotaxy" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "epididymis: 37.6" "Cell type enhanced" "Detected in single" 32 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.8" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.1 0.1 0.4 0.1 0.3 0.7 0.0 0.1 0.2 0.1 0.1 37.6 0.1 0.4 0.2 0.9 0.0 0.4 0.1 1.0 0.1 0.1 0.0 2.8 0.8 0.0 0.3 0.0 0.6 0.1 0.5 0.1 0.0 0.1 0.5 0.1 0.0 0.7 0.2 0.1 0.6 0.1 0.2 0.0 1.1 0.0 0.0 0.1 0.5 0.6 0.0 0.1 0.0 0.0 0.8 0.3 0.0 1.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.7 0.0 2.1 1.8 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MMP26 "endometase, MGC126590, MGC126592" ENSG00000167346 "Matrix metallopeptidase 26" Q9NRE1 11 4704927-4992429 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "endometrium 1: 19.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "endometrial cancer: 8.8;prostate cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (4.21e-3)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9" "Lineage enriched" "Detected in many" 5 "T-cells: 7.2" "Cell line enriched" "Detected in some" 7 "HaCaT: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" NA NA Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 8.0 1.6 1.8 2.7 3.7 0.5 4.3 0.0 5.1 1.7 7.3 1.6 1.4 3.0 3.2 4.8 4.3 1.5 12.3 0.5 2.8 0.8 0.2 10.3 0.4 0.0 2.9 0.1 1.3 0.5 0.0 0.7 1.3 2.9 4.1 2.7 0.1 2.1 0.6 4.5 9.3 4.3 0.2 0.6 7.2 13.4 0.2 0.0 4.2 4.4 2.5 5.5 2.2 1.1 1.5 0.1 0.2 1.3 7.2 0.9 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.7 0.0 0.1 28.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.0 3.9 0.2 0.6 0.0 0.0 0.0 1.6 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.0 1.1 0.4 1.7 0.1 0.9 7.2 5.9 0.1 1.3 0.2 1.5 0.0 0.9 26.8 20.8 0.0 5.1 34.2 0.4 1.0 2.5 5.3 5.7 7.0 0.0 0.0 0.0 0.1 5.0 8.1 39.1 0.0 0.3 0.0 1.6 1.8 0.0 0.0 0.1 1.6 3.5 6.2 0.0 7.1 1.1 0.9 3.3 0.0 31.9 9.1 9.7 47.6 2.8 0.7 0.5 6.5 2.0 0.5 2.5 29.0 0.0 0.7 18.5 34.5 MOGAT1 "DGAT2L, DGAT2L1, MGAT1" ENSG00000124003 "Monoacylglycerol O-acyltransferase 1" Q96PD6 2 222671786-222709930 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "gallbladder: 40.9" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 5.1;Exocrine glandular cells: 4.5;Hepatocytes: 2.1;Muller glia cells: 2.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.4" "Cell line enhanced" "Detected in single" "Hep G2: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049944 Uncertain NA NA "HPA049944: AB_2680964" "unprognostic (6.32e-2)" "unprognostic (2.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.41e-1)" "unprognostic (4.28e-3)" "unprognostic (4.39e-2)" "unprognostic (4.32e-2)" "unprognostic (9.44e-2)" "unprognostic (1.91e-1)" "unprognostic (8.59e-2)" "unprognostic (3.07e-3)" "unprognostic (4.99e-2)" "unprognostic (3.89e-1)" "unprognostic (9.03e-3)" 2.3 0.1 0.6 0.1 0.5 0.1 1.3 0.2 0.9 0.3 0.6 0.5 0.2 0.0 1.0 1.1 0.5 0.1 40.9 0.8 0.5 0.2 5.7 7.6 1.1 0.3 0.2 0.9 0.1 1.5 2.3 0.4 0.0 0.9 0.2 0.1 0.0 1.4 2.6 0.5 1.6 0.2 0.1 0.3 0.1 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.5 0.2 0.9 0.5 0.2 0.2 0.9 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 2.2 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305200 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027292 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 5.9 6.8 12.9 2.7 17.3 3.7 7.8 9.7 15.9 7.6 3.6 8.7 6.2 4.7 7.6 10.2 3.9 26.4 6.4 8.3 13.5 10.2 7.7 3.6 6.1 2.5 6.0 13.7 12.4 8.6 9.4 22.1 3.6 16.6 5.1 3.0 15.2 6.1 5.4 1.9 8.6 4.1 5.9 6.2 3.8 11.7 45.0 6.2 0.4 11.7 2.3 2.2 6.2 3.9 0.7 3.9 0.9 1.1 10.6 2.4 1.3 3.4 3.0 0.4 1.7 0.7 2.5 0.7 7.0 2.0 10.1 12.2 0.2 8.4 2.6 0.5 1.3 2.2 0.7 0.6 3.6 28.6 2.9 2.6 0.6 0.4 2.3 3.1 0.3 3.4 2.1 0.9 72.8 6.7 7.9 0.3 0.5 0.6 0.1 6.6 2.3 0.2 90.6 0.1 1.5 7.4 0.4 0.2 0.0 4.1 0.1 1.1 0.7 1.2 0.4 19.6 0.1 2.1 0.2 0.2 38.5 1.9 1.4 2.2 0.2 0.4 0.2 7.7 0.2 17.4 0.0 1.1 0.0 0.7 0.7 1.2 0.0 0.5 1.9 3.9 0.7 1.1 2.4 0.9 10.6 0.1 0.0 0.0 1.3 12.9 17.3 9.7 15.9 13.5 10.2 6.0 13.7 16.6 6.2 17.9 17.4 0.5 6.5 9.5 36.2 12.2 10.2 214.2 43.3 12.2 174.7 1.0 5.0 7.0 171.0 6.7 3.8 0.0 14.2 2.1 7.6 3.6 3.5 1.7 2.0 15.9 4.6 7.4 1.8 130.3 28.1 4.2 75.9 0.0 2.0 58.0 5.6 0.0 15.2 8.1 441.5 25.8 12.1 81.9 27.2 5.1 1.0 6.7 3.8 3.0 MORC1 "CT33, MORC, ZCW6" ENSG00000114487 "MORC family CW-type zinc finger 1" Q86VD1 3 108958239-109118142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 21.0" "Group enriched" "Detected in some" 5 "Early spermatids: 45.5;Late spermatids: 21.8;Spermatocytes: 37.7;Spermatogonia: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.0" "Group enriched" "Detected in some" 10 "Karpas-707: 4.4;RPMI-8226: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036413 Enhanced NA NA "HPA036413: AB_10669989" "unprognostic (1.66e-1)" "unprognostic (4.30e-2)" "unprognostic (2.17e-2)" "unprognostic (2.63e-1)" "unprognostic (7.45e-6)" "unprognostic (4.80e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 2.2 21.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 37.7 41.6 0.0 0.0 0.0 0.0 0.1 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 34.8;Rod photoreceptor cells: 21.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: AB_2686299" "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 4.2 4.0 6.9 5.6 15.1 2.5 4.9 25.8 6.6 7.3 4.4 6.1 14.4 4.5 9.3 13.9 3.7 23.5 7.4 3.0 5.5 5.7 7.8 4.1 5.8 3.5 3.9 8.0 15.2 8.6 4.9 11.6 2.5 11.7 6.7 3.1 8.8 9.1 11.7 4.7 6.4 4.3 6.0 4.9 4.6 5.4 17.3 4.8 5.8 15.0 3.3 3.8 3.5 4.6 2.1 3.7 4.2 4.3 0.8 2.6 1.0 6.4 7.8 5.4 4.9 1.9 0.9 5.6 2.0 1.4 3.2 2.7 3.7 7.3 1.7 4.2 1.2 2.4 8.0 1.1 3.1 3.1 3.9 8.3 1.7 14.3 4.2 1.6 2.1 0.9 1.1 0.7 3.0 2.7 2.4 2.2 3.4 2.7 2.0 1.1 8.9 2.1 0.8 3.2 3.4 6.9 2.2 5.0 2.7 2.5 2.9 8.9 4.3 5.2 9.5 4.1 2.5 5.0 0.6 0.7 3.7 5.3 2.6 2.3 4.8 1.7 1.1 7.4 1.3 2.5 0.0 0.8 0.2 1.4 0.3 0.8 1.0 1.5 1.1 1.0 2.1 2.6 1.2 4.2 0.8 4.3 3.7 0.1 1.0 6.9 15.1 25.8 6.6 5.5 5.7 3.9 8.0 11.7 4.8 3.0 2.7 1.5 3.6 1.4 8.5 3.2 5.1 34.8 4.5 14.0 19.6 3.1 3.3 1.8 16.8 1.0 2.1 0.0 1.2 1.4 2.1 2.7 5.7 1.0 2.3 9.5 5.2 1.8 0.6 19.5 2.3 0.6 1.7 1.0 0.6 8.4 1.4 0.0 2.8 7.9 21.9 0.0 2.0 19.2 5.9 1.9 1.6 0.8 1.9 2.3 MORN5 "C9orf113, C9orf18, FLJ46909" ENSG00000185681 "MORN repeat containing 5" Q5VZ52 9 122159908-122200088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 56.9;testis: 52.1" "Group enriched" "Detected in many" 6 "Ciliated cells: 386.8;Early spermatids: 358.0;Late spermatids: 462.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;HHSteC: 3.2;JURKAT: 1.4;NB-4: 5.0;RPTEC TERT1: 1.3;U-87 MG: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.24e-3)" "unprognostic (7.30e-3)" "unprognostic (1.12e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (7.80e-3)" "unprognostic (1.91e-3)" "unprognostic (3.25e-3)" "unprognostic (2.64e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.95e-1)" 0.2 0.2 2.8 0.5 4.1 0.1 0.3 0.3 2.1 1.8 10.7 4.5 2.1 0.6 2.9 5.3 1.3 56.9 2.2 0.2 3.1 3.4 0.8 0.1 5.4 0.2 1.1 2.7 4.1 0.4 1.8 3.8 0.2 9.2 0.6 3.1 0.7 0.9 2.2 0.1 0.1 1.2 8.8 0.9 0.1 2.1 52.1 1.3 0.0 0.2 0.0 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 1.4 0.1 0.0 0.0 0.0 0.0 5.0 0.0 1.1 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 4.1 0.3 2.1 3.1 3.4 1.1 2.7 9.2 1.3 0.0 2.2 0.0 0.1 0.0 0.9 0.0 0.0 386.8 28.4 3.5 2.0 0.0 0.0 0.1 358.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 1.6 0.0 0.0 0.0 462.5 6.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.9 2.2 4.7 0.0 0.0 68.8 4.5 0.0 0.0 0.0 0.0 0.0 MOSMO "ATTHOG, BC030336, C16orf52" ENSG00000185716 "Modulator of smoothened" Q8NHV5 16 22007638-22087534 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 2: 6.7;Club cells: 9.1;Collecting duct cells: 5.2;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 6.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (2.78e-2)" "unprognostic (8.84e-2)" "unprognostic (5.50e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-2)" "unprognostic (2.22e-3)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (2.75e-1)" 10.7 23.3 9.7 9.2 14.3 2.5 11.9 19.0 25.6 11.8 8.3 9.3 13.9 8.4 13.8 8.6 10.5 9.4 11.3 11.1 11.3 11.6 9.5 13.9 11.2 10.1 10.8 10.0 14.2 8.1 26.6 18.3 13.3 12.8 11.9 8.9 9.2 9.3 13.6 10.9 10.3 7.4 10.6 9.3 9.5 10.4 10.3 9.5 8.2 10.4 5.8 9.8 9.0 15.1 2.4 0.7 1.2 0.9 1.0 1.9 0.2 5.8 2.2 4.1 3.2 7.4 15.2 2.9 6.2 7.4 3.3 5.0 1.9 3.8 3.0 2.5 6.4 5.2 3.3 2.6 6.4 6.1 7.1 2.9 2.5 4.3 7.0 6.8 2.1 3.9 8.7 4.4 4.9 12.1 5.6 7.8 2.5 1.7 7.9 14.2 3.6 2.0 1.8 3.0 2.8 5.5 4.4 4.2 3.0 3.0 2.9 2.8 4.9 3.2 1.6 10.9 4.3 3.4 2.2 4.4 6.3 4.7 4.5 2.7 4.0 3.6 2.0 4.5 2.6 29.8 0.9 0.7 1.2 1.2 0.9 1.0 0.9 0.5 0.6 0.1 2.4 1.0 1.1 0.4 1.0 0.8 0.7 1.9 0.2 9.7 14.3 19.0 25.6 11.3 11.6 10.8 10.0 12.8 9.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 9.1 5.2 0.0 4.6 1.7 3.6 0.0 0.0 0.0 0.0 4.9 3.6 0.0 0.0 2.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.5 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887626-134915267 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 80.8;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 11.0 19.7 6.2 6.5 8.0 12.3 7.9 7.8 10.4 11.1 6.9 8.8 5.5 5.4 19.3 12.5 20.5 25.1 6.6 17.4 7.3 6.2 11.8 10.3 8.0 5.5 9.9 7.4 12.9 8.9 10.3 8.1 23.2 21.2 8.1 7.0 10.3 14.6 7.6 17.6 14.5 6.9 10.7 9.0 8.3 7.5 16.4 7.5 10.2 9.1 13.5 10.1 9.5 12.0 6.2 8.3 12.3 6.8 6.0 14.3 5.1 7.7 6.1 5.2 3.6 8.2 4.8 11.3 13.1 23.8 12.6 12.3 15.0 3.1 2.6 18.3 8.3 22.9 2.8 8.0 6.8 16.7 8.7 4.7 2.2 16.2 6.0 34.9 6.1 3.8 8.7 8.3 14.2 6.1 14.4 9.2 5.4 2.7 10.7 15.2 10.8 4.3 2.8 5.3 4.1 13.9 3.3 9.2 4.8 5.4 22.3 3.1 3.8 6.6 6.7 22.5 26.3 2.7 3.8 4.6 6.2 3.8 23.2 11.6 8.3 11.1 4.2 8.5 10.6 8.1 6.0 6.8 12.3 7.6 5.0 10.0 6.2 9.0 8.3 7.5 5.1 10.2 9.8 4.0 6.0 5.5 8.3 14.3 5.1 6.2 8.0 7.8 10.4 7.3 6.2 9.9 7.4 21.2 7.5 6.0 4.3 6.7 9.8 18.9 9.0 42.3 5.1 16.0 6.8 10.4 2.0 6.1 18.3 21.3 80.8 12.7 5.7 46.7 10.7 12.5 9.1 9.7 5.7 4.9 13.2 4.8 4.1 13.5 11.4 57.7 6.4 7.2 28.7 5.4 7.2 8.3 17.9 11.5 10.3 20.2 9.0 6.5 15.3 3.0 5.3 17.9 21.9 10.1 6.6 8.1 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: AB_2680325" "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 6.0 8.2 6.6 11.4 3.5 2.6 4.7 4.6 5.5 4.8 4.9 7.6 8.1 3.8 10.2 4.2 6.8 4.7 3.8 6.6 0.9 9.8 5.1 3.9 6.1 11.4 4.5 3.0 15.1 7.4 5.7 4.1 2.4 4.2 8.2 6.4 9.1 7.8 4.9 17.9 8.4 23.0 6.0 7.9 12.4 7.9 6.9 9.1 7.6 9.1 3.6 21.7 8.6 13.4 4.6 2.8 8.1 8.9 9.2 9.3 14.7 19.3 4.4 6.2 5.8 2.6 9.3 33.7 11.4 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 8.9 6.5 11.9 14.9 10.8 6.6 3.2 17.8 9.4 4.5 19.2 5.9 6.0 36.5 33.9 271.2 15.7 8.7 0.0 37.6 23.2 22.0 20.1 3.5 26.2 25.2 6.4 20.7 19.0 23.0 1149.7 25.6 15.1 25.3 14.4 14.9 11.4 39.0 17.5 20.5 35.7 3.4 12.9 20.0 17.7 21.5 17.1 5.1 29.3 16.9 17.8 MOV10L1 "CHAMP, DJ402G11.8, DKFZp434B0717" ENSG00000073146 "Mov10 RISC complex RNA helicase like 1" Q9BXT6 22 50089879-50161690 "Enzymes, Predicted intracellular proteins" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 27.7" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 110.5;Late spermatids: 224.1;Spermatocytes: 68.2;Spermatogonia: 38.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 3.3;HUVEC TERT2: 16.1;TIME: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019034 Approved NA NA "HPA019034: AB_1854070" "unprognostic (1.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.88e-2)" "unprognostic (7.91e-2)" "unprognostic (4.29e-2)" "unprognostic (4.05e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (9.43e-2)" "unprognostic (7.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.03e-1)" "unprognostic (8.02e-3)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" 0.4 0.1 0.7 0.2 1.5 0.3 0.2 1.3 1.3 0.9 0.8 0.6 0.2 0.1 3.0 2.0 0.4 1.0 1.2 0.3 0.9 0.6 0.3 1.0 0.3 0.2 0.5 1.5 1.8 0.2 0.1 0.4 0.6 2.1 1.0 0.2 0.6 0.2 0.2 0.2 0.3 0.4 1.9 0.7 0.2 0.1 27.7 0.2 0.2 0.5 0.2 0.3 0.4 2.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 0.5 1.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 3.3 0.0 1.5 0.2 0.0 0.0 0.0 0.2 16.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 1.3 1.3 0.9 0.6 0.5 1.5 2.1 0.2 0.0 0.0 0.0 0.1 0.2 2.4 1.4 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 110.5 1.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 1.4 4.8 0.0 0.0 0.0 224.1 1.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.8 0.8 3.8 12.9 0.0 68.2 38.5 0.0 0.1 0.0 0.0 0.0 MPC1L SLC54A3 ENSG00000238205 "Mitochondrial pyruvate carrier 1 like" P0DKB6 X 40623566-40624136 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 26.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.1;BJ hTERT+: 1.1;PC-3: 1.9;U-2197: 1.4" "Not detected" "Not detected" NA NA "unprognostic (8.47e-4)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPEG1 MPG1 ENSG00000197629 "Macrophage expressed 1" Q2M385 11 59208510-59212951 "Predicted membrane proteins, Transporters" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.3;lymphoid tissue: 108.6" "Cell type enriched" "Detected in many" 5 "Kupffer cells: 355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3" "Group enriched" "Detected in many" 6 "dendritic cells: 38.3;monocytes: 47.3" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HMC-1: 1.3;THP-1: 3.8" HPA046801 Approved NA NA "HPA046801: AB_2679814" "unprognostic (1.24e-1)" "unprognostic (2.17e-3)" "unprognostic (1.05e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-2)" "unprognostic (2.79e-3)" "unprognostic (7.82e-2)" "unprognostic (1.41e-2)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (5.48e-2)" "unprognostic (3.51e-1)" "unprognostic (1.48e-1)" "unprognostic (9.38e-2)" "unprognostic (2.48e-2)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" 17.6 6.4 2.2 27.7 2.1 3.6 5.9 1.3 1.8 3.3 9.5 4.9 0.9 9.0 3.2 13.2 3.7 4.9 8.2 7.7 2.2 2.3 7.0 17.3 13.1 51.3 2.6 1.0 4.2 2.7 0.8 2.3 13.4 2.5 5.6 10.0 8.9 7.5 2.4 2.9 2.6 20.6 6.0 3.9 108.6 4.0 3.2 1.7 18.5 3.7 5.5 23.0 11.0 2.7 2.9 38.3 7.0 47.3 0.2 0.1 29.1 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.5 0.5 0.1 0.0 0.5 0.4 0.7 0.0 0.5 0.3 0.5 0.2 0.0 0.0 0.0 0.0 3.8 0.5 0.0 0.2 0.4 0.0 0.9 0.1 0.5 0.0 0.2 0.1 0.0 47.3 1.4 0.1 38.9 0.1 2.4 0.0 0.0 26.6 2.9 0.0 0.0 7.0 0.2 41.6 38.3 0.1 29.1 2.2 2.1 1.3 1.8 2.2 2.3 2.6 1.0 2.5 1.7 0.0 12.2 29.3 0.0 1.0 0.0 1.2 2.5 1.4 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.9 0.0 2.3 1.7 41.8 0.0 0.0 6.2 355.6 0.0 0.0 71.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 6.5 0.3 0.0 0.0 1.4 0.2 0.0 0.0 0.0 MPPED1 "239AB, C22orf1, FAM1A" ENSG00000186732 "Metallophosphoesterase domain containing 1" O15442 22 43411196-43507848 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 33.0;liver: 11.0" "Group enriched" "Detected in some" 6 "Hepatocytes: 8.9;Peritubular cells: 7.1" "Cancer enhanced" "Detected in some" "liver cancer: 1.6" "Group enriched" "Detected in many" 4 "amygdala: 9.3;basal ganglia: 11.0;cerebral cortex: 32.1;hippocampal formation: 16.2;olfactory region: 17.4" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 16 "dendritic cells: 1.8;granulocytes: 1.3" "Group enriched" "Detected in some" 5 "HaCaT: 11.9;SCLC-21H: 4.9" "Group enriched" "Detected in many" 5 "amygdala: 108.6;basal ganglia: 66.9;cerebral cortex: 165.8;hippocampal formation: 190.7" "Group enriched" "Detected in all" 5 "cerebral cortex: 131.1;hippocampal formation: 116.7" NA NA "unprognostic (1.15e-1)" "unprognostic (4.29e-1)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (9.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.47e-2)" "unprognostic (2.04e-1)" "unprognostic (3.19e-1)" "unprognostic (4.46e-4)" "unprognostic (1.09e-1)" "unprognostic (4.32e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-1)" "unprognostic (6.92e-3)" 0.5 0.8 9.3 0.6 11.0 0.5 0.8 0.5 33.0 0.6 0.6 0.8 0.0 0.7 1.2 1.2 0.5 0.7 0.5 0.7 16.2 2.2 0.6 11.0 0.5 0.6 3.8 17.4 1.9 0.5 0.5 0.9 0.5 0.7 1.2 0.6 0.0 0.6 0.6 0.5 1.4 0.7 0.6 2.9 0.6 0.9 2.1 0.1 0.0 0.5 0.0 0.6 0.6 0.1 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 9.3 11.0 0.5 32.1 16.2 2.2 3.8 17.4 0.7 0.1 0.0 0.0 0.0 0.0 0.5 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 MRGPRD mrgD ENSG00000172938 "MAS related GPR family member D" Q8TDS7 11 68980021-68980986 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "JURKAT: 4.7" "Not detected" "Not detected" HPA031346 Uncertain NA NA "HPA031346: AB_10602710" "unprognostic (1.92e-1)" "unprognostic (7.14e-2)" "unprognostic (1.72e-1)" 0.4 0.4 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.9 2.5 0.0 1.8 0.0 0.9 0.9 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.2 0.0 0.1 0.8 1.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3227698-3232386 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 34.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in many" 14 "pons and medulla: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 2.6;RPMI-8226: 5.0;SCLC-21H: 8.2" "Low region specificity" "Detected in many" HPA046556 Uncertain NA NA "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.1 0.8 0.1 0.1 0.3 2.1 0.8 1.5 2.0 3.5 0.8 0.0 0.0 0.0 2.0 0.7 0.6 1.7 0.5 1.1 0.6 2.3 0.1 0.0 0.3 0.0 2.5 0.0 0.1 0.3 0.0 0.5 1.8 34.9 1.1 0.0 3.9 1.6 1.3 0.1 0.3 0.3 0.5 1.5 1.9 0.1 0.2 0.1 0.0 0.9 0.2 0.0 0.6 1.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 8.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.1 0.3 1.5 2.0 0.6 2.3 2.5 0.0 34.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013409 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2" "Region enriched" "Detected in some" 5 "cerebellum: 16.6" "Low region specificity" "Detected in all" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 10.8 1.7 0.8 7.6 1.2 0.0 26.6 7.8 1.5 61.9 39.5 1.2 13.9 4.8 49.2 22.3 28.2 28.0 30.6 6.2 0.7 0.4 4.2 2.1 4.8 5.6 1.1 1.3 25.6 0.9 0.4 1.1 5.9 1.8 29.6 4.8 5.8 2.9 25.5 3.1 4.0 10.1 41.1 1.0 8.2 14.2 13.1 0.6 0.1 3.8 6.4 2.7 42.2 19.6 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.8 12.0 0.5 15.1 38.1 14.3 9.5 0.0 0.6 0.0 0.3 11.6 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.1 0.0 3.3 0.0 0.0 8.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 18.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 7.8 1.5 0.7 0.4 1.1 1.3 1.8 0.6 0.0 0.0 0.0 0.2 4.4 0.0 0.6 2.5 0.0 0.0 10.4 0.0 0.6 0.0 0.0 3.6 0.6 0.0 0.0 0.0 0.6 34.7 0.3 0.0 3.4 0.9 0.0 0.0 5.5 0.0 5.2 61.2 0.0 6.8 0.0 0.0 2.8 0.1 0.0 94.7 0.6 0.2 51.8 90.4 1.0 0.5 3.3 0.9 0.0 0.0 0.2 MRGPRG "GPR169, mrgG" ENSG00000182170 "MAS related GPR family member G" Q86SM5 11 3217944-3218813 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NB-4: 1.1;REH: 2.6;SCLC-21H: 4.0" "Not detected" "Not detected" HPA058909 Uncertain NA NA "HPA058909: AB_2683852" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRX3 MRGX3 ENSG00000179826 "MAS related GPR family member X3" Q96LB0 11 18120955-18138480 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 10.3;salivary gland: 7.9;tongue: 4.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HBEC3-KT: 18.2" NA NA "unprognostic (1.54e-3)" "unprognostic (5.07e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.8 0.1 0.4 10.3 0.1 0.3 0.3 0.1 0.1 0.1 0.3 0.1 0.1 3.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.1 0.9 0.1 0.1 0.1 4.4 1.4 0.1 0.5 0.1 0.2 1.6 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 2.6 0.4 0.0 18.2 0.0 0.1 0.3 0.0 0.1 0.6 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.7 0.4 0.2 0.3 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.7 0.1 0.0 0.8 0.2 0.2 0.5 0.4 0.2 0.1 1.9 1.2 0.4 0.2 0.7 0.2 0.1 0.2 0.3 0.5 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 MRGPRX4 MRGX4 ENSG00000179817 "MAS related GPR family member X4" Q96LA9 11 18172837-18174280 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "melanoma: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SK-MEL-30: 4.4;WM-115: 5.7" NA NA "unprognostic (2.10e-2)" 0.1 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.5 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRO "B29, C18orf3, FLJ30140" ENSG00000134042 Maestro Q9BYG7 18 50795120-50825402 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;kidney: 24.3;testis: 30.9" "Group enriched" "Detected in some" 4 "Ito cells: 55.9;Kupffer cells: 14.2" "Cancer enriched" "Detected in some" 7 "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 4.6;ASC TERT1: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022011 Approved NA NA "HPA022011: AB_2670880" "unprognostic (9.21e-5)" "unprognostic (5.22e-2)" "unprognostic (7.87e-3)" "unprognostic (1.45e-2)" "unprognostic (2.47e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.32e-1)" "unprognostic (4.71e-1)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (3.99e-3)" "unprognostic (6.06e-4)" 2.7 3.2 12.2 0.9 13.9 0.6 1.0 4.5 17.5 0.7 0.7 13.9 1.0 8.3 0.5 4.1 0.9 0.7 1.7 4.4 15.4 5.9 24.3 7.7 0.7 0.7 9.1 10.3 3.8 2.2 3.8 1.3 1.2 11.1 0.7 0.6 1.6 0.7 2.7 2.4 0.5 5.3 0.7 10.7 2.5 1.8 30.9 12.4 0.0 6.6 0.0 0.5 0.8 0.6 0.8 0.9 2.1 1.2 0.5 0.4 0.0 0.0 0.0 0.1 0.3 4.6 14.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.0 0.5 0.2 0.3 0.9 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.1 0.5 1.2 0.9 0.2 0.0 12.2 13.9 4.5 11.2 15.4 5.9 9.1 10.3 11.1 12.4 0.0 0.0 2.2 0.1 0.0 0.0 5.3 2.5 0.0 0.0 0.0 2.0 0.0 5.0 0.0 0.5 0.0 0.0 0.0 0.9 0.6 0.2 0.1 0.0 4.3 8.7 0.0 0.0 55.9 14.2 2.2 1.1 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.7 7.5 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 MROH1 "HEATR7A, KIAA1833" ENSG00000179832 "Maestro heat like repeat family member 1" Q8NDA8 8 144148016-144261940 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024287, HPA044465" Approved Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024287: , HPA044465: AB_10960985" "unprognostic (1.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (6.74e-4)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.48e-2)" "unprognostic (6.64e-2)" "unprognostic (1.92e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-2)" 5.7 7.5 11.9 7.6 10.0 19.7 6.1 17.8 16.0 6.0 8.5 4.5 13.0 16.7 5.4 7.3 9.2 6.8 7.0 5.4 7.0 6.0 8.3 5.8 9.4 8.1 5.2 11.7 5.1 17.3 5.4 11.1 8.3 10.3 9.0 4.5 6.9 14.3 9.8 5.2 13.4 14.3 6.5 3.9 11.5 14.0 7.5 5.0 5.2 33.3 3.9 7.5 8.5 6.6 1.9 5.5 4.4 9.5 1.1 5.6 2.8 9.8 4.1 0.5 4.0 1.9 2.1 18.0 4.4 3.1 2.4 3.4 6.9 17.9 5.3 6.4 2.5 6.0 9.5 0.6 6.7 1.1 3.0 5.8 6.3 12.0 6.2 4.9 2.8 6.7 3.8 7.0 3.9 5.7 2.9 3.5 4.3 2.6 2.4 2.7 21.2 4.8 5.9 1.5 6.8 19.4 6.3 1.3 5.4 3.6 19.7 4.5 3.9 11.0 10.6 3.3 1.6 7.8 3.9 8.7 5.0 9.5 10.1 3.6 4.2 2.0 5.6 9.8 8.5 2.9 4.4 7.4 1.9 2.4 9.5 1.9 1.1 2.1 2.5 5.5 1.9 2.0 1.4 1.5 1.1 7.9 1.7 5.6 2.8 11.9 10.0 17.8 16.0 7.0 6.0 5.2 11.7 10.3 5.0 8.9 29.5 3.9 7.0 5.6 34.8 9.5 2.5 9.4 15.9 5.2 11.8 23.8 3.3 10.4 3.8 5.8 32.2 0.0 14.2 16.8 5.9 13.3 13.9 7.6 17.4 35.0 22.5 3.1 11.3 9.9 2.8 12.0 1.7 8.2 20.3 6.7 14.9 14.4 2.5 4.9 3.5 6.5 5.8 9.3 14.5 5.1 41.9 5.7 18.1 10.6 MROH2B "DKFZp781F0822, FLJ40243, HEATR7B2" ENSG00000171495 "Maestro heat like repeat family member 2B" Q7Z745 5 40998017-41071342 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 107 "testis: 46.4" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 16.6;Late spermatids: 26.6;Spermatocytes: 5.6" "Cancer enriched" "Detected in single" 6 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059457 Enhanced NA NA "HPA059457: AB_2684026" "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.41e-2)" "unprognostic (2.35e-1)" "unprognostic (8.91e-5)" "unprognostic (2.51e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.6 0.7 0.0 0.0 0.0 0.0 0.0 MROH7 "C1orf175, FLJ46354, HEATR8" ENSG00000184313 "Maestro heat like repeat family member 7" Q68CQ1 1 54641754-54710266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 54.2" "Group enriched" "Detected in many" 59 "Early spermatids: 146.5;Late spermatids: 448.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 29 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;SH-SY5Y: 1.6" HPA071840 Enhanced NA NA "HPA071840: AB_2732187" "unprognostic (1.52e-3)" "unprognostic (1.51e-3)" "unprognostic (1.65e-2)" "unprognostic (2.77e-4)" "unprognostic (1.81e-1)" "unprognostic (9.88e-4)" "unprognostic (1.09e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (4.16e-2)" "unprognostic (1.79e-2)" "unprognostic (7.93e-2)" "unprognostic (7.40e-3)" "unprognostic (2.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.15e-2)" 0.3 0.0 0.5 0.3 0.4 0.5 0.3 0.3 0.4 0.3 1.0 0.3 0.8 0.1 0.3 0.9 0.5 0.4 0.3 0.7 0.3 0.4 0.7 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.7 1.8 0.3 0.3 0.8 0.3 0.3 1.4 0.6 0.6 0.9 0.4 0.3 0.3 0.3 0.5 54.2 0.3 0.3 2.3 0.3 0.3 0.8 0.3 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.0 2.2 0.0 0.6 0.8 1.7 1.8 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 146.5 0.1 3.9 0.0 0.3 0.0 0.4 0.2 4.7 0.4 0.4 0.0 2.4 0.6 1.0 448.4 4.0 0.0 0.0 1.0 2.6 4.3 0.1 3.1 4.2 0.0 0.2 0.0 0.0 5.0 2.5 0.4 0.1 0.0 1.7 0.5 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" Q9H579 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 27.0;Late spermatids: 25.0;Spermatocytes: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA060298 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060298: AB_2684246" "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 3.6 3.1 4.0 1.8 5.9 2.7 2.9 6.6 7.7 3.4 3.4 4.6 2.4 2.1 4.3 9.5 2.0 4.0 2.2 4.9 3.6 5.0 3.6 4.0 1.7 5.5 3.8 5.0 3.7 4.5 4.8 7.3 1.9 4.1 3.4 2.1 6.2 4.7 5.9 12.0 3.4 1.9 4.1 3.4 2.6 2.5 33.7 2.7 3.1 4.8 2.4 3.7 2.8 2.0 2.6 7.2 8.0 2.2 1.0 2.0 1.1 1.3 3.6 8.9 2.2 3.5 3.6 1.4 1.3 5.0 3.1 3.8 2.3 1.8 7.7 0.4 1.3 5.8 2.2 2.3 1.0 2.5 1.3 0.2 2.4 1.9 1.9 3.1 2.5 3.8 2.1 2.2 1.2 0.1 2.6 2.4 3.6 3.2 1.6 2.0 0.7 6.9 7.0 1.0 1.0 2.2 5.9 1.9 1.5 1.7 1.4 3.1 4.2 2.3 0.9 1.5 2.5 2.2 2.7 2.8 9.5 1.5 0.5 0.6 2.9 2.2 4.8 3.2 1.6 3.1 1.9 2.1 0.7 1.8 2.2 2.0 2.6 1.2 2.0 1.0 2.5 0.6 1.4 8.0 1.0 1.0 7.2 0.7 1.1 4.0 5.9 6.6 7.7 3.6 5.0 3.8 5.0 4.1 2.7 3.0 1.1 0.0 0.8 0.6 5.7 2.8 0.0 1.4 0.0 0.0 7.9 3.5 0.0 0.1 27.0 2.4 1.3 0.0 0.2 0.9 3.1 0.8 0.0 3.4 2.4 0.0 1.2 1.3 2.6 25.0 1.4 0.2 1.7 1.0 1.0 3.3 0.1 0.8 2.8 1.7 4.2 0.0 1.0 18.2 3.7 0.4 1.1 0.7 1.3 0.3 MROH9 "ARMC11, C1orf129, FLJ23550" ENSG00000117501 "Maestro heat like repeat family member 9" Q5TGP6 1 170935471-171064765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.1;testis: 4.7" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 17.4;Club cells: 4.5;Early spermatids: 2.7;granulocytes: 3.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "pons and medulla: 1.9" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "BJ: 1.3;BJ hTERT+: 1.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;Daudi: 2.2;SK-MEL-30: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" "unprognostic (1.04e-1)" "unprognostic (7.94e-3)" "unprognostic (3.67e-2)" "unprognostic (9.73e-2)" "unprognostic (7.62e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (8.07e-5)" "unprognostic (3.66e-8)" "unprognostic (5.96e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 7.1 0.1 0.1 0.1 0.0 0.1 0.1 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 4.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 1.0 0.7 1.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.9 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 4.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 MS4A10 "CD20L7, MS4A9" ENSG00000172689 "Membrane spanning 4-domains A10" Q96PG2 11 60785348-60801305 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "intestine: 115.7" "Cell type enhanced" "Detected in single" 26 "Enterocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 2.4" "Low region specificity" "Detected in all" HPA014778 Uncertain NA NA "HPA014778: AB_2669089" "unprognostic (7.67e-3)" "unprognostic (1.28e-1)" "unprognostic (8.73e-3)" "unprognostic (1.27e-1)" "unprognostic (5.21e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 28.3 0.0 0.0 33.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 115.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 3.5 0.5 0.9 0.5 0.1 0.3 0.9 0.4 0.2 0.2 0.0 2.3 0.2 0.1 0.1 0.0 0.8 0.2 0.4 0.3 0.1 0.0 0.7 0.2 0.3 0.2 0.0 0.3 2.1 0.7 0.3 0.1 0.6 1.9 0.0 0.0 0.6 0.3 0.2 0.0 0.3 0.5 1.4 0.7 0.3 0.5 2.4 0.0 0.4 0.3 0.2 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.6 0.0 0.8 0.4 0.2 1.5 0.7 0.2 1.5 0.3 0.2 0.2 0.4 0.4 0.7 0.2 3.5 0.4 0.7 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.8 0.5 0.5 1.4 0.9 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515413-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "testis: 8.4" "Group enriched" "Detected in some" 6 "Early spermatids: 20.4;Late spermatids: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "U-2 OS: 2.1;U-266/70: 6.4;U-266/84: 2.0" "HPA045017, HPA063626" Uncertain NA NA "HPA045017: AB_10962976, HPA063626: AB_2685065" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.7 0.0 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 2.1 0.0 0.0 0.0 0.0 0.0 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Group enriched" "Detected in some" 41 "Early spermatids: 207.0;Late spermatids: 514.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" "Cell line enriched" "Detected in single" 24 "THP-1: 14.6" HPA058973 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 207.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.5 514.6 3.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.7 2.4 0.3 0.1 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MS4A18 ENSG00000214782 "Membrane spanning 4-domains A18" Q3C1V0 11 60729304-60744212 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 7.8;intestine: 21.9;testis: 4.3" "Group enriched" "Detected in some" 41 "Early spermatids: 3.9;Late spermatids: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.4" HPA045121 Approved NA NA "HPA045121: AB_10969456" "unprognostic (1.02e-1)" "unprognostic (8.87e-2)" "unprognostic (2.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098466 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 72.0" "Cell type enriched" "Detected in some" 18 "granulocytes: 912.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 720 "basophil: 72.0" "Lineage enriched" "Detected in single" 720 "granulocytes: 72.0" "Cell line enhanced" "Detected in some" "HEL: 7.1;NB-4: 2.6;THP-1: 4.2;U-937: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059967 Enhanced NA NA "HPA059967: AB_2684183" "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 4.9 0.5 0.4 5.1 0.4 0.2 2.1 0.4 0.4 11.9 4.6 0.1 4.5 4.7 14.3 11.2 5.9 1.1 14.6 2.1 0.4 0.4 1.5 0.9 12.9 0.5 0.4 0.1 1.1 1.2 0.2 0.6 0.6 0.1 17.5 5.6 4.5 3.2 5.4 1.5 4.3 7.4 15.9 0.4 0.6 4.5 2.7 0.2 1.2 0.6 6.7 3.4 5.1 4.1 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 7.1 0.5 0.2 0.3 0.9 0.4 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.9 0.3 0.0 0.1 0.0 2.6 0.1 0.0 0.1 0.1 0.0 0.2 0.0 1.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 4.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.2 1.9 0.2 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.1 0.2 0.0 51.4 0.0 0.6 0.0 0.4 0.4 0.0 1.4 12.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 912.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MS4A4E ENSG00000214787 "Membrane spanning 4-domains A4E" Q96PG1 11 60201253-60243088 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.1" "Cell type enhanced" "Detected in some" 21 "Club cells: 1.2;Kupffer cells: 2.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 17.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 17.1" "Cell line enhanced" "Detected in some" "K-562: 5.2;NB-4: 1.7;THP-1: 7.5;U-937: 1.0" HPA040075 Uncertain NA NA "HPA040075: AB_10793915" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (9.42e-2)" "unprognostic (5.99e-2)" "unprognostic (1.45e-2)" "unprognostic (8.97e-2)" "unprognostic (1.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (4.16e-2)" "unprognostic (9.88e-3)" "unprognostic (4.97e-2)" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (4.05e-2)" 4.7 2.2 0.2 1.2 0.2 7.1 3.4 0.1 0.2 0.5 1.6 1.0 0.8 1.1 1.2 0.9 2.9 1.2 0.3 0.3 1.0 0.8 1.9 1.6 0.2 0.8 0.8 0.8 0.7 1.0 0.9 1.2 1.9 0.1 0.6 1.0 2.8 3.3 0.5 3.1 1.6 0.5 0.7 0.4 2.1 0.9 0.0 2.4 17.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.6 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 17.1 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 1.3 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A5 CD20L2 ENSG00000166930 "Membrane spanning 4-domains A5" Q9H3V2 11 60429589-60455214 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 46.6" "Group enriched" "Detected in some" 89 "Early spermatids: 541.0;Late spermatids: 817.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 2.1;U-2 OS: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA043732 Uncertain NA NA "HPA043732: AB_10959759" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 541.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 817.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.5 0.0 7.6 2.0 0.0 0.0 0.0 0.0 0.0 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 112.4;lymphoid tissue: 89.5" "Group enriched" "Detected in many" 14 "Hofbauer cells: 335.3;Ito cells: 767.3;Kupffer cells: 1329.9;Macrophages: 569.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3" "Group enriched" "Detected in many" 96 "dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4" "Cell line enriched" "Detected in some" 9 "THP-1: 32.6" "HPA011391, HPA076623" Approved Approved Vesicles NA NA Vesicles "HPA011391: AB_10603876, HPA076623: AB_2686809" "unprognostic (1.17e-1)" "prognostic favorable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 29.3 17.8 12.3 18.3 26.7 9.1 18.1 2.8 14.6 10.2 14.9 4.7 4.0 9.0 7.0 28.3 8.7 11.3 21.0 23.1 10.7 6.9 18.0 35.6 23.0 89.5 22.2 2.4 7.7 6.0 2.4 8.8 21.5 20.5 9.6 19.0 10.2 11.8 6.3 6.0 5.1 20.4 17.2 32.0 78.1 8.5 8.3 19.4 8.5 7.0 6.7 15.4 21.5 6.3 0.7 65.3 32.4 112.4 0.2 0.3 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 32.4 112.4 0.7 0.1 35.6 0.3 0.7 0.2 0.1 65.3 0.1 0.1 0.1 7.4 0.2 2.3 46.3 0.1 61.3 12.3 26.7 2.8 14.6 10.7 6.9 22.2 2.4 20.5 19.4 6.0 31.7 53.0 0.4 8.2 0.0 2.4 30.6 2.7 4.5 3.5 0.0 1.6 0.0 0.0 2.0 8.5 0.0 0.0 0.0 1.7 7.3 0.2 12.8 6.0 335.3 0.0 0.0 767.3 1329.9 1.1 1.4 569.3 13.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 45.3 7.2 0.3 1.0 6.9 1.7 27.7 0.0 0.1 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.2" "Cell type enriched" "Detected in some" 21 "Early spermatids: 1123.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 6 "monocytes: 1.2" "Group enriched" "Detected in some" 7 "K-562: 2.1;SuSa: 4.2" HPA076623 Approved Vesicles NA NA Vesicles "HPA076623: AB_2686809" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 2.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 28.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 53.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 5.1 2.5 0.0 0.0 0.0 0.0 0.0 MS4A7 "CD20L4, CFFM4, MS4A8" ENSG00000166927 "Membrane spanning 4-domains A7" Q9GZW8 11 60378482-60395951 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in all" 4 "blood: 132.8;lymphoid tissue: 126.7" "Group enriched" "Detected in many" 12 "Hofbauer cells: 291.6;Kupffer cells: 748.0;Macrophages: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 71.2;non-classical monocyte: 132.8" "Lineage enriched" "Detected in many" 11 "monocytes: 132.8" "Cell line enriched" "Detected in some" 24 "THP-1: 51.2" "Low region specificity" "Detected in all" "HPA017418, CAB026387" Approved NA NA "CAB026387: , HPA017418: AB_1854137" "unprognostic (1.43e-1)" "unprognostic (2.60e-3)" "unprognostic (3.24e-2)" "unprognostic (9.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (3.02e-2)" "unprognostic (4.85e-2)" "unprognostic (5.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" "unprognostic (4.59e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" 24.2 11.9 4.4 15.1 4.9 2.0 9.7 1.3 3.5 5.9 7.4 4.2 2.9 5.2 4.2 11.0 4.0 4.8 15.2 11.3 5.1 3.9 6.8 22.3 29.7 19.1 4.6 1.3 3.2 3.4 2.3 6.2 13.3 5.0 5.9 7.5 8.4 5.3 3.4 2.2 2.3 8.1 4.8 9.9 126.7 4.3 6.0 3.5 7.0 3.3 2.3 5.6 9.7 3.9 2.0 11.9 0.9 132.8 0.1 0.1 10.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 51.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.2 0.0 1.6 0.0 0.5 18.8 0.2 0.1 71.2 0.1 2.0 0.0 0.0 11.9 1.8 0.0 0.0 0.9 0.1 132.8 0.3 0.0 10.9 4.4 4.9 1.3 3.5 5.1 3.9 4.6 1.3 5.0 3.5 11.9 38.5 23.0 0.6 2.4 0.8 1.9 0.0 13.4 6.8 8.7 0.0 1.0 0.0 0.0 2.0 2.1 0.0 0.0 0.2 1.2 3.1 1.2 12.8 0.9 291.6 0.0 0.0 16.0 748.0 0.5 1.1 338.5 1.7 15.4 0.0 0.3 0.1 0.0 0.0 0.6 0.5 19.4 1.2 0.0 0.3 1.6 1.6 4.1 0.0 0.8 MS4A8 "CD20L5, MS4A4, MS4A8B" ENSG00000166959 "Membrane spanning 4-domains A8" Q9BY19 11 60699574-60715811 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "fallopian tube: 36.8;intestine: 123.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 681.3;Intestinal endocrine cells: 454.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;CAPAN-2: 1.5;HDLM-2: 1.4;NB-4: 2.2;OE19: 5.3;RPMI-8226: 3.9;SCLC-21H: 2.8;SH-SY5Y: 1.5" "Not detected" "Not detected" HPA007319 Enhanced NA NA "HPA007319: AB_1854138" "unprognostic (7.28e-3)" "unprognostic (2.11e-1)" "unprognostic (9.03e-2)" "unprognostic (1.91e-2)" "unprognostic (2.52e-2)" "unprognostic (9.41e-2)" "unprognostic (4.89e-3)" "unprognostic (9.33e-2)" "unprognostic (7.97e-3)" "unprognostic (2.40e-1)" "unprognostic (2.40e-9)" "unprognostic (2.46e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-3)" 0.1 0.2 1.4 2.0 0.2 0.0 0.1 0.2 0.6 7.1 43.9 0.4 0.6 46.6 2.5 5.9 0.3 36.8 8.9 0.3 0.6 0.3 0.2 0.1 8.6 0.1 0.1 0.5 4.2 1.2 0.0 4.7 0.1 1.0 2.3 4.0 0.2 0.4 10.9 0.8 0.1 123.9 0.1 0.1 0.1 12.7 0.7 0.1 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 5.3 0.0 0.0 0.0 3.9 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.2 0.6 0.6 0.3 0.1 0.5 1.0 0.1 6.0 5.4 0.0 0.1 0.0 0.0 0.3 20.4 681.3 94.4 1.8 0.0 0.0 0.0 0.2 1.1 0.0 24.2 0.0 2.3 0.0 0.0 1.9 1.1 0.0 0.0 0.0 454.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 10.5 0.0 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 MSANTD1 "C4orf44, LOC345222" ENSG00000188981 "Myb/SANT DNA binding domain containing 1" Q6ZTZ1 4 3244369-3271738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.7;testis: 6.3" "Group enriched" "Detected in some" 5 "Early spermatids: 34.1;Late spermatids: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enhanced" "Detected in single" "T-cells: 1.0" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-3)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (3.99e-1)" "unprognostic (5.50e-2)" "unprognostic (2.34e-3)" "unprognostic (6.36e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-2)" "unprognostic (8.57e-2)" "unprognostic (5.96e-2)" "unprognostic (1.24e-1)" 0.7 0.8 3.3 1.0 9.4 1.0 0.7 2.0 9.7 0.5 0.7 1.3 0.0 0.8 0.7 1.6 0.5 0.6 0.5 0.5 6.9 4.7 1.0 0.5 1.3 0.8 0.8 5.8 0.8 1.5 0.5 1.4 0.7 1.4 1.0 0.5 0.3 1.5 0.8 2.4 0.8 0.8 0.6 0.4 1.3 1.1 6.3 1.0 0.0 1.2 0.0 0.7 0.3 0.4 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.5 1.7 0.4 0.1 0.7 0.3 0.2 0.1 0.4 0.9 0.8 0.7 0.6 0.3 1.8 0.4 0.3 0.1 0.3 0.5 0.4 0.8 1.2 1.2 0.0 0.1 2.2 0.7 0.5 0.3 0.5 0.3 0.3 1.0 0.4 1.0 0.0 0.7 0.6 2.0 1.4 0.5 1.5 0.4 0.1 0.5 0.2 0.8 2.3 0.5 0.3 0.1 0.5 1.2 0.6 0.3 0.5 0.7 1.4 0.9 0.9 1.6 1.3 0.4 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 9.4 2.0 9.7 6.9 4.7 0.8 5.8 1.4 1.0 0.0 0.0 0.0 0.1 0.9 1.4 1.1 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 34.1 0.0 0.0 0.0 6.2 0.2 0.2 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.4 0.0 1.9 0.0 0.0 3.8 1.2 0.3 0.0 0.0 0.0 0.0 MTHFD2L MGC72244 ENSG00000163738 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like" Q9H903 4 74114174-74303099 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 105.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035434 Uncertain NA NA "HPA035434: AB_10601038" "unprognostic (2.01e-1)" "unprognostic (2.19e-1)" "unprognostic (2.03e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-2)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.42e-4)" "unprognostic (3.45e-3)" "unprognostic (4.23e-2)" "unprognostic (5.07e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-2)" "unprognostic (1.19e-1)" "unprognostic (3.00e-1)" "unprognostic (1.81e-3)" 5.4 11.7 10.2 6.0 8.8 5.2 10.3 6.9 8.5 4.5 5.6 5.9 8.2 5.3 5.6 10.9 6.3 5.0 5.6 17.7 9.3 10.7 6.9 16.2 7.0 5.8 10.5 4.1 5.8 13.6 6.1 7.4 5.8 6.6 5.3 4.0 4.8 4.9 6.2 9.3 4.2 5.6 4.9 11.0 5.1 4.1 2.9 7.3 14.8 10.5 5.0 3.8 3.8 8.4 3.9 3.9 1.4 6.5 2.5 2.7 2.5 2.6 2.8 3.9 3.6 1.4 2.1 0.9 3.3 2.6 2.2 2.4 2.1 2.5 2.9 4.5 1.5 1.6 1.7 3.2 2.1 3.3 2.9 1.9 3.5 1.9 2.5 2.5 5.5 0.7 1.5 5.1 3.3 7.9 4.1 4.6 6.5 6.2 3.6 2.7 2.6 10.2 7.9 1.2 4.3 3.1 10.4 2.7 4.8 14.2 1.3 3.7 8.1 1.8 2.8 3.3 4.5 1.5 3.9 4.7 2.5 3.8 4.8 5.4 3.6 4.6 8.5 15.6 1.3 3.8 0.4 2.1 0.9 0.7 2.0 0.7 3.9 0.6 0.9 3.3 1.5 2.1 2.2 1.4 2.5 6.5 3.9 2.7 2.5 10.2 8.8 6.9 7.3 9.3 10.7 10.5 4.1 6.6 7.3 20.8 15.8 16.8 49.0 14.7 0.0 21.3 25.5 22.7 21.6 47.1 0.0 16.4 71.3 20.8 53.1 14.3 16.8 46.7 16.6 6.3 12.2 87.5 10.3 105.4 21.6 0.0 35.7 18.4 22.7 16.4 11.8 19.6 15.1 11.8 31.5 0.0 16.0 17.5 8.1 35.8 0.0 25.8 18.4 6.5 10.0 19.7 10.3 12.2 33.8 58.9 MTMR11 CRA ENSG00000014914 "Myotubularin related protein 11" A4FU01 1 149928651-149936869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 108.3;Mucus-secreting cells: 58.0;Paneth cells: 72.4;Undifferentiated cells: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 37 "dendritic cells: 4.2;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.7;OE19: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030351, HPA072906" Enhanced Approved Centrosome NA NA Centrosome "HPA030351: AB_10602185, HPA072906: " "unprognostic (1.14e-1)" "unprognostic (3.01e-3)" "unprognostic (1.42e-1)" "unprognostic (1.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.37e-2)" "unprognostic (5.81e-2)" "unprognostic (7.94e-2)" "unprognostic (2.98e-1)" "unprognostic (2.88e-2)" "unprognostic (1.22e-1)" "unprognostic (5.83e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (1.80e-2)" "unprognostic (9.12e-2)" 3.2 12.0 4.9 15.0 8.4 0.0 5.4 1.5 3.9 9.5 36.8 2.7 5.8 15.9 10.0 6.2 4.4 7.2 17.0 3.1 2.6 2.8 9.7 1.8 3.4 1.5 2.0 2.8 14.5 2.2 5.8 6.3 9.6 5.2 5.5 20.8 4.5 2.1 6.5 1.1 7.4 49.9 11.4 5.0 1.8 4.0 4.9 2.5 0.0 1.6 4.0 1.5 5.8 6.8 0.0 4.2 0.0 3.2 0.0 0.0 0.5 2.3 5.7 2.5 2.1 7.4 8.4 4.7 2.4 8.2 3.2 4.0 0.1 10.3 0.0 5.6 8.4 4.0 3.3 0.3 4.1 1.8 0.1 0.0 0.0 1.7 0.7 1.9 0.0 0.0 5.2 1.3 3.2 5.3 13.7 3.8 0.0 0.1 0.1 6.3 7.7 0.0 0.0 0.5 16.5 2.0 0.0 0.9 0.1 4.8 0.7 0.1 0.2 1.4 2.3 0.8 1.2 2.5 0.0 2.6 3.5 4.3 2.9 1.9 0.2 0.9 0.0 3.3 0.0 0.3 0.0 1.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 4.9 8.4 1.5 3.9 2.6 2.8 2.0 2.8 5.2 2.5 0.0 1.1 0.0 2.5 3.7 0.0 1.6 10.2 1.4 3.4 14.0 0.0 11.9 1.7 12.5 0.5 2.1 108.3 0.0 15.3 9.0 8.1 2.6 0.0 1.1 4.9 0.0 15.1 4.9 13.3 0.0 5.2 6.4 1.7 3.6 58.0 0.0 28.8 72.4 11.3 15.3 0.0 6.5 6.2 0.3 0.2 5.6 23.8 1.3 48.1 3.7 MTRNR2L1 ENSG00000256618 "MT-RNR2-like 1" P0CJ68 17 22523111-22524663 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 4 "blood: 249.5" "Cell type enriched" "Detected in many" 13 "Cardiomyocytes: 14115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 249.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 249.5" "Cell line enhanced" "Detected in all" "HeLa: 188.9;Hep G2: 129.8" "Secreted to blood" NA NA "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.41e-3)" "unprognostic (2.99e-2)" "unprognostic (9.82e-3)" "prognostic favorable (8.99e-4)" "unprognostic (2.14e-1)" "unprognostic (2.59e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-2)" "unprognostic (1.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (5.21e-3)" 9.4 16.2 7.9 3.7 10.0 2.3 3.0 4.0 8.4 2.5 8.9 3.3 4.8 4.5 2.6 6.8 4.8 2.6 3.3 34.3 8.1 6.1 17.8 12.8 4.2 5.6 8.9 3.0 4.1 15.0 1.5 3.4 2.5 4.6 3.5 7.7 3.3 5.9 5.0 55.5 5.3 5.2 7.5 5.9 3.3 5.6 4.4 4.0 1.8 2.7 6.8 1.8 3.3 2.6 29.4 21.6 249.5 34.3 15.0 18.3 28.7 20.6 48.2 18.6 62.5 29.5 12.2 23.6 19.5 4.6 4.5 5.3 29.6 33.5 28.1 21.3 10.0 3.2 55.0 1.4 7.0 5.6 16.5 34.6 25.7 188.9 129.8 9.6 6.0 31.0 27.3 15.1 5.0 12.2 32.8 4.8 18.4 20.8 17.2 13.4 16.7 9.3 41.3 5.3 16.1 10.8 15.3 11.8 14.6 25.7 29.5 9.9 17.6 9.4 17.9 28.7 18.7 16.8 43.0 9.3 24.9 21.0 29.6 12.0 16.0 5.1 13.3 14.2 38.0 5.4 74.4 34.3 62.1 10.9 16.7 13.5 28.7 13.9 11.8 12.1 29.4 18.3 15.9 249.5 15.0 16.1 21.6 12.1 28.7 7.9 10.0 4.0 6.8 8.1 6.1 8.9 3.0 4.6 4.0 122.1 126.9 16.9 1081.8 75.0 0.0 14115.0 2.5 184.7 263.9 73.3 0.0 0.7 94.5 0.5 4.6 52.2 1.1 0.0 0.6 0.6 57.9 106.8 153.5 10.2 0.7 0.0 1.7 4.9 6.9 6.9 14.4 92.3 59.1 0.0 1.3 0.0 0.2 1.4 3.9 12.2 0.0 0.0 31.1 6.6 18.6 149.7 0.8 7.5 1.2 234.3 MTRNR2L10 ENSG00000256045 "MT-RNR2-like 10" P0CJ77 X 55181391-55182920 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.2" "Cell type enriched" "Detected in many" 21 "Cardiomyocytes: 8067.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 60.2" "Group enriched" "Detected in many" 4 "A549: 22.8;HeLa: 83.8;Hep G2: 71.6" "Secreted to blood" NA NA "unprognostic (4.42e-1)" "unprognostic (3.04e-2)" "unprognostic (1.15e-1)" "unprognostic (5.10e-4)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-2)" "unprognostic (8.42e-2)" "unprognostic (1.58e-2)" "unprognostic (9.01e-2)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (6.28e-2)" "unprognostic (2.97e-2)" "unprognostic (4.99e-2)" "unprognostic (3.97e-4)" 4.2 3.8 3.2 0.6 4.6 0.0 1.0 1.3 4.4 1.2 4.5 1.2 0.6 0.6 1.0 4.7 2.2 1.5 1.5 19.8 4.1 2.2 14.3 8.5 2.0 5.1 2.6 0.6 1.2 2.4 0.0 2.5 1.0 2.7 1.1 8.4 0.6 3.0 0.6 16.9 1.1 1.0 2.6 2.1 1.0 1.1 3.7 1.0 0.6 1.0 1.6 1.7 1.0 1.0 6.1 3.9 60.2 6.9 3.5 3.4 7.4 1.3 22.8 0.3 6.5 0.5 0.3 1.6 2.0 0.1 0.1 0.0 1.4 3.3 3.1 0.4 0.1 0.2 4.8 0.0 0.1 0.0 0.9 4.7 1.5 83.8 71.6 0.1 0.5 0.8 0.8 0.3 0.0 0.2 5.6 0.0 2.4 2.7 1.8 0.2 8.4 0.4 3.6 0.1 0.1 1.8 1.2 1.3 1.4 0.5 13.9 0.3 1.3 0.6 0.5 2.2 3.2 1.9 2.7 3.3 2.4 0.5 0.8 0.2 0.6 0.3 0.2 1.5 0.6 0.5 16.9 6.9 19.1 1.5 3.8 1.8 5.8 2.4 2.0 3.2 6.1 3.1 3.4 60.2 3.5 3.5 3.9 2.4 7.4 3.2 4.6 1.3 4.4 4.1 2.2 2.6 0.6 2.7 1.0 0.0 0.0 8.0 376.7 7.2 0.0 8067.8 0.0 0.0 0.0 40.1 0.0 0.2 71.3 0.0 0.2 2.2 0.0 0.0 0.0 0.2 13.1 232.2 0.0 4.9 0.5 0.0 0.0 1.8 3.2 0.4 0.6 10.6 15.1 0.0 0.0 0.0 0.0 0.0 1.1 4.3 0.0 0.0 22.6 0.5 0.7 8.0 0.2 0.0 0.0 338.2 MTRNR2L3 ENSG00000256222 "MT-RNR2-like 3" P0CJ70 20 57358442-57359980 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 13.3" "Cell type enriched" "Detected in many" 94 "Cardiomyocytes: 2712.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.0;Hep G2: 1.6" "Secreted - unknown location" NA NA "unprognostic (1.55e-4)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (8.34e-2)" "unprognostic (2.64e-1)" "unprognostic (1.80e-2)" "unprognostic (9.44e-6)" "unprognostic (2.56e-1)" "unprognostic (6.68e-2)" "unprognostic (5.35e-3)" "unprognostic (1.52e-3)" "unprognostic (7.52e-2)" "unprognostic (5.36e-2)" "unprognostic (4.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (2.94e-3)" 0.8 1.0 2.9 0.3 2.4 2.4 0.5 1.0 3.6 0.7 0.9 0.0 2.5 0.6 0.5 1.4 0.7 0.5 1.0 1.3 2.5 0.7 1.2 1.1 0.4 0.5 2.1 2.7 0.8 1.2 0.2 0.5 0.3 2.4 0.5 0.9 0.0 2.4 1.1 13.3 1.1 0.5 0.5 1.7 0.4 0.9 1.2 2.7 0.0 0.6 0.0 0.3 0.3 0.6 1.0 0.8 3.7 0.7 0.1 1.3 0.4 0.3 0.0 0.2 0.9 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.0 1.6 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.6 0.1 0.2 0.1 0.5 0.3 0.6 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.2 0.6 0.2 0.3 0.5 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.7 0.7 1.1 0.8 0.2 0.6 0.4 0.5 0.5 0.8 1.0 1.3 0.5 3.7 0.1 0.6 0.2 0.7 0.4 2.9 2.4 1.0 3.6 2.5 0.7 2.1 2.7 2.4 2.7 0.0 0.0 0.9 28.7 2.9 0.0 2712.0 2.5 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.3 5.1 15.0 0.0 2.4 0.6 0.0 0.0 1.8 1.6 0.4 1.4 0.4 6.8 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 8.5 0.2 0.8 2.8 0.5 0.0 0.0 16.2 MTRNR2L4 ENSG00000232196 "MT-RNR2-like 4" P0CJ71 16 3370979-3372740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 49.5;skeletal muscle: 52.2" "Cell type enriched" "Detected in some" 24 "Cardiomyocytes: 125.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 49.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 49.5" "Cell line enhanced" "Detected in many" "AN3-CA: 22.3;HaCaT: 23.3;HeLa: 31.2" "Secreted to blood" NA NA "unprognostic (8.53e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-1)" "unprognostic (1.05e-1)" "unprognostic (3.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (6.81e-3)" "unprognostic (1.65e-1)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (9.27e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" 2.5 10.3 3.5 1.3 4.4 0.9 1.2 2.7 6.6 1.5 2.2 0.5 0.3 3.4 1.6 0.9 1.5 2.0 1.7 11.7 2.3 1.2 5.8 2.5 1.0 0.3 6.3 4.8 5.8 9.7 0.0 3.1 1.0 2.5 1.7 1.1 1.2 2.7 3.3 52.2 1.2 3.6 2.1 1.5 1.1 3.1 2.3 3.1 0.3 2.6 1.1 0.8 1.5 1.3 5.4 3.8 49.5 6.4 2.5 2.5 5.0 6.0 4.0 1.2 22.3 0.5 0.7 6.9 3.3 0.1 0.4 0.3 1.8 13.1 4.5 6.7 0.2 0.1 23.3 0.0 0.2 0.2 3.4 2.2 4.0 31.2 16.2 0.1 1.3 10.9 0.4 0.3 0.1 0.2 0.5 0.0 0.5 3.0 6.3 0.7 1.3 2.8 10.5 1.8 0.2 0.8 5.2 3.2 4.1 0.9 4.6 2.7 6.0 2.1 5.3 8.0 0.4 7.4 10.1 2.9 7.2 6.4 8.3 2.3 3.3 1.1 4.2 4.9 10.3 1.6 12.1 6.4 19.1 1.4 3.7 1.7 4.2 1.9 1.9 3.1 5.4 2.1 2.5 49.5 2.5 3.6 3.8 2.1 5.0 3.5 4.4 2.7 5.5 2.3 1.2 6.3 4.8 2.5 3.1 0.0 0.0 0.0 2.4 0.1 0.0 125.1 5.1 0.0 0.0 1.8 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 1.7 0.5 0.2 0.3 0.1 0.0 0.0 1.4 MTRNR2L5 ENSG00000249860 "MT-RNR2-like 5" P0CJ72 10 55599303-55600041 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6" "Cell type enriched" "Detected in single" 42 "Cardiomyocytes: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "HeLa: 1.7;Hep G2: 2.5;HL-60: 1.0" "Secreted - unknown location" NA NA "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" 0.4 1.8 1.5 1.2 2.5 0.2 0.4 0.4 2.3 0.4 0.6 0.4 0.0 0.5 0.4 1.3 0.4 0.4 0.6 0.5 1.0 0.5 0.9 0.4 0.4 0.3 1.4 0.6 0.4 0.7 0.1 0.8 0.1 0.6 0.4 0.3 0.0 4.7 7.0 16.4 0.4 0.8 0.5 0.4 0.4 0.5 0.5 0.9 0.0 0.4 6.6 0.3 1.0 0.4 0.2 0.1 1.8 0.4 0.1 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.5 0.0 1.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.0 0.4 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 1.8 0.1 0.1 0.1 0.0 0.1 1.5 2.5 0.4 2.3 1.0 0.5 1.4 0.6 0.6 0.9 0.0 0.0 0.0 0.1 0.6 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MTRNR2L6 ENSG00000270672 "MT-RNR2-like 6" P0CJ73 7 142666272-142667718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.7;skeletal muscle: 39.1" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 849.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 81.7" "Lineage enriched" "Detected in all" 10 "granulocytes: 81.7" "Cell line enhanced" "Detected in many" "HeLa: 50.0;Hep G2: 44.1" "Secreted to blood" NA NA "unprognostic (5.34e-2)" "unprognostic (1.34e-3)" "unprognostic (3.80e-1)" "unprognostic (4.45e-3)" "unprognostic (1.33e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-2)" "unprognostic (3.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-2)" "unprognostic (6.02e-2)" "unprognostic (1.04e-1)" "unprognostic (3.69e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-3)" 3.4 8.2 1.4 0.8 2.3 0.1 1.1 1.2 5.5 1.1 3.9 1.5 0.8 1.1 1.1 0.8 1.7 1.1 0.8 17.9 6.1 1.4 7.3 4.7 1.1 5.9 2.2 3.9 1.1 2.2 0.0 1.1 0.8 4.5 1.1 2.3 0.8 2.5 0.8 39.1 1.5 2.6 0.8 3.5 1.1 2.2 1.7 1.8 0.8 1.5 0.8 0.8 1.8 1.1 8.4 4.2 81.7 8.2 4.7 3.9 9.5 5.6 9.6 3.3 22.6 3.8 2.0 5.5 6.0 0.5 0.6 1.0 3.1 10.3 4.9 8.2 1.1 0.5 19.9 0.1 1.1 0.5 3.1 3.7 6.8 50.0 44.1 1.2 1.4 7.3 3.4 1.4 0.5 1.6 12.7 0.5 6.1 5.8 7.3 1.8 3.1 2.8 15.2 1.2 3.1 1.1 4.5 2.8 3.7 3.9 8.3 2.2 8.2 1.6 3.8 11.5 4.9 5.3 9.6 6.9 6.5 6.6 7.8 2.0 2.9 1.3 3.1 3.9 8.7 1.6 20.0 8.2 21.6 2.4 4.9 2.4 8.4 2.9 2.9 4.1 7.7 3.2 3.9 81.7 4.7 4.4 4.2 3.1 9.5 1.4 2.3 1.2 2.9 6.1 1.4 2.2 3.9 4.5 1.8 35.7 50.8 1.4 7.4 5.7 0.0 849.8 0.0 75.0 127.4 31.4 0.0 0.5 38.1 0.0 0.3 1.5 0.0 23.3 0.0 0.6 7.1 3.3 51.1 1.9 0.5 0.0 0.0 0.6 0.6 0.6 2.3 14.5 3.3 0.0 0.0 0.0 0.0 0.0 0.4 4.9 0.0 0.0 4.7 0.3 2.0 3.9 0.2 1.0 0.0 3.7 MTRNR2L7 ENSG00000256892 "MT-RNR2-like 7" P0CJ74 10 37601440-37602974 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9" "Cell type enriched" "Detected in single" 277 "Cardiomyocytes: 171.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HeLa: 3.2;Hep G2: 1.6" "Secreted - unknown location" NA NA "unprognostic (2.28e-1)" "unprognostic (5.87e-2)" 0.3 0.6 0.1 0.0 0.1 0.2 0.1 0.1 0.4 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 1.6 0.1 0.1 0.9 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.5 0.1 0.0 1.9 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.3 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.3 0.0 0.3 0.2 0.0 0.1 0.0 0.7 0.0 0.6 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 3.2 1.6 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.0 0.5 0.0 0.1 0.3 0.5 0.4 0.3 0.0 0.2 0.8 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.8 0.0 1.2 0.2 0.6 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.3 0.2 0.2 2.1 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.6 0.1 0.0 171.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 MTRNR2L8 ENSG00000255823 "MT-RNR2-like 8" P0CJ75 11 10507887-10509189 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 329.5;skeletal muscle: 107.4" "Cell type enriched" "Detected in many" 28 "Cardiomyocytes: 28256.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 329.5" "Cell line enhanced" "Detected in many" "HeLa: 192.6;Hep G2: 140.8" "Secreted to blood" NA NA "unprognostic (6.19e-2)" "unprognostic (1.43e-1)" "unprognostic (6.66e-2)" "unprognostic (3.26e-2)" "unprognostic (3.71e-2)" "unprognostic (3.52e-2)" "unprognostic (2.81e-2)" "unprognostic (3.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (4.59e-2)" "unprognostic (4.59e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-2)" 35.7 33.4 22.5 4.2 22.8 6.6 4.3 7.3 17.5 6.5 15.6 3.6 19.3 10.2 3.8 6.1 12.7 4.6 14.1 73.2 20.1 14.7 30.7 21.7 6.3 4.0 22.0 7.3 7.0 10.9 1.9 6.9 7.0 9.0 7.7 15.5 3.3 12.3 14.8 107.4 12.0 12.9 8.8 16.1 9.7 10.2 28.4 6.5 2.2 4.4 32.3 4.3 10.0 5.8 35.3 24.5 329.5 42.7 16.6 19.0 36.2 30.8 55.6 21.8 97.9 21.9 12.0 30.1 29.2 4.3 4.1 5.2 33.8 47.5 43.4 34.3 6.3 3.2 87.4 0.6 6.6 4.4 18.4 48.1 40.4 192.6 140.8 8.5 7.4 39.0 21.3 10.4 3.3 10.0 43.4 4.0 24.4 34.1 22.6 12.6 19.7 11.3 55.8 7.2 14.6 15.5 19.5 18.7 20.8 24.9 31.3 12.3 28.0 14.6 21.4 44.5 21.4 25.1 56.1 26.1 28.8 25.6 30.4 11.4 12.7 6.0 23.0 18.9 66.2 6.9 89.7 42.7 97.5 11.6 21.0 14.3 33.7 14.8 13.0 16.3 35.3 19.0 17.5 329.5 16.6 20.1 24.5 14.9 36.2 22.5 22.8 7.3 16.7 20.1 14.7 22.0 7.3 9.0 6.5 771.2 760.8 62.0 993.3 419.0 0.0 28256.5 137.6 867.3 881.5 54.1 0.0 5.8 61.3 0.0 12.2 397.4 0.0 140.2 0.0 5.0 628.6 627.3 501.1 277.9 11.0 0.0 0.0 103.2 108.7 41.9 60.7 803.5 686.7 0.0 0.3 0.0 0.1 0.0 42.1 73.2 0.0 64.7 701.4 22.4 27.9 427.3 9.4 68.2 0.6 948.0 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559033-26572233 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8" "Cell type enhanced" "Detected in many" 25 "Alveolar cells type 1: 101.3;Ciliated cells: 164.6;Syncytiotrophoblasts: 556.9" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.8;K-562: 9.7;SK-BR-3: 16.6;SuSa: 11.3;U-266/70: 6.5;U-266/84: 17.4" "Group enriched" "Detected in some" 4 "cerebellum: 1.3;thalamus: 1.5" "Low region specificity" "Detected in many" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" NA NA "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.9 0.0 0.0 9.3 0.0 0.1 265.1 11.0 1.0 0.1 0.1 0.0 0.0 5.2 0.1 4.8 0.1 0.0 0.0 0.1 1.8 0.0 2.1 56.8 0.0 0.8 0.0 0.0 14.4 1.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 1.1 77.8 8.1 1.7 3.0 6.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.6 0.0 16.6 0.0 11.3 0.1 0.0 0.0 0.0 2.5 0.0 0.0 6.5 17.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 20.9 0.0 12.3 3.1 0.0 0.0 0.0 164.6 64.8 47.1 0.0 52.1 26.6 3.0 0.4 0.0 0.0 0.0 0.0 15.5 0.5 0.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.0 556.9 0.0 0.0 10.5 MUM1L1 FLJ33516 ENSG00000157502 "MUM1 like 1" Q5H9M0 X 106168305-106208956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 79.4;thyroid gland: 26.9" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 25.5;Leydig cells: 42.0;Peritubular cells: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.1;HHSteC: 2.8;HSkMC: 5.3;LHCN-M2: 9.5;NTERA-2: 3.6;SuSa: 2.9;T-47d: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000168, HPA020464" Enhanced NA NA "HPA000168: AB_1079431, HPA020464: AB_1854209" "unprognostic (2.79e-1)" "unprognostic (1.08e-2)" "unprognostic (3.83e-2)" "unprognostic (6.08e-2)" "unprognostic (5.06e-2)" "unprognostic (4.12e-6)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.86e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (8.43e-3)" "unprognostic (2.11e-5)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.53e-2)" 1.5 1.8 5.2 0.2 1.3 0.2 0.6 0.1 8.8 7.3 0.2 0.0 2.0 0.2 7.3 4.2 0.3 6.7 0.7 1.9 2.9 2.3 1.0 0.8 0.4 0.2 0.5 4.9 79.4 11.4 0.2 12.8 4.8 4.8 2.3 0.2 0.0 0.2 1.7 4.1 0.2 0.2 1.5 0.3 0.2 0.6 17.0 0.8 0.0 26.9 1.5 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.1 0.0 0.0 2.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 2.9 3.3 0.0 0.0 0.4 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.1 8.8 2.9 2.3 0.5 4.9 4.8 0.8 3.0 0.0 0.0 1.6 0.0 0.2 11.4 25.5 6.7 2.3 0.0 0.0 1.3 1.7 5.5 1.1 0.3 0.0 0.0 1.0 0.4 0.3 0.9 0.0 0.0 0.2 0.0 0.0 2.5 0.0 1.8 42.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 67.5 2.1 0.0 12.9 0.6 1.4 1.0 0.0 3.0 0.0 0.0 0.5 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "skeletal muscle: 44.5" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 4.8;Early spermatids: 1.4;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 8.4" "Low region specificity" "Detected in all" "HPA041856, HPA048476" Uncertain NA NA "HPA041856: AB_2677709, HPA048476: AB_2680410" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.4 2.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.5 0.6 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 44.5 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.3 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.7 0.0 0.6 0.0 0.1 0.6 0.1 0.5 0.0 0.4 0.1 0.0 0.2 8.4 0.7 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.3 0.7 0.2 0.0 1.5 1.1 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell type enriched" "Detected in some" 8 "Pancreatic endocrine cells: 116.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 59.2 28.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.7 0.2 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.0 2.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.0 0.1 0.8 0.0 13.1 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 15.5 10.5 0.0 0.4 0.0 8.4 0.2 0.2 1.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 4.7 0.3 0.0 0.0 0.0 1.0 0.0 116.0 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.1 0.1 0.0 0.5 6.8 MYF5 bHLHc2 ENSG00000111049 "Myogenic factor 5" P13349 12 80716912-80719673 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "skeletal muscle: 23.1;tongue: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "LHCN-M2: 104.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041691 Supported Nucleoplasm NA NA Nucleoplasm "HPA041691: AB_10796780" "unprognostic (2.65e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH13 MyHC-eo ENSG00000006788 "Myosin heavy chain 13" Q9UKX3 17 10300865-10373130 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 1.9;skeletal muscle: 5.2;stomach 1: 4.8" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 7.2;Spermatogonia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" NA NA "unprognostic (8.86e-2)" "unprognostic (2.45e-2)" "unprognostic (7.81e-2)" "unprognostic (3.95e-1)" "unprognostic (8.35e-2)" "unprognostic (1.42e-2)" "unprognostic (7.50e-3)" "unprognostic (3.15e-2)" "unprognostic (1.08e-1)" "unprognostic (8.74e-2)" "unprognostic (3.40e-9)" "unprognostic (2.44e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.9 0.1 0.1 0.0 0.1 0.1 0.1 5.2 0.0 0.8 0.1 0.1 0.4 4.8 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 MYH4 "MYH2B, MyHC-2B, MyHC-IIb" ENSG00000264424 "Myosin heavy chain 4" Q9Y623 17 10443290-10469559 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "skeletal muscle: 15.1" "Cell type enriched" "Detected in single" 25 "Cardiomyocytes: 2.5" "Cancer enriched" "Detected in single" 115 "liver cancer: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 25 "OE19: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA001349 Supported NA NA 34000000 "HPA001349: AB_1079437" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (4.94e-2)" "unprognostic (1.69e-2)" "unprognostic (4.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.21e-3)" "unprognostic (3.52e-4)" "unprognostic (9.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL1 ENSG00000168530 "Myosin light chain 1" P05976 2 210290150-210315190 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "skeletal muscle: 743.1;tongue: 350.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "head and neck cancer: 36.0;prostate cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HSkMC: 34.6" "Not detected" "Not detected" "HPA046859, HPA063034, HPA073827" Enhanced "Intracellular and membrane" NA NA 20000000 "HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: " "prognostic unfavorable (6.59e-4)" "unprognostic (1.88e-1)" 12.9 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 16.1 9.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 6.1 0.0 0.0 13.4 0.0 743.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 2.4 350.7 9.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 7.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 MYL10 "MGC3479, MYLC2PL, PLRLC" ENSG00000106436 "Myosin light chain 10" Q9BUA6 7 101613325-101629296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.5;skeletal muscle: 9.1" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 1.4;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "PC-3: 12.3;RH-30: 7.1;SuSa: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA019763 Uncertain Uncertain Microtubules NA NA Microtubules "HPA019763: AB_1854243" "unprognostic (2.32e-2)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-2)" "unprognostic (2.78e-3)" "unprognostic (5.04e-3)" "unprognostic (8.93e-2)" "unprognostic (1.10e-2)" 0.2 0.1 0.2 0.2 0.2 1.5 0.2 0.2 0.3 1.9 0.2 0.2 0.2 0.1 0.9 0.4 0.2 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 2.7 2.0 0.2 2.9 0.9 0.2 0.3 0.2 9.1 1.1 0.2 0.2 0.2 0.2 0.1 0.9 0.2 0.2 0.2 2.9 0.6 1.0 0.2 1.4 1.0 4.5 0.9 1.4 1.3 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.9 0.0 0.3 0.1 0.5 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.8 0.1 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.5 0.0 0.2 0.3 0.0 12.3 0.0 7.1 0.0 0.1 0.5 0.2 0.0 0.1 0.1 1.2 3.7 0.2 0.1 0.3 0.6 1.3 0.0 0.2 0.4 0.2 1.2 0.1 0.3 0.0 4.5 0.9 0.8 0.4 0.5 0.4 0.9 0.6 0.8 0.3 1.4 0.9 0.7 3.4 1.4 0.5 1.0 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 71.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.0;ASC TERT1: 23.4" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.7 13.6 7.2 34.0 23.4 6.5 5.5 7.4 5.6 5.2 4.5 9.6 2.6 2.6 8.9 4.0 3.3 2.1 3.7 1.6 4.8 2.7 3.9 5.1 4.1 11.9 5.9 3.6 17.6 3.6 4.4 4.7 8.2 3.4 5.6 4.0 3.5 6.9 4.2 3.1 4.1 2.8 4.7 5.7 2.8 2.9 1.5 9.2 10.6 6.2 3.5 1.8 4.6 3.7 4.6 7.4 5.4 5.6 4.8 0.9 4.1 3.1 13.6 2.6 1.6 5.3 5.3 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 0.0 11.0 9.5 6.0 10.6 5.7 1.2 7.6 6.7 2.3 7.0 19.6 5.7 10.0 8.8 16.6 4.5 31.5 0.0 4.0 4.3 6.6 7.4 12.8 14.9 18.5 11.1 5.2 9.2 16.2 71.2 6.6 7.5 6.8 20.8 8.8 16.6 6.2 10.5 3.5 30.0 78.4 6.5 5.0 14.4 3.1 11.7 4.6 6.1 13.3 8.9 MYLPF "HUMMLC2B, MRLC2, MYL11" ENSG00000180209 "Myosin light chain, phosphorylatable, fast skeletal muscle" Q96A32 16 30370934-30377991 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "skeletal muscle: 689.9;tongue: 215.7" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 18.9;Early spermatids: 13.3;Late spermatids: 16.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 71 "plasmacytoid DC: 16.5" "Lineage enriched" "Detected in single" 71 "dendritic cells: 16.5" "Group enriched" "Detected in some" 18 "BEWO: 26.1;HSkMC: 58.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039262, HPA055059" Enhanced NA NA 28000 "HPA039262: AB_2676418, HPA055059: AB_2732591" "unprognostic (8.81e-3)" "unprognostic (7.55e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.37e-3)" "unprognostic (8.26e-4)" "unprognostic (1.28e-1)" "unprognostic (1.16e-2)" "unprognostic (5.52e-2)" "unprognostic (4.14e-4)" "unprognostic (1.84e-1)" "unprognostic (3.88e-1)" "unprognostic (7.07e-3)" "unprognostic (1.44e-2)" 16.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.1 5.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 10.4 0.0 689.9 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 215.7 5.8 0.0 0.0 0.1 16.5 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 26.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 16.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 2.9 3.0 1.5 0.8 0.9 1.6 2.5 5.3 0.0 7.0 0.0 18.9 0.0 0.5 13.3 0.7 1.1 0.0 0.8 8.3 1.3 1.2 8.1 0.9 3.7 0.0 3.5 4.3 6.6 16.9 1.1 1.7 1.7 1.8 2.5 1.0 0.4 5.8 0.4 2.6 1.8 0.0 1.8 0.7 1.6 1.0 5.5 3.1 1.8 2.2 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "intestine: 148.0" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 221.7;Mucus-secreting cells: 59.5;Paneth cells: 51.8;Undifferentiated cells: 76.4" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;monocytes: 1.2" "Cell line enriched" "Detected in some" 5 "OE19: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA053490: AB_2682168" "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.1 0.1 0.1 5.2 0.2 0.0 0.1 0.1 0.2 0.1 57.2 0.3 0.1 70.0 0.1 0.1 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 14.1 0.1 0.2 0.1 0.1 0.1 148.0 0.4 4.7 0.1 3.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 2.9 0.0 1.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 1.1 0.0 30.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 221.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 23.7 0.0 0.3 0.2 0.0 0.9 0.0 0.0 59.5 0.0 0.2 51.8 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 76.4 0.0 MYO3B ENSG00000071909 "Myosin IIIB" Q8WXR4 2 170178145-170655171 "Enzymes, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 80.5;Early spermatids: 23.6;Late spermatids: 18.5;Rod photoreceptor cells: 57.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Group enriched" "Detected in some" 10 "HDLM-2: 11.3;HEL: 10.4;RT4: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 4.7" "Not detected" "Not detected" HPA045483 Approved NA NA "HPA045483: AB_2679344" "unprognostic (1.65e-1)" "unprognostic (7.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" "unprognostic (7.15e-3)" "unprognostic (5.07e-2)" "unprognostic (2.61e-2)" "unprognostic (5.84e-3)" "unprognostic (2.12e-1)" "unprognostic (7.99e-3)" "unprognostic (2.59e-1)" "unprognostic (4.25e-5)" "unprognostic (2.34e-1)" "unprognostic (8.12e-3)" "unprognostic (1.18e-1)" "unprognostic (1.07e-1)" 0.2 0.2 0.3 0.0 0.3 0.0 0.2 0.2 0.3 0.6 0.2 0.0 4.6 0.0 0.3 20.0 0.3 0.5 0.0 0.3 0.3 0.5 8.5 0.2 0.3 0.5 0.3 0.3 0.4 2.2 12.6 1.0 0.0 0.3 0.3 0.0 21.6 1.4 1.1 0.2 0.5 0.2 0.5 0.2 0.3 0.2 4.2 0.0 0.0 2.2 0.0 0.8 4.4 0.3 0.1 0.3 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.3 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.2 0.3 0.3 0.5 0.3 0.3 0.3 0.0 0.0 0.3 0.0 0.3 0.6 2.9 0.4 0.0 0.0 0.0 3.5 80.5 0.0 11.6 0.3 23.6 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.3 18.5 0.3 0.2 0.0 0.0 0.2 1.6 0.1 0.0 0.4 0.1 57.8 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.0 0.1 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.1 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.5 0.0 1.2 15.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.5 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 5.2 0.0 0.2 3.3 0.8 12.4 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.2 0.9 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.4 0.5 0.0 0.0 0.0 0.7 0.4 1.0 0.0 0.0 0.0 0.0 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331348 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.2" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 49.9;Horizontal cells: 111.2;Spermatocytes: 36.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 8 "granulocytes: 2.3;T-cells: 1.6" "Group enriched" "Detected in some" 9 "SCLC-21H: 11.3;SH-SY5Y: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles NA NA Vesicles "HPA060245: AB_2732643" "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 1.2 3.4 11.0 1.4 20.0 1.1 1.1 19.5 50.2 1.1 1.2 0.5 0.0 1.1 1.2 1.1 1.3 1.1 1.1 1.1 15.6 10.3 1.1 1.1 1.1 1.2 5.1 14.5 1.1 1.5 1.0 10.7 1.1 6.8 1.3 1.3 0.4 1.1 1.1 1.1 1.1 1.2 1.1 1.5 1.0 1.1 4.6 2.0 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.2 2.3 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.6 0.1 0.0 0.0 11.3 8.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.2 0.0 0.6 11.0 20.0 19.5 26.7 15.6 10.3 5.1 14.5 6.8 2.0 6.0 6.7 0.0 0.5 1.5 49.9 3.6 0.0 2.7 5.7 1.8 2.0 0.1 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.1 0.8 0.2 5.8 0.4 0.1 111.2 0.0 1.3 0.3 2.9 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.0 1.4 0.0 6.8 6.5 0.3 36.2 17.4 0.9 0.2 0.0 0.0 0.5 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 13.1;JURKAT: 12.5;NB-4: 33.0" "Low region specificity" "Detected in all" HPA038971 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038971: AB_10673408" "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 12.1 9.4 19.6 10.5 22.2 29.5 22.1 24.5 21.8 12.3 11.0 9.4 4.2 11.6 14.6 12.8 8.3 14.0 9.6 6.3 15.0 16.6 7.4 57.8 17.3 17.6 12.1 18.8 30.1 11.0 7.3 21.2 10.0 11.0 11.3 11.3 7.3 7.6 9.5 11.0 17.5 13.4 11.3 10.6 19.2 7.2 3.6 15.5 14.2 10.4 5.1 12.9 13.5 16.5 15.9 28.0 24.2 25.5 15.2 13.5 17.4 0.5 0.1 0.7 0.2 2.9 2.3 0.2 0.3 1.2 0.7 1.2 2.1 2.9 5.6 0.8 0.6 2.1 0.0 2.1 0.2 0.9 8.5 1.3 13.1 0.6 6.2 4.6 4.9 0.8 1.6 0.5 0.5 0.6 5.2 0.4 12.5 0.0 10.5 0.5 0.4 10.0 33.0 1.1 0.0 0.3 9.6 0.3 4.7 2.8 1.0 2.0 2.4 2.1 0.0 0.9 1.5 0.3 9.3 0.2 0.2 0.1 0.1 0.1 5.9 3.5 0.3 0.3 1.8 0.4 24.2 25.5 6.6 9.8 23.1 8.5 14.0 9.5 11.9 21.9 15.9 13.1 11.3 6.2 15.2 15.8 28.0 13.5 17.4 19.6 22.2 24.5 21.8 15.0 16.6 12.1 18.8 11.0 15.5 41.7 25.1 28.7 27.2 26.8 7.4 3.4 10.2 5.3 22.7 5.2 0.0 17.0 8.3 8.8 17.8 35.7 4.5 0.0 7.4 0.9 15.9 22.7 8.1 57.2 20.1 0.0 36.5 11.6 41.3 15.5 25.3 44.8 28.7 143.3 11.5 10.0 6.2 10.7 20.8 8.4 1.6 77.6 56.7 0.7 0.2 30.9 8.7 43.1 13.3 12.8 NANOGNB ENSG00000205857 "NANOG neighbor homeobox" Q7Z5D8 12 7765216-7774121 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.0;testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 18 "testis cancer: 1.2" "Group enriched" "Detected in some" 4 "basophil: 1.8;neutrophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "A549: 2.0;HL-60: 1.7;HSkMC: 1.7;U-2197: 3.0" HPA060371 Uncertain NA NA "HPA060371: AB_2684266" "unprognostic (2.76e-1)" 0.1 0.3 0.1 0.7 0.1 1.4 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 1.2 0.6 0.1 0.0 0.1 0.0 0.1 0.3 0.9 0.5 0.1 0.0 0.1 0.2 0.1 2.0 0.1 0.0 0.1 0.1 0.4 0.2 2.0 0.4 0.3 0.4 0.1 0.1 2.0 0.2 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.5 0.4 1.0 0.0 0.0 1.7 0.0 1.7 0.0 0.4 0.0 0.6 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.9 0.2 0.2 0.0 0.1 0.4 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.3 1.0 0.4 1.3 3.0 0.2 0.9 0.5 0.1 0.8 0.2 0.0 1.8 0.3 0.3 0.4 0.4 0.4 0.2 0.3 0.3 0.0 0.4 0.4 0.3 2.0 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 NAP1L3 "MB20, MGC26312, NPL3" ENSG00000186310 "Nucleosome assembly protein 1 like 3" Q99457 X 93670930-93673568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.2" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 38.8;Horizontal cells: 58.8;Peritubular cells: 18.4" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.9" "Group enriched" "Detected in many" 24 "NK-cells: 4.5;T-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 9.9;HAP1: 9.5;NTERA-2: 17.4;SuSa: 15.8;U-2197: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026075 Approved Vesicles NA NA Vesicles "HPA026075: AB_1854301" "unprognostic (7.18e-2)" "unprognostic (1.81e-2)" "unprognostic (9.26e-2)" "unprognostic (4.83e-4)" "unprognostic (3.06e-1)" "unprognostic (1.28e-2)" "unprognostic (5.10e-2)" "unprognostic (1.76e-1)" "unprognostic (3.31e-2)" "unprognostic (9.29e-2)" "unprognostic (2.75e-3)" "unprognostic (5.01e-2)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.75e-1)" "unprognostic (5.23e-4)" 2.3 10.4 24.4 2.4 25.7 1.2 2.4 44.9 60.2 16.0 2.4 5.3 0.0 1.6 9.5 4.7 1.5 8.1 4.4 8.4 22.0 42.3 2.9 1.4 1.8 2.1 18.5 31.0 13.1 1.5 1.1 7.9 1.6 20.9 3.9 2.3 2.4 1.6 4.6 0.8 1.7 2.0 6.5 13.1 3.6 1.4 11.9 7.0 0.0 4.6 0.0 1.5 3.3 1.2 0.0 0.0 0.2 0.0 4.5 6.9 1.6 0.0 0.1 9.9 7.2 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.4 0.2 0.0 9.5 0.0 0.0 0.0 0.2 4.5 0.0 0.1 0.5 0.0 0.3 4.5 0.0 0.5 4.6 0.0 0.0 4.9 0.0 0.0 0.5 0.0 0.0 0.0 17.4 0.0 4.1 0.0 7.7 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 15.8 0.0 0.5 0.0 5.5 8.0 11.7 0.4 7.5 3.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.1 0.0 4.3 1.6 0.0 0.0 6.9 4.8 0.2 4.5 0.0 0.0 1.3 1.6 24.4 25.7 44.9 60.2 22.0 42.3 18.5 31.0 20.9 7.0 0.0 0.0 0.0 0.2 0.6 38.8 7.3 0.0 2.7 1.2 0.0 5.9 0.2 14.9 0.0 0.8 0.7 0.0 0.0 0.0 0.1 6.6 0.0 5.7 0.0 0.3 58.8 0.0 1.8 0.0 1.7 10.9 0.0 5.0 0.0 0.0 14.5 0.3 0.0 18.4 0.3 11.1 0.0 3.4 2.2 6.9 0.4 0.2 0.0 0.0 0.0 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170493-101180276 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6" "Cell type enriched" "Detected in some" 45 "Horizontal cells: 276.5" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Group enriched" "Detected in many" 4 "amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4" HPA021918 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.2 0.4 3.1 0.2 9.1 0.7 0.1 0.4 8.2 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.1 0.9 4.8 0.1 0.5 0.1 0.2 0.7 0.6 0.1 6.0 0.2 5.8 0.1 0.8 0.2 0.3 0.5 0.3 0.1 0.3 0.4 0.2 0.2 0.4 0.3 1.2 0.4 1.2 0.0 4.6 0.0 0.0 0.1 0.0 1.2 0.7 2.2 0.6 1.3 0.8 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.3 0.5 0.5 0.1 0.1 0.8 0.0 0.6 0.2 0.1 4.6 0.1 0.5 0.1 6.9 0.0 0.3 5.2 0.5 0.3 0.0 0.0 0.4 6.1 0.5 0.1 0.1 0.0 0.1 3.4 0.0 1.6 0.4 0.6 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.2 1.2 0.8 0.4 2.2 1.3 0.3 0.7 0.3 0.0 3.1 9.1 0.4 2.9 0.9 4.8 0.7 0.6 0.8 1.2 0.0 0.0 0.0 0.0 0.0 1.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 276.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NAT6 FUS2 ENSG00000243477 "N-acetyltransferase 6" Q93015 3 50296402-50299421 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.3" "Group enriched" "Detected in many" 21 "Early spermatids: 179.7;Late spermatids: 391.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "eosinophil: 29.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.0" "Cell line enhanced" "Detected in all" "HMC-1: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039576 Approved NA NA "HPA039576: AB_10794750" "prognostic favorable (3.62e-4)" "unprognostic (1.02e-2)" "unprognostic (6.04e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-1)" "unprognostic (7.78e-2)" "unprognostic (7.49e-2)" "unprognostic (4.62e-2)" "unprognostic (1.89e-1)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (4.38e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.88e-1)" "unprognostic (1.01e-1)" "unprognostic (9.16e-2)" "unprognostic (2.55e-1)" 7.9 6.9 9.3 7.7 17.5 30.6 8.6 15.4 24.8 9.6 7.0 8.8 12.9 6.8 10.7 11.1 9.7 10.6 11.6 10.9 11.5 9.9 8.9 8.8 9.8 10.1 8.8 12.1 13.4 8.8 14.5 8.8 6.3 22.3 10.6 8.7 8.5 13.2 12.6 12.0 15.5 7.9 7.6 8.9 9.9 10.0 59.3 6.7 7.2 8.8 11.1 10.4 8.0 9.3 6.1 2.8 29.0 2.3 5.3 6.1 2.8 4.0 3.1 4.8 5.0 5.8 6.8 3.1 3.9 7.8 6.2 5.3 2.7 7.8 12.6 2.9 6.7 5.0 5.2 2.9 12.7 2.6 8.0 5.0 25.2 18.0 6.3 5.2 4.2 32.3 8.1 9.0 10.3 7.2 9.4 7.4 7.0 2.3 12.0 5.5 4.3 4.9 19.3 2.6 1.8 10.6 3.2 1.7 15.1 10.5 2.1 3.4 4.8 4.4 9.2 1.8 3.2 4.0 12.3 6.0 5.0 5.0 6.0 3.7 8.2 4.3 3.1 8.6 7.9 4.6 6.7 1.6 29.0 4.2 2.3 6.1 6.1 5.7 5.0 2.8 4.3 4.6 3.7 0.5 5.3 1.4 1.4 5.1 2.8 9.3 17.5 15.4 24.8 11.5 9.9 8.8 12.1 22.3 6.7 6.0 5.1 2.2 7.5 3.0 5.0 0.0 0.0 5.3 3.4 0.0 3.9 4.7 0.0 0.0 179.7 7.1 3.0 0.0 0.0 4.3 4.1 5.5 12.7 4.7 4.1 0.0 8.7 8.6 4.0 391.0 7.8 2.6 5.0 0.0 2.4 3.7 0.0 3.5 8.5 0.0 2.7 12.9 5.7 13.6 10.2 3.4 4.2 7.2 3.3 8.1 NBEAL1 "ALS2CR16, ALS2CR17, MGC164581" ENSG00000144426 "Neurobeachin like 1" Q6ZS30 2 203014879-203226378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 915.3;Suprabasal keratinocytes: 1140.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049189, HPA049447" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049189: AB_2680669, HPA049447: AB_2680771" "unprognostic (3.66e-2)" "unprognostic (5.26e-2)" "unprognostic (2.86e-2)" "unprognostic (1.11e-1)" "unprognostic (4.52e-4)" "unprognostic (1.16e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-3)" "unprognostic (2.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (7.98e-3)" "unprognostic (7.59e-2)" 11.2 7.8 5.2 7.3 7.9 2.7 13.4 7.5 6.0 9.2 14.5 6.5 8.4 9.9 19.1 7.0 8.7 7.9 8.9 8.2 4.8 2.9 14.4 12.3 14.7 3.3 5.1 2.7 8.8 8.5 9.2 13.6 10.2 7.0 6.7 14.4 9.7 8.1 10.6 6.9 6.6 11.7 11.9 7.3 5.0 14.7 9.9 6.2 2.8 10.1 6.4 5.3 9.8 9.5 0.9 0.7 0.9 0.6 0.6 3.0 0.2 4.9 4.7 2.0 1.7 12.2 9.5 2.8 4.8 3.5 2.6 3.9 5.2 2.6 1.1 4.0 8.1 5.0 4.1 3.9 5.6 6.0 2.2 1.7 1.9 7.0 2.9 2.9 1.7 2.3 3.6 3.7 4.2 5.3 6.2 4.0 2.0 3.3 1.8 5.8 3.5 0.7 0.9 1.0 2.1 4.3 0.8 3.2 1.1 7.2 9.4 1.3 1.0 4.1 3.1 3.1 5.1 3.6 1.7 6.8 6.8 5.8 3.2 2.2 2.9 2.2 1.5 4.1 0.8 2.3 0.0 0.5 0.9 0.8 0.4 1.0 0.4 0.9 0.5 0.4 0.9 0.7 0.5 0.3 0.6 0.6 0.7 3.0 0.2 5.2 7.9 7.5 6.0 4.8 2.9 5.1 2.7 7.0 6.2 35.7 64.5 271.2 252.7 915.3 18.0 15.9 229.3 49.5 45.5 36.6 25.5 175.9 71.3 47.8 23.3 102.0 184.3 0.0 85.7 226.2 143.2 257.6 106.1 170.8 139.2 77.9 282.5 298.9 603.4 33.7 254.0 131.4 597.2 39.7 387.3 18.1 70.0 210.5 121.6 72.5 26.3 116.4 186.6 37.7 34.6 1140.0 191.8 258.9 547.2 252.4 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favorable (3.20e-5)" 1.5 2.1 3.4 2.1 3.9 3.0 3.8 5.7 5.3 4.6 1.5 3.1 9.6 1.4 5.7 9.6 1.2 3.0 1.5 0.7 3.0 1.4 3.7 3.3 3.0 6.0 1.1 5.3 3.2 5.4 1.6 3.3 4.4 2.9 2.4 3.4 3.2 5.6 0.6 5.7 2.0 3.0 5.7 3.1 2.1 1.5 3.1 1.5 3.0 0.0 3.5 1.3 0.0 5.2 3.9 6.1 3.5 1.0 4.1 1.0 5.5 4.4 8.8 8.4 6.1 5.2 5.9 5.0 4.6 4.3 4.5 3.4 5.6 9.2 3.9 5.9 3.9 7.2 5.5 1.8 5.2 5.1 6.0 4.0 13.8 3.7 4.3 5.8 14.9 4.4 5.1 5.4 10.2 6.3 3.1 8.0 6.6 0.6 4.3 10.8 6.6 10.5 7.6 12.3 5.7 8.9 5.1 3.5 4.2 10.7 3.5 9.3 7.9 5.4 7.4 12.1 7.9 9.9 7.6 5.6 4.6 8.6 6.3 5.5 4.5 6.4 5.3 3.7 3.1 6.1 1.9 5.7 4.1 1.3 2.9 3.3 3.4 2.4 1.9 5.2 3.8 2.9 0.3 1.0 3.5 3.9 1.3 1.0 11.9 11.8 0.8 2.0 1.0 4.8 5.1 2.5 6.7 9.1 3.5 9.8 3.9 0.0 2.5 3.5 5.8 3.9 0.0 2.9 2.8 4.1 1.6 12.8 16.6 2.9 4.8 3.4 5.5 7.3 1.0 4.9 3.1 6.8 2.8 6.3 2.7 3.4 7.0 2.5 1.9 7.0 6.5 1.4 6.2 4.5 1.3 2.4 5.0 9.0 1.1 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 41.7;Club cells: 22.7;Paneth cells: 30.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 2.2 1.1 1.3 2.7 3.3 0.0 4.9 6.1 3.6 3.2 1.1 1.8 2.9 0.4 4.0 7.7 1.7 2.4 1.9 0.5 7.1 1.5 4.9 2.8 5.0 1.4 1.5 3.4 1.7 3.6 3.2 2.7 4.2 2.8 2.1 3.0 5.2 3.1 0.7 2.2 0.7 3.8 6.3 3.6 0.9 0.9 4.8 1.0 3.0 1.9 3.7 1.4 0.5 3.1 0.2 0.6 0.4 2.7 5.5 1.8 7.5 4.9 8.9 16.7 10.6 16.7 11.0 13.6 13.3 8.3 8.6 4.2 8.1 3.8 3.8 9.9 9.7 5.9 9.8 4.3 13.3 12.5 5.3 0.3 11.1 5.3 8.0 0.3 3.7 13.6 7.6 9.9 20.7 12.0 11.6 1.5 1.7 11.5 20.1 16.1 0.2 3.4 3.6 2.7 11.1 3.3 5.3 5.9 9.2 6.8 0.8 20.2 5.7 8.9 9.4 12.0 8.9 3.4 12.4 13.5 8.9 11.9 12.6 10.2 11.0 6.4 0.2 0.4 6.2 0.2 0.3 0.1 1.3 0.0 1.9 3.1 3.5 2.4 0.2 1.8 4.2 1.6 0.6 2.7 0.4 0.2 5.5 1.8 41.7 21.0 0.9 0.8 1.8 2.5 7.5 5.1 8.1 22.7 1.8 5.9 1.3 0.0 5.3 1.6 3.8 1.0 0.0 3.7 2.6 3.9 1.2 14.0 7.8 1.4 3.2 5.8 6.2 9.2 0.5 8.1 1.8 1.7 3.6 3.7 2.7 6.0 30.2 9.9 0.9 7.0 0.0 6.2 2.6 1.7 1.1 0.2 2.5 5.0 0.3 NBPF3 AE2 ENSG00000142794 "NBPF member 3" Q9H094 1 21440128-21485005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 29.5" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 9.4;Early spermatids: 10.3;Spermatocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HHSteC: 14.9" "HPA042595, HPA043692, HPA044023, HPA046971, HPA058050" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.49e-2)" "unprognostic (1.19e-2)" "unprognostic (5.09e-3)" "unprognostic (2.57e-2)" "unprognostic (3.11e-1)" "unprognostic (2.01e-1)" "unprognostic (2.82e-2)" "unprognostic (2.10e-1)" "unprognostic (2.22e-3)" "unprognostic (1.09e-1)" "unprognostic (3.11e-3)" "unprognostic (1.63e-1)" "unprognostic (5.31e-5)" "unprognostic (8.35e-2)" "unprognostic (1.23e-2)" "unprognostic (2.69e-2)" "unprognostic (1.66e-2)" 3.2 5.1 4.5 2.6 4.6 2.3 6.5 12.7 5.3 4.1 3.5 3.7 4.2 1.5 3.7 4.6 3.7 3.6 2.9 2.8 4.7 3.5 4.0 4.6 3.0 3.0 5.0 3.8 4.7 4.3 2.6 9.4 11.7 4.5 4.5 3.6 3.3 4.9 4.0 2.2 6.2 4.0 5.3 4.6 3.2 4.7 29.5 4.9 2.4 4.8 1.3 4.5 5.1 5.6 1.1 0.3 2.3 0.7 1.1 5.3 1.6 1.8 2.5 0.2 5.7 3.8 1.3 4.8 3.2 15.4 4.5 3.8 3.4 5.8 2.9 1.3 8.4 1.3 0.2 2.7 3.8 0.5 1.5 2.9 2.0 0.1 1.2 14.9 1.2 2.0 1.0 1.1 4.1 0.7 2.2 0.4 0.0 0.8 1.0 1.0 6.4 0.0 2.8 0.8 2.6 3.6 0.0 0.0 2.7 0.7 2.4 3.9 4.1 5.0 1.3 3.9 1.4 1.8 2.4 3.7 1.9 2.2 5.6 1.3 0.0 1.6 4.5 0.4 2.5 2.5 0.0 0.5 2.3 3.8 0.7 5.3 1.1 1.6 3.0 0.3 0.5 2.8 3.5 0.2 1.1 0.0 0.0 1.5 1.6 4.5 4.6 12.7 5.3 4.7 3.5 5.0 3.8 4.5 4.9 0.0 3.0 0.8 2.2 1.1 1.4 2.6 2.5 9.4 1.2 1.8 5.9 2.5 0.0 1.0 10.3 1.4 0.0 0.0 2.2 1.0 3.1 1.5 2.3 1.0 0.8 0.0 0.0 3.7 0.6 1.6 2.6 2.2 0.0 0.0 3.3 1.0 2.0 0.0 1.8 1.6 1.8 0.0 1.0 14.4 7.0 2.6 2.1 1.3 1.2 1.6 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.1;testis: 8.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 3.5 0.0 13.9 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.2 4.2 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;testis: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 1.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.5 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687330 "Plasma proteins, Predicted membrane proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 218.9;Peritubular cells: 195.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.5;plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.3" "Cell line enhanced" "Detected in many" "AF22: 20.6;ASC diff: 20.3;HSkMC: 27.3;NTERA-2: 16.4;SuSa: 22.6;U-2 OS: 30.6;U-266/70: 19.4;U-266/84: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA074457: AB_2686691" "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 29.9 35.5 19.2 7.7 39.1 1.3 25.0 2.6 28.2 32.7 12.9 12.9 8.1 8.0 29.9 17.7 12.3 21.4 19.1 20.3 18.1 40.3 6.9 3.0 10.3 8.9 14.8 17.6 50.7 7.1 2.1 23.2 22.4 19.0 18.8 8.1 16.5 9.2 29.3 9.2 4.7 8.4 23.5 11.8 11.8 8.6 16.4 7.3 7.1 8.4 8.7 4.9 13.1 17.3 0.0 4.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 20.6 0.0 20.3 7.8 0.0 13.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 3.9 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 12.0 27.3 0.0 3.8 0.0 0.0 0.0 8.0 0.4 0.0 6.7 0.0 9.7 0.0 16.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 22.6 3.5 0.0 0.0 0.9 30.6 0.0 0.0 19.4 18.0 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.6 4.3 0.0 0.0 19.2 39.1 2.6 28.2 18.1 40.3 14.8 17.6 19.0 7.3 23.8 8.3 0.0 15.5 11.6 59.9 32.5 12.7 6.7 2.3 12.2 19.6 1.7 19.9 16.4 1.9 15.7 4.6 0.0 9.4 1.1 70.8 4.8 0.0 0.2 6.3 47.7 6.4 30.1 7.8 3.8 218.9 3.2 37.1 0.0 4.5 81.6 7.3 0.0 195.2 0.5 41.1 97.0 76.9 10.9 21.7 7.2 2.1 0.7 6.9 3.1 NDST3 HSST3 ENSG00000164100 "N-deacetylase and N-sulfotransferase 3" O95803 4 118033618-118258648 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "MOLT-4: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056189 Uncertain NA NA "HPA056189: AB_2683061" "unprognostic (1.95e-2)" "unprognostic (7.58e-2)" "unprognostic (4.34e-3)" "unprognostic (2.55e-7)" "unprognostic (4.05e-2)" "unprognostic (2.18e-2)" "unprognostic (2.86e-3)" "unprognostic (2.32e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-2)" "unprognostic (7.43e-2)" "unprognostic (1.99e-2)" "unprognostic (1.09e-3)" "unprognostic (1.37e-1)" "unprognostic (4.39e-3)" "unprognostic (6.83e-2)" "unprognostic (8.85e-2)" 0.3 2.0 3.2 0.3 17.0 0.6 0.3 22.2 6.9 2.1 0.4 0.0 0.0 0.3 0.4 0.2 0.3 1.3 0.4 0.3 2.3 2.0 0.9 4.6 0.4 0.6 0.9 1.7 0.6 0.2 0.2 7.6 0.4 1.7 0.5 0.4 1.3 0.2 1.2 0.3 0.4 0.4 0.4 0.6 6.8 1.0 0.5 2.4 6.8 0.6 0.0 0.4 0.3 0.3 0.3 0.4 1.3 0.2 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.9 1.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.3 0.4 0.1 0.4 0.0 0.0 3.2 17.0 22.2 5.7 2.3 2.0 0.9 1.7 1.7 2.4 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.4 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NDST4 ENSG00000138653 "N-deacetylase and N-sulfotransferase 4" Q9H3R1 4 114827763-115113876 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 17 "pons and medulla: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011129 Uncertain NA NA "HPA011129: AB_1079460" "unprognostic (5.58e-2)" "unprognostic (5.90e-2)" "unprognostic (4.82e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (6.55e-2)" 0.1 0.0 1.3 0.0 1.7 0.0 0.1 0.2 3.4 1.4 0.3 0.3 0.3 0.1 1.5 0.0 0.1 0.1 0.3 0.1 0.7 1.9 0.1 0.0 0.1 0.0 1.3 1.4 5.7 0.1 0.0 0.6 0.0 34.6 1.5 0.1 0.0 0.5 0.6 0.1 0.2 0.1 1.6 1.0 2.5 1.1 0.7 0.0 0.0 0.1 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.2 1.7 0.7 1.9 1.3 1.4 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.4 0.5 4.5 0.5 14.6 0.4 14.2 0.6 6.8 1.6 2.0 1.1 2.0 2.5 0.9 8.3 2.0 10.5 2.1 3.1 8.4 3.8 1.4 2.5 4.5 0.6 0.8 6.7 2.7 0.8 0.5 9.0 0.3 3.4 1.9 0.7 1.3 0.5 1.4 10.5 0.4 1.0 1.2 0.8 0.6 1.1 31.4 1.3 0.3 0.8 0.3 0.7 1.4 0.4 0.4 0.2 1.9 0.1 0.1 0.6 0.1 1.0 2.1 1.1 1.2 0.9 2.1 0.4 7.7 1.2 2.1 1.9 0.0 0.5 0.7 1.9 3.2 1.5 0.1 0.5 0.5 2.3 1.4 0.8 0.2 4.1 3.7 0.2 0.4 1.0 2.5 0.5 3.3 0.1 2.7 1.5 4.4 0.1 0.7 10.6 0.1 0.8 0.5 0.7 0.2 0.3 1.0 0.4 0.3 4.1 0.6 0.2 0.2 1.2 0.5 0.6 0.8 6.2 0.4 0.9 5.7 9.0 0.3 0.8 0.3 0.2 0.5 4.8 0.9 2.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.5 0.4 0.0 0.4 0.1 0.5 1.9 0.1 0.0 0.2 0.0 0.1 4.5 14.6 0.6 6.8 8.4 3.8 0.8 6.7 3.4 1.3 6.0 0.0 0.0 0.2 0.2 4.0 10.2 2.5 97.7 13.6 1.8 82.5 0.0 0.0 0.3 98.7 0.7 0.7 0.0 0.0 0.2 2.9 1.5 0.0 0.5 0.2 0.0 0.0 0.6 1.3 45.8 1.7 0.4 0.0 0.0 0.1 1.4 0.2 0.6 1.1 0.0 19.6 0.0 1.1 25.4 1.7 0.4 0.0 0.0 0.1 0.1 NEK5 ENSG00000197168 "NIMA related kinase 5" Q6P3R8 13 52033611-52129078 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.8;fallopian tube: 12.7;testis: 15.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 172.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 3.5;OE19: 6.4;T-47d: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035565, HPA041399" Enhanced NA NA "HPA035565: AB_10672095, HPA041399: AB_2677453" "unprognostic (4.14e-2)" "unprognostic (1.49e-1)" "unprognostic (1.89e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-2)" "unprognostic (2.47e-1)" "unprognostic (3.57e-2)" "unprognostic (6.50e-2)" "unprognostic (8.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.94e-1)" "unprognostic (2.06e-3)" "unprognostic (1.83e-3)" "unprognostic (1.10e-1)" "unprognostic (1.19e-3)" "unprognostic (9.44e-3)" 0.6 0.3 3.2 1.4 3.2 0.7 0.9 0.4 2.6 0.9 0.4 5.4 0.3 0.5 2.5 3.0 0.4 12.7 0.5 1.3 3.2 1.6 0.9 0.3 4.9 0.5 0.7 1.3 2.8 0.5 0.9 5.3 0.8 11.8 1.5 0.4 0.3 0.5 0.3 0.6 0.5 0.4 0.5 0.9 0.4 0.3 15.7 2.1 0.0 0.7 0.0 0.3 0.4 0.4 0.9 1.1 2.5 0.5 0.6 0.4 0.0 0.4 0.5 0.3 1.7 0.2 1.1 2.2 0.0 0.0 0.0 0.2 0.1 1.1 0.5 0.2 0.0 0.1 0.4 0.2 0.4 0.0 0.1 0.3 0.6 0.6 0.4 0.3 1.1 1.3 0.3 0.8 0.1 0.6 0.4 0.2 3.5 1.2 0.8 0.0 1.3 0.6 0.8 0.5 6.4 0.6 0.2 0.1 0.0 1.9 0.5 0.6 0.8 0.4 0.0 1.0 1.0 3.3 1.3 0.4 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.1 0.2 0.3 2.5 0.5 0.1 0.3 0.3 0.4 0.5 0.2 0.2 0.1 0.9 0.3 0.3 0.9 0.6 0.1 1.1 0.2 0.0 3.2 3.2 0.4 2.6 3.2 1.6 0.7 1.3 11.8 2.1 0.0 1.3 2.2 1.7 0.0 8.0 1.6 2.5 172.6 21.6 7.0 13.7 2.2 1.7 1.1 43.0 1.7 0.8 0.0 2.6 1.5 1.1 3.2 2.3 0.9 1.0 12.7 1.7 0.6 0.0 24.4 2.0 0.8 0.0 1.0 0.3 2.4 0.7 0.0 2.1 1.0 11.4 6.5 0.3 21.1 12.0 0.1 1.6 0.0 1.0 0.8 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504342-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.3" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057719 Approved Nucleoplasm NA NA Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 7.8 4.9 2.9 14.5 2.9 4.5 4.3 7.5 3.6 6.0 3.6 4.3 2.2 2.5 8.5 6.8 4.4 3.3 3.0 4.3 3.5 2.9 5.7 5.7 9.3 11.3 3.8 3.2 5.6 3.2 2.6 4.0 3.7 3.4 3.9 2.6 6.6 9.3 4.8 1.7 5.1 4.5 3.4 3.4 12.3 5.1 8.1 2.4 27.3 5.4 3.5 15.8 4.4 4.3 3.6 3.4 0.2 0.8 2.4 5.6 2.2 5.2 2.8 1.9 2.4 1.1 3.0 5.1 3.8 3.3 3.8 4.7 4.2 7.3 7.6 2.5 1.9 2.7 9.3 3.0 8.1 7.6 5.6 2.6 5.5 2.8 2.9 2.9 5.9 1.9 3.1 3.4 17.3 4.5 3.5 1.7 8.5 4.7 9.0 7.3 2.4 6.4 2.8 2.1 2.9 3.1 2.7 4.2 3.5 3.4 3.9 3.5 3.0 5.9 0.6 5.7 3.4 1.5 6.4 3.1 8.5 6.6 1.6 4.1 4.9 5.3 4.1 6.5 6.2 6.1 0.1 0.8 0.1 3.0 0.7 3.9 2.7 3.3 2.7 0.9 3.6 5.4 4.6 0.2 2.4 0.6 3.4 5.6 2.2 2.9 2.9 7.5 3.6 3.5 2.9 3.8 3.2 3.4 2.4 0.0 1.1 2.4 1.3 0.0 4.5 1.6 0.0 0.0 0.0 1.8 0.0 2.1 0.0 1.5 2.5 3.8 0.0 0.0 1.7 2.8 1.3 1.5 1.1 2.5 2.6 3.2 0.0 3.1 5.4 4.2 2.6 2.3 0.0 1.8 1.2 3.3 0.6 1.5 1.1 2.1 2.1 0.0 2.5 16.7 5.9 0.0 1.0 5.7 1.8 1.3 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell type enriched" "Detected in some" 38 "Bipolar cells: 163.9" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA064630: AB_2685305" "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 6.9 0.0 0.0 14.9 0.0 23.7 3.7 15.7 20.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 0.0 0.0 0.0 0.0 0.0 163.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 NEURL1 "h-neu, neu-1, NEURL, RNF67" ENSG00000107954 "Neuralized E3 ubiquitin protein ligase 1" O76050 10 103493979-103592552 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Translation regulation, Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.1;skeletal muscle: 83.5" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 105.4;Late spermatids: 383.1;Paneth cells: 157.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "intermediate monocyte: 16.0;non-classical monocyte: 37.1" "Lineage enriched" "Detected in many" 17 "monocytes: 37.1" "Cell line enhanced" "Detected in some" "BEWO: 13.0;HeLa: 7.7;HMC-1: 6.6;JURKAT: 6.9;SCLC-21H: 16.4;SiHa: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044204 Enhanced NA NA "HPA044204: AB_10959383" "unprognostic (1.21e-2)" "unprognostic (8.14e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-4)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (5.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (4.31e-2)" "unprognostic (1.32e-3)" "unprognostic (1.08e-1)" "unprognostic (8.61e-3)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.91e-4)" "unprognostic (3.23e-1)" 1.1 3.9 18.5 3.0 17.5 2.0 1.0 28.2 27.2 6.1 8.6 0.6 1.2 7.7 13.2 11.0 3.6 2.1 2.0 1.1 12.0 7.6 1.3 1.1 1.3 1.3 4.5 18.9 2.1 12.8 2.9 6.5 13.3 6.1 2.8 7.3 7.8 1.5 1.7 83.5 1.9 11.7 11.7 1.2 2.0 4.4 7.5 2.1 0.0 1.2 8.5 1.1 9.2 1.7 0.4 2.1 1.0 37.1 0.2 0.4 1.2 0.8 0.2 1.3 0.0 0.4 0.1 13.0 0.5 0.8 0.2 0.1 0.3 0.3 0.4 0.7 0.1 0.9 0.7 0.4 0.2 0.1 0.3 0.7 0.2 7.7 0.6 0.0 0.3 6.6 0.2 0.5 0.1 0.6 0.2 0.0 6.9 2.1 0.4 0.2 1.1 1.3 0.8 0.0 0.5 3.9 0.2 0.6 1.4 0.0 0.5 16.4 5.6 8.2 0.0 0.4 2.5 0.7 1.5 0.0 0.1 0.9 0.2 0.2 0.9 0.2 0.3 0.5 0.0 0.3 0.2 1.0 0.2 0.3 16.0 0.4 0.4 0.4 0.4 2.1 0.3 0.4 0.3 1.0 0.2 37.1 1.7 0.1 1.2 18.5 17.5 28.2 27.2 12.0 7.6 4.5 18.9 6.1 2.1 0.0 1.1 1.4 1.3 0.5 42.1 1.2 0.0 0.0 0.0 0.0 88.4 3.4 0.0 9.1 105.4 1.0 6.9 0.0 0.6 10.0 1.9 0.5 0.0 0.0 4.2 3.2 75.1 0.0 4.1 383.1 5.2 2.0 0.0 0.0 92.0 6.4 0.9 157.0 4.9 0.0 83.3 6.5 0.6 47.6 28.8 1.6 94.9 3.9 7.8 0.5 NEURL2 "C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3" ENSG00000124257 "Neuralized E3 ubiquitin protein ligase 2" Q9BR09 20 45888625-45891287 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 10.0;Proximal tubular cells: 11.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043402, HPA059842" Approved Approved Vesicles NA NA Vesicles "HPA043402: AB_2678464, HPA059842: AB_2684139" "unprognostic (6.26e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (8.04e-2)" "unprognostic (2.90e-1)" "unprognostic (1.73e-3)" "unprognostic (5.58e-2)" "unprognostic (1.99e-2)" "unprognostic (6.94e-2)" "unprognostic (1.97e-1)" "unprognostic (8.12e-2)" "unprognostic (1.58e-1)" 7.9 6.3 2.8 3.0 2.6 1.3 4.8 5.5 3.3 4.6 7.6 2.9 4.5 5.2 5.7 6.0 3.3 5.2 9.0 7.6 1.9 1.6 8.8 12.3 2.4 1.5 1.5 2.3 8.7 2.8 6.2 4.2 3.7 2.7 5.7 2.7 5.9 4.0 3.7 21.6 4.3 10.3 10.2 2.3 4.5 3.3 3.2 1.1 1.1 4.0 21.5 2.1 6.6 2.8 5.4 0.8 3.6 1.3 2.3 3.8 0.9 1.0 0.9 2.5 1.9 4.0 1.7 2.3 1.5 2.1 1.7 0.8 10.0 6.5 1.5 2.2 1.1 3.1 3.4 2.0 0.2 1.1 0.8 1.8 0.8 7.2 9.9 5.6 0.7 1.7 3.9 1.4 1.7 0.7 2.6 1.6 2.1 0.6 2.6 0.9 4.0 1.2 0.7 1.6 0.6 3.6 2.0 1.8 0.7 1.0 0.9 5.7 4.7 2.0 5.2 6.2 0.6 4.2 2.1 2.5 2.0 1.6 1.4 1.3 8.2 1.5 0.3 2.1 1.0 1.7 0.0 1.3 3.6 0.9 0.7 0.5 5.4 1.8 1.6 0.4 2.6 3.8 3.5 0.7 2.3 0.4 0.8 1.0 0.9 2.8 2.6 5.5 3.0 1.9 1.6 1.5 2.3 2.7 1.1 0.0 0.0 1.3 1.9 0.1 3.6 4.8 0.0 0.0 0.0 0.0 3.9 0.6 6.6 2.5 2.0 1.9 4.2 0.0 1.8 0.6 1.7 2.0 0.0 3.8 10.0 0.0 2.9 6.7 3.7 6.5 4.9 0.1 0.0 1.8 1.7 2.5 3.1 0.0 3.5 11.1 2.8 12.9 3.4 0.0 0.3 1.0 0.5 0.0 2.1 1.6 NEURL3 "Lincr, LOC93082, RNF132" ENSG00000163121 "Neuralized E3 ubiquitin protein ligase 3" Q96EH8 2 96497643-96508109 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8" "Cell type enhanced" "Detected in many" 21 "Ductal cells: 94.8;Exocrine glandular cells: 31.1;monocytes: 20.8;Pancreatic endocrine cells: 20.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.1;CAPAN-2: 16.7;GAMG: 6.0;RPMI-8226: 10.5;RT4: 5.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (4.97e-2)" "unprognostic (6.07e-2)" "unprognostic (7.22e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.29e-1)" "unprognostic (9.55e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (8.14e-3)" "unprognostic (1.23e-2)" "unprognostic (5.83e-2)" "unprognostic (6.57e-2)" "unprognostic (2.44e-1)" "unprognostic (6.57e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.9 0.9 0.0 0.1 0.0 0.0 1.3 0.0 0.0 5.3 0.6 1.8 0.0 0.0 0.1 0.0 26.3 0.0 0.0 0.0 0.2 1.4 0.1 0.0 22.4 10.8 0.4 0.0 1.2 0.0 0.2 0.0 0.1 0.2 0.0 6.4 0.0 0.5 0.1 0.4 0.0 0.3 0.2 0.7 0.1 0.1 0.1 3.0 1.0 0.5 0.0 0.3 0.0 0.0 4.1 0.0 0.4 0.3 0.2 2.4 16.7 0.0 1.3 0.0 6.0 2.5 0.2 0.0 0.0 0.6 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.0 0.0 10.5 2.2 5.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.3 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.1 3.0 0.0 1.0 1.3 10.0 0.0 0.0 0.4 2.5 0.0 1.2 8.7 0.0 0.1 3.3 94.8 0.0 0.0 7.9 0.0 31.1 0.0 0.0 13.5 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.5 0.7 20.7 2.3 0.0 3.6 0.0 0.0 0.3 0.4 1.1 0.0 0.0 0.0 0.6 4.3 NEUROD2 "bHLHa1, NDRF" ENSG00000171532 "Neuronal differentiation 2" Q15784 17 39603536-39609777 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "brain: 51.4" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 7.7;Cone photoreceptor cells: 3.9;Intestinal endocrine cells: 22.8" "Cancer enhanced" "Detected in some" "cervical cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 245 "SCLC-21H: 24.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "amygdala: 28.0;cerebellum: 127.9;cerebral cortex: 45.1;hippocampal formation: 107.5" NA NA "unprognostic (5.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.87e-1)" "unprognostic (3.51e-3)" "unprognostic (2.44e-2)" "unprognostic (3.04e-1)" "unprognostic (4.69e-1)" "unprognostic (1.72e-1)" "unprognostic (2.16e-1)" "unprognostic (3.96e-1)" "unprognostic (6.15e-2)" "unprognostic (4.09e-2)" "unprognostic (3.21e-6)" "unprognostic (4.20e-1)" "unprognostic (2.66e-1)" "unprognostic (2.52e-2)" "unprognostic (2.57e-3)" 0.7 0.7 10.9 0.7 8.3 0.7 0.7 51.4 22.1 0.7 0.7 0.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 18.8 0.6 0.7 0.7 0.7 0.7 1.1 18.3 0.7 0.7 0.7 0.2 0.7 12.3 0.7 0.7 0.0 0.7 0.7 0.7 0.8 0.7 0.7 1.1 0.7 0.9 0.7 0.0 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.3 51.4 18.8 18.8 0.6 1.1 18.3 12.3 0.0 0.0 0.0 0.0 0.7 0.2 7.7 1.2 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.2 0.0 22.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.5 0.3 0.0 0.7 0.0 0.0 1.0 NEUROD6 "Atoh2, bHLHa2, Math-2, Nex1, NEX1M" ENSG00000164600 "Neuronal differentiation 6" Q96NK8 7 31337461-31340894 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "brain: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 119 "SCLC-21H: 11.8" "Group enriched" "Detected in many" 5 "cerebral cortex: 99.2;hippocampal formation: 246.6" "Group enriched" "Detected in many" 9 "cerebral cortex: 26.0;hippocampal formation: 108.7" HPA074530 Enhanced NA NA "HPA074530: AB_2732257" "unprognostic (3.68e-2)" 0.5 0.5 8.3 0.5 10.7 0.5 0.5 3.9 25.5 0.5 0.5 0.7 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 30.6 0.5 0.5 0.5 0.5 0.5 1.3 17.4 0.5 0.5 0.5 0.1 0.5 0.4 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 10.7 3.9 25.5 30.6 0.5 1.3 17.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEUROG2 "Atoh4, bHLHa8, Math4A, ngn-2, NGN2" ENSG00000178403 "Neurogenin 2" Q9H2A3 4 112513516-112516172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 5.1" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 8.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 68.9" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 18 "hippocampal formation: 17.3" CAB012342 Uncertain NA NA "CAB012342: " "unprognostic (1.09e-1)" "unprognostic (2.52e-2)" "unprognostic (7.51e-2)" "unprognostic (4.10e-1)" "unprognostic (1.62e-1)" "unprognostic (7.75e-2)" "unprognostic (1.04e-1)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (3.30e-1)" 0.4 0.1 3.0 0.0 3.6 0.1 1.2 4.1 1.6 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.6 4.1 0.8 3.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 NHLRC3 ENSG00000188811 "NHL repeat containing 3" Q5JS37 13 39038306-39050109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013738 Uncertain "Secreted - unknown location" NA NA 240000 "HPA013738: AB_1854455" "unprognostic (7.92e-2)" "unprognostic (3.51e-2)" "unprognostic (5.96e-2)" "unprognostic (3.90e-1)" "unprognostic (2.92e-2)" "unprognostic (1.22e-1)" "unprognostic (2.99e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-1)" "unprognostic (8.88e-2)" "unprognostic (2.28e-2)" "unprognostic (4.83e-2)" "unprognostic (3.21e-1)" "unprognostic (1.58e-2)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (7.81e-2)" 21.3 14.5 12.3 18.8 14.7 7.3 17.6 13.8 19.1 13.9 14.2 18.2 16.4 12.7 17.8 37.1 9.8 13.8 18.0 13.0 12.4 12.2 20.1 28.2 17.6 17.7 15.5 15.9 21.9 17.2 7.8 16.5 24.4 15.2 13.0 19.0 18.4 15.7 22.9 10.8 13.5 14.8 13.6 17.3 20.1 18.3 14.0 13.1 13.0 21.2 8.9 13.1 14.6 12.6 5.7 7.9 2.0 9.2 5.6 7.3 4.6 3.4 2.2 9.6 4.5 11.1 11.5 14.6 5.4 6.7 5.8 7.6 6.8 15.5 9.4 10.3 3.5 7.3 7.3 3.7 3.1 5.0 13.5 4.2 7.6 4.5 7.5 7.1 7.4 11.1 9.3 4.1 3.9 3.9 8.8 3.6 7.8 2.6 11.7 5.2 2.6 5.8 11.8 2.5 7.9 2.2 6.2 25.5 5.2 8.8 6.9 2.2 4.0 3.4 4.8 12.2 5.6 6.3 12.0 4.2 7.9 3.9 10.3 5.6 9.4 8.0 3.8 10.5 8.1 5.7 2.0 9.0 1.0 6.6 9.2 7.3 5.7 4.8 5.3 7.9 4.6 4.9 7.0 0.8 5.6 8.2 7.3 5.4 4.6 12.3 14.7 13.8 19.1 12.4 12.2 15.5 15.9 15.2 13.1 11.9 19.8 23.0 12.8 7.4 71.9 10.8 17.8 25.4 29.6 33.2 53.0 56.2 8.3 16.4 5.1 23.3 21.0 0.0 14.5 13.2 18.0 9.5 15.1 29.4 37.9 74.7 13.3 43.6 40.6 2.8 56.7 39.9 16.9 16.2 25.9 44.6 14.0 34.0 39.3 13.3 83.5 58.2 11.1 32.5 31.9 7.9 20.3 35.5 26.2 6.8 NICN1 MGC12936 ENSG00000145029 "Nicolin 1" Q9BSH3 3 49422946-49429326 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 25.0;Erythroid cells: 23.3;Late spermatids: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA058014 Supported Nucleoplasm NA NA Nucleoplasm "HPA058014: AB_2683579" "unprognostic (4.10e-2)" "unprognostic (1.08e-2)" "unprognostic (7.31e-2)" "unprognostic (1.33e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.50e-3)" "unprognostic (1.04e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.46e-1)" "prognostic favorable (8.81e-7)" "unprognostic (3.11e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-2)" "unprognostic (2.96e-2)" 9.6 12.1 19.3 5.7 23.4 3.6 10.5 21.5 27.9 9.2 9.7 8.4 12.8 7.8 12.0 12.8 5.3 10.7 8.7 16.9 12.7 10.9 16.8 10.9 10.4 8.5 9.6 21.6 13.7 12.6 10.1 10.2 6.1 12.5 10.9 5.8 10.3 13.0 10.2 14.4 8.6 8.3 9.7 8.1 9.7 10.0 13.5 10.6 7.0 13.7 7.0 8.8 9.5 8.9 9.2 8.1 8.1 8.5 6.7 10.9 7.3 2.5 8.5 8.8 6.2 3.7 4.5 3.3 3.0 2.9 2.9 3.5 1.9 7.9 8.2 3.2 6.6 6.3 2.3 5.1 4.0 2.8 14.7 3.2 7.9 8.8 9.5 6.9 3.5 5.3 9.2 4.8 6.4 2.1 14.0 4.0 17.0 4.9 0.2 3.2 2.6 5.7 5.6 3.4 3.3 2.6 4.2 2.8 10.3 5.3 1.4 2.1 3.5 2.3 2.5 6.1 19.1 4.4 2.3 10.5 2.0 2.3 2.1 1.6 9.1 3.7 2.8 7.1 8.6 3.8 8.1 7.3 6.9 8.0 5.4 5.3 9.2 5.0 9.4 5.9 5.6 6.2 7.6 2.1 6.7 8.5 8.1 10.9 7.3 19.3 23.4 21.5 26.2 12.7 10.9 9.6 21.6 12.5 10.6 0.0 0.6 0.5 5.0 3.7 6.1 10.7 5.1 1.4 1.2 0.0 9.8 5.3 0.0 0.0 25.0 3.8 4.0 23.3 0.0 1.7 4.6 2.6 1.1 4.5 4.9 3.2 11.6 1.8 4.7 27.9 8.9 1.5 3.3 0.0 3.4 5.8 0.0 1.4 5.6 0.0 6.3 6.5 3.1 12.2 2.3 2.9 2.7 5.2 2.3 4.2 NIPA2 SLC57A2 ENSG00000140157 "Non imprinted in Prader-Willi/Angelman syndrome 2" Q8N8Q9 15 22838641-22868384 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA067160: AB_2685794, HPA071342: AB_2686391" "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 19.3 26.9 18.6 26.1 22.2 22.1 19.9 17.7 28.2 16.8 30.0 16.6 23.9 28.4 21.7 18.3 26.5 16.1 21.3 17.4 16.7 21.3 26.3 27.8 22.5 35.0 17.9 13.8 19.0 30.8 21.1 24.7 31.3 18.5 20.6 30.1 20.0 26.9 14.0 18.8 16.4 37.1 18.2 13.5 43.9 21.4 19.5 13.1 27.9 21.1 19.2 31.5 22.2 17.2 38.1 40.3 27.2 26.5 22.1 24.6 21.5 30.1 30.8 15.8 18.6 15.2 17.3 17.9 33.9 30.0 23.3 27.3 22.8 19.2 29.8 21.6 19.5 24.0 24.2 29.1 17.1 23.7 31.6 18.8 26.7 20.6 18.4 22.6 37.8 25.3 16.9 19.3 19.2 20.1 15.1 27.2 24.6 40.0 35.8 29.8 12.0 12.0 17.7 18.5 32.4 28.5 26.2 26.8 22.6 22.3 37.1 21.3 22.5 25.9 25.7 28.5 15.3 23.3 35.6 28.2 30.9 20.1 22.3 68.6 28.4 41.1 32.3 23.6 38.3 26.5 27.2 21.4 18.0 21.4 26.5 24.4 38.1 19.3 23.5 26.2 32.7 18.4 18.7 15.8 22.1 24.9 40.3 24.6 21.5 18.6 22.2 17.7 28.2 16.7 21.3 17.9 13.8 18.5 13.1 14.9 20.2 64.8 29.3 40.1 8.8 2.0 15.3 16.0 14.8 12.2 11.8 35.4 18.3 36.8 4.8 28.5 29.6 0.0 38.2 54.4 23.4 34.7 9.3 19.4 43.1 20.6 23.4 24.5 25.4 2.2 12.4 28.7 21.9 27.9 26.1 23.6 43.8 31.3 19.8 18.6 11.6 12.9 29.9 21.5 32.4 50.6 70.6 34.6 32.2 91.1 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.8" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 40.1;Paneth cells: 31.6;Urothelial cells: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.0;CAPAN-2: 9.9;HaCaT: 13.1;HBEC3-KT: 9.4;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.5 0.4 0.4 5.4 1.4 0.0 2.2 0.8 0.7 3.6 9.1 0.1 0.0 3.3 0.4 6.3 18.5 1.1 1.8 0.6 0.7 0.7 4.6 10.7 0.5 0.0 0.4 0.2 0.8 6.6 2.9 5.5 30.8 0.7 3.0 8.9 1.2 5.3 0.6 0.7 17.1 12.6 1.0 0.6 0.4 4.3 0.8 0.3 0.2 2.0 9.8 11.2 4.2 5.3 1.0 1.4 1.4 0.8 0.6 0.9 0.0 11.0 0.2 0.0 0.0 0.0 0.0 1.8 2.1 2.0 1.6 2.8 6.6 9.9 0.0 1.5 0.0 2.9 13.1 1.9 9.4 4.1 0.1 2.4 0.0 0.1 0.4 0.0 0.1 0.1 0.1 3.5 0.1 2.3 2.7 0.5 0.7 0.1 0.0 2.3 4.2 0.1 0.1 1.7 7.6 2.9 0.0 0.0 0.0 5.6 15.1 1.0 0.3 1.0 3.7 1.6 0.9 2.4 0.0 4.2 0.1 3.9 0.0 0.2 0.1 0.1 0.0 0.2 0.0 4.2 0.9 0.8 0.5 0.8 0.4 0.6 0.4 0.5 0.3 0.1 1.0 0.7 0.9 1.4 0.6 0.5 1.4 0.3 0.0 0.4 1.4 0.8 0.7 0.7 0.7 0.4 0.2 0.7 0.3 8.9 6.7 0.0 22.7 12.8 0.1 2.6 0.0 2.7 14.8 40.1 0.0 1.6 0.0 8.8 0.5 0.3 27.6 0.0 5.8 1.0 1.3 24.9 0.0 10.4 0.3 0.0 11.1 0.6 0.0 0.0 0.0 0.2 1.7 1.0 27.4 0.5 10.3 31.6 0.0 1.0 3.8 0.0 2.1 1.0 1.5 28.9 3.0 0.7 29.9 36.3 NIPAL2 "FLJ13955, NPAL2" ENSG00000104361 "NIPA like domain containing 2" Q9H841 8 98189833-98294393 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.9;OE19: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071759 Uncertain NA NA "HPA071759: AB_2686443" "unprognostic (5.14e-3)" "unprognostic (6.43e-2)" "unprognostic (8.01e-2)" "unprognostic (2.02e-1)" "unprognostic (4.52e-2)" "unprognostic (5.18e-2)" "unprognostic (3.72e-1)" "unprognostic (9.45e-2)" "unprognostic (1.90e-2)" "unprognostic (3.67e-1)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.18e-3)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (4.76e-2)" 9.1 10.1 6.0 7.7 8.5 3.6 11.5 8.0 18.3 13.6 11.3 2.0 13.8 5.8 10.8 27.8 22.2 8.6 11.5 6.5 6.5 5.9 4.6 4.9 7.9 8.0 3.2 8.8 22.2 18.3 8.4 28.9 5.4 6.9 15.5 15.9 9.1 15.4 14.0 3.4 33.8 7.9 5.2 3.1 5.9 12.5 4.9 1.8 2.3 5.8 9.4 13.5 11.0 15.6 4.2 6.7 4.9 3.6 2.7 3.6 2.8 4.0 1.6 0.5 0.0 24.9 15.2 0.1 7.3 9.3 1.3 1.8 0.0 12.0 7.6 8.5 10.2 2.0 4.8 0.3 4.3 1.0 0.6 1.5 2.8 1.1 0.5 3.2 2.9 3.0 15.6 11.6 1.3 4.1 0.8 1.6 0.0 0.0 15.5 5.4 5.6 0.1 1.6 1.0 19.7 0.6 0.0 0.1 0.8 4.9 9.2 0.8 1.6 5.3 4.6 1.8 0.6 4.9 5.4 4.9 1.0 0.1 3.8 0.0 0.2 0.0 0.0 1.8 9.5 5.0 0.2 3.6 4.9 1.3 3.4 0.1 3.4 1.2 1.3 6.7 4.2 0.1 1.0 0.7 2.7 2.6 2.8 3.6 2.8 6.0 8.5 8.0 18.3 6.5 5.9 3.2 8.8 6.9 1.8 3.0 5.7 4.2 7.0 13.6 16.1 4.2 7.6 12.0 4.5 3.5 2.0 0.1 0.0 7.2 5.7 8.7 10.3 0.0 11.0 0.9 7.5 17.9 5.7 3.0 4.1 20.6 6.9 9.8 4.7 2.9 23.9 7.4 3.3 1.0 21.4 11.4 9.8 7.0 21.5 1.0 2.7 6.5 3.9 0.7 0.6 19.9 0.2 1.9 12.8 19.2 NIPSNAP3B FLJ11275 ENSG00000165028 "Nipsnap homolog 3B" Q9BS92 9 104764157-104777457 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 28.6;skeletal muscle: 34.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 19.0;Ito cells: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 1.7;granulocytes: 6.5" "Cell line enhanced" "Detected in some" "REH: 7.6;THP-1: 5.3;U-266/70: 5.9" "Low region specificity" "Detected in all" HPA042491 Uncertain NA NA "HPA042491: AB_2678023" "unprognostic (1.72e-2)" "unprognostic (1.47e-2)" "unprognostic (9.76e-2)" "unprognostic (1.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (8.36e-2)" "unprognostic (1.41e-3)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (4.25e-5)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (5.61e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (4.81e-2)" 14.4 8.4 6.1 2.1 11.3 1.2 10.1 3.7 7.8 4.0 1.7 1.5 4.2 1.5 5.0 4.5 3.1 3.5 3.0 28.6 4.4 6.8 2.3 1.3 2.1 2.2 4.4 7.7 5.4 4.7 2.5 8.0 5.1 5.0 5.1 1.7 3.8 2.2 5.9 34.6 1.7 1.9 3.2 3.4 2.5 1.9 2.0 2.8 0.4 3.1 14.1 2.8 2.2 2.5 3.5 1.7 6.5 0.5 0.8 0.6 0.5 0.0 0.3 0.5 0.2 2.0 1.8 1.4 0.4 0.9 1.3 0.6 0.3 0.8 0.9 0.3 0.8 0.0 0.0 0.6 0.5 0.5 0.0 0.6 3.5 1.9 0.2 1.6 0.6 0.8 1.4 0.7 0.5 0.1 1.6 0.5 1.4 3.1 0.2 0.2 0.4 1.5 3.2 0.7 0.0 0.5 7.6 0.0 0.2 0.5 0.4 1.3 4.0 4.7 0.0 0.4 0.4 3.7 5.3 0.3 0.6 1.6 0.7 0.1 5.9 2.3 0.1 0.0 0.3 0.1 6.5 0.1 2.4 0.2 0.1 0.0 3.5 0.4 0.0 1.7 2.0 0.6 0.3 0.0 0.8 0.5 1.2 0.0 0.5 6.1 11.3 3.7 7.8 4.4 6.8 4.4 7.7 5.0 2.8 0.0 1.4 2.7 1.5 0.3 4.4 19.0 0.0 4.0 0.0 3.5 0.0 0.6 5.0 0.5 0.0 2.2 0.0 0.0 0.2 0.2 1.3 0.3 1.1 0.0 4.8 0.0 1.2 7.4 1.6 0.0 2.3 2.3 0.0 6.4 0.0 0.9 0.1 0.0 6.3 0.0 0.3 0.0 3.3 0.1 1.1 0.6 0.7 0.0 0.0 0.1 NKAIN1 "FAM77C, FLJ12650" ENSG00000084628 "Sodium/potassium transporting ATPase interacting 1" Q4KMZ8 1 31179745-31239554 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 1.7;Suprabasal keratinocytes: 1.3" "Group enriched" "Detected in many" 5 "breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.4;AN3-CA: 17.2;NTERA-2: 44.3;SCLC-21H: 13.2;SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006873 Uncertain NA NA "HPA006873: AB_1848410" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (8.54e-2)" "unprognostic (6.11e-5)" "unprognostic (6.59e-2)" "unprognostic (1.24e-1)" "unprognostic (4.30e-4)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (2.78e-2)" "unprognostic (2.01e-2)" "unprognostic (8.07e-2)" "unprognostic (6.31e-9)" "unprognostic (1.00e-2)" "unprognostic (8.83e-3)" "unprognostic (1.62e-4)" "unprognostic (5.50e-2)" 0.7 15.5 4.2 0.8 13.3 0.5 1.2 23.2 11.8 0.6 0.7 10.7 0.0 0.7 1.5 5.8 1.4 0.8 0.6 0.6 6.3 4.3 0.6 0.5 0.5 0.5 4.7 7.2 0.6 0.7 0.7 0.3 0.9 18.2 2.2 0.7 0.0 0.7 1.1 26.2 1.9 0.7 0.8 3.3 0.5 0.6 0.9 9.0 0.0 0.5 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.4 17.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 44.3 0.0 0.4 0.0 0.1 0.0 0.0 1.5 13.2 21.0 0.4 0.1 1.1 1.2 4.6 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.3 23.2 9.5 6.3 4.3 4.7 7.2 18.2 9.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 0.1 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Group enriched" "Detected in some" 16 "Horizontal cells: 44.5;Muller glia cells: 20.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol NA NA Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.2 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 0.0 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 44.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NKAIN3 "FAM77D, FLJ39630" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-62999652 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.4;Early spermatids: 1.9;Late spermatids: 2.9;Melanocytes: 1.7;Proximal tubular cells: 1.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.5;HeLa: 2.0;OE19: 1.0;PC-3: 2.5;REH: 2.6;RT4: 1.6;SCLC-21H: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced NA NA "HPA018833: AB_2669943" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.8 3.4 13.7 1.2 15.5 0.8 1.0 0.6 9.7 1.3 1.4 6.9 0.0 0.7 1.7 0.7 0.8 1.1 0.8 1.1 15.1 1.6 0.8 0.9 0.7 0.8 2.3 7.5 0.9 0.7 0.7 0.8 1.0 7.3 1.0 0.8 0.3 5.9 1.4 2.2 0.7 2.3 0.7 7.3 0.9 0.9 1.9 7.1 0.0 0.8 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 2.6 0.0 0.0 0.0 1.6 5.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.5 0.6 9.7 15.1 1.6 2.3 7.5 7.3 7.1 0.0 0.0 0.0 0.1 0.3 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.3 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 NKAIN4 "bA261N11.2, C20orf58, FAM77A" ENSG00000101198 "Sodium/potassium transporting ATPase interacting 4" Q8IVV8 20 63240784-63272694 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 51.7" "Group enriched" "Detected in some" 11 "Muller glia cells: 68.6;Proximal tubular cells: 169.4" "Cancer enriched" "Detected in many" 6 "glioma: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.6;MOLT-4: 25.4;SK-MEL-30: 5.6;SuSa: 20.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5" HPA029876 Approved NA NA "HPA029876: AB_10602038" "unprognostic (1.26e-1)" "unprognostic (4.27e-1)" "unprognostic (6.07e-5)" "prognostic unfavorable (3.14e-4)" "unprognostic (6.65e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-3)" "unprognostic (1.94e-1)" "unprognostic (3.62e-2)" "unprognostic (2.69e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (2.12e-2)" "unprognostic (1.44e-4)" "unprognostic (5.66e-2)" "unprognostic (6.74e-2)" "unprognostic (4.01e-1)" 1.1 1.9 21.7 1.2 23.0 1.0 1.0 5.7 51.7 1.3 1.1 9.9 0.0 1.2 1.4 1.3 0.9 1.3 1.0 0.9 15.5 15.5 10.9 0.9 0.9 0.9 18.5 11.8 0.9 1.0 0.9 0.4 3.9 6.2 1.0 1.0 1.0 0.9 1.1 0.9 1.4 1.1 1.0 9.1 1.0 1.1 2.7 7.1 0.0 1.2 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.4 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 25.4 0.0 3.2 0.0 0.0 4.6 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.1 5.6 20.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 23.0 5.7 13.2 15.5 15.5 18.5 11.8 6.2 7.1 0.0 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 10.4 0.0 0.6 5.0 0.2 0.1 0.1 0.0 0.0 0.5 3.6 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 4.9 0.0 0.0 0.0 0.0 68.6 2.6 0.0 0.0 169.4 1.7 0.0 0.2 0.2 1.9 0.0 1.9 0.0 0.0 0.0 NKAPL "bA424I5.1, C6orf194" ENSG00000189134 "NFKB activating protein like" Q5M9Q1 6 28259320-28260958 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 35.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 224.7;Rod photoreceptor cells: 72.8;Spermatocytes: 169.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 6.1;BJ: 2.6;fHDF/TERT166: 4.0;HHSteC: 8.7;HSkMC: 5.7;HUVEC TERT2: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.93e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (9.73e-2)" "unprognostic (2.47e-1)" "unprognostic (7.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.88e-2)" "unprognostic (3.84e-3)" "unprognostic (5.78e-2)" "unprognostic (5.83e-5)" "unprognostic (6.65e-3)" "unprognostic (2.38e-1)" "unprognostic (2.08e-2)" "unprognostic (2.47e-2)" 2.8 2.3 3.2 1.4 5.1 0.8 2.6 6.7 5.1 1.4 2.4 1.7 2.7 0.9 1.6 2.8 1.8 1.2 2.2 6.9 2.7 2.6 1.8 1.6 1.5 1.4 3.8 1.2 3.2 2.5 0.7 10.3 1.6 9.9 2.4 1.1 2.0 2.4 4.1 7.0 1.4 1.1 5.1 3.9 2.2 1.6 35.4 4.0 0.0 1.9 2.0 1.2 2.3 3.9 2.2 5.2 4.8 2.6 0.5 0.8 0.4 0.0 0.0 0.0 0.0 6.1 1.8 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 5.7 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 2.1 3.1 0.3 2.6 0.8 2.2 0.1 0.5 1.9 0.4 0.5 0.4 4.8 0.5 2.1 5.2 0.0 0.4 3.2 5.1 6.7 5.1 2.7 2.6 3.8 1.2 9.9 4.0 0.0 0.0 0.5 1.6 0.9 25.4 12.0 2.5 0.0 2.3 1.8 41.2 0.1 8.3 1.5 224.7 3.6 0.0 0.0 0.6 0.0 2.8 1.1 0.0 2.9 2.7 31.8 0.0 3.1 3.8 15.8 5.2 2.6 5.0 3.6 0.0 15.8 1.6 0.0 6.0 3.6 72.8 0.0 4.6 169.4 25.8 0.6 0.2 0.0 0.0 0.5 NKPD1 FLJ33600 ENSG00000179846 "NTPase KAP family P-loop domain containing 1" Q17RQ9 19 45149750-45158737 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 17.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 4.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043339 Uncertain NA NA "HPA043339: AB_10962493" "unprognostic (3.98e-2)" "unprognostic (5.94e-2)" "unprognostic (2.14e-1)" "unprognostic (8.30e-4)" "unprognostic (2.23e-1)" "unprognostic (4.60e-2)" "unprognostic (2.41e-3)" "unprognostic (2.01e-2)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (7.73e-4)" "unprognostic (1.30e-1)" "unprognostic (2.77e-5)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" 0.0 0.1 0.0 0.0 0.1 0.2 0.8 0.5 0.2 0.9 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.8 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.4 0.2 0.2 0.5 0.1 0.2 1.8 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.5 0.6 1.5 0.1 0.1 0.1 0.0 0.0 0.2 4.0 0.0 0.1 0.1 0.1 0.2 0.4 0.7 0.0 1.1 0.7 0.5 0.3 1.8 0.4 0.1 0.0 0.3 0.0 0.1 0.6 0.3 3.5 1.8 0.1 0.5 1.3 0.3 0.0 0.0 0.0 0.0 0.0 7.3 1.7 0.3 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.6 0.0 0.2 1.8 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 1.1 0.1 0.0 0.0 0.0 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406331 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "pituitary gland: 1.0;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 0.2" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445239-124450184 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;intestine: 2.9;skin 1: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.0;hTCEpi: 5.9;NTERA-2: 11.6;SCLC-21H: 5.1;SuSa: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029367 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.9 0.2 2.9 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.4 0.0 0.7 3.7 0.3 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 1.2 0.0 0.0 2.2 2.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 6.0 0.5 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.1 14.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.2 2.9 0.6 0.3 0.7 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-2 "NKX2.2, NKX2B" ENSG00000125820 "NK2 homeobox 2" O95096 20 21511010-21514026 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.6;pancreas: 12.1" "Cell type enriched" "Detected in some" 68 "Intestinal endocrine cells: 159.5" "Group enriched" "Detected in many" 5 "glioma: 9.5;pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.5;T-47d: 5.3;U-138 MG: 18.9;U-2 OS: 3.9;WM-115: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003468 Approved NA NA "HPA003468: AB_1079490" "unprognostic (5.13e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" 0.6 0.6 6.5 0.7 8.1 0.7 0.6 3.4 15.5 0.6 1.4 19.1 0.0 6.2 0.6 0.6 0.6 0.6 0.6 0.6 7.8 6.9 0.6 0.6 0.6 0.7 14.2 6.4 0.6 12.1 1.0 4.6 0.6 10.9 0.7 1.4 0.0 0.6 0.6 0.6 0.8 2.5 0.6 30.6 0.6 7.0 0.6 9.4 0.0 0.6 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.0 18.9 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.1 3.4 7.6 7.8 6.9 14.2 6.4 10.9 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532933-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.8 0.0 0.1 17.2 0.1 0.0 0.1 0.1 0.1 0.3 21.6 0.1 0.1 10.4 0.2 0.1 0.5 0.0 12.5 0.1 0.1 0.0 0.1 0.2 0.1 1.1 0.1 0.1 0.1 6.4 0.0 0.1 0.1 0.1 0.1 4.6 0.1 9.0 0.5 0.1 0.0 19.1 3.1 0.1 36.8 1.8 0.1 0.1 0.2 1.0 0.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 6.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.4 0.0 1.6 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell type enhanced" "Detected in single" 18 "Basal glandular cells: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.5 10.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13545050 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 18.3;lymphoid tissue: 6.5" "Cell type enriched" "Detected in single" 31 "Cardiomyocytes: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 1.7 0.0 0.1 6.5 0.1 0.0 0.1 0.1 0.1 1.1 18.3 0.1 0.1 1.6 0.9 0.1 2.3 0.2 0.4 1.8 0.1 0.0 0.4 0.1 0.1 2.0 0.1 0.1 2.9 0.2 0.0 0.9 0.1 0.1 0.6 2.4 0.1 1.5 0.6 0.1 0.1 2.0 3.2 0.1 5.3 2.8 0.9 0.1 0.1 0.3 0.9 0.1 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.9 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 1.0 0.0 4.6 0.0 0.0 0.0 2.6 0.6 1.7 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 1.9 0.0 0.7 1.7 0.0 0.7 0.0 0.4 12.7 7.2 0.0 0.5 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.3 1.0 7.6 0.0 0.5 3.0 0.1 0.5 2.2 0.0 0.0 0.4 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX6-3 FLJ25169 ENSG00000165066 "NK6 homeobox 3" A6NJ46 8 41645178-41650669 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.8;intestine: 10.8;stomach 1: 33.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "endometrial cancer: 0.9;pancreatic cancer: 3.1;stomach cancer: 3.9;testis cancer: 1.6" "Region enriched" "Detected in some" 10 "cerebellum: 13.8" "Cell type enriched" "Detected in single" 17 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Group enriched" "Detected in some" 7 "Daudi: 11.0;THP-1: 5.1" NA NA "unprognostic (1.87e-1)" "unprognostic (9.91e-3)" "unprognostic (4.04e-1)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (1.13e-1)" "unprognostic (2.17e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-1)" 0.2 0.0 0.4 0.2 0.5 0.0 0.2 13.8 1.3 0.2 4.6 0.2 0.2 10.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.8 2.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.7 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 13.8 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4, Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;seminal vesicle: 15.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 9.5;Bipolar cells: 8.5;Urothelial cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;memory CD4 T-cell: 1.7" "Group enriched" "Detected in many" 12 "B-cells: 3.0;T-cells: 1.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;SuSa: 12.8;U-138 MG: 14.3" HPA001651 Approved "Intracellular and membrane" NA NA "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.4 1.9 4.7 1.4 18.7 0.4 1.3 11.2 23.8 0.4 2.5 11.2 2.4 1.2 0.4 4.0 4.3 0.4 4.8 0.8 4.9 5.7 2.0 4.4 1.3 2.7 3.7 0.0 0.5 3.3 0.4 2.9 0.9 12.6 12.6 3.1 7.2 2.2 15.3 0.6 1.3 2.0 3.7 3.5 1.1 1.5 1.3 0.0 2.5 2.6 4.0 2.5 6.0 0.0 3.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 19.6 1.2 1.6 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 3.1 17.5 0.0 0.0 0.0 2.8 2.1 0.0 0.0 6.8 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.2 0.0 3.9 0.0 0.0 0.0 1.2 0.0 4.7 7.5 2.6 0.0 0.0 0.0 0.0 12.8 0.0 0.4 5.6 14.3 0.0 0.0 3.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.0 1.7 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 4.7 18.7 11.2 23.8 4.9 5.7 3.7 0.0 12.6 0.0 0.0 2.2 0.0 9.5 3.1 8.5 0.7 2.5 2.7 6.8 7.0 0.0 0.3 0.0 1.6 0.0 0.7 0.0 0.0 0.0 0.1 7.1 4.5 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 2.6 0.0 1.7 4.6 0.0 4.0 0.0 0.0 7.8 0.6 0.7 0.0 1.0 0.1 0.4 2.8 0.2 0.0 0.0 10.1 NLRP11 "CLR19.6, NALP11, NOD17, PAN10, PYPAF6" ENSG00000179873 "NLR family pyrin domain containing 11" P59045 19 55785397-55836800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6" "Cell type enhanced" "Detected in some" 26 "Collecting duct cells: 1.8;Early spermatids: 10.0;Late spermatids: 2.7;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 39.1;RPMI-8226: 22.0;U-266/70: 38.9;U-266/84: 16.8;U-698: 28.3" "Not detected" "Not detected" "HPA046402, HPA078027" Uncertain Supported Cytosol NA NA Cytosol "HPA046402: AB_10962951, HPA078027: AB_2732369" "unprognostic (2.36e-2)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (4.36e-3)" "unprognostic (3.31e-2)" "unprognostic (7.88e-2)" "unprognostic (9.95e-3)" "unprognostic (8.04e-2)" "unprognostic (1.94e-1)" "unprognostic (2.52e-1)" "unprognostic (3.75e-2)" "unprognostic (3.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.06e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-2)" "unprognostic (7.61e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 4.0 0.1 0.3 0.2 0.1 0.1 0.0 0.7 3.3 0.1 0.6 0.1 0.1 0.9 0.4 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 1.2 0.1 0.1 0.3 0.5 3.6 0.1 0.1 0.1 0.1 4.5 0.1 0.1 1.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.0 0.0 38.9 16.8 28.3 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 2.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 NLRP13 "CLR19.7, NALP13, NOD14, PAN13" ENSG00000173572 "NLR family pyrin domain containing 13" Q86W25 19 55891699-55932336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "breast: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060459 Uncertain NA NA "HPA060459: AB_2684284" "unprognostic (2.16e-1)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP2B "CLRX.1, NALP2P, NLRP2P, NOD24, POP4" ENSG00000215174 "NLR family pyrin domain containing 2B" P0DMW2 X 57677067-57680260 "Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.9" NA NA "unprognostic (3.37e-2)" "unprognostic (1.07e-1)" "unprognostic (6.67e-2)" "unprognostic (3.84e-2)" "unprognostic (1.80e-1)" "unprognostic (5.78e-3)" "unprognostic (3.49e-2)" "unprognostic (1.44e-3)" "unprognostic (1.39e-2)" "unprognostic (7.56e-4)" "unprognostic (7.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.75e-3)" "unprognostic (9.00e-2)" 0.3 0.2 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP5 "CLR19.8, MATER, NALP5, PAN11, PYPAF8" ENSG00000171487 "NLR family pyrin domain containing 5" P59047 19 55999726-56061813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "parathyroid gland: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "Karpas-707: 3.1;U-2 OS: 9.2" HPA056271 Uncertain "Intracellular and membrane" NA NA "HPA056271: AB_2683083" "unprognostic (9.67e-2)" "unprognostic (2.22e-2)" "unprognostic (5.03e-1)" "unprognostic (7.78e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 19.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP8 "CLR19.2, NALP8, NOD16, PAN4" ENSG00000179709 "NLR family pyrin domain containing 8" Q86W28 19 55947832-55988629 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.7;breast: 1.9;heart muscle: 1.5" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 10.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA056989 Uncertain NA NA "HPA056989: AB_2683301" "unprognostic (2.43e-2)" "unprognostic (3.35e-1)" "unprognostic (3.13e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.3 1.7 0.2 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.3 0.7 0.5 0.0 0.7 0.7 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.3 1.7 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.0 0.7 0.3 0.3 0.8 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 NME8 "CILD6, NM23-H8, SPTRX2, TXNDC3" ENSG00000086288 "NME/NM23 family member 8" Q8N427 7 37848597-37900401 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 7.9;bone marrow: 13.4;testis: 11.3" "Group enriched" "Detected in some" 5 "Early spermatids: 33.4;Late spermatids: 14.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.5;THP-1: 3.2;U-937: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016416, HPA019259, HPA029572" Enhanced Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB016416: , HPA019259: AB_1858475, HPA029572: " "unprognostic (7.44e-3)" "unprognostic (2.32e-2)" "unprognostic (9.11e-2)" "unprognostic (2.97e-2)" "unprognostic (6.05e-2)" "unprognostic (1.20e-2)" "unprognostic (6.56e-2)" "unprognostic (4.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (2.34e-2)" "unprognostic (8.13e-8)" "unprognostic (5.90e-2)" "unprognostic (3.36e-1)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 0.5 0.1 13.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 1.9 0.1 11.3 0.0 0.2 0.0 0.0 0.0 7.9 3.8 1.9 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 1.9 1.5 0.7 0.4 0.0 0.0 0.1 1.3 1.5 0.0 0.0 0.7 3.8 0.2 0.0 7.9 0.0 0.8 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 3.0 14.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 3.8 0.0 0.0 NME9 "NM23-H9, TXL-2, TXNDC6" ENSG00000181322 "NME/NM23 family member 9" Q86XW9 3 138261437-138329886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.4" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.2" "Lineage enriched" "Detected in single" 4 "T-cells: 4.2" "Cell line enhanced" "Detected in many" "HMC-1: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020943, HPA040000, HPA043881" Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712" "unprognostic (2.71e-5)" "unprognostic (1.68e-1)" "unprognostic (5.09e-2)" "unprognostic (3.01e-3)" "unprognostic (3.67e-1)" "unprognostic (1.69e-3)" "unprognostic (4.58e-2)" "unprognostic (5.19e-2)" "unprognostic (1.66e-1)" "unprognostic (1.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.72e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (9.14e-2)" "unprognostic (4.89e-2)" "unprognostic (7.17e-3)" 1.0 1.7 5.3 1.3 11.3 4.4 1.0 6.2 8.3 1.5 0.8 4.1 3.5 1.1 1.6 3.6 0.8 30.4 1.3 0.9 5.6 8.2 1.7 0.8 4.0 1.1 3.6 3.1 2.5 3.3 1.8 7.5 1.1 10.3 1.7 0.8 0.9 3.4 1.9 4.3 1.8 1.1 1.0 3.6 1.2 1.5 6.0 3.9 0.9 2.3 0.0 1.0 0.8 0.5 0.6 0.6 0.3 0.9 0.3 4.2 0.5 1.1 1.6 1.1 0.5 0.0 0.0 1.7 0.7 0.0 0.2 0.1 0.9 1.9 2.5 1.2 0.0 1.3 1.3 0.2 0.0 0.0 0.5 1.8 2.1 1.6 0.6 0.0 2.7 4.9 0.9 0.0 0.1 0.0 2.9 0.1 3.2 0.6 1.4 0.2 0.4 0.6 2.5 0.7 0.5 1.2 1.0 0.0 0.7 1.7 2.6 3.7 1.0 1.6 0.6 0.4 0.9 0.9 0.1 3.0 0.5 0.8 0.8 0.6 0.9 1.2 1.1 1.0 1.1 0.5 0.1 0.9 0.0 0.5 0.0 4.2 0.2 1.7 0.4 0.3 0.6 2.8 1.2 0.3 0.3 0.2 0.6 0.7 0.5 5.3 11.3 6.2 8.3 5.6 8.2 3.6 3.1 10.3 3.9 0.0 0.3 0.0 0.2 0.0 1.3 1.1 2.5 64.3 3.4 1.8 0.0 0.1 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 2.3 0.0 0.0 5.5 0.5 0.0 0.2 0.0 0.0 0.0 NMS ENSG00000204640 "Neuromedin S" Q5H8A3 2 100470482-100483280 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 3.2;testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HL-60: 12.6;HMC-1: 7.7" "Group enriched" "Detected in some" 4 "basal ganglia: 2.6;hypothalamus: 6.3;pons and medulla: 1.4" "Secreted in brain" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMUR1 "FM-3, GPC-R, GPR66, NMU1R" ENSG00000171596 "Neuromedin U receptor 1" Q9HB89 2 231523160-231530495 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ito cells: 8.0;Peritubular cells: 7.1;Rod photoreceptor cells: 15.5;T-cells: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 15.2;MAIT T-cell: 3.9;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.6;NK-cell: 8.1" "Group enriched" "Detected in many" 18 "NK-cells: 8.1;T-cells: 15.2" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA027895 Uncertain NA NA "HPA027895: AB_10602713" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (6.74e-3)" "unprognostic (9.44e-3)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.22e-2)" "unprognostic (2.07e-1)" "unprognostic (4.08e-4)" "unprognostic (3.76e-3)" "unprognostic (2.26e-1)" "unprognostic (2.61e-1)" "unprognostic (5.25e-2)" 13.6 2.2 0.6 1.2 0.9 3.5 3.2 2.1 0.8 2.5 3.5 0.4 4.4 4.4 1.8 3.8 3.3 3.0 4.6 12.6 0.3 0.3 2.1 2.0 6.4 0.5 0.3 0.1 2.8 7.7 0.2 0.6 4.8 0.6 4.0 1.2 8.4 4.6 3.6 0.3 0.8 7.3 8.4 0.6 7.3 1.7 3.0 0.7 0.2 1.8 0.6 0.8 4.4 1.4 0.0 0.3 0.6 0.1 8.1 15.2 3.6 0.3 1.2 1.5 1.5 0.1 0.4 1.3 0.5 0.0 0.0 0.1 0.4 0.5 0.8 0.4 0.4 0.7 0.7 2.6 0.5 0.1 0.5 0.9 0.8 1.1 0.4 0.1 0.8 1.3 0.7 0.3 0.4 0.0 1.2 0.6 0.6 2.5 1.4 0.1 0.8 0.6 1.1 0.7 0.6 0.3 0.4 0.8 0.7 0.1 0.9 0.6 0.7 1.0 0.6 0.3 1.1 1.3 1.6 1.6 1.7 1.3 0.8 0.4 2.0 0.1 0.6 0.5 0.8 0.6 0.4 0.1 0.0 15.2 0.0 3.9 0.0 1.2 7.3 0.0 0.0 0.1 4.6 0.6 8.1 0.1 0.3 0.5 3.6 0.6 0.9 2.1 0.8 0.3 0.3 0.3 0.1 0.6 0.7 0.0 0.0 0.0 0.1 0.9 1.4 2.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.8 0.4 0.0 0.0 0.2 0.1 1.4 0.0 1.1 0.0 0.2 1.6 0.0 8.0 1.9 0.2 2.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 7.1 0.0 15.5 0.0 0.3 1.5 3.2 0.4 0.6 10.9 0.0 0.1 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521215-37523693 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 117.2;pituitary gland: 165.1;placenta: 69.1" "Group enriched" "Detected in many" 9 "Early spermatids: 30.8;Late spermatids: 51.7;Muller glia cells: 77.7" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Region enhanced" "Detected in all" "basal ganglia: 117.2" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 22 "SH-SY5Y: 127.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 17.0 11.6 35.4 2.6 117.2 2.3 3.5 4.9 68.4 2.3 7.0 11.1 0.0 3.4 4.6 2.5 2.6 2.8 4.2 1.7 35.0 21.4 1.4 1.1 1.7 1.9 4.9 14.0 1.3 1.6 1.0 165.1 69.1 7.9 2.4 3.9 1.5 3.4 1.5 8.0 3.8 3.2 4.4 2.1 1.8 2.1 2.9 3.8 0.2 1.5 0.0 1.1 3.3 0.6 0.7 0.7 0.3 0.3 0.0 1.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.6 0.0 0.0 3.2 0.3 127.5 0.1 0.7 0.0 0.1 0.2 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 1.0 0.3 0.0 0.0 0.7 0.0 0.0 35.4 117.2 4.9 41.0 35.0 21.4 4.9 14.0 7.9 3.8 0.0 0.0 0.0 0.7 3.5 3.7 0.0 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.4 1.0 2.2 1.1 0.0 1.4 0.0 0.0 0.0 0.0 51.7 0.6 0.0 1.7 0.0 0.0 77.7 0.0 0.0 1.1 0.0 6.0 0.0 0.4 1.1 3.8 0.9 0.2 0.0 0.0 2.3 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.7 5.5 2.2 4.1 5.0 2.1 13.5 7.1 5.1 10.1 7.3 7.3 2.0 15.8 5.7 5.3 14.3 3.4 11.4 6.2 9.6 7.0 4.6 7.3 3.3 6.4 4.5 10.7 4.3 2.4 3.1 11.2 7.6 2.0 4.4 3.2 13.1 5.2 4.5 5.4 7.3 5.6 7.0 2.1 5.9 6.0 6.4 5.6 6.8 3.1 8.2 5.5 4.5 5.1 4.0 8.9 3.7 8.3 6.6 5.5 7.1 5.2 8.4 4.3 4.0 10.0 5.1 21.2 6.9 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 8.9 0.6 0.0 2.6 0.0 4.7 0.0 2.5 1.4 1.2 0.0 13.7 4.3 1.7 1.9 0.6 0.0 0.3 0.0 0.2 7.7 0.5 2.0 2.3 1.5 1.4 1.6 0.0 0.6 2.2 0.0 0.9 0.7 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.1 4.6 0.0 0.0 0.9 3.2 0.0 10.1 0.0 0.0 1.7 NOTO ENSG00000214513 "Notochord homeobox" A8MTQ0 2 73202258-73212513 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034660, HPA063906" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034660: AB_10601974, HPA063906: " "unprognostic (6.09e-2)" "unprognostic (9.77e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.68e-2)" 0.2 0.8 0.3 0.6 0.4 2.3 0.3 1.4 0.2 0.1 0.5 0.1 0.1 0.8 0.1 0.6 0.1 0.1 0.4 0.2 0.2 0.6 0.1 0.2 0.3 0.5 0.3 0.1 0.2 0.1 0.0 0.4 0.1 2.4 1.3 0.3 0.6 0.2 0.1 0.5 2.2 2.7 0.1 0.5 0.5 0.5 5.7 0.1 0.7 0.1 0.1 0.1 0.4 0.1 0.8 0.8 2.6 0.8 1.4 1.0 0.3 0.2 0.2 0.4 0.5 0.2 0.3 0.7 0.3 0.0 0.1 0.2 1.1 0.8 0.3 0.2 0.3 0.3 1.1 0.1 0.4 0.5 0.8 0.4 0.5 1.8 0.7 0.0 0.6 1.4 0.2 0.4 0.1 0.0 0.3 0.0 0.5 0.1 1.0 0.0 0.6 0.1 0.4 0.7 0.0 0.5 0.7 0.2 0.3 0.1 0.8 0.9 0.6 1.1 0.8 0.0 0.6 0.7 0.6 1.3 0.8 0.4 0.2 0.7 0.7 0.2 0.8 0.3 1.0 0.2 1.9 0.8 0.3 0.6 0.3 0.9 0.6 0.8 0.5 0.3 0.8 0.8 1.0 2.6 1.4 0.5 0.8 0.5 0.3 0.3 0.4 1.4 0.2 0.2 0.6 0.3 0.1 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.9" "Group enriched" "Detected in some" 27 "Early spermatids: 112.2;Late spermatids: 97.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.9" "Lineage enhanced" "Detected in single" "granulocytes: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055658 Approved NA NA "HPA055658: AB_2682878" "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.4 0.8 0.5 0.4 0.9 0.1 0.7 0.4 0.4 0.4 0.7 0.4 0.4 0.7 0.6 0.8 0.4 1.2 0.9 0.4 0.5 0.7 0.6 0.5 0.4 0.8 0.4 0.4 0.4 0.7 0.8 1.4 0.4 0.4 0.4 0.6 0.4 0.4 0.5 0.4 1.8 0.4 0.6 0.4 0.6 0.2 13.9 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.2 0.0 2.9 0.0 0.0 0.8 0.0 1.2 2.5 1.0 1.4 0.5 2.5 1.8 1.1 1.8 1.3 0.8 1.4 1.2 2.5 0.6 2.1 0.5 0.7 0.4 0.5 1.4 1.2 0.9 1.4 0.1 2.4 0.9 0.5 2.3 1.4 3.4 1.1 1.8 1.5 0.7 2.9 0.5 1.8 0.6 2.7 0.6 0.8 0.0 0.7 2.2 0.7 0.6 0.1 1.2 0.6 2.5 1.8 1.6 0.6 0.4 2.7 2.4 1.5 3.0 0.8 0.8 1.6 0.4 2.5 2.3 1.4 1.2 0.3 1.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.5 0.9 0.4 0.4 0.5 0.7 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 97.5 0.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 1.7 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.1 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019820-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.2;skin 1: 10.5;stomach 1: 8.0" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 15.7;Muller glia cells: 5.6;Rod photoreceptor cells: 5.1" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Lineage enhanced" "Detected in single" "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ: 8.9;Daudi: 9.1;HEK 293: 10.0;HMC-1: 8.3;NB-4: 15.9;U-266/84: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.6 0.6 9.5 1.3 4.1 0.9 1.3 0.4 14.2 0.4 0.9 0.4 0.0 0.5 0.6 0.4 0.8 1.2 0.5 0.9 9.0 5.2 1.2 0.8 0.9 1.7 3.0 4.1 0.4 1.5 0.7 1.1 0.8 5.1 0.6 0.5 3.4 0.7 0.5 0.5 10.5 0.4 0.7 0.8 3.9 8.0 0.8 0.2 0.0 0.6 0.0 1.3 0.5 0.4 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.2 0.2 0.4 0.2 0.2 0.0 8.9 0.2 0.1 0.4 0.7 0.5 9.1 2.0 7.2 0.4 0.2 1.9 0.2 0.1 0.6 10.0 0.7 0.8 2.2 0.0 4.8 8.3 0.8 0.4 0.0 0.1 0.5 0.2 1.2 3.1 0.8 1.2 0.7 0.3 15.9 2.2 0.4 1.5 0.8 0.3 0.7 0.5 0.5 0.7 0.6 0.8 0.3 2.1 0.7 1.9 1.5 0.1 0.1 0.9 0.1 0.2 5.0 9.7 1.9 1.1 1.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.1 0.4 14.2 9.0 5.2 3.0 4.1 5.1 0.2 0.0 1.1 0.0 1.2 0.7 0.7 0.8 0.0 2.7 0.0 0.0 15.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.8 0.0 0.0 0.5 5.1 0.0 0.3 0.0 2.0 1.9 0.0 0.0 0.5 0.9 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934933-33804176 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 7.8;Early spermatids: 16.1;Horizontal cells: 9.5;Late spermatids: 12.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 6.4;glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.0;U-266/70: 22.3;U-266/84: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 1.8 2.4 17.4 1.4 14.4 1.0 2.7 8.5 29.8 14.0 1.8 15.8 0.7 1.5 9.1 2.6 1.6 8.5 2.2 1.6 18.7 10.3 2.4 1.3 1.3 1.3 11.7 13.0 6.4 2.2 2.5 1.6 2.0 16.2 2.5 1.7 0.8 2.7 3.6 2.0 1.4 1.6 2.2 13.8 3.1 2.8 3.5 16.3 0.0 4.4 0.0 1.5 1.1 1.4 0.0 0.6 0.1 0.2 0.0 0.2 0.0 0.0 0.0 9.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 22.3 6.4 0.0 0.3 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.0 0.0 17.4 14.4 8.5 15.3 18.7 10.3 11.7 13.0 16.2 16.3 0.0 0.0 0.0 0.7 0.9 7.8 2.0 0.0 2.7 0.0 1.8 0.0 1.2 1.7 0.1 16.1 1.9 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.4 9.5 1.2 6.2 0.0 12.4 6.6 0.0 0.0 0.0 0.0 5.8 0.3 0.0 4.9 0.6 0.3 0.0 3.1 0.2 0.1 0.4 0.2 0.0 0.0 0.4 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70283676 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 34.9" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 15.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in all" 5 "basal ganglia: 10.2;cerebellum: 34.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 4.8" "Group enriched" "Detected in some" 6 "basal ganglia: 16.1;hypothalamus: 7.3" "Low region specificity" "Detected in many" HPA037521 Uncertain NA NA "HPA037521: AB_2675520" "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.6 0.5 1.9 1.8 10.2 1.3 0.9 34.9 2.6 0.9 0.6 2.6 0.0 0.8 1.0 1.2 0.4 1.6 0.6 0.4 2.7 4.1 0.5 0.5 1.3 2.5 2.2 4.1 0.8 0.3 0.9 0.4 0.4 4.7 0.6 0.8 5.4 0.4 1.1 1.0 1.0 0.8 0.4 4.0 1.0 1.4 4.7 2.0 0.0 0.6 0.0 1.4 0.6 0.7 1.0 1.2 2.4 2.2 1.3 0.6 2.6 1.1 0.8 0.9 0.7 0.8 1.3 0.7 0.3 0.4 0.3 0.3 1.3 2.3 0.8 0.7 1.0 0.4 1.0 2.2 1.2 0.7 0.7 0.9 1.1 1.0 1.0 0.8 0.8 1.3 0.7 1.1 0.5 0.8 0.9 0.9 1.0 0.9 0.9 0.5 0.9 0.7 0.9 0.8 1.9 0.3 0.9 0.8 0.5 0.8 0.8 0.8 0.8 0.8 1.2 0.4 0.8 0.5 0.6 1.0 0.9 4.8 0.8 1.0 0.7 0.8 0.5 0.6 0.9 0.7 2.4 2.2 0.4 0.5 0.7 0.5 0.5 0.5 0.4 1.2 1.0 0.6 0.6 1.9 1.3 0.4 0.9 0.4 2.6 1.9 10.2 34.9 2.6 2.7 4.1 2.2 4.1 4.7 2.0 0.0 1.3 0.0 1.2 1.4 0.7 0.8 2.5 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.1 1.0 1.0 2.3 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.6 1.1 0.0 0.0 0.0 15.1 0.1 0.0 0.4 0.0 1.5 0.0 1.4 0.2 0.4 1.8 0.9 0.0 0.0 0.8 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 54.9;Early spermatids: 43.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 34.1" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.3 24.6 9.5 0.0 0.4 4.2 9.3 6.5 8.6 7.7 3.7 5.8 1.5 13.4 12.9 10.3 4.3 11.3 1.3 8.9 4.8 4.3 0.0 8.3 19.6 34.1 11.7 2.8 18.9 18.5 7.2 13.1 5.1 4.1 8.1 1.3 6.5 9.7 11.3 0.0 6.3 0.2 0.0 0.2 4.6 0.1 2.1 13.8 11.3 1.0 9.3 5.0 0.6 10.6 3.1 1.9 10.3 0.8 11.5 0.5 0.2 2.9 3.9 2.8 3.1 0.4 0.7 5.8 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 6.0 18.3 0.0 1.1 8.2 7.4 2.0 0.0 54.9 29.6 8.7 5.9 1.8 0.0 5.2 43.7 3.6 2.6 0.0 1.7 1.2 6.2 1.3 20.9 2.9 2.0 6.4 4.7 6.7 5.2 17.6 19.8 4.0 0.0 6.4 4.5 3.0 4.9 3.5 18.0 1.0 4.8 19.4 3.9 12.2 10.4 3.4 1.0 5.0 7.5 0.9 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Early spermatids: 15.7;granulocytes: 10.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "THP-1: 15.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.3 9.9 0.7 1.9 4.6 6.4 6.6 2.0 0.8 2.1 0.5 4.9 2.0 2.1 1.7 4.9 3.3 3.9 1.9 2.6 5.9 9.8 1.4 0.7 3.7 1.9 8.5 2.5 3.4 2.9 3.4 7.7 2.8 1.5 6.2 1.0 2.1 3.2 6.9 4.0 0.9 0.7 0.7 0.6 5.5 1.9 0.0 0.7 5.5 2.4 6.1 0.6 2.4 15.7 7.8 0.0 2.5 7.6 0.4 4.3 6.0 7.3 0.9 3.8 1.4 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 0.0 3.0 0.0 0.2 4.2 1.7 2.8 0.0 13.4 3.4 1.8 0.0 0.5 0.0 0.1 15.7 2.1 0.3 0.0 0.2 0.2 7.3 0.3 10.5 1.0 0.3 1.6 0.0 1.3 1.5 2.2 1.4 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 2.7 0.0 5.7 3.9 0.9 4.0 0.2 0.0 0.0 0.1 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.5;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7;Suprabasal keratinocytes: 1.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 54.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 7.3 5.0 8.2 8.6 9.8 32.4 8.8 15.5 8.8 6.4 7.6 6.9 5.2 12.4 6.2 6.4 6.8 5.5 9.6 7.2 8.2 9.6 7.9 18.1 6.7 6.7 5.9 4.0 9.5 5.0 9.8 8.2 11.7 5.6 19.7 36.9 9.6 6.1 7.6 14.6 7.1 7.3 9.7 7.9 5.2 6.6 5.3 9.0 6.5 3.6 3.4 5.7 0.4 13.7 12.5 8.6 14.9 11.5 6.6 25.5 9.5 3.4 5.1 5.7 19.3 17.0 20.0 9.6 13.0 6.2 15.7 5.6 14.1 4.7 11.2 7.9 8.8 17.2 54.1 10.4 16.0 16.9 3.5 6.1 12.2 15.6 7.3 6.7 18.2 15.9 26.6 6.9 24.7 16.9 39.2 15.8 7.5 14.7 26.9 8.9 11.8 10.2 8.0 10.9 8.3 5.5 13.1 10.0 16.4 12.9 7.8 11.0 24.2 13.3 2.3 13.8 14.1 9.9 18.1 9.6 14.1 12.7 6.5 3.6 2.6 5.7 2.7 2.3 4.4 3.0 2.9 2.2 5.3 3.9 2.6 3.9 3.4 2.0 9.0 2.0 0.4 0.0 0.0 0.0 0.4 2.5 0.0 0.8 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.1 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 44.9;Ciliated cells: 54.9;Club cells: 89.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 10.8 7.0 13.4 34.7 12.0 30.6 10.4 18.3 13.4 9.6 10.8 9.6 12.5 7.7 8.6 33.3 7.2 8.4 6.6 8.4 24.1 6.1 8.7 6.1 13.6 19.3 17.5 16.7 9.9 10.1 6.4 8.7 7.2 13.7 10.5 12.1 14.6 12.2 22.9 17.8 54.2 17.1 6.8 9.7 16.3 8.9 10.6 11.8 7.0 14.4 6.8 14.2 8.0 10.0 11.7 7.0 8.3 3.5 4.4 5.9 1.3 10.9 9.6 6.1 7.8 10.4 9.8 14.5 6.7 2.4 4.2 5.3 13.5 18.5 15.1 12.5 8.9 4.0 9.8 14.2 9.6 7.5 18.6 5.2 5.8 25.2 26.0 10.1 31.6 9.8 11.9 7.3 10.3 19.0 7.7 7.4 17.5 16.1 24.6 5.1 18.6 14.0 42.3 17.0 2.0 4.1 15.3 4.4 18.0 7.6 6.4 6.8 5.7 8.3 11.7 5.6 15.1 6.9 10.9 25.2 13.5 6.1 11.2 11.3 13.6 6.4 19.7 5.6 23.0 6.0 6.7 3.5 2.7 5.5 1.7 2.3 8.6 5.2 3.7 2.0 11.7 5.9 4.9 8.3 4.4 3.2 7.0 2.4 1.3 13.4 12.0 18.3 13.4 24.1 6.1 17.5 16.7 13.7 11.8 26.8 44.9 3.7 11.4 12.8 13.0 28.7 2.5 54.9 89.9 5.2 9.8 3.6 0.0 3.1 4.7 11.9 2.6 0.0 1.2 2.3 8.9 9.1 9.3 1.6 3.7 6.4 1.2 6.7 4.6 1.8 9.5 11.0 5.0 9.0 3.0 5.0 4.0 4.9 6.0 0.7 24.7 0.0 17.6 3.0 2.6 10.0 4.9 11.4 3.9 9.2 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 15.2 0.1 0.0 0.0 0.0 7.6 9.9 0.1 0.4 0.1 0.0 0.9 3.8 0.0 0.0 0.0 3.9 0.4 17.2 13.7 0.0 0.0 0.1 1.7 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 12.2 0.2 0.7 0.1 0.0 6.2 0.0 0.0 0.1 20.0 0.8 0.9 0.3 0.9 7.4 0.0 2.3 26.8 0.6 0.0 0.3 0.2 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 172.7 69.4 0.0 4.6 1.6 0.2 2.0 33.1 10.7 97.8 31.4 0.0 2.2 1.7 19.0 11.6 8.0 8.0 0.0 2.1 0.1 0.9 29.6 0.0 0.0 0.3 0.0 15.0 3.1 0.0 11.8 2.3 1.3 5.0 0.0 9.2 0.0 6.3 3.1 0.0 3.0 0.1 0.0 33.5 0.5 1.5 1.0 1.3 0.0 6.9 2.8 NPTX1 ENSG00000171246 "Neuronal pentraxin 1" Q15818 17 80467148-80477843 "Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.9" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 164.9" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Cell line enhanced" "Detected in some" "HAP1: 12.4;HeLa: 9.7;SiHa: 15.8;U-138 MG: 33.8;WM-115: 46.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6" HPA077062 Enhanced Approved "Secreted in brain" NA NA 1000000 "HPA077062: AB_2732329" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-2)" "unprognostic (6.95e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.63e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "unprognostic (9.63e-3)" "unprognostic (1.05e-6)" "unprognostic (1.41e-4)" "unprognostic (1.35e-1)" "unprognostic (8.86e-6)" "unprognostic (2.71e-3)" 1.0 3.4 28.8 1.4 14.7 0.8 1.1 68.9 62.5 0.8 9.1 0.2 0.0 1.3 1.3 2.5 1.4 1.4 1.7 0.7 15.5 3.0 0.8 0.7 1.0 1.4 1.0 18.2 0.7 0.7 0.7 0.8 1.6 4.6 1.3 2.5 0.6 0.7 2.9 1.0 3.2 1.5 1.4 1.9 2.3 1.5 1.3 0.0 0.9 0.7 0.0 0.7 0.9 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.7 0.2 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 1.3 0.0 12.4 0.0 0.0 0.0 7.7 0.0 9.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.2 0.0 0.0 8.4 0.0 15.8 0.0 0.0 0.1 0.0 0.2 0.1 33.8 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 28.8 14.7 68.9 29.9 15.5 3.0 1.0 18.2 4.6 0.0 0.0 0.0 0.0 0.1 1.3 8.7 2.8 0.0 0.0 1.2 0.0 164.9 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.1 0.0 2.6 0.0 0.9 1.1 0.5 2.6 0.1 0.0 0.0 0.0 NPY4R "PP1, PPYR1, Y4" ENSG00000204174 "Neuropeptide Y receptor Y4" P50391 10 46461099-46465881 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 9.4;skin 1: 4.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Group enriched" "Detected in some" 5 "cerebellum: 1.6;cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "A549: 25.5" HPA027863 Approved NA NA "HPA027863: AB_10602819" "unprognostic (2.26e-6)" "unprognostic (2.94e-1)" "unprognostic (8.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (1.77e-3)" "unprognostic (1.98e-1)" "unprognostic (2.64e-3)" "unprognostic (6.58e-2)" "unprognostic (9.79e-2)" 0.2 0.0 0.2 0.7 0.2 0.0 0.2 1.6 1.2 0.3 7.4 0.2 0.2 2.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.9 9.4 0.2 0.2 0.2 0.2 4.3 2.6 1.4 0.2 0.2 2.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.7 0.0 0.0 5.2 0.0 0.4 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.6 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY5R NPYR5 ENSG00000164129 "Neuropeptide Y receptor Y5" Q15761 4 163343939-163351934 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.2;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in single" 21 "Spermatocytes: 1.6" "Cancer enhanced" "Detected in single" "breast cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;RPTEC TERT1: 3.5;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.63e-6)" "unprognostic (3.00e-1)" "unprognostic (2.79e-1)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "unprognostic (3.74e-2)" "unprognostic (3.94e-2)" "unprognostic (5.40e-2)" "unprognostic (4.30e-2)" "unprognostic (3.99e-2)" "unprognostic (1.76e-1)" "unprognostic (3.94e-1)" 10.6 5.7 3.6 1.6 12.2 0.1 3.2 0.3 6.2 1.5 0.7 0.1 0.3 0.2 2.2 1.9 0.6 1.4 1.0 1.3 4.5 3.1 7.8 1.8 0.7 6.6 1.3 4.6 0.5 1.8 0.8 0.6 4.9 2.3 0.5 0.6 1.1 6.1 1.7 0.4 1.4 0.3 1.5 4.2 13.6 0.5 9.1 2.2 0.0 1.3 0.4 0.3 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 12.2 0.3 6.2 4.5 3.1 1.3 4.6 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137300482-137302251 "Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 41.7" "Group enriched" "Detected in many" 7 "Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.9 1.6 6.5 8.4 7.8 1.7 13.8 3.9 11.7 5.6 41.7 6.1 1.1 17.1 5.2 1.9 17.4 3.2 26.0 7.1 5.0 6.5 3.2 2.9 7.0 1.8 6.0 3.0 5.6 14.2 3.1 7.1 8.9 7.4 11.8 22.8 5.6 1.9 2.8 4.4 19.7 15.7 4.5 3.2 7.7 8.7 6.0 3.4 2.3 4.2 14.0 14.4 7.6 10.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.5 3.5 4.2 0.0 0.0 1.6 0.1 0.1 0.0 0.0 2.8 1.4 0.0 6.4 0.0 0.1 23.4 6.4 0.2 0.1 0.2 11.8 0.7 1.0 2.6 0.4 0.9 2.3 0.0 1.1 0.0 0.2 0.0 5.3 0.1 6.9 0.1 0.0 7.7 0.1 2.7 17.2 11.5 3.5 4.6 0.7 8.4 0.6 0.2 2.4 4.4 0.7 1.2 0.0 0.7 11.9 1.9 17.1 0.0 0.0 0.1 1.0 0.1 0.1 1.4 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 6.5 7.8 3.9 6.8 5.0 6.5 6.0 3.0 7.4 3.4 0.0 0.0 0.5 2.8 86.2 0.3 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.7 6.0 10.7 0.0 1.0 0.0 0.6 6.0 0.0 0.0 0.4 0.0 9.8 5.5 0.8 2.9 0.0 0.0 16.9 0.0 15.3 9.4 0.6 31.1 0.4 0.0 2.5 6.5 23.4 0.0 0.8 333.1 0.0 0.0 19.6 5.5 NRN1 NRN ENSG00000124785 "Neuritin 1" Q9NPD7 6 5997999-6007605 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 32.1;brain: 59.3" "Group enriched" "Detected in many" 4 "Endothelial cells: 56.9;Extravillous trophoblasts: 52.2;Ito cells: 80.4" "Cancer enhanced" "Detected in all" "glioma: 38.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 5.7;neutrophil: 5.6" "Group enriched" "Detected in many" 8 "granulocytes: 5.6;T-cells: 5.7" "Cell line enhanced" "Detected in many" "ASC diff: 37.3;ASC TERT1: 29.0;fHDF/TERT166: 37.6;JURKAT: 34.8;REH: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.24e-2)" "unprognostic (2.47e-2)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.26e-2)" "unprognostic (5.57e-2)" "unprognostic (4.70e-3)" "unprognostic (2.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (1.67e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.90e-1)" "unprognostic (4.37e-3)" 32.1 3.7 38.8 4.0 21.5 0.7 16.8 53.3 59.3 6.1 5.8 3.5 1.1 2.6 5.9 2.9 5.4 6.2 6.9 9.9 40.2 9.8 3.2 3.1 9.3 5.3 10.0 22.1 2.5 1.9 1.9 3.5 25.5 23.4 3.2 3.4 4.1 3.7 5.2 10.0 7.8 3.4 6.8 5.6 9.3 3.2 0.8 1.8 0.0 3.0 2.8 2.5 7.8 5.7 0.7 0.5 5.6 0.4 0.0 5.7 0.2 4.2 0.2 0.4 0.1 37.3 29.0 5.7 0.7 0.0 3.1 4.3 0.0 0.0 0.0 0.6 37.6 6.6 0.1 11.1 0.0 3.0 6.9 5.7 3.5 0.2 0.0 0.0 14.6 11.6 4.6 0.0 2.8 0.0 0.0 14.9 34.8 0.1 0.2 11.0 1.0 22.2 0.7 0.1 0.0 0.0 49.3 12.6 0.1 0.0 0.1 6.6 2.4 0.0 0.2 3.5 0.1 0.1 4.4 3.1 15.1 0.4 5.7 9.3 0.0 0.5 0.3 22.8 0.3 2.3 1.0 0.3 0.0 0.3 0.4 5.7 0.7 0.4 0.7 0.0 0.0 0.0 0.1 5.6 0.0 0.3 0.5 0.2 0.2 38.8 21.5 53.3 58.3 40.2 9.8 10.0 22.1 23.4 1.8 0.0 2.2 3.7 0.0 9.3 6.2 2.2 2.5 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 56.9 0.0 0.0 0.4 52.2 3.2 0.4 0.0 0.0 1.5 3.2 0.0 80.4 3.4 0.0 0.9 1.4 15.1 0.0 0.0 4.7 0.3 0.0 0.0 0.0 12.7 0.0 5.0 0.3 0.1 9.8 1.1 0.0 0.0 0.6 NRN1L "MRCC2446, UNQ2446" ENSG00000188038 "Neuritin 1 like" Q496H8 16 67884805-67888855 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 20.9" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 8.1;Bipolar cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "BEWO: 27.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041761 Uncertain "Secreted - unknown location" NA NA "HPA041761: AB_10961155" "unprognostic (2.79e-2)" "unprognostic (3.32e-1)" "unprognostic (1.19e-1)" "unprognostic (3.99e-2)" "unprognostic (4.85e-1)" 1.9 2.1 3.4 1.9 11.6 7.2 1.8 8.5 5.1 2.0 1.7 6.3 0.4 3.1 2.2 0.9 1.5 2.5 1.7 4.8 5.9 5.3 1.6 1.8 4.4 4.4 5.7 3.1 4.9 2.6 3.6 6.5 1.6 6.4 2.6 1.4 20.9 4.4 2.0 4.5 6.8 2.6 1.6 3.5 4.3 2.2 2.6 6.1 0.4 2.4 1.5 1.5 3.9 1.9 1.6 0.5 2.1 1.9 0.8 3.8 0.9 0.1 0.4 0.6 0.7 0.3 0.8 27.1 0.4 0.0 0.3 0.2 0.0 0.4 0.3 0.5 0.1 0.1 0.3 0.0 0.2 0.2 0.3 0.6 0.2 1.1 1.5 0.6 0.1 1.1 0.5 0.9 0.0 0.0 0.4 0.0 1.1 0.7 0.6 0.2 1.4 0.5 3.3 5.1 0.0 0.3 1.3 0.0 0.5 0.2 0.4 0.8 0.3 0.4 0.4 0.4 5.3 0.9 1.1 0.5 0.3 0.2 0.0 0.0 0.2 0.3 0.7 0.1 0.4 0.1 0.0 1.9 0.0 3.8 1.1 2.0 1.6 2.3 1.2 0.5 1.3 2.0 1.1 2.1 0.8 1.3 0.4 1.3 0.9 3.4 11.6 8.5 5.1 5.9 5.3 5.7 3.1 6.4 6.1 3.0 8.1 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.9 23.0 13.9 13.1 18.4 20.6 5.4 12.6 24.3 22.9 23.0 12.6 0.4 0.0 4.4 23.3 16.8 8.3 11.2 1.9 14.6 0.1 11.3 6.8 11.0 24.0 18.6 0.2 1.1 23.3 1.5 16.3 2.7 18.7 15.7 0.1 13.5 12.3 20.0 3.3 0.3 5.8 10.7 0.2 11.9 10.8 7.8 0.9 22.8 0.1 28.4 20.4 15.0 4.4 21.5 9.5 18.4 7.1 10.4 24.5 13.0 0.9 15.3 2.3 0.4 5.1 3.2 0.2 12.9 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 0.0 1.9 0.0 3.1 2.9 24.5 4.0 0.0 2.7 7.9 12.2 2.0 6.1 1.7 11.0 5.5 4.5 1.3 0.0 1.4 5.3 10.8 2.5 4.7 0.4 2.7 15.9 28.3 4.3 1.2 10.0 12.0 1.2 3.3 3.6 2.7 12.3 3.8 1.9 9.9 5.7 12.7 19.4 9.2 21.3 6.6 1.9 3.7 1.0 2.0 2.7 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 70.6;Early spermatids: 130.0;Horizontal cells: 73.1;Late spermatids: 79.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" NA NA 620000 "Plasma membrane" "HPA071400: AB_2732180" "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 0.0 0.0 0.0 0.4 0.0 70.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 130.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 73.1 1.7 5.5 0.0 79.3 2.3 0.2 1.7 0.0 0.0 20.9 0.3 0.0 0.7 0.0 8.0 0.0 0.3 9.9 3.8 0.1 0.2 0.0 0.0 0.0 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723188 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.5" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 43.6;Horizontal cells: 141.4;Muller glia cells: 51.8;Peritubular cells: 55.5" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.0;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.0" "Cell line enhanced" "Detected in some" "REH: 28.4;SCLC-21H: 14.3;SH-SY5Y: 6.5;U-2 OS: 16.6;U-87 MG: 11.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 3.4 7.5 33.3 4.1 26.3 2.5 2.3 68.8 101.5 7.3 4.6 6.5 1.0 3.1 11.7 3.3 2.5 6.4 4.4 2.9 28.8 23.5 3.8 2.4 2.5 3.0 15.2 32.8 6.3 2.5 2.2 1.3 2.8 14.0 4.5 2.7 3.5 3.2 5.6 2.5 2.2 3.0 4.7 12.4 3.5 2.4 11.6 8.7 0.0 2.9 0.0 2.5 2.4 2.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.2 1.5 1.3 0.0 2.0 0.0 0.0 0.2 0.2 3.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 5.5 1.9 0.0 0.4 0.2 4.7 0.0 0.0 28.4 0.9 1.1 0.0 0.0 14.3 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 16.6 0.3 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 33.3 26.3 68.8 41.2 28.8 23.5 15.2 32.8 14.0 8.7 0.0 0.0 0.0 0.0 0.5 43.6 2.4 0.0 0.0 0.0 1.8 5.9 0.1 3.3 0.0 19.4 0.9 2.0 0.0 2.3 0.2 2.5 0.0 0.0 6.4 0.2 141.4 6.4 3.1 0.0 37.1 39.4 0.0 0.0 1.0 1.1 51.8 0.7 3.4 55.5 34.9 18.9 0.0 3.1 19.5 7.0 0.1 0.2 0.0 0.6 0.0 NSG2 "CALY3, HMP19, Nsg2" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045604-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 120.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 58 "SCLC-21H: 21.9;SH-SY5Y: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 1.7 23.1 31.6 3.0 92.4 1.4 1.4 19.7 120.8 1.4 3.6 5.0 0.0 2.8 1.4 1.7 1.5 1.4 1.6 1.6 27.3 40.2 1.6 1.4 1.6 1.4 20.2 27.6 1.4 2.0 1.4 0.9 1.4 22.5 1.4 4.1 0.8 1.4 1.5 1.4 1.4 3.8 2.5 4.6 1.4 3.3 5.0 11.7 0.0 1.8 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 92.4 19.7 49.8 27.3 40.2 20.2 27.6 22.5 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NSUN7 FLJ14001 ENSG00000179299 "NOP2/Sun RNA methyltransferase family member 7" Q8NE18 4 40749897-40809985 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.5" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 48.2;Early spermatids: 34.5;Late spermatids: 53.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.1" "Cell line enhanced" "Detected in some" "A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;SuSa: 5.1;T-47d: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020653 Uncertain Approved Vesicles NA NA Vesicles "HPA020653: AB_1848710" "unprognostic (2.32e-1)" "unprognostic (4.22e-1)" "unprognostic (4.77e-2)" "unprognostic (1.50e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (4.01e-3)" "unprognostic (4.37e-2)" "unprognostic (3.06e-1)" "unprognostic (2.24e-1)" "unprognostic (8.42e-2)" "prognostic favorable (2.76e-8)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-2)" 0.7 1.2 0.9 2.8 2.0 0.7 5.1 0.2 1.0 3.2 7.0 2.4 7.3 2.3 5.9 9.7 4.5 9.1 5.4 5.5 1.0 1.9 6.6 0.7 8.1 4.2 1.0 0.5 4.6 14.1 7.7 7.5 2.8 2.6 5.7 3.2 4.3 15.2 10.3 0.1 1.9 6.7 2.6 1.8 3.6 3.8 39.5 0.2 2.4 11.9 1.5 5.3 3.7 1.5 1.1 0.0 6.1 0.1 0.0 0.0 0.0 3.9 0.4 1.9 0.0 0.0 0.0 2.9 0.0 0.3 0.2 0.2 1.5 8.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 4.1 0.1 0.0 2.3 0.0 0.5 0.1 0.1 0.0 4.2 1.1 1.0 2.3 0.6 2.7 0.0 5.1 6.3 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.2 1.0 1.0 1.9 1.0 0.5 2.6 0.2 8.9 5.6 0.0 3.3 1.0 0.0 3.7 0.0 48.2 15.9 8.7 0.0 7.5 8.3 4.4 34.5 0.3 2.1 0.0 4.7 2.8 0.5 4.2 0.0 0.0 3.0 0.0 7.9 0.6 0.3 53.6 1.4 0.7 0.0 1.8 5.8 2.0 5.3 0.0 0.0 5.2 0.0 0.0 0.3 22.8 12.4 0.9 3.8 0.5 7.5 4.3 NT5C1B "AIRP, CN-IB" ENSG00000185013 "5'-nucleotidase, cytosolic IB" Q96P26 2 18562872-18589572 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 52.6" "Group enriched" "Detected in some" 90 "Early spermatids: 137.7;Late spermatids: 218.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA056683 Uncertain NA NA "HPA056683: AB_2683207" "unprognostic (4.18e-2)" "unprognostic (1.20e-2)" "unprognostic (7.67e-2)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "unprognostic (4.97e-2)" "unprognostic (4.96e-2)" "unprognostic (4.84e-1)" "unprognostic (8.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.91e-2)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (6.96e-2)" "unprognostic (2.50e-1)" "unprognostic (1.15e-1)" "unprognostic (3.77e-1)" 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.7 0.0 0.4 0.3 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 52.6 0.1 0.1 0.5 0.1 0.1 0.5 0.1 1.2 3.7 0.0 0.1 0.7 2.6 0.4 3.2 0.7 0.3 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 3.5 1.6 0.5 0.0 2.2 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.9 0.0 0.6 0.1 0.0 0.0 0.2 0.0 3.3 0.0 0.5 1.1 0.2 0.0 2.9 0.1 0.2 0.6 0.6 1.6 0.3 0.7 0.8 0.1 2.9 2.4 1.2 2.6 0.4 1.5 0.4 0.7 0.7 1.6 1.5 1.0 2.9 0.5 1.0 0.7 2.0 2.5 0.0 1.2 0.0 0.1 0.0 1.3 0.0 2.3 0.1 1.3 1.3 0.3 1.2 2.6 2.2 0.0 0.7 0.1 3.7 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 NT5DC4 ENSG00000144130 "5'-nucleotidase domain containing 4" Q86YG4 2 112721486-112742879 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.0;testis: 6.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 20.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Cell type enhanced" "Detected in single" "eosinophil: 3.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.0" "Cell line enriched" "Detected in some" 7 "K-562: 18.7" "Low region specificity" "Detected in all" HPA046856 Uncertain NA NA "HPA046856: AB_2679841" "unprognostic (2.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-2)" "unprognostic (1.34e-2)" "unprognostic (2.20e-4)" "unprognostic (2.26e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-1)" "unprognostic (1.19e-1)" "unprognostic (5.38e-4)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-4)" "unprognostic (9.02e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-4)" 0.1 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 3.0 0.4 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.0 1.3 0.4 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.7 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.7 1.5 0.0 0.0 0.2 2.6 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 NTN5 ENSG00000142233 "Netrin 5" Q8WTR8 19 48661407-48673081 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 7.0" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 4.3;Early spermatids: 3.9;Horizontal cells: 7.9;Late spermatids: 8.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 3.1;Karpas-707: 4.1;U-266/70: 3.1;U-266/84: 2.6" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Region enriched" "Detected in single" 5 "cerebellum: 7.5" "Secreted in brain" NA NA "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "unprognostic (5.26e-6)" "unprognostic (4.48e-2)" "unprognostic (2.23e-1)" "unprognostic (4.33e-2)" "unprognostic (3.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.89e-3)" "unprognostic (9.40e-3)" "unprognostic (1.74e-3)" "unprognostic (4.60e-1)" "unprognostic (5.11e-2)" "unprognostic (1.60e-3)" "unprognostic (3.51e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-3)" 0.3 0.8 1.1 0.3 1.6 0.6 1.5 1.6 0.9 1.1 0.3 0.3 2.6 1.6 0.8 3.9 1.8 0.1 0.9 0.6 0.6 0.1 0.3 1.9 0.7 3.7 0.0 2.1 7.0 0.0 3.1 0.0 3.2 2.4 0.6 3.5 0.4 0.1 0.7 1.3 0.6 0.3 2.3 0.7 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.7 0.1 0.1 0.1 0.4 0.0 1.0 0.0 0.0 0.5 0.9 1.8 0.7 0.0 0.0 2.0 0.0 0.8 3.1 0.3 0.0 0.0 1.1 0.7 1.3 0.0 4.1 0.0 1.2 0.9 0.8 0.0 0.3 2.2 0.6 0.0 0.0 1.1 0.7 0.3 0.4 0.0 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.0 3.1 2.6 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 7.9 0.0 0.0 0.0 8.1 0.6 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.4 0.0 2.1 0.0 0.0 2.5 0.2 0.1 0.1 0.0 0.0 0.1 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 4.3 7.4 3.7 9.9 8.9 5.0 6.3 3.5 5.1 3.4 8.1 7.2 9.5 7.0 6.5 13.8 3.8 4.5 7.0 7.0 5.9 3.0 7.1 12.8 5.1 5.3 7.3 4.5 4.4 7.8 7.4 4.1 3.6 5.8 5.2 4.7 3.7 5.0 8.8 8.6 7.2 5.8 5.2 11.8 5.8 6.0 5.6 7.2 2.4 4.6 2.8 4.8 6.8 3.7 6.2 1.9 2.5 3.4 4.9 3.7 1.1 5.1 3.7 6.0 7.5 3.8 3.2 1.3 4.6 4.1 2.4 2.7 9.7 10.8 2.5 2.3 2.8 3.9 6.1 0.6 4.3 2.4 1.9 10.5 7.0 6.0 5.3 0.3 3.9 2.9 2.3 4.7 3.1 1.7 6.4 1.8 4.6 5.9 4.0 2.4 2.4 2.3 5.6 2.3 3.3 11.9 5.1 1.0 0.2 3.3 2.4 2.7 3.9 2.5 6.2 2.0 2.7 3.4 2.5 3.4 2.1 8.2 0.8 1.7 2.9 3.3 3.4 5.9 7.2 2.0 0.1 2.6 2.5 1.8 2.5 2.1 3.0 1.5 1.6 1.9 6.2 2.3 2.4 1.0 4.9 3.4 0.6 3.7 1.1 3.7 8.9 3.5 5.1 5.9 3.0 7.3 4.5 5.8 7.2 6.0 1.3 2.2 2.3 0.8 1.3 6.2 0.0 6.7 2.3 3.5 3.9 3.0 3.3 1.6 2.6 1.0 1.2 0.0 0.6 0.7 1.3 1.4 0.0 3.2 1.5 0.0 1.2 0.6 1.3 3.4 0.9 1.5 0.0 1.8 1.8 0.8 1.2 2.9 0.7 4.1 1.7 0.0 1.0 3.2 0.5 1.3 0.9 0.0 1.3 0.9 NUGGC "C8orf80, HMFN0672, SLIP-GC" ENSG00000189233 "Nuclear GTPase, germinal center associated" Q68CJ6 8 28021964-28083871 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 21.1;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 14 "Club cells: 6.8;Hepatocytes: 12.3;Proximal tubular cells: 4.6;T-cells: 6.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Daudi: 45.7;Karpas-707: 15.7;U-698: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.23e-2)" "unprognostic (2.17e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (2.15e-2)" "unprognostic (1.83e-4)" "unprognostic (2.08e-3)" "unprognostic (6.19e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-3)" "unprognostic (2.45e-1)" "unprognostic (1.95e-1)" "unprognostic (3.39e-3)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (6.14e-2)" 0.8 0.3 0.3 32.2 0.4 0.5 0.4 0.3 0.3 0.3 4.9 0.1 0.4 1.1 0.3 0.4 1.6 0.5 0.4 0.5 0.3 0.3 4.1 21.1 1.1 12.9 0.3 0.0 0.9 0.3 0.0 0.3 0.0 0.0 0.5 0.8 0.3 3.6 2.7 0.3 0.3 4.6 0.0 0.3 5.2 1.6 0.5 0.0 0.1 2.3 1.4 23.2 1.8 0.4 3.3 1.2 2.5 1.1 1.2 7.8 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 45.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.7 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 6.1 0.5 33.6 0.1 0.1 0.0 1.8 1.1 0.5 7.8 0.7 1.0 3.3 3.4 4.9 0.3 1.9 0.7 2.1 2.5 1.2 0.4 1.2 0.2 0.9 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 2.1 0.8 0.2 0.2 0.0 0.5 0.0 0.0 6.8 1.8 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 12.3 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.5 0.0 0.0 0.9 0.0 6.9 0.0 0.2 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 42.7" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.2;Late spermatids: 6.7;Sertoli cells: 6.5;Spermatocytes: 26.5;Spermatogonia: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 43 "MCF7: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" No No "Nuclear bodies" "HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.1 1.5 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.6 0.1 0.0 0.8 0.9 0.4 0.1 0.1 0.1 3.4 0.2 0.1 0.1 42.7 0.0 0.3 0.3 0.0 0.1 1.2 0.1 0.6 0.6 1.8 0.2 0.9 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.1 0.2 0.6 0.4 0.5 0.0 0.5 0.8 0.3 1.8 0.9 0.0 0.6 0.7 0.0 0.1 0.3 0.1 0.9 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 6.5 0.1 26.5 5.1 0.5 0.0 0.0 0.0 0.2 NUPR2 NUPR1L ENSG00000185290 "Nuclear protein 2, transcriptional regulator" A6NF83 7 56114681-56116400 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 93.5" "Group enriched" "Detected in many" 21 "Early spermatids: 3268.4;Late spermatids: 11633.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.3" "Lineage enriched" "Detected in many" 4 "T-cells: 9.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (5.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (9.52e-2)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.53e-5)" "unprognostic (1.66e-1)" "unprognostic (8.44e-2)" "unprognostic (2.74e-1)" "unprognostic (5.44e-2)" 1.1 2.1 2.0 0.4 2.7 0.3 1.6 2.0 1.5 1.0 0.3 0.1 7.8 0.5 0.2 6.5 0.3 0.9 1.1 0.6 0.8 1.5 4.1 1.3 0.8 0.2 0.8 0.7 0.7 3.2 1.1 3.7 0.3 1.2 1.8 0.3 0.2 5.2 11.8 0.7 0.4 0.2 0.2 0.4 0.2 1.9 93.5 0.1 0.0 4.8 0.0 0.4 0.3 0.3 0.9 1.4 2.1 0.7 0.6 9.3 1.6 1.2 3.9 1.8 5.0 4.7 2.0 0.6 0.2 1.8 0.9 0.6 0.5 2.7 0.4 6.0 0.2 1.9 0.4 2.4 0.6 1.1 0.9 7.6 2.9 1.7 3.4 2.5 0.9 0.5 3.6 2.6 1.3 5.6 2.2 1.7 3.9 3.6 3.2 1.8 4.1 1.6 3.7 1.6 1.5 4.2 1.4 2.0 14.4 2.8 0.7 5.0 4.6 2.4 0.6 6.7 6.2 1.5 0.9 1.3 0.8 2.1 1.2 0.9 4.8 5.6 5.5 3.1 3.7 1.4 2.1 0.6 1.0 0.6 0.1 0.9 0.8 3.2 1.0 0.7 0.9 9.3 2.6 0.1 0.6 0.7 1.4 0.8 1.6 2.0 2.7 2.0 1.5 0.8 1.5 0.8 0.7 1.2 0.1 0.0 1.0 0.0 18.3 0.0 0.8 0.0 0.0 5.3 3.4 85.5 0.0 9.2 358.1 3.1 3268.4 0.0 0.0 0.0 1.7 0.9 0.0 39.9 1.1 0.0 0.5 15.9 14.0 0.0 0.0 11633.4 87.2 0.4 0.0 0.0 2.5 0.2 0.9 0.0 64.3 1.9 0.4 84.1 0.0 86.6 50.7 0.0 2.4 0.0 1.0 16.6 NUTM2A FAM22A ENSG00000184923 "NUT family member 2A" Q8IVF1 10 87225448-87236908 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 14.5" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (1.75e-2)" "unprognostic (1.33e-2)" "unprognostic (1.03e-1)" "unprognostic (8.29e-2)" "unprognostic (5.67e-2)" "unprognostic (8.08e-2)" "unprognostic (1.75e-2)" "unprognostic (6.84e-2)" "unprognostic (2.46e-3)" "unprognostic (1.75e-2)" "unprognostic (7.24e-2)" "unprognostic (1.40e-1)" "unprognostic (4.24e-3)" "unprognostic (1.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-2)" "unprognostic (2.65e-1)" 3.5 1.8 2.8 0.4 2.5 1.7 1.1 1.5 2.9 1.1 1.8 1.3 1.7 2.1 0.9 1.9 0.8 3.0 3.4 2.2 1.5 1.3 1.6 0.9 2.9 3.0 2.4 2.9 2.0 1.3 2.5 1.0 5.9 0.8 2.3 4.4 2.0 0.7 3.6 1.7 1.8 2.4 2.6 0.2 1.4 1.2 0.4 0.0 1.3 0.2 0.0 0.2 0.2 1.4 0.2 0.7 0.0 1.9 0.9 0.9 0.7 1.8 0.8 0.5 0.2 0.8 1.4 0.1 0.0 0.2 1.4 0.0 1.0 0.1 0.3 1.5 1.7 0.4 0.2 0.7 0.6 14.5 0.5 4.2 1.0 1.2 1.1 0.0 2.5 1.8 0.4 0.2 0.7 1.2 2.5 3.2 0.0 0.5 1.7 0.2 0.0 0.5 0.1 1.8 2.8 0.7 0.6 0.6 0.0 0.3 0.9 1.5 0.0 0.2 0.8 0.1 0.0 0.1 0.7 0.9 1.5 0.0 0.0 0.2 1.3 0.1 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 NUTM2F "DKFZp434I1117, FAM22F" ENSG00000130950 "NUT family member 2F" A1L443 9 94318196-94328644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NTERA-2: 5.5" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (1.40e-1)" "unprognostic (4.93e-3)" "unprognostic (4.16e-2)" "unprognostic (1.47e-1)" "unprognostic (9.26e-3)" "unprognostic (1.03e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (6.72e-3)" "unprognostic (8.48e-2)" "unprognostic (1.11e-2)" "unprognostic (5.14e-1)" "unprognostic (1.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NWD2 KIAA1239 ENSG00000174145 "NACHT and WD repeat domain containing 2" Q9ULI1 4 37244220-37449465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;breast: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046911 Uncertain NA NA "HPA046911: AB_2679861" "unprognostic (1.14e-2)" "unprognostic (3.12e-2)" "unprognostic (2.53e-1)" "unprognostic (5.47e-2)" "unprognostic (9.42e-2)" "unprognostic (2.55e-1)" "unprognostic (5.15e-2)" "unprognostic (1.63e-2)" "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (7.00e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (7.65e-2)" "unprognostic (4.36e-2)" "unprognostic (1.26e-2)" 4.9 0.3 2.1 0.3 2.9 0.2 20.0 1.0 11.8 0.3 1.6 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 2.3 3.2 0.2 0.5 0.2 0.3 0.7 2.0 0.2 0.7 0.3 0.3 0.3 2.0 0.2 0.8 0.0 0.4 0.2 0.2 0.7 0.4 0.4 0.3 0.2 0.3 0.6 0.0 0.4 2.7 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.9 1.0 8.9 2.3 3.2 0.7 2.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXF5 ENSG00000126952 "Nuclear RNA export factor 5" Q9H1B4 X 101832112-101857577 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" HPA002079 Uncertain NA NA "HPA002079: AB_1079515" "unprognostic (1.23e-1)" "unprognostic (2.85e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-3)" "unprognostic (9.58e-2)" "unprognostic (5.65e-2)" "unprognostic (2.24e-1)" "unprognostic (2.91e-2)" 0.7 0.2 0.3 0.0 0.4 0.7 0.2 0.8 0.7 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.4 0.1 0.6 0.5 0.8 0.5 0.2 0.4 0.7 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.2 0.9 0.8 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXNL1 "RDCVF, TXNL6" ENSG00000171773 "Nucleoredoxin like 1" Q96CM4 19 17455425-17460954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 48.8" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 90.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.62e-1)" "unprognostic (5.49e-1)" "unprognostic (1.81e-1)" "unprognostic (3.63e-1)" "unprognostic (1.13e-1)" 5.6 4.3 1.2 0.3 1.8 0.5 2.2 0.4 1.0 0.3 0.3 0.5 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.9 1.2 0.6 0.3 0.3 0.4 0.4 1.6 0.3 0.8 0.3 0.0 0.3 0.3 1.8 0.5 0.1 48.8 1.2 0.3 1.9 1.9 0.3 0.3 0.8 0.3 0.2 0.7 0.3 0.3 0.9 0.3 0.3 0.3 0.3 1.8 1.8 1.8 1.0 0.7 1.3 0.2 0.9 2.2 1.2 1.7 2.4 1.6 0.9 0.7 0.2 2.1 0.4 1.0 0.4 0.2 0.9 1.9 0.8 1.0 1.0 1.1 0.2 0.8 1.5 1.1 0.5 1.8 1.8 0.8 1.6 0.4 0.5 0.9 1.1 0.6 0.0 1.9 0.8 2.2 0.0 2.5 0.3 1.1 0.7 0.6 1.4 1.1 2.3 0.5 0.6 0.3 1.8 0.6 0.3 0.0 1.8 1.4 0.7 0.4 0.1 0.3 0.9 1.4 0.3 1.4 1.4 2.0 0.1 1.2 0.0 0.2 1.0 1.2 0.8 0.9 0.2 0.7 0.7 0.4 0.2 1.8 1.1 0.7 1.8 0.7 0.6 1.8 1.3 0.2 1.2 1.8 0.4 1.0 1.2 0.6 1.6 0.3 1.8 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 90.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXNL2 "C9orf121, RdCVF2" ENSG00000130045 "Nucleoredoxin like 2" Q5VZ03 9 88535101-88584274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.7" "Group enriched" "Detected in some" 5 "Early spermatids: 8.6;Proximal tubular cells: 12.2" "Group enriched" "Detected in some" 7 "breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045526 Uncertain Approved Cytosol NA NA Cytosol "HPA045526: AB_10961044" "prognostic favorable (6.53e-4)" "unprognostic (9.70e-2)" "unprognostic (4.78e-3)" "prognostic favorable (3.83e-8)" "unprognostic (2.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-4)" "unprognostic (1.92e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-3)" "unprognostic (5.58e-2)" "prognostic favorable (9.60e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-2)" 7.2 0.4 1.6 1.0 1.6 4.4 3.2 0.6 1.1 6.7 0.5 2.0 0.4 0.6 6.2 9.7 0.8 6.6 0.7 0.5 1.8 2.9 4.4 5.1 0.4 0.4 1.3 1.0 11.7 0.5 0.0 0.7 3.9 1.2 0.8 0.0 2.0 1.4 3.7 1.0 1.3 0.5 0.4 1.8 0.8 0.5 2.2 0.4 0.4 1.2 0.4 0.4 1.2 1.5 1.2 1.1 4.8 1.0 1.7 2.4 0.7 2.0 4.2 1.7 1.5 0.2 1.1 1.2 3.9 1.0 0.5 0.7 0.9 1.3 1.0 1.6 0.4 1.0 2.0 0.6 0.2 1.4 0.6 1.3 1.9 4.0 1.3 0.8 1.2 1.4 0.8 0.3 0.4 0.4 0.6 0.0 1.4 1.3 4.2 1.0 1.0 1.1 1.9 2.1 0.7 0.9 0.8 0.8 1.4 15.3 1.4 1.1 0.7 2.3 1.3 0.7 1.1 1.7 1.0 1.5 1.5 2.9 2.1 0.9 1.4 1.2 1.1 1.3 1.6 1.0 4.8 1.0 2.3 2.1 0.5 2.1 0.8 1.2 2.4 0.3 1.2 2.1 2.4 2.8 1.7 0.5 1.1 2.0 0.7 1.6 1.6 0.6 1.1 1.8 2.9 1.3 1.0 1.2 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.5 8.6 0.0 0.0 0.0 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.1 12.2 0.7 0.0 0.8 0.3 0.4 0.1 0.9 0.0 0.0 1.8 NXPE1 "FAM55A, MGC34290" ENSG00000095110 "Neurexophilin and PC-esterase domain family member 1" Q8N323 11 114521645-114559895 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 44.0;lymphoid tissue: 20.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 50.2;Late spermatids: 47.7;Mucus-secreting cells: 34.2;Undifferentiated cells: 40.5" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;U-138 MG: 1.1;WM-115: 1.0" HPA049133 Enhanced "Intracellular and membrane" NA NA "HPA049133: AB_2680647" "unprognostic (2.81e-1)" "unprognostic (2.19e-3)" "unprognostic (3.40e-3)" "unprognostic (4.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (1.76e-1)" 0.1 0.0 0.1 20.4 0.1 0.0 0.1 0.1 0.1 0.1 44.0 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 36.9 0.1 0.3 0.1 0.1 0.0 4.4 1.0 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 12.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.0 0.0 47.7 0.3 0.0 0.0 0.0 34.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 40.5 0.0 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.8 12.0 10.4 3.7 11.2 11.7 2.3 8.7 11.1 10.5 15.3 2.8 0.8 11.5 25.8 9.8 12.7 1.7 11.5 9.4 13.0 14.3 3.6 8.9 7.6 7.4 14.8 7.5 8.3 6.7 1.6 8.7 3.2 13.7 11.3 11.2 1.8 37.8 17.3 4.1 10.0 1.8 5.9 0.4 7.4 4.6 12.6 4.9 7.7 2.0 8.2 9.8 3.7 0.9 6.5 6.5 1.7 10.8 9.8 11.7 13.9 1.3 9.0 18.0 17.8 13.6 10.0 33.3 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 23.8 6.1 9.7 1.9 3.3 23.7 37.8 5.1 2.7 3.4 0.0 7.9 0.7 0.0 2.6 1.0 11.7 0.0 0.0 2.2 1.2 7.8 0.8 12.7 1.6 6.3 46.1 6.9 40.5 18.4 1.3 8.6 9.5 6.8 10.8 0.5 22.7 2.0 0.0 7.1 0.5 15.7 19.4 7.6 9.3 15.2 2.6 0.6 10.9 0.4 1.0 NXPE4 "C11orf33, FAM55D, FLJ20127" ENSG00000137634 "Neurexophilin and PC-esterase domain family member 4" Q6UWF7 11 114570591-114595762 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 29.3;Mucus-secreting cells: 101.9;Paneth cells: 37.4;Undifferentiated cells: 91.1" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA042801 Approved "Secreted to digestive system" NA NA "HPA042801: AB_10793986" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-3)" "unprognostic (1.27e-1)" "unprognostic (3.51e-3)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (7.47e-3)" "unprognostic (4.36e-2)" "unprognostic (2.05e-1)" 0.2 0.2 0.2 21.7 0.2 0.0 0.2 0.2 0.2 0.2 41.5 0.1 0.1 0.0 0.2 2.4 0.3 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.1 0.1 2.1 44.3 0.1 71.7 0.1 0.2 0.2 0.5 1.9 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.3 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 29.3 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.1 0.1 NXPH1 ENSG00000122584 "Neurexophilin 1" P58417 7 8433955-8752963 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "adrenal gland: 41.1;brain: 30.1" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.1;Early spermatids: 4.3;Late spermatids: 1.3;Rod photoreceptor cells: 3.4" "Group enriched" "Detected in some" 62 "breast cancer: 2.3;glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 15.4;WM-115: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-2)" "unprognostic (1.46e-4)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (5.32e-1)" "unprognostic (9.46e-2)" 0.8 41.1 9.6 0.7 9.8 0.7 1.1 3.6 30.1 0.7 0.7 3.0 0.0 0.7 0.7 0.7 0.7 0.7 0.8 0.7 6.5 13.9 0.7 0.7 0.7 0.7 6.2 7.1 0.7 0.7 0.7 1.9 0.7 6.8 0.7 0.7 0.0 1.0 0.7 0.7 0.7 0.7 0.7 3.3 0.7 0.7 0.9 1.9 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.4 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 9.8 3.6 11.5 6.5 13.9 6.2 7.1 6.8 1.9 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138670772-138780348 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "brain: 23.0;kidney: 8.0;ovary: 19.3" "Cell type enriched" "Detected in single" 7 "Distal tubular cells: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 4 "pons and medulla: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" NA Yes "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.4 0.5 3.1 0.6 3.7 0.2 0.4 0.8 6.0 0.6 0.3 0.0 0.0 0.2 1.1 0.5 0.2 0.6 0.2 0.2 1.9 1.5 8.0 0.3 0.3 0.2 2.4 2.0 19.3 0.2 0.4 0.4 0.4 23.0 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 0.3 0.7 0.2 0.2 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 1.6 6.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.7 0.8 5.6 1.9 1.5 2.4 2.0 23.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXPH4 NPH4 ENSG00000182379 "Neurexophilin 4" O95158 12 57216795-57226449 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;skin 1: 17.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 12.9;Cytotrophoblasts: 24.5;Muller glia cells: 15.7;Syncytiotrophoblasts: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 35.1;RH-30: 28.7;RPMI-8226: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.08e-2)" "unprognostic (4.84e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (6.21e-4)" "prognostic unfavorable (5.42e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (3.07e-1)" "unprognostic (1.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (7.83e-2)" "unprognostic (2.73e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-3)" 2.8 1.4 2.6 0.8 3.8 0.9 1.9 18.1 9.4 1.9 0.4 0.0 0.0 0.3 0.3 0.7 2.5 0.4 0.4 4.6 1.6 3.7 0.7 1.1 0.4 1.1 2.6 6.2 0.3 1.6 0.7 0.7 4.8 10.9 8.2 0.3 2.7 3.2 0.4 0.6 17.7 0.4 0.5 3.4 0.8 0.4 1.3 0.0 0.0 1.0 0.7 1.7 0.5 2.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.6 0.1 35.1 4.0 1.0 3.2 2.2 5.2 1.0 1.2 2.2 0.4 8.6 3.5 2.3 1.5 7.3 4.7 1.0 0.3 1.5 9.4 0.0 0.3 0.1 3.5 0.3 1.1 0.9 1.8 0.9 1.5 1.1 0.0 0.5 0.3 9.1 0.7 8.2 0.0 0.0 0.3 0.1 6.1 0.4 28.7 18.8 0.0 1.4 5.7 0.3 5.0 10.3 10.0 0.1 10.2 0.2 0.0 2.5 8.4 1.0 2.5 5.0 1.0 3.0 1.6 4.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.8 18.1 5.7 1.6 3.7 2.6 6.2 10.9 0.0 0.0 0.0 1.3 0.2 12.9 2.7 0.6 0.0 0.0 0.0 0.0 7.9 24.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.6 0.2 2.9 0.0 0.0 1.7 1.6 6.9 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 15.7 0.9 0.0 0.4 0.0 0.3 0.0 2.0 0.0 4.9 9.2 24.5 0.0 0.0 0.3 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 4.3;Horizontal cells: 12.7;Muller glia cells: 3.8;Peritubular cells: 4.2" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 10.5;HUVEC TERT2: 5.2;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 3.1 6.3 11.8 1.6 15.2 1.3 1.4 15.4 32.8 1.8 1.6 3.8 0.0 1.6 2.8 1.3 1.5 1.9 1.6 1.2 13.2 12.8 1.9 1.1 1.3 1.4 7.4 13.4 5.7 2.1 1.1 10.2 1.7 11.4 2.9 1.4 1.0 2.3 3.2 1.2 1.9 1.8 2.1 3.9 1.6 2.3 9.0 4.4 0.0 1.2 0.0 1.2 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 4.1 1.8 2.7 1.7 0.3 0.1 1.3 0.2 0.6 0.5 0.2 0.0 1.4 0.4 10.5 0.1 0.8 0.2 0.0 1.8 0.2 0.2 0.4 0.2 2.0 0.0 1.1 1.8 0.0 0.6 0.7 0.4 5.2 0.3 0.7 0.1 0.0 0.4 0.0 0.0 0.8 0.4 0.1 0.1 0.0 0.0 0.1 0.0 1.2 12.7 0.4 0.3 1.2 1.6 0.2 0.0 1.9 0.0 2.6 0.7 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.2 15.4 20.6 13.2 12.8 7.4 13.4 11.4 4.4 0.0 0.0 0.0 0.1 0.1 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 4.2 0.0 0.7 0.0 0.0 0.9 2.4 0.1 0.0 0.0 0.0 0.0 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell type enhanced" "Detected in many" 5 "Club cells: 12.5;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.1;HEL: 9.1;HUVEC TERT2: 22.7;RT4: 18.7;TIME: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 3.0 0.0 4.1 8.7 0.2 1.4 1.4 0.9 1.1 2.1 9.1 0.2 0.4 5.4 0.1 0.0 4.8 0.1 1.0 0.0 0.5 9.1 1.2 0.2 3.1 0.0 0.0 8.8 0.4 0.6 0.0 1.6 22.7 0.1 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.6 0.0 1.2 0.0 0.0 0.0 18.7 0.4 6.5 0.0 0.8 0.1 7.6 1.6 1.3 10.9 0.1 5.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 3.0 1.7 0.0 3.9 4.0 0.4 1.7 7.6 1.4 12.5 8.7 0.0 0.9 0.0 3.3 0.7 7.1 1.3 0.0 2.7 0.9 6.6 0.8 0.0 1.8 8.5 0.0 5.2 16.0 5.1 0.0 2.3 0.8 3.3 1.0 8.5 5.3 3.7 3.5 0.4 0.1 0.3 0.0 4.7 0.0 1.1 3.3 0.9 0.0 8.3 3.1 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120210767-120230332 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6" "Group enriched" "Detected in many" 12 "dendritic cells: 4.6;monocytes: 6.2" "Cell line enhanced" "Detected in many" "EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 65000000 Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 16.2 22.5 8.6 6.9 15.4 3.5 24.9 1.2 10.3 18.7 16.8 4.0 8.0 19.4 14.3 17.2 10.7 13.4 20.6 13.7 8.7 1.4 21.5 93.4 5.6 8.1 5.4 6.4 26.2 43.7 2.4 7.4 4.6 3.2 10.3 13.5 18.2 26.5 5.8 3.7 3.0 22.1 11.7 3.3 15.3 9.9 5.5 5.5 1.2 6.8 8.6 3.6 11.2 10.9 0.1 4.6 0.3 6.2 0.0 0.4 1.3 7.0 2.2 8.4 4.2 13.1 14.8 0.5 13.8 14.3 5.6 8.2 2.2 11.0 0.0 35.0 9.3 9.2 7.4 2.3 3.5 2.2 5.1 5.7 5.8 1.4 54.7 11.7 12.8 2.3 18.4 2.1 5.3 14.9 10.8 16.0 3.5 3.7 6.7 1.3 2.6 0.0 36.7 3.4 1.9 11.2 3.3 0.2 6.8 8.4 3.9 0.4 3.0 4.0 4.5 11.4 2.4 1.4 21.3 9.7 12.0 4.4 12.2 1.3 0.2 0.1 0.1 9.2 21.4 4.1 0.0 6.2 0.0 0.2 2.9 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.4 0.3 0.0 0.6 0.9 0.3 1.3 8.6 15.4 1.2 10.3 8.7 1.4 5.4 6.4 3.2 5.5 0.0 1.1 1.5 19.1 8.4 3.2 3.6 33.1 0.0 2.3 68.0 2.0 1.8 23.2 14.3 0.1 24.8 97.4 23.3 24.3 4.7 46.2 12.2 1.1 187.7 5.5 0.0 21.9 11.1 10.6 0.0 15.5 9.7 15.1 1.8 55.8 261.4 23.5 41.9 4.2 64.1 8.0 51.8 45.3 0.5 6.7 8.9 5.1 3.2 42.0 195.3 OBP2B "hOBPIIb, LCN14" ENSG00000171102 "Odorant binding protein 2B" Q9NPH6 9 133205277-133209250 "Predicted secreted proteins" "Olfaction, Sensory transduction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 3.6;skin 1: 3.0;testis: 12.1" "Cell type enhanced" "Detected in some" 13 "Late spermatids: 1.4;Leydig cells: 1.1;Melanocytes: 1.7" "Group enriched" "Detected in many" 8 "breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 2.4" "Secreted in other tissues" NA NA "unprognostic (1.40e-1)" "unprognostic (5.70e-2)" "unprognostic (9.45e-3)" "unprognostic (6.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (7.03e-2)" "unprognostic (6.82e-6)" "unprognostic (2.00e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OC90 PLA2L ENSG00000253117 "Otoconin 90" Q02509 8 132024220-132059380 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "SK-MEL-30: 4.7" "Secreted in other tissues" NA NA "unprognostic (1.92e-1)" "unprognostic (2.93e-1)" 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.2 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OCEL1 FLJ22709 ENSG00000099330 "Occludin/ELL domain containing 1" Q9H607 19 17226204-17229219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.0" "HPA042070, HPA043223" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042070: AB_2677830, HPA043223: " "unprognostic (6.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.13e-1)" "unprognostic (3.00e-3)" "unprognostic (6.40e-2)" "unprognostic (2.06e-2)" "unprognostic (4.33e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (4.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.52e-1)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "unprognostic (1.18e-3)" 12.1 14.3 9.2 7.3 7.4 5.9 10.6 7.3 16.5 9.6 18.6 6.2 14.0 20.4 9.7 21.3 8.8 14.7 11.0 9.1 8.3 8.2 23.3 48.1 11.1 7.6 9.9 9.5 12.3 15.9 12.3 6.5 13.0 7.8 13.4 13.7 9.9 11.5 21.7 8.6 5.6 32.2 8.2 8.1 11.8 15.1 4.9 8.1 9.4 20.5 6.8 10.0 9.7 13.6 12.2 18.2 17.2 23.7 11.2 14.4 9.5 5.8 4.4 2.5 2.0 24.0 9.8 6.2 3.6 9.5 2.9 4.9 3.2 6.7 5.0 13.9 5.2 2.5 2.7 3.1 3.7 2.7 4.2 3.7 4.8 4.8 15.4 8.1 1.0 7.4 8.1 3.8 3.6 5.3 9.7 4.0 6.7 3.9 4.8 5.2 4.7 2.4 2.7 3.8 8.3 7.8 2.2 2.1 12.1 12.1 7.7 0.8 3.9 2.2 7.3 6.2 5.1 11.1 4.2 2.5 1.7 2.1 3.7 1.9 13.6 10.2 3.8 6.1 4.4 1.2 17.2 23.7 11.2 8.1 15.7 7.9 12.0 12.2 9.2 18.2 12.2 14.0 8.7 7.5 11.2 12.4 8.0 14.4 9.5 9.2 7.4 7.3 16.5 8.3 8.2 9.9 9.5 7.8 8.1 11.9 5.1 15.2 23.6 5.7 11.6 5.9 30.6 62.9 7.9 19.2 2.0 35.5 51.4 17.4 3.9 15.0 74.1 0.0 24.2 36.0 17.5 26.5 16.1 76.1 23.5 23.8 16.7 21.5 20.4 12.0 26.2 17.1 15.1 10.8 30.2 29.0 21.0 49.1 21.9 112.8 8.2 32.3 13.4 7.7 13.8 5.8 86.3 19.7 25.9 18.2 OCLM ENSG00000262180 Oculomedin Q9Y5M6 1 186400572-186401455 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 8.5" NA NA "unprognostic (1.83e-1)" "unprognostic (3.14e-2)" "unprognostic (3.23e-2)" "unprognostic (2.99e-2)" "unprognostic (2.70e-1)" "unprognostic (3.84e-2)" "unprognostic (7.14e-2)" "unprognostic (2.98e-1)" "unprognostic (1.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-5)" "unprognostic (2.65e-1)" "unprognostic (1.79e-1)" "unprognostic (1.11e-1)" "unprognostic (5.81e-2)" 1.8 0.9 0.1 1.1 0.2 6.2 1.8 1.5 0.9 1.3 0.9 0.5 1.7 4.2 1.2 1.4 0.7 1.9 0.2 0.2 0.7 1.2 2.1 1.8 0.1 2.8 4.9 2.2 1.5 1.7 1.3 1.6 2.2 0.1 1.1 3.5 1.4 1.0 0.5 1.2 1.6 1.4 2.0 1.2 1.4 2.0 1.1 1.3 0.6 1.0 0.9 1.8 0.0 0.6 2.1 1.6 3.8 1.2 1.0 3.7 0.9 0.3 0.4 0.8 1.9 2.6 2.4 1.0 1.4 0.1 2.7 1.5 0.6 0.4 0.3 0.8 0.5 5.6 1.0 0.2 1.7 1.6 1.2 2.4 1.1 4.0 1.8 0.8 1.0 2.0 4.2 1.1 1.8 0.8 0.9 3.1 0.4 0.0 1.6 1.1 1.3 0.1 2.5 1.6 2.3 1.6 2.4 0.0 2.9 1.5 0.9 2.6 3.5 1.8 3.1 1.3 8.5 1.7 1.0 1.0 1.1 1.2 0.0 1.0 0.4 0.8 0.2 0.5 0.3 1.0 0.6 0.6 1.1 1.2 1.8 0.6 0.9 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OCSTAMP "C20orf123, dJ257E24.3" ENSG00000149635 "Osteoclast stimulatory transmembrane protein" Q9BR26 20 46540946-46550574 "Predicted membrane proteins, Transporters" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.9;blood: 2.6" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 26 "dendritic cells: 2.6" "Cell line enhanced" "Detected in some" "AF22: 2.7;HMC-1: 5.2;Karpas-707: 3.0;NB-4: 5.7;RPMI-8226: 2.4;U-266/70: 1.9;U-266/84: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA031116 Uncertain NA NA "HPA031116: AB_10600758" "unprognostic (2.77e-1)" "unprognostic (3.04e-1)" "unprognostic (8.80e-2)" "unprognostic (5.02e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "unprognostic (9.59e-2)" "unprognostic (2.08e-1)" 6.9 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.6 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.4 0.0 0.1 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODF2L KIAA1229 ENSG00000122417 "Outer dense fiber of sperm tails 2 like" Q9ULJ1 1 86346824-86396342 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 455.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028020, HPA028095, HPA028333" Uncertain NA NA "HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007" "unprognostic (4.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.03e-1)" "unprognostic (4.72e-2)" "unprognostic (2.92e-2)" "unprognostic (3.80e-3)" "unprognostic (5.61e-3)" "unprognostic (2.25e-1)" "unprognostic (2.08e-3)" "unprognostic (1.07e-1)" "unprognostic (6.27e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (4.69e-7)" "unprognostic (2.40e-1)" "unprognostic (5.86e-2)" "unprognostic (2.40e-1)" "unprognostic (5.04e-3)" 16.1 15.7 14.9 13.8 16.7 15.4 22.3 16.6 23.0 18.1 14.4 10.6 14.8 8.6 19.1 26.0 13.8 22.6 16.2 10.2 12.2 15.6 14.1 6.6 19.2 15.4 9.6 16.9 16.7 9.5 6.3 37.8 10.5 15.9 15.7 15.9 13.5 14.4 13.6 4.1 12.4 17.4 10.3 15.3 29.0 7.2 10.9 12.6 36.5 18.5 9.5 13.4 12.3 13.9 11.0 6.1 6.3 2.0 6.7 27.2 2.5 14.2 3.9 9.8 7.5 10.7 18.4 10.3 14.0 8.6 14.0 16.1 3.0 8.0 0.3 13.2 7.4 17.7 7.4 4.0 8.2 11.9 6.7 6.3 3.5 11.7 0.3 8.1 6.2 4.7 8.6 10.1 20.8 5.7 10.1 22.2 9.7 4.8 3.4 8.1 2.0 7.4 6.6 11.9 3.1 7.1 10.0 7.4 1.5 14.5 19.4 9.7 7.1 12.6 12.9 25.8 16.1 4.2 6.1 20.3 11.6 10.8 15.8 14.1 1.0 0.5 5.9 2.7 3.2 13.0 2.2 1.2 6.3 13.8 1.6 27.2 10.2 16.1 10.9 1.1 11.0 10.4 9.9 3.2 6.7 2.0 6.1 14.9 2.5 14.9 16.7 16.6 23.0 12.2 15.6 9.6 16.9 15.9 12.6 86.4 63.3 68.6 42.7 22.1 90.4 8.5 20.4 455.0 182.0 76.8 133.5 7.0 19.9 48.6 23.9 74.5 12.0 0.0 23.7 30.1 39.8 14.4 34.8 2.6 12.9 54.0 39.6 62.0 16.8 5.0 23.0 16.5 54.0 22.6 51.0 32.7 46.9 31.6 26.9 15.9 124.7 19.4 19.3 58.1 26.0 15.2 2.4 71.4 24.7 59.5 ODF3 "CT135, hSHIPPO, SHIPPO1" ENSG00000177947 "Outer dense fiber of sperm tails 3" Q96PU9 11 196738-200261 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 12.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 76.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038919, HPA039241" Enhanced NA NA "HPA038919: AB_2676270, HPA039241: AB_10673417" "unprognostic (4.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.24e-2)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 ODF3B ENSG00000177989 "Outer dense fiber of sperm tails 3B" A8MYP8 22 50529710-50532580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 218.2;Late spermatids: 631.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 31.6;intermediate monocyte: 24.3;myeloid DC: 18.2;neutrophil: 19.2;non-classical monocyte: 16.4" "Group enriched" "Detected in many" 15 "dendritic cells: 18.2;granulocytes: 19.2;monocytes: 31.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;Karpas-707: 23.3;U-266/70: 33.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062837 Enhanced NA NA "HPA062837: AB_2684877" "unprognostic (4.30e-3)" "unprognostic (1.45e-2)" "unprognostic (5.98e-2)" "prognostic favorable (2.84e-4)" "unprognostic (2.60e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (5.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (2.72e-1)" "unprognostic (1.51e-2)" "unprognostic (6.10e-2)" "unprognostic (3.61e-2)" 16.1 2.6 3.4 18.8 5.7 8.8 10.7 5.9 2.5 7.5 6.3 7.4 5.4 5.2 5.0 31.1 11.7 49.0 9.3 5.8 4.7 5.0 9.6 20.1 33.2 15.4 1.4 1.2 12.4 8.8 1.7 3.9 6.5 12.3 10.4 1.4 6.2 34.3 8.7 5.4 5.6 9.3 3.5 6.2 16.3 9.1 7.4 2.3 4.0 12.4 13.7 13.0 6.3 4.9 1.4 18.2 19.2 31.6 0.0 0.8 8.0 1.5 1.0 0.1 0.4 0.0 2.1 0.9 0.0 0.3 0.1 1.0 1.8 7.6 0.5 1.9 0.0 0.2 4.5 0.0 0.0 0.0 0.8 0.5 0.3 1.1 1.3 5.8 0.0 3.7 1.2 0.9 0.0 0.0 0.6 0.1 0.6 0.4 23.3 0.0 0.0 0.0 0.8 0.1 0.4 1.0 0.8 0.1 3.8 0.0 0.0 0.1 6.6 0.7 0.9 0.1 0.1 0.7 1.1 0.6 0.2 0.6 0.4 0.1 33.1 3.0 0.5 0.7 0.1 0.6 2.3 31.6 3.4 0.2 24.3 0.3 1.4 0.6 0.4 18.2 0.8 0.3 0.2 19.2 0.0 16.4 1.7 0.8 8.0 3.4 5.7 5.9 2.5 4.7 5.0 1.4 1.2 12.3 2.3 17.9 60.6 18.4 15.7 21.4 0.1 2.5 22.9 218.2 51.2 3.5 0.0 1.6 0.0 53.7 129.9 21.8 10.3 0.0 65.6 34.2 17.9 27.3 5.8 31.1 34.8 0.0 19.7 11.6 55.4 631.1 4.9 45.8 16.9 114.6 13.6 0.0 42.1 11.5 3.2 13.2 0.0 0.0 15.3 4.3 3.0 31.6 4.6 5.7 4.5 27.3 ODF3L1 MGC48986 ENSG00000182950 "Outer dense fiber of sperm tails 3 like 1" Q8IXM7 15 75723977-75727688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 53.2" "Cell type enriched" "Detected in some" 10 "Early spermatids: 64.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Cell line enhanced" "Detected in some" "A549: 3.0;CAPAN-2: 2.7;HaCaT: 2.7;HeLa: 3.6;U-87 MG: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.24e-2)" "unprognostic (1.97e-2)" "unprognostic (4.58e-2)" "unprognostic (8.42e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (7.55e-4)" "unprognostic (9.65e-2)" "unprognostic (9.96e-3)" "unprognostic (6.40e-2)" "unprognostic (4.14e-2)" "unprognostic (8.94e-3)" "unprognostic (1.45e-2)" 1.5 0.1 0.5 0.8 0.7 0.1 1.3 0.3 0.5 0.6 1.2 0.3 0.5 0.4 1.3 1.5 1.8 1.1 3.1 1.2 0.6 0.6 0.3 1.2 1.8 0.1 0.3 0.4 0.8 0.3 0.0 1.2 1.3 0.8 0.8 0.3 0.8 0.5 0.5 0.1 1.7 1.5 3.0 0.2 0.4 2.0 53.2 0.2 0.5 1.6 1.2 0.6 0.6 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.2 0.6 0.2 0.4 1.5 0.1 0.2 0.6 2.7 0.0 0.1 0.4 0.0 2.7 0.1 1.7 0.0 2.1 1.2 0.0 3.6 0.5 0.8 0.0 0.0 2.0 0.1 0.6 1.1 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.3 0.3 0.0 0.0 0.2 1.4 0.1 1.6 0.0 0.7 0.1 0.0 0.1 0.6 0.2 0.0 3.8 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.5 0.6 0.6 0.3 0.4 0.8 0.2 0.0 0.6 0.0 3.6 5.5 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.6 0.0 0.2 64.7 0.2 0.7 0.0 0.0 0.6 2.0 1.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 4.2 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.7 0.6 0.0 6.5 0.2 0.9 0.2 5.6 1.6 0.0 0.0 2.2 OGFOD2 "FLJ13491, FLJ37501" ENSG00000111325 "2-oxoglutarate and iron dependent oxygenase domain containing 2" Q6N063 12 122974580-122980043 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 85.8;Late spermatids: 337.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039448, HPA040306" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039448: AB_10795035, HPA040306: AB_10794026" "unprognostic (2.14e-1)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" "unprognostic (3.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.57e-2)" "unprognostic (6.12e-3)" "unprognostic (1.14e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.07e-3)" "unprognostic (2.48e-3)" "unprognostic (1.13e-3)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" 6.2 15.0 8.9 11.7 11.7 10.0 7.5 13.4 10.6 7.5 13.4 11.6 14.1 18.5 9.6 14.9 11.2 12.8 13.1 8.5 8.0 8.8 12.9 18.9 8.0 13.4 14.5 9.3 11.6 24.3 10.9 13.5 10.6 13.4 11.4 7.8 9.7 20.1 14.6 13.2 15.9 17.9 8.7 8.0 14.4 11.5 25.1 13.8 10.9 13.3 10.8 12.0 7.4 8.0 16.4 13.4 18.0 16.6 8.8 15.6 9.3 7.2 11.8 4.9 8.0 3.4 3.7 13.3 4.4 4.6 6.2 5.6 11.0 6.5 8.1 9.2 3.8 3.6 10.5 3.5 6.0 2.3 5.6 7.7 12.9 10.0 11.4 7.4 12.8 10.1 5.4 9.1 5.7 5.1 9.0 6.5 15.8 14.9 6.0 3.1 13.9 10.7 24.2 3.0 5.0 15.1 12.0 4.7 14.3 4.7 6.5 6.3 5.8 6.0 8.7 8.3 3.4 21.9 11.0 4.1 8.5 8.7 10.0 4.5 15.2 9.1 7.7 11.7 6.7 8.2 12.5 12.2 18.0 10.1 13.1 8.7 16.4 8.2 9.8 13.4 11.4 9.3 8.5 10.0 8.8 16.6 8.0 15.6 9.3 8.9 11.7 13.4 10.6 8.0 8.8 14.5 9.3 13.4 13.8 0.0 6.5 8.4 5.1 2.6 3.3 0.3 7.6 28.1 6.8 12.2 2.0 21.9 8.3 9.9 85.8 5.4 10.7 0.0 13.0 12.2 4.3 4.0 0.0 18.7 11.3 11.1 2.4 6.2 11.4 337.1 8.1 5.2 6.8 5.4 9.6 7.3 11.3 7.0 4.2 23.7 5.8 12.9 2.7 25.1 15.2 4.0 13.7 7.2 11.0 2.4 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288803-71308950 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 16.9 8.7 20.2 11.3 26.8 16.9 36.0 22.3 33.3 6.7 7.2 29.1 2.8 2.9 8.3 10.7 24.5 5.2 8.3 5.8 30.2 17.6 5.7 4.8 8.5 9.6 27.7 18.3 5.4 6.0 5.8 10.0 9.9 37.8 6.7 4.3 3.3 31.8 10.3 4.1 14.6 5.7 24.1 52.2 11.7 5.4 2.4 29.1 3.2 4.8 4.3 17.8 5.4 9.4 0.7 2.4 12.8 3.0 0.5 0.5 0.6 3.8 1.1 4.1 0.0 11.2 10.3 1.5 17.4 10.8 7.0 7.2 1.4 0.7 23.7 24.0 7.5 6.5 1.9 3.1 12.0 25.0 5.0 2.5 5.2 4.2 0.6 9.1 2.4 1.8 10.3 10.3 5.2 16.4 5.9 5.6 0.0 0.3 1.9 24.1 3.2 0.0 3.8 1.7 1.5 1.0 1.6 12.6 5.4 16.3 0.3 14.1 6.4 5.1 3.2 1.1 6.2 5.5 19.2 8.6 17.3 8.7 1.8 5.7 2.5 0.1 3.1 5.8 16.5 3.0 3.1 3.0 0.1 0.5 2.0 0.5 0.4 0.4 0.5 2.4 0.7 0.1 0.3 12.8 0.5 1.4 0.9 0.2 0.6 20.2 26.8 22.3 27.4 30.2 17.6 27.7 18.3 37.8 29.1 6.0 21.8 14.3 18.0 34.6 15.3 7.8 5.1 1.4 11.4 10.4 23.6 19.2 1.7 12.9 0.4 21.0 0.0 0.0 27.8 10.1 31.4 13.9 5.8 4.0 53.5 36.5 13.8 8.6 79.5 1.1 15.3 93.2 30.4 27.9 2.4 83.6 18.3 0.0 31.1 3.1 5.0 25.8 18.6 0.4 1.1 40.7 15.9 12.1 4.3 14.9 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777158-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 17.3 2.1 1.0 7.4 1.7 0.1 10.9 1.9 3.4 34.2 18.9 3.1 6.3 2.3 29.2 8.3 11.8 4.2 7.6 12.5 1.2 1.0 3.0 0.6 10.3 1.5 2.1 1.5 13.2 3.4 3.6 2.1 5.0 4.0 16.1 4.6 18.9 4.7 9.5 9.8 11.6 5.0 33.7 1.6 23.8 4.0 3.1 0.6 3.7 20.0 11.9 5.0 22.0 10.4 1.4 0.7 2.6 0.9 0.6 0.6 0.4 0.3 5.2 0.4 0.1 6.1 58.3 0.0 0.8 2.9 1.2 1.2 0.0 0.7 0.0 1.5 0.0 12.1 9.7 0.1 0.3 1.4 0.0 0.0 0.0 14.7 0.0 0.3 0.0 0.0 4.1 0.9 3.6 0.5 13.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.3 0.0 0.5 0.0 3.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 1.5 10.6 1.4 0.1 0.0 1.8 1.9 2.0 0.2 0.7 0.0 0.0 5.6 0.3 22.8 1.9 0.9 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.7 1.4 0.4 0.6 2.6 0.6 0.3 0.6 0.3 0.4 1.0 1.7 1.9 3.4 1.2 1.0 2.1 1.5 4.0 0.6 0.0 2.2 0.0 3.7 10.6 0.5 12.1 0.0 1.4 0.0 0.0 2.0 0.2 0.0 0.1 0.6 14.2 0.0 0.0 0.6 0.2 13.1 1.0 0.0 0.0 0.1 0.0 0.0 3.1 2.4 1.2 2.6 0.5 10.1 0.0 0.0 0.2 0.0 0.0 1.4 0.0 3.9 12.9 28.8 0.2 0.7 7.3 0.0 0.0 0.0 1.6 OLFML2B DKFZP586L151 ENSG00000162745 "Olfactomedin like 2B" Q68BL8 1 161983192-162023854 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 8.8;non-classical monocyte: 6.5" "Lineage enriched" "Detected in single" 10 "monocytes: 8.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6" "Region enriched" "Detected in many" 6 "hippocampal formation: 45.1" "Low region specificity" "Detected in many" "HPA054136, HPA062739" Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA054136: AB_2682397, HPA062739: AB_2684858" "unprognostic (2.97e-2)" "unprognostic (1.79e-1)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (6.01e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (5.97e-3)" "unprognostic (7.32e-2)" "unprognostic (7.68e-3)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.01e-12)" "unprognostic (1.64e-3)" "unprognostic (2.11e-2)" "unprognostic (4.53e-3)" "unprognostic (1.97e-2)" 19.6 6.6 1.7 12.8 3.0 0.3 12.3 0.6 4.1 13.0 14.5 2.9 6.5 1.5 14.2 21.8 3.2 9.8 33.7 25.4 2.9 1.6 3.9 1.2 12.8 24.1 2.9 1.2 7.0 2.3 3.2 2.6 27.6 2.2 6.6 2.2 14.5 9.0 6.1 6.1 8.9 5.0 15.1 3.6 22.4 3.4 12.5 2.1 1.9 18.3 13.7 8.5 12.4 7.3 0.0 0.8 0.3 8.8 0.0 0.1 0.2 0.0 0.1 2.6 0.8 8.4 16.0 0.0 0.8 4.1 1.7 4.6 0.0 0.0 0.0 0.1 9.7 1.7 0.0 0.2 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 45.3 0.0 2.0 0.0 0.8 0.2 0.0 0.0 0.4 7.4 0.0 0.0 0.1 0.8 0.0 0.4 0.0 34.6 3.3 0.6 0.0 0.3 0.1 3.4 0.0 0.2 8.0 0.0 0.0 0.0 1.0 0.2 1.5 1.3 0.0 0.0 0.0 9.9 1.0 0.5 0.0 0.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.3 0.0 6.5 0.0 0.0 0.2 1.7 3.0 0.6 4.1 2.9 1.6 2.9 1.2 2.2 2.1 0.0 1.1 0.0 0.0 3.0 0.0 2.5 0.0 0.0 1.2 1.8 0.0 0.2 0.0 0.0 56.2 0.0 0.0 0.0 0.0 0.3 9.3 0.1 1.1 0.0 31.7 0.0 0.0 1.8 20.4 4.5 19.2 9.9 1.7 1.0 0.0 0.9 0.0 0.0 27.6 0.0 0.0 6.5 12.6 1.5 0.9 1.9 0.2 0.0 0.0 0.0 OLFML3 "HNOEL-iso, OLF44" ENSG00000116774 "Olfactomedin like 3" Q9NRN5 1 113979391-114035572 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Fibroblasts: 177.9;Ito cells: 73.6;Leydig cells: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "myeloid DC: 5.4" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.4" "Cell line enhanced" "Detected in many" "ASC diff: 84.8;ASC TERT1: 46.4;BJ hTERT+: 52.9;HSkMC: 84.8;LHCN-M2: 84.6" "Low region specificity" "Detected in many" HPA027991 Supported Vesicles "Secreted to extracellular matrix" NA NA 1500000 Vesicles "HPA027991: AB_2732440" "unprognostic (1.04e-1)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (2.02e-1)" "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.80e-3)" "unprognostic (1.88e-1)" "unprognostic (2.61e-1)" "unprognostic (4.41e-3)" 25.8 11.8 3.9 9.7 6.6 0.0 25.6 1.4 7.9 75.3 22.7 16.2 17.9 3.9 57.7 41.8 13.8 33.9 31.5 20.3 3.0 2.3 9.7 9.4 18.4 5.7 7.1 4.0 52.6 11.7 1.0 6.6 29.1 8.9 33.1 9.6 41.4 6.1 21.9 5.8 13.5 10.8 29.4 5.1 2.5 19.1 13.3 4.6 0.6 7.8 15.0 7.0 28.0 37.6 0.0 5.4 0.0 0.4 0.0 0.0 0.2 0.0 2.7 1.4 0.0 84.8 46.4 0.0 10.8 52.9 3.7 12.3 3.5 0.0 0.0 0.6 31.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.6 22.0 0.0 0.0 84.8 0.0 5.3 0.0 1.5 0.3 0.0 0.0 0.0 84.6 0.0 0.0 0.0 6.4 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.4 21.4 31.4 0.1 0.2 2.1 4.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.9 6.6 1.4 7.9 3.0 2.3 7.1 4.0 8.9 4.6 0.0 5.9 0.5 0.1 11.6 0.0 1.4 2.5 0.0 1.2 1.8 0.0 5.6 0.0 0.6 1.5 3.5 0.0 0.0 0.0 5.0 177.9 1.1 1.1 0.2 33.4 0.0 5.8 73.6 5.0 1.1 67.9 3.6 11.8 1.0 0.2 0.0 0.4 0.0 31.1 0.5 0.0 0.0 37.3 0.2 0.4 10.0 10.4 0.7 0.0 0.3 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Cell line enhanced" "Detected in some" "HMC-1: 30.0;NB-4: 21.7;THP-1: 18.8;WM-115: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.8 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.7 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.1 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OMP ENSG00000254550 "Olfactory marker protein" P47874 11 77102840-77103331 "Predicted intracellular proteins" "Olfaction, Sensory transduction" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.4;liver: 3.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.7;CACO-2: 3.3;OE19: 4.5" "Region enriched" "Detected in single" 63 "olfactory region: 119.4" NA NA "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (8.53e-2)" "unprognostic (3.54e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.52e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-2)" "unprognostic (4.23e-1)" "unprognostic (5.33e-3)" "unprognostic (3.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (8.17e-2)" 0.0 0.8 0.1 0.2 0.2 1.9 0.0 0.1 0.1 0.4 3.0 5.4 0.0 0.0 1.3 0.2 2.3 0.2 0.0 0.1 0.6 3.9 0.2 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.5 3.8 0.3 0.1 0.0 0.0 5.0 0.1 0.1 0.1 1.9 0.7 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 1.1 0.0 2.7 0.4 3.3 0.0 0.0 0.6 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.3 0.3 0.2 0.0 0.7 0.0 0.3 0.0 0.0 4.5 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.3 1.1 1.1 0.0 1.3 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ONECUT1 "HNF-6, HNF6, HNF6A" ENSG00000169856 "One cut homeobox 1" Q9UBC0 15 52756989-52791078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "gallbladder: 40.1;liver: 59.9;pancreas: 46.3" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 611.8" "Group enriched" "Detected in some" 7 "liver cancer: 2.9;pancreatic cancer: 0.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.1;WM-115: 3.7" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Low region specificity" "Detected in all" HPA003457 Enhanced NA NA "HPA003457: AB_1079525" "unprognostic (5.12e-2)" "unprognostic (2.45e-2)" "unprognostic (2.64e-2)" "unprognostic (4.82e-2)" "unprognostic (9.19e-2)" "unprognostic (7.05e-2)" "unprognostic (5.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.70e-7)" "unprognostic (9.76e-3)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.5 0.0 0.1 1.2 0.1 0.9 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 40.1 0.1 0.2 0.2 0.1 59.9 0.1 0.0 0.1 0.0 0.1 46.3 0.0 0.1 0.0 1.4 0.1 0.0 3.5 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 1.2 3.3 1.5 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.4 0.2 2.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.2 1.4 4.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.3 0.4 0.0 5.1 0.0 0.0 2.5 0.4 0.3 0.9 0.3 0.0 0.0 4.1 1.7 0.0 0.6 0.1 0.4 2.9 1.0 0.2 0.0 2.1 2.7 0.0 0.4 0.3 0.1 0.3 0.4 0.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.9 0.3 0.2 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 35.7 0.0 0.0 0.0 0.0 0.0 1.7 10.3 0.9 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 8.2 0.0 611.8 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.0 0.0 0.0 3.6 0.0 0.3 2.3 0.5 0.0 0.0 0.0 0.0 0.0 ONECUT2 OC-2 ENSG00000119547 "One cut homeobox 2" O95948 18 57435685-57491297 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;gallbladder: 60.7;intestine: 18.0" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 910.5" "Group enriched" "Detected in many" 7 "liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4" "Region enhanced" "Detected in many" "basal ganglia: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3" HPA057058 Enhanced Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA057058: AB_2683323" "unprognostic (3.02e-2)" "unprognostic (5.36e-2)" "unprognostic (9.06e-3)" "unprognostic (3.79e-5)" "unprognostic (1.13e-2)" "unprognostic (4.48e-4)" "unprognostic (2.10e-2)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (4.56e-3)" "unprognostic (8.66e-3)" "unprognostic (1.16e-2)" "unprognostic (5.34e-4)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.13e-1)" "unprognostic (3.21e-1)" 0.3 0.4 0.3 0.3 18.6 0.2 0.3 3.0 3.7 0.2 16.5 0.0 0.0 15.0 0.3 0.3 0.3 0.2 60.7 0.2 0.5 0.9 0.3 12.8 0.3 0.3 0.5 0.9 0.3 4.3 3.2 5.1 0.2 1.1 0.3 0.3 0.7 0.3 0.3 0.3 0.3 18.0 0.3 0.3 0.3 0.5 0.6 6.6 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.1 3.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 1.4 0.0 3.3 0.0 0.1 18.7 3.0 0.7 11.9 2.7 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.2 3.6 0.6 0.0 0.4 1.7 0.0 0.1 1.5 0.7 0.0 1.1 0.0 1.6 6.3 9.8 1.6 0.1 0.0 0.2 0.1 0.4 0.7 0.0 1.0 1.3 0.2 0.2 0.3 2.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 3.0 3.7 0.5 0.9 0.5 0.9 1.1 6.6 0.0 0.0 0.0 0.2 0.1 3.0 2.6 155.4 0.0 0.0 7.0 13.7 0.0 0.0 69.5 2.0 0.6 0.3 0.0 7.6 0.1 0.0 0.3 0.0 44.2 0.8 910.5 8.5 9.2 0.6 2.8 0.3 0.0 0.0 0.0 0.7 2.9 24.1 3.1 0.0 0.0 4.9 0.0 0.7 1.4 1.7 0.1 0.0 0.0 0.4 0.0 OOSP2 "FLJ36198, PLAC1L, TMEM122" ENSG00000149507 "Oocyte secreted protein 2" Q86WS3 11 60040275-60048044 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 48.6" "Cell type enriched" "Detected in single" 4 "Late spermatids: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 32 "basophil: 3.2" "Lineage enriched" "Detected in single" 32 "granulocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA050914 Enhanced "Secreted in male reproductive system" NA NA "HPA050914: AB_2681271" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343216-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 69.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "JURKAT: 1.2;MOLT-4: 2.2;REH: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014372 Supported NA NA "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 1.5 1.5 35.0 1.5 42.1 1.6 1.5 2.8 69.7 1.5 1.5 52.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 1.5 40.1 15.1 1.5 1.5 1.5 1.5 19.9 17.8 1.5 1.5 1.5 0.0 1.5 13.8 1.5 1.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 17.8 1.5 1.5 1.5 29.5 0.0 1.5 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 42.1 2.8 33.4 40.1 15.1 19.9 17.8 13.8 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A2 "OR10A2P, OST363" ENSG00000170790 "Olfactory receptor family 10 subfamily A member 2" Q9H208 11 6863057-6874717 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.04e-2)" 0.0 0.3 0.2 0.4 0.6 1.0 0.0 0.0 0.3 0.2 0.0 0.5 0.2 0.0 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.8 0.0 0.0 0.2 0.4 0.0 0.6 0.1 0.1 0.3 0.0 0.6 0.8 2.9 0.4 0.5 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.3 0.1 0.8 0.1 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.6 0.3 0.5 0.3 0.0 0.8 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.2 0.2 0.1 0.1 0.8 0.3 0.0 0.4 0.6 0.0 0.4 0.5 0.0 0.3 0.1 0.4 0.2 0.0 0.4 0.2 0.2 0.4 0.1 0.3 1.2 0.4 0.3 0.3 0.2 0.2 0.4 0.2 0.1 0.0 0.6 0.3 0.3 2.9 0.5 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A3 "HSHTPCRX12, HTPCRX12" ENSG00000170683 "Olfactory receptor family 10 subfamily A member 3" P58181 11 7937171-7941708 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 1.4;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "A-431: 2.2;HMC-1: 2.8" NA NA "unprognostic (2.53e-2)" "unprognostic (3.24e-3)" 0.1 0.1 0.0 0.2 0.0 1.4 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 1.8 0.2 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.5 0.4 2.2 0.3 0.2 0.3 0.1 2.2 0.2 0.0 0.4 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.8 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.8 0.3 0.4 0.2 0.5 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.3 0.3 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.3 1.7 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A4 OR10A4P ENSG00000170782 "Olfactory receptor family 10 subfamily A member 4" Q9H209 11 6876625-6877619 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 4 "NTERA-2: 1.6" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A5 "JCG6, OR10A1, OR11-403" ENSG00000166363 "Olfactory receptor family 10 subfamily A member 5" Q9H207 11 6845652-6846705 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.14e-5)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10AD1 OR10AD1P ENSG00000172640 "Olfactory receptor family 10 subfamily AD member 1" Q8NGE0 12 48202083-48203387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;K-562: 1.2;U-937: 4.2" HPA049913 Uncertain NA NA "HPA049913: AB_2680950" "unprognostic (2.90e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-2)" "unprognostic (1.70e-2)" "unprognostic (6.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-2)" "unprognostic (1.74e-1)" 0.0 2.5 0.2 1.7 0.5 0.2 0.0 1.9 0.6 0.3 0.6 1.0 0.6 0.0 0.6 0.6 0.1 0.2 0.1 0.3 0.4 0.0 0.3 1.6 0.0 1.4 0.3 0.0 2.9 0.4 0.7 0.0 0.7 0.0 0.3 0.9 0.7 0.0 0.0 0.9 0.6 2.5 1.5 0.0 0.6 0.3 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.3 0.2 1.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.3 0.0 0.0 0.4 0.0 0.0 1.0 0.9 0.1 0.0 4.2 0.1 0.0 0.4 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10AG1 ENSG00000174970 "Olfactory receptor family 10 subfamily AG member 1" Q8NH19 11 55965755-55969945 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10C1 "hs6M1-17, OR10C1P, OR10C2" ENSG00000206474 "Olfactory receptor family 10 subfamily C member 1 (gene/pseudogene)" Q96KK4 6 29439306-29440977 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049336 Uncertain NA NA "HPA049336: AB_2680718" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G2 ENSG00000255582 "Olfactory receptor family 10 subfamily G member 2" Q8NGC3 14 21633836-21634940 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "GAMG: 1.4" "Not detected" "Not detected" NA NA "unprognostic (7.80e-3)" 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G8 ENSG00000234560 "Olfactory receptor family 10 subfamily G member 8" Q8NGN5 11 124026798-124030634 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HUVEC TERT2: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H1 ENSG00000186723 "Olfactory receptor family 10 subfamily H member 1" Q9Y4A9 19 15804549-15815664 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.7;urinary bladder: 6.1" "Group enriched" "Detected in some" 60 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 43.2;Ciliated cells: 37.5;Club cells: 54.6;granulocytes: 36.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 8.0" NA NA "unprognostic (3.29e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-1)" "unprognostic (1.63e-2)" "unprognostic (2.38e-1)" "unprognostic (9.30e-2)" 0.4 0.3 0.3 0.4 0.3 2.3 0.5 0.3 0.8 0.3 0.3 1.1 0.3 1.3 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.6 0.3 0.2 0.4 0.0 0.9 0.2 0.4 0.0 2.1 1.8 0.6 0.2 0.3 0.3 0.3 1.8 0.3 0.1 6.1 0.4 1.1 1.0 3.7 0.7 1.2 0.7 0.1 1.1 0.5 1.2 0.9 0.1 0.5 1.2 1.6 0.0 0.2 0.2 0.5 2.0 1.2 1.3 0.4 1.9 1.0 0.4 0.6 0.3 0.9 0.6 1.7 1.5 0.6 0.2 1.0 2.1 0.4 0.2 0.4 0.4 1.6 0.0 1.1 0.7 2.7 0.3 0.3 0.7 1.1 1.2 1.0 0.6 0.9 0.9 0.7 0.6 8.0 0.7 0.7 3.0 0.9 0.9 1.4 0.5 0.5 1.6 2.4 2.1 1.1 1.6 1.4 0.9 1.1 1.0 0.7 0.7 3.7 0.7 0.6 0.5 0.4 0.6 0.6 0.5 0.4 0.2 1.1 0.6 0.7 3.7 1.2 0.4 1.0 0.4 0.1 53.6 43.2 0.0 0.0 0.0 0.0 0.0 0.0 37.5 54.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 OR10H2 ENSG00000171942 "Olfactory receptor family 10 subfamily H member 2" O60403 19 15728020-15729060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H3 ENSG00000171936 "Olfactory receptor family 10 subfamily H member 3" O60404 19 15737985-15742343 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H5 ENSG00000172519 "Olfactory receptor family 10 subfamily H member 5" Q8NGA6 19 15787661-15801025 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.3" "Group enriched" "Detected in some" 19 "Alveolar cells type 2: 1.7;Ciliated cells: 2.7;Club cells: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.2 0.3 0.4 0.4 0.3 2.5 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.5 0.3 0.3 0.3 0.2 0.4 0.6 0.2 0.2 0.2 0.5 0.4 0.4 0.3 0.0 0.5 0.1 0.2 0.4 0.2 0.0 2.2 1.7 0.4 0.0 0.3 0.4 0.3 1.1 0.4 0.1 1.0 0.2 1.5 1.2 4.3 0.9 1.2 0.7 0.1 0.9 0.8 1.0 1.3 0.9 0.4 1.7 0.7 0.1 0.3 0.4 0.7 1.5 1.3 0.5 0.4 0.7 0.9 1.1 0.8 0.2 0.7 1.4 1.2 2.8 0.9 0.2 1.6 1.3 0.5 0.3 0.5 0.4 0.5 0.3 1.2 0.8 1.9 0.1 1.6 0.7 1.8 0.7 0.3 0.5 1.0 0.3 0.7 0.4 1.4 1.0 0.8 1.0 1.0 0.6 1.0 1.0 0.9 0.9 1.3 1.2 1.3 0.9 1.3 0.5 1.0 1.1 1.6 1.0 4.3 0.9 0.7 0.6 0.5 0.4 0.6 0.5 0.4 0.2 1.5 0.6 0.7 3.3 1.2 0.5 1.2 0.4 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10J1 "HGMP07J, HSHGMP07J" ENSG00000196184 "Olfactory receptor family 10 subfamily J member 1" P30954 1 159437845-159443078 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 10.9" "Group enriched" "Detected in some" 47 "Early spermatids: 31.7;Late spermatids: 34.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;RT4: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.8 0.4 2.4 0.5 0.5 0.5 0.2 0.2 0.5 0.3 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.6 0.7 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.8 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.2 1.1 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.2 0.2 1.0 0.1 1.1 0.1 0.0 0.1 0.3 0.0 0.1 0.4 0.3 0.0 0.6 0.6 0.2 0.4 0.3 0.2 0.3 0.4 0.2 0.3 2.4 0.5 0.4 0.3 0.2 0.2 0.3 0.3 0.3 0.1 0.8 0.3 0.5 2.1 0.5 0.5 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 OR10J5 ENSG00000184155 "Olfactory receptor family 10 subfamily J member 5" Q8NHC4 1 159535078-159536007 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "liver: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10K1 ENSG00000173285 "Olfactory receptor family 10 subfamily K member 1" Q8NGX5 1 158461574-158470857 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;esophagus: 2.9" "Group enriched" "Detected in some" 149 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 13.9;Ciliated cells: 22.7;Club cells: 9.1;granulocytes: 8.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.2 0.4 0.2 0.8 0.3 2.0 0.2 0.2 0.4 0.7 0.3 0.2 0.3 0.8 2.9 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.3 0.0 0.2 0.0 0.2 0.0 1.6 0.4 0.3 0.0 0.3 0.5 0.3 0.9 0.2 1.0 0.8 0.3 1.4 0.5 2.4 0.6 0.9 1.2 0.1 1.2 1.0 1.0 1.0 0.7 0.6 1.3 0.7 0.5 0.1 0.4 0.6 0.9 1.2 1.8 0.3 2.8 1.0 0.4 0.4 1.5 1.6 0.4 1.3 1.1 0.8 0.3 0.9 1.6 0.1 0.1 0.9 0.4 0.7 0.1 0.6 0.9 3.8 0.1 0.4 1.2 1.6 2.1 0.2 0.2 1.0 0.5 0.8 0.0 0.9 0.8 1.2 0.8 0.4 2.0 0.9 0.9 1.1 0.4 1.2 2.2 2.1 0.9 2.1 1.6 1.0 0.7 1.0 1.9 1.6 0.6 0.2 1.2 0.5 1.2 0.7 0.9 1.0 0.3 1.4 0.9 1.0 2.4 0.9 0.4 0.5 0.8 0.1 20.8 13.9 0.0 0.0 0.0 0.0 0.0 0.0 22.7 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10P1 "OR10P1P, OR10P2P, OR10P3P, OST701" ENSG00000175398 "Olfactory receptor family 10 subfamily P member 1" Q8NGE3 12 55636860-55637854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 2.0;heart muscle: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "THP-1: 2.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074114 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074114: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10S1 ENSG00000196248 "Olfactory receptor family 10 subfamily S member 1" Q8NGN2 11 123976661-123977781 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "thyroid gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.4;hTCEpi: 3.1" "Not detected" "Not detected" HPA019038 Uncertain NA NA "HPA019038: AB_1854785" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10W1 OR10W1P ENSG00000172772 "Olfactory receptor family 10 subfamily W member 1" Q8NGF6 11 58266792-58268260 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.61e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11A1 "hs6M1-18, OR11A2" ENSG00000204694 "Olfactory receptor family 11 subfamily A member 1" Q9GZK7 6 29425504-29457071 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Group enriched" "Detected in some" 73 "Early spermatids: 29.0;Late spermatids: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.3;U-2197: 1.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 1.1 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 1.3 0.1 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR11H12 ENSG00000257115 "Olfactory receptor family 11 subfamily H member 12" B2RN74 14 18601045-18602129 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AN3-CA: 1.0;JURKAT: 1.2" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H4 ENSG00000176198 "Olfactory receptor family 11 subfamily H member 4" Q8NGC9 14 20239286-20244349 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.1;U-266/70: 1.5" "Not detected" "Not detected" HPA052790 Uncertain NA NA "HPA052790: AB_2681950" 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR12D2 hs6M1-20 ENSG00000280236 "Olfactory receptor family 12 subfamily D member 2 (gene/pseudogene)" P58182 6 29395631-29398008 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR12D3 hs6M1-27 ENSG00000112462 "Olfactory receptor family 12 subfamily D member 3" Q9UGF7 6 29373423-29375291 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13A1 ENSG00000256574 "Olfactory receptor family 13 subfamily A member 1" Q8NGR1 10 45302298-45315608 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.3;urinary bladder: 4.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "Daudi: 13.5;U-698: 12.5" "Not detected" "Not detected" HPA057237 Uncertain NA NA "HPA057237: AB_2683378" "unprognostic (7.88e-2)" "unprognostic (1.90e-1)" "unprognostic (5.52e-2)" "unprognostic (2.33e-5)" "unprognostic (6.43e-3)" "unprognostic (6.04e-2)" "unprognostic (8.65e-2)" "unprognostic (3.59e-1)" "unprognostic (2.45e-1)" "unprognostic (2.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.67e-15)" "unprognostic (6.54e-2)" "unprognostic (2.87e-1)" "unprognostic (8.55e-2)" "unprognostic (4.09e-3)" 0.0 0.0 0.1 0.4 0.2 0.5 0.1 1.9 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.4 2.2 0.2 0.1 0.2 0.0 0.0 0.0 0.9 0.3 0.5 0.0 0.3 0.0 1.6 0.0 0.4 2.3 0.2 0.3 0.0 2.0 4.2 0.3 2.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OR13C2 ENSG00000276119 "Olfactory receptor family 13 subfamily C member 2" Q8NGS9 9 104604671-104605627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "ASC diff: 1.5" NA NA 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.2 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C3 ENSG00000204246 "Olfactory receptor family 13 subfamily C member 3" Q8NGS6 9 104535749-104536856 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Not detected" "Not detected" HPA053978 Uncertain NA NA "HPA053978: AB_2682330" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C5 ENSG00000277556 "Olfactory receptor family 13 subfamily C member 5" Q8NGS8 9 104598457-104599413 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.1;CACO-2: 1.0;HEL: 1.6" NA NA "unprognostic (4.88e-2)" 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.4 0.0 0.3 0.6 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR13D1 ENSG00000179055 "Olfactory receptor family 13 subfamily D member 1" Q8NGV5 9 104694379-104695485 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.0" "Not detected" "Not detected" HPA055921 Uncertain NA NA "HPA055921: AB_2682970" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13G1 ENSG00000197437 "Olfactory receptor family 13 subfamily G member 1" Q8NGZ3 1 247670812-247679739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;NB-4: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 0.1" NA NA 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13H1 ENSG00000171054 "Olfactory receptor family 13 subfamily H member 1" Q8NG92 X 131543976-131545056 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "NTERA-2: 1.3" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13J1 ENSG00000168828 "Olfactory receptor family 13 subfamily J member 1" Q8NGT2 9 35869263-35870601 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.2;skeletal muscle: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "AN3-CA: 2.4" "Not detected" "Not detected" NA NA "unprognostic (6.58e-2)" "unprognostic (2.89e-2)" "unprognostic (1.82e-1)" "unprognostic (2.49e-1)" "unprognostic (9.58e-2)" "unprognostic (7.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.07e-1)" 0.1 0.2 1.2 0.2 1.6 0.0 0.0 0.9 2.2 0.0 0.1 0.4 0.1 0.0 0.4 0.1 0.2 0.6 1.7 0.8 0.1 0.1 0.0 0.2 0.6 0.4 0.0 0.0 0.4 0.1 0.3 0.1 1.1 0.0 1.4 0.5 0.0 0.0 0.8 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14J1 "hs6M1-28, OR5U1" ENSG00000204695 "Olfactory receptor family 14 subfamily J member 1" Q9UGF5 6 29301701-29313017 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.5;testis: 4.4" "Group enriched" "Detected in some" 9 "Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.4 0.4 0.4 1.0 0.4 3.0 0.4 0.4 0.7 0.4 0.4 0.8 0.4 1.5 0.4 0.4 0.5 0.4 0.4 0.5 0.4 1.4 0.4 0.8 0.4 0.6 0.4 0.0 0.4 0.4 0.4 0.1 0.7 0.0 0.9 2.0 0.7 0.0 0.4 0.9 0.6 4.4 0.4 0.0 0.4 0.4 1.7 1.0 3.5 0.8 1.0 1.2 0.0 2.3 0.9 1.9 2.1 0.7 0.6 1.3 1.6 0.2 0.2 0.1 1.4 1.8 1.9 2.3 0.4 1.0 1.0 0.3 0.3 0.2 2.2 0.5 1.8 3.6 1.8 0.1 1.9 1.8 0.2 0.2 0.4 0.5 0.8 0.1 1.3 1.5 5.4 0.5 1.1 1.1 1.9 2.4 0.7 0.7 1.1 1.3 1.5 0.4 2.3 1.6 2.2 1.9 1.2 0.7 1.9 1.7 1.5 3.9 2.2 2.0 3.7 1.8 3.4 2.0 1.4 1.7 1.6 1.8 3.5 0.8 0.7 1.2 0.5 0.8 0.9 0.7 0.8 0.3 1.7 0.8 0.8 3.2 1.0 0.8 1.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1A1 OR17-7 ENSG00000172146 "Olfactory receptor family 1 subfamily A member 1" Q9P1Q5 17 3207539-3218896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.1;bone marrow: 3.2;salivary gland: 4.2" "Group enriched" "Detected in some" 169 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 15.6;Ciliated cells: 13.4;Club cells: 27.3;granulocytes: 10.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 7.9" NA NA 0.3 0.3 0.4 0.6 0.5 3.2 0.3 0.4 0.6 1.2 0.4 0.8 0.3 0.9 0.4 0.3 0.1 0.5 0.4 0.3 0.4 0.4 0.3 0.5 0.3 0.4 0.5 0.0 0.3 0.0 0.3 0.0 4.2 0.0 0.5 1.5 0.3 0.0 0.4 0.5 0.4 1.2 0.3 0.1 0.6 0.4 2.2 1.4 4.1 1.3 1.5 1.6 0.3 1.6 0.9 0.8 1.4 0.4 0.3 1.6 0.8 0.3 0.2 0.3 0.6 1.1 1.9 1.5 0.4 1.6 0.9 0.1 0.2 0.3 2.1 0.6 1.3 2.9 0.8 0.1 1.4 4.3 0.4 0.3 0.3 0.4 0.4 0.3 1.2 0.9 7.9 0.0 0.9 1.6 1.5 1.9 0.6 1.0 2.0 1.3 2.4 0.2 1.8 1.5 1.2 0.6 1.0 1.0 1.4 1.6 1.5 0.8 1.4 2.6 1.4 1.5 3.3 2.0 1.5 1.1 1.5 1.2 4.1 1.2 1.0 1.4 1.2 1.2 1.3 1.2 1.0 0.8 2.2 1.6 1.5 2.0 1.5 1.3 1.4 0.9 0.3 17.9 15.6 0.0 0.0 0.0 0.0 0.0 0.0 13.4 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1A2 OR17-6 ENSG00000172150 "Olfactory receptor family 1 subfamily A member 2" Q9Y585 17 3197519-3198448 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1C1 "HSTPCR27, TPCR27" ENSG00000221888 "Olfactory receptor family 1 subfamily C member 1" Q15619 1 247754846-247760556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 1.4;testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA "unprognostic (3.40e-1)" "unprognostic (3.58e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 5.7 0.1 0.0 0.1 0.0 0.7 0.5 1.4 0.6 0.4 0.6 0.3 0.7 1.4 0.6 0.7 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.6 0.8 0.4 0.1 1.0 0.6 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.4 0.0 0.8 0.7 0.0 0.4 0.5 0.0 0.3 0.0 0.1 0.4 0.7 0.0 0.8 0.2 0.2 0.3 0.6 0.7 0.1 0.4 0.0 0.1 0.3 0.4 0.1 0.1 0.2 0.1 1.4 0.5 0.5 0.9 1.0 1.1 0.4 0.7 0.0 0.1 0.3 0.6 0.3 1.5 1.3 0.2 0.4 0.3 0.6 0.3 0.4 0.5 0.2 0.4 0.7 0.4 0.6 1.4 0.4 0.6 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1E2 "OR17-135, OR17-93, OR1E4" ENSG00000127780 "Olfactory receptor family 1 subfamily E member 2" P47887 17 3432870-3433841 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "HL-60: 1.6" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1F1 "Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145" ENSG00000168124 "Olfactory receptor family 1 subfamily F member 1" O43749 16 3204247-3205188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;brain: 7.4;testis: 2.8" "Group enriched" "Detected in some" 33 "Early spermatids: 2.7;Late spermatids: 4.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 2.2;memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 18 "granulocytes: 2.2;T-cells: 1.2" "Cell line enhanced" "Detected in some" "THP-1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.72e-1)" "unprognostic (2.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.94e-2)" "unprognostic (4.88e-1)" "unprognostic (4.16e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.5 0.2 1.8 0.4 0.0 7.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.7 2.2 1.4 0.2 0.0 0.0 0.3 1.2 0.2 1.1 0.8 2.3 0.0 0.0 0.0 0.6 0.3 0.7 0.0 1.8 0.7 1.0 0.0 1.3 1.2 0.6 0.3 0.3 0.0 1.5 0.0 0.0 0.7 1.7 0.8 1.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 1.5 0.6 0.0 0.0 1.1 0.7 2.4 0.0 0.0 1.6 0.0 0.0 1.2 0.3 0.0 3.5 2.1 0.0 1.1 0.3 0.3 0.4 0.0 0.0 1.4 1.4 0.3 0.0 0.0 2.2 0.3 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1G1 "OR17-209, OR1G2" ENSG00000183024 "Olfactory receptor family 1 subfamily G member 1" P47890 17 3126584-3127581 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 1.6;urinary bladder: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.2" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J1 hg32 ENSG00000136834 "Olfactory receptor family 1 subfamily J member 1" Q8NGS3 9 122476958-122477926 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;JURKAT: 3.0;MCF7: 1.1;PC-3: 1.3;REH: 1.4;RT4: 1.3;U-266/70: 1.1" "Not detected" "Not detected" NA NA "unprognostic (5.33e-2)" "unprognostic (2.86e-2)" "unprognostic (3.08e-2)" "unprognostic (9.41e-2)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.10e-1)" 0.3 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.6 0.4 0.0 0.4 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.2 0.3 0.0 0.5 0.6 0.3 0.0 0.4 0.2 1.4 0.3 0.1 0.5 0.2 0.3 0.1 1.1 0.1 0.0 0.3 0.0 0.1 0.7 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 1.2 0.0 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.0 0.0 1.3 0.6 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J2 "OR1J3, OR1J5, OST044" ENSG00000197233 "Olfactory receptor family 1 subfamily J member 2" Q8NGS2 9 122510802-122511743 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.3;testis: 1.2;urinary bladder: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HSkMC: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 1.3 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 1.2 0.0 0.0 1.7 0.0 0.5 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J4 "HSHTPCRX01, HTPCRX01" ENSG00000239590 "Olfactory receptor family 1 subfamily J member 4" Q8NGS1 9 122519141-122520082 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.4;BJ hTERT+: 3.1;fHDF/TERT166: 2.6;HMC-1: 1.3;JURKAT: 1.6;U-266/70: 1.2" "Not detected" "Not detected" NA NA "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.82e-1)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.3 2.0 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.6 0.2 0.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 1.4 3.1 0.0 0.0 0.0 0.4 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1K1 "hg99, MNAB" ENSG00000165204 "Olfactory receptor family 1 subfamily K member 1" Q8NGR3 9 122800123-122801073 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.8 0.0 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L3 OR9-D ENSG00000171481 "Olfactory receptor family 1 subfamily L member 3" Q8NH93 9 122675036-122676153 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" HPA058878 Uncertain NA NA "HPA058878: AB_2683843" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.1 1.3 0.7 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L8 ENSG00000171496 "Olfactory receptor family 1 subfamily L member 8" Q8NGR8 9 122567117-122583384 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "RT4: 10.4" "Not detected" "Not detected" NA NA "unprognostic (9.76e-2)" "unprognostic (1.11e-1)" "unprognostic (4.32e-2)" "unprognostic (3.86e-2)" "unprognostic (1.68e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-2)" "unprognostic (9.11e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-4)" "unprognostic (9.82e-3)" "unprognostic (3.33e-1)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" 0.9 0.1 0.3 0.0 0.6 0.1 1.0 0.3 0.7 0.8 0.4 0.1 1.4 0.7 0.2 0.9 0.8 0.9 0.7 0.9 0.7 0.6 0.8 0.5 0.5 0.4 0.1 0.0 0.6 0.5 0.6 0.2 0.8 0.4 0.7 0.6 0.3 0.4 0.9 3.7 0.3 2.0 0.7 0.2 1.1 0.5 0.6 0.2 1.6 0.2 1.1 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.6 1.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1M1 OR19-6 ENSG00000170929 "Olfactory receptor family 1 subfamily M member 1" Q8NGA1 19 9087061-9095669 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (3.29e-2)" 0.2 0.3 0.3 0.4 0.3 2.7 0.3 0.3 0.7 0.7 0.3 0.4 0.2 0.4 0.3 1.2 0.7 0.3 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.7 0.4 0.1 0.3 0.1 0.3 0.1 0.9 0.0 0.4 2.2 0.5 0.0 0.2 0.2 0.3 0.5 1.7 0.0 0.8 0.3 1.7 1.1 4.2 1.0 1.0 0.9 0.2 0.8 0.6 0.6 1.2 0.9 1.0 2.5 0.4 0.1 0.3 0.7 1.5 2.0 1.1 0.5 0.4 0.7 1.7 0.0 0.3 0.8 0.6 1.0 0.7 1.3 0.9 0.5 0.8 1.2 0.6 0.2 0.8 0.7 0.6 0.2 1.2 0.5 2.8 0.3 1.1 1.1 0.9 0.8 0.7 0.1 0.5 1.0 0.7 0.6 1.8 1.0 1.3 0.2 1.2 0.4 1.0 1.6 0.2 0.7 2.1 1.1 1.7 0.9 1.3 0.7 0.7 0.7 1.5 0.9 2.8 0.9 1.0 0.8 0.6 0.7 0.9 0.7 0.6 0.3 1.7 0.9 0.9 4.2 1.0 1.0 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR1Q1 "HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106" ENSG00000165202 "Olfactory receptor family 1 subfamily Q member 1" Q15612 9 122614738-122615682 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "epididymis: 4.4;urinary bladder: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;JURKAT: 1.7;Karpas-707: 1.6" "Not detected" "Not detected" HPA044828 Uncertain NA NA "HPA044828: AB_10960565" "unprognostic (5.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.98e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.2 0.0 0.7 4.4 0.2 0.5 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.3 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.4 0.3 0.0 0.1 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.2 0.2 1.0 3.2 0.0 0.0 0.0 1.4 0.0 0.2 2.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A2 "OR2A17P, OR2A2P, OST008" ENSG00000221989 "Olfactory receptor family 2 subfamily A member 2" Q6IF42 7 144109514-144110564 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A25 "OR2A25P, OR2A27" ENSG00000221933 "Olfactory receptor family 2 subfamily A member 25" A4D2G3 7 144069811-144075870 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in some" 55 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 6.9;Club cells: 3.4;granulocytes: 5.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;THP-1: 1.5" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" 0.1 0.7 0.0 1.1 0.0 0.5 0.3 0.0 0.1 0.3 0.1 0.5 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.2 1.0 0.3 0.0 0.0 0.2 0.1 0.4 1.0 0.1 0.1 0.2 1.4 0.8 3.4 0.5 0.7 0.5 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.3 0.4 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 1.5 0.0 0.0 0.3 0.4 0.1 0.4 0.0 0.0 0.2 0.2 0.2 3.4 0.5 0.2 0.3 0.3 0.3 0.6 0.5 0.4 0.2 1.4 0.4 0.5 1.8 0.7 0.2 0.8 0.4 0.5 6.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A4 OR2A10 ENSG00000180658 "Olfactory receptor family 2 subfamily A member 4" O95047 6 131699644-131701401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 10.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "renal cancer: 0.8" "Group enriched" "Detected in some" 48 "basophil: 10.6;NK-cell: 3.8" "Group enriched" "Detected in many" 48 "granulocytes: 10.6;NK-cells: 3.8" "Cell line enhanced" "Detected in some" "HEL: 1.3;HMC-1: 1.1;MCF7: 1.7" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.22e-5)" "unprognostic (3.60e-2)" 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 1.4 2.1 0.0 0.0 0.4 0.4 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.0 1.0 0.3 0.5 0.0 0.6 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.9 0.2 0.0 0.0 10.6 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.5 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.3 1.3 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.9 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A5 "OR2A26, OR2A8, OR7-138, OR7-141" ENSG00000221836 "Olfactory receptor family 2 subfamily A member 5" Q96R48 7 144048948-144058845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7" "Not detected" "Not detected" NA NA 0.3 0.2 0.0 0.6 0.1 1.0 0.7 0.0 0.1 0.0 0.2 0.1 0.4 0.5 0.1 0.3 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.3 0.1 0.3 0.4 0.2 0.2 0.3 0.3 0.2 0.6 0.1 0.1 0.8 0.1 0.0 0.0 0.3 0.2 0.6 0.9 0.1 0.6 0.2 0.4 0.3 1.8 0.2 0.5 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.4 0.4 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.5 0.2 0.2 0.2 0.1 0.1 0.0 0.3 0.2 0.5 0.1 0.5 0.4 1.7 0.2 0.1 0.9 0.4 0.2 0.0 0.0 1.1 1.2 0.2 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.5 0.0 0.0 0.7 0.4 0.4 0.5 0.3 0.6 0.8 0.3 0.2 0.2 0.1 0.6 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.2 1.8 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A7 HSDJ0798C17 ENSG00000243896 "Olfactory receptor family 2 subfamily A member 7" Q96R45 7 144257663-144264792 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Ciliated cells: 1.4;Club cells: 1.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 7.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.2;hTCEpi: 5.2;RT4: 4.1;SK-BR-3: 4.5" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.57e-1)" "unprognostic (1.40e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (4.13e-2)" "unprognostic (5.75e-2)" "unprognostic (7.28e-2)" "unprognostic (3.33e-1)" "unprognostic (9.08e-2)" "unprognostic (3.58e-3)" "unprognostic (5.52e-2)" "unprognostic (5.13e-2)" "unprognostic (3.06e-1)" "unprognostic (3.22e-1)" 0.9 0.1 0.0 0.2 0.0 1.4 3.9 0.0 0.0 2.7 3.4 6.5 0.7 2.2 3.9 2.3 1.6 0.7 0.0 0.0 3.3 2.1 2.1 0.4 0.0 2.6 4.8 2.3 1.3 0.7 3.7 3.4 4.0 0.6 0.0 7.9 4.5 0.3 0.0 0.8 3.8 0.2 8.1 0.4 2.5 2.8 2.0 0.0 7.8 0.0 1.5 1.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 1.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 5.2 0.3 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 2.7 4.1 0.0 0.0 2.6 4.5 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.8 0.0 0.0 0.7 0.0 0.2 0.5 1.0 0.5 0.0 2.0 0.6 0.5 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AE1 OR2AE2 ENSG00000244623 "Olfactory receptor family 2 subfamily AE member 1" Q8NHA4 7 99875987-99877057 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enhanced" "Detected in single" "B-cells: 1.5" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.0;hTEC/SVTERT24-B: 1.2;U-2197: 2.3;U-266/70: 1.0;U-266/84: 1.2" HPA042957 Uncertain NA NA "HPA042957: AB_10794539" "unprognostic (6.75e-2)" "unprognostic (6.22e-2)" "unprognostic (5.21e-2)" "unprognostic (1.58e-1)" "unprognostic (3.16e-2)" 0.4 0.4 0.0 0.0 0.2 0.1 1.2 0.3 0.2 0.4 0.1 1.1 0.7 1.4 0.3 0.4 0.0 0.3 0.0 0.1 0.3 0.1 0.4 0.6 0.0 0.2 0.3 1.2 0.8 0.2 0.5 0.5 1.3 0.2 1.2 0.8 0.2 0.4 0.1 0.3 0.1 0.1 0.3 0.4 0.3 0.1 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.1 1.0 1.2 0.1 0.2 0.5 0.5 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AK2 OR2AK1P ENSG00000187080 "Olfactory receptor family 2 subfamily AK member 2" Q8NG84 1 247965233-247966386 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 2.5;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.5" HPA052544 Uncertain NA NA "HPA052544: AB_2681865" 0.0 0.2 0.0 0.0 0.3 2.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AT4 ENSG00000171561 "Olfactory receptor family 2 subfamily AT member 4" A6NND4 11 75081753-75096876 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;bone marrow: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 6.8" "Not detected" "Not detected" NA NA 0.4 0.5 0.4 0.4 0.6 3.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.2 0.4 1.7 0.4 0.3 0.5 0.4 0.4 0.4 0.4 1.7 0.5 0.7 0.4 0.4 0.8 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 1.9 0.6 0.4 0.4 0.6 0.4 1.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 1.2 0.8 3.6 0.8 0.7 0.7 0.1 1.1 0.8 1.5 1.3 0.7 0.8 1.2 0.7 0.4 0.4 0.4 1.3 1.3 2.1 0.7 0.7 0.9 1.1 0.7 0.5 0.8 1.0 0.9 2.3 2.2 1.2 0.4 1.6 1.7 0.6 0.6 0.7 0.7 1.2 0.6 1.6 6.8 3.1 0.4 1.3 0.8 1.7 2.0 0.5 0.8 1.1 1.6 1.9 0.5 1.9 1.7 1.2 0.7 1.1 1.0 1.7 1.0 0.9 1.6 1.2 1.3 1.2 0.7 1.7 1.5 1.3 1.1 1.1 1.3 1.7 0.8 0.5 0.7 0.5 0.6 0.6 0.6 0.5 0.3 1.2 0.7 0.7 3.6 0.7 0.7 0.8 0.5 0.1 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B11 ENSG00000177535 "Olfactory receptor family 2 subfamily B member 11" Q5JQS5 1 247449118-247458105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.1" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 14.7;Club cells: 9.1;granulocytes: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "THP-1: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047459 Uncertain NA NA "HPA047459: AB_10963692" "unprognostic (1.83e-1)" 1.5 0.1 0.1 1.2 0.1 3.1 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.7 1.0 0.2 0.1 0.1 0.0 0.1 0.4 0.3 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.7 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 1.5 0.0 0.3 0.0 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.0 5.2 0.6 0.1 0.4 0.1 0.1 0.1 0.1 0.4 0.9 0.6 0.1 0.5 0.8 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 14.7 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B2 "hs6M1-10, OR2B2Q, OR2B9, OR6-1" ENSG00000168131 "Olfactory receptor family 2 subfamily B member 2" Q9GZK3 6 27911185-27912396 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "liver: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;U-266/84: 2.4" "Low region specificity" "Detected in some" NA NA "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B6 "dJ408B20.2, OR2B1, OR2B1P, OR2B5, OR2B6P, OR5-40, OR5-41, OR6-31" ENSG00000124657 "Olfactory receptor family 2 subfamily B member 6" P58173 6 27957241-27958182 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.1;neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "HeLa: 3.0;K-562: 3.3;U-266/84: 8.5;U-937: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (7.98e-2)" "unprognostic (3.10e-3)" "unprognostic (7.02e-3)" "unprognostic (1.58e-4)" "unprognostic (3.07e-1)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (4.29e-2)" "unprognostic (6.54e-3)" "unprognostic (1.75e-2)" "unprognostic (1.89e-15)" "unprognostic (1.23e-2)" "unprognostic (5.26e-1)" "unprognostic (1.25e-1)" "unprognostic (3.47e-3)" 0.0 0.4 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.2 0.3 0.0 0.4 0.4 0.1 0.0 0.1 0.1 0.1 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.0 0.0 1.2 1.7 1.2 0.0 0.0 0.0 0.3 0.2 0.0 0.3 1.6 0.3 1.6 0.3 0.4 0.3 0.0 0.0 0.2 1.1 0.1 0.0 0.1 1.3 0.4 0.0 1.1 0.4 0.2 0.0 0.1 0.2 0.1 2.0 0.8 0.0 0.5 0.0 0.7 0.0 0.7 1.2 0.8 0.0 1.1 1.0 0.4 0.0 3.0 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 3.3 2.3 0.1 0.4 0.0 0.4 0.3 0.9 0.2 0.0 0.2 0.6 0.1 0.0 2.7 0.0 2.5 0.6 0.7 0.9 0.5 0.0 0.0 0.2 0.0 0.0 0.1 1.4 8.5 0.3 0.0 4.2 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 OR2C1 "OLFmf3, OR2C2P" ENSG00000168158 "Olfactory receptor family 2 subfamily C member 1" O95371 16 3355889-3357294 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Daudi: 3.9;RPMI-8226: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.40e-1)" "unprognostic (1.46e-1)" "unprognostic (7.58e-2)" "unprognostic (1.01e-2)" "unprognostic (2.76e-1)" "unprognostic (7.11e-3)" "unprognostic (5.26e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-2)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" 0.2 0.3 0.7 0.0 1.0 0.0 0.5 0.9 1.0 0.3 0.1 0.1 0.7 0.0 0.0 3.8 0.1 0.1 0.9 0.7 0.5 0.3 0.0 0.8 0.7 0.6 0.2 1.3 0.1 0.2 0.5 0.3 0.1 0.7 0.1 0.3 0.2 0.3 1.3 0.6 0.1 0.7 0.3 0.8 0.3 0.1 1.3 0.1 0.0 0.0 0.4 1.9 0.4 0.1 0.0 0.3 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.6 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.6 0.1 1.3 1.9 0.8 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 18 "dendritic cells: 1.3;granulocytes: 4.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8" HPA058578 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.2 0.4 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.9 0.1 0.0 0.2 0.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.3 0.1 0.4 0.7 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.1 0.1 0.1 4.6 0.1 0.0 0.2 0.1 0.0 1.3 4.2 0.0 0.1 0.1 0.0 0.5 0.3 0.6 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.3 1.8 0.6 0.2 0.0 1.1 0.3 0.0 0.1 0.0 0.7 0.5 0.1 0.2 0.1 0.1 0.2 0.5 0.5 0.0 0.1 0.0 0.4 0.1 0.5 1.2 0.7 0.1 0.0 0.4 0.2 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.5 0.6 0.6 0.3 0.7 0.4 1.2 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.5 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 OR2D2 "hg27, OR11-610, OR2D1" ENSG00000166368 "Olfactory receptor family 2 subfamily D member 2" Q9H210 11 6891490-6892599 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;HSkMC: 1.6;U-698: 1.3" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2D3 ENSG00000178358 "Olfactory receptor family 2 subfamily D member 3" Q8NGH3 11 6920974-6922043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.2" "Low region specificity" "Detected in single" HPA052551 Uncertain NA NA "HPA052551: AB_2681867" "unprognostic (4.52e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2F1 "OLF3, OR14-60, OR2F3, OR2F3P, OR2F4, OR2F5, OR7-139, OR7-140" ENSG00000213215 "Olfactory receptor family 2 subfamily F member 1 (gene/pseudogene)" Q13607 7 143954844-143997312 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.2" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2F2 OR7-1 ENSG00000221910 "Olfactory receptor family 2 subfamily F member 2" O95006 7 143935166-143936279 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2G3 ENSG00000177476 "Olfactory receptor family 2 subfamily G member 3" Q8NGZ4 1 247605586-247606515 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2G6 ENSG00000188558 "Olfactory receptor family 2 subfamily G member 6" Q5TZ20 1 248508073-248527337 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 2: 2.6;Ciliated cells: 2.7;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2" NA NA 0.2 0.2 0.2 0.2 0.2 3.2 0.2 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 1.1 0.0 0.2 0.1 0.8 0.0 0.6 0.0 0.3 0.9 0.3 0.0 0.2 0.5 1.1 1.9 0.2 0.3 0.4 0.2 1.4 0.7 1.8 0.8 0.6 0.6 0.1 0.7 0.5 0.6 0.7 0.1 0.4 1.0 1.0 0.1 0.1 0.2 0.7 0.9 0.8 1.1 0.0 0.6 0.8 0.3 0.1 0.4 0.9 0.7 0.8 1.3 0.4 0.0 1.0 0.9 0.1 0.4 0.1 0.4 0.5 0.3 0.9 0.7 3.2 0.1 0.6 0.7 0.8 1.2 0.3 0.7 0.9 0.6 0.4 0.2 1.4 0.6 0.8 0.8 0.7 0.7 0.6 2.0 0.9 2.4 0.9 1.2 1.2 0.8 1.3 0.9 1.0 0.5 0.9 0.7 1.7 0.5 0.5 0.5 0.3 0.4 0.4 0.4 0.4 0.2 1.4 0.5 0.6 1.8 0.6 0.8 0.7 0.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2H1 "OR2H6, OR2H8, OR6-2" ENSG00000204688 "Olfactory receptor family 2 subfamily H member 1" Q9GZK4 6 29457181-29464328 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 124 "testis: 12.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 OR2H2 hs6M1-12 ENSG00000204657 "Olfactory receptor family 2 subfamily H member 2" O95918 6 29585121-29590500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.3;epididymis: 11.7;testis: 4.8" "Cell type enriched" "Detected in some" 7 "Early spermatids: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;NTERA-2: 3.5;TIME: 1.9" NA NA "unprognostic (2.95e-1)" "unprognostic (3.76e-1)" "unprognostic (2.33e-2)" "unprognostic (2.42e-1)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" 0.2 0.1 1.5 0.3 3.3 1.5 0.1 2.2 0.9 0.1 0.1 0.0 0.2 11.7 0.1 0.1 0.1 0.3 1.2 0.9 0.1 0.1 0.2 0.4 0.6 0.2 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.9 0.1 0.4 0.1 0.1 0.2 0.4 0.2 4.8 0.2 0.2 0.1 0.1 0.4 0.2 0.8 0.1 0.1 0.3 0.0 0.4 0.0 2.3 0.3 0.0 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.5 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.2 0.7 0.9 0.7 0.6 0.1 0.6 1.0 0.1 0.1 0.0 0.2 0.3 0.3 0.7 0.4 0.7 0.2 0.1 0.0 0.2 3.5 0.1 0.2 0.4 0.3 0.0 0.0 0.2 0.7 0.2 0.3 0.2 0.0 1.1 0.2 0.2 1.9 0.4 0.9 0.3 0.2 1.0 0.2 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2J2 "dJ80I19.4, hs6M1-6, OR6-8" ENSG00000204700 "Olfactory receptor family 2 subfamily J member 2" O76002 6 29170907-29175811 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.6;bone marrow: 1.5;testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 2.2" NA NA 0.0 0.0 0.3 0.4 0.7 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.6 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.3 3.0 0.5 0.0 0.1 0.0 1.0 0.7 1.6 0.4 0.3 0.5 0.0 0.1 0.3 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.2 0.3 1.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.7 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.6 0.4 0.7 0.5 0.2 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.3 1.6 0.3 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 OR2K2 "HSHTPCRH06, HTPCRH06, OR2AR1P" ENSG00000171133 "Olfactory receptor family 2 subfamily K member 2" Q8NGT1 9 111327483-111330183 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2;skeletal muscle: 1.6;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA024261 Uncertain NA NA "HPA024261: AB_1854786" "unprognostic (1.03e-1)" 0.0 0.2 0.3 0.0 0.4 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.7 0.0 0.2 3.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L13 OR2L14 ENSG00000196071 "Olfactory receptor family 2 subfamily L member 13" Q8N349 1 248095184-248101103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;brain: 7.3" "Cell type enhanced" "Detected in single" 20 "Early spermatids: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 13 "B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5" "Group enriched" "Detected in some" 9 "ASC diff: 1.1;GAMG: 2.5;WM-115: 2.9" NA NA "unprognostic (1.39e-2)" "unprognostic (1.53e-1)" "unprognostic (9.89e-2)" "unprognostic (3.66e-1)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.14e-1)" 0.0 2.0 2.1 0.0 2.4 0.2 0.6 0.7 7.3 0.1 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.5 3.2 0.0 0.0 0.0 0.2 3.5 0.2 0.0 0.0 0.2 0.1 1.8 0.1 0.0 0.6 0.0 0.0 0.0 0.1 4.5 1.1 0.0 1.2 0.9 0.1 0.1 0.0 1.0 0.1 3.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.6 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 OR2L2 "HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P" ENSG00000203663 "Olfactory receptor family 2 subfamily L member 2" Q8NH16 1 248030070-248042305 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 3.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 10.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 10.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.37e-2)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (2.96e-2)" 0.3 0.4 1.1 0.4 1.1 2.7 0.0 0.4 0.9 0.1 0.1 0.9 0.2 0.1 0.3 0.1 0.4 0.0 1.6 1.2 0.2 1.7 0.2 0.3 1.7 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.0 2.2 0.6 1.0 0.0 4.1 0.7 0.9 3.3 0.2 0.0 0.0 0.0 1.7 0.8 2.7 0.8 1.2 1.0 0.2 1.0 0.7 0.9 1.0 0.2 0.1 2.3 0.6 0.0 0.0 0.0 0.6 1.2 1.2 1.2 0.1 0.9 0.8 0.0 0.0 0.3 1.2 0.3 1.0 1.8 0.7 0.0 0.7 1.2 0.0 0.1 0.1 0.0 1.0 0.1 1.0 0.5 2.9 0.1 0.6 0.4 1.4 1.2 1.0 1.4 1.2 1.4 0.8 0.2 1.6 1.3 2.2 1.3 0.7 0.5 1.4 0.9 0.7 1.4 0.9 1.9 1.9 1.4 2.2 1.3 1.1 1.3 1.0 1.3 2.5 0.8 0.6 1.0 0.4 0.8 0.7 0.6 0.5 0.2 1.7 0.8 0.9 2.7 1.2 0.6 0.8 0.4 0.2 17.9 10.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR2L3 ENSG00000198128 "Olfactory receptor family 2 subfamily L member 3" Q8NG85 1 248046836-248063407 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.0;prostate: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.8;Karpas-707: 1.9" NA NA 0.3 0.2 0.4 1.0 0.4 3.0 0.6 1.3 0.5 0.4 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.0 0.6 0.8 0.0 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.9 0.2 4.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 1.5 0.8 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.0 0.5 0.2 0.1 0.3 0.0 0.5 0.4 0.8 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.0 0.9 0.3 0.0 0.0 0.1 0.3 0.3 0.0 1.8 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.2 1.9 0.0 0.8 0.4 0.5 0.5 0.2 0.7 0.1 0.8 0.2 0.1 0.5 0.2 0.1 0.4 0.0 0.0 0.5 0.1 1.0 0.0 0.8 0.5 0.3 0.4 1.0 0.5 0.7 1.1 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M3 "OR2M3P, OR2M6, OST003" ENSG00000228198 "Olfactory receptor family 2 subfamily M member 3" Q8NG83 1 248197265-248212925 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 23 "Club cells: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.5 0.5 0.9 0.5 0.9 3.6 0.5 0.6 1.2 1.5 1.2 0.7 0.6 2.0 0.5 0.5 0.6 0.5 1.0 1.1 1.6 1.6 0.5 0.8 1.1 1.0 0.7 0.0 0.7 0.3 0.5 1.4 1.4 0.0 0.8 2.4 0.6 0.0 0.7 0.8 0.8 1.6 0.9 0.0 0.7 0.5 1.7 1.4 3.3 1.9 0.9 1.4 0.5 2.8 1.6 2.5 2.6 1.0 1.1 2.4 2.2 0.3 0.3 0.6 6.2 3.7 3.3 2.4 0.5 3.6 2.6 1.1 0.8 0.9 3.2 2.2 1.7 5.2 2.0 0.4 2.2 2.1 0.9 1.1 0.6 0.8 1.7 0.5 2.3 3.7 6.6 0.7 2.4 1.8 2.5 3.9 2.4 1.4 2.1 2.8 3.0 1.0 2.2 2.7 2.3 2.9 1.5 1.7 3.1 2.9 2.0 3.1 2.9 3.6 2.9 1.9 4.2 2.6 2.5 2.4 2.0 2.6 3.3 1.6 0.8 1.4 1.9 1.2 1.0 1.1 0.9 0.6 1.7 1.2 1.2 3.2 0.9 1.3 1.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M4 "HSHTPCRX18, HTPCRX18, OST710, TPCR100" ENSG00000171180 "Olfactory receptor family 2 subfamily M member 4" Q96R27 1 248231417-248244679 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" HPA051308 Uncertain NA NA "HPA051308: AB_2681435" 0.4 0.1 0.5 0.0 0.6 2.6 0.5 0.4 1.3 0.3 0.2 0.2 0.3 1.1 0.1 0.5 0.5 0.1 0.7 1.3 0.1 1.5 0.1 0.2 1.1 0.8 1.4 0.6 0.3 0.0 0.2 0.0 0.7 0.0 0.1 1.0 0.2 0.0 1.0 0.2 0.2 0.4 0.4 0.0 0.2 0.2 1.0 0.6 2.1 0.6 1.3 0.7 0.3 0.7 0.2 0.5 0.7 1.2 2.3 0.4 0.4 0.2 0.1 0.0 0.8 0.4 0.7 0.3 0.3 0.9 0.4 0.5 0.7 0.1 0.1 0.3 1.0 1.6 0.7 0.1 1.2 0.7 1.6 0.1 0.3 0.2 0.4 0.8 0.5 0.9 1.8 0.2 0.9 0.3 1.0 0.9 0.2 0.8 1.9 0.4 0.8 0.2 1.4 1.3 1.0 0.4 0.5 0.8 0.5 0.6 0.1 1.7 0.8 0.8 0.9 0.3 1.3 0.7 0.4 0.6 1.0 1.0 1.9 0.6 0.4 0.6 0.5 0.4 0.5 0.5 0.4 0.1 1.0 0.5 0.7 2.1 1.3 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M7 ENSG00000177186 "Olfactory receptor family 2 subfamily M member 7" Q8NG81 1 248323630-248324568 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2S2 ENSG00000278889 "Olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)" Q9NQN1 9 35957108-35958154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;BJ: 1.3;BJ hTERT+: 1.9;fHDF/TERT166: 1.3;HeLa: 1.3;HHSteC: 1.6;U-138 MG: 2.2" "Region enriched" "Detected in single" 8 "cerebellum: 0.6" NA NA 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T10 ENSG00000184022 "Olfactory receptor family 2 subfamily T member 10" Q8NGZ9 1 248590487-248597700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "kidney: 11.2" "Cell type enriched" "Detected in single" 59 "Proximal tubular cells: 5.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" "Group enriched" "Detected in some" 7 "BJ hTERT+: 3.1;Karpas-707: 2.4" HPA052019 Uncertain NA NA "HPA052019: AB_2681696" "unprognostic (8.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T2 OR2T2P ENSG00000196240 "Olfactory receptor family 2 subfamily T member 2" Q6IF00 1 248445512-248455725 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 14.1" "Cell type enriched" "Detected in single" 14 "Proximal tubular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enriched" "Detected in single" 22 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T3 ENSG00000196539 "Olfactory receptor family 2 subfamily T member 3" Q8NH03 1 248473351-248474307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T33 ENSG00000177212 "Olfactory receptor family 2 subfamily T member 33" Q8NG76 1 248269917-248277976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.2;thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 2.1" NA NA "unprognostic (5.79e-2)" "unprognostic (2.22e-1)" 0.1 0.2 0.4 0.2 1.0 2.2 0.1 0.0 0.8 0.5 0.1 0.5 0.0 0.5 0.1 0.2 0.3 0.0 0.2 1.1 0.1 0.2 0.0 0.2 0.8 0.5 0.0 0.0 0.1 0.1 0.5 0.0 1.5 0.0 0.7 0.3 0.6 0.0 0.1 0.3 0.7 1.7 2.4 0.1 0.6 0.0 0.6 0.9 1.3 0.3 0.4 0.7 0.0 0.6 0.0 0.3 0.4 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.4 2.1 0.5 0.0 1.2 0.6 0.0 0.0 0.0 0.6 0.1 1.6 0.7 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.3 0.9 0.0 0.6 0.5 0.7 0.4 0.5 1.8 0.3 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.8 0.1 0.4 0.6 0.7 0.9 1.8 0.1 0.8 0.3 0.8 0.2 1.2 0.5 1.3 0.2 0.3 0.5 0.3 0.3 0.6 0.4 0.4 0.2 0.6 0.7 0.7 0.7 0.4 0.3 0.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T34 ENSG00000183310 "Olfactory receptor family 2 subfamily T member 34" Q8NGX1 1 248573801-248574757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 15 "T-cells: 1.4" "Cell line enriched" "Detected in single" 15 "Karpas-707: 1.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W1 hs6M1-15 ENSG00000204704 "Olfactory receptor family 2 subfamily W member 1" Q9Y3N9 6 29044213-29045240 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W3 "OR2W3P, OR2W8P, OST718" ENSG00000238243 "Olfactory receptor family 2 subfamily W member 3" Q7Z3T1 1 247895587-247896531 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 13.8;thyroid gland: 8.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Cell type enhanced" "Detected in some" "myeloid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 13.1;PC-3: 13.2;U-2 OS: 8.6;U-937: 6.2;WM-115: 9.4" HPA045594 Uncertain NA NA "HPA045594: AB_10960280" "unprognostic (9.44e-2)" "unprognostic (3.03e-1)" "unprognostic (3.29e-2)" "unprognostic (1.57e-5)" "unprognostic (1.98e-1)" "unprognostic (5.11e-2)" "unprognostic (2.79e-6)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.71e-3)" "unprognostic (9.05e-3)" "unprognostic (9.34e-3)" "unprognostic (5.66e-2)" "unprognostic (1.48e-1)" 0.2 0.7 0.6 0.3 1.6 13.8 0.2 0.0 2.2 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.4 1.7 0.0 0.1 0.5 0.0 1.1 0.0 0.2 0.0 0.3 1.6 0.5 0.6 0.0 0.0 0.0 0.3 0.2 0.4 0.4 0.8 0.1 1.1 8.2 0.0 0.3 0.2 0.6 1.4 1.0 0.6 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 3.9 0.0 0.0 0.0 0.3 13.1 0.0 0.0 0.0 1.7 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.1 0.5 0.0 13.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 8.6 0.0 0.0 1.5 0.0 0.0 0.0 6.2 9.4 0.0 0.2 1.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.6 0.2 0.0 0.8 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2Y1 ENSG00000174339 "Olfactory receptor family 2 subfamily Y member 1" Q8NGV0 5 180739042-180740099 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2Z1 OR2Z2 ENSG00000181733 "Olfactory receptor family 2 subfamily Z member 1" Q8NG97 19 8721634-8732160 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Not detected" "Not detected" HPA048760 Uncertain NA NA "HPA048760: AB_2680513" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A1 "OLFRA03, OR17-40, OR40" ENSG00000180090 "Olfactory receptor family 3 subfamily A member 1" P47881 17 3291017-3298360 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 1.4;dendritic cells: 1.8;T-cells: 2.4" "Cell line enriched" "Detected in some" 20 "HDLM-2: 20.9" "Low region specificity" "Detected in many" NA NA "unprognostic (3.69e-3)" "unprognostic (4.73e-2)" 0.0 0.4 0.1 0.0 0.4 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.2 4.1 0.0 0.2 0.0 0.0 1.4 1.8 0.0 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 1.9 1.4 1.4 1.6 0.6 0.4 0.0 2.4 0.0 0.0 0.0 1.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A2 "OLFRA04, OR17-228, OR228" ENSG00000221882 "Olfactory receptor family 3 subfamily A member 2" P47893 17 3276942-3386317 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 4.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 13.1;JURKAT: 14.2" NA NA "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" 0.5 0.5 2.2 0.5 8.6 0.5 0.6 0.4 2.8 0.6 0.4 1.2 0.0 0.4 0.5 1.5 0.4 0.3 0.2 0.4 2.5 1.2 0.5 0.3 0.8 6.5 1.4 0.6 1.0 0.4 0.2 5.5 1.0 2.7 0.7 0.4 1.3 0.3 0.5 0.8 0.6 0.5 0.4 1.9 0.9 0.4 10.9 2.1 2.3 0.3 0.0 0.7 0.6 0.4 3.0 3.4 3.6 0.6 0.7 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.6 0.7 0.9 0.3 1.6 3.0 1.2 0.3 0.8 0.8 1.2 1.8 1.6 0.7 0.4 3.4 0.5 0.8 2.2 8.6 0.4 2.8 2.5 1.2 1.4 0.6 2.7 2.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A3 "OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P" ENSG00000159961 "Olfactory receptor family 3 subfamily A member 3" P47888 17 3411370-3424070 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 10.6;bone marrow: 2.6" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 10.6" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.4" NA NA "unprognostic (2.01e-1)" 0.1 0.0 0.6 0.2 0.9 2.6 0.1 1.2 0.4 0.2 0.2 0.5 0.4 0.1 0.0 0.2 0.5 0.2 0.6 0.5 0.2 0.2 0.1 0.8 1.1 0.1 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.1 0.5 1.0 0.0 0.0 0.5 0.4 0.4 1.1 0.2 0.4 0.3 0.2 0.3 10.6 0.6 0.2 0.2 0.2 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 4.4 0.5 0.4 0.6 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.4 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.0 0.3 0.2 0.3 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.6 0.2 0.1 10.6 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C11 OR4C11P ENSG00000172188 "Olfactory receptor family 4 subfamily C member 11" Q6IEV9 11 55602360-55607645 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C12 ENSG00000221954 "Olfactory receptor family 4 subfamily C member 12" Q96R67 11 49981473-49982535 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C13 ENSG00000258817 "Olfactory receptor family 4 subfamily C member 13" Q8NGP0 11 49952391-49953419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C3 ENSG00000176547 "Olfactory receptor family 4 subfamily C member 3" Q8NH37 11 48324920-48328471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049116 Uncertain NA NA "HPA049116: AB_2680638" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C6 ENSG00000181903 "Olfactory receptor family 4 subfamily C member 6" Q8NH72 11 55662201-55666195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 1.8;lymphoid tissue: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "memory B-cell: 1.8" "Lineage enriched" "Detected in single" 18 "B-cells: 1.8" "Group enriched" "Detected in some" 5 "CAPAN-2: 8.1;Karpas-707: 8.6" NA NA 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 1.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D1 "OR4D3, TPCR16" ENSG00000141194 "Olfactory receptor family 4 subfamily D member 1" Q15615 17 58148449-58159555 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 4.4;bone marrow: 2.2;lymphoid tissue: 1.8;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 2.0;NK-cells: 4.4;T-cells: 3.7" "Cell line enhanced" "Detected in some" "BEWO: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.5 0.1 2.2 0.1 0.1 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.1 1.3 0.1 1.5 0.1 0.9 0.5 0.1 0.2 0.4 2.0 0.1 4.4 3.7 0.9 0.2 0.3 0.1 0.7 0.0 0.3 3.7 0.2 0.0 0.1 0.3 0.4 0.6 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.2 0.4 1.1 0.2 0.4 0.3 0.3 0.5 0.3 0.0 0.4 0.4 0.4 0.1 0.1 0.5 0.6 1.0 0.0 0.4 0.3 0.7 1.9 0.1 0.4 0.2 0.1 0.5 0.1 0.5 0.7 0.6 0.3 0.8 0.0 0.7 0.4 0.8 0.0 0.4 1.1 0.6 0.3 0.4 0.4 0.5 0.5 1.0 0.6 2.0 0.1 0.8 2.3 0.1 2.4 0.2 2.2 2.1 0.1 0.2 3.4 3.7 0.8 4.4 0.1 0.4 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D10 "OR4D10P, OST711" ENSG00000254466 "Olfactory receptor family 4 subfamily D member 10" Q8NGI6 11 59473315-59479361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D2 ENSG00000255713 "Olfactory receptor family 4 subfamily D member 2" P58180 17 58166982-58171411 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D5 ENSG00000171014 "Olfactory receptor family 4 subfamily D member 5" Q8NGN0 11 123939543-123940637 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045005 Uncertain NA NA "HPA045005: AB_10959302" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D6 ENSG00000166884 "Olfactory receptor family 4 subfamily D member 6" Q8NGJ1 11 59456938-59457991 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.96e-3)" 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F15 ENSG00000182854 "Olfactory receptor family 4 subfamily F member 15" Q8NGB8 15 101812202-101820197 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 2.7;neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.7" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.8 0.1 0.7 0.1 0.1 0.3 0.7 0.1 0.5 0.3 0.2 0.4 0.4 0.4 0.4 0.0 0.1 0.1 0.1 0.5 0.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.1 0.8 0.1 0.4 0.4 0.0 0.3 0.2 0.5 0.3 2.7 0.3 0.5 0.2 0.1 0.1 0.0 0.9 0.9 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.5 1.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.7 1.1 0.4 0.0 0.2 1.0 0.6 0.0 0.2 0.0 0.3 0.0 0.5 0.3 0.4 0.0 0.7 0.1 0.7 0.5 0.0 0.5 0.3 0.1 0.3 0.5 0.3 0.3 0.0 0.2 0.3 0.0 0.5 0.5 0.6 0.0 1.5 0.5 1.2 0.7 0.9 0.3 0.5 1.5 0.3 0.8 2.7 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.2 0.2 1.9 0.5 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F16 ENSG00000284662 "Olfactory receptor family 4 subfamily F member 16" Q6IEY1 1 685679-686673 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F17 "OR4F11P, OR4F18, OR4F19" ENSG00000176695 "Olfactory receptor family 4 subfamily F member 17" Q8NGA8 19 107104-117102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.0" "Group enriched" "Detected in some" 462 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 42.0;Ciliated cells: 44.2;Club cells: 47.8;granulocytes: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 71.5 42.0 0.0 0.0 0.0 0.0 0.0 0.0 44.2 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F29 ENSG00000284733 "Olfactory receptor family 4 subfamily F member 29" Q6IEY1 1 450703-451697 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F3 ENSG00000230178 "Olfactory receptor family 4 subfamily F member 3" Q6IEY1 5 181367268-181368262 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.1 0.1 0.0 0.4 0.0 0.4 0.2 0.2 0.3 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.1 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F4 OR4F18 ENSG00000177693 "Olfactory receptor family 4 subfamily F member 4" Q96R69 15 101922042-101923095 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "cervix, uterine: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F6 OR4F12 ENSG00000184140 "Olfactory receptor family 4 subfamily F member 6" Q8NGB9 15 101803509-101806887 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K1 ENSG00000155249 "Olfactory receptor family 4 subfamily K member 1" Q8NGD4 14 19930917-19936757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEL: 3.2" "Not detected" "Not detected" HPA028877 Uncertain NA NA "HPA028877: AB_10600923" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K15 OR4K15Q ENSG00000169488 "Olfactory receptor family 4 subfamily K member 15" Q8NH41 14 19975444-19976659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055732 Uncertain NA NA "HPA055732: AB_2682900" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K2 ENSG00000165762 "Olfactory receptor family 4 subfamily K member 2" Q8NGD2 14 19875142-19883932 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M1 ENSG00000176299 "Olfactory receptor family 4 subfamily M member 1" Q8NGD0 14 19773504-19783696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "testis: 3.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR4M2 ENSG00000274102 "Olfactory receptor family 4 subfamily M member 2" Q8NGB6 15 22070241-22083221 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Cell type enriched" "Detected in single" 9 "Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-2 OS: 1.0" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.9" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 OR4X2 ENSG00000172208 "Olfactory receptor family 4 subfamily X member 2 (gene/pseudogene)" Q8NGF9 11 48245056-48246080 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A7 ENSG00000176895 "Olfactory receptor family 51 subfamily A member 7" Q8NH64 11 4903783-4909462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA061356 Uncertain NA NA "HPA061356: AB_2684488" "unprognostic (4.57e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B4 ENSG00000183251 "Olfactory receptor family 51 subfamily B member 4" Q9Y5P0 11 5301014-5301946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 7.2;U-2197: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.16e-2)" "unprognostic (5.01e-1)" 0.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.7 0.1 0.0 0.6 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.6 0.2 0.0 0.3 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 9.2 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B5 ENSG00000167355 "Olfactory receptor family 51 subfamily B member 5" Q9H339 11 5303444-5505652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.0;epididymis: 1.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.1" "Cell type enriched" "Detected in single" 4 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 4 "T-cells: 1.0" "Group enriched" "Detected in some" 6 "K-562: 9.3;U-2197: 2.8" "Region enhanced" "Detected in single" "olfactory region: 0.3" HPA063124 Uncertain NA NA "HPA063124: AB_2684943" "unprognostic (9.22e-3)" "unprognostic (1.80e-1)" "unprognostic (2.01e-1)" "unprognostic (3.76e-2)" "unprognostic (4.75e-1)" "unprognostic (1.36e-1)" "unprognostic (7.37e-5)" "unprognostic (2.94e-1)" "unprognostic (2.43e-1)" "unprognostic (4.20e-2)" "unprognostic (2.71e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 0.0 0.1 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51D1 OR51D1Q ENSG00000197428 "Olfactory receptor family 51 subfamily D member 1" Q8NGF3 11 4637477-4643060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.0;SCLC-21H: 1.1" "Not detected" "Not detected" HPA061240 Uncertain NA NA "HPA061240: AB_2684457" "unprognostic (1.90e-1)" 1.1 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.4 0.0 0.0 0.7 0.1 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.5 0.0 1.0 0.6 1.3 0.7 0.1 0.6 0.0 0.3 0.3 0.0 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.1 0.3 0.0 0.1 1.3 0.7 0.4 0.6 0.3 0.5 0.4 0.5 0.3 0.1 1.0 0.5 0.6 1.3 0.1 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 10.0;prostate: 12.1" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 20.4;Sertoli cells: 25.8" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 114 "SCLC-21H: 14.4" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved NA NA "CAB019995: AB_10283600, HPA051439: AB_2681487" "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 7.6 0.0 0.6 1.9 0.8 0.0 5.1 0.1 0.6 0.9 2.6 0.1 0.1 0.4 2.5 0.3 0.8 0.8 0.7 4.8 0.1 0.2 1.6 0.1 0.1 1.9 0.6 0.1 1.0 0.1 0.2 1.0 10.0 0.6 12.1 1.1 0.8 4.4 0.8 2.4 0.3 2.1 1.3 1.8 0.1 0.9 0.3 0.1 0.1 0.9 0.9 0.4 1.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.1 0.6 0.1 0.2 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.1 0.0 20.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 25.8 3.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 OR51E2 PSGR ENSG00000167332 "Olfactory receptor family 51 subfamily E member 2" Q9H255 11 4680171-4697854 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "prostate: 42.1;retina: 14.6" "Cell type enriched" "Detected in some" 13 "Intestinal endocrine cells: 74.5" "Cancer enriched" "Detected in some" 274 "prostate cancer: 217.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.9;BJ hTERT+: 3.3;hTERT-RPE1: 4.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.98e-3)" "unprognostic (1.91e-1)" "unprognostic (6.09e-3)" "unprognostic (1.57e-2)" "unprognostic (8.00e-4)" "unprognostic (3.61e-2)" "unprognostic (6.27e-2)" "unprognostic (1.66e-1)" "unprognostic (3.05e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-1)" "unprognostic (3.61e-1)" "unprognostic (5.04e-5)" "unprognostic (3.34e-2)" "unprognostic (4.66e-2)" "unprognostic (5.76e-2)" "unprognostic (3.29e-1)" 0.7 0.2 0.2 5.0 0.2 0.1 1.7 0.1 0.5 0.6 8.2 0.0 0.5 0.2 1.6 1.3 0.6 0.6 0.3 1.1 0.2 0.2 0.4 0.1 0.1 0.0 0.2 0.0 1.1 0.2 0.1 0.2 5.1 0.4 42.1 2.2 14.6 0.2 2.4 0.5 0.3 0.9 2.0 0.2 0.1 0.5 0.7 0.0 0.0 0.2 0.4 0.0 1.6 0.3 1.6 0.9 2.2 0.6 0.8 1.2 0.4 0.0 0.0 0.1 0.1 0.7 5.9 0.2 0.0 3.3 0.0 0.2 0.2 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.1 1.1 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 4.3 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.3 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.4 0.7 0.3 0.0 0.4 0.0 0.1 0.4 0.0 0.0 1.5 0.6 0.5 1.2 0.5 0.8 0.8 0.8 0.6 0.3 1.6 0.8 1.1 2.2 0.8 0.5 0.9 0.4 0.4 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 0.1 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51F2 ENSG00000176925 "Olfactory receptor family 51 subfamily F member 2" Q8NH61 11 4821321-4822456 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G1 OR51G3P ENSG00000278870 "Olfactory receptor family 51 subfamily G member 1 (gene/pseudogene)" Q8NGK1 11 4923374-4924339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "CAPAN-2: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G2 ENSG00000176893 "Olfactory receptor family 51 subfamily G member 2" Q8NGK0 11 4912588-4919350 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I1 ENSG00000167359 "Olfactory receptor family 51 subfamily I member 1" Q9H343 11 5440570-5441514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.0;U-2197: 1.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "olfactory region: 6.3" NA NA "unprognostic (2.36e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.2 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "RT4: 8.0" "Region enriched" "Detected in single" 11 "olfactory region: 4.5" HPA044998 Uncertain NA NA "HPA044998: AB_10794780" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51S1 ENSG00000176922 "Olfactory receptor family 51 subfamily S member 1" Q8NGJ8 11 4847489-4849238 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A1 HPFH1OR ENSG00000182070 "Olfactory receptor family 52 subfamily A member 1" Q9UKL2 11 5143219-5154757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 1.9" "Group enriched" "Detected in some" 33 "Ciliated cells: 22.7;Club cells: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.0;U-266/70: 3.5" NA NA 0.2 0.3 0.2 0.5 0.2 0.6 0.4 1.1 0.3 0.2 0.2 0.4 0.3 0.4 0.2 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1.2 0.9 0.4 0.0 0.2 0.2 0.5 1.9 0.2 0.0 0.2 0.2 1.3 0.6 2.3 0.5 0.8 0.5 0.1 0.4 0.6 0.1 0.5 0.0 0.1 1.2 0.4 0.0 0.2 0.0 0.6 1.1 0.5 0.5 0.0 0.3 0.5 0.0 0.0 0.0 2.5 0.4 0.6 1.6 0.5 0.0 0.7 1.6 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.9 2.6 0.0 0.7 0.3 1.5 1.7 0.3 0.3 0.6 0.3 0.7 0.1 0.5 0.8 0.9 0.4 1.7 0.3 0.6 0.7 1.3 0.4 0.6 3.0 0.6 0.4 3.5 0.8 1.0 0.4 0.6 0.3 1.7 0.5 1.4 0.4 0.3 0.4 1.2 0.4 0.4 0.2 1.3 0.5 0.4 2.3 0.8 0.3 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B2 ENSG00000255307 "Olfactory receptor family 52 subfamily B member 2" Q96RD2 11 6169330-6170408 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.53e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.3 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52D1 ENSG00000181609 "Olfactory receptor family 52 subfamily D member 1" Q9H346 11 5488685-5489749 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046965 Uncertain NA NA "HPA046965: AB_2679878" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E8 ENSG00000183269 "Olfactory receptor family 52 subfamily E member 8" Q6IFG1 11 5856674-5857734 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52H1 ENSG00000181616 "Olfactory receptor family 52 subfamily H member 1" Q8NGJ2 11 5544489-5548533 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "BJ hTERT+ SV40 Large T+ RasG12V: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (2.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.1 0.0 0.2 1.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.8 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR52I2 ENSG00000226288 "Olfactory receptor family 52 subfamily I member 2" Q8NH67 11 4581743-4593340 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049343 Uncertain NA NA "HPA049343: AB_2680721" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 2.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K1 ENSG00000196778 "Olfactory receptor family 52 subfamily K member 1" Q8NGK4 11 4482646-4493497 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1;bone marrow: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 5.1;RT4: 7.5" NA NA 0.3 0.3 0.3 0.8 0.3 3.9 0.2 0.2 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.3 0.2 0.2 0.3 0.2 0.9 0.8 0.5 0.9 0.4 1.2 0.3 0.0 0.2 1.4 0.3 0.1 0.3 0.0 0.4 1.2 1.8 0.0 0.5 0.9 0.2 1.1 0.3 0.6 0.4 0.4 0.6 0.6 3.1 1.4 0.3 0.5 0.3 0.9 1.9 1.4 1.5 0.3 0.2 0.9 1.3 0.3 0.8 0.8 1.8 1.5 1.1 1.2 0.7 0.9 1.8 1.4 0.8 1.0 0.6 0.8 1.4 5.1 1.9 0.2 0.7 2.0 0.4 0.3 0.9 0.7 0.5 0.6 1.4 0.9 2.7 2.1 1.0 0.5 1.6 0.8 0.3 1.1 1.8 1.0 0.8 0.5 7.5 1.6 0.7 0.4 0.6 0.3 1.3 1.1 0.5 0.3 2.6 0.7 0.8 2.7 1.5 0.7 0.7 0.6 2.5 1.6 0.7 1.4 0.4 0.4 1.2 0.2 0.3 0.3 0.5 0.6 0.6 0.4 0.5 3.1 0.3 1.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K2 ENSG00000181963 "Olfactory receptor family 52 subfamily K member 2" Q8NGK3 11 4449295-4450361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 6.9;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.9;neutrophil: 6.9" "Group enriched" "Detected in many" 25 "granulocytes: 6.9;monocytes: 1.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 6.9 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52L1 ENSG00000183313 "Olfactory receptor family 52 subfamily L member 1" Q8NGH7 11 5985892-5986985 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N4 ENSG00000181074 "Olfactory receptor family 52 subfamily N member 4 (gene/pseudogene)" Q8NGI2 11 5754243-5755905 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;T-reg: 3.1" "Group enriched" "Detected in many" 6 "B-cells: 2.3;T-cells: 3.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.5;hTERT-RPE1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-4)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (3.03e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (5.62e-2)" "unprognostic (1.41e-3)" "unprognostic (1.41e-1)" "unprognostic (3.80e-2)" "unprognostic (3.18e-2)" "unprognostic (4.41e-2)" 1.3 0.4 0.1 1.1 0.1 0.8 1.4 0.0 0.4 0.8 0.6 0.0 1.4 3.4 0.7 1.6 0.5 0.7 0.2 0.1 1.1 0.3 1.3 2.9 0.2 3.5 0.0 0.0 0.9 0.0 1.2 0.6 0.6 1.8 0.2 0.6 3.6 0.1 0.5 5.7 0.4 0.6 0.6 2.9 0.5 1.4 2.3 0.4 0.0 0.1 0.0 3.1 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.0 0.2 0.2 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.0 2.3 0.4 0.6 0.0 0.0 0.1 0.4 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N5 OR52N5Q ENSG00000181009 "Olfactory receptor family 52 subfamily N member 5" Q8NH56 11 5776165-5783355 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "adipose tissue: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1.8 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.8 0.3 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 2.1 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52W1 OR52W1P ENSG00000175485 "Olfactory receptor family 52 subfamily W member 1" Q6IF63 11 6199146-6200259 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 0.0 0.0 0.1 0.2 0.7 1.9 0.0 0.8 0.4 0.0 0.3 0.5 0.3 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.3 0.8 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A1 ENSG00000180934 "Olfactory receptor family 56 subfamily A member 1" Q8NGH5 11 6019336-6034338 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.2 0.1 1.8 0.1 0.1 0.2 0.1 0.4 0.0 0.2 0.8 0.1 0.2 0.5 0.1 0.1 0.2 0.3 0.8 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.0 0.1 0.3 0.1 0.0 0.1 0.3 0.1 2.7 0.3 0.0 0.2 0.1 0.8 0.4 0.8 0.1 0.6 1.2 0.1 0.4 0.1 0.8 0.6 0.1 0.5 0.3 0.7 0.6 0.5 0.2 0.2 1.0 0.9 1.2 0.2 0.6 0.6 0.1 0.0 0.9 0.3 0.3 0.6 0.7 0.8 0.2 0.9 0.8 0.3 1.2 0.6 0.2 0.7 0.2 0.5 0.8 0.8 0.2 1.0 0.2 0.6 1.2 0.4 0.4 0.6 0.8 0.1 0.5 0.8 0.6 0.8 0.1 0.5 0.5 2.1 0.6 0.6 0.5 0.9 0.9 0.5 0.3 1.0 0.7 0.4 0.5 0.5 0.6 0.7 0.1 0.4 0.6 0.0 1.0 0.5 1.0 0.8 0.1 0.8 1.2 0.9 0.8 0.6 0.1 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A4 ENSG00000183389 "Olfactory receptor family 56 subfamily A member 4" Q8NGH8 11 5999445-6006946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 1.5" "Cell type enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.1" NA NA 0.3 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.4 0.6 0.4 0.0 0.1 0.1 0.1 1.0 0.1 0.0 0.0 0.1 0.5 0.4 2.2 0.5 0.4 0.4 0.0 0.7 0.2 0.2 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.6 0.9 0.5 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.5 1.3 0.1 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.6 0.0 0.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.4 0.7 0.5 0.2 0.3 0.2 0.5 0.0 1.4 0.4 1.3 0.2 0.4 0.8 0.6 0.4 0.5 0.2 0.4 0.6 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.5 0.4 0.4 2.2 0.4 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56B1 OR56B1P ENSG00000181023 "Olfactory receptor family 56 subfamily B member 1" Q8NGI3 11 5736448-5738522 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045043 Uncertain NA NA "HPA045043: AB_10794296" 0.2 0.0 0.0 1.2 0.0 0.3 0.3 0.0 0.2 0.9 0.1 0.0 0.3 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.5 1.3 0.0 0.8 0.0 0.7 0.1 0.0 0.3 0.1 0.2 0.5 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.2 0.1 0.9 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56B4 ENSG00000180919 "Olfactory receptor family 56 subfamily B member 4" Q8NH76 11 6107684-6108835 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;SuSa: 1.0;U-266/70: 4.6;U-266/84: 2.7" NA NA "unprognostic (2.04e-3)" "unprognostic (8.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (3.83e-1)" "unprognostic (3.01e-1)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-1)" "unprognostic (2.46e-1)" 0.2 0.2 0.0 1.0 0.0 0.0 0.2 0.0 0.1 0.3 0.6 0.4 0.4 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.2 0.6 0.5 0.2 0.0 0.3 1.1 0.0 0.2 0.3 0.3 0.0 0.5 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.1 0.4 0.9 0.0 0.7 0.2 0.1 0.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.6 0.3 0.2 0.1 0.0 4.6 2.7 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A1 "OR5A1P, OST181" ENSG00000172320 "Olfactory receptor family 5 subfamily A member 1" Q8NGJ0 11 59436469-59451380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;bone marrow: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "Not detected" "Not detected" NA NA "unprognostic (1.73e-2)" 0.2 0.4 0.2 0.4 0.2 2.4 0.2 0.2 0.3 0.7 0.3 0.1 0.3 1.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.5 0.2 0.5 0.3 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.5 2.0 0.4 0.0 0.2 0.5 0.3 1.6 0.4 0.0 0.3 0.2 0.8 0.4 2.4 0.3 0.3 0.5 0.0 0.7 0.3 0.8 1.2 0.5 0.3 0.8 0.6 0.1 0.1 0.1 0.8 0.7 1.3 0.6 0.1 0.7 0.7 0.3 0.0 0.1 0.7 1.0 0.9 2.6 0.6 0.1 0.7 1.7 0.0 0.3 0.1 0.1 0.7 0.1 0.9 1.0 3.5 0.3 0.7 0.8 1.0 1.3 0.3 0.8 0.7 0.7 1.4 0.2 1.5 1.0 0.9 0.7 0.4 0.4 1.1 1.2 0.7 0.6 0.9 1.1 0.9 0.7 1.3 1.0 0.8 1.1 1.0 0.8 0.9 0.3 0.2 0.5 0.2 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.4 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A2 ENSG00000172324 "Olfactory receptor family 5 subfamily A member 2" Q8NGI9 11 59416969-59426412 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 4.9" "Not detected" "Not detected" "HPA047135, HPA049575" Uncertain NA NA "HPA047135: AB_2679948, HPA049575: AB_2680820" 0.4 0.4 0.4 0.5 0.4 2.1 0.4 0.4 0.9 0.9 0.4 0.6 0.9 1.1 0.4 1.0 0.2 0.4 0.4 0.4 0.5 0.6 0.4 0.8 0.4 0.4 0.4 0.0 0.4 0.0 0.4 0.2 0.6 0.1 0.8 1.5 1.0 0.0 0.5 1.2 0.4 1.2 0.6 0.1 0.4 0.4 1.2 0.7 2.7 1.3 1.0 1.1 0.2 0.7 0.9 1.6 1.3 0.5 0.6 1.0 0.6 0.4 0.5 0.8 0.8 0.9 1.4 0.4 0.3 0.7 1.2 1.6 0.2 0.8 4.9 0.7 1.2 2.0 1.2 0.1 0.7 2.5 0.4 0.5 0.3 0.4 0.9 0.3 2.0 1.2 2.7 0.3 0.9 0.8 1.3 1.9 0.6 0.3 1.8 1.1 0.8 0.6 1.1 1.3 0.5 0.9 0.4 1.7 1.7 0.7 0.8 1.1 0.6 1.3 1.7 0.4 2.4 1.7 1.0 0.8 2.3 0.6 1.5 0.7 1.0 1.1 0.8 0.9 0.8 1.0 0.9 0.4 1.2 1.1 0.8 2.7 1.0 1.3 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AK2 ENSG00000181273 "Olfactory receptor family 5 subfamily AK member 2" Q8NH90 11 56988872-56989867 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "lymphoid tissue: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AN1 ENSG00000176495 "Olfactory receptor family 5 subfamily AN member 1" Q8NGI8 11 59358895-59371714 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.5;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.5" NA NA 0.1 0.0 0.0 0.0 0.1 2.2 0.1 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.4 0.1 0.1 1.5 0.7 0.4 0.0 0.1 0.0 0.4 0.1 0.2 0.5 0.0 0.5 0.2 0.7 0.5 0.1 0.1 0.2 0.1 1.0 0.2 1.4 0.6 0.2 0.2 0.8 0.4 0.4 0.3 0.6 0.7 0.7 0.0 0.3 0.4 0.0 0.0 0.5 2.5 0.5 0.1 0.2 0.7 1.2 0.7 1.1 0.1 0.4 0.3 0.1 1.5 0.6 0.4 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.2 0.2 0.2 0.2 1.4 0.4 1.4 0.8 0.3 0.4 0.6 0.7 0.7 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AP2 ENSG00000172464 "Olfactory receptor family 5 subfamily AP member 2" Q8NGF4 11 56641466-56642471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AU1 ENSG00000169327 "Olfactory receptor family 5 subfamily AU member 1" Q8NGC0 14 21148370-21159060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;bone marrow: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2197: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.1 0.1 0.2 0.1 0.3 2.4 0.6 0.1 0.3 0.4 0.2 0.4 0.2 0.5 0.2 0.1 0.2 0.1 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.4 0.9 1.7 0.6 0.4 0.0 0.1 0.4 0.2 0.9 0.3 0.0 0.1 0.5 0.8 0.8 2.3 0.7 0.7 0.4 0.0 0.3 0.4 0.3 0.3 0.2 0.1 0.5 0.4 0.0 0.0 0.0 0.7 0.6 0.3 0.3 0.2 0.3 0.7 0.1 0.0 0.1 0.3 0.2 0.7 0.9 0.8 0.3 0.6 0.6 0.1 0.0 0.1 0.2 0.1 0.1 0.8 0.7 1.0 0.1 0.5 0.3 0.9 0.4 0.5 0.1 0.5 0.7 0.3 0.1 0.8 0.7 0.6 0.6 1.7 0.1 0.8 0.3 0.1 0.1 0.7 0.4 4.5 0.4 0.6 0.4 0.4 0.4 1.0 0.5 1.1 0.7 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.3 2.3 0.7 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B12 "OR5B12P, OR5B16, OST743" ENSG00000172362 "Olfactory receptor family 5 subfamily B member 12" Q96R08 11 58439077-58442758 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.0" NA NA 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.5 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.4 0.0 0.3 1.2 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.3 0.6 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B2 OST073 ENSG00000172365 "Olfactory receptor family 5 subfamily B member 2" Q96R09 11 58421264-58428121 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.2 0.6 0.0 0.0 0.1 1.8 0.5 0.4 0.3 0.5 0.1 0.0 0.2 0.2 0.3 0.4 0.4 0.1 0.1 0.1 0.4 0.3 0.3 0.6 0.0 0.6 0.1 0.3 0.2 0.3 0.4 0.3 0.2 0.3 0.3 0.5 0.5 0.0 0.1 0.5 0.2 1.0 0.2 0.1 0.7 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.5 0.2 0.0 0.6 0.0 0.8 0.4 0.2 0.0 0.2 0.3 1.4 0.3 0.8 0.2 0.3 0.1 0.2 0.6 0.9 0.2 1.3 0.9 0.0 0.0 0.4 1.2 1.0 0.5 0.4 0.4 0.6 0.0 1.7 0.3 1.2 0.7 0.5 1.6 0.6 0.3 0.5 0.2 1.0 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.6 0.7 0.3 1.0 0.5 0.0 0.3 0.1 0.2 0.8 0.4 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5C1 "hRPK-465_F_21, OR5C2P, OR9-F" ENSG00000148215 "Olfactory receptor family 5 subfamily C member 1" Q8NGR4 9 122788933-122789895 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.0" "Not detected" "Not detected" NA NA "unprognostic (2.73e-1)" 1.0 0.2 0.3 0.2 1.3 0.2 2.8 0.4 0.8 0.5 0.2 0.3 0.0 0.2 0.2 0.4 0.2 0.5 0.6 6.1 1.2 0.2 0.8 0.5 0.3 0.5 0.1 0.4 0.4 0.3 0.2 0.4 1.0 0.1 1.0 0.2 0.0 1.5 0.2 2.4 0.8 0.3 0.2 0.9 0.6 0.2 1.0 0.1 0.0 1.2 0.7 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.7 1.2 0.2 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D18 ENSG00000186119 "Olfactory receptor family 5 subfamily D member 18" Q8NGL1 11 55819607-55820597 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5F1 OR11-10 ENSG00000149133 "Olfactory receptor family 5 subfamily F member 1" O95221 11 55993681-55994625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059360 Uncertain NA NA "HPA059360: AB_2683990" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H1 "HSHTPCRX14, HTPCRX14" ENSG00000231192 "Olfactory receptor family 5 subfamily H member 1" A6NKK0 3 98130721-98138548 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.1" "Cell line enriched" "Detected in single" 6 "BEWO: 5.2" NA NA 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.5 0.1 1.5 0.2 0.0 0.6 0.1 0.2 1.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H14 ENSG00000236032 "Olfactory receptor family 5 subfamily H member 14" A6NHG9 3 98147479-98156614 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;placenta: 2.1" "Group enriched" "Detected in some" 17 "Collecting duct cells: 1.8;Early spermatids: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.2 0.1 0.0 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.2 0.1 0.4 0.4 2.1 0.4 0.4 0.4 0.0 0.6 0.6 0.6 0.6 0.3 0.1 0.5 0.8 0.5 0.1 0.0 0.9 0.5 0.3 0.4 0.0 0.6 0.9 0.1 0.3 0.0 0.5 0.6 0.6 1.0 0.7 0.2 0.4 0.5 0.1 0.7 0.2 0.0 0.5 0.0 1.1 0.3 1.4 0.0 1.0 0.3 0.7 0.7 0.3 1.1 0.7 0.2 0.4 0.1 1.0 0.3 0.5 0.4 0.4 0.5 1.1 0.6 0.3 0.1 0.6 1.1 0.9 0.4 0.8 0.8 0.7 0.5 0.3 0.5 2.1 0.4 0.4 0.4 0.2 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H6 ENSG00000230301 "Olfactory receptor family 5 subfamily H member 6 (gene/pseudogene)" Q8NGV6 3 98263252-98265356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Group enriched" "Detected in some" 12 "Early spermatids: 1.2;Late spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NTERA-2: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5I1 "HSOlf1, OLF1" ENSG00000167825 "Olfactory receptor family 5 subfamily I member 1" Q13606 11 55935456-55936400 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "NTERA-2: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K1 "HSHTPCRX10, HTPCRX10" ENSG00000232382 "Olfactory receptor family 5 subfamily K member 1" Q8NHB7 3 98463201-98472924 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K2 ENSG00000231861 "Olfactory receptor family 5 subfamily K member 2" Q8NHB8 3 98497604-98498663 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;THP-1: 3.0;U-266/70: 1.5" NA NA "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (8.45e-3)" "unprognostic (1.69e-3)" "unprognostic (6.47e-3)" "unprognostic (7.17e-2)" "unprognostic (1.45e-1)" "unprognostic (3.61e-2)" "unprognostic (1.19e-2)" "unprognostic (6.57e-2)" "unprognostic (3.77e-2)" "unprognostic (5.93e-2)" 0.4 0.4 0.0 0.6 1.3 0.0 0.4 2.3 0.8 0.9 1.4 0.2 1.2 0.0 0.6 0.1 0.4 0.9 0.0 0.0 0.4 0.0 1.4 1.2 0.0 1.4 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 4.3 1.5 1.3 0.0 0.0 1.4 0.4 0.6 0.4 0.0 1.1 0.6 0.5 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.9 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L1 OST262 ENSG00000279395 "Olfactory receptor family 5 subfamily L member 1 (gene/pseudogene)" Q8NGL2 11 55811367-55812476 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L2 "HSHTPCRX16, HTPCRX16" ENSG00000205030 "Olfactory receptor family 5 subfamily L member 2" Q8NGL0 11 55827219-55828154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M10 ENSG00000254834 "Olfactory receptor family 5 subfamily M member 10" Q6IEU7 11 56576736-56577787 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M11 OR11-199 ENSG00000255223 "Olfactory receptor family 5 subfamily M member 11" Q96RB7 11 56542262-56543281 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 1.3;urinary bladder: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.6" NA NA "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M3 ENSG00000174937 "Olfactory receptor family 5 subfamily M member 3" Q8NGP4 11 56469274-56473352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M8 ENSG00000181371 "Olfactory receptor family 5 subfamily M member 8" Q8NGP6 11 56490349-56491395 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-2 OS: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P2 JCG3 ENSG00000183303 "Olfactory receptor family 5 subfamily P member 2" Q8WZ92 11 7795905-7796973 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "skin 1: 1.7;urinary bladder: 1.3" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P3 JCG1 ENSG00000182334 "Olfactory receptor family 5 subfamily P member 3" Q8WZ94 11 7824818-7830840 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0" "Group enriched" "Detected in some" 21 "Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060787 Uncertain NA NA "HPA060787: AB_2684364" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 OR5T1 OR5T1P ENSG00000181698 "Olfactory receptor family 5 subfamily T member 1" Q8NG75 11 56274154-56276819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050952 Uncertain NA NA "HPA050952: AB_2681287" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T2 ENSG00000181718 "Olfactory receptor family 5 subfamily T member 2" Q8NGG2 11 56231282-56234255 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.3 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.7 0.2 0.3 1.6 0.3 0.0 0.4 0.1 0.1 0.9 0.1 0.0 0.3 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.7 2.2 0.2 0.6 0.2 0.3 0.6 0.2 0.5 1.4 0.0 0.8 0.1 0.1 1.0 1.2 0.5 0.6 0.1 1.3 1.8 0.6 0.7 1.4 0.0 0.4 0.5 0.2 0.0 0.3 0.2 0.7 0.9 1.0 0.6 0.5 0.0 0.4 0.6 1.1 0.9 0.1 0.4 0.4 0.8 0.2 0.0 1.0 0.7 0.5 0.1 0.3 0.3 0.5 0.5 0.4 0.4 1.0 0.2 0.5 0.4 1.1 2.4 0.7 0.3 1.0 0.8 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5V1 hs6M1-21 ENSG00000243729 "Olfactory receptor family 5 subfamily V member 1" Q9UGF6 6 29353749-29431967 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.1" "Group enriched" "Detected in some" 23 "Early spermatids: 13.0;Late spermatids: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046707 Uncertain NA NA "HPA046707: AB_2679763" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6A2 "OR11-55, OR6A1, OR6A2P" ENSG00000184933 "Olfactory receptor family 6 subfamily A member 2" O95222 11 6791736-6799689 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B1 OR7-3 ENSG00000221813 "Olfactory receptor family 6 subfamily B member 1" O95007 7 144000320-144008793 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 3.2;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;RPMI-8226: 2.1;U-266/84: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 20 "olfactory region: 0.1" HPA053164 Uncertain NA NA "HPA053164: AB_2682065" 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C1 OST267 ENSG00000205330 "Olfactory receptor family 6 subfamily C member 1" Q96RD1 12 55314343-55322364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C4 ENSG00000179626 "Olfactory receptor family 6 subfamily C member 4" Q8NGE1 12 55549602-55555832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-266/84: 3.2" NA NA 0.3 0.2 0.1 0.9 0.2 1.3 0.2 0.2 0.8 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.3 0.8 0.1 0.1 0.3 0.2 0.2 1.0 0.2 0.6 0.8 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.5 1.6 0.4 0.0 0.1 0.4 0.3 0.4 0.6 0.0 0.5 0.2 0.9 1.6 2.9 0.6 1.2 1.1 0.2 0.8 0.0 1.1 1.3 0.1 0.0 0.9 0.8 0.1 0.0 0.0 0.6 0.7 1.5 0.2 0.2 0.6 0.6 0.0 0.0 0.0 1.5 0.6 0.6 1.2 0.6 0.1 1.6 1.0 0.0 0.1 0.0 0.0 0.5 0.2 0.9 0.6 2.1 0.1 0.4 0.7 1.0 0.8 0.1 0.6 0.4 0.9 1.6 0.1 0.9 1.4 1.1 0.4 0.8 1.7 0.7 0.1 1.3 1.1 1.8 0.8 0.7 0.5 1.1 3.2 1.2 0.9 1.2 1.5 2.9 0.6 0.7 0.7 0.4 0.7 0.6 0.7 0.6 0.2 0.9 1.1 0.9 1.5 1.2 0.4 1.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C65 ENSG00000205328 "Olfactory receptor family 6 subfamily C member 65" A6NJZ3 12 55400430-55401505 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6F1 OST731 ENSG00000169214 "Olfactory receptor family 6 subfamily F member 1" Q8NGZ6 1 247711436-247716646 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 4.6" "Group enriched" "Detected in some" 63 "Early spermatids: 13.9;Late spermatids: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 57 "GAMG: 6.4" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR6K2 ENSG00000196171 "Olfactory receptor family 6 subfamily K member 2" Q8NGY2 1 158699678-158700652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K6 ENSG00000180433 "Olfactory receptor family 6 subfamily K member 6" Q8NGW6 1 158754720-158755891 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 57 "basophil: 5.7" "Lineage enriched" "Detected in single" 57 "granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6M1 ENSG00000196099 "Olfactory receptor family 6 subfamily M member 1" Q8NGM8 11 123805335-123806387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "pancreas: 3.1;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;SCLC-21H: 2.1" "Not detected" "Not detected" HPA048674 Uncertain NA NA "HPA048674: AB_2680489" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6Q1 ENSG00000279051 "Olfactory receptor family 6 subfamily Q member 1 (gene/pseudogene)" Q8NGQ2 11 58030930-58031931 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6T1 ENSG00000181499 "Olfactory receptor family 6 subfamily T member 1" Q8NGN1 11 123942785-123943873 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "pancreas: 4.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "hTCEpi: 2.3" "Low region specificity" "Detected in some" HPA060893 Uncertain NA NA "HPA060893: AB_2684380" "unprognostic (9.30e-4)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6V1 GPR138 ENSG00000225781 "Olfactory receptor family 6 subfamily V member 1" Q8N148 7 143052320-143053347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.24e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6X1 ENSG00000221931 "Olfactory receptor family 6 subfamily X member 1" Q8NH79 11 123753488-123754545 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A17 HTPCRX19 ENSG00000185385 "Olfactory receptor family 7 subfamily A member 17" O14581 19 14878203-14886132 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1" "Group enriched" "Detected in some" 59 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.3;Club cells: 6.8;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA 0.2 0.3 0.2 0.9 0.2 1.5 0.2 0.2 0.6 1.0 0.2 0.0 0.2 1.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.4 1.6 0.2 0.0 0.2 0.4 0.2 0.2 0.9 0.0 0.4 0.2 1.4 1.0 3.1 0.7 1.0 0.7 0.2 1.4 0.6 0.7 1.6 0.5 0.4 0.5 0.6 0.8 0.6 0.7 0.5 2.4 0.1 0.5 0.5 0.2 1.0 1.2 0.2 0.7 0.4 1.0 0.5 1.9 0.5 0.0 1.0 0.5 0.5 0.6 0.7 0.2 1.0 0.3 0.3 1.1 1.9 1.4 0.3 0.7 1.1 0.6 0.0 0.3 0.3 0.6 0.4 0.3 1.1 0.7 0.7 0.2 0.1 0.4 0.5 0.7 0.1 0.9 1.8 0.4 1.1 0.3 0.5 0.4 0.4 0.6 0.6 0.1 2.3 0.7 0.7 0.7 0.5 0.4 0.8 0.5 0.3 0.2 1.4 0.5 0.7 3.1 1.0 0.5 1.0 0.4 0.2 8.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A5 HTPCR2 ENSG00000188269 "Olfactory receptor family 7 subfamily A member 5" Q15622 19 14824251-14835285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.4;pituitary gland: 33.6" "Cell type enhanced" "Detected in single" 25 "Spermatocytes: 1.2" "Cancer enriched" "Detected in single" 8 "melanoma: 2.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA053823 Uncertain NA NA "HPA053823: AB_2682274" "unprognostic (3.26e-4)" "unprognostic (1.44e-1)" "unprognostic (7.46e-2)" "unprognostic (6.19e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (6.78e-2)" "unprognostic (2.01e-7)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (6.44e-2)" "unprognostic (2.47e-3)" 0.3 0.7 1.7 0.4 7.3 1.0 2.0 0.4 3.8 0.7 0.5 4.7 3.2 0.5 0.4 10.1 0.5 0.5 0.5 0.3 4.4 2.1 0.6 0.8 0.6 0.5 16.4 1.3 0.4 0.8 6.9 33.6 0.4 10.9 1.5 0.6 7.0 0.9 2.6 0.5 2.2 0.7 0.3 6.1 0.5 6.4 5.0 16.4 0.0 0.5 0.0 0.3 0.4 0.9 1.0 0.7 1.3 0.3 0.4 0.5 0.0 0.5 0.6 0.4 0.6 0.1 0.1 0.7 0.2 0.2 0.0 0.1 0.6 0.7 0.6 0.3 0.0 0.3 0.5 0.2 0.1 0.0 0.3 0.3 0.5 1.8 0.6 0.1 1.2 0.3 1.8 0.7 0.4 0.2 0.4 0.2 0.5 0.4 1.0 0.0 0.6 0.3 0.5 1.1 0.1 0.2 0.6 0.1 0.6 0.0 1.5 0.4 0.4 0.6 0.2 1.8 0.8 0.1 0.1 0.7 0.4 0.5 0.5 0.3 1.0 0.3 0.5 0.5 0.6 0.7 1.1 0.3 0.3 0.5 0.2 0.3 0.4 0.3 0.2 0.1 1.0 0.4 0.5 1.3 0.4 0.2 0.7 0.1 0.0 1.7 7.3 0.4 3.8 4.4 2.1 16.4 1.3 10.9 16.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 OR7C1 "OR19-5, OR7C4" ENSG00000127530 "Olfactory receptor family 7 subfamily C member 1" O76099 19 14789260-14835376 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;pituitary gland: 34.0" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 5.6;Ciliated cells: 2.7;Club cells: 4.5;Melanocytes: 1.7" "Cancer enriched" "Detected in single" 9 "melanoma: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;monocytes: 1.5" "Low cell line specificity" "Detected in many" HPA047127 Uncertain NA NA "HPA047127: AB_2679944" "unprognostic (7.68e-4)" "unprognostic (1.31e-1)" "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.39e-1)" "unprognostic (4.30e-2)" "unprognostic (6.11e-4)" "unprognostic (1.90e-1)" "unprognostic (6.80e-2)" "unprognostic (6.91e-2)" 0.5 3.3 1.4 0.7 7.4 1.9 1.5 0.5 3.9 0.7 0.5 4.7 3.2 0.7 0.5 5.9 0.5 0.5 0.6 0.5 3.2 0.9 0.6 0.6 0.5 0.8 16.6 1.4 0.5 0.5 7.3 34.0 0.5 11.0 3.0 0.4 7.1 1.1 2.9 3.6 3.1 0.7 0.3 3.8 0.7 0.6 6.3 16.6 0.0 1.0 0.0 0.4 0.5 1.0 0.7 0.5 4.8 1.5 0.5 0.4 0.2 0.8 1.1 0.8 2.2 0.7 0.5 1.1 0.5 0.3 0.6 0.8 1.2 1.8 1.4 1.5 0.6 0.8 1.0 0.3 0.6 0.8 0.7 0.6 1.0 2.2 0.7 0.6 0.9 1.4 0.8 0.3 0.5 0.5 1.0 0.3 1.1 0.7 3.1 0.3 0.5 0.7 1.5 1.1 0.5 1.0 0.8 0.4 0.6 0.7 1.3 1.7 1.0 0.6 0.7 1.0 1.0 0.6 1.6 0.9 1.0 2.2 1.1 0.7 1.3 0.8 1.0 1.0 0.8 0.7 2.9 0.9 1.7 0.3 0.8 0.3 0.4 0.3 0.2 0.4 0.7 0.3 0.4 4.8 0.5 1.5 0.5 0.2 0.2 1.4 7.4 0.5 3.9 3.2 0.9 16.6 1.4 11.0 16.6 0.0 5.6 0.0 0.6 0.0 0.0 0.0 0.0 2.7 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 OR7D2 "FLJ38149, HTPCRH03, OR19-4" ENSG00000188000 "Olfactory receptor family 7 subfamily D member 2" Q96RA2 19 9178979-9188817 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 4.4" "Cell type enriched" "Detected in single" 9 "Early spermatids: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 6.0" NA NA "unprognostic (5.00e-4)" "unprognostic (2.03e-1)" "unprognostic (3.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-1)" "unprognostic (2.86e-2)" "unprognostic (2.56e-2)" "unprognostic (3.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "unprognostic (5.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.63e-1)" "unprognostic (4.08e-2)" "unprognostic (4.92e-4)" 0.6 0.8 0.6 0.9 0.8 2.3 0.5 0.7 1.5 0.6 0.5 0.1 0.7 0.8 0.4 0.5 0.2 0.4 0.6 0.8 0.6 0.5 0.3 1.9 0.4 0.3 0.6 0.1 0.8 0.1 0.6 0.4 0.5 1.2 0.9 1.9 0.8 0.6 0.6 1.5 1.2 4.4 0.6 0.9 0.9 0.3 1.0 1.2 3.1 0.7 1.3 1.0 0.1 0.6 0.5 0.8 2.8 0.9 0.8 0.6 0.6 0.1 0.3 0.2 0.5 0.7 1.2 1.4 0.2 0.8 1.3 0.5 0.4 0.5 0.9 0.7 6.0 1.2 1.0 0.2 0.8 1.4 0.2 0.8 0.2 0.3 0.7 0.2 1.4 1.8 2.9 0.1 0.3 1.4 1.6 0.8 0.3 0.8 1.3 1.3 0.0 0.1 1.8 1.1 0.8 0.6 1.1 0.4 1.2 1.0 0.3 0.0 1.0 1.1 0.6 0.7 1.6 0.9 1.0 0.8 0.7 0.5 2.8 0.7 0.5 0.9 0.4 0.7 0.6 0.6 0.5 0.3 1.0 0.7 1.0 3.1 1.3 0.6 1.2 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 OR7D4 "hg105, OR19-B, OR7D4P" ENSG00000174667 "Olfactory receptor family 7 subfamily D member 4" Q8NG98 19 9210276-9219589 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.8;testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6" NA NA "unprognostic (1.30e-1)" 0.1 0.2 0.1 0.3 0.1 2.0 0.2 0.2 0.7 0.4 0.2 0.2 0.2 0.6 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.3 0.2 0.0 0.5 1.1 0.5 0.0 0.1 0.6 0.2 2.1 0.3 0.4 0.2 0.2 0.7 0.7 3.8 0.4 0.9 0.4 0.0 0.3 0.2 0.7 1.2 0.4 0.1 0.8 0.2 0.0 0.4 0.0 0.5 0.3 1.0 0.3 0.1 0.5 1.1 0.6 0.1 0.3 2.6 1.1 0.8 1.4 0.9 0.1 0.8 1.3 0.4 0.1 0.5 0.2 0.6 0.0 0.6 0.5 1.4 0.0 0.9 1.0 0.6 0.9 0.1 0.1 0.7 0.6 0.2 0.2 0.6 0.6 0.4 0.7 0.4 0.5 0.6 0.9 0.3 1.2 0.9 0.5 1.0 0.4 1.1 0.3 0.6 0.5 0.6 0.9 3.8 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.4 0.3 2.3 0.9 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7E24 "HSHT2, OR19-8, OR7E24P, OR7E24Q" ENSG00000237521 "Olfactory receptor family 7 subfamily E member 24" Q6IFN5 19 9247344-9252625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 5.8" "Group enriched" "Detected in some" 32 "Early spermatids: 12.3;Late spermatids: 4.0" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR8A1 OST025 ENSG00000196119 "Olfactory receptor family 8 subfamily A member 1" Q8NGG7 11 124566660-124582942 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 20 "Early spermatids: 1.3;granulocytes: 3.5;Late spermatids: 2.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.2 0.2 0.2 0.2 0.3 2.5 1.0 0.2 0.2 0.4 0.2 0.0 0.2 0.4 0.2 0.2 0.6 0.2 0.2 0.4 0.2 2.6 0.2 0.3 0.2 0.3 0.5 1.7 0.2 0.2 0.3 0.0 0.4 0.0 0.2 1.8 0.5 0.0 0.2 0.3 0.3 2.4 0.3 0.0 0.2 0.2 0.9 0.6 1.8 0.3 0.4 0.6 0.0 0.4 0.3 0.8 1.2 0.8 0.6 2.7 0.6 0.3 0.0 0.3 0.2 0.9 0.5 0.4 0.1 1.0 0.7 0.3 0.2 0.4 0.7 0.2 0.7 1.2 0.4 0.3 0.8 0.6 1.1 0.3 0.3 0.6 0.8 0.2 1.3 1.3 2.8 0.5 1.6 0.6 1.1 0.9 0.5 0.3 0.7 0.4 0.5 0.4 0.9 1.6 0.5 0.7 1.0 0.1 1.0 1.0 0.1 1.2 0.8 0.9 0.9 0.5 2.1 0.9 0.8 0.7 0.7 0.4 1.8 0.3 0.4 0.4 0.2 0.3 0.5 0.5 0.4 0.1 0.9 0.4 0.6 1.7 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B12 ENSG00000170953 "Olfactory receptor family 8 subfamily B member 12" Q8NGG6 11 124539635-124545333 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.1" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B4 OR8B4P ENSG00000280090 "Olfactory receptor family 8 subfamily B member 4 (gene/pseudogene)" Q96RC9 11 124423904-124424893 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B8 TPCR85 ENSG00000197125 "Olfactory receptor family 8 subfamily B member 8" Q15620 11 124437445-124445696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.4" NA NA 0.2 0.3 0.2 0.7 0.2 1.3 0.2 0.4 0.7 0.4 0.2 1.2 0.4 0.0 0.3 0.4 0.4 0.9 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.7 0.7 0.0 0.2 0.3 0.2 0.0 0.7 0.0 0.2 2.0 0.6 0.0 0.2 0.8 1.1 0.4 0.6 0.0 0.5 0.2 1.2 1.1 2.6 1.6 0.8 0.9 0.5 0.7 0.5 0.7 1.7 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.1 1.4 0.4 0.8 0.0 0.8 1.3 0.0 0.0 0.0 0.5 0.6 0.9 0.7 0.3 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.9 2.2 1.8 0.0 1.3 0.7 0.8 0.4 0.8 0.6 0.9 0.5 1.1 0.0 0.4 0.9 1.6 0.8 1.5 0.7 0.9 2.9 0.9 1.9 1.3 0.9 0.8 0.5 3.0 0.7 1.2 0.9 1.7 1.4 2.6 1.6 1.2 0.8 1.0 0.6 1.0 0.8 0.7 1.1 1.2 0.9 0.8 2.2 0.8 0.6 0.8 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D1 "OR8D3, OST004" ENSG00000196341 "Olfactory receptor family 8 subfamily D member 1" Q8WZ84 11 124302831-124315099 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.2;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.3;K-562: 1.8;PC-3: 1.5" "Not detected" "Not detected" HPA059510 Uncertain NA NA "HPA059510: AB_2684045" 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.1 0.0 0.1 0.2 1.2 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.3 0.2 0.0 0.4 1.8 0.7 0.0 0.9 0.1 0.0 0.2 0.1 1.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.6 0.8 0.1 0.6 0.2 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D2 ENSG00000279116 "Olfactory receptor family 8 subfamily D member 2 (gene/pseudogene)" Q9GZM6 11 124319238-124320288 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D4 ENSG00000181518 "Olfactory receptor family 8 subfamily D member 4" Q8NGM9 11 123902167-123909229 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "U-138 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 1.0 0.3 0.0 0.3 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 2.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.3 0.0 0.6 0.6 1.8 0.5 0.9 0.5 0.3 0.0 0.0 0.4 0.6 0.0 0.7 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.3 0.0 0.6 0.0 0.2 0.3 0.2 0.0 0.4 0.1 0.3 0.0 0.9 0.1 0.0 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.1 0.0 0.3 0.0 0.8 0.1 0.0 0.0 1.2 0.1 0.2 0.4 0.2 0.0 0.0 0.2 0.6 0.2 1.6 0.5 0.6 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.6 0.4 0.5 1.8 0.9 0.4 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G1 "HSTPCR25, OR8G1P, TPCR25" ENSG00000197849 "Olfactory receptor family 8 subfamily G member 1 (gene/pseudogene)" Q15617 11 124241095-124254364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 18.2" "Group enriched" "Detected in some" 21 "Early spermatids: 2.7;Late spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 18.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.3 0.7 0.4 0.1 0.3 0.0 0.3 0.1 0.7 0.2 0.0 0.6 1.2 0.4 0.4 0.7 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.6 0.3 0.4 0.2 0.2 0.4 0.5 0.6 0.5 0.1 1.3 0.5 0.1 0.2 0.4 0.4 0.3 0.1 0.8 1.0 0.7 0.1 1.2 0.5 0.5 0.6 0.3 0.4 0.2 0.3 0.1 0.1 0.3 0.9 0.4 0.1 0.3 0.0 0.5 0.4 0.5 0.8 0.3 0.2 0.7 0.2 0.4 0.6 0.3 0.2 0.3 0.4 0.3 0.4 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR8G5 "OR8G5P, OR8G6" ENSG00000255298 "Olfactory receptor family 8 subfamily G member 5" Q8NG78 11 124256376-124266218 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.2;lung: 4.0;testis: 7.8" "Group enriched" "Detected in some" 23 "Early spermatids: 12.8;Late spermatids: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 5.1;PC-3: 3.2;T-47d: 5.4" NA NA "unprognostic (1.48e-1)" 5.2 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.1 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 17.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 OR8H1 ENSG00000181693 "Olfactory receptor family 8 subfamily H member 1" Q8NGG4 11 56288462-56292254 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.2;NTERA-2: 1.0" NA NA 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.6 0.1 0.9 0.8 2.6 0.7 1.2 1.5 0.2 1.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.7 0.4 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.5 0.0 0.5 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.4 0.0 0.0 0.2 0.0 0.6 1.0 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.3 0.6 0.0 0.0 0.2 0.8 0.2 0.2 0.0 0.1 0.3 0.0 0.2 0.7 0.4 0.0 0.4 0.1 0.0 1.7 0.7 0.6 1.5 0.4 0.7 0.6 1.1 0.7 0.4 0.9 1.0 1.0 2.6 1.2 0.7 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8I2 ENSG00000172154 "Olfactory receptor family 8 subfamily I member 2" Q8N0Y5 11 56093277-56094286 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8J1 ENSG00000172487 "Olfactory receptor family 8 subfamily J member 1" Q8NGP2 11 56354291-56361511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K1 ENSG00000150261 "Olfactory receptor family 8 subfamily K member 1" Q8NGG5 11 56345945-56347031 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055233 Uncertain NA NA "HPA055233: AB_2682749" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A4 ENSG00000258083 "Olfactory receptor family 9 subfamily A member 4" Q8NGU2 7 141916399-141920625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;epididymis: 1.0;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-937: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.77e-1)" 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.1 0.2 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9K2 ENSG00000170605 "Olfactory receptor family 9 subfamily K member 2" Q8NGE7 12 55126406-55132750 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA015808 Uncertain NA NA "HPA015808: AB_2669306" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q1 ENSG00000186509 "Olfactory receptor family 9 subfamily Q member 1" Q8NGQ5 11 58023881-58181616 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "skeletal muscle: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.65e-3)" "unprognostic (2.27e-1)" 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.4 0.3 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.2 0.5 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria NA NA Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favorable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 6.6 17.0 8.6 6.5 12.1 2.6 11.1 12.9 10.9 7.3 5.6 14.8 2.9 5.0 11.8 9.1 7.0 8.1 4.8 13.0 8.4 7.3 13.0 11.6 5.8 11.2 18.9 9.3 13.8 6.1 7.5 9.8 6.1 11.6 6.9 6.1 9.0 9.7 6.1 16.6 9.2 6.5 8.1 13.4 9.6 5.8 9.4 15.4 10.6 8.2 7.3 9.2 8.0 5.8 9.3 6.0 2.1 2.6 6.6 11.5 3.0 5.6 3.1 13.9 10.6 11.0 6.1 8.3 8.8 6.2 12.5 13.5 3.7 5.9 3.8 9.9 3.7 7.0 8.3 12.4 10.4 14.3 9.7 9.5 12.3 7.7 4.8 5.8 6.9 6.4 6.7 8.9 9.4 4.7 8.6 9.3 9.7 4.4 6.0 8.2 3.2 5.4 8.0 6.7 7.7 14.5 5.9 11.2 6.5 8.1 3.2 8.5 9.4 5.9 10.8 19.2 18.1 8.4 7.6 3.9 8.2 7.2 11.9 5.4 6.1 5.1 6.1 10.8 8.9 8.9 0.2 2.6 2.1 7.3 2.4 10.5 7.4 7.7 8.4 3.5 9.3 11.5 10.2 0.4 6.6 2.1 6.0 5.9 3.0 8.6 12.1 12.9 10.9 8.4 7.3 18.9 9.3 11.6 15.4 6.0 2.2 1.3 2.3 1.6 8.0 8.1 2.5 8.1 1.2 0.0 11.8 8.6 6.6 2.4 0.6 2.3 0.9 0.0 2.0 6.1 3.8 1.2 3.5 3.0 3.8 9.5 0.0 4.3 1.0 0.0 10.3 2.3 1.7 0.0 1.1 12.4 1.5 0.0 7.8 8.4 10.0 25.8 3.1 10.7 12.6 1.8 1.8 5.0 2.3 0.5 OSGIN2 "C8orf1, hT41" ENSG00000164823 "Oxidative stress induced growth inhibitor family member 2" Q9Y236 8 89901859-89927888 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 59.6;Early spermatids: 185.9;Late spermatids: 163.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Lineage enriched" "Detected in all" 6 "granulocytes: 17.0" "Cell line enhanced" "Detected in all" "SK-BR-3: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028515, HPA050595" Approved Approved Nucleoli NA NA Nucleoli "HPA028515: AB_10602014, HPA050595: AB_2681186" "unprognostic (3.29e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (4.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.26e-2)" "prognostic unfavorable (3.91e-6)" "prognostic unfavorable (2.93e-4)" "unprognostic (2.32e-1)" "unprognostic (2.22e-3)" "unprognostic (4.38e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-1)" "unprognostic (1.09e-1)" "unprognostic (7.25e-2)" 15.2 7.5 12.5 7.8 13.9 40.4 16.8 9.6 17.5 7.6 13.3 26.4 6.0 6.8 26.1 6.1 11.7 8.1 14.2 11.2 14.2 13.4 14.7 16.2 15.7 9.1 13.7 13.0 15.9 7.8 53.5 25.2 6.5 18.2 9.1 8.6 8.3 8.6 7.3 13.2 7.6 8.7 17.1 25.3 9.0 7.5 20.5 14.7 7.1 12.9 8.0 8.9 11.1 8.5 3.0 1.5 17.0 1.4 2.0 2.5 1.3 12.2 12.0 3.0 6.1 6.7 4.9 4.0 8.8 16.9 8.1 7.9 5.6 11.7 8.4 18.0 4.5 10.1 4.5 5.7 6.9 12.7 12.1 4.6 12.8 4.7 3.0 11.4 6.4 8.0 5.7 9.1 9.4 7.8 7.0 9.9 11.1 7.4 15.0 5.8 9.5 11.1 4.3 1.5 12.3 6.4 4.9 4.5 7.2 12.2 9.5 2.8 7.1 6.5 57.5 10.6 5.4 11.7 9.6 6.7 8.9 8.2 7.3 8.0 13.9 11.9 9.2 14.8 7.9 6.2 17.0 1.4 5.8 1.7 0.9 2.4 3.0 2.5 1.5 1.5 1.8 2.1 2.3 10.3 2.0 1.1 1.1 2.5 1.3 12.5 13.9 9.6 17.5 14.2 13.4 13.7 13.0 18.2 14.7 59.6 15.0 11.9 5.9 5.4 7.8 11.6 20.4 10.7 13.6 7.0 2.0 6.5 8.3 12.6 185.9 5.6 2.6 0.0 13.9 6.9 9.4 6.7 16.2 15.8 14.2 3.2 9.2 15.4 18.3 163.7 11.5 10.8 6.8 7.2 4.6 23.0 11.2 3.5 11.7 11.9 5.2 12.9 6.2 12.2 5.9 3.8 1.4 5.3 5.2 5.2 OSR1 ODD ENSG00000143867 "Odd-skipped related transciption factor 1" Q8TAX0 2 19351485-19358653 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 68.3;urinary bladder: 62.1" "Cell type enhanced" "Detected in some" 29 "Fibroblasts: 21.5;Leydig cells: 123.7;Peritubular cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "U-2197: 48.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015525 Uncertain NA NA "HPA015525: AB_1854822" "unprognostic (1.71e-3)" "unprognostic (1.23e-1)" "unprognostic (6.85e-4)" "unprognostic (1.42e-1)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (8.47e-4)" "unprognostic (2.79e-1)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "unprognostic (3.56e-2)" "unprognostic (1.03e-1)" "unprognostic (2.21e-3)" "unprognostic (1.89e-1)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (1.62e-1)" 16.9 1.3 0.2 5.0 0.5 0.1 40.0 0.7 1.0 12.6 11.7 0.3 2.0 1.3 9.2 5.6 18.5 4.0 5.7 21.3 0.6 0.2 0.9 0.3 7.9 2.6 0.2 0.8 5.2 2.6 0.2 1.2 3.7 1.5 45.5 1.9 1.6 28.4 3.6 5.9 5.1 5.2 68.3 0.5 0.1 5.1 5.7 0.0 0.1 6.0 7.2 5.0 62.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.2 1.5 4.5 0.0 2.7 1.3 2.6 1.3 0.0 0.0 0.0 0.0 3.9 1.2 0.0 1.4 0.6 0.6 0.0 0.1 0.0 0.0 1.5 1.9 0.0 0.1 2.2 0.0 2.4 3.2 1.9 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.6 2.3 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 48.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.7 1.0 0.6 0.2 0.2 0.8 1.5 0.0 0.0 0.3 0.0 0.8 4.1 0.0 3.9 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 21.5 0.4 1.1 0.0 0.8 0.0 0.0 0.0 0.0 1.1 123.7 0.0 3.3 0.0 0.0 0.0 0.4 0.0 43.2 2.4 0.0 0.0 3.8 0.3 0.0 3.6 0.3 0.0 0.0 1.1 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OTOP1 ENSG00000163982 "Otopetrin 1" Q7RTM1 4 4188803-4226889 "Predicted membrane proteins, Transporters" "Biomineralization, Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.1;skin 1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035599 Uncertain NA NA "HPA035599: AB_10600924" "unprognostic (1.83e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOP2 ENSG00000183034 "Otopetrin 2" Q7RTS6 17 74924275-74933912 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 20.4;testis: 5.1" "Cell type enriched" "Detected in some" 48 "Paneth cells: 508.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 47 "HDLM-2: 15.2" "Region enriched" "Detected in single" 13 "olfactory region: 15.6" "Low region specificity" "Detected in all" "HPA024524, HPA053090" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024524: AB_2671592, HPA053090: AB_2682041" "unprognostic (1.62e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (3.21e-2)" "unprognostic (3.62e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.81e-1)" "unprognostic (9.04e-2)" "unprognostic (2.04e-2)" 0.1 0.0 0.1 2.9 0.1 0.0 0.1 0.1 0.1 0.1 20.4 0.1 0.1 0.2 0.5 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.9 0.1 0.1 0.1 0.1 0.2 11.3 0.2 0.1 0.1 0.0 5.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 508.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 OTOS OTOSP ENSG00000178602 Otospiralin Q8NHW6 2 240139026-240144562 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "pituitary gland: 39.1;thyroid gland: 41.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 6.5;thyroid cancer: 28.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.8" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (8.52e-2)" "unprognostic (1.73e-1)" "unprognostic (9.01e-3)" "unprognostic (1.35e-1)" "unprognostic (2.72e-1)" "unprognostic (3.27e-3)" 0.3 0.3 4.5 0.3 4.6 0.3 0.4 0.3 3.8 0.5 0.3 0.7 0.0 0.3 0.4 0.7 0.3 0.4 0.3 0.3 2.4 1.1 0.3 0.3 0.3 0.3 0.6 2.0 0.3 0.3 0.3 39.1 0.3 5.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.4 0.8 0.0 41.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 0.7 0.0 0.5 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.6 0.3 3.8 2.4 1.1 0.6 2.0 5.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVCH1 OVCH ENSG00000187950 "Ovochymase 1" Q7RTY7 12 29412474-29497686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 9.5;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 2.4;Late spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "Daudi: 11.0" "Low region specificity" "Detected in many" "Secreted in female reproductive system" NA NA "unprognostic (3.32e-1)" "unprognostic (2.20e-1)" "unprognostic (2.03e-1)" "unprognostic (1.56e-5)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.36e-1)" "unprognostic (5.48e-2)" "unprognostic (5.59e-3)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" 0.6 0.4 0.0 0.4 0.3 0.1 0.5 0.0 0.1 0.4 0.2 0.0 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.2 0.3 9.5 0.2 0.1 0.3 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.3 0.5 0.1 0.0 0.2 1.9 0.2 4.6 2.1 0.0 0.1 0.2 0.5 0.2 1.3 0.5 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.3 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.8 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.5 0.0 0.6 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414314-111427777 "Plasma proteins, Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 240.9" "Cell type enhanced" "Detected in many" 11 "Syncytiotrophoblasts: 14.5" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 7.2;OE19: 9.2;SK-BR-3: 7.4" "Region enhanced" "Detected in some" "cerebellum: 6.6" "Not detected" "Not detected" "HPA031666, HPA062205" Enhanced Approved Vesicles,Microtubules "Intracellular and membrane" NA NA "Vesicles, Microtubules" "HPA031666: , HPA062205: AB_2684710" "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favorable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favorable (3.93e-5)" 0.4 0.1 0.4 0.4 0.9 0.2 0.4 1.9 1.0 0.7 0.4 0.4 0.4 0.2 9.7 7.1 0.4 240.9 0.4 0.4 0.5 0.5 0.5 1.0 0.4 0.4 0.4 0.4 32.5 0.4 1.5 0.4 0.4 0.4 0.7 0.3 0.4 0.4 0.4 0.4 1.1 0.6 0.4 0.4 0.5 0.2 1.3 0.4 0.6 0.4 0.4 0.4 0.5 0.4 0.8 0.9 0.0 0.5 0.0 1.6 0.2 0.7 0.5 1.4 0.7 2.8 3.1 2.5 0.3 2.0 0.5 1.1 0.8 0.0 1.2 2.6 0.9 0.0 0.8 0.4 0.4 0.8 2.9 7.2 0.4 1.0 3.4 1.0 1.2 3.3 2.8 4.4 0.1 1.6 2.1 0.6 4.9 0.4 2.3 0.2 0.8 0.9 1.7 0.3 9.2 2.6 0.9 0.3 1.0 2.1 5.3 0.9 0.9 0.2 7.4 1.0 3.8 0.5 1.2 1.2 0.3 0.3 3.7 1.0 2.8 0.8 0.6 0.3 2.3 0.3 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.5 0.0 0.9 0.8 1.6 1.2 0.0 0.0 0.5 0.0 0.1 0.2 0.4 0.9 1.9 1.0 0.5 0.5 0.4 0.4 0.4 0.4 0.0 1.4 0.0 1.0 2.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 5.0 1.7 0.3 2.4 1.5 0.7 0.0 0.0 2.1 0.6 1.2 0.0 3.0 0.5 0.0 0.0 1.3 0.3 4.9 1.4 0.3 0.0 0.0 0.9 0.3 0.1 0.0 1.8 1.7 0.7 0.0 0.9 4.1 0.7 2.8 14.5 0.0 1.7 1.4 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell type enhanced" "Detected in many" 16 "Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.8 16.9 0.1 0.0 0.0 13.4 0.1 3.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.5 0.0 33.3 23.7 0.0 0.4 10.2 8.1 2.3 3.5 0.0 20.8 0.0 2.2 61.4 0.4 47.4 0.0 3.4 12.0 1.1 21.2 2.3 0.0 1.8 0.0 30.3 0.0 0.0 65.1 1.1 1.3 0.0 0.0 49.6 0.0 3.6 38.6 1.8 4.2 0.0 0.0 0.4 13.7 5.4 50.2 291.8 0.0 42.1 75.8 OXCT2 "FKSG25, FLJ00030, SCOT-T" ENSG00000198754 "3-oxoacid CoA-transferase 2" Q9BYC2 1 39769523-39771348 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 31.8" "Group enriched" "Detected in some" 89 "Early spermatids: 428.2;Late spermatids: 642.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 3.3;naive B-cell: 1.9;NK-cell: 1.4" "Group enriched" "Detected in many" 9 "B-cells: 3.3;NK-cells: 1.4" "Cell line enhanced" "Detected in many" "Karpas-707: 9.9;THP-1: 10.6;U-266/70: 8.2" HPA075423 Enhanced NA NA "HPA075423: AB_2732292" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (6.50e-2)" "unprognostic (7.16e-2)" "unprognostic (9.68e-2)" "unprognostic (1.13e-1)" "unprognostic (1.32e-1)" "unprognostic (1.93e-3)" "unprognostic (2.74e-1)" "unprognostic (3.16e-1)" "unprognostic (2.57e-3)" "unprognostic (4.18e-2)" "unprognostic (5.39e-5)" "unprognostic (3.24e-1)" "unprognostic (4.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.85e-1)" 0.0 0.6 0.2 0.2 0.2 0.1 0.0 0.8 0.5 0.3 0.3 0.4 0.5 0.7 0.4 0.2 0.5 3.9 0.4 0.1 0.0 0.1 0.0 0.3 0.3 1.5 0.4 0.2 0.3 0.0 0.8 0.2 0.0 1.2 0.0 1.4 0.5 0.4 0.4 0.3 0.2 31.8 1.6 0.0 0.1 0.0 3.3 0.0 0.0 0.2 1.4 0.0 0.1 0.5 0.3 0.0 1.2 0.4 1.5 0.0 1.5 0.0 1.4 0.7 5.0 0.6 0.0 1.0 2.0 0.2 0.5 1.5 0.1 0.7 0.0 3.3 0.9 3.3 0.2 2.4 0.0 0.5 0.7 0.4 0.2 0.1 0.0 1.1 0.4 0.3 9.9 0.2 1.4 0.0 1.5 0.1 0.0 1.3 1.3 1.6 1.5 0.4 1.0 1.7 0.9 4.3 0.3 1.5 0.1 0.5 10.6 1.2 0.0 0.3 4.8 0.0 8.2 4.3 0.6 0.1 0.6 2.4 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.1 0.8 0.2 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 428.2 0.5 0.5 0.0 0.6 0.1 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 642.7 3.7 0.8 1.7 1.0 0.6 0.3 0.6 0.0 6.0 0.0 0.0 0.0 5.6 2.7 2.2 0.4 0.0 0.0 0.3 0.1 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell type enriched" "Detected in some" 11 "Extravillous trophoblasts: 35.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Cell line enhanced" "Detected in some" "RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.2 0.0 3.6 0.0 0.2 1.7 0.0 0.0 0.0 4.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 35.1 0.1 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.8 0.0 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 29.7" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA056878: AB_2683265, HPA057019: AB_2683310" "unprognostic (1.08e-1)" "prognostic favorable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 13.7 12.2 11.0 10.1 11.5 16.0 8.4 6.0 15.1 6.4 12.4 7.0 16.0 14.0 6.5 11.8 10.3 8.7 9.2 11.4 10.2 8.5 9.2 11.9 7.7 9.9 9.6 6.5 4.2 19.6 2.7 4.6 8.2 8.0 8.2 1.9 9.4 27.7 10.8 17.3 12.9 10.3 4.7 7.1 15.1 11.2 18.5 7.1 11.6 10.2 7.2 11.4 7.8 5.6 22.8 23.7 13.3 18.5 25.1 27.9 18.7 8.0 29.7 0.3 7.0 1.9 0.5 5.2 3.2 0.1 0.1 1.1 7.9 7.9 2.4 6.5 0.0 4.3 7.1 0.0 4.6 0.0 4.0 14.6 2.3 13.7 19.2 12.7 1.5 6.1 3.1 3.9 1.7 1.8 0.4 2.9 11.4 3.8 4.2 0.6 19.5 5.8 6.1 3.9 4.1 12.8 4.9 0.2 10.4 1.5 4.4 1.5 6.5 1.6 10.6 14.7 0.1 16.0 9.2 2.1 6.0 4.2 6.6 4.6 10.6 3.7 3.3 8.3 6.2 6.2 12.9 18.5 13.3 19.1 15.1 20.0 19.7 25.9 22.2 17.2 22.8 27.9 21.5 13.1 25.1 15.6 23.7 21.8 18.7 11.0 11.5 6.0 15.1 10.2 8.5 9.6 6.5 8.0 7.1 29.8 17.9 22.7 17.7 7.6 18.5 15.6 35.7 26.8 6.8 22.7 5.9 32.3 61.3 31.9 57.7 14.5 42.4 23.3 41.5 25.7 13.5 32.7 13.9 43.3 38.3 22.3 20.8 20.9 33.7 24.3 30.8 16.8 15.1 37.9 30.8 30.3 38.4 28.8 22.3 52.3 25.8 25.8 12.5 76.4 20.2 7.4 23.3 23.8 30.0 22.2 OXTR ENSG00000180914 "Oxytocin receptor" P30559 3 8750408-8769628 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 42.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-1)" "unprognostic (7.94e-2)" "unprognostic (4.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (2.02e-1)" "unprognostic (1.46e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (3.42e-1)" "unprognostic (2.76e-1)" "unprognostic (3.80e-2)" "unprognostic (4.24e-4)" "unprognostic (8.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-1)" 0.5 0.4 1.8 0.3 6.5 0.6 42.5 0.9 2.2 0.5 0.3 0.1 0.0 0.3 2.8 0.5 1.1 2.7 1.0 0.6 1.8 4.0 0.6 0.4 1.0 0.4 8.6 0.8 2.8 0.3 0.3 0.3 1.3 3.7 0.9 0.3 1.6 0.4 0.9 0.3 0.4 0.4 0.6 2.5 0.5 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.4 0.0 0.0 0.2 1.6 0.1 0.1 0.3 1.0 0.2 0.8 0.4 0.1 0.1 0.2 0.1 81.2 24.9 23.6 12.6 0.1 2.1 0.0 0.1 81.3 0.3 0.1 0.3 0.1 18.4 0.7 0.4 0.2 0.3 0.1 0.4 0.1 0.2 0.1 0.1 0.3 0.1 7.1 0.0 0.2 0.0 0.1 13.1 0.0 0.1 0.6 0.5 0.2 3.6 0.1 0.3 4.8 0.9 0.0 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.1 0.1 1.1 0.3 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.2 0.5 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.3 1.6 0.1 0.0 0.1 0.1 1.0 1.8 6.5 0.9 2.2 1.8 4.0 8.6 0.8 3.7 1.2 8.9 1.4 0.0 0.4 0.3 0.2 1.2 0.0 93.7 11.4 0.0 0.0 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 5.8 1.0 0.0 0.4 0.0 0.0 0.0 0.5 0.7 1.3 0.1 0.0 0.0 0.0 0.1 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696404 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4" "Cell type enriched" "Detected in some" 7 "B-cells: 69.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 18 "memory B-cell: 28.1;naive B-cell: 30.4" "Lineage enriched" "Detected in many" 19 "B-cells: 30.4" "Cell line enhanced" "Detected in many" "Daudi: 24.5;Karpas-707: 15.9;RPMI-8226: 27.6;U-698: 22.8" "HPA021948, HPA067827" Supported Supported Cytosol NA NA Cytosol "HPA021948: AB_1854878, HPA067827: AB_2685908" "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.6 0.3 2.2 32.0 4.9 4.8 0.5 4.1 5.1 0.3 1.4 0.0 0.4 0.9 0.2 0.2 2.4 0.2 0.8 4.9 1.8 3.0 0.8 0.4 1.0 39.1 1.5 2.1 0.2 0.8 0.1 1.2 0.2 1.7 0.5 1.2 0.0 5.4 0.1 11.4 0.2 12.0 0.4 0.6 29.6 1.8 0.6 0.2 9.3 0.5 1.9 27.6 2.2 0.3 30.4 0.1 0.7 0.0 0.0 1.6 1.6 3.9 3.2 0.0 0.0 0.1 0.6 0.0 4.1 1.9 0.4 1.3 2.4 4.8 24.5 2.5 1.9 1.3 2.1 8.8 0.0 0.8 0.4 1.5 1.2 8.7 2.9 0.6 1.6 2.1 1.0 0.9 0.1 5.7 3.2 0.0 5.8 0.2 15.9 8.9 0.0 11.0 3.7 2.4 1.9 9.9 0.5 0.0 27.6 0.1 3.0 2.0 0.0 3.4 1.1 1.8 0.0 1.0 1.5 0.0 0.0 2.3 0.1 0.7 5.6 11.9 22.8 0.0 2.4 0.2 0.0 0.0 0.7 1.1 0.0 1.6 28.1 1.0 0.8 0.1 30.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.6 2.2 4.9 4.1 5.1 1.8 3.0 1.5 2.1 1.7 0.2 0.0 1.1 69.3 0.1 0.3 0.4 2.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 0.4 0.2 0.0 0.0 0.6 1.2 2.2 1.4 0.6 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.7 0.0 0.0 9.6 0.0 0.0 P2RY10 P2Y10 ENSG00000078589 "P2Y receptor family member 10" O00398 X 78945332-78961954 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.6;lymphoid tissue: 47.0" "Group enriched" "Detected in some" 5 "B-cells: 33.8;granulocytes: 29.9;monocytes: 54.1;T-cells: 38.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 51.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 53.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036757, HPA065766" Enhanced NA NA "HPA036757: AB_10696786, HPA065766: AB_2685556" "unprognostic (3.02e-3)" "unprognostic (1.47e-3)" "unprognostic (1.50e-6)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.13e-4)" "unprognostic (3.33e-2)" "unprognostic (8.30e-2)" "unprognostic (1.13e-2)" "unprognostic (4.13e-3)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (2.23e-1)" "unprognostic (6.54e-2)" "unprognostic (3.85e-2)" "unprognostic (3.99e-2)" 1.9 0.5 0.4 19.1 0.5 5.7 1.0 0.4 0.4 1.4 3.8 0.0 0.1 1.7 1.0 0.5 2.6 0.8 2.2 0.8 0.5 0.5 1.4 1.0 6.2 47.0 0.5 0.0 1.1 0.5 0.0 0.6 0.1 0.1 0.9 2.5 0.8 3.9 0.3 0.5 0.8 11.0 0.4 0.7 31.2 2.3 0.5 0.0 23.3 1.5 1.8 30.0 9.9 1.3 19.3 0.9 51.6 2.3 4.0 9.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.6 0.0 0.1 0.0 51.6 0.0 36.8 3.2 0.2 2.9 17.8 7.3 6.4 0.9 19.3 6.8 5.0 6.8 4.0 2.3 0.7 9.7 3.2 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.1 0.0 0.0 1.7 33.8 0.0 1.5 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 29.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 8.5 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 38.8 0.0 0.1 P2RY11 P2Y11 ENSG00000244165 "Purinergic receptor P2Y11" Q96G91 19 10111538-10115372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Hofbauer cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 6.8;MAIT T-cell: 16.4;memory CD8 T-cell: 6.9;naive CD8 T-cell: 5.4;NK-cell: 10.7" "Group enriched" "Detected in all" 6 "NK-cells: 10.7;T-cells: 16.4" "Cell line enhanced" "Detected in many" "HEK 293: 20.5;NB-4: 21.3" HPA014232 Approved NA NA "HPA014232: AB_1854883" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (2.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (2.34e-1)" "unprognostic (5.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-1)" "unprognostic (2.04e-3)" "unprognostic (2.22e-2)" "unprognostic (4.32e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.77e-4)" 9.0 3.6 4.8 21.7 6.7 8.5 4.9 5.5 6.5 3.1 9.4 6.0 3.4 7.8 3.2 3.2 4.4 5.3 3.5 3.8 5.1 4.6 2.9 4.9 13.6 11.1 3.2 2.3 4.3 6.3 1.5 4.2 3.4 4.0 5.0 1.8 5.0 7.6 2.5 6.6 9.0 9.2 2.8 4.9 13.4 5.1 4.9 2.5 7.5 5.2 2.6 22.8 2.9 3.1 1.5 1.2 2.1 2.1 10.7 16.4 4.3 3.6 3.4 1.2 3.9 1.6 1.3 6.7 1.5 0.6 0.7 1.2 4.0 1.8 6.4 2.3 0.3 0.6 5.3 1.0 3.0 0.1 3.1 20.5 5.7 5.1 2.4 2.3 3.0 9.6 2.2 2.5 1.2 1.7 1.4 0.4 4.1 2.8 8.5 0.7 5.3 4.5 21.3 7.6 3.1 4.2 6.8 2.4 3.7 1.2 4.6 4.7 7.8 1.0 2.7 8.4 0.5 2.1 8.5 1.4 4.3 2.1 7.7 2.8 17.3 12.4 2.3 3.1 12.7 3.8 2.1 1.9 0.3 6.8 2.1 16.4 1.5 1.5 6.9 1.2 1.0 1.2 5.4 0.4 10.7 1.4 0.7 1.8 4.3 4.8 6.7 5.5 5.2 5.1 4.6 3.2 2.3 4.0 2.5 6.0 3.0 0.0 2.5 4.2 7.7 1.4 5.1 2.7 2.3 1.8 2.0 1.4 1.7 1.3 0.2 2.1 1.3 23.3 1.0 1.0 1.2 1.6 3.5 3.0 39.3 6.4 3.5 2.5 1.3 0.0 3.1 6.7 1.7 0.0 4.6 1.6 1.1 1.5 1.1 1.0 5.3 0.0 1.7 1.7 3.6 3.4 1.1 12.7 3.4 1.1 P2RY13 "FKSG77, GPR86, GPR94, P2Y13" ENSG00000181631 "Purinergic receptor P2Y13" Q9BPV8 3 151326312-151329548 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 88.4;lymphoid tissue: 44.1" "Group enriched" "Detected in some" 6 "Kupffer cells: 83.1;Macrophages: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 88.4" "Group enriched" "Detected in many" 6 "granulocytes: 88.4;monocytes: 26.1" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;U-937: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049047 Enhanced NA NA "HPA049047: AB_2680611" "unprognostic (1.09e-3)" "unprognostic (7.51e-4)" "unprognostic (1.68e-2)" "unprognostic (2.37e-3)" "unprognostic (3.95e-2)" "unprognostic (8.66e-3)" "unprognostic (7.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.84e-3)" "unprognostic (1.83e-1)" "unprognostic (4.97e-2)" "unprognostic (1.17e-1)" "unprognostic (4.05e-1)" "unprognostic (4.46e-1)" "unprognostic (5.95e-2)" "unprognostic (2.21e-3)" "unprognostic (3.78e-1)" 4.0 2.6 5.1 13.4 6.1 15.1 2.7 1.7 8.2 1.7 2.8 13.8 0.1 3.0 1.5 2.2 2.1 2.1 2.5 1.7 4.9 4.7 1.8 5.1 5.0 35.1 7.1 3.4 1.3 2.1 1.0 1.7 3.2 8.1 2.1 4.2 2.0 1.9 2.1 1.3 1.6 7.4 3.5 8.2 44.1 1.8 1.2 5.1 2.0 1.5 1.1 5.5 3.8 1.5 0.2 10.1 88.4 26.1 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.2 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 23.6 20.3 0.0 23.5 0.0 0.2 0.0 0.0 10.1 0.0 0.0 0.0 88.4 0.0 26.1 0.1 0.0 10.2 5.1 6.1 1.7 8.2 4.9 4.7 7.1 3.4 8.1 5.1 0.0 9.6 3.2 0.1 0.0 0.8 0.4 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 6.6 1.6 0.0 0.6 83.1 0.0 0.0 40.1 0.0 6.4 0.0 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 P2RY14 "GPR105, KIAA0001" ENSG00000174944 "Purinergic receptor P2Y14" Q15391 3 151212117-151278467 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 54.9" "Group enriched" "Detected in some" 4 "granulocytes: 45.0;Macrophages: 18.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 54.9;plasmacytoid DC: 24.4" "Group enriched" "Detected in many" 8 "dendritic cells: 24.4;granulocytes: 54.9" "Cell line enriched" "Detected in single" 73 "HMC-1: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022646 Uncertain NA NA "CAB022646: " "unprognostic (9.78e-2)" "unprognostic (7.47e-4)" "unprognostic (3.89e-2)" "unprognostic (4.52e-4)" "unprognostic (1.69e-2)" "unprognostic (2.57e-5)" "unprognostic (2.68e-2)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (1.64e-3)" "unprognostic (6.30e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.72e-5)" "unprognostic (3.79e-2)" "unprognostic (6.89e-2)" "unprognostic (1.58e-1)" "unprognostic (2.58e-2)" 14.3 0.9 3.9 9.0 6.9 0.5 6.1 1.9 3.8 5.2 17.6 1.3 1.3 5.7 7.2 9.4 17.6 1.2 4.4 4.4 4.3 3.0 2.1 0.7 8.5 7.1 5.0 2.8 1.8 0.9 2.2 4.7 25.9 3.7 10.4 8.3 11.2 2.1 1.1 4.2 2.8 16.3 15.8 2.3 4.4 17.2 2.1 4.2 4.7 3.6 8.9 5.3 21.4 1.7 4.9 24.4 54.9 0.1 2.8 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.1 54.9 0.2 0.0 5.0 0.8 0.1 0.5 3.3 4.9 0.0 0.0 2.2 2.8 0.0 24.4 0.2 0.5 3.9 6.9 1.9 3.8 4.3 3.0 5.0 2.8 3.7 4.2 3.0 0.3 6.7 0.0 2.1 1.7 1.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 2.8 0.0 45.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 18.5 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 25.8 2.7 0.0 0.1 1.5 0.2 2.9 0.0 0.1 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218298-73236352 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.1;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 14.0;Enterocytes: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 28.1" "Group enriched" "Detected in many" 12 "granulocytes: 28.1;monocytes: 10.4" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.4 2.3 0.9 1.4 1.2 10.8 1.3 0.3 1.1 5.5 3.1 1.1 0.3 2.2 1.3 2.3 20.0 1.2 2.8 11.7 0.6 0.3 0.9 2.6 2.9 1.5 1.2 0.6 1.7 1.7 6.1 1.1 10.3 1.0 1.7 2.4 3.3 4.0 1.6 29.5 3.4 10.8 0.4 0.4 6.6 0.6 0.7 0.6 0.6 20.2 20.6 12.8 2.1 10.9 0.0 1.6 28.1 10.4 0.0 0.0 1.2 3.6 3.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 8.4 2.8 0.0 5.6 0.2 0.0 16.4 0.4 7.7 0.0 0.0 0.3 1.2 0.2 1.5 0.0 15.5 0.0 0.0 3.6 1.2 0.2 0.0 0.7 0.0 0.7 0.0 0.0 12.4 0.0 12.6 0.2 3.3 12.9 0.0 0.0 0.5 1.2 8.8 0.0 0.0 0.2 14.3 0.0 0.1 6.6 36.3 5.3 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.2 3.4 28.1 0.0 10.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 1.2 0.9 1.2 0.3 1.1 0.6 0.3 1.2 0.6 1.0 0.6 3.0 0.3 0.0 6.8 3.3 0.5 5.3 7.6 0.0 4.5 0.0 0.0 14.0 1.7 5.0 5.3 0.5 12.9 0.0 5.6 0.5 0.4 1.1 0.0 4.5 2.3 0.0 0.0 0.0 2.7 6.7 0.0 0.9 0.0 0.0 2.9 5.2 11.6 10.5 0.0 0.3 0.2 0.0 0.2 0.0 0.0 6.4 9.2 0.0 2.3 11.1 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910062-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 17.4;Club cells: 25.0;Collecting duct cells: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066650 Approved "Nuclear bodies,Cytosol" NA Yes Cytosol "Nuclear bodies" "HPA066650: AB_2685698" "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavorable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favorable (8.84e-4)" 4.7 8.1 9.8 29.3 20.4 14.0 16.0 3.4 6.0 8.4 5.7 6.2 20.4 6.9 8.3 26.1 7.6 9.1 13.0 3.7 8.6 4.2 21.7 29.2 14.6 16.3 5.6 9.3 16.9 29.3 7.7 23.7 5.1 7.1 15.2 6.4 7.6 10.2 14.7 0.9 10.3 10.0 6.2 10.9 12.5 10.0 9.2 6.5 20.3 28.1 6.3 12.9 9.0 12.1 3.3 0.4 3.9 0.5 0.3 1.9 0.1 6.6 8.7 11.7 16.9 4.4 9.4 26.8 14.7 3.0 5.7 7.6 23.7 12.2 8.7 24.8 5.8 9.2 15.5 5.2 13.5 4.7 5.2 10.6 7.0 23.8 21.9 10.1 6.0 2.9 9.9 23.8 12.1 21.5 6.5 1.4 13.5 7.8 12.6 6.8 19.0 7.4 14.3 4.6 6.9 15.3 9.6 2.5 4.6 8.0 8.3 7.3 7.3 5.8 18.3 19.9 15.4 35.8 4.8 4.7 25.5 17.2 11.1 7.0 16.6 16.5 4.4 8.2 2.5 8.4 0.1 0.5 0.1 0.9 0.1 1.9 1.4 0.2 0.7 0.2 3.3 0.3 0.5 3.9 0.3 0.2 0.4 0.5 0.1 9.8 20.4 3.4 6.0 8.6 4.2 5.6 9.3 7.1 6.5 6.0 17.4 0.5 2.5 1.6 0.3 1.4 7.6 12.0 25.0 19.2 0.0 4.5 0.0 2.9 0.4 0.7 1.6 0.0 0.4 3.8 2.3 3.2 3.5 5.0 2.5 0.0 4.1 0.6 0.6 0.0 1.7 2.2 0.0 1.8 2.3 2.4 2.2 3.1 1.8 0.8 1.1 0.0 0.9 0.7 2.1 1.5 3.2 4.4 3.1 2.4 PABPC1L2A RBM32A ENSG00000186288 "Poly(A) binding protein cytoplasmic 1 like 2A" Q5JQF8 X 73077276-73079512 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;prostate: 5.2" "Group enriched" "Detected in some" 12 "Early spermatids: 10.8;Late spermatids: 36.2" "Cancer enriched" "Detected in single" 15 "prostate cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 9.1;NTERA-2: 3.3;SK-MEL-30: 1.8" HPA041573 Approved NA NA "HPA041573: AB_2677556" "unprognostic (4.30e-2)" "unprognostic (2.19e-1)" "unprognostic (3.22e-1)" 0.1 3.5 3.3 0.2 5.0 0.0 0.1 7.1 9.6 0.1 0.2 0.4 0.1 1.4 0.0 0.2 0.2 0.0 3.5 9.2 0.2 0.1 0.1 0.0 2.9 0.4 0.1 0.0 1.2 0.0 5.2 0.1 0.8 0.6 0.1 0.1 0.2 0.0 2.4 0.7 0.1 3.2 0.3 0.1 0.2 0.0 0.2 0.1 0.7 0.2 0.8 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 9.1 0.4 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.5 0.1 1.8 0.3 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.7 0.3 0.1 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.8 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 PABPC1L2B RBM32B ENSG00000184388 "Poly(A) binding protein cytoplasmic 1 like 2B" Q5JQF8 X 73003517-73005713 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 12.2;prostate: 6.6" "Cell type enhanced" "Detected in single" 34 "Early spermatids: 1.2" "Cancer enriched" "Detected in single" 23 "prostate cancer: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "HAP1: 2.7;NTERA-2: 5.8;U-2 OS: 1.9" HPA041573 Approved NA NA "HPA041573: AB_2677556" "unprognostic (1.73e-1)" "unprognostic (2.26e-1)" "unprognostic (3.31e-1)" 0.1 1.6 3.3 0.1 4.9 0.1 0.1 6.4 12.2 0.1 0.1 0.4 0.1 0.5 0.1 0.1 0.1 0.1 3.5 10.2 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 1.0 0.1 6.6 0.1 0.8 0.5 0.1 0.1 0.1 0.1 2.1 0.2 0.1 1.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 PABPC4L ENSG00000254535 "Poly(A) binding protein cytoplasmic 4 like" P0CB38 4 134196333-134201748 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Early spermatids: 2.6;Endothelial cells: 2.4;Leydig cells: 5.2;Peritubular cells: 3.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 11.3;HeLa: 15.0;REH: 7.7;RH-30: 8.5;U-2 OS: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.00e-1)" "unprognostic (3.53e-2)" "unprognostic (1.96e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (2.55e-3)" "unprognostic (1.58e-1)" "unprognostic (3.63e-1)" "unprognostic (9.05e-3)" "unprognostic (2.97e-1)" "unprognostic (9.52e-2)" "unprognostic (6.44e-2)" "prognostic favorable (1.11e-5)" "unprognostic (4.41e-3)" "unprognostic (1.82e-1)" "unprognostic (1.22e-1)" "unprognostic (4.14e-3)" 3.8 0.9 0.7 0.5 0.8 0.0 5.4 0.6 0.7 8.8 1.5 0.0 3.5 0.3 10.3 2.6 3.3 2.7 1.4 4.7 0.8 0.8 2.5 0.6 1.1 0.5 0.9 0.4 3.2 1.1 11.0 2.1 13.2 0.6 6.5 0.3 2.7 2.7 5.9 1.7 0.8 1.4 5.0 0.8 0.6 1.3 2.3 0.2 6.0 4.7 1.5 1.1 2.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 3.3 2.3 1.6 1.9 0.0 0.0 0.0 3.6 0.0 0.0 0.3 11.3 0.1 2.4 0.0 2.6 4.3 15.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.6 0.0 2.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 1.4 7.7 8.5 0.0 0.5 0.0 3.4 0.9 0.0 0.7 0.2 3.1 0.0 1.5 0.2 2.9 8.8 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.6 0.7 0.8 0.8 0.9 0.4 0.6 0.2 3.0 0.6 0.0 0.5 0.2 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.3 1.8 0.4 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.9 0.5 0.4 0.1 0.7 0.0 0.0 0.0 PABPC5 PABP5 ENSG00000174740 "Poly(A) binding protein cytoplasmic 5" Q96DU9 X 91434595-91438584 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 20.9" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 10.6;Horizontal cells: 7.9;Leydig cells: 5.5;Peritubular cells: 11.0;Sertoli cells: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.9;HSkMC: 4.1;LHCN-M2: 2.7;RH-30: 11.9;U-2 OS: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000164, HPA000165" Approved NA NA "HPA000164: AB_1079551, HPA000165: AB_1079552" "unprognostic (1.05e-1)" "unprognostic (2.98e-1)" "unprognostic (3.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.37e-1)" "unprognostic (1.56e-2)" "unprognostic (1.23e-1)" "unprognostic (3.52e-1)" "unprognostic (2.89e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "unprognostic (2.46e-1)" "unprognostic (1.26e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.55e-2)" "unprognostic (8.07e-2)" 4.3 14.1 5.3 1.9 4.3 0.4 7.3 2.2 6.2 8.1 4.0 5.7 1.3 1.2 10.3 5.2 2.8 3.9 2.9 3.6 3.7 3.7 2.0 1.0 2.4 1.8 5.1 2.4 20.9 1.3 1.5 11.7 1.8 4.9 5.5 1.9 3.8 1.9 4.3 1.3 1.3 1.9 5.8 5.2 3.4 2.3 3.3 4.9 0.0 4.5 2.1 1.4 4.9 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.3 0.0 0.1 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.3 2.2 5.9 3.7 3.7 5.1 2.4 4.9 4.9 0.0 0.0 0.0 0.3 0.1 10.6 0.6 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.1 7.9 0.0 1.3 0.0 0.4 5.5 0.0 3.3 0.0 0.0 3.2 0.0 0.0 11.0 0.0 2.8 12.9 2.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 PABPN1L ePABP2 ENSG00000205022 "Poly(A) binding protein nuclear 1 like, cytoplasmic" A6NDY0 16 88863333-88866660 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.6;bone marrow: 3.0;brain: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 5.0;NB-4: 3.5;SCLC-21H: 9.6;T-47d: 2.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 3.6" HPA043415 Uncertain NA NA "HPA043415: AB_10981610" "unprognostic (2.19e-1)" "unprognostic (1.50e-2)" "unprognostic (1.40e-3)" "unprognostic (8.96e-3)" "unprognostic (1.57e-1)" "unprognostic (3.19e-1)" 0.5 3.6 0.0 0.2 1.1 3.0 0.1 5.3 0.5 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.2 1.1 0.0 0.1 1.8 0.0 0.3 0.0 0.8 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 5.0 0.6 3.5 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 9.6 0.2 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PANO1 PANO ENSG00000274897 "Proapoptotic nucleolar protein 1" I0J062 11 797511-799190 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.7;pancreas: 5.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.7;Cone photoreceptor cells: 11.8;Early spermatids: 9.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.7;SCLC-21H: 7.5" NA NA "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (9.77e-3)" "unprognostic (2.56e-4)" "unprognostic (1.41e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.34e-1)" "unprognostic (7.81e-2)" "unprognostic (1.84e-2)" "unprognostic (2.32e-5)" "unprognostic (5.96e-2)" "unprognostic (2.02e-5)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (4.64e-1)" "unprognostic (1.33e-1)" 0.2 1.2 0.5 1.9 0.0 1.4 0.0 0.0 0.3 0.2 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.3 5.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.1 0.1 0.0 1.0 0.5 0.9 0.0 0.0 0.0 0.8 0.8 3.7 0.6 2.2 1.3 0.2 1.7 1.6 2.6 4.5 0.6 1.1 9.7 3.0 0.4 0.6 0.3 1.0 2.0 2.2 1.2 1.0 1.1 4.3 0.6 0.2 0.2 4.4 3.5 1.6 1.3 1.0 0.6 1.5 4.7 1.6 0.6 0.3 0.4 0.9 0.2 2.4 0.8 2.3 0.8 1.9 2.2 2.7 3.2 2.0 1.0 2.7 0.8 0.2 1.2 0.5 7.5 3.4 1.1 2.1 1.2 0.7 1.5 0.8 1.2 2.0 1.4 1.0 1.4 2.3 1.3 1.9 1.8 1.7 2.0 2.4 0.5 0.3 0.7 0.5 0.6 0.4 0.6 0.8 0.3 0.8 0.7 1.3 3.7 2.2 0.6 0.8 0.2 0.2 0.0 0.0 0.9 1.5 0.0 5.7 0.2 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.3 9.9 0.1 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.3 7.9 0.0 1.3 0.0 0.5 0.3 0.0 0.0 0.0 0.2 2.9 0.2 0.0 0.4 0.4 1.4 0.0 0.1 0.2 0.7 0.0 0.2 0.0 0.0 0.8 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180294 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 10.2;Hepatocytes: 6.8;Muller glia cells: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 36 "dendritic cells: 1.8;granulocytes: 5.2" "Cell line enhanced" "Detected in many" "EFO-21: 9.1;HDLM-2: 13.9;Hep G2: 16.3;MCF7: 9.0;SCLC-21H: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 1.6 2.6 10.3 2.6 9.2 5.3 1.4 22.4 31.4 1.8 1.1 1.2 10.5 1.1 2.4 2.7 3.8 4.9 2.3 1.1 14.2 8.8 3.4 7.8 2.4 1.2 15.9 7.9 3.5 3.0 1.0 4.1 1.6 23.9 3.8 1.0 1.5 5.5 6.2 1.5 2.6 1.2 1.2 4.5 2.7 1.4 2.6 2.4 0.0 3.8 0.2 1.5 1.8 0.9 0.0 1.8 5.2 0.0 0.0 0.0 0.0 0.8 1.8 0.3 2.0 0.0 0.2 4.3 2.2 2.2 0.5 0.4 0.4 6.9 0.0 9.1 0.2 1.3 0.4 1.1 0.9 0.1 13.9 1.2 0.3 2.9 16.3 0.7 0.1 1.1 0.2 0.9 0.6 0.0 1.0 0.5 0.0 1.1 0.0 0.2 9.0 0.0 0.8 3.4 0.0 3.7 0.8 0.0 3.3 0.0 1.4 8.6 0.8 1.4 0.1 5.2 0.4 0.6 0.6 3.8 0.4 3.7 5.9 4.1 1.6 0.1 0.5 0.2 0.0 6.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.8 0.0 0.0 10.3 9.2 22.4 31.4 14.2 8.8 15.9 7.9 23.9 2.4 0.0 1.4 0.0 2.3 0.5 10.2 0.6 2.5 4.0 4.5 0.0 0.0 0.0 5.0 1.7 0.2 0.0 0.0 0.0 2.4 0.1 0.5 4.0 0.0 6.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 21.1 2.2 0.0 1.1 1.2 3.6 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 2.8 PANX3 Px3 ENSG00000154143 "Pannexin 3" Q96QZ0 11 124611490-124620356 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;MCF7: 2.6;U-266/70: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.80e-2)" "unprognostic (3.10e-1)" 0.1 0.4 0.1 0.1 1.8 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 2.8 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.5 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PAPLN MGC50452 ENSG00000100767 "Papilin, proteoglycan like sulfated glycoprotein" O95428 14 73237497-73274640 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 31.9;Muller glia cells: 21.2;Peritubular cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "neutrophil: 4.4;plasmacytoid DC: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 8.8;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HHSteC: 13.1;HSkMC: 24.7;hTCEpi: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA048682, HPA053453" Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 46000000 Nucleoplasm "HPA048682: AB_2680492, HPA053453: AB_2682155" "unprognostic (1.97e-3)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (3.56e-3)" "unprognostic (7.42e-2)" "unprognostic (7.91e-3)" "unprognostic (2.01e-2)" "unprognostic (2.46e-3)" "unprognostic (9.13e-3)" "unprognostic (3.69e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.89e-2)" "unprognostic (2.14e-2)" "unprognostic (3.05e-3)" "unprognostic (2.69e-2)" "unprognostic (5.58e-2)" 9.3 6.1 13.6 11.8 14.8 2.9 11.0 4.1 11.1 10.8 7.0 6.0 3.8 4.1 14.2 19.5 4.6 12.1 8.0 4.8 15.7 3.0 24.9 1.9 7.8 23.3 4.1 9.7 10.9 2.7 1.0 11.1 5.2 5.7 8.1 6.2 14.9 4.7 10.2 1.8 16.2 10.3 8.6 6.0 17.6 7.4 6.5 8.9 5.1 15.3 2.2 16.5 6.8 5.6 1.1 8.8 4.4 0.8 0.5 0.5 0.2 2.0 2.0 0.8 0.3 1.5 1.9 4.6 0.4 0.0 0.1 0.1 2.6 0.6 0.4 2.1 0.0 0.1 3.3 2.1 1.5 0.2 2.3 3.1 0.9 3.2 0.3 13.1 0.3 1.7 24.7 9.1 0.4 1.4 0.1 0.4 1.9 0.6 0.3 0.0 1.0 0.2 2.2 0.5 0.2 0.6 0.3 0.3 2.1 1.8 0.4 0.2 0.4 4.8 5.5 0.9 6.6 0.1 3.7 0.4 0.6 1.9 0.2 0.2 1.1 0.1 0.2 1.1 1.1 0.5 1.1 0.8 0.6 0.4 0.5 0.2 0.7 0.3 0.5 0.2 1.1 0.5 0.5 4.4 0.5 0.4 8.8 0.5 0.2 13.6 14.8 4.1 11.1 15.7 3.0 4.1 9.7 5.7 8.9 0.0 1.6 0.0 0.5 1.8 1.0 1.3 2.5 1.4 5.7 5.2 7.9 0.5 0.0 3.0 0.3 1.1 0.1 0.0 0.0 0.9 6.1 1.7 0.0 0.0 1.2 0.0 0.0 1.8 0.3 1.4 31.9 0.9 1.7 2.8 0.0 21.2 0.4 0.0 41.4 13.4 3.0 6.5 1.0 0.6 0.1 2.6 0.3 0.0 0.9 0.4 PAPOLB PAPT ENSG00000218823 "Poly(A) polymerase beta" Q9NRJ5 7 4857733-4861994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Group enriched" "Detected in some" 4 "Early spermatids: 67.3;Late spermatids: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" HPA047285 Approved Nucleoplasm NA NA Nucleoplasm "HPA047285: " "unprognostic (7.58e-2)" "unprognostic (1.25e-1)" "unprognostic (1.68e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.3 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.3 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.7 0.0 0.5 16.1 2.3 0.6 0.2 0.0 0.0 0.3 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles NA Yes Vesicles "HPA068394: AB_2685980" "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.01e-6)" "prognostic favorable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.9 11.0 12.5 18.0 2.0 3.7 4.2 4.9 5.9 9.1 8.6 6.6 13.8 12.9 6.7 5.6 6.4 18.2 12.9 7.7 3.8 13.7 5.6 3.9 21.6 8.9 0.2 8.4 14.4 0.9 4.1 4.9 1.3 4.6 5.9 11.0 7.7 35.1 7.7 25.9 12.1 9.0 10.5 19.4 7.5 24.1 16.4 41.6 6.2 4.5 28.6 13.3 18.2 17.6 13.2 1.7 18.9 13.1 3.6 16.0 9.8 7.3 6.9 15.3 10.6 17.2 7.0 11.4 17.5 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 0.0 0.0 2.9 1.4 2.7 14.6 0.8 12.7 10.7 6.8 0.0 55.0 0.7 0.0 4.4 0.5 1.0 2.0 0.0 9.9 7.2 0.8 7.5 2.3 0.0 11.5 6.4 4.1 3.7 9.5 3.0 0.6 4.5 5.0 1.0 5.3 15.7 6.5 2.9 0.0 0.3 145.7 0.0 1.2 1.6 5.2 4.4 0.5 0.0 9.3 0.8 PAQR7 "MPRA, mSR" ENSG00000182749 "Progestin and adipoQ receptor family member 7" Q86WK9 1 25861210-25871253 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 12 "Early spermatids: 346.5;Late spermatids: 1377.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.3;HaCaT: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046936 Approved Approved Cytosol NA NA Cytosol "HPA046936: AB_2679869" "unprognostic (1.12e-1)" "unprognostic (2.08e-2)" "unprognostic (8.03e-2)" "unprognostic (4.54e-3)" "unprognostic (1.32e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.47e-1)" "unprognostic (4.59e-3)" "unprognostic (7.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.05e-5)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.15e-2)" "unprognostic (1.54e-2)" 1.2 9.5 1.8 0.7 2.3 1.0 1.4 1.8 1.8 2.8 1.6 6.7 4.1 10.2 6.1 6.8 2.1 0.6 1.7 2.6 11.9 1.9 1.6 0.6 2.0 13.2 1.8 3.9 2.1 6.9 2.4 0.4 1.5 8.9 0.2 10.7 5.7 2.9 1.4 3.5 2.3 16.2 1.4 1.0 6.3 4.6 3.2 5.5 10.8 11.7 2.4 1.4 0.8 11.7 2.3 2.4 7.8 2.9 6.2 8.4 7.7 6.9 7.8 7.0 3.9 30.3 0.1 5.5 7.6 2.5 24.9 1.3 13.1 4.7 4.6 1.3 10.0 3.3 4.7 4.9 0.1 1.3 6.3 17.5 5.5 4.1 6.9 2.9 1.1 1.0 0.8 5.7 2.7 0.0 0.7 3.7 1.2 4.0 0.8 0.2 1.4 15.8 9.1 1.2 4.7 12.6 16.5 5.7 3.5 4.7 1.8 3.2 1.3 4.0 4.1 2.1 0.1 0.1 0.5 5.9 0.3 2.6 3.1 5.7 10.8 1.1 10.2 1.1 3.2 0.6 0.8 5.5 1.2 1.0 1.4 2.6 2.4 11.7 0.6 0.2 0.8 0.0 1.9 1.9 4.7 16.1 1.9 1.6 17.8 10.7 6.8 73.3 0.0 36.5 18.3 4.9 346.5 4.5 1.3 0.0 12.5 10.0 7.5 1.0 6.9 4.9 9.2 3.2 4.6 10.4 7.3 1377.7 18.4 5.3 20.3 5.4 1.5 2.0 7.0 3.5 14.2 49.2 0.6 12.9 4.0 11.1 9.1 11.4 29.9 0.9 2.9 2.2 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.4;OE19: 41.1;SuSa: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA064625: AB_2685304" "prognostic favorable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favorable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.4 0.4 5.2 2.2 3.1 5.1 3.5 1.5 5.8 1.0 2.1 1.9 1.8 0.5 0.5 1.0 2.3 0.2 0.6 2.5 1.6 6.9 0.8 3.1 0.4 19.4 0.8 0.8 0.4 1.4 0.3 0.6 3.7 3.6 5.5 6.1 0.7 3.1 4.0 0.7 2.0 2.8 2.6 41.1 0.2 5.3 0.8 1.2 6.0 1.4 1.9 4.2 0.4 0.1 5.8 17.5 0.1 6.9 2.3 2.0 0.8 0.5 0.9 0.9 1.2 0.7 1.8 8.0 10.3 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 3.0 8.8 0.0 3.2 1.8 1.6 4.6 15.3 0.0 1.2 3.5 7.9 1.4 0.0 3.2 0.4 3.8 94.7 0.0 1.0 2.6 4.7 6.0 4.6 0.0 7.9 0.0 22.1 3.7 16.7 1.0 5.2 3.9 13.5 5.4 40.0 4.5 3.0 55.1 9.6 0.0 3.0 0.0 1.9 11.4 2.9 0.9 0.7 5.9 24.1 7.8 PARP6 pART17 ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 137.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favorable (3.17e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavorable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 13.7 16.6 28.0 12.8 32.4 25.1 26.5 46.6 41.2 15.5 16.2 16.9 18.2 14.1 23.3 23.8 14.0 17.0 20.2 18.4 26.1 22.4 14.3 9.0 15.7 16.8 19.9 21.8 26.3 20.9 20.6 30.8 17.0 19.4 19.3 14.3 14.5 21.3 18.8 23.9 20.3 14.4 19.6 14.2 18.2 18.2 25.1 15.8 9.6 21.7 12.5 15.8 16.3 15.8 4.1 4.0 12.1 5.3 4.3 4.3 2.9 7.3 13.2 13.9 18.1 15.0 12.5 11.3 6.3 9.5 10.4 15.4 8.7 13.3 10.0 3.9 9.5 15.3 9.6 15.3 8.5 6.0 11.9 13.8 14.6 23.1 0.1 12.5 7.5 14.0 16.0 21.0 9.7 26.8 16.4 6.9 16.8 7.4 11.6 8.3 13.3 6.4 13.2 6.4 6.1 0.0 11.9 9.9 7.9 9.6 14.5 39.4 20.9 10.5 8.6 17.1 19.3 10.9 8.7 6.5 13.1 12.0 17.0 9.5 13.1 12.0 10.9 9.4 14.7 9.0 1.7 5.3 12.1 3.8 4.4 2.7 3.3 2.7 4.0 4.0 4.1 4.3 3.2 5.7 4.3 4.9 3.1 4.2 2.9 28.0 32.4 46.6 41.2 26.1 22.4 19.9 21.8 19.4 15.8 20.8 20.5 4.7 8.4 12.8 14.0 14.6 0.0 2.7 15.9 8.7 19.6 5.9 6.6 7.3 49.1 9.8 9.2 0.0 11.2 4.3 9.3 7.6 15.1 4.2 8.1 17.5 16.7 7.4 12.4 137.7 11.5 8.2 15.1 6.4 5.3 7.4 8.1 5.8 9.2 10.3 15.1 6.5 9.5 39.0 8.3 13.8 5.4 7.5 5.6 8.3 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "T-cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.6 0.0 5.4 8.6 1.5 2.6 8.6 1.9 7.0 1.9 5.5 0.3 15.4 6.9 8.2 0.2 19.8 5.8 0.9 5.8 4.5 9.7 7.4 5.1 4.7 0.4 2.8 11.9 0.1 3.3 4.9 3.8 2.7 11.6 0.1 10.9 0.7 4.2 2.6 3.8 14.2 15.0 5.8 0.2 2.8 7.2 11.4 7.9 3.5 5.8 6.0 9.3 6.2 10.2 1.6 8.3 0.4 42.0 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.4 6.5 3.3 7.9 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 29.8 22.6 12.3 4.8 7.1 13.4 4.5 12.7 21.4 21.6 21.0 0.0 17.5 6.6 11.2 19.7 4.5 6.9 0.0 8.8 5.9 9.1 8.6 13.9 3.6 12.9 6.4 14.5 8.6 28.5 11.4 1.1 17.1 8.5 13.6 3.6 0.5 14.3 7.6 2.8 3.7 2.1 6.5 6.9 5.1 5.5 3.4 20.7 90.6 6.5 13.5 PATE2 "C11orf38, LVLF3112, PATE-M, UNQ3112" ENSG00000196844 "Prostate and testis expressed 2" Q6UY27 11 125776113-125778819 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Early spermatids: 3.8;Late spermatids: 8.2;Spermatocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 4.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (3.28e-1)" "unprognostic (7.26e-2)" "unprognostic (2.95e-1)" "unprognostic (1.18e-2)" "unprognostic (2.63e-1)" "unprognostic (6.84e-3)" "unprognostic (1.55e-2)" "unprognostic (5.08e-1)" "unprognostic (2.55e-1)" 0.1 0.1 0.4 0.0 1.0 0.1 0.1 0.7 0.6 0.1 0.2 0.0 56.1 0.0 0.1 112.4 0.0 0.1 0.0 0.2 0.5 0.9 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 44.9 0.1 0.0 0.0 0.0 0.4 0.0 0.1 4.2 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.5 0.2 1.6 0.6 0.2 1.0 0.0 0.9 0.0 0.2 0.7 0.4 0.0 1.7 0.5 0.2 0.6 0.3 0.4 0.8 0.2 0.7 0.5 0.8 0.4 0.1 0.3 0.8 0.7 0.3 0.8 1.1 0.0 0.0 0.7 1.4 0.0 0.1 0.7 0.5 0.6 0.0 0.3 0.6 1.8 0.1 1.7 0.5 4.5 1.6 0.6 1.6 1.2 0.1 1.9 0.8 0.7 0.5 0.5 2.6 1.6 0.3 0.7 1.4 2.0 2.7 0.9 0.6 0.9 0.6 0.9 0.5 0.8 1.6 0.8 1.5 0.7 0.6 0.6 0.3 0.6 0.2 0.3 0.2 0.1 0.2 0.5 1.0 0.3 1.6 0.2 0.3 0.2 0.3 0.0 0.4 1.0 0.7 0.6 0.5 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.7 0.0 0.0 0.0 0.0 0.0 PATE3 "HEL-127, PATE-DJ" ENSG00000236027 "Prostate and testis expressed 3" B3GLJ2 11 125788111-125791600 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "epididymis: 86.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RPMI-8226: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.3 0.2 0.1 0.1 0.0 8.7 0.0 0.1 86.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 3.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PATE4 "FLJ41047, PATE-B" ENSG00000237353 "Prostate and testis expressed 4" P0C8F1 11 125833316-125840069 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "ductus deferens: 194.5;seminal vesicle: 232.9" "Group enriched" "Detected in some" 108 "Early spermatids: 16.9;Late spermatids: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA045632 Approved "Secreted in male reproductive system" NA NA "HPA045632: AB_10960489" "unprognostic (4.90e-1)" "unprognostic (2.93e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.4 0.2 0.2 0.1 0.0 194.5 0.0 0.1 7.3 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.1 232.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 2.1 0.2 1.6 1.5 1.2 0.6 0.6 0.9 0.1 0.5 0.5 0.8 1.5 0.4 0.5 0.4 0.3 0.2 0.0 0.3 0.6 1.0 1.7 0.5 0.0 1.0 0.9 0.1 0.1 0.4 0.3 0.3 0.6 1.6 0.8 0.1 0.5 3.2 0.7 0.3 0.2 0.6 0.7 0.1 0.5 0.9 2.6 0.2 0.7 0.2 0.9 1.6 0.4 0.8 0.6 0.6 0.6 0.6 1.9 0.4 0.3 0.5 0.1 0.3 0.9 0.9 0.1 1.8 1.3 1.6 2.6 0.8 1.4 0.7 0.8 1.1 0.2 1.3 0.6 0.6 0.3 0.9 0.5 0.6 1.4 0.7 0.4 0.3 1.6 0.9 0.8 1.2 0.6 0.4 1.5 0.2 0.1 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PBOV1 "UC28, UROC28" ENSG00000254440 "Prostate and breast cancer overexpressed 1" Q9GZY1 6 138215986-138218491 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.5;bone marrow: 1.9;brain: 1.9" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 1.0;Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "MCF7: 1.1" HPA063021 Uncertain NA NA "HPA063021: AB_2684923" "unprognostic (3.32e-3)" "unprognostic (8.23e-2)" "unprognostic (9.35e-2)" "unprognostic (1.22e-1)" "unprognostic (4.77e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-4)" 0.0 0.0 0.2 0.0 0.3 1.9 0.2 1.9 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.2 1.1 0.1 0.1 0.0 0.1 0.0 0.8 0.7 0.3 0.0 0.5 0.0 0.5 0.0 0.2 0.5 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.8 0.4 2.5 0.4 1.1 0.4 0.1 0.0 0.5 0.1 0.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.8 0.2 1.1 0.4 0.8 0.4 0.1 0.0 0.3 0.1 0.3 0.0 0.4 0.3 0.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.9 0.1 0.0 0.5 0.1 0.0 2.5 0.4 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.4 0.1 0.1 0.0 0.3 0.0 0.3 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" "HPA030247, HPA073145" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244, HPA073145: " "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.9 14.9 0.0 0.8 0.2 1.6 0.7 0.0 0.0 0.0 0.3 4.0 1.9 0.0 0.8 0.0 0.2 27.2 0.1 0.0 0.0 0.0 7.0 0.0 0.0 20.9 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.1 0.9 0.3 7.7 1.6 0.4 0.0 1.3 0.0 0.0 1.1 0.0 0.0 2.6 23.6 0.5 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 6.1 0.0 0.3 1.5 0.0 12.6 15.1 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 0.0 0.0 1.4 0.1 0.2 151.7 2.8 0.0 0.0 1.2 1.8 47.1 0.0 0.0 0.1 29.4 0.5 0.0 0.0 0.2 0.1 1.3 0.9 0.0 0.0 0.4 109.7 2.9 2.5 0.0 60.8 7.8 0.2 3.3 0.0 0.0 29.6 1.4 0.0 12.0 0.0 75.1 0.0 5.3 25.0 12.0 0.0 0.0 0.0 0.0 0.3 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.5" "Group enriched" "Detected in many" 7 "Bipolar cells: 389.4;Cone photoreceptor cells: 616.5;Rod photoreceptor cells: 516.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 20 "B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 49.4;SK-MEL-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 19.5 16.6 27.2 9.6 21.9 3.0 10.6 86.0 56.3 12.7 16.7 36.2 16.0 15.1 15.4 12.1 14.5 10.4 18.3 36.5 29.2 29.9 21.2 38.9 13.9 17.0 28.9 13.0 16.3 22.0 22.9 15.8 7.8 16.4 20.1 8.6 47.3 20.3 19.6 97.5 13.6 29.0 14.4 44.4 10.9 13.3 10.6 19.7 11.9 17.3 11.0 15.7 13.3 9.6 4.6 0.3 4.6 0.0 0.1 10.2 2.4 10.2 3.5 14.1 20.5 6.4 11.5 2.4 23.6 11.5 14.2 9.2 13.0 3.7 0.3 3.5 18.6 12.6 2.4 13.1 8.2 6.7 16.2 2.1 1.3 11.8 13.5 10.4 1.3 10.0 15.5 15.4 9.0 4.0 17.7 7.1 6.0 0.6 4.6 22.7 4.8 0.5 1.6 6.8 6.5 9.5 7.1 6.8 1.8 5.0 7.3 27.8 49.4 6.4 3.5 41.8 3.9 6.5 5.0 14.1 15.2 28.8 4.8 12.5 3.1 1.9 2.0 17.6 2.9 22.1 4.6 0.0 3.1 10.2 0.0 7.1 4.6 9.6 9.8 0.3 2.3 4.6 3.5 0.0 0.1 0.0 0.1 10.0 2.4 27.2 21.9 86.0 24.2 29.2 29.9 28.9 13.0 16.4 19.7 3.0 2.7 2.2 13.9 7.7 389.4 6.7 2.5 1.4 4.5 8.7 616.5 1.2 14.9 28.1 52.1 11.2 7.3 0.0 20.1 1.1 16.4 16.8 1.1 3.9 1.0 39.7 59.5 12.3 0.3 76.2 20.8 1.1 21.9 1.0 8.6 56.4 34.6 14.0 15.2 7.9 516.1 6.5 15.3 0.9 2.3 10.3 0.5 6.9 4.8 9.7 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 5.0 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 16.1 0.0 0.2 0.0 2.4 0.0 13.4 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 32.0 8.6 0.0 0.0 7.3 0.0 0.0 0.0 0.6 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 0.0 1.1 0.0 0.2 0.1 16.2 2.0 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.0 3.3 1.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 2.3 0.0 4.7 1.8 0.7 0.3 2.4 0.0 0.0 0.4 PCDH11X "PCDH-X, PCDH11, PCDHX, PPP1R119" ENSG00000102290 "Protocadherin 11 X-linked" Q9BZA7 X 91779261-92623230 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.0;ovary: 12.6;parathyroid gland: 5.2" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 16.9;Horizontal cells: 31.8;Syncytiotrophoblasts: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;AN3-CA: 6.5;NTERA-2: 1.1;SuSa: 1.9;THP-1: 1.1" HPA077495 Approved NA NA "HPA077495: " "unprognostic (4.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.39e-4)" "unprognostic (1.18e-1)" "unprognostic (8.20e-3)" "unprognostic (6.32e-2)" "unprognostic (9.10e-2)" "unprognostic (6.19e-2)" "unprognostic (4.58e-1)" "unprognostic (1.58e-1)" "unprognostic (2.45e-2)" "unprognostic (3.86e-1)" 0.0 0.3 2.6 0.1 7.0 0.0 0.2 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 4.2 0.0 0.0 0.0 0.2 1.3 12.6 0.0 5.2 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 9.0 0.0 0.3 1.3 3.5 0.6 0.0 1.4 5.7 0.0 0.0 16.9 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.8 0.2 1.1 0.4 0.9 31.8 0.0 1.3 0.0 0.0 8.9 1.4 10.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 6.5 1.0 0.0 0.9 0.6 13.2 0.0 0.0 0.4 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 31.0;Endothelial cells: 49.1;Ito cells: 86.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 16.2;HEK 293: 10.1;U-87 MG: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 0.0 7.0 0.0 0.0 2.4 3.5 4.2 0.0 9.4 15.9 1.8 0.0 0.2 0.0 6.9 31.0 49.1 0.0 0.0 7.0 0.1 1.8 0.3 0.0 0.0 0.5 0.0 0.0 86.5 2.8 11.9 1.7 0.8 10.1 2.8 0.0 2.1 2.1 0.0 1.1 0.0 0.0 6.5 7.6 15.8 10.1 0.9 0.0 0.0 0.0 0.1 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Fibroblasts: 43.4;Leydig cells: 35.1;Peritubular cells: 55.2;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 35.8;ASC diff: 43.2;ASC TERT1: 48.1;BJ hTERT+: 21.1;fHDF/TERT166: 34.1;HHSteC: 31.9;HSkMC: 48.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" No NA 1200000 Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.71e-4)" 28.4 3.5 4.2 7.2 4.0 0.0 16.2 2.0 2.7 30.4 13.3 2.1 9.8 6.0 34.0 8.7 11.2 8.6 14.9 8.9 2.7 3.6 5.4 3.0 5.9 2.6 5.2 1.4 14.9 2.4 1.8 3.5 29.0 5.4 23.3 9.5 21.8 6.3 9.5 10.3 5.1 9.0 25.4 5.4 4.0 5.5 9.7 4.0 1.0 8.2 7.7 1.9 17.5 16.3 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 35.8 0.0 43.2 48.1 0.0 6.4 21.1 1.2 1.9 0.0 0.0 0.0 0.0 34.1 0.1 0.0 8.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 31.9 0.0 0.0 48.9 0.0 2.3 0.9 1.2 0.2 0.1 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.0 0.6 2.7 1.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 9.8 0.2 0.0 0.0 16.7 1.0 3.3 0.1 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.2 4.0 2.0 2.7 2.7 3.6 5.2 1.4 5.4 4.0 0.0 0.3 0.0 0.2 3.7 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 43.4 0.0 0.0 0.0 2.6 0.0 0.0 4.3 0.0 0.2 35.1 0.0 1.7 0.0 0.0 6.5 0.0 0.0 55.2 0.0 0.1 19.4 8.6 0.7 0.1 2.3 0.7 0.0 0.0 0.0 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;smooth muscle: 12.7" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Melanocytes: 1.7;Mucus-secreting cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 34.6" HPA062669 Approved "Vesicles,Cytokinetic bridge" NA NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.3 1.6 6.7 0.4 5.8 0.0 1.3 0.0 13.1 3.5 4.5 0.0 0.2 1.2 4.3 4.3 1.8 0.2 0.9 4.8 13.4 1.2 1.8 4.7 0.0 8.8 3.8 0.3 0.1 0.0 0.7 1.3 6.9 1.5 2.5 0.0 0.7 1.5 0.1 0.5 1.4 12.7 8.4 1.6 1.5 0.4 6.3 0.0 0.3 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 34.6 0.0 0.5 1.3 0.0 2.4 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.1 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 31.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 0.0 0.0 0.0 2.5 0.1 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 1.3 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 0.3 14.4 0.5 0.0 1.6 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA10 "CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10" ENSG00000250120 "Protocadherin alpha 10" Q9Y5I2 5 140855883-141012344 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.0;Cone photoreceptor cells: 7.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "EFO-21: 20.2" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (4.24e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (4.70e-2)" "unprognostic (4.19e-1)" "unprognostic (2.36e-1)" "unprognostic (6.46e-2)" "unprognostic (8.24e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-2)" "unprognostic (2.65e-1)" "unprognostic (6.14e-3)" "unprognostic (1.93e-2)" "unprognostic (3.57e-3)" "unprognostic (5.21e-2)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" 2.1 1.7 6.1 1.1 6.6 0.6 2.4 8.0 20.3 3.0 0.9 4.9 0.9 1.1 4.5 6.3 0.5 2.7 3.1 0.8 7.1 2.7 4.3 0.6 2.1 0.7 7.2 3.6 2.8 7.8 0.8 11.2 0.5 6.1 1.6 0.9 1.9 3.2 1.0 0.5 0.7 1.8 4.0 6.9 0.7 1.1 1.9 8.2 0.0 5.0 0.0 0.5 0.7 0.7 0.6 0.4 1.5 0.3 0.6 0.3 0.0 0.0 0.2 0.4 2.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.3 1.6 0.8 0.0 0.1 0.0 4.1 0.3 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.1 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.6 0.2 0.3 1.5 0.6 0.2 0.4 0.1 0.0 6.1 6.6 8.0 6.9 7.1 2.7 7.2 3.6 6.1 8.2 0.0 1.0 0.0 0.3 0.0 7.0 0.5 2.5 0.0 0.0 0.0 7.9 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 7.9 1.7 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.4 2.6 0.0 0.3 1.0 0.2 0.0 0.0 0.0 0.0 0.2 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell type enhanced" "Detected in single" 20 "Bipolar cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;EFO-21: 8.8;MCF7: 4.5;T-47d: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" NA NA "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: AB_2686827" "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.0 16.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.8 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.5 0.4 0.0 1.0 0.0 0.1 0.0 4.5 0.0 0.0 3.7 0.8 3.2 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 2.4 6.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 2.4 2.6 7.8 0.0 0.0 0.0 0.3 7.7 0.3 4.4 0.0 0.9 0.1 0.5 1.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 26.8 3.2 0.0 0.0 0.0 11.2 0.4 5.1 0.0 0.0 1.8 5.9 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.4 0.2 2.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PCDHA13 "CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13" ENSG00000239389 "Protocadherin alpha 13" Q9Y5I0 5 140882208-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 5.6;parathyroid gland: 12.2" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Bipolar cells: 2.5;Club cells: 1.2;Horizontal cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 2.7;PC-3: 9.0;WM-115: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.07e-1)" "unprognostic (5.25e-2)" "unprognostic (5.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.48e-2)" "unprognostic (2.64e-3)" "unprognostic (5.53e-2)" "unprognostic (1.36e-1)" 1.0 0.9 2.1 0.6 2.3 0.2 0.6 5.6 5.3 1.0 0.2 2.3 0.0 0.3 0.8 1.2 0.2 0.5 2.4 0.3 1.7 1.6 0.7 1.2 0.8 0.6 1.1 3.8 0.2 1.9 12.2 1.2 0.2 1.0 0.6 0.2 2.7 1.0 0.2 0.3 0.2 0.2 0.5 1.1 0.3 0.3 1.6 1.0 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 9.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.8 1.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 5.6 5.3 1.7 1.6 1.1 3.8 1.0 1.0 3.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 PCDHA3 PCDH-ALPHA3 ENSG00000255408 "Protocadherin alpha 3" Q9Y5H8 5 140801028-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.3;pituitary gland: 9.9" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;AF22: 2.4;SH-SY5Y: 2.4;T-47d: 14.4;WM-115: 3.6" NA NA "unprognostic (5.21e-2)" "unprognostic (2.77e-2)" "unprognostic (7.20e-3)" "unprognostic (2.69e-1)" "unprognostic (1.62e-1)" "unprognostic (7.83e-2)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (7.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.09e-3)" "unprognostic (1.72e-2)" "unprognostic (7.25e-3)" "unprognostic (8.41e-2)" "unprognostic (5.66e-3)" "unprognostic (2.67e-2)" 2.0 3.8 3.1 0.7 5.0 0.2 2.2 10.3 5.8 2.6 1.4 2.6 0.3 1.0 5.9 1.4 0.9 2.3 2.6 0.9 2.8 3.1 3.4 0.6 2.6 0.9 3.7 2.5 4.9 4.8 0.6 9.9 0.4 3.7 2.2 1.0 1.3 1.0 1.8 0.6 0.6 1.4 2.1 6.4 0.9 1.1 2.9 4.8 0.0 2.6 0.4 0.4 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.3 1.0 0.6 14.4 0.0 0.5 0.1 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 10.3 5.6 2.8 3.1 3.7 2.5 3.7 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 2.2;Horizontal cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" NA NA "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.1 7.7 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 0.0 2.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.0;EFO-21: 12.6;hTERT-RPE1: 3.3;U-2 OS: 5.2;WM-115: 7.5" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.2 0.6 0.0 2.0 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA7 "CNR4, CNRS4, CRNR4" ENSG00000204963 "Protocadherin alpha 7" Q9UN72 5 140834248-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 10.1;testis: 2.9" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 1.4;Horizontal cells: 1.6;Spermatocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.0;NTERA-2: 3.2;SCLC-21H: 2.0;SK-BR-3: 2.8;SK-MEL-30: 3.6;U-2 OS: 2.4;WM-115: 3.5" NA NA "unprognostic (1.99e-1)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (5.28e-2)" "unprognostic (3.05e-1)" "unprognostic (7.08e-2)" "unprognostic (9.29e-3)" "unprognostic (4.11e-3)" "unprognostic (7.20e-2)" "unprognostic (3.18e-3)" "unprognostic (3.12e-4)" "unprognostic (9.54e-4)" "unprognostic (6.86e-5)" "unprognostic (5.34e-4)" "unprognostic (2.88e-1)" "unprognostic (3.72e-1)" "unprognostic (1.14e-1)" 0.9 1.1 0.9 0.6 2.3 0.2 1.0 10.1 6.8 0.6 0.8 3.2 0.0 1.2 1.3 0.9 0.2 0.6 1.5 0.6 1.8 1.1 0.8 0.3 1.0 0.5 2.2 1.8 1.4 1.1 0.7 1.4 0.4 4.3 0.6 0.6 0.3 1.1 0.4 0.2 0.5 1.0 1.3 3.7 0.3 0.9 2.9 0.4 0.0 0.7 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.9 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.6 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 2.8 3.6 1.4 0.9 0.0 0.5 0.5 2.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 10.1 6.8 1.8 1.1 2.2 1.8 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 PCDHA8 ENSG00000204962 "Protocadherin alpha 8" Q9Y5H6 5 140841187-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 18.3;SCLC-21H: 5.1" HPA044585 Uncertain NA NA "HPA044585: AB_10793953" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (4.20e-2)" "unprognostic (9.67e-2)" "unprognostic (8.58e-3)" "unprognostic (7.87e-4)" "unprognostic (5.62e-3)" "unprognostic (2.22e-2)" "unprognostic (5.48e-1)" "unprognostic (1.20e-2)" 0.2 1.6 1.0 0.2 2.3 0.2 0.2 6.2 4.7 0.4 0.4 1.4 0.0 0.3 0.8 0.2 0.3 0.3 0.4 0.2 1.2 1.2 0.5 0.3 0.4 0.3 1.0 3.6 0.7 0.9 0.2 1.8 0.3 2.8 0.3 0.5 0.7 0.5 0.2 0.2 0.2 0.4 0.7 1.1 0.2 0.2 1.7 1.3 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.1 2.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 6.2 4.7 1.2 1.2 1.0 3.6 2.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA9 "KIAA0345, PCDH-ALPHA9" ENSG00000204961 "Protocadherin alpha 9" Q9Y5H5 5 140847463-141012344 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 1.8;brain: 3.1;pancreas: 3.4;testis: 3.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.7;Early spermatids: 1.3;Horizontal cells: 1.6;Spermatocytes: 1.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.6" NA NA "unprognostic (1.53e-3)" "unprognostic (1.13e-1)" "unprognostic (7.54e-4)" "unprognostic (1.28e-2)" "unprognostic (4.65e-2)" "unprognostic (1.48e-1)" "unprognostic (5.20e-3)" "unprognostic (6.49e-3)" "unprognostic (1.31e-4)" "unprognostic (1.82e-1)" "unprognostic (8.79e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-1)" 0.2 0.4 0.4 0.1 0.5 0.6 0.0 3.1 1.8 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.3 0.2 3.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.9 0.1 0.0 3.5 0.2 0.0 0.0 0.0 0.9 0.5 1.8 0.4 0.7 0.5 0.2 0.0 0.1 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 11.6 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 0.4 0.4 0.5 0.3 0.4 0.4 0.3 0.4 0.2 0.9 0.4 0.5 1.8 0.7 0.4 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.9" HPA076190 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA076190: AB_2686785" "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 1.5 0.0 0.7 4.0 0.0 0.0 0.1 0.0 8.4 0.0 0.5 0.0 0.0 0.1 5.5 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.6 0.0 0.0 0.1 0.8 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199582-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Bipolar cells: 2.7;Peritubular cells: 3.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;EFO-21: 11.8;U-2 OS: 4.3" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 13.6 2.4 2.8 2.0 4.1 1.1 3.4 8.8 5.0 8.6 3.1 1.4 0.0 1.4 4.9 3.4 4.1 3.1 3.1 3.0 1.4 1.8 5.0 1.3 2.9 1.0 1.5 3.7 11.0 12.0 15.8 3.6 2.2 3.0 4.5 1.7 6.8 3.3 3.6 2.0 2.9 1.8 5.1 1.6 2.2 2.9 2.6 1.3 0.0 2.8 2.3 1.1 5.5 4.2 1.2 1.0 2.8 0.9 1.4 0.8 0.1 0.0 0.2 2.5 8.2 0.1 0.3 1.8 0.2 0.8 0.0 0.0 0.0 0.2 0.0 11.8 0.7 0.7 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.2 0.3 0.3 0.0 0.0 1.0 0.1 0.1 0.1 2.0 0.4 0.2 0.0 0.2 0.3 0.0 0.4 0.0 3.2 0.0 0.1 0.3 3.4 0.5 1.8 0.2 1.1 0.4 1.9 0.0 0.5 0.2 4.3 3.3 0.1 0.1 0.1 0.1 2.2 0.2 2.1 2.2 0.9 0.8 0.8 0.5 0.5 0.6 0.6 0.5 0.3 1.2 0.5 0.7 2.8 1.4 0.4 1.0 0.4 0.1 2.8 4.1 8.8 5.0 1.4 1.8 1.5 3.7 3.0 1.3 3.0 0.3 0.0 0.7 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 1.7 1.1 0.0 3.2 0.5 0.2 6.5 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.6 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 3.2;Intestinal endocrine cells: 1.7;Melanocytes: 3.3;Peritubular cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;ASC diff: 4.7;EFO-21: 5.4;RH-30: 5.8;U-2 OS: 4.4;U-2197: 4.4" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 4.2 2.5 4.4 1.9 5.0 0.4 3.4 9.1 7.5 5.8 3.3 2.5 1.5 1.3 8.0 3.5 1.8 4.9 3.9 3.9 3.1 2.2 2.6 1.5 3.6 0.9 3.0 6.4 8.3 4.0 3.6 13.9 2.0 3.7 4.5 1.8 3.2 1.9 3.9 1.8 1.6 1.7 6.8 3.9 2.6 2.1 3.1 2.7 0.0 1.9 1.2 0.9 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.8 4.7 2.7 0.7 0.1 3.4 0.3 0.4 0.0 0.0 0.0 5.4 0.5 2.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 1.3 0.4 0.0 0.0 1.2 1.2 0.3 0.0 0.0 0.1 0.0 1.0 0.9 5.8 0.0 0.0 0.0 2.8 1.6 0.0 0.0 1.0 0.4 3.7 0.8 0.3 0.7 4.4 4.4 0.1 0.0 0.0 0.0 2.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 9.1 7.5 3.1 2.2 3.0 6.4 3.7 2.7 0.0 0.6 0.0 0.0 0.3 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 1.1 0.0 3.3 0.0 0.0 1.4 0.4 0.0 2.5 0.0 0.3 0.0 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 PCDHB13 PCDH-BETA13 ENSG00000187372 "Protocadherin beta 13" Q9Y5F0 5 141213919-141218979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Bipolar cells: 3.4;Cholangiocytes: 2.5;Exocrine glandular cells: 2.7;Horizontal cells: 3.2;Melanocytes: 3.3;Muller glia cells: 2.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;T-47d: 15.1;U-2197: 12.3" NA NA "unprognostic (9.91e-3)" "unprognostic (3.34e-2)" "unprognostic (8.89e-2)" "unprognostic (2.06e-3)" "unprognostic (2.06e-1)" "unprognostic (1.29e-1)" "unprognostic (9.59e-2)" "unprognostic (3.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.61e-3)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (4.49e-2)" "unprognostic (2.80e-2)" "unprognostic (3.99e-2)" "unprognostic (8.19e-2)" "unprognostic (6.93e-3)" 2.1 2.9 1.0 0.6 1.4 0.0 2.1 1.7 2.3 3.2 1.8 0.0 3.4 2.6 1.4 2.0 3.3 2.8 1.0 1.0 1.6 0.9 1.5 0.2 0.7 3.1 4.2 1.5 3.3 2.5 2.4 1.0 2.8 2.3 0.5 3.8 0.4 2.7 1.2 1.4 1.4 1.8 1.7 0.1 1.5 1.6 1.2 0.5 6.7 0.5 0.4 0.6 0.0 0.0 0.2 1.9 1.4 5.0 5.4 0.4 0.3 2.5 0.7 1.5 0.0 2.1 0.0 7.8 1.8 2.6 0.5 1.8 0.0 0.5 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.9 0.4 1.4 0.1 0.1 2.3 0.7 0.2 0.3 1.9 2.4 0.3 0.2 0.1 0.4 0.0 0.2 5.7 0.9 0.0 0.1 0.1 1.8 0.7 2.5 0.2 0.8 0.5 15.1 0.1 2.3 0.6 1.5 12.3 0.0 0.0 0.1 0.0 3.5 0.1 3.8 1.8 0.5 1.7 0.4 0.4 0.3 0.7 0.4 0.4 0.1 1.2 0.6 0.6 6.7 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.7 3.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.5 0.0 0.0 2.7 0.0 0.6 0.1 0.0 0.4 0.1 3.2 0.0 0.6 0.0 0.0 0.9 0.0 3.3 0.0 0.0 2.6 0.8 0.0 1.1 0.8 0.3 0.0 0.5 0.5 0.2 0.6 0.0 0.0 0.0 0.3 PCDHB15 PCDH-BETA15 ENSG00000113248 "Protocadherin beta 15" Q9Y5E8 5 141245349-141249365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.2;Early spermatids: 5.6;Horizontal cells: 4.8;Peritubular cells: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 9.3;LHCN-M2: 7.7;WM-115: 7.5" "HPA007172, CAB026471, HPA074676" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (7.37e-3)" "unprognostic (1.75e-1)" "unprognostic (2.06e-2)" "unprognostic (6.19e-2)" "unprognostic (1.60e-1)" "unprognostic (4.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.58e-2)" "unprognostic (7.01e-2)" "unprognostic (6.00e-2)" "unprognostic (9.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 8.6 3.6 7.9 5.5 8.4 0.6 4.0 15.1 17.1 8.5 5.3 8.0 0.3 1.5 12.9 6.0 3.5 7.2 4.7 8.6 5.9 4.1 3.8 2.6 5.4 2.0 4.9 6.0 13.6 5.7 2.7 5.7 3.6 8.9 6.4 2.6 3.7 3.1 5.1 2.9 2.6 2.7 9.1 9.4 5.6 4.8 9.1 7.6 0.0 4.5 4.4 1.6 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.1 9.3 1.2 2.5 2.6 0.1 0.7 1.8 0.1 0.5 0.0 0.5 0.0 1.8 1.4 2.4 0.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 1.2 2.2 0.1 0.3 2.4 0.4 0.0 0.1 1.7 7.7 0.0 0.0 0.2 2.3 0.0 0.1 0.3 0.6 0.0 0.6 0.0 0.5 1.3 0.3 0.5 2.5 1.3 0.4 0.0 0.0 0.7 1.0 2.9 0.1 0.1 1.2 0.0 1.2 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.4 15.1 7.3 5.9 4.1 4.9 6.0 8.9 7.6 0.0 0.0 0.0 0.1 0.1 4.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.7 0.0 0.0 1.3 0.0 0.5 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 2.0 0.6 0.0 1.7 0.0 0.0 1.5 1.0 0.0 3.2 0.3 0.5 0.0 2.0 1.8 0.1 0.5 0.0 0.0 0.0 0.2 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.3" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 5.7 4.6 3.1 2.6 9.3 0.4 5.9 3.8 6.2 4.8 2.5 2.2 1.3 1.4 8.0 3.0 1.3 3.1 3.1 3.6 3.8 3.0 4.9 0.8 3.3 1.0 3.0 3.8 5.6 3.9 4.4 17.3 1.8 4.0 5.4 2.1 3.4 2.4 2.4 1.9 2.0 2.1 3.8 3.0 1.5 1.8 11.6 2.0 0.0 2.1 2.3 0.7 2.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.4 2.1 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.2 1.8 0.0 3.8 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 16.5 0.0 0.2 0.0 0.6 2.1 0.1 0.0 5.8 0.8 0.6 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.3 3.8 6.2 3.8 3.0 3.0 3.8 4.0 2.0 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.3 0.7 0.6 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 7.9 0.0 0.6 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.8 0.5 0.0 0.7 0.0 0.2 0.0 0.5 1.4 0.9 0.3 0.0 0.0 0.0 0.3 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 5.1;Horizontal cells: 7.9;Peritubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.0;SH-SY5Y: 8.8" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.0 8.8 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 0.0 0.3 0.0 0.4 1.0 5.1 0.6 0.0 4.0 4.5 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 1.4 0.0 3.8 0.9 0.0 0.0 0.1 7.9 0.0 4.3 0.0 0.0 1.4 0.0 1.7 0.0 0.0 3.5 0.4 0.0 6.0 0.0 0.6 0.0 3.1 1.1 0.2 1.8 0.0 0.0 0.0 0.2 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135218-141138625 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.5;Spermatocytes: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;GAMG: 8.9;NTERA-2: 11.3;RH-30: 9.0;SCLC-21H: 10.6;SuSa: 14.6;T-47d: 11.2;U-138 MG: 21.0;U-2 OS: 9.4;WM-115: 9.3" "Low region specificity" "Detected in all" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 3.8 4.6 8.1 1.6 10.7 0.7 3.6 7.7 11.0 9.0 2.9 7.9 3.6 1.2 10.4 9.2 2.5 7.5 4.9 4.9 7.9 4.1 6.6 2.3 4.0 1.1 3.6 7.1 14.9 11.2 6.3 7.6 1.6 6.4 7.6 1.4 6.9 5.6 5.9 3.0 1.9 1.5 5.7 5.2 2.2 2.4 6.1 5.9 0.0 6.6 0.7 1.0 4.4 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.6 12.0 0.2 0.9 0.5 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 6.2 0.0 8.9 0.0 6.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 10.6 0.3 0.0 0.1 3.6 14.6 11.2 2.6 0.0 21.0 9.4 3.4 0.0 0.0 0.0 0.0 1.1 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.1 10.7 7.7 10.5 7.9 4.1 3.6 7.1 6.4 5.9 0.0 0.0 0.0 1.5 0.0 3.7 0.6 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.4 4.5 0.1 0.0 0.0 3.1 0.0 1.0 0.9 0.0 0.2 0.0 3.2 0.0 0.6 0.0 2.7 2.8 0.0 0.0 0.0 0.0 4.3 3.1 0.0 4.2 0.2 0.7 0.0 1.5 10.3 0.0 0.1 0.0 0.0 0.0 0.6 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.9 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.2 0.0 0.1 3.6 0.4 5.4 2.2 0.0 0.6 1.3 7.6 0.0 0.0 0.0 0.0 3.9 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 9.9 0.1 0.4 0.0 0.0 0.0 0.0 PCDHB7 PCDH-BETA7 ENSG00000113212 "Protocadherin beta 7" Q9Y5E2 5 141172619-141176383 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 32.2;Late spermatids: 14.3;Muller glia cells: 6.1;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.5;EFO-21: 6.6;U-138 MG: 4.4;U-2197: 13.0;U-87 MG: 4.5;WM-115: 4.4" "Low region specificity" "Detected in all" HPA059271 Approved NA NA "HPA059271: AB_2683962" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.97e-1)" "unprognostic (5.95e-2)" "unprognostic (3.69e-4)" "unprognostic (1.04e-2)" "unprognostic (2.78e-2)" "unprognostic (8.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.57e-3)" "unprognostic (2.29e-1)" "unprognostic (1.83e-3)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.48e-1)" "unprognostic (5.78e-4)" 5.8 2.5 4.0 2.7 3.4 0.4 4.3 3.7 4.9 8.1 3.1 8.9 0.0 1.5 11.6 5.0 1.4 5.0 4.6 3.6 4.0 1.8 3.0 1.4 4.9 1.9 3.0 2.7 7.5 1.5 1.6 8.1 1.1 4.5 4.8 1.7 7.0 1.5 3.4 1.4 1.6 2.3 9.0 3.9 3.6 1.8 3.6 5.1 0.0 3.3 0.9 1.0 6.2 5.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.6 5.5 2.7 0.0 0.3 0.7 0.1 0.1 0.0 0.1 0.0 6.6 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 1.9 1.3 0.4 0.0 1.0 0.0 2.9 0.0 0.9 4.4 0.8 13.0 0.1 0.0 0.0 0.0 4.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 3.7 4.9 4.0 1.8 3.0 2.7 4.5 5.1 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.2 0.6 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 14.3 0.9 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.8 0.0 0.2 6.5 1.2 2.8 0.5 0.6 0.1 0.0 0.0 0.0 PCDHB8 "PCDH-BETA8, PCDH3I" ENSG00000120322 "Protocadherin beta 8" Q9UN66 5 141177790-141180529 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 14.0;T-47d: 20.8;U-138 MG: 8.2;U-2197: 22.8" HPA057773 Uncertain NA NA "HPA057773: AB_2683525" "unprognostic (1.16e-3)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (1.72e-1)" "unprognostic (7.56e-2)" "unprognostic (2.02e-2)" "unprognostic (5.72e-3)" "unprognostic (5.82e-4)" "unprognostic (3.54e-2)" "unprognostic (5.52e-3)" "unprognostic (1.95e-2)" "unprognostic (2.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.11e-2)" "unprognostic (8.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.30e-4)" 2.3 1.2 0.9 0.3 1.3 0.0 1.5 0.8 2.7 1.3 0.8 0.0 3.7 1.8 0.9 1.1 1.7 1.5 1.1 0.6 1.3 0.1 1.8 0.0 0.8 2.9 1.5 1.2 2.2 0.4 0.9 0.3 0.6 0.8 0.1 0.9 0.2 1.9 1.4 0.3 0.3 2.5 0.5 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.6 1.7 0.1 0.1 5.1 0.0 0.0 0.0 0.0 0.0 14.0 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 1.1 4.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.5 0.0 0.0 0.0 4.1 1.0 0.0 0.0 0.7 0.0 20.8 0.0 0.5 8.2 4.2 22.8 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 19.7;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.8;ASC TERT1: 10.0;SH-SY5Y: 14.8" HPA013445 Uncertain NA NA "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 1.9 1.9 5.3 0.3 4.1 0.3 1.6 1.8 10.9 3.6 1.0 3.2 0.0 0.2 2.8 4.7 0.9 2.3 1.6 2.0 5.9 0.9 0.2 1.4 0.2 1.2 3.1 4.7 1.7 2.1 6.6 1.1 4.1 1.1 0.6 1.2 1.4 0.8 0.7 0.9 1.0 2.6 4.6 0.6 0.5 1.2 2.5 0.0 0.8 0.3 0.2 0.7 1.0 0.5 0.2 1.9 0.2 0.9 1.3 0.0 0.0 0.0 0.9 6.2 10.8 10.0 0.3 0.1 3.6 0.4 0.6 0.0 1.1 0.4 4.1 0.1 2.9 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 2.0 0.0 0.1 0.0 2.7 3.0 0.9 0.5 0.7 0.4 0.0 0.4 2.8 5.6 0.0 0.6 0.1 2.1 14.8 0.6 0.1 1.0 0.4 2.9 0.2 0.9 6.0 0.5 5.0 1.2 0.1 0.0 0.0 3.3 0.2 2.2 1.1 0.2 0.5 0.2 0.1 0.1 0.2 0.4 1.3 0.0 0.5 0.3 0.3 1.9 0.9 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.2 0.0 19.7 0.2 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 9.5 0.0 1.3 0.3 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.8 0.2 0.7 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.2 6.2 5.4 2.3 5.8 2.1 0.1 3.0 4.8 0.3 0.7 0.7 8.1 3.0 0.2 0.3 2.9 1.9 2.4 0.8 0.0 0.0 0.3 0.0 2.2 1.2 0.2 13.8 0.3 2.0 0.8 0.3 1.1 0.3 0.0 0.1 7.4 0.0 0.1 0.3 1.2 0.0 0.1 0.1 1.0 0.0 2.1 0.1 1.6 0.6 0.3 0.0 0.3 3.0 16.3 1.5 2.7 5.6 0.3 9.6 0.1 0.2 0.9 0.1 2.9 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 0.0 1.3 0.0 1.8 0.1 27.0 2.3 2.5 0.0 2.3 1.8 15.7 1.7 0.0 0.9 0.0 2.1 0.4 0.0 1.2 1.1 1.2 3.2 1.1 1.1 0.8 22.3 1.2 3.1 0.0 0.0 3.1 0.3 1.7 0.0 1.1 8.7 2.1 0.0 2.1 0.0 5.2 6.5 1.1 0.3 0.7 0.4 0.3 0.0 0.8 0.9 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 12.0 13.0 0.4 2.6 5.0 2.0 3.2 0.0 0.1 0.3 4.3 2.6 22.7 1.7 0.0 0.3 3.2 0.0 1.1 0.0 0.0 0.0 2.0 0.2 0.0 9.3 0.1 3.5 0.0 33.8 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.0 0.2 1.5 3.6 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 0.0 0.6 0.0 0.1 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 11.2;BJ: 3.7;EFO-21: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.2 1.5 0.0 3.7 0.3 0.0 0.1 0.0 0.0 0.1 9.2 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.1 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 0.0 0.0 0.0 0.1 0.0 2.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.3 0.0 5.7 4.6 0.3 1.1 0.0 0.1 1.0 2.0 4.8 1.8 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 6.0 0.2 0.1 0.0 3.5 5.7 0.0 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.0 0.3 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.3 0.3 1.1 0.5 2.2 0.0 3.7 2.4 0.7 3.2 0.5 0.2 0.3 0.2 8.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.2 0.7 1.8 0.1 0.3 0.2 0.8 0.0 0.7 0.7 0.3 0.4 1.4 4.1 2.2 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.3 4.6 0.2 0.4 0.3 19.1 1.1 0.1 0.1 0.2 0.4 0.4 0.2 0.5 0.2 0.1 0.0 0.2 0.5 0.0 0.2 0.2 0.5 1.2 0.4 0.1 0.6 0.5 1.1 0.5 5.0 0.3 0.3 0.1 2.7 0.2 0.1 0.1 5.8 0.1 1.0 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 0.0 0.0 0.0 0.1 0.2 3.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350" "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 7.5 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 4.9 1.7 0.1 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 1.6 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 0.0 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.6;SuSa: 10.9;TIME: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.1 0.0 4.6 5.9 0.8 6.8 28.6 2.9 1.9 0.0 0.0 0.2 5.5 0.2 0.1 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 0.1 4.4 0.0 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 10.9 3.6 2.6 14.3 3.9 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.7;Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.2 0.1 0.0 32.8 24.8 0.6 8.7 0.0 14.2 16.0 1.4 4.7 4.9 11.4 9.6 0.0 6.6 0.0 3.6 8.0 0.0 1.4 0.0 0.0 0.0 3.4 0.0 3.1 8.7 0.7 0.8 4.6 6.1 4.3 0.0 0.1 0.0 0.4 3.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.0 1.0 9.2 0.0 4.4 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.6 0.2 0.6 0.7 0.9 1.7 0.0 0.4 1.0 0.2 0.3 1.5 6.3 1.0 0.3 0.3 0.0 0.4 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.3 2.1 0.9 0.1 0.2 0.6 0.4 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.0 0.2 0.1 0.1 3.0 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.5 0.4 3.0 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.9 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 3.0 0.3 0.0 1.3 0.0 6.4 2.5 0.0 1.4 2.3 0.0 5.9 0.1 0.0 0.4 0.0 0.9 0.0 0.0 1.1 0.1 0.4 0.6 0.0 0.8 0.2 9.5 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.3 1.6 0.0 1.1 0.0 2.4 0.0 1.0 0.2 0.3 0.1 0.1 0.0 0.0 0.6 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 38.8 0.9 0.1 0.4 2.5 0.3 0.9 1.9 0.0 2.3 0.3 2.1 5.1 0.3 0.6 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 2.9 0.2 0.0 12.3 0.3 0.7 0.4 32.9 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 4.3 0.8 0.0 0.1 0.0 4.2 5.8 0.1 0.0 0.0 0.5 0.4 0.4 5.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 3.0 2.2 0.0 0.5 0.3 7.4 1.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.1 0.8 0.3 1.1 0.0 0.1 3.2 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 1.8 0.2 0.4 0.0 1.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell type enhanced" "Detected in single" 32 "Horizontal cells: 3.2" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 1.5 0.0 0.0 9.3 0.5 0.0 0.0 0.1 7.9 15.2 0.1 0.0 0.2 11.2 0.1 0.3 0.1 0.8 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Rod photoreceptor cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA057849: AB_2683544" "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 18.5 22.6 24.2 28.9 24.9 9.7 32.4 49.7 27.3 20.1 14.9 21.1 19.2 14.9 26.0 33.5 15.2 17.2 21.2 26.2 19.8 20.2 22.9 20.2 20.0 25.6 18.5 22.8 38.9 18.1 20.4 21.8 26.3 18.0 19.9 13.6 57.8 20.5 16.9 25.7 42.1 15.7 17.3 19.6 22.1 13.7 17.0 18.2 31.2 19.5 10.5 18.5 17.7 18.1 9.5 7.5 8.3 6.6 14.1 18.1 7.9 10.9 4.0 15.9 12.4 15.4 19.1 15.2 6.8 7.5 9.9 6.1 9.4 17.6 16.4 12.1 8.1 7.8 13.6 8.7 11.0 13.4 3.5 11.9 7.9 17.9 15.7 13.0 8.2 12.1 27.0 15.3 5.2 9.0 17.7 14.3 16.7 14.5 14.8 8.0 7.1 18.8 27.1 11.7 15.2 16.9 15.7 6.3 19.5 15.0 12.7 25.3 29.9 13.0 15.0 17.5 26.0 16.0 16.5 10.4 14.9 5.3 9.5 5.4 18.0 14.6 15.8 9.8 8.7 8.6 7.6 6.6 7.6 8.4 4.5 10.0 8.9 12.5 9.5 7.5 9.5 17.7 12.7 8.3 14.1 4.1 4.7 18.1 7.9 24.2 24.9 49.7 27.3 19.8 20.2 18.5 22.8 18.0 18.2 20.8 21.1 17.1 14.0 18.1 110.9 54.5 20.4 30.8 22.7 27.9 88.4 26.4 19.9 6.5 7.3 34.6 6.7 46.7 7.9 6.2 23.4 15.8 12.7 26.8 12.1 35.0 21.9 52.8 33.3 8.2 39.7 12.8 45.5 5.4 18.1 55.9 9.2 16.7 29.0 18.4 170.0 25.8 19.8 42.9 28.3 18.6 18.3 17.5 14.0 7.8 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex homolog 2" A6NKB5 1 232983435-233295713 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 29.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 4.7 4.7 11.4 7.5 16.8 4.2 7.7 29.6 23.1 4.9 3.9 6.3 4.2 3.4 6.6 14.0 5.2 9.0 8.1 2.3 11.9 8.2 5.4 1.2 4.7 9.4 8.0 13.1 11.4 5.2 8.6 18.6 2.4 14.3 6.2 4.8 6.0 6.0 8.1 5.6 6.3 5.6 5.2 5.8 5.3 5.8 5.5 5.5 4.0 7.9 3.4 8.8 6.0 5.7 1.5 1.8 0.9 0.9 0.8 3.1 1.1 3.8 9.4 5.1 0.1 8.4 9.2 1.5 2.3 6.8 2.4 4.3 3.0 4.7 8.1 5.5 6.3 9.0 6.4 2.3 6.7 5.7 6.8 6.9 0.1 4.8 0.0 3.8 2.6 1.6 7.0 5.9 4.8 19.1 8.3 4.5 6.1 0.0 4.3 2.4 2.3 7.4 0.2 16.5 3.3 5.7 0.1 1.4 1.1 4.4 6.0 8.8 7.3 3.4 1.5 1.4 3.0 3.4 0.7 1.7 6.8 4.4 7.7 7.6 5.2 5.4 0.1 6.2 3.0 7.8 0.9 0.9 0.4 3.1 0.5 2.4 1.5 2.5 2.9 1.8 1.3 1.1 2.1 0.7 0.8 0.7 0.6 2.7 1.1 11.4 16.8 29.6 23.1 11.9 8.2 8.0 13.1 14.3 5.5 8.9 5.1 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.5 12.2 0.0 0.3 6.6 5.1 0.0 0.0 0.0 0.0 2.9 1.1 0.0 0.0 1.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.0 0.0 4.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in many" 6 "Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.0 22.8 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 13.5 0.0 0.0 28.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 0.0 1.6 0.0 2.2 1.1 12.6 3.6 0.0 0.0 2.3 26.2 0.0 0.1 157.5 0.3 314.8 5.8 0.0 0.0 0.3 0.0 1.9 2.0 0.0 0.0 0.1 0.0 0.0 8.0 0.0 455.7 13.8 0.2 0.0 0.0 0.6 0.2 0.2 0.0 7.8 1.4 1.1 51.8 47.4 4.4 3.9 1.1 0.0 0.0 0.0 0.7 PDP2 "KIAA1348, PPM2B, PPM2C2" ENSG00000172840 "Pyruvate dehyrogenase phosphatase catalytic subunit 2" Q9P2J9 16 66878589-66895754 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019950, HPA062059" Approved Approved Mitochondria NA NA Mitochondria "HPA019950: AB_1855156, HPA062059: AB_2684671" "unprognostic (8.42e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.31e-2)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (4.90e-3)" "unprognostic (1.57e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" "unprognostic (1.39e-1)" "prognostic favorable (9.75e-7)" "unprognostic (1.89e-1)" "unprognostic (5.10e-1)" "unprognostic (3.20e-1)" "unprognostic (6.15e-2)" 10.7 7.2 7.4 3.7 10.5 3.2 8.7 11.5 16.5 4.9 7.5 10.1 5.7 10.4 7.9 7.2 8.9 7.2 6.0 4.8 7.4 7.1 18.1 16.5 8.6 5.0 9.0 9.4 14.9 13.8 12.0 7.0 7.7 16.0 7.8 8.4 8.5 7.1 6.9 6.3 4.7 6.2 4.6 6.3 4.0 6.7 8.6 8.9 4.6 18.0 4.0 5.9 6.3 5.5 3.3 1.3 1.8 0.4 6.1 6.3 2.0 7.2 8.9 5.5 10.8 14.9 7.7 6.9 3.8 14.8 8.9 13.4 18.1 5.2 10.2 5.5 5.3 8.5 9.3 16.0 8.6 8.6 2.4 8.1 5.1 4.5 11.8 8.1 6.5 9.0 5.8 6.5 12.6 13.1 9.7 3.8 11.5 9.8 7.3 7.9 4.8 12.6 4.7 6.5 4.9 11.3 12.5 7.7 16.0 4.7 7.8 11.1 6.3 12.3 5.0 4.6 4.5 6.7 3.2 3.5 5.4 7.4 3.3 5.6 13.0 12.0 10.1 7.5 5.2 5.4 1.3 0.4 1.8 6.3 0.3 5.2 1.8 3.1 5.1 1.3 3.3 4.5 5.0 1.3 6.1 0.2 0.8 0.9 2.0 7.4 10.5 11.5 16.5 7.4 7.1 9.0 9.4 16.0 8.9 8.9 18.5 5.9 4.3 4.6 7.9 4.5 7.6 1.4 4.5 8.7 13.7 9.1 6.6 2.7 0.1 1.8 5.1 0.0 2.5 1.6 4.2 6.7 5.8 11.5 2.1 4.8 3.5 6.7 0.6 1.9 2.8 0.8 3.3 0.0 4.0 8.4 2.8 5.8 4.2 8.1 6.3 0.0 3.1 4.4 1.3 2.0 3.0 1.9 5.8 7.0 PDZD9 "C16orf65, MGC50721" ENSG00000155714 "PDZ domain containing 9" Q8IXQ8 16 21983865-22001110 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 34.1" "Group enriched" "Detected in some" 19 "Early spermatids: 69.0;Late spermatids: 148.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;MOLT-4: 1.0;U-87 MG: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.66e-2)" "unprognostic (6.23e-4)" "unprognostic (2.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-3)" "unprognostic (8.29e-3)" "unprognostic (2.05e-3)" "unprognostic (3.93e-2)" "unprognostic (1.11e-2)" "unprognostic (3.85e-3)" "unprognostic (1.42e-2)" "unprognostic (1.97e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (1.63e-1)" "unprognostic (4.69e-2)" 0.2 0.2 0.5 0.1 1.2 0.1 0.1 2.6 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 34.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 1.0 0.1 0.5 1.2 2.6 1.0 0.5 0.6 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.7 1.1 0.0 0.0 0.0 0.0 0.0 PDZRN4 "DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4" ENSG00000165966 "PDZ domain containing ring finger 4" Q6ZMN7 12 41188448-41574590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 18.3;seminal vesicle: 20.8" "Cell type enhanced" "Detected in some" 25 "Fibroblasts: 10.4;Leydig cells: 25.9;Peritubular cells: 53.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/70: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042101 Enhanced NA NA "HPA042101: AB_2732496" "unprognostic (6.74e-2)" "unprognostic (6.86e-2)" "unprognostic (3.82e-2)" "unprognostic (2.88e-2)" "unprognostic (1.49e-1)" "unprognostic (5.34e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-2)" "unprognostic (8.19e-2)" "unprognostic (7.85e-3)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" "unprognostic (7.44e-2)" "unprognostic (1.90e-3)" "unprognostic (1.80e-1)" "unprognostic (7.33e-2)" "unprognostic (1.41e-3)" 1.6 1.3 2.4 5.0 1.8 0.1 2.6 2.7 3.7 3.1 13.9 1.0 13.8 1.3 1.1 18.3 4.1 3.4 3.0 0.5 2.1 2.1 0.8 0.9 0.5 0.1 1.8 2.4 3.3 0.8 0.3 0.7 4.5 2.5 8.3 4.0 4.8 0.6 20.8 0.6 0.8 4.2 17.2 5.0 0.4 5.9 4.1 2.0 0.0 0.5 0.5 0.5 7.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.8 2.7 3.3 2.1 2.1 1.8 2.4 2.5 2.0 0.0 0.0 0.0 0.0 0.7 4.7 0.3 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 10.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 1.2 25.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 53.0 0.0 0.9 0.0 7.3 0.0 0.1 0.5 0.3 0.0 0.0 0.0 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274622-2282176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;lymphoid tissue: 19.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 1.4;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 24.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 10 "HMC-1: 16.9" "Group enriched" "Detected in many" 5 "basal ganglia: 6.4;cerebellum: 6.0" HPA057806 Uncertain Uncertain Cytosol NA NA Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 1.9 1.3 1.4 4.7 3.3 8.2 0.9 0.8 2.0 1.3 1.7 2.1 0.1 1.1 0.7 1.0 0.8 1.6 0.9 2.1 2.0 0.9 3.8 2.0 4.4 14.3 3.3 0.9 1.0 0.8 0.6 1.2 0.8 2.3 1.0 1.1 0.7 0.8 0.6 1.5 1.0 2.5 0.9 4.0 19.1 1.1 0.6 1.7 0.6 0.8 0.0 2.7 0.9 1.9 0.2 1.1 24.5 3.4 2.8 1.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.2 0.6 0.1 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 5.3 2.7 6.6 1.0 3.4 0.1 0.1 0.1 0.1 1.1 0.2 0.0 0.2 24.5 2.8 1.1 0.1 0.0 0.5 1.4 3.3 0.8 2.0 2.0 0.9 3.3 0.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PERM1 "C1orf170, MGC13275, Perm1, RP11-54O7.8" ENSG00000187642 "PPARGC1 and ESRR induced regulator, muscle 1" Q5SV97 1 975204-982093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 18.8;Early spermatids: 5.1;Late spermatids: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.5;HaCaT: 4.4;MCF7: 3.1;SK-BR-3: 4.7" "Not detected" "Not detected" "HPA031711, HPA031712" Enhanced NA NA "HPA031711: AB_10669636, HPA031712: AB_2674005" "unprognostic (3.67e-2)" "unprognostic (5.72e-2)" "unprognostic (6.05e-2)" "unprognostic (1.89e-1)" "unprognostic (2.86e-2)" "unprognostic (4.25e-2)" "unprognostic (7.58e-4)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (2.64e-1)" "unprognostic (1.69e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.70e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.96e-2)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 23.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.9 0.0 68.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 24.7 0.9 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.5 0.1 0.0 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.5 1.6 0.0 0.5 0.0 1.1 4.4 0.0 0.0 0.0 1.4 0.5 0.0 1.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 3.1 0.0 0.0 0.0 0.7 1.1 0.0 0.0 1.8 0.0 0.9 0.0 0.1 1.3 4.7 1.0 0.3 0.4 0.0 0.9 0.7 0.9 0.0 0.7 0.5 0.0 0.0 1.8 0.4 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 18.8 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 1.4 PERP "dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW" ENSG00000112378 "PERP, TP53 apoptosis effector" Q96FX8 6 138088505-138107511 "Predicted membrane proteins" "Apoptosis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 250.2;skin 1: 157.9;tongue: 230.6" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 2942.7;Suprabasal keratinocytes: 5094.7;Urothelial cells: 1450.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.3" "Group enriched" "Detected in many" 9 "granulocytes: 21.3;T-cells: 5.6" "Cell line enhanced" "Detected in many" "HaCaT: 37.9;hTCEpi: 142.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022269 Enhanced NA NA "HPA022269: AB_1855219" "prognostic unfavorable (5.46e-4)" "unprognostic (2.90e-1)" "unprognostic (1.94e-1)" "unprognostic (5.18e-2)" "unprognostic (2.82e-2)" "unprognostic (1.27e-1)" "unprognostic (6.28e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.92e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (4.02e-2)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.51e-2)" 4.2 1.6 1.0 2.7 1.2 0.0 25.5 1.3 0.9 51.9 12.5 0.5 7.1 6.3 6.4 11.7 250.2 7.7 15.6 14.7 1.2 1.5 4.4 28.0 8.4 1.7 1.3 0.3 3.3 11.5 5.0 3.3 31.5 1.6 17.5 5.0 2.4 46.6 7.9 1.4 157.9 23.4 7.1 1.3 0.6 8.4 1.9 0.6 6.7 8.7 230.6 113.6 14.0 57.8 1.4 0.0 21.3 0.0 0.0 5.6 0.8 10.2 11.5 0.0 1.1 8.1 8.6 24.0 16.7 18.9 2.4 1.7 9.4 21.2 0.0 6.0 4.2 19.9 37.9 2.0 30.2 0.5 16.1 9.4 0.0 11.5 8.8 5.8 0.0 0.0 6.4 142.2 0.2 15.5 13.8 9.4 0.6 0.1 4.5 0.2 7.1 0.0 0.5 4.9 24.5 6.2 0.0 3.8 0.0 16.1 12.0 4.0 0.0 17.7 9.5 8.1 11.6 5.3 2.1 11.2 4.2 1.6 4.5 0.0 1.4 1.8 0.0 3.3 0.0 8.8 21.3 0.0 0.0 3.0 0.0 5.2 1.4 3.8 2.6 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.0 5.6 0.8 1.0 1.2 1.3 0.9 1.2 1.5 1.3 0.3 1.6 0.6 196.5 66.8 11.7 1261.9 2942.7 3.4 114.6 234.4 397.5 227.5 146.5 15.7 849.6 53.0 494.4 1.4 53.7 255.2 0.0 273.4 823.5 67.6 524.2 10.4 153.4 71.8 3.2 141.3 9.8 2.2 2.0 9.8 5.1 332.3 18.0 159.9 23.8 453.2 273.5 2.5 10.1 25.6 6.5 122.7 1.8 0.9 5094.7 689.2 31.2 162.2 1450.6 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.0" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2" "Group enriched" "Detected in many" 6 "granulocytes: 21.6;monocytes: 12.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 2.0 2.2 4.0 3.9 4.9 12.7 2.1 6.3 6.3 2.6 17.1 8.6 3.0 17.8 2.1 18.5 6.4 1.5 1.8 1.4 4.2 5.2 3.6 1.7 3.8 6.3 7.4 2.7 3.5 18.9 4.1 5.1 9.5 6.9 3.3 3.5 3.3 2.5 2.0 4.8 3.3 24.0 2.5 5.3 10.0 1.2 26.0 5.2 0.4 1.6 3.6 2.6 4.9 4.2 0.2 2.7 21.6 12.2 0.2 0.5 2.1 5.0 1.5 3.6 3.3 1.2 1.8 7.1 2.5 4.3 5.2 12.6 2.5 1.8 2.2 2.4 1.9 12.4 1.4 1.5 4.4 4.6 1.5 1.2 5.1 3.3 2.7 1.0 0.9 2.3 1.8 6.6 8.3 0.8 22.9 1.2 2.9 1.7 1.9 4.1 1.1 0.3 7.1 2.2 1.0 3.4 0.4 1.7 2.3 2.0 4.7 1.0 2.2 2.7 1.2 9.9 3.7 2.8 2.2 0.3 5.3 2.1 0.6 15.3 8.8 1.9 1.3 36.5 1.8 31.7 0.0 6.5 11.4 0.2 7.3 0.1 0.2 0.3 0.0 2.7 0.1 0.5 0.1 21.6 0.2 12.2 0.3 0.0 2.1 4.0 4.9 6.3 6.3 4.2 5.2 7.4 2.7 6.9 5.2 0.0 2.2 0.0 0.3 2.9 5.0 0.6 0.0 1.4 1.2 0.0 2.0 11.1 0.0 2.0 2.6 0.4 1.7 0.0 1.3 36.2 1.5 0.4 1.1 0.0 5.3 6.4 4.1 1.8 11.0 2.0 0.9 4.4 1.7 0.0 11.8 3.6 2.9 0.3 0.7 0.0 4.3 0.0 0.8 0.5 0.5 1.5 4.6 0.0 1.5 0.0 PFN3 ENSG00000196570 "Profilin 3" P60673 5 177400107-177400636 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 24.8" "Group enriched" "Detected in some" 135 "Early spermatids: 653.6;Late spermatids: 972.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;HDLM-2: 2.5" "Region enhanced" "Detected in single" "cerebral cortex: 0.3" NA NA "unprognostic (1.03e-2)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 653.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 972.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 5.2 4.6 0.0 0.0 0.0 0.0 0.0 PGBD2 ENSG00000185220 "PiggyBac transposable element derived 2" Q6P3X8 1 248906196-248919946 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Syncytiotrophoblasts: 23.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029888, HPA029889, HPA029890" Uncertain Approved Vesicles NA NA Vesicles "HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002" "unprognostic (1.06e-2)" "unprognostic (8.05e-2)" "unprognostic (2.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.08e-4)" "unprognostic (1.94e-2)" "unprognostic (2.11e-2)" "unprognostic (2.71e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.41e-1)" "unprognostic (7.91e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.05e-4)" 5.8 7.0 5.0 11.1 6.8 5.7 9.5 10.5 7.7 7.6 7.7 11.9 10.2 8.9 8.6 8.2 11.1 6.8 8.6 4.5 5.1 4.6 7.2 11.8 5.7 10.4 7.4 5.4 10.2 14.7 8.3 5.6 12.7 7.8 9.9 9.9 6.0 10.0 12.8 2.9 12.3 11.9 8.4 5.6 17.3 7.9 13.9 8.6 5.5 12.5 3.9 12.2 7.5 18.2 12.7 8.0 13.9 9.1 7.8 10.9 5.7 4.5 6.2 9.9 5.7 8.8 5.8 12.0 4.4 3.9 7.7 7.3 4.6 6.2 12.0 5.7 4.3 4.4 7.4 5.9 5.5 8.9 7.1 2.8 11.5 9.7 7.0 5.0 5.9 11.3 5.2 5.9 9.1 5.1 6.3 4.4 5.8 18.2 10.5 5.5 8.2 3.3 6.9 9.1 15.5 7.3 14.2 3.1 3.9 4.6 5.9 3.7 6.5 6.3 9.2 7.1 7.0 4.1 11.6 5.3 5.2 5.2 4.6 4.8 10.1 10.0 5.4 5.6 13.2 4.7 13.9 8.8 13.2 9.8 6.2 9.4 12.7 8.6 9.1 8.0 12.6 8.7 10.9 6.5 7.8 9.1 3.8 5.8 5.7 5.0 6.8 10.5 7.7 5.1 4.6 7.4 5.4 7.8 8.6 0.0 9.9 5.0 2.5 4.6 3.0 2.0 2.5 4.0 7.9 5.2 2.0 9.6 1.7 3.8 2.8 4.5 6.4 23.3 2.6 3.5 3.8 2.0 2.3 3.2 2.7 1.6 1.2 3.7 1.5 1.9 2.8 3.1 6.8 3.6 4.3 2.7 1.9 6.5 1.8 2.1 2.5 0.0 3.6 13.0 10.4 5.6 23.2 6.4 4.4 2.1 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102073-34108684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 2.5 3.6 3.9 4.1 8.5 6.7 3.4 5.3 11.1 2.6 2.8 4.8 4.7 3.2 2.6 3.9 3.8 4.6 2.4 4.0 5.4 3.6 3.4 5.3 2.4 5.2 6.0 6.1 3.0 4.6 4.9 6.7 2.5 12.7 3.0 3.4 3.2 3.3 2.6 18.6 4.4 5.1 2.2 4.0 6.0 4.5 7.9 5.8 4.5 3.3 2.0 4.2 3.2 2.7 2.8 1.7 6.4 1.4 1.6 2.6 0.6 2.0 3.6 2.5 4.1 7.4 4.9 1.5 3.1 3.0 2.0 2.5 2.5 2.7 4.1 2.6 2.4 4.0 5.6 1.4 3.6 2.5 4.3 3.8 6.7 6.9 1.8 3.1 2.3 6.1 3.8 4.1 2.6 4.7 3.4 2.2 7.6 4.6 5.0 4.1 1.4 3.7 5.4 1.0 4.1 2.7 5.6 3.4 2.1 2.6 4.2 3.7 3.4 1.6 3.5 1.1 3.1 3.5 3.6 2.5 6.1 3.5 3.2 2.0 5.9 3.8 2.3 5.4 5.2 3.6 6.4 1.4 1.5 1.3 1.2 1.1 1.5 1.7 1.3 0.8 2.8 2.6 2.4 3.2 1.6 0.9 1.7 1.3 0.6 3.9 8.5 5.3 11.1 5.4 3.6 6.0 6.1 12.7 5.8 0.0 2.7 4.9 1.9 0.7 5.3 3.7 2.5 5.3 3.4 0.0 5.9 1.5 8.3 1.1 8.8 1.4 3.2 0.0 0.6 0.6 0.6 1.8 1.1 1.7 1.1 9.5 0.0 4.3 3.5 10.2 1.1 2.1 0.0 1.8 1.8 3.8 1.7 0.9 0.4 0.7 6.1 12.9 0.9 6.0 0.7 0.3 2.7 4.5 1.7 1.4 PGPEP1L ENSG00000183571 "Pyroglutamyl-peptidase I-like" A6NFU8 15 98968230-99007795 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7;Early spermatids: 2.7;Spermatocytes: 2.8;Spermatogonia: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "basophil: 2.0;neutrophil: 1.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "HeLa: 1.9;U-2 OS: 4.5" "Not detected" "Not detected" HPA041781 Uncertain NA NA "HPA041781: AB_10795642" "unprognostic (2.48e-1)" "unprognostic (2.82e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-3)" "unprognostic (7.18e-2)" "unprognostic (3.99e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (9.78e-2)" "unprognostic (1.58e-1)" "unprognostic (4.53e-3)" "unprognostic (1.86e-1)" "unprognostic (2.62e-1)" "unprognostic (2.00e-2)" "unprognostic (1.65e-1)" 0.7 0.1 0.5 0.2 1.4 0.1 0.6 0.2 0.5 0.4 0.4 0.4 0.0 0.2 0.2 0.4 0.8 0.2 0.5 3.6 0.6 0.4 0.4 0.0 0.2 0.3 0.4 0.2 0.2 0.5 0.0 0.1 0.3 0.4 0.6 0.0 1.6 0.9 0.5 34.7 0.1 0.2 0.3 0.3 0.1 0.2 5.0 0.2 0.1 0.1 8.6 0.5 0.2 0.3 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.2 0.7 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 1.9 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.9 1.4 0.1 0.0 0.2 0.4 1.3 0.2 0.4 0.4 0.1 1.2 0.0 1.0 0.3 0.4 0.5 1.4 0.2 0.4 0.8 0.0 0.7 0.0 4.5 0.2 0.1 0.8 0.2 0.7 0.0 0.6 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.2 0.5 0.6 0.4 0.4 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 2.8 2.0 0.0 0.1 0.0 0.0 0.0 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378640-78425114 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved NA NA "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favorable (7.33e-5)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 16.4 11.6 14.5 20.8 20.3 41.4 28.2 17.6 17.4 14.4 13.1 18.4 13.2 13.7 17.3 13.2 14.5 16.9 17.2 14.0 15.7 16.1 14.3 8.0 25.5 19.1 21.6 17.0 18.3 14.0 16.0 13.3 24.0 15.3 13.9 10.2 12.9 13.1 16.8 13.8 11.9 15.1 13.4 18.0 22.6 12.6 13.9 18.8 17.7 18.6 7.8 14.3 16.9 32.3 8.0 14.0 26.0 12.6 6.7 11.3 8.4 13.3 11.8 11.5 8.6 10.1 16.2 13.6 12.5 12.0 13.5 14.9 10.9 10.5 13.7 7.6 7.1 13.3 10.3 13.6 8.5 10.6 20.6 15.4 15.0 14.0 10.9 9.9 11.3 12.2 16.5 11.2 9.7 8.8 11.7 25.7 10.9 17.5 9.6 9.1 7.3 25.6 10.3 12.0 5.8 11.4 13.5 20.5 11.7 13.2 12.2 15.2 23.1 10.7 11.8 11.4 11.6 12.4 13.8 16.1 17.5 12.1 9.3 10.5 10.6 6.3 10.5 13.2 12.7 12.9 1.5 12.6 13.2 8.4 10.4 9.8 7.8 8.8 8.8 14.0 8.0 11.3 8.1 26.0 6.7 4.6 6.6 10.4 8.4 14.5 20.3 17.6 17.4 15.7 16.1 21.6 17.0 15.3 18.8 11.9 12.6 7.5 10.1 3.9 12.5 4.2 7.6 6.7 10.3 12.2 2.0 15.2 3.3 5.3 14.1 14.3 7.1 0.0 6.0 7.3 8.9 6.8 7.0 3.0 13.3 19.1 4.1 13.5 13.1 7.9 9.8 17.5 5.0 10.0 5.2 9.7 5.8 12.5 8.1 4.3 10.5 32.3 7.6 18.0 15.9 3.3 16.1 6.9 7.6 8.2 PHKG1 PHKG ENSG00000164776 "Phosphorylase kinase catalytic subunit gamma 1" Q16816 7 56080283-56092996 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 105.6;tongue: 32.9" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 50.9" "Cancer enriched" "Detected in many" 18 "glioma: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012057 Enhanced NA NA "HPA012057: AB_1855305" "unprognostic (2.00e-3)" "unprognostic (1.09e-1)" "unprognostic (7.09e-3)" "unprognostic (5.87e-3)" "unprognostic (2.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (6.69e-3)" "unprognostic (2.10e-1)" "unprognostic (1.99e-1)" "unprognostic (9.14e-4)" "unprognostic (1.92e-1)" "unprognostic (7.97e-9)" "unprognostic (6.61e-3)" "unprognostic (2.34e-1)" "unprognostic (1.12e-2)" "unprognostic (3.85e-2)" 2.0 1.5 4.9 0.8 6.1 1.1 1.5 6.0 5.8 0.7 2.6 6.5 0.0 1.0 0.9 1.5 3.2 0.9 1.1 11.8 4.1 2.9 0.6 0.7 0.9 0.8 3.5 3.9 1.0 0.8 1.2 0.6 0.6 6.8 1.4 0.8 0.0 1.6 0.8 105.6 1.6 0.9 1.1 3.6 0.8 0.8 0.7 4.8 0.0 0.6 32.9 1.2 1.8 0.3 1.3 0.6 3.3 0.7 0.3 1.9 0.2 2.9 2.1 0.5 1.8 3.2 5.4 1.4 0.4 0.6 1.0 0.8 0.7 1.3 0.8 0.5 1.0 1.2 1.6 1.2 0.2 0.8 0.8 2.1 0.8 3.0 0.7 0.8 1.5 3.3 3.4 2.3 1.6 0.7 0.8 0.3 2.1 2.2 4.0 0.1 1.3 2.2 5.6 1.0 0.9 1.3 1.2 0.3 1.0 0.6 1.9 1.5 1.6 0.3 2.2 0.1 0.5 1.2 1.9 0.8 0.5 1.7 4.5 1.1 1.8 0.7 2.2 1.2 1.4 1.0 0.4 0.5 0.0 0.8 0.2 1.9 0.3 1.2 0.3 0.2 1.3 0.6 0.6 3.3 0.3 0.7 0.6 0.5 0.2 4.9 6.1 6.0 5.8 4.1 2.9 3.5 3.9 6.8 4.8 11.9 3.4 25.1 6.4 1.1 4.0 1.4 50.9 4.0 6.8 26.2 0.0 6.6 1.7 13.2 2.2 1.4 11.4 23.3 10.9 11.6 6.1 9.6 8.1 41.4 11.0 11.1 16.0 20.9 30.5 5.6 16.7 6.0 1.7 8.2 10.9 4.8 12.7 10.5 15.2 9.0 4.3 12.9 1.0 7.6 9.4 0.9 6.1 8.7 14.4 7.0 PHLDB3 FLJ40193 ENSG00000176531 "Pleckstrin homology like domain family B member 3" Q6NSJ2 19 43474954-43504935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 48.5;Urothelial cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043425 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA043425: AB_10797142" "unprognostic (2.50e-2)" "unprognostic (4.22e-3)" "unprognostic (3.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "unprognostic (4.43e-1)" "unprognostic (1.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.60e-2)" "prognostic favorable (6.36e-6)" "unprognostic (4.62e-2)" "prognostic unfavorable (4.11e-5)" "prognostic unfavorable (5.77e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (2.37e-1)" 2.7 8.5 6.6 11.7 5.9 3.6 6.0 2.1 5.2 8.7 4.8 1.8 7.1 5.8 8.8 6.5 28.4 7.3 15.9 4.5 5.2 2.9 4.8 9.6 4.0 7.8 3.5 5.8 9.5 7.7 6.8 7.9 6.4 3.2 11.7 2.2 6.7 11.1 7.6 9.0 28.7 9.4 7.5 3.0 6.4 5.4 18.7 3.0 12.2 5.7 15.2 23.2 9.3 14.8 4.4 8.1 0.9 3.3 2.6 5.5 2.3 5.3 5.6 2.3 5.8 2.1 4.4 15.2 3.8 3.4 3.8 2.7 5.7 5.6 3.2 12.1 2.3 3.0 6.2 1.7 6.7 0.7 7.5 5.3 3.5 5.3 6.8 5.3 1.3 6.8 3.7 8.5 4.1 2.5 3.0 3.4 8.0 6.2 4.9 1.9 8.3 5.4 0.3 1.4 12.7 4.6 6.4 3.1 2.1 1.8 18.0 0.1 5.1 4.9 10.7 4.6 1.5 7.6 4.5 4.3 2.5 6.6 3.0 3.6 12.6 13.7 3.5 2.3 2.6 4.1 0.3 3.3 0.5 4.0 2.3 2.9 3.7 3.7 3.0 6.9 4.4 5.5 4.8 0.9 2.6 0.2 8.1 3.6 2.3 6.6 5.9 2.1 5.2 5.2 2.9 3.5 5.8 3.2 3.0 0.0 1.7 13.7 24.7 25.8 1.0 1.7 7.6 10.7 2.3 8.7 0.0 18.0 1.7 4.8 7.6 5.0 6.4 0.0 2.1 4.1 8.5 20.4 5.7 9.5 3.2 0.0 2.9 4.9 3.7 7.4 3.4 4.1 5.0 5.4 3.9 3.7 2.4 3.1 3.2 5.5 1.8 6.5 15.5 20.7 5.3 33.5 48.5 6.9 3.3 40.7 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 138.9;Late spermatids: 106.5;Spermatocytes: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" No No "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.8 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.2 7.8 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.2 3.1 15.4 19.5 0.0 5.3 17.1 12.8 19.0 0.1 11.0 15.1 4.8 10.9 11.5 28.7 7.4 17.0 5.6 13.5 12.4 13.2 6.5 7.0 10.4 2.6 8.9 20.6 8.4 11.6 15.4 11.4 23.9 24.2 6.9 20.6 9.5 22.7 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 6.0 10.9 21.0 6.3 2.2 28.1 7.4 15.3 49.5 10.3 5.2 51.1 17.2 8.3 9.9 138.9 17.6 2.7 23.3 18.2 7.7 11.1 7.1 20.8 7.6 10.9 27.0 18.4 9.2 13.2 106.5 7.5 9.8 5.0 10.8 2.7 5.3 15.5 0.0 8.5 5.4 45.4 0.0 11.4 106.3 31.1 1.5 22.1 18.7 2.9 6.5 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012312: AB_2668649" "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.2 7.0 9.6 19.5 8.4 9.3 8.0 27.0 24.7 16.2 18.4 11.9 12.4 13.7 2.2 20.9 17.6 12.7 13.7 7.0 23.1 9.2 10.9 5.6 7.7 3.5 9.2 7.4 15.5 5.5 6.7 9.4 14.2 10.4 5.7 7.7 9.1 24.4 17.2 9.6 6.0 4.8 8.7 4.3 8.3 6.1 19.5 11.2 4.4 20.6 9.3 13.0 15.1 17.2 9.8 14.8 18.2 5.8 5.7 27.9 15.0 15.6 15.8 11.5 13.4 17.1 8.8 12.0 24.0 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 6.0 17.5 23.8 17.3 14.2 7.8 21.5 15.3 9.4 9.1 7.0 11.8 11.2 0.0 4.0 10.8 9.0 5.3 0.0 5.8 7.0 14.7 6.5 37.1 4.3 10.4 3.2 5.2 23.4 33.1 4.4 11.2 29.4 10.1 1.8 6.0 4.0 6.0 5.8 12.7 1.8 9.3 12.9 12.8 22.9 32.2 15.6 12.4 35.5 4.5 20.4 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 5.9 1.1 0.2 0.3 0.2 1.5 7.9 4.1 3.7 0.1 0.2 0.1 0.0 2.8 0.6 0.2 7.8 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.2 1.0 0.0 1.6 0.0 13.1 0.0 2.4 0.0 0.2 0.3 0.2 0.2 0.2 16.5 0.0 0.0 1.1 0.0 0.1 0.1 0.1 2.1 15.6 0.0 0.1 0.0 1.1 0.0 0.0 0.0 4.3 8.7 4.4 1.1 0.2 0.0 0.3 5.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 0.0 0.0 0.0 0.0 0.2 13.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 13.1 0.0 3.0 0.0 1.4 0.1 4.5 0.1 0.1 0.0 0.0 0.0 PIGC ENSG00000135845 "Phosphatidylinositol glycan anchor biosynthesis class C" Q92535 1 172370189-172444086 "Enzymes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036663 Uncertain NA NA "HPA036663: AB_10669912" "unprognostic (3.35e-1)" "unprognostic (3.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (2.65e-1)" "unprognostic (3.72e-3)" "prognostic unfavorable (4.49e-4)" "unprognostic (7.25e-2)" "unprognostic (2.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.43e-8)" "unprognostic (1.09e-1)" "unprognostic (1.77e-1)" "unprognostic (6.04e-2)" "unprognostic (1.90e-1)" 13.8 13.1 10.0 9.0 11.2 14.4 13.9 11.3 12.3 14.4 12.3 9.0 20.9 9.3 14.5 26.1 11.6 15.1 12.1 14.1 8.4 10.2 11.5 12.5 9.0 13.1 12.0 6.6 14.9 16.4 9.2 11.6 14.4 9.6 17.1 12.3 13.2 12.7 15.7 14.8 21.3 15.8 13.5 9.9 12.4 10.5 13.5 9.8 14.2 15.8 10.8 12.3 11.0 10.8 18.9 12.5 27.4 14.5 25.1 33.8 19.2 17.7 15.3 20.9 14.2 15.8 14.4 15.6 11.6 13.0 20.1 17.6 13.7 26.1 9.6 17.1 13.8 15.9 19.2 13.6 16.8 16.2 21.1 15.7 11.7 14.6 17.1 17.6 23.9 15.4 21.5 20.2 14.4 15.9 15.7 12.7 18.5 17.6 18.4 16.1 9.1 18.1 21.4 21.5 36.5 21.5 15.0 17.0 17.0 30.9 13.2 10.9 20.9 16.8 19.9 26.1 30.9 17.6 17.1 11.6 12.8 21.5 15.6 12.3 12.3 17.4 15.0 9.2 15.7 24.2 27.4 14.5 27.3 19.4 13.5 16.4 18.9 22.7 20.4 12.5 16.7 33.8 24.2 9.5 25.1 14.1 12.4 19.8 19.2 10.0 11.2 11.3 12.3 8.4 10.2 12.0 6.6 9.6 9.8 8.9 10.1 18.2 17.0 11.9 14.3 17.9 15.3 20.1 7.9 27.9 7.9 53.2 28.2 27.8 72.4 18.6 18.4 23.3 35.8 42.5 35.1 14.9 7.0 12.5 31.2 19.1 7.5 19.6 25.3 53.5 43.7 17.2 25.3 25.2 19.3 18.1 26.8 22.6 38.2 18.2 14.2 32.3 18.5 28.9 16.0 16.7 19.8 26.6 20.4 14.1 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 22.3 10.2 13.4 9.4 14.2 10.8 7.6 10.1 12.2 12.4 12.9 9.8 14.6 11.0 33.9 10.1 15.4 12.3 11.4 9.6 15.4 10.0 10.6 9.1 7.1 6.6 13.1 10.2 17.0 8.1 15.0 10.0 9.5 9.9 6.7 18.0 6.2 22.1 11.3 20.3 26.3 13.3 6.0 17.8 11.6 14.3 15.8 15.9 12.8 7.5 13.0 14.4 17.0 11.7 13.9 10.5 40.5 9.5 3.5 11.9 5.2 13.0 15.5 27.9 32.1 20.8 10.8 12.6 12.3 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 17.9 21.8 19.9 24.6 15.1 31.0 10.7 20.4 9.4 11.4 27.9 45.2 17.1 29.9 6.9 19.9 15.7 18.7 0.0 4.9 17.4 22.4 27.9 11.5 14.4 17.0 31.8 15.1 17.8 18.3 17.2 25.9 19.4 20.3 10.8 17.7 33.8 5.4 14.4 32.9 29.9 34.6 25.8 19.4 21.4 33.5 13.9 9.7 17.8 26.3 16.3 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946343-196969060 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 26.5" "Group enriched" "Detected in many" 4 "Enterocytes: 66.9;Mucus-secreting cells: 56.2;Paneth cells: 75.0;Undifferentiated cells: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.3" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058599, HPA059920" Approved NA NA "HPA058599: AB_2683771, HPA059920: AB_2684162" "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.6 3.1 5.7 5.3 8.6 1.9 3.4 18.5 16.3 3.3 26.5 3.2 2.0 2.9 2.3 1.7 3.2 2.8 4.5 6.4 5.3 7.5 1.6 1.6 3.1 2.0 4.4 6.4 0.8 5.9 2.7 2.9 2.1 10.8 4.6 24.5 4.3 4.7 4.6 10.0 4.5 7.4 5.3 2.8 1.8 3.1 1.4 3.0 3.2 1.7 2.8 2.1 9.9 2.9 0.1 1.6 1.4 3.3 0.0 0.2 0.3 2.0 1.4 0.8 3.3 9.3 4.5 0.9 3.0 8.6 2.3 1.9 1.9 1.7 0.3 6.1 6.8 1.6 3.5 0.2 0.4 0.6 0.6 0.4 0.9 0.7 7.4 4.4 0.0 3.4 4.5 6.6 0.3 1.1 2.6 2.9 5.5 0.2 2.6 2.3 3.6 0.3 1.7 0.1 2.5 1.1 0.5 0.1 0.6 3.6 3.8 1.3 1.5 4.3 0.4 1.6 0.4 8.5 3.0 7.0 1.9 0.5 5.5 1.0 1.2 0.2 0.1 0.4 1.2 0.7 0.0 1.1 0.8 0.2 3.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 1.4 0.0 1.4 0.3 0.0 0.3 5.7 8.6 18.5 16.3 5.3 7.5 4.4 6.4 10.8 3.0 0.0 0.6 3.7 8.0 6.9 6.1 6.5 2.5 1.4 1.2 8.7 2.0 0.0 5.0 1.9 1.7 4.4 66.9 0.0 3.2 0.0 2.3 9.3 5.7 7.3 1.7 14.3 13.3 12.3 4.9 3.1 3.7 1.1 8.5 2.8 56.2 1.5 2.8 75.0 6.0 2.1 6.9 0.0 8.5 0.5 0.1 4.4 0.1 1.9 35.8 10.1 PINLYP ENSG00000234465 "Phospholipase A2 inhibitor and LY6/PLAUR domain containing" A6NC86 19 43576800-43583964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 19.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 17.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 33.8;HMC-1: 22.6;JURKAT: 17.5;REH: 13.7;THP-1: 17.0" HPA061218 Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA061218: AB_2684453" "unprognostic (6.72e-2)" "unprognostic (6.21e-2)" "unprognostic (4.72e-1)" "unprognostic (3.13e-2)" "unprognostic (2.46e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" "unprognostic (5.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.85e-2)" "unprognostic (1.14e-1)" "unprognostic (4.36e-3)" "unprognostic (1.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (3.60e-2)" 3.6 2.0 5.6 1.8 6.5 1.2 4.0 3.7 2.5 7.4 3.9 0.6 6.8 7.1 5.0 13.1 6.6 4.2 4.4 4.6 7.9 0.3 2.9 2.9 4.2 13.1 0.6 0.0 5.6 1.6 4.5 2.0 2.3 8.1 0.0 2.0 1.7 8.3 2.9 3.0 2.1 1.8 4.0 3.3 2.7 4.4 3.2 17.4 6.6 1.2 0.9 3.3 1.5 0.3 0.1 0.9 0.0 1.6 2.2 0.1 0.4 0.6 0.8 2.1 0.0 0.0 0.0 0.1 8.9 0.8 2.0 0.0 0.0 0.8 0.0 0.1 33.8 0.3 0.0 5.1 0.0 22.6 5.0 0.3 5.1 0.0 2.4 1.4 17.5 0.4 0.4 0.3 0.2 4.0 0.5 0.8 0.0 0.3 13.7 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 17.0 0.6 2.2 0.4 0.0 1.5 0.0 0.0 2.0 7.8 0.0 0.1 6.6 1.2 0.5 2.6 0.8 3.2 1.4 0.8 2.1 1.8 3.2 0.2 3.3 0.0 0.9 0.2 17.4 1.6 1.5 11.9 2.7 1.3 8.9 3.2 5.6 2.2 12.7 17.4 7.9 8.7 5.9 0.4 19.9 1.0 4.7 4.5 0.0 0.0 0.3 0.4 6.7 3.3 0.0 0.0 4.1 6.4 0.0 6.2 0.6 4.2 10.6 1.8 5.0 5.4 0.5 5.5 0.3 0.0 9.2 14.0 3.4 0.0 5.1 2.6 0.9 2.8 0.1 0.0 0.4 6.4 PIP5KL1 "bA203J24.5, MGC46424" ENSG00000167103 "Phosphatidylinositol-4-phosphate 5-kinase like 1" Q5T9C9 9 127920879-127930797 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 9.4;Ciliated cells: 9.4;Early spermatids: 20.0;Late spermatids: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Karpas-707: 29.6;RPMI-8226: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA056240 Uncertain Supported Cytosol NA NA Cytosol "HPA056240: AB_2683075" "unprognostic (2.15e-2)" "unprognostic (3.06e-1)" "unprognostic (1.23e-3)" "unprognostic (8.51e-5)" "unprognostic (1.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (5.20e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.57e-3)" "unprognostic (9.95e-8)" "unprognostic (1.87e-1)" "unprognostic (7.21e-2)" "unprognostic (6.05e-2)" "unprognostic (1.59e-1)" 0.6 0.7 3.1 0.6 1.0 1.4 2.5 2.4 5.3 2.1 0.6 1.9 0.6 0.5 1.3 0.6 3.7 1.8 1.2 0.6 2.1 2.9 1.3 0.6 2.9 0.6 1.4 2.6 0.7 1.3 6.5 4.8 1.6 8.3 3.3 0.2 1.0 8.7 4.1 0.6 4.7 0.6 1.0 1.5 0.6 2.4 2.5 1.2 0.6 2.9 0.6 0.6 1.2 4.0 2.4 1.3 0.0 1.2 0.0 1.0 0.3 0.0 0.5 0.4 0.5 0.5 1.3 2.8 0.6 0.5 0.1 0.1 0.2 3.6 0.3 1.1 2.4 1.1 1.1 0.0 2.6 0.1 0.3 1.7 0.0 0.8 0.0 0.9 0.0 0.1 1.4 1.7 0.3 0.0 0.9 0.0 2.4 0.0 29.6 0.0 2.5 0.0 1.0 0.2 1.1 0.4 0.2 0.0 19.3 0.0 0.0 1.0 1.8 0.1 0.7 0.0 0.3 1.1 1.4 0.3 0.3 1.0 0.6 0.1 2.6 1.7 0.7 5.3 0.4 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.0 0.1 0.0 1.0 2.4 0.2 0.1 0.0 0.0 0.1 1.3 0.0 0.3 3.1 1.0 2.4 5.3 2.1 2.9 1.4 2.6 8.3 1.2 0.0 9.4 0.5 3.7 1.9 0.2 0.5 0.0 9.4 1.2 5.2 0.0 0.7 1.7 1.2 20.0 0.6 0.0 0.0 1.3 3.8 0.8 1.9 0.0 0.0 0.3 4.8 0.0 0.6 0.3 14.7 0.9 0.0 0.0 0.0 0.2 1.7 1.2 0.0 0.4 0.0 0.7 0.0 0.8 1.1 0.9 1.0 2.6 0.0 0.2 1.8 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 177.5;Syncytiotrophoblasts: 204.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 39.6" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.27e-5)" 38.3 12.3 9.5 15.1 10.9 20.9 18.5 34.5 12.3 5.9 7.3 6.2 7.4 11.4 9.6 14.4 7.0 10.0 9.5 6.9 6.4 6.9 11.9 8.4 12.9 14.6 8.3 10.1 7.5 10.9 6.0 11.7 38.1 8.6 8.2 3.3 7.7 7.9 7.9 6.4 10.2 8.0 6.2 5.8 16.5 9.7 17.8 7.7 4.2 10.6 5.3 9.8 6.2 7.0 6.9 11.0 28.6 12.9 5.7 6.8 7.9 10.5 9.8 3.0 2.9 9.0 3.5 6.8 8.7 6.9 6.1 6.6 14.1 3.3 6.4 9.3 4.4 8.1 12.0 4.0 7.7 1.0 7.0 8.5 6.7 5.9 11.6 18.8 13.9 17.5 6.5 4.4 10.8 4.7 2.5 5.3 4.5 19.3 3.8 3.4 39.6 6.0 6.0 2.9 7.0 4.1 8.5 3.3 6.4 3.9 9.4 7.3 4.3 5.0 16.3 5.6 2.5 13.4 7.6 10.4 7.7 9.2 4.9 8.0 4.5 6.3 7.9 7.3 9.4 6.1 9.9 12.9 9.3 6.8 9.5 6.5 6.9 4.9 5.7 11.0 6.3 6.7 5.5 28.6 5.7 5.0 5.4 4.7 7.9 9.5 10.9 34.5 12.3 6.4 6.9 8.3 10.1 8.6 7.7 14.9 14.1 13.5 30.6 22.8 22.8 39.5 12.7 4.0 27.3 40.1 19.6 177.5 10.0 26.6 41.3 19.1 11.7 0.0 14.6 14.4 14.5 37.7 17.4 6.6 31.6 17.5 20.1 9.2 32.2 61.8 8.9 19.4 3.3 13.6 11.8 11.0 14.6 8.6 6.7 11.6 25.8 19.4 11.3 16.3 18.1 18.6 204.9 8.7 11.8 36.8 PIWIL3 HIWI3 ENSG00000184571 "Piwi like RNA-mediated gene silencing 3" Q7Z3Z3 22 24719034-24774720 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 4.7" "Cell type enriched" "Detected in some" 13 "Early spermatids: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;HeLa: 1.6;RPMI-8226: 1.1" HPA061955 Uncertain NA NA "HPA061955: AB_2684647" "unprognostic (9.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.12e-4)" "unprognostic (2.73e-1)" "unprognostic (7.33e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;testis: 30.9" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NB-4: 44.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036587, HPA036588, HPA057508" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 1.9 0.6 1.9 1.9 3.1 17.8 2.7 4.1 1.7 2.2 3.8 1.7 1.7 4.5 2.5 1.7 1.7 2.0 3.6 1.7 1.9 1.7 1.7 1.7 1.7 2.5 1.7 1.7 2.2 8.2 0.2 1.7 2.3 1.7 1.7 5.0 1.7 7.6 2.0 1.7 0.8 4.3 1.7 2.5 2.3 3.6 30.9 1.7 1.7 1.7 1.7 1.8 1.7 1.7 0.0 0.8 0.5 2.4 0.3 1.3 1.0 0.1 0.0 0.2 0.0 3.3 2.2 0.2 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 1.3 0.1 0.0 0.4 0.0 0.1 1.2 0.1 0.1 0.3 0.0 1.3 3.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.2 0.1 44.9 0.0 4.4 0.3 0.1 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.4 0.2 0.1 0.0 9.9 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 2.4 0.5 1.0 1.0 0.0 0.0 0.1 0.6 0.8 0.0 1.3 0.4 0.0 0.3 1.0 0.0 0.4 1.0 1.9 3.1 4.1 1.7 1.9 1.7 1.7 1.7 1.7 1.7 0.0 0.3 0.0 0.2 1.1 0.6 1.4 10.2 2.7 2.3 0.0 0.0 3.3 1.7 3.6 2.8 0.5 2.9 0.0 1.8 0.3 0.9 0.4 0.0 0.0 1.5 0.0 0.0 1.3 3.1 1.0 0.3 1.5 0.0 1.0 7.8 0.3 2.7 6.5 1.1 0.6 2.8 0.0 0.8 0.7 1.5 0.1 0.8 0.0 4.7 0.0 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Group enriched" "Detected in many" 5 "Early spermatids: 25.9;Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9;U-266/70: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.8 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.5 0.0 0.1 0.7 0.1 0.0 0.1 1.5 1.1 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.7 0.6 3.3 1.5 5.9 0.8 0.5 1.1 2.4 0.6 0.1 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.5 0.2 0.9 0.7 0.4 0.5 0.5 1.0 1.8 0.7 1.0 4.6 3.4 0.4 2.3 0.7 1.8 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 3.0 2.1 0.5 1.6 1.9 2.3 1.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 25.9 0.8 0.0 0.0 0.0 0.1 1.3 1.3 1.1 0.2 0.2 3.2 0.0 1.3 0.6 4.7 0.6 0.2 3.3 0.0 0.0 0.9 0.1 0.0 0.4 0.2 3.9 0.0 1.2 19.5 2.2 1.0 0.1 0.7 0.0 0.5 PKDCC "SgK493, Vlk" ENSG00000162878 "Protein kinase domain containing, cytoplasmic" Q504Y2 2 42048020-42058528 "Enzymes, Predicted secreted proteins" "Differentiation, Osteogenesis, Protein transport, Transport" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 69.1;Leydig cells: 127.4;Peritubular cells: 105.4;Rod photoreceptor cells: 93.6;Undifferentiated cells: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 31.2;ASC diff: 24.8;CACO-2: 36.9;HHSteC: 21.3;RH-30: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026427, HPA026442, HPA026526" Approved "Secreted to blood" NA NA 10000 "HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416" "unprognostic (6.77e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (3.59e-3)" "unprognostic (8.31e-2)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (5.79e-3)" "unprognostic (1.04e-2)" "unprognostic (1.32e-1)" "unprognostic (3.20e-1)" "unprognostic (6.09e-2)" "unprognostic (2.14e-2)" "unprognostic (9.08e-2)" "unprognostic (2.62e-1)" "unprognostic (4.73e-3)" "unprognostic (2.58e-3)" 21.4 5.7 1.9 8.4 1.8 0.8 18.9 0.3 4.7 20.8 13.7 1.7 6.3 9.3 17.6 16.0 9.2 10.0 29.6 17.0 2.3 0.7 4.7 3.5 8.0 3.7 3.7 0.3 43.6 3.3 0.9 3.2 3.2 2.6 13.0 5.2 17.0 38.6 5.6 40.2 1.7 7.7 26.2 2.3 4.6 4.8 14.1 2.3 4.2 3.1 13.1 2.1 22.8 23.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.0 5.5 31.2 24.8 0.3 2.0 0.1 0.0 0.4 0.6 36.9 0.0 0.0 0.1 0.6 0.7 0.0 0.5 0.0 0.0 3.0 1.3 0.0 1.3 9.8 21.3 0.0 0.4 2.1 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.1 0.1 0.0 0.1 9.1 2.5 0.6 0.0 10.8 0.0 0.0 0.0 1.1 1.9 0.5 0.0 0.0 6.7 0.0 0.2 0.0 0.2 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.8 0.3 4.7 2.3 0.7 3.7 0.3 2.6 2.3 17.9 0.3 0.5 0.2 2.9 2.1 8.1 2.5 0.0 0.0 1.8 15.7 0.4 0.0 1.8 1.1 1.9 11.8 0.0 1.2 1.2 21.1 0.9 0.0 2.6 0.6 0.0 69.1 3.7 0.3 2.6 127.4 0.2 1.7 0.0 11.8 20.3 1.2 14.0 105.4 3.2 93.6 12.9 8.5 0.5 1.2 1.6 0.2 0.0 34.2 0.1 PKDREJ ENSG00000130943 "Polycystin family receptor for egg jelly" Q9NTG1 22 46255663-46263355 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 13.8" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 3.9;Early spermatids: 1.8;Late spermatids: 1.9;Spermatocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;U-2 OS: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA034587 Enhanced NA NA "HPA034587: AB_10670570" "unprognostic (9.48e-3)" "unprognostic (1.09e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" "unprognostic (6.11e-2)" "unprognostic (5.06e-4)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (8.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-1)" "unprognostic (3.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.2 0.5 0.3 0.2 0.3 0.3 0.4 2.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.4 0.0 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.3 1.5 0.5 0.2 0.2 0.2 0.2 13.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.1 0.5 1.6 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.2 0.0 0.0 0.0 2.1 0.9 0.2 0.0 0.4 0.1 0.4 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 1.5 0.4 0.0 1.2 0.4 0.6 0.3 0.1 0.0 0.3 1.5 0.0 0.0 0.3 0.9 1.9 0.6 0.4 1.0 0.5 0.0 0.4 0.2 0.2 1.9 0.1 0.3 0.9 0.1 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 1.8 3.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 5.8 0.4 0.5 0.0 0.0 0.2 0.0 PKHD1L1 ENSG00000205038 "PKHD1 like 1" Q86WI1 8 109362477-109530330 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 91.7" "Group enriched" "Detected in some" 7 "B-cells: 36.0;Ito cells: 10.4" "Group enriched" "Detected in some" 18 "endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Group enriched" "Detected in some" 9 "memory B-cell: 1.8;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 10 "B-cells: 1.8" "Cell line enhanced" "Detected in some" "HHSteC: 4.2;HUVEC TERT2: 2.3;TIME: 4.7;U-266/70: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044458 Uncertain NA NA 5100000 "HPA044458: AB_2678949" "unprognostic (9.07e-3)" "unprognostic (3.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.61e-4)" "unprognostic (5.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.91e-2)" "unprognostic (3.45e-2)" "unprognostic (3.31e-2)" "unprognostic (1.98e-1)" "unprognostic (9.65e-3)" "unprognostic (1.92e-1)" "unprognostic (7.76e-6)" "unprognostic (4.56e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-3)" "unprognostic (2.73e-2)" 12.4 1.5 0.1 4.2 0.1 0.4 2.6 0.0 0.2 13.8 5.7 0.1 2.1 1.1 3.5 8.9 2.5 11.5 3.5 5.2 0.1 0.1 0.8 0.8 16.9 22.5 0.4 0.0 3.5 0.7 0.2 0.4 0.2 1.1 1.4 1.6 4.2 1.7 1.5 2.0 0.9 2.0 3.2 0.2 0.3 0.8 1.6 0.0 0.0 91.7 2.9 1.1 2.1 3.2 1.8 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.1 0.0 0.0 3.2 36.0 0.0 0.2 0.0 2.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.5 0.0 0.0 1.7 10.4 1.2 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 PKIG ENSG00000168734 "CAMP-dependent protein kinase inhibitor gamma" Q9Y2B9 20 44531785-44624247 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "memory B-cell: 58.2;naive B-cell: 62.1" "Lineage enriched" "Detected in many" 10 "B-cells: 62.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 104.3;HSkMC: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042703, HPA063690" Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA042703: AB_10797018, HPA063690: AB_2685091" "unprognostic (3.15e-2)" "unprognostic (5.65e-2)" "unprognostic (8.07e-2)" "unprognostic (1.44e-3)" "unprognostic (3.16e-1)" "unprognostic (9.49e-2)" "unprognostic (3.96e-2)" "unprognostic (6.46e-3)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "prognostic favorable (4.90e-5)" "unprognostic (6.26e-2)" "unprognostic (9.08e-2)" "unprognostic (1.19e-2)" "unprognostic (1.35e-2)" "unprognostic (4.22e-1)" "unprognostic (3.96e-2)" 21.1 25.1 39.2 22.7 31.9 7.5 18.4 12.9 37.7 28.0 44.0 13.5 15.4 12.5 31.8 19.3 31.7 31.4 29.3 107.1 23.0 17.2 22.9 14.4 39.0 17.9 16.7 25.9 17.2 13.3 13.8 19.5 32.6 14.3 30.2 13.3 26.2 18.8 32.5 25.6 8.0 17.9 52.8 11.9 13.2 24.1 41.5 11.4 3.2 25.8 18.6 18.2 42.2 20.3 62.1 6.2 0.4 0.3 0.7 1.6 3.1 5.3 5.4 8.8 5.8 13.4 27.4 1.3 12.8 104.3 14.5 11.0 12.4 2.4 20.5 10.5 11.2 12.1 2.0 1.7 2.8 4.7 10.4 3.2 3.2 0.8 8.8 12.4 0.4 0.2 42.3 5.7 7.0 1.6 7.3 32.3 5.7 2.5 0.5 1.3 6.7 3.2 5.2 4.7 0.0 7.8 0.5 0.2 0.5 8.0 1.1 3.6 11.8 3.3 1.5 8.6 4.0 4.1 2.6 20.9 19.9 8.9 8.8 6.1 2.8 7.7 14.4 9.9 0.3 8.5 0.4 0.3 0.1 0.2 0.2 0.2 58.2 0.3 0.3 1.5 62.1 1.0 1.6 0.4 0.7 0.2 6.2 0.1 3.1 39.2 31.9 12.9 37.7 23.0 17.2 16.7 25.9 14.3 11.4 8.9 6.7 86.2 15.6 22.3 17.8 177.7 22.9 76.3 13.6 43.6 19.6 11.6 107.8 61.0 80.2 91.6 30.7 0.0 27.2 12.5 63.7 12.6 46.2 28.4 7.2 9.5 42.4 39.3 3.1 23.1 67.6 9.1 47.2 11.8 13.1 46.7 31.9 44.8 57.7 115.7 24.6 116.4 170.2 111.2 27.2 26.2 30.7 5.2 21.3 9.2 PKNOX2 ENSG00000165495 "PBX/knotted 1 homeobox 2" Q96KN3 11 125164687-125433389 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 28.7;Melanocytes: 8.5;Peritubular cells: 16.6" "Cancer enhanced" "Detected in many" "melanoma: 8.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.2;AN3-CA: 6.8;hTEC/SVTERT24-B: 5.4;LHCN-M2: 8.0;SK-MEL-30: 5.4;WM-115: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028867, CAB034342, HPA055368, HPA066962" Supported Enhanced "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757" "unprognostic (2.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-2)" "unprognostic (7.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.44e-2)" "unprognostic (7.66e-2)" "unprognostic (3.70e-1)" "unprognostic (4.10e-6)" "unprognostic (1.76e-3)" "unprognostic (7.11e-2)" "unprognostic (1.71e-2)" "unprognostic (6.48e-3)" 5.8 4.1 10.0 3.3 12.4 0.7 1.7 16.3 25.7 5.1 2.8 3.6 0.2 2.0 5.6 4.7 2.7 9.8 3.4 7.9 7.3 6.9 2.9 1.1 9.6 2.4 5.2 12.3 23.6 6.3 0.9 7.3 12.8 6.9 10.2 2.8 24.3 2.5 8.7 19.5 4.0 2.4 4.6 4.6 3.4 2.5 7.2 3.1 0.0 18.3 8.4 2.2 3.3 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 27.2 6.8 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.4 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.4 16.3 25.7 7.3 6.9 5.2 12.3 6.9 3.1 0.0 0.0 0.0 0.0 0.8 0.9 4.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.7 28.7 0.5 0.0 0.0 0.2 0.0 1.4 1.8 0.0 0.0 0.2 7.9 0.0 1.3 0.0 7.4 4.6 0.0 8.5 0.0 0.0 3.3 0.2 0.0 16.6 0.0 0.2 6.5 3.1 0.7 0.1 0.4 0.1 0.0 0.0 0.0 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 0.3 0.5 0.1 0.0 0.2 0.0 0.0 23.9 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 0.0 1.7 0.0 0.3 0.6 0.0 1.2 2.5 2.7 1.2 14.0 0.0 0.1 1.7 2.7 5.2 8.7 0.0 0.0 1.9 0.0 0.6 0.3 1.1 21.7 1.6 0.0 1.7 4.9 0.3 2.2 0.3 5.3 1.7 7.2 0.0 0.0 2.2 0.0 13.4 4.9 0.0 0.0 0.3 0.0 0.2 0.5 1.6 0.0 0.0 0.3 PLA2G4E FLJ45651 ENSG00000188089 "Phospholipase A2 group IVE" Q3MJ16 15 41981582-42051190 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 19.9" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 2: 8.0;Basal keratinocytes: 16.1;Suprabasal keratinocytes: 39.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;HaCaT: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041105 Enhanced NA NA "HPA041105: AB_2677300" "unprognostic (2.98e-1)" "unprognostic (5.52e-1)" "unprognostic (2.60e-1)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.77e-1)" "unprognostic (4.22e-2)" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-7)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (4.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.2 16.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 39.3 0.0 0.0 0.0 0.5 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 14.1;RT4: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.1 0.0 14.1 0.1 0.0 0.0 0.1 0.0 10.6 0.6 0.1 0.0 1.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 54.9 0.0 3.3 4.8 0.0 3.2 0.0 0.0 0.0 5.2 0.0 1.5 3.3 0.2 0.0 0.0 12.0 0.0 1.2 0.7 0.2 2.7 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 4.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 1.0 0.0 4.3 1.6 PLAC1 "CT92, OOSP2L" ENSG00000170965 "Placenta specific 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 90.4" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 5.2;Peritubular cells: 7.4;Spermatogonia: 2.7;Syncytiotrophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 18.7;hTCEpi: 14.7;hTERT-HME1: 6.0" "Not detected" "Not detected" HPA063425 Enhanced "Secreted in female reproductive system" NA NA "HPA063425: AB_2685012" "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.2 1.1 0.3 0.3 1.0 0.0 1.7 0.2 0.1 1.7 0.3 0.4 18.7 0.0 0.1 0.2 2.3 0.0 0.0 0.8 14.7 0.1 6.0 0.1 2.2 0.1 0.1 1.6 0.1 0.9 0.0 0.2 0.0 1.2 2.4 0.0 0.3 3.2 0.0 0.0 2.9 0.0 0.0 3.5 0.6 2.2 0.1 0.0 0.0 0.4 0.7 0.2 0.0 0.4 0.0 0.3 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.0 0.0 0.9 2.7 0.0 8.9 0.0 0.0 0.0 PLAC8 "C15, onzin" ENSG00000145287 "Placenta specific 8" Q9NZF1 4 83090048-83137075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 305.1;Ciliated cells: 487.2;Enterocytes: 398.3;Extravillous trophoblasts: 527.8;Kupffer cells: 319.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 181.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 32.2;CAPAN-2: 93.1;HL-60: 57.7;NB-4: 28.4;RPMI-8226: 41.6;THP-1: 33.5;U-937: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040465, HPA077912" Enhanced Approved Cytosol NA NA Cytosol "HPA040465: AB_10794875, HPA077912: AB_2686870" "unprognostic (6.82e-5)" "prognostic favorable (3.03e-4)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.05e-1)" "unprognostic (4.86e-2)" "unprognostic (1.14e-1)" "unprognostic (1.94e-3)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (7.44e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-7)" "unprognostic (3.89e-2)" "unprognostic (2.85e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" 2.3 1.3 1.7 47.9 5.9 62.0 1.6 0.7 4.1 6.1 44.1 0.6 0.2 14.6 1.0 0.9 34.5 3.1 7.5 2.4 1.4 1.9 1.6 12.4 23.4 51.6 2.5 0.2 1.9 1.2 0.0 1.3 32.3 3.0 2.0 31.4 1.3 9.7 1.0 0.8 0.7 66.5 3.1 5.2 74.8 21.8 0.7 2.7 18.2 1.5 1.4 53.1 3.4 2.5 41.5 181.6 7.0 47.8 77.6 32.9 36.0 32.2 0.2 0.1 0.2 0.0 0.0 5.3 0.8 0.2 2.0 2.5 0.6 93.1 5.4 0.2 9.4 3.2 3.4 0.5 0.2 7.7 0.0 0.1 0.1 6.4 2.7 0.3 57.7 0.3 0.1 0.6 0.3 0.4 0.0 0.1 2.8 0.0 0.4 5.3 0.1 10.9 28.4 0.2 2.5 0.1 1.4 1.9 41.6 0.1 0.9 4.7 0.0 0.2 5.4 0.1 1.7 0.3 33.5 0.2 0.2 6.0 0.1 0.1 0.3 0.0 14.4 0.4 26.6 0.0 2.7 11.0 7.0 32.9 47.8 24.9 41.5 15.7 18.7 10.0 38.4 19.4 22.0 2.4 77.6 25.8 181.6 1.0 36.0 1.7 5.9 0.7 4.1 1.4 1.9 2.5 0.2 3.0 2.7 181.7 50.7 305.1 1.9 0.3 0.0 0.4 2.5 487.2 61.4 0.0 0.0 7.9 0.0 0.0 0.2 1.4 398.3 0.0 3.3 527.8 0.9 0.9 25.5 1.5 20.9 1.6 83.1 171.9 319.5 0.4 0.0 79.4 6.8 1.0 179.6 1.3 57.7 270.0 0.0 0.8 0.1 6.5 0.3 0.2 0.1 0.1 11.9 261.7 36.3 8.4 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084386-146104369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 20.4" "Group enriched" "Detected in some" 78 "Early spermatids: 401.3;Late spermatids: 218.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074266 Approved Nucleoplasm NA NA Nucleoplasm "HPA074266: AB_2686676" "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.4 0.1 0.9 0.4 1.0 0.1 1.0 1.6 0.8 0.4 0.4 0.4 0.4 0.0 0.5 0.5 0.4 0.6 0.4 0.4 1.0 1.0 0.4 0.5 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.9 3.1 0.6 0.5 1.9 0.4 0.1 20.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.9 2.7 2.6 9.8 0.7 1.1 0.6 1.0 0.4 4.2 2.7 0.4 1.2 1.5 2.2 1.1 0.9 0.7 4.0 0.0 3.5 3.2 5.6 2.2 0.9 1.1 0.5 0.9 1.8 0.0 6.3 3.2 2.5 0.5 1.5 3.3 0.2 2.0 1.1 0.0 0.9 2.9 0.5 0.3 3.8 0.9 0.5 0.0 0.3 0.0 2.4 1.2 1.1 0.4 2.3 0.8 0.2 0.9 1.1 0.0 3.7 1.1 1.9 1.2 3.2 1.3 0.8 1.6 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 1.0 1.6 0.8 1.0 1.0 1.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 218.3 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.2 3.2 1.5 0.0 0.1 0.0 0.1 0.0 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607765-218637184 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009914, HPA038139, HPA038140" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.1 2.5 1.5 1.0 1.6 0.5 1.0 0.9 2.4 0.6 6.4 0.3 3.8 0.9 0.8 1.1 3.7 0.6 0.9 0.9 1.0 1.5 3.9 0.5 0.7 0.7 1.6 1.0 0.7 0.4 1.4 4.7 0.6 2.6 6.4 1.5 23.0 1.4 0.6 62.5 0.8 1.4 33.1 1.1 0.5 3.5 3.9 0.5 0.0 1.4 6.8 0.5 9.6 5.3 0.9 1.2 0.3 0.4 0.9 0.9 1.0 0.6 1.6 2.2 0.4 0.2 1.4 1.2 1.2 2.6 0.4 1.4 2.4 0.3 1.4 1.8 0.4 1.0 1.0 0.0 1.5 0.3 0.5 1.8 1.2 3.6 1.9 0.2 1.2 0.6 3.0 0.1 2.0 0.5 4.8 2.8 0.8 1.0 1.1 2.3 1.8 0.4 1.2 0.7 0.2 3.4 0.9 0.8 0.5 4.4 3.0 2.3 21.5 1.0 0.8 0.3 1.3 2.6 0.5 6.1 1.6 1.2 0.7 0.7 0.5 0.8 0.9 4.7 0.3 1.6 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.3 0.9 0.3 0.9 0.7 0.8 0.3 0.9 0.0 1.2 0.7 1.0 1.5 1.6 0.9 2.4 1.0 1.5 1.6 1.0 2.6 0.5 0.0 1.4 0.0 0.2 0.5 81.4 0.8 0.0 0.0 0.0 0.0 231.7 0.1 0.0 0.2 14.2 1.1 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.0 0.5 7.9 0.0 0.0 0.0 22.0 0.3 0.0 0.0 0.0 0.0 8.8 0.4 0.0 0.0 1.4 181.4 0.0 1.4 2.2 0.8 0.1 0.7 0.0 0.0 0.1 PLCH2 "KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1" ENSG00000149527 "Phospholipase C eta 2" O75038 1 2425980-2505530 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;retina: 28.6;skin 1: 36.6" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 76.1;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 155.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "NK-cells: 2.9;T-cells: 2.4" "Group enriched" "Detected in some" 4 "HBEC3-KT: 50.7;hTCEpi: 23.9;hTERT-HME1: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072705 Enhanced NA NA "HPA072705: AB_2732211" "unprognostic (2.06e-3)" "unprognostic (1.30e-2)" "unprognostic (1.09e-3)" "unprognostic (3.84e-3)" "unprognostic (1.99e-1)" "unprognostic (1.59e-2)" "unprognostic (7.39e-2)" "unprognostic (7.70e-2)" "unprognostic (7.58e-2)" "unprognostic (9.28e-2)" "unprognostic (2.26e-1)" "unprognostic (5.95e-2)" "unprognostic (6.61e-3)" "unprognostic (8.43e-2)" "unprognostic (1.07e-1)" "unprognostic (8.64e-2)" "unprognostic (5.80e-2)" 0.5 1.2 6.4 2.9 9.1 1.4 3.1 32.0 25.1 3.2 0.9 1.6 0.5 1.6 0.3 1.7 9.7 2.5 2.4 0.3 20.2 2.7 0.8 0.8 1.2 4.0 2.6 8.4 0.2 1.7 0.1 3.0 0.4 2.6 6.7 0.7 28.6 8.6 4.9 0.2 36.6 2.0 0.2 6.4 4.0 1.7 0.8 2.0 0.2 1.2 0.2 4.9 8.3 6.4 0.3 0.1 0.0 0.0 2.9 2.4 0.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 7.0 0.0 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 14.3 0.0 0.0 0.0 0.0 1.2 0.1 0.4 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.1 2.8 5.7 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.3 1.5 1.4 0.0 0.3 1.1 0.7 0.0 2.9 0.0 0.1 2.1 0.9 6.4 9.1 32.0 25.1 20.2 2.7 2.6 8.4 2.6 2.0 0.0 1.7 2.0 13.5 13.7 76.1 3.2 5.1 1.4 4.5 0.0 70.7 0.0 1.7 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.5 4.9 0.0 0.0 0.1 25.4 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.4 12.3 0.2 0.0 0.0 16.6 155.3 0.0 0.9 0.1 0.2 12.8 0.0 6.9 0.4 6.7 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 25.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 53.8" "Low region specificity" "Detected in many" HPA007721 Approved Approved Cytosol NA Yes Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 7.4 1.5 6.5 5.3 42.3 18.8 8.7 24.6 19.1 8.9 3.7 2.1 2.1 5.3 9.1 2.1 11.4 3.5 5.3 2.8 7.1 4.2 3.1 5.4 3.5 10.0 4.8 3.6 19.3 4.3 2.3 5.5 12.5 29.2 3.5 3.5 2.1 7.0 2.4 4.5 11.6 5.9 2.1 22.2 10.5 17.3 3.6 6.7 2.1 5.1 2.1 5.4 4.7 7.9 5.8 2.9 6.3 11.9 1.8 4.1 2.7 8.8 33.9 8.2 12.3 1.7 1.3 6.5 8.0 0.9 4.3 4.2 13.7 9.6 11.4 5.6 3.5 6.4 2.8 2.0 5.3 2.3 6.8 15.1 53.8 11.0 18.2 5.3 5.5 21.2 7.0 0.7 15.8 1.6 2.9 3.3 18.6 14.0 6.2 3.1 2.8 16.6 8.1 17.4 2.3 6.6 9.4 4.4 16.6 1.3 4.1 8.8 4.7 8.1 4.8 7.4 5.9 9.2 7.7 2.3 5.7 9.1 6.2 8.8 2.1 5.6 26.3 3.7 14.6 6.1 4.3 3.8 6.3 2.8 8.1 3.9 2.3 2.2 3.4 2.9 5.8 2.8 2.7 4.9 1.8 11.9 2.7 4.1 2.7 6.5 42.3 24.6 19.1 7.1 4.2 4.8 3.6 29.2 6.7 8.9 25.9 6.1 8.4 6.2 8.1 2.2 7.6 0.0 2.3 0.0 2.0 8.4 0.0 5.1 0.6 3.9 11.5 0.0 1.6 9.0 3.4 4.9 3.5 6.4 4.8 7.9 2.9 6.2 6.5 0.6 2.3 6.4 0.0 1.0 7.5 2.8 12.0 8.7 3.5 1.4 6.1 12.9 4.1 7.9 18.3 7.5 22.5 4.4 7.4 7.1 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.0" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.2" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6" "Cell line enhanced" "Detected in many" "HBF TERT88: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 1.5 1.0 1.9 3.4 5.8 9.6 1.2 5.8 10.9 1.6 2.8 0.4 0.0 6.1 1.0 0.6 1.8 1.2 1.9 1.5 3.6 2.5 2.5 4.1 2.0 5.9 2.9 6.8 1.1 2.3 0.4 4.1 16.0 10.3 1.5 3.6 4.1 2.0 0.7 1.2 1.5 5.9 0.9 2.9 3.5 2.1 4.2 1.1 3.1 3.2 0.5 4.8 1.9 1.6 0.9 7.2 0.6 0.0 2.1 3.6 0.6 3.0 2.7 2.6 1.2 0.1 0.1 0.8 5.3 2.5 5.0 4.4 1.9 1.5 2.2 2.7 0.2 1.6 7.5 1.1 5.1 9.7 0.6 1.3 0.5 5.0 1.7 0.4 0.7 2.6 0.0 1.0 1.6 3.0 4.7 2.8 2.9 0.1 5.4 0.6 0.3 1.5 0.5 0.9 2.0 6.8 1.4 3.8 2.0 2.4 3.1 0.6 4.6 1.1 0.7 1.1 3.1 0.4 0.2 2.6 1.1 6.8 0.5 1.0 6.5 0.9 0.4 0.5 0.4 0.3 0.6 0.0 0.0 3.6 0.0 3.5 0.5 1.9 3.5 0.3 0.9 0.9 2.0 0.2 2.1 0.0 7.2 1.7 0.6 1.9 5.8 5.8 10.9 3.6 2.5 2.9 6.8 10.3 1.1 17.9 2.1 0.5 6.9 0.1 0.7 1.9 28.1 0.0 1.2 57.6 3.9 0.0 135.9 36.1 11.5 0.0 1.3 0.0 43.6 0.0 0.1 3.8 0.0 132.8 0.0 6.4 24.1 0.0 1.6 8.9 0.3 0.0 0.0 0.0 4.9 0.0 45.8 0.0 0.4 94.0 3.7 0.0 0.0 0.5 0.4 0.1 0.0 2.2 1.1 12.2 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306954-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4;heart muscle: 36.6;ovary: 27.6" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 124.0;Intestinal endocrine cells: 40.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 33.4" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 15 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.4;PC-3: 5.6;SH-SY5Y: 26.3;TIME: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 7.0 15.3 6.9 1.2 4.5 0.8 4.5 33.4 6.5 4.5 1.4 2.0 1.4 1.3 1.6 1.7 1.4 2.5 3.4 36.6 4.8 8.1 7.3 2.2 2.0 7.9 4.2 4.2 27.6 4.8 1.3 13.7 0.8 9.0 1.9 1.5 0.5 1.2 2.0 0.9 0.9 1.7 2.1 5.8 0.9 5.9 1.1 2.1 0.0 1.4 0.0 1.0 1.4 6.1 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.3 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 26.3 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 6.9 4.5 33.4 5.5 4.8 8.1 4.2 4.2 9.0 2.1 0.0 0.0 0.0 0.0 0.1 0.4 124.0 7.6 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.7 3.6 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.2 0.1 1.6 40.9 19.6 0.3 2.5 7.2 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.4 9.7 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924816-104937790 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 229.9" "Group enriched" "Detected in some" 4 "B-cells: 25.7;Hofbauer cells: 28.1;Macrophages: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 229.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 229.9" "Group enriched" "Detected in some" 5 "HMC-1: 34.9;RPMI-8226: 25.0;THP-1: 63.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2000000 "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.7 1.6 8.9 6.7 8.8 15.0 1.9 5.7 10.0 1.5 1.3 23.1 0.1 5.6 1.5 0.5 1.1 2.8 3.5 0.8 8.7 8.4 1.2 0.9 2.6 14.4 14.5 3.4 0.9 1.6 1.0 2.8 1.2 9.0 2.1 0.8 1.5 4.6 2.3 0.5 0.9 5.5 0.9 19.0 11.6 3.5 0.8 9.2 2.7 1.0 0.0 11.2 3.9 0.9 14.7 229.9 43.4 17.7 1.7 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 8.8 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 2.8 43.4 0.0 11.9 0.1 14.7 0.0 0.0 35.1 12.3 0.1 0.0 0.6 1.7 17.7 229.9 0.0 4.4 8.9 8.8 5.7 9.6 8.7 8.4 14.5 3.4 9.0 9.2 0.0 0.0 25.7 0.1 0.3 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.4 0.1 3.5 0.0 28.1 1.6 0.0 0.0 1.3 2.5 0.0 25.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.5 0.4 0.7 0.1 0.4 0.2 0.0 0.0 0.0 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol No No Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: AB_2681105" "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 4.0 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 4.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.5 0.0 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 PLEKHD1 UPF0639 ENSG00000175985 "Pleckstrin homology and coiled-coil domain containing D1" A6NEE1 14 69484692-69531551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.4;brain: 16.0" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 217.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "cerebellum: 16.0" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.4" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.4" "Cell line enhanced" "Detected in some" "OE19: 2.8;SK-BR-3: 6.2;T-47d: 6.0;U-266/70: 2.8" "Region enhanced" "Detected in many" "cerebellum: 33.7" "Low region specificity" "Detected in all" HPA051875 Uncertain NA NA "HPA051875: AB_2681648" "unprognostic (8.73e-2)" "unprognostic (4.64e-3)" "unprognostic (3.73e-2)" "unprognostic (4.03e-2)" "unprognostic (7.58e-2)" "unprognostic (3.15e-3)" "unprognostic (1.44e-1)" "unprognostic (1.64e-3)" "unprognostic (3.28e-1)" "unprognostic (1.83e-1)" "unprognostic (4.56e-3)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.42e-2)" 0.3 0.3 0.4 0.1 1.5 1.1 1.4 16.0 2.2 0.5 0.2 0.5 2.5 0.3 0.2 4.2 0.2 0.2 0.2 0.3 0.6 0.5 1.8 0.1 0.4 2.0 0.8 0.1 0.2 0.5 4.5 0.6 0.1 1.4 0.2 0.0 4.1 3.9 4.0 0.2 2.0 0.2 0.1 0.6 0.4 0.3 1.8 0.4 0.8 4.0 0.1 0.5 0.2 0.2 0.2 7.4 0.6 0.1 0.1 0.1 0.0 0.3 0.3 0.5 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.7 0.5 0.5 0.1 0.2 0.5 0.8 0.1 0.1 0.5 0.4 0.1 0.4 0.1 0.1 0.5 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.3 0.2 1.2 0.1 0.9 0.4 0.4 0.7 2.8 0.1 0.3 0.1 0.2 0.5 0.5 0.8 1.9 0.2 6.2 0.1 0.2 6.0 0.2 0.2 0.3 0.8 0.4 0.3 2.8 0.6 0.3 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.1 7.4 0.1 0.0 0.4 1.5 16.0 2.2 0.6 0.5 0.8 0.1 1.4 0.4 0.0 8.2 0.0 1.7 0.3 46.2 0.8 0.0 1.4 3.4 0.0 3.9 0.0 3.3 0.1 0.3 0.7 0.0 0.0 0.2 0.1 0.4 1.4 1.1 0.0 0.1 217.7 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.0 0.0 1.7 0.2 0.0 0.0 0.1 5.3 0.0 0.4 0.5 0.2 0.3 0.1 0.5 0.0 0.6 PLEKHG7 FLJ46688 ENSG00000187510 "Pleckstrin homology and RhoGEF domain containing G7" Q6ZR37 12 92721462-92772455 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 5.6;fallopian tube: 7.9" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 31 "memory B-cell: 4.5;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 45 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.1;RT4: 1.2;SK-BR-3: 4.2" HPA060632 Uncertain NA NA "HPA060632: AB_2684333" "unprognostic (4.47e-3)" "unprognostic (3.95e-2)" "unprognostic (1.16e-1)" "unprognostic (1.05e-3)" "unprognostic (1.80e-2)" "unprognostic (9.91e-5)" "unprognostic (1.38e-1)" "unprognostic (9.44e-2)" "unprognostic (1.61e-1)" "unprognostic (6.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.13e-1)" "unprognostic (2.75e-1)" "unprognostic (3.27e-5)" 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.3 0.6 0.1 0.4 5.6 0.1 7.9 0.3 0.0 0.0 0.0 0.7 0.5 2.2 2.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.4 0.1 0.6 0.0 0.0 2.6 0.0 0.0 1.6 2.7 0.1 0.0 2.9 2.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.2 1.8 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 5.1 0.1 1.2 0.0 0.0 0.0 4.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.9 0.1 0.1 0.3 0.6 0.0 56.2 11.4 1.8 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 1.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533301-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0;thyroid gland: 30.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 37.3;Mucus-secreting cells: 17.4;Rod photoreceptor cells: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;BEWO: 9.7;RT4: 9.8;SK-MEL-30: 12.1;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome NA NA Centrosome "HPA047707: AB_2680126, HPA051964: AB_2681675" "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favorable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" 1.3 4.5 9.7 1.6 33.7 0.5 2.9 8.6 26.8 3.5 6.8 61.0 2.5 11.6 1.9 8.9 1.6 3.8 2.5 1.1 16.2 8.7 2.7 0.8 1.2 0.6 35.8 16.6 0.6 7.7 10.3 3.3 2.0 26.9 10.7 7.0 5.1 20.3 2.9 1.1 4.1 9.0 1.3 38.1 1.3 6.6 2.3 34.4 0.0 30.2 0.0 0.7 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 2.0 10.0 0.2 0.0 9.7 0.0 0.0 0.1 0.1 3.1 1.6 0.0 1.6 0.0 0.9 2.2 3.5 0.8 0.1 0.3 3.5 0.0 1.6 2.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.2 3.7 0.0 0.0 7.2 0.0 0.2 3.0 5.7 0.6 0.1 0.3 1.4 1.1 9.8 2.7 2.5 0.8 1.9 12.1 4.9 9.6 2.0 0.0 0.8 3.7 1.0 0.6 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 33.7 8.6 18.1 16.2 8.7 35.8 16.6 26.9 34.4 3.0 8.3 0.0 0.7 0.1 6.9 3.1 2.5 1.4 0.0 8.7 37.3 2.2 3.3 1.8 0.4 0.0 11.9 0.0 3.5 0.3 0.4 3.5 0.0 0.0 0.7 3.2 7.0 0.0 0.8 0.0 0.3 0.8 3.3 0.0 17.4 5.5 2.5 8.6 0.4 1.3 37.9 0.0 0.4 0.4 1.4 1.9 8.9 0.0 16.1 1.0 PLEKHM3 "DAPR, PLEKHM1L" ENSG00000178385 "Pleckstrin homology domain containing M3" Q6ZWE6 2 207821288-208025560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.1;Club cells: 10.3;Cone photoreceptor cells: 11.8;Rod photoreceptor cells: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035046 Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA035046: AB_10603128" "unprognostic (3.62e-1)" "unprognostic (1.58e-2)" "unprognostic (8.27e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (4.77e-2)" "unprognostic (6.06e-2)" "unprognostic (8.20e-2)" "unprognostic (4.13e-2)" "unprognostic (2.92e-3)" "unprognostic (2.17e-1)" "unprognostic (1.09e-1)" "unprognostic (4.86e-4)" "unprognostic (2.42e-1)" "unprognostic (3.12e-1)" "unprognostic (5.72e-2)" "unprognostic (1.33e-2)" 6.5 10.9 10.0 4.1 11.2 11.1 5.1 11.8 16.8 5.6 5.0 10.6 2.1 3.3 6.2 3.4 4.2 4.5 4.5 6.6 7.3 7.8 5.1 6.8 6.2 4.3 6.2 11.4 9.1 4.8 17.3 7.2 4.6 13.1 6.4 4.9 6.5 5.4 4.8 5.1 5.2 3.9 5.9 8.6 4.9 4.6 5.3 7.5 4.1 10.6 2.3 4.5 4.8 5.4 2.3 1.9 6.7 2.1 2.0 2.7 0.6 1.5 1.3 3.4 1.9 5.6 5.7 5.1 3.1 3.3 2.5 2.3 1.7 1.3 1.3 3.1 3.5 2.4 1.6 3.4 4.4 3.3 2.4 5.3 2.6 4.2 2.7 3.4 2.8 1.5 4.7 5.4 2.8 3.3 3.8 2.6 4.2 1.6 3.6 3.1 0.8 3.4 1.9 3.2 1.1 1.6 2.7 2.8 2.7 1.2 1.7 7.2 3.8 2.8 0.3 3.0 5.7 0.9 2.3 3.7 3.9 2.4 2.4 2.0 4.0 4.7 1.3 4.5 1.7 2.9 3.0 2.1 0.9 2.5 0.8 1.0 2.3 2.3 2.2 1.9 1.7 2.7 2.3 6.7 2.0 1.7 1.9 1.3 0.6 10.0 11.2 11.8 16.8 7.3 7.8 6.2 11.4 13.1 7.5 17.9 17.1 0.0 0.3 0.0 3.0 0.8 2.5 1.4 10.3 1.8 11.8 0.2 0.0 2.5 2.1 0.1 1.1 0.0 3.0 0.4 0.2 0.3 0.0 0.4 0.5 6.4 0.0 0.0 1.2 3.3 0.3 2.5 0.0 7.2 0.0 3.1 3.2 1.4 0.0 3.8 9.9 0.0 0.4 0.2 0.7 0.1 0.1 0.5 0.3 0.0 PLET1 C11orf34 ENSG00000188771 "Placenta expressed transcript 1" Q6UQ28 11 112248479-112260860 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 3.5" HPA040237 Uncertain NA NA "HPA040237: AB_10793960" "unprognostic (8.70e-2)" "unprognostic (1.75e-1)" "unprognostic (8.51e-3)" "unprognostic (5.19e-2)" 0.2 0.7 0.0 0.2 0.0 1.1 0.2 0.3 0.1 0.5 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.5 0.0 1.2 0.1 0.1 0.0 0.2 0.0 0.5 2.8 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.5 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.7 0.0 0.7 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.0;skeletal muscle: 107.3" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 3.6 3.7 3.3 1.7 4.6 1.2 2.8 7.7 8.2 2.3 3.2 4.6 0.0 1.5 2.5 3.1 2.5 2.0 2.3 29.0 3.6 3.9 1.9 1.1 1.5 1.3 3.7 4.2 3.9 1.8 1.1 1.7 1.4 3.7 2.6 1.3 2.0 1.6 2.6 107.3 1.3 1.6 2.9 3.2 1.7 1.4 2.2 3.2 0.0 1.2 22.6 1.2 2.1 1.6 1.3 4.6 0.0 5.2 2.3 0.5 1.9 0.0 0.0 2.2 11.0 11.6 8.8 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.4 2.5 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.5 2.9 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.7 0.1 0.1 0.8 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.7 0.0 5.2 0.0 0.0 3.3 0.0 1.0 0.0 0.0 4.6 1.3 0.4 0.5 0.0 2.3 2.8 2.0 0.0 1.9 3.3 4.6 7.7 8.2 3.6 3.9 3.7 4.2 3.7 3.2 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.5 7.9 0.0 1.8 0.8 1.3 4.6 0.4 0.0 0.0 0.0 2.3 0.4 0.0 3.5 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 31.5;Proximal tubular cells: 27.8" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.8;SCLC-21H: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.9 10.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 0.0 4.6 0.0 0.0 0.0 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 31.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.1 0.0 1.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Cell line enhanced" "Detected in many" "U-2197: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA048973: AB_2680580" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.8 5.5 3.0 12.6 12.8 12.3 0.8 15.8 14.7 9.8 10.1 1.0 1.6 1.7 9.4 20.1 2.0 1.6 1.7 4.7 5.3 4.6 3.2 0.5 3.8 1.0 6.7 0.5 18.0 11.0 8.6 8.4 1.6 14.2 6.6 2.8 8.5 14.1 8.2 13.1 0.2 2.4 3.3 3.0 30.7 0.2 0.4 4.8 4.6 4.2 3.3 10.9 6.6 5.7 3.3 1.0 8.2 11.3 7.6 22.2 4.7 37.5 8.3 8.8 5.4 0.6 21.6 8.1 8.7 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 6.0 8.8 0.5 5.5 0.0 5.1 0.0 7.6 2.7 2.3 3.5 11.8 0.5 1.7 6.2 11.0 6.9 0.0 0.0 7.6 2.1 2.1 16.2 2.3 6.7 4.0 7.9 16.4 8.0 9.7 8.2 13.3 3.9 0.0 0.0 2.5 15.3 7.5 0.0 15.6 1.3 6.3 6.5 0.0 1.8 4.9 0.0 2.4 0.0 0.8 4.1 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Cell type enhanced" "Detected in single" 21 "Horizontal cells: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Group enriched" "Detected in some" 6 "NB-4: 24.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 5.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.2 1.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.4 0.0 24.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 2.7 2.2 51.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.9 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.2;Horizontal cells: 3.2" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 12.3;SH-SY5Y: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 12.3 0.0 0.0 0.0 0.5 0.1 0.4 22.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PLSCR5 ENSG00000231213 "Phospholipid scramblase family member 5" A0PG75 3 146576555-146606216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;intestine: 1.8;parathyroid gland: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "SuSa: 5.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047249 Uncertain NA NA "HPA047249: AB_2679997" 0.1 0.0 0.5 0.1 1.8 0.0 0.1 0.1 0.3 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.4 0.1 0.1 0.1 5.6 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.8 0.1 0.1 0.1 0.0 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.1 0.3 0.1 0.5 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Cell line enriched" "Detected in some" 28 "EFO-21: 112.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 6.0 0.0 0.0 0.7 20.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.7 32.1 0.0 0.0 2.3 0.1 5.6 1.4 0.0 0.0 1.4 0.0 0.0 41.7 2.7 0.6 0.0 3.8 21.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.4 0.4 14.6 0.1 0.0 0.0 1.7 PM20D1 "Cps1, FLJ32569" ENSG00000162877 "Peptidase M20 domain containing 1" Q6GTS8 1 205828022-205850132 "Enzymes, Predicted secreted proteins" "Hydrolase, Lyase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "pancreas: 103.5" "Group enriched" "Detected in some" 6 "Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8" "Cancer enriched" "Detected in some" 32 "urothelial cancer: 30.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in single" 5 "T-cells: 4.5" "Cell line enriched" "Detected in single" 9 "Karpas-707: 6.6" "Low region specificity" "Detected in all" "Secreted to digestive system" NA NA 3000000 "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (4.83e-1)" "unprognostic (4.08e-3)" "unprognostic (1.17e-3)" "unprognostic (3.11e-1)" "unprognostic (1.20e-1)" "unprognostic (5.50e-2)" "unprognostic (5.81e-2)" "unprognostic (4.57e-2)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (1.68e-2)" 0.5 0.0 0.0 0.5 0.2 0.0 0.6 0.1 0.4 0.0 0.2 0.6 0.4 0.0 0.2 0.3 0.0 0.1 0.0 0.3 0.3 0.0 3.2 0.1 0.2 0.5 0.2 0.0 0.3 103.5 0.0 0.0 0.1 0.4 0.8 0.0 0.3 0.2 0.4 0.0 14.3 0.1 0.1 0.1 0.4 1.2 0.2 0.1 0.1 0.1 0.1 0.4 1.5 0.3 0.3 0.0 0.8 0.2 0.0 4.5 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.3 0.3 0.9 2.4 0.0 0.2 0.3 0.9 0.0 0.0 0.2 0.0 4.5 1.0 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PMFBP1 ENSG00000118557 "Polyamine modulated factor 1 binding protein 1" Q8TBY8 16 72112157-72176878 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.6;testis: 30.8" "Group enriched" "Detected in some" 5 "Early spermatids: 98.0;Late spermatids: 189.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0;SH-SY5Y: 10.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA056716, HPA075825" Approved Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056716: AB_2683215, HPA075825: " "unprognostic (1.46e-1)" "unprognostic (3.62e-1)" "unprognostic (5.95e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-2)" "unprognostic (7.03e-2)" "unprognostic (1.06e-4)" "unprognostic (1.60e-1)" "unprognostic (3.81e-1)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (2.68e-5)" "unprognostic (9.85e-2)" "unprognostic (2.66e-1)" "unprognostic (9.85e-2)" "unprognostic (8.67e-2)" 1.1 0.9 1.1 1.1 1.1 3.9 1.1 2.1 1.1 1.1 2.1 1.1 1.1 2.6 1.1 13.6 1.6 0.9 1.1 1.1 1.1 0.7 1.3 1.6 1.1 1.5 1.1 1.1 1.5 4.2 2.9 1.5 1.1 1.1 2.1 3.3 1.1 1.1 1.1 1.1 4.1 2.9 1.1 1.1 2.9 1.1 30.8 1.1 1.1 1.1 1.1 1.1 1.1 1.1 0.5 1.9 0.9 2.0 0.0 0.3 0.2 0.2 0.4 2.8 2.5 0.0 0.6 1.8 0.5 0.2 0.5 2.1 1.0 2.6 1.8 0.4 0.1 0.1 1.8 1.0 0.1 1.3 0.2 4.2 1.8 3.0 2.9 0.0 4.1 3.2 0.0 0.8 0.1 2.1 0.6 0.8 2.1 0.3 1.6 0.1 2.3 1.0 6.0 0.8 0.1 1.2 2.7 0.2 1.4 0.3 0.7 21.0 10.5 0.0 0.0 0.2 2.0 0.5 2.6 1.7 1.3 2.1 0.6 1.3 3.9 1.4 1.2 0.6 2.7 0.7 0.0 1.6 0.9 0.1 0.5 0.0 0.0 0.1 0.2 1.6 0.5 0.1 0.1 0.2 0.0 2.0 1.9 0.3 0.2 1.1 1.1 2.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 0.0 1.1 0.0 0.1 0.3 0.0 0.7 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 98.0 0.2 0.0 0.0 0.2 0.1 0.2 0.1 3.5 0.0 4.6 28.6 5.2 0.0 1.0 189.3 1.1 2.8 0.0 0.0 0.3 1.3 0.1 0.0 1.4 0.3 0.1 0.0 0.1 1.6 0.8 0.0 0.1 0.0 0.5 0.0 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669730-153689010 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4;seminal vesicle: 38.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "AN3-CA: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.8 21.4 2.2 35.4 0.6 0.9 3.7 24.9 0.9 21.9 0.9 6.9 3.8 4.2 3.1 14.5 2.9 2.9 3.8 19.5 17.0 1.0 0.5 0.7 0.6 6.1 15.5 0.7 0.5 1.4 0.3 2.4 3.8 12.6 4.2 0.4 0.7 38.5 2.2 1.4 5.2 15.3 2.6 0.7 5.5 4.7 1.7 0.0 0.5 0.0 0.7 10.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 27.1 0.0 0.0 2.9 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.3 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.2 0.0 0.1 2.2 0.8 0.3 0.3 0.0 0.2 1.1 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 35.4 3.7 23.2 19.5 17.0 6.1 15.5 3.8 1.7 0.0 0.0 0.0 0.4 0.6 16.5 2.8 0.0 0.0 0.0 0.0 21.6 8.3 0.0 0.2 0.2 0.3 2.0 0.0 0.3 44.0 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.4 2.7 4.8 0.0 0.4 0.1 19.4 0.0 0.4 0.5 0.6 0.5 41.4 0.0 0.0 0.9 PNLIPRP3 ENSG00000203837 "Pancreatic lipase related protein 3" Q17RR3 10 116427867-116477957 "Enzymes, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "hTCEpi: 86.9" "Not detected" "Not detected" "HPA046202, HPA052009" Uncertain "Secreted - unknown location" NA NA "HPA046202: AB_10959739, HPA052009: AB_2681692" "unprognostic (2.62e-4)" "unprognostic (1.60e-1)" "unprognostic (6.97e-2)" 8.5 0.1 0.0 0.0 0.2 0.0 15.9 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.0 0.4 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 15.5 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 8.1 1.9 0.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 PNMA3 "MA3, MA5, MGC132756, MGC132758" ENSG00000183837 "PNMA family member 3" Q9UL41 X 153056409-153060467 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 17.4;epididymis: 35.5" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 4.3;Cardiomyocytes: 2.6;Horizontal cells: 6.4;Muller glia cells: 4.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;NTERA-2: 8.2;SCLC-21H: 2.7;SH-SY5Y: 2.0;THP-1: 2.1" "Low region specificity" "Detected in all" HPA047920 Approved NA NA "HPA047920: AB_2680210" "unprognostic (1.66e-2)" "unprognostic (8.97e-3)" "unprognostic (8.70e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (9.43e-2)" "unprognostic (3.10e-3)" "unprognostic (1.16e-1)" "unprognostic (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (6.20e-2)" "unprognostic (7.62e-4)" "unprognostic (1.93e-1)" "unprognostic (5.92e-3)" "unprognostic (2.93e-3)" "unprognostic (7.25e-2)" "unprognostic (7.84e-2)" "unprognostic (2.07e-2)" 0.4 1.4 4.8 0.8 6.8 0.4 0.3 3.0 17.4 0.5 0.3 0.2 0.0 0.4 0.5 35.5 0.3 1.2 0.4 1.4 4.9 1.0 0.3 0.3 1.4 0.0 13.7 0.6 0.5 0.4 0.7 0.3 11.2 0.5 0.3 0.7 0.4 0.6 0.3 0.6 0.5 0.3 1.3 0.8 0.3 5.9 0.0 0.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.7 2.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 6.4 0.0 0.6 1.9 1.1 1.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 1.9 1.6 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.1 PNMA8B "KIAA1183, PNMAL2" ENSG00000204851 "PNMA family member 8B" Q9ULN7 19 46486906-46496498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.3;brain: 22.5" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 2.2;Distal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "AF22: 3.7;AN3-CA: 4.7;fHDF/TERT166: 1.6;JURKAT: 2.7;NTERA-2: 1.9;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" HPA054810 Enhanced NA NA "HPA054810: AB_2682609" "unprognostic (1.31e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-2)" "unprognostic (3.38e-3)" "unprognostic (2.90e-1)" "unprognostic (1.35e-1)" "unprognostic (4.15e-1)" "unprognostic (4.19e-3)" "unprognostic (4.26e-4)" "unprognostic (7.30e-2)" "unprognostic (5.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.38e-1)" "unprognostic (1.32e-2)" 2.3 10.3 9.1 0.3 6.7 0.0 0.5 2.5 22.5 0.8 0.3 0.3 0.6 0.5 0.4 0.7 0.9 1.2 9.0 15.6 0.4 0.2 0.6 0.3 6.4 3.9 0.8 0.1 1.8 0.3 1.0 0.1 1.4 1.0 0.4 1.6 0.5 0.5 2.8 1.6 0.4 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.3 1.8 0.3 0.0 0.0 3.7 4.7 1.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.0 1.8 0.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PNPLA4 "DXS1283E, GS2, iPLA2eta" ENSG00000006757 "Patatin like phospholipase domain containing 4" P41247 X 7898247-7927739 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 81.2;Proximal tubular cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003656 Approved "Intracellular and membrane" NA NA "HPA003656: AB_1079033" "unprognostic (2.97e-1)" "unprognostic (2.45e-1)" "unprognostic (4.17e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.29e-4)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.15e-1)" "unprognostic (2.05e-1)" "unprognostic (9.42e-2)" "unprognostic (6.30e-2)" "unprognostic (7.83e-2)" "unprognostic (2.27e-1)" "prognostic favorable (2.23e-12)" "unprognostic (5.23e-2)" "unprognostic (6.71e-3)" "unprognostic (6.30e-2)" "unprognostic (2.12e-1)" 11.3 18.1 12.6 6.0 18.8 4.7 13.9 5.0 11.5 8.9 8.9 8.5 13.3 11.2 9.2 11.4 13.2 15.0 6.2 24.0 10.9 11.9 26.5 39.8 5.8 6.3 12.0 8.7 14.0 21.0 13.3 17.0 4.7 12.2 8.0 7.5 13.1 18.9 10.7 40.9 10.8 10.5 7.4 11.2 5.4 11.5 7.8 10.6 7.2 23.6 21.1 8.9 6.6 9.5 13.2 18.3 7.6 10.4 9.0 10.3 8.4 18.4 7.6 1.2 19.0 0.4 0.2 5.1 5.7 0.6 10.0 6.2 7.6 6.8 5.8 0.0 1.8 0.1 10.9 0.0 19.3 17.1 0.2 13.5 4.1 14.7 15.9 12.7 7.2 6.1 13.0 19.8 5.1 11.9 2.4 6.9 0.2 16.2 0.2 0.1 4.8 0.1 7.2 20.1 12.8 16.1 0.1 0.1 6.4 13.2 8.4 11.0 5.5 17.4 7.2 9.8 22.6 11.2 5.4 3.9 0.1 5.0 15.3 0.1 8.8 0.1 11.0 0.1 0.0 1.6 5.2 9.8 7.6 5.4 10.4 6.2 12.3 7.8 5.9 18.3 13.2 10.3 9.8 0.7 9.0 9.7 13.5 4.8 8.4 12.6 18.8 5.0 11.5 10.9 11.9 12.0 8.7 12.2 10.6 8.9 12.2 10.2 12.9 10.5 11.3 43.9 22.9 26.8 9.1 19.2 0.0 24.2 81.2 29.5 2.3 11.6 26.5 0.0 42.6 18.0 10.3 13.5 8.1 58.6 26.3 9.5 19.0 13.5 7.2 2.2 15.3 11.0 16.9 17.2 30.1 29.0 29.8 28.1 19.1 97.0 12.8 6.5 11.3 15.9 21.3 14.6 11.7 5.2 34.5 13.7 PNPLA5 "dJ388M5.4, GS2L" ENSG00000100341 "Patatin like phospholipase domain containing 5" Q7Z6Z6 22 43879678-43892013 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.6;epididymis: 6.2;skin 1: 4.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 4.0;RPMI-8226: 7.3;SCLC-21H: 2.5" "Not detected" "Not detected" "HPA050409, HPA054211" Uncertain NA NA "HPA050409: AB_2681118, HPA054211: AB_2682418" "unprognostic (6.69e-5)" "unprognostic (3.53e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (3.33e-3)" "unprognostic (1.05e-1)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" 0.0 0.1 0.5 0.2 5.6 1.0 0.9 0.1 2.4 0.1 0.0 0.1 0.3 6.2 0.0 0.6 0.5 0.0 0.8 0.9 0.0 1.7 0.1 0.1 0.4 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.1 0.0 4.6 0.0 0.1 0.1 0.2 0.1 0.4 0.5 0.0 0.0 0.0 0.7 1.0 2.2 0.5 0.2 0.7 0.0 0.2 0.0 0.2 0.4 0.1 0.4 0.2 0.1 0.3 0.1 0.9 0.4 0.4 0.1 0.4 0.2 0.3 0.4 0.2 0.5 0.1 0.8 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.3 0.1 0.4 0.2 0.3 0.4 0.3 0.1 0.3 4.0 0.0 0.1 0.2 0.2 7.3 0.1 0.0 2.5 0.2 0.5 0.1 0.1 0.5 0.3 0.1 0.2 0.6 0.2 0.3 0.1 0.3 0.1 0.3 0.4 0.2 0.1 2.2 0.5 0.1 0.7 0.3 0.5 0.4 0.6 0.6 0.1 0.7 0.4 0.6 1.6 0.2 0.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PODNL1 "FLJ23447, SLRR5B" ENSG00000132000 "Podocan like 1" Q6PEZ8 19 13931187-13953392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.5" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 34.2;Leydig cells: 17.0;Peritubular cells: 35.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.8;HSkMC: 16.2;hTERT-RPE1: 25.7;SiHa: 13.0;U-2 OS: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA042807 Approved "Secreted - unknown location" NA NA "HPA042807: AB_10795514" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (8.08e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.61e-8)" "unprognostic (1.78e-1)" "unprognostic (1.86e-2)" "unprognostic (3.68e-1)" "unprognostic (2.02e-1)" "unprognostic (3.08e-3)" "unprognostic (4.37e-2)" "unprognostic (1.01e-1)" "unprognostic (0.00e+0)" "unprognostic (3.94e-3)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.49e-4)" 2.4 1.6 2.2 3.5 4.1 2.2 4.5 7.9 3.2 6.7 2.3 3.0 2.2 1.9 1.7 2.5 8.7 1.7 5.9 4.4 2.0 7.5 1.4 1.0 3.8 1.3 4.2 2.3 3.1 2.5 0.7 4.7 24.5 5.0 6.1 1.5 11.1 4.2 4.1 3.7 12.7 2.7 2.6 3.8 1.3 3.0 7.6 2.1 0.8 2.4 14.9 3.9 4.8 9.9 0.9 3.4 1.3 1.7 1.0 0.8 0.6 0.4 0.5 0.5 0.3 0.8 2.1 0.1 5.5 3.3 1.1 2.2 0.4 0.6 0.3 0.4 8.8 0.2 2.1 0.2 0.2 0.6 2.0 0.9 1.1 0.4 0.1 6.8 0.3 0.7 16.2 1.0 1.5 0.2 25.7 0.0 0.1 0.5 0.4 2.2 3.5 0.3 0.3 0.2 0.4 0.5 0.2 0.1 0.0 0.4 0.1 1.0 0.6 13.0 0.1 0.4 0.6 0.1 0.6 1.0 2.7 9.4 0.7 0.3 0.4 0.0 0.1 1.1 1.2 0.2 0.7 1.7 0.7 0.8 1.4 0.3 0.9 0.6 0.3 3.4 0.5 0.4 0.3 1.3 1.0 0.2 0.5 0.2 0.6 2.2 4.1 7.9 3.2 2.0 7.5 4.2 2.3 5.0 2.1 0.0 0.3 0.0 0.8 1.1 34.2 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.1 1.2 1.0 1.1 0.0 0.0 0.1 7.7 0.4 0.0 0.0 7.5 1.6 0.0 0.6 1.5 1.6 17.0 1.1 1.7 0.0 1.3 1.6 0.4 6.2 35.7 0.0 4.0 0.0 0.5 0.7 0.5 3.8 0.7 0.0 1.1 1.2 POM121L12 DKFZp564N2472 ENSG00000221900 "POM121 transmembrane nucleoporin like 12" Q8N7R1 7 53035642-53036924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 175 "testis: 36.1" "Cell type enriched" "Detected in single" 7 "Spermatocytes: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027836 Enhanced NA NA "HPA027836: AB_10669592" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 38.3;Late spermatids: 28.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049817 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA049817: AB_2680896" "unprognostic (2.23e-1)" "prognostic favorable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favorable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 4.0 3.0 4.7 3.4 5.6 6.6 4.5 6.0 5.3 4.7 4.6 2.4 5.8 5.2 3.8 2.8 2.1 3.8 4.7 3.5 4.4 2.2 3.6 3.1 3.5 5.8 4.7 2.0 3.1 1.7 4.5 3.7 4.3 5.1 14.2 5.3 3.0 7.0 4.0 2.5 3.9 9.5 3.9 3.6 4.0 3.9 4.2 3.5 5.7 3.3 3.0 4.8 1.1 1.9 8.1 13.0 16.7 8.6 3.4 1.9 2.9 4.5 2.1 2.7 4.7 3.6 1.2 0.8 2.6 4.6 1.1 3.0 1.3 2.0 4.9 4.6 5.4 4.4 2.7 2.0 2.4 3.6 2.9 5.4 7.2 2.5 1.0 1.3 2.1 2.9 9.4 9.2 2.5 4.2 10.0 5.7 3.0 4.0 1.8 9.5 2.0 1.5 3.0 6.8 12.3 2.5 11.8 4.2 14.4 4.5 3.1 5.0 6.6 0.9 16.4 6.7 2.4 2.1 8.7 1.3 9.7 9.2 1.4 3.3 5.7 2.4 1.5 3.5 2.5 3.9 4.0 3.3 4.2 4.8 2.7 3.8 3.0 1.6 3.5 3.4 1.1 3.0 2.6 3.0 6.4 6.3 4.1 6.0 2.5 4.0 0.0 5.2 11.8 5.7 0.0 1.1 38.3 3.0 4.5 0.0 1.9 3.1 6.0 4.2 5.7 1.7 2.6 3.2 12.5 1.8 4.1 28.3 5.8 3.0 10.1 0.0 2.7 4.6 1.6 4.0 7.4 3.5 5.2 12.9 3.2 22.1 4.1 6.0 8.7 2.2 5.6 8.4 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 90.5" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 250.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA024255 Enhanced NA NA "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 1.3 0.3 0.2 1.0 0.2 0.0 0.6 0.3 0.2 1.8 16.0 0.2 7.6 0.6 2.0 1.3 3.3 1.8 6.1 90.5 0.2 0.0 0.5 0.3 0.3 1.4 0.2 0.3 0.8 0.7 0.1 0.2 0.3 0.3 5.0 1.5 0.3 0.6 13.4 12.1 0.4 2.2 12.6 0.2 0.5 2.4 0.5 0.2 0.3 0.5 3.8 0.8 10.2 1.1 0.9 0.7 2.1 3.0 0.3 2.2 0.4 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 26.1 0.0 0.0 0.4 2.5 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.7 0.0 0.1 0.1 0.2 0.5 2.1 0.1 1.3 0.9 0.1 1.1 0.3 1.1 1.0 0.1 0.9 2.2 0.7 0.1 0.3 3.0 0.7 1.6 0.4 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.3 0.0 0.2 0.3 2.4 250.7 0.0 2.7 1.2 0.0 0.0 0.4 0.0 0.4 0.2 3.6 0.3 0.0 0.2 0.1 1.4 0.7 1.1 0.0 1.3 1.6 2.9 1.3 1.2 0.4 1.1 2.2 0.0 2.8 0.6 1.2 0.7 0.0 1.8 0.3 2.8 58.2 8.5 0.5 0.4 0.5 1.0 1.0 0.4 0.2 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105158280-105179995 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "heart muscle: 23.9;skeletal muscle: 68.9" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012514 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.9 0.8 2.2 1.4 4.5 0.6 2.5 0.4 6.8 0.8 1.4 2.1 0.8 0.7 1.3 2.2 2.1 0.7 1.1 23.9 3.7 2.3 0.6 0.6 0.7 0.7 6.1 3.5 0.7 0.6 0.6 3.2 1.2 4.0 1.2 0.6 1.9 1.0 0.8 68.9 0.6 0.6 0.6 3.6 0.6 1.6 3.6 4.0 0.0 0.8 8.8 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.1 2.4 6.3 0.5 2.4 2.6 4.3 5.2 0.0 1.4 0.0 1.0 4.9 25.2 0.0 1.2 1.1 3.6 0.0 2.6 0.0 0.9 0.0 0.1 0.0 0.0 2.5 0.2 6.9 0.9 1.2 0.3 0.0 2.6 7.3 11.9 0.0 0.0 0.9 2.8 0.0 4.1 0.4 13.4 0.0 0.0 0.0 6.1 11.0 0.0 0.0 8.6 1.5 0.0 4.7 5.4 2.6 0.0 1.7 9.0 0.0 0.0 0.0 12.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.5 0.4 6.8 3.7 2.3 6.1 3.5 4.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 75.0 0.0 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.1 0.0 0.0 0.0 POTEB3 ENSG00000278522 "POTE ankyrin domain family member B3" "A0JP26, Q6S5H4" 15 21408243-21440451 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 53 "testis: 5.2" "Cell type enriched" "Detected in single" 10 "Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 POTEC "A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18" ENSG00000183206 "POTE ankyrin domain family member C" B2RU33 18 14507339-14543585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "testis: 5.9" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 1.4" NA NA "unprognostic (1.63e-1)" "unprognostic (9.88e-2)" "unprognostic (8.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 3.8 0.0 0.2 0.0 0.0 0.0 POTED "A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21" ENSG00000166351 "POTE ankyrin domain family member D" Q86YR6 21 13609858-13641585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 63 "testis: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 POTEE "A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma" ENSG00000188219 "POTE ankyrin domain family member E" Q6S8J3 2 131218067-131265278 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 2.4;prostate: 2.0;testis: 4.9" "Cell type enhanced" "Detected in some" 19 "Basal glandular cells: 2.6;Glandular cells: 1.9;Spermatocytes: 6.6;Spermatogonia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BEWO: 3.6;K-562: 3.6;U-2 OS: 7.0;U-266/84: 2.1" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (3.13e-2)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.84e-2)" "unprognostic (1.05e-1)" "unprognostic (6.61e-3)" "unprognostic (5.77e-2)" "unprognostic (7.60e-2)" "unprognostic (7.46e-3)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 2.4 0.1 0.0 0.2 2.8 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.7 2.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.6 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 6.6 1.9 0.1 0.3 0.0 0.0 1.1 POTEG "A26C2, CT104.4, POTE-14, POTE14, POTE14alpha" ENSG00000187537 "POTE ankyrin domain family member G" Q6S5H5 14 19402486-19434341 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 14.0;prostate: 7.4" "Cell type enhanced" "Detected in single" 31 "Spermatocytes: 1.4" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 2.2;U-2 OS: 2.9" NA NA "unprognostic (4.01e-1)" "unprognostic (1.51e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (2.69e-2)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (2.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.9 10.2 14.0 10.7 3.7 6.8 12.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.8 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.2 6.4 14.0 4.8 10.7 3.7 2.9 4.3 4.5 10.2 2.9 3.4 5.2 7.6 3.7 10.3 2.8 6.8 12.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 POTEH "A26C3, ACTBL1, CT104.7, POTE22" ENSG00000198062 "POTE ankyrin domain family member H" Q6S545 22 15690026-15721631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "prostate: 9.5;testis: 2.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;U-2 OS: 4.8;U-266/84: 1.3" NA NA "unprognostic (4.66e-2)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38044611-38046794 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.5;skin 1: 31.0" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.8 2.1 4.0 0.9 10.5 0.7 0.8 1.2 6.8 0.6 0.7 1.1 0.0 0.6 0.7 0.8 3.4 0.7 0.7 0.7 7.7 0.9 0.7 0.6 0.6 1.7 3.9 2.9 0.7 0.8 0.6 0.0 0.6 1.4 3.6 0.6 1.6 0.6 0.7 1.3 31.0 0.7 2.5 0.6 0.7 0.7 1.5 2.6 0.0 0.7 1.3 1.7 1.5 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 11.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 19.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 3.8 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 10.5 1.2 6.8 7.7 0.9 3.9 2.9 1.4 2.6 0.0 0.0 0.0 1.7 24.3 7.4 4.3 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.9 0.8 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 14.6 0.0 0.0 0.0 0.0 19.3 0.0 2.0 0.2 1.7 48.8 0.1 0.0 0.4 2.1 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 55.8;Distal tubular cells: 23.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.6 26.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.9 0.6 0.0 31.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.0 0.0 0.0 55.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.3" "Cell type enhanced" "Detected in some" 14 "Rod photoreceptor cells: 1.1;Spermatocytes: 1.6;Spermatogonia: 2.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 23 "pons and medulla: 25.3" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "HEK 293: 10.9;HEL: 11.6;JURKAT: 9.3;REH: 8.2;RH-30: 14.0;SCLC-21H: 13.4;U-266/70: 12.6" "Group enriched" "Detected in some" 14 "midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4" "Group enriched" "Detected in some" 26 "midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5" HPA068024 Enhanced Approved NA NA "HPA068024: AB_2685943" "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.1 0.0 1.1 2.3 1.0 1.2 1.0 0.2 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.2 1.0 1.0 0.0 0.5 0.1 2.3 0.7 0.0 0.0 0.1 0.1 0.0 0.9 25.3 0.0 0.3 6.3 0.2 0.0 1.8 0.4 0.3 0.0 2.5 0.3 0.3 4.4 0.4 2.7 0.0 0.2 3.5 0.3 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.0 0.0 0.0 10.9 11.6 0.0 1.4 0.0 5.7 3.4 0.0 0.1 0.0 0.0 0.0 0.0 9.3 2.3 0.0 0.5 0.0 0.8 1.0 0.0 1.5 0.0 8.2 14.0 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.2 0.0 12.6 3.8 0.0 0.0 6.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 1.0 0.2 0.4 1.0 1.0 0.7 0.0 25.3 0.4 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.1 0.0 0.0 1.6 2.5 0.4 0.0 0.0 0.0 0.0 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741637 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 15.9;Rod photoreceptor cells: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-2 OS: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077615 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.2 0.2 0.2 0.2 0.2 1.2 0.8 0.2 0.9 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.2 1.4 0.6 0.2 0.2 0.3 0.5 26.8 0.2 0.2 0.5 0.2 0.2 0.2 0.2 2.0 0.5 2.7 0.6 1.1 1.3 0.3 0.4 0.6 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.3 0.1 0.3 0.5 0.9 0.4 0.2 0.7 0.6 0.9 0.3 0.5 0.6 0.7 0.8 0.7 0.7 0.2 0.8 0.8 0.5 0.7 0.5 0.4 0.5 0.2 0.8 0.6 1.1 0.4 0.4 0.7 1.0 0.7 0.3 0.3 0.5 1.2 0.9 0.2 0.3 1.0 0.9 0.6 0.7 0.2 0.5 0.5 0.7 0.7 0.6 8.5 0.7 0.7 0.8 0.5 0.8 0.5 0.9 0.4 1.4 0.6 0.3 1.0 0.4 1.0 0.8 0.7 0.6 0.1 2.0 0.7 1.1 2.7 1.1 0.4 0.5 1.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 2.1 3.0 2.1 1.9 10.5 0.4 2.5 1.4 0.0 1.8 5.9 0.7 0.0 1.5 1.7 1.4 1.4 0.0 0.8 0.9 1.4 2.0 8.1 0.8 1.0 15.9 2.9 2.5 1.3 4.5 4.4 2.9 1.7 2.8 0.5 5.4 1.7 0.0 1.4 0.1 15.8 0.0 0.9 6.9 2.3 2.4 0.5 5.4 1.0 2.0 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Group enriched" "Detected in some" 83 "Early spermatids: 319.7;Late spermatids: 185.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/84: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.6 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.4 0.3 0.9 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.3 1.4 1.1 0.7 0.8 0.3 0.0 0.3 0.3 0.5 0.6 4.1 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 319.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 PPAN "BXDC3, SSF, SSF1, SSF2" ENSG00000130810 "Peter pan homolog (Drosophila)" Q9NQ55 19 10106289-10111634 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 68.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043265 Approved NA NA "HPA043265: AB_10793943" "unprognostic (1.91e-2)" "unprognostic (1.27e-1)" "unprognostic (7.97e-2)" "unprognostic (1.30e-1)" "unprognostic (4.93e-2)" "unprognostic (4.23e-2)" "unprognostic (9.47e-3)" "unprognostic (2.13e-1)" "unprognostic (3.80e-1)" "unprognostic (5.51e-2)" "unprognostic (3.10e-2)" "unprognostic (1.94e-2)" "unprognostic (2.01e-3)" "unprognostic (8.75e-3)" "unprognostic (7.52e-2)" "unprognostic (4.27e-2)" "unprognostic (2.92e-3)" 18.9 17.5 15.9 26.0 23.2 19.2 17.8 21.5 21.7 14.9 15.1 15.3 8.8 20.8 18.7 14.4 24.6 17.3 13.1 14.9 15.0 12.2 13.0 22.3 13.5 29.3 15.0 15.7 22.1 25.3 16.9 13.2 14.0 14.8 17.8 11.3 13.5 19.5 15.1 27.4 27.2 17.2 15.5 10.8 24.7 16.4 19.7 19.6 23.3 14.8 17.5 25.3 15.0 17.5 13.8 6.0 4.2 6.4 5.6 12.0 2.8 13.8 11.7 4.4 9.8 3.1 3.3 10.1 7.8 3.6 9.7 7.5 15.4 5.3 16.1 14.2 4.7 7.0 11.9 11.9 13.2 4.2 8.8 32.3 29.7 12.9 15.3 8.0 18.2 17.6 5.1 10.3 10.5 13.4 6.2 4.8 12.5 21.2 14.7 5.0 20.5 22.0 68.5 21.3 7.2 32.6 16.1 5.8 22.0 5.4 12.0 9.6 11.7 6.8 11.9 10.6 3.1 6.5 9.7 5.9 12.9 7.1 14.2 19.5 32.5 15.4 16.8 8.8 15.9 11.3 1.6 6.4 3.1 7.0 4.7 9.2 13.8 8.9 11.6 6.0 13.2 12.0 6.3 4.2 5.6 3.3 4.5 8.0 2.8 15.9 23.2 21.5 21.7 15.0 12.2 15.0 15.7 14.8 19.6 3.0 8.3 20.9 27.5 50.9 9.8 3.2 2.5 4.0 10.3 5.2 5.9 24.2 3.3 28.7 6.9 9.8 10.4 0.0 26.2 25.2 16.7 13.2 6.9 9.6 30.1 17.5 6.4 4.9 4.7 7.2 17.3 14.3 11.8 18.0 13.5 5.1 26.5 12.9 9.9 13.9 9.9 0.0 29.3 21.2 48.3 46.2 14.9 19.2 19.9 19.2 PPFIA4 ENSG00000143847 "PTPRF interacting protein alpha 4" O75335 1 203026498-203078740 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 32.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 72.6;cerebral cortex: 21.1" "Cell type enhanced" "Detected in some" "myeloid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053419, HPA054132" Enhanced NA NA "HPA053419: AB_2682143, HPA054132: AB_2682393" "unprognostic (2.83e-1)" "unprognostic (2.34e-3)" "unprognostic (3.38e-5)" "unprognostic (3.19e-1)" "unprognostic (6.58e-2)" "unprognostic (5.36e-2)" "unprognostic (7.49e-8)" "unprognostic (4.65e-1)" "unprognostic (6.01e-4)" "unprognostic (1.29e-1)" "unprognostic (7.70e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.73e-8)" "unprognostic (6.82e-3)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (4.28e-2)" 0.6 1.3 9.2 1.0 10.9 1.6 0.9 72.6 21.1 1.8 1.0 1.4 0.0 1.1 1.7 3.5 1.3 1.2 2.6 26.2 6.6 5.0 1.9 0.6 1.2 0.8 3.0 10.8 0.9 0.6 1.3 0.7 3.9 11.4 1.5 0.8 0.6 1.4 1.3 20.4 2.9 1.3 2.0 2.0 2.2 0.8 3.3 2.3 0.0 0.9 0.4 0.8 0.9 0.9 0.0 1.4 1.3 0.9 0.0 0.6 0.0 7.4 0.0 0.1 1.9 0.0 0.3 0.3 0.4 0.9 0.7 3.1 0.3 0.3 0.3 1.6 1.7 0.2 0.8 0.6 1.4 1.5 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.0 2.4 0.1 0.4 0.0 12.8 0.0 1.5 0.1 0.3 6.2 1.0 0.5 0.9 0.9 0.0 0.3 1.3 13.2 2.1 0.0 0.0 2.5 3.2 0.8 0.1 1.0 1.2 0.2 0.6 0.0 4.7 2.8 0.1 0.0 8.3 0.2 0.1 12.1 0.6 0.5 0.0 0.9 1.3 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.6 0.0 9.2 10.9 72.6 21.1 6.6 5.0 3.0 10.8 11.4 2.3 0.0 0.0 0.0 0.1 0.0 2.4 32.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 1.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 6.4 0.0 1.3 0.0 1.9 0.3 0.0 0.0 0.0 0.0 2.6 0.5 0.0 1.8 0.0 0.8 0.0 0.9 0.5 1.2 0.0 0.2 0.0 0.0 0.0 PPIAL4A "COAS2, PPIAL4, PPIAL4B" ENSG00000263353 "Peptidylprolyl isomerase A like 4A" Q9Y536 1 120889746-120890405 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.5;intestine: 1.6" "Cell type enriched" "Detected in single" 10 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 3.8;NB-4: 4.6;SK-BR-3: 4.7" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (3.49e-3)" "unprognostic (2.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-1)" "unprognostic (1.77e-1)" "unprognostic (2.09e-1)" "unprognostic (1.42e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.83e-2)" "unprognostic (1.74e-1)" 0.3 0.8 1.0 1.4 0.2 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 3.0 3.2 0.6 1.6 2.2 2.4 3.5 0.9 0.0 0.1 1.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 1.0 0.7 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.2 3.8 0.3 0.6 1.7 4.6 2.5 0.0 0.0 0.8 1.5 1.9 0.0 0.0 1.0 0.3 0.3 4.7 0.4 0.1 3.1 2.5 0.7 3.0 1.2 2.9 1.7 1.4 0.9 2.5 2.6 1.6 3.2 0.2 1.6 0.6 1.4 1.2 1.4 3.0 2.3 2.4 3.1 2.2 1.5 2.4 0.0 2.2 1.2 3.2 2.4 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIAL4C ENSG00000263464 "Peptidylprolyl isomerase A like 4C" A0A0B4J2A2 1 149583865-149584464 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 10.9;intestine: 5.5" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 14.4;THP-1: 16.9" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (3.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (7.93e-2)" "unprognostic (5.98e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.25e-1)" 0.0 3.3 2.7 0.1 0.0 1.5 0.0 0.8 5.5 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 2.9 0.2 0.0 0.9 0.7 0.3 0.0 0.0 0.0 0.2 0.5 2.9 0.0 1.4 0.9 0.0 0.0 0.3 0.0 9.1 9.7 1.9 6.0 4.6 7.8 10.9 3.6 0.3 0.4 3.1 0.1 0.3 2.0 0.6 0.4 1.0 0.7 0.0 4.8 1.3 2.1 0.0 2.5 3.9 0.0 0.2 0.6 3.5 0.0 0.5 0.0 0.0 0.1 2.0 1.9 0.1 0.5 0.6 0.3 0.0 0.0 0.5 0.9 5.4 0.7 0.4 5.3 14.4 6.2 1.0 0.1 5.3 0.0 9.0 0.2 0.0 4.0 5.5 1.1 11.3 6.2 0.3 5.3 16.9 1.3 3.6 5.6 3.3 8.2 4.2 5.6 9.2 3.9 4.6 7.8 0.9 4.3 1.9 5.4 6.0 6.0 9.1 6.1 5.7 9.4 7.2 5.0 5.9 0.0 4.6 5.3 9.7 7.8 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Group enriched" "Detected in many" 4 "Ciliated cells: 187.4;Early spermatids: 262.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.0 1.2 6.5 10.4 12.9 1.1 0.0 2.3 0.5 0.2 0.1 1.8 0.0 0.5 0.6 0.9 1.2 1.0 0.0 0.3 0.5 0.9 0.5 0.1 0.0 5.2 0.6 0.3 2.7 6.2 0.2 3.9 9.3 0.8 1.4 0.9 0.3 0.4 0.6 0.1 0.6 0.2 4.2 1.3 0.8 0.0 0.6 5.0 0.1 1.5 2.5 0.2 0.3 4.3 0.3 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.1 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 6.0 5.8 0.0 3.5 1.9 2.1 3.3 5.1 187.4 22.7 3.5 2.0 0.5 21.6 1.6 262.5 1.5 0.7 0.0 1.0 0.7 1.7 2.9 0.0 0.0 0.3 1.6 2.9 0.6 0.0 40.8 4.9 0.5 3.3 1.0 1.8 4.9 0.7 0.0 4.9 8.0 11.5 0.0 1.2 52.6 22.0 2.6 0.6 0.5 1.7 1.1 PPM1M "FLJ32332, PP2Ceta" ENSG00000164088 "Protein phosphatase, Mg2+/Mn2+ dependent 1M" Q96MI6 3 52245793-52250597 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 38.2;Kupffer cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 26.2" "HPA036905, HPA062291" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA036905: AB_10602818, HPA062291: AB_2684740" "unprognostic (4.26e-3)" "prognostic favorable (7.73e-4)" "unprognostic (2.55e-2)" "unprognostic (4.85e-3)" "unprognostic (5.64e-2)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "prognostic favorable (6.69e-4)" "unprognostic (4.63e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.49e-1)" "unprognostic (4.14e-2)" "unprognostic (9.27e-2)" "unprognostic (4.37e-2)" 14.3 7.2 13.9 22.7 14.8 16.5 26.3 3.6 9.2 16.9 12.5 4.6 7.8 4.4 13.6 12.0 10.8 11.7 19.4 14.5 8.7 8.5 8.7 4.9 30.1 38.0 5.4 12.3 14.9 5.9 6.9 7.5 8.6 4.9 15.1 6.7 11.0 10.8 12.4 3.1 7.5 8.8 18.1 6.8 22.5 8.3 6.2 5.9 20.5 11.3 9.9 20.5 11.3 13.5 5.0 9.6 19.6 18.6 7.4 15.0 10.1 0.4 2.5 1.5 3.7 22.8 22.8 2.4 5.8 12.5 8.2 6.4 1.4 2.0 4.2 1.7 15.1 4.6 0.7 5.1 1.1 3.3 5.0 1.2 9.6 6.7 1.5 16.7 1.4 9.1 18.8 2.5 9.2 5.8 13.3 10.6 19.5 1.6 7.0 9.6 1.0 6.2 0.4 2.0 1.9 7.0 1.4 0.7 9.2 3.5 1.1 1.1 4.5 4.2 1.0 5.2 3.4 3.6 3.7 7.3 3.1 5.3 1.8 0.7 26.2 4.8 4.5 6.2 2.5 3.8 1.2 15.7 8.5 15.0 12.4 11.7 5.0 11.8 13.8 9.6 3.8 11.1 13.8 19.6 7.4 18.6 5.8 13.2 10.1 13.9 14.8 3.6 9.2 8.7 8.5 5.4 12.3 4.9 5.9 0.0 4.8 11.5 3.9 4.5 1.0 2.0 5.1 1.4 3.4 1.8 0.0 3.0 3.3 1.7 9.9 6.9 0.7 0.0 1.0 5.3 8.2 2.7 5.7 2.4 38.2 1.6 1.2 10.4 40.0 14.2 11.8 24.5 5.0 10.0 0.2 5.1 1.6 1.9 9.2 2.2 0.4 19.4 6.1 0.4 3.6 3.3 1.6 22.0 0.7 1.8 PPM1N FLJ40125 ENSG00000213889 "Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)" Q8N819 19 45488777-45502510 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 43.7;skeletal muscle: 81.9" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 29.5;Extravillous trophoblasts: 60.2;Rod photoreceptor cells: 73.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "non-classical monocyte: 43.7" "Lineage enriched" "Detected in all" 10 "monocytes: 43.7" "Cell line enhanced" "Detected in many" "OE19: 16.9;RT4: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043577 Supported Vesicles NA NA Vesicles "HPA043577: " "unprognostic (2.38e-2)" "unprognostic (1.11e-2)" "unprognostic (8.53e-2)" "unprognostic (6.59e-2)" "unprognostic (4.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-3)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-16)" "unprognostic (3.42e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (1.86e-3)" 1.7 0.9 5.4 1.2 4.5 1.3 1.9 0.7 4.1 1.3 1.7 0.1 0.7 0.6 1.5 1.0 2.2 0.8 1.0 0.9 3.3 2.3 1.2 1.5 1.5 1.6 2.6 2.2 0.8 0.5 1.3 1.4 2.4 2.7 2.3 1.0 10.6 1.5 1.4 81.9 2.4 1.4 2.6 3.4 15.7 1.7 2.9 3.5 2.5 0.9 0.0 2.4 4.0 1.9 1.9 4.3 2.3 43.7 1.1 2.9 1.9 1.9 5.0 0.9 3.8 4.4 5.9 11.0 1.4 2.2 0.4 1.7 1.2 11.7 7.9 2.4 1.3 3.0 5.5 2.2 1.6 0.7 7.7 3.2 6.3 2.0 1.4 1.1 0.5 13.4 2.5 2.5 2.2 1.3 2.9 0.7 3.1 7.1 7.2 0.8 1.3 2.2 3.4 3.0 16.9 1.1 1.4 1.1 2.2 2.4 21.3 4.3 5.1 0.7 8.1 6.2 6.8 2.8 1.9 1.0 6.2 3.8 3.0 1.0 1.2 3.1 1.6 4.5 1.6 5.4 1.7 1.6 1.0 2.2 7.2 2.0 1.9 1.4 2.2 4.3 1.3 1.6 2.9 2.3 1.1 43.7 0.8 1.5 1.9 5.4 4.5 0.7 4.1 3.3 2.3 2.6 2.2 2.7 3.5 0.0 2.4 10.4 8.5 3.1 9.5 1.6 2.5 0.0 1.2 3.5 29.5 2.7 0.0 2.5 12.0 1.8 5.2 0.0 1.6 60.2 3.8 5.0 6.9 0.8 16.7 1.6 2.9 4.9 10.1 4.5 0.9 14.1 1.7 1.8 3.1 8.1 3.2 2.5 0.7 0.3 73.0 0.0 0.9 1.0 9.8 3.6 7.1 6.9 2.5 7.6 PPP1R42 "dtr, LRRC67, TLLR" ENSG00000178125 "Protein phosphatase 1 regulatory subunit 42" Q7Z4L9 8 66964099-67056604 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.2;fallopian tube: 10.2;testis: 20.2" "Group enriched" "Detected in some" 5 "Ciliated cells: 158.0;Spermatocytes: 89.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.3;RPTEC TERT1: 1.8;SCLC-21H: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024313, HPA027983, HPA028628" Uncertain NA NA "HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064" "unprognostic (8.03e-3)" "unprognostic (5.45e-2)" "unprognostic (4.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.99e-2)" "unprognostic (1.03e-1)" "unprognostic (3.61e-3)" "unprognostic (6.86e-2)" "unprognostic (8.58e-3)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-1)" 0.3 0.5 2.3 0.3 5.7 0.3 0.3 0.3 2.3 0.9 0.3 3.5 0.0 0.3 0.6 8.0 0.3 10.2 0.4 0.4 3.1 1.4 1.1 0.3 4.1 0.3 0.6 0.8 2.6 0.5 1.0 6.7 0.3 11.2 0.3 0.3 0.8 0.3 1.5 0.3 0.3 0.3 0.4 2.0 0.3 0.3 20.2 1.8 0.0 1.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 5.7 0.3 2.3 3.1 1.4 0.6 0.8 11.2 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 158.0 13.6 5.2 0.0 0.0 3.3 0.3 25.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.8 1.3 2.6 6.5 0.2 89.9 3.3 0.0 0.0 0.0 0.0 0.0 PPP4R3C "FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1" ENSG00000224960 "Protein phosphatase 4 regulatory subunit 3C" Q6ZMV5 X 27460211-27463341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 6.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "liver cancer: 0.6;testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 148 "U-2197: 21.8" "Not detected" "Not detected" NA NA "unprognostic (8.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP5D1 ENSG00000230510 "PPP5 tetratricopeptide repeat domain containing 1" E7EU14 19 46480796-46601200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6;Early spermatids: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 6.7" HPA073186 Uncertain Uncertain Cytosol NA NA Cytosol "HPA073186: AB_2732220" "unprognostic (2.84e-2)" "unprognostic (3.26e-1)" "unprognostic (3.50e-2)" "unprognostic (2.26e-1)" "unprognostic (7.10e-2)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.00e-4)" "unprognostic (3.90e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" 1.9 4.5 8.9 0.9 6.8 1.5 2.2 3.6 7.5 3.5 1.5 5.8 6.6 0.9 3.9 7.4 1.1 6.8 2.6 2.8 6.5 8.7 1.6 1.2 2.2 1.4 6.9 5.9 5.8 2.3 2.8 6.9 2.3 4.1 4.4 0.9 3.7 7.2 4.3 2.4 2.2 0.9 1.9 5.4 1.9 1.8 5.3 4.7 1.0 5.8 0.6 1.4 1.9 2.4 2.0 2.2 6.2 1.4 2.6 1.8 0.5 1.7 1.0 1.4 1.0 0.9 3.0 0.3 1.0 0.9 2.6 0.6 0.1 1.2 1.8 1.7 3.4 2.6 1.0 2.3 0.4 1.4 2.1 5.8 3.0 1.5 1.7 1.4 1.0 2.4 2.3 3.6 0.4 1.2 2.1 0.8 3.1 1.2 1.4 2.3 6.7 1.0 3.0 0.7 0.3 1.4 3.3 0.6 0.5 1.3 1.0 4.4 1.6 1.0 0.6 0.7 0.3 0.8 1.6 1.9 0.2 0.6 0.4 0.8 0.9 0.8 1.5 0.9 3.1 0.7 6.2 1.4 0.7 0.9 1.0 0.5 1.7 0.4 0.7 2.2 2.0 0.8 1.8 2.0 2.6 0.4 0.9 0.4 0.5 8.9 6.8 3.6 7.5 6.5 8.7 6.9 5.9 4.1 4.7 3.0 1.3 2.7 2.4 1.4 8.1 1.6 10.2 1.4 0.0 1.8 19.6 1.7 1.7 1.2 14.6 3.0 1.6 0.0 1.6 1.4 2.8 2.4 0.0 0.8 2.5 9.5 0.0 5.5 2.9 2.7 3.7 2.1 3.3 4.6 0.6 8.6 0.7 0.0 2.8 0.4 9.1 0.0 1.7 4.9 3.6 1.1 1.4 2.9 1.7 1.7 PPTC7 TA-PP2C ENSG00000196850 "PTC7 protein phosphatase homolog" Q8NI37 12 110533245-110583320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.8" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.43e-5)" "prognostic unfavorable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favorable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 10.4 15.3 6.5 10.3 9.6 26.2 10.3 8.3 12.9 9.7 11.8 5.7 4.9 7.5 9.3 4.6 12.6 7.8 8.8 35.3 9.0 9.0 12.6 11.9 13.1 10.9 10.4 6.8 8.9 7.5 13.0 12.7 6.9 15.3 7.7 9.8 8.0 12.9 8.2 53.8 13.4 11.7 13.1 7.4 9.4 8.4 8.2 6.5 16.1 8.0 15.5 13.1 12.4 12.4 2.1 1.4 6.1 1.7 1.7 2.4 0.6 12.2 7.0 6.0 6.3 15.0 13.2 8.6 5.6 7.5 6.2 6.2 7.9 4.8 21.5 5.9 5.5 8.9 11.9 12.0 13.1 12.6 15.6 10.0 19.0 7.5 8.5 14.3 21.0 15.7 11.4 21.6 8.8 25.9 9.3 11.7 15.0 14.1 6.1 10.0 3.1 18.5 18.0 8.5 6.6 13.1 15.5 8.1 13.1 25.7 13.7 9.7 7.6 10.7 14.8 12.4 6.1 7.0 11.3 13.4 5.7 6.1 17.3 9.5 17.8 19.7 24.0 9.6 11.6 11.2 0.1 1.7 1.3 2.3 1.5 2.4 1.3 1.9 1.8 1.3 2.1 2.2 1.9 6.1 1.7 1.1 1.4 1.3 0.6 6.5 9.6 8.3 12.9 9.0 9.0 10.4 6.8 15.3 6.5 20.8 21.2 21.7 47.9 81.6 8.5 96.6 15.3 25.4 22.7 8.7 13.7 6.3 14.9 6.8 29.6 22.2 18.4 23.3 7.1 7.0 37.6 42.4 23.1 24.9 15.0 12.7 16.1 14.7 25.1 17.5 10.6 19.9 32.1 10.0 14.2 3.9 11.1 14.4 9.2 10.5 24.1 12.9 39.1 12.5 22.5 91.1 5.6 20.8 13.8 64.3 PQLC2L C3orf55 ENSG00000174899 "PQ loop repeat containing 2 like" A1A4F0 3 157543246-157677749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.8;breast: 36.0" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 21.0;Ductal cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0" HPA054395 Uncertain Approved "Nucleoplasm,Nuclear bodies" No NA "Nucleoplasm, Nuclear bodies" "HPA054395: AB_2682473" "unprognostic (1.25e-1)" "unprognostic (1.19e-1)" "unprognostic (6.80e-2)" "unprognostic (1.41e-2)" "unprognostic (3.80e-3)" "unprognostic (1.65e-3)" "unprognostic (1.83e-5)" "unprognostic (2.29e-2)" "unprognostic (2.67e-1)" "unprognostic (3.56e-2)" "unprognostic (3.34e-2)" "unprognostic (4.59e-3)" "unprognostic (7.47e-7)" "unprognostic (1.17e-3)" "unprognostic (2.75e-1)" "unprognostic (4.81e-2)" "unprognostic (7.56e-3)" 29.8 1.6 0.2 1.8 1.3 0.1 36.0 0.0 0.8 5.3 4.1 0.0 0.0 0.1 1.3 2.0 3.1 1.8 4.3 5.6 0.3 1.2 4.5 0.1 8.4 1.6 0.5 0.1 0.4 1.4 0.1 5.9 2.6 1.3 3.9 1.4 4.6 4.5 1.0 4.8 2.2 1.6 3.4 0.3 0.1 3.8 2.7 0.0 0.0 11.8 3.0 0.5 4.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 0.0 33.9 18.8 0.0 1.7 3.5 0.7 1.0 0.0 2.4 0.0 12.8 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 12.1 0.6 5.2 0.3 13.4 5.3 0.0 0.3 0.0 17.0 0.1 0.0 0.0 0.1 0.6 3.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.1 0.0 0.0 4.8 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.8 0.3 1.2 0.5 0.1 1.3 0.0 0.0 0.3 0.0 0.6 0.0 0.3 0.3 2.5 1.4 1.2 21.0 0.0 0.0 0.0 5.8 4.2 0.0 0.0 0.0 1.8 0.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.7 0.8 1.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.6 PQLC3 "C2orf22, MGC33602" ENSG00000162976 "PQ loop repeat containing 3" Q8N755 2 11155198-11178874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 30.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061607 Approved Cytosol NA NA Cytosol "HPA061607: AB_2797264" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.19e-1)" "unprognostic (5.55e-2)" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.09e-3)" "unprognostic (9.11e-2)" "unprognostic (3.14e-1)" "unprognostic (2.24e-1)" "unprognostic (4.93e-3)" "unprognostic (2.93e-1)" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.34e-1)" "unprognostic (4.00e-2)" 26.9 21.3 5.1 16.5 6.2 4.2 16.7 2.4 6.2 22.2 14.4 11.3 8.6 5.6 19.7 27.0 18.1 15.4 19.5 14.9 5.4 5.1 20.6 9.8 21.0 26.9 7.9 5.8 20.7 33.3 5.3 5.4 15.5 7.8 18.5 10.5 15.5 14.1 11.2 14.0 9.8 16.5 19.8 13.1 26.3 12.7 12.0 5.7 12.0 17.6 13.0 15.0 15.7 14.7 11.4 36.9 37.0 46.9 14.4 18.4 33.0 3.1 10.8 2.0 6.1 30.8 21.1 7.3 6.6 8.7 3.1 3.7 2.0 12.5 1.1 5.0 12.9 13.6 4.1 3.1 3.4 3.2 20.0 1.6 3.0 1.4 1.3 12.3 1.5 9.3 15.3 11.6 2.0 4.5 6.9 7.0 7.1 2.8 7.0 8.5 14.3 2.2 3.0 4.3 11.2 3.8 2.8 3.3 3.4 11.6 5.4 0.7 3.4 5.6 17.6 12.4 9.3 15.7 5.5 9.9 4.5 1.9 4.8 1.8 12.0 8.7 0.5 11.9 7.1 8.8 15.1 37.3 37.0 18.4 45.7 16.1 11.4 18.2 18.0 36.9 7.7 10.1 13.9 2.3 14.4 46.9 7.1 18.2 33.0 5.1 6.2 2.4 6.2 5.4 5.1 7.9 5.8 7.8 5.7 23.8 6.2 18.0 19.8 22.2 1.7 2.4 20.4 12.0 14.8 50.6 15.7 16.2 8.3 32.7 0.5 17.5 10.7 0.0 56.6 70.6 37.3 19.5 12.7 10.9 53.1 1.6 6.4 38.6 87.8 0.7 43.4 62.1 55.6 84.8 10.7 4.5 41.4 3.5 55.5 11.7 0.9 58.2 38.7 2.1 18.5 20.5 9.4 45.9 11.5 16.9 PRAC1 "C17orf92, PRAC" ENSG00000159182 "PRAC1 small nuclear protein" Q96KF2 17 48721719-48722522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 62.1;prostate: 40.3" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 873.8;Mucus-secreting cells: 545.9;Undifferentiated cells: 434.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 291.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 33 "PC-3: 92.5" HPA047871 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047871: AB_2680195" "unprognostic (7.59e-2)" "unprognostic (2.43e-2)" "unprognostic (2.04e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.6 2.0 30.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 40.3 62.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 9.9 5.1 0.8 0.0 2.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 92.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.5 0.0 0.2 0.5 0.0 0.4 0.0 0.8 0.1 0.1 2.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 67.9 0.0 0.0 0.0 0.1 118.0 0.0 0.0 0.0 0.0 873.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 545.9 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 434.0 46.7 PRAMEF1 ENSG00000116721 "PRAME family member 1" O95521 1 12791397-12796628 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Group enriched" "Detected in some" 48 "Early spermatids: 6.8;Late spermatids: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" NA NA "unprognostic (2.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PRAMEF10 ENSG00000187545 "PRAME family member 10" O60809 1 12892896-12898270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 67 "liver: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "liver cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "SCLC-21H: 2.7" NA NA "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF15 ENSG00000204501 "PRAME family member 15" Q5VWM5 1 13315581-13322598 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "liver: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF17 ENSG00000204479 "PRAME family member 17" Q5VTA0 1 13389632-13392629 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF2 FLJ43580 ENSG00000120952 "PRAME family member 2" O60811 1 12857086-12861909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "HDLM-2: 1.8" NA NA "unprognostic (1.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF4 RP5-845O24.6 ENSG00000243073 "PRAME family member 4" O60810 1 12879224-12886201 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "liver: 1.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF5 "PRAMEF23, PRAMEF5L" ENSG00000270601 "PRAME family member 5" Q5TYX0 1 13254212-13263314 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF6 ENSG00000232423 "PRAME family member 6" Q5VXH4 1 12938472-12947580 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF7 ENSG00000204510 "PRAME family member 7" Q5VXH5 1 12916610-12920482 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049887, HPA051704" Uncertain NA NA "HPA049887: AB_2680935, HPA051704: AB_2681581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF8 ENSG00000182330 "PRAME family member 8" Q5VWM4 1 13281035-13285174 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049887, HPA051704" Uncertain NA NA "HPA049887: AB_2680935, HPA051704: AB_2681581" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRDM13 ENSG00000112238 "PR/SET domain 13" Q9H4Q3 6 99606730-99615578 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.1" "Cell type enhanced" "Detected in single" 19 "Horizontal cells: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070592 Uncertain NA NA "HPA070592: AB_2686283" "unprognostic (4.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.30e-1)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (3.16e-2)" "unprognostic (1.24e-2)" "unprognostic (2.93e-1)" "unprognostic (1.86e-2)" "unprognostic (7.54e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 PRELID2 "FLJ38376, MGC21644" ENSG00000186314 "PRELI domain containing 2" Q8N945 5 145471799-145835369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.2" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 377.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 15.8;myeloid DC: 5.2" "Group enriched" "Detected in all" 5 "dendritic cells: 5.2;granulocytes: 15.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042486 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042486: AB_10797498" "unprognostic (9.45e-3)" "unprognostic (1.95e-1)" "unprognostic (7.58e-3)" "unprognostic (2.71e-5)" "unprognostic (1.96e-3)" "unprognostic (6.53e-4)" "unprognostic (6.62e-5)" "unprognostic (2.27e-1)" "unprognostic (4.21e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (9.65e-6)" "unprognostic (2.65e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-4)" "unprognostic (6.42e-3)" 6.6 2.4 1.6 5.3 2.0 3.9 4.4 0.7 2.9 4.9 16.4 2.3 2.8 10.6 5.2 2.9 2.4 3.0 14.5 6.4 1.4 1.4 2.6 2.7 2.4 2.7 2.3 1.1 5.2 15.9 1.3 2.8 0.9 2.0 4.2 16.2 9.2 4.3 2.7 1.3 3.0 31.2 6.2 2.5 2.1 7.8 2.5 1.5 0.8 4.1 2.4 1.9 4.3 11.6 1.8 5.2 15.8 1.9 1.8 2.0 0.9 10.8 3.6 3.4 5.4 0.8 1.9 0.0 3.6 6.3 6.8 9.6 11.6 17.9 0.0 6.2 4.3 15.6 3.3 2.6 8.2 10.1 3.1 4.2 12.5 4.0 6.0 2.1 1.6 13.3 1.1 3.5 7.8 6.9 9.5 7.6 0.0 6.8 5.0 3.3 1.8 0.0 1.9 1.7 12.6 2.4 0.0 0.0 1.7 3.2 1.7 1.5 3.0 4.6 0.6 7.2 1.6 5.5 2.4 7.0 5.9 3.2 10.4 8.1 0.2 0.0 0.0 10.6 0.0 2.4 15.8 1.3 0.4 0.8 1.9 0.4 1.7 1.6 1.2 5.2 1.8 0.2 1.2 0.5 1.8 1.3 0.6 2.0 0.9 1.6 2.0 0.7 2.9 1.4 1.4 2.3 1.1 2.0 1.5 0.0 2.4 1.9 11.1 3.7 19.4 7.7 5.1 2.7 6.8 0.0 377.0 0.1 0.0 11.6 3.4 5.8 91.5 0.0 11.4 2.4 5.3 2.7 17.3 2.1 2.4 4.8 9.2 3.1 2.1 1.0 3.1 4.3 0.0 3.6 27.5 7.5 15.0 48.0 4.2 2.4 47.8 0.0 4.7 0.9 1.0 2.9 0.2 3.2 32.3 8.0 PRELID3B "C20orf45, dJ543J19.5, SLMO2" ENSG00000101166 "PRELI domain containing 3B" Q9Y3B1 20 59033145-59042909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 91.2" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 165.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047721 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047721: AB_2680131" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.37e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.96e-5)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (1.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.20e-3)" "unprognostic (5.84e-2)" "unprognostic (2.64e-1)" "unprognostic (2.61e-2)" "unprognostic (8.96e-2)" 18.6 17.0 14.1 17.0 13.9 13.7 20.4 10.3 14.1 10.0 45.2 8.7 11.2 41.3 9.6 9.6 26.7 8.8 10.3 13.3 12.9 13.4 20.5 30.1 13.5 19.1 15.4 10.0 11.1 24.2 12.7 34.3 28.8 12.3 10.5 30.0 6.1 15.3 12.6 17.2 14.0 91.2 11.6 16.7 19.9 19.3 11.5 12.1 21.4 18.9 25.5 21.2 13.9 14.4 25.8 17.5 26.6 21.0 27.1 27.6 20.2 25.9 12.8 12.5 16.3 9.3 13.2 17.6 19.2 17.1 36.1 19.3 35.7 22.0 41.3 34.0 14.7 27.9 28.4 25.4 30.6 38.0 24.4 15.9 28.6 21.8 7.6 19.8 37.3 26.6 11.7 40.4 20.7 48.3 11.9 11.7 34.3 11.2 18.1 15.4 33.3 42.0 16.6 6.2 42.2 35.6 21.9 28.4 23.4 17.9 22.2 22.6 21.7 30.8 52.4 44.3 9.6 26.5 29.2 13.7 13.1 12.7 23.9 10.1 12.3 17.5 33.4 14.3 18.4 14.6 26.6 13.6 13.5 21.4 17.9 25.9 25.8 26.1 24.0 17.5 18.6 23.6 24.8 11.7 27.1 21.0 14.7 27.6 20.2 14.1 13.9 10.3 14.1 12.9 13.4 15.4 10.0 12.3 12.1 20.8 31.8 13.4 46.7 0.0 8.1 0.0 25.5 41.5 28.4 21.0 5.9 58.5 58.0 57.9 52.0 18.0 96.3 0.0 49.8 92.9 28.8 59.3 15.1 23.2 49.1 11.1 26.9 12.3 34.8 17.4 13.8 30.9 0.0 55.9 65.9 14.3 59.9 56.1 14.9 41.1 6.5 25.8 0.0 62.2 36.7 0.0 103.8 36.2 68.2 165.6 PREX2 "DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129" ENSG00000046889 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2" Q70Z35 8 67952118-68237030 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 31.5;Endothelial cells: 35.0;Ito cells: 52.8;Muller glia cells: 74.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 12.8;HUVEC TERT2: 17.4;JURKAT: 7.5;NTERA-2: 11.1;RH-30: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015234, HPA075956" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA015234: AB_1847604, HPA075956: AB_2686769" "unprognostic (2.25e-1)" "unprognostic (3.32e-2)" "unprognostic (1.30e-2)" "unprognostic (3.39e-2)" "unprognostic (1.79e-1)" "unprognostic (2.37e-2)" "unprognostic (4.19e-1)" "unprognostic (8.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.98e-2)" "unprognostic (2.53e-2)" "unprognostic (8.77e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.30e-3)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (6.64e-2)" 18.8 3.0 14.1 3.3 17.9 1.0 8.5 11.4 16.4 10.8 4.4 13.1 3.0 4.3 6.2 4.5 4.4 12.4 7.6 7.6 15.5 8.1 4.1 3.2 9.1 2.4 12.4 10.0 5.2 3.1 3.7 4.4 17.5 17.2 6.3 4.4 2.6 3.0 5.7 4.9 4.4 4.0 6.1 12.7 3.5 4.1 2.7 16.2 0.0 12.1 3.9 2.9 5.9 15.8 1.1 0.3 0.8 0.1 0.2 0.4 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 7.5 0.0 0.0 0.0 0.0 2.6 0.0 11.1 0.0 0.0 0.0 5.0 0.0 0.6 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.1 0.1 0.4 0.1 0.2 0.5 0.2 0.2 0.0 1.1 0.2 0.3 0.5 0.2 0.1 0.3 0.0 0.0 14.1 17.9 11.4 13.6 15.5 8.1 12.4 10.0 17.2 16.2 3.0 5.3 0.0 3.2 3.5 24.6 4.4 0.0 1.4 5.7 1.8 2.0 0.0 0.0 0.0 31.5 35.0 0.0 0.0 0.0 0.0 5.5 0.5 1.1 0.4 0.1 4.8 0.0 52.8 3.1 4.9 10.3 0.2 8.5 0.0 0.0 74.9 0.0 0.0 9.9 0.0 3.0 25.8 3.4 0.7 0.7 2.3 0.0 0.0 0.0 1.4 PRICKLE4 "C6orf49, DKFZp761H221, OEBT" ENSG00000278224 "Prickle planar cell polarity protein 4" Q2TBC4 6 41780762-41787372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 2.6;Intestinal endocrine cells: 3.4;Rod photoreceptor cells: 3.4;Undifferentiated cells: 2.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "BEWO: 5.3;HeLa: 6.0;hTERT-RPE1: 15.2" "HPA031240, HPA055593" Approved Approved "Mitotic spindle,Centriolar satellite" NA NA "Centriolar satellite" "Mitotic spindle" "HPA031240: AB_10600929, HPA055593: " "unprognostic (1.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.56e-2)" "unprognostic (6.86e-2)" "unprognostic (1.58e-1)" "unprognostic (2.15e-2)" "unprognostic (6.41e-2)" "unprognostic (1.93e-2)" "unprognostic (3.47e-4)" "unprognostic (4.25e-2)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (1.56e-5)" "unprognostic (3.64e-3)" "unprognostic (5.74e-2)" "unprognostic (1.50e-1)" "unprognostic (2.17e-3)" 4.5 2.2 0.5 3.9 1.2 0.0 8.9 0.0 2.1 6.8 3.0 0.4 5.4 1.8 10.8 4.7 4.1 4.8 5.5 2.1 0.9 2.1 1.6 12.2 0.6 0.6 0.2 2.6 1.0 3.7 1.6 2.5 1.9 5.6 2.6 2.0 2.3 8.4 2.7 1.9 0.4 4.4 0.5 8.8 5.0 1.3 0.2 0.0 5.8 4.4 4.2 3.6 13.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 1.1 3.3 1.7 0.3 2.3 5.3 0.2 0.3 0.0 0.1 1.3 1.2 0.6 2.1 1.4 0.1 2.9 0.0 0.2 0.0 0.4 0.5 0.2 6.0 1.3 0.0 0.0 0.1 2.0 0.3 0.1 0.0 15.2 0.1 0.9 1.8 0.7 0.7 0.9 0.1 0.9 0.4 3.8 0.3 1.9 0.9 0.0 2.1 3.2 0.4 0.7 0.0 3.8 0.3 4.5 0.9 0.9 2.5 1.2 1.3 0.6 0.0 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.6 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.1 1.7 0.0 0.0 2.5 0.0 3.4 0.0 0.3 1.0 1.4 1.8 0.0 0.0 2.7 1.1 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;heart muscle: 4.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;MCF7: 4.4;RPMI-8226: 3.7;SK-BR-3: 1.8;T-47d: 2.1;U-87 MG: 2.4" "Group enriched" "Detected in some" 58 "hypothalamus: 13.4;pons and medulla: 22.5" "Region enriched" "Detected in single" 13 "pons and medulla: 5.1" HPA014976 Approved "Secreted - unknown location" NA NA "HPA014976: AB_2732413" "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 25.4;Ito cells: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HDLM-2: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053354, HPA060103" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053354: , HPA060103: AB_2684205" "unprognostic (4.14e-2)" "prognostic favorable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 2.0 1.3 3.0 0.5 1.6 0.0 0.3 0.2 0.0 0.1 48.1 0.6 0.7 1.2 0.2 1.3 0.0 1.6 0.4 0.4 1.2 0.3 0.4 0.1 2.0 0.2 3.0 1.7 0.5 2.5 1.2 0.6 0.3 1.2 7.7 0.2 5.8 0.1 0.0 0.6 0.3 2.8 3.0 0.1 0.7 1.1 1.6 0.2 0.1 0.1 0.1 0.2 0.4 0.8 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.2 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.0 1.1 1.4 0.0 6.5 1.7 0.1 0.3 0.0 2.2 0.0 0.2 0.3 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 58.8" "Group enriched" "Detected in many" 45 "Early spermatids: 1437.9;Late spermatids: 5492.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.3;REH: 12.6" "Not detected" "Not detected" "HPA023648, HPA030218" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA023648: AB_1855726, HPA030218: AB_10601152" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 1.2 1.1 1.7 1.8 2.6 1.6 1.1 7.8 2.8 2.1 2.0 2.6 2.9 1.8 1.8 1.2 0.9 2.2 1.0 1.0 1.9 2.0 1.8 0.5 1.3 2.6 1.7 2.3 3.1 0.7 0.9 1.2 0.9 3.5 1.2 1.0 4.0 0.8 1.4 2.2 1.3 2.1 1.2 2.4 3.5 1.1 58.8 1.6 1.0 0.7 0.0 1.5 0.9 1.6 3.1 5.0 6.2 3.0 1.1 2.2 1.1 1.1 1.4 4.6 8.6 3.4 2.4 3.1 1.5 0.6 1.1 0.9 1.4 4.2 0.2 0.8 0.8 0.6 3.7 3.6 0.2 0.6 2.1 1.9 3.4 3.4 0.9 0.5 6.4 0.3 1.6 0.4 1.8 0.7 2.6 0.8 2.5 4.1 2.8 0.9 0.9 4.1 12.3 7.1 0.9 0.9 12.6 4.7 0.1 1.3 1.0 2.2 1.9 1.4 0.6 0.5 5.7 7.0 5.4 0.5 0.8 1.4 0.9 0.9 1.5 2.0 1.9 1.3 7.0 1.1 6.2 2.2 6.2 1.1 3.0 0.4 3.1 2.2 0.7 1.4 1.1 1.0 1.8 1.3 1.1 2.5 5.0 1.2 1.1 1.7 2.6 7.8 2.8 1.9 2.0 1.7 2.3 3.5 1.6 0.0 1.4 0.0 1.1 0.9 3.3 5.5 0.0 1.4 2.3 0.0 3.9 0.7 0.0 0.4 1437.9 0.6 1.0 0.0 0.2 1.6 1.8 0.7 15.0 0.0 2.4 3.2 2.4 3.7 4.3 5492.6 23.6 4.3 0.0 1.0 1.1 7.8 0.5 0.0 18.4 0.8 4.6 19.4 1.9 76.2 19.6 0.3 0.6 1.0 1.6 0.3 PRORY CYorf17 ENSG00000183146 "Proline rich, Y-linked" Q9H606 Y 21382954-21386360 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "intestine: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-266/84: 8.5" NA NA "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.4 5.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 1.2 0.4 0.3 0.9 0.2 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.6 1.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.5 0.1 0.7 0.5 0.6 0.0 0.2 0.4 1.0 0.0 0.9 8.5 0.2 0.2 0.7 0.1 0.6 0.2 0.5 0.7 0.4 0.5 0.4 0.4 0.7 0.2 0.9 0.7 0.9 1.2 0.3 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROSER3 "C19orf55, FLJ30657" ENSG00000167595 "Proline and serine rich 3" Q2NL68 19 35758143-35771028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 84.4;Rod photoreceptor cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058492 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA058492: AB_2683733" "unprognostic (1.35e-2)" "unprognostic (1.29e-2)" "unprognostic (6.74e-3)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (9.29e-3)" "unprognostic (1.25e-3)" "unprognostic (5.13e-2)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (2.52e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (3.74e-7)" "unprognostic (8.60e-2)" "unprognostic (2.41e-1)" "unprognostic (2.87e-2)" "unprognostic (9.54e-2)" 4.6 5.2 4.4 7.5 6.8 8.5 5.6 3.9 8.6 6.7 6.0 6.3 7.3 3.5 8.9 7.0 5.6 8.5 6.4 4.9 4.4 3.6 5.0 3.6 6.3 5.4 4.2 4.3 10.3 9.4 7.5 12.8 5.4 5.0 6.2 3.6 8.8 5.8 7.2 3.7 10.5 5.7 9.6 3.5 5.2 7.2 26.2 5.1 13.9 8.7 3.3 6.5 8.3 6.6 3.6 1.7 12.4 2.1 0.9 2.3 0.2 7.8 22.8 8.2 7.9 3.3 3.5 2.6 5.8 6.7 6.4 6.9 6.8 5.5 4.4 6.4 5.5 3.1 4.7 3.5 10.3 4.3 10.5 5.9 6.2 9.6 2.9 2.9 5.0 13.8 4.1 5.9 9.0 8.0 5.1 2.8 5.6 5.4 8.2 5.6 3.9 8.8 2.0 2.2 4.6 3.4 6.6 2.0 3.2 4.2 8.4 8.1 7.2 6.4 4.8 0.9 3.2 7.5 4.3 6.9 6.7 7.3 7.0 6.0 10.4 6.9 3.6 7.2 3.3 4.9 5.8 2.1 4.6 1.4 1.2 2.3 2.5 2.0 1.3 0.5 3.6 1.8 0.7 12.4 0.9 1.2 1.7 1.7 0.2 4.4 6.8 3.9 8.6 4.4 3.6 4.2 4.3 5.0 5.1 8.9 1.0 8.2 9.9 0.0 10.1 1.1 2.5 26.8 3.4 10.4 84.4 6.7 0.0 5.0 29.6 2.1 3.9 0.0 1.6 4.2 7.2 6.1 2.3 1.7 2.5 6.4 9.1 6.7 3.2 16.7 13.3 3.9 0.0 7.2 2.5 6.3 4.6 3.5 3.9 1.1 39.2 6.5 1.0 25.1 4.9 0.0 6.1 9.6 4.4 4.6 PROX2 FLJ36749 ENSG00000119608 "Prospero homeobox 2" Q3B8N5 14 74852871-74871940 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 5.8" "Cell type enhanced" "Detected in some" 31 "Alveolar cells type 2: 3.4;granulocytes: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.2;CACO-2: 3.9;U-698: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045057 Uncertain NA NA "HPA045057: AB_10960259" "unprognostic (4.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (1.36e-2)" "unprognostic (1.31e-2)" "unprognostic (3.95e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (5.98e-3)" "unprognostic (2.98e-1)" "unprognostic (1.22e-2)" "unprognostic (9.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.59e-2)" "unprognostic (1.73e-4)" 0.6 0.3 0.4 1.6 1.6 4.1 0.6 1.8 1.2 1.9 0.5 0.6 0.9 2.1 0.6 1.2 0.3 0.4 0.5 0.9 0.5 0.2 0.8 2.4 0.8 2.9 0.6 0.8 1.4 0.6 1.3 1.0 0.9 1.1 0.5 5.8 1.0 0.2 1.0 2.0 0.4 0.7 1.7 1.5 0.6 1.2 0.8 1.0 4.2 0.7 3.5 0.7 0.3 0.2 0.5 5.2 1.9 1.5 0.7 1.5 0.4 0.0 0.0 0.3 3.9 0.5 0.3 0.4 0.0 0.1 1.2 0.4 0.0 0.0 0.0 0.2 1.8 1.8 1.0 0.5 0.1 2.4 0.0 0.4 0.0 0.0 1.3 0.0 0.3 0.2 0.3 0.0 2.2 0.2 0.8 0.3 0.1 0.5 1.2 0.9 0.1 0.0 1.0 1.4 0.6 0.2 0.4 0.0 0.5 0.5 1.8 0.4 1.3 0.5 0.5 0.3 0.8 0.5 3.7 0.1 1.6 0.0 0.2 0.7 3.0 0.5 0.6 0.7 0.8 0.2 0.4 0.4 0.5 0.4 0.6 4.2 3.5 0.5 1.0 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563811-29567295 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 66.9;Enterocytes: 108.9;Paneth cells: 46.5;Undifferentiated cells: 48.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enhanced" "Detected in single" "B-cells: 1.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.5;HaCaT: 17.9;OE19: 38.3;RT4: 13.7;SK-BR-3: 30.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA040996: AB_2677241, HPA048121: AB_2680271" "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favorable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favorable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 3.8 0.5 0.7 14.4 0.4 0.0 3.1 0.4 0.8 22.8 58.9 0.8 2.6 24.8 6.8 13.3 0.7 2.9 12.1 1.0 0.6 0.5 12.7 0.5 3.7 0.6 0.4 0.4 4.0 2.0 0.0 2.7 19.0 0.5 2.7 18.5 0.3 4.6 0.9 0.5 0.3 66.1 1.1 1.1 0.4 16.6 1.4 0.4 0.3 1.0 1.0 1.9 7.0 1.9 1.6 0.0 0.0 0.5 0.0 0.0 0.6 6.5 9.3 0.0 0.0 3.6 4.5 11.9 0.3 0.4 0.1 0.1 8.1 15.5 0.0 1.7 2.2 0.2 17.9 1.9 0.0 0.0 0.0 1.3 0.5 1.7 8.8 1.2 0.0 0.0 0.0 3.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.2 1.2 1.4 38.3 7.4 0.0 0.0 8.2 10.7 13.7 0.2 0.1 0.9 30.2 0.0 5.5 2.2 0.0 7.9 0.2 0.0 0.0 0.3 0.7 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.4 0.8 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.3 0.0 1.1 0.1 0.0 0.3 10.2 66.9 6.8 36.6 0.0 12.5 24.9 6.1 0.6 0.3 108.9 0.0 19.6 8.7 0.3 2.1 0.0 0.0 2.5 0.0 8.1 0.0 0.0 0.0 1.4 2.7 0.0 1.0 37.6 0.0 10.9 46.5 2.1 9.2 0.0 0.0 0.4 0.0 0.4 0.0 5.3 0.0 48.1 19.0 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 35.7" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 5.1;Collecting duct cells: 1.8;Hepatocytes: 2.1" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 9.3;SH-SY5Y: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077250 Enhanced NA NA "HPA077250: AB_2732336" "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 1.3 0.9 12.4 0.9 17.3 0.9 0.9 1.7 34.8 1.1 0.9 35.7 0.0 1.4 0.9 0.9 0.9 4.4 0.9 0.9 18.6 9.0 1.0 6.4 1.1 0.9 23.1 7.0 1.0 1.1 3.3 0.4 0.9 11.0 1.3 0.9 0.0 1.0 1.1 0.9 0.9 1.0 0.9 21.7 0.9 1.2 0.9 18.9 0.0 1.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.3 5.5 0.6 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 17.3 1.7 14.9 18.6 9.0 23.1 7.0 11.0 18.9 0.0 0.0 0.0 0.1 0.0 1.0 0.6 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20A "FLJ40296, PRR20" ENSG00000204919 "Proline rich 20A" P86496 13 57140918-57143939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Group enriched" "Detected in many" 13 "Early spermatids: 151.0;Late spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.2 1.4 6.6 0.0 0.2 6.6 1.3 0.6 1.0 1.6 3.2 1.8 2.9 3.7 0.2 0.7 2.4 1.0 1.3 0.2 4.5 10.3 1.4 1.4 1.1 0.6 3.1 16.1 0.8 1.1 1.4 0.4 0.1 0.2 3.6 7.2 0.0 0.8 6.9 3.6 3.8 8.3 0.3 3.3 3.5 1.2 4.6 0.3 2.1 1.8 3.3 0.3 2.4 3.7 0.3 2.8 2.5 1.0 2.5 6.8 8.7 1.6 9.4 7.3 5.6 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 3.0 0.3 0.8 0.4 0.2 5.3 0.3 2.5 0.0 2.3 3.5 0.0 1.9 0.0 0.7 151.0 0.4 2.6 0.0 0.6 0.7 0.8 1.1 0.0 2.1 0.9 4.8 2.4 0.6 1.0 60.2 2.0 0.0 0.0 0.0 2.6 2.2 0.7 1.5 0.4 1.0 5.3 6.5 0.0 8.3 6.6 1.0 1.5 0.0 2.7 0.5 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 4.7" "Group enriched" "Detected in some" 13 "Spermatocytes: 6.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 4.1 0.0 0.0 0.0 0.0 0.1 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 3.4;testis: 4.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.2" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 4.3 0.0 0.0 0.0 0.0 1.0 0.4 3.4 0.4 0.8 0.4 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.9 1.2 0.0 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 3.4 0.4 0.6 0.2 0.2 0.2 0.3 0.3 0.1 0.0 1.0 0.3 0.4 2.2 0.8 0.1 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.1 0.0 0.0 0.0 0.0 PRR26 "C10orf108, FLJ38681" ENSG00000180525 "Proline rich 26" Q8N8Z3 10 649948-669581 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Intestinal endocrine cells: 39.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;CAPAN-2: 3.3;EFO-21: 3.7;Hep G2: 2.5;hTERT-RPE1: 3.7;OE19: 2.1;RPTEC TERT1: 6.2" HPA066037 Uncertain NA NA "HPA066037: AB_2685601" "unprognostic (2.29e-1)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.92e-2)" "unprognostic (8.67e-3)" "unprognostic (1.69e-2)" "unprognostic (4.53e-2)" "unprognostic (1.91e-1)" "unprognostic (2.59e-2)" "unprognostic (2.03e-2)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (3.48e-1)" "unprognostic (1.98e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-3)" 18.5 0.2 0.5 3.5 0.6 0.2 3.2 0.6 0.3 3.4 18.8 0.0 1.9 8.4 5.1 1.3 7.1 1.8 18.0 10.2 0.6 0.4 9.6 13.6 0.7 0.9 0.5 0.0 2.6 17.9 0.0 2.9 0.2 2.9 5.3 7.2 2.5 0.3 3.1 2.5 0.5 15.9 8.2 0.5 1.8 6.8 1.5 0.0 0.0 0.5 0.3 0.0 4.9 3.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.9 3.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.3 0.0 0.5 0.3 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.0 6.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.3 0.6 0.4 0.5 0.0 2.9 0.0 0.0 0.3 0.0 0.6 0.1 2.3 4.3 7.6 2.7 0.0 1.8 3.9 0.0 0.0 5.3 0.5 0.7 12.1 0.0 7.6 0.1 0.0 0.2 0.0 6.8 0.0 4.8 39.9 1.3 0.0 0.4 1.1 0.0 1.7 0.0 11.8 3.2 2.9 11.5 3.2 3.1 9.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 9.2 0.9 PRR27 C4orf40 ENSG00000187533 "Proline rich 27" Q6MZM9 4 70133616-70176799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 268 "salivary gland: 669.3" "Group enriched" "Detected in some" 32 "Early spermatids: 11.0;Late spermatids: 7.0" "Cancer enriched" "Detected in single" 10 "breast cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.4" "Cell line enhanced" "Detected in single" "HeLa: 1.3" "HPA036150, HPA036151" Enhanced "Secreted to digestive system" NA NA "HPA036150: AB_10673001, HPA036151: AB_2674971" "unprognostic (9.52e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 669.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.5 0.2 2.4 0.3 0.5 0.2 0.0 0.3 0.2 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.2 1.3 0.1 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.2 0.5 0.0 0.7 0.1 0.4 0.5 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.1 0.4 0.2 0.2 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.2 0.4 0.1 0.3 0.1 0.0 0.4 1.5 0.3 0.2 0.2 0.2 0.0 0.3 0.1 0.2 0.0 0.5 0.2 0.2 2.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004304 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 17.9;fallopian tube: 48.7;testis: 23.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.8;REH: 7.0;TIME: 5.6" HPA051264 Uncertain Nucleoli NA NA Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 0.9 0.5 3.3 0.8 7.6 0.6 0.9 0.1 2.1 4.0 0.5 8.3 0.4 0.6 1.0 17.9 0.6 48.7 1.0 0.7 5.6 5.5 0.6 0.6 7.3 0.7 1.6 0.8 8.1 0.5 0.9 5.8 0.7 15.2 0.6 0.4 0.2 0.9 0.9 0.6 0.5 0.5 0.6 1.1 2.5 0.5 23.5 1.0 0.0 2.5 0.0 0.7 1.0 0.0 1.0 0.7 3.1 1.8 1.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.0 0.0 0.4 0.0 6.8 0.0 0.7 0.0 1.5 0.0 0.1 0.5 0.2 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.2 1.9 1.0 0.0 0.0 0.0 2.4 0.0 0.2 1.4 0.2 7.0 0.1 2.9 0.5 0.0 0.4 2.1 0.0 0.3 0.4 1.1 1.1 0.0 5.6 0.2 2.4 0.7 0.2 0.7 0.2 0.5 0.9 0.3 0.0 3.1 0.9 0.0 2.0 1.8 0.4 0.7 1.7 1.0 0.7 1.0 3.0 1.7 0.8 1.0 1.7 0.1 1.1 1.6 3.3 7.6 0.1 2.1 5.6 5.5 1.6 0.8 15.2 1.0 0.0 3.2 0.5 0.0 0.0 0.0 0.1 0.0 164.6 18.2 3.5 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.8 1.4 0.0 0.2 0.0 0.0 0.0 PRR30 "C2orf53, MGC44505" ENSG00000186143 "Proline rich 30" Q53SZ7 2 27136848-27139410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 66.1" "Group enriched" "Detected in some" 79 "Early spermatids: 529.6;Late spermatids: 559.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 529.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 559.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 6.9 3.8 0.0 0.0 0.0 0.0 0.0 PRRG3 TMG3 ENSG00000130032 "Proline rich and Gla domain 3" Q9BZD7 X 151695124-151705924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.4;epididymis: 10.3" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 16.4;Cardiomyocytes: 5.0;Melanocytes: 6.8;Suprabasal keratinocytes: 19.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 2.0;NTERA-2: 3.0;SuSa: 7.5;U-2197: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060566 Uncertain NA NA "HPA060566: AB_2684321" "unprognostic (1.85e-1)" "unprognostic (1.21e-1)" "unprognostic (7.71e-2)" "unprognostic (1.77e-2)" "unprognostic (4.42e-4)" "unprognostic (7.24e-2)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" "unprognostic (5.11e-2)" "unprognostic (3.01e-2)" "unprognostic (2.26e-1)" "unprognostic (1.98e-2)" "unprognostic (7.69e-2)" "unprognostic (4.64e-2)" "unprognostic (1.57e-1)" "unprognostic (1.84e-2)" 3.1 0.2 5.6 1.2 12.4 0.4 2.0 1.0 10.2 9.2 1.1 1.0 0.1 0.3 3.0 10.3 4.0 1.0 3.3 1.6 5.3 11.6 0.4 0.1 2.0 0.2 3.2 5.3 3.9 0.1 0.4 1.3 1.3 5.3 1.1 1.0 1.4 1.3 0.4 3.3 2.5 0.5 2.4 1.2 2.6 0.6 0.6 0.7 0.1 0.7 0.6 0.4 1.4 2.4 1.2 1.4 3.8 1.8 2.4 1.4 1.0 0.1 0.1 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.2 0.1 0.2 1.6 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.4 3.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.7 0.3 0.0 0.2 0.0 7.5 0.1 0.1 0.0 0.4 0.3 1.7 0.1 0.1 1.0 0.0 0.2 0.1 0.1 3.8 1.3 1.3 1.2 1.2 1.4 1.1 0.9 0.9 1.0 1.2 1.3 1.1 3.1 2.4 1.8 1.4 1.1 1.0 5.6 12.4 1.0 10.2 5.3 11.6 3.2 5.3 5.3 0.7 0.0 0.0 0.0 0.3 16.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 19.7 0.0 0.0 0.0 0.1 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PRRX2 "PMX2, PRX2" ENSG00000167157 "Paired related homeobox 2" Q99811 9 129665641-129722674 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 24.4;Early spermatids: 53.9;Fibroblasts: 25.4;Smooth muscle cells: 37.7;Suprabasal keratinocytes: 26.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.1;BJ: 17.1;BJ hTERT+: 12.2;fHDF/TERT166: 24.6;U-2197: 20.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006607, HPA026808" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006607: AB_2667623, HPA026808: AB_10603228" "unprognostic (4.02e-2)" "unprognostic (5.17e-2)" "unprognostic (7.65e-3)" "unprognostic (4.47e-3)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (2.16e-2)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.94e-10)" "unprognostic (6.66e-2)" "unprognostic (4.48e-1)" "unprognostic (2.65e-2)" "unprognostic (9.47e-3)" 8.4 2.1 0.4 2.5 0.4 0.2 7.3 0.2 0.6 15.6 2.4 0.5 3.5 0.7 4.6 5.4 5.3 2.1 2.3 8.6 0.4 0.2 0.6 0.4 2.8 1.8 0.3 0.1 3.2 2.2 0.3 2.8 2.6 1.7 15.1 0.7 12.8 4.6 5.2 6.6 15.8 1.1 10.2 1.2 0.4 1.6 6.7 0.0 0.6 7.9 9.3 6.5 10.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 2.1 8.1 0.0 17.1 12.2 2.2 2.5 0.0 0.0 0.0 6.2 24.6 0.9 0.2 0.5 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 2.6 1.2 3.8 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.8 0.0 0.0 0.9 1.6 0.3 0.0 0.0 5.1 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.4 0.2 0.3 0.1 1.7 0.0 0.0 0.0 0.0 1.2 24.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 53.9 0.1 0.0 0.0 0.0 0.3 25.4 2.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.7 2.6 0.0 8.5 0.0 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 37.7 3.2 6.8 26.0 0.3 0.0 0.0 5.0 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.5;testis: 31.3" "Group enriched" "Detected in many" 4 "Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5" "Group enriched" "Detected in many" 5 "amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" NA NA "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favorable (2.66e-4)" "prognostic favorable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.9 0.5 2.1 4.1 1.4 0.0 1.9 0.5 2.8 16.5 6.0 2.0 1.3 2.2 3.0 2.7 3.6 9.8 27.5 0.3 2.2 0.9 1.1 0.8 8.0 0.0 0.7 2.4 1.9 9.8 0.0 0.9 20.4 4.1 2.0 5.8 20.0 3.1 3.2 0.3 5.9 8.6 1.0 0.5 0.3 8.1 31.3 0.2 0.3 0.6 7.7 7.7 3.1 16.2 0.3 0.4 0.0 0.1 0.0 0.7 0.0 1.5 0.0 0.5 0.0 0.0 4.2 0.0 13.7 12.5 2.9 4.9 0.0 5.6 0.0 0.0 20.8 1.5 0.2 9.3 2.8 3.9 0.0 2.1 0.0 1.1 0.0 0.4 0.0 0.0 1.3 5.3 1.0 3.0 9.6 0.0 0.1 0.0 0.0 2.4 0.0 0.1 2.8 0.6 10.7 0.9 0.0 11.8 0.0 0.0 2.0 1.5 66.0 0.0 0.0 0.8 9.9 0.0 29.5 0.0 5.9 0.8 3.7 2.7 0.3 0.0 0.0 0.3 0.9 3.4 0.0 0.1 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.1 1.4 0.5 2.8 2.2 0.9 0.7 2.4 4.1 0.2 6.0 2.9 0.0 0.8 7.4 0.4 1.2 12.7 84.3 46.6 1.8 0.0 36.7 0.0 0.4 7.1 0.7 9.7 0.0 8.8 2.7 5.6 0.3 6.9 0.0 3.2 0.0 5.1 0.0 0.0 11.8 0.0 1.1 5.0 0.0 2.2 0.0 6.5 8.0 0.0 0.3 0.2 0.0 2.1 8.0 13.8 3.8 10.0 0.0 4.2 4.2 PRSS16 TSSP ENSG00000112812 "Serine protease 16" Q9NQE7 6 27247701-27256624 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 14 "lymphoid tissue: 242.8" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4" "Group enriched" "Detected in many" 39 "B-cells: 5.4;T-cells: 2.3" "Cell line enhanced" "Detected in many" "hTCEpi: 19.9;RPMI-8226: 10.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (9.21e-3)" "unprognostic (1.57e-1)" "unprognostic (7.89e-2)" "prognostic favorable (6.46e-5)" "unprognostic (1.57e-1)" "unprognostic (3.49e-2)" "unprognostic (5.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.62e-2)" 0.9 0.5 0.9 0.9 0.9 0.0 3.6 0.9 0.9 2.0 3.3 0.9 0.9 2.3 0.9 9.3 3.6 3.3 2.1 0.9 0.9 0.0 1.4 0.9 2.4 0.9 0.9 0.9 1.2 17.1 6.4 1.8 2.1 0.9 1.8 4.1 0.9 4.3 2.5 0.9 2.9 2.8 0.9 0.9 0.9 3.9 0.9 0.9 242.8 8.7 0.9 0.9 2.0 1.1 5.4 0.0 0.0 0.0 0.0 2.3 0.4 3.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 3.4 4.6 0.0 0.7 0.0 0.0 1.5 2.5 3.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.0 0.5 0.0 19.9 0.0 4.0 0.5 0.0 1.6 2.3 1.9 0.0 1.2 0.4 0.0 0.7 1.9 0.5 0.0 0.0 10.7 2.3 3.4 0.0 0.0 1.3 3.0 0.0 4.6 1.9 0.8 0.0 0.0 0.8 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 2.0 5.4 2.3 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 8.9 7.7 0.8 9.8 5.7 0.0 0.4 7.6 2.7 3.4 14.0 0.0 36.3 1.7 6.8 0.5 0.3 16.0 0.0 15.6 21.7 0.4 6.6 5.7 0.0 3.4 0.0 4.1 0.0 0.3 0.0 0.6 0.0 5.0 0.0 17.5 1.0 10.5 19.8 0.0 0.2 0.0 0.0 0.7 1.0 5.3 5.6 26.5 0.0 14.5 7.4 PRSS35 "C6orf158, dJ223E3.1, MGC46520" ENSG00000146250 "Serine protease 35" Q8N3Z0 6 83512538-83525704 "Enzymes, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.1;ovary: 16.3" "Cell type enriched" "Detected in some" 55 "Muller glia cells: 458.8" "Cancer enhanced" "Detected in some" "testis cancer: 4.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "MAIT T-cell: 17.1" "Lineage enriched" "Detected in single" 172 "T-cells: 17.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7" "HPA038787, HPA038788" Uncertain "Secreted in female reproductive system" NA NA "HPA038787: AB_10675951, HPA038788: AB_2676208" "unprognostic (6.17e-2)" "unprognostic (8.75e-2)" "unprognostic (1.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.70e-4)" "unprognostic (6.08e-2)" "unprognostic (1.18e-3)" "unprognostic (2.33e-2)" "unprognostic (7.01e-2)" "unprognostic (9.07e-2)" "unprognostic (3.88e-6)" "unprognostic (7.15e-3)" "unprognostic (5.81e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-4)" 2.0 3.8 7.7 1.3 11.3 0.0 0.6 0.2 9.3 4.8 0.4 2.5 0.3 0.5 2.2 2.1 0.6 2.2 6.2 5.6 4.8 1.1 4.9 0.7 2.0 3.0 1.1 5.4 16.3 0.6 0.9 1.5 5.2 2.7 2.7 0.6 11.1 0.4 0.7 0.4 0.5 0.4 2.2 1.4 1.1 0.6 4.6 1.3 0.0 0.7 0.4 0.2 2.0 0.9 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.2 5.2 0.5 1.0 42.7 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 4.1 0.0 0.0 0.0 12.6 0.0 0.0 0.5 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 17.1 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.7 11.3 0.2 7.1 4.8 1.1 1.1 5.4 2.7 1.3 3.0 0.3 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.0 1.8 0.0 0.1 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.3 6.4 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 458.8 0.0 0.0 8.1 0.0 7.1 6.5 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 PRSS38 MPN2 ENSG00000185888 "Serine protease 38" A1L453 1 227815693-227846470 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "blood: 2.2;testis: 8.4" "Group enriched" "Detected in some" 10 "Spermatocytes: 9.6;Spermatogonia: 8.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "gdT-cell: 1.4;NK-cell: 2.2" "Group enriched" "Detected in many" 18 "NK-cells: 2.2;T-cells: 1.4" "Cell line enriched" "Detected in single" 20 "U-266/84: 5.2" "Not detected" "Not detected" "HPA028003, HPA055809" Enhanced "Secreted in male reproductive system" NA NA "HPA028003: AB_1853572, HPA055809: AB_2682931" "unprognostic (9.54e-3)" "unprognostic (3.61e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 8.5 0.0 0.0 0.0 0.0 0.0 PRSS41 TESSP1 ENSG00000215148 "Serine protease 41" Q7RTY9 16 2798485-2805302 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 11.6;testis: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Cell type enriched" "Detected in single" 116 "eosinophil: 11.6" "Lineage enriched" "Detected in single" 116 "granulocytes: 11.6" "Cell line enriched" "Detected in single" 11 "BEWO: 6.5" NA NA "unprognostic (1.58e-1)" "unprognostic (3.65e-1)" "unprognostic (3.04e-3)" "unprognostic (1.03e-1)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (1.98e-1)" "unprognostic (1.24e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS45 TESSP5 ENSG00000188086 "Serine protease 45" Q7RTY3 3 46742092-46744755 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 7.6;skeletal muscle: 6.7" "Cell type enhanced" "Detected in some" 14 "Late spermatids: 1.1;Melanocytes: 1.7;Spermatocytes: 1.9;Spermatogonia: 1.2" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "Daudi: 1.1;HHSteC: 2.4;OE19: 1.7;SuSa: 1.1" HPA060284 Uncertain NA NA "HPA060284: AB_2684242" "unprognostic (4.55e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-2)" "unprognostic (2.50e-1)" "unprognostic (6.07e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (6.20e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-4)" "unprognostic (2.33e-2)" "unprognostic (6.60e-3)" "unprognostic (1.27e-2)" "unprognostic (1.57e-2)" "unprognostic (2.15e-1)" "unprognostic (5.97e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.5 0.2 0.1 0.2 7.6 0.1 0.8 0.0 0.2 0.0 0.0 0.9 0.7 0.2 0.1 0.0 0.3 1.3 2.0 0.5 0.1 0.5 0.0 0.5 0.3 6.7 0.3 0.0 0.0 0.0 0.0 0.2 1.6 3.2 0.0 0.4 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 PRSS48 ESSPL ENSG00000189099 "Serine protease 48" Q7RTY5 4 151277171-151291453 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.0;skin 1: 1.9;testis: 4.1" "Cell type enriched" "Detected in some" 6 "Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053801 Uncertain "Secreted in male reproductive system" NA NA "HPA053801: AB_2682267" "unprognostic (9.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.76e-2)" "unprognostic (4.10e-2)" 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 6.5 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 PRSS53 POL3S ENSG00000151006 "Serine protease 53" Q2L4Q9 16 31083425-31089628 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 10.9" "Cell type enhanced" "Detected in some" 10 "Leydig cells: 1.7;Peritubular cells: 1.1;Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034955, HPA034956" Uncertain "Secreted - unknown location" NA NA "HPA034955: AB_2674380, HPA034956: AB_10696365" "unprognostic (3.13e-1)" "unprognostic (4.15e-1)" "unprognostic (3.88e-3)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-2)" "unprognostic (2.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.63e-4)" "unprognostic (2.53e-12)" "unprognostic (1.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" 0.3 0.0 0.0 0.5 0.3 0.0 0.1 2.9 0.4 0.2 0.3 1.4 1.0 0.0 0.1 0.3 0.6 0.2 0.1 0.3 0.6 10.9 0.5 0.9 0.1 0.3 2.2 0.0 0.8 0.2 1.2 0.0 0.0 0.8 0.0 3.9 0.5 0.4 0.2 1.0 1.3 0.0 0.3 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.0 0.0 0.0 1.0 0.5 1.2 1.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.1 1.3 0.3 1.6 0.8 0.0 2.0 1.6 0.0 0.0 0.0 0.0 10.0 0.8 0.9 0.0 1.0 0.0 0.8 0.1 0.7 1.0 0.7 2.5 0.2 1.4 0.1 0.3 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.0 0.3 0.0 0.3 0.0 0.0 1.3 0.0 0.7 0.1 0.3 PRSS54 "CT67, FLJ25339, KLKBL4" ENSG00000103023 "Serine protease 54" Q6PEW0 16 58279997-58295047 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 35.1" "Group enriched" "Detected in some" 63 "Early spermatids: 433.8;Late spermatids: 185.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041549 Enhanced "Secreted in male reproductive system" NA NA "HPA041549: AB_10795640" "unprognostic (1.13e-1)" "unprognostic (3.24e-2)" "unprognostic (3.09e-2)" "unprognostic (3.08e-1)" "unprognostic (4.88e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.6 2.2 0.0 0.0 0.0 0.0 0.0 PRSS58 TRYX3 ENSG00000258223 "Serine protease 58" Q8IYP2 7 142252143-142258058 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 27.2" "Group enriched" "Detected in some" 128 "Early spermatids: 636.2;Late spermatids: 161.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 22 "RH-30: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 636.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Group enriched" "Detected in some" 7 "AF22: 47.4;SuSa: 57.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.0 47.4 1.0 0.0 0.0 4.8 0.4 1.4 1.2 1.7 7.9 0.2 0.0 2.0 0.0 1.8 0.0 0.1 0.1 1.7 0.0 2.5 0.3 0.3 3.0 0.3 0.3 0.0 0.1 0.0 0.5 0.8 0.9 0.8 0.0 0.8 0.0 0.7 0.6 0.0 0.0 1.9 0.0 1.1 0.0 7.5 0.0 0.9 0.1 0.6 2.7 0.4 0.6 2.6 57.9 0.2 0.1 0.0 0.6 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 8.9 13.2 0.0 0.0 0.2 9.5 4.6 0.0 0.0 4.5 15.7 180.6 18.0 0.0 0.0 13.5 5.3 0.0 0.0 0.2 4.2 1.9 0.1 0.0 0.0 1.5 0.0 0.0 2.5 0.0 18.8 4.9 0.0 0.0 0.0 0.0 2.8 0.4 0.0 2.5 1.1 63.9 0.0 1.0 7.2 13.4 0.0 5.0 0.0 0.0 0.1 PSAPL1 ENSG00000178597 "Prosaposin like 1 (gene/pseudogene)" Q6NUJ1 4 7430294-7434973 "Predicted secreted proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skin 1: 42.2;stomach 1: 23.9;testis: 19.9" "Cell type enriched" "Detected in single" 14 "Suprabasal keratinocytes: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038013, HPA038482" Approved Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038013: AB_10673652, HPA038482: AB_2676037" "unprognostic (2.64e-2)" "unprognostic (2.40e-1)" "unprognostic (9.33e-2)" "unprognostic (2.40e-1)" "unprognostic (2.61e-1)" "unprognostic (7.90e-3)" "unprognostic (2.52e-1)" "unprognostic (2.08e-2)" "unprognostic (2.75e-1)" "unprognostic (2.63e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 1.4 0.6 0.0 1.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 42.2 0.1 0.1 0.1 0.1 23.9 19.9 0.1 2.5 0.1 0.1 2.1 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795821-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 52.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 1.5;Muller glia cells: 2.7;Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 3.6;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054625 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054625: " "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 1.3 1.7 21.1 1.3 28.9 1.3 1.7 12.6 52.4 1.9 1.3 15.2 0.0 1.4 1.4 3.6 1.3 1.6 1.3 1.4 16.1 15.2 1.3 1.3 1.3 1.3 18.9 14.4 1.3 1.6 1.3 0.2 1.3 24.7 1.4 1.3 0.0 3.5 1.7 1.4 1.3 1.3 1.4 12.8 1.4 1.3 2.2 17.0 0.0 1.3 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.2 0.9 0.1 0.2 0.0 0.0 0.2 0.3 0.9 1.4 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 2.2 3.6 0.0 0.7 0.1 0.3 0.0 0.2 0.0 0.2 1.7 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 28.9 12.6 17.5 16.1 15.2 18.9 14.4 24.7 17.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 PSG11 "MGC22484, PSG13, PSG14" ENSG00000243130 "Pregnancy specific beta-1-glycoprotein 11" Q9UQ72 19 43007656-43026512 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 220 "placenta: 151.1" "Cell type enriched" "Detected in single" 172 "Syncytiotrophoblasts: 135.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-2197: 19.7" "HPA042240, HPA046327" Enhanced "Secreted in female reproductive system" NA NA "HPA042240: AB_10797384, HPA046327: AB_2679624" "unprognostic (2.58e-1)" 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 151.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.4 0.0 0.0 0.0 PSG2 "CEA, PSBG2, PSG1, PSGGB" ENSG00000242221 "Pregnancy specific beta-1-glycoprotein 2" P11465 19 43064211-43083045 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 102 "placenta: 75.3" "Cell type enriched" "Detected in some" 35 "Syncytiotrophoblasts: 671.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.5;fHDF/TERT166: 14.0;HBF TERT88: 21.8;SuSa: 6.1;U-2197: 28.0" "Secreted in female reproductive system" NA NA "unprognostic (1.02e-2)" 0.4 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 75.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.6 2.9 0.0 0.0 0.0 0.0 14.0 0.8 0.3 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.8 0.2 0.0 0.0 0.0 0.0 19.2 0.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 671.0 0.0 0.0 0.6 PSG3 ENSG00000221826 "Pregnancy specific beta-1-glycoprotein 3" Q16557 19 42721638-42740569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 146 "placenta: 495.8" "Cell type enriched" "Detected in some" 171 "Syncytiotrophoblasts: 1321.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 495.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.7 0.4 0.1 0.0 0.0 0.0 0.5 0.6 0.6 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.5 6.3 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1321.0 0.0 0.0 0.0 PSG4 ENSG00000243137 "Pregnancy specific beta-1-glycoprotein 4" Q00888 19 43192702-43207299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 348.5" "Cell type enriched" "Detected in some" 54 "Syncytiotrophoblasts: 463.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 107.6;U-2197: 29.2" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (4.29e-2)" "unprognostic (5.18e-2)" "unprognostic (9.49e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (7.75e-2)" "unprognostic (8.82e-3)" "unprognostic (1.03e-3)" "unprognostic (1.68e-2)" "unprognostic (2.85e-1)" "unprognostic (2.57e-1)" 0.6 0.4 0.2 0.5 0.2 0.0 1.4 0.2 0.2 0.2 8.2 0.2 0.2 0.0 0.2 0.2 1.2 0.0 0.2 0.2 0.2 0.0 2.0 0.2 0.2 0.2 0.2 0.2 0.2 2.0 49.1 0.6 348.5 0.2 0.6 5.8 0.2 4.4 0.2 0.2 6.3 0.2 0.2 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.3 107.6 0.8 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 11.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 3.0 0.0 0.0 0.8 0.4 1.1 29.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 4.9 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 463.1 0.0 0.0 0.3 PSG6 ENSG00000170848 "Pregnancy specific beta-1-glycoprotein 6" Q00889 19 42902079-42919563 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 124 "placenta: 330.8" "Cell type enriched" "Detected in some" 204 "Syncytiotrophoblasts: 304.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 27 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" "Cell line enriched" "Detected in some" 17 "U-2197: 57.9" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (4.23e-1)" 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 330.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 57.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 304.0 0.0 0.0 0.0 PSG8 ENSG00000124467 "Pregnancy specific beta-1-glycoprotein 8" Q9UQ74 19 42752686-42855691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "placenta: 142.2" "Cell type enriched" "Detected in some" 12 "Syncytiotrophoblasts: 28.7" "Cancer enriched" "Detected in single" 17 "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;SuSa: 1.7;U-2197: 2.5" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 142.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 PSG9 "PSG11, PSGII" ENSG00000183668 "Pregnancy specific beta-1-glycoprotein 9" Q00887 19 43211791-43269530 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "placenta: 299.0" "Cell type enriched" "Detected in some" 109 "Syncytiotrophoblasts: 231.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (9.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.15e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.2 299.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.0 2.8 4.4 2.3 0.1 0.1 0.0 0.2 1.3 16.0 0.3 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.5 11.0 4.2 0.0 0.2 0.1 2.1 9.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 231.8 0.0 0.0 0.0 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMA8 "MGC26605, PSMA7L" ENSG00000154611 "Proteasome subunit alpha 8" Q8TAA3 18 26133852-26193355 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.5" "Cell type enriched" "Detected in some" 26 "Spermatocytes: 183.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 80 "Daudi: 23.7;JURKAT: 6.8;U-266/70: 14.7;U-266/84: 15.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (5.39e-3)" "unprognostic (7.45e-5)" "unprognostic (2.94e-1)" "unprognostic (3.04e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (8.30e-2)" "unprognostic (7.54e-4)" "unprognostic (4.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.56e-1)" 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 1.1 0.0 36.5 0.2 0.7 0.1 0.0 2.2 0.1 0.0 4.0 1.9 0.2 0.1 1.2 5.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 15.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.1 2.2 4.0 2.1 3.9 0.3 3.1 2.4 5.8 0.2 1.2 0.1 1.9 4.3 1.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.2 0.0 0.0 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.6 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 183.4 7.0 0.0 0.8 0.0 0.0 0.0 PSMB11 beta5t ENSG00000222028 "Proteasome subunit beta 11" A5LHX3 14 23042167-23044276 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 32.7" "Group enriched" "Detected in some" 7 "Early spermatids: 1.3;Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enriched" "Detected in single" 4 "PC-3: 1.8" "Region enriched" "Detected in single" 7 "olfactory region: 2.3" "Not detected" "Not detected" "HPA028967, HPA056970" Enhanced NA NA "HPA028967: AB_2732444, HPA056970: AB_2683293" "unprognostic (7.96e-2)" "unprognostic (2.77e-1)" 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 32.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 52.2" "Group enriched" "Detected in many" 5 "Early spermatids: 289.3;Late spermatids: 996.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 5.5;JURKAT: 2.4;U-2 OS: 1.7" HPA045049 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.9 0.7 1.1 0.7 2.8 0.7 0.8 0.5 1.5 3.4 6.9 2.2 2.6 0.7 7.7 6.4 2.1 1.1 7.5 0.7 0.7 0.6 1.0 0.7 3.7 0.7 4.4 0.0 1.9 1.5 0.7 0.4 1.7 3.0 1.7 1.1 0.2 0.9 1.8 0.7 2.0 6.0 6.5 3.4 0.7 1.1 52.2 0.9 0.0 1.8 1.1 0.7 3.6 3.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 5.5 0.6 1.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.8 0.5 1.5 0.7 0.6 4.4 0.0 3.0 0.9 17.9 2.7 0.0 3.6 7.8 0.0 2.0 17.8 0.0 3.4 8.7 0.0 0.1 0.0 13.8 289.3 3.6 20.7 0.0 1.9 0.4 8.0 2.6 0.0 0.0 0.3 0.0 2.9 3.7 0.0 996.1 8.6 0.0 3.3 1.0 4.6 0.5 9.4 8.0 6.3 0.7 0.0 6.5 1.4 117.0 17.9 9.3 0.1 0.0 4.7 2.3 PSPN PSP ENSG00000125650 Persephin O60542 19 6375148-6379058 "Predicted secreted proteins" "Growth factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 18.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB025366 Uncertain "Secreted in other tissues" NA NA "CAB025366: " "unprognostic (3.21e-1)" "unprognostic (3.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (3.67e-1)" "unprognostic (2.05e-2)" "unprognostic (5.80e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (6.27e-2)" "unprognostic (1.54e-6)" "unprognostic (5.39e-3)" "unprognostic (1.01e-3)" "unprognostic (4.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" 1.0 1.7 2.5 1.1 2.7 1.6 1.1 6.4 3.4 1.8 1.4 1.1 1.6 3.5 1.3 2.5 1.3 1.1 2.3 2.1 2.5 2.2 1.1 1.2 1.5 2.8 1.6 2.7 2.4 1.1 1.8 1.5 1.8 1.6 1.3 1.7 1.8 1.4 0.8 1.9 1.5 1.5 2.5 1.5 1.1 1.0 2.6 2.8 4.6 2.6 1.8 3.0 1.6 1.6 3.8 2.2 5.5 5.1 3.4 1.2 1.9 1.9 2.1 2.3 3.7 1.4 2.0 3.1 2.4 1.9 2.4 3.7 1.4 2.4 3.0 2.9 2.0 2.2 2.9 3.7 1.6 2.9 4.0 4.3 1.7 2.8 5.7 1.4 3.2 2.4 2.5 2.4 2.9 3.7 3.3 2.2 3.8 4.3 3.2 2.6 1.3 3.5 2.2 3.0 4.6 3.2 3.0 2.5 3.0 3.4 1.9 1.8 2.7 2.6 4.7 1.2 4.4 7.0 1.1 5.0 3.3 2.6 4.6 2.1 1.8 2.1 1.6 3.0 2.0 1.5 2.6 1.2 2.6 2.3 2.3 3.6 1.8 2.6 2.8 1.7 1.6 0.0 1.7 0.0 0.8 0.6 1.8 1.5 0.0 0.0 0.0 1.8 0.0 0.8 0.0 1.0 3.6 1.2 4.1 0.0 0.2 0.6 1.3 1.4 1.1 2.6 1.8 1.6 2.9 1.8 2.2 18.9 0.9 0.2 1.7 1.0 2.0 1.5 1.1 2.9 2.1 2.2 1.8 0.0 0.9 1.4 0.7 0.9 1.1 0.5 2.4 0.9 PTCH2 ENSG00000117425 "Patched 2" Q9Y6C5 1 44819844-44843063 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0" "Cell type enhanced" "Detected in many" 15 "Leydig cells: 99.8;Peritubular cells: 64.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.54e-5)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (3.65e-3)" "unprognostic (3.89e-1)" "unprognostic (7.42e-3)" "unprognostic (3.01e-1)" "unprognostic (2.94e-2)" "unprognostic (1.51e-1)" "unprognostic (8.67e-2)" "prognostic favorable (5.74e-5)" "unprognostic (2.92e-1)" "unprognostic (5.74e-6)" "unprognostic (1.55e-2)" "unprognostic (4.86e-2)" "unprognostic (6.31e-2)" "unprognostic (6.81e-2)" 2.5 1.9 8.0 2.4 5.2 6.0 2.2 9.7 7.2 2.5 2.0 1.2 1.3 1.5 6.7 1.9 1.3 2.7 2.4 3.3 6.2 6.1 1.0 1.2 1.2 2.2 2.5 5.8 19.1 1.1 82.4 6.8 1.0 6.0 1.8 1.4 4.6 44.3 1.7 2.0 2.3 1.3 6.6 5.5 1.8 1.2 32.0 5.2 0.0 3.1 2.4 1.3 2.2 2.3 3.4 7.6 3.3 3.8 2.0 2.4 0.5 0.3 0.4 1.6 3.7 1.3 1.4 1.4 1.2 2.4 0.8 0.7 0.4 0.5 1.5 0.7 0.6 0.8 0.1 1.6 0.1 0.3 3.2 2.8 0.9 1.2 1.1 0.4 0.9 1.8 0.5 0.6 1.5 0.1 2.5 0.2 1.5 1.0 1.6 0.1 0.8 1.8 3.0 0.5 0.1 0.6 1.4 0.3 0.7 0.3 0.1 2.2 0.9 0.4 0.6 1.0 0.9 0.3 1.8 0.2 0.3 0.9 1.9 0.7 2.7 15.3 4.5 0.9 4.4 0.5 3.3 3.8 0.3 1.1 2.0 2.4 2.2 1.4 1.4 2.5 3.4 1.7 1.3 1.3 2.0 1.8 7.6 0.7 0.5 8.0 5.2 9.7 7.2 6.2 6.1 2.5 5.8 6.0 5.2 0.0 1.4 20.6 0.4 0.5 0.6 0.9 7.6 1.4 1.2 1.8 2.0 1.9 0.0 3.2 1.4 1.6 8.4 0.0 1.6 1.4 3.4 0.5 0.0 5.9 6.3 7.9 11.1 1.3 23.6 4.3 99.8 3.4 0.0 2.8 4.9 1.9 2.6 0.0 64.0 0.0 1.0 12.9 3.3 3.4 2.7 1.4 1.9 3.8 5.6 0.1 PTCHD1 FLJ30296 ENSG00000165186 "Patched domain containing 1" Q96NR3 X 23334016-23404372 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Autism, Autism spectrum disorder" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 6.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 27.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 3.4;RT4: 3.2;SuSa: 1.6;WM-115: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046110 Uncertain NA NA "HPA046110: AB_2679541" "unprognostic (1.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.43e-3)" "unprognostic (1.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-4)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" "unprognostic (2.78e-1)" "unprognostic (2.13e-1)" "unprognostic (3.50e-1)" "unprognostic (3.19e-2)" "unprognostic (3.68e-4)" "unprognostic (5.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 1.6 2.3 6.6 0.9 5.5 0.7 6.0 27.8 8.9 6.2 8.4 1.0 3.5 1.4 5.1 2.1 4.5 0.9 0.8 0.8 5.3 2.7 0.8 0.6 1.2 0.6 3.1 5.8 0.8 0.8 0.5 1.7 0.5 6.5 4.4 2.9 0.0 1.8 11.7 1.1 0.8 1.8 10.2 2.6 1.4 3.4 1.1 3.8 0.0 1.0 0.0 0.6 5.4 2.9 0.7 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.4 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 10.6 1.2 0.3 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.1 0.7 0.3 0.3 1.0 0.3 0.2 0.4 0.1 0.0 6.6 5.5 27.8 6.5 5.3 2.7 3.1 5.8 6.5 3.8 0.0 1.3 0.0 2.0 0.2 1.3 1.7 0.0 2.7 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 2.0 2.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.4 12.9 2.3 0.5 1.5 0.0 1.8 0.0 0.0 0.7 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 1.4;Collecting duct cells: 1.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.1 0.0 1.7 5.0 13.5 1.5 3.2 0.1 0.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 22.5 0.5 0.0 0.0 7.4 7.2 0.0 0.1 5.4 1.5 2.3 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.5 0.0 0.0 0.0 22.9 0.0 0.0 11.4 2.5 1.6 0.0 0.2 0.0 0.0 0.0 3.4 0.0 9.9 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267713-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.1" "Group enriched" "Detected in some" 5 "T-cells: 31.9;Undifferentiated cells: 11.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons and medulla: 13.9" "Group enriched" "Detected in many" 5 "gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1" "Group enriched" "Detected in many" 30 "NK-cells: 30.1;T-cells: 25.4" "Group enriched" "Detected in some" 4 "ASC diff: 1.4;HSkMC: 1.6;REH: 2.4;U-138 MG: 1.8" "Low region specificity" "Detected in many" HPA049668 Enhanced NA NA "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 3.9 0.9 0.7 9.6 2.5 1.8 9.3 1.4 1.4 5.5 10.0 0.7 0.9 1.1 4.1 2.2 2.1 2.5 4.9 2.3 0.8 0.8 1.5 1.8 3.4 8.9 1.0 3.5 2.3 0.8 0.8 4.5 0.4 13.9 2.1 12.8 11.2 2.6 3.5 0.9 1.3 2.4 2.0 3.6 10.9 2.0 0.9 0.8 1.8 2.5 0.1 3.1 3.3 3.2 0.0 0.0 0.9 0.1 30.1 25.4 4.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 25.4 0.0 12.7 0.0 3.5 15.2 0.0 0.0 0.6 8.9 0.9 30.1 0.1 0.0 0.0 4.1 0.7 2.5 1.4 1.4 0.8 0.8 1.0 3.5 13.9 0.8 3.0 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 1.2 3.1 2.1 0.0 0.0 0.2 1.7 0.0 4.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 31.9 11.2 0.0 PTGER1 EP1 ENSG00000160951 "Prostaglandin E receptor 1" P34995 19 14472466-14475362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 13.6;lymphoid tissue: 14.2" "Cell type enriched" "Detected in some" 75 "Collecting duct cells: 188.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.5;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 2.9;PC-3: 7.2;SH-SY5Y: 4.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (3.31e-1)" "unprognostic (2.68e-1)" "unprognostic (3.50e-4)" "unprognostic (8.69e-2)" "unprognostic (5.58e-2)" "unprognostic (2.39e-2)" "unprognostic (3.19e-2)" "unprognostic (2.05e-1)" "unprognostic (3.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (7.74e-8)" "unprognostic (1.19e-1)" "unprognostic (4.41e-2)" "unprognostic (4.27e-3)" "unprognostic (4.88e-2)" 0.7 1.4 1.1 2.7 1.3 0.2 1.5 0.6 1.2 1.3 1.5 0.1 0.0 1.2 0.4 0.3 1.7 1.0 0.4 3.1 0.4 0.4 13.6 0.5 4.9 6.7 1.8 0.0 1.6 1.8 0.2 1.4 0.3 1.0 0.5 0.3 0.3 0.3 0.4 0.7 0.2 1.9 1.4 0.1 14.2 3.2 0.4 0.6 0.0 0.7 0.0 0.3 0.6 1.3 0.0 0.4 0.0 1.5 2.6 1.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.3 0.6 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.9 0.3 0.0 7.2 0.8 0.0 0.2 0.0 0.1 0.5 4.2 0.1 0.1 0.2 0.0 0.2 0.4 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.2 1.1 1.3 0.6 1.2 0.4 0.4 1.8 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.8 2.5 0.0 0.0 188.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.2 PTGER2 EP2 ENSG00000125384 "Prostaglandin E receptor 2" P43116 14 52314305-52328606 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.3" "Cell type enhanced" "Detected in many" 18 "granulocytes: 19.7;Kupffer cells: 20.5;T-cells: 80.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 33.6;HHSteC: 21.3;HL-60: 12.0;HSkMC: 26.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (2.48e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (1.55e-2)" "unprognostic (3.24e-1)" "unprognostic (3.11e-3)" "unprognostic (1.79e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-3)" "unprognostic (1.18e-1)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (8.48e-3)" "unprognostic (5.26e-3)" "unprognostic (6.71e-2)" "unprognostic (5.74e-2)" 8.2 1.2 0.4 9.4 0.5 21.8 9.3 0.4 0.5 22.1 8.7 0.6 2.9 4.0 13.6 5.5 5.4 4.5 6.5 4.8 0.4 0.6 5.5 2.8 8.8 15.9 1.1 0.3 8.2 1.1 0.0 1.4 14.1 1.8 19.4 4.3 10.9 4.1 2.6 1.8 1.6 14.9 3.2 1.1 20.4 11.8 4.1 0.3 4.4 2.2 1.1 3.0 6.0 6.0 0.0 5.6 9.8 17.1 19.7 40.3 17.4 0.7 0.2 0.0 0.0 12.5 33.6 0.1 1.0 0.1 1.1 1.3 0.0 0.0 0.0 0.9 0.7 0.0 4.5 0.0 0.2 1.6 0.0 6.0 0.0 0.3 0.0 21.3 12.0 0.1 26.9 0.5 2.7 0.4 3.6 0.0 0.0 0.0 0.0 6.3 0.5 0.0 0.4 0.5 2.0 4.1 0.0 0.0 0.0 9.6 0.0 0.4 10.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.7 7.7 0.0 0.0 0.0 0.0 2.8 6.7 0.1 1.8 11.2 9.8 33.8 8.9 40.3 0.0 28.7 35.2 5.6 0.0 7.2 21.8 1.5 19.7 17.1 0.2 13.4 17.4 0.4 0.5 0.4 0.5 0.4 0.6 1.1 0.3 1.8 0.3 3.0 1.7 0.9 0.2 1.5 0.0 1.5 0.0 8.1 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 16.9 0.8 19.7 0.4 10.4 0.0 5.8 4.3 20.5 0.0 3.7 15.1 3.3 4.6 4.9 0.0 0.9 0.0 2.8 0.0 0.0 0.0 5.2 0.0 0.1 1.4 0.2 80.9 0.4 0.1 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960435-37961125 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.8" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.4;T-reg: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 1.0 0.4 0.9 5.2 1.2 5.0 0.5 2.2 2.4 1.1 3.9 0.2 0.0 0.0 1.6 2.2 3.3 1.8 1.5 2.5 1.0 0.4 0.7 0.5 0.9 1.0 0.7 0.4 1.2 1.0 1.4 0.4 1.8 0.3 0.8 0.7 0.0 0.2 1.4 1.9 0.6 3.1 2.0 0.9 2.3 1.0 5.3 0.0 15.8 1.3 7.5 7.3 1.8 0.7 0.4 0.0 1.4 0.4 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.7 0.5 0.9 0.0 0.5 0.3 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 1.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 1.4 0.0 0.0 0.0 1.0 0.1 0.9 1.2 2.2 2.4 1.0 0.4 0.7 0.4 0.3 0.0 0.0 0.0 1.4 0.5 4.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.2 2.5 0.0 0.0 0.0 0.3 PTX4 C16orf38 ENSG00000251692 "Pentraxin 4" Q96A99 16 1485886-1488981 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;bone marrow: 4.0;testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 21 "intermediate monocyte: 1.1;non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 31 "monocytes: 3.0" "Group enriched" "Detected in some" 6 "HL-60: 19.5;NB-4: 14.5" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Low region specificity" "Detected in all" HPA073694 Supported "Secreted - unknown location" NA NA "HPA073694: AB_2732237" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.54e-2)" "unprognostic (1.55e-2)" "unprognostic (1.12e-1)" "unprognostic (1.84e-4)" "unprognostic (3.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.10e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (3.54e-1)" "unprognostic (1.52e-4)" "unprognostic (2.23e-3)" "unprognostic (4.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.03e-1)" 0.2 1.0 0.6 0.2 0.8 4.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.4 0.3 0.2 0.8 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.4 0.0 0.4 0.4 0.2 0.9 0.1 3.9 0.2 1.5 0.2 0.2 0.2 0.4 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 14.5 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.6 0.8 0.8 0.3 0.8 1.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2, small subunit processome component" Q15269 21 44107290-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 9.5;Smooth muscle cells: 13.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 31.0;Daudi: 26.8" HPA024573 Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 6.1 6.1 11.3 7.7 14.6 3.6 6.3 9.7 12.8 4.0 9.0 9.6 2.4 4.4 7.8 9.2 8.2 5.9 4.8 4.6 6.8 4.8 6.9 8.7 5.0 7.9 15.4 5.7 5.0 12.8 1.4 4.0 7.6 8.9 8.1 1.8 4.9 8.2 5.2 8.0 14.7 5.6 2.2 6.4 8.8 10.6 5.3 17.2 3.6 4.8 8.6 16.8 5.0 5.7 6.8 2.6 2.9 4.3 3.4 6.9 5.0 1.2 0.4 0.3 1.2 3.6 3.6 9.3 12.0 6.3 16.0 10.8 31.0 0.5 26.8 0.4 0.0 0.9 1.4 0.5 9.1 9.2 6.6 19.4 3.2 5.6 7.2 2.3 2.4 0.9 0.3 0.0 11.1 0.0 2.8 0.5 11.4 10.2 10.8 5.3 0.4 0.1 0.7 0.3 0.7 1.2 1.5 0.1 13.9 0.0 0.4 9.4 1.6 0.6 1.0 7.5 4.6 0.0 1.0 6.1 6.5 1.1 14.4 1.4 14.5 17.3 1.2 0.4 2.9 9.2 0.2 2.2 2.9 6.0 3.1 6.6 6.8 4.9 6.9 1.6 4.1 4.9 6.1 1.2 3.4 4.3 2.6 3.5 5.0 11.3 14.6 9.7 12.8 6.8 4.8 15.4 5.7 8.9 17.2 0.0 1.3 0.5 0.1 9.5 0.1 3.4 0.0 1.4 2.3 0.0 0.0 0.1 1.7 0.0 0.1 1.4 2.6 0.0 0.0 1.2 1.0 0.7 0.0 0.0 1.7 0.0 2.4 3.1 5.4 0.0 1.1 0.0 1.7 0.0 4.7 0.2 0.0 3.2 0.0 0.0 0.2 0.0 13.4 0.6 1.7 7.4 0.6 2.9 4.7 0.0 PXDC1 C6orf145 ENSG00000168994 "PX domain containing 1" Q5TGL8 6 3722614-3752026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 79.6" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 93.5;Extravillous trophoblasts: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.2" "Lineage enriched" "Detected in single" 4 "B-cells: 4.2" "Cell line enhanced" "Detected in many" "HHSteC: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019246 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019246: AB_2670113" "unprognostic (1.55e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.82e-2)" "unprognostic (3.80e-2)" "unprognostic (2.95e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" "unprognostic (2.01e-2)" "unprognostic (6.17e-3)" "unprognostic (1.10e-1)" "unprognostic (2.97e-1)" "unprognostic (2.84e-1)" 26.3 5.5 5.9 5.9 6.5 0.4 30.6 3.2 6.6 11.1 10.3 6.4 5.3 10.7 10.1 14.4 13.9 8.3 18.5 10.8 6.5 4.4 13.4 79.6 14.2 5.8 7.5 3.1 6.2 10.0 3.4 4.3 32.9 6.2 9.1 3.1 7.5 12.3 8.1 11.9 11.7 16.9 20.6 7.0 6.1 8.9 3.9 6.9 1.0 16.8 11.5 5.8 14.9 21.0 4.2 0.3 0.5 0.0 0.0 0.9 0.3 11.7 5.0 8.2 5.5 26.0 19.7 26.4 21.4 16.5 18.3 14.2 8.3 2.3 0.0 13.9 35.0 13.5 8.8 1.6 5.9 8.7 11.9 1.6 0.0 3.6 7.4 43.5 0.0 0.0 17.8 19.4 11.3 24.4 15.1 20.0 0.8 0.0 1.5 14.3 0.7 0.0 0.1 0.3 2.3 6.0 0.6 4.4 0.4 6.9 9.9 0.9 0.4 14.2 14.6 28.7 11.4 1.2 0.7 20.8 15.5 6.6 6.0 14.5 0.0 0.0 0.0 3.5 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.3 4.2 0.1 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.3 5.9 6.5 3.2 6.6 6.5 4.4 7.5 3.1 6.2 6.9 44.7 10.4 4.2 93.5 42.8 0.4 6.9 15.3 5.3 12.5 7.0 0.0 26.6 10.0 30.2 0.4 37.0 1.3 0.0 44.5 114.0 36.1 45.1 3.5 57.1 21.2 0.0 0.0 36.2 9.1 0.2 21.0 17.8 23.6 37.9 0.8 14.3 55.0 0.0 17.0 16.8 0.7 0.0 31.6 0.5 3.8 29.0 65.6 2.9 0.0 38.2 PXT1 STEPP ENSG00000179165 "Peroxisomal, testis specific 1" Q8NFP0 6 36390551-36442889 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 6.4" "Group enriched" "Detected in some" 8 "Kupffer cells: 1.9;Spermatocytes: 7.1;Spermatogonia: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2;neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.85e-2)" "unprognostic (1.12e-3)" "unprognostic (9.92e-2)" "unprognostic (5.49e-2)" "unprognostic (4.43e-1)" "unprognostic (9.38e-2)" "unprognostic (2.28e-2)" "unprognostic (2.92e-3)" "unprognostic (4.64e-2)" "unprognostic (1.92e-1)" "unprognostic (5.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.94e-5)" "unprognostic (2.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.21e-3)" "unprognostic (2.61e-3)" 0.2 0.0 0.5 1.0 0.5 0.7 0.2 2.2 1.9 0.1 0.1 0.1 0.1 1.1 0.3 0.7 0.1 0.3 2.7 0.3 0.5 0.2 1.2 0.1 0.4 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 1.8 0.2 0.0 0.1 0.3 0.1 0.7 0.2 0.4 0.1 0.2 0.4 0.1 6.4 0.1 0.1 0.1 0.1 1.0 0.3 0.1 2.2 0.0 1.5 0.2 0.0 0.7 0.2 0.1 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.2 0.2 0.0 1.0 0.8 0.1 0.1 0.0 0.4 0.0 0.0 0.5 0.0 6.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.6 1.0 0.0 0.0 0.4 0.2 1.1 0.1 1.3 0.2 0.3 0.0 0.0 0.9 0.0 0.2 0.5 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.2 0.5 0.5 2.2 1.9 0.5 0.2 0.2 0.1 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.2 0.0 0.0 0.1 QRFP "26RFa, P518" ENSG00000188710 "Pyroglutamylated RFamide peptide" P83859 9 130892702-130896812 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 20 "Alveolar cells type 1: 3.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 10 "classical monocyte: 1.8;intermediate monocyte: 3.3;non-classical monocyte: 1.5" "Lineage enriched" "Detected in single" 15 "monocytes: 3.3" "Cell line enhanced" "Detected in many" "U-138 MG: 7.5" "Region enriched" "Detected in single" 18 "hypothalamus: 1.0" "Low region specificity" "Detected in all" HPA043377 Uncertain "Secreted in other tissues" NA NA "HPA043377: AB_10959754" "unprognostic (1.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-3)" "unprognostic (4.14e-3)" "unprognostic (7.78e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-3)" "unprognostic (5.11e-3)" "unprognostic (1.77e-1)" "unprognostic (2.28e-1)" "unprognostic (5.43e-3)" "unprognostic (1.02e-1)" "unprognostic (2.52e-2)" "unprognostic (2.48e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (7.04e-3)" 0.9 0.3 0.0 0.9 0.1 0.6 0.3 0.0 0.4 1.4 3.7 0.7 1.1 0.0 4.2 0.8 1.1 0.5 0.1 0.2 0.4 0.0 0.5 0.4 0.0 1.0 4.9 0.0 1.8 0.4 3.2 0.2 0.3 0.0 0.4 0.7 1.3 0.0 0.2 0.2 1.7 1.8 1.1 0.0 3.0 1.0 0.0 0.0 0.0 3.3 0.0 0.2 0.5 1.3 0.7 0.5 3.3 0.0 0.0 1.7 1.3 0.0 0.0 0.0 2.1 0.8 0.5 0.5 0.0 2.1 0.5 0.0 0.0 0.0 0.2 0.4 0.1 1.8 1.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.3 2.7 0.0 0.0 4.4 0.5 3.0 2.9 0.4 0.4 3.1 1.9 1.3 0.0 1.1 1.1 1.4 1.1 0.4 1.3 1.0 1.8 1.0 0.4 7.5 1.9 3.0 3.5 0.3 1.2 1.5 1.3 0.9 3.8 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 3.0 0.6 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 QRFPR GPR103 ENSG00000186867 "Pyroglutamylated RFamide peptide receptor" Q96P65 4 121329312-121381059 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.9;heart muscle: 4.6" "Cell type enhanced" "Detected in some" 29 "Cardiomyocytes: 3.2;Early spermatids: 1.6" "Cancer enriched" "Detected in some" 6 "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 5.3;hTERT-HME1: 7.2;JURKAT: 2.3;RPTEC TERT1: 4.6;SCLC-21H: 2.9;U-2 OS: 7.8;WM-115: 4.4" "Low region specificity" "Detected in many" HPA050236 Approved NA NA "HPA050236: " "unprognostic (1.24e-2)" "unprognostic (2.30e-1)" "unprognostic (1.93e-2)" "unprognostic (3.21e-1)" "unprognostic (2.77e-1)" "unprognostic (3.21e-4)" "unprognostic (2.71e-1)" "unprognostic (5.77e-3)" "unprognostic (5.37e-2)" "unprognostic (6.33e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.09e-4)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 1.6 1.2 0.7 0.3 1.9 0.0 0.5 0.1 2.0 0.3 0.2 0.3 0.0 0.0 0.2 1.1 0.8 0.1 1.1 4.6 1.3 6.9 3.2 0.2 0.1 0.0 0.8 0.8 0.4 0.0 1.0 0.8 0.2 4.9 0.6 0.1 3.3 0.0 2.3 0.1 0.0 0.4 0.2 2.6 0.0 1.3 0.7 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 7.8 0.0 0.0 0.1 1.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.1 2.0 1.3 6.9 0.8 0.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 R3HDML dJ881L22.3 ENSG00000101074 "R3H domain containing like" Q9H3Y0 20 44336986-44351235 "Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.4;intestine: 5.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;CACO-2: 3.6;OE19: 3.6;U-2 OS: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA070264 Enhanced "Secreted - unknown location" NA NA "HPA070264: AB_2686244" "unprognostic (1.89e-1)" "unprognostic (2.23e-1)" "unprognostic (9.86e-2)" "unprognostic (9.12e-2)" "unprognostic (6.06e-3)" "unprognostic (2.64e-1)" "unprognostic (6.32e-2)" "unprognostic (4.95e-3)" 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.0 1.5 5.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.8 1.4 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.0 0.2 0.2 0.0 0.0 0.3 1.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.6 0.8 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.6 0.4 0.2 1.2 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.1 0.0 0.2 3.6 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.4 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.4 2.7 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.5 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB19 RAB19B ENSG00000146955 "RAB19, member RAS oncogene family" A4D1S5 7 140404043-140426250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 14.5" "Cell type enriched" "Detected in single" 12 "Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 3.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.9;HDLM-2: 12.8;MCF7: 5.7;RPTEC TERT1: 4.2;RT4: 8.3;SK-BR-3: 6.5;T-47d: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051077 Uncertain NA NA "HPA051077: AB_2681336" "unprognostic (3.40e-1)" "unprognostic (2.07e-2)" "unprognostic (2.26e-1)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-2)" "unprognostic (1.65e-1)" "unprognostic (2.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.91e-2)" "unprognostic (2.53e-1)" "prognostic favorable (2.36e-8)" "unprognostic (1.73e-3)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (6.09e-3)" 0.4 0.3 0.3 2.8 0.3 6.7 0.8 0.3 0.3 0.6 5.2 0.0 0.8 4.0 0.4 2.8 0.7 1.2 8.7 0.3 0.3 0.3 8.9 0.5 2.4 4.7 0.3 0.0 0.3 14.5 5.6 10.5 1.5 0.0 2.6 5.0 0.0 5.7 0.2 0.3 0.7 12.1 0.0 0.3 1.1 2.4 0.5 0.0 3.6 11.3 1.7 3.6 1.7 0.4 0.8 0.0 0.3 0.0 0.6 3.5 0.4 0.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.1 5.9 0.0 0.6 0.0 0.0 0.9 0.0 1.6 0.0 12.8 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.2 8.3 1.1 0.0 0.0 6.5 0.0 0.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.1 0.8 0.9 3.2 0.0 0.0 1.4 1.4 0.3 0.6 0.0 0.0 3.5 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB36 ENSG00000100228 "RAB36, member RAS oncogene family" O95755 22 23145326-23164350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 38.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 53.5;Late spermatids: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 12.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 12.7" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.8;U-266/84: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059631 Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059631: " "unprognostic (2.74e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-2)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (6.60e-2)" "unprognostic (1.22e-1)" "unprognostic (3.46e-1)" "unprognostic (2.49e-2)" "unprognostic (7.94e-2)" "unprognostic (2.02e-3)" "unprognostic (5.56e-3)" "prognostic favorable (4.55e-4)" "unprognostic (7.08e-2)" "unprognostic (7.18e-2)" "unprognostic (1.64e-1)" "unprognostic (3.08e-1)" 2.4 5.9 7.6 2.0 11.9 1.3 3.5 2.7 14.1 6.5 2.8 6.8 9.3 1.4 5.4 12.7 3.0 38.2 6.6 1.9 7.7 8.4 8.2 0.8 6.1 1.7 4.5 9.3 8.1 4.3 1.9 16.6 7.0 5.8 5.1 1.8 4.8 4.6 11.2 1.2 1.9 1.5 4.9 2.6 1.9 2.7 12.8 3.1 0.0 20.7 1.2 1.9 3.6 2.1 1.0 0.3 12.7 0.6 1.7 0.7 0.3 5.6 6.6 5.1 7.7 1.2 2.5 2.1 3.2 6.5 7.1 2.7 0.4 0.0 0.0 3.5 4.2 4.0 7.1 0.2 3.7 2.3 0.0 3.0 0.0 0.2 0.6 3.0 0.0 0.9 3.2 1.4 6.6 1.3 4.7 1.0 0.0 0.3 5.8 0.3 4.5 0.0 0.1 0.6 3.7 1.8 0.0 0.0 17.8 9.2 1.0 12.6 5.5 0.3 2.8 1.6 0.4 0.0 0.6 0.5 0.9 2.2 2.5 4.6 12.6 17.5 0.0 6.5 0.0 4.2 0.3 0.6 0.0 0.7 0.3 0.4 1.0 0.1 0.2 0.3 0.3 0.5 0.4 12.7 1.7 0.3 0.0 0.1 0.3 7.6 11.9 2.7 14.1 7.7 8.4 4.5 9.3 5.8 3.1 0.0 2.7 0.8 0.6 0.5 0.6 0.8 5.1 53.5 9.1 1.8 5.9 5.3 5.0 2.8 10.0 0.1 0.0 0.0 0.2 0.3 1.0 0.4 1.1 0.0 0.3 1.6 6.4 0.6 1.2 16.9 3.1 0.0 1.7 0.0 0.5 3.2 0.1 0.0 2.8 7.8 0.5 0.0 0.8 1.9 1.6 0.1 2.4 0.0 0.0 0.3 RAB3C ENSG00000152932 "RAB3C, member RAS oncogene family" Q96E17 5 58582221-58859394 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 35.2;Early spermatids: 17.4;Intestinal endocrine cells: 55.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEL: 3.5;NB-4: 2.2;SCLC-21H: 14.6;SH-SY5Y: 5.3" "Low region specificity" "Detected in all" "HPA003160, HPA048156" Enhanced Approved Cytosol NA NA Cytosol "HPA003160: AB_1079731, HPA048156: AB_2680291" "unprognostic (1.30e-1)" "unprognostic (3.35e-2)" "unprognostic (9.94e-2)" "unprognostic (2.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (8.73e-3)" "unprognostic (3.40e-2)" "unprognostic (6.90e-2)" "unprognostic (7.58e-2)" "unprognostic (9.52e-4)" "unprognostic (1.51e-3)" "unprognostic (3.70e-5)" "unprognostic (4.70e-2)" "unprognostic (1.05e-1)" "unprognostic (9.65e-2)" "unprognostic (3.61e-3)" 2.5 13.6 19.8 2.5 36.1 1.1 1.3 7.7 47.4 1.3 1.8 2.1 0.0 3.1 2.1 1.0 1.3 1.3 1.9 1.1 22.9 23.6 1.2 1.2 1.2 1.3 14.5 23.6 1.2 3.3 1.4 14.1 1.2 25.6 1.1 2.1 0.0 1.1 1.1 1.1 1.1 3.3 2.0 3.2 1.0 2.3 1.3 4.1 0.0 1.1 0.0 1.4 1.7 0.4 0.3 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.6 5.3 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.8 36.1 7.7 32.4 22.9 23.6 14.5 23.6 25.6 4.1 0.0 1.1 0.0 0.0 0.1 35.2 0.6 0.0 0.0 0.0 0.0 3.9 0.0 3.3 0.1 17.4 3.3 0.0 0.0 8.4 0.7 0.2 0.0 2.3 0.4 0.1 3.2 55.3 6.7 0.0 7.7 0.9 0.0 1.7 0.0 0.3 1.5 6.4 0.0 0.7 0.0 6.8 12.9 0.0 2.5 1.7 0.1 0.0 0.0 0.0 0.0 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 34.0" "Cell type enriched" "Detected in single" 7 "Peritubular cells: 5.6" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "AF22: 6.5;NTERA-2: 7.2" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 2.0 1.4 0.6 0.6 4.2 0.0 0.8 0.6 1.1 2.8 0.8 0.6 11.9 0.5 5.5 34.0 10.6 2.6 2.9 0.6 0.6 0.9 1.3 0.6 2.0 1.7 0.6 0.6 5.4 0.6 0.6 2.4 0.8 0.8 5.5 0.4 0.6 0.6 6.2 0.6 0.7 0.9 1.3 0.6 0.8 0.5 7.8 0.6 0.6 0.6 0.6 0.6 1.5 2.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 1.7 6.5 0.2 1.5 1.9 3.2 1.9 0.4 0.3 0.5 1.3 0.9 1.6 2.5 0.3 2.0 0.1 0.4 0.1 0.3 0.0 3.8 0.5 3.0 0.3 0.6 0.1 0.3 1.5 0.3 0.6 0.4 2.5 0.3 0.5 2.3 1.0 0.6 0.4 0.4 0.2 7.2 0.0 1.0 0.0 0.5 0.1 0.1 0.6 2.7 3.4 0.6 0.1 1.4 2.0 0.0 0.2 3.2 2.7 1.5 4.1 1.8 1.2 0.7 1.2 3.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.6 4.2 0.6 0.6 0.6 0.9 0.6 0.6 0.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 RAB40B "RAR, SEC4L" ENSG00000141542 "RAB40B, member RAS oncogene family" Q12829 17 82654973-82698728 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.3;OE19: 25.4" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (2.21e-2)" "unprognostic (7.50e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-1)" "unprognostic (6.03e-2)" "unprognostic (2.34e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.74e-1)" "unprognostic (3.28e-2)" "unprognostic (1.36e-1)" "unprognostic (3.14e-2)" "prognostic favorable (2.95e-6)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (9.83e-3)" 6.3 7.5 29.7 2.1 43.4 1.0 6.5 9.3 34.2 6.2 12.5 38.3 1.5 7.3 6.5 15.0 5.0 5.8 5.3 13.4 25.8 13.7 15.9 6.4 5.3 2.1 21.3 17.0 8.6 5.0 5.3 5.9 3.3 19.8 8.7 7.9 2.2 8.0 5.9 29.6 8.5 5.3 4.4 28.7 4.0 16.7 3.0 23.2 0.0 4.3 3.9 2.5 4.6 3.4 3.5 10.0 2.1 4.5 2.8 2.6 1.0 4.5 7.4 2.3 6.8 5.7 7.2 3.3 5.0 1.4 3.2 1.0 2.4 1.2 0.6 10.1 5.0 2.0 8.3 4.3 4.0 2.8 0.3 21.3 1.8 7.6 6.7 2.8 0.5 2.0 6.1 6.6 1.8 1.4 3.1 2.9 4.5 5.2 0.6 4.3 6.0 1.7 3.9 0.4 25.4 9.8 4.2 5.9 3.8 11.1 8.4 12.5 7.9 3.6 3.2 6.8 10.9 6.9 3.7 5.9 9.0 2.7 9.3 4.1 3.6 2.8 6.4 2.1 1.2 1.5 2.1 0.7 0.1 1.6 1.9 2.2 3.5 2.0 2.6 1.2 1.3 2.5 1.3 0.3 2.8 4.5 10.0 2.6 1.0 29.7 43.4 9.3 26.8 25.8 13.7 21.3 17.0 19.8 23.2 8.9 9.1 4.5 25.1 26.7 9.9 28.0 22.9 5.3 4.5 14.0 0.0 2.2 69.6 16.8 27.4 14.3 30.2 0.0 7.8 4.3 23.5 40.6 1.1 17.1 5.4 31.8 20.2 18.4 1.9 20.4 18.7 6.0 45.5 1.8 41.7 7.4 8.8 25.9 17.3 54.3 11.0 25.8 15.6 1.6 11.5 25.5 1.0 7.5 36.0 61.2 RAB6D "RAB6CL, WTH3DI" ENSG00000233087 "RAB6D, member RAS oncogene family" 2 131361111-131364142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 13.4" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Cancer enhanced" "Detected in some" "prostate cancer: 1.3" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MOLT-4: 6.4;OE19: 2.6;REH: 2.5;U-2 OS: 2.5" HPA059131 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (4.19e-2)" "unprognostic (8.54e-2)" "unprognostic (1.16e-1)" "unprognostic (3.03e-2)" "unprognostic (4.08e-1)" "unprognostic (4.79e-2)" "unprognostic (4.41e-2)" "unprognostic (1.01e-1)" "unprognostic (1.87e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-1)" "unprognostic (2.55e-2)" "unprognostic (2.61e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 1.9 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 1.4 0.4 0.5 0.5 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 6.4 0.1 0.9 2.6 0.0 2.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 2.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.4 0.3 0.5 0.4 0.4 0.4 0.1 0.5 0.3 0.3 0.2 0.5 0.4 0.2 0.5 0.4 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB7B "MGC16212, MGC9726" ENSG00000276600 "RAB7B, member RAS oncogene family" Q96AH8 1 205976740-206003461 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 21.3;skin 1: 23.7" "Cell type enhanced" "Detected in many" 12 "Club cells: 11.4;Cytotrophoblasts: 23.0;Hofbauer cells: 33.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "myeloid DC: 8.4" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 11.7;HBEC3-KT: 15.3;HL-60: 9.6;HMC-1: 41.5;hTCEpi: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.18e-2)" "unprognostic (2.14e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (9.14e-2)" "unprognostic (2.23e-3)" "unprognostic (5.97e-2)" "unprognostic (8.57e-2)" "unprognostic (3.89e-3)" "unprognostic (3.13e-2)" "unprognostic (8.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.82e-3)" 21.3 0.0 0.5 1.9 1.3 0.0 4.5 0.0 2.0 6.6 0.6 4.0 3.6 0.6 3.3 4.7 7.7 0.9 6.5 1.7 0.5 0.0 0.5 6.1 2.6 0.5 0.0 1.7 0.0 0.0 0.0 5.8 3.0 2.5 0.9 1.5 1.9 3.2 0.6 23.7 0.5 4.2 1.3 1.0 2.5 1.6 0.8 3.4 3.0 13.3 4.4 3.3 0.3 0.0 8.4 0.0 1.0 0.0 0.0 0.4 0.6 0.0 0.3 0.3 0.9 6.9 1.6 3.0 3.7 1.3 1.2 0.4 1.1 0.0 1.1 11.7 1.4 3.0 0.0 15.3 0.4 0.1 0.0 0.0 0.0 0.4 0.0 9.6 41.5 2.3 17.8 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.8 0.1 0.0 5.9 0.1 0.5 0.0 0.0 0.8 0.3 0.4 0.1 0.0 0.0 0.4 0.0 1.9 3.3 1.0 3.4 0.0 0.8 2.1 0.8 0.2 0.0 0.0 0.0 5.6 4.1 1.4 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 3.0 4.6 0.0 7.4 0.0 0.0 0.6 5.1 0.0 11.4 0.0 0.0 23.0 0.0 3.1 0.0 0.1 0.0 0.0 0.2 0.9 4.8 0.6 2.3 0.0 33.5 0.0 0.0 0.0 4.5 0.4 1.7 8.5 0.0 6.4 0.0 2.8 0.5 0.0 3.2 0.0 0.2 0.0 1.1 0.0 0.0 0.0 5.3 0.0 0.0 1.4 RAD21L1 "dJ545L17.2, RAD21L" ENSG00000244588 "RAD21 cohesin complex component like 1" Q9H4I0 20 1226056-1296421 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 17.4" "Group enriched" "Detected in some" 21 "Early spermatids: 95.6;Late spermatids: 76.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.1;cerebral cortex: 1.2;olfactory region: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;BJ hTERT+ SV40 Large T+: 2.5;TIME: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA053282 Approved NA NA "HPA053282: AB_2682099" "unprognostic (2.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.62e-4)" "unprognostic (2.04e-1)" "unprognostic (8.87e-4)" "unprognostic (1.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.1 0.0 0.7 0.0 0.0 17.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.6 4.7 2.5 0.9 0.0 0.0 0.0 0.4 0.8 1.9 0.0 0.0 0.1 1.3 0.8 0.2 0.1 0.1 0.0 0.8 0.0 0.7 0.1 0.0 0.6 0.0 1.2 0.7 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.8 0.1 1.1 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.1 0.1 1.2 0.3 0.1 0.1 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.0 0.0 0.0 0.0 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.5 4.5 1.5 0.5 3.4 4.0 1.8 2.9 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 0.0 1.7 5.8 0.0 4.3 1.1 2.2 0.0 1.6 0.0 0.0 4.5 0.3 0.3 0.0 0.3 2.6 0.0 0.4 0.0 1.6 2.8 0.0 0.0 0.4 0.8 0.5 0.0 3.6 0.0 0.9 1.4 0.3 2.0 0.0 5.5 2.8 2.5 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 8.9 1.3 0.0 5.2 0.2 20.8 1.4 5.1 0.0 2.3 0.0 13.7 8.7 0.0 6.3 76.6 2.8 2.8 0.0 1.2 2.7 2.6 5.1 0.0 1.3 1.6 0.0 5.2 3.1 1.2 31.1 2.6 0.0 1.7 1.8 3.3 5.6 3.6 3.5 2.8 0.7 24.1 0.0 2.2 27.1 24.0 0.0 2.1 0.0 4.5 6.1 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616757 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 58.0" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 65.5;Intestinal endocrine cells: 69.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 27.6" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 5.5 2.3 4.2 2.5 2.6 1.6 4.4 2.7 4.7 4.9 4.0 3.6 6.3 1.8 1.9 3.6 1.9 1.5 3.6 3.0 3.3 0.2 2.7 3.6 1.9 4.1 2.1 6.8 3.7 4.0 3.3 1.6 2.0 5.6 58.0 5.4 4.3 3.2 1.2 4.1 2.2 0.6 2.2 2.4 3.9 4.7 3.6 11.3 2.2 9.4 1.5 3.7 3.1 0.7 1.2 9.2 1.9 1.7 4.7 0.3 9.4 4.8 3.2 3.3 3.8 2.7 7.2 7.0 14.3 0.3 9.2 0.4 0.1 2.4 1.3 2.4 2.0 3.7 0.9 1.8 1.3 2.7 4.4 1.1 0.8 0.4 12.3 1.6 4.9 3.2 10.6 0.7 3.7 7.2 5.0 0.7 5.0 4.8 9.9 2.0 10.3 0.3 3.5 9.0 18.8 1.7 2.2 1.2 6.1 1.9 3.6 2.3 27.6 13.4 3.1 2.4 16.8 10.3 6.2 3.4 3.0 3.4 0.4 8.4 0.3 1.9 9.4 3.7 2.8 3.2 2.2 11.3 3.6 3.4 2.4 2.2 1.5 1.2 9.8 3.5 3.1 11.9 10.4 6.0 4.5 3.4 65.5 0.6 2.5 6.7 7.9 3.5 15.7 0.2 11.6 1.1 0.4 10.8 6.2 0.0 0.6 0.1 2.3 0.9 1.1 0.8 5.8 27.0 69.0 3.7 8.0 0.0 7.8 16.2 1.7 2.8 12.1 5.8 1.4 2.9 7.4 7.5 11.0 12.9 7.2 2.1 2.3 3.0 0.3 5.0 1.9 2.7 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43266919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.6;brain: 18.3" "Cell type enhanced" "Detected in some" 5 "Collecting duct cells: 3.5;Spermatogonia: 3.4;T-cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 13.2;SCLC-21H: 12.8;SK-BR-3: 11.6;T-47d: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favorable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 1.1 2.3 13.1 1.6 16.2 16.6 4.4 11.0 18.3 2.1 0.9 4.0 0.0 1.2 1.6 0.7 1.5 3.4 3.0 1.5 12.3 10.6 1.4 0.4 1.8 6.0 7.2 8.7 1.8 4.8 10.7 3.3 1.1 7.2 1.7 0.7 2.3 4.6 2.6 1.1 0.9 0.8 1.7 3.5 3.5 1.0 3.1 4.1 0.0 1.2 0.2 4.6 2.2 1.9 2.1 5.8 10.4 0.6 7.1 3.6 1.1 7.5 6.5 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.2 4.2 6.6 7.1 0.6 0.0 0.1 1.0 6.2 0.0 0.0 5.1 0.0 0.1 0.3 3.1 0.0 2.5 1.6 7.2 0.6 0.0 0.0 0.0 0.3 13.2 0.0 0.0 1.5 0.0 0.1 0.6 3.3 0.0 0.0 0.0 0.2 0.5 3.6 12.8 0.0 0.0 11.6 0.1 6.1 12.7 0.1 0.0 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.6 3.6 0.6 1.3 0.2 0.9 2.6 3.3 2.1 0.3 1.8 10.4 7.1 0.4 5.8 0.0 1.1 13.1 16.2 11.0 17.8 12.3 10.6 7.2 8.7 7.2 4.1 0.0 0.0 2.2 0.2 0.5 0.7 2.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.3 1.1 0.4 0.0 0.0 1.2 0.9 0.4 0.6 0.0 0.0 1.0 1.6 0.0 1.8 0.3 0.4 0.0 1.5 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.5 0.6 3.4 0.3 0.2 2.9 0.8 0.0 RASGEF1C FLJ35841 ENSG00000146090 "RasGEF domain family member 1C" Q8N431 5 180100791-180209153 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 27.4;testis: 7.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 2.5;Late spermatids: 3.2;Spermatocytes: 5.5;Syncytiotrophoblasts: 1.6" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 3.7;HEK 293: 2.8;MCF7: 3.9;SCLC-21H: 12.6;U-2 OS: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028242 Uncertain Approved Mitochondria NA NA Mitochondria "HPA028242: AB_10602294" "unprognostic (2.21e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (4.75e-4)" "unprognostic (4.65e-2)" "unprognostic (4.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.02e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.65e-4)" "unprognostic (5.89e-2)" "unprognostic (8.25e-3)" "unprognostic (3.70e-1)" "unprognostic (1.77e-2)" 1.1 1.1 7.0 1.1 5.4 0.6 1.4 27.4 22.0 1.4 2.3 9.2 0.0 0.8 0.6 0.8 1.2 1.7 1.2 1.5 4.5 2.8 0.6 0.6 0.6 0.6 5.1 4.9 0.8 0.9 0.8 0.2 0.8 7.7 0.8 1.1 0.4 3.0 2.7 0.7 1.1 1.4 1.0 8.3 0.7 0.8 7.1 4.7 0.0 2.1 0.0 0.6 0.8 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.2 0.0 3.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 7.0 5.4 27.4 11.1 4.5 2.8 5.1 4.9 7.7 4.7 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 5.5 0.9 0.0 1.6 0.0 0.0 0.0 RASL10B "RRP17, VTS58635" ENSG00000270885 "RAS like family 10 member B" Q96S79 17 35731649-35743521 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.6;skeletal muscle: 26.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 12.2;Early spermatids: 9.3;Horizontal cells: 6.4;Late spermatids: 25.1;Muller glia cells: 17.6" "Cancer enhanced" "Detected in many" "testis cancer: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 14.1;HHSteC: 16.1;HSkMC: 11.7;NTERA-2: 24.1;REH: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046842, HPA057092" Enhanced Approved Vesicles NA NA Vesicles "HPA046842: AB_2679835, HPA057092: AB_2683332" "unprognostic (5.78e-2)" "unprognostic (2.15e-2)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (8.60e-2)" "unprognostic (1.24e-1)" "unprognostic (2.69e-2)" "unprognostic (4.98e-2)" "unprognostic (1.97e-2)" "unprognostic (7.13e-2)" "unprognostic (2.61e-2)" "unprognostic (3.18e-2)" "unprognostic (1.71e-6)" "unprognostic (2.41e-3)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (9.60e-3)" 12.8 0.9 6.3 0.3 9.1 0.2 2.8 0.3 12.3 1.8 0.3 1.0 24.6 0.8 1.3 0.8 0.3 3.9 0.8 10.9 4.7 1.0 1.1 0.4 0.2 0.0 2.8 2.5 4.7 2.5 1.1 2.8 6.3 0.9 0.2 1.1 12.6 15.2 26.7 0.3 0.9 0.9 0.6 0.2 0.3 1.6 2.5 0.0 0.9 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 3.6 0.0 0.6 0.4 1.1 0.7 0.4 2.5 2.1 4.6 0.0 0.0 0.4 0.1 0.0 0.0 14.1 0.0 0.8 0.0 4.6 0.0 2.3 5.2 16.1 0.0 0.0 11.7 0.9 0.8 0.0 2.0 0.0 7.6 3.0 0.0 0.2 0.2 6.4 0.0 24.1 0.0 0.0 11.7 6.5 10.4 0.0 0.0 10.8 10.5 0.7 0.2 0.9 11.0 1.3 0.7 0.0 1.2 8.7 0.0 0.3 0.0 0.0 2.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 2.9 12.2 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.9 9.3 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 3.0 0.2 6.4 0.0 0.0 0.3 25.1 2.0 0.0 0.0 0.0 0.0 17.6 0.5 0.0 2.8 0.0 1.1 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 RASL11A ENSG00000122035 "RAS like family 11 member A" Q6T310 13 27270327-27273690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 18.7;Sertoli cells: 32.3;Smooth muscle cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.5" "Group enriched" "Detected in many" 5 "B-cells: 4.5;granulocytes: 3.3;monocytes: 2.9" "Cell line enriched" "Detected in many" 4 "ASC diff: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004859, HPA053296" Supported Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA004859: AB_2667270, HPA053296: AB_2682106" "unprognostic (1.59e-1)" "unprognostic (9.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (6.65e-2)" "prognostic favorable (5.43e-4)" "unprognostic (3.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.65e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (3.71e-2)" "unprognostic (3.34e-1)" 18.9 5.0 2.3 8.1 9.8 3.3 36.4 5.9 5.8 11.6 15.7 7.3 4.3 13.1 14.1 10.4 9.7 14.1 6.5 9.4 4.7 2.1 17.1 30.0 11.6 26.7 3.3 1.2 13.7 3.2 1.4 7.2 5.2 3.6 15.9 20.7 8.1 6.6 10.4 4.9 6.1 24.4 28.5 3.3 17.7 8.9 8.7 5.3 0.9 7.6 3.9 16.4 16.8 27.5 4.5 0.6 3.3 2.9 0.4 0.7 0.2 0.3 1.2 0.3 0.6 43.1 4.4 0.2 1.8 1.9 0.1 0.1 7.8 0.8 0.4 0.6 1.4 1.0 0.2 2.2 0.8 0.1 1.7 8.9 1.7 0.2 0.5 7.0 0.5 0.7 4.7 0.7 0.1 0.1 1.7 0.6 0.7 0.2 0.0 0.0 0.8 0.0 2.3 1.2 7.7 10.0 0.5 0.0 0.2 1.5 5.8 0.8 0.2 0.7 3.2 0.2 1.1 0.2 0.7 0.3 0.1 0.4 2.9 0.3 0.1 0.0 0.0 0.3 1.9 0.1 1.2 2.0 0.8 0.0 0.4 0.0 0.1 0.0 0.1 0.6 4.5 0.2 0.7 3.3 0.4 2.9 0.1 0.0 0.2 2.3 9.8 5.9 5.8 4.7 2.1 3.3 1.2 3.6 5.3 14.9 9.1 0.0 2.4 4.0 0.0 1.1 0.0 18.7 14.8 7.0 0.0 0.6 3.3 1.0 0.0 1.2 6.3 0.0 2.0 0.1 1.9 1.0 0.0 0.0 1.1 0.0 0.0 1.8 0.6 0.0 0.3 3.5 1.7 1.0 5.2 0.0 0.6 11.5 1.4 1.1 0.0 32.3 45.0 0.0 0.0 3.9 0.7 0.0 6.0 0.9 RASL11B ENSG00000128045 "RAS like family 11 member B" Q9BPW5 4 52862290-52866835 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 38.0" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 31.4;Cytotrophoblasts: 80.5;Extravillous trophoblasts: 60.5;Peritubular cells: 64.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.9;CACO-2: 7.7;NTERA-2: 10.5;RPTEC TERT1: 6.6;SH-SY5Y: 26.8;SuSa: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057803 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA057803: AB_2683533" "unprognostic (1.60e-1)" "unprognostic (1.95e-1)" "unprognostic (7.32e-3)" "unprognostic (1.19e-1)" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (1.22e-1)" "unprognostic (7.66e-2)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (9.71e-2)" "unprognostic (8.72e-2)" "unprognostic (7.20e-4)" "unprognostic (7.17e-2)" "unprognostic (1.35e-1)" "unprognostic (5.00e-6)" "unprognostic (1.10e-1)" 1.1 1.6 9.2 0.6 3.8 0.2 0.7 9.8 11.5 2.2 0.4 0.1 12.5 0.1 5.3 2.7 0.3 2.9 2.4 12.4 2.7 1.9 8.5 0.5 0.7 0.7 0.7 5.5 38.0 0.8 19.9 0.4 8.8 0.4 2.2 0.3 1.3 0.8 20.2 0.3 2.0 0.5 1.9 0.5 15.2 2.5 3.9 0.0 0.0 0.6 0.0 1.0 1.2 2.8 0.2 0.9 0.0 0.1 2.2 1.3 0.2 0.2 0.0 3.9 0.0 3.5 1.6 9.9 0.1 0.0 0.2 0.0 7.7 0.0 0.0 0.3 0.0 0.1 0.0 0.5 2.3 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.0 0.3 1.7 4.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.8 0.7 0.0 10.5 0.8 0.1 0.0 4.5 0.0 6.6 1.0 2.2 26.8 0.1 1.7 0.8 6.9 0.9 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.9 0.0 2.2 0.0 0.9 0.0 0.2 9.2 3.8 9.8 11.5 2.7 1.9 0.7 5.5 0.4 0.0 6.0 0.0 0.0 1.2 0.8 3.5 4.1 0.0 0.0 2.3 31.4 0.0 80.5 0.0 1.1 0.3 0.7 0.5 0.0 0.5 60.5 7.3 0.5 0.0 0.0 6.9 0.0 0.0 1.3 0.0 1.5 22.5 0.0 0.0 1.0 0.5 2.0 0.6 3.5 64.3 0.0 1.1 0.0 3.8 2.1 8.1 0.4 19.3 0.0 0.5 0.2 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009577-13012106 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 13.4;Distal tubular cells: 21.6;Pancreatic endocrine cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 9.5;CAPAN-2: 8.5;HaCaT: 13.1;HMC-1: 6.5;RPTEC TERT1: 13.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.4 0.2 1.0 0.0 3.9 0.0 1.7 1.1 1.4 1.0 0.0 1.8 0.0 1.3 9.3 5.2 2.5 0.2 1.0 4.7 0.0 1.8 0.0 0.0 0.6 1.2 0.0 3.8 0.1 0.0 0.6 1.6 0.5 0.4 8.0 0.1 0.8 4.1 0.6 0.0 0.1 0.0 5.6 2.4 1.0 1.1 0.1 8.1 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.5 0.0 0.6 0.0 0.3 13.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.4 0.0 1.3 0.0 0.0 13.3 1.4 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 3.8 0.0 0.0 0.8 0.0 13.4 4.5 1.8 0.0 0.1 21.6 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 1.1 0.0 0.1 0.0 2.4 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.5 6.7 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 5.3 3.5 RASSF9 "P-CIP1, PAMCI" ENSG00000198774 "Ras association domain family member 9" O75901 12 85800697-85836570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 36.1;Club cells: 58.0;Endothelial cells: 18.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 19.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 4.9;hTERT-RPE1: 16.0;RPTEC TERT1: 4.8;U-138 MG: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039428, HPA039678" Approved NA NA "HPA039428: AB_10795251, HPA039678: AB_10796332" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-3)" "unprognostic (2.88e-3)" "unprognostic (7.78e-3)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" "unprognostic (1.93e-2)" "unprognostic (3.17e-1)" "unprognostic (1.12e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-1)" "unprognostic (6.10e-2)" "unprognostic (9.90e-5)" 7.9 5.1 1.7 4.1 4.6 0.1 9.1 0.5 0.6 14.4 3.2 4.7 3.1 3.1 15.8 6.3 10.6 11.6 4.4 7.4 3.0 2.8 7.1 3.9 17.1 7.6 4.4 1.4 7.6 4.1 1.2 2.6 0.7 19.1 6.6 2.1 2.5 4.2 6.1 5.0 7.1 3.0 5.5 4.6 10.4 2.6 3.1 2.8 2.6 14.8 8.1 4.6 6.8 12.1 0.7 0.4 1.1 0.5 0.6 0.3 0.0 0.1 1.6 0.0 0.0 0.1 1.2 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.1 2.0 0.2 0.2 0.0 2.7 0.0 0.0 0.4 0.0 4.9 0.0 0.2 0.0 0.0 1.9 2.6 0.8 0.1 16.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.5 0.0 3.6 1.2 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.5 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.1 0.7 0.3 0.3 1.1 0.6 0.1 0.4 0.3 0.0 1.7 4.6 0.5 0.6 3.0 2.8 4.4 1.4 19.1 2.8 14.9 13.1 0.0 5.5 4.2 0.0 2.4 15.3 36.1 58.0 3.5 0.0 0.0 1.7 5.6 0.3 18.5 0.0 0.0 1.4 0.0 1.6 6.3 0.0 0.0 0.1 0.0 0.0 16.0 2.1 0.0 2.3 0.7 0.0 0.0 0.0 12.3 3.5 0.0 0.4 0.0 0.3 0.0 1.4 0.0 1.7 2.9 0.0 0.0 0.0 3.3 RBBP8NL "C20orf151, dJ908M14.3" ENSG00000130701 "RBBP8 N-terminal like" Q8NC74 20 62410237-62427533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 17.4" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 72.5;Mucus-secreting cells: 38.7;Paneth cells: 57.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.9;CACO-2: 21.4;MCF7: 8.7;SK-BR-3: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.99e-2)" "unprognostic (6.95e-3)" "unprognostic (2.71e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.27e-3)" "unprognostic (2.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (2.76e-1)" "unprognostic (2.15e-1)" "unprognostic (1.44e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.91e-4)" 0.2 0.0 0.2 1.7 0.2 0.0 1.4 0.2 0.5 2.2 1.9 0.2 13.9 7.6 0.6 2.9 10.7 1.2 2.3 0.2 0.2 0.0 1.7 0.2 0.8 0.2 0.2 0.2 1.1 5.5 2.9 2.6 4.4 0.2 4.4 1.0 0.2 17.4 12.2 0.2 5.3 7.9 0.2 0.2 0.2 2.6 3.1 0.2 0.5 7.7 2.0 5.6 3.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 21.4 2.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 10.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.6 0.0 1.6 0.2 0.0 1.6 10.2 0.0 1.2 1.8 0.0 4.9 0.0 0.2 9.7 0.0 72.5 0.0 0.2 4.5 0.0 1.4 0.0 0.0 0.5 0.0 9.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 38.7 0.0 0.1 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 0.0 16.4 0.7 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.4;seminal vesicle: 21.5" "Cell type enhanced" "Detected in many" 12 "Glandular cells: 12.8;Peritubular cells: 9.9;Spermatogonia: 21.3" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in all" "cerebellum: 60.4" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 13.2;NTERA-2: 11.9;SCLC-21H: 19.2;U-2 OS: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, HPA075862, CAB078782" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB078782: , HPA030790: AB_10602305, HPA075862: " "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 1.0 10.2 0.6 23.5 0.6 0.2 60.4 33.2 0.5 15.2 0.3 0.2 1.5 9.3 3.0 8.3 1.0 0.3 0.3 8.6 3.3 0.4 0.2 0.3 0.4 1.8 3.5 0.3 0.5 0.2 0.9 0.3 5.5 13.2 2.2 0.2 0.2 21.5 0.3 0.3 1.3 8.1 2.3 0.4 0.5 7.2 5.6 0.2 0.3 0.2 0.2 15.2 1.0 0.7 0.2 0.0 0.7 0.0 1.4 0.2 0.0 13.2 0.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 11.9 0.0 0.2 0.2 0.5 0.0 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.8 0.0 0.3 0.4 0.3 0.0 0.0 0.7 0.0 1.4 0.3 0.0 0.7 0.1 0.4 0.2 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.2 10.2 23.5 60.4 19.5 8.6 3.3 1.8 3.5 5.5 5.6 0.0 0.0 0.0 4.7 1.8 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.4 0.0 0.0 0.0 0.1 1.0 12.8 0.0 0.0 0.1 4.8 0.0 0.0 0.8 7.1 0.3 0.7 5.0 0.0 0.0 1.0 0.0 0.0 9.9 0.0 3.3 0.0 2.3 0.7 21.3 1.3 0.1 2.1 0.0 2.0 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.2 12.4 15.4 7.3 13.3 10.9 9.1 8.5 7.0 5.8 10.2 5.8 8.6 10.1 13.7 13.1 13.8 11.5 10.4 5.9 7.6 10.2 5.9 14.0 15.1 10.5 13.1 15.7 9.6 19.6 9.2 13.1 8.3 10.4 8.0 13.6 6.3 7.8 9.3 6.5 19.8 10.2 7.0 17.4 13.8 12.7 6.6 17.6 9.3 10.0 14.1 15.0 6.9 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.7 21.5 8.5 14.1 9.4 10.2 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 29.8 10.9 16.7 9.8 19.3 11.8 46.6 7.6 17.4 13.6 24.4 2.0 28.1 23.2 20.9 61.1 24.8 12.3 0.0 14.0 35.6 16.0 18.9 17.3 13.7 24.5 3.2 18.9 13.5 21.4 54.6 12.4 16.2 18.6 10.0 16.7 15.8 18.5 13.9 15.9 18.9 11.6 19.4 23.1 10.1 19.4 22.6 47.6 17.3 13.6 14.1 RBM44 FLJ40411 ENSG00000177483 "RNA binding motif protein 44" Q6ZP01 2 237798389-237842808 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 40.1" "Group enriched" "Detected in some" 7 "Spermatocytes: 107.6;Spermatogonia: 72.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 33 "basophil: 3.3" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.3" "Cell line enhanced" "Detected in some" "NB-4: 3.5;RPTEC TERT1: 3.5" "Not detected" "Not detected" HPA003298 Enhanced NA NA "HPA003298: AB_2284846" "unprognostic (1.29e-1)" "unprognostic (2.66e-1)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "unprognostic (8.47e-3)" "unprognostic (3.15e-2)" "unprognostic (2.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.83e-2)" "unprognostic (8.12e-2)" "unprognostic (4.10e-2)" "unprognostic (4.57e-2)" "unprognostic (5.01e-5)" "unprognostic (1.90e-1)" "unprognostic (4.27e-2)" "unprognostic (6.85e-3)" "unprognostic (7.89e-3)" 0.5 0.0 0.1 0.1 0.1 0.8 0.4 0.1 0.3 0.4 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.3 0.1 0.5 0.8 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.6 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 40.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.4 0.9 0.3 1.0 0.7 0.5 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.3 0.3 1.3 0.4 0.2 0.9 0.7 0.1 1.5 1.3 0.8 0.6 1.4 1.3 0.1 1.0 0.2 1.2 1.9 0.4 1.3 0.1 1.2 0.0 0.2 0.9 3.5 0.7 0.2 1.1 0.4 0.2 0.9 3.5 1.1 0.6 0.9 0.0 0.4 0.3 0.7 0.5 2.1 0.0 0.0 0.3 0.0 0.8 0.7 0.2 0.2 0.7 1.5 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.1 0.0 0.6 0.0 0.6 0.7 0.0 0.6 2.5 2.7 2.3 1.8 0.0 0.1 0.0 0.1 13.1 0.9 0.0 0.0 0.2 0.2 0.5 1.5 0.0 0.4 0.3 0.0 0.0 0.0 0.8 10.9 2.6 1.8 1.7 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 6.5 0.4 107.6 72.4 0.5 0.0 0.0 0.0 1.0 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Group enriched" "Detected in some" 13 "Spermatocytes: 74.4;Spermatogonia: 75.5" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.7;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079488 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA079488: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 74.4 75.5 0.0 0.0 0.0 0.0 0.0 RBM48 "C7orf64, DKFZp564O0523, HSPC304" ENSG00000127993 "RNA binding motif protein 48" Q5RL73 7 92528773-92538005 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021777, HPA025306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021777: AB_1845763, HPA025306: AB_1845764" "unprognostic (2.79e-2)" "unprognostic (2.15e-1)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (2.81e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.86e-2)" "unprognostic (2.37e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-3)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (2.43e-2)" "unprognostic (8.04e-2)" 11.1 13.0 23.9 10.8 36.0 24.6 14.1 28.3 34.2 11.7 9.0 18.4 7.1 10.3 12.0 12.4 9.9 10.9 8.9 12.1 22.8 15.2 12.4 10.5 9.9 17.1 42.4 15.1 17.0 10.6 11.1 18.3 10.6 20.7 11.5 11.0 9.0 13.0 8.9 16.5 10.8 10.7 9.7 28.0 14.5 9.8 12.5 36.9 13.6 14.5 6.6 13.9 10.2 10.1 20.1 10.6 37.5 12.1 18.1 25.8 14.0 7.5 5.6 9.7 15.2 11.9 12.4 7.6 9.1 9.4 12.1 11.5 6.5 10.4 10.8 16.5 7.7 15.2 7.8 9.9 7.3 13.5 12.2 12.2 8.5 12.2 7.4 10.1 14.9 10.2 9.5 14.4 11.9 12.7 13.9 12.1 14.1 16.8 19.2 11.2 8.9 19.2 15.2 8.6 10.8 9.4 8.9 8.5 14.6 9.6 7.3 11.5 16.2 9.1 17.6 12.7 13.3 5.5 14.7 6.2 17.1 9.3 13.5 13.0 11.4 15.1 18.5 8.1 13.1 15.6 37.5 10.1 21.0 18.5 12.1 20.2 20.1 20.3 18.9 9.7 18.5 25.8 22.1 13.4 18.1 9.9 10.6 18.3 14.0 23.9 36.0 28.3 34.2 22.8 15.2 42.4 15.1 20.7 36.9 11.9 6.9 15.6 11.1 7.6 12.2 14.6 5.1 9.4 11.4 3.5 0.0 8.8 6.6 6.9 6.1 9.3 5.8 23.3 5.2 4.8 8.7 8.9 29.0 3.8 5.4 11.1 0.0 4.9 6.5 5.7 5.5 8.9 5.0 8.2 3.8 12.5 4.1 6.6 6.0 7.4 12.5 12.9 8.3 21.2 15.6 9.9 12.8 14.1 5.2 10.3 RBMXL3 "CXorf55, FLJ40249" ENSG00000175718 "RNA binding motif protein, X-linked like 3" Q8N7X1 X 115189427-115192868 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 6.8" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 15.8" "Cancer enriched" "Detected in single" 25 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051842 Supported NA NA "HPA051842: AB_2681634" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 15.8 0.0 0.0 0.0 0.0 0.0 RBMY1B ENSG00000242875 "RNA binding motif protein, Y-linked, family 1, member B" A6NDE4 Y 21511338-21549094 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 47 "testis: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEL: 1.6" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1D ENSG00000244395 "RNA binding motif protein, Y-linked, family 1, member D" P0C7P1 Y 21880076-21894526 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1E ENSG00000242389 "RNA binding motif protein, Y-linked, family 1, member E" A6NEQ0 Y 21903618-21918067 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 71 "testis: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-266/84: 7.1" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 RBPJL "RBP-L, RBPSUHL, SUH, SUHL" ENSG00000124232 "Recombination signal binding protein for immunoglobulin kappa J region like" Q9UBG7 20 45306851-45317824 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 279 "pancreas: 188.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "liver cancer: 1.2;ovarian cancer: 1.2;pancreatic cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.2;NB-4: 4.8;SK-MEL-30: 1.3;U-937: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB006846 Enhanced NA NA "CAB006846: " "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.34e-2)" "unprognostic (6.09e-1)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (9.60e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.65e-1)" "unprognostic (3.92e-3)" "unprognostic (2.48e-7)" "unprognostic (5.08e-1)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (3.49e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 2.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 25.3;HDLM-2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053880: AB_2682290" "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 6.1 0.4 0.0 0.0 0.0 0.0 0.3 25.3 0.0 0.0 0.0 0.0 0.1 50.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 5.6 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 6.0 4.3 0.8 3.8 5.6 19.4 229.0 2.5 0.0 0.0 3.5 3.9 0.0 59.7 5.8 22.0 10.8 0.0 0.0 2.1 0.0 5.6 1.7 0.0 0.2 0.1 28.6 24.1 0.0 0.3 11.0 27.0 1.8 30.4 0.0 0.3 167.3 4.3 0.0 47.4 1.4 8.0 97.0 159.7 0.7 0.9 6.5 0.0 0.0 0.1 1.1 REC114 "C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677" ENSG00000183324 "REC114 meiotic recombination protein" Q7Z4M0 15 73443158-73560014 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 35.7" "Group enriched" "Detected in some" 6 "Early spermatids: 128.3;Spermatocytes: 118.3" "Cancer enriched" "Detected in single" 11 "testis cancer: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.6;U-266/84: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (4.58e-2)" "unprognostic (2.97e-1)" "unprognostic (8.06e-2)" "unprognostic (2.63e-2)" "unprognostic (2.48e-2)" "unprognostic (1.53e-7)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (1.98e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.2 1.7 0.2 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.4 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 1.1 1.7 0.3 0.1 0.1 0.3 0.2 0.2 0.3 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 118.3 20.8 0.0 0.0 0.0 0.0 0.0 REELD1 ENSG00000250673 "Reeler domain containing 1" 4 146214515-146230878 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 1.3;epididymis: 1.5;skin 1: 1.7" "Cell type enriched" "Detected in single" 17 "Ciliated cells: 2.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 87 "HDLM-2: 14.6" NA NA "unprognostic (6.26e-3)" "unprognostic (1.40e-1)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (3.77e-2)" "unprognostic (7.75e-2)" "unprognostic (7.88e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.40e-1)" "unprognostic (3.55e-6)" "unprognostic (2.19e-2)" "unprognostic (3.14e-1)" "unprognostic (3.90e-1)" "unprognostic (3.13e-2)" 0.1 0.0 0.9 0.4 1.3 0.2 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.7 0.2 0.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.5 1.7 0.0 0.0 1.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RERGL FLJ22655 ENSG00000111404 "RERG like" Q9H628 12 18080869-18320107 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 32 "Sertoli cells: 161.7;Smooth muscle cells: 159.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 719 "REH: 72.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA041740 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041740: AB_10795694" "unprognostic (3.53e-2)" "unprognostic (7.03e-4)" "unprognostic (6.29e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-2)" "unprognostic (4.39e-2)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (5.51e-2)" "unprognostic (7.26e-2)" "unprognostic (8.47e-2)" "unprognostic (1.25e-1)" "unprognostic (6.76e-3)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "unprognostic (1.66e-2)" 22.4 4.0 5.4 3.2 8.3 0.0 13.0 1.8 8.9 33.4 10.3 4.3 3.5 2.1 16.5 29.2 8.7 19.6 17.3 4.7 7.5 6.1 12.8 0.9 3.1 0.9 9.4 6.0 11.3 1.0 0.8 0.7 0.3 9.0 12.6 12.3 1.6 2.1 14.1 7.7 5.6 6.3 11.8 6.2 1.1 3.9 11.7 4.2 0.4 7.0 8.0 1.1 8.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 8.3 1.8 8.9 7.5 6.1 9.4 6.0 9.0 4.2 0.0 0.0 0.0 0.1 3.9 0.0 3.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.1 0.0 1.4 0.4 0.0 161.7 159.4 0.1 0.7 2.0 0.1 0.0 0.0 0.3 RESP18 ENSG00000182698 "Regulated endocrine specific protein 18" Q5W5W9 2 219327409-219333177 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.7" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 6.6;Intestinal endocrine cells: 3.4;Late spermatids: 18.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" NA NA "unprognostic (2.57e-2)" "unprognostic (2.12e-1)" 0.4 0.4 2.6 0.4 28.7 0.4 0.5 0.1 7.5 0.4 0.4 0.3 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.1 4.0 0.4 0.4 0.4 0.4 3.6 1.0 0.4 0.4 0.4 0.0 0.4 2.3 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 2.4 2.5 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 28.7 0.1 1.8 3.1 4.0 3.6 1.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 18.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RETNLB "FIZZ2, HXCP2, RELMb" ENSG00000163515 "Resistin like beta" Q9BQ08 3 108743424-108757384 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 71.9" "Group enriched" "Detected in some" 5 "Early spermatids: 1.9;Intestinal endocrine cells: 1.7;Late spermatids: 3.5;Mucus-secreting cells: 4.5" "Cancer enriched" "Detected in some" 10 "colorectal cancer: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 6.6" "Not detected" "Not detected" HPA049152 Enhanced "Secreted to blood" NA NA 123000 "HPA049152: AB_2680655" "prognostic favorable (6.86e-5)" "unprognostic (1.19e-3)" "unprognostic (3.37e-2)" "unprognostic (4.69e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-2)" "unprognostic (4.26e-1)" 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 20.6 0.1 0.1 4.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 71.9 0.1 0.1 0.1 0.1 0.0 24.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Cell line enhanced" "Detected in many" "K-562: 24.4;U-266/70: 25.2" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.4 3.6 5.7 2.5 2.3 4.8 1.9 4.3 4.8 4.8 5.3 2.7 5.6 3.9 6.9 3.6 3.3 3.2 4.3 1.9 5.0 4.1 3.1 6.5 5.4 3.7 0.5 9.6 9.5 2.2 0.8 5.6 7.3 2.1 1.6 0.0 24.4 17.5 11.7 8.3 1.5 7.2 3.1 2.5 3.7 7.8 10.8 7.0 1.4 2.2 5.1 5.7 4.0 5.5 1.4 1.7 9.3 8.2 0.8 3.5 3.2 4.7 5.1 25.2 17.0 1.5 7.4 12.4 3.4 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.3 2.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RFNG ENSG00000169733 "RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q9Y644 17 82047902-82051831 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011564, HPA031673" Uncertain Approved Nucleoplasm No No 450000 Nucleoplasm "HPA011564: AB_1079803, HPA031673: AB_2673989" "unprognostic (4.17e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-3)" "unprognostic (2.49e-1)" "unprognostic (2.05e-1)" "unprognostic (2.65e-2)" "unprognostic (1.62e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "prognostic favorable (4.81e-4)" "unprognostic (1.20e-1)" "unprognostic (6.96e-3)" "unprognostic (1.77e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (4.14e-2)" 19.5 13.0 13.8 9.3 13.3 11.7 43.8 14.3 13.8 11.4 11.8 9.0 22.7 14.9 13.5 20.9 13.4 16.3 17.0 12.2 11.6 8.7 12.5 34.5 16.7 10.1 11.2 8.0 19.7 26.6 4.1 10.7 8.2 9.9 11.8 4.8 10.6 27.3 20.4 32.6 13.3 12.7 12.9 8.5 8.9 13.2 12.8 10.6 5.7 12.6 10.5 7.6 12.4 12.8 3.4 3.4 4.3 5.0 0.4 6.3 1.5 9.5 9.5 2.8 9.6 7.2 6.3 12.3 8.9 5.2 4.3 3.4 5.8 6.8 2.2 6.4 14.1 8.8 5.3 1.9 7.7 0.9 2.9 10.0 3.2 2.3 23.6 35.5 1.2 7.1 11.5 5.2 7.3 12.5 8.4 8.0 7.5 4.0 8.4 3.4 11.7 7.1 3.3 2.8 6.4 10.0 5.0 3.4 5.0 4.8 5.8 5.0 12.4 3.4 5.8 26.3 3.2 16.1 6.8 3.0 6.8 9.2 6.4 4.8 11.3 2.1 2.3 8.5 2.0 5.8 2.3 5.0 4.3 4.1 1.4 1.5 2.5 2.8 4.3 3.4 3.4 2.8 1.9 2.0 0.4 1.5 2.7 6.3 1.5 13.8 13.3 14.3 13.8 11.6 8.7 11.2 8.0 9.9 10.6 6.0 11.3 5.2 11.2 8.7 28.3 10.0 7.6 4.0 3.4 22.7 23.6 4.8 6.6 7.0 2.9 9.2 17.1 0.0 12.8 2.8 17.9 13.2 1.1 42.9 8.3 11.1 10.9 17.8 9.7 8.5 20.1 6.1 10.1 2.8 13.3 30.4 11.9 17.3 18.7 28.9 24.4 0.0 7.0 17.9 3.1 8.9 3.1 7.5 11.1 7.0 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 6.5;Ito cells: 12.9;Kupffer cells: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 11.2;HMC-1: 4.3;Karpas-707: 4.7;SH-SY5Y: 5.8;SiHa: 2.8;THP-1: 5.3" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 11.2 0.7 0.0 1.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.8 2.8 0.0 0.0 0.3 0.0 5.3 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell type enriched" "Detected in single" 4 "Glandular cells: 3.1" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL4AL1 RNF210B ENSG00000229292 "Ret finger protein like 4A like 1" F8VTS6 19 55769141-55773179 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 5.4;myeloid DC: 2.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.5;monocytes: 5.4" "Cell line enriched" "Detected in some" 24 "U-2 OS: 24.8" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (8.87e-2)" 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.0 0.0 0.3 3.0 0.0 0.4 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 2.3 0.2 1.5 0.3 0.0 0.3 0.0 0.0 2.5 0.4 5.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 RFPL4B RNF211 ENSG00000251258 "Ret finger protein like 4B" Q6ZWI9 6 112347330-112351296 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.0" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 13.9" "Group enriched" "Detected in some" 7 "liver cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;K-562: 3.1;RPTEC TERT1: 4.1;U-266/70: 1.7;U-266/84: 12.7" "HPA059324, HPA066464" Uncertain NA NA "HPA059324: , HPA066464: " "unprognostic (4.26e-1)" "unprognostic (1.45e-1)" "unprognostic (6.66e-2)" "unprognostic (3.78e-1)" "unprognostic (2.80e-3)" "unprognostic (3.73e-2)" 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.3 0.0 0.0 0.0 RFX8 FLJ42986 ENSG00000196460 "RFX family member 8, lacking RFX DNA binding domain" Q6ZV50 2 101397361-101474703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8" "Group enriched" "Detected in some" 5 "Early spermatids: 14.4;Late spermatids: 6.0;Spermatocytes: 4.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 12 "basophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;hTEC/SVTERT24-B: 15.7;LHCN-M2: 7.5;U-87 MG: 10.4;U-937: 4.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA059745: AB_2684120" "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 2.1 0.6 0.4 0.8 0.7 10.0 7.5 0.2 2.3 0.9 0.5 0.8 1.3 0.4 0.7 1.7 0.7 0.2 1.0 0.8 0.4 0.9 0.6 0.7 0.7 0.9 0.7 1.6 0.7 0.6 1.0 2.2 0.9 1.6 0.5 0.1 0.8 0.9 0.1 0.5 1.4 0.3 0.8 0.8 0.4 0.4 2.6 0.0 7.8 1.5 0.0 0.3 0.6 2.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.0 1.4 1.4 1.4 0.0 3.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.1 0.0 15.7 0.1 0.0 0.0 0.5 0.0 0.0 7.5 0.0 0.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 1.9 2.8 0.0 0.0 0.0 10.4 4.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 2.3 0.4 0.9 0.7 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.5 4.7 0.7 0.0 1.1 0.0 0.0 0.1 RGL4 Rgr ENSG00000159496 "Ral guanine nucleotide dissociation stimulator like 4" Q8IZJ4 22 23688136-23699176 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3;bone marrow: 55.8" "Cell type enriched" "Detected in some" 7 "T-cells: 53.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "neutrophil: 81.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 81.3" "Group enriched" "Detected in many" 5 "MOLT-4: 15.1;U-937: 35.7" HPA035979 Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA035979: AB_10673227" "unprognostic (1.48e-4)" "unprognostic (2.75e-4)" "unprognostic (4.44e-2)" "unprognostic (1.11e-4)" "unprognostic (3.10e-1)" "unprognostic (2.93e-4)" "unprognostic (4.92e-2)" "unprognostic (2.06e-2)" "unprognostic (2.78e-1)" "unprognostic (3.11e-1)" "unprognostic (4.25e-2)" "unprognostic (3.80e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-3)" 1.6 1.0 0.5 9.8 0.6 55.8 0.6 1.0 0.8 0.4 1.0 0.2 0.0 1.3 1.0 1.0 1.1 1.2 1.8 10.8 0.5 0.5 0.8 1.5 6.7 19.9 0.6 0.0 1.4 1.0 0.0 0.7 0.8 0.5 0.5 0.2 0.4 2.2 0.0 0.8 1.9 4.1 0.0 0.6 21.6 0.9 18.4 0.3 11.1 1.0 0.3 8.9 1.1 3.6 0.9 0.8 81.3 12.0 4.8 17.8 5.8 0.9 0.3 3.5 1.5 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.6 1.1 0.3 0.0 0.6 1.7 0.0 0.0 0.0 1.1 2.2 0.5 1.2 0.2 0.0 1.9 2.3 0.0 0.0 0.0 0.0 1.8 0.0 1.2 1.2 1.8 0.0 0.5 15.1 2.1 0.2 0.3 0.4 5.4 1.2 0.8 0.0 1.0 1.1 1.7 1.0 2.2 0.3 2.0 0.7 1.2 1.5 2.0 1.2 1.3 0.6 3.2 0.5 0.8 1.1 35.7 0.9 11.8 0.4 58.6 9.5 2.9 9.8 0.9 12.4 10.9 0.8 0.7 17.8 15.9 81.3 4.8 12.0 0.1 17.0 5.8 0.5 0.6 1.0 0.5 0.5 0.5 0.6 0.0 0.5 0.3 0.0 7.9 5.0 0.0 0.8 0.5 0.4 0.0 0.0 2.3 0.0 2.0 0.0 0.0 1.9 4.4 0.0 0.0 0.0 1.5 0.1 0.2 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.8 0.4 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.3 0.0 53.2 0.0 0.0 RGPD1 RGP1 ENSG00000187627 "RANBP2-like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.4;placenta: 8.0;testis: 17.7" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 1.6;Early spermatids: 1.9;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.8;MOLT-4: 13.2;NTERA-2: 4.0;RPMI-8226: 2.9;SuSa: 7.7" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.1 0.2 0.2 1.7 1.1 4.8 8.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.3 17.7 0.2 0.5 0.0 0.1 1.3 0.0 0.1 0.0 1.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 13.2 0.2 4.0 0.2 0.0 0.1 0.1 2.9 0.0 0.0 0.1 0.8 0.2 0.0 0.0 7.7 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.7 0.0 0.2 0.1 0.8 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2-like and GRIP domain containing 2" P0DJD1 2 87755955-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.3;testis: 12.3" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 5.7;Early spermatids: 4.3;Late spermatids: 2.3;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "T-reg: 11.3" "Lineage enriched" "Detected in single" 12 "T-cells: 11.3" "Cell line enhanced" "Detected in some" "BEWO: 10.7;JURKAT: 5.2;MOLT-4: 12.2;NTERA-2: 5.3;SuSa: 15.5;THP-1: 4.9" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 0.7 2.1 0.1 0.6 0.2 7.1 0.8 1.3 0.3 4.6 0.8 1.2 1.1 0.0 0.3 2.4 0.0 0.5 0.0 0.2 0.4 0.8 1.2 1.3 0.1 1.7 6.3 0.1 2.7 7.5 0.6 0.1 0.8 0.1 0.6 0.6 1.8 0.0 0.1 0.9 1.7 12.3 0.9 1.6 0.3 0.9 0.9 0.0 0.5 0.1 0.0 11.3 0.4 0.0 0.0 0.6 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.1 2.5 0.2 0.0 0.1 0.0 5.2 3.7 0.3 0.0 0.4 12.2 0.0 5.3 2.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.7 4.3 0.1 0.0 15.5 0.0 4.9 0.1 0.8 0.1 0.0 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.4 0.9 2.7 0.5 0.0 0.9 1.4 0.2 0.4 0.0 0.0 0.0 11.3 0.4 0.0 0.6 0.0 0.0 0.1 0.2 5.7 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.1 4.3 0.0 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.4 0.0 0.8 0.0 0.0 0.0 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.8;Early spermatids: 7.2;Late spermatids: 2.1;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.4" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 RGS13 ENSG00000127074 "Regulator of G protein signaling 13" O14921 1 192636138-192660306 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.9" "Cell type enriched" "Detected in some" 9 "granulocytes: 489.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 35 "basophil: 9.2" "Lineage enriched" "Detected in single" 35 "granulocytes: 9.2" "Cell line enriched" "Detected in some" 17 "Daudi: 34.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA076656 Enhanced NA NA "HPA076656: " "unprognostic (1.99e-2)" "unprognostic (6.08e-3)" "unprognostic (3.25e-4)" "unprognostic (1.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.37e-5)" "unprognostic (1.93e-1)" "unprognostic (2.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (7.39e-2)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (3.42e-1)" "unprognostic (2.35e-1)" "unprognostic (6.86e-2)" "unprognostic (1.96e-1)" 2.2 0.1 0.1 46.9 0.6 0.2 1.3 0.1 0.1 2.4 4.2 0.0 1.1 2.2 1.5 1.3 1.3 0.4 3.5 0.4 0.1 0.4 0.5 0.2 3.6 31.7 0.2 0.0 0.2 0.7 0.0 0.8 0.0 0.1 3.9 1.0 0.5 1.4 1.6 0.3 1.9 11.9 2.9 0.2 1.2 1.9 0.7 0.0 0.6 0.6 1.7 22.9 1.4 1.8 0.2 0.1 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.4 0.2 0.0 0.1 0.0 3.0 53.5 3.7 2.5 1.6 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 489.4 0.0 0.3 0.0 6.8 0.0 0.8 0.0 0.0 4.6 6.8 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.3 0.3 0.0 RGS21 ENSG00000253148 "Regulator of G protein signaling 21" Q2M5E4 1 192316992-192367285 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "Early spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052843 Uncertain NA NA "HPA052843: AB_2681971" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506257-64612312 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1" "Cell type enhanced" "Detected in some" 14 "Ito cells: 20.3;Leydig cells: 6.6;Peritubular cells: 13.1;Sertoli cells: 6.5;Smooth muscle cells: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: AB_2676591" "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.8 4.7 10.2 1.1 22.6 0.4 1.1 10.4 31.1 6.0 1.3 1.5 0.5 1.6 3.7 5.7 2.7 10.9 2.7 3.7 10.8 4.3 3.3 1.7 2.2 0.8 4.0 16.0 3.8 0.8 0.7 1.7 0.4 8.2 7.8 1.4 1.8 2.7 10.9 0.7 1.0 1.7 2.3 1.9 1.3 1.5 1.5 6.7 0.0 1.0 0.0 0.6 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.6 10.4 25.1 10.8 4.3 4.0 16.0 8.2 6.7 0.0 0.0 0.0 0.1 0.0 4.3 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 0.0 1.3 6.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 13.1 0.0 1.7 6.5 7.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 10.7;HMC-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.5 0.1 0.5 0.1 1.8 0.1 0.1 0.5 0.2 10.7 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.2 0.0 0.1 0.9 1.5 0.2 0.5 0.0 1.7 0.0 0.1 2.0 0.2 0.4 0.2 0.0 0.1 0.4 0.1 0.0 1.1 0.1 0.0 1.1 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 0.0 0.0 0.0 0.1 0.0 30.8 3.9 0.0 0.0 0.0 1.8 53.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.6 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 RGSL1 RGSL2 ENSG00000121446 "Regulator of G protein signaling like 1" A5PLK6 1 182409192-182560599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.6" "Group enriched" "Detected in some" 34 "Early spermatids: 91.5;Late spermatids: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;T-47d: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.33e-1)" "unprognostic (5.20e-2)" "unprognostic (2.07e-1)" "unprognostic (6.47e-2)" "unprognostic (4.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.69e-5)" "unprognostic (2.93e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 91.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 233.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavorable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favorable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 12.3 50.9 44.3 9.2 64.6 12.1 12.1 14.4 68.3 17.9 11.9 18.5 43.8 18.2 8.5 31.8 14.2 22.6 12.5 14.1 48.5 69.1 18.5 21.7 22.1 8.9 33.6 29.9 12.3 23.6 81.3 56.5 10.6 37.1 15.8 9.1 23.0 22.8 57.3 6.0 14.4 12.5 7.0 16.2 9.5 15.3 15.5 10.7 9.5 34.3 4.2 7.6 10.0 9.6 11.1 13.5 76.4 14.0 13.2 27.4 12.2 7.5 25.0 11.2 22.7 6.6 4.3 4.7 4.6 18.1 10.5 8.9 13.5 20.9 2.9 4.1 8.7 22.9 12.3 7.4 5.4 3.2 8.6 14.7 2.5 15.8 12.9 18.2 4.3 23.6 9.4 13.3 11.7 5.3 16.2 6.7 19.4 5.8 18.6 8.9 50.4 8.1 24.1 11.0 14.9 14.3 6.0 7.8 21.7 17.2 13.6 14.9 29.7 17.1 36.3 17.4 9.0 23.7 8.2 6.2 16.4 13.7 10.8 9.4 15.4 5.3 4.5 16.4 6.8 20.0 76.4 14.0 17.6 18.9 13.9 16.6 11.1 21.3 16.7 13.5 10.8 18.0 15.3 24.0 13.2 7.9 11.1 27.4 12.2 44.3 64.6 14.4 68.3 48.5 69.1 33.6 29.9 37.1 10.7 38.7 29.3 20.0 41.3 20.6 34.2 7.7 53.5 46.8 39.8 82.0 31.4 45.1 16.6 79.5 128.0 23.5 40.6 0.0 89.9 35.2 36.2 52.9 189.3 34.5 39.0 17.5 86.2 65.7 29.1 233.4 39.4 32.1 57.3 21.6 32.4 62.9 61.3 31.6 49.5 44.0 27.9 6.5 24.7 38.5 29.7 20.7 43.5 43.7 23.9 42.0 RHBDD3 "C22orf3, PTAG" ENSG00000100263 "Rhomboid domain containing 3" Q9Y3P4 22 29259852-29268209 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043979 Approved Approved Microtubules NA NA Microtubules "HPA043979: AB_10960539" "unprognostic (9.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.22e-1)" "prognostic favorable (2.67e-6)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.13e-3)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (8.46e-2)" "unprognostic (4.42e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.11e-3)" "unprognostic (1.84e-1)" "unprognostic (1.03e-1)" "unprognostic (3.42e-3)" 9.6 16.2 9.0 6.8 10.0 7.9 4.9 13.0 10.1 6.7 7.9 8.1 15.8 14.0 8.8 12.7 6.2 9.0 8.2 7.3 8.9 10.3 7.7 16.4 5.6 8.6 9.2 6.7 6.2 15.4 5.5 11.7 10.9 8.9 11.5 2.7 11.4 10.9 14.2 12.1 7.6 9.7 5.3 8.7 8.2 8.4 17.6 6.9 7.1 8.9 3.5 4.5 5.3 4.1 2.4 13.2 2.2 5.7 3.8 4.7 3.1 3.1 5.3 3.1 8.9 1.0 1.7 17.3 2.0 2.8 2.6 3.2 4.7 7.2 9.0 9.0 2.0 1.5 10.0 1.8 1.6 0.3 11.5 14.4 3.2 4.2 6.0 11.2 7.3 8.3 4.8 4.5 1.1 3.1 1.8 3.5 3.7 3.8 5.9 1.8 6.4 4.6 11.0 14.1 2.0 6.2 8.2 5.6 10.1 1.1 3.3 6.7 3.5 7.1 7.5 8.2 0.8 5.0 6.1 4.9 7.0 3.1 2.9 3.0 14.7 4.4 10.4 2.9 3.1 5.8 0.0 5.7 2.2 3.2 4.7 3.8 2.4 3.1 4.7 5.6 1.3 2.4 3.3 1.8 3.8 4.5 13.2 4.6 3.1 9.0 10.0 13.0 10.1 8.9 10.3 9.2 6.7 8.9 6.9 6.0 6.5 0.0 9.0 5.5 17.8 7.9 12.7 6.7 4.5 14.0 5.9 37.5 0.0 14.8 6.6 7.4 21.0 0.0 17.4 15.1 14.2 14.3 0.0 13.9 22.3 15.9 8.1 16.0 11.4 5.6 13.0 6.6 6.8 10.8 10.2 13.3 12.1 17.3 11.3 5.7 21.4 6.5 7.2 26.8 25.8 5.3 32.0 7.2 14.5 8.0 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Cell line enhanced" "Detected in many" "HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.8 2.3 1.3 2.0 1.0 2.7 6.9 0.8 1.3 0.4 0.1 4.8 1.3 0.7 1.6 0.5 0.2 1.2 0.1 0.4 0.0 1.7 8.7 1.0 9.3 1.9 1.0 1.7 1.3 1.8 3.3 0.3 0.0 1.0 0.1 3.1 1.3 1.3 0.1 9.8 0.4 4.7 1.3 2.5 0.7 8.3 1.2 1.8 0.1 1.6 1.7 2.3 1.0 0.5 2.2 0.9 3.6 4.9 0.5 2.8 2.6 0.9 0.6 11.9 1.6 2.3 1.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 0.0 0.0 0.0 4.2 1.9 12.0 0.8 0.0 8.1 1.2 0.0 11.8 0.2 0.0 0.7 2.0 0.0 3.9 0.0 0.5 0.2 0.9 1.4 0.0 0.8 0.3 14.3 2.4 0.6 1.2 1.1 1.4 0.0 0.0 0.0 4.5 2.0 1.0 3.6 2.5 7.4 35.2 0.0 0.5 0.7 2.1 1.6 0.2 0.0 4.7 1.6 RHBDL3 "RHBDL4, VRHO" ENSG00000141314 "Rhomboid like 3" P58872 17 32266176-32324661 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7" "Group enriched" "Detected in some" 9 "Horizontal cells: 96.9;Rod photoreceptor cells: 33.8" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.9;AF22: 5.9;GAMG: 6.8;HDLM-2: 8.0;NTERA-2: 8.7;U-2 OS: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059607 Uncertain NA NA "HPA059607: AB_2684081" "unprognostic (7.70e-2)" "unprognostic (3.71e-2)" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.91e-1)" "unprognostic (2.83e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "unprognostic (2.18e-3)" "unprognostic (2.11e-1)" "unprognostic (1.23e-1)" "unprognostic (8.87e-2)" 1.0 8.2 6.8 1.2 7.4 0.7 1.1 11.3 23.7 1.4 1.2 2.9 3.3 0.9 2.0 1.9 1.3 4.4 0.9 9.7 10.1 6.6 0.8 0.6 0.7 0.7 9.1 4.6 3.4 1.1 0.6 1.9 1.0 6.7 2.1 1.4 3.9 1.0 5.6 0.6 0.9 0.9 1.8 3.6 0.6 0.9 2.5 4.0 0.0 0.6 0.0 0.8 1.9 1.1 0.8 0.0 0.0 0.0 0.0 0.3 0.3 0.0 5.9 5.9 4.6 0.9 0.0 0.1 0.3 0.6 1.9 1.9 0.1 0.0 0.0 0.4 0.7 6.8 0.1 1.6 0.0 0.5 8.0 2.3 1.0 4.0 0.3 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.3 0.0 0.3 0.5 0.0 0.5 0.1 0.2 0.0 8.7 0.0 0.0 1.0 0.0 0.0 0.0 3.2 0.1 1.5 0.8 0.1 0.1 2.2 0.4 0.1 0.0 0.0 6.1 0.2 2.9 0.0 0.0 0.0 0.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 6.8 7.4 11.3 15.6 10.1 6.6 9.1 4.6 6.7 4.0 0.0 0.0 0.0 0.6 0.3 6.0 4.3 0.0 0.0 0.0 0.0 5.9 1.3 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 96.9 0.0 0.6 0.8 1.5 0.9 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 33.8 0.0 1.0 0.0 0.9 0.1 0.5 0.0 0.0 0.5 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.2 9.5 0.0 4.5 4.0 0.0 2.7 2.5 2.3 3.5 0.3 0.1 0.0 11.7 14.5 1.1 0.1 2.8 0.8 2.7 0.0 2.5 0.5 4.5 34.5 4.9 0.7 0.2 5.7 1.6 1.4 1.4 8.8 10.8 2.0 5.1 0.0 10.1 0.2 2.6 0.0 4.1 0.1 4.1 2.3 13.3 3.2 7.5 0.3 2.6 10.2 3.3 3.6 3.6 6.2 0.7 1.2 9.6 4.4 11.7 0.1 3.0 0.0 0.0 0.0 2.2 2.0 2.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 14.9 8.3 0.0 0.8 1.5 2.7 24.9 2.5 12.0 3.4 1.8 127.6 49.5 1.7 3.2 49.1 7.1 0.6 0.0 13.6 3.6 9.0 1.0 0.0 1.8 10.1 316.2 7.9 16.5 12.3 26.5 7.5 3.2 1.7 0.0 6.7 20.9 14.1 3.4 4.6 30.1 26.0 6.5 4.1 1.6 1.0 1.3 252.8 0.0 2.3 0.2 RIMKLA "FAM80A, MGC47816, NAAGS-II, RP11-157D18.1" ENSG00000177181 "Ribosomal modification protein rimK like family member A" Q8IXN7 1 42380795-42422578 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 33.4;Rod photoreceptor cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;JURKAT: 6.3;Karpas-707: 9.1;SCLC-21H: 11.9;U-266/70: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027826 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027826: AB_10603992" "unprognostic (4.04e-2)" "unprognostic (1.61e-1)" "unprognostic (3.68e-3)" "unprognostic (9.84e-2)" "unprognostic (2.49e-2)" "unprognostic (1.06e-1)" "unprognostic (2.63e-3)" "prognostic favorable (1.43e-4)" "unprognostic (8.89e-2)" "unprognostic (3.76e-1)" "unprognostic (9.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" "unprognostic (7.07e-2)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" 0.9 1.2 6.2 1.5 10.4 0.8 1.3 7.8 18.4 1.0 7.9 1.7 0.0 1.4 1.0 0.8 1.0 0.9 1.8 8.5 7.5 5.9 2.5 0.7 5.4 0.8 7.9 8.5 0.7 2.5 6.6 2.0 1.3 20.1 2.2 9.0 3.3 1.1 1.2 1.4 1.1 1.3 2.4 3.6 1.1 2.1 2.3 1.2 0.0 2.2 0.0 0.8 1.1 0.4 0.3 1.6 1.3 0.2 0.4 2.0 0.1 0.0 0.8 0.1 7.8 0.1 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.2 0.0 1.6 0.0 1.3 0.0 4.6 0.0 0.4 4.1 3.1 0.3 0.1 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 9.1 0.0 0.3 2.1 0.0 4.0 0.6 5.5 0.0 0.3 0.4 0.7 2.1 11.9 5.1 0.4 0.3 0.1 0.9 0.4 2.0 0.0 0.0 0.4 0.0 0.8 8.3 4.7 5.5 0.1 0.0 0.0 1.1 0.2 1.3 0.2 0.2 2.0 0.2 0.1 1.0 0.0 0.3 0.1 0.2 1.0 0.4 0.1 1.6 0.1 0.1 6.2 10.4 7.8 18.4 7.5 5.9 7.9 8.5 20.1 1.2 14.9 4.6 0.0 0.8 0.6 13.2 13.0 0.0 0.0 1.2 1.8 41.2 1.0 1.7 3.2 4.7 0.9 7.8 0.0 4.2 11.6 0.3 2.9 0.0 0.0 0.8 33.4 10.9 1.3 0.0 6.4 0.3 0.8 5.0 0.0 7.5 4.5 6.8 5.9 0.0 2.4 23.9 0.0 0.5 1.0 2.5 0.1 1.4 0.0 5.5 0.7 RIMKLB "FAM80B, KIAA1238, NAAGS, NAAGS-I" ENSG00000166532 "Ribosomal modification protein rimK like family member B" Q9ULI2 12 8681600-8783095 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 171.4;Late spermatids: 230.6;Syncytiotrophoblasts: 114.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 31.2;U-698: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059552 Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA059552: " "unprognostic (5.29e-3)" "unprognostic (2.26e-2)" "unprognostic (1.89e-5)" "unprognostic (2.40e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-2)" "unprognostic (6.56e-2)" "unprognostic (8.52e-2)" "unprognostic (8.67e-3)" "unprognostic (1.76e-1)" "unprognostic (3.25e-1)" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-2)" "unprognostic (3.02e-1)" "unprognostic (3.74e-1)" "unprognostic (3.99e-1)" 22.5 10.7 15.9 10.7 19.2 15.8 20.1 23.3 21.2 18.1 17.6 16.4 11.2 5.1 35.9 18.2 10.4 25.4 12.5 10.7 17.6 12.8 9.2 3.2 13.9 7.6 10.2 19.0 22.7 7.3 36.2 10.1 21.2 19.9 11.7 6.5 18.0 9.0 13.5 9.5 8.8 8.7 25.5 14.0 11.5 7.7 27.8 12.1 13.6 15.6 4.8 6.4 11.8 18.4 4.0 1.3 5.3 2.9 2.8 3.9 2.5 1.2 7.1 16.5 17.5 2.2 2.0 23.5 6.9 3.3 5.8 4.0 0.6 7.5 10.3 6.5 4.5 6.5 2.6 8.3 9.2 6.5 0.1 5.1 4.8 20.1 0.0 2.6 1.4 4.9 4.3 4.1 5.5 9.6 4.0 7.5 8.7 6.6 0.0 3.6 4.3 9.5 0.6 19.4 0.0 0.4 14.9 22.5 0.0 8.9 3.6 0.5 10.8 7.6 9.8 6.7 31.2 2.1 4.7 14.1 6.1 20.4 3.2 2.2 0.1 0.0 52.5 5.3 0.9 4.2 5.3 2.9 1.2 2.4 1.1 3.0 2.2 2.4 3.5 1.2 4.0 3.9 1.5 0.7 2.8 1.4 1.3 0.1 2.5 15.9 19.2 23.3 19.5 17.6 12.8 10.2 19.0 19.9 12.1 26.8 40.5 5.0 21.6 13.5 20.8 13.7 10.2 41.5 35.2 12.2 0.0 49.9 13.3 12.1 171.4 30.3 2.0 23.3 2.6 14.1 23.7 15.5 11.5 0.0 16.2 12.7 8.6 20.3 7.5 230.6 21.6 7.7 32.1 1.0 2.5 35.5 5.6 2.9 29.0 7.9 3.1 12.9 22.8 49.1 26.8 11.7 114.2 5.1 1.0 15.0 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867834-38878279 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 17.3;Karpas-707: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favorable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 5.5 3.7 6.3 10.2 10.3 5.4 10.4 6.5 5.8 2.6 3.9 4.2 6.2 3.4 1.8 2.4 5.3 4.6 6.1 3.9 5.1 6.4 5.0 6.0 7.0 20.4 5.5 3.8 1.7 17.4 4.9 5.7 3.3 5.5 2.6 3.5 5.9 7.9 4.5 3.0 3.2 6.3 2.6 4.5 13.0 6.1 1.4 3.5 7.6 6.4 3.1 15.7 4.3 2.9 16.6 12.3 3.1 2.1 4.1 8.7 2.9 0.0 1.4 0.4 0.2 0.6 0.3 2.6 0.3 0.2 0.3 0.4 2.3 7.0 7.9 3.7 0.4 0.1 0.2 1.3 3.0 0.4 1.7 0.8 9.8 2.0 5.0 1.7 5.5 17.3 1.6 0.6 0.9 0.6 0.3 3.5 6.1 2.0 20.3 0.0 1.2 1.7 3.9 0.6 4.1 0.3 1.1 0.1 5.9 1.9 0.2 2.6 1.1 3.2 5.2 2.8 0.4 0.6 6.7 2.2 0.1 1.5 0.4 0.0 8.7 7.2 6.2 0.6 3.1 0.4 3.1 0.9 1.5 8.7 2.1 5.5 12.4 5.8 6.3 1.6 16.6 4.6 5.4 2.8 4.1 2.0 12.3 6.1 2.9 6.3 10.3 6.5 5.8 5.1 6.4 5.5 3.8 5.5 3.5 3.0 7.7 15.2 4.6 2.9 3.2 3.0 12.7 1.4 1.2 3.5 7.9 11.3 6.6 5.6 0.4 6.8 0.0 0.0 6.2 5.5 3.8 2.2 15.0 5.4 7.9 0.0 6.9 8.6 5.9 0.4 2.8 5.0 10.1 10.8 0.3 4.8 4.8 1.7 2.5 8.1 10.5 0.0 1.9 2.9 1.8 3.3 3.4 24.5 1.0 3.0 RNASE10 "RAH1, RNASE9" ENSG00000182545 "Ribonuclease A family member 10 (inactive)" Q5GAN6 14 20505537-20511169 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Fertilization" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "head and neck cancer: 2.0;testis cancer: 1.8" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 9.0;U-2 OS: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052593 Uncertain "Secreted in male reproductive system" NA NA "HPA052593: AB_2681878" "unprognostic (2.48e-3)" "unprognostic (2.22e-1)" "unprognostic (2.46e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (5.91e-3)" "unprognostic (5.03e-3)" "unprognostic (5.58e-3)" "unprognostic (4.20e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-3)" "unprognostic (1.11e-1)" "unprognostic (7.88e-4)" "unprognostic (1.58e-1)" "unprognostic (3.62e-1)" "unprognostic (8.76e-2)" "unprognostic (2.58e-1)" 3.1 3.2 0.9 2.3 1.1 1.4 1.2 1.4 2.0 1.5 1.0 2.5 3.5 1.6 2.0 3.0 0.7 0.9 1.0 1.0 1.5 2.4 2.5 0.9 1.1 2.6 1.1 0.5 1.7 1.1 1.8 0.2 1.4 0.9 3.0 4.2 2.7 0.5 1.3 1.9 1.7 3.4 1.6 0.2 1.8 1.7 0.9 1.3 3.5 1.3 0.6 0.5 0.1 5.5 2.7 1.1 2.6 0.3 0.6 3.6 0.3 0.6 0.1 0.4 1.8 1.6 0.8 1.8 0.7 0.8 2.9 0.0 0.3 0.2 2.3 0.9 0.1 1.9 0.9 0.8 0.3 2.8 0.9 2.0 0.2 3.0 0.5 1.4 1.0 1.3 3.2 0.0 1.5 0.9 1.6 0.8 0.8 0.4 4.3 0.4 3.3 0.9 2.3 1.6 1.9 9.0 2.3 1.0 1.3 2.2 0.9 0.6 1.0 14.8 1.2 1.1 3.1 1.4 0.4 1.1 0.8 1.2 3.5 0.5 0.0 0.5 0.4 0.4 0.9 0.4 0.2 0.1 0.8 0.2 0.5 2.1 0.6 1.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 RNASE11 "C14orf6, RAJ1" ENSG00000173464 "Ribonuclease A family member 11 (inactive)" Q8TAA1 14 20583559-20609884 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 18 "epididymis: 106.3;testis: 33.6" "Group enriched" "Detected in some" 53 "Early spermatids: 32.3;Late spermatids: 41.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 2.8;RPMI-8226: 1.5;SH-SY5Y: 1.4;U-937: 1.2" HPA003724 Uncertain "Secreted in male reproductive system" NA NA "HPA003724: AB_1079817" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 106.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RNASE12 RAI1 ENSG00000258436 "Ribonuclease A family member 12 (inactive)" Q5GAN4 14 20590193-20590823 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 43 "epididymis: 143.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NB-4: 3.7;SH-SY5Y: 1.2" "HPA044175, HPA059465" Enhanced "Secreted in male reproductive system" NA NA "HPA044175: AB_10960390, HPA059465: AB_2732638" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE13 RAL1 ENSG00000206150 "Ribonuclease A family member 13 (inactive)" Q5GAN3 14 21032820-21034785 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "epididymis: 95.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "unprognostic (2.54e-1)" "unprognostic (2.52e-1)" "unprognostic (2.86e-1)" "unprognostic (8.40e-2)" "unprognostic (1.93e-1)" "unprognostic (7.15e-2)" "unprognostic (1.63e-3)" "unprognostic (5.20e-4)" "unprognostic (1.47e-2)" 0.5 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 95.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.8 0.5 0.2 0.2 0.2 0.2 0.9 0.0 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 0.5 0.5 0.2 0.2 0.2 1.9 0.0 1.8 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASEK MGC71993 ENSG00000219200 "Ribonuclease K" Q6P5S7 17 7012417-7014532 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 97.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044708 Uncertain NA NA "HPA044708: AB_10962051" "unprognostic (7.59e-2)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "unprognostic (5.92e-2)" "unprognostic (9.73e-3)" "unprognostic (4.82e-2)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (6.50e-3)" "prognostic favorable (1.92e-4)" "unprognostic (2.93e-3)" "unprognostic (1.72e-3)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.14e-1)" "unprognostic (2.33e-3)" 61.6 116.2 79.8 55.0 81.4 86.1 114.0 49.9 121.1 56.4 50.2 41.5 64.3 54.0 50.7 51.3 60.4 67.0 65.9 90.9 79.4 95.6 92.6 85.2 111.9 141.9 76.7 69.2 57.2 72.7 61.5 98.7 56.3 76.3 53.3 41.6 51.0 69.4 64.6 74.0 60.1 50.2 50.5 82.8 80.7 51.0 61.3 34.7 62.8 64.6 56.6 55.5 63.2 47.0 52.7 92.8 191.8 97.9 34.9 39.2 73.7 33.2 55.9 25.3 43.1 66.0 59.9 22.6 34.6 62.2 45.9 52.1 23.5 31.6 23.9 35.1 67.3 54.2 50.1 31.0 42.6 24.8 48.0 81.5 23.6 45.6 38.0 75.8 14.7 117.7 74.6 51.8 53.9 30.9 50.5 54.3 26.2 20.5 51.4 54.7 31.5 20.2 49.2 17.4 27.1 48.9 24.0 14.5 27.3 59.2 29.9 13.0 46.5 29.4 21.1 61.2 25.9 27.3 26.9 49.2 48.5 21.0 59.7 43.3 42.0 41.0 10.2 75.4 34.4 39.3 67.6 97.9 114.1 35.0 86.6 34.7 52.7 39.2 35.4 73.9 49.1 31.9 30.5 191.8 34.9 81.4 92.8 38.4 73.7 79.8 81.4 49.9 121.1 79.4 95.6 76.7 69.2 76.3 34.7 53.6 59.1 23.1 6.8 18.2 14.5 0.4 10.2 97.7 78.5 5.2 39.3 4.5 3.3 14.4 4.5 17.3 18.2 0.0 4.8 2.6 14.5 9.2 50.0 14.0 12.8 11.1 12.7 25.8 72.0 4.1 8.3 36.6 20.3 38.7 7.7 8.9 12.8 12.7 6.0 3.0 32.2 25.8 10.3 3.7 0.7 19.1 9.8 32.4 9.3 10.5 RNF122 FLJ12526 ENSG00000133874 "Ring finger protein 122" Q9H9V4 8 33547755-33567125 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 66.3" "Cell type enhanced" "Detected in many" 5 "Ito cells: 5.5;Kupffer cells: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 39.7;Karpas-707: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003888 Uncertain NA NA "HPA003888: AB_1079822" "unprognostic (2.36e-2)" "unprognostic (3.13e-1)" "unprognostic (2.09e-2)" "unprognostic (9.19e-3)" "unprognostic (2.46e-1)" "unprognostic (8.78e-3)" "unprognostic (1.71e-2)" "unprognostic (5.46e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (6.95e-2)" "prognostic favorable (5.37e-4)" "prognostic unfavorable (4.50e-7)" "unprognostic (4.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (7.15e-2)" 23.6 14.6 2.3 15.9 5.9 6.5 13.4 16.7 4.4 8.3 8.2 3.2 3.1 2.5 8.8 10.3 9.3 20.0 13.3 28.5 6.7 2.1 4.4 7.1 25.0 10.1 4.3 0.7 66.3 5.6 3.4 3.2 2.8 12.3 12.8 5.1 5.5 5.1 5.8 31.9 6.4 8.3 14.4 14.4 13.3 7.9 9.6 2.5 8.1 4.3 17.3 11.4 20.6 11.8 5.0 14.2 7.4 9.9 1.8 1.6 0.3 0.3 2.1 10.6 4.4 0.9 0.3 1.4 0.6 1.0 1.3 2.2 0.3 0.4 4.9 3.2 1.6 1.8 0.4 2.3 0.9 0.7 0.3 39.7 1.0 0.5 2.8 0.6 0.3 8.1 1.0 0.8 0.7 0.5 2.2 4.2 4.3 1.0 25.7 1.1 0.9 4.3 3.3 5.8 1.5 1.2 4.7 2.0 3.8 1.5 0.6 2.1 11.9 0.7 0.3 1.6 3.9 0.4 1.3 2.4 1.8 1.7 3.3 0.7 10.3 5.8 9.0 1.1 1.3 0.2 4.6 0.9 7.4 1.5 4.5 1.3 2.9 0.9 1.1 0.8 5.0 1.5 1.6 6.7 1.8 9.9 14.2 0.6 0.3 2.3 5.9 16.7 4.4 6.7 2.1 4.3 0.7 12.3 2.5 0.0 1.1 1.5 0.5 3.8 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.0 3.5 0.3 0.0 0.6 0.4 4.1 0.3 0.0 0.0 1.4 0.0 0.0 5.5 6.0 0.8 1.4 2.2 0.0 0.0 0.4 0.8 0.9 0.8 1.1 0.6 1.4 0.0 4.1 0.0 0.9 1.8 0.0 0.7 0.6 1.0 RNF133 ENSG00000188050 "Ring finger protein 133" Q8WVZ7 7 122697712-122699156 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 28.3" "Group enriched" "Detected in some" 104 "Early spermatids: 461.8;Late spermatids: 540.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;MCF7: 1.5;NTERA-2: 1.2;PC-3: 1.1;U-266/70: 1.1" "Not detected" "Not detected" NA NA "unprognostic (2.82e-1)" "unprognostic (2.52e-2)" "unprognostic (1.77e-1)" "unprognostic (3.04e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.87e-3)" "unprognostic (3.56e-2)" "unprognostic (3.72e-1)" "unprognostic (3.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.02e-2)" "unprognostic (7.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.39e-1)" "unprognostic (2.37e-2)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 4.1 0.0 1.5 0.0 0.0 1.2 0.5 1.1 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 540.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.8 1.5 0.0 0.0 0.0 0.0 0.0 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.3 20.1 31.0 37.2 32.8 14.6 6.0 16.3 28.5 15.1 24.6 6.9 16.9 7.0 29.4 14.3 28.8 26.7 24.4 21.5 26.7 28.8 8.7 14.7 22.9 5.7 14.1 9.7 14.1 9.0 38.9 14.1 20.7 21.2 14.8 17.1 14.6 27.1 14.2 0.5 11.0 3.0 13.4 6.4 10.3 14.7 13.5 14.0 20.2 7.0 11.3 20.9 16.5 17.7 26.8 22.1 12.4 8.9 15.8 17.0 15.6 13.6 28.9 6.0 8.3 6.5 19.8 12.1 36.3 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 104.2 213.5 76.8 93.4 109.1 103.7 10.0 79.0 48.2 106.9 34.9 55.0 2.7 16.6 63.7 22.1 50.7 48.5 46.7 99.7 20.5 58.0 100.6 68.1 16.3 39.0 108.1 52.0 127.7 90.9 29.9 42.8 54.8 62.4 223.6 41.8 63.1 90.1 51.8 48.8 8.4 48.6 45.3 49.5 14.9 33.0 86.9 9.2 73.0 57.2 150.2 RNF148 MGC35222 ENSG00000235631 "Ring finger protein 148" Q8N7C7 7 122701664-122702967 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 31.0" "Cell type enriched" "Detected in some" 9 "Early spermatids: 297.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 7.4;MCF7: 2.8;OE19: 1.6;RPMI-8226: 1.8;SK-BR-3: 1.6" "Not detected" "Not detected" NA NA "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (3.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.85e-1)" "unprognostic (3.23e-2)" "unprognostic (1.04e-2)" "unprognostic (9.81e-2)" "unprognostic (8.48e-2)" "unprognostic (2.14e-2)" "unprognostic (2.18e-1)" "unprognostic (2.37e-1)" "unprognostic (3.33e-2)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-2)" "unprognostic (1.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.0 0.0 7.4 0.0 2.8 0.0 0.0 1.0 1.6 0.8 0.0 0.0 1.8 0.0 0.6 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 1.3 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 297.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 34.3 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 6.5 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.1 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 255.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.7 5.8 4.4 5.5 16.5 16.6 25.7 12.1 15.9 16.4 18.5 14.5 25.8 2.9 14.7 11.9 21.7 19.9 6.2 12.3 15.3 8.4 8.5 6.0 5.1 24.5 22.1 6.5 9.8 15.1 20.3 19.4 12.9 12.6 29.8 6.4 5.3 9.1 16.4 8.3 8.7 6.5 3.0 13.2 10.5 5.7 7.3 11.2 19.3 23.9 5.8 4.3 7.3 18.1 17.5 5.0 4.9 8.8 19.7 8.3 4.7 12.4 2.6 18.4 10.8 0.1 2.7 9.1 6.1 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 44.7 56.9 34.7 63.4 68.3 20.3 10.6 48.4 24.1 23.9 52.4 53.0 48.5 1.7 48.9 61.2 33.8 33.9 0.0 36.5 60.6 44.7 62.7 37.1 38.9 76.7 7.9 8.2 28.8 255.2 27.7 28.4 171.2 38.8 16.2 35.9 11.9 49.2 36.6 18.4 25.1 19.7 58.2 44.3 31.2 36.2 80.0 107.1 69.8 31.9 137.0 RNF150 KIAA1214 ENSG00000170153 "Ring finger protein 150" Q9ULK6 4 140859807-141212877 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 45.5;Cardiomyocytes: 62.2;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 67.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;fHDF/TERT166: 17.7;SH-SY5Y: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037987 Uncertain "Intracellular and membrane" NA NA "HPA037987: AB_10669512" "prognostic favorable (1.41e-4)" "unprognostic (1.95e-2)" "unprognostic (8.26e-3)" "unprognostic (2.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.38e-2)" "unprognostic (2.38e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (9.32e-2)" "unprognostic (3.10e-3)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (3.88e-3)" "unprognostic (9.68e-2)" "unprognostic (1.32e-3)" "unprognostic (2.41e-2)" 12.3 14.4 9.2 4.1 26.2 0.9 7.6 13.2 9.6 12.2 18.9 2.5 5.1 1.5 14.1 13.0 8.3 14.5 4.4 18.6 8.0 5.1 10.3 1.5 2.0 3.6 3.2 6.7 12.8 2.8 0.9 18.1 2.6 4.7 10.2 4.8 17.2 30.3 13.6 18.9 1.6 5.0 19.2 4.4 7.7 6.3 2.3 3.8 0.6 7.3 5.9 3.7 12.4 5.8 0.1 0.9 0.4 1.1 0.1 0.1 0.1 0.2 0.3 3.2 2.9 13.8 1.0 0.1 5.6 2.3 1.8 0.8 0.0 0.1 0.0 0.7 17.7 0.1 0.0 7.1 0.1 1.0 0.0 3.4 0.0 7.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 1.1 0.0 3.5 0.0 0.1 0.6 0.1 3.6 0.1 1.8 0.0 1.3 2.1 8.3 0.1 1.9 0.0 1.5 25.7 0.4 0.2 1.2 1.7 0.1 0.0 0.0 9.1 3.8 5.9 2.5 0.2 0.0 0.0 0.1 0.0 6.7 0.4 1.1 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.9 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 9.2 26.2 13.2 9.6 8.0 5.1 3.2 6.7 4.7 3.8 0.0 0.3 0.0 0.6 1.0 45.5 62.2 2.5 0.0 3.4 10.4 106.0 0.5 1.7 0.3 3.0 1.9 0.0 0.0 0.5 0.1 2.7 0.9 0.0 0.0 0.5 25.4 1.7 2.5 0.6 1.1 26.4 0.5 0.0 0.0 0.0 11.5 0.1 0.0 17.0 1.1 67.8 12.9 18.4 0.0 1.5 0.5 0.3 0.0 0.0 0.0 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.2 6.8 5.3 8.4 2.6 2.2 10.1 4.3 2.8 5.1 2.3 4.6 2.7 5.1 5.6 2.5 2.9 4.7 3.1 2.8 2.0 2.6 9.2 6.9 5.0 7.7 6.9 6.8 8.8 2.6 2.7 4.0 3.3 2.8 5.3 8.7 11.5 3.8 2.1 8.3 15.9 44.6 8.7 1.8 9.1 14.9 3.3 13.2 2.3 1.9 4.9 5.5 9.8 2.0 5.3 2.7 5.8 23.3 7.3 3.8 5.7 5.7 5.1 8.6 5.0 12.4 3.4 25.9 5.3 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 8.9 5.1 15.7 4.7 4.2 10.1 2.4 7.6 1.4 3.4 7.0 5.9 7.4 8.3 5.2 1.1 8.0 2.0 0.0 8.0 7.5 8.2 3.6 20.7 4.0 34.7 7.9 4.7 10.4 37.7 1.8 8.6 37.5 10.1 11.8 2.7 8.9 4.6 0.0 7.4 5.6 8.6 6.5 7.1 9.4 8.6 5.1 3.1 66.8 4.1 1.3 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165844-64372869 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 54.0" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol NA NA Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favorable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 8.1 8.1 9.9 3.1 12.8 1.6 6.3 6.0 13.0 10.1 7.1 5.5 20.1 3.4 12.7 11.8 6.9 8.1 7.3 10.4 7.4 10.6 12.4 7.2 6.1 3.4 9.4 9.3 12.0 6.6 54.0 16.1 2.0 10.7 11.5 3.0 11.3 7.3 16.4 4.4 6.6 3.2 15.0 11.0 5.1 5.0 8.1 7.1 0.0 20.6 2.5 2.4 10.9 7.9 2.4 1.0 4.2 1.8 2.0 4.2 0.3 0.0 0.1 1.3 0.0 0.0 0.0 0.3 1.1 0.5 1.1 0.6 0.0 0.1 0.0 0.1 0.8 0.6 0.2 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.1 2.7 0.0 0.1 5.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.5 0.0 1.3 0.1 3.3 25.4 1.9 0.3 0.3 0.1 0.0 0.3 0.0 1.7 1.3 0.1 0.1 0.0 3.2 0.1 2.9 0.0 0.0 0.0 0.5 0.0 3.6 3.0 1.8 4.2 1.9 0.6 2.5 1.4 3.0 3.2 0.6 2.4 4.2 3.9 2.6 2.0 0.8 1.0 1.8 0.3 9.9 12.8 6.0 11.7 7.4 10.6 9.4 9.3 10.7 7.1 14.9 10.5 0.0 6.5 4.0 16.5 9.6 12.7 2.7 7.9 15.7 13.7 0.0 6.6 4.5 3.7 5.6 0.0 0.0 2.3 0.1 2.5 5.0 0.0 5.4 0.1 11.1 1.2 12.3 1.2 5.5 31.9 0.2 5.0 0.0 1.6 32.9 2.8 0.6 23.7 14.3 17.3 38.8 17.9 15.4 9.7 6.5 0.0 0.0 0.1 3.8 RNF186 FLJ20225 ENSG00000178828 "Ring finger protein 186" Q9NXI6 1 19814029-19815278 "Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 83.2;Mucus-secreting cells: 32.9;Paneth cells: 108.7;Proximal tubular cells: 98.1;Undifferentiated cells: 113.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034547, HPA035558" Enhanced NA NA "HPA034547: AB_10670975, HPA035558: AB_2674678" "unprognostic (1.66e-2)" "unprognostic (2.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.93e-3)" "unprognostic (1.77e-3)" "unprognostic (3.23e-1)" "unprognostic (3.05e-1)" "unprognostic (3.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (1.40e-1)" "unprognostic (8.60e-3)" 0.2 0.1 0.1 7.8 0.1 0.0 0.8 0.1 0.1 0.2 38.2 0.0 0.5 47.1 0.2 25.8 0.2 0.2 0.1 0.1 0.1 0.1 44.0 0.7 0.1 0.0 0.1 0.0 0.3 30.5 0.0 0.2 0.0 0.0 0.6 5.4 0.0 0.2 0.0 0.1 0.2 59.0 0.0 0.1 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.5 6.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.9 0.0 0.0 17.2 0.0 16.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 7.1 108.7 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.9 0.1 RNF212 "FLJ38841, LOC285498" ENSG00000178222 "Ring finger protein 212" Q495C1 4 1056250-1113562 "Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 18.1" "Group enriched" "Detected in many" 4 "Distal tubular cells: 53.0;Spermatocytes: 40.2;Spermatogonia: 38.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 8.5;HeLa: 26.0;JURKAT: 13.1;SiHa: 15.6" HPA057527 Uncertain NA NA "HPA057527: AB_2683457" "unprognostic (2.75e-2)" "prognostic favorable (1.39e-4)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (1.10e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "unprognostic (1.33e-1)" "unprognostic (2.09e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (8.36e-2)" "unprognostic (1.60e-1)" "unprognostic (5.52e-2)" "unprognostic (1.05e-1)" 2.9 1.9 3.1 1.7 8.4 4.5 3.9 11.4 4.7 4.6 2.4 4.3 2.0 1.2 2.7 4.3 2.4 4.0 2.1 1.3 2.4 1.6 4.7 0.6 2.9 2.7 3.4 1.1 8.8 13.0 0.8 18.1 1.0 5.3 3.3 1.8 3.6 4.2 1.4 1.9 4.4 1.8 2.2 4.1 1.9 2.6 12.1 2.1 0.5 8.2 1.0 1.9 1.4 3.0 2.1 1.2 0.1 0.7 0.4 3.8 0.9 8.5 0.5 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 3.8 0.1 0.0 2.2 0.0 2.1 0.0 0.0 0.0 13.1 0.1 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.9 0.0 15.6 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 2.2 0.7 1.8 0.6 3.8 1.0 1.2 2.1 3.8 1.2 0.0 0.4 0.0 0.4 1.1 0.9 3.1 8.4 11.4 4.7 2.4 1.6 3.4 1.1 5.3 2.1 3.0 5.8 0.0 5.2 2.5 2.3 0.5 0.0 2.7 10.3 0.0 2.0 0.0 53.0 2.7 3.4 0.5 0.1 0.0 0.8 0.1 5.8 3.6 4.6 0.0 0.5 0.0 4.7 0.0 0.0 5.1 7.8 1.6 0.0 1.0 2.3 4.5 1.0 1.4 0.7 6.0 5.7 0.0 2.0 40.2 38.5 2.8 0.2 0.5 0.7 3.8 RNF212B C14orf164 ENSG00000215277 "Ring finger protein 212B" A8MTL3 14 23185316-23273477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "kidney: 24.3;testis: 7.5" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 25.0;Late spermatids: 7.6;Proximal tubular cells: 14.6;Spermatocytes: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CAPAN-2: 2.6;Daudi: 3.8;hTERT-RPE1: 1.8;Karpas-707: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" HPA053574 Uncertain NA NA "HPA053574: AB_2682195" "unprognostic (2.88e-1)" "unprognostic (2.17e-1)" "unprognostic (4.65e-1)" "unprognostic (8.54e-2)" "unprognostic (1.30e-1)" "unprognostic (4.79e-1)" "unprognostic (4.48e-2)" "unprognostic (2.98e-2)" "unprognostic (3.82e-1)" "unprognostic (1.83e-2)" "unprognostic (4.96e-3)" "unprognostic (4.45e-1)" "unprognostic (7.33e-5)" "unprognostic (9.60e-2)" "unprognostic (3.40e-1)" "unprognostic (7.56e-2)" "unprognostic (5.39e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 7.5 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 2.6 3.8 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 0.2 2.6 0.0 0.8 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.2 0.0 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.6 0.9 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.4 14.6 0.2 0.0 0.1 14.2 4.2 0.0 0.0 0.0 0.0 0.0 RNF217 "C6orf172, dJ84N20.1, IBRDC1, MGC26996" ENSG00000146373 "Ring finger protein 217" Q8TC41 6 124962545-125092633 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 63.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9;myeloid DC: 1.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029598 Uncertain NA NA "HPA029598: AB_10602297" "unprognostic (2.96e-2)" "unprognostic (2.34e-3)" "unprognostic (8.07e-2)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (7.22e-3)" "unprognostic (4.94e-2)" "unprognostic (6.69e-2)" "unprognostic (2.47e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (4.60e-5)" "unprognostic (8.29e-4)" "unprognostic (2.16e-1)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.92e-4)" 9.6 3.5 3.3 4.2 4.7 10.5 14.6 3.8 3.5 8.0 7.7 5.7 6.4 2.3 5.9 5.6 6.2 7.5 12.1 6.5 3.8 1.7 2.5 6.3 7.3 3.7 4.3 2.9 11.5 3.8 63.3 4.0 12.0 3.4 6.4 2.3 6.0 6.0 6.9 10.1 10.9 3.1 13.0 2.3 2.6 4.5 7.4 5.7 0.1 7.4 3.6 1.6 8.7 13.6 0.0 1.2 0.6 1.9 0.3 0.2 0.3 4.1 4.3 1.5 0.5 5.4 2.1 8.6 5.7 7.7 3.9 5.1 0.0 3.9 0.0 8.0 5.4 8.9 6.0 0.9 5.1 5.5 0.0 4.8 2.3 6.4 1.3 5.2 0.0 0.2 5.9 4.8 2.9 8.6 4.6 4.4 0.0 11.6 0.0 6.8 0.0 0.0 0.0 1.3 0.0 1.1 0.1 6.0 0.0 4.0 1.9 0.7 0.0 2.5 0.6 2.2 4.4 4.2 0.7 6.9 3.2 10.4 0.0 12.2 0.0 0.0 0.0 2.4 0.0 3.8 0.6 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.3 3.3 4.7 3.8 3.5 3.8 1.7 4.3 2.9 3.4 5.7 20.8 16.0 0.0 12.7 42.7 6.2 12.5 2.5 5.3 10.3 5.2 15.7 15.2 0.0 6.8 92.0 15.0 1.7 0.0 8.3 23.6 21.6 10.4 1.1 24.6 8.5 20.6 2.9 14.1 12.9 49.9 23.9 13.3 18.6 2.8 3.0 4.0 10.7 0.0 19.8 1.9 5.0 6.5 12.3 1.4 2.6 41.0 15.0 0.5 2.7 9.7 RNF223 ENSG00000237330 "Ring finger protein 223" E7ERA6 1 1070966-1074307 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 16.4;Urothelial cells: 31.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 11.9;CAPAN-2: 8.9;HaCaT: 5.6;MCF7: 19.0;OE19: 5.5;SK-BR-3: 13.0;T-47d: 8.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (4.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.08e-5)" "unprognostic (3.50e-1)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (3.91e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-3)" "unprognostic (1.50e-1)" "unprognostic (1.16e-1)" "unprognostic (4.58e-1)" "unprognostic (9.52e-3)" 0.0 0.0 0.0 1.4 0.0 0.4 0.8 0.0 0.5 8.3 1.4 0.0 0.0 0.4 1.0 0.3 28.8 0.2 1.9 0.0 0.0 0.0 0.6 0.3 0.9 0.1 0.0 0.0 0.0 1.0 0.1 0.0 6.5 0.0 4.2 0.8 0.0 3.3 0.4 0.7 3.5 0.2 2.6 0.0 0.2 7.8 0.1 0.0 0.0 0.2 14.8 17.1 4.9 9.3 0.6 0.6 1.9 0.4 0.3 0.4 0.0 11.9 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 8.9 0.0 0.1 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.0 0.0 0.1 0.0 5.5 0.2 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 13.0 0.2 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.4 0.2 0.3 0.1 0.1 0.3 0.2 0.4 0.0 0.6 0.2 0.4 0.9 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 6.4 0.5 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.2 0.0 6.7 0.0 0.0 5.1 0.0 2.8 16.4 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 9.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.2 0.0 2.8 31.4 RNF44 KIAA1100 ENSG00000146083 "Ring finger protein 44" Q7L0R7 5 176526697-176538025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 100.6;Late spermatids: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038981: AB_10674846" "unprognostic (1.85e-1)" "unprognostic (3.07e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.57e-7)" "unprognostic (1.50e-1)" "unprognostic (2.56e-2)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" "unprognostic (4.54e-2)" "unprognostic (5.36e-2)" "unprognostic (5.78e-2)" "unprognostic (1.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-3)" "unprognostic (1.62e-1)" "unprognostic (5.12e-3)" "unprognostic (1.15e-2)" 10.8 12.7 16.5 27.1 17.7 38.5 12.4 27.1 21.6 10.3 14.8 14.3 7.3 20.5 12.6 10.0 17.0 12.1 12.4 10.0 15.7 10.9 15.2 9.3 14.1 34.9 14.6 13.7 17.8 16.0 10.3 11.0 20.6 13.4 12.8 13.5 11.1 15.9 10.8 10.2 20.5 22.2 8.6 14.5 38.1 16.4 14.5 16.1 43.3 17.3 7.5 24.1 14.1 13.3 4.1 1.9 9.4 3.1 3.3 5.5 2.6 3.7 8.6 13.8 12.8 2.7 2.3 37.0 2.2 1.9 1.4 1.9 13.0 8.3 7.2 13.6 1.2 6.7 10.2 6.1 13.1 1.7 27.7 10.8 7.6 7.3 12.0 3.5 8.8 10.6 4.4 10.6 1.6 5.0 4.8 4.0 14.0 8.5 10.8 2.0 13.0 20.5 19.9 18.2 4.9 10.6 8.4 3.6 10.3 5.0 8.8 17.0 20.7 3.3 9.1 12.5 9.5 10.0 17.8 6.6 3.7 5.6 3.0 4.0 13.8 10.3 9.8 1.8 18.3 4.8 0.0 2.7 4.7 5.5 3.1 4.1 3.5 4.2 4.6 1.8 4.1 4.2 5.0 9.4 3.3 2.5 1.9 5.0 2.6 16.5 17.7 27.1 21.6 15.7 10.9 14.6 13.7 13.4 16.1 11.9 29.4 27.6 8.3 35.7 14.8 11.0 17.8 8.1 15.9 12.2 9.8 8.2 6.6 10.2 100.6 18.0 25.7 0.0 13.9 10.1 10.4 14.5 15.1 8.7 13.1 27.0 39.1 15.4 41.2 305.8 18.4 19.0 5.0 7.2 38.5 8.8 18.6 20.1 11.7 8.4 7.7 6.5 7.2 3.4 10.0 43.3 10.1 35.5 34.0 12.3 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA064161: AB_2685202" "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.2 4.8 15.6 0.2 0.0 8.0 0.6 0.7 1.9 1.7 3.6 1.8 8.1 2.3 0.1 2.4 1.9 10.2 0.7 1.9 7.6 5.1 1.5 7.4 4.9 2.1 0.6 4.7 0.2 0.2 3.2 1.0 1.6 0.3 5.7 6.2 2.9 0.2 7.8 7.8 1.9 4.8 2.0 1.8 5.1 2.7 4.1 3.7 1.9 7.4 6.7 2.3 1.2 2.2 3.3 7.3 1.8 0.5 1.3 5.3 3.1 3.1 3.7 12.2 8.4 5.9 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 0.0 0.3 0.0 0.2 0.0 15.3 0.8 2.5 1.4 0.0 7.0 15.7 2.7 0.0 0.8 40.0 2.1 0.4 0.0 0.2 2.3 0.6 0.3 0.0 0.0 1.8 9.5 4.1 0.0 2.2 40.6 0.6 1.0 1.7 1.0 0.4 6.9 0.7 0.0 1.4 0.8 8.9 0.0 0.4 2.6 3.6 0.0 1.4 0.0 0.6 0.1 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.1" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.7 0.2 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.5 0.0 0.0 1.2 0.0 7.9 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.2 0.3 0.3 0.0 0.7 0.0 RPL3L ENSG00000140986 "Ribosomal protein L3 like" Q92901 16 1943974-1957606 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 115.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049136 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049136: AB_2680648" "unprognostic (2.53e-1)" "unprognostic (2.63e-2)" "unprognostic (9.27e-4)" "unprognostic (6.38e-4)" "unprognostic (4.36e-2)" "unprognostic (3.48e-3)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.46e-2)" "unprognostic (4.53e-3)" "unprognostic (3.32e-1)" "unprognostic (4.24e-1)" "unprognostic (8.32e-3)" "unprognostic (4.60e-2)" 1.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 1.4 0.0 0.1 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.8 0.0 148.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 36.7 2.1 0.0 0.0 1.8 1.7 4.9 1.5 0.9 1.4 0.5 2.1 2.5 0.6 2.3 0.1 0.1 1.5 1.0 0.0 0.1 0.0 7.8 4.2 1.3 1.4 0.0 1.9 2.1 0.2 0.2 0.0 1.0 1.3 0.8 1.7 2.7 0.0 0.5 0.9 0.2 0.3 0.2 0.2 1.5 0.0 1.4 0.8 5.8 0.1 1.3 1.6 1.9 1.3 2.3 5.0 0.7 0.7 1.8 0.3 0.8 3.4 1.0 1.0 2.8 1.2 1.5 1.4 1.1 1.2 1.2 2.9 1.6 0.8 2.5 1.2 1.2 1.7 0.6 0.4 1.6 1.5 1.3 1.4 1.1 0.9 1.4 1.1 1.2 0.5 1.8 1.2 1.4 4.9 0.9 1.0 1.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 115.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.3 0.4 0.0 0.0 0.0 0.4 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979248 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 27.0" "Cell type enriched" "Detected in some" 9 "Intestinal endocrine cells: 30.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 2.6;Daudi: 16.2;HEK 293: 5.0;NTERA-2: 2.5;SCLC-21H: 2.5" "Group enriched" "Detected in many" 13 "amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9" "Region enhanced" "Detected in many" "basal ganglia: 311.4" HPA062668 Uncertain NA NA "HPA062668: AB_2684827" "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.8 0.6 6.6 0.6 27.0 0.6 0.8 3.6 16.5 0.6 0.8 0.0 0.0 0.8 0.6 2.5 0.6 0.7 0.6 0.6 4.9 1.3 0.7 0.6 0.6 0.6 0.8 10.1 0.6 0.6 0.6 0.1 0.6 0.0 0.8 0.6 0.4 0.7 0.6 3.9 1.0 0.8 0.6 0.0 0.7 1.3 0.7 2.7 0.0 0.6 0.0 0.6 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.0 0.6 0.9 0.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 27.0 3.6 11.6 4.9 1.3 0.8 10.1 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.3 0.0 1.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.0 RPS4Y2 RPS4Y2P ENSG00000280969 "Ribosomal protein S4, Y-linked 2" Q8TD47 Y 20756164-20781032 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 2.9;Smooth muscle cells: 2.2;Spermatogonia: 2.3;Suprabasal keratinocytes: 5.1" "Cancer enriched" "Detected in single" 9 "prostate cancer: 1.8" "Cell type enriched" "Detected in some" 5 "neutrophil: 10.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.7" "Cell line enriched" "Detected in some" 5 "U-266/84: 6.4" HPA000857 Uncertain NA NA "HPA000857: AB_1079849" "unprognostic (1.50e-2)" "unprognostic (3.63e-1)" "unprognostic (6.39e-6)" "unprognostic (5.92e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 10.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 2.2 0.1 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 1.5 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 1.1 2.3 5.1 0.2 0.0 0.0 0.9 RPS6KL1 MGC11287 ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903954-74923396 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 67.9;Cone photoreceptor cells: 78.5;Horizontal cells: 38.1;Rod photoreceptor cells: 72.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 26 "B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0" "Cell line enhanced" "Detected in many" "HMC-1: 13.0;SCLC-21H: 24.9;SK-BR-3: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 4.2 7.5 14.7 2.3 13.6 4.2 5.7 18.2 29.1 2.1 4.8 9.0 2.2 3.8 5.1 8.8 5.3 2.5 3.7 10.2 14.3 13.7 2.3 2.1 2.5 2.5 11.1 15.3 1.5 6.7 4.0 10.6 1.4 8.4 2.8 5.6 5.9 3.2 5.4 12.7 1.2 2.8 6.9 8.8 1.7 2.0 11.4 6.8 0.0 3.8 1.2 2.5 1.9 0.8 2.0 5.4 0.1 0.0 0.0 2.0 0.1 2.3 0.3 1.0 3.8 0.1 0.0 4.5 0.4 0.2 1.8 0.5 5.6 1.6 0.0 3.5 0.7 0.5 0.3 1.8 0.3 2.4 0.0 0.8 1.9 0.8 4.2 4.7 2.2 13.0 0.3 3.2 2.0 0.0 0.0 5.9 0.0 2.7 0.7 0.1 7.6 0.0 0.8 0.8 0.7 3.7 1.8 0.0 7.2 1.8 0.0 24.9 3.0 0.3 14.4 2.4 2.0 1.4 1.5 4.0 0.1 0.2 3.1 0.0 10.1 5.3 5.3 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 2.0 0.4 0.1 0.0 0.4 1.9 2.0 0.1 0.0 0.0 5.4 0.0 0.1 14.7 13.6 18.2 18.2 14.3 13.7 11.1 15.3 8.4 6.8 0.0 0.0 0.0 1.8 0.7 67.9 5.1 0.0 5.3 0.0 3.5 78.5 1.4 1.7 1.2 6.5 2.6 2.0 0.0 5.3 1.1 1.0 1.6 0.0 2.1 3.0 38.1 6.4 1.3 0.0 5.6 2.0 1.2 3.3 0.0 1.5 4.0 3.1 1.5 2.5 0.8 72.2 6.5 2.7 22.3 15.8 1.1 1.1 1.3 2.5 1.3 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047426: AB_2680041" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 14.1 19.4 12.4 22.6 19.0 8.7 19.1 15.3 18.8 17.6 25.7 20.8 31.2 22.5 20.3 22.9 18.4 24.4 20.2 12.5 13.3 10.9 15.9 25.8 14.5 14.4 19.9 14.5 24.5 29.2 24.3 18.8 20.5 16.1 21.8 14.8 20.2 22.5 24.5 21.9 23.9 26.6 12.9 14.7 18.5 19.3 25.9 17.7 11.9 30.3 13.5 15.9 21.7 27.9 4.9 5.9 7.0 4.0 6.5 8.6 2.9 5.9 11.8 8.8 8.6 23.7 10.9 13.4 4.5 13.9 7.8 5.9 6.4 27.6 10.2 13.6 7.1 11.0 25.6 12.2 10.6 3.2 20.2 10.3 6.1 11.2 4.7 14.9 9.1 16.8 16.8 20.4 7.8 14.9 9.3 6.5 9.2 14.6 23.1 4.1 14.4 4.6 10.7 10.1 26.0 3.7 7.6 5.8 23.6 9.3 6.5 11.4 16.5 8.0 16.5 9.8 14.0 21.8 19.6 6.3 4.9 6.0 7.5 6.0 26.9 26.3 12.6 5.4 10.3 5.8 6.7 3.3 4.7 6.8 2.5 6.9 3.4 6.6 4.8 5.9 4.9 5.3 6.0 7.0 6.5 4.0 2.2 8.6 2.9 12.4 19.0 15.3 18.8 13.3 10.9 19.9 14.5 16.1 17.7 6.0 10.8 9.7 21.1 9.0 9.9 6.1 20.4 6.7 10.3 3.5 11.8 21.2 8.3 10.3 44.1 11.3 18.0 0.0 11.6 14.3 9.4 17.5 4.7 18.5 9.6 7.9 9.2 9.2 10.2 10.3 10.3 6.6 8.5 9.0 16.6 20.3 9.4 17.5 8.9 11.6 11.6 12.9 6.2 15.8 22.8 10.0 27.1 8.3 16.5 15.9 RSAD1 FLJ11164 ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478800-50485975 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967, HPA024459" Approved Approved "Nucleoli,Mitotic chromosome,Mitochondria" NA NA Mitochondria "Nucleoli, Mitotic chromosome" "HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: " "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 13.5 22.2 16.1 16.8 23.9 8.9 14.1 32.2 20.3 16.8 13.1 12.7 13.5 13.9 13.8 15.1 8.8 12.9 13.6 25.7 13.7 11.6 18.5 28.2 14.0 16.6 19.0 13.7 20.9 46.0 20.3 12.9 10.1 16.3 12.8 14.9 12.6 21.4 14.0 37.0 13.5 12.0 13.7 23.6 16.7 16.0 8.8 19.1 11.6 15.8 20.9 14.0 11.7 12.4 7.4 5.8 3.8 4.6 6.7 10.9 5.1 5.7 19.7 9.5 15.6 16.3 13.3 3.4 10.2 9.9 13.1 11.1 19.5 7.4 15.7 22.6 7.1 13.0 5.5 10.7 14.2 11.3 17.3 19.5 21.1 8.8 18.9 11.4 12.7 14.9 9.7 15.7 8.7 16.9 10.9 12.7 38.8 16.3 15.0 10.9 13.5 21.2 9.3 3.8 24.6 21.3 8.7 10.9 14.2 15.8 8.8 5.2 17.8 2.6 12.2 13.1 12.6 18.4 13.0 8.9 13.7 14.6 10.4 11.9 23.5 16.4 6.1 10.3 18.2 9.5 1.1 4.1 3.8 9.5 4.6 9.9 5.1 8.2 9.4 5.1 7.4 10.9 10.5 0.0 6.7 4.3 5.8 6.2 5.1 16.1 23.9 32.2 20.3 13.7 11.6 19.0 13.7 16.3 19.1 3.0 12.5 11.2 4.6 9.0 12.3 23.6 12.7 1.4 6.8 15.7 2.0 15.8 19.9 10.9 7.3 13.7 8.7 0.0 25.4 9.6 10.3 5.5 3.5 15.8 14.2 7.9 24.2 6.7 7.8 5.4 14.4 9.6 16.9 10.8 12.6 30.7 11.1 3.5 10.3 8.7 7.4 12.9 12.4 8.4 21.2 8.7 8.5 13.1 13.0 2.8 RSPH10B ENSG00000155026 "Radial spoke head 10 homolog B" P0C881 7 5925550-5970683 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "fallopian tube: 9.6;testis: 20.8" "Group enriched" "Detected in some" 16 "Ciliated cells: 69.6;Early spermatids: 44.5;Late spermatids: 98.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enhanced" "Detected in some" "hTCEpi: 2.9" HPA049182 Supported NA NA "HPA049182: AB_2680666" "unprognostic (4.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.47e-1)" "unprognostic (5.31e-2)" "unprognostic (9.41e-3)" "unprognostic (2.80e-1)" "unprognostic (2.88e-3)" "unprognostic (1.11e-3)" "unprognostic (2.93e-3)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (1.76e-3)" "unprognostic (1.75e-2)" "unprognostic (4.06e-2)" "unprognostic (5.80e-2)" "unprognostic (1.31e-3)" 0.0 0.1 1.1 0.0 1.3 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.3 0.2 0.0 9.6 0.0 0.0 1.5 1.6 0.0 0.2 1.4 0.0 0.1 0.0 0.0 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 20.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.7 0.1 0.2 1.0 0.0 0.4 0.2 0.0 0.0 0.2 0.1 0.1 0.4 0.2 0.4 0.8 0.3 0.2 0.0 0.1 0.6 1.1 0.4 0.2 1.9 0.6 0.0 0.5 0.4 2.9 0.1 0.5 0.0 0.1 0.1 1.0 0.7 1.0 0.2 0.5 0.4 1.6 0.0 0.7 0.4 0.4 0.1 0.0 0.0 0.0 0.6 0.1 0.7 0.1 1.2 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.9 1.3 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 69.6 4.5 0.0 0.0 0.0 0.0 0.0 44.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 98.8 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.9 0.3 0.0 0.0 0.0 0.0 RSPH10B2 ENSG00000169402 "Radial spoke head 10 homolog B2" B2RC85 7 6754109-6799365 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 10.7;testis: 19.3" "Group enriched" "Detected in some" 7 "Ciliated cells: 84.3;Early spermatids: 26.3;Late spermatids: 46.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;SH-SY5Y: 1.4;U-266/84: 3.3" HPA049182 Supported NA NA "HPA049182: AB_2680666" "unprognostic (7.74e-2)" "unprognostic (1.60e-1)" "unprognostic (2.28e-2)" "unprognostic (5.35e-3)" "unprognostic (3.41e-1)" "unprognostic (3.05e-3)" "unprognostic (2.58e-2)" "unprognostic (4.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-5)" "unprognostic (1.66e-1)" "unprognostic (4.38e-2)" "unprognostic (8.27e-3)" "unprognostic (7.02e-2)" 0.0 0.0 0.4 0.0 0.9 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.0 10.7 0.0 0.0 0.9 1.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.8 0.0 0.1 2.0 0.1 0.0 0.2 0.0 0.1 0.0 0.8 0.0 0.0 0.5 0.0 1.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.1 1.0 0.1 0.1 1.1 0.0 0.3 0.0 0.9 0.0 0.3 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.4 0.2 0.0 0.3 3.3 0.0 0.4 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 84.3 7.9 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 RSPH6A "RSHL1, RSP4, RSP6, RSPH4B" ENSG00000104941 "Radial spoke head 6 homolog A" Q9H0K4 19 45795710-45815319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 48.1" "Cell type enriched" "Detected in some" 10 "Early spermatids: 57.7" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RPMI-8226: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA045382 Enhanced NA NA "HPA045382: AB_10959735" "unprognostic (1.99e-1)" "unprognostic (3.23e-1)" "unprognostic (6.55e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" "unprognostic (4.16e-4)" "unprognostic (2.33e-1)" "unprognostic (5.89e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-5)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (5.99e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.8 0.6 0.0 0.1 0.0 0.0 0.0 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 1628.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "A-431: 25.5;HaCaT: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 25.5 1.4 13.7 6.3 0.0 0.1 3.3 3.7 4.3 4.2 6.7 10.6 5.1 0.1 1.6 1.4 4.3 20.5 7.6 0.6 4.4 3.6 5.2 4.2 3.1 4.4 0.0 5.7 3.3 0.2 0.3 5.2 0.5 2.3 0.6 6.8 0.2 0.2 5.6 3.2 11.0 7.3 5.8 3.8 5.2 9.5 14.6 0.0 2.7 11.1 7.5 8.6 2.4 8.6 3.5 4.2 7.8 3.1 0.0 1.9 12.5 0.1 9.3 0.1 0.0 9.8 2.5 0.0 3.0 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 1628.8 44.5 0.9 8.3 4.1 0.6 0.4 0.0 4.0 15.9 0.0 0.0 3.0 0.0 1.4 376.8 0.1 0.4 0.0 1.4 4.9 2.5 7.0 3.5 0.0 2.1 0.0 1.7 1.8 0.6 65.6 2.0 2.2 1.7 0.0 5.9 0.4 9.1 0.0 1.8 1.4 0.5 0.0 1.9 21.3 23.6 1.6 1.7 12.7 3.3 87.2 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;GAMG: 3.2;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.6 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Ciliated cells: 4.0;Club cells: 3.4;Distal tubular cells: 1.7;granulocytes: 2.3;Hofbauer cells: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;AN3-CA: 6.3;SCLC-21H: 7.6;SH-SY5Y: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favorable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favorable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 5.4 7.2 7.0 2.7 12.5 1.9 7.7 22.7 14.2 4.9 4.5 3.5 6.2 2.8 9.6 10.1 2.6 4.9 6.0 4.0 10.3 8.9 4.4 4.2 5.5 2.4 5.2 11.2 10.5 1.1 7.4 16.3 5.2 6.3 5.7 3.0 3.0 3.7 6.9 2.3 2.1 3.2 6.7 9.5 2.7 5.4 12.4 4.8 0.0 11.7 0.8 2.0 5.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 5.6 6.3 1.5 1.8 0.3 2.1 0.8 0.3 0.9 0.4 0.0 0.0 0.9 0.4 1.0 0.0 1.1 0.1 1.1 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.7 3.4 0.1 0.9 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.6 10.6 0.4 0.0 0.0 2.4 0.2 0.0 0.7 0.8 0.7 1.4 0.0 0.1 0.0 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 12.5 22.7 14.2 10.3 8.9 5.2 11.2 6.3 4.8 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492572-44498298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 13.4;Collecting duct cells: 12.2;Ductal cells: 6.3;Exocrine glandular cells: 5.6;Pancreatic endocrine cells: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 11.6 14.1 19.3 7.7 17.4 3.2 10.2 16.2 30.0 13.6 12.2 14.7 15.2 9.7 17.8 14.2 9.4 19.1 12.4 16.7 17.1 16.1 10.9 4.9 10.4 6.3 16.9 11.4 22.6 12.1 18.9 9.9 5.9 11.9 11.5 10.4 9.2 7.7 16.3 15.5 3.7 9.2 19.0 16.5 7.9 10.7 12.6 9.5 14.4 11.6 7.2 5.3 11.8 10.2 0.2 1.1 0.1 1.4 0.9 4.5 2.1 7.0 9.8 12.7 16.9 10.0 8.1 3.3 9.3 11.1 13.1 10.4 3.2 4.2 0.0 5.9 17.4 9.9 6.1 8.5 9.2 8.2 3.3 16.7 0.0 18.9 0.0 12.4 0.9 4.7 8.8 9.0 12.0 9.3 18.0 11.7 11.3 3.9 0.0 8.9 12.4 22.3 2.0 7.8 7.8 10.5 6.1 6.7 0.0 11.3 8.2 13.7 16.0 15.2 7.4 9.4 6.4 7.4 9.9 12.0 10.3 14.0 13.6 7.4 4.4 1.7 0.0 15.4 2.3 15.4 0.0 1.4 0.1 4.3 0.6 4.5 0.0 2.5 3.6 1.1 0.2 1.0 2.5 0.0 0.9 0.8 0.1 0.4 2.1 19.3 17.4 16.2 27.8 17.1 16.1 16.9 11.4 11.9 9.5 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 13.4 4.5 12.2 0.0 2.2 0.0 6.3 0.0 0.0 0.0 0.0 5.6 2.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 6.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 RTP1 "MGC35450, Z3CXXC1" ENSG00000175077 "Receptor transporter protein 1" P59025 3 187197486-187201465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5;testis: 1.9" "Group enriched" "Detected in some" 14 "Early spermatids: 1.9;Late spermatids: 1.1;Spermatocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "SuSa: 9.2;T-47d: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.29e-1)" "unprognostic (1.91e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.3 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.8 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 13.2;brain: 16.4" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 13.7;Hepatocytes: 16.6;Spermatocytes: 20.2;Spermatogonia: 21.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.0;HEK 293: 2.5;SCLC-21H: 6.7;SH-SY5Y: 3.0;U-138 MG: 2.5;U-266/70: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 1.1 13.2 3.6 0.8 9.4 0.1 1.4 16.4 7.9 2.7 3.7 1.0 1.0 4.7 3.4 1.2 1.0 2.0 1.7 1.4 2.8 5.1 3.3 9.7 0.8 0.4 2.8 4.8 2.3 0.5 0.5 2.0 0.2 7.9 1.1 2.7 0.7 0.9 0.8 1.1 0.9 5.2 3.8 2.2 0.4 0.6 3.1 1.0 0.0 0.6 0.1 0.5 1.6 1.1 0.1 0.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 3.0 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 2.5 0.1 1.5 1.0 0.1 1.2 0.4 0.0 0.7 0.0 0.4 0.0 1.2 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.2 6.7 3.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 2.5 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.4 2.1 0.0 0.8 0.1 0.0 1.7 0.0 0.1 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.1 3.6 9.4 16.4 6.5 2.8 5.1 2.8 4.8 7.9 1.0 0.0 0.0 0.0 0.1 4.2 8.0 2.2 5.1 0.0 0.0 0.0 5.9 0.5 1.7 0.9 2.0 13.7 9.7 0.0 0.2 0.3 0.1 0.1 0.0 16.6 0.1 11.1 0.0 1.8 0.0 1.0 3.7 0.0 3.3 0.0 2.9 0.7 0.8 5.8 1.4 8.7 7.6 0.0 1.2 20.2 21.5 2.6 1.0 0.0 3.8 0.0 S1PR5 "Edg-8, EDG8" ENSG00000180739 "Sphingosine-1-phosphate receptor 5" Q9H228 19 10512742-10517931 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;brain: 37.8;skin 1: 25.4" "Cell type enriched" "Detected in some" 12 "T-cells: 52.4" "Group enriched" "Detected in many" 5 "cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2" "Lineage enriched" "Detected in many" 8 "T-cells: 62.0" "Cell line enhanced" "Detected in many" "HaCaT: 21.9;HBEC3-KT: 8.4;RT4: 14.3;T-47d: 9.1;U-2 OS: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029683 Enhanced NA NA "HPA029683: AB_10603237" "unprognostic (9.07e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (5.55e-4)" "unprognostic (4.21e-1)" "unprognostic (4.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.55e-1)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (2.46e-2)" "unprognostic (2.90e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-1)" 1.4 1.0 10.0 1.6 17.4 21.0 1.1 1.9 15.1 2.7 1.0 37.8 0.0 0.9 1.1 6.9 6.5 1.0 1.0 0.9 15.7 8.0 1.1 2.7 3.0 1.7 28.8 9.3 0.7 0.8 0.6 0.2 2.8 13.9 2.0 0.8 0.7 1.3 1.4 1.4 25.4 1.0 0.9 26.2 11.6 0.9 0.9 21.0 0.0 0.8 0.2 3.3 3.1 5.0 0.1 0.1 0.8 0.1 8.1 62.0 10.2 1.4 2.2 0.4 0.0 0.0 0.1 0.1 0.5 0.3 0.7 0.4 0.2 0.1 0.0 6.0 0.2 1.0 21.9 1.4 8.4 1.6 0.0 1.4 0.2 1.8 0.0 0.0 0.0 0.1 0.0 4.0 2.4 0.4 0.1 0.0 0.0 0.2 0.0 0.0 2.8 0.8 0.0 3.5 0.4 0.4 0.0 1.6 0.0 0.0 14.3 0.0 0.0 3.6 0.0 0.4 1.6 9.1 2.5 0.0 1.1 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 62.0 0.0 38.0 0.1 7.8 29.2 0.1 0.1 2.4 23.2 0.8 8.1 0.1 0.1 0.1 10.2 10.0 17.4 1.9 15.1 15.7 8.0 28.8 9.3 13.9 21.0 3.0 3.4 0.0 1.6 3.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.2 0.9 0.2 2.3 0.0 0.2 0.0 0.0 1.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.1 52.4 0.0 0.4 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974113-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;T-cells: 6.2" "Cell line enhanced" "Detected in many" "HMC-1: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 2.4 2.8 6.4 6.1 14.5 3.4 5.4 25.7 10.4 2.3 4.4 1.6 9.2 7.3 1.4 3.0 10.3 4.7 8.8 3.2 5.5 5.0 6.5 4.4 3.6 10.1 3.5 3.5 0.5 5.6 5.3 3.3 3.3 3.2 4.8 3.7 2.7 9.7 6.5 1.7 9.3 6.8 1.5 1.9 5.7 10.2 3.2 2.4 5.7 3.1 2.7 12.3 5.4 4.2 2.9 1.0 0.6 0.4 1.0 6.2 1.6 5.9 0.0 2.0 0.2 0.5 0.6 0.1 1.9 1.6 3.9 1.8 5.7 11.6 0.4 4.0 0.9 0.2 8.1 1.9 2.4 2.0 12.1 4.0 2.0 5.9 8.6 0.8 10.0 16.2 0.5 4.4 2.1 0.3 2.9 1.8 4.3 4.8 4.9 0.7 4.5 4.5 9.3 3.2 8.5 9.2 6.3 0.1 10.5 6.4 10.5 2.2 4.7 1.3 11.3 2.4 0.8 7.6 5.0 1.7 1.2 2.8 0.0 0.3 1.0 0.7 3.3 3.8 8.1 1.1 0.0 0.2 0.6 4.9 0.2 2.7 2.9 3.3 2.9 0.6 1.3 5.6 6.2 0.0 1.0 0.4 1.0 2.5 1.6 6.4 14.5 25.7 10.4 5.5 5.0 3.5 3.5 3.2 2.4 3.0 0.0 2.2 2.2 0.9 6.1 2.0 0.0 2.7 1.2 8.7 2.0 2.3 1.7 3.4 0.0 1.0 2.6 0.0 3.0 0.4 0.3 2.6 0.0 0.6 1.1 0.0 4.7 2.5 1.5 0.0 0.0 0.7 1.7 2.8 4.2 2.7 5.2 1.9 0.0 3.1 2.6 0.0 0.8 0.5 1.3 1.6 2.3 4.4 2.2 3.4 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189459-118621995 "Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 104.2;Alveolar cells type 2: 67.7;Ciliated cells: 112.4;Club cells: 92.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 6.8;dendritic cells: 4.3;T-cells: 3.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.6;U-266/70: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favorable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 2.1 3.0 14.1 3.1 16.2 1.1 5.0 13.8 20.2 4.6 6.9 7.7 8.9 7.1 2.7 8.0 9.7 8.8 6.7 10.8 10.8 7.0 8.3 4.0 6.2 2.3 9.6 13.7 2.1 4.7 12.7 20.8 0.9 13.7 6.3 8.1 2.6 5.7 12.8 2.0 2.3 4.8 1.9 10.9 4.2 9.5 3.2 8.6 0.7 15.8 2.5 4.5 10.8 3.0 6.8 4.3 0.2 0.0 1.1 3.7 0.9 7.5 0.3 0.6 0.0 0.0 0.0 2.0 3.5 5.5 6.3 3.3 1.7 7.1 10.5 0.7 4.3 1.6 1.8 2.4 4.1 9.2 0.2 0.8 0.1 4.7 0.0 0.0 0.0 0.3 0.2 1.3 4.6 0.7 1.6 0.2 5.9 0.0 6.2 3.2 1.9 2.2 0.0 1.0 6.7 1.2 0.0 0.0 7.3 2.8 11.4 3.3 0.0 2.3 23.6 0.3 1.9 1.7 0.0 0.0 0.1 3.1 1.4 0.8 12.1 9.9 0.8 1.4 0.0 1.3 0.1 0.0 0.0 0.6 0.0 3.7 6.8 2.6 1.7 0.3 2.9 3.7 1.8 0.2 1.1 0.0 4.3 2.4 0.9 14.1 16.2 13.8 20.2 10.8 7.0 9.6 13.7 13.7 8.6 104.2 67.7 0.5 8.7 1.4 16.8 9.4 15.3 112.4 92.1 27.9 41.2 0.0 16.6 9.9 4.9 4.0 7.3 0.0 10.9 0.1 0.5 3.4 52.3 3.2 0.1 28.6 13.7 3.7 0.0 3.8 0.3 0.9 6.8 1.0 9.8 3.4 10.8 0.0 0.4 14.0 26.5 0.0 1.0 0.5 1.9 1.5 0.0 2.5 11.1 10.8 SAMD13 ENSG00000203943 "Sterile alpha motif domain containing 13" Q5VXD3 1 84298366-84389957 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.4" "Cell type enhanced" "Detected in many" 10 "Mucus-secreting cells: 19.6;Paneth cells: 35.1;Spermatocytes: 20.4;Undifferentiated cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 11.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058929 Enhanced Approved Mitochondria NA NA Mitochondria "HPA058929: AB_2683855" "unprognostic (3.78e-2)" "unprognostic (4.93e-2)" "unprognostic (8.51e-3)" "unprognostic (7.55e-2)" "prognostic favorable (1.14e-8)" "unprognostic (1.78e-1)" "unprognostic (1.65e-6)" "unprognostic (2.05e-1)" "unprognostic (5.50e-2)" "unprognostic (2.80e-3)" "unprognostic (9.42e-2)" "unprognostic (3.29e-1)" "unprognostic (1.98e-7)" "unprognostic (3.99e-2)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.56e-3)" 1.2 5.2 4.9 1.0 12.9 2.1 2.0 9.1 5.8 1.5 16.6 7.4 0.6 2.6 1.8 4.5 1.1 3.7 1.4 1.7 4.8 2.3 1.7 0.4 0.7 0.8 7.9 6.5 0.5 2.3 1.0 2.3 0.5 4.5 3.4 19.4 0.4 13.6 1.9 7.6 1.2 3.0 2.1 5.1 1.5 5.6 12.4 8.5 3.5 8.6 2.0 0.4 2.7 0.7 0.6 1.4 11.2 0.8 0.7 0.5 0.3 0.7 2.5 1.2 4.0 4.3 4.3 2.7 0.3 0.3 0.3 0.3 0.2 4.0 4.2 7.5 0.2 0.8 0.8 0.4 1.3 0.6 2.2 2.1 1.5 1.8 0.3 1.1 4.8 0.1 1.5 1.9 0.1 1.2 3.0 10.1 9.5 0.6 1.2 1.2 1.2 6.2 0.6 4.0 3.2 2.6 0.7 3.1 1.6 7.9 2.7 1.6 6.2 0.1 0.2 9.2 1.7 1.2 4.5 1.6 1.4 0.4 0.4 1.1 3.2 0.6 7.2 0.5 4.3 1.2 11.2 0.4 0.0 0.1 0.8 0.3 0.2 0.1 0.1 0.9 0.6 0.5 0.5 0.2 0.7 0.3 1.4 0.0 0.3 4.9 12.9 9.1 5.8 4.8 2.3 7.9 6.5 4.5 8.5 0.0 1.1 0.0 0.6 0.3 1.0 1.2 5.1 1.4 1.2 1.8 0.0 3.4 5.0 1.3 3.9 1.3 6.2 0.0 0.6 0.6 2.0 2.8 5.7 0.0 1.4 0.0 10.9 1.8 1.6 3.1 1.7 0.9 8.5 0.0 19.6 2.6 0.9 35.1 2.5 2.2 0.0 0.0 0.1 20.4 2.0 0.3 0.7 0.0 16.6 1.3 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 42.7;Horizontal cells: 11.1;Intestinal endocrine cells: 12.2" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HEL: 6.9;HMC-1: 23.2;SH-SY5Y: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: AB_2681662" "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 4.0 0.0 1.1 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.7 1.0 0.0 0.1 0.2 0.0 0.1 10.9 0.1 6.9 0.2 0.0 0.6 0.0 23.2 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 10.9 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.4 1.4 0.3 0.0 0.2 0.0 0.0 2.0 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 0.0 0.3 0.0 0.1 0.3 42.7 1.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 2.1 2.9 0.0 0.0 0.3 0.1 1.4 0.1 2.3 0.0 0.1 11.1 12.2 4.9 0.3 1.9 1.4 0.8 0.0 2.8 0.0 1.4 0.3 0.0 3.2 0.8 3.1 0.0 2.2 1.4 1.1 0.1 0.3 0.0 0.0 0.0 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762799-31764851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.8;skin 1: 14.7" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 7.3;JURKAT: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071699 Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA071699: AB_2686433" "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 0.8 0.3 0.7 1.6 1.0 4.8 1.8 0.7 1.3 2.0 1.0 1.3 0.7 0.2 1.2 0.8 0.7 1.8 2.5 0.7 0.7 0.8 3.2 0.9 1.4 2.5 1.9 0.7 1.6 0.7 0.2 2.9 3.3 3.9 2.6 1.1 8.8 0.7 1.6 0.7 14.7 1.5 0.7 3.1 2.1 0.8 1.2 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.0 0.5 0.2 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.5 0.4 0.8 0.8 0.4 0.2 0.2 0.0 2.8 1.0 0.8 0.1 0.2 0.0 1.6 0.0 0.7 0.1 0.0 3.1 3.8 7.3 1.0 0.2 0.3 0.1 0.2 0.0 1.1 1.4 0.3 0.5 6.4 0.4 1.1 0.0 3.7 2.8 2.3 0.0 0.3 0.8 0.4 0.9 0.0 0.6 0.7 1.2 0.6 0.3 0.7 0.4 0.9 0.3 0.0 0.2 0.1 2.9 0.0 0.3 2.1 2.0 2.0 0.2 2.7 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.7 1.0 0.7 1.3 0.7 0.8 1.9 0.7 3.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SATL1 ENSG00000184788 "Spermidine/spermine N1-acetyl transferase like 1" Q86VE3 X 85092287-85243961 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0" HPA060369 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060369: AB_2684265" "unprognostic (1.77e-1)" "unprognostic (2.06e-1)" "unprognostic (4.69e-3)" "unprognostic (7.88e-2)" 0.3 2.7 2.9 0.4 2.6 0.4 0.4 5.4 4.6 0.4 0.4 0.2 0.0 0.3 0.4 0.3 0.3 0.4 0.3 0.5 2.2 2.0 1.1 0.4 0.3 0.3 1.1 2.7 0.4 0.3 0.3 7.2 0.4 2.2 0.5 0.4 0.0 0.4 0.3 0.7 0.6 0.3 0.3 1.4 0.4 0.3 4.8 0.4 0.0 0.4 0.2 0.3 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 3.5 0.0 0.0 0.0 0.6 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.6 5.4 4.6 2.2 2.0 1.1 2.7 2.2 0.4 11.9 11.7 0.0 0.0 0.0 0.0 0.0 0.0 17.4 12.5 0.0 0.0 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.8" "Cell type enhanced" "Detected in many" 28 "Ciliated cells: 370.7;Early spermatids: 61.6;Late spermatids: 100.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 12.3;K-562: 11.2;SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.3 4.1 1.3 5.4 0.7 2.8 4.4 5.3 2.7 1.2 3.5 5.0 0.9 2.1 14.8 0.7 46.8 1.9 1.4 5.5 2.8 2.3 1.1 9.1 1.1 3.1 2.8 9.2 2.6 4.7 11.5 0.7 5.6 2.4 1.8 1.6 2.3 3.0 1.2 1.9 1.6 0.9 2.3 1.3 2.3 18.0 3.7 1.0 3.1 0.1 1.6 1.0 1.2 6.7 1.3 5.3 0.2 3.2 2.7 0.5 1.6 2.2 1.3 4.9 1.1 2.2 0.6 0.5 0.4 0.9 1.8 0.2 2.7 1.6 1.2 0.0 2.6 12.3 2.1 1.8 2.1 1.1 8.0 0.6 3.8 0.0 0.1 0.4 0.5 1.5 2.6 1.7 1.4 2.8 1.9 3.4 11.2 0.9 1.2 1.1 0.6 0.0 3.2 0.6 0.9 1.5 0.6 1.0 0.9 1.1 9.4 1.5 1.3 0.0 1.7 0.8 4.7 0.5 0.2 2.4 1.4 5.0 0.9 2.6 2.8 1.0 2.3 0.6 1.6 0.0 0.1 5.3 1.1 0.0 1.4 2.5 0.4 2.7 0.1 6.7 1.8 0.8 0.1 3.2 0.2 1.3 0.1 0.5 4.1 5.4 4.4 5.3 5.5 2.8 3.1 2.8 5.6 3.7 0.0 2.4 0.0 1.7 0.0 2.6 1.1 2.5 370.7 44.3 3.5 3.9 0.4 1.7 0.4 61.6 0.5 0.0 0.0 0.4 0.4 0.2 1.8 1.1 0.0 0.1 0.0 2.4 0.0 0.0 100.5 2.3 0.0 0.0 0.0 2.1 3.3 0.3 0.0 2.1 3.5 4.9 6.5 0.1 40.5 7.2 0.0 0.2 0.0 0.6 1.2 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104064-39115189 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 85.1;Spermatocytes: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles NA NA Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.2 7.2 7.2 5.7 8.7 5.9 11.2 7.1 9.0 7.9 7.3 8.1 6.9 8.8 7.9 10.5 6.5 8.1 9.3 6.7 7.3 6.9 8.1 8.3 6.3 8.2 9.3 6.5 8.4 9.5 4.9 6.1 6.1 7.0 8.5 7.2 6.4 11.1 8.0 5.6 6.6 8.6 6.3 7.0 6.8 6.9 52.7 7.3 18.2 8.4 5.1 9.0 6.2 7.7 14.8 9.3 19.4 12.2 11.7 19.1 9.5 11.4 7.4 6.7 7.9 11.1 14.7 6.9 5.3 5.8 6.4 6.8 10.6 8.1 10.4 7.6 6.9 9.1 7.9 5.8 5.0 6.8 6.5 10.5 6.8 4.5 9.2 9.0 7.7 10.3 10.1 12.4 2.5 6.4 4.5 5.9 15.8 11.5 6.4 7.1 15.7 12.2 12.8 5.8 7.5 3.8 1.7 8.1 4.1 13.4 8.1 18.8 7.6 9.2 8.0 8.1 5.6 13.1 10.2 7.6 8.5 6.2 2.6 6.8 0.1 3.2 12.8 4.9 11.2 6.2 7.6 9.0 19.4 12.2 12.2 14.2 13.1 13.3 11.0 9.3 14.8 19.1 15.8 4.3 11.7 11.9 7.4 17.3 9.5 7.2 8.7 7.1 9.0 7.3 6.9 9.3 6.5 7.0 7.3 3.0 5.9 9.3 11.4 13.7 5.5 17.5 17.8 12.0 5.7 17.4 7.9 28.7 14.9 19.4 85.1 11.3 11.8 0.0 18.9 26.3 17.4 17.9 8.1 18.7 23.2 6.4 8.1 3.1 15.6 40.0 19.0 12.2 11.8 9.0 15.0 13.7 14.7 7.0 18.0 23.0 3.6 6.5 10.3 202.1 11.9 14.4 10.3 10.2 18.4 11.5 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28292519-28323849 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6" "Cell type enriched" "Detected in many" 8 "Cone photoreceptor cells: 76.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4" "Group enriched" "Detected in many" 10 "NK-cells: 1.4;T-cells: 4.3" "Cell line enhanced" "Detected in some" "AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9" "Region enriched" "Detected in all" 5 "cerebellum: 306.7" NA NA "unprognostic (5.15e-2)" "prognostic favorable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.9 2.0 8.0 1.8 7.3 2.0 1.7 31.1 17.5 1.7 1.2 1.5 0.0 1.1 1.9 1.3 1.5 1.6 1.0 1.8 9.9 5.6 1.6 0.9 1.8 2.7 6.0 4.0 1.1 2.7 4.2 4.1 0.8 8.3 2.6 1.2 1.4 3.8 1.0 39.6 1.4 1.1 0.9 3.1 2.8 1.6 2.3 3.1 22.1 2.6 0.0 1.7 1.2 0.3 0.2 0.2 0.2 0.1 1.4 4.3 0.4 0.1 0.2 15.3 11.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.3 0.3 4.6 0.1 0.0 1.5 0.5 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 5.8 0.0 1.0 0.0 1.8 7.0 0.1 15.8 1.0 0.1 16.7 0.8 0.1 0.1 0.9 24.3 22.9 0.4 1.4 0.2 1.9 1.7 0.0 0.4 0.0 2.4 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.9 0.2 0.1 0.1 4.3 0.0 1.4 0.0 1.2 2.4 0.0 0.2 1.4 3.0 0.1 1.4 0.1 0.2 1.4 0.4 8.0 7.3 31.1 17.5 9.9 5.6 6.0 4.0 8.3 3.1 3.0 0.3 0.0 0.8 0.6 9.4 3.1 2.5 2.7 3.4 0.0 76.6 0.0 1.7 6.1 1.0 0.0 0.0 0.0 4.8 0.0 0.4 1.5 0.0 0.2 0.1 0.0 5.8 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.3 4.2 4.7 0.0 0.0 0.5 2.7 0.0 0.3 1.4 2.3 0.1 0.1 2.5 0.8 0.3 SBNO2 "FLJ00173, KIAA0963, Sno, Stno" ENSG00000064932 "Strawberry notch homolog 2" Q9Y2G9 19 1107636-1174283 "Predicted intracellular proteins" "Differentiation, Osteogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.3" "Cell line enhanced" "Detected in many" "A-431: 20.6;HDLM-2: 31.6;U-266/70: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041867 Approved NA NA "HPA041867: AB_2677715" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (6.20e-3)" "unprognostic (4.68e-2)" "unprognostic (8.48e-3)" "unprognostic (1.19e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (1.58e-3)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (7.98e-8)" "unprognostic (1.34e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.88e-1)" 36.6 13.8 6.5 25.3 11.1 29.8 15.4 4.0 10.3 12.6 14.6 7.3 11.5 7.9 11.6 10.2 19.9 12.6 13.7 10.5 6.7 2.9 16.4 16.3 24.6 22.6 12.9 1.6 15.7 12.1 3.3 17.6 13.6 9.8 16.7 3.8 9.6 17.3 18.4 19.7 16.7 14.2 9.3 12.1 26.0 30.8 9.1 9.2 14.5 13.3 12.4 23.8 13.5 24.7 0.3 0.3 6.3 0.8 0.2 0.5 0.3 20.6 2.6 0.4 0.2 0.0 1.5 7.7 6.2 0.6 1.4 0.8 0.1 3.4 4.4 8.9 1.1 1.1 6.8 0.0 0.9 0.5 31.6 4.7 4.6 7.6 0.0 1.2 2.6 13.8 3.5 0.9 2.1 0.8 1.1 1.3 1.8 7.1 6.1 0.5 2.7 2.9 3.4 6.1 0.4 9.0 6.3 3.6 4.7 2.0 0.9 5.2 7.8 3.7 7.1 7.1 0.6 2.4 2.1 7.0 3.8 3.1 11.7 10.2 24.2 11.5 3.4 7.8 2.3 4.3 0.1 0.8 0.3 0.5 0.5 0.1 0.3 0.3 0.5 0.3 0.3 0.3 0.3 6.3 0.2 0.3 0.2 0.1 0.3 6.5 11.1 4.0 10.3 6.7 2.9 12.9 1.6 9.8 9.2 8.9 31.0 11.7 10.0 13.3 4.7 4.3 7.6 12.0 23.9 3.5 2.0 3.9 3.3 8.1 2.0 11.7 14.8 0.0 5.9 4.5 8.4 12.5 3.5 7.4 8.9 6.4 2.9 15.4 13.6 1.3 8.6 16.0 8.5 14.4 8.4 3.3 12.5 8.2 3.9 1.4 4.8 6.5 9.0 3.6 8.6 16.4 9.2 7.5 7.3 18.7 SCGB1D2 "LIPB, LPHB" ENSG00000124935 "Secretoglobin family 1D member 2" O95969 11 62242210-62244808 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 101.5;cervix, uterine: 315.2" "Cell type enriched" "Detected in some" 25 "Melanocytes: 781.1" "Group enriched" "Detected in many" 6 "breast cancer: 625.1;endometrial cancer: 226.0" "Region enriched" "Detected in some" 6 "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 14.7" HPA035318 Approved "Secreted in other tissues" NA NA "HPA035318: AB_10610421" "unprognostic (8.76e-2)" "unprognostic (2.14e-1)" "prognostic favorable (3.46e-6)" "unprognostic (2.39e-2)" "unprognostic (5.89e-2)" "unprognostic (4.72e-2)" "unprognostic (1.99e-1)" "unprognostic (6.43e-2)" "prognostic favorable (8.03e-6)" "unprognostic (1.55e-1)" "unprognostic (1.15e-2)" 1.8 0.4 0.8 0.2 0.6 0.0 101.5 0.9 0.5 315.2 0.2 0.9 6.2 0.0 18.4 43.8 0.8 8.5 0.4 1.0 1.2 0.4 1.1 0.2 0.2 0.2 1.0 0.5 1.1 2.9 0.0 1.0 0.6 7.3 1.1 0.0 1.2 9.5 0.5 2.4 59.6 0.2 0.2 0.4 0.2 0.0 1.6 0.5 0.2 0.3 2.1 1.2 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.7 0.2 0.0 2.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.9 0.5 1.2 0.4 1.0 0.5 7.3 0.5 0.0 0.0 0.0 5.0 24.4 0.5 6.5 0.0 0.0 0.0 7.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 31.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 781.1 0.0 0.0 17.0 0.0 0.0 0.0 13.2 0.6 0.0 0.3 0.0 0.0 6.0 0.1 0.0 0.0 1.0 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;pancreas: 39.7;pituitary gland: 47.9" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 576.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2" "Group enriched" "Detected in many" 11 "cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 23.6" "Region enriched" "Detected in single" 16 "olfactory region: 100.5" "Region enriched" "Detected in some" 9 "olfactory region: 282.4" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 1.5 2.1 0.7 6.0 0.8 0.1 2.0 22.3 1.5 0.4 10.5 0.5 0.9 7.2 0.1 0.3 0.3 0.0 0.5 5.0 6.2 22.0 3.8 2.5 0.4 0.1 0.5 1.2 0.2 39.7 0.0 47.9 1.8 1.4 1.1 11.7 1.8 3.7 3.0 0.1 0.3 8.0 0.7 1.0 0.1 12.5 0.6 0.1 0.5 1.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 23.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 22.3 1.5 6.2 22.0 0.5 1.2 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 99.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.1 0.0 4.7 0.0 0.0 0.1 0.0 576.5 1.8 0.0 0.0 0.6 0.0 0.0 1.8 2.8 0.0 7.8 2.9 0.0 2.2 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 SCP2D1 "C20orf79, dJ1068E13.2, HSD22" ENSG00000132631 "SCP2 sterol binding domain containing 1" Q9UJQ7 20 18813726-18814392 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 82 "testis: 30.5" "Group enriched" "Detected in some" 158 "Early spermatids: 915.6;Late spermatids: 727.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 915.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 727.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.9 2.8 0.0 0.0 0.0 0.0 0.0 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-676179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.9;retina: 6.1" "Cell type enriched" "Detected in some" 51 "Horizontal cells: 57.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Group enriched" "Detected in many" 4 "cerebellum: 8.8;cerebral cortex: 17.9" "Cell type enriched" "Detected in single" 25 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.4" "Group enriched" "Detected in some" 5 "Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067697 Approved Nucleoplasm NA NA Nucleoplasm "HPA067697: AB_2685890" "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.3 0.3 0.7 0.3 0.7 0.3 0.3 8.8 17.9 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.6 0.3 0.3 0.3 0.3 1.9 0.0 0.3 1.3 0.3 0.0 0.4 3.2 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.6 0.3 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 8.8 17.9 0.7 0.6 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCTR ENSG00000080293 "Secretin receptor" P47872 2 119439843-119525301 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;pancreas: 35.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 64.4;Ductal cells: 72.3;Exocrine glandular cells: 84.2;Pancreatic endocrine cells: 51.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.3" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.8" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5" HPA007269 Uncertain NA NA "HPA007269: AB_1856640" "unprognostic (1.51e-1)" "unprognostic (2.22e-1)" "unprognostic (4.99e-2)" "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (9.08e-2)" "unprognostic (7.35e-2)" "unprognostic (2.38e-2)" "unprognostic (6.11e-3)" "unprognostic (1.65e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (4.38e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.2 4.1 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.2 0.2 0.0 0.0 0.0 0.5 0.1 3.8 0.3 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 8.2 0.7 0.5 0.1 0.0 0.9 0.3 0.0 0.1 0.0 1.5 0.3 0.5 0.0 0.3 0.0 0.3 0.0 0.3 0.0 1.1 0.0 0.0 0.4 0.6 0.0 0.9 0.3 0.1 0.0 0.0 0.1 3.8 0.3 0.9 0.3 0.2 0.4 0.3 0.3 0.0 0.0 0.5 0.3 0.2 1.2 0.3 0.3 0.1 0.4 0.0 0.0 64.4 0.0 0.2 0.0 0.0 3.1 0.0 0.0 3.4 5.2 0.0 0.0 10.0 72.3 0.4 0.0 0.0 0.0 84.2 0.0 0.0 0.0 2.3 0.0 0.5 4.8 2.4 0.0 0.0 1.1 0.0 0.0 0.0 2.8 0.0 0.2 51.5 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301448-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 99.7;Late spermatids: 120.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 28 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 28 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol NA NA 2700000 Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 5.8 1.1 2.2 6.1 1.7 1.4 5.8 0.9 3.1 16.6 6.2 1.4 6.8 1.8 6.1 10.9 2.9 4.5 4.8 1.9 3.4 2.2 3.9 0.7 7.0 8.7 1.6 1.4 4.3 22.4 1.5 6.3 2.9 2.1 6.9 2.4 5.6 2.6 9.4 1.8 2.9 4.2 16.5 1.9 16.3 3.6 7.7 1.9 1.8 1.5 3.6 3.4 9.5 13.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.0 1.7 7.9 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.3 0.0 3.1 0.1 0.8 0.0 0.2 0.0 4.6 0.0 0.3 0.2 3.9 0.0 0.0 1.6 0.0 0.3 0.5 0.0 0.6 0.1 0.0 0.0 3.9 2.0 0.0 0.0 2.7 0.1 0.0 5.6 5.5 0.0 8.2 10.2 4.9 7.2 0.0 0.0 0.0 9.9 0.0 2.5 0.2 0.0 12.3 0.0 3.4 0.0 0.0 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.2 1.7 0.9 3.1 3.4 2.2 1.6 1.4 2.1 1.9 0.0 4.0 0.0 0.4 1.1 10.0 20.4 2.5 9.4 7.9 5.2 0.0 2.3 0.0 1.0 99.7 0.6 0.0 0.0 4.7 0.8 4.1 0.6 0.0 0.0 0.5 1.6 4.7 1.3 0.0 120.8 1.7 0.5 5.0 0.0 0.5 0.3 3.5 0.0 5.3 1.4 0.7 6.5 2.1 6.6 5.1 0.4 1.6 0.0 0.0 0.3 SDR16C5 "EPHD-2, RDH-E2, RDHE2" ENSG00000170786 "Short chain dehydrogenase/reductase family 16C member 5" Q8N3Y7 8 56300010-56320776 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "memory B-cell: 9.1;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 56 "B-cells: 9.1" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025224 Enhanced NA NA "HPA025224: AB_1856163" "unprognostic (1.66e-1)" "unprognostic (8.88e-2)" "unprognostic (9.46e-2)" "unprognostic (4.18e-4)" "unprognostic (8.83e-3)" "prognostic favorable (7.88e-4)" "unprognostic (1.66e-1)" "unprognostic (2.51e-1)" "unprognostic (2.42e-1)" "unprognostic (1.78e-3)" "unprognostic (2.39e-1)" "unprognostic (2.48e-5)" "unprognostic (2.55e-1)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" 0.3 0.2 2.0 2.0 1.9 0.0 7.4 0.9 6.2 8.1 5.9 0.2 0.0 1.7 0.2 0.0 27.5 0.2 1.5 0.2 0.6 1.2 0.2 0.2 34.0 0.3 1.4 2.9 0.2 0.3 0.0 0.5 0.0 10.6 0.3 3.0 0.2 9.2 0.0 0.3 35.9 16.9 0.2 0.4 0.2 12.9 0.5 0.2 0.0 0.2 25.8 21.1 1.0 11.5 9.1 0.0 0.0 0.0 0.0 0.1 0.1 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 9.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 21.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 1.9 0.9 6.2 0.6 1.2 1.4 2.9 10.6 0.2 44.7 125.1 0.0 5.5 45.3 0.2 0.1 10.2 48.2 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 0.0 1.2 0.0 1.5 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 3.3 1.0 7.1 9.9 58.7 3.2 0.0 0.0 1.4 0.0 0.3 0.2 4.1 63.1 0.0 0.0 4.5 19.5 SDR42E1 HSPC105 ENSG00000184860 "Short chain dehydrogenase/reductase family 42E, member 1" Q8WUS8 16 81988855-82011488 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 8.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;NK-cells: 3.6;T-cells: 4.6" "Cell line enhanced" "Detected in some" "HaCaT: 7.5;hTCEpi: 10.8;MCF7: 7.1;RT4: 17.4;SCLC-21H: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014388 Uncertain NA NA "HPA014388: AB_1851226" "unprognostic (2.09e-1)" "unprognostic (4.90e-1)" "unprognostic (9.52e-3)" "unprognostic (3.81e-1)" "unprognostic (3.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.51e-2)" "unprognostic (3.96e-2)" "unprognostic (4.93e-4)" "unprognostic (4.90e-7)" "unprognostic (2.18e-1)" "unprognostic (1.82e-1)" "unprognostic (3.21e-2)" "unprognostic (8.27e-2)" 1.3 0.3 0.2 6.5 0.5 0.3 5.8 0.2 0.2 3.5 12.2 0.0 4.1 7.9 4.6 3.9 11.5 2.1 2.6 2.2 0.2 0.4 7.4 8.3 4.1 3.6 0.2 0.1 0.6 14.3 3.8 14.9 0.3 0.2 3.1 2.2 1.4 18.8 3.4 0.7 16.7 21.3 1.5 0.3 3.8 3.6 7.3 0.1 8.2 6.1 7.3 13.7 4.3 4.7 4.0 0.4 0.8 0.0 3.6 4.6 2.0 3.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 0.0 1.5 0.0 0.3 7.5 0.0 5.8 0.0 0.0 0.5 0.0 1.5 0.0 0.1 0.0 0.0 0.3 10.8 1.4 5.5 0.0 0.0 0.0 1.2 0.0 0.8 7.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 2.3 17.4 7.5 0.0 0.2 3.6 0.0 0.2 0.1 0.0 0.2 0.0 4.0 0.0 0.0 3.7 5.0 0.4 0.0 0.0 0.0 0.1 0.0 0.8 1.8 0.0 2.4 4.0 1.5 2.5 0.3 2.1 4.6 3.6 0.1 3.6 0.0 0.4 3.0 2.0 0.2 0.5 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.6 1.7 3.5 5.3 0.0 2.4 2.5 4.0 2.3 1.8 0.0 0.4 3.3 8.0 0.9 0.3 3.1 0.0 6.5 0.1 0.5 3.2 0.0 3.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 1.7 0.0 4.9 0.0 4.9 3.5 0.0 2.1 0.0 0.0 0.3 8.2 3.4 8.0 0.2 1.0 3.3 4.1 SEC61A2 FLJ10578 ENSG00000065665 "Sec61 translocon alpha 2 subunit" Q9H9S3 10 12129637-12169961 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.5" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 33.4;Late spermatids: 23.8;Spermatocytes: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.83e-2)" "unprognostic (2.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.01e-3)" "unprognostic (4.18e-2)" "unprognostic (1.84e-2)" "unprognostic (1.28e-3)" "unprognostic (1.55e-2)" "unprognostic (2.97e-1)" "unprognostic (3.95e-2)" "prognostic favorable (1.08e-5)" "unprognostic (3.14e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (6.41e-2)" "unprognostic (4.95e-2)" "unprognostic (6.18e-2)" "prognostic favorable (8.75e-4)" 4.0 5.6 14.3 5.1 19.7 14.1 5.3 16.5 33.5 3.8 3.8 20.3 3.2 3.7 7.8 9.2 3.9 4.1 5.2 11.3 16.8 22.1 3.1 7.8 3.8 5.8 15.6 14.6 5.8 3.3 5.5 9.4 4.5 22.7 6.0 5.9 5.7 2.7 6.3 6.9 8.6 3.3 5.9 21.1 4.8 3.6 17.3 9.9 5.0 5.2 1.3 6.1 4.1 3.6 1.3 5.8 4.1 0.5 2.0 2.7 0.4 5.9 10.8 14.1 8.7 6.0 3.7 4.7 6.0 3.3 11.8 12.5 10.2 4.0 2.2 3.3 9.4 15.9 4.9 19.5 7.8 10.2 6.6 7.4 2.7 12.6 7.2 5.9 1.6 6.5 5.5 4.7 21.5 3.4 5.2 3.0 13.3 3.2 6.5 10.0 5.2 5.4 2.7 13.9 5.3 3.3 5.8 5.8 1.4 7.3 6.2 6.7 9.9 8.8 4.7 4.3 11.5 9.0 2.7 5.4 10.3 12.0 13.1 4.1 6.0 8.5 3.5 8.0 2.2 3.1 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.3 1.3 1.0 1.3 2.7 1.7 4.1 2.0 0.5 5.8 1.9 0.4 14.3 19.7 16.5 26.4 16.8 22.1 15.6 14.6 22.7 9.9 3.0 3.2 7.5 2.3 1.5 13.1 6.5 2.5 1.4 3.4 8.7 7.9 2.8 0.0 2.4 15.5 2.7 1.1 0.0 2.0 2.1 4.1 2.8 2.3 13.2 2.3 33.4 1.2 3.7 1.9 23.8 6.4 2.5 5.0 1.8 1.6 6.9 1.7 2.9 4.2 1.3 13.8 0.0 3.8 28.9 13.9 1.3 2.9 1.9 1.0 1.4 SEL1L2 "C20orf50, DKFZp434C1826" ENSG00000101251 "SEL1L2 ERAD E3 ligase adaptor subunit" Q5TEA6 20 13849247-13996443 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 13.7" "Group enriched" "Detected in some" 8 "Early spermatids: 138.6;Late spermatids: 119.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA059121 Approved NA NA "HPA059121: AB_2683911" "unprognostic (6.70e-2)" "unprognostic (1.64e-2)" "unprognostic (2.72e-3)" "unprognostic (2.19e-1)" "unprognostic (8.51e-2)" "unprognostic (5.33e-2)" "unprognostic (2.13e-2)" "unprognostic (2.54e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "unprognostic (3.12e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 119.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 15.6 4.2 0.0 0.0 0.0 0.0 0.0 SEM1 "C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1" ENSG00000127922 "SEM1, 26S proteasome complex subunit" "P60896, Q6ZVN7" 7 96481626-96709891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 543.9;Exocrine glandular cells: 464.8;Extravillous trophoblasts: 599.1;Syncytiotrophoblasts: 729.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020429, HPA072648" Uncertain Approved Cytosol NA NA Cytosol "HPA020429: AB_1859527, HPA072648: AB_2686543" "unprognostic (5.41e-3)" "unprognostic (6.25e-2)" "unprognostic (1.62e-2)" "unprognostic (2.14e-3)" "unprognostic (1.24e-3)" "unprognostic (6.16e-3)" "unprognostic (4.29e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.52e-4)" "unprognostic (4.55e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.32e-1)" "unprognostic (2.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (8.00e-5)" 44.1 58.5 33.3 38.6 48.7 23.1 29.0 25.0 36.3 29.6 48.4 16.8 44.0 41.5 33.5 44.1 45.4 24.0 29.5 69.9 34.8 27.9 34.7 91.6 24.3 28.2 31.7 31.8 45.7 43.6 14.8 51.2 63.5 32.2 32.2 27.8 22.0 43.4 34.5 109.5 34.2 39.0 42.1 43.8 25.0 40.0 52.5 28.8 28.8 28.7 61.8 28.0 31.5 34.0 50.6 94.9 36.7 65.7 42.0 79.0 48.9 63.4 37.5 52.3 54.3 22.4 19.5 28.2 51.9 25.5 21.9 27.4 33.9 52.8 41.9 129.0 25.2 67.7 32.9 43.7 35.0 31.1 48.7 33.0 50.2 55.2 52.6 20.5 74.2 37.6 24.8 27.5 32.7 33.5 34.3 29.2 50.4 65.0 51.8 22.2 80.4 83.8 105.3 70.7 64.4 34.3 32.6 67.4 49.5 31.0 63.2 43.1 54.5 96.9 81.4 52.8 83.8 23.2 56.6 60.0 43.2 75.2 79.8 64.7 32.6 87.4 121.2 47.2 65.6 59.4 36.7 61.3 15.8 45.5 65.7 43.2 50.6 59.3 53.1 86.3 45.3 46.9 47.2 4.1 42.0 55.4 94.9 79.0 48.9 33.3 48.7 25.0 36.3 34.8 27.9 31.7 31.8 32.2 28.8 160.8 197.7 0.0 0.0 0.0 0.0 0.0 0.0 274.4 190.0 232.1 0.0 543.9 349.8 309.5 0.0 0.0 0.0 0.0 464.8 599.1 0.0 0.0 94.2 0.0 339.5 0.0 0.0 0.0 0.0 0.0 0.0 130.5 0.0 421.2 0.0 0.0 446.5 0.0 0.0 414.8 0.0 0.0 0.0 0.0 0.0 0.0 729.5 0.0 0.0 0.0 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 151.8;Enterocytes: 193.7;Syncytiotrophoblasts: 93.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "eosinophil: 3.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "HeLa: 23.0;Hep G2: 34.8;SK-BR-3: 18.1;WM-115: 56.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA030651 Uncertain "Secreted in other tissues" NA NA 29000 "HPA030651: AB_10602224" "prognostic favorable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 3.3 18.8 2.5 2.0 7.4 0.0 1.0 0.3 9.2 9.2 6.0 18.6 2.3 13.3 4.4 3.5 2.5 3.4 5.6 3.4 3.6 7.7 0.0 8.1 0.0 12.9 4.9 2.6 5.6 3.5 0.0 147.6 8.2 2.8 2.8 8.5 1.2 6.8 1.5 0.5 19.7 3.9 5.9 0.3 11.9 0.5 9.5 0.0 1.6 0.6 0.0 1.9 0.6 0.0 0.4 3.3 0.0 0.0 0.0 0.0 4.0 2.6 0.2 2.6 0.2 0.3 0.6 5.3 7.3 1.5 2.6 2.0 10.1 0.0 4.9 5.1 0.0 0.6 0.1 8.5 0.6 0.0 0.2 0.0 23.0 34.8 5.8 0.0 0.2 1.7 0.1 1.7 1.3 6.8 0.0 0.0 0.0 0.6 0.2 7.2 0.0 0.2 0.3 7.5 1.4 0.1 0.4 0.1 2.5 0.4 0.3 1.2 1.3 18.1 2.7 0.8 1.3 0.0 0.1 0.4 5.3 1.4 1.7 1.4 0.0 0.0 2.7 0.0 56.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 151.8 18.1 2.7 7.9 0.0 3.7 11.6 43.3 9.4 34.2 61.1 0.0 3.3 1.7 32.0 9.1 3.6 193.7 0.0 20.4 0.9 22.9 9.4 11.5 0.9 1.7 0.0 9.9 8.0 2.6 14.9 3.7 1.3 0.0 1.0 31.6 18.8 31.2 56.1 2.8 45.3 1.6 6.5 2.1 4.9 4.7 0.0 93.4 0.0 25.9 27.1 SEMA3C "SEMAE, SemE" ENSG00000075223 "Semaphorin 3C" Q99985 7 80742538-80922359 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 109.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "basophil: 25.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.8" "Cell line enhanced" "Detected in many" "GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042418 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Golgi apparatus, Cytosol" "Plasma membrane" "HPA042418: AB_10797389" "unprognostic (1.93e-2)" "unprognostic (2.54e-3)" "unprognostic (4.94e-1)" "unprognostic (9.86e-2)" "unprognostic (6.74e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (9.28e-3)" "unprognostic (1.91e-3)" "unprognostic (1.39e-2)" "unprognostic (9.01e-2)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.07e-2)" "unprognostic (1.55e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-2)" 27.1 4.1 3.7 11.9 5.6 0.2 25.1 1.2 6.8 37.0 31.7 7.6 21.6 4.3 26.9 25.1 20.0 7.1 16.4 12.4 5.2 6.1 5.8 1.1 12.3 0.3 13.1 3.0 23.5 1.5 0.0 4.1 5.9 25.5 29.6 14.1 27.4 13.6 19.7 7.3 9.7 10.6 48.8 8.5 8.9 13.3 11.6 6.0 0.2 2.5 15.2 1.5 35.5 14.5 0.0 2.0 25.8 3.2 0.0 0.0 0.8 1.1 14.6 30.4 0.1 6.8 16.5 0.0 9.9 11.4 5.0 6.4 2.3 27.6 0.0 0.4 3.3 49.5 5.9 0.1 8.9 8.2 0.0 3.0 1.8 13.1 0.1 8.2 0.1 0.0 7.2 5.9 12.4 12.2 43.2 0.0 0.0 0.1 0.0 8.4 21.1 0.0 0.0 0.2 4.1 2.3 0.0 14.7 0.2 26.3 45.2 0.1 15.7 27.8 7.2 1.7 13.5 51.2 0.0 23.8 27.5 12.6 66.4 17.4 0.2 0.0 0.0 10.4 0.0 27.2 25.8 3.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 1.0 1.8 0.0 0.8 3.7 5.6 1.2 6.8 5.2 6.1 13.1 3.0 25.5 6.0 8.9 12.8 0.0 33.4 23.5 0.0 35.1 0.0 109.7 19.4 7.0 5.9 0.3 1.7 3.6 0.4 3.5 25.9 0.0 5.8 0.5 25.3 36.0 4.7 0.0 9.3 0.0 5.8 1.3 2.6 1.7 7.2 8.6 52.3 4.6 16.2 1.3 40.1 15.8 49.1 0.1 0.3 0.0 16.2 0.3 0.2 16.6 0.2 0.0 23.4 52.9 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.8;thyroid gland: 33.0" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "amygdala: 17.1" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 5 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 77000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 4.1 2.2 17.1 1.9 2.3 0.1 4.3 0.8 2.8 4.6 2.9 1.8 2.5 1.4 1.9 7.4 1.3 3.9 1.4 2.0 3.6 2.7 3.0 1.0 3.6 6.1 2.4 3.1 4.1 0.8 0.4 1.5 0.6 5.4 6.2 2.6 2.6 5.6 2.9 0.7 2.1 2.7 3.2 4.8 33.8 2.4 4.3 2.5 0.0 33.0 0.6 1.1 4.7 3.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 4.6 5.0 5.4 2.6 0.0 0.0 0.0 1.4 17.0 0.1 17.3 1.9 0.0 3.6 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 6.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 4.5 1.2 5.5 4.0 1.7 0.0 0.1 0.6 0.0 0.0 0.2 8.9 0.2 0.0 26.5 0.0 1.7 0.2 0.0 3.3 1.9 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.1 2.3 0.8 2.2 3.6 2.7 2.4 3.1 5.4 2.5 0.0 3.5 0.8 2.3 3.2 1.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 137.5 5.2 0.0 0.0 0.2 0.0 6.7 7.1 2.3 0.0 0.9 1.6 25.4 1.8 0.0 14.9 48.6 0.8 11.8 0.0 0.0 0.9 0.0 0.0 58.7 4.5 4.1 0.0 2.1 0.7 0.7 2.0 0.0 0.0 0.1 0.4 SEMA3F "Sema4, SEMAK" ENSG00000001617 "Semaphorin 3F" Q13275 3 50155045-50189075 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 23.1;Collecting duct cells: 17.4;Ito cells: 28.3;Rod photoreceptor cells: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 24.3;HUVEC TERT2: 42.3;RT4: 24.6;SK-BR-3: 39.5;TIME: 76.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035008 Approved "Secreted to blood" NA NA 1700000 4000000 "HPA035008: AB_10604091" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (1.12e-2)" "unprognostic (1.87e-2)" "unprognostic (5.52e-3)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.71e-1)" "unprognostic (9.05e-2)" "unprognostic (4.20e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-1)" "unprognostic (2.23e-2)" "unprognostic (6.19e-2)" "unprognostic (8.56e-2)" "unprognostic (3.88e-3)" "unprognostic (6.87e-3)" 17.4 3.7 2.8 5.0 3.6 1.5 26.5 3.5 5.0 12.2 7.5 2.5 45.3 8.1 9.2 10.5 42.6 9.7 8.2 12.3 3.1 3.1 15.1 4.9 20.4 5.8 2.9 0.5 5.5 4.2 2.9 5.7 28.9 6.4 14.8 4.1 19.3 12.5 22.1 7.9 44.4 9.3 5.7 2.6 57.6 10.2 3.1 3.6 2.7 13.8 19.5 21.5 14.7 22.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.0 0.7 0.1 3.2 0.0 0.3 0.6 1.7 5.5 1.5 2.3 1.2 1.4 0.1 17.7 0.2 0.1 10.5 1.5 22.8 0.5 0.0 0.4 0.1 24.3 4.0 1.3 0.3 0.7 1.5 12.7 3.4 10.5 21.1 42.3 0.2 0.6 0.0 0.3 2.6 0.3 1.6 1.9 1.4 2.2 2.5 0.0 0.1 1.6 24.6 0.2 0.6 2.8 39.5 0.0 2.5 15.4 1.6 76.0 0.9 7.5 6.7 1.2 0.0 0.0 0.1 0.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.6 3.5 5.0 3.1 3.1 2.9 0.5 6.4 3.6 0.0 1.4 0.0 3.0 6.1 23.1 1.4 2.5 1.4 2.3 17.4 9.8 8.2 0.0 0.2 0.0 13.5 5.0 0.0 0.7 0.3 1.5 2.5 0.0 0.5 1.2 6.4 0.0 28.3 0.8 0.0 0.3 0.0 0.0 0.0 9.1 8.1 4.0 3.5 0.0 0.6 18.6 0.0 2.3 0.0 0.4 7.9 5.3 0.0 5.0 6.7 SEMA3G "FLJ00014, sem2" ENSG00000010319 "Semaphorin 3G" Q9NS98 3 52433053-52445085 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 46.2;breast: 89.1" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 8.2;Endothelial cells: 9.0;Intestinal endocrine cells: 9.2;Syncytiotrophoblasts: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "T-reg: 4.5" "Lineage enriched" "Detected in single" 18 "T-cells: 4.5" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;Hep G2: 6.3;HUVEC TERT2: 6.7;THP-1: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001761 Uncertain "Secreted to blood" NA NA 4400000 "HPA001761: AB_1079902" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "unprognostic (7.08e-2)" "unprognostic (1.47e-2)" "unprognostic (2.85e-1)" "unprognostic (5.79e-4)" "unprognostic (5.20e-3)" "unprognostic (9.14e-2)" "unprognostic (5.54e-2)" "unprognostic (5.64e-2)" "unprognostic (1.34e-3)" "unprognostic (4.14e-1)" "prognostic favorable (8.86e-5)" "unprognostic (5.63e-2)" "unprognostic (2.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.14e-1)" 46.2 1.6 3.1 2.4 5.0 0.2 89.1 11.5 5.3 3.5 5.4 2.8 1.5 2.1 3.3 3.0 3.5 3.2 4.5 8.0 3.8 3.3 8.8 0.7 30.4 1.2 5.5 2.5 2.0 2.2 1.1 1.1 19.3 3.1 2.9 2.8 6.8 13.6 2.1 8.0 5.2 6.7 3.2 3.6 7.2 2.7 2.0 1.1 0.4 3.5 4.7 1.4 3.7 5.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.1 0.2 23.9 0.2 2.7 0.0 0.0 0.0 0.0 0.7 0.4 3.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 3.5 0.2 6.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 6.7 2.4 0.0 0.3 0.0 0.2 0.2 4.1 1.2 0.6 0.1 0.0 0.0 3.8 0.0 0.2 0.6 0.6 0.0 0.3 0.5 0.1 2.0 5.9 2.5 0.0 2.5 0.0 0.0 0.5 1.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.1 5.0 11.5 5.3 3.8 3.3 5.5 2.5 3.1 1.1 3.0 2.2 0.0 0.0 0.3 0.5 8.2 0.0 0.0 0.0 3.5 0.0 1.4 0.0 0.0 2.1 9.0 0.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.2 0.0 9.2 1.3 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 6.3 0.0 0.1 0.0 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 2.5;Cardiomyocytes: 3.2;Cholangiocytes: 2.5;Ito cells: 3.1;Muller glia cells: 10.6" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 42.4;NTERA-2: 8.2;SH-SY5Y: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 42.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 0.0 0.6 0.0 0.0 0.0 2.5 3.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 1.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 2.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.8 0.8 11.9 4.6 5.1 1.7 1.1 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.7 1.2 1.1 0.4 0.7 1.0 3.5 6.2 0.5 1.0 0.7 0.1 2.3 2.9 1.4 1.0 0.5 2.4 20.9 3.4 0.5 0.6 2.0 0.4 1.0 0.8 5.4 0.1 1.4 7.4 2.6 0.3 0.4 0.3 6.1 7.9 1.1 0.5 1.0 3.1 1.3 1.0 9.7 2.0 2.9 3.0 0.4 5.0 0.9 5.1 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 0.0 3.2 1.7 0.8 1.4 4.2 15.3 2.5 0.0 1.2 0.0 19.6 0.2 0.0 0.3 0.5 3.1 0.3 0.0 0.4 0.4 2.1 0.5 0.0 2.4 0.3 6.4 0.0 4.9 1.6 2.1 5.2 0.0 1.7 0.0 0.0 1.7 0.4 0.0 2.5 2.7 6.9 0.0 2.0 2.8 1.1 0.9 0.1 0.0 0.2 0.5 SERF1A "4F5, FAM2A, H4F5, SERF1, SMAM1" ENSG00000172058 "Small EDRK-rich factor 1A" O75920 5 70900665-70918530 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 81.1;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 24.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA075271 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.14e-1)" "unprognostic (3.00e-2)" "unprognostic (9.58e-2)" "unprognostic (3.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.81e-3)" "unprognostic (1.29e-3)" "unprognostic (1.40e-2)" "unprognostic (2.55e-2)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (4.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.98e-2)" "unprognostic (1.22e-2)" "unprognostic (9.53e-2)" 1.3 1.2 6.4 1.8 5.0 3.0 1.5 5.3 7.2 1.2 1.8 0.2 3.1 7.8 1.8 1.1 3.7 1.6 5.4 5.2 4.1 0.4 1.9 3.3 4.9 2.6 2.6 3.2 2.5 0.8 2.4 3.5 2.1 1.2 1.9 2.8 1.4 3.1 3.5 2.4 2.0 2.8 4.4 0.6 5.8 1.6 7.3 2.6 2.8 1.2 2.1 6.3 0.9 3.7 0.3 3.2 4.6 3.0 4.3 6.4 1.0 0.8 0.9 1.4 1.2 1.5 3.2 6.4 2.6 1.8 1.0 1.8 1.1 2.4 1.5 3.2 3.6 2.1 1.7 1.5 0.7 1.3 2.0 1.4 0.7 1.0 3.6 2.6 0.5 0.5 2.0 2.5 1.7 9.7 11.5 2.3 0.3 1.0 0.5 4.6 5.1 3.3 3.0 9.8 2.9 10.2 0.5 10.1 1.5 6.4 1.3 8.8 3.8 1.2 3.0 1.4 0.8 1.0 3.2 1.9 0.5 8.8 1.0 0.3 2.8 4.2 1.2 5.1 4.9 4.0 6.3 0.5 7.3 4.7 3.9 2.8 2.1 0.8 2.6 3.0 0.9 0.0 3.4 0.8 2.0 1.6 2.6 81.1 0.0 6.7 4.5 3.5 23.6 0.2 3.3 1.2 2.0 2.4 2.4 0.0 0.4 0.3 1.3 1.9 2.3 0.0 0.5 0.0 5.2 1.3 0.0 1.0 2.0 0.8 0.0 1.8 1.2 2.3 0.9 2.9 3.5 0.8 24.0 0.0 1.2 3.1 1.3 1.9 0.1 2.9 1.8 0.9 SERF1B "FAM2B, H4F5C" ENSG00000205572 "Small EDRK-rich factor 1B" O75920 5 70025247-70043113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 8.9;Cardiomyocytes: 34.7;Ciliated cells: 9.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.2;SiHa: 39.6;SK-MEL-30: 26.3;WM-115: 21.0" HPA075271 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.00e-1)" "unprognostic (2.52e-4)" "unprognostic (2.60e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (5.98e-2)" "unprognostic (4.92e-3)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-4)" "unprognostic (1.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (6.74e-2)" "unprognostic (3.52e-1)" 3.7 2.4 7.6 1.6 8.3 2.6 2.6 5.7 10.4 2.9 3.4 0.9 3.2 22.7 5.0 1.6 4.7 3.1 6.6 6.7 8.4 1.6 3.5 3.2 7.5 2.5 3.9 11.6 4.0 2.0 4.7 3.9 7.8 5.1 4.1 2.7 2.6 10.3 5.5 3.9 5.7 20.5 4.9 1.4 7.9 3.0 7.0 6.4 10.9 4.5 5.7 8.7 1.8 11.8 0.3 1.7 2.3 8.6 6.5 8.5 3.4 6.2 2.2 1.9 0.3 1.2 1.1 24.2 5.3 1.4 3.3 0.9 0.7 3.7 2.9 0.4 6.5 0.4 0.6 0.5 0.7 1.1 0.4 12.9 0.7 0.1 6.6 0.6 0.3 0.4 1.6 0.2 0.1 11.1 6.8 1.7 0.0 0.2 1.2 6.7 4.9 1.3 0.5 8.7 6.4 39.6 1.8 26.3 0.7 17.5 3.2 18.8 10.2 0.7 0.4 0.6 0.7 1.2 9.1 0.6 0.0 21.0 0.3 0.9 10.9 6.4 3.0 6.9 6.0 8.2 5.8 3.5 7.0 8.7 5.8 2.5 5.7 4.5 6.4 5.8 1.8 8.9 2.1 0.0 0.5 0.3 0.0 34.7 0.0 9.4 5.7 0.0 2.0 0.0 1.7 0.2 1.6 0.5 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 1.2 0.0 0.4 0.7 0.4 0.5 0.0 0.0 0.2 0.4 SERHL2 ENSG00000183569 "Serine hydrolase like 2" Q9H4I8 22 42553617-42574382 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "breast: 155.6" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 15.9;Ito cells: 15.4;Sertoli cells: 19.4" "Group enriched" "Detected in all" 5 "breast cancer: 8.0;prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 4.1;naive B-cell: 8.9;plasmacytoid DC: 4.5" "Group enriched" "Detected in many" 11 "B-cells: 8.9;dendritic cells: 4.5" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.14e-1)" "unprognostic (1.56e-2)" "unprognostic (8.61e-2)" "unprognostic (2.52e-2)" "unprognostic (3.27e-1)" "unprognostic (7.24e-2)" "unprognostic (1.25e-3)" "unprognostic (1.47e-2)" "unprognostic (1.55e-3)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.92e-1)" "unprognostic (7.04e-2)" "unprognostic (4.08e-2)" "unprognostic (2.06e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" 1.4 1.8 2.4 1.1 11.9 1.3 155.6 1.1 10.9 2.2 1.4 5.0 10.5 0.9 1.8 14.0 1.6 2.5 1.3 2.3 4.5 3.4 1.5 3.1 1.3 1.8 13.9 2.2 9.5 0.9 2.6 0.7 1.0 8.7 7.3 1.2 0.9 3.9 6.1 1.2 10.9 1.4 1.5 4.3 1.3 1.8 1.9 14.1 0.0 1.7 0.6 1.2 2.3 4.4 8.9 4.5 0.5 0.1 0.2 0.4 0.3 0.0 0.0 0.4 0.8 1.1 2.5 0.1 0.5 0.5 0.6 0.7 0.0 0.1 0.3 0.3 1.6 0.3 0.3 0.4 0.2 0.3 0.1 0.1 0.2 0.0 0.7 0.5 0.2 0.5 2.6 0.4 0.4 0.0 0.4 0.1 0.0 2.9 0.0 0.6 1.1 7.3 0.3 0.0 0.1 0.0 3.5 0.0 0.1 0.2 0.1 0.1 0.1 0.1 79.5 0.0 0.8 0.2 0.4 0.5 0.2 0.0 0.2 0.0 0.3 0.0 3.3 0.3 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.2 4.1 0.1 0.4 0.1 8.9 0.0 0.1 0.0 0.2 0.1 4.5 0.0 0.3 2.4 11.9 1.1 10.9 4.5 3.4 13.9 2.2 8.7 14.1 3.0 0.0 3.0 5.5 1.1 1.3 0.4 0.0 1.4 1.2 12.2 0.0 4.2 3.3 1.1 3.2 1.9 0.4 0.0 0.2 3.6 2.5 15.9 0.0 1.0 1.0 1.6 0.0 15.4 2.2 2.2 4.9 2.1 5.0 0.0 1.3 4.5 0.4 0.0 6.3 0.6 1.4 19.4 2.9 4.2 7.8 1.4 6.8 0.5 1.3 4.2 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 13.0 3.1 2.7 8.9 6.0 8.1 7.6 25.2 18.7 1.6 2.0 4.7 47.3 8.6 33.2 23.6 2.0 53.9 0.3 85.2 0.3 0.8 2.0 0.0 2.7 2.4 6.8 0.0 10.1 7.4 48.5 10.4 22.9 7.2 1.0 1.0 0.3 0.0 2.8 2.1 0.3 0.3 2.8 26.1 6.6 0.0 5.4 2.9 9.0 58.3 1.2 6.7 6.4 48.8 1.0 1.4 28.5 1.5 6.2 0.4 2.1 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.1 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 14.9 6.2 0.5 97.8 11.0 0.0 0.6 127.4 8.1 21.6 111.7 0.0 323.0 61.3 546.6 3.9 4.4 427.6 0.0 288.5 86.2 3.3 137.4 0.0 45.6 43.7 0.0 111.9 8.6 7.6 6.6 2.0 6.8 38.8 83.8 168.4 0.6 386.0 170.9 0.0 57.4 0.0 0.0 1.4 0.6 3.6 18.4 373.5 0.0 116.2 257.8 SERINC3 "AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1" ENSG00000132824 "Serine incorporator 3" Q13530 20 44496221-44522109 "Predicted membrane proteins, Transporters" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 455.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048116 Uncertain NA NA "HPA048116: AB_2680269" "unprognostic (3.16e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (2.60e-1)" "unprognostic (2.74e-1)" "unprognostic (7.34e-2)" "unprognostic (1.85e-3)" "unprognostic (6.26e-2)" "unprognostic (7.41e-2)" "unprognostic (3.11e-1)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-3)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" 42.5 47.1 35.5 22.8 63.0 21.0 38.9 28.9 80.6 39.0 27.4 52.8 14.8 22.9 31.8 25.4 32.8 28.3 34.2 34.9 40.8 35.2 25.0 45.1 33.0 20.6 40.5 33.9 35.4 24.7 55.9 33.6 55.8 60.9 29.6 31.8 29.4 30.2 33.4 45.3 35.9 25.6 35.2 42.6 26.3 26.2 51.2 33.3 29.2 40.6 20.5 23.8 32.8 28.8 19.6 31.4 58.9 34.5 34.4 34.4 38.7 14.6 15.7 7.5 9.6 66.4 47.8 11.7 30.2 52.5 24.4 22.4 35.4 36.5 10.7 41.2 35.8 27.9 26.5 9.0 30.9 26.0 12.4 10.1 12.5 16.3 17.9 36.0 15.4 27.4 33.8 45.3 24.0 36.0 29.4 23.7 17.5 13.9 31.8 25.5 18.4 15.7 12.2 4.4 19.2 23.9 7.9 11.3 16.3 19.5 16.9 9.5 7.2 28.9 28.3 19.1 11.0 20.2 17.3 30.2 58.1 9.6 25.5 20.9 18.9 20.7 8.2 43.3 10.9 18.1 57.9 30.2 37.9 33.8 31.5 34.4 19.3 29.5 32.8 31.4 19.6 30.6 30.4 58.9 34.4 34.5 28.9 33.1 38.7 35.5 63.0 28.9 80.6 40.8 35.2 40.5 33.9 60.9 33.3 68.5 57.7 38.9 69.7 48.7 35.4 62.4 84.1 45.5 55.7 45.4 33.4 80.2 13.3 67.0 180.5 98.3 50.9 70.0 61.0 74.0 82.1 72.9 98.4 97.2 51.5 42.9 63.8 98.8 68.4 455.0 97.2 53.4 37.1 19.8 58.5 49.9 82.3 52.6 107.1 21.9 28.9 97.0 84.6 177.2 84.8 73.5 138.3 59.8 49.3 65.0 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 24.5" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 41.2;Early spermatids: 27.9;Late spermatids: 27.6;Rod photoreceptor cells: 53.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;OE19: 1.9;RT4: 1.4;SCLC-21H: 3.0;U-138 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.5 0.0 0.6 0.2 0.1 0.6 0.4 0.0 0.4 0.3 0.0 0.7 0.7 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.4 0.0 0.4 0.2 0.8 0.0 0.3 0.0 0.0 0.1 0.2 1.8 0.3 0.3 24.5 0.1 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.1 5.8 0.0 0.0 0.2 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.6 0.1 0.0 0.0 1.4 3.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.3 0.3 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.1 4.6 0.0 0.0 0.0 0.0 0.0 41.2 0.1 0.0 0.0 27.9 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 4.8 0.0 0.6 0.3 27.6 0.3 0.0 0.0 1.0 0.3 5.5 0.1 0.0 0.0 0.0 53.4 0.0 0.0 4.7 2.6 0.0 0.3 0.0 0.0 0.3 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 145.8;Urothelial cells: 161.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: AB_2675727" "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 4.9 8.9 3.0 1.9 4.2 4.4 9.1 4.1 2.7 1.8 1.9 18.0 25.9 0.8 4.2 5.2 4.2 14.5 4.1 10.8 2.6 0.7 2.2 0.6 1.1 9.6 1.5 0.6 1.9 5.1 6.0 4.7 12.3 5.1 3.3 24.6 1.6 4.3 4.8 8.6 10.0 2.4 4.2 7.0 3.1 12.0 2.7 1.3 5.3 24.7 0.2 2.9 3.6 8.5 15.9 16.2 3.7 3.1 3.6 5.3 1.5 5.3 5.0 5.6 1.5 13.0 9.9 1.7 21.5 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 56.6 23.8 3.7 42.8 5.7 3.7 7.5 22.9 2.7 23.9 15.7 0.0 14.2 8.3 21.5 1.4 17.5 72.2 0.0 16.8 20.9 20.6 145.8 8.1 74.0 19.5 3.2 57.7 43.0 25.4 4.2 17.0 27.0 5.0 36.1 63.6 60.6 25.3 57.5 37.4 4.6 4.8 32.3 3.8 1.2 7.9 8.5 108.0 16.7 74.3 161.9 SERPINA11 ENSG00000186910 "Serpin family A member 11" Q86U17 14 94442464-94452790 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 140 "liver: 189.6" "Cell type enriched" "Detected in some" 50 "Hepatocytes: 255.3" "Cancer enriched" "Detected in some" 9 "liver cancer: 94.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 460000000 "unprognostic (2.50e-2)" "unprognostic (3.26e-1)" "unprognostic (9.00e-2)" "prognostic favorable (6.30e-4)" "unprognostic (7.44e-2)" "unprognostic (2.02e-2)" "unprognostic (1.70e-1)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 189.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 255.3 0.0 0.0 0.0 3.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SERPINB11 EPIPIN ENSG00000206072 "Serpin family B member 11 (gene/pseudogene)" Q96P15 18 63647579-63726432 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 8.1;Club cells: 12.5;Glandular cells: 4.0;Urothelial cells: 19.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;BEWO: 2.1;hTCEpi: 1.3" "Low region specificity" "Detected in all" NA NA "unprognostic (5.04e-3)" "unprognostic (4.76e-2)" "unprognostic (4.05e-2)" "unprognostic (3.44e-1)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 23.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 19.1 2.0 2.4 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 8.1 12.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 SERPINE3 ENSG00000253309 "Serpin family E member 3" A8MV23 13 51335773-51364735 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "retina: 49.3" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 1.7;Spermatocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 2.7;TIME: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051904, HPA055804" Uncertain "Secreted in other tissues" NA NA "HPA051904: AB_2681659, HPA055804: AB_2682928" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (9.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (8.54e-3)" "unprognostic (2.67e-3)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (3.94e-6)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" 2.6 0.9 0.6 1.2 0.8 0.2 0.6 1.9 1.7 0.6 0.8 0.6 0.6 0.8 1.1 2.0 1.1 0.9 1.4 1.9 0.7 0.5 0.8 1.2 0.6 1.4 0.6 0.6 1.0 5.7 0.1 0.6 0.6 1.2 0.6 0.1 49.3 0.9 0.6 0.6 4.0 3.2 0.6 1.1 0.8 0.8 1.0 0.6 0.6 1.1 0.6 0.6 0.9 0.9 1.6 0.0 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.2 0.8 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.9 0.1 0.9 2.7 0.2 0.0 2.0 0.9 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.1 0.1 0.0 0.2 0.4 0.3 0.9 0.9 2.3 0.0 0.3 0.0 0.0 1.3 1.1 0.3 2.1 0.1 0.2 0.2 1.1 2.2 2.9 0.7 1.9 0.2 1.4 0.4 0.7 0.2 1.5 0.2 1.4 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.8 0.1 0.0 1.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.9 0.6 0.7 0.5 0.6 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 SERTAD4 DJ667H12.2 ENSG00000082497 "SERTA domain containing 4" Q9NUC0 1 210232799-210246631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 36.3" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 14.8;Ciliated cells: 14.7;Extravillous trophoblasts: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.4;BEWO: 7.7;SCLC-21H: 7.7;SK-BR-3: 8.8;T-47d: 10.8;U-2 OS: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027344, HPA028514" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA027344: AB_10601770, HPA028514: AB_10611391" "unprognostic (1.75e-2)" "unprognostic (3.92e-2)" "unprognostic (3.83e-2)" "unprognostic (9.74e-2)" "unprognostic (1.98e-2)" "unprognostic (1.27e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-1)" "unprognostic (7.74e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-2)" "unprognostic (5.98e-2)" "unprognostic (6.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.85e-2)" "unprognostic (6.55e-2)" "unprognostic (4.24e-1)" 1.5 1.0 2.3 0.7 7.7 0.1 12.3 2.6 4.3 6.2 6.2 1.5 4.6 1.1 6.2 3.2 15.7 3.2 2.9 4.2 1.8 2.1 2.5 0.2 3.4 0.4 2.8 0.4 2.5 0.2 1.5 1.4 11.7 3.0 3.6 3.3 1.0 36.3 11.1 0.5 5.3 1.1 6.0 2.7 0.3 2.3 0.7 2.1 1.9 3.2 14.6 7.7 1.7 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.2 1.6 0.0 0.8 0.8 7.7 1.9 1.9 1.4 2.6 0.3 0.9 0.0 0.2 0.4 1.2 3.6 0.3 0.6 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 1.8 0.3 0.0 0.0 0.0 0.3 1.8 0.0 0.0 5.4 6.0 0.3 0.0 2.5 0.0 1.3 1.3 7.7 6.7 1.2 8.8 0.1 3.2 10.8 0.0 2.4 2.1 9.2 0.1 5.6 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.7 2.6 4.3 1.8 2.1 2.8 0.4 3.0 2.1 6.0 3.8 0.0 10.1 14.8 0.5 0.6 2.5 14.7 11.4 8.7 0.0 13.2 6.6 1.6 0.6 1.4 0.0 0.0 3.5 37.9 4.4 2.2 0.0 0.0 1.3 0.0 1.2 1.3 0.0 0.6 0.6 0.6 10.1 0.0 4.3 0.3 5.2 0.0 1.4 0.0 0.2 0.0 0.9 0.0 0.6 4.1 3.7 0.0 3.7 1.8 SETD4 "C21orf18, C21orf27" ENSG00000185917 "SET domain containing 4" Q9NVD3 21 36034541-36079389 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024073, HPA035405" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024073: AB_1856755, HPA035405: AB_2674612" "unprognostic (4.23e-1)" "unprognostic (5.67e-2)" "unprognostic (6.98e-2)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (8.05e-3)" "unprognostic (7.86e-2)" "unprognostic (2.13e-3)" "unprognostic (2.17e-2)" "unprognostic (5.81e-2)" "unprognostic (1.33e-1)" "unprognostic (4.60e-3)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "unprognostic (8.09e-3)" "unprognostic (3.30e-2)" "unprognostic (1.28e-2)" 10.9 12.1 14.4 10.6 19.4 10.2 12.4 19.8 20.8 11.5 12.9 22.0 13.8 15.1 14.7 15.8 14.1 14.9 10.6 13.4 13.6 13.6 12.6 9.1 11.2 10.6 21.0 14.0 13.8 10.5 18.0 17.2 11.9 18.9 13.2 13.0 14.2 12.7 11.3 11.6 18.0 18.0 15.1 14.5 11.1 13.1 28.9 21.7 10.9 13.5 8.6 16.3 12.3 13.4 17.1 17.4 11.9 14.2 10.9 13.4 8.4 9.4 6.7 10.2 13.0 5.1 6.2 16.6 12.6 11.1 13.0 8.8 14.1 8.7 5.1 8.9 5.7 10.1 7.2 7.6 7.5 11.4 9.1 9.2 13.9 10.7 8.8 12.3 13.1 8.0 6.4 12.8 8.9 11.4 7.4 9.7 7.1 18.0 9.6 8.0 9.9 8.7 19.0 21.3 8.1 8.6 13.1 7.5 12.6 14.3 6.8 8.4 13.5 12.8 14.0 12.8 9.3 12.2 11.1 8.1 11.4 4.3 7.1 11.5 15.2 22.0 8.0 12.0 18.2 9.8 6.7 14.2 11.9 9.8 11.0 10.8 17.1 12.1 10.3 16.2 13.9 8.9 10.3 10.7 10.9 10.5 17.4 13.4 8.4 14.4 19.4 19.8 20.8 13.6 13.6 21.0 14.0 18.9 21.7 8.9 6.5 11.6 9.8 10.8 12.3 8.5 2.5 21.4 10.3 8.7 29.5 13.8 5.0 10.7 28.5 7.0 8.4 0.0 7.2 7.7 9.3 9.5 10.5 4.7 8.9 3.2 3.5 8.6 7.1 5.3 8.9 4.8 10.1 7.2 9.9 8.6 8.5 7.0 9.6 7.4 19.5 6.5 7.2 44.6 18.5 8.0 7.9 5.1 10.0 9.6 SETD9 "C5orf35, MGC33648" ENSG00000155542 "SET domain containing 9" Q8NE22 5 56909260-56925532 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.8" "Group enriched" "Detected in many" 6 "Early spermatids: 523.2;Late spermatids: 284.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049936 Approved Nucleoplasm NA NA Nucleoplasm "HPA049936: " "unprognostic (1.13e-1)" "unprognostic (3.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-1)" "unprognostic (2.29e-1)" "unprognostic (7.37e-2)" "unprognostic (8.75e-3)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-2)" "unprognostic (1.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" 7.2 2.6 2.3 1.2 4.4 2.4 11.1 1.4 5.2 2.6 4.4 4.7 4.6 4.4 2.7 2.5 2.4 1.9 2.1 7.0 2.1 2.4 5.4 8.8 2.4 5.3 5.3 3.8 2.6 7.3 2.4 2.0 2.6 3.7 4.3 3.3 2.8 5.3 1.2 4.1 1.9 5.2 4.4 3.6 1.8 2.7 23.8 3.2 1.1 4.4 3.4 2.0 2.9 8.1 1.1 2.0 4.3 3.0 1.6 2.9 0.8 4.9 1.8 3.0 3.8 4.6 2.6 5.2 1.4 2.2 2.4 6.1 4.5 5.7 4.5 7.0 2.1 3.1 4.6 3.2 1.8 6.3 3.2 6.7 1.2 1.5 3.7 1.8 1.4 4.3 1.2 2.5 2.2 3.2 3.6 3.9 1.9 3.7 3.3 5.5 7.1 0.7 3.5 4.7 0.0 7.2 4.6 1.9 6.0 2.6 1.7 3.4 5.4 1.2 3.5 5.9 2.0 5.5 3.4 4.2 1.6 7.3 4.6 3.1 3.3 9.5 7.4 2.2 1.3 0.7 1.4 2.3 4.3 1.4 2.0 1.3 0.5 1.6 0.4 2.0 1.1 0.5 0.6 2.7 1.6 3.0 0.8 2.9 0.8 2.3 4.4 1.4 5.2 2.1 2.4 5.3 3.8 3.7 3.2 3.0 2.4 10.3 12.8 15.5 3.0 14.8 10.2 5.3 1.2 7.0 0.0 13.2 48.0 13.9 523.2 6.8 19.6 0.0 15.2 17.3 15.0 18.2 14.9 24.6 13.3 0.0 17.7 9.8 13.9 284.0 9.5 15.7 27.0 11.8 9.2 2.8 8.6 17.5 5.3 36.6 2.9 0.0 10.2 63.8 8.4 13.4 12.0 8.9 12.0 16.4 SFRP5 SARP3 ENSG00000120057 "Secreted frizzled related protein 5" Q5T4F7 10 97766751-97771952 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6" "Cell type enriched" "Detected in some" 15 "Cholangiocytes: 226.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 30.4" "Group enriched" "Detected in some" 5 "hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6" "Cell type enriched" "Detected in some" 5 "naive CD8 T-cell: 7.4" "Lineage enriched" "Detected in many" 5 "T-cells: 7.4" "Cell line enhanced" "Detected in some" "A549: 3.3;CACO-2: 16.3;RPMI-8226: 5.8;SCLC-21H: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (2.63e-4)" "unprognostic (3.03e-3)" "unprognostic (6.74e-2)" "unprognostic (3.43e-2)" "unprognostic (9.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.19e-1)" "unprognostic (2.85e-1)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (4.51e-9)" "unprognostic (1.67e-2)" "unprognostic (1.57e-1)" "unprognostic (9.17e-2)" "unprognostic (1.62e-1)" 0.9 5.1 0.0 1.3 0.8 0.4 0.6 0.5 0.4 1.8 10.9 1.1 9.1 14.7 1.1 2.8 4.3 0.6 34.9 27.1 0.7 1.8 0.2 3.2 1.9 0.4 4.5 0.1 0.3 70.4 0.2 0.1 0.2 5.6 1.9 0.5 67.6 9.2 2.4 0.4 0.9 17.8 1.0 1.9 0.3 3.4 0.4 0.3 0.0 0.2 1.6 0.3 1.3 1.4 0.0 1.5 0.0 0.0 0.0 7.4 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 5.8 0.0 0.0 2.7 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 7.4 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.8 0.5 0.3 0.7 1.8 4.5 0.1 5.6 0.3 3.0 2.2 0.0 0.0 0.0 0.2 6.7 226.7 0.0 1.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 15.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 1.7 0.0 0.0 1.8 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 6.1 0.0 0.0 0.0 0.0 0.0 SFT2D3 MGC5391 ENSG00000173349 "SFT2 domain containing 3" Q587I9 2 127701508-127705242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 7 "NK-cells: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 8.9;ASC TERT1: 5.2;HHSteC: 6.1;hTCEpi: 8.4;hTERT-HME1: 6.2;RPTEC TERT1: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 4.2 4.4 4.7 2.6 4.3 0.7 11.3 4.6 4.4 9.0 7.4 5.1 4.0 0.7 3.3 13.8 5.0 9.4 5.6 4.5 3.9 3.5 7.1 12.3 3.9 5.5 5.1 1.8 4.6 15.3 11.2 5.5 3.9 2.8 6.9 12.0 5.1 5.3 8.4 2.4 3.6 6.3 6.8 3.9 5.5 6.6 3.6 4.1 8.2 7.0 3.2 10.0 3.4 2.4 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 8.9 5.2 0.0 0.0 4.9 4.9 3.8 0.0 0.0 0.0 0.0 3.6 0.0 0.0 4.1 3.4 3.9 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.6 8.4 2.4 6.2 0.0 4.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.7 4.3 4.6 4.4 3.9 3.5 5.1 1.8 2.8 4.1 3.0 5.0 3.9 6.9 1.1 6.9 0.0 5.1 2.7 1.2 7.0 15.7 3.6 8.3 2.3 2.8 2.7 4.9 0.0 5.2 3.8 3.9 7.7 1.1 6.0 3.7 7.9 5.2 3.7 5.7 1.2 5.2 4.5 3.3 1.0 10.8 9.1 2.3 7.0 7.1 6.0 9.6 0.0 2.1 8.6 3.6 2.4 2.4 4.8 8.4 5.0 SGCZ ZSG1 ENSG00000185053 "Sarcoglycan zeta" Q96LD1 8 14089864-15238339 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;ovary: 11.3;pituitary gland: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;REH: 2.5" "Low region specificity" "Detected in many" HPA017585 Uncertain NA NA "HPA017585: AB_1856799" "unprognostic (3.83e-1)" "unprognostic (1.41e-1)" "unprognostic (5.87e-4)" "unprognostic (1.21e-1)" 1.1 0.4 5.6 0.5 9.5 0.6 2.6 21.2 6.8 0.8 0.7 0.0 0.0 0.7 0.9 1.4 0.4 0.5 0.7 0.5 1.4 2.2 1.0 0.7 0.4 0.4 1.3 2.3 11.3 0.7 0.4 7.3 0.5 5.3 0.8 0.5 0.1 0.4 0.6 0.4 0.9 0.5 0.9 3.2 0.5 0.7 1.4 1.1 0.0 0.4 0.0 0.5 1.5 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 9.5 21.2 6.8 1.4 2.2 1.3 2.3 5.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SGPP2 "FLJ39004, SPP2" ENSG00000163082 "Sphingosine-1-phosphate phosphatase 2" Q8IWX5 2 222424517-222560948 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Urothelial cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;EFO-21: 8.2;hTCEpi: 25.9;RPTEC TERT1: 25.6;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.56e-3)" "unprognostic (1.79e-1)" "unprognostic (8.50e-2)" "unprognostic (2.97e-2)" "unprognostic (1.24e-3)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.31e-2)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (2.69e-2)" 2.9 7.8 5.4 3.1 12.8 1.2 3.9 14.6 8.4 8.6 16.2 2.2 19.5 12.9 2.2 2.0 19.9 10.4 11.5 5.8 5.0 6.1 16.1 0.7 7.7 2.7 4.4 3.8 1.9 3.7 30.5 12.1 0.3 17.1 2.3 13.4 0.3 8.6 22.1 1.1 16.5 23.5 1.3 3.2 1.4 18.3 1.8 3.3 1.7 16.9 9.8 13.9 8.1 9.3 1.1 0.5 1.3 0.5 0.4 2.3 0.2 0.8 0.8 0.3 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 9.4 0.4 8.2 0.0 0.1 0.2 0.2 0.0 0.0 0.2 3.0 0.7 0.2 0.1 0.0 1.0 0.5 0.0 25.9 0.0 0.1 0.0 0.0 0.5 0.2 0.4 0.0 0.5 0.2 0.8 0.3 5.6 0.3 0.4 0.2 0.4 25.6 2.5 10.4 0.4 0.0 1.1 0.1 0.5 0.1 0.1 0.0 0.1 0.3 0.4 0.3 0.3 0.2 0.6 0.1 0.1 0.1 1.3 0.5 0.2 0.4 0.2 1.0 1.1 1.9 0.5 0.0 1.1 0.4 0.2 1.3 0.4 0.2 0.5 2.3 0.2 5.4 12.8 14.6 8.4 5.0 6.1 4.4 3.8 17.1 3.3 3.0 7.8 0.5 2.3 3.3 4.7 4.9 10.2 10.7 11.4 12.2 5.9 0.1 1.7 12.9 6.9 0.1 11.8 0.0 1.6 0.2 0.8 5.6 0.0 0.0 0.2 1.6 1.2 0.0 0.0 2.5 0.6 0.4 0.0 0.0 5.8 1.1 6.9 13.6 0.4 0.2 6.8 0.0 0.2 0.5 0.2 12.5 2.1 0.0 9.3 38.2 SH2D4B ENSG00000178217 "SH2 domain containing 4B" Q5SQS7 10 80537902-80646560 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8;bone marrow: 2.5;epididymis: 2.4" "Cell type enhanced" "Detected in single" 22 "Spermatogonia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enriched" "Detected in single" 87 "REH: 24.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA040022 Uncertain NA NA "HPA040022: AB_10805601" "unprognostic (1.19e-2)" "unprognostic (4.51e-3)" "unprognostic (4.45e-2)" "unprognostic (2.94e-2)" "unprognostic (3.31e-1)" "unprognostic (1.09e-1)" "unprognostic (2.36e-1)" "unprognostic (2.87e-2)" "unprognostic (3.80e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" "unprognostic (2.65e-6)" "unprognostic (9.37e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-3)" "unprognostic (3.81e-1)" 0.6 0.0 0.2 0.2 0.3 2.5 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.0 1.3 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 SH2D6 FLJ35993 ENSG00000152292 "SH2 domain containing 6" Q7Z4S9 2 85418721-85437029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 4.2;pancreas: 1.7;testis: 6.4;thyroid gland: 2.4" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 10.2;Proximal tubular cells: 14.7;Spermatocytes: 7.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.6;LHCN-M2: 6.7;RH-30: 2.4;SCLC-21H: 1.5" "Low region specificity" "Detected in many" HPA053873 Uncertain NA NA "HPA053873: AB_2682286" "unprognostic (4.70e-1)" "unprognostic (3.55e-2)" "unprognostic (3.30e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-2)" "unprognostic (7.95e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (1.46e-1)" "unprognostic (2.70e-1)" "unprognostic (2.49e-1)" "unprognostic (5.06e-7)" "unprognostic (2.54e-1)" "unprognostic (8.65e-2)" "unprognostic (1.23e-2)" "unprognostic (5.65e-3)" 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.3 0.4 0.0 1.9 4.2 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.6 0.0 1.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.8 6.4 2.4 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.6 0.3 0.0 0.1 0.6 0.2 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.4 0.3 0.0 1.6 0.0 0.2 6.7 0.0 0.0 0.0 0.1 0.4 0.4 0.1 2.4 0.0 0.7 0.0 1.5 0.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 1.3 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.3 0.1 0.0 0.5 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 10.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.1 0.2 0.4 14.7 0.0 0.0 0.2 7.0 0.7 0.0 0.1 0.0 0.3 0.0 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 161.5;Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.6;U-87 MG: 48.5" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: AB_2673570" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.1 1.3 1.7 2.5 3.8 4.4 0.5 2.0 0.9 0.9 0.7 0.7 2.2 3.4 5.2 5.1 7.0 0.1 0.9 1.5 1.4 2.0 3.5 3.4 0.6 1.4 7.7 1.2 0.7 3.6 6.3 3.2 6.4 3.2 1.0 6.5 2.6 4.4 3.6 4.1 2.2 2.0 1.7 2.9 2.9 3.6 6.5 2.1 4.7 0.8 5.0 2.1 3.0 2.4 3.1 1.6 9.2 0.6 0.8 2.6 0.3 1.5 3.8 15.6 3.3 3.4 48.5 3.0 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 3.0 3.8 0.9 6.0 2.4 2.1 161.5 5.1 5.3 2.3 5.2 3.9 3.1 39.7 3.5 91.7 1.8 1.3 0.0 19.1 1.3 3.5 3.4 4.6 6.4 2.2 4.8 1.2 1.8 2.1 20.4 2.0 1.3 11.8 1.8 1.9 14.0 5.8 1.9 5.3 11.9 6.1 6.5 27.4 23.3 21.1 1.5 1.6 1.9 3.2 4.8 SH3D21 "C1orf113, FLJ22938" ENSG00000214193 "SH3 domain containing 21" A4FU49 1 36306387-36324886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 26.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 13.1;Late spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2" "HPA042212, HPA042456, HPA066168" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627" "prognostic favorable (2.60e-4)" "unprognostic (8.35e-3)" "unprognostic (3.86e-3)" "unprognostic (9.01e-2)" "unprognostic (2.07e-3)" "unprognostic (7.32e-3)" "unprognostic (2.04e-4)" "unprognostic (7.47e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.38e-3)" "prognostic unfavorable (1.76e-6)" "unprognostic (8.88e-2)" "unprognostic (2.25e-1)" "unprognostic (7.99e-2)" "unprognostic (8.59e-2)" 1.6 1.1 11.6 3.4 9.5 1.9 10.1 12.2 11.3 4.4 5.3 1.1 1.4 16.6 2.8 2.7 7.1 1.9 3.0 2.2 5.2 2.2 8.6 1.4 4.5 2.8 1.9 7.0 4.0 1.0 1.3 2.2 19.4 7.4 7.0 6.0 12.4 12.7 2.6 1.0 16.2 24.3 2.0 2.4 1.6 2.3 6.6 1.9 0.0 26.2 4.1 4.5 3.7 6.7 0.1 0.3 2.0 0.5 2.7 0.6 0.0 8.3 0.2 1.6 1.9 0.5 1.0 9.1 4.0 0.8 3.0 1.3 4.7 3.4 1.5 4.4 1.7 0.3 13.5 1.4 3.0 2.5 0.4 0.6 1.3 2.9 3.7 1.3 0.7 2.0 0.5 2.5 2.0 1.5 22.0 1.1 4.1 0.2 2.6 1.4 4.9 1.4 0.7 1.0 2.2 1.6 2.0 0.1 1.0 3.4 1.0 3.4 1.7 0.9 10.1 3.1 11.2 0.3 0.3 2.3 1.2 0.7 4.0 0.4 3.0 0.9 1.7 3.4 0.7 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 11.6 9.5 12.2 11.3 5.2 2.2 1.9 7.0 7.4 1.9 0.0 1.3 0.8 1.5 2.7 5.2 0.9 0.0 0.0 0.0 5.2 0.0 2.5 1.7 0.5 13.1 0.9 11.8 0.0 0.3 2.1 1.4 2.0 1.1 0.0 7.0 11.1 0.0 0.6 3.2 38.8 1.1 4.7 3.3 3.6 2.0 1.0 2.7 0.8 2.5 0.8 1.1 0.0 1.7 2.1 1.5 2.8 4.8 0.0 1.6 1.1 SHISA4 "C1orf40, hShisa4, TMEM58" ENSG00000198892 "Shisa family member 4" Q96DD7 1 201888680-201892306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 175.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8" "Group enriched" "Detected in many" 9 "granulocytes: 18.3;monocytes: 7.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061273, HPA067885" Uncertain NA NA "HPA061273: AB_2684460, HPA067885: " "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (1.48e-3)" "unprognostic (2.12e-3)" "unprognostic (6.59e-2)" "unprognostic (8.29e-3)" "unprognostic (7.06e-2)" "unprognostic (5.00e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-1)" "unprognostic (8.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.63e-3)" "unprognostic (1.20e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" 5.2 15.8 22.2 3.8 18.8 2.5 3.3 9.6 34.8 4.7 3.3 29.1 2.1 2.7 4.4 4.5 4.0 3.9 4.7 14.7 17.5 14.6 4.1 3.8 4.0 2.7 19.2 14.8 6.8 4.1 4.1 3.8 3.8 21.3 6.2 2.9 7.2 12.1 5.1 175.2 4.2 3.2 4.7 14.0 3.4 3.2 4.2 8.2 0.0 6.3 18.8 2.7 3.9 2.6 0.0 0.7 18.3 7.8 0.0 1.5 0.5 1.1 8.8 1.0 6.3 9.5 5.7 0.9 7.7 12.6 3.2 4.5 1.5 2.3 0.0 10.5 9.5 12.6 2.2 0.1 1.3 2.1 0.9 0.5 0.1 2.6 1.0 6.7 0.0 5.6 5.8 2.8 4.1 2.0 16.6 5.8 0.1 0.0 0.3 5.6 1.0 0.0 0.0 0.6 0.6 10.7 0.1 0.0 1.7 3.1 3.4 0.4 5.7 2.7 1.3 7.8 5.3 3.6 0.7 5.9 4.6 4.5 2.5 3.9 1.5 1.2 0.0 7.4 0.0 7.9 0.0 1.4 18.3 1.5 6.4 0.6 0.0 0.3 0.3 0.7 0.0 0.0 0.3 8.2 0.0 7.8 0.0 0.0 0.5 22.2 18.8 9.6 34.8 17.5 14.6 19.2 14.8 21.3 8.2 0.0 1.7 0.0 3.6 12.6 9.2 18.3 7.6 0.0 2.3 10.4 3.9 1.5 28.2 22.4 0.5 7.4 0.0 0.0 13.5 19.0 16.6 9.5 1.1 3.4 2.9 4.8 1.7 11.6 2.9 1.5 14.7 4.2 21.9 6.4 0.0 19.3 10.6 0.0 27.6 5.0 3.4 19.4 13.3 1.4 0.7 5.9 2.3 2.2 0.0 1.8 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.8;Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 6.7;HMC-1: 7.0;THP-1: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol NA NA Cytosol "HPA058935: AB_2683857" "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901620-13240413 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.3;Ciliated cells: 21.4;Club cells: 12.5;granulocytes: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "EFO-21: 29.8;LHCN-M2: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 1.2 4.8 17.2 1.6 23.5 2.7 1.3 0.9 21.3 0.9 3.4 3.6 0.4 1.6 1.1 2.3 1.2 0.7 0.9 1.3 10.2 6.7 3.4 1.4 0.7 1.0 3.3 12.6 1.1 1.3 0.6 1.9 1.0 10.2 6.9 1.8 0.6 1.7 1.4 4.2 1.9 1.7 1.2 2.1 1.0 1.3 1.6 4.0 0.0 3.5 0.0 0.8 0.8 0.9 2.0 1.2 3.9 0.9 1.2 0.9 0.0 0.6 0.3 0.5 0.5 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.5 0.5 29.8 0.1 0.6 0.5 0.1 0.1 0.1 0.5 0.2 0.7 0.6 0.3 0.0 0.5 0.8 0.9 0.0 0.1 2.1 0.3 0.1 0.5 0.4 1.2 24.2 3.3 0.4 0.7 6.4 0.5 0.3 0.6 0.4 0.3 6.6 1.1 6.4 0.5 0.3 1.0 0.4 3.1 0.8 0.4 0.4 0.6 3.9 0.6 0.4 1.2 1.2 0.6 0.4 0.2 0.8 3.9 0.9 0.4 0.8 0.5 0.6 1.1 0.7 0.8 0.3 2.0 0.9 0.8 3.2 1.2 0.7 1.2 0.7 0.0 17.2 23.5 0.9 18.8 10.2 6.7 3.3 12.6 10.2 4.0 23.8 15.3 0.0 0.5 0.1 0.6 0.8 0.0 21.4 12.5 1.8 0.0 0.0 1.7 0.7 3.8 0.3 0.0 0.0 0.0 0.0 0.2 1.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.2 0.0 0.0 0.0 0.5 0.1 2.9 0.0 0.9 0.3 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.3 0.5 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA051178: AB_2681374" "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.7 0.6 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 7.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.9 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 17.0 0.0 0.1 0.2 0.0 0.1 0.0 6.4 1.0 38.7 0.2 0.0 0.0 0.0 22.5 0.0 12.9 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633344-52669683 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.8;lymphoid tissue: 25.4" "Cell type enhanced" "Detected in single" 26 "Hofbauer cells: 1.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 8.8" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9" "Cell line enhanced" "Detected in some" "Daudi: 5.4;Karpas-707: 13.0;NB-4: 3.7;RPMI-8226: 17.1" "Region enhanced" "Detected in single" "hypothalamus: 4.7" "Low region specificity" "Detected in many" HPA030744 Uncertain NA NA "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.6 0.4 1.0 25.4 1.4 3.5 0.5 1.3 2.0 1.3 1.2 1.2 0.0 1.0 1.1 1.9 1.0 0.9 1.3 0.3 0.9 8.8 0.8 0.4 1.2 20.4 2.8 0.2 0.2 0.7 0.0 3.2 0.5 1.2 0.7 0.9 0.6 3.7 1.0 0.7 0.2 5.7 0.6 2.1 12.1 1.2 1.2 0.7 3.5 1.3 0.3 24.0 3.2 0.4 10.8 0.1 1.9 0.0 5.7 7.9 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 3.7 2.2 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.5 0.0 1.1 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 7.9 0.0 4.5 10.7 7.2 6.4 0.1 10.8 5.0 3.1 0.0 5.7 0.0 0.1 2.2 1.8 1.0 1.4 1.3 2.0 0.9 8.8 2.8 0.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SHOX2 "OG12, OG12X, SHOT" ENSG00000168779 "Short stature homeobox 2" O60902 3 158095954-158106503 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "Early spermatids: 89.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "pons and medulla: 10.1;thalamus: 2.9" "Cell type enriched" "Detected in single" 4 "neutrophil: 2.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "ASC diff: 15.5;SH-SY5Y: 15.0;THP-1: 24.8" "Group enriched" "Detected in some" 5 "midbrain: 43.1;thalamus: 60.0" "Group enriched" "Detected in some" 36 "midbrain: 13.2;pons and medulla: 15.8;thalamus: 28.2" NA NA "unprognostic (2.62e-1)" "unprognostic (6.32e-2)" "unprognostic (3.32e-2)" "unprognostic (1.08e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-3)" "unprognostic (2.28e-3)" "unprognostic (7.66e-2)" "unprognostic (7.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.31e-2)" "unprognostic (8.75e-3)" "unprognostic (0.00e+0)" "unprognostic (4.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" 10.0 0.3 0.1 0.1 0.1 0.4 6.6 0.1 0.2 10.0 0.5 3.0 2.8 0.0 1.1 1.4 2.5 0.2 0.6 9.9 0.1 1.5 0.1 0.2 0.4 4.1 0.4 0.1 1.0 1.5 0.0 0.4 1.3 10.1 1.5 0.1 0.3 2.8 1.1 3.6 2.5 0.3 1.3 0.3 0.1 0.3 4.4 2.9 0.0 0.7 2.4 1.1 1.7 4.6 0.3 0.0 2.9 0.7 0.0 0.1 0.0 3.2 0.3 0.1 5.3 15.5 9.7 0.9 5.9 2.1 2.9 5.5 1.1 0.4 0.7 0.1 7.6 6.3 0.1 6.2 0.0 1.2 3.6 1.9 8.9 1.3 0.0 0.0 0.7 7.3 4.4 0.1 2.9 0.3 9.5 0.0 0.4 2.4 0.5 1.4 0.2 0.0 0.4 0.0 0.0 0.2 3.7 4.9 0.8 0.0 0.0 1.8 15.0 0.7 0.1 3.2 0.1 0.1 24.8 0.3 9.7 2.1 10.7 9.4 0.7 1.6 0.5 9.3 4.9 9.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 2.9 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 1.5 0.4 0.1 10.1 2.9 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.3 0.1 0.0 0.0 0.2 0.6 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 7.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 4.7 5.5 1.4 0.4 0.2 0.0 0.0 0.0 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 6 "EFO-21: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 5.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 4.0 0.0 1.8 2.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532296-113629578 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.6" "Cell type enhanced" "Detected in many" 8 "B-cells: 13.7;Mucus-secreting cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 11.6;OE19: 12.3;PC-3: 16.4;RT4: 11.4;T-47d: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035862 Approved NA NA "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.8 4.1 7.5 13.6 5.9 4.1 7.8 17.3 11.7 4.7 8.4 5.5 3.7 2.8 1.2 0.7 2.7 2.8 5.1 1.1 7.9 9.2 1.6 1.1 2.7 17.6 4.7 8.5 0.9 1.7 1.5 12.8 1.6 4.7 7.2 14.0 0.4 13.2 9.7 0.8 1.3 8.4 1.3 4.5 11.6 4.9 1.8 1.2 13.2 1.3 0.7 13.3 6.8 1.9 4.9 21.6 0.2 0.4 5.9 4.9 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.4 0.0 11.6 3.1 0.1 0.0 12.3 16.4 4.7 0.0 0.4 0.0 11.4 0.1 0.1 0.0 3.3 0.1 0.0 10.8 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.9 0.1 4.9 4.9 3.2 3.9 0.9 4.3 4.2 3.5 0.1 5.9 0.0 21.6 2.5 2.1 7.5 5.9 17.3 11.7 7.9 9.2 4.7 8.5 4.7 1.2 6.0 3.5 13.7 1.6 0.3 0.0 0.8 2.5 9.4 3.4 1.8 0.0 0.0 0.0 0.3 2.8 0.7 4.3 0.0 1.0 0.1 0.3 6.3 3.5 0.0 8.7 0.0 9.8 0.6 3.5 1.3 0.0 2.5 5.0 2.8 20.6 0.0 0.7 2.9 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.1 8.9 6.3 1.4 SIGLEC12 "S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG" ENSG00000254521 "Sialic acid binding Ig like lectin 12 (gene/pseudogene)" Q96PQ1 19 51491357-51501789 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 13.1;lymphoid tissue: 29.6" "Group enriched" "Detected in some" 14 "granulocytes: 2.3;Hofbauer cells: 1.8;Kupffer cells: 2.8;Macrophages: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HMC-1: 54.1;U-937: 28.9" NA NA "unprognostic (1.46e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-2)" "unprognostic (9.13e-2)" "unprognostic (9.58e-4)" "unprognostic (1.38e-1)" "unprognostic (3.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (3.73e-1)" "unprognostic (1.29e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-5)" "unprognostic (2.45e-1)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-1)" 2.8 1.0 0.2 6.2 1.2 1.3 0.3 0.1 0.3 0.3 1.5 0.2 0.6 0.4 0.4 0.5 0.6 0.4 1.6 0.7 0.2 0.2 0.4 13.1 5.3 3.9 0.2 0.0 0.3 0.3 0.0 0.2 0.0 0.3 0.5 2.6 0.6 1.2 0.0 0.2 0.2 2.5 3.4 0.3 29.6 0.5 1.4 0.0 2.4 0.2 1.0 1.7 0.6 0.3 0.7 0.8 3.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 2.0 3.0 0.0 0.9 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 0.1 0.3 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIGLECL1 "C19orf75, FLJ40235, SIGLEC23P, SIGLECP7" ENSG00000179213 "SIGLEC family like 1" Q8N7X8 19 51246348-51269330 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 29.7" "Group enriched" "Detected in some" 6 "Early spermatids: 33.0;Late spermatids: 49.4;Spermatocytes: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Group enriched" "Detected in many" 19 "dendritic cells: 2.6;monocytes: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;HEL: 2.6;HMC-1: 2.8;NB-4: 2.2;U-937: 1.8" HPA079471 Enhanced NA NA "HPA079471: " "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 2.6 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.8 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 25.1 6.3 0.0 0.0 0.0 0.0 0.0 SIM1 bHLHe14 ENSG00000112246 "Single-minded family bHLH transcription factor 1" P81133 6 100385015-100464929 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5" "Group enriched" "Detected in some" 4 "Collecting duct cells: 19.2;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in single" "renal cancer: 1.8" "Region enriched" "Detected in single" 21 "hypothalamus: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7" "Region enriched" "Detected in single" 7 "hypothalamus: 6.1" "Group enriched" "Detected in some" 5 "basal ganglia: 2.6;hypothalamus: 5.2" HPA024385 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024385: AB_1856879" "unprognostic (1.04e-1)" "unprognostic (4.34e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-1)" "unprognostic (4.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (4.64e-2)" "unprognostic (3.76e-2)" "prognostic favorable (5.32e-7)" "unprognostic (1.00e-1)" "unprognostic (1.19e-1)" 5.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 13.2 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 2.2 21.6 0.5 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 17.5 4.7 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 8.0 0.0 12.8 18.7 5.8 5.4 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 4.9 5.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 19.2 0.0 0.0 6.6 3.0 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 1.6 0.0 0.4 0.0 0.0 0.0 0.0 SIRPB2 "dJ776F14.2, PTPN1L, PTPNS1L3" ENSG00000196209 "Signal regulatory protein beta 2" Q5JXA9 20 1470741-1491587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.5;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 4.4;Kupffer cells: 18.9;Macrophages: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 194 "dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8" "Cell line enhanced" "Detected in some" "A-431: 5.3;HBEC3-KT: 4.5;HMC-1: 9.3;hTCEpi: 10.0;HUVEC TERT2: 5.0;THP-1: 8.8;TIME: 4.4;U-937: 9.4" "Low region specificity" "Detected in all" "HPA011548, HPA048032" Uncertain Approved "Nuclear bodies" NA NA 100000 "Nuclear bodies" "HPA011548: AB_2668514, HPA048032: AB_2680236" "unprognostic (3.22e-2)" "unprognostic (5.57e-2)" "unprognostic (2.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (3.50e-5)" "unprognostic (3.59e-3)" "unprognostic (9.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" 8.1 4.2 5.8 15.8 11.0 8.1 5.2 0.8 6.5 2.8 2.4 3.3 0.0 1.3 1.9 4.5 2.6 3.1 5.2 2.7 5.9 3.1 2.6 2.5 9.5 17.3 9.2 1.7 1.4 1.6 0.7 1.4 10.0 7.9 1.8 2.5 2.4 2.8 1.0 1.2 1.5 3.3 5.5 13.1 21.2 2.0 1.8 9.1 1.0 1.7 0.3 4.3 6.4 3.9 0.0 8.8 29.5 19.8 0.0 0.0 6.4 5.3 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 1.3 0.0 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.2 9.3 0.0 10.0 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 8.8 4.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 9.4 0.1 1.2 19.8 12.3 0.0 12.8 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 29.5 0.0 9.7 0.3 0.0 6.4 5.8 11.0 0.8 6.5 5.9 3.1 9.2 1.7 7.9 9.1 0.0 0.6 0.5 0.7 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.4 1.1 0.0 4.4 0.0 0.0 0.6 18.9 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 SIRPD "dJ576H24.4, PTPNS1L2" ENSG00000125900 "Signal regulatory protein delta" Q9H106 20 1534251-1558843 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "blood: 19.9;testis: 64.2" "Group enriched" "Detected in some" 90 "Early spermatids: 387.0;Late spermatids: 441.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 19.9" "Group enriched" "Detected in many" 4 "granulocytes: 19.9;monocytes: 12.5" "Cell line enhanced" "Detected in some" "HL-60: 2.6;HMC-1: 3.5;NB-4: 4.6;THP-1: 9.9;U-937: 2.2" HPA042663 Enhanced "Secreted in male reproductive system" NA NA "HPA042663: AB_2678102" "unprognostic (4.91e-2)" "unprognostic (1.51e-2)" "unprognostic (3.01e-2)" "unprognostic (4.47e-1)" "unprognostic (2.49e-1)" "unprognostic (1.02e-1)" "unprognostic (1.48e-2)" "unprognostic (2.79e-1)" "unprognostic (3.66e-8)" "unprognostic (2.14e-1)" "unprognostic (3.32e-2)" "unprognostic (9.57e-3)" "unprognostic (2.44e-2)" 0.1 0.1 0.1 1.9 0.1 1.7 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.1 1.3 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.0 64.2 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.0 4.0 19.9 12.5 0.0 0.1 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.5 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 12.5 11.2 0.0 7.3 0.1 0.0 0.0 0.1 4.0 0.0 0.0 0.0 19.9 0.0 3.1 2.3 0.1 3.6 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 387.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.6 441.6 3.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 1.7 0.0 0.0 0.0 0.0 0.0 SLAMF9 "CD2F-10, CD84-H1, SF2001" ENSG00000162723 "SLAM family member 9" Q96A28 1 159951492-159954254 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "adipose tissue: 20.3;blood: 5.5" "Group enriched" "Detected in some" 5 "Early spermatids: 8.9;Hofbauer cells: 7.2;Late spermatids: 22.7;Macrophages: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.5" "Lineage enriched" "Detected in single" 9 "dendritic cells: 5.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 6.7;HEL: 9.1;PC-3: 3.7;SK-MEL-30: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035153 Uncertain NA NA "HPA035153: AB_10670586" "unprognostic (1.05e-1)" "unprognostic (1.54e-5)" "unprognostic (6.12e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (7.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" "unprognostic (2.46e-1)" "unprognostic (3.54e-4)" "unprognostic (5.27e-4)" "unprognostic (5.47e-2)" "unprognostic (6.17e-5)" "unprognostic (8.97e-3)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" 20.3 0.0 0.1 2.3 0.1 1.1 0.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.7 1.0 0.1 0.4 0.1 0.0 0.1 2.6 1.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.7 0.2 2.9 0.1 0.5 0.1 0.7 0.5 2.9 0.5 0.1 5.5 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 6.7 0.0 0.0 0.0 9.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 4.0 1.0 0.7 1.5 0.0 1.3 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 2.4 7.2 0.0 0.0 0.0 1.8 22.7 0.3 7.3 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.6 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 9 "basophil: 51.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 51.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favorable (4.53e-4)" "prognostic unfavorable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavorable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 14.5 14.6 3.6 11.6 5.1 22.5 13.4 5.0 8.1 21.5 15.3 8.1 16.3 10.6 25.0 36.1 22.8 15.4 21.1 19.5 6.0 4.6 17.7 6.7 16.3 14.0 5.8 6.2 32.3 25.7 6.1 12.7 40.1 7.6 23.7 6.4 12.4 11.7 13.3 13.7 26.2 13.6 20.1 5.3 13.1 12.6 11.6 4.7 12.6 15.7 23.3 18.6 23.3 18.3 1.6 2.7 51.2 1.7 2.2 3.8 1.8 24.9 10.7 2.9 14.6 10.1 11.0 19.0 18.6 11.4 12.6 12.7 9.5 12.1 19.0 35.4 17.8 16.8 21.5 9.4 9.5 3.4 12.3 4.4 5.9 14.1 7.5 18.6 7.0 9.6 13.7 10.9 11.7 6.3 11.3 8.6 3.3 6.6 18.7 8.2 33.1 3.8 6.3 2.2 12.2 20.8 6.1 7.7 14.4 9.5 9.3 2.6 4.7 11.7 21.3 4.9 3.5 6.8 5.6 11.3 15.0 9.4 34.8 23.5 13.4 12.9 19.6 16.0 14.7 7.7 51.2 1.3 5.6 3.8 1.7 2.9 1.6 2.6 2.8 1.1 1.6 1.9 1.8 1.7 2.2 1.5 2.7 1.8 1.8 3.6 5.1 5.0 8.1 6.0 4.6 5.8 6.2 7.6 4.7 3.0 6.5 11.7 23.8 20.0 2.0 3.6 7.6 4.0 3.4 17.4 5.9 42.9 6.6 15.3 2.4 14.3 14.4 0.0 17.0 52.6 23.3 12.1 12.7 1.6 17.2 3.2 9.8 18.4 7.8 1.0 25.0 10.5 3.3 16.2 14.0 2.3 15.9 15.3 12.4 7.7 1.6 6.5 22.6 1.2 2.7 24.3 86.2 17.5 10.6 24.7 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.7 0.3 0.9 0.9 0.7 1.4 0.7 0.9 0.4 0.3 0.5 0.4 0.5 0.9 1.3 0.2 0.2 0.9 1.1 0.8 1.3 0.7 2.4 1.8 2.6 1.4 0.4 0.1 0.3 0.4 2.2 0.7 1.7 1.5 0.4 0.6 1.6 1.2 1.3 0.7 0.5 1.2 0.4 6.5 0.5 0.3 0.3 0.6 1.2 3.1 2.1 0.9 0.7 0.6 0.3 0.5 1.6 0.6 0.9 1.1 1.5 1.4 1.4 1.5 2.2 0.1 1.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 6.7 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 5.2 0.0 1.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 3.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 1.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.4 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.6;lymphoid tissue: 23.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 3.7;NB-4: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 13.5 4.7 4.3 14.9 13.3 11.6 2.6 0.6 9.3 1.7 1.8 4.6 0.0 1.3 1.3 2.1 1.4 4.1 3.0 6.5 15.0 2.6 2.1 3.2 37.6 19.9 17.1 0.7 2.4 3.3 1.2 1.9 6.2 11.3 1.7 1.0 1.7 2.0 1.2 2.0 1.0 1.2 4.6 18.1 23.8 1.7 2.4 10.3 0.0 1.8 0.2 1.0 7.1 1.3 0.4 2.4 6.0 7.9 0.2 0.4 2.6 0.3 0.7 0.0 0.4 0.1 0.1 0.9 0.0 0.0 0.1 0.2 1.0 2.1 0.2 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.1 3.8 0.6 0.7 0.1 0.0 3.7 0.3 0.1 0.0 0.2 0.3 0.0 1.2 1.0 0.7 0.1 1.3 0.2 3.1 0.0 0.6 0.2 0.2 0.6 0.4 0.1 0.3 0.8 0.2 0.5 0.4 0.4 0.2 0.3 1.1 0.3 0.7 0.4 0.2 0.0 0.3 0.3 0.7 0.2 0.4 0.4 0.3 7.9 0.6 0.4 5.8 0.3 0.1 0.2 0.2 2.4 0.4 0.4 0.3 6.0 0.2 7.0 0.2 0.2 2.6 4.3 13.3 0.6 9.3 15.0 2.6 17.1 0.7 11.3 10.3 20.8 52.4 3.0 3.9 0.8 3.6 6.3 5.1 17.4 22.7 8.7 0.0 1.6 8.3 0.8 1.2 4.7 1.2 0.0 1.8 7.2 2.4 5.7 24.3 4.7 110.2 1.6 1.2 8.6 163.4 0.4 2.0 201.4 1.7 1.0 4.0 7.6 0.6 0.9 0.7 6.8 3.0 19.4 5.0 0.5 1.7 0.9 6.8 1.7 2.2 2.7 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 18.2;OE19: 17.3;U-2197: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.1 1.1 11.1 0.7 19.4 0.0 2.0 0.8 7.0 1.2 3.0 1.7 0.4 4.9 0.4 2.9 3.5 1.7 8.1 0.5 3.8 1.2 2.1 5.7 1.9 0.4 1.0 3.6 0.5 9.0 8.2 1.9 2.2 8.6 2.5 4.1 6.2 10.0 0.4 1.8 1.0 3.4 0.4 1.3 0.4 3.8 4.6 2.0 0.4 20.5 0.4 0.7 1.9 1.7 0.2 0.2 1.8 0.5 0.0 0.2 0.0 8.2 0.0 1.4 0.0 1.7 2.4 4.1 0.4 1.0 0.4 0.9 10.7 3.9 0.0 1.0 3.7 1.4 5.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 18.2 0.0 0.6 4.7 5.0 1.4 0.5 9.7 0.0 0.0 0.0 0.3 0.6 2.2 0.0 0.0 5.7 17.3 0.4 0.0 0.1 0.0 4.2 0.6 2.4 0.0 4.8 5.1 0.1 0.6 9.1 0.2 0.1 0.1 0.7 35.3 0.0 0.1 1.0 2.7 1.7 0.0 0.7 1.8 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 19.4 0.8 7.0 3.8 1.2 1.0 3.6 8.6 2.0 0.0 0.3 0.0 1.1 0.9 0.0 1.0 0.0 0.0 1.2 22.7 0.0 0.3 0.0 3.9 0.2 0.0 2.0 0.0 2.9 6.2 1.3 5.0 18.4 6.4 0.8 0.0 5.2 0.0 0.0 0.0 0.0 0.6 0.0 3.6 28.6 0.0 4.3 2.9 0.0 1.1 0.0 0.0 0.3 0.7 0.4 0.3 2.5 0.0 5.0 0.9 SLC13A2 NaDC-1 ENSG00000007216 "Solute carrier family 13 member 2" Q13183 17 28473293-28497781 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 181.4" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 28.1;Enterocytes: 37.5;Mucus-secreting cells: 25.2;Proximal tubular cells: 82.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;RPMI-8226: 2.4;SH-SY5Y: 1.2;SK-BR-3: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA014963 Enhanced NA NA "HPA014963: AB_1857096" "unprognostic (8.47e-2)" "unprognostic (7.63e-3)" "unprognostic (4.36e-3)" "unprognostic (2.06e-1)" "unprognostic (2.36e-3)" "unprognostic (3.06e-1)" "unprognostic (2.28e-4)" "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "prognostic favorable (9.00e-4)" "unprognostic (2.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.50e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 1.4 0.1 0.1 0.1 142.8 0.0 10.7 34.6 0.1 0.5 0.1 0.1 3.4 0.1 0.1 0.1 12.5 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 1.8 0.0 14.9 17.1 0.1 2.1 181.4 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.7 0.1 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 28.1 0.0 0.0 3.5 11.8 0.0 8.3 0.0 0.0 0.0 37.5 0.0 6.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.2 0.0 0.2 8.6 0.0 82.9 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 13.9 0.3 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 30.1;SK-BR-3: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 30.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 6.8 0.0 0.0 0.0 1.7 1.7 0.6 0.1 0.3 0.0 29.9 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 3.0 0.0 0.0 0.1 0.1 0.0 0.4 30.6 1.4 2.3 1.8 0.0 0.0 1.7 9.1 0.0 0.0 51.2 0.0 0.7 0.0 0.0 0.8 0.0 29.9 0.1 0.0 3.5 0.6 0.3 0.0 0.0 0.0 1.7 0.0 1.7 0.0 2.9 5.8 0.0 9.8 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 1.7 0.3 SLC16A14 "FLJ30794, MCT14" ENSG00000163053 "Solute carrier family 16 member 14" Q7RTX9 2 230034974-230068999 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 4.5;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 12.0" "Lineage enriched" "Detected in single" 22 "granulocytes: 12.0" "Cell line enhanced" "Detected in many" "HL-60: 16.7;Karpas-707: 11.5;REH: 14.3;RPMI-8226: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040518 Uncertain Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA040518: AB_10794877" "unprognostic (2.99e-1)" "unprognostic (1.74e-1)" "unprognostic (2.63e-1)" "unprognostic (1.74e-3)" "unprognostic (2.20e-3)" "unprognostic (2.01e-1)" "unprognostic (4.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.15e-1)" "unprognostic (5.70e-3)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.03e-3)" "unprognostic (3.51e-1)" "unprognostic (2.39e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" 5.4 5.2 7.0 2.2 11.1 6.6 4.0 14.4 16.2 6.5 4.6 3.2 1.1 1.3 4.9 3.2 5.3 4.1 3.6 3.0 6.9 8.2 1.7 2.5 2.5 1.6 6.2 8.2 10.2 1.1 12.4 1.9 1.6 6.7 5.9 5.0 12.0 20.5 4.7 1.3 13.4 1.6 4.9 4.4 10.1 1.8 2.0 1.3 1.1 2.0 3.4 3.3 3.8 4.8 0.4 0.5 12.0 0.0 0.1 0.4 0.1 2.1 1.3 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.4 3.7 1.1 0.1 0.0 6.3 0.1 2.5 0.0 0.2 16.7 0.0 0.4 2.9 0.0 0.0 3.1 0.1 3.4 0.0 11.5 0.2 0.0 1.6 2.1 0.8 0.2 2.0 14.3 0.0 12.9 4.4 1.9 4.8 1.5 3.5 0.0 0.1 0.0 5.7 1.5 0.0 0.0 0.9 2.4 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.4 0.0 0.3 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 7.0 11.1 14.4 16.2 6.9 8.2 6.2 8.2 6.7 1.3 0.0 0.0 0.0 0.6 2.3 2.9 3.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 4.5 0.0 0.0 0.5 0.0 0.8 0.8 0.0 1.0 0.1 3.2 3.5 3.1 0.3 0.0 1.1 0.0 1.7 0.0 0.0 1.8 0.7 0.0 2.8 0.5 1.1 0.0 1.0 0.2 0.2 4.1 0.2 0.0 1.6 0.2 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 68.0;Proximal tubular cells: 176.8" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 5.5 1.2 1.8 4.0 7.8 11.6 3.0 11.7 1.0 2.9 1.7 17.3 0.3 3.3 9.4 0.1 0.3 0.0 1.1 1.1 0.3 1.4 0.3 1.1 1.7 11.6 0.3 0.3 5.7 0.1 1.7 0.1 25.2 2.4 0.4 0.2 0.6 1.9 0.5 0.2 0.3 0.3 0.0 0.2 0.1 0.8 0.1 2.0 0.2 0.7 0.4 0.3 5.6 17.8 5.6 0.3 0.0 0.2 0.7 0.4 0.2 0.8 0.3 0.0 0.9 0.6 0.2 3.2 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 11.9 17.3 3.2 5.2 2.7 11.1 1.1 15.3 0.0 5.7 68.0 5.9 28.5 3.3 2.9 0.4 4.4 1.3 23.3 0.8 29.3 13.9 2.7 4.7 4.5 3.7 3.2 3.4 3.1 1.0 1.1 16.7 0.8 10.1 1.0 0.9 2.3 1.3 0.2 11.0 176.8 17.7 0.0 5.2 3.0 2.0 3.1 29.4 4.6 0.5 5.0 SLC16A5 "MCT5, MCT6" ENSG00000170190 "Solute carrier family 16 member 5" O15375 17 75087727-75106162 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 45.5;Collecting duct cells: 83.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 8.4;neutrophil: 22.1" "Group enriched" "Detected in many" 6 "granulocytes: 22.1;monocytes: 8.4" "Cell line enhanced" "Detected in many" "A549: 23.1;OE19: 24.8;RPTEC TERT1: 24.7;RT4: 49.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" "unprognostic (2.51e-2)" "unprognostic (2.90e-2)" "unprognostic (2.72e-1)" "unprognostic (6.30e-2)" "unprognostic (2.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (8.43e-3)" "unprognostic (8.07e-2)" "unprognostic (9.63e-2)" "unprognostic (3.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" 6.0 1.0 0.9 6.3 1.0 4.1 4.9 2.0 1.1 8.9 18.7 1.5 7.5 19.4 6.6 14.6 6.9 9.4 15.3 8.6 1.2 0.9 35.0 2.3 16.9 7.5 1.7 1.2 8.3 4.1 3.6 2.0 30.8 2.3 13.0 5.7 9.5 5.2 15.2 7.9 8.8 30.5 4.7 1.5 6.8 14.6 4.9 1.0 1.8 13.3 9.5 8.8 15.3 11.0 0.7 2.5 22.1 8.4 0.6 1.0 2.4 4.8 23.1 0.4 0.0 1.2 1.5 7.9 2.7 7.0 2.7 1.9 6.0 14.0 0.0 3.3 8.4 0.3 14.0 1.1 3.8 1.0 0.0 0.0 1.7 10.7 3.0 5.5 0.0 0.0 3.7 4.6 2.8 0.0 0.0 5.6 0.2 0.3 0.0 0.2 0.8 0.1 2.4 1.8 24.8 0.0 0.5 0.0 0.1 24.7 49.0 0.0 0.1 6.8 1.6 3.4 4.1 11.4 2.4 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 1.5 2.4 8.4 2.1 0.3 3.1 0.2 0.7 0.4 0.1 2.5 0.2 1.0 0.3 22.1 0.6 1.6 0.0 0.4 2.4 0.9 1.0 2.0 1.1 1.2 0.9 1.7 1.2 2.3 1.0 35.7 30.9 0.0 6.8 2.3 0.0 4.8 7.6 45.5 30.7 83.7 0.0 16.4 5.0 5.3 41.8 2.9 30.7 0.0 1.2 3.2 3.3 9.6 6.9 0.0 6.1 0.0 6.4 17.2 8.4 26.5 0.6 5.4 6.8 4.6 11.9 0.0 0.7 19.8 0.0 1.8 0.0 0.0 1.9 0.3 1.7 1.1 16.4 0.5 10.1 13.3 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell type enhanced" "Detected in some" 9 "Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" No NA "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.7 1.2 0.2 0.0 0.0 6.1 0.5 0.0 0.0 0.0 1.3 3.5 0.4 1.7 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.9 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 1.6 0.0 4.0 0.0 0.0 1.4 0.1 0.1 2.0 0.0 0.0 0.0 4.5 2.0 0.3 6.5 0.3 1.0 0.6 7.8 0.2 0.0 0.0 3.6 0.3 0.0 11.5 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 0.0 0.0 0.0 0.5 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.0 0.0 1.3 0.3 1.6 4.0 0.0 5.0 0.0 0.0 0.9 0.2 0.0 2.1 0.0 0.5 0.0 0.9 0.9 4.1 0.6 0.0 0.0 0.0 0.1 SLC17A2 NPT3 ENSG00000112337 "Solute carrier family 17 member 2" O00624 6 25912754-25930726 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 333 "liver: 80.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 29.7" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "Hep G2: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA038270 Uncertain NA NA "HPA038270: AB_10672511" "prognostic favorable (8.54e-4)" "unprognostic (1.90e-2)" "unprognostic (4.14e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SLC17A4 KIAA2138 ENSG00000146039 "Solute carrier family 17 member 4" Q9Y2C5 6 25754699-25781191 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2" "Group enriched" "Detected in some" 4 "Cholangiocytes: 86.6;Enterocytes: 45.7;Hepatocytes: 37.5;Paneth cells: 43.2" "Group enriched" "Detected in some" 6 "liver cancer: 11.0;renal cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 5.8" "Not detected" "Not detected" HPA055564 Approved NA NA "HPA055564: AB_2682852" "unprognostic (6.52e-2)" "unprognostic (5.64e-3)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (1.19e-3)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" 0.2 0.0 0.2 1.8 0.2 0.0 0.2 0.2 0.2 0.2 12.8 0.2 0.2 14.8 0.2 0.4 0.2 0.1 14.9 0.2 0.2 0.1 2.2 27.2 0.2 0.2 0.2 0.2 0.2 14.2 0.0 0.2 0.2 0.2 0.2 14.2 0.2 0.2 0.2 0.2 0.0 24.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 1.3 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.1 0.8 5.8 0.0 0.2 0.4 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.1 0.1 0.2 0.0 0.3 0.0 0.1 1.3 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 86.6 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.8 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 37.5 0.1 0.0 12.6 0.6 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.2 43.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338097-22379503 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 75.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 1.6;Muller glia cells: 1.3;Rod photoreceptor cells: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "hypothalamus: 20.2;pons and medulla: 75.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 222 "SCLC-21H: 26.6" "Group enriched" "Detected in many" 5 "basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7" "Low region specificity" "Detected in all" "CAB037130, HPA039226, CAB078204" Supported Supported NA NA "CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.5 0.5 7.6 0.5 1.1 0.5 0.5 0.2 13.8 0.5 0.5 1.3 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1.1 20.2 0.5 0.5 0.5 0.5 7.1 2.1 0.5 1.5 0.5 5.3 0.5 75.2 0.5 0.5 1.4 0.5 0.5 0.5 0.5 0.5 0.5 5.9 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 1.1 0.2 8.4 1.1 20.2 7.1 2.1 75.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A7 "BNPI, VGLUT1" ENSG00000104888 "Solute carrier family 17 member 7" Q9P2U7 19 49429401-49442360 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 150.0" "Group enriched" "Detected in some" 27 "Bipolar cells: 377.4;Cone photoreceptor cells: 347.5;Rod photoreceptor cells: 343.9" "Cancer enriched" "Detected in some" 6 "glioma: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 21.2;K-562: 6.7;REH: 3.9;SCLC-21H: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6" "CAB037183, HPA050458, HPA063679" Enhanced Supported NA NA "CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086" "unprognostic (1.79e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (1.52e-2)" "unprognostic (9.12e-2)" "unprognostic (3.03e-2)" "unprognostic (1.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.32e-2)" "unprognostic (6.61e-2)" "unprognostic (4.26e-12)" "unprognostic (8.36e-4)" "unprognostic (4.27e-1)" "unprognostic (1.35e-2)" "unprognostic (6.17e-3)" 2.1 1.2 58.3 1.0 27.6 1.0 1.7 52.7 150.0 1.3 1.3 1.5 0.0 1.1 1.2 1.2 1.4 1.3 1.3 1.4 74.3 1.7 1.1 1.0 1.1 1.3 6.0 36.4 1.0 1.0 1.0 0.1 1.0 20.0 1.0 1.2 9.1 1.1 1.1 1.4 1.6 1.3 1.2 0.9 1.0 1.1 1.5 0.0 0.0 1.2 0.0 1.2 1.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 1.7 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.3 0.5 1.3 0.1 1.9 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.1 0.3 0.0 0.4 0.0 0.3 6.7 1.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 3.9 0.1 0.1 0.0 0.0 4.9 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 2.4 0.9 0.0 0.4 0.3 0.3 0.6 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 27.6 52.7 76.0 74.3 1.7 6.0 36.4 20.0 0.0 0.0 0.0 0.0 0.1 1.1 377.4 2.4 0.0 0.0 0.0 0.0 347.5 0.1 0.0 0.0 4.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 11.1 0.0 0.0 0.0 0.0 6.1 0.3 1.7 0.0 0.0 13.3 0.1 0.0 0.4 0.0 343.9 6.5 2.8 1.0 2.3 0.5 0.0 0.0 0.0 0.0 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.1 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.2 6.6 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.5 0.0 0.3 5.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.6 0.0 1.1 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.6 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 0.0 0.0 0.0 0.6 2.9 12.3 1.6 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 29.3 0.0 0.0 0.0 0.3 8.5 1.0 0.2 0.0 0.0 0.4 22.3 0.0 0.0 0.0 27.3 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.7 0.0 0.3 1.7 1.5 5.9 33.4 0.0 0.0 0.1 SLC1A7 EAAT5 ENSG00000162383 "Solute carrier family 1 member 7" O00341 1 53087179-53142632 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "retina: 70.1" "Group enriched" "Detected in some" 17 "Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6" "Cancer enhanced" "Detected in many" "lung cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 58 "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "HHSteC: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049124 Enhanced NA NA "HPA049124: AB_2680643" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (9.48e-4)" "unprognostic (2.31e-1)" "unprognostic (8.73e-2)" "unprognostic (1.52e-2)" "unprognostic (6.26e-3)" "unprognostic (4.35e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-1)" "unprognostic (7.65e-2)" "unprognostic (1.19e-3)" "unprognostic (2.58e-3)" "unprognostic (5.43e-2)" "unprognostic (8.12e-2)" "unprognostic (4.70e-3)" 2.0 0.2 1.1 0.6 0.6 0.0 1.2 0.6 0.7 0.9 1.0 0.7 0.6 4.1 1.3 1.2 2.1 2.2 9.6 2.9 1.7 1.1 0.7 2.8 0.9 0.6 1.2 0.6 3.8 0.6 0.0 0.6 0.6 1.1 0.9 0.0 70.1 0.6 0.6 2.1 1.2 5.3 0.6 1.3 0.6 1.1 0.9 0.6 0.6 0.6 0.6 0.6 2.5 0.9 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.6 0.6 0.7 1.7 1.1 1.2 0.6 1.1 0.6 0.0 0.6 0.0 0.0 0.0 228.0 0.4 0.0 0.0 0.0 0.0 66.8 0.1 0.0 0.0 0.0 0.0 7.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.2 0.0 2.9 1.1 0.2 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A10 "hOAT5, OAT5" ENSG00000184999 "Solute carrier family 22 member 10" Q63ZE4 11 63137867-63369718 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "liver: 41.7" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 15.5" "Cancer enriched" "Detected in single" 14 "liver cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.17e-2)" "unprognostic (9.77e-2)" "unprognostic (7.07e-3)" "unprognostic (7.46e-4)" "unprognostic (7.62e-3)" "unprognostic (2.87e-1)" "unprognostic (1.56e-1)" "unprognostic (6.52e-2)" "unprognostic (4.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278315 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 16.4" "Cell type enriched" "Detected in single" 23 "Proximal tubular cells: 6.5" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.3" "Lineage enriched" "Detected in single" 5 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "HeLa: 2.2" "Low region specificity" "Detected in all" "HPA035603, HPA035962" Enhanced NA NA "HPA035603: AB_10672869, HPA035962: AB_2674890" "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.3 0.0 2.3 0.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.3 0.0 0.2 0.3 0.0 0.5 0.9 0.2 0.1 0.6 0.8 0.5 0.7 0.1 0.4 0.1 0.0 2.2 0.0 0.1 0.0 0.8 0.0 0.5 0.1 1.5 0.8 0.0 0.9 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.0 0.5 0.0 0.4 0.1 0.1 0.0 0.3 0.7 1.2 0.3 0.3 0.4 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A14 "OCTL2, ORCTL4" ENSG00000144671 "Solute carrier family 22 member 14" Q9Y267 3 38282294-38318575 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 13.2" "Group enriched" "Detected in some" 44 "Early spermatids: 57.6;Late spermatids: 81.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "neutrophil: 1.4;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 13 "dendritic cells: 1.2;granulocytes: 1.4" "Cell line enhanced" "Detected in some" "hTCEpi: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (6.26e-2)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.17e-1)" "unprognostic (6.25e-2)" "unprognostic (4.78e-2)" "unprognostic (2.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.07e-1)" "unprognostic (4.97e-2)" "unprognostic (4.81e-2)" "unprognostic (1.69e-1)" "unprognostic (3.57e-4)" "unprognostic (2.19e-1)" "unprognostic (4.02e-2)" "unprognostic (1.69e-1)" "unprognostic (2.35e-1)" 0.1 0.0 0.2 0.0 0.3 0.5 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.7 0.7 1.3 0.2 0.1 0.6 0.4 1.0 1.6 0.1 0.0 0.4 0.9 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.9 2.9 0.0 0.8 1.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.4 0.7 0.1 1.4 0.0 0.0 1.9 0.0 1.1 0.6 0.3 0.3 0.3 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 57.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 81.6 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 SLC22A15 FLIPT1 ENSG00000163393 "Solute carrier family 22 member 15" Q8IZD6 1 115976498-116070054 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.6;brain: 27.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;monocytes: 2.9" "Cell line enhanced" "Detected in many" "hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019785 Uncertain NA NA "HPA019785: AB_1857011" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.01e-3)" "unprognostic (5.62e-2)" "unprognostic (5.22e-2)" "unprognostic (5.85e-5)" "unprognostic (8.91e-3)" "unprognostic (1.81e-1)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (9.06e-2)" "unprognostic (7.29e-3)" "unprognostic (8.78e-3)" "unprognostic (3.44e-1)" "unprognostic (9.97e-4)" "unprognostic (1.30e-1)" 2.9 4.5 7.0 3.2 14.1 34.6 2.3 8.6 11.1 2.6 2.1 27.8 0.7 1.7 1.9 2.2 5.5 2.4 2.9 6.1 9.9 8.0 4.9 1.3 6.3 1.7 20.0 8.1 2.0 4.2 7.5 4.5 2.9 15.1 2.8 2.7 2.5 4.6 2.7 0.8 11.8 1.7 1.7 14.1 3.5 4.8 1.8 17.6 0.0 4.0 0.8 1.9 2.5 4.6 0.5 0.3 3.9 2.9 0.2 0.0 0.3 1.6 0.1 1.2 0.0 2.2 2.7 0.8 2.7 3.9 1.6 2.9 0.0 0.3 1.8 2.9 1.3 1.4 2.5 2.0 5.5 1.6 0.0 1.3 1.8 1.9 0.2 7.3 2.7 2.5 2.7 21.1 0.0 27.9 0.1 0.0 0.0 0.1 0.0 2.7 1.5 0.0 15.2 1.7 1.5 1.3 0.0 0.0 0.0 2.3 0.9 1.3 1.1 4.6 0.9 7.8 1.9 0.2 16.5 0.0 2.9 1.6 0.5 0.6 2.8 2.6 0.2 3.1 4.5 4.6 1.0 2.5 0.9 0.0 0.7 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 3.9 0.2 2.9 0.0 0.0 0.3 7.0 14.1 8.6 11.1 9.9 8.0 20.0 8.1 15.1 17.6 0.0 10.7 0.8 2.9 2.5 2.1 7.5 0.0 4.0 2.3 5.2 9.8 0.5 1.7 1.1 0.6 0.0 0.0 0.0 0.3 0.3 1.3 0.8 1.1 0.0 2.9 7.9 8.1 1.3 8.6 0.0 0.9 5.9 1.7 1.0 0.2 0.8 1.7 0.2 0.4 0.1 2.0 0.0 1.0 0.2 0.2 2.6 0.0 0.5 0.4 0.9 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 112.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 190.7;Muller glia cells: 81.5;Rod photoreceptor cells: 64.5" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 26 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "AN3-CA: 20.8;ASC diff: 17.3;SH-SY5Y: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain NA NA "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 6.0 24.2 32.9 4.0 63.4 1.6 7.0 40.7 112.4 12.1 5.6 27.4 2.4 4.5 8.0 10.1 4.7 10.2 7.6 9.1 35.6 69.4 8.6 2.0 5.0 3.8 28.5 27.3 11.0 14.5 13.3 39.4 5.3 33.1 21.9 3.5 13.2 20.5 24.4 2.1 6.6 6.6 7.7 21.8 3.6 6.1 6.6 22.1 0.0 10.8 0.1 2.6 4.2 4.8 0.1 0.0 0.0 0.0 0.0 3.6 0.2 0.0 1.2 13.0 20.8 17.3 9.1 2.0 4.5 8.9 1.7 1.3 0.1 1.2 0.0 1.7 8.4 4.0 0.2 0.6 0.5 0.1 0.0 0.7 2.9 0.0 0.1 9.3 0.0 2.9 11.8 0.8 2.0 0.0 7.5 0.5 5.6 0.0 0.1 2.7 1.9 0.1 0.1 7.1 0.0 0.0 0.0 0.5 0.1 0.0 1.2 12.3 24.2 3.7 0.0 0.0 2.8 2.4 0.4 0.0 1.9 5.6 10.4 0.0 0.0 2.0 0.0 1.2 0.0 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 3.6 1.8 0.0 0.0 0.0 0.0 0.0 0.2 32.9 63.4 40.7 64.3 35.6 69.4 28.5 27.3 33.1 22.1 0.0 2.4 0.0 18.6 11.2 49.9 9.0 5.1 5.3 9.1 19.2 41.2 1.8 1.7 0.6 0.3 6.8 0.0 0.0 1.2 4.1 14.9 27.1 4.6 0.8 0.8 190.7 20.0 17.8 0.8 1.3 19.5 2.2 6.8 1.0 0.0 81.5 2.4 0.0 40.3 13.5 64.5 0.0 20.0 0.9 2.1 9.5 4.0 0.0 0.0 4.6 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887780-2903740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 20.1;kidney: 13.4;liver: 13.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 9.1" "Group enriched" "Detected in many" 10 "dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0" HPA068288 Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 1.4 0.3 0.2 6.0 0.7 0.0 0.6 0.2 2.2 0.5 13.7 0.6 0.2 12.8 0.8 1.2 1.1 0.4 4.9 0.3 0.2 0.3 13.4 13.6 0.6 0.2 1.3 1.5 0.4 0.2 0.0 0.3 2.0 1.6 0.7 9.8 0.2 4.2 0.2 0.4 1.0 20.1 0.6 1.6 0.8 1.4 0.6 0.4 0.2 0.3 1.6 0.3 0.5 0.9 0.0 4.9 5.2 9.1 0.5 0.6 2.7 0.8 7.1 0.1 0.3 0.0 0.0 0.7 0.4 0.3 0.0 0.2 1.6 7.0 0.0 0.6 0.0 0.4 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.6 4.1 0.5 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.4 0.0 0.7 0.0 13.2 0.0 0.3 0.1 6.7 0.3 0.2 0.0 0.6 0.6 0.0 0.1 0.2 0.3 0.3 24.5 0.1 0.0 0.7 1.4 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.2 1.9 11.0 5.2 9.1 1.6 0.3 5.1 0.1 0.0 0.1 0.3 4.9 0.0 0.0 0.1 2.2 0.5 3.5 0.0 0.6 2.7 0.2 0.7 0.2 2.2 0.2 0.3 1.3 1.5 1.6 0.4 0.0 0.3 1.3 1.1 0.5 0.0 0.1 2.5 0.0 0.0 7.0 0.0 16.4 8.3 0.8 0.0 0.0 89.5 0.0 0.7 8.2 0.8 1.4 1.1 18.4 15.6 0.0 8.7 1.8 4.1 0.0 0.3 5.4 3.3 3.6 25.4 0.0 1.5 107.4 0.0 73.1 0.0 0.0 0.6 0.0 0.2 1.0 67.5 0.0 23.7 2.3 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins, Transporters" "Ion transport, Lipid metabolism, Steroid metabolism, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 10.5" "Cell type enriched" "Detected in single" 30 "Proximal tubular cells: 8.4" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain NA NA "HPA045015: AB_2679183" "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A25 "HIMTP, MGC120420, UST6" ENSG00000196600 "Solute carrier family 22 member 25" Q6T423 11 63163776-63229652 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 165 "liver: 16.5" "Cell type enriched" "Detected in single" 9 "Hepatocytes: 5.8" "Cancer enriched" "Detected in single" 66 "liver cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039390 Uncertain NA NA "HPA039390: AB_10671996" "unprognostic (3.19e-2)" "unprognostic (2.38e-1)" "unprognostic (4.51e-1)" "prognostic favorable (7.04e-4)" "unprognostic (1.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 6.7;Proximal tubular cells: 8.9" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 9.0;U-266/70: 6.6" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Not detected" "Not detected" HPA019059 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 4.0 2.2 0.8 2.2 0.6 0.4 1.3 2.4 1.6 0.5 0.8 1.5 0.1 3.2 0.7 0.3 0.6 1.9 1.8 2.1 1.9 0.2 0.7 0.2 0.9 0.7 9.0 0.9 2.9 3.6 1.2 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.8 0.2 0.5 0.6 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.4 1.1 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.6 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 2.0 1.1 1.3 0.8 0.3 2.5 0.0 0.0 1.8 0.0 0.2 1.7 0.2 0.0 0.7 6.7 0.0 0.0 0.1 0.6 1.4 0.0 0.5 0.2 0.0 1.7 0.6 0.3 0.0 1.4 0.4 1.7 1.0 2.8 1.9 0.2 3.1 1.1 8.9 0.1 0.0 0.8 0.0 0.1 1.4 0.3 0.0 1.6 0.7 SLC24A3 ENSG00000185052 "Solute carrier family 24 member 3" Q9HC58 20 19212646-19722937 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 53 "basophil: 7.1;eosinophil: 3.3" "Lineage enriched" "Detected in single" 72 "granulocytes: 7.1" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043400, HPA045497" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA043400: AB_2678462, HPA045497: AB_2679349" "unprognostic (8.74e-2)" "unprognostic (1.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.41e-1)" "unprognostic (7.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.04e-2)" "unprognostic (3.25e-2)" "unprognostic (1.05e-1)" "unprognostic (5.40e-2)" "unprognostic (1.21e-3)" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (6.08e-4)" "unprognostic (7.36e-3)" 7.0 2.5 10.9 4.6 11.0 1.0 3.6 7.4 9.2 17.6 8.9 5.5 7.0 2.9 26.3 19.0 15.3 17.2 14.5 1.7 27.1 12.0 1.2 0.6 6.2 1.5 4.5 3.4 14.8 1.2 7.9 1.6 3.0 5.3 8.5 4.1 5.5 6.1 13.8 26.4 5.2 4.4 21.7 2.9 1.7 2.7 1.7 3.1 0.9 2.5 11.0 4.9 8.1 20.7 0.0 0.0 7.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 6.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.2 0.0 0.0 0.4 0.0 41.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 4.8 0.0 0.3 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.9 11.0 7.4 6.5 27.1 12.0 4.5 3.4 5.3 3.1 3.0 0.6 0.0 1.0 1.0 9.4 0.4 0.0 0.0 2.3 1.8 0.0 5.4 0.0 0.0 18.2 0.1 0.0 0.0 0.0 0.3 1.5 0.7 26.5 0.0 0.6 1.6 7.5 0.6 0.0 14.9 3.4 0.0 0.0 0.0 2.6 2.9 0.1 0.9 3.9 0.0 1.4 0.0 3.1 0.5 0.4 3.6 2.9 0.0 0.6 2.7 SLC25A14 "BMCP1, UCP5" ENSG00000102078 "Solute carrier family 25 member 14" O95258 X 130339888-130373361 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060316 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA060316: AB_2684251" "unprognostic (1.65e-2)" "prognostic favorable (1.72e-5)" "unprognostic (1.82e-1)" "unprognostic (2.74e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-1)" "unprognostic (3.36e-3)" "unprognostic (8.92e-3)" "unprognostic (3.52e-2)" "unprognostic (2.95e-3)" "prognostic favorable (1.78e-4)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.52e-6)" "unprognostic (6.05e-2)" "unprognostic (1.12e-1)" "unprognostic (6.92e-2)" "prognostic favorable (1.39e-5)" 3.1 9.3 9.2 3.4 18.3 3.7 5.5 13.6 20.6 4.8 3.8 6.1 4.2 2.2 6.7 11.0 4.3 9.7 4.6 7.7 8.7 15.8 5.2 4.1 4.6 4.1 7.3 11.4 6.8 4.5 5.6 15.0 3.6 11.2 5.1 4.1 5.7 5.1 6.7 3.4 4.7 3.6 7.7 5.3 3.5 4.8 10.2 4.2 4.2 5.7 4.6 5.3 3.1 3.8 7.5 9.3 8.7 7.2 8.1 9.5 4.9 6.9 9.1 6.5 4.8 4.4 4.2 3.5 5.2 7.0 10.2 10.2 3.6 4.2 4.7 18.2 7.0 12.5 3.9 9.4 3.9 10.1 6.0 11.9 1.5 8.4 8.5 6.2 5.9 2.8 3.9 4.7 12.8 3.9 6.0 5.6 6.6 4.1 6.7 16.1 10.6 6.2 8.3 5.5 7.5 15.0 5.3 8.5 9.4 5.9 3.0 8.2 7.3 5.5 5.6 8.8 4.5 3.6 3.3 3.7 5.5 3.6 12.5 10.5 6.3 16.1 4.1 10.0 7.3 4.9 5.8 7.2 5.2 6.4 5.8 7.8 7.5 5.4 6.1 7.5 4.6 4.2 7.0 8.7 8.1 5.2 9.3 9.5 4.9 9.2 18.3 13.6 15.6 8.7 15.8 7.3 11.4 11.2 4.2 6.0 2.1 8.3 6.8 8.9 8.8 3.2 7.6 26.8 1.2 3.5 2.0 8.0 14.9 9.4 9.0 4.4 3.8 0.0 7.9 7.3 6.0 4.1 3.5 3.8 4.6 6.4 8.6 4.9 3.3 5.1 4.6 5.1 8.5 2.8 4.0 8.5 7.5 4.5 7.8 8.3 12.7 6.5 6.2 21.6 39.2 7.3 4.5 7.0 5.2 4.7 SLC25A27 "FLJ33552, UCP4" ENSG00000153291 "Solute carrier family 25 member 27" O95847 6 46652915-46678193 "Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069732 Supported Mitochondria NA NA Mitochondria "HPA069732: AB_2686185" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (9.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.87e-1)" "unprognostic (2.03e-1)" "unprognostic (2.81e-1)" "unprognostic (1.24e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (3.82e-3)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.74e-1)" "unprognostic (7.47e-3)" 13.3 15.0 18.5 6.6 28.8 1.5 18.7 63.8 30.2 11.8 13.2 20.2 11.3 5.0 28.4 50.9 7.6 13.9 14.2 11.9 17.6 10.5 12.6 12.2 10.1 4.2 24.7 28.9 39.4 9.7 25.8 37.8 2.6 19.6 31.0 11.5 23.6 14.3 17.9 11.2 28.1 6.8 17.0 18.0 6.3 9.1 12.6 26.9 0.4 21.7 7.7 3.8 11.4 17.6 0.0 0.4 0.3 0.0 0.0 0.3 0.0 2.0 1.4 2.4 8.0 9.1 6.3 0.1 1.1 3.7 1.1 0.2 0.0 2.9 0.8 5.5 2.0 2.6 4.1 1.1 3.5 0.7 0.0 11.8 0.0 26.3 2.9 4.8 0.1 0.3 9.8 14.8 0.0 9.4 5.8 0.2 8.0 0.1 0.0 0.9 0.8 0.0 0.1 1.2 2.0 3.1 0.0 3.1 0.1 6.0 7.5 7.3 0.8 5.5 0.3 2.9 3.6 5.9 0.0 0.8 5.0 3.3 0.5 1.0 3.2 0.0 16.2 0.8 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 18.5 28.8 63.8 30.2 17.6 10.5 24.7 28.9 19.6 26.9 3.0 2.9 0.0 3.6 0.8 20.5 7.0 0.0 6.7 2.3 5.2 27.5 0.0 0.0 0.6 23.2 3.1 0.3 0.0 0.6 0.0 2.5 5.8 1.1 1.7 0.2 19.1 5.8 2.5 0.3 16.0 2.8 0.1 1.7 0.0 1.3 8.3 0.3 0.0 4.9 0.5 38.2 0.0 2.3 0.5 0.7 2.0 0.0 0.0 1.5 2.1 SLC25A28 "MRS3/4, MRS4L" ENSG00000155287 "Solute carrier family 25 member 28" Q96A46 10 99610522-99620609 "Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 121.1;Late spermatids: 296.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.87e-3)" "prognostic favorable (2.18e-6)" "unprognostic (8.59e-3)" "unprognostic (6.86e-2)" "unprognostic (4.29e-1)" "unprognostic (1.43e-2)" "unprognostic (3.39e-2)" "unprognostic (9.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.40e-2)" "unprognostic (9.80e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.12e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (7.62e-3)" 26.2 29.8 30.6 22.1 37.5 52.2 23.7 34.8 31.7 21.7 28.5 29.1 33.9 16.5 21.1 34.7 28.0 22.3 25.8 27.2 26.7 25.2 19.2 31.8 25.3 26.5 31.9 24.6 29.0 28.9 25.6 21.4 19.9 28.8 29.1 24.9 21.8 29.3 35.0 35.1 32.9 19.7 37.3 21.5 30.1 21.2 34.1 34.6 13.5 24.1 18.1 25.8 29.6 36.5 3.0 9.5 6.2 2.5 2.3 4.6 1.0 13.8 13.8 8.7 21.1 16.4 20.4 9.0 16.3 19.8 22.5 18.6 10.8 17.2 17.7 10.1 14.7 10.3 23.4 10.7 15.3 13.8 13.1 13.8 7.7 20.0 11.2 16.4 13.8 10.9 17.2 22.7 14.5 28.8 29.3 15.9 15.8 5.6 13.7 11.4 18.6 11.9 31.2 2.0 11.1 10.8 15.0 10.5 9.9 14.6 14.9 5.9 7.4 9.3 10.2 12.1 11.9 18.4 13.9 9.5 13.9 9.5 18.5 19.8 11.3 7.2 8.7 13.3 26.8 5.7 0.0 2.5 6.2 4.6 2.2 2.1 3.0 3.3 2.8 3.5 3.0 2.5 2.3 2.2 2.3 2.1 9.5 3.6 1.0 30.6 37.5 34.8 31.7 26.7 25.2 31.9 24.6 28.8 34.6 11.9 8.3 4.3 14.5 22.6 30.1 17.3 17.8 0.0 5.7 5.2 19.6 15.5 6.6 3.7 121.1 16.5 6.7 0.0 6.9 7.9 13.6 20.8 5.8 17.9 8.6 41.3 4.1 7.4 8.7 296.1 11.8 12.0 18.6 9.0 10.5 23.8 5.0 9.9 17.0 7.3 29.6 12.9 15.3 22.1 7.2 24.0 12.1 7.4 9.0 17.8 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 113.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 113.2 11.9 0.0 0.0 0.0 0.0 0.0 SLC25A34 DKFZp781A10161 ENSG00000162461 "Solute carrier family 25 member 34" Q6PIV7 1 15736405-15741396 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.8;skeletal muscle: 22.2" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 16.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 10.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069806 Approved Mitochondria NA NA Mitochondria "HPA069806: AB_2686202" "unprognostic (2.06e-1)" "unprognostic (4.72e-1)" "unprognostic (1.15e-1)" "unprognostic (2.43e-1)" "unprognostic (2.58e-1)" "unprognostic (8.08e-3)" "unprognostic (1.98e-2)" "unprognostic (9.92e-2)" "unprognostic (1.55e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-4)" "unprognostic (5.74e-2)" "unprognostic (6.10e-2)" "unprognostic (4.02e-1)" "unprognostic (1.82e-1)" "unprognostic (4.04e-2)" "unprognostic (2.40e-4)" 2.5 2.4 1.2 0.9 1.9 2.8 0.7 10.4 1.8 1.1 25.9 0.8 0.5 13.5 1.7 1.4 1.6 1.3 3.6 13.3 1.5 1.2 7.3 3.9 1.1 1.1 0.7 1.8 2.4 18.6 0.6 2.1 1.2 1.5 1.1 1.9 3.7 11.1 0.8 22.2 0.8 38.8 1.0 1.1 1.9 1.4 2.3 1.2 0.5 1.9 11.0 1.9 0.7 1.1 0.7 0.5 2.0 0.5 2.2 4.1 1.1 0.7 0.5 3.5 1.6 1.7 0.7 1.5 0.5 0.3 0.8 0.6 1.4 1.9 0.9 0.8 0.7 1.8 0.7 0.6 0.6 0.8 1.2 0.7 1.5 1.1 0.5 0.6 0.4 2.2 0.8 2.7 1.0 0.5 2.2 0.4 4.6 0.6 3.2 0.6 1.8 3.7 2.0 2.9 0.4 1.0 1.9 3.1 1.0 0.3 0.1 0.7 2.8 0.8 1.0 7.4 3.4 1.9 2.5 1.7 1.7 2.2 2.3 0.6 3.8 3.5 0.7 0.6 2.2 1.4 1.2 0.5 0.4 1.4 0.2 3.1 0.5 3.0 2.0 0.2 0.7 4.1 2.3 2.0 2.2 0.2 0.5 1.3 1.1 1.2 1.9 10.4 1.8 1.5 1.2 0.7 1.8 1.5 1.2 0.0 0.0 0.0 0.3 0.2 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.7 16.0 0.0 0.2 0.2 0.7 0.3 0.0 2.1 1.2 3.2 3.4 2.5 2.6 0.4 0.9 0.1 0.0 1.8 2.4 1.7 0.2 5.3 0.4 3.0 1.4 0.0 0.9 0.5 0.6 0.1 1.1 0.0 4.1 0.4 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051720 Uncertain Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA051720: AB_2681584" "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favorable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favorable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.5 12.5 2.1 9.4 7.2 2.8 5.2 2.9 2.7 3.3 3.6 1.5 11.7 5.2 3.1 3.4 6.7 10.1 2.7 3.6 1.8 2.8 3.3 4.4 9.2 1.8 2.7 0.5 11.9 5.9 2.1 6.2 1.1 2.3 5.1 6.1 1.2 1.8 2.7 2.5 4.7 2.4 0.7 3.1 4.2 5.1 1.5 2.3 2.5 11.6 1.1 2.8 8.6 5.2 3.7 2.3 11.6 3.3 6.7 2.2 1.7 5.3 2.5 4.0 2.4 1.8 5.7 7.8 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 0.0 4.8 5.4 1.5 0.7 3.7 1.2 2.5 0.0 1.2 10.4 7.9 7.3 10.0 2.4 2.4 2.2 2.5 0.0 6.2 2.0 1.3 1.8 4.7 2.4 5.9 1.6 8.6 2.5 3.7 3.6 1.4 2.7 0.0 8.2 2.7 6.8 2.6 3.1 1.1 5.7 8.9 0.0 0.7 27.9 0.7 0.3 14.5 3.8 3.0 1.1 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528805-23575463 "Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.8" "Cell type enriched" "Detected in all" 5 "Erythroid cells: 3550.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 28.9" "Lineage enriched" "Detected in many" 18 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "HEL: 47.7;hTERT-RPE1: 27.9" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 8.2 18.3 5.8 13.7 8.3 88.8 13.1 4.2 8.2 13.4 16.4 6.5 11.7 39.7 10.3 6.8 8.2 9.5 8.5 16.8 6.2 5.2 9.4 11.8 25.7 18.5 12.2 5.1 17.2 14.8 15.6 8.8 23.9 10.3 17.1 5.8 7.9 21.1 17.4 13.8 7.6 17.6 7.9 10.2 28.7 8.0 15.0 8.6 1.9 9.0 5.9 5.7 13.9 33.0 1.2 1.4 28.9 1.6 0.7 1.2 0.8 3.8 4.2 4.5 4.1 5.9 7.3 6.6 3.0 3.9 2.2 2.5 4.1 8.2 6.2 3.7 2.5 14.5 4.9 4.1 8.2 3.0 1.0 2.2 47.7 7.0 1.4 4.9 2.7 1.9 6.2 8.0 4.8 4.8 27.9 3.4 5.0 10.5 3.1 3.5 1.6 3.2 11.3 2.3 4.7 3.3 3.3 2.2 2.4 6.8 2.1 1.4 1.9 4.1 6.4 3.0 4.4 1.8 4.1 5.5 10.9 1.6 6.4 5.8 2.5 0.9 3.9 10.2 6.5 6.8 0.6 1.6 1.4 0.6 0.6 0.6 1.2 0.4 0.3 1.4 0.8 1.2 0.7 28.9 0.7 0.8 0.4 0.7 0.8 5.8 8.3 4.2 8.2 6.2 5.2 12.2 5.1 10.3 8.6 35.7 79.2 39.5 104.8 82.9 35.3 31.5 48.4 21.4 84.2 73.3 64.8 32.1 13.3 81.9 645.6 82.4 66.7 3550.9 197.4 63.8 90.2 258.9 35.8 34.3 36.1 6.4 19.5 100.7 50.6 772.4 48.6 101.8 65.8 8.2 33.2 41.6 177.5 34.5 35.0 24.5 60.7 19.4 95.7 12.5 47.1 47.0 15.3 22.7 43.1 139.3 SLC25A39 "CGI-69, FLJ22407" ENSG00000013306 "Solute carrier family 25 member 39" Q9BZJ4 17 44319625-44324870 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Heme biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 416.1;Erythroid cells: 584.0;Late spermatids: 585.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026785 Approved NA NA "HPA026785: AB_10601715" "unprognostic (8.10e-2)" "unprognostic (2.46e-1)" "unprognostic (1.41e-2)" "unprognostic (1.29e-1)" "unprognostic (6.04e-2)" "unprognostic (2.35e-3)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "prognostic favorable (3.58e-5)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (3.21e-2)" 14.6 36.5 17.8 19.0 19.4 101.0 21.9 15.4 18.1 18.8 29.8 17.4 22.9 30.2 16.0 20.5 43.2 19.1 24.5 19.3 16.4 18.5 58.8 69.8 25.0 29.8 18.6 15.6 25.1 63.3 27.2 24.6 33.5 17.1 23.4 19.9 20.6 39.9 26.5 13.7 25.6 28.7 13.5 17.6 28.8 23.8 39.7 16.2 18.0 46.4 36.4 29.3 16.8 18.6 34.0 35.2 11.2 27.4 43.9 30.2 31.0 44.3 28.2 8.8 37.0 17.2 13.4 30.9 14.8 13.4 19.3 14.9 27.8 21.5 23.9 26.2 20.9 34.3 22.9 27.5 44.9 6.8 27.9 44.1 12.5 25.5 50.6 18.8 21.7 27.5 20.2 40.0 18.0 23.3 17.5 19.7 36.3 36.7 38.2 16.2 83.9 27.3 21.2 17.3 34.1 78.2 33.0 24.4 68.4 33.2 23.7 60.0 22.4 17.1 27.4 30.0 17.0 52.6 18.6 14.0 25.3 35.6 43.2 28.9 24.0 28.8 21.9 22.8 17.0 15.3 11.2 19.5 9.4 26.6 27.3 30.2 34.0 28.9 28.6 30.5 25.3 29.9 27.4 2.9 43.9 27.4 35.2 26.6 31.0 17.8 19.4 15.4 18.1 16.4 18.5 18.6 15.6 17.1 16.2 8.9 23.1 46.2 55.8 47.4 17.1 21.2 45.9 18.7 26.1 66.3 9.8 75.3 416.1 140.7 181.7 45.0 106.3 584.0 271.0 134.5 37.6 112.5 31.3 61.9 122.6 12.7 62.7 26.4 47.0 585.1 36.8 47.7 87.7 148.7 86.5 37.5 164.8 80.6 36.4 185.1 14.0 19.4 41.2 103.7 99.4 56.6 98.2 55.8 137.6 83.2 SLC25A41 "APC4, FLJ40442, MGC34725" ENSG00000181240 "Solute carrier family 25 member 41" Q8N5S1 19 6426037-6433779 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.1;testis: 26.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 91.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;HMC-1: 7.1;K-562: 2.1;U-937: 4.2" "Low region specificity" "Detected in single" HPA043591 Uncertain NA NA "HPA043591: AB_10964585" "unprognostic (1.87e-3)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (8.75e-2)" "unprognostic (2.67e-1)" "unprognostic (8.29e-4)" "unprognostic (4.43e-3)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.19e-3)" "unprognostic (3.11e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" "unprognostic (3.63e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" 0.3 0.2 2.4 0.3 6.3 0.0 0.5 8.1 3.2 0.3 0.5 0.3 0.3 0.4 0.3 0.8 1.7 0.4 0.3 1.6 2.6 1.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.5 0.9 1.3 1.2 0.3 0.5 0.6 0.3 0.0 26.5 0.3 0.3 0.4 0.3 0.3 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.1 0.4 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.3 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 7.1 0.7 1.7 0.0 0.0 0.4 0.0 0.4 2.1 0.0 0.0 0.9 0.0 1.7 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.3 8.1 2.7 2.6 1.3 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.2 91.3 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 11.5 0.9 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.1 1.2 0.0 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.1 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399060-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035188, HPA078530" Uncertain Approved Cytosol NA NA Cytosol "HPA035188: AB_10602400, HPA078530: " "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 12.7 3.0 4.4 11.1 3.7 1.3 11.8 5.9 3.8 8.9 12.3 4.3 5.6 12.8 8.0 7.3 23.5 5.8 6.3 6.0 5.1 3.4 11.4 11.3 10.4 9.5 3.8 2.7 7.8 15.6 4.0 3.0 7.3 5.8 8.5 14.2 7.4 12.8 4.4 6.3 14.0 13.3 7.7 8.2 9.0 7.9 4.3 4.3 1.9 5.7 9.6 16.2 8.9 12.9 4.3 6.3 0.2 10.7 6.6 3.2 1.4 13.6 10.1 0.7 4.0 14.0 21.2 5.4 7.5 9.6 6.1 5.9 5.2 6.9 1.5 4.6 21.0 18.4 10.1 7.9 7.1 5.5 11.8 2.4 4.9 3.3 7.0 8.7 4.6 5.2 8.7 12.6 10.1 8.5 8.7 7.5 2.7 0.9 7.3 7.0 24.4 0.0 6.5 4.6 7.2 15.9 1.2 0.0 2.0 10.1 4.7 0.6 0.0 10.2 21.6 12.0 3.4 3.8 4.6 10.4 10.0 2.9 10.8 11.6 0.1 5.7 3.3 10.0 7.7 8.8 0.0 3.4 0.2 1.0 5.1 1.8 4.3 2.0 3.2 6.3 3.6 1.1 1.9 0.0 6.6 10.7 1.6 1.6 1.4 4.4 3.7 5.9 3.8 5.1 3.4 3.8 2.7 5.8 4.3 6.0 8.9 6.0 5.9 6.9 0.1 1.4 0.0 1.4 6.8 3.5 0.0 8.9 8.3 3.6 0.0 7.3 16.9 0.0 7.9 6.7 9.3 3.1 8.1 4.9 9.7 0.0 7.0 6.2 6.5 0.0 7.5 9.9 10.1 11.8 10.3 0.0 12.1 8.6 5.3 7.0 0.1 0.0 13.3 0.4 2.2 12.2 5.7 7.2 10.3 5.1 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 115.9;Late spermatids: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA065411: AB_2685486" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favorable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.3 17.7 8.7 11.5 19.0 10.3 6.8 11.1 16.4 20.3 16.6 17.3 9.4 8.2 9.8 16.6 11.0 15.5 31.7 13.1 18.0 9.4 10.6 7.5 11.3 10.4 14.5 9.7 13.8 14.4 11.5 20.5 12.4 9.8 16.4 10.2 7.8 13.6 13.9 18.6 10.1 6.9 20.5 19.8 18.4 6.5 8.8 14.0 26.5 12.3 13.6 18.3 13.0 23.6 14.8 16.0 17.8 15.9 13.2 11.7 9.9 13.1 13.2 14.0 10.6 12.5 12.9 10.2 11.5 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 11.9 24.8 12.3 4.8 24.6 12.6 30.7 7.6 4.0 14.8 8.7 19.6 4.3 5.0 5.4 115.9 11.7 9.2 0.0 4.9 3.3 17.9 6.1 4.7 29.8 6.5 19.1 5.8 10.4 8.6 71.2 6.6 12.2 11.8 1.8 8.5 7.2 4.9 5.8 5.3 13.9 8.8 19.4 12.2 9.1 7.7 29.7 6.9 7.5 7.5 6.3 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell type enhanced" "Detected in many" 5 "B-cells: 32.2;T-cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.7 0.2 6.9 1.3 0.6 3.5 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 1.8 0.6 0.5 0.3 0.0 13.8 1.0 4.5 2.5 0.3 0.8 1.4 4.8 1.6 0.1 0.5 0.4 0.4 0.7 8.0 0.6 18.7 0.7 1.5 3.3 0.1 0.3 0.2 2.2 6.1 0.9 13.6 0.7 0.0 2.3 3.1 1.4 3.7 0.7 0.4 1.9 0.7 1.3 0.5 1.8 4.5 0.3 7.8 4.9 1.2 1.4 1.0 2.7 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 0.0 3.5 32.2 5.2 2.5 9.0 5.5 10.2 17.4 4.5 12.2 0.0 1.4 0.0 4.9 5.2 2.9 23.9 0.0 4.7 1.0 3.3 7.8 4.6 12.1 6.3 6.4 6.4 7.4 7.0 3.3 6.4 13.8 5.0 18.0 12.9 7.7 4.3 8.6 3.5 6.2 0.3 6.5 2.5 2.3 0.2 1.8 1.3 35.9 7.4 3.5 SLC25A47 C14orf68 ENSG00000140107 "Solute carrier family 25 member 47" Q6Q0C1 14 100323337-100330378 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "liver: 127.2" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 185.9" "Cancer enriched" "Detected in single" 273 "liver cancer: 56.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (2.54e-3)" "unprognostic (2.57e-3)" "unprognostic (5.12e-2)" "unprognostic (2.27e-2)" "unprognostic (6.07e-2)" "unprognostic (1.30e-2)" "unprognostic (4.25e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (1.96e-3)" "unprognostic (4.46e-1)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-2)" "unprognostic (1.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 5.7 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 2.0 0.2 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 185.9 0.0 0.0 0.0 4.3 8.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 SLC25A51 "CG7943, MCART1, MGC14836" ENSG00000122696 "Solute carrier family 25 member 51" Q9H1U9 9 37879400-37904353 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 74.4;Late spermatids: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046388, HPA058261" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046388: AB_2679649, HPA058261: AB_2683657" "unprognostic (5.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.67e-2)" "unprognostic (5.63e-2)" "unprognostic (1.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (6.87e-2)" "unprognostic (1.04e-1)" "unprognostic (7.98e-3)" "unprognostic (1.26e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.52e-4)" "unprognostic (8.27e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (2.08e-2)" 17.6 9.1 11.7 9.9 12.9 21.2 27.6 11.3 14.2 12.0 10.7 12.0 10.8 15.3 10.3 10.2 12.6 8.1 10.7 11.5 12.9 9.3 13.3 9.7 14.6 10.8 11.9 14.9 11.0 16.7 20.6 12.8 9.7 11.9 10.5 9.0 8.2 13.3 8.4 15.9 11.7 13.4 12.2 11.4 12.6 9.7 18.8 12.4 14.4 9.8 7.6 12.9 9.1 10.2 3.1 1.4 13.4 3.9 2.1 3.6 1.1 8.2 6.6 5.1 8.0 24.5 10.7 5.2 7.0 7.3 6.1 8.9 8.6 3.6 17.4 4.1 16.6 8.6 4.1 13.6 9.9 11.8 11.9 4.2 5.3 18.2 12.0 13.8 8.3 7.8 10.7 11.6 9.1 11.7 9.7 11.0 16.7 11.6 13.9 13.0 4.7 10.0 1.9 6.3 8.5 4.8 7.0 6.8 10.7 6.1 6.0 10.7 6.9 5.6 6.8 4.0 9.0 3.7 9.1 11.9 10.3 12.1 4.8 8.7 5.3 11.2 12.2 13.5 6.1 8.5 13.4 1.9 3.2 2.1 3.9 3.6 3.1 2.3 3.0 1.4 2.2 2.2 2.5 1.5 2.1 1.6 0.6 3.4 1.1 11.7 12.9 11.3 14.2 12.9 9.3 11.9 14.9 11.9 12.4 8.9 0.6 4.2 5.0 4.1 4.3 5.7 2.5 1.4 2.3 1.8 3.9 3.2 14.9 8.3 74.4 3.4 5.1 0.0 6.3 11.8 4.2 3.9 3.5 3.2 10.5 1.6 3.5 0.6 5.9 125.5 3.4 5.0 1.7 9.0 4.2 3.4 7.2 7.0 3.9 13.4 3.4 0.0 3.1 10.2 10.3 5.1 3.3 3.2 3.5 3.4 SLC25A53 MCART6 ENSG00000269743 "Solute carrier family 25 member 53" Q5H9E4 X 104099214-104157027 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Daudi: 7.2;Karpas-707: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034959 Uncertain NA NA "HPA034959: AB_10602025" "unprognostic (4.70e-2)" "unprognostic (1.16e-2)" "unprognostic (7.16e-3)" "unprognostic (5.94e-2)" "unprognostic (2.68e-2)" "unprognostic (5.23e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" "unprognostic (4.45e-3)" "unprognostic (7.94e-2)" "unprognostic (9.76e-5)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (3.48e-2)" "unprognostic (1.74e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-2)" 2.8 2.4 3.2 5.6 4.6 2.8 2.1 6.3 8.6 3.9 2.5 2.8 5.7 3.1 5.1 3.4 2.2 1.9 2.9 2.8 3.6 1.8 1.6 2.0 8.8 3.1 2.7 3.2 4.4 1.2 5.8 1.4 3.6 4.6 2.9 3.1 3.0 5.0 1.5 2.1 3.8 4.8 4.2 6.6 3.1 3.9 4.5 1.4 2.7 0.8 8.4 4.7 9.0 1.7 0.5 3.0 0.5 1.0 2.9 0.7 0.1 0.1 2.1 1.3 0.1 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.0 7.2 0.2 0.1 0.4 0.1 2.4 0.0 0.2 0.6 1.0 0.8 0.2 0.2 0.2 1.4 0.8 0.4 0.1 0.3 0.0 0.4 0.5 0.8 0.2 17.1 0.1 0.1 0.3 0.1 2.7 0.1 0.5 2.9 1.1 0.3 0.3 0.2 1.9 2.7 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.2 1.0 0.1 0.5 0.2 0.0 2.6 0.1 1.9 0.5 0.9 0.4 0.8 1.3 0.5 2.9 1.7 1.2 2.4 0.5 1.4 0.4 1.6 3.0 1.0 0.3 0.3 1.8 0.7 6.0 2.9 11.5 6.5 4.6 3.0 11.7 2.5 14.7 2.3 8.7 0.0 3.1 21.6 3.5 2.6 4.5 15.9 70.0 5.2 3.6 3.8 8.3 6.9 21.2 9.4 3.2 6.9 4.9 9.8 0.4 2.8 7.2 1.7 12.6 8.3 3.5 6.4 21.0 2.8 11.0 7.8 0.0 4.4 2.3 2.1 5.0 5.1 12.8 4.3 11.5 SLC26A10 ENSG00000135502 "Solute carrier family 26 member 10" Q8NG04 12 57619527-57626151 "Predicted membrane proteins, Transporters" "Antiport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 9.1;Peritubular cells: 4.9" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Region enhanced" "Detected in single" "cerebellum: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.0;HEK 293: 3.5;NTERA-2: 5.6;RH-30: 4.4;SH-SY5Y: 7.9;U-266/70: 5.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA044719 Uncertain NA NA "HPA044719: AB_10962362" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.45e-1)" "unprognostic (3.12e-2)" "unprognostic (1.89e-1)" "unprognostic (6.12e-5)" "unprognostic (3.22e-3)" "unprognostic (2.65e-12)" "unprognostic (1.28e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (1.40e-1)" 2.0 0.7 0.4 0.5 0.9 0.0 0.4 3.8 0.9 0.4 0.8 0.4 0.4 0.0 2.9 1.2 0.4 1.9 1.8 8.5 0.4 0.2 0.4 0.4 0.4 0.5 0.4 0.4 0.9 0.4 0.0 0.4 0.4 0.4 2.1 0.5 0.4 0.8 1.6 2.6 0.1 1.1 1.9 0.4 0.7 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.0 0.0 0.0 0.5 1.1 0.2 0.7 0.3 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.7 0.0 0.2 0.0 3.5 0.4 0.2 0.7 0.7 0.0 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 2.3 7.9 0.0 0.0 0.5 0.4 0.1 0.6 0.0 0.6 1.3 0.7 0.0 5.4 0.5 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 3.8 0.9 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.3 9.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.9 0.0 0.8 0.0 1.7 0.5 0.2 0.4 0.1 0.0 0.0 0.0 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.2 9.7 7.5 4.9 3.6 11.2 4.7 5.9 10.6 6.6 9.4 1.7 0.1 9.6 4.9 7.7 3.1 5.4 3.5 4.2 11.2 9.7 0.0 10.4 8.7 12.9 0.0 1.5 6.6 5.7 5.1 2.3 1.0 8.9 1.9 4.0 11.9 6.2 7.7 0.4 0.2 4.3 2.3 8.0 0.4 1.0 4.3 9.6 9.0 3.8 11.9 4.7 11.8 12.2 15.8 14.1 0.2 6.6 8.6 5.0 7.3 0.5 13.5 5.1 1.3 4.4 0.0 6.8 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 6.0 12.0 0.9 9.3 4.0 28.0 2.0 0.0 2.7 5.7 12.2 55.0 12.2 1.7 6.3 0.4 14.1 3.9 0.0 5.3 7.0 8.2 9.4 1.1 2.0 14.0 3.2 9.8 6.2 5.9 0.2 15.8 8.3 3.3 2.8 2.5 21.0 3.9 3.5 11.7 4.8 37.6 32.3 4.7 0.2 1.5 4.1 21.7 5.7 2.8 5.2 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446177 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 8 "cerebellum: 20.4" "Cell type enriched" "Detected in single" 8 "basophil: 2.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 8 "basal ganglia: 9.5" NA NA "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 1.3 1.0 0.6 0.3 0.7 2.3 3.1 20.4 0.8 0.6 0.3 0.5 0.0 0.9 0.5 0.0 0.2 0.4 0.2 0.4 0.8 0.4 0.7 0.9 2.2 1.2 1.3 0.4 0.4 0.7 2.5 4.6 0.1 2.6 3.1 0.1 0.9 1.4 1.0 0.6 2.2 0.5 1.2 2.9 0.9 3.2 0.9 0.2 0.0 1.8 0.0 0.2 3.2 0.4 0.2 0.0 2.7 0.1 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.1 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 2.9 0.0 1.2 0.8 0.3 0.1 0.5 2.6 0.3 0.1 0.4 0.0 0.8 0.9 1.5 0.3 0.3 0.0 0.6 0.7 0.0 0.0 0.6 0.6 1.8 0.4 0.8 0.4 0.4 0.2 0.2 0.3 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.7 20.4 0.8 0.8 0.4 1.3 0.4 2.6 0.2 6.0 1.6 0.0 0.0 0.2 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 SLC26A7 SUT2 ENSG00000147606 "Solute carrier family 26 member 7" Q8TE54 8 91209494-91398152 "Predicted membrane proteins" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "thyroid gland: 194.5" "Group enriched" "Detected in some" 5 "Collecting duct cells: 22.7;Distal tubular cells: 11.6;Intestinal endocrine cells: 43.5;Ito cells: 15.4" "Group enriched" "Detected in some" 11 "renal cancer: 8.7;thyroid cancer: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 3.0;HEK 293: 1.7;U-266/70: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (5.84e-2)" "unprognostic (8.04e-3)" "unprognostic (4.15e-3)" "unprognostic (1.51e-1)" "unprognostic (2.39e-3)" "unprognostic (2.94e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (8.26e-2)" "unprognostic (4.82e-2)" "unprognostic (3.31e-2)" "unprognostic (2.07e-1)" "unprognostic (5.19e-3)" "unprognostic (6.83e-3)" 0.3 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.2 1.6 0.2 0.0 0.2 0.0 1.4 0.2 0.3 0.1 0.1 0.3 0.1 0.1 13.0 0.1 0.1 1.7 0.1 0.0 0.1 0.3 0.1 0.3 4.4 0.7 0.1 0.0 8.6 0.8 0.1 0.2 0.2 0.1 0.0 0.3 0.1 1.5 0.2 0.0 0.0 194.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.3 0.0 0.0 0.0 3.0 0.1 0.2 0.0 1.7 0.3 0.1 0.0 0.0 0.0 1.2 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.0 0.6 3.1 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.0 22.7 0.0 0.0 11.6 0.0 4.4 0.6 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 43.5 15.4 0.6 1.0 3.4 0.0 3.3 0.0 0.7 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.2 0.0 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 131.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7" "Cell line enhanced" "Detected in many" "ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: AB_2685857" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favorable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 20.7 3.7 4.9 6.4 4.3 3.7 15.0 7.5 6.6 11.1 11.6 3.6 7.9 3.5 10.1 39.1 9.4 9.5 9.2 7.0 3.5 2.4 12.2 19.5 21.1 7.0 3.5 4.7 13.6 5.7 4.5 6.7 9.7 3.3 11.6 6.1 4.6 7.7 9.7 3.6 11.0 6.8 10.5 1.8 6.9 14.4 15.4 3.4 3.5 8.6 10.3 5.5 9.7 9.4 0.6 5.9 13.7 8.7 2.2 2.2 2.5 4.0 0.2 1.7 0.8 35.6 6.9 3.1 1.5 3.0 0.6 0.8 2.3 1.8 0.5 4.2 1.7 0.3 12.5 1.7 1.4 0.4 0.3 2.3 0.8 2.2 1.0 4.3 1.4 2.9 4.6 4.7 0.2 0.9 0.6 4.8 0.2 0.4 0.7 0.2 18.8 0.1 4.1 4.1 8.6 1.9 7.1 0.3 0.4 1.0 0.5 3.5 3.9 0.8 8.3 1.5 2.4 2.2 4.1 1.1 0.8 1.7 4.4 0.0 1.3 1.2 0.1 2.0 4.8 0.6 7.2 8.7 13.7 2.1 7.3 1.5 0.5 1.0 2.2 5.9 0.6 0.5 1.1 1.7 2.2 7.2 1.0 0.3 2.5 4.9 4.3 7.5 6.6 3.5 2.4 3.5 4.7 3.3 3.4 17.9 43.8 4.5 9.1 10.4 0.8 2.5 38.2 0.0 7.9 3.5 0.0 24.4 0.0 3.1 0.4 20.2 2.5 0.0 6.4 10.1 17.3 4.2 25.3 25.9 29.3 1.6 4.1 131.3 31.9 2.4 17.5 32.9 21.9 45.1 16.0 1.5 3.7 33.6 13.4 3.4 1.0 6.5 12.8 1.1 3.4 6.8 7.3 15.9 9.1 2.6 SLC27A6 "ACSVL2, FACVL2, FATP6, VLCS-H1" ENSG00000113396 "Solute carrier family 27 member 6" Q9Y2P4 5 128538013-129033642 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.2" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 22.4;Cytotrophoblasts: 39.8;Extravillous trophoblasts: 30.2;Muller glia cells: 39.4;Syncytiotrophoblasts: 23.0" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 19.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "BEWO: 31.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA008987 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA008987: AB_1857065" "unprognostic (5.39e-5)" "unprognostic (4.79e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-1)" "unprognostic (3.55e-1)" "unprognostic (1.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" "unprognostic (2.14e-1)" "unprognostic (2.54e-2)" "unprognostic (9.66e-4)" 0.5 23.2 6.3 0.5 6.8 0.3 2.9 0.6 2.8 4.1 0.9 8.2 0.0 0.6 4.2 0.5 7.2 19.5 2.7 20.6 3.2 3.3 0.2 0.3 0.9 0.4 10.4 0.0 9.7 0.3 0.2 7.7 19.6 13.3 3.7 1.8 1.7 3.9 0.4 0.5 2.2 1.1 1.0 12.7 0.3 0.6 11.3 15.1 5.4 3.9 8.7 5.5 1.5 3.2 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 31.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 2.4 0.0 2.2 1.5 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.2 3.1 0.0 3.7 0.0 2.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 6.8 0.6 2.8 3.2 3.3 10.4 0.0 13.3 15.1 0.0 0.0 0.0 1.0 2.9 0.0 22.4 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 30.2 0.9 0.1 0.0 0.0 3.4 3.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.0 0.6 23.0 0.0 0.0 0.0 SLC28A2 "CNT2, HCNT2, HsT17153, SPNT1" ENSG00000137860 "Solute carrier family 28 member 2" O43868 15 45252230-45277845 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "gallbladder: 28.7;intestine: 49.3" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 26.0;Paneth cells: 17.3;Undifferentiated cells: 59.6" "Cancer enhanced" "Detected in many" "stomach cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 4.3;NB-4: 2.3" "Low region specificity" "Detected in all" "HPA046068, HPA055623" Enhanced NA NA "HPA046068: AB_2679523, HPA055623: AB_2682866" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (6.85e-2)" "unprognostic (6.31e-2)" "unprognostic (1.59e-2)" "unprognostic (1.61e-1)" "unprognostic (6.40e-4)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.44e-2)" "unprognostic (8.95e-2)" 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.8 18.5 0.2 0.1 25.7 0.4 0.1 0.3 0.2 28.7 0.1 0.2 0.2 1.0 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 1.6 0.1 0.2 13.8 0.1 0.1 0.1 0.1 0.2 49.3 0.1 0.2 0.1 8.5 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.6 0.2 1.3 0.5 0.6 0.7 0.0 0.1 0.3 0.1 0.1 0.0 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.5 0.6 0.2 0.0 0.0 0.7 0.0 0.1 0.2 0.6 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 1.5 0.0 0.1 0.3 2.3 0.2 0.9 0.3 0.2 0.4 1.3 0.0 0.2 1.1 1.6 0.0 0.1 0.3 0.6 0.2 0.6 0.3 0.4 0.5 1.2 0.2 0.8 0.2 0.3 0.4 0.6 0.3 1.3 0.2 0.1 0.4 0.1 0.2 0.5 0.3 0.1 0.2 0.6 0.4 0.7 0.2 0.6 0.5 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 7.2 0.9 0.2 0.1 2.7 0.4 12.7 8.1 7.9 0.0 2.0 11.0 0.0 0.0 0.4 0.4 26.0 0.0 0.0 1.6 0.4 0.2 8.1 0.0 0.8 1.6 13.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.5 0.0 17.3 0.7 0.3 4.6 0.0 0.0 1.9 1.7 0.3 3.9 0.9 59.6 0.1 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.0" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA042960: AB_2678241, HPA071184: AB_2686355" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favorable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 4.3 7.8 8.5 6.1 15.3 3.5 6.2 22.9 17.0 4.1 4.9 6.4 17.2 3.9 7.7 9.0 2.8 5.0 5.2 8.5 11.0 13.4 19.5 4.9 4.5 7.1 9.5 10.9 6.6 28.8 18.6 14.0 21.0 9.7 7.6 6.0 10.4 6.1 11.4 13.6 4.2 4.8 10.4 9.6 5.3 6.1 4.5 6.2 1.6 9.2 2.4 6.4 4.5 5.3 2.2 4.6 1.5 1.1 1.2 1.6 0.3 2.6 1.3 1.7 7.6 1.6 3.4 0.7 1.6 2.0 1.8 1.3 1.8 1.8 3.4 0.9 2.2 1.6 2.2 3.2 0.9 0.9 2.3 2.9 1.7 2.8 2.6 2.5 1.6 1.8 1.3 3.2 2.7 2.3 8.4 0.7 2.7 0.7 7.6 1.0 2.8 0.3 0.7 2.5 1.7 2.1 4.6 0.2 3.8 5.6 0.7 4.1 2.3 0.8 12.0 2.7 2.1 6.2 0.8 0.5 0.7 1.2 0.7 0.8 7.1 1.9 3.3 1.5 1.2 1.8 1.5 0.4 0.9 0.9 1.1 0.7 2.1 0.8 0.8 0.2 2.2 1.6 1.1 1.2 1.2 0.7 4.6 0.2 0.3 8.5 15.3 22.9 17.0 11.0 13.4 9.5 10.9 9.7 6.2 17.9 12.9 16.6 8.2 2.9 57.0 29.0 7.6 8.1 4.5 24.4 280.8 7.0 11.6 4.7 5.9 3.3 3.4 0.0 4.9 7.6 4.5 8.0 2.3 5.8 5.2 35.0 10.4 4.9 3.1 8.5 8.6 4.2 3.3 2.8 4.9 15.4 3.5 2.9 9.2 20.7 194.1 0.0 6.2 3.9 5.1 2.8 16.7 7.5 7.3 5.4 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133988697-134052636 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.6" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.0" "Group enriched" "Detected in many" 6 "dendritic cells: 1.0;monocytes: 1.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: AB_2673948" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.9 1.2 5.2 0.4 6.7 0.1 1.5 14.6 5.5 4.8 3.0 7.1 4.9 8.1 9.7 2.6 7.0 3.4 3.0 11.4 6.5 2.8 6.7 7.9 3.4 0.2 3.4 5.2 1.5 1.3 1.2 2.5 1.9 19.7 27.0 1.4 46.6 5.2 11.2 4.2 3.9 11.9 14.8 1.6 0.3 14.4 0.5 3.3 0.6 0.6 1.9 2.7 6.7 2.0 0.0 1.0 0.0 1.3 0.0 0.1 0.1 2.1 0.7 1.8 0.0 1.4 0.7 0.1 1.3 5.4 0.7 3.0 0.0 7.4 0.2 1.1 0.1 5.5 5.6 0.0 0.5 1.0 0.0 4.7 0.0 0.6 0.1 0.2 0.0 0.0 1.0 0.5 0.6 0.1 13.5 0.4 0.3 0.4 0.6 0.1 0.6 0.1 0.1 1.6 0.0 0.5 0.0 0.9 2.0 1.6 0.7 0.2 0.5 0.0 1.7 0.0 22.1 0.0 0.0 0.0 0.2 8.0 0.2 0.7 2.8 2.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 5.2 6.7 14.6 5.5 6.5 2.8 3.4 5.2 19.7 3.3 0.0 4.8 0.0 0.8 1.8 0.1 5.7 0.0 9.4 2.3 0.0 0.0 1.9 3.3 1.2 0.0 0.4 0.0 0.0 0.2 0.5 0.3 11.7 0.0 0.9 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.8 2.9 1.4 0.3 0.5 0.0 0.1 0.0 0.0 1.6 30.7 0.0 0.3 1.4 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 60.6" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2" HPA006539 Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.3 0.3 0.2 0.2 0.6 12.6 0.0 0.0 0.0 0.2 20.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.5 5.3 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.9 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 25.2 0.0 1.3 0.3 0.1 0.5 0.3 0.1 0.1 0.1 0.2 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 3.7 2.3 0.0 0.0 1.3 0.9 1.9 0.0 9.2 0.4 0.2 0.0 0.0 8.0 4.4 0.9 0.3 3.1 1.7 0.0 0.0 0.0 0.5 5.8 2.5 0.0 0.4 0.0 4.2 60.6 2.7 0.1 0.3 3.2 0.0 0.0 SLC2A7 GLUT7 ENSG00000197241 "Solute carrier family 2 member 7" Q6PXP3 1 9003300-9026345 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in single" "Daudi: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039931 Uncertain NA NA "HPA039931: AB_10671046" "unprognostic (4.19e-2)" "unprognostic (3.68e-1)" "unprognostic (1.96e-2)" "unprognostic (2.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.43e-1)" "unprognostic (9.05e-2)" "unprognostic (5.69e-4)" "unprognostic (5.09e-2)" "unprognostic (7.12e-2)" "unprognostic (1.60e-1)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 7.2 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 19.3 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC30A7 "ZNT7, ZnTL2" ENSG00000162695 "Solute carrier family 30 member 7" Q8NEW0 1 100896076-100981753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018034 Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA018034: AB_1857089" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (8.05e-3)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "unprognostic (3.18e-1)" "unprognostic (2.89e-3)" "unprognostic (1.24e-1)" "unprognostic (1.61e-1)" "unprognostic (1.11e-3)" "unprognostic (2.78e-2)" "unprognostic (1.95e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (3.37e-1)" 15.6 14.2 5.0 13.1 6.4 10.3 12.7 7.4 7.6 13.3 10.8 6.2 17.2 10.8 13.3 13.7 10.8 9.4 13.2 9.3 5.9 5.6 13.0 43.1 18.1 25.6 7.7 4.6 10.5 19.1 17.1 17.7 25.2 9.2 11.9 14.7 10.8 17.5 18.1 5.7 12.6 15.8 9.0 8.1 16.2 13.3 7.5 6.4 24.7 13.2 10.9 17.4 10.5 11.1 5.5 8.2 13.9 14.9 8.4 10.7 5.9 10.9 5.7 6.2 13.6 13.2 13.5 15.7 7.2 19.3 8.8 11.6 5.8 7.9 4.4 15.7 14.7 7.0 10.9 7.2 10.7 13.5 6.9 4.5 8.6 9.7 10.4 14.8 11.3 9.2 15.4 6.9 14.8 18.1 8.5 14.2 8.4 5.2 19.3 11.9 4.9 8.2 5.7 6.6 5.5 7.1 4.1 11.1 5.7 7.8 12.8 3.4 6.7 12.9 14.5 9.3 4.9 7.2 6.3 15.3 20.8 8.0 19.2 11.5 13.1 6.9 4.9 21.2 9.3 5.5 13.9 10.7 7.4 10.7 10.4 9.2 5.3 9.9 8.4 8.2 5.5 8.9 9.6 5.3 8.4 14.9 7.7 7.2 5.9 5.0 6.4 7.4 7.6 5.9 5.6 7.7 4.6 9.2 6.4 29.8 16.3 25.1 16.5 50.9 8.9 3.2 15.3 10.7 12.5 22.7 5.9 26.3 1.7 20.8 0.6 24.6 16.0 0.0 23.0 19.6 25.5 36.1 36.9 38.5 19.8 4.8 21.9 35.0 29.4 0.9 15.8 29.5 30.4 14.4 32.0 7.8 29.1 24.6 15.6 16.2 12.4 6.5 22.3 6.2 7.6 55.8 34.9 29.8 20.1 24.8 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724462-38729372 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 38.3" "Cell type enriched" "Detected in some" 14 "Horizontal cells: 55.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Group enriched" "Detected in some" 12 "MOLT-4: 5.5;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported NA NA "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 1.0 1.1 4.6 1.0 38.3 1.5 1.0 4.9 25.8 1.0 1.0 0.8 0.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0 3.9 9.7 1.0 1.0 1.0 1.0 4.4 6.8 1.0 1.1 1.0 4.1 1.0 10.4 1.0 1.0 0.7 1.0 1.0 1.0 1.0 1.1 1.0 4.4 1.0 1.0 1.6 7.9 0.0 1.0 0.0 1.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.6 38.3 4.9 11.9 3.9 9.7 4.4 6.8 10.4 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 SLC35A1 "CMPST, hCST" ENSG00000164414 "Solute carrier family 35 member A1" P78382 6 87470623-87512336 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.04e-2)" "unprognostic (1.93e-1)" "unprognostic (6.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.82e-1)" "unprognostic (4.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.58e-2)" "unprognostic (3.01e-3)" "unprognostic (7.26e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.70e-6)" "unprognostic (2.85e-1)" "unprognostic (8.51e-2)" "unprognostic (5.48e-2)" "unprognostic (1.04e-1)" 11.0 18.0 14.0 9.2 19.8 6.3 20.5 24.1 22.9 19.2 25.3 10.0 8.0 12.0 20.1 15.1 10.0 13.6 12.7 10.6 15.2 13.8 15.7 20.8 24.2 10.3 16.3 11.6 15.8 11.6 13.0 24.4 12.6 21.4 24.9 31.6 13.1 19.4 11.4 9.1 15.9 14.5 18.9 12.2 14.0 18.8 8.1 14.5 18.6 14.2 8.2 11.8 17.4 12.0 9.4 24.6 21.6 28.4 8.7 15.1 17.2 2.0 5.0 9.1 10.7 24.9 22.8 7.3 6.1 5.4 5.1 7.1 4.3 37.8 7.6 7.5 7.5 14.2 8.1 10.9 4.9 6.6 10.8 8.1 8.6 6.8 7.6 16.4 11.1 6.0 11.6 12.0 6.0 11.8 12.1 12.2 11.2 11.0 12.6 7.5 19.0 3.0 16.9 4.9 26.0 8.2 9.6 8.9 8.1 15.8 8.8 6.0 6.6 11.2 21.1 9.7 10.9 18.7 22.9 11.3 7.4 5.0 8.1 4.9 9.4 13.6 2.8 6.2 19.9 10.5 21.6 28.4 11.6 9.8 22.1 15.1 9.4 10.6 11.9 24.6 8.7 13.6 12.6 7.0 8.7 21.5 9.1 13.6 17.2 14.0 19.8 24.1 22.9 15.2 13.8 16.3 11.6 21.4 14.5 41.7 25.2 6.9 15.8 13.2 6.9 5.2 17.8 16.0 10.3 15.7 11.8 20.9 6.6 8.2 5.8 14.3 15.8 0.0 7.9 15.9 17.7 17.6 21.8 17.4 14.5 11.1 14.5 47.3 30.6 4.9 15.3 13.6 20.3 10.8 73.6 18.1 8.5 14.0 18.0 9.3 6.4 19.4 16.5 7.5 9.7 12.9 23.0 13.8 25.5 7.4 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.5 46.7 18.7 35.2 25.7 16.1 27.9 22.7 15.3 27.7 29.2 56.5 18.0 46.0 28.1 21.3 32.3 17.2 0.0 33.1 23.8 55.9 25.6 34.4 45.6 0.2 18.3 33.6 26.0 21.3 25.9 27.5 24.7 13.0 23.7 22.8 26.6 46.5 27.4 28.8 35.0 14.6 12.7 22.4 23.9 26.1 37.9 39.9 20.7 30.8 20.9 27.9 28.7 47.8 22.3 19.2 39.7 14.4 27.7 24.9 17.4 24.7 25.4 19.3 45.3 19.3 18.4 38.0 28.9 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 11.9 24.8 21.9 20.2 9.3 12.2 23.8 43.3 6.7 17.0 15.7 3.9 26.8 38.1 28.1 58.7 14.7 37.1 0.0 30.4 42.8 19.5 22.2 20.7 19.5 28.5 12.7 24.2 27.6 21.1 94.4 11.5 15.8 16.9 31.5 27.2 20.3 31.1 21.0 11.7 31.1 8.5 32.3 12.6 5.4 16.4 10.2 25.5 20.3 28.7 29.1 SLC35D1 "KIAA0260, UGTREL7" ENSG00000116704 "Solute carrier family 35 member D1" Q9NTN3 1 66999332-67054099 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.91e-2)" "unprognostic (3.69e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.63e-1)" "unprognostic (6.53e-2)" "unprognostic (2.49e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (2.12e-3)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (2.07e-1)" "unprognostic (7.65e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.08e-3)" "unprognostic (3.20e-1)" 4.0 6.3 5.1 7.5 7.0 4.7 4.7 6.6 5.5 6.2 16.2 7.5 4.8 9.9 5.4 3.8 5.3 4.4 4.4 3.8 4.7 3.8 8.1 50.4 3.8 5.7 7.4 4.0 6.4 7.2 6.4 8.7 6.0 5.4 5.6 17.3 7.1 3.9 4.0 6.9 6.2 14.3 5.4 4.0 4.0 8.0 4.1 5.6 11.1 5.1 4.0 6.4 5.8 6.5 2.3 1.8 9.7 2.4 5.1 4.3 1.4 5.0 2.9 8.9 7.5 9.3 10.8 10.6 11.3 15.0 8.2 5.8 6.2 1.2 15.6 5.0 8.9 9.7 7.7 6.1 7.2 10.4 15.5 2.8 11.6 6.1 12.2 7.8 13.1 7.7 10.5 16.1 9.7 6.9 13.3 3.1 6.6 7.0 8.3 19.9 1.7 8.0 4.1 3.7 13.6 4.0 6.2 18.4 1.7 3.8 9.6 1.1 4.0 17.1 5.3 7.2 5.2 4.4 9.8 3.4 15.4 3.6 9.4 10.8 17.4 9.0 8.7 11.0 2.0 6.5 9.7 1.5 4.0 3.4 1.1 4.2 2.3 2.6 2.7 1.8 1.7 3.7 3.3 0.3 5.1 2.4 1.0 4.3 1.4 5.1 7.0 6.6 5.5 4.7 3.8 7.4 4.0 5.4 5.6 6.0 2.1 4.3 4.7 4.8 6.9 2.6 33.1 6.7 2.3 5.2 11.8 30.4 0.0 2.8 37.3 4.2 36.7 23.3 8.6 4.0 7.2 5.6 4.6 84.4 6.2 6.4 14.5 6.7 9.2 6.6 5.8 3.8 1.7 1.0 14.9 21.0 7.2 14.4 4.2 8.4 8.7 0.0 3.9 7.6 6.7 6.8 13.6 6.9 13.4 7.4 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922264-136925639 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;retina: 16.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Group enriched" "Detected in some" 4 "basal ganglia: 9.9;hypothalamus: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 18.7" "Group enriched" "Detected in many" 5 "basal ganglia: 26.6;olfactory region: 10.4" "Region enriched" "Detected in many" 6 "basal ganglia: 24.4" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: AB_2685854" "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.1 4.9 0.0 0.4 9.9 1.2 0.1 0.0 0.4 2.0 0.4 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 0.4 0.0 4.8 4.0 0.0 2.1 0.0 1.7 0.0 0.8 1.2 0.0 0.0 0.1 0.5 4.3 0.6 16.4 0.2 0.1 0.0 0.2 1.3 0.3 0.0 0.2 3.2 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 18.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 9.9 0.0 0.4 0.0 4.8 1.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 SLC35E2 KIAA0447 ENSG00000215790 "Solute carrier family 35 member E2" P0CK97 1 1724838-1745999 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA006118, HPA062711" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA006118: , HPA062711: AB_2684844" "unprognostic (3.03e-1)" "unprognostic (2.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.28e-4)" "unprognostic (9.52e-4)" "unprognostic (6.57e-2)" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (9.15e-3)" "unprognostic (4.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.83e-1)" "unprognostic (8.41e-2)" "unprognostic (2.43e-3)" "unprognostic (4.87e-4)" 3.0 4.1 8.0 5.2 5.1 0.6 3.0 9.8 6.2 4.0 3.0 2.9 1.6 4.9 6.0 10.5 4.5 5.8 7.6 3.0 5.0 3.5 2.5 2.4 4.8 11.6 4.4 4.7 5.5 3.5 6.9 5.9 3.5 4.0 3.6 5.4 3.6 9.1 1.6 4.7 6.4 4.8 3.7 3.7 6.8 6.2 6.2 5.5 5.5 3.5 3.8 4.3 4.3 7.7 5.0 5.2 6.4 3.4 3.1 6.5 3.2 1.6 1.6 5.4 11.5 11.2 11.0 3.6 7.4 15.3 7.0 9.0 4.6 15.1 4.9 1.3 1.7 1.7 7.5 1.4 2.9 7.6 6.8 1.7 6.4 7.5 1.2 2.3 1.3 7.2 8.8 3.7 1.2 6.3 5.8 2.1 9.2 2.1 2.2 1.3 1.2 1.9 3.2 1.0 0.9 1.9 3.7 5.0 1.0 7.4 5.3 15.2 3.1 2.2 9.2 8.8 1.3 17.9 3.6 9.6 7.3 1.5 2.2 0.4 3.0 0.4 1.6 5.2 3.9 1.2 6.4 3.4 2.1 5.5 2.6 6.5 4.5 4.8 5.3 1.5 5.0 5.5 4.8 4.0 3.1 1.6 5.2 4.5 3.2 8.0 5.1 9.8 6.2 5.0 3.5 4.4 4.7 4.0 5.5 26.8 22.1 0.0 0.5 0.5 5.1 0.0 2.5 10.7 11.4 0.0 2.0 0.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.0 0.4 2.3 0.8 0.6 12.7 0.0 1.8 0.6 0.0 2.8 0.3 0.0 0.0 0.7 1.2 0.0 0.0 3.2 0.0 3.9 0.0 0.0 0.7 1.3 1.5 0.2 4.9 1.2 0.4 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692728 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 7.4 9.7 11.3 5.8 9.3 6.4 14.2 15.5 14.5 8.1 15.4 9.7 15.4 12.5 10.2 10.5 6.8 9.0 9.8 5.0 11.7 7.5 7.7 14.2 8.6 18.8 10.0 8.5 15.0 16.6 6.5 14.4 11.0 9.2 9.7 7.3 8.7 12.1 10.2 10.4 10.5 12.1 13.6 7.1 12.8 8.2 3.9 12.6 8.5 9.8 7.2 10.2 7.3 13.0 4.8 8.7 6.8 3.9 4.5 9.5 5.0 6.1 7.7 27.5 19.4 15.4 14.7 6.9 3.4 8.0 4.0 4.1 3.5 8.4 8.3 12.4 16.4 9.9 4.5 10.9 5.9 3.5 11.7 10.3 12.3 13.7 9.9 15.3 11.6 10.0 13.7 13.8 10.7 12.0 21.4 16.8 16.0 14.6 14.9 9.3 3.8 15.2 13.2 9.5 5.1 9.1 12.7 5.8 14.4 9.9 3.4 18.6 23.8 12.7 11.2 20.1 12.5 9.0 15.8 12.4 11.5 6.1 4.9 4.1 12.5 9.6 17.5 9.1 21.1 8.1 1.7 3.9 3.3 8.3 3.5 8.9 4.3 6.8 9.5 2.8 4.8 8.1 6.7 6.8 4.5 2.5 8.7 6.4 5.0 11.3 9.3 15.5 14.5 11.7 7.5 10.0 8.5 9.2 12.6 11.9 27.0 23.5 6.5 6.5 33.6 15.3 35.7 13.4 27.3 3.5 72.6 11.2 0.0 5.0 0.8 18.6 25.2 0.0 5.3 7.3 19.3 8.4 22.0 18.1 8.9 28.6 24.5 30.1 33.0 1.3 28.1 8.0 11.8 6.4 23.6 12.3 4.8 17.5 25.1 2.2 66.3 6.5 9.5 6.1 15.5 8.4 7.3 30.6 26.7 6.7 SLC35E3 BLOV1 ENSG00000175782 "Solute carrier family 35 member E3" Q7Z769 12 68746106-68793964 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 19.2;U-698: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049403 Uncertain NA NA "HPA049403: AB_2680747" "unprognostic (1.49e-1)" "unprognostic (6.47e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.61e-2)" "unprognostic (2.49e-1)" "unprognostic (1.26e-4)" "unprognostic (2.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-2)" "unprognostic (6.98e-2)" "unprognostic (6.85e-3)" "unprognostic (1.48e-1)" "unprognostic (3.22e-2)" "unprognostic (2.89e-3)" "unprognostic (1.80e-1)" 8.1 12.3 7.9 7.2 11.9 12.0 12.4 14.1 13.7 8.2 6.2 18.9 3.5 5.7 7.4 9.6 8.7 5.5 5.8 6.2 8.9 7.4 8.0 12.7 7.6 9.2 13.9 10.6 8.7 9.8 7.7 6.7 5.8 14.4 10.2 5.9 9.7 11.8 5.8 7.3 14.5 5.5 7.4 15.7 8.2 9.2 5.7 11.0 18.8 6.9 5.3 9.0 8.0 6.6 4.4 3.7 9.5 3.8 3.6 4.6 1.5 2.2 2.4 3.7 2.3 4.8 2.2 3.4 2.0 4.1 4.6 2.0 4.9 2.8 10.5 1.3 4.1 3.0 3.2 2.1 4.2 2.8 2.3 3.7 4.5 3.0 8.1 3.5 2.3 2.3 4.8 3.2 5.7 2.9 3.3 3.7 3.6 2.3 3.9 4.6 3.4 2.9 7.3 3.7 1.5 3.5 19.2 5.9 2.6 3.4 5.5 2.9 5.0 4.0 3.2 2.6 3.8 5.7 1.1 2.7 5.6 2.3 3.2 2.1 8.6 4.2 19.5 6.7 2.0 2.9 4.7 3.3 4.2 4.0 3.1 4.6 3.1 3.2 3.2 2.4 4.4 3.6 2.9 9.5 3.6 3.8 3.7 2.7 1.5 7.9 11.9 14.1 13.7 8.9 7.4 13.9 10.6 14.4 11.0 11.9 24.8 17.1 19.2 7.0 61.6 12.9 10.2 26.8 21.6 17.4 37.3 21.6 5.0 16.2 3.2 12.8 7.1 0.0 19.5 20.0 16.0 14.6 17.4 20.2 13.6 41.3 12.6 14.7 21.1 1.7 14.1 26.5 6.8 19.0 8.4 28.1 16.8 5.8 21.5 11.3 61.9 25.8 12.0 9.6 13.5 6.6 10.4 29.9 12.3 14.9 SLC35E4 ENSG00000100036 "Solute carrier family 35 member E4" Q6ICL7 22 30635652-30669016 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.2;testis: 22.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 93.5;Late spermatids: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049558 Approved Approved Cytosol NA NA Cytosol "HPA049558: AB_2680817" "unprognostic (2.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.05e-1)" "unprognostic (1.01e-2)" "unprognostic (4.99e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-4)" "unprognostic (5.71e-2)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (3.45e-7)" "unprognostic (2.77e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (8.05e-3)" 4.0 2.5 5.6 3.3 11.8 3.4 2.6 4.0 11.4 2.7 5.9 8.1 2.1 2.7 4.2 3.5 4.5 3.1 2.9 5.6 5.2 4.7 2.0 1.1 2.4 2.1 13.0 6.3 2.8 4.1 3.1 2.8 1.6 6.6 2.9 4.2 2.4 2.6 3.5 20.2 7.3 2.5 3.5 2.6 2.4 3.8 22.5 10.1 0.0 2.0 6.6 2.1 3.6 7.6 0.7 3.6 1.6 2.8 2.1 3.2 0.9 6.5 2.9 1.1 2.2 3.0 7.7 0.6 4.3 3.8 3.0 2.8 0.2 1.8 0.4 2.3 4.4 4.2 4.2 1.9 2.5 1.5 15.0 2.1 0.1 2.1 0.2 4.3 0.3 1.8 2.4 1.1 11.9 3.7 4.7 10.1 0.5 0.6 2.0 4.6 1.9 0.2 1.3 1.3 1.9 10.9 1.2 2.2 0.2 1.4 0.5 6.0 2.3 4.4 1.9 2.1 0.5 1.3 0.5 13.4 12.7 4.0 14.5 4.1 0.6 0.5 0.2 15.5 0.2 3.3 1.6 2.1 0.3 0.9 2.8 1.4 0.3 2.1 3.2 3.6 0.7 2.1 1.7 0.8 2.1 2.2 1.0 2.3 0.9 5.6 11.8 4.0 11.4 5.2 4.7 13.0 6.3 6.6 10.1 0.0 1.0 0.9 2.0 12.9 8.8 1.6 0.0 8.1 1.2 1.8 21.6 0.0 0.0 3.2 93.5 4.9 2.6 0.0 2.1 0.4 3.7 1.5 1.1 0.0 1.7 11.1 2.4 4.9 0.3 68.4 3.1 4.5 3.3 2.8 2.6 17.3 1.9 5.7 3.5 0.3 9.3 0.0 4.1 21.8 3.4 16.7 0.1 2.5 4.4 1.4 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "AF22: 23.9;WM-115: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.4 0.0 0.0 0.1 0.0 40.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 0.0 0.0 0.0 0.0 0.3 11.0 4.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.1 15.9 0.0 0.0 0.0 17.4 0.6 0.0 13.5 0.0 0.0 27.9 0.0 0.0 1.1 0.0 1.8 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904933-234324516 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 9 "Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 49 "plasmacytoid DC: 7.1" "Lineage enriched" "Detected in single" 69 "dendritic cells: 7.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.8 3.5 4.6 1.3 26.0 0.7 6.8 25.1 16.7 1.4 0.8 0.5 0.0 0.8 1.0 2.5 1.6 1.7 0.8 0.6 5.4 4.6 1.6 0.6 1.2 2.4 4.8 6.6 0.6 3.6 4.6 2.8 0.7 4.1 2.0 0.8 0.0 6.6 1.1 1.1 0.8 0.9 1.1 4.8 1.0 2.5 1.1 4.3 0.5 1.9 0.3 1.9 0.8 0.6 0.0 7.1 0.0 0.1 0.0 0.0 0.0 1.4 3.9 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.1 0.3 0.0 3.6 0.0 49.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.4 0.0 0.0 0.0 3.6 0.0 2.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 4.6 26.0 25.1 11.6 5.4 4.6 4.8 6.6 4.1 4.3 0.0 0.0 0.0 2.4 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.6 0.0 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.0 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563922-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 29.5;seminal vesicle: 10.5" "Cell type enhanced" "Detected in some" 24 "Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.5;U-87 MG: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043853 Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.1 0.1 1.2 0.1 4.9 0.1 0.1 29.5 1.1 1.0 0.2 0.1 0.5 0.2 1.5 0.2 0.1 0.2 0.5 0.1 0.9 2.2 0.4 0.1 0.1 0.1 0.8 1.2 0.3 0.1 0.1 0.2 0.1 2.9 3.5 0.1 2.4 0.1 10.5 0.1 0.1 0.4 1.1 1.3 0.1 0.1 2.7 0.7 0.0 2.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 29.5 1.1 0.9 2.2 0.8 1.2 2.9 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 2.8 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G3 "AMAC1, FLJ40154, TMEM21A" ENSG00000164729 "Solute carrier family 35 member G3" Q8N808 17 35192520-35194523 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1;skeletal muscle: 1.4;testis: 6.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 16.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Lineage enriched" "Detected in single" 31 "T-cells: 3.1" "Not detected" "Not detected" NA NA "unprognostic (1.88e-1)" "unprognostic (2.67e-1)" "unprognostic (6.17e-3)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 3.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 SLC35G5 "AMAC, AMAC1L2" ENSG00000177710 "Solute carrier family 35 member G5" Q96KT7 8 11330888-11332208 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.5" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 8.2;Rod photoreceptor cells: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "TIME: 2.4" NA NA "unprognostic (7.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (9.67e-2)" "unprognostic (2.60e-4)" "unprognostic (6.48e-3)" "unprognostic (4.09e-1)" "unprognostic (5.79e-2)" "unprognostic (1.06e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-2)" "unprognostic (3.44e-1)" "unprognostic (2.06e-6)" "unprognostic (7.88e-2)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (2.04e-3)" 0.0 0.2 0.4 0.7 0.5 1.3 0.0 0.5 0.4 0.3 0.6 0.1 0.2 0.2 0.4 0.2 0.5 1.1 0.5 0.6 0.5 0.3 0.5 0.8 0.6 0.2 0.9 0.0 0.8 0.1 1.1 0.2 0.3 0.0 1.9 1.2 0.6 0.1 0.5 1.4 0.5 5.5 0.6 0.5 0.3 0.4 0.4 1.7 0.1 0.8 0.0 2.1 0.0 0.3 0.0 0.2 0.8 0.7 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.3 0.2 0.8 0.8 0.3 0.6 0.1 0.2 0.2 0.4 0.1 0.5 1.5 0.1 0.0 0.1 0.8 1.1 0.4 0.0 0.0 0.3 0.1 0.7 0.8 0.7 1.1 0.8 0.3 0.3 0.5 0.4 0.7 0.6 0.5 0.6 0.1 0.7 0.9 1.4 1.6 0.1 0.2 0.5 0.5 0.0 2.4 0.5 0.8 0.7 0.3 0.5 0.6 1.0 0.3 0.4 0.7 0.1 0.3 0.0 2.1 0.1 0.2 0.0 0.8 0.0 0.6 0.4 0.4 0.1 0.1 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.2 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.4 1.6 0.0 1.8 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.4 0.0 3.2 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.4 0.3 SLC35G6 "AMAC1L3, TMEM21B" ENSG00000259224 "Solute carrier family 35 member G6" P0C7Q6 17 7481332-7483496 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 26.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HeLa: 3.7;U-138 MG: 1.2" NA NA "unprognostic (3.81e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (1.65e-3)" "unprognostic (3.29e-1)" "unprognostic (9.19e-3)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (5.21e-2)" "unprognostic (3.79e-2)" "unprognostic (2.01e-2)" 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 0.0 0.0 1.1 0.9 1.1 0.3 0.0 0.3 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.1 3.7 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 1.2 0.1 0.6 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 1.1 0.3 0.1 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 SLC36A3 "PAT3, TRAMD2, tramdorin2" ENSG00000186334 "Solute carrier family 36 member 3" Q495N2 5 151276762-151303766 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 14.5" "Group enriched" "Detected in some" 57 "Early spermatids: 47.0;Late spermatids: 85.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.41e-1)" "unprognostic (5.38e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-1)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (2.57e-2)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SLC37A1 ENSG00000160190 "Solute carrier family 37 member 1" P57057 21 42496008-42581440 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.9" "Group enriched" "Detected in many" 4 "Early spermatids: 254.9;Late spermatids: 218.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 48.5;MCF7: 19.3;OE19: 20.9;SK-BR-3: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030418, CAB034154" Approved NA NA "CAB034154: AB_2190373, HPA030418: AB_10601602" "unprognostic (1.44e-2)" "unprognostic (2.93e-2)" "unprognostic (2.12e-1)" "prognostic favorable (9.22e-5)" "unprognostic (1.59e-2)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (7.99e-2)" "unprognostic (5.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.16e-1)" "unprognostic (4.08e-2)" "unprognostic (7.94e-2)" "prognostic favorable (3.43e-5)" "unprognostic (1.61e-2)" 4.7 6.6 7.2 15.8 5.3 7.5 7.3 8.0 6.1 6.3 28.6 2.7 5.1 31.0 2.4 10.6 9.8 6.9 18.4 2.3 3.4 4.9 4.7 4.0 8.0 6.1 3.5 4.6 3.9 4.8 2.2 14.0 9.7 3.9 10.8 13.7 5.5 14.5 9.0 6.4 4.6 45.9 3.0 7.1 7.0 16.7 16.8 3.3 9.3 9.3 4.4 16.2 7.1 5.9 7.8 13.1 23.0 10.5 4.1 6.7 4.0 5.2 2.1 0.5 1.0 0.0 0.1 4.6 0.2 0.0 0.2 0.1 1.2 10.7 3.7 5.5 0.0 3.3 2.1 1.0 2.7 0.0 1.7 2.6 48.5 1.8 0.1 1.3 1.0 4.8 0.2 1.6 0.0 0.1 0.0 1.6 4.2 0.9 5.2 0.0 19.3 3.6 2.6 3.7 20.9 1.2 3.7 0.0 0.1 4.5 10.0 5.7 0.7 3.1 16.9 1.2 0.5 6.3 5.4 2.8 0.0 1.0 0.0 0.0 10.0 6.1 3.6 0.0 8.0 0.5 2.1 3.2 23.0 5.2 8.6 6.7 7.8 3.6 4.6 4.6 5.4 3.1 4.3 3.8 4.1 10.5 13.1 1.8 4.0 7.2 5.3 8.0 6.1 3.4 4.9 3.5 4.6 3.9 3.3 17.9 23.0 14.6 7.2 1.9 2.7 3.2 20.4 22.7 10.3 12.2 5.9 5.4 0.0 21.7 254.9 4.6 47.1 0.0 27.2 4.9 3.2 22.1 1.1 4.9 7.7 3.2 28.9 4.9 6.4 218.7 6.6 5.1 6.8 21.6 37.8 37.2 27.4 56.0 2.5 1.1 4.1 0.0 3.3 25.0 4.6 1.4 7.2 7.5 35.5 16.1 SLC37A2 FLJ00171 ENSG00000134955 "Solute carrier family 37 member 2" Q8TED4 11 125063067-125090312 "Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.2;salivary gland: 85.6" "Group enriched" "Detected in many" 7 "Hofbauer cells: 32.3;Kupffer cells: 15.9;Macrophages: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 12 "dendritic cells: 3.7;monocytes: 11.9" "Cell line enhanced" "Detected in some" "A-431: 12.7;CAPAN-2: 27.2;hTCEpi: 12.2;hTERT-HME1: 29.3;U-138 MG: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014948 Uncertain NA NA "HPA014948: AB_2190374" "unprognostic (8.47e-2)" "unprognostic (4.85e-1)" "unprognostic (9.64e-2)" "unprognostic (2.91e-2)" "unprognostic (7.88e-2)" "unprognostic (2.84e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-2)" "unprognostic (3.11e-1)" "unprognostic (6.61e-2)" "unprognostic (1.94e-3)" "unprognostic (1.66e-3)" "unprognostic (7.01e-2)" "unprognostic (3.24e-2)" 7.1 26.4 1.0 47.2 1.4 0.0 3.4 0.4 1.0 2.5 3.6 3.5 0.5 3.7 0.7 2.0 7.2 1.0 2.4 2.3 1.3 0.7 1.0 2.7 7.2 6.4 1.5 0.3 1.8 0.7 0.0 0.6 3.2 1.5 2.0 4.6 2.4 85.6 0.6 0.4 16.3 4.6 1.3 1.7 10.2 0.8 0.7 1.2 1.4 0.6 3.3 3.1 6.6 6.5 0.1 3.7 0.6 11.9 0.0 0.0 3.1 12.7 0.0 0.2 0.0 0.3 0.4 0.0 0.4 1.2 0.4 1.2 0.1 27.2 0.0 3.9 0.1 1.0 6.7 0.2 7.2 1.8 0.3 0.2 2.9 0.2 0.6 0.0 0.0 0.1 0.3 12.2 1.2 29.3 0.7 0.7 0.2 0.1 0.1 1.3 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.9 0.2 0.3 6.6 0.0 0.1 2.3 0.0 0.8 0.2 0.0 0.6 1.5 20.9 0.0 0.2 0.5 0.3 0.4 0.0 0.7 0.7 1.6 0.0 8.0 0.0 0.0 9.9 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.6 0.0 11.9 0.0 0.0 3.1 1.0 1.4 0.4 1.0 1.3 0.7 1.5 0.3 1.5 1.2 0.0 1.1 1.4 1.2 0.2 1.4 0.8 0.0 0.0 2.3 0.0 2.0 0.5 0.0 0.1 1.3 0.8 0.0 0.0 0.0 0.6 0.3 0.8 2.3 0.0 32.3 0.0 0.0 1.8 15.9 1.7 0.9 9.3 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.0 0.7 0.0 0.4 2.2 1.0 0.6 2.9 0.7 0.0 2.6 SLC37A3 DKFZp761N0624 ENSG00000157800 "Solute carrier family 37 member 3" Q8NCC5 7 140293693-140404433 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-1)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.44e-1)" "unprognostic (5.59e-2)" "unprognostic (2.69e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.78e-5)" "unprognostic (1.97e-1)" "unprognostic (2.94e-1)" "unprognostic (3.78e-2)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-2)" "unprognostic (3.31e-1)" "unprognostic (3.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.50e-2)" 11.7 6.9 8.4 6.2 13.6 6.6 14.1 14.0 15.0 18.7 16.3 9.1 5.1 8.7 31.5 16.1 7.7 15.6 12.3 8.5 10.1 7.9 10.2 8.2 10.5 5.0 8.4 12.3 14.6 20.4 20.0 17.4 13.9 10.6 9.8 16.1 10.4 26.6 8.6 5.0 8.7 10.4 21.6 9.6 10.6 11.6 6.8 8.6 10.0 13.8 6.8 9.2 13.5 12.0 2.5 3.2 12.8 3.9 5.6 8.6 4.0 7.8 13.2 13.8 24.2 20.0 22.0 16.5 11.8 13.9 8.2 12.3 10.5 17.1 1.1 15.0 10.6 21.1 6.5 8.4 14.3 12.6 17.7 12.2 1.3 3.4 10.6 16.8 0.0 4.5 16.9 14.8 8.6 10.2 14.4 12.5 7.0 7.8 3.3 12.6 15.1 7.5 0.7 20.4 19.0 8.3 4.0 3.7 3.6 15.7 16.1 13.5 16.9 3.3 13.4 12.9 15.5 7.2 0.7 14.3 9.4 6.9 23.6 12.0 6.4 11.8 3.0 9.9 0.1 21.5 6.3 3.9 3.7 7.4 2.2 4.1 2.5 8.0 5.6 3.2 2.0 8.6 6.4 12.8 5.6 1.3 1.0 8.6 4.0 8.4 13.6 14.0 15.0 10.1 7.9 8.4 12.3 10.6 8.6 8.9 11.3 4.7 35.2 13.5 9.3 4.3 12.7 10.7 15.9 12.2 9.8 15.5 1.7 19.3 0.9 11.2 12.4 0.0 23.4 22.0 24.6 26.5 8.1 6.6 3.4 12.7 20.7 16.0 5.9 1.1 18.7 4.1 18.6 3.6 21.2 3.1 24.0 10.5 12.7 4.6 9.2 6.5 12.2 3.6 6.5 10.8 11.0 9.6 13.6 33.9 SLC38A11 "AVT2, FLJ39822" ENSG00000169507 "Solute carrier family 38 member 11" Q08AI6 2 164896186-164955525 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 35.6" "Cell type enhanced" "Detected in some" 27 "Intestinal endocrine cells: 167.1;Sertoli cells: 71.1;Smooth muscle cells: 32.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 7.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 54 "memory B-cell: 2.7;naive B-cell: 7.9" "Lineage enriched" "Detected in single" 79 "B-cells: 7.9" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043432 Uncertain NA NA "HPA043432: AB_10793948" "unprognostic (1.52e-1)" "unprognostic (2.59e-1)" "unprognostic (4.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" "unprognostic (6.28e-3)" "unprognostic (3.53e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "prognostic favorable (2.00e-8)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (2.43e-2)" "unprognostic (2.36e-2)" 1.8 3.9 5.1 1.4 8.0 0.4 1.1 1.4 9.7 2.7 1.5 2.7 6.5 5.4 2.1 35.6 1.3 1.2 19.1 1.1 5.6 4.0 7.2 2.5 0.6 2.8 5.8 2.6 0.6 2.7 2.1 11.7 0.5 22.1 9.9 2.7 15.6 1.0 15.9 1.8 0.8 2.6 2.1 2.4 11.2 10.2 1.1 3.2 0.0 2.1 2.9 1.4 2.1 1.5 7.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 75.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 8.0 1.4 9.7 5.6 4.0 5.8 2.6 22.1 3.2 0.0 0.0 2.0 0.2 0.0 0.0 0.7 20.4 0.0 0.0 3.5 0.0 0.4 0.0 1.6 1.4 0.0 0.5 0.0 0.5 0.4 0.2 4.0 0.0 3.0 0.0 0.0 167.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 1.2 2.9 0.0 1.9 0.0 71.1 32.0 0.0 0.0 0.3 1.3 0.0 0.4 0.1 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 49.0;Mucus-secreting cells: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm NA NA Nucleoplasm "HPA021455: AB_2670710" "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 10.4 7.4 12.4 7.8 17.9 10.7 10.8 5.3 14.4 9.3 13.3 19.8 6.6 11.5 4.8 9.6 13.0 5.6 8.6 4.2 13.3 6.3 7.9 21.9 8.2 4.8 27.8 6.6 2.8 23.8 3.1 3.8 7.0 15.3 5.3 13.8 6.7 16.6 5.2 3.7 11.2 12.7 5.7 15.7 6.5 27.6 4.1 22.5 6.0 20.6 3.6 8.6 8.3 7.6 6.0 14.9 9.8 16.2 8.7 6.9 6.3 4.3 7.9 0.9 3.8 6.9 5.6 5.4 4.6 4.1 2.1 2.9 2.9 19.7 5.4 4.8 4.7 3.4 3.7 1.3 2.3 3.3 5.8 2.8 5.0 2.1 3.4 4.1 5.3 48.4 4.8 4.5 4.4 2.6 2.3 2.2 2.8 2.6 6.8 2.7 6.1 3.4 11.6 0.7 13.3 3.4 2.3 3.6 4.5 3.5 4.5 2.2 3.1 2.5 18.7 2.8 3.9 12.8 7.4 1.8 4.2 4.0 3.6 2.8 5.5 2.5 3.8 6.9 10.8 2.4 5.5 16.2 9.8 6.9 15.4 4.6 6.0 5.3 5.2 14.9 3.9 3.8 5.2 2.5 8.7 11.9 10.5 6.5 6.3 12.4 17.9 5.3 14.4 13.3 6.3 27.8 6.6 15.3 22.5 0.0 4.6 3.7 4.4 3.9 2.3 2.0 7.6 6.7 7.9 3.5 0.0 4.7 0.0 6.8 19.2 3.6 19.9 23.3 12.3 14.7 3.6 5.1 29.9 25.0 25.0 4.8 8.1 4.3 15.5 49.0 3.7 7.6 10.1 15.4 73.3 3.9 8.3 20.4 3.2 9.8 1.5 12.9 6.1 1.9 2.5 3.9 4.1 3.2 14.7 6.3 SLC39A12 FLJ30499 ENSG00000148482 "Solute carrier family 39 member 12" Q504Y0 10 17951839-18043292 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "brain: 42.3;retina: 19.2" "Cell type enriched" "Detected in some" 30 "Muller glia cells: 85.4" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (3.30e-1)" "unprognostic (8.70e-2)" "unprognostic (1.02e-1)" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.40e-6)" "unprognostic (1.94e-1)" "unprognostic (8.11e-2)" "unprognostic (3.76e-2)" 1.2 1.0 13.7 1.0 14.6 0.9 2.3 2.2 31.2 0.9 1.0 14.8 0.0 0.9 0.9 0.9 0.9 0.9 0.9 1.0 21.4 5.5 0.9 0.9 1.0 0.9 9.9 5.6 0.9 1.2 0.9 1.5 1.1 42.3 1.0 1.1 19.2 1.0 0.9 0.9 0.9 0.9 1.0 1.5 1.0 0.9 1.4 8.7 0.0 0.9 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.3 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 14.6 2.2 17.5 21.4 5.5 9.9 5.6 42.3 8.7 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 85.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 SLC39A8 BIGM103 ENSG00000138821 "Solute carrier family 39 member 8" Q9C0K1 4 102251041-102431258 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 67.3;salivary gland: 54.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038832, HPA038833" Approved NA NA "HPA038832: AB_2676226, HPA038833: AB_10670910" "prognostic favorable (6.69e-4)" "unprognostic (1.29e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (6.50e-2)" "unprognostic (9.59e-2)" "unprognostic (6.07e-2)" "unprognostic (2.74e-1)" "unprognostic (1.20e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-3)" "unprognostic (2.78e-2)" "prognostic favorable (6.34e-6)" "unprognostic (3.25e-1)" "unprognostic (6.54e-2)" "unprognostic (6.40e-2)" "unprognostic (7.13e-3)" 22.0 2.0 3.7 11.4 5.5 10.3 6.1 2.8 4.3 31.4 18.1 2.2 1.1 2.1 3.9 7.3 1.7 7.2 2.6 17.8 4.3 3.5 6.2 18.4 67.3 8.6 5.1 1.6 5.4 42.1 25.7 6.7 44.8 5.9 5.7 14.9 4.3 54.6 2.3 1.8 5.1 3.4 3.0 8.8 6.5 2.5 2.3 3.2 7.5 4.9 2.3 5.6 5.8 6.0 3.1 2.7 1.0 1.5 11.5 10.5 3.4 5.5 5.5 1.2 0.0 4.6 10.6 2.9 0.6 45.5 1.7 2.7 0.2 20.6 5.4 6.0 0.1 5.7 0.4 3.8 1.2 1.0 9.3 11.3 14.1 11.6 0.1 1.8 33.1 4.8 5.6 1.4 0.8 2.6 4.5 0.6 13.4 14.1 49.4 8.8 3.7 11.9 15.5 3.7 7.5 5.4 3.0 0.0 17.6 9.6 2.1 1.6 4.0 15.5 0.2 1.5 1.1 3.8 12.4 3.1 5.5 2.1 11.2 8.7 22.1 9.2 25.6 9.1 21.7 5.0 0.0 1.5 1.0 5.6 1.0 9.8 1.3 10.5 9.0 2.7 3.1 7.9 5.4 0.1 11.5 0.3 1.0 3.9 3.4 3.7 5.5 2.8 4.3 4.3 3.5 5.1 1.6 5.9 3.2 723.6 227.4 10.4 9.5 10.4 0.8 22.6 7.6 1.4 27.3 5.2 3.9 12.1 10.0 1.9 0.3 8.0 3.3 23.3 28.2 184.5 25.7 10.8 3.5 22.1 43.3 3.2 23.1 6.7 29.8 0.4 1.1 25.3 27.0 16.2 72.2 4.5 16.3 7.0 1.1 8.1 1.2 6.5 14.6 2.7 5.9 6.0 50.7 13.8 56.9 6.8 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789093-205813748 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.1;pancreas: 36.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria NA NA Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 6.0 7.2 6.2 4.0 7.3 3.3 3.4 9.0 8.3 3.6 3.9 10.8 4.0 1.6 5.0 5.9 3.8 7.3 4.7 78.1 7.2 3.8 6.1 1.2 5.3 4.5 7.8 4.9 7.5 36.8 5.8 3.6 2.6 6.9 5.1 1.5 5.8 2.8 4.8 26.5 2.6 2.7 4.0 8.5 3.3 6.6 11.6 7.3 2.1 11.2 11.9 4.5 5.2 5.0 1.8 0.0 0.1 0.3 1.0 4.6 2.0 10.8 9.6 6.1 9.7 7.6 7.5 8.3 11.2 11.0 11.4 10.1 4.8 6.2 15.7 7.1 10.2 9.5 11.3 5.9 8.2 3.9 28.8 9.0 3.8 9.5 0.7 7.3 0.0 11.0 9.5 6.9 13.0 9.3 9.5 7.0 12.8 7.0 6.6 9.1 6.7 7.0 1.1 7.2 2.9 4.4 8.3 18.3 3.8 2.6 13.5 5.1 6.5 8.6 7.7 7.0 5.3 5.5 4.0 8.7 13.6 8.8 12.4 11.6 22.0 14.6 5.2 10.6 5.0 8.4 0.0 0.1 0.1 3.6 0.3 4.6 1.5 3.4 3.4 0.0 1.8 3.2 3.3 0.0 1.0 0.0 0.0 3.3 2.0 6.2 7.3 9.0 8.3 7.2 3.8 7.8 4.9 6.9 7.3 3.0 16.5 12.6 19.3 18.4 12.9 157.4 10.2 9.4 12.5 0.0 47.1 1.7 1.7 8.2 1.5 20.4 0.0 0.0 9.4 12.7 8.0 15.4 6.9 1.8 2.7 17.5 5.8 4.3 2.2 1.7 9.2 3.2 8.5 0.0 0.8 18.0 8.8 0.6 8.9 13.7 21.3 0.0 19.4 6.8 15.0 15.8 2.6 8.5 1.0 20.0 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.6" "Group enriched" "Detected in some" 7 "Early spermatids: 63.4;Late spermatids: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 1.0 0.4 2.4 1.0 1.5 0.0 6.3 1.0 3.6 1.0 1.8 1.0 1.0 0.9 1.0 1.0 7.7 3.7 1.0 2.2 2.8 2.8 2.0 1.0 1.0 1.0 2.3 1.0 1.0 1.8 5.6 3.7 3.8 1.0 1.0 2.9 1.0 1.6 1.0 1.5 11.3 1.0 1.0 1.0 1.0 1.3 32.6 1.0 1.0 1.0 1.0 1.8 2.2 1.9 3.2 0.3 0.6 0.3 0.5 1.1 0.3 0.2 0.2 4.5 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.5 0.6 1.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.4 2.4 2.6 0.0 0.0 1.7 0.0 4.5 2.9 0.6 0.0 0.0 2.1 7.1 4.8 1.0 11.1 0.0 4.6 0.0 11.8 0.2 0.0 13.7 0.4 1.2 0.0 1.4 2.0 1.9 3.0 0.2 0.0 0.7 0.4 0.3 0.2 0.4 0.1 0.9 3.2 0.8 1.1 0.1 2.4 0.6 0.4 0.6 0.5 0.2 0.3 0.6 0.3 2.4 1.5 1.0 3.4 2.8 2.8 2.3 1.0 1.0 1.0 0.0 0.6 0.0 0.6 1.6 3.7 0.6 0.0 2.7 1.2 0.0 0.0 6.8 0.0 0.1 63.4 0.4 0.4 0.0 0.8 3.2 0.2 0.8 0.0 0.0 1.0 0.0 2.4 3.1 0.0 27.3 0.9 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 5.8 3.2 0.0 0.2 3.1 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Group enriched" "Detected in many" 11 "Glandular cells: 50.8;granulocytes: 117.6" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Cell line enriched" "Detected in some" 30 "HMC-1: 141.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.5 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.5 0.2 0.5 0.0 0.6 0.4 4.7 0.1 0.3 0.3 0.8 141.5 0.0 0.1 0.3 0.0 0.3 1.6 0.7 0.7 0.2 0.2 0.3 0.1 1.3 2.0 2.7 1.7 0.1 0.7 0.2 0.6 2.2 0.2 0.5 0.2 3.5 0.6 0.4 0.8 0.2 1.5 0.2 1.6 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 0.0 5.6 1.3 1.1 0.0 0.2 1.7 5.1 2.7 1.2 1.8 0.0 0.4 0.0 1.8 0.1 0.6 3.4 0.0 0.5 0.1 0.6 50.8 117.6 4.9 2.0 0.0 0.0 0.0 0.6 0.0 1.7 0.9 0.0 1.0 7.4 0.2 2.4 7.0 1.4 1.8 0.0 6.5 1.0 0.0 1.5 0.1 0.0 0.0 4.4 0.8 SLC46A2 "Ly110, TSCOT" ENSG00000119457 "Solute carrier family 46 member 2" Q9BY10 9 112878920-112890913 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 35.7;Kupffer cells: 13.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "classical monocyte: 17.0;intermediate monocyte: 8.7" "Lineage enriched" "Detected in many" 4 "monocytes: 17.0" "Cell line enhanced" "Detected in some" "U-138 MG: 1.1;U-2197: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA020098 Approved NA NA "HPA020098: AB_2670363" "unprognostic (1.26e-1)" "unprognostic (5.15e-3)" "unprognostic (1.10e-2)" "unprognostic (1.53e-3)" "unprognostic (3.57e-3)" "unprognostic (2.10e-2)" "unprognostic (4.56e-1)" "unprognostic (2.18e-1)" "unprognostic (8.10e-2)" "unprognostic (1.50e-3)" "unprognostic (3.50e-1)" "unprognostic (1.38e-1)" "unprognostic (1.77e-2)" "unprognostic (2.37e-1)" "unprognostic (2.71e-2)" "unprognostic (1.83e-1)" "unprognostic (7.82e-2)" 0.2 0.1 0.1 0.5 0.1 0.0 1.0 1.1 0.5 17.7 0.1 0.0 21.1 0.0 3.6 10.4 1.4 0.1 0.3 0.1 0.1 0.3 0.2 0.2 17.1 1.9 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.8 0.0 0.1 0.4 9.9 0.1 22.3 0.2 0.6 0.2 1.0 0.1 1.5 0.0 31.8 0.1 0.0 0.3 5.4 0.7 0.0 3.8 0.2 17.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.0 1.1 0.0 1.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 6.5 0.1 0.0 4.1 0.1 0.1 1.1 0.5 0.1 0.3 0.1 0.2 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.4 2.5 1.4 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 13.2 1.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 62.9;liver: 50.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 58.8;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.5;T-47d: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favorable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 6.9 14.2 3.8 5.9 5.7 1.4 6.4 7.6 6.5 8.3 19.6 6.9 2.8 24.0 5.2 7.4 3.1 4.1 12.7 8.1 4.2 4.2 10.4 50.0 6.0 11.4 4.7 3.9 5.0 5.5 4.2 18.2 5.0 6.6 5.3 10.1 17.4 10.3 5.6 8.2 4.0 62.9 4.5 5.1 11.6 4.8 9.3 3.7 11.8 6.8 3.0 6.9 6.1 4.7 9.1 10.4 22.6 15.9 5.6 11.2 7.4 0.0 2.0 0.0 5.5 4.5 1.8 0.1 2.0 11.1 2.2 3.2 0.1 4.7 3.8 3.7 2.8 8.4 0.4 2.5 1.0 3.3 2.8 4.9 2.5 0.0 0.0 8.4 0.0 3.3 7.2 2.1 3.3 5.4 2.2 4.0 11.3 2.7 0.0 10.5 2.0 6.2 0.4 0.2 5.6 1.7 2.6 9.9 0.1 20.5 0.6 0.9 0.3 0.0 10.2 4.0 2.4 15.0 3.3 1.5 1.1 2.1 0.3 11.7 3.1 1.5 0.5 0.6 0.0 2.0 22.6 8.0 3.0 9.8 11.5 8.4 6.6 7.9 9.6 10.4 9.1 11.2 10.6 8.2 5.6 15.9 9.7 9.2 7.4 3.8 5.7 7.6 6.5 4.2 4.2 4.7 3.9 6.6 3.7 0.0 4.8 5.1 0.0 1.6 22.0 7.7 17.8 10.7 1.2 8.7 7.9 0.5 1.7 11.8 3.0 8.9 58.8 0.0 4.9 0.2 5.4 0.6 24.4 50.6 9.7 20.6 3.5 19.6 25.4 1.7 1.4 14.5 6.8 4.6 7.0 14.1 3.8 5.8 2.1 8.4 9.5 0.0 2.8 2.3 0.5 1.5 0.6 10.0 10.0 0.1 SLC49A3 "FLJ22269, LP2561, MFSD7" ENSG00000169026 "Solute carrier family 49 member 3" Q6UXD7 4 681829-689441 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Collecting duct cells: 14.0;Ductal cells: 14.4;Extravillous trophoblasts: 28.5;Hofbauer cells: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.5;SK-BR-3: 7.4;T-47d: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043593 Uncertain NA NA "HPA043593: AB_10959611" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (8.77e-2)" "unprognostic (4.70e-2)" "unprognostic (9.40e-2)" "unprognostic (1.84e-3)" "unprognostic (2.22e-1)" "unprognostic (1.56e-2)" "unprognostic (1.83e-1)" "unprognostic (2.56e-1)" "unprognostic (9.22e-2)" "unprognostic (2.08e-1)" "prognostic favorable (2.66e-5)" "unprognostic (8.35e-2)" "unprognostic (4.92e-2)" "unprognostic (7.48e-2)" "unprognostic (1.11e-1)" 13.8 3.3 4.8 5.4 3.1 3.8 13.9 4.6 4.5 4.7 6.5 1.7 4.1 7.4 4.2 10.0 7.5 3.5 5.0 8.9 1.8 1.5 7.7 8.8 17.6 9.2 2.4 2.4 2.8 8.7 11.1 2.4 4.1 3.6 5.3 2.8 7.4 10.6 2.8 2.9 9.6 7.2 4.2 3.0 9.7 9.8 23.6 2.2 2.2 9.2 4.6 2.8 4.9 5.2 0.0 0.6 4.2 1.8 1.2 0.3 0.9 0.1 0.1 2.4 1.7 1.7 3.9 7.5 0.8 0.0 0.8 0.5 0.4 5.1 0.1 0.2 3.9 0.4 0.2 0.0 0.0 0.2 0.5 0.4 1.4 0.6 0.2 0.7 0.0 1.1 2.4 0.0 3.2 0.0 0.0 1.1 0.2 0.3 0.5 0.0 0.1 0.1 0.5 0.2 0.4 0.3 0.0 0.3 0.5 0.0 0.3 0.8 0.6 0.0 7.4 0.4 0.4 23.1 1.4 0.3 0.7 0.2 0.3 0.2 2.5 1.3 0.1 0.3 0.6 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.2 1.2 0.7 0.0 0.3 0.9 4.8 3.1 4.6 4.5 1.8 1.5 2.4 2.4 3.6 2.2 3.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 14.0 0.0 0.6 1.7 14.4 0.0 0.0 0.0 0.0 0.3 28.5 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.4 0.0 0.0 5.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SLC4A10 "NBCn2, NCBE" ENSG00000144290 "Solute carrier family 4 member 10" Q6U841 2 161424332-161985282 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 31.2;brain: 48.1" "Cell type enriched" "Detected in some" 12 "Bipolar cells: 116.7" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 31.2" "Lineage enriched" "Detected in single" 78 "T-cells: 31.2" "Cell line enriched" "Detected in some" 11 "Karpas-707: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034755, HPA076725" Enhanced NA NA "HPA034755: AB_10670296, HPA076725: " "unprognostic (4.64e-4)" "unprognostic (3.88e-1)" "unprognostic (2.88e-2)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "unprognostic (7.89e-3)" "unprognostic (5.99e-4)" "unprognostic (1.12e-1)" "unprognostic (2.27e-1)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" "unprognostic (5.65e-2)" "unprognostic (9.23e-3)" "unprognostic (1.87e-1)" "unprognostic (2.10e-3)" "unprognostic (2.26e-1)" 1.0 3.7 21.6 1.9 24.1 1.2 1.3 14.9 48.1 1.1 3.3 2.1 0.0 1.4 1.0 2.8 1.0 1.8 1.5 1.0 20.4 10.8 1.0 1.3 1.1 1.1 4.3 29.6 1.0 2.9 1.0 4.4 1.0 17.7 1.3 2.7 1.7 1.0 1.1 1.0 1.0 1.5 1.1 1.9 3.0 1.3 1.4 3.5 0.0 1.0 0.0 1.5 1.3 0.3 0.0 0.0 0.0 0.0 0.4 31.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 31.2 0.0 0.6 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 21.6 24.1 14.9 37.9 20.4 10.8 4.3 29.6 17.7 3.5 0.0 0.0 0.0 0.0 0.0 116.7 0.4 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 1.8 1.2 8.4 0.0 0.0 0.0 0.0 2.2 2.4 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.9 0.2 0.0 0.0 4.4 0.0 0.0 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627327-219641980 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.6;ovary: 30.2" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 201.0;Horizontal cells: 527.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "myeloid DC: 2.3;plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 58 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 1.8 5.4 11.8 1.6 22.5 1.2 2.0 8.8 22.0 2.8 1.3 3.0 0.4 1.4 3.4 2.6 2.9 2.7 2.3 103.6 10.4 8.2 1.6 1.0 1.3 1.4 6.5 9.0 30.2 2.7 4.5 9.9 2.5 24.1 4.2 1.1 4.9 3.1 4.3 1.2 1.6 1.3 3.1 1.6 2.6 1.4 4.2 3.5 0.0 1.5 0.0 1.3 1.6 0.9 0.0 8.9 0.0 0.1 0.0 0.0 0.0 6.2 0.2 2.2 6.5 0.4 0.4 4.4 3.9 4.1 5.3 3.8 4.5 3.6 0.0 1.5 1.4 9.2 3.6 1.1 7.1 1.6 0.0 1.0 0.0 0.0 0.1 1.1 0.1 0.3 3.1 6.7 0.0 2.1 13.4 0.0 0.0 0.2 0.0 1.5 2.1 0.0 0.0 3.6 0.2 5.3 0.0 0.0 0.0 3.6 1.5 1.3 6.4 2.5 6.8 3.3 7.5 0.6 1.6 0.0 3.3 5.8 0.0 3.1 0.0 0.0 0.0 2.7 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 11.8 22.5 8.8 22.0 10.4 8.2 6.5 9.0 24.1 3.5 0.0 0.0 0.0 0.6 0.2 8.9 201.0 0.0 0.0 1.2 1.8 0.0 10.5 1.7 2.8 2.0 0.1 0.0 0.0 1.5 2.5 2.2 0.3 0.0 0.0 1.6 527.6 0.0 0.0 0.0 11.9 14.1 1.1 0.0 1.0 0.0 7.0 1.3 0.0 21.2 0.3 6.7 6.5 1.4 0.5 1.1 0.6 11.6 0.0 0.0 0.0 SLC4A5 NBC4 ENSG00000188687 "Solute carrier family 4 member 5" Q9BY07 2 74216242-74343414 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Anion exchange, Ion transport, Sodium transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 109.1" "Cell type enhanced" "Detected in some" 28 "Cone photoreceptor cells: 33.4;Horizontal cells: 158.9;Rod photoreceptor cells: 43.4" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 3.3" "Group enriched" "Detected in many" 5 "cerebellum: 3.4;pons and medulla: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036621 Uncertain NA NA "HPA036621: AB_10696779" "unprognostic (1.30e-1)" "unprognostic (3.78e-2)" "unprognostic (2.75e-2)" "unprognostic (1.83e-4)" "unprognostic (3.38e-1)" "unprognostic (2.36e-2)" "unprognostic (2.56e-3)" "unprognostic (5.37e-4)" "unprognostic (1.39e-1)" "unprognostic (2.55e-1)" "unprognostic (1.55e-3)" "unprognostic (3.24e-2)" "unprognostic (1.72e-5)" "unprognostic (1.57e-1)" "unprognostic (1.06e-2)" "unprognostic (8.47e-2)" "unprognostic (9.27e-4)" 1.2 0.4 1.0 0.8 0.8 1.6 1.1 3.4 1.2 0.7 0.8 2.5 0.6 0.3 0.9 1.7 0.6 1.4 0.8 0.7 1.2 1.0 0.7 3.2 1.7 1.0 1.0 0.6 1.3 0.9 1.5 2.3 0.6 9.0 0.9 0.3 109.1 1.3 0.8 1.1 3.7 0.7 0.9 1.6 0.7 0.5 16.1 0.7 1.0 21.4 0.6 0.7 0.9 0.9 2.5 5.8 6.1 0.9 1.7 2.5 0.6 0.4 0.8 1.4 1.4 1.5 2.6 1.9 0.4 1.4 0.8 1.2 0.4 1.0 2.2 0.4 0.0 0.5 0.1 1.6 0.2 0.3 1.9 0.9 3.3 1.4 0.8 0.2 1.1 2.3 0.7 2.0 0.1 0.3 0.7 0.5 1.6 0.7 2.4 0.3 5.2 0.5 2.2 1.1 1.0 0.3 1.1 1.4 0.0 0.3 1.0 1.0 2.1 0.5 1.7 2.3 1.4 1.6 2.2 0.0 1.5 2.4 1.6 0.5 14.6 2.0 1.7 0.9 1.2 0.3 6.1 0.9 0.9 1.5 0.8 1.0 1.8 2.3 2.0 0.6 2.5 2.1 2.5 4.2 1.7 0.3 5.8 2.4 0.6 1.0 0.8 3.4 1.2 1.2 1.0 1.0 0.6 9.0 0.7 3.0 6.7 0.0 0.6 0.6 12.6 0.4 2.5 4.0 4.5 0.0 33.4 0.0 0.0 0.3 0.4 0.8 0.0 0.0 0.6 0.0 0.4 0.8 0.0 0.0 0.1 158.9 0.0 0.0 0.0 0.0 1.1 0.2 1.7 0.0 0.1 2.9 0.2 0.0 0.4 0.0 43.4 0.0 0.4 1.7 1.4 0.4 0.0 0.0 0.0 0.5 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360202-140375143 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 26.7" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.8;U-698: 2.0" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Low region specificity" "Detected in all" HPA051307 Uncertain NA NA "HPA051307: AB_2681434" "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 26.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.2 0.0 0.7 0.6 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.8 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 1.0 0.5 2.0 0.0 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.0 0.1 SLC50A1 "HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1" ENSG00000169241 "Solute carrier family 50 member 1" Q9BRV3 1 155135344-155138857 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 115.3;Mucus-secreting cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018095 Approved NA NA "HPA018095: AB_1856048" "unprognostic (4.75e-2)" "unprognostic (1.21e-1)" "unprognostic (7.57e-2)" "unprognostic (2.24e-1)" "unprognostic (3.29e-1)" "unprognostic (9.30e-2)" "unprognostic (1.64e-3)" "unprognostic (1.95e-1)" "unprognostic (1.38e-1)" "unprognostic (5.51e-2)" "unprognostic (3.53e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (4.36e-2)" "unprognostic (1.40e-1)" "unprognostic (3.50e-3)" "unprognostic (4.39e-2)" 11.6 23.4 4.9 16.3 5.7 7.2 13.6 4.2 6.7 13.6 19.8 5.6 28.7 17.2 11.5 49.0 20.3 10.0 21.3 7.5 5.1 7.0 23.8 34.5 22.8 24.3 5.3 4.3 13.6 55.3 12.7 10.3 19.5 6.2 14.4 25.0 11.3 37.5 17.2 4.5 15.9 28.6 9.8 6.1 27.0 19.9 9.3 6.7 12.8 23.4 15.9 25.0 12.4 10.2 32.2 15.3 12.0 18.2 24.0 14.7 15.3 15.8 4.9 5.2 9.4 13.7 13.1 10.7 6.2 16.1 10.5 14.1 8.6 54.8 11.2 17.1 9.1 11.1 22.6 7.1 18.8 8.2 19.6 2.4 9.2 4.6 5.4 21.2 6.1 12.5 14.3 42.7 12.4 30.7 13.7 9.3 5.4 10.1 17.3 10.1 15.6 4.5 8.7 7.0 30.1 16.3 8.6 3.0 33.6 21.3 4.6 9.2 6.9 10.4 21.3 16.9 8.0 44.3 8.8 5.3 7.0 6.1 9.1 3.1 19.6 11.6 9.8 11.3 13.9 6.9 11.3 12.9 12.0 10.4 18.2 12.6 27.1 13.6 12.2 15.3 32.2 14.7 12.9 5.8 24.0 16.8 14.9 13.7 15.3 4.9 5.7 4.2 6.7 5.1 7.0 5.3 4.3 6.2 6.7 20.8 28.1 41.2 17.9 14.3 6.6 4.1 10.2 22.7 26.1 22.7 11.8 31.6 11.6 37.2 0.4 30.6 61.6 23.3 42.8 115.3 23.2 36.2 23.1 16.3 41.3 6.4 22.4 22.1 24.0 1.1 12.4 30.6 27.0 43.3 113.0 6.2 34.6 38.6 5.3 20.4 6.7 6.5 21.7 9.3 5.2 16.2 52.5 27.4 43.3 33.3 SLC51A OSTalpha ENSG00000163959 "Solute carrier family 51 alpha subunit" Q86UW1 3 196211487-196243178 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "intestine: 53.9;liver: 59.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.2;Leydig cells: 57.0;Peritubular cells: 95.5;Sertoli cells: 142.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 15.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045488 Enhanced NA NA "HPA045488: " "unprognostic (1.63e-2)" "unprognostic (1.27e-3)" "unprognostic (2.80e-1)" "unprognostic (7.66e-2)" "unprognostic (5.16e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.02e-2)" "unprognostic (1.07e-1)" "unprognostic (5.98e-3)" "unprognostic (5.41e-2)" "unprognostic (2.90e-2)" "unprognostic (2.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-5)" 0.5 2.3 0.3 3.8 0.3 2.4 0.4 0.3 0.4 0.5 12.3 0.4 0.7 13.6 0.4 2.8 0.5 0.5 0.5 0.5 0.3 0.1 2.2 59.5 0.8 0.3 0.3 0.3 0.6 0.3 1.4 0.5 0.3 0.3 0.5 0.1 0.3 0.6 0.3 0.5 1.0 53.9 0.3 0.3 0.8 0.2 1.8 0.3 0.6 0.8 0.3 0.5 0.3 0.7 0.2 0.0 1.7 0.6 0.4 0.6 0.1 1.1 1.7 1.4 1.7 0.0 1.1 0.1 0.8 0.0 0.1 0.0 0.7 0.5 0.1 2.0 1.1 0.1 0.9 0.2 0.0 0.0 0.7 2.9 1.0 0.8 1.8 0.2 1.4 1.4 0.3 0.0 0.2 1.3 1.5 0.2 0.3 0.2 3.3 0.0 0.6 0.1 1.2 0.1 0.4 2.0 8.1 0.1 0.5 0.0 0.9 0.3 0.5 0.5 3.3 0.3 0.4 2.4 0.5 0.6 1.7 0.7 1.3 0.9 3.3 4.0 0.6 1.1 0.7 0.6 0.0 0.2 1.7 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.6 1.6 0.4 0.5 0.0 0.1 0.1 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.3 0.0 1.9 3.0 0.5 3.3 2.5 10.7 4.5 0.0 3.9 0.5 3.3 0.3 16.2 1.8 130.2 23.3 0.2 0.3 3.1 1.4 0.0 38.6 0.5 1.6 0.0 4.3 3.8 10.3 57.0 3.3 3.3 0.0 0.4 0.3 0.1 8.6 95.5 4.9 0.9 142.3 2.0 2.1 1.1 2.3 0.8 2.6 0.5 2.6 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Cell type enriched" "Detected in many" 6 "Enterocytes: 518.3" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.9 0.0 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 14.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 0.0 0.6 1.5 0.1 0.0 0.0 0.0 2.5 10.7 0.0 0.0 0.0 0.0 11.6 0.0 48.8 0.0 518.3 0.0 0.0 0.0 0.0 0.0 4.6 1.5 0.1 0.0 1.7 0.6 0.0 9.7 0.3 0.0 0.0 0.0 7.7 0.0 0.0 84.2 0.0 54.0 0.0 6.5 0.0 1.5 0.4 0.0 0.1 0.0 19.7 0.0 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 69.3;SK-BR-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.7 17.4 11.1 14.6 10.3 3.7 69.3 6.1 4.1 9.3 6.4 25.6 6.0 11.6 9.3 3.3 10.1 9.4 23.7 7.0 6.5 9.0 13.9 20.6 7.4 39.2 12.2 26.4 10.8 12.9 6.0 11.4 8.9 2.6 8.3 9.5 30.1 4.8 5.9 34.4 8.9 12.9 32.0 19.4 6.4 15.1 13.1 16.8 5.3 16.1 9.4 13.9 6.6 74.6 8.8 11.3 16.6 5.7 3.8 10.3 14.1 6.2 16.3 8.0 18.3 18.5 5.6 18.6 14.4 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 0.0 4.1 13.4 6.8 7.1 4.5 5.9 7.6 4.0 2.3 7.0 3.9 98.8 1.7 9.6 11.6 3.8 6.0 0.0 7.0 89.2 5.4 7.1 0.0 36.0 19.5 11.1 5.2 7.4 10.0 25.3 6.6 6.5 0.0 78.5 6.8 3.9 6.2 2.9 13.1 3.6 3.4 12.9 5.9 31.1 18.5 5.5 190.6 7.5 13.3 6.4 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 12.7 0.0 2.1 0.0 0.0 0.2 0.2 0.0 14.6 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 4.4 3.7 0.1 0.0 0.1 4.8 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 0.0 0.0 0.0 0.2 1.1 7.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 21.8 0.3 0.0 6.3 0.0 1.3 0.0 0.0 0.2 1.5 3.1 0.8 0.0 0.0 1.5 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436622-116461458 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 8.2;OE19: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA003193 Uncertain Approved Vesicles NA NA Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 5.9 0.0 0.0 6.3 0.8 0.0 11.8 0.4 0.1 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.2 0.5 0.3 0.0 26.3 5.8 0.0 1.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 23.5 1.2 1.0 1.0 0.4 0.2 1.1 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 3.8 8.2 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 1.4 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.0 20.8 100.3 0.0 0.1 0.1 0.0 0.2 0.0 10.7 33.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 28.5 0.0 0.0 5.2 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.1 0.0 101.5 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.0 3.2 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "testis: 102.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 81.2;Late spermatids: 36.5;Spermatocytes: 90.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3;SuSa: 10.0" HPA076812 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA076812: AB_2686816" "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 1.5 0.4 0.8 1.1 0.9 1.9 1.0 0.8 0.8 1.3 1.1 0.8 0.8 0.3 1.5 1.0 0.8 2.0 1.0 0.8 0.8 0.3 2.0 3.6 1.6 3.1 0.8 0.8 2.9 2.6 0.7 0.8 1.3 0.8 1.8 0.3 0.9 0.8 1.2 0.8 0.7 1.2 0.8 0.8 1.7 1.0 102.2 0.8 0.8 1.1 0.8 2.4 0.8 1.2 7.8 2.1 4.8 3.7 3.8 3.1 2.2 0.0 6.8 17.3 6.2 0.3 2.8 3.1 0.9 1.4 0.6 1.9 0.4 0.5 8.0 1.1 0.7 0.3 0.2 1.9 0.3 2.1 1.3 2.0 0.7 0.7 1.5 1.3 0.5 2.9 2.7 1.1 1.3 0.9 5.1 1.5 1.4 1.5 1.1 2.2 1.5 0.4 0.5 6.1 0.3 0.9 0.3 4.2 1.5 0.9 0.0 0.2 0.3 2.7 0.1 0.6 10.0 2.8 0.2 8.6 1.4 6.6 4.0 0.0 3.8 4.0 7.2 0.1 1.9 0.4 0.4 0.8 4.8 3.1 2.2 3.0 7.8 1.1 3.1 0.8 4.5 2.7 1.8 4.0 3.8 3.7 2.1 1.7 2.2 0.8 0.9 0.8 0.8 0.8 0.3 0.8 0.8 0.8 0.8 0.0 0.6 3.7 0.8 1.3 6.3 1.2 2.5 17.4 0.0 1.8 2.0 0.0 10.0 0.6 81.2 3.9 0.0 0.0 0.5 0.0 1.6 0.4 1.1 4.9 0.7 0.0 0.0 1.3 0.3 36.5 3.4 0.8 5.0 0.0 0.0 0.5 0.3 0.0 3.2 0.0 1.3 0.0 7.2 90.2 2.1 1.1 0.0 0.5 0.0 0.2 SLC6A18 "FLJ31236, Xtrp2" ENSG00000164363 "Solute carrier family 6 member 18" Q96N87 5 1225355-1246189 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "kidney: 14.1" "Group enriched" "Detected in some" 71 "Distal tubular cells: 6.6;Proximal tubular cells: 21.3" "Cancer enriched" "Detected in single" 44 "renal cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011885 Enhanced NA NA "HPA011885: AB_1857198" "unprognostic (2.02e-1)" "unprognostic (5.69e-3)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A7 PROT ENSG00000011083 "Solute carrier family 6 member 7" Q99884 5 150189957-150222788 "Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 40.2" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 2.1;Intestinal endocrine cells: 3.5;Mucus-secreting cells: 4.8;Paneth cells: 8.6;Undifferentiated cells: 3.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;HeLa: 1.8;SK-BR-3: 1.4;U-87 MG: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028907 Uncertain NA NA "HPA028907: AB_10602404" "unprognostic (3.01e-1)" "unprognostic (1.97e-2)" "unprognostic (3.70e-2)" "unprognostic (1.42e-3)" "unprognostic (1.09e-2)" "unprognostic (1.82e-4)" "unprognostic (6.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.55e-1)" "unprognostic (3.50e-1)" "unprognostic (3.73e-4)" "unprognostic (8.11e-2)" "unprognostic (5.46e-2)" "unprognostic (2.73e-1)" "unprognostic (3.70e-3)" 0.5 0.4 3.9 1.0 9.7 0.4 0.5 40.2 22.4 0.6 5.7 0.3 0.0 2.6 0.5 0.6 0.4 0.4 0.5 0.5 6.5 4.5 0.4 0.4 0.5 0.7 1.3 14.5 0.4 0.5 0.4 0.2 0.4 1.6 0.4 7.7 0.0 0.8 0.4 0.5 0.5 4.9 0.7 1.4 0.4 0.4 0.5 0.0 0.0 0.4 0.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 9.7 40.2 22.4 6.5 4.5 1.3 14.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.8 0.0 0.1 8.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 3.4 0.1 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "Muller glia cells: 1.8;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 SLC7A13 "AGT-1, XAT2" ENSG00000164893 "Solute carrier family 7 member 13" Q8TCU3 8 86214052-86321146 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "kidney: 31.7" "Cell type enhanced" "Detected in some" 31 "Collecting duct cells: 1.8;Distal tubular cells: 3.3;Proximal tubular cells: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.96e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 31.5;Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.3 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 1.8 0.0 0.1 1.3 0.8 0.2 0.1 0.0 0.2 7.2 0.0 0.0 0.2 1.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 7.2 2.1 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 3.0 2.1 0.0 0.3 0.3 31.5 0.8 0.0 5.3 4.5 0.0 2.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.2 2.3 1.0 0.0 27.0 1.7 0.0 0.0 0.4 2.0 0.9 3.3 0.0 0.0 1.8 0.1 0.0 2.5 0.0 3.9 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 SLC7A4 "CAT-4, HCAT3, VH" ENSG00000099960 "Solute carrier family 7 member 4" O43246 22 21028718-21032840 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.6;testis: 29.1" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Cytotrophoblasts: 9.1;granulocytes: 4.6;Mucus-secreting cells: 7.9;Syncytiotrophoblasts: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.4;naive CD8 T-cell: 2.4" "Group enriched" "Detected in many" 18 "NK-cells: 1.0;T-cells: 2.4" "Cell line enriched" "Detected in some" 21 "BEWO: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031023 Enhanced NA NA "HPA031023: AB_10669669" "unprognostic (1.02e-3)" "unprognostic (4.34e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.82e-2)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.91e-2)" "unprognostic (3.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (9.69e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" 2.7 3.5 2.2 0.4 3.8 0.1 2.6 6.0 5.9 2.8 1.8 0.4 1.4 1.7 1.5 0.7 8.5 1.6 4.1 1.2 2.7 7.1 0.2 0.3 1.4 1.2 2.4 4.3 0.3 0.4 0.1 5.1 19.6 2.4 4.1 1.4 3.3 4.3 5.3 0.6 1.9 2.0 0.6 0.6 0.9 2.4 29.1 0.4 0.2 0.1 1.3 2.1 2.4 0.7 0.0 0.0 0.0 0.0 1.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.2 1.2 0.0 0.0 0.1 2.4 0.0 1.0 0.0 0.0 0.0 0.8 2.2 3.8 6.0 5.9 2.7 7.1 2.4 4.3 2.4 0.4 6.0 3.4 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 2.8 0.1 0.4 4.6 0.0 1.2 0.0 1.2 1.8 0.0 1.3 1.7 0.0 0.0 0.0 7.9 1.8 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 8.5 0.0 0.6 0.1 SLC8A2 "KIAA1087, NCX2" ENSG00000118160 "Solute carrier family 8 member A2" Q9UPR5 19 47428017-47472168 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.9" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 16.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1" "Group enriched" "Detected in many" 4 "amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1" "Low region specificity" "Detected in all" "HPA050818, HPA054671" Enhanced NA NA "HPA050818: AB_2681248, HPA054671: AB_2682568" "unprognostic (3.75e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (4.32e-2)" "unprognostic (1.34e-1)" "unprognostic (6.00e-3)" "unprognostic (1.38e-1)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (8.95e-2)" "unprognostic (4.77e-2)" "unprognostic (2.04e-2)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (9.40e-2)" "unprognostic (1.53e-1)" "unprognostic (1.63e-2)" 1.2 4.0 16.6 1.0 18.1 0.9 0.9 50.9 50.7 1.0 2.4 1.8 1.0 1.3 5.4 1.0 2.3 2.2 1.1 0.9 21.4 6.8 1.0 0.9 0.9 0.9 2.1 21.1 0.9 10.3 0.9 3.2 1.0 2.0 1.4 1.4 0.0 1.2 4.4 0.9 1.0 1.2 5.5 2.0 1.0 1.3 1.9 1.2 0.0 1.0 0.0 0.9 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 4.4 0.6 0.0 0.0 0.0 0.0 0.4 0.1 12.5 6.7 5.2 0.6 0.4 0.4 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 18.1 50.9 34.6 21.4 6.8 2.1 21.1 2.0 1.2 0.0 0.0 0.0 0.1 0.0 16.2 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.3 1.1 1.7 0.0 0.1 0.0 0.0 0.1 SLC9A2 NHE2 ENSG00000115616 "Solute carrier family 9 member A2" Q9UBY0 2 102619707-102711318 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035121, HPA035122" Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA035121: AB_10602894, HPA035122: AB_2674477" "unprognostic (1.53e-2)" "unprognostic (8.05e-3)" "unprognostic (6.00e-2)" "unprognostic (3.00e-3)" "unprognostic (3.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-1)" "unprognostic (2.37e-2)" "unprognostic (1.97e-1)" "unprognostic (1.40e-3)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.70e-1)" 0.2 0.4 0.9 10.8 1.4 0.0 1.0 0.5 1.9 1.0 15.0 0.6 8.4 4.6 0.2 5.8 0.5 0.2 16.8 0.2 1.5 1.0 4.6 0.2 0.2 0.0 0.9 0.7 0.2 0.2 0.1 1.7 0.0 1.8 4.5 16.1 0.9 3.7 11.7 4.4 1.3 9.5 0.4 1.3 0.2 19.8 5.3 0.6 1.0 0.6 1.8 3.1 2.8 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 6.8 4.3 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.1 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.3 2.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.3 0.0 0.0 0.1 25.9 3.6 0.0 0.0 0.0 0.8 11.9 0.0 0.0 0.0 10.5 0.0 0.0 13.2 0.0 0.0 0.0 0.5 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.9 1.4 0.5 1.9 1.5 1.0 0.9 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.4 0.0 0.2 19.1 0.0 23.6 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 9.4 0.0 0.0 22.4 0.6 0.0 0.0 0.0 26.9 0.5 4.9 40.3 0.0 1.0 0.0 0.0 0.3 0.7 0.1 0.5 0.2 0.0 31.4 0.7 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Group enriched" "Detected in many" 7 "Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.4 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 0.9 1.3 4.5 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.5 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 1.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 3.0 1.0 1.9 0.5 1.1 1.9 0.8 0.0 0.0 0.0 0.0 15.7 0.4 1.7 0.3 118.1 0.7 0.0 0.0 0.4 0.2 1.5 0.8 0.0 0.0 1.1 3.2 0.0 0.6 4.1 86.8 4.9 0.8 1.7 1.8 0.0 2.7 0.7 0.0 2.8 0.6 5.0 0.0 1.4 121.2 8.1 0.5 0.5 1.0 0.0 0.5 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140887-112294258 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 25.5" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.3 0.1 0.1 1.4 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.3 1.7 0.5 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.3 1.2 0.0 0.8 0.7 0.4 0.1 0.1 0.3 0.2 1.1 0.1 4.0 1.0 0.2 0.3 0.4 0.3 25.5 0.0 1.0 0.5 0.5 0.4 0.3 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.4 0.0 0.3 0.0 0.0 0.0 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Cell type enhanced" "Detected in some" 13 "Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Group enriched" "Detected in some" 4 "BEWO: 1.8;THP-1: 3.7" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.1 0.0 0.0 0.0 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 32.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.0 0.5 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 2.9 1.7 0.1 2.1 0.1 0.0 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.4 1.1 0.0 0.3 0.2 0.0 1.3 0.1 0.1 1.2 0.1 0.4 3.4 1.4 0.0 2.0 0.3 0.1 13.3 1.5 0.1 0.1 0.2 9.2 0.0 2.0 1.8 2.3 0.0 0.2 0.2 14.2 2.6 0.7 0.0 0.0 1.4 0.6 0.3 19.8 8.0 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 32.8 1.9 0.0 0.0 0.0 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 SLCO1C1 "OATP-F, OATP1, OATP1C1, SLC21A14" ENSG00000139155 "Solute carrier organic anion transporter family member 1C1" Q9NYB5 12 20695355-20753386 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 32.4;retina: 15.3" "Group enriched" "Detected in some" 4 "Early spermatids: 5.8;Late spermatids: 10.3;Muller glia cells: 4.9" "Cancer enriched" "Detected in single" 17 "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HeLa: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (4.64e-1)" "unprognostic (3.16e-2)" "unprognostic (1.76e-1)" "unprognostic (7.32e-2)" "unprognostic (8.89e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (2.70e-2)" "unprognostic (2.37e-4)" "unprognostic (1.56e-3)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.76e-2)" 3.5 1.2 11.6 1.0 16.2 0.9 1.2 1.1 32.4 0.9 1.4 6.2 0.0 1.1 0.9 1.3 1.2 0.9 2.1 1.5 10.4 2.8 1.1 0.9 1.2 1.2 6.5 8.0 0.9 1.0 1.5 5.5 1.0 20.3 1.0 1.3 15.3 1.1 1.0 0.9 1.2 1.6 1.2 4.9 0.9 1.0 3.3 8.1 0.0 1.7 0.2 1.4 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 16.2 1.1 11.5 10.4 2.8 6.5 8.0 20.3 8.1 0.0 0.0 0.0 0.0 0.1 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 10.3 1.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.1 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667047-69835064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2" "Group enriched" "Detected in many" 6 "Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory region: 8.2" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.7 0.2 0.5 1.5 0.7 1.5 0.2 0.1 0.8 0.3 0.4 0.1 0.0 0.4 0.5 1.5 1.0 0.5 0.4 21.4 0.7 0.7 0.2 0.4 0.3 4.1 0.3 0.3 0.2 0.7 0.0 4.7 0.0 0.5 4.2 0.7 0.6 0.9 0.0 13.9 0.3 0.7 0.2 0.2 0.8 0.3 0.4 0.0 9.5 0.5 16.2 1.7 0.9 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.0 0.0 0.0 2.4 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 6.0 0.0 0.9 1.0 0.9 5.7 0.1 0.0 6.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 1.2 3.5 0.6 0.0 0.3 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.0 1.7 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.7 0.1 0.7 0.7 0.7 0.3 0.3 0.5 0.0 3.0 0.0 1.9 1.1 0.2 12.4 13.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.5 0.4 0.7 0.0 0.0 1.2 0.0 0.6 10.0 0.0 0.0 0.1 1.6 15.0 0.0 0.0 0.4 0.0 0.3 0.0 36.9 1.6 0.3 2.4 0.0 0.0 0.0 0.2 0.0 1.0 0.9 1.7 0.4 0.0 0.0 0.9 0.7 SLCO6A1 "CT48, MGC26949, OATP6A1, OATPY" ENSG00000205359 "Solute carrier organic anion transporter family member 6A1" Q86UG4 5 102371782-102499016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "testis: 39.2" "Group enriched" "Detected in some" 6 "Early spermatids: 111.3;Spermatocytes: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.8;SuSa: 4.2;U-266/84: 1.4" "Low region specificity" "Detected in some" HPA054126 Enhanced NA NA "HPA054126: AB_2682390" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (4.37e-2)" "unprognostic (4.65e-1)" "unprognostic (1.84e-1)" "unprognostic (2.60e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.6 1.8 0.1 0.7 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 59.8 2.6 0.0 0.0 0.0 0.0 0.0 SLFN12 FLJ10260 ENSG00000172123 "Schlafen family member 12" Q8IYM2 17 35411060-35433283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 23.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA022523 Uncertain NA NA "HPA022523: AB_2670945" "unprognostic (7.08e-2)" "unprognostic (1.87e-2)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (7.72e-2)" "unprognostic (9.31e-2)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.93e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (4.00e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (5.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" 12.4 10.2 2.6 8.5 4.9 2.0 10.5 2.0 2.4 10.1 6.0 2.4 7.9 3.4 10.8 9.0 5.1 7.1 7.4 5.4 5.5 2.0 6.3 2.9 9.9 9.7 9.3 1.9 7.2 3.4 4.7 3.7 6.3 5.1 9.0 3.8 6.9 6.9 5.0 2.1 2.9 5.3 6.2 4.3 16.4 4.6 4.8 4.8 5.8 13.3 3.2 5.0 9.7 9.2 1.5 6.8 23.0 10.5 6.0 2.3 2.0 0.1 0.1 9.9 0.0 2.7 4.5 0.0 8.0 5.0 19.5 19.8 0.0 0.0 0.0 17.2 7.4 14.1 5.4 0.2 5.4 19.0 0.4 1.5 3.0 8.3 0.0 3.5 3.9 2.1 7.0 1.9 8.5 1.8 4.7 14.5 0.1 0.0 1.0 15.4 0.0 0.0 4.9 0.2 0.0 0.0 0.4 13.6 0.0 7.6 9.7 0.0 0.0 0.0 2.2 6.6 0.3 4.5 3.6 16.0 9.4 13.3 3.1 10.7 3.1 0.7 0.1 3.5 4.0 11.4 23.0 10.5 7.5 2.2 6.0 2.0 1.5 1.1 1.9 6.8 1.4 0.6 1.7 4.9 6.0 3.0 1.1 2.3 2.0 2.6 4.9 2.0 2.4 5.5 2.0 9.3 1.9 5.1 4.8 6.0 1.9 1.3 1.2 0.7 0.0 1.4 5.1 5.3 10.3 12.2 0.0 0.9 3.3 5.4 0.1 8.0 0.0 0.0 1.2 1.2 4.1 0.9 13.9 0.5 6.9 0.0 0.0 12.3 7.6 0.2 1.7 11.3 0.0 10.0 0.9 1.2 2.9 0.0 2.8 6.3 0.0 19.4 9.8 0.0 0.2 0.6 0.2 4.3 0.6 0.3 SLFN12L ENSG00000205045 "Schlafen family member 12 like" Q6IEE8 17 35464249-35537861 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.4" "Cell type enriched" "Detected in some" 7 "T-cells: 20.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7" "Group enriched" "Detected in many" 7 "NK-cells: 6.8;T-cells: 9.5" "Cell line enhanced" "Detected in some" "HDLM-2: 19.9;Karpas-707: 14.1;U-266/70: 5.0;U-266/84: 4.4" HPA024447 Uncertain NA NA "HPA024447: AB_1856614" "unprognostic (1.93e-3)" "unprognostic (2.10e-4)" "unprognostic (3.77e-2)" "unprognostic (2.67e-2)" "unprognostic (8.18e-3)" "unprognostic (2.98e-5)" "unprognostic (4.59e-3)" "unprognostic (2.75e-2)" "unprognostic (6.82e-2)" "unprognostic (1.67e-2)" "unprognostic (9.51e-2)" "unprognostic (1.78e-1)" "unprognostic (2.25e-6)" "unprognostic (2.30e-1)" "unprognostic (3.88e-2)" "unprognostic (7.02e-2)" "unprognostic (8.88e-3)" 7.2 0.9 1.0 11.2 1.2 6.6 2.7 0.8 1.4 1.6 3.0 0.9 1.2 3.9 3.6 3.0 2.3 2.0 3.8 1.4 1.1 1.1 1.8 1.8 9.1 10.6 1.7 0.5 1.3 1.2 0.5 1.0 0.6 2.9 1.8 2.0 2.1 6.2 1.3 0.9 1.2 7.0 1.1 1.9 18.4 3.0 0.8 1.1 5.8 2.8 2.1 16.3 2.3 2.0 0.4 0.3 1.1 0.4 6.8 9.5 1.9 0.5 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.6 1.5 0.1 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.8 19.9 0.1 1.2 0.7 0.1 0.0 0.4 0.2 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.3 14.1 0.1 0.0 0.4 0.3 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.1 0.1 0.2 0.1 1.9 0.5 0.3 1.2 0.5 0.2 5.0 4.4 0.1 0.2 0.3 0.6 0.8 0.4 0.9 9.5 0.1 8.8 0.3 6.3 8.0 0.3 0.4 4.8 5.2 1.1 6.8 0.1 0.3 4.7 1.9 1.0 1.2 0.8 1.4 1.1 1.1 1.7 0.5 2.9 1.1 3.0 2.4 0.0 0.5 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 20.6 0.0 0.2 SLFN13 FLJ31952 ENSG00000154760 "Schlafen family member 13" Q68D06 17 35435096-35448837 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 50.6" "Cell type enhanced" "Detected in many" 22 "Cholangiocytes: 22.9;Ciliated cells: 81.7;Club cells: 18.2;T-cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 8.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;HL-60: 46.9;Karpas-707: 13.7;REH: 26.9;U-266/70: 23.7" "HPA022532, HPA023064" Uncertain Approved "Cytokinetic bridge" Yes No "Cytokinetic bridge" "HPA022532: AB_1856615, HPA023064: AB_1856616" "unprognostic (1.11e-1)" "prognostic favorable (3.82e-4)" "unprognostic (4.73e-2)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (5.74e-2)" "unprognostic (9.38e-3)" "unprognostic (1.32e-2)" "unprognostic (3.34e-1)" "unprognostic (3.55e-1)" "unprognostic (5.06e-3)" "unprognostic (2.33e-1)" "unprognostic (1.33e-1)" "unprognostic (3.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 3.0 1.0 1.1 6.4 1.7 11.8 4.8 0.5 1.0 5.2 6.5 2.6 4.8 4.0 5.6 6.0 6.5 12.4 6.1 1.8 1.3 0.7 5.1 1.7 5.2 4.8 0.9 0.5 2.7 2.0 14.3 3.2 1.2 2.0 2.4 3.1 0.9 50.6 2.0 1.4 1.5 5.7 1.8 1.5 11.3 5.7 1.5 1.1 24.8 12.7 5.4 12.9 2.0 2.0 1.4 0.4 6.5 0.5 8.1 1.9 0.5 0.0 2.5 5.1 0.0 0.1 0.5 0.0 0.6 0.1 2.5 4.0 0.0 0.0 0.0 14.7 0.4 0.1 4.3 0.5 1.8 2.8 1.4 0.8 13.4 2.2 0.0 0.2 46.9 0.4 0.1 0.2 1.3 0.0 0.0 0.8 0.1 0.0 13.7 0.0 0.0 0.3 10.2 2.5 0.0 0.0 26.9 0.1 1.3 4.3 12.4 0.0 0.0 0.0 2.3 0.1 0.3 3.6 7.5 0.1 0.0 0.7 3.8 0.2 23.7 3.2 0.0 0.0 7.5 0.3 5.0 0.4 6.5 1.9 0.5 1.5 1.4 0.9 1.0 0.4 1.3 0.8 0.6 1.4 8.1 0.2 0.1 0.7 0.5 1.1 1.7 0.5 1.0 1.3 0.7 0.9 0.5 2.0 1.1 0.0 3.0 2.2 3.1 0.9 0.0 0.6 22.9 81.7 18.2 5.2 0.0 0.4 1.7 1.1 0.1 0.7 0.5 0.0 0.3 0.2 0.8 1.0 3.5 0.4 1.3 0.0 2.9 3.1 0.6 0.0 0.9 1.6 0.0 1.8 2.7 0.2 1.1 0.0 0.4 0.8 0.1 0.0 0.6 0.2 0.1 1.0 0.0 15.7 3.9 1.0 SLFNL1 FLJ23878 ENSG00000171790 "Schlafen like 1" Q499Z3 1 41015597-41023237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 49.7" "Group enriched" "Detected in some" 83 "Early spermatids: 200.0;Late spermatids: 500.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054956 Approved Cytosol NA NA Cytosol "HPA054956: AB_2682649" "unprognostic (7.01e-3)" "unprognostic (1.62e-1)" "unprognostic (1.54e-3)" "unprognostic (4.35e-2)" "unprognostic (3.39e-1)" "unprognostic (4.11e-4)" "unprognostic (8.98e-3)" "unprognostic (1.02e-3)" "unprognostic (8.40e-3)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.71e-4)" "unprognostic (2.70e-3)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (3.26e-1)" "unprognostic (2.43e-1)" 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.3 0.2 0.4 0.2 0.2 0.2 0.5 2.6 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.8 1.9 0.2 0.2 0.2 0.6 0.3 0.1 0.3 0.2 0.2 0.6 0.0 0.2 3.4 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.1 49.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 1.3 0.0 0.0 0.7 0.0 1.0 1.6 0.7 1.1 0.0 0.3 4.9 2.1 0.1 0.0 0.1 10.2 1.0 1.8 1.8 0.1 0.3 1.8 0.1 0.0 0.0 1.3 3.0 1.3 2.4 1.3 0.7 1.9 1.2 0.2 0.2 0.1 0.0 0.5 0.2 1.5 1.1 2.2 0.1 0.9 1.1 2.0 1.9 0.2 2.6 2.5 1.3 1.1 0.0 2.8 1.3 0.6 0.4 0.9 0.8 0.9 0.6 1.2 0.8 2.0 2.4 1.0 1.5 1.1 0.6 2.3 0.3 2.2 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.4 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 3.2 0.0 0.1 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 200.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 500.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.2 2.4 0.1 0.0 0.0 0.0 0.0 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Group enriched" "Detected in some" 6 "Early spermatids: 27.2;Late spermatids: 15.4" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "JURKAT: 12.4;MOLT-4: 41.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" NA NA "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.3 0.0 0.1 41.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.7 0.0 0.3 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.1 SLIT3 "MEGF5, SLIL2, Slit-3, SLIT1, slit2" ENSG00000184347 "Slit guidance ligand 3" O75094 5 168661733-169301129 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 32.9;Melanocytes: 33.7;Sertoli cells: 84.1;Smooth muscle cells: 67.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "NK-cell: 4.1" "Lineage enriched" "Detected in single" 7 "NK-cells: 4.1" "Cell line enhanced" "Detected in some" "ASC diff: 81.4;fHDF/TERT166: 28.9;RT4: 25.2;SH-SY5Y: 18.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051630 Approved Supported "Cell Junctions" "Secreted in other tissues" NA NA "Cell Junctions" "HPA051630: AB_2681557" "unprognostic (2.86e-2)" "unprognostic (2.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-2)" "unprognostic (3.53e-2)" "unprognostic (9.21e-3)" "unprognostic (3.06e-2)" "unprognostic (1.71e-1)" "unprognostic (9.50e-3)" "unprognostic (1.57e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.45e-5)" "unprognostic (5.90e-3)" "unprognostic (8.56e-2)" "unprognostic (4.27e-1)" "unprognostic (3.53e-1)" 38.5 12.5 6.7 6.3 7.9 0.2 31.8 20.3 10.8 28.0 13.2 1.8 13.0 3.2 21.6 22.4 18.2 14.8 32.5 28.3 6.2 4.6 12.0 1.5 24.9 6.7 2.2 7.1 29.4 4.6 37.6 3.8 12.4 10.7 28.5 5.9 7.7 10.7 9.8 4.9 17.5 7.1 44.4 2.0 7.7 8.2 6.3 0.3 11.8 16.6 10.8 6.2 36.8 32.1 0.1 0.0 0.5 0.1 4.1 0.0 0.0 0.0 2.7 0.0 0.0 81.4 1.5 0.0 4.5 0.7 1.0 2.1 0.0 0.0 0.0 1.1 28.9 3.3 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.0 0.1 1.0 11.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.3 18.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.7 0.5 6.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 4.1 0.0 0.0 0.0 0.0 6.7 7.9 20.3 10.8 6.2 4.6 2.2 7.1 10.7 0.3 0.0 2.9 0.0 1.6 23.7 2.4 22.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 9.7 3.1 0.0 0.0 0.0 0.4 32.9 0.6 1.1 0.0 1.1 0.0 0.0 2.5 0.0 6.2 0.9 1.5 33.7 0.0 0.0 12.3 0.0 0.0 0.4 1.7 0.2 84.1 67.6 0.5 1.6 15.4 0.9 0.0 0.0 0.7 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Group enriched" "Detected in some" 9 "Bipolar cells: 4.5;Hepatocytes: 2.4" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria No NA 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: AB_2732542" "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 5.1 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.7 0.0 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 0.0 0.6 0.0 1.7 0.1 11.5 1.6 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.1 1.1 0.0 0.0 20.6 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.5 6.5 0.0 0.0 4.6 0.0 1.6 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.9 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792787-85806683 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 14.0;Ciliated cells: 69.6;Club cells: 25.0" "Cancer enhanced" "Detected in many" "breast cancer: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 11.1;cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 13.5;OE19: 10.9;RT4: 46.2;WM-115: 10.9" "Region enhanced" "Detected in many" "thalamus: 24.7" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" NA NA 9500 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: AB_2669026" "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.4 0.3 0.3 2.7 11.1 0.0 2.9 4.9 0.3 1.0 4.5 0.0 0.2 2.8 0.7 3.4 3.6 0.3 1.1 1.9 0.3 1.3 0.3 1.1 3.1 0.0 0.6 0.0 0.3 0.4 0.0 0.4 4.1 0.8 24.2 5.8 1.7 22.8 1.8 0.3 4.5 7.2 22.4 0.4 0.2 1.2 0.5 1.8 0.0 0.6 3.4 0.7 27.8 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 13.5 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.9 0.9 0.1 0.0 0.0 0.0 46.2 0.4 0.5 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 4.9 0.3 0.3 1.3 0.6 0.0 0.8 1.8 0.0 2.6 0.0 4.8 3.4 14.0 0.3 0.0 69.6 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 8.9 0.0 0.0 0.0 0.4 1.1 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 3.1 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 35.4" "Group enriched" "Detected in some" 5 "Spermatocytes: 487.9;Spermatogonia: 418.0" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.2;EFO-21: 4.4;SiHa: 19.1;U-266/70: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA001500 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.5 0.0 9.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.0 19.1 0.1 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.0 0.3 2.0 0.0 0.2 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 28.8 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.2 0.0 1.0 97.0 0.0 487.9 418.0 0.0 0.7 0.0 0.0 0.1 SMCO1 "C3orf43, DKFZp313B0440, FLJ41923" ENSG00000214097 "Single-pass membrane protein with coiled-coil domains 1" Q147U7 3 196506877-196515366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 22 "heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9" "Cell type enriched" "Detected in single" 76 "Cardiomyocytes: 71.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 5 "NK-cells: 2.1" "Cell line enhanced" "Detected in some" "MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.86e-2)" "unprognostic (1.62e-1)" "unprognostic (1.51e-2)" "unprognostic (6.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-2)" "unprognostic (2.95e-1)" "unprognostic (2.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 48.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 2.1 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 66.9 2.5 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.4 0.6 0.9 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.2 0.2 0.0 0.7 0.2 0.4 0.2 0.8 0.2 1.5 0.7 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.3 0.3 0.4 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.0 1.3 0.5 0.5 0.4 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 SMCO2 "C12orf70, LOC341346" ENSG00000165935 "Single-pass membrane protein with coiled-coil domains 2" A6NFE2 12 27466810-27502185 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.3;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 9.8;Late spermatids: 3.6;Urothelial cells: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;HDLM-2: 5.6" "Not detected" "Not detected" HPA014366 Uncertain NA NA "HPA014366: AB_1845544" "unprognostic (2.64e-2)" "unprognostic (3.11e-1)" "unprognostic (1.33e-2)" "unprognostic (4.10e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (7.86e-3)" "unprognostic (5.44e-3)" "unprognostic (2.81e-1)" "unprognostic (8.86e-2)" "unprognostic (9.21e-5)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (5.48e-2)" "unprognostic (3.01e-1)" "unprognostic (3.65e-1)" "unprognostic (1.69e-1)" 0.2 0.3 0.2 1.7 0.1 0.1 0.4 0.3 0.5 0.1 0.4 0.0 0.1 0.0 2.3 0.0 0.8 0.0 0.3 0.4 0.0 0.7 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.1 2.1 0.0 0.4 0.0 0.0 1.5 3.1 0.0 1.9 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.2 0.1 0.0 0.2 2.5 0.2 0.1 0.1 1.8 0.0 3.8 0.0 0.9 0.0 1.3 0.6 0.2 0.6 1.1 5.6 0.0 0.2 1.0 0.0 0.0 2.1 0.4 1.2 0.6 0.8 3.2 1.0 2.0 0.8 0.0 1.6 0.0 0.3 0.9 2.3 1.0 1.5 2.0 0.9 0.0 0.0 0.6 0.8 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.7 1.7 0.7 1.9 3.1 0.1 0.3 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.7 SMIM11A "C21orf51, FAM165B, SMIM11" ENSG00000205670 "Small integral membrane protein 11A" P58511 21 34375480-34407866 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Ciliated cells: 4.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051321 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA051321: AB_2681440" "unprognostic (2.62e-2)" "unprognostic (4.28e-2)" "unprognostic (1.27e-1)" "unprognostic (5.86e-3)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.04e-1)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" "unprognostic (8.84e-2)" "unprognostic (4.83e-3)" 2.1 6.7 7.8 1.4 7.4 1.0 5.0 4.4 9.5 2.9 4.1 2.2 4.3 6.0 1.4 6.3 4.8 8.8 6.9 6.1 5.1 4.5 5.0 3.3 6.7 5.0 3.8 5.2 4.1 2.4 3.7 6.2 4.8 2.9 16.4 2.6 4.6 3.7 6.5 3.7 17.0 1.7 12.1 5.0 4.3 2.2 4.6 6.5 6.3 4.8 3.4 11.8 3.6 7.7 8.9 0.0 6.0 6.3 5.3 0.0 0.0 4.7 5.8 6.1 6.2 7.6 14.8 4.3 0.4 10.2 5.7 0.0 0.1 8.5 27.3 17.1 3.2 0.0 3.6 4.8 3.9 7.3 0.1 9.1 0.0 4.9 5.9 10.3 9.3 13.7 12.5 3.7 5.7 2.2 3.8 12.6 13.9 17.6 4.9 7.2 20.8 2.6 2.4 5.3 10.5 0.1 8.7 12.4 4.5 15.8 5.1 0.0 14.3 1.7 4.1 10.3 10.6 13.0 5.2 4.4 6.9 7.0 0.3 3.0 6.3 1.8 4.8 2.7 4.6 3.4 5.0 6.5 2.5 4.6 2.5 0.7 3.4 1.2 1.2 11.8 3.6 3.0 1.6 0.0 0.3 0.0 0.2 0.0 0.0 4.0 1.2 0.0 0.0 0.3 1.7 1.1 0.4 0.0 0.0 0.0 0.6 0.3 0.0 0.3 0.0 1.1 0.6 0.0 1.2 1.3 0.3 0.0 0.0 1.3 0.0 0.0 0.9 0.2 0.9 0.0 0.4 1.4 0.4 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.7 0.1 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 68.7 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.2 58.6 0.0 0.1 0.1 5.8 0.3 25.3 17.9 0.3 0.1 51.6 0.0 0.1 4.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 44.7 91.2 2.2 16.6 1.9 3.3 0.4 239.5 456.4 104.6 237.3 0.0 3.6 21.6 209.7 33.3 0.4 1586.1 0.0 336.4 0.4 0.3 47.7 18.4 0.0 0.3 1.6 452.3 0.0 0.0 89.0 0.6 2.7 21.9 9.0 1138.7 0.5 428.0 989.0 1.1 55.8 4.1 0.0 0.2 15.1 0.4 1.9 3.1 0.0 572.8 123.6 SMIM23 "C5orf50, LOC644994" ENSG00000185662 "Small integral membrane protein 23" A6NLE4 5 171782432-171796126 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 166 "testis: 21.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 170.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 1.5;U-266/70: 1.0" NA NA "unprognostic (6.47e-3)" "unprognostic (1.71e-1)" "unprognostic (7.80e-2)" "unprognostic (1.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.72e-1)" "unprognostic (5.36e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SMIM29 "C6orf1, LBH, MGC57858" ENSG00000186577 "Small integral membrane protein 29" Q86T20 6 34246380-34249470 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 67.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 61.3;Ductal cells: 41.8;Hofbauer cells: 88.6;monocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA037659, HPA037660" Uncertain NA NA "HPA037659: AB_2675591, HPA037660: AB_10671881" "unprognostic (2.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.10e-1)" "unprognostic (3.23e-1)" "unprognostic (1.93e-3)" "unprognostic (1.36e-2)" "unprognostic (2.62e-1)" "unprognostic (4.12e-2)" "prognostic favorable (7.98e-4)" "unprognostic (9.32e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (3.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.66e-1)" 9.6 18.5 42.0 10.4 21.8 9.9 12.4 14.8 36.8 10.5 7.6 15.2 4.6 7.1 9.1 24.4 13.3 11.5 12.3 19.0 34.6 34.4 7.9 6.0 13.3 13.5 35.7 16.5 8.8 10.7 7.0 12.2 10.0 25.7 9.7 4.8 12.5 7.5 13.6 7.8 29.2 6.7 8.3 23.9 15.2 9.4 5.2 14.0 5.8 15.2 8.3 11.0 16.0 9.3 22.4 10.4 67.8 15.0 9.8 15.8 11.0 8.9 9.9 2.0 11.7 24.7 20.6 2.0 9.2 19.5 8.5 10.4 2.4 3.4 5.0 7.4 8.2 16.1 5.5 3.7 8.8 2.5 12.9 6.4 3.7 2.5 6.8 13.7 4.4 23.3 11.2 8.4 12.0 12.8 10.8 13.6 3.8 4.8 25.0 19.3 5.7 4.6 8.0 0.7 10.9 7.3 1.6 1.3 7.7 10.2 11.5 9.5 4.5 0.9 6.6 24.0 1.7 4.8 5.2 10.0 19.4 5.3 22.4 7.7 15.9 22.4 1.6 11.4 8.7 28.3 15.3 15.0 67.8 15.8 10.7 10.3 22.4 12.6 13.5 10.4 21.8 8.7 12.5 38.7 9.8 7.6 8.8 15.3 11.0 42.0 21.8 14.8 36.8 34.6 34.4 35.7 16.5 25.7 14.0 8.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 12.5 29.6 0.0 30.4 61.3 41.8 0.0 0.0 0.0 0.0 20.4 10.4 0.0 0.0 11.6 0.0 88.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 77.5 0.0 0.0 25.6 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 SMIM34A ENSG00000243627 "Small integral membrane protein 34A" A8MWV9 21 34418715-34423966 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.5;SK-MEL-30: 1.2;U-87 MG: 1.0" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.3 0.1 0.3 0.3 0.5 0.2 2.9 1.6 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.1 0.3 0.6 0.3 0.2 9.6 0.5 0.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.3 0.7 1.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 1.6 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34B ENSG00000278961 "Small integral membrane protein 34B" A8MWV9 21 7784482-7793954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.5;kidney: 16.1" "Group enriched" "Detected in some" 7 "Ciliated cells: 12.0;Distal tubular cells: 5.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.1;myeloid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 6.5;SK-MEL-30: 2.7;U-87 MG: 2.5" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.4 16.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 3.1 0.6 0.0 0.0 0.4 1.1 0.2 0.2 0.0 0.0 0.0 0.3 0.2 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.7 0.0 1.2 0.3 0.0 0.0 0.5 0.4 0.0 1.2 0.1 0.0 2.5 0.3 0.1 0.0 0.5 3.1 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMOC2 SMAP2 ENSG00000112562 "SPARC related modular calcium binding 2" Q9H3U7 6 168441151-168673445 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Leydig cells: 298.0;Peritubular cells: 723.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "naive B-cell: 3.3" "Lineage enriched" "Detected in single" 7 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "AF22: 9.5;EFO-21: 3.3;RPMI-8226: 12.6;RPTEC TERT1: 4.5;SuSa: 11.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (3.23e-1)" "unprognostic (5.29e-2)" "unprognostic (3.70e-2)" "unprognostic (1.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (4.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.16e-6)" "unprognostic (3.50e-2)" "unprognostic (2.68e-1)" "unprognostic (6.35e-2)" "unprognostic (6.20e-3)" 17.9 3.4 1.9 17.2 5.0 0.0 26.2 0.8 2.3 37.3 11.7 2.5 5.0 5.1 57.7 40.6 17.9 34.4 73.2 25.3 1.9 1.7 3.0 1.3 5.3 4.8 2.7 2.9 45.0 8.5 1.8 1.5 5.4 6.0 22.3 6.4 76.2 6.9 15.1 21.8 8.0 9.4 53.9 1.6 1.3 50.0 31.1 1.3 2.3 13.6 12.3 3.5 36.8 11.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 1.2 0.0 0.0 0.0 0.0 12.6 4.5 0.0 2.0 0.4 0.0 0.4 0.1 11.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 5.0 0.8 2.3 1.9 1.7 2.7 2.9 6.0 1.3 0.0 1.7 0.0 6.1 9.8 2.8 7.0 0.0 4.0 3.4 10.4 0.0 2.0 0.0 0.0 2.3 3.5 1.6 0.0 0.0 1.6 18.5 5.5 0.0 0.0 1.2 0.0 18.9 4.3 0.0 5.7 298.0 0.6 3.3 0.0 3.0 0.4 0.1 0.0 723.1 0.0 0.6 45.3 73.7 2.7 4.5 2.4 2.2 0.0 12.5 0.6 SMPX "DFN6, DFNX4" ENSG00000091482 "Small muscle protein, X-linked" Q9UHP9 X 21705972-21758163 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5" "Cell type enriched" "Detected in single" 2069 "Cardiomyocytes: 810.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "GAMG: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA077360 Approved "Plasma membrane" NA NA 45000 "Plasma membrane" "HPA077360: AB_2732342" "unprognostic (7.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.39e-2)" "unprognostic (7.46e-2)" "unprognostic (5.27e-1)" "unprognostic (1.96e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (2.82e-1)" "unprognostic (8.38e-2)" 1.4 0.0 0.1 0.6 0.1 0.0 0.2 0.6 0.9 0.1 4.0 0.0 0.0 0.1 0.1 4.7 4.0 0.1 0.1 108.8 0.1 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.5 0.0 3.6 0.1 155.8 0.0 0.9 1.8 0.1 0.0 1.5 0.1 0.0 0.0 1.0 74.5 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.9 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 810.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SMTNL2 FLJ42461 ENSG00000188176 "Smoothelin like 2" Q2TAL5 17 4583999-4608319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 99.7" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 7.2;Collecting duct cells: 8.7;Distal tubular cells: 28.2;Fibroblasts: 7.7;Proximal tubular cells: 27.5;Sertoli cells: 25.8" "Cancer enhanced" "Detected in many" "renal cancer: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 2.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "CACO-2: 32.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (8.62e-2)" "unprognostic (5.40e-2)" "unprognostic (7.13e-2)" "unprognostic (2.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-2)" "unprognostic (4.89e-3)" "unprognostic (2.73e-1)" "unprognostic (3.73e-3)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (5.89e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.43e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-3)" "unprognostic (2.22e-1)" 3.0 0.1 0.1 0.5 0.2 0.1 0.5 0.1 0.5 1.0 0.3 0.0 0.0 0.1 0.9 4.7 3.4 1.8 2.4 4.8 0.8 0.1 17.9 0.1 1.0 0.1 0.1 0.0 5.3 0.1 0.2 0.6 1.4 0.1 2.7 0.2 0.1 1.4 0.4 99.7 0.2 0.2 2.1 0.1 0.2 0.3 0.6 0.0 0.0 0.8 24.6 1.1 3.3 0.7 0.0 0.4 0.0 2.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.2 0.0 0.5 0.0 1.8 0.0 0.4 0.0 1.9 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.0 3.6 0.0 7.8 0.0 0.0 0.0 0.0 7.2 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.5 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.0 7.2 0.0 0.0 1.2 8.7 0.0 0.8 28.2 0.0 0.0 0.8 0.0 0.0 0.0 1.0 7.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 25.8 4.4 0.0 0.7 0.0 0.5 0.0 0.0 0.0 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.4 11.5 8.2 7.9 5.4 13.4 9.9 5.7 10.5 10.9 18.1 5.2 16.2 6.7 4.0 7.1 11.8 10.9 6.4 13.2 4.6 11.0 5.9 12.1 4.9 3.9 6.0 5.8 3.8 5.8 10.8 9.6 5.4 5.2 14.0 6.2 6.3 8.2 3.7 10.9 4.2 5.2 7.2 5.6 13.6 5.8 4.1 4.2 7.4 4.7 6.5 9.2 3.8 9.5 9.8 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.1 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 6.0 26.7 8.5 8.1 4.4 19.2 4.5 7.6 17.4 17.0 7.0 31.4 7.8 1.7 4.6 19.6 9.0 8.1 0.0 2.9 8.7 10.3 5.9 7.0 5.9 11.2 25.4 3.5 19.6 13.7 5.1 25.0 14.5 5.0 15.4 4.2 7.0 3.2 0.0 23.3 2.2 19.3 45.3 21.7 13.3 14.9 5.8 6.8 7.5 5.0 3.1 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677682-88686493 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;skeletal muscle: 33.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NB-4: 14.7;RPMI-8226: 23.2" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.9 0.8 2.4 6.3 2.3 2.3 0.8 1.9 2.9 1.3 3.4 2.1 0.2 2.2 0.8 1.3 1.3 1.4 2.6 2.4 2.5 1.7 1.3 1.0 5.3 4.5 3.1 0.8 1.5 6.1 2.1 1.0 0.9 2.2 1.6 0.8 1.4 3.6 0.7 33.9 1.1 4.6 1.1 2.4 9.2 3.5 2.1 2.2 2.1 3.0 9.5 13.0 2.7 2.4 4.6 9.2 25.5 7.7 0.5 11.6 5.4 0.2 0.8 0.2 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 2.9 0.2 1.9 0.5 0.0 0.7 0.6 0.2 0.2 0.0 0.3 1.1 0.9 0.1 0.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 1.7 3.6 0.0 2.6 0.1 14.7 0.3 0.3 0.3 3.2 0.2 23.2 0.0 0.4 1.4 0.2 0.6 0.0 0.2 0.4 1.0 1.8 0.3 0.1 0.9 0.2 0.0 0.6 3.3 3.3 0.2 4.0 0.4 2.8 7.7 25.5 6.1 2.9 10.9 4.6 9.9 5.7 9.2 3.8 6.1 3.8 17.1 0.5 0.7 6.5 11.6 5.4 2.4 2.3 1.9 2.4 2.5 1.7 3.1 0.8 2.2 2.2 3.0 0.0 8.0 0.1 0.5 0.2 2.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.1 9.2 0.0 7.0 0.0 0.0 0.6 14.2 0.0 0.0 10.3 5.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.8 0.0 1.1 0.3 0.1 10.9 0.0 0.0 SNED1 "FLJ00133, Snep, SST3" ENSG00000162804 "Sushi, nidogen and EGF like domains 1" Q8TER0 2 240998838-241095568 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Ito cells: 27.6;Leydig cells: 88.1;Peritubular cells: 66.8;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.3" "Group enriched" "Detected in many" 28 "B-cells: 5.3;monocytes: 1.7;T-cells: 1.3" "Group enriched" "Detected in some" 5 "ASC TERT1: 94.4;HSkMC: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA036414, HPA036415" Uncertain "Secreted - unknown location" NA NA 15000000 "HPA036414: AB_10960852, HPA036415: AB_10964128" "unprognostic (1.41e-1)" "unprognostic (3.92e-2)" "unprognostic (1.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.57e-3)" "unprognostic (4.62e-2)" "unprognostic (7.77e-4)" "unprognostic (3.49e-2)" "unprognostic (4.96e-1)" "unprognostic (7.85e-3)" "unprognostic (3.42e-2)" "unprognostic (2.06e-2)" "unprognostic (2.80e-2)" "unprognostic (1.16e-1)" "unprognostic (3.72e-1)" "unprognostic (5.51e-3)" "unprognostic (4.95e-3)" 18.8 8.3 4.6 10.3 3.7 1.3 23.7 21.9 7.4 21.7 7.0 7.6 19.1 4.9 19.1 23.9 6.8 17.4 19.2 8.4 5.6 2.5 6.0 5.4 9.5 6.3 5.8 3.9 23.2 7.8 2.4 5.5 2.2 11.8 12.9 3.9 15.6 11.0 11.1 14.3 9.0 6.8 8.2 7.7 11.0 4.2 11.9 7.3 2.7 29.1 8.4 5.7 9.0 17.1 5.3 0.0 0.0 1.7 0.0 1.3 0.2 0.0 0.1 0.0 1.0 13.9 94.4 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.9 0.0 0.5 0.0 0.1 47.8 0.0 0.1 0.0 6.3 2.0 0.0 0.0 0.6 2.5 0.5 0.3 0.0 0.1 0.0 0.0 0.0 1.8 0.0 1.2 0.1 0.1 0.0 0.4 1.8 0.9 0.1 0.3 0.1 5.1 1.9 0.1 11.1 0.3 0.1 0.0 0.3 2.6 0.0 0.5 0.0 0.1 0.0 0.0 0.9 1.0 5.3 1.3 0.7 0.0 2.0 0.7 0.7 0.0 0.0 1.7 0.0 1.3 0.2 4.6 3.7 21.9 7.4 5.6 2.5 5.8 3.9 11.8 7.3 6.0 8.3 3.2 0.8 3.2 2.6 2.0 2.5 5.3 14.8 5.2 0.0 0.1 0.0 0.7 1.1 7.0 0.0 0.0 1.1 0.2 6.6 3.6 0.0 4.9 0.2 1.6 2.4 27.6 1.9 1.9 88.1 0.5 1.7 0.0 0.0 9.9 0.6 0.0 66.8 0.1 1.4 25.8 2.7 0.5 1.9 2.3 0.3 0.0 0.0 0.4 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Group enriched" "Detected in some" 4 "Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 14 "Hep G2: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.9 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 36.4 0.5 0.0 1.1 0.0 0.9 0.2 0.5 0.4 1.0 0.4 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.6 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.4 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SNTN "FLJ44379, S100AL" ENSG00000188817 "Sentan, cilia apical structure protein" A6NMZ2 3 63652668-63679020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 823.1" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 3.1;RH-30: 2.4;SH-SY5Y: 3.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA043322, HPA058399" Enhanced NA NA "HPA043322: AB_10793945, HPA058399: AB_2683705" "unprognostic (9.70e-3)" "unprognostic (3.67e-1)" "unprognostic (4.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.34e-3)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (8.43e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.1 26.6 0.0 73.9 0.0 0.0 0.6 0.3 0.0 0.0 29.5 0.0 0.0 0.0 18.5 0.1 0.0 1.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 5.8 0.0 0.1 0.0 0.0 0.9 0.4 1.6 0.2 0.4 0.5 0.1 0.3 0.2 0.6 0.8 0.1 1.4 0.5 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.5 0.0 0.0 0.2 0.4 0.2 3.1 0.0 0.3 2.4 0.2 0.1 0.3 0.3 3.4 0.1 0.3 0.0 0.6 0.1 0.3 0.0 0.6 0.6 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.6 1.6 0.2 0.2 0.3 0.2 0.3 0.1 0.2 0.3 0.0 0.9 0.5 0.4 1.1 0.4 0.2 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 823.1 64.8 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 SNX21 "C20orf161, dJ337O18.4, SNX-L" ENSG00000124104 "Sorting nexin family member 21" Q969T3 20 45833810-45843275 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.9;classical monocyte: 2.9;eosinophil: 7.3;intermediate monocyte: 5.0;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 6 "granulocytes: 7.3;monocytes: 5.0" "Cell line enhanced" "Detected in many" "EFO-21: 16.4;PC-3: 20.0;U-87 MG: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046359 Approved Approved "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA046359: AB_10963216" "unprognostic (1.97e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (4.96e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-2)" "unprognostic (2.18e-1)" 25.4 21.0 10.0 4.4 9.8 1.9 14.1 10.3 18.3 18.8 8.4 8.6 10.3 10.0 17.6 13.8 11.3 14.3 15.3 9.1 7.5 6.4 8.9 5.2 9.5 2.7 7.9 7.5 19.1 4.2 5.5 6.9 6.9 8.8 14.1 2.9 13.6 10.2 11.2 43.4 35.2 6.1 19.8 7.6 6.6 9.3 7.2 6.4 0.0 6.0 14.9 3.7 15.4 12.0 0.2 0.3 7.3 5.0 0.0 1.0 0.7 3.6 4.7 0.8 6.8 3.8 3.5 3.3 4.8 4.3 5.2 3.9 3.4 2.8 0.0 16.4 4.8 3.9 4.8 0.1 3.8 0.5 0.4 0.6 0.1 2.3 3.2 2.9 0.0 1.1 2.6 2.2 4.6 0.2 1.2 3.2 0.4 0.0 0.0 1.7 9.2 0.0 0.3 1.2 0.6 20.0 0.0 0.6 0.0 1.6 0.6 0.8 7.4 10.7 10.2 5.7 0.3 6.6 0.9 3.5 7.6 5.9 14.2 4.3 0.0 0.5 0.2 18.1 0.0 4.0 3.9 2.9 7.3 0.0 5.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 3.3 0.1 1.0 0.7 10.0 9.8 10.3 18.3 7.5 6.4 7.9 7.5 8.8 6.4 8.9 8.8 0.0 5.8 9.0 12.7 4.5 5.1 6.7 12.5 5.2 7.9 4.1 21.6 8.5 3.7 7.7 10.7 0.0 10.3 4.6 37.9 3.2 0.0 3.0 4.2 14.3 8.6 8.6 5.9 11.4 18.1 5.8 10.1 0.0 8.7 12.7 7.0 4.2 15.9 11.7 12.5 6.5 18.9 0.9 1.9 19.8 2.1 1.5 7.2 2.7 SOAT2 ACAT2 ENSG00000167780 "Sterol O-acyltransferase 2" O75908 12 53103518-53124538 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 60.8" "Cell type enhanced" "Detected in single" 15 "Club cells: 1.2" "Group enriched" "Detected in some" 8 "liver cancer: 5.2;testis cancer: 5.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 7 "T-cells: 3.7" "Group enriched" "Detected in some" 5 "CACO-2: 9.8;Hep G2: 21.4;U-266/70: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.53e-1)" "unprognostic (2.72e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (1.30e-4)" "unprognostic (3.88e-3)" "unprognostic (9.26e-2)" "unprognostic (4.20e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (9.05e-2)" "unprognostic (2.37e-1)" "unprognostic (7.58e-3)" "unprognostic (3.28e-1)" 0.5 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 0.9 16.4 0.2 0.2 12.3 0.7 0.3 0.2 0.9 0.4 0.2 0.2 0.0 0.6 4.2 0.2 0.6 0.2 0.2 0.4 0.2 0.0 0.3 0.2 0.2 0.6 0.0 0.2 0.4 0.2 0.2 0.4 60.8 0.2 0.3 2.2 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 1.1 0.0 0.0 0.0 0.3 0.5 3.7 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.4 9.8 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.9 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.1 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.7 0.0 1.5 2.7 0.0 0.0 0.4 1.5 0.0 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168208-36214615 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 23.6" "Group enriched" "Detected in some" 8 "Early spermatids: 52.6;Extravillous trophoblasts: 15.9;Late spermatids: 58.0;Spermatocytes: 19.1;Spermatogonia: 40.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.2;HL-60: 9.5;Karpas-707: 10.9;NB-4: 13.9;U-266/84: 13.9" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.3 0.3 0.9 0.3 2.1 0.5 0.4 0.3 3.5 0.3 1.8 0.3 0.3 0.2 0.3 2.0 0.3 0.2 0.3 0.9 1.2 1.2 0.6 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.2 0.3 3.5 0.3 1.8 0.0 0.3 0.3 1.2 0.4 0.2 0.3 0.4 0.6 0.3 0.1 23.6 0.3 0.3 0.4 0.3 0.3 1.3 0.3 1.0 0.3 0.5 0.3 0.0 0.5 0.0 7.2 0.2 0.8 0.0 0.6 1.2 4.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.1 9.5 0.0 2.1 0.6 0.0 0.0 0.4 0.9 0.2 0.4 10.9 2.2 0.1 0.0 13.9 0.2 0.0 0.0 0.2 0.2 0.8 1.0 0.7 0.1 1.3 0.0 0.0 0.0 2.7 0.1 0.6 0.0 0.0 0.8 0.5 0.5 1.4 13.9 0.2 0.8 5.1 0.5 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.3 3.5 1.2 1.2 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 52.6 0.0 0.0 0.0 0.0 15.9 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 1.1 0.3 0.0 0.0 19.1 40.2 0.1 2.9 0.0 0.0 0.1 SORCS3 "KIAA1059, SORCS" ENSG00000156395 "Sortilin related VPS10 domain containing receptor 3" Q9UPU3 10 104641101-105265235 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 5.8;brain: 19.1" "Cell type enriched" "Detected in some" 7 "Early spermatids: 11.2" "Group enriched" "Detected in some" 13 "glioma: 1.8;renal cancer: 2.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;RPTEC TERT1: 4.6;SH-SY5Y: 1.0;SuSa: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-2)" "unprognostic (8.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-1)" "unprognostic (1.98e-1)" "unprognostic (3.63e-1)" "unprognostic (4.78e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.63e-2)" "unprognostic (1.97e-1)" 1.1 5.8 5.4 0.8 15.5 0.7 0.9 2.9 19.1 1.2 0.9 2.3 0.0 0.7 1.0 0.7 0.8 0.7 1.1 0.7 6.3 8.5 1.3 0.6 0.6 0.7 2.0 8.1 2.7 0.6 0.6 3.0 0.6 3.4 0.8 0.9 0.0 0.9 0.9 0.6 1.0 1.1 1.1 2.3 0.6 0.9 2.9 2.0 0.0 0.6 0.0 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 1.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.4 15.5 2.9 12.7 6.3 8.5 2.0 8.1 3.4 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 SOWAHD ANKRD58 ENSG00000187808 "Sosondowah ankyrin repeat domain family member D" A6NJG2 X 119758613-119760164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.1;lymphoid tissue: 12.6" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.5;Extravillous trophoblasts: 27.9;Hofbauer cells: 15.7;Syncytiotrophoblasts: 7.9" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.2;NB-4: 3.9;SK-BR-3: 4.6;THP-1: 11.5;U-937: 10.2" "Not detected" "Not detected" HPA065955 Uncertain NA NA "HPA065955: AB_2685586" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.10e-2)" "unprognostic (8.88e-2)" "unprognostic (1.67e-1)" "unprognostic (4.38e-2)" "unprognostic (2.03e-1)" "unprognostic (7.20e-2)" "unprognostic (3.45e-2)" "unprognostic (6.07e-2)" "unprognostic (5.80e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-5)" "unprognostic (5.82e-2)" "unprognostic (3.14e-2)" "unprognostic (9.22e-2)" "unprognostic (3.74e-3)" 0.7 0.9 1.0 3.9 2.5 4.2 0.5 0.7 2.1 0.6 1.8 4.0 2.0 4.6 0.4 0.0 0.6 0.8 1.5 1.1 0.9 0.9 1.3 0.8 3.5 6.7 2.5 1.1 0.8 2.2 0.3 0.5 9.6 1.5 0.9 1.1 0.9 5.0 1.0 0.4 0.6 6.7 0.2 3.0 12.6 1.8 8.0 2.0 0.7 0.4 1.1 3.2 0.8 0.5 11.1 2.3 3.7 3.6 0.3 1.9 0.7 0.6 0.0 0.2 0.1 0.0 0.0 6.2 0.1 0.0 0.7 1.0 1.3 0.2 0.3 0.8 0.0 0.7 0.1 0.0 0.0 0.1 1.0 0.7 0.1 0.1 1.6 0.4 1.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.1 0.1 0.6 0.0 3.9 1.3 1.1 0.4 3.4 0.1 0.2 0.1 0.2 0.4 0.2 1.3 4.6 0.2 0.5 0.8 11.5 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.0 10.2 0.1 0.0 3.4 1.9 0.1 3.6 0.0 9.0 0.5 0.4 2.3 11.1 1.9 1.0 3.7 0.3 3.0 1.1 0.0 0.7 1.0 2.5 0.7 2.1 0.9 0.9 2.5 1.1 1.5 2.0 0.0 0.0 8.5 0.1 0.0 0.5 0.4 0.0 0.0 0.0 3.5 0.0 5.6 0.0 0.2 0.4 0.0 4.1 0.0 0.4 27.9 0.2 0.0 0.0 0.0 15.7 1.6 0.0 0.0 4.7 0.4 0.0 4.5 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.4 0.1 7.9 0.0 1.8 0.0 SOX12 SOX22 ENSG00000177732 "SRY-box 12" O15370 20 325595-330224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 53.0;Cone photoreceptor cells: 39.3;Horizontal cells: 30.2;Rod photoreceptor cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055052, HPA061627" Enhanced Nucleoplasm No No Nucleoplasm "HPA055052: AB_2682685, HPA061627: AB_2684571" "unprognostic (1.02e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-3)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.64e-5)" "unprognostic (1.90e-1)" "unprognostic (1.49e-3)" "unprognostic (3.55e-1)" "unprognostic (5.02e-3)" "unprognostic (4.66e-1)" "unprognostic (3.12e-3)" "unprognostic (7.91e-2)" "unprognostic (1.55e-1)" "unprognostic (8.36e-2)" "unprognostic (2.20e-2)" 5.2 7.4 11.0 4.9 10.2 5.4 10.3 27.5 14.1 8.2 7.8 10.1 11.0 4.1 10.9 11.3 5.8 10.2 5.2 6.8 10.9 8.8 8.3 4.7 5.3 5.1 11.3 5.7 14.6 12.6 7.7 7.0 5.0 8.4 8.7 3.0 7.8 8.8 13.8 2.3 9.0 4.8 8.5 6.9 7.6 5.0 8.2 10.9 12.1 8.2 2.0 3.8 7.8 9.0 1.8 1.5 0.3 0.2 0.2 1.3 0.2 3.7 13.2 12.9 8.7 6.3 4.6 3.9 5.2 4.5 4.7 4.7 2.6 3.9 8.4 4.0 6.0 9.9 4.4 9.4 1.7 2.7 4.2 6.5 5.4 5.1 26.3 8.1 7.4 1.4 6.3 5.4 4.0 1.6 7.8 6.2 5.8 12.7 4.4 3.0 9.1 2.5 18.3 21.1 2.1 17.4 13.2 3.3 6.8 6.7 0.4 15.9 18.5 3.5 15.3 19.2 5.6 14.5 10.4 7.0 18.4 18.3 0.5 4.5 12.8 13.4 8.7 3.4 7.4 3.5 0.3 0.2 0.3 0.5 0.1 0.2 1.7 0.6 0.8 0.2 1.8 1.3 1.1 0.1 0.2 0.0 1.5 0.8 0.2 11.0 10.2 27.5 10.7 10.9 8.8 11.3 5.7 8.4 10.9 0.0 2.7 0.8 2.1 3.1 53.0 11.0 5.1 1.4 1.2 7.0 39.3 1.2 13.3 1.1 0.6 3.8 1.1 0.0 0.3 0.4 4.3 2.6 0.0 4.7 1.8 30.2 8.7 8.6 1.9 1.7 9.5 0.7 5.0 0.0 4.0 8.3 0.4 0.0 11.7 4.8 37.2 0.0 5.7 0.9 7.0 1.0 0.6 2.1 3.7 0.3 SOX21 SOX25 ENSG00000125285 "SRY-box 21" Q9Y651 13 94709622-94712399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;skin 1: 18.3;stomach 1: 38.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 4.7;Suprabasal keratinocytes: 8.0" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.6;NTERA-2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048337, HPA064084" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048337: AB_2732547, HPA064084: AB_2685187" "unprognostic (3.33e-1)" "prognostic favorable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favorable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.6 0.6 11.0 0.7 10.1 0.6 1.5 2.5 13.2 0.7 0.6 7.5 0.0 0.6 0.7 0.6 8.3 0.7 0.7 0.6 10.9 5.5 0.6 0.6 0.8 0.6 6.0 8.2 0.6 0.6 0.6 0.1 0.6 5.8 1.2 0.6 0.0 1.7 0.6 0.7 18.3 0.6 0.7 6.1 0.6 38.7 0.8 9.8 0.0 0.7 1.0 4.3 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 3.3 6.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.1 2.5 12.3 10.9 5.5 6.0 8.2 5.8 9.8 0.0 0.0 0.0 1.2 4.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.7 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 120.0" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "RH-30: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm No NA Nucleoplasm "HPA041640: AB_10964357, HPA058665: AB_2683792" "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.3 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 51.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 0.0 0.0 0.0 0.4 0.3 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.1 2.1 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.1 0.0 1.7 1.0 0.0 120.0 0.1 0.0 1.8 0.0 5.3 0.0 0.8 0.0 4.3 0.9 0.0 0.0 0.0 0.1 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715351-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 3.3;Fibroblasts: 2.3;Mucus-secreting cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 51.7" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Group enriched" "Detected in many" 4 "cerebellum: 5.3;hippocampal formation: 1.2;olfactory region: 5.8;thalamus: 3.6" HPA074123 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA074123: AB_2686664" "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 8.7 1.8 0.5 2.5 0.6 0.1 7.4 1.6 1.0 11.4 3.9 1.4 3.2 3.1 7.2 3.0 1.9 3.0 5.1 0.8 0.6 1.4 0.8 5.9 4.6 3.1 0.2 0.8 1.5 0.5 0.1 0.1 2.1 0.4 7.2 1.0 3.8 2.1 0.9 0.7 6.6 3.1 3.1 0.1 0.2 7.3 2.4 0.0 0.2 0.1 0.8 6.5 3.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 0.0 1.5 0.1 0.2 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.6 1.0 0.6 1.4 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.8 0.0 0.0 0.0 1.8 0.0 0.9 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.9 0.0 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SPACA5 "dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288" ENSG00000171489 "Sperm acrosome associated 5" Q96QH8 X 48004336-48009729 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 15.1" "Cell type enriched" "Detected in single" 29 "Early spermatids: 2.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;JURKAT: 1.3;NB-4: 3.9;U-266/70: 1.2;U-266/84: 2.1" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" NA NA "HPA044747: AB_2679071, HPA047149: AB_2679955" 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.8 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.4 0.3 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 15.1 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.3 3.9 0.9 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.5 1.1 0.0 0.0 0.4 0.0 0.7 0.0 1.2 2.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA5B LYZL5B ENSG00000171478 "Sperm acrosome associated 5B" Q96QH8 X 48130657-48132613 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 18.3" "Cell type enriched" "Detected in single" 12 "Early spermatids: 1.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "T-reg: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Not detected" "Not detected" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" NA NA "HPA044747: AB_2679071, HPA047149: AB_2679955" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 225 "epididymis: 332.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 10.4" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 332.8 1.4 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11B "EDDM2B, EP2, EP2C, EP2D, HE2" ENSG00000164871 "Sperm associated antigen 11B" Q08648 8 7442684-7463674 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 232 "epididymis: 362.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 5.7;NB-4: 12.6;RPMI-8226: 5.8;SH-SY5Y: 5.1" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 362.2 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 261.0;Early spermatids: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 33.9" "Low region specificity" "Detected in many" HPA037542 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.90e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 11.1 13.0 28.2 5.4 29.8 1.7 15.8 12.0 22.0 16.7 11.5 21.9 23.1 13.7 14.0 24.8 16.0 34.8 17.0 15.7 27.7 24.6 22.6 13.8 8.1 7.7 31.5 22.0 20.2 11.2 24.0 32.8 7.3 25.7 17.1 13.1 11.1 11.8 19.8 6.1 18.2 7.9 14.3 36.9 5.7 19.2 34.3 18.1 10.5 19.9 11.4 9.8 14.8 11.9 7.5 4.1 1.1 1.1 12.1 10.6 3.0 12.4 5.0 14.3 0.0 9.8 17.6 0.1 6.8 8.2 8.9 9.5 9.8 13.8 5.2 8.2 7.5 14.3 8.8 6.4 8.3 19.0 0.0 5.1 2.7 12.7 12.7 10.9 2.9 0.0 15.0 11.5 7.9 4.6 12.3 3.6 5.5 8.7 6.0 8.9 0.0 9.8 0.0 7.9 0.0 4.2 10.5 15.0 0.2 14.3 12.2 10.4 12.3 7.9 7.3 9.6 12.9 33.9 1.2 3.8 8.6 5.2 4.5 7.1 9.8 4.4 0.2 14.0 0.0 3.8 1.1 0.2 0.7 7.1 1.1 10.1 7.5 8.0 8.9 2.5 7.3 10.6 9.2 0.4 12.1 0.8 4.1 7.4 3.0 28.2 29.8 12.0 22.0 27.7 24.6 31.5 22.0 25.7 18.1 14.9 17.9 11.0 36.9 37.5 34.4 59.6 58.6 261.0 58.0 38.4 90.3 41.9 64.6 34.0 200.5 21.0 10.6 23.3 21.5 17.0 30.9 34.4 9.3 16.0 10.0 38.1 36.7 9.2 4.5 48.7 38.3 6.9 21.9 49.5 35.2 69.4 27.0 10.5 42.1 72.5 64.3 12.9 31.9 158.7 19.0 49.3 19.7 12.1 36.5 43.0 SPAG17 "CT143, FLJ34497, PF6, RP4-776P7.2" ENSG00000155761 "Sperm associated antigen 17" Q6Q759 1 117953861-118185223 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1;epididymis: 16.3;testis: 24.7" "Cell type enhanced" "Detected in many" 20 "Ciliated cells: 444.4;Early spermatids: 203.6;Late spermatids: 292.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 24.1" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 1.7;HMC-1: 1.5;RT4: 2.7;SCLC-21H: 3.1;SuSa: 2.8;U-2 OS: 1.1" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 12.2" "HPA028597, HPA028666" Enhanced NA NA "HPA028597: AB_10600221, HPA028666: AB_10602281" "unprognostic (3.67e-2)" "unprognostic (4.86e-3)" "unprognostic (3.42e-1)" "unprognostic (1.50e-2)" "unprognostic (1.56e-2)" "unprognostic (6.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.20e-2)" "unprognostic (3.19e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.76e-5)" "unprognostic (4.81e-1)" "unprognostic (9.90e-2)" "unprognostic (8.23e-2)" "unprognostic (9.67e-2)" 0.8 0.1 1.4 0.2 5.6 0.2 1.3 0.0 0.2 2.0 0.2 7.4 2.2 0.2 0.9 16.3 8.6 11.8 0.7 0.2 2.6 3.0 3.0 0.1 6.1 0.1 0.1 0.3 7.8 0.7 0.3 9.2 0.3 24.1 0.2 0.2 0.6 0.3 0.4 0.5 0.3 0.2 0.2 0.4 0.2 0.9 24.7 1.5 0.0 1.4 0.1 0.8 2.1 2.7 0.0 1.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.7 3.1 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.0 0.2 2.6 3.0 0.1 0.3 24.1 1.5 6.0 3.8 0.0 0.1 0.3 0.4 0.6 0.0 444.4 78.5 10.4 31.4 1.7 1.7 0.4 203.6 0.1 0.0 0.0 0.6 0.5 0.6 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 292.1 1.4 0.2 0.0 0.0 0.0 1.0 0.3 0.0 1.1 0.6 0.0 0.0 0.1 43.2 5.6 0.3 0.6 0.0 0.0 0.7 SPAG6 "CT141, pf16, Repro-SA-1" ENSG00000077327 "Sperm associated antigen 6" O75602 10 22345445-22454224 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.1;fallopian tube: 29.5;testis: 70.6" "Group enriched" "Detected in some" 8 "Ciliated cells: 262.3;Early spermatids: 120.4;Spermatocytes: 275.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 31.1" "Cell type enhanced" "Detected in some" "eosinophil: 2.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 28 "U-937: 48.8" "Region enhanced" "Detected in many" "midbrain: 17.9" HPA038440 Enhanced NA NA "HPA038440: AB_10671742" "unprognostic (5.02e-2)" "unprognostic (9.52e-2)" "unprognostic (8.94e-6)" "unprognostic (2.21e-1)" "unprognostic (2.51e-2)" "unprognostic (4.91e-3)" "unprognostic (1.68e-1)" "unprognostic (2.38e-1)" "unprognostic (8.68e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-3)" "unprognostic (3.10e-2)" "unprognostic (2.78e-4)" 0.3 0.3 2.8 0.3 5.2 0.5 1.4 0.0 2.0 1.1 0.3 8.6 0.0 0.3 0.4 8.7 0.3 29.5 0.3 0.3 5.0 5.1 0.5 0.4 5.3 0.3 0.7 0.6 3.1 0.5 0.3 12.4 0.3 31.1 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.3 0.3 70.6 1.6 0.0 0.3 0.0 0.3 0.3 0.1 0.0 1.2 2.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 48.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.5 0.0 2.8 5.2 0.0 2.0 5.0 5.1 0.7 0.6 31.1 1.6 0.0 3.7 0.0 0.1 0.1 0.1 0.6 0.0 262.3 27.3 0.0 0.0 0.0 1.7 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 25.3 4.6 0.8 1.7 0.0 0.0 0.0 0.6 0.0 4.6 0.3 1.0 0.0 0.2 275.9 3.7 0.1 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002591-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.5" "Group enriched" "Detected in some" 136 "Early spermatids: 450.0;Late spermatids: 1630.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 41.1;GAMG: 8.8;U-2 OS: 14.4" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (8.55e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 41.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 14.4 1.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 450.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1630.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 7.6 4.0 0.0 0.0 0.0 0.0 0.0 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 28.4" "Group enriched" "Detected in some" 116 "Early spermatids: 353.2;Late spermatids: 183.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2 OS: 6.6" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 353.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 183.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 SPATA19 "CT132, FLJ25851, SPAS1, spergen1" ENSG00000166118 "Spermatogenesis associated 19" Q7Z5L4 11 133840631-133845538 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 128 "testis: 46.8" "Group enriched" "Detected in some" 143 "Early spermatids: 721.0;Late spermatids: 1661.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HBEC3-KT: 2.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA040082 Enhanced NA NA "HPA040082: AB_2676836" "unprognostic (9.90e-3)" "unprognostic (3.34e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 721.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1661.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 7.6 4.9 0.0 0.0 0.0 0.0 0.0 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 24 "Early spermatids: 516.6;Late spermatids: 1225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.1;MCF7: 26.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favorable (9.69e-5)" 9.7 29.0 14.9 15.2 13.1 4.6 8.2 17.7 22.8 11.7 13.4 11.4 16.8 9.8 16.0 21.1 10.7 13.5 25.4 36.3 9.8 14.3 15.7 13.1 11.2 8.7 15.0 18.3 20.4 22.4 11.9 10.4 6.9 13.3 15.4 5.8 29.0 18.9 15.0 17.9 8.7 9.9 12.7 13.0 14.1 22.8 62.7 6.8 2.5 22.3 8.5 9.9 13.1 7.9 3.2 8.9 1.1 4.7 9.3 2.6 2.9 3.4 16.0 0.9 10.5 2.4 7.5 2.9 5.9 6.8 2.8 2.2 11.9 5.1 3.7 14.3 4.2 3.1 2.7 0.6 2.9 1.4 5.0 2.3 2.5 3.5 27.1 11.1 0.9 7.4 11.9 3.9 1.5 4.4 3.7 3.6 0.6 0.3 6.9 2.5 26.8 0.0 0.9 1.1 7.3 7.0 1.5 2.5 1.0 13.7 17.0 1.8 4.3 5.2 3.9 6.3 1.1 7.5 0.4 8.1 2.8 8.9 1.6 1.2 13.2 4.0 0.0 5.9 0.5 2.9 0.0 4.5 1.1 2.0 4.7 2.6 3.2 1.5 1.5 8.9 2.2 2.0 2.2 0.3 9.3 4.0 2.0 0.8 2.9 14.9 13.1 17.7 22.8 9.8 14.3 15.0 18.3 13.3 6.8 6.0 5.3 3.4 11.9 9.5 3.4 26.6 17.8 4.0 12.5 22.7 3.9 14.5 23.2 29.1 516.6 10.5 20.1 0.0 34.6 8.5 19.4 14.3 17.3 19.8 30.3 11.1 36.5 9.8 22.6 1225.1 35.4 15.4 20.3 19.0 31.6 24.6 24.1 25.9 35.7 30.1 1.9 6.5 20.6 8.1 10.4 7.8 8.2 10.2 20.5 12.0 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 4.6;testis: 11.3" "Group enriched" "Detected in some" 7 "Early spermatids: 35.1;Late spermatids: 31.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "Hep G2: 11.0" HPA032080 Approved Vesicles,Cytosol No NA "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.2 0.0 0.0 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.2 0.3 11.3 0.0 0.0 0.3 0.0 1.3 0.6 4.6 0.8 0.9 0.8 0.4 0.2 0.8 0.4 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 1.5 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 1.5 11.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.2 0.7 0.2 0.1 0.5 0.2 0.3 0.0 0.4 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.0 1.2 0.6 0.3 0.6 0.2 0.3 0.2 0.1 0.4 0.0 0.4 0.4 0.2 0.3 0.3 0.0 4.6 0.5 0.9 0.7 0.8 0.5 1.1 0.7 0.6 0.4 1.3 0.8 0.3 2.3 0.9 0.5 0.6 0.7 0.4 0.0 0.6 0.0 0.2 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 35.1 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.1 4.8 0.0 0.0 1.2 31.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.1 0.0 0.3 1.1 0.1 0.4 0.2 0.0 0.0 0.1 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.3 4.2 1.5 7.0 1.2 1.2 8.2 3.7 1.7 1.7 1.1 8.0 4.5 1.8 5.0 1.2 2.3 9.3 1.3 2.0 0.3 1.7 15.1 1.2 1.5 10.8 3.9 1.0 3.7 1.2 2.6 2.8 0.8 2.0 1.9 2.1 5.5 1.3 1.2 24.2 3.1 5.7 4.3 5.4 5.7 6.8 0.7 5.2 2.5 1.9 8.3 5.4 3.9 4.0 4.5 0.7 10.3 4.1 4.8 1.7 6.4 0.3 1.7 3.2 1.9 1.6 5.3 3.0 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 3.0 0.3 1.4 16.6 14.0 6.6 0.4 5.1 0.0 0.0 10.4 0.0 7.5 1.7 11.7 4.4 4.9 29.5 0.0 11.8 4.1 5.7 10.1 4.6 5.0 6.8 3.2 22.8 5.5 7.5 1.0 2.6 7.2 8.5 3.6 6.8 5.1 10.5 17.3 2.1 8.4 7.4 0.0 9.2 1.0 2.5 17.3 20.8 5.0 6.2 11.6 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "testis: 82.0" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3891.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.6;U-698: 1.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 11 "cerebellum: 11.0" HPA018254 Enhanced NA NA "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.2 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.0 0.2 3.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.5 0.1 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.1 0.0 0.9 0.0 0.2 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.2 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.2 0.5 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 761.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3891.5 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 6.5 0.0 21.5 10.9 0.0 0.0 0.0 0.0 0.0 SPATA31A3 "DKFZp434B204, FAM75A3" ENSG00000275969 "SPATA31 subfamily A member 3" Q5VYP0 9 66986304-66992583 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 81 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A7 "FAM75A4, FAM75A7, SPATA31A4" ENSG00000276040 "SPATA31 subfamily A member 7" Q8IWB4 9 61190003-61196280 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D1 "FAM75D1, FLJ46321" ENSG00000214929 "SPATA31 subfamily D member 1" Q6ZQQ2 9 81988772-81995256 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "testis: 13.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 3.7" HPA047897 Uncertain NA NA "HPA047897: AB_2680204" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SPATA31D3 "FAM75D3, FLJ44082" ENSG00000186788 "SPATA31 subfamily D member 3" P0C874 9 81943586-81950038 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 99 "testis: 9.9" "Cell type enriched" "Detected in some" 13 "Early spermatids: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31E1 "C9orf79, FAM75E1, FLJ35866" ENSG00000177992 "SPATA31 subfamily E member 1" Q6ZUB1 9 87882826-87888899 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 18.6" "Group enriched" "Detected in some" 94 "Early spermatids: 42.3;Late spermatids: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;hTEC/SVTERT24-B: 1.2;Karpas-707: 1.1;SCLC-21H: 4.5" HPA024253 Enhanced NA NA "HPA024253: AB_1845839" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Group enriched" "Detected in many" 10 "Early spermatids: 1519.3;Late spermatids: 2991.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: AB_2686570" "unprognostic (1.05e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.3 9.9 12.3 4.4 3.3 2.9 4.3 7.0 2.9 10.2 4.4 9.3 8.7 1.1 3.8 4.7 6.9 14.0 5.4 3.8 7.7 2.0 7.6 1.7 12.0 13.7 1.5 2.2 4.2 3.0 4.5 7.0 3.0 3.9 2.3 9.6 11.1 1.5 6.6 12.1 6.5 5.6 6.8 6.2 7.6 13.3 6.8 3.4 6.0 3.5 11.5 6.3 15.6 2.9 3.8 5.8 12.7 3.0 2.1 7.9 9.8 6.6 5.6 3.6 5.3 4.1 7.7 12.4 2.8 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 6.0 8.9 5.1 7.9 6.4 17.7 5.2 10.2 109.7 13.6 27.9 60.9 3.2 19.9 12.3 1519.3 10.2 15.9 0.0 15.4 4.9 10.5 5.5 1.1 9.8 7.9 22.3 16.8 8.6 2.7 2991.1 28.1 7.3 16.9 4.6 8.9 16.6 11.2 8.6 22.3 26.7 69.1 12.9 12.3 232.7 101.0 6.1 1.1 12.5 12.0 5.5 SPATA6L "C9orf68, FLJ10058" ENSG00000106686 "Spermatogenesis associated 6 like" Q8N4H0 9 4553386-4666674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 23.0" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 96.7;Late spermatids: 69.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 3.4;CAPAN-2: 5.8;HDLM-2: 3.2;RPTEC TERT1: 4.4;SCLC-21H: 3.8" "Low region specificity" "Detected in all" HPA039585 Enhanced NA NA "HPA039585: AB_10674984" "unprognostic (8.18e-3)" "unprognostic (1.69e-1)" "unprognostic (4.10e-2)" "unprognostic (2.39e-3)" "unprognostic (5.65e-2)" "unprognostic (4.38e-2)" "unprognostic (3.23e-2)" "unprognostic (8.03e-3)" "unprognostic (4.10e-3)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (5.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.27e-3)" 1.7 1.1 4.9 0.6 7.3 0.2 3.0 15.3 5.3 1.5 1.6 1.7 4.1 2.6 1.7 5.4 2.3 9.4 4.0 1.4 3.2 1.7 2.5 7.6 4.0 1.7 1.2 2.5 1.7 5.3 3.9 23.0 1.3 3.8 1.9 1.2 0.0 1.3 1.6 0.9 1.6 3.6 0.5 1.3 1.0 3.4 13.2 1.5 0.0 2.9 0.8 0.9 1.6 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.4 1.2 0.4 0.6 0.0 0.0 0.1 3.4 0.1 0.3 0.0 0.1 0.1 5.8 0.0 0.2 0.2 0.1 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 1.4 0.0 0.3 0.0 0.0 0.0 0.2 1.7 0.9 0.0 0.0 0.0 0.4 4.4 0.0 3.8 2.1 0.0 1.5 0.0 0.4 0.6 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 1.0 0.9 0.0 0.0 1.7 1.8 0.0 0.0 0.0 0.0 0.9 0.4 4.9 7.3 15.3 5.3 3.2 1.7 1.2 2.5 3.8 1.5 8.9 13.0 0.0 2.3 0.6 1.7 1.6 12.7 21.4 10.3 3.5 11.8 2.1 3.3 4.3 96.7 5.8 1.7 0.0 4.6 0.3 1.1 2.3 1.1 10.5 0.5 0.0 0.0 3.1 0.0 69.3 1.7 0.6 0.0 0.0 4.4 1.4 4.3 3.2 2.5 2.2 0.7 0.0 0.5 6.0 2.9 1.0 1.7 0.5 2.0 2.2 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Group enriched" "Detected in some" 15 "Early spermatids: 467.1;Late spermatids: 349.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 4.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA010848, HPA076967" Approved Approved Mitochondria NA NA Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 0.8 2.8 0.0 0.0 0.0 0.2 0.5 1.8 0.2 0.0 0.6 0.6 0.5 1.6 0.0 0.6 0.0 0.9 0.6 1.1 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.5 0.0 4.0 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 467.1 0.0 0.0 0.0 0.0 27.7 0.4 0.2 0.0 0.0 1.1 1.6 0.0 0.0 0.3 349.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.2 0.0 0.2 0.0 0.5 3.6 2.9 0.1 3.5 0.0 0.0 0.1 SPATC1 "MGC61633, SPATA15, SPERIOLIN" ENSG00000186583 "Spermatogenesis and centriole associated 1" Q76KD6 8 144012414-144047085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "bone marrow: 10.9;testis: 36.6" "Group enriched" "Detected in some" 24 "Early spermatids: 70.9;Late spermatids: 269.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "U-937: 13.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 30.1" NA NA "unprognostic (2.96e-1)" "unprognostic (1.41e-3)" "unprognostic (3.34e-1)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (4.59e-3)" "unprognostic (6.96e-2)" "unprognostic (4.30e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (4.12e-2)" "unprognostic (4.39e-2)" "unprognostic (1.34e-3)" "unprognostic (2.74e-1)" "unprognostic (5.81e-3)" "unprognostic (2.19e-1)" "unprognostic (2.74e-1)" 0.2 0.1 0.2 2.2 0.3 10.9 0.1 0.2 0.3 0.1 0.1 0.5 0.0 0.1 0.0 0.7 0.5 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.7 0.7 0.1 0.0 0.0 0.1 0.0 0.9 0.3 0.4 0.5 0.0 0.5 0.5 0.0 0.1 0.0 0.6 0.1 0.6 1.8 0.2 36.6 0.0 0.9 0.1 0.3 1.9 0.5 0.1 1.8 1.3 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 13.4 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.5 1.8 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 269.9 2.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342660-44377167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 9.0;testis: 33.5" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-MEL-30: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030897, HPA049722" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030897: AB_2673647, HPA049722: AB_2680861" "unprognostic (2.30e-3)" 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.0 0.0 0.1 4.8 0.1 9.0 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.0 0.4 0.0 1.6 0.0 0.2 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.4 0.7 0.7 0.4 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE1 "Ringo1, SPDYE, WBSCR19" ENSG00000136206 "Speedy/RINGO cell cycle regulator family member E1" Q8NFV5 7 44000889-44010122 "Disease related genes, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 10.2" "Group enriched" "Detected in some" 21 "Early spermatids: 56.7;Late spermatids: 38.3" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.0" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (2.16e-1)" "unprognostic (1.44e-1)" "unprognostic (3.98e-2)" "unprognostic (6.20e-2)" "unprognostic (1.22e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "unprognostic (8.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.69e-2)" "unprognostic (1.95e-6)" "unprognostic (2.68e-1)" "unprognostic (2.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.19e-2)" 0.1 0.2 0.1 1.1 0.2 1.7 0.2 0.5 0.5 0.3 0.2 0.8 0.3 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.3 1.0 0.1 0.5 0.5 0.0 0.3 0.2 0.4 0.0 0.6 0.0 1.5 2.2 0.9 0.0 0.1 0.8 0.5 10.2 0.5 0.0 0.3 0.3 2.9 2.3 3.0 1.6 1.0 1.5 0.6 1.6 1.0 1.4 2.5 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.8 1.8 1.7 0.9 0.0 0.8 2.5 0.0 0.0 0.0 1.4 1.3 0.8 3.0 0.7 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.9 5.0 0.0 1.3 1.3 1.7 2.0 1.1 0.6 2.6 0.8 1.7 0.0 2.2 1.6 1.0 1.6 1.0 0.1 1.6 1.6 0.7 1.5 2.3 2.0 1.0 2.3 2.7 1.8 1.7 0.7 2.1 3.0 3.0 1.6 1.9 1.5 1.6 1.5 1.5 1.3 0.4 0.6 2.9 1.0 1.5 2.8 1.0 1.0 2.3 0.3 0.6 0.0 0.6 0.0 0.0 0.3 1.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 56.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.3 38.3 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 2.2 0.0 0.0 0.5 0.2 0.3 0.1 0.0 0.0 0.0 SPDYE3 ENSG00000214300 "Speedy/RINGO cell cycle regulator family member E3" A6NKU9 7 100307702-100322196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 1.3;testis: 5.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 174.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" HPA051750 Supported NA NA "HPA051750: AB_2681590" "prognostic favorable (8.73e-4)" "unprognostic (6.27e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.06e-2)" "unprognostic (1.54e-1)" "unprognostic (5.04e-2)" "unprognostic (2.96e-2)" "unprognostic (2.90e-1)" "unprognostic (6.91e-2)" "unprognostic (3.99e-2)" "unprognostic (7.32e-2)" "unprognostic (5.25e-2)" "unprognostic (9.08e-2)" "unprognostic (5.06e-2)" "unprognostic (9.17e-2)" "unprognostic (3.58e-1)" 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.1 5.2 0.1 0.0 0.0 0.0 1.3 0.7 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.2 1.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.3 0.0 1.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 2.4 0.0 0.1 0.2 0.8 0.5 0.1 0.1 0.3 0.3 0.1 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.5 0.5 0.3 0.6 0.6 1.1 0.1 0.6 0.3 0.0 0.1 0.0 0.2 0.1 0.2 1.3 0.2 0.1 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.6 1.4 5.3 1.8 0.0 1.4 1.2 0.0 9.8 0.1 0.0 0.0 174.4 0.6 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 36.7 2.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 3.5 0.0 1.9 3.3 0.9 1.5 0.1 1.3 0.0 0.7 SPDYE4 ENSG00000183318 "Speedy/RINGO cell cycle regulator family member E4" A6NLX3 17 8753106-8758559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 17.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.6;HeLa: 4.7;NB-4: 2.9;RT4: 2.2" "HPA025704, HPA051750" Enhanced NA NA "HPA025704: AB_1853093, HPA051750: AB_2681590" "unprognostic (3.20e-1)" "unprognostic (7.16e-4)" "unprognostic (3.15e-3)" "unprognostic (2.79e-1)" 0.1 0.0 0.1 0.2 0.2 1.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.2 17.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.6 0.7 1.2 0.9 0.0 1.1 0.4 0.9 4.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.7 0.0 0.0 1.3 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.0 1.6 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.8 0.2 0.8 1.0 0.0 0.0 0.9 0.0 0.0 0.4 0.3 1.4 1.0 0.7 0.1 0.8 0.0 0.2 0.5 0.7 0.9 1.2 1.0 0.4 0.5 0.5 0.6 0.6 0.0 1.6 0.8 1.1 0.4 0.0 0.9 0.7 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPEF2 "CT122, FLJ23577, KPL2" ENSG00000152582 "Sperm flagellar 2" Q9C093 5 35617844-35814611 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 327.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 5.2;MAIT T-cell: 6.5;memory CD4 T-cell: 3.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 4.1" "Group enriched" "Detected in many" 8 "NK-cells: 4.1;T-cells: 6.5" "Cell line enhanced" "Detected in many" "HDLM-2: 14.2;T-47d: 8.4" "Low region specificity" "Detected in many" "HPA039606, HPA040343" Enhanced NA NA "HPA039606: AB_10671044, HPA040343: AB_2676930" "unprognostic (3.81e-2)" "unprognostic (3.17e-1)" "unprognostic (6.23e-2)" "unprognostic (8.71e-2)" "unprognostic (4.55e-2)" "unprognostic (8.23e-2)" "unprognostic (8.11e-4)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (9.96e-2)" "unprognostic (1.01e-4)" "unprognostic (4.50e-2)" "unprognostic (6.34e-3)" "unprognostic (1.53e-2)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (2.12e-2)" 2.4 5.4 5.9 4.1 14.5 2.1 7.6 3.6 10.3 15.8 2.6 5.3 8.8 1.5 17.3 19.1 1.8 21.7 4.5 2.8 4.7 7.0 10.9 2.1 6.8 2.7 3.0 6.1 9.1 6.4 13.3 22.5 6.5 12.9 8.3 3.1 4.9 4.7 9.4 1.0 1.9 2.3 6.4 3.0 3.6 3.3 9.0 3.1 2.3 11.9 0.6 1.5 3.7 7.9 0.6 0.6 0.4 0.5 4.1 6.5 1.3 0.9 1.4 1.7 4.7 1.2 1.4 0.2 2.2 1.4 5.3 3.5 0.0 2.5 0.0 1.2 3.1 5.9 0.1 1.5 2.1 5.3 14.2 0.5 0.0 6.2 0.5 1.6 3.7 0.0 2.1 3.8 2.9 1.6 6.4 0.1 0.9 1.7 0.9 0.8 2.4 0.0 0.0 0.1 3.4 1.3 3.2 0.0 0.0 3.7 0.4 0.1 1.3 0.0 2.6 0.4 1.0 8.4 7.2 0.0 1.5 2.0 3.0 0.8 0.0 0.0 0.3 4.3 0.1 0.0 0.0 0.5 0.0 5.2 0.5 6.5 0.2 3.1 5.4 0.6 0.6 3.5 4.2 0.4 4.1 0.2 0.2 0.7 1.3 5.9 14.5 3.6 10.3 4.7 7.0 3.0 6.1 12.9 3.1 8.9 5.4 0.0 2.5 1.4 15.0 5.3 5.1 327.9 46.6 5.2 35.3 1.3 5.0 3.1 59.7 3.2 0.4 0.0 1.5 0.7 6.8 2.4 5.7 0.9 1.0 19.1 2.4 6.2 0.6 15.5 9.5 2.4 1.7 34.3 3.4 14.6 1.3 0.0 6.7 9.9 39.9 0.0 1.9 18.2 9.1 0.9 0.7 7.5 2.6 0.2 SPEM1 "C17orf83, FLJ40081" ENSG00000181323 "Spermatid maturation 1" Q8N4L4 17 7420360-7421632 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 61.9" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3850.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 3.3" "Low region specificity" "Detected in single" NA NA "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.5 0.2 0.0 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.3 0.4 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 833.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3850.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.5 0.0 11.5 4.0 0.0 0.0 0.0 0.0 0.0 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425615-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.3;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPIC "MGC40611, SPI-C" ENSG00000166211 "Spi-C transcription factor" Q8N5J4 12 101475421-101486997 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 74.6" "Cell type enriched" "Detected in single" 12 "Kupffer cells: 11.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.1;non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.82e-2)" "unprognostic (2.43e-2)" "unprognostic (9.03e-3)" "unprognostic (2.51e-1)" "unprognostic (4.85e-2)" "unprognostic (5.78e-2)" "unprognostic (5.30e-2)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.1 4.7 0.1 16.7 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.1 74.6 0.1 0.1 0.0 3.1 0.1 0.0 2.4 0.1 0.1 0.0 0.0 0.0 4.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPNS3 MGC29671 ENSG00000182557 "Sphingolipid transporter 3 (putative)" Q6ZMD2 17 4433688-4488208 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 51.8;bone marrow: 23.1;lymphoid tissue: 15.1" "Group enriched" "Detected in many" 5 "Proximal tubular cells: 44.0;T-cells: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 51.8;plasmacytoid DC: 25.1" "Group enriched" "Detected in many" 24 "dendritic cells: 25.1;granulocytes: 51.8" "Cell line enhanced" "Detected in some" "JURKAT: 12.9;MOLT-4: 4.6;NB-4: 15.6;THP-1: 16.9;U-937: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023928 Uncertain NA NA "HPA023928: AB_1844393" "unprognostic (4.39e-2)" "unprognostic (8.10e-5)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.94e-4)" "unprognostic (2.86e-2)" "unprognostic (1.96e-2)" "unprognostic (1.81e-2)" "unprognostic (6.46e-2)" "unprognostic (1.37e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (6.18e-2)" "unprognostic (6.57e-2)" "unprognostic (4.13e-2)" "unprognostic (9.69e-2)" 0.3 0.5 1.1 2.0 0.9 23.1 0.3 0.5 1.6 0.4 1.3 3.7 0.0 0.6 0.5 0.1 0.4 0.7 0.7 0.7 1.2 1.6 0.4 0.3 1.2 1.3 2.4 0.1 0.2 0.3 0.1 0.5 0.1 2.0 0.5 0.2 0.0 1.3 0.5 0.1 0.5 0.8 0.2 4.2 2.9 0.3 1.3 2.2 15.1 0.2 0.0 1.6 0.3 0.3 0.0 25.1 51.8 1.5 0.0 0.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 1.0 0.0 0.0 4.6 15.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 13.0 0.0 0.0 1.5 51.8 0.1 0.3 0.1 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.2 0.0 0.0 25.1 0.0 1.0 1.1 0.9 0.5 1.6 1.2 1.6 2.4 0.1 2.0 2.2 3.0 1.4 3.2 0.1 1.1 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 3.3 1.8 0.6 0.0 1.0 0.0 0.0 4.2 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.6 3.3 1.5 0.0 7.6 1.7 0.0 1.4 0.0 0.7 0.3 0.0 44.0 0.0 0.0 0.4 0.0 0.0 0.4 0.2 27.1 1.2 0.4 SPO11 "CT35, SPATA43, TOPVIA" ENSG00000054796 "SPO11, initiator of meiotic double stranded breaks" Q9Y5K1 20 57329759-57343994 "Enzymes, Plasma proteins, Predicted intracellular proteins" Meiosis "DNA-binding, Hydrolase, Isomerase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 142 "testis: 14.2" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 58.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "Daudi: 1.7;SiHa: 1.3;U-698: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.6 11.7 0.0 0.0 0.0 0.0 0.0 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 7.3;Intestinal endocrine cells: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.8 3.1 0.6 1.8 2.1 7.5 5.0 2.5 2.3 0.4 0.8 0.2 2.7 2.5 2.0 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.3 2.0 0.1 1.3 0.9 5.9 1.7 12.3 7.8 0.6 0.6 1.4 7.6 0.4 0.0 0.1 1.7 0.5 3.8 0.9 1.3 0.1 5.4 0.6 0.2 2.9 0.1 0.2 0.3 1.7 0.6 0.1 14.7 2.8 8.6 2.3 4.1 0.6 0.2 0.5 9.4 0.3 4.7 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 0.0 0.0 0.0 1.1 0.0 7.3 1.0 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.8 0.3 0.1 0.7 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.1 1.6 10.4 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 2.5 2.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 0.6 0.1 0.7 0.0 0.6 0.6 SPRN "bA108K14.1, FLJ41197, Shadoo, Sprn" ENSG00000203772 "Shadow of prion protein" Q5BIV9 10 133420666-133424572 "Predicted intracellular proteins, Transporters" Prion "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 1.2;Horizontal cells: 3.2;Ito cells: 2.5;Kupffer cells: 2.2" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.66e-1)" "unprognostic (1.64e-3)" "unprognostic (3.38e-3)" "unprognostic (1.95e-1)" "unprognostic (1.35e-1)" "unprognostic (3.31e-2)" "unprognostic (1.07e-1)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.58e-7)" 0.5 2.5 4.3 1.5 3.8 0.8 0.1 7.4 20.7 0.4 0.5 3.3 1.1 0.0 1.0 0.2 1.3 0.8 6.1 2.7 1.1 6.9 0.6 1.6 1.7 1.0 1.7 0.0 1.7 0.8 1.2 0.0 2.0 0.1 2.3 2.0 2.2 0.4 0.9 1.7 2.2 1.9 0.9 0.0 0.9 0.1 1.1 1.0 0.4 4.5 0.2 1.2 0.6 2.7 5.2 3.9 7.8 0.0 0.0 6.3 4.2 0.0 1.0 0.1 6.3 1.9 3.9 1.5 2.1 0.9 3.4 0.6 0.0 0.0 2.5 7.3 3.7 6.0 7.1 0.3 3.9 3.2 0.5 0.0 0.0 0.0 2.5 0.0 2.9 4.0 2.7 0.5 2.7 2.2 7.4 3.8 1.4 2.1 5.4 2.5 0.7 0.0 3.2 2.3 3.5 1.4 3.8 4.7 1.5 2.4 2.8 2.8 2.3 3.0 1.7 3.2 3.2 1.6 3.0 1.7 2.6 1.2 0.4 0.3 0.0 0.4 0.9 0.8 0.3 0.9 1.2 0.2 1.1 1.0 0.4 0.0 0.2 4.5 1.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 2.5 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SPRR2B ENSG00000196805 "Small proline rich protein 2B" P35325 1 153070224-153070840 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2" "Cell type enriched" "Detected in single" 58 "Leydig cells: 5.8" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 77.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.7;SiHa: 1.3;U-2197: 1.2" NA NA "unprognostic (1.52e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 11.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPRR2D ENSG00000163216 "Small proline rich protein 2D" P22532 1 153039725-153041931 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "esophagus: 246.4;tongue: 317.8" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 13.7" "Group enriched" "Detected in many" 5 "cervical cancer: 80.9;head and neck cancer: 353.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTCEpi: 26.2;hTERT-HME1: 23.0;SK-MEL-30: 11.3" NA NA "unprognostic (7.50e-2)" "unprognostic (1.84e-1)" "unprognostic (5.17e-2)" "unprognostic (5.14e-2)" "unprognostic (1.49e-3)" "unprognostic (3.58e-1)" "unprognostic (1.37e-3)" "unprognostic (6.85e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.62e-4)" 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.4 0.1 246.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 29.9 0.1 0.1 14.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 317.8 63.5 0.1 40.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 26.2 0.0 23.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.1 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.7 0.1 0.1 4.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.2 0.0 0.0 0.7 SPRR2E ENSG00000203785 "Small proline rich protein 2E" P22531 1 153093135-153106184 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 210.2;skin 1: 94.0;tongue: 291.9" "Cell type enriched" "Detected in some" 22 "Suprabasal keratinocytes: 38.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 612.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "hTCEpi: 19.7" NA NA "unprognostic (2.27e-1)" "unprognostic (3.86e-2)" "unprognostic (5.04e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (9.47e-4)" 0.3 0.0 0.3 0.3 0.3 0.0 5.7 0.3 0.3 25.9 0.3 0.3 0.3 0.0 0.6 0.3 210.2 0.0 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 26.8 0.3 0.3 94.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.4 0.3 291.9 54.7 0.3 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 19.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970666-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 51.9;tongue: 18.9" "Group enriched" "Detected in some" 27 "Early spermatids: 9.1;Late spermatids: 36.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.6;hTCEpi: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.1 0.0 0.1 0.7 0.1 0.0 4.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.4 0.1 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 51.9 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.8 0.1 18.9 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SRL ENSG00000185739 Sarcalumenin Q86TD4 16 4189374-4242080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 216.0" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.5;thyroid cancer: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 13 "HSkMC: 9.8" "Low region specificity" "Detected in some" "HPA041535, HPA045520" Enhanced "Intracellular and membrane" NA NA 26000 "HPA041535: AB_2677538, HPA045520: AB_2679358" "unprognostic (1.24e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (8.11e-2)" "unprognostic (2.04e-7)" "unprognostic (1.41e-1)" "unprognostic (8.28e-2)" "unprognostic (7.40e-4)" "unprognostic (4.91e-2)" "unprognostic (8.70e-2)" "unprognostic (7.78e-4)" "unprognostic (3.33e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-3)" "unprognostic (1.68e-4)" 3.1 0.1 0.2 0.2 0.2 0.0 0.4 0.1 1.0 0.8 0.3 0.0 1.2 0.1 0.9 4.2 2.9 0.8 0.4 70.9 0.2 0.2 0.5 0.1 0.3 0.1 0.3 0.2 0.4 0.1 0.1 0.1 0.3 0.4 1.3 0.2 0.1 2.1 0.6 104.1 0.2 0.4 0.8 0.2 0.4 0.3 0.5 0.1 0.2 0.9 48.3 3.4 0.9 0.7 0.6 0.3 2.4 0.5 0.8 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.2 0.2 9.8 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.0 2.4 0.2 0.8 0.5 0.5 0.2 0.3 0.3 0.3 0.1 0.6 0.4 0.4 1.3 0.8 0.3 0.3 0.3 0.9 0.2 0.2 0.1 1.0 0.2 0.2 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.6 216.0 0.0 0.0 0.0 1.8 7.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 3.5 0.0 11.6 6.5 32.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 SRP19 ENSG00000153037 "Signal recognition particle 19" "P09132, Q15695" 5 112861188-112898371 "Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029272 Approved NA NA "HPA029272: AB_10600910" "unprognostic (4.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.37e-1)" "unprognostic (5.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.98e-3)" "unprognostic (5.55e-2)" "unprognostic (2.62e-2)" "unprognostic (3.62e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (3.72e-10)" "unprognostic (1.82e-1)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (2.69e-3)" 20.3 24.6 21.2 21.3 24.2 52.3 23.0 20.2 27.4 16.9 17.9 18.4 20.1 18.7 20.1 30.7 23.1 17.5 18.3 20.2 20.0 25.2 27.1 53.2 18.8 27.2 19.3 21.6 16.6 36.2 18.2 45.2 24.5 24.9 26.3 21.7 12.7 34.5 19.9 25.6 18.3 20.4 23.5 19.3 23.4 19.4 14.7 19.8 23.5 31.2 20.1 29.3 18.5 16.9 27.3 43.0 26.2 19.3 23.8 35.0 17.5 22.3 15.1 19.2 30.8 18.0 21.0 46.9 31.8 19.6 27.1 32.7 25.8 17.8 23.4 21.9 20.2 43.7 15.0 20.6 32.4 32.8 25.1 33.6 21.0 28.7 30.3 28.5 16.6 23.2 24.4 31.9 25.7 37.8 18.0 25.0 25.8 15.4 28.4 23.1 26.4 26.7 29.7 19.9 22.7 24.0 17.3 17.1 35.1 26.6 28.5 22.0 19.4 25.4 16.7 14.7 23.2 25.2 24.2 20.1 22.8 19.2 22.5 37.2 33.6 40.6 40.8 22.1 28.4 23.4 26.2 17.7 20.9 26.5 18.0 32.4 27.3 29.8 27.9 19.8 23.2 25.6 28.3 24.2 23.8 19.3 43.0 35.0 17.5 21.2 24.2 20.2 27.4 20.0 25.2 19.3 21.6 24.9 19.8 74.5 47.1 73.7 61.1 76.7 15.1 38.0 38.2 71.0 80.8 41.8 19.6 67.2 87.9 85.6 16.7 40.6 28.5 46.7 89.8 103.9 58.3 74.4 71.6 58.2 75.1 12.7 114.2 34.4 53.7 16.7 35.9 72.3 49.0 83.8 43.5 23.4 113.3 35.1 37.1 90.1 21.5 25.8 39.2 85.2 43.5 76.8 123.9 69.2 34.6 107.5 SRRD "HC/HCC, SRR1L" ENSG00000100104 "SRR1 domain containing" Q9UH36 22 26483877-26494658 "Predicted intracellular proteins" "Biological rhythms, Heme biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002945 Uncertain Approved Cytosol NA NA Cytosol "HPA002945: AB_1079265" "unprognostic (3.25e-1)" "unprognostic (3.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (9.00e-2)" "unprognostic (8.51e-3)" "unprognostic (2.49e-2)" "unprognostic (4.50e-3)" "unprognostic (3.93e-2)" "unprognostic (2.63e-1)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (1.76e-3)" "unprognostic (2.96e-1)" 8.7 7.2 12.5 7.1 14.3 9.6 11.3 20.0 17.2 10.6 10.9 10.4 10.5 6.6 12.7 11.5 9.9 10.3 6.9 16.2 10.5 10.1 11.5 15.7 9.5 11.4 10.5 11.8 13.3 14.9 11.8 10.6 9.4 9.4 12.7 9.6 9.6 13.1 13.7 30.0 10.8 7.8 12.5 9.6 9.7 9.0 13.8 7.5 10.4 18.8 11.4 12.4 10.0 9.1 3.2 1.6 1.4 1.4 2.6 3.8 1.0 7.4 4.5 7.7 7.9 8.0 4.8 4.4 5.3 7.4 10.7 9.9 4.4 3.3 16.5 3.7 6.9 5.4 6.8 11.9 11.0 10.5 8.5 11.8 7.3 3.8 7.0 5.7 16.0 5.7 4.6 9.7 7.6 12.0 7.1 9.2 9.9 11.9 10.5 7.0 6.4 7.1 5.0 4.7 8.2 5.7 16.3 9.6 11.9 7.0 5.4 8.2 5.6 6.1 5.5 13.6 6.7 6.6 6.3 7.1 8.3 27.7 4.7 9.2 6.9 5.6 13.9 5.7 6.6 10.8 0.6 1.4 0.8 2.3 1.4 3.4 3.2 2.8 3.3 1.6 2.4 3.8 3.8 1.4 2.6 1.2 1.2 0.7 1.0 12.5 14.3 20.0 17.2 10.5 10.1 10.5 11.8 9.4 7.5 0.0 5.4 8.2 13.0 26.4 12.7 2.4 15.3 1.4 4.5 1.8 2.0 12.1 8.3 23.7 17.5 7.9 2.9 0.0 42.8 18.5 7.5 9.4 11.5 12.7 12.1 12.7 4.6 9.8 2.4 35.9 6.6 7.3 8.5 5.4 4.3 7.1 37.1 0.0 8.5 15.5 7.8 6.5 6.6 14.4 11.0 27.9 14.0 6.7 5.6 14.8 SRSF12 "SFRS13B, SFRS19, SRrp35" ENSG00000154548 "Serine and arginine rich splicing factor 12" Q8WXF0 6 89095959-89118081 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 130.7;Late spermatids: 165.7;Spermatogonia: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.7;AN3-CA: 9.9;HAP1: 7.8;HEK 293: 7.9;REH: 7.7;SCLC-21H: 8.6;SH-SY5Y: 8.4;SuSa: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049782 Approved NA NA "HPA049782: AB_2680880" "unprognostic (6.18e-2)" "unprognostic (1.23e-1)" "unprognostic (7.66e-3)" "unprognostic (1.58e-4)" "unprognostic (4.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.11e-3)" "unprognostic (4.17e-2)" "unprognostic (9.53e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-4)" "unprognostic (2.83e-1)" "unprognostic (9.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.78e-2)" "unprognostic (2.04e-1)" "unprognostic (9.96e-3)" 1.5 1.5 6.2 1.7 8.8 1.2 1.5 5.5 9.0 2.0 0.9 1.0 1.1 0.7 2.2 1.8 1.0 1.7 2.3 0.9 7.5 6.3 1.5 0.8 0.8 1.0 3.1 4.5 3.2 1.8 3.2 4.5 1.1 5.7 2.6 0.8 1.6 1.0 2.0 0.7 1.2 0.7 2.3 2.2 0.8 1.4 21.4 2.5 0.0 3.0 0.0 0.9 1.2 0.8 1.4 0.8 1.6 0.6 2.9 1.1 0.2 0.0 0.9 9.7 9.9 0.0 0.0 0.1 0.1 0.1 0.5 1.0 0.3 0.1 0.0 0.9 0.0 0.3 0.0 7.8 0.2 1.0 0.1 7.9 0.0 0.1 0.6 1.1 0.0 0.0 0.1 0.4 0.2 0.5 0.0 0.0 0.7 0.1 0.2 0.2 0.1 0.0 0.3 2.2 0.0 0.2 7.7 0.5 0.1 4.9 0.0 8.6 8.4 0.2 0.1 1.4 6.1 0.1 2.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 1.1 0.6 0.4 1.1 0.4 0.8 0.6 0.8 0.6 0.2 1.4 1.1 0.7 1.6 2.9 0.3 0.8 0.5 0.2 6.2 8.8 5.5 8.9 7.5 6.3 3.1 4.5 5.7 2.5 0.0 0.6 0.0 3.1 0.9 9.0 2.0 0.0 0.0 0.0 0.0 7.9 0.7 1.7 4.5 130.7 0.7 0.0 0.0 2.7 0.4 2.1 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 165.7 3.1 0.2 3.3 10.8 0.0 4.5 4.1 0.0 2.5 2.7 1.1 6.5 1.9 33.2 47.5 0.5 0.2 0.0 0.0 1.6 SSC4D "S4D-SRCRB, SRCRB-S4D, SRCRB4D" ENSG00000146700 "Scavenger receptor cysteine rich family member with 4 domains" Q8WTU2 7 76389334-76409695 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 10.4;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 5 "monocytes: 1.6" "Group enriched" "Detected in some" 12 "EFO-21: 5.9;Hep G2: 8.1;SuSa: 9.9;U-2 OS: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA062611 Uncertain "Secreted - unknown location" NA NA "HPA062611: AB_2684807" "unprognostic (3.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.83e-6)" "prognostic unfavorable (7.08e-4)" "unprognostic (3.52e-2)" "unprognostic (3.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.49e-2)" "unprognostic (8.49e-3)" "unprognostic (3.18e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.59e-1)" "unprognostic (3.90e-1)" "unprognostic (2.56e-2)" "unprognostic (1.73e-2)" 1.1 0.5 0.1 0.1 0.1 0.0 0.4 0.0 0.2 1.0 0.2 0.3 3.0 0.2 0.3 0.8 0.0 0.4 0.1 0.0 0.2 0.2 7.7 0.7 0.2 0.1 0.2 0.8 2.3 4.4 7.8 7.2 0.7 0.4 0.1 0.0 0.8 9.3 9.5 0.4 0.0 0.0 0.2 0.7 0.3 0.1 0.3 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.3 0.1 0.0 1.6 0.0 0.2 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.8 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.1 0.9 0.4 0.0 0.0 9.9 0.1 0.0 0.0 0.0 23.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.1 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.2 0.2 0.8 0.4 0.0 0.0 0.3 0.0 0.4 0.0 0.2 1.5 0.0 0.0 0.0 10.4 0.0 0.2 3.3 1.7 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.3 0.0 2.1 2.7 1.6 0.0 1.3 1.2 0.0 0.9 0.8 0.0 0.0 0.0 2.0 0.4 0.0 0.4 1.0 0.1 0.0 0.0 0.5 3.0 0.0 0.2 0.0 0.0 0.3 SSMEM1 "C7orf45, FLJ40316" ENSG00000165120 "Serine rich single-pass membrane protein 1" Q8WWF3 7 130207860-130216843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 31.7" "Cell type enriched" "Detected in some" 13 "Early spermatids: 346.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.7;U-87 MG: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.08e-1)" "unprognostic (1.79e-1)" "unprognostic (5.24e-1)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.3 0.2 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.8 0.9 0.1 0.2 0.2 0.3 0.2 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.3 2.7 0.0 0.0 0.0 0.0 0.0 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 172.0;Peritubular cells: 251.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.0;hTERT-RPE1: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA066432: AB_2685669" "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.3 0.7 2.0 0.0 13.0 7.4 0.1 3.8 5.3 0.5 1.5 0.0 4.7 0.0 0.8 5.2 3.0 1.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.6 0.4 1.7 0.4 46.8 0.2 0.0 0.0 0.0 4.0 0.8 0.2 1.1 4.4 0.2 1.2 0.1 5.3 1.4 1.2 4.0 0.2 3.8 1.4 0.3 3.7 2.1 0.4 0.1 1.4 1.8 1.0 1.8 0.9 0.1 0.5 0.0 2.8 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 3.0 2.7 20.9 16.5 12.0 1.7 79.0 7.6 6.7 19.4 17.4 0.0 63.3 5.0 8.5 3.3 8.3 8.4 0.0 6.5 5.6 56.4 10.8 0.0 0.0 12.1 6.4 4.7 8.6 0.0 3.1 172.0 7.9 18.6 32.5 9.1 35.9 2.4 7.0 251.4 2.2 2.6 38.8 42.9 0.3 0.9 6.1 23.2 1.0 5.8 17.1 SSTR4 ENSG00000132671 "Somatostatin receptor 4" P31391 20 23035386-23036812 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Low region specificity" "Detected in many" HPA064252 Uncertain NA NA "HPA064252: AB_2685227" 0.0 0.0 1.7 0.0 1.1 0.0 0.0 3.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644090-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 8.1;RT4: 4.3" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.29e-1)" 0.1 0.2 0.2 0.4 0.1 0.7 0.1 0.1 1.0 0.1 0.2 0.6 0.2 0.0 1.5 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.5 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.1 1.5 0.1 0.0 0.1 0.6 0.4 1.0 0.4 0.0 0.2 0.1 0.0 0.2 1.0 0.7 0.3 0.4 0.0 0.4 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.1 0.6 0.3 1.7 0.7 0.3 0.0 0.0 8.1 0.0 0.2 0.2 0.0 0.3 0.1 0.4 0.2 1.4 0.1 1.0 0.7 0.2 0.0 0.2 0.0 0.4 0.5 0.0 0.0 4.3 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 0.3 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.5 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ST20 HCCS-1 ENSG00000180953 "Suppressor of tumorigenicity 20" Q9HBF5 15 79898840-79923702 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Cell type enhanced" "Detected in many" 10 "monocytes: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 18.6;neutrophil: 69.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 69.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.7" NA NA "unprognostic (2.48e-1)" "unprognostic (1.28e-1)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (2.04e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (1.35e-3)" "unprognostic (4.21e-2)" "unprognostic (3.03e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (7.69e-8)" "unprognostic (6.49e-2)" "unprognostic (2.61e-2)" "unprognostic (9.88e-2)" "unprognostic (4.19e-2)" 7.5 5.4 9.9 15.0 10.7 7.9 8.6 15.4 8.0 5.5 8.2 6.4 4.5 4.0 6.5 16.3 6.0 8.3 10.3 9.3 8.8 8.2 12.3 23.1 12.7 13.1 10.8 5.3 7.1 6.2 9.2 12.7 7.7 10.1 13.3 5.4 8.6 11.5 8.4 5.6 12.6 9.8 5.4 10.7 22.9 5.5 10.8 6.1 9.0 12.2 5.7 10.5 5.5 10.1 4.0 3.0 69.3 5.3 3.9 2.1 2.6 4.8 10.4 4.4 5.5 7.6 6.4 10.0 5.0 3.3 2.6 3.3 2.2 7.9 6.1 3.3 3.6 8.6 8.3 9.2 2.8 1.9 8.6 8.6 6.9 7.1 3.4 7.2 2.5 3.9 7.2 3.9 1.8 5.4 7.3 2.8 11.1 5.9 3.6 4.0 15.8 3.5 17.9 10.4 14.9 6.9 5.1 1.4 3.8 6.6 4.0 6.6 7.2 9.8 6.1 28.7 12.0 5.1 16.5 3.6 6.7 1.8 0.0 4.1 4.1 20.0 9.2 5.2 14.3 3.4 0.5 3.9 18.6 1.9 2.2 1.5 4.0 2.1 2.1 3.0 3.8 2.1 1.9 69.3 3.9 5.3 1.8 1.8 2.6 9.9 10.7 15.4 8.0 8.8 8.2 10.8 5.3 10.1 6.1 6.0 17.0 5.4 6.4 4.2 7.1 10.4 2.5 6.7 5.7 14.0 7.9 10.0 19.9 15.2 10.0 3.8 9.6 0.0 10.4 9.3 6.1 9.1 6.9 35.0 35.3 1.6 18.6 6.2 11.2 3.6 6.6 12.0 5.0 137.1 10.6 7.7 12.5 17.3 4.6 32.7 4.4 6.5 3.8 19.4 20.6 3.8 36.0 6.4 10.0 3.9 ST3GAL1 "SIAT4A, SIATFL, ST3GalA.1, ST3O" ENSG00000008513 "ST3 beta-galactoside alpha-2,3-sialyltransferase 1" Q11201 8 133454848-133571940 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 143.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 47.7;RT4: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040466 Approved "Intracellular and membrane" NA NA 290000 "HPA040466: AB_10805712" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.66e-2)" "unprognostic (1.83e-3)" "unprognostic (5.53e-3)" "unprognostic (4.43e-2)" "unprognostic (4.79e-2)" "unprognostic (2.66e-1)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (1.10e-1)" "unprognostic (1.83e-3)" "unprognostic (1.67e-2)" "unprognostic (3.29e-2)" "unprognostic (8.64e-3)" "unprognostic (2.95e-2)" 14.4 14.4 5.1 11.8 3.6 10.2 7.8 3.7 6.5 9.8 5.4 4.1 18.1 1.8 8.5 11.8 9.0 9.0 17.0 35.4 4.2 3.4 23.1 44.5 11.9 12.4 4.7 2.5 10.3 8.2 4.4 7.6 49.8 6.4 7.1 2.9 11.2 18.2 15.1 20.9 4.0 6.5 12.3 3.9 17.3 9.4 5.0 1.4 6.3 40.2 7.9 16.8 14.0 14.3 22.7 7.0 21.3 9.8 21.9 19.9 9.5 4.7 2.5 1.0 2.9 10.3 5.4 5.3 5.4 13.1 2.1 1.6 4.4 5.3 1.1 3.7 9.9 1.0 1.4 3.4 4.0 1.9 13.3 0.6 9.9 7.6 8.8 7.9 2.0 7.9 6.3 2.0 7.5 4.2 9.7 9.2 2.6 0.1 15.3 1.5 5.0 2.8 2.7 0.7 25.6 47.7 3.3 1.3 8.1 0.9 36.7 0.2 0.8 2.4 8.2 2.5 5.8 1.5 2.7 8.9 6.5 10.3 5.6 2.3 18.9 13.6 1.2 14.7 6.9 6.6 20.5 4.7 21.3 14.4 4.5 13.3 12.8 14.6 16.4 2.9 22.7 19.9 18.5 8.6 21.9 9.8 7.0 8.9 9.5 5.1 3.6 3.7 6.5 4.2 3.4 4.7 2.5 6.4 1.4 6.0 58.6 36.0 6.4 5.0 7.4 59.9 12.7 8.1 21.6 1.8 2.0 8.2 5.0 34.3 2.8 41.9 0.0 23.3 21.6 34.2 37.0 10.6 8.1 143.6 32.3 57.2 0.0 33.7 44.5 0.9 33.9 42.2 13.5 78.5 0.4 10.1 25.8 0.0 67.5 39.3 21.7 12.9 32.2 0.2 1.9 3.0 22.1 43.7 0.0 37.3 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375978-70439237 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favorable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavorable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 12.6 9.1 9.3 17.2 11.9 14.3 8.9 24.1 10.6 11.3 8.8 5.1 9.3 9.2 13.9 5.6 5.8 9.0 6.8 9.2 10.4 6.0 8.8 12.9 9.3 14.9 5.1 4.7 13.6 4.2 8.8 7.2 8.8 6.8 7.5 4.7 9.9 4.9 9.0 33.3 6.0 10.5 12.0 4.0 17.7 5.4 9.6 5.9 16.0 6.6 4.9 12.6 9.1 12.0 3.2 14.3 11.2 2.2 2.8 4.2 1.1 1.4 8.5 7.4 9.8 4.0 5.4 1.7 6.0 6.4 6.7 3.3 5.1 3.3 4.1 10.8 6.5 6.0 1.0 2.9 2.5 3.2 9.7 4.7 17.5 3.5 7.6 4.9 6.4 28.9 4.1 1.4 6.8 1.2 8.2 9.2 7.1 23.9 4.0 3.7 0.7 6.7 17.5 10.0 2.8 4.6 12.9 2.8 5.5 4.5 1.1 3.3 9.7 15.1 0.3 6.6 8.0 1.6 7.1 9.8 8.5 10.2 3.6 4.4 8.4 3.3 8.4 9.3 5.4 11.9 2.7 2.0 5.7 2.0 2.2 1.9 1.7 2.4 2.2 1.0 3.2 4.2 3.3 11.2 2.8 1.3 14.3 2.7 1.1 9.3 11.9 24.1 10.6 10.4 6.0 5.1 4.7 6.8 5.9 8.9 6.9 13.0 3.6 3.0 15.1 5.6 10.2 1.4 2.3 8.7 13.7 3.7 0.0 5.4 14.0 13.1 5.1 46.7 3.8 1.6 10.6 2.2 17.3 11.5 11.6 17.5 12.7 14.7 10.0 25.8 10.9 14.4 1.7 23.4 4.0 5.1 2.4 0.0 7.8 5.0 10.2 6.5 7.1 5.4 8.1 2.0 1.5 8.6 5.2 1.8 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 74.2" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 804.9" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6" "Group enriched" "Detected in many" 11 "dendritic cells: 29.6;granulocytes: 31.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.3;WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049827 Approved "Intracellular and membrane" NA NA "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 7.8 38.0 6.2 6.5 12.2 7.8 12.9 4.0 13.6 8.3 27.0 26.4 5.1 2.0 6.0 42.1 25.5 6.0 11.4 26.5 8.6 6.2 16.7 11.5 12.4 9.0 18.7 9.0 39.3 5.1 0.8 5.6 74.2 13.8 12.1 31.5 35.7 14.4 8.0 1.9 5.6 3.8 11.0 23.0 17.0 4.8 18.8 12.4 2.2 6.1 4.3 10.1 21.1 13.2 0.1 29.6 31.3 2.6 1.2 1.7 1.8 4.9 4.1 3.2 2.7 9.5 7.9 8.0 5.7 11.1 5.2 3.6 2.4 8.5 1.4 4.3 9.0 17.7 7.7 6.7 3.7 4.1 5.3 1.9 12.6 10.2 2.7 6.2 15.0 25.8 6.3 6.0 7.8 12.4 9.6 6.9 5.5 7.8 3.8 6.4 20.2 4.7 15.4 2.0 31.9 26.8 4.9 9.9 0.6 1.2 14.2 6.1 3.9 6.3 38.2 45.3 2.2 13.3 10.0 2.5 12.5 2.8 8.8 10.7 0.3 0.8 0.7 5.7 23.0 102.8 31.3 1.6 0.2 1.7 2.6 1.6 0.1 0.6 1.1 6.6 0.0 0.1 0.8 22.8 1.2 1.2 29.6 0.0 1.8 6.2 12.2 4.0 13.6 8.6 6.2 18.7 9.0 13.8 12.4 8.9 1.1 3.7 5.3 9.4 4.2 26.6 7.6 1.4 4.5 29.6 9.8 90.3 41.4 4.3 1.1 9.8 34.8 0.0 5.6 59.0 44.0 13.8 41.5 8.9 16.2 4.8 5.1 36.8 4.1 3.8 70.5 7.2 74.2 10.8 43.5 5.0 7.3 93.0 88.1 3.4 8.3 12.9 23.6 1.4 3.8 5.8 804.9 12.2 8.8 13.1 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enriched" "Detected in many" 6 "Mucus-secreting cells: 708.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Group enriched" "Detected in some" 4 "K-562: 23.7;OE19: 44.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.4 0.0 0.0 4.9 0.0 1.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.7 0.0 0.0 0.0 0.1 0.0 0.0 44.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 14.9 6.9 0.0 5.2 0.1 0.0 1.5 30.6 112.4 76.2 0.0 0.0 0.1 0.0 1.6 0.2 14.2 50.8 0.0 16.6 0.1 0.6 3.2 0.0 0.0 0.2 0.0 31.7 4.3 0.0 0.5 1.4 0.3 0.0 0.0 708.1 0.0 27.0 66.2 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 108.2 20.7 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054566: AB_2682526, HPA055399: AB_2682806" "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.6 0.0 0.3 0.0 0.0 0.0 2.2 0.3 0.2 6.0 0.0 0.3 1.2 0.1 1.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.5 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.9 0.8 0.0 0.0 0.0 1.4 4.6 0.0 0.0 32.2 4.5 0.0 0.1 10.4 0.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 4.2 2.8 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 3.0 1.0 1.3 0.1 0.2 3.0 1.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 0.8 0.0 0.0 57.1 11.7 0.4 0.0 1.5 5.0 0.0 0.3 11.0 0.2 3.2 0.0 0.0 0.5 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.1 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Cell line enhanced" "Detected in many" "HDLM-2: 35.5;RPMI-8226: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.2 5.5 1.4 7.0 9.9 7.6 1.0 5.6 6.2 5.7 3.3 3.1 5.9 20.5 8.5 7.0 8.1 7.9 2.9 5.9 0.9 35.5 2.4 6.5 17.6 11.6 12.1 0.5 6.8 9.2 6.3 5.1 4.6 4.6 15.2 3.9 4.6 13.7 2.7 1.5 1.2 0.7 1.6 10.5 13.6 6.2 3.7 50.3 5.8 0.1 12.0 2.7 8.1 17.6 1.0 0.5 3.6 4.2 10.8 4.7 5.4 14.6 8.7 22.4 11.5 6.4 9.4 2.9 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 8.9 24.5 43.4 11.9 1.9 2.4 10.3 10.2 5.3 4.5 1.8 0.0 0.9 1.7 14.0 0.1 10.8 19.6 23.3 12.5 14.4 11.9 2.0 8.1 1.5 22.1 0.0 65.1 4.9 11.4 0.0 16.1 8.5 6.8 12.6 13.1 14.1 11.9 6.5 40.3 17.3 1.7 12.9 8.9 0.2 1.3 2.8 3.8 10.2 16.4 10.0 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enriched" "Detected in some" 7 "Alveolar cells type 1: 50.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA065593: AB_2685515, HPA070354: AB_2686260" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.4 0.0 9.1 0.0 0.0 0.0 0.0 0.8 3.2 2.6 0.8 0.0 0.2 0.0 0.0 10.9 0.0 5.2 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 9.0 0.0 5.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 50.6 0.3 0.0 0.0 0.0 7.3 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523518-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Group enriched" "Detected in many" 5 "Early spermatids: 151.6;Late spermatids: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome NA NA Centrosome "HPA042324: AB_10794273, HPA075418: AB_2686749" "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favorable (8.34e-5)" "prognostic unfavorable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.16e-4)" "prognostic favorable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 7.7 9.3 5.7 5.5 9.0 8.6 8.2 12.1 7.9 8.1 6.9 10.0 7.2 5.5 10.0 7.8 6.1 7.9 6.0 8.6 5.6 5.9 6.3 7.6 5.7 5.3 6.1 5.1 9.4 11.6 5.2 12.8 6.4 6.3 7.3 8.0 9.4 7.0 9.0 10.2 8.9 6.2 7.9 6.4 5.2 5.8 49.0 7.0 4.6 11.8 4.6 5.6 6.8 7.7 4.2 3.5 0.3 2.1 6.9 5.2 1.9 4.8 1.5 8.7 6.1 11.9 11.8 2.1 6.3 4.8 2.7 4.0 2.8 4.8 2.1 2.6 2.5 8.1 3.4 10.2 8.1 4.1 3.1 6.0 5.9 7.6 1.8 6.8 5.0 6.4 2.2 2.0 3.1 6.4 6.4 8.7 7.4 3.4 6.9 11.0 1.9 2.6 2.0 3.9 2.3 5.3 4.2 4.6 0.8 5.5 6.0 6.4 3.9 3.4 4.7 4.4 1.6 3.6 3.0 8.3 6.2 6.1 8.0 6.0 1.8 1.3 2.1 5.6 8.0 13.5 0.1 1.8 0.2 2.4 2.1 3.9 4.2 3.6 1.8 1.7 1.8 5.2 2.8 0.3 6.9 1.6 3.5 2.4 1.9 5.7 9.0 12.1 7.9 5.6 5.9 6.1 5.1 6.3 7.0 20.8 8.1 4.5 14.2 15.0 16.4 6.1 20.4 12.0 13.6 8.7 5.9 11.0 8.3 7.6 151.6 11.9 5.1 0.0 7.4 5.7 9.2 11.9 8.1 6.8 7.5 23.8 5.2 4.9 7.8 193.4 16.7 7.5 20.3 4.6 9.5 19.1 6.4 3.5 15.2 5.7 22.0 19.4 7.6 33.6 11.3 15.9 5.1 8.7 9.7 9.3 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.5;Muller glia cells: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 3.5 0.0 0.0 0.0 10.1 7.3 0.0 0.0 0.5 4.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.7 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ST8SIA6 SIAT8F ENSG00000148488 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6" P61647 10 17318383-17454330 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.5" "Group enriched" "Detected in some" 7 "Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5" "Cancer enhanced" "Detected in some" "breast cancer: 5.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "HMC-1: 108.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011635, HPA072708" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011635: AB_2194921, HPA072708: " "unprognostic (4.86e-3)" "unprognostic (7.01e-2)" "unprognostic (5.85e-3)" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.11e-2)" "unprognostic (6.81e-2)" "unprognostic (2.32e-1)" "unprognostic (3.23e-2)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.43e-1)" "unprognostic (2.22e-1)" "unprognostic (1.07e-3)" 1.8 0.9 3.1 1.0 5.0 4.0 14.4 2.5 3.4 1.1 1.7 3.3 0.4 1.0 1.6 10.4 2.4 1.3 1.9 9.1 3.7 4.4 2.5 2.4 17.5 0.8 8.8 1.7 1.1 0.5 0.3 1.3 3.5 5.5 4.3 1.8 13.7 1.9 0.6 2.0 2.8 1.3 1.3 4.3 1.5 1.0 1.2 2.5 0.0 1.8 0.5 2.0 1.1 3.9 0.9 0.7 3.8 1.4 2.1 5.6 0.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 13.3 0.0 0.1 0.0 0.0 108.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.1 0.9 1.3 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.4 1.3 2.5 0.4 0.5 0.3 1.2 1.4 0.7 0.9 1.0 1.7 2.9 2.1 0.7 0.6 5.6 0.9 3.1 5.0 2.5 3.4 3.7 4.4 8.8 1.7 5.5 2.5 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 0.2 1.6 10.3 0.0 0.1 0.0 0.0 15.4 0.8 0.4 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.0 0.0 0.0 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 5.2 12.4 9.7 11.2 27.3 12.6 3.2 20.7 17.5 8.5 11.0 6.8 5.5 30.0 6.4 12.9 8.4 4.6 7.6 11.0 12.5 12.5 8.2 25.3 22.0 8.8 10.5 7.3 6.6 4.7 17.2 10.8 27.8 25.5 16.5 13.1 7.1 5.9 8.0 1.6 2.6 29.9 5.4 17.0 8.8 13.2 5.1 16.3 5.1 7.7 5.7 7.4 5.2 8.8 2.8 2.8 11.0 3.1 2.9 4.2 2.1 6.8 3.4 16.7 10.0 15.0 30.1 5.7 7.0 16.0 10.6 31.6 12.6 20.5 8.2 2.9 4.5 31.0 3.0 8.4 24.4 10.1 7.8 3.6 6.3 10.9 7.6 16.7 3.1 4.0 16.0 16.8 22.4 16.7 12.4 19.4 8.0 3.5 15.9 7.1 1.3 7.7 5.7 5.7 0.2 1.8 1.8 18.6 7.5 15.4 2.2 9.5 37.1 0.0 4.2 6.3 11.6 5.5 10.1 28.7 8.9 8.1 5.9 2.9 5.5 5.0 7.3 8.5 11.8 4.5 11.0 2.1 1.5 4.2 3.1 2.2 2.8 2.0 3.0 2.8 2.7 2.1 3.1 0.0 2.9 2.2 1.9 1.2 2.1 9.7 27.3 20.7 17.5 12.5 12.5 10.5 7.3 25.5 16.3 23.8 33.3 11.0 1.2 0.9 9.5 17.7 12.7 1.4 4.5 8.7 7.9 13.3 1.7 6.8 6.1 14.6 33.7 0.0 8.1 5.1 5.1 3.1 31.2 16.4 16.3 6.4 20.5 4.9 18.3 7.0 6.6 18.3 3.3 6.4 21.7 6.0 7.4 17.5 7.4 5.3 7.3 19.4 8.7 7.7 9.7 2.3 11.8 8.6 15.5 2.8 STEAP1 "PRSS24, STEAP" ENSG00000164647 "STEAP family member 1" Q9UHE8 7 90154375-90164829 "Cancer-related genes, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 44.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.1;Exocrine glandular cells: 33.5;Glandular cells: 64.3;Urothelial cells: 39.0" "Cancer enriched" "Detected in all" 6 "prostate cancer: 94.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 29.6;CAPAN-2: 35.5;U-138 MG: 45.1" HPA030985 Uncertain NA NA "HPA030985: AB_2673686" "unprognostic (2.88e-3)" "unprognostic (2.29e-1)" "unprognostic (1.19e-1)" "unprognostic (3.21e-3)" "unprognostic (9.20e-3)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" "unprognostic (6.74e-3)" "unprognostic (6.36e-2)" "unprognostic (6.45e-3)" "unprognostic (8.31e-3)" "unprognostic (3.79e-1)" "unprognostic (2.60e-2)" "unprognostic (4.39e-2)" "unprognostic (2.42e-1)" "unprognostic (6.09e-2)" "unprognostic (1.38e-1)" 19.8 1.5 2.9 16.5 1.4 0.0 26.0 0.9 6.3 5.5 10.0 0.1 0.7 2.7 3.0 4.4 10.0 7.3 8.4 7.1 1.4 0.5 5.3 21.2 9.3 2.9 0.5 2.7 12.4 6.5 0.2 5.8 0.5 1.4 44.7 7.3 1.2 9.8 5.3 3.9 3.3 7.4 13.7 1.4 2.8 7.4 2.1 0.7 0.0 4.6 6.5 3.7 12.5 16.1 0.8 1.7 0.0 0.0 0.0 0.0 0.2 6.8 13.9 0.8 2.5 29.6 24.6 0.2 4.7 5.8 0.6 0.8 10.3 35.5 0.0 0.2 7.7 12.6 1.4 6.0 6.6 1.3 0.0 2.2 0.0 0.1 3.4 1.1 0.0 0.0 17.3 1.0 19.6 10.4 4.6 25.4 2.1 0.3 19.8 8.1 0.1 0.0 0.1 4.2 0.3 6.7 0.0 0.0 0.0 5.6 1.4 0.0 0.3 1.8 0.0 3.1 0.5 7.8 0.1 13.0 45.1 2.3 22.7 5.7 3.7 0.1 0.0 22.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 1.4 0.9 6.3 1.4 0.5 0.5 2.7 1.4 0.7 0.0 0.3 0.0 43.1 3.8 0.0 0.8 0.0 6.7 2.3 1.8 0.0 0.0 0.0 2.1 0.3 2.2 3.5 0.0 33.5 0.1 15.0 64.3 0.0 30.1 0.5 0.0 6.9 1.8 1.0 1.0 0.9 1.8 6.8 0.0 4.1 9.4 29.2 10.5 1.4 13.9 0.2 6.5 5.6 12.6 30.9 1.9 0.2 0.0 13.5 39.0 STEAP1B ENSG00000105889 "STEAP family member 1B" Q6NZ63 7 22419444-22632925 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.6" "Cell type enhanced" "Detected in some" 16 "Horizontal cells: 11.1;monocytes: 20.8;Spermatocytes: 7.2;Spermatogonia: 13.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 88 "memory B-cell: 9.9;naive B-cell: 8.6" "Lineage enriched" "Detected in single" 94 "B-cells: 9.9" "Group enriched" "Detected in many" 4 "hTEC/SVTERT24-B: 29.7;HUVEC TERT2: 33.4;K-562: 19.4;WM-115: 36.7" NA NA "unprognostic (7.35e-2)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-3)" "unprognostic (3.96e-2)" "unprognostic (2.18e-1)" "unprognostic (2.31e-5)" "unprognostic (2.29e-3)" "unprognostic (4.96e-2)" "unprognostic (7.37e-3)" "unprognostic (7.38e-2)" "unprognostic (1.27e-2)" "unprognostic (2.85e-10)" "unprognostic (1.06e-4)" "unprognostic (3.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-3)" 3.5 1.8 5.3 3.9 14.5 0.6 1.8 0.6 9.3 2.3 1.6 13.5 0.8 0.5 0.7 1.4 1.7 1.0 2.2 1.4 5.2 2.9 0.4 0.7 1.4 5.9 14.9 2.7 0.5 1.1 0.8 1.0 3.6 9.0 1.5 1.5 1.0 1.4 2.1 3.2 1.1 1.0 1.9 8.6 6.4 1.1 7.5 15.6 0.6 0.8 0.3 5.5 2.1 3.6 9.9 0.0 0.0 0.0 0.0 0.1 0.4 4.1 0.0 2.9 0.0 1.8 1.9 0.0 2.9 0.4 0.0 0.1 0.0 0.1 0.4 0.9 5.7 1.0 0.0 4.2 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.0 3.5 0.0 29.7 0.0 3.5 33.4 0.1 19.4 1.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.4 0.0 0.0 3.4 0.4 0.1 4.5 0.0 0.4 3.8 3.9 7.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 14.5 0.6 9.3 5.2 2.9 14.9 2.7 9.0 15.6 0.0 0.0 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 11.1 0.0 0.6 0.3 1.3 0.0 0.1 3.3 20.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 7.2 13.0 0.1 0.1 0.0 0.0 0.1 STK31 "SgK396, TDRD8" ENSG00000196335 "Serine/threonine kinase 31" Q9BXU1 7 23710167-23832513 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 56.0" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 163.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "CACO-2: 20.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023194 Enhanced NA NA "HPA023194: AB_1857590" "unprognostic (4.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.50e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.42e-3)" "unprognostic (2.92e-1)" "unprognostic (1.29e-6)" "unprognostic (7.83e-2)" "unprognostic (9.21e-3)" "unprognostic (1.46e-1)" "unprognostic (3.65e-1)" 0.1 0.0 0.1 0.1 0.7 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 56.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 20.1 2.5 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.1 0.2 0.0 0.1 0.1 0.1 0.1 3.0 1.4 0.0 0.2 0.1 1.7 0.4 2.5 6.7 4.5 0.0 0.0 0.5 0.0 0.2 16.5 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.0 0.8 0.2 0.0 1.2 0.0 0.0 12.3 3.1 0.0 0.0 0.0 0.2 1.3 0.4 0.8 2.8 0.0 1.2 0.0 0.0 163.1 32.6 0.1 0.5 0.0 0.4 0.4 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell type enhanced" "Detected in some" 25 "Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.8 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.9 8.2 11.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 11.7 0.6 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 0.0 10.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.3 0.0 0.0 3.0 0.0 1.2 18.7 0.0 0.4 0.0 0.0 0.0 0.0 47.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 0.0 0.6 0.0 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.8 83.1 1.6 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.4 1.4 0.9 5.0 0.0 0.0 0.0 0.3 0.0 1.1 13.3 0.0 0.0 0.3 0.9 3.0 0.9 0.0 0.0 0.0 0.0 STKLD1 "C9orf96, MGC43306, SGK071" ENSG00000198870 "Serine/threonine kinase like domain containing 1" Q8NE28 9 133376367-133406096 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 16.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 27.3;Late spermatids: 39.6;Spermatocytes: 15.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA029902 Uncertain NA NA "HPA029902: AB_10603554" "unprognostic (6.65e-2)" "unprognostic (9.43e-3)" "unprognostic (7.54e-4)" "unprognostic (8.15e-2)" "unprognostic (9.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-3)" "unprognostic (6.05e-2)" "unprognostic (2.94e-4)" "unprognostic (1.92e-4)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "unprognostic (4.69e-2)" "unprognostic (3.65e-1)" "unprognostic (5.86e-2)" "unprognostic (4.52e-2)" 0.4 0.4 0.4 0.2 1.4 0.5 0.4 0.7 2.2 0.4 0.3 2.2 1.3 0.5 0.9 2.1 0.3 0.6 0.5 0.3 0.8 0.3 0.3 0.4 0.3 0.8 0.5 1.3 0.8 0.4 0.1 0.3 0.5 1.5 0.5 0.1 0.8 0.6 0.4 0.6 0.8 0.5 0.3 0.5 0.4 0.4 16.2 0.7 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.4 0.0 0.2 0.2 0.6 0.0 0.0 0.6 0.4 0.7 0.5 0.5 1.1 0.2 0.0 0.1 0.2 0.9 0.3 0.3 0.2 0.0 0.6 0.6 0.1 0.0 0.0 0.4 0.8 0.7 0.9 0.5 0.3 0.5 0.4 0.4 0.1 0.0 0.1 0.4 0.0 1.5 0.8 1.0 0.0 0.2 0.6 0.8 0.3 0.6 1.0 0.3 0.3 0.8 0.1 0.1 1.0 1.0 0.3 0.9 2.2 0.3 1.3 0.3 0.6 1.0 0.6 0.9 0.1 2.2 2.2 0.6 0.4 0.4 0.3 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.2 0.1 0.6 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.0 0.4 1.4 0.7 2.2 0.8 0.3 0.5 1.3 1.5 0.7 0.0 0.0 0.0 1.1 0.0 3.3 1.2 2.5 0.0 1.2 0.0 2.0 3.6 8.3 0.4 27.3 0.5 0.0 0.0 1.0 0.6 0.3 0.7 0.0 1.0 0.8 1.6 0.0 0.0 0.3 39.6 2.0 0.0 0.0 0.0 0.3 1.2 0.3 0.0 1.8 1.7 2.3 0.0 0.2 15.1 3.4 0.0 2.7 0.0 0.7 0.6 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Group enriched" "Detected in some" 6 "Bipolar cells: 43.7;Horizontal cells: 87.4" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 45.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 0.0 0.0 0.0 0.1 0.3 43.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 1.4 0.0 11.1 0.0 0.0 0.5 1.2 0.1 0.0 0.0 0.0 0.0 STMND1 FLJ23152 ENSG00000230873 "Stathmin domain containing 1" H3BQB6 6 17102258-17131372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.8;pancreas: 9.1" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 48.2;Club cells: 10.3;Spermatogonia: 21.3" "Group enriched" "Detected in some" 6 "breast cancer: 4.1;endometrial cancer: 1.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEK 293: 4.1;SCLC-21H: 9.8;T-47d: 11.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA067970 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA067970: AB_2685934" "unprognostic (7.70e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-2)" "unprognostic (2.09e-3)" "unprognostic (6.88e-2)" "unprognostic (6.64e-2)" "unprognostic (4.29e-2)" "unprognostic (4.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.72e-2)" "unprognostic (5.29e-4)" "unprognostic (7.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" 0.1 0.0 0.4 0.1 0.8 0.0 3.7 0.6 0.6 1.6 1.0 2.8 1.4 0.1 0.6 4.7 0.1 21.8 6.0 0.1 0.7 0.9 0.1 0.1 7.7 0.1 0.1 0.1 3.5 9.1 0.0 0.7 0.1 2.5 0.1 1.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.0 7.4 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.9 1.6 2.8 1.1 0.8 0.8 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.3 0.7 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.2 0.8 0.0 4.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 9.8 0.0 0.0 0.1 0.0 1.1 11.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.1 0.7 0.3 0.8 0.6 0.4 0.7 0.3 0.2 0.9 0.8 0.7 2.8 0.8 0.8 1.6 0.2 0.4 0.4 0.8 0.6 0.6 0.7 0.9 0.1 0.1 2.5 0.1 0.0 2.2 0.0 1.2 0.0 0.0 0.4 2.5 48.2 10.3 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.6 1.0 0.8 0.0 0.4 0.0 0.0 6.5 0.3 7.1 21.3 0.6 0.0 0.0 1.0 0.5 STOX2 DKFZp762K222 ENSG00000173320 "Storkhead box 2" Q9P2F5 4 183797692-184023526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.6;Horizontal cells: 31.8;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.6;HeLa: 9.9;NTERA-2: 14.7;SH-SY5Y: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049776, HPA065002" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA049776: AB_2680875, HPA065002: " "unprognostic (9.79e-3)" "unprognostic (3.46e-1)" "unprognostic (2.10e-1)" "unprognostic (6.57e-3)" "unprognostic (3.33e-1)" "unprognostic (6.41e-2)" "unprognostic (4.57e-4)" "unprognostic (8.97e-3)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-3)" "unprognostic (2.49e-1)" 3.0 2.8 12.0 1.2 12.6 8.4 3.1 20.3 17.5 3.9 2.1 18.2 1.6 1.6 3.2 5.9 8.2 4.7 4.5 4.9 9.6 8.3 3.4 4.0 3.5 1.1 16.2 18.0 5.8 10.6 12.0 8.1 2.4 11.8 4.1 1.7 2.5 11.0 4.2 3.2 6.2 1.8 3.2 9.2 6.2 3.7 1.6 16.4 0.8 9.6 0.8 1.9 4.3 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.7 3.7 11.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 1.5 0.0 2.3 0.0 2.4 0.2 6.4 1.0 0.0 0.0 5.1 0.0 9.9 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.0 1.5 0.0 0.5 0.0 0.1 14.7 0.0 0.5 0.1 4.3 0.0 2.8 3.5 6.0 14.0 2.7 0.0 0.0 4.4 0.2 0.3 0.0 0.0 2.5 0.0 0.1 0.1 3.2 1.8 0.6 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 12.0 12.6 20.3 16.6 9.6 8.3 16.2 18.0 11.8 16.4 11.9 16.6 0.0 5.8 3.8 30.6 19.3 5.1 20.1 12.5 7.0 0.0 2.3 3.3 3.9 0.8 18.3 0.0 0.0 2.7 1.7 1.5 4.2 0.0 4.9 0.9 31.8 1.7 22.1 2.6 2.2 0.6 0.2 1.7 0.0 0.0 15.1 2.4 0.0 4.2 1.9 3.4 0.0 1.0 0.5 2.4 2.9 0.6 0.0 0.0 2.6 STPG2 "C4orf37, MGC46496" ENSG00000163116 "Sperm tail PG-rich repeat containing 2" Q8N412 4 97184093-98143240 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.0;testis: 11.1" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 5.9;Distal tubular cells: 3.3;Spermatocytes: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.1;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;SuSa: 2.4;U-266/70: 2.1" "Low region specificity" "Detected in all" NA NA "unprognostic (3.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.12e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-2)" "unprognostic (6.59e-3)" "unprognostic (8.87e-3)" "unprognostic (2.18e-1)" "unprognostic (2.05e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-3)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" "unprognostic (7.55e-3)" "unprognostic (5.78e-2)" 1.0 1.5 2.5 1.2 5.3 0.8 2.9 1.9 2.5 1.3 0.9 4.5 3.7 1.3 0.9 3.9 1.0 1.8 1.3 1.0 1.8 1.4 3.5 1.9 1.7 1.3 3.7 1.5 1.6 2.1 2.1 17.0 1.7 3.8 1.4 1.2 1.7 1.5 5.8 0.6 1.7 1.1 0.7 2.3 1.5 1.3 11.1 3.4 0.4 3.0 0.0 1.0 1.4 1.2 1.1 1.3 0.0 0.0 0.5 0.3 0.0 0.2 0.3 0.0 0.0 1.0 0.5 0.0 0.0 0.3 0.0 0.6 0.0 1.2 0.1 0.3 0.3 1.1 0.6 0.1 0.8 0.0 0.0 1.8 0.8 0.6 0.0 0.0 0.1 0.6 0.0 0.6 0.0 0.5 0.4 0.0 0.0 0.2 0.9 0.4 0.3 0.2 0.7 0.4 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.3 0.2 0.4 0.7 2.4 0.5 0.6 0.0 0.2 0.3 0.0 0.1 2.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 2.5 5.3 1.9 2.5 1.8 1.4 3.7 1.5 3.8 3.4 0.0 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.7 1.5 0.0 0.0 2.6 0.9 0.0 0.1 0.0 0.0 0.1 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 55.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.3;RPMI-8226: 3.0;SK-BR-3: 3.0;T-47d: 4.6;U-266/70: 2.9" HPA044352 Uncertain Vesicles NA NA Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.8 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.2 4.4 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 1.7 0.2 0.2 0.2 0.2 0.2 1.4 0.0 1.1 0.2 0.2 0.2 0.0 0.2 1.5 0.2 0.2 0.5 3.2 0.2 0.2 0.2 0.5 55.3 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 2.0 1.2 0.3 0.0 0.0 1.0 0.0 0.0 0.0 7.3 0.0 0.1 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 1.3 1.1 0.0 1.7 0.0 0.2 0.0 0.5 0.4 0.0 0.0 3.0 0.0 0.0 0.9 0.6 0.4 3.0 0.0 0.6 4.6 0.0 0.0 0.8 1.4 0.2 0.0 2.9 1.5 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;RT4: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047366: , HPA052691: AB_2681918" "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.3 0.4 0.1 0.2 0.8 0.5 0.5 0.4 0.4 0.5 0.0 0.2 0.0 0.7 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 1.0 0.1 0.8 0.3 0.2 0.1 6.6 0.9 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 0.4 1.8 0.4 0.1 0.0 0.4 0.1 0.3 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRA8 ENSG00000146857 "Stimulated by retinoic acid 8" Q7Z7C7 7 135231979-135258492 "Predicted intracellular proteins" "Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.0;skin 1: 2.5;testis: 4.0" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 1.4;Early spermatids: 1.1;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;K-562: 1.2;SK-BR-3: 2.3;THP-1: 6.9;U-266/84: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.84e-1)" "unprognostic (4.86e-2)" "unprognostic (3.89e-2)" "unprognostic (9.67e-4)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (1.26e-3)" "unprognostic (1.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.45e-1)" "unprognostic (2.69e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 3.0 0.0 0.7 0.0 0.0 0.0 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 22.9" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 5.9;Horizontal cells: 3.2;Rod photoreceptor cells: 9.2;Spermatocytes: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;hTCEpi: 2.2;JURKAT: 1.7;SCLC-21H: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048083 Enhanced NA NA "HPA048083: AB_2732545" "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.2 0.5 1.7 0.2 4.2 0.1 0.8 22.9 5.1 0.0 0.2 0.4 0.1 4.7 0.1 0.3 0.2 0.0 2.3 3.2 0.0 0.1 0.1 0.0 1.6 0.4 0.5 0.1 1.7 0.0 0.7 0.2 1.5 0.1 0.4 2.7 0.4 0.0 1.1 0.2 0.2 3.3 0.6 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.1 1.0 1.4 0.0 0.7 0.0 0.0 0.5 0.6 0.5 2.2 0.0 0.0 0.2 0.0 1.7 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.5 0.0 0.0 0.1 0.1 1.9 0.1 0.0 0.4 0.9 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.2 0.3 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.2 0.2 0.4 0.0 9.2 0.0 0.0 3.6 0.6 0.4 0.6 0.0 0.0 0.0 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548800-226609214 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 25.6" "Group enriched" "Detected in many" 5 "amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4" "Low region specificity" "Detected in many" HPA074381 Approved Cytosol NA NA Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 2.8 2.2 30.4 2.1 16.2 0.6 3.5 2.4 32.2 3.7 8.1 6.3 0.0 2.8 3.7 3.0 8.9 3.1 1.6 2.5 21.8 7.0 5.8 0.7 1.2 0.9 6.8 15.9 2.7 1.0 1.9 4.2 1.2 18.2 6.2 3.7 1.4 2.0 2.4 5.0 3.7 3.5 8.7 3.0 1.8 1.8 2.0 7.4 0.0 0.8 0.4 1.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 4.2 0.3 25.6 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 0.2 0.0 3.9 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 16.2 2.4 30.0 21.8 7.0 6.8 15.9 18.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 STYXL1 "DUSP24, MK-STYX" ENSG00000127952 "Serine/threonine/tyrosine interacting like 1" Q9Y6J8 7 75996338-76048004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050261 Uncertain NA No "HPA050261: AB_2681066" "unprognostic (6.24e-2)" "unprognostic (1.12e-1)" "unprognostic (7.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.88e-3)" "unprognostic (9.33e-2)" "unprognostic (1.50e-3)" "unprognostic (4.77e-2)" "unprognostic (8.01e-2)" "unprognostic (4.02e-2)" "unprognostic (4.47e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (3.17e-2)" "unprognostic (2.28e-1)" "prognostic favorable (8.22e-4)" 9.4 19.2 16.0 10.2 23.1 12.7 17.5 12.8 19.8 15.7 15.1 19.6 13.9 10.5 10.3 21.0 21.1 28.2 9.4 13.2 16.6 12.1 14.8 20.1 11.3 13.7 20.9 13.5 15.4 30.0 15.9 19.9 24.6 16.8 16.6 20.1 12.2 16.0 13.9 12.4 19.3 10.3 14.0 17.0 17.4 14.0 25.0 19.7 20.8 19.9 12.1 19.5 14.8 14.6 19.7 23.0 30.8 29.3 24.7 22.1 17.4 19.8 10.6 8.4 11.2 13.3 14.5 8.7 9.0 12.8 14.6 14.5 12.3 18.1 4.6 4.5 11.8 23.1 8.8 13.5 17.9 21.2 14.8 6.0 5.6 5.0 11.0 18.9 7.8 10.3 14.0 21.1 17.4 43.9 18.8 14.1 7.0 18.1 14.0 13.0 16.0 3.1 33.5 7.1 19.2 25.7 11.9 7.0 12.2 18.5 13.0 11.0 11.4 8.4 19.2 22.4 21.9 21.1 15.1 7.0 12.6 5.3 13.8 12.7 15.2 9.6 15.7 11.1 15.0 19.5 30.8 29.3 25.8 13.7 25.3 15.2 19.7 13.2 15.2 23.0 15.6 11.7 13.2 24.6 24.7 23.7 15.1 22.1 17.4 16.0 23.1 12.8 19.8 16.6 12.1 20.9 13.5 16.8 19.7 20.8 10.4 12.3 13.2 6.5 5.6 15.4 10.2 54.9 30.7 10.4 0.0 25.9 33.2 13.9 68.8 7.8 14.4 0.0 22.7 20.3 7.6 16.5 10.4 15.5 26.7 3.2 19.4 12.9 23.8 50.5 10.6 18.9 3.3 32.5 24.6 18.8 19.6 40.3 9.6 16.3 8.9 6.5 6.1 22.2 12.6 8.7 37.6 9.6 17.7 15.9 SULT6B1 ENSG00000138068 "Sulfotransferase family 6B member 1" Q6IMI4 2 37167820-37196598 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;fallopian tube: 2.0;testis: 7.1" "Cell type enhanced" "Detected in single" 25 "Late spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 6 "WM-115: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.86e-1)" "unprognostic (8.98e-2)" 0.1 0.1 0.1 0.1 0.3 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 7.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085138 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.8;testis: 64.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 27.5;Hepatocytes: 48.7;Hofbauer cells: 38.0;Proximal tubular cells: 50.4;T-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 51.7;Karpas-707: 11.5;MCF7: 12.5;NB-4: 26.4;RPMI-8226: 28.0;THP-1: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042310 Uncertain NA NA "HPA042310: AB_10796902" "prognostic favorable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 3.2 1.0 3.3 16.9 3.2 18.7 8.0 1.2 3.2 8.3 3.3 8.5 0.6 2.2 11.6 12.8 1.9 18.2 1.9 1.0 2.4 2.7 18.5 13.9 3.8 25.8 4.0 2.3 20.9 0.8 0.2 3.2 1.4 3.7 1.8 0.9 3.0 7.5 1.5 0.4 1.6 9.7 3.0 5.4 20.2 1.9 64.8 3.1 13.9 2.5 0.8 19.9 3.0 3.7 20.4 9.2 16.7 3.9 2.2 52.8 17.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.1 1.1 0.4 51.7 0.2 0.2 0.0 0.1 0.8 0.0 0.0 4.5 0.0 7.0 0.0 0.8 3.4 0.0 1.6 3.6 0.2 0.0 0.0 0.0 0.0 0.0 2.1 11.5 0.0 12.5 0.0 26.4 0.6 0.4 1.6 2.2 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 6.8 11.9 0.1 0.0 0.0 0.0 0.0 2.3 1.2 3.2 0.0 0.0 0.1 0.1 3.9 16.7 5.7 3.4 6.4 20.4 30.1 10.5 9.2 14.4 52.8 21.3 1.3 2.2 0.6 0.8 39.8 17.0 3.3 3.2 1.2 3.2 2.4 2.7 4.0 2.3 3.7 3.1 0.0 7.9 27.5 0.1 0.6 0.2 0.6 15.3 1.4 0.0 0.0 3.9 0.8 8.3 0.6 2.4 0.4 0.0 0.0 0.2 1.5 1.5 0.6 3.5 48.7 38.0 0.0 0.0 1.8 10.8 9.0 5.2 8.5 1.7 1.0 0.1 0.5 0.4 0.0 4.9 50.4 7.8 0.0 0.9 2.1 2.7 0.3 1.1 30.9 0.4 0.2 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.3 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.7 0.5 4.5 1.3 0.0 1.4 0.1 0.0 7.1 0.2 1.1 0.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 5.0 0.4 0.0 0.3 3.2 3.1 0.0 0.1 2.1 0.9 0.0 0.1 0.0 8.4 2.0 29.0 0.3 0.0 2.4 0.0 0.6 1.8 0.2 0.0 1.3 5.2 0.0 2.6 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 0.0 4.5 0.0 5.3 0.6 15.9 9.1 0.0 8.1 12.5 15.7 9.8 0.0 26.6 0.6 2.5 0.4 0.0 0.0 6.3 0.0 0.7 6.8 0.0 1.5 2.1 20.6 1.2 0.0 0.0 2.8 19.0 0.1 5.0 0.0 0.0 1.1 2.7 0.0 11.7 0.2 6.1 0.0 1.0 0.5 5.9 1.5 0.0 1.3 0.0 26.8 SVOP DKFZp761H039 ENSG00000166111 "SV2 related protein" Q8N4V2 12 108907741-109021240 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 30.3" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 39.3;Early spermatids: 59.5;Late spermatids: 90.9" "Group enriched" "Detected in some" 9 "glioma: 0.6;pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 13 "Karpas-707: 6.3;RPMI-8226: 6.4;SCLC-21H: 3.5;SH-SY5Y: 3.1;U-266/84: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016573 Uncertain NA NA "HPA016573: AB_2197027" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (6.51e-3)" "unprognostic (2.18e-2)" "unprognostic (3.79e-1)" "unprognostic (1.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "unprognostic (4.29e-3)" "unprognostic (3.07e-1)" "unprognostic (4.28e-3)" "unprognostic (3.94e-2)" "unprognostic (2.26e-2)" "unprognostic (6.17e-2)" 0.6 2.9 6.9 0.7 14.0 0.7 0.6 8.2 30.3 0.6 0.8 0.5 0.0 1.3 0.6 0.7 0.6 1.1 0.6 1.1 8.9 1.9 0.7 0.6 0.7 0.6 0.7 10.0 0.6 1.7 0.5 6.8 0.6 6.4 0.8 0.8 1.5 0.6 0.7 0.7 0.6 1.0 0.6 0.8 0.6 1.8 1.0 0.7 0.0 0.7 0.0 0.5 0.6 0.7 0.6 0.4 2.0 0.4 0.9 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 3.5 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 2.9 0.1 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.6 0.3 0.3 2.0 0.9 0.3 0.4 0.2 0.1 6.9 14.0 8.2 21.6 8.9 1.9 0.7 10.0 6.4 0.7 11.9 11.1 0.0 0.6 0.0 15.9 1.2 0.0 0.0 9.1 1.8 39.3 1.2 0.0 0.0 59.5 0.4 0.0 0.0 0.0 0.1 0.1 0.3 2.3 0.0 0.1 11.1 16.1 1.3 0.0 90.9 0.3 0.4 0.0 0.0 0.0 1.6 0.2 0.0 0.7 0.0 20.4 0.0 0.0 0.5 0.8 0.0 0.7 0.0 0.0 0.3 SVOPL MGC46715 ENSG00000157703 "SVOP like" Q8N434 7 138594285-138701352 "Predicted membrane proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 13.9;salivary gland: 6.5" "Cell type enriched" "Detected in some" 9 "granulocytes: 73.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 41 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 41 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "HMC-1: 8.3;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018035 Uncertain NA NA "HPA018035: AB_2197028" "unprognostic (6.70e-5)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (2.49e-1)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "unprognostic (7.69e-3)" "unprognostic (2.59e-3)" "unprognostic (7.16e-2)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (5.03e-3)" "unprognostic (2.22e-4)" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (8.51e-2)" 0.0 2.1 0.5 0.0 1.1 0.0 1.2 0.0 0.1 0.3 0.9 0.0 0.0 0.7 0.0 2.3 0.0 0.0 1.0 0.8 2.7 0.0 0.2 0.0 0.2 0.7 0.3 13.9 1.8 0.5 0.1 0.1 6.5 0.7 0.0 0.4 0.0 0.0 0.8 0.0 0.0 1.5 1.0 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.3 0.0 0.0 1.0 0.0 0.3 0.0 1.9 0.1 1.0 0.0 0.8 0.0 0.7 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.1 0.1 0.6 1.7 0.0 1.4 2.3 1.8 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.4 0.0 73.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 8.0 0.0 0.0 0.7 0.2 0.1 1.6 0.0 0.2 0.3 SWT1 "C1orf26, FLJ20121, HsSwt1" ENSG00000116668 "SWT1, RNA endoribonuclease homolog" Q5T5J6 1 185157080-185291765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 99.9;Late spermatids: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024214, HPA027334" Enhanced Approved Cytosol NA NA Cytosol "HPA024214: AB_1845642, HPA027334: AB_1845643" "unprognostic (2.67e-3)" "unprognostic (1.32e-1)" "unprognostic (3.65e-1)" "unprognostic (4.26e-2)" "unprognostic (3.17e-3)" "unprognostic (8.41e-3)" "unprognostic (5.71e-3)" "unprognostic (9.26e-3)" "unprognostic (7.37e-2)" "unprognostic (2.68e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.97e-1)" "unprognostic (4.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.35e-2)" 5.0 4.8 4.1 3.4 6.0 8.7 8.4 6.5 5.9 5.0 5.8 5.7 7.1 5.6 6.6 5.4 3.8 4.1 4.5 4.4 4.2 4.7 5.7 4.7 5.4 7.6 5.2 4.6 7.7 12.4 5.8 9.9 18.1 6.8 5.7 4.1 3.2 6.7 7.9 5.0 3.9 5.4 4.0 9.1 4.8 6.1 39.1 6.5 7.6 6.1 3.2 3.6 5.2 9.1 4.5 1.5 12.0 4.8 1.0 7.2 1.5 1.9 1.7 4.7 2.6 7.9 6.1 4.0 1.9 3.3 2.4 3.8 1.4 1.6 1.9 3.9 1.5 2.5 1.6 2.8 2.6 3.1 5.1 1.9 2.0 1.2 1.8 3.9 0.6 1.7 4.4 2.7 2.7 2.4 4.2 5.9 3.9 4.3 9.6 2.5 0.6 2.2 1.8 5.1 5.1 1.0 1.7 4.2 4.6 2.3 1.1 1.0 7.4 1.6 2.4 6.7 11.6 2.8 1.3 2.8 3.2 2.1 3.1 1.2 17.5 13.3 0.7 3.6 1.2 1.2 12.0 2.5 3.4 2.0 2.2 3.7 3.1 4.0 3.0 1.5 4.5 3.9 2.9 7.2 1.0 4.8 1.4 7.2 1.5 4.1 6.0 6.5 5.9 4.2 4.7 5.2 4.6 6.8 6.5 3.0 0.6 2.2 1.7 0.9 3.9 7.0 2.5 1.4 4.5 5.2 3.9 2.8 0.0 2.2 99.9 3.4 3.5 0.0 2.3 5.4 4.1 2.4 2.3 3.2 3.0 7.9 0.0 8.6 5.7 37.0 4.4 2.8 1.7 3.6 2.9 2.4 1.6 8.6 5.3 5.0 4.4 0.0 1.9 22.7 11.5 0.5 5.6 2.1 2.4 1.6 SYCE1L MRP2 ENSG00000205078 "Synaptonemal complex central element protein 1 like" A8MT33 16 77199397-77213215 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 22.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.0;U-698: 10.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062464, HPA066691" Enhanced "Intermediate filaments" No No "Intermediate filaments" "HPA062464: , HPA066691: AB_2685702" "unprognostic (5.54e-3)" "unprognostic (2.15e-1)" "unprognostic (1.65e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (2.00e-3)" "unprognostic (6.28e-3)" "unprognostic (1.02e-1)" "unprognostic (7.48e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (9.27e-2)" "unprognostic (4.27e-1)" "unprognostic (2.68e-2)" "unprognostic (1.73e-2)" 3.5 3.4 2.8 4.1 2.7 2.9 3.7 5.2 2.4 8.7 5.0 0.4 11.5 2.1 7.8 7.6 4.4 2.8 1.8 7.0 2.8 3.0 4.3 1.4 1.9 4.5 2.1 1.4 8.5 2.7 2.3 2.3 1.6 1.5 6.6 1.6 5.4 11.1 8.7 1.7 4.3 4.6 2.0 2.5 4.2 2.3 22.4 0.4 6.4 8.0 2.0 2.4 2.3 4.4 3.5 12.2 12.0 2.2 2.7 10.5 3.4 2.8 1.1 2.8 1.3 0.3 0.0 0.5 0.8 0.3 0.5 0.9 0.6 5.7 1.9 3.8 0.6 0.2 4.1 0.2 0.0 0.3 1.7 13.0 0.4 1.0 0.0 1.9 0.9 1.2 0.1 0.4 0.1 0.3 0.5 2.0 2.6 0.7 0.2 0.3 4.2 0.7 1.3 1.9 0.4 4.5 6.7 0.7 0.6 2.5 0.8 2.9 3.4 0.4 0.3 0.0 0.3 0.1 1.2 6.5 0.4 6.5 0.9 0.2 5.5 2.1 10.1 2.8 0.7 0.2 4.0 1.3 12.0 6.1 2.2 7.3 3.5 7.9 8.4 1.6 2.6 8.7 8.0 1.3 2.7 1.6 12.2 10.5 3.4 2.8 2.7 5.2 2.2 2.8 3.0 2.1 1.4 1.5 0.4 3.0 3.0 6.0 9.6 15.3 3.7 2.0 30.6 1.4 5.7 26.2 9.8 5.2 13.3 23.2 19.5 7.5 6.9 0.0 24.3 3.8 9.0 15.6 1.1 10.6 2.1 1.6 21.6 16.5 13.5 35.7 12.7 3.1 18.6 2.8 30.3 14.0 19.1 22.4 6.3 17.9 35.5 6.5 4.2 34.7 8.1 14.9 2.4 13.4 29.9 5.7 SYCN "FLJ27441, INSSA1, SYL" ENSG00000179751 Syncollin Q0VAF6 19 39202831-39204266 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 681 "pancreas: 1347.2" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 3381.8" "Cancer enriched" "Detected in single" 842 "pancreatic cancer: 369.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.3;U-266/84: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA047654 Enhanced "Intracellular and membrane" NA NA 1100000 "HPA047654: AB_2680112" "unprognostic (8.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1347.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.3 0.0 0.0 0.0 3381.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.1 0.0 0.0 17.2 0.0 0.0 825.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 330.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.3 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.4 0.0 19.1 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.6 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 0.7 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 0.0 0.6 0.5 1.0 0.9 1.3 3.6 2.5 14.7 10.3 1.8 2.0 0.5 1.7 0.6 36.7 2.3 0.0 0.0 3.1 0.2 1.2 2.0 2.3 0.0 0.5 0.0 0.0 3.1 0.6 13.5 4.4 1.1 5.0 0.0 0.0 2.2 1.6 0.2 1.8 2.6 1.0 51.8 1.9 330.2 31.3 0.0 0.3 1.3 0.2 1.1 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364395-48376376 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 41.5" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 147.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 4.1" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "A549: 9.1;SCLC-21H: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 4.1 2.0 0.0 0.2 0.0 0.9 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.7 3.0 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.0 41.5 0.0 0.3 0.1 0.0 0.2 0.2 0.0 1.3 0.7 0.1 0.5 0.0 0.9 0.6 0.1 9.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 2.9 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 3.4 0.1 0.2 0.5 0.2 0.0 0.6 1.7 0.6 0.0 2.6 0.0 0.0 22.9 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.1 1.0 0.7 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.7 4.1 0.9 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 8.7 0.0 0.0 18.9 0.9 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 6.5 0.0 147.5 4.5 0.0 0.0 0.0 0.1 0.1 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3" "Cell type enriched" "Detected in some" 220 "Cardiomyocytes: 650.0" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 3.8 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 3.2 3.3 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.8 0.0 0.0 1.6 0.0 72.8 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 29.3 3.4 0.0 0.3 0.7 1.0 3.0 0.7 0.7 0.7 0.1 0.5 0.1 0.8 0.3 0.1 0.0 1.1 0.9 1.2 0.2 0.0 7.7 0.7 0.4 0.5 0.9 0.1 0.1 0.1 0.0 0.4 0.2 0.2 0.3 0.6 0.4 0.6 0.2 0.3 6.2 0.1 1.2 0.1 0.3 0.0 0.5 0.3 0.3 0.3 0.3 0.2 1.9 0.2 0.0 0.7 0.2 5.9 0.3 0.0 0.6 0.3 0.4 0.1 6.3 0.1 0.3 0.4 0.7 0.0 0.6 1.0 0.2 0.3 1.0 0.3 0.3 0.2 0.6 0.0 2.9 0.7 0.7 0.7 0.4 0.3 0.5 0.3 0.3 0.2 0.7 0.4 0.4 3.0 0.7 0.4 1.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 1.4 1.3 1.4 650.0 0.0 1.4 1.2 0.0 2.0 0.1 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.9 0.7 1.1 0.2 0.2 0.0 0.0 0.0 0.3 1.0 0.9 0.8 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.3 0.0 0.5 0.7 0.6 0.4 0.0 0.7 0.0 0.9 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 20.2 8.5 0.0 8.6 27.3 2.7 1.0 0.0 0.0 0.0 0.0 14.1 0.3 0.0 7.3 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 2.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.5 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 4.9 0.0 0.0 2.3 0.4 1.5 0.0 0.1 0.0 0.0 0.0 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.0 4.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.4 4.5 0.0 0.0 0.0 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 4.5 0.0 0.1 0.0 0.0 0.0 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 50.6;Alveolar cells type 2: 43.8;Endothelial cells: 14.6;Ito cells: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.7" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 4.7 2.4 5.7 6.5 4.8 0.2 3.9 3.1 7.0 11.5 1.6 3.3 1.1 1.3 7.1 3.9 5.3 5.3 3.3 4.3 6.1 4.7 2.9 1.1 13.2 5.3 5.1 2.8 2.4 10.4 4.7 2.3 5.6 11.3 2.7 2.0 7.4 9.2 5.6 2.3 11.4 2.4 3.8 2.7 3.1 1.4 2.4 1.1 1.1 2.7 8.3 4.1 3.1 4.3 1.2 1.8 1.2 3.8 1.8 2.2 1.1 2.3 2.8 1.6 0.7 1.6 1.6 1.9 2.9 4.8 1.9 2.3 5.6 4.8 0.6 1.9 2.5 1.7 8.5 0.0 0.7 2.8 1.2 3.0 1.3 2.4 3.8 5.0 2.6 2.4 3.0 0.9 1.4 3.9 2.4 1.1 1.9 0.6 1.7 0.9 4.0 1.3 4.2 1.1 0.4 0.9 1.7 0.0 1.6 3.0 1.2 0.9 1.2 2.0 26.7 1.3 1.5 3.8 1.3 3.0 0.8 3.0 2.0 1.8 2.3 2.3 2.0 1.8 1.6 0.7 0.0 1.7 1.2 2.2 3.8 2.1 1.0 1.7 1.1 1.8 1.2 1.5 1.9 0.7 1.8 2.3 1.1 0.5 1.1 5.7 4.8 3.1 6.4 6.1 4.7 5.1 2.8 11.3 1.1 50.6 43.8 0.0 2.1 5.5 1.8 3.6 0.0 1.4 3.4 1.8 2.0 0.9 1.7 0.8 0.4 14.6 0.9 0.0 5.0 1.0 3.2 1.8 2.3 1.0 0.1 0.0 1.2 25.2 3.1 0.0 3.4 1.1 3.3 0.0 1.2 0.2 3.5 0.0 3.5 1.9 1.6 6.5 3.3 1.1 0.7 4.8 1.0 0.0 1.3 2.2 SYT3 ENSG00000213023 "Synaptotagmin 3" Q9BQG1 19 50621307-50639827 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 24.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 4.0;Ciliated cells: 2.7;Collecting duct cells: 1.8;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 10.1;HMC-1: 7.1;JURKAT: 4.1;NTERA-2: 7.3;SH-SY5Y: 8.2;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (1.90e-1)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (4.36e-3)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-4)" "unprognostic (1.12e-1)" "unprognostic (3.49e-4)" "unprognostic (1.82e-4)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" 0.9 1.8 8.7 1.0 8.8 0.7 0.8 16.1 24.2 1.0 0.9 1.0 0.0 1.0 0.9 1.1 0.9 0.9 0.8 0.7 10.9 8.9 1.2 0.8 1.1 0.9 6.7 6.6 0.7 2.1 1.0 2.2 2.3 6.3 1.2 0.8 0.3 1.4 1.7 0.8 0.8 1.0 0.9 2.4 0.8 0.8 2.7 2.2 0.0 1.3 0.0 0.9 1.0 0.0 0.0 1.3 0.1 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.0 0.5 0.1 0.4 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.4 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.2 4.1 1.2 0.0 0.0 3.0 0.0 0.0 7.3 0.2 0.0 2.5 0.0 0.1 0.0 0.0 0.1 8.2 0.4 0.0 0.2 0.1 0.2 2.3 0.0 0.0 5.2 0.0 0.0 0.8 0.1 0.0 0.3 3.7 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.1 8.7 8.8 16.1 16.3 10.9 8.9 6.7 6.6 6.3 2.2 0.0 4.0 0.0 0.0 0.0 1.4 0.5 0.0 2.7 0.0 1.8 3.9 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 164.0;Cholangiocytes: 229.3;Extravillous trophoblasts: 178.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 27.8;hTCEpi: 44.2;T-47d: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA052700 Uncertain NA NA "HPA052700: AB_2681920" "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.7 0.9 0.0 6.8 0.7 0.1 7.3 19.9 0.6 61.8 0.1 0.1 0.0 0.5 0.3 2.3 0.0 0.0 0.0 0.1 7.8 0.0 0.1 5.7 0.0 5.6 0.1 0.3 11.8 4.2 0.1 41.6 3.6 6.3 0.1 0.1 3.1 0.1 0.0 0.0 0.1 19.4 13.3 31.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 27.8 0.0 0.0 0.0 0.5 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.2 0.0 5.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.2 0.0 2.4 0.0 0.0 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 3.8 0.0 5.8 164.0 0.0 0.6 229.3 60.2 42.1 5.2 0.0 22.5 0.0 23.0 0.0 0.1 4.5 0.0 8.3 178.7 5.2 0.8 1.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.1 0.0 0.6 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 41.3 30.8 0.0 1.0 22.4 SYT9 ENSG00000170743 "Synaptotagmin 9" Q86SS6 11 7238778-7469042 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 10.8;Early spermatids: 13.1;Hepatocytes: 5.0;Late spermatids: 15.3" "Cancer enhanced" "Detected in some" "breast cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 8.9;RT4: 15.5;SH-SY5Y: 11.6;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.47e-1)" "unprognostic (9.41e-2)" "unprognostic (1.39e-5)" "unprognostic (1.63e-1)" "unprognostic (1.12e-1)" "unprognostic (5.50e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (3.31e-3)" "unprognostic (4.35e-2)" "unprognostic (1.92e-4)" "unprognostic (1.22e-4)" 0.5 6.0 7.5 0.7 7.4 0.5 2.8 23.6 10.2 1.7 0.8 15.5 5.6 0.5 3.8 0.6 0.5 0.9 0.9 1.4 7.5 5.3 6.0 9.8 0.7 0.5 11.1 5.6 0.8 4.0 1.2 5.1 0.5 7.1 3.5 0.7 3.3 0.7 10.5 0.5 0.7 0.8 1.0 7.9 0.5 0.7 2.8 11.5 0.0 3.6 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 15.5 2.8 11.6 0.0 0.0 0.0 0.4 0.0 0.0 17.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 7.4 23.6 6.4 7.5 5.3 11.1 5.6 7.1 11.5 0.0 0.0 0.0 0.1 0.0 10.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 3.2 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 58.9;granulocytes: 129.6;T-cells: 171.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "basophil: 55.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 55.6" "Cell line enhanced" "Detected in many" "HMC-1: 16.8;SCLC-21H: 11.2;U-138 MG: 12.8;U-2 OS: 13.9;U-266/70: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favorable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 8.3 1.5 2.3 9.0 3.7 9.4 3.8 0.8 2.4 5.1 7.4 7.1 0.6 2.9 4.6 5.5 3.6 11.6 7.3 5.3 3.4 2.0 4.7 2.2 20.2 26.7 3.5 1.3 2.5 2.3 0.9 2.1 1.3 5.5 5.3 1.8 4.8 12.4 4.8 11.4 3.0 12.0 3.5 10.4 21.9 5.8 3.2 3.9 2.3 21.7 1.2 24.5 18.8 3.6 0.2 1.3 55.6 4.5 10.9 10.2 4.4 4.9 0.7 0.0 0.3 0.7 0.7 0.2 2.0 1.3 0.5 1.4 0.4 3.9 0.0 0.4 3.4 1.8 0.5 0.1 0.6 2.0 9.7 0.3 3.8 0.1 0.0 1.2 1.0 16.8 2.2 1.5 4.2 0.7 1.8 1.0 0.7 0.2 3.8 5.0 0.2 0.1 1.3 0.1 0.9 0.7 0.0 4.1 0.5 1.9 0.2 11.2 0.8 0.7 7.1 0.5 0.2 1.3 0.2 5.8 12.8 13.9 0.3 0.4 19.6 4.4 0.4 8.2 5.4 0.4 55.6 4.5 0.2 10.2 0.8 6.0 0.2 4.1 6.8 1.3 0.0 4.5 5.5 9.2 10.9 0.3 0.3 4.1 4.4 2.3 3.7 0.8 2.4 3.4 2.0 3.5 1.3 5.5 3.9 14.9 12.5 12.8 3.1 4.0 0.0 4.0 2.5 58.9 20.5 14.0 2.0 1.1 5.0 0.6 6.2 2.4 1.4 0.0 0.5 0.4 2.4 2.4 129.6 0.9 4.2 0.0 0.0 4.3 8.9 9.9 0.0 9.1 10.1 14.4 1.3 0.1 0.4 0.0 0.7 1.4 0.4 0.0 2.5 2.2 6.6 3.9 1.6 171.2 0.4 2.6 TAAR1 "TA1, TAR1, TRAR1" ENSG00000146399 "Trace amine associated receptor 1" Q96RJ0 6 132644984-132646003 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "stomach 1: 13.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HBF TERT88: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055614 Approved NA NA "HPA055614: AB_2682862" "unprognostic (2.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 13.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR2 GPR58 ENSG00000146378 "Trace amine associated receptor 2 (gene/pseudogene)" Q9P1P5 6 132617022-132624275 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.3" "Cell type enhanced" "Detected in single" 35 "Early spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR5 PNR ENSG00000135569 "Trace amine associated receptor 5" O14804 6 132588673-132589686 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051703 Uncertain NA NA "HPA051703: AB_2681580" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR6 "TA4, TRAR4" ENSG00000146383 "Trace amine associated receptor 6" Q96RI8 6 132570322-132571359 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "kidney: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "REH: 1.0" "Not detected" "Not detected" NA NA "unprognostic (1.70e-1)" 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR8 "GPR102, TA5, TAR5, TRAR5" ENSG00000146385 "Trace amine associated receptor 8" Q969N4 6 132552693-132553721 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.2" NA NA 0.0 0.6 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR9 "TA3, TAR3, TRAR3" ENSG00000237110 "Trace amine associated receptor 9 (gene/pseudogene)" Q96RI9 6 132538290-132539336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NTERA-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 36.1" "Group enriched" "Detected in some" 6 "Early spermatids: 20.1;Late spermatids: 11.5;Spermatocytes: 29.8;Spermatogonia: 20.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 17 "SiHa: 36.0" "Low region specificity" "Detected in all" "HPA001879, HPA072008" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001879: AB_1857751, HPA072008: " "unprognostic (1.70e-2)" "prognostic favorable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.0 1.4 0.1 1.7 0.2 0.1 0.1 0.6 1.6 0.5 0.2 0.1 0.0 0.7 3.5 0.1 0.0 0.1 0.1 0.8 0.2 0.3 0.5 0.1 0.1 0.1 0.8 0.1 0.1 2.5 0.2 0.4 0.3 1.8 0.0 0.4 0.1 1.8 0.1 0.6 0.3 0.1 0.4 0.1 0.1 36.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.6 0.0 0.1 0.2 0.1 1.7 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 36.0 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.7 0.1 0.6 0.8 0.2 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 20.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.4 0.1 0.0 0.0 0.6 0.0 11.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.2 29.8 20.2 0.1 1.4 0.0 0.0 0.0 TAS1R1 "GPR70, T1R1, TR1" ENSG00000173662 "Taste 1 receptor member 1" Q7RTX1 1 6555181-6579757 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "salivary gland: 10.9;testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 6.0;Late spermatids: 14.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.7;HDLM-2: 4.7;Hep G2: 4.6;LHCN-M2: 3.7;U-698: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034579, HPA034580" Approved NA NA "HPA034579: AB_2674232, HPA034580: AB_10671504" "unprognostic (2.03e-2)" "unprognostic (9.29e-3)" "unprognostic (5.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (4.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.53e-4)" "unprognostic (3.89e-2)" "unprognostic (3.15e-1)" "unprognostic (3.26e-2)" "unprognostic (3.17e-1)" "unprognostic (5.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.26e-2)" "unprognostic (8.28e-2)" "unprognostic (6.22e-2)" 0.4 0.8 0.7 0.1 0.8 1.5 0.4 0.6 1.2 0.7 0.9 0.1 0.1 0.4 0.1 0.1 0.4 0.4 1.0 0.1 1.2 0.2 0.1 0.1 0.6 0.2 0.2 0.1 0.9 0.1 0.0 0.5 0.3 0.5 0.1 0.0 0.7 10.9 2.1 0.6 1.4 0.5 0.1 0.1 1.3 0.5 8.7 0.1 0.1 0.1 2.2 0.5 0.4 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.5 0.1 0.3 0.1 2.7 0.0 0.0 0.3 0.0 0.0 4.7 0.0 0.0 0.1 4.6 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.7 0.8 0.6 1.2 1.2 0.2 0.2 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.1 0.0 0.0 0.0 0.0 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Cell type enriched" "Detected in single" 5 "T-reg: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.3;HDLM-2: 1.1;hTERT-HME1: 2.9;SuSa: 1.2" NA NA "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.5 0.4 0.3 0.4 0.5 0.7 3.4 0.7 0.5 0.4 0.6 1.1 0.1 0.2 0.7 0.6 1.4 0.6 0.5 0.4 0.2 0.4 0.2 0.4 3.0 0.4 1.1 1.9 0.4 0.6 0.3 0.3 0.6 1.1 0.5 0.3 0.5 0.7 0.4 0.3 0.8 1.0 0.3 0.4 0.5 0.0 0.1 0.0 0.2 0.1 1.0 0.0 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.4 0.3 0.7 0.2 0.1 1.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 1.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.4 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R20 "T2R20, T2R56, TAS2R49" ENSG00000255837 "Taste 2 receptor member 20" P59543 12 10996495-10997875 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (1.12e-3)" "unprognostic (2.16e-4)" "unprognostic (2.92e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.98e-2)" "unprognostic (5.14e-4)" "unprognostic (6.23e-3)" "unprognostic (1.27e-9)" "unprognostic (2.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-2)" "unprognostic (6.44e-3)" 1.3 0.8 0.5 1.3 0.5 0.9 2.6 1.7 0.9 1.4 0.9 0.3 1.6 0.2 0.4 1.0 0.4 0.9 1.0 0.4 0.4 1.1 1.3 1.4 0.7 3.5 1.0 1.0 1.9 1.2 1.3 1.4 1.1 1.4 3.0 4.6 1.3 1.0 1.4 1.9 0.6 0.7 1.8 0.8 0.5 1.9 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.9 0.5 0.4 1.5 0.2 0.0 0.5 0.2 0.5 0.2 0.7 1.6 0.1 0.1 0.3 0.6 0.3 0.3 0.6 0.6 0.1 0.7 1.7 1.0 0.7 0.6 0.2 0.7 0.0 0.3 1.4 1.1 0.5 0.6 1.0 0.4 0.1 0.3 0.1 0.3 1.7 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.5 2.0 0.1 0.4 0.7 1.2 0.7 0.8 1.1 0.0 0.1 0.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R3 T2R3 ENSG00000127362 "Taste 2 receptor member 3" Q9NYW6 7 141764097-141765197 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "T-reg: 1.3" "Lineage enriched" "Detected in single" 8 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.9;HAP1: 1.7;HL-60: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.11e-2)" "unprognostic (2.27e-1)" "unprognostic (4.40e-2)" "unprognostic (7.38e-2)" "unprognostic (4.04e-1)" "unprognostic (1.51e-2)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.0 0.5 0.0 1.9 2.5 0.6 0.6 0.3 0.0 0.6 1.7 0.3 0.9 0.1 0.1 0.1 0.1 0.4 0.0 0.2 1.0 0.0 2.6 0.5 0.7 0.2 0.4 0.2 0.3 0.5 0.0 0.2 1.9 0.5 0.0 0.0 0.3 0.3 0.1 0.5 0.5 0.3 0.5 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.4 0.7 0.2 0.0 2.9 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.6 3.3 0.0 0.4 0.8 0.5 0.3 0.3 0.2 0.4 1.5 0.2 0.2 0.0 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.9 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R30 "T2R30, TAS2R47" ENSG00000256188 "Taste 2 receptor member 30" P59541 12 11132958-11134644 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" 21 "Cone photoreceptor cells: 7.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.0" NA NA "unprognostic (7.19e-3)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (3.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (7.01e-6)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.14e-1)" 0.3 0.3 0.2 0.1 0.3 1.0 1.0 1.3 0.6 0.9 0.3 0.2 0.9 0.4 0.2 0.4 0.3 0.4 0.3 0.1 0.2 0.5 0.4 0.5 0.1 1.8 0.3 1.0 0.6 0.5 0.8 0.3 0.4 0.4 0.3 0.7 0.5 0.1 0.2 0.5 0.3 0.6 0.8 0.3 0.4 0.6 0.2 0.5 0.4 0.2 0.2 0.6 0.0 0.4 0.3 0.5 0.6 0.1 0.7 0.1 0.3 0.3 0.1 0.6 0.5 0.1 0.6 0.0 0.2 1.4 0.3 0.0 0.0 0.9 0.6 0.0 0.1 0.2 0.0 0.5 0.5 0.0 1.1 0.1 1.1 2.0 0.8 0.4 1.3 0.2 0.9 0.5 0.6 0.0 0.2 1.6 0.0 0.2 0.0 0.7 0.1 1.1 0.6 0.4 0.3 0.4 0.0 0.0 1.3 0.1 0.0 0.3 1.1 0.7 0.4 0.1 0.1 0.0 0.7 0.3 0.0 0.2 0.4 0.2 0.2 0.6 0.1 0.1 0.1 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.6 0.0 0.1 0.1 1.3 0.0 0.0 0.0 1.2 0.0 7.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.1 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 TAS2R31 "T2R31, T2R53, TAS2R44" ENSG00000256436 "Taste 2 receptor member 31" P59538 12 11030387-11031407 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 3.9;SuSa: 1.7" NA NA "unprognostic (2.23e-2)" "unprognostic (3.80e-1)" "unprognostic (2.85e-2)" "unprognostic (4.70e-3)" "unprognostic (2.16e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-1)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (1.60e-2)" "unprognostic (2.72e-2)" "unprognostic (4.32e-2)" "unprognostic (7.54e-4)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (6.53e-3)" "unprognostic (1.83e-1)" 0.7 0.8 0.2 0.1 0.3 0.5 1.0 1.4 1.1 0.8 0.3 0.0 1.6 2.2 0.7 0.9 0.4 0.5 0.3 0.3 0.2 0.3 0.7 0.5 0.2 2.8 0.7 1.8 1.6 0.7 0.6 0.1 0.5 0.2 0.2 0.4 0.5 0.5 0.5 0.6 0.3 1.6 1.1 0.1 0.3 0.7 0.1 1.5 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.4 0.3 0.0 1.1 0.1 0.2 0.9 0.0 0.0 0.9 0.3 0.0 0.0 0.2 0.6 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 3.9 0.1 0.1 0.6 0.3 0.5 0.5 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.1 1.7 0.8 0.0 1.1 1.3 0.2 0.6 0.3 0.0 0.0 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R38 "PTC, T2R61" ENSG00000257138 "Taste 2 receptor member 38" P59533 7 141972631-141973773 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.3;NB-4: 1.1;OE19: 1.6;SK-BR-3: 1.1;U-266/70: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043862, HPA054366" Uncertain NA NA "HPA043862: AB_2678703, HPA054366: AB_2682464" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.58e-1)" "unprognostic (1.25e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-2)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.9 0.1 0.0 0.0 0.0 2.2 0.2 0.0 0.2 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R39 ENSG00000236398 "Taste 2 receptor member 39" P59534 7 143183419-143184435 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA053456, HPA060680" Uncertain NA NA "HPA053456: AB_2682157, HPA060680: AB_2684341" 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R40 GPR60 ENSG00000221937 "Taste 2 receptor member 40" P59535 7 143222037-143223079 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 6.3;lymphoid tissue: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 6.3" "Cell line enhanced" "Detected in some" "PC-3: 1.0;SK-BR-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R41 T2R59 ENSG00000221855 "Taste 2 receptor member 41" P59536 7 143477873-143478796 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA057063 Uncertain NA NA "HPA057063: AB_2683324" 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R43 T2R52 ENSG00000255374 "Taste 2 receptor member 43" P59537 12 11091287-11092313 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTERT-HME1: 4.6" NA NA "unprognostic (5.69e-3)" "unprognostic (1.48e-1)" "unprognostic (2.19e-1)" "unprognostic (1.48e-2)" "unprognostic (2.67e-1)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (3.49e-1)" "unprognostic (1.59e-1)" 0.4 0.2 0.0 0.0 0.0 0.6 1.0 1.8 0.0 0.4 0.3 0.0 0.7 1.0 0.2 0.4 0.3 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.0 1.1 0.4 0.8 0.6 0.1 0.3 0.1 0.3 0.7 0.4 0.1 0.6 0.3 0.1 0.6 0.2 0.4 0.5 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R46 T2R54 ENSG00000226761 "Taste 2 receptor member 46" P59540 12 11061365-11062294 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (7.73e-4)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" 0.3 0.5 0.0 0.5 0.0 1.0 0.2 1.4 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.9 0.4 0.1 0.4 0.1 0.3 0.3 0.1 0.1 0.1 0.8 0.3 0.1 0.2 0.3 0.2 0.4 0.4 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R50 T2R51 ENSG00000212126 "Taste 2 receptor member 50" P59544 12 10985913-10986912 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.55e-2)" "unprognostic (4.25e-1)" "unprognostic (1.14e-1)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (2.94e-1)" "unprognostic (2.24e-1)" "unprognostic (1.73e-1)" 0.3 0.1 0.0 0.2 0.1 0.4 0.6 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.6 0.2 0.0 0.3 0.4 0.1 0.0 0.2 0.0 1.0 0.3 0.3 0.1 0.1 0.4 0.1 0.2 0.3 0.3 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R60 T2R60 ENSG00000185899 "Taste 2 receptor member 60" P59551 7 143443453-143444409 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;liver: 1.4;pancreas: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;U-937: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA030416 Uncertain NA NA "HPA030416: AB_10603344" "unprognostic (1.78e-2)" "unprognostic (7.98e-2)" 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 1.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.5 1.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBATA "C10orf27, FLJ32820, spatial" ENSG00000166220 "Thymus, brain and testes associated" Q96M53 10 70771239-70785401 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 34.7" "Group enriched" "Detected in some" 20 "Early spermatids: 96.6;Late spermatids: 232.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 9.6" "Group enriched" "Detected in many" 4 "cerebellum: 31.5;hippocampal formation: 18.1" "Low region specificity" "Detected in single" NA NA "unprognostic (2.54e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "unprognostic (6.24e-2)" "unprognostic (1.45e-1)" "unprognostic (4.88e-1)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 96.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 232.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 TBC1D16 "FLJ20748, MGC25062" ENSG00000167291 "TBC1 domain family member 16" Q8TBP0 17 79932343-80035848 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 290.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 1.5;monocytes: 4.7" "Cell line enhanced" "Detected in many" "ASC diff: 52.5;SK-MEL-30: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024482, HPA065839" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA024482: AB_1857790, HPA065839: AB_2685566" "unprognostic (4.53e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" "unprognostic (4.92e-2)" "unprognostic (7.21e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (5.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-3)" "unprognostic (3.99e-3)" 32.2 8.1 10.1 7.8 18.2 1.0 32.6 25.5 11.2 10.7 8.6 6.0 28.4 7.5 11.9 20.9 9.8 12.8 9.3 10.0 8.1 7.8 18.1 13.2 8.5 13.7 8.7 5.6 11.8 18.7 9.3 6.6 7.1 8.2 17.3 5.8 15.4 25.5 24.2 4.5 15.8 7.9 10.8 8.1 8.7 7.6 5.2 9.5 2.7 9.7 7.0 3.9 9.2 14.6 1.5 0.3 0.1 4.7 0.1 0.5 0.3 8.2 7.9 12.3 14.4 52.5 27.7 2.3 4.8 4.8 3.0 3.5 14.8 2.9 0.0 3.4 8.1 5.8 2.6 12.9 4.5 2.3 0.4 6.1 0.0 3.6 6.8 8.9 0.1 1.1 31.1 8.0 6.6 4.8 4.9 13.0 5.6 1.9 5.6 5.7 5.1 2.1 0.7 14.7 10.8 4.3 6.9 7.8 4.7 3.6 10.2 12.6 16.3 4.3 12.1 55.7 8.0 7.9 3.7 8.7 10.7 7.7 8.4 4.2 17.2 3.0 0.9 4.6 3.1 13.5 0.0 0.3 0.0 0.1 4.6 0.5 0.0 0.1 0.2 0.3 1.5 0.2 0.3 0.1 0.1 4.7 0.0 0.0 0.3 10.1 18.2 25.5 11.2 8.1 7.8 8.7 5.6 8.2 9.5 0.0 9.3 0.8 3.6 4.8 6.6 7.2 17.8 2.7 2.3 7.0 9.8 5.2 8.3 13.8 1.0 9.0 3.2 0.0 19.3 1.1 12.8 9.6 7.0 16.2 3.0 290.8 30.5 15.4 43.0 1.6 5.5 3.8 72.6 1.0 6.4 21.5 16.9 2.8 7.4 10.0 7.4 6.5 10.5 0.2 3.4 4.0 1.6 3.8 5.0 5.7 TBC1D26 MGC51025 ENSG00000214946 "TBC1 domain family member 26" Q86UD7 17 15732247-15749192 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 15.3" "Group enriched" "Detected in some" 62 "Early spermatids: 164.5;Late spermatids: 74.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4;HMC-1: 1.9;SuSa: 1.8;U-698: 5.3" HPA050460 Uncertain NA NA "HPA050460: AB_2681136" "unprognostic (3.65e-2)" "unprognostic (2.31e-1)" "unprognostic (7.90e-2)" "unprognostic (3.22e-1)" "unprognostic (1.16e-1)" "unprognostic (3.20e-1)" "unprognostic (5.15e-9)" "unprognostic (9.32e-2)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "unprognostic (6.16e-2)" 0.1 0.0 1.5 0.1 3.3 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.0 15.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.4 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.9 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.8 0.0 0.2 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.3 0.0 1.8 0.0 1.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 TBC1D28 FLJ40244 ENSG00000189375 "TBC1 domain family member 28" Q2M2D7 17 18635006-18661950 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 19.0" "Group enriched" "Detected in some" 73 "Early spermatids: 45.5;Late spermatids: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;Karpas-707: 3.2;SuSa: 1.0;U-266/70: 2.5" NA NA "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 19.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D29 DKFZP434O047 ENSG00000266733 "TBC1 domain family member 29" Q9UFV1 17 30557112-30563493 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 10.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 9.8;Early spermatids: 10.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-937: 4.1" HPA059178 Uncertain NA NA "HPA059178: AB_2683939" "unprognostic (5.64e-2)" "unprognostic (1.01e-1)" "unprognostic (8.58e-2)" "unprognostic (9.36e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-1)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (7.96e-2)" "unprognostic (2.57e-1)" "unprognostic (3.49e-4)" "unprognostic (7.32e-2)" "unprognostic (2.97e-3)" "unprognostic (1.15e-1)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-4)" 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.2 0.1 0.3 0.8 0.1 0.0 0.1 0.2 0.2 10.9 0.3 0.3 0.2 0.0 0.9 0.3 1.1 0.2 0.0 0.4 0.0 1.5 1.4 1.1 0.5 0.5 0.5 2.0 0.6 0.2 0.4 0.7 0.8 1.3 0.5 0.5 0.1 0.3 2.5 0.4 0.3 0.4 0.5 1.2 0.8 2.8 0.1 0.0 1.1 1.5 1.0 0.8 1.1 0.3 1.3 0.2 0.9 0.2 1.5 0.2 0.6 0.2 1.2 0.4 0.2 0.7 0.7 0.8 0.9 0.3 2.2 0.4 0.7 0.1 0.2 0.2 1.3 1.6 0.2 0.6 0.6 1.3 0.8 0.3 1.6 1.2 0.1 0.4 4.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.9 0.0 0.4 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.1 0.0 0.0 0.0 1.8 9.8 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.0 0.9 TBC1D32 "bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235" ENSG00000146350 "TBC1 domain family member 32" Q96NH3 6 121079494-121334745 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.4" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 111.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013413 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013413: AB_10602702" "unprognostic (3.31e-2)" "unprognostic (1.28e-1)" "unprognostic (9.12e-3)" "unprognostic (4.82e-2)" "unprognostic (2.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.60e-4)" "unprognostic (7.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (8.14e-2)" "unprognostic (2.01e-2)" "unprognostic (3.73e-2)" "unprognostic (1.57e-2)" "unprognostic (7.62e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 3.2 7.3 7.3 5.5 8.8 2.4 5.0 3.9 11.1 5.7 3.5 4.8 3.8 4.5 5.1 4.1 4.1 4.8 5.6 3.5 7.0 4.1 4.5 1.8 3.2 3.0 8.1 7.8 6.5 4.0 9.7 25.4 8.2 8.0 5.0 2.4 4.2 4.6 3.2 1.7 5.5 4.6 2.4 7.0 3.1 3.8 9.2 7.9 8.1 7.0 2.1 3.2 3.7 5.1 6.4 10.7 5.8 1.3 3.4 3.7 0.4 1.6 2.0 3.2 4.2 2.9 4.4 1.6 1.8 2.7 3.1 4.6 0.1 1.1 2.9 3.1 2.0 4.7 1.5 1.5 1.6 3.8 22.0 2.1 3.7 0.6 0.7 1.3 1.8 1.5 1.7 1.1 2.9 2.0 3.7 0.6 3.7 2.1 0.0 2.4 1.0 2.1 1.1 1.9 1.0 0.7 1.8 1.6 0.3 1.7 0.8 6.6 3.3 2.3 1.3 1.0 1.8 2.0 1.5 0.4 2.1 2.1 0.5 2.1 1.5 0.0 1.3 2.8 1.0 3.2 5.8 1.3 1.7 2.6 0.7 1.9 3.4 1.9 1.8 0.8 6.4 3.7 2.8 1.1 3.4 1.1 10.7 2.1 0.4 7.3 8.8 3.9 11.1 7.0 4.1 8.1 7.8 8.0 7.9 3.0 5.9 1.5 3.2 5.5 27.8 2.9 5.1 24.1 13.6 7.0 41.2 3.8 0.0 2.2 3.4 3.2 4.2 0.0 1.9 1.3 6.1 2.8 3.5 1.0 1.2 12.7 5.2 3.7 1.3 2.1 2.3 3.3 1.7 1.0 5.2 5.8 0.9 3.5 1.8 1.0 111.1 0.0 3.1 12.6 7.9 4.4 1.9 3.2 2.8 1.8 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 6.6;testis: 3.5" "Cell type enriched" "Detected in some" 11 "Early spermatids: 11.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.5;HeLa: 9.8;T-47d: 8.0" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 0.0 0.1 1.0 0.4 0.4 0.1 0.0 0.1 1.2 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.2 0.0 0.8 0.8 1.2 6.6 0.5 0.0 2.0 1.9 3.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 1.0 0.4 0.1 1.5 2.5 1.5 1.8 1.5 1.8 4.9 1.2 0.7 1.3 2.1 0.5 11.5 0.2 1.0 0.7 0.6 5.0 0.7 1.1 0.5 2.0 3.9 0.8 9.8 0.7 0.9 0.3 1.4 1.5 2.3 1.6 0.2 3.3 1.0 1.2 0.7 1.1 0.5 0.1 1.0 4.4 0.5 0.4 0.5 1.5 0.4 0.2 1.6 1.5 1.0 1.3 1.1 0.7 0.9 2.0 8.0 1.0 2.7 0.5 0.4 4.0 0.5 1.6 1.2 0.5 1.5 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;skin 1: 3.5;testis: 3.4" "Cell type enriched" "Detected in single" 8 "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 27.5" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 1.2 0.5 0.1 0.0 1.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 3.5 0.0 0.1 0.0 1.5 3.4 0.0 0.9 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.3 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 1.0 0.0 0.0 2.8 5.6 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 7.9;skin 1: 4.2" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Cholangiocytes: 2.5;Club cells: 2.3;Cone photoreceptor cells: 5.9;Pancreatic endocrine cells: 2.5;Syncytiotrophoblasts: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;CAPAN-2: 11.6;HaCaT: 8.4;HeLa: 9.4;RPMI-8226: 5.0;RT4: 5.6" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.8 1.5 0.8 0.0 0.0 0.8 4.2 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 1.1 8.4 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 5.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.9 1.0 0.0 3.5 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.4 2.5 0.0 2.3 0.0 5.9 0.3 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HHSteC: 9.8" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 9.8 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "SiHa: 5.5;U-2197: 1.6" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3H ENSG00000274226 "TBC1 domain family member 3H" P0C7X1 17 36377531-36388423 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "CAPAN-2: 11.5" "HPA046969, HPA047745, HPA052553" Approved Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 1.8;Early spermatids: 2.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.7;hTERT-RPE1: 24.9" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 0.5 2.4 1.8 0.6 1.8 1.3 0.2 1.2 2.4 0.0 2.9 2.4 1.2 0.8 0.0 0.0 0.6 1.0 1.8 0.5 0.3 0.1 0.3 1.4 1.1 3.3 1.3 4.1 10.8 1.0 0.2 2.7 1.8 0.9 0.0 0.3 1.2 0.6 0.3 3.8 0.8 1.0 1.0 0.4 7.0 9.3 3.8 5.7 7.2 6.6 22.7 3.2 2.2 2.9 3.4 5.1 0.1 2.4 0.1 4.1 2.6 11.6 3.4 3.1 1.9 7.0 8.8 0.0 15.1 2.2 5.1 0.9 8.9 5.5 7.6 3.8 2.2 24.9 3.9 4.6 1.8 8.4 4.8 3.8 4.2 21.0 3.6 5.4 2.1 2.8 4.4 0.0 9.2 9.7 5.2 7.2 0.0 3.8 4.2 9.3 5.5 1.5 8.9 0.0 5.1 3.9 4.4 5.9 2.6 0.0 5.9 3.0 3.3 0.0 0.8 0.9 0.3 0.6 0.0 0.1 0.3 0.9 0.1 0.6 0.6 1.0 3.8 1.0 0.8 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.4 0.0 TBC1D9 "GRAMD9, KIAA0882, MDR1" ENSG00000109436 "TBC1 domain family member 9" Q6ZT07 4 140620765-140756120 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 52.4" "Cancer enriched" "Detected in all" 7 "breast cancer: 85.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.0" "Group enriched" "Detected in many" 38 "B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000262, HPA006503" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000262: AB_2665956, HPA006503: AB_2667604" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.22e-2)" "unprognostic (9.17e-2)" "unprognostic (2.11e-3)" "unprognostic (2.64e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-3)" "unprognostic (6.77e-2)" "prognostic favorable (1.61e-6)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.16e-2)" 15.9 6.2 8.1 9.2 10.0 1.0 33.6 37.6 13.7 9.2 6.7 3.8 32.1 5.2 5.5 6.4 5.9 6.7 9.4 5.7 7.5 13.9 10.7 8.0 10.4 9.6 9.6 8.2 10.9 6.0 9.9 5.7 13.1 11.0 9.8 4.3 10.6 7.3 27.4 1.7 2.8 9.9 5.0 5.3 20.4 10.0 2.9 3.8 1.6 4.3 3.0 12.2 11.1 8.9 9.0 4.6 0.1 2.4 0.1 0.0 0.9 0.4 6.4 6.0 5.1 14.6 13.8 12.2 8.1 8.8 5.9 7.6 1.3 5.6 0.0 5.2 10.6 7.4 1.2 7.4 5.8 5.6 0.0 4.1 3.6 4.6 5.5 5.3 0.5 0.5 11.3 9.7 5.1 20.6 17.3 16.4 2.0 0.0 0.0 5.5 6.3 0.8 0.0 0.9 6.7 5.6 3.9 9.8 9.3 6.8 11.8 8.8 6.2 8.5 15.0 5.5 10.6 3.5 0.2 25.4 15.7 4.7 10.2 7.0 0.0 0.0 0.0 9.5 0.7 8.5 0.0 2.4 0.0 0.0 1.9 0.0 9.0 0.0 0.0 4.0 4.0 0.0 0.0 0.1 0.1 0.7 4.6 0.0 0.9 8.1 10.0 37.6 13.7 7.5 13.9 9.6 8.2 11.0 3.8 50.6 9.4 15.7 8.9 4.0 33.1 6.5 17.8 5.3 6.8 52.4 3.9 10.8 6.6 13.3 0.4 24.1 4.1 0.0 15.0 3.9 11.5 19.8 0.0 14.5 15.9 9.5 7.5 17.8 30.7 0.0 12.0 30.7 8.5 25.2 4.5 40.9 13.2 5.9 25.1 3.8 7.0 0.0 9.5 0.7 1.5 3.3 36.2 0.5 1.7 8.4 TBCCD1 FLJ10560 ENSG00000113838 "TBCC domain containing 1" Q9NVR7 3 186546073-186570543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.15e-1)" "unprognostic (7.41e-3)" "unprognostic (6.36e-2)" "unprognostic (2.62e-2)" "unprognostic (8.79e-2)" "unprognostic (7.14e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.10e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-3)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (2.27e-1)" 9.9 9.2 6.9 8.8 9.9 8.3 14.3 14.4 11.6 9.2 9.1 10.5 13.5 8.5 11.9 10.6 10.4 9.1 8.6 8.6 8.6 6.7 8.7 12.6 8.4 11.9 11.5 8.5 10.8 11.7 13.2 13.2 10.3 12.0 8.2 9.9 14.2 10.6 7.7 8.9 10.2 10.0 8.8 7.9 9.3 8.5 27.2 10.5 15.1 11.8 5.8 13.4 9.0 9.9 12.8 13.5 15.7 10.8 14.9 18.2 9.8 8.2 6.3 9.5 9.5 8.9 9.9 6.9 6.4 4.6 8.4 9.4 10.9 7.2 9.3 17.0 5.1 7.0 9.3 13.5 6.4 10.8 15.3 7.6 12.8 5.2 6.7 5.2 12.1 9.1 5.8 7.2 7.2 9.3 5.5 12.9 12.8 9.9 10.0 8.2 10.2 11.4 7.2 5.6 18.6 10.7 13.0 10.2 11.8 6.0 5.6 10.9 6.9 11.7 13.9 6.7 8.3 18.5 8.0 8.1 6.2 7.6 7.1 10.2 13.9 22.4 24.6 6.6 11.5 11.7 15.7 10.4 12.0 13.4 10.2 17.3 12.8 14.5 15.0 13.5 11.6 12.1 14.7 4.6 14.9 10.8 7.9 18.2 9.8 6.9 9.9 14.4 11.6 8.6 6.7 11.5 8.5 12.0 10.5 14.9 5.9 4.9 2.2 5.7 6.0 2.7 2.5 10.7 1.2 1.8 2.0 3.2 10.0 5.4 1.3 4.5 3.6 0.0 5.7 4.7 4.1 1.8 11.5 4.0 4.2 0.0 3.5 6.7 4.6 2.4 5.5 5.4 5.0 5.4 5.9 4.8 4.1 3.7 3.5 2.8 6.3 6.5 3.8 40.3 18.3 3.6 3.4 5.7 5.2 1.8 TBL1Y TBL1 ENSG00000092377 "Transducin beta like 1 Y-linked" Q9BQ87 Y 6910686-7091683 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1;thyroid gland: 10.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "prostate cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enriched" "Detected in some" 6 "U-698: 14.5" "HPA050857, HPA060073" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA050857: , HPA060073: AB_2684196" "unprognostic (2.81e-3)" "unprognostic (2.94e-1)" "unprognostic (3.06e-1)" "unprognostic (7.76e-2)" "unprognostic (1.17e-2)" "unprognostic (1.28e-1)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.24e-2)" 1.0 0.0 0.1 0.2 0.5 0.1 1.0 0.1 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.5 1.3 0.1 3.8 0.1 0.1 0.2 1.4 3.3 3.0 0.8 0.1 0.0 0.1 15.1 0.0 0.1 0.3 0.7 7.2 0.4 1.6 5.8 0.7 1.3 0.6 0.3 0.1 0.0 0.1 0.7 3.5 0.0 0.1 10.8 2.9 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 2.2 0.0 2.4 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.4 0.1 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 TBPL2 "TBP2, TRF3" ENSG00000182521 "TATA-box binding protein like 2" Q6SJ96 14 55413541-55456726 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "testis cancer: 2.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 9.1;HMC-1: 5.3;U-2 OS: 4.3;U-937: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056241 Uncertain NA NA "HPA056241: AB_2683076" "unprognostic (3.42e-1)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (3.06e-4)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" 0.4 0.9 0.2 1.7 0.6 0.7 0.4 0.4 0.4 0.8 0.5 2.0 1.3 0.0 0.2 0.2 0.0 0.3 0.3 0.4 0.6 0.3 0.5 0.4 0.5 1.1 0.2 0.2 0.3 0.0 0.3 0.0 1.0 0.0 3.9 3.1 1.2 0.0 0.3 0.8 0.9 1.9 0.5 0.0 0.2 0.3 1.5 1.1 1.5 1.1 1.6 0.9 0.5 3.3 1.0 0.0 1.0 0.0 1.1 2.2 0.0 0.0 0.0 0.4 0.5 0.5 0.6 2.8 0.0 0.3 0.8 0.2 0.0 0.0 9.1 0.0 0.7 0.8 0.0 0.0 0.0 5.3 0.0 1.7 0.0 0.4 0.0 0.0 0.2 0.5 3.3 0.0 2.3 0.5 1.7 0.7 0.1 0.9 0.8 0.0 0.6 0.0 1.3 1.8 0.9 0.0 0.2 0.3 0.0 1.2 1.2 0.0 0.3 4.3 0.4 0.7 3.1 1.4 0.4 0.5 6.8 0.2 1.5 0.5 0.5 0.9 1.1 0.6 1.0 0.5 0.4 0.6 1.5 0.5 0.2 1.0 1.6 0.3 1.1 0.1 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 TBX10 "TBX13, TBX7" ENSG00000167800 "T-box 10" O75333 11 67631303-67639560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "intestine: 12.1" "Group enriched" "Detected in some" 8 "Enterocytes: 18.4;Mucus-secreting cells: 66.7" "Group enriched" "Detected in some" 5 "breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.9;NTERA-2: 6.8;RPMI-8226: 4.4;SK-BR-3: 15.9;U-2 OS: 3.4" "Region enriched" "Detected in single" 7 "pons and medulla: 0.4" "Low region specificity" "Detected in many" HPA047881 Uncertain "Intracellular and membrane" NA NA "HPA047881: AB_2680199" "unprognostic (4.66e-2)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (1.83e-4)" "unprognostic (3.12e-1)" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (4.90e-1)" "unprognostic (1.17e-10)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (2.95e-1)" "unprognostic (2.75e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 9.9 0.2 0.2 6.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.4 0.2 0.2 0.0 12.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.0 15.9 0.0 0.1 0.0 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 66.7 0.0 0.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 TCAIM "C3orf23, DKFZp313N0621, TOAG-1" ENSG00000179152 "T cell activation inhibitor, mitochondrial" Q8N3R3 3 44338119-44409451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.15e-1)" "unprognostic (9.21e-2)" "unprognostic (1.98e-1)" "unprognostic (4.24e-1)" "unprognostic (1.82e-1)" "unprognostic (8.55e-2)" "unprognostic (1.93e-3)" "unprognostic (5.07e-3)" "unprognostic (5.60e-2)" "prognostic favorable (2.19e-7)" "unprognostic (4.03e-1)" "unprognostic (1.49e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.81e-4)" 10.1 10.0 10.4 7.4 11.7 5.1 9.7 17.4 12.2 6.5 9.9 9.9 5.9 9.7 9.4 8.7 12.0 6.4 9.3 15.4 9.8 10.4 21.8 38.4 9.4 7.4 12.9 6.4 8.2 8.4 17.9 11.6 8.6 12.0 10.2 10.3 7.6 7.2 8.0 17.0 7.5 10.1 8.4 19.6 9.8 9.9 5.5 11.1 12.0 7.5 8.5 7.7 11.3 6.8 3.5 10.7 11.5 10.1 3.2 8.6 4.1 9.4 4.9 4.7 6.5 7.3 5.3 10.5 7.6 9.8 10.1 9.9 4.6 23.8 13.7 6.3 5.5 7.6 4.2 4.6 11.2 10.4 5.6 6.2 9.8 6.8 10.3 14.4 14.2 8.9 7.8 20.3 9.8 11.8 7.6 12.6 14.2 12.3 8.4 8.4 6.4 15.1 7.5 4.3 11.0 11.2 3.2 5.6 10.3 19.2 13.8 5.2 9.7 10.8 14.7 14.9 8.5 10.7 9.8 10.5 5.3 7.1 13.7 13.0 4.4 8.3 10.0 13.2 13.0 7.5 11.5 8.2 10.0 3.8 10.1 4.0 2.4 4.6 3.9 10.7 3.5 3.9 5.6 3.9 3.2 9.8 5.7 8.6 4.1 10.4 11.7 17.4 12.2 9.8 10.4 12.9 6.4 12.0 11.1 8.9 17.3 6.0 8.3 9.2 16.5 28.1 25.5 10.7 6.8 14.0 11.8 11.3 51.4 21.1 1.8 9.5 10.4 0.0 18.1 16.8 10.8 9.1 20.7 41.9 17.5 23.8 5.8 14.7 16.7 1.4 8.1 12.5 6.8 12.6 15.4 12.8 20.4 16.9 4.6 33.8 12.7 12.9 8.2 5.4 9.5 8.3 11.2 7.5 15.1 9.5 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 143.3;Distal tubular cells: 59.7;Horizontal cells: 92.2;Muller glia cells: 150.4" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" "Group enriched" "Detected in some" 4 "HAP1: 7.4;SCLC-21H: 8.1;U-2 OS: 14.6" HPA076317 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA076317: AB_2686794" "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 6.0 12.3 0.0 55.7 1.6 143.3 4.6 0.0 0.0 22.7 29.6 5.9 0.0 59.7 0.1 2.9 8.7 0.0 0.0 0.3 0.1 5.3 42.5 2.3 0.0 0.0 92.2 0.0 3.7 0.0 7.5 6.1 1.0 6.8 1.0 0.0 150.4 1.6 0.0 5.3 0.5 40.9 6.5 17.0 1.7 1.1 1.1 0.0 0.0 0.0 6.3 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 30.0;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.1;SCLC-21H: 2.0" "HPA045564, HPA058982" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 1.1 14.3 16.6 1.3 15.2 1.0 1.1 31.4 48.4 1.2 1.4 2.5 0.0 1.3 5.3 2.8 1.1 3.2 1.1 1.1 11.3 26.0 1.2 1.0 1.0 1.0 15.2 7.5 6.1 1.3 1.1 20.7 1.0 12.5 1.9 1.3 2.0 3.1 1.9 1.0 1.0 1.3 1.9 7.5 1.0 1.0 21.9 2.8 0.0 1.8 0.0 1.0 1.0 1.7 0.7 0.6 0.1 0.5 1.3 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.1 0.5 0.3 0.7 0.4 0.2 0.3 0.5 0.7 0.4 0.6 0.0 1.3 0.0 0.6 0.6 0.6 16.6 15.2 31.4 26.0 11.3 26.0 15.2 7.5 12.5 2.8 0.0 0.0 0.0 0.2 0.1 30.0 4.0 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 2.6 2.3 0.0 1.7 0.0 0.0 2.0 0.7 0.0 0.7 0.0 4.3 0.0 1.9 1.1 0.8 0.3 0.0 0.0 0.0 0.0 TCEAL7 "MGC23947, WEX5" ENSG00000182916 "Transcription elongation factor A like 7" Q9BRU2 X 103330196-103332326 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 70.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 34.8;Horizontal cells: 46.1;Leydig cells: 40.6;Muller glia cells: 77.7;Peritubular cells: 36.7;Smooth muscle cells: 31.7" "Cancer enriched" "Detected in many" 10 "glioma: 39.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.3" "Lineage enhanced" "Detected in single" "NK-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 23.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;GAMG: 31.8;hTEC/SVTERT24-B: 23.0;SCLC-21H: 58.2;U-87 MG: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051507, HPA065080" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051507: AB_2681512, HPA065080: AB_2685419" "unprognostic (1.09e-2)" "unprognostic (4.36e-2)" "unprognostic (5.54e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (4.52e-2)" "unprognostic (2.17e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (1.12e-1)" "unprognostic (4.18e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.62e-1)" "unprognostic (2.28e-2)" "unprognostic (1.35e-3)" 4.9 22.1 31.7 3.8 33.4 1.0 7.8 33.0 70.4 16.8 6.4 20.1 1.8 3.9 36.4 14.7 5.1 5.4 9.7 9.5 31.1 44.2 4.6 2.6 3.8 2.5 34.4 27.4 23.2 1.3 1.3 14.0 2.5 51.8 10.3 6.9 2.0 2.9 11.3 2.9 1.5 4.9 23.3 45.1 5.0 2.6 3.2 19.4 0.0 3.0 2.2 1.9 7.5 5.7 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 23.0 0.0 10.1 15.6 4.1 3.2 16.9 7.2 20.7 0.0 0.0 0.0 0.0 3.4 31.8 0.0 0.0 0.4 12.5 0.0 0.2 0.1 0.0 0.0 5.1 0.0 0.0 13.1 0.0 23.0 0.0 0.0 7.5 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.6 0.0 0.0 0.0 58.2 15.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.7 33.4 33.0 46.7 31.1 44.2 34.4 27.4 51.8 19.4 0.0 2.2 0.0 5.2 2.3 34.8 14.1 0.0 0.0 1.2 3.5 3.9 1.2 5.0 0.2 0.2 1.9 0.0 0.0 0.0 0.3 6.1 0.9 0.0 0.0 0.5 46.1 0.0 2.5 0.0 1.4 40.6 0.8 8.5 0.0 0.0 77.7 0.5 0.0 36.7 1.0 10.2 12.9 31.7 3.1 0.9 2.8 0.2 0.0 0.0 0.9 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.7;thyroid gland: 24.1" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 96.9" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.4 1.9 2.7 0.4 4.1 0.4 0.6 3.0 9.7 0.5 0.4 0.0 0.0 0.4 0.6 1.1 0.6 0.4 0.4 0.4 3.8 3.5 0.4 0.4 0.5 0.4 0.9 3.9 5.5 0.8 0.4 4.8 0.4 1.5 1.4 0.4 3.8 0.3 1.3 0.3 1.2 0.4 0.4 2.2 0.6 0.5 1.8 0.0 0.6 24.1 0.0 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 4.1 3.0 9.7 3.8 3.5 0.9 3.9 1.5 0.0 0.0 0.0 0.0 0.1 0.6 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.6 0.0 0.0 0.0 96.9 0.0 0.0 0.0 0.0 4.4 0.0 10.1 0.0 0.0 0.8 0.1 0.0 4.2 0.0 3.6 0.0 0.0 0.1 4.7 0.5 0.1 0.0 0.0 0.0 TCF15 "bHLHa40, EC2, PARAXIS" ENSG00000125878 "Transcription factor 15" Q12870 20 603797-610398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 8.5;Endothelial cells: 4.3;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 10.9;HMC-1: 17.9;SuSa: 3.3;U-2 OS: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050998, HPA060221" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA050998: AB_2681302, HPA060221: AB_2684225" "unprognostic (2.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.58e-2)" "unprognostic (3.55e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.57e-2)" "unprognostic (2.33e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.52e-1)" "unprognostic (9.43e-2)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (8.56e-2)" "unprognostic (5.11e-1)" "unprognostic (6.99e-2)" 8.4 0.3 0.9 0.4 1.0 0.2 11.4 0.1 1.1 0.6 1.3 0.1 0.0 0.4 0.8 0.3 1.7 0.4 0.7 19.4 1.2 0.7 0.5 0.3 0.9 0.3 1.0 0.0 0.2 0.1 0.4 0.3 8.2 0.7 1.0 0.3 0.3 0.8 0.3 18.0 0.2 0.4 1.3 1.1 0.2 0.4 1.6 0.6 0.2 1.3 6.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.1 10.9 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 1.6 0.0 1.4 0.0 3.3 0.0 1.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.1 1.1 1.2 0.7 1.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.1 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 12.9 1.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 TCF21 "bHLHa23, POD1" ENSG00000118526 "Transcription factor 21" O43680 6 133889138-133895553 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 74.4;ovary: 61.6" "Group enriched" "Detected in some" 5 "Leydig cells: 94.6;Peritubular cells: 110.0;Sertoli cells: 116.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HHSteC: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA013189 Uncertain NA NA "HPA013189: AB_10601215" "unprognostic (2.43e-2)" "unprognostic (8.45e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "unprognostic (4.78e-5)" "unprognostic (2.58e-2)" "unprognostic (6.66e-2)" "unprognostic (9.74e-2)" "unprognostic (2.88e-2)" "unprognostic (2.91e-3)" "unprognostic (2.01e-2)" "unprognostic (8.48e-2)" "unprognostic (5.37e-2)" "unprognostic (2.95e-1)" 4.7 2.2 0.2 11.6 0.5 0.0 0.4 0.2 0.2 12.7 16.8 0.4 9.6 5.2 12.9 9.6 19.1 2.2 14.6 13.2 0.2 0.2 17.0 4.1 74.4 1.0 0.2 0.0 61.6 1.9 0.0 2.4 48.4 1.2 57.8 5.3 0.0 0.2 16.0 0.8 0.3 13.9 21.1 0.2 52.2 5.7 5.9 0.0 0.0 0.5 0.0 0.0 19.6 24.6 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.0 1.2 0.0 3.0 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 19.5 0.3 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 94.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.0 0.0 0.0 116.4 1.7 0.2 0.4 0.0 4.8 0.0 0.0 0.4 TCF23 "bHLHa24, OUT" ENSG00000163792 "Transcription factor 23" Q7RTU1 2 27149004-27156974 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9" "Group enriched" "Detected in some" 4 "Peritubular cells: 27.3;Sertoli cells: 51.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 10 "THP-1: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044596 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044596: AB_10797258" "unprognostic (1.04e-1)" "unprognostic (2.47e-3)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (3.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-2)" "unprognostic (4.07e-2)" "unprognostic (3.21e-1)" "unprognostic (1.74e-2)" "unprognostic (4.08e-2)" "unprognostic (8.58e-2)" "unprognostic (2.41e-5)" "unprognostic (7.58e-3)" "unprognostic (3.01e-1)" "unprognostic (8.58e-4)" "unprognostic (2.64e-2)" 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 28.0 0.5 0.0 0.5 0.0 56.4 7.2 0.1 14.0 0.4 0.6 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 49.9 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 16.7 0.1 6.2 0.1 7.5 0.0 0.0 0.1 0.0 0.0 0.7 1.5 1.8 1.4 4.4 1.0 1.3 1.2 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.5 0.1 0.6 0.3 0.0 0.1 0.9 0.1 0.7 0.0 0.3 0.2 0.1 0.2 0.3 0.1 0.3 0.3 8.8 0.0 0.2 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 4.4 1.0 0.9 1.0 0.5 0.8 1.1 1.1 0.8 0.2 1.8 1.2 1.0 3.9 1.3 0.5 1.4 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.1 0.0 0.5 0.0 0.1 0.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.3 0.7 9.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.3 0.0 0.5 51.8 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.5 TCF7L1 TCF3 ENSG00000152284 "Transcription factor 7 like 1" Q9HCS4 2 85133410-85310388 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 37.8;Ito cells: 37.4;Leydig cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.2;NTERA-2: 42.5;RH-30: 19.3;T-47d: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071298 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071298: AB_2686383" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.05e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (6.16e-5)" "unprognostic (1.79e-2)" "unprognostic (3.59e-3)" "unprognostic (2.73e-1)" "unprognostic (5.17e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.06e-4)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (5.38e-4)" 21.0 3.9 3.3 6.5 6.4 4.2 28.7 5.1 5.3 28.2 14.7 7.5 14.5 4.1 21.2 11.8 13.8 10.4 9.1 11.6 6.0 3.0 9.3 7.6 11.1 5.5 4.5 3.8 20.3 3.2 11.6 5.7 4.8 6.3 14.0 4.3 16.8 8.8 19.6 13.4 8.3 6.9 17.8 5.9 7.9 6.8 7.3 5.5 2.2 18.6 8.7 6.1 18.0 20.4 3.7 2.0 8.4 1.2 1.8 2.2 0.4 0.9 0.7 14.5 11.0 5.5 1.1 8.8 1.0 3.6 2.5 2.3 2.1 0.9 0.4 1.7 2.3 2.8 2.3 11.0 18.2 1.7 0.8 1.8 0.3 0.8 0.9 0.5 0.8 2.2 0.9 3.4 0.2 0.6 1.2 4.8 0.7 0.3 0.8 2.9 0.6 0.0 0.8 42.5 0.5 0.4 0.3 19.3 0.2 1.2 1.6 0.5 4.5 1.7 7.4 0.5 11.7 18.9 0.3 5.2 2.8 4.2 0.2 1.3 0.5 0.2 0.3 0.1 0.5 2.2 8.4 1.2 2.2 1.2 1.0 1.5 2.1 1.4 1.6 0.4 3.7 1.7 2.2 3.4 1.8 1.0 2.0 1.1 0.4 3.3 6.4 5.1 4.0 6.0 3.0 4.5 3.8 6.3 5.5 6.0 37.8 0.0 11.9 5.4 0.0 6.2 5.1 9.4 11.4 15.7 0.0 5.3 0.0 3.0 22.5 21.0 0.7 0.0 5.0 4.0 12.1 7.6 4.7 5.9 1.5 0.0 0.0 37.4 6.6 3.6 60.4 2.8 3.3 1.8 1.7 5.2 1.3 0.0 26.9 1.4 0.2 6.5 18.1 1.9 10.9 3.0 1.1 0.5 1.2 2.2 TCFL5 "bHLHe82, CHA, E2BP-1, Figlb" ENSG00000101190 "Transcription factor like 5" Q9UL49 20 62841115-62861763 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.9;testis: 55.7" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055223, HPA076419" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA055223: AB_2682745, HPA076419: " "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.78e-1)" "unprognostic (2.72e-3)" "unprognostic (3.95e-2)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.88e-1)" "unprognostic (1.54e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-1)" "unprognostic (1.33e-3)" "unprognostic (1.01e-2)" 5.4 3.9 18.6 4.0 18.9 3.7 6.4 4.6 14.8 6.5 4.1 22.5 6.1 3.2 5.7 6.6 6.0 5.9 5.0 5.5 20.0 15.5 5.0 4.6 3.6 4.7 25.4 10.7 8.3 4.8 7.5 3.0 4.8 17.0 4.9 3.8 6.3 4.9 6.3 4.5 10.9 3.5 5.5 32.9 4.1 3.7 55.7 12.0 8.3 14.9 2.1 5.0 4.6 3.2 1.4 1.9 2.9 1.6 1.2 3.2 0.7 12.9 3.9 8.6 9.9 18.6 18.9 7.7 8.4 11.7 16.4 9.2 9.5 8.0 6.6 9.7 7.4 8.8 14.3 8.6 9.5 14.4 4.6 7.2 5.4 11.2 14.0 7.3 7.9 6.6 6.9 14.2 4.6 9.7 7.1 7.4 10.2 6.0 2.5 7.6 15.7 34.7 10.0 5.6 10.8 12.4 19.2 15.1 9.2 4.4 3.8 12.4 6.7 14.9 6.1 22.7 6.3 10.4 14.8 7.9 13.1 8.6 11.4 9.8 6.4 4.3 5.5 7.9 9.9 7.1 0.5 1.6 2.9 3.2 1.5 1.9 1.3 2.3 2.1 1.2 1.4 2.5 1.7 2.8 1.2 1.5 1.9 2.3 0.7 18.6 18.9 4.6 14.8 20.0 15.5 25.4 10.7 17.0 12.0 0.0 1.0 0.0 1.2 9.3 9.2 3.6 2.5 0.0 1.2 7.0 5.9 0.5 1.7 1.2 11.4 3.6 1.4 0.0 1.1 0.8 3.1 1.4 0.0 2.9 0.9 7.9 2.4 3.1 4.4 5.9 7.2 1.7 3.3 1.0 2.4 9.7 0.8 1.9 6.7 1.7 6.7 0.0 2.1 62.7 8.4 12.4 0.2 1.0 2.6 0.9 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084144-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 1.7;skin 1: 3.8;tongue: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "SK-BR-3: 10.7" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCP10 ENSG00000203690 "T-complex 10" Q12799 6 167357031-167384510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 16.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 50.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 2.5;SCLC-21H: 1.9" "HPA044709, HPA078219" Enhanced NA NA "HPA044709: AB_10961410, HPA078219: " "unprognostic (8.33e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 50.1 0.4 0.0 0.0 0.0 0.2 0.0 TCP11L2 MGC40368 ENSG00000166046 "T-complex 11 like 2" Q8N4U5 12 106301929-106347015 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 21.6;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 32.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 32.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039483, HPA042188" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA039483: AB_10795291, HPA042188: AB_10794415" "unprognostic (1.41e-1)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (8.15e-2)" "unprognostic (1.97e-1)" "prognostic favorable (9.52e-4)" "unprognostic (3.87e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-1)" "unprognostic (9.05e-3)" "unprognostic (5.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-2)" "unprognostic (3.67e-1)" 9.1 12.0 8.1 6.2 18.2 22.3 9.0 10.4 13.0 9.7 8.6 31.5 3.3 6.2 10.3 7.1 20.1 11.6 8.1 18.9 8.3 5.8 6.1 5.6 14.4 12.9 22.2 9.4 9.7 8.6 11.1 7.2 12.3 16.2 7.5 7.9 9.5 15.9 5.9 18.0 14.0 10.3 10.2 14.6 10.2 10.2 8.7 18.4 16.4 12.2 6.3 14.0 11.3 11.8 6.2 0.8 32.1 3.2 1.9 6.3 1.7 2.5 6.2 0.9 1.8 8.6 10.0 3.9 1.6 8.0 1.0 2.6 1.0 3.3 0.8 2.5 6.2 2.4 11.7 0.8 3.5 1.9 1.3 2.6 0.5 2.4 3.8 8.4 0.2 1.7 12.5 8.1 1.2 6.1 20.0 5.8 4.6 1.5 1.2 1.4 1.8 1.5 1.3 1.1 3.3 3.9 0.7 0.2 2.8 8.1 11.6 3.9 2.8 4.2 1.3 4.8 6.9 3.6 0.3 4.4 1.5 1.3 2.2 0.4 7.8 0.6 3.0 4.2 0.2 0.7 10.8 3.2 4.9 2.4 1.4 1.8 6.2 4.9 2.7 0.8 5.7 6.3 4.1 32.1 1.9 2.2 0.6 5.6 1.7 8.1 18.2 10.4 13.0 8.3 5.8 22.2 9.4 16.2 18.4 11.9 11.8 9.3 3.0 1.0 7.0 8.5 0.0 16.0 10.3 3.5 21.6 1.2 1.7 2.6 4.2 7.7 3.3 0.0 2.2 0.6 2.9 3.7 2.3 1.3 1.2 20.6 4.1 3.1 1.5 3.3 5.5 3.3 3.3 3.6 3.1 3.1 2.9 3.5 2.5 0.8 13.8 12.9 2.8 1.5 2.1 2.3 12.6 4.3 1.5 2.6 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278743-44297688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 17.3;testis: 48.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.7;Late spermatids: 222.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.2;U-266/70: 1.8;U-266/84: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031739 Uncertain Vesicles NA NA Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 2.2 0.2 2.2 1.1 0.2 5.8 1.8 0.7 0.2 1.1 0.0 0.2 0.6 3.0 0.2 17.3 0.3 0.2 2.8 2.0 0.2 0.2 2.1 0.2 0.8 1.0 2.2 0.3 0.2 0.2 0.2 3.2 0.4 0.2 0.0 0.4 0.4 0.2 0.6 0.3 0.3 0.6 0.3 0.2 48.6 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.3 0.1 0.2 0.1 0.6 0.3 0.0 0.0 2.6 0.3 0.0 0.4 0.1 3.8 0.0 0.3 0.2 0.5 0.2 0.2 0.0 0.9 0.4 0.0 0.0 0.1 3.2 1.1 0.0 0.2 1.2 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 1.8 3.2 0.3 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.1 0.2 0.0 2.2 2.2 5.8 1.8 2.8 2.0 0.8 1.0 3.2 0.3 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.0 16.0 2.3 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 10.7 1.9 0.0 0.1 0.0 0.0 0.0 TCTN1 "FLJ21127, JBTS13, TECT1" ENSG00000204852 "Tectonic family member 1" Q2MV58 12 110614027-110649430 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 186.0;Spermatocytes: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039687, HPA040036" Approved Approved "Nucleoplasm,Actin filaments" "Intracellular and membrane" NA NA "Nucleoplasm, Actin filaments" "HPA039687: AB_10795293, HPA040036: AB_10794759" "unprognostic (2.54e-1)" "unprognostic (7.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (1.13e-5)" "unprognostic (2.89e-2)" "unprognostic (6.53e-2)" "unprognostic (2.11e-1)" "unprognostic (3.05e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (9.60e-2)" "unprognostic (9.97e-2)" "unprognostic (2.15e-2)" "unprognostic (8.41e-2)" "unprognostic (1.24e-1)" "unprognostic (4.27e-2)" 8.0 12.4 11.2 5.1 13.8 3.0 8.9 5.6 10.1 17.7 5.4 12.3 20.6 4.1 10.3 28.7 5.4 35.4 12.3 14.4 11.0 13.0 16.1 7.2 11.6 5.5 11.0 5.3 15.5 9.1 24.1 32.9 8.4 22.1 14.5 4.0 16.3 10.2 20.6 8.0 5.3 4.1 10.3 8.9 6.0 7.2 24.7 8.0 4.4 25.5 3.9 5.2 8.8 12.2 13.7 5.0 8.4 3.5 1.1 2.9 1.9 6.9 8.8 6.2 16.9 17.7 15.4 3.1 4.9 10.2 4.6 4.0 2.0 2.1 1.4 4.4 12.2 4.5 4.9 3.6 3.7 3.3 3.0 5.7 0.4 3.6 4.2 8.4 0.7 0.7 9.6 5.7 6.0 7.3 29.2 3.3 2.2 4.8 2.9 5.6 10.1 0.5 2.4 3.0 3.7 11.8 1.7 3.3 9.9 14.1 1.6 5.3 7.0 8.5 2.0 4.1 4.8 14.2 8.0 3.6 7.9 2.0 2.8 4.2 2.8 1.3 1.9 7.9 0.7 6.3 0.3 2.4 0.4 1.3 3.5 2.9 6.3 1.9 2.7 3.7 13.7 2.9 2.4 8.4 1.1 2.0 5.0 0.6 1.9 11.2 13.8 5.6 10.1 11.0 13.0 11.0 5.3 22.1 8.0 3.0 13.1 7.7 24.6 12.2 10.1 10.2 22.9 186.0 23.9 15.7 29.5 22.5 8.3 18.4 56.3 9.8 0.4 0.0 4.2 7.8 27.9 22.4 3.5 6.8 10.3 3.2 17.3 8.6 3.2 9.5 15.8 7.6 21.9 1.0 5.6 27.8 5.2 0.0 26.9 32.2 30.2 6.5 15.6 102.1 36.2 9.8 15.3 2.2 3.9 12.4 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671113-123708403 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.5 5.5 6.4 5.1 18.1 2.3 8.4 10.5 10.0 11.2 5.6 9.1 12.0 2.9 15.7 14.1 4.1 32.0 7.2 5.4 6.2 10.2 11.8 2.3 9.4 4.0 4.4 8.3 18.0 7.9 16.1 18.8 5.3 18.5 11.0 4.9 17.6 11.9 10.2 1.9 10.2 3.9 7.1 4.2 4.5 6.1 17.2 3.2 3.1 15.6 5.1 4.2 5.9 7.5 4.5 4.7 2.4 1.1 1.4 5.4 0.4 10.1 10.0 7.6 10.5 10.4 11.7 8.8 3.9 7.4 8.0 6.7 6.3 10.2 0.3 6.3 6.0 7.3 13.2 4.1 3.4 8.1 2.1 6.1 1.0 7.0 4.7 3.6 2.6 3.9 5.8 7.0 11.3 3.3 24.0 10.7 3.6 5.4 0.2 5.6 5.3 2.9 5.4 4.7 3.9 6.1 2.9 7.6 1.4 10.0 7.4 4.5 5.9 11.9 4.1 5.5 8.1 17.2 3.6 6.6 11.3 5.8 10.1 4.7 2.9 5.8 0.9 14.4 0.3 6.7 2.4 0.5 2.2 3.9 1.1 5.4 3.8 4.4 4.0 0.8 4.5 5.0 5.0 0.8 1.4 0.9 4.7 2.5 0.4 6.4 18.1 10.5 10.0 6.2 10.2 4.4 8.3 18.5 3.2 3.0 4.0 1.7 2.1 3.7 4.8 3.1 7.6 45.5 5.7 7.0 11.8 2.5 0.0 2.5 5.7 1.4 0.5 0.0 1.8 2.7 2.7 2.0 3.5 0.0 1.2 0.0 1.2 4.3 0.0 2.3 2.3 0.4 5.0 1.8 2.0 5.2 1.6 0.0 4.6 1.1 14.4 0.0 1.4 11.9 10.9 1.9 0.9 2.5 2.4 0.8 TDRD10 DKFZp434M202 ENSG00000163239 "Tudor domain containing 10" Q5VZ19 1 154502219-154548147 "Cancer-related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 48.4" "Group enriched" "Detected in some" 5 "Early spermatids: 47.9;Late spermatids: 66.1;Spermatocytes: 133.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 2.2;HUVEC TERT2: 7.7;RPMI-8226: 2.1;TIME: 4.1" "Low region specificity" "Detected in all" HPA054327 Approved Vesicles NA NA Vesicles "HPA054327: AB_2682452" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.33e-3)" "unprognostic (9.69e-3)" "unprognostic (5.80e-3)" "unprognostic (2.99e-1)" "unprognostic (5.97e-3)" "unprognostic (2.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.00e-3)" "unprognostic (1.61e-1)" "unprognostic (1.34e-3)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (8.04e-5)" "unprognostic (1.62e-1)" 4.1 1.4 0.7 1.1 0.9 0.0 2.6 0.7 1.4 1.3 0.8 0.9 1.4 0.5 2.1 2.0 1.0 2.1 1.2 2.3 0.7 0.0 1.0 1.5 3.3 1.6 0.9 1.2 4.6 0.7 0.8 0.8 1.4 1.2 1.1 1.1 0.7 0.7 1.0 1.1 0.7 1.0 1.4 1.2 3.5 0.5 48.4 0.8 0.7 4.9 1.5 1.0 1.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.1 4.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.9 0.7 1.4 0.7 0.0 0.9 1.2 1.2 0.8 3.0 7.9 0.0 0.0 0.6 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 47.9 4.7 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.3 0.0 0.0 6.2 3.5 66.1 2.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 133.2 17.2 0.3 0.0 0.0 0.0 0.0 TDRD12 "ECAT8, FLJ13072" ENSG00000173809 "Tudor domain containing 12" Q587J7 19 32719753-32829580 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 36.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 18.5;Spermatocytes: 43.5;Spermatogonia: 44.9" "Cancer enriched" "Detected in many" 9 "testis cancer: 10.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Group enriched" "Detected in some" 30 "HDLM-2: 12.8;NTERA-2: 42.6" "Low region specificity" "Detected in many" NA NA "unprognostic (5.43e-2)" "unprognostic (3.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.87e-7)" "unprognostic (5.44e-2)" "unprognostic (1.78e-1)" "unprognostic (6.79e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.40e-1)" "unprognostic (9.69e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-4)" "unprognostic (2.09e-1)" "unprognostic (4.75e-2)" "unprognostic (3.08e-2)" "unprognostic (2.69e-2)" 0.2 0.7 0.2 0.1 0.4 0.0 0.4 0.2 0.5 0.9 0.3 0.2 0.6 0.0 1.1 8.5 0.2 1.1 0.3 0.3 0.1 0.2 0.9 0.1 0.2 0.8 0.3 0.1 1.8 0.1 0.0 0.2 0.2 0.6 0.2 0.0 0.3 0.2 0.6 0.1 1.7 1.2 0.1 0.1 0.9 0.2 36.1 0.1 0.6 0.9 0.1 0.6 0.5 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 12.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.2 0.5 0.1 0.2 0.3 0.1 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.6 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 18.5 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 9.0 2.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.4 0.2 0.3 0.0 0.1 43.5 44.9 0.1 0.2 0.0 0.2 0.0 TDRD15 ENSG00000218819 "Tudor domain containing 15" B5MCY1 2 21123917-21143272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 11.3" "Cell type enhanced" "Detected in some" 24 "Late spermatids: 7.8;Sertoli cells: 6.5;Spermatocytes: 22.8;Spermatogonia: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-266/70: 13.0;U-266/84: 4.7" "Not detected" "Not detected" "HPA051770, HPA054675" Uncertain NA NA "HPA051770: AB_2681601, HPA054675: AB_2682569" "unprognostic (4.20e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 1.3 0.0 7.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 22.8 4.5 0.0 0.0 0.0 0.0 0.0 TDRD6 "bA446F17.4, CT41.2, NY-CO-45, SPATA36" ENSG00000180113 "Tudor domain containing 6" O60522 6 46687875-46704319 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 37.9" "Cell type enhanced" "Detected in many" 23 "Early spermatids: 172.1;Spermatocytes: 66.0;Spermatogonia: 30.6" "Cancer enhanced" "Detected in some" "prostate cancer: 2.1" "Region enriched" "Detected in many" 6 "cerebellum: 8.2" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 1.4" "Lineage enhanced" "Detected in single" "monocytes: 2.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.6;HeLa: 4.0;hTCEpi: 2.3;PC-3: 3.4;SCLC-21H: 1.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA075923, HPA077353" Enhanced Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Vesicles "HPA075923: , HPA077353: " "unprognostic (2.01e-1)" "unprognostic (7.41e-3)" "unprognostic (7.25e-3)" "unprognostic (3.88e-2)" "unprognostic (3.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (7.97e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-3)" "unprognostic (2.20e-1)" "unprognostic (2.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.00e-1)" "unprognostic (2.16e-2)" "unprognostic (4.38e-3)" 0.7 1.4 0.7 2.6 1.3 0.0 0.7 8.2 1.3 0.7 0.7 0.7 0.7 0.3 0.7 2.9 0.7 0.3 1.7 0.7 1.0 0.8 0.7 1.3 0.7 3.0 1.1 0.7 0.7 0.7 0.4 1.8 1.1 0.7 1.6 0.0 0.9 0.9 0.7 1.5 2.9 0.7 0.7 0.9 1.9 0.3 37.9 0.7 0.7 5.2 0.7 0.7 1.6 0.7 0.0 0.7 0.1 2.4 0.0 0.0 0.4 0.0 0.0 0.2 1.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 3.4 0.0 0.0 0.0 0.9 0.7 1.7 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.3 0.6 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.7 0.0 2.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.7 1.3 8.2 0.9 1.0 0.8 1.1 0.7 0.7 0.7 8.9 0.3 0.0 0.4 0.5 8.3 2.9 0.0 0.0 6.8 7.0 5.9 0.0 1.7 0.1 172.1 0.6 0.0 0.0 0.2 0.0 0.5 0.5 0.0 1.6 0.1 4.8 4.1 0.0 0.3 17.5 3.7 0.0 3.3 0.0 0.0 1.4 0.1 0.0 4.2 0.0 6.2 12.9 0.5 66.0 30.6 1.4 0.0 0.0 0.5 0.1 TDRD9 "C14orf75, DKFZp434N0820, FLJ36164, NET54" ENSG00000156414 "Tudor domain containing 9" Q8NDG6 14 103928462-104052667 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "parathyroid gland: 19.9;testis: 48.0" "Group enriched" "Detected in many" 5 "Spermatocytes: 69.1;Spermatogonia: 37.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "classical monocyte: 4.6" "Lineage enriched" "Detected in single" 5 "monocytes: 4.6" "Cell line enhanced" "Detected in some" "HDLM-2: 11.1;HeLa: 9.7;HMC-1: 45.2;RPTEC TERT1: 12.3;SK-MEL-30: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-1)" "unprognostic (2.74e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-4)" "unprognostic (1.60e-2)" "unprognostic (4.57e-3)" "unprognostic (8.97e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.41e-2)" 0.4 0.4 0.7 0.4 1.5 1.2 0.5 1.5 1.5 0.3 0.3 0.8 0.6 0.1 0.3 0.3 0.2 0.7 2.1 0.6 0.8 0.7 1.8 0.5 1.0 0.3 0.8 1.3 0.3 0.7 19.9 0.9 0.4 3.4 0.3 0.1 1.8 0.9 1.0 0.1 0.1 0.3 0.4 1.6 2.8 0.6 48.0 0.5 0.2 4.2 0.0 0.8 0.4 0.2 0.0 0.8 0.0 4.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 9.7 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 4.1 0.0 0.0 0.3 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 1.5 1.5 1.5 0.8 0.7 0.8 1.3 3.4 0.5 6.0 1.3 0.0 0.0 0.0 3.1 9.7 0.0 0.0 1.2 0.0 3.9 0.0 1.7 0.6 11.1 0.7 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 1.8 6.4 0.0 0.0 2.4 6.0 0.9 0.2 0.0 0.0 0.0 0.5 0.5 0.0 2.1 1.9 1.7 6.5 0.5 69.1 37.7 0.0 0.0 0.0 0.0 0.0 TECTB ENSG00000119913 "Tectorin beta" Q96PL2 10 112283400-112305035 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 7.4;U-2197: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted in other tissues" NA NA "unprognostic (3.14e-2)" "unprognostic (2.84e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.32e-2)" "unprognostic (5.54e-2)" "unprognostic (2.80e-2)" "unprognostic (8.10e-2)" 0.1 0.0 0.8 0.1 1.3 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 3.5 0.1 0.0 0.1 0.1 0.4 0.2 0.1 2.4 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 15.8 0.1 0.1 0.1 0.0 0.3 0.1 0.5 0.1 0.0 0.2 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.1 0.3 0.4 0.2 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400616 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "epididymis: 128.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 1.3" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.2;NB-4: 4.3" "Not detected" "Not detected" NA NA "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.1 0.0 0.1 0.1 0.2 0.0 0.4 1.3 0.1 0.5 0.1 0.1 1.8 0.0 0.4 128.3 0.1 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.3 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.9 0.4 3.8 0.5 0.4 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.1 4.3 0.2 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.4 0.3 0.4 0.2 0.1 0.2 0.4 0.4 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 1.3 0.5 1.0 0.6 0.1 0.4 0.1 0.2 0.1 0.1 0.9 0.5 0.3 3.8 0.4 0.5 0.4 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TENM3 "KIAA1455, ODZ3, Ten-M3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Bipolar cells: 28.4;Cytotrophoblasts: 88.5;Extravillous trophoblasts: 46.4;Syncytiotrophoblasts: 111.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 24.4;BEWO: 23.3;HDLM-2: 31.7;T-47d: 31.4" "Low region specificity" "Detected in many" HPA047043 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047043: AB_2679914" "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 9.5 10.8 11.3 3.7 12.5 1.0 9.3 8.5 17.8 3.9 8.5 1.5 5.7 2.4 6.4 2.6 2.4 2.9 5.3 3.5 11.8 9.4 2.7 1.4 2.4 2.3 3.5 15.4 8.4 3.2 17.0 15.0 24.5 5.4 8.3 2.5 6.4 2.0 8.0 4.3 1.4 2.5 5.2 6.1 4.8 2.2 4.7 2.3 0.8 12.3 1.8 3.0 3.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 24.4 0.1 5.0 8.9 23.3 2.8 1.0 2.5 2.2 12.1 6.3 0.0 0.3 18.8 10.6 1.2 5.8 1.2 2.5 31.7 9.7 0.0 0.0 0.0 0.5 0.0 0.0 11.7 0.4 7.9 5.5 5.7 3.5 0.0 0.0 0.1 3.8 0.8 0.0 0.0 7.8 0.0 1.0 0.0 6.3 0.0 0.0 0.0 10.0 9.3 1.4 0.1 0.0 13.8 31.4 1.2 7.6 20.0 14.4 0.0 14.1 0.0 0.0 0.0 10.5 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.5 8.5 17.8 11.8 9.4 3.5 15.4 5.4 2.3 0.0 0.0 0.0 0.2 0.3 28.4 3.3 0.0 0.0 0.0 3.5 3.9 88.5 1.7 0.0 8.3 0.3 0.0 0.0 1.5 46.4 3.1 0.2 0.0 0.6 9.0 4.8 5.1 0.6 0.0 1.8 7.8 0.0 1.7 0.0 0.0 11.8 0.6 0.0 2.5 0.1 2.8 0.0 1.0 3.7 7.1 0.0 111.6 0.0 0.0 0.0 TEPP ENSG00000159648 "Testis, prostate and placenta expressed" Q6URK8 16 57976435-57988116 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 46.3" "Group enriched" "Detected in many" 11 "Early spermatids: 286.9;Late spermatids: 318.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 4.5" "Lineage enriched" "Detected in single" 6 "T-cells: 4.5" "Cell line enhanced" "Detected in some" "BEWO: 2.9;HMC-1: 2.0;RPMI-8226: 2.4;TIME: 2.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062092 Enhanced "Secreted in male reproductive system" NA NA "HPA062092: AB_2684679" "unprognostic (4.86e-2)" "unprognostic (2.72e-1)" "unprognostic (4.12e-2)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (8.04e-2)" "unprognostic (3.67e-1)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.46e-1)" "unprognostic (3.97e-3)" "unprognostic (2.59e-1)" 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.6 0.1 0.3 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.3 0.7 0.1 0.0 0.1 0.1 0.4 0.3 0.0 0.1 0.2 1.2 0.1 0.1 0.1 0.1 0.3 0.1 0.0 46.3 0.2 0.1 2.6 0.1 0.2 1.6 0.5 0.7 0.2 0.3 0.0 0.2 4.5 1.3 0.0 0.0 0.6 0.0 0.0 0.0 2.9 0.0 0.4 0.5 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 2.5 0.1 3.0 2.0 0.0 0.7 2.9 4.5 0.0 0.2 0.0 0.2 1.4 1.3 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.3 0.4 0.2 11.9 5.1 0.0 8.2 0.1 0.0 27.4 2.5 1.4 11.4 1.8 0.0 2.1 0.0 0.0 286.9 0.7 0.0 0.0 0.5 3.1 1.5 0.6 2.3 0.0 0.4 0.0 0.0 1.8 0.0 318.3 3.4 0.2 1.7 0.0 0.0 0.6 0.1 0.0 0.4 0.0 1.3 0.0 1.4 2.1 2.3 0.0 0.9 0.0 0.0 3.3 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX101 "CT131, MGC4766, SGRG, SPATA44" ENSG00000131126 "Testis expressed 101" Q9BY14 19 43401496-43418597 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "blood: 24.5;testis: 56.6" "Cell type enriched" "Detected in some" 15 "Spermatocytes: 911.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 246 "basophil: 24.5" "Lineage enriched" "Detected in single" 246 "granulocytes: 24.5" "Cell line enhanced" "Detected in many" "THP-1: 4.9" "HPA041915, HPA042513" Enhanced "Secreted in male reproductive system" NA NA "HPA041915: AB_10795268, HPA042513: AB_10795507" "unprognostic (2.50e-2)" "unprognostic (5.67e-4)" "unprognostic (2.64e-1)" "unprognostic (6.89e-2)" "unprognostic (1.87e-1)" "unprognostic (5.78e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (6.54e-2)" "unprognostic (4.06e-1)" "unprognostic (2.49e-2)" "unprognostic (1.67e-7)" "unprognostic (8.83e-2)" "unprognostic (2.24e-1)" "unprognostic (7.49e-2)" "unprognostic (7.04e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.0 56.6 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.9 0.6 1.3 0.7 1.0 2.4 0.7 0.4 0.6 1.0 1.0 0.2 0.4 0.4 1.0 1.6 1.1 0.4 0.4 1.0 0.7 1.2 0.0 0.3 1.3 0.4 2.0 0.4 0.9 1.2 1.6 0.1 1.0 0.9 2.0 1.1 0.3 1.0 1.1 0.2 0.6 1.0 0.7 0.8 1.0 2.7 0.2 1.3 2.3 0.2 0.9 0.4 0.3 0.8 2.3 0.7 0.3 4.9 0.4 0.8 0.8 0.8 1.4 1.0 1.2 0.6 0.9 0.7 0.6 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 32.3 0.0 911.6 62.4 0.0 0.0 0.0 0.0 0.0 TEX12 ENSG00000150783 "Testis expressed 12" Q9BXU0 11 112167372-112172559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 29.9" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 158.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-698: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038289, HPA038290" Enhanced NA NA "HPA038289: AB_10672742, HPA038290: AB_2675934" "unprognostic (1.49e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.92e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-3)" "unprognostic (2.03e-1)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (2.91e-1)" "unprognostic (9.20e-4)" "unprognostic (1.71e-2)" "unprognostic (2.97e-1)" "unprognostic (6.54e-2)" "unprognostic (4.10e-2)" "unprognostic (3.16e-3)" 0.3 0.0 0.1 0.6 0.2 0.3 0.4 0.1 0.4 0.2 0.2 0.3 0.1 0.6 0.2 0.5 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.9 0.7 0.4 0.2 0.1 0.2 0.2 29.9 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.5 1.5 0.5 0.0 0.9 0.3 0.1 0.0 0.6 0.3 1.1 0.7 0.2 0.3 0.4 0.5 1.1 0.4 1.5 2.5 0.6 0.7 0.5 0.0 0.5 0.4 0.8 1.5 0.0 1.2 0.0 0.0 1.5 1.4 0.9 0.9 0.6 1.0 0.4 0.2 0.1 0.8 0.3 1.2 0.0 0.0 1.1 2.5 0.1 1.3 0.9 0.8 0.3 2.2 1.1 0.1 0.3 0.4 0.0 1.5 0.0 0.0 0.1 2.6 0.0 0.4 1.5 0.8 0.5 0.3 0.2 4.9 0.6 1.3 0.0 0.0 0.1 1.5 0.1 0.5 0.0 0.5 0.5 0.9 0.0 0.0 0.0 0.3 0.8 0.0 0.4 0.5 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.6 0.5 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 6.5 0.1 158.2 23.2 0.4 0.0 0.0 0.0 0.1 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Group enriched" "Detected in some" 4 "Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3" "Not detected" "Not detected" HPA036800 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.0 0.0 8.9 1.1 0.0 1.2 3.2 20.1 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.0 0.0 0.1 0.1 0.1 3.8 4.1 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.3 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 38.7 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 4.2 0.0 0.0 12.9 0.0 14.2 62.1 0.0 0.1 0.0 0.0 0.0 TEX22 ENSG00000226174 "Testis expressed 22" C9J3V5 14 105398579-105450106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 25.4" "Group enriched" "Detected in some" 18 "Early spermatids: 235.7;Late spermatids: 433.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;HDLM-2: 6.4;U-266/70: 5.4;U-937: 4.0" "Low region specificity" "Detected in all" HPA065576 Enhanced NA NA "HPA065576: AB_2685513" "unprognostic (3.99e-2)" "unprognostic (6.00e-2)" "unprognostic (1.30e-3)" "unprognostic (2.06e-1)" "unprognostic (3.36e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (1.52e-2)" "unprognostic (3.95e-2)" "unprognostic (1.53e-5)" "unprognostic (1.42e-4)" "unprognostic (8.13e-2)" "unprognostic (5.96e-2)" "unprognostic (2.18e-2)" "unprognostic (5.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.91e-3)" 1.2 0.7 3.2 2.4 3.1 2.3 4.2 4.6 4.2 1.5 0.8 1.5 1.4 1.3 1.3 3.8 0.8 2.9 1.3 0.9 4.3 1.5 1.5 0.7 3.0 2.9 3.0 3.0 2.3 4.6 2.0 1.0 1.0 3.0 2.0 0.8 0.9 1.9 2.5 1.2 1.7 1.5 0.6 2.7 2.5 1.6 25.4 2.9 4.0 1.4 0.5 1.7 1.0 1.7 0.5 1.1 0.0 1.4 0.0 0.6 0.1 0.3 0.7 0.7 3.2 1.0 0.1 0.7 0.3 0.1 0.0 0.4 0.4 0.5 1.9 0.2 0.2 0.1 0.3 0.5 0.1 0.1 6.4 0.3 0.3 0.8 0.0 0.4 0.5 2.0 0.7 0.4 0.1 0.1 0.7 0.1 0.6 0.2 2.0 0.1 1.8 0.2 0.4 0.2 0.1 0.1 1.8 0.1 0.1 0.4 0.5 0.6 0.7 0.0 0.1 0.3 0.5 0.5 0.7 0.0 0.3 0.1 0.8 0.1 5.4 0.7 0.8 0.1 4.0 2.7 0.0 1.4 0.0 0.0 0.3 0.5 0.2 0.0 0.6 0.1 0.5 0.3 0.0 0.0 0.0 0.4 1.1 0.5 0.1 3.2 3.1 4.6 4.2 4.3 1.5 3.0 3.0 3.0 2.9 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.5 235.7 0.1 0.0 0.0 0.6 0.1 0.4 0.5 4.6 0.0 0.7 0.0 0.0 0.0 1.5 433.0 3.7 0.0 1.7 1.0 0.1 0.4 0.6 0.0 2.1 0.4 0.0 6.5 0.5 18.7 2.3 0.1 0.1 0.0 0.1 0.1 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932703-30975502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 19.7;testis: 29.3" "Group enriched" "Detected in some" 48 "Early spermatids: 816.5;Late spermatids: 1222.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Region enhanced" "Detected in many" "pons and medulla: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SuSa: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079709 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA079709: " "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.5 1.2 1.6 0.4 6.3 0.4 0.5 0.2 3.0 1.7 0.4 4.8 0.3 0.4 0.5 1.3 0.5 1.3 0.8 0.5 3.7 5.5 0.4 0.6 0.6 0.4 1.1 2.7 0.4 0.4 0.4 4.2 0.4 19.7 0.7 0.5 0.0 0.5 0.8 0.5 0.4 0.5 0.4 3.7 0.4 0.5 29.3 2.0 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.3 0.2 3.0 3.7 5.5 1.1 2.7 19.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 21.4 2.3 0.0 0.0 0.0 0.0 0.0 816.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1222.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 9.2 3.3 0.0 0.0 0.0 0.0 0.0 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985938-70994945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 22.9 27.1 14.5 11.1 15.4 9.3 22.2 13.4 21.4 19.9 15.9 21.6 20.9 13.8 17.3 27.2 17.3 20.9 21.2 21.6 14.4 12.0 25.1 36.9 19.8 16.1 17.0 10.9 23.7 50.8 36.1 20.1 19.3 15.0 18.9 18.9 28.7 22.3 21.0 33.5 12.9 23.6 19.6 17.4 16.0 18.4 23.8 15.3 15.5 31.7 14.3 16.3 14.9 13.9 3.8 4.4 12.0 5.3 3.4 6.7 2.8 20.0 19.0 13.3 16.9 40.7 20.8 15.1 23.2 22.2 27.1 17.1 22.2 16.7 16.4 8.8 40.7 25.6 15.2 25.3 27.7 39.5 12.3 21.1 19.6 9.8 23.5 24.0 22.8 16.5 18.7 18.5 26.0 17.8 14.9 27.5 17.1 24.3 10.9 31.6 15.7 19.6 12.6 8.8 32.6 22.4 14.0 41.2 14.1 19.7 17.6 21.9 11.5 24.1 24.1 15.1 9.4 15.6 13.5 22.0 33.4 28.9 17.7 30.8 8.5 7.5 19.5 29.1 30.1 27.9 12.0 5.3 10.0 5.1 5.3 4.3 2.6 5.4 6.7 4.0 3.8 6.2 4.9 4.0 3.4 5.2 4.4 4.3 2.8 14.5 15.4 13.4 21.4 14.4 12.0 17.0 10.9 15.0 15.3 3.0 17.1 18.2 9.4 7.3 13.4 19.8 17.8 1.4 7.9 22.7 35.3 14.3 6.6 21.9 12.0 14.6 19.3 0.0 20.5 14.3 14.1 13.7 2.3 30.4 17.3 7.9 8.1 18.4 15.1 21.6 14.7 8.4 18.6 9.0 17.0 20.6 18.7 13.6 17.3 14.1 68.9 0.0 16.0 46.6 10.9 6.6 15.0 9.2 16.5 7.1 TEX28 "CXorf2, fTEX" ENSG00000278057 "Testis expressed 28" O15482 X 154271265-154295853 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.7" "Group enriched" "Detected in some" 41 "Early spermatids: 37.0;Late spermatids: 56.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 TEX29 "bA474D23.1, C13orf16, MGC35169" ENSG00000153495 "Testis expressed 29" Q8N6K0 13 111316184-111344249 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 596.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebral cortex: 6.1" "Cell type enhanced" "Detected in some" "eosinophil: 1.8;memory B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 54 "U-698: 22.4" NA NA "unprognostic (2.93e-1)" "unprognostic (2.26e-2)" "unprognostic (8.62e-4)" "unprognostic (4.56e-1)" "unprognostic (7.26e-2)" "unprognostic (4.93e-1)" "unprognostic (2.08e-2)" "unprognostic (8.51e-2)" "unprognostic (5.45e-2)" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (7.86e-2)" "unprognostic (1.13e-9)" "unprognostic (3.41e-1)" "unprognostic (1.51e-1)" "unprognostic (5.07e-2)" "unprognostic (4.21e-2)" 0.3 0.2 2.7 0.3 1.7 0.0 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.4 0.1 0.3 0.3 0.9 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.5 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.5 0.1 0.4 0.3 0.3 0.3 0.2 36.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.3 0.6 1.8 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 22.4 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.1 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.7 1.7 0.3 6.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 596.2 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 114.3 4.4 0.0 0.0 0.0 0.2 0.0 1.7 0.2 3.9 0.0 0.0 0.0 1.2 1.9 3.1 0.4 0.5 0.0 0.0 0.4 TEX30 C13orf27 ENSG00000151287 "Testis expressed 30" Q5JUR7 13 102765990-102773811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 64.1;testis: 71.9" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 279.0;Spermatocytes: 887.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 64.1;eosinophil: 16.4" "Lineage enriched" "Detected in all" 11 "granulocytes: 64.1" "Cell line enhanced" "Detected in many" "NB-4: 75.0;THP-1: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053545 Enhanced NA NA "HPA053545: AB_2682181" "unprognostic (5.26e-2)" "prognostic favorable (2.09e-5)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" "unprognostic (7.48e-2)" "unprognostic (1.54e-2)" "unprognostic (7.49e-2)" "unprognostic (9.86e-3)" "unprognostic (1.22e-1)" "unprognostic (1.25e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.89e-2)" "unprognostic (1.79e-1)" "unprognostic (8.66e-3)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" 4.5 2.9 4.3 3.0 4.6 5.6 3.6 5.8 5.3 3.1 2.6 1.7 14.0 2.6 5.4 34.7 4.1 2.7 2.4 6.1 3.5 4.9 8.8 18.5 2.9 4.9 6.3 2.8 3.7 2.8 1.2 4.5 7.1 5.2 3.2 2.2 2.0 2.4 7.0 4.4 3.5 2.7 3.9 3.9 3.2 2.7 71.9 3.1 7.0 2.8 3.8 3.3 3.5 3.5 2.7 3.7 64.1 2.0 5.9 3.8 1.9 11.7 4.3 10.1 8.2 6.5 4.7 0.1 15.1 4.1 10.5 9.9 10.3 11.2 6.7 6.5 6.0 13.9 6.4 9.1 5.6 15.0 13.7 5.5 11.6 9.0 0.1 4.4 23.0 22.8 2.6 3.6 9.3 5.7 3.9 8.3 16.9 6.8 0.0 12.7 6.1 15.4 75.0 3.7 16.0 10.0 9.5 4.5 4.7 15.8 4.6 13.6 6.2 9.5 11.9 8.9 6.5 8.4 48.1 3.5 7.3 5.6 11.6 16.2 6.2 7.3 0.0 12.6 13.7 12.0 64.1 1.7 16.4 2.4 1.9 3.4 2.7 2.7 3.1 1.8 2.5 3.1 2.6 0.8 5.9 2.0 3.7 3.8 1.9 4.3 4.6 5.8 5.3 3.5 4.9 6.3 2.8 5.2 3.1 0.0 3.0 19.7 12.9 21.1 7.3 10.4 5.1 8.1 5.7 12.2 3.9 92.4 31.5 13.6 279.0 11.9 4.5 0.0 8.5 89.1 12.9 10.7 26.5 34.7 38.9 6.4 2.9 14.7 5.6 54.6 28.1 17.4 27.0 24.4 3.4 6.0 9.4 2.6 17.7 70.8 5.4 90.5 17.6 887.6 162.4 17.3 119.0 26.1 3.9 8.5 TEX35 "C1orf49, DKFZP564J047, TSC24" ENSG00000240021 "Testis expressed 35" Q5T0J7 1 178513077-178548602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 66.9" "Group enriched" "Detected in some" 127 "Early spermatids: 1093.6;Late spermatids: 1941.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA039190 Approved NA NA "HPA039190: AB_10794425" "unprognostic (2.20e-1)" "unprognostic (1.77e-2)" "unprognostic (1.26e-1)" "unprognostic (1.89e-2)" "unprognostic (8.92e-3)" "unprognostic (1.08e-2)" "unprognostic (7.04e-2)" "unprognostic (9.60e-2)" "unprognostic (1.21e-1)" "unprognostic (2.51e-3)" "unprognostic (2.01e-2)" "unprognostic (1.92e-1)" "unprognostic (5.23e-1)" "unprognostic (5.41e-2)" 0.2 0.1 0.2 0.2 0.3 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 1.0 0.2 0.1 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.6 66.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.0 3.4 0.9 0.4 1.1 0.0 1.4 0.8 2.9 3.9 2.4 3.6 8.5 1.5 2.3 1.4 0.8 2.0 1.0 2.5 1.5 1.1 2.0 1.2 2.7 0.8 1.2 2.1 1.0 2.6 3.3 3.7 0.5 3.3 1.4 3.0 1.3 1.7 3.5 2.0 0.6 2.5 2.2 2.3 1.1 1.0 1.9 2.2 5.2 1.7 1.5 1.7 1.3 2.0 2.2 2.1 2.2 1.7 2.9 3.5 0.8 2.6 1.5 2.2 2.3 3.4 2.4 2.1 2.1 2.7 3.2 2.0 2.6 2.5 0.8 0.9 0.8 1.2 1.0 0.3 0.3 0.9 0.9 0.7 0.5 1.7 1.1 0.7 3.4 0.4 0.9 1.0 0.5 0.0 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1093.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1941.7 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 6.5 0.0 11.8 4.3 0.0 0.0 0.0 0.0 0.0 TEX36 "bA383C5.1, C10orf122" ENSG00000175018 "Testis expressed 36" Q5VZQ5 10 125576522-125683144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "testis: 24.6" "Group enriched" "Detected in some" 43 "Early spermatids: 289.0;Late spermatids: 264.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2197: 14.0" "Region enriched" "Detected in single" 14 "cerebellum: 2.6" "Low region specificity" "Detected in all" NA NA "unprognostic (7.72e-3)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 289.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 264.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.5 0.0 3.4 1.3 0.0 0.0 0.0 0.0 0.0 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 109.8" "Group enriched" "Detected in some" 114 "Early spermatids: 1833.7;Late spermatids: 4115.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA073711 Uncertain Vesicles NA NA Vesicles "HPA073711: " "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 2.5 0.3 0.1 1.6 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 1.3 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.8 0.3 0.0 0.5 0.4 0.0 0.6 0.6 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.9 0.0 0.6 0.6 2.0 1.4 1.0 2.2 0.0 1.8 0.8 0.0 2.5 0.3 0.0 1.0 0.2 0.9 0.3 0.6 0.2 0.0 0.2 0.0 0.3 2.5 1.2 0.2 1.6 0.9 0.1 0.9 0.4 0.4 0.9 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1833.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4115.3 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.4 6.5 0.0 24.7 13.3 0.0 0.0 0.0 0.0 0.0 TEX43 "C5orf48, FLJ27505, MGC163367, MGC163369, Tseg7" ENSG00000196900 "Testis expressed 43" Q6ZNM6 5 126631722-126636287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 23.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 386.4" "Cancer enriched" "Detected in single" 7 "colorectal cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;HeLa: 1.1;SK-BR-3: 1.9" "Region enhanced" "Detected in single" "pons and medulla: 0.4" "Not detected" "Not detected" NA NA "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "unprognostic (4.06e-2)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 2.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 386.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 TEX45 "C19orf45, FLJ35784" ENSG00000198723 "Testis expressed 45" Q8NA69 19 7492976-7508450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 40.1" "Group enriched" "Detected in some" 9 "Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (7.96e-3)" "unprognostic (3.90e-2)" "unprognostic (5.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.44e-2)" "unprognostic (1.50e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (6.42e-2)" "unprognostic (4.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (4.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-3)" 0.2 0.6 0.3 0.2 0.3 2.2 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.1 0.3 0.4 0.2 0.1 0.4 0.2 0.4 0.3 0.2 0.2 0.3 0.2 0.5 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 2.7 1.5 0.2 0.6 0.2 0.2 40.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.6 1.0 3.0 0.8 0.4 0.9 0.2 0.4 0.0 0.5 1.7 0.0 0.0 0.1 0.9 0.0 0.8 0.5 1.2 1.5 0.3 0.7 0.5 0.3 1.1 0.2 0.0 0.0 0.4 0.9 0.0 1.3 0.8 0.1 0.0 2.5 0.0 1.1 0.0 0.6 0.1 0.0 1.0 1.2 2.4 0.3 1.9 1.6 1.0 0.4 2.2 0.4 0.3 0.3 1.0 0.1 1.1 2.9 0.7 1.4 1.6 0.0 0.4 1.5 2.9 0.8 0.2 0.9 0.6 0.9 1.3 0.3 1.2 1.0 1.4 0.0 3.0 0.4 0.5 0.9 0.8 0.7 1.0 0.6 0.5 0.1 1.6 0.8 0.7 1.7 0.4 0.3 1.0 0.3 0.2 0.3 0.3 0.3 0.2 0.4 0.3 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX46 C1orf234 ENSG00000227868 "Testis expressed 46" H3BTG2 1 23010834-23015850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HSkMC: 3.9" "Not detected" "Not detected" NA NA "unprognostic (3.11e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (2.13e-1)" "unprognostic (1.24e-2)" "unprognostic (6.33e-2)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (9.76e-2)" "unprognostic (8.12e-2)" "unprognostic (3.82e-3)" "unprognostic (2.29e-5)" "unprognostic (1.06e-1)" "unprognostic (1.15e-1)" "unprognostic (7.60e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 39.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 1.4 0.5 3.1 0.8 1.4 0.0 0.6 1.1 0.9 0.0 0.8 0.4 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.3 3.9 1.3 0.6 0.8 0.0 0.7 2.3 0.7 0.4 0.7 1.1 0.0 0.7 1.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 1.4 0.5 0.2 0.2 1.4 0.0 1.5 0.3 0.5 0.4 0.0 2.4 0.0 0.2 0.4 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX54 ENSG00000283268 "Testis expressed 54" 11 62832319-62832803 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 47.4;testis: 21.2" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 8 "neutrophil: 47.4" "Lineage enriched" "Detected in all" 16 "granulocytes: 47.4" "Low cell line specificity" "Detected in some" NA NA 1.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 4.2 0.0 0.6 1.5 0.0 0.0 0.8 1.2 0.7 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.0 0.0 0.0 0.8 0.5 0.0 1.0 0.2 0.5 21.2 0.7 0.0 0.5 0.0 0.5 1.5 0.0 2.3 2.3 47.4 2.9 1.3 2.9 0.3 0.3 0.0 2.3 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 2.7 0.8 0.4 0.0 0.4 2.7 0.0 0.0 0.0 2.5 0.8 0.0 2.7 0.9 0.8 0.0 1.0 0.0 0.0 0.6 0.0 0.6 0.0 1.6 0.0 1.5 0.0 0.0 1.4 1.3 0.4 0.0 1.6 1.0 0.0 2.8 0.0 0.5 1.0 0.0 0.0 1.9 0.3 0.5 0.7 0.0 1.5 0.7 0.7 2.0 0.0 2.5 0.8 1.1 0.0 0.0 1.8 6.1 2.9 5.9 1.6 2.0 2.7 1.7 1.7 1.4 0.8 2.3 2.9 2.1 47.4 1.3 0.8 2.3 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP2E AP2E ENSG00000116819 "Transcription factor AP-2 epsilon" Q6VUC0 1 35573370-35595328 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 22.0;skin 1: 11.4" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 3.3;Bipolar cells: 9.1;Rod photoreceptor cells: 5.1;Suprabasal keratinocytes: 3.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 22.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 10.5;SK-MEL-30: 5.7;THP-1: 5.0;U-937: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (7.06e-4)" "unprognostic (1.96e-2)" "unprognostic (9.05e-2)" "unprognostic (2.29e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-2)" "unprognostic (3.27e-2)" "unprognostic (9.39e-2)" "unprognostic (4.02e-1)" "unprognostic (7.45e-2)" "unprognostic (1.67e-15)" "unprognostic (2.03e-1)" "unprognostic (4.83e-1)" "unprognostic (3.48e-2)" "unprognostic (7.40e-2)" 0.6 0.5 2.5 2.6 4.3 4.7 1.3 22.0 3.4 1.2 1.3 1.1 0.6 0.3 1.3 1.8 0.7 1.3 0.7 0.6 4.8 2.9 0.6 0.6 8.2 3.0 2.2 0.6 1.7 0.6 0.2 1.5 0.7 4.7 1.2 0.4 2.2 1.1 0.7 0.6 11.4 0.6 0.7 4.3 1.9 1.0 1.7 2.9 0.6 0.6 0.6 1.6 0.6 1.3 1.4 1.2 5.2 3.1 3.5 3.1 1.6 0.4 0.4 0.6 0.3 0.5 0.9 1.8 0.3 0.3 0.2 0.1 1.2 1.0 0.2 0.8 0.3 0.1 0.4 0.1 0.0 0.3 0.5 1.2 4.3 0.8 1.1 1.3 0.7 0.3 0.3 0.9 0.6 0.4 1.8 0.0 0.9 0.1 1.3 0.0 0.7 0.9 10.5 0.9 0.0 0.6 0.4 0.3 0.3 0.0 0.1 0.4 0.8 1.2 0.5 5.7 0.6 1.6 5.0 0.5 0.3 1.8 2.6 0.7 2.2 1.1 0.1 0.3 8.8 1.6 1.6 3.1 5.2 3.1 1.1 1.5 1.4 1.8 2.5 1.2 1.3 0.8 2.5 0.0 3.5 1.4 1.0 2.1 1.6 2.5 4.3 22.0 3.4 4.8 2.9 2.2 0.6 4.7 2.9 0.0 2.2 0.0 0.1 3.3 9.1 0.3 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.6 0.6 1.0 2.0 0.6 1.7 0.0 0.0 0.2 0.2 0.0 0.7 0.0 5.1 0.0 0.3 1.1 0.3 3.9 0.1 0.0 0.5 0.1 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 12.9;T-cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "PC-3: 5.7;REH: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074356 Enhanced Approved Vesicles NA NA Vesicles "HPA074356: AB_2686681" "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.7 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 0.0 2.0 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.4 0.2 0.1 0.0 0.0 0.3 0.0 3.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 0.2 5.7 13.8 0.0 3.1 0.2 0.0 1.0 2.5 0.3 0.0 0.7 0.0 0.9 0.6 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 0.0 0.0 0.8 3.2 1.3 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.0 0.0 0.0 0.2 0.5 1.7 0.6 0.0 2.8 0.2 0.0 0.0 2.5 0.0 3.3 1.1 0.5 5.0 0.0 0.0 2.7 0.4 0.0 1.1 4.4 2.4 12.9 4.2 0.2 0.9 1.3 0.3 6.9 0.0 0.4 TGM7 TGMZ ENSG00000159495 "Transglutaminase 7" Q96PF1 15 43276280-43302255 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.9;testis: 2.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 60.4" "Cancer enriched" "Detected in single" 13 "endometrial cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 78 "EFO-21: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.9 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 2.8 THEGL ENSG00000249693 "Theg spermatid protein like" P0DJG4 4 56530609-56603507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.9;vagina: 10.7" "Group enriched" "Detected in some" 58 "Early spermatids: 18.2;Late spermatids: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.8;HSkMC: 3.7;hTEC/SVTERT24-B: 2.3;K-562: 3.0;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA066627, HPA068093" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA066627: , HPA068093: AB_2685951" "unprognostic (4.33e-2)" "unprognostic (2.88e-3)" "unprognostic (7.97e-2)" "unprognostic (1.19e-1)" "unprognostic (3.69e-2)" "unprognostic (3.26e-1)" "unprognostic (1.90e-2)" "unprognostic (6.55e-2)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" "unprognostic (4.70e-2)" "unprognostic (4.49e-2)" "unprognostic (1.73e-1)" "unprognostic (8.41e-2)" 0.1 0.2 0.6 0.1 0.5 0.8 1.9 0.1 1.1 1.7 0.7 0.6 1.0 0.1 0.4 1.3 0.2 0.4 0.8 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.8 0.7 0.1 0.2 0.2 0.5 0.1 1.2 0.2 1.8 0.2 0.1 0.3 8.9 0.4 0.0 0.1 0.0 0.1 3.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 3.7 0.0 2.3 0.0 0.5 0.4 0.0 3.0 0.0 0.9 0.0 0.8 0.0 0.2 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.1 0.3 0.8 0.1 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 1.1 0.2 0.4 0.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 THNSL2 "FLJ10916, SOFAT, TSH2" ENSG00000144115 "Threonine synthase like 2" Q86YJ6 2 88170295-88186636 "Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 49.7;Proximal tubular cells: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 16.8;hTCEpi: 10.3;MCF7: 10.7;SuSa: 16.9;T-47d: 15.7" "Low region specificity" "Detected in all" HPA035395 Approved "Secreted - unknown location" NA NA "HPA035395: AB_10601600" "unprognostic (1.51e-2)" "unprognostic (1.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (4.53e-2)" "unprognostic (8.73e-2)" "unprognostic (6.64e-2)" "unprognostic (7.26e-2)" "unprognostic (1.93e-1)" "unprognostic (3.47e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "unprognostic (2.01e-3)" "unprognostic (6.98e-2)" "unprognostic (8.81e-2)" "unprognostic (1.40e-1)" "unprognostic (1.24e-2)" 8.6 9.5 5.5 6.0 8.1 0.7 12.0 3.3 10.8 8.7 10.5 17.3 16.3 7.8 11.5 27.0 11.2 11.1 15.1 10.9 5.0 7.1 24.0 29.9 11.7 3.6 7.2 8.6 10.4 8.7 32.4 16.2 14.4 11.3 12.5 3.7 21.1 15.4 9.6 28.7 7.0 12.8 13.7 7.5 4.7 6.6 13.6 1.0 0.9 18.0 9.3 3.8 6.5 5.8 3.4 1.5 0.9 1.1 0.5 1.3 0.8 0.9 0.0 0.0 0.0 2.0 1.3 1.6 4.6 3.4 5.5 6.9 7.0 5.4 0.0 2.1 0.0 0.0 0.2 0.0 0.1 4.7 0.0 0.0 0.0 0.2 0.0 16.8 0.0 0.9 3.1 10.3 1.7 0.0 0.3 0.0 0.0 0.0 0.0 3.2 10.7 0.0 0.0 4.2 8.0 0.7 0.0 0.0 0.0 3.3 0.3 2.0 0.0 5.4 0.8 8.8 16.9 15.7 1.0 0.0 4.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.9 1.3 1.0 0.9 1.6 0.4 1.0 1.5 3.4 0.7 0.3 0.4 0.5 1.1 0.0 0.0 0.8 5.5 8.1 3.3 10.8 5.0 7.1 7.2 8.6 11.3 1.0 3.0 12.4 3.2 7.8 6.0 10.9 17.3 20.4 4.0 2.3 14.0 0.0 33.4 49.7 12.1 1.3 1.8 8.8 0.0 2.6 14.3 8.0 7.3 0.0 39.2 4.1 12.7 2.4 7.4 9.4 3.4 8.3 2.2 13.5 19.0 7.2 34.2 8.4 7.0 9.2 73.9 6.9 0.0 6.1 2.8 11.0 4.4 20.0 0.0 8.9 5.7 THSD1 TMTSP ENSG00000136114 "Thrombospondin type 1 domain containing 1" Q9NS62 13 52377167-52406494 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 26.3;Ito cells: 12.9;Spermatocytes: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.3;HBEC3-KT: 12.3;hTCEpi: 12.3;hTERT-HME1: 12.6;HUVEC TERT2: 25.6;LHCN-M2: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012611, CAB020796" Uncertain Supported Cytosol "Intracellular and membrane" No No 810000 Cytosol "CAB020796: , HPA012611: AB_1857990" "unprognostic (1.21e-1)" "unprognostic (7.54e-3)" "unprognostic (3.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-1)" "unprognostic (6.10e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-3)" "unprognostic (8.44e-2)" "unprognostic (1.31e-1)" "unprognostic (3.35e-2)" "unprognostic (4.90e-2)" 9.7 1.8 8.3 1.8 7.2 0.4 11.1 2.9 6.4 7.6 2.6 1.9 3.6 1.2 6.8 4.9 4.4 5.7 4.9 9.0 8.1 2.2 2.0 2.1 19.8 4.7 2.2 4.6 2.3 1.2 2.5 3.4 16.8 2.1 8.5 2.3 5.5 3.9 3.2 9.7 6.0 2.3 7.4 2.2 6.6 1.9 2.7 1.1 0.7 5.2 5.2 2.5 5.9 4.5 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.5 2.4 0.2 2.2 2.0 6.7 0.5 5.2 2.6 2.0 3.3 0.0 0.3 0.2 0.6 12.3 2.0 2.7 0.0 12.3 3.2 5.7 1.8 0.3 0.0 0.0 1.2 1.2 0.3 2.6 12.3 9.9 12.6 1.1 25.6 0.7 0.0 0.1 11.7 0.0 0.4 0.2 0.1 0.1 0.5 0.3 2.7 0.0 2.8 0.1 0.0 0.4 0.1 0.0 0.4 0.1 0.2 0.2 5.9 0.6 1.1 0.0 3.8 0.4 0.0 0.0 1.1 0.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.3 7.2 2.9 6.4 8.1 2.2 2.2 4.6 2.1 1.1 0.0 1.4 1.4 0.9 1.3 0.8 2.7 0.0 0.0 1.2 1.8 2.0 4.2 3.3 0.2 0.8 26.3 0.0 0.0 0.6 1.5 2.7 1.3 0.0 1.6 2.4 0.0 0.0 12.9 2.6 0.0 3.1 0.7 5.0 0.0 0.2 1.2 0.2 0.0 3.5 0.8 2.8 6.5 1.9 19.1 9.1 1.4 2.9 1.9 0.4 0.3 THSD4 "ADAMTSL6, FLJ13710, FVSY9334, PRO34005" ENSG00000187720 "Thrombospondin type 1 domain containing 4" Q6ZMP0 15 71096952-71783383 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 60.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 104.8;Cardiomyocytes: 53.7;Glandular cells: 73.8;Peritubular cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 19.3;ASC TERT1: 18.1;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (3.14e-2)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.80e-2)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (3.01e-3)" 2.4 4.6 1.5 3.6 2.7 0.2 8.5 1.4 3.0 60.5 8.7 2.4 5.1 4.3 19.9 12.8 36.9 20.3 18.7 17.4 2.1 2.0 5.1 3.3 5.0 2.3 2.7 4.2 8.0 8.7 1.2 4.5 12.4 5.3 19.0 4.0 29.7 6.5 8.8 1.6 4.4 8.4 10.6 6.4 1.2 6.2 3.9 1.4 0.0 6.6 13.3 5.3 7.2 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 19.3 0.3 5.6 3.0 18.1 0.0 9.4 23.0 4.9 2.5 0.1 3.7 0.0 7.8 3.3 17.0 7.2 0.7 3.9 3.0 0.8 0.8 0.0 2.0 0.0 1.9 0.0 0.0 1.3 2.9 2.9 11.8 13.4 8.9 0.0 0.0 0.2 4.0 3.8 0.0 0.0 1.7 0.0 3.4 0.0 0.3 0.3 13.0 2.6 0.3 2.4 3.7 4.7 0.0 2.3 18.8 0.0 28.5 0.1 0.4 19.4 5.0 0.0 0.1 0.0 4.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 1.4 3.0 2.1 2.0 2.7 4.2 5.3 1.4 17.9 7.0 0.0 104.8 12.4 2.6 53.7 45.9 13.4 5.7 5.2 5.9 0.3 1.7 16.1 6.1 11.9 10.5 0.0 1.6 0.2 10.3 73.8 0.0 10.6 0.2 0.0 2.9 6.7 0.0 11.4 16.1 0.9 8.5 0.0 3.6 0.0 8.6 5.8 70.0 0.3 0.8 0.0 3.8 1.0 1.5 9.5 0.7 0.0 10.9 25.5 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Daudi: 10.3;SCLC-21H: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051416: AB_2681477, HPA056745: AB_2683224" "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 0.0 0.0 0.0 0.4 0.1 1.2 0.6 0.0 0.0 0.0 0.0 23.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 85.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 31.7 6.5 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 THUMPD2 "C2orf8, MGC2454" ENSG00000138050 "THUMP domain containing 2" Q9BTF0 2 39736060-39779267 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043042, HPA058025" Approved Uncertain Nucleoplasm Yes No Nucleoplasm "HPA043042: AB_10964424, HPA058025: " "unprognostic (6.30e-2)" "unprognostic (9.12e-3)" "unprognostic (2.48e-2)" "unprognostic (4.62e-3)" "unprognostic (2.16e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.22e-1)" "unprognostic (2.31e-2)" "unprognostic (1.30e-1)" "unprognostic (2.72e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-3)" 6.9 7.1 6.3 8.2 7.4 13.3 9.3 21.1 7.9 8.5 6.0 5.0 4.5 7.7 12.0 6.8 9.2 4.3 5.1 8.7 6.0 6.8 7.9 7.3 5.8 9.4 7.1 5.0 10.8 5.9 5.4 19.7 4.3 6.7 6.9 5.1 6.4 6.0 6.4 14.5 5.8 6.5 6.4 5.5 6.6 6.7 3.8 6.4 13.5 7.8 5.1 9.3 6.0 9.6 6.1 9.9 0.3 4.5 8.6 5.2 3.1 9.2 6.0 2.1 8.9 2.9 4.7 4.7 3.9 4.3 4.3 4.7 7.5 6.9 11.9 4.3 2.8 9.9 3.3 11.5 6.7 5.0 14.6 13.8 8.7 4.2 7.3 6.5 10.2 5.4 4.9 4.3 4.1 1.6 4.6 6.4 2.7 9.4 4.1 8.3 3.1 8.8 8.6 0.2 16.9 4.2 6.7 7.8 7.0 4.6 5.5 9.0 6.6 3.3 8.4 5.9 0.7 3.7 5.7 3.9 7.2 6.2 3.2 8.1 6.6 7.6 12.5 4.2 16.3 5.5 0.0 4.5 0.2 3.3 3.2 3.9 6.1 5.2 3.4 5.5 4.7 4.8 4.2 0.3 8.6 2.1 9.9 4.2 3.1 6.3 7.4 21.1 7.9 6.0 6.8 7.1 5.0 6.7 6.4 23.8 19.4 14.8 22.9 12.7 22.1 20.6 7.6 13.4 25.0 14.0 17.7 10.0 16.6 15.0 1.9 11.7 7.3 0.0 12.0 11.4 8.6 13.8 6.9 7.6 9.5 6.4 9.2 9.8 12.4 2.8 25.9 10.6 5.0 7.2 8.4 11.5 13.2 13.3 24.1 11.5 18.3 6.5 12.2 8.9 16.9 11.8 5.7 10.2 11.8 22.1 TIAF1 ENSG00000221995 "TGFB1-induced anti-apoptotic factor 1" O95411 17 29073521-29078857 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 3.0;Bipolar cells: 1.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 29.0" NA NA "unprognostic (1.16e-1)" "unprognostic (8.34e-2)" "unprognostic (7.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.07e-3)" "unprognostic (1.35e-1)" "unprognostic (3.97e-8)" "unprognostic (1.54e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" 1.0 1.4 2.5 1.7 3.3 1.9 1.1 10.0 4.7 1.1 1.3 2.5 1.5 4.2 1.8 0.7 1.7 3.0 3.8 2.7 0.8 4.7 0.7 2.2 4.3 1.1 0.8 1.8 1.2 1.1 1.5 2.0 1.8 1.5 8.3 7.4 1.9 1.8 4.7 1.7 1.4 1.1 0.7 2.8 0.6 1.8 1.8 1.9 3.0 1.1 0.9 1.5 0.2 0.4 0.2 0.8 0.4 0.5 0.6 0.6 0.6 0.2 0.3 0.4 0.6 0.6 0.4 0.4 0.7 0.7 1.3 0.6 0.5 0.7 0.5 0.3 0.1 0.9 0.5 0.2 0.6 0.6 0.4 0.3 0.8 0.2 1.6 0.2 1.3 1.4 0.9 0.4 0.4 0.6 1.5 0.1 29.0 0.5 5.4 0.4 0.6 0.9 0.3 0.6 0.3 0.3 2.7 0.2 1.7 0.4 2.3 0.1 0.5 0.5 0.2 0.4 0.3 0.6 0.3 0.6 0.6 0.4 1.1 0.9 0.4 1.1 0.4 1.5 0.9 1.2 0.8 0.4 1.8 0.8 1.1 3.0 0.9 1.1 1.9 0.3 0.2 3.0 1.3 0.0 0.3 0.3 1.9 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.6 0.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 1.0 6.5 0.2 0.3 0.2 0.3 0.0 0.0 0.0 0.7 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Cell line enhanced" "Detected in many" "AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in all" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 35.1 4.1 1.5 4.3 0.4 1.8 1.1 1.7 2.9 0.5 2.6 1.0 1.9 3.2 0.6 0.7 1.2 0.0 1.2 15.0 1.9 0.3 0.6 2.0 0.9 0.3 1.1 2.9 0.1 0.6 0.1 1.6 2.4 0.5 0.5 0.1 3.9 0.4 0.4 0.9 2.5 0.2 1.0 4.5 22.9 0.4 0.1 0.2 0.9 8.0 0.1 0.4 0.2 6.9 0.3 0.5 0.8 0.3 8.9 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 3.0 1.6 8.1 16.3 2.7 13.8 7.3 7.6 2.7 1.2 1.8 76.6 1.2 0.0 4.7 131.1 3.0 2.9 0.0 2.7 2.1 4.7 7.7 19.6 0.9 1.7 22.3 0.0 7.4 2.1 220.7 9.2 4.7 11.8 14.4 4.2 6.9 4.2 2.0 7.4 0.7 25.2 0.0 3.8 5.2 5.5 2.3 0.3 4.8 2.6 7.4 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Cell type enhanced" "Detected in some" 16 "Spermatocytes: 16.6;Spermatogonia: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.4 2.6 2.3 6.0 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.1 0.3 1.0 1.0 0.2 1.0 1.4 2.3 0.1 0.2 1.8 2.3 0.4 1.4 4.7 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.1 0.3 2.3 1.4 3.1 0.0 3.4 2.9 1.9 1.3 1.3 1.1 4.2 1.0 4.0 0.1 1.3 6.7 4.2 1.7 2.6 1.1 0.2 4.3 1.4 0.0 0.2 1.1 1.6 1.0 6.4 4.1 1.3 0.1 1.8 0.7 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 0.0 0.6 0.0 0.2 1.3 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 2.2 0.0 1.0 0.0 0.5 0.3 0.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.8 1.8 0.0 0.9 1.7 1.0 0.3 1.0 0.6 0.0 0.4 0.5 3.8 0.0 0.8 16.6 5.3 1.4 0.7 0.0 0.4 0.1 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779764 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.1;testis: 11.8" "Group enriched" "Detected in some" 4 "Early spermatids: 76.3;Rod photoreceptor cells: 29.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035649, HPA073768" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035649: AB_10670956, HPA073768: " "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.7 1.0 2.2 0.7 8.6 0.2 2.1 3.5 3.6 2.5 0.8 2.1 3.9 1.1 2.0 4.2 0.6 5.5 0.8 1.0 4.8 2.1 2.0 0.6 3.5 0.5 1.6 3.2 1.7 0.9 5.4 14.1 0.5 5.8 1.3 0.9 5.4 2.0 1.1 1.2 1.3 0.8 0.9 2.7 0.8 1.0 11.8 1.3 0.3 2.1 0.6 0.5 1.0 0.8 0.4 0.0 1.6 1.1 2.1 1.3 0.0 0.6 0.5 3.0 1.2 0.2 0.4 0.3 0.1 0.7 0.3 0.6 0.6 1.3 1.0 0.1 0.1 1.4 0.5 1.1 0.5 0.5 1.0 0.2 1.5 0.7 0.3 0.2 0.6 0.3 0.1 0.5 0.5 0.3 0.6 0.1 2.2 0.4 4.6 0.3 0.3 2.9 0.4 1.4 0.4 0.4 0.5 0.6 0.0 2.0 0.1 1.4 1.6 0.2 0.3 2.9 1.4 0.7 0.2 0.0 0.4 0.6 0.5 0.6 6.8 13.2 0.6 1.0 1.6 2.2 0.0 0.3 0.8 0.0 1.1 0.2 0.0 0.3 1.3 0.0 0.4 0.1 0.4 1.6 2.1 0.2 0.0 0.0 0.0 2.2 8.6 3.5 3.6 4.8 2.1 1.6 3.2 5.8 1.3 0.0 1.0 0.0 0.4 0.0 6.7 0.0 0.0 12.0 0.0 1.8 11.8 0.1 0.0 0.5 76.3 0.1 0.0 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.5 1.6 1.2 0.0 0.0 8.5 0.3 0.0 0.0 0.0 0.1 12.1 0.4 0.0 0.4 1.5 29.0 0.0 0.0 5.1 1.7 0.0 0.2 0.0 0.4 0.3 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150001167 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favorable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 6.9 10.5 5.9 3.9 10.7 2.8 9.9 9.3 9.4 5.8 6.1 10.0 8.9 4.7 6.5 11.1 5.0 6.9 5.1 4.5 6.4 4.7 7.7 7.0 5.3 3.9 7.3 7.1 8.6 6.8 28.0 10.5 5.5 7.1 8.8 5.7 6.4 8.1 12.6 3.8 7.2 5.2 5.9 7.6 5.8 6.1 9.8 8.0 6.1 6.5 3.6 4.3 6.2 6.1 3.5 3.3 2.1 4.0 6.3 8.0 2.6 2.3 6.4 4.3 9.2 12.4 10.2 6.7 6.7 7.1 5.3 5.3 4.1 4.2 1.1 6.0 7.9 6.4 4.2 3.8 4.9 6.3 5.0 3.2 2.0 3.3 2.2 11.0 2.8 5.0 10.5 9.4 6.8 8.9 6.2 4.1 4.6 2.7 5.4 6.5 5.5 3.7 1.3 1.8 3.0 5.4 4.2 4.9 3.0 5.0 3.4 3.3 4.3 4.7 7.6 9.5 5.5 8.5 4.9 5.4 4.3 3.3 4.7 4.9 4.0 1.5 3.0 6.8 3.1 6.6 0.2 4.0 2.1 2.8 3.9 2.5 2.7 3.8 2.8 3.3 3.5 8.0 5.1 0.0 6.3 2.2 2.2 3.7 2.6 5.9 10.7 9.3 9.4 6.4 4.7 7.3 7.1 7.1 8.0 11.9 2.4 0.0 5.8 1.9 4.8 4.6 2.5 2.7 4.5 3.5 0.0 4.6 6.6 4.3 1.1 2.3 2.5 0.0 4.2 2.2 2.5 6.1 3.5 1.3 3.7 3.2 2.9 3.1 1.2 1.9 4.0 2.2 3.3 7.2 2.5 6.1 3.4 2.3 3.2 6.7 5.6 0.0 3.9 16.4 5.5 1.0 3.0 0.9 2.3 3.8 TIMP4 ENSG00000157150 "TIMP metallopeptidase inhibitor 4" Q99727 3 12153051-12159351 "Plasma proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 72.2;breast: 97.5" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Ito cells: 14.7;Sertoli cells: 32.3" "Cancer enriched" "Detected in many" 13 "glioma: 66.4" "Region enriched" "Detected in all" 5 "cerebellum: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 54.7;ASC TERT1: 13.7;HSkMC: 23.7;NTERA-2: 13.6;U-87 MG: 13.9" "Region enhanced" "Detected in all" "cerebellum: 118.9" "Region enriched" "Detected in all" 5 "cerebellum: 100.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.99e-2)" "unprognostic (5.14e-3)" "unprognostic (1.02e-2)" "unprognostic (2.10e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-4)" "unprognostic (9.33e-3)" "unprognostic (4.26e-3)" "unprognostic (1.36e-1)" "unprognostic (1.74e-2)" "unprognostic (3.78e-1)" "unprognostic (6.81e-2)" "unprognostic (4.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (6.66e-5)" "unprognostic (2.86e-1)" 72.2 4.3 1.9 2.2 1.6 0.7 97.5 17.8 11.2 2.6 11.7 2.4 0.7 1.1 1.9 0.9 3.2 1.6 2.9 10.9 1.7 1.5 1.9 0.8 2.6 6.0 3.1 1.5 1.2 1.5 1.2 3.2 4.6 3.8 2.9 2.4 2.4 3.1 1.6 7.7 1.7 2.4 2.4 2.9 0.8 2.3 1.8 1.2 0.1 6.1 3.8 0.6 3.7 9.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 6.0 0.2 0.0 54.7 13.7 6.7 0.2 2.2 0.2 0.3 0.1 0.0 0.0 0.5 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 3.5 0.2 8.5 0.0 0.0 23.7 0.5 1.4 0.0 0.4 0.0 0.0 0.1 4.4 0.0 0.1 0.0 0.0 13.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 13.9 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 17.8 1.3 1.7 1.5 3.1 1.5 3.8 1.2 0.0 0.0 0.0 1.2 0.1 0.3 4.8 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.7 1.1 2.9 0.7 23.3 2.4 1.9 1.4 5.6 0.0 0.0 2.9 0.0 6.3 14.7 0.6 4.8 11.2 0.1 3.3 0.0 2.6 0.7 2.7 2.8 2.5 0.3 0.0 32.3 3.4 0.0 0.0 0.1 0.1 0.0 2.3 2.0 TINAG ENSG00000137251 "Tubulointerstitial nephritis antigen" Q9UJW2 6 54307859-54390152 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 27.2;kidney: 53.0" "Group enriched" "Detected in some" 6 "Enterocytes: 52.3;Proximal tubular cells: 176.4" "Cancer enhanced" "Detected in some" "renal cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "RPTEC TERT1: 46.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035427, HPA073753" Approved "Secreted to extracellular matrix" NA NA 26000 "HPA035427: AB_10601822, HPA073753: " "unprognostic (7.62e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (7.27e-2)" "unprognostic (5.99e-3)" "prognostic favorable (8.75e-5)" "unprognostic (7.10e-2)" 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 53.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.2 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 0.0 0.0 19.9 0.0 0.7 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 1.3 10.5 0.0 176.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 TIPARP "DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1" ENSG00000163659 "TCDD inducible poly(ADP-ribose) polymerase" Q7Z3E1 3 156673235-156706770 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 174.1;Early spermatids: 204.3;Urothelial cells: 186.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 24.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036796 Approved Microtubules NA NA Microtubules "HPA036796: AB_10672268" "prognostic favorable (2.00e-5)" "unprognostic (3.50e-1)" "unprognostic (7.62e-2)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (4.56e-2)" "unprognostic (9.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.43e-1)" "unprognostic (4.27e-3)" "unprognostic (2.01e-1)" "unprognostic (4.69e-2)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (6.16e-3)" "unprognostic (4.90e-3)" 31.6 29.8 10.9 11.1 24.7 31.8 19.9 7.1 16.3 16.2 12.7 14.2 18.8 6.8 18.3 20.7 27.2 27.8 18.8 26.5 16.0 9.4 14.2 21.3 20.2 15.2 16.2 6.2 37.0 14.5 73.8 11.4 6.1 30.9 13.6 7.5 10.0 8.2 36.0 17.4 26.2 22.1 21.6 37.4 8.4 11.3 23.1 12.5 8.4 10.8 19.1 13.8 18.7 16.7 3.7 3.3 24.1 5.4 7.0 6.0 2.2 12.5 8.8 3.0 2.5 11.1 8.2 2.4 21.0 17.0 10.7 14.9 5.0 26.2 3.7 6.8 23.8 14.3 13.1 7.6 50.4 15.9 7.9 5.6 6.3 9.2 3.4 4.7 2.1 11.7 6.6 31.6 10.9 26.3 29.0 9.7 2.8 4.9 15.1 37.1 2.4 1.8 2.8 3.4 15.8 7.4 3.1 6.8 12.9 11.3 6.0 9.2 2.3 16.5 5.1 3.5 7.2 7.9 3.7 21.0 4.6 1.5 8.7 7.5 16.9 3.0 3.3 7.9 3.3 15.5 24.1 3.5 4.7 4.2 2.2 6.0 1.9 4.2 5.6 2.3 3.7 2.6 3.5 10.7 7.0 5.4 3.3 4.7 2.2 10.9 24.7 7.1 16.3 16.0 9.4 16.2 6.2 30.9 12.5 80.4 77.0 6.1 84.9 174.1 4.4 21.3 30.6 46.8 81.9 7.0 37.3 3.3 18.3 29.3 204.3 26.0 33.2 0.0 20.7 6.8 35.1 72.6 116.2 17.0 17.1 20.6 52.3 13.5 16.1 11.0 18.1 36.2 35.4 20.8 21.8 7.8 28.1 28.1 18.0 8.2 9.4 12.9 57.7 61.8 20.2 106.1 6.3 34.5 12.3 186.7 TKTL2 "DKFZP434L1717, FLJ32975" ENSG00000151005 "Transketolase like 2" Q9H0I9 4 163471093-163473746 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "testis: 66.8" "Group enriched" "Detected in some" 19 "Early spermatids: 47.2;Late spermatids: 27.7;Spermatocytes: 100.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (8.62e-2)" "unprognostic (2.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (7.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 66.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 100.1 1.6 0.0 0.0 0.0 0.0 0.0 TLCD1 ENSG00000160606 "TLC domain containing 1" Q96CP7 17 28724348-28727935 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "plasmacytoid DC: 17.7" "Lineage enriched" "Detected in many" 14 "dendritic cells: 17.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042366 Enhanced NA NA "HPA042366: AB_10794419" "unprognostic (1.23e-1)" "unprognostic (3.78e-2)" "unprognostic (8.52e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.47e-3)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.05e-5)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (1.86e-2)" "unprognostic (3.93e-2)" 2.7 3.7 10.0 4.5 12.6 1.0 5.3 6.3 9.5 4.5 7.7 3.0 9.0 7.8 1.7 14.4 8.7 14.7 3.2 1.4 8.6 5.7 12.9 12.0 6.0 4.6 7.0 7.7 2.1 12.4 5.0 2.8 9.0 4.8 5.7 8.3 1.6 9.8 9.6 1.8 13.0 5.5 0.9 3.0 2.5 8.6 7.8 1.7 5.3 4.4 9.6 9.3 4.2 3.4 1.2 17.7 1.1 0.8 0.3 0.5 0.4 4.8 22.0 6.0 5.0 4.2 7.7 14.1 4.0 7.1 1.8 2.7 12.2 8.6 1.5 6.3 4.8 8.6 7.7 6.6 12.5 2.9 1.3 6.4 2.5 14.3 14.7 4.5 5.3 0.4 5.2 10.2 6.9 12.2 3.0 1.6 0.5 9.3 0.2 3.2 16.5 0.6 2.1 6.8 16.3 4.0 1.8 2.5 9.1 15.4 8.6 11.5 2.3 8.3 46.2 4.3 9.3 23.0 1.9 1.7 2.0 6.7 3.6 6.4 1.6 1.7 3.4 3.7 3.1 6.4 1.1 0.8 0.1 0.2 0.8 0.5 1.2 0.5 0.3 0.8 0.6 0.2 0.3 0.5 0.3 0.6 17.7 0.3 0.4 10.0 12.6 6.3 9.5 8.6 5.7 7.0 7.7 4.8 1.7 0.0 5.9 1.7 8.1 2.2 0.0 0.7 7.6 14.7 2.3 12.2 0.0 15.4 0.0 8.1 12.6 0.7 6.9 0.0 7.3 30.5 3.5 16.2 0.0 8.7 3.1 1.6 4.6 1.3 0.0 12.2 1.1 2.1 3.3 3.6 7.0 4.7 9.3 2.9 0.4 6.8 0.6 0.0 2.2 23.2 1.7 1.8 27.0 0.0 8.0 24.4 TLDC2 "C20orf118, dJ132F21.2" ENSG00000101342 "TBC/LysM-associated domain containing 2" A0PJX2 20 36876121-36894235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.9" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 13.4;granulocytes: 14.0;Paneth cells: 13.3;Undifferentiated cells: 6.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "basophil: 7.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.1" "Cell line enriched" "Detected in some" 6 "HMC-1: 28.0" "Region enriched" "Detected in many" 4 "cerebellum: 6.3" "Region enriched" "Detected in single" 12 "cerebellum: 15.5" HPA047468 Enhanced NA NA "HPA047468: AB_2680059" "unprognostic (9.06e-3)" "unprognostic (3.35e-4)" "unprognostic (4.60e-1)" "unprognostic (1.07e-3)" "unprognostic (1.40e-1)" "unprognostic (6.51e-3)" "unprognostic (1.09e-3)" "unprognostic (5.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.82e-2)" "unprognostic (3.67e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.97e-5)" "unprognostic (7.25e-2)" "unprognostic (6.20e-2)" "unprognostic (5.59e-2)" "unprognostic (4.87e-2)" 5.5 1.2 0.9 11.3 0.9 1.4 3.4 0.9 0.9 2.1 21.1 0.9 1.6 18.4 2.5 1.8 1.8 2.7 16.0 3.5 0.9 0.2 3.2 0.9 6.0 2.5 0.9 0.9 2.8 2.1 0.0 1.1 0.9 0.9 2.8 12.8 1.6 2.1 0.9 0.9 2.3 54.9 1.8 0.9 4.5 1.5 1.9 0.9 1.1 2.0 1.7 1.3 2.3 2.6 0.8 1.4 7.1 1.0 1.4 1.2 0.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.1 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.2 1.0 0.1 2.9 0.0 0.3 28.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.6 0.5 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.1 7.1 1.0 0.1 0.3 0.9 0.6 0.3 0.5 0.2 1.4 0.8 1.2 0.3 0.0 1.4 0.9 0.4 0.7 0.7 0.9 0.9 0.9 0.9 0.9 0.2 0.9 0.9 0.9 0.9 0.0 1.7 0.0 0.1 0.0 0.0 0.5 2.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 0.0 0.0 0.0 0.2 0.0 14.0 0.0 0.2 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.0 TLR7 ENSG00000196664 "Toll like receptor 7" Q9NYK1 X 12867083-12890380 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Cell type enhanced" "Detected in some" 16 "Hofbauer cells: 20.2;Macrophages: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.0;U-266/70: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059613 Supported NA NA "HPA059613: AB_2684083" "unprognostic (1.22e-1)" "unprognostic (1.09e-2)" "unprognostic (2.36e-3)" "unprognostic (9.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (8.27e-2)" "unprognostic (6.20e-3)" "unprognostic (3.75e-1)" "unprognostic (6.91e-2)" "unprognostic (3.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (4.17e-3)" "unprognostic (1.19e-3)" "unprognostic (1.53e-3)" "unprognostic (1.34e-1)" 2.9 3.1 7.6 7.2 11.3 1.0 7.6 1.7 7.9 2.5 3.3 10.6 0.0 3.2 1.8 2.9 1.8 1.7 5.3 4.1 8.4 5.1 2.2 1.5 7.7 6.9 17.4 2.6 1.6 1.9 1.5 2.2 11.0 12.9 2.2 4.0 1.5 2.7 2.0 1.4 1.4 4.9 3.5 26.5 6.7 3.0 1.5 17.2 7.7 1.7 0.5 9.4 5.2 1.6 6.9 15.7 3.2 8.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 16.5 0.0 3.1 0.0 0.3 0.0 0.2 7.2 3.2 0.0 8.9 0.0 6.9 0.0 0.0 3.7 5.8 0.0 0.0 0.4 0.0 6.8 15.7 0.0 2.2 7.6 11.3 1.7 7.9 8.4 5.1 17.4 2.6 12.9 17.2 0.0 4.6 2.4 1.1 1.1 0.0 0.5 0.0 4.0 1.2 0.0 2.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.7 1.1 0.0 20.2 0.0 0.0 0.6 2.4 0.0 0.6 14.8 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.1 0.9 0.2 0.0 0.0 1.4 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: AB_2679957, HPA050547: AB_2681168" "prognostic unfavorable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 14.0 22.7 10.6 14.6 24.8 16.7 14.6 29.9 18.4 22.7 20.6 17.3 12.2 4.9 23.6 22.1 25.5 15.3 11.2 18.1 24.8 5.9 8.6 11.3 13.3 18.6 22.0 3.3 14.7 20.3 17.8 17.8 8.7 16.6 29.1 8.4 12.4 14.7 30.2 8.7 8.2 11.4 13.4 21.2 9.0 7.0 13.7 8.3 25.9 11.2 3.5 6.9 11.4 8.0 14.7 19.6 19.6 7.1 26.1 18.4 13.8 26.8 15.0 10.3 22.7 8.7 14.0 7.7 12.8 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 11.9 14.3 17.6 48.8 31.1 21.6 15.1 30.6 20.1 20.5 48.8 19.6 78.2 24.9 57.6 44.6 26.6 11.9 0.0 33.5 82.1 36.1 49.2 21.9 33.7 172.6 22.3 9.9 66.3 32.3 35.5 33.4 33.8 25.3 106.4 10.7 40.2 58.6 15.2 23.3 48.2 29.3 0.0 18.1 33.0 59.4 13.6 66.8 22.0 14.9 50.4 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.5 21.3 11.4 20.6 32.9 24.5 14.0 11.3 18.8 13.5 15.1 11.4 24.4 14.0 15.7 15.4 22.7 20.2 17.7 14.6 10.7 13.3 39.0 20.9 18.5 19.3 21.7 16.2 25.0 20.3 29.6 8.1 16.9 18.9 18.5 18.2 17.1 21.2 21.2 17.3 11.8 17.2 17.6 38.9 7.2 14.5 14.5 21.7 27.2 22.6 15.4 14.1 15.6 16.6 22.5 20.5 15.7 21.5 14.7 14.3 14.7 9.5 12.4 20.1 29.7 15.1 12.1 20.4 11.7 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 23.8 33.2 37.0 49.5 58.8 44.9 33.5 22.9 16.0 28.4 40.1 31.4 64.8 16.6 54.9 5.7 52.5 22.0 0.0 37.4 54.4 51.9 46.9 24.3 51.6 29.9 65.2 25.9 53.4 45.9 8.8 68.1 37.2 25.3 39.7 23.1 57.0 28.6 23.2 59.1 32.7 43.7 71.1 42.7 85.4 85.7 48.4 76.1 47.2 25.4 34.6 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endothelial cells: 155.8;Ito cells: 174.3" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9" "Low region specificity" "Detected in all" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 17.9 4.8 7.1 4.0 8.8 0.1 14.4 3.7 7.3 7.9 3.5 1.7 4.7 3.1 7.6 7.2 5.4 5.6 9.0 10.8 8.4 6.2 26.6 9.7 7.4 8.0 9.3 1.5 5.4 8.0 4.2 7.4 14.1 12.3 9.1 2.9 11.9 3.5 5.6 9.3 2.7 3.9 12.3 7.4 34.6 3.5 2.6 8.2 0.6 12.0 5.7 4.0 6.0 5.8 0.9 0.6 1.2 0.4 2.8 0.5 0.0 0.0 29.6 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 62.5 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 20.7 0.0 0.0 0.0 1.9 0.2 0.0 0.0 14.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.6 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 1.2 0.4 0.4 0.3 0.2 0.1 0.5 0.4 0.2 0.0 0.9 0.4 0.5 0.5 2.8 0.3 0.6 0.1 0.0 7.1 8.8 3.7 7.3 8.4 6.2 9.3 1.5 12.3 8.2 0.0 4.1 2.2 0.0 2.9 0.1 1.1 7.6 1.4 0.0 1.8 0.0 0.0 8.3 21.2 0.3 155.8 0.0 0.0 0.2 0.0 0.9 1.0 1.1 0.6 0.1 0.0 0.0 174.3 13.0 1.0 2.0 0.2 1.7 1.0 0.0 0.6 1.2 0.0 6.3 25.4 0.0 0.0 2.1 0.0 0.2 2.5 0.0 1.3 0.0 0.4 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "adipose tissue: 69.9" "Cell type enriched" "Detected in some" 9 "Hofbauer cells: 78.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4" "Lineage enriched" "Detected in single" 19 "T-cells: 14.8" "Cell line enriched" "Detected in some" 12 "GAMG: 100.5" NA NA "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 69.9 0.4 0.4 0.7 0.4 0.9 4.5 0.4 0.5 2.1 0.4 0.4 0.4 0.0 0.4 0.6 5.0 0.3 0.8 0.4 0.4 0.1 0.4 0.8 4.9 0.6 0.4 0.4 1.2 0.4 0.0 0.4 1.1 0.4 0.6 0.1 0.4 2.2 0.4 2.1 3.2 0.4 0.4 0.4 0.8 0.6 8.2 0.4 0.5 1.0 2.0 1.3 0.9 2.1 0.3 0.5 0.6 0.4 0.8 14.8 1.4 3.4 1.6 0.1 0.1 0.2 1.1 0.1 0.0 1.0 0.3 0.7 0.0 1.9 0.0 0.6 0.0 100.5 0.5 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.3 4.4 7.4 0.0 0.0 0.2 2.1 0.2 1.1 0.2 0.0 0.1 0.0 0.0 8.4 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.3 4.4 3.6 0.6 2.0 0.1 1.2 0.0 4.7 0.1 0.1 0.6 0.3 0.4 14.8 0.4 0.1 0.1 1.4 3.8 0.1 0.3 0.8 5.4 0.6 0.8 0.1 0.5 0.3 1.4 0.4 0.4 0.4 0.5 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 78.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 3.8 0.0 0.3 0.0 0.0 0.0 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 176.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.6 8.5 12.2 3.4 0.2 5.4 0.6 1.3 1.0 1.1 8.8 12.4 5.4 9.6 0.4 0.3 4.3 3.7 6.0 0.7 5.2 1.9 3.3 1.0 17.7 6.9 1.3 3.7 1.5 1.8 4.9 0.6 4.0 0.9 10.3 1.9 4.2 0.3 22.1 2.3 5.8 4.6 5.6 4.1 7.2 0.4 12.7 25.4 3.9 9.6 10.8 0.4 9.3 2.1 5.6 49.4 3.6 0.6 0.1 1.3 1.2 0.8 9.6 6.0 3.1 0.8 2.1 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 8.9 36.6 11.1 5.3 1.6 15.6 89.9 50.9 6.7 5.7 41.8 9.8 64.7 14.9 20.7 26.9 4.5 21.7 0.0 24.2 1.7 3.3 37.3 6.9 79.7 12.7 23.8 57.1 4.3 6.3 49.4 9.2 3.5 11.8 13.6 16.5 176.3 28.8 11.5 2.1 62.4 21.2 12.9 2.3 10.9 9.4 6.0 68.7 8.5 12.4 8.4 TM7SF3 ENSG00000064115 "Transmembrane 7 superfamily member 3" Q9NS93 12 26973195-27014434 "Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057640 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA057640: " "unprognostic (4.24e-1)" "unprognostic (1.90e-2)" "unprognostic (1.04e-3)" "unprognostic (8.80e-2)" "unprognostic (5.82e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-2)" "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" 12.0 27.6 12.1 8.1 17.4 18.5 15.9 7.9 18.9 12.4 17.2 18.1 13.1 10.7 10.9 16.6 27.8 12.7 16.4 10.6 11.7 11.6 69.8 39.9 15.9 15.0 13.0 11.6 12.1 52.6 15.4 33.2 11.0 10.7 14.5 19.7 20.5 21.9 14.2 5.8 15.4 12.8 13.2 13.9 12.0 14.9 11.0 10.6 31.2 14.1 12.3 17.1 15.3 16.5 10.5 10.6 16.0 6.9 11.8 11.4 3.9 8.4 20.1 12.0 14.5 18.3 12.1 63.1 10.5 17.0 8.6 14.9 11.1 36.2 11.4 13.5 9.8 7.8 9.3 12.5 70.9 12.0 11.1 7.4 17.0 25.3 21.0 12.1 61.3 12.0 7.4 60.5 18.5 16.7 26.3 22.7 30.9 7.3 7.8 13.0 17.3 29.9 35.7 24.4 32.7 12.0 28.0 18.9 20.1 15.0 38.7 2.0 10.7 12.9 6.9 18.4 59.2 19.1 13.0 8.5 7.6 12.4 20.7 12.9 4.7 12.1 21.3 14.6 20.9 11.4 8.6 6.9 16.0 6.0 6.9 5.7 7.3 7.6 7.8 10.2 10.5 10.9 7.2 7.8 11.8 3.5 10.6 11.4 3.9 12.1 17.4 7.9 18.9 11.7 11.6 13.0 11.6 10.7 10.6 11.9 22.2 20.8 43.3 25.5 44.9 8.6 94.3 5.3 25.0 40.1 41.2 35.0 14.9 48.9 75.7 18.9 16.7 23.3 35.2 13.0 17.5 22.1 13.9 37.8 34.8 22.3 12.7 15.4 19.7 123.7 14.4 20.3 62.4 21.6 21.2 29.6 27.4 31.6 21.5 79.2 34.9 6.5 12.8 6.2 26.2 24.3 13.6 20.3 29.9 34.1 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189143-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 13.3 20.4 6.3 10.9 6.6 3.4 14.0 5.4 8.1 18.5 15.6 10.4 33.1 10.7 17.7 21.8 14.1 23.4 18.4 14.6 6.2 6.0 24.5 46.4 17.0 14.6 6.2 7.1 17.6 39.9 27.4 12.3 25.1 6.5 16.9 9.4 15.6 31.8 36.0 10.1 12.0 16.8 13.6 5.9 12.7 14.7 10.3 5.6 9.6 32.3 12.9 12.1 12.8 12.4 10.6 25.8 18.0 13.6 14.5 10.8 8.6 9.5 16.0 7.1 5.5 14.1 11.0 11.1 18.7 21.3 22.5 25.3 8.0 18.6 5.7 12.5 15.9 10.7 21.5 4.4 11.3 12.3 9.5 7.5 4.4 8.3 16.5 9.9 8.1 10.3 12.8 15.9 14.2 8.2 10.9 12.8 3.2 5.2 11.0 13.4 15.0 4.8 5.6 3.3 13.5 18.9 7.2 10.5 9.5 7.8 13.0 7.2 8.3 22.6 10.2 9.1 5.4 9.6 3.6 12.8 19.7 9.0 10.3 11.7 15.5 11.8 4.1 6.6 4.5 13.4 17.2 13.6 15.2 10.0 10.9 10.8 10.2 9.9 8.7 15.0 10.6 9.2 8.7 18.0 14.5 10.4 25.8 9.9 8.6 6.3 6.6 5.4 8.1 6.2 6.0 6.2 7.1 6.5 5.6 14.9 4.0 3.9 5.0 3.0 4.2 1.0 5.1 45.5 7.9 1.8 13.7 8.2 0.0 6.6 9.3 6.0 4.2 0.0 4.3 8.1 5.9 6.7 2.3 4.3 3.7 0.0 1.7 4.9 1.0 3.8 4.9 3.2 1.7 5.4 2.3 6.1 4.6 4.2 4.2 2.3 6.6 6.5 6.2 5.6 5.1 4.1 10.0 4.5 3.7 3.5 TMC2 "C20orf145, dJ686C3.3" ENSG00000149488 "Transmembrane channel like 2" Q8TDI7 20 2536607-2641784 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.1;pituitary gland: 3.2" "Cell type enriched" "Detected in some" 6 "Late spermatids: 9.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enhanced" "Detected in single" "ASC diff: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (8.30e-4)" "unprognostic (2.86e-3)" "unprognostic (3.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.07e-2)" "unprognostic (4.54e-1)" "unprognostic (1.41e-2)" "unprognostic (4.05e-5)" "unprognostic (2.90e-1)" "unprognostic (3.21e-7)" "unprognostic (2.47e-2)" "unprognostic (2.56e-1)" "unprognostic (1.93e-1)" "unprognostic (5.74e-2)" 2.3 0.4 0.3 0.3 0.8 0.0 0.7 8.1 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.2 0.9 0.0 0.0 3.0 0.2 0.1 0.5 0.1 0.1 3.2 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.0 2.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.1 0.2 0.4 0.3 0.2 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331217-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "parathyroid gland: 66.9" "Cell type enhanced" "Detected in single" 24 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Region enhanced" "Detected in some" "pons and medulla: 1.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.0 0.1 0.0 1.7 0.0 0.3 0.2 0.4 1.4 1.5 1.5 0.0 0.0 0.2 0.8 4.6 0.7 0.8 0.2 0.2 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.2 0.2 66.9 1.5 0.7 1.6 1.0 0.1 0.4 0.2 2.9 0.0 0.2 0.5 1.7 1.9 0.1 0.8 3.0 0.0 0.0 1.5 0.0 0.0 1.3 3.6 1.6 0.7 0.2 0.2 0.2 1.8 0.7 0.9 1.0 0.5 2.7 0.4 0.2 1.9 0.8 0.3 0.2 0.3 0.7 1.9 2.3 0.1 0.0 2.4 0.7 0.3 0.2 0.1 1.7 1.4 1.9 1.1 0.9 0.3 1.5 1.1 0.5 0.1 0.4 0.3 1.2 0.0 2.8 0.6 2.8 0.2 0.8 1.0 1.4 1.5 0.8 0.9 0.7 1.0 4.3 0.2 0.6 1.1 2.0 0.9 1.0 2.0 0.6 2.3 1.1 0.4 1.5 1.8 1.3 0.5 4.6 1.8 1.4 1.1 2.5 0.9 0.1 0.0 0.2 0.7 0.1 0.6 1.2 0.8 0.4 0.1 1.6 1.8 1.3 0.2 0.2 0.2 0.7 0.9 0.7 0.0 0.0 0.4 1.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.3;OE19: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.5 5.8 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.2 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.3 21.6 1.6 0.0 0.0 1.3 0.1 0.1 0.3 0.1 0.0 1.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 145.9 125.6 0.0 19.6 0.7 0.1 0.8 122.3 547.4 299.1 21.0 2.0 31.1 0.0 107.5 21.7 0.4 170.3 0.0 144.9 1.6 0.8 88.4 5.7 0.0 2.3 3.2 37.4 0.6 0.0 28.2 0.3 0.9 1.7 1.8 97.1 0.1 236.7 190.0 0.7 0.4 1.5 0.0 0.9 1.8 1.1 1.5 13.6 0.0 77.1 46.1 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567124-94650562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 44.2;Urothelial cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.2;neutrophil: 30.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 30.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 18.2;Karpas-707: 24.6;U-266/84: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 10.6 4.0 10.2 7.7 20.9 8.1 9.9 2.7 9.9 11.0 19.7 32.6 6.8 13.1 6.9 3.0 6.1 5.5 4.7 4.4 14.7 10.8 7.4 3.5 5.9 3.9 25.8 7.4 5.2 2.8 5.0 4.7 15.7 17.8 7.7 15.0 7.3 5.8 5.1 20.2 7.0 23.0 7.2 25.5 11.6 6.4 2.2 20.4 0.1 12.0 3.3 5.3 7.2 5.9 2.5 1.1 30.0 3.0 1.3 1.5 1.1 4.4 0.2 1.1 0.0 0.4 1.6 8.0 0.0 0.0 0.3 1.1 0.0 1.0 0.1 0.0 0.0 4.0 11.0 6.2 7.5 1.5 2.0 1.5 2.9 0.5 0.0 0.3 0.0 6.0 1.0 1.0 4.2 6.0 6.7 18.2 0.0 0.1 24.6 0.6 0.2 0.0 0.2 0.5 1.5 3.8 0.0 0.3 2.9 1.2 9.4 0.1 0.5 0.1 4.7 0.2 5.4 0.0 0.2 11.0 0.0 0.1 0.0 1.9 11.5 16.4 0.1 2.3 0.9 1.0 6.5 1.8 19.2 1.5 2.6 0.1 2.5 0.6 0.8 1.0 1.4 0.0 1.0 30.0 1.3 3.0 1.1 0.0 1.1 10.2 20.9 2.7 9.9 14.7 10.8 25.8 7.4 17.8 20.4 0.0 2.4 6.0 26.2 18.3 1.7 1.7 5.1 0.0 0.0 7.0 0.0 12.5 0.0 1.4 4.6 12.1 44.2 0.0 3.4 2.7 3.4 12.5 0.0 0.5 3.5 0.0 11.5 21.5 13.7 4.7 1.7 11.0 3.3 22.6 11.3 0.0 7.7 18.7 1.1 8.4 0.2 6.5 3.1 0.0 1.1 14.2 5.9 4.9 5.5 78.1 TMCO4 DKFZp686C23231 ENSG00000162542 "Transmembrane and coiled-coil domains 4" Q5TGY1 1 19682213-19799945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA014601, HPA014620" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA014601: AB_2204302, HPA014620: AB_2669051" "unprognostic (3.31e-3)" "unprognostic (8.94e-2)" "unprognostic (9.71e-2)" "prognostic favorable (3.71e-4)" "unprognostic (6.99e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (9.21e-2)" "unprognostic (2.60e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (2.71e-2)" "prognostic favorable (4.12e-11)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" "unprognostic (9.81e-2)" "prognostic favorable (3.64e-4)" 10.6 8.8 2.4 9.0 3.3 2.5 11.3 0.9 2.3 9.1 6.1 2.8 15.2 11.8 16.9 15.1 8.0 7.3 7.4 4.9 1.6 1.3 9.5 7.9 5.2 12.6 2.6 1.2 8.6 15.3 17.3 10.5 7.3 3.3 12.1 3.9 8.8 25.8 19.0 2.0 5.2 6.4 11.2 2.0 9.1 8.7 3.3 2.4 3.5 10.8 7.6 9.5 11.6 10.0 7.2 9.3 2.7 8.1 4.6 6.7 4.4 5.8 3.6 0.0 0.2 5.0 3.6 4.1 4.4 13.4 8.6 4.8 2.9 27.5 10.2 6.5 12.5 3.8 4.5 1.1 4.4 1.7 8.6 1.1 3.9 4.3 1.4 4.1 0.0 5.4 3.7 4.9 2.9 1.6 3.1 4.1 0.2 0.7 6.9 3.7 4.9 0.0 2.2 0.4 7.8 5.1 1.9 11.5 6.2 7.4 4.6 0.0 0.5 5.8 8.0 9.1 0.6 7.0 6.6 2.5 6.7 3.1 4.6 3.0 0.8 0.3 2.9 7.6 8.8 4.1 0.1 4.8 2.7 6.3 8.1 6.2 5.6 6.7 6.6 9.3 7.2 5.2 4.3 0.3 4.6 4.9 0.2 4.9 4.4 2.4 3.3 0.9 2.3 1.6 1.3 2.6 1.2 3.3 2.4 11.9 8.3 8.2 10.2 2.5 0.1 5.6 2.5 24.1 7.9 10.4 0.0 8.0 8.3 9.0 0.3 4.3 6.7 0.0 14.6 16.0 4.5 12.2 3.5 4.4 8.2 0.0 5.8 5.5 6.3 0.0 5.8 5.7 10.1 12.6 10.8 2.8 10.4 5.8 5.3 6.0 0.6 0.0 7.5 0.2 2.0 2.3 6.1 8.2 12.1 6.5 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 43.9" "Group enriched" "Detected in some" 135 "Early spermatids: 1004.2;Late spermatids: 3019.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.2;hTERT-HME1: 1.9" "Group enriched" "Detected in many" 4 "amygdala: 6.0;basal ganglia: 2.2;cerebral cortex: 5.7;hippocampal formation: 6.7" "Not detected" "Not detected" HPA056530 Enhanced NA NA "HPA056530: AB_2683167" "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1004.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3019.1 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 6.5 0.0 14.9 5.2 0.0 0.0 0.0 0.0 0.0 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343248-69351809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pancreas: 144.2" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 31.9;Pancreatic endocrine cells: 21.0;Proximal tubular cells: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 17.2;OE19: 8.2" HPA012532 Approved NA NA "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favorable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.4 0.9 0.2 2.0 2.7 0.3 4.5 0.2 5.6 0.3 0.2 0.2 0.1 6.1 3.1 0.7 0.2 0.2 0.2 1.0 144.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 3.5 0.2 0.1 2.8 0.2 0.2 0.3 16.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.6 0.0 2.0 0.2 0.7 1.8 1.6 1.1 0.1 0.1 1.0 2.3 0.1 0.0 0.3 2.4 1.0 4.7 0.8 0.0 0.7 1.2 0.2 0.2 0.4 0.7 2.0 2.4 0.8 17.2 0.1 2.9 1.1 0.2 0.9 0.1 0.3 0.9 0.1 2.3 1.6 0.6 0.3 1.8 1.3 3.3 2.2 8.2 1.7 2.6 1.4 1.8 0.7 2.0 3.8 1.5 3.1 1.1 1.2 0.6 0.6 2.1 2.1 2.7 1.5 0.9 1.5 1.6 1.4 5.2 1.4 2.5 0.8 0.0 0.4 0.0 0.8 0.6 1.5 0.6 2.0 0.4 0.2 0.3 0.5 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.1 0.0 2.3 0.1 0.0 5.6 0.0 31.9 0.0 0.0 0.2 1.1 3.4 0.3 0.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.7 21.0 5.5 0.0 16.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.1 TMEM105 FLJ38792 ENSG00000185332 "Transmembrane protein 105" Q8N8V8 17 81311270-81330674 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 7.5" "Cell type enhanced" "Detected in some" 9 "Hepatocytes: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.3;MCF7: 3.3;OE19: 3.3;T-47d: 2.1;THP-1: 2.7;U-937: 5.1" NA NA "unprognostic (4.99e-3)" "unprognostic (6.49e-3)" "unprognostic (4.62e-2)" "unprognostic (3.67e-2)" "unprognostic (2.54e-1)" "unprognostic (3.65e-4)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.32e-3)" "unprognostic (7.49e-2)" "unprognostic (9.81e-4)" "unprognostic (1.33e-1)" "unprognostic (6.04e-6)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.48e-2)" "unprognostic (3.38e-1)" 0.1 0.8 0.1 0.1 0.1 0.6 0.7 0.0 0.1 0.5 1.7 0.0 0.0 0.5 0.1 0.2 2.4 0.7 5.0 0.0 0.1 0.0 2.4 7.5 4.7 0.1 0.1 0.0 0.2 0.1 0.0 0.1 1.0 0.5 0.8 0.4 0.7 4.0 0.0 0.5 1.1 2.0 1.3 0.2 1.3 0.3 0.2 0.0 0.0 2.4 3.3 2.4 3.3 1.0 0.5 1.0 1.9 0.4 0.8 0.4 0.1 0.5 1.1 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.2 0.0 3.3 0.1 0.0 0.5 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.1 2.1 2.7 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.6 0.4 0.3 0.3 0.1 0.2 0.3 0.2 0.3 0.0 0.5 0.2 0.4 1.9 0.8 0.1 1.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 2.1 0.0 0.4 0.5 0.0 0.4 2.5 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.6 0.0 2.6 0.0 0.2 1.1 0.2 0.4 0.0 4.3 0.3 0.0 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.0 2.3 0.0 6.5 0.3 0.0 0.0 0.6 0.1 0.0 2.9 0.4 TMEM106A MGC20235 ENSG00000184988 "Transmembrane protein 106A" Q96A25 17 43211835-43220041 "Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 31.9" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 36.4;Kupffer cells: 35.3;Macrophages: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 15.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (9.71e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (9.61e-5)" "unprognostic (4.95e-3)" "unprognostic (8.62e-2)" "unprognostic (1.79e-1)" "unprognostic (9.11e-2)" "unprognostic (1.76e-1)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (2.99e-2)" "unprognostic (6.08e-2)" "unprognostic (7.89e-3)" "unprognostic (1.39e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (8.30e-2)" 7.6 4.8 4.7 17.2 5.9 3.5 8.9 1.1 3.6 7.4 4.1 5.0 2.6 4.4 7.3 9.1 2.5 6.2 5.2 5.5 4.1 2.8 24.9 5.5 11.0 31.9 5.7 3.6 9.3 6.2 2.6 3.8 18.7 4.1 5.2 6.3 7.2 5.8 6.0 1.9 2.4 6.2 9.9 7.4 16.5 5.5 5.5 5.4 5.3 7.3 4.1 12.0 5.6 5.2 3.3 5.3 17.4 4.9 1.7 2.2 1.7 2.7 0.9 0.3 0.2 3.5 3.9 2.1 7.0 4.5 6.1 9.6 2.1 5.7 4.0 1.4 10.6 2.4 1.3 0.7 0.9 7.2 6.2 0.0 2.7 2.3 9.4 2.0 0.1 15.4 2.4 0.2 11.3 0.3 2.2 5.3 4.8 0.1 2.9 7.6 1.2 4.7 1.8 0.3 0.0 0.0 3.5 1.2 2.4 2.6 0.2 0.6 0.0 1.3 3.3 1.5 1.6 5.0 4.0 6.1 3.1 0.4 3.1 1.4 4.6 0.4 1.2 2.5 4.8 6.0 17.4 4.3 4.8 1.5 4.9 0.6 1.7 1.0 1.4 3.6 3.3 0.7 1.3 1.3 1.7 1.7 5.3 2.2 1.7 4.7 5.9 1.1 3.6 4.1 2.8 5.7 3.6 4.1 5.4 3.0 5.0 11.5 9.6 2.2 4.7 0.8 0.0 5.3 3.4 7.0 2.0 4.6 3.3 1.9 4.1 3.7 2.1 0.0 3.4 5.5 6.6 9.5 8.1 1.6 36.4 0.0 2.9 3.7 35.3 2.1 13.0 31.1 0.0 9.0 3.1 2.0 4.1 2.5 6.7 13.0 3.4 12.9 3.8 7.7 3.8 1.5 4.3 7.0 2.6 10.5 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.8 4.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.3 0.0 0.1 1.8 0.0 0.0 0.0 2.3 0.0 0.5 0.0 10.3 45.3 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.9 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 3.0 2.9 0.0 0.5 2.2 11.4 1.2 0.0 0.0 9.1 0.0 96.2 1.8 0.0 0.0 57.1 1.4 0.0 0.0 0.3 7.2 1.1 0.2 1.1 0.0 0.2 1.6 0.0 0.0 0.0 29.1 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.7 0.0 56.3 0.0 1.4 19.1 8.0 1.4 0.9 0.0 0.0 0.3 TMEM114 ENSG00000232258 "Transmembrane protein 114" B3SHH9 16 8537605-8590193 "Disease related genes, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "ductus deferens: 60.1;seminal vesicle: 24.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "hypothalamus: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.5;U-2 OS: 2.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 9.6" NA NA "unprognostic (3.72e-5)" "unprognostic (2.26e-1)" "unprognostic (3.98e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 60.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.4 0.0 0.0 0.0 24.7 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 8.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.7;Spermatocytes: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 14.9" "Cell line enhanced" "Detected in many" "RT4: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.7 10.7 4.4 3.0 8.4 1.0 10.2 6.7 6.6 5.3 4.1 11.2 9.1 9.5 3.9 6.4 4.9 4.2 5.8 20.2 5.3 3.7 26.8 10.0 7.2 3.7 8.7 5.5 4.7 4.1 31.2 9.6 2.7 14.0 4.5 3.4 5.9 12.5 7.0 5.0 11.8 9.0 5.1 8.2 3.9 8.7 20.8 7.3 6.0 6.6 3.6 5.6 8.6 4.5 2.5 3.0 3.0 3.3 1.5 14.9 3.4 4.2 4.4 6.3 7.0 6.3 5.0 4.3 3.4 5.6 4.5 4.9 3.3 3.5 4.9 2.2 2.6 5.5 4.3 3.5 3.7 3.9 11.7 2.8 3.1 4.2 4.1 10.1 1.2 0.5 6.1 6.4 5.8 10.1 4.8 1.5 9.4 5.9 4.0 4.6 6.3 1.8 10.0 7.8 10.2 2.9 5.0 2.5 8.4 14.1 23.9 6.0 4.0 3.7 3.3 5.8 8.9 11.9 16.5 1.1 4.3 1.3 3.8 1.5 4.7 8.2 4.6 6.0 3.9 6.0 0.8 1.8 3.0 6.5 3.3 5.2 2.1 14.9 12.1 2.1 2.5 7.9 8.6 0.3 1.5 2.4 3.0 13.5 3.4 4.4 8.4 6.7 6.6 5.3 3.7 8.7 5.5 14.0 7.3 3.0 14.4 1.5 6.8 4.8 10.6 21.6 5.1 12.0 2.3 27.9 15.7 16.1 19.9 3.0 48.7 3.4 7.8 0.0 3.6 4.8 5.6 3.6 5.7 5.0 4.5 9.5 0.0 1.8 5.2 26.7 8.6 3.7 6.8 2.8 2.4 13.0 3.0 1.9 4.6 8.8 17.6 6.5 4.2 128.4 21.3 4.6 33.5 12.9 2.6 5.9 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 9.5;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.5 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.5 0.0 0.0 1.5 1.3 9.5 0.0 0.8 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.9 0.2 0.0 1.4 0.1 11.7 7.5 0.0 0.1 0.1 0.0 6.1 2.3 0.5 0.0 2.2 0.1 2.7 0.3 1.6 1.3 2.4 0.2 0.5 0.7 0.0 0.0 0.1 0.5 6.2 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 0.0 0.3 0.5 2.4 4.0 4.3 1.2 0.0 1.4 1.2 5.2 0.0 0.2 0.0 1.0 1.3 7.1 0.0 0.0 0.2 1.2 3.8 1.7 0.0 1.7 0.3 9.5 0.0 7.4 0.3 1.5 4.0 0.0 6.8 0.0 0.0 17.0 0.0 0.0 6.0 0.0 1.1 0.0 1.7 0.5 3.1 2.3 0.2 0.0 0.0 0.6 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Group enriched" "Detected in some" 8 "granulocytes: 1.1;Hofbauer cells: 2.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.2 0.0 0.1 0.2 3.1 0.0 0.3 0.1 15.0 2.3 0.0 0.0 0.3 0.9 0.0 12.1 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 10.0 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269994-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 73.6;salivary gland: 47.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol NA NA "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.8 0.0 5.3 4.6 7.1 0.0 4.9 0.9 5.0 7.4 14.4 1.0 20.7 15.1 1.8 12.5 3.3 6.6 18.9 1.0 8.9 4.3 9.4 1.4 42.5 0.8 10.7 0.8 2.0 73.6 9.6 15.7 5.6 1.1 8.8 9.1 1.5 47.8 19.0 0.8 3.7 29.4 0.8 21.1 0.8 11.6 1.2 0.8 1.1 33.6 3.8 5.0 1.4 3.5 0.0 0.8 0.0 0.0 1.8 0.9 0.2 13.4 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 10.5 25.1 0.0 0.6 0.0 0.0 6.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 16.0 0.0 0.0 0.0 0.3 0.2 4.3 6.5 0.0 0.0 21.6 0.0 2.0 17.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.2 0.0 1.8 0.0 0.8 0.0 0.2 5.3 7.1 0.9 1.9 8.9 4.3 10.7 0.8 1.1 0.8 113.2 120.0 0.5 1.7 0.0 0.0 0.4 43.3 29.4 47.8 15.7 0.0 26.1 14.9 32.4 3.1 0.0 84.2 0.0 34.1 1.2 0.2 16.8 1.1 0.0 2.0 0.0 20.8 0.0 0.0 6.0 0.3 0.8 0.0 1.0 59.6 1.7 27.0 37.4 1.1 23.1 0.0 0.0 0.2 1.0 0.2 0.4 6.1 0.0 32.2 5.4 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 49.7" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 1.3 28.2 27.3 2.0 53.8 1.4 1.8 14.1 82.2 3.5 1.8 2.8 0.0 1.6 1.8 8.0 2.2 1.7 2.2 1.4 29.3 47.0 2.8 1.1 5.4 2.4 13.4 35.1 1.7 1.6 1.5 24.0 1.3 25.8 2.7 1.9 1.0 1.3 6.2 2.1 1.3 2.1 1.6 9.2 1.4 1.4 26.4 3.9 0.1 1.4 0.0 1.2 1.7 1.2 1.0 0.6 4.8 0.9 1.0 0.7 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.2 3.4 7.6 0.6 0.5 0.1 0.1 0.1 7.4 1.9 8.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 12.8 0.3 0.1 0.1 0.6 0.4 0.6 0.1 0.1 4.4 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.5 9.1 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.4 0.2 0.1 0.3 0.4 0.1 2.2 0.9 0.6 0.5 0.4 0.4 0.7 0.5 0.4 0.2 1.0 0.7 0.6 4.8 1.0 0.6 0.6 0.4 0.3 27.3 53.8 14.1 44.2 29.3 47.0 13.4 35.1 25.8 3.9 0.0 0.0 0.0 0.3 0.3 49.7 0.8 2.5 0.0 3.4 1.8 2.0 0.1 0.0 0.0 1.3 0.3 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.9 0.9 0.2 0.0 0.0 0.0 1.3 0.0 0.0 6.3 0.0 3.7 0.0 0.3 0.4 0.7 0.3 0.2 0.0 0.0 0.1 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 19.3" "Group enriched" "Detected in some" 4 "Early spermatids: 22.6;Late spermatids: 28.8" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "AF22: 3.6;HSkMC: 8.0;NTERA-2: 9.1;RPMI-8226: 3.9;U-138 MG: 14.2;U-937: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035661, HPA035662" Uncertain NA NA "HPA035661: AB_10669774, HPA035662: AB_2674726" "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.2 0.2 6.1 0.1 7.5 0.0 0.1 0.2 19.3 0.6 0.3 0.2 0.8 1.0 0.5 0.2 0.3 0.7 5.1 2.6 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.0 1.1 0.2 0.4 0.4 2.8 0.6 0.5 2.4 0.2 0.2 0.5 0.0 0.3 0.8 2.7 0.3 0.1 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2.7 2.9 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 14.2 0.0 0.1 0.0 0.0 0.2 0.0 2.2 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 1.9 2.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 28.8 0.3 0.0 1.7 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.2 0.0 0.2 0.9 3.6 2.9 0.0 0.0 0.0 0.5 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Group enriched" "Detected in some" 6 "AF22: 6.1;ASC diff: 8.7;Daudi: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 6.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 0.0 0.0 0.0 0.0 0.3 14.3 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 1.7 0.0 0.0 0.4 0.1 0.0 14.2 0.0 2.1 0.0 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87323758 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles NA NA Vesicles "HPA056685: AB_2683208, HPA069473: AB_2686139" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 31.6 28.9 10.5 9.5 12.0 5.9 23.3 11.4 14.8 8.3 14.3 12.8 18.9 21.8 15.1 7.8 7.4 8.4 12.6 12.6 9.9 11.3 16.5 31.2 11.7 9.8 13.8 10.2 14.1 9.2 14.7 24.4 13.5 12.9 15.4 12.1 12.8 16.9 17.8 14.9 7.5 20.1 11.1 11.2 8.3 10.1 15.7 11.4 14.1 15.0 6.4 7.0 10.7 9.9 5.9 7.0 2.2 6.0 8.4 10.4 4.5 4.2 6.9 4.9 6.7 15.8 15.2 6.2 3.3 8.5 4.0 8.4 12.2 19.2 12.0 8.5 4.2 9.2 4.1 6.6 8.0 4.2 10.5 4.1 9.6 7.3 42.3 8.8 5.2 5.0 17.4 4.8 5.2 3.6 5.0 9.9 11.9 8.8 16.5 4.2 3.4 12.8 6.1 5.8 22.0 5.9 6.7 3.9 9.5 8.8 13.2 2.5 6.3 5.1 14.6 7.0 9.5 20.9 5.8 5.2 4.3 5.3 14.8 2.5 6.9 12.4 13.0 3.0 5.9 7.8 0.9 5.8 1.7 9.7 6.0 8.5 5.9 6.3 10.4 6.6 5.2 7.1 6.8 2.2 8.4 2.7 7.0 6.5 4.5 10.5 12.0 11.4 14.8 9.9 11.3 13.8 10.2 12.9 11.4 8.9 6.9 1.5 3.9 3.8 5.8 4.6 0.0 1.4 6.8 1.8 3.9 1.7 5.0 2.6 2.2 6.3 12.6 0.0 2.9 7.1 7.5 9.3 9.2 14.7 4.3 1.6 3.5 8.6 6.3 5.2 6.6 4.2 5.0 3.6 6.5 5.0 2.9 6.2 6.7 8.4 4.2 32.3 5.3 2.1 3.6 4.3 1.3 3.2 7.8 3.7 TMEM136 MGC17839 ENSG00000181264 "Transmembrane protein 136" Q6ZRR5 11 120325129-120333682 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 91.0;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.7" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA074432: AB_2686689" "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 18.9 9.1 2.7 13.8 1.0 5.7 5.8 15.1 4.6 2.9 13.8 3.2 2.1 7.6 14.0 2.6 7.4 5.6 19.1 8.2 5.7 4.8 1.9 4.9 4.0 13.0 7.7 9.0 9.7 9.4 7.9 10.4 12.0 8.4 2.3 9.0 2.4 5.9 1.8 2.0 3.1 6.9 13.7 4.2 2.8 5.4 8.8 0.0 7.8 0.7 2.9 3.2 4.1 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.6 4.3 8.2 7.8 8.2 12.9 2.1 3.6 8.9 5.8 9.5 2.2 7.3 0.0 11.3 2.3 12.0 1.2 7.2 2.7 6.5 0.0 4.5 5.4 3.9 3.8 9.2 0.0 0.0 11.1 2.0 8.2 12.7 13.1 6.7 6.7 1.4 10.8 7.8 2.0 0.0 0.0 3.5 0.4 2.7 4.1 3.3 0.5 7.7 1.6 5.3 5.1 5.1 0.6 1.0 9.6 6.8 0.2 4.8 6.4 6.6 1.4 2.1 0.1 0.0 0.0 1.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 9.1 13.8 5.8 11.5 8.2 5.7 13.0 7.7 12.0 8.8 8.9 5.1 0.0 16.7 3.3 12.1 21.0 7.6 6.7 9.1 22.7 51.1 9.2 5.0 19.5 1.5 6.3 0.5 0.0 11.4 3.2 11.6 28.9 0.0 0.5 1.1 12.7 18.8 4.9 0.6 1.5 3.1 1.0 5.0 23.4 1.6 17.1 17.9 0.0 2.1 3.7 91.0 45.3 14.6 6.9 6.5 3.1 7.9 0.0 0.7 10.7 TMEM143 FLJ10922 ENSG00000161558 "Transmembrane protein 143" Q96AN5 19 48332356-48364237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 22.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014476, HPA058645" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA014476: AB_1858092, HPA058645: " "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (5.23e-2)" "unprognostic (2.50e-1)" "unprognostic (5.94e-2)" "unprognostic (2.11e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (4.08e-1)" "unprognostic (2.25e-1)" "unprognostic (7.29e-2)" "unprognostic (9.82e-2)" "prognostic favorable (1.53e-7)" "unprognostic (5.46e-2)" "unprognostic (1.24e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-1)" 6.2 5.6 3.3 3.5 5.7 2.7 3.2 5.1 6.6 2.6 4.4 4.4 4.1 4.3 4.1 3.8 4.0 3.0 3.2 27.0 3.4 2.7 6.1 9.7 2.9 3.5 4.7 4.5 3.2 4.2 3.1 3.2 3.0 3.9 3.4 3.1 4.7 4.5 4.1 70.1 4.8 4.8 5.3 3.2 4.6 3.7 2.5 4.3 5.4 3.9 16.5 5.1 3.7 2.5 5.0 3.4 3.6 2.3 7.6 5.7 2.7 3.6 5.7 1.9 3.5 3.9 6.3 3.8 3.4 2.0 2.4 3.1 5.0 4.7 6.6 6.5 2.3 1.1 4.1 1.9 2.5 1.4 9.1 4.3 4.0 4.6 8.3 3.3 3.2 3.9 5.4 3.1 1.2 3.4 2.8 1.9 10.4 2.9 9.9 3.0 2.1 4.4 12.3 2.4 6.7 2.1 7.1 1.4 11.0 3.2 2.7 7.2 7.0 1.9 2.5 1.5 2.3 3.5 2.8 2.3 2.8 3.2 2.0 1.7 20.9 6.2 5.4 2.3 4.3 2.4 3.6 2.3 2.7 4.7 1.5 5.7 5.0 3.7 4.0 3.4 3.4 5.5 3.3 1.7 7.6 2.3 1.3 2.3 2.7 3.3 5.7 5.1 6.6 3.4 2.7 4.7 4.5 3.9 4.3 3.0 0.6 0.8 3.1 0.2 3.2 22.1 0.0 6.7 0.0 1.8 7.9 8.4 11.6 2.4 0.5 1.5 4.3 23.3 2.1 5.0 4.1 0.9 1.1 6.7 4.7 0.0 2.9 0.6 1.0 0.4 2.3 2.2 8.5 2.8 3.0 4.0 1.2 5.8 1.1 12.7 6.5 0.0 3.1 4.7 5.5 0.9 3.1 4.4 3.9 0.8 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 195.0;Late spermatids: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 23.7;hTCEpi: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria NA NA Mitochondria "HPA063554: AB_2685039" "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favorable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.6 7.1 0.1 1.4 5.2 7.8 23.7 1.2 1.9 1.1 1.7 8.9 9.8 0.0 1.4 0.3 5.1 1.2 3.3 11.0 1.5 0.0 3.2 4.4 2.2 7.9 1.8 5.5 1.4 5.6 13.6 4.6 1.6 0.3 5.9 1.1 2.9 0.1 8.2 3.0 0.0 0.0 1.8 7.3 1.7 0.0 0.0 0.3 2.0 7.5 1.1 0.0 0.2 9.6 2.7 4.3 6.8 1.5 1.2 2.2 1.8 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 8.9 7.8 0.0 6.7 2.7 0.0 10.6 17.8 5.3 4.5 0.0 0.0 11.5 0.0 9.5 195.0 3.6 34.8 0.0 11.4 5.8 2.0 5.7 4.6 1.0 24.1 0.0 4.7 3.1 19.9 77.6 9.8 10.7 3.3 3.6 17.2 1.3 10.6 14.7 8.5 5.6 0.0 0.0 2.2 1.2 1.7 4.4 7.3 0.0 14.5 4.2 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 57.8;Cone photoreceptor cells: 27.5;Horizontal cells: 65.2;Rod photoreceptor cells: 30.8" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.9;PC-3: 8.8;SCLC-21H: 22.7;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.8 2.1 6.5 0.2 0.2 0.9 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.7 0.6 0.2 1.5 0.4 1.2 6.8 1.7 2.8 2.6 2.4 0.2 1.7 11.9 0.6 0.5 0.4 0.6 0.2 1.1 0.8 1.5 5.6 0.1 0.6 0.4 1.9 1.3 2.0 8.8 0.2 0.6 5.3 0.1 1.0 22.7 10.8 1.0 0.7 1.4 0.1 2.0 1.9 0.3 1.9 1.9 1.3 0.7 1.2 3.1 1.4 0.7 1.1 5.2 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 0.0 0.0 0.0 0.4 0.2 57.8 0.4 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.3 1.1 0.0 0.3 65.2 0.0 1.8 1.2 0.0 0.0 0.0 5.0 0.0 0.0 11.9 0.1 0.0 0.4 0.0 30.8 0.0 0.0 5.1 17.9 0.1 0.0 0.0 0.0 0.0 TMEM150B "TMEM224, TTN2" ENSG00000180061 "Transmembrane protein 150B" A6NC51 19 55312801-55334048 "Predicted membrane proteins" Autophagy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 37.0" "Cell type enriched" "Detected in some" 5 "Enterocytes: 30.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 9.3" "Group enriched" "Detected in many" 8 "granulocytes: 3.7;monocytes: 9.3" "Cell line enhanced" "Detected in some" "CACO-2: 9.1;HMC-1: 4.7;U-937: 20.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "unprognostic (5.76e-2)" "unprognostic (4.94e-2)" "unprognostic (5.33e-2)" "unprognostic (6.70e-2)" "unprognostic (5.51e-2)" "unprognostic (1.35e-1)" "unprognostic (5.35e-2)" "unprognostic (4.00e-2)" "unprognostic (4.74e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (6.14e-6)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (2.45e-1)" "unprognostic (1.18e-2)" 10.5 2.2 0.5 3.1 1.5 0.3 8.3 0.4 1.1 0.8 6.1 0.4 1.2 37.0 0.7 3.0 1.0 1.4 1.7 3.5 1.8 0.6 2.4 5.4 12.7 7.3 0.6 0.3 2.3 0.8 0.0 0.8 5.4 2.1 2.7 4.2 1.2 1.1 0.2 1.5 0.6 31.5 2.3 1.2 14.1 1.2 1.7 0.4 0.3 1.2 0.2 2.0 1.8 3.0 0.0 0.8 3.7 9.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 1.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.1 0.1 2.1 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 20.5 0.1 3.7 9.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 1.2 0.5 1.5 0.4 1.1 1.8 0.6 0.6 0.3 2.1 0.4 0.0 0.0 0.0 1.7 0.1 0.0 0.3 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.0 0.0 0.0 0.0 5.4 0.0 0.0 2.0 0.0 1.0 2.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.1 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 74.9" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 67.6;Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 9.1;MCF7: 25.1;SCLC-21H: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 7.0 30.0 10.8 3.2 12.8 1.5 12.4 0.6 16.0 8.4 4.4 8.3 12.9 4.4 3.2 74.9 2.5 4.6 3.9 7.4 12.7 7.9 9.7 7.7 3.6 8.1 7.5 10.3 18.0 2.2 1.7 10.5 5.5 7.3 7.1 2.6 12.4 10.3 4.7 3.5 3.1 4.4 4.0 5.4 7.6 3.0 4.2 6.8 2.7 7.0 1.6 6.9 3.2 3.3 5.5 1.4 5.0 0.9 1.3 0.7 0.3 0.3 0.9 7.0 9.1 0.0 0.1 0.7 1.5 3.8 1.0 1.1 0.0 0.4 0.2 0.7 0.2 2.8 0.2 4.3 0.0 1.1 0.4 2.1 0.5 0.8 0.0 0.0 0.0 1.0 4.2 0.4 0.0 0.0 0.6 2.2 4.4 0.0 0.1 0.1 25.1 0.5 0.6 3.2 0.0 0.4 0.9 0.1 0.8 0.3 3.4 17.7 2.7 0.5 0.3 2.4 3.3 0.4 0.2 0.5 0.4 0.2 0.1 0.8 0.1 0.4 0.3 0.5 0.3 1.9 5.0 0.9 1.0 0.7 0.4 0.4 3.5 0.7 0.6 0.2 5.5 0.5 0.6 3.7 1.3 0.6 1.4 0.2 0.3 10.8 12.8 0.6 16.0 12.7 7.9 7.5 10.3 7.3 6.8 0.0 0.6 0.0 3.0 2.2 0.4 7.2 5.1 12.0 9.1 14.0 2.0 67.6 0.0 5.2 2.6 16.1 0.0 0.0 2.3 0.9 4.8 7.9 5.8 20.3 5.1 1.6 1.2 19.0 1.8 2.2 13.3 0.9 1.7 13.6 0.0 16.7 1.7 0.0 9.2 1.8 1.6 0.0 2.0 0.7 3.4 1.0 98.1 0.5 0.5 0.9 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 8.1;Cholangiocytes: 5.1;Horizontal cells: 14.3;Intestinal endocrine cells: 7.5" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 18.4 4.2 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 0.0 0.0 0.0 0.1 0.0 8.1 0.6 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM151B "bA444E17.5, C6orf137, TMEM193" ENSG00000178233 "Transmembrane protein 151B" Q8IW70 6 44270466-44307506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 6 "Bipolar cells: 4.5;Cardiomyocytes: 2.2;Horizontal cells: 4.8;Rod photoreceptor cells: 1.2" "Cancer enhanced" "Detected in single" "glioma: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 25.3" "Low region specificity" "Detected in all" HPA055167 Uncertain NA NA "HPA055167: AB_2682723" "unprognostic (1.28e-3)" "unprognostic (6.25e-2)" "unprognostic (5.06e-2)" "unprognostic (7.02e-3)" "unprognostic (6.61e-2)" "unprognostic (1.22e-3)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-4)" "unprognostic (1.48e-1)" "unprognostic (4.56e-3)" "unprognostic (1.85e-1)" "unprognostic (9.15e-2)" "unprognostic (3.86e-2)" "unprognostic (1.66e-1)" 1.0 5.7 16.9 1.6 8.4 1.2 1.0 52.2 39.5 0.9 1.7 1.2 0.0 1.7 1.3 1.0 1.2 1.0 1.0 1.1 21.6 8.9 1.0 0.9 1.0 1.2 7.9 18.1 1.0 1.1 0.9 1.4 1.0 10.0 1.1 1.5 0.0 1.2 0.9 1.2 1.2 2.0 1.1 2.3 1.0 1.4 1.6 3.7 0.0 0.9 0.0 1.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 5.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.1 0.5 4.3 0.1 0.2 0.4 0.0 0.1 0.0 0.1 25.3 5.2 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 16.9 8.4 52.2 28.1 21.6 8.9 7.9 18.1 10.0 3.7 0.0 0.0 0.0 0.0 0.0 4.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 TMEM155 FLJ30834 ENSG00000164112 "Transmembrane protein 155" Q4W5P6 4 121758933-121765427 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.6" "Cell type enriched" "Detected in some" 4 "Cytotrophoblasts: 15.1" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 25.6" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.3;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3" HPA077585 Approved "Secreted in brain" NA NA "HPA077585: AB_2732353" "unprognostic (9.67e-3)" "unprognostic (3.25e-3)" "unprognostic (3.13e-2)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (5.73e-3)" "unprognostic (3.63e-2)" "unprognostic (1.49e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-3)" "unprognostic (4.40e-3)" "unprognostic (1.38e-1)" "unprognostic (3.82e-7)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.02e-2)" "unprognostic (2.04e-1)" 0.6 0.3 5.9 0.5 8.3 0.3 0.3 0.3 25.6 0.4 1.3 0.0 0.0 0.4 0.3 0.3 0.5 0.3 0.4 0.4 7.9 1.6 0.3 0.3 0.6 4.0 0.9 8.9 0.3 0.3 0.2 0.2 6.1 0.7 0.5 0.7 0.9 0.5 0.6 0.3 0.3 0.6 0.9 0.3 0.8 0.5 0.7 0.0 0.0 0.3 0.0 0.6 0.5 0.3 0.0 0.0 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.1 0.0 1.4 0.3 1.0 0.7 0.2 0.3 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 3.4 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 10.5 0.0 6.3 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 5.9 8.3 0.3 25.6 7.9 1.6 0.9 8.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 3.8 0.0 0.0 0.0 TMEM156 FLJ23235 ENSG00000121895 "Transmembrane protein 156" Q8N614 4 38966744-39032922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7" "Cell type enhanced" "Detected in some" 23 "B-cells: 75.1;Cholangiocytes: 20.4;T-cells: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 30.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 16.3;GAMG: 12.7;HBEC3-KT: 34.9;hTERT-HME1: 27.5;NB-4: 14.2;PC-3: 15.6;U-698: 18.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "prognostic favorable (4.09e-4)" "unprognostic (7.36e-3)" "unprognostic (3.31e-3)" "unprognostic (4.17e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-3)" "unprognostic (4.10e-2)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (9.45e-3)" "unprognostic (5.17e-2)" "unprognostic (8.73e-4)" "unprognostic (3.89e-1)" "unprognostic (1.74e-2)" "unprognostic (3.92e-4)" "unprognostic (9.06e-2)" 0.9 1.7 5.8 11.8 6.6 1.7 1.1 0.7 4.1 0.6 1.7 6.1 0.0 1.7 0.6 0.3 2.0 1.0 1.9 0.6 4.1 2.6 1.4 2.6 1.6 20.2 6.2 0.8 0.5 0.8 0.3 0.7 0.2 5.3 0.9 2.0 0.0 2.0 0.6 0.6 0.5 8.3 0.5 12.7 17.3 2.3 0.6 4.2 7.4 1.0 0.3 23.7 4.5 0.8 30.6 5.0 18.8 0.3 4.8 9.0 3.6 1.0 9.8 0.1 0.1 0.0 0.3 0.1 0.0 2.7 0.0 0.0 0.1 0.1 16.3 0.1 0.0 12.7 0.1 0.1 34.9 0.1 0.2 0.0 0.9 3.3 0.2 5.8 6.7 0.1 0.0 1.8 0.7 27.5 2.1 3.0 2.7 2.3 0.1 1.2 0.1 1.2 14.2 0.0 0.4 15.6 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 7.4 1.2 0.2 0.0 0.3 0.0 0.0 18.6 2.2 6.3 0.0 5.4 0.3 18.8 5.2 0.1 6.1 30.6 9.0 5.2 3.3 21.9 3.5 4.6 0.8 4.8 0.1 5.0 6.0 3.6 5.8 6.6 0.7 4.1 4.1 2.6 6.2 0.8 5.3 4.2 0.0 2.6 75.1 0.5 0.5 0.6 0.3 20.4 1.4 1.2 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.4 1.1 0.7 0.0 0.2 1.6 1.6 0.0 2.5 12.0 1.4 0.0 2.7 10.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.5 0.2 28.7 0.0 0.7 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158 (gene/pseudogene)" Q8WZ71 3 45224466-45226278 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.8;endometrium 1: 31.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 21.8;Muller glia cells: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 66.1;GAMG: 22.4;U-138 MG: 28.0;U-87 MG: 91.7" "Region enhanced" "Detected in many" "basal ganglia: 85.5" "Low region specificity" "Detected in all" HPA074974 Approved NA NA "HPA074974: AB_2732274" "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favorable (6.43e-5)" "prognostic unfavorable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 1.8 6.4 16.4 4.5 46.8 2.2 2.3 2.1 10.9 13.1 3.4 2.3 18.5 1.4 31.1 7.3 21.3 2.0 11.0 0.8 9.0 11.2 1.9 1.2 1.0 1.1 2.5 5.0 1.7 2.4 0.7 5.7 1.4 2.6 15.6 2.7 0.5 1.3 27.0 2.4 2.7 1.2 19.6 1.8 0.8 2.2 3.0 4.3 0.0 0.7 0.8 1.7 6.7 1.6 0.0 0.0 0.9 0.1 0.0 0.0 1.1 2.4 0.4 0.8 0.1 1.5 3.7 0.7 6.1 66.1 3.4 5.5 0.1 0.1 0.0 0.3 2.0 22.4 3.3 1.0 0.2 10.1 0.1 0.3 0.0 1.2 0.0 2.2 0.4 1.2 5.0 0.1 6.7 0.5 7.9 0.3 0.0 15.0 0.1 6.0 0.1 0.0 4.2 7.5 0.0 9.1 0.0 0.2 0.9 1.3 2.3 1.2 0.2 2.3 0.0 0.3 0.7 0.0 0.8 1.0 28.0 2.1 17.6 21.2 0.0 0.0 0.0 91.7 2.4 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 16.4 46.8 2.1 10.9 9.0 11.2 2.5 5.0 2.6 4.3 0.0 0.3 0.0 1.8 21.8 3.8 0.8 2.5 0.0 1.2 8.7 0.0 0.1 0.0 3.3 0.1 0.1 0.0 0.0 0.3 0.1 2.9 1.6 0.0 2.6 4.0 1.6 7.5 1.3 0.3 0.2 7.8 4.5 0.0 1.8 0.2 57.5 0.7 0.0 0.0 0.0 2.7 0.0 2.3 0.1 0.4 9.3 0.2 0.0 0.0 2.0 TMEM161B MGC33214 ENSG00000164180 "Transmembrane protein 161B" Q8NDZ6 5 88189633-88269476 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 36.1;HMC-1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044562 Uncertain NA NA "HPA044562: AB_10794291" "unprognostic (2.08e-1)" "unprognostic (6.02e-2)" "unprognostic (2.06e-2)" "unprognostic (5.64e-2)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" "unprognostic (3.07e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-1)" "unprognostic (1.01e-1)" "unprognostic (6.96e-3)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-3)" "unprognostic (9.35e-2)" 9.7 11.7 10.5 13.0 12.8 6.7 19.2 34.0 14.7 10.4 12.2 10.4 13.5 14.6 15.4 17.6 13.9 10.6 7.2 10.0 10.8 10.3 13.4 14.5 11.9 10.0 11.1 10.7 13.8 16.2 29.5 24.0 15.3 10.9 15.0 13.8 9.6 15.9 11.4 15.4 17.9 17.2 7.9 11.0 11.9 25.1 16.1 13.6 13.5 24.8 9.7 13.2 11.2 11.8 4.8 5.2 2.8 5.7 5.6 6.3 2.3 5.3 3.6 4.1 4.4 2.6 4.9 8.5 4.6 7.0 6.9 10.2 4.1 14.1 8.1 2.5 3.5 12.6 5.6 4.6 6.1 8.8 7.2 5.1 36.1 4.5 2.6 6.8 7.2 39.4 4.5 8.9 5.9 8.6 5.0 3.0 5.6 17.4 7.5 6.0 2.6 5.1 6.0 2.5 3.8 6.7 4.4 4.8 8.9 6.2 7.5 5.2 4.4 2.8 7.5 10.9 3.8 4.6 6.2 2.5 4.4 4.0 6.5 8.6 9.5 14.8 6.8 10.8 7.0 6.3 2.8 3.0 1.9 6.3 5.7 6.1 4.8 5.4 4.6 1.6 4.8 5.5 4.1 1.7 5.6 2.0 5.2 4.3 2.3 10.5 12.8 34.0 14.7 10.8 10.3 11.1 10.7 10.9 13.6 26.8 16.0 17.1 6.6 6.9 14.7 14.1 12.7 8.1 13.6 8.7 15.7 6.8 3.3 7.6 2.2 5.9 11.9 0.0 8.3 3.3 4.9 6.8 16.1 20.7 4.5 6.4 13.7 15.4 9.7 1.5 9.8 7.7 0.0 4.6 12.8 17.5 9.0 5.8 12.0 3.7 19.3 6.5 3.6 32.1 8.1 6.1 12.6 10.2 13.9 6.2 TMEM163 "DKFZP566N034, SV31" ENSG00000152128 "Transmembrane protein 163" Q8TC26 2 134455759-134719000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;pancreas: 19.7" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 28.8;Exocrine glandular cells: 26.7;Pancreatic endocrine cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5" "Cell line enhanced" "Detected in some" "HEL: 10.7;RPTEC TERT1: 37.0;SCLC-21H: 16.8;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007224 Uncertain NA NA "HPA007224: AB_2667780" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (7.25e-3)" "unprognostic (3.18e-1)" "unprognostic (1.47e-1)" "unprognostic (2.25e-1)" "unprognostic (6.08e-3)" "prognostic favorable (7.94e-4)" "unprognostic (9.05e-2)" "unprognostic (9.62e-2)" "unprognostic (6.02e-2)" "unprognostic (2.04e-1)" "unprognostic (2.60e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" "unprognostic (6.75e-3)" "prognostic favorable (3.15e-4)" 3.8 6.4 8.1 5.4 5.7 0.5 1.5 31.8 13.4 0.5 0.8 5.8 0.0 0.9 0.8 0.7 0.4 3.4 10.4 7.2 9.1 13.7 1.8 1.7 16.4 10.9 6.9 3.8 1.2 19.7 0.4 11.2 4.2 14.8 0.5 0.9 2.6 3.5 0.5 0.6 0.4 0.8 0.7 13.9 1.9 8.3 6.9 5.0 0.0 1.3 0.0 17.4 9.9 0.3 1.6 0.3 0.1 0.0 2.0 2.5 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 3.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.9 0.5 1.2 0.0 0.0 0.0 37.0 5.4 16.8 0.6 0.0 0.0 0.9 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.9 0.0 0.0 0.0 6.7 0.7 0.0 0.0 0.0 1.3 0.0 1.7 1.6 0.5 2.4 0.3 0.6 0.1 0.5 0.1 2.0 0.0 0.0 2.5 0.8 8.1 5.7 31.8 9.7 9.1 13.7 6.9 3.8 14.8 5.0 3.0 28.8 0.0 0.0 0.0 2.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 3.5 0.3 0.0 0.0 26.7 0.2 0.3 0.0 0.0 0.0 4.0 1.6 0.0 0.0 1.0 1.8 0.0 1.3 0.0 4.6 0.1 1.0 11.4 0.0 0.4 0.1 4.0 0.0 0.3 1.5 0.2 0.4 0.1 0.0 0.0 0.5 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 69.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8" "Lineage enriched" "Detected in many" 15 "granulocytes: 25.9" "Cell line enhanced" "Detected in all" "HMC-1: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favorable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 15.0 8.6 9.2 6.1 10.9 11.1 9.2 2.6 6.8 3.9 17.0 6.0 36.3 14.5 4.5 4.1 10.5 5.5 8.8 14.7 6.6 5.9 8.4 1.7 35.8 7.6 4.6 3.5 11.9 17.2 11.1 8.7 6.6 7.0 6.2 14.8 18.7 7.6 69.7 32.0 15.2 33.1 4.6 2.9 6.9 9.9 2.2 5.1 4.5 11.4 6.0 5.8 5.0 5.1 0.4 1.4 25.9 1.7 1.1 0.9 0.8 4.8 11.1 9.1 5.9 11.3 8.3 5.5 2.4 5.7 5.2 3.3 8.6 7.6 3.8 16.5 3.7 12.7 7.1 7.9 12.8 5.1 10.6 5.4 26.3 6.0 3.6 6.7 11.5 37.6 11.5 22.6 9.3 12.9 14.2 10.0 7.0 8.1 4.7 9.1 9.7 12.0 14.7 8.1 16.6 8.0 5.5 7.0 3.2 8.2 5.1 8.5 9.5 15.5 15.3 7.1 8.8 4.4 11.5 22.3 4.4 3.2 5.1 3.4 2.8 3.4 3.1 11.5 14.5 11.6 25.9 1.7 7.2 0.3 1.5 0.9 0.1 0.4 0.3 1.4 0.4 0.2 0.3 8.8 1.1 0.9 0.2 0.5 0.8 9.2 10.9 2.6 6.8 6.6 5.9 4.6 3.5 7.0 5.1 3.0 26.0 3.2 3.3 4.2 0.2 19.7 10.2 1.4 6.8 15.7 2.0 1.9 3.3 4.0 0.3 5.2 32.2 0.0 9.9 4.7 3.4 7.9 3.5 1.5 12.0 0.0 26.6 6.2 25.0 0.5 1.7 5.8 1.7 21.6 12.9 0.8 9.8 14.4 1.4 3.0 0.9 0.0 3.1 0.2 0.0 6.9 2.3 4.3 17.8 6.4 TMEM168 "DKFZp564C012, FLJ13576" ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762382-112790592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favorable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 14.4 14.9 9.0 11.4 14.6 5.6 15.4 6.9 15.7 15.7 21.2 17.9 17.6 13.2 17.4 18.3 19.1 15.0 12.1 18.9 11.8 8.2 18.8 11.8 13.5 21.3 12.6 7.8 17.5 9.9 28.2 12.7 26.3 15.5 16.6 24.3 18.4 19.6 14.5 11.0 25.5 18.4 19.7 15.7 16.4 14.3 13.9 12.4 17.8 17.5 12.6 17.4 14.7 16.9 15.4 17.9 16.5 16.9 13.7 22.4 10.0 9.2 7.9 7.4 6.7 12.8 26.2 10.5 10.4 9.8 3.9 3.4 10.0 9.9 9.9 7.0 10.2 8.9 10.1 7.5 9.0 10.2 15.5 7.7 8.4 9.8 5.7 8.6 9.5 11.0 12.7 23.5 4.5 6.7 3.7 11.4 8.0 11.5 9.1 14.1 14.9 8.2 6.0 6.0 9.8 6.1 5.5 3.7 14.4 9.8 17.8 5.6 11.0 13.6 18.6 7.9 9.5 10.4 8.5 16.2 18.9 9.6 8.7 13.3 15.6 13.2 11.2 12.2 8.4 23.7 16.5 16.9 12.5 14.2 13.7 16.9 12.4 15.3 13.8 17.9 15.4 22.4 15.5 9.4 13.7 13.5 12.2 13.7 10.0 9.0 14.6 6.9 15.7 11.8 8.2 12.6 7.8 15.5 12.4 11.9 18.2 6.4 16.7 27.6 30.5 13.7 10.2 2.7 22.7 31.4 25.5 25.1 0.0 5.4 1.5 13.4 13.1 0.0 7.8 7.0 13.4 17.7 11.5 11.1 7.7 15.9 19.8 18.4 8.9 1.5 17.0 9.4 23.6 1.8 33.2 19.0 4.6 7.0 13.8 7.1 28.6 6.5 8.5 16.2 12.1 22.7 11.9 11.4 26.4 11.9 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 76.8;liver: 234.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 38.4;intermediate monocyte: 27.1" "Lineage enriched" "Detected in many" 4 "monocytes: 38.4" "Cell line enriched" "Detected in some" 30 "HSkMC: 127.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria NA NA Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 10.5 4.9 5.8 17.1 6.0 0.7 7.8 1.2 4.3 6.2 32.2 4.8 2.0 16.1 3.6 12.8 7.5 6.3 34.2 15.0 5.2 4.5 76.8 234.5 8.8 23.5 6.9 3.4 19.0 5.0 0.4 2.2 8.9 6.6 6.3 22.3 22.8 3.9 2.0 3.1 3.3 51.2 6.5 6.9 17.3 7.1 3.7 5.4 2.1 4.8 4.8 9.2 13.5 9.1 0.4 9.3 3.3 38.4 0.0 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 3.3 0.1 27.1 0.1 0.4 0.0 0.1 9.3 0.0 0.0 0.0 0.5 0.0 12.9 0.6 0.1 10.7 5.8 6.0 1.2 4.3 5.2 4.5 6.9 3.4 6.6 5.4 0.0 6.9 29.6 0.4 6.5 48.5 19.4 150.3 14.7 15.9 190.1 3.9 0.5 129.3 42.7 0.1 9.6 542.2 0.0 23.6 0.8 57.1 2.4 26.7 864.2 53.0 0.0 71.1 29.4 40.2 0.5 55.8 35.8 5.0 525.8 156.3 73.3 68.7 691.0 7.1 954.7 4.4 0.0 20.0 0.7 1.5 7.3 1.1 7.2 159.5 0.9 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052128: AB_2681738" "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 1.8 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.1 0.1 0.0 0.6 0.0 0.0 0.4 0.1 10.4 0.2 0.0 0.2 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 0.0 1.3 0.0 0.6 0.3 2.1 3.7 0.0 4.0 1.2 12.2 5.9 0.3 0.0 0.3 0.3 3.1 0.4 0.0 0.2 0.0 0.2 4.1 0.0 0.2 0.2 1.6 15.4 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.3 0.0 0.0 0.7 5.8 0.0 0.4 0.2 0.2 0.5 0.5 0.0 0.4 0.1 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.8 0.8 1.0 0.0 0.0 2.2 2.4 0.2 0.5 0.0 7.1 0.0 2.3 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 6.0 0.0 0.0 0.4 1.1 3.0 9.8 2.8 7.7 4.7 0.1 0.3 1.0 1.5 1.0 0.0 0.0 0.1 1.2 3.2 0.0 0.1 0.0 0.0 0.5 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 0.0 0.0 0.0 0.4 0.5 23.0 39.1 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.8 0.1 0.0 0.0 0.3 0.0 0.2 3.1 0.0 0.0 0.1 28.6 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 3.8 1.2 0.0 0.7 2.8 1.6 0.0 0.8 0.5 0.7 0.1 0.2 0.0 0.0 1.6 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Group enriched" "Detected in some" 12 "Bipolar cells: 41.7;Horizontal cells: 62.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.3 8.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 0.0 0.0 0.0 0.0 0.0 41.7 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 4.3 0.0 0.1 0.6 3.2 0.0 0.0 0.0 0.0 0.0 TMEM186 "C16orf51, DKFZP564K2062" ENSG00000184857 "Transmembrane protein 186" Q96B77 16 8780384-8797648 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018226, HPA063559" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA018226: AB_1845579, HPA063559: AB_2685041" "unprognostic (3.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.11e-2)" "unprognostic (2.98e-2)" "unprognostic (4.81e-2)" "unprognostic (1.18e-1)" "unprognostic (2.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.06e-2)" "unprognostic (9.35e-2)" "unprognostic (2.45e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.93e-8)" "unprognostic (1.06e-1)" "unprognostic (3.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.89e-2)" 6.6 12.0 8.2 6.2 10.4 1.9 11.0 5.4 13.2 7.4 10.6 8.2 9.4 10.1 11.0 14.2 9.6 10.4 9.7 11.5 7.4 7.6 9.6 15.9 6.2 8.2 9.1 12.6 9.7 11.8 16.3 11.8 8.4 7.8 8.4 12.5 10.4 14.0 8.4 16.9 8.8 9.2 15.1 10.3 10.1 9.1 11.7 6.2 7.0 11.9 7.7 11.0 10.4 6.2 14.3 10.4 11.8 13.8 9.5 17.2 8.4 6.8 10.7 8.0 10.1 13.7 7.3 7.6 7.8 8.1 10.4 8.6 10.3 11.4 20.7 6.7 5.7 7.1 13.1 14.1 11.1 11.9 12.0 13.6 8.7 13.8 21.9 15.4 9.6 7.1 8.7 18.9 11.3 16.7 8.5 9.3 17.3 14.8 11.4 6.0 18.3 7.4 9.4 10.1 14.6 9.4 15.7 10.4 22.7 11.0 5.8 12.3 11.7 10.7 15.2 9.2 8.5 18.2 7.8 5.9 7.4 10.4 18.1 6.4 10.5 11.1 10.0 11.5 17.8 5.9 11.8 10.0 7.5 9.4 9.6 12.5 14.3 10.0 10.6 10.4 12.7 17.2 13.2 4.8 9.5 13.8 8.1 13.0 8.4 8.2 10.4 5.4 13.2 7.4 7.6 9.1 12.6 7.8 6.2 6.0 7.0 11.3 6.9 7.2 5.8 2.5 5.1 8.1 11.4 10.4 0.0 19.8 18.3 12.1 34.1 4.4 8.5 0.0 9.7 10.0 4.3 6.0 6.9 11.6 11.6 12.7 13.2 4.3 3.3 62.1 8.6 3.7 6.8 10.0 8.6 8.9 8.9 7.0 6.0 16.1 5.3 12.9 4.7 13.2 10.0 8.3 12.6 6.4 15.3 5.5 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 51.1" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 8.8;ASC TERT1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.8 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM200B TTMB ENSG00000253304 "Transmembrane protein 200B" Q69YZ2 1 29119428-29123935 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 11.8;Melanocytes: 8.5;Peritubular cells: 14.2;Sertoli cells: 6.5;Smooth muscle cells: 8.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.8;ASC TERT1: 13.2;BJ hTERT+ SV40 Large T+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 16.3;fHDF/TERT166: 15.4;HBF TERT88: 14.0" "Group enriched" "Detected in many" 4 "basal ganglia: 14.0;cerebellum: 23.9" HPA055254 Uncertain NA NA "HPA055254: AB_2682760" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" "unprognostic (8.25e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-3)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (1.52e-2)" "unprognostic (6.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.24e-2)" "unprognostic (1.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-3)" 9.1 2.0 1.4 2.9 3.7 0.0 15.7 9.7 1.3 33.3 10.9 1.2 7.4 1.1 32.8 7.7 6.0 7.0 7.3 2.4 0.5 0.2 3.5 3.0 3.7 1.2 1.3 0.9 21.6 0.7 15.4 1.2 3.5 2.5 17.2 2.3 6.0 1.5 23.9 2.9 2.1 3.4 20.6 1.4 2.4 2.3 13.6 0.6 0.7 2.1 3.5 1.5 13.1 12.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 10.9 0.0 1.8 0.0 15.8 13.2 0.6 7.7 12.2 14.6 16.3 0.6 1.2 0.0 1.9 15.4 5.3 0.2 1.2 0.0 14.0 0.0 0.5 0.0 2.8 0.9 11.0 0.0 0.0 7.0 1.4 11.0 2.2 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 11.0 0.0 0.0 5.4 0.0 0.0 0.0 5.2 0.2 10.8 0.2 0.0 0.0 0.0 6.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.4 3.7 9.7 1.3 0.5 0.2 1.3 0.9 2.5 0.6 3.0 1.1 0.0 0.2 1.6 0.8 1.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 5.4 0.2 0.0 1.0 0.1 0.0 0.0 1.3 0.0 0.9 11.8 0.0 8.5 0.0 0.0 0.1 0.0 0.0 14.2 3.8 1.7 6.5 8.3 0.2 0.7 0.5 0.5 0.0 0.0 0.3 TMEM200C TTMA ENSG00000206432 "Transmembrane protein 200C" A6NKL6 18 5882072-5895955 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 6.6;Cone photoreceptor cells: 5.9;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.8;NTERA-2: 4.5;PC-3: 20.8;SH-SY5Y: 3.3;U-2 OS: 10.6;U-251 MG: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047253, HPA050490" Uncertain Approved Microtubules NA NA Microtubules "HPA047253: AB_2680001, HPA050490: AB_2681144" "unprognostic (6.57e-4)" "unprognostic (3.09e-1)" "unprognostic (1.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (3.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.12e-2)" "unprognostic (2.29e-2)" "unprognostic (6.31e-2)" "unprognostic (3.82e-4)" "unprognostic (2.48e-10)" "unprognostic (2.94e-2)" "unprognostic (6.38e-2)" "unprognostic (7.22e-2)" "unprognostic (2.38e-2)" 0.4 6.3 2.6 1.0 3.7 0.1 3.5 0.7 5.7 0.8 0.5 1.7 0.1 0.5 1.6 3.2 0.6 1.1 1.3 2.9 2.7 3.5 2.0 5.3 0.5 1.1 3.7 1.6 1.9 0.2 0.1 3.3 0.1 1.7 0.9 0.3 2.7 10.1 0.7 0.1 0.7 0.6 0.5 1.2 1.6 1.3 3.5 1.5 0.1 0.2 0.1 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 20.8 1.2 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.6 0.0 3.6 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 0.7 4.7 2.7 3.5 3.7 1.6 1.7 1.5 0.0 1.4 0.0 0.0 0.1 6.6 1.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.1 0.0 1.2 0.0 0.9 0.1 0.4 0.3 0.0 0.0 0.0 0.1 TMEM204 "C16orf30, CLP24, FLJ20898" ENSG00000131634 "Transmembrane protein 204" Q9BSN7 16 1528688-1555580 "Predicted membrane proteins" "Stress response" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 85.4;Ito cells: 126.4;Peritubular cells: 63.3;Sertoli cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 44.7" "Lineage enriched" "Detected in many" 5 "T-cells: 44.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.7;BJ: 10.3;BJ hTERT+: 14.0;fHDF/TERT166: 9.4;HHSteC: 25.4;HSkMC: 10.1;TIME: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014028 Approved NA NA "HPA014028: AB_2204906" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.81e-3)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (1.81e-2)" "prognostic favorable (4.76e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (8.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.04e-2)" "unprognostic (7.62e-3)" "unprognostic (5.11e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (2.53e-2)" 36.4 12.9 3.7 9.6 6.2 0.6 33.4 2.9 6.6 20.2 11.5 3.4 9.0 5.9 17.1 11.4 11.5 10.5 13.9 19.8 4.2 3.3 24.3 12.6 29.6 22.9 5.3 6.2 11.5 9.2 3.4 6.4 11.6 5.5 14.6 2.9 18.4 7.7 13.9 13.9 7.6 11.8 10.5 3.4 12.3 9.3 7.8 4.7 4.2 21.0 12.2 9.8 12.1 14.2 0.4 0.5 0.8 0.2 8.2 44.7 12.1 0.0 0.1 0.6 0.1 5.1 8.7 0.1 10.3 14.0 1.7 1.7 0.4 0.0 0.1 0.1 9.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.1 25.4 0.0 0.0 10.1 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.3 0.2 0.3 0.0 1.1 0.3 0.0 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.1 0.0 6.8 0.2 12.6 0.1 22.3 15.3 0.5 0.4 44.7 22.9 0.8 8.2 0.2 0.1 9.4 12.1 3.7 6.2 2.9 6.6 4.2 3.3 5.3 6.2 5.5 4.7 0.0 5.9 1.9 9.1 5.0 0.0 5.9 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.3 0.8 85.4 0.0 23.3 0.2 0.1 12.1 0.5 0.0 1.5 0.3 0.0 0.0 126.4 4.5 0.5 21.9 2.1 6.8 0.0 0.0 0.2 0.0 0.0 63.3 0.0 0.4 116.4 34.2 0.0 0.0 2.8 0.3 11.4 0.0 1.1 TMEM211 bA9F11.1 ENSG00000206069 "Transmembrane protein 211" Q6ICI0 22 24934954-24946695 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "cervix, uterine: 5.3;salivary gland: 6.6;stomach 1: 5.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.8;endometrial cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;HEK 293: 1.1;OE19: 2.3" HPA066784 Uncertain NA NA "HPA066784: AB_2685722" "unprognostic (7.89e-3)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" "unprognostic (1.09e-2)" "unprognostic (5.97e-3)" "unprognostic (5.88e-2)" "unprognostic (1.31e-3)" "unprognostic (3.26e-2)" "unprognostic (2.06e-1)" "unprognostic (6.42e-2)" "unprognostic (2.65e-2)" "unprognostic (8.61e-3)" "unprognostic (3.59e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.0 0.4 0.4 0.0 0.8 0.4 0.1 5.3 0.4 0.0 1.2 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.1 6.6 0.0 0.0 1.4 0.1 0.0 0.0 0.0 5.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.2;lung: 10.0;ovary: 12.8" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 0.4 0.4 0.5 0.6 0.8 2.2 0.4 0.4 0.5 1.6 0.8 0.9 0.4 0.2 1.3 2.5 0.8 19.2 0.4 0.4 0.6 0.7 0.4 3.3 10.0 0.6 0.4 0.4 12.8 0.4 0.0 0.4 0.4 0.7 0.4 0.8 0.4 0.4 2.1 1.1 1.5 0.5 0.4 0.4 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 4.1 3.2 6.3 2.1 3.8 2.7 0.5 4.1 2.5 2.8 3.1 0.8 0.4 5.5 3.0 0.9 1.2 1.2 2.0 3.3 5.4 3.6 1.4 3.1 2.9 1.7 1.3 2.6 7.1 2.8 6.4 6.5 2.7 0.5 3.7 5.4 1.1 1.5 1.4 1.2 1.8 1.3 3.4 4.4 8.6 0.9 2.7 3.2 4.1 4.9 2.1 2.7 2.7 4.4 4.5 1.1 3.2 3.4 3.3 4.1 3.1 2.3 3.3 3.6 3.3 6.6 4.6 5.0 7.2 3.2 5.1 4.0 3.6 2.3 3.4 2.4 6.3 2.1 1.8 2.7 1.8 2.1 1.9 2.0 1.8 1.1 4.1 2.3 2.5 5.0 3.8 2.0 3.2 1.3 0.5 0.5 0.8 0.4 0.4 0.6 0.7 0.4 0.4 0.7 0.4 32.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 167.3 46.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Cell type enhanced" "Detected in some" 32 "Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 6.6;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: AB_2681957, HPA063207: AB_2732697" "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 564.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 188.4 2.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.7 0.0 21.9 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.3 0.0 0.4 2.8 1.0 3.7 0.7 0.5 0.1 0.2 0.0 1.5 0.5 0.3 0.3 1.1 0.1 0.2 4.8 0.0 0.1 0.3 0.0 2.8 0.5 0.7 3.4 0.2 1.2 5.0 0.4 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.6 0.0 0.1 13.1 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 0.0 1.1 0.0 8.5 2.3 0.4 0.2 0.0 2.7 2.3 1.8 0.0 0.7 3.3 13.1 12.1 2.1 1.2 0.0 13.9 0.4 2.4 6.4 5.7 0.0 0.8 3.2 1.7 0.0 0.0 11.8 0.6 1.4 1.7 0.0 0.2 6.0 14.4 0.0 0.0 1.0 0.5 0.0 0.8 19.2 0.8 2.6 0.9 0.0 0.4 14.2 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.3 5.2 5.2 1.0 6.9 7.3 4.7 6.8 0.0 0.3 1.2 0.5 4.3 0.4 0.4 3.4 0.6 3.5 0.4 1.5 0.5 0.2 2.9 7.6 0.9 0.8 3.4 0.4 1.5 0.3 1.0 2.2 3.0 0.4 0.3 3.0 0.4 1.1 1.5 5.0 0.4 0.0 4.8 0.2 0.6 11.1 0.2 0.5 6.0 0.3 0.1 0.7 1.9 0.4 1.8 4.8 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 3.0 8.3 5.6 13.2 8.5 1.5 8.8 56.0 8.1 11.4 17.4 7.9 10.1 18.3 13.7 72.2 7.9 60.8 23.3 20.8 20.6 12.0 37.1 39.3 146.5 20.4 0.0 2.9 10.4 11.8 12.5 16.7 5.4 23.6 6.4 15.2 44.1 14.9 28.8 9.2 20.3 22.1 19.4 9.6 52.0 7.5 6.9 3.8 2.5 10.0 21.1 TMEM225 "PMP22CD, PPP1R154, SPATA47" ENSG00000204300 "Transmembrane protein 225" Q6GV28 11 123882926-123885642 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 35.8" "Cell type enriched" "Detected in some" 4 "Early spermatids: 78.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.9 0.8 0.0 0.0 0.0 0.0 0.0 TMEM225B ENSG00000244219 "Transmembrane protein 225B" P0DP42 7 99598066-99610813 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 86.7" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 4.0;Club cells: 1.2;Exocrine glandular cells: 2.2;granulocytes: 1.1;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 14.6;U-266/70: 8.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.91e-3)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.95e-1)" "unprognostic (6.27e-3)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.25e-1)" "unprognostic (7.08e-2)" "unprognostic (1.62e-1)" "unprognostic (4.00e-1)" "unprognostic (6.86e-2)" "unprognostic (1.17e-1)" "unprognostic (2.50e-1)" 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 86.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 4.5 3.6 2.9 0.3 3.0 3.6 1.8 1.2 1.8 0.9 0.2 4.9 1.3 0.0 0.6 3.1 1.7 2.1 0.2 1.1 1.3 0.0 0.1 0.6 0.1 0.5 0.1 3.6 4.6 0.8 0.2 0.0 0.3 1.4 1.0 1.0 0.4 0.6 0.1 2.8 5.9 0.0 2.3 0.8 14.6 0.7 0.0 2.5 5.4 0.1 0.0 0.0 0.8 1.3 1.9 0.5 0.0 0.6 1.4 0.3 0.0 0.5 0.7 0.0 0.7 0.1 0.7 2.3 4.3 0.2 8.2 1.8 2.8 0.8 1.7 1.4 0.0 0.1 2.9 1.7 0.3 3.0 2.9 2.2 1.1 1.2 4.5 2.1 3.6 0.7 3.0 0.3 3.6 1.4 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 0.0 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8;ductus deferens: 27.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 13.7;Early spermatids: 11.9;Late spermatids: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 9.3;MCF7: 9.7;SK-MEL-30: 8.2;U-937: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved NA NA "HPA046562: AB_10960265" "prognostic favorable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.79e-5)" 1.6 14.5 9.4 5.2 7.1 1.6 3.8 27.8 11.5 11.8 5.9 2.7 27.5 15.9 1.5 11.9 1.3 2.2 4.2 1.7 10.6 7.9 2.2 1.5 3.5 8.3 9.0 5.7 1.2 5.7 5.8 8.1 7.7 13.3 2.9 3.4 5.1 4.1 11.8 0.6 1.4 14.1 3.3 6.5 9.4 4.2 5.6 2.0 8.9 9.7 0.0 6.1 5.9 1.7 1.2 2.8 8.7 6.9 5.5 11.0 5.0 2.2 0.3 0.0 0.6 0.2 0.0 0.9 0.4 0.5 0.6 2.5 0.0 7.4 9.3 0.0 0.2 2.1 0.0 0.2 0.5 0.1 3.0 0.7 5.6 0.0 0.0 0.8 6.0 1.1 0.1 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.3 0.0 9.7 3.6 2.3 0.1 4.8 0.4 3.4 0.1 1.3 0.1 4.9 1.4 0.3 0.0 3.6 8.2 0.4 7.6 5.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.4 24.8 5.2 6.0 5.1 8.7 11.0 6.7 10.6 1.2 6.5 8.7 2.8 1.1 5.7 7.1 0.1 5.5 6.9 1.6 2.6 5.0 9.4 7.1 27.8 11.5 10.6 7.9 9.0 5.7 13.3 2.0 0.0 0.3 1.3 0.3 0.2 2.9 1.2 2.5 0.0 0.0 0.0 13.7 0.0 0.0 1.2 11.9 1.3 4.2 0.0 3.1 0.0 0.2 0.3 0.0 0.0 1.7 0.0 2.4 3.7 4.3 16.7 0.0 1.1 6.8 1.8 4.7 0.2 0.6 1.9 0.7 0.8 3.7 0.0 0.2 0.5 0.2 0.1 0.1 4.3 1.9 0.7 TMEM232 FLJ43080 ENSG00000186952 "Transmembrane protein 232" C9JQI7 5 110289233-110738956 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.8;pituitary gland: 19.8;testis: 23.7" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 115.1;Early spermatids: 85.8;Late spermatids: 50.0;Spermatocytes: 33.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049386 Uncertain NA NA "HPA049386: AB_2680739" "unprognostic (1.12e-2)" "unprognostic (1.43e-1)" "unprognostic (7.27e-2)" "unprognostic (1.47e-2)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.49e-2)" "unprognostic (9.88e-2)" "unprognostic (1.91e-1)" "unprognostic (1.22e-1)" "unprognostic (6.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.32e-5)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (3.14e-4)" "unprognostic (8.96e-2)" 1.2 2.3 4.6 0.7 5.9 0.5 2.0 3.0 6.8 2.1 1.0 3.7 4.9 1.2 1.7 4.8 1.2 21.8 2.8 1.4 4.7 4.5 6.1 1.4 2.9 0.9 2.9 4.8 3.4 1.3 3.6 19.8 1.1 9.2 1.6 0.9 3.1 1.3 1.6 0.7 1.0 0.9 1.0 3.1 0.8 1.7 23.7 4.4 0.5 6.1 0.0 0.8 1.3 0.9 1.1 0.0 0.8 0.1 0.3 0.6 0.1 0.9 0.3 2.6 0.8 2.3 3.8 0.5 0.0 0.0 0.5 0.5 0.4 0.4 1.1 0.7 0.1 3.9 0.8 0.4 1.9 0.5 2.4 0.3 0.4 0.0 0.0 1.9 0.6 0.5 1.1 0.3 0.5 0.9 3.5 0.4 2.8 0.6 0.7 1.5 0.3 1.3 0.7 0.3 0.3 0.0 0.5 0.2 0.4 2.7 0.0 2.5 2.6 0.3 0.0 2.1 4.1 0.9 0.2 0.0 2.4 0.3 0.1 0.1 6.2 2.1 0.9 2.0 0.7 0.4 0.0 0.1 0.8 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.1 4.6 5.9 3.0 6.8 4.7 4.5 2.9 4.8 9.2 4.4 0.0 4.8 0.0 0.8 0.3 5.3 1.2 2.5 115.1 14.8 7.0 25.5 0.2 8.3 0.6 85.8 0.1 0.2 0.0 0.4 0.1 0.2 0.9 0.0 0.8 0.1 3.2 1.2 0.0 1.0 50.0 1.1 0.6 0.0 0.0 0.6 5.0 0.1 0.0 0.7 4.2 15.9 0.0 0.3 33.8 3.8 0.4 0.2 0.0 0.0 0.6 TMEM235 ENSG00000204278 "Transmembrane protein 235" A6NFC5 17 78231310-78240987 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 26 "brain: 33.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HUVEC TERT2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA053939 Uncertain NA NA "HPA053939: AB_2682316" "unprognostic (1.47e-1)" "unprognostic (6.91e-3)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" 1.0 1.0 12.2 1.0 17.4 1.0 1.0 2.0 25.6 1.0 1.0 33.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 20.9 9.7 1.0 1.0 1.0 1.1 18.3 8.6 1.1 1.0 1.0 0.0 1.2 10.3 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 20.7 1.0 1.0 1.2 18.0 0.0 1.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 17.4 2.0 10.2 20.9 9.7 18.3 8.6 10.3 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752252-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 76.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 63.2;Intestinal endocrine cells: 22.5;Mucus-secreting cells: 22.8;Paneth cells: 49.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "MOLT-4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA045096 Enhanced NA NA "HPA045096: AB_2732516" "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.5 0.3 0.3 4.9 0.3 0.0 0.3 0.3 0.3 0.4 32.0 0.1 0.1 13.7 0.5 0.1 0.4 0.2 0.1 0.3 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.1 0.3 0.7 0.0 0.3 0.6 0.1 0.3 9.1 0.1 0.3 0.1 0.5 0.3 76.4 0.3 0.3 0.3 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 1.3 0.9 2.6 0.6 1.0 0.6 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.6 0.3 0.0 0.1 0.3 0.5 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.8 0.2 0.5 0.6 0.5 0.5 0.1 0.5 1.6 0.2 0.4 0.2 0.3 0.2 0.4 0.7 0.2 0.4 0.2 0.3 15.3 0.3 0.3 0.1 0.1 0.6 0.4 0.3 0.1 0.3 0.4 0.2 0.2 0.1 0.5 0.6 0.2 0.0 0.7 0.5 0.6 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 2.6 0.6 0.9 0.6 0.4 0.4 0.7 0.5 0.4 0.4 1.3 0.5 0.6 2.2 1.0 0.4 0.9 0.4 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 63.2 0.0 0.8 0.1 0.0 0.3 1.1 0.0 5.4 0.0 22.5 1.8 4.0 0.4 0.0 4.9 0.0 0.0 22.8 0.2 0.8 49.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.7 0.4 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA029489: AB_2673067, HPA059922: AB_2684164" "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavorable (5.80e-4)" 5.8 3.6 6.4 4.3 11.3 2.6 6.3 2.0 11.9 6.0 4.3 4.2 2.2 4.1 5.7 5.0 5.2 4.6 4.5 4.0 3.9 4.0 3.1 5.4 4.3 3.6 3.1 5.2 4.9 6.5 7.0 6.5 6.1 5.2 2.7 6.3 3.5 4.8 2.6 3.4 3.9 2.9 7.6 3.5 4.1 3.7 2.1 2.6 1.9 6.8 4.9 5.1 5.4 4.7 3.0 2.3 1.3 3.1 8.4 2.2 1.4 3.1 6.2 1.2 4.1 6.5 5.8 3.7 1.5 1.9 1.5 3.5 1.2 7.4 11.9 3.4 2.9 6.8 6.0 3.2 5.5 5.2 1.4 0.4 2.5 4.5 2.6 3.6 2.6 2.0 6.6 6.1 6.2 7.4 4.0 6.7 5.4 5.2 4.2 5.4 3.4 2.7 0.5 1.4 10.6 1.2 2.0 5.6 11.4 2.6 2.3 4.4 4.2 7.3 3.9 4.7 5.5 4.1 1.2 2.5 10.6 2.5 3.7 4.2 8.4 6.4 5.0 3.4 8.0 6.7 1.3 0.7 0.0 1.3 3.1 2.2 1.8 0.2 1.2 2.3 3.0 1.1 1.9 0.0 8.4 1.2 0.7 1.5 1.4 6.4 11.3 2.0 11.9 3.9 4.0 3.1 5.2 5.2 2.6 0.0 5.8 0.0 2.4 2.5 1.0 1.4 0.0 9.4 5.7 3.5 3.9 6.8 0.0 2.0 0.0 1.6 2.0 0.0 1.9 8.0 2.7 3.0 2.3 3.4 2.8 9.5 1.2 3.7 0.3 0.0 1.7 2.1 1.7 0.0 2.9 1.0 2.5 2.5 1.1 3.0 1.1 0.0 2.2 0.5 5.3 3.9 3.9 1.5 2.3 2.6 TMEM249 C8orfK29 ENSG00000261587 "Transmembrane protein 249" Q2WGJ8 8 144352219-144354914 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 35.1" "Group enriched" "Detected in some" 8 "Early spermatids: 25.7;Late spermatids: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;PC-3: 2.3;SK-MEL-30: 2.1" "Low region specificity" "Detected in all" HPA078901 Approved NA NA "HPA078901: " "unprognostic (2.23e-1)" "unprognostic (8.91e-3)" "unprognostic (1.72e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.03e-4)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (3.21e-1)" "unprognostic (1.13e-7)" "unprognostic (6.56e-3)" "unprognostic (1.62e-2)" "unprognostic (8.44e-3)" "unprognostic (3.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.3 0.0 0.6 0.2 0.2 2.5 0.8 0.0 0.3 0.2 0.0 0.7 1.6 0.0 0.3 0.0 0.2 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 2.3 1.7 0.7 0.0 0.0 1.2 1.3 1.7 0.0 0.3 2.1 0.0 0.9 1.0 0.0 0.5 2.0 0.8 0.2 0.6 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 24.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.2 0.0 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93187089 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 96.2;Hofbauer cells: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 15.8 19.5 12.2 10.7 14.3 3.9 23.1 11.5 14.2 21.9 19.6 11.4 19.6 15.5 13.0 26.2 10.8 15.8 11.5 23.2 12.2 12.8 25.0 14.4 24.1 19.1 19.0 11.1 12.4 23.6 16.4 17.2 12.5 15.8 26.1 19.5 18.3 18.7 18.5 22.6 10.4 17.9 11.5 17.3 13.3 16.5 8.7 15.1 14.2 19.4 11.0 11.7 13.3 11.8 6.0 8.7 13.7 12.7 5.4 6.6 4.4 7.1 7.5 10.1 10.7 11.8 4.6 6.8 4.9 5.8 8.6 11.2 5.3 7.4 8.1 10.1 4.7 11.4 9.5 11.0 8.1 11.8 7.3 8.6 6.9 5.6 10.6 11.2 9.5 11.0 6.1 9.3 6.9 11.1 4.5 8.7 9.0 5.6 7.9 6.9 33.9 6.9 7.8 5.9 18.1 8.1 4.1 10.2 7.1 10.7 14.3 9.8 9.2 7.5 4.1 29.1 9.0 11.3 7.0 3.8 4.3 7.0 9.1 6.3 10.5 12.6 8.2 8.1 4.0 6.5 4.8 10.8 13.7 4.7 9.7 3.1 5.3 5.5 5.3 8.7 6.0 6.1 6.6 10.7 5.4 12.7 7.6 4.4 4.4 12.2 14.3 11.5 14.2 12.2 12.8 19.0 11.1 15.8 15.1 3.0 11.8 14.9 29.1 20.6 14.3 17.3 22.9 10.7 9.1 29.6 25.5 33.6 96.2 24.2 1.6 10.0 23.3 0.0 23.1 15.7 13.9 37.4 17.3 14.7 100.3 12.7 14.5 8.0 21.1 1.5 10.9 26.7 30.4 10.0 33.3 20.5 15.7 17.5 10.3 58.4 25.2 38.8 15.6 3.3 14.3 27.1 22.9 10.7 30.8 29.7 TMEM252 "C9orf71, MGC34760" ENSG00000181778 "Transmembrane protein 252" Q8N6L7 9 68536580-68540867 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 16.0;kidney: 64.2" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 15.1" "Cancer enriched" "Detected in many" 17 "renal cancer: 35.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 7.6" "Group enriched" "Detected in some" 6 "EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA079457 Enhanced NA NA "HPA079457: " "unprognostic (2.64e-1)" "unprognostic (3.28e-3)" "unprognostic (3.72e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.64e-2)" "unprognostic (6.42e-2)" "prognostic favorable (1.75e-7)" "unprognostic (7.63e-2)" "unprognostic (6.15e-2)" "unprognostic (7.66e-2)" "unprognostic (2.50e-1)" 0.5 2.0 0.4 0.6 0.4 0.0 0.4 0.9 0.4 0.6 5.6 0.4 0.4 1.0 4.3 0.8 4.3 2.7 0.7 3.0 0.4 0.0 64.2 0.9 0.4 0.4 0.4 0.4 0.6 0.4 0.0 0.4 2.6 0.4 1.8 0.0 0.4 0.4 0.4 0.7 0.2 16.0 0.9 0.4 0.4 1.7 0.6 0.4 0.4 0.4 0.4 0.5 6.0 0.6 0.0 0.1 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.9 0.0 6.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.9 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Cell line enhanced" "Detected in some" "Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 1.8 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 17.3 0.3 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 3.5 0.2 0.3 0.0 18.1 0.2 0.0 0.2 0.0 0.0 7.8 0.0 2.8 0.0 3.3 2.4 19.8 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 3.0 0.0 0.0 0.0 0.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.6 1.1 0.6 0.7 5.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.1 0.0 0.0 0.0 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759240-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 51.3;granulocytes: 39.2;Ito cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 7 "granulocytes: 17.0;monocytes: 4.8" "Cell line enhanced" "Detected in many" "HMC-1: 15.7;HUVEC TERT2: 20.4;PC-3: 20.7;RPMI-8226: 13.2;TIME: 19.1;U-87 MG: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 18.5 6.6 3.9 7.1 4.5 1.5 11.8 2.0 4.7 11.1 3.9 2.3 4.3 3.5 10.1 5.3 3.9 6.6 7.5 7.3 6.5 3.7 9.0 6.6 11.7 7.9 5.4 2.1 4.6 4.7 3.1 8.0 2.4 6.1 8.8 3.2 3.3 3.8 5.1 4.6 6.0 4.5 10.4 4.9 9.5 4.4 4.6 4.0 0.1 12.4 2.4 3.7 8.1 29.9 1.5 1.3 17.0 4.8 0.0 0.0 1.0 5.3 0.0 0.3 0.0 1.5 0.0 0.0 2.5 5.7 2.9 1.8 0.2 0.1 0.1 0.0 3.9 6.8 0.8 0.5 0.3 1.2 0.0 0.6 0.1 0.2 0.0 0.9 1.4 15.7 1.1 1.3 6.3 2.4 8.4 20.4 0.3 0.0 0.1 6.3 0.1 0.7 0.4 0.6 0.8 20.7 0.9 0.4 13.2 2.9 0.2 1.2 2.8 0.1 0.7 0.0 0.6 0.3 4.2 19.1 0.8 5.8 0.3 0.9 0.0 0.0 1.0 21.8 1.4 0.1 17.0 4.8 0.6 0.0 4.5 0.0 0.8 0.0 0.0 1.3 1.5 0.0 0.0 2.2 0.0 3.2 0.0 0.0 1.0 3.9 4.5 2.0 4.7 6.5 3.7 5.4 2.1 6.1 4.0 6.0 7.4 0.5 1.1 5.3 0.7 6.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 8.3 0.6 51.3 0.0 23.3 1.5 0.1 3.7 1.3 39.2 0.4 11.0 0.0 1.2 111.1 17.8 0.4 7.2 14.4 8.5 4.6 0.0 0.5 1.5 0.0 2.8 0.0 0.7 6.5 4.1 1.4 17.0 4.1 0.0 0.0 0.4 0.6 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.9 0.1 0.8 0.8 0.0 2.0 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 2.7 0.0 1.8 9.8 12.8 1.7 0.0 5.9 0.0 0.0 0.0 0.2 1.7 0.7 0.8 0.0 0.0 4.2 1.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.5 7.6 6.5 0.0 0.5 2.1 0.0 4.9 0.0 0.0 0.4 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 15.7;Cytotrophoblasts: 23.5;Distal tubular cells: 23.2;Ductal cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059946, HPA072991" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA059946: AB_2684175, HPA072991: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 9.9 8.1 9.0 7.8 9.4 3.9 14.2 13.8 12.5 11.7 7.7 5.7 6.8 7.1 11.1 11.7 9.4 8.9 7.5 8.3 6.3 8.5 12.1 7.1 8.1 9.0 9.9 11.2 10.9 17.3 9.9 23.0 6.3 11.6 9.6 9.7 8.9 12.3 9.9 7.1 9.8 8.6 9.2 9.4 9.5 9.1 7.9 7.9 6.1 36.8 7.6 8.8 10.4 9.0 11.6 9.7 9.0 11.6 13.7 18.0 11.0 10.1 9.3 5.0 11.2 9.5 19.1 5.7 14.6 9.0 7.9 5.8 4.0 21.8 11.3 20.1 14.8 8.3 8.6 4.8 6.6 11.5 13.5 7.8 6.5 20.1 4.5 17.4 13.3 9.5 15.6 18.9 11.8 16.8 8.0 8.8 13.6 8.5 21.0 17.3 8.7 7.3 7.9 2.2 10.2 9.2 5.0 12.4 13.7 9.8 10.3 7.0 5.0 29.1 16.7 14.2 4.8 24.2 9.7 11.4 12.9 10.5 7.9 7.2 9.0 12.8 11.1 9.7 19.3 11.3 9.0 8.6 3.1 12.3 10.0 18.0 11.6 16.4 13.0 9.7 9.6 16.9 14.0 1.6 13.7 11.6 7.5 13.0 11.0 9.0 9.4 13.8 12.5 6.3 8.5 9.9 11.2 11.6 7.9 6.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 12.0 3.4 15.7 0.0 23.5 23.2 13.2 0.0 0.0 0.0 0.0 12.1 8.1 0.0 0.0 2.3 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.4 0.0 0.0 10.7 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 9.1 9.0 9.6 8.5 15.8 3.8 9.7 4.4 31.0 7.3 6.6 5.1 3.4 4.3 7.7 7.6 4.8 5.7 4.8 3.7 12.5 9.1 3.8 6.3 6.6 10.6 8.5 15.3 10.2 5.6 15.1 4.6 5.9 8.7 15.9 6.8 11.1 8.9 9.1 5.0 4.3 6.4 8.8 7.7 15.5 7.5 4.8 5.0 10.3 7.9 2.0 11.4 7.8 5.4 4.3 8.4 2.3 2.5 1.5 1.9 0.9 2.6 4.6 2.2 4.7 6.3 4.6 1.7 2.6 4.5 3.6 3.6 3.5 1.0 11.6 2.2 2.9 10.2 4.5 4.3 2.1 3.0 5.9 2.9 3.6 3.4 2.1 10.8 7.5 1.8 4.1 3.8 4.9 5.2 4.5 2.3 14.9 7.1 30.3 2.5 7.8 8.7 2.2 5.7 3.3 4.6 9.9 2.5 9.8 2.0 2.1 7.5 4.8 8.5 11.2 22.9 1.4 14.9 7.0 1.3 3.5 4.1 1.4 4.6 16.8 15.7 12.5 1.9 6.4 6.4 0.5 2.5 0.5 1.3 2.1 0.5 2.3 1.3 0.7 1.4 4.3 1.9 1.5 2.3 1.5 1.8 8.4 0.2 0.9 9.6 15.8 4.4 31.0 12.5 9.1 8.5 15.3 8.7 5.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 33.3 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 35.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "T-reg: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;GAMG: 1.5;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.4 1.5 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.0 0.3 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM272 "FLJ37307, LINC00282, NCRNA00282" ENSG00000281106 "Transmembrane protein 272" 13 51813347-51845175 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 24.5;brain: 35.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 54 "neutrophil: 24.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 24.5" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HEL: 1.5;SK-MEL-30: 6.8" NA NA "unprognostic (2.27e-2)" "unprognostic (2.50e-1)" "unprognostic (5.12e-2)" "unprognostic (8.71e-7)" "unprognostic (4.52e-2)" "unprognostic (1.78e-4)" "unprognostic (6.16e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.02e-1)" "unprognostic (3.73e-3)" "unprognostic (1.32e-5)" "unprognostic (2.12e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.58e-2)" 0.2 0.0 2.7 3.3 35.4 1.7 0.0 0.0 2.4 0.0 0.0 0.4 0.0 1.0 0.7 0.0 0.0 0.0 0.3 4.1 1.2 0.0 0.1 0.2 4.0 0.1 0.4 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.0 0.0 0.0 1.4 0.0 1.2 5.6 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.8 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.1 0.1 1.5 0.1 0.5 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.9 0.5 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.4 0.0 2.5 6.5 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 1.1 0.0 4.7 32.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.9 8.0 14.3 10.1 28.5 26.7 15.1 15.8 27.1 17.1 23.8 14.0 12.2 6.7 15.0 14.5 21.2 16.6 14.7 6.2 18.9 6.6 5.7 8.2 6.1 14.2 19.2 15.2 12.3 16.1 10.4 12.4 30.3 19.5 11.3 10.4 8.0 19.3 9.5 7.3 8.0 5.5 13.7 15.9 16.0 8.7 7.4 14.3 5.0 6.2 6.2 8.7 14.9 8.6 21.3 10.5 8.1 14.3 9.7 10.6 10.1 7.4 9.9 22.2 6.2 15.9 15.9 11.0 15.1 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 8.9 12.0 7.5 13.8 20.3 4.5 9.8 2.5 12.0 7.9 7.0 5.9 22.9 5.0 10.2 19.6 8.0 5.6 0.0 12.5 45.9 30.1 16.5 1.1 9.8 12.1 1.6 10.4 7.4 21.0 4.2 15.8 13.2 10.1 45.9 14.6 4.8 9.1 3.5 12.4 3.4 6.3 6.5 13.9 23.2 14.7 19.1 50.0 15.8 10.8 17.5 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861869-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 11.1 14.6 18.6 5.7 26.1 4.6 13.4 7.8 17.3 12.7 8.5 17.7 8.5 6.1 10.4 25.9 7.2 16.8 8.9 10.2 18.4 19.7 12.9 19.1 9.7 9.3 19.1 14.1 17.1 17.5 12.7 16.5 8.9 16.4 12.7 8.5 8.5 10.9 12.7 16.6 8.6 6.2 9.2 19.8 8.7 9.9 20.0 15.5 11.6 17.1 6.5 9.1 7.5 8.7 13.9 11.8 4.2 10.2 9.1 15.9 9.2 4.1 4.2 1.2 2.4 16.1 12.7 0.1 3.4 4.8 4.2 4.2 0.9 8.2 2.8 6.7 6.6 1.9 2.8 0.3 5.2 4.2 4.4 0.0 1.7 5.4 4.4 17.1 2.0 0.1 13.1 13.4 4.3 9.7 9.0 7.1 7.2 0.1 5.8 6.3 3.2 1.7 3.4 2.3 5.0 1.9 1.5 0.7 0.6 9.1 1.6 1.3 1.7 4.1 1.4 1.6 4.2 3.0 3.5 4.6 3.7 0.4 5.4 3.7 2.0 1.5 0.8 7.4 2.4 1.6 3.7 8.6 4.2 7.8 7.7 8.2 13.9 11.6 7.2 10.6 11.9 15.9 12.6 1.6 9.1 10.2 11.8 9.2 9.2 18.6 26.1 7.8 17.3 18.4 19.7 19.1 14.1 16.4 15.5 20.8 4.8 10.7 14.4 5.5 8.0 10.1 15.3 16.0 4.5 31.4 2.0 17.6 11.6 15.3 56.7 9.3 5.2 0.0 8.9 11.3 14.2 14.8 3.5 15.3 19.8 17.5 11.5 11.6 13.3 73.6 25.3 10.3 6.8 9.0 9.1 20.9 11.7 8.4 18.4 17.0 15.9 6.5 6.9 36.1 19.3 7.9 8.1 13.1 11.8 6.2 TMEM52 ENSG00000178821 "Transmembrane protein 52" Q8NDY8 1 1917590-1919273 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 19.1;Hepatocytes: 22.7;Spermatocytes: 23.3;Spermatogonia: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 14.2;OE19: 12.8;RPMI-8226: 25.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (4.39e-2)" "unprognostic (2.60e-1)" "unprognostic (3.76e-2)" "unprognostic (7.35e-3)" "unprognostic (1.04e-5)" "unprognostic (1.46e-1)" "unprognostic (6.71e-3)" "unprognostic (3.68e-2)" "unprognostic (9.49e-2)" "unprognostic (1.69e-1)" "unprognostic (3.83e-3)" "unprognostic (5.80e-2)" "unprognostic (8.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" 1.7 12.5 0.5 0.2 0.5 0.1 1.3 1.5 0.4 0.3 0.9 0.4 0.1 1.0 0.3 1.5 2.0 0.8 0.4 0.4 0.4 0.5 0.6 3.3 1.0 0.1 0.2 0.5 0.5 67.1 0.9 0.3 0.2 0.4 0.5 0.4 0.5 13.8 0.1 77.9 0.8 1.7 0.2 0.3 0.7 1.2 7.9 0.2 0.2 0.9 38.9 2.5 0.3 0.4 0.2 2.3 0.0 0.4 0.0 0.6 0.0 2.3 0.2 0.6 1.3 0.2 0.1 5.5 0.3 0.1 1.6 1.0 3.9 1.6 0.6 1.6 2.5 0.6 0.8 3.9 1.1 0.3 0.2 2.9 0.0 0.6 14.2 0.8 0.0 0.9 0.0 2.3 0.5 0.2 0.1 0.1 2.8 3.5 1.4 0.0 4.5 0.3 1.1 2.1 12.8 7.7 1.0 0.0 25.8 0.8 0.1 2.7 1.8 0.0 2.2 0.3 1.0 1.5 0.3 0.0 0.0 1.1 0.7 0.0 1.8 0.6 0.7 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.5 1.5 0.4 0.4 0.5 0.2 0.5 0.4 0.2 0.0 0.0 1.5 2.5 3.9 0.2 0.6 5.1 4.0 3.4 0.0 0.0 0.9 1.7 1.8 3.4 0.2 9.1 0.0 19.1 5.3 1.7 4.9 0.0 22.7 0.6 0.0 0.0 1.3 0.3 4.5 13.8 0.7 8.5 1.0 7.3 1.2 10.4 2.9 9.2 8.2 1.0 0.0 0.7 23.3 33.4 2.5 3.1 0.0 7.0 2.7 TMEM52B "C12orf59, FLJ31166" ENSG00000165685 "Transmembrane protein 52B" Q4KMG9 12 10170542-10191801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "kidney: 85.1" "Cell type enriched" "Detected in some" 16 "Distal tubular cells: 603.5" "Cancer enriched" "Detected in some" 5 "renal cancer: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "CACO-2: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058096 Enhanced Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058096: AB_2683603" "unprognostic (1.10e-2)" "unprognostic (7.61e-2)" "unprognostic (1.37e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (5.33e-3)" "unprognostic (1.37e-1)" "unprognostic (8.65e-2)" "unprognostic (7.14e-4)" "unprognostic (2.23e-1)" "unprognostic (6.36e-2)" "unprognostic (7.33e-2)" "unprognostic (3.24e-2)" "unprognostic (5.80e-2)" "unprognostic (5.51e-2)" "unprognostic (1.66e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.6 0.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 85.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 2.0 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 3.7 1.4 1.3 0.6 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.3 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 6.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.4 4.4 0.0 1.6 2.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 1.4 1.3 1.0 0.4 0.2 0.4 0.4 0.4 0.5 3.7 0.9 0.5 0.5 1.0 0.6 0.2 0.6 0.4 0.4 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 12.2 0.0 38.1 603.5 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.6 0.0 0.3 4.2 1.7 2.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.2 0.0 16.2 0.0 0.0 0.0 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674555 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7;liver: 44.7" "Cell type enriched" "Detected in all" 5 "Late spermatids: 845.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 38.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 38.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favorable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 8.3 9.0 6.0 4.4 8.7 6.0 7.0 2.4 11.8 4.9 11.0 8.8 4.6 16.6 5.7 7.2 4.5 5.3 7.6 9.3 6.2 6.1 14.8 44.7 7.3 6.4 6.8 6.2 7.7 5.4 3.3 6.4 4.3 8.0 5.2 7.2 13.9 6.0 3.8 4.2 3.9 16.4 4.5 6.1 4.8 7.7 18.8 4.4 3.6 8.2 3.1 4.0 7.3 3.7 5.3 38.7 3.6 8.6 2.8 3.1 2.8 7.6 8.8 8.0 5.8 10.4 7.9 9.6 2.2 6.7 4.4 6.6 2.8 24.2 2.4 7.3 2.1 17.0 6.9 2.2 4.7 2.3 3.8 5.6 2.8 3.6 13.4 10.4 2.2 10.3 9.3 7.3 8.8 1.9 4.8 2.4 5.5 1.2 3.1 2.6 4.5 2.5 6.5 4.6 5.9 5.2 4.0 1.1 23.6 13.1 8.0 5.6 5.4 2.4 9.6 12.4 5.9 3.0 5.8 1.0 3.2 5.5 4.6 2.8 2.2 2.6 1.3 8.4 5.7 3.7 3.6 5.2 2.3 3.0 8.6 2.6 5.3 3.1 2.5 2.6 5.0 1.5 2.0 0.5 2.8 6.0 38.7 3.0 2.8 6.0 8.7 2.4 11.8 6.2 6.1 6.8 6.2 8.0 4.4 6.0 11.8 2.4 6.7 1.4 5.6 24.6 10.2 18.7 9.1 19.2 3.9 11.6 38.1 14.3 155.5 8.7 50.1 23.3 22.5 13.2 5.6 7.8 5.8 81.3 29.8 17.5 13.8 8.0 8.3 845.8 8.3 7.2 8.5 1.8 18.4 12.9 16.0 56.1 11.7 39.8 12.4 25.8 7.3 5.1 8.3 1.9 7.8 4.1 15.4 10.3 TMEM54 CAC-1 ENSG00000121900 "Transmembrane protein 54" Q969K7 1 32894594-32901438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.7" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.3;OE19: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061992 Approved Vesicles NA NA Vesicles "HPA061992: AB_2684652" "unprognostic (2.67e-1)" "unprognostic (2.57e-2)" "unprognostic (2.55e-1)" "unprognostic (4.98e-2)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.42e-2)" "unprognostic (3.48e-2)" "unprognostic (9.43e-2)" "unprognostic (6.82e-3)" "unprognostic (2.13e-2)" "unprognostic (9.06e-2)" "unprognostic (3.12e-2)" "unprognostic (3.40e-2)" 3.2 3.3 16.1 21.5 10.7 0.0 8.5 2.7 10.6 10.0 70.0 8.2 7.0 37.9 8.5 9.4 28.8 5.0 24.2 4.5 9.7 9.4 11.4 4.4 7.2 2.4 10.9 5.7 6.2 12.4 9.0 4.7 47.3 6.8 14.7 37.4 7.4 11.8 8.4 1.9 26.9 76.7 7.3 7.3 3.1 35.0 3.7 6.0 1.1 23.6 16.9 14.2 12.5 15.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 29.9 8.1 0.0 7.8 14.9 9.0 29.3 4.4 7.2 10.7 13.8 20.2 48.3 0.0 13.1 5.9 13.6 18.4 7.0 25.9 3.2 34.8 1.4 0.0 2.9 1.0 10.8 0.1 0.4 7.7 23.7 16.3 4.5 7.2 4.7 3.1 4.1 0.0 5.5 32.1 0.0 0.6 2.5 57.6 14.1 4.0 12.2 0.1 3.9 38.5 0.4 4.0 3.1 20.1 10.1 5.0 21.8 5.8 8.9 10.5 11.2 23.5 9.4 1.1 2.5 3.5 7.5 0.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 10.7 2.7 10.6 9.7 9.4 10.9 5.7 6.8 6.0 17.9 25.1 9.7 74.9 18.1 5.9 2.8 76.5 6.7 6.8 45.4 3.9 34.8 23.2 128.9 43.4 11.3 673.9 0.0 180.9 127.1 10.8 130.2 5.7 1.5 7.4 0.0 58.3 12.9 1.8 20.3 18.4 3.7 13.5 5.4 310.3 13.7 137.0 422.1 23.0 38.7 8.7 6.5 11.3 11.1 8.9 55.7 53.8 0.0 231.5 148.6 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 92.0;Horizontal cells: 47.7;Muller glia cells: 72.1;Rod photoreceptor cells: 22.8" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 20.4;ASC diff: 24.8;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;hTERT-RPE1: 13.4;SH-SY5Y: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010661 Approved NA NA "HPA010661: AB_1078338" "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favorable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.4 24.8 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 2.0 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 13.4 0.0 0.8 0.0 0.1 0.5 0.9 0.1 0.0 1.8 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.1 1.4 0.0 0.0 0.2 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 0.0 0.0 0.0 0.2 0.0 92.0 0.4 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.2 47.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 72.1 0.3 0.0 0.0 0.0 22.8 0.0 2.7 2.6 0.9 0.1 0.1 0.0 0.0 0.0 TMEM60 "C7orf35, DC32" ENSG00000135211 "Transmembrane protein 60" Q9H2L4 7 77793728-77798580 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062625 Approved NA NA "HPA062625: AB_2684811" "prognostic favorable (3.09e-4)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-3)" "unprognostic (3.91e-2)" "unprognostic (5.28e-3)" "unprognostic (2.73e-3)" "unprognostic (3.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (2.72e-2)" "unprognostic (9.44e-2)" "unprognostic (2.07e-3)" "unprognostic (4.43e-3)" 16.4 19.7 14.6 16.2 14.8 6.9 22.8 8.6 21.3 17.4 18.0 10.0 17.1 13.3 16.4 23.1 15.0 14.5 13.6 15.1 14.6 17.8 25.5 25.8 19.3 18.8 15.7 12.2 18.6 24.1 33.9 30.6 20.1 19.7 17.9 18.4 16.0 27.5 21.3 19.2 15.1 19.6 14.7 15.3 22.7 14.2 20.3 9.8 18.8 30.9 17.2 20.5 14.0 14.1 25.9 15.6 48.3 17.2 8.8 23.1 12.2 15.1 10.2 16.2 18.7 21.6 19.2 7.4 14.3 27.0 15.2 24.3 9.4 19.5 11.8 3.5 13.1 52.9 16.1 15.0 8.2 17.2 9.1 14.2 6.3 9.6 13.0 15.3 8.9 11.9 14.0 12.0 11.3 13.8 15.0 10.7 11.0 14.8 23.7 23.7 16.1 6.7 22.8 11.3 18.6 13.3 8.1 12.7 16.8 17.9 11.3 8.1 13.1 10.7 15.1 21.4 17.8 18.3 16.5 7.2 19.7 13.8 17.1 10.5 9.7 14.8 16.8 14.9 18.6 17.3 48.3 16.0 28.6 9.4 17.2 10.1 25.9 16.5 11.6 11.9 20.9 14.0 11.8 15.6 8.8 15.7 15.6 23.1 12.2 14.6 14.8 8.6 21.3 14.6 17.8 15.7 12.2 19.7 9.8 8.9 11.5 29.7 29.5 26.7 6.9 5.6 12.7 21.4 7.9 41.8 7.9 49.2 44.7 24.1 6.5 19.7 20.7 0.0 25.8 34.9 31.9 26.7 24.3 23.5 59.9 12.7 8.7 25.8 36.2 8.4 42.3 34.9 27.0 33.3 30.3 16.2 24.9 24.6 33.2 41.8 9.3 51.8 17.0 43.3 39.5 29.2 36.7 16.6 26.4 33.5 TMEM61 ENSG00000143001 "Transmembrane protein 61" Q8N0U2 1 54980792-54992293 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1" "Group enriched" "Detected in many" 4 "Distal tubular cells: 41.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 52.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 5.2;pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 22.6" "Low region specificity" "Detected in many" HPA030614 Uncertain NA NA "HPA030614: AB_10603216" "unprognostic (7.62e-2)" "unprognostic (1.67e-3)" "prognostic favorable (1.07e-4)" "unprognostic (1.00e-1)" "unprognostic (6.63e-4)" "unprognostic (6.15e-2)" "unprognostic (2.67e-3)" "unprognostic (1.49e-1)" "unprognostic (3.05e-1)" "unprognostic (4.46e-2)" "unprognostic (1.91e-2)" "unprognostic (7.24e-2)" "prognostic favorable (1.78e-7)" "unprognostic (8.47e-2)" "unprognostic (2.20e-2)" "unprognostic (4.01e-2)" "unprognostic (4.62e-3)" 0.2 3.9 0.4 0.7 1.0 0.0 2.7 5.2 0.5 0.9 3.7 0.2 4.9 2.4 0.2 3.8 2.9 2.0 1.7 0.0 0.5 0.6 22.1 0.0 2.4 0.0 1.1 0.7 1.1 4.2 7.8 29.1 0.5 5.2 2.4 2.3 0.5 34.1 6.7 0.4 1.8 3.5 5.3 0.8 0.4 2.2 0.2 0.1 0.1 0.6 0.8 1.8 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 22.6 2.4 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 5.2 0.5 0.5 0.6 1.1 0.7 5.2 0.1 0.0 1.9 0.0 6.7 0.8 0.7 0.0 0.0 10.7 2.3 7.0 2.0 0.1 41.4 4.0 0.1 0.0 1.7 0.0 3.0 0.1 0.2 3.1 0.0 0.0 0.1 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 52.9 0.1 4.2 5.8 0.7 0.0 0.8 0.0 0.1 0.1 0.7 2.0 0.2 0.0 2.0 2.6 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.8;pituitary gland: 21.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.4 14.1 3.4 1.0 8.4 1.1 5.2 63.8 16.3 1.5 5.8 1.9 0.0 1.8 0.3 6.8 4.8 0.6 0.5 0.3 3.2 9.7 0.7 0.4 0.9 0.6 4.6 6.0 0.4 6.7 1.2 21.1 1.1 6.6 0.4 4.3 0.9 1.3 0.2 0.8 4.4 2.2 1.1 1.8 3.2 3.1 9.9 1.2 0.0 3.2 0.6 0.6 0.3 2.9 0.1 0.7 2.0 1.7 1.7 1.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 11.8 2.3 0.0 2.0 1.6 2.5 0.9 0.0 0.8 0.9 0.2 1.2 0.0 0.0 2.0 0.1 0.0 5.0 0.0 0.1 0.0 0.0 5.6 0.0 15.9 0.0 5.9 1.6 0.1 0.5 0.0 0.0 0.0 0.8 8.1 0.2 0.0 21.7 3.2 0.2 19.2 0.0 0.4 1.9 1.0 0.0 0.0 4.1 0.0 0.0 1.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.5 1.0 0.7 0.1 0.5 0.4 2.0 1.7 1.7 0.0 0.0 0.4 3.4 8.4 63.8 13.0 3.2 9.7 4.6 6.0 6.6 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 7.2 0.0 2.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 2.0 3.2 18.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.1 0.1 0.3 6.6 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "epididymis: 84.0" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 42.9;Leydig cells: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Uncertain NA NA "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 9.2 12.6 4.3 5.2 5.3 2.1 6.1 2.7 6.1 10.6 10.8 16.2 14.5 5.7 11.9 84.0 7.3 5.7 6.3 5.8 6.2 5.5 11.6 11.7 7.2 6.7 11.2 3.3 10.1 11.3 4.1 5.9 6.1 10.0 10.7 3.7 15.1 12.4 11.0 8.2 6.8 11.3 9.6 12.1 7.2 5.4 9.7 7.5 2.3 20.0 5.2 7.2 11.9 10.9 5.7 0.6 3.2 0.8 5.9 3.7 1.6 12.8 10.0 5.1 2.7 23.7 17.3 2.7 9.5 9.1 7.5 8.4 2.8 8.9 8.4 3.8 5.8 3.2 4.5 13.5 6.5 10.0 16.8 4.9 15.6 4.0 6.3 8.4 0.9 2.6 22.5 7.1 3.1 7.0 8.7 7.5 2.0 7.0 18.6 12.6 17.1 0.0 2.2 0.7 6.6 5.3 1.8 11.2 4.2 14.8 25.0 3.6 10.2 6.2 5.5 11.5 7.1 5.5 0.7 7.4 7.6 6.7 5.5 7.7 12.3 0.2 9.2 6.9 1.9 10.0 3.2 0.2 0.3 3.0 0.6 3.7 5.7 3.2 3.4 0.6 2.9 1.5 2.1 0.1 5.9 0.8 0.4 1.4 1.6 4.3 5.3 2.7 6.1 6.2 5.5 11.2 3.3 10.0 7.5 8.9 12.2 16.1 8.7 21.4 0.6 17.1 10.2 4.0 3.4 21.0 0.0 20.2 1.7 3.8 2.4 7.0 3.4 0.0 8.8 5.2 14.6 15.6 13.9 42.9 3.6 1.6 7.5 5.5 7.5 2.1 43.4 6.5 23.6 0.0 4.3 2.6 8.2 3.1 20.1 22.1 0.0 0.0 10.8 3.4 1.6 20.6 13.2 9.6 5.1 6.2 TMEM68 FLJ32370 ENSG00000167904 "Transmembrane protein 68" Q96MH6 8 55696424-55773407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018216, HPA019173" Uncertain Approved Vesicles NA NA Vesicles "HPA018216: AB_2205185, HPA019173: AB_1858129" "unprognostic (4.43e-2)" "unprognostic (3.10e-2)" "unprognostic (8.04e-2)" "unprognostic (2.40e-1)" "unprognostic (4.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.46e-3)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (3.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.41e-2)" "unprognostic (1.63e-1)" 10.4 18.3 14.0 8.4 18.0 10.6 14.6 18.9 20.5 13.0 15.1 16.3 16.0 14.6 15.4 17.9 16.1 25.4 12.5 7.4 13.8 13.2 20.6 14.6 11.3 10.5 12.7 10.2 15.7 13.5 15.9 18.5 15.6 13.2 15.8 16.6 13.1 14.0 12.2 7.8 17.6 18.3 14.4 13.3 12.9 12.0 9.8 11.7 22.7 18.8 13.4 12.3 17.1 13.0 9.2 7.2 21.7 7.7 8.2 10.5 3.9 12.4 7.5 12.8 7.7 10.8 12.5 22.4 11.0 8.5 10.7 10.4 10.6 23.5 13.7 13.1 7.3 13.7 15.8 9.9 14.7 11.9 18.7 11.2 16.5 6.8 11.1 11.9 7.0 9.2 8.4 22.7 10.8 25.5 15.8 9.7 14.9 15.8 13.8 15.6 6.5 17.4 9.6 13.8 27.2 3.9 12.8 5.3 8.8 17.7 9.7 10.6 9.4 7.4 12.1 21.7 17.4 17.8 9.1 7.6 8.2 10.3 14.0 9.0 11.9 14.9 17.2 11.1 11.7 12.6 21.7 7.1 5.0 7.2 4.4 10.5 9.2 8.6 7.6 7.2 9.2 7.2 10.1 7.9 8.2 7.7 6.4 6.3 3.9 14.0 18.0 18.9 20.5 13.8 13.2 12.7 10.2 13.2 11.7 11.9 10.1 7.5 25.1 30.3 17.3 4.1 20.4 56.2 21.6 24.4 13.7 26.7 11.6 14.9 1.3 9.5 14.5 0.0 7.0 17.4 11.9 20.6 5.7 11.0 11.5 20.6 14.5 10.4 14.9 1.1 12.0 10.1 6.8 13.6 23.7 17.2 12.5 19.2 13.1 17.7 15.2 25.8 9.5 15.8 12.3 31.0 18.5 11.5 14.1 24.8 TMEM69 "C1orf154, FLJ21029" ENSG00000159596 "Transmembrane protein 69" Q5SWH9 1 45687214-45694443 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026993 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026993: AB_10601824" "prognostic favorable (2.24e-4)" "unprognostic (2.47e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.66e-8)" "unprognostic (4.05e-2)" "unprognostic (1.59e-3)" "unprognostic (5.17e-2)" "unprognostic (3.98e-3)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (1.49e-2)" "unprognostic (1.96e-1)" "unprognostic (4.41e-3)" "unprognostic (3.65e-2)" 6.0 9.0 7.0 5.8 11.0 2.6 12.2 6.8 13.8 5.3 7.5 7.3 2.9 8.3 5.6 9.9 12.1 6.0 5.6 11.6 6.3 6.2 8.4 7.6 8.3 8.8 6.9 5.0 8.9 7.8 10.7 5.5 6.8 10.8 7.0 8.4 4.7 7.9 5.7 8.2 7.7 8.2 6.2 9.1 7.8 5.7 12.1 9.4 10.1 7.5 8.8 9.3 8.4 11.1 8.7 10.9 5.4 15.6 4.6 8.2 6.1 13.1 3.2 9.1 7.4 7.0 9.0 22.4 8.6 10.2 14.6 14.2 9.0 6.9 16.0 6.0 8.2 10.8 17.8 7.3 19.6 15.0 11.1 8.5 32.6 8.0 9.7 12.4 15.6 16.1 10.5 20.4 13.4 8.5 9.4 11.9 15.4 19.5 11.1 9.1 4.8 8.6 11.2 21.7 8.0 8.8 13.5 8.3 16.2 15.4 14.0 10.6 9.5 9.1 24.6 14.7 16.6 12.8 16.0 8.9 6.7 11.5 14.8 10.3 8.9 11.0 12.2 9.4 11.7 9.8 5.0 12.2 5.0 5.1 12.7 6.4 8.7 7.2 5.7 10.9 8.3 8.2 6.3 5.4 4.6 15.6 6.8 6.8 6.1 7.0 11.0 6.8 13.8 6.3 6.2 6.9 5.0 10.8 9.4 0.0 12.2 15.7 21.6 17.9 11.2 7.9 7.6 13.4 17.0 17.4 0.0 53.1 36.5 19.2 1.5 11.6 17.1 0.0 15.4 28.9 13.5 20.5 5.8 12.5 33.1 6.4 23.1 14.1 39.0 3.0 17.3 26.0 16.9 12.6 21.0 12.4 13.5 10.5 12.0 27.2 10.5 12.9 8.6 18.4 14.9 22.7 49.9 14.9 23.6 18.4 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA058401: AB_2683707, HPA070655: AB_2686292" "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.8 8.2 0.3 0.6 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.2 0.9 33.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 1.3 0.9 0.6 4.2 0.0 7.0 1.4 0.0 1.6 1.3 0.7 0.0 0.2 0.1 1.1 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.4 0.5 0.7 3.4 0.0 1.6 0.0 5.8 19.5 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 0.0 4.8 4.2 1.0 0.8 0.0 14.8 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 0.0 3.1 0.0 0.0 1.3 23.3 3.6 0.0 22.7 5.0 0.0 0.0 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 41.5 0.0 5.1 TMEM72 "bA285G1.3, C10orf127, KSP37" ENSG00000187783 "Transmembrane protein 72" A0PK05 10 44911200-44937002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.5;retina: 17.1" "Group enriched" "Detected in some" 4 "Collecting duct cells: 26.2;Distal tubular cells: 28.2;Late spermatids: 11.4;Paneth cells: 8.6" "Cancer enriched" "Detected in some" 8 "renal cancer: 8.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.2;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 118 "RPMI-8226: 26.1;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA039894, HPA062907" Enhanced NA NA "HPA039894: AB_10795261, HPA062907: AB_2684900" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (8.58e-2)" "unprognostic (5.45e-2)" "prognostic favorable (1.01e-4)" "unprognostic (4.99e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" 0.1 0.0 0.1 0.9 0.2 0.1 0.0 0.3 0.2 0.0 4.2 1.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.3 46.5 0.1 0.0 0.0 0.4 0.0 0.0 5.7 0.1 0.3 0.0 4.9 0.0 4.9 17.1 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 1.9 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 1.2 0.3 0.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 26.2 0.0 0.0 28.2 0.0 4.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 8.6 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.7 0.0 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favorable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 5.0 2.8 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.7 0.1 1.0 0.0 2.9 0.3 3.7 0.5 0.1 0.0 4.7 1.1 0.0 9.9 0.0 0.0 1.4 0.0 1.1 0.0 0.2 0.2 0.1 0.7 16.8 7.6 0.0 0.1 0.1 0.1 3.4 1.2 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 1.2 0.0 0.1 2.0 0.0 3.3 0.1 0.2 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.2 10.3 1.6 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.5 0.8 3.6 2.0 0.0 0.2 1.0 0.2 0.7 0.0 0.6 0.0 17.5 15.0 3.1 0.8 0.4 0.0 0.0 1.7 1.8 2.7 0.2 1.4 1.7 0.0 0.3 2.7 19.4 5.7 0.2 0.2 0.6 1.1 0.0 0.8 0.4 TMEM78 FLJ40168 ENSG00000177800 "Transmembrane protein 78" Q5T7P6 1 229249636-229251810 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;bone marrow: 2.5" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA042351 Uncertain NA NA "HPA042351: AB_10961259" "unprognostic (2.45e-2)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (3.33e-1)" "unprognostic (9.45e-2)" "unprognostic (5.59e-2)" "unprognostic (1.29e-1)" 0.1 0.4 0.5 0.2 0.5 2.5 0.4 0.7 0.7 0.1 0.1 0.1 0.5 0.6 0.1 0.3 0.2 0.1 0.4 0.3 0.1 0.6 0.0 0.7 0.3 0.2 0.7 0.5 0.2 0.0 0.4 0.3 0.7 0.0 1.8 1.2 0.2 0.0 0.3 0.6 0.1 0.7 0.3 0.2 0.1 0.1 1.3 2.6 5.3 0.5 1.3 0.9 0.1 0.4 1.3 0.8 2.1 0.2 0.0 0.6 0.4 0.0 0.1 0.1 0.2 1.9 0.5 0.5 0.4 0.2 1.0 0.0 0.0 0.3 0.6 0.6 0.8 1.8 0.3 0.0 0.6 0.5 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.3 0.7 0.0 0.3 0.6 1.5 0.6 0.4 0.6 0.4 0.4 0.2 0.3 1.1 0.4 0.5 0.5 0.2 0.0 1.1 0.5 0.1 0.0 0.6 0.5 0.5 0.3 0.9 0.6 0.8 0.5 0.6 0.8 5.3 0.5 0.7 0.7 0.3 0.5 0.8 0.6 0.5 0.1 1.3 0.9 0.8 2.6 1.3 0.5 2.6 0.4 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 12.9 12.7 10.5 17.7 18.9 4.4 20.0 15.9 20.5 14.8 14.1 18.3 12.8 19.1 17.9 21.8 22.9 17.0 10.9 7.7 15.3 9.4 16.5 10.2 12.2 15.5 12.6 15.2 18.2 16.1 16.8 19.7 7.6 13.5 17.9 15.0 18.1 25.2 19.1 12.6 20.4 16.5 15.4 9.4 20.0 19.3 13.8 14.3 33.8 27.2 7.4 18.3 16.3 15.8 21.5 16.1 24.6 21.5 13.9 17.7 14.0 19.7 10.0 6.4 8.3 14.2 6.7 10.1 4.9 2.7 5.2 5.7 11.2 24.1 8.9 4.2 7.6 9.3 15.2 9.4 5.6 3.8 6.1 23.8 5.3 9.9 8.0 8.4 7.0 9.8 15.5 11.5 2.3 3.7 10.3 6.1 10.7 6.6 10.3 6.6 6.5 9.2 4.8 5.9 16.7 4.6 6.4 4.3 17.3 7.4 3.1 17.6 5.7 7.2 13.8 6.8 4.5 10.1 6.7 8.6 8.8 4.3 1.9 3.6 4.9 1.5 8.0 9.3 8.9 3.7 6.1 19.8 24.6 16.3 18.8 14.2 19.8 12.3 12.2 15.7 21.5 17.7 15.5 9.4 13.9 21.5 16.1 14.8 14.0 10.5 18.9 15.9 20.5 15.3 9.4 12.6 15.2 13.5 14.3 6.0 16.5 15.2 16.9 13.6 19.0 14.6 12.7 12.0 9.1 19.2 7.9 28.0 10.0 10.3 5.0 15.7 16.4 23.3 14.9 7.3 14.1 13.9 6.9 5.8 15.3 52.4 11.6 14.7 12.1 9.2 39.4 14.4 11.8 10.0 19.9 20.9 9.4 5.8 26.9 7.9 8.6 32.3 20.8 50.2 65.2 15.1 12.7 15.7 20.0 9.0 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 3.5;Early spermatids: 7.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA052515: AB_2681858" "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.1 9.1 3.6 3.1 4.5 2.7 2.3 1.4 6.5 1.7 4.5 3.2 2.5 3.4 2.1 9.9 3.8 4.0 3.9 3.9 3.7 5.2 3.2 6.3 1.9 2.1 3.6 6.8 3.6 1.8 6.1 4.5 5.4 8.3 1.9 2.9 4.7 4.3 8.1 4.7 3.0 5.4 3.0 7.1 4.6 5.3 2.3 3.9 6.1 2.8 3.4 7.1 10.0 2.5 8.0 2.1 4.3 2.3 5.5 4.8 4.3 5.3 3.6 6.2 2.9 7.3 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 0.0 0.0 0.5 0.5 2.1 0.6 1.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.5 7.9 1.0 0.3 0.0 0.5 0.3 0.8 0.6 0.0 1.0 0.5 1.6 0.0 0.6 0.0 1.3 0.0 0.0 1.7 0.0 0.2 1.1 0.7 0.0 0.4 1.4 1.0 0.0 0.6 0.2 1.1 2.3 0.1 0.0 0.8 0.4 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Group enriched" "Detected in some" 9 "Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.1 6.6 0.0 0.0 0.0 86.8 0.0 0.2 1.9 0.0 0.0 0.0 38.2 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 57.5 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.3 0.0 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.5" "Group enriched" "Detected in many" 12 "dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA057119: AB_2683342" "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 6.9 4.9 4.7 3.6 5.7 0.7 5.6 3.4 9.7 3.8 3.3 7.0 1.2 2.5 4.0 3.8 3.9 4.4 6.6 8.1 6.9 3.7 15.3 6.7 5.7 11.1 6.7 3.2 12.3 8.2 7.0 3.9 7.1 5.0 2.9 3.2 16.7 4.6 2.7 4.7 24.4 3.2 3.4 7.2 9.2 3.3 4.1 3.7 5.3 3.7 3.9 4.2 5.2 5.4 0.2 6.5 0.3 3.7 0.2 1.7 1.4 0.0 0.2 0.7 3.4 3.1 0.0 0.1 0.7 0.6 0.6 0.5 0.0 0.4 0.0 1.3 0.6 3.4 0.3 0.2 0.1 0.4 0.2 2.0 0.2 0.1 0.0 2.4 0.0 3.0 4.3 1.3 0.1 0.3 0.8 1.8 1.9 0.6 0.0 1.4 1.8 0.0 0.0 0.2 0.5 1.8 0.0 5.6 0.0 19.2 4.1 1.1 1.4 1.0 3.5 1.5 1.3 4.2 0.4 2.1 0.6 0.3 0.2 0.1 3.5 2.7 0.0 1.2 0.0 1.2 0.0 3.7 0.3 0.4 2.8 1.0 0.0 0.4 0.9 6.5 0.2 1.0 1.7 0.0 0.2 0.9 3.8 1.0 1.4 4.7 5.7 3.4 9.7 6.9 3.7 6.7 3.2 5.0 3.7 0.0 0.0 0.0 0.6 0.1 3.9 2.0 0.0 0.0 0.0 10.4 7.9 0.4 6.6 5.3 6.8 0.6 0.0 0.0 6.9 0.3 0.8 0.9 0.0 1.0 34.1 0.0 3.4 4.3 6.4 6.3 2.0 5.7 0.0 1.8 0.6 2.9 7.5 0.0 1.8 5.6 4.5 6.5 0.1 6.5 0.7 0.3 1.9 0.0 0.0 0.3 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 28.3" "Group enriched" "Detected in some" 79 "Early spermatids: 252.0;Late spermatids: 154.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.8;U-2197: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053577 Uncertain NA NA "HPA053577: AB_2682196" "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.7 28.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.7 0.4 1.1 0.3 1.1 0.7 0.0 0.2 0.0 1.1 1.8 0.2 0.4 0.0 0.0 0.3 0.0 0.5 0.8 0.6 0.5 0.0 1.5 0.0 1.4 1.9 0.6 0.2 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.8 0.6 0.4 0.0 0.7 0.5 0.0 0.7 1.2 0.1 0.9 0.0 0.7 0.4 0.5 0.8 0.0 0.0 1.4 1.5 3.1 1.6 0.5 0.8 0.5 1.8 0.7 2.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 154.1 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 TMEM91 "FLJ27310, IFITMD6" ENSG00000142046 "Transmembrane protein 91" Q6ZNR0 19 41350911-41384083 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 178.4;Late spermatids: 342.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 51.9" "Cell line enhanced" "Detected in many" "HEL: 15.2;HSkMC: 16.2;TIME: 15.2" "Low region specificity" "Detected in all" HPA053240 Uncertain NA NA "HPA053240: AB_2682085" "unprognostic (3.02e-3)" "unprognostic (1.92e-2)" "unprognostic (5.13e-3)" "unprognostic (2.97e-2)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (4.70e-2)" "unprognostic (2.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.69e-3)" "prognostic favorable (3.54e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.06e-2)" 10.5 6.2 12.1 9.2 42.0 35.5 22.0 5.2 13.0 12.1 9.8 9.5 12.9 4.3 17.3 12.8 11.2 15.8 9.7 7.2 11.3 22.9 8.3 4.2 13.9 6.8 9.3 13.7 9.7 12.9 4.3 19.2 10.8 11.6 12.3 5.1 12.3 8.6 13.5 4.0 29.7 5.4 10.9 8.1 15.7 6.0 15.2 14.7 6.0 10.7 3.8 8.6 14.4 12.1 0.4 3.4 51.9 12.5 0.3 2.0 11.0 2.2 5.5 4.2 1.9 5.1 11.0 3.7 1.7 2.5 0.9 1.7 0.4 2.0 1.1 1.7 2.2 1.6 0.7 1.1 1.9 2.3 1.6 2.5 15.2 3.6 8.1 9.3 2.5 4.1 16.2 9.6 3.1 7.0 11.5 6.9 2.9 2.8 4.5 1.6 5.0 1.4 4.6 1.7 0.7 3.3 3.0 1.1 1.0 2.6 1.3 1.2 2.3 3.9 0.8 2.5 2.9 0.8 7.0 15.2 2.6 2.3 2.3 2.1 3.0 0.4 0.9 5.0 3.1 0.9 7.1 12.5 0.9 1.5 2.6 1.8 0.1 0.8 0.7 2.1 0.4 2.0 0.9 51.9 0.3 1.8 3.4 1.0 11.0 12.1 42.0 5.2 13.0 11.3 22.9 9.3 13.7 11.6 14.7 3.0 21.9 3.0 19.5 15.9 9.2 3.0 0.0 5.3 9.1 7.0 5.9 1.6 1.7 3.0 178.4 13.0 1.0 0.0 2.8 59.8 10.3 5.3 33.5 3.0 13.8 7.9 13.8 16.5 57.3 342.9 13.0 14.6 8.5 1.8 1.9 3.8 5.2 14.4 6.7 2.1 6.0 6.5 4.6 2.8 9.6 18.6 7.2 8.7 1.6 9.6 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Cell type enhanced" "Detected in many" 15 "Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 0.9 9.1 0.2 0.0 0.0 0.4 2.0 0.2 0.3 0.0 0.0 15.5 14.8 0.0 30.9 0.6 3.5 0.0 0.2 1.7 0.0 2.4 0.1 0.0 0.9 1.5 0.1 0.1 0.1 0.1 1.7 0.1 0.5 1.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 3.4 17.9 4.0 0.2 0.0 3.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 20.9 1.9 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 3.0 17.1 0.0 6.4 0.5 0.0 0.1 22.9 2.7 1.2 7.0 0.0 0.0 0.0 6.2 0.0 0.0 8.0 0.0 17.8 1.2 1.0 16.8 0.0 11.3 0.4 0.0 5.2 1.8 0.3 0.0 0.0 0.0 0.0 1.8 20.4 0.0 31.5 16.4 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.9 0.0 0.0 14.9 92.2 TMEM95 "MGC129793, UNQ9390" ENSG00000182896 "Transmembrane protein 95" Q3KNT9 17 7355123-7357219 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 21 "testis: 19.3" "Group enriched" "Detected in some" 23 "Early spermatids: 20.4;Late spermatids: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;BJ: 1.0;hTERT-RPE1: 1.4" "Intracellular and membrane" NA NA "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "unprognostic (5.15e-2)" "unprognostic (7.42e-2)" "unprognostic (7.44e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM99 MGC21518 ENSG00000167920 "Transmembrane protein 99" Q8N816 17 40819106-40836274 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 63.4" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 234.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.14e-2)" "unprognostic (1.25e-1)" "unprognostic (1.58e-1)" "unprognostic (5.30e-3)" "unprognostic (8.83e-2)" "unprognostic (4.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (9.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (4.73e-2)" "unprognostic (5.24e-2)" "unprognostic (8.68e-3)" "unprognostic (7.19e-2)" 4.5 6.1 4.5 2.6 4.5 0.4 11.8 4.1 4.3 7.1 3.7 4.6 15.8 3.5 4.9 21.5 7.0 8.8 8.3 6.8 3.7 3.4 8.5 11.3 7.1 3.1 4.2 3.3 7.5 22.8 7.8 9.1 4.9 5.5 8.2 3.8 4.8 29.1 9.9 5.2 27.6 4.1 3.8 3.0 4.8 6.1 63.4 3.8 4.9 13.3 6.0 4.0 5.5 8.3 9.5 5.9 7.8 2.4 10.8 14.1 4.0 10.4 13.5 6.8 7.9 16.1 20.4 6.6 9.8 5.4 12.4 14.8 10.2 6.8 4.4 14.9 11.3 15.7 20.4 9.9 15.3 18.0 3.7 21.5 6.6 9.8 22.4 14.8 10.0 9.2 10.3 27.5 19.4 19.6 8.7 4.2 13.3 24.0 6.5 16.4 3.9 8.2 5.7 11.1 11.1 7.7 10.4 13.5 8.4 13.6 6.8 15.1 0.6 4.9 25.1 17.9 16.9 19.2 10.6 2.6 10.6 7.5 17.6 11.4 0.1 3.3 8.0 11.8 5.6 6.1 7.8 1.6 4.6 10.1 2.2 12.8 7.8 8.5 12.7 4.0 9.5 14.1 11.7 0.1 10.8 2.4 5.9 5.2 4.0 4.5 4.5 4.1 4.3 3.7 3.4 4.2 3.3 5.5 3.8 6.0 1.6 11.1 23.3 13.1 5.7 7.9 40.8 10.7 12.5 14.0 0.0 35.5 41.4 21.3 65.9 8.0 8.5 0.0 13.6 35.7 12.5 14.4 5.7 46.6 8.5 4.8 2.9 8.6 8.6 42.9 28.7 5.9 10.1 2.8 10.8 14.6 9.4 8.6 28.0 28.3 7.3 25.8 6.4 234.1 41.7 20.3 21.7 8.7 14.6 28.2 TMOD4 Sk-Tmod ENSG00000163157 "Tropomodulin 4" Q9NZQ9 1 151169986-151176284 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 153.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0" "Group enriched" "Detected in many" 5 "B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5" "Cell line enhanced" "Detected in many" "HEK 293: 6.5;NB-4: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA028203 Enhanced NA NA "HPA028203: AB_10600830" 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 4.0 1.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 1.6 0.1 153.5 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.3 35.0 1.6 0.4 0.1 1.7 1.0 0.4 0.3 0.0 3.5 0.6 0.5 0.4 0.9 0.1 0.7 0.2 1.6 0.1 0.6 0.4 0.1 0.0 0.6 1.4 0.7 1.7 0.5 0.5 1.4 0.3 0.5 2.7 6.5 2.6 2.2 0.0 1.1 1.5 3.2 0.0 0.4 1.3 3.0 1.6 0.8 3.4 1.6 2.3 0.2 2.3 0.7 8.1 1.4 0.1 2.7 2.5 0.3 0.1 0.5 1.6 1.8 1.1 0.7 0.0 0.1 0.7 0.8 5.0 1.0 0.2 1.1 2.3 0.7 3.0 5.6 1.2 0.8 4.5 0.6 0.0 0.3 0.4 1.5 0.0 0.4 1.7 1.5 0.2 0.1 1.0 1.6 3.5 0.2 0.0 0.3 1.0 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.3 1.7 1.0 1.6 1.2 1.0 25.5 0.6 0.9 1.5 0.9 2.5 3.5 0.7 1.1 1.6 0.8 1.4 1.6 1.4 2.5 3.8 0.6 3.1 1.7 1.9 0.8 2.6 4.5 1.1 1.2 1.9 1.3 0.7 1.8 1.6 2.3 2.7 1.1 1.2 1.1 1.2 1.0 0.3 1.0 1.3 0.5 1.7 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 1.3 3.8 2.5 2.3 2.9 1.2 2.4 2.2 1.4 0.4 2.9 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 0.0 2.2 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 1.3 0.0 0.7 1.2 0.3 0.2 0.0 0.2 0.8 1.6 0.0 0.6 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.4 0.9 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.6 0.1 TMPRSS11B ENSG00000185873 "Transmembrane serine protease 11B" Q86T26 4 68226653-68245720 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0" "Group enriched" "Detected in some" 35 "Early spermatids: 8.5;Late spermatids: 11.5" "Group enriched" "Detected in some" 12 "cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.24e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.92e-1)" "unprognostic (3.96e-1)" 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 11.2 0.1 0.0 0.0 0.1 0.5 0.1 138.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 13.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 44.0 57.0 0.1 23.2 0.7 0.6 2.4 0.5 0.4 0.7 0.0 0.3 1.4 0.8 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.9 0.4 1.4 0.2 0.4 0.4 1.1 0.2 0.1 0.0 0.1 1.6 0.8 1.9 2.1 0.1 1.1 1.4 0.5 0.2 0.0 0.1 0.2 0.0 0.5 0.7 2.0 0.1 0.7 0.5 1.3 0.1 0.3 1.0 0.6 0.6 0.5 0.2 1.5 0.9 0.3 0.1 0.2 0.1 0.6 0.4 0.2 1.3 1.0 0.3 0.5 0.1 0.3 0.9 0.8 0.3 1.0 0.1 0.3 0.4 0.2 0.4 0.1 0.3 0.3 0.3 0.4 0.0 0.7 0.3 0.7 2.4 0.4 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 TMPRSS11F FLJ16046 ENSG00000198092 "Transmembrane serine protease 11F" Q6ZWK6 4 68053198-68129880 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1" "Cell type enhanced" "Detected in single" 19 "Cytotrophoblasts: 1.1" "Group enriched" "Detected in some" 7 "cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 2.5;K-562: 5.5;Karpas-707: 1.6;U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA026911 Uncertain NA NA "HPA026911: AB_2205589" "unprognostic (9.46e-2)" "unprognostic (5.30e-1)" "unprognostic (7.16e-2)" "unprognostic (8.79e-3)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "unprognostic (5.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.1 0.0 0.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 13.1 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.3 TMPRSS13 "MSPL, TMPRSS11" ENSG00000137747 "Transmembrane serine protease 13" Q9BYE2 11 117900643-117929459 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.1;salivary gland: 16.6;skin 1: 26.0" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 7.6;Cytotrophoblasts: 12.9;Extravillous trophoblasts: 12.2;Syncytiotrophoblasts: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.5;BEWO: 17.9;MCF7: 15.1;SK-BR-3: 25.9;T-47d: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.08e-3)" "unprognostic (5.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.06e-3)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (5.61e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-1)" "unprognostic (3.16e-6)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.08e-1)" "unprognostic (3.44e-1)" 0.2 0.3 0.2 0.6 0.2 0.3 6.2 0.2 0.2 5.8 0.2 0.2 0.2 0.2 0.9 0.7 14.8 0.1 0.2 0.2 0.4 0.0 0.7 0.2 4.0 0.7 0.2 0.2 0.3 5.7 0.0 0.5 22.1 0.2 0.9 0.2 0.6 16.6 0.2 0.2 26.0 0.5 0.2 0.2 1.0 0.1 0.3 0.2 0.4 9.5 13.7 10.6 0.3 5.6 1.0 2.6 1.0 0.7 1.9 1.2 0.8 7.5 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 5.7 0.1 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 2.1 0.2 0.0 0.0 25.9 0.3 0.9 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.6 0.0 0.9 0.7 0.0 1.0 0.1 1.2 1.8 0.5 0.4 0.1 0.0 1.9 0.5 2.6 0.7 0.8 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.0 2.9 0.0 3.7 1.4 0.0 1.4 7.6 0.0 2.3 0.0 0.0 12.9 0.0 6.2 0.3 0.0 0.4 0.0 1.0 12.2 0.5 5.3 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.6 0.0 0.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.9 16.2 0.0 0.4 6.9 TMPRSS7 ENSG00000176040 "Transmembrane serine protease 7" Q7RTY8 3 112034843-112081269 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;testis: 5.2" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.4;Ciliated cells: 10.7;Early spermatids: 3.3;Urothelial cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;hTCEpi: 2.8;RT4: 1.3;U-266/70: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040630 Uncertain NA NA "HPA040630: AB_10796124" "unprognostic (4.02e-2)" "unprognostic (9.87e-2)" "unprognostic (9.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.24e-1)" "unprognostic (4.64e-3)" "unprognostic (6.63e-2)" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.94e-1)" "unprognostic (7.23e-2)" "unprognostic (2.96e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.5 0.8 0.0 0.0 0.0 1.0 5.2 0.3 0.0 0.2 0.0 0.8 0.5 2.2 0.3 0.5 0.7 0.1 0.3 0.0 0.7 0.2 0.4 0.1 0.9 0.6 0.7 0.2 0.5 0.6 0.2 0.0 0.0 0.0 0.8 1.4 0.0 0.9 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.9 0.4 0.0 0.8 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.7 0.2 0.2 0.1 0.6 0.3 0.2 0.0 0.8 0.7 0.2 1.7 0.5 0.2 0.5 0.2 0.1 0.0 0.0 0.0 3.4 0.5 0.0 0.3 0.0 10.7 2.3 0.0 0.0 0.3 0.0 0.2 3.3 0.0 1.4 0.0 0.2 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.1 2.6 TMTC2 DKFZp762A217 ENSG00000179104 "Transmembrane and tetratricopeptide repeat containing 2" Q8N394 12 82686880-83134870 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 30.2;Melanocytes: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.1;myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.6;WM-115: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026954, HPA026955" Uncertain Approved "Plasma membrane,Actin filaments" No No "Plasma membrane" "Actin filaments" "HPA026954: AB_2256025, HPA026955: AB_10602282" "unprognostic (1.56e-1)" "unprognostic (5.62e-2)" "unprognostic (9.61e-2)" "unprognostic (7.38e-2)" "unprognostic (2.60e-2)" "unprognostic (3.66e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (7.16e-2)" "unprognostic (1.73e-3)" "unprognostic (5.06e-2)" "prognostic favorable (2.84e-5)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.06e-2)" "unprognostic (8.06e-2)" 4.7 1.7 9.1 8.9 19.7 2.9 5.9 8.1 15.7 8.1 12.5 27.3 15.2 4.6 8.5 7.4 11.4 15.4 11.9 3.1 13.4 8.7 10.6 1.7 9.6 2.8 17.6 15.3 3.1 6.6 6.5 4.7 5.1 14.3 9.9 9.1 2.5 8.3 30.3 2.0 7.4 6.2 10.4 22.5 2.2 13.1 4.6 18.0 0.4 7.9 1.1 4.3 10.5 11.5 0.8 2.6 0.0 3.1 0.0 0.3 0.9 0.8 3.3 16.6 0.1 2.2 2.1 1.5 1.0 0.3 0.9 0.1 0.2 1.7 0.0 0.3 5.9 0.6 1.4 4.8 2.5 0.2 3.7 2.8 0.0 2.5 0.1 0.2 1.1 0.5 0.6 2.2 0.1 0.8 1.7 1.4 1.8 0.0 2.2 0.2 1.7 0.8 4.3 0.6 3.0 2.8 0.0 0.7 0.3 1.5 7.2 4.4 8.0 1.5 2.4 10.8 3.0 2.5 0.2 0.8 2.9 0.9 3.7 1.3 4.1 2.8 0.6 0.6 1.9 40.4 0.0 3.1 0.0 0.1 1.0 0.3 0.8 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 9.1 19.7 8.1 11.6 13.4 8.7 17.6 15.3 14.3 18.0 8.9 6.2 2.4 14.8 12.8 30.2 1.1 15.3 10.7 15.9 14.0 7.9 9.2 0.0 3.9 5.6 8.0 2.6 0.0 7.1 1.6 7.9 11.3 0.0 1.0 1.8 7.9 2.4 1.3 9.8 4.0 5.5 5.5 30.4 1.8 8.2 12.1 8.1 2.9 1.1 1.4 1.6 6.5 2.1 0.4 0.9 10.0 3.4 1.3 4.8 12.8 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Cell type enhanced" "Detected in many" 6 "Ito cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016489, HPA057056" Approved Approved Vesicles NA NA Vesicles "HPA016489: AB_1858157, HPA057056: " "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 5.0 4.3 22.2 11.7 2.9 6.0 24.9 2.9 2.5 2.7 2.2 4.3 9.3 15.0 9.6 2.4 5.2 3.6 6.9 3.0 3.3 8.5 4.9 6.3 8.0 6.7 3.1 8.2 0.1 8.4 5.9 1.0 5.0 7.6 12.1 8.2 4.7 1.9 3.2 4.4 5.9 4.7 6.0 14.8 4.2 6.5 3.9 3.3 11.2 3.9 11.4 11.9 5.5 10.8 2.8 14.0 7.9 23.2 18.9 2.4 4.2 2.2 4.9 5.0 4.1 2.9 11.9 5.4 7.1 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 6.0 3.8 4.6 6.6 2.7 17.6 9.0 17.8 6.7 6.8 5.2 7.9 9.1 1.7 9.8 4.1 4.6 7.9 0.0 16.4 15.9 5.7 9.1 0.0 12.4 3.8 25.4 10.3 52.2 8.7 4.7 3.7 4.1 3.3 0.0 11.2 9.6 12.0 7.0 6.3 12.4 7.5 6.5 4.2 8.8 31.8 5.1 2.6 2.6 12.6 4.7 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103123442-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 414.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 25.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 128.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 27.3 17.0 3.8 58.2 5.7 20.1 19.3 2.5 3.6 23.5 12.9 2.8 4.7 8.1 16.7 18.7 35.5 14.3 30.9 12.7 2.9 3.6 18.8 13.6 32.0 17.9 4.6 3.0 9.7 9.0 17.4 3.5 33.0 6.1 21.7 6.1 16.3 25.1 7.1 12.5 13.2 11.3 28.0 3.8 35.9 8.3 13.0 2.9 11.0 8.5 31.4 48.6 39.8 16.3 0.1 5.0 25.9 9.8 0.1 0.1 1.9 5.5 27.4 0.2 0.1 1.8 7.9 9.2 1.6 7.0 4.4 1.5 0.3 24.9 0.0 20.5 8.0 23.4 17.7 1.9 0.0 2.1 0.9 0.1 2.5 19.1 0.1 3.4 1.2 3.4 3.0 0.2 1.4 0.0 1.7 2.3 1.3 2.5 6.0 0.6 0.5 0.0 1.9 1.6 3.2 2.2 1.1 3.1 4.0 14.0 128.9 0.2 0.3 25.2 8.8 0.3 1.0 14.2 8.1 4.7 0.9 2.4 5.1 5.0 5.4 0.4 0.1 6.7 5.6 2.6 2.5 8.8 4.6 0.0 9.8 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 25.9 0.1 6.9 0.2 0.0 1.9 3.8 5.7 2.5 3.6 2.9 3.6 4.6 3.0 6.1 2.9 0.0 33.8 0.5 27.9 25.1 0.6 12.5 40.8 25.4 30.7 26.2 0.0 0.8 0.0 129.0 29.4 40.9 0.4 0.0 39.8 58.7 62.7 91.7 33.4 6.4 46.3 0.0 16.6 22.1 116.0 36.8 7.8 125.1 28.7 414.8 0.0 8.0 86.0 6.5 2.1 5.5 0.4 19.4 41.0 1.1 2.8 29.2 4.0 2.5 0.2 83.4 TNFSF8 "CD153, CD30LG" ENSG00000106952 "TNF superfamily member 8" P32971 9 114893343-114930595 "Cancer-related genes, CD markers, Predicted membrane proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.6;lymphoid tissue: 48.1" "Group enriched" "Detected in some" 4 "B-cells: 4.4;Hofbauer cells: 3.2;Kupffer cells: 6.5;Macrophages: 4.4;T-cells: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Daudi: 34.1;SuSa: 16.1;U-698: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.82e-2)" "unprognostic (6.56e-3)" "unprognostic (7.79e-2)" "unprognostic (6.05e-2)" "unprognostic (2.67e-1)" "unprognostic (5.58e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-1)" "unprognostic (1.70e-1)" "unprognostic (2.02e-1)" "unprognostic (4.75e-2)" "unprognostic (3.01e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-2)" "unprognostic (1.82e-1)" 3.6 1.7 1.1 12.0 1.7 12.7 1.8 0.5 0.9 1.6 2.4 1.4 0.6 0.3 1.1 2.5 1.4 1.5 4.6 2.8 1.1 1.2 1.8 1.4 4.9 48.1 1.6 0.6 0.9 1.1 0.0 0.8 2.2 1.0 1.3 1.9 1.4 3.7 0.9 0.7 1.0 7.0 1.3 2.8 14.9 1.7 1.1 1.0 45.6 1.6 0.8 18.5 3.2 1.3 1.7 7.3 3.9 14.1 1.0 18.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 14.1 0.0 4.1 7.3 13.8 1.0 16.4 9.8 7.3 1.7 18.6 13.5 3.9 1.0 0.9 4.0 5.9 8.7 1.1 1.7 0.5 0.9 1.1 1.2 1.6 0.6 1.0 1.0 0.0 0.0 4.4 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.2 0.0 0.0 1.3 6.5 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.2 0.0 0.0 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.3 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.8 0.3 2.7 0.3 1.0 0.8 0.2 0.8 3.6 2.7 1.2 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 56.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395916-58408701 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 28.3" "Cell type enriched" "Detected in some" 8 "Early spermatids: 116.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076397 Enhanced NA NA "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.5 0.4 0.2 0.2 0.6 0.1 0.5 0.6 0.8 0.5 0.5 0.8 0.0 0.0 0.9 1.8 0.2 0.4 0.5 0.3 0.2 0.2 0.7 0.3 0.4 2.2 0.3 0.0 0.7 1.2 1.1 0.5 0.3 0.6 0.8 0.5 1.7 0.5 0.5 0.2 0.3 0.4 1.4 0.3 0.3 0.6 28.3 0.0 0.0 0.9 0.0 0.6 0.3 0.2 1.0 0.1 0.0 0.1 0.0 1.9 0.4 1.8 0.0 0.5 1.9 0.0 0.0 2.1 0.3 0.0 0.3 0.0 0.0 0.5 1.6 0.2 1.0 0.0 0.3 0.0 0.0 0.0 2.8 0.6 0.5 0.0 0.5 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.2 0.9 0.7 0.3 0.2 0.0 0.9 1.2 0.5 0.8 0.3 2.0 2.2 0.8 0.3 0.3 0.5 3.4 2.3 0.5 0.4 0.5 1.2 1.4 2.8 0.0 0.2 0.4 0.0 0.5 0.0 0.4 0.2 1.5 1.5 0.5 0.0 0.0 0.0 0.4 0.1 0.0 1.0 0.1 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.6 0.6 0.8 0.2 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 116.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.5 0.9 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.4 0.0 0.0 0.0 6.7 0.9 0.4 0.0 0.0 0.2 0.1 TOPAZ1 "C3orf77, FLJ36157" ENSG00000173769 "Testis and ovary specific PAZ domain containing 1" Q8N9V7 3 44241886-44332098 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 9.2" "Group enriched" "Detected in some" 17 "Sertoli cells: 19.4;Spermatocytes: 62.3;Spermatogonia: 44.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047431, HPA051034" Uncertain NA NA "HPA047431: AB_2680045, HPA051034: AB_2681318" "unprognostic (1.68e-1)" "unprognostic (8.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 19.4 0.0 62.3 44.4 0.0 0.0 0.0 0.0 0.0 TOR2A "FLJ14771, TORP1" ENSG00000160404 "Torsin family 2 member A" "Q5JU69, Q8N2E6" 9 127731524-127735317 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071229 Approved "Secreted to blood" NA NA "HPA071229: AB_2732175" "unprognostic (1.67e-1)" "unprognostic (9.19e-3)" "unprognostic (1.47e-1)" "unprognostic (1.27e-3)" "unprognostic (3.04e-2)" "unprognostic (6.97e-2)" "unprognostic (2.43e-3)" "unprognostic (4.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.33e-1)" "unprognostic (6.51e-3)" "unprognostic (1.05e-2)" "unprognostic (6.98e-2)" "prognostic favorable (7.51e-4)" "unprognostic (1.72e-1)" "unprognostic (3.27e-1)" "unprognostic (2.82e-2)" 7.3 10.1 6.2 11.8 6.2 33.3 10.9 11.3 9.1 7.2 13.5 6.1 8.2 16.4 6.3 10.1 9.9 7.9 11.8 5.8 5.8 5.6 10.2 16.2 12.8 22.8 4.9 7.3 7.9 18.3 3.2 8.3 15.0 5.1 7.1 8.4 6.1 9.7 10.2 2.8 8.3 20.9 4.5 4.0 18.9 12.6 16.9 5.6 18.6 8.0 6.8 10.9 7.2 6.3 6.2 26.3 34.5 28.8 10.0 13.1 13.4 4.0 6.2 5.4 6.6 2.7 2.6 7.1 3.1 3.5 4.4 3.5 4.2 6.9 7.5 4.3 2.4 3.4 12.9 1.7 3.5 1.2 11.9 6.1 2.9 5.5 5.1 4.4 5.9 15.4 4.2 6.5 4.1 2.2 2.2 6.3 8.9 8.6 20.6 2.6 22.9 7.5 18.5 4.8 12.9 5.8 12.9 2.5 16.2 4.6 3.8 11.7 4.7 2.6 9.1 2.6 3.1 20.3 11.5 3.9 2.8 3.4 5.1 3.2 13.3 11.4 3.0 3.6 9.6 2.8 8.8 25.3 34.5 13.1 28.8 10.2 4.8 7.6 12.6 26.3 6.2 5.8 10.2 17.1 10.0 26.6 6.1 11.6 13.4 6.2 6.2 11.3 9.1 5.8 5.6 4.9 7.3 5.1 5.6 3.0 6.1 19.7 3.6 1.3 12.3 0.6 12.7 4.0 3.4 3.5 0.0 32.4 1.7 16.6 51.5 3.5 22.2 46.7 24.4 32.1 2.9 4.9 5.7 6.4 49.3 7.9 21.9 14.7 28.1 6.2 10.6 16.9 3.3 16.2 20.3 12.8 13.5 21.0 10.6 7.3 12.1 0.0 3.1 30.4 7.5 1.3 43.4 15.0 18.5 4.0 TP53AIP1 p53AIP1 ENSG00000120471 "Tumor protein p53 regulated apoptosis inducing protein 1" Q9HCN2 11 128934731-128943399 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5" "Cell type enhanced" "Detected in some" 18 "Basal glandular cells: 9.5;Basal keratinocytes: 40.4;Ciliated cells: 14.7;Suprabasal keratinocytes: 28.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;RT4: 3.4;SK-BR-3: 2.3" "HPA044300, HPA048797" Uncertain NA NA "HPA044300: AB_2678888, HPA048797: AB_2680524" "unprognostic (4.12e-7)" "unprognostic (3.00e-2)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-2)" "unprognostic (1.18e-1)" "unprognostic (4.66e-2)" "unprognostic (1.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.94e-1)" "unprognostic (6.57e-6)" "unprognostic (1.10e-2)" "unprognostic (3.71e-1)" "unprognostic (7.75e-2)" "unprognostic (1.78e-2)" 0.1 0.3 0.3 0.1 0.3 0.2 1.6 0.3 0.3 4.6 0.1 0.2 4.2 0.0 0.4 8.9 19.6 3.2 0.1 0.1 0.3 0.6 0.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 1.2 0.1 0.1 3.0 1.2 0.9 22.5 0.2 0.1 0.1 0.1 0.2 0.6 0.1 15.2 0.1 31.5 6.7 0.2 11.0 0.4 0.1 1.9 0.2 0.2 0.3 0.1 0.4 0.0 0.2 0.5 0.7 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.6 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.2 0.0 0.4 0.4 0.5 0.2 0.0 0.1 0.1 1.6 0.0 0.2 1.0 0.0 0.8 0.4 0.6 0.0 0.4 0.0 0.0 3.4 1.2 0.1 0.0 2.3 0.0 0.1 0.7 0.0 0.0 0.8 0.7 0.5 0.4 0.0 0.0 0.4 0.0 0.3 0.1 1.3 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.4 0.2 0.1 1.9 0.2 0.1 0.1 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.5 40.4 0.2 0.2 0.0 14.7 3.4 0.0 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 28.5 0.2 0.0 0.2 2.5 TP53I13 DSCP1 ENSG00000167543 "Tumor protein p53 inducible protein 13" Q8NBR0 17 29566052-29573157 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 41.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (4.90e-2)" "unprognostic (2.50e-3)" "unprognostic (9.31e-3)" "unprognostic (4.94e-3)" "unprognostic (1.05e-2)" "unprognostic (2.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.47e-2)" "prognostic favorable (3.13e-5)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (2.92e-2)" 28.2 10.4 10.2 19.4 10.5 19.6 24.2 4.8 8.2 17.9 17.6 9.3 14.7 27.3 16.3 17.3 9.7 10.2 17.4 28.5 9.8 5.3 20.4 30.2 14.6 22.9 13.8 5.6 16.1 33.3 8.7 30.2 21.9 8.8 17.1 5.6 11.2 15.4 13.9 14.5 8.8 27.1 15.7 10.3 24.3 25.1 33.5 12.0 13.3 18.9 7.3 12.4 15.2 16.3 9.7 41.6 16.8 5.3 9.4 10.6 5.1 9.7 26.6 8.2 23.3 14.0 9.6 14.9 16.2 7.5 10.0 10.8 11.0 4.0 6.8 17.9 10.0 14.2 23.9 3.8 4.8 1.4 29.5 14.3 4.1 26.5 10.0 12.5 6.8 12.6 8.3 6.9 8.8 3.1 6.9 6.0 14.3 5.9 12.7 4.4 15.9 16.7 27.4 3.5 11.5 10.0 31.7 19.5 24.0 9.2 6.4 3.6 11.7 20.3 7.6 7.7 3.1 22.0 29.1 6.8 9.9 15.1 10.5 12.7 26.3 11.5 5.4 17.5 4.2 11.6 16.8 4.3 7.4 10.5 5.3 10.6 9.3 10.2 7.9 9.6 9.7 8.1 7.2 0.3 9.4 3.5 41.6 9.1 5.1 10.2 10.5 4.8 8.2 9.8 5.3 13.8 5.6 8.8 12.0 0.0 4.8 25.1 34.4 12.2 0.6 24.5 7.6 2.7 5.7 38.4 5.9 41.8 6.6 32.4 9.4 11.3 28.2 0.0 25.0 31.8 50.5 24.6 16.1 17.4 24.6 6.4 19.1 10.4 10.5 5.7 31.9 29.3 28.7 33.3 26.3 19.3 27.3 28.8 17.7 14.9 6.8 19.4 15.6 62.6 38.7 6.5 18.9 27.7 26.9 31.5 TP53TG3 "P53TG3, TP53TG3A" ENSG00000183632 "TP53 target 3" Q9ULZ0 16 32673528-32676732 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.9;placenta: 1.4;testis: 4.3" "Cell type enhanced" "Detected in single" 34 "Early spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.4;HMC-1: 1.5;SK-MEL-30: 1.2;SuSa: 1.1;U-2 OS: 1.6" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3B ENSG00000261509 "TP53 target 3B" Q9ULZ0 16 33360274-33363478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "epididymis: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 3.6;K-562: 2.1;SH-SY5Y: 2.0" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3C ENSG00000205457 "TP53 target 3C" Q9ULZ0 16 33193659-33196858 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 3.0;epididymis: 4.3;testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;REH: 1.1" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.1 0.1 0.8 0.1 1.3 0.1 0.1 3.0 1.3 0.1 0.1 0.1 0.1 4.3 0.3 0.1 0.1 0.1 0.6 1.3 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.3 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 2.0 0.1 0.1 3.9 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3D ENSG00000205456 "TP53 target 3D" Q9ULZ0 16 32252719-32255922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 8.7;testis: 5.1" "Group enriched" "Detected in some" 5 "Early spermatids: 53.8;Late spermatids: 17.1;Spermatocytes: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.5;HEL: 3.2;HMC-1: 4.0;RH-30: 3.1;SCLC-21H: 3.4;U-2 OS: 3.6" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (5.98e-3)" "unprognostic (1.47e-2)" "unprognostic (2.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" 0.1 2.0 0.9 0.2 1.5 0.0 0.1 3.3 1.8 0.0 0.1 0.1 0.4 8.7 0.8 0.3 0.1 0.6 0.6 1.8 0.0 0.0 0.1 0.2 1.0 0.2 0.0 0.0 0.6 1.0 0.7 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.1 5.1 0.2 0.0 0.0 0.4 0.8 0.0 0.7 0.4 0.0 0.6 1.5 0.6 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.5 0.2 0.0 0.0 0.1 3.1 0.3 0.0 0.0 3.4 1.0 0.0 0.0 0.9 0.6 0.8 0.0 0.0 0.3 3.6 0.6 0.0 1.7 0.8 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.5 0.1 0.7 0.0 0.2 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 1.1 0.0 5.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.0 6.5 0.0 29.4 5.0 0.1 0.0 0.0 0.0 0.0 TP53TG3E ENSG00000275034 "TP53 target 3 family member E" Q9ULZ0 16 33303739-33306935 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;placenta: 1.6;salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "A549: 1.5;AN3-CA: 3.2;SH-SY5Y: 1.3;U-266/70: 1.1" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 1.2 0.0 1.5 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3F ENSG00000278848 "TP53 target 3 family member F" Q9ULZ0 16 33459045-33462249 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 21 "epididymis: 11.6;testis: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.4;EFO-21: 1.8;HEL: 3.5;HMC-1: 2.1;K-562: 1.9;RPMI-8226: 1.6;U-2 OS: 2.6;U-266/84: 3.7" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.7 0.5 0.0 0.0 0.5 2.6 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TPGS2 "C18orf10, DKFZP586M1523, HsT3006" ENSG00000134779 "Tubulin polyglutamylase complex subunit 2" Q68CL5 18 36777647-36829216 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 400.9;Late spermatids: 769.5;Spermatocytes: 273.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040596, HPA040617" Uncertain NA NA "HPA040596: AB_10796458, HPA040617: AB_10794037" "unprognostic (6.51e-3)" "prognostic favorable (4.09e-4)" "unprognostic (5.82e-2)" "unprognostic (1.18e-1)" "unprognostic (5.05e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.78e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.93e-5)" "unprognostic (2.50e-2)" "unprognostic (1.33e-3)" "unprognostic (7.19e-3)" "unprognostic (2.51e-2)" "prognostic favorable (7.74e-4)" "unprognostic (4.03e-2)" "unprognostic (5.28e-2)" 16.3 21.1 27.6 10.4 31.1 22.3 20.9 15.2 38.3 18.3 14.9 26.0 7.2 10.2 14.8 13.1 22.2 21.8 16.7 21.9 23.9 36.0 18.5 10.1 18.4 13.7 43.8 19.9 27.4 15.3 15.9 8.4 13.3 42.1 13.9 16.1 21.8 12.4 14.3 5.5 17.5 12.8 18.6 35.7 9.5 12.2 72.2 14.0 37.0 19.7 10.3 23.7 22.3 15.2 13.1 13.3 57.4 16.6 14.3 27.0 15.2 29.7 23.5 45.7 39.8 22.9 25.1 19.2 32.9 45.0 46.5 56.4 11.3 21.5 29.3 23.0 65.7 29.4 29.7 37.6 46.2 55.0 38.2 12.8 20.5 43.0 30.5 23.6 26.3 18.4 33.4 24.1 41.3 21.4 44.8 55.2 30.7 29.5 21.8 60.9 17.7 41.7 15.5 27.6 13.2 15.4 31.3 42.3 35.6 51.2 29.2 32.2 35.3 49.4 12.9 14.4 41.8 24.7 25.5 30.8 47.0 17.4 6.6 26.2 27.8 26.2 34.7 37.7 21.5 26.1 57.4 13.4 25.6 14.2 14.7 14.0 13.1 16.6 14.6 13.3 9.5 12.6 14.3 4.1 14.3 16.6 10.6 27.0 15.2 27.6 31.1 15.2 38.3 23.9 36.0 43.8 19.9 42.1 14.0 41.7 25.9 27.4 33.2 25.6 18.1 14.8 53.5 60.2 46.6 24.4 7.9 68.2 61.3 109.7 400.9 22.4 15.8 70.0 68.2 126.5 48.1 17.0 18.5 17.4 70.3 7.9 19.0 32.5 26.5 769.5 33.9 27.0 30.4 69.5 19.0 19.7 79.7 24.6 46.3 33.5 21.0 32.3 28.3 273.9 121.6 34.9 26.2 29.8 42.2 32.1 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.3;lymphoid tissue: 32.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 35.7;Early spermatids: 102.2" "Cancer enhanced" "Detected in many" "breast cancer: 7.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.8;Karpas-707: 4.5;OE19: 21.7;U-266/70: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 16.1 1.0 0.3 0.9 0.8 0.0 14.4 1.7 0.8 19.7 1.2 0.1 1.0 0.0 5.0 1.6 43.3 5.2 1.6 2.4 0.2 0.2 0.6 5.1 2.7 0.3 0.3 0.5 1.9 0.3 0.0 0.8 1.0 0.5 2.5 0.0 0.8 3.7 0.7 5.0 14.5 0.5 1.9 0.3 0.7 0.4 2.6 0.3 7.9 0.8 25.5 32.9 2.3 17.8 0.2 0.7 1.3 2.3 0.0 6.3 1.3 0.8 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.1 1.0 2.1 1.2 3.3 0.1 0.5 0.2 0.0 0.0 0.0 8.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.6 21.7 0.3 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.7 3.9 0.6 0.0 0.1 0.3 0.0 0.3 4.2 3.3 0.3 0.1 0.0 0.1 0.0 2.3 0.0 6.0 1.8 0.9 0.2 4.9 6.3 0.7 0.0 1.0 2.5 1.3 0.0 1.6 0.1 5.4 1.3 0.3 0.8 1.7 0.8 0.2 0.2 0.3 0.5 0.5 0.3 35.7 1.7 5.7 16.1 4.9 0.2 0.7 0.0 1.4 10.3 0.0 0.0 0.3 0.0 0.3 102.2 0.7 0.0 0.0 0.5 0.2 1.4 1.5 1.1 6.6 5.0 0.0 0.0 0.0 1.9 7.8 6.6 2.2 0.0 0.0 0.0 0.0 4.6 0.0 2.8 0.0 0.0 0.0 0.7 1.2 1.1 5.1 0.2 13.4 0.2 5.1 TPSD1 ENSG00000095917 "Tryptase delta 1" Q9BZJ3 16 1256059-1258998 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 17 "granulocytes: 189.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 65 "basophil: 6.4" "Lineage enriched" "Detected in single" 65 "granulocytes: 6.4" "Group enriched" "Detected in some" 48 "HEL: 18.7;HMC-1: 28.6" "CAB002215, CAB032871, HPA040182, HPA049554" Supported "Intracellular and membrane" NA NA "CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815" "unprognostic (5.99e-2)" "unprognostic (3.00e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "unprognostic (8.97e-3)" "unprognostic (1.15e-4)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" "unprognostic (9.00e-2)" "unprognostic (2.88e-1)" "unprognostic (4.30e-1)" "unprognostic (2.94e-2)" "unprognostic (2.50e-3)" "unprognostic (3.74e-2)" "unprognostic (4.14e-1)" "unprognostic (3.89e-1)" "unprognostic (7.46e-3)" 6.6 0.1 0.6 3.8 0.6 0.8 3.7 0.6 0.8 3.2 5.6 0.6 0.6 2.7 7.5 3.3 7.6 2.3 13.0 2.0 0.6 0.0 1.3 2.3 17.0 13.7 0.6 0.6 0.6 0.9 0.1 0.6 0.9 0.6 4.3 0.4 3.1 3.6 0.7 1.6 7.8 9.3 4.7 0.6 0.6 15.7 3.5 0.6 1.6 1.1 2.8 2.6 8.9 6.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.1 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.8 0.6 0.0 0.6 0.6 0.6 0.6 3.0 11.4 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 189.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TPSG1 "PRSS31, TMT" ENSG00000116176 "Tryptase gamma 1" Q9NRR2 16 1221651-1225257 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 16.0" "Cell type enriched" "Detected in some" 6 "Mucus-secreting cells: 264.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HMC-1: 22.8;MCF7: 7.4" "Not detected" "Not detected" HPA060458 Enhanced NA NA "HPA060458: AB_2684283" "unprognostic (1.86e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-3)" "unprognostic (1.27e-1)" "unprognostic (5.58e-2)" "unprognostic (1.18e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-2)" "unprognostic (9.97e-2)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.76e-8)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (8.65e-4)" "unprognostic (5.70e-2)" 1.3 0.6 0.4 4.5 0.4 0.0 3.1 0.4 0.4 0.6 14.4 0.4 0.4 14.0 1.2 0.4 0.7 0.5 1.0 0.4 0.4 0.0 0.4 0.4 0.6 0.4 0.4 0.4 2.0 0.4 0.0 3.2 0.4 0.4 1.1 8.8 0.4 0.4 0.4 0.4 1.1 16.0 1.2 0.4 0.4 1.0 1.3 0.4 0.4 0.4 1.1 0.4 1.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 264.6 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Group enriched" "Detected in some" 14 "Spermatocytes: 282.4;Spermatogonia: 73.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA049690: AB_2680850, HPA068342: AB_2685976" "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 7.0 0.0 5.1 0.0 0.0 1.2 0.0 5.2 0.0 0.0 9.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 8.9 0.0 0.0 0.0 2.0 4.6 2.4 0.0 8.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 12.9 0.0 282.4 73.0 0.0 0.9 0.0 0.0 0.0 TRABD2A "C2orf89, TIKI1" ENSG00000186854 "TraB domain containing 2A" Q86V40 2 84821650-84907008 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 450.4;Late spermatids: 221.7;Undifferentiated cells: 92.9" "Group enriched" "Detected in many" 9 "colorectal cancer: 14.4;stomach cancer: 3.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 29.3" "Lineage enriched" "Detected in many" 17 "T-cells: 29.3" "Cell line enhanced" "Detected in many" "BEWO: 24.7;HDLM-2: 18.6;HSkMC: 13.3;hTEC/SVTERT24-B: 10.9;SiHa: 10.6" HPA045817 Approved "Intracellular and membrane" NA NA "HPA045817: AB_2679460" "unprognostic (7.49e-3)" "unprognostic (3.35e-1)" "unprognostic (3.08e-1)" "unprognostic (3.29e-2)" "unprognostic (3.82e-5)" "unprognostic (2.46e-2)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.68e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.47e-4)" "unprognostic (4.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.41e-3)" "unprognostic (1.37e-1)" 1.8 0.5 0.7 24.7 1.6 2.1 6.3 0.6 3.7 0.5 23.2 0.9 0.0 2.4 0.5 0.4 0.5 1.3 0.2 0.7 0.9 0.8 0.9 0.9 3.0 11.3 0.9 3.1 23.7 0.4 0.4 0.6 2.0 0.2 0.5 26.6 1.2 3.3 0.0 0.3 1.2 9.3 1.8 0.9 3.1 0.6 0.6 0.0 6.4 0.7 0.0 6.3 0.7 0.7 1.7 0.6 0.5 0.1 1.3 29.3 5.3 0.7 0.6 0.2 0.1 7.3 7.9 24.7 1.2 1.9 3.6 6.5 0.3 2.8 0.0 0.3 3.8 6.6 0.0 1.7 0.3 5.3 18.6 0.4 0.0 5.2 0.0 0.9 0.0 0.0 13.3 0.0 10.9 4.8 0.8 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 1.2 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.2 0.0 0.1 0.2 3.5 0.5 0.0 1.2 2.2 0.0 0.0 3.1 2.0 0.0 0.0 0.1 0.0 3.3 0.1 4.0 0.3 13.1 5.0 0.6 1.7 29.3 18.2 0.5 1.3 0.0 0.6 8.5 5.3 0.7 1.6 0.6 3.7 0.9 0.8 0.9 3.1 0.2 0.0 3.0 11.2 8.2 0.7 0.9 1.2 59.0 0.0 1.4 1.2 0.0 0.0 8.6 0.0 0.0 450.4 4.5 20.6 0.0 0.8 36.4 2.4 0.5 2.3 0.0 2.5 0.0 12.2 1.8 0.6 221.7 4.6 3.6 3.3 18.0 53.4 0.0 0.5 56.1 2.5 1.1 0.0 6.5 1.0 3.2 4.3 0.5 3.7 8.7 92.9 0.3 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 6.9;Horizontal cells: 4.8;Spermatogonia: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.6;U-138 MG: 11.8;U-266/70: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044560 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 2.1 4.3 7.8 1.1 10.0 0.3 7.3 5.6 14.9 4.6 1.8 9.4 0.0 0.9 3.4 10.5 1.6 6.8 3.1 2.2 8.8 8.6 11.9 0.5 2.9 1.0 8.5 5.9 4.1 5.0 0.6 8.5 1.2 10.3 7.5 2.2 4.5 2.5 4.7 0.7 4.1 1.1 3.6 10.3 1.2 3.2 5.9 7.4 0.0 8.4 0.3 0.9 3.2 1.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 1.4 1.0 4.5 2.2 0.0 0.0 0.0 0.6 0.5 0.9 2.7 0.1 5.2 0.0 0.5 1.2 5.8 0.1 2.1 2.4 3.7 0.0 0.1 1.2 1.2 0.6 1.3 1.3 0.0 4.9 2.1 1.1 0.0 3.8 0.0 0.0 0.0 2.7 7.3 0.3 2.3 0.0 0.3 0.0 1.1 0.0 5.8 0.0 0.8 0.3 2.6 9.6 0.0 3.8 4.4 2.5 6.5 1.4 3.1 11.8 5.2 0.1 1.8 9.6 2.1 0.0 4.5 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 7.8 10.0 5.6 13.9 8.8 8.6 8.5 5.9 10.3 7.4 0.0 1.0 0.0 0.2 0.8 6.9 0.6 0.0 4.0 2.3 1.8 3.9 1.7 1.7 2.1 0.1 1.0 0.0 0.0 0.6 0.2 2.2 0.2 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.1 3.1 0.3 0.0 1.8 1.8 2.9 0.0 0.9 1.7 5.1 1.3 0.2 0.0 0.0 0.0 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826820-36945098 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 14.9;Enterocytes: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 42.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 42.3" "Cell line enhanced" "Detected in many" "Daudi: 38.8;HMC-1: 15.6" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 4.1 3.6 4.5 10.4 11.2 6.9 4.7 21.5 12.0 8.5 14.2 1.7 3.1 8.6 12.3 4.5 3.1 19.3 7.3 4.1 3.3 3.9 3.2 7.9 6.2 13.9 2.9 6.6 9.0 2.8 5.0 3.8 3.7 6.0 7.9 10.9 4.4 4.9 5.0 2.6 2.9 23.1 10.5 3.2 9.9 6.0 2.9 1.7 15.1 5.8 1.1 16.2 9.8 6.0 5.2 0.5 42.3 1.3 2.8 5.7 0.9 0.7 0.9 0.2 0.0 2.4 9.7 0.0 0.7 5.1 2.3 4.5 0.0 3.9 38.8 1.6 2.9 7.7 0.2 0.1 0.5 0.4 1.9 0.0 6.3 2.6 0.0 3.1 1.7 15.6 3.2 2.0 1.7 0.1 0.5 2.8 4.2 5.0 5.6 1.7 0.0 4.9 0.7 0.2 0.0 1.0 1.4 0.1 0.7 0.8 1.7 0.3 0.0 3.9 1.0 0.3 0.4 0.6 2.2 1.9 1.8 0.7 0.1 0.6 5.5 1.1 8.6 0.3 1.4 0.2 2.5 0.6 3.9 5.6 0.9 4.2 4.0 4.8 5.7 0.5 5.2 4.4 4.2 42.3 2.8 1.3 0.0 4.0 0.9 4.5 11.2 21.5 12.0 3.3 3.9 2.9 6.6 6.0 1.7 14.9 5.6 3.9 1.2 0.7 1.1 2.4 2.5 5.3 4.5 3.5 2.0 1.0 0.0 2.2 0.2 3.3 15.2 0.0 1.6 1.1 3.0 1.9 5.8 13.9 4.2 0.0 5.2 6.2 6.3 0.0 4.0 3.6 5.0 1.0 8.8 1.4 3.0 12.2 5.6 0.6 0.7 0.0 1.7 0.2 0.2 0.6 0.6 13.8 3.8 1.4 TREML4 TLT4 ENSG00000188056 "Triggering receptor expressed on myeloid cells like 4" Q6UXN2 6 41228324-41238882 "Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 5.4;neutrophil: 10.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.3" "Cell line enriched" "Detected in some" 4 "HEL: 4.6" HPA065044 Uncertain "Secreted - unknown location" NA NA "HPA065044: AB_2685411" "unprognostic (1.49e-1)" "unprognostic (1.51e-1)" "unprognostic (5.58e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (9.50e-3)" "unprognostic (1.18e-4)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (5.26e-2)" "unprognostic (1.21e-2)" 0.3 0.1 0.1 1.2 0.3 3.1 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.2 0.1 0.2 3.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.4 9.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 1.3 0.9 10.3 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.5 1.3 0.0 0.0 10.3 0.0 0.4 0.9 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRHDE "PAP-II, PGPEP2, TRH-DE" ENSG00000072657 "Thyrotropin releasing hormone degrading enzyme" Q9UKU6 12 72087266-72670757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;pancreas: 19.4" "Group enriched" "Detected in some" 4 "Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7" "Cancer enhanced" "Detected in some" "renal cancer: 1.9" "Region enhanced" "Detected in many" "cerebellum: 30.3" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 6200000 "unprognostic (3.56e-2)" "unprognostic (4.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.44e-6)" "unprognostic (1.77e-1)" "unprognostic (6.37e-2)" "unprognostic (7.79e-2)" "unprognostic (6.96e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (5.14e-4)" "unprognostic (2.40e-1)" "prognostic favorable (1.53e-7)" "unprognostic (2.55e-2)" "unprognostic (2.48e-1)" "unprognostic (8.91e-3)" "unprognostic (2.94e-2)" 6.2 2.2 2.9 1.0 4.7 1.0 7.6 30.3 12.3 10.2 2.4 0.1 2.5 4.8 2.7 1.7 0.9 2.5 2.5 2.2 7.3 2.8 9.9 1.5 3.0 0.6 1.2 5.5 6.5 19.4 0.4 1.6 0.7 1.5 5.5 1.5 1.0 2.4 5.8 0.7 0.8 4.2 1.2 0.9 4.8 1.1 1.7 0.5 0.0 0.5 0.4 1.0 2.8 7.6 0.2 0.0 1.0 0.3 0.3 0.0 0.0 2.4 0.0 0.4 0.0 1.1 0.0 6.7 20.8 20.2 2.0 1.4 0.0 0.0 0.0 10.9 3.0 2.1 0.2 3.8 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.6 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 6.9 4.6 2.0 0.0 0.0 0.0 0.0 0.4 0.0 4.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 2.9 4.7 30.3 12.3 7.3 2.8 1.2 5.5 1.5 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 1.4 0.0 1.8 0.0 0.0 3.3 0.0 30.7 0.0 6.9 0.0 2.2 0.3 0.5 0.2 0.0 1.3 0.2 0.0 0.0 0.0 0.0 47.8 27.3 0.3 0.0 0.0 1.5 0.3 2.1 2.9 12.7 7.4 0.6 0.0 0.4 0.1 0.7 0.0 0.1 0.0 0.7 0.1 TRIM16L TRIM70 ENSG00000108448 "Tripartite motif containing 16 like" Q309B1 17 18697998-18736118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.5" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 44.3;HaCaT: 22.6;HeLa: 35.4;OE19: 51.5" HPA066431 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA066431: AB_2685668" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (2.00e-1)" "unprognostic (7.89e-3)" "unprognostic (5.66e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.08e-2)" "unprognostic (5.79e-2)" "unprognostic (6.28e-2)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" 2.8 4.4 2.0 1.0 3.1 0.5 7.1 1.0 3.0 2.2 3.6 1.3 1.0 2.0 1.4 3.2 10.5 3.3 8.1 16.8 2.0 2.5 3.5 2.8 2.4 1.0 4.7 1.0 1.3 1.3 0.1 1.0 1.8 3.1 3.6 1.0 2.1 2.6 3.7 22.5 0.8 1.1 6.5 4.7 1.0 3.0 2.9 1.4 1.0 4.5 12.7 3.4 6.7 11.8 1.5 0.8 0.4 1.4 2.7 2.1 1.8 4.7 44.3 0.2 1.9 5.4 2.2 3.5 0.4 3.7 1.6 3.3 0.8 19.1 0.5 3.5 12.7 8.8 22.6 0.5 1.0 0.8 0.1 0.6 0.3 35.4 0.4 13.3 0.0 0.4 2.3 1.3 2.4 0.9 7.0 0.5 0.4 0.0 0.0 4.3 4.7 0.1 0.5 0.4 51.5 0.9 0.5 2.3 0.0 3.2 2.8 0.1 1.0 5.0 1.0 2.7 0.3 2.3 0.3 9.9 1.1 5.7 1.8 6.3 0.5 0.5 0.0 3.7 0.4 8.4 0.1 0.7 0.4 0.7 1.4 1.0 1.5 1.0 0.6 0.8 1.1 1.6 1.5 0.3 2.7 0.5 0.2 2.1 1.8 2.0 3.1 1.0 1.9 2.0 2.5 4.7 1.0 3.1 1.4 6.0 3.2 0.8 8.5 3.4 2.7 5.5 10.2 8.1 1.2 1.8 7.9 2.0 3.3 9.0 0.5 2.6 0.9 0.0 5.3 3.7 2.5 3.8 3.5 2.5 1.4 3.2 2.4 2.5 3.4 0.7 3.4 2.1 0.0 15.4 3.2 3.5 21.6 0.0 1.8 6.8 2.4 0.0 2.8 3.2 5.6 5.6 0.9 1.3 3.4 6.3 TRIM46 "FLJ23229, TRIFIC" ENSG00000163462 "Tripartite motif containing 46" Q7Z4K8 1 155173787-155184971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4;epididymis: 11.0" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 5.3;Early spermatids: 4.7;Late spermatids: 4.2;monocytes: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055583 Enhanced NA NA "HPA055583: AB_2732599" "unprognostic (1.06e-1)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "prognostic unfavorable (2.61e-7)" "unprognostic (1.75e-1)" "unprognostic (7.26e-2)" "unprognostic (1.59e-2)" "unprognostic (4.65e-2)" "unprognostic (4.09e-1)" "unprognostic (2.88e-2)" "unprognostic (2.18e-3)" "unprognostic (1.24e-1)" "unprognostic (2.29e-12)" "unprognostic (8.58e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.72e-2)" 1.3 1.7 6.0 2.4 12.6 1.7 1.7 21.4 15.5 1.7 1.2 6.5 0.0 1.6 3.4 11.0 1.1 2.9 2.0 1.0 7.8 7.4 1.1 0.9 1.7 2.3 5.1 7.3 1.0 2.1 0.8 4.5 1.1 7.4 1.7 1.4 0.5 0.9 3.6 1.0 1.2 1.8 3.9 5.8 1.8 1.6 2.5 3.5 6.7 0.9 0.0 1.7 1.3 0.8 0.4 0.5 1.5 0.4 0.8 3.0 0.6 2.0 2.8 2.1 0.2 0.4 1.7 0.1 2.1 2.2 2.5 3.0 0.0 1.2 0.9 1.5 2.4 0.5 2.4 0.0 1.0 0.7 5.0 0.9 1.7 3.0 0.1 1.1 0.5 6.2 1.9 0.5 2.6 0.9 6.2 3.8 5.5 0.0 4.4 1.3 1.4 3.3 0.3 7.6 0.3 3.1 5.1 0.2 1.0 0.6 0.0 5.7 13.0 0.9 0.7 1.5 0.8 4.1 4.1 4.5 4.9 1.9 0.3 1.0 4.1 1.6 0.8 5.2 0.8 1.4 1.5 0.1 0.1 1.2 0.4 1.1 0.3 2.1 2.0 0.2 0.4 0.8 1.0 0.8 0.8 0.3 0.5 3.0 0.6 6.0 12.6 21.4 14.2 7.8 7.4 5.1 7.3 7.4 3.5 0.0 0.0 0.0 0.8 0.3 5.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.5 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.8 0.0 1.7 0.6 0.0 4.2 0.3 0.0 0.0 4.6 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.4 0.4 0.0 0.0 1.0 0.0 0.5 TRIM48 RNF101 ENSG00000150244 "Tripartite motif containing 48" Q8IWZ4 11 55262182-55271119 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;skin 1: 2.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enriched" "Detected in single" 5 "SK-MEL-30: 4.4" NA NA "unprognostic (8.04e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49 "RNF18, TRIM49A" ENSG00000168930 "Tripartite motif containing 49" P0CI25 11 89797655-89808575 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "basophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Cell line enhanced" "Detected in single" "U-2 OS: 2.0" NA NA "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49B ENSG00000182053 "Tripartite motif containing 49B" A6NDI0 11 49027501-49038451 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-2 OS: 3.4" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49C TRIM49L2 ENSG00000204449 "Tripartite motif containing 49C" P0CI26 11 90031106-90042025 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 1.3;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "basophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Group enriched" "Detected in some" 19 "CACO-2: 3.2;U-2 OS: 3.7" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "blood: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 199 "basophil: 19.8" "Lineage enriched" "Detected in single" 199 "granulocytes: 19.8" "Cell line enhanced" "Detected in single" "U-2 OS: 2.1" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "blood: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 160 "basophil: 15.9" "Lineage enriched" "Detected in single" 160 "granulocytes: 15.9" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.5" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 11.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Cell type enriched" "Detected in single" 111 "basophil: 11.0" "Lineage enriched" "Detected in single" 111 "granulocytes: 11.0" "Group enriched" "Detected in some" 124 "SK-MEL-30: 36.0;WM-115: 9.2" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM58 BIA2 ENSG00000162722 "Tripartite motif containing 58" Q8NG06 1 247857199-247878205 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2" "Cell type enriched" "Detected in many" 16 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023637 Uncertain NA NA 310000 "HPA023637: AB_1858309" "unprognostic (3.85e-1)" "unprognostic (5.24e-3)" "unprognostic (7.00e-2)" "unprognostic (6.52e-4)" "unprognostic (1.46e-1)" "unprognostic (3.47e-2)" "unprognostic (1.10e-1)" "unprognostic (4.14e-5)" "unprognostic (3.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (3.31e-1)" "unprognostic (1.08e-2)" "unprognostic (3.34e-1)" "unprognostic (1.00e-2)" "unprognostic (2.57e-2)" 0.7 0.8 1.3 1.0 4.4 24.8 0.7 0.3 3.7 0.6 1.3 0.2 0.0 0.3 0.5 0.4 0.5 1.4 0.5 0.8 1.5 3.2 0.5 0.6 3.4 0.4 2.4 1.2 1.1 0.4 0.3 0.7 22.4 6.9 1.7 1.0 1.1 0.5 0.4 0.5 1.2 0.6 0.8 1.3 5.8 0.7 4.9 0.1 0.0 15.2 0.0 0.4 1.9 0.7 3.1 0.6 3.7 0.7 1.7 0.3 1.9 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 1.0 8.0 0.0 0.0 0.0 0.8 21.4 0.0 0.0 0.0 2.8 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 11.8 0.1 0.0 0.0 0.0 0.1 1.4 0.0 20.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 2.1 0.0 0.0 16.8 0.0 0.0 3.6 0.0 0.0 0.0 6.1 21.8 2.8 0.7 1.8 0.3 0.5 0.2 3.1 0.2 0.2 0.6 1.0 0.3 0.2 3.7 1.7 0.6 0.6 0.2 1.9 1.3 4.4 0.3 3.7 1.5 3.2 2.4 1.2 6.9 0.1 3.0 4.0 1.7 0.6 0.9 2.3 0.4 0.0 6.7 10.3 1.8 11.8 2.4 0.0 0.1 3.1 0.8 0.0 186.9 0.0 3.3 1.5 2.9 8.1 0.0 2.0 0.0 1.2 1.8 2.6 0.5 0.9 1.6 1.7 0.0 0.4 1.5 0.2 0.0 0.7 0.0 3.5 0.0 0.8 2.8 10.9 0.6 4.1 1.3 0.8 0.9 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM61 RNF35 ENSG00000183439 "Tripartite motif containing 61" Q5EBN2 4 164954446-164977668 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.1;thyroid gland: 15.5" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 14.4;Late spermatids: 9.0;Spermatocytes: 18.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HHSteC: 9.7;HSkMC: 6.5;hTERT-RPE1: 5.2;SuSa: 6.9;U-266/70: 12.9;U-266/84: 6.5" HPA049109 Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA049109: AB_2680636" "unprognostic (2.05e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (1.02e-2)" "unprognostic (8.24e-2)" "unprognostic (1.51e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (7.81e-2)" "unprognostic (1.51e-1)" "unprognostic (3.67e-1)" "unprognostic (2.92e-1)" "unprognostic (9.77e-5)" "unprognostic (4.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.36e-1)" "unprognostic (4.32e-2)" 2.4 5.4 1.8 3.0 2.5 3.3 1.6 1.3 2.1 2.6 1.4 1.1 7.2 2.2 2.8 1.9 0.8 3.5 3.1 5.9 2.4 3.0 1.0 1.1 2.1 2.9 2.7 1.3 5.8 0.9 1.5 6.8 1.8 3.8 2.1 1.1 2.9 0.9 1.9 1.2 1.1 1.7 2.1 4.2 4.7 1.5 16.1 1.6 2.7 15.5 0.7 2.8 3.0 5.2 5.5 5.1 3.6 1.3 7.8 4.1 1.5 0.2 0.4 0.9 0.8 0.6 0.6 0.6 2.4 0.8 0.0 0.0 0.3 0.3 0.7 0.2 3.5 0.2 0.3 0.6 0.6 0.4 0.4 0.5 0.2 0.5 0.7 9.7 0.5 0.6 6.5 0.5 2.1 0.2 5.2 0.2 0.3 0.5 1.4 0.3 0.4 0.3 0.7 3.8 0.0 0.0 0.5 0.2 1.0 0.3 0.9 0.8 0.5 0.1 0.3 0.4 6.9 0.3 0.3 0.7 1.2 0.4 0.1 0.2 12.9 6.5 0.4 0.3 0.2 0.3 3.6 1.3 0.1 3.3 1.1 3.4 3.6 1.6 3.3 1.5 5.5 4.1 4.0 0.5 7.8 0.8 5.1 0.4 1.5 1.8 2.5 1.3 2.1 2.4 3.0 2.7 1.3 3.8 1.6 0.0 3.5 2.2 0.6 0.2 0.7 1.7 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.3 14.4 0.3 0.0 0.0 0.6 0.0 0.7 0.3 0.0 0.4 1.0 1.6 0.0 0.0 0.6 9.0 1.1 0.3 0.0 2.8 0.0 2.8 0.1 0.0 1.4 2.5 0.3 0.0 0.3 18.1 3.4 0.0 0.2 2.9 0.0 0.5 TRIM64 "C11orf28, TRIM64A" ENSG00000204450 "Tripartite motif containing 64" A6NGJ6 11 89968502-89975228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 65 "blood: 8.6;placenta: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 86 "basophil: 8.6" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.6" "Not detected" "Not detected" HPA045370 Approved NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM66 "C11orf29, KIAA0298, TIF1D" ENSG00000166436 "Tripartite motif containing 66" O15016 11 8612037-8682694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 38.1;Late spermatids: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027420 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027420: AB_1858316" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.99e-2)" "unprognostic (1.37e-3)" "unprognostic (8.01e-2)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (6.79e-2)" "prognostic favorable (8.89e-4)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.67e-1)" "unprognostic (4.26e-1)" "unprognostic (4.67e-2)" "unprognostic (4.31e-1)" 5.6 8.0 4.1 7.0 12.1 4.5 8.3 10.5 11.3 4.9 6.0 12.5 13.2 6.1 9.9 19.4 6.7 5.7 6.1 3.2 4.4 5.2 5.6 12.9 4.8 8.6 3.5 5.8 5.5 11.3 7.8 17.3 4.1 8.3 5.6 8.3 9.3 5.7 11.3 5.7 19.9 6.9 6.3 5.3 7.7 6.4 19.8 3.7 8.8 9.2 4.5 12.3 5.9 5.3 2.5 3.8 0.9 3.5 1.9 3.3 0.7 5.8 5.3 3.2 11.6 7.1 5.4 4.0 3.6 4.1 2.5 3.3 6.8 11.1 5.7 2.4 3.1 2.3 7.7 3.5 3.1 3.1 6.6 2.7 5.4 8.5 3.7 2.9 4.4 4.5 8.4 3.2 2.2 7.4 2.8 3.3 14.7 3.0 6.1 3.3 6.4 2.3 3.7 1.7 2.9 4.9 3.3 2.5 2.3 3.7 7.1 2.4 2.3 5.2 3.6 2.4 3.4 4.8 1.1 2.6 4.9 4.5 2.7 3.1 2.6 3.9 7.2 3.3 5.2 2.7 0.1 1.4 0.9 1.9 0.4 1.2 1.5 2.1 2.5 2.0 2.5 1.9 3.3 0.7 1.9 3.5 3.8 1.4 0.7 4.1 12.1 10.5 11.3 4.4 5.2 3.5 5.8 8.3 3.7 3.0 3.5 2.2 2.3 1.5 8.8 1.7 7.6 2.7 5.7 5.2 11.8 2.8 0.0 3.2 38.1 1.7 4.2 0.0 2.8 1.5 2.0 1.4 1.1 7.4 2.2 11.1 5.8 5.5 2.4 22.4 1.7 2.7 0.0 5.4 3.3 5.8 3.2 3.5 2.1 1.5 9.2 12.9 1.1 10.2 6.6 1.0 1.1 2.5 4.1 0.9 TRIM67 TNL ENSG00000119283 "Tripartite motif containing 67" Q6ZTA4 1 231162112-231221556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 14.4" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 65.2" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.4;HMC-1: 1.6;HSkMC: 1.4;SCLC-21H: 7.2;SH-SY5Y: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034776 Uncertain NA NA "HPA034776: AB_10603997" "unprognostic (1.56e-3)" "unprognostic (1.54e-1)" "unprognostic (5.20e-2)" "unprognostic (5.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.82e-2)" "unprognostic (6.02e-2)" "unprognostic (4.63e-3)" "unprognostic (1.84e-2)" "unprognostic (1.74e-1)" "unprognostic (4.93e-10)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.30e-2)" "unprognostic (5.10e-3)" 0.3 0.7 1.3 0.2 1.3 0.1 0.1 13.3 14.4 0.2 0.2 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.3 1.2 1.9 0.2 0.1 0.1 0.2 1.5 0.0 0.2 0.2 0.1 1.9 0.4 1.9 0.1 0.2 1.7 0.2 0.1 0.1 0.4 0.3 0.2 0.9 0.2 0.2 0.5 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.0 0.0 7.2 1.9 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 13.3 1.9 1.2 1.9 1.5 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 11.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.9;Hep G2: 13.3" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 1.9 1.6 0.3 1.2 0.9 2.4 1.6 4.0 0.6 2.4 0.6 4.2 1.7 0.3 0.3 3.8 1.0 0.9 0.4 0.5 1.7 2.3 1.1 2.3 0.2 2.3 7.2 1.3 1.7 0.1 2.1 0.0 1.9 1.9 2.6 2.4 2.2 0.0 0.5 1.8 11.5 5.4 2.4 0.2 0.7 1.3 1.3 1.4 2.0 0.8 1.7 2.2 1.3 1.3 4.1 1.7 2.5 0.0 0.9 0.6 0.5 0.1 0.1 1.0 0.0 2.0 2.3 0.4 0.2 0.3 1.4 0.3 0.0 0.2 5.1 7.9 1.5 3.1 13.3 0.9 0.8 5.6 2.3 0.0 0.3 0.4 1.2 0.1 3.3 0.7 6.5 0.0 0.9 2.1 2.7 0.2 0.3 1.4 3.6 0.2 1.2 0.4 0.0 2.1 1.6 2.6 0.9 2.1 0.7 0.6 2.4 1.6 1.1 1.9 1.7 1.1 3.1 1.8 2.4 1.7 3.3 1.5 1.1 0.8 0.7 2.2 0.6 1.2 1.1 1.3 0.4 0.4 1.3 2.1 1.6 2.0 1.7 0.2 1.4 2.0 1.3 0.0 0.3 1.9 2.2 0.8 20.3 2.0 2.5 5.3 3.4 5.2 17.7 1.9 5.0 1.6 5.0 2.2 2.0 0.0 4.0 0.6 1.3 2.7 0.0 1.8 2.5 30.2 4.7 3.1 1.0 8.5 6.1 1.7 1.7 1.0 4.0 9.5 3.1 4.0 3.5 2.9 12.6 0.0 1.1 9.4 2.7 1.8 0.9 4.5 3.3 2.4 TRIM77 TRIM77P ENSG00000214414 "Tripartite motif containing 77" I1YAP6 11 89710299-89717872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" HPA039896 Uncertain NA NA "HPA039896: AB_2676732" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIML1 "FLJ36180, RNF209" ENSG00000184108 "Tripartite motif family like 1" Q8N9V2 4 188139419-188147743 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 94.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.99e-2)" "unprognostic (5.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 94.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.9 0.0 0.0 0.0 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922570 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021281: AB_2670649, HPA052197: AB_2681758" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favorable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 12.2 15.9 13.6 22.5 14.2 20.4 19.3 15.9 14.9 13.5 10.0 19.2 14.9 9.4 15.1 17.3 12.9 15.0 10.6 9.1 13.0 12.3 13.9 17.6 17.9 23.0 14.2 16.3 13.9 13.7 15.7 26.7 10.4 13.3 14.0 11.6 13.4 19.7 11.7 14.1 15.0 14.8 10.1 15.0 20.8 12.8 18.2 14.2 22.8 26.1 10.3 19.1 11.9 10.7 15.8 13.4 28.8 13.7 11.9 25.8 12.0 14.9 9.6 5.2 6.3 6.5 5.4 9.0 7.7 8.8 12.2 9.2 13.3 10.9 9.5 5.3 7.4 13.8 14.2 8.4 6.1 9.6 11.2 6.9 7.6 11.6 11.8 13.6 14.7 12.8 9.5 13.6 6.6 5.7 7.4 5.4 7.6 12.2 12.1 8.4 21.7 6.2 10.2 7.2 16.3 10.8 7.6 11.5 6.9 11.4 12.2 9.4 8.2 5.8 12.2 12.4 4.6 5.3 8.2 8.1 6.8 6.8 14.1 11.5 13.4 9.5 4.8 7.1 7.7 5.9 20.1 12.8 28.8 12.9 13.7 15.9 11.9 19.8 15.5 13.4 15.8 25.8 17.9 20.9 11.9 9.1 7.8 20.2 12.0 13.6 14.2 15.9 14.9 13.0 12.3 14.2 16.3 13.3 14.2 11.9 4.0 7.8 13.4 0.0 8.7 0.0 7.6 10.7 12.5 5.2 0.0 7.7 6.6 7.8 27.5 3.7 2.6 0.0 8.5 6.1 4.1 4.9 0.0 6.4 9.5 6.4 2.4 3.1 8.9 10.5 4.6 2.8 0.0 8.2 7.0 11.6 8.4 7.0 6.7 7.0 4.2 6.5 0.0 14.8 14.5 0.0 15.3 10.2 4.9 6.4 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favorable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.1 0.0 0.0 0.0 1.7 10.2 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.7 1.3 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.6 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.1 0.0 1.1 0.1 0.1 4.8 0.2 5.2 0.1 0.1 0.1 0.2 2.4 0.2 0.0 0.0 0.2 0.9 1.0 0.2 0.4 4.9 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 6.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 26.8 18.2 14.0 0.0 0.9 10.0 0.9 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRNP1 "C1orf225, LOC388610" ENSG00000253368 "TMF1-regulated nuclear protein 1" Q6NT89 1 26993707-27000898 "Predicted intracellular proteins" "Cell cycle, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 81.1" "Cell type enriched" "Detected in many" 12 "Bipolar cells: 375.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 12 "monocytes: 2.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 46.9;BJ hTERT+: 44.5;EFO-21: 37.6;RPTEC TERT1: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.41e-1)" "unprognostic (7.15e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-3)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.53e-1)" "unprognostic (8.39e-3)" "unprognostic (1.64e-1)" "unprognostic (1.90e-1)" "unprognostic (9.71e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.55e-2)" 4.1 4.3 11.3 2.0 11.7 0.9 8.5 12.3 22.0 6.3 5.3 1.8 0.5 3.7 6.8 3.7 32.0 7.9 20.9 11.6 9.7 10.2 9.3 2.6 5.1 2.3 10.1 9.2 3.6 13.2 12.9 5.3 5.8 18.4 5.9 2.6 9.6 6.0 8.1 1.6 4.2 3.7 7.8 2.8 3.0 81.1 2.1 1.7 0.1 2.8 2.4 16.2 9.1 9.3 0.0 0.2 0.0 2.8 0.0 0.0 0.0 6.3 18.7 4.6 2.9 36.2 46.9 0.0 32.7 44.5 3.0 1.4 2.5 3.1 0.0 37.6 30.4 1.2 6.6 2.4 13.2 3.7 0.1 1.9 0.0 0.4 13.0 26.2 0.0 0.0 26.8 28.1 1.5 28.9 2.9 2.9 0.2 0.4 0.0 7.2 0.9 0.0 0.4 6.0 28.7 31.0 1.8 0.0 0.5 37.5 1.9 7.7 0.5 6.3 1.3 14.9 3.0 0.6 0.1 15.3 1.0 7.5 16.0 1.4 0.0 0.1 0.1 1.0 0.1 1.8 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 11.3 11.7 12.3 22.0 9.7 10.2 10.1 9.2 18.4 1.7 17.9 1.1 0.0 10.1 6.5 375.7 21.9 30.6 2.7 3.4 8.7 7.9 0.1 26.6 6.9 0.4 1.0 0.0 0.0 27.2 0.1 1.4 4.0 0.0 0.2 0.2 7.9 11.5 1.8 1.9 0.0 8.9 0.8 3.3 1.8 0.5 27.5 20.3 0.0 2.8 0.0 31.8 25.8 13.3 1.4 0.5 7.8 0.0 0.0 0.2 9.5 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 278.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Cell line enriched" "Detected in some" 4 "HAP1: 19.4" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles NA NA Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.1 0.1 1.3 3.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.4 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.2 0.0 0.0 1.2 4.5 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 1.0 0.0 1.3 0.0 0.2 0.0 0.4 0.2 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 3.0 4.0 0.0 0.9 0.3 9.5 4.8 2.5 1.4 4.5 15.7 62.8 0.0 5.0 0.0 3.9 1.3 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.0 0.2 1.6 14.8 0.6 0.0 1.7 5.2 1.1 0.0 0.0 0.0 278.6 0.1 0.0 8.5 25.8 4.7 0.0 1.0 1.5 0.4 0.6 0.2 0.8 0.0 0.3 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0" "Cell type enhanced" "Detected in single" 14 "Undifferentiated cells: 1.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 2.6;OE19: 3.6;RPMI-8226: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.1 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.5 0.0 0.2 0.5 0.0 4.0 0.0 0.0 6.3 0.0 0.0 0.0 0.5 0.9 3.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 3.6 0.1 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 TSGA13 ENSG00000213265 "Testis specific 13" Q96PP4 7 130668648-130687432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.5" "Group enriched" "Detected in some" 9 "Early spermatids: 62.7;Late spermatids: 126.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0;THP-1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA022968 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA022968: AB_2671013" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.2 0.6 0.8 0.5 0.3 0.1 0.5 0.0 0.0 0.9 0.7 0.2 0.4 0.0 0.2 1.0 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 0.9 0.1 0.3 0.4 0.1 0.2 1.1 0.6 0.2 0.5 0.2 0.3 0.2 0.2 0.1 0.2 0.6 0.5 0.4 1.2 0.8 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.6 0.5 0.1 1.4 1.4 0.0 0.0 10.7 3.4 0.0 7.9 0.1 0.0 0.0 62.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 126.7 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.1 1.2 0.6 0.4 0.6 0.0 0.0 0.0 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798154 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.8" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 427.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 41.4;ASC diff: 70.9;OE19: 44.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted - unknown location" NA NA 2100000 Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (2.87e-4)" "prognostic favorable (1.66e-4)" "prognostic unfavorable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 33.1 2.8 1.0 3.6 1.4 0.6 26.9 1.5 2.0 38.8 16.1 1.8 6.4 11.5 13.2 25.5 17.8 15.3 8.6 9.3 1.2 0.3 31.8 86.8 5.1 3.7 1.7 1.3 27.8 12.2 2.6 4.3 43.0 3.4 15.7 4.5 48.5 9.3 10.8 7.0 15.0 21.4 13.0 0.8 3.0 8.7 9.0 0.8 1.5 12.2 16.0 12.4 18.2 27.9 1.8 0.7 2.1 0.4 0.7 1.3 0.2 0.8 41.4 4.6 4.5 70.9 9.1 8.5 1.4 7.8 3.1 3.0 5.3 11.4 0.1 8.1 5.1 13.2 16.6 2.6 10.2 0.9 8.5 1.4 2.0 10.7 14.8 13.4 0.7 3.1 9.3 11.2 5.5 4.5 5.9 3.8 1.5 4.5 0.3 2.8 19.1 0.1 1.5 6.1 44.7 1.8 1.3 4.4 6.5 7.3 7.2 4.2 6.9 7.9 6.2 3.8 4.1 8.3 0.6 1.1 8.7 6.9 21.1 3.3 0.3 0.1 0.3 4.1 2.1 1.5 1.8 0.4 0.5 0.9 0.2 0.4 1.8 0.8 0.7 0.4 1.8 0.9 1.3 2.1 0.7 0.4 0.7 0.8 0.2 1.0 1.4 1.5 2.0 1.2 0.3 1.7 1.3 3.4 0.8 0.0 0.3 0.0 13.0 15.3 3.2 3.9 15.3 2.7 5.7 1.8 0.0 42.8 0.0 5.8 0.2 3.6 20.6 23.3 19.6 58.8 39.7 6.5 1.1 427.8 8.4 0.0 7.5 8.6 9.5 1.2 34.5 1.6 5.0 2.8 14.2 10.4 17.7 20.1 42.5 21.9 0.5 0.0 13.4 0.4 2.3 19.7 36.6 4.4 11.3 17.0 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996599 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.6" "Cell type enhanced" "Detected in some" 10 "Ito cells: 7.4;Late spermatids: 8.4;Leydig cells: 4.4;Muller glia cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.6;HSkMC: 18.4;NTERA-2: 14.8;SCLC-21H: 7.1;SH-SY5Y: 14.2;SuSa: 9.1" "Low region specificity" "Detected in many" HPA066789 Approved Vesicles NA NA Vesicles "HPA066789: AB_2685723" "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favorable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 3.1 2.5 6.4 16.0 3.8 0.0 2.5 15.2 12.7 9.0 25.6 9.0 3.0 4.4 6.4 7.8 8.8 2.4 12.2 8.8 5.0 4.7 1.6 1.0 8.5 2.6 4.1 3.8 1.9 1.4 0.3 1.5 0.8 3.8 5.4 11.0 12.2 3.8 6.8 0.8 6.5 10.9 8.3 2.6 2.6 4.5 1.6 3.7 0.0 4.0 12.3 8.9 6.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.5 0.0 1.1 1.6 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.1 14.2 0.1 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.8 15.2 4.3 5.0 4.7 4.1 3.8 3.8 3.7 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 7.4 0.0 8.4 4.4 1.1 1.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 0.2 1.0 0.0 0.0 0.0 0.0 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753535-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 24.7;plasmacytoid DC: 51.3" "Group enriched" "Detected in many" 41 "B-cells: 24.7;dendritic cells: 51.3" "Cell line enhanced" "Detected in many" "OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favorable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 20.8 24.2 17.7 7.6 24.9 6.2 25.6 10.7 33.0 18.6 23.6 3.0 21.0 25.2 5.9 12.3 8.8 5.7 16.0 6.8 14.5 21.7 3.3 22.2 53.4 14.8 12.0 15.9 2.1 55.2 4.6 48.0 19.0 14.0 15.1 29.1 8.5 49.1 19.2 4.1 4.7 27.8 5.9 3.6 12.9 31.3 3.1 3.4 3.6 13.0 7.1 18.5 12.1 10.6 24.7 51.3 0.9 0.0 0.8 0.0 1.2 7.1 5.9 7.6 8.0 0.9 0.0 2.1 15.4 2.5 0.4 0.7 20.8 11.1 0.2 3.9 5.5 1.9 11.1 8.7 12.9 3.4 0.2 9.4 3.0 2.4 2.2 2.1 0.2 0.6 0.9 5.6 0.8 0.9 4.4 4.7 3.2 10.0 0.0 0.4 20.4 0.4 0.4 5.3 74.3 7.2 8.2 0.0 7.4 24.0 13.6 34.3 5.2 2.8 49.6 0.7 11.3 92.8 0.8 0.4 0.2 2.7 0.2 5.0 4.5 0.1 0.1 7.1 0.1 10.8 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 24.7 0.0 0.0 0.9 0.8 0.0 51.3 0.0 1.2 17.7 24.9 10.7 33.0 14.5 21.7 12.0 15.9 14.0 3.4 461.6 65.1 58.0 67.1 37.8 65.4 15.8 38.2 25.4 58.0 27.9 7.9 258.0 6.6 62.2 1.0 52.8 83.8 46.7 178.4 88.6 42.3 128.5 9.2 25.9 34.7 14.3 103.4 9.8 15.8 1.8 0.6 4.3 30.4 105.6 362.8 2.3 99.4 94.7 0.7 0.7 7.4 32.3 10.8 0.7 16.8 34.6 168.2 8.7 117.0 107.7 TSPAN16 "TM-8, TM4-B, TM4SF16" ENSG00000130167 "Tetraspanin 16" Q9UKR8 19 11296139-11326996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "blood: 21.8;testis: 46.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 4024.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "basophil: 6.9;eosinophil: 10.8;neutrophil: 21.8" "Lineage enriched" "Detected in many" 16 "granulocytes: 21.8" "Cell line enhanced" "Detected in some" "MCF7: 3.0;THP-1: 1.1;U-937: 3.0" "Not detected" "Not detected" HPA076551 Enhanced NA NA "HPA076551: " "unprognostic (1.06e-1)" "unprognostic (2.82e-2)" "unprognostic (1.73e-2)" "unprognostic (4.74e-3)" "unprognostic (1.53e-1)" "unprognostic (2.06e-3)" "unprognostic (1.37e-1)" "unprognostic (2.21e-1)" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (8.69e-4)" "unprognostic (8.81e-8)" "unprognostic (1.98e-1)" "unprognostic (1.12e-1)" "unprognostic (1.95e-3)" "unprognostic (2.67e-1)" 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.7 0.0 3.0 0.0 0.9 0.3 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.6 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 3.0 0.0 6.9 1.3 10.8 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 21.8 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 855.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4024.1 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 18.6 10.1 0.0 0.0 0.0 0.0 0.0 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved Nucleoplasm NA NA Nucleoplasm "HPA030447: AB_2673484" "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 11.1 29.3 18.7 12.8 12.6 39.1 14.7 18.3 20.9 8.7 14.7 7.1 12.4 13.1 9.0 10.5 16.6 11.2 16.8 16.5 13.3 10.4 16.4 15.0 13.5 19.8 9.2 9.2 8.6 30.5 12.3 19.5 10.3 10.4 12.4 11.8 9.1 11.7 15.8 30.2 11.2 14.6 11.7 6.6 15.7 15.3 18.4 11.2 3.4 11.9 13.7 15.8 14.5 9.4 2.6 3.1 0.8 4.9 3.7 9.3 3.4 16.0 16.3 10.9 19.9 15.2 13.1 17.0 12.1 17.7 17.9 17.9 4.9 18.5 7.2 22.1 20.8 37.0 12.3 5.4 28.1 11.0 53.0 11.4 2.7 7.1 5.8 13.9 5.8 10.1 15.5 15.9 14.2 8.7 12.2 24.5 5.6 13.5 7.8 18.1 26.5 1.2 2.5 8.8 15.7 17.9 6.1 9.3 4.0 16.8 11.9 16.6 11.7 13.1 15.3 16.3 9.5 12.5 7.4 18.9 19.5 20.3 14.6 15.1 4.4 5.7 3.1 21.3 12.4 11.3 0.0 3.1 0.8 5.4 3.1 4.3 1.6 4.1 8.8 3.1 2.6 2.9 3.9 0.5 3.7 4.9 0.8 9.3 3.4 18.7 12.6 18.3 20.9 13.3 10.4 9.2 9.2 10.4 11.2 11.9 9.8 8.2 9.5 2.6 9.7 12.3 12.7 1.4 5.7 10.4 11.8 0.8 5.0 32.2 0.8 7.9 26.0 23.3 49.2 16.3 9.1 11.8 0.0 11.6 13.6 1.6 13.8 12.3 8.9 0.4 6.4 8.6 6.8 14.4 19.4 6.5 35.7 19.5 6.7 11.0 24.8 0.0 8.6 1.1 2.4 4.6 1.0 13.1 20.4 11.9 TSPAN18 TSPAN ENSG00000157570 "Tetraspanin 18" Q96SJ8 11 44726465-44932421 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 24.2;Early spermatids: 32.7;Endothelial cells: 35.8;Ito cells: 55.3;Proximal tubular cells: 23.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 28.1;hippocampal formation: 12.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 3.7;NK-cells: 1.0;T-cells: 3.3" "Cell line enhanced" "Detected in some" "AF22: 14.5;CAPAN-2: 23.9;GAMG: 14.1;HDLM-2: 19.4;NTERA-2: 13.6;RH-30: 15.2;SCLC-21H: 13.0;SH-SY5Y: 14.7;SuSa: 41.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (1.97e-1)" "unprognostic (8.53e-3)" "unprognostic (3.48e-2)" "unprognostic (6.30e-2)" "unprognostic (8.64e-2)" "unprognostic (7.17e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.04e-3)" "unprognostic (6.78e-3)" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-2)" 10.1 22.4 1.4 11.1 2.0 0.3 4.7 28.1 2.7 12.8 21.1 4.5 30.6 3.0 23.6 8.9 15.0 10.6 14.3 40.0 12.2 2.5 13.5 4.1 10.6 4.7 1.7 1.6 17.4 1.0 2.3 3.0 14.3 3.1 15.3 4.9 16.7 2.5 28.0 6.8 2.9 8.0 23.3 2.5 8.0 9.7 2.8 1.8 1.4 7.1 7.4 2.6 14.9 11.9 0.5 0.2 3.7 0.1 1.0 3.3 4.5 0.0 0.2 14.5 0.2 0.0 0.0 0.0 0.2 0.2 0.9 0.0 2.8 23.9 0.0 7.1 0.4 14.1 0.0 2.6 0.0 0.2 19.4 0.9 0.1 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.4 0.0 15.2 0.0 0.0 0.0 13.0 14.7 0.1 0.0 0.0 41.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 3.7 0.3 0.0 2.1 0.5 2.9 1.3 0.0 0.1 3.3 0.5 0.9 1.0 0.0 0.2 0.8 4.5 1.4 2.0 28.1 2.7 12.2 2.5 1.7 1.6 3.1 1.8 0.0 5.9 2.4 0.1 1.4 1.3 24.2 0.0 0.0 0.0 7.0 0.0 0.1 0.0 0.6 32.7 35.8 0.0 0.0 0.2 0.2 9.1 0.1 1.1 0.6 0.4 1.6 0.0 55.3 3.4 4.2 2.6 0.0 6.8 0.0 0.0 0.2 0.4 0.0 1.4 23.1 0.2 0.0 2.1 0.7 0.7 1.0 0.2 0.9 0.0 0.0 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 483.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 20.8 56.9 47.3 29.8 83.1 51.2 15.6 33.4 36.4 41.2 45.1 34.6 43.6 20.5 49.7 34.5 39.4 47.4 44.8 22.9 31.0 22.9 67.9 14.6 43.6 32.7 40.3 18.8 10.8 48.1 27.7 22.7 20.3 63.0 50.4 13.7 15.4 18.1 40.3 7.9 16.6 17.9 33.4 67.0 25.3 21.0 58.8 21.6 67.8 11.9 42.9 47.5 22.9 19.4 62.1 47.4 20.8 35.7 47.7 38.3 15.0 23.0 46.7 39.9 54.2 10.9 33.9 28.2 21.8 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 104.2 182.8 49.0 53.9 30.8 241.7 81.1 112.1 176.7 158.1 64.6 172.8 77.0 21.6 218.3 24.0 52.8 344.7 0.0 309.7 26.2 81.8 155.9 22.0 27.0 57.7 120.8 87.8 60.2 53.5 44.3 59.5 31.1 69.2 23.4 234.6 483.1 209.9 302.5 48.4 50.7 133.3 25.8 63.7 84.0 50.0 29.9 63.5 26.1 164.4 170.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.6 8.8 9.1 2.3 21.0 13.9 5.9 5.8 7.6 3.1 3.1 6.1 19.6 3.3 12.8 13.2 3.8 7.6 2.4 12.2 4.4 8.7 6.5 4.4 7.3 2.5 20.8 4.4 7.8 12.3 14.5 6.0 12.7 9.4 8.1 1.7 3.2 9.6 9.9 7.3 3.4 2.6 1.9 6.6 2.8 4.2 60.0 8.5 12.7 7.4 3.1 7.8 6.2 9.1 4.5 2.2 17.1 6.9 11.1 5.0 4.1 2.7 3.0 11.9 2.6 1.6 13.5 3.0 7.6 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 44.7 25.9 22.0 37.5 10.0 39.9 4.2 22.9 25.4 21.6 29.6 39.3 16.4 8.3 31.1 0.9 23.2 21.6 0.0 34.1 12.3 23.7 26.6 43.9 17.4 19.7 20.6 25.4 20.3 15.6 2.1 23.9 24.1 30.4 24.4 20.3 54.9 31.7 21.0 16.3 15.9 55.1 19.4 23.6 8.7 4.8 11.0 20.5 14.9 21.2 28.5 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.8 0.0 0.1 0.7 6.9 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 9.6 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 0.0 10.7 2.7 0.0 0.8 0.0 13.4 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.9 0.0 29.0 0.0 4.4 0.0 0.0 0.0 6.6 3.5 0.9 13.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.0 23.5 0.0 0.0 TSPEAR "C21orf29, DFNB98, MGC11251, TSP-EAR" ENSG00000175894 "Thrombospondin type laminin G domain and EAR repeats" Q8WU66 21 44497892-44711580 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 14.9" "Cell type enriched" "Detected in single" 4 "Early spermatids: 3.4" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 2.5" "Cell type enriched" "Detected in single" 10 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.6;SH-SY5Y: 5.1;U-2 OS: 3.6" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Region enhanced" "Detected in some" "olfactory region: 2.0" "CAB034203, CAB034204, HPA052995" Uncertain "Secreted in other tissues" NA NA "CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008" "unprognostic (8.61e-3)" "unprognostic (2.45e-1)" "unprognostic (1.86e-4)" "unprognostic (7.87e-3)" "unprognostic (4.08e-2)" "unprognostic (1.00e-3)" "unprognostic (7.92e-3)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-2)" "unprognostic (3.86e-4)" "unprognostic (2.13e-2)" "unprognostic (4.80e-7)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" 0.3 0.1 0.2 0.3 2.5 0.0 0.5 0.2 0.9 0.2 0.2 0.2 0.2 0.7 0.2 0.4 0.2 1.1 0.2 2.7 0.2 0.1 0.5 1.4 1.4 0.8 0.2 0.2 0.2 0.2 2.6 14.9 0.2 1.0 0.2 0.0 0.2 0.2 0.2 0.2 3.9 0.5 0.2 0.2 0.6 0.3 4.6 0.2 0.5 2.8 0.2 0.4 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.2 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 1.1 0.0 0.0 1.1 5.1 0.0 0.1 0.0 0.4 0.1 0.3 1.4 0.0 3.6 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.2 0.9 0.2 0.1 0.2 0.2 1.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018022: AB_2211524, HPA051558: AB_2681534" "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favorable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favorable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 10.5 7.1 8.9 16.6 26.7 13.1 9.6 11.2 12.4 7.3 13.6 12.5 8.6 10.5 9.3 9.2 8.5 9.2 8.9 7.0 9.9 7.9 6.9 9.0 12.2 23.4 13.3 9.3 8.2 13.7 13.5 15.5 9.9 12.6 8.1 21.6 7.9 9.6 9.5 15.6 12.8 15.6 8.4 14.7 21.3 15.6 3.9 13.7 18.4 9.8 6.2 18.9 8.0 9.1 4.2 10.8 7.6 7.7 11.9 10.0 5.1 7.6 7.8 7.7 14.9 7.2 4.7 15.8 11.2 8.8 6.3 7.1 11.4 8.3 14.1 10.3 6.7 6.3 12.3 5.0 4.1 4.2 15.7 15.4 4.2 8.3 7.7 7.6 8.6 3.9 4.1 7.3 5.9 5.5 6.3 11.1 6.1 4.4 8.2 5.8 3.9 4.5 8.2 8.7 25.5 9.7 7.4 11.0 19.6 6.6 5.3 10.6 9.2 8.5 8.8 14.9 3.5 9.4 11.2 5.6 7.5 1.0 10.0 19.7 10.2 16.7 4.3 7.3 5.5 12.2 7.6 7.6 6.8 10.0 5.8 6.8 4.2 7.0 8.2 10.8 3.9 5.7 6.8 2.9 11.9 7.7 7.4 5.4 5.1 8.9 26.7 11.2 12.4 9.9 7.9 13.3 9.3 12.6 13.7 6.0 9.0 9.9 1.2 3.0 4.0 2.5 0.0 0.0 4.5 1.8 5.9 3.7 1.7 4.4 1.4 4.5 2.6 0.0 7.5 4.4 2.8 1.5 9.2 5.9 4.6 11.1 5.8 2.5 7.0 1.7 2.6 7.1 1.7 1.0 10.7 4.0 3.5 8.6 6.3 1.1 10.0 6.5 3.9 2.3 2.4 2.4 1.4 12.8 7.0 1.0 TTC16 FLJ32780 ENSG00000167094 "Tetratricopeptide repeat domain 16" Q8NEE8 9 127716066-127731600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 30.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 54.9;Early spermatids: 91.4;Late spermatids: 218.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "gdT-cell: 3.9;MAIT T-cell: 2.4;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 40 "T-cells: 3.9" "Cell line enhanced" "Detected in some" "JURKAT: 3.1;MOLT-4: 1.7;REH: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.10e-3)" "unprognostic (1.63e-3)" "unprognostic (3.86e-3)" "unprognostic (2.02e-4)" "unprognostic (4.08e-3)" "unprognostic (2.25e-3)" "unprognostic (8.87e-4)" "unprognostic (2.91e-2)" "unprognostic (2.25e-2)" "unprognostic (2.36e-1)" "unprognostic (1.96e-3)" "unprognostic (7.32e-2)" "unprognostic (9.14e-3)" "unprognostic (6.35e-3)" "unprognostic (5.29e-2)" "unprognostic (1.17e-1)" "unprognostic (5.54e-3)" 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.6 0.4 0.0 0.4 0.0 0.0 0.2 1.3 0.0 10.4 0.1 0.0 0.3 0.3 0.2 0.0 2.1 0.4 0.0 0.2 1.3 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 2.4 0.0 1.3 2.8 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.5 0.0 0.6 0.3 0.3 0.0 0.2 0.6 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.0 54.9 9.1 0.0 0.0 0.0 0.0 0.0 91.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 218.9 1.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 3.5 0.2 0.4 0.0 0.0 23.2 1.5 0.0 0.0 0.5 0.0 0.0 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 51.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 41.5;Early spermatids: 60.9;Late spermatids: 68.3;Spermatocytes: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.7" "Group enriched" "Detected in many" 6 "B-cells: 2.7;monocytes: 1.7" "Cell line enhanced" "Detected in some" "Karpas-707: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.9 0.8 2.5 2.2 4.1 0.7 0.8 1.0 2.9 0.9 0.9 2.2 1.9 0.9 1.8 3.0 0.9 2.0 0.7 0.9 2.4 0.8 0.9 0.9 1.0 1.0 0.9 3.6 1.0 2.1 0.9 7.0 0.7 2.9 0.9 0.7 1.4 1.0 0.8 1.0 0.9 0.8 0.6 0.9 0.8 0.9 51.9 1.9 0.0 0.9 0.0 1.6 0.8 0.9 2.7 0.3 0.3 1.7 0.0 0.0 0.1 0.6 1.1 0.3 0.7 0.0 0.7 0.9 1.2 0.9 0.9 0.5 0.0 0.6 2.6 0.0 0.4 0.2 0.5 0.4 1.7 0.2 1.1 0.5 0.1 1.1 0.0 1.3 1.0 0.8 0.9 0.9 0.0 1.3 1.1 0.0 0.7 0.0 3.8 0.0 1.2 0.1 0.4 0.1 0.0 0.0 0.2 0.2 0.4 0.0 1.1 1.3 0.5 1.2 3.0 1.3 0.3 2.9 0.1 0.6 0.3 0.5 2.5 0.5 2.7 0.3 0.2 1.0 0.0 0.6 0.0 0.5 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.3 2.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 2.5 4.1 1.0 2.9 2.4 0.8 0.9 3.6 2.9 1.9 0.0 4.0 3.2 3.9 0.6 3.8 5.6 2.5 41.5 5.7 1.8 7.9 1.2 0.0 1.3 60.9 1.8 2.0 0.0 1.6 1.5 1.7 1.9 1.1 1.0 1.3 4.8 4.1 3.7 1.8 68.3 6.6 2.1 3.3 1.0 2.2 3.1 1.4 2.5 5.6 0.8 13.9 6.5 2.3 73.9 3.4 0.5 3.1 1.3 1.9 2.1 TTC22 FLJ20619 ENSG00000006555 "Tetratricopeptide repeat domain 22" Q5TAA0 1 54779712-54801267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 46.8" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 45.7;Mucus-secreting cells: 19.6;Paneth cells: 38.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.4;CAPAN-2: 10.4;HaCaT: 11.9;hTCEpi: 6.8;OE19: 14.0;RPMI-8226: 7.6" "Low region specificity" "Detected in single" HPA035072 Uncertain NA NA "HPA035072: AB_10602252" "prognostic favorable (2.06e-4)" "unprognostic (8.52e-2)" "unprognostic (4.84e-2)" "unprognostic (4.98e-2)" "unprognostic (1.01e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.02e-1)" "unprognostic (2.60e-1)" "unprognostic (3.07e-2)" "unprognostic (4.57e-2)" "unprognostic (7.27e-2)" "unprognostic (1.51e-3)" "unprognostic (5.08e-3)" "unprognostic (1.00e-1)" "unprognostic (3.16e-2)" "unprognostic (2.21e-1)" 0.3 0.4 1.0 4.2 3.5 0.6 1.5 0.2 0.4 12.1 11.8 0.2 5.1 10.1 1.6 2.4 46.8 2.1 7.7 0.2 1.1 0.6 6.6 6.4 5.0 1.5 0.3 0.5 0.6 5.7 8.2 5.7 0.5 0.6 3.6 7.3 1.0 9.5 3.9 0.1 12.2 27.7 0.3 0.3 1.1 8.7 0.5 0.7 3.0 5.3 18.4 21.0 1.8 18.8 1.2 0.1 4.0 0.1 2.9 6.5 0.7 8.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 10.4 0.1 0.4 0.0 0.0 11.9 0.0 3.5 0.0 3.7 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.1 0.1 14.0 1.1 0.1 0.0 7.6 0.4 2.1 0.3 0.2 0.7 0.1 0.0 0.2 0.3 0.2 0.1 0.2 0.0 0.2 0.1 0.8 2.0 0.1 0.1 0.1 0.0 1.4 0.1 4.0 6.0 0.0 3.6 1.2 2.9 6.5 0.1 0.9 2.5 3.1 2.3 2.9 0.1 0.1 3.9 0.7 1.0 3.5 0.2 0.4 1.1 0.6 0.3 0.5 0.6 0.7 0.0 1.9 0.0 5.9 1.1 0.0 1.8 12.7 2.7 2.3 3.5 0.0 0.2 6.6 4.5 3.0 0.0 45.7 0.0 7.9 0.4 0.2 5.1 0.0 1.8 0.0 0.0 2.4 0.0 0.0 0.4 0.3 0.0 1.7 0.0 19.6 0.0 7.9 38.5 0.0 7.4 0.0 0.0 0.0 0.2 0.6 4.0 0.0 3.5 11.9 11.7 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 89.7;Spermatocytes: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036338, HPA036339" Enhanced Approved "Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles, Intermediate filaments, Cytosol" "HPA036338: AB_10673351, HPA036339: AB_10673386" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 3.5 6.5 6.9 2.5 8.1 3.3 5.6 6.9 8.3 6.1 3.1 4.4 7.4 1.3 6.6 7.6 3.1 20.9 4.5 3.5 5.7 5.1 8.3 1.9 5.1 2.8 2.7 4.8 8.8 3.2 13.0 20.1 3.8 8.4 5.6 2.8 5.4 3.6 5.5 2.3 3.2 2.2 4.6 2.7 2.6 3.1 17.4 3.9 3.8 7.3 2.8 3.1 3.7 3.9 3.6 2.5 5.3 1.5 1.6 2.3 0.9 11.2 8.5 7.5 8.9 9.4 10.9 3.7 5.5 5.7 9.0 9.2 5.4 8.1 2.4 9.2 4.2 14.7 5.6 8.3 6.4 13.1 7.0 7.2 3.0 6.8 4.6 4.7 8.6 2.1 6.2 5.8 13.4 6.1 5.6 6.6 5.9 6.7 1.6 7.1 10.5 14.7 10.1 7.5 3.3 7.5 5.1 8.9 4.0 7.7 3.3 11.0 7.9 13.4 5.7 7.7 2.3 6.9 4.7 4.6 8.4 7.3 7.6 10.0 3.6 4.6 1.8 14.6 4.3 9.8 1.2 0.5 1.2 2.1 0.5 1.1 3.6 1.5 1.4 1.1 2.4 2.3 1.7 5.3 1.6 1.5 2.5 1.0 0.9 6.9 8.1 6.9 8.3 5.7 5.1 2.7 4.8 8.4 3.9 0.0 2.6 2.7 1.7 1.0 6.9 1.7 7.6 89.7 19.4 5.2 11.8 1.0 0.0 4.8 15.8 2.1 0.0 0.0 2.3 2.8 3.1 1.1 5.7 1.7 1.8 0.0 1.2 4.3 0.6 12.2 3.7 2.2 3.3 2.8 0.9 4.5 1.6 2.9 4.9 4.6 16.0 0.0 2.1 40.9 5.7 1.5 0.3 1.7 0.6 0.5 TTC29 NYD-SP14 ENSG00000137473 "Tetratricopeptide repeat domain 29" Q8NA56 4 146706638-146945882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 55.9" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 136.5;Early spermatids: 509.6;Late spermatids: 355.5" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 4.3;pons and medulla: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;hTERT-HME1: 3.2;Karpas-707: 2.3;U-266/70: 4.2;U-87 MG: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA037006, HPA061473" Uncertain NA NA "HPA037006: AB_10670379, HPA061473: AB_2684534" "unprognostic (1.28e-3)" "unprognostic (1.52e-2)" "unprognostic (8.21e-2)" "unprognostic (1.70e-1)" "unprognostic (6.70e-2)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (1.32e-1)" "unprognostic (5.67e-4)" "unprognostic (9.81e-4)" "unprognostic (7.30e-2)" "unprognostic (6.88e-4)" 0.2 0.1 0.9 0.1 4.3 0.1 0.1 0.1 1.2 0.8 0.1 1.7 0.5 0.1 0.3 10.7 0.1 13.3 0.1 0.1 1.5 1.3 0.2 0.1 7.0 0.1 0.3 0.7 2.6 0.1 0.8 0.2 0.1 12.7 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 55.9 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 10.1 0.0 0.0 0.8 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.9 3.2 0.3 0.3 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.2 0.0 0.0 4.2 0.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.1 1.2 1.5 1.3 0.3 0.7 12.7 0.6 0.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 136.5 15.9 0.0 0.0 0.0 0.0 0.0 509.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 355.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 85.1 7.3 0.0 0.0 0.0 0.0 0.0 TTC30A "FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612992-177618966 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.7 4.1 3.8 1.5 7.1 0.4 5.6 2.2 7.1 4.2 3.4 5.9 7.8 2.2 5.0 10.9 2.4 8.4 4.8 4.4 3.7 4.2 6.9 4.6 3.7 1.4 3.6 6.6 5.5 4.4 11.6 8.1 1.9 4.8 3.9 3.3 5.0 8.1 4.0 3.5 1.9 2.5 3.6 3.0 1.7 3.6 24.5 2.1 2.6 9.6 4.6 1.7 3.1 1.7 0.5 1.6 1.9 1.6 0.2 2.7 1.0 5.7 3.3 3.3 0.0 6.7 5.6 2.4 2.8 8.1 5.0 5.3 1.0 4.2 1.3 5.4 4.8 6.8 4.8 2.2 6.1 5.5 0.4 1.8 1.1 1.6 1.4 2.7 1.4 1.3 3.4 4.0 2.8 1.1 4.8 2.3 2.9 0.8 0.5 3.5 2.9 4.4 2.6 1.8 2.0 1.2 2.9 8.8 0.6 6.3 1.5 10.8 7.2 2.5 4.9 3.0 8.1 2.8 1.4 2.1 3.1 1.9 3.4 2.3 2.2 2.1 0.4 7.7 0.1 3.0 0.0 1.3 1.9 0.4 1.6 0.1 0.4 0.1 0.4 1.6 0.5 2.7 1.2 0.7 0.2 1.3 0.6 1.0 1.0 3.8 7.1 2.2 7.1 3.7 4.2 3.6 6.6 4.8 2.1 8.9 1.9 0.0 1.1 0.7 2.2 3.1 2.5 29.4 4.5 7.0 2.0 0.8 1.7 4.1 31.2 1.4 1.7 0.0 3.5 0.7 1.5 1.0 0.0 2.9 0.7 15.9 6.9 4.3 0.3 6.8 2.0 0.2 1.7 0.0 2.5 10.6 2.4 0.0 2.1 3.8 11.3 0.0 0.9 33.6 4.6 0.4 0.2 0.0 2.3 0.3 TTC34 ENSG00000215912 "Tetratricopeptide repeat domain 34" A8MYJ7 1 2635976-2801717 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.5;testis: 4.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 16.9;Late spermatids: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;JURKAT: 1.7;Karpas-707: 1.9" "Low region specificity" "Detected in many" HPA066832 Uncertain NA NA "HPA066832: AB_2685731" "unprognostic (1.45e-4)" "unprognostic (5.00e-2)" "unprognostic (7.09e-2)" "unprognostic (3.25e-2)" "unprognostic (3.55e-2)" "unprognostic (3.52e-2)" "unprognostic (1.70e-1)" "unprognostic (3.93e-2)" "unprognostic (1.98e-3)" "unprognostic (1.71e-1)" "unprognostic (3.69e-3)" "unprognostic (9.93e-2)" "unprognostic (1.95e-1)" "unprognostic (9.16e-3)" "unprognostic (2.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.68e-4)" 0.1 0.2 0.6 0.3 1.2 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.5 0.6 0.0 3.5 0.0 0.0 0.9 0.7 0.0 0.0 0.4 0.1 0.1 0.6 0.0 0.2 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.1 0.5 0.3 4.6 1.5 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.6 0.1 0.7 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.7 0.2 0.0 0.0 0.4 0.8 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.3 0.2 0.0 0.7 0.5 0.2 0.0 0.0 0.2 0.0 1.7 0.0 1.9 0.0 0.7 0.1 0.2 0.4 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.3 0.4 0.1 0.3 0.0 0.6 0.1 0.0 0.2 0.7 0.7 0.1 0.0 0.6 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.0 0.0 0.0 0.4 0.0 3.6 5.3 2.5 4.0 1.2 0.0 0.0 0.1 0.0 0.5 16.9 0.3 0.0 0.0 0.5 0.0 0.2 0.3 4.6 0.0 0.2 0.0 0.0 0.0 0.3 19.7 0.6 0.0 1.7 0.0 0.2 3.4 0.4 0.0 0.0 0.3 4.1 0.0 0.1 1.8 0.7 0.1 0.0 0.0 0.4 0.0 TTC39A "C1orf34, DEME-6, KIAA0452" ENSG00000085831 "Tetratricopeptide repeat domain 39A" Q5SRH9 1 51287258-51345116 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 357.0;Late spermatids: 452.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 23.4" "Lineage enriched" "Detected in single" 46 "dendritic cells: 23.4" "Cell line enhanced" "Detected in some" "HDLM-2: 21.9;MCF7: 17.2;SK-BR-3: 53.6;T-47d: 38.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028098, HPA043440" Uncertain Enhanced Centrosome NA NA Centrosome "HPA028098: AB_10601705, HPA043440: AB_2678483" "unprognostic (5.05e-2)" "unprognostic (1.95e-1)" "unprognostic (3.35e-2)" "unprognostic (7.60e-2)" "unprognostic (8.53e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (8.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.89e-2)" "unprognostic (1.73e-3)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 1.2 4.9 3.2 6.0 5.5 0.6 23.4 0.7 4.3 8.5 18.0 0.2 8.1 3.3 1.4 10.4 10.4 4.5 17.9 8.3 3.3 7.4 40.4 3.1 12.4 0.5 4.2 2.4 0.9 22.3 6.1 12.1 0.9 10.1 12.3 20.2 3.1 10.1 10.7 2.2 5.6 4.5 0.8 4.9 0.3 18.7 28.2 2.0 0.2 5.5 8.5 6.2 5.0 5.0 0.1 23.4 0.5 0.0 0.0 0.0 0.2 2.2 1.3 0.2 0.1 0.1 0.2 9.5 0.1 0.0 0.0 0.0 5.8 0.9 0.0 4.2 0.1 0.1 0.0 1.2 0.0 0.0 21.9 4.4 0.1 0.5 1.1 0.4 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 17.2 0.2 0.0 1.6 11.9 0.2 0.0 0.0 1.4 9.4 2.9 7.9 0.7 0.1 53.6 0.5 0.7 38.8 0.2 0.2 0.1 1.0 0.1 0.1 2.2 2.9 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 23.4 0.0 0.2 3.2 5.5 0.7 4.3 3.3 7.4 4.2 2.4 10.1 2.0 3.0 25.1 1.5 3.8 1.3 1.3 11.3 7.6 10.7 4.5 8.7 0.0 0.4 10.0 31.3 357.0 1.4 9.5 23.3 46.7 4.0 0.6 16.7 3.5 0.6 1.6 0.0 39.7 0.6 0.3 452.0 2.3 0.8 0.0 4.6 53.2 1.7 28.2 8.6 2.5 21.6 6.2 6.5 1.4 6.0 5.9 5.6 2.9 1.3 17.1 11.4 TTC39C "C18orf17, FLJ33761, HsT2697" ENSG00000168234 "Tetratricopeptide repeat domain 39C" Q8N584 18 23992773-24135610 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 92.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 120.1;Hepatocytes: 148.6;Late spermatids: 236.0;Rod photoreceptor cells: 233.7" "Cancer enhanced" "Detected in all" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 35.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065705, HPA065713" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA065705: AB_2685538, HPA065713: AB_2685542" "prognostic favorable (1.48e-4)" "unprognostic (6.37e-2)" "unprognostic (3.66e-1)" "unprognostic (9.97e-2)" "unprognostic (4.37e-2)" "unprognostic (2.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (2.32e-1)" "unprognostic (3.51e-1)" "unprognostic (8.94e-3)" "unprognostic (4.48e-3)" 9.0 14.2 6.2 12.0 4.9 17.7 10.9 5.1 12.2 8.7 6.3 2.4 1.5 5.1 9.8 6.5 9.4 9.0 17.2 3.9 5.3 2.7 3.3 92.2 7.1 14.1 2.2 6.7 5.9 9.8 1.3 13.4 1.5 6.2 9.7 4.6 20.8 11.8 3.9 4.7 24.2 6.2 5.3 2.2 6.7 6.1 14.3 1.0 12.0 3.7 5.7 20.9 8.3 9.3 5.2 8.8 0.5 1.9 5.7 35.5 4.2 6.6 4.9 3.3 2.2 21.1 22.3 12.1 9.5 21.8 7.6 7.8 0.6 3.7 10.9 9.4 16.6 5.7 8.3 6.5 8.3 6.1 16.3 6.7 3.2 23.9 12.3 4.1 17.1 8.5 18.0 11.3 4.3 6.1 14.1 0.5 7.9 0.1 0.1 4.8 5.1 2.8 5.2 8.2 2.9 12.7 15.7 5.0 4.2 7.9 10.1 8.8 7.0 18.4 6.1 5.8 3.6 4.8 6.3 4.2 6.7 5.0 5.1 4.8 0.2 0.0 15.9 9.0 17.9 4.5 0.5 1.9 0.0 11.2 1.9 28.8 5.2 24.9 14.0 2.5 3.3 10.7 9.0 0.5 5.7 1.5 8.8 35.5 4.2 6.2 4.9 5.1 12.2 5.3 2.7 2.2 6.7 6.2 1.0 0.0 4.3 22.3 15.8 40.9 14.4 3.1 53.5 12.0 2.3 7.0 43.2 0.5 0.0 9.7 120.1 3.0 2.2 0.0 10.1 12.5 12.4 19.8 2.3 148.6 11.3 12.7 4.1 4.9 24.7 236.0 10.3 20.8 13.5 1.8 9.0 20.5 8.2 0.0 7.4 1.1 233.7 0.0 8.3 23.8 1.7 75.3 0.5 59.9 4.6 16.7 TTC6 "C14orf25, NCRNA00291" ENSG00000139865 "Tetratricopeptide repeat domain 6" Q86TZ1 14 37595847-38041442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 9.7;prostate: 20.5" "Cell type enhanced" "Detected in some" 14 "Club cells: 18.2;Early spermatids: 30.4;Late spermatids: 14.0" "Group enriched" "Detected in some" 7 "breast cancer: 2.2;prostate cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 7.3;MCF7: 10.7;RT4: 7.5;T-47d: 20.7" HPA069293 Approved Centrosome NA NA Centrosome "HPA069293: AB_2686110" "unprognostic (7.92e-2)" "unprognostic (6.95e-2)" "unprognostic (9.22e-2)" "unprognostic (1.98e-1)" "unprognostic (7.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.68e-1)" "unprognostic (3.60e-4)" "unprognostic (6.75e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-4)" "unprognostic (5.60e-2)" "unprognostic (8.91e-8)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-1)" "unprognostic (6.07e-3)" 0.0 0.0 0.3 1.3 0.6 0.0 9.7 0.3 0.6 0.2 2.2 0.2 0.0 0.6 0.0 1.3 0.6 0.4 1.0 0.0 0.8 0.9 0.0 7.9 5.6 0.0 0.7 0.4 0.4 0.0 0.0 1.1 0.3 0.1 20.5 0.5 0.0 3.0 1.1 0.0 0.8 1.2 2.5 0.6 0.0 3.8 6.0 0.0 0.0 0.0 0.6 2.3 2.2 4.6 0.6 0.2 0.4 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.4 0.0 0.0 2.2 1.2 0.2 0.0 0.0 3.1 0.0 0.9 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 10.7 0.0 0.0 0.0 1.5 4.0 0.0 0.0 0.0 1.0 7.5 2.2 0.0 0.0 4.1 0.0 0.0 20.7 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.3 0.6 0.8 0.9 0.7 0.4 0.1 0.0 0.0 6.7 0.0 2.6 0.0 0.0 0.6 2.5 8.1 18.2 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 2.5 0.0 0.0 7.5 0.0 0.0 14.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.8 2.7 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 25.1 1.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 0.0 0.0 0.0 0.0 0.0 37.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 17.5 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.7 0.0 7.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.2 0.1 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039644-43089428 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 24.1;Early spermatids: 30.7;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria No No Nucleoli Mitochondria "HPA048392: AB_2680384" "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavorable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favorable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 4.0 7.3 16.5 3.6 12.0 2.9 6.8 12.8 16.6 7.6 4.6 8.8 0.9 2.5 7.1 12.5 5.7 14.6 5.7 12.5 13.9 12.6 6.1 2.1 5.3 4.9 9.2 14.1 8.3 4.2 8.5 9.8 3.9 13.2 7.7 4.6 6.8 4.7 6.0 4.4 5.8 2.9 5.9 10.0 4.5 5.4 14.0 8.4 4.7 10.3 1.8 4.8 5.4 4.6 4.7 10.4 7.0 6.5 9.9 14.1 6.2 0.8 1.5 12.8 9.7 14.5 12.9 0.6 4.3 4.8 2.5 4.2 0.1 1.9 0.9 3.1 7.9 1.5 0.6 1.1 1.1 2.5 1.1 2.1 1.3 0.7 1.2 10.4 3.2 1.7 10.6 16.6 1.6 4.1 10.7 8.2 10.9 0.3 8.3 9.2 4.2 3.0 5.2 1.7 3.4 0.9 7.4 7.2 0.7 4.6 1.1 3.2 6.1 3.4 1.7 11.8 6.9 5.1 5.4 7.8 2.7 1.8 6.2 0.6 2.9 0.8 0.3 6.8 5.9 4.8 5.2 5.9 7.0 13.0 6.5 12.2 3.1 11.4 14.1 10.4 4.7 9.7 12.2 1.7 9.9 4.9 6.7 6.9 6.2 16.5 12.0 12.8 16.6 13.9 12.6 9.2 14.1 13.2 8.4 0.0 2.4 0.5 2.5 2.1 5.3 4.0 2.5 24.1 4.5 1.8 5.9 2.5 13.3 5.5 30.7 3.3 0.5 0.0 4.2 1.2 5.1 3.2 1.1 0.4 4.3 4.8 0.0 6.7 2.1 14.5 3.7 2.3 8.5 4.6 2.6 5.5 4.4 7.0 5.6 5.7 10.1 6.5 1.4 8.6 37.7 2.4 0.6 2.9 1.5 1.3 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325086-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 54.1" "Group enriched" "Detected in some" 167 "Early spermatids: 407.9;Late spermatids: 161.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "CACO-2: 6.3" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 TTLL8 ENSG00000138892 "Tubulin tyrosine ligase like 8" A6PVC2 22 50015123-50056935 "Predicted intracellular proteins" Ligase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 8.4" "Group enriched" "Detected in some" 38 "Cardiomyocytes: 1.7;Early spermatids: 4.6;Late spermatids: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-266/70: 4.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA016882 Uncertain NA NA "HPA016882: AB_10603223" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (8.18e-2)" "unprognostic (1.21e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 30.5;Ciliated cells: 65.6;Early spermatids: 31.2;Late spermatids: 53.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.8;REH: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.4 0.6 3.4 0.5 8.9 0.4 1.3 1.0 2.8 0.6 0.5 10.9 1.8 0.6 1.1 8.9 0.6 9.2 0.8 0.5 4.8 3.7 0.8 0.5 1.7 0.7 5.2 0.6 1.8 0.4 2.8 2.8 0.7 16.0 0.6 0.5 0.0 0.5 1.8 0.4 0.6 0.4 0.6 4.5 0.5 0.6 11.0 4.0 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 1.8 0.0 0.9 0.0 0.8 0.0 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.5 0.3 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 8.9 1.0 2.7 4.8 3.7 5.2 0.6 16.0 4.0 11.9 30.5 0.0 0.9 0.1 1.7 0.8 0.0 65.6 13.6 0.0 3.9 0.1 0.0 0.1 31.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 7.0 0.0 0.0 4.8 0.0 0.6 0.0 53.4 1.4 0.8 0.0 1.0 0.0 0.3 0.2 0.0 1.1 0.0 0.5 0.0 0.0 9.7 1.1 0.1 0.0 0.0 0.0 0.3 TTYH1 ENSG00000167614 "Tweety family member 1" Q9H313 19 54415219-54436900 "Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 66.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 594.3;Rod photoreceptor cells: 149.3" "Cancer enriched" "Detected in many" 15 "glioma: 63.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 6.3;AN3-CA: 19.6;U-2 OS: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023617, HPA050655" Approved NA NA "HPA023617: AB_10600836, HPA050655: AB_2681204" "prognostic favorable (3.64e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.50e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (5.94e-3)" "unprognostic (1.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.60e-1)" "unprognostic (0.00e+0)" "unprognostic (2.09e-1)" "unprognostic (1.41e-1)" "unprognostic (4.45e-2)" "unprognostic (1.69e-1)" 2.2 2.7 49.5 2.1 55.4 2.1 2.3 17.9 66.9 2.4 2.3 33.9 0.0 2.4 2.6 2.1 2.2 4.4 2.3 2.3 31.0 23.4 2.1 2.1 2.1 2.1 39.3 24.4 2.2 10.4 2.1 1.9 2.1 19.7 2.5 2.1 1.9 2.8 2.4 3.0 2.2 2.1 2.2 29.7 2.4 2.2 7.4 18.0 0.0 2.1 0.0 2.1 2.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.3 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 49.5 55.4 17.9 42.9 31.0 23.4 39.3 24.4 19.7 18.0 3.0 1.1 0.0 1.0 0.7 84.6 1.1 0.0 1.4 1.2 0.0 19.6 0.4 0.0 25.4 3.1 0.6 0.0 0.0 0.5 0.6 0.5 2.1 0.0 0.0 0.2 9.5 1.2 1.3 0.0 4.0 1.7 0.0 21.9 0.0 0.0 594.3 2.2 0.0 0.7 0.6 149.3 6.5 1.4 2.1 4.4 0.6 3.5 0.0 0.2 1.0 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859482-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 8.7 8.0 9.3 8.1 13.8 6.8 12.4 19.9 12.2 12.3 11.2 13.5 16.6 6.7 13.6 16.4 18.2 10.0 8.3 8.4 8.9 7.2 8.5 9.3 8.8 10.2 16.1 8.5 16.3 13.2 10.4 18.7 7.2 12.3 12.3 8.2 11.7 11.4 12.2 9.9 11.6 7.5 9.3 13.4 9.3 9.6 9.2 16.4 16.2 15.5 10.3 13.8 14.1 13.0 10.1 8.8 14.1 7.6 8.1 17.6 6.9 6.0 8.3 6.5 6.8 3.7 2.6 5.5 4.7 2.8 6.3 5.2 9.0 3.9 5.5 8.1 1.1 4.3 5.1 9.1 2.8 6.0 3.2 11.1 6.4 7.0 10.6 2.0 3.8 3.5 1.4 4.5 5.4 2.0 2.2 4.9 5.5 13.8 3.8 2.1 42.9 7.8 4.4 5.7 6.7 3.7 8.4 9.6 8.6 2.4 2.8 6.1 3.7 3.4 2.7 3.2 8.2 6.4 3.7 1.5 4.5 10.1 3.1 5.1 4.5 6.8 8.4 2.1 4.3 4.0 5.6 7.6 14.1 10.9 5.0 12.4 10.1 13.5 11.5 5.2 8.6 17.6 14.2 8.2 8.1 5.3 8.8 14.1 6.9 9.3 13.8 19.9 12.2 8.9 7.2 16.1 8.5 12.3 16.4 11.9 45.1 5.4 12.7 14.0 7.1 4.8 7.6 12.0 20.5 3.5 5.9 5.1 10.0 4.6 1.3 7.7 2.6 0.0 4.2 6.5 8.2 11.1 10.5 3.2 3.5 3.2 9.9 6.7 4.8 0.4 5.2 6.2 6.8 3.6 5.5 7.7 3.3 4.9 7.8 3.1 7.7 6.5 10.3 11.4 28.1 14.8 3.3 13.6 5.4 5.7 TUBE1 "dJ142L7.2, FLJ22589, TUBE" ENSG00000074935 "Tubulin epsilon 1" Q9UJT0 6 112070777-112087529 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 158.3;Spermatocytes: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 29.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA032073, HPA032074" Approved NA NA "HPA032073: AB_10601773, HPA032074: AB_10601216" "unprognostic (4.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-2)" "unprognostic (7.36e-2)" "unprognostic (1.22e-1)" "unprognostic (8.36e-3)" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (4.99e-3)" "unprognostic (1.70e-1)" "unprognostic (5.15e-3)" "unprognostic (1.64e-1)" "unprognostic (7.68e-2)" "unprognostic (2.50e-1)" "unprognostic (1.59e-3)" 10.3 10.7 12.4 7.0 18.5 5.1 11.9 32.4 18.9 15.5 10.3 12.2 11.4 6.7 21.4 11.5 6.6 12.7 11.6 17.4 10.5 12.2 11.4 47.4 8.4 8.8 15.4 14.5 14.9 12.5 11.8 20.4 11.7 14.0 12.1 8.5 9.3 9.9 12.6 7.1 13.8 7.0 14.4 18.2 8.0 10.5 32.7 15.5 5.3 10.6 4.3 7.3 11.5 12.6 3.2 1.7 2.2 1.4 3.6 7.5 2.8 1.2 1.8 4.7 14.0 10.6 5.8 4.0 5.7 8.3 4.2 7.2 3.0 2.5 4.5 3.6 2.2 6.2 3.9 5.3 2.6 7.1 2.7 4.9 2.1 1.1 3.5 17.4 9.8 6.4 6.2 15.5 5.5 13.5 5.0 5.1 15.8 9.3 6.5 3.2 1.1 5.5 11.5 4.3 7.9 3.7 6.0 2.9 3.0 5.3 1.3 7.0 6.3 4.4 3.6 14.6 4.2 2.7 20.0 2.8 3.3 3.2 29.3 5.4 2.1 0.7 5.3 5.0 10.9 8.1 0.1 0.9 2.2 2.7 1.2 7.5 3.2 5.3 3.5 1.7 2.5 7.4 5.8 0.6 3.6 1.4 1.5 5.1 2.8 12.4 18.5 32.4 18.9 10.5 12.2 15.4 14.5 14.0 15.5 6.0 14.7 11.2 16.2 21.9 20.7 14.9 10.2 10.7 11.4 21.0 33.4 4.2 13.3 9.3 158.3 15.6 8.7 23.3 15.8 9.6 11.5 11.9 16.1 56.2 6.4 12.7 5.8 16.0 6.4 39.6 14.4 7.4 6.8 4.6 9.8 11.0 9.6 8.0 18.7 19.4 29.4 19.4 14.4 75.1 27.4 10.9 2.7 15.0 6.9 12.4 TUBG2 ENSG00000037042 "Tubulin gamma 2" Q9NRH3 17 42659305-42667006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011495 Approved Supported "Centriolar satellite" NA NA "Centriolar satellite" "CAB011495: AB_443396" "unprognostic (2.60e-1)" "unprognostic (5.85e-3)" "unprognostic (6.21e-3)" "unprognostic (5.79e-2)" "unprognostic (1.33e-3)" "unprognostic (5.11e-2)" "prognostic unfavorable (4.68e-5)" "unprognostic (3.53e-2)" "unprognostic (2.20e-2)" "unprognostic (7.88e-3)" "unprognostic (1.82e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.31e-2)" "unprognostic (3.59e-2)" "unprognostic (3.73e-1)" "unprognostic (7.61e-3)" 15.4 17.7 32.9 5.8 34.5 2.8 10.3 21.7 55.7 13.3 9.6 24.2 5.5 5.8 13.9 14.2 9.9 14.4 10.2 17.2 34.5 24.3 12.6 5.2 10.9 6.6 25.7 29.2 20.7 29.9 17.6 14.2 8.7 30.4 13.5 5.4 11.7 15.7 22.5 6.6 11.2 5.3 13.5 19.4 9.1 9.5 8.3 20.8 1.0 13.0 3.1 5.2 12.2 9.7 2.1 7.1 0.5 1.4 1.4 5.9 2.7 5.1 10.7 5.2 7.9 20.6 11.4 3.4 9.2 10.3 7.4 7.4 6.0 3.8 2.5 5.5 13.1 7.8 19.3 0.2 8.3 6.0 5.0 6.2 1.9 13.6 11.7 8.9 0.2 6.9 12.5 8.8 8.5 9.2 12.7 5.3 6.0 0.5 5.7 14.1 10.7 4.9 4.4 1.9 5.0 2.8 3.8 3.2 5.7 7.8 5.3 6.0 4.2 5.8 9.4 6.1 9.8 18.0 2.4 6.0 23.7 1.7 5.9 5.2 30.0 5.3 0.8 8.3 0.2 13.7 0.0 1.4 0.3 5.0 0.9 2.3 2.1 5.4 1.9 1.5 0.9 5.9 3.9 0.5 1.4 0.3 7.1 2.4 2.7 32.9 34.5 21.7 55.7 34.5 24.3 25.7 29.2 30.4 20.8 3.0 3.4 1.4 17.2 4.8 16.2 10.8 2.5 9.4 5.7 3.5 3.9 4.4 14.9 4.4 6.1 6.0 0.0 0.0 8.2 3.6 10.2 4.5 11.5 3.4 3.0 19.1 1.2 7.4 1.3 9.0 16.1 3.2 15.1 4.6 1.0 7.3 4.3 0.0 20.1 11.2 4.5 12.9 9.6 5.1 3.5 3.4 2.1 4.1 0.4 3.1 TULP2 "CT65, TUBL2" ENSG00000104804 "Tubby like protein 2" O00295 19 48880965-48898733 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.6;testis: 25.5" "Group enriched" "Detected in some" 43 "Early spermatids: 174.6;Late spermatids: 168.8" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.6" "Cell line enhanced" "Detected in some" "BEWO: 5.5;U-266/70: 6.4;U-266/84: 6.9" "Not detected" "Not detected" HPA075828 Approved Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA075828: " "unprognostic (9.97e-2)" "unprognostic (5.55e-3)" "unprognostic (1.15e-1)" "unprognostic (9.39e-2)" "unprognostic (1.69e-4)" "unprognostic (6.79e-4)" "unprognostic (1.07e-2)" "unprognostic (2.57e-1)" "unprognostic (5.94e-3)" "unprognostic (1.08e-2)" "unprognostic (9.82e-2)" "unprognostic (1.33e-1)" "unprognostic (4.59e-4)" "unprognostic (6.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.08e-1)" "unprognostic (1.97e-1)" 0.2 0.3 0.2 0.2 0.2 4.3 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.8 0.8 0.5 0.6 0.5 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 1.3 0.2 0.0 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.0 0.2 25.5 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 6.6 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.1 1.9 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.9 0.9 1.8 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.7 0.0 0.9 0.0 1.1 0.0 0.0 0.0 0.1 0.0 6.4 6.9 0.3 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 6.6 0.0 0.0 0.2 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.8 168.8 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 1.4 0.4 0.0 0.0 0.0 0.0 TUSC5 "BEC-1, IFITMD3, LOST1" ENSG00000184811 "Tumor suppressor candidate 5" Q8IXB3 17 1279663-1300987 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "adipose tissue: 79.1;breast: 63.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 268 "ASC diff: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA050825 Approved NA NA "HPA050825: AB_2681252" "unprognostic (5.84e-2)" "unprognostic (7.21e-2)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (2.91e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (1.90e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (5.10e-1)" 79.1 0.9 0.0 2.1 0.0 0.1 63.0 0.0 0.1 0.2 4.1 0.0 0.0 0.1 0.1 0.9 0.2 0.2 3.4 5.2 0.0 0.0 0.4 0.1 0.1 2.2 0.0 0.0 0.2 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 2.5 1.4 4.4 0.8 1.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.6 2.7 0.1 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell type enriched" "Detected in many" 8 "monocytes: 50.5" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.6;SH-SY5Y: 6.1;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles NA NA Vesicles "HPA060582: AB_2684326" "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.4 0.8 0.9 1.0 0.0 0.3 0.8 0.2 0.0 0.0 0.1 0.2 0.8 1.3 0.5 0.2 0.7 1.2 0.0 0.0 0.0 2.8 0.6 0.4 1.7 1.2 0.0 0.3 1.6 0.4 0.0 0.4 0.0 0.6 0.0 0.7 0.4 1.2 0.0 0.8 0.8 1.1 3.6 0.3 0.1 2.0 0.3 0.3 0.1 1.3 0.6 6.1 0.2 0.6 0.1 0.7 0.6 0.5 0.9 1.0 0.8 1.2 0.5 3.2 0.5 0.9 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 0.0 2.6 0.0 0.0 1.0 6.4 0.5 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.6 0.6 0.0 0.0 0.5 0.2 1.5 0.0 0.0 0.0 0.8 1.6 0.0 0.0 1.3 0.0 2.6 5.0 1.7 50.5 0.0 4.8 0.2 0.0 1.4 1.0 0.9 0.0 0.8 1.4 2.7 0.9 1.1 0.0 0.0 0.1 TXNRD3NB "TR2IT1, TXNRD3IT1, TXNRD3NT1" ENSG00000206483 "Thioredoxin reductase 3 neighbor" Q6F5E7 3 126571789-126572636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.4;testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;HL-60: 2.2;NTERA-2: 1.5;PC-3: 1.0;U-937: 1.1" HPA058257 Uncertain NA NA "HPA058257: AB_2683655" 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.6 0.1 0.4 0.0 0.0 0.3 0.7 0.8 0.8 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.8 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 1.0 0.2 0.0 0.8 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TXNRD3NB "TR2IT1, TXNRD3IT1, TXNRD3NT1" ENSG00000283374 "Thioredoxin reductase 3 neighbor" Q6F5E7 3 126571779-126608555 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "parathyroid gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;PC-3: 1.4" HPA058257 Uncertain NA NA "HPA058257: AB_2683655" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.6 13.6 8.3 17.2 12.5 8.7 9.7 11.4 8.7 9.0 8.5 15.5 13.9 18.5 17.5 10.5 12.7 12.6 17.2 14.0 13.1 14.5 13.2 8.0 11.3 10.5 12.4 18.4 10.6 8.9 14.2 12.2 18.8 7.1 8.2 13.5 21.0 11.2 10.3 10.5 11.6 15.5 14.6 18.0 12.2 13.2 11.6 23.3 12.2 10.8 12.8 12.7 13.7 26.6 11.4 16.6 18.1 13.1 9.6 10.4 7.4 8.2 15.5 11.3 15.9 22.3 8.5 17.4 14.3 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 6.0 15.4 4.5 4.9 9.3 9.0 8.1 10.2 9.4 4.5 10.4 3.9 16.5 0.0 6.6 5.5 6.7 4.7 0.0 6.0 10.7 7.7 4.9 33.5 12.5 6.9 3.2 4.6 6.7 4.3 3.1 7.8 8.9 8.5 10.0 12.1 7.7 6.1 3.5 7.8 2.1 11.7 19.4 7.1 17.0 22.7 14.8 12.7 8.5 9.7 2.8 TYW3 "C1orf171, FLJ40918" ENSG00000162623 "TRNA-yW synthesizing protein 3 homolog" Q6IPR3 1 74733152-74766678 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029641 Approved Approved "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA029641: AB_2272535" "unprognostic (6.89e-3)" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (1.49e-7)" "unprognostic (3.79e-1)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-2)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (2.05e-1)" "unprognostic (8.90e-2)" "unprognostic (2.98e-3)" 16.5 19.7 13.7 13.5 17.7 11.9 18.3 15.0 19.9 20.4 17.7 7.5 13.7 9.5 21.0 15.2 20.6 16.4 10.0 21.1 11.1 12.9 20.4 17.0 11.3 14.3 16.2 17.2 30.0 14.4 22.2 34.3 13.5 17.0 20.7 12.3 8.6 13.8 15.7 12.3 10.5 10.9 24.7 15.6 16.0 14.8 12.3 18.1 12.3 23.5 14.3 16.9 23.5 33.3 9.7 9.0 6.0 8.0 13.6 13.9 5.2 8.6 7.3 12.6 8.9 14.3 15.7 19.1 14.9 13.7 14.3 12.6 15.4 7.4 22.7 13.7 12.8 21.0 7.1 14.4 17.2 17.9 14.1 12.4 17.8 22.3 29.8 9.4 35.6 11.6 11.9 17.4 18.2 17.6 11.5 12.7 15.8 30.8 17.5 18.3 7.3 17.3 11.9 33.5 13.0 17.0 16.4 26.3 10.2 12.2 11.3 9.8 8.3 7.1 19.4 22.9 14.3 10.6 13.1 8.2 6.3 17.3 17.1 17.8 10.1 18.3 15.9 14.2 12.9 18.2 6.0 6.0 1.6 10.3 8.0 9.9 9.7 9.1 9.3 9.0 8.8 13.2 13.9 0.5 13.6 5.9 8.7 8.4 5.2 13.7 17.7 15.0 19.9 11.1 12.9 16.2 17.2 17.0 18.1 14.9 22.9 32.0 34.6 22.8 31.3 26.5 17.8 24.1 36.4 15.7 3.9 37.5 66.3 29.4 14.9 24.8 8.0 0.0 51.1 41.5 28.2 34.8 20.7 29.2 29.0 47.7 13.3 17.8 27.2 18.5 40.3 22.8 20.3 29.7 17.0 18.0 31.2 7.0 57.7 43.8 19.9 12.9 38.0 31.8 45.3 19.8 18.7 27.7 24.9 23.3 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: AB_2685717" "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.9 3.8 5.9 2.5 3.3 17.0 8.3 3.4 3.2 4.6 7.8 6.5 8.2 9.3 2.6 2.4 15.2 2.4 8.4 0.9 17.1 24.2 7.6 16.6 12.0 5.2 4.7 13.1 4.7 6.3 4.9 2.4 3.7 3.4 6.3 11.5 8.6 1.2 27.1 7.9 26.0 14.2 4.9 14.1 11.4 4.7 26.4 2.8 8.0 11.0 10.1 9.8 15.2 13.0 2.3 9.7 7.8 10.1 6.5 7.4 26.1 5.3 16.8 13.5 9.2 2.6 6.5 3.4 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 8.9 8.0 9.8 49.6 97.9 8.9 3.6 7.6 2.7 7.9 17.4 3.9 58.7 26.6 19.0 30.4 15.8 17.3 0.0 20.4 54.1 23.1 30.9 10.4 31.6 20.8 9.5 81.1 15.4 16.8 89.2 15.0 18.1 20.3 17.2 21.3 12.0 21.6 17.5 18.7 33.8 8.7 45.3 30.6 11.5 17.7 89.8 90.2 15.3 12.8 32.8 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092770-65115197 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "retina: 91.1" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 149.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.9;U-266/70: 3.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 10 "cerebellum: 49.0;pons and medulla: 8.6" HPA065334 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA065334: AB_2685472" "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.4 1.5 2.4 0.9 2.4 1.1 1.3 11.5 3.6 1.5 0.9 0.9 0.9 0.4 2.7 1.1 1.2 1.5 0.9 0.9 2.8 3.2 0.9 1.1 1.0 1.1 2.6 0.9 3.2 1.0 0.5 0.9 0.9 3.6 1.1 0.2 91.1 2.0 1.8 6.2 1.5 1.1 1.2 3.1 2.0 0.9 1.5 0.9 0.9 1.2 0.9 2.2 0.9 0.9 0.1 1.3 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.8 2.0 0.6 0.2 1.8 1.3 0.1 0.6 0.6 1.2 0.3 0.9 1.6 0.2 0.3 1.4 1.1 0.1 0.0 1.7 1.1 0.1 1.1 0.2 0.8 1.0 0.9 0.6 0.9 0.3 0.4 1.7 0.2 0.8 0.5 0.8 0.2 0.2 0.3 1.3 0.7 0.2 0.7 1.5 0.5 1.1 0.0 0.4 1.1 0.7 0.6 0.2 6.9 1.0 0.4 1.0 0.0 0.6 0.3 0.7 0.6 3.6 0.6 0.4 0.4 0.7 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 1.3 0.0 0.0 2.4 2.4 11.5 3.1 2.8 3.2 2.6 0.9 3.6 0.9 0.0 1.4 0.0 1.1 0.6 26.4 5.2 0.0 0.0 1.2 3.5 227.8 0.6 1.7 0.5 0.4 1.4 0.4 0.0 0.7 0.2 0.9 1.1 0.0 2.1 0.3 3.2 1.2 1.8 0.6 0.9 3.1 0.4 1.7 0.0 1.2 16.6 0.9 0.0 3.2 2.2 149.2 6.5 1.4 1.8 3.6 0.6 0.6 3.2 0.7 0.6 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.7 0.3 1.3 1.6 0.6 0.7 0.7 1.2 0.6 0.4 0.2 0.0 3.1 1.4 0.6 1.3 1.3 0.6 0.8 0.4 1.1 2.5 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 1.4 0.9 0.9 0.8 1.3 0.3 0.0 1.6 2.6 1.4 0.2 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.9 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBQLNL "MGC20470, MGC26958" ENSG00000175518 "Ubiquilin like" Q8IYU4 11 5514393-5516705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 31.9" "Group enriched" "Detected in some" 69 "Early spermatids: 172.7;Late spermatids: 509.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "hTCEpi: 2.4;hTERT-RPE1: 3.4;SK-BR-3: 2.4" NA NA "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-4)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.60e-2)" "unprognostic (7.69e-2)" "unprognostic (2.22e-2)" "unprognostic (3.64e-1)" "unprognostic (1.17e-3)" "unprognostic (1.73e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-8)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (1.17e-1)" "unprognostic (9.69e-5)" 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.6 0.6 0.3 0.2 0.2 0.1 0.5 1.2 0.2 0.4 0.2 0.2 0.2 0.0 0.5 0.4 0.3 0.2 0.2 0.2 1.6 0.3 0.1 0.2 0.2 0.2 0.8 0.1 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 0.8 0.1 31.9 0.2 0.2 0.6 0.2 0.2 0.2 0.4 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 1.0 0.7 0.5 0.2 0.4 0.3 0.4 0.0 0.5 0.0 0.2 0.5 0.6 0.2 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.3 1.6 2.4 0.0 0.1 3.4 0.0 0.7 0.1 0.0 0.4 0.1 0.0 1.0 0.0 0.2 0.6 1.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.4 0.3 0.4 0.0 0.0 0.3 0.1 1.0 0.0 0.0 1.6 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 172.7 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 1.8 0.0 509.3 4.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 3.4 2.5 0.1 0.2 0.0 0.1 0.0 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 97.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.9 7.6 8.1 10.7 16.2 12.9 6.8 16.2 9.4 9.4 7.6 11.7 5.7 10.2 14.1 12.6 7.6 11.9 9.7 8.2 11.7 10.5 8.3 37.1 8.1 12.3 8.1 12.2 12.0 7.7 7.7 12.3 8.2 7.5 9.2 5.1 19.3 11.1 16.0 8.4 7.9 6.0 6.3 9.1 6.4 7.6 13.3 10.8 6.8 12.7 16.0 8.7 11.4 10.5 6.5 6.8 6.9 6.9 11.7 14.2 5.7 11.1 10.2 9.0 7.0 9.4 11.7 7.2 7.8 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 41.7 21.1 7.5 11.4 23.0 40.4 97.6 15.3 9.4 19.4 12.2 76.6 14.8 3.3 8.0 6.6 23.7 13.4 23.3 9.5 6.8 18.3 22.3 16.1 32.7 8.9 60.4 16.0 31.9 21.5 7.4 23.9 16.8 15.1 4.6 12.5 63.3 9.4 14.0 18.0 10.2 53.7 25.8 26.4 13.0 7.6 25.3 19.2 13.1 9.9 12.3 UCMA C10orf49 ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221767-13234334 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in some" 6 "amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;THP-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" NA NA "HPA046718: AB_2679771" "unprognostic (4.25e-1)" 0.0 0.0 6.2 0.2 3.7 0.0 0.0 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.2 0.7 0.2 0.0 0.1 0.5 0.0 0.1 0.9 5.4 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.7 0.2 6.1 0.7 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 UFSP1 UFSP ENSG00000176125 "UFM1 specific peptidase 1 (inactive)" Q6NVU6 7 100888723-100889718 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 6.6;Proximal tubular cells: 5.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA027099 Uncertain NA NA "HPA027099: AB_2214069" "unprognostic (8.56e-2)" "unprognostic (2.62e-2)" "unprognostic (2.23e-1)" "unprognostic (1.94e-1)" "unprognostic (7.21e-3)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (2.11e-1)" "unprognostic (3.55e-3)" "unprognostic (5.71e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-1)" "unprognostic (2.48e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" 7.4 6.3 2.8 3.9 5.4 2.6 4.0 3.1 4.1 3.1 4.5 6.1 2.8 4.3 5.6 6.1 4.1 4.6 2.5 3.6 4.8 4.6 5.3 6.5 2.8 5.9 8.9 4.1 5.8 8.6 3.4 6.8 5.7 3.9 4.8 2.8 3.0 6.4 5.0 10.6 3.4 5.8 4.0 3.5 4.3 5.1 2.0 7.8 6.5 4.2 2.8 5.0 4.8 4.7 5.9 7.2 2.4 3.9 4.4 6.4 3.1 3.7 4.7 1.1 4.9 4.9 2.9 3.1 2.8 0.9 1.2 0.8 1.9 2.6 0.8 2.2 2.3 1.8 7.1 1.5 1.7 0.7 3.2 10.7 3.1 3.9 2.2 4.8 1.3 1.5 3.2 2.2 1.6 6.1 1.3 0.3 1.9 4.6 2.3 1.8 9.1 3.0 7.5 3.7 3.8 6.6 1.5 1.5 7.0 2.1 1.5 3.5 5.6 5.6 7.3 3.1 1.4 1.8 1.1 1.2 3.3 3.2 3.5 2.2 2.3 2.7 0.2 1.1 2.4 3.6 0.0 3.9 2.4 5.4 3.4 6.1 1.8 4.7 2.9 4.8 5.9 5.3 6.4 0.8 4.4 3.3 7.2 2.0 3.1 2.8 5.4 3.1 4.1 4.8 4.6 8.9 4.1 3.9 7.8 0.0 0.0 0.0 1.9 0.6 0.2 0.6 0.0 0.0 0.0 1.8 0.0 2.0 6.6 2.0 0.3 0.6 1.7 0.0 1.8 1.1 1.2 1.1 0.0 2.9 1.6 0.0 2.9 1.8 1.2 0.0 1.7 0.3 0.0 0.0 1.4 2.0 1.8 1.7 1.8 5.3 0.5 6.5 1.2 0.2 0.2 0.9 1.4 0.0 2.0 1.8 UGT1A5 UGT1E ENSG00000240224 "UDP glucuronosyltransferase family 1 member A5" P35504 2 233712992-233773299 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 3.7;intestine: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;RT4: 1.6" NA NA "unprognostic (2.18e-3)" "unprognostic (1.36e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 11.2 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951791 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 150.5;kidney: 43.2" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 9 "Hep G2: 21.0" HPA045108 Supported NA NA "HPA045108: AB_2679218" "prognostic favorable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favorable (6.07e-7)" "unprognostic (2.10e-2)" 0.1 0.1 0.1 4.3 0.1 0.0 0.7 0.1 0.1 0.1 63.8 0.1 0.1 31.9 0.1 1.7 0.1 0.1 14.6 0.3 0.1 0.1 43.2 9.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.1 0.1 0.1 0.1 8.6 0.1 0.1 0.1 0.1 0.1 150.5 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 94.3 0.0 0.0 3.5 0.0 0.0 10.0 21.3 0.0 0.0 115.5 0.0 2.3 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 28.2 0.0 6.0 52.6 0.0 125.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214731 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "breast: 77.4" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 12.7" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "basophil: 6.8;eosinophil: 5.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 6.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 77.4 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 3.3 0.1 0.1 0.0 1.2 7.3 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 6.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 25.3" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 47.1 0.0 0.0 3.3 0.0 91.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.1 0.0 0.0 2.5 2.2 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 58.6 0.3 6.5 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria No No Mitochondria "HPA014405: AB_1858606, HPA065785: AB_2685559" "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favorable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.2 0.1 1.7 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.2 5.8 21.5 6.4 0.5 0.1 5.1 9.1 0.0 0.0 0.0 0.1 4.5 0.1 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 5.4 1.3 0.0 0.1 0.1 0.7 2.5 41.1 3.2 0.6 10.3 0.1 21.3 0.2 12.1 1.8 0.0 1.9 0.3 0.4 0.3 2.1 0.4 0.5 7.3 0.3 6.8 2.1 0.3 0.2 10.6 0.3 6.6 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 6.0 1.0 8.1 1.2 0.0 0.0 0.4 7.6 2.7 6.8 24.4 0.0 0.0 8.3 1.8 5.5 0.1 20.6 0.0 11.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 46.4 0.0 0.0 1.7 1.1 0.7 1.7 0.0 25.7 0.0 9.1 17.5 0.0 1.3 0.0 0.0 0.2 10.6 36.2 0.1 0.0 0.0 21.1 0.9 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.7" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 1.2;Early spermatids: 3.1;Late spermatids: 1.7;Spermatocytes: 2.3" "Group enriched" "Detected in some" 7 "lung cancer: 0.6;testis cancer: 2.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "SCLC-21H: 3.7;U-266/70: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067245 Uncertain NA NA "HPA067245: AB_2685810" "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.6 0.1 0.4 3.6 0.1 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 4.9 0.0 0.2 0.2 0.3 0.4 0.4 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.2 3.8 0.0 22.7 0.1 0.0 2.0 0.1 0.0 0.5 0.1 0.3 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.5 0.5 0.0 0.1 0.3 0.7 0.6 0.0 0.0 0.5 0.0 1.0 0.2 0.4 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 UNC13A "KIAA1032, Munc13-1" ENSG00000130477 "Unc-13 homolog A" Q9UPW8 19 17601328-17688365 "Predicted intracellular proteins" "Differentiation, Exocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.4;pituitary gland: 16.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 41.3;Cone photoreceptor cells: 51.1;Horizontal cells: 112.8;Rod photoreceptor cells: 22.2" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.3;NTERA-2: 16.4;SCLC-21H: 27.1;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (4.96e-3)" "unprognostic (1.69e-1)" "unprognostic (3.98e-3)" "unprognostic (2.13e-3)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.89e-1)" "unprognostic (4.33e-3)" "unprognostic (1.40e-2)" "unprognostic (8.19e-3)" "unprognostic (1.94e-1)" "unprognostic (4.83e-2)" "unprognostic (2.14e-2)" "unprognostic (2.00e-1)" 1.3 4.9 15.8 1.7 25.3 1.2 1.2 24.6 48.4 1.3 1.4 1.9 0.0 1.5 1.3 1.3 1.2 1.3 1.3 1.1 16.8 7.5 1.3 1.1 1.3 1.5 4.1 16.3 1.3 2.5 1.3 16.7 1.4 8.2 1.2 1.5 1.2 1.2 1.3 1.1 1.2 1.4 1.4 1.9 3.8 2.4 2.1 1.6 0.0 1.2 0.0 1.6 1.2 0.1 0.4 0.3 1.1 0.2 0.2 0.3 0.0 0.0 1.6 1.4 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.7 0.4 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 11.3 0.0 0.0 0.0 1.0 0.3 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 16.4 0.1 0.4 0.4 0.0 0.2 0.0 0.0 27.1 6.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.3 1.1 0.2 0.1 0.3 0.0 0.0 15.8 25.3 24.6 35.4 16.8 7.5 4.1 16.3 8.2 1.6 0.0 0.0 0.0 0.2 0.2 41.3 1.8 0.0 0.0 0.0 0.0 51.1 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.2 112.8 8.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.7 0.9 0.0 1.4 0.0 22.2 0.0 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.3 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 54012904-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.7;testis: 11.6" "Group enriched" "Detected in some" 13 "Bipolar cells: 67.9;Early spermatids: 140.5;Late spermatids: 51.5;Rod photoreceptor cells: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 32.1;U-266/70: 42.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 419.8" NA NA "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.2 0.4 13.3 0.3 2.6 0.5 0.3 19.7 16.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.7 0.4 3.5 2.6 1.1 0.2 0.2 0.5 8.3 0.9 1.4 0.2 0.1 0.2 0.2 1.5 0.2 0.2 0.5 0.3 0.2 1.5 0.3 0.2 0.2 1.4 0.2 0.3 11.6 1.1 0.2 1.0 0.2 0.6 0.2 0.2 2.2 0.4 1.4 0.4 0.6 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.8 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.3 0.3 0.1 0.2 2.2 0.3 0.3 0.0 0.6 0.3 0.4 1.2 0.6 0.2 0.4 0.2 0.3 13.3 2.6 19.7 11.1 3.5 2.6 8.3 0.9 1.5 1.1 0.0 0.0 0.0 0.5 0.3 67.9 0.6 2.5 0.0 0.0 3.5 5.9 0.8 0.0 0.0 140.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 51.5 2.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 35.7 0.0 0.5 1.4 0.5 0.1 0.2 0.0 0.0 0.5 UNC5C ENSG00000182168 "Unc-5 netrin receptor C" O95185 4 95162504-95549206 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3" "Group enriched" "Detected in some" 7 "Leydig cells: 19.5;Paneth cells: 11.5;Peritubular cells: 11.0;Rod photoreceptor cells: 10.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 230000 "unprognostic (1.55e-1)" "unprognostic (2.72e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (3.03e-1)" "unprognostic (3.20e-1)" "unprognostic (3.48e-1)" "unprognostic (3.40e-1)" "unprognostic (3.12e-1)" "unprognostic (1.11e-3)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (2.70e-5)" "unprognostic (1.25e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (3.62e-4)" 3.2 17.4 13.5 2.4 16.2 0.7 3.2 4.7 14.2 4.2 5.9 31.3 1.8 3.0 5.1 4.1 1.9 4.3 4.4 5.8 10.7 7.3 2.9 2.6 5.0 1.5 13.7 10.8 6.2 1.3 1.0 2.6 3.8 19.6 7.2 7.0 6.4 11.4 8.3 0.8 1.0 4.0 5.1 13.1 7.9 4.4 5.3 19.9 0.0 22.7 0.0 1.3 4.7 7.9 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 0.1 2.7 0.1 6.3 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 13.5 16.2 4.7 14.2 10.7 7.3 13.7 10.8 19.6 19.9 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 1.5 0.2 0.0 0.0 1.4 0.0 1.2 0.6 0.0 0.2 19.5 0.0 1.7 0.0 0.2 1.4 0.0 11.5 11.0 0.0 10.3 6.5 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.0 8.5 0.0 0.0 0.2 0.2 6.3 4.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 0.0 0.0 0.0 0.2 0.2 42.7 2.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.3 28.8 0.3 0.4 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 38.1 0.0 0.0 0.6 12.6 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.4 1.4 4.7 0.0 1.0 3.3 1.6 0.3 0.6 0.0 0.1 0.3 UNC93A "dJ366N23.1, dJ366N23.2" ENSG00000112494 "Unc-93 homolog A" Q86WB7 6 167271169-167316019 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.8;liver: 17.4;skin 1: 18.8" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 10.4;Hepatocytes: 4.9;Mucus-secreting cells: 2.4;Undifferentiated cells: 1.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 10.4;Hep G2: 4.3;OE19: 10.6;SCLC-21H: 4.6" "Not detected" "Not detected" HPA035729 Uncertain NA NA "HPA035729: AB_10696508" "unprognostic (2.49e-1)" "unprognostic (2.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.28e-1)" "unprognostic (2.28e-1)" "unprognostic (2.26e-1)" "unprognostic (2.32e-1)" "unprognostic (2.10e-1)" "unprognostic (3.32e-3)" "unprognostic (2.99e-2)" "unprognostic (5.97e-3)" "unprognostic (1.85e-1)" "unprognostic (4.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.5 1.4 0.1 0.1 9.2 0.1 0.5 5.9 1.0 1.6 0.1 0.1 0.0 2.5 17.4 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.5 0.1 0.1 18.8 9.8 0.1 0.1 0.1 0.1 0.1 0.1 1.6 0.1 3.9 2.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 UPK3BL1 "UPK3BL, UPLP" ENSG00000267368 "Uroplakin 3B like 1" "B0FP48, E5RIL1" 7 102637025-102642791 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.1;lymphoid tissue: 34.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.7;Ciliated cells: 9.4;Club cells: 5.7;granulocytes: 7.0;monocytes: 3.6;Pancreatic endocrine cells: 2.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 48.8" HPA011403 Supported NA NA "HPA011403: AB_2668503" "unprognostic (4.63e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (6.19e-3)" "unprognostic (3.35e-1)" "unprognostic (2.88e-1)" "unprognostic (9.39e-3)" "unprognostic (4.00e-1)" "unprognostic (8.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.93e-2)" 3.0 2.2 2.1 3.3 2.7 7.9 3.0 4.5 2.1 6.5 2.9 3.6 3.4 1.7 45.1 3.7 1.0 2.2 3.0 1.9 4.6 4.0 3.4 7.1 2.1 3.7 3.8 3.4 4.3 1.7 5.9 1.5 7.7 23.7 6.5 5.1 4.6 0.9 2.0 8.8 3.0 1.3 13.1 34.6 11.8 15.1 5.3 6.8 13.6 5.9 7.1 9.6 4.7 7.4 5.9 3.8 1.6 1.6 0.2 5.2 0.0 0.8 0.9 2.2 0.9 4.0 1.1 1.4 0.9 1.2 48.8 1.1 5.4 0.6 6.6 8.6 1.1 2.4 1.7 0.5 1.9 2.0 3.2 7.1 0.0 1.3 6.7 6.9 0.2 2.8 4.1 2.5 16.9 3.0 16.2 1.7 6.4 1.8 3.0 2.1 6.1 7.0 5.9 2.6 6.0 10.1 2.6 2.4 3.2 0.8 3.0 2.3 14.5 6.2 5.1 2.8 4.3 2.0 0.7 3.1 4.5 2.4 13.6 5.9 8.5 9.6 5.2 4.4 5.3 5.0 4.7 6.8 4.9 6.3 4.8 7.1 7.1 1.7 6.8 7.9 4.7 8.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 URB2 "KIAA0133, NET10, NPA2" ENSG00000135763 "URB2 ribosome biogenesis 2 homolog (S. cerevisiae)" Q14146 1 229626234-229660199 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008902, HPA046788" Uncertain Enhanced Nucleoli NA NA Nucleoli "HPA008902: AB_2213805, HPA046788: AB_2679807" "unprognostic (1.26e-1)" "unprognostic (4.03e-3)" "unprognostic (2.16e-2)" "unprognostic (3.63e-2)" "unprognostic (1.79e-1)" "unprognostic (2.48e-1)" "unprognostic (5.53e-3)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-3)" "unprognostic (7.81e-2)" "unprognostic (2.72e-1)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" 9.8 6.2 7.0 7.2 7.8 7.6 6.5 5.8 11.0 4.7 5.0 9.5 2.9 4.3 7.4 3.8 8.0 6.9 5.2 4.9 5.3 3.7 4.3 10.4 4.9 12.0 8.2 7.7 7.2 13.7 6.5 9.9 6.5 8.0 5.0 4.9 6.4 5.8 3.8 14.0 5.8 5.3 6.6 5.8 8.4 5.8 15.6 7.2 10.3 4.6 6.2 9.0 5.5 4.8 2.7 2.7 0.5 3.9 1.9 5.6 2.9 7.3 11.1 7.2 9.6 4.6 3.8 22.1 5.9 3.6 9.1 6.9 11.0 5.8 15.2 6.8 4.1 4.8 10.2 17.8 7.2 8.4 7.4 17.0 9.5 9.3 6.4 4.3 13.8 8.2 3.7 5.3 9.0 7.1 2.3 4.3 9.0 20.0 7.1 5.6 5.8 15.4 6.8 24.2 13.1 7.4 17.3 10.3 15.2 4.1 9.3 10.8 13.3 6.9 7.3 5.8 2.6 8.2 7.9 4.7 7.5 9.5 9.5 16.7 7.9 7.6 22.9 4.0 10.4 13.6 0.2 1.9 0.5 3.0 3.9 5.6 2.0 2.8 3.6 2.7 2.7 4.3 3.3 0.2 1.9 1.3 1.6 3.1 2.9 7.0 7.8 5.8 11.0 5.3 3.7 8.2 7.7 8.0 7.2 0.0 0.6 1.9 4.7 9.0 6.8 2.4 2.5 0.0 2.3 5.2 27.5 4.2 0.0 2.3 0.3 5.5 0.9 0.0 2.4 8.6 2.7 4.3 0.0 2.9 2.5 3.2 6.3 4.3 1.8 0.8 2.0 2.4 5.0 2.8 1.8 2.7 2.3 0.0 3.2 1.6 17.2 0.0 3.0 5.2 2.9 8.0 2.7 0.0 3.0 3.1 USP29 ENSG00000131864 "Ubiquitin specific peptidase 29" Q9HBJ7 19 57119138-57131926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4" "Group enriched" "Detected in some" 9 "Collecting duct cells: 1.8;Early spermatids: 1.7;Spermatocytes: 4.8;Spermatogonia: 1.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HEK 293: 3.2" "Not detected" "Not detected" HPA076515 Enhanced NA NA "HPA076515: " "unprognostic (1.32e-1)" 0.1 0.1 0.2 0.0 0.2 2.7 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.2 2.1 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 2.3 0.1 0.0 0.1 0.1 0.4 8.4 0.4 0.0 0.7 0.1 1.1 1.9 4.1 1.1 1.2 0.8 0.6 0.1 0.7 0.8 0.3 0.0 0.0 3.3 0.0 0.0 0.1 0.1 1.7 0.0 0.9 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 3.2 0.8 0.0 0.0 1.1 0.0 2.0 0.9 1.0 1.4 0.0 0.0 0.0 1.0 0.3 0.9 0.0 0.7 0.0 1.2 0.0 0.5 1.0 0.9 0.0 1.0 0.0 2.1 2.1 0.7 0.6 0.4 0.3 1.2 0.8 1.3 1.5 1.3 0.5 0.0 0.0 1.6 0.5 1.5 0.5 0.8 0.0 3.1 1.1 1.1 0.8 0.7 0.6 0.5 0.7 0.3 0.3 1.1 0.7 0.7 4.1 1.2 0.4 1.9 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.5 0.0 0.0 0.0 0.0 0.1 USP31 KIAA1203 ENSG00000103404 "Ubiquitin specific peptidase 31" Q70CQ4 16 23061406-23149270 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 55.8;Basal keratinocytes: 59.3;Spermatogonia: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006937 Uncertain Approved Cytosol NA NA Cytosol "HPA006937: AB_1080523" "unprognostic (6.45e-2)" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.52e-1)" "unprognostic (6.15e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.41e-5)" "unprognostic (5.59e-2)" "unprognostic (3.75e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-3)" 6.3 5.3 11.2 4.0 16.6 7.1 8.7 12.7 16.5 10.9 4.9 19.7 2.6 3.7 15.3 7.7 9.3 6.5 4.1 11.0 9.0 6.3 6.2 7.7 7.3 3.6 24.6 8.1 3.7 6.3 20.6 10.4 7.4 17.4 9.6 4.9 2.8 6.0 8.5 10.9 15.9 3.4 14.2 14.8 2.8 3.5 20.7 19.3 1.7 4.2 2.4 4.9 13.4 9.5 0.5 0.8 0.6 1.3 0.1 2.1 0.2 9.5 10.1 2.9 4.0 5.3 4.2 2.7 3.3 3.0 4.3 5.2 6.4 5.8 3.2 3.6 4.2 7.0 12.6 7.2 13.1 7.1 2.3 2.9 1.3 5.8 13.4 6.7 3.3 3.6 3.5 11.3 8.0 18.5 1.6 7.6 3.2 3.9 10.0 5.8 6.5 1.6 2.8 5.8 3.2 3.1 7.9 8.2 6.4 6.4 14.3 7.8 5.1 5.2 10.3 2.9 3.4 4.1 7.4 4.5 8.8 6.5 4.4 9.0 3.3 5.4 3.4 6.3 4.5 3.5 0.1 0.7 0.6 0.8 0.3 2.1 0.1 0.7 1.5 0.8 0.5 0.8 0.8 0.1 0.1 1.3 0.2 1.3 0.2 11.2 16.6 12.7 16.5 9.0 6.3 24.6 8.1 17.4 19.3 6.0 3.0 6.1 55.8 59.3 12.6 9.2 10.2 8.1 7.9 5.2 2.0 11.1 0.0 6.1 3.6 14.6 1.4 0.0 7.2 6.2 5.4 14.2 1.1 25.0 4.2 0.0 4.6 7.4 3.1 8.9 7.2 2.9 6.8 1.0 3.5 4.8 7.6 0.0 4.2 9.1 7.4 19.4 7.1 23.8 60.3 23.2 6.3 1.3 5.2 19.5 USP41 ENSG00000161133 "Ubiquitin specific peptidase 41" Q3LFD5 22 20350578-20390758 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;RH-30: 4.2;RT4: 1.7;SCLC-21H: 4.9;SK-BR-3: 1.8;U-937: 1.5" NA NA "unprognostic (4.01e-6)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (4.63e-3)" "unprognostic (7.44e-2)" "unprognostic (1.75e-1)" "unprognostic (5.28e-2)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (9.91e-5)" "unprognostic (3.43e-2)" "unprognostic (3.51e-2)" "unprognostic (2.54e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-1)" "unprognostic (4.63e-1)" 0.7 0.3 0.4 0.0 0.6 1.0 0.6 0.0 1.8 0.3 0.3 1.6 0.2 0.0 0.2 0.2 0.0 0.1 0.4 0.4 0.1 0.9 1.3 0.1 0.2 0.1 0.2 0.0 0.4 0.1 0.4 0.2 0.5 0.0 0.7 0.1 0.3 0.0 0.3 0.3 2.0 0.3 0.4 0.3 0.3 0.1 0.4 1.2 0.3 0.4 0.4 0.5 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.9 0.0 1.6 0.0 0.4 0.0 4.2 0.0 0.0 1.7 4.9 0.2 0.0 1.8 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.8 1.2 1.5 0.3 0.0 0.0 0.3 0.2 0.2 0.4 0.4 0.1 0.5 0.1 0.2 0.0 0.2 0.0 0.4 0.4 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP50 ENSG00000170236 "Ubiquitin specific peptidase 50" Q70EL3 15 50500562-50546708 "Enzymes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "testis: 20.2" "Group enriched" "Detected in some" 87 "Early spermatids: 76.1;Late spermatids: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 1.2;HaCaT: 1.2;HEL: 1.1;OE19: 1.3;RH-30: 1.0;SK-BR-3: 1.6;SK-MEL-30: 2.8;U-698: 1.0" "Region enriched" "Detected in single" 9 "hippocampal formation: 0.4" "Not detected" "Not detected" HPA039470 Uncertain NA NA "HPA039470: AB_10672964" "unprognostic (7.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.01e-2)" "unprognostic (4.04e-3)" "unprognostic (3.37e-1)" "unprognostic (2.53e-2)" "unprognostic (3.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.81e-2)" "unprognostic (4.65e-2)" "unprognostic (2.47e-1)" "unprognostic (7.49e-4)" "unprognostic (3.03e-1)" 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.2 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 USP9Y DFFRY ENSG00000114374 "Ubiquitin specific peptidase 9, Y-linked" O00507 Y 12701231-12860839 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 16.2;RT4: 8.7" "Not detected" "Not detected" HPA057687 Uncertain Vesicles NA NA Vesicles "HPA057687: " "unprognostic (2.63e-1)" "unprognostic (8.97e-2)" "unprognostic (1.10e-5)" "unprognostic (8.46e-3)" "unprognostic (4.93e-2)" "unprognostic (2.53e-2)" "unprognostic (2.77e-1)" "unprognostic (3.17e-2)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-4)" "unprognostic (2.28e-1)" "unprognostic (1.19e-2)" "unprognostic (1.42e-1)" 1.2 2.2 1.4 0.9 3.1 1.7 1.1 9.6 4.0 0.0 1.6 1.4 0.0 8.6 4.4 0.0 3.8 2.4 1.8 3.4 2.9 2.2 2.2 1.4 2.1 0.0 2.7 0.0 4.8 1.7 9.3 4.8 2.3 7.6 2.8 2.0 1.8 0.0 1.5 2.2 1.5 2.9 2.8 4.5 3.2 0.0 2.4 2.0 0.1 0.2 0.5 2.7 0.2 0.0 2.3 0.0 0.0 0.0 0.0 2.5 7.2 7.2 3.6 3.9 0.0 0.0 4.1 0.0 6.0 0.0 0.0 0.0 0.0 3.3 2.3 0.0 2.6 0.0 7.1 4.0 0.0 0.0 6.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.5 0.0 4.0 0.0 1.5 0.0 0.0 0.0 2.0 0.9 16.2 8.7 2.8 0.0 0.0 0.0 2.1 5.4 0.0 0.0 5.5 4.4 0.0 0.0 3.2 0.0 3.8 7.1 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.2 2.7 1.2 2.2 1.5 0.3 2.4 2.2 1.3 0.1 0.5 0.0 2.0 1.6 0.2 23.8 19.7 0.8 7.4 10.4 22.1 24.6 2.5 21.4 15.9 19.2 60.9 4.3 1.7 4.1 0.4 5.8 0.0 0.0 0.0 1.1 9.3 11.2 2.3 0.2 2.5 25.4 0.0 5.5 6.9 0.0 11.5 7.3 3.3 2.8 0.3 8.1 3.7 0.0 14.5 5.4 24.9 0.0 7.6 3.2 1.7 10.2 2.9 10.0 0.0 9.9 UST 2OST ENSG00000111962 "Uronyl 2-sulfotransferase" Q9Y2C2 6 148747328-149076990 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 17.0;Muller glia cells: 13.3;Peritubular cells: 10.6;Suprabasal keratinocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032022 Approved NA NA "HPA032022: AB_10603326" "unprognostic (3.43e-1)" "unprognostic (1.90e-1)" "unprognostic (7.87e-3)" "unprognostic (3.22e-5)" "unprognostic (1.83e-3)" "unprognostic (1.50e-1)" "unprognostic (5.71e-2)" "unprognostic (1.96e-2)" "unprognostic (8.31e-3)" "unprognostic (2.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.11e-1)" "unprognostic (9.25e-3)" "unprognostic (9.48e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (3.02e-2)" 8.6 16.0 4.8 7.1 9.3 0.8 8.5 20.9 10.8 12.8 8.6 6.0 6.6 2.6 10.8 8.1 8.2 10.4 12.2 4.5 6.3 12.6 5.2 2.2 8.6 4.9 14.1 4.5 15.6 19.0 0.7 2.3 6.1 13.0 9.8 4.0 10.7 4.3 6.9 3.7 8.6 5.6 11.5 9.1 8.0 5.7 12.1 6.5 3.1 37.5 5.7 4.9 10.6 21.0 1.5 1.3 0.1 0.9 6.2 1.7 0.4 0.0 2.1 12.0 9.2 14.6 12.2 0.1 5.1 13.4 2.5 6.5 0.0 0.8 4.2 1.1 7.9 6.3 3.7 8.5 4.3 5.1 5.6 6.4 0.1 6.8 0.1 5.4 0.2 1.8 6.2 9.7 6.5 12.1 5.1 0.1 7.1 0.0 0.0 2.0 5.3 0.0 0.0 7.0 20.7 2.7 2.0 1.6 4.9 0.1 9.6 6.2 0.0 17.0 4.2 3.1 9.0 3.1 0.2 0.2 7.3 0.8 1.6 4.5 0.0 0.0 0.0 8.1 3.4 4.1 0.0 0.2 0.0 1.7 0.7 1.4 0.8 1.3 1.5 1.1 1.5 0.1 0.7 0.1 6.2 0.9 1.3 0.4 0.4 4.8 9.3 20.9 7.4 6.3 12.6 14.1 4.5 13.0 6.5 3.0 2.7 0.5 4.2 8.4 0.0 1.2 0.0 1.4 1.2 1.8 0.0 1.4 0.0 0.1 0.6 0.1 0.0 0.0 1.7 0.2 8.1 4.2 0.0 0.0 1.4 0.0 0.0 2.5 1.3 2.6 17.0 1.1 5.0 1.0 1.4 13.3 1.5 0.0 10.6 0.4 0.4 0.0 2.2 1.7 3.2 10.2 1.1 1.5 0.6 6.8 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6, small subunit processome component" Q9NYH9 17 31860899-31901765 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA025936: AB_1845588, HPA055806: AB_2682930" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 19.3 17.9 18.7 16.9 19.3 19.0 26.4 28.7 19.3 17.7 19.5 18.0 12.5 10.8 23.4 30.4 15.7 13.3 10.7 13.0 19.5 17.0 16.7 20.7 15.4 23.3 16.2 16.1 19.5 17.0 14.1 26.0 21.4 16.2 19.9 15.9 15.0 15.9 15.0 17.0 25.3 15.2 17.0 18.8 23.1 16.4 18.5 19.1 23.2 17.1 18.5 28.1 16.0 15.5 15.4 19.7 13.1 10.9 5.7 8.0 7.0 8.5 5.6 7.9 4.5 8.2 5.4 9.6 7.4 4.2 11.3 8.7 20.1 4.5 12.9 9.3 6.8 10.9 11.2 11.1 9.2 10.4 3.3 16.8 8.0 12.6 18.2 9.0 12.3 8.3 8.3 9.2 11.0 8.1 10.2 7.2 8.5 14.1 7.4 9.0 7.0 11.4 32.8 10.4 10.6 8.8 12.0 11.3 12.6 11.6 7.9 5.2 7.9 7.8 5.6 12.4 12.8 13.6 23.0 7.5 17.0 12.8 8.9 14.8 8.3 14.8 18.7 11.6 8.5 9.1 10.6 10.8 6.7 7.6 10.9 7.3 12.7 8.0 8.0 13.6 15.4 7.1 8.0 13.1 5.7 9.7 19.7 7.7 7.0 18.7 19.3 28.7 19.3 19.5 17.0 16.2 16.1 16.2 19.1 17.9 22.4 27.9 22.9 22.9 16.2 12.5 7.6 30.8 30.7 5.2 7.9 36.3 8.3 22.3 20.6 18.0 9.1 0.0 20.7 41.1 23.1 22.0 35.7 14.4 32.5 11.1 5.2 12.9 20.5 3.6 17.3 29.1 8.5 44.1 14.6 17.8 22.2 7.0 15.9 15.0 16.0 6.5 23.1 62.6 62.6 22.7 32.0 13.3 15.3 27.6 VCX "VCX-10r, VCX-B1, VCX1, VCX10R" ENSG00000182583 "Variable charge, X-linked" Q9H320 X 7842262-7844143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 51 "testis: 22.7" "Group enriched" "Detected in some" 8 "Spermatocytes: 368.4;Spermatogonia: 931.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.6;NB-4: 3.8;RPMI-8226: 3.0;THP-1: 3.5;U-138 MG: 3.3;U-266/70: 6.7" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.65e-1)" "unprognostic (3.39e-1)" "unprognostic (1.17e-3)" "unprognostic (1.71e-1)" "unprognostic (1.50e-1)" "unprognostic (2.73e-1)" "unprognostic (7.89e-2)" "unprognostic (6.44e-2)" "unprognostic (1.20e-1)" "unprognostic (7.18e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.8 0.0 3.8 1.8 0.9 0.4 0.5 0.0 3.0 0.0 1.5 0.1 0.2 0.0 0.0 0.0 0.9 1.5 3.5 0.0 3.3 0.8 2.3 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 58.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 72.2 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 84.1 0.0 368.4 931.5 0.0 0.1 0.0 0.0 0.0 VCX2 VCX-2r ENSG00000177504 "Variable charge, X-linked 2" Q9H322 X 8169944-8171267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 106 "testis: 21.5" "Group enriched" "Detected in some" 5 "Spermatocytes: 168.0;Spermatogonia: 388.8" "Cancer enhanced" "Detected in some" "stomach cancer: 0.8;testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "T-47d: 1.8;U-266/70: 2.4" "HPA044642, HPA044996, HPA049357" Enhanced NA NA "HPA044642: AB_2679033, HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 58.2 0.0 168.0 388.8 0.0 0.0 0.0 0.0 0.0 VCX3A "VCX-8r, VCX-A, VCX3" ENSG00000169059 "Variable charge, X-linked 3A" Q9NNX9 X 6533618-6535118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 195 "testis: 28.8" "Group enriched" "Detected in some" 4 "Spermatocytes: 209.9;Spermatogonia: 564.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 7.4;PC-3: 3.7;U-138 MG: 11.2;U-2197: 2.8;U-266/70: 7.0" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (2.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.64e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 3.7 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 11.2 0.0 2.8 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.9 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 90.5 0.0 209.9 564.1 0.0 0.2 0.0 0.0 0.0 VCX3B VCX-C ENSG00000205642 "Variable charge, X-linked 3B" Q9H321 X 8464830-8466510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 61 "testis: 21.7" "Group enriched" "Detected in some" 5 "Spermatocytes: 324.1;Spermatogonia: 857.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "U-138 MG: 20.9" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-2)" "unprognostic (2.07e-1)" "unprognostic (4.19e-3)" "unprognostic (4.41e-2)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (3.58e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 20.9 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 41.3 7.5 0.0 1.7 0.0 0.0 0.3 0.1 0.0 1.8 0.0 0.0 109.9 0.0 324.1 857.5 0.3 0.1 0.0 0.0 0.0 VCY "BPY1, VCY1, VCY1A" ENSG00000129864 "Variable charge, Y-linked" O14598 Y 13985772-13986513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 122 "testis: 31.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/70: 5.6" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.6 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCY1B BPY1B ENSG00000129862 "Variable charge, Y-linked 1B" O14598 Y 14056217-14056958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 113 "testis: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/70: 5.6" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.6 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.3;stomach 1: 52.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.9;Paneth cells: 94.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;OE19: 40.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 2.7 2.1 7.1 12.3 7.2 6.3 3.4 4.7 5.3 5.3 28.0 1.7 3.9 33.2 6.2 3.2 3.8 4.1 21.8 3.3 5.3 4.1 2.8 0.6 7.0 7.3 2.9 4.6 3.9 2.2 0.6 3.4 3.6 2.9 8.5 14.8 4.5 3.8 4.8 1.0 5.1 46.3 3.8 3.4 6.3 52.5 3.5 3.5 12.1 4.5 3.1 9.6 15.0 3.8 5.4 4.6 0.1 3.9 4.0 9.2 4.8 4.2 0.0 0.1 0.2 1.5 1.2 0.4 1.2 1.0 1.2 1.2 3.2 13.2 2.0 1.9 0.8 0.0 1.0 0.9 0.1 0.2 0.4 0.0 3.7 0.0 0.3 1.9 3.9 5.1 1.8 1.2 1.2 0.0 0.0 2.4 8.5 3.7 1.2 1.4 0.0 6.2 4.4 0.1 40.5 0.0 2.4 0.0 1.0 0.4 5.1 0.0 0.1 0.0 0.3 0.9 0.0 0.3 6.4 1.4 0.5 0.2 1.6 0.0 0.7 1.5 0.6 0.3 5.6 2.6 0.0 3.9 0.0 8.7 2.4 9.2 4.4 5.8 4.9 2.6 5.4 7.4 5.4 0.1 4.0 1.6 4.6 6.8 4.8 7.1 7.2 4.7 5.3 5.3 4.1 2.9 4.6 2.9 3.5 8.9 9.0 0.5 5.1 2.1 0.8 1.5 10.2 12.0 14.8 0.0 0.0 2.4 0.0 2.1 4.9 3.7 130.9 0.0 15.4 2.8 3.7 5.4 8.1 0.0 2.0 1.6 9.2 3.1 1.0 14.5 3.4 2.7 1.7 1.8 40.6 26.2 22.9 94.7 2.5 1.4 0.4 0.0 3.8 4.5 2.4 1.3 0.8 10.0 38.0 23.8 VIT ENSG00000205221 Vitrin Q6UXI7 2 36696690-36814792 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "Leydig cells: 106.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 8 "gdT-cell: 5.3;memory CD8 T-cell: 2.3;naive CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 11 "T-cells: 5.3" "Cell line enhanced" "Detected in some" "ASC diff: 13.5;ASC TERT1: 26.5;BJ: 12.7;fHDF/TERT166: 43.0;SuSa: 25.7;THP-1: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 120000 "unprognostic (5.34e-4)" "unprognostic (4.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.20e-1)" "unprognostic (7.78e-3)" "unprognostic (8.32e-2)" "unprognostic (1.81e-1)" "unprognostic (3.08e-1)" "unprognostic (3.35e-1)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (3.66e-6)" "unprognostic (2.09e-1)" "unprognostic (2.01e-1)" "unprognostic (3.62e-3)" "unprognostic (1.41e-2)" 25.5 1.2 0.2 0.6 0.4 0.9 10.3 2.5 1.0 7.4 2.1 0.3 6.3 0.6 1.9 11.4 17.1 5.0 2.7 14.2 0.2 0.1 0.5 0.2 1.2 2.3 3.4 0.7 30.0 2.2 1.0 2.0 6.8 1.0 15.3 1.7 18.1 7.8 2.9 11.6 8.3 1.5 20.5 5.1 0.3 3.4 10.5 0.0 0.0 7.9 22.0 3.9 21.4 10.9 0.0 0.0 0.0 0.1 0.4 5.3 1.1 0.0 0.0 0.0 0.0 13.5 26.5 0.0 12.7 3.0 4.1 1.7 0.0 0.0 0.0 0.0 43.0 0.0 0.0 2.4 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 25.7 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 3.4 0.0 0.4 0.1 0.0 0.0 1.1 0.2 0.4 2.5 0.6 0.2 0.1 3.4 0.7 1.0 0.0 0.0 0.0 0.0 1.0 3.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 1.1 0.3 0.0 0.0 0.0 6.9 7.4 0.1 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.2 106.7 0.0 6.8 0.0 0.3 0.0 0.0 0.0 21.9 0.0 0.0 6.5 2.1 1.1 0.2 3.0 3.5 0.0 0.0 0.1 VMAC ENSG00000187650 "Vimentin type intermediate filament associated coiled-coil protein" Q2NL98 19 5904858-5910853 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 22.2;Late spermatids: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.8" NA NA "unprognostic (6.81e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.67e-6)" "unprognostic (3.59e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.40e-1)" "unprognostic (1.73e-3)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (9.52e-2)" "unprognostic (5.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (7.24e-4)" 7.7 9.3 11.9 13.9 10.7 12.4 8.7 6.1 12.4 9.3 7.9 14.8 19.6 7.4 9.7 10.3 9.0 9.7 10.4 6.3 12.2 4.6 7.8 7.5 6.7 13.0 20.9 7.5 9.8 13.8 6.2 12.5 6.1 11.4 13.1 7.6 8.7 12.8 21.0 6.2 10.7 11.3 10.6 10.4 12.2 12.2 4.3 16.5 8.9 12.8 3.7 11.2 12.6 7.8 8.8 10.8 9.7 10.5 6.5 10.8 6.7 1.5 0.9 1.6 2.8 2.8 1.9 1.6 1.1 1.6 0.5 0.7 1.1 1.7 1.6 4.3 1.6 0.9 2.6 0.3 2.0 0.3 3.2 2.3 1.4 1.6 0.9 2.1 1.9 3.5 4.6 2.5 0.6 2.1 4.0 1.6 5.0 1.1 5.4 0.7 1.8 2.7 1.9 0.8 5.7 3.2 2.2 0.5 4.1 1.0 2.7 1.1 4.5 1.5 5.0 2.2 4.1 3.9 2.8 3.4 1.2 0.5 4.1 1.4 18.8 4.1 1.3 2.0 1.6 1.8 9.7 7.7 5.7 9.0 8.0 6.6 7.7 7.8 9.5 4.7 8.8 10.8 10.2 7.1 6.5 10.5 10.8 10.5 6.7 11.9 10.7 6.1 12.4 12.2 4.6 20.9 7.5 11.4 16.5 0.0 1.4 6.4 4.4 1.5 1.7 1.1 0.0 0.0 1.2 10.4 0.0 13.1 11.6 5.0 22.2 1.3 3.5 0.0 7.6 6.6 4.7 2.8 2.3 3.0 7.7 0.0 4.7 3.7 8.6 22.2 1.1 3.9 3.3 4.6 6.1 4.5 4.5 3.5 2.5 4.9 3.5 0.0 2.3 0.6 1.0 2.6 7.3 4.4 3.9 3.5 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.5 0.7 0.4 1.9 0.0 0.2 0.2 0.9 0.2 0.3 0.0 0.4 0.2 0.7 0.0 6.2 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.7 0.1 0.4 1.0 0.2 0.6 0.3 0.9 0.9 0.3 0.4 2.1 0.5 0.1 0.6 0.4 1.2 0.9 0.6 1.1 3.4 1.4 0.0 0.5 0.1 1.0 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.6 6.7 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 0.0 0.6 0.5 0.0 0.0 4.8 0.2 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.7 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 VN1R2 V1RL2 ENSG00000196131 "Vomeronasal 1 receptor 2" Q8NFZ6 19 53258292-53261837 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 5.0;testis: 3.2" "Group enriched" "Detected in some" 10 "Early spermatids: 16.0;Late spermatids: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA044551 Uncertain NA NA "HPA044551: AB_2678982" "unprognostic (9.54e-2)" "unprognostic (3.17e-1)" "unprognostic (1.06e-1)" 0.2 0.2 0.4 0.8 0.4 0.5 0.3 0.6 0.8 0.2 0.3 0.2 0.5 1.6 0.3 0.2 0.0 5.0 0.4 0.4 0.3 0.3 0.2 1.7 0.3 0.6 0.2 0.3 0.2 0.0 0.3 0.0 0.4 0.0 0.4 0.9 0.6 0.0 0.3 0.3 0.2 3.2 0.5 0.0 0.3 0.3 0.8 0.5 1.3 0.5 0.6 1.1 0.2 0.8 0.8 0.8 1.3 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 2.2 2.0 0.5 0.5 0.7 0.6 0.0 0.0 0.0 0.8 0.8 1.2 2.7 1.6 0.0 0.2 1.7 0.6 0.4 0.2 0.0 0.6 0.0 0.7 0.8 0.7 0.4 0.9 0.4 1.1 0.5 0.3 0.7 1.1 2.1 0.0 0.5 2.3 1.3 1.3 0.2 0.8 0.3 0.4 1.4 0.1 1.7 1.0 0.8 1.3 0.4 1.7 0.6 0.8 1.2 0.5 0.8 0.4 0.5 0.5 1.1 0.3 0.4 0.2 0.4 0.2 0.2 0.8 0.3 1.0 1.3 0.6 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 VN1R4 V1RL4 ENSG00000228567 "Vomeronasal 1 receptor 4" Q7Z5H5 19 53266676-53267723 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" HPA027018 Uncertain NA NA "HPA027018: AB_10603142" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 VNN3 HSA238982 ENSG00000093134 "Vanin 3" Q9NY84 6 132722787-132734765 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 39.5;bone marrow: 29.8;liver: 29.4" "Group enriched" "Detected in some" 5 "Ciliated cells: 69.6;Club cells: 19.4" "Cancer enhanced" "Detected in some" "liver cancer: 3.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "neutrophil: 39.5" "Lineage enriched" "Detected in single" 40 "granulocytes: 39.5" "Cell line enhanced" "Detected in some" "Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3" "Secreted to blood" NA NA 150000000 "unprognostic (3.20e-2)" "unprognostic (2.70e-1)" "unprognostic (7.92e-3)" "unprognostic (1.71e-2)" "unprognostic (3.05e-3)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.01e-1)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (5.84e-8)" "unprognostic (1.25e-2)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" 1.1 0.1 0.4 3.3 0.4 29.8 0.2 0.2 0.6 2.4 1.2 0.2 0.2 0.0 0.2 0.8 0.9 2.4 1.3 1.0 0.4 0.0 0.3 29.4 6.1 1.2 0.4 0.2 1.2 0.2 0.0 0.2 5.8 0.3 0.5 0.0 0.4 1.1 0.2 0.2 0.1 0.2 0.2 0.2 7.6 0.4 0.3 0.2 0.2 0.3 2.4 0.7 0.6 0.3 0.0 0.0 39.5 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.5 3.7 0.0 1.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.2 0.6 0.4 0.0 0.4 0.2 0.3 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 69.6 19.4 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 9.7 0.1 0.0 0.0 0.6 9.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 VOPP1 "DKFZp564K0822, ECop, FLJ20532, GASP, WBP1L2" ENSG00000154978 "VOPP1, WBP1/VOPP1 family member" Q96AW1 7 55436056-55572988 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 200.3;monocytes: 192.0;Rod photoreceptor cells: 193.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 79.8;HDLM-2: 69.6;Karpas-707: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.60e-2)" "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.35e-5)" "unprognostic (8.65e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-2)" "unprognostic (1.91e-3)" "unprognostic (5.15e-2)" "prognostic unfavorable (6.99e-8)" "unprognostic (3.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.23e-1)" "unprognostic (4.60e-2)" 13.3 7.9 24.0 27.8 19.1 14.3 19.5 15.0 26.2 16.8 17.8 11.6 10.0 15.4 14.7 13.7 9.1 17.7 14.5 12.7 17.1 21.1 15.5 13.4 15.3 38.5 20.5 14.4 13.7 10.2 11.4 27.6 9.0 12.1 10.5 19.2 20.4 16.3 10.0 18.6 6.3 20.8 12.8 24.3 36.4 17.1 7.9 11.6 40.5 10.2 8.3 33.7 19.0 14.1 37.0 13.3 16.0 9.0 13.5 18.7 10.9 79.8 15.5 8.2 7.9 18.3 10.4 3.6 20.3 18.6 17.8 17.8 7.2 20.1 17.8 14.1 18.3 29.3 12.9 8.6 17.1 19.1 69.6 4.9 0.0 9.5 10.0 4.2 6.4 8.0 8.9 9.0 16.0 6.2 12.0 23.4 6.0 4.5 89.9 29.9 5.9 2.5 4.4 18.1 10.1 9.3 4.2 8.4 42.6 19.6 7.7 16.7 6.3 11.7 8.4 4.2 14.6 9.4 7.9 19.9 18.3 27.3 24.2 21.3 43.1 30.3 19.1 7.8 5.9 27.8 7.3 4.6 16.0 12.6 5.4 9.8 37.0 16.0 16.6 12.1 16.2 12.7 13.8 11.8 13.5 9.0 13.3 18.7 10.9 24.0 19.1 15.0 26.2 17.1 21.1 20.5 14.4 12.1 11.6 3.0 12.7 87.0 21.7 11.2 50.8 6.6 35.7 5.3 13.6 47.1 200.3 1.0 8.3 33.8 10.9 31.2 31.5 23.3 28.3 5.1 14.2 24.1 5.8 19.8 35.4 39.7 51.2 40.5 74.3 7.3 17.8 89.3 37.1 192.0 45.8 64.4 43.8 37.4 21.2 9.2 193.8 32.3 12.7 1.5 28.8 7.3 1.0 41.5 32.2 22.0 VPREB3 8HS20 ENSG00000128218 "V-set pre-B cell surrogate light chain 3" Q9UKI3 22 23752743-23754468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9" "Cell type enriched" "Detected in some" 41 "B-cells: 216.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 730 "memory B-cell: 79.9;naive B-cell: 90.4" "Lineage enriched" "Detected in single" 775 "B-cells: 90.4" "Group enriched" "Detected in some" 45 "Daudi: 58.3;REH: 68.9;U-698: 18.2" "Not detected" "Not detected" HPA003041 Supported "Intracellular and membrane" NA NA "HPA003041: AB_1080577" "unprognostic (2.06e-3)" "unprognostic (4.75e-3)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.75e-2)" "unprognostic (4.79e-2)" "unprognostic (6.63e-3)" "unprognostic (9.15e-2)" "unprognostic (1.38e-2)" "unprognostic (4.93e-2)" "unprognostic (4.84e-2)" "unprognostic (8.44e-2)" "unprognostic (4.19e-2)" "unprognostic (1.18e-1)" "unprognostic (2.87e-1)" "unprognostic (4.12e-1)" 0.5 9.2 0.7 62.6 0.9 7.5 0.3 0.7 0.8 0.3 1.3 0.3 0.2 0.2 0.3 27.9 2.3 0.1 0.7 0.4 0.6 0.7 1.1 0.9 1.2 77.9 0.8 0.2 0.3 0.3 0.1 1.4 0.3 0.2 0.6 0.9 0.4 4.8 0.2 0.8 0.4 32.7 0.2 0.5 31.6 1.4 1.4 0.2 1.6 0.8 1.0 36.0 3.1 0.2 90.4 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 58.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.3 68.9 0.1 1.0 0.0 0.0 0.1 0.2 0.0 0.1 0.8 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.3 0.0 18.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.9 0.0 0.0 0.0 90.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.7 0.9 0.7 0.8 0.6 0.7 0.8 0.2 0.2 0.2 0.0 0.3 216.6 0.6 0.3 4.6 0.4 2.5 0.0 1.2 0.0 2.0 0.0 1.7 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 5.2 0.0 0.3 0.0 0.0 0.0 5.0 0.0 0.6 0.7 0.1 0.0 0.0 1.4 1.7 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.4 VPS26C "DCRA, DSCR3" ENSG00000157538 "VPS26 endosomal protein sorting factor C" O14972 21 37223420-37267919 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 23.9;Exocrine glandular cells: 24.1;Hofbauer cells: 29.0;monocytes: 28.9;Pancreatic endocrine cells: 26.6;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023288 Uncertain Approved Mitochondria NA NA Mitochondria "HPA023288: AB_1847872" "unprognostic (1.01e-3)" "unprognostic (6.42e-2)" "unprognostic (7.96e-3)" "unprognostic (2.15e-2)" "unprognostic (4.10e-3)" "unprognostic (2.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "unprognostic (7.76e-2)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.54e-4)" "unprognostic (1.72e-1)" "unprognostic (3.24e-1)" "unprognostic (5.24e-2)" "unprognostic (3.16e-1)" 23.5 29.1 14.2 15.9 17.4 16.5 17.0 17.1 19.4 16.2 23.4 20.8 12.1 25.5 17.8 13.8 20.6 15.4 17.6 21.3 17.1 11.9 29.2 28.6 19.9 18.1 18.3 16.9 16.8 23.9 14.5 14.7 20.9 15.6 15.9 23.7 22.1 17.3 15.3 30.8 16.8 31.2 19.7 17.4 24.6 21.5 7.4 17.8 21.3 16.7 13.3 20.6 23.0 16.1 19.6 24.2 40.3 30.2 24.9 26.9 24.5 12.2 5.8 12.8 10.8 23.6 21.3 14.2 12.3 27.4 11.4 16.7 8.0 13.4 8.8 4.6 28.3 26.8 6.1 13.6 13.2 10.9 21.1 9.8 14.9 5.9 7.7 20.6 11.0 10.2 18.4 13.1 13.0 21.1 20.1 21.0 16.6 9.4 19.7 21.5 5.8 18.9 9.4 14.2 19.4 5.7 17.5 6.1 12.9 13.9 9.5 10.3 14.0 8.5 16.6 26.1 17.1 15.7 8.9 16.6 12.9 4.5 13.6 7.1 30.3 30.5 12.2 20.4 18.9 14.1 23.5 24.5 40.3 26.9 30.2 25.0 19.6 23.2 24.4 24.2 14.7 21.5 22.6 25.4 24.9 26.3 9.6 26.7 24.5 14.2 17.4 17.1 19.4 17.1 11.9 18.3 16.9 15.6 17.8 8.9 21.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.5 8.7 0.0 13.0 18.3 23.9 0.0 0.0 0.0 0.0 24.1 21.0 0.0 0.0 8.1 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 28.9 0.0 0.0 26.6 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA062022: AB_2732675" "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 8.1 10.2 2.6 9.8 3.1 0.4 18.0 2.9 2.6 8.2 31.6 2.7 5.2 11.7 4.5 4.5 8.9 4.0 7.6 3.6 2.4 2.2 6.2 11.9 11.6 3.8 3.2 1.4 5.9 10.9 8.9 4.0 12.2 3.4 8.4 13.9 4.0 6.3 6.4 12.9 4.6 60.9 3.8 2.5 3.3 5.5 3.9 2.5 1.7 26.3 6.1 4.9 6.1 8.6 0.7 2.4 3.5 2.0 0.4 0.6 0.4 4.9 7.3 3.1 10.5 13.1 5.9 7.9 8.5 5.5 4.2 3.5 2.1 11.8 0.7 3.4 6.3 7.9 12.1 22.0 2.2 5.0 2.4 3.3 1.1 6.9 3.2 2.6 0.6 1.8 2.7 6.4 3.2 2.0 12.3 9.2 2.4 1.4 0.1 3.9 5.2 0.0 0.7 9.7 14.5 4.6 1.8 8.6 0.0 6.2 16.1 2.7 3.4 8.3 3.5 2.2 7.0 7.7 3.3 10.7 4.9 3.1 6.0 4.3 0.1 0.1 0.0 7.1 3.5 9.7 0.6 2.0 2.3 0.4 0.6 0.6 0.0 0.4 0.2 2.4 0.7 0.4 0.6 3.5 0.4 0.2 0.7 0.6 0.4 2.6 3.1 2.9 2.2 2.4 2.2 3.2 1.4 3.4 2.5 17.9 22.9 0.8 12.2 2.2 9.7 9.2 20.4 4.0 6.8 27.9 11.8 33.6 16.6 22.4 5.1 15.5 75.3 0.0 17.6 31.6 6.0 13.2 2.3 24.2 9.5 4.8 48.5 16.5 4.3 6.5 16.7 7.2 3.3 10.8 45.7 23.2 20.5 45.6 13.8 9.9 8.0 0.0 5.6 3.9 6.5 2.8 11.7 2.9 51.9 14.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Melanocytes: 5.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 5.9;OE19: 13.7;T-47d: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060453: AB_2684280, HPA066745: AB_2685712" "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.1 0.5 0.5 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.9 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.1 0.2 5.9 0.0 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.0 0.3 0.5 1.7 0.0 0.5 0.0 0.1 0.8 13.7 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 10.8 0.0 0.1 0.0 0.2 0.9 0.0 1.4 0.9 0.1 0.7 0.2 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 1.1 0.6 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.4 0.7 0.0 0.0 0.7 1.4 0.9 1.1 1.0 4.0 9.5 1.2 1.3 3.2 0.0 2.0 1.8 5.0 1.8 0.6 1.2 0.4 0.2 3.9 0.8 0.4 6.5 1.0 0.5 2.2 0.4 0.5 0.0 0.4 0.3 VSIG8 ENSG00000243284 "V-set and immunoglobulin domain containing 8" P0DPA2 1 159854316-159862657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 83.5" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 10.0;Collecting duct cells: 5.2;Intestinal endocrine cells: 3.5;Suprabasal keratinocytes: 4.0" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0" "Region enriched" "Detected in single" 13 "cerebellum: 4.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.4;U-87 MG: 2.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023219 Uncertain NA NA "HPA023219: AB_1845635" "unprognostic (8.66e-3)" "unprognostic (2.17e-1)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (4.50e-3)" "unprognostic (1.15e-2)" "unprognostic (9.26e-2)" "unprognostic (6.28e-2)" "unprognostic (1.68e-2)" "unprognostic (2.79e-1)" "unprognostic (2.93e-3)" "unprognostic (9.32e-2)" "unprognostic (7.94e-7)" "unprognostic (1.72e-2)" "unprognostic (4.25e-1)" "unprognostic (1.81e-3)" "unprognostic (1.99e-1)" 0.4 0.1 0.2 0.2 0.3 0.0 0.2 4.2 0.2 2.2 0.2 0.2 0.2 0.2 0.2 0.2 2.5 1.0 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.2 0.2 0.2 1.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 0.2 4.3 0.2 0.2 18.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.4 83.5 9.2 0.2 2.0 0.6 0.0 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.4 1.0 1.1 0.2 0.0 1.4 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.6 0.3 0.5 0.0 0.0 0.7 0.5 0.1 0.7 0.0 0.0 0.3 0.0 0.2 0.3 4.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.5 10.0 2.6 0.0 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.2 0.0 3.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 1.7 1.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.0 0.1 0.5 1.1 0.6 VWA3A "FLJ40941, FLJ46765" ENSG00000175267 "Von Willebrand factor A domain containing 3A" A6NCI4 16 22092538-22156966 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.8;fallopian tube: 27.0" "Group enriched" "Detected in some" 5 "Ciliated cells: 101.7;Club cells: 27.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.5;WM-115: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041696, HPA042044" Uncertain "Secreted - unknown location" NA NA "HPA041696: AB_10964202, HPA042044: AB_10968997" "unprognostic (2.69e-2)" "unprognostic (1.54e-1)" "unprognostic (9.75e-4)" "prognostic favorable (8.15e-4)" "unprognostic (2.70e-1)" "unprognostic (4.46e-2)" "unprognostic (1.65e-2)" "unprognostic (6.79e-3)" "unprognostic (5.55e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (1.40e-1)" "unprognostic (2.16e-5)" "unprognostic (1.08e-1)" "unprognostic (2.97e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-4)" 1.0 1.1 3.6 0.7 8.3 1.1 0.9 0.3 12.2 8.1 0.8 13.2 0.0 0.8 2.3 9.6 0.8 27.0 0.7 0.9 4.8 5.8 0.9 0.7 5.5 0.8 0.7 6.7 3.0 1.0 0.9 10.0 0.8 26.8 0.9 0.8 0.0 0.8 0.8 0.8 2.3 1.1 0.7 3.8 1.0 0.9 5.0 3.6 0.0 0.9 0.0 0.9 0.9 0.1 0.2 0.1 0.0 0.5 0.0 0.4 0.0 0.1 1.1 0.6 0.7 0.3 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.5 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.2 2.5 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 3.6 8.3 0.3 12.2 4.8 5.8 0.7 6.7 26.8 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 101.7 27.3 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115362-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 15 "granulocytes: 538.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 14.8 20.2 13.8 7.5 13.4 1.6 16.0 2.3 9.3 15.5 23.9 7.5 10.0 16.7 16.6 17.0 12.6 9.9 19.9 6.5 14.1 24.6 16.0 4.3 19.4 6.8 12.5 6.6 9.6 15.3 5.5 34.2 25.9 15.2 22.5 28.4 10.3 31.2 13.2 3.0 17.9 24.0 13.6 15.0 6.0 17.8 6.3 7.6 3.9 13.7 7.1 9.8 14.9 11.8 4.5 4.8 25.6 5.3 4.3 7.5 3.6 0.0 0.2 3.6 0.2 3.9 3.6 1.3 0.5 0.2 0.3 0.1 0.2 28.2 0.0 3.5 0.6 4.9 0.1 0.7 6.4 0.0 9.6 0.0 20.3 5.1 0.6 15.8 0.2 9.5 10.7 0.7 0.6 2.1 1.4 18.7 2.7 1.1 3.5 1.1 0.1 0.4 0.3 5.7 0.0 0.7 0.0 12.6 0.1 20.6 0.2 3.2 0.3 0.5 0.2 1.0 8.7 2.5 0.9 0.5 0.1 2.7 0.1 0.0 1.3 1.1 0.0 11.7 0.4 0.2 25.6 4.8 0.5 2.9 3.3 0.7 4.5 3.2 1.7 4.8 2.3 4.1 2.6 0.3 4.3 5.3 2.6 7.5 3.6 13.8 13.4 2.3 9.3 14.1 24.6 12.5 6.6 15.2 7.6 8.9 36.5 0.8 11.6 15.2 2.9 2.4 7.6 25.4 14.8 31.4 2.0 7.8 8.3 19.7 32.8 3.6 25.8 0.0 25.0 2.1 7.8 8.4 538.2 2.4 29.2 30.2 14.5 1.8 5.6 3.6 2.6 6.0 5.0 2.8 22.5 12.0 20.8 17.3 0.4 11.5 1.1 0.0 3.8 0.2 2.3 10.9 1.6 4.9 22.5 14.0 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 35.9;brain: 10.1;pancreas: 11.0" "Cell type enriched" "Detected in some" 34 "Intestinal endocrine cells: 107.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.4 35.9 9.2 0.4 4.8 0.2 0.4 9.8 10.1 0.5 2.5 0.4 0.4 1.7 0.4 0.4 0.4 1.2 0.4 0.4 9.5 3.3 0.4 0.4 2.4 0.4 1.9 0.4 3.7 11.0 1.6 3.4 0.4 0.4 0.9 0.4 0.4 0.5 2.4 0.4 0.1 2.4 0.4 0.4 0.4 2.8 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.0 0.0 27.1 1.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.7 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 4.8 9.8 10.1 9.5 3.3 1.9 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 3.2 107.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777294 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 20.5" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5" "Group enriched" "Detected in some" 5 "cerebellum: 7.8;pons and medulla: 4.1" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 1.1 1.6 3.1 1.4 9.5 1.1 1.2 5.6 10.5 1.1 1.9 0.0 3.9 2.6 4.6 3.0 1.1 19.6 2.0 3.9 1.6 5.5 5.6 1.5 2.5 1.2 1.7 5.4 1.4 2.5 5.1 20.5 1.0 9.7 1.3 1.7 0.8 1.7 2.0 5.3 1.7 3.3 2.3 2.3 1.3 5.8 1.3 2.3 0.0 1.8 0.6 1.3 1.3 0.8 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.5 1.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 2.2 0.5 0.7 0.3 0.1 0.9 0.7 0.2 0.0 0.0 0.0 0.1 3.4 0.5 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.2 0.0 0.6 0.2 3.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.3 0.0 2.1 2.2 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.1 4.5 1.3 0.1 0.0 0.6 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 3.1 9.5 5.6 10.5 1.6 5.5 1.7 5.4 9.7 2.3 0.0 0.6 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.4 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.8 0.0 0.3 5.7 0.0 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 19.3 1.1 0.0 0.1 11.4 0.5 0.5 0.0 0.1 1.8 2.6 0.2 0.3 0.3 0.1 4.2 0.0 1.6 0.0 0.0 10.9 0.1 0.0 0.1 0.1 0.4 0.9 0.0 0.1 0.6 2.0 0.7 0.0 0.5 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 3.0 1.7 0.0 1.5 1.5 3.2 0.7 0.0 5.3 2.3 0.0 27.5 0.9 0.0 0.1 0.4 2.2 0.0 0.0 0.4 2.2 1.4 0.4 3.5 14.0 1.1 0.0 1.7 3.1 4.0 0.0 6.4 2.2 1.7 1.8 0.0 3.2 0.0 0.0 1.8 0.3 17.1 0.0 0.5 0.9 3.0 1.9 3.7 0.5 0.1 0.7 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Cytosol Nucleoplasm "HPA026619: AB_2671920, HPA036044: AB_2674916" "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.8 0.0 2.1 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.7 0.4 2.1 2.0 0.6 4.0 2.2 3.5 4.8 0.0 0.0 1.1 2.4 0.1 0.3 0.0 1.2 2.7 0.8 1.2 10.8 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.6 0.0 0.0 1.6 0.0 1.3 8.7 1.4 0.0 1.7 0.0 1.4 0.0 1.1 0.1 0.0 1.0 0.0 0.9 3.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 0.0 1.0 0.0 1.7 0.2 0.0 4.7 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.2 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.4 1.6 WBP2NL "FLJ26145, GRAMD7, MGC26816, PAWP" ENSG00000183066 "WBP2 N-terminal like" Q6ICG8 22 41998725-42058456 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 24.8" "Group enriched" "Detected in many" 16 "Early spermatids: 223.5;Late spermatids: 587.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.1;THP-1: 1.6" HPA048557 Enhanced Approved Cytosol NA NA Cytosol "HPA048557: AB_2680440" "unprognostic (1.90e-2)" "unprognostic (2.25e-4)" "unprognostic (2.77e-3)" "unprognostic (6.12e-2)" "unprognostic (6.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (9.84e-4)" "unprognostic (3.31e-2)" "unprognostic (4.19e-2)" "unprognostic (1.79e-1)" "unprognostic (2.06e-1)" "unprognostic (2.85e-3)" "unprognostic (9.36e-5)" 1.1 0.9 3.0 1.2 2.9 0.6 2.4 3.6 4.6 0.9 0.9 3.2 1.8 0.8 1.4 4.1 0.8 2.0 1.1 0.8 2.3 1.2 1.2 0.9 1.3 1.1 2.0 2.4 2.4 2.8 2.6 2.4 0.8 2.8 1.3 1.0 2.0 1.9 1.5 0.8 1.6 1.0 0.9 3.7 1.0 1.1 24.8 3.3 0.0 2.3 0.0 1.1 0.9 1.7 1.1 1.5 0.0 0.6 0.4 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 0.0 0.0 0.9 0.4 0.0 1.5 1.1 0.3 0.3 0.0 0.4 0.2 0.6 1.4 0.2 3.0 2.9 3.6 4.6 2.3 1.2 2.0 2.4 2.8 3.3 0.0 3.2 2.0 1.2 0.3 16.2 0.7 2.5 0.0 5.7 0.0 19.6 1.8 3.3 0.9 223.5 0.7 2.0 0.0 1.2 0.9 0.3 0.9 0.0 1.5 1.2 9.5 4.6 2.5 4.6 587.8 6.1 2.1 1.7 0.0 1.9 2.8 0.9 3.7 5.3 1.5 20.6 0.0 0.8 25.5 15.6 0.6 1.6 2.5 1.7 0.9 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065834-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 15.7;Cone photoreceptor cells: 60.9;Horizontal cells: 20.6;Rod photoreceptor cells: 35.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.9;SCLC-21H: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: AB_2732586" "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 2.1 5.8 12.4 2.2 22.1 1.5 3.3 12.2 23.9 2.0 2.9 3.4 0.0 1.6 4.5 6.2 1.9 3.5 3.0 1.3 9.7 7.1 6.2 1.0 3.6 1.8 4.4 16.3 4.0 3.0 19.0 22.5 0.7 7.9 2.3 3.1 6.0 1.7 2.2 0.7 1.2 1.8 2.8 4.0 2.9 3.1 4.1 6.9 0.1 10.2 0.0 1.6 1.9 1.5 1.1 0.7 2.6 1.6 1.3 0.8 0.2 0.0 3.7 8.9 0.1 0.2 0.6 0.3 0.2 0.0 0.8 3.1 0.2 0.1 6.1 0.0 0.1 4.8 0.1 3.9 2.0 0.8 0.0 3.1 0.0 0.7 0.0 0.3 3.3 4.8 1.4 1.2 0.1 0.5 1.3 0.0 7.1 0.0 0.3 0.6 1.6 3.4 0.1 2.0 0.0 1.9 0.0 3.8 0.0 0.5 0.0 10.2 7.4 0.0 2.4 6.2 1.4 0.4 0.0 0.0 1.2 1.7 0.1 5.7 4.4 2.9 3.5 7.0 0.0 2.4 2.6 0.6 0.3 0.6 1.6 0.3 1.1 0.6 0.4 0.2 0.8 0.7 0.8 1.7 1.3 0.3 0.7 0.3 0.2 12.4 22.1 12.2 21.8 9.7 7.1 4.4 16.3 7.9 6.9 0.0 4.3 0.0 0.4 0.1 15.7 0.8 2.5 12.0 2.3 0.0 60.9 0.0 1.7 0.3 1.2 0.5 0.0 0.0 0.5 0.0 0.5 0.2 3.5 0.0 0.2 20.6 4.6 1.8 0.3 0.8 0.9 0.2 1.7 0.0 0.0 9.5 0.3 0.0 1.4 4.4 35.8 0.0 1.0 2.6 4.5 0.0 0.0 0.0 0.0 0.3 WDR31 FLJ35921 ENSG00000148225 "WD repeat domain 31" Q8NA23 9 113313222-113340298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 54.9;Ciliated cells: 34.8;Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019340, HPA019347" Approved Approved "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA019340: AB_1858800, HPA019347: AB_2215267" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.78e-3)" "prognostic favorable (1.85e-4)" "unprognostic (4.54e-2)" "unprognostic (1.59e-1)" "unprognostic (2.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.48e-1)" "unprognostic (2.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.90e-9)" "unprognostic (9.11e-2)" "unprognostic (1.65e-1)" "unprognostic (7.96e-3)" "unprognostic (8.50e-2)" 2.2 6.8 4.1 1.0 8.2 1.5 4.7 1.7 5.5 3.2 2.4 4.0 8.8 1.5 4.5 3.3 2.4 6.3 2.3 8.9 3.3 4.1 5.6 3.1 2.3 0.9 3.5 2.7 3.7 3.0 16.6 11.2 1.0 4.0 3.4 2.2 5.8 10.2 7.5 1.3 2.5 1.1 2.2 3.6 0.8 2.1 7.3 1.7 3.8 7.1 1.4 0.8 3.0 2.0 1.6 0.9 4.4 1.0 2.3 1.4 0.8 5.5 4.2 1.5 3.0 5.1 5.9 1.4 1.4 2.7 1.4 1.7 0.7 3.6 2.1 1.0 2.1 4.1 3.7 1.2 2.7 2.7 3.3 0.3 1.7 2.2 0.7 5.8 0.9 0.3 3.1 3.6 5.8 5.2 4.0 1.1 3.3 4.5 1.9 1.5 3.8 2.4 1.4 0.9 5.3 5.3 2.1 1.3 2.6 3.7 1.2 3.6 2.7 6.7 1.2 3.2 1.2 8.8 0.9 0.6 2.0 2.2 5.0 1.5 4.0 3.8 0.5 3.0 1.4 1.9 4.4 1.0 1.0 0.9 0.6 0.8 0.9 1.0 0.8 0.8 1.6 1.4 1.3 3.4 2.3 0.7 0.9 0.7 0.8 4.1 8.2 1.7 5.5 3.3 4.1 3.5 2.7 4.0 1.7 6.0 8.0 0.0 4.6 4.7 4.5 54.9 5.1 34.8 12.5 1.8 27.5 0.3 5.0 1.4 23.9 1.5 0.3 0.0 0.2 0.2 1.7 3.4 4.7 2.6 0.7 6.4 0.0 0.6 1.2 21.5 1.7 2.0 0.0 0.0 1.5 7.2 1.2 0.0 1.4 4.8 40.9 0.0 2.3 22.7 8.7 3.8 0.2 0.0 2.3 2.4 WDR38 ENSG00000136918 "WD repeat domain 38" Q5JTN6 9 124853417-124857890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "fallopian tube: 51.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 83.0;Early spermatids: 23.2;Late spermatids: 80.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 12.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.5;HDLM-2: 3.0;HeLa: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA056607 Approved Vesicles NA NA Vesicles "HPA056607: AB_2683188" "unprognostic (5.66e-3)" "unprognostic (2.15e-3)" "unprognostic (1.51e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.14e-1)" "unprognostic (2.17e-3)" "unprognostic (4.29e-3)" "unprognostic (7.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.82e-1)" "unprognostic (1.38e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-5)" "unprognostic (1.01e-1)" "unprognostic (3.25e-2)" "unprognostic (6.36e-2)" "unprognostic (4.42e-2)" 0.2 0.2 2.0 0.2 3.1 0.2 0.2 0.2 0.5 2.9 0.2 10.6 0.0 0.2 0.7 11.9 0.2 51.4 0.2 0.3 2.8 3.3 0.2 0.2 10.8 0.2 0.3 0.4 6.0 0.2 0.2 1.0 0.2 8.8 0.2 0.2 0.0 0.2 0.3 0.3 0.3 0.2 0.3 0.7 0.2 0.2 7.0 1.3 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.3 0.5 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.1 0.4 2.5 0.1 0.1 0.3 1.1 0.1 0.2 0.0 0.0 3.0 0.3 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.7 0.1 0.3 0.6 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.7 0.0 0.2 1.3 0.0 0.0 0.0 0.5 0.5 0.2 0.4 0.5 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 0.2 0.5 2.8 3.3 0.3 0.4 8.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 83.0 9.1 0.0 0.0 0.0 0.0 0.2 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 80.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Predicted intracellular proteins" Autophagy "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 316.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 25.4 31.0 37.1 17.2 39.0 38.7 38.9 30.3 38.1 27.4 23.5 35.3 19.9 21.8 25.6 24.9 39.9 32.7 29.5 29.4 36.6 29.2 26.6 22.9 23.5 26.6 38.2 28.5 32.8 35.6 29.9 24.2 19.6 39.2 26.6 21.2 18.8 32.6 23.8 20.9 28.4 25.0 29.3 53.3 19.3 29.5 47.7 39.1 6.8 26.5 23.3 23.5 23.3 24.8 10.0 15.6 22.1 19.3 8.9 12.6 11.9 29.2 20.1 17.0 15.5 15.7 14.6 20.2 21.9 24.7 35.9 30.8 24.0 15.6 8.4 13.7 19.5 22.9 16.3 16.3 18.6 33.1 5.3 32.4 17.1 11.5 18.6 20.7 13.5 13.1 15.8 19.6 19.1 18.0 15.5 28.9 11.3 12.7 7.9 20.0 18.8 9.6 9.2 21.7 23.5 26.8 10.5 30.7 8.6 19.4 29.3 22.1 32.6 21.6 22.2 25.6 20.8 26.4 10.3 19.7 37.3 29.3 26.2 39.0 20.4 8.7 12.4 24.3 13.6 27.3 16.5 19.3 22.1 12.3 19.2 12.6 10.0 9.7 10.4 15.6 9.9 8.7 7.9 16.2 8.9 14.8 8.0 7.6 11.9 37.1 39.0 30.3 38.1 36.6 29.2 38.2 28.5 39.2 39.1 29.8 45.5 39.3 40.6 53.1 35.0 17.3 63.7 66.9 76.2 40.1 11.8 45.7 74.6 105.9 126.0 49.0 65.0 0.0 119.7 62.3 43.4 67.1 71.6 61.8 40.3 42.9 45.5 45.4 49.5 316.4 52.9 44.0 54.0 54.1 58.5 56.9 135.0 52.0 45.3 50.9 30.8 32.3 51.5 70.5 153.1 63.2 90.4 39.5 52.5 79.5 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Group enriched" "Detected in some" 5 "Ciliated cells: 50.9;Club cells: 18.2" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Cell line enhanced" "Detected in some" "AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 0.0 1.1 0.0 0.8 0.0 0.0 1.0 0.0 50.9 18.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.0" "Group enriched" "Detected in many" 6 "Early spermatids: 232.6;Late spermatids: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 4.3 4.3 5.9 6.8 6.9 7.2 5.2 6.4 5.9 4.0 4.2 4.5 7.1 2.1 4.9 6.6 5.1 3.9 3.5 4.0 4.8 3.8 4.0 5.4 3.8 5.5 5.9 4.3 4.3 3.3 7.5 11.9 4.4 6.1 4.1 4.1 4.8 4.0 4.5 6.8 6.7 4.5 4.1 5.0 6.2 4.0 48.0 4.6 7.4 4.2 3.2 6.5 3.9 4.2 7.5 5.9 13.9 6.7 6.5 14.9 4.9 19.1 4.1 7.4 6.6 7.6 6.6 11.9 10.1 7.9 11.5 10.9 11.2 10.2 9.1 34.1 6.1 10.6 11.2 9.3 8.7 14.4 14.3 8.1 9.2 10.1 7.3 9.5 12.9 7.6 5.4 12.8 10.2 11.2 5.7 8.9 11.6 8.9 17.6 8.7 17.8 10.9 13.2 10.1 12.2 12.0 13.1 12.7 19.4 6.3 6.7 7.3 8.0 7.0 10.5 14.8 10.4 27.0 12.1 8.3 9.8 9.2 10.9 19.7 15.0 30.0 27.2 6.5 16.6 9.8 9.6 5.1 13.9 8.6 4.4 14.0 7.5 12.3 8.7 4.1 7.1 10.3 6.2 4.4 6.5 6.7 5.9 14.9 4.9 5.9 6.9 6.4 5.9 4.8 3.8 5.9 4.3 6.1 4.6 0.0 3.2 0.8 2.8 3.8 3.1 2.7 2.5 1.4 4.5 3.5 0.0 4.7 5.0 4.2 232.6 5.2 1.0 0.0 3.7 5.5 2.8 2.3 9.2 2.4 3.9 3.2 0.0 3.1 4.5 86.7 4.6 5.0 5.0 8.2 1.5 3.6 2.6 1.9 3.2 3.5 2.3 19.4 6.2 27.9 13.1 4.1 3.9 5.7 2.3 2.3 WDR5B FLJ11287 ENSG00000196981 "WD repeat domain 5B" Q86VZ2 3 122412332-122416051 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042994 Approved NA NA "HPA042994: AB_10960397" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (2.09e-1)" "unprognostic (3.31e-1)" "unprognostic (1.12e-1)" "unprognostic (3.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-2)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (7.45e-3)" 10.8 8.4 6.2 5.8 9.0 2.8 11.0 7.1 6.3 7.6 4.2 7.6 13.7 5.8 6.2 17.5 5.4 12.5 3.8 4.9 6.9 4.6 7.4 10.4 5.6 8.7 11.3 5.0 8.6 12.5 7.9 19.5 7.4 10.7 8.2 4.8 5.7 7.8 15.5 3.9 5.8 7.5 4.4 9.2 10.9 7.7 7.3 11.1 12.3 14.7 3.4 8.9 5.7 4.7 4.6 2.3 5.1 8.1 2.4 6.7 2.6 6.6 4.2 6.3 7.3 11.9 9.9 4.0 5.1 7.7 7.1 6.2 3.7 6.0 4.0 7.1 4.9 5.9 9.5 5.0 3.8 9.4 2.5 4.1 5.9 4.7 3.7 7.7 3.2 6.6 6.5 10.6 5.4 12.4 8.0 5.5 7.2 2.6 3.6 5.9 7.9 5.1 5.9 3.1 10.1 7.0 5.0 6.2 3.5 6.7 2.9 7.2 7.7 5.2 3.4 9.8 7.5 9.9 7.1 4.3 5.6 6.9 2.6 3.3 3.0 1.3 8.0 7.3 3.2 6.9 5.1 4.3 2.8 2.9 4.7 3.6 2.7 4.3 2.5 2.3 4.6 6.7 4.8 1.6 2.4 8.1 1.4 4.8 2.6 6.2 9.0 7.1 6.3 6.9 4.6 11.3 5.0 10.7 11.1 3.0 3.7 0.0 2.9 0.5 3.6 2.1 7.6 10.7 1.2 12.2 5.9 4.6 6.6 3.5 6.3 3.6 1.2 0.0 3.5 1.7 2.1 3.3 0.0 4.0 2.1 6.4 0.0 5.5 3.3 0.0 4.4 1.3 0.0 1.0 2.7 6.0 1.9 2.0 2.8 5.3 7.1 0.0 2.3 6.3 4.6 1.8 2.4 1.8 2.3 1.4 WDR63 "DIC3, FLJ30067, NYD-SP29" ENSG00000162643 "WD repeat domain 63" Q8IWG1 1 84999147-85133138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 21.3;brain: 39.7;testis: 31.0" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 167.3" "Cancer enhanced" "Detected in some" "melanoma: 2.9" "Region enriched" "Detected in many" 9 "pons and medulla: 39.7" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Lineage enriched" "Detected in single" 4 "T-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.9;HBEC3-KT: 5.4;HSkMC: 7.2;hTCEpi: 8.7;LHCN-M2: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038526 Enhanced NA NA "HPA038526: AB_2676063" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.61e-2)" "unprognostic (1.09e-4)" "unprognostic (1.10e-3)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.56e-1)" "unprognostic (2.53e-1)" "unprognostic (1.82e-3)" "unprognostic (2.31e-1)" "unprognostic (1.14e-5)" "unprognostic (8.57e-3)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" 0.3 21.3 2.0 0.4 4.6 0.1 0.9 0.1 0.9 1.3 0.6 4.2 1.0 0.3 0.7 11.7 0.6 14.0 0.4 0.9 3.0 2.9 2.5 0.1 3.7 0.3 0.4 0.9 4.9 0.5 3.9 14.6 0.5 39.7 0.3 0.6 0.3 1.8 0.3 0.3 1.9 0.2 0.4 0.9 0.2 0.2 31.0 1.9 0.0 1.1 1.0 0.2 0.7 0.3 0.0 0.5 0.0 0.0 0.0 2.2 0.4 0.2 0.5 0.1 0.4 3.9 10.9 2.0 2.1 4.3 0.7 1.1 0.0 0.6 0.5 0.0 0.4 2.6 0.0 0.4 5.4 0.9 0.1 0.4 0.3 0.0 0.0 0.6 0.0 0.0 7.2 8.7 3.6 0.2 0.4 0.1 0.6 0.0 0.0 7.8 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.2 0.2 0.0 0.0 0.2 1.3 2.2 0.0 3.4 0.0 0.6 0.3 0.0 0.5 0.0 0.0 0.4 4.2 0.2 1.4 0.0 0.0 0.0 2.2 0.0 1.3 0.0 1.2 0.9 0.1 0.0 0.8 1.9 0.0 0.0 0.0 0.5 0.0 0.4 2.0 4.6 0.1 0.9 3.0 2.9 0.4 0.9 39.7 1.9 0.0 1.7 0.0 0.4 0.9 0.0 0.7 0.0 167.3 18.2 0.0 3.9 0.1 3.3 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 5.1 0.0 0.0 3.6 1.7 0.0 18.6 4.6 0.0 0.5 0.0 0.0 0.0 0.7 0.4 0.0 0.0 36.6 2.9 0.1 0.1 0.0 0.0 0.1 WDR64 FLJ32978 ENSG00000162843 "WD repeat domain 64" B1ANS9 1 241652278-241802133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 17.8" "Group enriched" "Detected in some" 78 "Early spermatids: 168.8;Late spermatids: 96.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.1;JURKAT: 1.0;U-266/84: 1.3" "Not detected" "Not detected" HPA046186 Uncertain NA NA "HPA046186: AB_10960064" "unprognostic (6.44e-2)" "unprognostic (1.13e-1)" "unprognostic (2.34e-1)" "unprognostic (2.78e-1)" "unprognostic (1.87e-3)" "unprognostic (1.52e-1)" "unprognostic (9.26e-2)" "unprognostic (2.35e-1)" "unprognostic (1.40e-2)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (4.49e-2)" "unprognostic (4.56e-4)" "unprognostic (2.43e-1)" "unprognostic (1.93e-1)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.2 0.5 0.1 0.1 0.2 0.1 1.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.0 0.3 0.1 0.1 0.2 0.2 17.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 168.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 96.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.7 0.0 0.0 0.0 WDR66 "CaM-IP4, MGC33630" ENSG00000158023 "WD repeat domain 66" Q8TBY9 12 121917862-122003927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 228.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.3 1.2 6.3 1.0 13.2 0.4 1.7 0.4 4.0 4.4 0.5 4.5 1.5 0.4 2.5 11.3 0.5 24.6 2.0 1.5 6.4 3.7 3.2 1.8 6.4 0.9 0.7 3.2 3.9 2.1 4.7 28.4 1.3 18.0 0.8 0.4 1.3 1.3 2.2 0.5 1.8 0.5 1.0 0.9 2.0 0.8 35.0 2.4 0.0 6.7 0.0 1.2 0.8 1.7 0.2 4.9 0.4 0.0 0.1 0.3 0.0 1.8 0.2 0.3 0.1 0.3 0.3 0.3 0.2 1.7 0.8 2.1 0.2 0.9 0.1 2.5 0.1 0.5 0.6 0.2 21.9 3.1 0.1 0.3 0.1 0.4 0.2 2.6 0.0 6.0 1.2 20.7 1.7 14.0 0.4 0.9 0.3 5.0 0.0 1.3 0.6 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.0 3.8 0.3 1.7 0.1 0.2 0.0 0.1 0.6 0.5 0.1 0.7 1.8 2.7 0.3 0.3 0.3 0.1 2.6 2.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.0 4.9 0.3 0.0 6.3 13.2 0.4 4.0 6.4 3.7 0.7 3.2 18.0 2.4 6.0 10.0 1.5 5.9 5.5 5.0 2.2 5.1 228.8 36.4 10.4 29.5 0.2 3.3 3.1 38.6 1.3 0.0 0.0 0.4 0.1 1.9 1.9 8.1 0.8 0.5 7.9 1.7 28.3 2.2 49.3 6.9 1.8 1.7 1.0 0.0 1.8 0.7 0.0 7.1 1.1 16.8 6.5 1.0 34.9 14.4 3.1 0.5 0.8 0.0 2.2 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 64.1;thyroid gland: 36.3" "Group enriched" "Detected in some" 5 "Collecting duct cells: 21.0;Hepatocytes: 38.9;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.1;OE19: 14.9;RPMI-8226: 13.9;RPTEC TERT1: 9.1;SuSa: 13.6;U-266/70: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles NA NA Vesicles "HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133" "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favorable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.7 0.2 0.1 3.0 0.8 0.6 4.9 0.3 0.8 4.6 0.2 0.1 0.1 64.1 13.1 0.8 0.1 0.1 0.1 0.5 1.3 1.5 0.9 0.8 0.1 0.2 0.1 0.3 11.2 0.4 0.1 1.1 0.6 0.1 0.1 0.1 0.2 1.1 0.1 0.1 36.3 0.4 0.5 0.6 0.1 0.2 0.0 0.1 0.0 0.2 0.8 0.1 0.0 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.6 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 14.9 0.1 0.0 0.1 13.9 9.1 2.9 1.6 0.0 0.0 0.1 0.0 13.6 2.0 0.0 0.1 0.3 0.4 0.0 0.1 6.4 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.0 5.1 0.0 0.8 0.1 0.4 0.4 7.6 0.0 0.0 21.0 0.0 0.3 8.3 1.0 0.9 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.0 38.9 0.1 3.2 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 75.4 0.0 0.0 0.0 1.1 0.9 0.4 0.1 0.0 0.3 4.9 WDR78 "DIC4, FLJ23129" ENSG00000152763 "WD repeat domain 78" Q5VTH9 1 66812885-66924887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.7;testis: 29.8" "Group enriched" "Detected in many" 5 "Ciliated cells: 310.5;Early spermatids: 118.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.8;RPTEC TERT1: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.26e-2)" "unprognostic (4.04e-1)" "unprognostic (1.58e-3)" "unprognostic (2.19e-2)" "unprognostic (1.85e-1)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (8.19e-2)" "unprognostic (4.00e-1)" "unprognostic (1.68e-3)" "unprognostic (2.08e-2)" "prognostic favorable (9.60e-5)" "unprognostic (1.98e-1)" "unprognostic (5.79e-2)" "unprognostic (5.03e-2)" "unprognostic (1.69e-1)" 1.6 2.0 3.1 2.7 7.5 0.3 3.0 0.9 3.9 4.2 5.1 4.0 4.0 0.9 3.1 16.0 0.9 25.7 2.5 1.7 4.2 4.1 6.8 1.3 5.6 1.0 2.0 4.0 7.6 2.0 6.3 7.0 2.1 16.8 2.4 4.0 2.4 2.1 5.8 0.9 1.3 1.2 1.5 2.4 1.2 1.2 29.8 3.3 1.6 6.2 1.1 0.9 1.7 1.5 1.6 0.0 0.2 0.0 7.6 1.0 0.2 3.3 1.4 1.8 2.5 5.8 8.8 0.6 1.5 2.6 2.0 2.0 0.3 2.9 1.7 0.3 1.5 5.9 0.3 1.4 0.3 3.0 0.2 0.4 0.5 0.7 0.3 2.0 0.1 0.1 4.0 4.2 7.2 1.5 6.9 0.7 1.8 0.5 0.1 3.2 1.2 0.7 0.5 2.4 1.1 0.7 0.8 0.0 0.0 13.6 0.0 2.3 1.1 1.5 0.6 1.2 2.0 0.6 1.2 0.3 0.8 0.0 5.5 0.7 0.5 0.0 3.8 1.6 0.4 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.7 0.6 0.3 0.0 1.6 1.0 0.4 0.2 7.6 0.0 0.0 0.1 0.2 3.1 7.5 0.9 3.9 4.2 4.1 2.0 4.0 16.8 3.3 6.0 4.6 0.0 1.7 1.1 3.1 6.5 0.0 310.5 40.9 15.7 17.7 1.4 13.3 2.7 118.7 1.4 2.1 0.0 1.4 0.4 1.8 0.8 3.5 1.0 0.6 1.6 4.1 3.1 0.3 19.1 9.8 0.1 0.0 1.8 3.8 3.8 1.8 5.1 9.2 8.4 11.9 0.0 3.3 21.7 1.3 0.6 0.6 0.0 2.6 0.9 WDR86 ENSG00000187260 "WD repeat domain 86" Q86TI4 7 151375909-151410727 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 33.8" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 2.7;Fibroblasts: 3.8;Muller glia cells: 9.1;Peritubular cells: 2.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 14.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 16.8;NTERA-2: 3.1;SCLC-21H: 7.1;SH-SY5Y: 5.1;SuSa: 4.8" "Group enriched" "Detected in many" 4 "basal ganglia: 1.5;cerebellum: 1.4;hippocampal formation: 4.4;pons and medulla: 3.6;thalamus: 2.7" "Low region specificity" "Detected in all" NA NA "unprognostic (8.93e-3)" "unprognostic (1.83e-2)" "unprognostic (3.13e-4)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.34e-2)" "unprognostic (6.02e-2)" "unprognostic (1.14e-2)" "unprognostic (6.32e-3)" "unprognostic (2.20e-1)" "unprognostic (1.84e-6)" "unprognostic (7.22e-2)" "unprognostic (1.96e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-1)" 7.4 1.7 6.8 0.9 4.2 0.7 5.0 0.6 4.7 11.1 5.6 1.5 15.7 1.8 7.7 8.8 0.9 8.2 2.1 1.1 5.5 1.0 2.3 0.8 1.0 2.1 2.4 2.4 4.5 0.7 21.7 5.0 5.6 3.2 2.9 0.7 14.7 1.9 11.3 1.2 0.7 1.7 1.9 1.3 15.6 2.6 1.9 0.3 0.8 33.8 0.4 0.8 2.3 4.5 0.0 0.0 0.0 0.7 0.7 1.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.0 0.0 4.8 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 6.8 4.2 0.6 4.7 5.5 1.0 2.4 2.4 3.2 0.3 0.0 0.3 0.0 0.2 0.0 0.2 1.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 3.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.8 0.0 9.1 0.0 0.0 2.8 0.0 0.6 0.0 2.0 0.0 0.1 0.3 0.7 0.7 0.0 0.1 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 25.2" "Group enriched" "Detected in some" 15 "Early spermatids: 24.8;Late spermatids: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 6.4" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: AB_2681093" "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.3 0.5 0.4 1.1 0.6 1.0 0.3 0.7 1.4 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.7 0.2 0.6 1.2 0.4 0.4 0.3 0.3 0.3 1.6 0.3 0.3 1.0 1.0 0.0 0.5 0.3 0.3 0.3 0.0 0.3 1.1 0.3 0.3 0.9 0.9 0.3 0.3 0.6 0.3 25.2 0.3 0.3 1.4 0.3 0.3 0.3 0.3 1.2 0.6 0.6 1.3 2.9 1.4 0.3 1.0 2.2 1.5 2.7 0.8 0.0 2.0 0.8 0.0 0.2 0.0 1.1 2.2 2.7 1.4 0.0 1.6 0.8 0.0 0.3 0.0 5.5 0.8 2.5 1.7 0.5 0.0 1.9 2.2 0.0 0.0 0.0 0.0 0.6 0.0 6.4 1.7 2.8 0.0 3.2 1.1 1.2 1.1 0.9 0.9 2.1 0.8 0.5 0.0 1.3 3.9 3.9 2.7 1.2 0.6 1.9 3.4 2.0 1.5 0.7 2.1 1.2 0.4 2.6 1.8 1.5 0.4 4.2 1.1 0.0 0.4 0.4 1.4 1.3 1.3 0.0 1.2 1.0 0.3 1.2 0.8 0.7 0.6 2.9 0.6 0.6 0.2 0.3 0.4 0.6 0.7 0.8 0.4 0.4 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 0.0 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641861 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 13.2 12.6 11.5 11.6 13.4 4.6 13.7 19.3 18.8 12.5 10.3 9.5 7.4 8.0 14.6 11.5 10.5 11.9 8.6 8.1 11.0 10.7 14.8 16.1 9.1 17.8 15.7 11.6 15.0 14.0 16.2 16.3 12.9 12.3 12.0 12.1 8.3 8.7 8.4 13.2 10.8 8.9 10.5 11.8 13.8 8.5 8.6 14.4 21.0 16.9 7.6 17.0 11.6 10.2 7.0 4.3 0.6 3.6 8.4 14.0 4.9 25.1 11.0 13.7 7.3 8.3 9.0 19.6 10.2 5.6 10.3 11.5 7.8 11.9 24.5 8.4 3.0 7.1 11.7 16.7 9.9 18.3 15.8 9.6 16.6 6.9 9.7 10.5 21.1 11.5 8.2 12.8 11.8 17.7 6.4 10.0 18.2 13.5 13.6 7.7 12.6 17.6 12.0 12.3 18.0 21.9 13.0 13.9 13.7 11.4 9.7 11.7 9.6 10.9 11.7 7.7 13.8 13.5 11.5 6.8 12.5 11.8 8.1 12.1 7.9 5.8 15.0 5.6 15.5 8.8 0.0 2.5 0.3 8.2 2.5 10.5 7.0 8.7 7.5 4.3 6.9 14.0 12.1 0.6 8.4 3.6 2.8 8.7 4.9 11.5 13.4 19.3 18.8 11.0 10.7 15.7 11.6 12.3 14.4 8.9 4.1 4.5 10.0 8.7 6.6 4.0 5.1 1.4 9.1 5.2 3.9 9.1 11.6 6.2 2.2 5.8 2.6 0.0 4.8 11.5 4.5 6.4 1.1 7.8 5.6 1.6 3.5 6.2 6.0 3.6 4.0 4.0 3.3 3.6 4.2 6.5 3.2 0.0 6.0 6.2 8.2 12.9 4.3 6.2 12.6 9.5 5.8 5.2 5.0 5.5 WDR93 ENSG00000140527 "WD repeat domain 93" Q6P2C0 15 89690797-89743638 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.0;testis: 28.6" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 58.9;Cone photoreceptor cells: 19.6;Early spermatids: 41.0;Late spermatids: 27.2;Spermatocytes: 24.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA046196, HPA048112" Uncertain Uncertain "Actin filaments" NA NA "Actin filaments" "HPA046196: AB_2679582, HPA048112: AB_2680267" "unprognostic (2.56e-3)" "unprognostic (3.21e-3)" "unprognostic (7.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.90e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-2)" "unprognostic (2.08e-2)" "unprognostic (1.22e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.40e-2)" "unprognostic (4.73e-2)" "unprognostic (9.84e-2)" "unprognostic (4.44e-2)" 0.5 0.3 1.2 0.7 2.3 0.8 1.1 1.1 1.4 1.2 0.2 3.7 0.0 0.0 0.6 8.0 0.1 12.0 0.3 1.6 1.6 1.6 2.5 0.2 1.3 0.3 0.3 0.4 1.7 0.8 0.4 3.0 0.2 6.2 0.9 0.2 2.5 1.1 1.9 0.3 0.4 0.2 0.0 0.5 0.3 0.2 28.6 1.2 0.1 3.3 0.0 0.2 0.2 0.1 0.5 1.1 2.2 0.3 1.3 0.6 0.2 1.1 1.0 0.1 0.5 1.3 1.0 1.5 1.0 0.5 1.2 0.7 0.5 2.8 0.6 1.1 0.7 0.4 0.7 0.1 0.8 1.9 1.3 0.8 0.8 1.3 0.6 1.8 1.1 0.2 1.6 2.0 0.4 0.1 0.5 0.3 1.1 0.1 0.9 0.9 1.0 1.0 0.5 1.5 0.4 0.6 0.4 0.4 0.4 2.7 0.6 3.4 0.8 2.8 0.8 3.7 0.9 0.5 1.8 0.0 1.0 0.8 1.6 0.6 0.5 0.9 0.9 1.2 0.4 0.7 1.2 0.3 0.4 0.5 0.3 0.2 0.2 0.3 0.2 0.3 0.5 0.3 0.6 2.2 1.3 0.2 1.1 0.2 0.2 1.2 2.3 1.1 1.4 1.6 1.6 0.3 0.4 6.2 1.2 3.0 0.3 0.0 0.5 0.2 3.0 0.3 0.0 58.9 5.7 8.7 19.6 0.3 3.3 0.7 41.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.0 0.0 0.2 3.2 0.0 0.6 0.8 27.2 1.4 0.7 1.7 1.0 0.0 0.6 0.2 0.0 0.7 1.3 14.9 0.0 0.1 24.5 5.9 0.1 0.2 0.7 0.0 0.2 WDR97 KIAA1875 ENSG00000179698 "WD repeat domain 97" A6NE52 8 144107726-144118315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.1;testis: 7.8" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 6.5;Cone photoreceptor cells: 5.9;Horizontal cells: 4.8;Muller glia cells: 5.4;Rod photoreceptor cells: 9.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 7 "pons and medulla: 4.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.2;NB-4: 1.1;PC-3: 2.8;U-2 OS: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059409 Uncertain NA NA "HPA059409: AB_2684005" "unprognostic (3.95e-2)" "unprognostic (1.31e-2)" "unprognostic (3.58e-3)" "unprognostic (1.70e-1)" "unprognostic (2.70e-1)" "unprognostic (3.01e-4)" "unprognostic (3.10e-2)" "unprognostic (2.40e-1)" "unprognostic (6.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.97e-3)" "unprognostic (6.92e-2)" "unprognostic (6.11e-6)" "unprognostic (2.79e-3)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (3.73e-4)" 0.1 0.5 0.2 0.2 0.1 0.6 0.0 0.2 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.0 4.1 0.1 0.2 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.1 0.2 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.9 0.3 1.3 0.8 0.1 0.2 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.5 0.4 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.3 1.2 0.1 0.2 0.1 0.4 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.1 2.8 0.2 0.4 0.2 0.0 0.6 0.4 0.4 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.6 0.3 0.2 0.4 0.1 0.7 0.3 0.4 0.2 0.0 0.7 0.8 0.4 0.9 1.3 0.2 0.6 0.1 0.1 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.0 4.1 0.0 0.0 1.7 0.0 0.2 0.0 6.5 0.0 0.0 1.4 0.0 0.0 5.9 0.1 1.7 0.5 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.7 0.2 4.8 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.5 5.4 0.5 0.3 0.0 0.0 9.1 0.0 0.0 3.4 1.7 0.0 0.0 0.0 0.4 0.1 WFDC1 PS20 ENSG00000103175 "WAP four-disulfide core domain 1" Q9HC57 16 84294646-84329851 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 64.5" "Group enriched" "Detected in many" 5 "Bipolar cells: 68.7;Peritubular cells: 241.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 19.1;BJ: 13.0;HEL: 10.9;HeLa: 17.4;THP-1: 6.3;U-937: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031411 Uncertain "Secreted to extracellular matrix" NA NA "HPA031411: AB_10600921" "unprognostic (6.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.61e-2)" "unprognostic (8.66e-4)" "unprognostic (1.41e-2)" "unprognostic (1.50e-3)" "unprognostic (1.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.78e-2)" "unprognostic (5.49e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (3.04e-1)" 3.9 12.0 6.3 4.2 5.5 0.9 1.9 7.0 5.9 15.8 28.8 2.2 12.0 3.9 11.4 8.3 10.6 3.4 64.5 2.8 5.5 5.0 8.7 1.9 16.0 2.5 3.7 4.3 3.3 0.6 0.3 2.2 40.7 1.9 29.9 7.5 43.8 4.2 50.6 1.2 1.1 6.6 47.5 1.7 1.9 8.9 9.4 0.7 0.0 2.0 4.6 2.2 30.3 5.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 19.1 0.0 0.1 0.1 13.0 1.6 0.0 0.0 0.0 0.0 0.0 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.2 0.0 0.0 1.4 0.0 0.0 3.6 0.1 0.0 0.3 2.1 0.0 0.1 6.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.3 5.5 7.0 5.9 5.5 5.0 3.7 4.3 1.9 0.7 3.0 0.3 0.0 0.9 1.5 68.7 1.1 0.0 1.4 0.0 1.8 0.0 1.8 10.0 0.0 23.3 2.0 0.2 0.0 0.0 1.7 14.3 1.2 0.0 0.0 5.5 4.8 4.1 19.0 0.0 20.9 14.7 0.0 0.0 0.0 4.2 1.2 0.1 0.0 241.9 1.0 3.9 0.0 30.9 0.7 0.9 0.4 3.2 0.0 3.3 0.8 WFDC10B WAP12 ENSG00000182931 "WAP four-disulfide core domain 10B" Q8IUB3 20 45684653-45705019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 27.3;testis: 5.9;urinary bladder: 8.0" "Group enriched" "Detected in some" 5 "Early spermatids: 4.4;Late spermatids: 7.3;Rod photoreceptor cells: 8.7;Spermatocytes: 3.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;Daudi: 2.7;HHSteC: 2.3;hTEC/SVTERT24-B: 1.8;PC-3: 5.7;U-87 MG: 2.6" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (2.31e-1)" "unprognostic (1.37e-4)" "unprognostic (1.60e-1)" "unprognostic (2.69e-1)" "unprognostic (4.81e-2)" "unprognostic (4.30e-3)" "unprognostic (5.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.36e-1)" "unprognostic (0.00e+0)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" "unprognostic (2.21e-2)" "unprognostic (3.17e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.2 0.0 0.3 27.3 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 1.0 0.5 0.2 0.2 0.2 0.2 1.5 0.2 0.3 0.2 0.2 0.4 5.9 0.2 0.2 0.2 0.2 0.2 8.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 2.0 2.7 0.1 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 1.8 0.0 1.7 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.8 1.8 5.7 0.0 0.3 0.0 0.6 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 8.7 0.0 0.0 3.2 0.2 0.0 0.1 0.0 0.0 0.3 WFDC3 "dJ447F3.3, WAP14" ENSG00000124116 "WAP four-disulfide core domain 3" Q8IUB2 20 45747944-45791932 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "skin 1: 14.9;testis: 45.2" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 81.6;Late spermatids: 127.9;Spermatocytes: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enhanced" "Detected in single" "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HUVEC TERT2: 1.0;PC-3: 5.0" "Secreted in male reproductive system" NA NA "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (2.64e-1)" "unprognostic (2.39e-2)" "unprognostic (1.06e-1)" "unprognostic (5.75e-2)" "unprognostic (9.30e-4)" "unprognostic (6.63e-3)" "unprognostic (4.02e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-3)" "unprognostic (1.79e-1)" "unprognostic (1.36e-8)" "unprognostic (8.53e-2)" "unprognostic (2.45e-1)" "unprognostic (5.27e-3)" "unprognostic (3.03e-2)" 0.4 0.1 0.2 0.3 1.1 0.0 1.8 0.2 1.0 0.1 0.2 1.4 1.3 0.5 0.2 1.1 0.1 0.9 0.1 0.3 0.5 0.2 0.1 0.1 0.2 0.0 0.5 0.4 0.1 0.2 0.0 1.1 0.1 0.6 0.2 0.2 0.0 0.0 0.6 0.1 14.9 0.1 1.2 0.5 0.1 0.1 45.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.5 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 5.0 0.2 0.5 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 1.0 0.5 0.2 0.5 0.4 0.6 0.4 0.0 1.6 0.0 4.4 1.0 1.0 0.8 0.0 5.3 11.4 3.5 5.9 0.3 10.0 1.3 81.6 0.1 2.9 0.0 8.9 0.6 2.2 4.2 1.1 0.4 1.0 0.0 3.5 3.1 1.2 127.9 1.4 0.0 0.0 0.0 6.8 1.4 7.6 2.5 2.5 3.0 30.4 0.0 1.4 67.1 2.5 2.8 0.0 0.0 0.9 11.2 WFDC5 "dJ211D12.5, WAP1" ENSG00000175121 "WAP four-disulfide core domain 5" Q8TCV5 20 45109452-45115172 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 99.0" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 49.6;Early spermatids: 17.0;Suprabasal keratinocytes: 37.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBEC3-KT: 2.4;Karpas-707: 3.8;RT4: 3.5" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.32e-1)" "unprognostic (3.22e-2)" "unprognostic (3.05e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-4)" "unprognostic (6.59e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.32e-5)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.4 0.7 0.2 99.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.8 0.0 22.6 11.4 0.2 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.3 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.4 49.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 37.8 0.0 0.0 0.0 0.3 WFDC6 "C20orf171, dJ461P17.11, WAP6" ENSG00000243543 "WAP four-disulfide core domain 6" Q9BQY6 20 45534196-45539495 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "epididymis: 79.9;testis: 25.5" "Cell type enriched" "Detected in some" 16 "Ciliated cells: 56.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-87 MG: 7.8" "Secreted in male reproductive system" NA NA "unprognostic (3.68e-3)" "unprognostic (2.21e-3)" "unprognostic (1.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.91e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 7.6 0.0 0.2 79.9 0.1 2.8 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.0 25.5 0.1 0.1 0.3 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.2 3.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.1 WFDC8 "C20orf170, dJ461P17.1, WAP8" ENSG00000158901 "WAP four-disulfide core domain 8" Q8IUA0 20 45551153-45579326 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "epididymis: 103.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "U-87 MG: 7.8" "Not detected" "Not detected" "HPA042710, HPA071119" Enhanced "Secreted in male reproductive system" NA NA "HPA042710: AB_2732501, HPA071119: AB_2732172" "unprognostic (5.63e-3)" "unprognostic (1.09e-2)" "unprognostic (2.34e-1)" "unprognostic (9.96e-2)" "unprognostic (1.07e-2)" 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 5.6 0.0 1.0 103.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.1 0.1 1.0 0.6 1.0 0.9 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 7.8 0.0 0.1 0.6 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.1 0.1 1.0 0.4 0.4 1.0 0.7 0.4 0.6 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WNT16 ENSG00000002745 "Wnt family member 16" Q9UBV4 7 121325367-121341104 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4" "Group enriched" "Detected in some" 49 "Basal keratinocytes: 9.0;Suprabasal keratinocytes: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 125 "memory B-cell: 13.1;naive B-cell: 11.8" "Lineage enriched" "Detected in single" 132 "B-cells: 13.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.2;HEK 293: 10.0;hTEC/SVTERT24-B: 3.0;U-2197: 4.9;U-266/70: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "unprognostic (6.53e-2)" "unprognostic (3.63e-2)" "unprognostic (7.24e-2)" "unprognostic (1.90e-2)" "unprognostic (2.94e-3)" "unprognostic (5.23e-2)" "unprognostic (1.77e-2)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (1.94e-1)" "unprognostic (3.77e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-10)" "unprognostic (5.89e-3)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" 0.3 0.5 0.8 0.7 1.0 0.2 2.0 0.9 2.2 19.7 1.0 0.2 11.7 0.2 2.1 7.9 0.3 0.4 0.3 0.2 0.8 0.4 0.2 0.4 0.4 1.3 0.8 0.9 0.1 0.2 0.1 0.6 0.8 1.6 1.0 0.3 0.0 0.5 4.0 0.3 24.4 0.7 0.3 2.3 1.2 0.3 0.6 0.8 0.0 0.2 0.0 0.6 0.5 5.5 13.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.2 0.3 4.2 0.3 0.0 0.9 0.2 1.0 0.0 0.0 0.1 0.0 10.0 0.0 0.4 0.1 0.0 0.0 0.0 1.9 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 4.9 0.5 3.0 0.1 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.0 0.9 2.2 0.8 0.4 0.8 0.9 1.6 0.8 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.0 0.0 0.0 0.0 0.0 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117276631-117323289 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 10.4;lung: 10.9;placenta: 40.9" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 21.6" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in all" HPA020920 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 1.8 0.0 0.2 0.1 1.1 0.0 1.4 0.3 2.3 3.0 0.2 0.4 0.4 0.0 10.4 2.7 0.4 1.0 0.2 0.7 0.9 0.9 0.3 0.8 10.9 0.0 0.1 0.5 0.8 0.1 0.0 0.2 40.9 0.5 7.6 0.0 0.9 0.1 0.5 0.0 1.1 0.2 1.2 0.2 1.5 0.1 0.7 0.0 0.0 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 2.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 2.3 0.9 0.9 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.0 24.8 0.4 0.0 0.0 0.0 2.9 9.4 0.2 0.0 0.0 6.8 0.0 0.0 11.1 1.0 7.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 1.6 0.1 2.4 7.6 0.0 0.0 0.1 WNT5B ENSG00000111186 "Wnt family member 5B" Q9H1J7 12 1529891-1647243 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Muller glia cells: 42.4;Urothelial cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6" "Cell line enhanced" "Detected in many" "BJ: 51.9;BJ hTERT+: 32.6;BJ hTERT+ SV40 Large T+: 38.0;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 36.2;HBF TERT88: 33.4;hTEC/SVTERT24-B: 33.2;U-138 MG: 33.0" "Low region specificity" "Detected in many" HPA061991 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA061991: " "unprognostic (7.44e-2)" "unprognostic (5.59e-2)" "unprognostic (8.14e-2)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-1)" "unprognostic (5.53e-3)" "unprognostic (1.26e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (4.08e-2)" "unprognostic (2.16e-2)" "unprognostic (1.49e-3)" "unprognostic (1.90e-1)" "unprognostic (2.93e-2)" "unprognostic (2.77e-1)" "unprognostic (2.71e-2)" 4.1 1.7 1.6 6.5 3.4 0.1 4.1 1.0 1.7 8.0 14.1 1.3 19.4 3.0 6.3 6.2 11.9 4.8 3.6 2.9 1.4 3.0 2.7 3.3 2.7 4.0 1.8 0.5 5.3 0.7 13.6 7.1 2.7 2.3 23.4 4.4 5.8 14.2 16.5 0.7 3.4 5.2 17.8 1.4 4.3 4.0 1.7 1.0 2.9 1.2 5.1 5.0 23.3 14.3 0.0 2.1 3.5 4.6 0.0 0.2 1.3 0.0 0.0 0.3 0.0 8.1 14.4 0.0 51.9 32.6 38.0 31.6 1.9 0.2 0.6 0.1 36.2 25.6 0.7 0.7 0.0 33.4 12.0 1.7 2.8 0.0 0.0 2.0 0.0 0.0 12.0 0.7 33.2 9.5 15.4 0.0 0.0 2.0 11.8 8.9 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.5 0.8 0.4 0.0 0.2 0.7 1.1 0.1 0.0 4.2 0.0 0.2 0.0 33.0 1.3 12.9 26.4 3.2 0.4 0.1 3.2 0.0 0.3 0.0 4.6 3.5 0.0 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.3 1.6 3.4 1.0 1.7 1.4 3.0 1.8 0.5 2.3 1.0 0.0 1.1 0.0 10.4 0.8 1.1 1.6 0.0 4.0 3.4 0.0 0.0 0.8 0.0 0.8 0.1 0.5 1.0 0.0 0.6 0.7 3.3 9.8 0.0 1.5 4.1 0.0 0.0 0.6 1.9 0.2 2.0 1.3 3.3 5.4 2.2 42.4 1.7 4.8 2.5 0.0 2.8 6.5 2.3 0.5 5.3 1.1 0.6 0.0 1.9 15.0 WNT8B ENSG00000075290 "Wnt family member 8B" Q93098 10 100463041-100483744 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.3;parathyroid gland: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 5.6;JURKAT: 7.3;RPMI-8226: 2.2;SCLC-21H: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036570 Uncertain "Secreted to extracellular matrix" NA NA "HPA036570: AB_10670113" "unprognostic (6.92e-2)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (6.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.90e-1)" "unprognostic (2.64e-1)" "unprognostic (9.16e-4)" "unprognostic (1.95e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (7.83e-2)" "unprognostic (2.42e-3)" "unprognostic (5.02e-2)" "unprognostic (1.63e-1)" "unprognostic (2.68e-2)" "unprognostic (1.24e-2)" 0.2 3.3 0.2 0.2 0.5 0.0 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.4 2.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 3.8 0.5 0.2 0.2 0.7 0.0 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.1 2.6 0.2 2.2 0.2 0.2 0.2 1.6 0.2 0.0 0.3 0.7 0.0 0.0 1.3 0.3 0.0 0.0 5.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.5 1.1 0.0 0.0 0.2 0.0 1.5 0.2 0.0 0.1 0.0 0.0 0.3 0.0 7.3 0.0 0.6 0.0 1.5 1.9 0.0 0.0 0.1 0.3 0.6 0.0 2.2 0.0 1.6 2.6 0.7 0.0 0.0 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.7 0.0 0.0 0.3 0.0 0.3 0.2 0.5 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WSB2 "MGC10210, SBA2" ENSG00000176871 "WD repeat and SOCS box containing 2" Q9NYS7 12 118032694-118062430 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052606 Uncertain NA NA "HPA052606: AB_2681882" "unprognostic (5.02e-3)" "unprognostic (4.57e-2)" "unprognostic (4.85e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.91e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.42e-3)" "unprognostic (4.66e-3)" "unprognostic (7.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.93e-1)" "unprognostic (4.05e-1)" "unprognostic (2.92e-1)" "unprognostic (2.66e-1)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" 15.6 21.2 50.8 13.3 39.3 7.8 19.2 20.2 61.7 10.0 20.8 16.7 7.1 16.5 9.0 12.1 25.0 8.6 12.1 25.5 44.3 29.3 17.3 19.8 14.5 10.3 39.7 26.5 6.8 17.9 14.8 14.0 9.0 21.7 13.2 22.1 9.4 8.2 13.4 41.9 9.9 17.9 16.6 37.4 8.6 14.9 8.6 12.7 5.6 22.4 17.9 12.7 18.4 7.6 2.3 4.9 13.5 8.8 3.8 6.0 2.1 11.2 18.3 13.2 22.5 19.8 11.5 9.4 30.3 22.7 33.1 20.1 9.5 16.0 1.6 10.1 39.6 18.6 6.1 11.0 18.4 24.2 20.5 7.1 6.2 9.1 9.2 20.8 3.6 17.1 15.5 18.8 17.6 12.5 36.4 17.4 11.2 18.5 3.1 34.5 16.9 2.3 2.4 7.8 26.0 11.4 6.6 13.8 0.5 20.4 49.4 14.2 21.1 23.4 5.2 16.7 13.9 18.0 8.9 26.6 40.1 16.8 12.7 36.3 5.1 3.3 3.2 36.0 4.8 63.4 9.3 6.4 13.5 5.9 8.8 5.2 0.9 5.8 6.0 4.2 2.3 2.8 4.7 6.6 3.8 5.9 4.9 5.9 2.1 50.8 39.3 20.2 61.7 44.3 29.3 39.7 26.5 21.7 12.7 23.8 14.9 6.0 32.4 14.7 20.6 31.9 22.9 2.7 10.3 19.2 3.9 8.5 18.3 30.5 1.6 12.4 44.3 0.0 72.6 20.1 14.9 42.2 6.9 32.1 31.8 54.0 69.9 19.6 43.0 1.8 6.9 18.0 27.0 33.3 33.5 20.0 74.0 32.5 16.3 27.0 12.0 12.9 18.6 2.7 3.7 16.3 14.4 10.2 20.6 55.9 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Group enriched" "Detected in many" 6 "Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.4 0.1 0.0 0.0 7.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 13.4 0.0 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.9 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 0.0 0.0 0.0 0.0 0.3 5.6 2.8 0.0 0.0 0.0 1.8 0.0 0.7 1.7 0.3 70.9 3.0 18.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.9 1.6 0.0 8.0 0.3 67.5 0.6 0.0 1.7 0.0 2.8 9.1 0.3 5.7 0.0 1.2 2.8 0.0 1.4 0.5 2.8 0.5 0.0 0.0 5.6 0.1 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Group enriched" "Detected in some" 10 "Bipolar cells: 35.7;Horizontal cells: 20.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enriched" "Detected in some" 21 "RT4: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 0.0 0.0 0.5 0.0 0.1 35.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.6 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 XG PBDX ENSG00000124343 "Xg blood group" P55808 X 2752048-2816500 "Blood group antigen proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8" "Group enriched" "Detected in some" 8 "Basal keratinocytes: 12.8;Melanocytes: 10.1;Suprabasal keratinocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 2.1;naive B-cell: 1.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.1" "Group enriched" "Detected in some" 6 "ASC diff: 34.4;ASC TERT1: 25.6;fHDF/TERT166: 16.1;hTCEpi: 23.9;T-47d: 12.9" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (4.25e-4)" "unprognostic (1.69e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" "unprognostic (8.62e-2)" "unprognostic (7.21e-2)" "unprognostic (2.30e-1)" "unprognostic (8.10e-6)" "unprognostic (3.96e-3)" "unprognostic (7.98e-2)" "unprognostic (5.83e-3)" "unprognostic (6.77e-3)" 8.9 0.0 0.3 0.3 0.6 0.8 9.1 0.5 0.6 22.8 0.3 0.3 0.3 0.0 2.6 0.3 7.1 0.6 3.0 1.2 1.4 0.0 1.3 0.3 0.3 0.3 0.6 0.3 1.1 0.3 0.0 0.3 18.4 1.9 0.5 0.0 0.3 4.1 0.4 1.4 25.8 0.3 0.3 4.2 0.3 0.1 0.3 0.3 0.3 0.9 0.3 2.4 1.2 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 25.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 23.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 1.7 0.0 12.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.6 1.4 0.0 0.6 0.3 1.9 0.3 0.0 0.0 0.0 0.6 12.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.5 19.2 0.5 0.0 0.0 0.1 XKR3 "MGC57211, XTES" ENSG00000172967 "XK related 3" Q5GH77 22 16783412-16821699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "blood: 4.7;testis: 13.5" "Cell type enriched" "Detected in some" 15 "Early spermatids: 93.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 1.5;neutrophil: 4.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 4.7" "Cell line enriched" "Detected in some" 16 "Karpas-707: 73.1" "HPA003379, HPA035081" Uncertain NA NA "HPA003379: AB_10602682, HPA035081: AB_2674451" "unprognostic (4.57e-1)" "unprognostic (3.37e-1)" "unprognostic (3.11e-2)" "unprognostic (3.13e-2)" "unprognostic (5.77e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.5 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.1 0.0 0.0 0.0 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102389-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 25.5;Club cells: 17.0;Cone photoreceptor cells: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "REH: 3.7;RPTEC TERT1: 15.0" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles NA NA Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 1.2 1.4 18.7 4.3 5.6 0.8 0.7 4.4 12.1 2.1 5.1 0.6 0.3 1.5 1.0 1.4 2.5 1.1 1.4 2.6 8.6 4.5 0.9 0.7 0.7 2.0 2.0 8.8 0.9 1.1 0.5 5.3 0.6 2.0 1.2 2.2 2.5 2.0 2.9 0.8 1.4 2.0 3.5 1.2 0.9 1.5 0.9 3.4 0.6 0.7 0.6 2.3 1.0 1.6 0.8 0.3 2.2 0.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.7 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.8 0.2 0.3 1.2 0.7 0.1 0.3 0.1 0.1 18.7 5.6 4.4 11.5 8.6 4.5 2.0 8.8 2.0 3.4 8.9 25.5 0.0 0.5 0.3 6.5 1.4 0.0 9.4 17.0 3.5 33.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 1.1 8.5 2.8 0.0 0.6 0.7 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.7 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201366 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 13.7;Horizontal cells: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 6.2;U-266/84: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA024828: AB_2215165, HPA064769: AB_2732720" "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 2.0 2.9 3.0 4.8 13.1 4.1 2.5 21.4 6.3 1.9 2.7 1.4 1.9 1.7 2.4 1.3 3.8 2.2 2.0 1.5 3.4 1.6 2.3 1.0 2.7 3.9 1.3 4.4 0.9 5.1 3.3 8.8 1.2 5.3 3.2 2.1 1.1 5.2 5.0 0.8 3.9 3.3 1.6 1.4 3.8 3.3 7.5 2.4 0.1 3.0 0.2 3.6 3.0 2.3 1.3 0.6 0.0 0.0 1.2 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.6 0.6 1.8 0.0 0.5 5.0 0.0 1.0 3.0 0.2 2.2 2.7 0.9 0.1 0.6 1.6 0.2 0.0 0.9 0.0 4.3 0.5 1.8 0.0 2.2 2.2 1.1 0.0 0.1 6.2 0.8 0.5 0.0 0.0 3.3 0.3 1.2 0.0 0.0 1.2 2.4 1.8 3.3 1.9 1.0 0.1 0.0 2.7 0.0 0.8 0.0 2.6 1.3 0.0 0.9 1.8 10.2 4.6 1.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 1.2 0.0 0.6 0.2 0.1 3.0 13.1 21.4 6.3 3.4 1.6 1.3 4.4 5.3 2.4 6.0 0.3 6.4 3.7 1.5 39.8 1.5 5.1 0.0 1.2 3.5 13.7 0.0 1.7 2.0 6.5 1.0 1.0 0.0 4.5 0.0 0.4 3.2 0.0 0.0 0.4 25.4 4.1 4.3 1.0 1.4 0.0 0.0 1.7 0.0 0.7 6.6 3.1 0.9 0.0 0.8 6.0 0.0 1.0 3.5 4.5 1.1 0.0 1.5 1.2 3.1 XKR7 "C20orf159, dJ310O13.4" ENSG00000260903 "XK related 7" Q5GH72 20 31968002-32003387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 28.0;pituitary gland: 12.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Early spermatids: 1.3;Horizontal cells: 1.6;Rod photoreceptor cells: 2.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 21.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.6" HPA040854 Uncertain NA NA "HPA040854: AB_10795481" "unprognostic (2.74e-2)" "unprognostic (5.60e-3)" "unprognostic (8.03e-2)" "unprognostic (3.74e-7)" "unprognostic (4.29e-2)" "unprognostic (9.34e-2)" "unprognostic (1.45e-1)" "unprognostic (2.69e-2)" "unprognostic (4.47e-2)" "unprognostic (2.68e-3)" "unprognostic (2.12e-1)" "unprognostic (1.26e-3)" "unprognostic (3.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-5)" "unprognostic (1.99e-1)" 0.5 1.5 2.9 0.6 4.4 0.5 0.4 28.0 10.0 0.4 0.5 0.0 0.0 0.6 0.4 0.5 0.4 0.5 0.5 0.4 1.2 1.5 0.5 0.4 0.5 0.4 0.8 4.6 0.4 1.8 0.4 12.3 0.4 3.5 0.4 0.6 2.0 0.4 0.5 0.4 0.5 0.5 0.4 0.6 0.5 1.7 1.2 0.0 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 21.7 4.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.9 4.4 28.0 8.7 1.2 1.5 0.8 4.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.8 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669365-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.1" "Cell type enriched" "Detected in many" 11 "Spermatocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;hTCEpi: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044430 Enhanced Approved Mitochondria NA NA Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.9 3.4 1.9 0.8 4.3 0.9 1.1 0.6 6.4 0.9 1.7 1.9 0.0 4.9 0.7 2.5 1.1 0.7 4.1 1.0 2.3 1.5 1.0 7.5 2.1 1.0 1.3 7.3 1.0 1.3 0.3 2.1 0.8 7.4 1.4 1.0 2.6 2.0 0.2 0.9 1.7 9.6 3.5 1.7 1.0 3.6 17.1 0.7 0.0 1.0 0.0 1.0 2.5 1.2 1.2 0.3 0.9 0.2 0.6 3.1 0.2 3.9 0.3 0.8 0.4 0.0 1.0 0.6 1.6 0.8 0.5 1.7 5.4 0.4 0.5 2.7 0.1 1.9 0.1 0.1 0.9 2.0 0.8 0.5 0.4 0.3 0.6 0.1 1.2 2.2 1.1 11.1 0.3 0.0 0.5 0.0 2.6 0.2 3.9 0.3 0.5 0.7 0.6 2.2 0.1 0.5 0.5 1.1 0.2 0.3 2.9 2.4 0.4 0.9 1.6 0.5 0.3 0.5 0.2 0.4 0.5 1.1 0.8 0.6 3.4 0.9 2.5 0.2 0.5 0.3 0.9 0.1 0.3 0.9 0.1 1.7 0.9 1.7 0.8 0.1 1.2 2.6 1.7 0.6 0.6 0.2 0.3 3.1 0.2 1.9 4.3 0.6 6.4 2.3 1.5 1.3 7.3 7.4 0.7 6.0 2.1 0.0 3.1 2.4 2.3 0.4 2.5 4.0 4.5 0.0 7.9 0.8 0.0 1.0 4.0 0.1 1.2 0.0 3.9 0.3 0.7 1.1 0.0 0.5 0.3 1.6 0.0 0.0 0.0 2.9 0.9 0.2 0.0 0.0 1.0 1.5 5.3 0.2 0.4 0.3 5.4 0.0 0.3 89.2 5.1 0.6 0.8 0.0 0.1 1.8 XKRX "XKR2, XPLAC" ENSG00000182489 "XK related, X-linked" Q6PP77 X 100913445-100929433 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0" "Cell type enhanced" "Detected in some" 17 "Melanocytes: 1.7;Syncytiotrophoblasts: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 44 "B-cells: 5.0;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "CACO-2: 13.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (3.35e-1)" "unprognostic (2.38e-2)" "unprognostic (4.51e-3)" "unprognostic (1.87e-1)" "unprognostic (8.53e-2)" "unprognostic (2.67e-2)" "unprognostic (2.96e-2)" "unprognostic (5.18e-2)" "unprognostic (3.69e-2)" "unprognostic (7.37e-2)" "unprognostic (5.70e-2)" "unprognostic (1.58e-2)" "unprognostic (5.60e-6)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.18e-1)" 0.1 1.0 0.2 2.1 0.3 0.1 1.1 0.1 0.1 1.2 7.2 0.2 8.3 0.4 0.2 1.9 3.5 1.1 0.5 0.1 0.2 0.4 0.3 0.1 3.3 2.4 0.2 0.0 0.3 0.2 0.0 12.0 12.2 0.2 0.5 1.3 0.0 1.0 1.8 0.2 12.9 6.8 0.0 0.2 0.6 0.5 0.4 0.0 0.8 11.0 1.9 5.4 0.5 2.4 5.0 0.0 0.0 0.0 0.0 3.7 0.6 0.3 1.0 0.1 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 13.2 1.6 1.0 0.1 0.0 1.1 0.2 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 2.5 1.0 0.0 0.1 0.1 0.6 0.1 0.0 0.4 2.5 0.0 0.0 0.0 2.5 0.1 2.1 0.3 1.1 0.2 1.1 0.0 0.3 0.4 0.0 2.3 0.0 0.3 0.0 0.0 2.0 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 5.0 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.2 0.0 0.1 0.3 XRRA1 FLJ00225 ENSG00000166435 "X-ray radiation resistance associated 1" Q6P2D8 11 74807739-74949200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 131.6;Spermatocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039263 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039263: AB_2676419" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" "unprognostic (7.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (3.31e-1)" "unprognostic (1.23e-1)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (5.94e-3)" "unprognostic (2.13e-1)" "unprognostic (3.31e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-1)" 7.1 7.9 6.2 19.5 8.6 3.7 10.7 5.7 7.5 8.6 7.3 7.6 22.9 5.8 9.0 13.5 6.6 9.6 8.7 9.5 7.9 5.9 6.9 8.1 9.5 4.1 5.7 7.0 9.3 22.7 11.9 8.1 5.3 10.8 10.5 5.6 7.4 13.1 16.8 15.7 5.8 5.9 10.1 13.7 7.2 6.4 35.0 6.1 5.6 14.3 4.1 5.8 6.3 7.4 3.5 3.4 6.2 5.2 2.0 8.5 3.0 3.9 2.3 0.5 3.7 5.9 3.9 1.6 1.7 1.9 1.0 1.0 1.2 2.1 1.6 6.4 1.9 8.5 3.2 4.6 2.3 2.2 6.4 0.4 1.4 1.3 2.2 1.7 0.8 0.7 3.7 2.6 4.2 27.9 8.1 2.0 5.4 3.6 3.8 4.9 1.4 1.4 2.0 1.3 4.8 2.0 0.7 3.0 1.2 0.8 3.0 3.6 3.0 8.0 3.4 10.7 1.9 2.1 4.1 1.3 6.0 3.9 4.4 1.6 5.4 4.7 4.4 1.4 0.8 2.0 2.9 4.3 3.8 6.3 5.2 6.6 3.5 4.6 4.7 3.4 3.5 4.6 4.5 6.2 2.0 3.2 2.5 8.5 3.0 6.2 8.6 5.7 7.5 7.9 5.9 5.7 7.0 10.8 6.1 8.9 9.1 42.7 9.6 9.7 52.4 5.5 7.6 14.7 11.4 21.0 131.6 10.3 13.3 6.9 31.4 11.9 13.5 0.0 7.0 8.3 11.6 7.7 11.5 10.2 6.9 46.1 11.6 17.8 10.4 63.5 27.6 7.4 27.0 9.0 13.3 27.7 5.6 14.4 28.7 13.9 79.0 25.8 8.4 100.4 34.9 6.6 9.2 37.0 16.9 5.8 YPEL3 MGC10500 ENSG00000090238 "Yippee like 3" P61236 16 30092314-30096915 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 8.7;eosinophil: 15.6;neutrophil: 24.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 24.8" "Cell line enhanced" "Detected in many" "EFO-21: 29.2;RPMI-8226: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030501, HPA045621" Uncertain NA NA "HPA030501: AB_10602683, HPA045621: " "unprognostic (1.11e-1)" "unprognostic (1.14e-3)" "unprognostic (3.06e-2)" "unprognostic (1.49e-1)" "unprognostic (4.58e-2)" "prognostic favorable (1.09e-4)" "unprognostic (2.06e-1)" "unprognostic (1.47e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-1)" "unprognostic (2.02e-3)" "unprognostic (2.64e-1)" "unprognostic (5.42e-3)" "unprognostic (3.90e-2)" "unprognostic (2.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 32.6 24.5 49.7 26.6 34.7 36.7 27.6 68.4 77.5 17.5 20.5 27.5 15.1 26.1 23.2 14.5 21.6 20.7 19.6 26.0 43.7 32.1 20.1 13.4 28.9 30.1 31.6 37.7 30.5 43.8 25.4 19.1 31.0 38.8 21.4 10.6 19.4 44.8 24.8 77.4 41.0 31.8 13.6 22.5 46.4 27.5 9.1 30.2 20.1 27.9 16.0 25.7 22.3 31.3 2.3 1.0 24.8 1.7 2.7 2.4 0.7 5.0 1.2 3.4 1.1 13.2 13.2 14.4 8.2 5.3 2.0 4.9 0.6 17.3 1.6 29.2 6.1 0.0 2.9 1.9 4.4 0.8 9.9 6.7 1.9 3.5 6.8 9.9 0.0 16.0 21.9 6.1 2.9 0.8 18.5 6.9 0.1 1.6 13.0 2.7 9.6 0.3 1.6 3.1 1.8 1.1 9.1 0.0 37.1 3.9 4.4 7.1 18.8 3.3 4.2 6.7 4.5 5.9 6.2 7.2 0.5 3.6 1.6 0.0 21.9 7.0 2.6 5.8 3.0 1.6 8.7 1.7 15.6 1.3 0.8 1.5 1.8 2.4 1.8 1.0 2.3 2.3 1.3 24.8 2.7 0.7 1.0 2.1 0.7 49.7 34.7 68.4 77.5 43.7 32.1 31.6 37.7 38.8 30.2 38.7 52.0 76.6 81.7 47.9 83.2 47.2 61.1 24.1 25.0 68.0 51.1 136.8 77.9 58.9 21.1 54.7 29.0 140.2 60.7 108.5 42.1 105.3 23.1 17.8 42.7 52.4 45.5 74.3 70.0 25.4 91.2 53.6 30.4 52.3 46.3 96.0 105.6 38.6 60.1 52.5 86.5 58.2 33.0 7.1 14.7 67.2 95.0 63.4 21.6 92.5 YPEL4 FLJ30213 ENSG00000166793 "Yippee like 4" Q96NS1 11 57645087-57649944 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Group enriched" "Detected in many" 5 "Bipolar cells: 32.5;Early spermatids: 30.9;Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 6.2;ASC diff: 3.8;SK-MEL-30: 7.3;SuSa: 3.6;U-87 MG: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045621 Uncertain NA NA "HPA045621: " "unprognostic (6.91e-3)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (8.62e-3)" "unprognostic (2.40e-1)" "unprognostic (7.50e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" "unprognostic (4.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.18e-1)" "unprognostic (1.34e-6)" "unprognostic (1.50e-4)" "unprognostic (9.56e-2)" "unprognostic (1.86e-3)" "unprognostic (2.92e-1)" 2.1 7.5 17.8 1.5 13.5 12.3 2.4 27.4 26.3 5.0 1.7 6.0 0.0 1.9 5.1 1.3 1.9 1.8 3.1 1.9 9.8 10.6 1.1 1.1 1.9 1.3 8.0 17.7 8.7 1.6 1.0 3.5 2.2 8.5 1.3 1.4 0.2 1.4 2.0 1.0 1.6 1.9 3.5 5.3 1.8 1.3 2.5 8.9 0.0 1.1 0.0 1.2 1.6 1.9 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.7 0.1 6.2 0.3 3.8 3.5 0.7 0.2 2.8 0.0 0.0 0.4 0.1 0.1 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 3.3 1.5 0.0 0.4 0.0 2.9 0.0 1.2 0.0 0.2 0.0 0.0 0.9 0.4 2.5 0.2 0.0 2.4 0.7 0.4 0.1 0.0 0.0 1.6 0.3 0.6 7.3 3.6 0.5 0.0 0.0 0.4 1.6 0.0 0.0 2.7 0.0 0.0 3.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 17.8 13.5 27.4 23.1 9.8 10.6 8.0 17.7 8.5 8.9 0.0 0.0 0.8 0.6 1.0 32.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 30.9 1.3 0.0 70.0 0.0 0.2 1.2 0.3 3.5 0.0 0.9 7.9 0.0 0.6 1.5 9.6 1.1 4.2 5.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 2.4 0.0 2.1 0.3 0.0 1.1 2.7 0.0 0.0 0.1 YY2 ZNF631 ENSG00000230797 "YY2 transcription factor" O15391 X 21855987-21858727 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.5" "Cell type enriched" "Detected in many" 8 "Spermatogonia: 52.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001119, HPA030335" Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001119: AB_1858930, HPA030335: AB_2673434" "unprognostic (1.90e-2)" "unprognostic (3.34e-2)" "unprognostic (2.75e-2)" "unprognostic (8.39e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-2)" "unprognostic (4.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (2.21e-2)" "unprognostic (2.03e-1)" "unprognostic (8.78e-4)" "unprognostic (4.04e-1)" "unprognostic (9.38e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" 1.6 1.8 0.7 1.4 0.9 0.3 1.4 1.8 0.8 1.6 1.2 0.3 2.8 1.9 1.3 1.6 1.2 1.2 0.5 0.6 1.0 2.5 1.4 0.7 0.8 3.3 1.4 1.5 2.5 2.2 1.8 0.9 1.3 1.6 1.2 1.8 0.8 2.0 1.1 0.9 0.9 9.5 1.6 0.6 1.1 1.5 1.5 1.2 0.0 0.6 1.4 2.7 0.5 3.6 3.3 2.3 7.3 2.9 1.2 0.3 4.0 2.3 4.7 5.3 2.7 6.1 4.2 2.4 5.2 6.0 2.0 5.0 5.5 8.2 3.0 4.8 1.1 8.9 2.2 5.0 4.5 2.2 2.4 4.1 3.5 5.8 3.6 2.9 1.6 4.2 5.0 8.2 2.5 2.4 4.6 4.3 1.8 4.4 2.3 3.9 6.4 2.5 1.6 1.3 3.3 2.3 2.0 6.6 6.3 3.5 1.5 3.1 8.6 1.7 14.9 4.7 3.4 3.9 2.6 5.6 2.2 6.8 0.0 0.6 0.0 0.8 0.1 0.6 1.5 1.3 0.8 0.6 1.1 2.7 0.6 0.0 1.4 0.4 1.2 1.2 0.5 0.0 1.6 0.0 0.7 0.8 2.3 0.8 0.0 0.0 0.0 1.8 3.9 2.5 0.0 0.8 0.4 1.8 0.4 0.0 0.6 1.1 1.9 1.2 1.1 2.1 1.9 6.4 1.2 1.8 2.2 1.0 5.8 1.8 0.0 3.6 0.3 1.3 1.3 0.0 3.5 0.3 3.4 0.0 0.5 6.9 52.4 1.3 1.7 0.0 0.6 1.1 ZAR1 Z3CXXC6 ENSG00000182223 "Zygote arrest 1" Q86SH2 4 48490252-48494389 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2" "Group enriched" "Detected in some" 13 "Early spermatids: 3.4;Late spermatids: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.3;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.2" "Low region specificity" "Detected in some" NA NA "unprognostic (9.71e-2)" "unprognostic (2.58e-1)" "unprognostic (4.59e-3)" "unprognostic (2.47e-2)" "unprognostic (6.83e-2)" "unprognostic (2.41e-1)" "unprognostic (3.54e-1)" "unprognostic (1.08e-1)" "unprognostic (6.35e-2)" "unprognostic (6.32e-5)" "unprognostic (4.51e-1)" 0.0 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.7 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.2 0.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 ZAR1L Z3CXXC7 ENSG00000189167 "Zygote arrest 1 like" A6NP61 13 32303700-32315344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;gallbladder: 2.7;testis: 3.5" "Cell type enhanced" "Detected in single" 27 "Spermatocytes: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "cerebral cortex: 2.2;thalamus: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;MCF7: 2.2;U-698: 2.4" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.8;cerebral cortex: 2.8;hippocampal formation: 2.2" "Low region specificity" "Detected in many" HPA041319 Uncertain NA NA "HPA041319: AB_10794407" "unprognostic (4.03e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (8.33e-3)" "unprognostic (6.08e-2)" "unprognostic (1.47e-2)" "unprognostic (1.66e-1)" "unprognostic (8.34e-2)" "unprognostic (3.73e-1)" "unprognostic (7.51e-2)" 0.2 0.1 0.1 0.1 0.1 0.8 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.7 0.0 0.1 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 3.5 1.3 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.8 0.5 0.3 0.2 0.0 0.1 0.0 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.6 0.5 3.0 0.3 1.3 0.4 0.0 0.3 0.3 1.3 0.2 0.4 0.6 0.0 0.3 0.5 0.3 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.6 0.5 0.4 0.2 2.2 0.3 0.6 1.1 0.4 0.7 1.2 1.0 0.3 0.0 0.3 0.1 0.2 0.0 0.4 0.2 0.1 0.1 1.0 0.0 0.4 0.0 0.9 0.0 0.8 0.5 2.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.1 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 0.0 0.0 0.0 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167240287-167381346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3" "Group enriched" "Detected in some" 7 "Ciliated cells: 290.4;Early spermatids: 339.8;Late spermatids: 178.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.4;CAPAN-2: 1.7;SCLC-21H: 1.5;SuSa: 5.2;U-87 MG: 1.8" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.3 0.6 2.5 0.3 12.9 0.3 0.3 0.0 3.3 1.3 0.4 4.5 0.0 0.3 1.1 14.2 0.3 23.4 0.3 0.3 4.7 3.9 0.5 0.3 7.2 0.4 0.4 2.6 6.9 0.3 0.8 5.3 0.4 22.0 0.4 0.3 0.0 0.3 0.4 0.4 0.3 0.3 0.4 0.5 0.3 0.4 33.3 3.4 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.2 0.4 0.0 0.0 1.1 0.6 0.0 0.1 0.6 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 12.9 0.0 3.3 4.7 3.9 0.4 2.6 22.0 3.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 290.4 40.9 1.8 0.0 0.0 0.0 0.0 339.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.7 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 21.8 10.0 0.0 0.0 0.0 0.0 0.0 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 21.6 18.5 20.4 32.6 21.6 21.5 27.5 43.2 30.2 35.6 24.7 22.0 17.2 18.4 34.7 27.6 22.5 30.8 19.8 32.7 21.3 13.1 24.0 13.0 24.5 38.1 24.0 23.4 40.2 24.4 42.0 44.6 20.9 27.1 30.1 22.7 16.3 24.9 19.1 32.6 36.8 29.4 22.4 30.5 35.6 22.2 17.2 25.3 45.0 34.9 17.7 32.3 30.0 26.4 18.4 12.4 5.8 8.4 13.4 14.5 6.2 20.1 16.3 28.5 18.5 15.5 24.4 14.7 16.5 17.2 11.4 11.2 11.6 44.0 22.4 12.5 12.2 15.6 25.0 17.7 17.2 15.4 21.5 16.0 5.7 34.2 7.1 12.8 18.3 7.7 16.4 25.2 8.5 18.9 20.1 14.0 11.2 15.0 25.4 16.2 10.2 17.8 19.9 15.4 14.8 21.7 27.1 15.8 11.8 13.3 28.4 14.1 25.1 17.1 22.1 13.1 16.9 20.9 10.3 13.8 24.4 17.6 16.2 11.5 12.5 15.4 17.6 21.1 13.0 18.5 0.7 6.7 5.8 9.3 7.3 12.0 16.7 11.1 11.7 9.6 18.4 14.5 14.0 5.6 13.4 8.4 12.4 9.4 6.2 20.4 21.6 43.2 30.2 21.3 13.1 24.0 23.4 27.1 25.3 53.6 24.1 23.3 40.9 30.8 31.1 31.9 17.8 56.2 47.8 21.0 27.5 14.5 19.9 19.1 5.8 16.5 10.2 0.0 14.1 8.6 17.9 19.1 8.1 5.7 10.6 27.0 26.6 23.9 15.9 4.9 25.3 17.7 15.1 11.8 15.8 20.1 15.4 17.5 25.8 12.4 32.3 19.4 24.0 41.8 17.0 31.1 10.4 17.3 16.0 21.0 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150329789-150332721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.4;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 7.9;Exocrine glandular cells: 11.0;Pancreatic endocrine cells: 19.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 40.8;K-562: 17.5" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 0.4 37.4 0.4 2.6 0.4 1.7 0.8 0.3 0.2 1.1 1.4 1.6 2.0 0.2 1.2 1.9 0.4 0.4 0.3 0.6 1.8 5.6 1.5 3.9 0.3 3.1 3.2 11.3 2.5 0.0 1.5 1.5 1.1 0.9 0.1 2.2 2.1 0.6 0.1 2.3 1.7 0.3 1.8 3.7 1.3 0.8 3.6 1.0 2.8 1.0 2.8 3.5 2.4 4.5 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 6.3 4.7 2.6 2.3 0.0 0.0 1.8 0.0 0.0 0.3 40.8 3.3 3.1 6.7 10.7 1.3 0.0 4.8 0.9 2.4 0.0 0.0 0.1 0.2 9.1 17.5 6.8 0.0 2.0 7.7 1.9 3.0 1.8 0.0 0.0 0.3 5.7 2.1 9.0 8.6 5.0 6.9 1.9 0.3 1.4 0.6 2.1 0.1 0.0 0.0 0.0 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.0 1.0 1.0 2.7 0.7 3.2 2.2 2.4 3.4 0.7 3.6 3.5 2.9 2.8 2.8 0.2 1.0 2.2 2.4 0.0 1.0 0.0 0.3 0.2 1.0 0.6 5.1 0.0 2.3 1.8 7.9 1.3 5.0 2.1 0.0 0.0 0.9 0.0 11.0 0.7 0.6 0.3 1.1 2.6 0.5 0.0 4.6 0.0 1.6 0.0 2.6 0.0 0.0 3.6 2.0 1.4 19.3 0.0 1.1 0.7 0.5 0.0 0.2 0.5 0.9 0.1 1.6 0.0 2.3 0.5 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Group enriched" "Detected in many" 4 "Early spermatids: 17.9;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.9 0.0 0.0 0.0 2.3 0.4 0.0 0.4 1.2 0.0 1.2 0.0 7.8 0.1 3.8 1.0 0.0 2.1 0.4 0.0 5.2 0.5 1.2 1.8 1.3 0.0 0.0 1.1 7.1 0.1 3.5 1.1 0.0 0.0 12.5 0.0 0.1 1.4 0.0 0.1 1.8 0.0 0.9 0.7 0.8 0.1 2.0 2.2 2.0 4.9 0.0 2.0 0.0 2.8 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 0.0 2.7 0.0 0.8 0.0 1.6 1.6 5.1 1.4 1.2 0.0 2.0 2.0 1.7 1.7 17.9 0.0 0.4 0.0 1.2 1.1 0.4 1.1 0.0 1.6 0.3 0.0 1.2 0.0 0.0 3.2 2.3 0.0 0.0 0.0 1.4 1.1 0.6 0.0 0.0 0.7 1.1 0.0 0.0 27.7 2.9 0.0 0.8 0.0 0.9 0.6 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 49.0;Rod photoreceptor cells: 67.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 6.4 4.0 6.9 6.5 9.8 11.1 5.8 6.4 7.9 5.3 4.0 11.2 3.7 4.0 9.1 5.5 3.4 4.6 4.7 5.6 7.2 3.7 5.3 4.8 6.0 7.7 9.9 5.2 7.6 4.5 6.8 9.2 4.7 7.8 5.3 3.9 10.6 4.6 4.9 4.0 7.0 5.2 6.8 9.5 7.9 5.1 18.4 8.8 7.7 6.1 2.8 6.3 4.8 5.5 1.8 2.4 6.0 1.0 2.3 2.8 0.8 2.4 3.7 5.6 2.4 3.5 2.8 6.2 2.2 1.6 4.0 2.9 4.6 3.1 6.6 4.7 3.4 2.1 3.1 4.8 2.4 3.4 3.7 3.0 9.1 3.9 2.2 2.1 5.3 5.8 2.5 1.7 6.0 4.0 2.5 2.0 4.7 8.0 4.4 4.2 1.8 3.6 1.4 5.4 1.8 0.9 2.4 5.0 2.2 2.2 6.1 4.2 5.3 3.1 4.3 4.4 6.2 6.2 5.6 3.6 5.3 5.7 2.6 3.5 8.0 5.9 10.6 3.5 3.0 3.2 0.4 1.0 3.4 2.8 1.0 1.2 0.7 1.3 2.0 0.6 1.8 0.7 1.8 6.0 2.3 1.0 2.4 1.0 0.8 6.9 9.8 6.4 7.9 7.2 3.7 9.9 5.2 7.8 8.8 6.0 4.6 11.9 3.1 2.6 26.9 8.4 12.7 9.4 2.3 10.4 31.4 6.8 6.6 2.8 40.4 5.2 3.9 0.0 3.3 3.4 4.3 4.2 2.3 4.3 4.2 17.5 3.4 13.5 15.1 49.0 8.1 7.6 10.1 2.8 3.6 11.9 2.5 3.5 12.4 4.4 67.3 6.5 6.2 17.6 13.3 5.1 7.7 12.9 3.3 2.7 ZBTB45 "FLJ14486, ZNF499" ENSG00000119574 "Zinc finger and BTB domain containing 45" Q96K62 19 58513530-58538911 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035754, HPA075485" Uncertain Approved "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA035754: AB_10603461, HPA075485: " "unprognostic (1.38e-1)" "unprognostic (7.12e-2)" "unprognostic (2.31e-1)" "unprognostic (7.34e-2)" "unprognostic (2.60e-1)" "unprognostic (4.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.19e-2)" "unprognostic (2.63e-2)" "unprognostic (3.02e-1)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.38e-4)" "unprognostic (2.08e-1)" "unprognostic (1.06e-1)" "unprognostic (5.47e-2)" "unprognostic (1.40e-1)" 15.3 11.1 11.8 12.0 13.4 11.1 10.2 15.1 24.9 15.2 10.9 13.5 11.4 14.6 14.9 8.7 11.6 12.5 10.3 10.0 12.6 10.0 9.8 7.7 11.0 10.1 10.3 8.5 16.6 13.9 9.1 8.8 10.9 11.2 14.5 4.7 13.2 21.5 11.0 21.0 17.2 14.7 11.8 7.3 13.3 14.6 7.5 9.2 15.8 15.9 9.1 14.4 13.5 10.5 7.9 8.7 13.2 11.3 7.0 9.8 5.5 10.4 15.1 4.0 6.2 4.0 3.3 4.7 5.5 2.3 1.4 1.4 2.9 7.0 16.7 8.4 3.2 4.2 6.6 2.0 4.9 0.6 10.8 27.0 8.8 7.6 3.6 2.4 5.3 5.7 3.1 3.6 2.3 2.0 2.8 2.9 17.6 7.8 0.8 2.3 7.6 8.7 5.7 5.7 5.9 13.1 6.8 2.4 10.1 3.1 10.1 12.7 8.8 4.2 11.8 3.0 2.4 18.4 3.8 5.4 6.7 2.9 2.2 5.5 19.4 13.6 8.7 7.8 2.2 4.2 9.2 6.7 13.2 8.1 10.2 9.8 6.1 5.8 7.7 7.2 7.9 7.1 5.0 5.9 7.0 11.3 8.7 5.1 5.5 11.8 13.4 15.1 24.9 12.6 10.0 10.3 8.5 11.2 9.2 8.9 0.3 5.9 3.1 1.4 4.1 2.8 0.0 2.7 1.2 12.2 0.0 8.2 5.0 9.9 0.6 4.4 3.9 0.0 7.7 6.0 3.2 3.2 0.0 5.7 5.8 6.4 9.9 9.8 4.0 0.6 5.5 2.6 6.8 14.4 4.7 2.9 7.4 0.0 9.2 3.6 2.8 12.9 2.7 3.1 3.2 2.4 4.7 4.5 5.7 1.7 ZBTB7C "ZBTB36, ZNF857C" ENSG00000184828 "Zinc finger and BTB domain containing 7C" A1YPR0 18 48026673-48410752 "Predicted intracellular proteins, Transcription factors" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 19.7;Mucus-secreting cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "RT4: 30.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.83e-3)" "unprognostic (6.60e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.58e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (2.71e-1)" "unprognostic (5.52e-3)" "unprognostic (3.85e-3)" "unprognostic (2.89e-2)" 3.3 6.8 1.7 4.9 1.8 0.1 4.5 0.8 4.9 10.4 10.2 1.9 7.3 1.2 3.0 13.5 38.6 10.3 18.2 3.0 1.8 2.7 1.6 1.3 5.8 0.2 2.9 2.1 10.8 1.1 6.1 2.8 3.5 3.8 3.6 9.6 5.9 12.8 5.7 1.6 19.2 2.7 3.0 4.9 8.7 9.9 6.5 1.5 0.0 15.7 22.9 20.8 6.7 14.9 1.5 1.1 3.2 2.2 0.7 1.3 0.2 0.0 0.0 1.0 0.8 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.0 1.2 2.0 0.1 0.3 0.1 0.2 0.9 0.1 2.4 0.0 0.0 0.1 0.4 0.1 0.5 0.1 0.3 0.0 0.0 0.9 0.1 0.0 0.4 0.5 1.3 0.3 0.4 6.1 0.1 0.1 0.0 6.8 1.0 30.5 4.1 5.0 0.4 0.2 0.0 1.2 0.7 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.3 0.1 2.0 0.1 0.2 3.2 0.8 0.7 1.3 0.9 0.6 0.3 0.6 1.1 0.0 1.5 0.5 0.9 1.1 0.7 2.2 1.1 0.3 0.2 1.7 1.8 0.8 4.9 1.8 2.7 2.9 2.1 3.8 1.5 6.0 1.0 0.0 4.9 5.5 0.6 2.4 15.3 8.1 5.7 1.8 0.0 10.8 0.0 0.7 8.7 2.7 19.7 0.0 3.6 0.4 1.9 5.0 0.0 0.6 1.3 1.6 4.6 0.0 1.3 2.6 3.4 0.0 3.3 0.0 27.8 0.3 0.9 7.0 11.3 0.0 2.3 12.9 11.4 0.7 0.4 7.8 10.5 0.0 17.2 9.7 ZBTB8B "DKFZp547H154, RP1-27O5.1, ZNF916B" ENSG00000273274 "Zinc finger and BTB domain containing 8B" Q8NAP8 1 32465069-32496686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 10.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 5.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 3.6;SCLC-21H: 3.6" HPA055553 Enhanced NA NA "HPA055553: AB_2682848" "unprognostic (8.32e-4)" "unprognostic (1.23e-1)" "unprognostic (3.83e-1)" "unprognostic (3.83e-5)" "unprognostic (1.86e-2)" "unprognostic (5.65e-2)" "unprognostic (1.67e-4)" "unprognostic (1.57e-2)" "unprognostic (5.94e-2)" "unprognostic (3.43e-3)" "unprognostic (9.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.93e-2)" "unprognostic (3.44e-2)" "unprognostic (6.11e-2)" "unprognostic (3.26e-3)" "unprognostic (5.88e-3)" 0.4 1.3 5.1 0.6 2.8 2.5 0.6 2.2 5.0 0.4 0.3 1.3 0.7 0.5 1.2 1.3 0.7 0.7 0.6 0.4 3.3 4.7 0.6 0.6 0.5 0.9 2.6 2.7 1.0 0.8 1.0 10.8 0.7 4.1 0.8 0.4 0.2 1.7 0.5 3.4 1.7 0.5 0.5 1.6 0.8 0.5 3.1 1.6 0.0 0.8 0.0 0.6 1.0 0.4 1.4 1.2 3.2 0.8 1.3 0.7 0.2 0.2 0.1 2.0 1.5 0.2 0.5 0.6 0.2 0.1 0.7 0.6 0.2 0.5 0.4 0.7 0.1 1.1 0.7 2.3 0.2 0.5 0.7 2.4 0.3 0.7 0.4 0.0 0.3 0.4 0.2 0.2 0.5 0.0 0.4 0.2 0.2 0.2 0.9 0.1 0.3 0.3 0.6 2.1 0.1 0.9 0.3 0.2 0.3 0.4 3.6 3.6 2.1 1.3 0.5 0.2 2.9 0.4 0.3 0.9 0.5 0.4 0.6 0.3 0.7 0.7 0.4 0.5 0.4 0.4 3.2 0.8 1.0 0.6 0.5 0.6 0.8 0.6 0.5 0.3 1.4 0.7 0.7 2.9 1.3 0.7 1.2 0.5 0.2 5.1 2.8 2.2 5.0 3.3 4.7 2.6 2.7 4.1 1.6 0.0 2.6 0.0 0.8 1.4 2.9 0.6 0.0 2.7 1.2 0.0 5.9 1.5 0.0 0.0 1.5 0.7 0.0 0.0 0.0 1.0 0.8 0.7 3.5 0.2 0.3 3.2 0.0 1.3 0.3 1.0 0.6 1.5 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.3 1.9 1.2 0.5 0.2 1.0 0.0 0.7 ZC2HC1B "C6orf94, dJ468K18.5, FAM164B" ENSG00000118491 "Zinc finger C2HC-type containing 1B" Q5TFG8 6 143864436-143938356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 29.1" "Cell type enhanced" "Detected in some" 30 "Early spermatids: 8.8;Late spermatids: 3.6;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.3;U-266/70: 1.1;U-266/84: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 6.0;Bipolar cells: 3.8;Intestinal endocrine cells: 4.1;Peritubular cells: 3.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.3 0.9 2.6 0.5 3.9 0.1 0.5 2.8 6.1 1.9 1.1 0.9 2.6 0.8 0.4 2.0 1.1 0.5 2.8 2.5 1.2 0.5 0.6 0.7 1.7 3.3 0.1 2.7 2.7 0.0 1.8 1.1 0.3 2.4 0.0 0.3 0.9 1.8 1.5 0.4 1.3 0.0 1.5 0.2 1.0 0.7 1.3 0.8 0.7 0.4 0.8 1.8 0.2 0.3 0.4 5.1 0.7 0.0 0.0 0.6 1.2 2.7 0.0 0.8 0.7 0.5 0.8 0.3 1.4 0.0 0.8 1.3 0.0 0.1 0.7 3.7 1.7 2.3 0.7 0.1 1.5 0.4 0.2 0.0 0.1 0.0 1.1 0.0 4.1 0.9 4.1 0.1 0.0 2.1 0.6 2.1 2.8 1.0 2.4 0.2 1.0 0.1 0.2 0.2 2.4 0.0 0.1 0.2 3.0 0.1 1.2 0.0 0.1 1.0 1.7 0.5 0.9 1.0 1.7 3.2 2.2 0.0 0.6 0.4 0.1 0.6 0.2 0.5 0.9 0.8 0.8 0.2 1.3 1.8 0.8 0.7 0.8 0.2 0.8 0.4 0.2 6.0 0.3 1.5 0.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.2 0.1 0.4 0.3 0.0 0.4 0.1 1.6 4.1 0.6 0.0 0.0 2.3 0.0 0.0 0.0 1.3 0.8 0.2 0.0 3.9 0.3 1.4 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.9 0.1 ZDHHC1 "C16orf1, HSU90653, ZNF377" ENSG00000159714 "Zinc finger DHHC-type containing 1" Q8WTX9 16 67394419-67416833 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 24.6;Late spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042531, HPA048659" Uncertain Approved Cytosol NA NA Cytosol "HPA042531: AB_2678041, HPA048659: AB_2680483" "unprognostic (8.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.05e-3)" "prognostic favorable (1.25e-6)" "unprognostic (1.68e-2)" "unprognostic (9.33e-2)" "unprognostic (6.03e-2)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" "prognostic favorable (5.99e-4)" "unprognostic (2.17e-1)" "prognostic favorable (1.55e-6)" "unprognostic (2.10e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (5.63e-3)" 9.6 6.3 4.3 3.9 6.6 0.5 10.2 5.3 10.5 16.9 7.4 5.5 7.9 3.8 13.5 16.4 6.3 22.6 14.0 6.2 4.5 3.7 11.2 3.8 7.8 4.9 5.3 3.5 17.1 16.2 11.5 14.0 15.1 6.5 11.6 3.2 11.2 14.7 12.1 8.0 10.8 3.9 9.3 3.3 10.1 6.2 25.7 2.6 0.6 31.3 9.3 4.9 6.9 9.7 0.0 2.4 0.3 3.6 0.0 0.0 0.8 5.1 6.2 1.5 8.2 13.6 15.1 0.0 2.9 11.1 2.9 3.5 0.0 3.2 0.0 1.3 5.2 3.0 3.3 0.5 0.5 0.6 1.6 4.7 0.4 0.1 0.4 6.9 0.3 4.3 7.2 6.4 3.2 0.9 6.9 3.8 0.0 0.0 0.0 2.0 0.5 0.0 0.0 3.0 2.0 0.1 0.0 0.1 0.0 4.2 3.1 2.2 7.5 0.5 0.2 6.7 0.6 2.1 1.2 5.0 13.1 2.1 6.3 3.5 1.5 0.3 0.0 8.0 0.1 5.4 0.0 2.6 0.0 0.0 3.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.8 4.3 6.6 5.3 10.5 4.5 3.7 5.3 3.5 6.5 2.6 0.0 0.0 0.0 5.5 6.4 2.4 0.8 15.3 1.4 1.2 7.0 3.9 1.4 8.3 2.9 24.6 4.5 2.1 0.0 3.4 0.1 6.6 6.0 0.0 1.6 2.0 3.2 8.6 7.4 15.2 44.2 13.6 1.3 5.0 0.0 12.5 8.3 2.2 3.5 10.3 5.1 0.3 0.0 6.4 8.7 5.1 6.1 4.8 0.0 6.2 4.4 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.8 1.4 3.4 1.0 4.2 0.7 2.7 11.0 3.8 1.6 1.5 6.3 1.0 9.5 1.7 2.9 3.2 10.3 1.2 6.4 4.2 3.8 2.0 2.6 7.5 1.0 15.2 1.9 1.5 1.9 1.8 7.8 1.2 10.9 2.7 1.2 1.0 1.4 3.4 2.1 2.7 1.7 1.0 5.0 2.4 5.9 6.3 6.1 1.0 1.1 2.3 1.8 1.0 1.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 7.4 4.1 0.8 1.3 0.3 5.5 0.3 0.1 0.2 0.1 1.0 0.3 3.0 0.8 0.1 0.9 6.9 2.2 0.0 0.1 9.0 4.8 0.3 2.6 3.7 0.3 4.3 0.3 0.4 0.3 0.9 1.0 0.3 0.0 1.2 0.7 1.7 0.2 3.3 0.4 2.6 7.3 0.0 2.9 4.5 2.8 4.1 0.2 1.5 4.1 0.7 0.2 0.1 3.1 8.4 11.5 0.7 0.4 0.2 6.9 3.9 0.1 5.5 7.7 0.9 0.3 8.9 0.2 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.2 11.0 3.8 4.2 3.8 15.2 1.9 10.9 6.1 17.9 9.6 0.0 0.3 1.6 2.0 6.7 0.0 42.8 23.9 0.0 0.0 0.2 0.0 0.4 6.6 0.8 1.7 0.0 0.0 0.1 1.7 0.4 3.5 1.7 0.3 6.4 1.7 1.3 0.0 6.8 0.6 0.0 0.0 0.0 2.0 0.3 0.2 1.1 0.0 0.8 1.7 6.5 1.0 9.3 3.8 1.4 0.2 0.0 1.1 0.3 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 54.8" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.2 39.0 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.1 6.8 31.9 16.5 9.9 8.6 6.9 17.6 37.7 3.5 18.2 1.0 18.2 9.4 5.2 29.7 14.0 10.4 8.7 24.2 5.6 12.6 8.2 3.1 4.8 7.4 18.8 5.2 25.3 1.9 54.8 11.9 17.5 7.2 31.7 32.3 5.4 5.9 28.5 7.7 13.4 11.6 8.4 12.5 17.3 4.9 2.7 26.7 9.3 7.4 0.0 10.5 7.1 12.3 16.4 28.9 4.4 16.8 10.1 11.1 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 14.9 8.1 54.1 42.0 14.3 0.9 9.6 79.0 4.0 11.4 43.6 0.0 147.4 11.6 94.7 58.6 14.7 157.1 70.0 176.4 191.0 11.1 49.6 18.4 48.9 121.4 0.0 49.2 28.3 52.9 22.4 8.9 39.8 40.5 159.7 93.7 14.5 109.4 171.9 6.7 32.7 1.7 6.5 9.5 23.1 17.5 24.6 112.1 48.4 94.2 52.6 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type containing 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003618 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA003618: AB_2217686" "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 3.0 5.4 4.9 1.5 6.8 1.1 5.3 6.2 9.9 5.8 3.4 3.9 2.4 1.3 6.5 3.7 3.2 4.5 3.3 5.4 5.9 8.7 5.3 1.2 4.1 1.6 4.8 5.3 8.5 4.7 5.0 8.7 0.7 7.0 4.0 2.3 5.4 12.7 6.9 1.6 2.8 1.8 5.2 6.4 2.9 2.1 2.6 3.1 2.0 6.6 2.1 1.5 2.6 3.1 0.3 0.4 0.7 0.2 0.5 1.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 3.6 0.1 4.0 0.0 4.2 0.1 3.7 0.0 0.0 0.0 5.8 0.0 3.2 0.0 1.6 4.8 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.5 1.0 0.0 0.7 2.9 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 1.6 1.1 0.7 0.5 0.1 0.4 0.0 0.3 4.9 6.8 6.2 9.6 5.9 8.7 4.8 5.3 7.0 3.1 6.0 1.9 0.0 1.4 3.5 3.7 6.9 2.5 0.0 2.3 5.2 3.9 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.6 0.0 0.9 1.0 1.1 0.0 0.1 0.0 1.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.3 0.3 0.0 3.5 1.0 2.1 6.5 1.4 0.1 0.4 3.1 0.0 0.0 0.0 0.3 ZDHHC19 MGC33345 ENSG00000163958 "Zinc finger DHHC-type containing 19" Q8WVZ1 3 196197449-196211437 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 53.4" "Group enriched" "Detected in some" 15 "Early spermatids: 298.7;Late spermatids: 632.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4" "Group enriched" "Detected in many" 24 "B-cells: 5.2;granulocytes: 3.4" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;K-562: 1.2;NTERA-2: 1.1;SH-SY5Y: 1.9;THP-1: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (7.50e-4)" "unprognostic (2.87e-3)" "unprognostic (6.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (3.66e-3)" "unprognostic (4.63e-2)" "unprognostic (6.52e-2)" "unprognostic (2.86e-2)" "unprognostic (3.46e-7)" "unprognostic (8.05e-4)" "unprognostic (4.71e-1)" "unprognostic (7.08e-3)" "unprognostic (4.28e-2)" 0.0 0.6 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 298.7 0.7 0.0 0.0 0.0 0.4 0.3 0.1 0.0 3.4 1.3 0.0 0.0 0.0 1.5 632.3 15.3 1.4 0.0 0.0 0.0 0.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 4.9 3.0 0.0 2.1 0.0 0.0 0.0 ZDHHC21 "DHHC21, DNZ1, HSPC097" ENSG00000175893 "Zinc finger DHHC-type containing 21" Q8IVQ6 9 14611071-14693471 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065254 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA065254: AB_2685446" "unprognostic (2.95e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-2)" "unprognostic (2.01e-1)" "unprognostic (4.19e-2)" "unprognostic (2.58e-2)" "unprognostic (2.81e-2)" "unprognostic (1.13e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (9.79e-3)" "unprognostic (3.97e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (8.87e-2)" "prognostic favorable (9.28e-6)" 6.5 10.8 15.9 7.9 16.8 4.2 11.6 29.0 22.6 7.8 8.5 9.3 3.8 12.2 9.8 11.7 14.4 7.5 6.7 9.0 13.8 10.4 9.4 4.8 9.2 11.1 9.4 16.5 10.0 8.4 11.5 22.2 7.8 14.8 10.0 9.9 6.6 8.3 7.4 7.7 15.7 12.6 7.7 9.9 9.5 7.9 7.3 9.7 4.7 11.3 9.9 10.7 7.7 11.3 5.2 1.4 0.5 0.8 2.8 1.7 0.6 5.4 2.8 5.6 3.6 0.9 1.0 4.3 7.0 2.2 2.5 2.9 1.4 2.6 5.4 1.7 4.9 3.1 3.6 3.8 2.3 3.6 10.8 2.9 23.0 6.1 2.7 3.0 4.0 7.7 1.9 5.3 2.9 1.9 4.6 14.6 2.2 1.9 0.6 4.4 3.0 0.9 3.9 3.9 2.3 5.3 0.0 2.6 2.7 7.7 6.1 3.4 9.1 3.2 4.0 2.1 4.4 5.0 6.6 10.3 1.8 2.7 1.8 6.4 2.3 4.2 0.0 3.8 0.2 1.8 0.5 0.4 0.1 1.2 0.8 1.3 5.2 1.2 1.1 0.2 3.5 0.8 1.2 0.0 2.8 0.6 1.4 1.7 0.6 15.9 16.8 29.0 22.6 13.8 10.4 9.4 16.5 14.8 9.7 20.8 17.9 23.9 7.6 8.5 42.8 16.2 20.4 10.7 22.7 41.8 41.2 7.1 5.0 13.7 4.0 14.8 33.7 0.0 15.6 5.4 9.4 16.4 10.4 6.8 9.6 35.0 15.0 30.7 15.1 4.5 17.8 11.7 1.7 12.6 13.4 75.7 25.7 10.5 29.4 7.9 50.3 6.5 11.3 14.6 16.1 17.6 6.4 10.2 10.2 13.2 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615501-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Group enriched" "Detected in many" 9 "Early spermatids: 369.5;Late spermatids: 511.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "Daudi: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.7 4.1 3.0 7.3 5.2 2.6 4.5 14.7 3.6 3.5 2.9 6.8 4.2 2.9 5.0 2.5 2.5 4.1 2.9 3.3 3.2 4.4 3.2 4.4 3.3 6.1 5.0 1.7 3.3 3.7 3.1 9.7 2.0 5.5 3.9 3.5 4.8 2.9 3.9 2.7 4.0 2.6 3.0 5.1 3.6 2.4 49.1 5.8 9.7 4.8 2.1 6.2 2.9 2.8 1.9 0.8 2.0 1.6 3.2 2.4 0.4 0.9 0.8 1.4 1.9 3.1 2.5 0.0 1.2 2.4 1.3 1.4 0.0 0.9 31.3 1.4 0.8 1.9 0.2 1.1 0.7 1.7 4.6 1.3 0.9 1.1 0.9 2.2 0.0 6.5 2.3 1.5 0.4 1.3 1.1 1.5 4.4 0.8 5.5 1.3 0.1 3.0 0.6 1.3 1.1 0.7 0.4 1.1 0.0 1.2 0.9 2.6 1.8 0.9 1.2 1.0 1.7 2.7 1.7 1.0 0.5 2.3 2.1 1.6 3.8 6.7 0.0 1.1 3.0 0.5 2.0 0.8 0.0 1.9 0.6 2.4 1.9 1.9 1.6 0.7 1.4 1.5 2.2 0.1 3.2 1.6 0.8 1.2 0.4 3.0 5.2 14.7 3.6 3.2 4.4 5.0 1.7 5.5 5.8 6.0 1.9 4.7 2.9 0.7 6.9 3.1 2.5 10.7 0.0 1.8 25.5 0.2 1.7 1.1 369.5 2.0 2.0 0.0 1.5 0.2 1.1 3.5 2.3 4.5 1.9 3.2 1.7 1.8 1.8 511.2 6.1 1.1 3.3 1.8 2.1 4.0 1.4 0.0 2.8 3.1 7.3 6.5 0.6 51.6 13.9 1.9 0.1 3.2 1.9 1.4 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 30.6;Late spermatids: 13.8;Spermatocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;SuSa: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.1 4.1 8.1 2.8 0.4 0.3 1.1 0.4 0.6 2.1 0.5 0.4 0.3 0.5 0.1 0.5 0.1 2.1 0.3 0.9 3.6 1.3 4.1 0.0 1.0 0.4 0.7 3.0 0.6 0.1 0.8 0.3 2.2 0.5 3.6 0.6 0.7 0.1 1.4 0.5 0.5 5.0 0.6 1.2 2.2 0.1 0.0 2.2 1.9 4.5 2.9 0.7 1.1 0.3 6.6 1.7 1.0 0.1 0.0 2.1 1.3 0.5 0.5 1.6 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 0.0 0.6 0.0 0.4 0.1 9.0 2.0 0.0 6.7 3.4 1.8 0.0 0.2 1.7 2.8 30.6 0.6 0.0 0.0 2.1 0.0 0.8 1.2 0.0 0.0 0.8 7.9 6.4 0.6 0.6 13.8 0.6 0.7 0.0 1.8 0.7 3.9 1.3 0.0 0.4 1.0 3.2 0.0 0.2 19.2 1.1 0.0 0.2 0.0 0.6 0.1 ZFP14 "KIAA1559, ZNF531" ENSG00000142065 "ZFP14 zinc finger protein" Q9HCL3 19 36334453-36379199 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 58.6;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030637 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA030637: AB_10602353" "unprognostic (1.89e-1)" "unprognostic (3.80e-2)" "unprognostic (9.61e-2)" "unprognostic (3.53e-1)" "unprognostic (2.20e-2)" "unprognostic (3.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-2)" "unprognostic (1.17e-1)" "unprognostic (3.18e-3)" "unprognostic (1.91e-1)" "unprognostic (5.51e-2)" "unprognostic (1.86e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.75e-5)" 4.8 6.7 9.1 6.0 11.7 2.7 10.0 13.8 11.5 7.5 5.1 10.3 5.6 6.7 11.4 13.1 5.6 8.0 4.8 4.6 9.6 7.8 8.2 5.0 5.0 8.3 14.6 9.8 10.7 5.1 12.9 14.9 5.1 10.6 7.8 5.2 6.5 6.0 8.0 3.5 7.9 6.5 7.6 11.6 8.3 6.1 2.8 12.8 9.2 10.9 3.1 8.3 6.2 7.0 10.4 5.7 5.7 4.4 5.8 9.5 1.7 2.1 3.8 7.7 7.1 6.7 3.4 1.8 1.0 3.3 2.1 3.3 2.5 1.7 6.1 2.8 1.5 1.7 0.8 3.2 0.5 2.3 2.3 2.4 5.4 3.8 2.1 2.2 4.4 5.8 1.5 1.4 0.9 0.2 4.0 2.9 7.2 1.6 0.1 3.3 1.5 6.8 1.8 5.8 3.2 1.7 5.7 4.4 1.8 2.2 4.2 4.3 6.5 3.8 1.2 2.2 4.2 2.4 3.5 2.0 2.2 4.9 2.3 1.1 1.7 2.8 3.2 0.4 0.6 3.8 5.7 4.0 5.3 6.2 4.4 6.3 10.4 6.8 7.8 3.8 9.4 9.5 9.5 2.5 5.8 3.9 5.7 6.3 1.7 9.1 11.7 13.8 11.5 9.6 7.8 14.6 9.8 10.6 12.8 0.0 4.0 26.2 5.8 2.9 58.6 4.9 12.7 12.0 4.5 12.2 49.1 6.7 6.6 6.4 1.5 9.2 8.7 0.0 3.9 2.0 5.8 5.7 12.7 3.4 7.2 44.5 12.7 7.4 6.7 0.4 14.4 8.5 3.3 7.2 9.5 21.4 4.4 12.7 18.4 7.9 95.4 32.3 4.1 4.7 7.7 2.3 2.1 11.5 8.0 4.8 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038380-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA049112: AB_2680637" "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favorable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 3.8 4.4 4.9 3.1 19.2 0.9 6.7 10.9 9.9 6.5 3.6 5.3 4.0 2.1 10.5 5.8 3.2 6.3 3.5 3.7 10.5 5.6 5.8 1.7 3.2 2.8 6.7 10.6 17.0 3.2 4.3 8.5 3.2 10.7 6.3 2.9 2.8 3.2 4.8 3.2 3.2 2.5 6.2 9.1 4.7 3.0 5.1 5.9 0.4 6.9 2.4 3.2 4.3 5.6 2.3 0.9 0.2 0.4 1.3 5.6 0.7 0.6 1.8 7.7 6.4 4.3 8.3 3.9 2.4 3.6 2.7 2.3 0.0 1.8 4.3 1.9 2.5 3.5 1.6 0.0 0.9 4.2 5.3 0.9 0.2 3.8 2.0 2.3 0.0 0.9 2.3 0.8 3.2 6.3 6.6 1.5 0.0 0.4 3.8 5.6 0.0 0.0 0.0 7.9 4.6 0.0 0.0 10.7 0.6 2.0 0.0 6.6 6.2 7.5 1.6 1.4 4.0 6.3 0.0 0.6 6.3 2.8 7.3 3.6 1.5 2.9 0.0 4.8 0.1 3.8 0.2 0.1 0.1 2.5 0.4 1.9 2.3 2.2 2.2 0.9 1.1 1.8 2.5 0.2 1.3 0.0 0.1 5.6 0.7 4.9 19.2 10.9 9.9 10.5 5.6 6.7 10.6 10.7 5.9 0.0 0.3 0.0 0.8 0.2 10.6 2.0 0.0 0.0 0.0 0.0 5.9 0.7 3.3 1.2 0.6 2.2 0.0 0.0 0.8 1.3 2.1 0.4 5.7 1.1 0.4 6.4 1.2 1.3 0.0 0.0 2.0 0.4 0.0 0.0 0.1 3.1 0.2 0.2 2.1 2.2 5.2 6.5 1.5 5.6 4.1 0.0 0.1 0.5 0.1 0.4 ZFP69 "FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A" ENSG00000187815 "ZFP69 zinc finger protein" Q49AA0 1 40477215-40496343 "Predicted intracellular proteins, Transcription factors" "Lipid metabolism, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Early spermatids: 5.9;Spermatogonia: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "THP-1: 36.3" "Low region specificity" "Detected in many" "HPA027808, HPA054942" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027808: AB_10601031, HPA054942: AB_2682644" "unprognostic (1.07e-2)" "unprognostic (6.00e-2)" "unprognostic (7.58e-3)" "unprognostic (4.15e-2)" "unprognostic (1.52e-1)" "prognostic favorable (9.31e-4)" "unprognostic (7.21e-3)" "unprognostic (1.72e-1)" "unprognostic (8.40e-3)" "unprognostic (6.34e-3)" "unprognostic (2.31e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (1.05e-1)" "unprognostic (3.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.81e-1)" 5.1 3.4 8.3 5.8 8.5 4.1 5.1 6.8 5.8 4.7 5.3 7.5 5.1 4.4 5.6 5.6 4.4 5.2 8.9 7.3 6.7 5.6 3.7 4.7 5.6 6.3 9.0 2.4 6.8 6.7 8.1 3.1 5.3 8.6 5.6 4.9 3.9 4.9 6.0 1.2 6.7 4.9 9.7 8.7 6.9 4.8 8.4 8.4 9.4 5.2 2.9 6.8 6.1 14.3 1.1 0.6 0.1 0.5 4.8 2.0 0.6 3.3 0.0 2.0 2.6 2.5 2.6 3.4 1.8 2.1 2.8 3.3 1.8 2.6 6.0 2.4 2.9 3.7 2.7 3.8 1.6 3.3 5.4 2.6 4.4 3.0 2.9 2.0 0.1 4.8 2.6 4.0 1.9 2.9 0.9 1.6 0.1 2.5 0.0 1.6 1.7 4.5 5.6 3.8 0.3 0.0 2.5 7.1 2.8 1.5 2.5 2.6 4.2 3.1 2.9 5.1 3.2 0.0 36.3 0.7 1.3 2.6 3.6 0.2 0.1 4.6 3.8 2.4 0.9 3.5 0.0 0.5 0.1 1.6 0.2 2.0 1.1 1.2 1.9 0.6 0.6 0.6 2.0 0.1 4.8 0.4 0.0 0.6 0.6 8.3 8.5 6.8 5.8 6.7 5.6 9.0 2.4 8.6 8.4 6.0 0.0 0.9 0.3 0.9 1.3 1.2 0.0 1.4 0.0 0.0 0.0 1.0 1.7 1.3 5.9 1.8 0.3 0.0 1.2 1.2 0.7 0.2 0.0 0.9 1.1 0.0 0.0 0.6 1.5 2.5 1.1 1.4 1.7 1.8 1.4 1.6 0.8 0.0 1.8 0.5 0.8 0.0 0.5 2.7 4.6 0.4 0.2 0.7 1.4 0.1 ZFP92 ZNF897 ENSG00000189420 "ZFP92 zinc finger protein" A6NM28 X 153418322-153426481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 6.7" "Cell type enriched" "Detected in some" 6 "Sertoli cells: 19.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.2" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 6.1;HMC-1: 5.9;THP-1: 3.9;U-937: 10.1" "Region enhanced" "Detected in many" "hypothalamus: 10.3" "Low region specificity" "Detected in all" HPA003030 Uncertain NA NA "HPA003030: AB_2666758" "unprognostic (6.94e-2)" "unprognostic (2.54e-2)" "unprognostic (7.85e-2)" "unprognostic (2.57e-4)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.62e-2)" "unprognostic (6.51e-3)" "unprognostic (6.71e-2)" "unprognostic (1.84e-1)" "unprognostic (8.49e-4)" "unprognostic (1.81e-1)" "unprognostic (2.71e-2)" "unprognostic (6.66e-3)" 2.0 2.8 1.1 0.4 1.5 4.0 0.8 3.6 2.5 1.1 0.5 0.1 1.8 4.3 0.0 5.4 0.4 0.7 0.9 1.9 0.8 0.2 2.3 0.3 0.9 6.7 0.8 1.3 1.8 0.8 0.5 0.0 0.0 2.5 0.0 0.0 0.6 1.5 0.2 0.6 0.4 0.7 0.4 0.4 0.0 0.0 0.4 0.0 0.1 1.8 0.0 0.9 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.8 1.5 1.4 1.3 0.7 0.1 0.0 0.8 0.9 0.4 0.7 0.6 0.7 1.1 6.1 0.0 2.3 0.0 0.0 2.5 0.7 5.9 0.4 0.9 0.0 0.1 0.0 2.4 1.5 1.8 0.0 0.0 0.0 1.5 0.5 0.3 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 1.6 0.0 0.1 3.9 0.0 0.0 3.0 0.0 0.0 1.4 0.0 1.6 0.0 10.1 0.6 0.0 0.7 0.0 0.9 1.8 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.8 0.0 2.3 0.5 0.0 0.0 0.0 0.2 0.3 0.0 3.2 0.2 0.2 19.4 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869032 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;pituitary gland: 19.8;testis: 20.3" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 29.9;Cone photoreceptor cells: 25.5;Early spermatids: 21.1;Horizontal cells: 30.2;Rod photoreceptor cells: 35.3;Spermatocytes: 26.9" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HMC-1: 17.8;NTERA-2: 30.6;SiHa: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 1.0 6.8 13.0 1.2 17.0 1.3 1.3 2.2 16.9 1.5 0.9 1.9 0.0 0.9 0.9 0.8 0.8 2.4 1.2 1.1 7.6 12.2 0.9 0.9 1.4 1.1 4.9 10.9 1.0 1.7 0.8 19.8 0.8 7.4 1.3 1.0 5.7 1.2 1.1 0.9 1.2 1.4 0.8 3.9 1.3 1.3 20.3 2.3 0.0 1.2 0.0 1.4 0.8 0.2 0.9 0.2 1.5 0.2 1.7 4.5 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 30.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 9.0 0.0 0.5 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.2 3.4 0.0 4.5 0.2 2.6 1.9 0.0 0.9 3.9 3.4 0.5 1.7 0.0 0.2 0.8 1.4 13.0 17.0 2.2 15.0 7.6 12.2 4.9 10.9 7.4 2.3 0.0 0.6 0.0 0.5 0.9 29.9 1.1 0.0 2.7 0.0 0.0 25.5 0.0 0.0 0.3 21.1 0.5 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 30.2 0.0 0.0 0.0 7.5 0.9 0.0 1.7 0.0 0.0 4.0 0.3 0.0 0.0 0.2 35.3 0.0 0.3 26.9 14.1 0.1 0.0 2.2 0.0 0.4 ZFX ZNF926 ENSG00000005889 "Zinc finger protein, X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463" "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 20.3 8.8 10.8 8.2 11.7 25.9 23.5 22.1 12.6 18.5 12.2 7.2 8.4 6.6 18.5 11.0 10.6 15.8 7.2 17.8 10.1 6.6 16.6 11.3 9.7 12.7 13.1 9.6 20.2 11.8 20.2 17.9 23.2 10.4 16.4 6.5 7.0 9.4 13.1 24.1 8.9 11.8 15.7 11.3 12.4 10.1 5.4 14.7 16.4 13.9 8.9 10.6 12.5 25.3 11.9 9.6 16.6 10.3 9.9 10.7 7.0 8.0 10.9 11.3 13.1 15.3 10.7 5.9 7.6 7.2 8.8 9.2 6.7 6.0 9.3 10.3 11.7 19.3 10.3 12.9 14.1 11.8 9.0 16.0 8.2 33.8 3.9 6.4 10.8 14.5 9.3 4.5 17.1 22.3 9.5 11.0 5.6 9.7 10.1 6.3 4.4 7.7 8.0 6.5 3.5 8.4 10.6 9.0 8.1 5.2 13.0 6.0 9.0 23.0 9.2 7.4 7.8 5.8 5.7 10.8 7.8 4.6 10.8 5.3 5.7 7.5 9.3 6.1 4.6 9.0 11.2 8.7 13.5 10.6 10.3 10.7 8.4 9.9 10.6 9.6 11.9 9.9 9.4 16.6 9.9 9.4 6.9 5.7 7.0 10.8 11.7 22.1 12.6 10.1 6.6 13.1 9.6 10.4 14.7 17.9 11.8 18.4 16.0 19.6 19.3 13.7 22.9 16.0 22.7 7.0 19.6 46.1 5.0 13.6 1.5 25.5 11.9 23.3 13.8 10.2 28.3 17.9 27.6 20.7 15.1 14.3 19.7 27.6 25.3 3.1 33.1 20.1 28.7 19.8 15.1 15.6 11.6 14.2 33.6 9.4 19.1 32.3 26.9 9.3 25.2 18.2 17.3 22.5 15.1 15.4 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger, GATA-like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 12.3;Kupffer cells: 16.8;Macrophages: 7.8;Spermatogonia: 16.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 26.6;U-937: 6.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA049855: AB_2680916" "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 0.5 0.9 2.5 2.0 6.5 0.9 1.0 8.0 5.4 1.4 0.9 2.2 2.1 0.7 0.6 2.6 1.8 0.6 2.9 3.4 2.4 3.0 1.0 3.6 1.0 3.9 3.1 1.9 4.8 2.0 3.4 0.3 5.1 2.5 1.4 4.8 1.6 0.2 0.9 2.6 1.4 3.7 5.3 1.4 1.2 0.9 0.3 0.3 0.1 0.3 0.0 1.0 0.1 0.4 1.0 1.4 0.5 0.9 0.4 3.6 0.8 0.2 0.7 1.5 1.0 0.3 1.5 0.8 0.2 0.6 1.5 1.0 0.3 0.2 1.3 4.6 1.4 1.3 0.5 0.6 0.0 0.4 0.8 2.1 0.7 0.4 0.6 0.2 1.2 1.4 1.0 0.9 1.6 0.1 26.6 2.2 0.3 1.7 1.5 0.7 0.7 0.6 0.6 1.2 1.4 0.3 0.3 1.2 0.4 2.1 0.4 0.5 2.1 2.4 2.0 0.2 5.2 6.1 0.6 0.4 6.7 0.9 0.0 0.3 0.0 1.0 0.1 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 2.6 0.9 0.4 0.8 1.4 0.4 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.4 0.4 0.8 0.4 0.0 0.0 0.3 0.6 0.8 0.0 1.0 12.3 6.4 0.0 0.6 16.8 0.6 0.9 7.8 3.3 1.8 0.2 1.1 0.3 0.8 0.7 0.3 1.3 0.0 0.4 1.8 16.8 0.6 0.1 0.0 1.1 0.0 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 9.5;Urothelial cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.3" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 8.6 7.4 11.4 5.0 11.0 25.9 8.7 10.3 10.7 8.5 6.2 5.9 8.9 8.1 7.3 8.1 10.4 5.9 5.4 8.7 11.2 5.0 7.1 9.7 9.7 8.7 9.6 7.4 8.7 6.8 7.1 12.7 7.1 8.8 8.7 9.9 4.5 9.0 8.7 11.9 9.9 9.3 7.7 11.4 10.5 6.6 5.1 11.7 5.8 10.5 4.6 10.2 7.5 11.6 5.5 4.6 8.0 8.3 4.8 8.5 3.3 3.0 3.9 2.9 2.0 1.8 2.0 2.1 1.3 1.4 3.4 2.6 3.2 2.4 1.8 1.2 2.3 2.0 2.1 3.3 1.8 5.1 2.9 6.7 5.3 2.7 3.8 1.9 1.1 3.0 2.7 2.7 2.8 1.7 1.5 3.9 5.6 4.4 2.6 3.0 9.5 4.4 3.5 0.7 6.2 4.4 3.5 1.9 2.5 2.4 3.1 4.5 3.3 2.8 24.3 1.4 1.7 3.6 1.0 0.3 1.5 2.7 2.3 3.2 3.7 4.5 3.9 2.0 2.9 1.0 3.1 5.7 8.0 4.1 8.3 3.7 5.5 5.3 3.5 4.6 4.6 4.4 3.6 1.8 4.8 5.9 4.0 8.5 3.3 11.4 11.0 10.3 10.7 11.2 5.0 9.6 7.4 8.8 11.7 0.0 1.4 0.5 3.5 0.0 0.4 0.8 2.5 2.7 1.2 3.5 0.0 1.6 1.7 1.6 0.7 1.5 1.1 0.0 1.6 2.0 0.1 2.4 0.0 0.9 2.5 9.5 2.9 1.3 0.6 0.9 0.9 1.2 0.0 1.8 1.3 0.8 1.7 0.0 1.1 1.2 1.1 0.0 0.9 2.5 2.2 0.0 0.8 0.7 1.0 6.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 0.0 5.3 2.2 4.0 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 4.4 2.0 0.0 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 16.7;NTERA-2: 20.0;REH: 14.3;U-266/84: 18.7" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA059975: AB_2684184" "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 4.0 4.9 5.6 4.1 6.7 6.2 5.2 14.4 8.2 5.2 4.5 4.8 4.7 1.2 5.0 7.5 2.3 8.3 4.0 5.4 4.3 5.0 3.8 1.3 4.1 10.8 3.7 5.3 10.4 2.7 12.9 6.2 5.4 5.5 6.2 2.4 7.5 5.7 7.2 5.0 3.8 5.0 4.5 3.7 8.4 2.8 8.2 3.0 12.7 9.3 1.9 10.1 6.5 2.8 10.8 3.3 8.8 2.2 4.3 8.4 3.0 0.0 0.0 13.1 0.0 0.5 0.5 0.0 4.5 4.2 6.6 6.0 0.0 0.1 0.0 3.3 2.3 5.2 0.3 0.0 7.2 9.4 0.0 16.7 2.6 0.0 1.3 1.5 0.0 5.0 2.8 0.0 5.1 0.0 0.6 0.5 1.0 0.1 0.0 2.2 0.0 9.8 1.3 20.0 0.0 1.6 14.3 0.0 3.1 1.9 0.0 9.6 9.7 0.1 0.0 0.4 10.7 0.0 0.2 0.0 6.0 3.1 0.0 5.3 0.1 18.7 4.9 0.0 0.0 5.9 2.1 1.8 8.8 2.2 2.2 4.4 8.0 4.3 2.8 2.9 10.8 8.4 3.9 0.5 4.3 1.8 3.3 4.9 3.0 5.6 6.7 14.4 8.2 4.3 5.0 3.7 5.3 5.5 3.0 0.0 0.0 1.3 1.6 0.9 3.4 2.0 5.1 0.0 1.2 5.2 0.0 2.0 3.3 2.7 1.7 2.1 0.0 0.0 0.2 0.7 1.3 1.0 3.5 0.0 1.6 3.2 0.0 2.5 1.0 2.2 2.0 0.9 0.0 1.0 0.0 4.5 0.3 0.0 2.1 0.4 4.4 6.5 0.9 0.7 4.9 0.6 1.0 2.6 0.0 1.1 ZIM3 ZNF657 ENSG00000141946 "Zinc finger imprinted 3" Q96PE6 19 57134096-57145202 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.5;testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" HPA034575 Uncertain NA NA "HPA034575: AB_10603463" "unprognostic (9.06e-2)" "unprognostic (1.46e-1)" 0.1 0.1 0.1 0.3 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.4 1.6 0.1 0.0 0.1 0.5 0.1 2.8 0.2 0.1 0.1 0.1 1.4 0.7 3.5 0.5 0.7 1.0 0.3 0.6 0.9 0.1 1.1 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.5 0.4 0.1 0.0 0.0 0.2 0.2 0.6 0.9 0.9 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.5 0.2 1.1 0.0 0.3 0.7 0.5 0.3 0.3 0.0 0.4 0.1 0.2 0.0 0.8 0.5 0.3 0.0 0.8 0.0 0.7 0.8 0.1 0.0 0.4 0.6 0.3 0.2 1.2 0.4 0.2 0.6 0.8 0.1 3.5 0.4 0.5 0.5 0.3 0.5 0.7 0.7 0.5 0.1 1.4 0.6 1.0 2.1 0.7 0.5 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932031 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 38.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 12.6;U-266/70: 6.3" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.1 13.0 11.4 9.9 12.4 10.0 9.9 7.1 12.8 5.0 4.9 16.5 7.0 4.0 7.4 38.7 3.0 7.3 7.2 7.6 11.1 9.6 9.6 6.5 10.8 10.9 10.2 11.4 11.9 7.3 14.5 31.4 2.3 9.2 9.3 3.4 13.6 7.9 14.2 5.1 4.3 5.4 8.3 12.0 10.7 4.1 5.9 11.3 7.0 18.8 3.2 7.5 3.3 3.7 3.7 3.2 2.6 1.1 0.6 1.6 0.6 0.4 0.0 1.5 1.5 0.0 0.0 0.2 0.6 0.1 0.0 0.7 0.0 1.8 2.7 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.3 0.3 1.1 2.8 0.0 12.6 1.0 0.0 0.1 0.2 1.9 0.0 0.2 2.1 0.0 0.1 3.4 0.0 0.6 1.7 1.0 0.0 0.1 1.7 2.2 3.1 3.1 0.9 0.0 0.0 0.1 6.3 0.4 0.0 0.6 3.0 0.9 2.6 1.1 1.7 0.9 0.4 1.6 2.0 1.3 1.4 0.2 3.7 1.6 1.4 0.8 0.6 0.7 3.2 0.6 0.6 11.4 12.4 7.1 12.8 11.1 9.6 10.2 11.4 9.2 11.3 14.9 34.0 4.5 5.8 3.7 34.3 22.7 5.1 22.7 26.1 14.0 41.2 0.0 3.3 3.2 8.5 10.8 1.1 23.3 2.5 0.0 5.4 9.2 15.1 9.0 3.1 15.9 9.9 12.3 6.1 7.5 1.7 9.3 6.8 8.2 2.9 38.4 1.6 1.4 1.1 3.7 54.5 0.0 8.6 10.3 9.7 2.5 0.1 8.7 2.1 4.1 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4740015-4746119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Group enriched" "Detected in many" 6 "Early spermatids: 141.0;monocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.1;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;monocytes: 1.5" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 3.6 1.6 2.3 2.9 2.0 0.9 2.0 0.7 2.7 1.3 1.0 5.1 1.4 5.2 1.8 4.5 1.2 1.5 3.8 3.8 3.6 1.8 2.4 3.5 6.1 4.9 3.7 1.7 0.9 4.7 12.5 1.8 1.5 3.4 1.9 1.0 4.2 3.8 2.7 0.4 1.8 3.9 1.2 4.8 6.2 2.4 25.6 2.9 0.7 1.4 0.7 0.8 1.6 0.9 0.0 0.1 1.1 1.5 0.0 0.0 0.2 5.1 0.9 0.0 2.5 0.1 0.2 0.4 0.1 1.4 1.3 3.1 2.3 4.8 0.0 0.2 0.0 0.6 3.9 0.9 0.4 0.1 0.5 1.7 0.0 0.5 1.3 0.8 0.1 1.4 0.2 0.6 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.6 0.6 0.0 0.1 1.4 1.6 2.3 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.2 2.3 2.0 0.7 2.7 3.6 1.8 3.7 1.7 3.4 2.9 0.0 1.3 0.0 5.2 0.8 0.1 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.4 141.0 0.3 4.0 0.0 3.5 0.0 0.3 5.3 0.0 0.2 5.0 0.0 1.2 3.7 7.6 15.1 0.6 10.7 1.7 36.9 2.6 1.4 2.6 0.6 2.1 0.7 0.2 0.0 0.5 0.7 1.2 0.6 0.0 0.0 0.6 7.4 ZNF100 ENSG00000197020 "Zinc finger protein 100" Q8IYN0 19 21722766-21767628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 66.9;Late spermatids: 56.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 22.0" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (2.20e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-2)" "unprognostic (6.03e-3)" "unprognostic (2.67e-2)" "unprognostic (3.78e-2)" "unprognostic (1.64e-2)" "unprognostic (2.51e-2)" "unprognostic (7.02e-4)" "unprognostic (1.94e-3)" "unprognostic (9.27e-2)" "unprognostic (2.47e-3)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.84e-1)" "unprognostic (3.22e-2)" "prognostic favorable (5.47e-4)" 17.6 7.7 5.0 9.2 7.3 9.9 7.5 20.5 7.9 10.9 8.3 8.1 2.1 2.3 8.3 6.5 5.1 6.9 4.1 5.1 4.7 4.7 7.4 3.7 6.4 10.0 9.1 8.7 13.9 7.3 3.7 7.0 10.0 11.1 6.8 7.6 5.4 6.7 11.3 7.2 6.6 6.6 7.1 10.1 12.4 5.8 18.8 6.9 22.6 11.4 1.8 10.1 7.5 6.3 8.8 6.3 7.5 6.0 4.8 6.3 2.3 0.3 0.1 8.3 2.9 1.4 1.8 8.1 3.1 2.4 5.6 8.3 2.7 2.1 4.9 5.7 1.7 3.5 2.3 8.4 2.4 10.5 0.0 6.1 5.7 2.6 1.4 1.0 0.1 3.6 2.2 0.3 4.1 0.2 1.6 2.1 11.6 10.1 0.3 4.1 3.2 22.0 3.5 7.1 0.1 3.9 9.5 9.9 3.3 2.8 8.5 5.3 3.9 5.1 0.2 2.3 6.7 2.9 4.1 3.1 2.4 1.9 4.0 4.3 0.3 3.2 9.8 0.0 5.3 2.8 6.8 6.0 6.0 2.6 5.6 2.5 5.7 4.0 3.2 6.3 8.8 6.3 5.0 7.5 4.8 3.8 3.9 3.7 2.3 5.0 7.3 20.5 7.8 4.7 4.7 9.1 8.7 11.1 6.9 3.0 5.0 2.4 5.4 2.7 6.9 4.4 2.5 10.7 6.8 8.7 2.0 6.6 3.3 4.0 66.9 4.7 2.7 0.0 5.0 6.6 4.9 4.8 9.3 0.8 4.8 1.6 2.9 4.9 6.9 56.1 10.6 10.4 8.5 6.4 3.0 3.9 5.2 5.9 4.2 1.7 5.4 25.8 3.3 18.6 7.5 2.5 7.3 4.9 3.8 8.9 ZNF117 "H-plk, HPF9" ENSG00000152926 "Zinc finger protein 117" Q03924 7 64971776-65006684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 34.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.2;SuSa: 16.7;THP-1: 15.4" HPA031148 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA031148: AB_2673759" "unprognostic (1.04e-1)" "unprognostic (3.04e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.35e-2)" "unprognostic (1.45e-2)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (2.17e-11)" "unprognostic (1.08e-1)" "unprognostic (9.19e-2)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" 11.1 13.2 1.3 3.4 1.5 2.1 7.1 2.1 3.7 3.1 2.1 0.5 4.2 6.5 5.2 2.8 5.6 2.7 1.1 1.3 2.3 0.9 3.9 2.6 1.0 5.0 2.1 2.4 4.0 5.3 2.8 2.2 3.6 2.4 0.6 4.2 1.6 2.8 1.3 3.4 1.8 5.3 3.4 2.6 2.5 4.5 1.0 0.7 6.2 1.9 0.9 0.6 0.2 1.2 0.1 14.5 15.2 5.5 2.5 8.2 3.1 0.7 0.8 1.5 0.6 6.2 5.3 2.6 1.6 2.4 0.9 1.7 0.4 1.8 1.6 1.4 2.4 0.4 2.9 0.5 0.0 1.5 3.2 0.6 0.6 0.6 5.9 2.4 6.3 9.8 3.6 3.6 2.7 5.4 5.5 6.1 1.7 0.2 7.2 1.0 1.0 2.0 2.3 2.3 12.4 1.5 0.6 0.7 16.7 2.7 15.4 7.2 4.4 0.5 2.6 1.9 2.5 4.5 2.8 1.6 6.9 2.7 0.4 0.6 1.0 0.6 1.9 0.6 1.0 0.4 0.4 0.7 1.0 0.4 0.4 6.2 0.9 0.5 0.7 0.5 0.2 3.0 34.7 0.0 4.9 3.0 14.3 6.1 15.3 22.7 25.0 5.2 0.0 4.1 10.0 9.4 1.7 7.0 1.7 0.0 24.3 2.3 5.0 6.1 10.4 3.0 5.5 27.0 5.1 19.0 9.8 2.5 8.1 7.0 5.0 1.8 3.6 10.0 17.7 0.0 4.9 2.1 7.4 6.5 4.1 6.5 7.9 4.1 9.3 4.9 2.8 10.4 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440222 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 7 "Cholangiocytes: 2.5;Cone photoreceptor cells: 3.9;Horizontal cells: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" NA NA Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favorable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 2.9 4.7 4.0 2.5 5.9 0.8 5.1 11.8 8.5 5.9 4.1 6.6 4.5 2.5 4.2 7.2 3.5 7.9 4.7 5.9 6.0 4.5 6.2 2.1 3.6 3.3 4.4 5.5 7.6 4.3 15.3 12.1 3.7 5.9 6.1 2.4 5.4 5.8 6.7 3.7 4.7 2.6 5.9 4.2 4.5 3.6 7.2 6.0 3.1 10.8 2.8 4.3 5.7 6.3 3.9 2.9 2.0 2.6 2.6 5.7 2.1 1.7 2.1 4.8 1.7 5.6 4.6 0.2 3.7 4.5 3.0 2.7 0.1 1.5 4.5 0.3 4.4 3.0 1.8 0.0 5.4 2.1 0.7 8.2 0.8 1.4 1.1 5.0 1.7 3.0 5.2 1.9 5.2 3.2 3.5 2.6 0.7 0.7 0.5 5.6 0.6 1.0 0.1 4.9 0.6 1.7 0.6 1.1 1.3 1.8 2.0 4.3 4.4 1.5 1.3 1.5 5.4 0.3 4.4 3.3 3.1 0.4 0.8 0.7 5.9 1.1 0.0 1.5 0.1 1.9 0.0 1.9 2.0 2.2 2.2 5.7 2.9 2.9 1.2 2.9 3.9 4.6 3.7 0.2 2.6 2.6 2.4 2.5 2.1 4.0 5.9 11.8 8.5 6.0 4.5 4.4 5.5 5.9 6.0 0.0 0.3 0.0 0.5 0.0 0.8 2.2 2.5 0.0 0.0 0.0 3.9 0.4 0.0 0.4 2.2 0.0 0.0 0.0 0.3 0.1 0.4 0.9 1.1 1.0 0.4 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 1.0 0.1 0.0 0.7 1.2 1.5 0.0 0.4 1.4 0.4 0.3 0.3 0.0 0.0 0.2 ZNF135 "pHZ-17, ZNF61, ZNF78L1" ENSG00000176293 "Zinc finger protein 135" P52742 19 58059239-58086310 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Distal tubular cells: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 6.7;MOLT-4: 7.0;T-47d: 8.2" "Low region specificity" "Detected in all" HPA006961 Approved Approved Cytosol NA NA Cytosol "HPA006961: AB_1080670" "unprognostic (4.87e-2)" "unprognostic (7.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.96e-1)" "unprognostic (1.01e-1)" "unprognostic (6.54e-2)" "unprognostic (1.70e-1)" "unprognostic (5.85e-2)" "unprognostic (9.18e-3)" "unprognostic (1.20e-2)" "unprognostic (1.01e-3)" "unprognostic (2.34e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (1.25e-1)" 4.6 3.5 8.4 3.1 13.7 1.7 8.6 7.3 10.6 7.9 5.4 12.0 4.5 1.9 11.8 11.2 3.9 8.6 5.7 4.5 6.4 5.2 5.9 1.1 3.8 2.9 6.4 9.1 15.9 3.3 21.4 11.0 5.3 8.1 8.6 3.0 9.5 3.0 7.6 2.6 6.2 2.7 9.6 5.3 4.9 3.4 8.9 10.4 7.3 10.6 1.2 3.2 6.4 5.1 3.9 3.9 3.4 0.2 4.5 3.7 0.8 0.0 0.0 1.5 0.0 0.1 0.0 0.0 3.7 0.0 5.1 0.3 0.0 0.2 0.0 3.9 5.5 3.0 0.2 0.0 0.0 5.7 0.0 6.0 0.0 0.0 0.0 2.3 0.0 6.2 6.7 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 7.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 2.7 4.4 5.8 0.2 0.0 0.0 0.0 5.9 8.2 0.0 0.0 0.0 3.4 0.0 0.0 0.3 2.4 0.0 0.0 0.0 2.9 0.0 0.1 3.4 0.0 0.2 0.2 0.9 0.3 0.3 1.7 3.9 3.7 2.1 0.1 4.5 0.0 3.9 0.2 0.8 8.4 13.7 7.3 10.6 6.4 5.2 6.4 9.1 8.1 10.4 0.0 0.6 0.0 2.4 2.1 10.7 5.3 2.5 5.3 1.2 8.7 15.7 0.8 18.3 5.3 11.1 2.4 0.0 0.0 0.6 0.1 1.5 2.5 4.7 0.2 0.5 14.3 2.4 6.2 0.3 8.2 7.2 0.0 1.7 0.0 1.0 7.1 0.3 0.0 6.3 2.1 14.4 0.0 3.1 8.9 7.2 2.8 0.6 1.0 0.6 1.3 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710471-19733097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049863 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049863: AB_2680921" "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favorable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 7.4 5.3 7.9 8.7 10.5 11.9 12.8 23.3 10.3 11.3 7.0 8.1 6.6 3.9 9.4 9.6 5.7 9.3 6.0 6.6 8.1 7.6 8.4 1.7 4.9 10.5 12.2 6.0 15.7 7.5 12.7 10.7 8.8 9.4 12.3 5.1 6.5 7.1 9.9 3.4 7.2 7.2 8.9 9.0 9.4 7.0 6.2 10.7 7.1 13.8 3.1 10.9 9.8 7.7 10.3 3.0 11.4 3.6 6.5 18.4 6.3 3.5 3.6 6.1 7.9 4.1 4.5 7.3 3.7 5.1 5.5 6.0 3.4 2.8 9.5 6.2 3.9 3.1 3.6 6.3 3.7 6.9 2.3 7.3 4.5 2.7 4.5 5.0 0.1 6.9 4.5 3.9 3.8 3.3 7.3 3.4 4.7 5.2 4.5 5.4 5.9 8.0 5.1 7.9 6.7 10.4 4.2 9.9 4.6 3.9 7.2 6.1 4.4 0.1 4.3 5.8 5.4 6.0 9.2 2.1 4.8 1.3 5.6 4.8 3.6 4.2 8.4 0.3 5.0 2.8 11.4 1.8 6.1 9.6 3.1 15.1 10.3 13.1 12.0 2.6 8.2 18.4 14.5 4.1 6.5 3.6 3.0 8.4 6.3 7.9 10.5 23.3 10.3 8.1 7.6 12.2 6.0 9.4 10.7 0.0 3.0 1.5 3.8 2.2 4.5 1.9 0.0 4.0 1.2 3.5 0.0 2.6 3.3 1.3 0.5 2.3 0.3 0.0 1.2 1.5 2.8 1.8 1.1 0.0 1.5 6.4 2.9 1.3 0.6 0.5 1.7 2.4 3.3 0.0 1.6 3.5 1.0 0.9 3.5 2.2 5.6 6.5 2.1 3.2 3.0 1.3 1.8 5.3 1.5 2.0 ZNF140 pHZ-39 ENSG00000196387 "Zinc finger protein 140" P52738 12 133079838-133107544 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003655, HPA048332" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003655: , HPA048332: AB_2680362" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.90e-2)" "unprognostic (3.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (5.76e-3)" "unprognostic (7.67e-2)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.96e-2)" "unprognostic (9.13e-3)" 13.0 12.5 8.8 8.3 11.8 5.4 14.7 15.5 12.7 14.4 9.4 11.1 12.7 11.5 16.6 13.9 10.7 13.8 10.6 10.4 11.0 8.2 11.4 10.9 9.0 14.0 12.2 10.0 18.1 14.4 9.6 23.5 9.9 9.2 14.4 7.4 9.4 12.9 12.5 9.6 13.5 9.6 15.5 8.8 10.0 10.3 10.2 10.2 15.0 17.6 9.3 13.4 10.8 11.6 13.7 9.4 14.9 8.7 14.2 18.8 8.0 4.4 3.7 7.8 0.2 4.8 8.2 8.3 4.2 2.3 2.9 3.0 2.5 2.1 1.8 7.1 4.8 3.7 4.0 4.1 3.0 3.6 0.2 5.1 5.1 4.7 4.0 8.6 4.5 9.4 9.0 7.6 5.1 13.4 9.2 5.7 7.2 2.5 2.2 7.1 6.2 9.4 10.0 7.8 2.1 2.6 7.3 1.0 4.8 5.4 8.0 7.1 10.1 8.2 4.9 4.9 4.3 7.7 8.2 8.3 0.7 5.2 4.1 2.6 2.3 0.0 4.0 0.8 4.9 4.5 10.2 5.5 14.9 10.8 8.7 14.8 13.7 12.5 12.5 9.4 10.8 18.8 14.0 9.8 14.2 5.3 4.9 13.8 8.0 8.8 11.8 15.5 12.7 11.0 8.2 12.2 10.0 9.2 10.2 0.0 16.0 5.6 10.1 6.4 7.1 6.1 2.5 10.7 19.4 0.0 9.8 7.2 11.6 8.3 9.2 6.4 4.7 0.0 5.2 6.2 7.4 7.7 7.0 3.9 5.0 6.4 13.2 9.2 5.4 3.6 8.3 5.6 8.5 2.8 6.3 8.3 5.8 8.5 7.8 7.9 6.7 0.0 6.6 18.8 11.3 5.3 12.5 9.6 5.9 8.4 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 7.6;Cone photoreceptor cells: 7.9;granulocytes: 10.4;Horizontal cells: 7.9;Rod photoreceptor cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 8.1;HSkMC: 4.6;MOLT-4: 6.5;NTERA-2: 4.5;SuSa: 10.0" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 2.8 5.9 7.9 5.7 10.2 2.5 4.3 17.9 9.3 3.1 5.7 2.6 9.9 2.2 2.8 3.6 4.4 3.1 4.1 5.6 7.8 3.1 3.8 1.8 3.6 8.8 2.2 6.4 3.4 3.4 11.9 11.5 6.0 5.1 4.5 2.8 7.3 5.0 12.6 3.1 2.0 5.4 5.6 3.6 8.4 3.2 2.3 3.9 11.4 10.5 0.6 8.3 6.6 2.1 3.1 1.5 5.1 0.3 2.7 3.2 0.8 0.2 0.3 8.1 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.1 0.2 0.4 0.4 0.2 2.0 0.3 0.2 0.0 0.0 0.2 0.2 0.6 0.3 1.1 0.2 2.9 0.4 0.8 4.6 0.0 0.5 0.0 2.8 0.1 0.4 0.3 0.6 1.8 0.1 6.5 0.3 4.5 0.3 0.2 0.3 0.8 0.2 0.1 1.1 0.5 0.3 0.3 0.3 0.1 10.0 0.4 0.5 0.2 0.2 0.5 0.2 0.3 0.8 0.3 0.4 0.1 0.3 0.2 1.8 0.3 5.1 1.1 0.1 3.2 1.3 0.6 1.5 0.3 3.1 1.0 1.4 1.9 2.7 0.2 1.5 0.1 0.8 7.9 10.2 17.9 9.3 7.8 3.1 2.2 6.4 5.1 3.9 0.0 3.4 2.2 1.1 0.3 7.6 3.1 0.0 1.4 0.0 1.8 7.9 0.2 0.0 1.7 0.0 1.6 0.0 0.0 0.2 0.1 1.4 1.7 10.4 0.2 1.3 7.9 0.0 1.8 0.0 0.0 0.3 1.1 0.0 1.0 0.0 3.2 0.1 0.0 1.4 0.0 10.1 0.0 0.4 0.4 0.9 0.4 0.2 3.1 0.0 1.5 ZNF157 HZF22 ENSG00000147117 "Zinc finger protein 157" P51786 X 47370583-47414305 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;epididymis: 4.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5;U-266/84: 6.0" "Low region specificity" "Detected in all" HPA003319 Uncertain NA NA "HPA003319: AB_1080677" "unprognostic (1.85e-1)" "unprognostic (3.99e-1)" "unprognostic (7.24e-4)" "unprognostic (1.17e-2)" "unprognostic (1.02e-2)" "unprognostic (7.38e-4)" "unprognostic (2.99e-1)" "unprognostic (2.32e-1)" "unprognostic (4.59e-4)" "unprognostic (5.36e-2)" "unprognostic (6.51e-2)" "unprognostic (1.80e-2)" "unprognostic (3.51e-2)" "unprognostic (7.15e-2)" "unprognostic (4.92e-2)" 0.1 0.3 0.8 0.2 1.0 0.4 0.3 4.4 1.6 0.6 0.1 0.2 0.7 4.4 0.2 3.8 0.1 0.1 0.8 1.0 0.6 0.0 0.1 1.4 0.8 1.0 0.1 2.3 3.0 0.0 0.5 0.1 0.2 0.7 0.1 0.3 0.2 0.5 0.9 0.4 0.1 0.8 1.4 0.8 0.3 0.3 1.4 0.7 1.3 0.3 0.7 2.8 0.9 0.0 0.3 1.0 0.1 0.3 0.3 0.2 0.0 0.0 0.2 0.5 0.1 0.3 1.4 0.7 0.3 0.9 0.0 2.5 1.3 0.2 0.1 1.1 0.5 0.4 0.0 0.0 0.0 0.5 0.3 0.0 1.4 0.1 0.0 0.0 2.4 0.1 3.5 0.4 0.0 1.0 0.3 2.1 0.2 0.1 0.3 0.0 0.0 0.5 0.2 2.6 2.9 0.0 0.3 0.2 2.5 1.6 0.3 0.0 1.1 1.1 0.1 0.1 1.9 6.0 1.7 0.3 0.1 0.0 0.7 0.3 0.4 0.4 0.3 0.2 1.4 0.5 2.2 0.1 1.2 2.8 1.8 1.3 0.7 0.3 0.7 0.8 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.1 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 28.8" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.67e-5)" 17.7 28.0 15.7 18.5 19.9 8.1 17.2 26.4 20.0 16.3 15.5 21.6 14.1 9.6 22.7 17.2 11.0 15.5 16.8 13.8 14.5 8.9 19.7 13.2 17.3 12.8 22.5 15.2 25.9 12.7 20.9 18.2 16.1 18.8 15.1 13.3 9.9 14.3 19.3 10.2 13.1 12.1 17.4 19.6 31.5 13.2 15.2 22.4 19.0 29.5 7.5 12.5 18.0 15.0 9.1 4.3 10.7 5.9 17.5 11.2 5.4 5.6 5.1 7.1 10.8 11.9 8.4 12.1 6.2 8.4 5.0 8.1 4.4 3.6 6.5 5.4 5.7 6.7 4.2 6.6 6.4 10.1 4.8 8.1 10.0 3.8 2.4 6.5 0.0 6.9 10.4 6.6 5.4 7.7 12.8 5.4 7.7 5.0 0.0 9.5 3.9 8.3 6.2 6.6 1.5 8.3 5.3 7.5 5.0 7.9 28.8 6.0 7.8 0.0 5.0 0.9 23.7 5.3 5.8 10.3 14.1 5.1 4.1 4.5 3.7 15.4 9.3 2.5 2.5 6.7 9.0 3.1 10.7 7.1 4.2 10.3 8.4 7.3 9.5 4.3 9.1 11.2 8.7 6.5 17.5 5.9 4.1 7.3 5.4 15.7 19.9 26.4 20.0 14.5 8.9 22.5 15.2 18.8 22.4 20.8 29.1 11.9 8.4 3.5 21.1 18.3 17.8 10.7 14.8 8.7 27.5 7.4 5.0 5.9 25.5 16.1 8.1 0.0 5.9 6.7 7.1 9.0 17.4 4.3 5.6 44.5 8.1 36.2 10.0 8.1 10.0 9.5 1.7 2.8 6.8 12.0 6.4 7.0 13.4 4.7 17.9 12.9 10.0 7.9 7.6 3.4 8.7 20.0 5.1 9.8 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003978 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059574: AB_2684068" "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favorable (1.55e-7)" 6.8 6.9 10.2 7.3 15.2 8.7 8.8 22.1 12.9 8.3 6.5 7.1 5.4 5.7 8.1 9.7 4.7 7.6 6.5 5.0 9.1 6.4 7.7 7.3 7.0 11.9 10.2 7.1 9.9 9.4 11.0 16.9 6.7 9.9 8.4 7.1 4.7 6.1 7.7 4.2 7.3 7.9 6.1 7.7 12.6 7.3 5.8 12.9 16.1 13.2 3.5 12.1 7.0 8.7 7.9 4.3 7.4 8.5 4.9 9.0 4.4 3.6 4.8 6.2 5.9 3.5 4.0 2.4 4.7 5.6 6.9 8.3 3.7 4.9 9.4 3.5 3.0 6.4 4.5 10.1 2.7 8.4 6.6 5.9 4.7 6.2 4.8 4.4 8.7 7.7 3.4 5.8 5.8 7.0 8.2 4.1 9.3 4.0 7.0 6.3 2.7 6.7 15.6 9.7 2.4 5.7 5.7 11.6 10.3 6.0 2.5 5.7 7.8 7.6 2.5 4.4 14.1 6.2 7.6 4.1 5.5 6.0 7.8 3.9 9.3 7.6 7.3 3.8 7.4 3.6 3.1 3.4 7.0 6.2 3.4 7.0 7.9 5.6 5.7 4.3 5.6 9.0 7.5 7.4 4.9 8.5 3.2 5.2 4.4 10.2 15.2 22.1 12.9 9.1 6.4 10.2 7.1 9.9 12.9 11.9 6.5 3.7 0.7 0.2 6.3 2.7 2.5 4.0 2.3 1.8 2.0 1.8 0.0 2.3 0.3 1.4 0.7 0.0 1.6 1.1 1.4 1.0 0.0 2.1 1.4 1.6 7.5 4.9 4.6 0.0 2.3 3.3 3.3 3.6 4.4 3.8 2.5 1.4 1.8 1.9 2.7 0.0 1.3 3.0 2.0 1.0 0.7 2.5 2.3 0.9 ZNF19 "KOX12, MGC51021" ENSG00000157429 "Zinc finger protein 19" P17023 16 71464555-71565089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 32.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Rod photoreceptor cells: 24.7;Spermatocytes: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063685 Approved Approved Mitochondria NA NA Mitochondria "HPA063685: AB_2685090" "unprognostic (5.59e-4)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-4)" "unprognostic (6.02e-3)" "unprognostic (4.92e-2)" "unprognostic (3.34e-2)" "unprognostic (6.97e-3)" "unprognostic (2.23e-1)" "unprognostic (4.84e-2)" "unprognostic (8.90e-4)" "unprognostic (1.31e-1)" "unprognostic (3.04e-6)" "unprognostic (3.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.83e-2)" "unprognostic (4.87e-2)" 4.7 3.3 4.8 4.1 6.8 2.5 6.3 4.3 5.2 3.8 2.6 7.1 2.9 3.3 5.6 14.4 4.6 9.1 6.9 4.7 4.9 4.1 5.6 3.4 4.5 3.4 3.0 4.4 4.8 6.4 3.9 32.0 1.7 6.8 3.6 2.2 5.2 4.9 3.2 9.0 6.9 3.4 2.6 4.5 3.1 3.0 18.7 5.5 3.0 8.9 2.0 2.6 2.8 1.9 6.1 3.5 4.4 2.5 2.5 4.3 1.7 2.5 1.7 5.7 6.2 2.8 3.8 3.7 3.0 1.4 2.4 3.0 3.8 6.3 4.5 4.1 1.6 3.8 2.4 3.0 2.9 1.1 2.7 3.3 4.6 4.1 4.9 0.9 4.9 4.1 5.0 3.8 2.8 5.3 4.8 2.3 6.2 2.9 4.2 1.8 3.5 3.3 3.6 2.9 1.1 4.5 2.1 4.7 1.8 2.9 5.5 9.1 5.8 6.1 1.8 5.0 4.2 4.5 3.7 2.7 6.2 3.1 4.3 3.5 4.0 3.3 1.7 5.6 3.0 3.4 4.4 2.4 2.1 3.1 2.2 1.3 5.4 3.4 3.0 1.9 6.1 4.3 3.9 4.3 2.5 2.5 3.5 1.4 1.7 4.8 6.8 4.3 4.8 4.9 4.1 3.0 4.4 6.8 5.5 0.0 2.7 0.5 2.0 0.2 3.2 1.1 0.0 13.4 2.3 1.8 9.8 1.1 5.0 3.4 2.4 1.1 1.7 0.0 1.2 0.7 1.0 1.6 0.0 2.9 1.2 9.5 1.2 2.5 0.6 3.6 0.6 0.6 0.0 1.0 1.5 3.8 2.2 1.4 1.8 2.1 24.7 6.5 1.0 14.6 7.0 0.5 0.5 0.9 1.2 0.7 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 9.9 9.9 14.0 12.4 16.1 4.2 12.7 23.7 15.4 13.5 10.9 8.6 18.3 8.9 13.6 13.4 8.3 11.0 9.2 9.8 13.2 12.4 10.2 12.8 9.4 9.7 15.0 14.0 18.4 10.2 17.8 23.5 11.1 16.0 13.7 11.1 9.2 9.0 19.8 18.2 10.8 8.8 17.6 18.3 10.1 9.2 10.1 16.2 11.8 15.9 8.9 9.6 12.0 15.7 2.7 3.2 0.9 8.4 2.5 1.7 0.7 3.0 1.4 14.0 4.5 7.9 8.6 0.4 6.2 7.9 5.4 5.8 3.0 2.6 3.0 3.7 5.2 3.1 2.1 7.1 5.4 6.1 0.7 1.7 12.7 5.3 2.1 7.6 10.2 3.3 9.1 8.1 5.8 9.8 7.9 3.8 4.4 7.9 5.0 8.7 0.7 5.8 6.7 9.2 3.3 4.4 1.9 10.1 3.7 5.7 3.7 6.0 10.1 5.8 2.7 8.4 7.9 7.8 8.8 4.4 6.0 4.3 8.4 5.1 6.5 7.5 2.0 4.7 3.1 5.9 0.6 1.4 0.9 1.5 0.6 1.5 1.1 1.4 1.4 1.9 2.7 1.7 1.0 0.9 2.5 8.4 3.2 1.5 0.7 14.0 16.1 23.7 14.7 13.2 12.4 15.0 14.0 16.0 16.2 14.9 5.4 3.7 4.2 2.3 11.8 10.1 2.5 5.3 14.8 0.0 7.9 1.0 1.7 6.4 11.8 4.5 4.5 0.0 7.7 0.5 4.3 4.0 3.5 6.7 4.0 15.9 5.8 5.5 3.5 2.2 5.2 3.6 5.0 7.2 6.5 12.2 5.8 7.0 4.9 3.7 8.9 6.5 4.2 10.8 5.3 3.0 0.3 5.2 5.0 2.6 ZNF200 ENSG00000010539 "Zinc finger protein 200" P98182 16 3222325-3236221 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.3" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.6;Spermatocytes: 38.8;Spermatogonia: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018981, HPA059310" Uncertain Approved Mitochondria No No Mitochondria "HPA018981: AB_1859021, HPA059310: AB_2683974" "unprognostic (1.74e-1)" "unprognostic (5.74e-2)" "unprognostic (3.21e-2)" "unprognostic (8.78e-2)" "unprognostic (9.72e-2)" "unprognostic (3.71e-2)" "unprognostic (1.31e-1)" "unprognostic (2.20e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.80e-2)" "unprognostic (2.98e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (1.89e-1)" "unprognostic (1.11e-1)" "unprognostic (5.23e-3)" 5.4 5.5 4.4 7.5 5.4 3.0 5.7 8.6 7.0 5.1 4.9 6.0 4.7 5.5 6.0 6.8 5.1 5.9 4.7 5.2 4.0 4.3 4.8 6.4 5.2 9.5 4.6 3.3 6.2 3.9 7.3 7.1 8.2 5.6 5.3 5.0 4.2 5.1 4.7 4.0 4.1 5.4 5.3 3.8 10.4 4.7 27.3 5.0 9.6 6.8 2.9 8.3 5.8 4.9 5.8 5.0 19.3 5.1 8.7 10.1 5.4 4.9 5.2 11.7 8.3 4.3 4.6 14.1 6.4 8.0 8.9 8.2 7.8 4.2 9.7 5.0 5.2 5.2 3.7 9.1 7.0 10.6 9.0 8.4 8.0 6.9 6.4 5.8 13.6 19.1 4.6 5.8 6.5 5.9 5.1 7.6 6.9 8.8 7.4 7.7 4.5 9.7 7.1 18.4 6.1 5.0 11.8 16.1 11.3 5.5 2.8 6.7 9.9 6.1 4.7 5.3 8.3 6.7 15.3 5.2 9.1 8.5 3.1 5.6 19.0 18.6 8.3 2.2 8.5 7.0 19.3 3.9 13.6 8.5 5.1 8.2 5.8 7.8 10.1 5.0 5.6 8.0 8.9 16.9 8.7 4.7 3.1 9.0 5.4 4.4 5.4 8.6 7.0 4.0 4.3 4.6 3.3 5.6 5.0 3.0 3.0 0.5 4.1 2.9 5.3 3.4 7.6 2.7 5.7 3.5 11.8 5.9 3.3 3.9 31.6 7.0 2.6 23.3 3.4 5.3 5.1 3.4 4.7 3.8 6.0 0.0 6.4 6.7 7.1 17.1 5.2 6.9 6.8 3.6 4.0 5.7 2.9 4.0 2.8 1.9 6.1 6.5 5.7 38.8 31.2 2.8 4.9 6.5 3.3 4.2 ZNF208 "PMIDP, ZNF95" ENSG00000160321 "Zinc finger protein 208" O43345 19 21932958-22010949 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 10.1;Early spermatids: 11.5;Late spermatids: 9.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "GAMG: 8.4;NTERA-2: 27.0;SuSa: 6.0;U-266/84: 8.1" NA NA "unprognostic (4.06e-3)" "unprognostic (2.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.75e-1)" "unprognostic (7.46e-2)" "unprognostic (1.66e-1)" "unprognostic (2.87e-1)" "unprognostic (6.23e-2)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.29e-2)" "unprognostic (1.66e-1)" "unprognostic (4.94e-2)" "unprognostic (7.21e-3)" "unprognostic (1.70e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-3)" 5.2 1.6 3.6 4.2 9.3 2.2 6.5 1.8 5.5 5.9 6.0 2.5 1.0 1.9 9.3 6.3 6.1 7.0 4.7 15.2 6.8 13.6 8.6 0.9 2.0 3.4 12.5 3.6 6.7 3.5 13.7 10.8 3.6 12.7 7.2 2.1 6.2 3.5 6.8 1.1 5.4 3.1 8.4 7.8 4.3 2.4 11.3 4.4 0.0 15.6 2.1 2.8 7.3 4.9 4.6 3.9 6.5 1.7 3.1 3.7 0.7 0.3 0.2 0.4 0.8 0.0 0.1 1.4 0.2 0.1 0.2 0.1 1.3 0.5 0.5 0.2 0.2 8.4 0.5 0.9 0.1 0.3 0.2 0.2 0.4 0.9 0.6 0.0 0.4 0.2 0.9 0.2 0.0 0.1 0.5 0.6 0.3 0.4 1.5 0.0 0.3 0.0 0.7 27.0 0.0 1.2 0.2 0.0 1.5 1.4 1.6 0.7 1.4 0.2 0.6 0.2 6.0 1.1 0.5 0.0 0.4 0.2 1.8 0.1 0.7 8.1 0.2 0.1 0.3 0.5 4.0 1.7 1.7 2.2 1.4 1.4 3.3 3.7 1.4 0.7 4.6 1.6 2.5 6.5 3.1 0.8 3.9 3.3 0.7 3.6 9.3 1.8 5.5 6.8 13.6 12.5 3.6 12.7 4.4 0.0 0.0 2.7 0.8 0.0 6.8 10.1 0.0 0.0 2.3 5.2 0.0 5.9 3.3 4.6 11.5 2.8 0.0 0.0 0.2 3.1 2.4 1.2 0.0 0.5 0.6 3.2 0.0 1.3 0.0 9.6 1.4 0.0 0.0 0.0 0.0 1.3 0.7 0.0 1.1 0.1 0.4 0.0 2.1 6.7 4.1 0.3 4.5 0.9 0.0 1.6 ZNF211 "CH2H2-25, ZNF-25" ENSG00000121417 "Zinc finger protein 211" Q13398 19 57630395-57642779 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA011340, HPA049967" Approved Approved "Mitochondria,Rods & Rings" NA NA Mitochondria "Rods & Rings" "HPA011340: AB_2668488, HPA049967: AB_2680973" "unprognostic (6.47e-2)" "unprognostic (3.28e-2)" "unprognostic (2.83e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-1)" "unprognostic (2.77e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "unprognostic (6.66e-2)" "unprognostic (1.03e-1)" "unprognostic (3.27e-3)" "unprognostic (1.83e-2)" "unprognostic (1.03e-1)" "unprognostic (3.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (4.72e-3)" 8.8 11.3 11.1 10.1 13.5 24.2 11.7 18.3 14.2 10.1 10.0 17.5 14.8 5.2 12.3 13.2 7.2 10.9 9.3 11.5 11.0 10.4 11.3 6.5 11.1 13.3 12.0 12.4 13.4 7.3 25.7 16.7 13.9 12.2 12.6 10.2 15.4 8.7 14.9 6.8 12.0 12.5 10.3 10.7 17.7 17.6 6.1 9.1 17.7 16.5 5.4 15.1 12.9 10.3 10.5 7.6 12.7 6.2 7.0 13.7 6.5 3.9 2.5 11.6 10.4 6.8 6.8 6.8 5.5 6.8 7.9 5.3 2.0 2.3 3.7 2.4 5.8 4.7 0.9 5.5 8.3 16.8 4.6 13.6 7.2 5.7 4.8 5.9 5.0 7.6 6.3 10.1 5.9 5.6 11.7 6.0 6.8 1.6 4.8 9.7 1.8 10.2 3.4 4.7 5.1 6.1 6.3 8.7 3.3 6.8 15.2 5.4 7.5 6.6 3.3 2.5 13.6 3.5 7.1 3.8 8.1 3.9 3.4 4.6 6.7 8.5 7.8 2.2 4.1 4.7 7.9 6.2 12.7 8.4 5.9 13.7 8.8 11.1 12.1 7.6 10.5 13.2 9.3 8.3 7.0 3.9 1.6 11.8 6.5 11.1 13.5 18.3 14.2 11.0 10.4 12.0 12.4 12.2 9.1 3.0 4.3 11.2 1.1 1.0 3.9 4.5 2.5 10.7 1.2 1.8 7.9 6.2 0.0 2.9 0.4 3.8 3.2 0.0 1.0 4.0 1.9 1.8 5.7 1.5 3.4 0.0 1.2 5.5 6.3 0.4 1.1 2.9 1.7 3.6 3.0 4.2 1.3 0.0 2.1 1.0 6.6 12.9 2.5 2.7 3.0 1.5 14.9 7.0 2.4 2.5 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 18.5;Late spermatids: 41.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: AB_2683225" "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.4 10.7 4.8 11.3 4.6 3.9 5.9 6.2 2.5 3.3 3.9 3.4 7.0 4.1 6.1 4.0 4.8 8.3 2.2 6.9 1.3 8.6 8.3 2.9 11.8 6.6 8.9 7.0 7.7 3.7 8.6 4.6 1.7 2.5 2.5 8.1 7.4 9.2 2.1 14.6 6.6 8.7 8.2 3.6 8.2 8.9 5.6 7.5 2.6 2.3 9.9 8.5 9.4 5.6 4.4 3.2 7.4 12.2 6.1 6.7 6.2 7.6 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 0.0 0.6 1.7 1.3 1.6 5.9 3.3 2.5 1.4 1.2 0.0 2.0 1.4 1.7 3.5 18.5 2.2 8.5 0.0 4.3 1.6 2.5 1.7 4.6 1.0 2.8 7.9 2.4 2.5 4.1 41.1 6.1 2.3 0.0 3.6 5.3 4.6 4.9 3.5 6.7 2.3 5.2 19.4 4.4 8.9 3.8 1.8 1.1 0.0 5.2 1.3 ZNF214 ENSG00000149050 "Zinc finger protein 214" Q9UL59 11 6999318-7020368 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 13.4;Spermatocytes: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA055391 Uncertain NA NA "HPA055391: AB_2682804" "unprognostic (3.01e-2)" "unprognostic (3.04e-1)" "unprognostic (1.56e-2)" "unprognostic (2.33e-1)" "unprognostic (8.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.28e-3)" "unprognostic (7.53e-4)" "unprognostic (1.71e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-1)" "unprognostic (1.29e-1)" "unprognostic (3.67e-3)" "unprognostic (3.00e-2)" "unprognostic (3.21e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-2)" 1.8 2.9 4.6 1.2 5.7 0.4 5.5 4.7 6.0 7.4 3.3 2.3 8.1 1.9 6.0 7.7 1.8 10.0 2.5 2.4 4.2 3.7 7.0 3.4 3.3 0.9 2.9 4.8 11.1 3.1 8.4 7.8 0.8 4.6 7.9 3.0 4.8 3.1 9.2 1.2 1.3 2.0 4.8 2.7 0.9 2.2 8.0 3.1 0.0 9.2 1.0 0.9 4.1 3.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 1.6 5.9 0.0 1.1 4.0 1.5 2.4 6.0 3.0 3.5 0.0 4.4 0.0 0.8 1.5 2.0 0.8 0.6 1.7 3.4 0.0 1.6 0.0 0.8 0.4 2.3 0.0 0.2 1.4 3.7 0.1 3.5 4.3 2.7 0.0 0.3 0.0 1.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.0 4.6 2.5 0.3 0.2 2.6 1.0 0.0 0.3 1.9 2.6 5.5 0.0 0.0 0.0 0.0 3.4 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.7 4.7 6.0 4.2 3.7 2.9 4.8 4.6 3.1 0.0 1.0 0.0 1.5 0.0 1.9 0.6 0.0 13.4 3.4 0.0 0.0 0.1 1.7 1.7 2.5 0.3 0.3 0.0 0.8 0.3 0.7 0.5 0.0 0.2 0.1 3.2 2.4 0.0 0.0 0.4 0.6 0.4 0.0 0.0 1.5 2.5 1.0 0.0 0.4 2.8 3.6 0.0 0.8 5.6 2.8 0.1 0.0 0.0 0.6 0.3 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 7.0;Cone photoreceptor cells: 5.9;Spermatogonia: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 18.1" "Low region specificity" "Detected in all" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: AB_2681308" "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 1.2 1.4 1.5 9.0 1.8 1.4 2.7 0.7 4.0 1.9 4.2 0.3 0.9 4.6 2.3 5.2 2.8 1.4 1.1 1.4 1.2 2.2 2.9 1.6 1.5 6.7 0.7 1.4 1.9 10.4 0.0 0.8 0.7 1.9 2.7 5.5 1.2 4.2 2.0 0.9 1.6 5.5 0.9 1.1 4.8 1.6 6.1 0.0 6.5 2.7 2.1 11.6 3.3 2.2 2.5 2.9 4.0 1.8 1.5 1.4 0.8 2.6 1.2 1.8 0.6 1.3 1.6 5.8 6.2 5.3 3.2 6.4 0.2 0.1 8.7 2.0 3.3 4.1 3.1 5.1 6.1 6.1 0.0 7.0 0.1 0.8 0.1 1.3 5.3 0.4 2.8 2.9 0.1 6.7 1.6 5.1 0.1 10.2 3.0 1.3 0.1 0.2 0.2 8.5 0.0 1.7 0.2 0.1 1.0 0.2 4.8 0.1 0.2 0.0 2.2 0.2 4.5 0.2 2.2 2.4 2.0 5.8 2.4 0.1 0.4 0.1 18.1 4.6 0.3 1.8 4.0 1.8 0.6 0.8 1.0 0.3 2.5 0.6 1.4 1.7 2.5 1.4 0.8 2.7 1.5 0.5 2.9 0.7 0.8 1.5 1.8 0.7 4.0 1.2 2.2 0.7 1.4 1.9 0.0 0.0 0.0 2.2 1.3 0.3 0.5 0.2 0.0 0.0 1.2 7.0 5.9 0.3 1.7 0.1 0.2 0.0 1.3 0.0 1.5 2.2 0.5 0.4 1.1 1.0 0.4 3.2 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.9 1.5 7.5 0.3 0.0 0.0 2.5 0.6 ZNF222 ENSG00000159885 "Zinc finger protein 222" Q9UK12 19 44025342-44033112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004086 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA004086: AB_2273259" "unprognostic (1.91e-3)" "unprognostic (3.41e-2)" "unprognostic (8.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (7.45e-2)" "unprognostic (1.75e-3)" "unprognostic (6.75e-2)" "unprognostic (1.58e-2)" "unprognostic (7.58e-2)" "prognostic favorable (5.56e-7)" "unprognostic (2.19e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-1)" "unprognostic (8.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-3)" 4.8 7.7 8.1 5.1 9.1 8.0 8.3 18.3 12.6 6.2 4.4 7.5 5.3 2.9 5.1 7.3 3.5 5.5 6.4 7.5 11.5 8.2 5.9 5.1 5.7 7.2 8.8 7.8 8.9 5.4 6.6 12.7 5.4 10.7 6.6 5.0 5.7 6.9 6.4 3.7 4.5 5.0 6.0 9.3 8.8 5.5 15.4 11.1 10.3 7.6 5.0 7.3 8.5 6.6 7.6 4.0 8.9 3.6 6.1 9.7 4.0 3.9 4.6 7.9 7.1 6.1 6.2 0.4 4.2 7.6 5.0 7.8 2.4 2.6 1.4 6.6 4.7 6.0 1.3 5.4 4.0 6.3 5.8 5.9 6.5 5.8 3.8 7.6 0.2 5.9 4.7 5.5 4.1 7.1 8.0 4.6 5.8 1.2 2.8 6.2 0.5 4.4 2.6 4.7 1.8 2.3 0.1 8.4 2.1 4.2 12.4 4.2 9.7 6.9 1.3 5.7 7.2 1.7 6.3 3.4 5.5 5.3 3.2 5.2 11.3 9.2 0.1 2.9 0.1 6.1 8.9 3.6 7.0 9.2 2.3 7.7 7.4 8.7 8.9 3.6 7.6 9.7 7.3 7.5 6.1 2.8 4.0 6.0 4.0 8.1 9.1 18.3 12.6 11.5 8.2 8.8 7.8 10.7 11.1 0.0 1.0 0.0 1.7 2.3 4.9 1.9 0.0 0.0 1.2 5.2 0.0 1.8 6.6 2.3 43.5 1.8 0.7 0.0 1.1 0.9 2.1 1.0 4.6 1.0 2.0 6.4 2.9 1.3 1.2 1.5 1.7 1.2 1.7 1.0 1.7 6.5 0.8 0.0 2.1 1.2 2.6 0.0 2.7 5.1 1.2 1.5 0.9 4.1 1.2 0.6 ZNF226 ENSG00000167380 "Zinc finger protein 226" Q9NYT6 19 44165073-44178381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006145, CAB034353" Uncertain Approved "Nuclear bodies" No No "Nuclear bodies" "CAB034353: AB_2219110, HPA006145: AB_10696203" "unprognostic (1.30e-2)" "unprognostic (5.53e-2)" "unprognostic (3.06e-1)" "unprognostic (3.41e-3)" "unprognostic (1.79e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (8.34e-4)" "unprognostic (4.09e-2)" "unprognostic (6.60e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-1)" "prognostic favorable (2.37e-5)" 10.5 26.2 23.2 10.2 24.9 8.9 18.6 37.6 20.8 9.6 12.0 18.0 14.9 12.0 12.4 23.9 9.4 14.7 15.0 13.9 19.9 19.1 13.8 15.6 11.1 16.0 26.8 22.3 18.7 7.8 12.2 38.7 11.5 21.3 19.6 13.1 12.2 9.7 14.8 7.6 10.9 12.0 11.0 21.5 15.5 14.0 14.5 28.6 15.9 21.5 5.5 13.5 14.4 11.3 19.4 13.3 24.6 10.6 16.9 19.7 9.4 9.3 10.4 11.7 8.6 11.1 17.8 5.3 9.7 21.9 11.0 20.1 7.2 11.6 3.3 12.4 12.4 15.2 5.2 5.1 9.6 13.3 5.3 12.2 13.2 12.7 5.4 9.7 8.5 9.0 20.1 12.8 13.3 26.9 21.3 14.2 10.0 2.7 3.3 20.9 3.1 9.2 3.6 5.7 5.4 7.7 5.6 9.3 6.5 10.7 25.9 8.4 13.4 19.6 7.2 4.5 12.0 11.7 12.4 11.1 10.1 12.5 5.5 11.5 16.3 14.8 9.6 9.2 5.9 10.7 24.6 10.5 6.6 16.2 10.6 18.2 13.8 16.4 15.9 12.4 19.4 19.7 17.2 7.9 16.9 9.0 13.3 17.7 9.4 23.2 24.9 37.6 20.8 19.9 19.1 26.8 22.3 21.3 28.6 14.9 14.4 12.9 14.5 3.5 41.4 25.8 20.4 24.1 10.3 10.4 25.5 11.6 29.9 20.2 11.2 13.5 15.4 0.0 24.4 5.9 15.4 23.8 10.5 21.5 15.3 20.6 11.6 16.0 20.5 5.1 17.8 15.0 20.3 19.8 17.5 25.6 19.2 20.1 20.8 33.8 29.7 6.5 11.3 14.3 18.3 5.1 10.8 27.3 11.3 16.5 ZNF233 FLJ38032 ENSG00000159915 "Zinc finger protein 233" A6NK53 19 44259880-44275317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 23.3;Spermatocytes: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 10.7;U-266/84: 10.0" HPA020975 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020975: AB_1859145" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-1)" "unprognostic (1.60e-1)" "unprognostic (3.72e-2)" "unprognostic (7.37e-3)" "unprognostic (2.77e-2)" "unprognostic (9.07e-3)" "unprognostic (1.48e-1)" "unprognostic (4.20e-3)" "unprognostic (1.65e-1)" "unprognostic (6.28e-3)" "unprognostic (6.88e-2)" "unprognostic (3.47e-2)" "unprognostic (2.71e-4)" "unprognostic (1.55e-1)" 0.6 2.3 4.4 2.1 6.3 3.9 2.5 10.9 8.5 1.3 4.3 0.8 0.2 1.9 0.9 2.8 1.4 2.2 1.8 4.8 4.1 5.0 2.1 0.8 1.2 2.3 3.3 6.1 1.2 1.6 3.1 11.2 2.2 6.2 4.8 2.2 2.1 1.6 2.3 2.5 3.8 1.8 1.6 3.4 2.2 2.1 25.2 2.4 3.3 3.5 2.7 1.0 1.6 0.8 4.7 3.9 3.3 1.2 3.4 2.2 0.5 0.7 2.7 3.1 3.1 3.2 0.6 1.3 1.2 0.8 1.0 1.8 2.8 3.3 1.2 2.9 0.8 1.5 1.3 0.1 0.7 1.1 0.6 3.8 1.9 3.5 2.9 2.2 1.3 1.3 0.7 0.5 0.7 1.9 4.3 1.3 1.4 1.3 5.9 0.2 1.6 1.0 1.0 3.2 0.6 0.8 2.0 0.4 2.4 0.7 2.4 4.3 6.4 1.2 0.8 2.1 5.7 5.1 1.5 0.8 1.3 0.8 0.9 0.8 10.7 10.0 2.2 4.4 1.3 1.4 3.3 1.0 0.9 1.6 1.1 1.5 2.7 1.4 1.1 0.5 4.7 2.0 2.2 2.4 3.4 1.2 3.9 2.1 0.5 4.4 6.3 10.9 8.5 4.1 5.0 3.3 6.1 6.2 2.4 0.0 0.3 0.0 0.1 0.0 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 23.3 0.0 0.4 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.5 0.0 1.2 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 4.2 0.0 0.1 8.7 1.9 0.0 0.0 0.0 0.3 0.0 ZNF234 "HZF4, ZNF269" ENSG00000263002 "Zinc finger protein 234" Q14588 19 44141557-44160309 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001664 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001664: AB_1080694" "unprognostic (9.03e-2)" "unprognostic (8.56e-2)" "unprognostic (5.31e-2)" "unprognostic (4.97e-2)" "unprognostic (2.53e-2)" "unprognostic (2.96e-1)" "unprognostic (7.77e-3)" "unprognostic (2.22e-1)" "unprognostic (5.07e-2)" "unprognostic (3.43e-1)" "unprognostic (3.77e-2)" "unprognostic (2.57e-2)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (1.70e-1)" "unprognostic (7.31e-2)" "prognostic favorable (4.34e-5)" 8.0 11.7 8.2 8.1 12.7 1.4 10.1 18.3 10.5 8.3 7.6 12.0 9.5 7.6 8.5 6.4 7.5 7.0 7.0 9.4 8.8 5.1 8.1 7.2 7.5 9.0 14.7 8.2 11.7 7.3 12.4 14.3 9.6 10.6 8.9 7.8 7.4 8.7 7.8 7.7 9.2 9.0 9.0 11.1 12.2 8.0 6.4 14.2 11.6 10.1 3.4 10.4 8.5 7.7 6.2 4.2 5.4 4.4 7.2 7.7 3.1 4.8 3.4 8.3 7.9 9.9 10.2 3.8 6.3 4.6 5.0 8.3 4.2 3.0 0.1 4.3 5.7 4.7 3.7 6.2 4.0 6.0 0.0 7.5 9.6 7.0 5.5 4.7 0.0 6.8 5.7 9.1 5.4 6.2 6.9 5.5 0.0 0.6 0.1 7.4 1.5 6.4 2.3 5.5 3.1 3.2 0.0 9.4 1.5 3.1 9.4 4.6 7.7 4.5 3.8 3.3 8.9 4.2 3.9 5.6 9.3 7.6 1.7 5.7 5.2 4.3 0.1 1.0 0.0 7.4 2.4 3.6 5.4 6.8 4.4 5.7 4.1 4.0 4.7 4.2 6.2 7.7 7.3 1.4 7.2 3.1 2.9 2.1 3.1 8.2 12.7 18.3 10.5 8.8 5.1 14.7 8.2 10.6 14.2 0.0 1.3 2.2 2.2 2.7 4.4 8.0 0.0 1.4 5.7 1.8 2.0 4.9 5.0 3.6 5.4 2.9 1.7 0.0 1.8 2.2 4.3 2.0 3.5 0.9 2.3 4.8 3.5 4.9 3.2 4.4 6.4 1.4 1.7 1.8 2.3 2.9 2.0 3.2 5.3 1.7 5.9 6.5 3.1 3.9 4.7 2.5 2.6 5.0 2.1 1.8 ZNF235 "ANF270, HZF6, ZFP93, ZNF270" ENSG00000159917 "Zinc finger protein 235" Q14590 19 44228729-44305046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045582 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045582: AB_10963792" "unprognostic (2.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.11e-2)" "unprognostic (9.91e-3)" "unprognostic (2.04e-2)" "unprognostic (1.23e-4)" "unprognostic (4.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (3.37e-1)" "unprognostic (1.46e-5)" "unprognostic (1.20e-2)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-3)" "unprognostic (3.38e-2)" 5.6 4.8 8.1 6.6 10.4 1.8 8.1 13.9 10.3 6.1 7.7 10.7 10.1 5.0 13.2 6.5 5.2 7.1 4.9 6.9 7.8 7.5 6.7 5.5 6.6 7.4 8.5 4.1 8.1 6.2 10.1 9.0 7.3 9.4 7.7 6.0 6.9 5.8 8.2 6.5 4.4 6.4 6.9 7.1 8.2 5.3 6.8 8.5 10.7 9.1 2.9 9.3 6.2 5.9 10.9 8.3 14.5 3.7 5.6 7.5 2.4 2.0 3.2 6.4 6.4 4.8 2.9 2.4 1.2 3.8 2.3 2.8 2.0 3.5 3.4 3.2 2.4 3.6 1.7 5.6 2.6 2.8 0.0 6.9 7.3 4.9 2.9 3.9 4.1 4.4 2.9 3.5 2.6 3.1 4.0 3.8 6.3 1.7 0.0 2.5 1.6 6.7 0.8 7.6 3.5 2.0 3.3 6.1 2.9 4.6 5.0 4.6 13.0 3.4 4.1 3.0 6.7 3.2 5.0 4.4 2.1 3.0 0.6 1.4 7.8 7.8 2.4 1.8 1.1 3.4 14.5 3.7 3.6 6.8 3.0 4.7 6.9 5.1 5.8 2.7 10.9 7.5 6.5 2.0 5.6 2.9 8.3 3.7 2.4 8.1 10.4 13.9 10.3 7.8 7.5 8.5 4.1 9.4 8.5 0.0 0.0 2.7 0.6 0.5 1.7 1.9 2.5 0.0 0.0 0.0 5.9 1.2 0.0 0.9 0.9 1.4 1.1 0.0 0.0 0.4 0.7 0.8 2.3 0.9 1.2 1.6 0.0 2.5 1.8 0.0 0.6 1.3 1.7 0.0 0.7 1.2 0.4 2.8 3.2 0.4 1.6 0.0 1.9 2.6 4.8 0.5 1.3 3.9 1.0 0.1 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.2 5.7 8.0 5.9 6.2 6.0 3.6 3.3 4.6 5.3 4.2 4.0 4.0 6.0 1.6 4.3 5.6 7.8 5.5 4.6 4.4 6.4 5.6 5.7 6.6 4.7 3.8 9.1 6.6 5.9 5.1 5.0 7.7 5.7 5.3 9.6 5.4 5.1 5.3 4.0 11.2 5.1 4.4 1.3 4.5 7.1 8.3 4.0 3.9 6.7 4.6 4.8 5.9 3.6 4.1 3.9 4.3 6.4 5.4 9.1 3.7 2.4 4.9 3.5 4.7 7.8 6.0 5.0 6.8 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 8.9 6.4 3.7 7.4 6.4 14.6 6.9 10.2 14.7 6.8 7.0 9.8 6.9 1.7 4.3 6.0 7.5 4.3 23.3 3.4 6.0 7.7 6.0 1.1 5.7 5.3 23.8 5.8 7.4 8.7 3.3 9.8 5.3 6.8 5.4 4.7 10.8 3.9 2.9 6.7 2.2 14.3 6.5 8.2 27.0 18.5 7.3 5.0 5.1 5.2 5.8 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949572-37976633 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" No No "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 9.7 12.1 17.0 4.0 21.7 2.7 8.7 23.2 27.6 10.9 8.1 7.3 3.4 2.7 11.3 7.5 6.5 7.3 7.1 11.1 13.3 16.7 6.8 3.5 6.9 4.9 12.7 23.7 13.1 4.0 7.1 10.7 5.4 16.0 8.9 5.4 5.1 4.5 11.0 22.9 5.1 3.7 11.6 9.5 7.1 4.4 5.2 11.6 1.2 6.3 5.7 4.9 8.4 5.4 2.3 3.4 6.0 8.5 1.8 3.7 2.2 1.6 3.0 3.3 6.7 12.5 9.6 0.6 3.6 4.9 2.8 4.3 0.5 2.3 3.0 1.0 6.3 1.1 0.4 0.9 1.5 4.6 7.0 1.6 4.8 0.0 1.0 7.9 3.2 3.1 6.8 6.6 3.1 3.6 11.3 4.8 3.9 0.4 2.3 6.8 0.9 1.0 2.4 0.6 0.5 2.2 1.1 3.7 0.6 3.4 0.6 1.2 7.7 1.2 0.2 4.5 1.3 2.9 5.1 6.9 4.4 0.8 7.1 2.2 2.9 1.3 1.2 8.4 6.2 2.9 2.3 2.8 6.0 3.1 4.7 3.4 2.0 2.7 2.6 3.4 2.3 3.7 3.0 0.5 1.8 8.5 0.5 2.2 2.2 17.0 21.7 23.2 27.6 13.3 16.7 12.7 23.7 16.0 11.6 3.0 2.7 3.4 2.0 3.1 17.7 20.4 5.1 12.0 3.4 7.0 5.9 1.0 1.7 1.7 26.3 5.8 0.8 0.0 2.1 0.4 8.5 2.0 8.1 2.9 5.1 15.9 0.0 10.4 10.2 20.4 11.2 10.1 3.3 5.4 1.1 12.8 1.6 0.0 15.2 3.0 7.1 0.0 13.3 3.2 7.2 3.4 0.2 4.5 0.7 0.7 ZNF253 "BMZF-1, FLJ90391, ZNF411" ENSG00000256771 "Zinc finger protein 253" O75346 19 19865886-19894674 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.03e-2)" "unprognostic (3.54e-1)" "unprognostic (7.10e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.39e-5)" "unprognostic (4.75e-2)" "unprognostic (4.77e-2)" "unprognostic (2.80e-2)" "unprognostic (5.26e-3)" "prognostic favorable (2.19e-4)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "prognostic favorable (9.69e-5)" "unprognostic (4.88e-2)" "unprognostic (3.68e-1)" "unprognostic (1.84e-3)" "unprognostic (4.54e-3)" 6.2 9.4 9.9 6.7 15.0 3.9 13.1 33.9 15.7 10.3 7.7 11.5 7.8 6.7 8.5 7.9 5.5 10.3 5.8 7.5 10.4 8.4 11.6 8.1 6.3 12.9 14.1 12.3 20.9 9.6 12.3 19.6 6.9 16.7 9.8 9.0 7.1 8.7 9.2 10.1 5.8 8.7 5.4 13.4 11.6 8.7 6.6 17.6 16.7 23.1 7.1 13.1 9.9 8.6 9.7 4.4 11.2 2.0 6.5 16.2 4.5 0.0 0.0 12.7 10.1 1.7 1.7 5.8 1.7 0.8 3.5 3.9 1.6 3.1 9.3 6.8 1.6 3.0 1.9 0.1 0.4 5.3 1.0 3.8 0.7 0.8 2.9 2.3 0.1 0.2 2.6 2.2 2.4 0.3 5.3 0.1 0.3 5.4 4.8 5.1 4.2 14.9 3.2 13.5 0.0 1.6 14.2 7.8 6.8 4.6 6.9 8.0 7.8 7.6 1.9 2.0 10.3 4.3 11.3 0.1 4.6 0.1 3.8 2.4 6.6 5.7 14.9 0.2 0.4 2.2 11.2 1.5 3.7 6.0 2.0 7.8 9.6 8.1 7.9 3.4 9.7 16.2 10.6 1.3 6.5 1.7 4.4 5.9 4.5 9.9 15.0 33.9 15.7 10.4 8.4 14.1 12.3 16.7 17.6 8.9 2.2 11.5 1.2 0.3 12.2 4.5 5.1 10.7 5.7 5.2 5.9 4.5 14.9 4.4 7.8 3.8 1.6 0.0 2.6 2.6 2.5 1.5 2.3 1.8 2.3 12.7 7.5 1.8 1.6 0.4 4.6 2.2 1.7 0.0 2.2 9.6 2.3 3.5 4.2 5.4 25.3 0.0 1.1 5.9 5.5 0.4 4.1 9.6 4.6 1.3 ZNF254 "BMZF-5, HD-ZNF1, ZNF539, ZNF91L" ENSG00000213096 "Zinc finger protein 254" O75437 19 24033405-24129961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.39e-2)" "unprognostic (2.51e-1)" "unprognostic (1.91e-1)" "unprognostic (1.31e-1)" "unprognostic (4.04e-2)" "unprognostic (6.92e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.60e-4)" "unprognostic (4.11e-3)" "unprognostic (2.23e-2)" "unprognostic (2.99e-3)" "unprognostic (1.96e-2)" "unprognostic (5.98e-3)" "unprognostic (4.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.12e-1)" "prognostic favorable (9.96e-4)" 9.4 10.2 12.0 7.8 15.3 12.4 14.9 30.7 17.4 18.7 11.3 14.5 17.7 8.1 14.8 17.6 12.0 11.9 10.7 10.7 12.1 12.9 15.1 16.3 12.1 12.3 13.7 11.7 20.6 10.3 19.8 37.0 10.8 15.2 15.3 14.4 15.1 12.3 26.2 5.4 9.4 8.8 10.2 14.1 11.1 11.8 9.5 16.2 24.1 32.2 7.0 11.5 14.1 13.4 6.0 4.5 10.9 4.6 4.8 5.3 2.3 2.7 3.6 16.2 8.3 3.4 3.9 2.9 3.8 6.3 5.1 8.3 4.2 4.9 3.8 6.9 3.1 3.0 1.5 9.9 3.3 7.7 22.7 16.3 7.3 4.6 2.1 3.0 3.6 1.6 4.2 3.7 5.3 4.8 7.5 6.2 9.1 10.3 0.0 6.1 4.1 7.6 6.7 12.1 1.0 6.4 10.7 8.4 9.3 7.0 7.9 9.6 9.1 0.0 0.3 4.6 13.7 4.0 6.0 4.6 2.5 0.7 5.0 5.3 0.1 4.2 10.1 0.0 4.3 2.1 10.9 2.2 6.8 3.5 2.4 3.7 6.0 4.4 3.8 3.7 5.9 5.2 4.5 5.3 4.8 4.6 4.5 5.3 2.3 12.0 15.3 30.7 17.4 12.1 12.9 13.7 11.7 15.2 16.2 35.7 14.4 11.6 8.2 3.1 21.3 15.2 22.9 9.4 11.4 12.2 13.7 5.2 13.3 9.9 38.1 6.8 2.9 0.0 6.5 8.4 6.9 8.4 6.9 9.6 4.9 35.0 16.1 6.2 7.3 13.5 10.9 8.3 6.8 5.4 5.4 15.4 8.1 2.9 15.6 7.1 15.1 12.9 9.5 4.6 7.0 4.5 7.3 7.2 6.3 7.3 ZNF257 BMZF-4 ENSG00000197134 "Zinc finger protein 257" Q9Y2Q1 19 22052452-22091480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 8.3;Spermatocytes: 11.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "GAMG: 6.2;NTERA-2: 13.6;RH-30: 7.2" NA NA "unprognostic (8.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.29e-3)" "unprognostic (1.99e-3)" "unprognostic (9.40e-3)" "unprognostic (7.00e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (7.13e-2)" "unprognostic (2.34e-3)" "unprognostic (2.21e-1)" "unprognostic (2.15e-1)" "unprognostic (6.62e-4)" 3.6 1.6 2.9 7.8 2.9 9.1 3.4 2.8 5.7 3.8 2.2 2.2 1.1 1.2 4.0 4.1 2.3 3.7 1.4 2.8 3.1 2.4 3.3 1.4 2.0 10.8 3.1 2.9 6.4 5.5 3.9 3.1 5.1 3.9 3.5 1.7 2.2 2.1 2.1 1.1 2.1 2.8 2.9 4.2 6.4 3.0 8.8 3.3 9.3 6.2 1.0 6.0 3.8 4.6 5.2 1.6 5.0 1.2 2.7 3.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.7 4.3 3.7 0.0 0.7 0.0 1.7 0.1 6.2 0.0 0.0 0.0 4.5 0.0 0.1 3.9 0.2 0.1 0.1 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 3.7 3.6 13.6 0.0 1.6 0.1 7.2 3.0 0.7 1.5 0.0 1.9 0.0 0.0 1.1 1.8 0.0 3.2 0.0 0.0 0.2 0.4 0.1 0.2 2.8 4.9 0.1 0.0 0.2 5.0 0.9 2.9 1.6 1.2 1.7 5.2 2.8 2.3 0.6 4.9 3.2 1.9 4.2 2.7 1.1 1.6 1.4 0.8 2.9 2.9 2.8 5.7 3.1 2.4 3.1 2.9 3.9 3.3 0.0 0.0 5.9 1.4 1.1 1.3 1.6 0.0 2.7 2.3 7.0 0.0 3.1 8.3 1.5 4.0 1.8 0.0 0.0 1.6 4.7 1.5 0.8 2.3 0.0 1.0 4.8 0.0 5.5 0.3 1.7 1.4 1.9 0.0 1.0 0.5 0.8 0.8 0.0 1.4 0.0 0.4 0.0 1.0 11.3 6.1 1.5 2.9 2.2 0.0 1.3 ZNF280A "3'OY11.1, SUHW1, ZNF280, ZNF636" ENSG00000169548 "Zinc finger protein 280A" P59817 22 22513736-22520270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.6;epididymis: 5.6;retina: 2.2" "Cell type enhanced" "Detected in some" 30 "Melanocytes: 1.7;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;EFO-21: 1.9;K-562: 13.0;SK-MEL-30: 3.5" "Not detected" "Not detected" HPA044475 Approved Nucleoplasm NA NA Nucleoplasm "HPA044475: AB_10960420" "unprognostic (7.53e-2)" "unprognostic (3.76e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (3.29e-1)" "unprognostic (4.65e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.1 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.5 0.3 0.5 0.2 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.0 ZNF284 DKFZp781F1775 ENSG00000186026 "Zinc finger protein 284" Q2VY69 19 44072144-44089613 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.88e-2)" "unprognostic (2.51e-1)" "unprognostic (3.50e-1)" "unprognostic (5.59e-2)" "unprognostic (3.36e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-3)" "unprognostic (8.56e-2)" "unprognostic (4.32e-2)" "unprognostic (4.15e-2)" "unprognostic (6.62e-3)" "unprognostic (3.10e-2)" "unprognostic (2.21e-1)" "unprognostic (2.46e-1)" "unprognostic (9.71e-2)" "unprognostic (7.63e-2)" "unprognostic (3.95e-3)" 5.1 6.0 5.8 4.8 7.0 3.2 5.2 12.9 7.6 4.8 4.0 6.2 4.5 5.6 7.4 6.5 3.7 4.2 3.7 4.1 6.4 4.4 4.5 3.7 4.3 6.5 8.1 5.8 5.3 4.4 5.5 8.9 4.4 8.9 5.0 3.6 3.8 4.9 3.6 6.4 12.4 5.1 3.8 6.3 7.9 4.8 2.5 6.8 10.4 5.8 2.3 5.2 5.8 4.5 3.7 2.0 3.7 3.1 7.7 5.6 1.8 1.3 1.2 3.6 7.6 3.7 3.3 2.0 2.1 1.7 1.4 4.1 2.1 1.5 0.2 1.5 1.8 0.8 2.8 2.5 1.7 2.6 0.1 2.3 4.5 6.1 1.9 2.0 0.3 3.3 3.1 2.9 2.3 3.6 5.1 1.6 1.0 0.2 0.4 2.4 0.5 3.5 2.9 4.2 1.1 1.8 0.1 6.2 1.0 2.0 3.2 2.3 5.8 0.1 0.5 1.4 2.7 1.5 2.7 3.9 4.3 6.7 1.7 1.6 5.2 2.9 0.2 2.0 0.2 1.8 2.6 2.1 3.7 4.6 3.1 3.8 3.1 4.6 3.5 2.0 3.7 5.6 5.6 2.3 7.7 1.8 1.8 4.3 1.8 5.8 7.0 12.9 7.6 6.4 4.4 8.1 5.8 8.9 6.8 3.0 1.4 2.2 0.2 1.6 1.2 0.9 0.0 1.4 0.0 0.0 2.0 0.7 3.3 0.9 0.0 2.8 0.2 0.0 0.4 0.4 1.3 0.6 1.1 0.6 0.7 0.0 2.4 3.1 2.1 0.4 1.7 0.8 3.3 1.0 1.9 0.8 1.3 2.9 2.8 1.8 1.6 6.5 1.5 0.2 1.5 1.6 0.8 2.5 1.2 0.6 ZNF285 ZNF285A ENSG00000267508 "Zinc finger protein 285" Q96NJ3 19 44382298-44401608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Cardiomyocytes: 3.8;Cone photoreceptor cells: 3.9;Spermatocytes: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 8.9" "HPA046100, HPA049212" Uncertain NA NA "HPA046100: AB_2679538, HPA049212: AB_2680677" "unprognostic (3.23e-2)" "unprognostic (1.90e-3)" "unprognostic (6.42e-2)" "unprognostic (9.86e-2)" "unprognostic (1.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.20e-2)" "unprognostic (2.91e-3)" "unprognostic (3.60e-2)" "unprognostic (6.41e-2)" "unprognostic (2.07e-2)" "unprognostic (2.42e-6)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.46e-1)" "unprognostic (1.55e-3)" 2.2 4.9 7.5 2.0 9.7 0.7 5.8 11.9 6.8 3.0 3.4 5.7 2.1 2.1 5.2 3.9 2.6 6.7 2.7 4.9 6.9 7.5 3.9 1.6 1.8 2.8 7.2 8.9 14.9 2.4 5.6 7.7 2.6 6.7 4.9 2.7 2.5 2.1 4.8 4.0 2.0 1.9 5.2 6.4 3.6 3.3 6.4 8.9 2.0 6.6 1.0 3.3 3.8 2.8 6.8 1.0 3.2 0.7 2.1 4.3 1.0 0.3 4.5 4.4 0.0 3.5 3.7 0.2 1.6 1.6 2.2 3.0 0.8 2.7 0.0 2.4 1.0 2.9 1.5 0.0 3.0 3.8 0.0 3.0 6.2 1.6 1.2 5.0 0.8 0.1 2.9 0.0 0.9 8.9 6.4 3.9 0.1 0.1 0.2 2.9 0.1 0.0 0.1 1.2 1.1 2.3 0.0 0.0 2.7 2.5 3.7 1.9 3.3 0.2 0.8 0.0 4.4 5.4 2.1 3.7 2.5 2.0 1.2 0.1 2.7 5.8 0.0 2.3 0.0 2.8 3.2 0.2 0.0 0.2 0.4 0.1 3.0 0.6 0.4 1.0 6.8 4.3 4.3 0.1 2.1 0.7 0.8 0.8 1.0 7.5 9.7 11.9 6.8 6.9 7.5 7.2 8.9 6.7 8.9 0.0 0.0 0.0 0.5 0.2 2.2 3.8 0.0 0.0 1.2 1.8 3.9 0.5 0.0 0.9 1.2 0.5 0.0 0.0 0.6 0.3 0.6 0.8 0.0 0.0 0.4 1.6 1.2 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.6 1.0 0.3 0.0 1.1 0.7 0.8 0.0 0.2 3.5 2.2 0.1 0.0 0.0 1.0 0.1 ZNF287 "ZKSCAN13, ZSCAN45" ENSG00000141040 "Zinc finger protein 287" Q9HBT7 17 16551387-16569206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029290 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA029290: AB_10603465" "unprognostic (4.74e-2)" "unprognostic (1.77e-2)" "unprognostic (2.88e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.99e-2)" "unprognostic (4.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "prognostic favorable (5.28e-5)" "unprognostic (5.69e-3)" "unprognostic (5.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.87e-1)" 5.9 8.8 7.3 3.6 10.2 1.4 7.1 13.7 12.6 7.2 4.8 11.5 3.0 1.9 6.7 9.1 4.5 6.5 4.5 9.8 7.7 6.0 6.5 0.8 4.9 5.2 9.5 7.3 9.8 4.7 16.3 13.6 3.3 10.8 7.1 4.3 8.1 4.5 8.3 6.2 7.5 4.0 6.8 6.4 5.1 5.1 5.5 9.9 8.2 8.4 4.5 6.0 7.7 4.3 9.6 2.7 0.4 2.5 6.0 9.5 4.1 3.6 6.6 6.1 6.4 4.2 8.1 1.4 3.2 5.7 6.2 7.7 1.3 2.8 1.7 3.5 5.2 4.2 5.8 3.7 5.5 7.5 2.5 3.1 0.0 0.4 0.0 5.3 0.0 5.5 6.1 3.9 2.6 3.9 6.0 3.8 7.7 0.4 0.0 8.6 3.4 5.3 0.2 1.5 3.1 3.2 0.0 7.0 0.1 3.8 1.9 3.5 5.7 9.7 1.3 3.9 17.5 4.8 0.6 2.9 3.8 2.0 4.8 4.1 3.0 2.2 0.0 5.6 0.0 4.8 0.0 0.6 0.4 7.9 0.8 6.7 9.6 8.5 7.9 2.7 7.0 9.5 9.4 0.0 6.0 2.5 1.7 6.3 4.1 7.3 10.2 13.7 12.6 7.7 6.0 9.5 7.3 10.8 9.9 3.0 1.7 0.0 1.4 0.6 4.0 7.7 0.0 9.4 4.5 0.0 3.9 0.1 5.0 4.4 1.6 3.1 0.0 0.0 7.9 0.8 2.5 0.7 6.9 0.0 1.0 15.9 2.4 1.3 1.0 2.3 2.0 1.3 0.0 1.0 0.5 4.0 3.7 0.0 3.2 1.9 3.7 6.5 1.2 7.0 4.7 1.3 0.0 4.5 1.0 0.3 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 12.7;Rod photoreceptor cells: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.6 8.2 3.5 8.8 6.3 4.0 0.1 3.6 2.6 3.3 3.7 5.8 1.2 0.0 4.8 2.3 1.2 2.3 10.1 5.1 4.2 0.0 4.8 2.7 4.4 4.4 3.2 3.6 2.5 3.5 4.6 3.3 4.4 1.4 5.2 7.2 8.7 0.0 5.3 2.7 2.6 1.6 4.9 8.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.6 0.0 0.1 3.4 3.8 3.3 1.0 3.7 7.0 3.7 2.5 4.8 2.4 11.5 1.0 1.4 0.0 4.0 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 0.0 0.6 0.0 0.2 0.3 5.3 2.8 0.0 4.0 0.0 1.8 5.9 0.1 3.3 0.9 0.2 3.5 0.0 0.0 1.2 0.5 0.6 0.3 5.7 1.0 0.7 12.7 1.2 5.5 1.8 0.4 2.0 0.1 1.7 0.0 1.4 3.5 1.0 0.0 2.1 1.3 10.0 0.0 1.0 2.6 2.4 0.1 0.0 1.7 1.3 0.3 ZNF311 ENSG00000197935 "Zinc finger protein 311" Q5JNZ3 6 28994785-29005316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Melanocytes: 3.3;Spermatocytes: 5.4;Spermatogonia: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;K-562: 1.2;MCF7: 1.5;RT4: 2.0;SK-MEL-30: 1.3;THP-1: 1.6;U-2 OS: 2.3" HPA050541 Approved NA NA "HPA050541: AB_2681164" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (1.23e-1)" "unprognostic (7.03e-4)" "unprognostic (1.79e-1)" "unprognostic (3.14e-1)" "unprognostic (1.68e-1)" "unprognostic (8.41e-2)" "unprognostic (4.24e-3)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (2.57e-1)" "unprognostic (3.05e-4)" "unprognostic (9.70e-2)" "unprognostic (1.82e-1)" "unprognostic (3.11e-1)" "unprognostic (1.14e-1)" 1.2 1.9 2.0 3.3 2.2 0.8 2.6 1.5 2.7 2.5 2.5 1.8 6.4 1.5 1.8 4.6 1.6 4.2 1.7 1.1 1.5 0.9 1.3 1.5 1.6 1.0 4.7 1.2 3.5 1.4 0.8 0.8 0.8 2.6 2.7 1.4 1.6 1.6 3.2 0.8 2.1 1.6 1.7 5.6 1.5 1.5 6.6 1.9 0.0 4.2 0.0 1.2 1.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 1.6 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.2 1.5 2.7 1.5 0.9 4.7 1.2 2.6 1.9 0.0 0.0 0.0 0.4 0.3 0.5 0.4 0.0 0.0 0.0 1.8 0.0 0.3 1.7 0.8 0.0 0.4 0.5 0.0 0.6 0.4 0.2 0.7 0.0 0.2 0.5 0.0 0.0 2.5 1.0 0.7 0.6 0.0 3.3 1.0 1.4 1.7 1.1 1.1 0.0 0.0 0.8 0.0 0.2 5.4 2.7 0.1 0.0 0.0 0.9 0.3 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.1 5.2 3.6 5.4 4.1 3.6 3.9 3.3 4.2 3.4 3.1 4.6 2.1 6.5 3.2 2.8 4.9 5.3 4.6 4.6 1.6 5.6 35.6 4.5 4.0 2.2 3.3 7.5 5.3 2.7 5.8 4.8 2.2 3.9 2.4 5.6 6.3 4.2 3.7 3.3 6.7 4.1 2.8 4.4 7.9 7.2 4.5 4.1 2.4 8.3 7.3 5.7 3.7 6.0 2.6 2.9 3.0 5.5 4.2 10.3 2.3 3.6 5.7 6.2 6.2 3.3 5.2 3.6 3.2 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 0.0 1.7 5.1 4.5 8.0 35.6 5.6 2.5 2.7 3.4 0.0 23.6 4.1 0.0 4.0 0.9 4.2 9.2 0.0 3.6 3.2 4.6 5.2 1.1 2.9 2.5 31.8 7.5 5.5 1.8 0.7 11.8 3.6 3.3 1.8 5.0 16.4 3.2 7.4 13.8 1.4 57.5 6.5 7.8 10.7 13.8 11.7 5.6 8.7 5.6 4.1 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043973: AB_10961277, HPA054680: AB_2682571" "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 10.7 8.1 8.8 7.8 11.3 12.2 9.4 16.2 12.1 11.4 9.9 14.3 7.0 4.5 16.5 11.0 5.3 10.8 6.6 6.3 8.6 6.9 5.8 4.9 8.7 7.3 16.8 9.8 15.3 9.1 8.2 7.5 7.4 10.3 8.8 5.9 10.3 5.7 8.5 14.5 7.7 6.5 11.6 9.6 13.0 6.7 8.8 12.8 6.7 6.9 4.3 6.6 9.5 8.8 2.7 4.9 7.9 5.0 13.5 5.4 2.4 1.5 0.9 5.8 7.8 8.4 7.9 2.2 3.5 4.9 3.1 4.5 0.4 1.4 2.4 4.0 4.6 1.0 1.5 2.0 1.4 4.6 5.6 1.5 9.9 2.1 2.4 6.9 4.0 5.7 7.3 3.9 2.9 8.2 4.3 4.5 3.0 2.0 4.8 3.9 0.8 2.6 9.5 2.3 3.3 1.8 3.7 3.3 2.3 3.0 2.1 3.2 6.2 3.2 0.4 5.7 2.5 1.5 6.7 7.2 5.3 2.4 8.5 3.7 2.3 1.0 2.5 5.5 6.9 6.2 7.9 4.0 6.0 4.0 5.0 5.4 2.6 3.6 3.0 4.9 2.7 4.1 3.6 7.0 13.5 4.3 2.4 3.0 2.4 8.8 11.3 16.2 12.1 8.6 6.9 16.8 9.8 10.3 12.8 6.0 8.3 1.7 5.0 2.7 12.5 2.7 0.0 4.0 2.3 3.5 3.9 2.5 1.7 2.2 4.6 6.5 1.1 0.0 2.6 2.1 5.9 3.7 16.1 1.8 4.4 7.9 2.4 6.7 9.9 2.5 9.2 6.5 1.7 4.6 1.0 5.2 2.1 2.5 8.5 1.3 17.7 12.9 6.2 10.8 6.8 2.4 1.1 4.9 2.2 3.1 ZNF345 HZF10 ENSG00000251247 "Zinc finger protein 345" Q14585 19 36850361-36913029 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 26 "Early spermatids: 279.7;Late spermatids: 276.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA025816 Uncertain NA NA "HPA025816: AB_10602354" "unprognostic (1.55e-3)" "unprognostic (9.11e-3)" "unprognostic (2.19e-1)" "unprognostic (5.17e-4)" "unprognostic (6.14e-2)" "unprognostic (2.53e-3)" "unprognostic (1.54e-2)" "unprognostic (5.78e-5)" "unprognostic (1.70e-2)" "unprognostic (2.07e-2)" "unprognostic (6.87e-3)" "unprognostic (1.27e-3)" "unprognostic (3.33e-3)" "unprognostic (1.22e-1)" "unprognostic (1.70e-1)" "unprognostic (9.32e-2)" "unprognostic (3.87e-5)" 7.4 6.8 10.6 7.0 13.6 6.0 10.1 27.9 16.3 7.7 7.4 7.4 8.9 7.4 9.4 11.2 6.5 7.2 6.4 6.6 9.7 4.7 6.2 5.6 6.9 9.4 14.6 5.1 11.5 5.8 12.4 11.9 6.9 11.6 8.6 7.1 7.6 8.8 6.7 3.7 11.7 8.4 7.0 8.6 8.9 6.8 21.3 12.3 10.1 9.6 4.2 8.0 8.7 8.7 4.1 2.1 12.0 1.9 3.5 7.7 3.2 0.3 1.0 10.8 6.3 3.0 3.4 3.5 2.3 2.4 2.3 4.6 0.7 2.9 2.3 5.1 1.5 4.1 2.6 3.0 2.3 3.0 8.1 6.3 4.8 2.3 2.5 2.4 3.8 4.7 6.8 3.2 3.0 0.0 4.8 3.2 8.5 1.0 1.2 3.4 1.8 7.7 5.3 4.0 0.2 2.2 5.6 7.8 3.9 1.5 7.6 7.3 7.2 5.5 0.6 1.7 4.7 3.4 3.7 2.9 4.7 5.8 3.1 1.8 7.5 4.4 4.8 0.2 0.2 5.7 12.0 1.9 6.0 4.6 1.7 4.7 2.7 5.4 4.2 1.6 4.1 7.7 6.1 2.5 3.5 1.7 2.1 5.3 3.2 10.6 13.6 27.9 16.3 9.7 4.7 14.6 5.1 11.6 12.3 8.9 3.8 3.2 3.4 3.2 4.9 2.8 0.0 10.7 4.5 1.8 0.0 3.6 6.6 2.0 279.7 3.5 1.6 0.0 0.9 2.0 2.1 2.1 3.5 1.7 2.8 0.0 2.4 5.5 2.6 276.5 5.8 3.7 5.0 1.0 2.7 4.3 1.4 0.0 9.9 3.1 6.1 6.5 3.3 9.0 9.1 3.3 3.9 5.7 2.3 6.0 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" "Q70YC4, Q70YC5" 10 62374192-62672011 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 12.6;Horizontal cells: 17.5;Rod photoreceptor cells: 4.9;Urothelial cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5" "Group enriched" "Detected in many" 51 "NK-cells: 7.4;T-cells: 7.5" "Cell line enhanced" "Detected in many" "HaCaT: 17.3;PC-3: 11.2;U-251 MG: 14.4;U-87 MG: 10.3" "Group enriched" "Detected in all" 4 "amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9" "Low region specificity" "Detected in all" HPA052446 Enhanced Supported "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.9 2.5 11.8 1.0 19.4 1.0 1.3 8.4 41.3 2.0 0.9 13.1 0.0 1.1 1.2 1.5 11.7 1.0 4.0 2.0 9.6 7.4 1.1 1.2 3.1 1.1 7.5 16.0 1.0 1.3 9.0 1.8 1.2 6.9 3.0 1.1 1.0 1.2 3.3 1.0 2.6 0.9 0.9 10.5 1.3 1.0 1.6 9.1 0.0 1.6 0.0 2.2 1.9 1.2 0.1 0.0 0.1 0.1 7.4 7.5 1.0 5.7 0.8 0.5 0.7 0.6 0.3 0.3 4.3 4.5 2.2 1.9 0.6 1.4 0.4 0.7 2.6 7.4 17.3 0.5 0.3 3.0 0.2 0.4 0.3 1.5 0.4 0.2 0.3 1.4 0.3 0.3 5.9 0.8 6.2 0.7 0.3 0.4 0.6 4.3 2.1 0.7 0.5 0.9 0.3 11.2 0.4 0.5 0.4 0.5 2.6 0.2 0.9 1.1 0.9 0.4 0.6 0.1 0.3 3.1 1.2 5.6 0.6 14.4 0.2 0.5 0.3 10.3 0.6 1.9 0.0 0.0 0.0 3.4 0.1 0.0 0.0 3.1 3.5 0.0 0.1 0.6 3.7 0.1 7.4 0.1 0.0 7.5 1.0 11.8 19.4 8.4 32.3 9.6 7.4 7.5 16.0 6.9 9.1 0.0 0.0 0.0 3.3 0.5 12.6 2.4 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.1 17.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.6 4.9 0.0 1.2 0.0 0.4 0.4 0.0 0.0 0.0 6.7 ZNF37A "KOX21, ZNF37" ENSG00000075407 "Zinc finger protein 37A" P17032 10 38094334-38150293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003172 Approved Approved Vesicles NA NA Vesicles "HPA003172: AB_1080709" "unprognostic (8.64e-2)" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" "unprognostic (6.87e-2)" "unprognostic (1.17e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.83e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (4.39e-2)" "unprognostic (1.29e-1)" "unprognostic (3.43e-2)" "unprognostic (3.09e-2)" 8.2 10.1 11.9 9.9 15.3 4.9 9.9 23.2 13.9 11.8 9.9 11.0 6.6 8.0 12.5 10.5 6.9 10.1 8.7 7.8 11.5 9.9 10.4 9.1 10.2 9.2 16.3 10.7 13.5 16.7 20.0 25.0 8.2 12.8 10.3 8.5 9.0 12.7 15.4 6.7 10.7 9.0 16.3 12.0 9.7 10.1 4.1 16.2 8.2 14.0 3.9 9.8 8.5 8.4 5.6 2.9 2.5 4.7 6.4 5.4 1.7 11.7 6.1 5.4 10.2 8.3 8.2 5.9 9.1 3.4 4.2 5.7 4.8 3.5 17.3 2.8 5.0 5.8 4.8 10.1 7.6 6.6 11.1 9.6 17.4 6.9 6.8 7.2 18.2 11.3 6.2 12.8 7.2 6.1 8.5 5.5 8.3 11.3 12.3 9.0 2.7 10.2 2.8 4.8 4.1 10.0 7.4 14.8 3.5 4.5 4.6 4.4 7.6 6.3 5.1 5.1 6.0 9.3 5.7 9.4 8.0 8.6 7.6 8.7 13.9 14.9 6.8 5.3 13.1 5.0 2.5 2.4 2.2 3.9 1.9 5.1 3.5 4.5 3.9 2.3 5.6 5.4 4.5 2.0 6.4 4.7 2.9 2.4 1.7 11.9 15.3 23.2 13.9 11.5 9.9 16.3 10.7 12.8 16.2 23.8 35.8 21.7 11.7 7.2 60.7 27.9 2.5 13.4 25.0 10.4 51.1 8.7 1.7 15.7 2.6 20.2 5.6 0.0 10.3 5.5 13.1 13.0 39.3 9.3 6.2 39.7 40.2 22.1 10.2 1.1 26.2 10.8 5.0 9.0 9.8 28.9 11.0 7.0 26.5 6.3 50.9 12.9 18.4 18.0 12.4 5.3 3.2 16.6 13.3 8.1 ZNF382 "FLJ14686, KS1" ENSG00000161298 "Zinc finger protein 382" Q96SR6 19 36604817-36634113 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.6" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 22.7;Early spermatids: 21.4;Horizontal cells: 47.7;Late spermatids: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049259 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049259: AB_2680694" "unprognostic (5.43e-3)" "unprognostic (5.16e-2)" "unprognostic (1.17e-1)" "unprognostic (2.68e-3)" "unprognostic (6.13e-2)" "unprognostic (1.85e-3)" "unprognostic (5.63e-2)" "unprognostic (6.64e-2)" "unprognostic (1.12e-2)" "unprognostic (5.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.07e-3)" "unprognostic (1.76e-5)" "unprognostic (8.71e-2)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" "unprognostic (6.22e-2)" 3.3 5.9 6.7 3.5 10.5 1.9 3.3 27.6 13.8 4.2 3.9 4.9 2.3 1.3 4.8 4.2 3.1 5.8 3.0 7.5 6.2 6.2 3.8 1.5 2.7 5.1 5.6 11.2 4.7 2.6 4.8 11.0 4.6 9.4 3.6 1.9 4.4 3.3 3.1 1.7 1.4 2.8 4.3 5.5 5.5 2.2 6.7 5.3 3.6 5.7 2.0 6.3 4.0 2.0 9.0 2.4 3.5 0.7 4.5 9.0 2.7 0.2 0.1 4.5 6.4 1.9 2.6 1.5 2.0 0.6 5.9 6.1 0.1 0.4 3.9 4.3 2.4 2.6 0.1 5.8 0.1 3.8 10.9 2.6 6.3 0.3 1.6 5.2 0.9 7.6 3.5 0.2 3.3 0.2 6.0 0.7 7.7 0.1 0.2 3.8 0.6 8.8 2.1 3.0 0.0 2.2 0.4 1.9 1.7 1.6 0.2 0.6 8.7 0.3 0.3 3.5 6.8 2.7 0.7 0.2 1.4 0.3 0.3 5.7 10.0 0.7 0.4 0.1 0.1 3.5 2.1 0.6 3.5 5.6 0.7 9.0 9.0 8.8 6.2 2.3 6.6 7.6 8.4 1.2 4.5 0.7 2.4 5.0 2.7 6.7 10.5 27.6 13.8 6.2 6.2 5.6 11.2 9.4 5.3 3.0 0.0 0.0 0.6 0.1 22.7 9.8 0.0 2.7 1.2 3.5 9.8 1.8 5.0 2.4 21.4 2.1 0.0 0.0 0.4 0.8 2.0 0.4 0.0 0.4 2.4 47.7 0.0 1.3 0.6 15.0 0.6 1.1 1.7 1.0 0.1 4.0 0.2 0.0 1.1 1.3 12.7 0.0 1.2 4.4 2.8 0.0 0.1 2.1 0.0 0.4 ZNF383 FLJ35863 ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA063945: AB_2685158" "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favorable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favorable (3.71e-4)" 9.1 7.5 9.3 10.4 12.1 6.9 10.7 20.4 10.8 9.1 8.2 12.6 10.4 7.5 11.6 7.8 8.9 8.2 6.1 9.6 8.7 6.9 9.3 7.4 7.2 11.3 14.2 6.5 12.9 9.2 9.4 11.0 6.5 11.8 9.6 7.4 8.7 8.5 8.7 14.0 11.8 9.5 10.8 13.7 10.8 8.4 10.5 12.1 13.2 11.4 5.7 11.9 10.2 9.4 11.4 4.0 6.3 5.4 5.7 11.6 4.8 3.8 8.7 6.1 9.2 7.6 7.8 4.0 5.2 7.2 5.3 8.0 4.0 4.6 5.2 8.0 5.0 4.9 3.8 5.0 7.0 7.8 7.2 5.4 7.8 6.5 3.2 8.5 9.0 8.6 10.0 6.0 5.1 10.0 6.9 4.8 7.4 4.0 2.7 6.8 1.6 7.7 4.1 5.4 7.5 3.0 5.6 10.9 4.6 4.6 10.8 7.3 5.4 8.4 5.0 7.3 8.2 5.9 5.3 3.0 7.0 4.7 4.8 5.0 8.5 8.0 10.0 1.0 4.3 6.3 3.6 4.1 6.3 7.6 4.7 10.7 9.8 7.2 9.2 4.0 11.4 11.6 9.1 5.0 5.7 5.4 3.8 7.0 4.8 9.3 12.1 20.4 10.8 8.7 6.9 14.2 6.5 11.8 12.1 3.0 4.1 6.5 3.7 2.4 8.3 11.7 2.5 2.7 2.3 1.8 13.7 3.4 1.7 3.0 7.3 4.2 4.1 0.0 3.1 3.6 2.9 3.9 5.7 2.1 3.1 14.3 2.4 6.2 5.0 2.5 6.1 4.8 8.5 4.6 4.5 7.3 2.6 3.5 7.1 3.7 9.5 12.9 5.1 4.8 5.3 2.9 4.1 7.2 5.0 3.3 ZNF385D "FLJ22419, ZNF659" ENSG00000151789 "Zinc finger protein 385D" Q9H6B1 3 21412222-22373321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 17.7;brain: 59.5;testis: 18.5" "Group enriched" "Detected in many" 5 "Early spermatids: 137.4;Horizontal cells: 305.1;Late spermatids: 198.0;Muller glia cells: 119.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 59.5" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.9;hTERT-RPE1: 4.2;RPTEC TERT1: 6.7;U-87 MG: 12.6" "Low region specificity" "Detected in all" HPA036190 Uncertain NA NA "HPA036190: AB_10602355" "unprognostic (4.07e-2)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (3.23e-2)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (8.20e-2)" "unprognostic (6.60e-2)" "unprognostic (7.84e-2)" "unprognostic (3.73e-1)" "unprognostic (2.35e-1)" "unprognostic (9.01e-2)" "unprognostic (3.49e-7)" "unprognostic (8.70e-3)" "unprognostic (5.38e-2)" "unprognostic (7.76e-3)" "unprognostic (2.15e-5)" 17.7 1.1 4.0 2.2 5.9 1.1 5.3 59.5 9.1 4.3 2.2 0.1 1.2 1.2 2.3 3.9 4.0 2.3 4.7 3.9 3.9 3.6 3.2 0.9 1.9 2.0 7.4 4.0 1.7 2.5 1.3 0.5 0.7 4.1 3.0 1.8 4.1 1.9 3.2 2.8 2.4 1.3 3.5 1.9 1.3 1.3 18.5 1.7 0.1 1.5 5.2 2.0 4.0 5.7 0.7 0.3 2.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.5 4.9 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 4.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 6.7 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.7 0.0 0.1 2.0 0.1 0.0 0.3 0.0 0.2 4.0 5.9 59.5 9.1 3.9 3.6 7.4 4.0 4.1 1.7 11.9 14.9 0.5 0.6 8.7 41.0 2.8 0.0 8.1 35.2 1.8 7.9 0.2 23.2 0.4 137.4 35.0 1.1 0.0 0.6 0.1 13.6 1.3 4.7 5.9 0.4 305.1 0.0 3.7 0.0 198.0 15.5 5.6 11.8 0.0 0.5 119.7 1.1 0.0 12.7 6.2 28.4 12.9 14.4 9.1 1.3 6.8 0.1 0.0 0.4 0.1 ZNF391 dJ153G14.3 ENSG00000124613 "Zinc finger protein 391" Q9UJN7 6 27374615-27403904 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Ciliated cells: 17.4;Early spermatids: 42.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA050886 Uncertain NA NA "HPA050886: AB_2681262" "unprognostic (1.59e-1)" "unprognostic (4.97e-2)" "unprognostic (1.85e-1)" "unprognostic (1.41e-1)" "unprognostic (1.88e-1)" "unprognostic (4.68e-3)" "unprognostic (6.27e-5)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.89e-4)" "unprognostic (5.62e-2)" "unprognostic (3.02e-1)" "unprognostic (3.73e-2)" "unprognostic (2.39e-2)" "unprognostic (3.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.82e-2)" 4.1 4.3 9.9 1.7 11.8 0.5 6.4 7.0 15.1 7.5 3.3 3.3 3.3 1.6 6.4 6.3 3.6 7.9 2.5 2.4 8.1 4.9 5.6 0.7 3.6 3.4 3.5 9.9 10.1 4.7 6.8 4.6 2.7 6.5 5.5 3.3 3.4 3.9 7.2 1.0 3.4 2.4 5.7 4.3 4.2 3.0 8.8 4.6 2.0 7.9 0.4 3.1 4.4 3.5 3.7 1.2 0.3 0.1 0.8 3.1 0.7 5.0 0.8 3.1 10.7 1.3 1.8 6.3 1.3 1.0 1.8 4.2 2.8 1.1 0.0 4.6 1.2 3.7 1.7 6.1 4.7 3.0 0.0 3.7 1.9 0.2 1.0 2.1 5.4 2.7 5.4 6.1 0.3 4.8 3.7 0.2 8.5 8.2 0.0 0.3 1.0 6.4 7.8 3.8 0.7 3.4 0.0 0.0 1.4 1.2 2.0 1.2 5.0 0.0 7.1 0.6 5.2 1.2 4.7 0.6 5.9 1.9 0.3 3.8 3.4 8.0 0.0 0.3 0.5 6.3 0.3 0.1 0.0 0.9 0.1 2.0 3.7 1.5 0.8 0.0 3.6 3.1 1.9 0.2 0.8 0.0 1.2 0.2 0.7 9.9 11.8 7.0 15.1 8.1 4.9 3.5 9.9 6.5 4.6 0.0 1.4 0.0 0.4 0.8 2.3 0.8 0.0 17.4 4.5 1.8 0.0 1.8 0.0 1.1 42.5 1.5 0.0 0.0 1.2 1.0 1.5 0.3 0.0 0.0 0.9 3.2 1.7 1.8 0.0 2.5 1.7 0.6 0.0 0.0 0.0 3.3 1.0 0.0 2.5 1.0 0.7 0.0 0.9 3.9 2.5 0.3 0.2 0.0 0.9 0.3 ZNF416 FLJ20557 ENSG00000083817 "Zinc finger protein 416" Q9BWM5 19 57571566-57578927 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 7.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063318 Approved "Nuclear bodies,Cytosol" No No Cytosol "Nuclear bodies" "HPA063318: AB_2684983" "unprognostic (1.40e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.14e-2)" "unprognostic (7.57e-3)" "unprognostic (3.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" "unprognostic (6.62e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.20e-5)" "unprognostic (1.31e-1)" "unprognostic (2.62e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-1)" 6.1 6.8 7.0 5.1 10.7 5.0 8.7 13.0 10.7 6.8 6.1 7.0 5.9 3.2 6.9 9.5 8.9 8.2 4.4 6.1 6.5 5.3 6.1 4.6 6.7 7.1 5.3 8.6 10.9 3.9 8.7 7.0 6.6 5.8 6.7 4.9 7.0 6.3 7.6 6.6 13.5 4.8 8.2 3.8 6.3 4.9 9.3 8.1 12.8 8.8 4.8 9.1 7.7 6.9 9.7 4.4 1.9 2.8 9.5 9.4 4.3 3.3 3.3 7.0 5.5 4.3 6.1 4.7 3.3 6.1 6.6 4.3 2.3 1.8 2.3 2.5 4.3 4.8 1.2 4.0 5.7 8.3 3.6 16.4 5.4 3.6 1.9 7.7 4.7 3.5 6.1 6.0 4.2 8.9 5.3 4.6 5.6 0.8 1.9 8.8 1.4 9.9 2.2 8.2 3.9 6.1 5.0 10.4 4.9 4.6 7.1 5.0 5.7 6.0 3.2 3.0 8.2 2.9 5.8 3.4 7.2 3.5 2.3 5.0 5.8 9.5 6.2 1.6 3.2 4.4 1.1 2.8 1.9 4.8 2.1 8.9 7.4 6.8 7.2 4.4 9.7 9.4 6.8 0.9 9.5 1.8 3.9 3.1 4.3 7.0 10.7 13.0 10.7 6.5 5.3 5.3 8.6 5.8 8.1 0.0 0.3 2.2 1.3 1.4 3.3 0.8 2.5 0.0 1.2 0.0 0.0 1.8 3.3 2.4 2.7 1.0 0.4 0.0 0.7 0.7 1.3 1.0 2.3 1.0 1.4 7.9 0.0 0.0 0.8 1.3 0.9 0.0 0.0 0.0 1.5 2.9 1.1 0.0 0.7 1.3 2.5 6.5 0.7 0.2 4.1 2.0 1.6 0.5 0.6 1.4 ZNF429 ENSG00000197013 "Zinc finger protein 429" Q86V71 19 21496682-21556270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004139 Approved Nucleoplasm NA NA Nucleoplasm "HPA004139: AB_2667147" "unprognostic (1.06e-1)" "unprognostic (1.88e-1)" "unprognostic (2.77e-1)" "unprognostic (1.75e-2)" "unprognostic (1.45e-2)" "unprognostic (3.13e-1)" "unprognostic (3.39e-2)" "unprognostic (1.95e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.96e-8)" "prognostic favorable (7.30e-4)" "unprognostic (5.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.48e-1)" 6.3 14.3 12.0 4.8 13.1 4.3 11.2 15.3 14.2 10.2 6.7 12.3 10.3 5.4 7.5 12.4 6.2 10.8 5.6 4.9 9.6 7.6 11.3 11.1 6.4 9.0 12.6 8.6 14.3 14.3 17.7 24.1 7.4 12.3 8.7 8.9 8.4 9.3 8.2 5.2 11.0 6.2 5.7 9.1 10.6 8.4 11.3 12.9 7.5 16.6 5.1 7.5 7.8 7.5 7.2 2.7 10.4 2.4 9.2 9.5 2.8 0.3 0.9 5.2 6.1 3.6 3.7 4.7 2.7 2.0 3.8 5.8 0.6 3.3 4.4 7.6 1.8 3.3 1.4 3.0 1.2 7.5 1.3 3.6 0.8 0.7 1.6 1.9 4.6 1.8 3.3 1.8 2.3 0.7 3.5 0.2 7.0 7.2 0.9 5.9 3.2 11.0 2.9 5.3 0.1 1.7 5.0 2.9 1.8 4.2 5.2 8.6 3.5 0.2 0.2 1.8 10.8 6.1 2.9 0.6 0.5 1.1 4.3 2.0 0.7 3.6 5.9 0.3 0.4 1.7 10.0 1.8 8.4 4.9 2.2 5.3 7.2 6.8 6.5 1.6 6.4 9.5 8.6 10.4 9.2 2.4 2.7 4.1 2.8 12.0 13.1 15.3 14.2 9.6 7.6 12.6 8.6 12.3 12.9 26.8 9.9 1.5 5.8 2.5 13.6 4.8 5.1 17.4 14.8 7.0 5.9 7.7 18.3 6.3 27.6 5.0 4.0 0.0 4.4 6.1 5.8 5.1 3.5 5.4 3.0 3.2 6.4 6.7 2.1 3.9 10.6 4.3 5.0 1.8 5.6 10.0 5.0 6.2 5.6 10.6 7.6 19.4 5.1 14.2 16.8 1.8 5.7 10.2 5.8 3.1 ZNF43 "HTF6, KOX27, ZNF39L1" ENSG00000198521 "Zinc finger protein 43" P17038 19 21804949-21852125 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 16.5;MOLT-4: 22.9" HPA050271 Uncertain NA NA "HPA050271: AB_2681070" "unprognostic (9.25e-3)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-2)" "unprognostic (1.25e-1)" "unprognostic (4.16e-3)" "unprognostic (3.61e-2)" "unprognostic (2.47e-3)" "unprognostic (4.45e-3)" "prognostic favorable (3.16e-5)" "unprognostic (2.73e-2)" "unprognostic (1.01e-1)" "unprognostic (3.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-3)" "unprognostic (1.43e-3)" 12.2 11.1 8.7 10.0 11.8 14.8 12.9 15.7 10.8 13.8 7.3 6.6 9.1 5.4 10.6 14.1 7.2 11.3 6.2 7.3 9.0 8.8 11.5 2.4 8.1 12.2 13.2 9.4 18.5 8.0 12.3 15.8 7.9 14.6 11.7 8.9 6.4 8.8 8.8 6.6 10.6 8.3 7.4 16.7 15.7 7.6 15.9 12.5 26.0 13.1 6.2 11.0 10.7 8.5 14.4 5.9 17.2 3.3 5.8 13.9 2.4 0.2 2.1 16.5 12.2 1.6 4.0 6.5 4.0 1.8 5.5 7.6 0.2 2.2 3.6 4.4 2.4 4.8 0.3 0.2 0.4 9.2 0.4 3.9 0.1 0.7 1.7 0.9 0.1 4.5 3.3 0.6 5.5 0.2 1.4 1.1 13.8 0.2 0.7 4.0 2.4 22.9 5.3 10.9 0.3 3.3 13.4 6.6 3.8 3.5 11.0 10.1 7.9 0.1 0.0 1.3 8.0 6.0 3.3 0.2 0.4 0.5 3.5 4.1 0.9 6.2 6.3 0.2 0.5 0.5 17.2 3.3 4.1 6.6 3.3 6.3 12.3 8.7 7.1 3.0 14.4 13.9 9.4 3.4 5.8 2.7 5.9 5.4 2.4 8.7 11.8 15.7 10.8 9.0 8.8 13.2 9.4 14.6 12.5 11.9 10.0 11.1 7.8 1.8 16.1 9.7 7.6 9.4 15.9 3.5 9.8 8.1 14.9 9.6 27.1 9.8 2.0 23.3 8.4 6.5 4.9 7.8 15.1 0.2 4.0 7.9 10.9 12.9 2.7 6.2 13.0 4.3 1.7 3.6 4.8 10.4 6.4 3.5 8.9 5.6 8.6 6.5 2.8 20.4 17.2 1.8 4.9 13.8 6.6 4.0 ZNF431 KIAA1969 ENSG00000196705 "Zinc finger protein 431" Q8TF32 19 21142024-21196053 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (1.37e-2)" "unprognostic (9.08e-2)" "unprognostic (2.30e-2)" "unprognostic (7.86e-2)" "unprognostic (1.97e-3)" "unprognostic (2.93e-3)" "unprognostic (5.91e-2)" "unprognostic (9.37e-3)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.29e-2)" "unprognostic (3.01e-3)" 9.2 16.2 8.0 11.8 13.0 16.7 9.7 21.9 12.3 10.0 6.1 8.0 8.8 4.7 9.1 10.1 27.8 6.9 4.5 9.5 8.3 4.1 5.8 2.7 10.1 11.5 11.3 5.0 29.5 9.6 7.1 12.5 7.4 8.8 8.2 6.9 6.2 10.7 7.7 8.4 15.0 7.5 9.3 14.0 9.4 8.3 13.1 14.0 18.0 16.7 7.6 12.5 7.7 16.5 10.4 7.7 8.7 5.3 11.6 8.5 2.3 8.7 2.7 8.1 9.5 2.3 4.6 12.3 4.6 4.0 8.8 8.8 4.8 6.4 11.1 8.2 3.1 4.1 5.9 7.0 5.0 10.8 4.0 9.0 8.5 6.1 2.9 2.3 4.2 8.9 3.4 9.2 5.5 5.3 5.0 6.7 10.1 15.4 6.7 5.1 3.8 13.3 4.8 9.4 3.4 7.5 7.3 10.5 3.2 3.4 10.2 7.8 6.5 11.9 0.1 4.2 13.3 5.0 7.5 4.0 5.5 0.4 7.6 6.6 5.3 10.1 15.0 1.3 7.4 3.7 4.3 4.7 8.7 4.1 4.1 5.7 9.9 6.9 5.2 3.1 10.4 8.5 6.6 6.8 11.6 5.3 7.7 5.1 2.3 8.0 13.0 21.9 12.3 8.3 4.1 11.3 5.0 8.8 14.0 113.2 16.6 13.7 13.2 11.2 32.2 15.3 7.6 14.7 25.0 22.7 35.3 15.2 3.3 10.6 2.3 13.5 5.9 0.0 7.5 13.7 10.7 15.3 19.7 0.8 9.2 14.3 16.3 17.2 15.6 2.5 30.2 13.2 3.3 10.0 9.4 10.6 11.6 0.0 20.1 3.3 31.1 19.4 7.6 26.6 15.9 13.6 9.7 22.3 10.1 25.4 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294887 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 81.2;Early spermatids: 95.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favorable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favorable (9.21e-6)" 10.5 8.4 9.6 7.3 13.1 20.2 13.6 19.3 9.8 9.8 11.6 7.9 20.8 8.2 9.6 13.2 10.3 9.5 8.1 7.0 8.5 4.6 11.7 15.2 9.6 9.6 12.2 6.9 15.9 11.1 8.7 12.1 7.0 9.4 11.1 13.0 9.1 9.2 18.1 17.3 15.4 11.1 14.1 11.6 13.9 9.6 13.8 12.8 6.5 11.3 6.5 10.5 10.7 10.8 4.7 3.1 15.1 3.0 11.5 9.5 3.5 3.6 1.0 2.8 4.9 2.8 2.8 12.0 5.2 2.3 8.3 7.4 4.9 2.0 3.6 6.5 4.9 2.4 3.8 3.5 3.6 7.2 0.0 3.3 3.4 4.8 12.9 3.8 0.0 9.3 2.9 5.7 5.1 6.6 3.4 3.2 4.4 2.2 0.7 5.2 3.7 5.2 6.0 2.7 3.6 6.2 3.6 6.2 4.4 5.0 8.6 3.1 3.7 6.6 2.6 1.6 7.8 5.5 5.8 3.7 10.0 2.7 9.7 4.5 7.7 9.7 3.5 0.2 3.1 2.9 9.8 1.6 15.1 8.0 3.0 9.4 4.7 8.6 8.6 1.4 3.2 9.5 9.2 5.3 11.5 3.0 3.1 5.7 3.5 9.6 13.1 19.3 9.8 8.5 4.6 12.2 6.9 9.4 12.8 26.8 14.5 9.3 5.4 8.0 16.5 15.1 22.9 32.1 17.0 61.1 35.3 14.0 81.2 8.3 95.8 7.1 14.2 0.0 8.0 6.3 8.0 6.5 23.1 11.1 7.2 15.9 15.0 14.1 7.9 23.8 13.0 10.8 10.1 3.6 11.5 10.6 7.3 11.5 5.6 9.1 35.3 19.4 9.8 17.6 17.9 10.2 7.2 19.2 11.8 8.6 ZNF441 FLJ38637 ENSG00000197044 "Zinc finger protein 441" Q8N8Z8 19 11767000-11784078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 14.9;Rod photoreceptor cells: 19.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063338 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA063338: AB_2684989" "unprognostic (1.97e-1)" "unprognostic (1.96e-1)" "unprognostic (2.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (6.42e-4)" "unprognostic (2.60e-2)" "unprognostic (1.92e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-2)" "unprognostic (1.33e-3)" "unprognostic (1.80e-1)" "unprognostic (1.75e-1)" "unprognostic (1.68e-2)" "unprognostic (2.70e-3)" 7.6 5.7 7.5 10.6 15.5 1.6 11.3 18.4 11.1 9.6 6.0 4.4 9.4 4.4 8.9 12.1 5.4 7.7 6.9 7.0 7.0 6.7 12.4 8.1 6.6 9.5 5.4 7.1 16.4 6.6 12.1 13.3 8.1 11.6 11.1 6.3 6.6 6.7 9.9 13.9 6.1 7.9 10.8 4.9 8.2 5.9 5.0 5.5 7.2 13.5 3.8 8.1 11.1 7.0 4.5 1.5 2.1 3.6 2.1 4.2 1.7 2.6 0.0 3.3 2.8 4.1 4.4 3.5 6.5 3.6 4.8 4.6 2.9 0.9 5.5 3.4 4.3 2.4 2.0 2.1 4.0 5.7 0.0 2.3 2.6 2.2 4.7 3.6 0.1 4.7 5.3 4.4 3.4 2.7 3.3 2.7 2.3 4.1 0.1 7.5 0.0 5.8 1.6 0.6 1.1 4.6 2.2 6.6 1.7 4.0 4.4 2.5 4.0 4.3 1.5 2.4 3.4 4.3 5.8 1.3 10.6 2.5 9.2 4.3 5.8 8.4 2.4 0.7 0.1 4.2 0.0 1.0 2.1 2.9 0.9 2.2 3.6 2.9 3.9 1.5 4.5 3.8 4.2 1.3 2.1 3.6 1.0 2.1 1.7 7.5 15.5 18.4 11.1 7.0 6.7 5.4 7.1 11.6 5.5 14.9 5.4 0.8 0.7 0.3 11.3 7.1 0.0 0.0 6.8 10.4 13.7 1.6 3.3 1.3 0.1 4.5 1.4 0.0 1.0 0.6 1.3 0.6 2.3 1.9 0.7 6.4 0.0 4.9 0.3 0.0 2.3 2.3 3.3 0.0 0.7 7.2 0.9 0.8 6.7 2.7 19.1 19.4 3.1 2.9 2.3 0.0 0.7 1.8 0.8 0.4 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345949-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 8.7" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: AB_2682138" "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 4.7 3.1 2.8 5.5 6.0 1.5 5.1 8.3 3.8 6.6 3.4 1.0 2.9 1.9 5.5 5.5 3.8 5.5 2.0 3.9 2.6 2.5 8.1 5.2 3.4 3.6 2.7 2.4 17.1 4.8 4.3 5.2 3.1 7.1 6.2 3.9 4.3 3.0 6.8 8.0 3.6 2.6 8.7 5.0 4.7 2.7 3.5 3.4 3.9 5.8 2.5 3.1 8.5 4.6 5.7 1.3 5.0 1.0 1.0 3.4 0.9 0.4 0.1 2.8 3.7 1.8 1.0 0.4 3.8 1.1 3.5 2.8 2.7 0.9 3.3 1.2 2.1 1.3 0.8 2.3 1.9 3.3 0.1 0.5 0.2 4.1 2.5 1.4 0.1 3.2 1.6 2.1 1.5 0.5 0.3 0.4 2.4 4.7 0.4 3.1 2.5 3.8 0.6 2.3 0.5 1.6 0.2 4.2 0.1 1.4 2.2 0.2 0.7 0.0 0.2 0.0 3.5 3.8 2.6 0.1 4.5 2.2 5.6 2.3 3.5 8.7 0.1 0.2 0.1 1.8 1.0 0.7 5.0 2.0 1.0 1.3 5.7 1.3 1.2 1.3 1.3 3.4 2.1 1.7 1.0 0.9 1.2 0.1 0.9 2.8 6.0 8.3 3.8 2.6 2.5 2.7 2.4 7.1 3.4 0.0 1.6 0.5 0.7 0.3 1.4 2.4 2.5 2.7 0.0 1.8 5.9 0.4 1.7 0.8 1.0 2.1 0.0 0.0 0.8 0.2 1.7 0.7 2.3 0.9 1.2 0.0 1.2 3.7 2.2 0.4 0.6 0.8 3.3 2.8 0.6 2.0 0.3 0.0 0.4 3.8 1.5 0.0 1.5 1.0 1.9 0.5 0.3 0.0 0.2 0.4 ZNF443 ZK1 ENSG00000180855 "Zinc finger protein 443" Q9Y2A4 19 12429707-12441112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 13.9" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (5.64e-3)" "unprognostic (1.51e-2)" "unprognostic (7.98e-2)" "unprognostic (1.45e-2)" "unprognostic (1.92e-1)" "unprognostic (7.38e-3)" "unprognostic (3.42e-1)" "unprognostic (1.64e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-2)" "unprognostic (7.10e-2)" "unprognostic (2.92e-2)" "prognostic favorable (2.74e-7)" "unprognostic (3.85e-3)" "unprognostic (2.16e-1)" "unprognostic (2.19e-2)" "prognostic favorable (3.91e-4)" 5.5 3.4 5.5 9.5 6.9 1.0 8.5 13.6 5.9 7.6 7.2 2.0 21.4 4.0 6.6 6.3 4.9 5.2 4.2 3.3 4.3 4.5 10.6 5.8 4.7 3.2 4.2 3.0 4.9 5.9 9.3 4.1 6.3 5.0 7.0 6.7 1.9 5.7 12.9 1.9 7.3 8.9 3.6 5.9 3.6 4.7 3.4 4.1 16.9 4.8 3.7 4.3 7.9 9.6 4.0 2.2 4.8 1.2 3.1 7.1 2.0 3.3 1.4 6.0 5.3 1.8 1.5 8.2 2.5 1.8 3.3 3.1 3.2 0.9 3.9 4.4 1.9 1.3 2.0 3.8 2.4 2.8 0.0 2.1 1.6 1.9 7.4 0.4 3.7 4.6 1.4 1.5 1.6 0.7 2.2 1.9 5.0 2.7 0.0 3.6 4.0 13.9 5.1 5.1 3.3 5.2 1.6 6.2 4.7 4.0 12.4 2.8 4.7 4.0 2.2 0.6 3.4 0.1 4.7 1.2 6.6 2.7 3.7 2.3 2.5 3.6 2.5 0.9 3.8 1.4 4.8 1.2 1.6 2.1 0.6 7.1 4.0 4.5 4.3 2.2 3.2 4.0 2.7 0.7 3.1 0.3 1.1 3.3 2.0 5.5 6.9 13.6 5.9 4.3 4.5 4.2 3.0 5.0 4.1 0.0 0.3 2.2 1.2 0.9 1.5 1.6 2.5 2.7 1.2 0.0 3.9 6.5 1.7 2.6 4.1 1.6 1.5 0.0 1.0 0.9 1.1 0.5 0.0 1.6 1.1 1.6 2.9 1.3 1.9 1.3 0.6 0.7 0.0 0.0 2.3 2.5 1.0 1.7 2.1 1.7 2.2 0.0 1.4 1.2 4.9 2.3 1.4 3.2 2.6 0.6 ZNF454 FLJ37444 ENSG00000178187 "Zinc finger protein 454" Q8N9F8 5 178941191-178966433 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 21.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 12.3;Spermatocytes: 14.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.5;EFO-21: 4.9;HHSteC: 3.7;HSkMC: 4.5;NTERA-2: 3.6;SH-SY5Y: 2.4;SuSa: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024556 Uncertain NA NA "HPA024556: AB_1859283" "unprognostic (1.27e-1)" "unprognostic (9.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (4.21e-2)" "unprognostic (1.41e-1)" "unprognostic (8.35e-2)" "unprognostic (3.72e-2)" "unprognostic (2.34e-2)" "unprognostic (9.52e-3)" "unprognostic (1.52e-1)" "unprognostic (3.95e-2)" "unprognostic (9.58e-2)" "unprognostic (3.68e-2)" "unprognostic (8.43e-3)" "unprognostic (2.78e-1)" 3.4 2.6 7.5 1.5 7.5 0.6 4.6 20.6 8.7 5.9 3.3 3.6 1.7 1.6 6.2 3.1 2.2 7.1 4.7 3.6 6.5 4.6 3.4 1.2 3.1 1.0 5.7 5.2 8.3 3.5 1.0 18.1 3.5 6.7 6.3 2.8 3.9 3.5 5.7 1.0 2.3 2.1 6.1 2.5 2.2 3.1 7.7 7.2 0.0 5.4 0.0 1.5 3.8 3.3 0.2 0.0 0.7 0.0 0.3 0.3 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.0 0.0 0.0 4.9 1.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 4.5 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 2.4 0.0 0.0 0.0 4.3 0.1 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.0 0.0 0.1 0.0 7.5 7.5 20.6 8.7 6.5 4.6 5.7 5.2 6.7 7.2 3.0 8.3 0.0 1.3 0.1 21.8 1.0 0.0 5.3 9.1 0.0 15.7 0.9 1.7 1.6 2.0 3.6 0.0 0.0 0.4 1.1 1.7 1.6 1.1 0.0 0.3 4.8 0.0 0.6 0.0 1.0 3.7 0.2 0.0 0.0 0.0 5.2 0.7 0.0 2.5 0.3 12.3 0.0 0.9 14.3 1.4 0.4 0.7 0.0 0.1 0.9 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 31.6;Club cells: 21.6;granulocytes: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.9 5.3 4.0 5.1 2.8 6.3 2.5 3.1 3.5 4.9 6.8 0.9 1.3 0.4 6.7 4.4 4.8 0.5 2.8 3.4 5.3 5.4 4.0 4.6 0.7 2.0 4.5 3.9 5.6 3.9 6.2 1.6 4.4 5.8 3.0 2.5 0.2 0.4 4.9 3.1 6.1 1.0 2.3 0.4 2.0 0.4 3.9 0.9 1.5 6.7 4.7 6.7 0.3 2.3 4.2 4.3 2.5 1.5 3.0 3.0 3.8 1.9 3.8 8.8 13.0 1.6 0.0 0.8 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 26.8 31.6 1.3 1.7 3.0 5.5 1.6 5.1 14.7 21.6 3.5 0.0 2.4 1.7 1.2 17.7 3.4 0.2 0.0 0.8 2.4 3.0 1.7 31.3 1.0 1.5 3.2 2.9 4.3 2.2 4.1 0.9 1.9 0.0 0.0 1.0 1.9 0.7 0.0 1.8 1.5 3.2 0.0 3.1 7.7 4.2 3.0 2.4 4.3 1.2 1.5 ZNF468 ENSG00000204604 "Zinc finger protein 468" "A2RRD8, Q5VIY5" 19 52838008-52890375 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 46.9" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "prognostic unfavorable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favorable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 6.6 7.6 6.6 3.5 5.1 5.2 6.9 8.4 5.1 6.2 6.2 4.3 11.0 3.2 4.7 6.4 6.3 6.3 8.0 4.6 4.2 2.9 8.2 3.4 4.9 9.8 4.2 2.8 4.8 10.0 8.8 5.5 65.5 5.2 7.9 7.2 3.1 7.0 5.8 3.7 4.6 10.8 6.2 3.9 5.1 7.1 3.4 3.3 12.0 10.4 1.9 5.5 8.0 5.4 8.8 7.0 11.5 10.3 19.1 12.5 8.6 6.2 0.8 5.7 10.0 6.1 4.5 16.7 5.0 6.3 6.5 9.7 6.2 3.9 9.6 5.1 5.3 7.7 3.3 3.9 5.1 8.6 0.0 5.8 7.3 6.4 2.6 12.4 0.4 9.4 7.2 6.1 8.0 6.6 3.6 5.4 5.3 7.2 0.4 5.7 1.4 9.1 5.9 7.0 4.5 6.1 5.5 8.2 6.4 8.8 46.9 5.9 8.7 6.3 5.7 1.5 12.6 7.5 5.7 4.4 2.2 5.7 3.0 7.3 3.9 13.9 8.6 0.5 0.8 8.0 8.3 6.1 11.5 12.3 10.3 12.5 8.1 8.0 9.8 7.0 8.8 10.0 9.2 6.3 19.1 8.0 5.3 9.3 8.6 6.6 5.1 8.4 5.1 4.2 2.9 4.2 2.8 5.2 3.3 3.0 3.7 4.5 4.7 3.0 1.0 3.3 7.6 0.0 5.7 8.7 0.0 6.4 14.9 6.1 2.4 3.1 5.3 0.0 8.3 10.7 2.5 8.9 17.3 2.6 5.4 0.0 8.2 3.1 10.0 0.4 0.9 3.5 1.7 3.6 12.2 0.8 7.5 7.0 2.5 5.4 0.2 0.0 2.7 0.5 4.0 4.6 20.1 6.9 6.9 9.7 ZNF469 KIAA1858 ENSG00000225614 "Zinc finger protein 469" Q96JG9 16 88427471-88440757 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 5.0;Ito cells: 3.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "A549: 5.7;BJ hTERT+: 6.3;HeLa: 5.6;SiHa: 6.7;THP-1: 8.6" "Low region specificity" "Detected in many" HPA069784 Approved Vesicles NA NA Vesicles "HPA069784: AB_2686196" "unprognostic (1.80e-1)" "unprognostic (7.79e-3)" "unprognostic (7.71e-2)" "unprognostic (7.01e-2)" "unprognostic (2.97e-1)" "unprognostic (2.30e-1)" "unprognostic (9.17e-3)" "unprognostic (7.08e-3)" "unprognostic (5.04e-2)" "unprognostic (5.02e-2)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (8.71e-7)" "unprognostic (2.24e-2)" "unprognostic (1.83e-2)" "unprognostic (2.20e-2)" "unprognostic (3.34e-2)" 1.8 0.8 2.5 2.3 2.2 0.1 0.7 0.0 2.2 4.3 0.2 0.4 2.9 0.0 0.2 1.3 2.6 0.4 2.5 1.6 0.0 0.1 0.5 1.3 1.6 4.3 0.8 0.0 0.0 0.5 1.3 0.0 0.6 0.8 1.5 0.2 0.8 2.1 1.6 1.9 0.9 0.3 0.0 0.5 1.7 0.4 0.1 1.5 0.0 0.3 0.0 0.2 0.0 0.0 5.7 0.2 0.0 0.9 1.3 0.0 3.6 6.3 0.8 0.1 0.0 0.2 0.0 0.1 4.8 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 5.6 0.0 4.1 0.2 0.1 1.4 0.0 1.4 0.0 1.0 3.7 0.0 0.0 0.0 1.0 0.5 0.0 0.9 0.7 0.1 4.7 0.4 0.0 0.0 0.0 0.0 0.0 2.9 6.7 0.0 0.0 0.1 1.2 8.6 4.5 5.1 1.3 2.8 0.9 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 0.0 0.5 0.2 0.0 5.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.9 0.2 0.4 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 2.5 3.2 0.0 3.7 0.3 0.0 0.0 1.3 0.0 1.0 0.0 0.3 0.5 0.0 1.4 0.0 0.0 6.5 3.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 ZNF470 "CZF-1, FLJ26175" ENSG00000197016 "Zinc finger protein 470" Q6ECI4 19 56567511-56588911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 11.1;Spermatogonia: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.3" "Low region specificity" "Detected in all" HPA029000 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA029000: AB_10603843" "unprognostic (1.40e-2)" "unprognostic (5.51e-2)" "unprognostic (5.91e-2)" "unprognostic (9.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.40e-2)" "unprognostic (7.11e-2)" "unprognostic (4.58e-2)" "unprognostic (6.91e-3)" "unprognostic (2.39e-2)" "unprognostic (3.45e-3)" "unprognostic (3.33e-3)" "unprognostic (3.89e-2)" "unprognostic (2.82e-2)" "unprognostic (4.68e-1)" "unprognostic (2.76e-3)" "unprognostic (2.88e-3)" 4.6 6.5 11.7 2.9 10.6 1.4 5.3 12.7 12.1 6.3 4.8 5.5 1.3 2.8 5.7 8.8 4.3 5.8 5.1 5.4 12.4 11.7 6.7 8.6 5.1 3.6 11.8 9.4 7.2 4.5 9.3 7.2 4.6 9.8 7.0 3.4 5.8 3.8 6.9 3.0 5.1 3.1 5.4 11.6 4.4 3.6 8.3 9.9 3.6 6.8 1.2 4.6 4.6 5.2 3.2 2.0 2.9 1.0 2.3 4.4 0.9 0.0 1.7 6.5 2.8 3.6 3.3 5.5 3.1 1.2 2.3 4.5 0.4 1.5 0.0 2.0 3.3 4.1 0.1 2.7 1.4 2.6 0.0 13.3 5.7 0.1 0.4 3.1 1.2 6.7 3.9 2.0 2.6 0.8 2.6 1.5 0.3 0.1 0.1 3.5 0.1 1.2 2.0 5.5 0.0 0.7 0.2 4.7 0.9 2.7 4.0 2.5 6.3 0.1 0.5 0.9 4.5 2.1 3.5 1.1 0.2 2.7 2.2 4.2 2.1 2.8 0.2 0.0 3.5 1.0 1.3 0.8 2.9 2.2 0.6 4.4 2.5 1.9 1.3 1.4 3.2 3.0 3.0 2.2 2.3 1.0 2.0 1.5 0.9 11.7 10.6 12.7 12.1 12.4 11.7 11.8 9.4 9.8 9.9 3.0 2.2 0.0 1.4 0.9 8.5 6.3 5.1 1.4 2.3 0.0 9.8 0.9 1.7 2.1 1.0 1.6 0.9 0.0 0.6 0.8 1.8 1.4 6.9 1.7 1.1 11.1 0.0 0.6 0.6 1.0 2.0 2.6 1.7 1.8 0.7 4.0 1.0 0.8 2.8 2.2 6.2 6.5 1.9 3.9 10.6 0.5 0.2 0.0 1.8 0.8 ZNF471 "KIAA1396, Z1971" ENSG00000196263 "Zinc finger protein 471" Q9BX82 19 56507843-56530221 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.3;Ciliated cells: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 9.5;hTERT-RPE1: 13.8;SuSa: 10.4" "Low region specificity" "Detected in all" HPA066695 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA066695: AB_2685704" "unprognostic (2.89e-2)" "unprognostic (2.79e-4)" "unprognostic (1.58e-1)" "unprognostic (2.90e-2)" "unprognostic (2.22e-1)" "unprognostic (2.42e-3)" "unprognostic (1.45e-1)" "unprognostic (8.44e-2)" "unprognostic (1.01e-2)" "unprognostic (4.14e-2)" "unprognostic (4.47e-4)" "unprognostic (9.36e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-2)" "unprognostic (3.44e-3)" 5.8 7.2 18.5 4.1 18.5 3.0 7.8 23.1 19.3 7.8 8.2 11.2 5.9 2.1 14.2 17.8 5.4 9.8 7.4 5.8 17.4 7.5 5.5 2.6 6.2 3.2 12.2 13.3 24.7 3.9 16.3 10.9 6.6 15.1 9.3 5.1 4.6 6.5 8.5 4.9 10.1 3.2 10.4 11.5 4.6 4.5 8.7 21.3 1.6 10.6 3.1 2.2 6.7 9.9 3.1 1.6 5.4 1.3 3.0 2.1 0.3 0.5 0.5 5.4 0.8 4.5 5.1 0.6 4.9 1.8 2.2 2.0 0.8 0.8 0.8 3.3 5.2 4.4 0.5 0.7 0.4 2.2 1.1 2.0 3.9 1.3 0.6 4.4 1.1 3.5 9.5 1.8 2.9 0.2 13.8 0.2 0.6 1.2 1.7 2.5 0.6 0.5 0.7 1.4 0.4 2.1 0.6 3.5 0.5 3.9 4.1 0.9 3.2 0.5 0.2 0.2 10.4 0.7 0.8 0.8 8.4 3.7 0.9 3.7 1.3 1.2 0.5 0.7 0.6 0.6 3.9 1.3 0.9 1.9 1.0 1.5 1.2 1.7 1.2 0.7 3.1 1.7 2.1 5.4 3.0 1.0 1.6 1.0 0.3 18.5 18.5 23.1 19.3 17.4 7.5 12.2 13.3 15.1 21.3 17.9 17.3 0.0 2.3 0.6 9.8 9.3 2.5 17.4 12.5 5.2 5.9 1.0 3.3 1.3 5.3 6.7 0.9 0.0 0.8 0.3 2.6 2.8 2.3 0.8 0.4 6.4 1.2 6.2 0.6 2.5 4.6 1.9 1.7 1.0 0.7 11.3 0.7 0.0 6.7 1.1 9.1 6.5 3.1 7.1 7.5 0.5 0.7 0.0 1.0 1.4 ZNF474 "4933409D10Rik, FLJ32921" ENSG00000164185 "Zinc finger protein 474" Q6S9Z5 5 122129513-122153571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.4;fallopian tube: 21.4;testis: 22.9" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 30.8;Club cells: 6.8;Early spermatids: 13.5;Late spermatids: 8.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "pons and medulla: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.3;CAPAN-2: 3.2;GAMG: 4.3;TIME: 3.8" "Low region specificity" "Detected in some" NA NA "unprognostic (9.98e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (5.90e-3)" "unprognostic (7.82e-2)" "unprognostic (2.49e-2)" "unprognostic (3.94e-2)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (1.51e-3)" "unprognostic (1.12e-3)" "unprognostic (9.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.09e-4)" 0.3 0.1 1.4 0.3 1.5 0.1 0.3 0.2 0.2 1.2 0.5 6.3 0.6 0.2 1.1 4.9 0.5 21.4 0.7 0.1 1.5 1.1 0.1 0.1 7.9 0.1 0.4 0.2 7.1 0.1 0.2 0.7 0.6 11.4 0.3 0.2 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.4 0.1 0.2 22.9 0.9 0.0 1.3 0.0 0.2 0.4 0.2 0.2 0.9 0.0 0.0 0.0 0.6 0.0 0.1 1.3 0.5 0.2 0.8 0.4 0.1 3.3 0.8 0.4 0.1 0.1 3.2 0.0 0.2 2.1 4.3 0.6 0.2 0.0 1.3 0.3 0.3 1.1 0.7 0.0 0.7 1.1 0.1 0.4 1.4 0.8 0.4 0.6 0.1 0.6 0.0 0.1 0.1 2.0 0.8 0.4 0.0 0.2 0.0 0.9 0.1 0.9 0.4 0.1 0.7 0.2 1.0 0.1 0.3 0.4 0.5 0.5 3.8 1.1 0.7 2.2 0.8 0.3 0.6 0.4 2.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.9 0.0 0.0 1.4 1.5 0.2 0.2 1.5 1.1 0.4 0.2 11.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.8 6.8 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF479 KR19 ENSG00000185177 "Zinc finger protein 479" Q96JC4 7 57119614-57139864 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.4" "Group enriched" "Detected in some" 7 "Early spermatids: 62.7;Late spermatids: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.2 1.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.5 0.2 0.3 0.4 0.3 0.3 0.2 0.5 0.8 0.8 0.2 1.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 6.0 0.0 0.0 0.0 0.0 0.1 ZNF485 ENSG00000198298 "Zinc finger protein 485" Q8NCK3 10 43606407-43617903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA059356 Uncertain NA NA "HPA059356: AB_2683988" "prognostic unfavorable (5.24e-4)" "unprognostic (1.34e-1)" "unprognostic (4.18e-1)" "unprognostic (1.08e-1)" "unprognostic (5.12e-3)" "unprognostic (3.21e-1)" "unprognostic (1.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (4.56e-3)" "unprognostic (4.12e-2)" "unprognostic (2.40e-2)" "unprognostic (3.46e-6)" "unprognostic (8.45e-2)" "unprognostic (1.61e-1)" "unprognostic (1.30e-1)" "unprognostic (1.41e-2)" 4.6 4.7 5.6 4.9 7.6 1.8 8.8 5.3 7.7 4.4 4.8 6.5 3.4 4.0 6.1 4.5 5.8 6.6 3.8 3.6 6.1 4.2 3.6 5.1 3.1 7.1 8.9 6.7 9.6 12.9 4.6 3.6 2.5 8.0 6.5 5.1 3.6 6.1 4.7 8.5 9.1 4.6 7.7 6.8 6.2 5.6 17.4 5.8 2.9 4.6 3.6 7.8 4.8 4.7 5.4 2.3 0.8 3.3 12.9 9.3 3.1 3.3 2.6 2.1 7.7 4.1 4.8 0.2 3.9 1.1 3.9 6.2 6.7 5.1 11.5 3.8 1.5 1.8 3.5 4.5 3.7 7.2 4.6 3.6 0.1 3.2 3.3 3.1 1.9 5.7 3.5 5.9 2.7 5.2 2.0 1.8 2.1 10.6 0.2 8.6 5.5 5.6 5.6 10.6 5.4 3.2 3.1 1.4 2.8 3.9 3.3 7.7 5.9 1.8 6.4 2.3 3.4 10.1 4.0 2.3 3.1 4.8 4.9 6.2 8.1 8.3 2.4 0.7 2.9 3.0 0.1 1.8 0.8 4.3 3.3 6.6 5.4 5.4 4.6 2.3 5.0 9.3 5.7 0.3 12.9 1.1 1.5 4.3 3.1 5.6 7.6 5.3 7.7 6.1 4.2 8.9 6.7 8.0 5.8 0.0 1.4 0.0 1.9 0.6 1.7 1.2 2.5 0.0 2.3 0.0 0.0 0.7 3.3 1.7 4.7 0.7 0.2 0.0 1.8 0.8 0.8 1.2 0.0 1.0 1.4 1.6 0.0 2.5 0.6 2.0 0.6 0.8 0.0 1.0 2.5 0.6 1.6 2.5 1.1 1.5 0.2 0.0 1.2 5.5 4.7 0.5 0.2 1.3 2.4 0.7 ZNF486 "KRBO2, MGC2396" ENSG00000256229 "Zinc finger protein 486" Q96H40 19 20167228-20200490 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 59.2" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 16.6;HBF TERT88: 16.5;SuSa: 15.8" NA NA "unprognostic (9.94e-3)" "unprognostic (1.29e-1)" "unprognostic (6.89e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-3)" "unprognostic (4.14e-2)" "unprognostic (4.83e-2)" "unprognostic (2.42e-2)" "unprognostic (1.51e-2)" "unprognostic (3.25e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (4.65e-2)" "unprognostic (2.43e-2)" 5.1 2.6 3.5 5.3 4.3 2.2 7.2 9.0 4.1 7.7 2.6 1.6 15.4 0.9 6.2 6.1 3.4 5.1 4.1 2.8 2.7 2.2 9.5 1.4 3.8 6.3 5.2 1.8 7.0 5.6 7.7 3.4 10.2 3.4 7.9 2.5 2.5 3.0 10.1 1.4 4.0 3.2 2.6 4.7 6.0 3.6 2.4 5.3 7.0 59.2 2.1 5.4 13.5 7.0 3.6 1.3 13.9 1.7 1.5 3.2 0.9 0.0 0.0 4.4 0.3 3.3 3.9 0.4 6.3 4.7 11.6 11.4 0.5 2.7 5.9 16.6 5.4 8.0 2.6 0.0 0.5 16.5 0.1 2.4 0.0 0.1 1.5 4.1 0.0 0.0 6.4 1.8 7.2 0.6 4.5 0.9 0.2 2.4 0.0 2.6 0.1 1.1 4.5 7.6 0.0 1.6 3.7 6.4 2.1 13.5 4.4 2.7 7.3 0.0 7.3 1.0 15.8 3.0 0.1 1.8 1.1 0.4 7.7 5.1 0.6 7.2 5.0 0.1 0.1 2.2 3.1 0.9 1.2 1.4 1.7 1.6 2.6 1.9 2.0 1.2 3.6 2.4 3.2 13.9 1.5 1.2 1.3 2.1 0.9 3.5 4.3 9.0 4.1 2.7 2.2 5.2 1.8 3.4 5.3 6.0 4.1 2.2 1.7 0.1 1.0 2.0 0.0 18.7 6.8 3.5 0.0 3.6 3.3 5.9 0.4 2.7 0.0 0.0 6.3 10.0 1.8 0.9 4.7 0.0 1.8 0.0 1.2 1.3 1.6 0.2 4.0 1.9 0.0 1.8 1.3 2.3 2.4 0.0 2.5 0.8 0.4 6.5 1.6 2.8 1.3 1.0 1.3 0.9 2.5 2.4 ZNF492 "KIAA1473, ZNF115" ENSG00000229676 "Zinc finger protein 492" Q9P255 19 22634324-22667670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.1" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 2: 6.7;Spermatocytes: 8.1;Spermatogonia: 8.5" "Group enriched" "Detected in some" 6 "ovarian cancer: 0.6;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 8.5;HAP1: 4.8;NB-4: 6.3;NTERA-2: 6.1;U-2197: 6.0" NA NA "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.14e-1)" "unprognostic (1.24e-3)" "unprognostic (7.94e-2)" "unprognostic (2.42e-2)" "unprognostic (1.47e-2)" "unprognostic (6.75e-2)" "unprognostic (1.08e-3)" "unprognostic (5.63e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.91e-2)" "unprognostic (2.65e-1)" "unprognostic (8.93e-2)" "unprognostic (6.04e-2)" 2.1 0.7 2.0 1.0 3.1 7.4 2.6 7.6 3.8 2.0 1.0 0.1 0.0 0.3 1.2 0.7 1.9 1.2 0.4 1.6 1.9 0.9 1.2 0.6 1.4 1.8 3.1 0.9 2.5 0.9 1.2 0.6 2.1 1.1 0.8 1.4 0.7 0.9 0.6 0.6 1.4 0.9 1.0 0.9 1.8 0.7 8.0 2.3 11.1 1.3 0.0 1.3 0.9 1.3 2.4 0.5 1.4 0.3 0.9 1.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 8.5 1.3 0.0 0.7 0.7 0.0 0.1 0.0 3.0 1.1 3.7 0.1 4.8 0.0 1.6 0.0 1.5 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 1.7 0.0 0.0 0.0 3.3 1.2 0.2 0.0 0.8 0.0 6.3 6.1 0.0 0.1 0.0 0.0 0.9 0.8 1.5 0.1 3.5 0.0 0.0 0.5 1.5 2.5 2.2 0.0 0.1 3.2 6.0 0.2 0.1 0.0 3.9 0.0 0.0 0.0 0.7 0.3 0.2 0.3 0.2 0.9 0.6 0.6 0.2 0.1 2.4 1.0 0.5 1.4 0.9 0.2 0.5 0.8 0.4 2.0 3.1 7.6 3.8 1.9 0.9 3.1 0.9 1.1 2.3 0.0 6.7 0.0 1.3 0.5 1.5 0.9 0.0 2.7 1.2 0.0 0.0 0.6 0.0 0.4 0.6 0.7 0.0 0.0 0.2 2.0 0.7 0.8 1.1 0.0 0.1 3.2 0.0 1.8 0.8 0.0 0.9 0.0 0.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 1.7 0.0 0.6 8.1 8.5 0.5 0.5 0.0 0.0 0.7 ZNF493 FLJ36504 ENSG00000196268 "Zinc finger protein 493" Q6ZR52 19 21397119-21427573 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 17.5" NA NA "unprognostic (3.49e-1)" "unprognostic (5.80e-3)" "unprognostic (1.28e-1)" "unprognostic (2.83e-2)" "unprognostic (2.54e-2)" "unprognostic (2.71e-3)" "unprognostic (5.90e-2)" "unprognostic (1.75e-3)" "unprognostic (2.30e-2)" "unprognostic (1.82e-3)" "unprognostic (4.13e-3)" "unprognostic (6.03e-3)" "unprognostic (2.08e-1)" "unprognostic (1.34e-2)" "unprognostic (4.80e-1)" "unprognostic (3.55e-1)" "unprognostic (6.00e-4)" 7.8 9.0 12.0 7.6 20.1 11.3 10.0 36.8 14.1 8.6 7.2 10.0 8.9 6.7 10.7 10.6 5.9 8.9 6.7 6.8 11.1 9.5 9.7 4.4 8.7 12.4 13.6 14.4 26.7 11.1 12.6 18.3 5.8 12.0 10.0 8.3 9.3 9.7 6.2 6.6 11.1 7.6 8.3 13.3 10.3 10.0 6.9 16.1 14.3 23.6 4.3 9.7 8.0 8.3 12.2 6.0 23.2 3.0 9.4 10.9 1.3 0.9 0.7 6.4 9.9 4.2 4.1 7.7 2.5 2.5 3.3 4.7 1.3 4.5 7.6 4.8 2.1 2.5 2.1 4.8 1.6 3.4 0.8 8.1 4.0 4.6 3.1 2.5 0.2 0.7 3.6 1.9 2.4 1.8 4.5 0.9 14.6 5.1 2.0 3.8 1.3 17.5 8.7 7.2 0.3 2.3 9.0 5.1 3.1 3.4 6.6 8.8 5.1 0.3 0.8 2.3 10.1 6.9 4.3 2.4 2.8 0.6 4.5 2.2 6.3 8.5 6.1 0.5 0.6 1.2 6.9 2.6 6.5 8.1 2.0 8.1 10.5 7.5 8.8 2.0 12.2 10.9 9.8 23.2 9.4 3.0 6.0 5.7 1.3 12.0 20.1 36.8 14.1 11.1 9.5 13.6 14.4 12.0 16.1 38.7 12.6 11.3 11.1 8.9 35.2 6.1 15.3 14.7 20.5 27.9 39.3 8.9 6.6 8.0 0.8 16.6 7.8 0.0 7.2 7.7 12.2 15.1 5.7 3.9 4.2 47.7 12.6 14.1 6.4 1.7 20.4 8.0 8.5 1.8 7.9 22.3 8.2 3.5 14.5 4.1 24.1 25.8 12.2 10.7 12.1 10.3 8.4 17.0 12.2 16.9 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 8.1 6.4 10.2 9.4 7.5 5.9 8.1 13.8 11.4 10.3 8.0 11.7 11.5 8.4 12.2 10.9 6.2 8.9 10.4 6.0 6.2 5.1 6.0 5.2 7.2 12.5 6.6 9.4 13.9 8.5 9.1 8.0 6.7 6.6 9.3 5.3 10.6 11.3 14.9 7.5 8.5 7.5 7.5 5.4 11.4 7.7 7.2 8.4 9.9 9.2 7.1 8.3 9.2 8.4 5.3 6.5 3.4 2.5 3.0 4.9 2.1 2.0 8.4 2.8 7.3 3.3 3.0 12.8 6.1 6.8 7.6 5.2 3.7 4.0 4.4 5.3 3.3 2.8 4.7 5.8 3.2 5.6 3.2 8.8 3.6 10.6 5.0 4.7 2.5 4.0 3.5 7.8 3.4 6.5 7.5 4.3 5.6 5.3 7.0 3.0 4.6 5.2 4.4 3.6 1.6 3.0 9.3 6.7 8.7 2.5 2.4 10.4 6.8 5.2 7.9 2.3 2.0 5.1 4.1 4.8 7.2 5.5 8.0 2.9 6.7 4.5 3.9 2.2 2.1 4.5 2.3 2.5 3.4 3.9 2.4 3.3 4.9 2.5 3.0 1.4 5.3 4.2 4.9 2.9 3.0 1.7 6.5 3.9 2.1 10.2 7.5 13.8 11.4 6.2 5.1 6.6 9.4 6.6 8.4 11.9 2.4 8.9 2.6 2.2 16.8 4.8 2.5 5.3 2.3 7.0 23.6 4.9 1.7 3.8 6.8 4.9 4.9 0.0 2.7 3.8 3.6 4.3 6.9 4.0 2.7 17.5 8.1 9.2 3.3 1.3 10.6 3.1 1.7 9.0 4.9 12.1 2.9 0.0 10.6 2.2 20.5 0.0 4.1 12.6 8.3 1.9 3.8 5.7 5.2 1.6 ZNF501 "MGC21738, ZNF52" ENSG00000186446 "Zinc finger protein 501" Q96CX3 3 44729596-44737083 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 9.5;Spermatogonia: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 6.7" "Low region specificity" "Detected in all" HPA044161 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044161: AB_2678841" "unprognostic (8.89e-2)" "unprognostic (5.04e-2)" "unprognostic (9.24e-2)" "unprognostic (3.03e-2)" "unprognostic (1.19e-2)" "unprognostic (3.46e-3)" "unprognostic (2.37e-1)" "unprognostic (2.25e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" "unprognostic (2.81e-1)" "unprognostic (3.81e-4)" "unprognostic (1.18e-1)" "unprognostic (4.48e-1)" "unprognostic (1.09e-2)" "unprognostic (3.02e-2)" 5.6 2.8 6.8 3.6 8.3 1.3 8.5 11.7 8.0 7.0 6.2 7.5 4.7 2.6 7.5 4.0 4.7 7.3 4.5 5.6 7.3 4.8 5.0 2.3 4.7 6.8 5.9 6.7 10.0 5.3 2.7 5.7 5.9 4.9 8.1 4.1 3.6 4.9 7.3 5.3 4.4 3.6 8.0 6.3 4.9 4.4 6.7 9.8 4.2 6.6 3.4 4.3 7.2 7.2 3.4 1.1 2.9 1.1 2.7 3.5 1.2 0.0 0.0 2.1 0.0 3.9 6.7 0.8 2.4 2.2 2.6 3.0 0.9 0.9 1.8 0.0 1.1 1.9 0.7 0.0 0.9 2.5 0.0 1.2 0.0 0.2 1.7 5.4 0.0 0.0 3.9 2.5 2.9 0.2 0.8 1.6 0.0 0.0 0.0 0.8 0.0 0.8 0.1 4.9 1.1 0.0 1.3 0.0 1.0 2.2 1.4 2.6 1.7 1.4 1.5 1.0 4.1 0.1 0.1 1.0 0.1 2.3 2.4 1.9 4.2 2.6 0.0 0.1 0.0 3.1 2.0 0.7 2.9 2.4 0.9 3.3 2.9 2.3 2.6 1.1 3.4 3.5 2.4 1.1 2.7 1.1 1.0 2.3 1.2 6.8 8.3 11.7 8.0 7.3 4.8 5.9 6.7 4.9 9.8 0.0 0.3 0.0 1.7 0.8 2.9 2.0 0.0 1.4 2.3 3.5 2.0 1.5 0.0 2.1 0.6 2.1 0.5 0.0 1.7 1.5 2.5 0.9 0.0 0.8 1.4 9.5 1.2 1.8 1.8 1.3 1.4 0.8 0.0 1.0 0.7 7.0 1.7 0.0 1.4 1.0 3.2 6.5 1.9 4.8 10.2 1.4 0.2 1.7 0.9 0.7 ZNF506 DKFZp761G1812 ENSG00000081665 "Zinc finger protein 506" Q5JVG8 19 19785839-19821751 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.88e-3)" "unprognostic (4.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" "unprognostic (6.26e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (3.68e-3)" "unprognostic (4.74e-3)" "unprognostic (7.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (4.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.28e-2)" "unprognostic (2.51e-3)" 14.6 9.3 16.8 13.4 23.9 11.5 11.6 23.1 18.4 13.9 10.7 15.8 10.5 8.6 10.9 12.2 12.2 12.4 10.7 13.7 17.6 15.3 13.4 4.9 8.7 14.0 18.5 10.4 17.6 14.2 7.6 24.0 9.8 11.0 11.8 10.4 11.5 9.0 14.0 13.5 14.7 11.8 10.0 13.4 13.1 11.9 7.9 19.5 13.9 19.0 6.3 15.5 16.8 8.6 13.6 12.3 9.1 5.8 7.0 13.4 4.8 1.2 0.7 5.6 1.1 4.8 6.4 6.1 3.5 1.8 3.0 2.4 2.8 5.9 9.2 8.6 2.4 6.4 6.0 4.3 0.5 2.9 1.2 6.5 2.8 2.2 1.5 6.9 2.2 1.9 5.1 6.5 3.2 0.7 2.7 0.7 5.4 1.0 2.6 4.9 1.1 15.7 2.4 7.9 2.2 1.9 4.3 8.4 4.0 7.5 4.0 9.0 5.0 5.8 2.9 3.7 6.4 7.6 6.7 3.6 3.7 1.0 8.4 3.2 2.8 2.3 5.4 0.6 4.0 6.1 7.0 4.8 9.1 6.8 4.6 8.0 10.6 6.8 6.5 3.1 13.6 13.4 11.2 8.9 7.0 5.8 12.3 6.6 4.8 16.8 23.9 23.1 18.4 17.6 15.3 18.5 10.4 11.0 19.5 14.9 9.3 7.6 8.4 5.6 16.9 8.5 15.3 14.7 13.6 34.9 25.5 9.6 29.9 8.6 25.9 12.0 9.3 0.0 10.0 5.3 8.4 12.1 9.2 3.4 7.1 25.4 9.9 14.1 8.5 5.1 11.2 11.4 8.5 4.6 13.8 13.3 9.9 7.0 9.2 25.9 17.6 6.5 9.5 5.4 5.7 7.4 12.2 18.8 12.8 7.2 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96755865-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 9.1 9.2 10.9 6.5 15.7 5.7 12.7 23.0 13.9 14.4 8.8 6.3 11.6 4.6 11.5 8.1 7.9 10.7 6.5 7.4 11.5 10.3 8.9 8.5 8.4 11.4 8.6 12.3 14.9 10.7 13.5 19.8 6.9 10.1 12.6 9.3 5.2 7.5 11.2 9.2 6.2 6.8 11.3 9.2 10.1 6.8 8.2 9.1 14.9 11.2 4.3 13.3 13.9 10.7 5.9 1.3 3.8 2.9 6.4 7.7 2.1 5.1 5.2 11.5 8.5 9.8 9.2 5.9 5.8 11.4 9.7 8.6 4.9 3.8 6.7 3.1 6.1 9.5 11.2 3.3 5.4 8.7 10.7 5.5 9.4 9.7 2.5 5.8 3.6 6.2 7.9 7.2 8.3 10.4 9.1 9.3 12.9 9.6 6.5 9.4 4.6 10.4 4.8 8.1 7.5 5.3 6.8 18.8 3.3 5.1 4.9 11.9 9.5 11.2 5.2 5.7 8.4 3.8 6.8 8.2 6.2 5.9 7.0 6.7 11.4 12.0 4.9 3.5 2.5 6.2 2.3 1.2 3.8 3.8 1.9 7.7 3.6 5.0 3.0 1.0 5.9 5.7 5.2 0.4 6.4 2.9 1.3 7.1 2.1 10.9 15.7 23.0 13.9 11.5 10.3 8.6 12.3 10.1 9.1 3.0 2.7 2.0 1.4 1.4 10.5 4.4 0.0 4.0 3.4 3.5 2.0 2.0 1.7 1.9 5.0 2.7 1.0 0.0 2.3 1.2 1.7 1.4 1.1 1.0 1.7 15.9 1.2 5.5 3.4 5.6 5.5 2.2 5.0 1.0 1.8 3.8 1.3 1.7 3.9 1.5 7.0 6.5 1.4 3.2 4.9 1.3 0.7 3.2 1.4 1.0 ZNF514 FLJ14457 ENSG00000144026 "Zinc finger protein 514" Q96K75 2 95147330-95165413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028974 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028974: AB_10603845" "unprognostic (8.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (4.68e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" "unprognostic (5.17e-2)" "unprognostic (1.80e-3)" "unprognostic (4.33e-2)" "unprognostic (1.91e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-2)" 7.1 7.6 7.8 5.1 16.4 1.7 12.7 14.9 12.9 10.4 10.5 15.7 12.0 9.4 15.0 27.1 8.1 11.5 6.7 8.4 14.2 8.4 9.8 5.0 8.4 7.0 17.0 9.9 20.6 9.6 12.5 23.5 7.9 11.5 12.1 9.6 10.1 11.5 11.6 12.0 11.6 9.4 10.6 12.5 8.9 10.0 19.8 18.0 14.0 15.2 10.3 7.8 8.9 10.9 7.7 5.2 10.4 5.3 6.4 11.3 5.5 13.4 4.7 12.5 8.4 9.4 12.6 9.7 5.3 5.7 8.6 9.2 7.0 5.0 2.1 2.7 5.7 14.3 8.2 6.6 4.9 9.8 4.4 8.8 2.5 6.3 5.7 4.0 1.4 6.8 7.7 15.1 5.4 3.8 13.5 4.2 7.6 6.9 2.4 6.7 6.4 3.6 6.8 4.2 4.4 4.7 6.5 4.4 4.7 5.8 5.7 11.7 8.5 5.6 2.7 5.7 19.1 5.2 5.0 4.4 6.2 8.5 2.0 4.3 7.1 5.2 3.5 6.8 2.8 4.1 10.4 5.3 9.9 5.1 2.6 6.1 7.3 6.8 4.8 5.2 7.7 11.3 9.2 1.5 6.4 3.0 4.1 7.1 5.5 7.8 16.4 14.9 12.9 14.2 8.4 17.0 9.9 11.5 18.0 8.9 6.4 7.8 7.3 4.9 14.3 11.4 17.8 8.1 4.5 0.0 17.7 5.3 23.2 5.3 34.4 8.3 5.3 0.0 4.5 3.0 5.6 9.3 1.1 6.4 6.8 14.3 9.2 7.4 3.5 34.3 9.8 3.8 6.8 3.6 10.1 11.8 4.6 3.5 7.1 15.0 34.1 6.5 4.1 12.2 10.6 5.5 3.1 6.9 6.8 9.5 ZNF517 ENSG00000197363 "Zinc finger protein 517" Q6ZMY9 8 144798876-144811169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 14.0" HPA055337 Approved Nucleoplasm NA NA Nucleoplasm "HPA055337: AB_2682788" "unprognostic (9.54e-3)" "unprognostic (4.72e-2)" "unprognostic (3.20e-2)" "unprognostic (3.06e-2)" "unprognostic (1.81e-1)" "unprognostic (1.55e-2)" "unprognostic (2.22e-2)" "unprognostic (3.13e-1)" "unprognostic (4.83e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.66e-4)" "unprognostic (1.83e-1)" "unprognostic (4.23e-2)" "unprognostic (2.75e-1)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "unprognostic (9.57e-2)" 2.9 6.5 5.3 3.1 4.5 1.5 8.5 7.3 8.6 3.3 3.0 2.7 5.3 3.6 5.6 3.1 3.2 4.1 3.2 5.8 6.8 3.2 3.9 3.2 4.6 6.5 5.6 6.1 7.5 3.8 4.5 3.9 4.4 4.2 3.7 0.5 5.4 6.9 1.9 9.6 10.5 4.5 1.4 4.1 4.3 3.6 3.6 4.4 3.0 4.1 1.4 1.4 4.1 2.8 4.1 1.1 0.5 2.4 1.4 2.2 1.2 2.1 3.9 6.6 6.4 1.0 2.0 3.4 1.9 0.5 0.4 0.3 1.3 2.3 1.2 4.6 0.6 2.8 2.1 0.3 0.7 0.9 4.6 1.7 2.7 2.1 14.0 2.5 0.6 2.8 1.4 1.7 0.3 1.3 3.7 1.5 3.4 3.1 1.8 1.1 3.4 2.7 1.6 4.6 4.2 4.4 3.9 2.0 0.9 0.6 2.6 2.9 8.4 5.3 2.1 2.0 3.4 5.4 2.4 1.8 4.4 6.9 2.3 1.9 3.0 0.5 0.8 4.8 1.1 3.6 0.4 1.2 0.0 1.8 2.4 1.5 4.1 1.7 1.2 1.1 0.7 1.4 1.2 0.5 1.4 1.4 0.5 2.2 1.2 5.3 4.5 7.3 8.6 6.8 3.2 5.6 6.1 4.2 4.4 0.0 0.3 0.0 5.0 0.5 3.6 2.8 5.1 0.0 1.2 0.0 7.9 0.6 1.7 0.8 1.2 1.1 1.0 0.0 0.4 0.5 0.8 1.2 0.0 1.7 1.3 3.2 1.2 3.1 1.6 0.0 0.9 1.3 0.0 0.0 1.0 2.3 0.7 0.0 1.1 2.2 3.7 0.0 1.4 3.0 2.6 1.0 0.3 1.0 0.8 4.4 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 14.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA028982 Uncertain Approved Nucleoli NA NA Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 1.8 1.4 2.8 1.9 7.6 1.4 2.8 13.7 14.4 5.7 4.6 0.7 0.8 1.2 7.0 2.6 3.4 4.5 1.8 1.9 3.4 1.6 0.8 1.0 2.7 6.6 1.7 4.0 8.7 1.2 1.1 1.5 1.2 3.0 2.6 2.6 2.0 1.6 2.7 1.0 2.0 2.1 6.0 2.1 2.2 1.4 3.0 2.5 1.1 2.0 0.9 1.9 4.3 3.8 1.7 0.1 0.0 0.6 0.5 3.5 0.7 1.3 0.3 6.0 6.3 0.8 1.2 1.6 1.6 0.9 3.5 3.2 2.7 1.2 3.1 1.7 1.2 1.6 1.0 4.9 1.2 4.1 1.9 3.3 5.5 1.8 1.1 0.2 11.3 2.4 0.6 1.6 2.9 1.2 1.0 0.6 4.7 2.7 4.7 2.0 1.8 6.9 4.4 2.7 3.5 1.4 7.4 5.8 3.9 0.9 1.9 9.3 2.5 2.3 0.8 1.8 4.0 0.7 3.1 0.4 5.7 7.6 2.5 1.8 1.8 1.2 4.5 1.8 4.4 4.7 0.0 0.3 0.0 1.1 0.6 1.8 1.7 1.4 1.5 0.1 0.8 3.5 2.2 0.0 0.5 0.5 0.1 2.0 0.7 2.8 7.6 13.7 14.4 3.4 1.6 1.7 4.0 3.0 2.5 6.0 7.4 4.2 2.4 1.8 14.4 4.4 2.5 2.7 1.2 0.0 2.0 2.3 1.7 2.0 0.7 2.1 0.1 0.0 1.7 3.5 3.9 1.2 3.5 0.8 1.5 3.2 1.2 3.7 2.4 1.1 6.1 1.8 1.7 1.0 1.3 5.0 0.8 0.0 8.5 0.6 6.8 0.0 2.2 6.9 11.5 1.1 0.7 4.4 2.5 1.4 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 11.8;Rod photoreceptor cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: AB_2675642" "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 6.0 6.3 6.7 4.7 10.2 6.6 8.5 10.2 13.0 7.8 6.8 9.3 2.7 3.4 9.6 6.0 5.5 6.1 4.3 7.1 8.0 5.7 7.3 5.9 5.2 7.2 6.8 9.1 10.8 6.4 10.2 13.5 5.4 9.8 6.9 7.4 8.2 5.8 7.6 10.1 5.0 5.0 9.5 5.8 6.7 5.1 7.2 7.5 6.7 7.6 4.8 7.3 6.9 7.2 6.3 2.6 6.8 2.5 4.7 6.8 3.9 3.9 4.4 4.0 4.8 4.1 6.9 2.4 4.0 3.6 4.1 5.2 3.6 1.0 3.6 5.0 3.8 3.4 1.1 6.9 3.6 5.0 6.8 2.7 4.4 4.7 0.9 4.8 7.2 4.8 4.9 4.0 4.7 8.2 4.3 3.6 6.1 1.8 2.5 4.4 1.4 5.6 1.6 2.3 4.8 1.5 4.6 6.1 4.9 2.6 3.8 5.1 2.7 6.4 2.0 2.0 4.0 4.7 4.9 5.1 5.1 4.4 3.8 4.6 7.3 9.3 10.5 0.0 5.0 3.3 2.7 1.6 6.8 6.5 2.5 5.5 6.3 4.0 5.9 2.6 5.4 6.4 6.8 0.8 4.7 1.4 2.4 4.2 3.9 6.7 10.2 10.2 13.0 8.0 5.7 6.8 9.1 9.8 7.5 8.9 7.4 0.5 1.7 2.4 6.4 7.2 2.5 4.0 3.4 0.0 11.8 1.9 3.3 1.4 1.0 2.5 1.1 0.0 1.4 1.1 2.2 1.6 1.1 1.8 1.4 6.4 1.2 3.1 0.6 0.8 2.3 1.6 0.0 1.0 2.0 3.6 0.4 0.0 1.4 2.1 10.6 0.0 2.5 5.0 3.4 1.4 1.7 1.8 1.7 1.1 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.5;U-266/84: 30.9" HPA065435 Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 9.8 11.7 16.6 8.9 20.2 5.8 12.2 21.1 21.4 12.4 9.1 15.7 7.9 5.5 15.3 21.7 10.0 15.6 11.4 11.4 15.3 11.2 11.1 5.2 9.3 9.3 17.5 11.4 21.3 6.4 12.7 21.0 10.9 15.3 13.4 10.0 13.3 12.8 12.1 7.6 12.6 7.5 9.8 15.6 11.8 10.0 13.8 22.0 8.2 19.9 5.1 11.5 12.6 10.8 10.5 8.4 10.6 5.0 16.5 12.7 3.4 0.1 0.0 2.9 17.7 6.9 8.5 7.5 6.6 10.9 4.0 9.0 0.2 3.3 0.1 1.6 8.1 10.3 2.0 0.0 4.3 5.2 0.0 4.9 2.7 1.0 1.6 10.1 0.1 7.4 8.6 7.6 4.4 0.0 1.2 9.6 0.1 1.7 0.3 5.8 0.1 9.9 1.4 7.7 0.1 4.7 0.1 12.0 3.1 5.0 24.5 12.3 10.2 0.0 0.5 4.1 11.1 11.8 1.5 11.0 7.0 8.1 2.7 8.9 0.3 30.9 6.0 3.5 0.1 10.9 7.1 5.0 10.6 6.7 4.7 12.7 7.3 8.1 10.0 5.0 10.5 8.0 7.1 1.4 16.5 5.0 8.4 8.9 3.4 16.6 20.2 21.1 21.4 15.3 11.2 17.5 11.4 15.3 22.0 6.0 2.7 2.7 3.5 3.3 18.7 10.9 5.1 10.7 6.8 1.8 13.7 3.5 3.3 4.1 1.1 7.5 2.6 0.0 1.7 4.0 3.0 6.9 8.1 1.0 3.1 20.6 1.2 4.9 3.2 2.9 4.6 4.7 1.7 0.0 4.9 14.1 5.0 7.0 3.9 3.1 21.5 0.0 3.9 13.0 10.4 2.8 2.6 9.6 3.4 3.8 ZNF530 KIAA1508 ENSG00000183647 "Zinc finger protein 530" Q6P9A1 19 57599885-57612722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 7.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEK 293: 37.8;U-266/84: 27.5" HPA045868 Uncertain Approved Vesicles NA NA Vesicles "HPA045868: AB_2679478" "unprognostic (1.57e-1)" "unprognostic (3.02e-3)" "unprognostic (5.65e-2)" "unprognostic (2.90e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (9.69e-3)" "unprognostic (4.98e-3)" "unprognostic (3.19e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.06e-1)" 3.2 3.5 6.3 4.7 6.9 7.0 4.4 12.4 7.1 2.5 2.6 2.6 1.4 2.7 2.9 5.3 2.3 2.0 3.1 11.0 5.1 4.4 3.2 2.3 4.6 7.6 5.8 4.0 2.4 4.1 3.2 2.0 3.4 3.3 4.0 2.3 4.5 3.7 3.9 14.6 4.7 2.6 2.1 4.1 5.4 4.6 3.6 3.5 7.2 2.5 2.7 5.6 3.6 2.5 6.5 3.6 3.5 3.1 5.6 6.5 3.4 3.2 3.0 2.2 1.8 0.1 1.0 3.4 2.0 0.8 3.4 2.0 2.1 0.5 0.4 1.7 0.7 2.1 1.1 1.8 1.5 3.7 0.1 37.8 6.5 5.5 1.2 0.3 2.3 3.1 0.7 0.8 3.2 0.9 1.0 0.7 2.4 0.8 1.6 1.1 1.2 3.3 1.8 3.3 0.2 7.2 0.4 6.9 3.2 0.6 5.6 2.5 2.3 2.4 0.6 0.6 2.0 1.5 3.7 1.0 4.4 2.7 0.9 4.1 7.5 27.5 4.5 2.7 2.6 3.0 1.9 3.1 1.8 6.3 1.9 5.0 6.5 4.3 6.5 3.6 5.8 5.9 4.8 3.5 5.6 2.1 3.5 5.6 3.4 6.3 6.9 12.4 7.1 5.1 4.4 5.8 4.0 3.3 3.5 6.0 1.0 0.0 0.5 1.5 2.9 7.3 2.5 0.0 0.0 0.0 0.0 1.4 1.7 1.7 0.2 2.2 0.4 0.0 2.5 1.1 1.2 1.2 2.3 0.6 1.6 0.0 0.0 1.3 0.3 0.0 0.9 1.1 5.0 1.0 0.0 5.8 1.0 1.1 1.4 0.5 4.3 6.5 1.4 2.3 2.9 1.5 1.1 1.5 0.8 0.8 ZNF534 "FLJ25344, KRBO3" ENSG00000198633 "Zinc finger protein 534" Q76KX8 19 52429187-52452315 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.8;testis: 8.9" "Group enriched" "Detected in some" 4 "Spermatocytes: 3.8;Spermatogonia: 12.0" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "K-562: 1.3;SuSa: 5.2" NA NA "unprognostic (2.66e-1)" "unprognostic (3.35e-1)" "unprognostic (2.35e-1)" "unprognostic (2.35e-1)" "unprognostic (7.65e-4)" "unprognostic (7.25e-2)" "unprognostic (9.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.36e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (9.57e-4)" "unprognostic (3.04e-2)" "unprognostic (4.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.80e-2)" 0.3 0.6 1.5 0.3 3.8 0.0 1.2 3.7 2.5 0.3 0.3 0.3 0.3 0.0 0.3 0.7 0.7 0.9 0.3 0.8 1.6 1.6 0.3 0.3 0.5 0.3 0.8 0.3 1.0 0.3 0.0 0.3 0.8 0.3 1.0 0.1 0.3 0.3 0.8 1.4 0.2 0.3 0.3 1.1 0.3 0.1 8.9 0.3 0.3 1.9 2.0 0.3 0.3 0.3 0.2 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.5 0.4 0.1 0.0 0.0 0.0 5.2 0.0 0.6 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 1.2 0.2 0.0 0.0 0.1 0.0 1.5 3.8 3.7 1.6 1.6 1.6 0.8 0.3 0.3 0.3 0.0 0.0 0.0 0.7 0.3 0.8 1.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.5 0.0 0.4 3.8 12.0 0.4 0.0 0.0 0.0 0.1 ZNF547 FLJ31100 ENSG00000152433 "Zinc finger protein 547" Q8IVP9 19 57363477-57379565 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 5.9;granulocytes: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 12.4" HPA056001 Uncertain NA NA "HPA056001: AB_2683005" "unprognostic (9.21e-2)" "unprognostic (6.44e-2)" "unprognostic (1.94e-1)" "unprognostic (4.33e-3)" "unprognostic (1.85e-1)" "unprognostic (4.97e-3)" "unprognostic (3.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.29e-1)" "unprognostic (5.23e-3)" "unprognostic (4.39e-5)" "unprognostic (7.16e-4)" "unprognostic (4.45e-3)" "unprognostic (1.69e-1)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (6.62e-4)" 6.6 9.0 7.6 5.5 10.3 3.1 8.9 21.3 9.0 4.6 5.1 3.1 6.2 3.4 4.2 11.7 5.7 5.8 7.1 14.6 9.7 8.9 6.3 4.7 6.3 7.9 6.8 7.6 7.6 7.1 9.9 11.9 9.0 9.7 8.3 5.8 4.4 6.4 9.1 11.9 13.3 5.1 5.7 7.9 10.8 5.3 17.3 4.8 6.5 10.5 8.9 11.4 8.1 4.7 9.4 4.8 5.1 4.8 4.8 5.2 2.6 1.3 1.5 4.5 5.8 5.4 2.4 2.1 3.3 4.2 3.1 8.0 1.5 0.8 3.6 2.1 1.7 1.6 0.9 2.7 1.4 4.8 0.9 12.4 2.5 5.5 3.1 1.6 2.2 5.5 2.5 5.8 1.8 3.9 6.5 1.7 4.0 0.5 0.1 5.3 0.1 3.8 1.5 2.0 0.1 3.6 1.7 5.1 0.9 2.4 5.9 4.2 3.1 2.2 0.6 1.7 3.8 2.4 3.5 5.2 5.7 1.8 2.1 3.0 2.5 1.4 2.2 2.5 1.4 2.9 5.1 3.3 2.5 2.4 4.8 5.2 9.4 3.7 3.5 3.7 5.9 4.8 3.7 2.2 4.8 2.7 4.8 1.9 2.6 7.6 10.3 21.3 9.0 9.7 8.9 6.8 7.6 9.7 4.8 0.0 0.0 0.5 0.7 0.6 1.9 1.6 0.0 1.4 1.2 1.8 5.9 1.4 1.7 0.7 1.7 1.0 0.0 0.0 0.2 0.2 0.4 0.8 6.9 0.8 1.0 0.0 0.0 1.3 0.3 0.4 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 1.1 0.2 1.5 0.0 0.4 2.8 2.7 0.5 2.5 0.0 0.3 0.4 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.6;brain: 22.3;ovary: 11.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 12.2;Ciliated cells: 8.1;Club cells: 9.1;granulocytes: 7.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 22.3" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 14.6" "Cell line enhanced" "Detected in some" "CACO-2: 7.2;HBEC3-KT: 7.7;Hep G2: 12.1;RH-30: 18.0;THP-1: 6.5" HPA060593 Approved Nucleoplasm NA NA Nucleoplasm "HPA060593: AB_2684328" "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.3 0.2 0.5 0.3 0.5 1.0 0.5 22.3 0.5 0.7 0.3 0.0 1.7 0.1 1.6 0.7 3.1 4.2 0.8 0.2 0.4 0.3 2.6 0.1 0.4 0.3 0.4 0.1 11.3 2.6 0.4 1.6 0.8 1.3 0.4 0.1 0.1 1.0 0.1 4.5 0.7 0.2 0.3 0.5 0.3 0.3 3.5 0.0 0.6 0.2 8.7 0.9 0.2 0.2 0.4 14.6 1.2 0.2 0.6 0.2 0.1 1.9 0.3 0.0 3.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.2 0.1 2.4 1.2 0.1 0.0 0.1 0.0 7.7 0.0 0.1 0.0 0.1 3.2 12.1 0.1 0.2 3.8 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 2.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 18.0 1.5 0.0 0.3 0.1 2.9 0.0 0.3 0.0 0.1 3.7 6.5 0.0 0.1 0.1 4.7 0.1 2.1 3.9 0.1 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.6 0.1 14.6 0.1 0.1 0.5 0.5 22.3 0.5 0.4 0.3 0.4 0.1 1.3 0.0 3.0 12.2 0.0 2.3 0.3 2.2 0.4 0.0 8.1 9.1 3.5 2.0 0.4 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.5 1.5 7.0 0.0 0.2 3.2 0.0 1.3 1.2 0.0 0.6 1.4 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.6 4.6 0.0 0.5 5.6 4.7 0.1 0.2 0.8 0.0 1.6 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.1 8.4 6.3 4.7 3.4 3.9 5.0 5.1 6.9 5.1 2.5 7.1 6.9 4.8 3.6 5.0 8.0 5.1 4.8 9.1 4.9 10.2 7.9 2.7 4.5 10.3 10.9 6.2 6.0 5.6 7.6 4.5 4.7 6.6 4.2 12.8 7.5 5.3 7.9 3.1 3.9 3.9 6.2 5.6 6.1 4.2 3.2 9.5 4.8 5.9 5.8 4.3 4.4 3.9 3.5 6.3 7.0 4.4 3.3 8.6 4.1 12.2 9.3 6.8 4.9 5.5 3.5 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 3.0 4.1 8.8 5.9 1.3 8.3 4.5 2.5 5.3 7.9 7.0 0.0 5.2 13.3 6.0 0.8 5.3 4.5 23.3 5.4 3.8 4.0 5.1 8.1 4.0 5.3 15.9 5.2 7.4 7.3 0.0 4.0 6.4 0.0 4.6 6.6 5.2 5.0 3.7 5.3 6.7 6.4 0.0 4.8 15.9 16.4 1.1 4.8 6.4 5.1 6.4 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 48.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA045439: AB_2732520, HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.0 8.3 0.0 0.0 0.0 0.0 0.0 ZNF562 FLJ20079 ENSG00000171466 "Zinc finger protein 562" Q6V9R5 19 9641808-9675086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (2.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (1.62e-1)" "unprognostic (2.02e-2)" "prognostic favorable (4.17e-4)" "unprognostic (4.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.88e-2)" "unprognostic (2.96e-3)" "unprognostic (1.81e-1)" "unprognostic (4.07e-2)" "unprognostic (1.81e-2)" "unprognostic (1.62e-3)" "unprognostic (9.44e-2)" "unprognostic (3.82e-2)" "unprognostic (1.13e-3)" 12.3 11.2 13.9 11.3 15.8 11.6 21.4 20.5 15.2 11.8 15.0 13.5 20.9 9.8 14.6 10.9 26.1 12.0 12.1 11.4 13.4 10.9 11.1 12.2 12.9 10.2 14.9 11.9 13.7 15.5 13.8 22.6 11.1 14.3 13.1 15.0 9.0 15.7 23.4 7.0 12.9 10.6 15.1 16.1 14.0 11.5 6.3 16.8 10.9 11.8 9.4 13.3 16.6 14.5 6.4 8.5 5.5 9.6 6.5 7.9 2.6 8.3 6.6 9.7 17.8 5.8 4.7 0.5 7.9 6.1 8.8 9.1 4.9 4.6 7.5 8.2 6.3 7.5 6.4 11.7 9.7 11.6 8.8 9.2 27.6 6.7 5.1 5.8 10.1 20.6 8.3 7.2 11.1 18.5 5.5 9.3 6.8 13.3 13.4 8.3 4.2 10.0 3.0 12.4 5.5 4.7 3.9 10.6 3.9 4.1 22.2 10.6 6.9 12.8 5.2 6.3 7.9 7.5 8.5 8.7 16.5 5.6 7.5 10.6 11.8 25.9 12.7 2.3 0.6 8.1 4.1 6.2 5.5 7.0 9.6 7.9 6.3 5.6 4.3 8.5 6.4 5.8 7.1 2.4 6.5 9.2 5.1 4.0 2.6 13.9 15.8 20.5 15.2 13.4 10.9 14.9 11.9 14.3 16.8 8.9 21.0 11.3 31.2 5.7 30.2 7.8 22.9 6.7 18.2 24.4 68.7 13.3 16.6 17.2 6.0 12.4 22.9 0.0 7.6 13.8 12.1 31.0 12.7 12.1 10.8 27.0 23.0 16.5 26.6 11.0 11.2 14.8 6.8 11.8 14.8 13.2 18.0 17.3 12.7 6.8 28.1 0.0 9.2 14.2 11.4 8.8 16.2 12.8 15.2 55.8 ZNF563 FLJ34797 ENSG00000188868 "Zinc finger protein 563" Q8TA94 19 12317477-12333720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "Early spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 5.5;T-cells: 11.6" "Cell line enhanced" "Detected in many" "Hep G2: 12.0" HPA042136 Uncertain Approved Vesicles NA NA Vesicles "HPA042136: AB_10795395" "unprognostic (1.40e-1)" "unprognostic (3.61e-1)" "unprognostic (1.02e-1)" "unprognostic (8.81e-2)" "unprognostic (9.88e-2)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (9.16e-4)" "unprognostic (1.02e-2)" "unprognostic (5.38e-2)" "unprognostic (3.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-3)" "unprognostic (9.90e-2)" "unprognostic (2.12e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-2)" 4.6 5.4 5.6 7.7 7.9 2.1 6.9 7.5 6.0 5.5 3.7 3.6 6.2 2.5 4.5 6.2 4.7 5.7 4.1 7.3 6.4 2.2 8.7 17.2 3.6 4.6 4.8 4.8 6.4 4.0 4.9 9.3 2.2 5.4 8.5 4.0 3.8 4.9 7.1 3.5 6.8 4.0 4.3 4.6 4.4 3.2 22.6 7.2 6.1 9.1 2.0 5.1 5.8 6.4 5.5 1.7 1.1 1.4 1.6 11.6 2.6 2.4 0.3 0.9 3.5 3.5 2.3 0.3 2.9 5.5 3.5 5.5 3.0 0.9 5.6 3.0 3.6 4.1 2.0 2.8 6.8 3.3 0.1 0.5 0.8 0.5 12.0 3.1 0.5 3.7 3.9 5.0 3.6 2.4 2.7 0.1 3.1 1.1 1.3 3.2 1.6 3.2 1.2 1.5 1.3 2.3 0.2 2.6 0.2 4.0 3.5 0.9 1.6 0.3 0.7 0.4 4.2 2.3 0.3 0.4 5.5 1.1 6.5 1.8 5.7 4.4 0.4 1.1 0.5 2.0 0.7 1.3 0.8 3.4 1.3 2.0 3.8 5.8 3.1 1.6 5.5 11.6 6.5 1.1 1.6 1.4 1.7 4.5 2.6 5.6 7.9 7.5 6.0 6.4 2.2 4.8 4.8 5.4 7.2 3.0 1.7 2.0 1.6 1.1 7.6 5.2 5.1 5.3 2.3 1.8 0.0 0.4 1.7 4.1 144.2 3.4 1.3 0.0 4.4 0.1 1.3 2.1 0.0 6.7 1.9 4.8 0.0 4.3 2.1 17.6 7.2 1.5 5.0 1.8 2.6 14.3 2.5 3.5 5.3 6.3 3.3 12.9 3.1 12.8 4.3 1.8 0.1 2.1 2.6 0.6 ZNF565 FLJ36991 ENSG00000196357 "Zinc finger protein 565" Q8N9K5 19 36182060-36246257 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 18.7;Late spermatids: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044123 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA044123: AB_10794395" "unprognostic (1.51e-1)" "unprognostic (3.77e-2)" "unprognostic (6.80e-2)" "unprognostic (7.46e-3)" "unprognostic (6.08e-3)" "unprognostic (7.97e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.90e-2)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-3)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (3.35e-2)" "unprognostic (1.55e-3)" "unprognostic (1.93e-4)" 5.9 5.7 12.1 4.2 11.6 7.1 7.1 10.4 12.8 5.7 5.2 16.8 4.8 4.4 7.1 6.5 5.2 6.7 4.8 5.3 8.0 7.7 5.5 6.2 4.6 4.4 17.3 10.1 11.1 5.7 4.9 7.5 4.6 12.1 7.0 5.8 4.1 8.0 5.6 7.8 6.6 4.1 6.2 17.3 4.5 6.1 13.5 14.9 2.3 6.8 3.5 5.7 6.6 8.4 2.1 3.6 13.8 3.7 3.1 4.5 2.3 3.8 5.5 6.6 4.6 10.4 6.9 1.8 3.8 6.3 4.6 7.9 3.2 3.4 2.9 5.0 4.9 2.2 2.3 3.3 2.8 7.3 5.0 1.5 5.3 4.8 4.2 4.4 3.5 3.7 8.1 8.0 3.0 8.0 4.9 5.5 3.4 3.5 3.6 5.6 4.9 4.2 0.9 2.6 8.4 2.6 3.6 3.9 2.9 4.6 5.2 5.3 5.5 3.1 3.6 3.5 4.2 2.5 3.8 4.5 6.6 3.8 4.8 5.5 1.1 1.8 1.9 6.3 2.9 3.2 13.8 3.1 4.8 3.5 3.2 3.8 2.1 4.0 3.4 3.6 2.1 4.5 3.5 1.5 3.1 3.7 1.9 2.0 2.3 12.1 11.6 10.4 12.8 8.0 7.7 17.3 10.1 12.1 14.9 3.0 0.6 0.0 5.2 1.9 3.6 2.5 0.0 4.0 0.0 1.8 5.9 1.1 0.0 2.5 18.7 3.0 0.9 0.0 2.6 1.6 2.5 3.3 0.0 0.8 1.4 1.6 1.2 1.3 2.4 12.4 4.9 1.7 0.0 1.0 1.0 2.4 2.4 0.0 2.5 1.0 4.6 6.5 2.3 10.9 7.3 1.3 1.7 2.2 1.5 3.7 ZNF568 DKFZp686B0797 ENSG00000198453 "Zinc finger protein 568" Q3ZCX4 19 36916329-36998700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024541, HPA052061" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024541: , HPA052061: AB_2681713" "unprognostic (3.62e-2)" "unprognostic (2.73e-1)" "unprognostic (9.97e-2)" "unprognostic (1.99e-3)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (8.64e-2)" "unprognostic (2.65e-2)" "unprognostic (5.83e-5)" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (2.05e-5)" "unprognostic (2.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.06e-3)" "unprognostic (9.98e-3)" 6.9 11.3 11.8 5.6 14.7 5.9 9.2 30.4 13.4 11.3 7.3 10.5 6.3 4.5 12.3 8.1 5.9 10.3 5.6 8.9 11.5 13.0 7.8 5.5 6.9 6.5 15.0 9.8 16.3 6.8 14.4 24.6 8.4 13.7 8.5 5.0 8.1 8.6 9.0 8.5 6.8 5.2 10.6 13.0 9.3 7.0 9.5 16.3 6.4 13.2 7.6 7.0 7.6 7.3 8.7 3.0 12.8 2.3 7.1 10.1 3.1 0.2 4.5 7.4 2.4 6.9 7.7 2.3 6.2 6.2 5.2 7.1 0.2 2.6 0.3 7.4 7.7 3.8 1.2 0.1 3.6 5.4 1.0 5.3 2.3 0.6 0.8 8.8 0.2 5.9 10.0 4.3 5.2 0.1 6.5 2.7 3.3 0.4 0.9 7.6 0.3 1.6 1.2 6.0 0.0 0.3 0.6 5.4 2.4 4.9 9.8 7.3 9.4 0.3 0.2 5.5 7.5 6.0 1.0 5.2 3.6 10.2 5.8 4.2 8.7 10.6 5.4 0.2 0.2 11.3 12.8 1.9 6.5 8.4 1.5 7.6 8.7 7.9 7.0 3.0 7.6 10.1 8.0 1.6 7.1 2.3 2.9 6.7 3.1 11.8 14.7 30.4 13.4 11.5 13.0 15.0 9.8 13.7 16.3 3.0 6.5 2.2 2.8 4.5 17.6 5.0 5.1 6.7 2.3 8.7 13.7 4.3 3.3 6.1 21.7 6.0 0.4 0.0 3.3 3.3 6.4 3.4 16.1 1.0 3.0 38.1 0.0 4.9 1.0 14.8 6.1 3.5 1.7 3.6 1.1 8.1 2.2 0.0 9.2 4.0 16.4 6.5 5.7 9.9 12.4 3.6 2.4 6.7 1.2 2.4 ZNF57 ZNF424 ENSG00000171970 "Zinc finger protein 57" Q68EA5 19 2900898-2918476 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 74.9;Late spermatids: 28.7;Suprabasal keratinocytes: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA061915 Approved Nucleoli NA NA Nucleoli "HPA061915: AB_2684635" "unprognostic (3.59e-2)" "unprognostic (1.53e-3)" "unprognostic (1.91e-2)" "unprognostic (8.86e-3)" "unprognostic (3.32e-2)" "unprognostic (3.07e-2)" "unprognostic (7.66e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.35e-1)" "unprognostic (4.04e-2)" "prognostic favorable (7.72e-4)" "unprognostic (2.34e-3)" "prognostic favorable (4.11e-9)" "unprognostic (6.26e-3)" "unprognostic (2.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.49e-3)" 3.6 2.9 3.6 3.2 4.7 4.0 7.3 17.2 5.7 6.2 15.7 2.3 5.1 7.8 5.6 4.2 11.0 4.7 4.0 4.2 3.3 2.7 9.2 3.9 4.9 2.9 2.6 3.2 5.4 7.4 3.9 4.1 5.8 4.2 6.1 10.1 3.6 5.5 8.7 7.4 18.6 18.5 2.1 2.4 3.6 11.7 26.4 3.9 2.9 5.4 7.0 6.6 5.0 7.9 4.9 3.6 1.4 5.8 6.3 8.4 4.1 6.7 3.2 4.4 6.4 4.3 3.7 7.4 2.9 2.3 4.6 4.8 6.5 2.6 5.7 3.7 2.3 6.7 7.9 7.0 9.9 5.8 0.0 3.6 3.3 3.7 8.6 3.3 0.0 6.3 2.9 11.1 4.1 8.8 3.8 3.5 13.8 5.8 0.1 3.6 6.8 8.6 3.7 2.9 8.0 5.6 8.0 13.5 1.3 6.3 11.1 2.2 3.3 4.2 7.9 2.7 6.5 4.9 5.5 2.7 3.2 3.1 7.3 4.0 1.2 6.5 2.8 2.6 0.9 2.5 0.0 3.3 1.4 6.5 5.8 5.4 4.9 7.1 6.7 3.6 4.9 8.4 7.4 1.2 6.3 3.1 3.4 7.1 4.1 3.6 4.7 17.2 5.7 3.3 2.7 2.6 3.2 4.2 3.9 0.0 4.0 0.0 17.8 19.1 1.9 2.5 2.5 4.0 10.3 0.0 5.9 3.6 3.3 2.8 74.9 1.4 11.8 0.0 2.0 3.4 2.5 3.4 0.0 1.6 1.9 1.6 0.0 1.8 1.0 28.7 2.3 1.9 5.0 1.8 5.0 1.6 1.4 7.0 2.8 2.4 2.6 0.0 3.9 4.1 11.5 25.1 5.5 0.0 6.0 8.9 ZNF570 FLJ30791 ENSG00000171827 "Zinc finger protein 570" Q96NI8 19 37467585-37488652 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 40.9;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028881 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA028881: AB_10603938" "unprognostic (2.93e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-2)" "unprognostic (1.24e-1)" "unprognostic (1.70e-2)" "unprognostic (1.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (6.54e-2)" "unprognostic (4.59e-2)" "prognostic favorable (4.06e-5)" "unprognostic (5.30e-2)" "unprognostic (2.85e-2)" "unprognostic (3.12e-2)" "unprognostic (2.20e-3)" 7.4 5.8 7.6 3.7 8.8 4.3 6.7 8.2 9.8 6.1 4.7 6.7 3.0 4.4 7.1 4.9 5.2 4.9 5.0 5.4 6.6 5.7 6.7 4.0 4.6 5.6 9.3 6.2 8.3 4.5 13.6 8.0 4.8 8.3 6.8 2.9 4.5 5.0 5.3 4.9 4.1 4.0 5.4 9.0 6.9 4.7 14.7 10.0 7.2 7.5 4.9 5.4 5.7 7.8 3.7 2.0 3.9 3.3 4.7 5.6 2.3 1.9 2.7 3.7 10.9 5.0 6.3 1.8 3.9 2.0 3.7 5.0 0.0 0.8 0.5 5.2 2.8 2.2 0.4 3.1 2.4 4.5 2.2 2.2 2.5 0.3 1.2 3.4 0.2 5.5 5.3 2.2 2.5 0.1 3.4 3.6 4.4 0.4 0.2 3.8 0.8 6.1 1.9 2.4 0.1 1.1 1.1 3.8 2.0 3.0 3.1 3.4 7.0 0.0 0.1 1.2 4.8 2.2 2.8 1.8 1.5 2.8 2.4 2.7 6.1 5.3 2.8 0.0 0.3 2.9 1.4 1.9 2.3 3.6 3.3 2.9 3.6 5.6 2.4 1.9 3.7 5.0 5.0 3.9 4.7 1.4 2.0 3.4 2.3 7.6 8.8 8.2 9.8 6.6 5.7 9.3 6.2 8.3 10.0 6.0 0.3 2.2 1.7 1.4 5.9 10.9 5.1 5.3 4.5 1.8 9.8 2.1 8.3 4.6 40.9 4.3 1.0 0.0 3.3 6.2 3.0 1.7 5.8 2.1 2.8 30.2 5.8 5.5 3.2 5.4 4.6 2.5 5.0 1.8 1.5 6.2 2.7 0.0 9.2 3.5 6.6 0.0 3.6 10.2 7.2 0.4 1.1 4.3 2.1 0.9 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 26.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 6.2 6.4 7.3 4.2 8.6 7.2 7.6 14.1 9.5 6.3 4.6 8.6 5.2 4.3 7.5 10.8 4.8 5.0 6.8 5.3 5.8 4.1 5.3 4.2 6.0 4.1 10.0 5.7 8.4 6.8 6.7 11.7 5.7 6.2 5.5 4.9 5.9 6.4 5.6 5.3 7.8 5.3 6.9 6.8 5.3 7.5 10.0 9.5 4.5 9.8 4.0 6.2 7.4 6.2 6.3 3.3 3.3 2.6 3.6 5.7 1.0 1.0 3.7 2.8 2.4 1.4 3.4 1.2 2.3 2.8 0.9 2.2 3.6 2.8 3.5 2.3 2.1 1.1 2.2 2.8 3.9 3.5 1.8 1.9 4.1 5.5 1.8 1.4 3.3 2.7 3.1 1.4 4.9 2.1 1.9 2.8 2.1 1.8 1.7 0.7 1.4 2.7 2.0 4.6 1.1 0.4 2.8 5.7 1.2 0.2 1.6 3.8 3.7 4.7 1.6 0.4 1.8 3.5 3.1 1.0 3.2 3.4 2.8 3.9 4.2 5.4 5.7 0.8 0.4 2.7 3.2 1.0 3.3 4.2 1.2 3.4 3.4 3.5 4.5 1.9 6.3 5.7 4.4 0.4 3.6 2.6 3.3 2.0 1.0 7.3 8.6 14.1 9.5 5.8 4.1 10.0 5.7 6.2 9.5 0.0 4.6 2.7 1.9 1.5 14.0 9.6 2.5 2.7 1.2 3.5 11.8 3.0 1.7 2.0 26.5 4.5 1.0 0.0 0.6 2.7 3.3 2.1 0.0 1.5 3.2 15.9 1.2 1.8 1.0 13.1 8.1 1.7 3.3 1.0 1.4 8.1 1.1 0.0 6.0 1.9 10.6 0.0 2.8 5.2 8.2 2.3 1.4 4.3 2.4 1.1 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 33.2;Early spermatids: 47.8;Late spermatids: 35.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041499: AB_2677516, HPA046761: AB_2679791" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favorable (2.03e-4)" 7.9 6.8 13.4 5.8 15.5 4.2 13.9 14.6 12.1 10.2 10.9 9.9 15.5 5.1 12.3 11.1 6.3 10.0 8.9 8.0 14.8 5.6 11.0 5.5 6.8 5.6 7.6 8.7 27.2 7.1 17.4 7.5 10.1 9.9 17.4 7.6 17.2 12.9 16.1 9.4 22.3 8.1 14.4 11.0 10.1 7.1 22.5 14.9 3.8 16.3 5.2 6.3 8.8 10.2 9.4 3.2 7.1 4.0 4.6 4.6 1.8 1.2 0.1 6.6 8.1 11.4 12.4 0.0 7.7 2.9 3.0 6.1 0.8 1.0 1.3 0.8 3.5 4.4 2.1 2.6 1.6 1.6 0.0 7.6 12.7 0.1 1.1 8.8 2.8 4.3 9.6 5.0 4.4 1.3 9.5 1.5 0.0 2.7 0.0 3.8 0.0 7.8 3.6 7.6 0.0 0.2 3.4 3.3 2.3 4.9 2.9 2.7 1.4 1.9 0.9 6.5 7.0 1.3 3.1 1.0 5.5 7.7 1.6 2.7 5.4 0.0 1.7 1.5 0.5 8.9 7.1 2.6 5.7 1.7 4.0 4.6 9.4 3.0 3.6 2.8 5.1 3.8 2.4 1.2 4.6 3.0 3.2 1.4 1.8 13.4 15.5 14.6 12.1 14.8 5.6 7.6 8.7 9.9 14.9 0.0 1.6 6.7 3.0 3.9 11.1 7.8 5.1 1.4 1.2 17.4 9.8 6.0 33.2 3.1 47.8 6.0 2.7 0.0 1.0 4.5 5.5 6.1 4.7 1.5 4.7 6.4 2.9 4.3 2.4 35.6 7.5 5.1 0.0 5.4 5.0 14.0 1.2 0.0 12.0 4.2 9.3 0.0 6.6 10.7 14.4 4.5 3.8 2.5 4.2 2.1 ZNF582 FLJ30927 ENSG00000018869 "Zinc finger protein 582" Q96NG8 19 56375846-56393545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 11.6;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 24.3" "Low region specificity" "Detected in all" HPA028858 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA028858: AB_10603247" "unprognostic (1.19e-3)" "unprognostic (9.86e-4)" "unprognostic (3.88e-1)" "unprognostic (3.46e-2)" "unprognostic (4.08e-3)" "unprognostic (1.04e-2)" "unprognostic (2.12e-2)" "unprognostic (6.05e-2)" "unprognostic (3.10e-2)" "unprognostic (4.12e-2)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (2.02e-7)" "unprognostic (3.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.54e-2)" "unprognostic (5.00e-3)" 4.8 8.7 7.7 4.7 8.9 2.7 6.3 9.4 9.0 4.7 4.9 7.8 3.6 2.3 7.9 13.5 4.8 6.1 6.4 8.0 8.2 7.1 5.9 4.8 5.2 8.0 9.6 3.9 10.2 4.0 7.5 11.4 5.4 8.9 8.4 2.7 4.4 4.1 5.5 3.5 5.6 3.3 5.5 7.7 7.2 3.4 8.9 13.1 7.8 13.8 2.2 3.7 5.4 5.9 5.9 3.4 5.9 3.3 11.0 6.5 2.8 0.0 1.1 6.1 1.2 1.5 1.6 0.0 2.4 2.6 1.6 1.3 0.0 0.3 0.0 1.6 1.4 3.5 0.0 0.8 0.3 1.3 0.0 24.3 5.8 0.0 0.4 2.6 1.6 4.7 5.4 1.3 1.0 0.0 1.5 1.0 0.6 1.3 0.0 1.0 0.0 3.4 3.7 3.3 0.0 0.0 1.6 2.1 2.1 1.3 3.3 0.0 3.9 0.0 0.8 0.0 4.7 2.7 3.2 1.0 3.2 6.4 0.8 3.3 5.2 5.6 3.7 0.2 0.4 1.8 4.3 2.2 5.9 4.4 3.3 6.5 5.9 5.2 4.4 3.3 4.3 3.8 4.8 0.5 11.0 2.4 3.4 1.6 2.8 7.7 8.9 9.4 9.0 8.2 7.1 9.6 3.9 8.9 13.1 0.0 0.0 5.2 2.1 1.1 3.3 2.7 0.0 1.4 1.2 7.0 2.0 2.1 11.6 2.4 0.7 5.3 0.0 0.0 0.6 0.6 2.6 3.3 8.1 2.1 2.5 1.6 0.0 1.8 1.0 0.4 2.0 2.9 3.3 1.8 0.6 8.0 1.0 0.0 3.9 3.3 5.7 12.9 2.1 1.8 5.7 0.9 3.0 2.5 0.6 1.7 ZNF583 FLJ31030 ENSG00000198440 "Zinc finger protein 583" Q96ND8 19 56397966-56436035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 53.6;Late spermatids: 29.3;Spermatocytes: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 14.0" "Low region specificity" "Detected in all" "HPA023805, HPA023957" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023805: AB_2671318, HPA023957: AB_2671383" "unprognostic (9.89e-3)" "unprognostic (5.52e-3)" "unprognostic (8.14e-2)" "unprognostic (2.89e-2)" "unprognostic (1.15e-1)" "unprognostic (6.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "unprognostic (2.31e-2)" "unprognostic (1.79e-2)" "unprognostic (8.43e-3)" "unprognostic (5.00e-2)" "unprognostic (9.54e-5)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" 7.2 5.9 7.9 3.9 9.3 2.3 4.7 11.6 12.4 5.6 4.6 5.6 3.7 3.2 6.1 5.5 3.6 5.8 5.4 5.0 7.7 7.3 6.6 5.9 6.6 4.5 7.5 6.3 11.2 5.9 7.3 8.4 4.7 8.3 6.0 3.5 3.3 2.6 4.7 4.8 2.1 3.1 6.2 7.6 5.4 3.9 15.8 7.6 5.0 7.9 2.1 4.1 4.4 5.7 6.3 3.5 9.4 4.7 9.2 7.4 2.8 0.0 2.0 4.7 0.0 3.3 2.7 0.0 5.8 5.9 2.7 2.2 0.2 0.6 4.3 2.9 5.3 5.0 0.3 1.9 1.8 2.9 2.0 10.2 5.7 0.0 1.0 3.8 4.7 5.2 3.7 2.9 3.9 1.9 4.0 2.6 4.5 2.1 1.6 8.8 0.0 5.8 1.6 1.2 0.0 1.9 2.9 8.9 3.2 2.1 4.2 2.7 4.1 0.0 0.5 1.5 2.5 2.9 6.1 1.8 14.0 3.8 2.7 11.4 6.0 11.0 6.8 0.3 1.3 4.9 9.4 2.2 4.7 4.9 3.2 7.2 6.3 4.0 4.5 2.5 5.5 7.4 4.4 1.0 9.2 4.7 3.5 4.9 2.8 7.9 9.3 11.6 12.4 7.7 7.3 7.5 6.3 8.3 7.6 3.0 1.0 3.2 3.1 1.5 16.1 4.4 0.0 1.4 0.0 1.8 5.9 1.4 8.3 5.1 53.6 5.5 0.4 0.0 2.4 0.4 5.0 2.5 10.4 1.6 3.4 9.5 0.0 6.2 4.0 29.3 6.4 3.5 3.3 1.8 1.5 10.2 2.3 1.5 12.7 4.8 14.3 6.5 5.3 25.1 12.8 1.5 0.9 8.5 1.7 1.4 ZNF584 FLJ39899 ENSG00000171574 "Zinc finger protein 584" Q8IVC4 19 58401504-58418327 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 31.4" "Low region specificity" "Detected in all" "HPA043408, HPA048075" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA043408: AB_2678466, HPA048075: AB_2680251" "unprognostic (6.06e-2)" "unprognostic (3.27e-3)" "unprognostic (3.76e-3)" "unprognostic (8.15e-3)" "unprognostic (5.50e-2)" "unprognostic (1.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-2)" "unprognostic (6.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.01e-3)" "unprognostic (1.90e-3)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.80e-1)" "unprognostic (3.27e-1)" "unprognostic (1.36e-2)" 10.4 9.3 7.3 7.4 11.7 3.3 11.7 16.6 12.1 10.6 8.6 9.5 6.4 7.4 10.5 8.2 9.2 13.8 10.5 13.3 7.6 9.6 10.4 13.4 7.9 6.7 7.2 5.0 11.9 13.1 13.6 11.6 5.8 7.9 8.6 5.5 10.8 7.6 13.0 13.3 11.7 4.6 10.9 6.2 6.4 8.1 6.3 7.8 6.6 11.5 10.3 6.7 8.7 16.6 4.4 5.0 1.2 4.5 4.1 8.4 3.9 7.0 10.3 7.1 9.2 6.9 7.0 2.9 5.6 9.9 3.4 4.2 1.7 2.0 3.4 4.5 9.0 9.1 4.0 7.6 9.1 3.9 4.6 31.4 9.5 5.9 2.0 11.9 10.4 2.6 7.1 6.6 10.5 14.7 7.6 6.8 5.9 9.4 3.2 5.6 5.0 8.6 3.2 1.7 4.6 14.6 6.3 5.3 5.4 4.8 8.3 5.7 6.0 12.1 3.4 4.7 1.9 2.2 5.2 4.2 13.6 4.1 5.6 8.7 3.2 5.6 0.7 9.8 3.6 4.4 0.0 3.2 1.2 5.0 3.1 8.4 3.3 6.8 7.2 5.0 4.4 3.8 5.7 1.0 4.1 4.5 4.4 7.2 3.9 7.3 11.7 16.6 12.1 7.6 9.6 7.2 5.0 7.9 7.8 3.0 3.8 0.5 2.3 10.0 3.9 11.7 2.5 6.7 1.2 8.7 3.9 0.9 11.6 4.4 8.2 3.6 1.4 0.0 4.4 1.2 4.3 2.3 2.3 4.9 2.4 3.2 6.4 5.5 3.1 4.6 4.9 1.4 1.7 1.0 1.7 5.8 3.9 2.9 6.0 5.0 8.9 6.5 6.2 7.2 3.9 13.9 0.3 4.9 3.0 1.1 ZNF585A FLJ23765 ENSG00000196967 "Zinc finger protein 585A" Q6P3V2 19 37106734-37172741 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 30.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (3.22e-2)" "unprognostic (1.50e-2)" "unprognostic (3.01e-2)" "unprognostic (4.12e-2)" "unprognostic (6.36e-4)" "unprognostic (1.65e-1)" "unprognostic (3.41e-2)" "unprognostic (3.71e-2)" "unprognostic (3.53e-2)" "unprognostic (1.76e-1)" "unprognostic (2.37e-2)" "unprognostic (3.45e-1)" "unprognostic (9.34e-3)" "unprognostic (1.20e-1)" "unprognostic (1.58e-2)" 12.4 17.6 12.5 10.3 20.6 8.1 19.5 21.4 14.2 13.7 12.0 13.3 10.7 11.7 9.9 14.8 14.8 11.6 10.4 13.1 13.1 9.8 17.6 11.5 11.1 17.4 22.5 8.9 12.8 13.8 18.1 24.6 15.7 12.2 11.6 12.3 10.8 13.4 9.2 11.2 12.1 13.6 10.5 15.4 15.5 13.5 13.4 17.8 14.1 20.2 9.8 14.5 13.2 13.1 14.6 14.3 32.7 11.8 14.7 22.5 10.2 5.6 4.4 6.9 8.5 8.6 7.5 5.3 5.3 11.4 10.4 11.7 3.5 5.5 0.9 13.0 9.5 11.4 2.1 3.3 8.9 9.6 6.5 4.4 3.8 4.1 4.0 21.0 0.0 8.6 12.4 8.7 8.6 2.8 9.1 4.8 1.0 2.2 0.0 7.8 5.1 7.9 4.3 7.8 7.8 4.1 0.0 7.5 10.9 7.4 8.1 4.4 9.0 7.4 3.4 9.2 10.3 6.1 4.2 1.5 3.6 4.8 5.4 13.4 23.1 19.7 10.7 0.3 1.5 11.3 28.7 10.2 32.7 15.8 11.8 17.2 14.6 16.9 18.3 9.1 14.4 18.0 17.6 20.7 14.7 10.0 14.3 22.5 10.2 12.5 20.6 21.4 14.2 13.1 9.8 22.5 8.9 12.2 17.8 6.0 4.8 2.2 1.2 1.1 22.1 12.2 7.6 13.4 4.5 3.5 15.7 3.5 1.7 2.5 30.3 3.0 2.0 0.0 0.7 2.6 3.3 2.0 18.5 1.6 3.1 23.8 2.9 7.4 3.1 10.5 3.7 3.1 0.0 4.6 3.6 12.2 1.9 5.8 4.6 2.4 13.1 0.0 3.3 13.2 4.8 1.4 2.9 3.5 2.3 0.9 ZNF585B "FLJ14928, SZFP41" ENSG00000245680 "Zinc finger protein 585B" Q52M93 19 37181579-37218153 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA075556 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA075556: AB_2686757" "unprognostic (9.53e-3)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.30e-2)" "unprognostic (9.52e-2)" "unprognostic (2.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.13e-1)" "unprognostic (3.11e-2)" "unprognostic (5.01e-2)" "unprognostic (3.56e-2)" "unprognostic (2.58e-1)" "unprognostic (3.26e-2)" "unprognostic (4.59e-2)" "unprognostic (2.79e-1)" "unprognostic (6.41e-2)" "unprognostic (4.18e-3)" 6.6 8.3 11.2 5.8 13.4 2.6 9.3 17.9 12.9 10.0 8.1 8.7 11.4 5.6 11.6 15.2 5.8 8.8 7.5 7.2 9.8 10.0 8.7 5.2 6.2 7.3 14.1 9.8 15.0 6.2 23.4 22.6 8.0 10.1 8.9 7.2 8.3 6.3 11.6 5.0 6.3 7.2 10.1 12.3 9.7 7.6 9.2 12.4 9.5 13.1 5.6 9.1 9.3 7.2 6.5 1.9 3.7 4.2 2.9 7.1 2.9 2.4 4.2 3.8 7.5 6.3 9.9 2.1 3.2 5.2 5.9 8.9 2.3 3.1 0.1 6.9 4.2 4.2 0.7 0.1 5.0 7.4 4.9 1.9 3.2 5.5 1.2 6.1 0.3 6.8 7.7 3.0 6.7 3.5 4.7 2.4 0.4 0.0 0.2 3.5 1.5 5.6 2.1 4.2 1.2 1.2 0.2 2.1 0.1 3.2 10.0 6.7 4.3 0.0 0.3 1.5 5.1 2.9 3.5 2.0 0.6 1.4 5.0 3.8 5.7 7.5 6.9 0.3 0.1 6.5 3.3 1.6 3.7 5.0 3.1 6.3 6.5 3.6 4.4 1.9 4.9 5.2 7.1 2.5 2.9 4.2 1.7 3.5 2.9 11.2 13.4 17.9 12.9 9.8 10.0 14.1 9.8 10.1 12.4 6.0 6.4 1.4 1.6 1.4 6.1 5.0 7.6 8.1 12.5 12.2 2.0 2.3 1.7 2.5 13.5 3.3 2.8 0.0 1.7 2.1 2.6 1.9 6.9 1.7 3.0 3.2 0.0 2.5 3.3 5.9 3.7 2.2 1.7 1.0 3.3 3.7 2.0 2.0 6.3 3.0 3.9 0.0 3.3 4.1 4.3 1.4 2.6 3.2 2.5 2.1 ZNF586 FLJ20070 ENSG00000083828 "Zinc finger protein 586" Q9NXT0 19 57769655-57819939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 24.6" "HPA030306, HPA060782" Approved Approved "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" Vesicles "HPA030306: AB_2673423, HPA060782: AB_2684362" "prognostic favorable (9.83e-5)" "unprognostic (1.60e-2)" "unprognostic (2.93e-1)" "unprognostic (1.72e-3)" "unprognostic (2.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.10e-2)" "unprognostic (1.02e-3)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (1.88e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (6.01e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.36e-4)" 7.6 6.9 11.7 12.3 11.7 27.3 10.6 22.4 13.8 8.5 7.7 6.6 14.7 7.9 9.1 10.0 10.8 8.9 9.2 10.0 11.8 4.4 8.5 7.8 16.5 16.2 9.3 8.7 13.9 8.4 6.6 13.4 9.0 8.4 13.5 8.1 9.8 14.3 18.4 33.3 12.4 10.2 7.7 8.7 16.2 9.8 7.0 13.0 11.6 10.7 8.8 12.2 12.0 11.5 7.2 6.1 20.8 6.6 6.3 10.0 5.2 5.0 4.5 6.1 7.2 3.1 2.8 10.2 3.6 3.6 5.1 2.6 2.0 5.2 10.8 0.4 3.3 4.8 3.8 1.1 4.8 9.2 1.6 24.6 8.5 10.1 1.3 5.3 8.0 7.7 4.5 5.7 3.6 5.6 5.9 5.9 11.2 5.4 0.6 5.8 1.7 8.2 5.7 9.1 3.3 11.8 8.3 2.3 13.6 5.8 13.3 8.9 4.1 1.7 5.2 3.9 5.7 5.4 6.3 3.3 6.8 3.7 0.3 6.0 12.1 15.0 11.4 3.7 0.9 4.8 4.4 6.6 20.5 6.1 5.5 5.9 5.2 7.9 6.5 6.1 7.2 10.0 9.0 20.8 6.3 3.6 4.7 9.9 5.2 11.7 11.7 22.4 13.8 11.8 4.4 9.3 8.7 8.4 13.0 0.0 1.0 12.3 7.2 10.8 3.2 4.6 0.0 0.0 1.2 3.5 0.0 5.8 8.3 2.4 0.2 5.5 2.7 0.0 1.7 6.1 4.5 3.2 3.5 2.5 4.7 6.4 2.9 3.7 8.6 0.8 0.9 6.3 3.3 6.4 3.2 2.9 2.0 0.0 2.5 4.5 4.9 6.5 2.6 4.9 6.8 9.9 8.4 8.7 3.8 7.0 ZNF594 KIAA1871 ENSG00000180626 "Zinc finger protein 594" Q96JF6 17 5179536-5191883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA060283, HPA067178, HPA069360, HPA074493, HPA077596" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: " "unprognostic (6.67e-2)" "unprognostic (1.07e-2)" "unprognostic (6.93e-2)" "unprognostic (7.92e-3)" "unprognostic (1.11e-1)" "unprognostic (8.24e-3)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (6.67e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-5)" "unprognostic (4.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.99e-1)" "unprognostic (5.21e-2)" "unprognostic (6.59e-2)" 4.0 6.2 11.8 8.4 11.2 1.3 8.8 13.8 13.4 7.5 6.3 8.0 5.3 3.1 9.3 8.4 4.2 8.3 4.2 4.9 8.9 5.9 6.7 3.8 4.1 10.1 13.6 6.6 19.8 6.0 15.3 15.9 5.8 9.2 9.6 5.1 6.0 6.5 10.2 6.7 3.8 6.8 6.0 8.3 8.4 5.2 7.8 11.1 11.9 10.2 2.1 10.2 6.6 5.6 5.9 4.5 1.1 1.0 2.4 5.2 1.0 5.5 2.5 10.7 8.3 1.7 1.9 8.9 3.8 1.9 6.8 6.5 7.0 2.0 12.6 6.0 3.0 5.0 6.2 6.8 0.2 8.7 6.7 6.9 4.1 8.8 3.5 2.4 0.0 4.1 1.4 1.1 4.0 0.0 1.8 0.7 7.5 1.6 3.2 2.3 5.3 3.4 1.7 4.8 0.9 3.4 7.3 9.0 1.7 1.9 1.5 6.3 8.4 2.9 1.5 5.7 4.9 3.4 3.0 0.1 0.1 3.8 3.4 2.7 2.1 4.1 3.0 0.6 0.0 4.1 0.4 0.8 1.1 3.2 1.0 2.3 3.5 3.3 2.9 1.0 5.9 5.2 3.4 0.4 2.4 0.9 4.5 4.4 1.0 11.8 11.2 13.8 13.4 8.9 5.9 13.6 6.6 9.2 11.1 6.0 3.8 1.4 1.2 1.0 9.4 4.2 7.6 6.7 4.5 5.2 5.9 1.0 6.6 1.3 0.6 1.0 0.0 0.0 1.0 0.6 0.9 0.8 3.5 0.8 0.8 14.3 1.2 3.7 2.2 2.6 3.1 0.0 0.0 1.8 0.9 8.2 0.7 1.1 2.5 0.6 9.8 0.0 1.0 2.3 3.8 0.3 0.2 0.8 1.2 0.4 ZNF596 ENSG00000172748 "Zinc finger protein 596" Q8TC21 8 232137-264703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.0" "Low region specificity" "Detected in all" HPA055463 Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA055463: AB_2682821" "unprognostic (3.30e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.90e-1)" "unprognostic (9.07e-3)" "unprognostic (9.68e-3)" "unprognostic (2.10e-3)" "unprognostic (1.74e-1)" "unprognostic (4.84e-1)" "unprognostic (1.70e-5)" "unprognostic (6.37e-2)" "unprognostic (1.20e-1)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "unprognostic (3.51e-1)" "unprognostic (4.53e-1)" 4.9 6.2 6.3 9.9 7.4 2.6 8.5 18.2 10.1 6.7 4.4 8.3 8.3 4.3 10.4 11.9 4.7 6.7 6.3 5.1 7.5 7.0 6.1 5.3 4.8 5.3 6.8 7.3 7.8 7.1 13.5 10.9 5.5 6.2 6.1 5.3 6.6 4.2 9.4 10.2 6.7 4.1 7.7 7.8 6.8 5.4 22.4 7.8 7.4 9.2 4.2 4.4 4.5 4.8 6.8 4.4 6.4 5.0 2.9 7.3 2.6 1.8 1.1 5.5 14.0 2.9 2.7 4.6 4.2 1.9 1.7 2.9 1.4 2.3 1.8 1.4 3.4 2.3 3.6 1.5 3.3 2.1 1.4 2.1 3.9 3.4 1.3 3.2 1.7 1.9 6.2 0.5 1.9 3.0 2.7 1.3 6.1 2.4 6.0 9.8 5.9 4.3 1.6 2.9 3.6 1.3 2.0 1.2 3.3 5.5 3.3 3.1 8.3 2.8 1.4 2.0 2.9 4.2 5.1 3.3 4.1 1.2 0.3 1.8 2.1 5.3 2.2 4.9 1.5 2.6 6.4 2.8 4.5 4.8 2.3 6.7 6.4 5.2 4.2 3.6 6.8 6.2 7.3 3.1 2.9 5.0 4.4 5.6 2.6 6.3 7.4 18.2 10.1 7.5 7.0 6.8 7.3 6.2 7.8 3.0 2.4 0.0 0.7 0.3 8.1 2.8 0.0 5.3 2.3 1.8 2.0 1.8 3.3 1.5 35.2 2.2 1.0 0.0 1.5 1.2 1.1 0.6 4.7 0.9 0.9 11.1 0.0 3.1 0.6 11.0 3.7 0.5 0.0 0.0 1.5 4.0 1.1 0.0 1.1 1.6 8.5 0.0 0.9 10.2 3.9 0.4 1.3 0.8 1.2 0.1 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918308-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061970: AB_2684649, HPA062655: AB_2684820" "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 5.5 8.2 10.9 7.6 9.9 3.2 12.2 19.0 12.8 10.1 8.3 8.4 9.5 6.7 10.2 13.1 7.3 9.3 6.6 9.9 10.8 7.9 9.9 8.1 7.6 8.0 7.8 8.2 13.3 8.2 16.9 12.9 10.2 8.1 10.7 6.9 9.9 8.8 9.6 14.6 11.5 8.3 8.2 7.4 7.4 8.7 4.8 9.1 8.5 15.5 6.1 7.5 8.5 9.9 2.6 1.4 1.9 1.2 1.7 3.0 0.8 4.5 3.7 9.6 9.1 5.3 10.9 7.2 6.3 3.6 2.9 2.1 0.6 0.6 1.9 3.4 5.4 3.6 2.5 4.2 1.6 3.6 1.6 7.1 8.7 2.9 2.9 4.0 3.6 9.7 7.0 7.0 2.0 4.5 9.0 2.2 4.6 1.3 0.1 7.3 1.3 4.8 5.1 7.4 1.3 5.1 4.4 6.3 1.3 5.0 7.9 6.2 7.1 2.8 1.7 4.3 5.9 10.4 10.6 4.3 3.7 5.9 5.4 2.5 0.0 0.0 1.6 0.1 3.1 2.1 1.6 1.2 1.3 1.6 0.8 0.9 2.6 1.4 1.7 0.9 2.2 3.0 1.9 1.9 1.7 0.9 1.4 0.4 0.8 10.9 9.9 19.0 12.8 10.8 7.9 7.8 8.2 8.1 9.1 17.9 36.9 2.7 8.2 3.1 33.5 19.9 20.4 21.4 39.8 8.7 27.5 5.6 8.3 5.7 1.5 8.3 4.5 0.0 3.0 3.1 7.6 7.4 9.3 4.3 3.2 38.1 5.8 13.5 6.5 1.3 14.7 3.8 0.0 4.6 9.8 19.8 6.8 0.0 12.7 4.2 36.9 12.9 6.2 5.4 7.3 4.0 4.7 5.0 7.3 6.5 ZNF606 "FLJ14260, KIAA1852, ZNF328" ENSG00000166704 "Zinc finger protein 606" Q8WXB4 19 57977053-58003349 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 29.4;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041712, HPA043584" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041712: AB_10960410, HPA043584: AB_2678565" "unprognostic (1.05e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (6.21e-2)" "unprognostic (1.10e-1)" "unprognostic (6.83e-2)" "unprognostic (3.48e-3)" "unprognostic (4.26e-2)" "unprognostic (1.29e-3)" "unprognostic (4.09e-2)" "unprognostic (1.03e-1)" "unprognostic (5.00e-2)" "unprognostic (3.21e-2)" "unprognostic (4.01e-2)" "prognostic favorable (4.75e-6)" 6.9 7.1 13.0 7.1 12.8 5.5 12.8 18.2 11.6 9.6 7.8 12.8 11.3 8.6 11.1 14.6 6.6 14.0 9.8 6.7 15.0 6.9 9.0 6.9 7.7 11.2 16.9 8.2 14.6 8.3 18.9 18.1 6.7 12.3 12.4 7.2 10.2 11.1 10.0 9.9 11.0 10.3 9.2 10.8 12.9 10.0 8.9 11.7 20.1 17.8 6.3 9.8 9.2 7.7 9.8 7.9 9.1 3.0 6.3 8.5 2.4 1.4 2.6 11.3 9.5 3.4 4.8 8.2 3.4 1.2 3.4 2.1 3.3 4.0 2.2 2.7 2.3 3.7 3.4 1.4 3.3 4.6 0.0 20.2 5.5 0.9 3.1 2.7 0.0 4.5 5.7 1.7 2.9 1.7 5.3 2.4 6.6 2.8 0.1 4.3 1.3 7.3 1.3 6.9 1.7 4.9 8.2 4.2 3.2 3.6 6.9 10.6 7.1 6.1 0.2 2.5 5.7 5.5 5.2 2.8 2.7 4.0 1.1 1.1 6.7 7.2 1.6 0.2 0.6 3.5 9.1 3.0 7.4 3.0 2.4 4.1 8.3 4.8 3.4 2.6 9.8 8.5 4.7 7.8 6.3 2.6 7.9 3.2 2.4 13.0 12.8 18.2 11.6 15.0 6.9 16.9 8.2 12.3 11.7 6.0 5.6 2.7 2.9 0.9 13.6 5.7 0.0 29.4 5.7 12.2 23.6 2.9 3.3 2.6 2.0 4.3 2.0 0.0 1.4 0.8 1.9 4.0 4.7 1.6 1.7 11.1 0.0 6.2 0.8 0.0 7.5 2.0 0.0 1.0 2.6 8.4 1.7 3.1 3.2 1.8 25.5 6.5 2.3 5.9 10.2 1.8 2.9 3.5 2.3 3.0 ZNF610 FLJ36040 ENSG00000167554 "Zinc finger protein 610" Q8N9Z0 19 52336245-52367778 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.7" "HPA055771, HPA078134" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA055771: AB_2682914, HPA078134: AB_2732372" "unprognostic (1.13e-1)" "unprognostic (5.48e-3)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (3.65e-2)" "unprognostic (1.27e-1)" "unprognostic (3.34e-1)" "unprognostic (2.84e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.38e-4)" "unprognostic (5.54e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.05e-7)" "unprognostic (2.46e-2)" "unprognostic (1.11e-2)" "unprognostic (1.88e-2)" "unprognostic (5.73e-3)" 2.3 4.8 7.9 2.1 11.9 0.8 5.5 11.0 9.7 5.5 3.0 6.9 3.3 1.5 5.1 11.7 2.1 7.4 4.3 4.2 7.6 7.7 5.9 1.0 3.3 2.6 7.5 7.2 14.3 2.9 7.5 6.8 4.5 10.0 7.6 2.9 5.7 2.2 4.1 1.9 1.6 1.8 4.4 8.5 4.1 2.7 18.1 7.3 3.6 7.7 0.2 2.1 3.6 2.4 3.6 1.5 4.0 0.5 2.5 4.8 1.6 0.2 0.0 6.0 4.9 4.0 3.4 4.6 1.8 3.3 1.1 3.3 0.0 0.4 0.4 3.7 0.8 7.4 0.2 0.0 0.0 2.8 0.1 2.9 0.1 0.3 0.2 4.8 0.0 1.5 4.6 0.1 1.2 0.2 2.9 3.4 3.3 0.3 0.2 5.4 1.2 3.1 0.9 5.7 0.0 0.4 2.2 4.5 0.6 2.1 4.3 7.5 4.3 0.1 0.4 1.8 8.9 3.6 2.6 2.7 0.3 2.0 0.1 2.3 0.2 11.7 0.0 0.0 0.1 2.3 4.0 0.5 1.1 2.9 0.1 4.4 2.5 2.4 2.3 1.4 3.6 4.8 2.0 1.4 2.5 0.1 1.5 3.2 1.6 7.9 11.9 11.0 9.7 7.6 7.7 7.5 7.2 10.0 7.3 0.0 0.3 0.0 0.8 0.0 2.9 2.6 2.5 2.7 3.4 3.5 3.9 1.2 5.0 1.6 28.1 1.1 0.0 0.0 0.0 1.4 0.8 0.9 2.3 0.0 0.5 0.0 0.0 0.6 0.8 7.0 0.9 0.0 1.7 0.0 0.0 3.8 0.2 0.0 1.1 0.6 2.4 6.5 0.4 5.0 2.3 0.3 0.6 0.0 0.4 0.3 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 25.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 4.7 5.3 7.1 3.9 7.4 1.6 9.5 14.2 7.4 5.3 6.5 5.2 1.9 2.8 5.5 5.3 4.7 4.3 3.7 4.3 9.7 4.7 8.7 4.0 4.9 6.3 7.2 4.9 6.5 3.4 7.4 7.0 8.2 8.8 25.4 6.7 5.4 4.5 5.6 3.9 4.5 4.9 5.8 7.5 6.7 4.2 3.5 7.0 9.0 7.3 2.6 5.2 5.8 4.1 10.1 9.6 14.1 11.3 9.5 14.3 7.0 3.1 4.1 6.8 6.8 5.9 6.8 1.7 5.2 8.4 7.0 9.1 1.3 3.7 2.6 2.8 6.5 6.2 3.5 6.6 6.5 7.6 0.1 8.6 5.5 2.9 3.9 6.1 0.3 7.8 5.0 7.5 6.6 5.4 8.6 7.5 6.5 2.5 0.0 7.0 0.5 9.1 4.0 4.9 1.3 5.9 5.0 7.3 2.8 6.8 10.7 4.6 4.5 8.5 6.2 5.0 11.2 6.5 6.7 4.8 3.1 5.8 2.3 5.6 6.0 0.0 5.1 0.2 0.0 9.2 7.7 7.4 14.1 10.4 7.5 9.3 7.6 11.1 12.1 9.6 10.1 11.2 14.3 7.6 9.5 11.3 4.8 10.0 7.0 7.1 7.4 14.2 7.4 9.7 4.7 7.2 4.9 8.8 7.0 3.0 1.6 0.0 0.5 0.5 2.1 3.1 2.5 0.0 3.4 3.5 0.0 4.9 3.3 2.1 2.0 2.4 1.0 0.0 1.9 1.5 0.9 1.1 1.1 1.5 2.6 0.0 1.2 1.8 1.8 0.4 1.1 1.1 0.0 3.6 2.9 2.2 1.7 2.8 1.4 1.4 4.2 0.0 0.5 1.6 1.1 0.5 5.9 0.9 1.7 0.5 ZNF615 FLJ33710 ENSG00000197619 "Zinc finger protein 615" Q8N8J6 19 51991332-52008230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052422 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA052422: AB_2681825" "unprognostic (2.20e-1)" "unprognostic (4.66e-2)" "unprognostic (4.56e-1)" "unprognostic (2.64e-1)" "unprognostic (4.08e-3)" "unprognostic (7.28e-2)" "unprognostic (5.23e-2)" "unprognostic (3.68e-1)" "unprognostic (4.44e-3)" "unprognostic (2.44e-2)" "unprognostic (4.41e-2)" "unprognostic (4.80e-2)" "unprognostic (1.77e-1)" "unprognostic (8.16e-3)" "unprognostic (3.03e-1)" "unprognostic (1.82e-1)" "prognostic favorable (2.98e-4)" 10.2 7.4 11.9 6.0 16.4 7.5 10.1 20.7 12.2 8.2 8.8 7.3 6.9 5.2 12.0 7.8 6.5 9.8 7.6 8.5 8.5 7.1 9.5 6.1 7.6 6.2 11.7 9.8 15.7 7.5 16.6 17.8 8.3 9.9 26.9 5.8 8.0 7.7 11.0 7.2 7.2 6.0 9.6 12.8 7.9 6.7 5.5 13.6 7.3 11.7 3.8 6.1 11.1 8.8 4.7 4.8 6.9 4.4 12.0 7.8 3.8 1.3 5.2 5.8 11.8 10.6 7.7 4.4 3.9 6.6 5.4 5.6 1.1 1.4 2.1 2.2 4.7 3.4 1.4 4.0 2.5 5.0 0.3 8.9 6.7 5.2 3.9 8.3 0.0 4.0 6.5 2.8 8.5 9.1 10.0 2.9 2.1 0.0 0.0 4.1 0.4 0.0 3.5 6.0 0.2 8.8 4.2 9.1 3.7 3.7 9.1 5.2 4.5 4.8 4.5 3.2 6.4 6.5 3.3 5.2 5.1 5.9 3.3 2.8 4.0 10.4 2.6 3.0 0.0 8.2 6.9 3.0 5.8 3.7 4.4 7.8 3.9 6.6 5.3 4.8 4.7 6.6 4.3 4.1 12.0 2.7 2.9 5.7 3.8 11.9 16.4 20.7 12.2 8.5 7.1 11.7 9.8 9.9 13.6 6.0 4.5 3.2 1.9 2.5 7.1 5.9 2.5 4.0 1.2 3.5 5.9 3.2 3.3 1.6 0.9 2.9 1.1 0.0 1.0 2.2 3.8 5.2 0.0 1.9 2.6 3.2 8.6 3.7 3.3 0.9 2.3 3.2 6.8 1.8 2.6 3.0 1.3 3.7 3.9 2.4 6.2 6.5 5.7 2.6 2.1 3.4 4.2 4.4 2.1 1.8 ZNF616 MGC45556 ENSG00000204611 "Zinc finger protein 616" Q08AN1 19 52113091-52139922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062639, HPA071539" Approved Approved Centrosome NA NA Centrosome "HPA062639: AB_2684815, HPA071539: AB_2686414" "unprognostic (5.98e-3)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (2.58e-2)" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (4.78e-3)" "unprognostic (1.97e-1)" "unprognostic (1.19e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (3.01e-2)" "unprognostic (1.32e-3)" 10.5 18.1 9.2 4.9 10.6 2.7 8.6 18.7 10.2 9.1 6.6 6.2 5.6 4.9 9.4 8.6 7.2 9.8 6.0 6.3 8.7 4.8 8.4 8.5 7.6 6.3 12.6 8.1 16.1 10.4 12.7 17.7 9.0 9.1 9.9 8.2 6.1 8.0 11.5 5.4 8.0 6.4 8.0 13.7 7.6 6.7 5.3 10.3 11.9 11.6 4.4 7.2 9.3 12.5 4.7 4.5 4.7 10.9 15.7 6.3 2.5 4.1 3.7 12.6 8.6 15.2 12.4 0.1 5.7 6.7 5.4 8.6 4.2 3.5 5.8 3.9 5.3 3.2 2.9 13.0 6.3 8.4 4.0 17.2 10.3 9.7 9.1 8.9 9.8 6.4 9.0 9.0 4.8 18.0 10.0 7.4 8.2 11.4 2.8 7.9 2.9 9.5 5.2 12.9 3.6 11.2 8.4 17.1 8.4 3.9 10.7 12.8 7.0 9.4 4.6 2.9 12.0 5.6 3.3 5.9 4.3 5.0 4.7 5.7 5.7 8.5 8.2 3.6 5.8 8.1 3.2 3.5 4.0 6.3 2.3 5.8 3.8 5.8 5.1 3.9 4.7 5.3 4.9 4.7 15.7 10.9 4.5 3.7 2.5 9.2 10.6 18.7 10.2 8.7 4.8 12.6 8.1 9.1 10.3 6.0 2.7 1.7 3.6 3.7 3.3 2.7 2.5 4.0 1.2 7.0 3.9 2.7 5.0 2.8 0.0 2.1 2.7 0.0 1.6 2.8 3.1 2.6 0.0 1.6 2.7 6.4 1.2 1.8 2.6 0.0 6.1 2.0 1.7 4.6 3.9 4.9 2.2 0.0 2.5 2.0 8.5 0.0 2.4 2.4 3.8 2.3 1.6 3.2 2.8 3.8 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40490236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 3.8;Collecting duct cells: 3.5;Rod photoreceptor cells: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 8.8 7.6 6.3 9.2 9.5 9.0 9.2 7.9 8.7 7.0 6.7 13.3 8.4 7.3 9.3 6.6 6.4 8.4 8.9 6.9 7.8 5.8 7.1 8.1 9.6 18.0 12.7 9.2 9.4 12.3 14.0 6.6 6.3 7.3 7.0 8.2 9.7 8.6 10.4 8.5 7.3 7.5 7.6 9.6 9.0 7.3 3.8 9.3 6.0 10.2 5.0 9.4 8.0 6.8 4.1 4.5 5.1 4.5 5.2 5.1 2.7 2.7 4.0 4.7 4.1 6.9 7.2 1.7 3.6 4.5 7.0 7.0 1.2 3.9 0.3 2.3 3.4 3.2 3.0 4.3 7.5 7.6 4.8 1.6 8.3 3.2 1.9 7.2 5.8 7.5 5.8 5.6 7.1 10.5 6.2 6.5 0.3 5.5 3.9 4.3 3.4 0.1 2.6 2.5 3.4 3.6 1.6 4.8 4.5 2.9 6.3 3.0 3.1 4.1 6.0 3.2 4.4 4.8 3.9 4.9 5.1 4.0 2.8 4.1 2.2 2.8 0.3 3.1 3.6 5.4 2.8 3.2 5.1 3.0 4.5 3.3 3.3 3.0 3.8 4.5 4.1 3.1 3.9 3.8 5.2 4.3 2.8 5.1 2.7 6.3 9.5 7.9 8.7 7.8 5.8 12.7 9.2 7.3 9.3 0.0 0.6 0.0 0.7 0.2 3.8 0.8 0.0 1.4 0.0 3.5 2.0 1.2 0.0 1.1 0.0 1.1 1.0 0.0 1.3 0.8 0.6 0.5 0.0 0.5 1.0 0.0 0.0 1.8 1.0 0.0 1.1 0.2 0.0 1.0 0.7 2.9 0.6 0.0 0.4 1.3 3.7 0.0 0.5 1.0 1.3 0.1 0.3 0.0 1.0 0.6 ZNF620 MGC50836 ENSG00000177842 "Zinc finger protein 620" Q6ZNG0 3 40505992-40518736 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;monocytes: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA031452, HPA059383" Uncertain Approved Centrosome NA NA Centrosome "HPA031452: AB_10603939, HPA059383: AB_2732636" "unprognostic (1.42e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-3)" "unprognostic (2.15e-2)" "unprognostic (7.73e-2)" "unprognostic (3.78e-2)" "unprognostic (1.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.21e-5)" "unprognostic (1.28e-1)" "unprognostic (4.78e-1)" "unprognostic (2.61e-2)" "unprognostic (9.19e-4)" 5.8 5.7 5.2 3.0 8.2 8.0 6.1 15.6 8.5 3.7 5.0 8.9 4.8 4.4 4.0 6.3 3.1 5.3 3.2 4.4 5.6 5.7 6.2 4.5 6.2 3.4 10.3 5.8 4.5 8.1 8.7 15.2 6.3 6.4 5.2 5.9 6.1 3.5 5.7 6.3 2.4 4.7 4.3 5.3 5.2 7.3 3.0 7.4 3.7 9.5 3.7 3.1 4.8 4.5 2.0 1.3 14.2 1.0 3.1 3.9 1.2 2.4 3.5 8.4 3.1 0.9 0.9 4.4 0.6 0.9 4.0 5.8 8.2 5.2 0.0 2.6 0.4 3.5 0.6 12.5 1.1 2.9 7.1 9.7 6.0 8.8 4.6 1.5 2.1 1.2 0.5 0.8 2.5 1.1 1.0 2.7 0.1 3.1 1.0 0.5 4.0 0.4 1.8 9.8 4.6 1.9 3.2 3.6 1.1 3.7 8.5 9.9 7.5 0.6 5.9 3.8 8.7 7.7 2.3 1.8 0.4 5.7 0.8 2.6 1.3 2.1 0.1 1.3 1.2 1.5 14.2 0.6 1.2 2.6 1.0 3.2 0.8 1.0 2.7 0.6 2.0 2.1 2.7 0.9 3.1 0.3 1.3 3.9 1.2 5.2 8.2 15.6 8.5 5.6 5.7 10.3 5.8 6.4 7.4 6.0 2.6 0.8 3.1 0.5 8.8 1.4 5.1 2.7 4.5 0.0 3.9 6.2 5.0 4.5 0.1 4.5 1.9 23.3 2.6 1.3 1.1 2.7 6.9 1.7 1.2 3.2 8.6 4.3 1.8 0.0 0.3 1.6 0.0 18.0 3.3 8.3 2.6 2.8 0.4 3.4 10.6 0.0 3.6 3.1 6.5 0.1 1.6 2.5 3.8 1.3 ZNF621 FLJ45246 ENSG00000172888 "Zinc finger protein 621" Q6ZSS3 3 40524878-40574685 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065518, HPA071440" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA065518: AB_2685501, HPA071440: AB_2686395" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (9.50e-3)" "unprognostic (3.06e-2)" "unprognostic (3.14e-2)" "unprognostic (2.62e-1)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.19e-1)" "unprognostic (5.33e-2)" "unprognostic (8.76e-2)" "unprognostic (2.50e-2)" "unprognostic (2.01e-3)" 12.3 11.3 14.6 10.6 27.1 11.6 16.6 20.4 17.3 14.2 11.1 26.2 15.5 9.6 16.4 18.3 9.1 10.9 11.3 9.3 17.3 14.1 11.8 10.0 12.5 11.1 26.7 12.1 14.1 15.0 18.4 15.6 10.6 17.6 13.3 11.4 12.1 12.6 14.8 10.5 16.2 10.4 15.9 22.7 11.6 11.2 8.6 24.7 4.8 13.9 8.1 11.5 10.4 10.6 7.4 4.3 5.5 3.4 4.9 4.8 1.8 9.2 4.9 13.0 12.8 9.5 14.1 7.0 9.6 11.8 12.7 12.2 10.4 5.0 3.7 7.2 12.9 8.6 3.1 12.4 7.1 14.9 13.0 13.7 12.4 18.4 9.6 15.1 11.7 12.1 11.2 16.3 12.8 20.7 14.1 9.9 4.5 12.7 10.9 10.5 5.0 2.9 13.7 7.6 3.3 10.1 1.3 8.4 3.9 6.7 11.2 4.3 11.4 9.0 7.2 11.4 13.5 10.9 9.7 12.2 21.4 10.6 10.1 13.8 16.5 15.4 7.9 10.1 8.7 13.2 5.5 3.0 2.5 3.9 3.4 2.7 6.1 3.8 4.8 2.4 7.4 4.4 3.9 4.4 4.9 1.9 4.3 3.1 1.8 14.6 27.1 20.4 17.3 17.3 14.1 26.7 12.1 17.6 24.7 8.9 10.5 7.5 4.2 1.3 12.5 10.1 10.2 4.0 11.4 10.4 11.8 4.5 5.0 6.0 6.0 8.7 5.0 0.0 4.9 2.9 5.1 4.9 3.5 4.0 3.3 14.3 9.8 5.5 6.7 5.7 6.9 4.4 3.3 10.0 5.6 9.4 5.5 3.5 11.3 2.9 15.0 0.0 4.9 9.4 7.0 1.6 4.6 5.7 5.8 4.2 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: AB_2679397" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.6 6.0 8.1 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.9 2.2 4.1 2.2 0.2 3.3 0.2 3.0 0.5 7.3 0.1 0.8 1.1 9.3 0.0 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 8.7 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 3.0 8.0 18.2 11.4 8.4 11.1 9.0 10.2 12.0 4.5 26.2 9.8 14.9 26.6 6.8 0.8 9.0 0.0 0.0 8.4 19.4 10.3 16.3 6.9 6.4 9.3 12.7 2.4 19.0 3.1 1.5 17.3 6.3 5.0 3.6 0.7 14.2 7.6 0.0 14.5 21.3 7.9 12.9 9.2 7.2 15.8 11.0 36.3 10.1 0.1 13.4 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Intestinal endocrine cells: 4.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001053: AB_2666183, HPA068130: AB_2685961" "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 4.0 5.2 5.3 6.4 9.0 2.1 6.7 8.8 8.5 7.0 5.4 5.9 11.3 3.5 6.3 7.5 5.0 4.8 5.8 5.9 6.0 4.6 5.2 3.0 5.0 5.4 12.3 5.8 11.2 8.3 11.9 10.1 4.9 8.8 8.4 6.2 6.4 6.1 6.9 2.3 4.0 4.2 7.5 7.3 4.8 6.8 1.8 10.1 1.0 9.3 1.5 3.6 8.4 13.7 2.6 3.8 5.8 1.9 1.5 2.8 2.0 1.4 1.1 0.3 0.0 0.1 0.1 0.0 1.9 0.6 1.0 0.9 3.3 5.4 0.1 1.0 2.0 2.3 2.3 0.0 1.0 1.3 0.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 1.3 5.6 3.2 0.0 3.9 1.0 0.0 0.0 5.4 3.6 5.7 0.0 0.0 2.1 4.8 1.6 0.7 1.2 0.0 2.5 3.0 3.2 2.6 7.0 4.8 2.1 5.0 5.7 1.3 1.2 0.0 2.5 2.5 0.0 0.0 4.7 0.0 0.0 0.1 4.5 5.8 1.9 4.8 2.2 1.0 2.4 2.6 2.0 2.0 3.8 1.8 2.5 2.8 2.1 1.5 0.6 0.9 1.1 2.0 5.3 9.0 8.8 8.5 6.0 4.6 12.3 5.8 8.8 10.1 0.0 0.0 0.0 1.0 0.1 2.1 1.0 0.0 0.0 0.0 1.8 0.0 0.1 1.7 1.2 0.0 0.6 0.7 0.0 1.0 0.7 0.6 0.9 0.0 0.0 0.8 0.0 4.1 2.5 0.0 0.0 0.3 0.0 0.0 1.0 1.4 1.1 0.8 0.0 0.4 0.6 0.9 6.5 1.0 0.1 0.5 0.3 0.2 0.8 1.0 0.7 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" Q8IZM8 3 88059274-88144665 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364" "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavorable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 18.2 8.9 10.9 13.2 11.6 15.1 12.6 18.6 13.3 13.5 11.8 9.8 13.5 9.7 14.0 12.1 14.4 9.5 10.8 10.4 11.3 8.5 11.0 15.4 11.8 12.3 13.9 10.3 14.7 9.5 12.8 21.8 11.9 11.1 12.8 9.8 10.7 12.5 10.2 13.9 14.9 13.4 13.1 15.8 10.1 10.0 12.3 14.8 22.2 13.4 9.4 12.0 16.6 14.6 2.6 2.3 10.0 2.0 6.5 4.0 1.7 4.7 2.0 3.4 4.8 7.6 6.3 3.1 6.3 5.7 4.2 6.0 3.0 2.9 7.5 4.3 5.4 3.0 3.2 3.7 5.8 8.5 4.6 2.0 4.7 2.7 2.2 5.7 5.3 5.3 6.2 5.8 4.7 5.6 9.0 5.7 4.4 3.1 6.2 9.5 3.6 5.3 4.9 1.8 3.9 3.2 3.7 2.3 3.6 4.1 6.2 2.6 2.3 4.5 3.7 11.9 4.6 5.0 4.2 6.4 9.4 6.2 35.2 4.5 7.0 4.8 5.3 7.6 5.1 6.0 10.0 1.9 2.7 2.9 2.0 3.3 1.8 3.2 4.0 2.3 2.6 3.9 2.6 2.7 6.5 1.4 1.1 2.2 1.7 10.9 11.6 18.6 13.3 11.3 8.5 13.9 10.3 11.1 14.8 8.9 13.3 6.9 8.9 19.9 12.3 10.9 7.6 9.4 11.4 5.2 11.8 3.7 1.7 5.6 0.8 11.3 8.7 0.0 4.5 2.9 14.1 9.3 15.1 11.3 5.3 15.9 5.1 9.2 11.7 1.1 6.9 13.3 8.5 1.8 9.2 9.5 7.0 7.0 11.7 4.8 13.3 6.5 6.2 10.4 7.9 16.3 6.9 11.7 7.1 11.5 ZNF665 FLJ14345 ENSG00000197497 "Zinc finger protein 665" Q9H7R5 19 53159213-53193386 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023437 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA023437: AB_2671205" "unprognostic (8.01e-2)" "unprognostic (2.44e-1)" "unprognostic (1.73e-1)" "unprognostic (8.04e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (1.26e-1)" "unprognostic (3.27e-2)" "unprognostic (5.81e-4)" "unprognostic (2.26e-1)" "unprognostic (1.04e-2)" "unprognostic (2.45e-1)" "unprognostic (9.27e-2)" 4.3 3.8 4.2 4.3 6.7 2.3 5.1 10.7 6.2 5.3 4.0 5.7 2.6 1.6 6.4 5.2 3.2 6.7 2.9 2.6 5.2 2.6 2.6 1.1 3.6 4.2 5.5 3.2 11.5 2.7 7.7 4.8 2.9 4.8 6.0 2.6 6.0 2.9 4.0 1.4 3.3 2.6 5.5 6.5 3.9 2.9 3.4 7.0 7.2 5.8 1.5 3.2 5.4 4.1 5.4 1.6 1.5 1.1 4.9 2.2 0.5 1.1 0.2 1.2 3.8 1.2 2.2 2.8 2.8 1.7 2.7 3.8 0.5 1.0 2.0 2.0 2.0 1.8 0.4 0.7 0.2 4.4 0.0 0.1 0.1 0.7 0.1 2.7 0.5 1.0 2.6 0.0 2.4 0.0 0.8 0.2 0.1 0.4 0.6 0.1 0.4 5.4 1.6 2.2 0.0 0.6 0.1 0.1 0.8 0.5 5.3 0.5 2.4 0.2 0.4 0.1 2.8 1.5 1.1 0.7 1.8 2.2 1.7 1.0 0.3 4.6 4.9 0.1 1.4 2.6 1.5 0.5 1.1 0.8 0.3 1.0 2.7 1.0 2.2 0.9 5.4 1.8 1.9 1.4 4.9 1.1 1.6 0.7 0.5 4.2 6.7 10.7 6.2 5.2 2.6 5.5 3.2 4.8 7.0 17.9 9.6 1.7 2.9 1.0 5.7 0.8 2.5 8.1 6.8 5.2 0.0 2.0 3.3 1.1 1.5 2.5 0.3 0.0 0.6 2.1 1.9 2.1 4.7 0.4 1.1 11.1 2.4 1.8 1.0 0.8 2.0 1.1 1.7 2.8 0.3 6.8 0.4 0.0 2.8 0.3 3.7 0.0 2.1 1.9 7.0 0.5 0.7 3.8 0.7 2.0 ZNF667 FLJ14011 ENSG00000198046 "Zinc finger protein 667" Q5HYK9 19 56439325-56478065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 27.9;Cone photoreceptor cells: 23.6;Horizontal cells: 30.2;Rod photoreceptor cells: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.1;hTERT-RPE1: 15.1;U-138 MG: 12.7" "Low region specificity" "Detected in all" "HPA030731, HPA046673" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030731: AB_2673584, HPA046673: AB_2679746" "unprognostic (6.10e-2)" "unprognostic (7.87e-3)" "unprognostic (2.91e-2)" "unprognostic (4.81e-2)" "unprognostic (6.38e-2)" "unprognostic (2.26e-3)" "unprognostic (8.55e-2)" "unprognostic (5.37e-2)" "unprognostic (1.05e-1)" "unprognostic (5.67e-2)" "unprognostic (3.77e-4)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (8.34e-3)" "unprognostic (3.54e-2)" "unprognostic (7.62e-2)" "unprognostic (1.55e-2)" 2.4 7.7 8.0 1.7 18.2 6.2 6.8 12.1 16.1 4.7 2.6 5.3 1.8 1.6 6.4 11.6 2.4 6.3 4.3 4.0 10.2 9.9 4.1 1.3 2.1 2.4 6.5 8.3 11.1 3.5 6.1 18.9 3.0 9.7 5.6 0.9 3.2 4.5 4.5 2.0 2.9 1.1 5.6 6.6 2.4 1.8 5.9 5.3 2.9 12.6 0.6 1.8 3.7 4.2 6.2 2.2 0.4 0.0 4.5 3.7 0.6 0.1 0.2 8.7 0.1 0.0 0.0 0.2 3.7 2.8 3.4 2.7 0.2 0.1 0.4 5.2 1.3 5.2 0.1 0.0 0.1 5.2 0.0 1.9 10.1 0.1 0.2 2.7 5.9 4.6 5.6 0.1 0.7 0.0 15.1 0.0 0.3 0.0 0.3 2.6 0.2 0.1 0.2 6.3 0.1 1.7 0.0 3.3 7.0 3.4 0.5 0.2 5.1 0.2 0.1 0.0 8.1 2.4 0.0 0.0 12.7 3.4 0.2 6.5 0.2 5.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.4 0.3 0.3 6.2 1.5 3.7 0.4 4.5 0.0 2.2 0.0 0.6 8.0 18.2 12.1 14.4 10.2 9.9 6.5 8.3 9.7 5.3 0.0 0.0 0.0 5.6 3.0 27.9 4.5 0.0 5.3 4.5 5.2 23.6 0.1 0.0 2.7 2.1 3.6 0.0 0.0 0.2 0.0 5.3 3.6 9.2 0.0 0.2 30.2 1.2 1.8 0.0 1.6 4.9 0.6 3.3 0.0 0.0 9.3 0.5 0.0 6.7 1.2 28.2 0.0 3.0 7.7 14.4 3.6 0.1 0.0 0.0 2.5 ZNF669 FLJ12606 ENSG00000188295 "Zinc finger protein 669" Q96BR6 1 247099962-247104372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 28.5;Rod photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044043 Uncertain NA NA "HPA044043: AB_10964039" "unprognostic (1.88e-1)" "unprognostic (6.57e-2)" "unprognostic (2.01e-2)" "unprognostic (1.32e-1)" "unprognostic (3.80e-2)" "unprognostic (6.04e-2)" "unprognostic (1.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (5.98e-2)" "unprognostic (1.09e-1)" "prognostic favorable (4.59e-7)" "unprognostic (2.60e-2)" "unprognostic (1.47e-1)" "unprognostic (3.11e-2)" "unprognostic (4.81e-2)" 10.6 5.3 4.7 7.1 6.5 17.4 9.6 11.0 9.2 8.8 6.2 8.2 3.0 4.9 9.7 5.8 5.5 7.3 5.2 4.5 5.2 5.5 7.7 4.8 6.2 11.1 4.9 3.9 8.6 8.3 5.8 9.1 5.0 8.2 6.5 6.4 5.2 7.0 6.0 5.0 6.2 7.0 6.6 5.2 10.5 6.6 9.6 4.4 24.1 8.8 4.3 9.4 6.9 5.2 8.2 5.5 11.1 3.3 5.6 8.5 3.4 3.3 2.3 7.7 8.8 4.5 4.0 7.8 4.7 5.0 7.0 6.8 5.6 3.5 4.7 7.4 3.3 4.8 4.2 7.4 5.8 7.4 2.4 1.8 0.3 5.4 4.0 3.6 4.1 5.6 3.7 6.1 5.4 3.9 3.2 3.9 12.1 8.1 3.3 6.9 2.9 11.2 4.5 17.9 6.8 4.8 8.9 7.5 3.4 4.9 9.5 8.3 14.7 6.3 3.3 2.4 9.0 6.5 16.0 4.2 4.7 5.3 4.4 9.0 8.4 15.1 9.6 1.3 2.3 4.7 11.1 3.3 9.9 6.1 2.1 8.0 8.2 7.4 5.8 4.1 7.2 8.5 8.0 8.1 5.6 3.0 5.5 7.6 3.4 4.7 6.5 11.0 9.2 5.2 5.5 4.9 3.9 8.2 4.4 3.0 8.8 12.7 4.8 8.7 28.5 1.4 12.7 10.7 4.5 1.8 11.8 3.2 6.6 4.3 9.2 5.8 1.9 0.0 6.7 3.6 3.2 2.5 14.0 2.5 4.4 15.9 7.5 6.2 5.4 5.3 6.6 9.1 11.8 1.8 2.1 9.8 6.5 0.0 3.5 2.6 29.5 0.0 2.5 7.0 9.2 7.4 1.9 13.3 1.9 3.3 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 7.8;Rod photoreceptor cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.4" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favorable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 3.3 7.9 9.1 6.3 10.1 5.6 6.6 28.5 10.4 5.4 6.7 4.5 4.5 2.7 3.3 8.4 3.2 6.9 4.2 8.1 9.0 6.7 6.2 3.3 5.6 13.2 8.0 7.5 5.4 4.1 16.1 11.3 5.9 7.9 6.6 3.7 7.8 4.5 9.4 10.3 3.2 7.1 6.6 9.0 15.1 3.8 7.1 8.9 15.6 10.4 1.1 12.1 6.2 2.5 22.2 11.0 13.7 10.0 13.9 19.4 10.9 0.1 0.2 2.4 0.0 0.4 0.1 0.0 2.7 1.6 5.4 1.9 0.3 0.4 5.5 0.9 3.9 1.7 0.1 2.0 2.2 6.3 6.0 3.9 0.1 0.9 0.0 4.7 0.0 8.1 7.0 1.6 3.4 1.8 6.2 0.8 5.9 0.8 2.7 4.7 0.1 10.4 0.1 3.5 0.0 5.6 4.1 7.5 3.3 2.0 0.2 0.2 0.0 0.0 0.1 3.6 6.3 1.6 7.7 0.0 0.6 2.9 0.0 2.0 4.9 0.1 3.0 0.6 1.3 1.8 12.1 7.6 13.7 6.4 7.0 16.7 17.2 13.3 11.0 11.0 22.2 19.4 15.5 5.6 13.9 10.0 10.0 13.1 10.9 9.1 10.1 28.5 10.4 9.0 6.7 8.0 7.5 7.9 8.9 0.0 1.1 0.9 0.6 0.6 5.3 4.8 2.5 0.0 1.2 3.5 0.0 1.8 1.7 2.6 0.1 1.0 0.0 0.0 0.0 0.9 1.0 0.5 2.3 1.0 3.3 6.4 0.0 1.3 1.6 0.4 0.0 1.6 1.7 1.8 0.0 7.8 0.5 0.0 0.4 1.3 6.8 0.0 0.4 5.6 4.5 0.4 0.7 4.3 0.3 0.1 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 11.3 12.5 11.1 16.4 13.6 15.1 12.1 18.6 15.3 10.2 13.0 17.3 15.0 13.8 12.1 10.7 15.9 11.3 13.3 20.1 11.4 10.2 14.8 27.5 13.6 16.7 14.1 7.5 12.0 14.1 20.4 14.1 16.1 12.4 18.7 11.1 15.1 24.1 14.8 46.6 13.3 16.8 11.3 11.2 16.0 12.7 12.4 14.5 28.1 21.7 21.0 17.3 14.5 10.4 14.5 20.8 9.6 13.4 10.5 8.0 10.3 10.2 11.7 9.6 10.7 5.4 3.8 18.1 9.8 5.3 6.9 7.6 6.4 10.8 11.6 10.1 6.4 5.4 10.1 5.2 7.2 4.6 16.8 2.9 17.7 10.8 8.6 7.0 7.7 13.7 4.2 6.0 9.2 6.6 5.7 6.5 8.0 21.5 9.7 4.9 7.4 13.6 7.7 11.0 11.8 19.9 25.7 9.1 9.1 7.2 8.5 14.1 12.4 8.7 13.3 8.6 6.0 7.7 15.8 5.5 9.8 5.8 6.5 19.8 29.1 10.9 6.8 9.1 13.6 8.0 7.6 13.3 9.6 8.0 13.4 6.7 10.8 5.7 7.9 20.8 14.5 6.3 5.6 8.1 10.5 12.4 11.7 6.5 10.3 11.1 13.6 18.6 15.3 11.4 10.2 14.1 7.5 12.4 14.5 3.0 17.5 21.4 22.4 11.6 21.0 16.9 7.6 5.3 4.5 15.7 11.8 28.2 18.3 16.4 6.2 12.1 18.8 0.0 9.4 16.4 10.8 20.5 28.7 14.8 15.4 9.5 17.3 5.5 15.2 8.9 5.2 14.1 11.8 12.6 16.6 19.2 12.1 17.3 5.3 13.5 30.2 6.5 9.9 22.9 13.6 12.8 59.6 13.8 15.2 19.9 ZNF674 "MRX92, ZNF673B" ENSG00000251192 "Zinc finger protein 674" Q2M3X9 X 46497727-46545457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 8.9;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031026, HPA065295" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031026: AB_10602690, HPA065295: AB_2685456" "unprognostic (6.11e-4)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.30e-2)" "unprognostic (1.54e-2)" "unprognostic (3.39e-2)" "unprognostic (6.41e-5)" "unprognostic (2.74e-4)" "unprognostic (5.68e-2)" "unprognostic (2.43e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (3.25e-4)" "unprognostic (8.45e-4)" 6.7 5.1 5.7 4.0 10.1 3.8 5.5 12.6 9.8 4.7 4.5 6.8 1.9 4.2 6.3 6.5 4.1 3.7 4.9 4.9 5.7 6.3 5.6 8.1 4.3 5.1 6.4 5.8 7.2 7.4 4.8 11.2 4.5 9.6 8.2 5.1 6.8 4.5 5.7 5.0 5.4 4.6 6.9 6.8 5.8 3.9 3.7 7.0 6.0 6.9 1.8 4.6 4.5 5.1 2.3 2.5 5.8 3.5 1.9 2.7 2.1 2.6 3.4 3.4 4.2 3.1 3.1 3.3 2.8 3.9 3.7 3.9 2.2 2.2 2.9 1.8 4.8 6.6 2.5 4.5 3.4 4.1 2.4 2.9 1.3 3.6 1.9 4.1 3.1 5.3 2.9 5.5 2.7 8.9 3.8 2.9 5.0 1.5 4.4 3.3 1.7 3.1 1.4 5.4 0.8 3.2 1.5 5.7 3.3 2.5 1.1 1.3 2.9 4.3 1.4 8.9 9.8 3.6 2.2 2.5 4.7 5.4 2.9 2.6 5.1 4.5 1.3 2.0 1.6 4.7 2.5 2.2 2.9 1.9 3.5 2.0 2.3 2.7 1.5 2.1 1.4 2.2 2.3 5.8 1.9 0.8 2.5 2.2 2.1 5.7 10.1 12.6 9.8 5.7 6.3 6.4 5.8 9.6 7.0 8.9 2.6 0.5 2.8 1.6 7.3 3.3 0.0 4.0 4.5 1.8 0.0 0.7 0.0 0.7 0.0 1.9 0.9 0.0 0.4 0.6 1.1 2.3 2.3 1.8 0.9 12.7 0.0 2.5 2.1 0.0 0.3 1.1 0.0 1.0 0.9 2.9 1.3 0.9 1.8 0.6 5.4 0.0 1.2 0.7 3.2 1.5 0.3 1.7 0.7 1.7 ZNF676 ENSG00000196109 "Zinc finger protein 676" Q8N7Q3 19 22179091-22196951 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 6.5" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 16.6;Early spermatids: 17.1;Spermatocytes: 17.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "NTERA-2: 12.6" NA NA "unprognostic (7.77e-2)" "unprognostic (2.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (8.33e-2)" "unprognostic (1.36e-2)" "unprognostic (1.64e-1)" "unprognostic (5.45e-1)" "unprognostic (6.76e-3)" "unprognostic (9.98e-3)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-3)" 1.4 0.1 0.0 0.2 0.1 0.0 1.6 0.0 1.3 1.2 1.3 0.0 2.4 1.1 0.1 2.3 0.5 2.1 0.1 0.2 1.4 0.0 0.1 0.1 0.4 2.4 1.6 6.5 1.9 0.0 0.6 0.2 0.2 0.5 0.0 0.4 0.2 1.8 0.8 0.8 0.1 4.6 4.3 0.0 0.3 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 3.3 0.0 0.0 0.0 5.2 0.0 0.9 16.6 6.1 17.1 2.9 0.0 0.0 2.3 0.5 0.5 0.2 0.0 0.0 0.2 1.6 0.0 2.5 0.0 3.6 0.9 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.4 1.0 0.0 6.5 0.9 17.7 7.5 0.3 0.7 0.0 0.0 0.3 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.5" "Group enriched" "Detected in many" 11 "Early spermatids: 557.4;Late spermatids: 339.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 19.6;SuSa: 17.4" HPA023106 Approved Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.1 7.3 5.9 4.3 8.3 4.2 9.3 13.0 7.3 7.4 7.0 13.9 1.3 2.9 12.3 5.7 4.6 9.7 6.2 9.4 5.3 4.3 6.3 2.3 6.8 7.3 9.9 4.8 14.3 4.4 9.1 9.9 7.5 6.6 8.9 3.4 7.6 7.4 6.2 3.9 7.5 3.9 8.1 10.5 7.0 5.7 40.5 8.7 6.7 10.1 5.2 5.0 8.2 6.6 17.4 14.5 10.1 2.8 10.3 15.4 4.1 0.2 0.2 11.4 0.4 3.9 6.0 2.0 7.4 5.6 7.7 7.0 0.0 0.4 0.1 5.6 6.4 9.7 0.7 0.0 5.8 2.3 0.2 4.1 0.3 0.5 0.2 9.6 0.1 7.6 10.3 0.0 7.4 0.1 0.2 3.4 0.1 0.1 0.5 5.2 0.2 6.2 0.2 19.6 0.1 2.6 0.1 0.0 0.2 2.2 3.0 0.2 10.8 0.2 2.8 0.1 17.4 0.4 0.3 2.1 12.1 0.2 0.2 4.9 0.3 0.1 0.2 0.2 0.3 0.1 10.1 2.2 6.4 5.1 2.8 7.3 9.6 7.2 5.6 6.1 17.4 15.4 10.0 2.6 10.3 1.8 14.5 4.5 4.1 5.9 8.3 13.0 7.0 5.3 4.3 9.9 4.8 6.6 8.7 23.8 3.2 10.7 23.0 10.2 23.9 15.9 15.3 9.4 17.0 19.2 13.7 10.7 29.9 13.8 557.4 22.4 0.7 23.3 6.0 17.2 15.5 23.9 13.9 0.4 6.7 27.0 0.0 22.7 4.0 339.6 25.3 10.3 13.5 9.0 2.4 20.1 6.5 0.0 16.3 2.2 19.1 19.4 17.6 39.3 35.1 12.8 9.8 10.4 1.9 22.1 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.9 13.5 1.5 3.4 7.2 2.7 2.7 4.1 4.4 2.6 2.6 8.3 7.2 1.2 2.2 4.0 7.0 1.8 6.8 3.5 13.4 3.9 2.5 1.6 2.7 6.6 10.6 3.0 3.4 2.5 5.3 3.1 3.9 9.3 9.9 13.1 4.5 1.7 9.1 2.3 10.4 3.0 5.4 7.1 7.7 3.2 3.0 6.5 5.1 9.9 4.1 4.9 2.0 6.1 6.8 8.4 2.5 5.1 4.9 4.6 5.6 4.2 9.6 9.1 2.1 1.2 5.3 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 3.0 5.3 4.7 3.6 2.1 11.6 3.6 5.1 5.3 4.5 3.5 3.9 1.8 1.7 3.3 0.6 4.7 1.5 0.0 4.4 2.1 3.4 5.6 3.5 1.6 1.4 1.6 9.2 3.7 3.7 0.2 6.9 2.2 0.0 1.8 3.9 4.2 2.9 4.5 2.5 1.1 6.7 0.0 2.1 7.2 10.0 0.5 1.1 7.5 2.6 3.4 ZNF681 FLJ31526 ENSG00000196172 "Zinc finger protein 681" Q96N22 19 23739195-23758891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 11.6;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 14.7" NA NA "unprognostic (1.48e-1)" "unprognostic (4.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (6.22e-2)" "unprognostic (1.01e-1)" "unprognostic (2.45e-3)" "unprognostic (8.55e-2)" "unprognostic (1.61e-2)" "unprognostic (5.24e-2)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (7.98e-2)" "unprognostic (2.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.55e-2)" 3.3 3.6 6.4 5.9 4.9 1.7 5.1 15.8 9.5 4.0 4.0 1.0 2.2 2.6 2.9 4.4 5.1 3.6 1.9 2.0 5.7 5.5 2.2 1.2 2.4 6.7 4.1 6.8 5.6 4.9 1.9 5.4 3.1 8.3 3.1 5.1 1.1 3.0 2.1 1.1 5.8 3.2 2.3 4.7 7.2 2.8 6.1 4.6 17.7 5.0 0.6 5.7 6.6 3.9 3.7 1.5 0.6 0.6 1.8 7.0 1.8 0.7 0.0 4.7 9.2 0.3 0.0 2.6 0.6 0.1 1.4 1.6 1.2 2.4 1.2 4.3 0.8 2.1 2.2 4.3 0.2 2.4 14.7 1.6 2.3 0.0 0.0 0.7 0.0 0.4 1.1 0.8 0.6 0.6 0.3 0.0 3.3 6.2 0.0 2.4 2.0 7.9 2.2 6.8 0.1 2.1 6.2 3.4 9.6 1.2 4.5 0.4 4.9 0.0 0.0 0.8 6.9 4.9 0.4 0.0 0.9 0.1 3.0 3.3 0.1 8.4 7.2 0.0 0.0 0.0 0.3 0.6 0.1 2.0 0.4 3.2 2.4 3.4 2.8 1.0 3.7 7.0 5.8 0.6 1.8 0.4 1.5 3.4 1.8 6.4 4.9 15.8 9.5 5.7 5.5 4.1 6.8 8.3 4.6 3.0 0.0 3.7 1.0 1.0 2.7 0.9 2.5 9.4 5.7 1.8 0.0 3.1 1.7 1.6 7.2 2.2 2.7 0.0 2.1 3.7 1.9 1.1 0.0 0.0 1.9 1.6 2.4 2.5 2.7 4.0 0.6 0.9 1.7 1.0 2.6 1.8 1.0 1.9 2.8 1.4 1.1 0.0 1.0 11.6 13.0 1.1 3.1 3.8 1.7 0.9 ZNF682 BC39498_3 ENSG00000197124 "Zinc finger protein 682" O95780 19 19997058-20039506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 13.7" "Cancer enhanced" "Detected in many" "testis cancer: 7.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 18.0" HPA055998 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA055998: AB_2683002" "unprognostic (8.96e-2)" "unprognostic (3.93e-2)" "unprognostic (4.78e-2)" "unprognostic (1.10e-1)" "unprognostic (6.16e-2)" "unprognostic (6.95e-3)" "unprognostic (1.69e-2)" "unprognostic (1.71e-2)" "unprognostic (6.44e-2)" "unprognostic (1.24e-3)" "unprognostic (7.70e-4)" "unprognostic (1.77e-3)" "unprognostic (4.06e-7)" "unprognostic (2.07e-1)" "unprognostic (2.10e-1)" "unprognostic (1.19e-1)" "prognostic favorable (3.51e-4)" 4.1 4.9 11.0 5.2 14.1 4.1 7.6 13.6 12.9 5.9 5.3 10.3 8.5 3.5 5.2 8.1 5.3 6.9 5.3 7.1 10.5 7.6 6.3 6.9 8.1 7.9 12.5 6.5 4.6 4.9 4.6 12.0 6.7 9.4 11.0 5.8 4.3 3.3 16.2 6.7 13.9 4.6 5.6 9.7 6.7 5.4 5.6 12.4 6.5 17.4 4.6 9.6 6.2 4.8 5.7 2.2 7.6 1.0 2.2 6.4 2.1 0.0 0.0 12.0 18.0 0.9 1.3 0.5 2.5 1.2 4.3 6.9 2.0 2.5 0.1 4.4 3.6 1.2 2.2 4.9 0.4 4.8 0.0 5.1 0.0 0.1 1.3 1.7 0.0 4.3 1.8 1.4 2.4 0.0 0.6 0.0 4.7 0.0 0.1 3.2 3.7 6.8 1.0 6.6 0.0 1.6 4.3 6.2 0.1 2.2 7.8 6.6 7.1 0.0 2.3 0.0 6.8 4.5 2.4 0.0 6.3 1.0 10.6 4.3 0.0 7.0 1.1 0.0 0.0 2.0 7.6 0.7 1.4 4.0 0.8 3.0 5.7 5.8 3.1 2.2 4.3 6.3 6.4 2.4 2.2 1.0 1.9 6.2 2.1 11.0 14.1 13.6 12.3 10.5 7.6 12.5 6.5 9.4 12.4 8.9 13.7 4.2 2.2 3.1 5.5 9.5 5.1 1.4 6.8 3.5 0.0 6.4 5.0 3.4 1.1 3.3 1.0 0.0 6.4 5.4 2.4 2.4 2.3 2.6 2.3 3.2 1.2 4.9 4.1 0.5 1.7 2.5 1.7 0.0 3.5 3.8 3.6 0.0 4.2 3.0 2.0 0.0 2.0 4.4 4.1 3.0 2.1 7.5 2.6 1.6 ZNF684 MGC27466 ENSG00000117010 "Zinc finger protein 684" Q5T5D7 1 40531561-40548169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 28.0" "Low region specificity" "Detected in all" HPA059153 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059153: AB_2683932" "unprognostic (4.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-4)" "unprognostic (2.29e-2)" "unprognostic (2.96e-2)" "unprognostic (3.67e-4)" "unprognostic (8.49e-2)" "unprognostic (2.26e-3)" "unprognostic (2.10e-2)" "unprognostic (7.00e-2)" "unprognostic (4.14e-3)" "unprognostic (3.96e-2)" "prognostic favorable (4.89e-10)" "unprognostic (4.76e-3)" "unprognostic (7.11e-2)" "unprognostic (5.98e-2)" "unprognostic (1.52e-2)" 3.6 6.4 4.1 2.9 8.9 8.2 4.2 5.8 7.4 3.6 3.8 2.3 5.4 3.2 3.6 4.3 3.2 3.1 3.4 10.6 4.4 3.3 18.3 20.8 3.4 4.4 9.8 3.6 3.8 5.4 2.5 4.6 2.1 5.4 5.1 4.8 1.6 3.5 4.1 4.4 4.1 3.4 3.2 5.9 5.1 4.2 4.3 7.8 6.4 5.6 4.1 3.5 3.1 2.7 6.0 3.9 7.0 7.7 3.5 5.9 2.4 2.2 0.7 2.8 3.8 2.6 3.8 1.7 2.0 2.0 2.4 4.1 1.4 2.9 3.8 1.7 1.3 1.6 2.7 2.8 2.0 3.8 3.3 4.7 4.1 2.6 3.6 1.3 4.4 4.5 2.5 0.8 2.9 1.1 1.4 3.7 3.0 2.1 5.7 3.4 0.6 6.4 5.1 6.8 0.9 2.3 3.0 8.4 2.6 3.6 1.9 2.1 3.6 3.7 3.7 4.1 3.6 1.6 28.0 2.1 2.5 5.2 2.4 3.9 4.8 3.4 4.4 2.2 4.7 3.8 7.0 4.0 1.9 5.9 7.7 3.2 6.0 4.2 3.6 2.4 3.5 2.8 5.5 2.3 3.5 4.1 3.9 4.7 2.4 4.1 8.9 5.8 7.4 4.4 3.3 9.8 3.6 5.4 7.8 6.0 2.7 3.7 1.7 2.1 3.0 9.9 2.5 5.3 3.4 7.0 0.0 1.0 14.9 4.4 1.8 3.5 1.3 0.0 12.9 2.1 2.8 1.0 2.3 14.5 4.2 3.2 1.2 4.3 4.3 2.6 2.3 4.3 8.5 7.2 1.7 3.5 4.9 2.0 2.8 12.4 2.3 0.0 4.7 6.1 3.2 1.1 0.0 4.8 3.8 0.9 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 132.4;Late spermatids: 434.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favorable (5.90e-4)" "prognostic favorable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favorable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favorable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favorable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.8 5.9 6.0 6.3 11.4 2.9 2.5 4.5 6.2 3.8 3.0 1.8 11.9 4.1 9.1 5.6 5.2 5.8 1.7 2.8 4.1 12.2 3.6 2.8 2.3 1.4 3.0 3.9 12.7 5.9 6.3 4.0 4.9 6.5 3.8 5.6 2.9 9.6 4.2 4.7 11.1 4.3 2.2 7.7 1.9 9.5 2.4 6.2 6.6 2.5 8.6 9.6 1.6 11.8 9.9 1.8 12.9 6.5 2.9 3.3 3.6 3.8 3.5 13.8 9.6 4.4 10.1 3.4 5.6 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 6.0 1.9 17.1 10.5 5.7 19.5 8.5 17.8 20.1 6.8 15.7 17.7 6.3 41.4 19.2 132.4 11.1 34.5 0.0 27.4 7.9 13.1 9.8 4.7 18.7 21.4 20.6 19.5 14.1 22.9 434.2 18.4 15.6 16.9 28.9 25.1 28.0 19.6 32.3 18.7 38.4 25.5 6.5 12.5 25.3 7.9 6.1 3.9 20.3 22.1 5.7 ZNF70 "Cos17, MGC48959" ENSG00000187792 "Zinc finger protein 70" Q9UC06 22 23738678-23751092 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018821 Uncertain Approved Cytosol NA NA Cytosol "HPA018821: AB_1859423" "unprognostic (3.17e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" "unprognostic (8.49e-3)" "unprognostic (1.08e-1)" "unprognostic (2.80e-2)" "unprognostic (6.07e-3)" "unprognostic (2.18e-3)" "unprognostic (9.93e-2)" "unprognostic (6.20e-2)" "unprognostic (1.73e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-2)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (5.69e-2)" 5.5 5.0 8.4 7.6 8.5 5.5 5.5 14.3 10.3 7.5 5.5 8.2 10.7 3.4 7.8 8.7 3.6 7.4 5.9 6.3 8.6 3.8 4.1 3.0 4.7 4.9 7.1 5.7 15.3 6.5 10.1 6.2 4.5 7.1 5.9 4.8 9.0 7.2 8.4 9.1 4.3 5.1 7.0 4.9 5.2 5.1 4.7 10.9 3.9 6.7 1.1 5.6 5.8 5.4 1.5 1.6 4.2 1.0 2.0 1.2 0.4 1.9 2.5 4.8 5.0 7.1 3.5 1.6 1.8 3.6 4.1 5.9 2.4 1.4 2.7 1.2 3.8 2.7 2.2 3.3 2.4 5.3 1.8 3.1 5.2 4.5 2.2 4.3 4.7 4.5 3.4 1.6 5.5 4.6 5.4 3.2 2.1 1.9 4.0 3.1 2.7 2.7 2.4 1.2 1.8 1.1 11.4 4.6 0.6 1.5 2.6 2.7 3.4 2.7 3.5 2.1 3.6 1.7 2.2 4.3 4.6 5.8 3.0 2.0 4.1 0.7 2.6 4.0 2.2 3.9 4.2 1.0 0.9 1.0 0.8 0.6 0.8 1.0 0.6 0.5 1.5 1.1 1.2 3.2 2.0 0.8 1.6 0.4 0.4 8.4 8.5 14.3 10.3 8.6 3.8 7.1 5.7 7.1 10.9 0.0 3.2 0.0 0.8 0.3 4.0 2.3 2.5 6.7 3.4 3.5 9.8 0.4 0.0 1.1 1.1 1.0 0.3 0.0 1.0 0.5 1.8 0.6 1.1 0.5 0.7 6.4 1.2 4.3 1.2 2.1 5.8 0.4 0.0 1.0 0.3 2.8 0.4 0.0 3.9 0.6 4.5 6.5 0.8 2.1 2.1 0.0 0.2 0.5 0.6 0.7 ZNF700 DKFZp434I1610 ENSG00000196757 "Zinc finger protein 700" Q9H0M5 19 11925068-11950773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.92e-1)" "unprognostic (1.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.27e-4)" "unprognostic (8.63e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (9.02e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (2.01e-5)" "unprognostic (8.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.53e-5)" 10.2 10.3 7.7 22.2 9.6 19.7 21.6 10.2 8.9 8.3 11.3 5.7 13.6 8.4 9.5 12.7 11.8 8.6 13.9 6.8 7.2 3.8 13.6 16.7 13.5 14.6 8.6 5.4 13.1 23.7 13.4 12.4 6.9 7.4 12.0 15.2 7.2 15.8 11.5 5.1 21.8 15.3 14.4 7.1 20.7 11.3 17.3 8.5 10.3 11.2 6.7 14.7 10.8 13.4 6.9 6.4 9.5 8.1 7.2 8.3 3.8 6.5 0.3 7.1 7.3 4.5 5.0 7.2 7.0 6.1 6.3 8.4 5.5 3.3 8.7 6.2 4.5 4.3 5.2 5.8 5.1 8.8 4.9 3.1 8.9 6.5 4.9 3.8 12.6 13.3 4.1 6.1 5.4 6.1 4.3 3.9 5.8 10.0 19.6 9.1 5.4 6.9 11.7 7.3 3.9 6.5 5.9 9.4 6.7 9.0 7.6 4.2 5.1 6.4 4.3 8.2 6.8 7.3 14.5 5.6 16.3 4.2 11.1 8.0 13.6 7.2 9.2 4.3 10.4 5.3 9.5 4.6 9.0 6.9 5.2 7.8 6.9 5.7 8.3 6.4 4.4 5.5 6.9 7.3 7.2 8.1 4.1 6.4 3.8 7.7 9.6 10.2 8.9 7.2 3.8 8.6 5.4 7.4 8.5 8.9 10.2 6.7 1.7 2.7 2.3 3.6 10.2 4.0 10.3 1.8 2.0 4.3 1.7 4.6 0.4 3.6 5.2 0.0 4.0 3.9 1.7 1.7 15.1 7.2 3.8 0.0 2.9 6.2 7.5 0.9 4.0 4.6 5.0 1.0 6.8 2.0 4.9 8.6 1.8 1.3 4.1 0.0 5.1 10.6 6.4 1.5 3.1 5.1 8.1 1.1 ZNF705A FLJ16353 ENSG00000196946 "Zinc finger protein 705A" Q6ZN79 12 8157034-8188537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.2" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 3.6;Late spermatids: 1.5;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "AN3-CA: 7.5;ASC TERT1: 5.8;BJ hTERT+: 8.8;HDLM-2: 7.2;HSkMC: 6.9;NTERA-2: 8.3" NA NA "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (8.16e-2)" "unprognostic (4.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.52e-3)" "unprognostic (4.31e-6)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (1.41e-2)" 0.6 0.5 0.6 0.6 0.6 0.0 0.8 0.6 4.9 2.6 0.6 0.6 0.6 0.0 1.8 4.7 0.6 2.5 0.8 0.6 0.6 0.6 0.6 0.6 0.8 0.6 0.6 0.6 4.1 1.4 2.3 0.6 1.1 0.6 1.6 0.0 0.6 0.6 2.1 0.6 0.5 0.6 1.5 0.6 0.6 0.5 7.2 0.6 0.6 3.6 0.6 0.6 0.6 0.6 0.4 0.1 0.0 0.3 0.2 2.2 0.1 0.0 2.8 0.6 7.5 2.7 5.8 0.3 1.2 8.8 0.9 4.0 0.0 1.1 0.2 0.0 2.0 4.2 0.0 1.4 0.7 2.3 7.2 2.8 0.0 0.0 0.0 2.0 0.0 0.2 6.9 0.6 0.5 1.5 2.0 0.0 2.0 0.0 0.3 0.9 4.1 0.5 0.0 8.3 0.1 0.0 1.4 0.9 0.0 1.9 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.1 0.4 0.6 0.1 1.1 0.4 1.1 0.0 0.0 0.0 0.5 0.1 0.4 0.2 0.3 1.2 0.1 0.4 0.7 2.2 0.0 0.2 0.3 0.0 0.0 0.1 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZNF705D ENSG00000215343 "Zinc finger protein 705D" P0CH99 8 12104389-12115516 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "epididymis: 9.7" "Group enriched" "Detected in some" 31 "Early spermatids: 4.2;Late spermatids: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" NA NA "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705G ENSG00000215372 "Zinc finger protein 705G" A8MUZ8 8 7355517-7385558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 28 "epididymis: 1.3;testis: 4.3" "Group enriched" "Detected in some" 15 "Early spermatids: 29.2;Late spermatids: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "LHCN-M2: 3.2" NA NA "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ZNF709 FLJ38281 ENSG00000242852 "Zinc finger protein 709" Q8N972 19 12461184-12513854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 31.1;Late spermatids: 26.0;Spermatocytes: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045573, HPA053153" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045573: AB_2679370, HPA053153: AB_2682060" "unprognostic (2.27e-1)" "unprognostic (7.40e-4)" "unprognostic (3.53e-2)" "unprognostic (3.01e-2)" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (4.19e-3)" "unprognostic (2.58e-4)" "unprognostic (6.76e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-3)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" "unprognostic (1.71e-1)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (8.53e-5)" 3.4 3.0 7.8 4.8 8.4 2.0 5.1 12.7 7.3 5.0 2.7 3.2 5.6 0.7 5.5 5.3 2.4 6.6 2.4 3.6 6.2 5.4 5.4 2.0 3.0 2.7 3.8 4.6 8.4 4.1 6.2 8.0 3.5 4.9 5.7 2.1 3.3 3.4 4.5 2.5 2.8 2.7 5.1 5.5 4.0 2.6 26.6 5.0 7.2 8.5 0.0 4.0 4.1 4.5 2.0 1.3 3.5 1.1 5.5 4.4 1.0 1.9 0.0 6.3 7.7 1.2 1.8 1.0 1.9 2.2 2.1 2.3 1.7 0.2 1.8 1.3 2.0 0.6 1.3 3.4 1.3 2.4 0.3 0.9 1.6 1.1 1.2 2.5 0.4 2.7 1.0 0.6 1.2 0.0 3.0 1.4 2.4 1.0 0.2 2.7 3.5 4.0 2.2 2.1 0.7 2.0 2.2 6.1 5.7 2.2 3.0 2.9 4.0 0.0 0.3 0.8 2.9 1.5 1.0 0.0 3.3 0.7 1.4 1.3 3.4 4.8 2.6 0.0 0.0 1.5 3.5 0.4 0.1 2.0 0.1 3.1 1.7 3.3 2.1 0.9 2.0 4.4 3.1 0.1 5.5 1.1 1.3 1.8 1.0 7.8 8.4 12.7 7.3 6.2 5.4 3.8 4.6 4.9 5.0 0.0 0.3 0.0 0.1 0.3 0.5 0.3 0.0 0.0 1.2 1.8 0.0 0.4 0.0 0.4 31.1 0.1 0.0 0.0 0.3 0.2 0.4 0.4 0.0 0.0 0.4 0.0 0.0 1.3 1.0 26.0 0.9 0.2 0.0 0.0 0.6 1.5 0.2 0.0 0.7 0.7 2.1 6.5 0.3 7.2 1.7 0.5 0.2 0.0 0.0 0.1 ZNF713 FLJ39963 ENSG00000178665 "Zinc finger protein 713" Q8N859 7 55887475-55942225 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 13.4;Early spermatids: 14.3;Late spermatids: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 10.2" "Low region specificity" "Detected in all" "HPA059425, HPA062887" Uncertain Approved Nucleoli NA NA Nucleoli "HPA059425: AB_2684013, HPA062887: AB_2684894" "unprognostic (5.27e-2)" "unprognostic (2.50e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" "unprognostic (1.36e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-3)" "unprognostic (1.46e-1)" "unprognostic (7.07e-2)" "unprognostic (4.63e-2)" "unprognostic (2.77e-3)" "unprognostic (7.78e-2)" "unprognostic (4.80e-2)" "unprognostic (8.00e-2)" "unprognostic (8.16e-3)" "unprognostic (1.34e-1)" "unprognostic (1.63e-3)" 2.0 2.7 7.0 2.6 9.7 4.1 4.0 5.6 9.3 3.8 2.2 10.6 2.7 2.7 5.5 3.5 1.7 7.1 2.9 2.4 7.8 6.1 3.9 1.7 2.6 1.7 13.4 4.8 5.6 3.2 4.2 8.1 2.2 7.3 4.1 1.9 2.6 2.4 2.9 4.7 3.1 1.9 3.7 9.8 2.5 4.0 9.4 10.6 6.9 4.9 0.4 1.8 2.1 2.0 2.2 1.7 6.9 1.3 1.4 1.0 0.4 1.8 1.2 7.4 6.7 0.9 1.0 2.6 0.8 0.5 1.0 1.4 0.7 2.4 3.1 2.7 0.6 2.1 0.7 1.8 0.6 1.4 1.7 2.9 0.7 2.5 1.9 1.2 3.7 2.0 1.7 1.5 0.5 1.4 1.7 1.8 3.4 2.0 1.4 1.2 1.6 3.7 2.2 5.0 1.9 1.4 3.1 1.8 0.4 3.6 3.3 8.6 10.2 4.3 1.2 1.2 4.1 2.8 3.3 1.9 0.9 3.6 0.7 1.2 1.6 2.2 1.4 0.6 2.1 6.3 3.7 1.3 3.3 0.9 1.0 0.6 1.3 0.7 0.6 0.4 2.2 0.9 1.0 6.9 1.4 1.0 1.7 0.4 0.4 7.0 9.7 5.6 9.3 7.8 6.1 13.4 4.8 7.3 10.6 0.0 3.0 0.0 2.8 1.1 2.8 1.5 5.1 13.4 4.5 0.0 9.8 1.0 0.0 1.0 14.3 1.4 0.3 0.0 1.2 1.0 1.4 1.6 1.1 0.0 0.4 7.9 0.0 1.3 2.1 12.1 0.6 1.8 0.0 0.0 1.0 5.8 1.3 0.0 2.5 0.5 2.7 6.5 1.4 6.0 6.1 1.6 1.7 1.3 0.9 2.2 ZNF716 FLJ46189 ENSG00000182111 "Zinc finger protein 716" A6NP11 7 57450177-57473546 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.9;testis: 6.9" "Group enriched" "Detected in some" 7 "Early spermatids: 3.2;Late spermatids: 2.5;Spermatocytes: 1.5;Spermatogonia: 4.3" "Cancer enriched" "Detected in single" 23 "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.8;SuSa: 1.2;T-47d: 3.1" NA NA "unprognostic (1.57e-1)" "unprognostic (1.95e-2)" "unprognostic (1.21e-1)" 0.1 0.2 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.7 0.2 0.1 0.1 0.1 0.1 6.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.9 0.6 2.9 0.6 1.1 0.9 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 1.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.1 4.8 0.0 0.2 0.2 0.1 0.1 0.1 0.0 1.2 3.1 0.0 0.0 0.2 0.8 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 2.4 0.6 0.7 0.6 0.4 0.3 0.6 0.6 0.4 0.2 0.9 0.9 0.8 2.9 1.1 0.3 0.6 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.5 4.3 0.0 0.0 0.0 0.0 0.3 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041570 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 15.1 15.8 11.1 13.7 11.8 9.9 12.7 16.8 17.6 14.3 12.4 11.3 17.7 7.2 11.7 17.4 16.4 12.8 10.3 10.1 11.1 15.1 14.2 11.6 10.7 17.5 15.5 11.0 9.6 12.9 13.4 24.5 19.4 15.5 14.5 14.0 11.4 13.9 17.7 10.3 17.3 10.1 13.2 14.3 18.4 14.1 13.7 15.9 16.6 19.2 11.0 18.1 14.6 11.6 14.4 8.9 23.0 5.5 12.8 14.2 5.0 10.3 7.3 9.1 8.0 7.9 12.1 8.8 11.0 7.2 5.4 7.2 5.2 11.1 5.0 19.5 3.7 8.0 7.2 8.8 4.3 8.1 22.3 4.7 2.8 3.9 14.9 11.9 5.9 15.4 8.2 11.9 3.8 5.4 10.9 10.1 12.3 9.3 6.6 5.8 16.7 6.1 7.8 8.9 7.2 5.8 11.5 4.0 7.8 6.1 6.5 4.1 6.2 11.2 5.1 9.9 14.9 9.7 11.8 6.6 3.9 3.1 7.9 3.3 11.1 12.1 14.4 3.5 9.2 6.2 13.9 4.8 23.0 14.2 5.4 10.6 13.7 10.0 12.7 5.2 14.4 9.3 11.7 6.3 12.8 5.5 8.9 12.2 5.0 11.1 11.8 16.8 17.6 11.1 15.1 15.5 11.0 15.5 15.9 14.9 15.2 14.3 15.8 8.0 23.9 12.0 5.1 20.1 13.6 5.2 5.9 27.2 19.9 15.4 1.7 17.9 6.3 0.0 11.9 10.9 12.4 22.4 20.8 8.9 14.6 22.3 16.7 16.0 9.7 1.5 12.4 15.1 10.1 12.6 12.4 19.0 14.5 10.5 17.3 11.8 8.9 32.3 11.4 24.1 17.6 10.0 59.4 16.0 10.7 18.7 ZNF724 ZNF724P ENSG00000196081 "Zinc finger protein 724" A8MTY0 19 23221599-23250390 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 1.4;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 4.3;granulocytes: 2.3;Syncytiotrophoblasts: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 14.3" NA NA "unprognostic (2.02e-1)" "unprognostic (1.65e-1)" "unprognostic (1.78e-2)" "unprognostic (3.80e-2)" "unprognostic (2.27e-2)" "unprognostic (2.33e-1)" "unprognostic (1.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (5.34e-2)" "unprognostic (3.07e-2)" "unprognostic (2.73e-2)" "unprognostic (3.20e-1)" "unprognostic (3.76e-1)" "unprognostic (3.30e-2)" 2.6 1.8 3.0 7.5 4.0 8.1 2.2 5.3 4.4 2.1 1.9 0.8 0.5 1.2 2.0 2.2 8.7 1.3 1.5 2.7 1.8 2.4 2.4 1.7 2.2 5.5 2.5 2.6 2.0 1.7 1.5 1.3 2.4 3.4 2.8 2.5 0.5 2.4 1.8 2.1 2.6 2.1 1.7 5.7 7.1 6.5 6.1 3.7 16.5 2.1 0.9 3.3 2.1 2.5 5.1 3.2 5.9 1.6 4.6 2.6 0.4 3.5 2.3 6.0 7.4 0.5 0.8 7.1 1.8 1.6 4.6 5.4 3.6 1.2 3.7 4.3 1.8 1.8 2.3 6.5 2.8 8.2 0.5 7.1 3.7 1.3 1.5 0.3 0.1 3.6 0.4 0.4 5.4 3.7 0.6 0.2 5.2 5.5 0.3 2.8 5.3 9.0 2.1 14.3 0.1 4.8 5.0 8.0 2.7 0.6 4.4 3.6 3.5 0.0 0.1 0.8 5.3 2.1 2.1 0.1 1.7 0.2 5.3 4.8 0.0 1.5 7.9 0.0 1.0 1.4 4.0 1.6 0.7 2.5 1.4 1.3 3.9 1.7 1.9 1.2 5.1 2.1 2.6 5.9 4.6 1.1 3.2 1.0 0.4 3.0 4.0 5.3 4.4 1.8 2.4 2.5 2.6 3.4 3.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 2.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 ZNF726 ENSG00000213967 "Zinc finger protein 726" A6NNF4 19 23914876-23945159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 19.6" NA NA "unprognostic (5.40e-2)" "unprognostic (2.27e-1)" "unprognostic (4.41e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.80e-1)" "unprognostic (2.91e-2)" "unprognostic (8.26e-4)" "unprognostic (5.65e-4)" "unprognostic (2.14e-2)" "unprognostic (9.87e-3)" "unprognostic (2.90e-2)" "unprognostic (4.25e-2)" "unprognostic (1.64e-1)" "unprognostic (4.97e-2)" "unprognostic (3.20e-3)" 2.3 2.4 4.9 6.5 5.5 9.1 7.9 9.0 7.1 7.2 3.4 4.8 6.1 2.2 4.3 10.0 6.5 3.3 5.5 1.5 5.5 6.7 5.4 5.6 3.9 7.2 4.3 4.8 3.1 2.2 5.5 2.1 7.7 6.2 4.9 7.3 3.8 3.5 4.8 2.7 8.9 3.5 2.1 4.9 5.8 5.7 10.1 4.5 23.2 4.2 3.0 6.8 5.0 7.3 2.0 1.8 9.2 0.8 5.2 2.1 0.8 0.8 1.3 11.5 6.3 0.8 0.8 0.6 2.8 0.9 6.1 5.9 0.9 3.7 0.0 5.4 1.2 4.5 0.8 10.6 0.1 8.4 7.6 5.6 4.5 0.9 0.2 0.4 0.1 2.6 0.8 0.6 3.7 0.2 0.7 0.0 6.6 3.4 0.1 2.3 3.8 19.6 13.3 6.9 0.0 6.0 14.6 8.6 3.3 2.2 4.6 3.8 6.4 0.0 0.1 2.8 5.9 7.4 0.9 0.8 2.2 1.7 9.6 5.8 0.1 6.0 9.1 0.1 1.7 3.1 9.2 0.8 0.4 0.9 0.8 0.3 1.4 1.9 1.7 0.7 2.0 1.8 2.1 1.5 5.2 0.6 1.8 1.9 0.8 4.9 5.5 9.0 7.1 5.5 6.7 4.3 4.8 6.2 4.5 3.0 0.0 1.5 1.2 0.8 3.0 3.5 2.5 4.0 1.2 3.5 0.0 6.2 1.7 1.1 0.1 1.0 0.0 0.0 0.2 5.6 1.7 0.7 3.5 1.7 1.9 4.8 0.0 1.8 1.0 0.0 0.3 1.4 0.0 1.0 0.7 0.3 0.5 0.0 1.8 0.4 1.3 0.0 0.8 1.6 5.1 1.5 3.4 3.9 0.4 1.3 ZNF729 ENSG00000196350 "Zinc finger protein 729" A6NN14 19 22286408-22317176 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.6;testis: 9.7" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Spermatocytes: 4.1;Spermatogonia: 4.4" "Cancer enriched" "Detected in single" 41 "testis cancer: 5.3" "Group enriched" "Detected in many" 5 "amygdala: 1.2;cerebral cortex: 1.1;hippocampal formation: 3.6;olfactory region: 1.5;pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.2;NTERA-2: 7.2;SuSa: 4.0;T-47d: 1.8" NA NA "unprognostic (1.84e-1)" "unprognostic (2.14e-3)" "unprognostic (3.05e-4)" "unprognostic (1.30e-1)" "unprognostic (1.74e-1)" 0.2 0.1 1.2 0.1 0.3 0.0 0.5 0.1 1.1 0.1 0.1 0.0 1.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 3.6 0.1 0.7 0.1 0.1 0.0 0.1 1.5 0.2 0.1 0.4 0.1 0.8 1.5 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 1.5 0.1 0.1 9.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 7.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.1 1.1 3.6 0.1 0.1 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.4 0.0 0.2 0.0 0.0 0.0 ZNF730 ENSG00000183850 "Zinc finger protein 730" Q6ZMV8 19 23075210-23147219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.2" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 18.6;Late spermatids: 11.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 12.0;NTERA-2: 15.8;REH: 13.9;U-698: 12.6" NA NA "unprognostic (6.75e-3)" "unprognostic (2.49e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-3)" "unprognostic (3.33e-2)" "unprognostic (1.78e-2)" "unprognostic (4.24e-4)" "unprognostic (9.34e-2)" "unprognostic (1.01e-1)" "unprognostic (4.92e-2)" "unprognostic (3.10e-2)" "unprognostic (5.98e-2)" "unprognostic (1.37e-3)" "unprognostic (5.53e-2)" "unprognostic (1.90e-1)" "unprognostic (6.67e-2)" "unprognostic (1.43e-2)" 0.9 0.7 3.4 3.6 3.0 2.5 2.0 2.5 3.6 1.2 0.9 1.9 1.1 0.1 2.5 2.7 1.2 1.9 1.5 1.1 2.2 3.1 0.9 0.7 1.3 3.2 2.2 3.5 5.1 0.8 2.3 1.8 6.3 7.2 3.2 1.4 3.5 0.8 0.8 0.7 0.9 0.8 1.9 4.1 0.9 0.8 9.9 1.0 25.2 2.0 0.2 3.7 1.1 1.3 0.9 1.5 0.3 0.4 0.2 0.5 0.3 0.0 0.0 11.6 8.4 0.5 0.9 2.5 3.4 0.0 7.1 12.0 0.0 0.0 0.0 4.3 2.1 3.4 0.0 1.2 0.4 10.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 1.4 0.0 3.2 1.0 0.8 0.0 9.2 4.0 0.0 6.3 1.6 10.4 3.2 15.8 0.0 2.0 13.9 7.0 0.7 0.9 7.7 0.0 6.7 0.0 0.0 0.0 8.5 5.5 3.7 0.1 0.1 0.6 2.3 3.4 0.0 2.4 12.6 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.4 0.0 0.6 0.3 0.3 0.6 0.9 0.0 0.1 0.0 0.2 0.0 1.5 0.0 0.3 3.4 3.0 2.5 2.3 2.2 3.1 2.2 3.5 7.2 1.0 0.0 2.6 0.0 0.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 18.6 0.4 0.0 0.0 0.2 1.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.3 1.9 3.2 0.0 1.1 0.0 0.0 0.1 ZNF732 FLJ59067 ENSG00000186777 "Zinc finger protein 732" B4DXR9 4 270675-305321 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 19.5" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 8.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NTERA-2: 12.3" NA NA "unprognostic (7.83e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.54e-2)" "unprognostic (8.99e-4)" "unprognostic (7.60e-3)" "unprognostic (8.13e-2)" "unprognostic (3.83e-2)" "unprognostic (4.89e-3)" "unprognostic (1.44e-3)" "unprognostic (3.60e-3)" "unprognostic (5.45e-3)" "unprognostic (8.40e-4)" "unprognostic (3.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-1)" 0.7 0.6 1.1 3.8 5.9 0.6 1.9 4.6 1.8 1.3 1.0 0.1 0.8 0.4 1.6 0.2 2.3 1.1 0.6 0.9 1.1 1.1 0.5 0.3 0.6 2.3 0.8 0.3 2.3 0.7 0.7 2.2 2.3 1.5 1.3 0.3 0.2 0.8 0.3 0.2 3.3 0.4 1.0 0.9 1.0 0.4 19.5 0.4 0.3 1.6 2.4 2.8 2.0 1.2 0.5 0.1 0.1 0.0 0.9 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.3 0.0 2.4 0.0 0.0 0.0 1.0 1.5 0.0 2.8 0.0 0.0 0.0 3.0 2.7 0.0 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.9 0.0 0.1 0.1 0.0 1.1 5.9 4.6 1.8 1.1 1.1 0.8 0.3 1.5 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 8.3 0.3 0.0 0.0 0.0 0.0 ZNF736 ENSG00000234444 "Zinc finger protein 736" B4DX44 7 64307459-64354860 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 36.3;Late spermatids: 47.2;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (2.41e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (4.14e-1)" "unprognostic (1.24e-1)" "unprognostic (1.20e-3)" "unprognostic (4.89e-2)" "unprognostic (2.51e-2)" "unprognostic (2.11e-2)" "unprognostic (2.01e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.26e-1)" "unprognostic (9.63e-2)" "unprognostic (5.28e-2)" "unprognostic (2.22e-3)" "prognostic favorable (8.65e-4)" 7.1 5.4 8.5 8.2 17.4 17.0 12.9 8.3 19.8 7.7 5.5 7.8 4.7 3.9 8.4 9.8 5.4 7.7 6.3 5.3 7.5 6.0 8.2 3.7 7.4 14.0 5.5 8.2 13.1 7.5 6.2 7.6 5.4 13.8 8.6 6.1 11.5 7.7 5.7 4.2 13.1 8.5 6.3 5.8 10.1 6.2 16.8 7.0 17.1 10.6 2.0 11.4 6.1 7.4 4.7 3.5 2.8 2.1 0.3 2.4 1.0 0.5 0.2 4.6 15.9 1.7 3.1 4.7 2.5 0.1 3.3 5.4 1.2 2.6 11.9 3.8 2.1 4.5 2.0 3.5 1.0 5.3 0.2 3.3 4.8 1.4 0.1 1.7 2.1 6.9 2.5 1.0 3.8 0.1 1.6 0.4 7.0 5.7 2.6 4.6 3.0 7.2 11.3 8.9 0.1 0.9 6.2 7.2 5.8 4.1 7.0 5.0 7.3 5.7 4.1 1.5 9.1 11.3 8.8 0.3 5.2 3.7 1.3 3.0 3.1 4.3 14.5 0.1 2.6 0.1 0.0 1.9 2.8 1.5 1.8 1.1 4.7 2.3 1.3 2.1 4.5 2.4 1.9 0.4 0.3 2.1 3.5 1.0 1.0 8.5 17.4 8.3 19.8 7.5 6.0 5.5 8.2 13.8 7.0 6.0 4.8 7.7 2.1 3.4 14.4 2.8 10.2 1.4 4.5 5.2 11.8 3.0 5.0 3.3 36.3 4.3 1.3 0.0 1.9 2.6 3.1 2.5 0.0 2.9 3.1 7.9 1.2 6.2 5.3 47.2 2.3 6.4 3.3 1.8 4.7 6.8 1.9 2.9 2.8 3.4 44.8 0.0 2.0 6.3 6.5 3.4 2.3 4.4 2.8 1.7 ZNF737 ZNF102 ENSG00000237440 "Zinc finger protein 737" O75373 19 20535825-20565809 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 8.3;Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 19.0;RT4: 20.0" NA NA "unprognostic (3.86e-2)" "unprognostic (1.61e-1)" "unprognostic (8.63e-2)" "unprognostic (3.42e-1)" "unprognostic (3.14e-2)" "unprognostic (1.23e-3)" "unprognostic (1.61e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-2)" "unprognostic (1.51e-2)" "unprognostic (2.62e-2)" "unprognostic (1.06e-1)" "unprognostic (1.33e-3)" "unprognostic (8.49e-2)" "unprognostic (8.28e-2)" "unprognostic (3.43e-2)" "unprognostic (1.47e-3)" 5.4 15.4 13.4 10.6 26.1 3.8 12.8 19.9 13.0 10.3 6.2 6.8 21.9 3.6 7.7 10.9 4.5 9.4 5.8 5.3 10.5 8.9 9.0 2.8 6.4 13.8 14.7 8.9 27.9 13.5 14.7 21.7 4.4 10.4 10.2 7.7 5.0 7.6 17.8 3.0 11.0 6.9 5.6 14.0 9.4 8.8 3.6 17.2 19.1 33.1 3.0 12.4 16.7 8.5 10.9 2.5 6.9 0.8 2.7 7.8 1.9 0.1 0.6 3.7 9.4 5.5 8.9 3.9 3.1 2.1 4.2 5.1 1.7 3.2 5.2 5.6 3.4 3.2 1.5 0.4 0.8 5.1 0.3 2.3 0.2 0.8 2.3 2.0 0.5 0.1 4.3 2.3 1.8 0.6 3.7 2.6 5.9 0.4 0.6 3.9 1.4 19.0 3.7 5.1 0.0 0.1 9.8 6.5 1.2 5.6 20.0 8.2 6.9 0.0 0.2 1.2 10.7 4.0 3.5 1.2 0.2 0.1 3.8 2.5 1.6 7.1 5.9 0.1 0.0 1.5 4.5 0.4 4.8 5.5 0.7 4.7 8.0 6.9 7.7 1.0 10.9 7.8 5.9 6.9 2.7 0.8 2.5 5.6 1.9 13.4 26.1 19.9 13.0 10.5 8.9 14.7 8.9 10.4 17.2 0.0 1.3 0.8 0.7 0.2 6.9 1.3 0.0 1.4 5.7 1.8 0.0 0.7 8.3 1.5 1.5 1.5 0.0 0.0 1.5 0.9 1.0 1.0 1.1 0.0 0.3 15.9 0.0 2.5 0.6 0.5 3.7 0.9 0.0 1.0 0.6 3.9 1.2 2.9 1.8 1.3 2.6 0.0 0.9 5.2 7.5 0.3 1.1 0.9 0.6 0.6 ZNF738 ENSG00000172687 "Zinc finger protein 738" Q8NE65 19 21358930-21379302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 25.3" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (1.00e-1)" "unprognostic (1.59e-1)" "unprognostic (4.48e-2)" "unprognostic (4.35e-3)" "unprognostic (4.47e-2)" "unprognostic (1.37e-1)" "unprognostic (1.55e-2)" "unprognostic (6.22e-2)" "unprognostic (4.27e-3)" "prognostic favorable (2.27e-4)" "unprognostic (2.10e-1)" "unprognostic (3.51e-2)" "unprognostic (7.39e-5)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.20e-2)" 5.1 4.6 8.1 7.8 21.5 17.5 5.8 25.1 12.5 6.3 4.7 13.6 3.4 4.8 9.4 6.7 5.9 6.3 4.8 4.3 9.3 10.1 4.4 1.4 5.3 9.8 18.6 9.9 14.8 4.7 3.9 4.5 10.6 14.7 6.3 6.4 7.3 6.0 5.2 3.0 6.7 5.5 6.5 13.2 6.9 5.2 7.5 16.0 14.8 6.3 3.0 9.5 5.8 6.2 8.8 5.4 10.0 7.9 7.6 7.2 3.2 1.5 0.9 23.9 9.0 2.9 2.3 16.9 5.8 2.3 11.0 11.4 2.0 7.5 5.1 6.1 2.1 6.7 4.2 8.3 2.7 15.1 6.5 6.4 4.1 1.7 1.6 1.6 1.5 1.4 2.0 1.6 6.3 3.5 4.2 4.8 13.9 0.2 0.2 6.6 1.6 19.0 7.8 25.3 0.1 4.3 19.9 9.7 3.2 2.7 3.6 11.3 5.5 2.2 0.2 3.2 18.2 2.8 14.3 3.2 1.4 1.6 7.4 5.2 0.5 7.9 13.5 0.3 0.5 2.8 7.2 6.2 7.8 3.9 6.4 3.5 7.2 4.8 4.6 5.3 8.8 4.8 4.7 10.0 7.6 7.9 5.4 7.2 3.2 8.1 21.5 25.1 12.5 9.3 10.1 18.6 9.9 14.7 16.0 8.9 0.6 3.2 4.8 3.1 8.6 1.4 5.1 2.7 1.2 14.0 13.7 20.6 6.6 5.5 1.7 6.8 0.8 0.0 6.6 22.2 6.1 3.6 2.3 0.0 9.8 0.0 4.1 5.5 8.3 1.7 4.9 5.6 5.0 0.0 2.9 3.5 5.4 0.0 3.9 0.7 13.1 32.3 5.3 12.7 20.0 1.6 13.0 5.1 3.4 4.7 ZNF75A FLJ31529 ENSG00000162086 "Zinc finger protein 75a" Q96N20 16 3305406-3318852 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA001665 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA001665: AB_1080751" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (1.64e-1)" "unprognostic (7.79e-3)" "unprognostic (6.32e-2)" "unprognostic (4.45e-1)" "unprognostic (2.67e-2)" "unprognostic (5.93e-2)" "unprognostic (4.66e-3)" "unprognostic (2.75e-3)" "unprognostic (6.79e-3)" "unprognostic (4.71e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "unprognostic (8.97e-3)" 10.0 11.4 13.6 14.8 15.7 9.0 15.0 19.6 15.4 10.6 10.1 17.2 14.4 8.0 12.4 26.1 9.5 14.1 9.0 9.0 13.2 12.2 12.7 16.2 10.4 18.1 12.8 14.4 19.3 13.6 32.1 23.5 12.7 17.7 16.2 15.1 10.1 10.6 15.4 10.4 13.8 12.8 10.8 10.3 15.6 10.1 13.5 15.9 15.8 17.9 7.7 18.0 10.2 8.6 25.2 13.8 15.2 9.1 17.8 23.0 3.3 4.5 6.8 12.7 6.4 6.0 5.5 10.8 7.3 3.0 6.9 8.2 0.1 5.9 7.3 5.0 5.3 8.5 3.4 7.6 4.4 10.4 3.1 10.2 15.6 7.9 0.6 4.3 9.9 15.8 7.5 4.6 7.3 5.5 6.8 6.2 7.1 8.8 12.1 9.6 6.3 15.1 6.8 19.6 4.4 4.7 31.5 6.2 8.8 7.4 7.5 11.5 8.2 11.5 4.6 4.5 18.2 14.9 12.7 7.2 5.1 13.0 4.9 5.8 8.4 7.4 21.0 1.7 11.3 7.9 13.3 6.7 15.2 13.0 6.2 16.0 16.8 14.8 13.3 5.2 25.2 23.0 17.2 4.8 17.8 9.1 13.8 11.9 3.3 13.6 15.7 19.6 15.4 13.2 12.2 12.8 14.4 17.7 15.9 20.8 9.4 33.5 23.3 3.7 39.7 10.6 10.2 9.4 14.8 15.7 31.4 15.0 5.0 18.8 2.1 11.8 12.0 0.0 8.9 8.4 8.8 17.0 12.8 7.8 9.0 46.1 5.8 12.9 9.5 1.9 21.6 13.3 8.5 17.2 7.9 32.0 10.4 9.5 25.1 6.3 63.2 25.8 9.5 37.6 26.6 3.0 13.2 34.9 11.5 14.6 ZNF75D "D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28" ENSG00000186376 "Zinc finger protein 75D" P51815 X 135248920-135344087 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 162.9;Late spermatids: 247.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004705 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA004705: AB_1080749" "unprognostic (1.56e-3)" "unprognostic (7.96e-3)" "unprognostic (3.07e-1)" "unprognostic (5.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "prognostic favorable (7.42e-5)" 8.4 18.8 8.2 14.6 9.7 9.2 9.9 11.4 10.5 11.8 10.6 9.2 10.4 6.9 10.7 12.8 7.6 9.8 7.9 7.6 5.6 7.7 10.6 13.4 9.7 11.2 6.2 7.7 10.1 12.9 12.6 14.7 8.0 9.2 15.0 8.4 7.5 10.0 11.8 6.6 9.9 10.6 7.5 5.9 18.6 9.7 3.4 6.7 16.6 13.2 9.3 13.3 8.0 8.6 3.7 1.8 4.1 2.1 5.2 6.5 2.9 3.5 4.6 5.1 8.1 8.6 10.5 7.7 5.9 8.1 4.9 10.5 2.8 4.4 3.6 8.8 5.0 9.4 4.8 16.5 2.7 4.7 3.5 4.4 2.5 8.4 3.7 3.8 4.3 7.3 5.1 6.5 3.0 3.7 6.1 4.9 4.8 2.2 5.9 4.2 8.4 5.2 7.8 2.4 7.1 6.3 5.0 5.0 3.2 5.4 4.8 1.7 5.7 3.3 5.7 0.9 5.6 2.0 6.2 5.2 4.6 1.1 7.8 5.6 3.0 4.2 2.7 2.9 4.7 2.9 4.1 2.1 3.7 4.9 1.5 4.5 2.9 5.2 5.6 1.8 3.7 6.5 5.9 2.6 5.2 1.5 1.6 6.3 2.9 8.2 9.7 11.4 10.5 5.6 7.7 6.2 7.7 9.2 6.7 6.0 14.6 1.4 1.1 1.5 4.2 3.9 0.0 5.3 6.8 0.0 5.9 1.9 1.7 1.5 162.9 7.0 2.7 0.0 3.5 1.1 3.1 2.1 5.8 4.3 2.0 4.8 1.7 6.2 3.1 247.1 6.1 3.3 0.0 1.0 5.3 4.5 2.7 2.9 3.2 3.1 4.5 0.0 3.1 3.5 2.7 1.3 1.5 5.4 3.1 1.4 ZNF763 ZNF440L ENSG00000197054 "Zinc finger protein 763" Q0D2J5 19 11965037-11980381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 9.7" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (4.09e-3)" "unprognostic (6.15e-4)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.43e-4)" "unprognostic (1.43e-1)" "unprognostic (8.26e-3)" "unprognostic (9.36e-3)" "unprognostic (1.93e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (6.07e-6)" "unprognostic (1.47e-1)" "unprognostic (3.08e-1)" "unprognostic (1.11e-1)" "unprognostic (8.89e-3)" 7.0 5.2 3.6 4.1 6.6 3.0 9.1 5.5 5.4 7.3 9.0 5.6 6.8 4.8 8.3 5.4 5.1 6.0 4.5 9.7 4.0 3.3 11.1 3.6 7.1 6.3 5.5 3.5 12.6 7.6 12.4 7.5 8.6 5.6 9.5 5.7 9.2 6.5 10.3 4.9 4.7 7.1 6.2 4.6 9.4 5.5 7.1 7.1 8.0 14.3 3.9 6.5 7.3 7.6 8.0 3.2 11.1 4.8 4.9 4.2 2.1 0.4 0.0 2.9 3.1 1.8 0.8 9.7 2.6 2.4 2.2 2.2 1.0 0.6 3.0 2.5 2.0 0.7 0.8 0.0 1.5 1.0 0.4 0.1 1.2 0.1 0.1 0.4 1.6 3.3 4.2 2.0 0.5 0.3 0.7 0.4 4.6 0.4 1.3 2.2 0.3 3.4 0.8 1.3 0.3 0.3 0.2 0.1 1.0 4.4 2.7 0.5 1.2 0.2 0.1 0.6 5.6 5.6 1.8 0.4 3.0 0.1 2.5 0.7 4.5 5.7 0.9 0.7 0.6 0.4 11.1 1.9 5.7 3.1 2.5 2.3 3.4 2.8 4.2 3.2 8.0 3.5 3.8 10.5 4.9 4.8 2.5 1.5 2.1 3.6 6.6 5.5 5.4 4.0 3.3 5.5 3.5 5.6 7.1 3.0 4.5 0.0 0.4 0.1 2.8 0.6 0.0 2.7 4.5 0.0 9.8 4.3 1.7 0.6 3.7 0.0 0.8 0.0 0.3 1.6 0.5 0.5 1.1 0.8 1.1 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 1.0 2.2 2.9 0.3 0.0 1.8 1.3 6.1 0.0 0.3 2.8 1.4 0.0 1.5 0.0 0.9 0.1 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favorable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favorable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 6.3 6.6 6.6 5.4 8.9 5.6 13.2 18.2 9.8 8.4 6.1 8.4 9.9 4.1 8.5 8.5 7.5 7.3 4.2 7.4 5.9 5.8 6.4 6.3 12.7 6.6 7.0 7.8 9.7 8.2 8.2 8.2 8.2 6.5 6.9 6.4 8.9 11.4 6.7 6.1 8.3 6.1 8.7 5.5 6.8 8.1 8.3 4.3 9.6 8.8 4.0 9.3 6.4 6.7 5.5 3.7 1.3 3.1 3.9 6.2 3.3 4.7 2.2 10.8 6.3 2.3 3.0 4.9 2.9 4.3 5.8 6.9 7.3 1.9 5.3 2.4 3.2 3.2 3.8 7.0 4.7 9.8 0.4 5.1 6.4 3.4 8.1 5.7 0.2 5.3 4.6 6.5 4.5 6.7 7.2 8.0 10.5 8.4 0.0 3.9 5.2 7.8 4.6 2.4 4.1 3.1 8.9 8.3 3.7 4.6 7.4 4.4 8.3 4.4 4.2 5.0 5.5 4.0 11.1 3.8 2.4 3.1 6.8 5.2 5.5 5.3 2.5 6.2 0.1 4.4 0.0 2.7 1.3 5.5 2.6 6.2 5.5 5.8 5.9 3.7 5.3 4.5 6.2 0.2 3.9 3.1 3.0 2.8 3.3 6.6 8.9 18.2 9.8 5.9 5.8 7.0 7.8 6.5 4.3 3.0 3.8 0.0 4.2 10.3 2.8 2.0 0.0 2.7 4.5 1.8 2.0 2.9 0.0 1.8 1.6 2.1 1.3 0.0 1.5 2.6 2.2 2.0 2.3 1.5 1.5 0.0 6.9 3.1 0.6 0.0 2.6 1.6 1.7 0.0 2.2 3.0 2.0 1.9 1.4 1.0 5.5 0.0 2.1 10.0 7.3 9.5 5.1 1.9 3.1 1.8 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 9.0 10.3 7.3 7.0 10.8 10.7 12.5 15.4 11.3 6.0 7.7 6.0 11.2 8.2 8.4 11.4 6.8 8.7 8.4 7.3 7.2 6.9 8.2 4.9 8.1 16.1 8.6 7.8 12.1 5.6 16.0 14.6 8.7 8.2 9.7 7.1 9.6 9.0 8.1 17.8 10.7 7.9 8.8 9.7 11.3 6.9 8.8 4.7 12.7 12.3 6.2 10.4 9.2 9.6 14.8 6.9 16.2 4.8 8.9 17.2 5.8 1.8 3.2 5.6 7.3 4.0 5.0 0.3 5.4 8.1 4.8 19.9 3.3 2.7 3.5 2.9 3.5 3.6 1.4 2.7 5.7 7.1 0.1 17.4 5.9 0.4 2.0 7.7 4.4 4.8 11.4 8.2 3.5 13.9 6.1 3.4 6.3 0.3 0.6 6.1 0.4 8.4 3.1 5.8 0.8 9.6 4.6 9.0 5.4 3.3 6.5 6.0 7.3 1.0 2.5 6.2 5.4 4.2 8.2 2.9 7.6 3.4 1.9 5.7 8.9 9.1 5.7 2.9 4.4 6.8 16.2 4.8 7.6 8.4 3.6 13.6 11.8 10.4 9.0 6.4 14.8 17.2 13.8 2.2 8.9 3.1 6.9 7.2 5.8 7.3 10.8 15.4 11.3 7.2 6.9 8.6 7.8 8.2 4.7 0.0 1.6 2.2 2.5 0.9 4.8 1.2 2.5 0.0 5.7 0.0 5.9 2.4 3.3 2.5 0.4 3.0 0.0 0.0 0.6 0.8 1.3 2.8 1.1 0.8 0.8 6.4 0.0 1.8 1.5 0.0 1.1 2.1 1.7 1.8 0.4 3.8 0.7 1.1 3.5 0.8 7.4 12.9 2.1 1.8 4.2 0.5 2.4 3.8 1.0 1.8 ZNF780A ZNF780 ENSG00000197782 "Zinc finger protein 780A" O75290 19 40069152-40090938 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (1.92e-1)" "unprognostic (9.25e-2)" "unprognostic (7.38e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (1.46e-2)" "unprognostic (1.19e-2)" "unprognostic (2.17e-1)" "unprognostic (4.47e-3)" "unprognostic (1.13e-1)" "unprognostic (9.49e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.30e-4)" 6.9 9.2 11.1 8.6 8.5 4.1 7.7 12.8 10.8 8.7 6.6 5.8 13.9 5.7 8.2 10.8 10.4 7.8 7.8 6.7 7.1 6.1 7.9 11.8 7.0 11.3 10.5 8.9 8.6 11.0 15.8 14.1 7.0 6.8 7.9 6.0 6.8 10.0 11.4 4.5 8.0 9.1 6.0 10.4 12.0 8.2 7.9 9.7 7.8 11.2 5.3 11.3 8.8 7.9 3.9 4.6 8.4 7.7 3.3 5.9 2.5 4.9 9.4 6.2 5.7 5.6 5.2 4.4 5.8 4.7 4.7 7.2 6.1 3.4 4.4 3.8 2.8 4.7 4.2 3.9 3.3 5.3 7.5 5.3 6.9 7.8 5.8 5.0 7.2 5.8 5.3 3.7 4.8 4.0 6.4 4.9 5.0 7.8 7.5 4.0 2.9 2.9 2.4 4.9 4.8 2.9 2.3 10.9 2.6 3.9 10.2 3.8 7.3 8.6 3.3 3.8 5.7 4.1 8.7 3.6 5.8 7.7 5.3 4.6 7.4 6.5 4.4 3.7 5.0 3.9 2.7 5.4 8.4 3.9 4.9 5.1 3.7 4.2 3.5 4.6 3.9 5.9 5.1 4.7 3.3 7.7 3.6 4.5 2.5 11.1 8.5 12.8 10.8 7.1 6.1 10.5 8.9 6.8 9.7 8.9 12.2 4.4 3.5 3.4 5.7 3.7 7.6 8.1 9.1 8.7 2.0 5.0 8.3 11.9 17.3 7.7 7.4 0.0 42.0 6.3 5.5 3.0 16.1 33.6 13.1 4.8 3.4 11.6 25.0 1.1 4.0 17.9 11.8 8.2 7.2 3.5 24.5 8.6 4.9 13.3 6.6 6.5 6.2 5.8 2.5 2.3 4.9 11.5 6.6 2.7 ZNF780B ZNF779 ENSG00000128000 "Zinc finger protein 780B" Q9Y6R6 19 40028260-40056209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.1;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (3.28e-1)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (3.56e-3)" "unprognostic (5.54e-2)" "unprognostic (1.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.24e-2)" "unprognostic (4.59e-3)" "unprognostic (1.83e-3)" "unprognostic (1.33e-2)" "unprognostic (4.89e-3)" "unprognostic (4.71e-2)" "unprognostic (1.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-3)" 6.3 8.2 12.4 9.8 18.8 3.3 10.3 22.2 14.0 8.2 8.5 8.2 11.6 5.7 10.8 12.3 5.5 10.0 6.6 12.5 9.4 7.2 9.4 6.7 5.9 9.7 8.1 10.8 16.6 8.1 10.5 24.7 7.1 11.6 9.7 7.6 9.3 7.9 10.5 6.9 7.1 7.6 9.7 7.8 9.2 7.2 5.0 11.4 8.7 14.0 6.4 9.8 9.1 8.2 4.2 5.9 1.5 3.2 2.3 5.1 1.3 2.6 3.5 5.9 4.1 3.6 2.4 0.0 3.1 2.3 3.4 4.5 6.3 2.4 6.6 2.9 3.2 3.4 1.6 4.9 1.9 4.0 5.5 2.5 5.1 6.2 3.9 2.4 7.6 4.3 3.4 1.2 4.7 2.9 2.6 3.2 3.0 5.3 8.9 3.4 1.2 2.5 1.2 5.8 2.3 3.7 3.5 10.4 2.3 2.0 14.5 6.5 6.9 5.4 2.4 1.9 3.7 2.8 3.3 5.8 3.3 8.3 5.8 4.7 6.7 8.6 5.1 3.1 4.0 2.8 0.1 3.2 1.5 2.8 2.8 2.9 2.5 3.4 3.3 2.4 4.2 5.1 4.2 0.6 2.3 1.8 5.9 1.9 1.3 12.4 18.8 22.2 14.0 9.4 7.2 8.1 10.8 11.6 11.4 8.9 8.1 4.2 2.3 1.6 28.1 13.0 10.2 4.0 10.3 8.7 31.4 1.6 3.3 4.4 6.0 5.8 2.6 0.0 8.6 1.2 2.7 2.1 7.0 4.9 3.2 9.5 9.9 9.8 4.8 1.1 3.4 7.2 5.0 5.4 4.3 7.2 4.7 4.5 2.8 2.4 35.0 6.5 3.9 2.7 1.3 2.6 0.6 5.2 4.2 2.2 ZNF781 FLJ37549 ENSG00000196381 "Zinc finger protein 781" Q8N8C0 19 37667751-37692322 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 57.2;Late spermatids: 45.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 4.7;ASC diff: 4.7;HSkMC: 4.6;SH-SY5Y: 4.6;U-266/84: 5.4" HPA062512 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062512: AB_2684788" "unprognostic (3.01e-1)" "unprognostic (8.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.82e-2)" "unprognostic (1.76e-3)" "unprognostic (2.68e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-1)" "unprognostic (1.84e-3)" "unprognostic (1.67e-1)" "unprognostic (1.23e-2)" "unprognostic (2.11e-2)" "unprognostic (8.12e-2)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" 4.9 5.3 5.7 4.6 12.9 0.5 2.9 15.8 13.6 4.3 4.5 3.8 1.9 1.6 7.3 4.8 2.2 4.8 3.1 6.5 5.8 5.8 2.6 1.3 3.7 3.5 6.1 6.8 9.8 1.3 4.8 7.4 5.0 7.6 4.5 3.1 3.8 1.5 5.2 1.5 2.0 2.4 8.5 9.6 5.0 2.2 4.8 5.5 0.6 5.3 1.3 2.5 4.7 5.4 1.0 0.1 0.1 0.2 0.0 3.2 0.7 0.0 0.0 1.9 4.7 4.7 1.0 1.0 1.7 0.0 1.7 1.2 0.2 0.0 0.2 0.0 1.1 3.0 0.0 0.1 0.0 2.0 0.0 0.1 0.1 0.0 2.0 2.3 0.0 0.1 4.6 0.0 1.3 0.1 0.6 0.4 0.2 0.9 0.0 0.0 0.0 1.2 1.0 0.5 0.0 0.0 0.0 3.3 0.0 0.7 1.2 0.0 4.6 0.0 0.0 0.0 2.4 2.2 0.1 0.0 0.2 0.0 0.0 1.1 1.5 5.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.1 0.4 1.8 2.5 0.1 1.0 2.6 3.2 0.1 0.0 0.0 0.1 0.8 0.7 5.7 12.9 15.8 13.6 5.8 5.8 6.1 6.8 7.6 5.5 0.0 1.1 1.3 0.5 0.5 6.1 12.9 2.5 0.0 0.0 0.0 19.6 5.8 0.0 0.8 57.2 4.5 0.0 0.0 0.0 3.4 1.6 0.1 3.5 0.0 3.0 3.2 7.5 11.6 1.5 45.4 4.4 0.0 1.7 0.0 0.0 5.5 0.1 0.0 6.3 0.2 7.8 12.9 6.6 14.8 3.2 0.0 1.1 1.3 0.0 0.0 ZNF782 FLJ16636 ENSG00000196597 "Zinc finger protein 782" Q6ZMW2 9 96816472-96875623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 8.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011013 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA011013: AB_1080758" "unprognostic (5.51e-2)" "unprognostic (5.29e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.48e-2)" "unprognostic (2.82e-2)" "unprognostic (9.89e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-2)" "unprognostic (4.68e-3)" "unprognostic (3.63e-3)" "unprognostic (4.84e-2)" "unprognostic (3.55e-1)" "unprognostic (4.95e-1)" "unprognostic (2.61e-2)" "unprognostic (4.39e-2)" 5.3 4.2 7.4 7.4 8.4 2.5 7.6 19.8 8.0 7.5 5.3 6.9 5.9 6.1 7.9 8.5 5.2 5.5 5.8 4.0 6.8 4.5 7.1 5.5 4.4 5.9 5.9 4.8 9.3 12.7 11.8 15.1 4.9 7.7 7.5 6.9 5.4 8.0 7.3 9.2 8.6 7.1 5.3 6.5 6.4 6.6 13.9 8.3 6.0 8.8 2.5 7.4 5.6 10.8 2.3 0.2 0.7 0.5 1.0 2.2 0.4 2.9 2.3 5.8 8.9 1.6 2.2 4.0 2.8 2.8 4.6 3.4 2.7 3.1 5.7 3.7 2.0 5.4 4.1 5.1 1.8 4.5 5.7 2.2 5.3 4.7 2.7 1.7 7.3 3.7 1.3 3.8 3.7 1.9 2.2 1.5 7.0 7.0 5.8 2.7 5.0 7.6 3.6 4.3 5.2 5.1 6.8 7.1 1.9 3.1 1.9 5.9 4.5 3.8 2.3 3.0 4.9 4.3 4.2 3.3 6.0 3.5 6.0 3.1 5.5 3.9 2.7 2.5 1.8 4.3 0.0 0.5 0.2 1.1 0.5 2.2 2.0 1.0 0.0 0.2 2.3 0.9 0.7 0.7 1.0 0.2 0.2 0.6 0.4 7.4 8.4 19.8 8.0 6.8 4.5 5.9 4.8 7.7 8.3 0.0 5.5 0.9 1.4 1.6 5.7 1.4 0.0 1.4 0.0 1.8 7.9 0.7 0.0 1.3 5.6 1.6 1.7 0.0 1.5 0.2 0.5 1.7 5.7 1.0 1.1 3.2 0.0 1.8 0.6 6.9 1.7 0.7 0.0 3.6 1.4 2.2 1.0 0.0 2.8 1.6 6.5 0.0 1.0 8.6 2.4 0.9 0.6 0.7 1.2 1.8 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069643-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 17.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA021518: AB_2670734, HPA053459: AB_2682159" "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favorable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 3.9 4.3 8.7 6.1 9.6 3.3 5.1 10.4 15.2 6.0 5.1 4.2 6.4 4.6 6.9 6.1 6.8 6.7 4.8 3.2 6.4 6.1 4.5 5.4 7.3 8.2 4.8 5.8 8.3 6.0 7.6 8.5 3.8 4.0 6.8 3.4 5.4 5.3 5.8 4.1 13.0 5.1 6.6 3.4 7.7 5.1 2.9 4.2 8.4 6.1 5.8 6.5 6.2 6.1 7.2 4.5 2.9 5.0 8.4 12.1 5.3 4.5 8.2 6.6 11.1 4.0 1.7 9.4 2.7 2.9 3.1 2.5 4.3 4.3 6.4 6.8 1.9 5.4 5.2 4.0 3.8 2.0 7.0 6.1 3.2 4.8 5.4 3.4 6.2 4.3 2.3 4.3 3.9 2.8 3.2 2.9 4.7 5.6 3.7 2.9 14.1 10.5 10.6 12.0 4.3 6.2 7.9 3.2 4.2 2.5 6.3 7.8 12.4 6.9 6.5 5.1 4.3 4.2 2.9 3.7 3.7 2.1 6.3 4.0 13.4 9.9 3.5 6.1 4.0 4.0 1.7 3.7 2.9 12.1 5.0 9.8 7.2 8.5 10.7 4.5 7.1 11.3 9.5 1.1 8.4 3.9 3.9 5.1 5.3 8.7 9.6 10.4 15.2 6.4 6.1 4.8 5.8 4.0 4.2 0.0 0.6 2.4 2.1 2.4 9.4 2.5 0.0 2.7 0.0 3.5 2.0 2.1 3.3 3.7 0.3 1.5 1.3 0.0 1.3 1.9 1.9 1.2 4.6 2.1 1.9 17.5 4.6 2.5 1.2 0.0 2.8 2.0 0.0 2.8 1.0 2.7 1.8 2.9 3.9 1.8 5.7 0.0 1.9 3.1 8.3 1.5 1.6 4.9 2.6 1.7 ZNF789 ENSG00000198556 "Zinc finger protein 789" Q5FWF6 7 99472841-99503650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029500, HPA050793" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029500: AB_10603009, HPA050793: AB_2681240" "unprognostic (6.84e-3)" "unprognostic (5.75e-2)" "unprognostic (5.71e-2)" "unprognostic (2.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (1.25e-3)" "unprognostic (4.38e-3)" "unprognostic (5.16e-2)" "unprognostic (1.56e-1)" "prognostic favorable (7.14e-4)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (6.63e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "prognostic favorable (5.31e-6)" 6.1 5.5 11.0 15.9 10.0 11.6 9.2 31.9 14.4 6.1 9.2 9.2 11.0 15.1 10.9 12.8 5.0 7.8 6.6 4.0 10.0 8.5 9.0 8.1 6.5 10.5 6.8 9.8 8.9 7.8 6.3 13.3 4.6 7.6 16.4 12.5 14.8 10.3 13.8 8.9 13.3 12.6 8.5 8.6 11.2 8.4 17.6 8.1 8.4 9.3 4.8 10.1 4.1 5.6 3.9 14.2 2.0 1.6 4.1 7.0 2.1 11.2 3.8 6.2 11.2 1.8 2.1 8.6 5.8 2.2 3.5 7.7 6.4 7.7 8.6 4.9 2.6 4.1 5.7 3.5 3.3 4.9 3.9 6.0 6.5 10.6 10.8 3.1 4.4 14.9 2.3 3.0 7.5 3.3 2.3 3.7 11.1 9.7 8.4 3.2 10.7 5.3 11.9 6.3 5.3 6.0 7.0 5.9 9.0 4.6 3.5 6.2 6.8 4.1 11.2 6.5 3.7 3.0 7.0 6.9 6.7 8.2 10.0 5.6 5.1 7.0 10.8 10.6 8.0 7.2 2.0 1.6 1.5 2.7 1.1 2.9 2.7 3.4 2.9 5.6 3.9 7.0 4.2 0.4 4.1 1.4 14.2 5.3 2.1 11.0 10.0 31.9 14.4 10.0 8.5 6.8 9.8 7.6 8.1 0.0 4.6 4.2 3.8 4.8 17.5 1.7 2.5 6.7 4.5 1.8 13.7 4.0 1.7 3.6 21.1 5.6 4.7 23.3 4.8 3.0 3.4 2.5 3.5 2.9 5.6 6.4 5.2 0.6 4.4 6.4 3.1 6.6 6.8 2.8 5.1 10.9 3.5 4.5 4.2 3.4 13.5 0.0 4.2 10.6 3.8 4.5 1.8 4.8 5.6 3.0 ZNF790 "FLJ20350, MGC62100" ENSG00000197863 "Zinc finger protein 790" Q6PG37 19 36817428-36850787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA056134, HPA060288" Uncertain Approved Nucleoli NA NA Nucleoli "HPA056134: AB_2683049, HPA060288: AB_2797260" "unprognostic (1.14e-1)" "unprognostic (3.79e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (1.55e-1)" "unprognostic (5.10e-2)" "unprognostic (1.05e-1)" "unprognostic (1.03e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.48e-2)" "unprognostic (5.54e-2)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (2.85e-2)" 6.6 8.9 9.3 9.9 15.9 3.2 7.2 21.5 14.8 7.6 6.4 12.5 7.1 6.4 7.7 7.7 7.5 6.1 8.1 8.8 10.8 7.9 10.3 13.8 6.1 7.9 14.2 7.2 7.8 7.3 11.6 14.5 6.0 13.1 6.8 4.5 7.4 5.7 7.3 7.3 15.6 6.1 6.1 11.4 7.4 7.9 20.4 15.9 8.5 13.2 4.9 6.8 7.7 7.9 9.7 6.8 6.8 6.2 6.7 9.0 3.0 0.0 0.7 6.4 11.6 4.5 4.8 4.1 4.5 6.1 3.6 6.5 0.0 1.4 1.4 9.1 3.3 4.5 1.7 5.0 4.1 3.3 10.4 4.5 7.4 0.7 1.7 3.8 3.3 5.6 6.1 3.4 3.1 0.0 4.3 6.1 5.8 0.2 0.1 8.0 3.5 8.4 2.6 4.3 0.0 0.8 1.5 5.3 5.6 3.9 8.4 8.0 7.3 4.2 0.1 2.5 7.6 5.2 6.2 6.7 5.0 3.8 4.5 5.9 9.1 12.7 5.2 0.0 0.2 4.0 6.0 3.7 6.8 5.9 6.2 6.1 9.0 8.4 8.3 6.8 9.7 9.0 7.4 1.3 6.7 2.2 5.6 6.8 3.0 9.3 15.9 21.5 14.8 10.8 7.9 14.2 7.2 13.1 15.9 3.0 0.6 5.9 3.0 1.5 23.7 3.4 7.6 1.4 1.2 7.0 29.5 5.5 5.0 4.1 72.8 6.6 5.1 0.0 4.5 3.0 3.3 3.0 4.6 5.5 3.7 11.1 2.4 5.5 3.7 24.9 7.8 3.2 3.3 4.6 2.7 10.1 3.8 3.1 4.6 8.1 25.0 0.0 5.0 5.6 1.6 3.6 4.9 7.5 2.3 7.2 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021537: AB_2670741" "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favorable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favorable (1.39e-5)" 16.7 12.0 11.9 18.0 15.4 22.5 18.6 30.3 17.1 20.0 15.0 12.7 14.1 10.9 16.6 16.3 14.0 15.4 10.1 13.0 11.5 10.9 13.4 11.9 17.0 15.8 14.7 12.5 21.5 15.3 20.2 32.1 13.4 15.5 16.6 13.4 11.8 15.5 18.2 15.9 17.1 15.3 17.9 16.0 16.6 13.8 7.0 13.8 14.4 25.4 8.9 19.6 23.7 18.1 11.6 10.5 9.7 3.8 10.9 8.3 2.6 6.9 3.9 7.5 7.4 9.3 12.0 6.5 9.0 9.9 6.7 8.2 4.8 4.2 1.6 8.7 9.3 4.0 6.6 7.3 8.5 11.2 4.7 7.6 6.9 9.5 6.7 7.6 8.9 7.7 10.3 9.8 8.0 13.0 10.5 7.0 4.5 7.9 11.2 8.3 11.1 5.5 3.4 8.6 3.9 11.7 4.0 12.3 5.7 6.7 13.4 8.3 10.0 8.0 6.5 8.5 9.3 6.5 7.7 8.7 13.5 5.7 11.7 7.2 16.8 20.0 4.9 9.2 7.0 7.9 9.7 3.3 5.2 7.0 2.1 7.2 7.4 6.3 8.0 3.0 11.6 7.4 8.3 5.6 10.9 3.8 10.5 5.4 2.6 11.9 15.4 30.3 17.1 11.5 10.9 14.7 12.5 15.5 13.8 11.9 23.3 34.0 30.3 26.0 68.5 16.8 25.5 29.4 23.9 17.4 92.3 25.1 16.6 20.7 4.3 43.4 26.2 0.0 15.2 15.5 23.7 31.2 9.2 26.0 12.2 33.4 35.6 47.3 15.5 1.8 36.2 24.5 13.5 9.0 24.2 38.4 21.5 11.5 36.7 9.2 75.6 38.8 33.9 11.2 13.7 24.2 32.7 38.4 20.6 29.8 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.5 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 1.0 0.4 0.3 2.9 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.6 0.6 0.1 0.3 0.1 0.3 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.0 0.3 0.1 0.1 0.6 2.9 9.8 3.1 6.7 0.2 0.2 0.0 8.1 6.4 0.3 0.4 0.1 1.8 0.3 3.3 17.0 11.3 0.3 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 3.0 7.2 0.8 3.4 3.0 28.0 7.3 12.7 6.7 5.7 12.2 29.5 4.8 3.3 3.1 32.2 6.3 1.4 0.0 1.3 3.6 3.1 2.6 2.3 0.4 0.8 46.1 8.6 6.2 0.0 7.7 4.6 2.0 0.0 1.8 3.4 16.2 1.6 0.0 9.6 1.5 33.5 0.0 5.1 5.4 6.4 2.9 1.6 4.3 3.4 1.4 ZNF799 "HIT-40, MGC71805, ZNF842" ENSG00000196466 "Zinc finger protein 799" Q96GE5 19 12390016-12401271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 13.2;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (2.96e-1)" "unprognostic (1.10e-1)" "unprognostic (8.84e-2)" "prognostic favorable (2.39e-4)" "unprognostic (3.63e-2)" "unprognostic (5.18e-3)" "unprognostic (3.02e-1)" "unprognostic (8.83e-3)" "unprognostic (4.47e-5)" "unprognostic (1.45e-1)" "unprognostic (5.56e-3)" "unprognostic (6.55e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.04e-1)" "unprognostic (8.91e-3)" "unprognostic (1.23e-3)" 7.9 7.2 6.1 11.9 5.5 3.2 10.1 7.7 8.0 12.6 8.2 4.6 12.9 4.7 6.9 5.8 7.6 9.3 4.9 4.1 6.6 4.3 7.8 8.3 6.6 5.3 6.3 1.8 10.8 10.7 7.6 2.8 10.5 6.3 8.4 6.2 3.3 6.2 6.8 5.5 5.6 6.1 5.6 5.0 7.4 4.5 5.8 6.7 9.1 7.5 6.4 5.2 7.1 6.5 7.5 4.6 4.6 4.3 4.5 10.3 3.9 3.8 2.9 4.1 9.4 2.1 2.1 8.2 2.1 2.9 5.1 5.0 6.0 1.5 4.9 3.8 2.4 2.6 3.1 3.1 3.7 5.0 0.1 3.1 3.8 2.4 9.7 0.7 3.0 7.2 2.5 2.3 3.6 2.9 1.5 2.5 4.7 4.0 0.0 3.3 5.2 6.2 4.2 2.1 4.9 8.2 0.7 6.0 4.9 5.2 9.4 3.0 3.1 4.3 0.9 1.1 3.1 4.2 5.4 2.3 5.5 3.1 6.3 2.4 3.5 5.5 3.9 0.8 3.1 2.2 4.4 4.1 4.6 6.9 4.3 8.3 7.5 6.5 10.3 3.4 6.7 6.5 5.0 4.3 4.5 2.6 4.6 6.9 3.9 6.1 5.5 7.7 8.0 6.6 4.3 6.3 1.8 6.3 6.7 6.0 1.0 0.5 2.7 2.2 2.5 3.0 2.5 5.3 2.3 3.5 0.0 13.2 5.0 3.8 5.4 4.9 2.6 0.0 1.2 2.1 3.2 2.2 3.5 0.9 3.6 0.0 4.1 3.7 1.5 2.1 2.3 2.3 0.0 1.8 5.2 1.3 2.3 2.9 1.1 2.8 2.5 12.9 5.1 4.8 4.4 1.3 3.8 3.3 3.7 2.0 ZNF804A C2orf10 ENSG00000170396 "Zinc finger protein 804A" Q7Z570 2 184598366-184939492 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 31.6;lymphoid tissue: 9.6" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 31.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Region enriched" "Detected in many" 4 "cerebellum: 31.6" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029195 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029195: AB_10603011" "unprognostic (1.10e-1)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.08e-2)" "unprognostic (1.26e-2)" "unprognostic (1.50e-1)" "unprognostic (2.41e-1)" "unprognostic (4.45e-1)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (5.20e-2)" "unprognostic (4.98e-4)" "unprognostic (6.21e-2)" "unprognostic (4.04e-1)" "unprognostic (8.45e-2)" "unprognostic (4.93e-2)" 0.4 1.0 4.3 9.6 7.2 1.8 0.4 31.6 10.7 0.6 0.8 0.1 0.8 1.5 0.4 0.3 0.6 0.4 4.8 0.3 5.2 7.3 1.8 0.6 1.2 2.7 2.2 3.0 0.8 0.3 0.2 0.4 0.5 5.4 4.1 1.1 2.4 1.1 4.4 0.3 0.3 3.3 0.5 1.5 1.8 1.2 0.9 0.4 0.0 4.4 0.0 2.9 1.8 2.1 2.0 1.2 1.0 1.7 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 4.9 1.6 1.5 0.0 0.0 20.8 0.0 0.0 2.1 0.0 0.3 0.0 3.7 0.1 0.0 5.5 0.8 0.1 8.2 5.2 0.0 2.5 0.0 0.0 1.3 2.5 3.9 0.0 0.0 0.9 0.0 0.0 0.0 4.9 0.0 0.0 3.3 0.0 14.3 0.8 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.1 0.0 10.5 0.0 5.3 0.1 0.2 2.1 2.2 0.0 15.5 6.1 1.5 1.7 0.0 1.1 0.0 0.0 1.7 0.0 2.0 0.0 0.0 1.2 0.3 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.3 4.3 7.2 31.6 7.5 5.2 7.3 2.2 3.0 5.4 0.4 0.0 1.1 3.4 0.0 0.0 31.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.0 2.7 0.4 0.3 3.2 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 2.6 6.5 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 ZNF804B FLJ32110 ENSG00000182348 "Zinc finger protein 804B" A4D1E1 7 88759368-89337057 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "thyroid gland: 31.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 11.9;Proximal tubular cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "AF22: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026702 Uncertain NA NA "HPA026702: AB_1859459" "unprognostic (1.10e-1)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" 0.2 0.2 0.6 0.7 1.3 0.1 0.4 0.2 2.0 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.2 0.4 2.5 0.2 0.2 3.3 0.2 0.5 0.5 1.3 0.1 0.4 0.6 1.6 0.6 0.1 1.3 1.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.0 0.0 31.4 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.2 2.0 0.2 0.4 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 ZNF805 ENSG00000204524 "Zinc finger protein 805" Q5CZA5 19 57240685-57255135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046330, HPA058895" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: , HPA058895: AB_2683846" "unprognostic (2.18e-1)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.22e-1)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.20e-1)" "unprognostic (1.95e-1)" "unprognostic (1.58e-2)" "unprognostic (3.51e-1)" "unprognostic (3.68e-2)" "unprognostic (7.16e-3)" "unprognostic (1.64e-1)" 8.4 8.8 3.6 5.5 7.2 18.5 9.6 4.8 9.4 6.6 6.1 8.3 5.8 3.9 9.1 6.4 6.6 6.0 5.9 6.3 3.4 3.5 5.4 6.2 6.8 5.1 6.4 5.2 10.2 7.2 9.8 9.0 7.5 5.8 6.2 5.7 6.8 7.9 5.8 9.0 7.7 6.3 7.2 5.2 7.2 6.1 8.6 5.9 9.2 6.7 2.4 7.4 7.1 11.6 3.9 2.1 5.3 1.8 5.6 4.9 2.4 2.4 3.7 3.6 4.8 6.6 4.9 4.5 2.3 5.4 4.0 7.9 3.1 2.2 4.6 1.8 5.6 2.5 1.5 4.0 3.9 7.1 2.4 10.0 4.7 3.0 3.0 5.9 4.2 4.7 6.1 4.9 5.2 9.0 3.6 3.7 5.0 1.7 6.2 2.8 1.7 5.1 1.5 3.0 2.1 4.2 2.5 7.7 4.0 2.6 7.8 3.8 3.8 6.2 3.5 3.6 5.1 2.4 4.2 4.1 5.7 3.9 2.6 2.7 6.2 4.3 4.5 3.6 2.3 3.1 0.0 1.8 5.3 3.8 0.5 4.9 3.9 3.3 4.8 2.1 1.7 3.3 3.1 2.0 5.6 0.9 1.5 3.6 2.4 3.6 7.2 4.8 9.4 3.4 3.5 6.4 5.2 5.8 5.9 3.0 0.3 0.0 1.8 1.4 5.4 1.6 0.0 1.4 0.0 1.8 7.9 0.9 1.7 1.2 1.8 2.1 0.4 0.0 1.0 1.4 1.0 1.9 4.6 0.0 0.8 3.2 1.2 1.3 0.6 0.0 1.1 0.7 0.0 0.0 1.2 1.9 1.2 0.0 0.7 0.5 5.4 0.0 2.7 4.7 2.8 1.0 1.9 0.7 0.6 2.3 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467735-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 17.7" HPA056406 Uncertain Approved Vesicles NA NA Vesicles "HPA056406: AB_2683119" "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 5.9 3.7 4.0 5.0 4.3 2.5 4.8 3.2 3.6 5.8 4.3 2.5 1.7 3.8 4.1 8.7 4.0 4.1 3.0 2.4 2.5 2.3 5.0 2.5 4.7 4.1 4.6 1.6 4.8 4.1 5.2 3.5 12.7 4.7 10.7 3.7 2.0 4.8 3.3 1.6 4.0 6.3 4.5 6.3 6.5 4.0 4.2 5.2 10.2 5.8 2.8 4.3 6.4 9.5 4.8 2.5 2.4 5.5 6.8 6.8 2.6 0.8 0.8 2.6 4.4 2.2 2.7 6.1 2.3 2.4 1.6 2.3 4.5 2.6 6.6 2.3 2.2 3.0 1.4 6.2 2.7 3.1 0.0 9.8 6.7 1.8 5.1 1.2 0.0 7.2 2.3 2.2 1.8 1.4 0.9 1.4 4.9 3.6 0.1 2.6 1.2 8.7 3.7 3.3 0.8 2.3 5.3 5.7 3.2 1.6 17.7 1.1 2.5 0.0 4.5 1.6 5.9 1.8 3.3 2.4 0.9 3.3 0.1 2.2 3.6 5.3 7.5 0.0 0.0 4.6 2.4 2.2 1.7 3.7 3.2 3.7 3.4 3.5 4.1 2.5 4.8 6.8 5.2 1.1 6.8 5.5 2.4 2.6 2.6 4.0 4.3 3.2 3.6 2.5 2.3 4.6 1.6 4.7 5.2 6.0 2.6 1.4 3.1 1.5 0.6 1.6 2.5 1.4 3.4 0.0 0.0 4.4 1.7 1.8 1.1 3.6 1.1 0.0 1.0 5.9 2.7 5.1 0.0 0.8 2.4 3.2 0.0 16.0 3.1 0.0 2.3 1.5 3.3 2.8 4.1 1.1 1.3 3.5 2.1 0.7 0.4 0.0 1.9 0.6 5.1 1.4 7.4 1.3 3.7 2.2 ZNF816 ZNF816A ENSG00000180257 "Zinc finger protein 816" Q0VGE8 19 52949379-52962911 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 33.6" HPA042466 Uncertain Approved "Nucleoli rim" NA NA "Nucleoli rim" "HPA042466: AB_10797497" "unprognostic (1.83e-2)" "unprognostic (1.90e-1)" "unprognostic (1.64e-1)" "unprognostic (4.81e-2)" "unprognostic (3.12e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-4)" "unprognostic (1.69e-1)" "unprognostic (1.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (3.72e-2)" "unprognostic (5.36e-3)" "unprognostic (6.21e-2)" "unprognostic (5.45e-1)" "unprognostic (8.59e-2)" "unprognostic (1.39e-2)" 6.2 6.4 4.9 8.0 8.3 2.8 8.0 14.7 6.6 10.2 8.9 4.5 12.5 4.7 6.7 10.1 8.4 12.1 9.8 5.8 5.0 3.3 9.6 3.2 7.0 7.1 10.4 3.4 9.5 8.7 6.7 11.8 9.2 6.1 15.5 10.4 4.5 8.6 9.8 2.4 5.3 7.3 8.0 9.1 11.0 9.4 5.4 8.9 18.9 10.2 5.8 8.5 14.3 9.4 11.6 8.4 14.4 7.7 17.6 17.5 7.4 4.1 0.1 3.8 9.7 7.1 7.8 11.1 3.5 3.5 4.5 6.6 3.3 2.8 11.2 7.3 3.0 6.9 2.5 5.4 4.0 4.3 5.5 11.4 5.2 4.3 5.0 2.4 0.0 8.1 3.7 5.1 2.6 5.2 5.3 3.8 5.2 8.2 0.4 5.6 3.2 8.9 5.9 4.5 2.3 5.1 5.0 8.2 5.5 7.1 33.6 2.9 5.3 0.4 5.9 2.3 7.8 3.9 6.0 3.6 3.3 3.3 2.2 3.9 3.9 11.1 10.4 0.4 5.6 3.9 10.0 7.3 14.4 13.6 6.2 17.5 9.9 12.7 13.1 8.4 11.6 17.2 13.8 4.1 17.6 7.7 8.3 11.5 7.4 4.9 8.3 14.7 6.6 5.0 3.3 10.4 3.4 6.1 8.9 3.0 1.0 0.0 2.8 0.8 1.1 1.7 0.0 1.4 5.7 1.8 5.9 3.9 6.6 3.3 2.1 2.1 1.3 0.0 1.4 3.0 1.3 1.6 7.0 0.0 2.1 0.0 0.0 0.6 1.0 1.6 1.4 1.8 5.0 3.6 2.6 1.0 1.6 2.9 1.1 0.7 0.9 0.0 1.3 1.4 4.3 1.4 3.0 2.5 3.0 4.2 ZNF823 HSZFP36 ENSG00000197933 "Zinc finger protein 823" P16415 19 11721265-11739009 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 15.9;Syncytiotrophoblasts: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.76e-5)" "unprognostic (2.50e-1)" "unprognostic (1.65e-1)" "unprognostic (8.69e-2)" "unprognostic (1.02e-2)" "unprognostic (5.50e-1)" "unprognostic (2.36e-2)" "prognostic favorable (4.49e-4)" "prognostic favorable (5.05e-4)" "unprognostic (7.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.47e-3)" 7.9 3.9 3.6 7.1 7.2 2.6 11.5 14.9 3.3 10.2 10.3 3.1 10.9 5.4 6.3 5.7 14.1 6.2 8.6 3.4 3.8 2.6 14.9 10.0 5.5 6.4 3.3 2.9 7.4 7.9 12.7 2.1 13.1 5.1 8.6 9.1 2.5 9.3 16.2 4.3 7.5 13.0 6.0 2.9 4.7 6.1 2.5 6.5 7.9 5.6 8.2 5.9 9.5 7.9 2.7 3.8 11.7 2.1 5.8 7.5 2.2 5.5 3.0 4.7 5.6 3.1 1.0 9.1 6.2 5.1 8.3 7.9 9.2 1.9 6.4 6.8 4.8 2.6 4.9 5.1 3.9 8.6 0.0 2.8 5.2 2.0 8.7 1.2 2.1 7.4 1.8 3.9 5.2 3.8 3.2 4.1 5.1 3.4 0.1 7.9 3.7 6.6 1.9 2.9 4.6 6.3 2.8 7.9 1.8 8.5 15.0 2.6 3.9 5.8 6.5 2.2 9.0 4.8 5.3 4.3 7.8 2.8 11.8 4.3 3.9 10.9 3.4 1.9 0.0 1.3 2.1 1.7 11.7 3.2 2.1 5.2 2.7 4.2 3.5 2.2 1.8 7.5 5.2 0.9 5.8 1.1 3.8 1.4 2.2 3.6 7.2 14.9 3.3 3.8 2.6 3.3 2.9 5.1 6.5 3.0 1.7 0.0 2.9 4.6 1.1 3.3 5.1 1.4 3.4 1.8 0.0 15.9 8.3 5.2 0.2 2.2 5.6 0.0 4.1 13.1 2.3 2.7 1.1 2.5 3.8 0.0 0.0 6.2 1.9 0.4 2.6 2.7 3.3 2.8 6.7 1.4 3.7 9.1 2.1 2.2 1.5 0.0 5.2 0.5 4.3 3.4 18.0 2.2 6.4 4.8 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.1" "Cell type enriched" "Detected in many" 8 "Early spermatids: 241.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 15.0" HPA073073 Approved "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA073073: AB_2686567" "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 2.6 2.8 4.9 2.4 5.9 1.9 4.3 8.0 4.8 2.9 2.6 2.3 5.0 1.7 3.6 2.0 2.2 3.1 1.8 2.4 3.3 2.5 2.6 1.8 2.2 2.8 6.4 2.9 5.3 2.1 3.8 3.4 3.6 3.3 3.6 1.6 1.6 2.6 3.0 1.9 3.5 2.1 4.8 4.4 2.8 2.3 20.1 5.1 3.4 5.2 1.0 2.9 3.1 4.7 3.3 1.4 4.2 0.8 2.1 4.9 1.0 0.0 1.2 3.3 0.1 1.8 2.8 1.4 3.7 2.2 4.6 7.1 0.1 0.6 0.1 4.4 2.3 4.3 0.7 0.0 2.7 5.4 0.0 5.3 1.9 0.1 0.1 1.8 0.0 5.2 2.8 2.6 5.1 0.0 1.5 0.5 1.4 0.0 0.1 5.0 0.8 0.7 0.8 5.5 0.0 0.0 0.0 4.5 1.7 1.3 5.5 3.8 5.6 0.1 0.0 3.1 4.9 3.5 0.3 1.4 3.0 3.9 3.8 4.0 9.8 15.0 6.3 0.0 0.1 6.9 4.2 0.6 2.9 3.2 0.7 4.2 2.2 3.2 4.9 1.0 3.3 4.1 4.2 1.3 2.1 0.8 1.4 3.2 1.0 4.9 5.9 8.0 4.8 3.3 2.5 6.4 2.9 3.3 5.1 0.0 4.3 1.3 1.8 1.3 5.8 4.6 5.1 1.4 5.7 3.5 3.9 3.2 0.0 2.3 241.5 3.9 0.0 0.0 0.9 2.1 2.8 1.6 1.1 0.0 1.4 11.1 0.0 1.3 0.3 29.7 5.5 2.5 3.3 1.8 0.9 2.4 0.8 0.0 6.7 1.1 11.3 0.0 2.3 9.5 10.0 2.4 3.5 2.9 0.4 0.7 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA025970 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavorable (9.20e-4)" "prognostic favorable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favorable (6.92e-6)" 13.1 19.0 14.5 16.2 66.8 14.6 22.3 42.6 20.2 21.6 16.4 11.7 41.4 8.4 23.3 54.0 11.4 27.2 16.0 11.1 17.2 11.5 26.0 4.0 12.9 18.5 25.7 12.5 34.5 11.8 22.3 29.4 44.2 21.9 25.5 14.0 11.0 11.8 32.6 5.8 16.2 12.3 21.0 20.4 19.0 14.7 9.8 24.4 16.9 24.3 8.1 15.9 15.9 34.3 9.9 4.3 8.5 4.9 12.8 9.3 3.7 8.7 0.4 12.5 9.0 11.3 22.9 7.0 13.6 9.4 8.2 11.2 3.4 7.6 9.1 7.1 9.2 6.1 3.9 7.5 9.0 11.5 1.3 8.7 7.7 7.8 4.3 9.3 5.4 10.8 18.4 11.4 6.9 34.4 29.1 9.2 10.3 8.4 7.5 13.5 5.9 7.6 9.4 3.5 1.5 8.6 7.7 10.7 6.1 21.0 17.6 7.3 5.9 8.7 8.6 3.4 21.1 9.1 5.7 12.5 8.3 5.1 4.2 13.9 0.8 8.0 12.6 0.4 5.8 6.6 4.4 3.6 8.5 7.6 3.9 7.8 6.9 8.9 9.3 4.3 9.9 7.6 8.7 3.3 12.8 4.9 2.9 4.3 3.7 14.5 66.8 42.6 20.2 17.2 11.5 25.7 12.5 21.9 24.4 32.8 21.2 4.2 45.7 9.2 27.1 12.9 7.6 28.1 33.0 38.4 33.4 40.1 16.6 16.3 20.0 24.8 7.0 0.0 6.1 16.9 23.5 72.4 34.8 1.3 11.8 46.1 10.4 16.0 4.9 11.1 39.4 15.8 28.7 9.0 14.0 14.3 8.5 17.5 32.5 17.0 38.2 6.5 16.6 13.0 14.7 8.4 53.5 19.2 6.5 63.1 ZNF831 "C20orf174, dJ492J12.1" ENSG00000124203 "Zinc finger protein 831" Q5JPB2 20 59123381-59259113 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.8;pituitary gland: 6.6" "Cell type enriched" "Detected in some" 5 "T-cells: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 4.1;MAIT T-cell: 3.3;memory CD4 T-cell: 2.3;memory CD8 T-cell: 3.3;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.4;NK-cell: 2.3;T-reg: 4.2" "Group enriched" "Detected in many" 6 "NK-cells: 2.3;T-cells: 4.2" "Group enriched" "Detected in some" 6 "Daudi: 9.3;HMC-1: 2.6" "Group enriched" "Detected in many" 4 "amygdala: 5.3;basal ganglia: 4.3;cerebral cortex: 5.1;hippocampal formation: 6.0;olfactory region: 4.7" "Group enriched" "Detected in many" 26 "amygdala: 6.5;basal ganglia: 5.1;cerebral cortex: 4.5;hippocampal formation: 7.1;olfactory region: 11.1" HPA016839 Uncertain NA NA "HPA016839: AB_1859466" "unprognostic (2.90e-3)" "unprognostic (7.70e-6)" "unprognostic (9.71e-4)" "unprognostic (1.31e-3)" "unprognostic (7.00e-2)" "unprognostic (3.00e-5)" "unprognostic (3.08e-3)" "unprognostic (2.23e-2)" "unprognostic (2.89e-3)" "unprognostic (2.21e-3)" "unprognostic (2.80e-3)" "unprognostic (4.31e-1)" "unprognostic (3.40e-3)" "unprognostic (2.39e-1)" "unprognostic (3.42e-2)" "unprognostic (2.21e-1)" "unprognostic (1.93e-2)" 0.6 0.1 1.7 9.1 3.6 1.3 0.4 0.2 1.2 0.2 0.4 0.2 0.2 0.3 0.2 0.4 0.8 0.4 0.8 0.2 1.5 0.6 0.3 0.3 1.3 10.0 0.2 0.2 0.2 0.3 0.0 6.6 0.2 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.1 4.2 0.2 0.2 9.3 0.9 0.4 0.2 0.4 0.7 0.9 13.8 3.1 0.2 0.4 0.0 0.5 0.0 2.3 4.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 4.1 0.0 3.3 0.4 2.3 3.3 0.0 0.4 1.9 2.4 0.2 2.3 0.0 0.0 4.2 0.8 1.7 3.6 0.2 1.2 1.5 0.6 0.2 0.2 0.2 0.2 0.0 1.1 2.7 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 13.8 0.0 0.0 ZNF835 BC37295_3 ENSG00000127903 "Zinc finger protein 835" Q9Y2P0 19 56661981-56671783 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.2;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 4.4;EFO-21: 3.7;HEL: 3.0;NTERA-2: 8.5;SH-SY5Y: 4.5;U-266/84: 6.9" "Low region specificity" "Detected in all" HPA051136 Uncertain Approved Microtubules NA NA Microtubules "HPA051136: AB_2681357" "unprognostic (3.15e-1)" "unprognostic (4.80e-2)" "unprognostic (4.89e-1)" "unprognostic (5.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-2)" "unprognostic (3.25e-2)" "unprognostic (3.39e-3)" "unprognostic (1.58e-5)" "unprognostic (6.65e-2)" "unprognostic (5.35e-4)" "unprognostic (2.33e-1)" "unprognostic (2.72e-4)" "unprognostic (5.31e-2)" "unprognostic (1.32e-1)" "unprognostic (9.29e-2)" "unprognostic (6.21e-2)" 4.8 5.0 6.8 3.8 7.1 2.2 3.0 12.2 10.5 4.7 5.4 7.8 5.0 1.6 6.4 3.2 3.5 6.6 2.4 6.8 6.6 5.4 3.6 1.3 3.1 3.8 5.7 7.2 14.0 3.4 7.9 4.7 2.6 4.8 4.8 1.2 3.6 6.1 5.3 6.3 1.7 2.2 5.1 5.4 5.5 2.4 1.8 7.8 1.1 5.5 1.6 3.5 4.6 3.5 5.2 3.3 4.7 1.0 3.8 5.1 1.4 0.1 0.1 1.0 0.1 0.0 0.0 4.4 0.3 0.0 0.3 0.0 0.1 0.3 0.1 3.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.3 3.0 0.3 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.4 8.5 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.1 4.5 0.1 0.2 0.0 1.5 0.3 0.1 0.0 0.2 1.2 0.3 0.1 0.4 6.9 0.5 0.1 0.1 0.1 4.7 1.0 0.9 0.8 0.7 1.8 3.8 3.0 2.0 1.2 5.2 5.1 3.4 2.3 3.8 0.7 3.3 1.6 1.4 6.8 7.1 12.2 10.5 6.6 5.4 5.7 7.2 4.8 7.8 3.0 0.0 0.5 0.1 0.0 4.2 2.0 0.0 0.0 1.2 0.0 7.9 0.9 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.4 0.4 0.2 0.0 0.0 0.3 15.9 0.0 0.6 0.3 0.0 2.0 0.1 0.0 1.0 0.0 2.9 0.1 0.0 3.2 0.5 2.6 0.0 0.3 0.0 0.8 0.1 0.2 0.0 0.0 0.0 ZNF836 FLJ16287 ENSG00000196267 "Zinc finger protein 836" Q6ZNA1 19 52153864-52171643 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.12e-3)" "prognostic favorable (5.11e-4)" "unprognostic (9.68e-2)" "unprognostic (2.83e-1)" "unprognostic (3.10e-1)" "unprognostic (1.42e-2)" "unprognostic (3.01e-3)" "unprognostic (8.52e-2)" "unprognostic (2.23e-2)" "unprognostic (5.22e-2)" "unprognostic (2.49e-2)" "unprognostic (1.37e-1)" "prognostic favorable (3.77e-4)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 8.5 33.4 9.7 5.7 10.7 5.7 8.8 20.7 11.1 9.9 8.9 4.1 6.4 7.1 8.2 8.7 7.9 7.3 6.6 6.3 8.3 5.8 7.9 3.8 8.5 11.4 7.4 7.6 13.5 5.0 19.3 17.3 5.5 7.3 8.9 6.6 6.1 7.3 8.9 4.5 9.1 6.8 6.9 12.5 9.7 7.3 3.8 8.8 14.1 8.2 4.4 8.6 10.2 9.9 7.1 3.9 9.4 2.9 8.3 7.6 2.6 6.0 0.9 3.7 8.6 4.5 7.8 3.0 2.9 7.2 2.8 10.2 2.2 2.8 0.7 1.9 4.4 3.8 4.9 4.9 5.7 3.5 4.9 11.7 2.3 8.2 4.4 3.2 0.0 5.2 7.1 5.3 3.2 4.4 10.8 5.8 2.5 0.4 0.7 6.9 1.8 10.7 3.3 1.3 1.8 5.0 5.4 2.4 4.3 2.9 15.3 5.8 4.2 5.7 4.4 3.5 6.1 4.3 1.8 5.3 3.0 3.5 1.7 2.3 8.0 12.4 7.1 4.4 0.3 4.3 9.4 2.9 3.2 6.6 1.6 6.4 5.4 6.7 7.6 2.6 7.1 5.6 5.4 3.7 8.3 1.0 3.9 5.9 2.6 9.7 10.7 20.7 11.1 8.3 5.8 7.4 7.6 7.3 8.8 11.9 2.9 8.8 12.8 4.9 4.9 1.6 0.0 10.7 9.1 8.7 2.0 2.5 6.6 4.4 0.6 5.6 2.3 0.0 4.6 3.9 3.1 10.2 10.4 2.6 4.1 3.2 6.4 7.4 5.6 0.0 3.7 6.7 5.0 1.0 2.7 7.7 4.3 2.9 2.5 3.8 5.2 19.4 2.7 1.4 1.4 5.0 1.1 7.9 3.7 23.8 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favorable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favorable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 8.9 9.9 10.9 10.6 14.1 11.3 15.7 11.6 16.9 11.1 10.2 14.4 9.0 8.1 15.3 11.2 8.4 19.7 7.8 8.4 11.1 10.1 9.7 13.0 6.8 11.0 8.8 13.4 12.9 15.6 14.3 13.2 9.0 8.9 10.1 9.5 13.0 11.9 13.4 18.6 21.6 10.3 10.6 8.3 15.2 8.7 39.7 7.8 11.3 12.9 8.8 11.8 7.8 9.5 1.9 2.1 3.5 1.9 0.3 2.6 0.4 8.7 8.0 10.4 18.7 4.8 8.3 17.8 6.8 5.6 8.6 7.1 3.0 7.5 9.0 5.6 4.6 3.5 8.6 6.7 17.2 6.6 12.0 12.8 6.3 7.2 5.0 4.3 5.8 5.5 6.6 13.0 16.6 15.5 13.1 11.4 12.8 13.3 11.9 12.0 16.2 8.9 9.4 13.9 4.8 8.0 19.3 6.3 5.7 7.6 7.2 5.6 17.7 5.7 7.2 6.0 10.3 16.3 9.7 4.4 5.5 5.0 7.6 6.0 11.7 8.4 10.3 4.3 7.0 9.1 0.0 0.7 2.3 2.4 1.9 2.6 1.9 1.6 1.5 1.3 1.4 2.6 2.2 3.5 0.3 0.4 2.1 2.1 0.4 10.9 14.1 11.6 16.9 11.1 10.1 8.8 13.4 8.9 7.8 0.0 7.7 0.0 2.3 2.7 6.8 2.0 5.1 6.7 4.5 10.4 7.9 4.6 10.0 3.1 12.3 1.8 3.9 23.3 2.5 2.5 2.1 2.0 3.5 4.7 2.6 3.2 1.2 5.5 2.2 1.4 4.6 2.1 3.3 1.0 5.8 6.0 2.1 0.0 3.9 5.5 9.0 0.0 0.9 12.5 12.7 2.3 4.7 2.5 5.2 1.4 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615617-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 28.9" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 13.0;Muller glia cells: 10.9;Rod photoreceptor cells: 9.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SH-SY5Y: 22.1;U-2 OS: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli NA NA Nucleoli "HPA067690: AB_2685888" "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 3.7 3.9 16.6 2.9 14.4 1.0 4.6 4.5 13.5 7.8 7.7 10.4 2.8 1.8 9.4 5.9 5.6 11.8 5.8 12.3 16.1 15.5 3.3 0.9 4.5 4.3 14.8 9.1 15.6 10.6 7.3 4.5 3.7 11.9 7.6 2.5 6.0 6.7 11.5 28.9 2.4 2.7 8.5 10.1 4.3 3.6 3.0 9.9 2.6 9.9 2.7 2.7 6.5 11.7 0.3 0.4 3.1 0.0 1.1 1.5 0.3 0.0 1.2 3.5 14.8 0.1 0.0 0.1 0.3 0.0 1.6 0.3 2.6 0.6 0.0 5.8 0.0 0.5 0.0 5.3 0.1 1.5 0.0 1.9 0.4 0.0 2.7 2.1 0.0 0.1 0.5 0.5 0.2 0.0 1.5 0.0 1.2 2.2 0.0 0.9 0.1 0.3 1.9 5.5 0.0 0.0 1.6 5.8 0.1 1.1 5.5 4.7 22.1 0.0 0.2 0.9 3.0 0.8 3.1 0.0 1.1 14.8 0.0 1.3 0.3 0.1 0.0 0.0 0.0 5.7 0.0 0.0 3.1 1.2 0.0 1.5 0.3 0.8 1.4 0.0 0.3 0.2 1.4 0.0 1.1 0.0 0.4 0.0 0.3 16.6 14.4 4.5 12.4 16.1 15.5 14.8 9.1 11.9 9.9 0.0 0.0 0.0 1.5 0.5 13.0 8.5 0.0 4.0 1.2 7.0 5.9 0.0 0.0 0.5 1.5 1.5 0.0 0.0 0.6 0.0 2.3 1.1 0.0 0.0 0.1 4.8 1.7 1.8 0.0 1.7 4.9 0.0 3.3 0.0 0.0 10.9 0.4 0.0 8.1 0.2 9.1 12.9 1.4 0.5 0.7 0.3 0.2 0.8 0.0 0.7 ZNF862 ENSG00000106479 "Zinc finger protein 862" O60290 7 149838367-149867479 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 11.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024154 Uncertain Approved Mitochondria NA NA Mitochondria "HPA024154: AB_1859469" "unprognostic (1.82e-2)" "unprognostic (2.33e-1)" "unprognostic (3.32e-3)" "unprognostic (1.97e-1)" "unprognostic (8.87e-2)" "unprognostic (4.87e-3)" "unprognostic (4.72e-3)" "unprognostic (2.74e-2)" "unprognostic (6.76e-2)" "unprognostic (2.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.73e-2)" "unprognostic (5.88e-2)" "unprognostic (4.29e-2)" "unprognostic (8.90e-2)" "unprognostic (1.30e-2)" "prognostic favorable (8.66e-4)" 7.1 9.7 12.7 11.2 15.5 7.5 11.8 22.6 13.6 11.1 10.0 16.7 18.8 6.6 12.1 18.1 9.0 13.7 12.2 8.0 13.1 8.7 11.3 9.4 9.6 12.8 17.1 12.1 15.1 14.7 22.6 17.7 5.8 12.2 11.5 10.7 12.3 16.9 14.5 8.6 24.1 10.8 10.0 12.6 13.2 9.4 7.4 19.8 18.7 18.2 6.7 13.2 9.9 9.1 3.1 3.0 1.6 4.3 1.6 6.9 2.0 2.9 3.2 7.2 11.3 8.3 9.1 0.2 6.1 6.0 2.1 3.3 0.3 7.8 1.4 8.0 6.9 2.8 2.0 2.0 2.9 1.5 4.4 3.1 1.3 2.2 0.0 7.3 2.1 1.3 10.0 10.8 2.0 3.2 9.0 4.9 8.3 1.5 5.6 3.4 7.5 2.5 5.5 2.4 5.6 3.2 4.5 0.9 8.0 5.8 1.8 2.8 9.6 5.3 3.9 5.3 3.6 3.0 2.6 8.7 5.2 0.2 11.7 2.2 8.7 4.7 1.3 8.8 5.7 5.9 0.0 2.4 1.6 6.9 4.3 1.9 3.1 2.6 3.6 3.0 1.3 3.1 2.7 0.2 1.6 1.3 3.0 1.8 2.0 12.7 15.5 22.6 13.6 13.1 8.7 17.1 12.1 12.2 19.8 0.0 1.0 0.0 0.6 0.7 5.1 3.2 2.5 2.7 3.4 7.0 11.8 0.9 1.7 1.5 1.1 1.7 1.0 0.0 1.2 0.2 1.0 1.5 4.6 2.1 0.9 9.5 1.7 1.3 1.2 1.0 1.4 2.1 0.0 1.0 2.6 2.8 1.2 2.3 2.1 0.7 5.8 0.0 1.0 0.9 2.3 1.1 2.2 2.6 1.3 0.8 ZNF879 DKFZp686E2433 ENSG00000234284 "Zinc finger protein 879" B4DU55 5 179023752-179035064 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 11.8;Spermatocytes: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;BEWO: 12.4" "Low region specificity" "Detected in all" HPA068608 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068608: AB_2686010" "unprognostic (3.20e-2)" "unprognostic (5.24e-3)" "unprognostic (7.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (5.83e-2)" "unprognostic (8.80e-3)" "unprognostic (3.19e-3)" "unprognostic (6.04e-2)" "unprognostic (5.69e-4)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (2.10e-1)" "unprognostic (3.79e-1)" "unprognostic (4.72e-2)" "unprognostic (5.17e-3)" 5.9 4.0 5.5 5.3 7.2 1.9 6.6 13.5 8.0 6.1 5.8 6.3 4.9 2.9 7.3 5.5 5.0 6.2 4.0 6.3 7.4 4.7 5.9 3.6 4.7 7.2 7.0 5.7 10.2 4.9 8.4 7.6 6.7 6.1 7.7 3.0 4.4 5.2 8.1 7.9 8.2 5.2 5.6 6.9 7.1 4.6 14.5 10.7 12.1 9.1 2.5 7.9 6.2 5.0 5.4 4.4 13.1 4.9 6.0 9.1 3.7 0.0 4.1 3.7 11.4 3.6 2.8 12.4 2.0 3.0 5.0 6.2 3.8 2.1 3.0 2.9 1.9 5.7 1.7 0.0 2.3 4.0 0.0 0.3 0.0 2.6 0.7 5.9 0.0 5.8 2.7 2.2 2.8 1.4 2.3 1.7 3.0 0.6 0.0 4.0 2.0 3.4 1.2 4.2 1.5 1.0 3.1 1.3 0.4 3.7 3.3 1.6 3.8 3.9 0.6 5.3 5.9 5.6 3.4 1.6 2.3 4.3 2.6 0.5 0.0 0.0 4.7 0.0 0.0 3.0 13.1 4.9 4.7 6.3 4.1 6.5 5.2 5.8 5.3 4.4 5.4 9.1 7.1 0.1 6.0 3.9 2.8 6.7 3.7 5.5 7.2 13.5 8.0 7.4 4.7 7.0 5.7 6.1 10.7 6.0 0.6 0.0 1.3 0.5 8.0 1.6 2.5 1.4 0.0 5.2 11.8 2.9 5.0 1.5 2.2 2.2 0.8 0.0 0.7 1.5 1.3 1.4 2.3 0.9 1.9 9.5 1.2 1.8 2.6 2.0 1.4 1.5 0.0 0.0 0.1 4.5 0.8 0.0 2.1 1.1 5.3 6.5 1.2 11.3 8.5 1.0 3.5 1.3 0.6 1.0 ZNF880 ENSG00000221923 "Zinc finger protein 880" Q6PDB4 19 52369917-52385795 "Predicted intracellular proteins, Transcription factors" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 21.2;SuSa: 20.9" HPA077316 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "HPA077316: AB_2686833" "unprognostic (2.66e-3)" "unprognostic (2.19e-2)" "unprognostic (2.55e-1)" "unprognostic (3.99e-2)" "unprognostic (7.72e-2)" "unprognostic (1.54e-2)" "unprognostic (7.61e-2)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (2.52e-1)" "prognostic favorable (4.33e-8)" "unprognostic (4.14e-2)" "unprognostic (4.99e-1)" "unprognostic (1.77e-1)" "unprognostic (5.60e-3)" 14.7 12.7 12.4 12.2 21.8 17.3 16.3 22.9 14.6 16.5 13.0 13.6 10.8 6.9 16.0 20.3 13.3 14.7 12.5 20.1 13.9 10.5 13.0 4.4 13.3 15.9 12.2 7.4 22.7 9.4 4.0 18.2 12.4 14.3 20.8 10.8 18.1 12.9 16.8 11.3 12.6 11.6 16.8 13.4 16.1 11.6 11.2 13.3 24.5 22.2 12.1 16.5 27.9 11.4 25.4 20.3 27.7 7.2 12.1 20.4 8.7 0.1 0.8 10.7 8.3 5.8 16.5 11.6 7.0 7.6 4.9 9.8 0.2 4.7 0.1 2.5 12.2 10.3 1.6 0.0 6.4 8.3 0.1 12.6 0.3 0.5 0.0 6.9 0.2 8.8 12.3 8.1 9.2 0.0 0.6 7.8 0.9 0.8 0.3 9.4 0.6 1.1 0.7 14.4 0.0 1.7 0.7 21.2 0.7 13.8 11.0 7.9 10.0 0.0 2.0 3.0 20.9 0.4 2.1 6.2 0.3 0.2 2.1 6.4 0.4 3.9 0.3 0.2 0.2 13.6 27.7 6.6 15.1 13.3 6.2 17.3 23.2 16.9 14.6 10.2 25.4 20.4 17.8 2.7 12.1 7.2 20.3 17.2 8.7 12.4 21.8 22.9 14.6 13.9 10.5 12.2 7.4 14.3 13.3 11.9 3.8 10.7 13.7 5.3 16.5 11.7 7.6 10.7 18.2 19.2 11.8 8.8 24.9 14.7 10.6 10.8 2.1 0.0 12.9 12.5 7.8 21.9 9.3 1.0 5.9 22.3 0.0 9.8 5.9 3.1 12.7 11.0 8.5 16.2 5.1 11.3 17.7 7.0 6.0 6.3 15.7 19.4 13.0 3.3 7.9 6.1 12.0 12.5 3.1 22.2 ZNF883 ENSG00000285447 "Zinc finger protein 883" P0CG24 9 112997120-113050043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 32.4;Cone photoreceptor cells: 15.7;Distal tubular cells: 18.3;Horizontal cells: 15.9;Rod photoreceptor cells: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;BJ: 1.2;BJ hTERT+ SV40 Large T+: 1.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;fHDF/TERT166: 3.6;RPTEC TERT1: 3.2;U-2 OS: 1.8" NA NA 0.7 0.2 0.0 0.6 0.0 0.6 1.3 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.9 0.9 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 1.2 3.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 1.8 0.7 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 32.4 10.5 0.0 0.0 0.0 3.5 15.7 0.0 18.3 5.8 1.7 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 15.9 1.2 4.3 0.8 2.1 0.3 0.2 0.0 0.0 0.1 13.5 0.2 0.0 4.6 2.3 39.3 0.0 1.0 3.0 9.7 0.5 0.0 0.0 0.6 0.9 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133106817-133130473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 52.6;Horizontal cells: 38.1;Rod photoreceptor cells: 34.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 3.6 5.3 7.0 4.0 9.3 4.2 5.4 13.2 7.2 4.6 4.4 3.6 2.6 3.4 5.5 4.6 2.9 4.0 2.9 3.5 7.9 3.3 3.4 2.9 2.9 4.3 7.8 2.7 6.4 3.8 4.9 8.8 3.0 6.6 3.8 3.5 2.3 4.5 4.0 4.3 6.9 3.3 4.5 7.0 4.5 4.0 14.0 8.9 4.2 5.6 2.9 3.8 4.3 4.5 2.9 1.6 2.3 1.2 2.4 2.7 0.7 1.5 1.7 4.6 0.3 1.9 2.2 3.0 0.8 0.9 1.2 1.0 1.3 0.7 0.3 1.3 1.0 2.0 2.1 2.4 1.2 1.3 0.1 2.3 3.8 5.0 1.7 0.9 3.4 2.7 1.6 1.2 1.9 1.6 2.3 1.0 4.1 2.3 0.8 1.6 1.0 3.8 4.1 2.9 1.2 1.9 3.5 2.6 1.5 1.0 2.7 4.6 2.9 3.0 1.1 1.0 2.9 3.1 1.4 1.8 2.4 2.4 2.1 1.3 0.5 0.2 3.1 0.6 1.3 1.8 2.0 1.2 1.4 1.8 0.7 1.6 1.9 1.7 1.7 0.6 2.9 2.7 2.3 2.3 2.4 0.8 1.6 1.1 0.7 7.0 9.3 13.2 7.2 7.9 3.3 7.8 2.7 6.6 8.9 3.0 4.0 2.7 5.5 1.5 30.2 4.4 2.5 16.0 10.3 10.4 27.5 3.1 0.0 3.5 52.6 3.9 1.4 0.0 1.7 1.9 3.1 2.9 1.1 1.9 1.6 38.1 6.4 4.3 1.0 4.2 4.9 3.2 1.7 0.0 2.4 10.9 1.6 2.5 5.6 1.3 34.9 19.4 5.2 14.0 14.6 1.5 1.9 5.0 3.1 2.3 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.3;seminal vesicle: 36.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 192.8;Suprabasal keratinocytes: 245.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.4;NTERA-2: 16.0;SuSa: 11.7;U-2197: 6.7" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 1.5 1.0 1.1 3.6 2.5 1.6 1.8 6.9 1.1 3.0 1.7 1.2 20.3 0.5 3.3 2.7 2.1 2.8 1.0 1.4 0.8 0.6 1.7 0.7 2.4 3.0 2.1 0.3 4.7 3.4 12.7 1.4 3.8 1.7 4.1 2.1 3.2 1.2 36.4 1.2 2.8 2.3 3.3 1.6 2.3 2.7 1.6 2.2 4.1 10.3 0.7 2.9 4.9 2.9 0.5 0.4 1.8 0.2 0.3 0.9 0.2 0.0 0.0 3.8 9.4 0.0 0.0 0.0 1.0 0.4 3.6 4.3 3.2 2.2 1.4 1.7 0.6 2.5 0.9 0.0 0.5 6.3 0.0 0.9 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 3.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.9 5.4 16.0 0.0 0.0 0.0 3.4 0.2 2.0 3.3 0.0 3.4 0.0 1.1 0.1 11.7 1.9 0.0 0.0 0.9 0.0 6.7 3.6 0.0 1.5 0.0 0.0 0.0 1.4 0.8 0.2 0.3 0.1 0.0 0.9 0.2 0.2 0.4 0.4 0.5 0.3 0.1 1.8 0.3 0.0 0.2 0.7 0.2 1.1 2.5 6.9 1.1 0.8 0.6 2.1 0.3 1.7 2.2 6.0 5.9 72.1 60.7 192.8 0.6 1.7 56.0 0.0 7.9 7.0 2.0 81.3 14.9 2.0 5.9 31.2 3.3 70.0 1.8 83.3 43.9 74.9 1.1 52.0 41.8 0.0 8.2 48.5 105.1 17.6 56.4 28.6 118.1 1.0 14.4 1.4 1.0 10.5 32.5 4.6 2.1 19.4 51.2 8.2 14.3 245.0 68.2 76.2 20.2 56.5 ZNF91 "HPF7, HTF10" ENSG00000167232 "Zinc finger protein 91" Q05481 19 23304991-23395560 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 322.5;Late spermatids: 383.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (4.94e-2)" "unprognostic (1.18e-2)" "unprognostic (3.32e-3)" "unprognostic (5.62e-2)" "unprognostic (1.99e-3)" "unprognostic (5.85e-2)" "unprognostic (9.85e-4)" "unprognostic (6.74e-3)" "unprognostic (3.02e-2)" "unprognostic (4.47e-2)" "prognostic favorable (7.58e-4)" "unprognostic (7.38e-3)" "unprognostic (1.09e-1)" "unprognostic (2.21e-2)" "prognostic favorable (3.48e-4)" 9.5 11.0 16.2 13.4 20.1 5.5 15.6 47.0 21.1 14.2 17.0 8.6 11.9 19.9 12.8 13.6 11.9 11.4 7.4 10.0 15.7 8.5 13.0 11.4 9.8 12.3 16.6 11.8 16.4 9.5 17.6 32.7 23.2 16.9 13.3 17.9 8.4 13.7 13.9 15.6 12.1 21.6 9.4 18.3 11.1 11.8 6.5 18.7 10.2 17.8 6.0 11.2 13.8 11.9 9.1 6.3 5.1 3.4 5.3 12.6 3.4 4.1 0.7 13.3 6.4 3.9 6.2 7.4 3.0 5.0 7.8 9.8 3.3 4.2 0.2 6.3 3.8 2.9 5.2 10.5 3.2 9.8 0.4 10.1 1.8 3.2 2.5 3.1 0.1 3.3 5.2 6.3 6.2 7.4 7.2 2.7 8.5 6.3 0.9 5.8 2.4 12.0 4.7 9.2 0.1 3.7 9.2 8.6 6.9 4.7 10.4 8.2 6.4 0.2 0.3 3.4 9.5 3.9 7.7 3.7 2.4 1.4 3.6 5.6 0.4 3.4 12.4 0.1 0.3 1.3 4.5 2.2 2.7 7.4 1.8 6.6 6.8 8.8 7.7 2.6 9.1 12.6 9.6 5.1 5.3 3.4 6.3 4.9 3.4 16.2 20.1 47.0 21.1 15.7 8.5 16.6 11.8 16.9 18.7 38.7 37.9 9.0 24.9 9.3 127.1 114.0 25.5 30.8 29.6 36.6 78.5 15.3 31.5 12.2 322.5 25.5 56.8 0.0 11.6 14.2 12.2 30.1 21.9 13.0 9.7 130.3 35.3 25.8 12.4 383.2 29.7 17.2 10.1 5.4 48.5 60.5 14.8 35.1 24.4 17.6 103.9 25.8 9.9 19.4 21.1 10.8 68.0 20.8 39.1 28.4 ZNF92 "HPF12, TF12" ENSG00000146757 "Zinc finger protein 92" Q03936 7 65373799-65401135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "unprognostic (8.53e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (5.48e-3)" "unprognostic (1.30e-2)" "unprognostic (3.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.40e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-3)" 6.7 9.3 9.6 13.7 13.0 20.8 16.3 24.4 11.9 8.3 6.2 5.0 6.1 6.1 5.7 7.2 11.2 5.4 6.3 4.6 9.6 8.9 7.9 5.6 5.7 14.8 12.1 8.6 8.8 6.9 7.7 13.4 5.7 12.6 6.6 7.0 2.5 6.9 6.6 4.7 4.9 10.1 3.9 18.5 14.8 7.6 7.6 15.7 26.0 9.4 5.1 14.0 8.3 5.7 10.7 2.3 5.6 2.7 9.4 6.0 2.2 4.5 3.1 13.7 13.5 3.5 4.2 6.5 3.8 2.8 4.2 6.1 5.7 6.8 17.7 7.4 2.1 6.3 4.5 10.6 2.6 6.9 6.6 7.1 7.9 1.7 5.6 1.2 9.5 7.6 3.6 2.3 3.8 2.9 5.7 5.1 9.4 10.3 7.3 6.0 1.3 14.0 10.8 18.5 4.8 4.2 12.8 8.0 6.0 4.6 9.2 11.7 8.9 5.8 9.1 4.3 13.9 6.5 13.0 3.7 4.9 4.4 2.9 5.4 4.6 4.1 25.7 3.2 7.7 4.3 5.6 1.6 4.0 2.7 2.1 5.7 10.7 4.2 4.1 2.3 9.2 5.1 5.2 1.3 9.4 2.7 2.2 6.0 2.2 9.6 13.0 24.4 11.9 9.6 8.9 12.1 8.6 12.6 15.7 8.9 0.6 34.0 6.2 4.9 7.6 3.4 5.1 1.4 7.9 5.2 0.0 5.3 10.0 6.3 1.0 5.8 2.6 0.0 4.2 4.4 5.1 6.3 11.5 2.1 3.7 4.8 6.9 6.2 5.4 1.7 6.6 6.8 5.0 9.0 7.2 7.7 6.3 7.0 6.0 3.5 4.8 0.0 5.7 19.6 24.5 3.3 4.1 7.9 4.7 7.0 ZNF93 "FLJ12488, HPF34, TF34, ZNF505" ENSG00000184635 "Zinc finger protein 93" P35789 19 19900913-19963464 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 22.4" NA NA "unprognostic (1.49e-1)" "unprognostic (2.28e-2)" "unprognostic (9.05e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-2)" "unprognostic (8.25e-2)" "unprognostic (4.88e-3)" "unprognostic (1.66e-1)" "unprognostic (6.80e-5)" "prognostic favorable (9.31e-6)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (3.18e-6)" "unprognostic (7.35e-2)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (6.06e-2)" 7.9 3.2 3.4 7.2 5.5 4.4 6.7 10.9 3.9 7.4 4.3 1.5 8.0 1.7 8.5 9.5 4.6 4.6 5.3 3.1 3.0 3.7 6.7 2.8 4.9 14.0 4.3 0.7 11.9 7.0 3.8 8.0 5.1 3.7 6.3 4.5 2.3 5.4 9.7 2.8 6.4 4.4 9.3 5.4 9.5 4.2 6.8 4.0 17.4 17.0 5.4 8.0 10.1 3.9 7.5 4.0 11.0 4.9 6.2 6.3 2.4 0.0 0.0 12.7 13.8 1.1 0.9 11.4 4.7 2.1 11.1 13.2 2.9 2.3 3.9 4.3 2.2 9.3 0.4 0.0 0.2 12.5 0.1 0.5 0.1 0.3 0.2 0.8 0.1 0.2 1.7 0.8 10.4 0.8 2.0 0.2 0.1 2.0 0.4 10.3 1.1 15.2 6.7 22.4 0.0 3.3 13.9 11.3 4.3 2.4 7.4 7.6 4.6 0.2 1.0 2.1 16.1 3.9 8.4 0.2 10.9 0.5 10.3 6.9 1.6 7.4 8.1 0.1 1.8 3.5 5.4 4.2 11.0 1.9 4.7 2.5 6.4 3.8 3.2 4.0 7.5 5.2 2.8 9.2 6.2 4.9 3.6 6.3 2.4 3.4 5.5 10.9 3.9 3.0 3.7 4.3 0.7 3.7 4.0 3.0 1.3 7.3 4.9 0.9 1.5 3.1 5.1 5.3 3.4 1.8 2.0 4.2 6.6 5.0 2.1 2.4 0.5 0.0 5.5 13.1 2.5 2.3 6.9 0.0 7.1 3.2 0.0 0.6 3.2 1.1 1.1 5.6 1.7 8.2 1.7 2.1 4.7 0.0 2.8 1.3 2.8 0.0 2.3 8.4 7.9 2.4 4.2 0.8 2.0 3.2 ZNF98 "F7175, ZNF739" ENSG00000197360 "Zinc finger protein 98" A6NK75 19 22391019-22532485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 36.9" "Group enriched" "Detected in some" 5 "Distal tubular cells: 13.3;Early spermatids: 10.7;Spermatocytes: 8.8;Spermatogonia: 23.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 1.0;naive B-cell: 1.5;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 5 "B-cells: 1.5;dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "BEWO: 3.0;GAMG: 8.8;NB-4: 7.4;RPMI-8226: 3.1;SuSa: 3.5;T-47d: 5.5;U-2197: 5.8" NA NA "unprognostic (1.11e-1)" "unprognostic (1.31e-2)" "unprognostic (6.95e-3)" "unprognostic (1.36e-3)" "unprognostic (3.07e-3)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.63e-1)" "unprognostic (1.81e-1)" "unprognostic (3.81e-2)" "unprognostic (1.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.56e-2)" 1.3 1.0 3.2 0.6 9.2 0.6 4.2 0.9 13.2 3.9 0.8 2.1 2.1 0.5 1.8 6.3 0.6 2.7 0.8 1.5 4.2 1.6 3.7 0.5 0.6 0.7 2.6 7.2 12.6 36.9 4.5 1.1 0.9 3.8 1.3 0.5 0.4 1.1 1.2 0.5 0.6 0.6 1.7 1.4 0.6 0.7 10.2 3.1 0.0 5.1 0.0 0.4 1.2 0.8 1.5 1.9 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.0 0.2 0.0 0.4 0.2 0.0 0.0 0.0 1.3 0.0 8.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.3 0.2 7.4 1.6 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 5.5 1.8 0.0 0.0 0.6 5.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.0 1.0 0.3 0.0 0.0 1.5 0.3 0.2 0.0 0.2 0.1 1.9 0.1 0.0 3.2 9.2 0.9 13.2 4.2 1.6 2.6 7.2 3.8 3.1 0.0 0.0 0.0 0.4 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.9 13.3 2.0 10.7 0.0 0.0 0.0 1.2 0.3 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.9 1.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 1.8 0.6 0.0 0.0 0.3 8.8 23.7 0.0 0.3 0.0 0.0 0.1 ZNF99 "C19orf9, MGC24986" ENSG00000213973 "Zinc finger protein 99" A8MXY4 19 22752183-22784107 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 5.5;testis: 11.2" "Group enriched" "Detected in some" 6 "Sertoli cells: 19.4;Spermatocytes: 11.2" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.7;NTERA-2: 3.5;SuSa: 2.5" NA NA "unprognostic (8.31e-2)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-2)" "unprognostic (2.28e-1)" "unprognostic (9.83e-2)" "unprognostic (4.22e-2)" "unprognostic (2.65e-1)" "unprognostic (1.92e-3)" "unprognostic (2.61e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (3.49e-1)" "unprognostic (4.05e-3)" "unprognostic (8.55e-2)" 0.7 0.5 1.6 0.4 2.9 1.0 1.1 1.1 2.8 0.8 0.5 0.3 0.0 0.4 1.5 1.3 0.5 0.7 0.4 0.8 1.6 0.6 5.5 0.5 0.5 1.5 0.6 1.4 0.8 0.5 0.3 0.5 0.5 2.4 0.5 0.3 0.3 0.5 0.4 0.7 0.9 0.5 0.7 0.6 0.7 0.5 11.2 0.7 0.4 0.8 0.0 0.3 0.6 0.7 1.1 1.2 2.9 0.6 0.8 0.8 0.2 0.1 0.4 0.2 0.3 0.1 0.0 2.7 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.2 0.1 0.4 3.5 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.4 0.6 0.0 0.3 0.1 2.5 0.8 0.1 0.3 0.2 0.1 1.2 0.2 0.3 0.3 0.2 0.1 0.2 0.0 1.7 0.5 0.5 0.5 0.5 0.4 0.7 0.5 0.3 0.2 1.1 0.8 0.7 2.9 0.8 0.6 1.2 0.4 0.2 1.6 2.9 1.1 2.8 1.6 0.6 0.6 1.4 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.7 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.4 0.0 11.2 2.5 0.0 0.2 0.0 0.0 0.1 ZNFX1 "FLJ11277, KIAA1404" ENSG00000124201 "Zinc finger NFX1-type containing 1" Q9P2E3 20 49237946-49278426 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046629 Approved Approved Mitochondria No No Mitochondria "HPA046629: AB_2616451" "unprognostic (1.03e-1)" "unprognostic (2.80e-1)" "unprognostic (1.15e-1)" "unprognostic (3.21e-2)" "unprognostic (1.21e-1)" "unprognostic (3.58e-1)" "unprognostic (2.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (1.49e-1)" "unprognostic (3.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.50e-1)" "unprognostic (2.79e-1)" "unprognostic (8.71e-3)" "unprognostic (7.40e-2)" "unprognostic (7.86e-2)" 27.2 14.9 13.2 21.5 15.1 32.8 19.3 14.4 19.7 16.6 16.0 20.1 12.1 14.5 21.3 17.4 13.1 17.2 19.2 16.5 12.3 12.0 16.5 13.4 28.2 20.5 13.4 13.8 18.3 12.2 23.8 14.6 17.4 17.1 15.5 14.4 21.1 14.4 13.7 23.0 17.6 20.6 18.3 14.4 25.9 16.2 23.9 14.6 18.6 21.4 14.4 22.7 16.8 15.0 5.7 5.1 30.0 14.0 5.6 8.3 5.4 5.8 9.1 2.2 3.1 12.1 9.5 3.7 8.0 18.9 50.3 21.0 10.4 4.9 4.9 10.3 15.9 14.3 11.4 4.1 10.8 17.5 4.6 1.3 5.8 6.6 4.5 10.5 4.6 7.1 10.0 10.2 11.2 8.4 9.2 7.6 2.9 4.4 6.1 12.5 2.4 5.0 3.1 2.1 5.1 7.7 3.2 7.5 1.3 8.3 8.1 2.2 1.6 11.8 23.0 8.2 2.8 5.9 3.9 18.8 24.7 7.0 8.9 7.7 4.0 1.4 2.7 9.9 3.2 5.4 8.8 6.7 10.8 8.3 8.8 7.3 5.7 8.3 7.8 5.1 4.6 8.0 6.1 30.0 5.6 14.0 3.0 6.0 5.4 13.2 15.1 14.4 19.7 12.3 12.0 13.4 13.8 17.1 14.6 38.7 29.3 17.4 18.7 24.6 14.7 11.4 12.7 29.4 22.7 19.2 9.8 5.5 0.0 20.8 27.6 39.1 15.6 0.0 19.7 6.0 27.4 21.6 26.5 11.5 14.0 11.1 12.6 26.4 25.9 16.0 21.0 25.7 18.6 27.9 11.0 37.0 25.1 17.5 25.5 6.3 12.7 0.0 28.4 41.6 5.7 19.1 9.5 15.2 9.7 31.2 ZNRD1 "HTEX-6, hZR14, RPA12, tctex-6" ENSG00000066379 "Zinc ribbon domain containing 1" Q9P1U0 6 30058899-30064909 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055074, HPA077979" Supported Supported "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA055074: AB_2682690, HPA077979: AB_2732366" "unprognostic (4.94e-2)" "unprognostic (2.93e-2)" "unprognostic (2.54e-1)" "unprognostic (3.81e-1)" "unprognostic (3.88e-2)" "unprognostic (8.55e-2)" "unprognostic (5.36e-2)" "unprognostic (2.82e-3)" "unprognostic (1.96e-1)" "unprognostic (9.52e-3)" "unprognostic (5.18e-1)" "unprognostic (3.28e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (2.57e-1)" "unprognostic (1.51e-1)" "unprognostic (9.97e-2)" "prognostic favorable (2.75e-5)" 11.7 13.5 6.7 14.1 7.2 8.7 17.1 7.4 8.9 12.3 15.3 6.8 9.1 13.2 12.5 10.2 15.4 13.0 10.4 11.0 6.4 6.3 13.4 12.2 14.8 18.8 8.3 6.1 13.6 22.0 10.2 9.4 11.4 6.2 12.5 14.5 9.7 14.7 10.2 13.5 11.2 14.2 9.1 6.3 17.5 12.7 22.9 6.8 37.0 15.0 15.3 18.9 12.2 15.0 8.2 8.4 6.4 5.9 8.1 13.0 7.9 4.1 0.9 4.6 6.5 2.2 2.7 1.7 1.6 2.4 2.9 2.6 4.6 2.9 3.3 1.4 2.6 4.9 3.5 7.6 6.2 3.1 2.3 7.7 7.8 2.1 6.8 9.3 8.2 3.6 5.4 3.6 4.6 15.8 1.7 8.0 16.8 13.1 2.1 1.9 5.5 7.1 17.8 0.0 9.2 5.4 8.7 4.3 6.4 2.5 6.9 1.6 3.1 2.8 4.4 2.6 2.2 3.3 6.8 1.7 3.4 3.0 0.0 5.1 5.2 9.8 10.6 1.2 13.3 4.5 6.2 5.9 5.7 12.5 5.6 13.0 7.3 10.8 11.5 5.6 8.2 9.8 10.2 6.4 8.1 5.2 8.4 10.9 7.9 6.7 7.2 7.4 8.9 6.4 6.3 8.3 6.1 6.2 6.8 20.8 16.8 48.4 63.0 69.8 13.3 13.3 20.4 16.0 22.7 21.0 2.0 21.3 43.1 28.3 106.8 37.6 47.7 0.0 39.7 37.2 41.2 27.6 31.1 25.8 31.4 11.1 42.2 28.8 38.9 11.9 36.8 27.6 28.7 33.3 41.2 14.0 40.2 59.6 23.0 47.3 13.3 19.4 39.1 52.1 5.9 60.3 14.8 62.3 48.4 68.8 ZPBP "SP38, ZPBP1" ENSG00000042813 "Zona pellucida binding protein" Q9BS86 7 49850421-50121329 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 90.4" "Group enriched" "Detected in some" 16 "Early spermatids: 705.4;Spermatocytes: 420.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.7;U-698: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058673 Enhanced "Secreted in male reproductive system" NA NA "HPA058673: AB_2683794" "unprognostic (1.16e-1)" "unprognostic (6.46e-2)" "unprognostic (7.80e-2)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.15e-7)" "unprognostic (9.49e-2)" "unprognostic (2.34e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 705.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 10.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 7.4 0.3 19.4 6.5 0.0 420.4 8.1 0.3 0.0 0.0 0.0 0.1 ZPBP2 "MGC41930, ZPBPL" ENSG00000186075 "Zona pellucida binding protein 2" Q6X784 17 39868164-39877896 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 85.7" "Group enriched" "Detected in some" 4 "Early spermatids: 159.4;Spermatocytes: 377.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 2.6;T-cells: 1.0" "Cell line enhanced" "Detected in some" "Daudi: 2.9;U-698: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027997, HPA053070" Enhanced "Secreted in male reproductive system" NA NA "HPA027997: AB_1859488, HPA053070: AB_2682033" "unprognostic (2.14e-2)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (2.87e-1)" "unprognostic (5.39e-1)" "unprognostic (2.54e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 85.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 0.1 0.1 0.2 0.0 1.0 0.2 0.1 0.1 1.0 0.4 0.3 0.6 0.1 0.3 0.2 0.2 0.5 0.4 0.2 2.9 0.2 0.4 0.2 0.1 0.6 0.2 0.5 0.6 1.3 0.4 0.4 0.0 0.3 0.4 0.2 0.2 0.7 0.1 0.2 0.4 0.3 0.3 0.3 0.9 0.0 0.1 0.1 0.6 1.0 0.7 0.7 0.4 0.9 2.2 0.3 0.3 1.0 0.3 0.1 0.6 0.3 1.3 0.3 0.0 0.4 0.3 0.3 0.6 0.1 1.0 0.2 10.4 0.3 0.4 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.8 0.4 1.0 0.0 2.6 1.0 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 377.5 8.5 0.0 0.0 0.0 0.0 0.0 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.4" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 1.3 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.4 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 ZSCAN18 "FLJ12895, ZNF447" ENSG00000121413 "Zinc finger and SCAN domain containing 18" Q8TBC5 19 58083838-58118427 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 49.8;SCLC-21H: 23.8" HPA024318 Supported Approved Nucleoplasm No No Nucleoplasm "HPA024318: AB_1859494" "unprognostic (1.85e-2)" "unprognostic (3.48e-2)" "unprognostic (7.07e-2)" "unprognostic (6.45e-3)" "unprognostic (1.28e-1)" "unprognostic (1.22e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (2.24e-1)" "unprognostic (8.27e-2)" "unprognostic (2.59e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.95e-7)" "unprognostic (3.68e-2)" "unprognostic (7.23e-2)" "unprognostic (3.70e-1)" "unprognostic (9.04e-2)" 18.1 18.1 26.7 10.4 34.3 5.3 11.8 27.9 47.7 20.5 17.1 20.8 16.0 8.7 26.2 20.3 13.4 33.9 18.6 28.9 27.0 33.7 19.3 7.3 15.0 12.2 23.7 31.1 31.8 16.8 23.7 28.0 15.1 21.1 21.1 6.0 17.7 18.2 27.5 15.9 9.9 10.0 29.0 20.7 17.0 12.9 20.0 18.3 7.4 28.9 8.7 6.1 15.9 14.6 4.6 2.3 3.9 0.8 2.2 2.4 0.7 0.0 0.4 5.2 13.4 0.6 0.8 12.9 3.3 0.1 4.3 0.7 0.0 3.1 1.2 7.6 4.6 5.2 0.0 0.4 2.5 4.6 0.0 49.8 0.1 0.0 0.0 9.2 0.0 10.1 7.9 0.1 3.3 0.0 5.4 0.2 3.1 0.0 0.6 6.5 0.0 6.9 2.5 8.5 0.0 0.0 8.2 0.0 0.6 4.2 10.2 23.8 5.7 0.0 0.2 0.0 4.8 15.6 0.0 0.0 0.2 6.2 5.8 0.0 5.9 17.1 0.0 0.0 0.0 4.0 2.0 0.5 3.5 0.4 0.3 2.1 1.7 1.7 1.8 0.9 4.6 2.4 2.2 3.9 2.2 0.8 2.3 0.1 0.7 26.7 34.3 27.9 31.4 27.0 33.7 23.7 31.1 21.1 18.3 14.9 24.0 31.8 44.4 10.8 77.2 38.7 20.4 28.1 37.5 40.1 31.4 38.9 13.3 19.4 41.6 32.5 3.6 0.0 5.1 7.1 18.3 35.8 23.1 3.8 8.0 106.5 25.4 20.3 1.3 55.0 37.2 6.5 10.1 9.0 12.0 72.0 6.3 11.5 55.2 9.1 103.9 19.4 25.8 25.1 26.9 10.7 54.9 14.6 9.9 29.4 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.9" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 9.8 7.6 5.2 7.2 7.4 9.7 15.0 5.9 6.3 7.3 6.2 5.8 9.0 4.1 9.5 8.4 3.4 5.3 8.2 8.2 4.8 4.7 9.1 10.1 4.5 8.0 6.2 5.0 10.2 36.9 6.9 6.3 2.8 5.1 7.1 4.3 6.7 12.4 5.1 9.5 3.4 5.5 9.0 5.1 8.1 8.5 12.0 6.0 24.4 6.3 3.9 6.9 6.5 9.7 7.1 10.5 10.0 12.2 9.0 12.1 6.4 1.6 9.5 7.5 12.3 4.4 3.0 6.5 1.8 5.2 3.9 5.3 7.3 3.9 3.5 5.3 2.9 7.2 4.1 6.3 3.6 3.5 7.2 9.7 4.5 5.5 15.4 3.8 2.8 3.6 4.4 4.3 5.1 4.9 5.4 11.8 18.7 5.9 2.8 4.8 4.7 13.0 6.7 13.7 3.3 5.7 13.6 4.2 6.6 4.2 12.1 10.5 18.5 5.7 3.2 8.8 11.7 6.6 8.0 7.7 4.9 9.4 2.3 2.3 4.9 6.4 11.8 3.2 6.6 3.0 10.0 9.6 8.3 10.9 10.5 5.4 7.1 9.2 8.2 10.5 7.1 7.6 8.2 5.4 9.0 12.2 10.2 12.1 6.4 5.2 7.4 5.9 6.3 4.8 4.7 6.2 5.0 5.1 6.0 0.0 1.3 2.2 1.1 0.8 3.5 2.2 7.6 2.7 0.0 7.0 2.0 1.4 5.0 5.4 11.3 1.9 1.1 0.0 7.3 3.9 2.2 2.8 1.1 7.8 3.1 0.0 2.9 0.6 3.2 9.5 0.9 3.1 1.7 7.2 2.9 2.4 10.1 3.5 1.4 14.3 2.9 6.5 1.4 3.4 8.1 0.4 1.1 3.2 2.4 1.3 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041147: AB_2677329, HPA046751: AB_2679785" "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 11.3 13.8 7.3 7.6 11.4 10.2 7.8 17.2 15.7 7.3 8.5 10.4 5.6 8.8 10.1 7.8 9.3 9.3 10.1 9.8 7.5 7.7 12.8 11.3 6.9 9.5 6.9 8.5 12.6 14.1 10.0 11.4 12.2 6.3 10.3 7.7 14.1 10.4 8.1 27.3 12.3 10.6 9.1 8.1 12.2 8.7 9.0 9.5 16.1 11.5 9.8 13.3 9.6 7.0 5.4 4.4 6.9 3.7 1.2 5.3 1.4 6.4 8.1 6.1 7.4 11.1 6.5 6.2 4.4 5.8 10.2 9.4 18.5 7.6 7.7 13.4 6.4 10.7 15.6 9.9 12.6 7.6 2.9 5.9 10.1 10.1 12.6 6.8 8.1 10.4 9.3 10.6 8.4 8.1 7.4 7.9 6.9 8.9 6.2 5.8 19.6 9.1 6.7 3.3 7.3 9.1 7.0 8.9 5.4 6.5 9.6 8.1 5.2 15.4 22.7 5.2 5.7 13.5 6.1 6.4 11.1 7.0 5.9 6.5 6.2 4.4 7.9 8.8 6.4 5.6 3.8 2.9 6.9 1.0 3.7 0.7 5.4 3.7 1.6 1.6 5.1 5.3 4.7 3.1 1.2 3.5 4.4 3.0 1.4 7.3 11.4 17.2 15.7 7.5 7.7 6.9 8.5 6.3 9.5 3.0 2.4 0.5 1.7 1.0 2.4 4.8 0.0 0.0 1.2 0.0 0.0 2.5 3.3 1.8 0.2 1.3 2.6 0.0 3.3 2.3 1.4 1.9 3.5 1.7 1.5 6.4 2.4 2.5 1.6 0.4 3.1 1.2 0.0 1.0 2.6 1.4 2.8 3.2 1.4 1.2 3.2 0.0 1.7 0.6 1.7 1.4 1.9 1.7 2.3 1.6 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857617-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 4.1;Rod photoreceptor cells: 4.2;Spermatogonia: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: AB_2682887, HPA060508: AB_2684297" "prognostic unfavorable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 5.1 9.6 8.3 5.6 8.2 2.2 5.7 15.2 9.6 6.1 6.7 6.3 5.2 7.4 6.7 8.9 5.9 6.8 5.4 6.0 7.3 7.2 5.6 7.0 5.9 9.3 6.2 7.4 9.0 5.0 6.9 9.5 5.3 6.7 6.1 7.3 9.4 5.4 5.4 3.9 6.7 7.4 5.5 6.0 10.5 5.8 9.5 6.3 13.7 5.9 2.9 11.2 6.1 4.7 4.3 3.8 3.2 8.5 3.3 6.3 2.1 2.1 1.8 5.4 3.1 6.6 4.7 3.2 3.3 4.1 6.2 6.2 7.5 3.4 6.7 11.7 2.8 3.1 3.6 7.7 3.6 4.7 4.1 3.2 6.5 3.4 4.8 8.0 3.6 8.9 4.3 4.1 4.7 3.0 6.6 5.3 5.9 5.9 3.2 4.7 10.7 5.0 7.3 2.1 4.9 7.3 5.0 5.0 4.9 1.7 1.3 7.1 3.5 5.4 6.3 4.2 4.2 3.0 9.6 5.2 6.3 2.0 2.3 2.0 7.1 3.7 4.3 5.3 4.4 2.0 2.1 2.3 3.2 3.0 3.2 6.3 4.3 3.3 4.2 3.8 3.6 3.2 4.3 1.7 3.3 8.5 2.3 4.9 2.1 8.3 8.2 15.2 9.6 7.3 7.2 6.2 7.4 6.7 6.3 3.0 1.4 0.5 0.2 0.3 4.1 0.8 0.0 0.0 0.0 1.8 0.0 1.2 0.0 1.2 0.4 0.7 1.5 0.0 1.2 0.5 1.5 0.2 0.0 0.8 0.8 0.0 2.4 0.6 0.8 0.0 0.3 0.9 0.0 0.0 1.1 2.2 0.7 0.0 1.1 1.0 4.2 0.0 1.0 2.1 3.9 0.3 0.7 2.9 1.0 0.3 ZSWIM4 FLJ12221 ENSG00000132003 "Zinc finger SWIM-type containing 4" Q9H7M6 19 13795460-13832230 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 19.6;Pancreatic endocrine cells: 20.6;Urothelial cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042084 Uncertain NA NA "HPA042084: AB_10795392" "unprognostic (3.29e-2)" "unprognostic (4.07e-1)" "unprognostic (4.15e-2)" "unprognostic (1.41e-3)" "unprognostic (4.78e-2)" "unprognostic (1.34e-3)" "unprognostic (4.25e-3)" "unprognostic (6.14e-2)" "unprognostic (5.36e-2)" "unprognostic (1.56e-2)" "unprognostic (1.78e-1)" "unprognostic (6.15e-2)" "prognostic unfavorable (7.85e-5)" "unprognostic (3.47e-1)" "unprognostic (4.95e-1)" "unprognostic (1.86e-1)" "unprognostic (8.63e-2)" 6.2 7.5 4.7 9.4 5.0 4.6 6.3 4.1 8.9 6.2 3.5 4.8 6.7 5.2 7.6 3.5 19.7 4.0 7.1 5.3 5.2 4.0 6.7 3.1 8.2 5.4 6.1 2.5 5.0 9.3 4.1 8.6 9.3 6.5 6.5 1.9 9.2 18.5 7.7 3.8 9.9 3.8 4.5 5.7 6.2 7.3 2.3 4.9 11.3 7.6 4.9 14.2 5.7 8.8 1.2 0.5 2.8 0.4 0.8 1.5 0.2 7.3 4.3 8.6 4.3 1.1 0.9 8.2 3.2 6.9 2.8 3.1 1.6 4.1 2.7 5.1 2.7 4.6 3.1 1.4 2.9 2.0 9.4 2.7 0.4 4.8 0.9 7.0 0.7 2.1 4.6 0.8 3.2 1.3 7.1 6.9 6.4 2.3 5.8 0.9 4.1 4.2 5.8 9.8 1.5 4.3 9.2 8.0 4.3 3.9 3.5 2.4 16.4 5.5 13.6 5.7 5.2 2.1 5.0 7.9 8.6 3.2 2.5 10.9 7.1 4.2 1.7 5.5 3.1 6.0 0.0 0.3 0.3 0.4 0.4 1.5 0.3 0.4 0.4 0.4 1.2 0.5 0.2 2.8 0.8 0.1 0.5 0.0 0.2 4.7 5.0 4.1 8.9 5.2 4.0 6.1 2.5 6.5 4.9 3.0 1.3 0.8 13.4 4.7 5.2 2.7 5.1 2.7 0.0 3.5 7.9 3.6 0.0 12.2 0.1 5.2 2.7 0.0 19.6 2.8 5.2 12.1 0.0 1.5 4.2 6.4 10.3 4.3 4.8 0.2 1.1 5.7 3.3 4.6 2.9 3.2 20.6 2.8 1.1 1.2 3.1 0.0 4.7 0.2 0.4 6.0 5.0 6.9 3.5 21.2 ZSWIM5 KIAA1511 ENSG00000162415 "Zinc finger SWIM-type containing 5" Q9P217 1 45016399-45306209 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 7.6;Cone photoreceptor cells: 9.8;Horizontal cells: 7.9;Intestinal endocrine cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 7.0;Hep G2: 7.9;SCLC-21H: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018211 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA018211: AB_1859502" "unprognostic (1.86e-1)" "unprognostic (2.58e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-3)" "unprognostic (3.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (2.65e-2)" "unprognostic (1.57e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-3)" "unprognostic (2.55e-1)" "unprognostic (4.12e-3)" "unprognostic (7.12e-2)" "unprognostic (3.09e-2)" "unprognostic (2.88e-2)" "unprognostic (1.16e-1)" 1.8 18.5 5.9 4.4 6.5 0.7 3.2 17.3 6.6 3.8 7.2 6.6 3.8 7.5 5.2 4.5 2.2 4.5 5.4 2.5 6.4 4.6 5.2 1.3 3.8 2.0 4.9 4.0 14.0 5.4 16.9 16.0 1.8 6.1 5.6 8.5 6.2 6.3 4.4 2.0 2.7 11.7 5.4 3.2 2.9 3.2 6.6 7.1 0.0 7.1 1.3 1.9 4.4 3.7 0.1 0.5 0.0 0.0 0.7 2.4 0.3 0.6 1.8 4.2 7.0 0.6 0.2 1.0 0.2 5.6 1.0 0.9 0.5 0.7 0.4 0.1 0.1 3.2 0.2 2.9 0.1 1.3 2.9 5.3 0.3 5.8 7.9 0.0 0.8 0.9 0.1 0.2 0.3 0.0 0.6 1.2 1.4 0.3 0.3 0.1 2.3 0.5 0.3 3.8 4.8 2.1 1.9 0.1 0.2 0.1 1.3 9.9 5.1 2.7 1.0 0.5 1.2 2.0 0.2 0.3 1.0 0.6 0.3 1.1 1.9 0.3 0.1 3.9 0.2 0.8 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.5 0.8 0.0 0.0 2.4 0.3 0.0 0.7 0.0 0.5 0.9 0.3 5.9 6.5 17.3 6.6 6.4 4.6 4.9 4.0 6.1 7.1 0.0 1.9 0.0 0.5 0.5 7.6 1.1 2.5 1.4 2.3 0.0 9.8 0.1 1.7 0.2 1.1 1.0 3.8 0.0 1.2 0.0 0.4 0.3 0.0 0.2 0.1 7.9 6.4 1.8 0.0 0.8 0.3 0.0 0.0 1.0 2.3 2.0 1.0 3.5 1.4 1.4 4.7 0.0 0.4 0.9 2.3 0.6 0.1 0.0 3.7 0.1 ZXDB ZNF905 ENSG00000198455 "Zinc finger, X-linked, duplicated B" P98169 X 57591652-57597545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 28.2;Suprabasal keratinocytes: 33.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 24.7" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.87e-1)" "unprognostic (3.22e-1)" "unprognostic (1.88e-1)" "unprognostic (8.61e-3)" "unprognostic (4.29e-2)" "unprognostic (2.80e-1)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (4.36e-1)" "unprognostic (9.04e-2)" "unprognostic (6.73e-2)" "unprognostic (2.16e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (4.02e-3)" "unprognostic (2.87e-3)" 2.6 2.1 2.4 1.9 3.0 5.1 3.4 6.3 3.4 3.5 2.5 1.6 4.0 2.0 2.1 4.1 2.8 2.3 2.4 3.2 2.4 11.2 2.3 2.9 2.3 4.5 4.3 5.3 1.9 1.4 3.6 2.5 2.8 3.1 3.6 3.9 2.9 4.2 2.4 2.9 3.2 0.5 3.8 2.9 4.1 2.3 1.3 1.3 0.0 0.6 0.5 2.4 0.3 3.7 4.4 2.9 3.9 5.0 4.9 4.0 2.7 3.3 2.2 2.3 1.8 2.7 3.2 4.0 4.8 3.6 4.2 8.3 14.2 4.3 8.0 4.5 1.8 5.8 5.0 6.4 3.0 2.0 4.3 24.7 5.6 15.3 4.8 6.6 3.6 2.0 3.5 5.9 2.6 2.6 2.5 11.6 1.5 5.6 3.4 10.6 1.8 3.0 6.0 2.4 4.6 5.4 3.9 4.1 6.8 4.0 3.4 5.7 4.8 9.5 4.1 2.7 0.0 1.4 4.4 3.4 2.6 2.2 0.0 0.3 0.0 1.5 0.5 1.3 1.3 1.1 2.4 0.4 1.2 2.1 1.1 0.0 0.5 0.6 1.3 0.9 0.3 6.0 1.6 5.2 9.6 28.2 3.9 5.3 10.2 2.7 3.4 1.8 0.0 1.9 3.3 2.4 0.0 3.6 2.3 0.0 3.0 1.2 5.0 10.9 0.0 11.4 1.0 6.4 0.0 3.7 2.7 0.0 4.6 1.5 6.8 1.8 6.1 1.2 3.1 0.0 5.3 2.8 2.9 0.0 3.8 0.0 0.0 33.2 2.4 2.2 3.7 12.4 ZYG11A ZYG11 ENSG00000203995 "Zyg-11 family member A, cell cycle regulator" Q6WRX3 1 52842511-52894998 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.2;thyroid gland: 8.1" "Cell type enhanced" "Detected in some" 18 "Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9" "Cancer enriched" "Detected in many" 7 "testis cancer: 11.1" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030378, HPA030379" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030378: AB_10604159, HPA030379: AB_2673451" "unprognostic (7.94e-2)" "unprognostic (6.71e-3)" "unprognostic (1.04e-2)" "unprognostic (4.06e-3)" "unprognostic (1.59e-2)" "unprognostic (1.00e-4)" "unprognostic (1.87e-1)" "unprognostic (2.34e-1)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "unprognostic (4.01e-2)" "unprognostic (1.01e-1)" "unprognostic (6.15e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" 0.3 0.1 0.2 3.0 0.2 0.4 1.4 0.7 0.1 0.6 0.2 0.1 0.8 0.4 0.1 3.0 1.7 0.1 0.4 0.9 0.1 0.3 6.4 3.1 0.1 1.0 0.1 0.0 0.6 0.3 0.6 0.5 1.0 2.2 1.7 0.2 1.0 0.5 0.0 0.3 0.6 0.3 0.5 1.3 0.3 0.1 21.2 0.0 0.9 8.1 1.3 5.6 0.5 1.1 1.0 0.8 3.1 0.6 0.9 0.7 0.2 0.0 1.9 0.3 0.0 0.0 0.0 4.4 1.2 1.3 5.7 4.6 0.1 0.1 0.0 3.0 1.7 0.0 0.1 3.8 0.1 6.8 0.3 7.3 0.0 10.6 0.0 2.8 0.0 0.9 0.0 0.3 10.3 0.1 0.3 1.3 0.1 9.9 5.5 0.2 5.3 0.0 5.3 1.4 0.0 1.0 0.0 1.3 4.7 3.6 0.2 1.5 2.2 10.3 0.5 0.0 4.6 5.8 2.9 0.1 0.0 0.1 0.0 0.0 2.8 4.5 0.1 0.0 0.1 0.8 1.8 0.6 0.8 0.5 0.3 0.3 0.7 0.5 0.5 0.1 1.0 0.6 0.7 3.1 0.9 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.1 0.1 0.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 1.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 1.3 0.0 0.0 3.4 6.9 0.1 0.2 0.0 0.0 0.3